id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
131546244|NCT00939484|473623022|FG000|Overall Study|Progression/Relapse|8|||
131546245|NCT00939484|473623023|FG001|Overall Study|Progression/Relapse|20|||
131546246|NCT00939484|473623024|FG002|Overall Study|Progression/Relapse|3|||
131546247|NCT01224925|473623025|FG000|Overall Study|Lost to Follow-up|3|||
131546248|NCT01224925|473623026|FG001|Overall Study|Lost to Follow-up|2|||
131546249|NCT00245102|473623028|FG000|Overall Study|Not Treated|1|||
131546250|NCT00245102|473623029|FG001|Overall Study|Not Treated|0|||
131546251|NCT00245102|473623030|FG002|Overall Study|Not Treated|1|||
131546252|NCT00245102|473623031|FG003|Overall Study|Not Treated|0|||
131546253|NCT00245102|473623032|FG004|Overall Study|Not Treated|0|||
131546254|NCT00245102|473623033|FG005|Overall Study|Not Treated|0|||
131546255|NCT00245102|473623028|FG000|Overall Study|Protocol Violation|1|||
131546256|NCT00245102|473623029|FG001|Overall Study|Protocol Violation|0|||
131546257|NCT00245102|473623030|FG002|Overall Study|Protocol Violation|0|||
131546258|NCT00245102|473623031|FG003|Overall Study|Protocol Violation|0|||
131546259|NCT00245102|473623032|FG004|Overall Study|Protocol Violation|0|||
131546260|NCT00245102|473623033|FG005|Overall Study|Protocol Violation|0|||
131546261|NCT00245102|473623028|FG000|Overall Study|Death|0|||
131546262|NCT00245102|473623029|FG001|Overall Study|Death|0|||
131546263|NCT00245102|473623030|FG002|Overall Study|Death|0|||
131546264|NCT00245102|473623031|FG003|Overall Study|Death|1|||
131546265|NCT00245102|473623032|FG004|Overall Study|Death|0|||
131546266|NCT00245102|473623033|FG005|Overall Study|Death|0|||
131546267|NCT00245102|473623028|FG000|Overall Study|Adverse Event|4|||
131546268|NCT00245102|473623029|FG001|Overall Study|Adverse Event|2|||
131546269|NCT00245102|473623030|FG002|Overall Study|Adverse Event|5|||
131546270|NCT00245102|473623031|FG003|Overall Study|Adverse Event|1|||
131546271|NCT00245102|473623032|FG004|Overall Study|Adverse Event|0|||
131546272|NCT00245102|473623033|FG005|Overall Study|Adverse Event|2|||
131546273|NCT00245102|473623028|FG000|Overall Study|Decline in performance|0|||
131546274|NCT00245102|473623029|FG001|Overall Study|Decline in performance|2|||
131546275|NCT00245102|473623030|FG002|Overall Study|Decline in performance|0|||
131546276|NCT00245102|473623031|FG003|Overall Study|Decline in performance|1|||
131546277|NCT00245102|473623032|FG004|Overall Study|Decline in performance|0|||
131546278|NCT00245102|473623033|FG005|Overall Study|Decline in performance|2|||
131546279|NCT00245102|473623028|FG000|Overall Study|Participant needed surgery|0|||
131546280|NCT00245102|473623029|FG001|Overall Study|Participant needed surgery|0|||
131546281|NCT00245102|473623030|FG002|Overall Study|Participant needed surgery|1|||
131546282|NCT00245102|473623031|FG003|Overall Study|Participant needed surgery|0|||
131546283|NCT00245102|473623032|FG004|Overall Study|Participant needed surgery|0|||
131546284|NCT00245102|473623033|FG005|Overall Study|Participant needed surgery|0|||
131546285|NCT00245102|473623028|FG000|Overall Study|Clinical progression|1|||
131546286|NCT00245102|473623029|FG001|Overall Study|Clinical progression|0|||
131546287|NCT00245102|473623030|FG002|Overall Study|Clinical progression|0|||
131546288|NCT00245102|473623031|FG003|Overall Study|Clinical progression|0|||
131546289|NCT00245102|473623032|FG004|Overall Study|Clinical progression|0|||
131546290|NCT00245102|473623033|FG005|Overall Study|Clinical progression|0|||
131546291|NCT01756352|473623036|FG000|Overall Study|moved away and lost to followup|1|||
131546292|NCT03315143|473623037|FG000|Overall Study|Death|240|||
131546293|NCT03315143|473623038|FG001|Overall Study|Death|246|||
131546294|NCT03315143|473623037|FG000|Overall Study|Withdrawal by Subject|57|||
131546295|NCT03315143|473623038|FG001|Overall Study|Withdrawal by Subject|68|||
131546296|NCT03315143|473623037|FG000|Overall Study|Site Terminated by Sponsor|256|||
131546297|NCT03315143|473623038|FG001|Overall Study|Site Terminated by Sponsor|282|||
131546298|NCT03315143|473623037|FG000|Overall Study|Study Terminated by Sponsor|4723|||
131546299|NCT03315143|473623038|FG001|Overall Study|Study Terminated by Sponsor|4664|||
131546300|NCT03315143|473623037|FG000|Overall Study|Reason not Specified|16|||
131546301|NCT03315143|473623038|FG001|Overall Study|Reason not Specified|32|||
131546302|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
131546303|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
131546304|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
131546305|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
131546306|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
131546307|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
131546308|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
131546309|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
131546310|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
131546311|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
131882600|NCT02417961|474852509|FG000|Overall Study|Adverse Event|1|||
131546312|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
131882601|NCT02417961|474852509|FG000|Overall Study|Lost to Follow-up|1|||
131546313|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
131546314|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
131546315|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
131546316|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
131546317|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
131546318|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
131546319|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
131546320|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
131546321|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
131546322|NCT00549757|473623039|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
131546323|NCT00549757|473623040|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
131546324|NCT00549757|473623039|FG000|Extension Period (in Average 9 Months)|Death|143|||
131546325|NCT00549757|473623040|FG001|Extension Period (in Average 9 Months)|Death|136|||
131546326|NCT00549757|473623039|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
131546327|NCT00549757|473623040|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
131546328|NCT00549757|473623039|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
131882602|NCT02417961|474852509|FG000|Overall Study|Withdrawal by Subject|2|||
131882603|NCT05079750|474852510|FG000|Overall Study|Lost to Follow-up|0|||
131882604|NCT05079750|474852511|FG001|Overall Study|Lost to Follow-up|0|||
131882605|NCT05079750|474852512|FG002|Overall Study|Lost to Follow-up|1|||
131882606|NCT03197467|474852515|FG000|Overall Study|Withdrawal by Subject|1|||
131882607|NCT03666533|474852517|FG000|Overall Study|Lost to Follow-up|2|||
131882608|NCT03666533|474852518|FG001|Overall Study|Lost to Follow-up|2|||
131882609|NCT02276053|474852523|FG000|Overall Study|Death|2|||
131882610|NCT02276053|474852523|FG000|Overall Study|Adverse Event|5|||
131882611|NCT02276053|474852523|FG000|Overall Study|Lack of Efficacy|2|||
131882612|NCT02276053|474852523|FG000|Overall Study|Withdrawal by Subject|1|||
131882613|NCT02276053|474852523|FG000|Overall Study|Patient does not meet selection criteria|3|||
131882614|NCT02276053|474852523|FG000|Overall Study|Patient needs to increase baseline AED|1|||
131882615|NCT01632904|474852524|FG000|Overall Study|Adverse Event|4|||
131882616|NCT01632904|474852525|FG001|Overall Study|Adverse Event|1|||
131882617|NCT01632904|474852524|FG000|Overall Study|Physician Decision|0|||
131882618|NCT01632904|474852525|FG001|Overall Study|Physician Decision|1|||
131882619|NCT01632904|474852524|FG000|Overall Study|Subject decision|3|||
131882620|NCT01632904|474852525|FG001|Overall Study|Subject decision|2|||
131882621|NCT01632904|474852524|FG000|Overall Study|Disease Progression|0|||
131882622|NCT01632904|474852525|FG001|Overall Study|Disease Progression|1|||
131882623|NCT01632904|474852524|FG000|Overall Study|Reason for discontinuation not available|0|||
131882624|NCT01632904|474852525|FG001|Overall Study|Reason for discontinuation not available|1|||
131882625|NCT04743804|474852526|FG000|Overall Study|Other|1|||
131882626|NCT04743804|474852527|FG001|Overall Study|Other|0|||
131882627|NCT04743804|474852526|FG000|Overall Study|Withdrawal by Subject|0|||
131882628|NCT04743804|474852527|FG001|Overall Study|Withdrawal by Subject|1|||
131882629|NCT04743804|474852526|FG000|Overall Study|Study Terminated by Sponsor|1|||
131882630|NCT04743804|474852527|FG001|Overall Study|Study Terminated by Sponsor|4|||
131882631|NCT04743804|474852526|FG000|Overall Study|Physician Decision|0|||
131882632|NCT04743804|474852527|FG001|Overall Study|Physician Decision|1|||
131882633|NCT04743804|474852526|FG000|Overall Study|Death|3|||
131882634|NCT04743804|474852527|FG001|Overall Study|Death|0|||
131882635|NCT04322539|474852542|FG000|Overall Study|Adverse Event|2|||
131882636|NCT04322539|474852543|FG001|Overall Study|Adverse Event|0|||
131882637|NCT04322539|474852542|FG000|Overall Study|Death|411|||
131882638|NCT04322539|474852543|FG001|Overall Study|Death|203|||
131882639|NCT04322539|474852542|FG000|Overall Study|Lost to Follow-up|3|||
131882640|NCT04322539|474852543|FG001|Overall Study|Lost to Follow-up|1|||
131882641|NCT04322539|474852542|FG000|Overall Study|Withdrawal of consent|14|||
131882642|NCT04322539|474852543|FG001|Overall Study|Withdrawal of consent|8|||
131882643|NCT04322539|474852542|FG000|Overall Study|Radiological Disease Progression|6|||
131882644|NCT04322539|474852543|FG001|Overall Study|Radiological Disease Progression|0|||
131882645|NCT04322539|474852542|FG000|Overall Study|Sponsor Decision|19|||
131882646|NCT04322539|474852543|FG001|Overall Study|Sponsor Decision|14|||
131882647|NCT04322539|474852542|FG000|Overall Study|Other|6|||
131882648|NCT04322539|474852543|FG001|Overall Study|Other|4|||
131882649|NCT04063657|474852549|FG000|Overall Study|Lost to Follow-up|1|||
131882650|NCT04063657|474852550|FG001|Overall Study|Lost to Follow-up|0|||
131882651|NCT03408444|474852551|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
131882652|NCT03408444|474852552|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
131882653|NCT03408444|474852553|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
131882654|NCT03408444|474852554|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
131882655|NCT03408444|474852551|FG000|Overall Study|Lens Discomfort|0|||
131882656|NCT03408444|474852552|FG001|Overall Study|Lens Discomfort|1|||
131882657|NCT03408444|474852553|FG002|Overall Study|Lens Discomfort|0|||
131882658|NCT03408444|474852554|FG003|Overall Study|Lens Discomfort|0|||
131882659|NCT03408444|474852551|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
131546329|NCT00549757|473623040|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
131546330|NCT00549757|473623039|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
131882660|NCT03408444|474852552|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
131882661|NCT03408444|474852553|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
131882662|NCT03408444|474852554|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
131882663|NCT03408444|474852551|FG000|Overall Study|Withdrawal by Subject|0|||
131882664|NCT03408444|474852552|FG001|Overall Study|Withdrawal by Subject|2|||
131882665|NCT03408444|474852553|FG002|Overall Study|Withdrawal by Subject|3|||
131882666|NCT03408444|474852554|FG003|Overall Study|Withdrawal by Subject|0|||
131882667|NCT03408444|474852551|FG000|Overall Study|Lost to Follow-up|0|||
131546331|NCT00549757|473623040|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
131546332|NCT02641392|473623041|FG000|Overall Study|Lost to Follow-up|0|||
131546333|NCT02641392|473623042|FG001|Overall Study|Lost to Follow-up|0|||
131546334|NCT02641392|473623043|FG002|Overall Study|Lost to Follow-up|2|||
131546335|NCT02641392|473623041|FG000|Overall Study|Withdrawal by Subject|0|||
131546336|NCT02641392|473623042|FG001|Overall Study|Withdrawal by Subject|0|||
131546337|NCT02641392|473623043|FG002|Overall Study|Withdrawal by Subject|17|||
131546338|NCT02641392|473623041|FG000|Overall Study|Adverse Event|0|||
131546339|NCT02641392|473623042|FG001|Overall Study|Adverse Event|1|||
131546340|NCT02641392|473623043|FG002|Overall Study|Adverse Event|25|||
131546341|NCT02641392|473623041|FG000|Overall Study|Study Terminated by Sponsor|4|||
131546342|NCT02641392|473623042|FG001|Overall Study|Study Terminated by Sponsor|12|||
131546343|NCT02641392|473623043|FG002|Overall Study|Study Terminated by Sponsor|144|||
131546344|NCT02641392|473623041|FG000|Overall Study|Lack of Efficacy|0|||
131882668|NCT03408444|474852552|FG001|Overall Study|Lost to Follow-up|0|||
131882669|NCT03408444|474852553|FG002|Overall Study|Lost to Follow-up|1|||
131882670|NCT03408444|474852554|FG003|Overall Study|Lost to Follow-up|0|||
131882671|NCT03408444|474852551|FG000|Overall Study|Adverse Event|0|||
131546345|NCT02641392|473623042|FG001|Overall Study|Lack of Efficacy|0|||
131546346|NCT02641392|473623043|FG002|Overall Study|Lack of Efficacy|101|||
131546347|NCT02641392|473623041|FG000|Overall Study|Miscellaneous|0|||
131546348|NCT02641392|473623042|FG001|Overall Study|Miscellaneous|0|||
131546349|NCT02641392|473623043|FG002|Overall Study|Miscellaneous|3|||
131546350|NCT02641392|473623041|FG000|Overall Study|Death|0|||
131546351|NCT02641392|473623042|FG001|Overall Study|Death|0|||
131546352|NCT02641392|473623043|FG002|Overall Study|Death|1|||
131546353|NCT01127646|473623044|FG000|Overall Study|Entry Criteria Not Met|1|||
131546354|NCT01127646|473623045|FG001|Overall Study|Entry Criteria Not Met|0|||
131546355|NCT01127646|473623044|FG000|Overall Study|Protocol Violation|0|||
131546356|NCT01127646|473623045|FG001|Overall Study|Protocol Violation|1|||
131546357|NCT01662063|473623046|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
131546358|NCT01662063|473623047|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
131546359|NCT01662063|473623048|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
131882672|NCT03408444|474852552|FG001|Overall Study|Adverse Event|0|||
131882673|NCT03408444|474852553|FG002|Overall Study|Adverse Event|0|||
131882674|NCT03408444|474852554|FG003|Overall Study|Adverse Event|1|||
131882675|NCT03408444|474852551|FG000|Overall Study|Lens Handling Difficulties|0|||
131882676|NCT03408444|474852552|FG001|Overall Study|Lens Handling Difficulties|0|||
131882677|NCT03408444|474852553|FG002|Overall Study|Lens Handling Difficulties|1|||
131882678|NCT03408444|474852554|FG003|Overall Study|Lens Handling Difficulties|0|||
131882679|NCT03408444|474852551|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
131882680|NCT03408444|474852552|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
131882681|NCT03408444|474852553|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
131882682|NCT03408444|474852554|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
131882683|NCT04984681|474852555|FG000|Overall Study|Lost to Follow-up|3|||
131882684|NCT04984681|474852556|FG001|Overall Study|Lost to Follow-up|1|||
131882685|NCT01473394|474852559|FG000|Overall Study|Adverse Event|13|||
131882686|NCT01473394|474852560|FG001|Overall Study|Adverse Event|16|||
131882687|NCT01473394|474852559|FG000|Overall Study|Insufficient Therapeutic Response|4|||
131882688|NCT01473394|474852560|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131882689|NCT01473394|474852559|FG000|Overall Study|Protocol Violation|7|||
131882690|NCT01473394|474852560|FG001|Overall Study|Protocol Violation|5|||
131882691|NCT01473394|474852559|FG000|Overall Study|Withdrew Consent|12|||
131882692|NCT01473394|474852560|FG001|Overall Study|Withdrew Consent|10|||
131882693|NCT01473394|474852559|FG000|Overall Study|Lost to Follow-up|9|||
131882694|NCT01473394|474852560|FG001|Overall Study|Lost to Follow-up|11|||
131882695|NCT01482962|474852563|FG000|Overall Study|Progressive Disease|65|||
131882696|NCT01482962|474852564|FG001|Overall Study|Progressive Disease|53|||
131882697|NCT01482962|474852563|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
131882698|NCT01482962|474852564|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
131882699|NCT01482962|474852563|FG000|Overall Study|Adverse Event|18|||
131882700|NCT01482962|474852564|FG001|Overall Study|Adverse Event|22|||
131882701|NCT01482962|474852563|FG000|Overall Study|Withdrawal by Participant|8|||
131546360|NCT01662063|473623046|FG000|Overall Study|Lack of Efficacy|1|||
131882702|NCT01482962|474852564|FG001|Overall Study|Withdrawal by Participant|13|||
131882703|NCT01482962|474852563|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
131882704|NCT01482962|474852564|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
131882705|NCT01482962|474852563|FG000|Overall Study|Other Reason|1|||
131546361|NCT01662063|473623047|FG001|Overall Study|Lack of Efficacy|6|||
131882706|NCT01482962|474852564|FG001|Overall Study|Other Reason|5|||
131882707|NCT01482962|474852563|FG000|Overall Study|Study Terminated by Sponsor|5|||
131882708|NCT01482962|474852564|FG001|Overall Study|Study Terminated by Sponsor|2|||
131882709|NCT01482962|474852563|FG000|Overall Study|Did not Receive Study Drug|1|||
131882710|NCT01482962|474852564|FG001|Overall Study|Did not Receive Study Drug|6|||
131546362|NCT01662063|473623048|FG002|Overall Study|Lack of Efficacy|0|||
131546363|NCT01662063|473623046|FG000|Overall Study|Lost to Follow-up|0|||
131882711|NCT04495816|474852567|FG000|Overall Study|Lost to Follow-up|10|||
131546364|NCT01662063|473623047|FG001|Overall Study|Lost to Follow-up|4|||
131546365|NCT01662063|473623048|FG002|Overall Study|Lost to Follow-up|0|||
131546366|NCT01662063|473623046|FG000|Overall Study|Protocol Violation|1|||
131882712|NCT04495816|474852568|FG001|Overall Study|Lost to Follow-up|4|||
131882713|NCT04495816|474852567|FG000|Overall Study|Withdrawal by Subject|3|||
131882714|NCT04495816|474852568|FG001|Overall Study|Withdrawal by Subject|5|||
131882715|NCT01793688|474852584|FG000|Overall Study|Protocol Violation|2|||
131882716|NCT04450407|474852585|FG000|Overall Study|Withdrawal by Subject|10|||
131882717|NCT04450407|474852586|FG001|Overall Study|Withdrawal by Subject|1|||
131882718|NCT04450407|474852587|FG002|Overall Study|Withdrawal by Subject|4|||
131882719|NCT04450407|474852585|FG000|Overall Study|Adverse Event|0|||
131882720|NCT04450407|474852586|FG001|Overall Study|Adverse Event|0|||
131882721|NCT04450407|474852587|FG002|Overall Study|Adverse Event|1|||
131546367|NCT01662063|473623047|FG001|Overall Study|Protocol Violation|0|||
131546368|NCT01662063|473623048|FG002|Overall Study|Protocol Violation|0|||
131546369|NCT01662063|473623046|FG000|Overall Study|Withdrawal by Subject|2|||
131546370|NCT01662063|473623047|FG001|Overall Study|Withdrawal by Subject|4|||
131546371|NCT01662063|473623048|FG002|Overall Study|Withdrawal by Subject|1|||
131546372|NCT01662063|473623046|FG000|Overall Study|Physician Decision|0|||
131546373|NCT01662063|473623047|FG001|Overall Study|Physician Decision|2|||
131546374|NCT01662063|473623048|FG002|Overall Study|Physician Decision|0|||
131546375|NCT01662063|473623046|FG000|Overall Study|Other|0|||
131546376|NCT01662063|473623047|FG001|Overall Study|Other|1|||
131546377|NCT01662063|473623048|FG002|Overall Study|Other|0|||
131546378|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
131882722|NCT04450407|474852585|FG000|Overall Study|Lost to Follow-up|1|||
131882723|NCT04450407|474852586|FG001|Overall Study|Lost to Follow-up|0|||
131546379|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
131546380|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
131546381|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
131546382|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
131546383|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
131546384|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
131546385|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
131546386|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
131546387|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
131546388|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
131546389|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
131546390|NCT00293267|473623049|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
131546391|NCT00293267|473623050|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
131546392|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
131546393|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
131546394|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
131546395|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
131546396|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
131882724|NCT04450407|474852587|FG002|Overall Study|Lost to Follow-up|0|||
131882725|NCT04450407|474852585|FG000|Overall Study|Physician Decision|0|||
131882726|NCT04450407|474852586|FG001|Overall Study|Physician Decision|0|||
131546397|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
131546398|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
131546399|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
131546400|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Death|3|||
131546401|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Death|0|||
131546402|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
131546403|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
131546404|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
131546405|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
131546406|NCT00293267|473623049|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
131546407|NCT00293267|473623050|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
131546408|NCT00293267|473623049|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
131882727|NCT04450407|474852587|FG002|Overall Study|Physician Decision|1|||
131882728|NCT04450407|474852585|FG000|Overall Study|Pregnancy|1|||
131546409|NCT00293267|473623050|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
131882729|NCT04450407|474852586|FG001|Overall Study|Pregnancy|0|||
131882730|NCT04450407|474852587|FG002|Overall Study|Pregnancy|0|||
131882731|NCT04450407|474852585|FG000|Overall Study|Protocol Violation|2|||
131882732|NCT04450407|474852586|FG001|Overall Study|Protocol Violation|0|||
131546410|NCT00293267|473623049|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
131882733|NCT04450407|474852587|FG002|Overall Study|Protocol Violation|0|||
131546411|NCT00293267|473623050|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
131546412|NCT00293267|473623049|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
131546413|NCT00293267|473623050|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
131546414|NCT00293267|473623049|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
131546415|NCT00293267|473623050|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
131546416|NCT00293267|473623049|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
131546417|NCT00293267|473623050|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
131546418|NCT00293267|473623049|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
131546419|NCT00293267|473623050|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
131546420|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
131546421|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
131546422|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
131546423|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
131546424|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
131546425|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
131546426|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
131546427|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
131546428|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
131546429|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
131546430|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
131546431|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
131546432|NCT00293267|473623049|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
131546433|NCT00293267|473623050|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
131546434|NCT01477853|473623051|FG000|Phase A|Adverse Event|1|||
131546435|NCT01477853|473623052|FG001|Phase A|Adverse Event|2|||
131546436|NCT01477853|473623053|FG002|Phase A|Adverse Event|2|||
131546437|NCT01477853|473623051|FG000|Phase A|Lost to Follow-up|4|||
131546438|NCT01477853|473623052|FG001|Phase A|Lost to Follow-up|3|||
131546439|NCT01477853|473623053|FG002|Phase A|Lost to Follow-up|2|||
131546440|NCT01477853|473623051|FG000|Phase A|Physician Decision|1|||
131546441|NCT01477853|473623052|FG001|Phase A|Physician Decision|0|||
131546442|NCT01477853|473623053|FG002|Phase A|Physician Decision|1|||
131546443|NCT01477853|473623051|FG000|Phase A|Study terminated by sponsor|37|||
131546444|NCT01477853|473623052|FG001|Phase A|Study terminated by sponsor|40|||
131546445|NCT01477853|473623053|FG002|Phase A|Study terminated by sponsor|39|||
131546446|NCT01477853|473623051|FG000|Phase B|Lost to Follow-up|0|||
131546447|NCT01477853|473623052|FG001|Phase B|Lost to Follow-up|1|||
131546448|NCT01477853|473623053|FG002|Phase B|Lost to Follow-up|0|||
131546449|NCT01477853|473623051|FG000|Phase B|Study terminated by sponsor|12|||
131546450|NCT01477853|473623052|FG001|Phase B|Study terminated by sponsor|10|||
131546451|NCT01477853|473623053|FG002|Phase B|Study terminated by sponsor|11|||
131546452|NCT03086330|473623054|FG000|Overall Study|Withdrawal by Subject|3|||
131546453|NCT03086330|473623055|FG001|Overall Study|Withdrawal by Subject|2|||
131546454|NCT03086330|473623054|FG000|Overall Study|Lost to Follow-up|1|||
131546455|NCT03086330|473623055|FG001|Overall Study|Lost to Follow-up|2|||
131546456|NCT01814748|473623058|FG000|Overall Study|Lost to Follow-up|1|||
131546457|NCT01814748|473623059|FG001|Overall Study|Lost to Follow-up|2|||
131546458|NCT01814748|473623058|FG000|Overall Study|Study site terminated by sponsor|1|||
131546459|NCT01814748|473623059|FG001|Overall Study|Study site terminated by sponsor|1|||
131546460|NCT01814748|473623058|FG000|Overall Study|Withdrawal by Subject|6|||
131546461|NCT01814748|473623059|FG001|Overall Study|Withdrawal by Subject|4|||
131546462|NCT04044456|473623060|FG000|Overall Study|Lost to Follow-up|4|||
131546463|NCT04044456|473623061|FG001|Overall Study|Lost to Follow-up|1|||
131546464|NCT04044456|473623060|FG000|Overall Study|Withdrawal by Subject|1|||
131546465|NCT04044456|473623061|FG001|Overall Study|Withdrawal by Subject|0|||
131882734|NCT04450407|474852585|FG000|Overall Study|Investigational site terminated by sponsor|3|||
131882735|NCT04450407|474852586|FG001|Overall Study|Investigational site terminated by sponsor|0|||
131882736|NCT04450407|474852587|FG002|Overall Study|Investigational site terminated by sponsor|2|||
131882737|NCT00191282|474852588|FG000|Overall Study|Adverse Event|5|||
131882738|NCT00191282|474852589|FG001|Overall Study|Adverse Event|6|||
131882739|NCT00191282|474852588|FG000|Overall Study|Death|51|||
131882740|NCT00191282|474852589|FG001|Overall Study|Death|51|||
131882741|NCT00191282|474852588|FG000|Overall Study|Lack of Efficacy|11|||
131882742|NCT00191282|474852589|FG001|Overall Study|Lack of Efficacy|6|||
131434149|NCT01232868|473217434|FG000|Overall Study|Lost to Follow-up|2|||
131546466|NCT00330174|473623064|FG000|Overall Study|Withdrawal by Subject|7|||
131546467|NCT00330174|473623065|FG001|Overall Study|Withdrawal by Subject|7|||
131546468|NCT00330174|473623064|FG000|Overall Study|Lost to Follow-up|4|||
131546469|NCT00330174|473623065|FG001|Overall Study|Lost to Follow-up|1|||
131882743|NCT00191282|474852588|FG000|Overall Study|Noncompliance|14|||
131882744|NCT00191282|474852589|FG001|Overall Study|Noncompliance|17|||
131546470|NCT00330174|473623064|FG000|Overall Study|Clinical deterioration|1|||
131546471|NCT00330174|473623065|FG001|Overall Study|Clinical deterioration|2|||
131546472|NCT00330174|473623064|FG000|Overall Study|Excessive missed visits|3|||
131546473|NCT00330174|473623065|FG001|Overall Study|Excessive missed visits|8|||
131546474|NCT00330174|473623064|FG000|Overall Study|Miscellaneous reasons|7|||
131546475|NCT00330174|473623065|FG001|Overall Study|Miscellaneous reasons|1|||
131546476|NCT01844284|473623066|FG000|Overall Study|Lost to Follow-up|12|||
131546477|NCT01844284|473623067|FG001|Overall Study|Lost to Follow-up|7|||
131546478|NCT02755597|473623068|FG000|Overall Study|Withdrew consent|27|||
131546479|NCT02755597|473623069|FG001|Overall Study|Withdrew consent|11|||
131882745|NCT00191282|474852588|FG000|Overall Study|Patient moved|11|||
131882746|NCT00191282|474852589|FG001|Overall Study|Patient moved|14|||
131882747|NCT00191282|474852588|FG000|Overall Study|Withdrawal by Subject|59|||
131882748|NCT00191282|474852589|FG001|Overall Study|Withdrawal by Subject|44|||
131882749|NCT00191282|474852588|FG000|Overall Study|Physician Decision|18|||
131882750|NCT00191282|474852589|FG001|Overall Study|Physician Decision|15|||
131882751|NCT00191282|474852588|FG000|Overall Study|Protocol entry criteria not met|14|||
131882752|NCT00191282|474852589|FG001|Overall Study|Protocol entry criteria not met|9|||
131546480|NCT02755597|473623068|FG000|Overall Study|Lost to Follow-up|1|||
131546481|NCT02755597|473623069|FG001|Overall Study|Lost to Follow-up|0|||
131882753|NCT00191282|474852588|FG000|Overall Study|Protocol Violation|9|||
131882754|NCT00191282|474852589|FG001|Overall Study|Protocol Violation|12|||
131882755|NCT00191282|474852588|FG000|Overall Study|Severity of outcome|2|||
131882756|NCT00191282|474852589|FG001|Overall Study|Severity of outcome|5|||
131882757|NCT00191282|474852588|FG000|Overall Study|Sponsor's decision|2|||
131546482|NCT02755597|473623068|FG000|Overall Study|Death|78|||
131546483|NCT02755597|473623069|FG001|Overall Study|Death|36|||
131546484|NCT02755597|473623068|FG000|Overall Study|Study terminated by Sponsor|67|||
131546485|NCT02755597|473623069|FG001|Overall Study|Study terminated by Sponsor|47|||
131546486|NCT02755597|473623068|FG000|Overall Study|Other, not specified|20|||
131546487|NCT02755597|473623069|FG001|Overall Study|Other, not specified|3|||
131546488|NCT02755597|473623068|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
131546489|NCT02755597|473623069|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
131546490|NCT03641313|473623073|FG000|Overall Study|Death|1|||
131546491|NCT03641313|473623073|FG000|Overall Study|Withdrawal by Subject|2|||
131546492|NCT03641313|473623073|FG000|Overall Study|Declining health|1|||
131546493|NCT03641313|473623073|FG000|Overall Study|Adverse Event|1|||
131546494|NCT02753595|473623078|FG000|Overall Study|Sponsor termination|2|||
131546495|NCT02753595|473623079|FG001|Overall Study|Sponsor termination|2|||
131546496|NCT01570868|473623080|FG000|Overall Study|Adverse Event|8|||
131546497|NCT01570868|473623081|FG001|Overall Study|Adverse Event|1|||
131546498|NCT01570868|473623080|FG000|Overall Study|FDA Recommendation|23|||
131546499|NCT01570868|473623081|FG001|Overall Study|FDA Recommendation|3|||
131546500|NCT01570868|473623080|FG000|Overall Study|Physician Decision|10|||
131546501|NCT01570868|473623081|FG001|Overall Study|Physician Decision|4|||
131546502|NCT01570868|473623080|FG000|Overall Study|Lost to Follow-up|1|||
131546503|NCT01570868|473623081|FG001|Overall Study|Lost to Follow-up|0|||
131546504|NCT01570868|473623080|FG000|Overall Study|Withdrawal by Subject|1|||
131546505|NCT01570868|473623081|FG001|Overall Study|Withdrawal by Subject|0|||
131546506|NCT01422408|473623088|FG000|Overall Study|Adverse Event|1|||
131546507|NCT01422408|473623088|FG000|Overall Study|Withdrawal by Subject|3|||
131546508|NCT02953938|473623089|FG000|Overall Study|Adverse Event|0|||
131546509|NCT02953938|473623090|FG001|Overall Study|Adverse Event|1|||
131546510|NCT02953938|473623089|FG000|Overall Study|Withdrawal by Subject|1|||
131546511|NCT02953938|473623090|FG001|Overall Study|Withdrawal by Subject|1|||
131546512|NCT05007392|473623091|FG000|Overall Study|Randomized but not treated|1|||
131546513|NCT05007392|473623092|FG001|Overall Study|Randomized but not treated|2|||
131546514|NCT05007392|473623091|FG000|Overall Study|Other|5|||
131882758|NCT00191282|474852589|FG001|Overall Study|Sponsor's decision|2|||
131882759|NCT00191282|474852588|FG000|Overall Study|Lost to Follow-up|24|||
131882760|NCT00191282|474852589|FG001|Overall Study|Lost to Follow-up|31|||
131882761|NCT04756154|474852592|FG000|Overall Study|Did not meet treatment day baseline|30|||
131882762|NCT04756154|474852593|FG001|Overall Study|Did not meet treatment day baseline|28|||
131546515|NCT05007392|473623092|FG001|Overall Study|Other|4|||
131546516|NCT05007392|473623091|FG000|Overall Study|Lost to Follow-up|1|||
131546517|NCT05007392|473623092|FG001|Overall Study|Lost to Follow-up|2|||
131546518|NCT05007392|473623091|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
131546519|NCT05007392|473623092|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
131546520|NCT05007392|473623091|FG000|Overall Study|Use of prohibited concomitant drug|1|||
131546521|NCT05007392|473623092|FG001|Overall Study|Use of prohibited concomitant drug|1|||
131546522|NCT05007392|473623091|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
131546523|NCT05007392|473623092|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
131546524|NCT05007392|473623091|FG000|Overall Study|Adverse Event|10|||
131882763|NCT04756154|474852594|FG002|Overall Study|Did not meet treatment day baseline|7|||
131882764|NCT04756154|474852592|FG000|Overall Study|Did not return for final sample collection|1|||
131546525|NCT05007392|473623092|FG001|Overall Study|Adverse Event|6|||
131546526|NCT05007392|473623091|FG000|Overall Study|Participant choice|5|||
131546527|NCT05007392|473623092|FG001|Overall Study|Participant choice|10|||
131546528|NCT05007392|473623091|FG000|Overall Study|Withdrawal of consent|5|||
131546529|NCT05007392|473623092|FG001|Overall Study|Withdrawal of consent|4|||
131546530|NCT01218126|473623093|FG000|Overall Study|Adverse Event|8|||
131546531|NCT01218126|473623094|FG001|Overall Study|Adverse Event|10|||
131546532|NCT01218126|473623095|FG002|Overall Study|Adverse Event|12|||
131546533|NCT01218126|473623096|FG003|Overall Study|Adverse Event|16|||
131546534|NCT01218126|473623093|FG000|Overall Study|Lack of Efficacy|7|||
131546535|NCT01218126|473623094|FG001|Overall Study|Lack of Efficacy|2|||
131546536|NCT01218126|473623095|FG002|Overall Study|Lack of Efficacy|2|||
131546537|NCT01218126|473623096|FG003|Overall Study|Lack of Efficacy|6|||
131546538|NCT01218126|473623093|FG000|Overall Study|Protocol Violation|5|||
131546539|NCT01218126|473623094|FG001|Overall Study|Protocol Violation|2|||
131546540|NCT01218126|473623095|FG002|Overall Study|Protocol Violation|2|||
131546541|NCT01218126|473623096|FG003|Overall Study|Protocol Violation|3|||
131546542|NCT01218126|473623093|FG000|Overall Study|Protocol-defined stopping criteria|1|||
131546543|NCT01218126|473623094|FG001|Overall Study|Protocol-defined stopping criteria|1|||
131546544|NCT01218126|473623095|FG002|Overall Study|Protocol-defined stopping criteria|0|||
131546545|NCT01218126|473623096|FG003|Overall Study|Protocol-defined stopping criteria|0|||
131546546|NCT01218126|473623093|FG000|Overall Study|Lost to Follow-up|0|||
131546547|NCT01218126|473623094|FG001|Overall Study|Lost to Follow-up|0|||
131546548|NCT01218126|473623095|FG002|Overall Study|Lost to Follow-up|0|||
131546549|NCT01218126|473623096|FG003|Overall Study|Lost to Follow-up|2|||
131546550|NCT01218126|473623093|FG000|Overall Study|Physician Decision|1|||
131546551|NCT01218126|473623094|FG001|Overall Study|Physician Decision|2|||
131546552|NCT01218126|473623095|FG002|Overall Study|Physician Decision|4|||
131546553|NCT01218126|473623096|FG003|Overall Study|Physician Decision|2|||
131546554|NCT01218126|473623093|FG000|Overall Study|Withdrawal by Subject|2|||
131546555|NCT01218126|473623094|FG001|Overall Study|Withdrawal by Subject|5|||
131546556|NCT01218126|473623095|FG002|Overall Study|Withdrawal by Subject|4|||
131546557|NCT01218126|473623096|FG003|Overall Study|Withdrawal by Subject|6|||
131546558|NCT01860703|473623097|FG000|Overall Study|Adverse Event|1|||
131546559|NCT01860703|473623098|FG001|Overall Study|Adverse Event|4|||
131546560|NCT01860703|473623099|FG002|Overall Study|Adverse Event|0|||
131546561|NCT01860703|473623100|FG003|Overall Study|Adverse Event|2|||
131546562|NCT01860703|473623097|FG000|Overall Study|Withdrawal by Subject|0|||
131546563|NCT01860703|473623098|FG001|Overall Study|Withdrawal by Subject|1|||
131546564|NCT01860703|473623099|FG002|Overall Study|Withdrawal by Subject|0|||
131546565|NCT01860703|473623100|FG003|Overall Study|Withdrawal by Subject|0|||
131546566|NCT01860703|473623097|FG000|Overall Study|Personal reason|1|||
131546567|NCT01860703|473623098|FG001|Overall Study|Personal reason|0|||
131546568|NCT01860703|473623099|FG002|Overall Study|Personal reason|1|||
131546569|NCT01860703|473623100|FG003|Overall Study|Personal reason|0|||
131434150|NCT01232868|473217435|FG001|Overall Study|Lost to Follow-up|4|||
131434151|NCT04481243|473217436|FG000|Overall Study|Withdrawal by Subject|4|||
131434152|NCT00865345|473217437|FG000|Overall Study|Withdrawal by Subject|2|||
131434153|NCT02544321|473217444|FG000|Overall Study|Withdrawal by Subject|1|||
131434154|NCT02544321|473217445|FG001|Overall Study|Withdrawal by Subject|2|||
131434155|NCT02544321|473217444|FG000|Overall Study|Adverse Event|1|||
131434156|NCT02544321|473217445|FG001|Overall Study|Adverse Event|1|||
131434157|NCT02544321|473217444|FG000|Overall Study|Protocol Violation|0|||
131434158|NCT02544321|473217445|FG001|Overall Study|Protocol Violation|1|||
131434159|NCT01517750|473217446|FG000|Overall Study|Lost to Follow-up|1|||
131434160|NCT01517750|473217447|FG001|Overall Study|Lost to Follow-up|2|||
131434161|NCT01517750|473217448|FG002|Overall Study|Lost to Follow-up|4|||
131434162|NCT01517750|473217449|FG003|Overall Study|Lost to Follow-up|1|||
131434163|NCT01584232|473217450|FG000|Overall Study|Adverse Event|3|||
131434164|NCT01584232|473217451|FG001|Overall Study|Adverse Event|1|||
131434165|NCT01584232|473217450|FG000|Overall Study|Withdrawal by Subject|2|||
131434166|NCT01584232|473217451|FG001|Overall Study|Withdrawal by Subject|1|||
131434167|NCT01584232|473217450|FG000|Overall Study|Physician Decision|2|||
131434168|NCT01584232|473217451|FG001|Overall Study|Physician Decision|1|||
131434169|NCT01584232|473217450|FG000|Overall Study|Lost to Follow-up|1|||
131434170|NCT01584232|473217451|FG001|Overall Study|Lost to Follow-up|0|||
131434171|NCT01307319|473217452|FG000|Overall Study|Adverse Event|2|||
131434172|NCT01307319|473217453|FG001|Overall Study|Adverse Event|2|||
131434173|NCT01307319|473217454|FG002|Overall Study|Adverse Event|1|||
131434174|NCT01307319|473217452|FG000|Overall Study|Lost to Follow-up|1|||
131434175|NCT01307319|473217453|FG001|Overall Study|Lost to Follow-up|0|||
131434176|NCT01307319|473217454|FG002|Overall Study|Lost to Follow-up|1|||
131434177|NCT01307319|473217452|FG000|Overall Study|Protocol Violation|1|||
131434178|NCT01307319|473217453|FG001|Overall Study|Protocol Violation|1|||
131434179|NCT01307319|473217454|FG002|Overall Study|Protocol Violation|0|||
131434180|NCT01307319|473217452|FG000|Overall Study|Withdrawal by Subject|0|||
131434181|NCT01307319|473217453|FG001|Overall Study|Withdrawal by Subject|1|||
131434182|NCT01307319|473217454|FG002|Overall Study|Withdrawal by Subject|2|||
131546570|NCT02453685|473623105|FG000|Overall Study|Adverse Event|0|||
131434183|NCT01307319|473217452|FG000|Overall Study|Other|0|||
131546571|NCT02453685|473623106|FG001|Overall Study|Adverse Event|1|||
131546572|NCT02453685|473623105|FG000|Overall Study|Protocol Violation|7|||
131546573|NCT02453685|473623106|FG001|Overall Study|Protocol Violation|4|||
131546574|NCT02453685|473623105|FG000|Overall Study|Lost to Follow-up|0|||
131546575|NCT02453685|473623106|FG001|Overall Study|Lost to Follow-up|1|||
131546576|NCT02453685|473623105|FG000|Overall Study|Withdrawal by Subject|8|||
131546577|NCT02453685|473623106|FG001|Overall Study|Withdrawal by Subject|4|||
131546578|NCT02453685|473623105|FG000|Overall Study|Unclassified|4|||
131546579|NCT02453685|473623106|FG001|Overall Study|Unclassified|2|||
131546580|NCT00453986|473623109|FG000|Overall Study|Lost to Follow-up|6|||
131546581|NCT00453986|473623110|FG001|Overall Study|Lost to Follow-up|5|||
131546582|NCT00453986|473623111|FG002|Overall Study|Lost to Follow-up|6|||
131546583|NCT00453986|473623112|FG003|Overall Study|Lost to Follow-up|2|||
131546584|NCT00453986|473623113|FG004|Overall Study|Lost to Follow-up|0|||
131546585|NCT02778100|473623116|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
131546586|NCT02778100|473623117|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
131546587|NCT01338025|473623123|FG000|Overall Study|Unexpected closure of study|10|||
131546588|NCT01338025|473623124|FG001|Overall Study|Unexpected closure of study|9|||
131546589|NCT01338025|473623123|FG000|Overall Study|Withdrawal by Subject|0|||
131546590|NCT01338025|473623124|FG001|Overall Study|Withdrawal by Subject|2|||
131546591|NCT01338025|473623123|FG000|Overall Study|Found ineligible after starting|1|||
131546592|NCT01338025|473623124|FG001|Overall Study|Found ineligible after starting|0|||
131546593|NCT04120233|473623127|FG000|Overall Study|Adverse Event|0|||
131546594|NCT04120233|473623128|FG001|Overall Study|Adverse Event|0|||
131546595|NCT04120233|473623129|FG002|Overall Study|Adverse Event|0|||
131546596|NCT04120233|473623130|FG003|Overall Study|Adverse Event|0|||
131546597|NCT04120233|473623131|FG004|Overall Study|Adverse Event|1|||
131546598|NCT04120233|473623132|FG005|Overall Study|Adverse Event|0|||
131546599|NCT03779906|473623133|FG000|Overall Study|Lost to Follow-up|7|||
131546600|NCT03779906|473623133|FG000|Overall Study|COVID pandemic|1|||
131546601|NCT02553460|473623136|FG000|Overall Study|Death|3|||
131546602|NCT02553460|473623136|FG000|Overall Study|Withdrawal by Subject|1|||
131546603|NCT02553460|473623136|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
131546604|NCT02553460|473623136|FG000|Overall Study|Relapse or Transplant|14|||
131546605|NCT02553460|473623136|FG000|Overall Study|No response to treatment|2|||
131546606|NCT02553460|473623136|FG000|Overall Study|CAR T cells|2|||
131546607|NCT04814368|473623137|FG000|Overall Study|Study Terminated by Sponsor|0|||
131546608|NCT04814368|473623138|FG001|Overall Study|Study Terminated by Sponsor|3|||
131546609|NCT04814368|473623139|FG002|Overall Study|Study Terminated by Sponsor|0|||
131546610|NCT04814368|473623140|FG003|Overall Study|Study Terminated by Sponsor|2|||
131546611|NCT04814368|473623137|FG000|Overall Study|Subject Decision|1|||
131546612|NCT04814368|473623138|FG001|Overall Study|Subject Decision|2|||
131546613|NCT04814368|473623139|FG002|Overall Study|Subject Decision|0|||
131546614|NCT04814368|473623140|FG003|Overall Study|Subject Decision|0|||
131546615|NCT00949884|473624850|FG000|Overall Study|Adverse Event|14|||
131546616|NCT00949884|473624851|FG001|Overall Study|Adverse Event|3|||
131546617|NCT00949884|473624852|FG002|Overall Study|Adverse Event|12|||
131546618|NCT00949884|473624850|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
131546619|NCT00949884|473624851|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
131546620|NCT00949884|473624852|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
131546621|NCT00949884|473624850|FG000|Overall Study|Lost to Follow-up|7|||
131546622|NCT00949884|473624851|FG001|Overall Study|Lost to Follow-up|5|||
131546623|NCT00949884|473624852|FG002|Overall Study|Lost to Follow-up|5|||
131546624|NCT00949884|473624850|FG000|Overall Study|Physician Decision|5|||
131546625|NCT00949884|473624851|FG001|Overall Study|Physician Decision|0|||
131546626|NCT00949884|473624852|FG002|Overall Study|Physician Decision|6|||
131546627|NCT00949884|473624850|FG000|Overall Study|Treatment non-compliance|5|||
131546628|NCT00949884|473624851|FG001|Overall Study|Treatment non-compliance|0|||
131546629|NCT00949884|473624852|FG002|Overall Study|Treatment non-compliance|8|||
131546630|NCT00949884|473624850|FG000|Overall Study|Withdrawal by Subject|13|||
131546631|NCT00949884|473624851|FG001|Overall Study|Withdrawal by Subject|4|||
131546632|NCT00949884|473624852|FG002|Overall Study|Withdrawal by Subject|16|||
131546633|NCT00949884|473624850|FG000|Overall Study|Lack of Efficacy|4|||
131546634|NCT00949884|473624851|FG001|Overall Study|Lack of Efficacy|2|||
131546635|NCT00949884|473624852|FG002|Overall Study|Lack of Efficacy|7|||
131546636|NCT00949884|473624850|FG000|Overall Study|Study terminated by sponsor|0|||
131546637|NCT00949884|473624851|FG001|Overall Study|Study terminated by sponsor|0|||
131546638|NCT00949884|473624852|FG002|Overall Study|Study terminated by sponsor|1|||
131546639|NCT01953003|473624853|FG000|Overall Study|Not treated|0|||
131546640|NCT01953003|473624854|FG001|Overall Study|Not treated|1|||
131546641|NCT01953003|473624853|FG000|Overall Study|Progressive disease|35|||
131546642|NCT01953003|473624854|FG001|Overall Study|Progressive disease|45|||
131546643|NCT01953003|473624853|FG000|Overall Study|Related Adverse events|7|||
131546644|NCT01953003|473624854|FG001|Overall Study|Related Adverse events|2|||
131546645|NCT01953003|473624853|FG000|Overall Study|Non-related adverse events|0|||
131546646|NCT01953003|473624854|FG001|Overall Study|Non-related adverse events|2|||
131546647|NCT01953003|473624853|FG000|Overall Study|Protocol Violation|0|||
131546648|NCT01953003|473624854|FG001|Overall Study|Protocol Violation|1|||
131546649|NCT01953003|473624853|FG000|Overall Study|Withdrawal by Subject|14|||
131546650|NCT01953003|473624854|FG001|Overall Study|Withdrawal by Subject|4|||
131546651|NCT03092375|473624855|FG000|Overall Study|Lack of Efficacy|0|||
131546652|NCT03092375|473624856|FG001|Overall Study|Lack of Efficacy|1|||
131546653|NCT03092375|473624857|FG002|Overall Study|Lack of Efficacy|1|||
131546654|NCT03092375|473624858|FG003|Overall Study|Lack of Efficacy|0|||
131546655|NCT00224770|473624867|FG000|Overall Study|Lost to Follow-up|4|||
131546656|NCT00224770|473624868|FG001|Overall Study|Lost to Follow-up|2|||
131546657|NCT00224770|473624869|FG002|Overall Study|Lost to Follow-up|0|||
131546658|NCT01106430|473624870|FG000|Overall Study|Adverse Event|8|||
131546659|NCT01106430|473624871|FG001|Overall Study|Adverse Event|10|||
131546660|NCT01106430|473624870|FG000|Overall Study|Lack of Efficacy|2|||
131546661|NCT01106430|473624871|FG001|Overall Study|Lack of Efficacy|13|||
131546662|NCT01106430|473624870|FG000|Overall Study|Lost to Follow-up|5|||
131546663|NCT01106430|473624871|FG001|Overall Study|Lost to Follow-up|1|||
131546664|NCT01106430|473624870|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
131546665|NCT01106430|473624871|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
131546666|NCT01106430|473624870|FG000|Overall Study|Moved Out Of State|0|||
131546667|NCT01106430|473624871|FG001|Overall Study|Moved Out Of State|1|||
131546668|NCT01106430|473624870|FG000|Overall Study|Refused To Take Medication|0|||
131546669|NCT01106430|473624871|FG001|Overall Study|Refused To Take Medication|1|||
131546670|NCT01106430|473624870|FG000|Overall Study|Noncompliance|0|||
131546671|NCT01106430|473624871|FG001|Overall Study|Noncompliance|1|||
131546672|NCT01106430|473624870|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
131882765|NCT04756154|474852593|FG001|Overall Study|Did not return for final sample collection|1|||
131882766|NCT04756154|474852594|FG002|Overall Study|Did not return for final sample collection|0|||
131882767|NCT03589976|474852598|FG000|Overall Study|Death|5|||
131882768|NCT03589976|474852599|FG001|Overall Study|Death|1|||
131882769|NCT03589976|474852598|FG000|Overall Study|Adverse Event|5|||
131882770|NCT03589976|474852599|FG001|Overall Study|Adverse Event|1|||
131882771|NCT03589976|474852598|FG000|Overall Study|Withdrawal by Subject|4|||
131882772|NCT03589976|474852599|FG001|Overall Study|Withdrawal by Subject|1|||
131882773|NCT03589976|474852598|FG000|Overall Study|Lost to Follow-up|1|||
131882774|NCT03589976|474852599|FG001|Overall Study|Lost to Follow-up|0|||
131882775|NCT03589976|474852598|FG000|Overall Study|Other|4|||
131882776|NCT03589976|474852599|FG001|Overall Study|Other|3|||
131882777|NCT03430895|474852600|FG000|Overall Study|Not Treated|2|||
131882778|NCT01317797|474852602|FG000|Overall Study|Other|0|||
131882779|NCT01317797|474852603|FG001|Overall Study|Other|1|||
131882780|NCT01317797|474852604|FG002|Overall Study|Other|0|||
131882781|NCT01317797|474852602|FG000|Overall Study|Withdrawal of Patient|0|||
131882782|NCT01317797|474852603|FG001|Overall Study|Withdrawal of Patient|0|||
131882783|NCT01317797|474852604|FG002|Overall Study|Withdrawal of Patient|1|||
131882784|NCT01645891|474852610|FG000|Overall Study|Adverse Event|6|||
131882785|NCT01645891|474852611|FG001|Overall Study|Adverse Event|10|||
131882786|NCT01645891|474852610|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
131882787|NCT01645891|474852611|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
131882788|NCT01645891|474852610|FG000|Overall Study|Withdrawal by Subject|3|||
131882789|NCT01645891|474852611|FG001|Overall Study|Withdrawal by Subject|3|||
131882790|NCT01645891|474852610|FG000|Overall Study|Protocol Violation|4|||
131882791|NCT01645891|474852611|FG001|Overall Study|Protocol Violation|0|||
131882792|NCT01645891|474852610|FG000|Overall Study|Lost to Follow-up|4|||
131882793|NCT01645891|474852611|FG001|Overall Study|Lost to Follow-up|1|||
131882794|NCT01645891|474852610|FG000|Overall Study|Death|0|||
131882795|NCT01645891|474852611|FG001|Overall Study|Death|2|||
131882796|NCT00138073|474852612|FG000|Overall Study|lack of resources|55|||
131882797|NCT00962091|474852614|FG000|Overall Study|Withdrawal by Subject|1|||
131882798|NCT00962091|474852615|FG001|Overall Study|Withdrawal by Subject|2|||
131882799|NCT00962091|474852616|FG002|Overall Study|Withdrawal by Subject|1|||
131882800|NCT00962091|474852617|FG003|Overall Study|Withdrawal by Subject|1|||
131882801|NCT00962091|474852618|FG004|Overall Study|Withdrawal by Subject|0|||
131882802|NCT00962091|474852619|FG005|Overall Study|Withdrawal by Subject|1|||
131882803|NCT00962091|474852620|FG006|Overall Study|Withdrawal by Subject|0|||
131882804|NCT00962091|474852614|FG000|Overall Study|Adverse Event|0|||
131882805|NCT00962091|474852615|FG001|Overall Study|Adverse Event|0|||
131882806|NCT00962091|474852616|FG002|Overall Study|Adverse Event|0|||
131546673|NCT01106430|473624871|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
131658945|NCT01732822|474037292|FG000|Overall Study|Withdrawal by Subject|123|||
131882807|NCT00962091|474852617|FG003|Overall Study|Adverse Event|0|||
131882808|NCT00962091|474852618|FG004|Overall Study|Adverse Event|0|||
131882809|NCT00962091|474852619|FG005|Overall Study|Adverse Event|0|||
131882810|NCT00962091|474852620|FG006|Overall Study|Adverse Event|1|||
131882811|NCT03721835|474852621|FG000|Overall Study|Participant not able to return|1|||
131882812|NCT03721835|474852621|FG000|Overall Study|Lost to Follow-up|1|||
131882813|NCT03721835|474852621|FG000|Overall Study|Revision of the components of the study device|2|||
131546674|NCT01106430|473624870|FG000|Overall Study|Previous Use Of Marijuana|1|||
131658946|NCT01732822|474037293|FG001|Overall Study|Withdrawal by Subject|113|||
131546675|NCT01106430|473624871|FG001|Overall Study|Previous Use Of Marijuana|0|||
131546676|NCT01106430|473624870|FG000|Overall Study|Protocol Violation|7|||
131546677|NCT01106430|473624871|FG001|Overall Study|Protocol Violation|2|||
131546678|NCT01106430|473624870|FG000|Overall Study|Withdrawal by Subject|8|||
131546679|NCT01106430|473624871|FG001|Overall Study|Withdrawal by Subject|4|||
131546680|NCT01255592|473624874|FG000|Overall Study|Adverse Event|5|||
131546681|NCT01255592|473624875|FG001|Overall Study|Adverse Event|0|||
131546682|NCT01255592|473624874|FG000|Overall Study|Withdrawal by Subject|1|||
131546683|NCT01255592|473624875|FG001|Overall Study|Withdrawal by Subject|0|||
131882814|NCT03721835|474852621|FG000|Overall Study|Sponsor terminated study|6|||
131882815|NCT03721835|474852621|FG000|Overall Study|Death|1|||
131882816|NCT03721835|474852621|FG000|Overall Study|Sponsor decision|1|||
131882817|NCT02326298|474852622|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131546684|NCT01255592|473624874|FG000|Overall Study|Other|0|||
131546685|NCT01255592|473624875|FG001|Overall Study|Other|1|||
131546686|NCT03704584|473624877|FG000|Overall Study|Withdrawal by Subject|1|||
131546687|NCT03704584|473624878|FG001|Overall Study|Withdrawal by Subject|0|||
131546688|NCT03439189|473624879|FG000|Overall Study|Protocol Violation|19|||
131546689|NCT03439189|473624879|FG000|Overall Study|Lack of Efficacy|63|||
131546690|NCT01777321|473624880|FG000|Overall Study|Withdrawal by Subject|0|||
131546691|NCT01777321|473624881|FG001|Overall Study|Withdrawal by Subject|1|||
131546692|NCT04791761|473624885|FG000|Overall Study|Lost to Follow-up|8|||
131546693|NCT04791761|473624886|FG001|Overall Study|Lost to Follow-up|6|||
131546694|NCT04791761|473624887|FG002|Overall Study|Lost to Follow-up|10|||
131546695|NCT04791761|473624885|FG000|Overall Study|Withdrawal by Subject|0|||
131546696|NCT04791761|473624886|FG001|Overall Study|Withdrawal by Subject|1|||
131546697|NCT04791761|473624887|FG002|Overall Study|Withdrawal by Subject|1|||
131546698|NCT04791761|473624885|FG000|Overall Study|Protocol Violation|0|||
131546699|NCT04791761|473624886|FG001|Overall Study|Protocol Violation|1|||
131546700|NCT04791761|473624887|FG002|Overall Study|Protocol Violation|1|||
131546701|NCT00089141|473624888|FG000|Overall Study|Termination of trial|18|||
131882818|NCT02326298|474852623|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882819|NCT02326298|474852624|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
131882820|NCT02326298|474852625|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882821|NCT02326298|474852626|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882822|NCT02326298|474852627|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882823|NCT02326298|474852628|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131546702|NCT00089141|473624889|FG001|Overall Study|Termination of trial|24|||
131546703|NCT00508261|473624892|FG000|Overall Study|Other|0|||
131546704|NCT00508261|473624893|FG001|Overall Study|Other|1|||
131546705|NCT00508261|473624894|FG002|Overall Study|Other|1|||
131546706|NCT00508261|473624895|FG003|Overall Study|Other|0|||
131546707|NCT00508261|473624892|FG000|Overall Study|Serious Adverse Event|0|||
131546708|NCT00508261|473624893|FG001|Overall Study|Serious Adverse Event|1|||
131546709|NCT00508261|473624894|FG002|Overall Study|Serious Adverse Event|0|||
131546710|NCT00508261|473624895|FG003|Overall Study|Serious Adverse Event|0|||
131546711|NCT00508261|473624892|FG000|Overall Study|Withdrawal by Subject|3|||
131882824|NCT02326298|474852629|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882825|NCT02326298|474852630|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882826|NCT02326298|474852631|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882827|NCT02326298|474852632|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882828|NCT02326298|474852633|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882829|NCT02326298|474852634|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882830|NCT02326298|474852635|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131882831|NCT02326298|474852622|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
131882832|NCT02326298|474852623|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131546712|NCT00508261|473624893|FG001|Overall Study|Withdrawal by Subject|4|||
131546713|NCT00508261|473624894|FG002|Overall Study|Withdrawal by Subject|4|||
131546714|NCT00508261|473624895|FG003|Overall Study|Withdrawal by Subject|0|||
131546715|NCT00508261|473624892|FG000|Overall Study|Migrated/ moved from study area|0|||
131546716|NCT00508261|473624893|FG001|Overall Study|Migrated/ moved from study area|1|||
131546717|NCT00508261|473624894|FG002|Overall Study|Migrated/ moved from study area|0|||
131546718|NCT00508261|473624895|FG003|Overall Study|Migrated/ moved from study area|0|||
131546719|NCT00508261|473624892|FG000|Overall Study|Lost to Follow-up|0|||
131546720|NCT00508261|473624893|FG001|Overall Study|Lost to Follow-up|1|||
131546721|NCT00508261|473624894|FG002|Overall Study|Lost to Follow-up|1|||
131546722|NCT00508261|473624895|FG003|Overall Study|Lost to Follow-up|1|||
131546723|NCT00180479|473624896|FG000|Overall Study|Death|4|||
131546724|NCT00180479|473624897|FG001|Overall Study|Death|2|||
131546725|NCT00180479|473624896|FG000|Overall Study|Lost to Follow-up|9|||
131546726|NCT00180479|473624897|FG001|Overall Study|Lost to Follow-up|7|||
131546727|NCT00180479|473624896|FG000|Overall Study|Withdrawal by Subject|3|||
131546728|NCT00180479|473624897|FG001|Overall Study|Withdrawal by Subject|3|||
131882833|NCT02326298|474852624|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131546729|NCT00180479|473624896|FG000|Overall Study|Informed consent not signed|0|||
131546730|NCT00180479|473624897|FG001|Overall Study|Informed consent not signed|1|||
131546731|NCT05131165|473624898|FG000|Overall Study|Death|1|||
131546732|NCT05131165|473624899|FG001|Overall Study|Death|1|||
131546733|NCT05131165|473624900|FG002|Overall Study|Death|0|||
131546734|NCT05131165|473624898|FG000|Overall Study|Lost to Follow-up|2|||
131546735|NCT05131165|473624899|FG001|Overall Study|Lost to Follow-up|2|||
131546736|NCT05131165|473624900|FG002|Overall Study|Lost to Follow-up|5|||
131546737|NCT05131165|473624898|FG000|Overall Study|Transferred out of clinic|1|||
131546738|NCT05131165|473624899|FG001|Overall Study|Transferred out of clinic|0|||
131546739|NCT05131165|473624900|FG002|Overall Study|Transferred out of clinic|3|||
131546740|NCT05131165|473624898|FG000|Overall Study|Dropped out|1|||
131546741|NCT05131165|473624899|FG001|Overall Study|Dropped out|2|||
131546742|NCT05131165|473624900|FG002|Overall Study|Dropped out|0|||
131546743|NCT00526630|473624914|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
131546744|NCT00526630|473624915|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
131546745|NCT00526630|473624914|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
131546746|NCT00526630|473624915|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
131546747|NCT02459262|473624916|FG000|Overall Study|Withdrawal by Subject|0|||
131546748|NCT02459262|473624917|FG001|Overall Study|Withdrawal by Subject|0|||
131546749|NCT02459262|473624918|FG002|Overall Study|Withdrawal by Subject|0|||
131546750|NCT02459262|473624919|FG003|Overall Study|Withdrawal by Subject|0|||
131546751|NCT02459262|473624920|FG004|Overall Study|Withdrawal by Subject|0|||
131546752|NCT02459262|473624921|FG005|Overall Study|Withdrawal by Subject|0|||
131546753|NCT02459262|473624922|FG006|Overall Study|Withdrawal by Subject|0|||
131546754|NCT02459262|473624923|FG007|Overall Study|Withdrawal by Subject|0|||
131546755|NCT02459262|473624924|FG008|Overall Study|Withdrawal by Subject|0|||
131546756|NCT02459262|473624925|FG009|Overall Study|Withdrawal by Subject|1|||
131546757|NCT02459262|473624926|FG010|Overall Study|Withdrawal by Subject|0|||
131546758|NCT00840801|473624927|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
131546759|NCT00840801|473624928|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
131546760|NCT00840801|473624929|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
131546761|NCT00840801|473624927|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
131546762|NCT00840801|473624928|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
131546763|NCT00840801|473624929|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
131546764|NCT00840801|473624927|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
131546765|NCT00840801|473624928|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
131546766|NCT00840801|473624929|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
131546767|NCT00840801|473624927|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
131546768|NCT00840801|473624928|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
131546769|NCT00840801|473624929|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
131546770|NCT01242748|473624930|FG000|Overall Study|Adverse Event|10|||
131546771|NCT01242748|473624931|FG001|Overall Study|Adverse Event|5|||
131546772|NCT01242748|473624930|FG000|Overall Study|Lost to Follow-up|6|||
131546773|NCT01242748|473624931|FG001|Overall Study|Lost to Follow-up|2|||
131546774|NCT01242748|473624930|FG000|Overall Study|Physician Decision|3|||
131546775|NCT01242748|473624931|FG001|Overall Study|Physician Decision|2|||
131546776|NCT01242748|473624930|FG000|Overall Study|Protocol Violation|1|||
131546777|NCT01242748|473624931|FG001|Overall Study|Protocol Violation|0|||
131546778|NCT01242748|473624930|FG000|Overall Study|Withdrawal by Subject|10|||
131546779|NCT01242748|473624931|FG001|Overall Study|Withdrawal by Subject|2|||
131546780|NCT01242748|473624930|FG000|Overall Study|Miscellaneous reasons|8|||
131546781|NCT01242748|473624931|FG001|Overall Study|Miscellaneous reasons|3|||
131546782|NCT01750879|473624940|FG000|Overall Study|Adverse Event|8|||
131546783|NCT01750879|473624941|FG001|Overall Study|Adverse Event|0|||
131546784|NCT01750879|473624940|FG000|Overall Study|Lack of Efficacy|1|||
131546785|NCT01750879|473624941|FG001|Overall Study|Lack of Efficacy|0|||
131546786|NCT01750879|473624940|FG000|Overall Study|Withdrawal by Subject|1|||
131546787|NCT01750879|473624941|FG001|Overall Study|Withdrawal by Subject|0|||
131546788|NCT01750879|473624940|FG000|Overall Study|Did not complete per protocol|0|||
131546789|NCT01750879|473624941|FG001|Overall Study|Did not complete per protocol|3|||
131546790|NCT03518125|473624946|FG000|Overall Study|Lost to Follow-up|0|||
131546791|NCT03518125|473624947|FG001|Overall Study|Lost to Follow-up|2|||
131546792|NCT03518125|473624948|FG002|Overall Study|Lost to Follow-up|0|||
131546793|NCT03518125|473624949|FG003|Overall Study|Lost to Follow-up|0|||
131546794|NCT03518125|473624950|FG004|Overall Study|Lost to Follow-up|3|||
131546795|NCT03518125|473624951|FG005|Overall Study|Lost to Follow-up|5|||
131546796|NCT03518125|473624946|FG000|Overall Study|Physician Decision|0|||
131546797|NCT03518125|473624947|FG001|Overall Study|Physician Decision|1|||
131546798|NCT03518125|473624948|FG002|Overall Study|Physician Decision|0|||
131546799|NCT03518125|473624949|FG003|Overall Study|Physician Decision|0|||
131546800|NCT03518125|473624950|FG004|Overall Study|Physician Decision|0|||
131546801|NCT03518125|473624951|FG005|Overall Study|Physician Decision|0|||
131546802|NCT03518125|473624946|FG000|Overall Study|Withdrawal by Subject|1|||
131546803|NCT03518125|473624947|FG001|Overall Study|Withdrawal by Subject|1|||
131546804|NCT03518125|473624948|FG002|Overall Study|Withdrawal by Subject|0|||
131546805|NCT03518125|473624949|FG003|Overall Study|Withdrawal by Subject|1|||
131546806|NCT03518125|473624950|FG004|Overall Study|Withdrawal by Subject|1|||
131546807|NCT03518125|473624951|FG005|Overall Study|Withdrawal by Subject|3|||
131546808|NCT03518125|473624946|FG000|Overall Study|Missed Day 394 Visit|1|||
131546809|NCT03518125|473624947|FG001|Overall Study|Missed Day 394 Visit|0|||
131546810|NCT03518125|473624948|FG002|Overall Study|Missed Day 394 Visit|0|||
131546811|NCT03518125|473624949|FG003|Overall Study|Missed Day 394 Visit|0|||
131546812|NCT03518125|473624950|FG004|Overall Study|Missed Day 394 Visit|0|||
131546813|NCT03518125|473624951|FG005|Overall Study|Missed Day 394 Visit|0|||
131546814|NCT02093663|473624956|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
131546815|NCT02093663|473624957|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
131546816|NCT02093663|473624958|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
131546817|NCT02093663|473624959|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
131546818|NCT02093663|473624960|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
131546819|NCT02093663|473624956|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
131546820|NCT02093663|473624957|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546821|NCT02093663|473624958|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546822|NCT02093663|473624959|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546823|NCT02093663|473624960|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546824|NCT02093663|473624956|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
131546825|NCT02093663|473624957|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
131546826|NCT02093663|473624958|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
131546827|NCT02093663|473624959|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
131546828|NCT02093663|473624960|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
131546829|NCT02093663|473624956|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
131546830|NCT02093663|473624957|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
131546831|NCT02093663|473624958|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
131546832|NCT02093663|473624959|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
131546833|NCT02093663|473624960|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
131546834|NCT02093663|473624956|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546835|NCT02093663|473624957|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546836|NCT02093663|473624958|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
131546837|NCT02093663|473624959|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546838|NCT02093663|473624960|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131546839|NCT02093663|473624956|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
131546840|NCT02093663|473624957|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
131546841|NCT02093663|473624958|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
131546842|NCT02093663|473624959|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
131546843|NCT02093663|473624960|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
131546844|NCT02093663|473624956|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
131546845|NCT02093663|473624957|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
131546846|NCT02093663|473624958|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
131546847|NCT02093663|473624959|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
131546848|NCT02093663|473624960|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
131546849|NCT02093663|473624956|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
131546850|NCT02093663|473624957|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
131546851|NCT02093663|473624958|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
131546852|NCT02093663|473624959|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
131546853|NCT02093663|473624960|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
131546854|NCT02093663|473624956|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
131546855|NCT02093663|473624957|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
131546856|NCT02093663|473624958|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
131546857|NCT02093663|473624959|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
131546858|NCT02093663|473624960|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
131546859|NCT00508404|473624963|FG000|Overall Study|Ongoing at Data Cut-off|12|||
131546860|NCT00508404|473624963|FG000|Overall Study|Adverse Event|2|||
131546861|NCT00508404|473624963|FG000|Overall Study|Death|16|||
131546862|NCT00508404|473624963|FG000|Overall Study|Physician Decision|2|||
131546863|NCT00508404|473624963|FG000|Overall Study|Withdrawal by Subject|3|||
131546864|NCT00508404|473624963|FG000|Overall Study|Protocol-specified Criteria|2|||
131546865|NCT00508404|473624963|FG000|Overall Study|Lost to Follow-up|2|||
131546866|NCT00508404|473624963|FG000|Overall Study|Other - Not Specified|3|||
131546867|NCT01078155|473624965|FG000|Overall Study|Adverse Event|7|||
131546868|NCT01078155|473624965|FG000|Overall Study|Lack of Efficacy|16|||
131546869|NCT01078155|473624965|FG000|Overall Study|Participant's Decision|6|||
131546870|NCT01078155|473624965|FG000|Overall Study|Lost to Follow-up|15|||
131546871|NCT03286751|473624966|FG000|Washout Period 1|Withdrawal by Subject|0|||
131546872|NCT03286751|473624967|FG001|Washout Period 1|Withdrawal by Subject|0|||
131658910|NCT01214642|474035459|FG001|Overall Study|Death|0|||
131434184|NCT01307319|473217453|FG001|Overall Study|Other|4|||
131546873|NCT03286751|473624968|FG002|Washout Period 1|Withdrawal by Subject|0|||
131546874|NCT03286751|473624969|FG003|Washout Period 1|Withdrawal by Subject|0|||
131546875|NCT03286751|473624970|FG004|Washout Period 1|Withdrawal by Subject|1|||
131546876|NCT03286751|473624971|FG005|Washout Period 1|Withdrawal by Subject|0|||
131658947|NCT02314780|474037294|FG000|Overall Study|organizational reasons|0|||
131658948|NCT02314780|474037295|FG001|Overall Study|organizational reasons|2|||
131658949|NCT02314780|474037296|FG002|Overall Study|organizational reasons|0|||
131658950|NCT02314780|474037294|FG000|Overall Study|Adverse Event|0|||
131658951|NCT02314780|474037295|FG001|Overall Study|Adverse Event|1|||
131658952|NCT02314780|474037296|FG002|Overall Study|Adverse Event|0|||
131658953|NCT00215137|474037300|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
131658954|NCT00215137|474037301|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
131658955|NCT00215137|474037302|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
131658956|NCT00215137|474037300|FG000|Randomization Period|Lost to Follow-up|0|||
131658957|NCT00215137|474037301|FG001|Randomization Period|Lost to Follow-up|1|||
131658958|NCT00215137|474037302|FG002|Randomization Period|Lost to Follow-up|0|||
131658959|NCT00215137|474037300|FG000|Randomization Period|Withdrawal by Subject|0|||
131658960|NCT00215137|474037301|FG001|Randomization Period|Withdrawal by Subject|1|||
131658961|NCT00215137|474037302|FG002|Randomization Period|Withdrawal by Subject|0|||
131658962|NCT03002220|474037304|FG000|Overall Study|Lack of Efficacy|2|||
131658963|NCT03002220|474037304|FG000|Overall Study|Withdrawal by Subject|3|||
131658964|NCT03002220|474037304|FG000|Overall Study|Adverse Event|2|||
131658965|NCT03002220|474037304|FG000|Overall Study|Disease progression|13|||
131658966|NCT03002220|474037304|FG000|Overall Study|Physician Decision|1|||
131658967|NCT01183260|474037307|FG000|Overall Study|Intraop screen failure|2|||
131658968|NCT01183260|474037308|FG001|Overall Study|Intraop screen failure|0|||
131658969|NCT01183260|474037307|FG000|Overall Study|Withdrawal by Subject|1|||
131658970|NCT01183260|474037308|FG001|Overall Study|Withdrawal by Subject|1|||
131658971|NCT01183260|474037307|FG000|Overall Study|Revised within 30 days|0|||
131658972|NCT01183260|474037308|FG001|Overall Study|Revised within 30 days|1|||
131658973|NCT01183260|474037307|FG000|Overall Study|Death|1|||
131658974|NCT01183260|474037308|FG001|Overall Study|Death|0|||
131658975|NCT00730275|474037309|FG000|Overall Study|Withdrawal by Subject|0|||
131658976|NCT00730275|474037310|FG001|Overall Study|Withdrawal by Subject|0|||
131658977|NCT00730275|474037311|FG002|Overall Study|Withdrawal by Subject|0|||
131658978|NCT00730275|474037312|FG003|Overall Study|Withdrawal by Subject|1|||
131658979|NCT03046121|474037317|FG000|Overall Study|Death|32|||
131658980|NCT03046121|474037318|FG001|Overall Study|Death|60|||
131658981|NCT03046121|474037317|FG000|Overall Study|Withdrawal by Subject|14|||
131658982|NCT03046121|474037318|FG001|Overall Study|Withdrawal by Subject|12|||
131658983|NCT00910039|474037319|FG000|Overall Study|Physician Decision|1|||
131658984|NCT04155047|474037322|FG000|Overall Study|Adverse Event|1|||
131658985|NCT04155047|474037323|FG001|Overall Study|Adverse Event|0|||
131658986|NCT04155047|474037322|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
131658987|NCT04155047|474037323|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
131658988|NCT03174431|474037331|FG000|Overall Study|Withdrawal by Subject|14|||
131658989|NCT03174431|474037332|FG001|Overall Study|Withdrawal by Subject|11|||
131658990|NCT03174431|474037331|FG000|Overall Study|alternative treatment|2|||
131658991|NCT03174431|474037332|FG001|Overall Study|alternative treatment|0|||
131658992|NCT03174431|474037331|FG000|Overall Study|Lost to Follow-up|1|||
131658993|NCT03174431|474037332|FG001|Overall Study|Lost to Follow-up|5|||
131658994|NCT03547739|474037333|FG000|Overall Study|Death|0|||
131658995|NCT03547739|474037334|FG001|Overall Study|Death|1|||
131658996|NCT03547739|474037335|FG002|Overall Study|Death|5|||
131658997|NCT03547739|474037333|FG000|Overall Study|Adverse Event|24|||
131658998|NCT03547739|474037334|FG001|Overall Study|Adverse Event|11|||
131658999|NCT03547739|474037335|FG002|Overall Study|Adverse Event|13|||
131659000|NCT03547739|474037333|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
131659001|NCT03547739|474037334|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
131659002|NCT03547739|474037335|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
131659003|NCT03547739|474037333|FG000|Overall Study|Lost to Follow-up|80|||
131434185|NCT01307319|473217454|FG002|Overall Study|Other|3|||
131434186|NCT04388111|473217456|FG000|Overall Study|Lost to Follow-up|5|||
131659004|NCT03547739|474037334|FG001|Overall Study|Lost to Follow-up|84|||
131659005|NCT03547739|474037335|FG002|Overall Study|Lost to Follow-up|116|||
131659006|NCT02075073|474037336|FG000|Overall Study|Withdrawal by Subject|0|||
131659007|NCT02075073|474037337|FG001|Overall Study|Withdrawal by Subject|1|||
131659008|NCT02075073|474037338|FG002|Overall Study|Withdrawal by Subject|0|||
131659009|NCT02797080|474037346|FG000|Overall Study|Lost to Follow-up|1|||
131659010|NCT02797080|474037346|FG000|Overall Study|Withdrawal by Subject|1|||
131659011|NCT04035499|474037349|FG000|Overall Study|Death|2|||
131659012|NCT04035499|474037349|FG000|Overall Study|Withdrawal by Subject|1|||
131659013|NCT00951015|474037350|FG000|Randomization Phase 96 Week|Adverse Event|1|||
131659014|NCT00951015|474037351|FG001|Randomization Phase 96 Week|Adverse Event|1|||
131659015|NCT00951015|474037352|FG002|Randomization Phase 96 Week|Adverse Event|2|||
131770294|NCT01266967|474437886|FG000|Overall Study|Death|69|||
131659016|NCT00951015|474037353|FG003|Randomization Phase 96 Week|Adverse Event|5|||
131659017|NCT00951015|474037354|FG004|Randomization Phase 96 Week|Adverse Event|0|||
131659018|NCT00951015|474037350|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
131659019|NCT00951015|474037351|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
131659020|NCT00951015|474037352|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
131659021|NCT00951015|474037353|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
131659022|NCT00951015|474037354|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
131659023|NCT00951015|474037350|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
131659024|NCT00951015|474037351|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
131659025|NCT00951015|474037352|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
131659026|NCT00951015|474037353|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
131659027|NCT00951015|474037354|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
131659028|NCT00951015|474037350|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131659029|NCT00951015|474037351|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131659030|NCT00951015|474037352|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131659031|NCT00951015|474037353|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
131659032|NCT00951015|474037354|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131659033|NCT00951015|474037350|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
131659034|NCT00951015|474037351|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
131659035|NCT00951015|474037352|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
131659036|NCT00951015|474037353|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
131659037|NCT00951015|474037354|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
131659038|NCT00951015|474037350|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
131659039|NCT00951015|474037351|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
131659040|NCT00951015|474037352|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
131659041|NCT00951015|474037353|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
131659042|NCT00951015|474037354|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
131659043|NCT00951015|474037350|FG000|Open-label Phase|Adverse Event|0|||
131659044|NCT00951015|474037351|FG001|Open-label Phase|Adverse Event|0|||
131659045|NCT00951015|474037352|FG002|Open-label Phase|Adverse Event|0|||
131659046|NCT00951015|474037353|FG003|Open-label Phase|Adverse Event|0|||
131659047|NCT00951015|474037354|FG004|Open-label Phase|Adverse Event|3|||
131659048|NCT00951015|474037350|FG000|Open-label Phase|Lack of Efficacy|0|||
131659049|NCT00951015|474037351|FG001|Open-label Phase|Lack of Efficacy|0|||
131659050|NCT00951015|474037352|FG002|Open-label Phase|Lack of Efficacy|0|||
131659051|NCT00951015|474037353|FG003|Open-label Phase|Lack of Efficacy|0|||
131659052|NCT00951015|474037354|FG004|Open-label Phase|Lack of Efficacy|1|||
131882834|NCT02326298|474852625|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131882835|NCT02326298|474852626|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131882836|NCT02326298|474852627|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131882837|NCT02326298|474852628|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131659053|NCT00951015|474037350|FG000|Open-label Phase|Protocol Violation|0|||
131659054|NCT00951015|474037351|FG001|Open-label Phase|Protocol Violation|0|||
131659055|NCT00951015|474037352|FG002|Open-label Phase|Protocol Violation|0|||
131659056|NCT00951015|474037353|FG003|Open-label Phase|Protocol Violation|0|||
131659057|NCT00951015|474037354|FG004|Open-label Phase|Protocol Violation|12|||
131659058|NCT00951015|474037350|FG000|Open-label Phase|Lost to Follow-up|0|||
131659059|NCT00951015|474037351|FG001|Open-label Phase|Lost to Follow-up|0|||
131659060|NCT00951015|474037352|FG002|Open-label Phase|Lost to Follow-up|0|||
131659061|NCT00951015|474037353|FG003|Open-label Phase|Lost to Follow-up|0|||
131659062|NCT00951015|474037354|FG004|Open-label Phase|Lost to Follow-up|12|||
131659063|NCT00951015|474037350|FG000|Open-label Phase|Withdrawal by Subject|0|||
131659064|NCT00951015|474037351|FG001|Open-label Phase|Withdrawal by Subject|0|||
131659065|NCT00951015|474037352|FG002|Open-label Phase|Withdrawal by Subject|0|||
131659066|NCT00951015|474037353|FG003|Open-label Phase|Withdrawal by Subject|0|||
131659067|NCT00951015|474037354|FG004|Open-label Phase|Withdrawal by Subject|14|||
131659068|NCT00951015|474037350|FG000|Open-label Phase|Physician Decision|0|||
131659069|NCT00951015|474037351|FG001|Open-label Phase|Physician Decision|0|||
131659070|NCT00951015|474037352|FG002|Open-label Phase|Physician Decision|0|||
131659071|NCT00951015|474037353|FG003|Open-label Phase|Physician Decision|0|||
131659072|NCT00951015|474037354|FG004|Open-label Phase|Physician Decision|8|||
131659073|NCT01208103|474037356|FG000|Overall Study|Adverse Event|1|||
131659074|NCT01208103|474037356|FG000|Overall Study|Withdrawal by Subject|1|||
131659075|NCT03819634|474037357|FG000|Overall Study|Physician Decision|2|||
131659076|NCT00299494|474037358|FG000|Overall Study|Withdrawal by Subject|0|||
131659077|NCT00299494|474037359|FG001|Overall Study|Withdrawal by Subject|0|||
131659078|NCT00299494|474037360|FG002|Overall Study|Withdrawal by Subject|0|||
131659079|NCT00299494|474037361|FG003|Overall Study|Withdrawal by Subject|3|||
131659080|NCT00299494|474037362|FG004|Overall Study|Withdrawal by Subject|1|||
131659081|NCT00299494|474037363|FG005|Overall Study|Withdrawal by Subject|4|||
131659082|NCT00299494|474037358|FG000|Overall Study|Physician Decision|0|||
131659083|NCT00299494|474037359|FG001|Overall Study|Physician Decision|0|||
131659084|NCT00299494|474037360|FG002|Overall Study|Physician Decision|0|||
131659085|NCT00299494|474037361|FG003|Overall Study|Physician Decision|0|||
131659086|NCT00299494|474037362|FG004|Overall Study|Physician Decision|1|||
131659087|NCT00299494|474037363|FG005|Overall Study|Physician Decision|0|||
131659088|NCT00299494|474037358|FG000|Overall Study|Death|3|||
131659089|NCT00299494|474037359|FG001|Overall Study|Death|1|||
131659090|NCT00299494|474037360|FG002|Overall Study|Death|4|||
131659091|NCT00299494|474037361|FG003|Overall Study|Death|6|||
131659092|NCT00299494|474037362|FG004|Overall Study|Death|18|||
131659093|NCT00299494|474037363|FG005|Overall Study|Death|19|||
131659094|NCT00299494|474037358|FG000|Overall Study|Lost to Follow-up|0|||
131659095|NCT00299494|474037359|FG001|Overall Study|Lost to Follow-up|0|||
131659096|NCT00299494|474037360|FG002|Overall Study|Lost to Follow-up|0|||
131659097|NCT00299494|474037361|FG003|Overall Study|Lost to Follow-up|0|||
131659098|NCT00299494|474037362|FG004|Overall Study|Lost to Follow-up|3|||
131659099|NCT00299494|474037363|FG005|Overall Study|Lost to Follow-up|1|||
131659100|NCT00299494|474037358|FG000|Overall Study|Other - Unspecified|0|||
131659101|NCT00299494|474037359|FG001|Overall Study|Other - Unspecified|0|||
131659102|NCT00299494|474037360|FG002|Overall Study|Other - Unspecified|0|||
131659103|NCT00299494|474037361|FG003|Overall Study|Other - Unspecified|0|||
131659104|NCT00299494|474037362|FG004|Overall Study|Other - Unspecified|3|||
131659105|NCT00299494|474037363|FG005|Overall Study|Other - Unspecified|1|||
131659106|NCT00299494|474037358|FG000|Overall Study|Other - site closure|0|||
131659107|NCT00299494|474037359|FG001|Overall Study|Other - site closure|0|||
131659108|NCT00299494|474037360|FG002|Overall Study|Other - site closure|0|||
131659109|NCT00299494|474037361|FG003|Overall Study|Other - site closure|1|||
131659110|NCT00299494|474037362|FG004|Overall Study|Other - site closure|1|||
131659111|NCT00299494|474037363|FG005|Overall Study|Other - site closure|1|||
131659112|NCT00416195|474037364|FG000|Overall Study|Adverse Event|1|||
131659113|NCT00416195|474037365|FG001|Overall Study|Adverse Event|2|||
131659114|NCT00416195|474037364|FG000|Overall Study|Protocol Violation|1|||
131659115|NCT00416195|474037365|FG001|Overall Study|Protocol Violation|1|||
131659116|NCT00416195|474037364|FG000|Overall Study|Other|0|||
131659117|NCT00416195|474037365|FG001|Overall Study|Other|1|||
131659118|NCT01417104|474037371|FG000|Overall Study|Withdrawal by Subject|5|||
131659119|NCT01417104|474037372|FG001|Overall Study|Withdrawal by Subject|1|||
131659120|NCT01417104|474037371|FG000|Overall Study|Failure to make contact|0|||
131659121|NCT01417104|474037372|FG001|Overall Study|Failure to make contact|1|||
131659122|NCT01417104|474037371|FG000|Overall Study|Adverse Event|1|||
131659123|NCT01417104|474037372|FG001|Overall Study|Adverse Event|0|||
131659124|NCT03361605|474037373|FG000|Overall Study|Analyzable data not available|3|||
131659125|NCT01305408|474037374|FG000|Overall Study|Adverse Event|10|||
131659126|NCT01305408|474037375|FG001|Overall Study|Adverse Event|7|||
131659127|NCT01305408|474037374|FG000|Overall Study|Lack of Efficacy|3|||
131659128|NCT01305408|474037375|FG001|Overall Study|Lack of Efficacy|4|||
131659129|NCT01305408|474037374|FG000|Overall Study|Withdrawal by Subject|9|||
131659130|NCT01305408|474037375|FG001|Overall Study|Withdrawal by Subject|9|||
131659131|NCT01305408|474037374|FG000|Overall Study|Protocol Violation|4|||
131659132|NCT01305408|474037375|FG001|Overall Study|Protocol Violation|6|||
131659133|NCT01305408|474037374|FG000|Overall Study|Lost to Follow-up|5|||
131659134|NCT01305408|474037375|FG001|Overall Study|Lost to Follow-up|3|||
131659135|NCT01305408|474037374|FG000|Overall Study|Noncompliance with study medication|0|||
131659136|NCT01305408|474037375|FG001|Overall Study|Noncompliance with study medication|1|||
131659137|NCT01305408|474037374|FG000|Overall Study|Noncompliance with study procedures|0|||
131659138|NCT01305408|474037375|FG001|Overall Study|Noncompliance with study procedures|1|||
131659139|NCT01305408|474037374|FG000|Overall Study|Other|1|||
131659140|NCT01305408|474037375|FG001|Overall Study|Other|0|||
131659141|NCT03101462|474037376|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
131659142|NCT03101462|474037377|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
131659143|NCT02530970|474037379|FG000|Overall Study|Adverse Event|8|||
131659144|NCT02530970|474037379|FG000|Overall Study|Lost to Follow-up|88|||
131659145|NCT02530970|474037379|FG000|Overall Study|Physician Decision|5|||
131659146|NCT02530970|474037379|FG000|Overall Study|Withdrawal by Subject|14|||
131659147|NCT02530970|474037379|FG000|Overall Study|Death|6|||
131659148|NCT02530970|474037379|FG000|Overall Study|Hospitalization|1|||
131659149|NCT02530970|474037379|FG000|Overall Study|Insurance|2|||
131659150|NCT02530970|474037379|FG000|Overall Study|Explant|2|||
131659151|NCT02530970|474037379|FG000|Overall Study|Change in Provider|5|||
131659152|NCT02530970|474037379|FG000|Overall Study|Relocation|3|||
131659153|NCT02770612|474037380|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
131659154|NCT00403767|474037383|FG000|Overall Study|Adverse Event|993|||
131659155|NCT00403767|474037384|FG001|Overall Study|Adverse Event|919|||
131659156|NCT00403767|474037383|FG000|Overall Study|Non-compliant with study medication|134|||
131659157|NCT00403767|474037384|FG001|Overall Study|Non-compliant with study medication|164|||
131659158|NCT00403767|474037383|FG000|Overall Study|Consent withdrawn|671|||
131659159|NCT00403767|474037384|FG001|Overall Study|Consent withdrawn|673|||
131659160|NCT00403767|474037383|FG000|Overall Study|Investigator dec./not protocol-related|191|||
131659161|NCT00403767|474037384|FG001|Overall Study|Investigator dec./not protocol-related|178|||
131659162|NCT00403767|474037383|FG000|Overall Study|Lost to Follow-up|6|||
131659163|NCT00403767|474037384|FG001|Overall Study|Lost to Follow-up|8|||
131434187|NCT04388111|473217457|FG001|Overall Study|Lost to Follow-up|3|||
131659164|NCT00403767|474037383|FG000|Overall Study|Protocol Violation|142|||
131659165|NCT00403767|474037384|FG001|Overall Study|Protocol Violation|124|||
131659166|NCT00403767|474037383|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
131659167|NCT00403767|474037384|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
131659168|NCT00403767|474037383|FG000|Overall Study|Study terminated by sponsor|82|||
131659169|NCT00403767|474037384|FG001|Overall Study|Study terminated by sponsor|69|||
131659170|NCT00403767|474037383|FG000|Overall Study|Missing/incomplete data|1|||
131659171|NCT00403767|474037384|FG001|Overall Study|Missing/incomplete data|1|||
131659172|NCT01152814|474037396|FG000|Overall Study|Lost to Follow-up|2|||
131659173|NCT01877239|474037397|FG000|Overall Study|Adverse Event|4|||
131659174|NCT01877239|474037397|FG000|Overall Study|Disease Remission|1|||
131659175|NCT01877239|474037397|FG000|Overall Study|Withdrawal by Subject|4|||
131659176|NCT01877239|474037397|FG000|Overall Study|Other|2|||
131659177|NCT01877239|474037397|FG000|Overall Study|Lack of Efficacy|4|||
131659178|NCT01877239|474037397|FG000|Overall Study|Data not available|35|||
131659179|NCT01669577|474037398|FG000|Overall Study|Death|22|||
131659180|NCT01669577|474037398|FG000|Overall Study|Lost to Follow-up|78|||
131659181|NCT01669577|474037398|FG000|Overall Study|Physician Decision|34|||
131659182|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
131434188|NCT04388111|473217456|FG000|Overall Study|Adverse Event|1|||
131434189|NCT04388111|473217457|FG001|Overall Study|Adverse Event|1|||
131434190|NCT04388111|473217456|FG000|Overall Study|Protocol Violation|2|||
131434191|NCT04388111|473217457|FG001|Overall Study|Protocol Violation|4|||
131434192|NCT04388111|473217456|FG000|Overall Study|Withdrawal by Subject|1|||
131434193|NCT04388111|473217457|FG001|Overall Study|Withdrawal by Subject|0|||
131434194|NCT02735239|473217458|FG000|Overall Study|Adverse Event|0|||
131434195|NCT02735239|473217459|FG001|Overall Study|Adverse Event|0|||
131546877|NCT03286751|473624966|FG000|Washout Period 2|Personal Reasons|0|||
131546878|NCT03286751|473624967|FG001|Washout Period 2|Personal Reasons|1|||
131546879|NCT03286751|473624968|FG002|Washout Period 2|Personal Reasons|0|||
131546880|NCT03286751|473624969|FG003|Washout Period 2|Personal Reasons|0|||
131546881|NCT03286751|473624970|FG004|Washout Period 2|Personal Reasons|0|||
131546882|NCT03286751|473624971|FG005|Washout Period 2|Personal Reasons|0|||
131434196|NCT02735239|473217460|FG002|Overall Study|Adverse Event|4|||
131434197|NCT02735239|473217461|FG003|Overall Study|Adverse Event|0|||
131434198|NCT02735239|473217462|FG004|Overall Study|Adverse Event|0|||
131434199|NCT02735239|473217463|FG005|Overall Study|Adverse Event|0|||
131434200|NCT02735239|473217458|FG000|Overall Study|Death|1|||
131434201|NCT02735239|473217459|FG001|Overall Study|Death|1|||
131434202|NCT02735239|473217460|FG002|Overall Study|Death|0|||
131434203|NCT02735239|473217461|FG003|Overall Study|Death|0|||
131434204|NCT02735239|473217462|FG004|Overall Study|Death|0|||
131434205|NCT02735239|473217463|FG005|Overall Study|Death|0|||
131434206|NCT02735239|473217458|FG000|Overall Study|Physician Decision|0|||
131434207|NCT02735239|473217459|FG001|Overall Study|Physician Decision|0|||
131434208|NCT02735239|473217460|FG002|Overall Study|Physician Decision|1|||
131434209|NCT02735239|473217461|FG003|Overall Study|Physician Decision|0|||
131434210|NCT02735239|473217462|FG004|Overall Study|Physician Decision|0|||
131434211|NCT02735239|473217463|FG005|Overall Study|Physician Decision|0|||
131434212|NCT02735239|473217458|FG000|Overall Study|Progressive disease|3|||
131434213|NCT02735239|473217459|FG001|Overall Study|Progressive disease|1|||
131546883|NCT03286751|473624966|FG000|Washout Period 5|Adverse Event|0|||
131546884|NCT03286751|473624967|FG001|Washout Period 5|Adverse Event|0|||
131546885|NCT03286751|473624968|FG002|Washout Period 5|Adverse Event|0|||
131546886|NCT03286751|473624969|FG003|Washout Period 5|Adverse Event|0|||
131546887|NCT03286751|473624970|FG004|Washout Period 5|Adverse Event|1|||
131546888|NCT03286751|473624971|FG005|Washout Period 5|Adverse Event|0|||
131546889|NCT04067401|473624972|FG000|Overall Study|Withdrawal by Subject|7|||
131546890|NCT04067401|473624973|FG001|Overall Study|Withdrawal by Subject|0|||
131546891|NCT04067401|473624972|FG000|Overall Study|no data provided|1|||
131546892|NCT04067401|473624973|FG001|Overall Study|no data provided|0|||
131546893|NCT01050816|473624976|FG000|Overall Study|Lost to Follow-up|2|||
131546894|NCT01050816|473624976|FG000|Overall Study|patient's refusal|2|||
131434214|NCT02735239|473217460|FG002|Overall Study|Progressive disease|3|||
131434215|NCT02735239|473217461|FG003|Overall Study|Progressive disease|0|||
131434216|NCT02735239|473217462|FG004|Overall Study|Progressive disease|0|||
131434217|NCT02735239|473217463|FG005|Overall Study|Progressive disease|2|||
131434218|NCT02735239|473217458|FG000|Overall Study|Withdrawal by Subject|0|||
131434219|NCT02735239|473217459|FG001|Overall Study|Withdrawal by Subject|1|||
131434220|NCT02735239|473217460|FG002|Overall Study|Withdrawal by Subject|0|||
131434221|NCT02735239|473217461|FG003|Overall Study|Withdrawal by Subject|0|||
131434222|NCT02735239|473217462|FG004|Overall Study|Withdrawal by Subject|0|||
131546895|NCT00238433|473624982|FG000|Overall Study|Screen failure|1|||
131546896|NCT00238433|473624982|FG000|Overall Study|Lost to Follow-up|1|||
131546897|NCT00238433|473624982|FG000|Overall Study|Death|1|||
131434223|NCT02735239|473217463|FG005|Overall Study|Withdrawal by Subject|0|||
131546898|NCT01972529|473624985|FG000|Overall Study|Adverse Event|0|||
131546899|NCT01972529|473624986|FG001|Overall Study|Adverse Event|1|||
131546900|NCT01972529|473624987|FG002|Overall Study|Adverse Event|0|||
131659183|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
131659184|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
131659185|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
131659186|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
131659187|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
131659188|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
131659189|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
131659190|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
131659191|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
131659192|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Adverse Event|0|||
131659193|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Adverse Event|0|||
131659194|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Adverse Event|3|||
131659195|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Adverse Event|2|||
131659196|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Adverse Event|13|||
131659197|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
131659198|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
131659199|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
131659200|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
131659201|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
131659202|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Patient's wish|0|||
131659203|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Patient's wish|0|||
131659204|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Patient's wish|19|||
131659205|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Patient's wish|9|||
131659206|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Patient's wish|20|||
131659207|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
131659208|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
131659209|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
131659210|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
131659211|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
131659212|NCT00444275|474037399|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
131659213|NCT00444275|474037400|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
131659214|NCT00444275|474037401|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
131659215|NCT00444275|474037402|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
131659216|NCT00444275|474037403|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
131659217|NCT01204710|474037404|FG000|Randomization Treatment|Lost to Follow-up|1|||
131659218|NCT01204710|474037405|FG001|Randomization Treatment|Lost to Follow-up|0|||
131659219|NCT01204710|474037404|FG000|Randomization Treatment|Withdrawal by Subject|6|||
131659220|NCT01204710|474037405|FG001|Randomization Treatment|Withdrawal by Subject|5|||
131659221|NCT01204710|474037404|FG000|Randomization Treatment|Physician Decision|3|||
131659222|NCT01204710|474037405|FG001|Randomization Treatment|Physician Decision|2|||
131659223|NCT01204710|474037404|FG000|Randomization Treatment|Entry criteria not met|0|||
131659224|NCT01204710|474037405|FG001|Randomization Treatment|Entry criteria not met|1|||
131659225|NCT01204710|474037404|FG000|Randomization Treatment|Adverse Event|4|||
131659226|NCT01204710|474037405|FG001|Randomization Treatment|Adverse Event|2|||
131659227|NCT01204710|474037404|FG000|Randomization Treatment|Sponsor Decision|0|||
131659228|NCT01204710|474037405|FG001|Randomization Treatment|Sponsor Decision|1|||
131659229|NCT01204710|474037404|FG000|Randomization Treatment|Worsening of General condition|0|||
131659230|NCT01204710|474037405|FG001|Randomization Treatment|Worsening of General condition|1|||
131659231|NCT01204710|474037404|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
131659232|NCT01204710|474037405|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
131659233|NCT01204710|474037404|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
131659234|NCT01204710|474037405|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
131659235|NCT01204710|474037404|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
131659236|NCT01204710|474037405|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
131659237|NCT01204710|474037404|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
131659238|NCT01204710|474037405|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
131659239|NCT00743431|474037406|FG000|Overall Study|Toxicity|6|||
131659240|NCT00743431|474037406|FG000|Overall Study|Tumor progression|56|||
131659241|NCT00743431|474037406|FG000|Overall Study|Withdrawal by Subject|13|||
131659242|NCT00743431|474037406|FG000|Overall Study|Death|9|||
131659243|NCT00743431|474037406|FG000|Overall Study|Reason for discontinuation not specified|29|||
131659244|NCT00743431|474037406|FG000|Overall Study|No documentation available|13|||
131659245|NCT03291288|474037407|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
131659246|NCT03291288|474037408|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
131659247|NCT03291288|474037407|FG000|Drug-drug Interaction Phase|Disease progression|1|||
131882838|NCT02326298|474852629|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131659248|NCT03291288|474037408|FG001|Drug-drug Interaction Phase|Disease progression|0|||
131659249|NCT03291288|474037407|FG000|Drug-drug Interaction Phase|Other|3|||
131882839|NCT02326298|474852630|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131659250|NCT03291288|474037408|FG001|Drug-drug Interaction Phase|Other|0|||
131659251|NCT03291288|474037407|FG000|Pexidartinib Only|Ongoing|0|||
131659252|NCT03291288|474037408|FG001|Pexidartinib Only|Ongoing|2|||
131659253|NCT04276415|474037409|FG000|Overall Study|Adverse Event|0|||
131659254|NCT04276415|474037410|FG001|Overall Study|Adverse Event|0|||
131659255|NCT04276415|474037411|FG002|Overall Study|Adverse Event|0|||
131659256|NCT04276415|474037412|FG003|Overall Study|Adverse Event|3|||
131659257|NCT04276415|474037413|FG004|Overall Study|Adverse Event|0|||
131659258|NCT04276415|474037414|FG005|Overall Study|Adverse Event|0|||
131659259|NCT04276415|474037409|FG000|Overall Study|Clinical progression|1|||
131659260|NCT04276415|474037410|FG001|Overall Study|Clinical progression|1|||
131659261|NCT04276415|474037411|FG002|Overall Study|Clinical progression|0|||
131659262|NCT04276415|474037412|FG003|Overall Study|Clinical progression|0|||
131659263|NCT04276415|474037413|FG004|Overall Study|Clinical progression|1|||
131659264|NCT04276415|474037414|FG005|Overall Study|Clinical progression|0|||
131659265|NCT04276415|474037409|FG000|Overall Study|Other|0|||
131659266|NCT04276415|474037410|FG001|Overall Study|Other|0|||
131659267|NCT04276415|474037411|FG002|Overall Study|Other|0|||
131659268|NCT04276415|474037412|FG003|Overall Study|Other|1|||
131659269|NCT04276415|474037413|FG004|Overall Study|Other|0|||
131659270|NCT04276415|474037414|FG005|Overall Study|Other|0|||
131659271|NCT04276415|474037409|FG000|Overall Study|Physician Decision|0|||
131659272|NCT04276415|474037410|FG001|Overall Study|Physician Decision|0|||
131659273|NCT04276415|474037411|FG002|Overall Study|Physician Decision|1|||
131659274|NCT04276415|474037412|FG003|Overall Study|Physician Decision|3|||
131659275|NCT04276415|474037413|FG004|Overall Study|Physician Decision|2|||
131659276|NCT04276415|474037414|FG005|Overall Study|Physician Decision|0|||
131659277|NCT04276415|474037409|FG000|Overall Study|Progressive disease|3|||
131659278|NCT04276415|474037410|FG001|Overall Study|Progressive disease|3|||
131659279|NCT04276415|474037411|FG002|Overall Study|Progressive disease|4|||
131659280|NCT04276415|474037412|FG003|Overall Study|Progressive disease|5|||
131659281|NCT04276415|474037413|FG004|Overall Study|Progressive disease|1|||
131659282|NCT04276415|474037414|FG005|Overall Study|Progressive disease|2|||
131659283|NCT04276415|474037409|FG000|Overall Study|Withdrawal by patient|0|||
131659284|NCT04276415|474037410|FG001|Overall Study|Withdrawal by patient|0|||
131659285|NCT04276415|474037411|FG002|Overall Study|Withdrawal by patient|0|||
131659286|NCT04276415|474037412|FG003|Overall Study|Withdrawal by patient|1|||
131659287|NCT04276415|474037413|FG004|Overall Study|Withdrawal by patient|2|||
131659288|NCT04276415|474037414|FG005|Overall Study|Withdrawal by patient|0|||
131659289|NCT03309813|474037415|FG000|Main Randomized Study|Withdrawal by Subject|1|||
131659290|NCT03309813|474037416|FG001|Main Randomized Study|Withdrawal by Subject|0|||
131659291|NCT01989169|474037419|FG000|Period 2|Adverse Event|0|||
131659292|NCT01989169|474037420|FG001|Period 2|Adverse Event|1|||
131659293|NCT02406677|474037421|FG000|Overall Study|Death|16|||
131659294|NCT02406677|474037422|FG001|Overall Study|Death|8|||
131659295|NCT02406677|474037421|FG000|Overall Study|Discharged without P2Y12|1|||
131659296|NCT02406677|474037422|FG001|Overall Study|Discharged without P2Y12|3|||
131659297|NCT02406677|474037421|FG000|Overall Study|Discharged on prasugrel|283|||
131659298|NCT02406677|474037422|FG001|Overall Study|Discharged on prasugrel|587|||
131659299|NCT02406677|474037421|FG000|Overall Study|Withdrawal by Subject|1|||
131659300|NCT02406677|474037422|FG001|Overall Study|Withdrawal by Subject|0|||
131659301|NCT04531904|474037423|FG000|Overall Study|Lost to Follow-up|1|||
131659302|NCT04531904|474037423|FG000|Overall Study|Death|14|||
131659303|NCT00283244|474037424|FG000|Overall Study|Adverse Event|0|||
131659304|NCT00283244|474037425|FG001|Overall Study|Adverse Event|8|||
131659305|NCT00283244|474037426|FG002|Overall Study|Adverse Event|11|||
131659306|NCT00283244|474037424|FG000|Overall Study|Death|4|||
131659307|NCT00283244|474037425|FG001|Overall Study|Death|3|||
131659308|NCT00283244|474037426|FG002|Overall Study|Death|2|||
131659309|NCT00283244|474037424|FG000|Overall Study|Lack of Efficacy|8|||
131659310|NCT00283244|474037425|FG001|Overall Study|Lack of Efficacy|32|||
131659311|NCT00283244|474037426|FG002|Overall Study|Lack of Efficacy|26|||
131659312|NCT00283244|474037424|FG000|Overall Study|Withdrawal by Subject|1|||
131659313|NCT00283244|474037425|FG001|Overall Study|Withdrawal by Subject|2|||
131659314|NCT00283244|474037426|FG002|Overall Study|Withdrawal by Subject|2|||
131659315|NCT00283244|474037424|FG000|Overall Study|Physician Decision|0|||
131659316|NCT00283244|474037425|FG001|Overall Study|Physician Decision|0|||
131659317|NCT00283244|474037426|FG002|Overall Study|Physician Decision|1|||
131659318|NCT00283244|474037424|FG000|Overall Study|Medical illness (other complicating dz)|4|||
131659319|NCT00283244|474037425|FG001|Overall Study|Medical illness (other complicating dz)|3|||
131882840|NCT02326298|474852631|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131659320|NCT00283244|474037426|FG002|Overall Study|Medical illness (other complicating dz)|6|||
131659321|NCT00283244|474037424|FG000|Overall Study|Clinical deterioration|1|||
131659322|NCT00283244|474037425|FG001|Overall Study|Clinical deterioration|3|||
131659323|NCT00283244|474037426|FG002|Overall Study|Clinical deterioration|3|||
131659324|NCT00586612|474037427|FG000|Primary Phase|Protocol Violation|1|||
131659325|NCT00586612|474037428|FG001|Primary Phase|Protocol Violation|0|||
131659326|NCT00586612|474037427|FG000|Primary Phase|Lost to Follow-up|0|||
131659327|NCT00586612|474037428|FG001|Primary Phase|Lost to Follow-up|1|||
131659328|NCT00586612|474037427|FG000|Primary Phase|Withdrawal by Subject|0|||
131659329|NCT00586612|474037428|FG001|Primary Phase|Withdrawal by Subject|2|||
131659330|NCT00586612|474037427|FG000|Booster Phase|Lost to Follow-up|3|||
131659331|NCT00586612|474037428|FG001|Booster Phase|Lost to Follow-up|1|||
131659332|NCT01609062|474037429|FG000|Extension Phase|Terminated by Sponsor|14|||
131659333|NCT01609062|474037430|FG001|Extension Phase|Terminated by Sponsor|9|||
131659334|NCT01609062|474037429|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
131659335|NCT01609062|474037430|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
131659336|NCT01609062|474037429|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
131659337|NCT01609062|474037430|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
131659338|NCT02738853|474037431|FG000|Enrollment|Inclusion/Exclusion not met|21|||
131659339|NCT02738853|474037431|FG000|Enrollment|Withdrawal by Subject|3|||
131659340|NCT02738853|474037431|FG000|Enrollment|Subject treated with commercially available device|6|||
131659341|NCT02738853|474037431|FG000|Enrollment|Study Enrollment Closed|3|||
131659342|NCT02738853|474037431|FG000|Procedure|Death|1|||
131659343|NCT02738853|474037431|FG000|1 Month|Death|2|||
131659344|NCT02738853|474037431|FG000|6 Month|Death|4|||
131659345|NCT02738853|474037431|FG000|6 Month|Withdrawal by Subject|2|||
131659346|NCT02738853|474037431|FG000|1 Year|Death|6|||
131659347|NCT02738853|474037431|FG000|1 Year|Withdrawal by Subject|1|||
131659348|NCT02738853|474037431|FG000|2 Year|Death|2|||
131659349|NCT02738853|474037431|FG000|2 Year|Lost to Follow-up|1|||
131659350|NCT02738853|474037431|FG000|3 Year|Death|2|||
131659351|NCT02738853|474037431|FG000|3 Year|Withdrawal by Subject|1|||
131659352|NCT02738853|474037431|FG000|4 Year|Death|9|||
131659353|NCT02738853|474037431|FG000|5 Year|Lost to Follow-up|4|||
131659354|NCT02235311|474037432|FG000|Overall Study|Lost to Follow-up|0|||
131546901|NCT01972529|473624988|FG003|Overall Study|Adverse Event|0|||
131546902|NCT01972529|473624985|FG000|Overall Study|Lost to Follow-up|1|||
131546903|NCT01972529|473624986|FG001|Overall Study|Lost to Follow-up|0|||
131546904|NCT01972529|473624987|FG002|Overall Study|Lost to Follow-up|0|||
131546905|NCT01972529|473624988|FG003|Overall Study|Lost to Follow-up|0|||
131546906|NCT01972529|473624985|FG000|Overall Study|Participant Choice|0|||
131546907|NCT01972529|473624986|FG001|Overall Study|Participant Choice|1|||
131546908|NCT01972529|473624987|FG002|Overall Study|Participant Choice|0|||
131546909|NCT01972529|473624988|FG003|Overall Study|Participant Choice|0|||
131546910|NCT01972529|473624985|FG000|Overall Study|Withdrawl of Consent|1|||
131546911|NCT01972529|473624986|FG001|Overall Study|Withdrawl of Consent|2|||
131546912|NCT01972529|473624987|FG002|Overall Study|Withdrawl of Consent|0|||
131546913|NCT01972529|473624988|FG003|Overall Study|Withdrawl of Consent|1|||
131546914|NCT01972529|473624985|FG000|Overall Study|Other|0|||
131546915|NCT01972529|473624986|FG001|Overall Study|Other|0|||
131546916|NCT01972529|473624987|FG002|Overall Study|Other|0|||
131546917|NCT01972529|473624988|FG003|Overall Study|Other|2|||
131546918|NCT01972529|473624985|FG000|Overall Study|Not treated|0|||
131546919|NCT01972529|473624986|FG001|Overall Study|Not treated|1|||
131546920|NCT01972529|473624987|FG002|Overall Study|Not treated|2|||
131546921|NCT01972529|473624988|FG003|Overall Study|Not treated|1|||
131659355|NCT02235311|474037433|FG001|Overall Study|Lost to Follow-up|1|||
131659356|NCT02235311|474037432|FG000|Overall Study|Protocol Violation|0|||
131659357|NCT02235311|474037433|FG001|Overall Study|Protocol Violation|1|||
131659358|NCT00658788|474037434|FG000|Overall Study|Adverse Event|11|||
131659359|NCT00658788|474037434|FG000|Overall Study|Withdrawal by Subject|13|||
131659360|NCT00658788|474037434|FG000|Overall Study|Lost to Follow-up|18|||
131659361|NCT00658788|474037434|FG000|Overall Study|Treatment Discontinuation|32|||
131659362|NCT05384938|474037435|FG000|Overall Study|Withdrawal by Subject|8|||
131659363|NCT05384938|474037435|FG000|Overall Study|Lost to Follow-up|6|||
131659364|NCT05384938|474037435|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
131659365|NCT02626455|474037436|FG000|Overall Study|Other|1|||
131659366|NCT02626455|474037437|FG001|Overall Study|Other|1|||
131659367|NCT02626455|474037438|FG002|Overall Study|Other|0|||
131659368|NCT02626455|474037439|FG003|Overall Study|Other|0|||
131659369|NCT02626455|474037440|FG004|Overall Study|Other|0|||
131659370|NCT02626455|474037441|FG005|Overall Study|Other|17|||
131882841|NCT02326298|474852632|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131882842|NCT02326298|474852633|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131882843|NCT02326298|474852634|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131546922|NCT02274857|473624989|FG000|Overall Study|Adverse Event|1|||
131546923|NCT02274857|473624990|FG001|Overall Study|Adverse Event|0|||
131546924|NCT02274857|473624989|FG000|Overall Study|Death|1|||
131659371|NCT02626455|474037442|FG006|Overall Study|Other|23|||
131659372|NCT02626455|474037436|FG000|Overall Study|Withdrawal by Subject|1|||
131659373|NCT02626455|474037437|FG001|Overall Study|Withdrawal by Subject|0|||
131546925|NCT02274857|473624990|FG001|Overall Study|Death|2|||
131546926|NCT02274857|473624989|FG000|Overall Study|Lost to Follow-up|3|||
131659374|NCT02626455|474037438|FG002|Overall Study|Withdrawal by Subject|0|||
131659375|NCT02626455|474037439|FG003|Overall Study|Withdrawal by Subject|0|||
131659376|NCT02626455|474037440|FG004|Overall Study|Withdrawal by Subject|0|||
131659377|NCT02626455|474037441|FG005|Overall Study|Withdrawal by Subject|10|||
131659378|NCT02626455|474037442|FG006|Overall Study|Withdrawal by Subject|6|||
131659379|NCT02626455|474037436|FG000|Overall Study|Physician Decision|0|||
131659380|NCT02626455|474037437|FG001|Overall Study|Physician Decision|2|||
131659381|NCT02626455|474037438|FG002|Overall Study|Physician Decision|2|||
131659382|NCT02626455|474037439|FG003|Overall Study|Physician Decision|2|||
131659383|NCT02626455|474037440|FG004|Overall Study|Physician Decision|1|||
131659384|NCT02626455|474037441|FG005|Overall Study|Physician Decision|10|||
131659385|NCT02626455|474037442|FG006|Overall Study|Physician Decision|3|||
131659386|NCT02626455|474037436|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131659387|NCT02626455|474037437|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131659388|NCT02626455|474037438|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131659389|NCT02626455|474037439|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131659390|NCT02626455|474037440|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131659391|NCT02626455|474037441|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131659392|NCT02626455|474037442|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
131882844|NCT02326298|474852635|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
131882845|NCT02326298|474852622|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
131882846|NCT02326298|474852623|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
131882847|NCT02326298|474852624|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882848|NCT02326298|474852625|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882849|NCT02326298|474852626|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882850|NCT02326298|474852627|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882851|NCT02326298|474852628|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882852|NCT02326298|474852629|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882853|NCT02326298|474852630|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882854|NCT02326298|474852631|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882855|NCT02326298|474852632|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882856|NCT02326298|474852633|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882857|NCT02326298|474852634|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882858|NCT02326298|474852635|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131882859|NCT02326298|474852622|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
131882860|NCT02326298|474852623|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
131882861|NCT02326298|474852624|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882862|NCT02326298|474852625|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882863|NCT02326298|474852626|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882864|NCT02326298|474852627|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882865|NCT02326298|474852628|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882866|NCT02326298|474852629|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882867|NCT02326298|474852630|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882868|NCT02326298|474852631|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882869|NCT02326298|474852632|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882870|NCT02326298|474852633|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882871|NCT02326298|474852634|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882872|NCT02326298|474852635|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131882873|NCT02326298|474852622|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882874|NCT02326298|474852623|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882875|NCT02326298|474852624|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
131882876|NCT02326298|474852625|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882877|NCT02326298|474852626|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882878|NCT02326298|474852627|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882879|NCT02326298|474852628|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882880|NCT02326298|474852629|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882881|NCT02326298|474852630|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882882|NCT02326298|474852631|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882883|NCT02326298|474852632|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882884|NCT02326298|474852633|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882885|NCT02326298|474852634|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131659393|NCT02626455|474037436|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131659394|NCT02626455|474037437|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131659395|NCT02626455|474037438|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131659396|NCT02626455|474037439|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131659397|NCT02626455|474037440|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131659398|NCT02626455|474037441|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131659399|NCT02626455|474037442|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
131659400|NCT02626455|474037436|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131882886|NCT02326298|474852635|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
131882887|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882888|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882889|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882890|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131659401|NCT02626455|474037437|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131659402|NCT02626455|474037438|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131659403|NCT02626455|474037439|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131659404|NCT02626455|474037440|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131659405|NCT02626455|474037441|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
131659406|NCT02626455|474037442|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
131659407|NCT02626455|474037436|FG000|Overall Study|Patient decision|0|||
131659408|NCT02626455|474037437|FG001|Overall Study|Patient decision|1|||
131659409|NCT02626455|474037438|FG002|Overall Study|Patient decision|0|||
131659410|NCT02626455|474037439|FG003|Overall Study|Patient decision|0|||
131659411|NCT02626455|474037440|FG004|Overall Study|Patient decision|1|||
131659412|NCT02626455|474037441|FG005|Overall Study|Patient decision|36|||
131659413|NCT02626455|474037442|FG006|Overall Study|Patient decision|22|||
131659414|NCT02626455|474037436|FG000|Overall Study|Protocol Violation|0|||
131659415|NCT02626455|474037437|FG001|Overall Study|Protocol Violation|0|||
131659416|NCT02626455|474037438|FG002|Overall Study|Protocol Violation|0|||
131659417|NCT02626455|474037439|FG003|Overall Study|Protocol Violation|0|||
131659418|NCT02626455|474037440|FG004|Overall Study|Protocol Violation|0|||
131659419|NCT02626455|474037441|FG005|Overall Study|Protocol Violation|0|||
131659420|NCT02626455|474037442|FG006|Overall Study|Protocol Violation|1|||
131659421|NCT02626455|474037436|FG000|Overall Study|Progressive disease - radiological progression|0|||
131659422|NCT02626455|474037437|FG001|Overall Study|Progressive disease - radiological progression|0|||
131659423|NCT02626455|474037438|FG002|Overall Study|Progressive disease - radiological progression|0|||
131659424|NCT02626455|474037439|FG003|Overall Study|Progressive disease - radiological progression|0|||
131659425|NCT02626455|474037440|FG004|Overall Study|Progressive disease - radiological progression|0|||
131659426|NCT02626455|474037441|FG005|Overall Study|Progressive disease - radiological progression|11|||
131659427|NCT02626455|474037442|FG006|Overall Study|Progressive disease - radiological progression|22|||
131659428|NCT02626455|474037436|FG000|Overall Study|Progressive disease - clinical progression|0|||
131659429|NCT02626455|474037437|FG001|Overall Study|Progressive disease - clinical progression|0|||
131659430|NCT02626455|474037438|FG002|Overall Study|Progressive disease - clinical progression|0|||
131659431|NCT02626455|474037439|FG003|Overall Study|Progressive disease - clinical progression|0|||
131659432|NCT02626455|474037440|FG004|Overall Study|Progressive disease - clinical progression|0|||
131659433|NCT02626455|474037441|FG005|Overall Study|Progressive disease - clinical progression|1|||
131659434|NCT02626455|474037442|FG006|Overall Study|Progressive disease - clinical progression|2|||
131659435|NCT02626455|474037436|FG000|Overall Study|Lost to Follow-up|0|||
131659436|NCT02626455|474037437|FG001|Overall Study|Lost to Follow-up|0|||
131659437|NCT02626455|474037438|FG002|Overall Study|Lost to Follow-up|0|||
131659438|NCT02626455|474037439|FG003|Overall Study|Lost to Follow-up|0|||
131659439|NCT02626455|474037440|FG004|Overall Study|Lost to Follow-up|0|||
131659440|NCT02626455|474037441|FG005|Overall Study|Lost to Follow-up|1|||
131659441|NCT02626455|474037442|FG006|Overall Study|Lost to Follow-up|0|||
131659442|NCT02626455|474037436|FG000|Overall Study|AE not associated with clinical disease progression|1|||
131659443|NCT02626455|474037437|FG001|Overall Study|AE not associated with clinical disease progression|1|||
131659444|NCT02626455|474037438|FG002|Overall Study|AE not associated with clinical disease progression|0|||
131659445|NCT02626455|474037439|FG003|Overall Study|AE not associated with clinical disease progression|2|||
131659446|NCT02626455|474037440|FG004|Overall Study|AE not associated with clinical disease progression|1|||
131659447|NCT02626455|474037441|FG005|Overall Study|AE not associated with clinical disease progression|65|||
131659448|NCT02626455|474037442|FG006|Overall Study|AE not associated with clinical disease progression|21|||
131659449|NCT02626455|474037436|FG000|Overall Study|AE associated with clinical disease progression|0|||
131659450|NCT02626455|474037437|FG001|Overall Study|AE associated with clinical disease progression|0|||
131659451|NCT02626455|474037438|FG002|Overall Study|AE associated with clinical disease progression|0|||
131659452|NCT02626455|474037439|FG003|Overall Study|AE associated with clinical disease progression|0|||
131659453|NCT02626455|474037440|FG004|Overall Study|AE associated with clinical disease progression|0|||
131659454|NCT02626455|474037441|FG005|Overall Study|AE associated with clinical disease progression|1|||
131659455|NCT02626455|474037442|FG006|Overall Study|AE associated with clinical disease progression|2|||
131659456|NCT02626455|474037436|FG000|Overall Study|Study intervention never administered|0|||
131659457|NCT02626455|474037437|FG001|Overall Study|Study intervention never administered|0|||
131659458|NCT02626455|474037438|FG002|Overall Study|Study intervention never administered|0|||
131659459|NCT02626455|474037439|FG003|Overall Study|Study intervention never administered|0|||
131659460|NCT02626455|474037440|FG004|Overall Study|Study intervention never administered|0|||
131659461|NCT02626455|474037441|FG005|Overall Study|Study intervention never administered|1|||
131659462|NCT02626455|474037442|FG006|Overall Study|Study intervention never administered|3|||
131659463|NCT00166712|474038918|FG000|Overall Study|Death|0|||
131659464|NCT00166712|474038919|FG001|Overall Study|Death|1|||
131659465|NCT00166712|474038918|FG000|Overall Study|Adverse Event|1|||
131659466|NCT00166712|474038919|FG001|Overall Study|Adverse Event|0|||
131659467|NCT00166712|474038918|FG000|Overall Study|Withdrawal by Subject|1|||
131659468|NCT00166712|474038919|FG001|Overall Study|Withdrawal by Subject|2|||
131659469|NCT00166712|474038918|FG000|Overall Study|Physician Decision|0|||
131659470|NCT00166712|474038919|FG001|Overall Study|Physician Decision|2|||
131659471|NCT03986944|474038920|FG000|Overall Study|Adverse Event|1|||
131659472|NCT03986944|474038921|FG001|Overall Study|Adverse Event|2|||
131882891|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882892|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131882893|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
131882894|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131882895|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131882896|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131882897|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882898|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882899|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882900|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131882901|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882902|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882903|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882904|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882905|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882906|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
131882907|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
131882908|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882909|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
131882910|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882911|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882912|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882913|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882914|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
131882915|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882916|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882917|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882918|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882919|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882920|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
131882921|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882922|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882923|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882924|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882925|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882926|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882927|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882928|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
131882929|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882930|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882931|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882932|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882933|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882934|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882935|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
131882936|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882937|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882938|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131659473|NCT03986944|474038922|FG002|Overall Study|Adverse Event|3|||
131546927|NCT02274857|473624990|FG001|Overall Study|Lost to Follow-up|0|||
131659474|NCT03986944|474038920|FG000|Overall Study|Protocol Violation|0|||
131659475|NCT03986944|474038921|FG001|Overall Study|Protocol Violation|1|||
131659476|NCT03986944|474038922|FG002|Overall Study|Protocol Violation|1|||
131659477|NCT03986944|474038920|FG000|Overall Study|Withdrawal by Subject|3|||
131659478|NCT03986944|474038921|FG001|Overall Study|Withdrawal by Subject|5|||
131659479|NCT03986944|474038922|FG002|Overall Study|Withdrawal by Subject|5|||
131659480|NCT03986944|474038920|FG000|Overall Study|Study termination|10|||
131659481|NCT03986944|474038921|FG001|Overall Study|Study termination|10|||
131659482|NCT03986944|474038922|FG002|Overall Study|Study termination|10|||
131659483|NCT03986944|474038920|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
131659484|NCT03986944|474038921|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
131659485|NCT03986944|474038922|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
131659486|NCT03986944|474038920|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
131659487|NCT03986944|474038921|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
131659488|NCT03986944|474038922|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
131659489|NCT01015560|474038924|FG000|Overall Study|Adverse Event|1|||
131659490|NCT01015560|474038924|FG000|Overall Study|Not protocol specified|1|||
131659491|NCT01015560|474038924|FG000|Overall Study|Withdrawal by Subject|1|||
131659492|NCT00640133|474038925|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
131659493|NCT00640133|474038926|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
131659494|NCT00640133|474038925|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
131659495|NCT00640133|474038926|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
131659496|NCT00640133|474038925|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
131659497|NCT00640133|474038926|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
131659498|NCT00128102|474038929|FG000|Overall Study|Site Discontinued|3|||
131659499|NCT00128102|474038930|FG001|Overall Study|Site Discontinued|6|||
131659500|NCT00128102|474038929|FG000|Overall Study|Other|0|||
131659501|NCT00128102|474038930|FG001|Overall Study|Other|1|||
131659502|NCT00128102|474038929|FG000|Overall Study|Progressive Disease|255|||
131659503|NCT00128102|474038930|FG001|Overall Study|Progressive Disease|285|||
131659504|NCT00128102|474038929|FG000|Overall Study|Adverse Event|34|||
131659505|NCT00128102|474038930|FG001|Overall Study|Adverse Event|11|||
131659506|NCT00128102|474038929|FG000|Overall Study|Death|12|||
131659507|NCT00128102|474038930|FG001|Overall Study|Death|13|||
131659508|NCT00128102|474038929|FG000|Overall Study|Physician Decision|3|||
131659509|NCT00128102|474038930|FG001|Overall Study|Physician Decision|3|||
131659510|NCT00128102|474038929|FG000|Overall Study|Withdrawal by Subject|19|||
131659511|NCT00128102|474038930|FG001|Overall Study|Withdrawal by Subject|11|||
131659512|NCT00128102|474038929|FG000|Overall Study|Protocol Violation|2|||
131659513|NCT00128102|474038930|FG001|Overall Study|Protocol Violation|2|||
131659514|NCT01202903|474038932|FG000|Overall Study|Administrative Probelms|1|||
131659515|NCT01202903|474038933|FG001|Overall Study|Administrative Probelms|4|||
131659516|NCT01202903|474038932|FG000|Overall Study|Protocol Violation|0|||
131659517|NCT01202903|474038933|FG001|Overall Study|Protocol Violation|1|||
131882939|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882940|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882941|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882942|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131882943|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882944|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882945|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882946|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882947|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882948|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882949|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882950|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
131882951|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882952|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882953|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882954|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882955|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882956|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
131882957|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882958|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882959|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131659518|NCT01202903|474038932|FG000|Overall Study|Death|1|||
131659519|NCT01202903|474038933|FG001|Overall Study|Death|0|||
131659520|NCT01202903|474038932|FG000|Overall Study|Lost to Follow-up|1|||
131659521|NCT01202903|474038933|FG001|Overall Study|Lost to Follow-up|1|||
131770295|NCT01266967|474437887|FG001|Overall Study|Death|61|||
131882960|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131659522|NCT01202903|474038932|FG000|Overall Study|Lack of Efficacy|1|||
131882961|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882962|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882963|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
131882964|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
131882965|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882966|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882967|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882968|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882969|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882970|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131882971|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882972|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882973|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882974|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882975|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882976|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882977|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882978|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
131882979|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131659523|NCT01202903|474038933|FG001|Overall Study|Lack of Efficacy|3|||
131659524|NCT01202903|474038932|FG000|Overall Study|Adverse Event|3|||
131659525|NCT01202903|474038933|FG001|Overall Study|Adverse Event|3|||
131659526|NCT01202903|474038932|FG000|Overall Study|Withdrawal by Subject|4|||
131659527|NCT01202903|474038933|FG001|Overall Study|Withdrawal by Subject|4|||
131659528|NCT01302080|474038934|FG000|Overall Study|Withdrew Consent|92|||
131659529|NCT01302080|474038935|FG001|Overall Study|Withdrew Consent|39|||
131659530|NCT01302080|474038934|FG000|Overall Study|Patient/Family Moved|28|||
131659531|NCT01302080|474038935|FG001|Overall Study|Patient/Family Moved|3|||
131659532|NCT01302080|474038934|FG000|Overall Study|Lost to Follow-up|192|||
131659533|NCT01302080|474038935|FG001|Overall Study|Lost to Follow-up|93|||
131659534|NCT01302080|474038934|FG000|Overall Study|Death|1|||
131659535|NCT01302080|474038935|FG001|Overall Study|Death|0|||
131659536|NCT01302080|474038934|FG000|Overall Study|Other|52|||
131659537|NCT01302080|474038935|FG001|Overall Study|Other|8|||
131659538|NCT01302080|474038934|FG000|Overall Study|Reason Missing For Discontinuation|1|||
131659539|NCT01302080|474038935|FG001|Overall Study|Reason Missing For Discontinuation|0|||
131659540|NCT03339245|474038938|FG000|Overall Study|Adverse Event|1|||
131659541|NCT03339245|474038939|FG001|Overall Study|Adverse Event|1|||
131659542|NCT03339245|474038938|FG000|Overall Study|Withdrawal by Subject|1|||
131659543|NCT03339245|474038939|FG001|Overall Study|Withdrawal by Subject|0|||
131659544|NCT00837694|474038940|FG000|Overall Study|Lost to Follow-up|2|||
131659545|NCT00837694|474038941|FG001|Overall Study|Lost to Follow-up|0|||
131659546|NCT00837694|474038942|FG002|Overall Study|Lost to Follow-up|2|||
131659547|NCT00837694|474038943|FG003|Overall Study|Lost to Follow-up|1|||
131659548|NCT00837694|474038944|FG004|Overall Study|Lost to Follow-up|1|||
131659549|NCT00837694|474038945|FG005|Overall Study|Lost to Follow-up|1|||
131659550|NCT00306670|474038950|FG000|Overall Study|patients recruited; Genentech, the st|0|||
131659551|NCT00306670|474038951|FG001|Overall Study|patients recruited; Genentech, the st|2|||
131659552|NCT00833833|474038955|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131659553|NCT00833833|474038956|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131659554|NCT00833833|474038957|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
131659555|NCT00833833|474038958|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
131659556|NCT00833833|474038959|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131659557|NCT00833833|474038960|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131659558|NCT00833833|474038955|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
131659559|NCT00833833|474038956|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
131659560|NCT00833833|474038957|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
131659561|NCT00833833|474038958|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
131659562|NCT00833833|474038959|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
131659563|NCT00833833|474038960|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
131659564|NCT00833833|474038955|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
131659565|NCT00833833|474038956|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
131659566|NCT00833833|474038957|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
131659567|NCT00833833|474038958|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
131659568|NCT00833833|474038959|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
131659569|NCT00833833|474038960|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
131659570|NCT00833833|474038955|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
131659571|NCT00833833|474038956|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
131659572|NCT00833833|474038957|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
131659573|NCT00833833|474038958|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
131659574|NCT00833833|474038959|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
131882980|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882981|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882982|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882983|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882984|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131882985|NCT02326298|474852622|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882986|NCT02326298|474852623|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882987|NCT02326298|474852624|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882988|NCT02326298|474852625|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882989|NCT02326298|474852626|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882990|NCT02326298|474852627|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
131882991|NCT02326298|474852628|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882992|NCT02326298|474852629|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882993|NCT02326298|474852630|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882994|NCT02326298|474852631|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882995|NCT02326298|474852632|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882996|NCT02326298|474852633|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882997|NCT02326298|474852634|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882998|NCT02326298|474852635|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
131882999|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
131883000|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
131883001|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
131883002|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
131883003|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
131883004|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
131883005|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
131883006|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
131883007|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
131883008|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
131883009|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
131883010|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
131883011|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
131883012|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
131883013|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883014|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883015|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883016|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883017|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883018|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883019|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883020|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131659575|NCT00833833|474038960|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
131659576|NCT00833833|474038955|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
131659577|NCT00833833|474038956|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659578|NCT00833833|474038957|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
131659579|NCT00833833|474038958|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659580|NCT00833833|474038959|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659581|NCT00833833|474038960|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659582|NCT00833833|474038955|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
131659583|NCT00833833|474038956|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
131659584|NCT00833833|474038957|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
131659585|NCT00833833|474038958|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
131659586|NCT00833833|474038959|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
131659587|NCT00833833|474038960|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
131659588|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131659589|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131659590|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131659591|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131659592|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
131659593|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
131659594|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131659595|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131659596|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131659597|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131659598|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
131659599|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
131659600|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
131659601|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
131659602|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
131659603|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
131659604|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
131659605|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
131659606|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659607|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659608|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659609|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131659610|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
131883021|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883022|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883023|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883024|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
131883025|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
131883026|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131883027|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883028|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883029|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883030|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883031|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883032|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883033|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883034|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883035|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883036|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883037|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883038|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
131883039|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
131883040|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131883041|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131659611|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
131659612|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131659613|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131659614|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131659615|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131659616|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
131659617|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
131659618|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
131659619|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
131659620|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
131659621|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
131659622|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
131659623|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
131659624|NCT00833833|474038955|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131659625|NCT00833833|474038956|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131659626|NCT00833833|474038957|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131659627|NCT00833833|474038958|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131659628|NCT00833833|474038959|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131659629|NCT00833833|474038960|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
131659630|NCT01994837|474038961|FG000|Overall Study|Progressive disease per protocol|23|||
131659631|NCT01994837|474038961|FG000|Overall Study|Adv event related to progressive disease|3|||
131659632|NCT01994837|474038961|FG000|Overall Study|Fatal progressive disease|2|||
131659633|NCT01994837|474038961|FG000|Overall Study|Adverse event not related to progression|1|||
131659634|NCT01994837|474038961|FG000|Overall Study|Chose palliative care|1|||
131659635|NCT01994837|474038961|FG000|Overall Study|Proceeded to transplant|1|||
131659636|NCT01994837|474038961|FG000|Overall Study|Removed from study due to no response|1|||
131659637|NCT01127893|474038962|FG000|Overall Study|Study Termination by the Sponsor|1|||
131659638|NCT00574873|474038963|FG000|Overall Study|Withdrawal by Subject|18|||
131659639|NCT00574873|474038964|FG001|Overall Study|Withdrawal by Subject|19|||
131659640|NCT00574873|474038963|FG000|Overall Study|Investigator request|18|||
131659641|NCT00574873|474038964|FG001|Overall Study|Investigator request|8|||
131883042|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883043|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131546928|NCT02274857|473624989|FG000|Overall Study|Physician Decision|2|||
131883044|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883045|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883046|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883047|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883048|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883049|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883050|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883051|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883052|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883053|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131883054|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
131883055|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883056|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883057|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883058|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883059|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883060|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883061|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883062|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883063|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883064|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883065|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131883066|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
131883067|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
131883068|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
131883069|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883070|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883071|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883072|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883073|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883074|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883075|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131659642|NCT00574873|474038963|FG000|Overall Study|Death|15|||
131659643|NCT00574873|474038964|FG001|Overall Study|Death|14|||
131659644|NCT00574873|474038963|FG000|Overall Study|Lost to Follow-up|14|||
131659645|NCT00574873|474038964|FG001|Overall Study|Lost to Follow-up|5|||
131659646|NCT00574873|474038963|FG000|Overall Study|Other|40|||
131659647|NCT00574873|474038964|FG001|Overall Study|Other|4|||
131659648|NCT00574873|474038963|FG000|Overall Study|Discontinuation of study by sponsor|5|||
131659649|NCT00574873|474038964|FG001|Overall Study|Discontinuation of study by sponsor|199|||
131659650|NCT00574873|474038963|FG000|Overall Study|Blank, site closed per local regulations|2|||
131659651|NCT00574873|474038964|FG001|Overall Study|Blank, site closed per local regulations|2|||
131659652|NCT00574873|474038963|FG000|Overall Study|Extension Study|126|||
131659653|NCT00574873|474038964|FG001|Overall Study|Extension Study|0|||
131659654|NCT03568318|474038967|FG000|Overall Study|Adverse Event|3|||
131659655|NCT03568318|474038968|FG001|Overall Study|Adverse Event|1|||
131659656|NCT03568318|474038969|FG002|Overall Study|Adverse Event|1|||
131659657|NCT03568318|474038970|FG003|Overall Study|Adverse Event|0|||
131659658|NCT03568318|474038971|FG004|Overall Study|Adverse Event|1|||
131659659|NCT03568318|474038972|FG005|Overall Study|Adverse Event|0|||
131659660|NCT03568318|474038967|FG000|Overall Study|Withdrawal by Subject|6|||
131659661|NCT03568318|474038968|FG001|Overall Study|Withdrawal by Subject|5|||
131659662|NCT03568318|474038969|FG002|Overall Study|Withdrawal by Subject|2|||
131659663|NCT03568318|474038970|FG003|Overall Study|Withdrawal by Subject|1|||
131659664|NCT03568318|474038971|FG004|Overall Study|Withdrawal by Subject|0|||
131659665|NCT03568318|474038972|FG005|Overall Study|Withdrawal by Subject|0|||
131659666|NCT03568318|474038967|FG000|Overall Study|Lost to Follow-up|3|||
131659667|NCT03568318|474038968|FG001|Overall Study|Lost to Follow-up|2|||
131659668|NCT03568318|474038969|FG002|Overall Study|Lost to Follow-up|2|||
131659669|NCT03568318|474038970|FG003|Overall Study|Lost to Follow-up|2|||
131659670|NCT03568318|474038971|FG004|Overall Study|Lost to Follow-up|1|||
131659671|NCT03568318|474038972|FG005|Overall Study|Lost to Follow-up|0|||
131659672|NCT03568318|474038967|FG000|Overall Study|Other|3|||
131659673|NCT03568318|474038968|FG001|Overall Study|Other|1|||
131659674|NCT03568318|474038969|FG002|Overall Study|Other|3|||
131659675|NCT03568318|474038970|FG003|Overall Study|Other|0|||
131659676|NCT03568318|474038971|FG004|Overall Study|Other|0|||
131659677|NCT03568318|474038972|FG005|Overall Study|Other|0|||
131659678|NCT03568318|474038967|FG000|Overall Study|Ongoing at Time of Analysis|5|||
131659679|NCT03568318|474038968|FG001|Overall Study|Ongoing at Time of Analysis|3|||
131659680|NCT03568318|474038969|FG002|Overall Study|Ongoing at Time of Analysis|2|||
131659681|NCT03568318|474038970|FG003|Overall Study|Ongoing at Time of Analysis|1|||
131659682|NCT03568318|474038971|FG004|Overall Study|Ongoing at Time of Analysis|0|||
131659683|NCT03568318|474038972|FG005|Overall Study|Ongoing at Time of Analysis|0|||
131659684|NCT01638429|474038975|FG000|Overall Study|Withdrawal by Subject|1|||
131659685|NCT03207451|474038976|FG000|Overall Study|scheduling conflict|1|||
131659686|NCT03207451|474038977|FG001|Overall Study|scheduling conflict|0|||
131659687|NCT03207451|474038978|FG002|Overall Study|scheduling conflict|2|||
131659688|NCT03207451|474038979|FG003|Overall Study|scheduling conflict|2|||
131659689|NCT03207451|474038976|FG000|Overall Study|Adverse Event|0|||
131659690|NCT03207451|474038977|FG001|Overall Study|Adverse Event|0|||
131659691|NCT03207451|474038978|FG002|Overall Study|Adverse Event|0|||
131659692|NCT03207451|474038979|FG003|Overall Study|Adverse Event|1|||
131659693|NCT01802567|474038981|FG000|Overall Study|Withdrawal by Subject|2|||
131659694|NCT01802567|474038981|FG000|Overall Study|Physician Decision|1|||
131659695|NCT01802567|474038981|FG000|Overall Study|Lack of Efficacy|7|||
131883076|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883077|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883078|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131883079|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131659696|NCT01802567|474038981|FG000|Overall Study|Consented but did not start therapy|7|||
131659697|NCT01802567|474038981|FG000|Overall Study|Protocol Violation|1|||
131659698|NCT03167359|474038982|FG000|Overall Study|Physician Decision|1|||
131659699|NCT03167359|474038982|FG000|Overall Study|Lost to Follow-up|1|||
131659700|NCT03339583|474038983|FG000|First Intervention (14 Days)|Adverse Event|1|||
131659701|NCT03339583|474038984|FG001|First Intervention (14 Days)|Adverse Event|0|||
131659702|NCT03339583|474038983|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
131659703|NCT03339583|474038984|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
131659704|NCT03339583|474038983|FG000|Second Intervention (14 Days)|Adverse Event|0|||
131659705|NCT03339583|474038984|FG001|Second Intervention (14 Days)|Adverse Event|1|||
131659706|NCT03339583|474038983|FG000|Follow-up (14 Days)|Physician Decision|6|||
131659707|NCT03339583|474038984|FG001|Follow-up (14 Days)|Physician Decision|3|||
131659708|NCT01896557|474038985|FG000|Clopidogrel Alone|Adverse Event|1|||
131659709|NCT01896557|474038986|FG001|Clopidogrel Alone|Adverse Event|0|||
131659710|NCT01896557|474038985|FG000|Clopidogrel + GI Protector|low adherence|1|||
131659711|NCT01896557|474038986|FG001|Clopidogrel + GI Protector|low adherence|1|||
131659712|NCT01896557|474038985|FG000|Clopidogrel + GI Protector|Reading error|1|||
131659713|NCT01896557|474038986|FG001|Clopidogrel + GI Protector|Reading error|3|||
131659714|NCT00734591|474038987|FG000|Screening for Prospective Period|Site did not participate|1604|||
131659715|NCT00734591|474038988|FG001|Screening for Prospective Period|Site did not participate|1488|||
131659716|NCT00734591|474038987|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
131659717|NCT00734591|474038988|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
131659718|NCT00734591|474038987|FG000|Prospective Period|Withdrawal by Subject|11|||
131659719|NCT00734591|474038988|FG001|Prospective Period|Withdrawal by Subject|9|||
131659720|NCT00734591|474038987|FG000|Prospective Period|Lost to Follow-up|37|||
131659721|NCT00734591|474038988|FG001|Prospective Period|Lost to Follow-up|33|||
131659722|NCT00734591|474038987|FG000|Prospective Period|Study Terminated|1|||
131659723|NCT00734591|474038988|FG001|Prospective Period|Study Terminated|0|||
131659724|NCT00734591|474038987|FG000|Prospective Period|Other|2|||
131659725|NCT00734591|474038988|FG001|Prospective Period|Other|2|||
131659726|NCT02236988|474038991|FG000|Overall Study|Lost to Follow-up|0|||
131659727|NCT02236988|474038992|FG001|Overall Study|Lost to Follow-up|0|||
131659728|NCT02236988|474038993|FG002|Overall Study|Lost to Follow-up|0|||
131659729|NCT02236988|474038994|FG003|Overall Study|Lost to Follow-up|1|||
131659730|NCT02236988|474038991|FG000|Overall Study|Unable to Comply with Study Visits|0|||
131659731|NCT02236988|474038992|FG001|Overall Study|Unable to Comply with Study Visits|0|||
131883080|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
131883081|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
131883082|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
131883083|NCT02326298|474852622|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883084|NCT02326298|474852623|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883085|NCT02326298|474852624|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883086|NCT02326298|474852625|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883087|NCT02326298|474852626|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883088|NCT02326298|474852627|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883089|NCT02326298|474852628|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883090|NCT02326298|474852629|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883091|NCT02326298|474852630|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883092|NCT02326298|474852631|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131883093|NCT02326298|474852632|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131659732|NCT02236988|474038993|FG002|Overall Study|Unable to Comply with Study Visits|0|||
131883094|NCT02326298|474852633|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
131883095|NCT02326298|474852634|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
131883096|NCT02326298|474852635|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
131883097|NCT05072964|474852642|FG000|Overall Study|Withdrawal by Subject|4|||
131883098|NCT05072964|474852642|FG000|Overall Study|Death|1|||
131883099|NCT02059434|474854008|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
131883100|NCT02059434|474854009|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
131883101|NCT02059434|474854010|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
131883102|NCT02059434|474854011|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
131883103|NCT02059434|474854012|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
131883104|NCT02059434|474854013|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
131883105|NCT02059434|474854014|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
131659733|NCT02236988|474038994|FG003|Overall Study|Unable to Comply with Study Visits|2|||
131659734|NCT00939822|474038995|FG000|Overall Study|Lost to Follow-up|1|||
131659735|NCT00939822|474038996|FG001|Overall Study|Lost to Follow-up|0|||
131659736|NCT00939822|474038995|FG000|Overall Study|withdrew from study due to busy schedule|1|||
131659737|NCT00939822|474038996|FG001|Overall Study|withdrew from study due to busy schedule|1|||
131659738|NCT00939822|474038995|FG000|Overall Study|Mental health issues|0|||
131883106|NCT02059434|474854015|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
131883107|NCT02059434|474854016|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
131883108|NCT02059434|474854008|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
131883109|NCT02059434|474854009|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
131883110|NCT02059434|474854010|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
131883111|NCT02059434|474854011|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
131883112|NCT02059434|474854012|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
131883113|NCT02059434|474854013|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
131883114|NCT02059434|474854014|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
131883115|NCT02059434|474854015|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
131883116|NCT02059434|474854016|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
131883117|NCT02059434|474854008|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
131883118|NCT02059434|474854009|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
131883119|NCT02059434|474854010|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
131883120|NCT02059434|474854011|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
131883121|NCT02059434|474854012|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
131883122|NCT02059434|474854013|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
131883123|NCT02059434|474854014|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
131883124|NCT02059434|474854015|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
131883125|NCT02059434|474854016|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
131883126|NCT02059434|474854008|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
131883127|NCT02059434|474854009|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
131883128|NCT02059434|474854010|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
131883129|NCT02059434|474854011|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
131883130|NCT02059434|474854012|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
131883131|NCT02059434|474854013|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
131883132|NCT02059434|474854014|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
131883133|NCT02059434|474854015|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
131883134|NCT02059434|474854016|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
131883135|NCT02059434|474854008|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883136|NCT02059434|474854009|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883137|NCT02059434|474854010|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883138|NCT02059434|474854011|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883139|NCT02059434|474854012|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883140|NCT02059434|474854013|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883141|NCT02059434|474854014|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883142|NCT02059434|474854015|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
131883143|NCT02059434|474854016|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
131883144|NCT02928770|474854019|FG000|Overall Study|Withdrawal by Subject|2|||
131883145|NCT01702532|474854024|FG000|Overall Study|Adverse Event|0|||
131883146|NCT01702532|474854025|FG001|Overall Study|Adverse Event|1|||
131883147|NCT04392167|474854029|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
131883148|NCT03226678|474854030|FG000|Part A (Core Study Phase)|Adverse Event|0|||
131883149|NCT03226678|474854031|FG001|Part A (Core Study Phase)|Adverse Event|1|||
131883150|NCT03226678|474854032|FG002|Part A (Core Study Phase)|Adverse Event|0|||
131883151|NCT03226678|474854033|FG003|Part A (Core Study Phase)|Adverse Event|0|||
131659739|NCT00939822|474038996|FG001|Overall Study|Mental health issues|2|||
131883152|NCT03226678|474854034|FG004|Part A (Core Study Phase)|Adverse Event|0|||
131883153|NCT03226678|474854035|FG005|Part A (Core Study Phase)|Adverse Event|0|||
131883154|NCT03226678|474854030|FG000|Part A (Core Study Phase)|Death|0|||
131883155|NCT03226678|474854031|FG001|Part A (Core Study Phase)|Death|0|||
131883156|NCT03226678|474854032|FG002|Part A (Core Study Phase)|Death|1|||
131883157|NCT03226678|474854033|FG003|Part A (Core Study Phase)|Death|0|||
131883158|NCT03226678|474854034|FG004|Part A (Core Study Phase)|Death|0|||
131883159|NCT03226678|474854035|FG005|Part A (Core Study Phase)|Death|0|||
131883160|NCT03226678|474854030|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
131883161|NCT03226678|474854031|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
131883162|NCT03226678|474854032|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
131883163|NCT03226678|474854033|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
131883164|NCT03226678|474854034|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
131883165|NCT03226678|474854035|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
131883166|NCT03226678|474854030|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
131883167|NCT03226678|474854031|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
131883168|NCT03226678|474854032|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
131883169|NCT03226678|474854033|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
131883170|NCT03226678|474854034|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
131883171|NCT03226678|474854035|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
131883172|NCT03226678|474854030|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
131883173|NCT03226678|474854031|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
131883174|NCT03226678|474854032|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
131883175|NCT03226678|474854033|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
131883176|NCT03226678|474854034|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
131883177|NCT03226678|474854035|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
131883178|NCT03226678|474854030|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
131883179|NCT03226678|474854031|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
131883180|NCT03226678|474854032|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
131883181|NCT03226678|474854033|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
131883182|NCT03226678|474854034|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
131883183|NCT03226678|474854035|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
131883184|NCT03226678|474854030|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
131883185|NCT03226678|474854031|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
131883186|NCT03226678|474854032|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
131883187|NCT03226678|474854033|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
131883188|NCT03226678|474854034|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
131883189|NCT03226678|474854035|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
131883190|NCT03226678|474854030|FG000|Part B (Long-Term Extension Phase)|Death|0|||
131883191|NCT03226678|474854031|FG001|Part B (Long-Term Extension Phase)|Death|0|||
131883192|NCT03226678|474854032|FG002|Part B (Long-Term Extension Phase)|Death|0|||
131883193|NCT03226678|474854033|FG003|Part B (Long-Term Extension Phase)|Death|0|||
131883194|NCT03226678|474854034|FG004|Part B (Long-Term Extension Phase)|Death|0|||
131883195|NCT03226678|474854035|FG005|Part B (Long-Term Extension Phase)|Death|1|||
131883196|NCT03226678|474854030|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
131883197|NCT03226678|474854031|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
131883198|NCT03226678|474854032|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
131883199|NCT03226678|474854033|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
131883200|NCT03226678|474854034|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
131883201|NCT03226678|474854035|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
131883202|NCT03226678|474854030|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
131883203|NCT03226678|474854031|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
131883204|NCT03226678|474854032|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
131883205|NCT03226678|474854033|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
131883206|NCT03226678|474854034|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
131883207|NCT03226678|474854035|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
131883208|NCT03226678|474854030|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
131883209|NCT03226678|474854031|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
131883210|NCT03226678|474854032|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
131883211|NCT03226678|474854033|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
131883212|NCT03226678|474854034|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
131883213|NCT03226678|474854035|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
131883214|NCT01120249|474854036|FG000|Overall Study|No protocol treatment received|21|||
131883215|NCT01120249|474854037|FG001|Overall Study|No protocol treatment received|15|||
131883216|NCT01120249|474854036|FG000|Overall Study|Disease recurrence|107|||
131883217|NCT01120249|474854037|FG001|Overall Study|Disease recurrence|57|||
131883218|NCT01120249|474854036|FG000|Overall Study|Death|1|||
131883219|NCT01120249|474854037|FG001|Overall Study|Death|0|||
131883220|NCT01120249|474854036|FG000|Overall Study|Adverse Event|40|||
131883221|NCT01120249|474854037|FG001|Overall Study|Adverse Event|276|||
131883222|NCT01120249|474854036|FG000|Overall Study|Participant refusal|34|||
131883223|NCT01120249|474854037|FG001|Overall Study|Participant refusal|42|||
131883224|NCT01120249|474854036|FG000|Overall Study|Other reasons, not protocol specified|29|||
131546929|NCT02274857|473624990|FG001|Overall Study|Physician Decision|0|||
131883225|NCT01120249|474854037|FG001|Overall Study|Other reasons, not protocol specified|22|||
131883226|NCT00250458|474854046|FG000|Overall Study|Lost to Follow-up|4|||
131883227|NCT00250458|474854047|FG001|Overall Study|Lost to Follow-up|2|||
131883228|NCT00250458|474854046|FG000|Overall Study|Protocol Violation|0|||
131883229|NCT00250458|474854047|FG001|Overall Study|Protocol Violation|1|||
131883230|NCT00250458|474854046|FG000|Overall Study|Withdrawal by Subject|4|||
131883231|NCT00250458|474854047|FG001|Overall Study|Withdrawal by Subject|2|||
131883232|NCT00250458|474854046|FG000|Overall Study|Lack of Migraine Attack|20|||
131883233|NCT00250458|474854047|FG001|Overall Study|Lack of Migraine Attack|9|||
131883234|NCT00250458|474854046|FG000|Overall Study|Qualifying migraine but did not treat|3|||
131883235|NCT00250458|474854047|FG001|Overall Study|Qualifying migraine but did not treat|3|||
131883236|NCT00250458|474854046|FG000|Overall Study|Other|1|||
131883237|NCT00250458|474854047|FG001|Overall Study|Other|0|||
131883238|NCT01801358|474854048|FG000|Overall Study|Adverse Event|0|||
131883239|NCT01801358|474854049|FG001|Overall Study|Adverse Event|2|||
131883240|NCT01801358|474854050|FG002|Overall Study|Adverse Event|1|||
131883241|NCT01801358|474854051|FG003|Overall Study|Adverse Event|0|||
131883242|NCT01801358|474854052|FG004|Overall Study|Adverse Event|0|||
131883243|NCT01801358|474854053|FG005|Overall Study|Adverse Event|1|||
131883244|NCT01801358|474854048|FG000|Overall Study|Physician Decision|0|||
131883245|NCT01801358|474854049|FG001|Overall Study|Physician Decision|0|||
131883246|NCT01801358|474854050|FG002|Overall Study|Physician Decision|1|||
131883247|NCT01801358|474854051|FG003|Overall Study|Physician Decision|0|||
131883248|NCT01801358|474854052|FG004|Overall Study|Physician Decision|0|||
131883249|NCT01801358|474854053|FG005|Overall Study|Physician Decision|0|||
131883250|NCT01801358|474854048|FG000|Overall Study|Progressive Disease|6|||
131883251|NCT01801358|474854049|FG001|Overall Study|Progressive Disease|4|||
131883252|NCT01801358|474854050|FG002|Overall Study|Progressive Disease|4|||
131883253|NCT01801358|474854051|FG003|Overall Study|Progressive Disease|5|||
131883254|NCT01801358|474854052|FG004|Overall Study|Progressive Disease|6|||
131883255|NCT01801358|474854053|FG005|Overall Study|Progressive Disease|5|||
131883256|NCT01801358|474854048|FG000|Overall Study|Withdrawal by Subject|0|||
131883257|NCT01801358|474854049|FG001|Overall Study|Withdrawal by Subject|0|||
131883258|NCT01801358|474854050|FG002|Overall Study|Withdrawal by Subject|0|||
131883259|NCT01801358|474854051|FG003|Overall Study|Withdrawal by Subject|1|||
131883260|NCT01801358|474854052|FG004|Overall Study|Withdrawal by Subject|0|||
131883261|NCT01801358|474854053|FG005|Overall Study|Withdrawal by Subject|2|||
131883262|NCT01892085|474854056|FG000|Overall Study|Death|4|||
131883263|NCT01892085|474854057|FG001|Overall Study|Death|1|||
131883264|NCT01892085|474854058|FG002|Overall Study|Death|3|||
131883265|NCT01892085|474854056|FG000|Overall Study|Withdrawal by Subject|2|||
131883266|NCT01892085|474854057|FG001|Overall Study|Withdrawal by Subject|0|||
131883267|NCT01892085|474854058|FG002|Overall Study|Withdrawal by Subject|2|||
131883268|NCT01549041|474854059|FG000|Overall Study|Lack of Efficacy|2|||
131883269|NCT01549041|474854060|FG001|Overall Study|Lack of Efficacy|4|||
131883270|NCT01549041|474854059|FG000|Overall Study|Adverse Event|0|||
131546930|NCT02274857|473624989|FG000|Overall Study|Trial screen failure|0|||
131546931|NCT02274857|473624990|FG001|Overall Study|Trial screen failure|2|||
131546932|NCT02274857|473624989|FG000|Overall Study|Withdrawal by Subject|11|||
131546933|NCT02274857|473624990|FG001|Overall Study|Withdrawal by Subject|2|||
131546934|NCT02274857|473624989|FG000|Overall Study|Other|2|||
131546935|NCT02274857|473624990|FG001|Overall Study|Other|0|||
131546936|NCT02403180|473624994|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
131546937|NCT02403180|473624995|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
131546938|NCT02403180|473624994|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
131546939|NCT02403180|473624995|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
131434224|NCT03629886|473217464|FG000|Overall Study|Migrated / moved from the study area|0|||
131434225|NCT03629886|473217465|FG001|Overall Study|Migrated / moved from the study area|55|||
131434226|NCT03629886|473217464|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
131434227|NCT03629886|473217465|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
131434228|NCT03629886|473217464|FG000|Overall Study|Study vaccine not administrated|0|||
131434229|NCT03629886|473217465|FG001|Overall Study|Study vaccine not administrated|3|||
131434230|NCT03629886|473217464|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
131434231|NCT03629886|473217465|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
131434232|NCT03629886|473217464|FG000|Overall Study|Refused vaccination step of the study|0|||
131434233|NCT03629886|473217465|FG001|Overall Study|Refused vaccination step of the study|44|||
131434234|NCT01790594|473217466|FG000|Overall Study|Death|1|||
131434235|NCT01790594|473217467|FG001|Overall Study|Death|0|||
131434236|NCT01790594|473217468|FG002|Overall Study|Death|0|||
131434237|NCT01790594|473217466|FG000|Overall Study|Physician Decision|2|||
131434238|NCT01790594|473217467|FG001|Overall Study|Physician Decision|1|||
131546940|NCT01445652|473624999|FG000|Overall Study|Not comfortable in lenses|5|||
131883271|NCT01549041|474854060|FG001|Overall Study|Adverse Event|4|||
131883272|NCT01629823|474854064|FG000|Trial Period|Missed visit|11|||
131883273|NCT01629823|474854065|FG001|Trial Period|Missed visit|9|||
131883274|NCT01629823|474854066|FG002|Trial Period|Missed visit|8|||
131883275|NCT01629823|474854064|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
131883276|NCT01629823|474854065|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
131883277|NCT01629823|474854066|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
131883278|NCT01629823|474854064|FG000|Trial Period|Pregnancy|1|||
131883279|NCT01629823|474854065|FG001|Trial Period|Pregnancy|0|||
131883280|NCT01629823|474854066|FG002|Trial Period|Pregnancy|0|||
131883281|NCT01629823|474854064|FG000|Trial Period|Adverse Event|0|||
131883282|NCT01629823|474854065|FG001|Trial Period|Adverse Event|1|||
131883283|NCT01629823|474854066|FG002|Trial Period|Adverse Event|0|||
131883284|NCT01629823|474854064|FG000|Trial Period|Out-of-window visit|0|||
131883285|NCT01629823|474854065|FG001|Trial Period|Out-of-window visit|2|||
131883286|NCT01629823|474854066|FG002|Trial Period|Out-of-window visit|0|||
131883287|NCT01629823|474854064|FG000|Trial Period|Failed to hold medication|0|||
131883288|NCT01629823|474854065|FG001|Trial Period|Failed to hold medication|0|||
131883289|NCT01629823|474854066|FG002|Trial Period|Failed to hold medication|1|||
131883290|NCT01629823|474854064|FG000|Washout Period|Safety|2|||
131883291|NCT01629823|474854065|FG001|Washout Period|Safety|5|||
131883292|NCT01629823|474854066|FG002|Washout Period|Safety|0|||
131883293|NCT01629823|474854064|FG000|Washout Period|Pregnancy|1|||
131883294|NCT01629823|474854065|FG001|Washout Period|Pregnancy|0|||
131883295|NCT01629823|474854066|FG002|Washout Period|Pregnancy|0|||
131883296|NCT01629823|474854064|FG000|Washout Period|Protocol Violation|0|||
131883297|NCT01629823|474854065|FG001|Washout Period|Protocol Violation|1|||
131883298|NCT01629823|474854066|FG002|Washout Period|Protocol Violation|0|||
131883299|NCT02609724|474854067|FG000|Overall Study|Death|2|||
131883300|NCT02609724|474854068|FG001|Overall Study|Death|0|||
131883301|NCT02609724|474854069|FG002|Overall Study|Death|1|||
131883302|NCT02609724|474854067|FG000|Overall Study|Withdrawal by Subject|1|||
131883303|NCT02609724|474854068|FG001|Overall Study|Withdrawal by Subject|2|||
131883304|NCT02609724|474854069|FG002|Overall Study|Withdrawal by Subject|3|||
131883305|NCT02609724|474854067|FG000|Overall Study|Illness|2|||
131883306|NCT02609724|474854068|FG001|Overall Study|Illness|1|||
131883307|NCT02609724|474854069|FG002|Overall Study|Illness|0|||
131883308|NCT00986986|474854071|FG000|Overall Study|Lost to Follow-up|0|||
131883309|NCT00986986|474854072|FG001|Overall Study|Lost to Follow-up|1|||
131883310|NCT02003963|474854073|FG000|Overall Study|Lost to Follow-up|2|||
131883311|NCT02003963|474854074|FG001|Overall Study|Lost to Follow-up|1|||
131883312|NCT05020366|474854076|FG000|Overall Study|Lost to Follow-up|2|||
131883313|NCT05020366|474854077|FG001|Overall Study|Lost to Follow-up|0|||
131883314|NCT05020366|474854076|FG000|Overall Study|Withdrawal by Subject|2|||
131883315|NCT05020366|474854077|FG001|Overall Study|Withdrawal by Subject|0|||
131883316|NCT04050124|474854078|FG000|Overall Study|Death|1|||
131883317|NCT04050124|474854079|FG001|Overall Study|Death|0|||
131883318|NCT01537068|474854081|FG000|Overall Study|Lost to Follow-up|2|||
131883319|NCT01537068|474854082|FG001|Overall Study|Lost to Follow-up|1|||
131883320|NCT01537068|474854081|FG000|Overall Study|Adverse Event|0|||
131883321|NCT01537068|474854082|FG001|Overall Study|Adverse Event|1|||
131883322|NCT01537068|474854081|FG000|Overall Study|Withdrawal by Subject|1|||
131883323|NCT01537068|474854082|FG001|Overall Study|Withdrawal by Subject|1|||
131883324|NCT01537068|474854081|FG000|Overall Study|Lack of Efficacy|1|||
131883325|NCT01537068|474854082|FG001|Overall Study|Lack of Efficacy|0|||
131883326|NCT00483704|474854083|FG000|Randomization|Withdrawal by Subject|19|||
131883327|NCT00483704|474854084|FG001|Randomization|Withdrawal by Subject|28|||
131883328|NCT00483704|474854085|FG002|Randomization|Withdrawal by Subject|18|||
131883329|NCT00483704|474854083|FG000|Randomization|Protocol Violation|14|||
131883330|NCT00483704|474854084|FG001|Randomization|Protocol Violation|25|||
131883331|NCT00483704|474854085|FG002|Randomization|Protocol Violation|22|||
131883332|NCT00483704|474854083|FG000|Randomization|Lost to Follow-up|14|||
131883333|NCT00483704|474854084|FG001|Randomization|Lost to Follow-up|14|||
131883334|NCT00483704|474854085|FG002|Randomization|Lost to Follow-up|19|||
131883335|NCT00483704|474854083|FG000|Randomization|Pregnancy|1|||
131883336|NCT00483704|474854084|FG001|Randomization|Pregnancy|0|||
131883337|NCT00483704|474854085|FG002|Randomization|Pregnancy|0|||
131883338|NCT00483704|474854083|FG000|Randomization|Physician Decision|2|||
131883339|NCT00483704|474854084|FG001|Randomization|Physician Decision|4|||
131883340|NCT00483704|474854085|FG002|Randomization|Physician Decision|0|||
131883341|NCT00483704|474854083|FG000|Randomization|Progressive disease|0|||
131883342|NCT00483704|474854084|FG001|Randomization|Progressive disease|0|||
131883343|NCT00483704|474854085|FG002|Randomization|Progressive disease|1|||
131883344|NCT00483704|474854083|FG000|Randomization|Lack of qualifying migraines|21|||
131883345|NCT00483704|474854084|FG001|Randomization|Lack of qualifying migraines|25|||
131883346|NCT00483704|474854085|FG002|Randomization|Lack of qualifying migraines|31|||
131883347|NCT00483704|474854083|FG000|Treatment|Lack of qualifying migraines|101|||
131883348|NCT00483704|474854084|FG001|Treatment|Lack of qualifying migraines|99|||
131883349|NCT00483704|474854085|FG002|Treatment|Lack of qualifying migraines|116|||
131883350|NCT00483704|474854083|FG000|Treatment|Adverse Event|3|||
131883351|NCT00483704|474854084|FG001|Treatment|Adverse Event|5|||
131883352|NCT00483704|474854085|FG002|Treatment|Adverse Event|4|||
131883353|NCT00483704|474854083|FG000|Treatment|Withdrawal by Subject|16|||
131883354|NCT00483704|474854084|FG001|Treatment|Withdrawal by Subject|12|||
131883355|NCT00483704|474854085|FG002|Treatment|Withdrawal by Subject|21|||
131883356|NCT00483704|474854083|FG000|Treatment|Protocol Violation|6|||
131883357|NCT00483704|474854084|FG001|Treatment|Protocol Violation|3|||
131883358|NCT00483704|474854085|FG002|Treatment|Protocol Violation|5|||
131883359|NCT00483704|474854083|FG000|Treatment|Lost to Follow-up|2|||
131883360|NCT00483704|474854084|FG001|Treatment|Lost to Follow-up|7|||
131883361|NCT00483704|474854085|FG002|Treatment|Lost to Follow-up|5|||
131883362|NCT00483704|474854083|FG000|Treatment|Lack of Efficacy|1|||
131883363|NCT00483704|474854084|FG001|Treatment|Lack of Efficacy|1|||
131883364|NCT00483704|474854085|FG002|Treatment|Lack of Efficacy|1|||
131883365|NCT00483704|474854083|FG000|Treatment|Pregnancy|0|||
131883366|NCT00483704|474854084|FG001|Treatment|Pregnancy|1|||
131883367|NCT00483704|474854085|FG002|Treatment|Pregnancy|0|||
131883368|NCT00483704|474854083|FG000|Treatment|Physician Decision|0|||
131883369|NCT00483704|474854084|FG001|Treatment|Physician Decision|1|||
131883370|NCT00483704|474854085|FG002|Treatment|Physician Decision|4|||
131883371|NCT04442269|474854086|FG000|Overall Study|Adverse Event|1|||
131883372|NCT04442269|474854087|FG001|Overall Study|Adverse Event|0|||
131883373|NCT04442269|474854086|FG000|Overall Study|Death|0|||
131883374|NCT04442269|474854087|FG001|Overall Study|Death|1|||
131883375|NCT04442269|474854086|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
131883376|NCT04442269|474854087|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
131883377|NCT04442269|474854086|FG000|Overall Study|Lost to Follow-up|1|||
131883378|NCT04442269|474854087|FG001|Overall Study|Lost to Follow-up|0|||
131883379|NCT04442269|474854086|FG000|Overall Study|Withdrawal by Subject|3|||
131883380|NCT04442269|474854087|FG001|Overall Study|Withdrawal by Subject|2|||
131883381|NCT04442269|474854086|FG000|Overall Study|Protocol Deviation|0|||
131883382|NCT04442269|474854087|FG001|Overall Study|Protocol Deviation|1|||
131883383|NCT04442269|474854086|FG000|Overall Study|Travel Limitations|1|||
131883384|NCT04442269|474854087|FG001|Overall Study|Travel Limitations|1|||
131883385|NCT00430352|474854088|FG000|Overall Study|Disease progression|58|||
131883386|NCT00430352|474854088|FG000|Overall Study|Withdrawal by Subject|11|||
131883387|NCT00430352|474854088|FG000|Overall Study|Adverse Event|16|||
131883388|NCT00430352|474854088|FG000|Overall Study|Death|5|||
131883389|NCT00430352|474854088|FG000|Overall Study|Other|48|||
131883390|NCT00819780|474854091|FG000|Overall Study|Did not receive study drug|3|||
131883391|NCT00819780|474854092|FG001|Overall Study|Did not receive study drug|4|||
131883392|NCT00819780|474854091|FG000|Overall Study|Still in treatment|25|||
131883393|NCT00819780|474854092|FG001|Overall Study|Still in treatment|17|||
131883394|NCT00150800|474854095|FG000|Overall Study|Adverse Event|89|||
131883395|NCT00150800|474854095|FG000|Overall Study|Death|18|||
131883396|NCT00150800|474854095|FG000|Overall Study|Lack of Efficacy|166|||
131883397|NCT00150800|474854095|FG000|Overall Study|Lost to Follow-up|58|||
131883398|NCT00150800|474854095|FG000|Overall Study|Subject's choice|90|||
131883399|NCT00150800|474854095|FG000|Overall Study|No compliance|18|||
131883400|NCT00150800|474854095|FG000|Overall Study|IP misshandling|1|||
131883401|NCT00150800|474854095|FG000|Overall Study|Site closure|24|||
131883402|NCT00150800|474854095|FG000|Overall Study|Protocol non-adherence|2|||
131883403|NCT00150800|474854095|FG000|Overall Study|Nobody to accompany patient|1|||
131883404|NCT00150800|474854095|FG000|Overall Study|Distance too long for patient|1|||
131883405|NCT00150800|474854095|FG000|Overall Study|Neurosurgery|2|||
131883406|NCT00150800|474854095|FG000|Overall Study|BRV monotherapy|1|||
131883407|NCT00150800|474854095|FG000|Overall Study|Visit refusal|3|||
131883408|NCT00150800|474854095|FG000|Overall Study|Sponsor's request|2|||
131883409|NCT00150800|474854095|FG000|Overall Study|Generalized Epilepsy|1|||
131883410|NCT00150800|474854095|FG000|Overall Study|Moved from area/country|8|||
131883411|NCT00150800|474854095|FG000|Overall Study|PI retiring|2|||
131883412|NCT00150800|474854095|FG000|Overall Study|PI leaving site|2|||
131883413|NCT00150800|474854095|FG000|Overall Study|Patient insurance|1|||
131883414|NCT00150800|474854095|FG000|Overall Study|Surgical intervention|4|||
131883415|NCT00150800|474854095|FG000|Overall Study|Pregnancy planned|1|||
131883416|NCT00150800|474854095|FG000|Overall Study|PI discontinuation request|1|||
131883417|NCT02089334|474854098|FG000|Overall Study|Withdrawal by Subject|0|||
131883418|NCT02089334|474854099|FG001|Overall Study|Withdrawal by Subject|0|||
131883419|NCT02089334|474854100|FG002|Overall Study|Withdrawal by Subject|0|||
131883420|NCT02089334|474854101|FG003|Overall Study|Withdrawal by Subject|2|||
131883421|NCT02089334|474854098|FG000|Overall Study|Adverse Event|0|||
131883422|NCT02089334|474854099|FG001|Overall Study|Adverse Event|0|||
131883423|NCT02089334|474854100|FG002|Overall Study|Adverse Event|0|||
131883424|NCT02089334|474854101|FG003|Overall Study|Adverse Event|2|||
131883425|NCT02089334|474854098|FG000|Overall Study|Progressive disease|0|||
131883426|NCT02089334|474854099|FG001|Overall Study|Progressive disease|0|||
131883427|NCT02089334|474854100|FG002|Overall Study|Progressive disease|0|||
131883428|NCT02089334|474854101|FG003|Overall Study|Progressive disease|2|||
131883429|NCT02089334|474854098|FG000|Overall Study|Physician Decision|0|||
131883430|NCT02089334|474854099|FG001|Overall Study|Physician Decision|0|||
131883431|NCT02089334|474854100|FG002|Overall Study|Physician Decision|1|||
131883432|NCT02089334|474854101|FG003|Overall Study|Physician Decision|1|||
131883433|NCT02832375|474854102|FG000|Overall Study|Lost to Follow-up|1|||
131883434|NCT02832375|474854103|FG001|Overall Study|Lost to Follow-up|0|||
131883435|NCT02832375|474854102|FG000|Overall Study|Withdrawal of Consent|1|||
131883436|NCT02832375|474854103|FG001|Overall Study|Withdrawal of Consent|0|||
131883437|NCT00084318|474854106|FG000|Overall Study|Withdrawal by Subject|5|||
131883438|NCT00084318|474854107|FG001|Overall Study|Withdrawal by Subject|2|||
131883439|NCT00084318|474854106|FG000|Overall Study|Protocol Violation|15|||
131883440|NCT00084318|474854107|FG001|Overall Study|Protocol Violation|11|||
131883441|NCT00084318|474854106|FG000|Overall Study|No protocol treatment|2|||
131883442|NCT00084318|474854107|FG001|Overall Study|No protocol treatment|0|||
131883443|NCT03301740|474854109|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
131883444|NCT03301740|474854110|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
131883445|NCT03301740|474854109|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
131883446|NCT03301740|474854110|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
131883447|NCT01037127|474854111|FG000|Overall Study|Lost to Follow-up|2|||
131883448|NCT01037127|474854112|FG001|Overall Study|Lost to Follow-up|4|||
131883449|NCT01037127|474854111|FG000|Overall Study|Physician Decision|1|||
131883450|NCT01037127|474854112|FG001|Overall Study|Physician Decision|0|||
131883451|NCT01037127|474854111|FG000|Overall Study|Study Closed Terminated|2|||
131883452|NCT01037127|474854112|FG001|Overall Study|Study Closed Terminated|17|||
131883453|NCT02637713|474854119|FG000|Overall Study|Screen Failure|2|||
131883454|NCT02847182|474854120|FG000|Overall Study|Withdrawal by Subject|0|||
131883455|NCT02847182|474854121|FG001|Overall Study|Withdrawal by Subject|1|||
131883456|NCT02345889|474854122|FG000|Overall Study|Inadequate Bowel Prep|17|||
131883457|NCT02345889|474854123|FG001|Overall Study|Inadequate Bowel Prep|16|||
131883458|NCT02345889|474854124|FG002|Overall Study|Inadequate Bowel Prep|18|||
131883459|NCT02345889|474854125|FG003|Overall Study|Inadequate Bowel Prep|14|||
131883460|NCT02345889|474854122|FG000|Overall Study|Polyposis identified during procedure|1|||
131883461|NCT02345889|474854123|FG001|Overall Study|Polyposis identified during procedure|1|||
131883462|NCT02345889|474854124|FG002|Overall Study|Polyposis identified during procedure|0|||
131883463|NCT02345889|474854125|FG003|Overall Study|Polyposis identified during procedure|1|||
131883464|NCT02345889|474854122|FG000|Overall Study|Recognized ineligible post-randomization|1|||
131883465|NCT02345889|474854123|FG001|Overall Study|Recognized ineligible post-randomization|0|||
131883466|NCT02345889|474854124|FG002|Overall Study|Recognized ineligible post-randomization|2|||
131883467|NCT02345889|474854125|FG003|Overall Study|Recognized ineligible post-randomization|1|||
131883468|NCT02345889|474854122|FG000|Overall Study|Ulcerative Colitis identified|1|||
131883469|NCT02345889|474854123|FG001|Overall Study|Ulcerative Colitis identified|0|||
131883470|NCT02345889|474854124|FG002|Overall Study|Ulcerative Colitis identified|0|||
131883471|NCT02345889|474854125|FG003|Overall Study|Ulcerative Colitis identified|0|||
131883472|NCT02345889|474854122|FG000|Overall Study|Cecum not intubated|1|||
131883473|NCT02345889|474854123|FG001|Overall Study|Cecum not intubated|0|||
131883474|NCT02345889|474854124|FG002|Overall Study|Cecum not intubated|0|||
131883475|NCT02345889|474854125|FG003|Overall Study|Cecum not intubated|0|||
131883476|NCT01173055|474854126|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
131883477|NCT01173055|474854127|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
131883478|NCT01173055|474854126|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
131883479|NCT01173055|474854127|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
131883480|NCT04325698|474854129|FG000|Overall Study|Study Terminated By Sponsor|1|||
131883481|NCT04325698|474854130|FG001|Overall Study|Study Terminated By Sponsor|1|||
131883482|NCT04325698|474854129|FG000|Overall Study|Withdrawal by Subject|0|||
131434239|NCT01790594|473217468|FG002|Overall Study|Physician Decision|0|||
131434240|NCT01790594|473217466|FG000|Overall Study|Withdrawal by Subject|2|||
131546941|NCT01445652|473625000|FG001|Overall Study|Not comfortable in lenses|0|||
131546942|NCT01445652|473624999|FG000|Overall Study|Failed to attend scheduled visit|2|||
131546943|NCT01445652|473625000|FG001|Overall Study|Failed to attend scheduled visit|3|||
131546944|NCT01445652|473624999|FG000|Overall Study|Failed teach session|2|||
131546945|NCT01445652|473625000|FG001|Overall Study|Failed teach session|0|||
131546946|NCT01445652|473624999|FG000|Overall Study|Adverse Event|1|||
131883483|NCT04325698|474854130|FG001|Overall Study|Withdrawal by Subject|2|||
131883484|NCT04253782|474854131|FG000|Overall Study|Death|2|||
131546947|NCT01445652|473625000|FG001|Overall Study|Adverse Event|0|||
131546948|NCT03595332|473625003|FG000|Overall Study|Lost to Follow-up|16|||
131546949|NCT03595332|473625004|FG001|Overall Study|Lost to Follow-up|22|||
131546950|NCT03595332|473625003|FG000|Overall Study|Unable to retrieve ID from school|0|||
131883485|NCT04253782|474854132|FG001|Overall Study|Death|0|||
131883486|NCT04216589|474854133|FG000|Overall Study|Withdrawal by Subject|2|||
131883487|NCT04216589|474854133|FG000|Overall Study|Protocol Violation|1|||
131883488|NCT04216589|474854133|FG000|Overall Study|Incarceration|1|||
131883489|NCT04240886|474855432|FG000|Treatment Phase|Death|4|||
131883490|NCT04240886|474855432|FG000|Treatment Phase|Discontinuation by Subject|1|||
131883491|NCT04240886|474855432|FG000|Treatment Phase|Adverse Event|5|||
131546951|NCT03595332|473625004|FG001|Overall Study|Unable to retrieve ID from school|2|||
131546952|NCT00611858|473625005|FG000|Overall Study|Adverse Event|2|||
131546953|NCT00611858|473625005|FG000|Overall Study|Withdrawal by Subject|2|||
131883492|NCT04240886|474855432|FG000|Follow-up Phase|Withdrawal by Subject|1|||
131883493|NCT04240886|474855432|FG000|Follow-up Phase|Discontinuation by Subject|1|||
131883494|NCT04240886|474855432|FG000|Follow-up Phase|Death|2|||
131883495|NCT01004406|474855433|FG000|Overall Study|Withdrawal by Subject|2|||
131883496|NCT01004406|474855434|FG001|Overall Study|Withdrawal by Subject|0|||
131883497|NCT01004406|474855433|FG000|Overall Study|Lost to Follow-up|1|||
131883498|NCT01004406|474855434|FG001|Overall Study|Lost to Follow-up|0|||
131883499|NCT03201874|474855435|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
131883500|NCT03201874|474855436|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
131883501|NCT03201874|474855435|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
131883502|NCT03201874|474855436|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
131883503|NCT02907593|474855437|FG000|Overall Study|Withdrawal by Subject|0|||
131883504|NCT02907593|474855438|FG001|Overall Study|Withdrawal by Subject|0|||
131883505|NCT02907593|474855439|FG002|Overall Study|Withdrawal by Subject|1|||
131883506|NCT02907593|474855440|FG003|Overall Study|Withdrawal by Subject|0|||
131883507|NCT04618471|474855441|FG000|Overall Study|Screen Failure|62|||
131883508|NCT04618471|474855441|FG000|Overall Study|Withdrawal by Subject|6|||
131883509|NCT04618471|474855441|FG000|Overall Study|Physician Decision|2|||
131883510|NCT04618471|474855441|FG000|Overall Study|Lost to Follow-up|1|||
131883511|NCT04618471|474855441|FG000|Overall Study|Various other reasons|2|||
131883512|NCT04618471|474855441|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
131883513|NCT01752634|474855442|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
131883514|NCT01752634|474855443|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
131883515|NCT01752634|474855444|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
131883516|NCT01752634|474855445|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
131883517|NCT01752634|474855446|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
131883518|NCT01752634|474855447|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
131883519|NCT01752634|474855442|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
131883520|NCT01752634|474855443|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
131883521|NCT01752634|474855444|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
131883522|NCT01752634|474855445|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
131883523|NCT01752634|474855446|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
131883524|NCT01752634|474855447|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
131883525|NCT01752634|474855442|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
131883526|NCT01752634|474855443|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
131883527|NCT01752634|474855444|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
131883528|NCT01752634|474855445|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
131546954|NCT01058304|473625006|FG000|Overall Study|Withdrawal by Subject|8|||
131546955|NCT01058304|473625007|FG001|Overall Study|Withdrawal by Subject|5|||
131546956|NCT01058304|473625006|FG000|Overall Study|Lost to Follow-up|13|||
131546957|NCT01058304|473625007|FG001|Overall Study|Lost to Follow-up|16|||
131546958|NCT01058304|473625006|FG000|Overall Study|Developed exclusion criterion|6|||
131546959|NCT01058304|473625007|FG001|Overall Study|Developed exclusion criterion|12|||
131546960|NCT01820559|473625008|FG000|Overall Study|Adverse Event|4|||
131546961|NCT01820559|473625009|FG001|Overall Study|Adverse Event|6|||
131546962|NCT01820559|473625010|FG002|Overall Study|Adverse Event|13|||
131546963|NCT01820559|473625008|FG000|Overall Study|Withdrawal by Subject|1|||
131546964|NCT01820559|473625009|FG001|Overall Study|Withdrawal by Subject|2|||
131546965|NCT01820559|473625010|FG002|Overall Study|Withdrawal by Subject|5|||
131546966|NCT01820559|473625008|FG000|Overall Study|Protocol Violation|2|||
131546967|NCT01820559|473625009|FG001|Overall Study|Protocol Violation|1|||
131546968|NCT01820559|473625010|FG002|Overall Study|Protocol Violation|3|||
131546969|NCT01820559|473625008|FG000|Overall Study|Subject's non-compliance|1|||
131546970|NCT01820559|473625009|FG001|Overall Study|Subject's non-compliance|0|||
131546971|NCT01820559|473625010|FG002|Overall Study|Subject's non-compliance|2|||
131546972|NCT01820559|473625008|FG000|Overall Study|Lost to Follow-up|3|||
131546973|NCT01820559|473625009|FG001|Overall Study|Lost to Follow-up|2|||
131546974|NCT01820559|473625010|FG002|Overall Study|Lost to Follow-up|2|||
131546975|NCT01820559|473625008|FG000|Overall Study|At sponsor request|0|||
131546976|NCT01820559|473625009|FG001|Overall Study|At sponsor request|0|||
131546977|NCT01820559|473625010|FG002|Overall Study|At sponsor request|1|||
131546978|NCT01820559|473625008|FG000|Overall Study|Lack of Efficacy|3|||
131546979|NCT01820559|473625009|FG001|Overall Study|Lack of Efficacy|2|||
131546980|NCT01820559|473625010|FG002|Overall Study|Lack of Efficacy|3|||
131546981|NCT02515279|473625018|FG000|Overall Study|Adverse Event|7|||
131546982|NCT02515279|473625018|FG000|Overall Study|Lack of Efficacy|31|||
131546983|NCT02515279|473625018|FG000|Overall Study|Lost to Follow-up|9|||
131883529|NCT01752634|474855446|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
131883530|NCT01752634|474855447|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
131546984|NCT02515279|473625018|FG000|Overall Study|Withdrawal by Subject|18|||
131546985|NCT02515279|473625018|FG000|Overall Study|End-of-treatment visit not attended|17|||
131546986|NCT02515279|473625018|FG000|Overall Study|Other|22|||
131546987|NCT01800968|473625019|FG000|Overall Study|Death|23|||
131546988|NCT01800968|473625020|FG001|Overall Study|Death|16|||
131546989|NCT01800968|473625019|FG000|Overall Study|Lost to Follow-up|5|||
131546990|NCT01800968|473625020|FG001|Overall Study|Lost to Follow-up|7|||
131546991|NCT01800968|473625019|FG000|Overall Study|Withdrawal by Subject|7|||
131883531|NCT01752634|474855442|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
131883532|NCT01752634|474855443|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
131883533|NCT01752634|474855444|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
131883534|NCT01752634|474855445|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
131883535|NCT01752634|474855446|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
131883536|NCT01752634|474855447|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
131883537|NCT01752634|474855442|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
131883538|NCT01752634|474855443|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
131883539|NCT01752634|474855444|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
131883540|NCT01752634|474855445|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
131883541|NCT01752634|474855446|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
131883542|NCT01752634|474855447|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
131546992|NCT01800968|473625020|FG001|Overall Study|Withdrawal by Subject|9|||
131546993|NCT01800968|473625019|FG000|Overall Study|Physician Decision|1|||
131883543|NCT01752634|474855442|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
131883544|NCT01752634|474855443|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
131883545|NCT01752634|474855444|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
131883546|NCT01752634|474855445|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
131883547|NCT01752634|474855446|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
131883548|NCT01752634|474855447|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
131883549|NCT01752634|474855442|FG000|Week 24 to Week 260|Physician Decision|1|||
131883550|NCT01752634|474855443|FG001|Week 24 to Week 260|Physician Decision|2|||
131883551|NCT01752634|474855444|FG002|Week 24 to Week 260|Physician Decision|4|||
131883552|NCT01752634|474855445|FG003|Week 24 to Week 260|Physician Decision|2|||
131883553|NCT01752634|474855446|FG004|Week 24 to Week 260|Physician Decision|1|||
131883554|NCT01752634|474855447|FG005|Week 24 to Week 260|Physician Decision|0|||
131883555|NCT01752634|474855442|FG000|Week 24 to Week 260|Death|0|||
131883556|NCT01752634|474855443|FG001|Week 24 to Week 260|Death|1|||
131883557|NCT01752634|474855444|FG002|Week 24 to Week 260|Death|0|||
131883558|NCT01752634|474855445|FG003|Week 24 to Week 260|Death|0|||
131883559|NCT01752634|474855446|FG004|Week 24 to Week 260|Death|0|||
131883560|NCT01752634|474855447|FG005|Week 24 to Week 260|Death|0|||
131883561|NCT01752634|474855442|FG000|Week 24 to Week 260|Pregnancy|0|||
131883562|NCT01752634|474855443|FG001|Week 24 to Week 260|Pregnancy|0|||
131883563|NCT01752634|474855444|FG002|Week 24 to Week 260|Pregnancy|1|||
131883564|NCT01752634|474855445|FG003|Week 24 to Week 260|Pregnancy|0|||
131883565|NCT01752634|474855446|FG004|Week 24 to Week 260|Pregnancy|0|||
131883566|NCT01752634|474855447|FG005|Week 24 to Week 260|Pregnancy|0|||
131883567|NCT01752634|474855442|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
131883568|NCT01752634|474855443|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
131883569|NCT01752634|474855444|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
131883570|NCT01752634|474855445|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
131883571|NCT01752634|474855446|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
131883572|NCT01752634|474855447|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
131883573|NCT01752634|474855442|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
131883574|NCT01752634|474855443|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
131883575|NCT01752634|474855444|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
131883576|NCT01752634|474855445|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
131883577|NCT01752634|474855446|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
131883578|NCT01752634|474855447|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
131883579|NCT01752634|474855442|FG000|Week 24 to Week 260|Adverse Event|4|||
131883580|NCT01752634|474855443|FG001|Week 24 to Week 260|Adverse Event|8|||
131883581|NCT01752634|474855444|FG002|Week 24 to Week 260|Adverse Event|8|||
131883582|NCT01752634|474855445|FG003|Week 24 to Week 260|Adverse Event|4|||
131883583|NCT01752634|474855446|FG004|Week 24 to Week 260|Adverse Event|2|||
131883584|NCT01752634|474855447|FG005|Week 24 to Week 260|Adverse Event|0|||
131883585|NCT01250171|474855448|FG000|Overall Study|Administrative reasons|1|||
131883586|NCT01250171|474855449|FG001|Overall Study|Administrative reasons|0|||
131883587|NCT01250171|474855450|FG002|Overall Study|Administrative reasons|0|||
131883588|NCT04250714|474855460|FG000|Overall Study|Treatment - withdrawal by subject|14|||
131883589|NCT04250714|474855460|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
131883590|NCT04250714|474855460|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
131883591|NCT04250714|474855460|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
131883592|NCT04250714|474855460|FG000|Overall Study|Treatment - Death|1|||
131883593|NCT04250714|474855460|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
131883594|NCT04250714|474855460|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
131883595|NCT04250714|474855460|FG000|Overall Study|Attempt|2|||
131883596|NCT04250714|474855460|FG000|Overall Study|Intent|7|||
131883597|NCT01451164|474855463|FG000|Overall Study|Adverse Event|19|||
131883598|NCT01451164|474855464|FG001|Overall Study|Adverse Event|12|||
131883599|NCT01451164|474855465|FG002|Overall Study|Adverse Event|18|||
131883600|NCT01451164|474855466|FG003|Overall Study|Adverse Event|21|||
131883601|NCT01451164|474855463|FG000|Overall Study|Withdrawal Criteria|1|||
131883602|NCT01451164|474855464|FG001|Overall Study|Withdrawal Criteria|1|||
131883603|NCT01451164|474855465|FG002|Overall Study|Withdrawal Criteria|1|||
131883604|NCT01451164|474855466|FG003|Overall Study|Withdrawal Criteria|1|||
131883605|NCT01451164|474855463|FG000|Overall Study|Physician Decision|2|||
131883606|NCT01451164|474855464|FG001|Overall Study|Physician Decision|0|||
131883607|NCT01451164|474855465|FG002|Overall Study|Physician Decision|1|||
131883608|NCT01451164|474855466|FG003|Overall Study|Physician Decision|0|||
131883609|NCT01451164|474855463|FG000|Overall Study|Withdrawal by Subject|14|||
131883610|NCT01451164|474855464|FG001|Overall Study|Withdrawal by Subject|11|||
131883611|NCT01451164|474855465|FG002|Overall Study|Withdrawal by Subject|16|||
131883612|NCT01451164|474855466|FG003|Overall Study|Withdrawal by Subject|17|||
131883613|NCT01451164|474855463|FG000|Overall Study|Protocol Violation|0|||
131883614|NCT01451164|474855464|FG001|Overall Study|Protocol Violation|1|||
131883615|NCT01451164|474855465|FG002|Overall Study|Protocol Violation|0|||
131883616|NCT01451164|474855466|FG003|Overall Study|Protocol Violation|0|||
131546994|NCT01800968|473625020|FG001|Overall Study|Physician Decision|0|||
131883617|NCT01451164|474855463|FG000|Overall Study|Lack of Efficacy|7|||
131883618|NCT01451164|474855464|FG001|Overall Study|Lack of Efficacy|9|||
131883619|NCT01451164|474855465|FG002|Overall Study|Lack of Efficacy|9|||
131883620|NCT01451164|474855466|FG003|Overall Study|Lack of Efficacy|7|||
131883621|NCT04599933|474855467|FG000|Overall Study|Adverse Event|4|||
131883622|NCT04599933|474855468|FG001|Overall Study|Adverse Event|1|||
131883623|NCT04599933|474855467|FG000|Overall Study|Withdrawal by Subject|4|||
131883624|NCT04599933|474855468|FG001|Overall Study|Withdrawal by Subject|2|||
131883625|NCT04599933|474855467|FG000|Overall Study|Lost to Follow-up|0|||
131883626|NCT04599933|474855468|FG001|Overall Study|Lost to Follow-up|1|||
131883627|NCT04599933|474855467|FG000|Overall Study|Physician Decision|0|||
131883628|NCT04599933|474855468|FG001|Overall Study|Physician Decision|1|||
131883629|NCT04599933|474855467|FG000|Overall Study|Screen Failure|1|||
131883630|NCT04599933|474855468|FG001|Overall Study|Screen Failure|2|||
131883631|NCT03117881|474855471|FG000|Baseline|Withdrawal by Subject|21|||
131883632|NCT03117881|474855472|FG001|Baseline|Withdrawal by Subject|10|||
131883633|NCT03117881|474855473|FG002|Baseline|Withdrawal by Subject|0|||
131883634|NCT03117881|474855471|FG000|Baseline|Lost to Follow-up|22|||
131883635|NCT03117881|474855472|FG001|Baseline|Lost to Follow-up|25|||
131883636|NCT03117881|474855473|FG002|Baseline|Lost to Follow-up|0|||
131883637|NCT03117881|474855471|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
131883638|NCT03117881|474855472|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
131883639|NCT03117881|474855473|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
131883640|NCT03117881|474855471|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
131883641|NCT03117881|474855472|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
131883642|NCT03117881|474855473|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
131883643|NCT03117881|474855471|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
131883644|NCT03117881|474855472|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
131883645|NCT03117881|474855473|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
131883646|NCT03117881|474855471|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
131883647|NCT03117881|474855472|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
131883648|NCT03117881|474855473|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
131883649|NCT03117881|474855471|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
131883650|NCT03117881|474855472|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
131883651|NCT03117881|474855473|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
131883652|NCT03117881|474855471|FG000|6-Month Follow-Up|Did not complete test|53|||
131883653|NCT03117881|474855472|FG001|6-Month Follow-Up|Did not complete test|25|||
131883654|NCT03117881|474855473|FG002|6-Month Follow-Up|Did not complete test|7|||
131883655|NCT03117881|474855471|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
131883656|NCT03117881|474855472|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
131883657|NCT03117881|474855473|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
131883658|NCT03117881|474855471|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
131883659|NCT03117881|474855472|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
131883660|NCT03117881|474855473|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
131883661|NCT03117881|474855471|FG000|12-Month Follow-Up|Did not complete test|40|||
131883662|NCT03117881|474855472|FG001|12-Month Follow-Up|Did not complete test|0|||
131883663|NCT03117881|474855473|FG002|12-Month Follow-Up|Did not complete test|0|||
131883664|NCT01027897|474855474|FG000|Overall Study|Protocol Violation|1|||
131883665|NCT01027897|474855474|FG000|Overall Study|Withdrawal by Subject|1|||
131883666|NCT02045732|474855477|FG000|Overall Study|At the discretion of the investigator|1|||
131883667|NCT02045732|474855478|FG001|Overall Study|At the discretion of the investigator|1|||
131883668|NCT00473824|474855479|FG000|Overall Study|Virologic Breakthrough|1|||
131883669|NCT00473824|474855480|FG001|Overall Study|Virologic Breakthrough|0|||
131546995|NCT03185481|473625022|FG000|Overall Study|Adverse Event|1|||
131546996|NCT03185481|473625022|FG000|Overall Study|Study Terminated by Sponsor|4|||
131546997|NCT03266770|473625027|FG000|Overall Study|Physician Decision|3|||
131659740|NCT00958841|474039003|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131883670|NCT00473824|474855479|FG000|Overall Study|Adverse Event|1|||
131883671|NCT00473824|474855480|FG001|Overall Study|Adverse Event|0|||
131883672|NCT00473824|474855479|FG000|Overall Study|Death|1|||
131883673|NCT00473824|474855480|FG001|Overall Study|Death|0|||
131883674|NCT00473824|474855479|FG000|Overall Study|Lost to Follow-up|1|||
131883675|NCT00473824|474855480|FG001|Overall Study|Lost to Follow-up|0|||
131883676|NCT00473824|474855479|FG000|Overall Study|Withdrawal by physician|1|||
131883677|NCT00473824|474855480|FG001|Overall Study|Withdrawal by physician|0|||
131883678|NCT02560623|474855481|FG000|Overall Study|Unable to swallow sponge|0|||
131883679|NCT02560623|474855482|FG001|Overall Study|Unable to swallow sponge|1|||
131883680|NCT02560623|474855483|FG002|Overall Study|Unable to swallow sponge|0|||
131883681|NCT02560623|474855484|FG003|Overall Study|Unable to swallow sponge|0|||
131883682|NCT02560623|474855481|FG000|Overall Study|Intervention prior to sponge administration|0|||
131883683|NCT02560623|474855482|FG001|Overall Study|Intervention prior to sponge administration|1|||
131883684|NCT02560623|474855483|FG002|Overall Study|Intervention prior to sponge administration|0|||
131883685|NCT02560623|474855484|FG003|Overall Study|Intervention prior to sponge administration|0|||
131883686|NCT05014815|474855485|FG000|Overall Study|Death|63|||
131883687|NCT05014815|474855486|FG001|Overall Study|Death|70|||
131883688|NCT05014815|474855485|FG000|Overall Study|Withdrawal by Subject|10|||
131883689|NCT05014815|474855486|FG001|Overall Study|Withdrawal by Subject|10|||
131883690|NCT05014815|474855485|FG000|Overall Study|Lost to Follow-up|4|||
131883691|NCT05014815|474855486|FG001|Overall Study|Lost to Follow-up|2|||
131883692|NCT05014815|474855485|FG000|Overall Study|Physician Decision|2|||
131883693|NCT05014815|474855486|FG001|Overall Study|Physician Decision|4|||
131883694|NCT04247880|474855487|FG000|Overall Study|Lost to Follow-up|24|||
131883695|NCT04247880|474855488|FG001|Overall Study|Lost to Follow-up|17|||
131883696|NCT04247880|474855487|FG000|Overall Study|Withdrawal by Subject|3|||
131883697|NCT04247880|474855488|FG001|Overall Study|Withdrawal by Subject|0|||
131883698|NCT06303167|474855489|FG000|Overall Study|Ineligible|1|||
131883699|NCT06303167|474855489|FG000|Overall Study|Never start protocol therapy|2|||
131883700|NCT06303167|474855489|FG000|Overall Study|Disease progression|16|||
131883701|NCT02453282|474855490|FG000|Overall Study|Death|275|||
131883702|NCT02453282|474855491|FG001|Overall Study|Death|277|||
131883703|NCT02453282|474855492|FG002|Overall Study|Death|296|||
131883704|NCT02453282|474855490|FG000|Overall Study|Lost to Follow-up|1|||
131883705|NCT02453282|474855491|FG001|Overall Study|Lost to Follow-up|0|||
131883706|NCT02453282|474855492|FG002|Overall Study|Lost to Follow-up|2|||
131883707|NCT02453282|474855490|FG000|Overall Study|Withdrawal by Subject|12|||
131883708|NCT02453282|474855491|FG001|Overall Study|Withdrawal by Subject|10|||
131883709|NCT02453282|474855492|FG002|Overall Study|Withdrawal by Subject|11|||
131883710|NCT02453282|474855490|FG000|Overall Study|Participants ongoing at data cut-off|85|||
131883711|NCT02453282|474855491|FG001|Overall Study|Participants ongoing at data cut-off|84|||
131883712|NCT02453282|474855492|FG002|Overall Study|Participants ongoing at data cut-off|62|||
131883713|NCT02453282|474855490|FG000|Overall Study|Other|1|||
131883714|NCT02453282|474855491|FG001|Overall Study|Other|1|||
131883715|NCT02453282|474855492|FG002|Overall Study|Other|1|||
131883716|NCT01661933|474855494|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
131883717|NCT01661933|474855494|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
131883718|NCT03385304|474855495|FG000|Overall Study|Death|19|||
131883719|NCT03385304|474855496|FG001|Overall Study|Death|7|||
131883720|NCT03385304|474855495|FG000|Overall Study|Lost to Follow-up|17|||
131883721|NCT03385304|474855496|FG001|Overall Study|Lost to Follow-up|14|||
131883722|NCT03385304|474855495|FG000|Overall Study|Withdrawal by Subject|3|||
131883723|NCT03385304|474855496|FG001|Overall Study|Withdrawal by Subject|2|||
131883724|NCT03385304|474855495|FG000|Overall Study|Incarceration|2|||
131883725|NCT03385304|474855496|FG001|Overall Study|Incarceration|3|||
131659741|NCT00958841|474039003|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131659742|NCT00958841|474039003|FG000|Overall Study|Administrative problems|1|||
131659743|NCT00958841|474039003|FG000|Overall Study|Adverse Event|8|||
131659744|NCT00958841|474039003|FG000|Overall Study|New cancer therapy|5|||
131659745|NCT00958841|474039003|FG000|Overall Study|Withdrawal by Subject|1|||
131659746|NCT00958841|474039003|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
131659747|NCT00958841|474039003|FG000|Overall Study|Completed M6/did not enter extension|27|||
131659748|NCT00958841|474039003|FG000|Overall Study|Discontinued prior to M*|28|||
131659749|NCT03014011|474039005|FG000|First Intervention|Withdrawal by Subject|1|||
131659750|NCT03014011|474039006|FG001|First Intervention|Withdrawal by Subject|0|||
131659751|NCT03014011|474039005|FG000|Washout|Withdrawal by Subject|1|||
131659752|NCT03014011|474039006|FG001|Washout|Withdrawal by Subject|0|||
131659753|NCT02416453|474039007|FG000|Overall Study|Adverse Event|0|||
131659754|NCT02416453|474039008|FG001|Overall Study|Adverse Event|0|||
131659755|NCT02416453|474039009|FG002|Overall Study|Adverse Event|0|||
131659756|NCT02416453|474039010|FG003|Overall Study|Adverse Event|2|||
131659757|NCT02416453|474039011|FG004|Overall Study|Adverse Event|0|||
131659758|NCT02416453|474039012|FG005|Overall Study|Adverse Event|1|||
131659759|NCT02416453|474039013|FG006|Overall Study|Adverse Event|0|||
131659760|NCT02416453|474039014|FG007|Overall Study|Adverse Event|0|||
131659761|NCT02416453|474039015|FG008|Overall Study|Adverse Event|0|||
131659762|NCT02416453|474039016|FG009|Overall Study|Adverse Event|0|||
131659763|NCT02416453|474039017|FG010|Overall Study|Adverse Event|0|||
131659764|NCT02416453|474039007|FG000|Overall Study|Lost to Follow-up|1|||
131659765|NCT02416453|474039008|FG001|Overall Study|Lost to Follow-up|3|||
131659766|NCT02416453|474039009|FG002|Overall Study|Lost to Follow-up|0|||
131659767|NCT02416453|474039010|FG003|Overall Study|Lost to Follow-up|8|||
131659768|NCT02416453|474039011|FG004|Overall Study|Lost to Follow-up|0|||
131659769|NCT02416453|474039012|FG005|Overall Study|Lost to Follow-up|5|||
131659770|NCT02416453|474039013|FG006|Overall Study|Lost to Follow-up|1|||
131659771|NCT02416453|474039014|FG007|Overall Study|Lost to Follow-up|3|||
131659772|NCT02416453|474039015|FG008|Overall Study|Lost to Follow-up|1|||
131659773|NCT02416453|474039016|FG009|Overall Study|Lost to Follow-up|0|||
131659774|NCT02416453|474039017|FG010|Overall Study|Lost to Follow-up|0|||
131659775|NCT02416453|474039007|FG000|Overall Study|Physician Decision|0|||
131659776|NCT02416453|474039008|FG001|Overall Study|Physician Decision|0|||
131659777|NCT02416453|474039009|FG002|Overall Study|Physician Decision|0|||
131659778|NCT02416453|474039010|FG003|Overall Study|Physician Decision|0|||
131659779|NCT02416453|474039011|FG004|Overall Study|Physician Decision|0|||
131659780|NCT02416453|474039012|FG005|Overall Study|Physician Decision|1|||
131659781|NCT02416453|474039013|FG006|Overall Study|Physician Decision|1|||
131659782|NCT02416453|474039014|FG007|Overall Study|Physician Decision|1|||
131659783|NCT02416453|474039015|FG008|Overall Study|Physician Decision|0|||
131659784|NCT02416453|474039016|FG009|Overall Study|Physician Decision|0|||
131659785|NCT02416453|474039017|FG010|Overall Study|Physician Decision|0|||
131659786|NCT02416453|474039007|FG000|Overall Study|Withdrawal by Subject|2|||
131659787|NCT02416453|474039008|FG001|Overall Study|Withdrawal by Subject|0|||
131659788|NCT02416453|474039009|FG002|Overall Study|Withdrawal by Subject|0|||
131659789|NCT02416453|474039010|FG003|Overall Study|Withdrawal by Subject|5|||
131659790|NCT02416453|474039011|FG004|Overall Study|Withdrawal by Subject|1|||
131659791|NCT02416453|474039012|FG005|Overall Study|Withdrawal by Subject|8|||
131659792|NCT02416453|474039013|FG006|Overall Study|Withdrawal by Subject|0|||
131659793|NCT02416453|474039014|FG007|Overall Study|Withdrawal by Subject|8|||
131659794|NCT02416453|474039015|FG008|Overall Study|Withdrawal by Subject|4|||
131659795|NCT02416453|474039016|FG009|Overall Study|Withdrawal by Subject|0|||
131659796|NCT02416453|474039017|FG010|Overall Study|Withdrawal by Subject|0|||
131659797|NCT02416453|474039007|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659798|NCT02416453|474039008|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659799|NCT02416453|474039009|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
131659800|NCT02416453|474039010|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659801|NCT02416453|474039011|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659802|NCT02416453|474039012|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659803|NCT02416453|474039013|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659804|NCT02416453|474039014|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659805|NCT02416453|474039015|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659806|NCT02416453|474039016|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659807|NCT02416453|474039017|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131659808|NCT02416453|474039007|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659809|NCT02416453|474039008|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659810|NCT02416453|474039009|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659811|NCT02416453|474039010|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659812|NCT02416453|474039011|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659813|NCT02416453|474039012|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
131659814|NCT02416453|474039013|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659815|NCT02416453|474039014|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659816|NCT02416453|474039015|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659817|NCT02416453|474039016|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659818|NCT02416453|474039017|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131659819|NCT02045875|474039030|FG000|Overall Study|Lost to Follow-up|3|||
131659820|NCT02045875|474039031|FG001|Overall Study|Lost to Follow-up|0|||
131659821|NCT02045875|474039030|FG000|Overall Study|Withdrawal by Subject|4|||
131659822|NCT02045875|474039031|FG001|Overall Study|Withdrawal by Subject|3|||
131659823|NCT00132873|474039032|FG000|Overall Study|Adverse Event|3|||
131659824|NCT00132873|474039032|FG000|Overall Study|Lost to Follow-up|1|||
131659825|NCT00132873|474039032|FG000|Overall Study|Lack of Efficacy|1|||
131659826|NCT00132873|474039032|FG000|Overall Study|Withdrawal by Subject|3|||
131659827|NCT00132873|474039032|FG000|Overall Study|Planned Pregnancy|1|||
131659828|NCT01803282|474039036|FG000|Overall Study|Progressive Disease|4|||
131659829|NCT01803282|474039037|FG001|Overall Study|Progressive Disease|3|||
131659830|NCT01803282|474039038|FG002|Overall Study|Progressive Disease|6|||
131659831|NCT01803282|474039039|FG003|Overall Study|Progressive Disease|22|||
131659832|NCT01803282|474039040|FG004|Overall Study|Progressive Disease|5|||
131659833|NCT01803282|474039041|FG005|Overall Study|Progressive Disease|8|||
131659834|NCT01803282|474039042|FG006|Overall Study|Progressive Disease|23|||
131883726|NCT01447446|474855497|FG000|Overall Study|Death|6|||
131883727|NCT01447446|474855498|FG001|Overall Study|Death|3|||
131659835|NCT01803282|474039043|FG007|Overall Study|Progressive Disease|24|||
131659836|NCT01803282|474039044|FG008|Overall Study|Progressive Disease|3|||
131659837|NCT01803282|474039045|FG009|Overall Study|Progressive Disease|29|||
131659838|NCT01803282|474039046|FG010|Overall Study|Progressive Disease|6|||
131659839|NCT01803282|474039047|FG011|Overall Study|Progressive Disease|11|||
131659840|NCT01803282|474039036|FG000|Overall Study|Death|0|||
131659841|NCT01803282|474039037|FG001|Overall Study|Death|0|||
131883728|NCT01447446|474855499|FG002|Overall Study|Death|2|||
131883729|NCT01447446|474855500|FG003|Overall Study|Death|1|||
131883730|NCT01447446|474855501|FG004|Overall Study|Death|7|||
131883731|NCT01447446|474855502|FG005|Overall Study|Death|0|||
131883732|NCT01447446|474855497|FG000|Overall Study|Adverse Event|3|||
131883733|NCT01447446|474855498|FG001|Overall Study|Adverse Event|0|||
131883734|NCT01447446|474855499|FG002|Overall Study|Adverse Event|1|||
131659842|NCT01803282|474039038|FG002|Overall Study|Death|0|||
131659843|NCT01803282|474039039|FG003|Overall Study|Death|0|||
131659844|NCT01803282|474039040|FG004|Overall Study|Death|2|||
131659845|NCT01803282|474039041|FG005|Overall Study|Death|1|||
131659846|NCT01803282|474039042|FG006|Overall Study|Death|1|||
131883735|NCT01447446|474855500|FG003|Overall Study|Adverse Event|0|||
131883736|NCT01447446|474855501|FG004|Overall Study|Adverse Event|2|||
131883737|NCT01447446|474855502|FG005|Overall Study|Adverse Event|0|||
131883738|NCT01447446|474855497|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
131883739|NCT01447446|474855498|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
131659847|NCT01803282|474039043|FG007|Overall Study|Death|5|||
131883740|NCT01447446|474855499|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
131883741|NCT01447446|474855500|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
131883742|NCT01447446|474855501|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
131883743|NCT01447446|474855502|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
131883744|NCT01447446|474855497|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
131883745|NCT01447446|474855498|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
131883746|NCT01447446|474855499|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
131883747|NCT01447446|474855500|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
131883748|NCT01447446|474855501|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
131883749|NCT01447446|474855502|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
131883750|NCT01447446|474855497|FG000|Overall Study|Administrative/Other|34|||
131883751|NCT01447446|474855498|FG001|Overall Study|Administrative/Other|9|||
131659848|NCT01803282|474039044|FG008|Overall Study|Death|1|||
131659849|NCT01803282|474039045|FG009|Overall Study|Death|1|||
131659850|NCT01803282|474039046|FG010|Overall Study|Death|0|||
131659851|NCT01803282|474039047|FG011|Overall Study|Death|0|||
131659852|NCT01803282|474039036|FG000|Overall Study|Withdrew Consent|0|||
131659853|NCT01803282|474039037|FG001|Overall Study|Withdrew Consent|0|||
131659854|NCT01803282|474039038|FG002|Overall Study|Withdrew Consent|0|||
131659855|NCT01803282|474039039|FG003|Overall Study|Withdrew Consent|6|||
131659856|NCT01803282|474039040|FG004|Overall Study|Withdrew Consent|1|||
131659857|NCT01803282|474039041|FG005|Overall Study|Withdrew Consent|0|||
131659858|NCT01803282|474039042|FG006|Overall Study|Withdrew Consent|8|||
131659859|NCT01803282|474039043|FG007|Overall Study|Withdrew Consent|3|||
131659860|NCT01803282|474039044|FG008|Overall Study|Withdrew Consent|1|||
131659861|NCT01803282|474039045|FG009|Overall Study|Withdrew Consent|5|||
131659862|NCT01803282|474039046|FG010|Overall Study|Withdrew Consent|0|||
131659863|NCT01803282|474039047|FG011|Overall Study|Withdrew Consent|1|||
131659864|NCT01803282|474039036|FG000|Overall Study|Investigator's Discretion|0|||
131659865|NCT01803282|474039037|FG001|Overall Study|Investigator's Discretion|0|||
131659866|NCT01803282|474039038|FG002|Overall Study|Investigator's Discretion|0|||
131659867|NCT01803282|474039039|FG003|Overall Study|Investigator's Discretion|7|||
131659868|NCT01803282|474039040|FG004|Overall Study|Investigator's Discretion|2|||
131659869|NCT01803282|474039041|FG005|Overall Study|Investigator's Discretion|1|||
131659870|NCT01803282|474039042|FG006|Overall Study|Investigator's Discretion|7|||
131659871|NCT01803282|474039043|FG007|Overall Study|Investigator's Discretion|10|||
131659872|NCT01803282|474039044|FG008|Overall Study|Investigator's Discretion|6|||
131659873|NCT01803282|474039045|FG009|Overall Study|Investigator's Discretion|7|||
131659874|NCT01803282|474039046|FG010|Overall Study|Investigator's Discretion|1|||
131659875|NCT01803282|474039047|FG011|Overall Study|Investigator's Discretion|0|||
131659876|NCT01803282|474039036|FG000|Overall Study|Adverse Event|0|||
131659877|NCT01803282|474039037|FG001|Overall Study|Adverse Event|0|||
131659878|NCT01803282|474039038|FG002|Overall Study|Adverse Event|0|||
131659879|NCT01803282|474039039|FG003|Overall Study|Adverse Event|0|||
131659880|NCT01803282|474039040|FG004|Overall Study|Adverse Event|0|||
131659881|NCT01803282|474039041|FG005|Overall Study|Adverse Event|0|||
131659882|NCT01803282|474039042|FG006|Overall Study|Adverse Event|1|||
131659883|NCT01803282|474039043|FG007|Overall Study|Adverse Event|2|||
131659884|NCT01803282|474039044|FG008|Overall Study|Adverse Event|0|||
131659885|NCT01803282|474039045|FG009|Overall Study|Adverse Event|1|||
131659886|NCT01803282|474039046|FG010|Overall Study|Adverse Event|0|||
131659887|NCT01803282|474039047|FG011|Overall Study|Adverse Event|3|||
131659888|NCT01803282|474039036|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131883752|NCT01447446|474855499|FG002|Overall Study|Administrative/Other|10|||
131883753|NCT01447446|474855500|FG003|Overall Study|Administrative/Other|2|||
131883754|NCT01447446|474855501|FG004|Overall Study|Administrative/Other|33|||
131883755|NCT01447446|474855502|FG005|Overall Study|Administrative/Other|4|||
131659889|NCT01803282|474039037|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131659890|NCT01803282|474039038|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131659891|NCT01803282|474039039|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131659892|NCT01803282|474039040|FG004|Overall Study|Non-Compliance with Study Drug|0|||
131659893|NCT01803282|474039041|FG005|Overall Study|Non-Compliance with Study Drug|0|||
131659894|NCT01803282|474039042|FG006|Overall Study|Non-Compliance with Study Drug|0|||
131659895|NCT01803282|474039043|FG007|Overall Study|Non-Compliance with Study Drug|0|||
131659896|NCT01803282|474039044|FG008|Overall Study|Non-Compliance with Study Drug|0|||
131659897|NCT01803282|474039045|FG009|Overall Study|Non-Compliance with Study Drug|0|||
131659898|NCT01803282|474039046|FG010|Overall Study|Non-Compliance with Study Drug|0|||
131659899|NCT01803282|474039047|FG011|Overall Study|Non-Compliance with Study Drug|0|||
131659900|NCT01803282|474039036|FG000|Overall Study|Unknown Reason|0|||
131659901|NCT01803282|474039037|FG001|Overall Study|Unknown Reason|0|||
131659902|NCT01803282|474039038|FG002|Overall Study|Unknown Reason|0|||
131659903|NCT01803282|474039039|FG003|Overall Study|Unknown Reason|0|||
131659904|NCT01803282|474039040|FG004|Overall Study|Unknown Reason|0|||
131659905|NCT01803282|474039041|FG005|Overall Study|Unknown Reason|0|||
131659906|NCT01803282|474039042|FG006|Overall Study|Unknown Reason|0|||
131659907|NCT01803282|474039043|FG007|Overall Study|Unknown Reason|1|||
131659908|NCT01803282|474039044|FG008|Overall Study|Unknown Reason|0|||
131659909|NCT01803282|474039045|FG009|Overall Study|Unknown Reason|0|||
131659910|NCT01803282|474039046|FG010|Overall Study|Unknown Reason|0|||
131659911|NCT01803282|474039047|FG011|Overall Study|Unknown Reason|0|||
131659912|NCT01803282|474039036|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
131659913|NCT01803282|474039037|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
131659914|NCT01803282|474039038|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
131659915|NCT01803282|474039039|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
131659916|NCT01803282|474039040|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
131659917|NCT01803282|474039041|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
131659918|NCT01803282|474039042|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
131659919|NCT01803282|474039043|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
131659920|NCT01803282|474039044|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
131659921|NCT01803282|474039045|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
131659922|NCT01803282|474039046|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
131659923|NCT01803282|474039047|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
131659924|NCT01803282|474039036|FG000|Overall Study|Enrolled but Never Treated|0|||
131659925|NCT01803282|474039037|FG001|Overall Study|Enrolled but Never Treated|0|||
131659926|NCT01803282|474039038|FG002|Overall Study|Enrolled but Never Treated|0|||
131659927|NCT01803282|474039039|FG003|Overall Study|Enrolled but Never Treated|0|||
131659928|NCT01803282|474039040|FG004|Overall Study|Enrolled but Never Treated|1|||
131659929|NCT01803282|474039041|FG005|Overall Study|Enrolled but Never Treated|0|||
131659930|NCT01803282|474039042|FG006|Overall Study|Enrolled but Never Treated|1|||
131659931|NCT01803282|474039043|FG007|Overall Study|Enrolled but Never Treated|1|||
131659932|NCT01803282|474039044|FG008|Overall Study|Enrolled but Never Treated|0|||
131659933|NCT01803282|474039045|FG009|Overall Study|Enrolled but Never Treated|1|||
131659934|NCT01803282|474039046|FG010|Overall Study|Enrolled but Never Treated|0|||
131659935|NCT01803282|474039047|FG011|Overall Study|Enrolled but Never Treated|0|||
131659936|NCT01743989|474039048|FG000|Treatment Phase|Unstable MR4.0|0|||
131659937|NCT01743989|474039049|FG001|Treatment Phase|Unstable MR4.0|6|||
131659938|NCT01743989|474039050|FG002|Treatment Phase|Unstable MR4.0|263|||
131659939|NCT01743989|474039048|FG000|Treatment Phase|Adverse Event|0|||
131659940|NCT01743989|474039049|FG001|Treatment Phase|Adverse Event|4|||
131659941|NCT01743989|474039050|FG002|Treatment Phase|Adverse Event|67|||
131659942|NCT01743989|474039048|FG000|Treatment Phase|Withdrawal by Subject|1|||
131659943|NCT01743989|474039049|FG001|Treatment Phase|Withdrawal by Subject|3|||
131659944|NCT01743989|474039050|FG002|Treatment Phase|Withdrawal by Subject|28|||
131659945|NCT01743989|474039048|FG000|Treatment Phase|Death|0|||
131659946|NCT01743989|474039049|FG001|Treatment Phase|Death|1|||
131770296|NCT01266967|474437886|FG000|Overall Study|Study Closed/Terminated|15|||
131770297|NCT01266967|474437887|FG001|Overall Study|Study Closed/Terminated|17|||
131770298|NCT01266967|474437886|FG000|Overall Study|Lost to Follow-up|2|||
131770299|NCT01266967|474437887|FG001|Overall Study|Lost to Follow-up|1|||
131770300|NCT01266967|474437886|FG000|Overall Study|Physician Decision|0|||
131770301|NCT01266967|474437887|FG001|Overall Study|Physician Decision|1|||
131770302|NCT01266967|474437886|FG000|Overall Study|Withdrawal by Subject|3|||
131770303|NCT01266967|474437887|FG001|Overall Study|Withdrawal by Subject|3|||
131770304|NCT00501969|474437890|FG000|Overall Study|Major Protocol Violation|4|||
131770305|NCT00501969|474437890|FG000|Overall Study|Lack of Efficacy|29|||
131770306|NCT00501969|474437890|FG000|Overall Study|Adverse Event|76|||
131770307|NCT00501969|474437890|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
131883756|NCT01447446|474855497|FG000|Overall Study|SVR12 Assessment|13|||
131770308|NCT00501969|474437890|FG000|Overall Study|Subject withdrew consent|51|||
131770309|NCT00501969|474437890|FG000|Overall Study|Lost to Follow-up|4|||
131770310|NCT00501969|474437890|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
131770311|NCT00501969|474437890|FG000|Overall Study|Other: Sponsors Request|10|||
131770312|NCT00501969|474437890|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
131770313|NCT00501969|474437890|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
131770314|NCT00501969|474437890|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
131659947|NCT01743989|474039050|FG002|Treatment Phase|Death|3|||
131659948|NCT01743989|474039048|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
131659949|NCT01743989|474039049|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
131659950|NCT01743989|474039050|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
131659951|NCT01743989|474039048|FG000|Treatment Phase|Protocol deviation|0|||
131659952|NCT01743989|474039049|FG001|Treatment Phase|Protocol deviation|0|||
131659953|NCT01743989|474039050|FG002|Treatment Phase|Protocol deviation|3|||
131659954|NCT01743989|474039048|FG000|Treatment Phase|Pregnancy|0|||
131659955|NCT01743989|474039049|FG001|Treatment Phase|Pregnancy|0|||
131659956|NCT01743989|474039050|FG002|Treatment Phase|Pregnancy|2|||
131659957|NCT01743989|474039048|FG000|Treatment Phase|Lost to Follow-up|0|||
131659958|NCT01743989|474039049|FG001|Treatment Phase|Lost to Follow-up|0|||
131659959|NCT01743989|474039050|FG002|Treatment Phase|Lost to Follow-up|2|||
131659960|NCT01743989|474039048|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
131659961|NCT01743989|474039049|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
131659962|NCT01743989|474039050|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
131659963|NCT01743989|474039048|FG000|Treatment Phase|Administrative problems|0|||
131659964|NCT01743989|474039049|FG001|Treatment Phase|Administrative problems|0|||
131659965|NCT01743989|474039050|FG002|Treatment Phase|Administrative problems|1|||
131659966|NCT01743989|474039048|FG000|Treatment Phase|New cancer (CML) therapy|0|||
131659967|NCT01743989|474039049|FG001|Treatment Phase|New cancer (CML) therapy|1|||
131659968|NCT01743989|474039050|FG002|Treatment Phase|New cancer (CML) therapy|0|||
131659969|NCT01743989|474039048|FG000|Treatment Phase|Physician Decision|0|||
131659970|NCT01743989|474039049|FG001|Treatment Phase|Physician Decision|0|||
131659971|NCT01743989|474039050|FG002|Treatment Phase|Physician Decision|3|||
131659972|NCT01743989|474039048|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
131659973|NCT01743989|474039049|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
131659974|NCT01743989|474039050|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
131659975|NCT01743989|474039048|FG000|Treatment Phase|Not randomized by mistake|0|||
131659976|NCT01743989|474039049|FG001|Treatment Phase|Not randomized by mistake|0|||
131659977|NCT01743989|474039050|FG002|Treatment Phase|Not randomized by mistake|1|||
131659978|NCT01743989|474039048|FG000|Treatment Phase|Included by mistake|0|||
131659979|NCT01743989|474039049|FG001|Treatment Phase|Included by mistake|0|||
131659980|NCT01743989|474039050|FG002|Treatment Phase|Included by mistake|1|||
131659981|NCT01743989|474039048|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
131659982|NCT01743989|474039049|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
131659983|NCT01743989|474039050|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
131659984|NCT01743989|474039048|FG000|TFR Phase|Adverse Event|0|||
131659985|NCT01743989|474039049|FG001|TFR Phase|Adverse Event|1|||
131659986|NCT01743989|474039050|FG002|TFR Phase|Adverse Event|0|||
131659987|NCT01743989|474039048|FG000|TFR Phase|Lost to Follow-up|0|||
131659988|NCT01743989|474039049|FG001|TFR Phase|Lost to Follow-up|2|||
131659989|NCT01743989|474039050|FG002|TFR Phase|Lost to Follow-up|0|||
131659990|NCT01743989|474039048|FG000|TFR Phase|Physician Decision|0|||
131659991|NCT01743989|474039049|FG001|TFR Phase|Physician Decision|1|||
131659992|NCT01743989|474039050|FG002|TFR Phase|Physician Decision|0|||
131659993|NCT01743989|474039048|FG000|TFR Phase|Logistical problems|0|||
131659994|NCT01743989|474039049|FG001|TFR Phase|Logistical problems|2|||
131659995|NCT01743989|474039050|FG002|TFR Phase|Logistical problems|0|||
131659996|NCT01743989|474039048|FG000|TFR Phase|Protocol deviation|0|||
131659997|NCT01743989|474039049|FG001|TFR Phase|Protocol deviation|1|||
131659998|NCT01743989|474039050|FG002|TFR Phase|Protocol deviation|0|||
131659999|NCT01743989|474039048|FG000|TFR Phase|Withdrawal by Subject|0|||
131660000|NCT01743989|474039049|FG001|TFR Phase|Withdrawal by Subject|2|||
131660001|NCT01743989|474039050|FG002|TFR Phase|Withdrawal by Subject|0|||
131660002|NCT01743989|474039048|FG000|Re-treatment Phase|Adverse Event|8|||
131660003|NCT01743989|474039049|FG001|Re-treatment Phase|Adverse Event|4|||
131660004|NCT01743989|474039050|FG002|Re-treatment Phase|Adverse Event|0|||
131660005|NCT01743989|474039048|FG000|Re-treatment Phase|Death|1|||
131660006|NCT01743989|474039049|FG001|Re-treatment Phase|Death|1|||
131660007|NCT01743989|474039050|FG002|Re-treatment Phase|Death|0|||
131660008|NCT01743989|474039048|FG000|Re-treatment Phase|Administrative problems|1|||
131660009|NCT01743989|474039049|FG001|Re-treatment Phase|Administrative problems|1|||
131660010|NCT01743989|474039050|FG002|Re-treatment Phase|Administrative problems|0|||
131660011|NCT01743989|474039048|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
131660012|NCT01743989|474039049|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
131660013|NCT01743989|474039050|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
131883757|NCT01447446|474855498|FG001|Overall Study|SVR12 Assessment|1|||
131660014|NCT01743989|474039048|FG000|Re-treatment Phase|Unstable MR|1|||
131660015|NCT01743989|474039049|FG001|Re-treatment Phase|Unstable MR|0|||
131660016|NCT01743989|474039050|FG002|Re-treatment Phase|Unstable MR|0|||
131660017|NCT01743989|474039048|FG000|Re-treatment Phase|Physician Decision|0|||
131660018|NCT01743989|474039049|FG001|Re-treatment Phase|Physician Decision|1|||
131660019|NCT01743989|474039050|FG002|Re-treatment Phase|Physician Decision|0|||
131660020|NCT01743989|474039048|FG000|Re-treatment Phase|Lost to Follow-up|0|||
131660021|NCT01743989|474039049|FG001|Re-treatment Phase|Lost to Follow-up|1|||
131660022|NCT01743989|474039050|FG002|Re-treatment Phase|Lost to Follow-up|0|||
131883758|NCT01447446|474855499|FG002|Overall Study|SVR12 Assessment|2|||
131883759|NCT01447446|474855500|FG003|Overall Study|SVR12 Assessment|1|||
131883760|NCT01447446|474855501|FG004|Overall Study|SVR12 Assessment|5|||
131883761|NCT01447446|474855502|FG005|Overall Study|SVR12 Assessment|5|||
131883762|NCT01447446|474855497|FG000|Overall Study|New Treatment Started|8|||
131883763|NCT01447446|474855498|FG001|Overall Study|New Treatment Started|2|||
131883764|NCT01447446|474855499|FG002|Overall Study|New Treatment Started|1|||
131883765|NCT01447446|474855500|FG003|Overall Study|New Treatment Started|0|||
131883766|NCT01447446|474855501|FG004|Overall Study|New Treatment Started|2|||
131883767|NCT01447446|474855502|FG005|Overall Study|New Treatment Started|0|||
131883768|NCT01447446|474855497|FG000|Overall Study|Reason not Specified|1|||
131883769|NCT01447446|474855498|FG001|Overall Study|Reason not Specified|1|||
131883770|NCT01447446|474855499|FG002|Overall Study|Reason not Specified|1|||
131883771|NCT01447446|474855500|FG003|Overall Study|Reason not Specified|1|||
131883772|NCT01447446|474855501|FG004|Overall Study|Reason not Specified|1|||
131883773|NCT01447446|474855502|FG005|Overall Study|Reason not Specified|0|||
131883774|NCT03536949|474855511|FG000|Overall Study|Adverse Event|4|||
131883775|NCT03536949|474855512|FG001|Overall Study|Adverse Event|0|||
131883776|NCT03536949|474855511|FG000|Overall Study|Lost to Follow-up|2|||
131883777|NCT03536949|474855512|FG001|Overall Study|Lost to Follow-up|1|||
131883778|NCT03536949|474855511|FG000|Overall Study|Withdrawal by Subject|6|||
131883779|NCT03536949|474855512|FG001|Overall Study|Withdrawal by Subject|0|||
131883780|NCT03536949|474855511|FG000|Overall Study|Non-compliance|2|||
131883781|NCT03536949|474855512|FG001|Overall Study|Non-compliance|1|||
131883782|NCT03077659|474855521|FG000|Overall Study|Withdrawal by Subject|0|||
131883783|NCT03077659|474855522|FG001|Overall Study|Withdrawal by Subject|0|||
131883784|NCT03077659|474855523|FG002|Overall Study|Withdrawal by Subject|1|||
131883785|NCT02844907|474855524|FG000|With Dexamethasone|No IV access|1|||
131883786|NCT00550862|474855525|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
131883787|NCT00550862|474855526|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
131883788|NCT00550862|474855527|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
131883789|NCT00550862|474855528|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
131883790|NCT00550862|474855529|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
131883791|NCT00550862|474855525|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
131883792|NCT00550862|474855526|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
131883793|NCT00550862|474855527|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
131883794|NCT00550862|474855528|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
131883795|NCT00550862|474855529|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
131883796|NCT00550862|474855525|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
131883797|NCT00550862|474855526|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
131883798|NCT00550862|474855527|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
131883799|NCT00550862|474855528|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
131883800|NCT00550862|474855529|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
131883801|NCT00550862|474855525|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
131883802|NCT00550862|474855526|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
131883803|NCT00550862|474855527|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
131883804|NCT00550862|474855528|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
131546998|NCT03266770|473625027|FG000|Overall Study|Insufficient study supplies|1|||
131546999|NCT03266770|473625027|FG000|Overall Study|Adverse Event|1|||
131547000|NCT02657031|473625028|FG000|Overall Study|Adverse Event|1|||
131547001|NCT02657031|473625029|FG001|Overall Study|Adverse Event|2|||
131547002|NCT05168579|473626245|FG000|Overall Study|Lack of Consent|1|||
131547003|NCT05168579|473626246|FG001|Overall Study|Lack of Consent|0|||
131547004|NCT05168579|473626245|FG000|Overall Study|Conflicts with time|2|||
131547005|NCT05168579|473626246|FG001|Overall Study|Conflicts with time|0|||
131547006|NCT05168579|473626245|FG000|Overall Study|Time slots were full|3|||
131547007|NCT05168579|473626246|FG001|Overall Study|Time slots were full|0|||
131547008|NCT05168579|473626245|FG000|Overall Study|Lost to Follow-up|0|||
131547009|NCT05168579|473626246|FG001|Overall Study|Lost to Follow-up|15|||
131547010|NCT01424930|473626247|FG000|Overall Study|Adverse Event|0|||
131547011|NCT01424930|473626248|FG001|Overall Study|Adverse Event|1|||
131547012|NCT01424930|473626247|FG000|Overall Study|Death|1|||
131547013|NCT01424930|473626248|FG001|Overall Study|Death|0|||
131547014|NCT01424930|473626247|FG000|Overall Study|Progressive Disease|3|||
131547015|NCT01424930|473626248|FG001|Overall Study|Progressive Disease|6|||
131547016|NCT01424930|473626247|FG000|Overall Study|Screen Failure|0|||
131547017|NCT01424930|473626248|FG001|Overall Study|Screen Failure|1|||
131547018|NCT01424930|473626247|FG000|Overall Study|Reason not specified|0|||
131547019|NCT01424930|473626248|FG001|Overall Study|Reason not specified|6|||
131547020|NCT01621880|473626249|FG000|Overall Study|Adverse Event|5|||
131883805|NCT00550862|474855529|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
131883806|NCT00550862|474855525|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
131883807|NCT00550862|474855526|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
131547021|NCT01621880|473626250|FG001|Overall Study|Adverse Event|1|||
131547022|NCT01621880|473626249|FG000|Overall Study|Withdrawal by Subject|5|||
131547023|NCT01621880|473626250|FG001|Overall Study|Withdrawal by Subject|4|||
131547024|NCT00948974|473626251|FG000|Overall Study|Lost to Follow-up|23|||
131547025|NCT00948974|473626252|FG001|Overall Study|Lost to Follow-up|20|||
131547026|NCT00118716|473626256|FG000|Overall Study|Adverse Event|2|||
131547027|NCT00118716|473626257|FG001|Overall Study|Adverse Event|7|||
131547028|NCT00118716|473626256|FG000|Overall Study|Protocol Violation|5|||
131547029|NCT00118716|473626257|FG001|Overall Study|Protocol Violation|4|||
131547030|NCT00118716|473626256|FG000|Overall Study|Withdrawal by Subject|0|||
131547031|NCT00118716|473626257|FG001|Overall Study|Withdrawal by Subject|1|||
131547032|NCT00118716|473626256|FG000|Overall Study|Exacerbation|2|||
131547033|NCT00118716|473626257|FG001|Overall Study|Exacerbation|2|||
131547034|NCT00118716|473626256|FG000|Overall Study|Discontinued by sponsor|1|||
131547035|NCT00118716|473626257|FG001|Overall Study|Discontinued by sponsor|1|||
131547036|NCT00118716|473626256|FG000|Overall Study|Non-compliance|1|||
131547037|NCT00118716|473626257|FG001|Overall Study|Non-compliance|3|||
131547038|NCT00118716|473626256|FG000|Overall Study|misrandomized|1|||
131547039|NCT00118716|473626257|FG001|Overall Study|misrandomized|1|||
131547040|NCT00118716|473626256|FG000|Overall Study|Expired drug use|1|||
131547041|NCT00118716|473626257|FG001|Overall Study|Expired drug use|2|||
131547042|NCT00118716|473626256|FG000|Overall Study|Investigator discretion|0|||
131547043|NCT00118716|473626257|FG001|Overall Study|Investigator discretion|1|||
131547044|NCT00454571|473626258|FG000|Overall Study|Adverse Event|2|||
131547045|NCT00454571|473626259|FG001|Overall Study|Adverse Event|0|||
131547046|NCT00454571|473626258|FG000|Overall Study|Physician Decision|0|||
131547047|NCT00454571|473626259|FG001|Overall Study|Physician Decision|1|||
131547048|NCT00454571|473626258|FG000|Overall Study|Protocol Violation|1|||
131547049|NCT00454571|473626259|FG001|Overall Study|Protocol Violation|0|||
131547050|NCT00454571|473626258|FG000|Overall Study|Withdrawal by Subject|10|||
131547051|NCT00454571|473626259|FG001|Overall Study|Withdrawal by Subject|5|||
131547052|NCT02436811|473626260|FG000|Overall Study|Lost to Follow-up|2|||
131547053|NCT02436811|473626261|FG001|Overall Study|Lost to Follow-up|9|||
131547054|NCT02436811|473626262|FG002|Overall Study|Lost to Follow-up|7|||
131547055|NCT02227875|473626263|FG000|Overall Study|Protocol Violation|10|||
131547056|NCT02227875|473626264|FG001|Overall Study|Protocol Violation|7|||
131547057|NCT02227875|473626263|FG000|Overall Study|Other|1|||
131547058|NCT02227875|473626264|FG001|Overall Study|Other|3|||
131547059|NCT02227875|473626263|FG000|Overall Study|Physician Decision|1|||
131547060|NCT02227875|473626264|FG001|Overall Study|Physician Decision|0|||
131547061|NCT02227875|473626263|FG000|Overall Study|Adverse Event|3|||
131547062|NCT02227875|473626264|FG001|Overall Study|Adverse Event|0|||
131547063|NCT02227875|473626263|FG000|Overall Study|Withdrawal by Subject|12|||
131547064|NCT02227875|473626264|FG001|Overall Study|Withdrawal by Subject|13|||
131547065|NCT02227875|473626263|FG000|Overall Study|Lost to Follow-up|10|||
131883808|NCT00550862|474855527|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
131883809|NCT00550862|474855528|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
131883810|NCT00550862|474855529|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
131883811|NCT00550862|474855525|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
131883812|NCT00550862|474855526|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
131883813|NCT00550862|474855527|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
131883814|NCT00550862|474855528|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
131883815|NCT00550862|474855529|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
131883816|NCT00550862|474855525|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
131883817|NCT00550862|474855526|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
131883818|NCT00550862|474855527|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
131547066|NCT02227875|473626264|FG001|Overall Study|Lost to Follow-up|10|||
131547067|NCT04209725|473626267|FG000|Overall Study|Adverse Event|1|||
131547068|NCT01089374|473626268|FG000|Overall Study|Lost to Follow-up|3|||
131547069|NCT01089374|473626269|FG001|Overall Study|Lost to Follow-up|0|||
131547070|NCT01089374|473626268|FG000|Overall Study|Withdrawal by Subject|1|||
131547071|NCT01089374|473626269|FG001|Overall Study|Withdrawal by Subject|0|||
131547072|NCT01089374|473626268|FG000|Overall Study|Study closed early - low accrual|6|||
131547073|NCT01089374|473626269|FG001|Overall Study|Study closed early - low accrual|0|||
131883819|NCT00550862|474855528|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
131883820|NCT00550862|474855529|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
131883821|NCT00550862|474855525|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
131883822|NCT00550862|474855526|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
131883823|NCT00550862|474855527|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
131883824|NCT00550862|474855528|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
131883825|NCT00550862|474855529|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
131547074|NCT01201811|473626270|FG000|Overall Study|Adverse Event|6|||
131547075|NCT01201811|473626270|FG000|Overall Study|Disease progression|3|||
131883826|NCT00550862|474855525|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
131547076|NCT01201811|473626270|FG000|Overall Study|Withdrawal by Subject|3|||
131547077|NCT01201811|473626270|FG000|Overall Study|Death|4|||
131547078|NCT01201811|473626270|FG000|Overall Study|Treatment Failure|2|||
131547079|NCT01201811|473626270|FG000|Overall Study|Physician Decision|1|||
131547080|NCT02657317|473626271|FG000|Overall Study|Withdrawal by Subject|2|||
131547081|NCT02657317|473626272|FG001|Overall Study|Withdrawal by Subject|0|||
131547082|NCT02657317|473626271|FG000|Overall Study|Lost to Follow-up|3|||
131547083|NCT02657317|473626272|FG001|Overall Study|Lost to Follow-up|3|||
131547084|NCT02856113|473626273|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131547085|NCT02856113|473626274|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131547086|NCT02856113|473626273|FG000|Overall Study|Significant Protocol Deviation|1|||
131547087|NCT02856113|473626274|FG001|Overall Study|Significant Protocol Deviation|0|||
131547088|NCT02856113|473626273|FG000|Overall Study|Lost to Follow-up|3|||
131547089|NCT02856113|473626274|FG001|Overall Study|Lost to Follow-up|5|||
131547090|NCT02856113|473626273|FG000|Overall Study|Voluntary Withdrawal|3|||
131547091|NCT02856113|473626274|FG001|Overall Study|Voluntary Withdrawal|5|||
131547092|NCT02856113|473626273|FG000|Overall Study|Pregnancy|0|||
131547093|NCT02856113|473626274|FG001|Overall Study|Pregnancy|1|||
131547094|NCT02856113|473626273|FG000|Overall Study|Principal Investigator Discretion|2|||
131883827|NCT00550862|474855526|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
131883828|NCT00550862|474855527|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
131883829|NCT00550862|474855528|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
131883830|NCT00550862|474855529|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
131883831|NCT00550862|474855525|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
131883832|NCT00550862|474855526|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
131883833|NCT00550862|474855527|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
131883834|NCT00550862|474855528|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
131883835|NCT00550862|474855529|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
131883836|NCT03488225|474855532|FG000|Overall Study|Off Protocol Therapy|2|||
131883837|NCT03488225|474855532|FG000|Overall Study|Stem Cell Transplant|2|||
131883838|NCT00435487|474855549|FG000|Overall Study|Death|3|||
131883839|NCT00435487|474855550|FG001|Overall Study|Death|4|||
131883840|NCT00435487|474855549|FG000|Overall Study|Adverse Event|0|||
131883841|NCT00435487|474855550|FG001|Overall Study|Adverse Event|3|||
131883842|NCT00435487|474855549|FG000|Overall Study|Lost to Follow-up|2|||
131883843|NCT00435487|474855550|FG001|Overall Study|Lost to Follow-up|2|||
131883844|NCT00435487|474855549|FG000|Overall Study|Other|5|||
131883845|NCT00435487|474855550|FG001|Overall Study|Other|2|||
131883846|NCT00435487|474855549|FG000|Overall Study|Withdrawal by Subject|2|||
131883847|NCT00435487|474855550|FG001|Overall Study|Withdrawal by Subject|1|||
131883848|NCT00435487|474855549|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
131883849|NCT00435487|474855550|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
131883850|NCT00435487|474855549|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
131883851|NCT00435487|474855550|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
131547095|NCT02856113|473626274|FG001|Overall Study|Principal Investigator Discretion|1|||
131547096|NCT02856113|473626273|FG000|Overall Study|Randomized but not Treated|1|||
131547097|NCT02856113|473626274|FG001|Overall Study|Randomized but not Treated|0|||
131547098|NCT02856113|473626273|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
131547099|NCT02856113|473626274|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
131547100|NCT02857426|473626275|FG000|Overall Study|Disease progression|34|||
131547101|NCT02857426|473626276|FG001|Overall Study|Disease progression|13|||
131547102|NCT02857426|473626275|FG000|Overall Study|Study drug toxicity|4|||
131547103|NCT02857426|473626276|FG001|Overall Study|Study drug toxicity|1|||
131547104|NCT02857426|473626275|FG000|Overall Study|Death|1|||
131547105|NCT02857426|473626276|FG001|Overall Study|Death|0|||
131547106|NCT02857426|473626275|FG000|Overall Study|Adverse event unrelated to study drug|6|||
131547107|NCT02857426|473626276|FG001|Overall Study|Adverse event unrelated to study drug|2|||
131547108|NCT02857426|473626275|FG000|Overall Study|Participant withdrew consent|1|||
131547109|NCT02857426|473626276|FG001|Overall Study|Participant withdrew consent|1|||
131547110|NCT02857426|473626275|FG000|Overall Study|Maximum clinical benefit|1|||
131547111|NCT02857426|473626276|FG001|Overall Study|Maximum clinical benefit|0|||
131547112|NCT02857426|473626275|FG000|Overall Study|Completed treatment|0|||
131547113|NCT02857426|473626276|FG001|Overall Study|Completed treatment|2|||
131547114|NCT02831257|473626280|FG000|Overall Study|Lack of Efficacy|3|||
131547115|NCT02831257|473626280|FG000|Overall Study|Adverse Event|2|||
131547116|NCT02831257|473626280|FG000|Overall Study|Physician Decision|1|||
131547117|NCT02831257|473626280|FG000|Overall Study|Withdrawal by Subject|6|||
131547118|NCT01780935|473626281|FG000|Overall Study|Admin problems due to early termination|321|||
131547119|NCT01780935|473626282|FG001|Overall Study|Admin problems due to early termination|309|||
131547120|NCT01780935|473626281|FG000|Overall Study|Adverse Event|2|||
131883852|NCT03301844|474855551|FG000|Overall Study|suspected colon cancer|1|||
131883853|NCT03301844|474855552|FG001|Overall Study|suspected colon cancer|1|||
131547121|NCT01780935|473626282|FG001|Overall Study|Adverse Event|4|||
131547122|NCT01780935|473626281|FG000|Overall Study|Death|1|||
131547123|NCT01780935|473626282|FG001|Overall Study|Death|6|||
131547124|NCT01780935|473626281|FG000|Overall Study|Lost to Follow-up|2|||
131547125|NCT01780935|473626282|FG001|Overall Study|Lost to Follow-up|6|||
131547126|NCT01780935|473626281|FG000|Overall Study|Physician Decision|1|||
131547127|NCT01780935|473626282|FG001|Overall Study|Physician Decision|1|||
131547128|NCT01780935|473626281|FG000|Overall Study|Protocol deviation|0|||
131547129|NCT01780935|473626282|FG001|Overall Study|Protocol deviation|1|||
131547130|NCT01780935|473626281|FG000|Overall Study|Patient withdrew consent|8|||
131547131|NCT01780935|473626282|FG001|Overall Study|Patient withdrew consent|9|||
131547132|NCT00855595|473626283|FG000|Overall Study|Withdrawal by Subject|1|||
131547133|NCT00855595|473626284|FG001|Overall Study|Withdrawal by Subject|2|||
131547134|NCT00855595|473626283|FG000|Overall Study|Lost to Follow-up|3|||
131547135|NCT00855595|473626284|FG001|Overall Study|Lost to Follow-up|3|||
131547136|NCT00855595|473626283|FG000|Overall Study|Adverse Event|1|||
131547137|NCT00855595|473626284|FG001|Overall Study|Adverse Event|1|||
131547138|NCT00855595|473626283|FG000|Overall Study|patient moved out of state|1|||
131547139|NCT00855595|473626284|FG001|Overall Study|patient moved out of state|0|||
131547140|NCT00855595|473626283|FG000|Overall Study|patient left country|0|||
131547141|NCT00855595|473626284|FG001|Overall Study|patient left country|1|||
131547142|NCT00166296|473626285|FG000|Overall Study|Withdrawal by Subject|1|||
131547143|NCT00166296|473626286|FG001|Overall Study|Withdrawal by Subject|3|||
131547144|NCT00166296|473626285|FG000|Overall Study|Adverse Event|2|||
131547145|NCT00166296|473626286|FG001|Overall Study|Adverse Event|4|||
131547146|NCT00166296|473626285|FG000|Overall Study|Lost to Follow-up|4|||
131547147|NCT00166296|473626286|FG001|Overall Study|Lost to Follow-up|2|||
131547148|NCT04035200|473626292|FG000|Overall Study|Lost to Follow-up|0|||
131547149|NCT04035200|473626293|FG001|Overall Study|Lost to Follow-up|1|||
131547150|NCT04035200|473626294|FG002|Overall Study|Lost to Follow-up|0|||
131547151|NCT04035200|473626292|FG000|Overall Study|Withdrawal by Subject|1|||
131547152|NCT04035200|473626293|FG001|Overall Study|Withdrawal by Subject|4|||
131547153|NCT04035200|473626294|FG002|Overall Study|Withdrawal by Subject|4|||
131547154|NCT04035200|473626292|FG000|Overall Study|COVID-19|1|||
131547155|NCT04035200|473626293|FG001|Overall Study|COVID-19|0|||
131547156|NCT04035200|473626294|FG002|Overall Study|COVID-19|0|||
131883854|NCT05087966|474855553|FG000|Overall Study|Lost to Follow-up|1|||
131883855|NCT05087966|474855553|FG000|Overall Study|Withdrawal by Subject|5|||
131883856|NCT01267201|474855554|FG000|First Intervention Period|Withdrawal by Subject|1|||
131883857|NCT01267201|474855555|FG001|First Intervention Period|Withdrawal by Subject|0|||
131883858|NCT01267201|474855556|FG002|First Intervention Period|Withdrawal by Subject|0|||
131883859|NCT01267201|474855557|FG003|First Intervention Period|Withdrawal by Subject|0|||
131883860|NCT01267201|474855558|FG004|First Intervention Period|Withdrawal by Subject|0|||
131883861|NCT01267201|474855559|FG005|First Intervention Period|Withdrawal by Subject|0|||
131883862|NCT01267201|474855554|FG000|Second Intervention Period|Withdrawal by Subject|0|||
131883863|NCT01267201|474855555|FG001|Second Intervention Period|Withdrawal by Subject|1|||
131883864|NCT01267201|474855556|FG002|Second Intervention Period|Withdrawal by Subject|0|||
131883865|NCT01267201|474855557|FG003|Second Intervention Period|Withdrawal by Subject|0|||
131883866|NCT01267201|474855558|FG004|Second Intervention Period|Withdrawal by Subject|0|||
131883867|NCT01267201|474855559|FG005|Second Intervention Period|Withdrawal by Subject|0|||
131883868|NCT00501059|474855560|FG000|Overall Study|Protocol Violation|80|||
131883869|NCT00501059|474855561|FG001|Overall Study|Protocol Violation|69|||
131883870|NCT00501059|474855560|FG000|Overall Study|Death|140|||
131883871|NCT00501059|474855561|FG001|Overall Study|Death|137|||
131883872|NCT00501059|474855560|FG000|Overall Study|Other|236|||
131883873|NCT00501059|474855561|FG001|Overall Study|Other|239|||
131883874|NCT00501059|474855560|FG000|Overall Study|Missing end-of-study page|91|||
131883875|NCT00501059|474855561|FG001|Overall Study|Missing end-of-study page|92|||
131883876|NCT00501059|474855560|FG000|Overall Study|Clinical endpoint reached|110|||
131883877|NCT00501059|474855561|FG001|Overall Study|Clinical endpoint reached|123|||
131883878|NCT00501059|474855560|FG000|Overall Study|Insufficient therapeutic effect|4|||
131883879|NCT00501059|474855561|FG001|Overall Study|Insufficient therapeutic effect|5|||
131883880|NCT00501059|474855560|FG000|Overall Study|Consent withdrawn by subject|817|||
131883881|NCT00501059|474855561|FG001|Overall Study|Consent withdrawn by subject|873|||
131547157|NCT04035200|473626292|FG000|Overall Study|Early Termination|0|||
131547158|NCT04035200|473626293|FG001|Overall Study|Early Termination|1|||
131547159|NCT04035200|473626294|FG002|Overall Study|Early Termination|0|||
131547160|NCT04035200|473626292|FG000|Overall Study|Non-compliance|0|||
131547161|NCT04035200|473626293|FG001|Overall Study|Non-compliance|1|||
131547162|NCT04035200|473626294|FG002|Overall Study|Non-compliance|0|||
131547163|NCT03033225|473626295|FG000|Overall Study|Withdrawal by Subject|5|||
131547164|NCT03412396|473626299|FG000|Overall Study|Withdrawal by Subject|2|||
131547165|NCT03412396|473626299|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
131547166|NCT03412396|473626299|FG000|Overall Study|Did not undergo RP|2|||
131547167|NCT04899245|473626308|FG000|Overall Study|Withdrawal by Subject|3|||
131883882|NCT00501059|474855560|FG000|Overall Study|Non-compliant with study treatment|23|||
131883883|NCT00501059|474855561|FG001|Overall Study|Non-compliant with study treatment|16|||
131547168|NCT04899245|473626309|FG001|Overall Study|Withdrawal by Subject|5|||
131547169|NCT04899245|473626310|FG002|Overall Study|Withdrawal by Subject|2|||
131547170|NCT04899245|473626308|FG000|Overall Study|No longer eligible - Left staff position|0|||
131883884|NCT00501059|474855560|FG000|Overall Study|Reason not given|3|||
131883885|NCT00501059|474855561|FG001|Overall Study|Reason not given|1|||
131883886|NCT00501059|474855560|FG000|Overall Study|Adverse Event|129|||
131883887|NCT00501059|474855561|FG001|Overall Study|Adverse Event|122|||
131883888|NCT00501059|474855560|FG000|Overall Study|Lost to Follow-up|210|||
131883889|NCT00501059|474855561|FG001|Overall Study|Lost to Follow-up|198|||
131883890|NCT00501059|474855560|FG000|Overall Study|Not treated|25|||
131883891|NCT00501059|474855561|FG001|Overall Study|Not treated|17|||
131883892|NCT05128773|474857856|FG000|Overall Study|Sponsor decision to terminate study|3|||
131883893|NCT04676412|474857857|FG000|Overall Study|Death|28|||
131883894|NCT04676412|474857858|FG001|Overall Study|Death|31|||
131883895|NCT04676412|474857857|FG000|Overall Study|Lost to Follow-up|1|||
131883896|NCT04676412|474857858|FG001|Overall Study|Lost to Follow-up|2|||
131883897|NCT04676412|474857857|FG000|Overall Study|Sponsor Decision|20|||
131883898|NCT04676412|474857858|FG001|Overall Study|Sponsor Decision|23|||
131883899|NCT04676412|474857857|FG000|Overall Study|Withdrawal by Subject|0|||
131883900|NCT04676412|474857858|FG001|Overall Study|Withdrawal by Subject|2|||
131883901|NCT04697056|474857859|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
131883902|NCT04697056|474857860|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
131883903|NCT04550832|474857861|FG000|Overall Study|Adverse Event|0|||
131883904|NCT04550832|474857862|FG001|Overall Study|Adverse Event|0|||
131883905|NCT04550832|474857863|FG002|Overall Study|Adverse Event|2|||
131883906|NCT04550832|474857864|FG003|Overall Study|Adverse Event|0|||
131883907|NCT04550832|474857865|FG004|Overall Study|Adverse Event|1|||
131883908|NCT04823130|474857866|FG000|Overall Study|Withdrawal by Subject|2|||
131883909|NCT04823130|474857867|FG001|Overall Study|Withdrawal by Subject|3|||
131883910|NCT04823130|474857866|FG000|Overall Study|Failure to meet inclusion criteria|6|||
131883911|NCT04823130|474857867|FG001|Overall Study|Failure to meet inclusion criteria|4|||
131883912|NCT04823130|474857866|FG000|Overall Study|Other-unspecified|1|||
131883913|NCT04823130|474857867|FG001|Overall Study|Other-unspecified|0|||
131883914|NCT03315455|474857869|FG000|Overall Study|Ongoing in the Study|13|||
131883915|NCT03315455|474857870|FG001|Overall Study|Ongoing in the Study|24|||
131883916|NCT03315455|474857871|FG002|Overall Study|Ongoing in the Study|17|||
131883917|NCT03315455|474857872|FG003|Overall Study|Ongoing in the Study|15|||
131883918|NCT03315455|474857869|FG000|Overall Study|Withdrawal by Subject|0|||
131883919|NCT03315455|474857870|FG001|Overall Study|Withdrawal by Subject|1|||
131883920|NCT03315455|474857871|FG002|Overall Study|Withdrawal by Subject|0|||
131883921|NCT03315455|474857872|FG003|Overall Study|Withdrawal by Subject|0|||
131883922|NCT04439357|474857876|FG000|Overall Study|Disease Progression|4|||
131883923|NCT05906836|474857879|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
131883924|NCT05906836|474857879|FG000|Overall Study|Lost to Follow-up|1|||
131883925|NCT03030118|474857880|FG000|Overall Study|Achieved SLE Diagnosis|11|||
131883926|NCT03030118|474857881|FG001|Overall Study|Achieved SLE Diagnosis|10|||
131547171|NCT04899245|473626309|FG001|Overall Study|No longer eligible - Left staff position|0|||
131547172|NCT04899245|473626310|FG002|Overall Study|No longer eligible - Left staff position|1|||
131547173|NCT04899245|473626308|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
131547174|NCT04899245|473626309|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
131547175|NCT04899245|473626310|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
131547176|NCT04899245|473626308|FG000|Overall Study|No longer eligible - Moved away from area|2|||
131547177|NCT04899245|473626309|FG001|Overall Study|No longer eligible - Moved away from area|2|||
131547178|NCT04899245|473626310|FG002|Overall Study|No longer eligible - Moved away from area|0|||
131547179|NCT03371940|473626320|FG000|Overall Study|Withdrawal by Subject|8|||
131547180|NCT03371940|473626321|FG001|Overall Study|Withdrawal by Subject|1|||
131547181|NCT03371940|473626322|FG002|Overall Study|Withdrawal by Subject|3|||
131547182|NCT03371940|473626323|FG003|Overall Study|Withdrawal by Subject|4|||
131547183|NCT05099926|473626329|FG000|Overall Study|Lost to Follow-up|1|||
131547184|NCT00724152|473626333|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
131883927|NCT03030118|474857880|FG000|Overall Study|Adverse Event|1|||
131883928|NCT03030118|474857881|FG001|Overall Study|Adverse Event|1|||
131883929|NCT03030118|474857880|FG000|Overall Study|Pregnancy|2|||
131883930|NCT03030118|474857881|FG001|Overall Study|Pregnancy|2|||
131883931|NCT03030118|474857880|FG000|Overall Study|Lost to Follow-up|5|||
131883932|NCT03030118|474857881|FG001|Overall Study|Lost to Follow-up|6|||
131883933|NCT03030118|474857880|FG000|Overall Study|Concomitant Medications|1|||
131883934|NCT03030118|474857881|FG001|Overall Study|Concomitant Medications|1|||
131883935|NCT03030118|474857880|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
131883936|NCT03030118|474857881|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
131883937|NCT03030118|474857880|FG000|Overall Study|Other|2|||
131883938|NCT03030118|474857881|FG001|Overall Study|Other|0|||
131883939|NCT03030118|474857880|FG000|Overall Study|Withdrawal by Subject|26|||
131883940|NCT03030118|474857881|FG001|Overall Study|Withdrawal by Subject|21|||
131883941|NCT03030118|474857880|FG000|Overall Study|Protocol Violation|1|||
131883942|NCT03030118|474857881|FG001|Overall Study|Protocol Violation|6|||
131883943|NCT04529850|474857882|FG000|Overall Study|Death|2|||
131883944|NCT04529850|474857882|FG000|Overall Study|Physician Decision|1|||
131883945|NCT04529850|474857882|FG000|Overall Study|Withdrawal by Subject|2|||
131883946|NCT01911780|474857883|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
131883947|NCT01911780|474857884|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
131883948|NCT01911780|474857883|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
131883949|NCT01911780|474857884|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
131883950|NCT01911780|474857883|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
131883951|NCT01911780|474857884|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
131883952|NCT01911780|474857883|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
131883953|NCT01911780|474857884|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
131883954|NCT01911780|474857883|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
131883955|NCT01911780|474857884|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
131883956|NCT01911780|474857883|FG000|Extension Period (52 Weeks)|Personal reason|1|||
131883957|NCT01911780|474857884|FG001|Extension Period (52 Weeks)|Personal reason|1|||
131883958|NCT02720744|474857888|FG000|Overall Study|Protocol Violation|0|||
131883959|NCT02720744|474857889|FG001|Overall Study|Protocol Violation|2|||
131883960|NCT02720744|474857888|FG000|Overall Study|Pregnancy|2|||
131883961|NCT02720744|474857889|FG001|Overall Study|Pregnancy|0|||
131883962|NCT02720744|474857888|FG000|Overall Study|Lack of Efficacy|2|||
131883963|NCT02720744|474857889|FG001|Overall Study|Lack of Efficacy|8|||
131883964|NCT02720744|474857888|FG000|Overall Study|Adverse Event|21|||
131883965|NCT02720744|474857889|FG001|Overall Study|Adverse Event|3|||
131883966|NCT02720744|474857888|FG000|Overall Study|Withdrawal by Subject|11|||
131883967|NCT02720744|474857889|FG001|Overall Study|Withdrawal by Subject|11|||
131883968|NCT02720744|474857888|FG000|Overall Study|Lost to follow up|2|||
131883969|NCT02720744|474857889|FG001|Overall Study|Lost to follow up|0|||
131883970|NCT02720744|474857888|FG000|Overall Study|Non Compliance with Investigational Product|0|||
131883971|NCT02720744|474857889|FG001|Overall Study|Non Compliance with Investigational Product|1|||
131883972|NCT02720744|474857888|FG000|Overall Study|Excluded Concomitant Medication|0|||
131883973|NCT02720744|474857889|FG001|Overall Study|Excluded Concomitant Medication|1|||
131883974|NCT01199822|474857891|FG000|Overall Study|Investigator discontinued therapy|0|||
131883975|NCT01199822|474857892|FG001|Overall Study|Investigator discontinued therapy|1|||
131883976|NCT01199822|474857893|FG002|Overall Study|Investigator discontinued therapy|0|||
131883977|NCT00480493|474857894|FG000|Overall Study|moved|2|||
131883978|NCT00480493|474857895|FG001|Overall Study|moved|7|||
131883979|NCT03769675|474857896|FG000|Overall Study|Lost to Follow-up|1|||
131883980|NCT04027075|474857897|FG000|Overall Study|Lost to Follow-up|41|||
131883981|NCT04027075|474857898|FG001|Overall Study|Lost to Follow-up|22|||
131883982|NCT01032070|474857899|FG000|Overall Study|Disease progression|13|||
131883983|NCT01032070|474857900|FG001|Overall Study|Disease progression|8|||
131883984|NCT01032070|474857899|FG000|Overall Study|Medical or ethical reasons|0|||
131883985|NCT01032070|474857900|FG001|Overall Study|Medical or ethical reasons|2|||
131883986|NCT01032070|474857899|FG000|Overall Study|Withdrawal by Subject|0|||
131883987|NCT01032070|474857900|FG001|Overall Study|Withdrawal by Subject|2|||
131883988|NCT00426660|474857901|FG000|Overall Study|Death|14|||
131883989|NCT00426660|474857901|FG000|Overall Study|Adverse Event|23|||
131883990|NCT00426660|474857901|FG000|Overall Study|Insufficient Clinical Response|22|||
131883991|NCT00426660|474857901|FG000|Overall Study|Lost to Follow-up|15|||
131883992|NCT00426660|474857901|FG000|Overall Study|Other|23|||
131883993|NCT00426660|474857901|FG000|Overall Study|Withdrawal by Subject|18|||
131883994|NCT00426660|474857901|FG000|Overall Study|Protocol Violation|1|||
131883995|NCT00426660|474857901|FG000|Overall Study|Enrolled Not Treated|15|||
131883996|NCT02772276|474857902|FG000|Overall Study|Lost to Follow-up|0|||
131883997|NCT02772276|474857903|FG001|Overall Study|Lost to Follow-up|0|||
131883998|NCT02772276|474857904|FG002|Overall Study|Lost to Follow-up|0|||
131883999|NCT02772276|474857905|FG003|Overall Study|Lost to Follow-up|0|||
131884000|NCT02772276|474857906|FG004|Overall Study|Lost to Follow-up|0|||
131884001|NCT02772276|474857907|FG005|Overall Study|Lost to Follow-up|0|||
131884002|NCT02772276|474857908|FG006|Overall Study|Lost to Follow-up|1|||
131884003|NCT02772276|474857909|FG007|Overall Study|Lost to Follow-up|0|||
131884004|NCT02772276|474857910|FG008|Overall Study|Lost to Follow-up|0|||
131884005|NCT02772276|474857911|FG009|Overall Study|Lost to Follow-up|0|||
131884006|NCT02772276|474857912|FG010|Overall Study|Lost to Follow-up|0|||
131884007|NCT02772276|474857913|FG011|Overall Study|Lost to Follow-up|0|||
131884008|NCT02772276|474857914|FG012|Overall Study|Lost to Follow-up|0|||
131884009|NCT02772276|474857902|FG000|Overall Study|Withdrew consent|0|||
131884010|NCT02772276|474857903|FG001|Overall Study|Withdrew consent|0|||
131884011|NCT02772276|474857904|FG002|Overall Study|Withdrew consent|0|||
131884012|NCT02772276|474857905|FG003|Overall Study|Withdrew consent|0|||
131884013|NCT02772276|474857906|FG004|Overall Study|Withdrew consent|0|||
131884014|NCT02772276|474857907|FG005|Overall Study|Withdrew consent|0|||
131884015|NCT02772276|474857908|FG006|Overall Study|Withdrew consent|0|||
131884016|NCT02772276|474857909|FG007|Overall Study|Withdrew consent|1|||
131884017|NCT02772276|474857910|FG008|Overall Study|Withdrew consent|0|||
131884018|NCT02772276|474857911|FG009|Overall Study|Withdrew consent|0|||
131884019|NCT02772276|474857912|FG010|Overall Study|Withdrew consent|0|||
131884020|NCT02772276|474857913|FG011|Overall Study|Withdrew consent|0|||
131884021|NCT02772276|474857914|FG012|Overall Study|Withdrew consent|0|||
131884022|NCT00738062|474857915|FG000|Open Label Treatment|Lack of Efficacy|5|||
131884023|NCT00738062|474857916|FG001|Open Label Treatment|Lack of Efficacy|0|||
131884024|NCT00738062|474857917|FG002|Open Label Treatment|Lack of Efficacy|0|||
131884025|NCT00738062|474857915|FG000|Open Label Treatment|Adverse Event|11|||
131884026|NCT00738062|474857916|FG001|Open Label Treatment|Adverse Event|0|||
131884027|NCT00738062|474857917|FG002|Open Label Treatment|Adverse Event|0|||
131884028|NCT00738062|474857915|FG000|Open Label Treatment|Protocol Violation|2|||
131884029|NCT00738062|474857916|FG001|Open Label Treatment|Protocol Violation|0|||
131884030|NCT00738062|474857917|FG002|Open Label Treatment|Protocol Violation|0|||
131884031|NCT00738062|474857915|FG000|Open Label Treatment|Withdrawal by Subject|9|||
131884032|NCT00738062|474857916|FG001|Open Label Treatment|Withdrawal by Subject|0|||
131884033|NCT00738062|474857917|FG002|Open Label Treatment|Withdrawal by Subject|0|||
131884034|NCT00738062|474857915|FG000|Open Label Treatment|Investigator Decision|1|||
131884035|NCT00738062|474857916|FG001|Open Label Treatment|Investigator Decision|0|||
131884036|NCT00738062|474857917|FG002|Open Label Treatment|Investigator Decision|0|||
131884037|NCT00738062|474857915|FG000|Open-Label Extension|Adverse Event|5|||
131884038|NCT00738062|474857916|FG001|Open-Label Extension|Adverse Event|0|||
131884039|NCT00738062|474857917|FG002|Open-Label Extension|Adverse Event|0|||
131884040|NCT00738062|474857915|FG000|Open-Label Extension|Physician Decision|1|||
131884041|NCT00738062|474857916|FG001|Open-Label Extension|Physician Decision|0|||
131884042|NCT00738062|474857917|FG002|Open-Label Extension|Physician Decision|0|||
131884043|NCT00738062|474857915|FG000|Open-Label Extension|Lack of Efficacy|2|||
131884044|NCT00738062|474857916|FG001|Open-Label Extension|Lack of Efficacy|0|||
131884045|NCT00738062|474857917|FG002|Open-Label Extension|Lack of Efficacy|0|||
131884046|NCT00738062|474857915|FG000|Open-Label Extension|Withdrawal by Subject|6|||
131884047|NCT00738062|474857916|FG001|Open-Label Extension|Withdrawal by Subject|0|||
131884048|NCT00738062|474857917|FG002|Open-Label Extension|Withdrawal by Subject|0|||
131884049|NCT00738062|474857915|FG000|Open-Label Extension|Protocol Violation|1|||
131884050|NCT00738062|474857916|FG001|Open-Label Extension|Protocol Violation|0|||
131884051|NCT00738062|474857917|FG002|Open-Label Extension|Protocol Violation|0|||
131884052|NCT00738062|474857915|FG000|Open-Label Extension|Study Terminated|2|||
131884053|NCT00738062|474857916|FG001|Open-Label Extension|Study Terminated|0|||
131884054|NCT00738062|474857917|FG002|Open-Label Extension|Study Terminated|0|||
131884055|NCT00980174|474857918|FG000|Overall Study|Withdrawal by Subject|1|||
131884056|NCT00980174|474857919|FG001|Overall Study|Withdrawal by Subject|4|||
131884057|NCT00980174|474857918|FG000|Overall Study|Adverse Event|0|||
131884058|NCT00980174|474857919|FG001|Overall Study|Adverse Event|3|||
131884059|NCT00980174|474857918|FG000|Overall Study|Ineligibility determined|2|||
131884060|NCT00980174|474857919|FG001|Overall Study|Ineligibility determined|1|||
131884061|NCT00980174|474857918|FG000|Overall Study|Death|1|||
131884062|NCT00980174|474857919|FG001|Overall Study|Death|1|||
131884063|NCT00980174|474857918|FG000|Overall Study|Other|0|||
131884064|NCT00980174|474857919|FG001|Overall Study|Other|1|||
131884065|NCT00455520|474857921|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
131884066|NCT00455520|474857922|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
131884067|NCT00455520|474857921|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
131884068|NCT00455520|474857922|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
131884069|NCT00455520|474857921|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
131884070|NCT00455520|474857922|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
131884071|NCT00455520|474857921|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
131884072|NCT00455520|474857922|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
131884073|NCT00455520|474857921|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
131884074|NCT00455520|474857922|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
131884075|NCT00455520|474857921|FG000|Open Label Tapentadol Extended Release|All other|33|||
131884076|NCT00455520|474857922|FG001|Open Label Tapentadol Extended Release|All other|0|||
131884077|NCT00455520|474857921|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
131884078|NCT00455520|474857922|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
131884079|NCT00455520|474857921|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
131884080|NCT00455520|474857922|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
131884081|NCT00455520|474857921|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
131884082|NCT00455520|474857922|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
131884083|NCT00455520|474857921|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
131884084|NCT00455520|474857922|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
131884085|NCT00455520|474857921|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
131884086|NCT00455520|474857922|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
131884087|NCT00455520|474857921|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
131884088|NCT00455520|474857922|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
131884089|NCT01935700|474857923|FG000|Overall Study|Withdrawal by Subject|1|||
131884090|NCT01935700|474857924|FG001|Overall Study|Withdrawal by Subject|0|||
131884091|NCT01935700|474857923|FG000|Overall Study|Physician Decision|4|||
131884092|NCT01935700|474857924|FG001|Overall Study|Physician Decision|0|||
131884093|NCT01935128|474857925|FG000|Overall Study|Death|1|||
131884094|NCT01935128|474857925|FG000|Overall Study|Adverse Event|6|||
131884095|NCT00772005|474857926|FG000|Overall Study|Adverse Event|9|||
131884096|NCT00772005|474857927|FG001|Overall Study|Adverse Event|14|||
131884097|NCT00772005|474857928|FG002|Overall Study|Adverse Event|10|||
131884098|NCT00772005|474857929|FG003|Overall Study|Adverse Event|13|||
131884099|NCT00772005|474857926|FG000|Overall Study|Lack of Efficacy|0|||
131884100|NCT00772005|474857927|FG001|Overall Study|Lack of Efficacy|1|||
131884101|NCT00772005|474857928|FG002|Overall Study|Lack of Efficacy|0|||
131884102|NCT00772005|474857929|FG003|Overall Study|Lack of Efficacy|0|||
131884103|NCT00772005|474857926|FG000|Overall Study|Withdrawal by Subject|3|||
131884104|NCT00772005|474857927|FG001|Overall Study|Withdrawal by Subject|7|||
131884105|NCT00772005|474857928|FG002|Overall Study|Withdrawal by Subject|10|||
131884106|NCT00772005|474857929|FG003|Overall Study|Withdrawal by Subject|2|||
131884107|NCT00772005|474857926|FG000|Overall Study|Protocol Violation|2|||
131884108|NCT00772005|474857927|FG001|Overall Study|Protocol Violation|4|||
131884109|NCT00772005|474857928|FG002|Overall Study|Protocol Violation|1|||
131884110|NCT00772005|474857929|FG003|Overall Study|Protocol Violation|6|||
131884111|NCT00772005|474857926|FG000|Overall Study|Lost to Follow-up|7|||
131884112|NCT00772005|474857927|FG001|Overall Study|Lost to Follow-up|3|||
131884113|NCT00772005|474857928|FG002|Overall Study|Lost to Follow-up|6|||
131884114|NCT00772005|474857929|FG003|Overall Study|Lost to Follow-up|3|||
131884115|NCT00772005|474857926|FG000|Overall Study|Non-compliance with study procedures|1|||
131884116|NCT00772005|474857927|FG001|Overall Study|Non-compliance with study procedures|1|||
131884117|NCT00772005|474857928|FG002|Overall Study|Non-compliance with study procedures|0|||
131884118|NCT00772005|474857929|FG003|Overall Study|Non-compliance with study procedures|1|||
131884119|NCT00772005|474857926|FG000|Overall Study|Non-compliance with drug administration|3|||
131884120|NCT00772005|474857927|FG001|Overall Study|Non-compliance with drug administration|0|||
131884121|NCT00772005|474857928|FG002|Overall Study|Non-compliance with drug administration|1|||
131884122|NCT00772005|474857929|FG003|Overall Study|Non-compliance with drug administration|1|||
131884123|NCT00955968|474857930|FG000|Overall Study|Death|2|||
131884124|NCT00955968|474857931|FG001|Overall Study|Death|4|||
131884125|NCT00955968|474857930|FG000|Overall Study|Withdrawal by Subject|35|||
131884126|NCT00955968|474857931|FG001|Overall Study|Withdrawal by Subject|31|||
131884127|NCT00955968|474857930|FG000|Overall Study|Lost to Follow-up|45|||
131884128|NCT00955968|474857931|FG001|Overall Study|Lost to Follow-up|39|||
131884129|NCT00955968|474857930|FG000|Overall Study|Site closed|55|||
131884130|NCT00955968|474857931|FG001|Overall Study|Site closed|52|||
131884131|NCT04326439|474857935|FG000|Overall Study|Withdrawal by Subject|1|||
131884132|NCT04326439|474857936|FG001|Overall Study|Withdrawal by Subject|0|||
131884133|NCT04326439|474857935|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
131884134|NCT04326439|474857936|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
131884135|NCT04326439|474857935|FG000|Overall Study|Relapse after Induction 2|0|||
131884136|NCT04326439|474857936|FG001|Overall Study|Relapse after Induction 2|1|||
131884137|NCT04326439|474857935|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
131884138|NCT04326439|474857936|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
131884139|NCT00204477|474857939|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
131884140|NCT00204477|474857940|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
131884141|NCT00204477|474857939|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
131884142|NCT00204477|474857940|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
131884143|NCT02431806|474857941|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
131884144|NCT02431806|474857942|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
131884145|NCT02431806|474857943|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
131884146|NCT02431806|474857944|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
131884147|NCT02431806|474857941|FG000|Double-blind Treatment Period|Adverse Event|4|||
131884148|NCT02431806|474857942|FG001|Double-blind Treatment Period|Adverse Event|7|||
131884149|NCT02431806|474857943|FG002|Double-blind Treatment Period|Adverse Event|11|||
131884150|NCT02431806|474857944|FG003|Double-blind Treatment Period|Adverse Event|7|||
131884151|NCT02431806|474857941|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
131884152|NCT02431806|474857942|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
131884153|NCT02431806|474857943|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
131884154|NCT02431806|474857944|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
131884155|NCT02431806|474857941|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
131884156|NCT02431806|474857942|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
131884157|NCT02431806|474857943|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
131884158|NCT02431806|474857944|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
131884159|NCT02431806|474857941|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
131884160|NCT02431806|474857942|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
131884161|NCT02431806|474857943|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
131884162|NCT02431806|474857944|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
131547185|NCT00724152|473626334|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
131884163|NCT02431806|474857941|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
131884164|NCT02431806|474857942|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
131884165|NCT02431806|474857943|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
131884166|NCT02431806|474857944|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
131884167|NCT02431806|474857941|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
131884168|NCT02431806|474857942|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
131884169|NCT02431806|474857943|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
131884170|NCT02431806|474857944|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
131884171|NCT03627416|474857945|FG000|Overall Study|Adverse Event|0|||
131884172|NCT03627416|474857946|FG001|Overall Study|Adverse Event|1|||
131884173|NCT04272606|474857949|FG000|Overall Study|Protocol Violation|1|||
131884174|NCT04272606|474857950|FG001|Overall Study|Protocol Violation|1|||
131884175|NCT04272606|474857949|FG000|Overall Study|Physician Decision|0|||
131884176|NCT04272606|474857950|FG001|Overall Study|Physician Decision|1|||
131884177|NCT03619902|474857951|FG000|Overall Study|Termination of Study by Investigator|1|||
131884178|NCT03619902|474857951|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
131884179|NCT02923245|474857952|FG000|Overall Study|ultrasound order was cancelled|2|||
131884180|NCT02923245|474857953|FG001|Overall Study|ultrasound order was cancelled|1|||
131884181|NCT00710684|474857956|FG000|Overall Study|Adverse Event|11|||
131884182|NCT00710684|474857957|FG001|Overall Study|Adverse Event|19|||
131884183|NCT00710684|474857958|FG002|Overall Study|Adverse Event|16|||
131884184|NCT00710684|474857956|FG000|Overall Study|Lack of Efficacy|4|||
131884185|NCT00710684|474857957|FG001|Overall Study|Lack of Efficacy|3|||
131884186|NCT00710684|474857958|FG002|Overall Study|Lack of Efficacy|5|||
131884187|NCT00710684|474857956|FG000|Overall Study|Protocol Violation|5|||
131884188|NCT00710684|474857957|FG001|Overall Study|Protocol Violation|5|||
131884189|NCT00710684|474857958|FG002|Overall Study|Protocol Violation|5|||
131884190|NCT00710684|474857956|FG000|Overall Study|Lost to Follow-up|4|||
131884191|NCT00710684|474857957|FG001|Overall Study|Lost to Follow-up|6|||
131884192|NCT00710684|474857958|FG002|Overall Study|Lost to Follow-up|7|||
131884193|NCT00710684|474857956|FG000|Overall Study|Physician Decision|0|||
131884194|NCT00710684|474857957|FG001|Overall Study|Physician Decision|2|||
131884195|NCT00710684|474857958|FG002|Overall Study|Physician Decision|4|||
131884196|NCT00710684|474857956|FG000|Overall Study|Withdrawal by Subject|24|||
131884197|NCT00710684|474857957|FG001|Overall Study|Withdrawal by Subject|18|||
131884198|NCT00710684|474857958|FG002|Overall Study|Withdrawal by Subject|11|||
131884199|NCT00710684|474857956|FG000|Overall Study|Missing|1|||
131884200|NCT00710684|474857957|FG001|Overall Study|Missing|0|||
131884201|NCT00710684|474857958|FG002|Overall Study|Missing|0|||
131884202|NCT00710684|474857956|FG000|Overall Study|Did not continue after week 24|25|||
131884203|NCT00710684|474857957|FG001|Overall Study|Did not continue after week 24|21|||
131884204|NCT00710684|474857958|FG002|Overall Study|Did not continue after week 24|16|||
131884205|NCT04778059|474857959|FG000|Overall Study|Death|2|||
131884206|NCT04778059|474857960|FG001|Overall Study|Death|2|||
131884207|NCT04778059|474857961|FG002|Overall Study|Death|1|||
131884208|NCT04778059|474857962|FG003|Overall Study|Death|1|||
131884209|NCT04778059|474857963|FG004|Overall Study|Death|1|||
131884210|NCT04778059|474857959|FG000|Overall Study|Lost to Follow-up|0|||
131884211|NCT04778059|474857960|FG001|Overall Study|Lost to Follow-up|0|||
131884212|NCT04778059|474857961|FG002|Overall Study|Lost to Follow-up|0|||
131884213|NCT04778059|474857962|FG003|Overall Study|Lost to Follow-up|0|||
131884214|NCT04778059|474857963|FG004|Overall Study|Lost to Follow-up|1|||
131884215|NCT04778059|474857959|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
131884216|NCT04778059|474857960|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
131884217|NCT04778059|474857961|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
131884218|NCT04778059|474857962|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
131884219|NCT04778059|474857963|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
131884220|NCT00157248|474857968|FG000|Overall Study|Adverse Event|36|||
131884221|NCT00157248|474857969|FG001|Overall Study|Adverse Event|25|||
131884222|NCT00157248|474857970|FG002|Overall Study|Adverse Event|13|||
131884223|NCT00157248|474857971|FG003|Overall Study|Adverse Event|33|||
131884224|NCT00157248|474857968|FG000|Overall Study|Protocol Violation|4|||
131884225|NCT00157248|474857969|FG001|Overall Study|Protocol Violation|0|||
131884226|NCT00157248|474857970|FG002|Overall Study|Protocol Violation|2|||
131884227|NCT00157248|474857971|FG003|Overall Study|Protocol Violation|2|||
131884228|NCT00157248|474857968|FG000|Overall Study|Lost to Follow-up|0|||
131884229|NCT00157248|474857969|FG001|Overall Study|Lost to Follow-up|1|||
131884230|NCT00157248|474857970|FG002|Overall Study|Lost to Follow-up|0|||
131884231|NCT00157248|474857971|FG003|Overall Study|Lost to Follow-up|0|||
131884232|NCT00157248|474857968|FG000|Overall Study|Withdrawal by Subject|1|||
131884233|NCT00157248|474857969|FG001|Overall Study|Withdrawal by Subject|4|||
131884234|NCT00157248|474857970|FG002|Overall Study|Withdrawal by Subject|3|||
131884235|NCT00157248|474857971|FG003|Overall Study|Withdrawal by Subject|3|||
131884236|NCT00157248|474857968|FG000|Overall Study|site closures, subject moving|7|||
131884237|NCT00157248|474857969|FG001|Overall Study|site closures, subject moving|7|||
131884238|NCT00157248|474857970|FG002|Overall Study|site closures, subject moving|3|||
131884239|NCT00157248|474857971|FG003|Overall Study|site closures, subject moving|9|||
131884240|NCT01306045|474857974|FG000|Met General Eligibility Criteria|Screen failures|193|||
131884241|NCT01306045|474857975|FG001|Met General Eligibility Criteria|Screen failures|11|||
131884242|NCT01306045|474857976|FG002|Met General Eligibility Criteria|Screen failures|8|||
131884243|NCT03191864|474857978|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
131884244|NCT03191864|474857979|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
131884245|NCT03191864|474857980|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
131884246|NCT03191864|474857981|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
131884247|NCT03191864|474857982|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
131884248|NCT03191864|474857983|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
131884249|NCT03191864|474857978|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
131884250|NCT03191864|474857979|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
131884251|NCT03191864|474857980|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
131884252|NCT03191864|474857981|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
131884253|NCT03191864|474857982|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
131884254|NCT03191864|474857983|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
131884255|NCT03191864|474857978|FG000|Baseline Symptom Assessment|Adverse Event|0|||
131884256|NCT03191864|474857979|FG001|Baseline Symptom Assessment|Adverse Event|0|||
131884257|NCT03191864|474857980|FG002|Baseline Symptom Assessment|Adverse Event|0|||
131884258|NCT03191864|474857981|FG003|Baseline Symptom Assessment|Adverse Event|0|||
131884259|NCT03191864|474857982|FG004|Baseline Symptom Assessment|Adverse Event|0|||
131884260|NCT03191864|474857983|FG005|Baseline Symptom Assessment|Adverse Event|2|||
131884261|NCT03191864|474857978|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
131884262|NCT03191864|474857979|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
131884263|NCT03191864|474857980|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
131884264|NCT03191864|474857981|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
131884265|NCT03191864|474857982|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
131884266|NCT03191864|474857983|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
131884267|NCT03191864|474857978|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
131884268|NCT03191864|474857979|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
131884269|NCT03191864|474857980|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
131884270|NCT03191864|474857981|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
131884271|NCT03191864|474857982|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
131884272|NCT03191864|474857983|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
131884273|NCT03191864|474857978|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
131884274|NCT03191864|474857979|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
131884275|NCT03191864|474857980|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
131884276|NCT03191864|474857981|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
131884277|NCT03191864|474857982|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
131884278|NCT03191864|474857983|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
131884279|NCT03191864|474857978|FG000|Part 1 - Induction|Adverse Event|0|||
131884280|NCT03191864|474857979|FG001|Part 1 - Induction|Adverse Event|2|||
131884281|NCT03191864|474857980|FG002|Part 1 - Induction|Adverse Event|0|||
131884282|NCT03191864|474857981|FG003|Part 1 - Induction|Adverse Event|1|||
131884283|NCT03191864|474857982|FG004|Part 1 - Induction|Adverse Event|0|||
131884284|NCT03191864|474857983|FG005|Part 1 - Induction|Adverse Event|2|||
131884285|NCT03191864|474857978|FG000|Part 1 - Induction|Randomized but never dosed|0|||
131884286|NCT03191864|474857979|FG001|Part 1 - Induction|Randomized but never dosed|0|||
131884287|NCT03191864|474857980|FG002|Part 1 - Induction|Randomized but never dosed|1|||
131884288|NCT03191864|474857981|FG003|Part 1 - Induction|Randomized but never dosed|0|||
131884289|NCT03191864|474857982|FG004|Part 1 - Induction|Randomized but never dosed|0|||
131884290|NCT03191864|474857983|FG005|Part 1 - Induction|Randomized but never dosed|0|||
131884291|NCT03191864|474857978|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
131884292|NCT03191864|474857979|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
131884293|NCT03191864|474857980|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
131884294|NCT03191864|474857981|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
131884295|NCT03191864|474857982|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
131884296|NCT03191864|474857983|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
131884297|NCT03191864|474857978|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
131884298|NCT03191864|474857979|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
131884299|NCT03191864|474857980|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
131884300|NCT03191864|474857981|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
131884301|NCT03191864|474857982|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
131884302|NCT03191864|474857983|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
131884303|NCT03191864|474857978|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
131884304|NCT03191864|474857979|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
131884305|NCT03191864|474857980|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
131884306|NCT03191864|474857981|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
131884307|NCT03191864|474857982|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
131884308|NCT03191864|474857983|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
131884309|NCT03191864|474857978|FG000|Part 2 - Maintenance|Physician Decision|1|||
131884310|NCT03191864|474857979|FG001|Part 2 - Maintenance|Physician Decision|0|||
131884311|NCT03191864|474857980|FG002|Part 2 - Maintenance|Physician Decision|0|||
131884312|NCT03191864|474857981|FG003|Part 2 - Maintenance|Physician Decision|0|||
131884313|NCT03191864|474857982|FG004|Part 2 - Maintenance|Physician Decision|0|||
131884314|NCT03191864|474857983|FG005|Part 2 - Maintenance|Physician Decision|0|||
131884315|NCT03191864|474857978|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
131884316|NCT03191864|474857979|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
131884317|NCT03191864|474857980|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
131884318|NCT03191864|474857981|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
131884319|NCT03191864|474857982|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
131884320|NCT03191864|474857983|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
131884321|NCT03191864|474857978|FG000|Part 2 - Maintenance|Adverse Event|0|||
131884322|NCT03191864|474857979|FG001|Part 2 - Maintenance|Adverse Event|0|||
131884323|NCT03191864|474857980|FG002|Part 2 - Maintenance|Adverse Event|0|||
131884324|NCT03191864|474857981|FG003|Part 2 - Maintenance|Adverse Event|0|||
131884325|NCT03191864|474857982|FG004|Part 2 - Maintenance|Adverse Event|1|||
131884326|NCT03191864|474857983|FG005|Part 2 - Maintenance|Adverse Event|0|||
131884327|NCT03191864|474857978|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
131547186|NCT00724152|473626335|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
131884328|NCT03191864|474857979|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
131884329|NCT03191864|474857980|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
131884330|NCT03191864|474857981|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
131884331|NCT03191864|474857982|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
131884332|NCT03191864|474857983|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
131884333|NCT03191864|474857978|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
131884334|NCT03191864|474857979|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
131884335|NCT03191864|474857980|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
131884336|NCT03191864|474857981|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
131884337|NCT03191864|474857982|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
131884338|NCT03191864|474857983|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
131884339|NCT02342548|474857984|FG000|Overall Study|Adverse Event|12|||
131884340|NCT02342548|474857985|FG001|Overall Study|Adverse Event|17|||
131884341|NCT02342548|474857986|FG002|Overall Study|Adverse Event|13|||
131884342|NCT02342548|474857984|FG000|Overall Study|Lost to Follow-up|0|||
131884343|NCT02342548|474857985|FG001|Overall Study|Lost to Follow-up|1|||
131884344|NCT02342548|474857986|FG002|Overall Study|Lost to Follow-up|0|||
131884345|NCT02342548|474857984|FG000|Overall Study|Study terminated by sponsor|20|||
131884346|NCT02342548|474857985|FG001|Overall Study|Study terminated by sponsor|39|||
131884347|NCT02342548|474857986|FG002|Overall Study|Study terminated by sponsor|25|||
131884348|NCT02342548|474857984|FG000|Overall Study|Protocol Violation|0|||
131884349|NCT02342548|474857985|FG001|Overall Study|Protocol Violation|1|||
131884350|NCT02342548|474857986|FG002|Overall Study|Protocol Violation|0|||
131884351|NCT02342548|474857984|FG000|Overall Study|Withdrawal by Subject|1|||
131884352|NCT02342548|474857985|FG001|Overall Study|Withdrawal by Subject|3|||
131884353|NCT02342548|474857986|FG002|Overall Study|Withdrawal by Subject|4|||
131884354|NCT02342548|474857984|FG000|Overall Study|Other|1|||
131884355|NCT02342548|474857985|FG001|Overall Study|Other|1|||
131884356|NCT02342548|474857986|FG002|Overall Study|Other|1|||
131884357|NCT01047332|474857987|FG000|Overall Study|SEMS Obstruction|11|||
131884358|NCT01047332|474857988|FG001|Overall Study|SEMS Obstruction|20|||
131884359|NCT01047332|474857987|FG000|Overall Study|Died Unobstructed|38|||
131884360|NCT01047332|474857988|FG001|Overall Study|Died Unobstructed|41|||
131884361|NCT01047332|474857987|FG000|Overall Study|Lost to Follow-up|8|||
131884362|NCT01047332|474857988|FG001|Overall Study|Lost to Follow-up|3|||
131884363|NCT00787917|474857994|FG000|Blinded Treatment|Adverse Event|1|||
131884364|NCT00787917|474857995|FG001|Blinded Treatment|Adverse Event|0|||
131884365|NCT00787917|474857994|FG000|Blinded Treatment|Lack of Efficacy|1|||
131884366|NCT00787917|474857995|FG001|Blinded Treatment|Lack of Efficacy|0|||
131884367|NCT00787917|474857994|FG000|Blinded Treatment|Administrative problems|3|||
131884368|NCT00787917|474857995|FG001|Blinded Treatment|Administrative problems|2|||
131884369|NCT00787917|474857994|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
131884370|NCT00787917|474857995|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
131884371|NCT00787917|474857994|FG000|Open Label|Administrative problems|3|||
131884372|NCT00787917|474857995|FG001|Open Label|Administrative problems|0|||
131884373|NCT03521817|474857996|FG000|Overall Study|Protocol Violation|0|||
131884374|NCT03521817|474857997|FG001|Overall Study|Protocol Violation|1|||
131547187|NCT00724152|473626333|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
131547188|NCT00724152|473626334|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
131658911|NCT01214642|474035460|FG002|Overall Study|Death|1|||
131884375|NCT00778102|474857999|FG000|Overall Study|Adverse Event|8|||
131884376|NCT00778102|474858000|FG001|Overall Study|Adverse Event|5|||
131884377|NCT00778102|474857999|FG000|Overall Study|Death|1|||
131884378|NCT00778102|474858000|FG001|Overall Study|Death|1|||
131884379|NCT00778102|474857999|FG000|Overall Study|Lost to Follow-up|1|||
131884380|NCT00778102|474858000|FG001|Overall Study|Lost to Follow-up|0|||
131884381|NCT00778102|474857999|FG000|Overall Study|Violation of Selection Criteria|1|||
131884382|NCT00778102|474858000|FG001|Overall Study|Violation of Selection Criteria|1|||
131884383|NCT00778102|474857999|FG000|Overall Study|Protocol Violation|0|||
131884384|NCT00778102|474858000|FG001|Overall Study|Protocol Violation|1|||
131884385|NCT00778102|474857999|FG000|Overall Study|Refused Treatment|2|||
131884386|NCT00778102|474858000|FG001|Overall Study|Refused Treatment|3|||
131884387|NCT00778102|474857999|FG000|Overall Study|Withdrawal by Subject|1|||
131884388|NCT00778102|474858000|FG001|Overall Study|Withdrawal by Subject|1|||
131884389|NCT00778102|474857999|FG000|Overall Study|Administrative Reason|7|||
131884390|NCT00778102|474858000|FG001|Overall Study|Administrative Reason|10|||
131884391|NCT01328548|474858003|FG000|Overall Study|Death|3|||
131884392|NCT01328548|474858004|FG001|Overall Study|Death|0|||
131884393|NCT01328548|474858003|FG000|Overall Study|Protocol Violation|1|||
131884394|NCT01328548|474858004|FG001|Overall Study|Protocol Violation|0|||
131884395|NCT05072106|474859581|FG000|Overall Study|Progressive disease|3|||
131884396|NCT05072106|474859582|FG001|Overall Study|Progressive disease|3|||
131884397|NCT05072106|474859581|FG000|Overall Study|Compassionate use|3|||
131884398|NCT05072106|474859582|FG001|Overall Study|Compassionate use|1|||
131884399|NCT05072106|474859581|FG000|Overall Study|Withdrawal by Subject|1|||
131884400|NCT05072106|474859582|FG001|Overall Study|Withdrawal by Subject|0|||
131884401|NCT03839459|474859583|FG000|Overall Study|Withdrawal by Subject|2|||
131884402|NCT03839459|474859583|FG000|Overall Study|progression of disease|3|||
131884403|NCT02542293|474859588|FG000|Overall Study|Death|367|||
131884404|NCT02542293|474859589|FG001|Overall Study|Death|377|||
131884405|NCT02542293|474859588|FG000|Overall Study|Withdrawal by Subject|8|||
131884406|NCT02542293|474859589|FG001|Overall Study|Withdrawal by Subject|19|||
131884407|NCT01458951|474859592|FG000|Overall Study|Other|1|||
131884408|NCT01458951|474859593|FG001|Overall Study|Other|0|||
131884409|NCT01458951|474859594|FG002|Overall Study|Other|0|||
131884410|NCT01458951|474859592|FG000|Overall Study|Protocol Violation|5|||
131884411|NCT01458951|474859593|FG001|Overall Study|Protocol Violation|1|||
131884412|NCT01458951|474859594|FG002|Overall Study|Protocol Violation|0|||
131884413|NCT01458951|474859592|FG000|Overall Study|Withdrawal by Subject|2|||
131884414|NCT01458951|474859593|FG001|Overall Study|Withdrawal by Subject|0|||
131884415|NCT01458951|474859594|FG002|Overall Study|Withdrawal by Subject|2|||
131884416|NCT01458951|474859592|FG000|Overall Study|Adverse Event|7|||
131884417|NCT01458951|474859593|FG001|Overall Study|Adverse Event|0|||
131884418|NCT01458951|474859594|FG002|Overall Study|Adverse Event|2|||
131884419|NCT01458951|474859592|FG000|Overall Study|Insufficient Clinical Response|17|||
131884420|NCT01458951|474859593|FG001|Overall Study|Insufficient Clinical Response|0|||
131884421|NCT01458951|474859594|FG002|Overall Study|Insufficient Clinical Response|11|||
131884422|NCT02963558|474859597|FG000|Overall Study|Withdrawn by investigator|1|||
131884423|NCT02963558|474859598|FG001|Overall Study|Withdrawn by investigator|0|||
131884424|NCT02963558|474859597|FG000|Overall Study|Withdrawal by Subject|0|||
131884425|NCT02963558|474859598|FG001|Overall Study|Withdrawal by Subject|1|||
131884426|NCT02255552|474859601|FG000|Overall Study|Participants enrolled into another study|0|||
131884427|NCT02255552|474859602|FG001|Overall Study|Participants enrolled into another study|11|||
131884428|NCT02255552|474859601|FG000|Overall Study|Withdrawal by Subject|1|||
131884429|NCT02255552|474859602|FG001|Overall Study|Withdrawal by Subject|4|||
131884430|NCT00894790|474859607|FG000|Overall Study|Protocol Violation|0|||
131884431|NCT00894790|474859608|FG001|Overall Study|Protocol Violation|1|||
131884432|NCT00894790|474859607|FG000|Overall Study|Lost to Follow-up|0|||
131884433|NCT00894790|474859608|FG001|Overall Study|Lost to Follow-up|1|||
131884434|NCT00894790|474859607|FG000|Overall Study|Did not meet entrance criteria|1|||
131884435|NCT00894790|474859608|FG001|Overall Study|Did not meet entrance criteria|0|||
131884436|NCT01472965|474859609|FG000|Overall Study|Withdrawal by Subject|1|||
131884437|NCT01472965|474859610|FG001|Overall Study|Withdrawal by Subject|0|||
131884438|NCT00628095|474859611|FG000|Overall Study|Adverse Event|5|||
131884439|NCT00628095|474859612|FG001|Overall Study|Adverse Event|3|||
131884440|NCT00628095|474859611|FG000|Overall Study|Lack of Efficacy|0|||
131884441|NCT00628095|474859612|FG001|Overall Study|Lack of Efficacy|3|||
131884442|NCT00628095|474859611|FG000|Overall Study|Withdrawal by Subject|2|||
131884443|NCT00628095|474859612|FG001|Overall Study|Withdrawal by Subject|0|||
131884444|NCT00628095|474859611|FG000|Overall Study|Other|0|||
131884445|NCT00628095|474859612|FG001|Overall Study|Other|1|||
131884446|NCT03235115|474859614|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
131884447|NCT03235115|474859615|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
131884448|NCT03235115|474859616|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
131884449|NCT03235115|474859617|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
131884450|NCT03235115|474859618|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
131884451|NCT03235115|474859619|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
131884452|NCT00006305|474859620|FG000|Overall Study|Withdrawal by Subject|17|||
131884453|NCT00006305|474859621|FG001|Overall Study|Withdrawal by Subject|10|||
131884454|NCT00006305|474859622|FG002|Overall Study|Withdrawal by Subject|15|||
131884455|NCT00006305|474859623|FG003|Overall Study|Withdrawal by Subject|14|||
131884456|NCT00783224|474859626|FG000|Overall Study|Adverse Event|0|||
131884457|NCT00783224|474859627|FG001|Overall Study|Adverse Event|0|||
131884458|NCT00783224|474859628|FG002|Overall Study|Adverse Event|1|||
131884459|NCT00783224|474859629|FG003|Overall Study|Adverse Event|0|||
131884460|NCT00783224|474859626|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
131884461|NCT00783224|474859627|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
131884462|NCT00783224|474859628|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
131884463|NCT00783224|474859629|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
131884464|NCT00783224|474859626|FG000|Overall Study|Inappropriate as a study subject|0|||
131884465|NCT00783224|474859627|FG001|Overall Study|Inappropriate as a study subject|0|||
131884466|NCT00783224|474859628|FG002|Overall Study|Inappropriate as a study subject|0|||
131884467|NCT00783224|474859629|FG003|Overall Study|Inappropriate as a study subject|1|||
131884468|NCT01711619|474859630|FG000|Overall Study|Early study termination|10|||
131884469|NCT01711619|474859631|FG001|Overall Study|Early study termination|14|||
131884470|NCT01711619|474859630|FG000|Overall Study|Withdrawal by Subject|3|||
131884471|NCT01711619|474859631|FG001|Overall Study|Withdrawal by Subject|7|||
131884472|NCT01711619|474859630|FG000|Overall Study|Protocol Violation|2|||
131884473|NCT01711619|474859631|FG001|Overall Study|Protocol Violation|3|||
131884474|NCT01711619|474859630|FG000|Overall Study|Adverse Event|2|||
131884475|NCT01711619|474859631|FG001|Overall Study|Adverse Event|0|||
131884476|NCT01711619|474859630|FG000|Overall Study|Lost to Follow-up|1|||
131884477|NCT01711619|474859631|FG001|Overall Study|Lost to Follow-up|0|||
131884478|NCT04631107|474859634|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
131884479|NCT04631107|474859634|FG000|Second Intervention (1 Night)|Adverse Event|1|||
131884480|NCT04631107|474859634|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
131884481|NCT04631107|474859634|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
131884482|NCT00503997|474859638|FG000|Overall Study|disease progression|1|||
131884483|NCT00503997|474859638|FG000|Overall Study|Adverse Event|5|||
131884484|NCT00503997|474859638|FG000|Overall Study|Death|1|||
131884485|NCT00503997|474859638|FG000|Overall Study|Withdrawal by Subject|1|||
131884486|NCT01195844|474859639|FG000|Overall Study|Fecal sample not collected|40|||
131884487|NCT05385224|474859640|FG000|Overall Study|Unable to swallow capsule|2|||
131884488|NCT05385224|474859640|FG000|Overall Study|Withdrawal by Subject|2|||
131884489|NCT05385224|474859640|FG000|Overall Study|Did not meet study criteria|1|||
131884490|NCT01432275|474859644|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
131884491|NCT01432275|474859645|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
131884492|NCT01432275|474859644|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
131884493|NCT01432275|474859645|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
131884494|NCT01432275|474859644|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
131884495|NCT01432275|474859645|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
131884496|NCT01432275|474859644|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
131884497|NCT01432275|474859645|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
131884498|NCT01432275|474859644|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
131884499|NCT01432275|474859645|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
131884500|NCT01432275|474859644|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
131884501|NCT01432275|474859645|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
131884502|NCT01432275|474859644|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
131884503|NCT01432275|474859645|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
131884504|NCT01432275|474859644|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
131884505|NCT01432275|474859645|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
131884506|NCT01432275|474859644|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
131884507|NCT01432275|474859645|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
131884508|NCT00551161|474859646|FG000|Overall Study|Withdrawal by Subject|1|||
131884509|NCT02565706|474859647|FG000|Overall Study|Withdrawal by Subject|5|||
131884510|NCT02565706|474859648|FG001|Overall Study|Withdrawal by Subject|7|||
131884511|NCT02565706|474859649|FG002|Overall Study|Withdrawal by Subject|7|||
131884512|NCT02565706|474859650|FG003|Overall Study|Withdrawal by Subject|11|||
131884513|NCT02565706|474859647|FG000|Overall Study|Lost to Follow-up|72|||
131884514|NCT02565706|474859648|FG001|Overall Study|Lost to Follow-up|75|||
131884515|NCT02565706|474859649|FG002|Overall Study|Lost to Follow-up|82|||
131884516|NCT02565706|474859650|FG003|Overall Study|Lost to Follow-up|74|||
131884517|NCT00096993|474859651|FG000|Overall Study|Death|1|||
131884518|NCT00096993|474859652|FG001|Overall Study|Death|0|||
131884519|NCT00096993|474859651|FG000|Overall Study|Disease progression|56|||
131884520|NCT00096993|474859652|FG001|Overall Study|Disease progression|53|||
131884521|NCT00096993|474859651|FG000|Overall Study|Adverse Event|2|||
131884522|NCT00096993|474859652|FG001|Overall Study|Adverse Event|8|||
131547189|NCT00724152|473626335|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
131660023|NCT00653523|474039055|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
131547190|NCT00386022|473626337|FG000|Plus Estrogen|Lost to Follow-up|2|||
131547191|NCT00386022|473626338|FG001|Plus Estrogen|Lost to Follow-up|0|||
131884523|NCT00096993|474859651|FG000|Overall Study|Subject's decision|3|||
131884524|NCT00096993|474859652|FG001|Overall Study|Subject's decision|1|||
131884525|NCT00096993|474859651|FG000|Overall Study|Physician Decision|2|||
131884526|NCT00096993|474859652|FG001|Overall Study|Physician Decision|1|||
131884527|NCT00096993|474859651|FG000|Overall Study|Non-compliance|0|||
131884528|NCT00096993|474859652|FG001|Overall Study|Non-compliance|1|||
131884529|NCT00096993|474859651|FG000|Overall Study|Other unspecified|1|||
131884530|NCT00096993|474859652|FG001|Overall Study|Other unspecified|1|||
131884531|NCT01440569|474859656|FG000|Main Study|Enrolled but not treated|1|||
131884532|NCT01440569|474859657|FG001|Main Study|Enrolled but not treated|0|||
131884533|NCT01440569|474859656|FG000|Main Study|Adverse Event|9|||
131884534|NCT01440569|474859657|FG001|Main Study|Adverse Event|0|||
131884535|NCT01440569|474859656|FG000|Main Study|Pregnancy|1|||
131884536|NCT01440569|474859657|FG001|Main Study|Pregnancy|0|||
131884537|NCT01440569|474859656|FG000|Main Study|Investigator's Discretion|1|||
131884538|NCT01440569|474859657|FG001|Main Study|Investigator's Discretion|1|||
131884539|NCT01440569|474859656|FG000|Main Study|Withdrew Consent|7|||
131884540|NCT01440569|474859657|FG001|Main Study|Withdrew Consent|1|||
131884541|NCT01440569|474859656|FG000|Main Study|Lost to Follow-up|13|||
131884542|NCT01440569|474859657|FG001|Main Study|Lost to Follow-up|2|||
131884543|NCT01440569|474859656|FG000|Main Study|Subject Non-Compliance|3|||
131884544|NCT01440569|474859657|FG001|Main Study|Subject Non-Compliance|0|||
131884545|NCT01440569|474859656|FG000|Main Study|Protocol Violation|1|||
131884546|NCT01440569|474859657|FG001|Main Study|Protocol Violation|0|||
131884547|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Adverse Event|3|||
131884548|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Adverse Event|0|||
131884549|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Pregnancy|1|||
131884550|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Pregnancy|0|||
131884551|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
131884552|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
131884553|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
131884554|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
131884555|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
131884556|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
131884557|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
131884558|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
131884559|NCT01440569|474859656|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
131884560|NCT01440569|474859657|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
131884561|NCT00835679|474859659|FG000|Overall Study|Withdrawal by Subject|1|||
131884562|NCT00835679|474859660|FG001|Overall Study|Withdrawal by Subject|0|||
131884563|NCT00835679|474859661|FG002|Overall Study|Withdrawal by Subject|0|||
131884564|NCT00835679|474859662|FG003|Overall Study|Withdrawal by Subject|0|||
131884565|NCT01068626|474859663|FG000|Overall Study|Adverse Event|3|||
131884566|NCT01068626|474859664|FG001|Overall Study|Adverse Event|0|||
131884567|NCT01068626|474859663|FG000|Overall Study|Withdrawal by Subject|0|||
131884568|NCT01068626|474859664|FG001|Overall Study|Withdrawal by Subject|2|||
131884569|NCT01634659|474859668|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
131884570|NCT01634659|474859669|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
131884571|NCT01634659|474859668|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
131884572|NCT01634659|474859669|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
131884573|NCT01294371|474859670|FG000|Overall Study|Adverse Event|1|||
131884574|NCT01294371|474859670|FG000|Overall Study|Withdrawal by Subject|12|||
131884575|NCT01294371|474859670|FG000|Overall Study|Lost to Follow-up|6|||
131884576|NCT01294371|474859670|FG000|Overall Study|Administrative Reason|1|||
131884577|NCT01294371|474859670|FG000|Overall Study|Other|14|||
131884578|NCT05619536|474859671|FG000|Overall Study|Withdrawal by Subject|0|||
131884579|NCT05619536|474859672|FG001|Overall Study|Withdrawal by Subject|1|||
131884580|NCT05619536|474859673|FG002|Overall Study|Withdrawal by Subject|0|||
131884581|NCT05619536|474859674|FG003|Overall Study|Withdrawal by Subject|1|||
131884582|NCT05619536|474859671|FG000|Overall Study|Lost to Follow-up|0|||
131884583|NCT05619536|474859672|FG001|Overall Study|Lost to Follow-up|1|||
131884584|NCT05619536|474859673|FG002|Overall Study|Lost to Follow-up|1|||
131884585|NCT05619536|474859674|FG003|Overall Study|Lost to Follow-up|0|||
131884586|NCT00875433|474859675|FG000|Overall Study|Progressive disease|41|||
131884587|NCT00875433|474859675|FG000|Overall Study|Other Adverse Event|14|||
131884588|NCT00875433|474859675|FG000|Overall Study|Withdrawal by Subject|2|||
131884589|NCT00875433|474859675|FG000|Overall Study|Other|3|||
131884590|NCT02520427|474859676|FG000|Overall Study|Decision by sponsor|0|||
131884591|NCT02520427|474859677|FG001|Overall Study|Decision by sponsor|0|||
131884592|NCT02520427|474859678|FG002|Overall Study|Decision by sponsor|0|||
131884593|NCT02520427|474859679|FG003|Overall Study|Decision by sponsor|0|||
131884594|NCT02520427|474859680|FG004|Overall Study|Decision by sponsor|0|||
131884595|NCT02520427|474859681|FG005|Overall Study|Decision by sponsor|0|||
131884596|NCT02520427|474859682|FG006|Overall Study|Decision by sponsor|0|||
131884597|NCT02520427|474859683|FG007|Overall Study|Decision by sponsor|0|||
131884598|NCT02520427|474859684|FG008|Overall Study|Decision by sponsor|1|||
131884599|NCT02520427|474859685|FG009|Overall Study|Decision by sponsor|1|||
131884600|NCT02520427|474859686|FG010|Overall Study|Decision by sponsor|0|||
131884601|NCT02520427|474859687|FG011|Overall Study|Decision by sponsor|0|||
131884602|NCT02520427|474859688|FG012|Overall Study|Decision by sponsor|0|||
131884603|NCT02520427|474859689|FG013|Overall Study|Decision by sponsor|0|||
131884604|NCT02520427|474859690|FG014|Overall Study|Decision by sponsor|0|||
131884605|NCT02520427|474859691|FG015|Overall Study|Decision by sponsor|0|||
131884606|NCT02520427|474859692|FG016|Overall Study|Decision by sponsor|0|||
131884607|NCT02520427|474859693|FG017|Overall Study|Decision by sponsor|0|||
131884608|NCT02520427|474859694|FG018|Overall Study|Decision by sponsor|0|||
131884609|NCT02520427|474859695|FG019|Overall Study|Decision by sponsor|0|||
131884610|NCT02520427|474859696|FG020|Overall Study|Decision by sponsor|0|||
131884611|NCT02520427|474859697|FG021|Overall Study|Decision by sponsor|0|||
131884612|NCT02520427|474859698|FG022|Overall Study|Decision by sponsor|0|||
131884613|NCT02520427|474859699|FG023|Overall Study|Decision by sponsor|0|||
131884614|NCT02520427|474859700|FG024|Overall Study|Decision by sponsor|0|||
131884615|NCT02520427|474859701|FG025|Overall Study|Decision by sponsor|0|||
131884616|NCT02520427|474859676|FG000|Overall Study|Withdrawal by Subject|0|||
131884617|NCT02520427|474859677|FG001|Overall Study|Withdrawal by Subject|0|||
131884618|NCT02520427|474859678|FG002|Overall Study|Withdrawal by Subject|1|||
131884619|NCT02520427|474859679|FG003|Overall Study|Withdrawal by Subject|0|||
131884620|NCT02520427|474859680|FG004|Overall Study|Withdrawal by Subject|0|||
131884621|NCT02520427|474859681|FG005|Overall Study|Withdrawal by Subject|0|||
131884622|NCT02520427|474859682|FG006|Overall Study|Withdrawal by Subject|0|||
131884623|NCT02520427|474859683|FG007|Overall Study|Withdrawal by Subject|0|||
131884624|NCT02520427|474859684|FG008|Overall Study|Withdrawal by Subject|0|||
131884625|NCT02520427|474859685|FG009|Overall Study|Withdrawal by Subject|0|||
131884626|NCT02520427|474859686|FG010|Overall Study|Withdrawal by Subject|0|||
131884627|NCT02520427|474859687|FG011|Overall Study|Withdrawal by Subject|0|||
131884628|NCT02520427|474859688|FG012|Overall Study|Withdrawal by Subject|1|||
131884629|NCT02520427|474859689|FG013|Overall Study|Withdrawal by Subject|1|||
131884630|NCT02520427|474859690|FG014|Overall Study|Withdrawal by Subject|1|||
131884631|NCT02520427|474859691|FG015|Overall Study|Withdrawal by Subject|0|||
131884632|NCT02520427|474859692|FG016|Overall Study|Withdrawal by Subject|1|||
131884633|NCT02520427|474859693|FG017|Overall Study|Withdrawal by Subject|0|||
131884634|NCT02520427|474859694|FG018|Overall Study|Withdrawal by Subject|0|||
131884635|NCT02520427|474859695|FG019|Overall Study|Withdrawal by Subject|3|||
131884636|NCT02520427|474859696|FG020|Overall Study|Withdrawal by Subject|2|||
131884637|NCT02520427|474859697|FG021|Overall Study|Withdrawal by Subject|0|||
131884638|NCT02520427|474859698|FG022|Overall Study|Withdrawal by Subject|0|||
131884639|NCT02520427|474859699|FG023|Overall Study|Withdrawal by Subject|0|||
131884640|NCT02520427|474859700|FG024|Overall Study|Withdrawal by Subject|0|||
131884641|NCT02520427|474859701|FG025|Overall Study|Withdrawal by Subject|0|||
131884642|NCT02520427|474859676|FG000|Overall Study|Death|1|||
131884643|NCT02520427|474859677|FG001|Overall Study|Death|0|||
131884644|NCT02520427|474859678|FG002|Overall Study|Death|0|||
131884645|NCT02520427|474859679|FG003|Overall Study|Death|0|||
131884646|NCT02520427|474859680|FG004|Overall Study|Death|0|||
131884647|NCT02520427|474859681|FG005|Overall Study|Death|0|||
131884648|NCT02520427|474859682|FG006|Overall Study|Death|0|||
131884649|NCT02520427|474859683|FG007|Overall Study|Death|0|||
131884650|NCT02520427|474859684|FG008|Overall Study|Death|0|||
131884651|NCT02520427|474859685|FG009|Overall Study|Death|0|||
131884652|NCT02520427|474859686|FG010|Overall Study|Death|0|||
131884653|NCT02520427|474859687|FG011|Overall Study|Death|0|||
131884654|NCT02520427|474859688|FG012|Overall Study|Death|0|||
131884655|NCT02520427|474859689|FG013|Overall Study|Death|0|||
131884656|NCT02520427|474859690|FG014|Overall Study|Death|0|||
131884657|NCT02520427|474859691|FG015|Overall Study|Death|0|||
131884658|NCT02520427|474859692|FG016|Overall Study|Death|2|||
131884659|NCT02520427|474859693|FG017|Overall Study|Death|1|||
131884660|NCT02520427|474859694|FG018|Overall Study|Death|3|||
131884661|NCT02520427|474859695|FG019|Overall Study|Death|2|||
131884662|NCT02520427|474859696|FG020|Overall Study|Death|0|||
131884663|NCT02520427|474859697|FG021|Overall Study|Death|0|||
131884664|NCT02520427|474859698|FG022|Overall Study|Death|1|||
131884665|NCT02520427|474859699|FG023|Overall Study|Death|0|||
131884666|NCT02520427|474859700|FG024|Overall Study|Death|1|||
131884667|NCT02520427|474859701|FG025|Overall Study|Death|0|||
131884668|NCT00793624|474859702|FG000|Overall Study|Adverse Event|18|||
131884669|NCT00793624|474859703|FG001|Overall Study|Adverse Event|16|||
131884670|NCT00793624|474859704|FG002|Overall Study|Adverse Event|15|||
131884671|NCT00793624|474859705|FG003|Overall Study|Adverse Event|20|||
131884672|NCT00793624|474859702|FG000|Overall Study|Lost to Follow-up|2|||
131884673|NCT00793624|474859703|FG001|Overall Study|Lost to Follow-up|2|||
131884674|NCT00793624|474859704|FG002|Overall Study|Lost to Follow-up|4|||
131884675|NCT00793624|474859705|FG003|Overall Study|Lost to Follow-up|0|||
131884676|NCT00793624|474859702|FG000|Overall Study|Withdrawal by Subject|20|||
131884677|NCT00793624|474859703|FG001|Overall Study|Withdrawal by Subject|9|||
131884678|NCT00793624|474859704|FG002|Overall Study|Withdrawal by Subject|11|||
131884679|NCT00793624|474859705|FG003|Overall Study|Withdrawal by Subject|14|||
131884680|NCT00793624|474859702|FG000|Overall Study|Lack of Efficacy|9|||
131884681|NCT00793624|474859703|FG001|Overall Study|Lack of Efficacy|2|||
131884682|NCT00793624|474859704|FG002|Overall Study|Lack of Efficacy|1|||
131884683|NCT00793624|474859705|FG003|Overall Study|Lack of Efficacy|3|||
131884684|NCT00793624|474859702|FG000|Overall Study|Non compliance with protocol|2|||
131884685|NCT00793624|474859703|FG001|Overall Study|Non compliance with protocol|3|||
131884686|NCT00793624|474859704|FG002|Overall Study|Non compliance with protocol|2|||
131884687|NCT00793624|474859705|FG003|Overall Study|Non compliance with protocol|3|||
131884688|NCT00793624|474859702|FG000|Overall Study|Other reason not described above|6|||
131884689|NCT00793624|474859703|FG001|Overall Study|Other reason not described above|4|||
131884690|NCT00793624|474859704|FG002|Overall Study|Other reason not described above|6|||
131884691|NCT00793624|474859705|FG003|Overall Study|Other reason not described above|3|||
131884692|NCT02987972|474859706|FG000|Overall Study|Adverse Event|1|||
131884693|NCT02987972|474859707|FG001|Overall Study|Adverse Event|1|||
131884694|NCT02987972|474859708|FG002|Overall Study|Adverse Event|0|||
131884695|NCT02987972|474859706|FG000|Overall Study|Death|1|||
131884696|NCT02987972|474859707|FG001|Overall Study|Death|0|||
131884697|NCT02987972|474859708|FG002|Overall Study|Death|0|||
131884698|NCT02987972|474859706|FG000|Overall Study|Lack of Efficacy|9|||
131884699|NCT02987972|474859707|FG001|Overall Study|Lack of Efficacy|12|||
131884700|NCT02987972|474859708|FG002|Overall Study|Lack of Efficacy|12|||
131884701|NCT02987972|474859706|FG000|Overall Study|Lost to Follow-up|7|||
131884702|NCT02987972|474859707|FG001|Overall Study|Lost to Follow-up|8|||
131884703|NCT02987972|474859708|FG002|Overall Study|Lost to Follow-up|4|||
131884704|NCT02987972|474859706|FG000|Overall Study|Physician Decision|1|||
131884705|NCT02987972|474859707|FG001|Overall Study|Physician Decision|6|||
131884706|NCT02987972|474859708|FG002|Overall Study|Physician Decision|0|||
131884707|NCT02987972|474859706|FG000|Overall Study|Protocol Violation|2|||
131884708|NCT02987972|474859707|FG001|Overall Study|Protocol Violation|1|||
131884709|NCT02987972|474859708|FG002|Overall Study|Protocol Violation|5|||
131884710|NCT02987972|474859706|FG000|Overall Study|Withdrawal by Subject|22|||
131884711|NCT02987972|474859707|FG001|Overall Study|Withdrawal by Subject|17|||
131884712|NCT02987972|474859708|FG002|Overall Study|Withdrawal by Subject|21|||
131884713|NCT00073983|474859711|FG000|Overall Study|not evaluable|1|||
131884714|NCT03800836|474859712|FG000|Overall Study|Other|2|||
131884715|NCT03800836|474859713|FG001|Overall Study|Other|1|||
131884716|NCT03800836|474859714|FG002|Overall Study|Other|0|||
131884717|NCT03800836|474859715|FG003|Overall Study|Other|2|||
131884718|NCT03800836|474859716|FG004|Overall Study|Other|0|||
131884719|NCT03800836|474859717|FG005|Overall Study|Other|1|||
131884720|NCT03800836|474859712|FG000|Overall Study|Lost to Follow-up|2|||
131884721|NCT03800836|474859713|FG001|Overall Study|Lost to Follow-up|0|||
131884722|NCT03800836|474859714|FG002|Overall Study|Lost to Follow-up|1|||
131884723|NCT03800836|474859715|FG003|Overall Study|Lost to Follow-up|1|||
131884724|NCT03800836|474859716|FG004|Overall Study|Lost to Follow-up|3|||
131884725|NCT03800836|474859717|FG005|Overall Study|Lost to Follow-up|0|||
131884726|NCT03800836|474859712|FG000|Overall Study|Withdrawal by Subject|1|||
131884727|NCT03800836|474859713|FG001|Overall Study|Withdrawal by Subject|0|||
131884728|NCT03800836|474859714|FG002|Overall Study|Withdrawal by Subject|0|||
131884729|NCT03800836|474859715|FG003|Overall Study|Withdrawal by Subject|0|||
131884730|NCT03800836|474859716|FG004|Overall Study|Withdrawal by Subject|0|||
131884731|NCT03800836|474859717|FG005|Overall Study|Withdrawal by Subject|0|||
131884732|NCT03800836|474859712|FG000|Overall Study|Physician Decision|31|||
131884733|NCT03800836|474859713|FG001|Overall Study|Physician Decision|3|||
131884734|NCT03800836|474859714|FG002|Overall Study|Physician Decision|6|||
131884735|NCT03800836|474859715|FG003|Overall Study|Physician Decision|4|||
131884736|NCT03800836|474859716|FG004|Overall Study|Physician Decision|4|||
131884737|NCT03800836|474859717|FG005|Overall Study|Physician Decision|5|||
131884738|NCT03800836|474859712|FG000|Overall Study|Death|34|||
131884739|NCT03800836|474859713|FG001|Overall Study|Death|16|||
131884740|NCT03800836|474859714|FG002|Overall Study|Death|5|||
131884741|NCT03800836|474859715|FG003|Overall Study|Death|5|||
131884742|NCT03800836|474859716|FG004|Overall Study|Death|10|||
131884743|NCT03800836|474859717|FG005|Overall Study|Death|0|||
131884744|NCT03800836|474859712|FG000|Overall Study|Symptomatic Deterioration|1|||
131884745|NCT03800836|474859713|FG001|Overall Study|Symptomatic Deterioration|0|||
131884746|NCT03800836|474859714|FG002|Overall Study|Symptomatic Deterioration|1|||
131884747|NCT03800836|474859715|FG003|Overall Study|Symptomatic Deterioration|0|||
131884748|NCT03800836|474859716|FG004|Overall Study|Symptomatic Deterioration|0|||
131884749|NCT03800836|474859717|FG005|Overall Study|Symptomatic Deterioration|0|||
131884750|NCT01573767|474860825|FG000|Overall Study|Adverse Event|0|||
131884751|NCT01573767|474860826|FG001|Overall Study|Adverse Event|1|||
131884752|NCT01573767|474860827|FG002|Overall Study|Adverse Event|0|||
131884753|NCT01573767|474860828|FG003|Overall Study|Adverse Event|1|||
131884754|NCT01573767|474860825|FG000|Overall Study|Lack of Efficacy|18|||
131884755|NCT01573767|474860826|FG001|Overall Study|Lack of Efficacy|15|||
131884756|NCT01573767|474860827|FG002|Overall Study|Lack of Efficacy|12|||
131884757|NCT01573767|474860828|FG003|Overall Study|Lack of Efficacy|17|||
131884758|NCT01573767|474860825|FG000|Overall Study|Protocol Violation|3|||
131884759|NCT01573767|474860826|FG001|Overall Study|Protocol Violation|1|||
131884760|NCT01573767|474860827|FG002|Overall Study|Protocol Violation|1|||
131884761|NCT01573767|474860828|FG003|Overall Study|Protocol Violation|3|||
131884762|NCT01573767|474860825|FG000|Overall Study|Lost to Follow-up|0|||
131884763|NCT01573767|474860826|FG001|Overall Study|Lost to Follow-up|1|||
131884764|NCT01573767|474860827|FG002|Overall Study|Lost to Follow-up|1|||
131884765|NCT01573767|474860828|FG003|Overall Study|Lost to Follow-up|1|||
131884766|NCT01573767|474860825|FG000|Overall Study|Physician Decision|1|||
131884767|NCT01573767|474860826|FG001|Overall Study|Physician Decision|2|||
131884768|NCT01573767|474860827|FG002|Overall Study|Physician Decision|0|||
131884769|NCT01573767|474860828|FG003|Overall Study|Physician Decision|2|||
131884770|NCT01573767|474860825|FG000|Overall Study|Withdrawal by Subject|0|||
131884771|NCT01573767|474860826|FG001|Overall Study|Withdrawal by Subject|1|||
131884772|NCT01573767|474860827|FG002|Overall Study|Withdrawal by Subject|0|||
131884773|NCT01573767|474860828|FG003|Overall Study|Withdrawal by Subject|0|||
131884774|NCT01371877|474860831|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
131884775|NCT01371877|474860832|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
131884776|NCT02368210|474860833|FG000|Overall Study|Withdrawal by Subject|1|||
131884777|NCT02368210|474860834|FG001|Overall Study|Withdrawal by Subject|0|||
131884778|NCT02368210|474860833|FG000|Overall Study|Adverse Event|0|||
131884779|NCT02368210|474860834|FG001|Overall Study|Adverse Event|1|||
131884780|NCT00078949|474860835|FG000|Overall Study|No treated|4|||
131884781|NCT00078949|474860836|FG001|Overall Study|No treated|5|||
131884782|NCT00078949|474860837|FG002|Overall Study|No treated|3|||
131884783|NCT00078949|474860838|FG003|Overall Study|No treated|3|||
131884784|NCT01143064|474860839|FG000|Overall Study|Death|109|||
131884785|NCT01143064|474860840|FG001|Overall Study|Death|91|||
131884786|NCT01143064|474860839|FG000|Overall Study|Adverse Event|0|||
131884787|NCT01143064|474860840|FG001|Overall Study|Adverse Event|1|||
131884788|NCT01143064|474860839|FG000|Overall Study|Withdrawal by Subject|7|||
131884789|NCT01143064|474860840|FG001|Overall Study|Withdrawal by Subject|5|||
131884790|NCT01143064|474860839|FG000|Overall Study|Lost to Follow-up|17|||
131884791|NCT01143064|474860840|FG001|Overall Study|Lost to Follow-up|14|||
131884792|NCT01143064|474860839|FG000|Overall Study|Physician Decision|0|||
131884793|NCT01143064|474860840|FG001|Overall Study|Physician Decision|4|||
131884794|NCT01565668|474860843|FG000|Overall Study|Death|2|||
131884795|NCT01565668|474860844|FG001|Overall Study|Death|1|||
131884796|NCT01565668|474860843|FG000|Overall Study|Lack of Efficacy|4|||
131884797|NCT01565668|474860844|FG001|Overall Study|Lack of Efficacy|2|||
131884798|NCT01565668|474860843|FG000|Overall Study|Participant went on Hospice Care|1|||
131884799|NCT01565668|474860844|FG001|Overall Study|Participant went on Hospice Care|0|||
131884800|NCT01565668|474860843|FG000|Overall Study|Adverse Event|6|||
131884801|NCT01565668|474860844|FG001|Overall Study|Adverse Event|1|||
131884802|NCT01565668|474860843|FG000|Overall Study|Randomized, but never received drug|0|||
131884803|NCT01565668|474860844|FG001|Overall Study|Randomized, but never received drug|2|||
131884804|NCT01565668|474860843|FG000|Overall Study|Progressive disease|13|||
131884805|NCT01565668|474860844|FG001|Overall Study|Progressive disease|14|||
131884806|NCT01565668|474860843|FG000|Overall Study|Withdrawal by Subject|1|||
131884807|NCT01565668|474860844|FG001|Overall Study|Withdrawal by Subject|3|||
131884808|NCT01565668|474860843|FG000|Overall Study|HSCT Transplant|11|||
131884809|NCT01565668|474860844|FG001|Overall Study|HSCT Transplant|15|||
131884810|NCT03747302|474860845|FG000|Overall Study|Withdrawal by Subject|1|||
131884811|NCT03747302|474860846|FG001|Overall Study|Withdrawal by Subject|2|||
131884812|NCT03448939|474860849|FG000|Overall Study|Adverse Event|5|||
131884813|NCT03448939|474860850|FG001|Overall Study|Adverse Event|1|||
131884814|NCT03448939|474860849|FG000|Overall Study|Lost to Follow-up|6|||
131884815|NCT03448939|474860850|FG001|Overall Study|Lost to Follow-up|6|||
131884816|NCT03448939|474860849|FG000|Overall Study|Pregnancy|1|||
131884817|NCT03448939|474860850|FG001|Overall Study|Pregnancy|1|||
131884818|NCT03448939|474860849|FG000|Overall Study|Withdrawal by Subject|9|||
131884819|NCT03448939|474860850|FG001|Overall Study|Withdrawal by Subject|3|||
131884820|NCT00662558|474860854|FG000|Overall Study|Adverse Event|21|||
131884821|NCT00662558|474860855|FG001|Overall Study|Adverse Event|59|||
131884822|NCT00662558|474860854|FG000|Overall Study|Lack of Efficacy|4|||
131884823|NCT00662558|474860855|FG001|Overall Study|Lack of Efficacy|7|||
131884824|NCT00662558|474860854|FG000|Overall Study|Lost to Follow-up|13|||
131884825|NCT00662558|474860855|FG001|Overall Study|Lost to Follow-up|10|||
131884826|NCT00662558|474860854|FG000|Overall Study|Other|9|||
131884827|NCT00662558|474860855|FG001|Overall Study|Other|14|||
131884828|NCT00662558|474860854|FG000|Overall Study|Withdrawal by Subject|7|||
131884829|NCT00662558|474860855|FG001|Overall Study|Withdrawal by Subject|12|||
131884830|NCT00662558|474860854|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
131884831|NCT00662558|474860855|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
131884832|NCT00980018|474860858|FG000|Overall Study|Adverse Event|8|||
131884833|NCT00980018|474860858|FG000|Overall Study|Patient withdrew consent|3|||
131884834|NCT00980018|474860858|FG000|Overall Study|Lost to Follow-up|1|||
131884835|NCT00087126|474860859|FG000|Overall Study|Ineligible - second primary|1|||
131884836|NCT00087126|474860859|FG000|Overall Study|Never treated|1|||
131884837|NCT01832818|474860860|FG000|Overall Study|Lost to Follow-up|6|||
131884838|NCT00934856|474860863|FG000|Feasibility Part|Progressive disease|4|||
131884839|NCT00934856|474860864|FG001|Feasibility Part|Progressive disease|4|||
131884840|NCT00934856|474860865|FG002|Feasibility Part|Progressive disease|2|||
131884841|NCT00934856|474860866|FG003|Feasibility Part|Progressive disease|3|||
131884842|NCT00934856|474860867|FG004|Feasibility Part|Progressive disease|0|||
131884843|NCT00934856|474860868|FG005|Feasibility Part|Progressive disease|0|||
131884844|NCT00934856|474860863|FG000|Feasibility Part|Physician Decision|0|||
131884845|NCT00934856|474860864|FG001|Feasibility Part|Physician Decision|0|||
131884846|NCT00934856|474860865|FG002|Feasibility Part|Physician Decision|1|||
131884847|NCT00934856|474860866|FG003|Feasibility Part|Physician Decision|0|||
131884848|NCT00934856|474860867|FG004|Feasibility Part|Physician Decision|0|||
131884849|NCT00934856|474860868|FG005|Feasibility Part|Physician Decision|0|||
131884850|NCT00934856|474860863|FG000|Feasibility Part|Adverse Event|1|||
131884851|NCT00934856|474860864|FG001|Feasibility Part|Adverse Event|1|||
131884852|NCT00934856|474860865|FG002|Feasibility Part|Adverse Event|0|||
131884853|NCT00934856|474860866|FG003|Feasibility Part|Adverse Event|1|||
131884854|NCT00934856|474860867|FG004|Feasibility Part|Adverse Event|0|||
131884855|NCT00934856|474860868|FG005|Feasibility Part|Adverse Event|2|||
131884856|NCT00934856|474860863|FG000|Feasibility Part|Withdrawal by Subject|0|||
131884857|NCT00934856|474860864|FG001|Feasibility Part|Withdrawal by Subject|0|||
131884858|NCT00934856|474860865|FG002|Feasibility Part|Withdrawal by Subject|0|||
131884859|NCT00934856|474860866|FG003|Feasibility Part|Withdrawal by Subject|1|||
131884860|NCT00934856|474860867|FG004|Feasibility Part|Withdrawal by Subject|0|||
131884861|NCT00934856|474860868|FG005|Feasibility Part|Withdrawal by Subject|1|||
131884862|NCT00934856|474860863|FG000|Extension Part|Adverse Event|0|||
131884863|NCT00934856|474860864|FG001|Extension Part|Adverse Event|0|||
131884864|NCT00934856|474860865|FG002|Extension Part|Adverse Event|0|||
131884865|NCT00934856|474860866|FG003|Extension Part|Adverse Event|1|||
131884866|NCT00934856|474860867|FG004|Extension Part|Adverse Event|4|||
131884867|NCT00934856|474860868|FG005|Extension Part|Adverse Event|4|||
131884868|NCT00934856|474860863|FG000|Extension Part|Progressive disease|0|||
131884869|NCT00934856|474860864|FG001|Extension Part|Progressive disease|0|||
131884870|NCT00934856|474860865|FG002|Extension Part|Progressive disease|0|||
131884871|NCT00934856|474860866|FG003|Extension Part|Progressive disease|1|||
131884872|NCT00934856|474860867|FG004|Extension Part|Progressive disease|0|||
131884873|NCT00934856|474860868|FG005|Extension Part|Progressive disease|0|||
131884874|NCT00934856|474860863|FG000|Extension Part|Non-compliance with drug|0|||
131884875|NCT00934856|474860864|FG001|Extension Part|Non-compliance with drug|0|||
131884876|NCT00934856|474860865|FG002|Extension Part|Non-compliance with drug|0|||
131884877|NCT00934856|474860866|FG003|Extension Part|Non-compliance with drug|0|||
131884878|NCT00934856|474860867|FG004|Extension Part|Non-compliance with drug|0|||
131884879|NCT00934856|474860868|FG005|Extension Part|Non-compliance with drug|1|||
131884880|NCT01256385|474860873|FG000|Overall Study|Physician Decision|1|||
131884881|NCT01256385|474860874|FG001|Overall Study|Physician Decision|1|||
131884882|NCT01256385|474860873|FG000|Overall Study|Withdrawal by Subject|2|||
131884883|NCT01256385|474860874|FG001|Overall Study|Withdrawal by Subject|2|||
131884884|NCT00401960|474860877|FG000|Overall Study|Lost to Follow-up|3|||
131884885|NCT00401960|474860878|FG001|Overall Study|Lost to Follow-up|0|||
131884886|NCT00401960|474860877|FG000|Overall Study|Death|2|||
131884887|NCT00401960|474860878|FG001|Overall Study|Death|0|||
131884888|NCT02649426|474860879|FG000|Overall Study|Follow-up on going|1|||
131884889|NCT02649426|474860880|FG001|Overall Study|Follow-up on going|26|||
131884890|NCT02649426|474860881|FG002|Overall Study|Follow-up on going|28|||
131884891|NCT02649426|474860882|FG003|Overall Study|Follow-up on going|31|||
131884892|NCT01606202|474860883|FG000|Overall Study|Adverse Event|5|||
131884893|NCT01606202|474860884|FG001|Overall Study|Adverse Event|0|||
131884894|NCT01606202|474860883|FG000|Overall Study|Withdrawal by Subject|2|||
131884895|NCT01606202|474860884|FG001|Overall Study|Withdrawal by Subject|1|||
131884896|NCT01606202|474860883|FG000|Overall Study|Personal problems|0|||
131884897|NCT01606202|474860884|FG001|Overall Study|Personal problems|1|||
131884898|NCT01606202|474860883|FG000|Overall Study|Problems with administration|0|||
131884899|NCT01606202|474860884|FG001|Overall Study|Problems with administration|1|||
131884900|NCT02584959|474860885|FG000|Period 1|Withdrawn from study|3|||
131884901|NCT02584959|474860886|FG001|Period 1|Withdrawn from study|4|||
131884902|NCT02584959|474860887|FG002|Period 1|Withdrawn from study|0|||
131884903|NCT02584959|474860885|FG000|Period 2|Withdrawn from study|6|||
131884904|NCT02584959|474860886|FG001|Period 2|Withdrawn from study|1|||
131884905|NCT02584959|474860887|FG002|Period 2|Withdrawn from study|2|||
131884906|NCT00195494|474860892|FG000|Year 1|Adverse Event|0|||
131884907|NCT00195494|474860893|FG001|Year 1|Adverse Event|0|||
131884908|NCT00195494|474860894|FG002|Year 1|Adverse Event|0|||
131884909|NCT00195494|474860895|FG003|Year 1|Adverse Event|0|||
131884910|NCT00195494|474860896|FG004|Year 1|Adverse Event|34|||
131884911|NCT00195494|474860897|FG005|Year 1|Adverse Event|27|||
131884912|NCT00195494|474860892|FG000|Year 1|System Toxicity|0|||
131884913|NCT00195494|474860893|FG001|Year 1|System Toxicity|0|||
131884914|NCT00195494|474860894|FG002|Year 1|System Toxicity|0|||
131884915|NCT00195494|474860895|FG003|Year 1|System Toxicity|0|||
131884916|NCT00195494|474860896|FG004|Year 1|System Toxicity|0|||
131884917|NCT00195494|474860897|FG005|Year 1|System Toxicity|1|||
131884918|NCT00195494|474860892|FG000|Year 1|Lack of Efficacy|0|||
131884919|NCT00195494|474860893|FG001|Year 1|Lack of Efficacy|0|||
131884920|NCT00195494|474860894|FG002|Year 1|Lack of Efficacy|0|||
131884921|NCT00195494|474860895|FG003|Year 1|Lack of Efficacy|0|||
131884922|NCT00195494|474860896|FG004|Year 1|Lack of Efficacy|24|||
131884923|NCT00195494|474860897|FG005|Year 1|Lack of Efficacy|9|||
131884924|NCT00195494|474860892|FG000|Year 1|Compliance|0|||
131884925|NCT00195494|474860893|FG001|Year 1|Compliance|0|||
131884926|NCT00195494|474860894|FG002|Year 1|Compliance|0|||
131884927|NCT00195494|474860895|FG003|Year 1|Compliance|0|||
131884928|NCT00195494|474860896|FG004|Year 1|Compliance|5|||
131884929|NCT00195494|474860897|FG005|Year 1|Compliance|1|||
131884930|NCT00195494|474860892|FG000|Year 1|Lost to Follow-up|0|||
131884931|NCT00195494|474860893|FG001|Year 1|Lost to Follow-up|0|||
131884932|NCT00195494|474860894|FG002|Year 1|Lost to Follow-up|0|||
131884933|NCT00195494|474860895|FG003|Year 1|Lost to Follow-up|0|||
131884934|NCT00195494|474860896|FG004|Year 1|Lost to Follow-up|1|||
131884935|NCT00195494|474860897|FG005|Year 1|Lost to Follow-up|0|||
131884936|NCT00195494|474860892|FG000|Year 1|Missed >4 consecutive doses|0|||
131884937|NCT00195494|474860893|FG001|Year 1|Missed >4 consecutive doses|0|||
131884938|NCT00195494|474860894|FG002|Year 1|Missed >4 consecutive doses|0|||
131884939|NCT00195494|474860895|FG003|Year 1|Missed >4 consecutive doses|0|||
131884940|NCT00195494|474860896|FG004|Year 1|Missed >4 consecutive doses|3|||
131884941|NCT00195494|474860897|FG005|Year 1|Missed >4 consecutive doses|2|||
131884942|NCT00195494|474860892|FG000|Year 1|Protocol deviation|0|||
131884943|NCT00195494|474860893|FG001|Year 1|Protocol deviation|0|||
131884944|NCT00195494|474860894|FG002|Year 1|Protocol deviation|0|||
131884945|NCT00195494|474860895|FG003|Year 1|Protocol deviation|0|||
131884946|NCT00195494|474860896|FG004|Year 1|Protocol deviation|2|||
131884947|NCT00195494|474860897|FG005|Year 1|Protocol deviation|3|||
131884948|NCT00195494|474860892|FG000|Year 1|Physician Decision|0|||
131884949|NCT00195494|474860893|FG001|Year 1|Physician Decision|0|||
131884950|NCT00195494|474860894|FG002|Year 1|Physician Decision|0|||
131884951|NCT00195494|474860895|FG003|Year 1|Physician Decision|0|||
131884952|NCT00195494|474860896|FG004|Year 1|Physician Decision|1|||
131884953|NCT00195494|474860897|FG005|Year 1|Physician Decision|0|||
131884954|NCT00195494|474860892|FG000|Year 1|Withdrawal by Subject|0|||
131884955|NCT00195494|474860893|FG001|Year 1|Withdrawal by Subject|0|||
131884956|NCT00195494|474860894|FG002|Year 1|Withdrawal by Subject|0|||
131884957|NCT00195494|474860895|FG003|Year 1|Withdrawal by Subject|0|||
131884958|NCT00195494|474860896|FG004|Year 1|Withdrawal by Subject|8|||
131884959|NCT00195494|474860897|FG005|Year 1|Withdrawal by Subject|9|||
131884960|NCT00195494|474860892|FG000|Year 1|Protocol Violation|0|||
131884961|NCT00195494|474860893|FG001|Year 1|Protocol Violation|0|||
131884962|NCT00195494|474860894|FG002|Year 1|Protocol Violation|0|||
131884963|NCT00195494|474860895|FG003|Year 1|Protocol Violation|0|||
131884964|NCT00195494|474860896|FG004|Year 1|Protocol Violation|1|||
131884965|NCT00195494|474860897|FG005|Year 1|Protocol Violation|1|||
131884966|NCT00195494|474860892|FG000|Year 2|Adverse Event|3|||
131884967|NCT00195494|474860893|FG001|Year 2|Adverse Event|7|||
131884968|NCT00195494|474860894|FG002|Year 2|Adverse Event|5|||
131884969|NCT00195494|474860895|FG003|Year 2|Adverse Event|9|||
131884970|NCT00195494|474860896|FG004|Year 2|Adverse Event|0|||
131884971|NCT00195494|474860897|FG005|Year 2|Adverse Event|0|||
131884972|NCT00195494|474860892|FG000|Year 2|Lack of Efficacy|0|||
131884973|NCT00195494|474860893|FG001|Year 2|Lack of Efficacy|1|||
131884974|NCT00195494|474860894|FG002|Year 2|Lack of Efficacy|7|||
131884975|NCT00195494|474860895|FG003|Year 2|Lack of Efficacy|7|||
131884976|NCT00195494|474860896|FG004|Year 2|Lack of Efficacy|0|||
131884977|NCT00195494|474860897|FG005|Year 2|Lack of Efficacy|0|||
131884978|NCT00195494|474860892|FG000|Year 2|Compliance|1|||
131884979|NCT00195494|474860893|FG001|Year 2|Compliance|0|||
131884980|NCT00195494|474860894|FG002|Year 2|Compliance|0|||
131884981|NCT00195494|474860895|FG003|Year 2|Compliance|2|||
131547192|NCT00386022|473626337|FG000|Plus Estrogen|Adverse Event|0|||
131884982|NCT00195494|474860896|FG004|Year 2|Compliance|0|||
131884983|NCT00195494|474860897|FG005|Year 2|Compliance|0|||
131884984|NCT00195494|474860892|FG000|Year 2|Lost to Follow-up|0|||
131884985|NCT00195494|474860893|FG001|Year 2|Lost to Follow-up|0|||
131884986|NCT00195494|474860894|FG002|Year 2|Lost to Follow-up|1|||
131884987|NCT00195494|474860895|FG003|Year 2|Lost to Follow-up|1|||
131884988|NCT00195494|474860896|FG004|Year 2|Lost to Follow-up|0|||
131884989|NCT00195494|474860897|FG005|Year 2|Lost to Follow-up|0|||
131884990|NCT00195494|474860892|FG000|Year 2|Missed >4 consecutive doses|1|||
131884991|NCT00195494|474860893|FG001|Year 2|Missed >4 consecutive doses|1|||
131884992|NCT00195494|474860894|FG002|Year 2|Missed >4 consecutive doses|1|||
131884993|NCT00195494|474860895|FG003|Year 2|Missed >4 consecutive doses|0|||
131884994|NCT00195494|474860896|FG004|Year 2|Missed >4 consecutive doses|0|||
131884995|NCT00195494|474860897|FG005|Year 2|Missed >4 consecutive doses|0|||
131884996|NCT00195494|474860892|FG000|Year 2|Protocol deviation|0|||
131884997|NCT00195494|474860893|FG001|Year 2|Protocol deviation|1|||
131884998|NCT00195494|474860894|FG002|Year 2|Protocol deviation|0|||
131884999|NCT00195494|474860895|FG003|Year 2|Protocol deviation|0|||
131885000|NCT00195494|474860896|FG004|Year 2|Protocol deviation|0|||
131885001|NCT00195494|474860897|FG005|Year 2|Protocol deviation|0|||
131885002|NCT00195494|474860892|FG000|Year 2|Physician Decision|1|||
131885003|NCT00195494|474860893|FG001|Year 2|Physician Decision|1|||
131885004|NCT00195494|474860894|FG002|Year 2|Physician Decision|0|||
131547193|NCT00386022|473626338|FG001|Plus Estrogen|Adverse Event|1|||
131547194|NCT00031486|473626345|FG000|Overall Study|Adverse Event|1|||
131547195|NCT00031486|473626346|FG001|Overall Study|Adverse Event|0|||
131547196|NCT00031486|473626345|FG000|Overall Study|Lost to Follow-up|0|||
131885005|NCT00195494|474860895|FG003|Year 2|Physician Decision|0|||
131885006|NCT00195494|474860896|FG004|Year 2|Physician Decision|0|||
131885007|NCT00195494|474860897|FG005|Year 2|Physician Decision|0|||
131885008|NCT00195494|474860892|FG000|Year 2|Withdrawal by Subject|1|||
131885009|NCT00195494|474860893|FG001|Year 2|Withdrawal by Subject|5|||
131885010|NCT00195494|474860894|FG002|Year 2|Withdrawal by Subject|4|||
131885011|NCT00195494|474860895|FG003|Year 2|Withdrawal by Subject|3|||
131885012|NCT00195494|474860896|FG004|Year 2|Withdrawal by Subject|0|||
131885013|NCT00195494|474860897|FG005|Year 2|Withdrawal by Subject|0|||
131885014|NCT00195494|474860892|FG000|Year 2|System toxicity|0|||
131885015|NCT00195494|474860893|FG001|Year 2|System toxicity|0|||
131885016|NCT00195494|474860894|FG002|Year 2|System toxicity|0|||
131885017|NCT00195494|474860895|FG003|Year 2|System toxicity|1|||
131885018|NCT00195494|474860896|FG004|Year 2|System toxicity|0|||
131885019|NCT00195494|474860897|FG005|Year 2|System toxicity|0|||
131885020|NCT02020512|474860898|FG000|Overall Study|Adverse Event|1|||
131885021|NCT02020512|474860898|FG000|Overall Study|Lost to Follow-up|3|||
131885022|NCT02020512|474860898|FG000|Overall Study|Protocol Violation|4|||
131885023|NCT00422422|474860902|FG000|Overall Study|Lack of Efficacy|1|||
131885024|NCT00422422|474860902|FG000|Overall Study|Protocol Violation|1|||
131885025|NCT00422422|474860902|FG000|Overall Study|Withdrawal by Subject|2|||
131885026|NCT00422422|474860902|FG000|Overall Study|SAE, non-fatal|1|||
131885027|NCT00422422|474860902|FG000|Overall Study|AE, non-serious non-fatal|5|||
131885028|NCT03802565|474860913|FG000|Overall Study|Adverse Event|0|||
131885029|NCT03802565|474860914|FG001|Overall Study|Adverse Event|1|||
131885030|NCT03802565|474860915|FG002|Overall Study|Adverse Event|2|||
131885031|NCT03802565|474860916|FG003|Overall Study|Adverse Event|1|||
131885032|NCT03802565|474860917|FG004|Overall Study|Adverse Event|1|||
131885033|NCT03802565|474860913|FG000|Overall Study|Withdrawal by Subject|2|||
131885034|NCT03802565|474860914|FG001|Overall Study|Withdrawal by Subject|2|||
131885035|NCT03802565|474860915|FG002|Overall Study|Withdrawal by Subject|2|||
131885036|NCT03802565|474860916|FG003|Overall Study|Withdrawal by Subject|0|||
131885037|NCT03802565|474860917|FG004|Overall Study|Withdrawal by Subject|1|||
131885038|NCT03802565|474860913|FG000|Overall Study|Protocol Violation|2|||
131885039|NCT03802565|474860914|FG001|Overall Study|Protocol Violation|1|||
131885040|NCT03802565|474860915|FG002|Overall Study|Protocol Violation|4|||
131885041|NCT03802565|474860916|FG003|Overall Study|Protocol Violation|5|||
131885042|NCT03802565|474860917|FG004|Overall Study|Protocol Violation|1|||
131885043|NCT03802565|474860913|FG000|Overall Study|Lost to Follow-up|0|||
131885044|NCT03802565|474860914|FG001|Overall Study|Lost to Follow-up|0|||
131885045|NCT03802565|474860915|FG002|Overall Study|Lost to Follow-up|1|||
131885046|NCT03802565|474860916|FG003|Overall Study|Lost to Follow-up|0|||
131885047|NCT03802565|474860917|FG004|Overall Study|Lost to Follow-up|0|||
131885048|NCT03802565|474860913|FG000|Overall Study|Subjects Related to Each Other|1|||
131885049|NCT03802565|474860914|FG001|Overall Study|Subjects Related to Each Other|0|||
131885050|NCT03802565|474860915|FG002|Overall Study|Subjects Related to Each Other|0|||
131885051|NCT03802565|474860916|FG003|Overall Study|Subjects Related to Each Other|2|||
131885052|NCT03802565|474860917|FG004|Overall Study|Subjects Related to Each Other|1|||
131885053|NCT03802565|474860913|FG000|Overall Study|Elevated Enzymes|0|||
131885054|NCT03802565|474860914|FG001|Overall Study|Elevated Enzymes|0|||
131885055|NCT03802565|474860915|FG002|Overall Study|Elevated Enzymes|0|||
131885056|NCT03802565|474860916|FG003|Overall Study|Elevated Enzymes|0|||
131885057|NCT03802565|474860917|FG004|Overall Study|Elevated Enzymes|2|||
131885058|NCT05020899|474860918|FG000|8 Week Follow-up|Lost to Follow-up|3|||
131885059|NCT05020899|474860919|FG001|8 Week Follow-up|Lost to Follow-up|6|||
131885060|NCT05020899|474860918|FG000|12 Week Follow-up|Lost to Follow-up|1|||
131885061|NCT05020899|474860919|FG001|12 Week Follow-up|Lost to Follow-up|0|||
131885062|NCT05020899|474860918|FG000|12 Week Follow-up|Death|0|||
131885063|NCT05020899|474860919|FG001|12 Week Follow-up|Death|1|||
131885064|NCT02124759|474860920|FG000|Overall Study|Withdrawal by Subject|3|||
131885065|NCT02124759|474860921|FG001|Overall Study|Withdrawal by Subject|1|||
131885066|NCT02124759|474860922|FG002|Overall Study|Withdrawal by Subject|1|||
131885067|NCT02124759|474860920|FG000|Overall Study|Screen Fail|2|||
131885068|NCT02124759|474860921|FG001|Overall Study|Screen Fail|2|||
131885069|NCT02124759|474860922|FG002|Overall Study|Screen Fail|3|||
131885070|NCT01785849|474860925|FG000|Overall Study|Death|7|||
131885071|NCT01785849|474860926|FG001|Overall Study|Death|9|||
131547197|NCT00031486|473626346|FG001|Overall Study|Lost to Follow-up|1|||
131885072|NCT01785849|474860925|FG000|Overall Study|Protocol Specified Criteria|29|||
131885073|NCT01785849|474860926|FG001|Overall Study|Protocol Specified Criteria|1|||
131885074|NCT01785849|474860925|FG000|Overall Study|Withdrawal by Subject|15|||
131885075|NCT01785849|474860926|FG001|Overall Study|Withdrawal by Subject|12|||
131885076|NCT01785849|474860925|FG000|Overall Study|Sponsor Decision|0|||
131885077|NCT01785849|474860926|FG001|Overall Study|Sponsor Decision|1|||
131885078|NCT01785849|474860925|FG000|Overall Study|Lost to Follow-up|10|||
131885079|NCT01785849|474860926|FG001|Overall Study|Lost to Follow-up|11|||
131885080|NCT04769739|474860927|FG000|Overall Study|Colorectal cancer obstruction|2|||
131885081|NCT04769739|474860928|FG001|Overall Study|Colorectal cancer obstruction|0|||
131885082|NCT04769739|474860929|FG002|Overall Study|Colorectal cancer obstruction|0|||
131885083|NCT04769739|474860930|FG003|Overall Study|Colorectal cancer obstruction|0|||
131885084|NCT04769739|474860927|FG000|Overall Study|Failed cecal intubation|1|||
131885085|NCT04769739|474860928|FG001|Overall Study|Failed cecal intubation|0|||
131885086|NCT04769739|474860929|FG002|Overall Study|Failed cecal intubation|0|||
131885087|NCT04769739|474860930|FG003|Overall Study|Failed cecal intubation|1|||
131885088|NCT04769739|474860927|FG000|Overall Study|Poor bowel preparation|0|||
131885089|NCT04769739|474860928|FG001|Overall Study|Poor bowel preparation|0|||
131885090|NCT04769739|474860929|FG002|Overall Study|Poor bowel preparation|0|||
131885091|NCT04769739|474860930|FG003|Overall Study|Poor bowel preparation|1|||
131885092|NCT04249622|474860931|FG000|Overall Study|Withdrawal by Subject|1|||
131885093|NCT04249622|474860932|FG001|Overall Study|Withdrawal by Subject|1|||
131885094|NCT04249622|474860931|FG000|Overall Study|Alternative therapy|1|||
131885095|NCT04249622|474860932|FG001|Overall Study|Alternative therapy|0|||
131885096|NCT04249622|474860931|FG000|Overall Study|Discontinuation of pertuzumab|1|||
131885097|NCT04249622|474860932|FG001|Overall Study|Discontinuation of pertuzumab|0|||
131885098|NCT03689543|474860933|FG000|Overall Study|Adverse Event|0|||
131885099|NCT03689543|474860934|FG001|Overall Study|Adverse Event|0|||
131885100|NCT03689543|474860935|FG002|Overall Study|Adverse Event|1|||
131885101|NCT00932451|474860946|FG000|Overall Study|Withdrawal by Subject|69|||
131885102|NCT00932451|474860946|FG000|Overall Study|Lost to Follow-up|22|||
131885103|NCT00932451|474860946|FG000|Overall Study|Death|726|||
131885104|NCT00932451|474860946|FG000|Overall Study|Other reasons|5|||
131885105|NCT02968433|474860954|FG000|Overall Study|Withdrawal by Subject|1|||
131885106|NCT00637806|474860955|FG000|Double-blind Phase|Study Discontinued|2|||
131885107|NCT00637806|474860956|FG001|Double-blind Phase|Study Discontinued|0|||
131885108|NCT00637806|474860957|FG002|Double-blind Phase|Study Discontinued|1|||
131885109|NCT00637806|474860958|FG003|Double-blind Phase|Study Discontinued|0|||
131885110|NCT00637806|474860955|FG000|Extension Phase|Study Discontinued|0|||
131885111|NCT00637806|474860956|FG001|Extension Phase|Study Discontinued|0|||
131885112|NCT00637806|474860957|FG002|Extension Phase|Study Discontinued|0|||
131885113|NCT00637806|474860958|FG003|Extension Phase|Study Discontinued|1|||
131885114|NCT00622336|474860959|FG000|Treatment Phase|Progression of Disease|181|||
131885115|NCT00622336|474860959|FG000|Treatment Phase|Adverse Event|46|||
131885116|NCT00622336|474860959|FG000|Treatment Phase|Other|40|||
131885117|NCT00622336|474860959|FG000|Treatment Phase|Death|14|||
131885118|NCT00622336|474860959|FG000|Treatment Phase|Lack of therapeutic effect|13|||
131885119|NCT00622336|474860959|FG000|Treatment Phase|Withdrawal by Subject|13|||
131885120|NCT00622336|474860959|FG000|Treatment Phase|Lost to Follow-up|2|||
131885121|NCT00622336|474860959|FG000|Extension Phase|Adverse Event|2|||
131885122|NCT00622336|474860959|FG000|Extension Phase|Progressive Disease|6|||
131885123|NCT00622336|474860959|FG000|Extension Phase|Lack of therapeutic effect|2|||
131885124|NCT00622336|474860959|FG000|Extension Phase|Withdrawal by Subject|1|||
131885125|NCT00622336|474860959|FG000|Extension Phase|Lost to Follow-up|1|||
131885126|NCT00622336|474860959|FG000|Extension Phase|Other|9|||
131885127|NCT04506905|474860962|FG000|Overall Study|Lost to Follow-up|1|||
131885128|NCT04506905|474860963|FG001|Overall Study|Lost to Follow-up|0|||
131885129|NCT04506905|474860964|FG002|Overall Study|Lost to Follow-up|0|||
131885130|NCT04506905|474860965|FG003|Overall Study|Lost to Follow-up|1|||
131885131|NCT04506905|474860966|FG004|Overall Study|Lost to Follow-up|0|||
131885132|NCT04506905|474860967|FG005|Overall Study|Lost to Follow-up|0|||
131885133|NCT04506905|474860968|FG006|Overall Study|Lost to Follow-up|0|||
131885134|NCT04506905|474860969|FG007|Overall Study|Lost to Follow-up|0|||
131885135|NCT04506905|474860970|FG008|Overall Study|Lost to Follow-up|0|||
131885136|NCT04506905|474860962|FG000|Overall Study|Withdrawal by Subject|0|||
131885137|NCT04506905|474860963|FG001|Overall Study|Withdrawal by Subject|0|||
131885138|NCT04506905|474860964|FG002|Overall Study|Withdrawal by Subject|0|||
131885139|NCT04506905|474860965|FG003|Overall Study|Withdrawal by Subject|2|||
131885140|NCT04506905|474860966|FG004|Overall Study|Withdrawal by Subject|0|||
131885141|NCT04506905|474860967|FG005|Overall Study|Withdrawal by Subject|0|||
131885142|NCT04506905|474860968|FG006|Overall Study|Withdrawal by Subject|0|||
131885143|NCT04506905|474860969|FG007|Overall Study|Withdrawal by Subject|0|||
131885144|NCT04506905|474860970|FG008|Overall Study|Withdrawal by Subject|0|||
131885145|NCT03309696|474862126|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
131885146|NCT03309696|474862127|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
131885147|NCT03309696|474862128|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
131885148|NCT03309696|474862129|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
131885149|NCT00869557|474862131|FG000|Randomized Phase|Lost to Follow-up|2|||
131885150|NCT00869557|474862132|FG001|Randomized Phase|Lost to Follow-up|1|||
131885151|NCT00869557|474862131|FG000|Randomized Phase|Investigator's Discretion|1|||
131885152|NCT00869557|474862132|FG001|Randomized Phase|Investigator's Discretion|0|||
131885153|NCT00869557|474862131|FG000|Randomized Phase|Withdrew Consent|0|||
131885154|NCT00869557|474862132|FG001|Randomized Phase|Withdrew Consent|1|||
131885155|NCT00869557|474862131|FG000|Extension Phase|Adverse Event|2|||
131885156|NCT00869557|474862132|FG001|Extension Phase|Adverse Event|2|||
131885157|NCT00869557|474862131|FG000|Extension Phase|Lack of Efficacy|1|||
131885158|NCT00869557|474862132|FG001|Extension Phase|Lack of Efficacy|0|||
131885159|NCT00869557|474862131|FG000|Extension Phase|Lost to Follow-up|3|||
131885160|NCT00869557|474862132|FG001|Extension Phase|Lost to Follow-up|1|||
131885161|NCT00869557|474862131|FG000|Extension Phase|Investigator's Discretion|2|||
131885162|NCT00869557|474862132|FG001|Extension Phase|Investigator's Discretion|0|||
131885163|NCT00869557|474862131|FG000|Extension Phase|Withdrew Consent|2|||
131885164|NCT00869557|474862132|FG001|Extension Phase|Withdrew Consent|0|||
131885165|NCT00328094|474862133|FG000|Overall Study|Physician Decision|3|||
131885166|NCT00328094|474862134|FG001|Overall Study|Physician Decision|3|||
131885167|NCT02309723|474862135|FG000|Overall Study|Withdrawal by Subject|24|||
131885168|NCT02309723|474862136|FG001|Overall Study|Withdrawal by Subject|23|||
131885169|NCT02309723|474862137|FG002|Overall Study|Withdrawal by Subject|24|||
131885170|NCT02604550|474862142|FG000|Overall Study|Lost to Follow-up|7|||
131885171|NCT02604550|474862143|FG001|Overall Study|Lost to Follow-up|6|||
131885172|NCT02604550|474862142|FG000|Overall Study|Withdrawal by Subject|0|||
131885173|NCT02604550|474862143|FG001|Overall Study|Withdrawal by Subject|1|||
131885174|NCT02604550|474862142|FG000|Overall Study|Incomplete data using paper journal|18|||
131885175|NCT02604550|474862143|FG001|Overall Study|Incomplete data using paper journal|19|||
131885176|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
131885177|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
131885178|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
131885179|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
131885180|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|Death|1|||
131660024|NCT00653523|474039055|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
131885181|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|Death|1|||
131885182|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
131885183|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
131885184|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
131885185|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
131885186|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
131885187|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
131885188|NCT00033657|474862147|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
131885189|NCT00033657|474862148|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
131885190|NCT00033657|474862147|FG000|Surgical Resection|not complete resection|0|||
131885191|NCT00033657|474862148|FG001|Surgical Resection|not complete resection|3|||
131885192|NCT00033657|474862147|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
131885193|NCT00033657|474862148|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
131885194|NCT00033657|474862147|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
131885195|NCT00033657|474862148|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
131885196|NCT00033657|474862147|FG000|Adjuvant Chemotherapy|Death|2|||
131885197|NCT00033657|474862148|FG001|Adjuvant Chemotherapy|Death|1|||
131885198|NCT00033657|474862147|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
131885199|NCT00033657|474862148|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
131885200|NCT00033657|474862147|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
131885201|NCT00033657|474862148|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
131885202|NCT00033657|474862147|FG000|Adjuvant Chemotherapy|Other|0|||
131885203|NCT00033657|474862148|FG001|Adjuvant Chemotherapy|Other|2|||
131885204|NCT04093492|474862149|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
131885205|NCT04093492|474862150|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
131885206|NCT04093492|474862151|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
131885207|NCT04093492|474862152|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
131885208|NCT04093492|474862149|FG000|25 Weeks Gestational Age (GA)|No response|5|||
131885209|NCT04093492|474862150|FG001|25 Weeks Gestational Age (GA)|No response|5|||
131885210|NCT04093492|474862151|FG002|25 Weeks Gestational Age (GA)|No response|5|||
131885211|NCT04093492|474862152|FG003|25 Weeks Gestational Age (GA)|No response|2|||
131885212|NCT04093492|474862149|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
131885213|NCT04093492|474862150|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
131885214|NCT04093492|474862151|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
131885215|NCT04093492|474862152|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
131885216|NCT04093492|474862149|FG000|30 Weeks GA|Delivered before assessment|1|||
131885217|NCT04093492|474862150|FG001|30 Weeks GA|Delivered before assessment|2|||
131885218|NCT04093492|474862151|FG002|30 Weeks GA|Delivered before assessment|0|||
131885219|NCT04093492|474862152|FG003|30 Weeks GA|Delivered before assessment|0|||
131885220|NCT04093492|474862149|FG000|30 Weeks GA|No response|7|||
131885221|NCT04093492|474862150|FG001|30 Weeks GA|No response|5|||
131885222|NCT04093492|474862151|FG002|30 Weeks GA|No response|5|||
131885223|NCT04093492|474862152|FG003|30 Weeks GA|No response|2|||
131660025|NCT00653523|474039055|FG000|Overall Study|Adverse Event|7|||
131885224|NCT04093492|474862149|FG000|30 Weeks GA|Lost to Follow-up|0|||
131885225|NCT04093492|474862150|FG001|30 Weeks GA|Lost to Follow-up|1|||
131885226|NCT04093492|474862151|FG002|30 Weeks GA|Lost to Follow-up|0|||
131885227|NCT04093492|474862152|FG003|30 Weeks GA|Lost to Follow-up|0|||
131885228|NCT04093492|474862149|FG000|34 Weeks GA|Delivered before assessment|6|||
131885229|NCT04093492|474862150|FG001|34 Weeks GA|Delivered before assessment|3|||
131885230|NCT04093492|474862151|FG002|34 Weeks GA|Delivered before assessment|0|||
131885231|NCT04093492|474862152|FG003|34 Weeks GA|Delivered before assessment|0|||
131885232|NCT04093492|474862149|FG000|34 Weeks GA|No response|0|||
131885233|NCT04093492|474862150|FG001|34 Weeks GA|No response|7|||
131885234|NCT04093492|474862151|FG002|34 Weeks GA|No response|5|||
131885235|NCT04093492|474862152|FG003|34 Weeks GA|No response|3|||
131885236|NCT04093492|474862149|FG000|34 Weeks GA|Lost to Follow-up|0|||
131885237|NCT04093492|474862150|FG001|34 Weeks GA|Lost to Follow-up|1|||
131885238|NCT04093492|474862151|FG002|34 Weeks GA|Lost to Follow-up|0|||
131885239|NCT04093492|474862152|FG003|34 Weeks GA|Lost to Follow-up|0|||
131885240|NCT00329641|474862153|FG000|Overall Study|Did not start treatment|1|||
131885241|NCT00329641|474862153|FG000|Overall Study|Not eligible|1|||
131885242|NCT00329641|474862153|FG000|Overall Study|Adverse Event|3|||
131885243|NCT00329641|474862153|FG000|Overall Study|Other reason, not protocol specified|1|||
131885244|NCT02945254|474862156|FG000|Overall Study|Lost to Follow-up|1|||
131885245|NCT02945254|474862157|FG001|Overall Study|Lost to Follow-up|0|||
131885246|NCT02945254|474862156|FG000|Overall Study|Withdrawal by Subject|1|||
131885247|NCT02945254|474862157|FG001|Overall Study|Withdrawal by Subject|0|||
131885248|NCT03422159|474862162|FG000|Overall Study|Exclusion due to terminal disease|2|||
131885249|NCT03422159|474862163|FG001|Overall Study|Exclusion due to terminal disease|1|||
131885250|NCT02631070|474862164|FG000|Overall Study|Withdrawal by Subject|35|||
131885251|NCT02631070|474862165|FG001|Overall Study|Withdrawal by Subject|13|||
131885252|NCT02631070|474862164|FG000|Overall Study|Death|45|||
131885253|NCT02631070|474862165|FG001|Overall Study|Death|24|||
131885254|NCT02631070|474862164|FG000|Overall Study|Lost to Follow-up|5|||
131885255|NCT02631070|474862165|FG001|Overall Study|Lost to Follow-up|1|||
131885256|NCT02631070|474862164|FG000|Overall Study|Transition to rollover protocol|52|||
131885257|NCT02631070|474862165|FG001|Overall Study|Transition to rollover protocol|21|||
131885258|NCT02631070|474862164|FG000|Overall Study|Other reasons|12|||
131885259|NCT02631070|474862165|FG001|Overall Study|Other reasons|5|||
131885260|NCT01870297|474862169|FG000|Overall Study|Adverse Event|0|||
131885261|NCT01870297|474862170|FG001|Overall Study|Adverse Event|0|||
131885262|NCT01870297|474862171|FG002|Overall Study|Adverse Event|0|||
131885263|NCT01870297|474862172|FG003|Overall Study|Adverse Event|0|||
131885264|NCT01870297|474862173|FG004|Overall Study|Adverse Event|2|||
131885265|NCT01870297|474862174|FG005|Overall Study|Adverse Event|0|||
131885266|NCT01870297|474862175|FG006|Overall Study|Adverse Event|0|||
131885267|NCT01870297|474862169|FG000|Overall Study|Lost to Follow-up|0|||
131885268|NCT01870297|474862170|FG001|Overall Study|Lost to Follow-up|1|||
131885269|NCT01870297|474862171|FG002|Overall Study|Lost to Follow-up|1|||
131885270|NCT01870297|474862172|FG003|Overall Study|Lost to Follow-up|0|||
131885271|NCT01870297|474862173|FG004|Overall Study|Lost to Follow-up|0|||
131885272|NCT01870297|474862174|FG005|Overall Study|Lost to Follow-up|0|||
131885273|NCT01870297|474862175|FG006|Overall Study|Lost to Follow-up|0|||
131885274|NCT01870297|474862169|FG000|Overall Study|Withdrawal by Subject|0|||
131885275|NCT01870297|474862170|FG001|Overall Study|Withdrawal by Subject|0|||
131885276|NCT01870297|474862171|FG002|Overall Study|Withdrawal by Subject|0|||
131885277|NCT01870297|474862172|FG003|Overall Study|Withdrawal by Subject|0|||
131885278|NCT01870297|474862173|FG004|Overall Study|Withdrawal by Subject|1|||
131885279|NCT01870297|474862174|FG005|Overall Study|Withdrawal by Subject|1|||
131885280|NCT01870297|474862175|FG006|Overall Study|Withdrawal by Subject|1|||
131885281|NCT01870297|474862169|FG000|Overall Study|Sponsor Decision|0|||
131885282|NCT01870297|474862170|FG001|Overall Study|Sponsor Decision|6|||
131885283|NCT01870297|474862171|FG002|Overall Study|Sponsor Decision|0|||
131885284|NCT01870297|474862172|FG003|Overall Study|Sponsor Decision|0|||
131885285|NCT01870297|474862173|FG004|Overall Study|Sponsor Decision|0|||
131885286|NCT01870297|474862174|FG005|Overall Study|Sponsor Decision|0|||
131885287|NCT01870297|474862175|FG006|Overall Study|Sponsor Decision|1|||
131885288|NCT03008278|474862176|FG000|Overall Study|Progressive Disease|0|||
131885289|NCT03008278|474862177|FG001|Overall Study|Progressive Disease|0|||
131885290|NCT03008278|474862178|FG002|Overall Study|Progressive Disease|32|||
131885291|NCT03008278|474862176|FG000|Overall Study|Adverse Event|0|||
131885292|NCT03008278|474862177|FG001|Overall Study|Adverse Event|0|||
131885293|NCT03008278|474862178|FG002|Overall Study|Adverse Event|4|||
131885294|NCT03008278|474862176|FG000|Overall Study|Withdrawal by Subject|0|||
131885295|NCT03008278|474862177|FG001|Overall Study|Withdrawal by Subject|0|||
131885296|NCT03008278|474862178|FG002|Overall Study|Withdrawal by Subject|3|||
131885297|NCT03008278|474862176|FG000|Overall Study|Physician Decision|0|||
131885298|NCT03008278|474862177|FG001|Overall Study|Physician Decision|2|||
131885299|NCT03008278|474862178|FG002|Overall Study|Physician Decision|0|||
131885300|NCT03313310|474862179|FG000|Phase 2|Lost to Follow-up|4|||
131885301|NCT03313310|474862180|FG001|Phase 2|Lost to Follow-up|0|||
131885302|NCT03313310|474862179|FG000|Phase 3|Lost to Follow-up|0|||
131885303|NCT03313310|474862180|FG001|Phase 3|Lost to Follow-up|1|||
131885304|NCT01217385|474862181|FG000|Overall Study|Withdrawal by Subject|3|||
131885305|NCT01217385|474862181|FG000|Overall Study|DOSI not performed/not eval|12|||
131885306|NCT01217385|474862181|FG000|Overall Study|Central Path not Available|1|||
131885307|NCT01217385|474862181|FG000|Overall Study|Normal Breast TOI not available|10|||
131885308|NCT00090987|474862182|FG000|Overall Study|Adverse Event|5|||
131885309|NCT00090987|474862182|FG000|Overall Study|Lack of Efficacy|7|||
131885310|NCT00090987|474862182|FG000|Overall Study|Withdrawal by Subject|3|||
131885311|NCT00090987|474862182|FG000|Overall Study|alternative therapy|1|||
131885312|NCT00090987|474862182|FG000|Overall Study|Non-compliance|4|||
131885313|NCT00090987|474862182|FG000|Overall Study|Incarcerated|1|||
131885314|NCT02079636|474862184|FG000|Overall Study|Death|2|||
131885315|NCT02079636|474862185|FG001|Overall Study|Death|1|||
131885316|NCT02079636|474862186|FG002|Overall Study|Death|0|||
131885317|NCT02079636|474862187|FG003|Overall Study|Death|5|||
131885318|NCT02079636|474862188|FG004|Overall Study|Death|1|||
131885319|NCT02079636|474862189|FG005|Overall Study|Death|2|||
131885320|NCT02079636|474862190|FG006|Overall Study|Death|1|||
131885321|NCT02079636|474862191|FG007|Overall Study|Death|0|||
131885322|NCT02079636|474862192|FG008|Overall Study|Death|0|||
131885323|NCT02079636|474862193|FG009|Overall Study|Death|0|||
131885324|NCT02079636|474862194|FG010|Overall Study|Death|0|||
131885325|NCT02079636|474862195|FG011|Overall Study|Death|1|||
131885326|NCT02079636|474862196|FG012|Overall Study|Death|1|||
131885327|NCT02079636|474862197|FG013|Overall Study|Death|0|||
131885328|NCT02079636|474862198|FG014|Overall Study|Death|2|||
131885329|NCT02079636|474862184|FG000|Overall Study|Adverse Event|1|||
131885330|NCT02079636|474862185|FG001|Overall Study|Adverse Event|1|||
131885331|NCT02079636|474862186|FG002|Overall Study|Adverse Event|0|||
131885332|NCT02079636|474862187|FG003|Overall Study|Adverse Event|1|||
131885333|NCT02079636|474862188|FG004|Overall Study|Adverse Event|1|||
131885334|NCT02079636|474862189|FG005|Overall Study|Adverse Event|2|||
131885335|NCT02079636|474862190|FG006|Overall Study|Adverse Event|0|||
131885336|NCT02079636|474862191|FG007|Overall Study|Adverse Event|0|||
131885337|NCT02079636|474862192|FG008|Overall Study|Adverse Event|0|||
131885338|NCT02079636|474862193|FG009|Overall Study|Adverse Event|0|||
131885339|NCT02079636|474862194|FG010|Overall Study|Adverse Event|0|||
131885340|NCT02079636|474862195|FG011|Overall Study|Adverse Event|0|||
131885341|NCT02079636|474862196|FG012|Overall Study|Adverse Event|0|||
131885342|NCT02079636|474862197|FG013|Overall Study|Adverse Event|0|||
131885343|NCT02079636|474862198|FG014|Overall Study|Adverse Event|0|||
131885344|NCT02079636|474862184|FG000|Overall Study|Progressive disease|0|||
131885345|NCT02079636|474862185|FG001|Overall Study|Progressive disease|0|||
131885346|NCT02079636|474862186|FG002|Overall Study|Progressive disease|0|||
131885347|NCT02079636|474862187|FG003|Overall Study|Progressive disease|2|||
131885348|NCT02079636|474862188|FG004|Overall Study|Progressive disease|0|||
131885349|NCT02079636|474862189|FG005|Overall Study|Progressive disease|0|||
131885350|NCT02079636|474862190|FG006|Overall Study|Progressive disease|0|||
131885351|NCT02079636|474862191|FG007|Overall Study|Progressive disease|0|||
131885352|NCT02079636|474862192|FG008|Overall Study|Progressive disease|0|||
131885353|NCT02079636|474862193|FG009|Overall Study|Progressive disease|0|||
131885354|NCT02079636|474862194|FG010|Overall Study|Progressive disease|0|||
131885355|NCT02079636|474862195|FG011|Overall Study|Progressive disease|0|||
131885356|NCT02079636|474862196|FG012|Overall Study|Progressive disease|1|||
131885357|NCT02079636|474862197|FG013|Overall Study|Progressive disease|0|||
131885358|NCT02079636|474862198|FG014|Overall Study|Progressive disease|0|||
131885359|NCT02079636|474862184|FG000|Overall Study|Withdrawal by Subject|0|||
131885360|NCT02079636|474862185|FG001|Overall Study|Withdrawal by Subject|0|||
131885361|NCT02079636|474862186|FG002|Overall Study|Withdrawal by Subject|0|||
131885362|NCT02079636|474862187|FG003|Overall Study|Withdrawal by Subject|4|||
131885363|NCT02079636|474862188|FG004|Overall Study|Withdrawal by Subject|0|||
131885364|NCT02079636|474862189|FG005|Overall Study|Withdrawal by Subject|1|||
131885365|NCT02079636|474862190|FG006|Overall Study|Withdrawal by Subject|0|||
131885366|NCT02079636|474862191|FG007|Overall Study|Withdrawal by Subject|0|||
131885367|NCT02079636|474862192|FG008|Overall Study|Withdrawal by Subject|0|||
131885368|NCT02079636|474862193|FG009|Overall Study|Withdrawal by Subject|2|||
131885369|NCT02079636|474862194|FG010|Overall Study|Withdrawal by Subject|1|||
131885370|NCT02079636|474862195|FG011|Overall Study|Withdrawal by Subject|1|||
131885371|NCT02079636|474862196|FG012|Overall Study|Withdrawal by Subject|1|||
131885372|NCT02079636|474862197|FG013|Overall Study|Withdrawal by Subject|0|||
131885373|NCT02079636|474862198|FG014|Overall Study|Withdrawal by Subject|2|||
131885374|NCT02079636|474862184|FG000|Overall Study|Physician Decision|0|||
131885375|NCT02079636|474862185|FG001|Overall Study|Physician Decision|0|||
131885376|NCT02079636|474862186|FG002|Overall Study|Physician Decision|0|||
131885377|NCT02079636|474862187|FG003|Overall Study|Physician Decision|0|||
131885378|NCT02079636|474862188|FG004|Overall Study|Physician Decision|0|||
131885379|NCT02079636|474862189|FG005|Overall Study|Physician Decision|1|||
131885380|NCT02079636|474862190|FG006|Overall Study|Physician Decision|0|||
131885381|NCT02079636|474862191|FG007|Overall Study|Physician Decision|0|||
131885382|NCT02079636|474862192|FG008|Overall Study|Physician Decision|0|||
131885383|NCT02079636|474862193|FG009|Overall Study|Physician Decision|1|||
131885384|NCT02079636|474862194|FG010|Overall Study|Physician Decision|1|||
131885385|NCT02079636|474862195|FG011|Overall Study|Physician Decision|0|||
131885386|NCT02079636|474862196|FG012|Overall Study|Physician Decision|0|||
131885387|NCT02079636|474862197|FG013|Overall Study|Physician Decision|0|||
131885388|NCT02079636|474862198|FG014|Overall Study|Physician Decision|1|||
131885389|NCT02079636|474862184|FG000|Overall Study|Lost to Follow-up|0|||
131885390|NCT02079636|474862185|FG001|Overall Study|Lost to Follow-up|0|||
131885391|NCT02079636|474862186|FG002|Overall Study|Lost to Follow-up|0|||
131885392|NCT02079636|474862187|FG003|Overall Study|Lost to Follow-up|0|||
131885393|NCT02079636|474862188|FG004|Overall Study|Lost to Follow-up|0|||
131885394|NCT02079636|474862189|FG005|Overall Study|Lost to Follow-up|0|||
131885395|NCT02079636|474862190|FG006|Overall Study|Lost to Follow-up|0|||
131885396|NCT02079636|474862191|FG007|Overall Study|Lost to Follow-up|1|||
131885397|NCT02079636|474862192|FG008|Overall Study|Lost to Follow-up|0|||
131885398|NCT02079636|474862193|FG009|Overall Study|Lost to Follow-up|0|||
131885399|NCT02079636|474862194|FG010|Overall Study|Lost to Follow-up|0|||
131885400|NCT02079636|474862195|FG011|Overall Study|Lost to Follow-up|0|||
131885401|NCT02079636|474862196|FG012|Overall Study|Lost to Follow-up|0|||
131885402|NCT02079636|474862197|FG013|Overall Study|Lost to Follow-up|0|||
131885403|NCT02079636|474862198|FG014|Overall Study|Lost to Follow-up|0|||
131885404|NCT00725101|474862199|FG000|Overall Study|Death|3|||
131885405|NCT00725101|474862199|FG000|Overall Study|Lost to Follow-up|353|||
131885406|NCT00725101|474862199|FG000|Overall Study|Protocol Violation|1|||
131885407|NCT00725101|474862199|FG000|Overall Study|Withdrawal by Subject|127|||
131885408|NCT00725101|474862199|FG000|Overall Study|not specified/no reason given|11|||
131885409|NCT01592292|474862200|FG000|Overall Study|Follow-up loss|3|||
131885410|NCT01592292|474862201|FG001|Overall Study|Follow-up loss|3|||
131885411|NCT01592292|474862202|FG002|Overall Study|Follow-up loss|1|||
131885412|NCT01592292|474862203|FG003|Overall Study|Follow-up loss|0|||
131885413|NCT01592292|474862200|FG000|Overall Study|Withdrew consent|2|||
131885414|NCT01592292|474862201|FG001|Overall Study|Withdrew consent|1|||
131885415|NCT01592292|474862202|FG002|Overall Study|Withdrew consent|0|||
131885416|NCT01592292|474862203|FG003|Overall Study|Withdrew consent|0|||
131885417|NCT01592292|474862200|FG000|Overall Study|Other|1|||
131885418|NCT01592292|474862201|FG001|Overall Study|Other|1|||
131885419|NCT01592292|474862202|FG002|Overall Study|Other|2|||
131885420|NCT01592292|474862203|FG003|Overall Study|Other|1|||
131885421|NCT04148287|474862205|FG000|Overall Study|Death|2|||
131885422|NCT03164265|474862206|FG000|Overall Study|Physician Decision|3|||
131885423|NCT03912428|474862209|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
131885424|NCT03912428|474862210|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
131885425|NCT03912428|474862211|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
131885426|NCT03912428|474862212|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
131885427|NCT03912428|474862209|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
131885428|NCT03912428|474862210|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
131547198|NCT00031486|473626345|FG000|Overall Study|Withdrawal by Subject|3|||
131547199|NCT00031486|473626346|FG001|Overall Study|Withdrawal by Subject|2|||
131547200|NCT00031486|473626345|FG000|Overall Study|Death|0|||
131547201|NCT00031486|473626346|FG001|Overall Study|Death|3|||
131547202|NCT00031486|473626345|FG000|Overall Study|Non-compliant|0|||
131547203|NCT00031486|473626346|FG001|Overall Study|Non-compliant|4|||
131547204|NCT00031486|473626345|FG000|Overall Study|Did not meet eligibility requirement|2|||
131547205|NCT00031486|473626346|FG001|Overall Study|Did not meet eligibility requirement|1|||
131547206|NCT00031486|473626345|FG000|Overall Study|Other|1|||
131547207|NCT00031486|473626346|FG001|Overall Study|Other|1|||
131547208|NCT03685591|473626349|FG000|Overall Study|Global Deterioration of Health Status|0|||
131547209|NCT03685591|473626350|FG001|Overall Study|Global Deterioration of Health Status|0|||
131547210|NCT03685591|473626351|FG002|Overall Study|Global Deterioration of Health Status|0|||
131547211|NCT03685591|473626352|FG003|Overall Study|Global Deterioration of Health Status|1|||
131547212|NCT03685591|473626353|FG004|Overall Study|Global Deterioration of Health Status|2|||
131547213|NCT03685591|473626354|FG005|Overall Study|Global Deterioration of Health Status|4|||
131547214|NCT03685591|473626355|FG006|Overall Study|Global Deterioration of Health Status|1|||
131547215|NCT03685591|473626356|FG007|Overall Study|Global Deterioration of Health Status|1|||
131547216|NCT03685591|473626357|FG008|Overall Study|Global Deterioration of Health Status|0|||
131547217|NCT03685591|473626349|FG000|Overall Study|Progressive Disease|1|||
131885429|NCT03912428|474862211|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
131885430|NCT03912428|474862212|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
131885431|NCT03912428|474862209|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
131885432|NCT03912428|474862210|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
131885433|NCT03912428|474862211|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
131885434|NCT03912428|474862212|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
131547218|NCT03685591|473626350|FG001|Overall Study|Progressive Disease|1|||
131547219|NCT03685591|473626351|FG002|Overall Study|Progressive Disease|0|||
131547220|NCT03685591|473626352|FG003|Overall Study|Progressive Disease|3|||
131547221|NCT03685591|473626353|FG004|Overall Study|Progressive Disease|5|||
131547222|NCT03685591|473626354|FG005|Overall Study|Progressive Disease|4|||
131885435|NCT03233204|474862213|FG000|Overall Study|Adverse Event|1|||
131885436|NCT03233204|474862213|FG000|Overall Study|Death|1|||
131885437|NCT03233204|474862213|FG000|Overall Study|Withdrawal by Subject|1|||
131885438|NCT03233204|474862213|FG000|Overall Study|Progressive Disease|3|||
131885439|NCT02680834|474862214|FG000|Overall Study|Physician Decision|5|||
131885440|NCT02680834|474862215|FG001|Overall Study|Physician Decision|2|||
131885441|NCT02680834|474862214|FG000|Overall Study|Withdrawal by Subject|6|||
131885442|NCT02680834|474862215|FG001|Overall Study|Withdrawal by Subject|0|||
131547223|NCT03685591|473626355|FG006|Overall Study|Progressive Disease|3|||
131547224|NCT03685591|473626356|FG007|Overall Study|Progressive Disease|2|||
131547225|NCT03685591|473626357|FG008|Overall Study|Progressive Disease|1|||
131547226|NCT03685591|473626349|FG000|Overall Study|Other|0|||
131547227|NCT03685591|473626350|FG001|Overall Study|Other|0|||
131547228|NCT03685591|473626351|FG002|Overall Study|Other|1|||
131547229|NCT03685591|473626352|FG003|Overall Study|Other|0|||
131547230|NCT03685591|473626353|FG004|Overall Study|Other|2|||
131547231|NCT03685591|473626354|FG005|Overall Study|Other|3|||
131547232|NCT03685591|473626355|FG006|Overall Study|Other|0|||
131547233|NCT03685591|473626356|FG007|Overall Study|Other|0|||
131547234|NCT03685591|473626357|FG008|Overall Study|Other|0|||
131547235|NCT03685591|473626349|FG000|Overall Study|Withdrawal by Subject|0|||
131547236|NCT03685591|473626350|FG001|Overall Study|Withdrawal by Subject|0|||
131547237|NCT03685591|473626351|FG002|Overall Study|Withdrawal by Subject|0|||
131547238|NCT03685591|473626352|FG003|Overall Study|Withdrawal by Subject|0|||
131885443|NCT02680834|474862214|FG000|Overall Study|Lost to Follow-up|0|||
131885444|NCT02680834|474862215|FG001|Overall Study|Lost to Follow-up|1|||
131885445|NCT02407054|474862216|FG000|Overall Study|Adverse Event|1|||
131885446|NCT02407054|474862217|FG001|Overall Study|Adverse Event|4|||
131885447|NCT02407054|474862218|FG002|Overall Study|Adverse Event|1|||
131885448|NCT02407054|474862216|FG000|Overall Study|Non-compliance with Study|0|||
131885449|NCT02407054|474862217|FG001|Overall Study|Non-compliance with Study|2|||
131885450|NCT02407054|474862218|FG002|Overall Study|Non-compliance with Study|1|||
131885451|NCT02407054|474862216|FG000|Overall Study|Physician Decision|1|||
131885452|NCT02407054|474862217|FG001|Overall Study|Physician Decision|3|||
131885453|NCT02407054|474862218|FG002|Overall Study|Physician Decision|3|||
131885454|NCT02407054|474862216|FG000|Overall Study|Withdrawal by Subject|5|||
131885455|NCT02407054|474862217|FG001|Overall Study|Withdrawal by Subject|9|||
131885456|NCT02407054|474862218|FG002|Overall Study|Withdrawal by Subject|2|||
131885457|NCT02044874|474862219|FG000|Overall Study|Adverse Event|5|||
131885458|NCT02044874|474862220|FG001|Overall Study|Adverse Event|6|||
131885459|NCT02044874|474862221|FG002|Overall Study|Adverse Event|6|||
131885460|NCT02044874|474862219|FG000|Overall Study|Withdrawal by Subject|8|||
131885461|NCT02044874|474862220|FG001|Overall Study|Withdrawal by Subject|16|||
131885462|NCT02044874|474862221|FG002|Overall Study|Withdrawal by Subject|23|||
131885463|NCT02044874|474862219|FG000|Overall Study|Physician Decision|0|||
131885464|NCT02044874|474862220|FG001|Overall Study|Physician Decision|2|||
131885465|NCT02044874|474862221|FG002|Overall Study|Physician Decision|1|||
131885466|NCT02044874|474862219|FG000|Overall Study|Lost to Follow-up|10|||
131885467|NCT02044874|474862220|FG001|Overall Study|Lost to Follow-up|27|||
131885468|NCT02044874|474862221|FG002|Overall Study|Lost to Follow-up|21|||
131885469|NCT02044874|474862219|FG000|Overall Study|Sponsor Decision|0|||
131885470|NCT02044874|474862220|FG001|Overall Study|Sponsor Decision|1|||
131885471|NCT02044874|474862221|FG002|Overall Study|Sponsor Decision|1|||
131885472|NCT02044874|474862219|FG000|Overall Study|Other|7|||
131885473|NCT02044874|474862220|FG001|Overall Study|Other|3|||
131885474|NCT02044874|474862221|FG002|Overall Study|Other|8|||
131885475|NCT02889835|474862222|FG000|Overall Study|Lost to Follow-up|13|||
131885476|NCT02889835|474862223|FG001|Overall Study|Lost to Follow-up|13|||
131885477|NCT02889835|474862224|FG002|Overall Study|Lost to Follow-up|13|||
131885478|NCT02889835|474862222|FG000|Overall Study|Withdrawal by Subject|2|||
131885479|NCT02889835|474862223|FG001|Overall Study|Withdrawal by Subject|2|||
131885480|NCT02889835|474862224|FG002|Overall Study|Withdrawal by Subject|2|||
131885481|NCT02889835|474862222|FG000|Overall Study|Protocol Violation|1|||
131885482|NCT02889835|474862223|FG001|Overall Study|Protocol Violation|1|||
131885483|NCT02889835|474862224|FG002|Overall Study|Protocol Violation|1|||
131885484|NCT02889835|474862222|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
131885485|NCT02889835|474862223|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
131885486|NCT02889835|474862224|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
131885487|NCT02889835|474862222|FG000|Overall Study|Death|1|||
131885488|NCT02889835|474862223|FG001|Overall Study|Death|1|||
131885489|NCT02889835|474862224|FG002|Overall Study|Death|1|||
131885490|NCT01447927|474862225|FG000|Overall Study|Adverse Event|4|||
131885491|NCT01447927|474862226|FG001|Overall Study|Adverse Event|3|||
131885492|NCT01447927|474862225|FG000|Overall Study|Withdrawal by Subject|1|||
131885493|NCT01447927|474862226|FG001|Overall Study|Withdrawal by Subject|0|||
131885494|NCT04102865|474862228|FG000|Overall Study|Adverse Event|4|||
131885495|NCT04102865|474862229|FG001|Overall Study|Adverse Event|0|||
131547239|NCT03685591|473626353|FG004|Overall Study|Withdrawal by Subject|3|||
131547240|NCT03685591|473626354|FG005|Overall Study|Withdrawal by Subject|2|||
131885496|NCT04102865|474862228|FG000|Overall Study|Lost to Follow-up|1|||
131885497|NCT04102865|474862229|FG001|Overall Study|Lost to Follow-up|0|||
131885498|NCT04102865|474862228|FG000|Overall Study|Withdrawal by Subject|2|||
131885499|NCT04102865|474862229|FG001|Overall Study|Withdrawal by Subject|0|||
131885500|NCT04683939|474862233|FG000|Overall Study|Study termination by the sponsor|0|||
131885501|NCT04683939|474862234|FG001|Overall Study|Study termination by the sponsor|1|||
131885502|NCT04683939|474862235|FG002|Overall Study|Study termination by the sponsor|2|||
131885503|NCT04683939|474862236|FG003|Overall Study|Study termination by the sponsor|2|||
131885504|NCT04683939|474862233|FG000|Overall Study|Death|1|||
131885505|NCT04683939|474862234|FG001|Overall Study|Death|1|||
131885506|NCT04683939|474862235|FG002|Overall Study|Death|2|||
131885507|NCT04683939|474862236|FG003|Overall Study|Death|1|||
131885508|NCT04683939|474862233|FG000|Overall Study|Withdrawal by Subject|1|||
131885509|NCT04683939|474862234|FG001|Overall Study|Withdrawal by Subject|0|||
131885510|NCT04683939|474862235|FG002|Overall Study|Withdrawal by Subject|0|||
131885511|NCT04683939|474862236|FG003|Overall Study|Withdrawal by Subject|0|||
131885512|NCT04683939|474862233|FG000|Overall Study|Physician Decision|1|||
131885513|NCT04683939|474862234|FG001|Overall Study|Physician Decision|0|||
131885514|NCT04683939|474862235|FG002|Overall Study|Physician Decision|0|||
131885515|NCT04683939|474862236|FG003|Overall Study|Physician Decision|0|||
131885516|NCT04683939|474862233|FG000|Overall Study|Lost to Follow-up|0|||
131885517|NCT04683939|474862234|FG001|Overall Study|Lost to Follow-up|1|||
131885518|NCT04683939|474862235|FG002|Overall Study|Lost to Follow-up|0|||
131885519|NCT04683939|474862236|FG003|Overall Study|Lost to Follow-up|0|||
131885520|NCT02502266|474864159|FG000|Overall Study|Adverse Event|0|||
131885521|NCT02502266|474864160|FG001|Overall Study|Adverse Event|0|||
131885522|NCT02502266|474864161|FG002|Overall Study|Adverse Event|0|||
131885523|NCT02502266|474864162|FG003|Overall Study|Adverse Event|0|||
131885524|NCT02502266|474864163|FG004|Overall Study|Adverse Event|1|||
131885525|NCT02502266|474864164|FG005|Overall Study|Adverse Event|1|||
131885526|NCT02502266|474864165|FG006|Overall Study|Adverse Event|1|||
131885527|NCT02502266|474864159|FG000|Overall Study|Withdrawal by Subject|30|||
131885528|NCT02502266|474864160|FG001|Overall Study|Withdrawal by Subject|15|||
131885529|NCT02502266|474864161|FG002|Overall Study|Withdrawal by Subject|16|||
131885530|NCT02502266|474864162|FG003|Overall Study|Withdrawal by Subject|0|||
131885531|NCT02502266|474864163|FG004|Overall Study|Withdrawal by Subject|0|||
131885532|NCT02502266|474864164|FG005|Overall Study|Withdrawal by Subject|0|||
131885533|NCT02502266|474864165|FG006|Overall Study|Withdrawal by Subject|0|||
131885534|NCT02502266|474864159|FG000|Overall Study|Still on Treatment|0|||
131885535|NCT02502266|474864160|FG001|Overall Study|Still on Treatment|0|||
131885536|NCT02502266|474864161|FG002|Overall Study|Still on Treatment|1|||
131885537|NCT02502266|474864162|FG003|Overall Study|Still on Treatment|0|||
131885538|NCT02502266|474864163|FG004|Overall Study|Still on Treatment|0|||
131885539|NCT02502266|474864164|FG005|Overall Study|Still on Treatment|0|||
131885540|NCT02502266|474864165|FG006|Overall Study|Still on Treatment|0|||
131885541|NCT02502266|474864159|FG000|Overall Study|Other Reasons|19|||
131885542|NCT02502266|474864160|FG001|Overall Study|Other Reasons|6|||
131885543|NCT02502266|474864161|FG002|Overall Study|Other Reasons|14|||
131885544|NCT02502266|474864162|FG003|Overall Study|Other Reasons|0|||
131885545|NCT02502266|474864163|FG004|Overall Study|Other Reasons|1|||
131885546|NCT02502266|474864164|FG005|Overall Study|Other Reasons|1|||
131885547|NCT02502266|474864165|FG006|Overall Study|Other Reasons|0|||
131885548|NCT02502266|474864159|FG000|Overall Study|Arm 4 Discontinued|0|||
131885549|NCT02502266|474864160|FG001|Overall Study|Arm 4 Discontinued|0|||
131885550|NCT02502266|474864161|FG002|Overall Study|Arm 4 Discontinued|0|||
131885551|NCT02502266|474864162|FG003|Overall Study|Arm 4 Discontinued|52|||
131885552|NCT02502266|474864163|FG004|Overall Study|Arm 4 Discontinued|0|||
131885553|NCT02502266|474864164|FG005|Overall Study|Arm 4 Discontinued|0|||
131885554|NCT02502266|474864165|FG006|Overall Study|Arm 4 Discontinued|0|||
131885555|NCT02502266|474864159|FG000|Overall Study|Never treated|0|||
131885556|NCT02502266|474864160|FG001|Overall Study|Never treated|0|||
131885557|NCT02502266|474864161|FG002|Overall Study|Never treated|0|||
131885558|NCT02502266|474864162|FG003|Overall Study|Never treated|0|||
131885559|NCT02502266|474864163|FG004|Overall Study|Never treated|0|||
131885560|NCT02502266|474864164|FG005|Overall Study|Never treated|1|||
131885561|NCT02502266|474864165|FG006|Overall Study|Never treated|0|||
131885562|NCT02921750|474864166|FG000|Overall Study|Adverse Event|1|||
131885563|NCT02921750|474864167|FG001|Overall Study|Adverse Event|2|||
131885564|NCT02921750|474864166|FG000|Overall Study|Withdrawal by Subject|1|||
131885565|NCT02921750|474864167|FG001|Overall Study|Withdrawal by Subject|1|||
131885566|NCT02921750|474864166|FG000|Overall Study|Lost to Follow-up|3|||
131885567|NCT02921750|474864167|FG001|Overall Study|Lost to Follow-up|3|||
131885568|NCT02921750|474864166|FG000|Overall Study|Wound healed|3|||
131885569|NCT02921750|474864167|FG001|Overall Study|Wound healed|3|||
131885570|NCT02921750|474864166|FG000|Overall Study|Serious Adverse Event|1|||
131885571|NCT02921750|474864167|FG001|Overall Study|Serious Adverse Event|2|||
131885572|NCT02638129|474864168|FG000|Overall Study|Study terminated|28|||
131885573|NCT02638129|474864169|FG001|Overall Study|Study terminated|30|||
131885574|NCT02949908|474864172|FG000|Overall Study|Study termination|2|||
131885575|NCT00114738|474864173|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
131885576|NCT00114738|474864174|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
131885577|NCT00114738|474864175|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
131885578|NCT00114738|474864173|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
131885579|NCT00114738|474864174|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
131885580|NCT00114738|474864175|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
131885581|NCT00114738|474864173|FG000|Screening for Randomization|Neuropathy|17|||
131885582|NCT00114738|474864174|FG001|Screening for Randomization|Neuropathy|0|||
131885583|NCT00114738|474864175|FG002|Screening for Randomization|Neuropathy|0|||
131885584|NCT00114738|474864173|FG000|Screening for Randomization|Progressive disease|2|||
131885585|NCT00114738|474864174|FG001|Screening for Randomization|Progressive disease|0|||
131885586|NCT00114738|474864175|FG002|Screening for Randomization|Progressive disease|0|||
131885587|NCT00114738|474864173|FG000|Screening for Randomization|CNS Hemorrhage|1|||
131885588|NCT00114738|474864174|FG001|Screening for Randomization|CNS Hemorrhage|0|||
131885589|NCT00114738|474864175|FG002|Screening for Randomization|CNS Hemorrhage|0|||
131885590|NCT00114738|474864173|FG000|Screening for Randomization|Other|1|||
131885591|NCT00114738|474864174|FG001|Screening for Randomization|Other|0|||
131885592|NCT00114738|474864175|FG002|Screening for Randomization|Other|0|||
131885593|NCT00308750|474864180|FG000|Overall Study|Adverse Event|9|||
131885594|NCT00308750|474864181|FG001|Overall Study|Adverse Event|9|||
131885595|NCT00308750|474864182|FG002|Overall Study|Adverse Event|13|||
131885596|NCT00308750|474864180|FG000|Overall Study|Withdrawal by Subject|6|||
131885597|NCT00308750|474864181|FG001|Overall Study|Withdrawal by Subject|2|||
131885598|NCT00308750|474864182|FG002|Overall Study|Withdrawal by Subject|3|||
131885599|NCT00308750|474864180|FG000|Overall Study|Physician Decision|3|||
131885600|NCT00308750|474864181|FG001|Overall Study|Physician Decision|4|||
131885601|NCT00308750|474864182|FG002|Overall Study|Physician Decision|3|||
131885602|NCT00308750|474864180|FG000|Overall Study|Sponsor Decision|1|||
131885603|NCT00308750|474864181|FG001|Overall Study|Sponsor Decision|0|||
131885604|NCT00308750|474864182|FG002|Overall Study|Sponsor Decision|0|||
131885605|NCT00308750|474864180|FG000|Overall Study|Disease Progression|47|||
131885606|NCT00308750|474864181|FG001|Overall Study|Disease Progression|24|||
131885607|NCT00308750|474864182|FG002|Overall Study|Disease Progression|28|||
131885608|NCT00308750|474864180|FG000|Overall Study|Unrelated Complication|3|||
131885609|NCT00308750|474864181|FG001|Overall Study|Unrelated Complication|0|||
131885610|NCT00308750|474864182|FG002|Overall Study|Unrelated Complication|1|||
131885611|NCT00308750|474864180|FG000|Overall Study|Death|1|||
131885612|NCT00308750|474864181|FG001|Overall Study|Death|0|||
131885613|NCT00308750|474864182|FG002|Overall Study|Death|1|||
131885614|NCT00308750|474864180|FG000|Overall Study|Protocol Violation|1|||
131885615|NCT00308750|474864181|FG001|Overall Study|Protocol Violation|0|||
131885616|NCT00308750|474864182|FG002|Overall Study|Protocol Violation|0|||
131885617|NCT00308750|474864180|FG000|Overall Study|New Primary Disease Identified|1|||
131885618|NCT00308750|474864181|FG001|Overall Study|New Primary Disease Identified|1|||
131885619|NCT00308750|474864182|FG002|Overall Study|New Primary Disease Identified|0|||
131885620|NCT01358578|474864183|FG000|Induction Period|Adverse Event|2|||
131885621|NCT01358578|474864184|FG001|Induction Period|Adverse Event|4|||
131885622|NCT01358578|474864185|FG002|Induction Period|Adverse Event|2|||
131885623|NCT01358578|474864186|FG003|Induction Period|Adverse Event|6|||
131885624|NCT01358578|474864187|FG004|Induction Period|Adverse Event|0|||
131885625|NCT01358578|474864188|FG005|Induction Period|Adverse Event|0|||
131885626|NCT01358578|474864183|FG000|Induction Period|Lack of Efficacy|0|||
131885627|NCT01358578|474864184|FG001|Induction Period|Lack of Efficacy|0|||
131885628|NCT01358578|474864185|FG002|Induction Period|Lack of Efficacy|9|||
131885629|NCT01358578|474864186|FG003|Induction Period|Lack of Efficacy|1|||
131885630|NCT01358578|474864187|FG004|Induction Period|Lack of Efficacy|0|||
131885631|NCT01358578|474864188|FG005|Induction Period|Lack of Efficacy|0|||
131885632|NCT01358578|474864183|FG000|Induction Period|Lost to Follow-up|0|||
131885633|NCT01358578|474864184|FG001|Induction Period|Lost to Follow-up|0|||
131885634|NCT01358578|474864185|FG002|Induction Period|Lost to Follow-up|1|||
131885635|NCT01358578|474864186|FG003|Induction Period|Lost to Follow-up|4|||
131885636|NCT01358578|474864187|FG004|Induction Period|Lost to Follow-up|0|||
131885637|NCT01358578|474864188|FG005|Induction Period|Lost to Follow-up|0|||
131885638|NCT01358578|474864183|FG000|Induction Period|Physician Decision|2|||
131885639|NCT01358578|474864184|FG001|Induction Period|Physician Decision|1|||
131885640|NCT01358578|474864185|FG002|Induction Period|Physician Decision|2|||
131885641|NCT01358578|474864186|FG003|Induction Period|Physician Decision|0|||
131885642|NCT01358578|474864187|FG004|Induction Period|Physician Decision|0|||
131660026|NCT00653523|474039055|FG000|Overall Study|Withdrawal by Subject|6|||
131885643|NCT01358578|474864188|FG005|Induction Period|Physician Decision|0|||
131885644|NCT01358578|474864183|FG000|Induction Period|Protocol Deviation|3|||
131885645|NCT01358578|474864184|FG001|Induction Period|Protocol Deviation|5|||
131885646|NCT01358578|474864185|FG002|Induction Period|Protocol Deviation|0|||
131885647|NCT01358578|474864186|FG003|Induction Period|Protocol Deviation|3|||
131885648|NCT01358578|474864187|FG004|Induction Period|Protocol Deviation|0|||
131885649|NCT01358578|474864188|FG005|Induction Period|Protocol Deviation|0|||
131885650|NCT01358578|474864183|FG000|Induction Period|technical problems|0|||
131885651|NCT01358578|474864184|FG001|Induction Period|technical problems|0|||
131885652|NCT01358578|474864185|FG002|Induction Period|technical problems|1|||
131885653|NCT01358578|474864186|FG003|Induction Period|technical problems|1|||
131885654|NCT01358578|474864187|FG004|Induction Period|technical problems|0|||
131885655|NCT01358578|474864188|FG005|Induction Period|technical problems|0|||
131885656|NCT01358578|474864183|FG000|Induction Period|Withdrawal by Subject|5|||
131885657|NCT01358578|474864184|FG001|Induction Period|Withdrawal by Subject|5|||
131885658|NCT01358578|474864185|FG002|Induction Period|Withdrawal by Subject|10|||
131885659|NCT01358578|474864186|FG003|Induction Period|Withdrawal by Subject|6|||
131885660|NCT01358578|474864187|FG004|Induction Period|Withdrawal by Subject|0|||
131885661|NCT01358578|474864188|FG005|Induction Period|Withdrawal by Subject|0|||
131885662|NCT01358578|474864183|FG000|Maintenance Period|Adverse Event|2|||
131885663|NCT01358578|474864184|FG001|Maintenance Period|Adverse Event|7|||
131885664|NCT01358578|474864185|FG002|Maintenance Period|Adverse Event|0|||
131885665|NCT01358578|474864186|FG003|Maintenance Period|Adverse Event|6|||
131885666|NCT01358578|474864187|FG004|Maintenance Period|Adverse Event|4|||
131885667|NCT01358578|474864188|FG005|Maintenance Period|Adverse Event|3|||
131885668|NCT01358578|474864183|FG000|Maintenance Period|Lack of Efficacy|10|||
131885669|NCT01358578|474864184|FG001|Maintenance Period|Lack of Efficacy|2|||
131885670|NCT01358578|474864185|FG002|Maintenance Period|Lack of Efficacy|0|||
131885671|NCT01358578|474864186|FG003|Maintenance Period|Lack of Efficacy|11|||
131885672|NCT01358578|474864187|FG004|Maintenance Period|Lack of Efficacy|3|||
131885673|NCT01358578|474864188|FG005|Maintenance Period|Lack of Efficacy|0|||
131885674|NCT01358578|474864183|FG000|Maintenance Period|Lost to Follow-up|4|||
131885675|NCT01358578|474864184|FG001|Maintenance Period|Lost to Follow-up|0|||
131885676|NCT01358578|474864185|FG002|Maintenance Period|Lost to Follow-up|0|||
131885677|NCT01358578|474864186|FG003|Maintenance Period|Lost to Follow-up|5|||
131885678|NCT01358578|474864187|FG004|Maintenance Period|Lost to Follow-up|1|||
131885679|NCT01358578|474864188|FG005|Maintenance Period|Lost to Follow-up|1|||
131885680|NCT01358578|474864183|FG000|Maintenance Period|Non-compliance with study treatment|3|||
131885681|NCT01358578|474864184|FG001|Maintenance Period|Non-compliance with study treatment|1|||
131885682|NCT01358578|474864185|FG002|Maintenance Period|Non-compliance with study treatment|0|||
131885683|NCT01358578|474864186|FG003|Maintenance Period|Non-compliance with study treatment|2|||
131885684|NCT01358578|474864187|FG004|Maintenance Period|Non-compliance with study treatment|1|||
131885685|NCT01358578|474864188|FG005|Maintenance Period|Non-compliance with study treatment|2|||
131885686|NCT01358578|474864183|FG000|Maintenance Period|Physician Decision|0|||
131885687|NCT01358578|474864184|FG001|Maintenance Period|Physician Decision|1|||
131885688|NCT01358578|474864185|FG002|Maintenance Period|Physician Decision|0|||
131885689|NCT01358578|474864186|FG003|Maintenance Period|Physician Decision|1|||
131885690|NCT01358578|474864187|FG004|Maintenance Period|Physician Decision|0|||
131885691|NCT01358578|474864188|FG005|Maintenance Period|Physician Decision|0|||
131885692|NCT01358578|474864183|FG000|Maintenance Period|Pregnancy|1|||
131885693|NCT01358578|474864184|FG001|Maintenance Period|Pregnancy|0|||
131885694|NCT01358578|474864185|FG002|Maintenance Period|Pregnancy|0|||
131885695|NCT01358578|474864186|FG003|Maintenance Period|Pregnancy|0|||
131885696|NCT01358578|474864187|FG004|Maintenance Period|Pregnancy|0|||
131885697|NCT01358578|474864188|FG005|Maintenance Period|Pregnancy|0|||
131885698|NCT01358578|474864183|FG000|Maintenance Period|Protocol deviation|7|||
131885699|NCT01358578|474864184|FG001|Maintenance Period|Protocol deviation|4|||
131885700|NCT01358578|474864185|FG002|Maintenance Period|Protocol deviation|0|||
131885701|NCT01358578|474864186|FG003|Maintenance Period|Protocol deviation|2|||
131885702|NCT01358578|474864187|FG004|Maintenance Period|Protocol deviation|2|||
131885703|NCT01358578|474864188|FG005|Maintenance Period|Protocol deviation|2|||
131885704|NCT01358578|474864183|FG000|Maintenance Period|Withdrawal by Subject|12|||
131885705|NCT01358578|474864184|FG001|Maintenance Period|Withdrawal by Subject|7|||
131885706|NCT01358578|474864185|FG002|Maintenance Period|Withdrawal by Subject|2|||
131885707|NCT01358578|474864186|FG003|Maintenance Period|Withdrawal by Subject|15|||
131885708|NCT01358578|474864187|FG004|Maintenance Period|Withdrawal by Subject|6|||
131885709|NCT01358578|474864188|FG005|Maintenance Period|Withdrawal by Subject|3|||
131885710|NCT01358578|474864183|FG000|Follow-up Period|Adverse Event|1|||
131885711|NCT01358578|474864184|FG001|Follow-up Period|Adverse Event|1|||
131885712|NCT01358578|474864185|FG002|Follow-up Period|Adverse Event|0|||
131885713|NCT01358578|474864186|FG003|Follow-up Period|Adverse Event|0|||
131885714|NCT01358578|474864187|FG004|Follow-up Period|Adverse Event|0|||
131885715|NCT01358578|474864188|FG005|Follow-up Period|Adverse Event|0|||
131885716|NCT01358578|474864183|FG000|Follow-up Period|Lack of Efficacy|3|||
131885717|NCT01358578|474864184|FG001|Follow-up Period|Lack of Efficacy|0|||
131885718|NCT01358578|474864185|FG002|Follow-up Period|Lack of Efficacy|4|||
131885719|NCT01358578|474864186|FG003|Follow-up Period|Lack of Efficacy|1|||
131885720|NCT01358578|474864187|FG004|Follow-up Period|Lack of Efficacy|0|||
131885721|NCT01358578|474864188|FG005|Follow-up Period|Lack of Efficacy|0|||
131885722|NCT01358578|474864183|FG000|Follow-up Period|Lost to Follow-up|0|||
131885723|NCT01358578|474864184|FG001|Follow-up Period|Lost to Follow-up|1|||
131547241|NCT03685591|473626355|FG006|Overall Study|Withdrawal by Subject|0|||
131547242|NCT03685591|473626356|FG007|Overall Study|Withdrawal by Subject|0|||
131885724|NCT01358578|474864185|FG002|Follow-up Period|Lost to Follow-up|0|||
131885725|NCT01358578|474864186|FG003|Follow-up Period|Lost to Follow-up|4|||
131885726|NCT01358578|474864187|FG004|Follow-up Period|Lost to Follow-up|0|||
131885727|NCT01358578|474864188|FG005|Follow-up Period|Lost to Follow-up|0|||
131885728|NCT01358578|474864183|FG000|Follow-up Period|non- compliance with study treatment|1|||
131885729|NCT01358578|474864184|FG001|Follow-up Period|non- compliance with study treatment|0|||
131885730|NCT01358578|474864185|FG002|Follow-up Period|non- compliance with study treatment|0|||
131885731|NCT01358578|474864186|FG003|Follow-up Period|non- compliance with study treatment|0|||
131885732|NCT01358578|474864187|FG004|Follow-up Period|non- compliance with study treatment|0|||
131885733|NCT01358578|474864188|FG005|Follow-up Period|non- compliance with study treatment|0|||
131885734|NCT01358578|474864183|FG000|Follow-up Period|Pregnancy|1|||
131885735|NCT01358578|474864184|FG001|Follow-up Period|Pregnancy|0|||
131885736|NCT01358578|474864185|FG002|Follow-up Period|Pregnancy|0|||
131885737|NCT01358578|474864186|FG003|Follow-up Period|Pregnancy|0|||
131885738|NCT01358578|474864187|FG004|Follow-up Period|Pregnancy|0|||
131885739|NCT01358578|474864188|FG005|Follow-up Period|Pregnancy|0|||
131885740|NCT01358578|474864183|FG000|Follow-up Period|Withdrawal by Subject|3|||
131885741|NCT01358578|474864184|FG001|Follow-up Period|Withdrawal by Subject|3|||
131885742|NCT01358578|474864185|FG002|Follow-up Period|Withdrawal by Subject|1|||
131885743|NCT01358578|474864186|FG003|Follow-up Period|Withdrawal by Subject|12|||
131885744|NCT01358578|474864187|FG004|Follow-up Period|Withdrawal by Subject|0|||
131885745|NCT01358578|474864188|FG005|Follow-up Period|Withdrawal by Subject|0|||
131885746|NCT01358578|474864183|FG000|Follow-up Period|Physician Decision|1|||
131885747|NCT01358578|474864184|FG001|Follow-up Period|Physician Decision|1|||
131885748|NCT01358578|474864185|FG002|Follow-up Period|Physician Decision|0|||
131885749|NCT01358578|474864186|FG003|Follow-up Period|Physician Decision|2|||
131885750|NCT01358578|474864187|FG004|Follow-up Period|Physician Decision|0|||
131885751|NCT01358578|474864188|FG005|Follow-up Period|Physician Decision|0|||
131885752|NCT05940077|474864189|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
131885753|NCT03605849|474864190|FG000|Overall Study|Adverse Event|20|||
131885754|NCT03605849|474864191|FG001|Overall Study|Adverse Event|21|||
131885755|NCT03605849|474864192|FG002|Overall Study|Adverse Event|29|||
131885756|NCT03605849|474864193|FG003|Overall Study|Adverse Event|11|||
131885757|NCT03605849|474864190|FG000|Overall Study|Lack of Efficacy|4|||
131885758|NCT03605849|474864191|FG001|Overall Study|Lack of Efficacy|7|||
131885759|NCT03605849|474864192|FG002|Overall Study|Lack of Efficacy|9|||
131885760|NCT03605849|474864193|FG003|Overall Study|Lack of Efficacy|2|||
131885761|NCT03605849|474864190|FG000|Overall Study|Lost to Follow-up|8|||
131885762|NCT03605849|474864191|FG001|Overall Study|Lost to Follow-up|8|||
131885763|NCT03605849|474864192|FG002|Overall Study|Lost to Follow-up|14|||
131885764|NCT03605849|474864193|FG003|Overall Study|Lost to Follow-up|11|||
131885765|NCT03605849|474864190|FG000|Overall Study|Non-compliance With IMP|6|||
131885766|NCT03605849|474864191|FG001|Overall Study|Non-compliance With IMP|5|||
131885767|NCT03605849|474864192|FG002|Overall Study|Non-compliance With IMP|2|||
131885768|NCT03605849|474864193|FG003|Overall Study|Non-compliance With IMP|1|||
131885769|NCT03605849|474864190|FG000|Overall Study|Protocol Deviation|1|||
131885770|NCT03605849|474864191|FG001|Overall Study|Protocol Deviation|2|||
131885771|NCT03605849|474864192|FG002|Overall Study|Protocol Deviation|1|||
131885772|NCT03605849|474864193|FG003|Overall Study|Protocol Deviation|3|||
131885773|NCT03605849|474864190|FG000|Overall Study|Withdrawal by Subject|33|||
131885774|NCT03605849|474864191|FG001|Overall Study|Withdrawal by Subject|28|||
131885775|NCT03605849|474864192|FG002|Overall Study|Withdrawal by Subject|30|||
131885776|NCT03605849|474864193|FG003|Overall Study|Withdrawal by Subject|28|||
131885777|NCT03605849|474864190|FG000|Overall Study|Site Terminated by Sponsor|0|||
131885778|NCT03605849|474864191|FG001|Overall Study|Site Terminated by Sponsor|0|||
131885779|NCT03605849|474864192|FG002|Overall Study|Site Terminated by Sponsor|0|||
131885780|NCT03605849|474864193|FG003|Overall Study|Site Terminated by Sponsor|1|||
131885781|NCT03605849|474864190|FG000|Overall Study|Physician Decision|2|||
131885782|NCT03605849|474864191|FG001|Overall Study|Physician Decision|1|||
131885783|NCT03605849|474864192|FG002|Overall Study|Physician Decision|2|||
131885784|NCT03605849|474864193|FG003|Overall Study|Physician Decision|1|||
131885785|NCT03605849|474864190|FG000|Overall Study|Enrolled, but not Treated|2|||
131885786|NCT03605849|474864191|FG001|Overall Study|Enrolled, but not Treated|2|||
131885787|NCT03605849|474864192|FG002|Overall Study|Enrolled, but not Treated|3|||
131885788|NCT03605849|474864193|FG003|Overall Study|Enrolled, but not Treated|2|||
131885789|NCT03605849|474864190|FG000|Overall Study|Other (COVID-19 Related)|0|||
131885790|NCT03605849|474864191|FG001|Overall Study|Other (COVID-19 Related)|1|||
131885791|NCT03605849|474864192|FG002|Overall Study|Other (COVID-19 Related)|1|||
131885792|NCT03605849|474864193|FG003|Overall Study|Other (COVID-19 Related)|0|||
131885793|NCT03605849|474864190|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
131885794|NCT03605849|474864191|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
131885795|NCT03605849|474864192|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
131885796|NCT03605849|474864193|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
131885797|NCT02304380|474864194|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
131885798|NCT02304380|474864195|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
131885799|NCT02304380|474864196|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
131885800|NCT02304380|474864197|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
131885801|NCT02304380|474864198|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
131885802|NCT02304380|474864199|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
131885803|NCT00577005|474864200|FG000|Overall Study|Lost to Follow-up|3|||
131885804|NCT00577005|474864201|FG001|Overall Study|Lost to Follow-up|2|||
131885805|NCT00577005|474864200|FG000|Overall Study|Withdrawal by Subject|2|||
131885806|NCT00577005|474864201|FG001|Overall Study|Withdrawal by Subject|1|||
131885807|NCT01004432|474864202|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
131885808|NCT01004432|474864203|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
131885809|NCT01004432|474864204|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
131885810|NCT01004432|474864205|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
131885811|NCT01004432|474864206|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
131547243|NCT03685591|473626357|FG008|Overall Study|Withdrawal by Subject|1|||
131547244|NCT03685591|473626349|FG000|Overall Study|Adverse Event|0|||
131547245|NCT03685591|473626350|FG001|Overall Study|Adverse Event|0|||
131547246|NCT03685591|473626351|FG002|Overall Study|Adverse Event|0|||
131547247|NCT03685591|473626352|FG003|Overall Study|Adverse Event|1|||
131547248|NCT03685591|473626353|FG004|Overall Study|Adverse Event|1|||
131547249|NCT03685591|473626354|FG005|Overall Study|Adverse Event|4|||
131547250|NCT03685591|473626355|FG006|Overall Study|Adverse Event|0|||
131547251|NCT03685591|473626356|FG007|Overall Study|Adverse Event|1|||
131547252|NCT03685591|473626357|FG008|Overall Study|Adverse Event|1|||
131547253|NCT00168038|473626358|FG000|Overall Study|Adverse Event|1|||
131547254|NCT00168038|473626358|FG000|Overall Study|Therapy failure|1|||
131547255|NCT01685138|473626359|FG000|Overall Study|Lost to Follow-up|1|||
131547256|NCT01685138|473626359|FG000|Overall Study|Protocol Violation|1|||
131547257|NCT01685138|473626359|FG000|Overall Study|No longer requires treatment|1|||
131547258|NCT01685138|473626359|FG000|Overall Study|Subject/guardian decision|2|||
131547259|NCT01685138|473626359|FG000|Overall Study|Physician Decision|6|||
131547260|NCT01685138|473626359|FG000|Overall Study|Death|10|||
131547261|NCT01685138|473626359|FG000|Overall Study|Adverse Event|18|||
131547262|NCT01685138|473626359|FG000|Overall Study|Progressive disease|53|||
131547263|NCT03078816|473626364|FG000|Overall Study|Withdrawal by Subject|1|||
131547264|NCT01648348|473626372|FG000|Overall Study|Cancel|1|||
131547265|NCT01648348|473626373|FG001|Overall Study|Cancel|0|||
131547266|NCT01648348|473626374|FG002|Overall Study|Cancel|0|||
131547267|NCT01648348|473626375|FG003|Overall Study|Cancel|0|||
131547268|NCT01648348|473626376|FG004|Overall Study|Cancel|3|||
131547269|NCT01648348|473626377|FG005|Overall Study|Cancel|6|||
131547270|NCT01648348|473626372|FG000|Overall Study|Replaced for MTD analysis|1|||
131885812|NCT01004432|474864202|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
131547271|NCT01648348|473626373|FG001|Overall Study|Replaced for MTD analysis|0|||
131547272|NCT01648348|473626374|FG002|Overall Study|Replaced for MTD analysis|1|||
131547273|NCT01648348|473626375|FG003|Overall Study|Replaced for MTD analysis|0|||
131547274|NCT01648348|473626376|FG004|Overall Study|Replaced for MTD analysis|0|||
131547275|NCT01648348|473626377|FG005|Overall Study|Replaced for MTD analysis|0|||
131547276|NCT01951638|473626380|FG000|Treatment Period|Protocol Violation|0|||
131547277|NCT01951638|473626381|FG001|Treatment Period|Protocol Violation|0|||
131547278|NCT01951638|473626382|FG002|Treatment Period|Protocol Violation|0|||
131547279|NCT01951638|473626383|FG003|Treatment Period|Protocol Violation|2|||
131547280|NCT01951638|473626384|FG004|Treatment Period|Protocol Violation|0|||
131547281|NCT01951638|473626380|FG000|Treatment Period|Protocol-driven decision point|1|||
131547282|NCT01951638|473626381|FG001|Treatment Period|Protocol-driven decision point|3|||
131547283|NCT01951638|473626382|FG002|Treatment Period|Protocol-driven decision point|0|||
131547284|NCT01951638|473626383|FG003|Treatment Period|Protocol-driven decision point|0|||
131547285|NCT01951638|473626384|FG004|Treatment Period|Protocol-driven decision point|0|||
131547286|NCT01951638|473626380|FG000|Treatment Period|Logistical difficulties|0|||
131547287|NCT01951638|473626381|FG001|Treatment Period|Logistical difficulties|1|||
131547288|NCT01951638|473626382|FG002|Treatment Period|Logistical difficulties|1|||
131547289|NCT01951638|473626383|FG003|Treatment Period|Logistical difficulties|0|||
131547290|NCT01951638|473626384|FG004|Treatment Period|Logistical difficulties|0|||
131547291|NCT01951638|473626380|FG000|Treatment Period|Withdrawal by Subject|9|||
131547292|NCT01951638|473626381|FG001|Treatment Period|Withdrawal by Subject|6|||
131547293|NCT01951638|473626382|FG002|Treatment Period|Withdrawal by Subject|4|||
131547294|NCT01951638|473626383|FG003|Treatment Period|Withdrawal by Subject|5|||
131547295|NCT01951638|473626384|FG004|Treatment Period|Withdrawal by Subject|4|||
131547296|NCT01951638|473626380|FG000|Treatment Period|Death|0|||
131547297|NCT01951638|473626381|FG001|Treatment Period|Death|0|||
131547298|NCT01951638|473626382|FG002|Treatment Period|Death|0|||
131547299|NCT01951638|473626383|FG003|Treatment Period|Death|3|||
131547300|NCT01951638|473626384|FG004|Treatment Period|Death|1|||
131885813|NCT01004432|474864203|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
131547301|NCT01951638|473626380|FG000|Treatment Period|Adverse Event|3|||
131547302|NCT01951638|473626381|FG001|Treatment Period|Adverse Event|4|||
131547303|NCT01951638|473626382|FG002|Treatment Period|Adverse Event|8|||
131547304|NCT01951638|473626383|FG003|Treatment Period|Adverse Event|6|||
131547305|NCT01951638|473626384|FG004|Treatment Period|Adverse Event|5|||
131885814|NCT01004432|474864204|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
131885815|NCT01004432|474864205|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
131885816|NCT01004432|474864206|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
131885817|NCT01004432|474864202|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
131885818|NCT01004432|474864203|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
131885819|NCT01004432|474864204|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
131885820|NCT01004432|474864205|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
131885821|NCT01004432|474864206|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
131885822|NCT01004432|474864202|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
131885823|NCT01004432|474864203|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
131885824|NCT01004432|474864204|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
131885825|NCT01004432|474864205|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
131885826|NCT01004432|474864206|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
131885827|NCT01004432|474864202|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
131885828|NCT01004432|474864203|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
131885829|NCT01004432|474864204|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
131885830|NCT01004432|474864205|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
131885831|NCT01004432|474864206|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
131885832|NCT01004432|474864202|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
131885833|NCT01004432|474864203|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
131885834|NCT01004432|474864204|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
131885835|NCT01004432|474864205|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
131885836|NCT01004432|474864206|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
131885837|NCT01004432|474864202|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
131885838|NCT01004432|474864203|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
131885839|NCT01004432|474864204|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
131885840|NCT01004432|474864205|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
131885841|NCT01004432|474864206|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
131885842|NCT01004432|474864202|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
131885843|NCT01004432|474864203|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
131885844|NCT01004432|474864204|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
131658912|NCT01214642|474035461|FG003|Overall Study|Death|0|||
131885845|NCT01004432|474864205|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
131885846|NCT01004432|474864206|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
131885847|NCT01004432|474864202|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
131885848|NCT01004432|474864203|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
131885849|NCT01004432|474864204|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
131885850|NCT01004432|474864205|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
131885851|NCT01004432|474864206|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
131885852|NCT01004432|474864202|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
131885853|NCT01004432|474864203|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
131885854|NCT01004432|474864204|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
131885855|NCT01004432|474864205|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
131885856|NCT01004432|474864206|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
131885857|NCT01004432|474864202|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
131885858|NCT01004432|474864203|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
131885859|NCT01004432|474864204|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
131885860|NCT01004432|474864205|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
131885861|NCT01004432|474864206|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
131885862|NCT01004432|474864202|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
131885863|NCT01004432|474864203|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
131885864|NCT01004432|474864204|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
131885865|NCT01004432|474864205|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
131885866|NCT01004432|474864206|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
131885867|NCT01004432|474864202|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
131885868|NCT01004432|474864203|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
131885869|NCT01004432|474864204|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
131885870|NCT01004432|474864205|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
131885871|NCT01004432|474864206|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
131885872|NCT01004432|474864202|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
131885873|NCT01004432|474864203|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
131885874|NCT01004432|474864204|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
131885875|NCT01004432|474864205|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
131885876|NCT01004432|474864206|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
131658913|NCT01214642|474035462|FG004|Overall Study|Death|0|||
131885877|NCT01004432|474864202|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
131885878|NCT01004432|474864203|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
131885879|NCT01004432|474864204|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
131885880|NCT01004432|474864205|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
131885881|NCT01004432|474864206|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
131885882|NCT02667626|474864207|FG000|Overall Study|Withdrawal by Subject|0|||
131885883|NCT02667626|474864208|FG001|Overall Study|Withdrawal by Subject|1|||
131885884|NCT00590538|474864209|FG000|Overall Study|Study terminated before completed|2|||
131885885|NCT01125813|474864210|FG000|Overall Study|Death|1|||
131885886|NCT01125813|474864210|FG000|Overall Study|Withdrawal by Subject|1|||
131885887|NCT01125813|474864210|FG000|Overall Study|Screen Failures|4|||
131885888|NCT02539134|474864211|FG000|Overall Study|Lost to Follow-up|1|||
131885889|NCT02539134|474864212|FG001|Overall Study|Lost to Follow-up|0|||
131885890|NCT02539134|474864213|FG002|Overall Study|Lost to Follow-up|0|||
131885891|NCT02539134|474864214|FG003|Overall Study|Lost to Follow-up|0|||
131885892|NCT02539134|474864215|FG004|Overall Study|Lost to Follow-up|0|||
131885893|NCT02539134|474864216|FG005|Overall Study|Lost to Follow-up|0|||
131885894|NCT00985426|474864217|FG000|Overall Study|Adverse Event|0|||
131885895|NCT00985426|474864218|FG001|Overall Study|Adverse Event|1|||
131885896|NCT00985426|474864217|FG000|Overall Study|Subject Non-Compliance|3|||
131885897|NCT00985426|474864218|FG001|Overall Study|Subject Non-Compliance|3|||
131885898|NCT00985426|474864217|FG000|Overall Study|Withdrawal by Subject|12|||
131885899|NCT00985426|474864218|FG001|Overall Study|Withdrawal by Subject|16|||
131885900|NCT00985426|474864217|FG000|Overall Study|Lost to Follow-up|8|||
131885901|NCT00985426|474864218|FG001|Overall Study|Lost to Follow-up|10|||
131885902|NCT00985426|474864217|FG000|Overall Study|Death|7|||
131885903|NCT00985426|474864218|FG001|Overall Study|Death|3|||
131885904|NCT00985426|474864217|FG000|Overall Study|Protocol Violation|2|||
131885905|NCT00985426|474864218|FG001|Overall Study|Protocol Violation|0|||
131885906|NCT00985426|474864217|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
131885907|NCT00985426|474864218|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
131885908|NCT02327013|474864219|FG000|Overall Study|Adverse Event|4|||
131885909|NCT02327013|474864220|FG001|Overall Study|Adverse Event|4|||
131885910|NCT02327013|474864221|FG002|Overall Study|Adverse Event|3|||
131885911|NCT02327013|474864222|FG003|Overall Study|Adverse Event|0|||
131885912|NCT02327013|474864223|FG004|Overall Study|Adverse Event|1|||
131885913|NCT02327013|474864219|FG000|Overall Study|Lack of Efficacy|2|||
131885914|NCT02327013|474864220|FG001|Overall Study|Lack of Efficacy|0|||
131885915|NCT02327013|474864221|FG002|Overall Study|Lack of Efficacy|5|||
131885916|NCT02327013|474864222|FG003|Overall Study|Lack of Efficacy|0|||
131885917|NCT02327013|474864223|FG004|Overall Study|Lack of Efficacy|1|||
131885918|NCT02327013|474864219|FG000|Overall Study|Non-compliance with IMP|1|||
131885919|NCT02327013|474864220|FG001|Overall Study|Non-compliance with IMP|2|||
131885920|NCT02327013|474864221|FG002|Overall Study|Non-compliance with IMP|7|||
131885921|NCT02327013|474864222|FG003|Overall Study|Non-compliance with IMP|0|||
131885922|NCT02327013|474864223|FG004|Overall Study|Non-compliance with IMP|0|||
131885923|NCT02327013|474864219|FG000|Overall Study|Withdrawal of Consent|1|||
131885924|NCT02327013|474864220|FG001|Overall Study|Withdrawal of Consent|0|||
131885925|NCT02327013|474864221|FG002|Overall Study|Withdrawal of Consent|3|||
131885926|NCT02327013|474864222|FG003|Overall Study|Withdrawal of Consent|0|||
131885927|NCT02327013|474864223|FG004|Overall Study|Withdrawal of Consent|0|||
131885928|NCT02327013|474864219|FG000|Overall Study|Lost to Follow-up|2|||
131885929|NCT02327013|474864220|FG001|Overall Study|Lost to Follow-up|4|||
131885930|NCT02327013|474864221|FG002|Overall Study|Lost to Follow-up|5|||
131885931|NCT02327013|474864222|FG003|Overall Study|Lost to Follow-up|0|||
131885932|NCT02327013|474864223|FG004|Overall Study|Lost to Follow-up|0|||
131885933|NCT02327013|474864219|FG000|Overall Study|Administrative or other reason(s)|1|||
131885934|NCT02327013|474864220|FG001|Overall Study|Administrative or other reason(s)|5|||
131885935|NCT02327013|474864221|FG002|Overall Study|Administrative or other reason(s)|11|||
131885936|NCT02327013|474864222|FG003|Overall Study|Administrative or other reason(s)|1|||
131885937|NCT02327013|474864223|FG004|Overall Study|Administrative or other reason(s)|1|||
131885938|NCT02327013|474864219|FG000|Overall Study|Protocol Violation|0|||
131885939|NCT02327013|474864220|FG001|Overall Study|Protocol Violation|0|||
131885940|NCT02327013|474864221|FG002|Overall Study|Protocol Violation|3|||
131885941|NCT02327013|474864222|FG003|Overall Study|Protocol Violation|0|||
131885942|NCT02327013|474864223|FG004|Overall Study|Protocol Violation|1|||
131885943|NCT02327013|474864219|FG000|Overall Study|Withdrawal before treatment|2|||
131885944|NCT02327013|474864220|FG001|Overall Study|Withdrawal before treatment|1|||
131885945|NCT02327013|474864221|FG002|Overall Study|Withdrawal before treatment|5|||
131885946|NCT02327013|474864222|FG003|Overall Study|Withdrawal before treatment|0|||
131885947|NCT02327013|474864223|FG004|Overall Study|Withdrawal before treatment|0|||
131885948|NCT02971800|474864224|FG000|Overall Study|Protocol Violation|1|||
131885949|NCT02971800|474864224|FG000|Overall Study|Withdrawal by Subject|1|||
131885950|NCT02971800|474864224|FG000|Overall Study|Exclusion criteria prior intervention|1|||
131885951|NCT02971800|474864224|FG000|Overall Study|Number evaluable participant already reached|4|||
131885952|NCT04258254|474864225|FG000|Overall Study|Withdrawal by Subject|0|||
131885953|NCT04258254|474864226|FG001|Overall Study|Withdrawal by Subject|1|||
131885954|NCT04258254|474864227|FG002|Overall Study|Withdrawal by Subject|0|||
131885955|NCT04829331|474864228|FG000|Overall Study|Lost to Follow-up|1|||
131885956|NCT04829331|474864229|FG001|Overall Study|Lost to Follow-up|0|||
131885957|NCT01149421|474864231|FG000|Overall Study|Adverse Event|22|||
131885958|NCT01149421|474864232|FG001|Overall Study|Adverse Event|6|||
131885959|NCT01149421|474864233|FG002|Overall Study|Adverse Event|11|||
131885960|NCT01149421|474864231|FG000|Overall Study|Withdrawal by Subject|20|||
131885961|NCT01149421|474864232|FG001|Overall Study|Withdrawal by Subject|12|||
131885962|NCT01149421|474864233|FG002|Overall Study|Withdrawal by Subject|13|||
131885963|NCT01149421|474864231|FG000|Overall Study|Sponsor Decision|0|||
131885964|NCT01149421|474864232|FG001|Overall Study|Sponsor Decision|1|||
131885965|NCT01149421|474864233|FG002|Overall Study|Sponsor Decision|1|||
131885966|NCT01149421|474864231|FG000|Overall Study|Lost to Follow-up|2|||
131885967|NCT01149421|474864232|FG001|Overall Study|Lost to Follow-up|4|||
131885968|NCT01149421|474864233|FG002|Overall Study|Lost to Follow-up|5|||
131885969|NCT01149421|474864231|FG000|Overall Study|Physician Decision|5|||
131885970|NCT01149421|474864232|FG001|Overall Study|Physician Decision|3|||
131885971|NCT01149421|474864233|FG002|Overall Study|Physician Decision|6|||
131885972|NCT01149421|474864231|FG000|Overall Study|Entry Criteria Not Met|1|||
131885973|NCT01149421|474864232|FG001|Overall Study|Entry Criteria Not Met|1|||
131885974|NCT01149421|474864233|FG002|Overall Study|Entry Criteria Not Met|2|||
131885975|NCT01149421|474864231|FG000|Overall Study|Protocol Violation|2|||
131885976|NCT01149421|474864232|FG001|Overall Study|Protocol Violation|2|||
131885977|NCT01149421|474864233|FG002|Overall Study|Protocol Violation|6|||
131885978|NCT00616603|474864234|FG000|Overall Study|Physician Decision|2|||
131885979|NCT00616603|474864235|FG001|Overall Study|Physician Decision|0|||
131885980|NCT00616603|474864236|FG002|Overall Study|Physician Decision|2|||
131885981|NCT03570554|474864241|FG000|Overall Study|Non-compliance with study drug|0|||
131885982|NCT03570554|474864242|FG001|Overall Study|Non-compliance with study drug|0|||
131885983|NCT03570554|474864243|FG002|Overall Study|Non-compliance with study drug|1|||
131885984|NCT03570554|474864244|FG003|Overall Study|Non-compliance with study drug|0|||
131547306|NCT01951638|473626380|FG000|Follow-up Period|Protocol Violation|0|||
131547307|NCT01951638|473626381|FG001|Follow-up Period|Protocol Violation|0|||
131547308|NCT01951638|473626382|FG002|Follow-up Period|Protocol Violation|0|||
131547309|NCT01951638|473626383|FG003|Follow-up Period|Protocol Violation|1|||
131547310|NCT01951638|473626384|FG004|Follow-up Period|Protocol Violation|0|||
131547311|NCT01951638|473626380|FG000|Follow-up Period|Logistical difficulties|0|||
131547312|NCT01951638|473626381|FG001|Follow-up Period|Logistical difficulties|2|||
131547313|NCT01951638|473626382|FG002|Follow-up Period|Logistical difficulties|0|||
131547314|NCT01951638|473626383|FG003|Follow-up Period|Logistical difficulties|0|||
131547315|NCT01951638|473626384|FG004|Follow-up Period|Logistical difficulties|1|||
131547316|NCT01951638|473626380|FG000|Follow-up Period|Withdrawal by Subject|1|||
131547317|NCT01951638|473626381|FG001|Follow-up Period|Withdrawal by Subject|5|||
131547318|NCT01951638|473626382|FG002|Follow-up Period|Withdrawal by Subject|2|||
131547319|NCT01951638|473626383|FG003|Follow-up Period|Withdrawal by Subject|1|||
131547320|NCT01951638|473626384|FG004|Follow-up Period|Withdrawal by Subject|2|||
131547321|NCT01951638|473626380|FG000|Follow-up Period|Lost to Follow-up|0|||
131547322|NCT01951638|473626381|FG001|Follow-up Period|Lost to Follow-up|1|||
131547323|NCT01951638|473626382|FG002|Follow-up Period|Lost to Follow-up|0|||
131547324|NCT01951638|473626383|FG003|Follow-up Period|Lost to Follow-up|1|||
131547325|NCT01951638|473626384|FG004|Follow-up Period|Lost to Follow-up|0|||
131547326|NCT01951638|473626380|FG000|Follow-up Period|Death|1|||
131547327|NCT01951638|473626381|FG001|Follow-up Period|Death|0|||
131547328|NCT01951638|473626382|FG002|Follow-up Period|Death|1|||
131547329|NCT01951638|473626383|FG003|Follow-up Period|Death|4|||
131547330|NCT01951638|473626384|FG004|Follow-up Period|Death|1|||
131547331|NCT01951638|473626380|FG000|Follow-up Period|Adverse Event|0|||
131547332|NCT01951638|473626381|FG001|Follow-up Period|Adverse Event|1|||
131547333|NCT01951638|473626382|FG002|Follow-up Period|Adverse Event|2|||
131547334|NCT01951638|473626383|FG003|Follow-up Period|Adverse Event|1|||
131547335|NCT01951638|473626384|FG004|Follow-up Period|Adverse Event|1|||
131547336|NCT00459342|473626386|FG000|Overall Study|Not eligible|1|||
131547337|NCT00552084|473626387|FG000|Overall Study|Adverse Event|2|||
131547338|NCT00552084|473626388|FG001|Overall Study|Adverse Event|3|||
131547339|NCT00552084|473626387|FG000|Overall Study|Withdrawal by Subject|4|||
131885985|NCT03570554|474864241|FG000|Overall Study|Adverse Event|0|||
131885986|NCT03570554|474864242|FG001|Overall Study|Adverse Event|0|||
131885987|NCT03570554|474864243|FG002|Overall Study|Adverse Event|0|||
131885988|NCT03570554|474864244|FG003|Overall Study|Adverse Event|1|||
131885989|NCT03738800|474864248|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
131547340|NCT00552084|473626388|FG001|Overall Study|Withdrawal by Subject|5|||
131885990|NCT03738800|474864249|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131885991|NCT03738800|474864250|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131885992|NCT03738800|474864248|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
131885993|NCT03738800|474864249|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
131547341|NCT00552084|473626387|FG000|Overall Study|Protocol Violation|1|||
131885994|NCT03738800|474864250|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
131885995|NCT03738800|474864248|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
131885996|NCT03738800|474864249|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
131885997|NCT03738800|474864250|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
131885998|NCT00766467|474864260|FG000|Overall Study|Withdrawal by Subject|7|||
131885999|NCT00766467|474864261|FG001|Overall Study|Withdrawal by Subject|2|||
131886000|NCT00766467|474864260|FG000|Overall Study|Adverse Event|1|||
131886001|NCT00766467|474864261|FG001|Overall Study|Adverse Event|1|||
131886002|NCT00766467|474864260|FG000|Overall Study|Protocol Violation|2|||
131886003|NCT00766467|474864261|FG001|Overall Study|Protocol Violation|4|||
131886004|NCT00766467|474864260|FG000|Overall Study|Tumor Progression on Study|0|||
131886005|NCT00766467|474864261|FG001|Overall Study|Tumor Progression on Study|1|||
131886006|NCT00766467|474864260|FG000|Overall Study|Physician Decision|1|||
131886007|NCT00766467|474864261|FG001|Overall Study|Physician Decision|0|||
131886008|NCT02223819|474864265|FG000|Overall Study|Lost to Follow-up|2|||
131886009|NCT02956057|474864267|FG000|Overall Study|Discontinued intervention|14|||
131886010|NCT02956057|474864268|FG001|Overall Study|Discontinued intervention|10|||
131886011|NCT02956057|474864269|FG002|Overall Study|Discontinued intervention|7|||
131886012|NCT02956057|474864270|FG003|Overall Study|Discontinued intervention|14|||
131886013|NCT02956057|474864271|FG004|Overall Study|Discontinued intervention|4|||
131886014|NCT02956057|474864272|FG005|Overall Study|Discontinued intervention|17|||
131886015|NCT02956057|474864267|FG000|Overall Study|Lost to Follow-up|0|||
131886016|NCT02956057|474864268|FG001|Overall Study|Lost to Follow-up|2|||
131886017|NCT02956057|474864269|FG002|Overall Study|Lost to Follow-up|1|||
131886018|NCT02956057|474864270|FG003|Overall Study|Lost to Follow-up|1|||
131886019|NCT02956057|474864271|FG004|Overall Study|Lost to Follow-up|1|||
131886020|NCT02956057|474864272|FG005|Overall Study|Lost to Follow-up|0|||
131886021|NCT00367484|474864279|FG000|Overall Study|Adverse Event|7|||
131886022|NCT00367484|474864279|FG000|Overall Study|Withdrew informed consent|5|||
131886023|NCT00367484|474864279|FG000|Overall Study|Travel to USA|1|||
131886024|NCT00367484|474864279|FG000|Overall Study|Lost to Follow-up|1|||
131886025|NCT00367484|474864279|FG000|Overall Study|Protocol Violation|1|||
131886026|NCT00367484|474864279|FG000|Overall Study|The choice of the patient|1|||
131886027|NCT00367484|474864279|FG000|Overall Study|Lack of Efficacy|1|||
131886028|NCT01404208|474864280|FG000|Overall Study|Discontinued|3|||
131886029|NCT01404208|474864281|FG001|Overall Study|Discontinued|0|||
131886030|NCT00908076|474864282|FG000|Overall Study|Lack of Efficacy|1|||
131886031|NCT00908076|474864283|FG001|Overall Study|Lack of Efficacy|1|||
131886032|NCT02382796|474864284|FG000|Overall Study|Global deterioration of health status|1|||
131886033|NCT02382796|474864284|FG000|Overall Study|Objective progression or relapse|3|||
131886034|NCT02382796|474864284|FG000|Overall Study|Commercial dacomitinib became available|3|||
131886035|NCT04007107|474864291|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
131886036|NCT04007107|474864292|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
131886037|NCT04007107|474864293|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
131886038|NCT04007107|474864294|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
131886039|NCT04068688|474864300|FG000|Overall Study|Lost to Follow-up|1|||
131886040|NCT04068688|474864301|FG001|Overall Study|Lost to Follow-up|1|||
131886041|NCT04068688|474864302|FG002|Overall Study|Lost to Follow-up|0|||
131886042|NCT04068688|474864303|FG003|Overall Study|Lost to Follow-up|0|||
131886043|NCT04068688|474864304|FG004|Overall Study|Lost to Follow-up|5|||
131886044|NCT04068688|474864305|FG005|Overall Study|Lost to Follow-up|5|||
131886045|NCT04068688|474864306|FG006|Overall Study|Lost to Follow-up|0|||
131886046|NCT04068688|474864307|FG007|Overall Study|Lost to Follow-up|0|||
131886047|NCT04068688|474864308|FG008|Overall Study|Lost to Follow-up|1|||
131886048|NCT04068688|474864309|FG009|Overall Study|Lost to Follow-up|0|||
131886049|NCT04068688|474864300|FG000|Overall Study|Withdrawal by Subject|1|||
131886050|NCT04068688|474864301|FG001|Overall Study|Withdrawal by Subject|1|||
131886051|NCT04068688|474864302|FG002|Overall Study|Withdrawal by Subject|0|||
131886052|NCT04068688|474864303|FG003|Overall Study|Withdrawal by Subject|0|||
131886053|NCT04068688|474864304|FG004|Overall Study|Withdrawal by Subject|0|||
131886054|NCT04068688|474864305|FG005|Overall Study|Withdrawal by Subject|0|||
131886055|NCT04068688|474864306|FG006|Overall Study|Withdrawal by Subject|0|||
131886056|NCT04068688|474864307|FG007|Overall Study|Withdrawal by Subject|0|||
131886057|NCT04068688|474864308|FG008|Overall Study|Withdrawal by Subject|0|||
131886058|NCT04068688|474864309|FG009|Overall Study|Withdrawal by Subject|0|||
131886059|NCT04068688|474864300|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
131886060|NCT04068688|474864301|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
131886061|NCT04068688|474864302|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886062|NCT04068688|474864303|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886063|NCT04068688|474864304|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886064|NCT04068688|474864305|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886065|NCT04068688|474864306|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886066|NCT04068688|474864307|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886067|NCT04068688|474864308|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886068|NCT04068688|474864309|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
131886069|NCT04679051|474864310|FG000|Overall Study|felt tired after restricted time in bed|3|||
131886070|NCT04679051|474864311|FG001|Overall Study|felt tired after restricted time in bed|0|||
131886071|NCT04679051|474864310|FG000|Overall Study|discomfort with blood pressure cuff|2|||
131886072|NCT04679051|474864311|FG001|Overall Study|discomfort with blood pressure cuff|0|||
131886073|NCT04679051|474864310|FG000|Overall Study|scheduling conflict|1|||
131886074|NCT04679051|474864311|FG001|Overall Study|scheduling conflict|1|||
131886075|NCT04679051|474864310|FG000|Overall Study|Protocol Violation|0|||
131886076|NCT04679051|474864311|FG001|Overall Study|Protocol Violation|4|||
131886077|NCT02554318|474864312|FG000|Overall Study|Withdrawal by Subject|10|||
131886078|NCT02554318|474864313|FG001|Overall Study|Withdrawal by Subject|8|||
131886079|NCT03515629|474864315|FG000|Overall Study|Death|0|||
131886080|NCT03515629|474864316|FG001|Overall Study|Death|1|||
131886081|NCT03515629|474864317|FG002|Overall Study|Death|1|||
131886082|NCT03515629|474864315|FG000|Overall Study|Progressive disease|0|||
131886083|NCT03515629|474864316|FG001|Overall Study|Progressive disease|1|||
131886084|NCT03515629|474864317|FG002|Overall Study|Progressive disease|0|||
131886085|NCT01522235|474864318|FG000|Overall Study|Physician Decision|1|||
131886086|NCT01522235|474864319|FG001|Overall Study|Physician Decision|1|||
131886087|NCT01273155|474864324|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
131886088|NCT01273155|474864325|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
131886089|NCT01273155|474864326|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
131886090|NCT01273155|474864327|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
131886091|NCT01273155|474864328|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
131886092|NCT01273155|474864329|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
131886093|NCT01273155|474864330|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
131886094|NCT01273155|474864324|FG000|Overall Study|Change in liver function/no longer eval.|0|||
131886095|NCT01273155|474864325|FG001|Overall Study|Change in liver function/no longer eval.|1|||
131886096|NCT01273155|474864326|FG002|Overall Study|Change in liver function/no longer eval.|0|||
131886097|NCT01273155|474864327|FG003|Overall Study|Change in liver function/no longer eval.|0|||
131886098|NCT01273155|474864328|FG004|Overall Study|Change in liver function/no longer eval.|1|||
131886099|NCT01273155|474864329|FG005|Overall Study|Change in liver function/no longer eval.|0|||
131886100|NCT01273155|474864330|FG006|Overall Study|Change in liver function/no longer eval.|0|||
131886101|NCT01273155|474864324|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
131886102|NCT01273155|474864325|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
131886103|NCT01273155|474864326|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
131886104|NCT01273155|474864327|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
131886105|NCT01273155|474864328|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
131886106|NCT01273155|474864329|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
131886107|NCT01273155|474864330|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
131886108|NCT01273155|474864324|FG000|Overall Study|Died during Cycle 1|0|||
131886109|NCT01273155|474864325|FG001|Overall Study|Died during Cycle 1|0|||
131886110|NCT01273155|474864326|FG002|Overall Study|Died during Cycle 1|1|||
131886111|NCT01273155|474864327|FG003|Overall Study|Died during Cycle 1|1|||
131886112|NCT01273155|474864328|FG004|Overall Study|Died during Cycle 1|0|||
131886113|NCT01273155|474864329|FG005|Overall Study|Died during Cycle 1|2|||
131886114|NCT01273155|474864330|FG006|Overall Study|Died during Cycle 1|2|||
131886115|NCT01273155|474864324|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
131886116|NCT01273155|474864325|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
131886117|NCT01273155|474864326|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
131886118|NCT01273155|474864327|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
131886119|NCT01273155|474864328|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
131886120|NCT01273155|474864329|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
131886121|NCT01273155|474864330|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
131886122|NCT00337779|474864338|FG000|Overall Study|Withdrawal by Subject|10|||
131886123|NCT00337779|474864339|FG001|Overall Study|Withdrawal by Subject|12|||
131886124|NCT00337779|474864338|FG000|Overall Study|Sponsor decision|1|||
131886125|NCT00337779|474864339|FG001|Overall Study|Sponsor decision|1|||
131886126|NCT00337779|474864338|FG000|Overall Study|Physician Decision|3|||
131886127|NCT00337779|474864339|FG001|Overall Study|Physician Decision|6|||
131547342|NCT00552084|473626388|FG001|Overall Study|Protocol Violation|0|||
131547343|NCT00552084|473626387|FG000|Overall Study|change in anti-arrythmic drug|1|||
131886128|NCT00337779|474864338|FG000|Overall Study|Protocol Violation|1|||
131886129|NCT00337779|474864339|FG001|Overall Study|Protocol Violation|1|||
131886130|NCT00337779|474864338|FG000|Overall Study|Lost to Follow-up|6|||
131886131|NCT00337779|474864339|FG001|Overall Study|Lost to Follow-up|5|||
131886132|NCT00337779|474864338|FG000|Overall Study|Adverse Event|28|||
131886133|NCT00337779|474864339|FG001|Overall Study|Adverse Event|51|||
131886134|NCT00337779|474864338|FG000|Overall Study|Pregnancy|3|||
131886135|NCT00337779|474864339|FG001|Overall Study|Pregnancy|2|||
131886136|NCT00337779|474864338|FG000|Overall Study|Death|0|||
131886137|NCT00337779|474864339|FG001|Overall Study|Death|1|||
131886138|NCT00513357|474864340|FG000|Overall Study|did not receive allocated placebo|2|||
131886139|NCT00513357|474864341|FG001|Overall Study|did not receive allocated placebo|3|||
131886140|NCT00513357|474864340|FG000|Overall Study|Adverse Event|4|||
131886141|NCT00513357|474864341|FG001|Overall Study|Adverse Event|2|||
131886142|NCT00513357|474864340|FG000|Overall Study|Death|2|||
131886143|NCT00513357|474864341|FG001|Overall Study|Death|0|||
131886144|NCT00513357|474864340|FG000|Overall Study|Withdrawal by Subject|5|||
131886145|NCT00513357|474864341|FG001|Overall Study|Withdrawal by Subject|4|||
131886146|NCT00513357|474864340|FG000|Overall Study|Disease Progression|2|||
131886147|NCT00513357|474864341|FG001|Overall Study|Disease Progression|1|||
131886148|NCT01162122|474864342|FG000|Overall Study|Withdrawal by Subject|52|||
131886149|NCT01162122|474864343|FG001|Overall Study|Withdrawal by Subject|43|||
131886150|NCT01162122|474864342|FG000|Overall Study|Lost to Follow-up|73|||
131886151|NCT01162122|474864343|FG001|Overall Study|Lost to Follow-up|91|||
131886152|NCT01162122|474864342|FG000|Overall Study|Adverse Event|3|||
131886153|NCT01162122|474864343|FG001|Overall Study|Adverse Event|2|||
131886154|NCT01162122|474864342|FG000|Overall Study|Death|51|||
131886155|NCT01162122|474864343|FG001|Overall Study|Death|46|||
131886156|NCT01162122|474864342|FG000|Overall Study|Protocol Violation|2|||
131886157|NCT01162122|474864343|FG001|Overall Study|Protocol Violation|2|||
131886158|NCT01162122|474864342|FG000|Overall Study|Inappropriate enrollment|5|||
131886159|NCT01162122|474864343|FG001|Overall Study|Inappropriate enrollment|4|||
131886160|NCT01162122|474864342|FG000|Overall Study|Administrative reason|1|||
131886161|NCT01162122|474864343|FG001|Overall Study|Administrative reason|1|||
131886162|NCT01162122|474864342|FG000|Overall Study|Unable to classify|3|||
131886163|NCT01162122|474864343|FG001|Overall Study|Unable to classify|7|||
131886164|NCT01162122|474864342|FG000|Overall Study|Missing primary reason|1|||
131886165|NCT01162122|474864343|FG001|Overall Study|Missing primary reason|0|||
131886166|NCT00990665|474864344|FG000|Overall Study|Unsuccessful Implant|8|||
131886167|NCT00990665|474864344|FG000|Overall Study|Death|29|||
131886168|NCT00990665|474864344|FG000|Overall Study|Heart Transplant|1|||
131886169|NCT00990665|474864344|FG000|Overall Study|Withdrawal by Subject|6|||
131886170|NCT00990665|474864344|FG000|Overall Study|Lost to Follow-up|1|||
131886171|NCT00990665|474864344|FG000|Overall Study|System Explant|3|||
131886172|NCT03578146|474864345|FG000|Overall Study|Did Not Receive Treatment|1|||
131886173|NCT03578146|474864346|FG001|Overall Study|Did Not Receive Treatment|0|||
131886174|NCT03578146|474864347|FG002|Overall Study|Did Not Receive Treatment|0|||
131886175|NCT03578146|474864348|FG003|Overall Study|Did Not Receive Treatment|0|||
131886176|NCT03578146|474864349|FG004|Overall Study|Did Not Receive Treatment|0|||
131886177|NCT03578146|474864350|FG005|Overall Study|Did Not Receive Treatment|2|||
131886178|NCT03578146|474864345|FG000|Overall Study|Lost to Follow-up|0|||
131886179|NCT03578146|474864346|FG001|Overall Study|Lost to Follow-up|1|||
131886180|NCT03578146|474864347|FG002|Overall Study|Lost to Follow-up|1|||
131886181|NCT03578146|474864348|FG003|Overall Study|Lost to Follow-up|0|||
131886182|NCT03578146|474864349|FG004|Overall Study|Lost to Follow-up|0|||
131886183|NCT03578146|474864350|FG005|Overall Study|Lost to Follow-up|1|||
131886184|NCT01717391|474864351|FG000|Overall Study|Withdrawal by Subject|5|||
131886185|NCT01717391|474864351|FG000|Overall Study|Physician Decision|1|||
131886186|NCT01717391|474864351|FG000|Overall Study|FLT technical failure|3|||
131886187|NCT03677934|474864352|FG000|Overall Study|Adverse Event|1|||
131886188|NCT03677934|474864353|FG001|Overall Study|Adverse Event|1|||
131886189|NCT03677934|474864352|FG000|Overall Study|Death|8|||
131886190|NCT03677934|474864353|FG001|Overall Study|Death|4|||
131886191|NCT03677934|474864352|FG000|Overall Study|Lost to Follow-up|3|||
131886192|NCT03677934|474864353|FG001|Overall Study|Lost to Follow-up|0|||
131886193|NCT03677934|474864352|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131886194|NCT03677934|474864353|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131886195|NCT03677934|474864352|FG000|Overall Study|Physician Decision|0|||
131886196|NCT03677934|474864353|FG001|Overall Study|Physician Decision|1|||
131886197|NCT03677934|474864352|FG000|Overall Study|Withdrawal by Subject|1|||
131886198|NCT03677934|474864353|FG001|Overall Study|Withdrawal by Subject|7|||
131886199|NCT01731470|474864355|FG000|Overall Study|Withdrawal by Subject|1|||
131886200|NCT01731470|474864355|FG000|Overall Study|Did not meet study criteria|1|||
131886201|NCT00335959|474864356|FG000|Overall Study|Adverse Event|2|||
131886202|NCT00335959|474864356|FG000|Overall Study|Ineligible|1|||
131886203|NCT02450552|474864359|FG000|Overall Study|Withdrawal by Subject|4|||
131886204|NCT02450552|474864360|FG001|Overall Study|Withdrawal by Subject|0|||
131886205|NCT02450552|474864361|FG002|Overall Study|Withdrawal by Subject|4|||
131886206|NCT02450552|474864359|FG000|Overall Study|Physician Decision|1|||
131886207|NCT02450552|474864360|FG001|Overall Study|Physician Decision|0|||
131886208|NCT02450552|474864361|FG002|Overall Study|Physician Decision|1|||
131886209|NCT01876979|474864368|FG000|Overall Study|Physician Decision|2|||
131886210|NCT01876979|474864369|FG001|Overall Study|Physician Decision|3|||
131886211|NCT00948506|474864370|FG000|Overall Study|Withdrawal by Subject|3|||
131886212|NCT00948506|474864371|FG001|Overall Study|Withdrawal by Subject|1|||
131886213|NCT00824382|474864372|FG000|Overall Study|Adverse Event|4|||
131886214|NCT00824382|474864373|FG001|Overall Study|Adverse Event|1|||
131886215|NCT00824382|474864374|FG002|Overall Study|Adverse Event|1|||
131886216|NCT00824382|474864375|FG003|Overall Study|Adverse Event|4|||
131886217|NCT00824382|474864372|FG000|Overall Study|Protocol Violation|1|||
131886218|NCT00824382|474864373|FG001|Overall Study|Protocol Violation|0|||
131886219|NCT00824382|474864374|FG002|Overall Study|Protocol Violation|0|||
131886220|NCT00824382|474864375|FG003|Overall Study|Protocol Violation|1|||
131886221|NCT00824382|474864372|FG000|Overall Study|Investigator's decision|0|||
131886222|NCT00824382|474864373|FG001|Overall Study|Investigator's decision|1|||
131886223|NCT00824382|474864374|FG002|Overall Study|Investigator's decision|2|||
131886224|NCT00824382|474864375|FG003|Overall Study|Investigator's decision|0|||
131886225|NCT00721279|474864376|FG000|Overall Study|Lack of Efficacy|6|||
131886226|NCT00721279|474864377|FG001|Overall Study|Lack of Efficacy|3|||
131886227|NCT00721279|474864376|FG000|Overall Study|Tolerability insufficient|5|||
131886228|NCT00721279|474864377|FG001|Overall Study|Tolerability insufficient|2|||
131886229|NCT00721279|474864376|FG000|Overall Study|Withdrawal by Subject|13|||
131886230|NCT00721279|474864377|FG001|Overall Study|Withdrawal by Subject|3|||
131886231|NCT00721279|474864376|FG000|Overall Study|Other|12|||
131886232|NCT00721279|474864377|FG001|Overall Study|Other|16|||
131886233|NCT03467763|474864378|FG000|Overall Study|Lost to Follow-up|1|||
131886234|NCT03467763|474864378|FG000|Overall Study|Protocol Violation|2|||
131886235|NCT00131365|474864379|FG000|Overall Study|Withdrawal by Subject|1|||
131886236|NCT00131365|474864379|FG000|Overall Study|Alternative treatment|3|||
131886237|NCT04608344|474864380|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
131886238|NCT04608344|474864381|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
131886239|NCT04608344|474864380|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
131886240|NCT04608344|474864381|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
131886241|NCT00415597|474864382|FG000|Enrollment|Withdrawal by Subject|1|||
131886242|NCT00415597|474864382|FG000|Enrollment|Protocol Violation|1|||
131886243|NCT00415597|474864382|FG000|Treatment|Adverse Event|110|||
131886244|NCT00415597|474864382|FG000|Treatment|Lack of Efficacy|39|||
131886245|NCT00415597|474864382|FG000|Treatment|Protocol Violation|67|||
131886246|NCT00415597|474864382|FG000|Treatment|Physician Decision|3|||
131886247|NCT00415597|474864382|FG000|Treatment|Withdrawal by Subject|51|||
131886248|NCT00415597|474864382|FG000|Treatment|Lost to Follow-up|28|||
131886249|NCT00415597|474864382|FG000|Treatment|Drug Screen|2|||
131886250|NCT00415597|474864382|FG000|Treatment|Administrative|3|||
131886251|NCT00415597|474864382|FG000|Treatment|Sponsor Decision|1|||
131886252|NCT00415597|474864382|FG000|Treatment|Multiple Reasons|1|||
131886253|NCT01764997|474864383|FG000|Run-in Period|Adverse Event|15|||
131886254|NCT01764997|474864384|FG001|Run-in Period|Adverse Event|0|||
131886255|NCT01764997|474864385|FG002|Run-in Period|Adverse Event|0|||
131886256|NCT01764997|474864386|FG003|Run-in Period|Adverse Event|0|||
131886257|NCT01764997|474864387|FG004|Run-in Period|Adverse Event|0|||
131886258|NCT01764997|474864383|FG000|Run-in Period|Lack of Efficacy|5|||
131886259|NCT01764997|474864384|FG001|Run-in Period|Lack of Efficacy|0|||
131886260|NCT01764997|474864385|FG002|Run-in Period|Lack of Efficacy|0|||
131886261|NCT01764997|474864386|FG003|Run-in Period|Lack of Efficacy|0|||
131886262|NCT01764997|474864387|FG004|Run-in Period|Lack of Efficacy|0|||
131886263|NCT01764997|474864383|FG000|Run-in Period|Poor compliance to protocol|1|||
131886264|NCT01764997|474864384|FG001|Run-in Period|Poor compliance to protocol|0|||
131886265|NCT01764997|474864385|FG002|Run-in Period|Poor compliance to protocol|0|||
131886266|NCT01764997|474864386|FG003|Run-in Period|Poor compliance to protocol|0|||
131886267|NCT01764997|474864387|FG004|Run-in Period|Poor compliance to protocol|0|||
131886268|NCT01764997|474864383|FG000|Run-in Period|Other than specified above|17|||
131886269|NCT01764997|474864384|FG001|Run-in Period|Other than specified above|0|||
131886270|NCT01764997|474864385|FG002|Run-in Period|Other than specified above|0|||
131886271|NCT01764997|474864386|FG003|Run-in Period|Other than specified above|0|||
131886272|NCT01764997|474864387|FG004|Run-in Period|Other than specified above|0|||
131886273|NCT01764997|474864383|FG000|Study Drug Treatment Period|Adverse Event|0|||
131886274|NCT01764997|474864384|FG001|Study Drug Treatment Period|Adverse Event|1|||
131886275|NCT01764997|474864385|FG002|Study Drug Treatment Period|Adverse Event|0|||
131886276|NCT01764997|474864386|FG003|Study Drug Treatment Period|Adverse Event|0|||
131886277|NCT01764997|474864387|FG004|Study Drug Treatment Period|Adverse Event|24|||
131886278|NCT01764997|474864383|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
131886279|NCT01764997|474864384|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
131886280|NCT01764997|474864385|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
131886281|NCT01764997|474864386|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
131886282|NCT01764997|474864387|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
131886283|NCT01764997|474864383|FG000|Study Drug Treatment Period|Other than specified above|0|||
131886284|NCT01764997|474864384|FG001|Study Drug Treatment Period|Other than specified above|0|||
131886285|NCT01764997|474864385|FG002|Study Drug Treatment Period|Other than specified above|0|||
131886286|NCT01764997|474864386|FG003|Study Drug Treatment Period|Other than specified above|0|||
131886287|NCT01764997|474864387|FG004|Study Drug Treatment Period|Other than specified above|10|||
131886288|NCT00224406|474866139|FG000|Overall Study|Re-transplant|0|||
131658914|NCT01214642|474035463|FG005|Overall Study|Death|0|||
131886289|NCT00224406|474866140|FG001|Overall Study|Re-transplant|2|||
131886290|NCT00224406|474866139|FG000|Overall Study|Death|0|||
131886291|NCT00224406|474866140|FG001|Overall Study|Death|1|||
131886292|NCT00224406|474866139|FG000|Overall Study|Transplant cancelled|0|||
131886293|NCT00224406|474866140|FG001|Overall Study|Transplant cancelled|4|||
131886294|NCT00224406|474866139|FG000|Overall Study|Drug not delivered|2|||
131886295|NCT00224406|474866140|FG001|Overall Study|Drug not delivered|0|||
131886296|NCT00224406|474866139|FG000|Overall Study|Other|4|||
131886297|NCT00224406|474866140|FG001|Overall Study|Other|0|||
131886298|NCT00224406|474866139|FG000|Overall Study|Transplant cancelled|3|||
131886299|NCT00224406|474866140|FG001|Overall Study|Transplant cancelled|0|||
131886300|NCT01556997|474866141|FG000|Overall Study|Adverse Event|10|||
131886301|NCT01556997|474866142|FG001|Overall Study|Adverse Event|12|||
131886302|NCT01556997|474866143|FG002|Overall Study|Adverse Event|12|||
131886303|NCT01556997|474866141|FG000|Overall Study|Lost to Follow-up|6|||
131886304|NCT01556997|474866142|FG001|Overall Study|Lost to Follow-up|6|||
131886305|NCT01556997|474866143|FG002|Overall Study|Lost to Follow-up|4|||
131886306|NCT01556997|474866141|FG000|Overall Study|Physician Decision|1|||
131886307|NCT01556997|474866142|FG001|Overall Study|Physician Decision|1|||
131886308|NCT01556997|474866143|FG002|Overall Study|Physician Decision|1|||
131886309|NCT01556997|474866141|FG000|Overall Study|Withdrawal by Subject|7|||
131886310|NCT01556997|474866142|FG001|Overall Study|Withdrawal by Subject|6|||
131886311|NCT01556997|474866143|FG002|Overall Study|Withdrawal by Subject|8|||
131886312|NCT01556997|474866141|FG000|Overall Study|Other|2|||
131886313|NCT01556997|474866142|FG001|Overall Study|Other|3|||
131886314|NCT01556997|474866143|FG002|Overall Study|Other|7|||
131886315|NCT05459558|474866155|FG000|Overall Study|Adverse Event|1|||
131886316|NCT05459558|474866156|FG001|Overall Study|Adverse Event|0|||
131886317|NCT05459558|474866157|FG002|Overall Study|Adverse Event|0|||
131886318|NCT05459558|474866155|FG000|Overall Study|Scheduling issue|0|||
131886319|NCT05459558|474866156|FG001|Overall Study|Scheduling issue|1|||
131886320|NCT05459558|474866157|FG002|Overall Study|Scheduling issue|3|||
131886321|NCT05459558|474866155|FG000|Overall Study|Withdrawal by Subject|0|||
131886322|NCT05459558|474866156|FG001|Overall Study|Withdrawal by Subject|0|||
131886323|NCT05459558|474866157|FG002|Overall Study|Withdrawal by Subject|2|||
131886324|NCT01777139|474866158|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
131886325|NCT01777139|474866159|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
131886326|NCT01777139|474866158|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
131886327|NCT01777139|474866159|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
131886328|NCT01777139|474866158|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
131886329|NCT01777139|474866159|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
131886330|NCT01777139|474866158|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
131886331|NCT01777139|474866159|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
131886332|NCT01777139|474866158|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
131886333|NCT01777139|474866159|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
131886334|NCT01777139|474866158|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
131886335|NCT01777139|474866159|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
131886336|NCT01777139|474866158|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
131886337|NCT01777139|474866159|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
131886338|NCT01777139|474866158|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
131886339|NCT01777139|474866159|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
131886340|NCT05625477|474866160|FG000|Overall Study|Lost to Follow-up|2|||
131886341|NCT05625477|474866161|FG001|Overall Study|Lost to Follow-up|2|||
131886342|NCT05625477|474866162|FG002|Overall Study|Lost to Follow-up|1|||
131886343|NCT05625477|474866163|FG003|Overall Study|Lost to Follow-up|1|||
131886344|NCT05625477|474866164|FG004|Overall Study|Lost to Follow-up|0|||
131886345|NCT05625477|474866160|FG000|Overall Study|Covid quarantine|1|||
131886346|NCT05625477|474866161|FG001|Overall Study|Covid quarantine|0|||
131886347|NCT05625477|474866162|FG002|Overall Study|Covid quarantine|0|||
131886348|NCT05625477|474866163|FG003|Overall Study|Covid quarantine|0|||
131886349|NCT05625477|474866164|FG004|Overall Study|Covid quarantine|0|||
131886350|NCT01092637|474866165|FG000|Overall Study|Death|47|||
131886351|NCT01092637|474866166|FG001|Overall Study|Death|49|||
131886352|NCT03292458|474866167|FG000|Period 1|Adverse Event|2|||
131886353|NCT03292458|474866168|FG001|Period 1|Adverse Event|0|||
131886354|NCT00593606|474866169|FG000|Overall Study|Adverse Event|13|||
131886355|NCT00593606|474866169|FG000|Overall Study|Withdrawal by Subject|1|||
131886356|NCT00593606|474866169|FG000|Overall Study|Protocol Violation|3|||
131886357|NCT00593606|474866169|FG000|Overall Study|Lost to Follow-up|2|||
131886358|NCT00593606|474866169|FG000|Overall Study|Run-In Failure|5|||
131886359|NCT00593606|474866169|FG000|Overall Study|Screen Failure|3|||
131886360|NCT02278367|474866170|FG000|Overall Study|Physician Decision|5|||
131886361|NCT02278367|474866171|FG001|Overall Study|Physician Decision|0|||
131886362|NCT02278367|474866170|FG000|Overall Study|Withdrawal by Subject|5|||
131886363|NCT02278367|474866171|FG001|Overall Study|Withdrawal by Subject|0|||
131886364|NCT04643964|474866172|FG000|Overall Study|Lost to Follow-up|55|||
131886365|NCT04643964|474866173|FG001|Overall Study|Lost to Follow-up|59|||
131886366|NCT04643964|474866174|FG002|Overall Study|Lost to Follow-up|54|||
131886367|NCT04643964|474866175|FG003|Overall Study|Lost to Follow-up|129|||
131886368|NCT04643964|474866176|FG004|Overall Study|Lost to Follow-up|48|||
131886369|NCT04643964|474866172|FG000|Overall Study|Failed attention check|1|||
131886370|NCT04643964|474866173|FG001|Overall Study|Failed attention check|8|||
131886371|NCT04643964|474866174|FG002|Overall Study|Failed attention check|2|||
131886372|NCT04643964|474866175|FG003|Overall Study|Failed attention check|14|||
131886373|NCT04643964|474866176|FG004|Overall Study|Failed attention check|11|||
131886374|NCT05932225|474866177|FG000|Overall Study|Lost to Follow-up|0|||
131886375|NCT05932225|474866178|FG001|Overall Study|Lost to Follow-up|1|||
131886376|NCT05932225|474866179|FG002|Overall Study|Lost to Follow-up|0|||
131886377|NCT05932225|474866177|FG000|Overall Study|Withdrawal by Subject|1|||
131886378|NCT05932225|474866178|FG001|Overall Study|Withdrawal by Subject|0|||
131886379|NCT05932225|474866179|FG002|Overall Study|Withdrawal by Subject|0|||
131886380|NCT05932225|474866177|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
131886381|NCT05932225|474866178|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
131886382|NCT05932225|474866179|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
131886383|NCT03435224|474866181|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
131886384|NCT04472026|474866182|FG000|Overall Study|Lost to Follow-up|5|||
131886385|NCT01777295|474866183|FG000|Overall Study|Withdrawal by Subject|2|||
131886386|NCT01777295|474866184|FG001|Overall Study|Withdrawal by Subject|2|||
131886387|NCT01777295|474866183|FG000|Overall Study|Pregnancy|0|||
131886388|NCT01777295|474866184|FG001|Overall Study|Pregnancy|1|||
131886389|NCT01777295|474866183|FG000|Overall Study|Personal problem|1|||
131886390|NCT01777295|474866184|FG001|Overall Study|Personal problem|0|||
131886391|NCT01777295|474866183|FG000|Overall Study|Investigator call for AEs check|1|||
131886392|NCT01777295|474866184|FG001|Overall Study|Investigator call for AEs check|0|||
131886393|NCT01069419|474866185|FG000|Overall Study|Adverse Event|233|||
131886394|NCT01069419|474866185|FG000|Overall Study|Lack of Efficacy|332|||
131886395|NCT01069419|474866185|FG000|Overall Study|Lost to Follow-up|49|||
131886396|NCT01069419|474866185|FG000|Overall Study|Remission of disease|11|||
131886397|NCT01069419|474866185|FG000|Overall Study|Withdrawal by Subject|34|||
131886398|NCT01069419|474866185|FG000|Overall Study|Other Reason|43|||
131886399|NCT01069419|474866185|FG000|Overall Study|Missing termination information|13|||
131886400|NCT04526574|474866186|FG000|Overall Study|Protocol Violation|3|||
131886401|NCT04526574|474866187|FG001|Overall Study|Protocol Violation|1|||
131886402|NCT04526574|474866186|FG000|Overall Study|Withdrawal by Subject|12|||
131886403|NCT04526574|474866187|FG001|Overall Study|Withdrawal by Subject|9|||
131886404|NCT04526574|474866186|FG000|Overall Study|Other|1|||
131886405|NCT04526574|474866187|FG001|Overall Study|Other|2|||
131886406|NCT04526574|474866186|FG000|Overall Study|Adverse Event|1|||
131886407|NCT04526574|474866187|FG001|Overall Study|Adverse Event|1|||
131886408|NCT04526574|474866186|FG000|Overall Study|Death|2|||
131886409|NCT04526574|474866187|FG001|Overall Study|Death|3|||
131886410|NCT04526574|474866186|FG000|Overall Study|Lost to Follow-up|9|||
131886411|NCT04526574|474866187|FG001|Overall Study|Lost to Follow-up|9|||
131886412|NCT04526574|474866186|FG000|Overall Study|No longer meets eligibility criteria|8|||
131886413|NCT04526574|474866187|FG001|Overall Study|No longer meets eligibility criteria|8|||
131886414|NCT02248974|474866190|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
131886415|NCT02248974|474866191|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
131886416|NCT02248974|474866190|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
131886417|NCT02248974|474866191|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
131886418|NCT02248974|474866190|FG000|1-Day Follow-Up|Enrolled in another study|1|||
131886419|NCT02248974|474866191|FG001|1-Day Follow-Up|Enrolled in another study|0|||
131886420|NCT02248974|474866190|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
131886421|NCT02248974|474866191|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
131886422|NCT02248974|474866190|FG000|1-Week Follow-Up|Enrolled in another study|1|||
131886423|NCT02248974|474866191|FG001|1-Week Follow-Up|Enrolled in another study|1|||
131886424|NCT02248974|474866190|FG000|1-Week Follow-Up|Transferred to another facility|1|||
131886425|NCT02248974|474866191|FG001|1-Week Follow-Up|Transferred to another facility|0|||
131886426|NCT02248974|474866190|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
131886427|NCT02248974|474866191|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
131886428|NCT02248974|474866190|FG000|1-Week Follow-Up|Death|1|||
131886429|NCT02248974|474866191|FG001|1-Week Follow-Up|Death|1|||
131886430|NCT02248974|474866190|FG000|1-Week Follow-Up|Excluded because of age|0|||
131886431|NCT02248974|474866191|FG001|1-Week Follow-Up|Excluded because of age|1|||
131886432|NCT02248974|474866190|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
131886433|NCT02248974|474866191|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
131886434|NCT02248974|474866190|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
131886435|NCT02248974|474866191|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
131886436|NCT02248974|474866190|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
131886437|NCT02248974|474866191|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
131886438|NCT02248974|474866190|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
131886439|NCT02248974|474866191|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
131886440|NCT02248974|474866190|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
131886441|NCT02248974|474866191|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
131886442|NCT02332239|474866192|FG000|Overall Study|Lost to Follow-up|4|||
131886443|NCT02332239|474866193|FG001|Overall Study|Lost to Follow-up|6|||
131886444|NCT00115037|474866194|FG000|Phase1|Lost to Follow-up|16|||
131886445|NCT00115037|474866195|FG001|Phase1|Lost to Follow-up|23|||
131886446|NCT00115037|474866196|FG002|Phase1|Lost to Follow-up|0|||
131886447|NCT00115037|474866197|FG003|Phase1|Lost to Follow-up|0|||
131886448|NCT00115037|474866198|FG004|Phase1|Lost to Follow-up|0|||
131886449|NCT00115037|474866199|FG005|Phase1|Lost to Follow-up|0|||
131886450|NCT00115037|474866194|FG000|Phase1|Withdrawal by Subject|9|||
131886451|NCT00115037|474866195|FG001|Phase1|Withdrawal by Subject|4|||
131886452|NCT00115037|474866196|FG002|Phase1|Withdrawal by Subject|0|||
131886453|NCT00115037|474866197|FG003|Phase1|Withdrawal by Subject|0|||
131886454|NCT00115037|474866198|FG004|Phase1|Withdrawal by Subject|0|||
131886455|NCT00115037|474866199|FG005|Phase1|Withdrawal by Subject|0|||
131886456|NCT00115037|474866194|FG000|Phase2|Death|0|||
131886457|NCT00115037|474866195|FG001|Phase2|Death|0|||
131886458|NCT00115037|474866196|FG002|Phase2|Death|1|||
131886459|NCT00115037|474866197|FG003|Phase2|Death|0|||
131886460|NCT00115037|474866198|FG004|Phase2|Death|0|||
131886461|NCT00115037|474866199|FG005|Phase2|Death|1|||
131886462|NCT00115037|474866194|FG000|Phase2|Withdrawal by Subject|0|||
131886463|NCT00115037|474866195|FG001|Phase2|Withdrawal by Subject|0|||
131886464|NCT00115037|474866196|FG002|Phase2|Withdrawal by Subject|2|||
131886465|NCT00115037|474866197|FG003|Phase2|Withdrawal by Subject|1|||
131886466|NCT00115037|474866198|FG004|Phase2|Withdrawal by Subject|2|||
131886467|NCT00115037|474866199|FG005|Phase2|Withdrawal by Subject|1|||
131886468|NCT00115037|474866194|FG000|Phase2|Lost to Follow-up|0|||
131886469|NCT00115037|474866195|FG001|Phase2|Lost to Follow-up|0|||
131886470|NCT00115037|474866196|FG002|Phase2|Lost to Follow-up|12|||
131886471|NCT00115037|474866197|FG003|Phase2|Lost to Follow-up|14|||
131886472|NCT00115037|474866198|FG004|Phase2|Lost to Follow-up|4|||
131886473|NCT00115037|474866199|FG005|Phase2|Lost to Follow-up|10|||
131886474|NCT00396877|474866200|FG000|Overall Study|Lost to Follow-up|2|||
131886475|NCT00396877|474866201|FG001|Overall Study|Lost to Follow-up|1|||
131886476|NCT00396877|474866200|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
131886477|NCT00396877|474866201|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
131886478|NCT00334802|474866202|FG000|Overall Study|Progressive Disease|2|||
131886479|NCT00334802|474866203|FG001|Overall Study|Progressive Disease|24|||
131886480|NCT00334802|474866202|FG000|Overall Study|Toxicity|1|||
131886481|NCT00334802|474866203|FG001|Overall Study|Toxicity|5|||
131886482|NCT00334802|474866202|FG000|Overall Study|Lack of Efficacy|1|||
131886483|NCT00334802|474866203|FG001|Overall Study|Lack of Efficacy|3|||
131886484|NCT00334802|474866202|FG000|Overall Study|Patient Condition Aggrevated|1|||
131886485|NCT00334802|474866203|FG001|Overall Study|Patient Condition Aggrevated|0|||
131886486|NCT00334802|474866202|FG000|Overall Study|Physician Decision|1|||
131886487|NCT00334802|474866203|FG001|Overall Study|Physician Decision|0|||
131886488|NCT00334802|474866202|FG000|Overall Study|Withdrawal by Subject|0|||
131886489|NCT00334802|474866203|FG001|Overall Study|Withdrawal by Subject|4|||
131886490|NCT00334802|474866202|FG000|Overall Study|Adverse Event|0|||
131886491|NCT00334802|474866203|FG001|Overall Study|Adverse Event|3|||
131886492|NCT00334802|474866202|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
131886493|NCT00334802|474866203|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
131886494|NCT03436199|474866204|FG000|Overall Study|Adverse Event|15|||
131886495|NCT03436199|474866205|FG001|Overall Study|Adverse Event|40|||
131886496|NCT03436199|474866206|FG002|Overall Study|Adverse Event|7|||
131886497|NCT03436199|474866204|FG000|Overall Study|Withdrawal by Subject|4|||
131886498|NCT03436199|474866205|FG001|Overall Study|Withdrawal by Subject|10|||
131886499|NCT03436199|474866206|FG002|Overall Study|Withdrawal by Subject|3|||
131886500|NCT03436199|474866204|FG000|Overall Study|Lost to Follow-up|1|||
131886501|NCT03436199|474866205|FG001|Overall Study|Lost to Follow-up|0|||
131886502|NCT03436199|474866206|FG002|Overall Study|Lost to Follow-up|2|||
131886503|NCT03436199|474866204|FG000|Overall Study|Protocol Violation|1|||
131886504|NCT03436199|474866205|FG001|Overall Study|Protocol Violation|1|||
131886505|NCT03436199|474866206|FG002|Overall Study|Protocol Violation|0|||
131886506|NCT03436199|474866204|FG000|Overall Study|Physician Decision|0|||
131886507|NCT03436199|474866205|FG001|Overall Study|Physician Decision|1|||
131886508|NCT03436199|474866206|FG002|Overall Study|Physician Decision|0|||
131886509|NCT03436199|474866204|FG000|Overall Study|Could not return to clinic|1|||
131886510|NCT03436199|474866205|FG001|Overall Study|Could not return to clinic|0|||
131886511|NCT03436199|474866206|FG002|Overall Study|Could not return to clinic|0|||
131886512|NCT03436199|474866204|FG000|Overall Study|Withdrawn per physician|0|||
131886513|NCT03436199|474866205|FG001|Overall Study|Withdrawn per physician|1|||
131886514|NCT03436199|474866206|FG002|Overall Study|Withdrawn per physician|0|||
131886515|NCT00085098|474866207|FG000|Overall Study|Withdrawal by Subject|0|||
131886516|NCT00085098|474866208|FG001|Overall Study|Withdrawal by Subject|1|||
131886517|NCT00085098|474866207|FG000|Overall Study|Ineligible|1|||
131886518|NCT00085098|474866208|FG001|Overall Study|Ineligible|1|||
131886519|NCT01886781|474866209|FG000|Overall Study|Protocol Violation|5|||
131547344|NCT00552084|473626388|FG001|Overall Study|change in anti-arrythmic drug|1|||
131547345|NCT03017079|473626389|FG000|Overall Study|Physician Decision|1|||
131547346|NCT03017079|473626390|FG001|Overall Study|Physician Decision|1|||
131547347|NCT03017079|473626389|FG000|Overall Study|Death|3|||
131547348|NCT03017079|473626390|FG001|Overall Study|Death|2|||
131547349|NCT03017079|473626389|FG000|Overall Study|Lack of Efficacy|2|||
131547350|NCT03017079|473626390|FG001|Overall Study|Lack of Efficacy|2|||
131547351|NCT03017079|473626389|FG000|Overall Study|Protocol Violation|0|||
131547352|NCT03017079|473626390|FG001|Overall Study|Protocol Violation|1|||
131547353|NCT02240108|473627867|FG000|Overall Study|Other than specified|8|||
131547354|NCT02240108|473627868|FG001|Overall Study|Other than specified|6|||
131547355|NCT02240108|473627867|FG000|Overall Study|Adverse Event|1|||
131547356|NCT02240108|473627868|FG001|Overall Study|Adverse Event|9|||
131886520|NCT01886781|474866210|FG001|Overall Study|Protocol Violation|0|||
131886521|NCT01886781|474866209|FG000|Overall Study|Adverse Event|1|||
131886522|NCT01886781|474866210|FG001|Overall Study|Adverse Event|0|||
131547357|NCT02240108|473627867|FG000|Overall Study|Pregnancy|1|||
131886523|NCT01886781|474866209|FG000|Overall Study|Lost to Follow-up|5|||
131886524|NCT01886781|474866210|FG001|Overall Study|Lost to Follow-up|0|||
131886525|NCT01886781|474866209|FG000|Overall Study|Withdrawal by Subject|2|||
131547358|NCT02240108|473627868|FG001|Overall Study|Pregnancy|0|||
131547359|NCT02240108|473627867|FG000|Overall Study|Withdrawal by Subject|4|||
131547360|NCT02240108|473627868|FG001|Overall Study|Withdrawal by Subject|9|||
131547361|NCT02240108|473627867|FG000|Overall Study|StudyTerminated by Sponsor|0|||
131547362|NCT02240108|473627868|FG001|Overall Study|StudyTerminated by Sponsor|1|||
131547363|NCT01345630|473627869|FG000|Overall Study|Adverse Event|22|||
131547364|NCT01345630|473627870|FG001|Overall Study|Adverse Event|23|||
131547365|NCT01345630|473627869|FG000|Overall Study|Lost to Follow-up|17|||
131547366|NCT01345630|473627870|FG001|Overall Study|Lost to Follow-up|16|||
131547367|NCT01345630|473627869|FG000|Overall Study|Protocol Violation|4|||
131547368|NCT01345630|473627870|FG001|Overall Study|Protocol Violation|1|||
131547369|NCT01345630|473627869|FG000|Overall Study|Medication error without associated AE|0|||
131547370|NCT01345630|473627870|FG001|Overall Study|Medication error without associated AE|1|||
131547371|NCT01345630|473627869|FG000|Overall Study|Study terminated by sponsor|254|||
131547372|NCT01345630|473627870|FG001|Overall Study|Study terminated by sponsor|285|||
131547373|NCT01345630|473627869|FG000|Overall Study|Other reasons|6|||
131547374|NCT01345630|473627870|FG001|Overall Study|Other reasons|8|||
131547375|NCT01345630|473627869|FG000|Overall Study|Withdrawn due to pregnancy|1|||
131660027|NCT00653523|474039055|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
131660028|NCT00653523|474039055|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
131660029|NCT02425904|474039056|FG000|Overall Study|Lost to Follow-up|1|||
131660030|NCT02425904|474039057|FG001|Overall Study|Lost to Follow-up|0|||
131660031|NCT02425904|474039056|FG000|Overall Study|Withdrawal by Subject|2|||
131660032|NCT02425904|474039057|FG001|Overall Study|Withdrawal by Subject|0|||
131660033|NCT02425904|474039056|FG000|Overall Study|Death|0|||
131660034|NCT02425904|474039057|FG001|Overall Study|Death|3|||
131660035|NCT03843554|474040677|FG000|Overall Study|Physician Decision|0|||
131660036|NCT03843554|474040678|FG001|Overall Study|Physician Decision|2|||
131660037|NCT04396366|474040681|FG000|Overall Study|Adverse Event|1|||
131660038|NCT04396366|474040682|FG001|Overall Study|Adverse Event|0|||
131660039|NCT00503139|474040685|FG000|Overall Study|Case Report Forms were not collected|4|||
131660040|NCT00503139|474040685|FG000|Overall Study|Protocol Violation|4|||
131660041|NCT02735577|474040686|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
131660042|NCT02735577|474040686|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
131660043|NCT02731690|474040687|FG000|Overall Study|Adverse Event|1|||
131660044|NCT02731690|474040687|FG000|Overall Study|Withdrawal by Subject|3|||
131660045|NCT02731690|474040687|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
131660046|NCT02040584|474040691|FG000|Overall Study|Adverse Event|13|||
131660047|NCT02040584|474040692|FG001|Overall Study|Adverse Event|6|||
131660048|NCT02040584|474040691|FG000|Overall Study|Protocol Violation|9|||
131660049|NCT02040584|474040692|FG001|Overall Study|Protocol Violation|11|||
131660050|NCT02040584|474040691|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131660051|NCT02040584|474040692|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131660052|NCT02040584|474040691|FG000|Overall Study|Death|6|||
131660053|NCT02040584|474040692|FG001|Overall Study|Death|3|||
131660054|NCT02040584|474040691|FG000|Overall Study|Transplant rejection/retransplant|0|||
131660055|NCT02040584|474040692|FG001|Overall Study|Transplant rejection/retransplant|1|||
131660056|NCT02040584|474040691|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
131660057|NCT02040584|474040692|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
131660058|NCT00996476|474040693|FG000|Overall Study|Withdrawal by Subject|1|||
131660059|NCT00996476|474040694|FG001|Overall Study|Withdrawal by Subject|2|||
131660060|NCT00996476|474040695|FG002|Overall Study|Withdrawal by Subject|1|||
131660061|NCT00996476|474040696|FG003|Overall Study|Withdrawal by Subject|0|||
131660062|NCT00996476|474040697|FG004|Overall Study|Withdrawal by Subject|1|||
131660063|NCT00996476|474040693|FG000|Overall Study|Adverse Event|0|||
131660064|NCT00996476|474040694|FG001|Overall Study|Adverse Event|1|||
131660065|NCT00996476|474040695|FG002|Overall Study|Adverse Event|0|||
131660066|NCT00996476|474040696|FG003|Overall Study|Adverse Event|0|||
131660067|NCT00996476|474040697|FG004|Overall Study|Adverse Event|1|||
131660068|NCT05540717|474040698|FG000|Overall Study|Lost to Follow-up|2|||
131660069|NCT05540717|474040699|FG001|Overall Study|Lost to Follow-up|5|||
131660070|NCT05540717|474040698|FG000|Overall Study|Withdrawal by Subject|6|||
131660071|NCT05540717|474040699|FG001|Overall Study|Withdrawal by Subject|6|||
131886526|NCT01886781|474866210|FG001|Overall Study|Withdrawal by Subject|1|||
131886527|NCT01886781|474866209|FG000|Overall Study|Worsening of symptoms|1|||
131886528|NCT01886781|474866210|FG001|Overall Study|Worsening of symptoms|1|||
131886529|NCT00424021|474866211|FG000|NCT00046319 Study Period|Adverse Event|1|||
131886530|NCT00424021|474866212|FG001|NCT00046319 Study Period|Adverse Event|0|||
131547376|NCT01345630|473627870|FG001|Overall Study|Withdrawn due to pregnancy|2|||
131547377|NCT01345630|473627869|FG000|Overall Study|No longer willing to participate|9|||
131660072|NCT05540717|474040698|FG000|Overall Study|Sponsor request|1|||
131660073|NCT05540717|474040699|FG001|Overall Study|Sponsor request|0|||
131660074|NCT05540717|474040698|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
131660075|NCT05540717|474040699|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
131660076|NCT05540717|474040698|FG000|Overall Study|Other|0|||
131886531|NCT00424021|474866213|FG002|NCT00046319 Study Period|Adverse Event|1|||
131547378|NCT01345630|473627870|FG001|Overall Study|No longer willing to participate|12|||
131547379|NCT01345630|473627869|FG000|Overall Study|Insufficient clinical response|48|||
131547380|NCT01345630|473627870|FG001|Overall Study|Insufficient clinical response|11|||
131547381|NCT04233372|473627871|FG000|Overall Study|Lost to Follow-up|104|||
131547382|NCT04233372|473627871|FG000|Overall Study|Adverse Event|8|||
131547383|NCT04233372|473627871|FG000|Overall Study|Withdrawal by Subject|2|||
131547384|NCT03938454|473627872|FG000|Overall Study|Protocol Violation|1|||
131547385|NCT03938454|473627872|FG000|Overall Study|Withdrawal by Subject|2|||
131547386|NCT03938454|473627872|FG000|Overall Study|Lost to Follow-up|3|||
131547387|NCT01090310|473627873|FG000|Core Study|Adverse Event|2|||
131547388|NCT01090310|473627874|FG001|Core Study|Adverse Event|2|||
131547389|NCT01090310|473627875|FG002|Core Study|Adverse Event|1|||
131547390|NCT01090310|473627876|FG003|Core Study|Adverse Event|1|||
131547391|NCT01090310|473627873|FG000|Core Study|Subject withdrew consent|0|||
131547392|NCT01090310|473627874|FG001|Core Study|Subject withdrew consent|3|||
131547393|NCT01090310|473627875|FG002|Core Study|Subject withdrew consent|1|||
131547394|NCT01090310|473627876|FG003|Core Study|Subject withdrew consent|1|||
131547395|NCT01090310|473627873|FG000|Core Study|Abnormal test procedure result|0|||
131547396|NCT01090310|473627874|FG001|Core Study|Abnormal test procedure result|0|||
131547397|NCT01090310|473627875|FG002|Core Study|Abnormal test procedure result|1|||
131547398|NCT01090310|473627876|FG003|Core Study|Abnormal test procedure result|0|||
131547399|NCT01090310|473627873|FG000|Core Study|Administrative reasons|5|||
131547400|NCT01090310|473627874|FG001|Core Study|Administrative reasons|6|||
131547401|NCT01090310|473627875|FG002|Core Study|Administrative reasons|4|||
131547402|NCT01090310|473627876|FG003|Core Study|Administrative reasons|4|||
131886532|NCT00424021|474866214|FG003|NCT00046319 Study Period|Adverse Event|1|||
131886533|NCT00424021|474866211|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
131886534|NCT00424021|474866212|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
131886535|NCT00424021|474866213|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
131547403|NCT01090310|473627873|FG000|Core Study|Protocol deviation|1|||
131547404|NCT01090310|473627874|FG001|Core Study|Protocol deviation|0|||
131547405|NCT01090310|473627875|FG002|Core Study|Protocol deviation|0|||
131547406|NCT01090310|473627876|FG003|Core Study|Protocol deviation|1|||
131547407|NCT01090310|473627873|FG000|Extension Study|Aministrative problems|13|||
131547408|NCT01090310|473627874|FG001|Extension Study|Aministrative problems|15|||
131547409|NCT01090310|473627875|FG002|Extension Study|Aministrative problems|14|||
131547410|NCT01090310|473627876|FG003|Extension Study|Aministrative problems|18|||
131547411|NCT01090310|473627873|FG000|Extension Study|Adverse Event|0|||
131547412|NCT01090310|473627874|FG001|Extension Study|Adverse Event|0|||
131547413|NCT01090310|473627875|FG002|Extension Study|Adverse Event|0|||
131547414|NCT01090310|473627876|FG003|Extension Study|Adverse Event|1|||
131547415|NCT01090310|473627873|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
131547416|NCT01090310|473627874|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
131547417|NCT01090310|473627875|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
131547418|NCT01090310|473627876|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
131547419|NCT01090310|473627873|FG000|Extension Study|Subject withdrew consent|0|||
131547420|NCT01090310|473627874|FG001|Extension Study|Subject withdrew consent|1|||
131547421|NCT01090310|473627875|FG002|Extension Study|Subject withdrew consent|0|||
131547422|NCT01090310|473627876|FG003|Extension Study|Subject withdrew consent|0|||
131547423|NCT01142388|473627877|FG000|Overall Study|Lack of Efficacy|21|||
131547424|NCT01142388|473627878|FG001|Overall Study|Lack of Efficacy|31|||
131547425|NCT01142388|473627877|FG000|Overall Study|Adverse Event|9|||
131547426|NCT01142388|473627878|FG001|Overall Study|Adverse Event|5|||
131547427|NCT01142388|473627877|FG000|Overall Study|Death|3|||
131547428|NCT01142388|473627878|FG001|Overall Study|Death|2|||
131547429|NCT01142388|473627877|FG000|Overall Study|Withdrawal by Subject|5|||
131547430|NCT01142388|473627878|FG001|Overall Study|Withdrawal by Subject|3|||
131547431|NCT01142388|473627877|FG000|Overall Study|Alternative therapy|1|||
131886536|NCT00424021|474866214|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
131886537|NCT00424021|474866211|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
131886538|NCT00424021|474866212|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
131886539|NCT00424021|474866213|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
131886540|NCT00424021|474866214|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
131886541|NCT00424021|474866211|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
131886542|NCT00424021|474866212|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
131886543|NCT00424021|474866213|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
131886544|NCT00424021|474866214|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
131886545|NCT00424021|474866211|FG000|AMB-220-E Study Period|Adverse Event|1|||
131886546|NCT00424021|474866212|FG001|AMB-220-E Study Period|Adverse Event|1|||
131886547|NCT00424021|474866213|FG002|AMB-220-E Study Period|Adverse Event|3|||
131886548|NCT00424021|474866214|FG003|AMB-220-E Study Period|Adverse Event|7|||
131886549|NCT00424021|474866211|FG000|AMB-220-E Study Period|Death|0|||
131886550|NCT00424021|474866212|FG001|AMB-220-E Study Period|Death|0|||
131886551|NCT00424021|474866213|FG002|AMB-220-E Study Period|Death|1|||
131886552|NCT00424021|474866214|FG003|AMB-220-E Study Period|Death|1|||
131547432|NCT01142388|473627878|FG001|Overall Study|Alternative therapy|0|||
131886553|NCT00424021|474866211|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
131547433|NCT01142388|473627877|FG000|Overall Study|Other complications|0|||
131547434|NCT01142388|473627878|FG001|Overall Study|Other complications|2|||
131547435|NCT01142388|473627877|FG000|Overall Study|Other|1|||
131547436|NCT01142388|473627878|FG001|Overall Study|Other|1|||
131547437|NCT01142388|473627877|FG000|Overall Study|Never started therapy|7|||
131547438|NCT01142388|473627878|FG001|Overall Study|Never started therapy|3|||
131547439|NCT00695786|473627879|FG000|Overall Study|Adverse Event|0|||
131547440|NCT00695786|473627880|FG001|Overall Study|Adverse Event|3|||
131547441|NCT00695786|473627881|FG002|Overall Study|Adverse Event|4|||
131547442|NCT00695786|473627882|FG003|Overall Study|Adverse Event|2|||
131547443|NCT00695786|473627879|FG000|Overall Study|Lost to Follow-up|0|||
131547444|NCT00695786|473627880|FG001|Overall Study|Lost to Follow-up|5|||
131547445|NCT00695786|473627881|FG002|Overall Study|Lost to Follow-up|1|||
131547446|NCT00695786|473627882|FG003|Overall Study|Lost to Follow-up|1|||
131547447|NCT00695786|473627879|FG000|Overall Study|Withdrawal by Subject|0|||
131547448|NCT00695786|473627880|FG001|Overall Study|Withdrawal by Subject|4|||
131547449|NCT00695786|473627881|FG002|Overall Study|Withdrawal by Subject|3|||
131547450|NCT00695786|473627882|FG003|Overall Study|Withdrawal by Subject|1|||
131547451|NCT00695786|473627879|FG000|Overall Study|Deemed Ineligible|1|||
131547452|NCT00695786|473627880|FG001|Overall Study|Deemed Ineligible|0|||
131547453|NCT00695786|473627881|FG002|Overall Study|Deemed Ineligible|0|||
131547454|NCT00695786|473627882|FG003|Overall Study|Deemed Ineligible|0|||
131547455|NCT00695786|473627879|FG000|Overall Study|Lack of Efficacy|0|||
131547456|NCT00695786|473627880|FG001|Overall Study|Lack of Efficacy|0|||
131547457|NCT00695786|473627881|FG002|Overall Study|Lack of Efficacy|0|||
131547458|NCT00695786|473627882|FG003|Overall Study|Lack of Efficacy|4|||
131547459|NCT01364922|473627883|FG000|Open-label (OL) Period|Adverse Event|7|||
131547460|NCT01364922|473627884|FG001|Open-label (OL) Period|Adverse Event|0|||
131547461|NCT01364922|473627885|FG002|Open-label (OL) Period|Adverse Event|0|||
131547462|NCT01364922|473627883|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
131547463|NCT01364922|473627884|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
131547464|NCT01364922|473627885|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
131547465|NCT01364922|473627883|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
131547466|NCT01364922|473627884|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
131547467|NCT01364922|473627885|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
131547468|NCT01364922|473627883|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
131547469|NCT01364922|473627884|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
131547470|NCT01364922|473627885|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
131547471|NCT01364922|473627883|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
131547472|NCT01364922|473627884|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
131547473|NCT01364922|473627885|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
131547474|NCT01364922|473627883|FG000|Open-label (OL) Period|Other, Unspecified|1|||
131547475|NCT01364922|473627884|FG001|Open-label (OL) Period|Other, Unspecified|0|||
131547476|NCT01364922|473627885|FG002|Open-label (OL) Period|Other, Unspecified|0|||
131547477|NCT01364922|473627883|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
131547478|NCT01364922|473627884|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
131547479|NCT01364922|473627885|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
131547480|NCT01364922|473627883|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
131547481|NCT01364922|473627884|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
131547482|NCT01364922|473627885|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
131547483|NCT01364922|473627883|FG000|Double-Blind (DB) Period|Adverse Event|0|||
131547484|NCT01364922|473627884|FG001|Double-Blind (DB) Period|Adverse Event|0|||
131547485|NCT01364922|473627885|FG002|Double-Blind (DB) Period|Adverse Event|1|||
131547486|NCT01364922|473627883|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
131547487|NCT01364922|473627884|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
131547488|NCT01364922|473627885|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
131547489|NCT04244396|473627886|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
131547490|NCT04244396|473627886|FG000|Overall Study|Withdrawal by Subject|2|||
131547491|NCT04244396|473627886|FG000|Overall Study|Study termination|37|||
131547492|NCT01787097|473627887|FG000|Overall Study|Withdrawal by Subject|1|||
131547493|NCT01787097|473627888|FG001|Overall Study|Withdrawal by Subject|0|||
131547494|NCT01787097|473627889|FG002|Overall Study|Withdrawal by Subject|0|||
131547495|NCT01787097|473627890|FG003|Overall Study|Withdrawal by Subject|0|||
131547496|NCT00553501|473627897|FG000|Overall Study|Adverse Event|2|||
131547497|NCT00553501|473627897|FG000|Overall Study|Death|1|||
131547498|NCT00553501|473627897|FG000|Overall Study|Progression|1|||
131547499|NCT02293395|473627898|FG000|Overall Study|Lost to Follow-up|1|||
131547500|NCT02293395|473627899|FG001|Overall Study|Lost to Follow-up|0|||
131547501|NCT02293395|473627898|FG000|Overall Study|Withdrawal by Subject|8|||
131547502|NCT02293395|473627899|FG001|Overall Study|Withdrawal by Subject|7|||
131547503|NCT01464021|473627902|FG000|Overall Study|Withdrawal by Subject|13|||
131547504|NCT01464021|473627902|FG000|Overall Study|Lost to Follow-up|1|||
131547505|NCT01464021|473627902|FG000|Overall Study|Lack of Efficacy|1|||
131660077|NCT05540717|474040699|FG001|Overall Study|Other|1|||
131547506|NCT01464021|473627902|FG000|Overall Study|various|11|||
131547507|NCT00861614|473627903|FG000|Overall Study|Disease Progression|182|||
131886554|NCT00424021|474866212|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
131886555|NCT00424021|474866213|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
131886556|NCT00424021|474866214|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
131886557|NCT00424021|474866211|FG000|AMB-220-E Study Period|Physician Decision|0|||
131886558|NCT00424021|474866212|FG001|AMB-220-E Study Period|Physician Decision|0|||
131886559|NCT00424021|474866213|FG002|AMB-220-E Study Period|Physician Decision|0|||
131886560|NCT00424021|474866214|FG003|AMB-220-E Study Period|Physician Decision|1|||
131886561|NCT03769194|474866215|FG000|Overall Study|Withdrawal by Subject|0|||
131886562|NCT03769194|474866216|FG001|Overall Study|Withdrawal by Subject|7|||
131886563|NCT03769194|474866217|FG002|Overall Study|Withdrawal by Subject|4|||
131886564|NCT03769194|474866218|FG003|Overall Study|Withdrawal by Subject|1|||
131886565|NCT03769194|474866215|FG000|Overall Study|moved from study area|0|||
131886566|NCT03769194|474866216|FG001|Overall Study|moved from study area|2|||
131886567|NCT03769194|474866217|FG002|Overall Study|moved from study area|1|||
131886568|NCT03769194|474866218|FG003|Overall Study|moved from study area|1|||
131886569|NCT03769194|474866215|FG000|Overall Study|Lost to Follow-up|3|||
131886570|NCT03769194|474866216|FG001|Overall Study|Lost to Follow-up|6|||
131886571|NCT03769194|474866217|FG002|Overall Study|Lost to Follow-up|3|||
131886572|NCT03769194|474866218|FG003|Overall Study|Lost to Follow-up|6|||
131886573|NCT03769194|474866215|FG000|Overall Study|other|1|||
131886574|NCT03769194|474866216|FG001|Overall Study|other|3|||
131547508|NCT00861614|473627904|FG001|Overall Study|Disease Progression|263|||
131547509|NCT00861614|473627903|FG000|Overall Study|Study Drug Toxicity|79|||
131547510|NCT00861614|473627904|FG001|Overall Study|Study Drug Toxicity|6|||
131886575|NCT03769194|474866217|FG002|Overall Study|other|0|||
131886576|NCT03769194|474866218|FG003|Overall Study|other|1|||
131886577|NCT03597022|474866221|FG000|Overall Study|Premature termination of the study|7|||
131547511|NCT00861614|473627903|FG000|Overall Study|Death|32|||
131547512|NCT00861614|473627904|FG001|Overall Study|Death|19|||
131547513|NCT00861614|473627903|FG000|Overall Study|Adverse Event|27|||
131547514|NCT00861614|473627904|FG001|Overall Study|Adverse Event|23|||
131547515|NCT00861614|473627903|FG000|Overall Study|Withdrawal by Subject|34|||
131547516|NCT00861614|473627904|FG001|Overall Study|Withdrawal by Subject|35|||
131547517|NCT00861614|473627903|FG000|Overall Study|Other|17|||
131547518|NCT00861614|473627904|FG001|Overall Study|Other|22|||
131547519|NCT03391765|473627905|FG000|Overall Study|Adverse Event|2|||
131547520|NCT03391765|473627906|FG001|Overall Study|Adverse Event|0|||
131547521|NCT03391765|473627907|FG002|Overall Study|Adverse Event|0|||
131547522|NCT03391765|473627908|FG003|Overall Study|Adverse Event|2|||
131547523|NCT03391765|473627905|FG000|Overall Study|Withdrew consent|5|||
131547524|NCT03391765|473627906|FG001|Overall Study|Withdrew consent|7|||
131547525|NCT03391765|473627907|FG002|Overall Study|Withdrew consent|2|||
131547526|NCT03391765|473627908|FG003|Overall Study|Withdrew consent|5|||
131547527|NCT03391765|473627905|FG000|Overall Study|Other, not specified|44|||
131547528|NCT03391765|473627906|FG001|Overall Study|Other, not specified|38|||
131547529|NCT03391765|473627907|FG002|Overall Study|Other, not specified|21|||
131547530|NCT03391765|473627908|FG003|Overall Study|Other, not specified|16|||
131547531|NCT00944658|473627909|FG000|Treatment 12 Weeks|Adverse Event|0|||
131547532|NCT00944658|473627910|FG001|Treatment 12 Weeks|Adverse Event|2|||
131547533|NCT01289418|473627914|FG000|Day 8 Survey|email address invalid|283|||
131547534|NCT01289418|473627914|FG000|Day 8 Survey|participants did not complete the survey|1935|||
131547535|NCT01289418|473627914|FG000|Day 29 Survey|email address invalid|283|||
131547536|NCT01289418|473627914|FG000|Day 29 Survey|participants did not complete the survey|2185|||
131547537|NCT02832622|473627920|FG000|Overall Study|MPP not programmed|1259|||
131547538|NCT02832622|473627920|FG000|Overall Study|Withdrawal by Subject|123|||
131547539|NCT02832622|473627920|FG000|Overall Study|Death|119|||
131547540|NCT02832622|473627920|FG000|Overall Study|Unsuccessful CRT implant|93|||
131547541|NCT02832622|473627920|FG000|Overall Study|Lost to Follow-up|45|||
131547542|NCT02832622|473627920|FG000|Overall Study|Patient non-compliance|42|||
131547543|NCT02832622|473627920|FG000|Overall Study|Withdrawal by other reasons|25|||
131886578|NCT03597022|474866222|FG001|Overall Study|Premature termination of the study|7|||
131886579|NCT03597022|474866223|FG002|Overall Study|Premature termination of the study|8|||
131886580|NCT03597022|474866221|FG000|Overall Study|Serious adverse event|1|||
131886581|NCT03597022|474866222|FG001|Overall Study|Serious adverse event|1|||
131547544|NCT02832622|473627920|FG000|Overall Study|System explant|24|||
131547545|NCT02832622|473627920|FG000|Overall Study|Physician Decision|6|||
131547546|NCT02472652|473627921|FG000|Overall Study|Lost to Follow-up|1|||
131547547|NCT00998400|473627926|FG000|Overall Study|Lack of interest/motivation|1|||
131547548|NCT00998400|473627927|FG001|Overall Study|Lack of interest/motivation|2|||
131547549|NCT00998400|473627926|FG000|Overall Study|Logistical problems|1|||
131547550|NCT00998400|473627927|FG001|Overall Study|Logistical problems|0|||
131547551|NCT03185832|473627928|FG000|Overall Study|Death|9|||
131547552|NCT03185832|473627929|FG001|Overall Study|Death|14|||
131547553|NCT03185832|473627930|FG002|Overall Study|Death|9|||
131547554|NCT03185832|473627931|FG003|Overall Study|Death|7|||
131547555|NCT03185832|473627928|FG000|Overall Study|Withdrawn - vital status available|0|||
131547556|NCT03185832|473627929|FG001|Overall Study|Withdrawn - vital status available|1|||
131547557|NCT03185832|473627930|FG002|Overall Study|Withdrawn - vital status available|1|||
131547558|NCT03185832|473627931|FG003|Overall Study|Withdrawn - vital status available|4|||
131660078|NCT01940939|474040700|FG000|Overall Study|Withdrawal by Subject|2|||
131660079|NCT01940939|474040701|FG001|Overall Study|Withdrawal by Subject|8|||
131660080|NCT01470001|474040702|FG000|Overall Study|Lost to Follow-up|1|||
131660081|NCT01470001|474040703|FG001|Overall Study|Lost to Follow-up|1|||
131660082|NCT01470001|474040702|FG000|Overall Study|Physician Decision|2|||
131660083|NCT01470001|474040703|FG001|Overall Study|Physician Decision|0|||
131660084|NCT01470001|474040702|FG000|Overall Study|Withdrawal by Subject|2|||
131660085|NCT01470001|474040703|FG001|Overall Study|Withdrawal by Subject|1|||
131660086|NCT01895101|474040704|FG000|Overall Study|OPCAB procedure|1|||
131660087|NCT01895101|474040705|FG001|Overall Study|OPCAB procedure|1|||
131660088|NCT01895101|474040706|FG002|Overall Study|OPCAB procedure|3|||
131660089|NCT01895101|474040704|FG000|Overall Study|Withdrawal by Subject|0|||
131660090|NCT01895101|474040705|FG001|Overall Study|Withdrawal by Subject|1|||
131660091|NCT01895101|474040706|FG002|Overall Study|Withdrawal by Subject|2|||
131660092|NCT01895101|474040704|FG000|Overall Study|another study, enrolled in other study|0|||
131660093|NCT01895101|474040705|FG001|Overall Study|another study, enrolled in other study|1|||
131660094|NCT01895101|474040706|FG002|Overall Study|another study, enrolled in other study|0|||
131660095|NCT01895101|474040704|FG000|Overall Study|Death|0|||
131660096|NCT01895101|474040705|FG001|Overall Study|Death|1|||
131660097|NCT01895101|474040706|FG002|Overall Study|Death|0|||
131660098|NCT01895101|474040704|FG000|Overall Study|coagulation disorder|0|||
131547559|NCT01083641|473627932|FG000|Overall Study|Withdrawal by Subject|2|||
131547560|NCT03386032|473627933|FG000|Overall Study|Lack of Efficacy|6|||
131547561|NCT03386032|473627934|FG001|Overall Study|Lack of Efficacy|2|||
131547562|NCT03386032|473627935|FG002|Overall Study|Lack of Efficacy|0|||
131547563|NCT03386032|473627933|FG000|Overall Study|Adverse Event|2|||
131547564|NCT03386032|473627934|FG001|Overall Study|Adverse Event|2|||
131547565|NCT03386032|473627935|FG002|Overall Study|Adverse Event|0|||
131547566|NCT03386032|473627933|FG000|Overall Study|Withdrawal by Subject|1|||
131547567|NCT03386032|473627934|FG001|Overall Study|Withdrawal by Subject|0|||
131547568|NCT03386032|473627935|FG002|Overall Study|Withdrawal by Subject|0|||
131547569|NCT03386032|473627933|FG000|Overall Study|Lost to Follow-up|9|||
131547570|NCT03386032|473627934|FG001|Overall Study|Lost to Follow-up|3|||
131547571|NCT03386032|473627935|FG002|Overall Study|Lost to Follow-up|0|||
131547572|NCT01807156|473627940|FG000|Overall Study|Physician Decision|1|||
131547573|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
131547574|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
131547575|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
131547576|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
131547577|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
131547578|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
131547579|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
131547580|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
131547581|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
131547582|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
131547583|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
131547584|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
131547585|NCT01493687|473627943|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
131547586|NCT01493687|473627944|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
131547587|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
131547588|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
131547589|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
131547590|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
131547591|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
131547592|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
131547593|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
131547594|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
131547595|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
131547596|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
131547597|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
131547598|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
131547599|NCT01493687|473627943|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
131547600|NCT01493687|473627944|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
131547601|NCT01493687|473627943|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
131547602|NCT01493687|473627944|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
131547603|NCT02364180|473627948|FG000|Overall Study|Screen Fail|1|||
131547604|NCT02323646|473627949|FG000|Treatment Course 1|Adverse Event|1|||
131547605|NCT02323646|473627950|FG001|Treatment Course 1|Adverse Event|0|||
131547606|NCT02323646|473627951|FG002|Treatment Course 1|Adverse Event|1|||
131660099|NCT01895101|474040705|FG001|Overall Study|coagulation disorder|1|||
131660100|NCT01895101|474040706|FG002|Overall Study|coagulation disorder|0|||
131547607|NCT02323646|473627949|FG000|Treatment Course 1|Heavy Bleeding|1|||
131547608|NCT02323646|473627950|FG001|Treatment Course 1|Heavy Bleeding|1|||
131547609|NCT02323646|473627951|FG002|Treatment Course 1|Heavy Bleeding|0|||
131547610|NCT02323646|473627949|FG000|Treatment Course 1|Lost to Follow-up|1|||
131547611|NCT02323646|473627950|FG001|Treatment Course 1|Lost to Follow-up|0|||
131547612|NCT02323646|473627951|FG002|Treatment Course 1|Lost to Follow-up|2|||
131547613|NCT02323646|473627949|FG000|Treatment Course 1|Withdrawal by Subject|0|||
131547614|NCT02323646|473627950|FG001|Treatment Course 1|Withdrawal by Subject|2|||
131547615|NCT02323646|473627951|FG002|Treatment Course 1|Withdrawal by Subject|0|||
131547616|NCT02323646|473627949|FG000|Treatment Course 2|Adverse Event|1|||
131547617|NCT02323646|473627950|FG001|Treatment Course 2|Adverse Event|0|||
131547618|NCT02323646|473627951|FG002|Treatment Course 2|Adverse Event|1|||
131547619|NCT02323646|473627949|FG000|Treatment Course 2|Lost to Follow-up|0|||
131547620|NCT02323646|473627950|FG001|Treatment Course 2|Lost to Follow-up|0|||
131547621|NCT02323646|473627951|FG002|Treatment Course 2|Lost to Follow-up|1|||
131547622|NCT02323646|473627949|FG000|Treatment Course 2|Non-compliance|0|||
131547623|NCT02323646|473627950|FG001|Treatment Course 2|Non-compliance|1|||
131547624|NCT02323646|473627951|FG002|Treatment Course 2|Non-compliance|1|||
131547625|NCT00521144|473627952|FG000|Overall Study|Not Treated|0|||
131547626|NCT00521144|473627953|FG001|Overall Study|Not Treated|0|||
131547627|NCT00521144|473627954|FG002|Overall Study|Not Treated|0|||
131547628|NCT00521144|473627955|FG003|Overall Study|Not Treated|1|||
131547629|NCT00521144|473627956|FG004|Overall Study|Not Treated|0|||
131547630|NCT00521144|473627952|FG000|Overall Study|Adverse Event|0|||
131547631|NCT00521144|473627953|FG001|Overall Study|Adverse Event|1|||
131547632|NCT00521144|473627954|FG002|Overall Study|Adverse Event|0|||
131547633|NCT00521144|473627955|FG003|Overall Study|Adverse Event|0|||
131547634|NCT00521144|473627956|FG004|Overall Study|Adverse Event|1|||
131547635|NCT00521144|473627952|FG000|Overall Study|Progressive Disease|4|||
131547636|NCT00521144|473627953|FG001|Overall Study|Progressive Disease|2|||
131547637|NCT00521144|473627954|FG002|Overall Study|Progressive Disease|2|||
131547638|NCT00521144|473627955|FG003|Overall Study|Progressive Disease|0|||
131547639|NCT00521144|473627956|FG004|Overall Study|Progressive Disease|6|||
131547640|NCT01370525|473627957|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
131547641|NCT01370525|473627958|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
131547642|NCT01370525|473627957|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131547643|NCT01370525|473627958|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131547644|NCT01370525|473627957|FG000|Overall Study|Adverse Event|0|||
131547645|NCT01370525|473627958|FG001|Overall Study|Adverse Event|1|||
131547646|NCT01370525|473627957|FG000|Overall Study|Protocol Violation|2|||
131547647|NCT01370525|473627958|FG001|Overall Study|Protocol Violation|1|||
131547648|NCT01370525|473627957|FG000|Overall Study|Lost to follow up|2|||
131547649|NCT01370525|473627958|FG001|Overall Study|Lost to follow up|6|||
131547650|NCT01059643|473627967|FG000|Overall Study|Adverse Event|3|||
131547651|NCT01059643|473627967|FG000|Overall Study|Withdrawal by Subject|2|||
131547652|NCT01059643|473627967|FG000|Overall Study|Physician Decision|1|||
131547653|NCT00106184|473627969|FG000|Overall Study|Withdrawal by Subject|3|||
131547654|NCT00106184|473627970|FG001|Overall Study|Withdrawal by Subject|2|||
131547655|NCT02313909|473627971|FG000|Overall Study|Consent withdrawn by participant|33|||
131547656|NCT02313909|473627972|FG001|Overall Study|Consent withdrawn by participant|33|||
131547657|NCT02313909|473627971|FG000|Overall Study|Lost to Follow-up|24|||
131547658|NCT02313909|473627972|FG001|Overall Study|Lost to Follow-up|17|||
131547659|NCT02923739|473627978|FG000|Overall Study|Withdrawal by Subject|2|||
131547660|NCT02923739|473627979|FG001|Overall Study|Withdrawal by Subject|0|||
131547661|NCT02923739|473627980|FG002|Overall Study|Withdrawal by Subject|0|||
131547662|NCT02923739|473627981|FG003|Overall Study|Withdrawal by Subject|0|||
131547663|NCT02923739|473627978|FG000|Overall Study|Failed Screening|3|||
131547664|NCT02923739|473627979|FG001|Overall Study|Failed Screening|0|||
131547665|NCT02923739|473627980|FG002|Overall Study|Failed Screening|0|||
131547666|NCT02923739|473627981|FG003|Overall Study|Failed Screening|0|||
131547667|NCT00409682|473627989|FG000|Open-label Induction Period|Adverse Event|1|||
131547668|NCT00409682|473627990|FG001|Open-label Induction Period|Adverse Event|0|||
131547669|NCT00409682|473627991|FG002|Open-label Induction Period|Adverse Event|0|||
131547670|NCT00409682|473627989|FG000|Open-label Induction Period|Lack of Efficacy|1|||
131547671|NCT00409682|473627990|FG001|Open-label Induction Period|Lack of Efficacy|0|||
131547672|NCT00409682|473627991|FG002|Open-label Induction Period|Lack of Efficacy|0|||
131547673|NCT00409682|473627989|FG000|Open-label Induction Period|Protocol Violation|1|||
131547674|NCT00409682|473627990|FG001|Open-label Induction Period|Protocol Violation|0|||
131547675|NCT00409682|473627991|FG002|Open-label Induction Period|Protocol Violation|0|||
131547676|NCT00409682|473627989|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
131547677|NCT00409682|473627990|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
131547678|NCT00409682|473627991|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
131547679|NCT00409682|473627989|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
131547680|NCT00409682|473627990|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
131547681|NCT00409682|473627991|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
131547682|NCT00409682|473627989|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
131547683|NCT00409682|473627990|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
131547684|NCT00409682|473627991|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
131886582|NCT03597022|474866223|FG002|Overall Study|Serious adverse event|0|||
131886583|NCT01672294|474866225|FG000|Overall Study|Withdrawal by Subject|4|||
131886584|NCT01672294|474866226|FG001|Overall Study|Withdrawal by Subject|4|||
131886585|NCT01672294|474866227|FG002|Overall Study|Withdrawal by Subject|4|||
131886586|NCT01672294|474866228|FG003|Overall Study|Withdrawal by Subject|4|||
131886587|NCT01672294|474866225|FG000|Overall Study|Excluded by study|1|||
131886588|NCT01672294|474866226|FG001|Overall Study|Excluded by study|1|||
131886589|NCT01672294|474866227|FG002|Overall Study|Excluded by study|0|||
131886590|NCT01672294|474866228|FG003|Overall Study|Excluded by study|0|||
131886591|NCT01672294|474866225|FG000|Overall Study|Lost to Follow-up|1|||
131886592|NCT01672294|474866226|FG001|Overall Study|Lost to Follow-up|16|||
131886593|NCT01672294|474866227|FG002|Overall Study|Lost to Follow-up|7|||
131886594|NCT01672294|474866228|FG003|Overall Study|Lost to Follow-up|9|||
131886595|NCT01438814|474866229|FG000|Overall Study|Adverse Event|3|||
131886596|NCT01438814|474866230|FG001|Overall Study|Adverse Event|3|||
131886597|NCT01438814|474866229|FG000|Overall Study|Protocol Violation|1|||
131886598|NCT01438814|474866230|FG001|Overall Study|Protocol Violation|2|||
131886599|NCT01438814|474866229|FG000|Overall Study|Lost to Follow-up|4|||
131886600|NCT01438814|474866230|FG001|Overall Study|Lost to Follow-up|3|||
131886601|NCT01438814|474866229|FG000|Overall Study|Withdrawal by Subject|4|||
131886602|NCT01438814|474866230|FG001|Overall Study|Withdrawal by Subject|2|||
131886603|NCT01438814|474866229|FG000|Overall Study|Other|2|||
131886604|NCT01438814|474866230|FG001|Overall Study|Other|4|||
131886605|NCT03887117|474866231|FG000|Overall Study|Discontinued prematurely|0|||
131886606|NCT03887117|474866232|FG001|Overall Study|Discontinued prematurely|1|||
131886607|NCT03887117|474866233|FG002|Overall Study|Discontinued prematurely|1|||
131886608|NCT03887117|474866234|FG003|Overall Study|Discontinued prematurely|2|||
131886609|NCT01389258|474866235|FG000|Overall Study|Lost to Follow-up|5|||
131886610|NCT00926536|474866236|FG000|Overall Study|Physician Decision|1|||
131547685|NCT00409682|473627989|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
131547686|NCT00409682|473627990|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
131547687|NCT00409682|473627991|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
131547688|NCT00409682|473627989|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
131547689|NCT00409682|473627990|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
131547690|NCT00409682|473627991|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
131547691|NCT00409682|473627989|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
131547692|NCT00409682|473627990|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
131886611|NCT00926536|474866237|FG001|Overall Study|Physician Decision|2|||
131886612|NCT03013985|474866238|FG000|Overall Study|Protocol Violation|2|||
131886613|NCT03013985|474866239|FG001|Overall Study|Protocol Violation|2|||
131886614|NCT03013985|474866238|FG000|Overall Study|Withdrawal by Subject|14|||
131886615|NCT03013985|474866239|FG001|Overall Study|Withdrawal by Subject|17|||
131886616|NCT01080391|474866240|FG000|Overall Study|Randomized but not treated|7|||
131886617|NCT01080391|474866241|FG001|Overall Study|Randomized but not treated|4|||
131886618|NCT01534208|474866242|FG000|Overall Study|Lost to Follow-up|19|||
131886619|NCT01534208|474866243|FG001|Overall Study|Lost to Follow-up|14|||
131886620|NCT01534208|474866242|FG000|Overall Study|Withdrawal by Subject|6|||
131886621|NCT01534208|474866243|FG001|Overall Study|Withdrawal by Subject|20|||
131886622|NCT01534208|474866242|FG000|Overall Study|Adverse Event|15|||
131886623|NCT01534208|474866243|FG001|Overall Study|Adverse Event|8|||
131886624|NCT01534208|474866242|FG000|Overall Study|Physician Decision|2|||
131886625|NCT01534208|474866243|FG001|Overall Study|Physician Decision|0|||
131886626|NCT01534208|474866242|FG000|Overall Study|Lack of Efficacy|0|||
131886627|NCT01534208|474866243|FG001|Overall Study|Lack of Efficacy|3|||
131886628|NCT01534208|474866242|FG000|Overall Study|Protocol Violation|2|||
131886629|NCT01534208|474866243|FG001|Overall Study|Protocol Violation|2|||
131886630|NCT01534208|474866242|FG000|Overall Study|Sponsor decision|4|||
131886631|NCT01534208|474866243|FG001|Overall Study|Sponsor decision|1|||
131886632|NCT01534208|474866242|FG000|Overall Study|Subject relocation|2|||
131886633|NCT01534208|474866243|FG001|Overall Study|Subject relocation|0|||
131886634|NCT01534208|474866242|FG000|Overall Study|Lab assessment|2|||
131886635|NCT01534208|474866243|FG001|Overall Study|Lab assessment|1|||
131886636|NCT01534208|474866242|FG000|Overall Study|Eligibility error|3|||
131547693|NCT00409682|473627991|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
131886637|NCT01534208|474866243|FG001|Overall Study|Eligibility error|0|||
131886638|NCT01534208|474866242|FG000|Overall Study|PCP decision|1|||
131886639|NCT01534208|474866243|FG001|Overall Study|PCP decision|0|||
131547694|NCT00409682|473627989|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
131547695|NCT00409682|473627990|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
131886640|NCT01534208|474866242|FG000|Overall Study|Needed prohibited meds|1|||
131886641|NCT01534208|474866243|FG001|Overall Study|Needed prohibited meds|0|||
131886642|NCT01904903|474866244|FG000|Overall Study|Withdrawal by Subject|1|||
131886643|NCT00672841|474866245|FG000|Overall Study|Comfort care|1|||
131886644|NCT00672841|474866246|FG001|Overall Study|Comfort care|4|||
131886645|NCT00672841|474866245|FG000|Overall Study|icteric specimens|0|||
131886646|NCT00672841|474866246|FG001|Overall Study|icteric specimens|3|||
131886647|NCT00672841|474866245|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
131886648|NCT00672841|474866246|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
131886649|NCT00672841|474866245|FG000|Overall Study|Adverse Event|0|||
131886650|NCT00672841|474866246|FG001|Overall Study|Adverse Event|3|||
131886651|NCT00672841|474866245|FG000|Overall Study|Pregnancy|0|||
131886652|NCT00672841|474866246|FG001|Overall Study|Pregnancy|1|||
131886653|NCT01260584|474866247|FG000|Period 1|Protocol Violation|0|||
131886654|NCT01260584|474866248|FG001|Period 1|Protocol Violation|0|||
131886655|NCT01260584|474866249|FG002|Period 1|Protocol Violation|1|||
131886656|NCT01260584|474866250|FG003|Period 1|Protocol Violation|1|||
131886657|NCT01260584|474866247|FG000|Period 1|Adverse Event|0|||
131886658|NCT01260584|474866248|FG001|Period 1|Adverse Event|0|||
131886659|NCT01260584|474866249|FG002|Period 1|Adverse Event|1|||
131886660|NCT01260584|474866250|FG003|Period 1|Adverse Event|0|||
131547696|NCT00409682|473627991|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
131547697|NCT01896869|473627994|FG000|Overall Study|Withdrawal by Subject|0|||
131547698|NCT01896869|473627995|FG001|Overall Study|Withdrawal by Subject|6|||
131547699|NCT01896869|473627994|FG000|Overall Study|Lost to Follow-up|1|||
131547700|NCT01896869|473627995|FG001|Overall Study|Lost to Follow-up|0|||
131886661|NCT01260584|474866247|FG000|Period 2|Protocol Violation|0|||
131886662|NCT01260584|474866248|FG001|Period 2|Protocol Violation|2|||
131886663|NCT01260584|474866249|FG002|Period 2|Protocol Violation|3|||
131886664|NCT01260584|474866250|FG003|Period 2|Protocol Violation|1|||
131886665|NCT01260584|474866247|FG000|Period 2|Adverse Event|1|||
131886666|NCT01260584|474866248|FG001|Period 2|Adverse Event|0|||
131886667|NCT01260584|474866249|FG002|Period 2|Adverse Event|2|||
131886668|NCT01260584|474866250|FG003|Period 2|Adverse Event|0|||
131886669|NCT01260584|474866247|FG000|Period 2|Withdrawal by Subject|0|||
131547701|NCT03494166|473628003|FG000|Overall Study|Death|0|||
131547702|NCT03494166|473628004|FG001|Overall Study|Death|0|||
131547703|NCT03494166|473628005|FG002|Overall Study|Death|0|||
131547704|NCT03494166|473628006|FG003|Overall Study|Death|1|||
131547705|NCT03494166|473628007|FG004|Overall Study|Death|3|||
131547706|NCT03494166|473628008|FG005|Overall Study|Death|0|||
131547707|NCT03494166|473628003|FG000|Overall Study|Lost to Follow-up|2|||
131547708|NCT03494166|473628004|FG001|Overall Study|Lost to Follow-up|2|||
131547709|NCT03494166|473628005|FG002|Overall Study|Lost to Follow-up|2|||
131547710|NCT03494166|473628006|FG003|Overall Study|Lost to Follow-up|2|||
131547711|NCT03494166|473628007|FG004|Overall Study|Lost to Follow-up|14|||
131547712|NCT03494166|473628008|FG005|Overall Study|Lost to Follow-up|0|||
131547713|NCT03494166|473628003|FG000|Overall Study|Withdrawal by Subject|10|||
131547714|NCT03494166|473628004|FG001|Overall Study|Withdrawal by Subject|7|||
131547715|NCT03494166|473628005|FG002|Overall Study|Withdrawal by Subject|0|||
131547716|NCT03494166|473628006|FG003|Overall Study|Withdrawal by Subject|5|||
131547717|NCT03494166|473628007|FG004|Overall Study|Withdrawal by Subject|3|||
131547718|NCT03494166|473628008|FG005|Overall Study|Withdrawal by Subject|17|||
131547719|NCT03494166|473628003|FG000|Overall Study|Screen failure|1|||
131547720|NCT03494166|473628004|FG001|Overall Study|Screen failure|0|||
131547721|NCT03494166|473628005|FG002|Overall Study|Screen failure|0|||
131547722|NCT03494166|473628006|FG003|Overall Study|Screen failure|0|||
131547723|NCT03494166|473628007|FG004|Overall Study|Screen failure|1|||
131547724|NCT03494166|473628008|FG005|Overall Study|Screen failure|0|||
131547725|NCT03138733|473628009|FG000|Overall Study|Death|17|||
131547726|NCT03138733|473628010|FG001|Overall Study|Death|18|||
131547727|NCT03138733|473628009|FG000|Overall Study|Withdrawal by Subject|11|||
131547728|NCT03138733|473628010|FG001|Overall Study|Withdrawal by Subject|6|||
131547729|NCT03138733|473628009|FG000|Overall Study|Lost to Follow-up|3|||
131547730|NCT03138733|473628010|FG001|Overall Study|Lost to Follow-up|2|||
131547731|NCT03138733|473628009|FG000|Overall Study|Adverse Event|1|||
131547732|NCT03138733|473628010|FG001|Overall Study|Adverse Event|0|||
131547733|NCT03138733|473628009|FG000|Overall Study|Protocol Violation|1|||
131547734|NCT03138733|473628010|FG001|Overall Study|Protocol Violation|3|||
131547735|NCT03138733|473628009|FG000|Overall Study|Administrative or logistical reason|1|||
131547736|NCT03138733|473628010|FG001|Overall Study|Administrative or logistical reason|0|||
131547737|NCT03138733|473628009|FG000|Overall Study|The patient was transferred to another hospital|1|||
131547738|NCT03138733|473628010|FG001|Overall Study|The patient was transferred to another hospital|0|||
131547739|NCT04252742|473628013|FG000|Overall Study|Decision by sponsor|0|||
131547740|NCT04252742|473628014|FG001|Overall Study|Decision by sponsor|2|||
131547741|NCT04252742|473628013|FG000|Overall Study|Withdrawal by Subject|15|||
131547742|NCT04252742|473628014|FG001|Overall Study|Withdrawal by Subject|9|||
131547743|NCT04252742|473628013|FG000|Overall Study|Lost to Follow-up|0|||
131547744|NCT04252742|473628014|FG001|Overall Study|Lost to Follow-up|1|||
131547745|NCT02220894|473628015|FG000|Overall Study|Adverse Event|127|||
131547746|NCT02220894|473628016|FG001|Overall Study|Adverse Event|74|||
131547747|NCT02220894|473628015|FG000|Overall Study|Death|418|||
131660101|NCT00370682|474040709|FG000|Overall Study|Moved from area|0|||
131886670|NCT01260584|474866248|FG001|Period 2|Withdrawal by Subject|1|||
131547748|NCT02220894|473628016|FG001|Overall Study|Death|508|||
131886671|NCT01260584|474866249|FG002|Period 2|Withdrawal by Subject|0|||
131886672|NCT01260584|474866250|FG003|Period 2|Withdrawal by Subject|0|||
131547749|NCT02220894|473628015|FG000|Overall Study|Lost to Follow-up|0|||
131547750|NCT02220894|473628016|FG001|Overall Study|Lost to Follow-up|4|||
131547751|NCT02220894|473628015|FG000|Overall Study|Site Terminated by Sponsor|2|||
131886673|NCT00045734|474866251|FG000|Overall Study|Protocol Violation|1|||
131886674|NCT00586508|474866254|FG000|Overall Study|Progressive disease|52|||
131886675|NCT00586508|474866255|FG001|Overall Study|Progressive disease|8|||
131886676|NCT00586508|474866254|FG000|Overall Study|Death|0|||
131886677|NCT00586508|474866255|FG001|Overall Study|Death|1|||
131886678|NCT00586508|474866254|FG000|Overall Study|Adverse Event|12|||
131886679|NCT00586508|474866255|FG001|Overall Study|Adverse Event|4|||
131886680|NCT00586508|474866254|FG000|Overall Study|Withdrawal by Subject|4|||
131886681|NCT00586508|474866255|FG001|Overall Study|Withdrawal by Subject|0|||
131886682|NCT00561470|474866256|FG000|Overall Study|Adverse Event|74|||
131886683|NCT00561470|474866257|FG001|Overall Study|Adverse Event|163|||
131886684|NCT00561470|474866256|FG000|Overall Study|Disease progression|437|||
131886685|NCT00561470|474866257|FG001|Overall Study|Disease progression|305|||
131886686|NCT00561470|474866256|FG000|Overall Study|poor compliance to protocol|4|||
131886687|NCT00561470|474866257|FG001|Overall Study|poor compliance to protocol|4|||
131886688|NCT00561470|474866256|FG000|Overall Study|Lost to Follow-up|2|||
131886689|NCT00561470|474866257|FG001|Overall Study|Lost to Follow-up|0|||
131886690|NCT00561470|474866256|FG000|Overall Study|Physician Decision|21|||
131886691|NCT00561470|474866257|FG001|Overall Study|Physician Decision|20|||
131886692|NCT00561470|474866256|FG000|Overall Study|Consent Withdrawn|2|||
131886693|NCT00561470|474866257|FG001|Overall Study|Consent Withdrawn|6|||
131886694|NCT00561470|474866256|FG000|Overall Study|Subject request|43|||
131886695|NCT00561470|474866257|FG001|Overall Study|Subject request|77|||
131886696|NCT00561470|474866256|FG000|Overall Study|Metastatic surgery|10|||
131886697|NCT00561470|474866257|FG001|Overall Study|Metastatic surgery|12|||
131886698|NCT00561470|474866256|FG000|Overall Study|Unauthorized procedure|3|||
131886699|NCT00561470|474866257|FG001|Overall Study|Unauthorized procedure|1|||
131886700|NCT00561470|474866256|FG000|Overall Study|Randomized but not treated|5|||
131886701|NCT00561470|474866257|FG001|Overall Study|Randomized but not treated|5|||
131886702|NCT00561470|474866256|FG000|Overall Study|Missed visit window|1|||
131886703|NCT00561470|474866257|FG001|Overall Study|Missed visit window|4|||
131886704|NCT00561470|474866256|FG000|Overall Study|Planning surgery|1|||
131886705|NCT00561470|474866257|FG001|Overall Study|Planning surgery|1|||
131547752|NCT02220894|473628016|FG001|Overall Study|Site Terminated by Sponsor|0|||
131547753|NCT02220894|473628015|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
131547754|NCT02220894|473628016|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
131547755|NCT02220894|473628015|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131547756|NCT02220894|473628016|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131547757|NCT02220894|473628015|FG000|Overall Study|Withdrawal by Subject|10|||
131547758|NCT02220894|473628016|FG001|Overall Study|Withdrawal by Subject|9|||
131547759|NCT00500903|473628019|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
131547760|NCT00500903|473628020|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
131547761|NCT00500903|473628021|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
131547762|NCT00500903|473628019|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
131547763|NCT00500903|473628020|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
131547764|NCT00500903|473628021|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
131547765|NCT00500903|473628019|FG000|Overall Study|Progressive Disease|41|||
131547766|NCT00500903|473628020|FG001|Overall Study|Progressive Disease|2|||
131547767|NCT00500903|473628021|FG002|Overall Study|Progressive Disease|15|||
131547768|NCT00500903|473628019|FG000|Overall Study|Patient Declined Further Treatment|0|||
131547769|NCT00500903|473628020|FG001|Overall Study|Patient Declined Further Treatment|0|||
131547770|NCT00500903|473628021|FG002|Overall Study|Patient Declined Further Treatment|3|||
131547771|NCT00500903|473628019|FG000|Overall Study|Symptomatic Deterioration|2|||
131547772|NCT00500903|473628020|FG001|Overall Study|Symptomatic Deterioration|0|||
131547773|NCT00500903|473628021|FG002|Overall Study|Symptomatic Deterioration|0|||
131547774|NCT00500903|473628019|FG000|Overall Study|Reason Not Specified|10|||
131547775|NCT00500903|473628020|FG001|Overall Study|Reason Not Specified|0|||
131547776|NCT00500903|473628021|FG002|Overall Study|Reason Not Specified|2|||
131547777|NCT00696410|473628022|FG000|Overall Study|Lost to Follow-up|2|||
131547778|NCT00696410|473628023|FG001|Overall Study|Lost to Follow-up|0|||
131547779|NCT00696410|473628022|FG000|Overall Study|Withdrawal by Subject|8|||
131547780|NCT00696410|473628023|FG001|Overall Study|Withdrawal by Subject|0|||
131547781|NCT00696410|473628022|FG000|Overall Study|Physician Decision|3|||
131547782|NCT00696410|473628023|FG001|Overall Study|Physician Decision|0|||
131547783|NCT02618616|473628024|FG000|Overall Study|Lack of Efficacy|4|||
131547784|NCT02618616|473628025|FG001|Overall Study|Lack of Efficacy|0|||
131660102|NCT00370682|474040710|FG001|Overall Study|Moved from area|2|||
131547785|NCT02618616|473628024|FG000|Overall Study|Pregnancy|0|||
131886706|NCT00561470|474866256|FG000|Overall Study|Ongoing Treatment|11|||
131886707|NCT00561470|474866257|FG001|Overall Study|Ongoing Treatment|14|||
131886708|NCT03434249|474866258|FG000|Overall Study|Adverse Event|1|||
131886709|NCT03434249|474866259|FG001|Overall Study|Adverse Event|0|||
131886710|NCT03434249|474866258|FG000|Overall Study|Lost to Follow-up|0|||
131886711|NCT03434249|474866259|FG001|Overall Study|Lost to Follow-up|1|||
131886712|NCT03434249|474866258|FG000|Overall Study|Non-compliance of family|2|||
131886713|NCT03434249|474866259|FG001|Overall Study|Non-compliance of family|1|||
131886714|NCT03434249|474866258|FG000|Overall Study|Difficulties in completing daily diary|2|||
131886715|NCT03434249|474866259|FG001|Overall Study|Difficulties in completing daily diary|1|||
131886716|NCT02054910|474866262|FG000|Overall Study|Lost to Follow-up|4|||
131886717|NCT02054910|474866263|FG001|Overall Study|Lost to Follow-up|1|||
131886718|NCT01096589|474866264|FG000|Overall Study|Adverse Event|2|||
131886719|NCT01096589|474866265|FG001|Overall Study|Adverse Event|1|||
131886720|NCT01096589|474866266|FG002|Overall Study|Adverse Event|2|||
131886721|NCT01096589|474866267|FG003|Overall Study|Adverse Event|1|||
131886722|NCT01096589|474866264|FG000|Overall Study|Withdrawal by Subject|2|||
131886723|NCT01096589|474866265|FG001|Overall Study|Withdrawal by Subject|1|||
131886724|NCT01096589|474866266|FG002|Overall Study|Withdrawal by Subject|1|||
131886725|NCT01096589|474866267|FG003|Overall Study|Withdrawal by Subject|1|||
131886726|NCT01096589|474866264|FG000|Overall Study|Compliance with protocol|0|||
131886727|NCT01096589|474866265|FG001|Overall Study|Compliance with protocol|0|||
131886728|NCT01096589|474866266|FG002|Overall Study|Compliance with protocol|1|||
131886729|NCT01096589|474866267|FG003|Overall Study|Compliance with protocol|0|||
131886730|NCT01096589|474866264|FG000|Overall Study|found treatment exhausting|0|||
131886731|NCT01096589|474866265|FG001|Overall Study|found treatment exhausting|0|||
131886732|NCT01096589|474866266|FG002|Overall Study|found treatment exhausting|0|||
131886733|NCT01096589|474866267|FG003|Overall Study|found treatment exhausting|1|||
131886734|NCT03673345|474866268|FG000|Overall Study|Lost to Follow-up|1|||
131886735|NCT03673345|474866269|FG001|Overall Study|Lost to Follow-up|0|||
131886736|NCT03673345|474866270|FG002|Overall Study|Lost to Follow-up|3|||
131886737|NCT03673345|474866271|FG003|Overall Study|Lost to Follow-up|3|||
131886738|NCT03673345|474866272|FG004|Overall Study|Lost to Follow-up|2|||
131886739|NCT03673345|474866273|FG005|Overall Study|Lost to Follow-up|1|||
131886740|NCT03673345|474866274|FG006|Overall Study|Lost to Follow-up|0|||
131886741|NCT03673345|474866275|FG007|Overall Study|Lost to Follow-up|0|||
131886742|NCT03673345|474866268|FG000|Overall Study|Withdrawal by Subject|1|||
131547786|NCT02618616|473628025|FG001|Overall Study|Pregnancy|1|||
131547787|NCT02618616|473628024|FG000|Overall Study|Adverse Event|8|||
131547788|NCT02618616|473628025|FG001|Overall Study|Adverse Event|0|||
131547789|NCT02618616|473628024|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
131547790|NCT02618616|473628025|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
131547791|NCT02618616|473628024|FG000|Overall Study|Consent withdrawn by subject|8|||
131547792|NCT02618616|473628025|FG001|Overall Study|Consent withdrawn by subject|5|||
131547793|NCT02618616|473628024|FG000|Overall Study|Lost to Follow-up|0|||
131547794|NCT02618616|473628025|FG001|Overall Study|Lost to Follow-up|1|||
131547795|NCT02686034|473628027|FG000|Run-In Period 1|Eligibility|12|||
131547796|NCT02686034|473628028|FG001|Run-In Period 1|Eligibility|10|||
131547797|NCT02686034|473628027|FG000|Run-In Period 1|Withdrawal by Subject|4|||
131547798|NCT02686034|473628028|FG001|Run-In Period 1|Withdrawal by Subject|3|||
131547799|NCT02686034|473628027|FG000|Run-In Period 1|Lost to Follow-up|4|||
131547800|NCT02686034|473628028|FG001|Run-In Period 1|Lost to Follow-up|4|||
131547801|NCT02686034|473628027|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
131547802|NCT02686034|473628028|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
131547803|NCT02686034|473628027|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
131547804|NCT02686034|473628028|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
131547805|NCT02686034|473628027|FG000|Randomized Controlled Period 2|Adverse Event|0|||
131547806|NCT02686034|473628028|FG001|Randomized Controlled Period 2|Adverse Event|2|||
131547807|NCT02686034|473628027|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
131547808|NCT02686034|473628028|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
131547809|NCT02686034|473628027|FG000|Open Label Period 3|Lost to Follow-up|0|||
131547810|NCT02686034|473628028|FG001|Open Label Period 3|Lost to Follow-up|1|||
131547811|NCT03538951|473628029|FG000|Overall Study|Withdrawal by Subject|1|||
131547812|NCT03538951|473628030|FG001|Overall Study|Withdrawal by Subject|2|||
131653509|NCT03412773|474018393|FG002|Overall Study|Withdrawal by Subject|19|||
131653510|NCT03412773|474018391|FG000|Overall Study|Study Closed By Sponsor|3|||
131653511|NCT03412773|474018392|FG001|Overall Study|Study Closed By Sponsor|46|||
131653512|NCT03412773|474018393|FG002|Overall Study|Study Closed By Sponsor|33|||
131653513|NCT03412773|474018391|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
131653514|NCT03412773|474018392|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
131653515|NCT03412773|474018393|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
131886743|NCT03673345|474866269|FG001|Overall Study|Withdrawal by Subject|0|||
131886744|NCT03673345|474866270|FG002|Overall Study|Withdrawal by Subject|4|||
131886745|NCT03673345|474866271|FG003|Overall Study|Withdrawal by Subject|2|||
131653516|NCT03412773|474018391|FG000|Overall Study|Death|7|||
131653517|NCT03412773|474018392|FG001|Overall Study|Death|259|||
131653518|NCT03412773|474018393|FG002|Overall Study|Death|273|||
131886746|NCT03673345|474866272|FG004|Overall Study|Withdrawal by Subject|0|||
131653519|NCT03412773|474018391|FG000|Overall Study|Physician Decision|0|||
131886747|NCT03673345|474866273|FG005|Overall Study|Withdrawal by Subject|0|||
131886748|NCT03673345|474866274|FG006|Overall Study|Withdrawal by Subject|0|||
131886749|NCT03673345|474866275|FG007|Overall Study|Withdrawal by Subject|0|||
131886750|NCT03673345|474866268|FG000|Overall Study|Physician Decision|0|||
131886751|NCT03673345|474866269|FG001|Overall Study|Physician Decision|0|||
131886752|NCT03673345|474866270|FG002|Overall Study|Physician Decision|2|||
131886753|NCT03673345|474866271|FG003|Overall Study|Physician Decision|0|||
131886754|NCT03673345|474866272|FG004|Overall Study|Physician Decision|0|||
131886755|NCT03673345|474866273|FG005|Overall Study|Physician Decision|0|||
131886756|NCT03673345|474866274|FG006|Overall Study|Physician Decision|0|||
131886757|NCT03673345|474866275|FG007|Overall Study|Physician Decision|0|||
131886758|NCT04438499|474866284|FG000|Overall Study|Lack of Efficacy|3|||
131886759|NCT02093390|474866285|FG000|Overall Study|Withdrawal by Subject|0|||
131886760|NCT02093390|474866286|FG001|Overall Study|Withdrawal by Subject|1|||
131886761|NCT04918355|474866287|FG000|Overall Study|no qualifying health encounter|497|||
131886762|NCT04918355|474866288|FG001|Overall Study|no qualifying health encounter|192|||
131886763|NCT04918355|474866289|FG002|Overall Study|no qualifying health encounter|438|||
131886764|NCT04918355|474866290|FG003|Overall Study|no qualifying health encounter|424|||
131886765|NCT02000882|474867696|FG000|Overall Study|Adverse Event|3|||
131886766|NCT02000882|474867696|FG000|Overall Study|Physician Decision|2|||
131886767|NCT02000882|474867696|FG000|Overall Study|Withdrawal by Subject|1|||
131886768|NCT00549601|474867697|FG000|Randomized|Protocol Violation|0|||
131886769|NCT00549601|474867698|FG001|Randomized|Protocol Violation|0|||
131886770|NCT00549601|474867699|FG002|Randomized|Protocol Violation|1|||
131886771|NCT00549601|474867697|FG000|Randomized|Withdrawal by Subject|0|||
131886772|NCT00549601|474867698|FG001|Randomized|Withdrawal by Subject|1|||
131886773|NCT00549601|474867699|FG002|Randomized|Withdrawal by Subject|1|||
131886774|NCT00549601|474867697|FG000|Received Study Drug|Adverse Event|2|||
131886775|NCT00549601|474867698|FG001|Received Study Drug|Adverse Event|5|||
131886776|NCT00549601|474867699|FG002|Received Study Drug|Adverse Event|1|||
131886777|NCT00549601|474867697|FG000|Received Study Drug|Death|0|||
131886778|NCT00549601|474867698|FG001|Received Study Drug|Death|1|||
131886779|NCT00549601|474867699|FG002|Received Study Drug|Death|0|||
131886780|NCT00549601|474867697|FG000|Received Study Drug|Lost to Follow-up|0|||
131886781|NCT00549601|474867698|FG001|Received Study Drug|Lost to Follow-up|1|||
131886782|NCT00549601|474867699|FG002|Received Study Drug|Lost to Follow-up|1|||
131886783|NCT00549601|474867697|FG000|Received Study Drug|Protocol Violation|3|||
131886784|NCT00549601|474867698|FG001|Received Study Drug|Protocol Violation|4|||
131886785|NCT00549601|474867699|FG002|Received Study Drug|Protocol Violation|1|||
131886786|NCT00549601|474867697|FG000|Received Study Drug|Withdrawal by Subject|2|||
131886787|NCT00549601|474867698|FG001|Received Study Drug|Withdrawal by Subject|0|||
131886788|NCT00549601|474867699|FG002|Received Study Drug|Withdrawal by Subject|1|||
131886789|NCT00908596|474867703|FG000|Overall Study|Other reasons|46|||
131886790|NCT00908596|474867704|FG001|Overall Study|Other reasons|6|||
131886791|NCT00908596|474867705|FG002|Overall Study|Other reasons|2|||
131886792|NCT00908596|474867706|FG003|Overall Study|Other reasons|0|||
131886793|NCT00908596|474867703|FG000|Overall Study|Lost to Follow-up|0|||
131886794|NCT00908596|474867704|FG001|Overall Study|Lost to Follow-up|1|||
131886795|NCT00908596|474867705|FG002|Overall Study|Lost to Follow-up|12|||
131886796|NCT00908596|474867706|FG003|Overall Study|Lost to Follow-up|4|||
131886797|NCT00908596|474867703|FG000|Overall Study|Death|0|||
131886798|NCT00908596|474867704|FG001|Overall Study|Death|5|||
131886799|NCT00908596|474867705|FG002|Overall Study|Death|57|||
131886800|NCT00908596|474867706|FG003|Overall Study|Death|32|||
131886801|NCT00908596|474867703|FG000|Overall Study|Protocol Violation|1|||
131886802|NCT00908596|474867704|FG001|Overall Study|Protocol Violation|0|||
131886803|NCT00908596|474867705|FG002|Overall Study|Protocol Violation|0|||
131886804|NCT00908596|474867706|FG003|Overall Study|Protocol Violation|0|||
131886805|NCT00908596|474867703|FG000|Overall Study|Withdrawal by Subject|0|||
131886806|NCT00908596|474867704|FG001|Overall Study|Withdrawal by Subject|1|||
131886807|NCT00908596|474867705|FG002|Overall Study|Withdrawal by Subject|3|||
131886808|NCT00908596|474867706|FG003|Overall Study|Withdrawal by Subject|1|||
131886809|NCT01709864|474867709|FG000|Overall Study|Physician Decision|0|||
131886810|NCT01709864|474867710|FG001|Overall Study|Physician Decision|1|||
131886811|NCT01709864|474867709|FG000|Overall Study|subject/guardian decision|5|||
131886812|NCT01709864|474867710|FG001|Overall Study|subject/guardian decision|6|||
131886813|NCT01709864|474867709|FG000|Overall Study|Lost to Follow-up|1|||
131886814|NCT01709864|474867710|FG001|Overall Study|Lost to Follow-up|0|||
131886815|NCT01709864|474867709|FG000|Overall Study|non-compliance with study treatment|1|||
131886816|NCT01709864|474867710|FG001|Overall Study|non-compliance with study treatment|1|||
131886817|NCT01709864|474867709|FG000|Overall Study|Adverse Event|0|||
131886818|NCT01709864|474867710|FG001|Overall Study|Adverse Event|2|||
131886819|NCT01709864|474867709|FG000|Overall Study|Death|0|||
131886820|NCT01709864|474867710|FG001|Overall Study|Death|1|||
131886821|NCT01472939|474867715|FG000|Overall Study|Adverse Event|3|||
131886822|NCT01472939|474867716|FG001|Overall Study|Adverse Event|7|||
131886823|NCT01472939|474867717|FG002|Overall Study|Adverse Event|7|||
131886824|NCT01472939|474867718|FG003|Overall Study|Adverse Event|14|||
131886825|NCT01472939|474867715|FG000|Overall Study|Lack of Efficacy|1|||
131886826|NCT01472939|474867716|FG001|Overall Study|Lack of Efficacy|0|||
131886827|NCT01472939|474867717|FG002|Overall Study|Lack of Efficacy|0|||
131886828|NCT01472939|474867718|FG003|Overall Study|Lack of Efficacy|1|||
131886829|NCT01472939|474867715|FG000|Overall Study|Lost to Follow-up|3|||
131886830|NCT01472939|474867716|FG001|Overall Study|Lost to Follow-up|0|||
131886831|NCT01472939|474867717|FG002|Overall Study|Lost to Follow-up|2|||
131886832|NCT01472939|474867718|FG003|Overall Study|Lost to Follow-up|0|||
131886833|NCT01472939|474867715|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
131886834|NCT01472939|474867716|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
131886835|NCT01472939|474867717|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
131886836|NCT01472939|474867718|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
131886837|NCT01472939|474867715|FG000|Overall Study|Prohibited Medication|0|||
131886838|NCT01472939|474867716|FG001|Overall Study|Prohibited Medication|1|||
131886839|NCT01472939|474867717|FG002|Overall Study|Prohibited Medication|0|||
131886840|NCT01472939|474867718|FG003|Overall Study|Prohibited Medication|0|||
131886841|NCT01472939|474867715|FG000|Overall Study|Withdrawal By PI|1|||
131886842|NCT01472939|474867716|FG001|Overall Study|Withdrawal By PI|0|||
131886843|NCT01472939|474867717|FG002|Overall Study|Withdrawal By PI|0|||
131886844|NCT01472939|474867718|FG003|Overall Study|Withdrawal By PI|0|||
131886845|NCT01472939|474867715|FG000|Overall Study|Protocol Violation|3|||
131886846|NCT01472939|474867716|FG001|Overall Study|Protocol Violation|3|||
131886847|NCT01472939|474867717|FG002|Overall Study|Protocol Violation|0|||
131886848|NCT01472939|474867718|FG003|Overall Study|Protocol Violation|1|||
131886849|NCT01472939|474867715|FG000|Overall Study|Withdrawal by Subject|9|||
131886850|NCT01472939|474867716|FG001|Overall Study|Withdrawal by Subject|3|||
131886851|NCT01472939|474867717|FG002|Overall Study|Withdrawal by Subject|1|||
131886852|NCT01472939|474867718|FG003|Overall Study|Withdrawal by Subject|4|||
131886853|NCT00388297|474867719|FG000|Overall Study|Lost to Follow-up|16|||
131886854|NCT00388297|474867720|FG001|Overall Study|Lost to Follow-up|12|||
131886855|NCT00388297|474867721|FG002|Overall Study|Lost to Follow-up|11|||
131886856|NCT00388297|474867722|FG003|Overall Study|Lost to Follow-up|8|||
131886857|NCT02607280|474867723|FG000|Overall Study|Adverse Event|4|||
131886858|NCT02607280|474867724|FG001|Overall Study|Adverse Event|0|||
131886859|NCT02607280|474867723|FG000|Overall Study|Decrease in CrCl <15|0|||
131886860|NCT02607280|474867724|FG001|Overall Study|Decrease in CrCl <15|1|||
131886861|NCT01492101|474867725|FG000|Overall Study|Death|323|||
131886862|NCT01492101|474867726|FG001|Overall Study|Death|322|||
131886863|NCT01492101|474867725|FG000|Overall Study|Withdrawal by Subject|14|||
131886864|NCT01492101|474867726|FG001|Overall Study|Withdrawal by Subject|18|||
131886865|NCT01492101|474867725|FG000|Overall Study|Lost to Follow-up|0|||
131886866|NCT01492101|474867726|FG001|Overall Study|Lost to Follow-up|2|||
131886867|NCT01675154|474867728|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
131886868|NCT01675154|474867729|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
131886869|NCT01675154|474867730|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
131886870|NCT01675154|474867731|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
131886871|NCT00987402|474867738|FG000|Overall Study|Insufficient data entry|86|||
131886872|NCT00987402|474867739|FG001|Overall Study|Insufficient data entry|98|||
131886873|NCT01430624|474867740|FG000|Overall Study|Lost to Follow-up|23|||
131886874|NCT01430624|474867741|FG001|Overall Study|Lost to Follow-up|29|||
131886875|NCT01430624|474867742|FG002|Overall Study|Lost to Follow-up|27|||
131886876|NCT01430624|474867740|FG000|Overall Study|technical or eligibility|5|||
131886877|NCT01430624|474867741|FG001|Overall Study|technical or eligibility|5|||
131886878|NCT01430624|474867742|FG002|Overall Study|technical or eligibility|2|||
131886879|NCT02614131|474867747|FG000|Overall Study|Withdrawal by Subject|1|||
131886880|NCT02614131|474867748|FG001|Overall Study|Withdrawal by Subject|0|||
131886881|NCT02614131|474867749|FG002|Overall Study|Withdrawal by Subject|0|||
131886882|NCT02614131|474867750|FG003|Overall Study|Withdrawal by Subject|0|||
131886883|NCT02614131|474867751|FG004|Overall Study|Withdrawal by Subject|0|||
131886884|NCT02614131|474867752|FG005|Overall Study|Withdrawal by Subject|0|||
131886885|NCT02614131|474867753|FG006|Overall Study|Withdrawal by Subject|0|||
131886886|NCT02614131|474867747|FG000|Overall Study|Adverse Event|0|||
131886887|NCT02614131|474867748|FG001|Overall Study|Adverse Event|0|||
131886888|NCT02614131|474867749|FG002|Overall Study|Adverse Event|0|||
131886889|NCT02614131|474867750|FG003|Overall Study|Adverse Event|0|||
131886890|NCT02614131|474867751|FG004|Overall Study|Adverse Event|0|||
131886891|NCT02614131|474867752|FG005|Overall Study|Adverse Event|0|||
131547813|NCT00949715|473629317|FG000|Overall Study|Physician Decision|1|||
131547814|NCT00949715|473629318|FG001|Overall Study|Physician Decision|0|||
131547815|NCT00949715|473629317|FG000|Overall Study|Lost to Follow-up|1|||
131886892|NCT02614131|474867753|FG006|Overall Study|Adverse Event|1|||
131886893|NCT01285492|474867758|FG000|Overall Study|Adverse Event|11|||
131886894|NCT01285492|474867759|FG001|Overall Study|Adverse Event|0|||
131886895|NCT01285492|474867758|FG000|Overall Study|Protocol Violation|3|||
131886896|NCT01285492|474867759|FG001|Overall Study|Protocol Violation|0|||
131886897|NCT01285492|474867758|FG000|Overall Study|Withdrawal by Subject|2|||
131886898|NCT01285492|474867759|FG001|Overall Study|Withdrawal by Subject|1|||
131886899|NCT01285492|474867758|FG000|Overall Study|Death|1|||
131886900|NCT01285492|474867759|FG001|Overall Study|Death|0|||
131886901|NCT01797094|474867760|FG000|Overall Study|Adverse Event|1|||
131886902|NCT01797094|474867761|FG001|Overall Study|Adverse Event|1|||
131886903|NCT01797094|474867760|FG000|Overall Study|Personal Reasons|4|||
131886904|NCT01797094|474867761|FG001|Overall Study|Personal Reasons|0|||
131886905|NCT01797094|474867760|FG000|Overall Study|Protocol Violation|0|||
131886906|NCT01797094|474867761|FG001|Overall Study|Protocol Violation|1|||
131886907|NCT01797094|474867760|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131886908|NCT01797094|474867761|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131886909|NCT03217968|474867766|FG000|Overall Study|Withdrawal by Subject|4|||
131886910|NCT03217968|474867766|FG000|Overall Study|Lost to Follow-up|1|||
131886911|NCT03217968|474867766|FG000|Overall Study|Protocol Violation|6|||
131886912|NCT01739764|474867768|FG000|Overall Study|Adverse Event|0|||
131886913|NCT01739764|474867769|FG001|Overall Study|Adverse Event|3|||
131886914|NCT01739764|474867770|FG002|Overall Study|Adverse Event|4|||
131886915|NCT01739764|474867768|FG000|Overall Study|Death|4|||
131886916|NCT01739764|474867769|FG001|Overall Study|Death|6|||
131886917|NCT01739764|474867770|FG002|Overall Study|Death|38|||
131886918|NCT01739764|474867768|FG000|Overall Study|Lost to Follow-up|0|||
131886919|NCT01739764|474867769|FG001|Overall Study|Lost to Follow-up|0|||
131886920|NCT01739764|474867770|FG002|Overall Study|Lost to Follow-up|5|||
131886921|NCT01739764|474867768|FG000|Overall Study|Non-Compliance|0|||
131886922|NCT01739764|474867769|FG001|Overall Study|Non-Compliance|0|||
131886923|NCT01739764|474867770|FG002|Overall Study|Non-Compliance|1|||
131886924|NCT01739764|474867768|FG000|Overall Study|Multiple Reasons|3|||
131886925|NCT01739764|474867769|FG001|Overall Study|Multiple Reasons|2|||
131886926|NCT01739764|474867770|FG002|Overall Study|Multiple Reasons|3|||
131886927|NCT01739764|474867768|FG000|Overall Study|Physician Decision|2|||
131886928|NCT01739764|474867769|FG001|Overall Study|Physician Decision|2|||
131886929|NCT01739764|474867770|FG002|Overall Study|Physician Decision|4|||
131886930|NCT01739764|474867768|FG000|Overall Study|Progressive Disease|3|||
131886931|NCT01739764|474867769|FG001|Overall Study|Progressive Disease|5|||
131886932|NCT01739764|474867770|FG002|Overall Study|Progressive Disease|16|||
131886933|NCT01739764|474867768|FG000|Overall Study|Protocol Violation|0|||
131886934|NCT01739764|474867769|FG001|Overall Study|Protocol Violation|0|||
131886935|NCT01739764|474867770|FG002|Overall Study|Protocol Violation|2|||
131886936|NCT01739764|474867768|FG000|Overall Study|Study Terminated by Sponsor|8|||
131886937|NCT01739764|474867769|FG001|Overall Study|Study Terminated by Sponsor|13|||
131886938|NCT01739764|474867770|FG002|Overall Study|Study Terminated by Sponsor|26|||
131886939|NCT01739764|474867768|FG000|Overall Study|Withdrawal by Subject|6|||
131886940|NCT01739764|474867769|FG001|Overall Study|Withdrawal by Subject|5|||
131886941|NCT01739764|474867770|FG002|Overall Study|Withdrawal by Subject|27|||
131886942|NCT00634049|474867779|FG000|Overall Study|Never received study drug|1|||
131886943|NCT00634049|474867779|FG000|Overall Study|Died prior to receiving study drug|1|||
131886944|NCT00634049|474867779|FG000|Overall Study|Screening failure|1|||
131886945|NCT00314132|474867780|FG000|Overall Study|Lost to Follow-up|3|||
131886946|NCT00314132|474867781|FG001|Overall Study|Lost to Follow-up|13|||
131886947|NCT00314132|474867780|FG000|Overall Study|Withdrawal by Subject|3|||
131886948|NCT00314132|474867781|FG001|Overall Study|Withdrawal by Subject|5|||
131886949|NCT00314132|474867780|FG000|Overall Study|Adverse Event|1|||
131886950|NCT00314132|474867781|FG001|Overall Study|Adverse Event|0|||
131886951|NCT00314132|474867780|FG000|Overall Study|Physician Decision|1|||
131886952|NCT00314132|474867781|FG001|Overall Study|Physician Decision|0|||
131886953|NCT02918552|474867784|FG000|Overall Study|Failed Pharmacokinetics|1|||
131886954|NCT02918552|474867785|FG001|Overall Study|Failed Pharmacokinetics|0|||
131886955|NCT02918552|474867784|FG000|Overall Study|Withdrawal by Subject|0|||
131886956|NCT02918552|474867785|FG001|Overall Study|Withdrawal by Subject|1|||
131886957|NCT02918552|474867784|FG000|Overall Study|Lost to Follow-up|0|||
131886958|NCT02918552|474867785|FG001|Overall Study|Lost to Follow-up|1|||
131886959|NCT04395274|474867786|FG000|Overall Study|Lost to Follow-up|20|||
131886960|NCT04395274|474867787|FG001|Overall Study|Lost to Follow-up|11|||
131886961|NCT04395274|474867786|FG000|Overall Study|Withdrawal by Subject|13|||
131886962|NCT04395274|474867787|FG001|Overall Study|Withdrawal by Subject|10|||
131886963|NCT04395274|474867786|FG000|Overall Study|Moved Abroad|0|||
131886964|NCT04395274|474867787|FG001|Overall Study|Moved Abroad|1|||
131886965|NCT03325894|474867788|FG000|Overall Study|Adverse Event|2|||
131886966|NCT03325894|474867789|FG001|Overall Study|Adverse Event|3|||
131886967|NCT03325894|474867788|FG000|Overall Study|Protocol Violation|1|||
131886968|NCT03325894|474867789|FG001|Overall Study|Protocol Violation|2|||
131886969|NCT03325894|474867788|FG000|Overall Study|Withdrawal by Subject|10|||
131886970|NCT03325894|474867789|FG001|Overall Study|Withdrawal by Subject|6|||
131886971|NCT03325894|474867788|FG000|Overall Study|Lost to Follow-up|4|||
131886972|NCT03325894|474867789|FG001|Overall Study|Lost to Follow-up|9|||
131886973|NCT03325894|474867788|FG000|Overall Study|Lack of Efficacy|8|||
131886974|NCT03325894|474867789|FG001|Overall Study|Lack of Efficacy|14|||
131886975|NCT03325894|474867788|FG000|Overall Study|Study Terminated by Sponsor|38|||
131886976|NCT03325894|474867789|FG001|Overall Study|Study Terminated by Sponsor|43|||
131886977|NCT03325894|474867788|FG000|Overall Study|Other (Not received Treatment)|1|||
131886978|NCT03325894|474867789|FG001|Overall Study|Other (Not received Treatment)|0|||
131886979|NCT03482167|474867792|FG000|Allocated to Intervention|Physician Decision|1|||
131886980|NCT03482167|474867793|FG001|Allocated to Intervention|Physician Decision|2|||
131886981|NCT03482167|474867792|FG000|Received Intervention|Adverse Event|3|||
131886982|NCT03482167|474867793|FG001|Received Intervention|Adverse Event|1|||
131886983|NCT03482167|474867792|FG000|Received Intervention|Physician Decision|1|||
131886984|NCT03482167|474867793|FG001|Received Intervention|Physician Decision|1|||
131886985|NCT03482167|474867792|FG000|Received Intervention|Withdrawal by Subject|1|||
131886986|NCT03482167|474867793|FG001|Received Intervention|Withdrawal by Subject|0|||
131886987|NCT01001598|474867797|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
131886988|NCT01001598|474867797|FG000|Overall Study|Adverse Event|1|||
131886989|NCT05079230|474867807|FG000|Overall Study|Study Terminated by Sponsor|101|||
131886990|NCT05079230|474867808|FG001|Overall Study|Study Terminated by Sponsor|102|||
131886991|NCT05079230|474867807|FG000|Overall Study|Death|72|||
131886992|NCT05079230|474867808|FG001|Overall Study|Death|66|||
131886993|NCT05079230|474867807|FG000|Overall Study|Withdrew Consent|16|||
131886994|NCT05079230|474867808|FG001|Overall Study|Withdrew Consent|18|||
131886995|NCT05079230|474867807|FG000|Overall Study|Lost to Follow-up|0|||
131886996|NCT05079230|474867808|FG001|Overall Study|Lost to Follow-up|3|||
131886997|NCT01524783|474867809|FG000|Blinded Period|Adverse Event|64|||
131886998|NCT01524783|474867810|FG001|Blinded Period|Adverse Event|7|||
131886999|NCT01524783|474867811|FG002|Blinded Period|Adverse Event|0|||
131887000|NCT01524783|474867809|FG000|Blinded Period|Disease Progression|89|||
131887001|NCT01524783|474867810|FG001|Blinded Period|Disease Progression|75|||
131887002|NCT01524783|474867811|FG002|Blinded Period|Disease Progression|0|||
131887003|NCT01524783|474867809|FG000|Blinded Period|Withdrawal by Subject|19|||
131887004|NCT01524783|474867810|FG001|Blinded Period|Withdrawal by Subject|6|||
131887005|NCT01524783|474867811|FG002|Blinded Period|Withdrawal by Subject|0|||
131887006|NCT01524783|474867809|FG000|Blinded Period|Protocol deviation|2|||
131887007|NCT01524783|474867810|FG001|Blinded Period|Protocol deviation|1|||
131887008|NCT01524783|474867811|FG002|Blinded Period|Protocol deviation|0|||
131887009|NCT01524783|474867809|FG000|Blinded Period|Death|5|||
131887010|NCT01524783|474867810|FG001|Blinded Period|Death|2|||
131887011|NCT01524783|474867811|FG002|Blinded Period|Death|0|||
131887012|NCT01524783|474867809|FG000|Open-label Period|Disease progression|13|||
131887013|NCT01524783|474867810|FG001|Open-label Period|Disease progression|0|||
131887014|NCT01524783|474867811|FG002|Open-label Period|Disease progression|2|||
131887015|NCT01524783|474867809|FG000|Open-label Period|Administrative problems|5|||
131887016|NCT01524783|474867810|FG001|Open-label Period|Administrative problems|0|||
131887017|NCT01524783|474867811|FG002|Open-label Period|Administrative problems|2|||
131887018|NCT01524783|474867809|FG000|Open-label Period|Adverse Event|5|||
131887019|NCT01524783|474867810|FG001|Open-label Period|Adverse Event|0|||
131887020|NCT01524783|474867811|FG002|Open-label Period|Adverse Event|1|||
131887021|NCT01524783|474867809|FG000|Open-label Period|Withdrawal by Subject|2|||
131887022|NCT01524783|474867810|FG001|Open-label Period|Withdrawal by Subject|0|||
131887023|NCT01524783|474867811|FG002|Open-label Period|Withdrawal by Subject|1|||
131887024|NCT01524783|474867809|FG000|Open-label Period|Protocol deviation|1|||
131887025|NCT01524783|474867810|FG001|Open-label Period|Protocol deviation|0|||
131887026|NCT01524783|474867811|FG002|Open-label Period|Protocol deviation|0|||
131887027|NCT02920177|474867812|FG000|Overall Study|Withdrawal by Subject|1|||
131887028|NCT02920177|474867813|FG001|Overall Study|Withdrawal by Subject|1|||
131887029|NCT02920177|474867812|FG000|Overall Study|Physician Decision|1|||
131887030|NCT02920177|474867813|FG001|Overall Study|Physician Decision|0|||
131887031|NCT02920177|474867812|FG000|Overall Study|Lost to Follow-up|0|||
131887032|NCT02920177|474867813|FG001|Overall Study|Lost to Follow-up|1|||
131887033|NCT01362244|474867817|FG000|Overall Study|Adverse Event|3|||
131887034|NCT01362244|474867818|FG001|Overall Study|Adverse Event|5|||
131887035|NCT01362244|474867817|FG000|Overall Study|Lack of Efficacy|5|||
131887036|NCT01362244|474867818|FG001|Overall Study|Lack of Efficacy|11|||
131887037|NCT01362244|474867817|FG000|Overall Study|Lost to Follow-up|0|||
131887038|NCT01362244|474867818|FG001|Overall Study|Lost to Follow-up|2|||
131887039|NCT01362244|474867817|FG000|Overall Study|Protocol Violation|5|||
131887040|NCT01362244|474867818|FG001|Overall Study|Protocol Violation|1|||
131887041|NCT01362244|474867817|FG000|Overall Study|Withdrawal by Subject|2|||
131887042|NCT01362244|474867818|FG001|Overall Study|Withdrawal by Subject|1|||
131887043|NCT01362244|474867817|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
131887044|NCT01362244|474867818|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
131887045|NCT01362244|474867817|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
131887046|NCT01362244|474867818|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
131887047|NCT03806231|474867819|FG000|Overall Study|Physician Decision|1|||
131887048|NCT03806231|474867820|FG001|Overall Study|Physician Decision|0|||
131887049|NCT03806231|474867819|FG000|Overall Study|Withdrawal by Subject|1|||
131887050|NCT03806231|474867820|FG001|Overall Study|Withdrawal by Subject|0|||
131887051|NCT02437188|474870061|FG000|Overall Study|Randomized but did not receive surgery|4|||
131887052|NCT02437188|474870062|FG001|Overall Study|Randomized but did not receive surgery|8|||
131887053|NCT02437188|474870061|FG000|Overall Study|Adverse Event|0|||
131887054|NCT02437188|474870062|FG001|Overall Study|Adverse Event|1|||
131887055|NCT01172808|474870063|FG000|Overall Study|Adverse Event|8|||
131887056|NCT01172808|474870064|FG001|Overall Study|Adverse Event|4|||
131887057|NCT01172808|474870065|FG002|Overall Study|Adverse Event|8|||
131887058|NCT01172808|474870066|FG003|Overall Study|Adverse Event|3|||
131887059|NCT01172808|474870063|FG000|Overall Study|Lack of Efficacy|1|||
131887060|NCT01172808|474870064|FG001|Overall Study|Lack of Efficacy|0|||
131887061|NCT01172808|474870065|FG002|Overall Study|Lack of Efficacy|0|||
131887062|NCT01172808|474870066|FG003|Overall Study|Lack of Efficacy|0|||
131887063|NCT01172808|474870063|FG000|Overall Study|Protocol Violation|2|||
131887064|NCT01172808|474870064|FG001|Overall Study|Protocol Violation|2|||
131887065|NCT01172808|474870065|FG002|Overall Study|Protocol Violation|2|||
131887066|NCT01172808|474870066|FG003|Overall Study|Protocol Violation|0|||
131887067|NCT01172808|474870063|FG000|Overall Study|Lost to Follow-up|0|||
131887068|NCT01172808|474870064|FG001|Overall Study|Lost to Follow-up|1|||
131887069|NCT01172808|474870065|FG002|Overall Study|Lost to Follow-up|1|||
131887070|NCT01172808|474870066|FG003|Overall Study|Lost to Follow-up|3|||
131887071|NCT01172808|474870063|FG000|Overall Study|Withdrawal by Subject|4|||
131887072|NCT01172808|474870064|FG001|Overall Study|Withdrawal by Subject|1|||
131887073|NCT01172808|474870065|FG002|Overall Study|Withdrawal by Subject|3|||
131887074|NCT01172808|474870066|FG003|Overall Study|Withdrawal by Subject|2|||
131887075|NCT01172808|474870063|FG000|Overall Study|Other|6|||
131887076|NCT01172808|474870064|FG001|Overall Study|Other|5|||
131887077|NCT01172808|474870065|FG002|Overall Study|Other|9|||
131887078|NCT01172808|474870066|FG003|Overall Study|Other|7|||
131887079|NCT02661061|474870067|FG000|Overall Study|Lack of Efficacy|1|||
131887080|NCT02661061|474870068|FG001|Overall Study|Lack of Efficacy|1|||
131887081|NCT02661061|474870067|FG000|Overall Study|Withdrawal by Subject|1|||
131887082|NCT02661061|474870068|FG001|Overall Study|Withdrawal by Subject|1|||
131887083|NCT03246061|474870069|FG000|Overall Study|Still in follow-up|15|||
131887084|NCT03246061|474870070|FG001|Overall Study|Still in follow-up|21|||
131887085|NCT01937715|474870071|FG000|Overall Study|Death|0|||
131887086|NCT01937715|474870072|FG001|Overall Study|Death|0|||
131887087|NCT01937715|474870073|FG002|Overall Study|Death|0|||
131887088|NCT01937715|474870074|FG003|Overall Study|Death|1|||
131887089|NCT01937715|474870075|FG004|Overall Study|Death|0|||
131887090|NCT01937715|474870071|FG000|Overall Study|Withdrawal by Subject|0|||
131887091|NCT01937715|474870072|FG001|Overall Study|Withdrawal by Subject|1|||
131887092|NCT01937715|474870073|FG002|Overall Study|Withdrawal by Subject|0|||
131887093|NCT01937715|474870074|FG003|Overall Study|Withdrawal by Subject|0|||
131887094|NCT01937715|474870075|FG004|Overall Study|Withdrawal by Subject|2|||
131887095|NCT01937715|474870071|FG000|Overall Study|Other|0|||
131887096|NCT01937715|474870072|FG001|Overall Study|Other|0|||
131887097|NCT01937715|474870073|FG002|Overall Study|Other|0|||
131887098|NCT01937715|474870074|FG003|Overall Study|Other|3|||
131887099|NCT01937715|474870075|FG004|Overall Study|Other|0|||
131887100|NCT02864316|474870076|FG000|Overall Study|Progressive Disease|2|||
131887101|NCT02864316|474870077|FG001|Overall Study|Progressive Disease|1|||
131887102|NCT02864316|474870076|FG000|Overall Study|Adverse Event|0|||
131887103|NCT02864316|474870077|FG001|Overall Study|Adverse Event|1|||
131887104|NCT01887288|474870078|FG000|Overall Study|The study was terminated and the PI has|16|||
131887105|NCT02696434|474870080|FG000|Overall Study|Adverse Event|3|||
131887106|NCT02696434|474870081|FG001|Overall Study|Adverse Event|1|||
131887107|NCT02696434|474870080|FG000|Overall Study|Lost to Follow-up|5|||
131887108|NCT02696434|474870081|FG001|Overall Study|Lost to Follow-up|4|||
131887109|NCT02696434|474870080|FG000|Overall Study|Withdrawal by Subject|14|||
131887110|NCT02696434|474870081|FG001|Overall Study|Withdrawal by Subject|12|||
131887111|NCT02696434|474870080|FG000|Overall Study|Physician Decision|0|||
131887112|NCT02696434|474870081|FG001|Overall Study|Physician Decision|1|||
131887113|NCT00316914|474870103|FG000|Overall Study|Withdrawal by Subject|5|||
131887114|NCT00316914|474870104|FG001|Overall Study|Withdrawal by Subject|3|||
131887115|NCT00316914|474870103|FG000|Overall Study|Adverse Event|8|||
131887116|NCT00316914|474870104|FG001|Overall Study|Adverse Event|7|||
131887117|NCT00316914|474870103|FG000|Overall Study|Other Problems|6|||
131887118|NCT00316914|474870104|FG001|Overall Study|Other Problems|11|||
131887119|NCT00316914|474870103|FG000|Overall Study|Missing end of treatment documentation|14|||
131887120|NCT00316914|474870104|FG001|Overall Study|Missing end of treatment documentation|15|||
131887121|NCT04105010|474870105|FG000|Overall Study|Death|3|||
131887122|NCT04105010|474870106|FG001|Overall Study|Death|1|||
131887123|NCT04105010|474870107|FG002|Overall Study|Death|1|||
131887124|NCT04105010|474870108|FG003|Overall Study|Death|54|||
131887125|NCT04105010|474870105|FG000|Overall Study|Lost to Follow-up|0|||
131887126|NCT04105010|474870106|FG001|Overall Study|Lost to Follow-up|0|||
131887127|NCT04105010|474870107|FG002|Overall Study|Lost to Follow-up|0|||
131887128|NCT04105010|474870108|FG003|Overall Study|Lost to Follow-up|4|||
131887129|NCT04105010|474870105|FG000|Overall Study|Withdrawal by Subject|8|||
131887130|NCT04105010|474870106|FG001|Overall Study|Withdrawal by Subject|1|||
131887131|NCT04105010|474870107|FG002|Overall Study|Withdrawal by Subject|1|||
131887132|NCT04105010|474870108|FG003|Overall Study|Withdrawal by Subject|4|||
131887133|NCT04105010|474870105|FG000|Overall Study|Other reason|4|||
131887134|NCT04105010|474870106|FG001|Overall Study|Other reason|7|||
131887135|NCT04105010|474870107|FG002|Overall Study|Other reason|0|||
131547816|NCT00949715|473629318|FG001|Overall Study|Lost to Follow-up|0|||
131547817|NCT00949715|473629317|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
131887136|NCT04105010|474870108|FG003|Overall Study|Other reason|19|||
131887137|NCT00427999|474870109|FG000|Overall Study|Adverse Event|6|||
131887138|NCT00427999|474870109|FG000|Overall Study|Abnormal laboratory values|1|||
131887139|NCT00427999|474870109|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
131887140|NCT00427999|474870109|FG000|Overall Study|Protocol Violation|2|||
131887141|NCT00427999|474870109|FG000|Overall Study|Withdrawal by Subject|9|||
131887142|NCT00427999|474870109|FG000|Overall Study|Death|1|||
131887143|NCT02380859|474870110|FG000|Overall Study|Withdrawal by Subject|2|||
131887144|NCT02380859|474870111|FG001|Overall Study|Withdrawal by Subject|0|||
131887145|NCT02284568|474870112|FG000|Overall Study|Adverse Event|2|||
131887146|NCT02284568|474870113|FG001|Overall Study|Adverse Event|9|||
131887147|NCT02284568|474870114|FG002|Overall Study|Adverse Event|4|||
131887148|NCT02284568|474870112|FG000|Overall Study|Withdrawal by Subject|22|||
131887149|NCT02284568|474870113|FG001|Overall Study|Withdrawal by Subject|21|||
131887150|NCT02284568|474870114|FG002|Overall Study|Withdrawal by Subject|1|||
131887151|NCT02284568|474870112|FG000|Overall Study|Noncompliance with study drug admin|1|||
131887152|NCT02284568|474870113|FG001|Overall Study|Noncompliance with study drug admin|2|||
131887153|NCT02284568|474870114|FG002|Overall Study|Noncompliance with study drug admin|0|||
131887154|NCT02284568|474870112|FG000|Overall Study|Noncompliance|1|||
131887155|NCT02284568|474870113|FG001|Overall Study|Noncompliance|0|||
131887156|NCT02284568|474870114|FG002|Overall Study|Noncompliance|0|||
131887157|NCT02284568|474870112|FG000|Overall Study|Protocol Violation|0|||
131887158|NCT02284568|474870113|FG001|Overall Study|Protocol Violation|1|||
131887159|NCT02284568|474870114|FG002|Overall Study|Protocol Violation|0|||
131887160|NCT02284568|474870112|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
131887161|NCT02284568|474870113|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
131887162|NCT02284568|474870114|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
131887163|NCT02284568|474870112|FG000|Overall Study|Lost to Follow-up|0|||
131887164|NCT02284568|474870113|FG001|Overall Study|Lost to Follow-up|3|||
131887165|NCT02284568|474870114|FG002|Overall Study|Lost to Follow-up|0|||
131887166|NCT02284568|474870112|FG000|Overall Study|Lack of Efficacy|4|||
131887167|NCT02284568|474870113|FG001|Overall Study|Lack of Efficacy|7|||
131887168|NCT02284568|474870114|FG002|Overall Study|Lack of Efficacy|0|||
131887169|NCT02284568|474870112|FG000|Overall Study|Other|1|||
131887170|NCT02284568|474870113|FG001|Overall Study|Other|2|||
131887171|NCT02284568|474870114|FG002|Overall Study|Other|0|||
131887172|NCT02284568|474870112|FG000|Overall Study|Withdrew before taking study drug|0|||
131887173|NCT02284568|474870113|FG001|Overall Study|Withdrew before taking study drug|1|||
131887174|NCT02284568|474870114|FG002|Overall Study|Withdrew before taking study drug|0|||
131887175|NCT05323994|474870115|FG000|Overall Study|Protocol Violation|1|||
131887176|NCT01420679|474870121|FG000|Overall Study|Disease Progression|3|||
131887177|NCT01420679|474870122|FG001|Overall Study|Disease Progression|2|||
131887178|NCT01420679|474870121|FG000|Overall Study|Adverse Event|4|||
131887179|NCT01420679|474870122|FG001|Overall Study|Adverse Event|0|||
131887180|NCT01420679|474870121|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
131887181|NCT01420679|474870122|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
131887182|NCT01420679|474870121|FG000|Overall Study|Patient Decision|1|||
131887183|NCT01420679|474870122|FG001|Overall Study|Patient Decision|0|||
131887184|NCT01420679|474870121|FG000|Overall Study|Investigator Decision|1|||
131887185|NCT01420679|474870122|FG001|Overall Study|Investigator Decision|2|||
131887186|NCT01420679|474870121|FG000|Overall Study|Sponsor Decision|3|||
131887187|NCT01420679|474870122|FG001|Overall Study|Sponsor Decision|3|||
131887188|NCT01420679|474870121|FG000|Overall Study|Other|1|||
131887189|NCT01420679|474870122|FG001|Overall Study|Other|0|||
131887190|NCT00943670|474870123|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
131887191|NCT00943670|474870123|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
131887192|NCT00943670|474870123|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
131887193|NCT00943670|474870123|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
131887194|NCT00943670|474870123|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
131887195|NCT00943670|474870123|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
131887196|NCT00943670|474870123|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
131887197|NCT00943670|474870123|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
131887198|NCT00943670|474870123|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
131887199|NCT00943670|474870123|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
131887200|NCT03956615|474870124|FG000|Overall Study|No multiple myeloma confirmed|2|||
131887201|NCT03956615|474870124|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
131887202|NCT03956615|474870124|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
131887203|NCT03956615|474870124|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
131887204|NCT03114657|474870130|FG000|Overall Study|Adverse Event|9|||
131887205|NCT03114657|474870131|FG001|Overall Study|Adverse Event|6|||
131887206|NCT03114657|474870130|FG000|Overall Study|Death|4|||
131887207|NCT03114657|474870131|FG001|Overall Study|Death|0|||
131887208|NCT03114657|474870130|FG000|Overall Study|Multiple Reasons|1|||
131887209|NCT03114657|474870131|FG001|Overall Study|Multiple Reasons|2|||
131887210|NCT03114657|474870130|FG000|Overall Study|Physician Decision|2|||
131887211|NCT03114657|474870131|FG001|Overall Study|Physician Decision|2|||
131887212|NCT03114657|474870130|FG000|Overall Study|Study Terminated By Sponsor|355|||
131887213|NCT03114657|474870131|FG001|Overall Study|Study Terminated By Sponsor|374|||
131887214|NCT03114657|474870130|FG000|Overall Study|Symptomatic Deterioration|0|||
131887215|NCT03114657|474870131|FG001|Overall Study|Symptomatic Deterioration|1|||
131887216|NCT03114657|474870130|FG000|Overall Study|Withdrawal by Subject|28|||
131887217|NCT03114657|474870131|FG001|Overall Study|Withdrawal by Subject|22|||
131887218|NCT01179737|474870133|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
131887219|NCT01179737|474870134|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
131887220|NCT01179737|474870135|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
131887221|NCT01179737|474870136|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
131887222|NCT01179737|474870133|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
131887223|NCT01179737|474870134|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
131434241|NCT01790594|473217467|FG001|Overall Study|Withdrawal by Subject|0|||
131434242|NCT01790594|473217468|FG002|Overall Study|Withdrawal by Subject|0|||
131434243|NCT01790594|473217466|FG000|Overall Study|Transplant was not done|0|||
131434244|NCT01790594|473217467|FG001|Overall Study|Transplant was not done|0|||
131434245|NCT01790594|473217468|FG002|Overall Study|Transplant was not done|3|||
131434246|NCT01790594|473217466|FG000|Overall Study|Terminated prior to week 76|0|||
131434247|NCT01790594|473217467|FG001|Overall Study|Terminated prior to week 76|2|||
131434248|NCT01790594|473217468|FG002|Overall Study|Terminated prior to week 76|0|||
131434249|NCT01050634|473217469|FG000|Overall Study|Enrolled, but Not Treated|56|||
131434250|NCT01050634|473217469|FG000|Overall Study|Death|2|||
131434251|NCT01050634|473217469|FG000|Overall Study|Adverse Event|42|||
131434252|NCT01050634|473217469|FG000|Overall Study|Lost to Follow-up|2|||
131434253|NCT01050634|473217469|FG000|Overall Study|Other|21|||
131434254|NCT01050634|473217469|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
131434255|NCT00496015|473217470|FG000|Overall Study|Other|1|||
131434256|NCT00496015|473217471|FG001|Overall Study|Other|0|||
131434257|NCT00496015|473217472|FG002|Overall Study|Other|0|||
131434258|NCT00496015|473217473|FG003|Overall Study|Other|1|||
131434259|NCT00496015|473217474|FG004|Overall Study|Other|0|||
131434260|NCT00527735|473217475|FG000|Overall Study|Disease progression|47|||
131434261|NCT00527735|473217476|FG001|Overall Study|Disease progression|61|||
131434262|NCT00527735|473217477|FG002|Overall Study|Disease progression|53|||
131434263|NCT00527735|473217475|FG000|Overall Study|Death|23|||
131434264|NCT00527735|473217476|FG001|Overall Study|Death|13|||
131434265|NCT00527735|473217477|FG002|Overall Study|Death|15|||
131434266|NCT00527735|473217475|FG000|Overall Study|Completed treatment in treatment phase|14|||
131434267|NCT00527735|473217476|FG001|Overall Study|Completed treatment in treatment phase|13|||
131434268|NCT00527735|473217477|FG002|Overall Study|Completed treatment in treatment phase|18|||
131434269|NCT00527735|473217475|FG000|Overall Study|Adverse Event|10|||
131434270|NCT00527735|473217476|FG001|Overall Study|Adverse Event|6|||
131434271|NCT00527735|473217477|FG002|Overall Study|Adverse Event|7|||
131434272|NCT00527735|473217475|FG000|Overall Study|Not identified|5|||
131434273|NCT00527735|473217476|FG001|Overall Study|Not identified|5|||
131434274|NCT00527735|473217477|FG002|Overall Study|Not identified|5|||
131434275|NCT00527735|473217475|FG000|Overall Study|Withdrawal by Subject|5|||
131434276|NCT00527735|473217476|FG001|Overall Study|Withdrawal by Subject|4|||
131434277|NCT00527735|473217477|FG002|Overall Study|Withdrawal by Subject|3|||
131434278|NCT00527735|473217475|FG000|Overall Study|No longer met study criteria|2|||
131434279|NCT00527735|473217476|FG001|Overall Study|No longer met study criteria|2|||
131434280|NCT00527735|473217477|FG002|Overall Study|No longer met study criteria|1|||
131434281|NCT00527735|473217475|FG000|Overall Study|Lost to Follow-up|0|||
131434282|NCT00527735|473217476|FG001|Overall Study|Lost to Follow-up|0|||
131434283|NCT00527735|473217477|FG002|Overall Study|Lost to Follow-up|3|||
131434284|NCT00527735|473217475|FG000|Overall Study|Poor compliance or noncompliance|0|||
131434285|NCT00527735|473217476|FG001|Overall Study|Poor compliance or noncompliance|1|||
131434286|NCT00527735|473217477|FG002|Overall Study|Poor compliance or noncompliance|1|||
131434287|NCT00527735|473217475|FG000|Overall Study|Completed treatment during maintenance|2|||
131434288|NCT00527735|473217476|FG001|Overall Study|Completed treatment during maintenance|2|||
131434289|NCT00527735|473217477|FG002|Overall Study|Completed treatment during maintenance|1|||
131434290|NCT01535807|473217478|FG000|Overall Study|Withdrawal by Subject|1|||
131887224|NCT01179737|474870135|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
131434291|NCT01535807|473217479|FG001|Overall Study|Withdrawal by Subject|1|||
131434292|NCT01535807|473217478|FG000|Overall Study|Data collection error|1|||
131434293|NCT01535807|473217479|FG001|Overall Study|Data collection error|1|||
131434294|NCT02730728|473217482|FG000|Overall Study|Withdrawal by Subject|0|||
131434295|NCT02730728|473217483|FG001|Overall Study|Withdrawal by Subject|1|||
131434296|NCT02730728|473217484|FG002|Overall Study|Withdrawal by Subject|0|||
131434297|NCT02730728|473217482|FG000|Overall Study|Lack of Efficacy|0|||
131434298|NCT02730728|473217483|FG001|Overall Study|Lack of Efficacy|1|||
131434299|NCT02730728|473217484|FG002|Overall Study|Lack of Efficacy|1|||
131434300|NCT00404651|473217485|FG000|Overall Study|Serious Adverse Event|0|||
131887225|NCT01179737|474870136|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
131887226|NCT01179737|474870133|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
131887227|NCT01179737|474870134|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
131887228|NCT01179737|474870135|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
131887229|NCT01179737|474870136|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
131887230|NCT01179737|474870133|FG000|Cohort 1 & Cohort 2|Death|0|||
131887231|NCT01179737|474870134|FG001|Cohort 1 & Cohort 2|Death|0|||
131887232|NCT01179737|474870135|FG002|Cohort 1 & Cohort 2|Death|1|||
131887233|NCT01179737|474870136|FG003|Cohort 1 & Cohort 2|Death|0|||
131887234|NCT01179737|474870133|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
131887235|NCT01179737|474870134|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
131887236|NCT01179737|474870135|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
131887237|NCT01179737|474870136|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
131887238|NCT01179737|474870133|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
131887239|NCT01179737|474870134|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
131887240|NCT01179737|474870135|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
131887241|NCT01179737|474870136|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
131887242|NCT01179737|474870133|FG000|Extension|The study was terminated|3|||
131887243|NCT01179737|474870134|FG001|Extension|The study was terminated|0|||
131887244|NCT01179737|474870135|FG002|Extension|The study was terminated|0|||
131887245|NCT01179737|474870136|FG003|Extension|The study was terminated|0|||
131887246|NCT01546038|474870137|FG000|Overall Study|Death|15|||
131887247|NCT01546038|474870138|FG001|Overall Study|Death|6|||
131887248|NCT01546038|474870139|FG002|Overall Study|Death|4|||
131887249|NCT01546038|474870140|FG003|Overall Study|Death|2|||
131887250|NCT01546038|474870141|FG004|Overall Study|Death|9|||
131887251|NCT01546038|474870142|FG005|Overall Study|Death|3|||
131887252|NCT01546038|474870143|FG006|Overall Study|Death|46|||
131887253|NCT01546038|474870144|FG007|Overall Study|Death|76|||
131887254|NCT01546038|474870145|FG008|Overall Study|Death|39|||
131887255|NCT01546038|474870137|FG000|Overall Study|Lost to Follow-up|0|||
131887256|NCT01546038|474870138|FG001|Overall Study|Lost to Follow-up|0|||
131887257|NCT01546038|474870139|FG002|Overall Study|Lost to Follow-up|0|||
131887258|NCT01546038|474870140|FG003|Overall Study|Lost to Follow-up|0|||
131887259|NCT01546038|474870141|FG004|Overall Study|Lost to Follow-up|1|||
131887260|NCT01546038|474870142|FG005|Overall Study|Lost to Follow-up|0|||
131887261|NCT01546038|474870143|FG006|Overall Study|Lost to Follow-up|2|||
131887262|NCT01546038|474870144|FG007|Overall Study|Lost to Follow-up|1|||
131887263|NCT01546038|474870145|FG008|Overall Study|Lost to Follow-up|0|||
131887264|NCT01546038|474870137|FG000|Overall Study|Withdrawal by Subject|1|||
131887265|NCT01546038|474870138|FG001|Overall Study|Withdrawal by Subject|0|||
131887266|NCT01546038|474870139|FG002|Overall Study|Withdrawal by Subject|0|||
131887267|NCT01546038|474870140|FG003|Overall Study|Withdrawal by Subject|1|||
131887268|NCT01546038|474870141|FG004|Overall Study|Withdrawal by Subject|0|||
131887269|NCT01546038|474870142|FG005|Overall Study|Withdrawal by Subject|1|||
131887270|NCT01546038|474870143|FG006|Overall Study|Withdrawal by Subject|3|||
131887271|NCT01546038|474870144|FG007|Overall Study|Withdrawal by Subject|3|||
131887272|NCT01546038|474870145|FG008|Overall Study|Withdrawal by Subject|1|||
131887273|NCT01546038|474870137|FG000|Overall Study|: Randomized, not treated|0|||
131887274|NCT01546038|474870138|FG001|Overall Study|: Randomized, not treated|0|||
131887275|NCT01546038|474870139|FG002|Overall Study|: Randomized, not treated|0|||
131887276|NCT01546038|474870140|FG003|Overall Study|: Randomized, not treated|0|||
131887277|NCT01546038|474870141|FG004|Overall Study|: Randomized, not treated|0|||
131887278|NCT01546038|474870142|FG005|Overall Study|: Randomized, not treated|0|||
131887279|NCT01546038|474870143|FG006|Overall Study|: Randomized, not treated|2|||
131887280|NCT01546038|474870144|FG007|Overall Study|: Randomized, not treated|4|||
131887281|NCT01546038|474870145|FG008|Overall Study|: Randomized, not treated|3|||
131887282|NCT04245202|474870146|FG000|Overall Study|Lack of Efficacy|10|||
131887283|NCT04245202|474870147|FG001|Overall Study|Lack of Efficacy|1|||
131887284|NCT02470403|474870148|FG000|Overall Study|Adverse Event|1|||
131887285|NCT02470403|474870149|FG001|Overall Study|Adverse Event|0|||
131887286|NCT02470403|474870150|FG002|Overall Study|Adverse Event|0|||
131887287|NCT02470403|474870151|FG003|Overall Study|Adverse Event|0|||
131887288|NCT02470403|474870152|FG004|Overall Study|Adverse Event|0|||
131887289|NCT02470403|474870148|FG000|Overall Study|Lost to Follow-up|0|||
131887290|NCT02470403|474870149|FG001|Overall Study|Lost to Follow-up|1|||
131887291|NCT02470403|474870150|FG002|Overall Study|Lost to Follow-up|0|||
131887292|NCT02470403|474870151|FG003|Overall Study|Lost to Follow-up|0|||
131887293|NCT02470403|474870152|FG004|Overall Study|Lost to Follow-up|0|||
131887294|NCT02470403|474870148|FG000|Overall Study|Subject/guardian decision|1|||
131887295|NCT02470403|474870149|FG001|Overall Study|Subject/guardian decision|0|||
131887296|NCT02470403|474870150|FG002|Overall Study|Subject/guardian decision|0|||
131887297|NCT02470403|474870151|FG003|Overall Study|Subject/guardian decision|4|||
131887298|NCT02470403|474870152|FG004|Overall Study|Subject/guardian decision|0|||
131887299|NCT00717275|474870153|FG000|Overall Study|Premature study termination.|3|||
131887300|NCT03329248|474870156|FG000|Overall Study|Progressive Disease|6|||
131887301|NCT01254721|474870161|FG000|Overall Study|Lost to Follow-up|0|||
131887302|NCT01254721|474870162|FG001|Overall Study|Lost to Follow-up|4|||
131547818|NCT00949715|473629318|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
131547819|NCT01352585|473629319|FG000|Overall Study|Adverse Event|2|||
131547820|NCT01352585|473629320|FG001|Overall Study|Adverse Event|1|||
131547821|NCT01352585|473629319|FG000|Overall Study|Lost to Follow-up|1|||
131547822|NCT01352585|473629320|FG001|Overall Study|Lost to Follow-up|0|||
131547823|NCT01352585|473629319|FG000|Overall Study|Other|5|||
131547824|NCT01352585|473629320|FG001|Overall Study|Other|2|||
131547825|NCT05050578|473629323|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
131547826|NCT05050578|473629324|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
131547827|NCT05050578|473629323|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
131547828|NCT05050578|473629324|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
131547829|NCT05050578|473629323|FG000|Period 2, 30 Days|Protocol Violation|0|||
131547830|NCT05050578|473629324|FG001|Period 2, 30 Days|Protocol Violation|1|||
131547831|NCT02243280|473629325|FG000|Treated|Adverse Event|1|||
131547832|NCT02243280|473629326|FG001|Treated|Adverse Event|0|||
131547833|NCT02243280|473629327|FG002|Treated|Adverse Event|0|||
131547834|NCT02243280|473629328|FG003|Treated|Adverse Event|0|||
131547835|NCT02243280|473629329|FG004|Treated|Adverse Event|0|||
131547836|NCT02243280|473629330|FG005|Treated|Adverse Event|0|||
131547837|NCT02243280|473629331|FG006|Treated|Adverse Event|0|||
131547838|NCT02243280|473629332|FG007|Treated|Adverse Event|0|||
131547839|NCT02243280|473629333|FG008|Treated|Adverse Event|0|||
131547840|NCT02243280|473629334|FG009|Treated|Adverse Event|0|||
131887303|NCT01254721|474870161|FG000|Overall Study|Lack of Efficacy|4|||
131887304|NCT01254721|474870162|FG001|Overall Study|Lack of Efficacy|2|||
131887305|NCT01254721|474870161|FG000|Overall Study|Death|0|||
131887306|NCT01254721|474870162|FG001|Overall Study|Death|1|||
131887307|NCT01254721|474870161|FG000|Overall Study|technical problum|1|||
131887308|NCT01254721|474870162|FG001|Overall Study|technical problum|0|||
131887309|NCT01254721|474870161|FG000|Overall Study|Adverse Event|2|||
131887310|NCT01254721|474870162|FG001|Overall Study|Adverse Event|3|||
131887311|NCT01254721|474870161|FG000|Overall Study|Withdrawal by Subject|8|||
131887312|NCT01254721|474870162|FG001|Overall Study|Withdrawal by Subject|11|||
131887313|NCT01254721|474870161|FG000|Overall Study|Wrongly randomization|0|||
131887314|NCT01254721|474870162|FG001|Overall Study|Wrongly randomization|1|||
131887315|NCT03000530|474870166|FG000|Overall Study|Adverse Event|0|||
131887316|NCT03000530|474870167|FG001|Overall Study|Adverse Event|0|||
131887317|NCT03000530|474870168|FG002|Overall Study|Adverse Event|2|||
131887318|NCT03000530|474870166|FG000|Overall Study|Lost to Follow-up|0|||
131887319|NCT03000530|474870167|FG001|Overall Study|Lost to Follow-up|3|||
131887320|NCT03000530|474870168|FG002|Overall Study|Lost to Follow-up|1|||
131887321|NCT03000530|474870166|FG000|Overall Study|Withdrawal by Subject|0|||
131887322|NCT03000530|474870167|FG001|Overall Study|Withdrawal by Subject|2|||
131887323|NCT03000530|474870168|FG002|Overall Study|Withdrawal by Subject|1|||
131887324|NCT00312572|474870169|FG000|Overall Study|Adverse Event|10|||
131887325|NCT00312572|474870170|FG001|Overall Study|Adverse Event|16|||
131887326|NCT00312572|474870169|FG000|Overall Study|Lost to Follow-up|1|||
131887327|NCT00312572|474870170|FG001|Overall Study|Lost to Follow-up|1|||
131887328|NCT00312572|474870169|FG000|Overall Study|Administrative|4|||
131887329|NCT00312572|474870170|FG001|Overall Study|Administrative|2|||
131887330|NCT00312572|474870169|FG000|Overall Study|Lack of Efficacy|1|||
131887331|NCT00312572|474870170|FG001|Overall Study|Lack of Efficacy|2|||
131887332|NCT01362517|474870171|FG000|Overall Study|Protocol Violation|1|||
131887333|NCT01362517|474870171|FG000|Overall Study|Lost to Follow-up|1|||
131887334|NCT03379792|474870173|FG000|Overall Study|Physician Decision|0|||
131887335|NCT03379792|474870174|FG001|Overall Study|Physician Decision|0|||
131887336|NCT03379792|474870175|FG002|Overall Study|Physician Decision|0|||
131887337|NCT03379792|474870176|FG003|Overall Study|Physician Decision|1|||
131887338|NCT03379792|474870177|FG004|Overall Study|Physician Decision|0|||
131887339|NCT03379792|474870178|FG005|Overall Study|Physician Decision|0|||
131887340|NCT03379792|474870173|FG000|Overall Study|Withdrawal by Subject|0|||
131887341|NCT03379792|474870174|FG001|Overall Study|Withdrawal by Subject|0|||
131887342|NCT03379792|474870175|FG002|Overall Study|Withdrawal by Subject|0|||
131887343|NCT03379792|474870176|FG003|Overall Study|Withdrawal by Subject|0|||
131547841|NCT02243280|473629335|FG010|Treated|Adverse Event|1|||
131547842|NCT02243280|473629325|FG000|Treated|Lost to Follow-up|0|||
131547843|NCT02243280|473629326|FG001|Treated|Lost to Follow-up|0|||
131547844|NCT02243280|473629327|FG002|Treated|Lost to Follow-up|0|||
131547845|NCT02243280|473629328|FG003|Treated|Lost to Follow-up|0|||
131547846|NCT02243280|473629329|FG004|Treated|Lost to Follow-up|0|||
131547847|NCT02243280|473629330|FG005|Treated|Lost to Follow-up|0|||
131547848|NCT02243280|473629331|FG006|Treated|Lost to Follow-up|0|||
131547849|NCT02243280|473629332|FG007|Treated|Lost to Follow-up|0|||
131547850|NCT02243280|473629333|FG008|Treated|Lost to Follow-up|1|||
131547851|NCT02243280|473629334|FG009|Treated|Lost to Follow-up|0|||
131887344|NCT03379792|474870177|FG004|Overall Study|Withdrawal by Subject|1|||
131887345|NCT03379792|474870178|FG005|Overall Study|Withdrawal by Subject|1|||
131887346|NCT01121536|474870179|FG000|Overall Study|Adverse Event|63|||
131887347|NCT01121536|474870179|FG000|Overall Study|Lack of Efficacy|35|||
131887348|NCT01121536|474870179|FG000|Overall Study|Withdrawal by Subject|65|||
131887349|NCT01121536|474870179|FG000|Overall Study|Protocol Violation|20|||
131887350|NCT01121536|474870179|FG000|Overall Study|Noncompliance with study medication|12|||
131887351|NCT01121536|474870179|FG000|Overall Study|Noncompliance with study procedures|9|||
131887352|NCT01121536|474870179|FG000|Overall Study|Lost to Follow-up|39|||
131887353|NCT01121536|474870179|FG000|Overall Study|Other|118|||
131887354|NCT00568334|474870180|FG000|Overall Study|Withdrawal by Subject|0|||
131887355|NCT00568334|474870181|FG001|Overall Study|Withdrawal by Subject|1|||
131887356|NCT00568334|474870180|FG000|Overall Study|Lost to Follow-up|1|||
131887357|NCT00568334|474870181|FG001|Overall Study|Lost to Follow-up|0|||
131887358|NCT00306787|474870182|FG000|Overall Study|Discontinued without taking study drug|208|||
131887359|NCT00306787|474870183|FG001|Overall Study|Discontinued without taking study drug|215|||
131887360|NCT00306787|474870182|FG000|Overall Study|Adverse Event|1|||
131887361|NCT00306787|474870183|FG001|Overall Study|Adverse Event|1|||
131887362|NCT00306787|474870182|FG000|Overall Study|Lack of Efficacy|1|||
131887363|NCT00306787|474870183|FG001|Overall Study|Lack of Efficacy|0|||
131887364|NCT00306787|474870182|FG000|Overall Study|Protocol Violation|8|||
131887365|NCT00306787|474870183|FG001|Overall Study|Protocol Violation|10|||
131887366|NCT00306787|474870182|FG000|Overall Study|Withdrawal by Subject|2|||
131887367|NCT00306787|474870183|FG001|Overall Study|Withdrawal by Subject|9|||
131887368|NCT00306787|474870182|FG000|Overall Study|Lost to Follow-up|9|||
131887369|NCT00306787|474870183|FG001|Overall Study|Lost to Follow-up|6|||
131887370|NCT00306787|474870182|FG000|Overall Study|Administrative problems|4|||
131887371|NCT00306787|474870183|FG001|Overall Study|Administrative problems|0|||
131887372|NCT00306787|474870182|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131887373|NCT00306787|474870183|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131887374|NCT02273908|474870184|FG000|Overall Study|Adverse Event|16|||
131887375|NCT02273908|474870185|FG001|Overall Study|Adverse Event|0|||
131887376|NCT02273908|474870184|FG000|Overall Study|Lost to Follow-up|10|||
131887377|NCT02273908|474870185|FG001|Overall Study|Lost to Follow-up|1|||
131887378|NCT02273908|474870184|FG000|Overall Study|Did not meet entrance criteria|3|||
131887379|NCT02273908|474870185|FG001|Overall Study|Did not meet entrance criteria|2|||
131887380|NCT02273908|474870184|FG000|Overall Study|Withdrawal by Subject|4|||
131887381|NCT02273908|474870185|FG001|Overall Study|Withdrawal by Subject|2|||
131887382|NCT05153148|474870186|FG000|Overall Study|Adverse Event|1|||
131887383|NCT05153148|474870187|FG001|Overall Study|Adverse Event|0|||
131887384|NCT05153148|474870188|FG002|Overall Study|Adverse Event|3|||
131887385|NCT05153148|474870189|FG003|Overall Study|Adverse Event|5|||
131887386|NCT05153148|474870186|FG000|Overall Study|Lost to Follow-up|1|||
131887387|NCT05153148|474870187|FG001|Overall Study|Lost to Follow-up|1|||
131887388|NCT05153148|474870188|FG002|Overall Study|Lost to Follow-up|2|||
131887389|NCT05153148|474870189|FG003|Overall Study|Lost to Follow-up|0|||
131887390|NCT05153148|474870186|FG000|Overall Study|Withdrawal by Subject|6|||
131887391|NCT05153148|474870187|FG001|Overall Study|Withdrawal by Subject|8|||
131887392|NCT05153148|474870188|FG002|Overall Study|Withdrawal by Subject|6|||
131887393|NCT05153148|474870189|FG003|Overall Study|Withdrawal by Subject|8|||
131887394|NCT05153148|474870186|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
131887395|NCT05153148|474870187|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
131887396|NCT05153148|474870188|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
131887397|NCT05153148|474870189|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
131887398|NCT05153148|474870186|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
131887399|NCT05153148|474870187|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
131887400|NCT05153148|474870188|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
131887401|NCT05153148|474870189|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
131887402|NCT05153148|474870186|FG000|Overall Study|Reason not Specified|1|||
131887403|NCT05153148|474870187|FG001|Overall Study|Reason not Specified|1|||
131887404|NCT05153148|474870188|FG002|Overall Study|Reason not Specified|1|||
131887405|NCT05153148|474870189|FG003|Overall Study|Reason not Specified|1|||
131887406|NCT01712334|474870190|FG000|Treatment Period 1|Randomized in Error|0|||
131887407|NCT01712334|474870191|FG001|Treatment Period 1|Randomized in Error|2|||
131887408|NCT01732471|474870192|FG000|Overall Study|Withdrawal by Subject|1|||
131887409|NCT01253174|474870193|FG000|Period 1|Randomized but not treated|0|||
131887410|NCT01253174|474870194|FG001|Period 1|Randomized but not treated|1|||
131887411|NCT01253174|474870195|FG002|Period 1|Randomized but not treated|1|||
131887412|NCT01253174|474870196|FG003|Period 1|Randomized but not treated|0|||
131887413|NCT01253174|474870197|FG004|Period 1|Randomized but not treated|1|||
131887414|NCT01253174|474870198|FG005|Period 1|Randomized but not treated|0|||
131887415|NCT01253174|474870193|FG000|Period 2|Adverse Event|0|||
131887416|NCT01253174|474870194|FG001|Period 2|Adverse Event|0|||
131887417|NCT01253174|474870195|FG002|Period 2|Adverse Event|1|||
131887418|NCT01253174|474870196|FG003|Period 2|Adverse Event|0|||
131547852|NCT02243280|473629335|FG010|Treated|Lost to Follow-up|2|||
131887419|NCT01253174|474870197|FG004|Period 2|Adverse Event|0|||
131887420|NCT01253174|474870198|FG005|Period 2|Adverse Event|0|||
131887421|NCT01253174|474870193|FG000|Period 3|Withdrawal by Subject|0|||
131887422|NCT01253174|474870194|FG001|Period 3|Withdrawal by Subject|1|||
131887423|NCT01253174|474870195|FG002|Period 3|Withdrawal by Subject|0|||
131887424|NCT01253174|474870196|FG003|Period 3|Withdrawal by Subject|0|||
131547853|NCT03928028|473629336|FG000|Overall Study|Physician Decision|9|||
131547854|NCT03928028|473629337|FG001|Overall Study|Physician Decision|6|||
131887425|NCT01253174|474870197|FG004|Period 3|Withdrawal by Subject|1|||
131887426|NCT01253174|474870198|FG005|Period 3|Withdrawal by Subject|0|||
131887427|NCT01253174|474870193|FG000|Period 3|Pregnancy|0|||
131887428|NCT01253174|474870194|FG001|Period 3|Pregnancy|0|||
131887429|NCT01253174|474870195|FG002|Period 3|Pregnancy|1|||
131887430|NCT01253174|474870196|FG003|Period 3|Pregnancy|0|||
131887431|NCT01253174|474870197|FG004|Period 3|Pregnancy|0|||
131887432|NCT01253174|474870198|FG005|Period 3|Pregnancy|0|||
131887433|NCT02892513|474870199|FG000|Overall Study|Withdrawal by Subject|0|||
131887434|NCT02892513|474870200|FG001|Overall Study|Withdrawal by Subject|1|||
131887435|NCT02267135|474870201|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
131887436|NCT02267135|474870202|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
131887437|NCT02267135|474870201|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
131887438|NCT02267135|474870202|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
131887439|NCT02267135|474870201|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
131887440|NCT02267135|474870202|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
131887441|NCT02267135|474870201|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
131887442|NCT02267135|474870202|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
131887443|NCT02267135|474870201|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
131887444|NCT02267135|474870202|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
131887445|NCT00900731|474870203|FG000|Overall Study|Adverse Event|31|||
131887446|NCT00900731|474870204|FG001|Overall Study|Adverse Event|27|||
131887447|NCT00900731|474870203|FG000|Overall Study|Withdrawal by Subject|8|||
131887448|NCT00900731|474870204|FG001|Overall Study|Withdrawal by Subject|7|||
131887449|NCT00900731|474870203|FG000|Overall Study|Protocol Deviation|8|||
131887450|NCT00900731|474870204|FG001|Overall Study|Protocol Deviation|11|||
131887451|NCT00900731|474870203|FG000|Overall Study|Administrative Problems|5|||
131887452|NCT00900731|474870204|FG001|Overall Study|Administrative Problems|4|||
131887453|NCT00900731|474870203|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
131887454|NCT00900731|474870204|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
131887455|NCT00900731|474870203|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
131887456|NCT00900731|474870204|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
131887457|NCT00900731|474870203|FG000|Overall Study|Lost to Follow-up|2|||
131887458|NCT00900731|474870204|FG001|Overall Study|Lost to Follow-up|3|||
131887459|NCT00900731|474870203|FG000|Overall Study|Lack of Efficacy|1|||
131887460|NCT00900731|474870204|FG001|Overall Study|Lack of Efficacy|3|||
131887461|NCT00900731|474870203|FG000|Overall Study|Death|0|||
131887462|NCT00900731|474870204|FG001|Overall Study|Death|2|||
131887463|NCT02919267|474870205|FG000|Overall Study|Protocol Violation|0|||
131887464|NCT02919267|474870206|FG001|Overall Study|Protocol Violation|3|||
131887465|NCT02919267|474870207|FG002|Overall Study|Protocol Violation|3|||
131887466|NCT02919267|474870208|FG003|Overall Study|Protocol Violation|4|||
131887467|NCT00932698|474870209|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
131887468|NCT00932698|474870210|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
131887469|NCT00932698|474870211|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
131887470|NCT00932698|474870212|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
131887471|NCT00932698|474870213|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
131887472|NCT00932698|474870214|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
131887473|NCT00932698|474870215|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
131887474|NCT00932698|474870216|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
131887475|NCT00932698|474870217|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
131887476|NCT00932698|474870218|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
131887477|NCT00932698|474870219|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
131887478|NCT00932698|474870209|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887479|NCT00932698|474870210|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
131887480|NCT00932698|474870211|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887481|NCT00932698|474870212|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
131887482|NCT00932698|474870213|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887483|NCT00932698|474870214|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
131887484|NCT00932698|474870215|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
131887485|NCT00932698|474870216|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887486|NCT00932698|474870217|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887487|NCT00932698|474870218|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887488|NCT00932698|474870219|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
131887489|NCT00932698|474870209|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
131887490|NCT00932698|474870210|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
131887491|NCT00932698|474870211|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
131887492|NCT00932698|474870212|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
131887493|NCT00932698|474870213|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
131887494|NCT00932698|474870214|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
131887495|NCT00932698|474870215|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
131887496|NCT00932698|474870216|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
131887497|NCT00932698|474870217|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
131887498|NCT00932698|474870218|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
131887499|NCT00932698|474870219|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
131887500|NCT00932698|474870209|FG000|Part 1 (Dose Escalation)|Other|0|||
131887501|NCT00932698|474870210|FG001|Part 1 (Dose Escalation)|Other|0|||
131887502|NCT00932698|474870211|FG002|Part 1 (Dose Escalation)|Other|1|||
131887503|NCT00932698|474870212|FG003|Part 1 (Dose Escalation)|Other|0|||
131887504|NCT00932698|474870213|FG004|Part 1 (Dose Escalation)|Other|0|||
131887505|NCT00932698|474870214|FG005|Part 1 (Dose Escalation)|Other|0|||
131887506|NCT00932698|474870215|FG006|Part 1 (Dose Escalation)|Other|1|||
131887507|NCT00932698|474870216|FG007|Part 1 (Dose Escalation)|Other|0|||
131887508|NCT00932698|474870217|FG008|Part 1 (Dose Escalation)|Other|0|||
131887509|NCT00932698|474870218|FG009|Part 1 (Dose Escalation)|Other|0|||
131887510|NCT00932698|474870219|FG010|Part 1 (Dose Escalation)|Other|0|||
131887511|NCT00932698|474870209|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887512|NCT00932698|474870210|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887513|NCT00932698|474870211|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887514|NCT00932698|474870212|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887515|NCT00932698|474870213|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887516|NCT00932698|474870214|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887517|NCT00932698|474870215|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
131887518|NCT00932698|474870216|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
131887519|NCT00932698|474870217|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
131887520|NCT00932698|474870218|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
131887521|NCT00932698|474870219|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
131887522|NCT00932698|474870209|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887523|NCT00932698|474870210|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887524|NCT00932698|474870211|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887525|NCT00932698|474870212|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887526|NCT00932698|474870213|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887527|NCT00932698|474870214|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887528|NCT00932698|474870215|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887529|NCT00932698|474870216|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
131887530|NCT00932698|474870217|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
131887531|NCT00932698|474870218|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
131887532|NCT00932698|474870219|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
131887533|NCT00932698|474870209|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
131547855|NCT03928028|473629338|FG002|Overall Study|Physician Decision|3|||
131547856|NCT03928028|473629336|FG000|Overall Study|Withdrawal by Subject|12|||
131547857|NCT03928028|473629337|FG001|Overall Study|Withdrawal by Subject|3|||
131547858|NCT03928028|473629338|FG002|Overall Study|Withdrawal by Subject|3|||
131547859|NCT04525547|473629339|FG000|Overall Study|Not treated with Ofev|2|||
131547860|NCT04525547|473629339|FG000|Overall Study|Off-label use|2|||
131547861|NCT04525547|473629339|FG000|Overall Study|Lost to Follow-up|1|||
131547862|NCT03122119|473629340|FG000|Overall Study|Did not meet eligibility critria|1|||
131547863|NCT00800202|473629341|FG000|Overall Study|Adverse Event|7|||
131547864|NCT00800202|473629342|FG001|Overall Study|Adverse Event|6|||
131547865|NCT00800202|473629341|FG000|Overall Study|Death|1|||
131547866|NCT00800202|473629342|FG001|Overall Study|Death|0|||
131547867|NCT00800202|473629341|FG000|Overall Study|Other|5|||
131547868|NCT00800202|473629342|FG001|Overall Study|Other|0|||
131547869|NCT00800202|473629341|FG000|Overall Study|Disease Progression|54|||
131547870|NCT00800202|473629342|FG001|Overall Study|Disease Progression|18|||
131547871|NCT04425902|473629343|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
131547872|NCT02940574|473629349|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
131547873|NCT02940574|473629350|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
131547874|NCT02940574|473629349|FG000|1-year Follow-up|Lost to Follow-up|3|||
131660103|NCT00370682|474040711|FG002|Overall Study|Moved from area|0|||
131887534|NCT00932698|474870210|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
131887535|NCT00932698|474870211|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
131887536|NCT00932698|474870212|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
131887537|NCT00932698|474870213|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
131887538|NCT00932698|474870214|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
131887539|NCT00932698|474870215|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
131887540|NCT00932698|474870216|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
131887541|NCT00932698|474870217|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
131887542|NCT00932698|474870218|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
131887543|NCT00932698|474870219|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
131887544|NCT00655681|474870220|FG000|Overall Study|Lost to Follow-up|1|||
131887545|NCT00655681|474870221|FG001|Overall Study|Lost to Follow-up|1|||
131887546|NCT05249127|474870222|FG000|Overall Study|Protocol Violation|13|||
131547875|NCT02940574|473629350|FG001|1-year Follow-up|Lost to Follow-up|4|||
131547876|NCT00387894|473629351|FG000|Overall Study|Withdrawal by Subject|1|||
131547877|NCT02421666|473629352|FG000|6-month Follow-up|Lost to Follow-up|8|||
131887547|NCT05249127|474870222|FG000|Overall Study|Physician Decision|4|||
131547878|NCT02421666|473629353|FG001|6-month Follow-up|Lost to Follow-up|7|||
131547879|NCT02421666|473629352|FG000|6-month Follow-up|Withdrawal by Subject|5|||
131547880|NCT02421666|473629353|FG001|6-month Follow-up|Withdrawal by Subject|6|||
131547881|NCT02421666|473629352|FG000|12-month Follow-up|Lost to Follow-up|5|||
131547882|NCT02421666|473629353|FG001|12-month Follow-up|Lost to Follow-up|5|||
131547883|NCT02421666|473629352|FG000|12-month Follow-up|Withdrawal by Subject|6|||
131547884|NCT02421666|473629353|FG001|12-month Follow-up|Withdrawal by Subject|11|||
131547885|NCT01119768|473629358|FG000|Treatment Period|Lack of Efficacy|18|||
131547886|NCT01119768|473629359|FG001|Treatment Period|Lack of Efficacy|25|||
131547887|NCT00643123|473629375|FG000|Overall Study|Lost to Follow-up|4|||
131547888|NCT00643123|473629376|FG001|Overall Study|Lost to Follow-up|0|||
131547889|NCT00643123|473629375|FG000|Overall Study|Withdrawal by Subject|1|||
131547890|NCT00643123|473629376|FG001|Overall Study|Withdrawal by Subject|1|||
131547891|NCT01591382|473629381|FG000|Overall Study|Discharged Prior to Study Completion|2|||
131547892|NCT01591382|473629382|FG001|Overall Study|Discharged Prior to Study Completion|1|||
131547893|NCT01591382|473629381|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
131547894|NCT01591382|473629382|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
131547895|NCT00855062|473629383|FG000|Step1|Early Study Closure|5|||
131547896|NCT00855062|473629384|FG001|Step1|Early Study Closure|7|||
131547897|NCT00855062|473629383|FG000|Step1|Adverse Event|1|||
131547898|NCT00855062|473629384|FG001|Step1|Adverse Event|1|||
131547899|NCT00855062|473629383|FG000|Step1|Protocol Violation|1|||
131547900|NCT00855062|473629384|FG001|Step1|Protocol Violation|0|||
131547901|NCT00855062|473629383|FG000|Step1|Pregnancy|1|||
131547902|NCT00855062|473629384|FG001|Step1|Pregnancy|0|||
131547903|NCT00855062|473629383|FG000|Step1|Withdrawal by Subject|2|||
131547904|NCT00855062|473629384|FG001|Step1|Withdrawal by Subject|3|||
131547905|NCT00855062|473629383|FG000|Step2|Early Study Closure|6|||
131547906|NCT00855062|473629384|FG001|Step2|Early Study Closure|2|||
131547907|NCT00855062|473629383|FG000|Step2|Adverse Event|0|||
131547908|NCT00855062|473629384|FG001|Step2|Adverse Event|3|||
131547909|NCT00855062|473629383|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
131547910|NCT00855062|473629384|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
131547911|NCT01960725|473629385|FG000|Overall Study|Lost to Follow-up|4|||
131547912|NCT01960725|473629386|FG001|Overall Study|Lost to Follow-up|3|||
131547913|NCT01960725|473629385|FG000|Overall Study|Withdrawal by Subject|1|||
131547914|NCT01960725|473629386|FG001|Overall Study|Withdrawal by Subject|0|||
131547915|NCT01960725|473629385|FG000|Overall Study|unable to obtain blood sample|1|||
131547916|NCT01960725|473629386|FG001|Overall Study|unable to obtain blood sample|2|||
131547917|NCT02110901|473629387|FG000|Overall Study|Death|6|||
131887548|NCT05249127|474870222|FG000|Overall Study|Withdrawal by Subject|2|||
131887549|NCT05249127|474870222|FG000|Overall Study|Participant Non-compliance|1|||
131887550|NCT02073565|474870224|FG000|Cohort A|Withdrawal by Subject|1|||
131887551|NCT02073565|474870225|FG001|Cohort A|Withdrawal by Subject|0|||
131887552|NCT02073565|474870224|FG000|Cohort B|Withdrawal by Subject|1|||
131887553|NCT02073565|474870225|FG001|Cohort B|Withdrawal by Subject|2|||
131887554|NCT02073565|474870224|FG000|Cohort C|Withdrawal by Subject|0|||
131887555|NCT02073565|474870225|FG001|Cohort C|Withdrawal by Subject|2|||
131887556|NCT02073565|474870224|FG000|Cohort C|Lost to Follow-up|0|||
131887557|NCT02073565|474870225|FG001|Cohort C|Lost to Follow-up|2|||
131887558|NCT02429310|474870226|FG000|Overall Study|Lost to Follow-up|1|||
131887559|NCT02429310|474870227|FG001|Overall Study|Lost to Follow-up|2|||
131887560|NCT02429310|474870226|FG000|Overall Study|Protocol Violation|1|||
131887561|NCT02429310|474870227|FG001|Overall Study|Protocol Violation|1|||
131887562|NCT00394433|474870228|FG000|Overall Study|Adverse Event|2|||
131887563|NCT00394433|474870228|FG000|Overall Study|Alternative Therapy|1|||
131887564|NCT01554176|474870229|FG000|Treatment Phase|Protocol Violation|1|||
131887565|NCT01554176|474870230|FG001|Treatment Phase|Protocol Violation|2|||
131887566|NCT01554176|474870231|FG002|Treatment Phase|Protocol Violation|0|||
131887567|NCT01554176|474870232|FG003|Treatment Phase|Protocol Violation|0|||
131887568|NCT01554176|474870233|FG004|Treatment Phase|Protocol Violation|0|||
131887569|NCT01554176|474870229|FG000|Treatment Phase|Physician Decision|1|||
131887570|NCT01554176|474870230|FG001|Treatment Phase|Physician Decision|1|||
131887571|NCT01554176|474870231|FG002|Treatment Phase|Physician Decision|0|||
131887572|NCT01554176|474870232|FG003|Treatment Phase|Physician Decision|0|||
131887573|NCT01554176|474870233|FG004|Treatment Phase|Physician Decision|0|||
131887574|NCT01554176|474870229|FG000|Treatment Phase|Lack of Efficacy|0|||
131887575|NCT01554176|474870230|FG001|Treatment Phase|Lack of Efficacy|1|||
131887576|NCT01554176|474870231|FG002|Treatment Phase|Lack of Efficacy|0|||
131887577|NCT01554176|474870232|FG003|Treatment Phase|Lack of Efficacy|0|||
131887578|NCT01554176|474870233|FG004|Treatment Phase|Lack of Efficacy|0|||
131887579|NCT01554176|474870229|FG000|Treatment Phase|Adverse event, non-fatal|1|||
131547918|NCT02110901|473629388|FG001|Overall Study|Death|3|||
131887580|NCT01554176|474870230|FG001|Treatment Phase|Adverse event, non-fatal|1|||
131887581|NCT01554176|474870231|FG002|Treatment Phase|Adverse event, non-fatal|0|||
131887582|NCT01554176|474870232|FG003|Treatment Phase|Adverse event, non-fatal|0|||
131887583|NCT01554176|474870233|FG004|Treatment Phase|Adverse event, non-fatal|0|||
131887584|NCT01554176|474870229|FG000|Treatment Phase|Non-compliance with study drug|1|||
131434301|NCT00404651|473217486|FG001|Overall Study|Serious Adverse Event|0|||
131434302|NCT00404651|473217487|FG002|Overall Study|Serious Adverse Event|2|||
131434303|NCT00404651|473217488|FG003|Overall Study|Serious Adverse Event|0|||
131434304|NCT00404651|473217485|FG000|Overall Study|Protocol Violation|10|||
131434305|NCT00404651|473217486|FG001|Overall Study|Protocol Violation|5|||
131434306|NCT00404651|473217487|FG002|Overall Study|Protocol Violation|14|||
131434307|NCT00404651|473217488|FG003|Overall Study|Protocol Violation|5|||
131434308|NCT00404651|473217485|FG000|Overall Study|Lost to Follow-up|15|||
131434309|NCT00404651|473217486|FG001|Overall Study|Lost to Follow-up|11|||
131434310|NCT00404651|473217487|FG002|Overall Study|Lost to Follow-up|13|||
131434311|NCT00404651|473217488|FG003|Overall Study|Lost to Follow-up|10|||
131434312|NCT00404651|473217485|FG000|Overall Study|Withdrawal by Subject|14|||
131434313|NCT00404651|473217486|FG001|Overall Study|Withdrawal by Subject|12|||
131434314|NCT00404651|473217487|FG002|Overall Study|Withdrawal by Subject|16|||
131434315|NCT00404651|473217488|FG003|Overall Study|Withdrawal by Subject|6|||
131434316|NCT03347123|473217490|FG000|Overall Study|Death|1|||
131434317|NCT03347123|473217491|FG001|Overall Study|Death|2|||
131434318|NCT03347123|473217492|FG002|Overall Study|Death|0|||
131434319|NCT03347123|473217493|FG003|Overall Study|Death|0|||
131434320|NCT03347123|473217494|FG004|Overall Study|Death|0|||
131434321|NCT03347123|473217495|FG005|Overall Study|Death|0|||
131434322|NCT03347123|473217496|FG006|Overall Study|Death|0|||
131434323|NCT03347123|473217490|FG000|Overall Study|Withdrawal by Subject|1|||
131434324|NCT03347123|473217491|FG001|Overall Study|Withdrawal by Subject|0|||
131434325|NCT03347123|473217492|FG002|Overall Study|Withdrawal by Subject|0|||
131434326|NCT03347123|473217493|FG003|Overall Study|Withdrawal by Subject|0|||
131434327|NCT03347123|473217494|FG004|Overall Study|Withdrawal by Subject|0|||
131434328|NCT03347123|473217495|FG005|Overall Study|Withdrawal by Subject|0|||
131434329|NCT03347123|473217496|FG006|Overall Study|Withdrawal by Subject|0|||
131434330|NCT03347123|473217490|FG000|Overall Study|Reason not Specified|3|||
131434331|NCT03347123|473217491|FG001|Overall Study|Reason not Specified|4|||
131434332|NCT03347123|473217492|FG002|Overall Study|Reason not Specified|0|||
131434333|NCT03347123|473217493|FG003|Overall Study|Reason not Specified|0|||
131434334|NCT03347123|473217494|FG004|Overall Study|Reason not Specified|0|||
131434335|NCT03347123|473217495|FG005|Overall Study|Reason not Specified|0|||
131434336|NCT03347123|473217496|FG006|Overall Study|Reason not Specified|0|||
131434337|NCT01702844|473217506|FG000|Overall Study|Adverse Event|9|||
131434338|NCT01702844|473217506|FG000|Overall Study|Death|1|||
131434339|NCT01702844|473217506|FG000|Overall Study|Withdrawal by Subject|3|||
131434340|NCT01702844|473217506|FG000|Overall Study|Physician Decision|6|||
131434341|NCT03431441|473217507|FG000|Overall Study|Withdrawal by Subject|2|||
131434342|NCT03431441|473217507|FG000|Overall Study|Adverse Event|2|||
131434343|NCT03431441|473217507|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
131434344|NCT00346216|473217508|FG000|Overall Study|Other|181|||
131434345|NCT00346216|473217509|FG001|Overall Study|Other|231|||
131547919|NCT02110901|473629387|FG000|Overall Study|Lost to Follow-up|12|||
131547920|NCT02110901|473629388|FG001|Overall Study|Lost to Follow-up|8|||
131547921|NCT02110901|473629387|FG000|Overall Study|Withdrawal by Subject|7|||
131547922|NCT02110901|473629388|FG001|Overall Study|Withdrawal by Subject|3|||
131547923|NCT02110901|473629387|FG000|Overall Study|received a kidney transplant|5|||
131547924|NCT02110901|473629388|FG001|Overall Study|received a kidney transplant|0|||
131547925|NCT02634788|473629389|FG000|Overall Study|Adverse Event|0|||
131547926|NCT02634788|473629390|FG001|Overall Study|Adverse Event|8|||
131547927|NCT02634788|473629391|FG002|Overall Study|Adverse Event|3|||
131547928|NCT02634788|473629392|FG003|Overall Study|Adverse Event|1|||
131434346|NCT00346216|473217510|FG002|Overall Study|Other|205|||
131434347|NCT00346216|473217508|FG000|Overall Study|No longer willing to participate|600|||
131434348|NCT00346216|473217509|FG001|Overall Study|No longer willing to participate|606|||
131434349|NCT00346216|473217510|FG002|Overall Study|No longer willing to participate|585|||
131434350|NCT00346216|473217508|FG000|Overall Study|Withdrawal by Subject|661|||
131434351|NCT00346216|473217509|FG001|Overall Study|Withdrawal by Subject|692|||
131434352|NCT00346216|473217510|FG002|Overall Study|Withdrawal by Subject|651|||
131434353|NCT00346216|473217508|FG000|Overall Study|Lost to Follow-up|611|||
131434354|NCT00346216|473217509|FG001|Overall Study|Lost to Follow-up|588|||
131434355|NCT00346216|473217510|FG002|Overall Study|Lost to Follow-up|542|||
131434356|NCT00346216|473217508|FG000|Overall Study|Physician Decision|80|||
131434357|NCT00346216|473217509|FG001|Overall Study|Physician Decision|76|||
131547929|NCT02634788|473629389|FG000|Overall Study|Lack of Efficacy|4|||
131434358|NCT00346216|473217510|FG002|Overall Study|Physician Decision|59|||
131434359|NCT00346216|473217508|FG000|Overall Study|Does not meet entrance criteria|13|||
131434360|NCT00346216|473217509|FG001|Overall Study|Does not meet entrance criteria|10|||
131434361|NCT00346216|473217510|FG002|Overall Study|Does not meet entrance criteria|8|||
131434362|NCT00346216|473217508|FG000|Overall Study|Death|189|||
131434363|NCT00346216|473217509|FG001|Overall Study|Death|192|||
131434364|NCT00346216|473217510|FG002|Overall Study|Death|228|||
131434365|NCT00346216|473217508|FG000|Overall Study|Study terminated by sponsor|11|||
131434366|NCT00346216|473217509|FG001|Overall Study|Study terminated by sponsor|4|||
131434367|NCT00346216|473217510|FG002|Overall Study|Study terminated by sponsor|8|||
131434368|NCT00346216|473217508|FG000|Overall Study|Missing Subject Summary Status|62|||
131434369|NCT00346216|473217509|FG001|Overall Study|Missing Subject Summary Status|61|||
131434370|NCT00346216|473217510|FG002|Overall Study|Missing Subject Summary Status|62|||
131434371|NCT01731912|473217516|FG000|Overall Study|noncompliance|2|||
131547930|NCT02634788|473629390|FG001|Overall Study|Lack of Efficacy|0|||
131547931|NCT02634788|473629391|FG002|Overall Study|Lack of Efficacy|1|||
131547932|NCT02634788|473629392|FG003|Overall Study|Lack of Efficacy|4|||
131547933|NCT02634788|473629389|FG000|Overall Study|Lost to Follow-up|0|||
131547934|NCT02634788|473629390|FG001|Overall Study|Lost to Follow-up|1|||
131547935|NCT02634788|473629391|FG002|Overall Study|Lost to Follow-up|0|||
131547936|NCT02634788|473629392|FG003|Overall Study|Lost to Follow-up|0|||
131547937|NCT02634788|473629389|FG000|Overall Study|Withdrawal by Subject|0|||
131547938|NCT02634788|473629390|FG001|Overall Study|Withdrawal by Subject|1|||
131547939|NCT02634788|473629391|FG002|Overall Study|Withdrawal by Subject|1|||
131547940|NCT02634788|473629392|FG003|Overall Study|Withdrawal by Subject|0|||
131547941|NCT00758459|473629393|FG000|Overall Study|Adverse Event|3|||
131547942|NCT00758459|473629394|FG001|Overall Study|Adverse Event|2|||
131434372|NCT02043938|473217517|FG000|Overall Study|Withdrawal by Subject|7|||
131434373|NCT02043938|473217517|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
131434374|NCT02043938|473217517|FG000|Overall Study|No show by subject|1|||
131434375|NCT02043938|473217517|FG000|Overall Study|Investigator decision|1|||
131434376|NCT00764699|473217522|FG000|Overall Study|PI left and study terminated|3|||
131434377|NCT03985761|473217529|FG000|Overall Study|Withdrawal by Subject|2|||
131434378|NCT03985761|473217530|FG001|Overall Study|Withdrawal by Subject|3|||
131434379|NCT02222558|473217531|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
131434380|NCT02222558|473217532|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
131434381|NCT02222558|473217533|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
131434382|NCT02222558|473217534|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
131434383|NCT02222558|473217535|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
131434384|NCT02222558|473217536|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
131434385|NCT02222558|473217531|FG000|Period 3|Withdrawal by Subject|0|||
131434386|NCT02222558|473217532|FG001|Period 3|Withdrawal by Subject|0|||
131434387|NCT02222558|473217533|FG002|Period 3|Withdrawal by Subject|0|||
131434388|NCT02222558|473217534|FG003|Period 3|Withdrawal by Subject|0|||
131434389|NCT02222558|473217535|FG004|Period 3|Withdrawal by Subject|0|||
131434390|NCT02222558|473217536|FG005|Period 3|Withdrawal by Subject|1|||
131434391|NCT01285401|473217537|FG000|Overall Study|Prematurely withdrawn from the study|17|||
131434392|NCT01285401|473217538|FG001|Overall Study|Prematurely withdrawn from the study|29|||
131434393|NCT00936702|473217547|FG000|Overall Study|Disease progression|34|||
131434394|NCT00936702|473217547|FG000|Overall Study|Adverse Event|8|||
131434395|NCT00936702|473217547|FG000|Overall Study|Withdrawal by Subject|2|||
131434396|NCT00936702|473217547|FG000|Overall Study|Alternative Treatment|1|||
131434397|NCT00936702|473217547|FG000|Overall Study|Other|1|||
131434398|NCT02366312|473217548|FG000|Overall Study|Lost to Follow-up|0|||
131434399|NCT02366312|473217549|FG001|Overall Study|Lost to Follow-up|1|||
131434400|NCT02532465|473217550|FG000|Overall Study|Protocol Violation|1|||
131434401|NCT02532465|473217551|FG001|Overall Study|Protocol Violation|0|||
131434402|NCT02532465|473217550|FG000|Overall Study|Lack of Efficacy|0|||
131434403|NCT02532465|473217551|FG001|Overall Study|Lack of Efficacy|1|||
131434404|NCT03719131|473217556|FG000|Overall Study|Death|1|||
131434405|NCT03719131|473217557|FG001|Overall Study|Death|2|||
131434406|NCT00622505|473217558|FG000|Overall Study|Adverse Event|9|||
131434407|NCT00622505|473217559|FG001|Overall Study|Adverse Event|7|||
131434408|NCT00622505|473217558|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
131434409|NCT00622505|473217559|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
131434410|NCT00622505|473217558|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
131434411|NCT00622505|473217559|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
131434412|NCT00622505|473217558|FG000|Overall Study|Withdrawal by Subject|12|||
131434413|NCT00622505|473217559|FG001|Overall Study|Withdrawal by Subject|5|||
131434414|NCT00622505|473217558|FG000|Overall Study|Administrative Problems|2|||
131434415|NCT00622505|473217559|FG001|Overall Study|Administrative Problems|4|||
131434416|NCT00622505|473217558|FG000|Overall Study|Death|2|||
131434417|NCT00622505|473217559|FG001|Overall Study|Death|2|||
131434418|NCT00619515|473217560|FG000|Overall Study|Study Termination by IRB|73|||
131434419|NCT03294590|473217563|FG000|Overall Study|Lost to Follow-up|105|||
131434420|NCT03294590|473217564|FG001|Overall Study|Lost to Follow-up|107|||
131434421|NCT04862065|473217569|FG000|Screening|Protocol Violation|54|||
131434422|NCT04862065|473217570|FG001|Screening|Protocol Violation|0|||
131434423|NCT04862065|473217571|FG002|Screening|Protocol Violation|0|||
131434424|NCT04862065|473217569|FG000|Screening|Insufficient Sample|1|||
131434425|NCT04862065|473217570|FG001|Screening|Insufficient Sample|0|||
131547943|NCT00758459|473629393|FG000|Overall Study|Protocol Violation|0|||
131547944|NCT00758459|473629394|FG001|Overall Study|Protocol Violation|1|||
131434426|NCT04862065|473217571|FG002|Screening|Insufficient Sample|0|||
131434427|NCT04862065|473217569|FG000|Follow-Up|Lost to Follow-up|3|||
131434428|NCT04862065|473217570|FG001|Follow-Up|Lost to Follow-up|0|||
131434429|NCT04862065|473217571|FG002|Follow-Up|Lost to Follow-up|0|||
131547945|NCT00758459|473629393|FG000|Overall Study|Withdrawal by Subject|0|||
131547946|NCT00758459|473629394|FG001|Overall Study|Withdrawal by Subject|1|||
131547947|NCT02496767|473629409|FG000|Open-label Lead-in Phase|Adverse Event|176|||
131547948|NCT02496767|473629410|FG001|Open-label Lead-in Phase|Adverse Event|0|||
131547949|NCT02496767|473629411|FG002|Open-label Lead-in Phase|Adverse Event|0|||
131547950|NCT02496767|473629412|FG003|Open-label Lead-in Phase|Adverse Event|0|||
131547951|NCT02496767|473629413|FG004|Open-label Lead-in Phase|Adverse Event|0|||
131547952|NCT02496767|473629414|FG005|Open-label Lead-in Phase|Adverse Event|0|||
131547953|NCT02496767|473629415|FG006|Open-label Lead-in Phase|Adverse Event|0|||
131547954|NCT02496767|473629416|FG007|Open-label Lead-in Phase|Adverse Event|0|||
131547955|NCT02496767|473629409|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
131547956|NCT02496767|473629410|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
131547957|NCT02496767|473629411|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
131547958|NCT02496767|473629412|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
131547959|NCT02496767|473629413|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
131547960|NCT02496767|473629414|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
131547961|NCT02496767|473629415|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
131547962|NCT02496767|473629416|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
131547963|NCT02496767|473629409|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
131547964|NCT02496767|473629410|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547965|NCT02496767|473629411|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547966|NCT02496767|473629412|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547967|NCT02496767|473629413|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547968|NCT02496767|473629414|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547969|NCT02496767|473629415|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547970|NCT02496767|473629416|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
131547971|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
131547972|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
131547973|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
131547974|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
131547975|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
131547976|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
131547977|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
131547978|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
131547979|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
131547980|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
131547981|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
131547982|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
131547983|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
131547984|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
131547985|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
131547986|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
131547987|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
131547988|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
131547989|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
131547990|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
131547991|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
131547992|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
131547993|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
131547994|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
131547995|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
131547996|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
131547997|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
131547998|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
131547999|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
131548000|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
131548001|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
131548002|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
131548003|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131548004|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
131548005|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
131548006|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
131548007|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
131548008|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131548009|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131548010|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131548011|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131548012|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
131548013|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
131548014|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131548015|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131548016|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131548017|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131548018|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131548019|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131548020|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
131548021|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131548022|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
131548023|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
131548024|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131548025|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131548026|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131548027|NCT02496767|473629409|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548028|NCT02496767|473629410|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
131548029|NCT02496767|473629411|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548030|NCT02496767|473629412|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548031|NCT02496767|473629413|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548032|NCT02496767|473629414|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548033|NCT02496767|473629415|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548034|NCT02496767|473629416|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
131548035|NCT02496767|473629409|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
131548036|NCT02496767|473629410|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
131548037|NCT02496767|473629411|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
131548038|NCT02496767|473629412|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
131548039|NCT02496767|473629413|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
131548040|NCT02496767|473629414|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
131548041|NCT02496767|473629415|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
131548042|NCT02496767|473629416|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
131548043|NCT02496767|473629409|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
131548044|NCT02496767|473629410|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
131548045|NCT02496767|473629411|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
131548046|NCT02496767|473629412|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
131548047|NCT02496767|473629413|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
131548048|NCT02496767|473629414|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
131548049|NCT02496767|473629415|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
131548050|NCT02496767|473629416|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
131548051|NCT02496767|473629409|FG000|Double-blind, Withdrawal Phase|Death|0|||
131548052|NCT02496767|473629410|FG001|Double-blind, Withdrawal Phase|Death|0|||
131548053|NCT02496767|473629411|FG002|Double-blind, Withdrawal Phase|Death|0|||
131548054|NCT02496767|473629412|FG003|Double-blind, Withdrawal Phase|Death|0|||
131548055|NCT02496767|473629413|FG004|Double-blind, Withdrawal Phase|Death|0|||
131548056|NCT02496767|473629414|FG005|Double-blind, Withdrawal Phase|Death|0|||
131548057|NCT02496767|473629415|FG006|Double-blind, Withdrawal Phase|Death|1|||
131548058|NCT02496767|473629416|FG007|Double-blind, Withdrawal Phase|Death|2|||
131548059|NCT02496767|473629409|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
131548060|NCT02496767|473629410|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
131548061|NCT02496767|473629411|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
131548062|NCT02496767|473629412|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
131548063|NCT02496767|473629413|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
131548064|NCT02496767|473629414|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
131548065|NCT02496767|473629415|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
131548066|NCT02496767|473629416|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
131548067|NCT02889133|473629420|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
131548068|NCT02889133|473629421|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
131548069|NCT02889133|473629420|FG000|Completed Primary Outcome|Manufacturing error|3|||
131548070|NCT02889133|473629421|FG001|Completed Primary Outcome|Manufacturing error|8|||
131548071|NCT02889133|473629420|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
131548072|NCT02889133|473629421|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
131548073|NCT02889133|473629420|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
131660104|NCT00370682|474040709|FG000|Overall Study|Lost to Follow-up|0|||
131548074|NCT02889133|473629421|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
131548075|NCT02889133|473629420|FG000|Completed Primary Outcome|Protocol Violation|1|||
131548076|NCT02889133|473629421|FG001|Completed Primary Outcome|Protocol Violation|0|||
131548077|NCT02889133|473629420|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
131548078|NCT02889133|473629421|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
131660105|NCT00370682|474040710|FG001|Overall Study|Lost to Follow-up|1|||
131548079|NCT02889133|473629420|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
131548080|NCT02889133|473629421|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
131548081|NCT02889133|473629420|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
131548082|NCT02889133|473629421|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
131548083|NCT02889133|473629420|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
131548084|NCT02889133|473629421|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
131548085|NCT02889133|473629420|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
131548086|NCT02889133|473629421|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
131548087|NCT02277990|473629422|FG000|Overall Study|Death|170|||
131548088|NCT02277990|473629423|FG001|Overall Study|Death|188|||
131548089|NCT02277990|473629422|FG000|Overall Study|Withdrawal by Subject|64|||
131548090|NCT02277990|473629423|FG001|Overall Study|Withdrawal by Subject|53|||
131548091|NCT02277990|473629422|FG000|Overall Study|Physician Decision|40|||
131548092|NCT02277990|473629423|FG001|Overall Study|Physician Decision|34|||
131548093|NCT02277990|473629422|FG000|Overall Study|Lost to Follow-up|66|||
131548094|NCT02277990|473629423|FG001|Overall Study|Lost to Follow-up|69|||
131548095|NCT02277990|473629422|FG000|Overall Study|Had other reason|26|||
131548096|NCT02277990|473629423|FG001|Overall Study|Had other reason|32|||
131548097|NCT04711603|473629424|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
131548098|NCT04711603|473629425|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
131548099|NCT04711603|473629426|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
131548100|NCT04711603|473629427|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
131548101|NCT04711603|473629424|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
131548102|NCT04711603|473629425|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
131548103|NCT04711603|473629426|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
131548104|NCT04711603|473629427|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
131548105|NCT04711603|473629424|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
131548106|NCT04711603|473629425|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
131548107|NCT04711603|473629426|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
131548108|NCT04711603|473629427|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
131548109|NCT04711603|473629424|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
131548110|NCT04711603|473629425|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
131548111|NCT04711603|473629426|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
131548112|NCT04711603|473629427|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
131548113|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
131548114|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
131548115|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
131548116|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
131548117|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
131548118|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
131548119|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
131548120|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
131548121|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
131548122|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
131548123|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
131548124|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
131548125|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
131548126|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
131548127|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
131548128|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
131548129|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
131548130|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
131548131|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
131548132|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
131548133|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
131548134|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
131548135|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
131548136|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
131548137|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
131548138|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
131548139|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
131548140|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
131548141|NCT04711603|473629424|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
131548142|NCT04711603|473629425|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
131548143|NCT04711603|473629426|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
131548144|NCT04711603|473629427|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
131548145|NCT05479604|473629432|FG000|Overall Study|Lost to Follow-up|1|||
131548146|NCT05479604|473629433|FG001|Overall Study|Lost to Follow-up|5|||
131548147|NCT00946296|473629435|FG000|Overall Study|Physician Decision|3|||
131548148|NCT00946296|473629436|FG001|Overall Study|Physician Decision|0|||
131548149|NCT02068495|473629440|FG000|Overall Study|Case Report Forms Uncollected|60|||
131548150|NCT02068495|473629440|FG000|Overall Study|Protocol Deviation|49|||
131548151|NCT00689026|473629441|FG000|Overall Study|Withdrawal by Subject|13|||
131548152|NCT00689026|473629442|FG001|Overall Study|Withdrawal by Subject|6|||
131548153|NCT02703922|473629444|FG000|Overall Study|Death|5|||
131548154|NCT02703922|473629445|FG001|Overall Study|Death|8|||
131548155|NCT02703922|473629444|FG000|Overall Study|Lost to Follow-up|10|||
131548156|NCT02703922|473629445|FG001|Overall Study|Lost to Follow-up|10|||
131548157|NCT00394355|473629447|FG000|Overall Study|Adverse Event|10|||
131548158|NCT00394355|473629448|FG001|Overall Study|Adverse Event|6|||
131548159|NCT00394355|473629449|FG002|Overall Study|Adverse Event|7|||
131548160|NCT00394355|473629450|FG003|Overall Study|Adverse Event|8|||
131548161|NCT00394355|473629447|FG000|Overall Study|Did not meet protocol eligibility|1|||
131548162|NCT00394355|473629448|FG001|Overall Study|Did not meet protocol eligibility|5|||
131548163|NCT00394355|473629449|FG002|Overall Study|Did not meet protocol eligibility|4|||
131548164|NCT00394355|473629450|FG003|Overall Study|Did not meet protocol eligibility|2|||
131548165|NCT00394355|473629447|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
131548166|NCT00394355|473629448|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
131548167|NCT00394355|473629449|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
131548168|NCT00394355|473629450|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
131548169|NCT00394355|473629447|FG000|Overall Study|Subject withdrawal - related to drug|1|||
131548170|NCT00394355|473629448|FG001|Overall Study|Subject withdrawal - related to drug|0|||
131548171|NCT00394355|473629449|FG002|Overall Study|Subject withdrawal - related to drug|0|||
131548172|NCT00394355|473629450|FG003|Overall Study|Subject withdrawal - related to drug|0|||
131548173|NCT00394355|473629447|FG000|Overall Study|Lost to Follow-up|7|||
131548174|NCT00394355|473629448|FG001|Overall Study|Lost to Follow-up|5|||
131548175|NCT00394355|473629449|FG002|Overall Study|Lost to Follow-up|4|||
131548176|NCT00394355|473629450|FG003|Overall Study|Lost to Follow-up|3|||
131548177|NCT00394355|473629447|FG000|Overall Study|Noncompliance with protocol|4|||
131548178|NCT00394355|473629448|FG001|Overall Study|Noncompliance with protocol|3|||
131548179|NCT00394355|473629449|FG002|Overall Study|Noncompliance with protocol|10|||
131548180|NCT00394355|473629450|FG003|Overall Study|Noncompliance with protocol|8|||
131548181|NCT00394355|473629447|FG000|Overall Study|Administrative|0|||
131548182|NCT00394355|473629448|FG001|Overall Study|Administrative|1|||
131548183|NCT00394355|473629449|FG002|Overall Study|Administrative|1|||
131548184|NCT00394355|473629450|FG003|Overall Study|Administrative|1|||
131548185|NCT00394355|473629447|FG000|Overall Study|Lack of Efficacy|0|||
131548186|NCT00394355|473629448|FG001|Overall Study|Lack of Efficacy|0|||
131548187|NCT00394355|473629449|FG002|Overall Study|Lack of Efficacy|2|||
131548188|NCT00394355|473629450|FG003|Overall Study|Lack of Efficacy|3|||
131548189|NCT04225988|473629452|FG000|Overall Study|Withdrawal by Subject|2|||
131548190|NCT04225988|473629453|FG001|Overall Study|Withdrawal by Subject|0|||
131548191|NCT01984697|473631548|FG000|Overall Study|Adverse Event|0|||
131548192|NCT01984697|473631549|FG001|Overall Study|Adverse Event|0|||
131548193|NCT01984697|473631550|FG002|Overall Study|Adverse Event|2|||
131548194|NCT01984697|473631551|FG003|Overall Study|Adverse Event|0|||
131548195|NCT01984697|473631552|FG004|Overall Study|Adverse Event|0|||
131548196|NCT01984697|473631548|FG000|Overall Study|Lost to Follow-up|14|||
131548197|NCT01984697|473631549|FG001|Overall Study|Lost to Follow-up|5|||
131548198|NCT01984697|473631550|FG002|Overall Study|Lost to Follow-up|10|||
131548199|NCT01984697|473631551|FG003|Overall Study|Lost to Follow-up|6|||
131548200|NCT01984697|473631552|FG004|Overall Study|Lost to Follow-up|21|||
131548201|NCT01984697|473631548|FG000|Overall Study|Physician Decision|3|||
131548202|NCT01984697|473631549|FG001|Overall Study|Physician Decision|0|||
131548203|NCT01984697|473631550|FG002|Overall Study|Physician Decision|0|||
131548204|NCT01984697|473631551|FG003|Overall Study|Physician Decision|1|||
131548205|NCT01984697|473631552|FG004|Overall Study|Physician Decision|0|||
131548206|NCT01984697|473631548|FG000|Overall Study|Protocol Violation|8|||
131548207|NCT01984697|473631549|FG001|Overall Study|Protocol Violation|5|||
131548208|NCT01984697|473631550|FG002|Overall Study|Protocol Violation|3|||
131548209|NCT01984697|473631551|FG003|Overall Study|Protocol Violation|2|||
131548210|NCT01984697|473631552|FG004|Overall Study|Protocol Violation|0|||
131548211|NCT01984697|473631548|FG000|Overall Study|Withdrawal by Subject|15|||
131548212|NCT01984697|473631549|FG001|Overall Study|Withdrawal by Subject|21|||
131653520|NCT03412773|474018392|FG001|Overall Study|Physician Decision|0|||
131653521|NCT03412773|474018393|FG002|Overall Study|Physician Decision|1|||
131653522|NCT04703192|474018396|FG000|Overall Study|Withdrawal by Subject|2|||
131653523|NCT04703192|474018397|FG001|Overall Study|Withdrawal by Subject|0|||
131653524|NCT04703192|474018396|FG000|Overall Study|Death|3|||
131653525|NCT04703192|474018397|FG001|Overall Study|Death|1|||
131653526|NCT04703192|474018396|FG000|Overall Study|Adverse Event|13|||
131653527|NCT04703192|474018397|FG001|Overall Study|Adverse Event|2|||
131660106|NCT00370682|474040711|FG002|Overall Study|Lost to Follow-up|1|||
131660107|NCT03651622|474040712|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
131660108|NCT03651622|474040713|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
131660109|NCT03651622|474040714|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
131660110|NCT03651622|474040712|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
131660111|NCT03651622|474040713|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
131660112|NCT03651622|474040714|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
131660113|NCT03651622|474040712|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
131660114|NCT03651622|474040713|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
131660115|NCT03651622|474040714|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
131660116|NCT03651622|474040712|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
131660117|NCT03651622|474040713|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
131660118|NCT03651622|474040714|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
131660119|NCT03651622|474040712|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
131660120|NCT03651622|474040713|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
131660121|NCT03651622|474040714|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
131660122|NCT01519089|474040715|FG000|Overall Study|Adverse Event|4|||
131660123|NCT01519089|474040716|FG001|Overall Study|Adverse Event|4|||
131660124|NCT01519089|474040715|FG000|Overall Study|Lack of Efficacy|0|||
131660125|NCT01519089|474040716|FG001|Overall Study|Lack of Efficacy|2|||
131660126|NCT01519089|474040715|FG000|Overall Study|Lost to Follow-up|1|||
131660127|NCT01519089|474040716|FG001|Overall Study|Lost to Follow-up|0|||
131660128|NCT01519089|474040715|FG000|Overall Study|Withdrawal by Subject|0|||
131660129|NCT01519089|474040716|FG001|Overall Study|Withdrawal by Subject|2|||
131660130|NCT01519089|474040715|FG000|Overall Study|Other|2|||
131660131|NCT01519089|474040716|FG001|Overall Study|Other|6|||
131660132|NCT01519089|474040715|FG000|Overall Study|Not received study drug|0|||
131660133|NCT01519089|474040716|FG001|Overall Study|Not received study drug|1|||
131660134|NCT04032613|474040717|FG000|Overall Study|Did not complete post-program assessment|5|||
131660135|NCT04032613|474040718|FG001|Overall Study|Did not complete post-program assessment|2|||
131660136|NCT01659853|474040719|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
131660137|NCT01659853|474040720|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
131660138|NCT01659853|474040719|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
131660139|NCT01659853|474040720|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
131660140|NCT03053518|474040723|FG000|Overall Study|Withdrawal by Subject|3|||
131660141|NCT03053518|474040723|FG000|Overall Study|Lost to Follow-up|2|||
131660142|NCT03053518|474040723|FG000|Overall Study|Ineligible|5|||
131660143|NCT05560243|474040725|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
131660144|NCT01072630|474040726|FG000|Overall Study|Adverse Event|11|||
131660145|NCT01072630|474040727|FG001|Overall Study|Adverse Event|19|||
131660146|NCT01072630|474040728|FG002|Overall Study|Adverse Event|2|||
131660147|NCT01072630|474040726|FG000|Overall Study|Lack of Efficacy|10|||
131660148|NCT01072630|474040727|FG001|Overall Study|Lack of Efficacy|10|||
131660149|NCT01072630|474040728|FG002|Overall Study|Lack of Efficacy|1|||
131660150|NCT01072630|474040726|FG000|Overall Study|Withdrawal by Subject|8|||
131660151|NCT01072630|474040727|FG001|Overall Study|Withdrawal by Subject|7|||
131660152|NCT01072630|474040728|FG002|Overall Study|Withdrawal by Subject|2|||
131660153|NCT01072630|474040726|FG000|Overall Study|Protocol Violation|10|||
131660154|NCT01072630|474040727|FG001|Overall Study|Protocol Violation|8|||
131660155|NCT01072630|474040728|FG002|Overall Study|Protocol Violation|4|||
131660156|NCT01072630|474040726|FG000|Overall Study|Lost to Follow-up|11|||
131660157|NCT01072630|474040727|FG001|Overall Study|Lost to Follow-up|11|||
131660158|NCT01072630|474040728|FG002|Overall Study|Lost to Follow-up|1|||
131660159|NCT01072630|474040726|FG000|Overall Study|Noncompliance with study medication|1|||
131660160|NCT01072630|474040727|FG001|Overall Study|Noncompliance with study medication|1|||
131660161|NCT01072630|474040728|FG002|Overall Study|Noncompliance with study medication|1|||
131660162|NCT01072630|474040726|FG000|Overall Study|Noncompliance with study procedures|1|||
131660163|NCT01072630|474040727|FG001|Overall Study|Noncompliance with study procedures|2|||
131660164|NCT01072630|474040728|FG002|Overall Study|Noncompliance with study procedures|1|||
131660165|NCT01072630|474040726|FG000|Overall Study|Other|3|||
131660166|NCT01072630|474040727|FG001|Overall Study|Other|2|||
131660167|NCT01072630|474040728|FG002|Overall Study|Other|1|||
131660168|NCT01232738|474040729|FG000|Overall Study|Death|3|||
131660169|NCT01232738|474040729|FG000|Overall Study|Physician Decision|2|||
131660170|NCT01232738|474040729|FG000|Overall Study|Lost to Follow-up|1|||
131660171|NCT01232738|474040729|FG000|Overall Study|Withdrawal by Subject|2|||
131660172|NCT01232738|474040729|FG000|Overall Study|Adverse Event|5|||
131660173|NCT00338962|474040730|FG000|Overall Study|Lost to Follow-up|3|||
131660174|NCT00338962|474040731|FG001|Overall Study|Lost to Follow-up|3|||
131660175|NCT00338962|474040732|FG002|Overall Study|Lost to Follow-up|2|||
131660176|NCT00338962|474040733|FG003|Overall Study|Lost to Follow-up|3|||
131434430|NCT03244917|473217575|FG000|Overall Study|Lost to Follow-up|2|||
131660177|NCT00338962|474040730|FG000|Overall Study|Withdrawal by Subject|1|||
131660178|NCT00338962|474040731|FG001|Overall Study|Withdrawal by Subject|0|||
131434431|NCT03244917|473217576|FG001|Overall Study|Lost to Follow-up|2|||
131548213|NCT01984697|473631550|FG002|Overall Study|Withdrawal by Subject|13|||
131548214|NCT01984697|473631551|FG003|Overall Study|Withdrawal by Subject|11|||
131548215|NCT01984697|473631552|FG004|Overall Study|Withdrawal by Subject|13|||
131548216|NCT01984697|473631548|FG000|Overall Study|Missed last follow-up visit|1|||
131548217|NCT01984697|473631549|FG001|Overall Study|Missed last follow-up visit|0|||
131548218|NCT01984697|473631550|FG002|Overall Study|Missed last follow-up visit|0|||
131548219|NCT01984697|473631551|FG003|Overall Study|Missed last follow-up visit|0|||
131548220|NCT01984697|473631552|FG004|Overall Study|Missed last follow-up visit|0|||
131548221|NCT01984697|473631548|FG000|Overall Study|Death|0|||
131548222|NCT01984697|473631549|FG001|Overall Study|Death|0|||
131548223|NCT01984697|473631550|FG002|Overall Study|Death|0|||
131548224|NCT01984697|473631551|FG003|Overall Study|Death|1|||
131548225|NCT01984697|473631552|FG004|Overall Study|Death|0|||
131548226|NCT01984697|473631548|FG000|Overall Study|Pregnancy|2|||
131548227|NCT01984697|473631549|FG001|Overall Study|Pregnancy|0|||
131548228|NCT01984697|473631550|FG002|Overall Study|Pregnancy|1|||
131548229|NCT01984697|473631551|FG003|Overall Study|Pregnancy|0|||
131548230|NCT01984697|473631552|FG004|Overall Study|Pregnancy|1|||
131548231|NCT00847405|473631553|FG000|First Intervention|Adverse Event|0|||
131548232|NCT00847405|473631554|FG001|First Intervention|Adverse Event|1|||
131548233|NCT00847405|473631553|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131548234|NCT00847405|473631554|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131548235|NCT04669600|473631567|FG000|Overall Study|Withdrawal by Subject|1|||
131548236|NCT04669600|473631567|FG000|Overall Study|Other|6|||
131548237|NCT00710606|473631568|FG000|Overall Study|Adverse Event|0|||
131548238|NCT00710606|473631569|FG001|Overall Study|Adverse Event|2|||
131548239|NCT00514683|473631574|FG000|Overall Study|Not treated|2|||
131548240|NCT00514683|473631575|FG001|Overall Study|Not treated|1|||
131548241|NCT00514683|473631576|FG002|Overall Study|Not treated|0|||
131548242|NCT00514683|473631577|FG003|Overall Study|Not treated|0|||
131548243|NCT00514683|473631578|FG004|Overall Study|Not treated|1|||
131548244|NCT00514683|473631574|FG000|Overall Study|Adverse Event|21|||
131548245|NCT00514683|473631575|FG001|Overall Study|Adverse Event|20|||
131548246|NCT00514683|473631576|FG002|Overall Study|Adverse Event|15|||
131548247|NCT00514683|473631577|FG003|Overall Study|Adverse Event|13|||
131548248|NCT00514683|473631578|FG004|Overall Study|Adverse Event|27|||
131548249|NCT00514683|473631574|FG000|Overall Study|Protocol Violation|1|||
131548250|NCT00514683|473631575|FG001|Overall Study|Protocol Violation|1|||
131548251|NCT00514683|473631576|FG002|Overall Study|Protocol Violation|0|||
131548252|NCT00514683|473631577|FG003|Overall Study|Protocol Violation|1|||
131548253|NCT00514683|473631578|FG004|Overall Study|Protocol Violation|0|||
131548254|NCT00514683|473631574|FG000|Overall Study|Withdrawal by Subject|2|||
131548255|NCT00514683|473631575|FG001|Overall Study|Withdrawal by Subject|2|||
131548256|NCT00514683|473631576|FG002|Overall Study|Withdrawal by Subject|1|||
131548257|NCT00514683|473631577|FG003|Overall Study|Withdrawal by Subject|0|||
131548258|NCT00514683|473631578|FG004|Overall Study|Withdrawal by Subject|4|||
131548259|NCT00514683|473631574|FG000|Overall Study|Reason other than listed above|0|||
131548260|NCT00514683|473631575|FG001|Overall Study|Reason other than listed above|1|||
131548261|NCT00514683|473631576|FG002|Overall Study|Reason other than listed above|2|||
131548262|NCT00514683|473631577|FG003|Overall Study|Reason other than listed above|0|||
131548263|NCT00514683|473631578|FG004|Overall Study|Reason other than listed above|1|||
131548264|NCT00335452|473631579|FG000|Overall Study|Death|156|||
131548265|NCT00335452|473631580|FG001|Overall Study|Death|144|||
131548266|NCT00335452|473631581|FG002|Overall Study|Death|158|||
131548267|NCT00335452|473631582|FG003|Overall Study|Death|129|||
131548268|NCT00335452|473631579|FG000|Overall Study|Lost to Follow-up|2|||
131548269|NCT00335452|473631580|FG001|Overall Study|Lost to Follow-up|3|||
131548270|NCT00335452|473631581|FG002|Overall Study|Lost to Follow-up|1|||
131548271|NCT00335452|473631582|FG003|Overall Study|Lost to Follow-up|2|||
131548272|NCT02901626|473631586|FG000|Overall Study|Lost to Follow-up|1|||
131548273|NCT02901626|473631587|FG001|Overall Study|Lost to Follow-up|1|||
131548274|NCT01373931|473631588|FG000|Lead-in Period|Adverse Event|2|||
131548275|NCT01373931|473631589|FG001|Lead-in Period|Adverse Event|0|||
131548276|NCT01373931|473631588|FG000|Period 1|Adverse Event|2|||
131548277|NCT01373931|473631589|FG001|Period 1|Adverse Event|0|||
131548278|NCT01373931|473631588|FG000|Period 1|Withdrawal by Subject|0|||
131548279|NCT01373931|473631589|FG001|Period 1|Withdrawal by Subject|2|||
131548280|NCT04857034|473631590|FG000|Placebo-Controlled Period|Request to discontinue|2|||
131548281|NCT04857034|473631591|FG001|Placebo-Controlled Period|Request to discontinue|2|||
131548282|NCT04857034|473631592|FG002|Placebo-Controlled Period|Request to discontinue|0|||
131548283|NCT04857034|473631593|FG003|Placebo-Controlled Period|Request to discontinue|0|||
131548284|NCT04857034|473631594|FG004|Placebo-Controlled Period|Request to discontinue|0|||
131548285|NCT04857034|473631590|FG000|Placebo-Controlled Period|withdrew consent|1|||
131548286|NCT04857034|473631591|FG001|Placebo-Controlled Period|withdrew consent|1|||
131548287|NCT04857034|473631592|FG002|Placebo-Controlled Period|withdrew consent|2|||
131548288|NCT04857034|473631593|FG003|Placebo-Controlled Period|withdrew consent|0|||
131548289|NCT04857034|473631594|FG004|Placebo-Controlled Period|withdrew consent|0|||
131548290|NCT04857034|473631590|FG000|Placebo-Controlled Period|Pregnancy|1|||
131548291|NCT04857034|473631591|FG001|Placebo-Controlled Period|Pregnancy|1|||
131548292|NCT04857034|473631592|FG002|Placebo-Controlled Period|Pregnancy|0|||
131548293|NCT04857034|473631593|FG003|Placebo-Controlled Period|Pregnancy|0|||
131548294|NCT04857034|473631594|FG004|Placebo-Controlled Period|Pregnancy|0|||
131548295|NCT04857034|473631590|FG000|Placebo-Controlled Period|Ongoing study period|0|||
131548296|NCT04857034|473631591|FG001|Placebo-Controlled Period|Ongoing study period|1|||
131548297|NCT04857034|473631592|FG002|Placebo-Controlled Period|Ongoing study period|0|||
131548298|NCT04857034|473631593|FG003|Placebo-Controlled Period|Ongoing study period|0|||
131548299|NCT04857034|473631594|FG004|Placebo-Controlled Period|Ongoing study period|0|||
131548300|NCT04857034|473631590|FG000|Active Treatment Period|Lack of Efficacy|1|||
131548301|NCT04857034|473631591|FG001|Active Treatment Period|Lack of Efficacy|0|||
131548302|NCT04857034|473631592|FG002|Active Treatment Period|Lack of Efficacy|0|||
131548303|NCT04857034|473631593|FG003|Active Treatment Period|Lack of Efficacy|0|||
131548304|NCT04857034|473631594|FG004|Active Treatment Period|Lack of Efficacy|0|||
131548305|NCT04857034|473631590|FG000|Active Treatment Period|request to discontinue|0|||
131548306|NCT04857034|473631591|FG001|Active Treatment Period|request to discontinue|1|||
131548307|NCT04857034|473631592|FG002|Active Treatment Period|request to discontinue|0|||
131548308|NCT04857034|473631593|FG003|Active Treatment Period|request to discontinue|1|||
131548309|NCT04857034|473631594|FG004|Active Treatment Period|request to discontinue|0|||
131548310|NCT04857034|473631590|FG000|Active Treatment Period|administrative reason by sponsor|1|||
131548311|NCT04857034|473631591|FG001|Active Treatment Period|administrative reason by sponsor|5|||
131548312|NCT04857034|473631592|FG002|Active Treatment Period|administrative reason by sponsor|0|||
131548313|NCT04857034|473631593|FG003|Active Treatment Period|administrative reason by sponsor|2|||
131548314|NCT04857034|473631594|FG004|Active Treatment Period|administrative reason by sponsor|2|||
131548315|NCT04857034|473631590|FG000|Active Treatment Period|other reasons|1|||
131548316|NCT04857034|473631591|FG001|Active Treatment Period|other reasons|1|||
131548317|NCT04857034|473631592|FG002|Active Treatment Period|other reasons|0|||
131548318|NCT04857034|473631593|FG003|Active Treatment Period|other reasons|0|||
131548319|NCT04857034|473631594|FG004|Active Treatment Period|other reasons|1|||
131548320|NCT04857034|473631590|FG000|Active Treatment Period|Ongoing Study Period|2|||
131548321|NCT04857034|473631591|FG001|Active Treatment Period|Ongoing Study Period|4|||
131548322|NCT04857034|473631592|FG002|Active Treatment Period|Ongoing Study Period|0|||
131548323|NCT04857034|473631593|FG003|Active Treatment Period|Ongoing Study Period|1|||
131548324|NCT04857034|473631594|FG004|Active Treatment Period|Ongoing Study Period|0|||
131548325|NCT05674890|473631599|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
131548326|NCT05674890|473631600|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
131548327|NCT05674890|473631599|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
131548328|NCT05674890|473631600|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
131548329|NCT05674890|473631599|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
131548330|NCT05674890|473631600|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
131548331|NCT00827541|473631601|FG000|Overall Study|Exitus|1|||
131548332|NCT00827541|473631602|FG001|Overall Study|Exitus|8|||
131548333|NCT00827541|473631601|FG000|Overall Study|Other|1|||
131548334|NCT00827541|473631602|FG001|Overall Study|Other|3|||
131548335|NCT00827541|473631601|FG000|Overall Study|Pathogen not susceptible|1|||
131548336|NCT00827541|473631602|FG001|Overall Study|Pathogen not susceptible|0|||
131548337|NCT00827541|473631601|FG000|Overall Study|Lack of effectiveness|1|||
131548338|NCT00827541|473631602|FG001|Overall Study|Lack of effectiveness|0|||
131548339|NCT01649232|473631603|FG000|Overall Study|Physician Decision|2|||
131548340|NCT01649232|473631604|FG001|Overall Study|Physician Decision|0|||
131548341|NCT04810221|473631605|FG000|Overall Study|Physician Decision|3|||
131548342|NCT03642938|473631606|FG000|Overall Study|Withdrawal by Subject|0|||
131548343|NCT03642938|473631607|FG001|Overall Study|Withdrawal by Subject|0|||
131548344|NCT03642938|473631608|FG002|Overall Study|Withdrawal by Subject|0|||
131548345|NCT03642938|473631609|FG003|Overall Study|Withdrawal by Subject|1|||
131548346|NCT00105235|473631610|FG000|Overall Study|Death|4|||
131548347|NCT00105235|473631610|FG000|Overall Study|Physician Decision|1|||
131548348|NCT00105235|473631610|FG000|Overall Study|Withdrawal by Subject|2|||
131548349|NCT01964326|473631611|FG000|Overall Study|Adverse Event|48|||
131548350|NCT01964326|473631611|FG000|Overall Study|Death|2|||
131548351|NCT01964326|473631611|FG000|Overall Study|Protocol Violation|4|||
131548352|NCT01964326|473631611|FG000|Overall Study|Lost to Follow-up|88|||
131548353|NCT01964326|473631611|FG000|Overall Study|Withdrawal by Subject|87|||
131548354|NCT01964326|473631611|FG000|Overall Study|Pregnancy|1|||
131548355|NCT01964326|473631611|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
131548356|NCT01964326|473631611|FG000|Overall Study|Physician Decision|55|||
131548357|NCT01964326|473631611|FG000|Overall Study|Investigator Discretion|1|||
131548358|NCT01964326|473631611|FG000|Overall Study|Other|9|||
131548359|NCT01964326|473631611|FG000|Overall Study|Did not meet eligibility criteria|1|||
131548360|NCT02347657|473631612|FG000|Overall Study|Physician Decision|0|||
131548361|NCT02347657|473631613|FG001|Overall Study|Physician Decision|1|||
131548362|NCT02347657|473631612|FG000|Overall Study|Adverse Event|8|||
131548363|NCT02347657|473631613|FG001|Overall Study|Adverse Event|4|||
131660179|NCT00338962|474040732|FG002|Overall Study|Withdrawal by Subject|0|||
131660180|NCT00338962|474040733|FG003|Overall Study|Withdrawal by Subject|0|||
131660181|NCT00338962|474040730|FG000|Overall Study|No Transportation|2|||
131660182|NCT00338962|474040731|FG001|Overall Study|No Transportation|0|||
131660183|NCT00338962|474040732|FG002|Overall Study|No Transportation|0|||
131660184|NCT00338962|474040733|FG003|Overall Study|No Transportation|0|||
131660185|NCT00338962|474040730|FG000|Overall Study|Time Constraint|2|||
131660186|NCT00338962|474040731|FG001|Overall Study|Time Constraint|0|||
131660187|NCT00338962|474040732|FG002|Overall Study|Time Constraint|0|||
131660188|NCT00338962|474040733|FG003|Overall Study|Time Constraint|0|||
131660189|NCT00338962|474040730|FG000|Overall Study|Moved|0|||
131660190|NCT00338962|474040731|FG001|Overall Study|Moved|1|||
131660191|NCT00338962|474040732|FG002|Overall Study|Moved|0|||
131660192|NCT00338962|474040733|FG003|Overall Study|Moved|0|||
131660193|NCT00338962|474040730|FG000|Overall Study|Adverse Event|0|||
131660194|NCT00338962|474040731|FG001|Overall Study|Adverse Event|0|||
131660195|NCT00338962|474040732|FG002|Overall Study|Adverse Event|2|||
131660196|NCT00338962|474040733|FG003|Overall Study|Adverse Event|0|||
131660197|NCT00338962|474040730|FG000|Overall Study|Poor Compliance|0|||
131660198|NCT00338962|474040731|FG001|Overall Study|Poor Compliance|0|||
131660199|NCT00338962|474040732|FG002|Overall Study|Poor Compliance|2|||
131660200|NCT00338962|474040733|FG003|Overall Study|Poor Compliance|0|||
131660201|NCT03214640|474040734|FG000|Overall Study|Protocol Violation|1|||
131660202|NCT03214640|474040735|FG001|Overall Study|Protocol Violation|2|||
131660203|NCT03214640|474040736|FG002|Overall Study|Protocol Violation|1|||
131660204|NCT03214640|474040737|FG003|Overall Study|Protocol Violation|4|||
131660205|NCT01253018|474040743|FG000|Overall Study|Lost to Follow-up|1|||
131660206|NCT01253018|474040744|FG001|Overall Study|Lost to Follow-up|1|||
131660207|NCT01253018|474040743|FG000|Overall Study|Robot Repair Issues|2|||
131660208|NCT01253018|474040744|FG001|Overall Study|Robot Repair Issues|0|||
131660209|NCT01253018|474040743|FG000|Overall Study|Withdrawal by Subject|1|||
131660210|NCT01253018|474040744|FG001|Overall Study|Withdrawal by Subject|1|||
131660211|NCT03449901|474040745|FG000|Overall Study|Progression|57|||
131660212|NCT03449901|474040746|FG001|Overall Study|Progression|12|||
131660213|NCT03449901|474040745|FG000|Overall Study|Adverse Event|3|||
131660214|NCT03449901|474040746|FG001|Overall Study|Adverse Event|0|||
131660215|NCT03449901|474040745|FG000|Overall Study|Death|6|||
131660216|NCT03449901|474040746|FG001|Overall Study|Death|2|||
131660217|NCT03449901|474040745|FG000|Overall Study|Withdrawal by Subject|12|||
131660218|NCT03449901|474040746|FG001|Overall Study|Withdrawal by Subject|1|||
131660219|NCT03449901|474040745|FG000|Overall Study|Physician Decision|1|||
131660220|NCT03449901|474040746|FG001|Overall Study|Physician Decision|0|||
131660221|NCT03449901|474040745|FG000|Overall Study|Patient elected for surgical intervention|1|||
131660222|NCT03449901|474040746|FG001|Overall Study|Patient elected for surgical intervention|0|||
131660223|NCT03449901|474040745|FG000|Overall Study|Patient off for other complicating disease|1|||
131660224|NCT03449901|474040746|FG001|Overall Study|Patient off for other complicating disease|0|||
131660225|NCT03466073|474040747|FG000|Overall Study|Death|1|||
131660226|NCT03466073|474040748|FG001|Overall Study|Death|0|||
131660227|NCT03466073|474040749|FG002|Overall Study|Death|0|||
131660228|NCT03466073|474040750|FG003|Overall Study|Death|0|||
131660229|NCT03466073|474040751|FG004|Overall Study|Death|0|||
131660230|NCT03466073|474040752|FG005|Overall Study|Death|1|||
131660231|NCT00744757|474040753|FG000|Overall Study|Objective disease progression|7|||
131660232|NCT00744757|474040753|FG000|Overall Study|Physician Decision|5|||
131660233|NCT00744757|474040753|FG000|Overall Study|Withdrawal by Subject|1|||
131660234|NCT00744757|474040753|FG000|Overall Study|Death|6|||
131660235|NCT00744757|474040753|FG000|Overall Study|Adverse Event|2|||
131660236|NCT03682302|474040754|FG000|Overall Study|Lost to Follow-up|1|||
131660237|NCT03682302|474040755|FG001|Overall Study|Lost to Follow-up|2|||
131660238|NCT03682302|474040756|FG002|Overall Study|Lost to Follow-up|0|||
131660239|NCT03682302|474040757|FG003|Overall Study|Lost to Follow-up|1|||
131660240|NCT03682302|474040754|FG000|Overall Study|Study drug was not administered|0|||
131660241|NCT03682302|474040755|FG001|Overall Study|Study drug was not administered|0|||
131660242|NCT03682302|474040756|FG002|Overall Study|Study drug was not administered|1|||
131660243|NCT03682302|474040757|FG003|Overall Study|Study drug was not administered|1|||
131660244|NCT01585155|474040758|FG000|Overall Study|Adverse Event|1|||
131660245|NCT01585155|474040758|FG000|Overall Study|Lack of Efficacy|2|||
131660246|NCT01585155|474040758|FG000|Overall Study|Worsening ulcerative colitis|2|||
131660247|NCT03772587|474040763|FG000|Overall Study|COVID-19|0|||
131660248|NCT03772587|474040764|FG001|Overall Study|COVID-19|0|||
131660249|NCT03772587|474040765|FG002|Overall Study|COVID-19|1|||
131660250|NCT03772587|474040766|FG003|Overall Study|COVID-19|1|||
131660251|NCT03772587|474040767|FG004|Overall Study|COVID-19|0|||
131660252|NCT03772587|474040763|FG000|Overall Study|Withdrawal by Subject|1|||
131660253|NCT03772587|474040764|FG001|Overall Study|Withdrawal by Subject|0|||
131660254|NCT03772587|474040765|FG002|Overall Study|Withdrawal by Subject|0|||
131660255|NCT03772587|474040766|FG003|Overall Study|Withdrawal by Subject|0|||
131660256|NCT03772587|474040767|FG004|Overall Study|Withdrawal by Subject|0|||
131660257|NCT05260021|474040769|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
131660258|NCT05260021|474040770|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
131660259|NCT05260021|474040771|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
131660260|NCT05260021|474040769|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
131660261|NCT05260021|474040770|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
131660262|NCT05260021|474040771|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
131660263|NCT05260021|474040769|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
131660264|NCT05260021|474040770|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
131660265|NCT05260021|474040771|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
131660266|NCT05260021|474040769|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
131660267|NCT05260021|474040770|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
131660268|NCT05260021|474040771|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
131660269|NCT05260021|474040769|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
131660270|NCT05260021|474040770|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
131660271|NCT05260021|474040771|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
131660272|NCT03842358|474040772|FG000|Overall Study|Poor DOT probe contact with breast|2|||
131660273|NCT03842358|474040772|FG000|Overall Study|DOT system problem|1|||
131660274|NCT03842358|474040772|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
131660275|NCT03842358|474040772|FG000|Overall Study|No biopsy after physician review|4|||
131660276|NCT03842358|474040772|FG000|Overall Study|Patient withdrew|2|||
131660277|NCT01525238|474040773|FG000|Overall Study|Withdrawal by Subject|1|||
131660278|NCT01525238|474040774|FG001|Overall Study|Withdrawal by Subject|0|||
131660279|NCT01525238|474040775|FG002|Overall Study|Withdrawal by Subject|0|||
131660280|NCT04625413|474040776|FG000|Overall Study|Hospice|2|||
131660281|NCT04625413|474040776|FG000|Overall Study|Distress|1|||
131660282|NCT04625413|474040776|FG000|Overall Study|Not feeling well|1|||
131660283|NCT04679935|474040777|FG000|Overall Study|Death|0|||
131660284|NCT04679935|474040778|FG001|Overall Study|Death|1|||
131660285|NCT02993146|474040779|FG000|Overall Study|Withdrawal by Subject|0|||
131660286|NCT02993146|474040780|FG001|Overall Study|Withdrawal by Subject|0|||
131660287|NCT02993146|474040781|FG002|Overall Study|Withdrawal by Subject|1|||
131660288|NCT02993146|474040782|FG003|Overall Study|Withdrawal by Subject|1|||
131660289|NCT04362189|474040783|FG000|Overall Study|Lost to Follow-up|0|||
131660290|NCT04362189|474040784|FG001|Overall Study|Lost to Follow-up|1|||
131660291|NCT04362189|474040783|FG000|Overall Study|Withdrawal by Subject|1|||
131660292|NCT04362189|474040784|FG001|Overall Study|Withdrawal by Subject|0|||
131660293|NCT04362189|474040783|FG000|Overall Study|FDA Clinical Hold|7|||
131660294|NCT04362189|474040784|FG001|Overall Study|FDA Clinical Hold|2|||
131660295|NCT04362189|474040783|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
131660296|NCT04362189|474040784|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
131660297|NCT04362189|474040783|FG000|Overall Study|Adverse Event|0|||
131660298|NCT04362189|474040784|FG001|Overall Study|Adverse Event|2|||
131660299|NCT04362189|474040783|FG000|Overall Study|Death|4|||
131660300|NCT04362189|474040784|FG001|Overall Study|Death|1|||
131660301|NCT02111681|474040785|FG000|Overall Study|Death|5|||
131660302|NCT02111681|474040785|FG000|Overall Study|Lack of Efficacy|2|||
131660303|NCT02111681|474040785|FG000|Overall Study|Progression of disease|4|||
131660304|NCT01077271|474042990|FG000|Overall Study|Parental desire|8|||
131660305|NCT01077271|474042990|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
131660306|NCT01077271|474042990|FG000|Overall Study|Noncompliance|2|||
131660307|NCT01077271|474042990|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
131660308|NCT01077271|474042990|FG000|Overall Study|Changed doctors|2|||
131660309|NCT01077271|474042990|FG000|Overall Study|Parents thought too many injections|2|||
131660310|NCT01077271|474042990|FG000|Overall Study|End of RSV season nearly reached|1|||
131660311|NCT01077271|474042990|FG000|Overall Study|Mother unconvinced of the necessity|1|||
131660312|NCT03333876|474042991|FG000|Screening Period|Screen Failure|4|||
131660313|NCT03333876|474042991|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
131660314|NCT03333876|474042991|FG000|Mandibular Advancement|Adverse Event|2|||
131660315|NCT03333876|474042991|FG000|Mandibular Advancement|Product Damage|2|||
131660316|NCT00095498|474042992|FG000|Overall Study|Physician Decision|9|||
131660317|NCT00095498|474042993|FG001|Overall Study|Physician Decision|10|||
131660318|NCT00095498|474042994|FG002|Overall Study|Physician Decision|8|||
131660319|NCT00095498|474042992|FG000|Overall Study|Adverse Event|1|||
131660320|NCT00095498|474042993|FG001|Overall Study|Adverse Event|0|||
131660321|NCT00095498|474042994|FG002|Overall Study|Adverse Event|1|||
131660322|NCT00095498|474042992|FG000|Overall Study|Withdrawal by Subject|15|||
131660323|NCT00095498|474042993|FG001|Overall Study|Withdrawal by Subject|16|||
131660324|NCT00095498|474042994|FG002|Overall Study|Withdrawal by Subject|15|||
131660325|NCT00095498|474042992|FG000|Overall Study|Disease progression|0|||
131660326|NCT00095498|474042993|FG001|Overall Study|Disease progression|1|||
131660327|NCT00095498|474042994|FG002|Overall Study|Disease progression|1|||
131660328|NCT00095498|474042992|FG000|Overall Study|Ineligibility determined|3|||
131660329|NCT00095498|474042993|FG001|Overall Study|Ineligibility determined|0|||
131660330|NCT00095498|474042994|FG002|Overall Study|Ineligibility determined|2|||
131660331|NCT00095498|474042992|FG000|Overall Study|Lost to Follow-up|1|||
131660332|NCT00095498|474042993|FG001|Overall Study|Lost to Follow-up|1|||
131660333|NCT00095498|474042994|FG002|Overall Study|Lost to Follow-up|2|||
131660334|NCT00095498|474042992|FG000|Overall Study|Noncompliance|1|||
131660335|NCT00095498|474042993|FG001|Overall Study|Noncompliance|0|||
131660336|NCT00095498|474042994|FG002|Overall Study|Noncompliance|1|||
131660337|NCT00095498|474042992|FG000|Overall Study|Other|6|||
131660338|NCT00095498|474042993|FG001|Overall Study|Other|7|||
131660339|NCT00095498|474042994|FG002|Overall Study|Other|6|||
131660340|NCT00095498|474042992|FG000|Overall Study|Protocol Violation|0|||
131660341|NCT00095498|474042993|FG001|Overall Study|Protocol Violation|0|||
131660342|NCT00095498|474042994|FG002|Overall Study|Protocol Violation|1|||
131660343|NCT00095498|474042992|FG000|Overall Study|Requirement for alternative therapy|1|||
131660344|NCT00095498|474042993|FG001|Overall Study|Requirement for alternative therapy|0|||
131660345|NCT00095498|474042994|FG002|Overall Study|Requirement for alternative therapy|2|||
131660346|NCT05020327|474042995|FG000|Overall Study|Physician Decision|3|||
131660347|NCT05020327|474042996|FG001|Overall Study|Physician Decision|0|||
131660348|NCT05020327|474042997|FG002|Overall Study|Physician Decision|0|||
131660349|NCT05020327|474042995|FG000|Overall Study|Withdrawal by Subject|1|||
131660350|NCT05020327|474042996|FG001|Overall Study|Withdrawal by Subject|1|||
131660351|NCT05020327|474042997|FG002|Overall Study|Withdrawal by Subject|0|||
131660352|NCT05020327|474042995|FG000|Overall Study|personal/cultural, ineligible|12|||
131660353|NCT05020327|474042996|FG001|Overall Study|personal/cultural, ineligible|0|||
131660354|NCT05020327|474042997|FG002|Overall Study|personal/cultural, ineligible|0|||
131660355|NCT04684394|474042998|FG000|Overall Study|Death|1|||
131660356|NCT04684394|474042999|FG001|Overall Study|Death|2|||
131660357|NCT04684394|474042998|FG000|Overall Study|Lost to Follow-up|1|||
131660358|NCT04684394|474042999|FG001|Overall Study|Lost to Follow-up|0|||
131660359|NCT04684394|474042998|FG000|Overall Study|Withdrawal by Subject|2|||
131660360|NCT04684394|474042999|FG001|Overall Study|Withdrawal by Subject|0|||
131660361|NCT04684394|474042998|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
131660362|NCT04684394|474042999|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
131660363|NCT00591370|474043001|FG000|Overall Study|Not Treated|2|||
131660364|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
131660365|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
131660366|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
131660367|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
131660368|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
131660369|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
131660370|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
131660371|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131660372|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131660373|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131660374|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131660375|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131660376|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Death|1|||
131660377|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Death|2|||
131660378|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Death|2|||
131660379|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Death|0|||
131660380|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Death|0|||
131660381|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Death|0|||
131660382|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131660383|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
131660384|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
131660385|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131660386|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131660387|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131660388|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
131660389|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131660390|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131660391|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131660392|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131660393|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131660394|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
131660395|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131660396|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131660397|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131660398|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131660399|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131660400|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
131660401|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131660402|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131660403|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131660404|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131660405|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131660406|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131660407|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
131660408|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131660409|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131660410|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131660411|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131660412|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
131660413|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
131660414|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
131660415|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
131660416|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
131660417|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
131660418|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131660419|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131548364|NCT02347657|473631612|FG000|Overall Study|Withdrawal by Subject|6|||
131548365|NCT02347657|473631613|FG001|Overall Study|Withdrawal by Subject|7|||
131548366|NCT02347657|473631612|FG000|Overall Study|Randomized but not treated|1|||
131548367|NCT02347657|473631613|FG001|Overall Study|Randomized but not treated|0|||
131548368|NCT02347657|473631612|FG000|Overall Study|Other|3|||
131548369|NCT02347657|473631613|FG001|Overall Study|Other|3|||
131548370|NCT00261495|473631614|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
131548371|NCT00261495|473631615|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
131548372|NCT00261495|473631614|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
131548373|NCT00261495|473631615|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
131548374|NCT00261495|473631614|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
131548375|NCT00261495|473631615|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
131548376|NCT00261495|473631614|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
131548377|NCT00261495|473631615|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
131548378|NCT00261495|473631614|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
131548379|NCT00261495|473631615|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
131548380|NCT00261495|473631614|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
131548381|NCT00261495|473631615|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
131548382|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
131548383|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
131548384|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
131548385|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
131548386|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
131548387|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
131548388|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
131548389|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
131548390|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
131548391|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
131548392|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
131548393|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
131548394|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
131548395|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
131548396|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
131548397|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
131548398|NCT00261495|473631614|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
131548399|NCT00261495|473631615|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
131548400|NCT00261495|473631614|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
131548401|NCT00261495|473631615|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
131548402|NCT00261495|473631614|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
131548403|NCT00261495|473631615|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131548404|NCT00261495|473631614|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
131548405|NCT00261495|473631615|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
131548406|NCT00261495|473631614|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131548407|NCT00261495|473631615|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
131548408|NCT00261495|473631614|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
131548409|NCT00261495|473631615|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
131548410|NCT00261495|473631614|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
131660420|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
131660421|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131660422|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131660423|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131660424|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Site closure|0|||
131660425|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Site closure|0|||
131660426|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Site closure|1|||
131660427|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Site closure|0|||
131660428|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Site closure|0|||
131660429|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Site closure|0|||
131660430|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
131660431|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
131660432|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
131660433|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
131660434|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
131660435|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
131660436|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
131660437|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
131660438|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
131660439|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
131660440|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
131660441|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
131660442|NCT03439254|474043002|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
131660443|NCT03439254|474043003|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
131660444|NCT03439254|474043004|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
131660445|NCT03439254|474043005|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
131660446|NCT03439254|474043006|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
131660447|NCT03439254|474043007|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
131660448|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
131660449|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
131660450|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
131660451|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
131660452|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
131660453|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
131660454|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131660455|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131660456|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131660457|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
131660458|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131660459|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
131660460|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131660461|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131660462|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131660463|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131660464|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131660465|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
131660466|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131660467|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131660468|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131660469|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131660470|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
131660471|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131660472|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131660473|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131660474|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131660475|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131660476|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
131660477|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131660478|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131660479|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131660480|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131660481|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131660482|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131660483|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
131660484|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131660485|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131660486|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131660487|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
131660488|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131660489|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131660490|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131660491|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131660492|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131660493|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
131660494|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
131660495|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131660496|NCT03439254|474043002|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
131660497|NCT03439254|474043003|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
131660498|NCT03439254|474043004|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
131660499|NCT03439254|474043005|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
131660500|NCT03439254|474043006|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
131660501|NCT03439254|474043007|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
131660502|NCT02075476|474043009|FG000|Overall Study|Death|2|||
131660503|NCT02075476|474043010|FG001|Overall Study|Death|2|||
131887585|NCT01554176|474870230|FG001|Treatment Phase|Non-compliance with study drug|0|||
131887586|NCT01554176|474870231|FG002|Treatment Phase|Non-compliance with study drug|0|||
131887587|NCT01554176|474870232|FG003|Treatment Phase|Non-compliance with study drug|0|||
131887588|NCT01554176|474870233|FG004|Treatment Phase|Non-compliance with study drug|0|||
131887589|NCT01554176|474870229|FG000|Treatment Phase|Withdrawal by Subject|1|||
131887590|NCT01554176|474870230|FG001|Treatment Phase|Withdrawal by Subject|0|||
131887591|NCT01554176|474870231|FG002|Treatment Phase|Withdrawal by Subject|0|||
131887592|NCT01554176|474870232|FG003|Treatment Phase|Withdrawal by Subject|0|||
131887593|NCT01554176|474870233|FG004|Treatment Phase|Withdrawal by Subject|0|||
131887594|NCT01554176|474870229|FG000|Treatment Phase|Lost to Follow-up|3|||
131887595|NCT01554176|474870230|FG001|Treatment Phase|Lost to Follow-up|0|||
131887596|NCT01554176|474870231|FG002|Treatment Phase|Lost to Follow-up|0|||
131887597|NCT01554176|474870232|FG003|Treatment Phase|Lost to Follow-up|0|||
131887598|NCT01554176|474870233|FG004|Treatment Phase|Lost to Follow-up|0|||
131887599|NCT01554176|474870229|FG000|Run-out Phase|Protocol Violation|0|||
131887600|NCT01554176|474870230|FG001|Run-out Phase|Protocol Violation|0|||
131434432|NCT03001557|473217577|FG000|Core Phase|Randomized but not treated|0|||
131434433|NCT03001557|473217578|FG001|Core Phase|Randomized but not treated|0|||
131887601|NCT01554176|474870231|FG002|Run-out Phase|Protocol Violation|0|||
131887602|NCT01554176|474870232|FG003|Run-out Phase|Protocol Violation|1|||
131887603|NCT01554176|474870233|FG004|Run-out Phase|Protocol Violation|0|||
131887604|NCT00386425|474870234|FG000|Overall Study|Physician Decision|3|||
131887605|NCT00386425|474870235|FG001|Overall Study|Physician Decision|0|||
131887606|NCT00386425|474870236|FG002|Overall Study|Physician Decision|0|||
131887607|NCT00386425|474870234|FG000|Overall Study|Withdrawal by Subject|0|||
131887608|NCT00386425|474870235|FG001|Overall Study|Withdrawal by Subject|1|||
131887609|NCT00386425|474870236|FG002|Overall Study|Withdrawal by Subject|0|||
131887610|NCT03053427|474870237|FG000|Overall Study|Adverse Event|4|||
131887611|NCT03053427|474870238|FG001|Overall Study|Adverse Event|4|||
131887612|NCT03053427|474870237|FG000|Overall Study|Lack of Efficacy|1|||
131887613|NCT03053427|474870238|FG001|Overall Study|Lack of Efficacy|3|||
131887614|NCT03053427|474870237|FG000|Overall Study|Lost to Follow-up|2|||
131887615|NCT03053427|474870238|FG001|Overall Study|Lost to Follow-up|2|||
131887616|NCT03053427|474870237|FG000|Overall Study|Worsening of the target disease|0|||
131887617|NCT03053427|474870238|FG001|Overall Study|Worsening of the target disease|1|||
131887618|NCT03053427|474870237|FG000|Overall Study|Protocol Deviation|3|||
131887619|NCT03053427|474870238|FG001|Overall Study|Protocol Deviation|3|||
131887620|NCT03053427|474870237|FG000|Overall Study|Withdrawal by Subject|3|||
131887621|NCT03053427|474870238|FG001|Overall Study|Withdrawal by Subject|2|||
131887622|NCT03053427|474870237|FG000|Overall Study|Miscellaneous|0|||
131887623|NCT03053427|474870238|FG001|Overall Study|Miscellaneous|1|||
131887624|NCT02172040|474870242|FG000|Overall Study|Adverse Event|0|||
131887625|NCT02172040|474870243|FG001|Overall Study|Adverse Event|2|||
131887626|NCT02172040|474870244|FG002|Overall Study|Adverse Event|0|||
131887627|NCT02172040|474870245|FG003|Overall Study|Adverse Event|0|||
131887628|NCT02172040|474870242|FG000|Overall Study|Protocol Violation|0|||
131887629|NCT02172040|474870243|FG001|Overall Study|Protocol Violation|1|||
131887630|NCT02172040|474870244|FG002|Overall Study|Protocol Violation|0|||
131887631|NCT02172040|474870245|FG003|Overall Study|Protocol Violation|0|||
131887632|NCT02172040|474870242|FG000|Overall Study|Withdrawal by Subject|0|||
131887633|NCT02172040|474870243|FG001|Overall Study|Withdrawal by Subject|0|||
131887634|NCT02172040|474870244|FG002|Overall Study|Withdrawal by Subject|1|||
131887635|NCT02172040|474870245|FG003|Overall Study|Withdrawal by Subject|0|||
131887636|NCT02172040|474870242|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
131887637|NCT02172040|474870243|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
131887638|NCT02172040|474870244|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
131887639|NCT02172040|474870245|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
131887640|NCT02172040|474870242|FG000|Overall Study|Family emergency abroad|0|||
131887641|NCT02172040|474870243|FG001|Overall Study|Family emergency abroad|0|||
131887642|NCT02172040|474870244|FG002|Overall Study|Family emergency abroad|0|||
131887643|NCT02172040|474870245|FG003|Overall Study|Family emergency abroad|1|||
131887644|NCT01324570|474870250|FG000|Overall Study|Adverse Event|4|||
131887645|NCT01324570|474870251|FG001|Overall Study|Adverse Event|7|||
131887646|NCT01324570|474870250|FG000|Overall Study|Withdrawal by Subject|0|||
131887647|NCT01324570|474870251|FG001|Overall Study|Withdrawal by Subject|3|||
131887648|NCT01324570|474870250|FG000|Overall Study|Lack of Efficacy|0|||
131887649|NCT01324570|474870251|FG001|Overall Study|Lack of Efficacy|1|||
131887650|NCT01324570|474870250|FG000|Overall Study|Confirmed or suspected diversion|0|||
131887651|NCT01324570|474870251|FG001|Overall Study|Confirmed or suspected diversion|1|||
131887652|NCT01324570|474870250|FG000|Overall Study|Administrative|0|||
131887653|NCT01324570|474870251|FG001|Overall Study|Administrative|2|||
131887654|NCT02607306|474870254|FG000|Overall Study|Adverse Event|8|||
131887655|NCT02607306|474870255|FG001|Overall Study|Adverse Event|6|||
131887656|NCT02607306|474870256|FG002|Overall Study|Adverse Event|6|||
131887657|NCT02607306|474870254|FG000|Overall Study|Unclassified|1|||
131887658|NCT02607306|474870255|FG001|Overall Study|Unclassified|4|||
131887659|NCT02607306|474870256|FG002|Overall Study|Unclassified|0|||
131887660|NCT02607306|474870254|FG000|Overall Study|Withdrawal by Subject|8|||
131887661|NCT02607306|474870255|FG001|Overall Study|Withdrawal by Subject|10|||
131887662|NCT02607306|474870256|FG002|Overall Study|Withdrawal by Subject|2|||
131887663|NCT02607306|474870254|FG000|Overall Study|Lack of Efficacy|0|||
131887664|NCT02607306|474870255|FG001|Overall Study|Lack of Efficacy|1|||
131887665|NCT02607306|474870256|FG002|Overall Study|Lack of Efficacy|1|||
131887666|NCT02607306|474870254|FG000|Overall Study|Protocol Violation|4|||
131887667|NCT02607306|474870255|FG001|Overall Study|Protocol Violation|2|||
131887668|NCT02607306|474870256|FG002|Overall Study|Protocol Violation|1|||
131887669|NCT00435019|474870262|FG000|Overall Study|Adverse Event|1|||
131887670|NCT00435019|474870263|FG001|Overall Study|Adverse Event|0|||
131887671|NCT00435019|474870262|FG000|Overall Study|Lack of Efficacy|1|||
131887672|NCT00435019|474870263|FG001|Overall Study|Lack of Efficacy|2|||
131887673|NCT00435019|474870262|FG000|Overall Study|Protocol Violation|3|||
131887674|NCT00435019|474870263|FG001|Overall Study|Protocol Violation|1|||
131887675|NCT00435019|474870262|FG000|Overall Study|Personal reasons for withdrawal|8|||
131887676|NCT00435019|474870263|FG001|Overall Study|Personal reasons for withdrawal|7|||
131887677|NCT00628927|474870264|FG000|Overall Study|Problems performing blood draw|6|||
131887678|NCT00628927|474870265|FG001|Overall Study|Problems performing blood draw|0|||
131887679|NCT00628927|474870264|FG000|Overall Study|Lost to Follow-up|1|||
131887680|NCT00628927|474870265|FG001|Overall Study|Lost to Follow-up|0|||
131887681|NCT00628927|474870264|FG000|Overall Study|Equipment failure|1|||
131660504|NCT02075476|474043009|FG000|Overall Study|Lost to Follow-up|1|||
131660505|NCT02075476|474043010|FG001|Overall Study|Lost to Follow-up|3|||
131660506|NCT00095056|474043011|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
131660507|NCT00095056|474043012|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
131660508|NCT00095056|474043011|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
131660509|NCT00095056|474043012|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
131660510|NCT00095056|474043011|FG000|Phase A (Weeks 0-12)|Death|1|||
131660511|NCT00095056|474043012|FG001|Phase A (Weeks 0-12)|Death|0|||
131660512|NCT00095056|474043011|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
131660513|NCT00095056|474043012|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
131660514|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
131660515|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
131660516|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
131660517|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
131660518|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
131660519|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
131660520|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
131660521|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
131660522|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Death|3|||
131660523|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Death|1|||
131660524|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
131660525|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
131660526|NCT00095056|474043011|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
131660527|NCT00095056|474043012|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
131660528|NCT00923260|474043018|FG000|Overall Study|Lost to Follow-up|1|||
131660529|NCT00923260|474043019|FG001|Overall Study|Lost to Follow-up|1|||
131660530|NCT01262677|474043021|FG000|Overall Study|Does not meet entrance criteria|0|||
131887682|NCT00628927|474870265|FG001|Overall Study|Equipment failure|0|||
131887683|NCT01313221|474872248|FG000|Overall Study|Protocol Violation|0|||
131887684|NCT01313221|474872249|FG001|Overall Study|Protocol Violation|1|||
131660531|NCT01262677|474043022|FG001|Overall Study|Does not meet entrance criteria|2|||
131660532|NCT01262677|474043023|FG002|Overall Study|Does not meet entrance criteria|0|||
131660533|NCT01262677|474043021|FG000|Overall Study|Insufficient clinical response|0|||
131660534|NCT01262677|474043022|FG001|Overall Study|Insufficient clinical response|0|||
131660535|NCT01262677|474043023|FG002|Overall Study|Insufficient clinical response|1|||
131660536|NCT01262677|474043021|FG000|Overall Study|Lost to Follow-up|1|||
131660537|NCT01262677|474043022|FG001|Overall Study|Lost to Follow-up|0|||
131660538|NCT01262677|474043023|FG002|Overall Study|Lost to Follow-up|2|||
131660539|NCT01262677|474043021|FG000|Overall Study|No longer willing to participate|3|||
131660540|NCT01262677|474043022|FG001|Overall Study|No longer willing to participate|3|||
131660541|NCT01262677|474043023|FG002|Overall Study|No longer willing to participate|2|||
131660542|NCT01262677|474043021|FG000|Overall Study|Reason not provided|2|||
131660543|NCT01262677|474043022|FG001|Overall Study|Reason not provided|1|||
131660544|NCT01262677|474043023|FG002|Overall Study|Reason not provided|3|||
131660545|NCT01262677|474043021|FG000|Overall Study|Protocol Violation|0|||
131660546|NCT01262677|474043022|FG001|Overall Study|Protocol Violation|1|||
131660547|NCT01262677|474043023|FG002|Overall Study|Protocol Violation|1|||
131660548|NCT01262677|474043021|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
131660549|NCT01262677|474043022|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
131660550|NCT01262677|474043023|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
131660551|NCT00201643|474043029|FG000|Overall Study|Withdrawal by Subject|5|||
131660552|NCT00201643|474043030|FG001|Overall Study|Withdrawal by Subject|4|||
131660553|NCT03446781|474043041|FG000|Overall Study|Lost to Follow-up|11|||
131660554|NCT03446781|474043042|FG001|Overall Study|Lost to Follow-up|5|||
131660555|NCT03446781|474043041|FG000|Overall Study|Withdrawal by Subject|9|||
131660556|NCT03446781|474043042|FG001|Overall Study|Withdrawal by Subject|7|||
131660557|NCT03446781|474043041|FG000|Overall Study|Adverse Event|8|||
131660558|NCT03446781|474043042|FG001|Overall Study|Adverse Event|2|||
131660559|NCT03446781|474043041|FG000|Overall Study|Protocol Violation|0|||
131660560|NCT03446781|474043042|FG001|Overall Study|Protocol Violation|3|||
131660561|NCT04410523|474043046|FG000|Overall Study|Study terminated by sponsor|1|||
131660562|NCT04410523|474043047|FG001|Overall Study|Study terminated by sponsor|3|||
131660563|NCT04410523|474043048|FG002|Overall Study|Study terminated by sponsor|2|||
131660564|NCT04410523|474043049|FG003|Overall Study|Study terminated by sponsor|6|||
131660565|NCT04410523|474043050|FG004|Overall Study|Study terminated by sponsor|3|||
131660566|NCT04410523|474043051|FG005|Overall Study|Study terminated by sponsor|4|||
131660567|NCT04410523|474043046|FG000|Overall Study|Adverse Event|1|||
131660568|NCT04410523|474043047|FG001|Overall Study|Adverse Event|0|||
131660569|NCT04410523|474043048|FG002|Overall Study|Adverse Event|0|||
131660570|NCT04410523|474043049|FG003|Overall Study|Adverse Event|0|||
131660571|NCT04410523|474043050|FG004|Overall Study|Adverse Event|0|||
131660572|NCT04410523|474043051|FG005|Overall Study|Adverse Event|2|||
131660573|NCT04410523|474043046|FG000|Overall Study|Lost to Follow-up|0|||
131660574|NCT04410523|474043047|FG001|Overall Study|Lost to Follow-up|1|||
131660575|NCT04410523|474043048|FG002|Overall Study|Lost to Follow-up|0|||
131660576|NCT04410523|474043049|FG003|Overall Study|Lost to Follow-up|0|||
131660577|NCT04410523|474043050|FG004|Overall Study|Lost to Follow-up|0|||
131660578|NCT04410523|474043051|FG005|Overall Study|Lost to Follow-up|0|||
131660579|NCT04410523|474043046|FG000|Overall Study|Physician Decision|0|||
131660580|NCT04410523|474043047|FG001|Overall Study|Physician Decision|1|||
131660581|NCT04410523|474043048|FG002|Overall Study|Physician Decision|0|||
131660582|NCT04410523|474043049|FG003|Overall Study|Physician Decision|0|||
131660583|NCT04410523|474043050|FG004|Overall Study|Physician Decision|0|||
131660584|NCT04410523|474043051|FG005|Overall Study|Physician Decision|0|||
131660585|NCT04410523|474043046|FG000|Overall Study|Pregnancy|0|||
131660586|NCT04410523|474043047|FG001|Overall Study|Pregnancy|0|||
131660587|NCT04410523|474043048|FG002|Overall Study|Pregnancy|0|||
131660588|NCT04410523|474043049|FG003|Overall Study|Pregnancy|0|||
131660589|NCT04410523|474043050|FG004|Overall Study|Pregnancy|0|||
131660590|NCT04410523|474043051|FG005|Overall Study|Pregnancy|1|||
131660591|NCT04410523|474043046|FG000|Overall Study|Protocol deviation|0|||
131660592|NCT04410523|474043047|FG001|Overall Study|Protocol deviation|0|||
131660593|NCT04410523|474043048|FG002|Overall Study|Protocol deviation|0|||
131660594|NCT04410523|474043049|FG003|Overall Study|Protocol deviation|0|||
131660595|NCT04410523|474043050|FG004|Overall Study|Protocol deviation|0|||
131660596|NCT04410523|474043051|FG005|Overall Study|Protocol deviation|2|||
131660597|NCT04410523|474043046|FG000|Overall Study|Subject decision|2|||
131660598|NCT04410523|474043047|FG001|Overall Study|Subject decision|0|||
131660599|NCT04410523|474043048|FG002|Overall Study|Subject decision|0|||
131660600|NCT04410523|474043049|FG003|Overall Study|Subject decision|1|||
131660601|NCT04410523|474043050|FG004|Overall Study|Subject decision|0|||
131660602|NCT04410523|474043051|FG005|Overall Study|Subject decision|1|||
131660603|NCT00127205|474043052|FG000|Overall Study|Adverse Event|228|||
131660604|NCT00127205|474043053|FG001|Overall Study|Adverse Event|387|||
131660605|NCT00127205|474043054|FG002|Overall Study|Adverse Event|273|||
131660606|NCT00127205|474043052|FG000|Overall Study|Death|8|||
131660607|NCT00127205|474043053|FG001|Overall Study|Death|6|||
131660608|NCT00127205|474043054|FG002|Overall Study|Death|5|||
131660609|NCT00127205|474043052|FG000|Overall Study|Withdrawal by Subject|318|||
131660610|NCT00127205|474043053|FG001|Overall Study|Withdrawal by Subject|310|||
131660611|NCT00127205|474043054|FG002|Overall Study|Withdrawal by Subject|172|||
131660612|NCT00127205|474043052|FG000|Overall Study|Other-non protocol specified|142|||
131660613|NCT00127205|474043053|FG001|Overall Study|Other-non protocol specified|129|||
131660614|NCT00127205|474043054|FG002|Overall Study|Other-non protocol specified|77|||
131660615|NCT00127205|474043052|FG000|Overall Study|Data not reported|6|||
131660616|NCT00127205|474043053|FG001|Overall Study|Data not reported|10|||
131660617|NCT00127205|474043054|FG002|Overall Study|Data not reported|1|||
131660618|NCT00127205|474043052|FG000|Overall Study|Progression|127|||
131660619|NCT00127205|474043053|FG001|Overall Study|Progression|131|||
131660620|NCT00127205|474043054|FG002|Overall Study|Progression|84|||
131660621|NCT02580305|474043058|FG000|Overall Study|Adverse Event|15|||
131660622|NCT02580305|474043059|FG001|Overall Study|Adverse Event|19|||
131660623|NCT02580305|474043060|FG002|Overall Study|Adverse Event|10|||
131660624|NCT02580305|474043058|FG000|Overall Study|Lack of Efficacy|5|||
131660625|NCT02580305|474043059|FG001|Overall Study|Lack of Efficacy|0|||
131660626|NCT02580305|474043060|FG002|Overall Study|Lack of Efficacy|2|||
131660627|NCT02580305|474043058|FG000|Overall Study|Protocol Violation|4|||
131660628|NCT02580305|474043059|FG001|Overall Study|Protocol Violation|9|||
131660629|NCT02580305|474043060|FG002|Overall Study|Protocol Violation|6|||
131660630|NCT02580305|474043058|FG000|Overall Study|Lost to Follow-up|4|||
131660631|NCT02580305|474043059|FG001|Overall Study|Lost to Follow-up|4|||
131660632|NCT02580305|474043060|FG002|Overall Study|Lost to Follow-up|2|||
131660633|NCT02580305|474043058|FG000|Overall Study|Withdrawal by Subject|11|||
131660634|NCT02580305|474043059|FG001|Overall Study|Withdrawal by Subject|9|||
131660635|NCT02580305|474043060|FG002|Overall Study|Withdrawal by Subject|7|||
131660636|NCT02580305|474043058|FG000|Overall Study|Randomized in error and never treated|4|||
131660637|NCT02580305|474043059|FG001|Overall Study|Randomized in error and never treated|8|||
131660638|NCT02580305|474043060|FG002|Overall Study|Randomized in error and never treated|5|||
131660639|NCT00224887|474043061|FG000|Overall Study|Pregnancy|6|||
131660640|NCT00224887|474043062|FG001|Overall Study|Pregnancy|6|||
131660641|NCT03582943|474043067|FG000|Allocated to Groups|Withdrawal by Subject|1|||
131660642|NCT03582943|474043068|FG001|Allocated to Groups|Withdrawal by Subject|1|||
131660643|NCT03582943|474043067|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
131660644|NCT03582943|474043068|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
131660645|NCT03582943|474043067|FG000|Analyzed|Protocol Violation|4|||
131660646|NCT03582943|474043068|FG001|Analyzed|Protocol Violation|1|||
131660647|NCT02071290|474043069|FG000|Overall Study|Death|1|||
131660648|NCT02071290|474043070|FG001|Overall Study|Death|0|||
131660649|NCT02071290|474043069|FG000|Overall Study|Withdrawal by Subject|0|||
131660650|NCT02071290|474043070|FG001|Overall Study|Withdrawal by Subject|1|||
131660651|NCT02071290|474043069|FG000|Overall Study|Protocol Violation|3|||
131660652|NCT02071290|474043070|FG001|Overall Study|Protocol Violation|5|||
131660653|NCT02071290|474043069|FG000|Overall Study|Physician Decision|0|||
131660654|NCT02071290|474043070|FG001|Overall Study|Physician Decision|1|||
131660655|NCT05032872|474043077|FG000|Overall Study|Adverse Event|1|||
131660656|NCT05032872|474043078|FG001|Overall Study|Adverse Event|0|||
131660657|NCT05032872|474043077|FG000|Overall Study|Lost to Follow-up|2|||
131660658|NCT05032872|474043078|FG001|Overall Study|Lost to Follow-up|4|||
131660659|NCT05032872|474043077|FG000|Overall Study|Withdrawal by Subject|4|||
131660660|NCT05032872|474043078|FG001|Overall Study|Withdrawal by Subject|3|||
131660661|NCT05870228|474043079|FG000|Overall Study|Lost to Follow-up|2|||
131660662|NCT05870228|474043080|FG001|Overall Study|Lost to Follow-up|0|||
131660663|NCT05870228|474043079|FG000|Overall Study|Withdrawal by Subject|1|||
131660664|NCT05870228|474043080|FG001|Overall Study|Withdrawal by Subject|0|||
131660665|NCT00488475|474043081|FG000|Overall Study|Other|1754|||
131660666|NCT00798590|474043100|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
131660667|NCT00798590|474043101|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
131660668|NCT01280357|474043104|FG000|Overall Study|Excluded no internal monitoring|14|||
131660669|NCT01280357|474043104|FG000|Overall Study|IInsufficient data/No data supplied|12|||
131660670|NCT01259089|474043105|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131660671|NCT01259089|474043106|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131660672|NCT01259089|474043107|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131660673|NCT01259089|474043108|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131660674|NCT01259089|474043109|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131660675|NCT01259089|474043110|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
131660676|NCT01259089|474043105|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
131660677|NCT01259089|474043106|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
131660678|NCT01259089|474043107|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
131660679|NCT01259089|474043108|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
131660680|NCT01259089|474043109|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
131660681|NCT01259089|474043110|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
131660682|NCT01259089|474043105|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131660683|NCT01259089|474043106|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131660684|NCT01259089|474043107|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131434434|NCT03001557|473217579|FG002|Core Phase|Randomized but not treated|1|||
131660685|NCT01259089|474043108|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131660686|NCT01259089|474043109|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131660687|NCT01259089|474043110|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
131660688|NCT01259089|474043105|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
131660689|NCT01259089|474043106|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
131660690|NCT01259089|474043107|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
131660691|NCT01259089|474043108|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
131660692|NCT01259089|474043109|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
131660693|NCT01259089|474043110|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
131660694|NCT01259089|474043105|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
131660695|NCT01259089|474043106|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
131660696|NCT01259089|474043107|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
131660697|NCT01259089|474043108|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
131660698|NCT01259089|474043109|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
131660699|NCT01259089|474043110|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
131660700|NCT01259089|474043105|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
131660701|NCT01259089|474043106|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131660702|NCT01259089|474043107|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131660703|NCT01259089|474043108|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131660704|NCT01259089|474043109|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131660705|NCT01259089|474043110|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131660706|NCT01259089|474043105|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
131660707|NCT01259089|474043106|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
131660708|NCT01259089|474043107|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
131660709|NCT01259089|474043108|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
131660710|NCT01259089|474043109|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
131660711|NCT01259089|474043110|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
131660712|NCT01259089|474043105|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
131660713|NCT01259089|474043106|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
131660714|NCT01259089|474043107|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
131660715|NCT01259089|474043108|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
131660716|NCT01259089|474043109|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
131660717|NCT01259089|474043110|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
131660718|NCT01259089|474043105|FG000|Survival Follow up for Two Years|Death|3|||
131660719|NCT01259089|474043106|FG001|Survival Follow up for Two Years|Death|2|||
131660720|NCT01259089|474043107|FG002|Survival Follow up for Two Years|Death|2|||
131660721|NCT01259089|474043108|FG003|Survival Follow up for Two Years|Death|3|||
131660722|NCT01259089|474043109|FG004|Survival Follow up for Two Years|Death|6|||
131660723|NCT01259089|474043110|FG005|Survival Follow up for Two Years|Death|13|||
131660724|NCT01259089|474043105|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
131660725|NCT01259089|474043106|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
131660726|NCT01259089|474043107|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
131660727|NCT01259089|474043108|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
131660728|NCT01259089|474043109|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
131660729|NCT01259089|474043110|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
131660730|NCT01259089|474043105|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131660731|NCT01259089|474043106|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131660732|NCT01259089|474043107|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131660733|NCT01259089|474043108|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131660734|NCT01259089|474043109|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131660735|NCT01259089|474043110|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
131660736|NCT00886795|474043115|FG000|Overall Study|Lack of Efficacy|1|||
131660737|NCT02310100|474043116|FG000|Overall Study|Physician Decision|3|||
131660738|NCT02310100|474043116|FG000|Overall Study|Withdrawal by Subject|10|||
131660739|NCT02310100|474043116|FG000|Overall Study|Enrollment closure|1|||
131660740|NCT02310100|474043116|FG000|Overall Study|Unapproved ablation operator|1|||
131660741|NCT02310100|474043116|FG000|Overall Study|Visit compliance|1|||
131660742|NCT02310100|474043116|FG000|Overall Study|Lost to Follow-up|2|||
131660743|NCT00688870|474043119|FG000|Infant Series|Parent or legal guardian request|4|||
131660744|NCT00688870|474043120|FG001|Infant Series|Parent or legal guardian request|0|||
131660745|NCT01769326|474043131|FG000|Overall Study|Lost to Follow-up|1|||
131660746|NCT01769326|474043132|FG001|Overall Study|Lost to Follow-up|2|||
131660747|NCT01769326|474043133|FG002|Overall Study|Lost to Follow-up|0|||
131660748|NCT01769326|474043134|FG003|Overall Study|Lost to Follow-up|0|||
131660749|NCT01769326|474043131|FG000|Overall Study|unrelated injry|1|||
131660750|NCT01769326|474043132|FG001|Overall Study|unrelated injry|1|||
131660751|NCT01769326|474043133|FG002|Overall Study|unrelated injry|0|||
131660752|NCT01769326|474043134|FG003|Overall Study|unrelated injry|0|||
131660753|NCT01769326|474043131|FG000|Overall Study|got a job|0|||
131660754|NCT01769326|474043132|FG001|Overall Study|got a job|1|||
131660755|NCT01769326|474043133|FG002|Overall Study|got a job|0|||
131660756|NCT01769326|474043134|FG003|Overall Study|got a job|0|||
131660757|NCT01769326|474043131|FG000|Overall Study|Got sick and could not complete study|0|||
131660758|NCT01769326|474043132|FG001|Overall Study|Got sick and could not complete study|0|||
131660759|NCT01769326|474043133|FG002|Overall Study|Got sick and could not complete study|1|||
131660760|NCT01769326|474043134|FG003|Overall Study|Got sick and could not complete study|0|||
131660761|NCT01278173|474043135|FG000|Overall Study|Lack of Efficacy|13|||
131660762|NCT01278173|474043135|FG000|Overall Study|Adverse Event|8|||
131660763|NCT01278173|474043135|FG000|Overall Study|Administrative or other reason|4|||
131660764|NCT01278173|474043135|FG000|Overall Study|Protocol Violation|1|||
131660765|NCT01278173|474043135|FG000|Overall Study|Withdrawal by Subject|1|||
131660766|NCT04662931|474043137|FG000|Overall Study|Withdrawal by Subject|17|||
131660767|NCT04662931|474043137|FG000|Overall Study|Death|3|||
131660768|NCT04662931|474043137|FG000|Overall Study|Lost to Follow-up|3|||
131660769|NCT04662931|474043137|FG000|Overall Study|Guardian Decision|1|||
131660770|NCT01397422|474043139|FG000|Overall Study|Adverse Event|0|||
131660771|NCT01397422|474043140|FG001|Overall Study|Adverse Event|3|||
131660772|NCT01397422|474043141|FG002|Overall Study|Adverse Event|3|||
131660773|NCT01397422|474043142|FG003|Overall Study|Adverse Event|8|||
131660774|NCT01397422|474043139|FG000|Overall Study|Withdrawal by Subject|1|||
131660775|NCT01397422|474043140|FG001|Overall Study|Withdrawal by Subject|0|||
131660776|NCT01397422|474043141|FG002|Overall Study|Withdrawal by Subject|0|||
131660777|NCT01397422|474043142|FG003|Overall Study|Withdrawal by Subject|0|||
131660778|NCT01397422|474043139|FG000|Overall Study|Increased bradykinesia related to PD|1|||
131660779|NCT01397422|474043140|FG001|Overall Study|Increased bradykinesia related to PD|0|||
131660780|NCT01397422|474043141|FG002|Overall Study|Increased bradykinesia related to PD|0|||
131660781|NCT01397422|474043142|FG003|Overall Study|Increased bradykinesia related to PD|0|||
131660782|NCT05051462|474043143|FG000|Overall Study|Lost to Follow-up|1|||
131660783|NCT05051462|474043144|FG001|Overall Study|Lost to Follow-up|8|||
131660784|NCT05051462|474043143|FG000|Overall Study|Withdrawal by Subject|1|||
131660785|NCT05051462|474043144|FG001|Overall Study|Withdrawal by Subject|0|||
131660786|NCT05051462|474043143|FG000|Overall Study|Protocol Violation|0|||
131660787|NCT05051462|474043144|FG001|Overall Study|Protocol Violation|2|||
131660788|NCT05148962|474043145|FG000|Overall Study|Withdrawal by Subject|1|||
131660789|NCT05148962|474043146|FG001|Overall Study|Withdrawal by Subject|1|||
131660790|NCT05148962|474043147|FG002|Overall Study|Withdrawal by Subject|0|||
131660791|NCT05148962|474043148|FG003|Overall Study|Withdrawal by Subject|1|||
131660792|NCT05148962|474043149|FG004|Overall Study|Withdrawal by Subject|0|||
131660793|NCT05148962|474043145|FG000|Overall Study|Participant was early terminated per protocol|0|||
131660794|NCT05148962|474043146|FG001|Overall Study|Participant was early terminated per protocol|0|||
131660795|NCT05148962|474043147|FG002|Overall Study|Participant was early terminated per protocol|3|||
131660796|NCT05148962|474043148|FG003|Overall Study|Participant was early terminated per protocol|5|||
131660797|NCT05148962|474043149|FG004|Overall Study|Participant was early terminated per protocol|2|||
131660798|NCT05148962|474043145|FG000|Overall Study|Miscellaneous|0|||
131660799|NCT05148962|474043146|FG001|Overall Study|Miscellaneous|0|||
131660800|NCT05148962|474043147|FG002|Overall Study|Miscellaneous|0|||
131660801|NCT05148962|474043148|FG003|Overall Study|Miscellaneous|1|||
131660802|NCT05148962|474043149|FG004|Overall Study|Miscellaneous|0|||
131660803|NCT01200290|474043150|FG000|Treatment Period|Adverse Event|1|||
131660804|NCT01200290|474043150|FG000|Post-Treatment Follow-Up Period|Death|2|||
131660805|NCT01144377|474043151|FG000|52 Week Treatment Period|Adverse Event|0|||
131660806|NCT01144377|474043152|FG001|52 Week Treatment Period|Adverse Event|0|||
131660807|NCT01144377|474043153|FG002|52 Week Treatment Period|Adverse Event|3|||
131660808|NCT01144377|474043154|FG003|52 Week Treatment Period|Adverse Event|2|||
131660809|NCT01144377|474043155|FG004|52 Week Treatment Period|Adverse Event|1|||
131660810|NCT01144377|474043151|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
131660811|NCT01144377|474043152|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
131660812|NCT01144377|474043153|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
131660813|NCT01144377|474043154|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
131660814|NCT01144377|474043155|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
131660815|NCT01144377|474043151|FG000|52 Week Treatment Period|Protocol Violation|0|||
131660816|NCT01144377|474043152|FG001|52 Week Treatment Period|Protocol Violation|0|||
131660817|NCT01144377|474043153|FG002|52 Week Treatment Period|Protocol Violation|0|||
131660818|NCT01144377|474043154|FG003|52 Week Treatment Period|Protocol Violation|0|||
131660819|NCT01144377|474043155|FG004|52 Week Treatment Period|Protocol Violation|1|||
131660820|NCT01144377|474043151|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
131660821|NCT01144377|474043152|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
131660822|NCT01144377|474043153|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
131660823|NCT01144377|474043154|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
131660824|NCT01144377|474043155|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
131660825|NCT01144377|474043151|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
131660826|NCT01144377|474043152|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
131887685|NCT01313221|474872250|FG002|Overall Study|Protocol Violation|1|||
131434435|NCT03001557|473217580|FG003|Core Phase|Randomized but not treated|0|||
131548411|NCT00261495|473631615|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131548412|NCT01059630|473631621|FG000|Overall Study|Death|100|||
131548413|NCT01059630|473631622|FG001|Overall Study|Death|84|||
131548414|NCT01059630|473631621|FG000|Overall Study|Lost to Follow-up|4|||
131548415|NCT01059630|473631622|FG001|Overall Study|Lost to Follow-up|1|||
131548416|NCT01059630|473631621|FG000|Overall Study|Physician Decision|2|||
131548417|NCT01059630|473631622|FG001|Overall Study|Physician Decision|4|||
131548418|NCT01059630|473631621|FG000|Overall Study|Withdrawal by Subject|21|||
131548419|NCT01059630|473631622|FG001|Overall Study|Withdrawal by Subject|14|||
131548420|NCT01376323|473631624|FG000|Overall Study|Adverse Event|1|||
131548421|NCT01376323|473631625|FG001|Overall Study|Adverse Event|0|||
131548422|NCT01376323|473631626|FG002|Overall Study|Adverse Event|0|||
131548423|NCT01376323|473631627|FG003|Overall Study|Adverse Event|2|||
131548424|NCT01376323|473631628|FG004|Overall Study|Adverse Event|0|||
131548425|NCT01376323|473631624|FG000|Overall Study|Lost to Follow-up|0|||
131548426|NCT01376323|473631625|FG001|Overall Study|Lost to Follow-up|0|||
131548427|NCT01376323|473631626|FG002|Overall Study|Lost to Follow-up|0|||
131548428|NCT01376323|473631627|FG003|Overall Study|Lost to Follow-up|2|||
131548429|NCT01376323|473631628|FG004|Overall Study|Lost to Follow-up|0|||
131548430|NCT01376323|473631624|FG000|Overall Study|Physician Decision|1|||
131548431|NCT01376323|473631625|FG001|Overall Study|Physician Decision|0|||
131548432|NCT01376323|473631626|FG002|Overall Study|Physician Decision|2|||
131548433|NCT01376323|473631627|FG003|Overall Study|Physician Decision|1|||
131548434|NCT01376323|473631628|FG004|Overall Study|Physician Decision|1|||
131548435|NCT01376323|473631624|FG000|Overall Study|Withdrawal by Subject|0|||
131548436|NCT01376323|473631625|FG001|Overall Study|Withdrawal by Subject|1|||
131548437|NCT01376323|473631626|FG002|Overall Study|Withdrawal by Subject|1|||
131548438|NCT01376323|473631627|FG003|Overall Study|Withdrawal by Subject|0|||
131548439|NCT01376323|473631628|FG004|Overall Study|Withdrawal by Subject|0|||
131548440|NCT04681729|473631629|FG000|Overall Study|Lack of Efficacy|2|||
131548441|NCT04681729|473631630|FG001|Overall Study|Lack of Efficacy|2|||
131548442|NCT04681729|473631629|FG000|Overall Study|Withdrawal by Subject|8|||
131548443|NCT04681729|473631630|FG001|Overall Study|Withdrawal by Subject|9|||
131548444|NCT01281202|473631631|FG000|Overall Study|Adverse Event|2|||
131548445|NCT01281202|473631632|FG001|Overall Study|Adverse Event|0|||
131548446|NCT01281202|473631631|FG000|Overall Study|Withdrawal by Subject|2|||
131548447|NCT01281202|473631632|FG001|Overall Study|Withdrawal by Subject|2|||
131548448|NCT01281202|473631631|FG000|Overall Study|Protocol Violation|11|||
131548449|NCT01281202|473631632|FG001|Overall Study|Protocol Violation|10|||
131548450|NCT01281202|473631631|FG000|Overall Study|Administrative|2|||
131548451|NCT01281202|473631632|FG001|Overall Study|Administrative|8|||
131548452|NCT01281202|473631631|FG000|Overall Study|Lost to Follow-up|11|||
131548453|NCT01281202|473631632|FG001|Overall Study|Lost to Follow-up|13|||
131548454|NCT01281202|473631631|FG000|Overall Study|Incarceration|0|||
131548455|NCT01281202|473631632|FG001|Overall Study|Incarceration|3|||
131548456|NCT04270747|473631639|FG000|Through Week 16|Adverse Event|1|||
131548457|NCT04270747|473631640|FG001|Through Week 16|Adverse Event|2|||
131548458|NCT04270747|473631641|FG002|Through Week 16|Adverse Event|0|||
131548459|NCT04270747|473631639|FG000|Through Week 16|Death|0|||
131548460|NCT04270747|473631640|FG001|Through Week 16|Death|2|||
131548461|NCT04270747|473631641|FG002|Through Week 16|Death|0|||
131548462|NCT04270747|473631639|FG000|Through Week 16|Consent Withdrawn|3|||
131548463|NCT04270747|473631640|FG001|Through Week 16|Consent Withdrawn|3|||
131548464|NCT04270747|473631641|FG002|Through Week 16|Consent Withdrawn|0|||
131548465|NCT04270747|473631639|FG000|Through Week 16|Physician Decision|1|||
131548466|NCT04270747|473631640|FG001|Through Week 16|Physician Decision|1|||
131548467|NCT04270747|473631641|FG002|Through Week 16|Physician Decision|0|||
131548468|NCT04270747|473631639|FG000|Through Week 16|Lost to Follow-up|2|||
131548469|NCT04270747|473631640|FG001|Through Week 16|Lost to Follow-up|0|||
131548470|NCT04270747|473631641|FG002|Through Week 16|Lost to Follow-up|0|||
131548471|NCT04270747|473631639|FG000|Through Week 16|Protocol Violation|1|||
131548472|NCT04270747|473631640|FG001|Through Week 16|Protocol Violation|2|||
131548473|NCT04270747|473631641|FG002|Through Week 16|Protocol Violation|0|||
131548474|NCT04270747|473631639|FG000|Through Week 16|Protocol Specified Criteria|6|||
131548475|NCT04270747|473631640|FG001|Through Week 16|Protocol Specified Criteria|7|||
131548476|NCT04270747|473631641|FG002|Through Week 16|Protocol Specified Criteria|0|||
131548477|NCT04270747|473631639|FG000|Through Week 16|Miscellaneous|1|||
131548478|NCT04270747|473631640|FG001|Through Week 16|Miscellaneous|1|||
131548479|NCT04270747|473631641|FG002|Through Week 16|Miscellaneous|0|||
131548480|NCT04270747|473631639|FG000|Post Week 16|Adverse Event|7|||
131548481|NCT04270747|473631640|FG001|Post Week 16|Adverse Event|5|||
131548482|NCT04270747|473631641|FG002|Post Week 16|Adverse Event|1|||
131548483|NCT04270747|473631639|FG000|Post Week 16|Death|2|||
131548484|NCT04270747|473631640|FG001|Post Week 16|Death|0|||
131548485|NCT04270747|473631641|FG002|Post Week 16|Death|2|||
131548486|NCT04270747|473631639|FG000|Post Week 16|Consent Withdrawn|4|||
131548487|NCT04270747|473631640|FG001|Post Week 16|Consent Withdrawn|3|||
131548488|NCT04270747|473631641|FG002|Post Week 16|Consent Withdrawn|6|||
131548489|NCT04270747|473631639|FG000|Post Week 16|Physician Decision|3|||
131660827|NCT01144377|474043153|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
131660828|NCT01144377|474043154|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
131660829|NCT01144377|474043155|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
131660830|NCT01144377|474043151|FG000|52 Week Treatment Period|Sponsor Decision|0|||
131660831|NCT01144377|474043152|FG001|52 Week Treatment Period|Sponsor Decision|0|||
131660832|NCT01144377|474043153|FG002|52 Week Treatment Period|Sponsor Decision|0|||
131660833|NCT01144377|474043154|FG003|52 Week Treatment Period|Sponsor Decision|0|||
131660834|NCT01144377|474043155|FG004|52 Week Treatment Period|Sponsor Decision|1|||
131660835|NCT01144377|474043151|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
131660836|NCT01144377|474043152|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
131660837|NCT01144377|474043153|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
131660838|NCT01144377|474043154|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
131660839|NCT01144377|474043155|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
131660840|NCT01144377|474043151|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131660841|NCT01144377|474043152|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131660842|NCT01144377|474043153|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131660843|NCT01144377|474043154|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131660844|NCT01144377|474043155|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
131660845|NCT01144377|474043151|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
131660846|NCT01144377|474043152|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131660847|NCT01144377|474043153|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131660848|NCT01144377|474043154|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131660849|NCT01144377|474043155|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131660850|NCT00151281|474043156|FG000|Overall Study|Not evaluable|3|||
131660851|NCT04150068|474043157|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
131660852|NCT04150068|474043158|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
131660853|NCT04150068|474043159|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
131660854|NCT04150068|474043157|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
131660855|NCT04150068|474043158|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
131660856|NCT04150068|474043159|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
131660857|NCT00836745|474044540|FG000|Overall Study|Death|2|||
131660858|NCT00836745|474044540|FG000|Overall Study|Lost to Follow-up|10|||
131660859|NCT00836745|474044540|FG000|Overall Study|Adverse Event|3|||
131660860|NCT00836745|474044540|FG000|Overall Study|Objective progression or relapse|4|||
131660861|NCT00836745|474044540|FG000|Overall Study|Other|2|||
131660862|NCT02898077|474044542|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
131660863|NCT02898077|474044543|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
131660864|NCT02898077|474044542|FG000|Overall Study|Lost to Follow-up|4|||
131660865|NCT02898077|474044543|FG001|Overall Study|Lost to Follow-up|3|||
131660866|NCT02898077|474044542|FG000|Overall Study|Physician Decision|0|||
131660867|NCT02898077|474044543|FG001|Overall Study|Physician Decision|2|||
131660868|NCT02898077|474044542|FG000|Overall Study|Sponsor Decision|32|||
131660869|NCT02898077|474044543|FG001|Overall Study|Sponsor Decision|13|||
131660870|NCT02898077|474044542|FG000|Overall Study|Withdrawal by Subject|6|||
131660871|NCT02898077|474044543|FG001|Overall Study|Withdrawal by Subject|3|||
131660872|NCT02898077|474044542|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
131660873|NCT02898077|474044543|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
131660874|NCT02898077|474044542|FG000|Overall Study|Ended extension period|3|||
131660875|NCT02898077|474044543|FG001|Overall Study|Ended extension period|0|||
131660876|NCT00621777|474044544|FG000|Open Phase|Adverse Event|20|||
131660877|NCT00621777|474044545|FG001|Open Phase|Adverse Event|0|||
131660878|NCT00621777|474044544|FG000|Open Phase|Did not abstain during open phase|56|||
131660879|NCT00621777|474044545|FG001|Open Phase|Did not abstain during open phase|0|||
131660880|NCT00621777|474044544|FG000|Open Phase|Withdrawal by Subject|17|||
131660881|NCT00621777|474044545|FG001|Open Phase|Withdrawal by Subject|0|||
131660882|NCT00621777|474044544|FG000|Open Phase|administrative|13|||
131660883|NCT00621777|474044545|FG001|Open Phase|administrative|0|||
131660884|NCT00621777|474044544|FG000|Open Phase|Lost to Follow-up|10|||
131660885|NCT00621777|474044545|FG001|Open Phase|Lost to Follow-up|0|||
131660886|NCT00621777|474044544|FG000|Randomized Phase|Adverse Event|3|||
131660887|NCT00621777|474044545|FG001|Randomized Phase|Adverse Event|3|||
131660888|NCT00621777|474044544|FG000|Randomized Phase|Lost to Follow-up|3|||
131660889|NCT00621777|474044545|FG001|Randomized Phase|Lost to Follow-up|3|||
131660890|NCT00621777|474044544|FG000|Randomized Phase|Withdrawal by Subject|1|||
131660891|NCT00621777|474044545|FG001|Randomized Phase|Withdrawal by Subject|9|||
131660892|NCT00621777|474044544|FG000|Randomized Phase|administrative|0|||
131660893|NCT00621777|474044545|FG001|Randomized Phase|administrative|3|||
131660894|NCT00621777|474044544|FG000|Randomized Phase|Death|0|||
131660895|NCT00621777|474044545|FG001|Randomized Phase|Death|1|||
131660896|NCT00490490|474044546|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
131660897|NCT00490490|474044546|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
131660898|NCT01239043|474044547|FG000|Overall Study|Protocol Violation|2|||
131660899|NCT01239043|474044548|FG001|Overall Study|Protocol Violation|1|||
131660900|NCT02121301|474044551|FG000|Overall Study|Protocol Violation|1|||
131660901|NCT02121301|474044552|FG001|Overall Study|Protocol Violation|4|||
131660902|NCT02121301|474044553|FG002|Overall Study|Protocol Violation|1|||
131660903|NCT00473265|474044554|FG000|Overall Study|Unrelated adverse event|5|||
131660904|NCT00473265|474044554|FG000|Overall Study|Off treatment early|15|||
131660905|NCT02663518|474044562|FG000|Part 1: Phase 1a Escalation|Death|0|||
131660906|NCT02663518|474044563|FG001|Part 1: Phase 1a Escalation|Death|0|||
131660907|NCT02663518|474044564|FG002|Part 1: Phase 1a Escalation|Death|1|||
131660908|NCT02663518|474044565|FG003|Part 1: Phase 1a Escalation|Death|0|||
131660909|NCT02663518|474044566|FG004|Part 1: Phase 1a Escalation|Death|0|||
131660910|NCT02663518|474044567|FG005|Part 1: Phase 1a Escalation|Death|0|||
131660911|NCT02663518|474044568|FG006|Part 1: Phase 1a Escalation|Death|0|||
131660912|NCT02663518|474044569|FG007|Part 1: Phase 1a Escalation|Death|0|||
131660913|NCT02663518|474044570|FG008|Part 1: Phase 1a Escalation|Death|0|||
131660914|NCT02663518|474044571|FG009|Part 1: Phase 1a Escalation|Death|0|||
131660915|NCT02663518|474044572|FG010|Part 1: Phase 1a Escalation|Death|0|||
131660916|NCT02663518|474044573|FG011|Part 1: Phase 1a Escalation|Death|0|||
131660917|NCT02663518|474044574|FG012|Part 1: Phase 1a Escalation|Death|0|||
131660918|NCT02663518|474044575|FG013|Part 1: Phase 1a Escalation|Death|0|||
131660919|NCT02663518|474044562|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660920|NCT02663518|474044563|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660921|NCT02663518|474044564|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
131660922|NCT02663518|474044565|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660923|NCT02663518|474044566|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660924|NCT02663518|474044567|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660925|NCT02663518|474044568|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660926|NCT02663518|474044569|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660927|NCT02663518|474044570|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660928|NCT02663518|474044571|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660929|NCT02663518|474044572|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660930|NCT02663518|474044573|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660931|NCT02663518|474044574|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660932|NCT02663518|474044575|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131660933|NCT02663518|474044562|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
131660934|NCT02663518|474044563|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
131660935|NCT02663518|474044564|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
131660936|NCT02663518|474044565|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
131887686|NCT01313221|474872248|FG000|Overall Study|Non-compliance|3|||
131887687|NCT01313221|474872249|FG001|Overall Study|Non-compliance|0|||
131887688|NCT01313221|474872250|FG002|Overall Study|Non-compliance|2|||
131887689|NCT01313221|474872248|FG000|Overall Study|Withdrawal by Subject|2|||
131887690|NCT01313221|474872249|FG001|Overall Study|Withdrawal by Subject|3|||
131887691|NCT01313221|474872250|FG002|Overall Study|Withdrawal by Subject|5|||
131887692|NCT01313221|474872248|FG000|Overall Study|Requirement for alternative therapy|0|||
131887693|NCT01313221|474872249|FG001|Overall Study|Requirement for alternative therapy|1|||
131887694|NCT01313221|474872250|FG002|Overall Study|Requirement for alternative therapy|1|||
131887695|NCT01313221|474872248|FG000|Overall Study|Lost to Follow-up|6|||
131887696|NCT01313221|474872249|FG001|Overall Study|Lost to Follow-up|3|||
131887697|NCT01313221|474872250|FG002|Overall Study|Lost to Follow-up|1|||
131887698|NCT01313221|474872248|FG000|Overall Study|Other|1|||
131887699|NCT01313221|474872249|FG001|Overall Study|Other|0|||
131887700|NCT01313221|474872250|FG002|Overall Study|Other|0|||
131887701|NCT01313221|474872248|FG000|Overall Study|Adverse Event|0|||
131887702|NCT01313221|474872249|FG001|Overall Study|Adverse Event|0|||
131887703|NCT01313221|474872250|FG002|Overall Study|Adverse Event|7|||
131887704|NCT01313221|474872248|FG000|Overall Study|Disease progression|0|||
131887705|NCT01313221|474872249|FG001|Overall Study|Disease progression|0|||
131887706|NCT01313221|474872250|FG002|Overall Study|Disease progression|2|||
131887707|NCT01313221|474872248|FG000|Overall Study|Physician Decision|0|||
131887708|NCT01313221|474872249|FG001|Overall Study|Physician Decision|0|||
131887709|NCT01313221|474872250|FG002|Overall Study|Physician Decision|2|||
131887710|NCT01313221|474872248|FG000|Overall Study|Pregnancy|0|||
131887711|NCT01313221|474872249|FG001|Overall Study|Pregnancy|0|||
131887712|NCT01313221|474872250|FG002|Overall Study|Pregnancy|2|||
131887713|NCT00994214|474872251|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
131887714|NCT00994214|474872252|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
131887715|NCT00994214|474872253|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
131887716|NCT00994214|474872254|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
131887717|NCT00994214|474872251|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
131887718|NCT00994214|474872252|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
131887719|NCT00994214|474872253|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
131434436|NCT03001557|473217581|FG004|Core Phase|Randomized but not treated|0|||
131660937|NCT02663518|474044566|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660938|NCT02663518|474044567|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660939|NCT02663518|474044568|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131887720|NCT00994214|474872254|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
131887721|NCT00994214|474872251|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
131887722|NCT00994214|474872252|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
131887723|NCT00994214|474872253|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
131887724|NCT00994214|474872254|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
131887725|NCT00994214|474872251|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
131660940|NCT02663518|474044569|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660941|NCT02663518|474044570|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660942|NCT02663518|474044571|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660943|NCT02663518|474044572|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660944|NCT02663518|474044573|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660945|NCT02663518|474044574|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660946|NCT02663518|474044575|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131660947|NCT02663518|474044562|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
131660948|NCT02663518|474044563|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660949|NCT02663518|474044564|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
131660950|NCT02663518|474044565|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
131660951|NCT02663518|474044566|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660952|NCT02663518|474044567|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660953|NCT02663518|474044568|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660954|NCT02663518|474044569|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660955|NCT02663518|474044570|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660956|NCT02663518|474044571|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660957|NCT02663518|474044572|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660958|NCT02663518|474044573|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660959|NCT02663518|474044574|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660960|NCT02663518|474044575|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131660961|NCT02663518|474044562|FG000|Part 1: Phase 1a Escalation|Other|0|||
131660962|NCT02663518|474044563|FG001|Part 1: Phase 1a Escalation|Other|0|||
131660963|NCT02663518|474044564|FG002|Part 1: Phase 1a Escalation|Other|2|||
131660964|NCT02663518|474044565|FG003|Part 1: Phase 1a Escalation|Other|0|||
131660965|NCT02663518|474044566|FG004|Part 1: Phase 1a Escalation|Other|0|||
131660966|NCT02663518|474044567|FG005|Part 1: Phase 1a Escalation|Other|0|||
131660967|NCT02663518|474044568|FG006|Part 1: Phase 1a Escalation|Other|0|||
131660968|NCT02663518|474044569|FG007|Part 1: Phase 1a Escalation|Other|0|||
131660969|NCT02663518|474044570|FG008|Part 1: Phase 1a Escalation|Other|0|||
131660970|NCT02663518|474044571|FG009|Part 1: Phase 1a Escalation|Other|0|||
131660971|NCT02663518|474044572|FG010|Part 1: Phase 1a Escalation|Other|0|||
131660972|NCT02663518|474044573|FG011|Part 1: Phase 1a Escalation|Other|0|||
131660973|NCT02663518|474044574|FG012|Part 1: Phase 1a Escalation|Other|0|||
131660974|NCT02663518|474044575|FG013|Part 1: Phase 1a Escalation|Other|0|||
131660975|NCT02663518|474044562|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660976|NCT02663518|474044563|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660977|NCT02663518|474044564|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660978|NCT02663518|474044565|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660979|NCT02663518|474044566|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
131660980|NCT02663518|474044567|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660981|NCT02663518|474044568|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
131660982|NCT02663518|474044569|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
131660983|NCT02663518|474044570|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660984|NCT02663518|474044571|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660985|NCT02663518|474044572|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660986|NCT02663518|474044573|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660987|NCT02663518|474044574|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660988|NCT02663518|474044575|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
131660989|NCT02663518|474044562|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660990|NCT02663518|474044563|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660991|NCT02663518|474044564|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660992|NCT02663518|474044565|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660993|NCT02663518|474044566|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
131660994|NCT02663518|474044567|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660995|NCT02663518|474044568|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
131660996|NCT02663518|474044569|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
131660997|NCT02663518|474044570|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660998|NCT02663518|474044571|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131660999|NCT02663518|474044572|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131661000|NCT02663518|474044573|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131661001|NCT02663518|474044574|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131661002|NCT02663518|474044575|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131661003|NCT02663518|474044562|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131887726|NCT00994214|474872252|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
131661004|NCT02663518|474044563|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661005|NCT02663518|474044564|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661006|NCT02663518|474044565|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661007|NCT02663518|474044566|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
131661008|NCT02663518|474044567|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661009|NCT02663518|474044568|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661010|NCT02663518|474044569|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661011|NCT02663518|474044570|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661012|NCT02663518|474044571|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661013|NCT02663518|474044572|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661014|NCT02663518|474044573|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661015|NCT02663518|474044574|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661016|NCT02663518|474044575|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131661017|NCT02663518|474044562|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661018|NCT02663518|474044563|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661019|NCT02663518|474044564|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661020|NCT02663518|474044565|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661021|NCT02663518|474044566|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
131661022|NCT02663518|474044567|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
131661023|NCT02663518|474044568|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
131661024|NCT02663518|474044569|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
131661025|NCT02663518|474044570|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661026|NCT02663518|474044571|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661027|NCT02663518|474044572|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661028|NCT02663518|474044573|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661029|NCT02663518|474044574|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661030|NCT02663518|474044575|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131661031|NCT02663518|474044562|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661032|NCT02663518|474044563|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661033|NCT02663518|474044564|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661034|NCT02663518|474044565|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661035|NCT02663518|474044566|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
131661036|NCT02663518|474044567|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661037|NCT02663518|474044568|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
131661038|NCT02663518|474044569|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661039|NCT02663518|474044570|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661040|NCT02663518|474044571|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661041|NCT02663518|474044572|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661042|NCT02663518|474044573|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661043|NCT02663518|474044574|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661044|NCT02663518|474044575|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
131661045|NCT02663518|474044562|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661046|NCT02663518|474044563|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661047|NCT02663518|474044564|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661048|NCT02663518|474044565|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661049|NCT02663518|474044566|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661050|NCT02663518|474044567|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661051|NCT02663518|474044568|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
131661052|NCT02663518|474044569|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661053|NCT02663518|474044570|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661054|NCT02663518|474044571|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661055|NCT02663518|474044572|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661056|NCT02663518|474044573|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661057|NCT02663518|474044574|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661058|NCT02663518|474044575|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131661059|NCT02663518|474044562|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
131661060|NCT02663518|474044563|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
131661061|NCT02663518|474044564|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
131661062|NCT02663518|474044565|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
131661063|NCT02663518|474044566|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
131661064|NCT02663518|474044567|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
131661065|NCT02663518|474044568|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
131661066|NCT02663518|474044569|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
131661067|NCT02663518|474044570|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
131661068|NCT02663518|474044571|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
131661069|NCT02663518|474044572|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
131661070|NCT02663518|474044573|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
131661071|NCT02663518|474044574|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
131661072|NCT02663518|474044575|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
131661073|NCT02663518|474044562|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661074|NCT02663518|474044563|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661075|NCT02663518|474044564|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661076|NCT02663518|474044565|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661077|NCT02663518|474044566|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661078|NCT02663518|474044567|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661079|NCT02663518|474044568|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661080|NCT02663518|474044569|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661081|NCT02663518|474044570|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661082|NCT02663518|474044571|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661083|NCT02663518|474044572|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661084|NCT02663518|474044573|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661085|NCT02663518|474044574|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
131661086|NCT02663518|474044575|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131661087|NCT02663518|474044562|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661088|NCT02663518|474044563|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661089|NCT02663518|474044564|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661090|NCT02663518|474044565|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661091|NCT02663518|474044566|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661092|NCT02663518|474044567|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661093|NCT02663518|474044568|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661094|NCT02663518|474044569|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661095|NCT02663518|474044570|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661096|NCT02663518|474044571|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661097|NCT02663518|474044572|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661098|NCT02663518|474044573|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
131661099|NCT02663518|474044574|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661100|NCT02663518|474044575|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131661101|NCT02663518|474044562|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661102|NCT02663518|474044563|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661103|NCT02663518|474044564|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661104|NCT02663518|474044565|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661105|NCT02663518|474044566|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661106|NCT02663518|474044567|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661107|NCT02663518|474044568|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661108|NCT02663518|474044569|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661109|NCT02663518|474044570|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661110|NCT02663518|474044571|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
131661111|NCT02663518|474044572|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131661112|NCT02663518|474044573|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
131661113|NCT02663518|474044574|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
131661114|NCT02663518|474044575|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
131661115|NCT02663518|474044562|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
131661116|NCT02663518|474044563|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
131661117|NCT02663518|474044564|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
131661118|NCT02663518|474044565|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
131661119|NCT02663518|474044566|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
131661120|NCT02663518|474044567|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
131661121|NCT02663518|474044568|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
131661122|NCT02663518|474044569|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
131661123|NCT02663518|474044570|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
131661124|NCT02663518|474044571|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
131661125|NCT02663518|474044572|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
131661126|NCT02663518|474044573|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
131661127|NCT02663518|474044574|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
131661128|NCT02663518|474044575|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
131661129|NCT02663518|474044562|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661130|NCT02663518|474044563|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661131|NCT02663518|474044564|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661132|NCT02663518|474044565|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661133|NCT02663518|474044566|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661134|NCT02663518|474044567|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661135|NCT02663518|474044568|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131887727|NCT00994214|474872253|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
131548490|NCT04270747|473631640|FG001|Post Week 16|Physician Decision|1|||
131661136|NCT02663518|474044569|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661137|NCT02663518|474044570|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661138|NCT02663518|474044571|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661139|NCT02663518|474044572|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661140|NCT02663518|474044573|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661141|NCT02663518|474044574|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
131661142|NCT02663518|474044575|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131661143|NCT03896152|474044581|FG000|Overall Study|Patient/guardian decision|1|||
131661144|NCT03896152|474044582|FG001|Overall Study|Patient/guardian decision|1|||
131661145|NCT03896152|474044581|FG000|Overall Study|Adverse Event|0|||
131661146|NCT03896152|474044582|FG001|Overall Study|Adverse Event|1|||
131661147|NCT03896152|474044581|FG000|Overall Study|Physician Decision|1|||
131661148|NCT03896152|474044582|FG001|Overall Study|Physician Decision|0|||
131661149|NCT03896152|474044581|FG000|Overall Study|Technical problems|1|||
131661150|NCT03896152|474044582|FG001|Overall Study|Technical problems|0|||
131661151|NCT00436852|474044583|FG000|Overall Study|Death|23|||
131661152|NCT00436852|474044584|FG001|Overall Study|Death|34|||
131661153|NCT00436852|474044583|FG000|Overall Study|Lack of Efficacy|9|||
131661154|NCT00436852|474044584|FG001|Overall Study|Lack of Efficacy|7|||
131661155|NCT00436852|474044583|FG000|Overall Study|Withdrawal by Subject|2|||
131661156|NCT00436852|474044584|FG001|Overall Study|Withdrawal by Subject|4|||
131661157|NCT00436852|474044583|FG000|Overall Study|Ineligible|1|||
131661158|NCT00436852|474044584|FG001|Overall Study|Ineligible|0|||
131661159|NCT00943852|474044585|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661160|NCT00943852|474044586|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661161|NCT00943852|474044587|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661162|NCT00943852|474044588|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
131434437|NCT03001557|473217582|FG005|Core Phase|Randomized but not treated|0|||
131434438|NCT03001557|473217583|FG006|Core Phase|Randomized but not treated|0|||
131434439|NCT03001557|473217584|FG007|Core Phase|Randomized but not treated|0|||
131434440|NCT03001557|473217577|FG000|Extension Phase|Adverse Event|0|||
131434441|NCT03001557|473217578|FG001|Extension Phase|Adverse Event|0|||
131434442|NCT03001557|473217579|FG002|Extension Phase|Adverse Event|0|||
131434443|NCT03001557|473217580|FG003|Extension Phase|Adverse Event|0|||
131434444|NCT03001557|473217581|FG004|Extension Phase|Adverse Event|0|||
131434445|NCT03001557|473217582|FG005|Extension Phase|Adverse Event|2|||
131434446|NCT03001557|473217583|FG006|Extension Phase|Adverse Event|0|||
131434447|NCT03001557|473217584|FG007|Extension Phase|Adverse Event|0|||
131434448|NCT03001557|473217577|FG000|Extension Phase|Withdrawal by Subject|0|||
131434449|NCT03001557|473217578|FG001|Extension Phase|Withdrawal by Subject|0|||
131434450|NCT03001557|473217579|FG002|Extension Phase|Withdrawal by Subject|0|||
131434451|NCT03001557|473217580|FG003|Extension Phase|Withdrawal by Subject|0|||
131434452|NCT03001557|473217581|FG004|Extension Phase|Withdrawal by Subject|0|||
131434453|NCT03001557|473217582|FG005|Extension Phase|Withdrawal by Subject|1|||
131434454|NCT03001557|473217583|FG006|Extension Phase|Withdrawal by Subject|5|||
131434455|NCT03001557|473217584|FG007|Extension Phase|Withdrawal by Subject|2|||
131434456|NCT03001557|473217577|FG000|Extension Phase|Lost to Follow-up|0|||
131434457|NCT03001557|473217578|FG001|Extension Phase|Lost to Follow-up|0|||
131434458|NCT03001557|473217579|FG002|Extension Phase|Lost to Follow-up|0|||
131434459|NCT03001557|473217580|FG003|Extension Phase|Lost to Follow-up|0|||
131434460|NCT03001557|473217581|FG004|Extension Phase|Lost to Follow-up|0|||
131434461|NCT03001557|473217582|FG005|Extension Phase|Lost to Follow-up|0|||
131434462|NCT03001557|473217583|FG006|Extension Phase|Lost to Follow-up|2|||
131434463|NCT03001557|473217584|FG007|Extension Phase|Lost to Follow-up|1|||
131434464|NCT03001557|473217577|FG000|Extension Phase|Administrative Reason|0|||
131434465|NCT03001557|473217578|FG001|Extension Phase|Administrative Reason|0|||
131434466|NCT03001557|473217579|FG002|Extension Phase|Administrative Reason|0|||
131434467|NCT03001557|473217580|FG003|Extension Phase|Administrative Reason|0|||
131434468|NCT03001557|473217581|FG004|Extension Phase|Administrative Reason|0|||
131434469|NCT03001557|473217582|FG005|Extension Phase|Administrative Reason|1|||
131434470|NCT03001557|473217583|FG006|Extension Phase|Administrative Reason|3|||
131434471|NCT03001557|473217584|FG007|Extension Phase|Administrative Reason|3|||
131434472|NCT03001557|473217577|FG000|Extension Phase|Loss of caregiver|0|||
131548491|NCT04270747|473631641|FG002|Post Week 16|Physician Decision|1|||
131548492|NCT04270747|473631639|FG000|Post Week 16|Lost to Follow-up|2|||
131434473|NCT03001557|473217578|FG001|Extension Phase|Loss of caregiver|0|||
131434474|NCT03001557|473217579|FG002|Extension Phase|Loss of caregiver|0|||
131548493|NCT04270747|473631640|FG001|Post Week 16|Lost to Follow-up|1|||
131434475|NCT03001557|473217580|FG003|Extension Phase|Loss of caregiver|0|||
131434476|NCT03001557|473217581|FG004|Extension Phase|Loss of caregiver|0|||
131661163|NCT00943852|474044589|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661164|NCT00943852|474044590|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661165|NCT00943852|474044591|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661166|NCT00943852|474044592|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661167|NCT00943852|474044593|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661168|NCT00943852|474044594|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131661169|NCT00943852|474044585|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661170|NCT00943852|474044586|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661171|NCT00943852|474044587|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661172|NCT00943852|474044588|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661173|NCT00943852|474044589|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661174|NCT00943852|474044590|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
131661175|NCT00943852|474044591|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661176|NCT00943852|474044592|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661177|NCT00943852|474044593|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661178|NCT00943852|474044594|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131661179|NCT00943852|474044585|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661180|NCT00943852|474044586|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661181|NCT00943852|474044587|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661182|NCT00943852|474044588|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661183|NCT00943852|474044589|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661184|NCT00943852|474044590|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661185|NCT00943852|474044591|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
131661186|NCT00943852|474044592|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661187|NCT00943852|474044593|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661188|NCT00943852|474044594|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131661189|NCT00943852|474044585|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661190|NCT00943852|474044586|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661191|NCT00943852|474044587|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661192|NCT00943852|474044588|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661193|NCT00943852|474044589|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661194|NCT00943852|474044590|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661195|NCT00943852|474044591|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661196|NCT00943852|474044592|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
131661197|NCT00943852|474044593|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661198|NCT00943852|474044594|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131661199|NCT00943852|474044585|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131661200|NCT00943852|474044586|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131661201|NCT00943852|474044587|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131661202|NCT00943852|474044588|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131661203|NCT00943852|474044589|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131661204|NCT00943852|474044590|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131661205|NCT00943852|474044591|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131661206|NCT00943852|474044592|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131661207|NCT00943852|474044593|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131661208|NCT00943852|474044594|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131661209|NCT02141620|474044595|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
131661210|NCT02141620|474044596|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
131661211|NCT00307684|474044597|FG000|Open Label Phase|Lack of Efficacy|0|||
131661212|NCT00307684|474044598|FG001|Open Label Phase|Lack of Efficacy|0|||
131661213|NCT00307684|474044599|FG002|Open Label Phase|Lack of Efficacy|3|||
131661214|NCT00307684|474044597|FG000|Open Label Phase|Adverse Event|0|||
131661215|NCT00307684|474044598|FG001|Open Label Phase|Adverse Event|0|||
131661216|NCT00307684|474044599|FG002|Open Label Phase|Adverse Event|16|||
131661217|NCT00307684|474044597|FG000|Open Label Phase|Withdrawal by Subject|0|||
131661218|NCT00307684|474044598|FG001|Open Label Phase|Withdrawal by Subject|0|||
131661219|NCT00307684|474044599|FG002|Open Label Phase|Withdrawal by Subject|15|||
131661220|NCT00307684|474044597|FG000|Open Label Phase|Lost to Follow-up|0|||
131661221|NCT00307684|474044598|FG001|Open Label Phase|Lost to Follow-up|0|||
131661222|NCT00307684|474044599|FG002|Open Label Phase|Lost to Follow-up|11|||
131661223|NCT00307684|474044597|FG000|Open Label Phase|non compliance|0|||
131661224|NCT00307684|474044598|FG001|Open Label Phase|non compliance|0|||
131661225|NCT00307684|474044599|FG002|Open Label Phase|non compliance|5|||
131661226|NCT00307684|474044597|FG000|Open Label Phase|other|0|||
131661227|NCT00307684|474044598|FG001|Open Label Phase|other|0|||
131661228|NCT00307684|474044599|FG002|Open Label Phase|other|6|||
131661229|NCT00307684|474044597|FG000|Double Blind Phase|Lack of Efficacy|2|||
131661230|NCT00307684|474044598|FG001|Double Blind Phase|Lack of Efficacy|5|||
131661231|NCT00307684|474044599|FG002|Double Blind Phase|Lack of Efficacy|0|||
131661232|NCT03377699|474044600|FG000|Overall Study|Withdrawal by Subject|2|||
131661233|NCT03377699|474044601|FG001|Overall Study|Withdrawal by Subject|9|||
131661234|NCT03377699|474044600|FG000|Overall Study|Lost to Follow-up|1|||
131661235|NCT03377699|474044601|FG001|Overall Study|Lost to Follow-up|1|||
131661236|NCT03377699|474044600|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
131661237|NCT03377699|474044601|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
131661238|NCT03377699|474044600|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
131661239|NCT03377699|474044601|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
131661240|NCT03377699|474044600|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
131661241|NCT03377699|474044601|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
131661242|NCT03377699|474044600|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
131661243|NCT03377699|474044601|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
131661244|NCT00941070|474044603|FG000|Overall Study|Patient non-compliant|1|||
131661245|NCT01163292|474044607|FG000|Overall Study|Lack of Efficacy|9|||
131661246|NCT01163292|474044608|FG001|Overall Study|Lack of Efficacy|0|||
131661247|NCT01163292|474044607|FG000|Overall Study|Adverse Event|6|||
131661248|NCT01163292|474044608|FG001|Overall Study|Adverse Event|0|||
131661249|NCT01163292|474044607|FG000|Overall Study|Initiation of biological therapy|0|||
131661250|NCT01163292|474044608|FG001|Overall Study|Initiation of biological therapy|15|||
131661251|NCT01163292|474044607|FG000|Overall Study|Sufficient response to adalimumab|8|||
131661252|NCT01163292|474044608|FG001|Overall Study|Sufficient response to adalimumab|0|||
131661253|NCT01163292|474044607|FG000|Overall Study|Refusal to receive adalimumab|7|||
131661254|NCT01163292|474044608|FG001|Overall Study|Refusal to receive adalimumab|0|||
131661255|NCT01163292|474044607|FG000|Overall Study|Economic reasons|6|||
131661256|NCT01163292|474044608|FG001|Overall Study|Economic reasons|0|||
131661257|NCT01163292|474044607|FG000|Overall Study|No further visits|5|||
131661258|NCT01163292|474044608|FG001|Overall Study|No further visits|7|||
131661259|NCT02643472|474044609|FG000|Overall Study|Death|2|||
131661260|NCT02643472|474044610|FG001|Overall Study|Death|5|||
131661261|NCT02643472|474044609|FG000|Overall Study|Withdrawal by Subject|3|||
131661262|NCT02643472|474044610|FG001|Overall Study|Withdrawal by Subject|2|||
131661263|NCT02643472|474044609|FG000|Overall Study|Protocol Violation|0|||
131661264|NCT02643472|474044610|FG001|Overall Study|Protocol Violation|1|||
131661265|NCT02643472|474044609|FG000|Overall Study|Lost to Follow-up|22|||
131661266|NCT02643472|474044610|FG001|Overall Study|Lost to Follow-up|26|||
131661267|NCT01127763|474044613|FG000|Overall Study|Adverse Event|2|||
131661268|NCT01127763|474044613|FG000|Overall Study|Withdrawal by Subject|1|||
131661269|NCT01127763|474044613|FG000|Overall Study|Physician Decision|2|||
131661270|NCT00992225|474044614|FG000|Overall Study|Entry Criteria Not Met|8|||
131661271|NCT00992225|474044614|FG000|Overall Study|Adverse Event|2|||
131661272|NCT00291642|474044617|FG000|Overall Study|Adverse Event|1|||
131661273|NCT00291642|474044618|FG001|Overall Study|Adverse Event|0|||
131661274|NCT00291642|474044619|FG002|Overall Study|Adverse Event|1|||
131661275|NCT00291642|474044620|FG003|Overall Study|Adverse Event|0|||
131661276|NCT00291642|474044621|FG004|Overall Study|Adverse Event|1|||
131661277|NCT00291642|474044617|FG000|Overall Study|Patient missed visit|0|||
131661278|NCT00291642|474044618|FG001|Overall Study|Patient missed visit|0|||
131661279|NCT00291642|474044619|FG002|Overall Study|Patient missed visit|1|||
131661280|NCT00291642|474044620|FG003|Overall Study|Patient missed visit|0|||
131661281|NCT00291642|474044621|FG004|Overall Study|Patient missed visit|0|||
131661282|NCT00291642|474044617|FG000|Overall Study|Intake of prohibited medication|1|||
131661283|NCT00291642|474044618|FG001|Overall Study|Intake of prohibited medication|0|||
131661284|NCT00291642|474044619|FG002|Overall Study|Intake of prohibited medication|0|||
131661285|NCT00291642|474044620|FG003|Overall Study|Intake of prohibited medication|0|||
131661286|NCT00291642|474044621|FG004|Overall Study|Intake of prohibited medication|0|||
131661287|NCT03459443|474044626|FG000|Overall Study|Lack of Efficacy|3|||
131661288|NCT03459443|474044626|FG000|Overall Study|Adverse Event|1|||
131661289|NCT03459443|474044626|FG000|Overall Study|Sponsor's decision to close the study|18|||
131661290|NCT00680992|474044629|FG000|Overall Study|Complete Resection (as per protocol)|25|||
131661291|NCT00680992|474044630|FG001|Overall Study|Complete Resection (as per protocol)|121|||
131661292|NCT00680992|474044631|FG002|Overall Study|Complete Resection (as per protocol)|0|||
131661293|NCT00680992|474044629|FG000|Overall Study|Administrative Decision|83|||
131661294|NCT00680992|474044630|FG001|Overall Study|Administrative Decision|42|||
131661295|NCT00680992|474044631|FG002|Overall Study|Administrative Decision|5|||
131661296|NCT00680992|474044629|FG000|Overall Study|End of Trial|32|||
131661297|NCT00680992|474044630|FG001|Overall Study|End of Trial|12|||
131661298|NCT00680992|474044631|FG002|Overall Study|End of Trial|3|||
131661299|NCT00680992|474044629|FG000|Overall Study|Withdrawal by Subject|33|||
131661300|NCT00680992|474044630|FG001|Overall Study|Withdrawal by Subject|11|||
131661301|NCT00680992|474044631|FG002|Overall Study|Withdrawal by Subject|1|||
131661302|NCT00680992|474044629|FG000|Overall Study|Adverse Event|21|||
131661303|NCT00680992|474044630|FG001|Overall Study|Adverse Event|19|||
131661304|NCT00680992|474044631|FG002|Overall Study|Adverse Event|1|||
131661305|NCT00680992|474044629|FG000|Overall Study|Other|19|||
131661306|NCT00680992|474044630|FG001|Overall Study|Other|14|||
131434477|NCT03001557|473217582|FG005|Extension Phase|Loss of caregiver|0|||
131434478|NCT03001557|473217583|FG006|Extension Phase|Loss of caregiver|1|||
131661307|NCT00680992|474044631|FG002|Overall Study|Other|1|||
131661308|NCT00680992|474044629|FG000|Overall Study|Disease Progression|21|||
131661309|NCT00680992|474044630|FG001|Overall Study|Disease Progression|9|||
131661310|NCT00680992|474044631|FG002|Overall Study|Disease Progression|0|||
131661311|NCT00680992|474044629|FG000|Overall Study|Lost to Follow-up|12|||
131661312|NCT00680992|474044630|FG001|Overall Study|Lost to Follow-up|14|||
131434479|NCT03001557|473217584|FG007|Extension Phase|Loss of caregiver|0|||
131434480|NCT03001557|473217577|FG000|Extension Phase|Others|0|||
131434481|NCT03001557|473217578|FG001|Extension Phase|Others|0|||
131434482|NCT03001557|473217579|FG002|Extension Phase|Others|0|||
131434483|NCT03001557|473217580|FG003|Extension Phase|Others|0|||
131434484|NCT03001557|473217581|FG004|Extension Phase|Others|0|||
131434485|NCT03001557|473217582|FG005|Extension Phase|Others|1|||
131434486|NCT03001557|473217583|FG006|Extension Phase|Others|3|||
131434487|NCT03001557|473217584|FG007|Extension Phase|Others|0|||
131434488|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
131434489|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
131434490|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Death|1|||
131434491|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Death|2|||
131434492|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
131434493|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
131434494|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
131434495|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
131434496|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
131661313|NCT00680992|474044631|FG002|Overall Study|Lost to Follow-up|0|||
131661314|NCT00680992|474044629|FG000|Overall Study|Noncompliance|4|||
131661315|NCT00680992|474044630|FG001|Overall Study|Noncompliance|6|||
131661316|NCT00680992|474044631|FG002|Overall Study|Noncompliance|0|||
131661317|NCT00680992|474044629|FG000|Overall Study|Requirement for Alternative Therapy|8|||
131661318|NCT00680992|474044630|FG001|Overall Study|Requirement for Alternative Therapy|2|||
131661319|NCT00680992|474044631|FG002|Overall Study|Requirement for Alternative Therapy|0|||
131661320|NCT00680992|474044629|FG000|Overall Study|Pregnancy|5|||
131661321|NCT00680992|474044630|FG001|Overall Study|Pregnancy|0|||
131661322|NCT00680992|474044631|FG002|Overall Study|Pregnancy|1|||
131661323|NCT00680992|474044629|FG000|Overall Study|Death|5|||
131661324|NCT00680992|474044630|FG001|Overall Study|Death|1|||
131661325|NCT00680992|474044631|FG002|Overall Study|Death|0|||
131661326|NCT00680992|474044629|FG000|Overall Study|Ineligibility Determined|0|||
131661327|NCT00680992|474044630|FG001|Overall Study|Ineligibility Determined|1|||
131661328|NCT00680992|474044631|FG002|Overall Study|Ineligibility Determined|0|||
131661329|NCT05597787|474044633|FG000|Overall Study|Withdrawal by Subject|0|||
131661330|NCT05597787|474044634|FG001|Overall Study|Withdrawal by Subject|0|||
131661331|NCT05597787|474044635|FG002|Overall Study|Withdrawal by Subject|1|||
131434497|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
131434498|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
131434499|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
131661332|NCT06665919|474044636|FG000|Overall Study|Withdrawal by Subject|4|||
131661333|NCT06665919|474044637|FG001|Overall Study|Withdrawal by Subject|4|||
131661334|NCT06665919|474044638|FG002|Overall Study|Withdrawal by Subject|4|||
131661335|NCT06665919|474044636|FG000|Overall Study|Non-compliance to Treatment|4|||
131661336|NCT06665919|474044637|FG001|Overall Study|Non-compliance to Treatment|1|||
131661337|NCT06665919|474044638|FG002|Overall Study|Non-compliance to Treatment|6|||
131661338|NCT06665919|474044636|FG000|Overall Study|Lost to Follow-up|3|||
131661339|NCT06665919|474044637|FG001|Overall Study|Lost to Follow-up|0|||
131661340|NCT06665919|474044638|FG002|Overall Study|Lost to Follow-up|2|||
131661341|NCT06665919|474044636|FG000|Overall Study|Physician Decision|4|||
131661342|NCT06665919|474044637|FG001|Overall Study|Physician Decision|0|||
131661343|NCT06665919|474044638|FG002|Overall Study|Physician Decision|1|||
131904612|NCT03964207|474937032|FG000|Second Treatment|Lost to Follow-up|0|||
131434500|NCT01794000|473217585|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
131434501|NCT01794000|473217586|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
131661344|NCT00607724|474044639|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
131661345|NCT00607724|474044640|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
131661346|NCT00607724|474044641|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
131661347|NCT00607724|474044642|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131661348|NCT00607724|474044643|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131661349|NCT00607724|474044644|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131661350|NCT00607724|474044645|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131661351|NCT00607724|474044639|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
131887728|NCT00994214|474872254|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
131887729|NCT00994214|474872251|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
131887730|NCT00994214|474872252|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
131887731|NCT00994214|474872253|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
131887732|NCT00994214|474872254|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
131887733|NCT00994214|474872251|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
131887734|NCT00994214|474872252|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
131887735|NCT00994214|474872253|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
131887736|NCT00994214|474872254|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
131434502|NCT01794000|473217585|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
131434503|NCT01794000|473217586|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
131434504|NCT01272232|473217589|FG000|Weeks 0-56|Adverse Event|39|||
131434505|NCT01272232|473217590|FG001|Weeks 0-56|Adverse Event|18|||
131434506|NCT01272232|473217591|FG002|Weeks 0-56|Adverse Event|7|||
131434507|NCT01272232|473217589|FG000|Weeks 0-56|Lack of Efficacy|0|||
131887737|NCT01698268|474872258|FG000|Overall Study|Physician Decision|2|||
131887738|NCT01698268|474872259|FG001|Overall Study|Physician Decision|1|||
131887739|NCT00298363|474872260|FG000|Overall Study|Lost to Follow-up|0|||
131887740|NCT00298363|474872261|FG001|Overall Study|Lost to Follow-up|0|||
131887741|NCT00298363|474872262|FG002|Overall Study|Lost to Follow-up|1|||
131887742|NCT00298363|474872260|FG000|Overall Study|Physician Decision|4|||
131887743|NCT00298363|474872261|FG001|Overall Study|Physician Decision|1|||
131887744|NCT00298363|474872262|FG002|Overall Study|Physician Decision|0|||
131887745|NCT00298363|474872260|FG000|Overall Study|Protocol Violation|1|||
131434508|NCT01272232|473217590|FG001|Weeks 0-56|Lack of Efficacy|0|||
131434509|NCT01272232|473217591|FG002|Weeks 0-56|Lack of Efficacy|3|||
131434510|NCT01272232|473217589|FG000|Weeks 0-56|Protocol Violation|12|||
131434511|NCT01272232|473217590|FG001|Weeks 0-56|Protocol Violation|8|||
131434512|NCT01272232|473217591|FG002|Weeks 0-56|Protocol Violation|13|||
131661352|NCT00607724|474044640|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
131661353|NCT00607724|474044641|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
131661354|NCT00607724|474044642|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
131661355|NCT00607724|474044643|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
131661356|NCT00607724|474044644|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
131661357|NCT00607724|474044645|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
131661358|NCT00607724|474044639|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
131434513|NCT01272232|473217589|FG000|Weeks 0-56|Withdrawal criteria|32|||
131434514|NCT01272232|473217590|FG001|Weeks 0-56|Withdrawal criteria|14|||
131434515|NCT01272232|473217591|FG002|Weeks 0-56|Withdrawal criteria|37|||
131434516|NCT01272232|473217589|FG000|Weeks 0-56|Unclassified|16|||
131434517|NCT01272232|473217590|FG001|Weeks 0-56|Unclassified|7|||
131434518|NCT01272232|473217591|FG002|Weeks 0-56|Unclassified|12|||
131434519|NCT01272232|473217589|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
131434520|NCT01272232|473217590|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
131434521|NCT01272232|473217591|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
131434522|NCT01272232|473217589|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
131434523|NCT01272232|473217590|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
131434524|NCT01272232|473217591|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
131434525|NCT01272232|473217589|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
131434526|NCT01272232|473217590|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
131434527|NCT01272232|473217591|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
131434528|NCT01272232|473217589|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
131434529|NCT01272232|473217590|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
131434530|NCT01272232|473217591|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
131434531|NCT01272232|473217589|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
131434532|NCT01272232|473217590|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
131434533|NCT01272232|473217591|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
131434534|NCT02159066|473217592|FG000|Part I|Adverse Event|7|||
131434535|NCT02159066|473217593|FG001|Part I|Adverse Event|5|||
131434536|NCT02159066|473217594|FG002|Part I|Adverse Event|0|||
131434537|NCT02159066|473217595|FG003|Part I|Adverse Event|0|||
131434538|NCT02159066|473217596|FG004|Part I|Adverse Event|0|||
131434539|NCT02159066|473217597|FG005|Part I|Adverse Event|0|||
131434540|NCT02159066|473217592|FG000|Part I|Death|11|||
131434541|NCT02159066|473217593|FG001|Part I|Death|9|||
131434542|NCT02159066|473217594|FG002|Part I|Death|0|||
131434543|NCT02159066|473217595|FG003|Part I|Death|0|||
131661359|NCT00607724|474044640|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
131887746|NCT00298363|474872261|FG001|Overall Study|Protocol Violation|1|||
131434544|NCT02159066|473217596|FG004|Part I|Death|0|||
131434545|NCT02159066|473217597|FG005|Part I|Death|0|||
131887747|NCT00298363|474872262|FG002|Overall Study|Protocol Violation|0|||
131887748|NCT00298363|474872260|FG000|Overall Study|Withdrawal by Subject|5|||
131434546|NCT02159066|473217592|FG000|Part I|Progressive Disease|37|||
131434547|NCT02159066|473217593|FG001|Part I|Progressive Disease|46|||
131434548|NCT02159066|473217594|FG002|Part I|Progressive Disease|0|||
131434549|NCT02159066|473217595|FG003|Part I|Progressive Disease|0|||
131434550|NCT02159066|473217596|FG004|Part I|Progressive Disease|0|||
131434551|NCT02159066|473217597|FG005|Part I|Progressive Disease|0|||
131434552|NCT02159066|473217592|FG000|Part I|New Therapy for Study Indication|5|||
131434553|NCT02159066|473217593|FG001|Part I|New Therapy for Study Indication|4|||
131434554|NCT02159066|473217594|FG002|Part I|New Therapy for Study Indication|0|||
131434555|NCT02159066|473217595|FG003|Part I|New Therapy for Study Indication|0|||
131434556|NCT02159066|473217596|FG004|Part I|New Therapy for Study Indication|0|||
131434557|NCT02159066|473217597|FG005|Part I|New Therapy for Study Indication|0|||
131434558|NCT02159066|473217592|FG000|Part I|Termination of participants from the study|3|||
131434559|NCT02159066|473217593|FG001|Part I|Termination of participants from the study|3|||
131434560|NCT02159066|473217594|FG002|Part I|Termination of participants from the study|0|||
131434561|NCT02159066|473217595|FG003|Part I|Termination of participants from the study|0|||
131434562|NCT02159066|473217596|FG004|Part I|Termination of participants from the study|0|||
131434563|NCT02159066|473217597|FG005|Part I|Termination of participants from the study|0|||
131434564|NCT02159066|473217592|FG000|Part I|Physician Decision|2|||
131434565|NCT02159066|473217593|FG001|Part I|Physician Decision|9|||
131434566|NCT02159066|473217594|FG002|Part I|Physician Decision|0|||
131434567|NCT02159066|473217595|FG003|Part I|Physician Decision|0|||
131434568|NCT02159066|473217596|FG004|Part I|Physician Decision|0|||
131434569|NCT02159066|473217597|FG005|Part I|Physician Decision|0|||
131434570|NCT02159066|473217592|FG000|Part I|Participant/Guardian Decision|9|||
131434571|NCT02159066|473217593|FG001|Part I|Participant/Guardian Decision|3|||
131434572|NCT02159066|473217594|FG002|Part I|Participant/Guardian Decision|0|||
131434573|NCT02159066|473217595|FG003|Part I|Participant/Guardian Decision|0|||
131434574|NCT02159066|473217596|FG004|Part I|Participant/Guardian Decision|0|||
131434575|NCT02159066|473217597|FG005|Part I|Participant/Guardian Decision|0|||
131434576|NCT02159066|473217592|FG000|Part I|Missing Data|1|||
131434577|NCT02159066|473217593|FG001|Part I|Missing Data|0|||
131434578|NCT02159066|473217594|FG002|Part I|Missing Data|0|||
131434579|NCT02159066|473217595|FG003|Part I|Missing Data|0|||
131434580|NCT02159066|473217596|FG004|Part I|Missing Data|0|||
131434581|NCT02159066|473217597|FG005|Part I|Missing Data|0|||
131434582|NCT02159066|473217592|FG000|Part II|Adverse Event|0|||
131434583|NCT02159066|473217593|FG001|Part II|Adverse Event|0|||
131434584|NCT02159066|473217594|FG002|Part II|Adverse Event|1|||
131434585|NCT02159066|473217595|FG003|Part II|Adverse Event|0|||
131434586|NCT02159066|473217596|FG004|Part II|Adverse Event|1|||
131434587|NCT02159066|473217597|FG005|Part II|Adverse Event|1|||
131434588|NCT02159066|473217592|FG000|Part II|Death|0|||
131434589|NCT02159066|473217593|FG001|Part II|Death|0|||
131434590|NCT02159066|473217594|FG002|Part II|Death|1|||
131434591|NCT02159066|473217595|FG003|Part II|Death|0|||
131434592|NCT02159066|473217596|FG004|Part II|Death|2|||
131434593|NCT02159066|473217597|FG005|Part II|Death|1|||
131434594|NCT02159066|473217592|FG000|Part II|Progressive Disease|0|||
131434595|NCT02159066|473217593|FG001|Part II|Progressive Disease|0|||
131434596|NCT02159066|473217594|FG002|Part II|Progressive Disease|35|||
131434597|NCT02159066|473217595|FG003|Part II|Progressive Disease|1|||
131434598|NCT02159066|473217596|FG004|Part II|Progressive Disease|7|||
131434599|NCT02159066|473217597|FG005|Part II|Progressive Disease|4|||
131434600|NCT02159066|473217592|FG000|Part II|New Therapy for Study Indication|0|||
131434601|NCT02159066|473217593|FG001|Part II|New Therapy for Study Indication|0|||
131434602|NCT02159066|473217594|FG002|Part II|New Therapy for Study Indication|0|||
131434603|NCT02159066|473217595|FG003|Part II|New Therapy for Study Indication|0|||
131434604|NCT02159066|473217596|FG004|Part II|New Therapy for Study Indication|1|||
131434605|NCT02159066|473217597|FG005|Part II|New Therapy for Study Indication|0|||
131434606|NCT02159066|473217592|FG000|Part II|Physician Decision|0|||
131434607|NCT02159066|473217593|FG001|Part II|Physician Decision|0|||
131434608|NCT02159066|473217594|FG002|Part II|Physician Decision|1|||
131434609|NCT02159066|473217595|FG003|Part II|Physician Decision|0|||
131434610|NCT02159066|473217596|FG004|Part II|Physician Decision|0|||
131434611|NCT02159066|473217597|FG005|Part II|Physician Decision|0|||
131434612|NCT02159066|473217592|FG000|Part II|Participant/Guardian Decision|0|||
131434613|NCT02159066|473217593|FG001|Part II|Participant/Guardian Decision|0|||
131434614|NCT02159066|473217594|FG002|Part II|Participant/Guardian Decision|0|||
131434615|NCT02159066|473217595|FG003|Part II|Participant/Guardian Decision|0|||
131548494|NCT04270747|473631641|FG002|Post Week 16|Lost to Follow-up|0|||
131434616|NCT02159066|473217596|FG004|Part II|Participant/Guardian Decision|2|||
131434617|NCT02159066|473217597|FG005|Part II|Participant/Guardian Decision|0|||
131434618|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
131434619|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
131434620|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
131434621|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131548495|NCT04270747|473631639|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
131434622|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434623|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131548496|NCT04270747|473631640|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
131548497|NCT04270747|473631641|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
131548498|NCT04270747|473631639|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
131548499|NCT04270747|473631640|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
131548500|NCT04270747|473631641|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
131548501|NCT04270747|473631639|FG000|Post Week 16|Miscellaneous|1|||
131548502|NCT04270747|473631640|FG001|Post Week 16|Miscellaneous|0|||
131548503|NCT04270747|473631641|FG002|Post Week 16|Miscellaneous|1|||
131548504|NCT01784068|473631645|FG000|NTCS Phase|Adverse Event|5|||
131548505|NCT01784068|473631646|FG001|NTCS Phase|Adverse Event|0|||
131548506|NCT01784068|473631645|FG000|NTCS Phase|Physician Decision|2|||
131548507|NCT01784068|473631646|FG001|NTCS Phase|Physician Decision|0|||
131548508|NCT01784068|473631645|FG000|NTCS Phase|Patient/guardian decision|3|||
131548509|NCT01784068|473631646|FG001|NTCS Phase|Patient/guardian decision|0|||
131548510|NCT01784068|473631645|FG000|NTCS Phase|Death|2|||
131548511|NCT01784068|473631646|FG001|NTCS Phase|Death|0|||
131548512|NCT01784068|473631645|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
131548513|NCT01784068|473631646|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
131548514|NCT01784068|473631645|FG000|TFR Phase|Physician Decision|0|||
131548515|NCT01784068|473631646|FG001|TFR Phase|Physician Decision|1|||
131548516|NCT01784068|473631645|FG000|TFR Phase|Patient/guardian decision|0|||
131548517|NCT01784068|473631646|FG001|TFR Phase|Patient/guardian decision|3|||
131548518|NCT01784068|473631645|FG000|TFR Phase|Death|0|||
131548519|NCT01784068|473631646|FG001|TFR Phase|Death|1|||
131548520|NCT01784068|473631645|FG000|TFR Phase|Lack of Efficacy|0|||
131548521|NCT01784068|473631646|FG001|TFR Phase|Lack of Efficacy|88|||
131548522|NCT00701038|473631657|FG000|Overall Study|study amended pilot group of patients|4|||
131548523|NCT00701038|473631658|FG001|Overall Study|study amended pilot group of patients|4|||
131548524|NCT04992546|473631663|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
131548525|NCT04992546|473631663|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
131548526|NCT04992546|473631663|FG000|Open-Label Treatment Period|Adverse Event|3|||
131548527|NCT04992546|473631663|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
131548528|NCT00717860|473631665|FG000|Overall Study|Clinical adverse experience|5|||
131548529|NCT00717860|473631666|FG001|Overall Study|Clinical adverse experience|9|||
131548530|NCT00717860|473631665|FG000|Overall Study|Laboratory adverse experience|2|||
131548531|NCT00717860|473631666|FG001|Overall Study|Laboratory adverse experience|2|||
131548532|NCT00717860|473631665|FG000|Overall Study|Lack of Efficacy|7|||
131548533|NCT00717860|473631666|FG001|Overall Study|Lack of Efficacy|13|||
131548534|NCT00717860|473631665|FG000|Overall Study|Discontinued for other reason|6|||
131548535|NCT00717860|473631666|FG001|Overall Study|Discontinued for other reason|1|||
131548536|NCT00717860|473631665|FG000|Overall Study|Withdrew consent|7|||
131548537|NCT00717860|473631666|FG001|Overall Study|Withdrew consent|3|||
131548538|NCT04058353|473631670|FG000|Overall Study|Adverse Event|2|||
131548539|NCT04058353|473631671|FG001|Overall Study|Adverse Event|1|||
131548540|NCT04058353|473631670|FG000|Overall Study|Physician Decision|1|||
131548541|NCT04058353|473631671|FG001|Overall Study|Physician Decision|0|||
131548542|NCT04058353|473631670|FG000|Overall Study|Other|1|||
131548543|NCT04058353|473631671|FG001|Overall Study|Other|0|||
131548544|NCT00698646|473631672|FG000|Overall Study|Adverse Event|8|||
131548545|NCT00698646|473631673|FG001|Overall Study|Adverse Event|7|||
131548546|NCT00698646|473631674|FG002|Overall Study|Adverse Event|8|||
131548547|NCT00698646|473631672|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
131548548|NCT00698646|473631673|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
131548549|NCT00698646|473631674|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
131548550|NCT00698646|473631672|FG000|Overall Study|Protocol Deviation|6|||
131548551|NCT00698646|473631673|FG001|Overall Study|Protocol Deviation|2|||
131548552|NCT00698646|473631674|FG002|Overall Study|Protocol Deviation|3|||
131548553|NCT00698646|473631672|FG000|Overall Study|Withdrawal by Subject|10|||
131548554|NCT00698646|473631673|FG001|Overall Study|Withdrawal by Subject|11|||
131548555|NCT00698646|473631674|FG002|Overall Study|Withdrawal by Subject|8|||
131548556|NCT00698646|473631672|FG000|Overall Study|Lost to Follow-up|0|||
131548557|NCT00698646|473631673|FG001|Overall Study|Lost to Follow-up|0|||
131548558|NCT00698646|473631674|FG002|Overall Study|Lost to Follow-up|2|||
131548559|NCT00698646|473631672|FG000|Overall Study|Administrative problems|1|||
131548560|NCT00698646|473631673|FG001|Overall Study|Administrative problems|0|||
131548561|NCT00698646|473631674|FG002|Overall Study|Administrative problems|1|||
131548562|NCT00279201|473631675|FG000|Initiation|Death|1|||
131548563|NCT00279201|473631676|FG001|Initiation|Death|5|||
131548564|NCT00279201|473631677|FG002|Initiation|Death|0|||
131548565|NCT00279201|473631678|FG003|Initiation|Death|0|||
131548566|NCT00279201|473631679|FG004|Initiation|Death|0|||
131548567|NCT00279201|473631680|FG005|Initiation|Death|0|||
131548568|NCT00279201|473631675|FG000|Initiation|Adverse Event|6|||
131548569|NCT00279201|473631676|FG001|Initiation|Adverse Event|15|||
131548570|NCT00279201|473631677|FG002|Initiation|Adverse Event|0|||
131548571|NCT00279201|473631678|FG003|Initiation|Adverse Event|0|||
131548572|NCT00279201|473631679|FG004|Initiation|Adverse Event|0|||
131548573|NCT00279201|473631680|FG005|Initiation|Adverse Event|0|||
131434624|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131548574|NCT00279201|473631675|FG000|Initiation|Lost to Follow-up|42|||
131548575|NCT00279201|473631676|FG001|Initiation|Lost to Follow-up|41|||
131548576|NCT00279201|473631677|FG002|Initiation|Lost to Follow-up|0|||
131548577|NCT00279201|473631678|FG003|Initiation|Lost to Follow-up|0|||
131661360|NCT00607724|474044641|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
131661361|NCT00607724|474044642|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
131661362|NCT00607724|474044643|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
131661363|NCT00607724|474044644|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
131661364|NCT00607724|474044645|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
131661365|NCT00607724|474044639|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
131661366|NCT00607724|474044640|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
131661367|NCT00607724|474044641|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
131661368|NCT00607724|474044642|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
131661369|NCT00607724|474044643|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
131661370|NCT00607724|474044644|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
131661371|NCT00607724|474044645|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
131661372|NCT00607724|474044639|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131661373|NCT00607724|474044640|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131661374|NCT00607724|474044641|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131661375|NCT00607724|474044642|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
131661376|NCT00607724|474044643|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131661377|NCT00607724|474044644|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131661378|NCT00607724|474044645|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131661379|NCT03738423|474044646|FG000|Overall Study|Withdrawal by Subject|9|||
131661380|NCT03738423|474044647|FG001|Overall Study|Withdrawal by Subject|12|||
131661381|NCT03738423|474044648|FG002|Overall Study|Withdrawal by Subject|9|||
131661382|NCT03738423|474044649|FG003|Overall Study|Withdrawal by Subject|12|||
131661383|NCT03738423|474044650|FG004|Overall Study|Withdrawal by Subject|10|||
131661384|NCT03738423|474044646|FG000|Overall Study|Lack of Efficacy|3|||
131661385|NCT03738423|474044647|FG001|Overall Study|Lack of Efficacy|1|||
131661386|NCT03738423|474044648|FG002|Overall Study|Lack of Efficacy|1|||
131661387|NCT03738423|474044649|FG003|Overall Study|Lack of Efficacy|1|||
131661388|NCT03738423|474044650|FG004|Overall Study|Lack of Efficacy|2|||
131661389|NCT03738423|474044646|FG000|Overall Study|Lost to Follow-up|1|||
131661390|NCT03738423|474044647|FG001|Overall Study|Lost to Follow-up|0|||
131661391|NCT03738423|474044648|FG002|Overall Study|Lost to Follow-up|1|||
131661392|NCT03738423|474044649|FG003|Overall Study|Lost to Follow-up|1|||
131661393|NCT03738423|474044650|FG004|Overall Study|Lost to Follow-up|0|||
131661394|NCT03738423|474044646|FG000|Overall Study|Protocol Violation|1|||
131661395|NCT03738423|474044647|FG001|Overall Study|Protocol Violation|0|||
131661396|NCT03738423|474044648|FG002|Overall Study|Protocol Violation|0|||
131661397|NCT03738423|474044649|FG003|Overall Study|Protocol Violation|0|||
131661398|NCT03738423|474044650|FG004|Overall Study|Protocol Violation|1|||
131661399|NCT03738423|474044646|FG000|Overall Study|Physician Decision|0|||
131661400|NCT03738423|474044647|FG001|Overall Study|Physician Decision|0|||
131887749|NCT00298363|474872261|FG001|Overall Study|Withdrawal by Subject|1|||
131887750|NCT00298363|474872262|FG002|Overall Study|Withdrawal by Subject|3|||
131887751|NCT00298363|474872260|FG000|Overall Study|Adverse Event|5|||
131887752|NCT00298363|474872261|FG001|Overall Study|Adverse Event|2|||
131887753|NCT00298363|474872262|FG002|Overall Study|Adverse Event|2|||
131887754|NCT00298363|474872260|FG000|Overall Study|Lack of Efficacy|2|||
131887755|NCT00298363|474872261|FG001|Overall Study|Lack of Efficacy|3|||
131887756|NCT00298363|474872262|FG002|Overall Study|Lack of Efficacy|0|||
131887757|NCT04710368|474872263|FG000|Overall Study|Withdrawal by Subject|9|||
131887758|NCT04710368|474872263|FG000|Overall Study|Lost to Follow-up|4|||
131887759|NCT04710368|474872263|FG000|Overall Study|Death|2|||
131887760|NCT04710368|474872263|FG000|Overall Study|Patient preference|11|||
131887761|NCT04710368|474872263|FG000|Overall Study|Treatment discontinuation|1|||
131887762|NCT00135356|474872264|FG000|Overall Study|Adverse Event|6|||
131887763|NCT00135356|474872265|FG001|Overall Study|Adverse Event|2|||
131887764|NCT00135356|474872264|FG000|Overall Study|Lack of Efficacy|2|||
131887765|NCT00135356|474872265|FG001|Overall Study|Lack of Efficacy|0|||
131887766|NCT00135356|474872264|FG000|Overall Study|Lost to Follow-up|3|||
131887767|NCT00135356|474872265|FG001|Overall Study|Lost to Follow-up|1|||
131887768|NCT00135356|474872264|FG000|Overall Study|Surgery for abdominal fat|1|||
131887769|NCT00135356|474872265|FG001|Overall Study|Surgery for abdominal fat|0|||
131887770|NCT00135356|474872264|FG000|Overall Study|Change in antiviral regimen|0|||
131887771|NCT00135356|474872265|FG001|Overall Study|Change in antiviral regimen|1|||
131887772|NCT00135356|474872264|FG000|Overall Study|Poor/noncompliance|1|||
131887773|NCT00135356|474872265|FG001|Overall Study|Poor/noncompliance|1|||
131887774|NCT00135356|474872264|FG000|Overall Study|No longer meets study criteria|2|||
131887775|NCT00135356|474872265|FG001|Overall Study|No longer meets study criteria|0|||
131887776|NCT00135356|474872264|FG000|Overall Study|Withdrawal by Subject|2|||
131887777|NCT00135356|474872265|FG001|Overall Study|Withdrawal by Subject|4|||
131887778|NCT00153816|474872266|FG000|Overall Study|Death|6|||
131887779|NCT00153816|474872267|FG001|Overall Study|Death|5|||
131887780|NCT00153816|474872268|FG002|Overall Study|Death|4|||
131887781|NCT00153816|474872269|FG003|Overall Study|Death|6|||
131887782|NCT00153816|474872270|FG004|Overall Study|Death|0|||
131887783|NCT00153816|474872271|FG005|Overall Study|Death|2|||
131887784|NCT00153816|474872266|FG000|Overall Study|Lost to Follow-up|7|||
131887785|NCT00153816|474872267|FG001|Overall Study|Lost to Follow-up|8|||
131887786|NCT00153816|474872268|FG002|Overall Study|Lost to Follow-up|5|||
131887787|NCT00153816|474872269|FG003|Overall Study|Lost to Follow-up|8|||
131887788|NCT00153816|474872270|FG004|Overall Study|Lost to Follow-up|7|||
131887789|NCT00153816|474872271|FG005|Overall Study|Lost to Follow-up|9|||
131887790|NCT00153816|474872266|FG000|Overall Study|Withdrawal by Subject|9|||
131887791|NCT00153816|474872267|FG001|Overall Study|Withdrawal by Subject|9|||
131887792|NCT00153816|474872268|FG002|Overall Study|Withdrawal by Subject|9|||
131887793|NCT00153816|474872269|FG003|Overall Study|Withdrawal by Subject|4|||
131887794|NCT00153816|474872270|FG004|Overall Study|Withdrawal by Subject|1|||
131887795|NCT00153816|474872271|FG005|Overall Study|Withdrawal by Subject|5|||
131887796|NCT00153816|474872266|FG000|Overall Study|Follow-up exam not done|8|||
131887797|NCT00153816|474872267|FG001|Overall Study|Follow-up exam not done|7|||
131887798|NCT00153816|474872268|FG002|Overall Study|Follow-up exam not done|11|||
131887799|NCT00153816|474872269|FG003|Overall Study|Follow-up exam not done|10|||
131887800|NCT00153816|474872270|FG004|Overall Study|Follow-up exam not done|8|||
131887801|NCT00153816|474872271|FG005|Overall Study|Follow-up exam not done|9|||
131887802|NCT00153816|474872266|FG000|Overall Study|Follow-up exam done, histology missing|2|||
131887803|NCT00153816|474872267|FG001|Overall Study|Follow-up exam done, histology missing|3|||
131887804|NCT00153816|474872268|FG002|Overall Study|Follow-up exam done, histology missing|3|||
131887805|NCT00153816|474872269|FG003|Overall Study|Follow-up exam done, histology missing|3|||
131887806|NCT00153816|474872270|FG004|Overall Study|Follow-up exam done, histology missing|1|||
131887807|NCT00153816|474872271|FG005|Overall Study|Follow-up exam done, histology missing|2|||
131887808|NCT01533688|474872272|FG000|Overall Study|Withdrawal by Subject|5|||
131887809|NCT01533688|474872273|FG001|Overall Study|Withdrawal by Subject|4|||
131887810|NCT01533688|474872274|FG002|Overall Study|Withdrawal by Subject|3|||
131887811|NCT01533688|474872272|FG000|Overall Study|Medically unstable|1|||
131887812|NCT01533688|474872273|FG001|Overall Study|Medically unstable|3|||
131887813|NCT01533688|474872274|FG002|Overall Study|Medically unstable|3|||
131887814|NCT01533688|474872272|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
131887815|NCT01533688|474872273|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
131887816|NCT01533688|474872274|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
131887817|NCT02509078|474872279|FG000|Overall Study|Protocol Violation|1|||
131887818|NCT02509078|474872280|FG001|Overall Study|Protocol Violation|1|||
131887819|NCT01211483|474872287|FG000|Phase 1b|Death|6|||
131887820|NCT01211483|474872288|FG001|Phase 1b|Death|0|||
131887821|NCT01211483|474872289|FG002|Phase 1b|Death|0|||
131887822|NCT01211483|474872290|FG003|Phase 1b|Death|0|||
131887823|NCT01211483|474872287|FG000|Phase 1b|Withdrawal by Subject|1|||
131887824|NCT01211483|474872288|FG001|Phase 1b|Withdrawal by Subject|0|||
131887825|NCT01211483|474872289|FG002|Phase 1b|Withdrawal by Subject|0|||
131887826|NCT01211483|474872290|FG003|Phase 1b|Withdrawal by Subject|0|||
131887827|NCT01211483|474872287|FG000|Phase 2|Lost to Follow-up|0|||
131887828|NCT01211483|474872288|FG001|Phase 2|Lost to Follow-up|1|||
131887829|NCT01211483|474872289|FG002|Phase 2|Lost to Follow-up|1|||
131887830|NCT01211483|474872290|FG003|Phase 2|Lost to Follow-up|2|||
131887831|NCT01211483|474872287|FG000|Phase 2|Death|0|||
131887832|NCT01211483|474872288|FG001|Phase 2|Death|64|||
131887833|NCT01211483|474872289|FG002|Phase 2|Death|53|||
131434625|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434626|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434627|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434628|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434629|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434630|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
131434631|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434632|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
131434633|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434634|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
131434635|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434636|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434637|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
131434638|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
131548578|NCT00279201|473631679|FG004|Initiation|Lost to Follow-up|0|||
131887834|NCT01211483|474872290|FG003|Phase 2|Death|53|||
131887835|NCT01211483|474872287|FG000|Phase 2|Withdrawal by Subject|0|||
131887836|NCT01211483|474872288|FG001|Phase 2|Withdrawal by Subject|1|||
131887837|NCT01211483|474872289|FG002|Phase 2|Withdrawal by Subject|10|||
131887838|NCT01211483|474872290|FG003|Phase 2|Withdrawal by Subject|5|||
131887839|NCT01211483|474872287|FG000|Phase 2|Study terminated by Sponsor|0|||
131887840|NCT01211483|474872288|FG001|Phase 2|Study terminated by Sponsor|6|||
131434639|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
131434640|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
131434641|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434642|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
131434643|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434644|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434645|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
131434646|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
131434647|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
131434648|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
131434649|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
131434650|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
131434651|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
131434652|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
131434653|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
131434654|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
131434655|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
131434656|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
131434657|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
131434658|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
131434659|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
131434660|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
131434661|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
131434662|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
131434663|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
131434664|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434665|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434666|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
131434667|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434668|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434669|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434670|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434671|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434672|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434673|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
131434674|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434675|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434676|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434677|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
131434678|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434679|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434680|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434681|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434682|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
131434683|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
131434684|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434685|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
131434686|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434687|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
131434688|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434689|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
131887841|NCT01211483|474872289|FG002|Phase 2|Study terminated by Sponsor|8|||
131887842|NCT01211483|474872290|FG003|Phase 2|Study terminated by Sponsor|11|||
131887843|NCT00460265|474872291|FG000|Overall Study|Lost to Follow-up|14|||
131887844|NCT00460265|474872292|FG001|Overall Study|Lost to Follow-up|15|||
131887845|NCT00460265|474872291|FG000|Overall Study|Physician Decision|1|||
131887846|NCT00460265|474872292|FG001|Overall Study|Physician Decision|2|||
131887847|NCT00460265|474872291|FG000|Overall Study|Withdrawal by Subject|10|||
131887848|NCT00460265|474872292|FG001|Overall Study|Withdrawal by Subject|25|||
131887849|NCT00460265|474872291|FG000|Overall Study|Ongoing|60|||
131887850|NCT00460265|474872292|FG001|Overall Study|Ongoing|47|||
131887851|NCT02719353|474872293|FG000|First Intervention|Physician Decision|0|||
131887852|NCT02719353|474872294|FG001|First Intervention|Physician Decision|1|||
131887853|NCT01917344|474872296|FG000|Overall Study|Withdrawal by Subject|1|||
131887854|NCT00412217|474872297|FG000|Overall Study|Insufficient Data Available|8|||
131887855|NCT00412217|474872298|FG001|Overall Study|Insufficient Data Available|3|||
131887856|NCT00412217|474872297|FG000|Overall Study|Death|5|||
131887857|NCT00412217|474872298|FG001|Overall Study|Death|4|||
131887858|NCT00412217|474872297|FG000|Overall Study|Disease Progression|2|||
131887859|NCT00412217|474872298|FG001|Overall Study|Disease Progression|3|||
131887860|NCT00412217|474872297|FG000|Overall Study|Investigator Decision|1|||
131887861|NCT00412217|474872298|FG001|Overall Study|Investigator Decision|0|||
131887862|NCT00412217|474872297|FG000|Overall Study|Withdrawal by Subject|2|||
131887863|NCT00412217|474872298|FG001|Overall Study|Withdrawal by Subject|0|||
131887864|NCT00412217|474872297|FG000|Overall Study|Lost to Follow-up|1|||
131887865|NCT00412217|474872298|FG001|Overall Study|Lost to Follow-up|4|||
131887866|NCT00412217|474872297|FG000|Overall Study|Study Terminated by Sponsor|26|||
131434690|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434691|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
131434692|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
131434693|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434694|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434695|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434696|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
131434697|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434698|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131887867|NCT00412217|474872298|FG001|Overall Study|Study Terminated by Sponsor|33|||
131434699|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434700|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434701|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434702|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434703|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
131434704|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434705|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434706|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434707|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
131434708|NCT01147666|473217598|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434709|NCT01147666|473217599|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434710|NCT01147666|473217600|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434711|NCT01147666|473217601|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434712|NCT01147666|473217602|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434713|NCT01147666|473217603|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434714|NCT01147666|473217604|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434715|NCT01147666|473217605|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434716|NCT01147666|473217606|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434717|NCT01147666|473217607|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434718|NCT01147666|473217608|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434719|NCT01147666|473217609|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
131434720|NCT01147666|473217610|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
131434721|NCT01147666|473217611|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
131434722|NCT01147666|473217612|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
131434723|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
131434724|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
131434725|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
131434726|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
131434727|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
131887868|NCT00412217|474872297|FG000|Overall Study|Other|1|||
131887869|NCT00412217|474872298|FG001|Overall Study|Other|1|||
131887870|NCT01398410|474872300|FG000|Overall Study|Adverse Event|12|||
131887871|NCT01398410|474872301|FG001|Overall Study|Adverse Event|16|||
131887872|NCT01398410|474872300|FG000|Overall Study|Participants Choice|8|||
131887873|NCT01398410|474872301|FG001|Overall Study|Participants Choice|11|||
131887874|NCT01398410|474872300|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
131887875|NCT01398410|474872301|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
131887876|NCT01398410|474872300|FG000|Overall Study|Other|36|||
131887877|NCT01398410|474872301|FG001|Overall Study|Other|29|||
131887878|NCT03209518|474872304|FG000|Overall Study|Case Report Forms Uncollected|1|||
131887879|NCT03209518|474872304|FG000|Overall Study|Protocol Deviation|1|||
131887880|NCT00236899|474872305|FG000|Overall Study|Adverse Event (Study Related)|1|||
131887881|NCT00236899|474872306|FG001|Overall Study|Adverse Event (Study Related)|1|||
131887882|NCT00236899|474872307|FG002|Overall Study|Adverse Event (Study Related)|2|||
131434728|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
131434729|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
131434730|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
131434731|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
131434732|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
131548579|NCT00279201|473631680|FG005|Initiation|Lost to Follow-up|0|||
131887883|NCT00236899|474872308|FG003|Overall Study|Adverse Event (Study Related)|1|||
131887884|NCT00236899|474872305|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
131887885|NCT00236899|474872306|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
131887886|NCT00236899|474872307|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
131434733|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
131434734|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
131434735|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
131434736|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
131434737|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
131434738|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434739|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434740|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434741|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434742|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
131434743|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
131434744|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
131434745|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
131434746|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434747|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
131434748|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434749|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434750|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
131434751|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
131434752|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
131434753|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434754|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434755|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434756|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
131434757|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434758|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434759|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434760|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434761|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434762|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434763|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434764|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434765|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434766|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434767|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
131434768|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434769|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434770|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434771|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434772|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
131434773|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
131434774|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434775|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
131434776|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434777|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
131434778|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434779|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434780|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434781|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
131434782|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
131434783|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434784|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434785|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434786|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
131434787|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434788|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434789|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434790|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434791|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434792|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434793|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
131434794|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434795|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434796|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131434797|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
131661401|NCT03738423|474044648|FG002|Overall Study|Physician Decision|1|||
131434798|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434799|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434800|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434801|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434802|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434803|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434804|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434805|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434806|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434807|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434808|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434809|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434810|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
131434811|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434812|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
131434813|NCT01147666|473217598|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434814|NCT01147666|473217599|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434815|NCT01147666|473217600|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434816|NCT01147666|473217601|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434817|NCT01147666|473217602|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434818|NCT01147666|473217603|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434819|NCT01147666|473217604|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434820|NCT01147666|473217605|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434821|NCT01147666|473217606|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434822|NCT01147666|473217607|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434823|NCT01147666|473217608|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434824|NCT01147666|473217609|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131548580|NCT00279201|473631675|FG000|Initiation|Entry Criteria Exclusion|7|||
131548581|NCT00279201|473631676|FG001|Initiation|Entry Criteria Exclusion|9|||
131548582|NCT00279201|473631677|FG002|Initiation|Entry Criteria Exclusion|0|||
131548583|NCT00279201|473631678|FG003|Initiation|Entry Criteria Exclusion|0|||
131548584|NCT00279201|473631679|FG004|Initiation|Entry Criteria Exclusion|0|||
131548585|NCT00279201|473631680|FG005|Initiation|Entry Criteria Exclusion|0|||
131548586|NCT00279201|473631675|FG000|Initiation|Protocol Violation|9|||
131548587|NCT00279201|473631676|FG001|Initiation|Protocol Violation|10|||
131548588|NCT00279201|473631677|FG002|Initiation|Protocol Violation|0|||
131548589|NCT00279201|473631678|FG003|Initiation|Protocol Violation|0|||
131548590|NCT00279201|473631679|FG004|Initiation|Protocol Violation|0|||
131548591|NCT00279201|473631680|FG005|Initiation|Protocol Violation|0|||
131548592|NCT00279201|473631675|FG000|Initiation|Withdrawal by Subject|35|||
131548593|NCT00279201|473631676|FG001|Initiation|Withdrawal by Subject|41|||
131548594|NCT00279201|473631677|FG002|Initiation|Withdrawal by Subject|0|||
131548595|NCT00279201|473631678|FG003|Initiation|Withdrawal by Subject|0|||
131548596|NCT00279201|473631679|FG004|Initiation|Withdrawal by Subject|0|||
131548597|NCT00279201|473631680|FG005|Initiation|Withdrawal by Subject|0|||
131548598|NCT00279201|473631675|FG000|Initiation|Physician Decision|15|||
131548599|NCT00279201|473631676|FG001|Initiation|Physician Decision|18|||
131548600|NCT00279201|473631677|FG002|Initiation|Physician Decision|0|||
131548601|NCT00279201|473631678|FG003|Initiation|Physician Decision|0|||
131548602|NCT00279201|473631679|FG004|Initiation|Physician Decision|0|||
131548603|NCT00279201|473631680|FG005|Initiation|Physician Decision|0|||
131548604|NCT00279201|473631675|FG000|Initiation|Sponsor Decision|13|||
131548605|NCT00279201|473631676|FG001|Initiation|Sponsor Decision|5|||
131548606|NCT00279201|473631677|FG002|Initiation|Sponsor Decision|0|||
131548607|NCT00279201|473631678|FG003|Initiation|Sponsor Decision|0|||
131548608|NCT00279201|473631679|FG004|Initiation|Sponsor Decision|0|||
131548609|NCT00279201|473631680|FG005|Initiation|Sponsor Decision|0|||
131548610|NCT00279201|473631675|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
131548611|NCT00279201|473631676|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
131548612|NCT00279201|473631677|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
131548613|NCT00279201|473631678|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
131548614|NCT00279201|473631679|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
131548615|NCT00279201|473631680|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
131548616|NCT00279201|473631675|FG000|Maintenance|Lack of Efficacy|32|||
131548617|NCT00279201|473631676|FG001|Maintenance|Lack of Efficacy|30|||
131548618|NCT00279201|473631677|FG002|Maintenance|Lack of Efficacy|0|||
131548619|NCT00279201|473631678|FG003|Maintenance|Lack of Efficacy|0|||
131548620|NCT00279201|473631679|FG004|Maintenance|Lack of Efficacy|0|||
131548621|NCT00279201|473631680|FG005|Maintenance|Lack of Efficacy|0|||
131548622|NCT00279201|473631675|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
131548623|NCT00279201|473631676|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
131548624|NCT00279201|473631677|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
131434825|NCT01147666|473217610|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
131434826|NCT01147666|473217611|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
131434827|NCT01147666|473217612|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
131434828|NCT01946139|473217618|FG000|Overall Study|Withdrawal by Subject|8|||
131434829|NCT01946139|473217618|FG000|Overall Study|ineligible|8|||
131434830|NCT01946139|473217618|FG000|Overall Study|Specimens not available|4|||
131434831|NCT00296816|473217625|FG000|Overall Study|Disease Progression|37|||
131434832|NCT00296816|473217625|FG000|Overall Study|Adverse Event|18|||
131434833|NCT00296816|473217625|FG000|Overall Study|Investigator/Participant request|5|||
131434834|NCT00296816|473217625|FG000|Overall Study|Non-compliance|1|||
131434835|NCT00296816|473217625|FG000|Overall Study|Missing for end of treatment|4|||
131434836|NCT00296816|473217625|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
131434837|NCT00296816|473217625|FG000|Overall Study|Poor performance status|1|||
131434838|NCT00296816|473217625|FG000|Overall Study|Relocation to Florida|1|||
131434839|NCT00296816|473217625|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
131434840|NCT00296816|473217625|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
131434841|NCT00296816|473217625|FG000|Overall Study|Neuropathy/patient preference|1|||
131434842|NCT00296816|473217625|FG000|Overall Study|Proteinuria|1|||
131434843|NCT00296816|473217625|FG000|Overall Study|ineligibility due to radiation treatment|1|||
131434844|NCT03275740|473217626|FG000|Overall Study|Adverse Event|0|||
131434845|NCT03275740|473217627|FG001|Overall Study|Adverse Event|0|||
131434846|NCT03275740|473217628|FG002|Overall Study|Adverse Event|0|||
131434847|NCT03275740|473217629|FG003|Overall Study|Adverse Event|0|||
131434848|NCT03275740|473217630|FG004|Overall Study|Adverse Event|1|||
131434849|NCT03275740|473217631|FG005|Overall Study|Adverse Event|0|||
131434850|NCT03275740|473217632|FG006|Overall Study|Adverse Event|0|||
131434851|NCT03275740|473217633|FG007|Overall Study|Adverse Event|0|||
131434852|NCT03275740|473217634|FG008|Overall Study|Adverse Event|0|||
131434853|NCT03275740|473217635|FG009|Overall Study|Adverse Event|0|||
131434854|NCT03275740|473217636|FG010|Overall Study|Adverse Event|0|||
131434855|NCT03275740|473217637|FG011|Overall Study|Adverse Event|0|||
131434856|NCT03275740|473217626|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434857|NCT03275740|473217627|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434858|NCT03275740|473217628|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434859|NCT03275740|473217629|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434860|NCT03275740|473217630|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434861|NCT03275740|473217631|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
131434862|NCT03275740|473217632|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434863|NCT03275740|473217633|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434864|NCT03275740|473217634|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434865|NCT03275740|473217635|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434866|NCT03275740|473217636|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434867|NCT03275740|473217637|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
131434868|NCT03275740|473217626|FG000|Overall Study|Withdrawal by Subject|0|||
131434869|NCT03275740|473217627|FG001|Overall Study|Withdrawal by Subject|0|||
131434870|NCT03275740|473217628|FG002|Overall Study|Withdrawal by Subject|0|||
131434871|NCT03275740|473217629|FG003|Overall Study|Withdrawal by Subject|0|||
131434872|NCT03275740|473217630|FG004|Overall Study|Withdrawal by Subject|0|||
131434873|NCT03275740|473217631|FG005|Overall Study|Withdrawal by Subject|0|||
131434874|NCT03275740|473217632|FG006|Overall Study|Withdrawal by Subject|0|||
131434875|NCT03275740|473217633|FG007|Overall Study|Withdrawal by Subject|0|||
131434876|NCT03275740|473217634|FG008|Overall Study|Withdrawal by Subject|1|||
131434877|NCT03275740|473217635|FG009|Overall Study|Withdrawal by Subject|1|||
131434878|NCT03275740|473217636|FG010|Overall Study|Withdrawal by Subject|0|||
131434879|NCT03275740|473217637|FG011|Overall Study|Withdrawal by Subject|0|||
131434880|NCT03827655|473217639|FG000|Overall Study|Death|0|||
131434881|NCT03827655|473217640|FG001|Overall Study|Death|0|||
131434882|NCT03827655|473217641|FG002|Overall Study|Death|0|||
131434883|NCT03827655|473217642|FG003|Overall Study|Death|0|||
131434884|NCT03827655|473217643|FG004|Overall Study|Death|1|||
131434885|NCT03827655|473217639|FG000|Overall Study|Protocol Deviation|1|||
131434886|NCT03827655|473217640|FG001|Overall Study|Protocol Deviation|0|||
131434887|NCT03827655|473217641|FG002|Overall Study|Protocol Deviation|1|||
131434888|NCT03827655|473217642|FG003|Overall Study|Protocol Deviation|1|||
131434889|NCT03827655|473217643|FG004|Overall Study|Protocol Deviation|0|||
131434890|NCT03827655|473217639|FG000|Overall Study|Withdrawal by Subject|3|||
131434891|NCT03827655|473217640|FG001|Overall Study|Withdrawal by Subject|2|||
131434892|NCT03827655|473217641|FG002|Overall Study|Withdrawal by Subject|2|||
131434893|NCT03827655|473217642|FG003|Overall Study|Withdrawal by Subject|0|||
131434894|NCT03827655|473217643|FG004|Overall Study|Withdrawal by Subject|1|||
131434895|NCT03827655|473217639|FG000|Overall Study|Reason not Specified|3|||
131434896|NCT03827655|473217640|FG001|Overall Study|Reason not Specified|1|||
131548625|NCT00279201|473631678|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
131548626|NCT00279201|473631679|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
131548627|NCT00279201|473631680|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
131548628|NCT00279201|473631675|FG000|Maintenance|Adverse Event|4|||
131548629|NCT00279201|473631676|FG001|Maintenance|Adverse Event|4|||
131434897|NCT03827655|473217641|FG002|Overall Study|Reason not Specified|1|||
131434898|NCT03827655|473217642|FG003|Overall Study|Reason not Specified|1|||
131434899|NCT03827655|473217643|FG004|Overall Study|Reason not Specified|1|||
131434900|NCT02336607|473217644|FG000|Overall Study|Physician Decision|1|||
131434901|NCT02336607|473217645|FG001|Overall Study|Physician Decision|4|||
131434902|NCT02336607|473217646|FG002|Overall Study|Physician Decision|3|||
131434903|NCT02336607|473217647|FG003|Overall Study|Physician Decision|15|||
131434904|NCT02336607|473217644|FG000|Overall Study|Lack of Efficacy|1|||
131434905|NCT02336607|473217645|FG001|Overall Study|Lack of Efficacy|0|||
131434906|NCT02336607|473217646|FG002|Overall Study|Lack of Efficacy|0|||
131434907|NCT02336607|473217647|FG003|Overall Study|Lack of Efficacy|2|||
131434908|NCT02336607|473217644|FG000|Overall Study|Lost to Follow-up|2|||
131434909|NCT02336607|473217645|FG001|Overall Study|Lost to Follow-up|1|||
131434910|NCT02336607|473217646|FG002|Overall Study|Lost to Follow-up|0|||
131434911|NCT02336607|473217647|FG003|Overall Study|Lost to Follow-up|21|||
131434912|NCT02336607|473217644|FG000|Overall Study|Protocol Violation|0|||
131434913|NCT02336607|473217645|FG001|Overall Study|Protocol Violation|1|||
131548630|NCT00279201|473631677|FG002|Maintenance|Adverse Event|0|||
131548631|NCT00279201|473631678|FG003|Maintenance|Adverse Event|0|||
131548632|NCT00279201|473631679|FG004|Maintenance|Adverse Event|0|||
131548633|NCT00279201|473631680|FG005|Maintenance|Adverse Event|0|||
131548634|NCT00279201|473631675|FG000|Maintenance|Death|4|||
131548635|NCT00279201|473631676|FG001|Maintenance|Death|4|||
131548636|NCT00279201|473631677|FG002|Maintenance|Death|0|||
131548637|NCT00279201|473631678|FG003|Maintenance|Death|0|||
131548638|NCT00279201|473631679|FG004|Maintenance|Death|0|||
131548639|NCT00279201|473631680|FG005|Maintenance|Death|0|||
131548640|NCT00279201|473631675|FG000|Maintenance|Lost to Follow-up|17|||
131548641|NCT00279201|473631676|FG001|Maintenance|Lost to Follow-up|13|||
131548642|NCT00279201|473631677|FG002|Maintenance|Lost to Follow-up|0|||
131548643|NCT00279201|473631678|FG003|Maintenance|Lost to Follow-up|0|||
131548644|NCT00279201|473631679|FG004|Maintenance|Lost to Follow-up|0|||
131548645|NCT00279201|473631680|FG005|Maintenance|Lost to Follow-up|0|||
131548646|NCT00279201|473631675|FG000|Maintenance|Entry Criteria Exclusion|1|||
131548647|NCT00279201|473631676|FG001|Maintenance|Entry Criteria Exclusion|4|||
131548648|NCT00279201|473631677|FG002|Maintenance|Entry Criteria Exclusion|0|||
131548649|NCT00279201|473631678|FG003|Maintenance|Entry Criteria Exclusion|0|||
131548650|NCT00279201|473631679|FG004|Maintenance|Entry Criteria Exclusion|0|||
131548651|NCT00279201|473631680|FG005|Maintenance|Entry Criteria Exclusion|0|||
131548652|NCT00279201|473631675|FG000|Maintenance|Protocol Violation|16|||
131548653|NCT00279201|473631676|FG001|Maintenance|Protocol Violation|24|||
131548654|NCT00279201|473631677|FG002|Maintenance|Protocol Violation|0|||
131548655|NCT00279201|473631678|FG003|Maintenance|Protocol Violation|0|||
131548656|NCT00279201|473631679|FG004|Maintenance|Protocol Violation|0|||
131548657|NCT00279201|473631680|FG005|Maintenance|Protocol Violation|0|||
131548658|NCT00279201|473631675|FG000|Maintenance|Withdrawal by Subject|18|||
131548659|NCT00279201|473631676|FG001|Maintenance|Withdrawal by Subject|18|||
131548660|NCT00279201|473631677|FG002|Maintenance|Withdrawal by Subject|0|||
131548661|NCT00279201|473631678|FG003|Maintenance|Withdrawal by Subject|0|||
131548662|NCT00279201|473631679|FG004|Maintenance|Withdrawal by Subject|0|||
131548663|NCT00279201|473631680|FG005|Maintenance|Withdrawal by Subject|0|||
131548664|NCT00279201|473631675|FG000|Maintenance|Physician Decision|9|||
131548665|NCT00279201|473631676|FG001|Maintenance|Physician Decision|9|||
131548666|NCT00279201|473631677|FG002|Maintenance|Physician Decision|0|||
131548667|NCT00279201|473631678|FG003|Maintenance|Physician Decision|0|||
131548668|NCT00279201|473631679|FG004|Maintenance|Physician Decision|0|||
131548669|NCT00279201|473631680|FG005|Maintenance|Physician Decision|0|||
131548670|NCT00279201|473631675|FG000|Maintenance|Sponsor Decision|4|||
131548671|NCT00279201|473631676|FG001|Maintenance|Sponsor Decision|0|||
131548672|NCT00279201|473631677|FG002|Maintenance|Sponsor Decision|0|||
131548673|NCT00279201|473631678|FG003|Maintenance|Sponsor Decision|0|||
131548674|NCT00279201|473631679|FG004|Maintenance|Sponsor Decision|0|||
131548675|NCT00279201|473631680|FG005|Maintenance|Sponsor Decision|0|||
131548676|NCT00279201|473631675|FG000|Maintenance|HbA1c>7.5%|123|||
131548677|NCT00279201|473631676|FG001|Maintenance|HbA1c>7.5%|126|||
131548678|NCT00279201|473631677|FG002|Maintenance|HbA1c>7.5%|0|||
131548679|NCT00279201|473631678|FG003|Maintenance|HbA1c>7.5%|0|||
131548680|NCT00279201|473631679|FG004|Maintenance|HbA1c>7.5%|0|||
131548681|NCT00279201|473631680|FG005|Maintenance|HbA1c>7.5%|0|||
131548682|NCT00279201|473631675|FG000|Intensification Addendum|Withdrawal by Subject|0|||
131548683|NCT00279201|473631676|FG001|Intensification Addendum|Withdrawal by Subject|0|||
131434914|NCT02336607|473217646|FG002|Overall Study|Protocol Violation|1|||
131548684|NCT00279201|473631677|FG002|Intensification Addendum|Withdrawal by Subject|12|||
131548685|NCT00279201|473631678|FG003|Intensification Addendum|Withdrawal by Subject|14|||
131434915|NCT02336607|473217647|FG003|Overall Study|Protocol Violation|3|||
131548686|NCT00279201|473631679|FG004|Intensification Addendum|Withdrawal by Subject|9|||
131548687|NCT00279201|473631680|FG005|Intensification Addendum|Withdrawal by Subject|18|||
131434916|NCT02336607|473217644|FG000|Overall Study|Adverse Event|0|||
131434917|NCT02336607|473217645|FG001|Overall Study|Adverse Event|2|||
131434918|NCT02336607|473217646|FG002|Overall Study|Adverse Event|2|||
131434919|NCT02336607|473217647|FG003|Overall Study|Adverse Event|26|||
131434920|NCT02336607|473217644|FG000|Overall Study|Withdrawal by Subject|0|||
131434921|NCT02336607|473217645|FG001|Overall Study|Withdrawal by Subject|2|||
131434922|NCT02336607|473217646|FG002|Overall Study|Withdrawal by Subject|0|||
131434923|NCT02336607|473217647|FG003|Overall Study|Withdrawal by Subject|20|||
131434924|NCT02552966|473217648|FG000|Overall Study|Lost to Follow-up|2|||
131434925|NCT02552966|473217648|FG000|Overall Study|Withdrawal by Subject|3|||
131434926|NCT06172348|473217649|FG000|Treatment Period 2|Adverse Event|0|||
131434927|NCT06172348|473217650|FG001|Treatment Period 2|Adverse Event|0|||
131434928|NCT06172348|473217651|FG002|Treatment Period 2|Adverse Event|1|||
131434929|NCT06172348|473217652|FG003|Treatment Period 2|Adverse Event|0|||
131434930|NCT06172348|473217653|FG004|Treatment Period 2|Adverse Event|0|||
131434931|NCT06172348|473217654|FG005|Treatment Period 2|Adverse Event|0|||
131434932|NCT05579977|473217662|FG000|Treatment Phase|Other|0|||
131434933|NCT05579977|473217663|FG001|Treatment Phase|Other|0|||
131434934|NCT05579977|473217664|FG002|Treatment Phase|Other|0|||
131434935|NCT05579977|473217665|FG003|Treatment Phase|Other|2|||
131434936|NCT05579977|473217666|FG004|Treatment Phase|Other|1|||
131434937|NCT05579977|473217667|FG005|Treatment Phase|Other|2|||
131434938|NCT05579977|473217668|FG006|Treatment Phase|Other|1|||
131434939|NCT05579977|473217669|FG007|Treatment Phase|Other|2|||
131434940|NCT05579977|473217670|FG008|Treatment Phase|Other|2|||
131434941|NCT05579977|473217671|FG009|Treatment Phase|Other|1|||
131434942|NCT05579977|473217672|FG010|Treatment Phase|Other|0|||
131434943|NCT05579977|473217673|FG011|Treatment Phase|Other|0|||
131434944|NCT05579977|473217674|FG012|Treatment Phase|Other|3|||
131434945|NCT05579977|473217662|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
131434946|NCT05579977|473217663|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
131434947|NCT05579977|473217664|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
131434948|NCT05579977|473217665|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
131434949|NCT05579977|473217666|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
131434950|NCT05579977|473217667|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
131434951|NCT05579977|473217668|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
131434952|NCT05579977|473217669|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
131434953|NCT05579977|473217670|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
131434954|NCT05579977|473217671|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
131434955|NCT05579977|473217672|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
131434956|NCT05579977|473217673|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
131434957|NCT05579977|473217674|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
131434958|NCT05579977|473217662|FG000|Treatment Phase|Withdrawal by Subject|2|||
131434959|NCT05579977|473217663|FG001|Treatment Phase|Withdrawal by Subject|0|||
131434960|NCT05579977|473217664|FG002|Treatment Phase|Withdrawal by Subject|0|||
131434961|NCT05579977|473217665|FG003|Treatment Phase|Withdrawal by Subject|1|||
131434962|NCT05579977|473217666|FG004|Treatment Phase|Withdrawal by Subject|2|||
131434963|NCT05579977|473217667|FG005|Treatment Phase|Withdrawal by Subject|0|||
131434964|NCT05579977|473217668|FG006|Treatment Phase|Withdrawal by Subject|1|||
131434965|NCT05579977|473217669|FG007|Treatment Phase|Withdrawal by Subject|8|||
131434966|NCT05579977|473217670|FG008|Treatment Phase|Withdrawal by Subject|3|||
131434967|NCT05579977|473217671|FG009|Treatment Phase|Withdrawal by Subject|3|||
131434968|NCT05579977|473217672|FG010|Treatment Phase|Withdrawal by Subject|5|||
131434969|NCT05579977|473217673|FG011|Treatment Phase|Withdrawal by Subject|1|||
131434970|NCT05579977|473217674|FG012|Treatment Phase|Withdrawal by Subject|3|||
131434971|NCT05579977|473217662|FG000|Treatment Phase|Study terminated by sponsor|70|||
131434972|NCT05579977|473217663|FG001|Treatment Phase|Study terminated by sponsor|70|||
131434973|NCT05579977|473217664|FG002|Treatment Phase|Study terminated by sponsor|61|||
131434974|NCT05579977|473217665|FG003|Treatment Phase|Study terminated by sponsor|59|||
131434975|NCT05579977|473217666|FG004|Treatment Phase|Study terminated by sponsor|63|||
131434976|NCT05579977|473217667|FG005|Treatment Phase|Study terminated by sponsor|53|||
131434977|NCT05579977|473217668|FG006|Treatment Phase|Study terminated by sponsor|66|||
131434978|NCT05579977|473217669|FG007|Treatment Phase|Study terminated by sponsor|48|||
131434979|NCT05579977|473217670|FG008|Treatment Phase|Study terminated by sponsor|47|||
131434980|NCT05579977|473217671|FG009|Treatment Phase|Study terminated by sponsor|37|||
131434981|NCT05579977|473217672|FG010|Treatment Phase|Study terminated by sponsor|44|||
131434982|NCT05579977|473217673|FG011|Treatment Phase|Study terminated by sponsor|36|||
131434983|NCT05579977|473217674|FG012|Treatment Phase|Study terminated by sponsor|32|||
131434984|NCT05579977|473217662|FG000|Treatment Phase|Pregnancy|0|||
131434985|NCT05579977|473217663|FG001|Treatment Phase|Pregnancy|0|||
131434986|NCT05579977|473217664|FG002|Treatment Phase|Pregnancy|0|||
131434987|NCT05579977|473217665|FG003|Treatment Phase|Pregnancy|0|||
131434988|NCT05579977|473217666|FG004|Treatment Phase|Pregnancy|0|||
131434989|NCT05579977|473217667|FG005|Treatment Phase|Pregnancy|0|||
131548688|NCT00279201|473631675|FG000|Intensification Addendum|Lost to Follow-up|0|||
131434990|NCT05579977|473217668|FG006|Treatment Phase|Pregnancy|0|||
131434991|NCT05579977|473217669|FG007|Treatment Phase|Pregnancy|0|||
131434992|NCT05579977|473217670|FG008|Treatment Phase|Pregnancy|0|||
131434993|NCT05579977|473217671|FG009|Treatment Phase|Pregnancy|1|||
131434994|NCT05579977|473217672|FG010|Treatment Phase|Pregnancy|0|||
131434995|NCT05579977|473217673|FG011|Treatment Phase|Pregnancy|0|||
131434996|NCT05579977|473217674|FG012|Treatment Phase|Pregnancy|0|||
131434997|NCT05579977|473217662|FG000|Treatment Phase|Physician Decision|0|||
131434998|NCT05579977|473217663|FG001|Treatment Phase|Physician Decision|0|||
131434999|NCT05579977|473217664|FG002|Treatment Phase|Physician Decision|0|||
131435000|NCT05579977|473217665|FG003|Treatment Phase|Physician Decision|0|||
131435001|NCT05579977|473217666|FG004|Treatment Phase|Physician Decision|0|||
131435002|NCT05579977|473217667|FG005|Treatment Phase|Physician Decision|0|||
131435003|NCT05579977|473217668|FG006|Treatment Phase|Physician Decision|0|||
131435004|NCT05579977|473217669|FG007|Treatment Phase|Physician Decision|0|||
131435005|NCT05579977|473217670|FG008|Treatment Phase|Physician Decision|0|||
131435006|NCT05579977|473217671|FG009|Treatment Phase|Physician Decision|0|||
131435007|NCT05579977|473217672|FG010|Treatment Phase|Physician Decision|0|||
131435008|NCT05579977|473217673|FG011|Treatment Phase|Physician Decision|1|||
131435009|NCT05579977|473217674|FG012|Treatment Phase|Physician Decision|0|||
131435010|NCT05579977|473217662|FG000|Treatment Phase|Lost to Follow-up|0|||
131435011|NCT05579977|473217663|FG001|Treatment Phase|Lost to Follow-up|0|||
131435012|NCT05579977|473217664|FG002|Treatment Phase|Lost to Follow-up|0|||
131435013|NCT05579977|473217665|FG003|Treatment Phase|Lost to Follow-up|1|||
131435014|NCT05579977|473217666|FG004|Treatment Phase|Lost to Follow-up|1|||
131435015|NCT05579977|473217667|FG005|Treatment Phase|Lost to Follow-up|1|||
131435016|NCT05579977|473217668|FG006|Treatment Phase|Lost to Follow-up|0|||
131435017|NCT05579977|473217669|FG007|Treatment Phase|Lost to Follow-up|1|||
131435018|NCT05579977|473217670|FG008|Treatment Phase|Lost to Follow-up|2|||
131435019|NCT05579977|473217671|FG009|Treatment Phase|Lost to Follow-up|2|||
131435020|NCT05579977|473217672|FG010|Treatment Phase|Lost to Follow-up|1|||
131435021|NCT05579977|473217673|FG011|Treatment Phase|Lost to Follow-up|4|||
131435022|NCT05579977|473217674|FG012|Treatment Phase|Lost to Follow-up|3|||
131435023|NCT05579977|473217662|FG000|Treatment Phase|Death|1|||
131435024|NCT05579977|473217663|FG001|Treatment Phase|Death|0|||
131435025|NCT05579977|473217664|FG002|Treatment Phase|Death|0|||
131435026|NCT05579977|473217665|FG003|Treatment Phase|Death|0|||
131435027|NCT05579977|473217666|FG004|Treatment Phase|Death|0|||
131435028|NCT05579977|473217667|FG005|Treatment Phase|Death|0|||
131435029|NCT05579977|473217668|FG006|Treatment Phase|Death|0|||
131435030|NCT05579977|473217669|FG007|Treatment Phase|Death|0|||
131435031|NCT05579977|473217670|FG008|Treatment Phase|Death|0|||
131435032|NCT05579977|473217671|FG009|Treatment Phase|Death|0|||
131435033|NCT05579977|473217672|FG010|Treatment Phase|Death|0|||
131435034|NCT05579977|473217673|FG011|Treatment Phase|Death|0|||
131435035|NCT05579977|473217674|FG012|Treatment Phase|Death|0|||
131435036|NCT05579977|473217662|FG000|Treatment Phase|Adverse Event|0|||
131435037|NCT05579977|473217663|FG001|Treatment Phase|Adverse Event|3|||
131435038|NCT05579977|473217664|FG002|Treatment Phase|Adverse Event|11|||
131435039|NCT05579977|473217665|FG003|Treatment Phase|Adverse Event|10|||
131435040|NCT05579977|473217666|FG004|Treatment Phase|Adverse Event|5|||
131435041|NCT05579977|473217667|FG005|Treatment Phase|Adverse Event|17|||
131435042|NCT05579977|473217668|FG006|Treatment Phase|Adverse Event|5|||
131435043|NCT05579977|473217669|FG007|Treatment Phase|Adverse Event|5|||
131435044|NCT05579977|473217670|FG008|Treatment Phase|Adverse Event|12|||
131435045|NCT05579977|473217671|FG009|Treatment Phase|Adverse Event|20|||
131435046|NCT05579977|473217672|FG010|Treatment Phase|Adverse Event|15|||
131435047|NCT05579977|473217673|FG011|Treatment Phase|Adverse Event|24|||
131435048|NCT05579977|473217674|FG012|Treatment Phase|Adverse Event|23|||
131435049|NCT05579977|473217662|FG000|Treatment Phase|Randomized not treated|0|||
131435050|NCT05579977|473217663|FG001|Treatment Phase|Randomized not treated|0|||
131435051|NCT05579977|473217664|FG002|Treatment Phase|Randomized not treated|0|||
131435052|NCT05579977|473217665|FG003|Treatment Phase|Randomized not treated|0|||
131435053|NCT05579977|473217666|FG004|Treatment Phase|Randomized not treated|1|||
131435054|NCT05579977|473217667|FG005|Treatment Phase|Randomized not treated|0|||
131435055|NCT05579977|473217668|FG006|Treatment Phase|Randomized not treated|0|||
131435056|NCT05579977|473217669|FG007|Treatment Phase|Randomized not treated|0|||
131435057|NCT05579977|473217670|FG008|Treatment Phase|Randomized not treated|0|||
131435058|NCT05579977|473217671|FG009|Treatment Phase|Randomized not treated|0|||
131435059|NCT05579977|473217672|FG010|Treatment Phase|Randomized not treated|0|||
131435060|NCT05579977|473217673|FG011|Treatment Phase|Randomized not treated|0|||
131435061|NCT05579977|473217674|FG012|Treatment Phase|Randomized not treated|0|||
131435062|NCT05579977|473217662|FG000|Follow up|Death|1|||
131435063|NCT05579977|473217663|FG001|Follow up|Death|0|||
131435064|NCT05579977|473217664|FG002|Follow up|Death|0|||
131435065|NCT05579977|473217665|FG003|Follow up|Death|0|||
131435066|NCT05579977|473217666|FG004|Follow up|Death|0|||
131435067|NCT05579977|473217667|FG005|Follow up|Death|0|||
131435068|NCT05579977|473217668|FG006|Follow up|Death|0|||
131435069|NCT05579977|473217669|FG007|Follow up|Death|0|||
131435070|NCT05579977|473217670|FG008|Follow up|Death|0|||
131435071|NCT05579977|473217671|FG009|Follow up|Death|0|||
131548689|NCT00279201|473631676|FG001|Intensification Addendum|Lost to Follow-up|0|||
131548690|NCT00279201|473631677|FG002|Intensification Addendum|Lost to Follow-up|4|||
131548691|NCT00279201|473631678|FG003|Intensification Addendum|Lost to Follow-up|6|||
131548692|NCT00279201|473631679|FG004|Intensification Addendum|Lost to Follow-up|7|||
131548693|NCT00279201|473631680|FG005|Intensification Addendum|Lost to Follow-up|7|||
131548694|NCT00279201|473631675|FG000|Intensification Addendum|Protocol Violation|0|||
131548695|NCT00279201|473631676|FG001|Intensification Addendum|Protocol Violation|0|||
131548696|NCT00279201|473631677|FG002|Intensification Addendum|Protocol Violation|2|||
131548697|NCT00279201|473631678|FG003|Intensification Addendum|Protocol Violation|2|||
131435072|NCT05579977|473217672|FG010|Follow up|Death|0|||
131548698|NCT00279201|473631679|FG004|Intensification Addendum|Protocol Violation|6|||
131548699|NCT00279201|473631680|FG005|Intensification Addendum|Protocol Violation|6|||
131548700|NCT00279201|473631675|FG000|Intensification Addendum|Adverse Event|0|||
131548701|NCT00279201|473631676|FG001|Intensification Addendum|Adverse Event|0|||
131548702|NCT00279201|473631677|FG002|Intensification Addendum|Adverse Event|0|||
131548703|NCT00279201|473631678|FG003|Intensification Addendum|Adverse Event|4|||
131548704|NCT00279201|473631679|FG004|Intensification Addendum|Adverse Event|1|||
131548705|NCT00279201|473631680|FG005|Intensification Addendum|Adverse Event|3|||
131548706|NCT00279201|473631675|FG000|Intensification Addendum|Physician Decision|0|||
131548707|NCT00279201|473631676|FG001|Intensification Addendum|Physician Decision|0|||
131548708|NCT00279201|473631677|FG002|Intensification Addendum|Physician Decision|4|||
131548709|NCT00279201|473631678|FG003|Intensification Addendum|Physician Decision|1|||
131548710|NCT00279201|473631679|FG004|Intensification Addendum|Physician Decision|3|||
131548711|NCT00279201|473631680|FG005|Intensification Addendum|Physician Decision|2|||
131548712|NCT00279201|473631675|FG000|Intensification Addendum|Sponsor Decision|0|||
131548713|NCT00279201|473631676|FG001|Intensification Addendum|Sponsor Decision|0|||
131435073|NCT05579977|473217673|FG011|Follow up|Death|0|||
131435074|NCT05579977|473217674|FG012|Follow up|Death|0|||
131435075|NCT05579977|473217662|FG000|Follow up|Lost to Follow-up|0|||
131435076|NCT05579977|473217663|FG001|Follow up|Lost to Follow-up|0|||
131435077|NCT05579977|473217664|FG002|Follow up|Lost to Follow-up|0|||
131435078|NCT05579977|473217665|FG003|Follow up|Lost to Follow-up|1|||
131435079|NCT05579977|473217666|FG004|Follow up|Lost to Follow-up|1|||
131435080|NCT05579977|473217667|FG005|Follow up|Lost to Follow-up|2|||
131435081|NCT05579977|473217668|FG006|Follow up|Lost to Follow-up|1|||
131435082|NCT05579977|473217669|FG007|Follow up|Lost to Follow-up|1|||
131435083|NCT05579977|473217670|FG008|Follow up|Lost to Follow-up|3|||
131435084|NCT05579977|473217671|FG009|Follow up|Lost to Follow-up|2|||
131435085|NCT05579977|473217672|FG010|Follow up|Lost to Follow-up|2|||
131435086|NCT05579977|473217673|FG011|Follow up|Lost to Follow-up|4|||
131435087|NCT05579977|473217674|FG012|Follow up|Lost to Follow-up|4|||
131435088|NCT05579977|473217662|FG000|Follow up|Withdrawal by Subject|2|||
131435089|NCT05579977|473217663|FG001|Follow up|Withdrawal by Subject|0|||
131435090|NCT05579977|473217664|FG002|Follow up|Withdrawal by Subject|0|||
131435091|NCT05579977|473217665|FG003|Follow up|Withdrawal by Subject|0|||
131435092|NCT05579977|473217666|FG004|Follow up|Withdrawal by Subject|1|||
131435093|NCT05579977|473217667|FG005|Follow up|Withdrawal by Subject|0|||
131435094|NCT05579977|473217668|FG006|Follow up|Withdrawal by Subject|1|||
131435095|NCT05579977|473217669|FG007|Follow up|Withdrawal by Subject|4|||
131435096|NCT05579977|473217670|FG008|Follow up|Withdrawal by Subject|2|||
131435097|NCT05579977|473217671|FG009|Follow up|Withdrawal by Subject|3|||
131435098|NCT05579977|473217672|FG010|Follow up|Withdrawal by Subject|3|||
131435099|NCT05579977|473217673|FG011|Follow up|Withdrawal by Subject|1|||
131435100|NCT05579977|473217674|FG012|Follow up|Withdrawal by Subject|3|||
131435101|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
131435102|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
131435103|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
131435104|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
131435105|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
131435106|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
131435107|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
131435108|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
131435109|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
131435110|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
131435111|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
131435112|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
131435113|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
131435114|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
131548714|NCT00279201|473631677|FG002|Intensification Addendum|Sponsor Decision|0|||
131548715|NCT00279201|473631678|FG003|Intensification Addendum|Sponsor Decision|0|||
131658915|NCT01214642|474035464|FG006|Overall Study|Death|0|||
131435115|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
131435116|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
131435117|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
131435118|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
131435119|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
131435120|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
131435121|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
131435122|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
131435123|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
131435124|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
131435125|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
131435126|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
131435127|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
131435128|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
131435129|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
131435130|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
131435131|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
131435132|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
131435133|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
131435134|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
131435135|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
131435136|NCT02831764|473219225|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
131435137|NCT02831764|473219226|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
131435138|NCT02831764|473219227|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
131435139|NCT02831764|473219228|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
131435140|NCT02831764|473219229|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
131435141|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131435142|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131435143|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
131435144|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
131435145|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131435146|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131435147|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131435148|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
131435149|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131435150|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131435151|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131435152|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131435153|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
131435154|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
131435155|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131435156|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
131435157|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
131435158|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
131435159|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
131435160|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
131435161|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131435162|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131435163|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
131435164|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
131435165|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131435166|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131435167|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131435168|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
131435169|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
131435170|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131435171|NCT02831764|473219225|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131435172|NCT02831764|473219226|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131435173|NCT02831764|473219227|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
131435174|NCT02831764|473219228|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
131435175|NCT02831764|473219229|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131435176|NCT02831764|473219225|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131435177|NCT02831764|473219226|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131548716|NCT00279201|473631679|FG004|Intensification Addendum|Sponsor Decision|1|||
131661402|NCT03738423|474044649|FG003|Overall Study|Physician Decision|0|||
131661403|NCT03738423|474044650|FG004|Overall Study|Physician Decision|1|||
131548717|NCT00279201|473631680|FG005|Intensification Addendum|Sponsor Decision|1|||
131548718|NCT00279201|473631675|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
131548719|NCT00279201|473631676|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
131548720|NCT00279201|473631677|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
131548721|NCT00279201|473631678|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
131548722|NCT00279201|473631679|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
131548723|NCT00279201|473631680|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
131548724|NCT00279201|473631675|FG000|Intensification Addendum|Lack of Efficacy|0|||
131548725|NCT00279201|473631676|FG001|Intensification Addendum|Lack of Efficacy|0|||
131548726|NCT00279201|473631677|FG002|Intensification Addendum|Lack of Efficacy|0|||
131548727|NCT00279201|473631678|FG003|Intensification Addendum|Lack of Efficacy|1|||
131548728|NCT00279201|473631679|FG004|Intensification Addendum|Lack of Efficacy|1|||
131548729|NCT00279201|473631680|FG005|Intensification Addendum|Lack of Efficacy|0|||
131548730|NCT00279201|473631675|FG000|Intensification Addendum|Death|0|||
131548731|NCT00279201|473631676|FG001|Intensification Addendum|Death|0|||
131548732|NCT00279201|473631677|FG002|Intensification Addendum|Death|0|||
131548733|NCT00279201|473631678|FG003|Intensification Addendum|Death|0|||
131548734|NCT00279201|473631679|FG004|Intensification Addendum|Death|1|||
131548735|NCT00279201|473631680|FG005|Intensification Addendum|Death|0|||
131548736|NCT02390531|473631683|FG000|Overall Study|Death|0|||
131548737|NCT02390531|473631684|FG001|Overall Study|Death|2|||
131548738|NCT02390531|473631685|FG002|Overall Study|Death|0|||
131548739|NCT02390531|473631686|FG003|Overall Study|Death|1|||
131548740|NCT02390531|473631687|FG004|Overall Study|Death|0|||
131548741|NCT02390531|473631688|FG005|Overall Study|Death|0|||
131548742|NCT02390531|473631689|FG006|Overall Study|Death|0|||
131548743|NCT02390531|473631690|FG007|Overall Study|Death|1|||
131548744|NCT02390531|473631683|FG000|Overall Study|Protocol Violation|0|||
131548745|NCT02390531|473631684|FG001|Overall Study|Protocol Violation|0|||
131548746|NCT02390531|473631685|FG002|Overall Study|Protocol Violation|0|||
131548747|NCT02390531|473631686|FG003|Overall Study|Protocol Violation|0|||
131548748|NCT02390531|473631687|FG004|Overall Study|Protocol Violation|1|||
131548749|NCT02390531|473631688|FG005|Overall Study|Protocol Violation|0|||
131548750|NCT02390531|473631689|FG006|Overall Study|Protocol Violation|2|||
131548751|NCT02390531|473631690|FG007|Overall Study|Protocol Violation|0|||
131548752|NCT00511875|473631691|FG000|Overall Study|Lost to Follow-up|4|||
131548753|NCT00511875|473631692|FG001|Overall Study|Lost to Follow-up|0|||
131548754|NCT00511875|473631691|FG000|Overall Study|Missing variables|1|||
131548755|NCT00511875|473631692|FG001|Overall Study|Missing variables|0|||
131548756|NCT00542880|473631693|FG000|Period 1|Eligibility criteria not fulfilled|2|||
131548757|NCT00542880|473631694|FG001|Period 1|Eligibility criteria not fulfilled|6|||
131548758|NCT00542880|473631693|FG000|Period 1|Adverse Event|2|||
131548759|NCT00542880|473631694|FG001|Period 1|Adverse Event|2|||
131548760|NCT00542880|473631693|FG000|Period 1|Development of study-specific criteria|1|||
131548761|NCT00542880|473631694|FG001|Period 1|Development of study-specific criteria|2|||
131548762|NCT00542880|473631693|FG000|Period 1|Withdrawal by Subject|1|||
131548763|NCT00542880|473631694|FG001|Period 1|Withdrawal by Subject|1|||
131548764|NCT00542880|473631693|FG000|Period 1|Protocol Violation|0|||
131435178|NCT02831764|473219227|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131435179|NCT02831764|473219228|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131435180|NCT02831764|473219229|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
131435181|NCT02831764|473219225|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131435182|NCT02831764|473219226|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131435183|NCT02831764|473219227|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131435184|NCT02831764|473219228|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131548765|NCT00542880|473631694|FG001|Period 1|Protocol Violation|1|||
131548766|NCT00542880|473631693|FG000|Period 2|Adverse Event|5|||
131548767|NCT00542880|473631694|FG001|Period 2|Adverse Event|7|||
131548768|NCT00542880|473631693|FG000|Period 2|Eligibility not fulfilled|0|||
131548769|NCT00542880|473631694|FG001|Period 2|Eligibility not fulfilled|1|||
131548770|NCT00542880|473631693|FG000|Period 2|Discontinuation criteria|2|||
131548771|NCT00542880|473631694|FG001|Period 2|Discontinuation criteria|0|||
131548772|NCT00542880|473631693|FG000|Period 2|Severe non-compliance|0|||
131548773|NCT00542880|473631694|FG001|Period 2|Severe non-compliance|1|||
131548774|NCT00542880|473631693|FG000|Period 2|Other|0|||
131548775|NCT00542880|473631694|FG001|Period 2|Other|1|||
131548776|NCT00542880|473631693|FG000|Period 3|Adverse Event|0|||
131548777|NCT00542880|473631694|FG001|Period 3|Adverse Event|2|||
131548778|NCT00696384|473631695|FG000|Open Label Phase|Adverse Event|27|||
131548779|NCT00696384|473631696|FG001|Open Label Phase|Adverse Event|0|||
131548780|NCT00696384|473631697|FG002|Open Label Phase|Adverse Event|0|||
131548781|NCT00696384|473631695|FG000|Open Label Phase|Protocol Violation|18|||
131435185|NCT02831764|473219229|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
131548782|NCT00696384|473631696|FG001|Open Label Phase|Protocol Violation|0|||
131548783|NCT00696384|473631697|FG002|Open Label Phase|Protocol Violation|0|||
131548784|NCT00696384|473631695|FG000|Open Label Phase|Lost to Follow-up|24|||
131548785|NCT00696384|473631696|FG001|Open Label Phase|Lost to Follow-up|0|||
131435186|NCT02831764|473219225|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131435187|NCT02831764|473219226|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131435188|NCT02831764|473219227|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131435189|NCT02831764|473219228|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131435190|NCT02831764|473219229|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
131435191|NCT02831764|473219225|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131435192|NCT02831764|473219226|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131435193|NCT02831764|473219227|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131435194|NCT02831764|473219228|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131435195|NCT02831764|473219229|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
131435196|NCT04564846|473219230|FG000|Overall Study|Withdrawal by Subject|2|||
131435197|NCT04564846|473219231|FG001|Overall Study|Withdrawal by Subject|1|||
131435198|NCT04564846|473219230|FG000|Overall Study|Physician Decision|0|||
131435199|NCT04564846|473219231|FG001|Overall Study|Physician Decision|1|||
131435200|NCT04564846|473219230|FG000|Overall Study|Lost to Follow-up|0|||
131435201|NCT04564846|473219231|FG001|Overall Study|Lost to Follow-up|1|||
131435202|NCT04564846|473219230|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
131435203|NCT04564846|473219231|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
131435204|NCT04564846|473219230|FG000|Overall Study|Subject non-compliance|1|||
131435205|NCT04564846|473219231|FG001|Overall Study|Subject non-compliance|0|||
131435206|NCT00387881|473219232|FG000|Overall Study|Lost to Follow-up|23|||
131435207|NCT00387881|473219233|FG001|Overall Study|Lost to Follow-up|23|||
131435208|NCT00387881|473219232|FG000|Overall Study|Protocol Violation|2|||
131435209|NCT00387881|473219233|FG001|Overall Study|Protocol Violation|12|||
131435210|NCT00387881|473219232|FG000|Overall Study|Withdrawal by Subject|15|||
131435211|NCT00387881|473219233|FG001|Overall Study|Withdrawal by Subject|18|||
131435212|NCT00387881|473219232|FG000|Overall Study|Sponsor terminated Study|0|||
131435213|NCT00387881|473219233|FG001|Overall Study|Sponsor terminated Study|1|||
131435214|NCT00387881|473219232|FG000|Overall Study|Not eligible|6|||
131435215|NCT00387881|473219233|FG001|Overall Study|Not eligible|7|||
131435216|NCT00387881|473219232|FG000|Overall Study|No opportunity to treat headache|32|||
131435217|NCT00387881|473219233|FG001|Overall Study|No opportunity to treat headache|34|||
131435218|NCT00387881|473219232|FG000|Overall Study|Not otherwise specified|11|||
131435219|NCT00387881|473219233|FG001|Overall Study|Not otherwise specified|7|||
131435220|NCT03291067|473219235|FG000|Overall Study|Adverse Event|0|||
131435221|NCT03291067|473219236|FG001|Overall Study|Adverse Event|2|||
131435222|NCT03291067|473219237|FG002|Overall Study|Adverse Event|17|||
131435223|NCT03291067|473219238|FG003|Overall Study|Adverse Event|3|||
131435224|NCT03291067|473219235|FG000|Overall Study|Lost to Follow-up|2|||
131435225|NCT03291067|473219236|FG001|Overall Study|Lost to Follow-up|1|||
131435226|NCT03291067|473219237|FG002|Overall Study|Lost to Follow-up|0|||
131435227|NCT03291067|473219238|FG003|Overall Study|Lost to Follow-up|1|||
131435228|NCT03291067|473219235|FG000|Overall Study|Physician Decision|0|||
131435229|NCT03291067|473219236|FG001|Overall Study|Physician Decision|0|||
131435230|NCT03291067|473219237|FG002|Overall Study|Physician Decision|1|||
131435231|NCT03291067|473219238|FG003|Overall Study|Physician Decision|0|||
131435232|NCT03291067|473219235|FG000|Overall Study|Protocol Violation|5|||
131435233|NCT03291067|473219236|FG001|Overall Study|Protocol Violation|3|||
131435234|NCT03291067|473219237|FG002|Overall Study|Protocol Violation|4|||
131435235|NCT03291067|473219238|FG003|Overall Study|Protocol Violation|2|||
131435236|NCT03291067|473219235|FG000|Overall Study|Withdrawal by Subject|3|||
131435237|NCT03291067|473219236|FG001|Overall Study|Withdrawal by Subject|4|||
131435238|NCT03291067|473219237|FG002|Overall Study|Withdrawal by Subject|7|||
131435239|NCT03291067|473219238|FG003|Overall Study|Withdrawal by Subject|5|||
131435240|NCT03291067|473219235|FG000|Overall Study|Other|0|||
131435241|NCT03291067|473219236|FG001|Overall Study|Other|4|||
131435242|NCT03291067|473219237|FG002|Overall Study|Other|4|||
131435243|NCT03291067|473219238|FG003|Overall Study|Other|6|||
131435244|NCT02038153|473219239|FG000|Overall Study|Withdrawal by Subject|1|||
131435245|NCT01855412|473219240|FG000|Overall Study|Death|77|||
131435246|NCT01855412|473219241|FG001|Overall Study|Death|123|||
131435247|NCT01855412|473219242|FG002|Overall Study|Death|30|||
131435248|NCT01855412|473219240|FG000|Overall Study|Lost to Follow-up|28|||
131435249|NCT01855412|473219241|FG001|Overall Study|Lost to Follow-up|46|||
131435250|NCT01855412|473219242|FG002|Overall Study|Lost to Follow-up|15|||
131435251|NCT01855412|473219240|FG000|Overall Study|Withdrawal by Subject|77|||
131435252|NCT01855412|473219241|FG001|Overall Study|Withdrawal by Subject|123|||
131435253|NCT01855412|473219242|FG002|Overall Study|Withdrawal by Subject|24|||
131435254|NCT01855412|473219240|FG000|Overall Study|Physician Decision|25|||
131435255|NCT01855412|473219241|FG001|Overall Study|Physician Decision|31|||
131435256|NCT01855412|473219242|FG002|Overall Study|Physician Decision|3|||
131435257|NCT01855412|473219240|FG000|Overall Study|Site Closure|4|||
131658916|NCT01214642|474035465|FG007|Overall Study|Death|0|||
131435258|NCT01855412|473219241|FG001|Overall Study|Site Closure|18|||
131435259|NCT01855412|473219242|FG002|Overall Study|Site Closure|1|||
131435260|NCT01855412|473219240|FG000|Overall Study|Reason not Specified|1|||
131548786|NCT00696384|473631697|FG002|Open Label Phase|Lost to Follow-up|0|||
131661404|NCT03738423|474044646|FG000|Overall Study|Death|0|||
131435261|NCT01855412|473219241|FG001|Overall Study|Reason not Specified|2|||
131435262|NCT01855412|473219242|FG002|Overall Study|Reason not Specified|3|||
131435263|NCT02123134|473219248|FG000|Overall Study|Withdrawal of consent|3|||
131435264|NCT02123134|473219249|FG001|Overall Study|Withdrawal of consent|2|||
131435265|NCT02123134|473219248|FG000|Overall Study|Administrative decision|0|||
131435266|NCT02123134|473219249|FG001|Overall Study|Administrative decision|1|||
131435267|NCT03010527|473219255|FG000|Overall Study|Death|0|||
131435268|NCT03010527|473219256|FG001|Overall Study|Death|0|||
131435269|NCT03010527|473219257|FG002|Overall Study|Death|1|||
131435270|NCT03010527|473219255|FG000|Overall Study|Adverse Event|0|||
131435271|NCT03010527|473219256|FG001|Overall Study|Adverse Event|4|||
131435272|NCT03010527|473219257|FG002|Overall Study|Adverse Event|2|||
131435273|NCT03010527|473219255|FG000|Overall Study|Protocol Violation|0|||
131435274|NCT03010527|473219256|FG001|Overall Study|Protocol Violation|1|||
131435275|NCT03010527|473219257|FG002|Overall Study|Protocol Violation|0|||
131435276|NCT03010527|473219255|FG000|Overall Study|Lost to Follow-up|0|||
131435277|NCT03010527|473219256|FG001|Overall Study|Lost to Follow-up|2|||
131435278|NCT03010527|473219257|FG002|Overall Study|Lost to Follow-up|1|||
131435279|NCT03010527|473219255|FG000|Overall Study|Withdrawal by Subject|0|||
131435280|NCT03010527|473219256|FG001|Overall Study|Withdrawal by Subject|3|||
131435281|NCT03010527|473219257|FG002|Overall Study|Withdrawal by Subject|4|||
131435282|NCT03010527|473219255|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
131435283|NCT03010527|473219256|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
131435284|NCT03010527|473219257|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
131435285|NCT03010527|473219255|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
131435286|NCT03010527|473219256|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
131435287|NCT03010527|473219257|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
131548787|NCT00696384|473631695|FG000|Open Label Phase|Withdrawal by Subject|37|||
131548788|NCT00696384|473631696|FG001|Open Label Phase|Withdrawal by Subject|0|||
131548789|NCT00696384|473631697|FG002|Open Label Phase|Withdrawal by Subject|0|||
131548790|NCT00696384|473631695|FG000|Open Label Phase|Other|6|||
131548791|NCT00696384|473631696|FG001|Open Label Phase|Other|0|||
131548792|NCT00696384|473631697|FG002|Open Label Phase|Other|0|||
131548793|NCT00696384|473631695|FG000|Open Label Phase|Lack of Efficacy|3|||
131548794|NCT00696384|473631696|FG001|Open Label Phase|Lack of Efficacy|0|||
131548795|NCT00696384|473631697|FG002|Open Label Phase|Lack of Efficacy|0|||
131548796|NCT00696384|473631695|FG000|Open Label Phase|Physician Decision|4|||
131548797|NCT00696384|473631696|FG001|Open Label Phase|Physician Decision|0|||
131548798|NCT00696384|473631697|FG002|Open Label Phase|Physician Decision|0|||
131548799|NCT00696384|473631695|FG000|Double Blind Phase|Adverse Event|0|||
131548800|NCT00696384|473631696|FG001|Double Blind Phase|Adverse Event|2|||
131548801|NCT00696384|473631697|FG002|Double Blind Phase|Adverse Event|2|||
131548802|NCT00696384|473631695|FG000|Double Blind Phase|Lost to Follow-up|0|||
131548803|NCT00696384|473631696|FG001|Double Blind Phase|Lost to Follow-up|2|||
131548804|NCT00696384|473631697|FG002|Double Blind Phase|Lost to Follow-up|1|||
131548805|NCT00696384|473631695|FG000|Double Blind Phase|Withdrawal by Subject|0|||
131548806|NCT00696384|473631696|FG001|Double Blind Phase|Withdrawal by Subject|4|||
131548807|NCT00696384|473631697|FG002|Double Blind Phase|Withdrawal by Subject|3|||
131548808|NCT00696384|473631695|FG000|Double Blind Phase|Lack of Efficacy|0|||
131548809|NCT00696384|473631696|FG001|Double Blind Phase|Lack of Efficacy|1|||
131548810|NCT00696384|473631697|FG002|Double Blind Phase|Lack of Efficacy|0|||
131548811|NCT00696384|473631695|FG000|Double Blind Phase|Physician Decision|0|||
131548812|NCT00696384|473631696|FG001|Double Blind Phase|Physician Decision|2|||
131548813|NCT00696384|473631697|FG002|Double Blind Phase|Physician Decision|0|||
131548814|NCT01678131|473631698|FG000|Overall Study|Adverse Event|0|||
131548815|NCT01678131|473631699|FG001|Overall Study|Adverse Event|1|||
131548816|NCT01678131|473631700|FG002|Overall Study|Adverse Event|0|||
131548817|NCT01678131|473631698|FG000|Overall Study|Withdrawal by Subject|0|||
131548818|NCT01678131|473631699|FG001|Overall Study|Withdrawal by Subject|0|||
131548819|NCT01678131|473631700|FG002|Overall Study|Withdrawal by Subject|2|||
131548820|NCT02027402|473631702|FG000|Overall Study|Withdrawal by Subject|4|||
131548821|NCT02027402|473631703|FG001|Overall Study|Withdrawal by Subject|1|||
131548822|NCT00941798|473631707|FG000|Overall Study|Withdrawal by Subject|72|||
131548823|NCT00941798|473631708|FG001|Overall Study|Withdrawal by Subject|74|||
131548824|NCT00941798|473631707|FG000|Overall Study|Adverse Event|43|||
131548825|NCT00941798|473631708|FG001|Overall Study|Adverse Event|23|||
131548826|NCT00941798|473631707|FG000|Overall Study|Lost to Follow-up|29|||
131548827|NCT00941798|473631708|FG001|Overall Study|Lost to Follow-up|23|||
131548828|NCT00941798|473631707|FG000|Overall Study|Protocol Violation|17|||
131661405|NCT03738423|474044647|FG001|Overall Study|Death|0|||
131435288|NCT03010527|473219255|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
131435289|NCT03010527|473219256|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
131548829|NCT00941798|473631708|FG001|Overall Study|Protocol Violation|20|||
131548830|NCT00941798|473631707|FG000|Overall Study|Administrative problems|13|||
131548831|NCT00941798|473631708|FG001|Overall Study|Administrative problems|23|||
131661406|NCT03738423|474044648|FG002|Overall Study|Death|0|||
131661407|NCT03738423|474044649|FG003|Overall Study|Death|0|||
131435290|NCT03010527|473219257|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
131435291|NCT03400852|473219258|FG000|Blinded Treatment Period|Physician Decision|0|||
131435292|NCT03400852|473219259|FG001|Blinded Treatment Period|Physician Decision|1|||
131435293|NCT03400852|473219260|FG002|Blinded Treatment Period|Physician Decision|0|||
131435294|NCT03400852|473219258|FG000|Blinded Treatment Period|Adverse Event|1|||
131435295|NCT03400852|473219259|FG001|Blinded Treatment Period|Adverse Event|1|||
131435296|NCT03400852|473219260|FG002|Blinded Treatment Period|Adverse Event|0|||
131435297|NCT03400852|473219258|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
131435298|NCT03400852|473219259|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
131435299|NCT03400852|473219260|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
131435300|NCT03400852|473219258|FG000|Open Label Period|Physician Decision|0|||
131435301|NCT03400852|473219259|FG001|Open Label Period|Physician Decision|0|||
131435302|NCT03400852|473219260|FG002|Open Label Period|Physician Decision|1|||
131435303|NCT03400852|473219258|FG000|Open Label Period|Study terminated by sponsor|0|||
131435304|NCT03400852|473219259|FG001|Open Label Period|Study terminated by sponsor|0|||
131435305|NCT03400852|473219260|FG002|Open Label Period|Study terminated by sponsor|21|||
131435306|NCT01755234|473219261|FG000|Overall Study|Lost to Follow-up|11|||
131435307|NCT01755234|473219262|FG001|Overall Study|Lost to Follow-up|6|||
131435308|NCT01755234|473219261|FG000|Overall Study|Change in surgical case|2|||
131435309|NCT01755234|473219262|FG001|Overall Study|Change in surgical case|1|||
131435310|NCT01755234|473219261|FG000|Overall Study|case cancelled|1|||
131435311|NCT01755234|473219262|FG001|Overall Study|case cancelled|0|||
131435312|NCT01755234|473219261|FG000|Overall Study|Withdrawal by Subject|0|||
131435313|NCT01755234|473219262|FG001|Overall Study|Withdrawal by Subject|1|||
131435314|NCT01755234|473219261|FG000|Overall Study|unblinded|1|||
131435315|NCT01755234|473219262|FG001|Overall Study|unblinded|0|||
131435316|NCT00248495|473219263|FG000|Overall Study|Withdrawal by Subject|1|||
131435317|NCT03812380|473219264|FG000|Overall Study|Protocol Violation|3|||
131435318|NCT03812380|473219265|FG001|Overall Study|Protocol Violation|3|||
131435319|NCT03812380|473219264|FG000|Overall Study|Withdrawal by Subject|5|||
131435320|NCT03812380|473219265|FG001|Overall Study|Withdrawal by Subject|4|||
131435321|NCT03812380|473219264|FG000|Overall Study|Early termination of study|14|||
131435322|NCT03812380|473219265|FG001|Overall Study|Early termination of study|14|||
131435323|NCT02648204|473219266|FG000|Overall Study|Withdrawal by Subject|12|||
131435324|NCT02648204|473219267|FG001|Overall Study|Withdrawal by Subject|8|||
131435325|NCT02648204|473219268|FG002|Overall Study|Withdrawal by Subject|2|||
131435326|NCT02648204|473219269|FG003|Overall Study|Withdrawal by Subject|6|||
131435327|NCT02648204|473219266|FG000|Overall Study|Lost to Follow-up|5|||
131435328|NCT02648204|473219267|FG001|Overall Study|Lost to Follow-up|8|||
131435329|NCT02648204|473219268|FG002|Overall Study|Lost to Follow-up|4|||
131435330|NCT02648204|473219269|FG003|Overall Study|Lost to Follow-up|6|||
131435331|NCT02648204|473219266|FG000|Overall Study|Missing follow-up information|4|||
131435332|NCT02648204|473219267|FG001|Overall Study|Missing follow-up information|4|||
131435333|NCT02648204|473219268|FG002|Overall Study|Missing follow-up information|4|||
131435334|NCT02648204|473219269|FG003|Overall Study|Missing follow-up information|2|||
131435335|NCT02648204|473219266|FG000|Overall Study|Death|1|||
131435336|NCT02648204|473219267|FG001|Overall Study|Death|1|||
131435337|NCT02648204|473219268|FG002|Overall Study|Death|2|||
131435338|NCT02648204|473219269|FG003|Overall Study|Death|2|||
131435339|NCT02648204|473219266|FG000|Overall Study|Adverse Event|0|||
131435340|NCT02648204|473219267|FG001|Overall Study|Adverse Event|0|||
131435341|NCT02648204|473219268|FG002|Overall Study|Adverse Event|1|||
131435342|NCT02648204|473219269|FG003|Overall Study|Adverse Event|0|||
131435343|NCT04537793|473219277|FG000|Part B (24 Weeks)|Adverse Event|0|||
131435344|NCT04537793|473219278|FG001|Part B (24 Weeks)|Adverse Event|1|||
131435345|NCT05470387|473219279|FG000|Overall Study|Protocol Violation|0|||
131435346|NCT05470387|473219280|FG001|Overall Study|Protocol Violation|3|||
131435347|NCT01255423|473219281|FG000|Overall Study|Abnormal Laboratory value|3|||
131435348|NCT01255423|473219282|FG001|Overall Study|Abnormal Laboratory value|2|||
131435349|NCT01255423|473219281|FG000|Overall Study|Use of prohibited medications|0|||
131435350|NCT01255423|473219282|FG001|Overall Study|Use of prohibited medications|1|||
131435351|NCT01176058|473219283|FG000|Overall Study|Adverse Event|1|||
131435352|NCT01176058|473219284|FG001|Overall Study|Adverse Event|0|||
131435353|NCT01176058|473219283|FG000|Overall Study|Insufficient clinical response|2|||
131435354|NCT01176058|473219284|FG001|Overall Study|Insufficient clinical response|2|||
131435355|NCT01176058|473219283|FG000|Overall Study|Insufficient mycological response|0|||
131435356|NCT01176058|473219284|FG001|Overall Study|Insufficient mycological response|1|||
131435357|NCT01176058|473219283|FG000|Overall Study|Withdrawal by Subject|1|||
131435358|NCT01176058|473219284|FG001|Overall Study|Withdrawal by Subject|0|||
131435359|NCT00101686|473219285|FG000|Overall Study|Progressive Disease|37|||
131661408|NCT03738423|474044650|FG004|Overall Study|Death|1|||
131435360|NCT00101686|473219286|FG001|Overall Study|Progressive Disease|28|||
131435361|NCT00101686|473219287|FG002|Overall Study|Progressive Disease|37|||
131435362|NCT00101686|473219288|FG003|Overall Study|Progressive Disease|38|||
131435363|NCT00101686|473219289|FG004|Overall Study|Progressive Disease|28|||
131661409|NCT03738423|474044646|FG000|Overall Study|Randomized but never treated|0|||
131661410|NCT03738423|474044647|FG001|Overall Study|Randomized but never treated|0|||
131661411|NCT03738423|474044648|FG002|Overall Study|Randomized but never treated|1|||
131661412|NCT03738423|474044649|FG003|Overall Study|Randomized but never treated|1|||
131661413|NCT03738423|474044650|FG004|Overall Study|Randomized but never treated|0|||
131661414|NCT01133418|474044651|FG000|Overall Study|Lost to Follow-up|5|||
131661415|NCT01133418|474044652|FG001|Overall Study|Lost to Follow-up|6|||
131661416|NCT05316701|474044653|FG000|Overall Study|Adverse Event|0|||
131661417|NCT05316701|474044654|FG001|Overall Study|Adverse Event|1|||
131661418|NCT05316701|474044653|FG000|Overall Study|Death|3|||
131661419|NCT05316701|474044654|FG001|Overall Study|Death|9|||
131661420|NCT05316701|474044653|FG000|Overall Study|Lost to Follow-up|1|||
131661421|NCT05316701|474044654|FG001|Overall Study|Lost to Follow-up|0|||
131661422|NCT05316701|474044653|FG000|Overall Study|Physician Decision|1|||
131661423|NCT05316701|474044654|FG001|Overall Study|Physician Decision|4|||
131661424|NCT05316701|474044653|FG000|Overall Study|Withdrawal by Subject|3|||
131661425|NCT05316701|474044654|FG001|Overall Study|Withdrawal by Subject|5|||
131661426|NCT05316701|474044653|FG000|Overall Study|Progression/Relapse|14|||
131661427|NCT05316701|474044654|FG001|Overall Study|Progression/Relapse|9|||
131661428|NCT05316701|474044653|FG000|Overall Study|Received Standard of Care|1|||
131661429|NCT05316701|474044654|FG001|Overall Study|Received Standard of Care|0|||
131661430|NCT05316701|474044653|FG000|Overall Study|Ongoing|70|||
131661431|NCT05316701|474044654|FG001|Overall Study|Ongoing|64|||
131661432|NCT04696653|474044655|FG000|Overall Study|left organization|18|||
131661433|NCT04696653|474044655|FG000|Overall Study|Lost to Follow-up|3|||
131661434|NCT04349631|474044656|FG000|Overall Study|Lost to Follow-up|3|||
131661435|NCT04349631|474044656|FG000|Overall Study|Withdrawal by Subject|7|||
131661436|NCT01982448|474044657|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
131661437|NCT01982448|474044658|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
131661438|NCT01982448|474044657|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
131661439|NCT01982448|474044658|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
131661440|NCT01982448|474044657|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
131661441|NCT01982448|474044658|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
131661442|NCT01982448|474044657|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
131661443|NCT01982448|474044658|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
131661444|NCT01198756|474046091|FG000|Overall Study|Adverse Event|0|||
131661445|NCT01198756|474046092|FG001|Overall Study|Adverse Event|0|||
131661446|NCT01198756|474046093|FG002|Overall Study|Adverse Event|0|||
131661447|NCT01198756|474046094|FG003|Overall Study|Adverse Event|1|||
131661448|NCT01198756|474046091|FG000|Overall Study|Protocol Violation|0|||
131661449|NCT01198756|474046092|FG001|Overall Study|Protocol Violation|0|||
131661450|NCT01198756|474046093|FG002|Overall Study|Protocol Violation|0|||
131661451|NCT01198756|474046094|FG003|Overall Study|Protocol Violation|2|||
131661452|NCT01198756|474046091|FG000|Overall Study|Withdrawal by Subject|9|||
131661453|NCT01198756|474046092|FG001|Overall Study|Withdrawal by Subject|4|||
131435364|NCT00101686|473219290|FG005|Overall Study|Progressive Disease|25|||
131435365|NCT00101686|473219291|FG006|Overall Study|Progressive Disease|5|||
131435366|NCT00101686|473219292|FG007|Overall Study|Progressive Disease|7|||
131435367|NCT00101686|473219293|FG008|Overall Study|Progressive Disease|10|||
131435368|NCT00101686|473219294|FG009|Overall Study|Progressive Disease|8|||
131435369|NCT00101686|473219285|FG000|Overall Study|initiation other anti-cancer treatment|4|||
131435370|NCT00101686|473219286|FG001|Overall Study|initiation other anti-cancer treatment|3|||
131435371|NCT00101686|473219287|FG002|Overall Study|initiation other anti-cancer treatment|4|||
131435372|NCT00101686|473219288|FG003|Overall Study|initiation other anti-cancer treatment|3|||
131435373|NCT00101686|473219289|FG004|Overall Study|initiation other anti-cancer treatment|1|||
131435374|NCT00101686|473219290|FG005|Overall Study|initiation other anti-cancer treatment|1|||
131435375|NCT00101686|473219291|FG006|Overall Study|initiation other anti-cancer treatment|2|||
131435376|NCT00101686|473219292|FG007|Overall Study|initiation other anti-cancer treatment|2|||
131435377|NCT00101686|473219293|FG008|Overall Study|initiation other anti-cancer treatment|3|||
131435378|NCT00101686|473219294|FG009|Overall Study|initiation other anti-cancer treatment|3|||
131435379|NCT00101686|473219285|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
131435380|NCT00101686|473219286|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
131435381|NCT00101686|473219287|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
131435382|NCT00101686|473219288|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
131435383|NCT00101686|473219289|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
131435384|NCT00101686|473219290|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
131661454|NCT01198756|474046093|FG002|Overall Study|Withdrawal by Subject|7|||
131661455|NCT01198756|474046094|FG003|Overall Study|Withdrawal by Subject|5|||
131661456|NCT01198756|474046091|FG000|Overall Study|Lost to Follow-up|29|||
131661457|NCT01198756|474046092|FG001|Overall Study|Lost to Follow-up|36|||
131661458|NCT01198756|474046093|FG002|Overall Study|Lost to Follow-up|23|||
131661459|NCT01198756|474046094|FG003|Overall Study|Lost to Follow-up|18|||
131661460|NCT00901186|474046098|FG000|Overall Study|Lack of Efficacy|0|||
131661461|NCT00901186|474046099|FG001|Overall Study|Lack of Efficacy|1|||
131435385|NCT00101686|473219291|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
131435386|NCT00101686|473219292|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
131435387|NCT00101686|473219293|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
131435388|NCT00101686|473219294|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
131435389|NCT00101686|473219285|FG000|Overall Study|unacceptable toxicity|3|||
131435390|NCT00101686|473219286|FG001|Overall Study|unacceptable toxicity|9|||
131435391|NCT00101686|473219287|FG002|Overall Study|unacceptable toxicity|10|||
131435392|NCT00101686|473219288|FG003|Overall Study|unacceptable toxicity|6|||
131435393|NCT00101686|473219289|FG004|Overall Study|unacceptable toxicity|16|||
131435394|NCT00101686|473219290|FG005|Overall Study|unacceptable toxicity|10|||
131435395|NCT00101686|473219291|FG006|Overall Study|unacceptable toxicity|4|||
131435396|NCT00101686|473219292|FG007|Overall Study|unacceptable toxicity|2|||
131435397|NCT00101686|473219293|FG008|Overall Study|unacceptable toxicity|1|||
131435398|NCT00101686|473219294|FG009|Overall Study|unacceptable toxicity|4|||
131435399|NCT00101686|473219285|FG000|Overall Study|Randomized but did not receive treament|1|||
131435400|NCT00101686|473219286|FG001|Overall Study|Randomized but did not receive treament|6|||
131435401|NCT00101686|473219287|FG002|Overall Study|Randomized but did not receive treament|2|||
131435402|NCT00101686|473219288|FG003|Overall Study|Randomized but did not receive treament|2|||
131435403|NCT00101686|473219289|FG004|Overall Study|Randomized but did not receive treament|2|||
131435404|NCT00101686|473219290|FG005|Overall Study|Randomized but did not receive treament|2|||
131435405|NCT00101686|473219291|FG006|Overall Study|Randomized but did not receive treament|0|||
131435406|NCT00101686|473219292|FG007|Overall Study|Randomized but did not receive treament|1|||
131435407|NCT00101686|473219293|FG008|Overall Study|Randomized but did not receive treament|0|||
131435408|NCT00101686|473219294|FG009|Overall Study|Randomized but did not receive treament|1|||
131435409|NCT00101686|473219285|FG000|Overall Study|intercurrent non-cancer related illness|0|||
131435410|NCT00101686|473219286|FG001|Overall Study|intercurrent non-cancer related illness|0|||
131435411|NCT00101686|473219287|FG002|Overall Study|intercurrent non-cancer related illness|2|||
131435412|NCT00101686|473219288|FG003|Overall Study|intercurrent non-cancer related illness|0|||
131435413|NCT00101686|473219289|FG004|Overall Study|intercurrent non-cancer related illness|1|||
131435414|NCT00101686|473219290|FG005|Overall Study|intercurrent non-cancer related illness|3|||
131435415|NCT00101686|473219291|FG006|Overall Study|intercurrent non-cancer related illness|1|||
131435416|NCT00101686|473219292|FG007|Overall Study|intercurrent non-cancer related illness|0|||
131435417|NCT00101686|473219293|FG008|Overall Study|intercurrent non-cancer related illness|1|||
131435418|NCT00101686|473219294|FG009|Overall Study|intercurrent non-cancer related illness|1|||
131435419|NCT00101686|473219285|FG000|Overall Study|Physician Decision|10|||
131435420|NCT00101686|473219286|FG001|Overall Study|Physician Decision|13|||
131435421|NCT00101686|473219287|FG002|Overall Study|Physician Decision|6|||
131435422|NCT00101686|473219288|FG003|Overall Study|Physician Decision|7|||
131435423|NCT00101686|473219289|FG004|Overall Study|Physician Decision|8|||
131435424|NCT00101686|473219290|FG005|Overall Study|Physician Decision|9|||
131435425|NCT00101686|473219291|FG006|Overall Study|Physician Decision|5|||
131435426|NCT00101686|473219292|FG007|Overall Study|Physician Decision|5|||
131435427|NCT00101686|473219293|FG008|Overall Study|Physician Decision|1|||
131435428|NCT00101686|473219294|FG009|Overall Study|Physician Decision|1|||
131435429|NCT00101686|473219285|FG000|Overall Study|Other|1|||
131435430|NCT00101686|473219286|FG001|Overall Study|Other|4|||
131435431|NCT00101686|473219287|FG002|Overall Study|Other|1|||
131435432|NCT00101686|473219288|FG003|Overall Study|Other|6|||
131435433|NCT00101686|473219289|FG004|Overall Study|Other|2|||
131435434|NCT00101686|473219290|FG005|Overall Study|Other|12|||
131435435|NCT00101686|473219291|FG006|Overall Study|Other|1|||
131435436|NCT00101686|473219292|FG007|Overall Study|Other|5|||
131435437|NCT00101686|473219293|FG008|Overall Study|Other|3|||
131435438|NCT00101686|473219294|FG009|Overall Study|Other|3|||
131548832|NCT00941798|473631707|FG000|Overall Study|Lack of Efficacy|10|||
131548833|NCT00941798|473631708|FG001|Overall Study|Lack of Efficacy|17|||
131548834|NCT00941798|473631707|FG000|Overall Study|Patient's inability to use device|6|||
131548835|NCT00941798|473631708|FG001|Overall Study|Patient's inability to use device|1|||
131548836|NCT00941798|473631707|FG000|Overall Study|Abnormal test procedure results|3|||
131548837|NCT00941798|473631708|FG001|Overall Study|Abnormal test procedure results|1|||
131548838|NCT00941798|473631707|FG000|Overall Study|Abnormal laboratory values|1|||
131548839|NCT00941798|473631708|FG001|Overall Study|Abnormal laboratory values|2|||
131548840|NCT00941798|473631707|FG000|Overall Study|Death|0|||
131548841|NCT00941798|473631708|FG001|Overall Study|Death|1|||
131548842|NCT03444376|473631713|FG000|Part A|Disease relapse or Progression|1|||
131548843|NCT03444376|473631713|FG000|Part A|Withdrawal by Subject|2|||
131548844|NCT03444376|473631713|FG000|Part A|Adverse Event|1|||
131548845|NCT03444376|473631713|FG000|Part B|Disease relapse or Progression|18|||
131548846|NCT03444376|473631713|FG000|Part B|Withdrawal by Subject|2|||
131548847|NCT03444376|473631713|FG000|Part B|Adverse Event|2|||
131435439|NCT00101686|473219285|FG000|Overall Study|Withdrawal by Subject|9|||
131548848|NCT03444376|473631713|FG000|Part B|Physician Decision|1|||
131548849|NCT03444376|473631713|FG000|Part C|Disease relapse or Progression|43|||
131548850|NCT03444376|473631713|FG000|Part C|Withdrawal by Subject|5|||
131548851|NCT03444376|473631713|FG000|Part C|Adverse Event|2|||
131548852|NCT03444376|473631713|FG000|Part C|Physician Decision|2|||
131548853|NCT03444376|473631713|FG000|Part C|Death|1|||
131548854|NCT00766675|473632796|FG000|Overall Study|Adverse Event|16|||
131548855|NCT00766675|473632796|FG000|Overall Study|Lost to Follow-up|2|||
131548856|NCT00766675|473632796|FG000|Overall Study|Withdrawal by Subject|11|||
131548857|NCT00766675|473632796|FG000|Overall Study|Protocol Violation|8|||
131548858|NCT00766675|473632796|FG000|Overall Study|Participant took prohibited medication|1|||
131548859|NCT00766675|473632796|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
131548860|NCT00766675|473632796|FG000|Overall Study|Insufficient therapy|1|||
131548861|NCT03308825|473632797|FG000|Overall Study|Lost to Follow-up|2|||
131548862|NCT03308825|473632798|FG001|Overall Study|Lost to Follow-up|2|||
131548863|NCT03308825|473632799|FG002|Overall Study|Lost to Follow-up|1|||
131548864|NCT03308825|473632800|FG003|Overall Study|Lost to Follow-up|0|||
131548865|NCT03308825|473632797|FG000|Overall Study|Protocol Violation|0|||
131548866|NCT03308825|473632798|FG001|Overall Study|Protocol Violation|2|||
131548867|NCT03308825|473632799|FG002|Overall Study|Protocol Violation|0|||
131548868|NCT03308825|473632800|FG003|Overall Study|Protocol Violation|0|||
131548869|NCT00685945|473632801|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
131548870|NCT01728792|473632802|FG000|Overall Study|Withdrawal of Consent|1|||
131548871|NCT01728792|473632803|FG001|Overall Study|Withdrawal of Consent|1|||
131548872|NCT01728792|473632804|FG002|Overall Study|Withdrawal of Consent|0|||
131548873|NCT01728792|473632805|FG003|Overall Study|Withdrawal of Consent|1|||
131661462|NCT00901186|474046098|FG000|Overall Study|Abnormal laboratory values|0|||
131661463|NCT00901186|474046099|FG001|Overall Study|Abnormal laboratory values|1|||
131661464|NCT00901186|474046098|FG000|Overall Study|Lost to Follow-up|2|||
131661465|NCT00901186|474046099|FG001|Overall Study|Lost to Follow-up|0|||
131661466|NCT00901186|474046098|FG000|Overall Study|Adverse Event|2|||
131661467|NCT00901186|474046099|FG001|Overall Study|Adverse Event|4|||
131661468|NCT00901186|474046098|FG000|Overall Study|Administration problems|0|||
131661469|NCT00901186|474046099|FG001|Overall Study|Administration problems|1|||
131661470|NCT00901186|474046098|FG000|Overall Study|Protocol deviations|5|||
131661471|NCT00901186|474046099|FG001|Overall Study|Protocol deviations|4|||
131661472|NCT00581555|474046102|FG000|Overall Study|Adverse Event|4|||
131661473|NCT00581555|474046103|FG001|Overall Study|Adverse Event|3|||
131661474|NCT00581555|474046102|FG000|Overall Study|Physician Decision|3|||
131661475|NCT00581555|474046103|FG001|Overall Study|Physician Decision|2|||
131661476|NCT00581555|474046102|FG000|Overall Study|Withdrawal by Subject|18|||
131661477|NCT00581555|474046103|FG001|Overall Study|Withdrawal by Subject|9|||
131548874|NCT01728792|473632806|FG004|Overall Study|Withdrawal of Consent|0|||
131548875|NCT01728792|473632802|FG000|Overall Study|Lost to Follow-up|2|||
131548876|NCT01728792|473632803|FG001|Overall Study|Lost to Follow-up|1|||
131548877|NCT01728792|473632804|FG002|Overall Study|Lost to Follow-up|4|||
131548878|NCT01728792|473632805|FG003|Overall Study|Lost to Follow-up|2|||
131548879|NCT01728792|473632806|FG004|Overall Study|Lost to Follow-up|0|||
131548880|NCT04277455|473632809|FG000|Overall Study|Lost to Follow-up|1|||
131548881|NCT04737109|473632810|FG000|Study Treatment|Disease Progression|5|||
131548882|NCT04737109|473632811|FG001|Study Treatment|Disease Progression|0|||
131548883|NCT04737109|473632812|FG002|Study Treatment|Disease Progression|0|||
131548884|NCT04737109|473632813|FG003|Study Treatment|Disease Progression|0|||
131548885|NCT04737109|473632810|FG000|Study Treatment|Death on study|1|||
131548886|NCT04737109|473632811|FG001|Study Treatment|Death on study|0|||
131548887|NCT04737109|473632812|FG002|Study Treatment|Death on study|0|||
131548888|NCT04737109|473632813|FG003|Study Treatment|Death on study|0|||
131548889|NCT01582789|473632818|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
131548890|NCT01582789|473632819|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
131661478|NCT00581555|474046102|FG000|Overall Study|Lost to Follow-up|2|||
131661479|NCT00581555|474046103|FG001|Overall Study|Lost to Follow-up|2|||
131661480|NCT00581555|474046102|FG000|Overall Study|Other reasons|16|||
131661481|NCT00581555|474046103|FG001|Overall Study|Other reasons|4|||
131661482|NCT05816330|474046104|FG000|Overall Study|Withdrawal by Subject|4|||
131661483|NCT05816330|474046105|FG001|Overall Study|Withdrawal by Subject|1|||
131661484|NCT03900416|474046106|FG000|Six Week Follow-up|Lost to Follow-up|1|||
131661485|NCT03900416|474046107|FG001|Six Week Follow-up|Lost to Follow-up|0|||
131661486|NCT03900416|474046106|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
131661487|NCT03900416|474046107|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
131548891|NCT02259517|473632820|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
131548892|NCT02259517|473632821|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
131661488|NCT03900416|474046106|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
131661489|NCT03900416|474046107|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
131887887|NCT00236899|474872308|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
131548893|NCT02259517|473632822|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
131548894|NCT02259517|473632820|FG000|Overall Study|Withdrawal by Subject|0|||
131548895|NCT02259517|473632821|FG001|Overall Study|Withdrawal by Subject|0|||
131548896|NCT02259517|473632822|FG002|Overall Study|Withdrawal by Subject|3|||
131548897|NCT02276066|473632823|FG000|Overall Study|Lost to Follow-up|21|||
131548898|NCT02276066|473632824|FG001|Overall Study|Lost to Follow-up|11|||
131548899|NCT02710292|473632832|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
131548900|NCT02710292|473632833|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
131548901|NCT02710292|473632832|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
131548902|NCT02710292|473632833|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
131548903|NCT01191840|473632834|FG000|Overall Study|withdrew consent|2|||
131548904|NCT01191840|473632835|FG001|Overall Study|withdrew consent|1|||
131548905|NCT01191840|473632834|FG000|Overall Study|Subject discontinued treatment|1|||
131548906|NCT01191840|473632835|FG001|Overall Study|Subject discontinued treatment|2|||
131548907|NCT01191840|473632834|FG000|Overall Study|Lost to Follow-up|4|||
131548908|NCT01191840|473632835|FG001|Overall Study|Lost to Follow-up|6|||
131548909|NCT01191840|473632834|FG000|Overall Study|Non Staph Infection|4|||
131548910|NCT01191840|473632835|FG001|Overall Study|Non Staph Infection|3|||
131548911|NCT01191840|473632834|FG000|Overall Study|ineligible at enrollment|1|||
131548912|NCT01191840|473632835|FG001|Overall Study|ineligible at enrollment|0|||
131548913|NCT01191840|473632834|FG000|Overall Study|IRB approval lapse|0|||
131661490|NCT03900416|474046106|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
131661491|NCT03900416|474046107|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
131661492|NCT03900416|474046106|FG000|Twelve Week Follow-up|Adverse Event|1|||
131661493|NCT03900416|474046107|FG001|Twelve Week Follow-up|Adverse Event|1|||
131661494|NCT03900416|474046106|FG000|Six Month Follow-up|Lost to Follow-up|4|||
131661495|NCT03900416|474046107|FG001|Six Month Follow-up|Lost to Follow-up|3|||
131661496|NCT03900416|474046106|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
131661497|NCT03900416|474046107|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
131661498|NCT00772330|474046108|FG000|Overall Study|Lost to Follow-up|3|||
131661499|NCT01353859|474046109|FG000|Overall Study|Adverse Event|3|||
131661500|NCT01353859|474046109|FG000|Overall Study|Lack of Efficacy|1|||
131661501|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
131661502|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131661503|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131661504|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131661505|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131661506|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
131661507|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131661508|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131661509|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131661510|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131661511|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
131661512|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131661513|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131661514|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131661515|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131661516|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
131661517|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131661518|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131661519|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131661520|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131661521|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
131661522|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131661523|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131661524|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131661525|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131661526|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
131661527|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131661528|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131661529|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131661530|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131661531|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
131661532|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131661533|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131661534|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131661535|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131661536|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
131661537|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131548914|NCT01191840|473632835|FG001|Overall Study|IRB approval lapse|2|||
131661538|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131548915|NCT01191840|473632834|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
131548916|NCT01191840|473632835|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
131548917|NCT01191840|473632834|FG000|Overall Study|Withdrawal by Subject|2|||
131548918|NCT01191840|473632835|FG001|Overall Study|Withdrawal by Subject|0|||
131548919|NCT02736825|473632836|FG000|Overall Study|Lost to Follow-up|10|||
131548920|NCT02736825|473632837|FG001|Overall Study|Lost to Follow-up|11|||
131548921|NCT02736825|473632836|FG000|Overall Study|Early Termination|0|||
131548922|NCT02736825|473632837|FG001|Overall Study|Early Termination|1|||
131548923|NCT00790452|473632838|FG000|Overall Study|Drug supply issue|1|||
131548924|NCT00790452|473632839|FG001|Overall Study|Drug supply issue|0|||
131548925|NCT01564368|473632846|FG000|Overall Study|Ineligible|18|||
131661539|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131661540|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131661541|NCT00700427|474046110|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
131661542|NCT00700427|474046111|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131661543|NCT00700427|474046112|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131661544|NCT00700427|474046113|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131661545|NCT00700427|474046114|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131661546|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131661547|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
131661548|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131661549|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131661550|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131661551|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131661552|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
131661553|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131661554|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131661555|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131661556|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131661557|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
131661558|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131661559|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131661560|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131661561|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131661562|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
131661563|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131661564|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131661565|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131661566|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131661567|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
131661568|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131661569|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131661570|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131661571|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131661572|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
131661573|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131661574|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131661575|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131661576|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131661577|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
131661578|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131661579|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131661580|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131661581|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131661582|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
131770315|NCT00501969|474437890|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
131770316|NCT00501969|474437890|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
131548926|NCT01564368|473632846|FG000|Overall Study|Not Randomized in Parent study|116|||
131548927|NCT01564368|473632846|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
131548928|NCT01564368|473632846|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
131548929|NCT01802437|473632847|FG000|Overall Study|Lost to Follow-up|1|||
131548930|NCT01802437|473632848|FG001|Overall Study|Lost to Follow-up|0|||
131548931|NCT01802437|473632847|FG000|Overall Study|Withdrawal by Subject|3|||
131548932|NCT01802437|473632848|FG001|Overall Study|Withdrawal by Subject|4|||
131548933|NCT04082884|473632849|FG000|Overall Study|Withdrawal by Subject|1|||
131770317|NCT00501969|474437890|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
131770318|NCT00501969|474437890|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
131770319|NCT00501969|474437890|FG000|Overall Study|Other: As Required by Local EC|2|||
131887888|NCT00236899|474872305|FG000|Overall Study|Death (Study Disease)|1|||
131548934|NCT00331344|473632850|FG000|Phase I|Adverse Event|0|||
131548935|NCT00331344|473632851|FG001|Phase I|Adverse Event|0|||
131548936|NCT00331344|473632852|FG002|Phase I|Adverse Event|0|||
131548937|NCT00331344|473632853|FG003|Phase I|Adverse Event|1|||
131548938|NCT00331344|473632854|FG004|Phase I|Adverse Event|2|||
131548939|NCT00331344|473632855|FG005|Phase I|Adverse Event|2|||
131548940|NCT00331344|473632856|FG006|Phase I|Adverse Event|0|||
131548941|NCT00331344|473632857|FG007|Phase I|Adverse Event|1|||
131548942|NCT00331344|473632858|FG008|Phase I|Adverse Event|0|||
131548943|NCT00331344|473632850|FG000|Phase II|Death|0|||
131548944|NCT00331344|473632851|FG001|Phase II|Death|0|||
131548945|NCT00331344|473632852|FG002|Phase II|Death|0|||
131548946|NCT00331344|473632853|FG003|Phase II|Death|0|||
131548947|NCT00331344|473632854|FG004|Phase II|Death|0|||
131548948|NCT00331344|473632855|FG005|Phase II|Death|0|||
131548949|NCT00331344|473632856|FG006|Phase II|Death|0|||
131548950|NCT00331344|473632857|FG007|Phase II|Death|0|||
131548951|NCT00331344|473632858|FG008|Phase II|Death|4|||
131548952|NCT00659490|473632864|FG000|Overall Study|Lost to Follow-up|2|||
131548953|NCT00659490|473632865|FG001|Overall Study|Lost to Follow-up|0|||
131548954|NCT00659490|473632866|FG002|Overall Study|Lost to Follow-up|1|||
131548955|NCT02228967|473632867|FG000|Overall Study|Lost to Follow-up|146|||
131548956|NCT02228967|473632868|FG001|Overall Study|Lost to Follow-up|142|||
131548957|NCT02228967|473632867|FG000|Overall Study|Withdrawal by Subject|13|||
131548958|NCT02228967|473632868|FG001|Overall Study|Withdrawal by Subject|18|||
131548959|NCT00520975|473632869|FG000|Overall Study|Disease progression|31|||
131548960|NCT00520975|473632870|FG001|Overall Study|Disease progression|23|||
131548961|NCT00520975|473632869|FG000|Overall Study|Adverse Event|7|||
131548962|NCT00520975|473632870|FG001|Overall Study|Adverse Event|10|||
131548963|NCT00520975|473632869|FG000|Overall Study|Death|0|||
131548964|NCT00520975|473632870|FG001|Overall Study|Death|2|||
131548965|NCT00520975|473632869|FG000|Overall Study|Withdrawal by Subject|3|||
131548966|NCT00520975|473632870|FG001|Overall Study|Withdrawal by Subject|5|||
131548967|NCT00520975|473632869|FG000|Overall Study|Other therapy|2|||
131548968|NCT00520975|473632870|FG001|Overall Study|Other therapy|4|||
131548969|NCT00520975|473632869|FG000|Overall Study|Other reasons|4|||
131548970|NCT00520975|473632870|FG001|Overall Study|Other reasons|2|||
131548971|NCT00520975|473632869|FG000|Overall Study|Not start protocol therapy|1|||
131548972|NCT00520975|473632870|FG001|Overall Study|Not start protocol therapy|2|||
131548973|NCT01995539|473632871|FG000|Overall Study|Screening Failure|1|||
131548974|NCT01995539|473632871|FG000|Overall Study|Withdrawal by Investigator|15|||
131548975|NCT01995539|473632871|FG000|Overall Study|Withdrawal by Subject|11|||
131548976|NCT01995539|473632871|FG000|Overall Study|Lost to Follow-up|5|||
131548977|NCT01995539|473632871|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
131548978|NCT02696564|473632872|FG000|Overall Study|Death|1|||
131548979|NCT02696564|473632873|FG001|Overall Study|Death|2|||
131548980|NCT02696564|473632872|FG000|Overall Study|Withdrawal by Subject|3|||
131548981|NCT02696564|473632873|FG001|Overall Study|Withdrawal by Subject|2|||
131548982|NCT02696564|473632872|FG000|Overall Study|Lost to Follow-up|3|||
131548983|NCT02696564|473632873|FG001|Overall Study|Lost to Follow-up|3|||
131548984|NCT02696564|473632872|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
131548985|NCT02696564|473632873|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
131548986|NCT02696564|473632872|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
131548987|NCT02696564|473632873|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
131548988|NCT02696564|473632872|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
131548989|NCT02696564|473632873|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
131548990|NCT02696564|473632872|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
131548991|NCT02696564|473632873|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
131548992|NCT02696564|473632872|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
131548993|NCT02696564|473632873|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
131548994|NCT00499863|473632875|FG000|Overall Study|Lack of Efficacy|21|||
131548995|NCT00499863|473632876|FG001|Overall Study|Lack of Efficacy|27|||
131548996|NCT00499863|473632875|FG000|Overall Study|Protocol Violation|12|||
131548997|NCT00499863|473632876|FG001|Overall Study|Protocol Violation|7|||
131548998|NCT00499863|473632875|FG000|Overall Study|Withdrawal by Subject|6|||
131548999|NCT00499863|473632876|FG001|Overall Study|Withdrawal by Subject|4|||
131549000|NCT00499863|473632875|FG000|Overall Study|Adverse Event|8|||
131549001|NCT00499863|473632876|FG001|Overall Study|Adverse Event|2|||
131549002|NCT00499863|473632875|FG000|Overall Study|Sponsor decision|2|||
131549003|NCT00499863|473632876|FG001|Overall Study|Sponsor decision|2|||
131549004|NCT00499863|473632875|FG000|Overall Study|Lost to Follow-up|1|||
131549005|NCT00499863|473632876|FG001|Overall Study|Lost to Follow-up|1|||
131549006|NCT03351738|473632877|FG000|Overall Study|Withdrawal by Subject|0|||
131549007|NCT03351738|473632878|FG001|Overall Study|Withdrawal by Subject|1|||
131549008|NCT03351738|473632879|FG002|Overall Study|Withdrawal by Subject|0|||
131549009|NCT03351738|473632880|FG003|Overall Study|Withdrawal by Subject|1|||
131549010|NCT03351738|473632881|FG004|Overall Study|Withdrawal by Subject|0|||
131549011|NCT03351738|473632882|FG005|Overall Study|Withdrawal by Subject|0|||
131549012|NCT01375205|473632883|FG000|Overall Study|Lost to Follow-up|15|||
131549013|NCT01375205|473632884|FG001|Overall Study|Lost to Follow-up|12|||
131770320|NCT00501969|474437890|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
131770321|NCT00501969|474437890|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
131770322|NCT05111548|474437896|FG000|Overall Study|Withdrawal by Subject|2|||
131770323|NCT05111548|474437897|FG001|Overall Study|Withdrawal by Subject|1|||
131661583|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131661584|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131661585|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131661586|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131770324|NCT05111548|474437896|FG000|Overall Study|Adverse Event|1|||
131770325|NCT05111548|474437897|FG001|Overall Study|Adverse Event|0|||
131770326|NCT00379639|474437898|FG000|Overall Study|Disease Progression|3|||
131770327|NCT00379639|474437899|FG001|Overall Study|Disease Progression|3|||
131770328|NCT00379639|474437900|FG002|Overall Study|Disease Progression|3|||
131770329|NCT00379639|474437901|FG003|Overall Study|Disease Progression|4|||
131770330|NCT00379639|474437902|FG004|Overall Study|Disease Progression|4|||
131770331|NCT00379639|474437898|FG000|Overall Study|Physician Decision|0|||
131770332|NCT00379639|474437899|FG001|Overall Study|Physician Decision|2|||
131770333|NCT00379639|474437900|FG002|Overall Study|Physician Decision|1|||
131770334|NCT00379639|474437901|FG003|Overall Study|Physician Decision|1|||
131770335|NCT00379639|474437902|FG004|Overall Study|Physician Decision|0|||
131770336|NCT00379639|474437898|FG000|Overall Study|Symptomatic Deterioration|0|||
131770337|NCT00379639|474437899|FG001|Overall Study|Symptomatic Deterioration|0|||
131770338|NCT00379639|474437900|FG002|Overall Study|Symptomatic Deterioration|1|||
131770339|NCT00379639|474437901|FG003|Overall Study|Symptomatic Deterioration|0|||
131770340|NCT00379639|474437902|FG004|Overall Study|Symptomatic Deterioration|1|||
131770341|NCT00379639|474437898|FG000|Overall Study|Adverse Event|0|||
131770342|NCT00379639|474437899|FG001|Overall Study|Adverse Event|0|||
131770343|NCT00379639|474437900|FG002|Overall Study|Adverse Event|1|||
131661587|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
131661588|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131661589|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131661590|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131661591|NCT00700427|474046110|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131661592|NCT00700427|474046111|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
131661593|NCT00700427|474046112|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131661594|NCT00700427|474046113|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131661595|NCT00700427|474046114|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131661596|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
131770344|NCT00379639|474437901|FG003|Overall Study|Adverse Event|0|||
131770345|NCT00379639|474437902|FG004|Overall Study|Adverse Event|1|||
131770346|NCT00379639|474437898|FG000|Overall Study|Lost to Follow-up|0|||
131661597|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
131661598|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
131661599|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
131661600|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
131661601|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
131661602|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
131661603|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
131661604|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
131661605|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
131661606|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
131661607|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
131661608|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
131661609|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
131661610|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
131661611|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
131661612|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
131661613|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
131661614|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
131661615|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
131661616|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
131661617|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
131661618|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
131661619|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
131770347|NCT00379639|474437899|FG001|Overall Study|Lost to Follow-up|0|||
131770348|NCT00379639|474437900|FG002|Overall Study|Lost to Follow-up|0|||
131887889|NCT00236899|474872306|FG001|Overall Study|Death (Study Disease)|4|||
131549014|NCT01375205|473632883|FG000|Overall Study|Withdrawal by Subject|6|||
131549015|NCT01375205|473632884|FG001|Overall Study|Withdrawal by Subject|1|||
131549016|NCT05687032|473632885|FG000|Treatment Phase|Adverse Event|13|||
131549017|NCT05687032|473632885|FG000|Treatment Phase|Death|1|||
131549018|NCT05687032|473632885|FG000|Treatment Phase|Physician Decision|3|||
131549019|NCT05687032|473632885|FG000|Treatment Phase|Progressive disease|9|||
131549020|NCT05687032|473632885|FG000|Treatment Phase|Withdrawal by Subject|5|||
131549021|NCT05687032|473632885|FG000|Follow-Up Phase|Death|16|||
131549022|NCT05687032|473632885|FG000|Follow-Up Phase|Ongoing|26|||
131549023|NCT05614089|473632886|FG000|Overall Study|Pregnancy|5|||
131549024|NCT05614089|473632887|FG001|Overall Study|Pregnancy|2|||
131549025|NCT05614089|473632886|FG000|Overall Study|Lost to Follow-up|5|||
131549026|NCT05614089|473632887|FG001|Overall Study|Lost to Follow-up|1|||
131549027|NCT05614089|473632886|FG000|Overall Study|Death|0|||
131549028|NCT05614089|473632887|FG001|Overall Study|Death|1|||
131549029|NCT05614089|473632886|FG000|Overall Study|Adverse Event|1|||
131549030|NCT05614089|473632887|FG001|Overall Study|Adverse Event|0|||
131549031|NCT03759834|473632888|FG000|Overall Study|Withdrawal by Subject|1|||
131549032|NCT05701995|473632889|FG000|Pre-Treatment|Randomization Error|1|||
131549033|NCT05701995|473632890|FG001|Pre-Treatment|Randomization Error|1|||
131549034|NCT05701995|473632889|FG000|Treatment|Withdrawal by Subject|8|||
131661620|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
131661621|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131661622|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131661623|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131661624|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
131661625|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131661626|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131661627|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131661628|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131661629|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
131661630|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131661631|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
131661632|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
131661633|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
131661634|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
131661635|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
131661636|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131661637|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131661638|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
131661639|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131661640|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131661641|NCT00700427|474046110|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
131661642|NCT00700427|474046111|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
131661643|NCT00700427|474046112|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
131661644|NCT00700427|474046113|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
131661645|NCT00700427|474046114|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
131661646|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131661647|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131661648|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131661649|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131661650|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
131661651|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
131661652|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
131661653|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
131661654|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
131661655|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
131661656|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131661657|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131661658|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131661659|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131661660|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
131661661|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131661662|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131549035|NCT05701995|473632890|FG001|Treatment|Withdrawal by Subject|4|||
131549036|NCT05701995|473632889|FG000|Treatment|Lost to Follow-up|2|||
131549037|NCT05701995|473632890|FG001|Treatment|Lost to Follow-up|3|||
131549038|NCT05701995|473632889|FG000|Treatment|Adverse Event|3|||
131549039|NCT05701995|473632890|FG001|Treatment|Adverse Event|1|||
131549040|NCT05701995|473632889|FG000|Treatment|Other Reason|1|||
131549041|NCT05701995|473632890|FG001|Treatment|Other Reason|1|||
131549042|NCT05701995|473632889|FG000|Treatment|Death|1|||
131661663|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131661664|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131661665|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
131661666|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131661667|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131661668|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131661669|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131661670|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
131661671|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131661672|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131661673|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131661674|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131661675|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
131661676|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131661677|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131661678|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131661679|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131661680|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
131661681|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131661682|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131661683|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131661684|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131661685|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
131661686|NCT00700427|474046110|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131661687|NCT00700427|474046111|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131661688|NCT00700427|474046112|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131661689|NCT00700427|474046113|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131661690|NCT00700427|474046114|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
131661691|NCT03231800|474046115|FG000|Overall Study|Lost to Follow-up|0|||
131661692|NCT03231800|474046116|FG001|Overall Study|Lost to Follow-up|2|||
131661693|NCT03231800|474046115|FG000|Overall Study|Protocol Violation|1|||
131661694|NCT03231800|474046116|FG001|Overall Study|Protocol Violation|1|||
131661695|NCT03231800|474046115|FG000|Overall Study|reason not provided|2|||
131661696|NCT03231800|474046116|FG001|Overall Study|reason not provided|0|||
131661697|NCT00859222|474046117|FG000|Overall Study|Adverse Event|2|||
131661698|NCT00859222|474046118|FG001|Overall Study|Adverse Event|3|||
131661699|NCT00859222|474046119|FG002|Overall Study|Adverse Event|6|||
131661700|NCT00859222|474046120|FG003|Overall Study|Adverse Event|24|||
131661701|NCT00859222|474046121|FG004|Overall Study|Adverse Event|15|||
131435440|NCT00101686|473219286|FG001|Overall Study|Withdrawal by Subject|8|||
131435441|NCT00101686|473219287|FG002|Overall Study|Withdrawal by Subject|6|||
131435442|NCT00101686|473219288|FG003|Overall Study|Withdrawal by Subject|8|||
131435443|NCT00101686|473219289|FG004|Overall Study|Withdrawal by Subject|8|||
131435444|NCT00101686|473219290|FG005|Overall Study|Withdrawal by Subject|7|||
131435445|NCT00101686|473219291|FG006|Overall Study|Withdrawal by Subject|7|||
131435446|NCT00101686|473219292|FG007|Overall Study|Withdrawal by Subject|7|||
131435447|NCT00101686|473219293|FG008|Overall Study|Withdrawal by Subject|8|||
131435448|NCT00101686|473219294|FG009|Overall Study|Withdrawal by Subject|9|||
131435449|NCT00687401|473219295|FG000|Overall Study|Protocol Violation|7|||
131435450|NCT00687401|473219295|FG000|Overall Study|Adverse Event|6|||
131435451|NCT00687401|473219295|FG000|Overall Study|Lack of Efficacy|6|||
131435452|NCT00687401|473219295|FG000|Overall Study|Withdrawal by Subject|4|||
131435453|NCT00687401|473219295|FG000|Overall Study|Did not return for visit|3|||
131435454|NCT00687401|473219295|FG000|Overall Study|For reasons different from those above|4|||
131435455|NCT02920892|473219296|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
131435456|NCT02920892|473219297|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
131435457|NCT02920892|473219298|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
131435458|NCT02920892|473219296|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
131435459|NCT02920892|473219297|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
131435460|NCT02920892|473219298|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
131435461|NCT02920892|473219296|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
131435462|NCT02920892|473219297|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
131435463|NCT02920892|473219298|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
131435464|NCT02920892|473219296|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
131435465|NCT02920892|473219297|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
131435466|NCT02920892|473219298|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
131435467|NCT02920892|473219296|FG000|Placebo-Controlled Period|Physician Decision|0|||
131435468|NCT02920892|473219297|FG001|Placebo-Controlled Period|Physician Decision|0|||
131435469|NCT02920892|473219298|FG002|Placebo-Controlled Period|Physician Decision|1|||
131435470|NCT02920892|473219296|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
131549043|NCT05701995|473632890|FG001|Treatment|Death|0|||
131435471|NCT02920892|473219297|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
131435472|NCT02920892|473219298|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
131435473|NCT02920892|473219296|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131435474|NCT02920892|473219297|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
131435475|NCT02920892|473219298|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
131435476|NCT02920892|473219296|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
131435477|NCT02920892|473219297|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
131435478|NCT02920892|473219298|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
131661702|NCT00859222|474046117|FG000|Overall Study|DLT|1|||
131661703|NCT00859222|474046118|FG001|Overall Study|DLT|0|||
131661704|NCT00859222|474046119|FG002|Overall Study|DLT|0|||
131661705|NCT00859222|474046120|FG003|Overall Study|DLT|0|||
131661706|NCT00859222|474046121|FG004|Overall Study|DLT|0|||
131661707|NCT00400725|474046122|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
131661708|NCT00400725|474046123|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
131661709|NCT00400725|474046124|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
131661710|NCT00400725|474046122|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
131661711|NCT00400725|474046123|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
131661712|NCT00400725|474046124|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
131661713|NCT00400725|474046122|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
131661714|NCT00400725|474046123|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
131661715|NCT00400725|474046124|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
131661716|NCT00400725|474046122|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
131661717|NCT00400725|474046123|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
131661718|NCT00400725|474046124|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
131661719|NCT00400725|474046122|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
131661720|NCT00400725|474046123|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
131661721|NCT00400725|474046124|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
131661722|NCT00400725|474046122|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
131661723|NCT00400725|474046123|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
131661724|NCT00400725|474046124|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
131661725|NCT00400725|474046122|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
131661726|NCT00400725|474046123|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
131661727|NCT00400725|474046124|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
131661728|NCT00400725|474046122|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
131661729|NCT00400725|474046123|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
131661730|NCT00400725|474046124|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
131661731|NCT00400725|474046122|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
131661732|NCT00400725|474046123|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
131661733|NCT00400725|474046124|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
131661734|NCT04075994|474046125|FG000|Overall Study|Withdrawal by Subject|8|||
131661735|NCT04075994|474046126|FG001|Overall Study|Withdrawal by Subject|9|||
131661736|NCT04075994|474046125|FG000|Overall Study|Adverse Event|2|||
131661737|NCT04075994|474046126|FG001|Overall Study|Adverse Event|2|||
131661738|NCT04075994|474046125|FG000|Overall Study|Investigator withdrew|3|||
131661739|NCT04075994|474046126|FG001|Overall Study|Investigator withdrew|1|||
131661740|NCT01941719|474046131|FG000|Overall Study|Lost to Follow-up|20|||
131661741|NCT01941719|474046132|FG001|Overall Study|Lost to Follow-up|19|||
131661742|NCT00252577|474046133|FG000|Overall Study|Lost to Follow-up|20|||
131661743|NCT01744392|474046136|FG000|Overall Study|Physician Decision|1|||
131661744|NCT01416389|474046137|FG000|Overall Study|Lost to Follow-up|1|||
131661745|NCT01416389|474046138|FG001|Overall Study|Lost to Follow-up|0|||
131661746|NCT01416389|474046137|FG000|Overall Study|Started New Therapy|2|||
131661747|NCT01416389|474046138|FG001|Overall Study|Started New Therapy|0|||
131661748|NCT01125514|474046139|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
131661749|NCT01125514|474046139|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
131661750|NCT01125514|474046139|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
131661751|NCT01125514|474046139|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
131661752|NCT01125514|474046139|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
131661753|NCT01125514|474046139|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
131661754|NCT00858364|474046142|FG000|Overall Study|Administrative Decision|3|||
131661755|NCT00858364|474046143|FG001|Overall Study|Administrative Decision|2|||
131661756|NCT00858364|474046142|FG000|Overall Study|Adverse Event|5|||
131661757|NCT00858364|474046143|FG001|Overall Study|Adverse Event|2|||
131661758|NCT00858364|474046142|FG000|Overall Study|Withdrawal by Subject|44|||
131435479|NCT02520726|473219299|FG000|Overall Study|Lost to Follow-up|3|||
131435480|NCT02520726|473219300|FG001|Overall Study|Lost to Follow-up|2|||
131661759|NCT00858364|474046143|FG001|Overall Study|Withdrawal by Subject|118|||
131661760|NCT00858364|474046142|FG000|Overall Study|Ineligibility Determined|1|||
131661761|NCT00858364|474046143|FG001|Overall Study|Ineligibility Determined|10|||
131661762|NCT00858364|474046142|FG000|Overall Study|Lost to Follow-up|24|||
131435481|NCT00721396|473219301|FG000|Overall Study|Adverse Event|4|||
131435482|NCT00721396|473219302|FG001|Overall Study|Adverse Event|7|||
131435483|NCT00721396|473219303|FG002|Overall Study|Adverse Event|2|||
131435484|NCT00721396|473219304|FG003|Overall Study|Adverse Event|0|||
131435485|NCT00721396|473219301|FG000|Overall Study|Withdrawal by Subject|12|||
131435486|NCT00721396|473219302|FG001|Overall Study|Withdrawal by Subject|15|||
131435487|NCT00721396|473219303|FG002|Overall Study|Withdrawal by Subject|3|||
131435488|NCT00721396|473219304|FG003|Overall Study|Withdrawal by Subject|7|||
131435489|NCT00721396|473219301|FG000|Overall Study|Lost to Follow-up|7|||
131435490|NCT00721396|473219302|FG001|Overall Study|Lost to Follow-up|9|||
131661763|NCT00858364|474046143|FG001|Overall Study|Lost to Follow-up|54|||
131661764|NCT00858364|474046142|FG000|Overall Study|Noncompliance|3|||
131661765|NCT00858364|474046143|FG001|Overall Study|Noncompliance|4|||
131661766|NCT00858364|474046142|FG000|Overall Study|Protocol Deviation|0|||
131661767|NCT00858364|474046143|FG001|Overall Study|Protocol Deviation|2|||
131435491|NCT00721396|473219303|FG002|Overall Study|Lost to Follow-up|3|||
131435492|NCT00721396|473219304|FG003|Overall Study|Lost to Follow-up|3|||
131435493|NCT00721396|473219301|FG000|Overall Study|Protocol Violation|4|||
131435494|NCT00721396|473219302|FG001|Overall Study|Protocol Violation|3|||
131435495|NCT00721396|473219303|FG002|Overall Study|Protocol Violation|1|||
131435496|NCT00721396|473219304|FG003|Overall Study|Protocol Violation|0|||
131435497|NCT00721396|473219301|FG000|Overall Study|Inappropriate enrollment|0|||
131435498|NCT00721396|473219302|FG001|Overall Study|Inappropriate enrollment|2|||
131435499|NCT00721396|473219303|FG002|Overall Study|Inappropriate enrollment|0|||
131435500|NCT00721396|473219304|FG003|Overall Study|Inappropriate enrollment|0|||
131435501|NCT00721396|473219301|FG000|Overall Study|Administrative reason|3|||
131435502|NCT00721396|473219302|FG001|Overall Study|Administrative reason|0|||
131435503|NCT00721396|473219303|FG002|Overall Study|Administrative reason|1|||
131435504|NCT00721396|473219304|FG003|Overall Study|Administrative reason|0|||
131435505|NCT01091675|473219307|FG000|Overall Study|Adverse Event|7|||
131435506|NCT01091675|473219307|FG000|Overall Study|Lack of Efficacy|27|||
131435507|NCT00614380|473219308|FG000|Overall Study|Adverse Event|14|||
131435508|NCT00614380|473219309|FG001|Overall Study|Adverse Event|4|||
131435509|NCT00614380|473219310|FG002|Overall Study|Adverse Event|0|||
131435510|NCT00614380|473219311|FG003|Overall Study|Adverse Event|0|||
131435511|NCT00614380|473219308|FG000|Overall Study|Lost to Follow-up|6|||
131435512|NCT00614380|473219309|FG001|Overall Study|Lost to Follow-up|1|||
131435513|NCT00614380|473219310|FG002|Overall Study|Lost to Follow-up|0|||
131435514|NCT00614380|473219311|FG003|Overall Study|Lost to Follow-up|0|||
131435515|NCT00614380|473219308|FG000|Overall Study|Non compliant with the protocol|12|||
131435516|NCT00614380|473219309|FG001|Overall Study|Non compliant with the protocol|2|||
131435517|NCT00614380|473219310|FG002|Overall Study|Non compliant with the protocol|1|||
131435518|NCT00614380|473219311|FG003|Overall Study|Non compliant with the protocol|2|||
131435519|NCT00614380|473219308|FG000|Overall Study|Consent withdrawn|3|||
131435520|NCT00614380|473219309|FG001|Overall Study|Consent withdrawn|1|||
131435521|NCT00614380|473219310|FG002|Overall Study|Consent withdrawn|0|||
131435522|NCT00614380|473219311|FG003|Overall Study|Consent withdrawn|0|||
131435523|NCT00871871|473219325|FG000|Part I|Adverse Event|0|||
131435524|NCT00871871|473219326|FG001|Part I|Adverse Event|2|||
131435525|NCT00871871|473219327|FG002|Part I|Adverse Event|0|||
131435526|NCT00871871|473219328|FG003|Part I|Adverse Event|0|||
131435527|NCT00871871|473219325|FG000|Part I|Withdrawal by Subject|3|||
131435528|NCT00871871|473219326|FG001|Part I|Withdrawal by Subject|0|||
131435529|NCT00871871|473219327|FG002|Part I|Withdrawal by Subject|0|||
131435530|NCT00871871|473219328|FG003|Part I|Withdrawal by Subject|0|||
131435531|NCT00871871|473219325|FG000|Part I|Laboratory abnormality|0|||
131435532|NCT00871871|473219326|FG001|Part I|Laboratory abnormality|1|||
131435533|NCT00871871|473219327|FG002|Part I|Laboratory abnormality|0|||
131435534|NCT00871871|473219328|FG003|Part I|Laboratory abnormality|0|||
131435535|NCT00871871|473219325|FG000|Part II|Lack of Efficacy|0|||
131435536|NCT00871871|473219326|FG001|Part II|Lack of Efficacy|0|||
131435537|NCT00871871|473219327|FG002|Part II|Lack of Efficacy|1|||
131435538|NCT00871871|473219328|FG003|Part II|Lack of Efficacy|0|||
131435539|NCT00871871|473219325|FG000|Part II|Withdrawal by Subject|0|||
131435540|NCT00871871|473219326|FG001|Part II|Withdrawal by Subject|0|||
131435541|NCT00871871|473219327|FG002|Part II|Withdrawal by Subject|2|||
131435542|NCT00871871|473219328|FG003|Part II|Withdrawal by Subject|1|||
131435543|NCT00871871|473219325|FG000|Part II|Adverse Event|0|||
131435544|NCT00871871|473219326|FG001|Part II|Adverse Event|0|||
131435545|NCT00871871|473219327|FG002|Part II|Adverse Event|1|||
131435546|NCT00871871|473219328|FG003|Part II|Adverse Event|2|||
131435547|NCT00871871|473219325|FG000|Part II|Protocol Violation|0|||
131435548|NCT00871871|473219326|FG001|Part II|Protocol Violation|0|||
131435549|NCT00871871|473219327|FG002|Part II|Protocol Violation|0|||
131435550|NCT00871871|473219328|FG003|Part II|Protocol Violation|1|||
131435551|NCT01808196|473219332|FG000|Overall Study|Lost to Follow-up|1|||
131435552|NCT00479713|473219333|FG000|Overall Study|Adverse Event|8|||
131435553|NCT00479713|473219334|FG001|Overall Study|Adverse Event|6|||
131435554|NCT00479713|473219333|FG000|Overall Study|Death|1|||
131435555|NCT00479713|473219334|FG001|Overall Study|Death|0|||
131435556|NCT00479713|473219333|FG000|Overall Study|Lost to Follow-up|0|||
131435557|NCT00479713|473219334|FG001|Overall Study|Lost to Follow-up|1|||
131435558|NCT00479713|473219333|FG000|Overall Study|Protocol Violation|0|||
131549044|NCT05701995|473632889|FG000|Treatment|Physician Decision|0|||
131549045|NCT05701995|473632890|FG001|Treatment|Physician Decision|1|||
131549046|NCT01064297|473632894|FG000|Overall Study|Lost to Follow-up|791|||
131549047|NCT01064297|473632895|FG001|Overall Study|Lost to Follow-up|48|||
131549048|NCT01064297|473632896|FG002|Overall Study|Lost to Follow-up|133|||
131549049|NCT04179721|473632901|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
131549050|NCT04179721|473632902|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
131549051|NCT04179721|473632901|FG000|Overall Study|Lost to Follow-up|0|||
131549052|NCT04179721|473632902|FG001|Overall Study|Lost to Follow-up|1|||
131549053|NCT00112580|473632903|FG000|Overall Study|Adverse Event|1|||
131549054|NCT00112580|473632904|FG001|Overall Study|Adverse Event|2|||
131549055|NCT00112580|473632903|FG000|Overall Study|Disease progression|5|||
131549056|NCT00112580|473632904|FG001|Overall Study|Disease progression|16|||
131549057|NCT00112580|473632903|FG000|Overall Study|Participant withdrew consent|2|||
131549058|NCT00112580|473632904|FG001|Overall Study|Participant withdrew consent|1|||
131549059|NCT05619003|473632905|FG000|Overall Study|Adverse Event|1|||
131549060|NCT03183388|473634077|FG000|Overall Study|Lost to Follow-up|3|||
131549061|NCT03183388|473634078|FG001|Overall Study|Lost to Follow-up|5|||
131549062|NCT03183388|473634077|FG000|Overall Study|Physician Decision|1|||
131549063|NCT03183388|473634078|FG001|Overall Study|Physician Decision|4|||
131549064|NCT03183388|473634077|FG000|Overall Study|Withdrawal by Subject|4|||
131549065|NCT03183388|473634078|FG001|Overall Study|Withdrawal by Subject|1|||
131549066|NCT03183388|473634077|FG000|Overall Study|Moved|1|||
131549067|NCT03183388|473634078|FG001|Overall Study|Moved|0|||
131549068|NCT03183388|473634077|FG000|Overall Study|Met Exclusion Criteria|2|||
131549069|NCT03183388|473634078|FG001|Overall Study|Met Exclusion Criteria|2|||
131549070|NCT03183388|473634077|FG000|Overall Study|COVID Pandemic Related|2|||
131549071|NCT03183388|473634078|FG001|Overall Study|COVID Pandemic Related|4|||
131549072|NCT01264380|473634081|FG000|Period C|Disease Progression|0|||
131549073|NCT01264380|473634082|FG001|Period C|Disease Progression|0|||
131549074|NCT01264380|473634083|FG002|Period C|Disease Progression|4|||
131549075|NCT01264380|473634081|FG000|Period C|Death|0|||
131549076|NCT01264380|473634082|FG001|Period C|Death|0|||
131549077|NCT01264380|473634083|FG002|Period C|Death|2|||
131549078|NCT01264380|473634081|FG000|Period C|Follow-up for survival status|0|||
131549079|NCT01264380|473634082|FG001|Period C|Follow-up for survival status|0|||
131549080|NCT01264380|473634083|FG002|Period C|Follow-up for survival status|6|||
131549081|NCT01264380|473634081|FG000|Period C|Withdrawal by Subject|0|||
131549082|NCT01264380|473634082|FG001|Period C|Withdrawal by Subject|0|||
131549083|NCT01264380|473634083|FG002|Period C|Withdrawal by Subject|1|||
131549084|NCT01264380|473634081|FG000|Period C|Adverse Event|0|||
131549085|NCT01264380|473634082|FG001|Period C|Adverse Event|0|||
131549086|NCT01264380|473634083|FG002|Period C|Adverse Event|1|||
131549087|NCT01147822|473634084|FG000|Overall Study|Lost to Follow-up|14|||
131549088|NCT01147822|473634085|FG001|Overall Study|Lost to Follow-up|6|||
131549089|NCT01147822|473634084|FG000|Overall Study|Withdrawal by Subject|10|||
131549090|NCT01147822|473634085|FG001|Overall Study|Withdrawal by Subject|16|||
131549091|NCT01147822|473634084|FG000|Overall Study|Physician Decision|9|||
131549092|NCT01147822|473634085|FG001|Overall Study|Physician Decision|8|||
131549093|NCT01147822|473634084|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
131549094|NCT01147822|473634085|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
131549095|NCT01147822|473634084|FG000|Overall Study|Protocol Violation|1|||
131435559|NCT00479713|473219334|FG001|Overall Study|Protocol Violation|1|||
131435560|NCT00479713|473219333|FG000|Overall Study|Withdrawal by Subject|4|||
131435561|NCT00479713|473219334|FG001|Overall Study|Withdrawal by Subject|1|||
131435562|NCT01670721|473219335|FG000|Overall Study|Participant's decision|15|||
131435563|NCT01670721|473219335|FG000|Overall Study|Other than specified above|38|||
131435564|NCT03863509|473219338|FG000|Overall Study|COVID-19 shutdown period|0|||
131435565|NCT03863509|473219339|FG001|Overall Study|COVID-19 shutdown period|4|||
131435566|NCT03863509|473219340|FG002|Overall Study|COVID-19 shutdown period|0|||
131435567|NCT03863509|473219338|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
131435568|NCT03863509|473219339|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
131435569|NCT03863509|473219340|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
131435570|NCT03863509|473219338|FG000|Overall Study|Lost to Follow-up|8|||
131435571|NCT03863509|473219339|FG001|Overall Study|Lost to Follow-up|0|||
131435572|NCT03863509|473219340|FG002|Overall Study|Lost to Follow-up|2|||
131435573|NCT03863509|473219338|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
131435574|NCT03863509|473219339|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
131435575|NCT03863509|473219340|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
131435576|NCT03863509|473219338|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
131435577|NCT03863509|473219339|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
131435578|NCT03863509|473219340|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
131549096|NCT01147822|473634085|FG001|Overall Study|Protocol Violation|1|||
131549097|NCT00642902|473634088|FG000|Overall Study|Adverse Event|0|||
131435579|NCT00141102|473219341|FG000|Overall Study|Adverse Event|233|||
131435580|NCT00141102|473219342|FG001|Overall Study|Adverse Event|305|||
131435581|NCT00141102|473219341|FG000|Overall Study|Laboratory Abnormality|9|||
131435582|NCT00141102|473219342|FG001|Overall Study|Laboratory Abnormality|33|||
131435583|NCT00141102|473219341|FG000|Overall Study|Lack of Efficacy|21|||
131435584|NCT00141102|473219342|FG001|Overall Study|Lack of Efficacy|26|||
131435585|NCT00141102|473219341|FG000|Overall Study|Lost to Follow-up|29|||
131435586|NCT00141102|473219342|FG001|Overall Study|Lost to Follow-up|32|||
131435587|NCT00141102|473219341|FG000|Overall Study|Other|87|||
131435588|NCT00141102|473219342|FG001|Overall Study|Other|76|||
131435589|NCT00141102|473219341|FG000|Overall Study|Withdrawal by Subject|112|||
131435590|NCT00141102|473219342|FG001|Overall Study|Withdrawal by Subject|142|||
131435591|NCT00141102|473219341|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
131435592|NCT00141102|473219342|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
131435593|NCT00141102|473219341|FG000|Overall Study|Death|2|||
131435594|NCT00141102|473219342|FG001|Overall Study|Death|2|||
131435595|NCT00191334|473219343|FG000|Overall Study|Adverse Event|4|||
131435596|NCT00191334|473219343|FG000|Overall Study|Disease Progression or Relapse|8|||
131435597|NCT00191334|473219343|FG000|Overall Study|Physician Decision|1|||
131435598|NCT00191334|473219343|FG000|Overall Study|Withdrawal by Subject|4|||
131435599|NCT00990106|473219344|FG000|Overall Study|"too busy to continue"|1|||
131435600|NCT00990106|473219345|FG001|Overall Study|"too busy to continue"|2|||
131435601|NCT00990106|473219344|FG000|Overall Study|Lost to Follow-up|1|||
131435602|NCT00990106|473219345|FG001|Overall Study|Lost to Follow-up|3|||
131435603|NCT00990106|473219344|FG000|Overall Study|Withdrawal by Subject|2|||
131435604|NCT00990106|473219345|FG001|Overall Study|Withdrawal by Subject|1|||
131435605|NCT00990106|473219344|FG000|Overall Study|opted for open label prazosin|1|||
131435606|NCT00990106|473219345|FG001|Overall Study|opted for open label prazosin|1|||
131435607|NCT00990106|473219344|FG000|Overall Study|relocation/deployment|4|||
131435608|NCT00990106|473219345|FG001|Overall Study|relocation/deployment|1|||
131435609|NCT00990106|473219344|FG000|Overall Study|started exclusionary medication|0|||
131435610|NCT00990106|473219345|FG001|Overall Study|started exclusionary medication|1|||
131435611|NCT00990106|473219344|FG000|Overall Study|planned major surgery|0|||
131435612|NCT00990106|473219345|FG001|Overall Study|planned major surgery|1|||
131435613|NCT00990106|473219344|FG000|Overall Study|scheduling conflicts|0|||
131435614|NCT00990106|473219345|FG001|Overall Study|scheduling conflicts|2|||
131435615|NCT05274958|473219347|FG000|Overall Study|Only completed 1 set of PROMs|22|||
131435616|NCT05274958|473219348|FG001|Overall Study|Only completed 1 set of PROMs|35|||
131435617|NCT00866814|473219351|FG000|Overall Study|Lost to Follow-up|12|||
131435618|NCT00866814|473219351|FG000|Overall Study|Adverse Event|2|||
131435619|NCT00866814|473219351|FG000|Overall Study|Physician Decision|1|||
131435620|NCT00866814|473219351|FG000|Overall Study|Death|1|||
131435621|NCT00866814|473219351|FG000|Overall Study|No longer wished to participate|1|||
131435622|NCT00866814|473219351|FG000|Overall Study|Unable to meet follow-up requirements|2|||
131435623|NCT00866814|473219351|FG000|Overall Study|Moved to area without study site|1|||
131435624|NCT01420926|473219354|FG000|Overall Study|Adverse Event|6|||
131435625|NCT01420926|473219355|FG001|Overall Study|Adverse Event|4|||
131435626|NCT01420926|473219354|FG000|Overall Study|Death|18|||
131435627|NCT01420926|473219355|FG001|Overall Study|Death|17|||
131435628|NCT01420926|473219354|FG000|Overall Study|Withdrawal by Subject|11|||
131435629|NCT01420926|473219355|FG001|Overall Study|Withdrawal by Subject|17|||
131435630|NCT01420926|473219354|FG000|Overall Study|Non-protocol treatment|17|||
131435631|NCT01420926|473219355|FG001|Overall Study|Non-protocol treatment|20|||
131435632|NCT01420926|473219354|FG000|Overall Study|Physician Decision|8|||
131435633|NCT01420926|473219355|FG001|Overall Study|Physician Decision|5|||
131448163|NCT03863080|473270887|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
131448164|NCT03863080|473270888|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
131448165|NCT03863080|473270889|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
131448166|NCT03863080|473270886|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
131448167|NCT03863080|473270887|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
131448168|NCT03863080|473270888|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
131448169|NCT03863080|473270889|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
131448170|NCT03863080|473270886|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
131448171|NCT03863080|473270887|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
131448172|NCT03863080|473270888|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
131448173|NCT03863080|473270889|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
131448174|NCT01342211|473270890|FG000|Overall Study|Lost to Follow-up|0|||
131448175|NCT01342211|473270891|FG001|Overall Study|Lost to Follow-up|0|||
131448176|NCT01342211|473270892|FG002|Overall Study|Lost to Follow-up|0|||
131448177|NCT01342211|473270893|FG003|Overall Study|Lost to Follow-up|1|||
131448178|NCT01342211|473270894|FG004|Overall Study|Lost to Follow-up|0|||
131448179|NCT01342211|473270890|FG000|Overall Study|Adverse Event|0|||
131448180|NCT01342211|473270891|FG001|Overall Study|Adverse Event|0|||
131448181|NCT01342211|473270892|FG002|Overall Study|Adverse Event|0|||
131448182|NCT01342211|473270893|FG003|Overall Study|Adverse Event|0|||
131435634|NCT01474317|473221802|FG000|Overall Study|Adverse Event|1|||
131435635|NCT01474317|473221802|FG000|Overall Study|Subject ineligible for study|1|||
131435636|NCT02152631|473221804|FG000|Overall Study|Adverse Event|32|||
131435637|NCT02152631|473221805|FG001|Overall Study|Adverse Event|4|||
131435638|NCT02152631|473221804|FG000|Overall Study|Withdrawal by Subject|13|||
131435639|NCT02152631|473221805|FG001|Overall Study|Withdrawal by Subject|16|||
131435640|NCT02152631|473221804|FG000|Overall Study|Noncompliance with study drug|1|||
131435641|NCT02152631|473221805|FG001|Overall Study|Noncompliance with study drug|0|||
131435642|NCT02152631|473221804|FG000|Overall Study|Physician Decision|1|||
131435643|NCT02152631|473221805|FG001|Overall Study|Physician Decision|2|||
131435644|NCT02152631|473221804|FG000|Overall Study|Lost to Follow-up|0|||
131435645|NCT02152631|473221805|FG001|Overall Study|Lost to Follow-up|1|||
131435646|NCT02152631|473221804|FG000|Overall Study|On Treatment|19|||
131435647|NCT02152631|473221805|FG001|Overall Study|On Treatment|3|||
131435648|NCT05473026|473221806|FG000|Overall Study|Lost to Follow-up|5|||
131435649|NCT05473026|473221807|FG001|Overall Study|Lost to Follow-up|2|||
131435650|NCT02647281|473221810|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435651|NCT02647281|473221811|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435652|NCT02647281|473221812|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435653|NCT02647281|473221813|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435654|NCT02647281|473221814|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435655|NCT02647281|473221815|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435656|NCT02647281|473221816|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435657|NCT02647281|473221817|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
131435658|NCT02647281|473221818|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
131435659|NCT03489863|473221822|FG000|Overall Study|Withdrawal by Subject|0|||
131435660|NCT03489863|473221823|FG001|Overall Study|Withdrawal by Subject|1|||
131435661|NCT00981149|473221826|FG000|Overall Study|Lost to Follow-up|1|||
131435662|NCT00981149|473221827|FG001|Overall Study|Lost to Follow-up|2|||
131435663|NCT00981149|473221826|FG000|Overall Study|Withdrawal by Subject|1|||
131435664|NCT00981149|473221827|FG001|Overall Study|Withdrawal by Subject|1|||
131435665|NCT02634333|473221828|FG000|Overall Study|Completed out of Window|3|||
131435666|NCT02634333|473221829|FG001|Overall Study|Completed out of Window|2|||
131435667|NCT02634333|473221828|FG000|Overall Study|Missed Visit|5|||
131435668|NCT02634333|473221829|FG001|Overall Study|Missed Visit|2|||
131435669|NCT02634333|473221828|FG000|Overall Study|Lost to Follow-up|12|||
131435670|NCT02634333|473221829|FG001|Overall Study|Lost to Follow-up|7|||
131435671|NCT02634333|473221828|FG000|Overall Study|Withdrawal by Subject|9|||
131435672|NCT02634333|473221829|FG001|Overall Study|Withdrawal by Subject|13|||
131435673|NCT02634333|473221828|FG000|Overall Study|Death|11|||
131435674|NCT02634333|473221829|FG001|Overall Study|Death|8|||
131435675|NCT01858363|473221835|FG000|Overall Study|Death|35|||
131435676|NCT01858363|473221836|FG001|Overall Study|Death|9|||
131435677|NCT01858363|473221835|FG000|Overall Study|Withdrawal by Subject|28|||
131435678|NCT01858363|473221836|FG001|Overall Study|Withdrawal by Subject|14|||
131435679|NCT01858363|473221835|FG000|Overall Study|Lost to Follow-up|13|||
131435680|NCT01858363|473221836|FG001|Overall Study|Lost to Follow-up|3|||
131435681|NCT03480152|473221842|FG000|Phase I|Signed consent. Died before treatment.|1|||
131435682|NCT03480152|473221843|FG001|Phase I|Signed consent. Died before treatment.|0|||
131435683|NCT03480152|473221844|FG002|Phase I|Signed consent. Died before treatment.|0|||
131435684|NCT04486235|473221847|FG000|Overall Study|Pregnancy|1|||
131435685|NCT04486235|473221848|FG001|Overall Study|Pregnancy|0|||
131435686|NCT04486235|473221847|FG000|Overall Study|Lost to Follow-up|1|||
131435687|NCT04486235|473221848|FG001|Overall Study|Lost to Follow-up|0|||
131435688|NCT01092728|473221849|FG000|Overall Study|Withdrawal by Subject|2|||
131435689|NCT01092728|473221850|FG001|Overall Study|Withdrawal by Subject|0|||
131435690|NCT01092728|473221849|FG000|Overall Study|Adverse Event|0|||
131435691|NCT01092728|473221850|FG001|Overall Study|Adverse Event|1|||
131661768|NCT00858364|474046142|FG000|Overall Study|Other|9|||
131661769|NCT00858364|474046143|FG001|Overall Study|Other|17|||
131435692|NCT01092728|473221849|FG000|Overall Study|Disease Progression|1|||
131435693|NCT01092728|473221850|FG001|Overall Study|Disease Progression|13|||
131435694|NCT01092728|473221849|FG000|Overall Study|Prohibited Concomitant Medications|1|||
131435695|NCT01092728|473221850|FG001|Overall Study|Prohibited Concomitant Medications|0|||
131435696|NCT03649217|473221851|FG000|Overall Study|subject had severe ataxia not initially found|1|||
131435697|NCT03649217|473221851|FG000|Overall Study|subject had cognitive issues not initially found|1|||
131435698|NCT03546621|473221852|FG000|Overall Study|Withdrawal by Subject|0|||
131435699|NCT03546621|473221853|FG001|Overall Study|Withdrawal by Subject|1|||
131435700|NCT03546621|473221854|FG002|Overall Study|Withdrawal by Subject|2|||
131435701|NCT03546621|473221855|FG003|Overall Study|Withdrawal by Subject|1|||
131661770|NCT00858364|474046142|FG000|Overall Study|Missing|1|||
131435702|NCT03546621|473221852|FG000|Overall Study|Lost to Follow-up|0|||
131435703|NCT03546621|473221853|FG001|Overall Study|Lost to Follow-up|1|||
131435704|NCT03546621|473221854|FG002|Overall Study|Lost to Follow-up|0|||
131435705|NCT03546621|473221855|FG003|Overall Study|Lost to Follow-up|0|||
131661771|NCT00858364|474046143|FG001|Overall Study|Missing|1|||
131435706|NCT03546621|473221852|FG000|Overall Study|Adverse Event|0|||
131435707|NCT03546621|473221853|FG001|Overall Study|Adverse Event|1|||
131435708|NCT03546621|473221854|FG002|Overall Study|Adverse Event|0|||
131435709|NCT03546621|473221855|FG003|Overall Study|Adverse Event|1|||
131435710|NCT03546621|473221852|FG000|Overall Study|Progressive disease|0|||
131435711|NCT03546621|473221853|FG001|Overall Study|Progressive disease|0|||
131435712|NCT03546621|473221854|FG002|Overall Study|Progressive disease|0|||
131435713|NCT03546621|473221855|FG003|Overall Study|Progressive disease|1|||
131435714|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131448183|NCT01342211|473270894|FG004|Overall Study|Adverse Event|1|||
131448184|NCT01342211|473270890|FG000|Overall Study|Withdrawal by Subject|0|||
131448185|NCT01342211|473270891|FG001|Overall Study|Withdrawal by Subject|0|||
131448186|NCT01342211|473270892|FG002|Overall Study|Withdrawal by Subject|0|||
131448187|NCT01342211|473270893|FG003|Overall Study|Withdrawal by Subject|1|||
131448188|NCT01342211|473270894|FG004|Overall Study|Withdrawal by Subject|0|||
131448189|NCT01342211|473270890|FG000|Overall Study|Randomized, but not Treated|0|||
131448190|NCT01342211|473270891|FG001|Overall Study|Randomized, but not Treated|2|||
131448191|NCT01342211|473270892|FG002|Overall Study|Randomized, but not Treated|0|||
131448192|NCT01342211|473270893|FG003|Overall Study|Randomized, but not Treated|0|||
131448193|NCT01342211|473270894|FG004|Overall Study|Randomized, but not Treated|1|||
131448194|NCT01648751|473270908|FG000|Overall Study|Withdrawal by Subject|2|||
131448195|NCT01648751|473270909|FG001|Overall Study|Withdrawal by Subject|3|||
131448196|NCT04145349|473272609|FG000|Overall Study|Withdrawal by Subject|3|||
131448197|NCT04145349|473272610|FG001|Overall Study|Withdrawal by Subject|0|||
131448198|NCT04145349|473272609|FG000|Overall Study|Lost to Follow-up|0|||
131448199|NCT04145349|473272610|FG001|Overall Study|Lost to Follow-up|1|||
131448200|NCT04145349|473272609|FG000|Overall Study|On study treatment (Ongoing)|0|||
131448201|NCT04145349|473272610|FG001|Overall Study|On study treatment (Ongoing)|1|||
131448202|NCT01148979|473272620|FG000|Overall Study|Lost to Follow-up|0|||
131448203|NCT01148979|473272621|FG001|Overall Study|Lost to Follow-up|1|||
131448204|NCT00777153|473272622|FG000|Overall Study|Lost to Follow-up|1|||
131448205|NCT00777153|473272623|FG001|Overall Study|Lost to Follow-up|1|||
131448206|NCT00777153|473272624|FG002|Overall Study|Lost to Follow-up|0|||
131448207|NCT00777153|473272622|FG000|Overall Study|Death|85|||
131448208|NCT00777153|473272623|FG001|Overall Study|Death|73|||
131448209|NCT00777153|473272624|FG002|Overall Study|Death|33|||
131448210|NCT00777153|473272622|FG000|Overall Study|Withdrawal by Subject|3|||
131448211|NCT00777153|473272623|FG001|Overall Study|Withdrawal by Subject|4|||
131448212|NCT00777153|473272624|FG002|Overall Study|Withdrawal by Subject|3|||
131448213|NCT00777153|473272622|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
131448214|NCT00777153|473272623|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
131448215|NCT00777153|473272624|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
131448216|NCT01646125|473272626|FG000|Overall Study|Untreated|2|||
131448217|NCT01646125|473272627|FG001|Overall Study|Untreated|5|||
131448218|NCT01646125|473272626|FG000|Overall Study|Adverse Event|2|||
131448219|NCT01646125|473272627|FG001|Overall Study|Adverse Event|1|||
131448220|NCT01646125|473272626|FG000|Overall Study|Death|1|||
131448221|NCT01646125|473272627|FG001|Overall Study|Death|1|||
131448222|NCT01646125|473272626|FG000|Overall Study|Physician Decision|1|||
131448223|NCT01646125|473272627|FG001|Overall Study|Physician Decision|3|||
131448224|NCT01646125|473272626|FG000|Overall Study|Progressive disease|22|||
131448225|NCT01646125|473272627|FG001|Overall Study|Progressive disease|16|||
131448226|NCT01646125|473272626|FG000|Overall Study|Study terminated by sponsor|2|||
131448227|NCT01646125|473272627|FG001|Overall Study|Study terminated by sponsor|1|||
131448228|NCT01646125|473272626|FG000|Overall Study|Subject/Guardian decision|1|||
131448229|NCT01646125|473272627|FG001|Overall Study|Subject/Guardian decision|1|||
131448230|NCT00554216|473272628|FG000|Overall Study|Lost to Follow-up|92|||
131448231|NCT00554216|473272629|FG001|Overall Study|Lost to Follow-up|31|||
131448232|NCT00554216|473272630|FG002|Overall Study|Lost to Follow-up|63|||
131448233|NCT00554216|473272628|FG000|Overall Study|Adverse Event|16|||
131448234|NCT00554216|473272629|FG001|Overall Study|Adverse Event|16|||
131448235|NCT00554216|473272630|FG002|Overall Study|Adverse Event|36|||
131448236|NCT00554216|473272628|FG000|Overall Study|Withdrawal by Subject|92|||
131448237|NCT00554216|473272629|FG001|Overall Study|Withdrawal by Subject|31|||
131448238|NCT00554216|473272630|FG002|Overall Study|Withdrawal by Subject|43|||
131448239|NCT00554216|473272628|FG000|Overall Study|Non compliance|10|||
131448240|NCT00554216|473272629|FG001|Overall Study|Non compliance|4|||
131448241|NCT00554216|473272630|FG002|Overall Study|Non compliance|5|||
131448242|NCT00554216|473272628|FG000|Overall Study|Pregnancy|2|||
131448243|NCT00554216|473272629|FG001|Overall Study|Pregnancy|1|||
131448244|NCT00554216|473272630|FG002|Overall Study|Pregnancy|14|||
131448245|NCT00554216|473272628|FG000|Overall Study|Restricted med|3|||
131448246|NCT00554216|473272629|FG001|Overall Study|Restricted med|1|||
131448247|NCT00554216|473272630|FG002|Overall Study|Restricted med|1|||
131448248|NCT00554216|473272628|FG000|Overall Study|Other|12|||
131448249|NCT00554216|473272629|FG001|Overall Study|Other|7|||
131549098|NCT00642902|473634089|FG001|Overall Study|Adverse Event|1|||
131549099|NCT00642902|473634090|FG002|Overall Study|Adverse Event|3|||
131549100|NCT00642902|473634091|FG003|Overall Study|Adverse Event|1|||
131549101|NCT00642902|473634088|FG000|Overall Study|Lost to Follow-up|1|||
131549102|NCT00642902|473634089|FG001|Overall Study|Lost to Follow-up|1|||
131549103|NCT00642902|473634090|FG002|Overall Study|Lost to Follow-up|0|||
131549104|NCT00642902|473634091|FG003|Overall Study|Lost to Follow-up|0|||
131549105|NCT00642902|473634088|FG000|Overall Study|Lack of Efficacy|0|||
131549106|NCT00642902|473634089|FG001|Overall Study|Lack of Efficacy|3|||
131549107|NCT00642902|473634090|FG002|Overall Study|Lack of Efficacy|3|||
131549108|NCT00642902|473634091|FG003|Overall Study|Lack of Efficacy|0|||
131549109|NCT00642902|473634088|FG000|Overall Study|Death|1|||
131549110|NCT00642902|473634089|FG001|Overall Study|Death|0|||
131549111|NCT00642902|473634090|FG002|Overall Study|Death|0|||
131549112|NCT00642902|473634091|FG003|Overall Study|Death|0|||
131549113|NCT00642902|473634088|FG000|Overall Study|Premature termination of clinical trial|37|||
131549114|NCT00642902|473634089|FG001|Overall Study|Premature termination of clinical trial|32|||
131549115|NCT00642902|473634090|FG002|Overall Study|Premature termination of clinical trial|35|||
131549116|NCT00642902|473634091|FG003|Overall Study|Premature termination of clinical trial|35|||
131549117|NCT00642902|473634088|FG000|Overall Study|Randomized, but not treated|0|||
131549118|NCT00642902|473634089|FG001|Overall Study|Randomized, but not treated|0|||
131549119|NCT00642902|473634090|FG002|Overall Study|Randomized, but not treated|1|||
131549120|NCT00642902|473634091|FG003|Overall Study|Randomized, but not treated|0|||
131549121|NCT00642902|473634088|FG000|Overall Study|Other|1|||
131549122|NCT00642902|473634089|FG001|Overall Study|Other|5|||
131549123|NCT00642902|473634090|FG002|Overall Study|Other|1|||
131549124|NCT00642902|473634091|FG003|Overall Study|Other|4|||
131549125|NCT00429663|473634092|FG000|Overall Study|Lost to Follow-up|24|||
131549126|NCT00429663|473634093|FG001|Overall Study|Lost to Follow-up|31|||
131549127|NCT00429663|473634092|FG000|Overall Study|Physician Decision|6|||
131549128|NCT00429663|473634093|FG001|Overall Study|Physician Decision|3|||
131549129|NCT00429663|473634092|FG000|Overall Study|Withdrawal by Subject|2|||
131549130|NCT00429663|473634093|FG001|Overall Study|Withdrawal by Subject|5|||
131549131|NCT00429663|473634092|FG000|Overall Study|Death|4|||
131549132|NCT00429663|473634093|FG001|Overall Study|Death|0|||
131549133|NCT03953898|473634099|FG000|Overall Study|Lack of Efficacy|8|||
131549134|NCT03953898|473634099|FG000|Overall Study|Death|3|||
131549135|NCT03953898|473634099|FG000|Overall Study|Withdrawal by Subject|2|||
131549136|NCT03953898|473634099|FG000|Overall Study|Adverse Event|1|||
131549137|NCT03261271|473634100|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
131549138|NCT03261271|473634101|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
131549139|NCT01932697|473634102|FG000|Overall Study|Received a different amount of tx|1|||
131549140|NCT01932697|473634103|FG001|Overall Study|Received a different amount of tx|0|||
131549141|NCT01932697|473634102|FG000|Overall Study|Ineligible|1|||
131549142|NCT01932697|473634103|FG001|Overall Study|Ineligible|0|||
131549143|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
131549144|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
131549145|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
131549146|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
131549147|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
131549148|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
131549149|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
131549150|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
131549151|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
131549152|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
131549153|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
131549154|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
131549155|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131549156|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131549157|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131549158|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
131549159|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
131549160|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131549161|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131549162|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131549163|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Death|2|||
131549164|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Death|2|||
131549165|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Death|0|||
131549166|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Death|0|||
131549167|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Death|0|||
131549168|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
131549169|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
131549170|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
131549171|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
131549172|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
131549173|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
131549174|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
131549175|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
131549176|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
131549177|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
131549178|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
131549179|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
131549180|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
131549181|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
131549182|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
131549183|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
131549184|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
131549185|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
131549186|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
131549187|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
131549188|NCT03420781|473634104|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
131549189|NCT03420781|473634105|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
131549190|NCT03420781|473634106|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
131549191|NCT03420781|473634107|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
131549192|NCT03420781|473634108|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
131549193|NCT03420781|473634104|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
131549194|NCT03420781|473634105|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
131549195|NCT03420781|473634106|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
131549196|NCT03420781|473634107|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
131549197|NCT03420781|473634108|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
131549198|NCT03420781|473634104|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
131549199|NCT03420781|473634105|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
131549200|NCT03420781|473634106|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
131549201|NCT03420781|473634107|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
131549202|NCT03420781|473634108|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
131549203|NCT03420781|473634104|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
131549204|NCT03420781|473634105|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
131549205|NCT03420781|473634106|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
131549206|NCT03420781|473634107|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
131549207|NCT03420781|473634108|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
131549208|NCT00246337|473634109|FG000|Overall Study|Lost to Follow-up|3|||
131549209|NCT00246337|473634110|FG001|Overall Study|Lost to Follow-up|0|||
131549210|NCT00246337|473634111|FG002|Overall Study|Lost to Follow-up|0|||
131549211|NCT00246337|473634112|FG003|Overall Study|Lost to Follow-up|0|||
131549212|NCT00246337|473634113|FG004|Overall Study|Lost to Follow-up|2|||
131549213|NCT00246337|473634114|FG005|Overall Study|Lost to Follow-up|2|||
131549214|NCT00246337|473634115|FG006|Overall Study|Lost to Follow-up|1|||
131549215|NCT00246337|473634116|FG007|Overall Study|Lost to Follow-up|2|||
131549216|NCT00246337|473634117|FG008|Overall Study|Lost to Follow-up|0|||
131549217|NCT00246337|473634109|FG000|Overall Study|Protocol Violation|1|||
131549218|NCT00246337|473634110|FG001|Overall Study|Protocol Violation|0|||
131549219|NCT00246337|473634111|FG002|Overall Study|Protocol Violation|0|||
131549220|NCT00246337|473634112|FG003|Overall Study|Protocol Violation|0|||
131549221|NCT00246337|473634113|FG004|Overall Study|Protocol Violation|1|||
131549222|NCT00246337|473634114|FG005|Overall Study|Protocol Violation|0|||
131549223|NCT00246337|473634115|FG006|Overall Study|Protocol Violation|1|||
131549224|NCT00246337|473634116|FG007|Overall Study|Protocol Violation|1|||
131549225|NCT00246337|473634117|FG008|Overall Study|Protocol Violation|0|||
131549226|NCT00246337|473634109|FG000|Overall Study|Withdrawal by Subject|2|||
131549227|NCT00246337|473634110|FG001|Overall Study|Withdrawal by Subject|0|||
131549228|NCT00246337|473634111|FG002|Overall Study|Withdrawal by Subject|0|||
131549229|NCT00246337|473634112|FG003|Overall Study|Withdrawal by Subject|0|||
131549230|NCT00246337|473634113|FG004|Overall Study|Withdrawal by Subject|0|||
131549231|NCT00246337|473634114|FG005|Overall Study|Withdrawal by Subject|0|||
131549232|NCT00246337|473634115|FG006|Overall Study|Withdrawal by Subject|1|||
131549233|NCT00246337|473634116|FG007|Overall Study|Withdrawal by Subject|1|||
131549234|NCT00246337|473634117|FG008|Overall Study|Withdrawal by Subject|0|||
131549235|NCT00246337|473634109|FG000|Overall Study|Lack of Qualifying Event|8|||
131549236|NCT00246337|473634110|FG001|Overall Study|Lack of Qualifying Event|2|||
131549237|NCT00246337|473634111|FG002|Overall Study|Lack of Qualifying Event|1|||
131549238|NCT00246337|473634112|FG003|Overall Study|Lack of Qualifying Event|1|||
131661772|NCT00858364|474046142|FG000|Overall Study|Still on-study|114|||
131661773|NCT00858364|474046143|FG001|Overall Study|Still on-study|247|||
131661774|NCT02755818|474046144|FG000|Overall Study|Withdrawal by Subject|0|||
131661775|NCT02755818|474046145|FG001|Overall Study|Withdrawal by Subject|0|||
131661776|NCT02755818|474046146|FG002|Overall Study|Withdrawal by Subject|0|||
131661777|NCT02755818|474046147|FG003|Overall Study|Withdrawal by Subject|2|||
131661778|NCT02755818|474046144|FG000|Overall Study|withdrawal by PI|0|||
131661779|NCT02755818|474046145|FG001|Overall Study|withdrawal by PI|0|||
131435715|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435716|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435717|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
131435718|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435719|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435720|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435721|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435722|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435723|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
131435724|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
131435725|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
131435726|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
131435727|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
131435728|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
131435729|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
131435730|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
131435731|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
131435732|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
131435733|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
131435734|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
131435735|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
131435736|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
131435737|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
131435738|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
131435739|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
131435740|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
131435741|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
131435742|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
131435743|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
131435744|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
131435745|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
131435746|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
131435747|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
131435748|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
131435749|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
131435750|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
131435751|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
131435752|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
131435753|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
131435754|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
131435755|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435756|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
131435757|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435758|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
131435759|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435760|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435761|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435762|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435763|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
131435764|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
131435765|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435766|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435767|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435768|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
131435769|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
131435770|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435771|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435772|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435773|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
131435774|NCT02365649|473221857|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435775|NCT02365649|473221858|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435776|NCT02365649|473221859|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
131448250|NCT00554216|473272630|FG002|Overall Study|Other|10|||
131448251|NCT00554216|473272628|FG000|Overall Study|Lack of Efficacy|15|||
131661780|NCT02755818|474046146|FG002|Overall Study|withdrawal by PI|1|||
131661781|NCT02755818|474046147|FG003|Overall Study|withdrawal by PI|1|||
131661782|NCT02535091|474046155|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
131661783|NCT02535091|474046156|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
131661784|NCT02535091|474046157|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
131661785|NCT02535091|474046155|FG000|Overall Study|Withdrawal by Subject|14|||
131661786|NCT02535091|474046156|FG001|Overall Study|Withdrawal by Subject|5|||
131661787|NCT02535091|474046157|FG002|Overall Study|Withdrawal by Subject|121|||
131661788|NCT02535091|474046155|FG000|Overall Study|Adverse Event|9|||
131661789|NCT02535091|474046156|FG001|Overall Study|Adverse Event|4|||
131661790|NCT02535091|474046157|FG002|Overall Study|Adverse Event|170|||
131661791|NCT02535091|474046155|FG000|Overall Study|Other|4|||
131661792|NCT02535091|474046156|FG001|Overall Study|Other|3|||
131661793|NCT02535091|474046157|FG002|Overall Study|Other|81|||
131661794|NCT02535091|474046155|FG000|Overall Study|Lost to Follow-up|0|||
131661795|NCT02535091|474046156|FG001|Overall Study|Lost to Follow-up|1|||
131661796|NCT02535091|474046157|FG002|Overall Study|Lost to Follow-up|19|||
131661797|NCT02535091|474046155|FG000|Overall Study|Protocol Violation|0|||
131661798|NCT02535091|474046156|FG001|Overall Study|Protocol Violation|1|||
131661799|NCT02535091|474046157|FG002|Overall Study|Protocol Violation|11|||
131661800|NCT02535091|474046155|FG000|Overall Study|Pregnancy|0|||
131661801|NCT02535091|474046156|FG001|Overall Study|Pregnancy|0|||
131661802|NCT02535091|474046157|FG002|Overall Study|Pregnancy|7|||
131661803|NCT03223662|474046158|FG000|Overall Study|Physician Decision|1|||
131661804|NCT03223662|474046158|FG000|Overall Study|Study closure|1|||
131661805|NCT02217475|474046159|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
131661806|NCT02217475|474046160|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
131661807|NCT02217475|474046161|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
131661808|NCT02217475|474046159|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
131661809|NCT02217475|474046160|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
131661810|NCT02217475|474046161|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
131661811|NCT02217475|474046159|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
131661812|NCT02217475|474046160|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
131661813|NCT02217475|474046161|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
131770349|NCT00379639|474437901|FG003|Overall Study|Lost to Follow-up|1|||
131770350|NCT00379639|474437902|FG004|Overall Study|Lost to Follow-up|0|||
131770351|NCT00379639|474437898|FG000|Overall Study|Other|0|||
131770352|NCT00379639|474437899|FG001|Overall Study|Other|0|||
131770353|NCT00379639|474437900|FG002|Overall Study|Other|3|||
131770354|NCT00379639|474437901|FG003|Overall Study|Other|0|||
131770355|NCT00379639|474437902|FG004|Overall Study|Other|0|||
131770356|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
131770357|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
131770358|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131661814|NCT02217475|474046159|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
131661815|NCT02217475|474046160|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
131661816|NCT02217475|474046161|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
131770359|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770360|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770361|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770362|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770363|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770364|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770365|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770366|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770367|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131770368|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
131770369|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770370|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770371|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770372|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770373|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770374|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
131770375|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131661817|NCT02217475|474046159|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
131661818|NCT02217475|474046160|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
131661819|NCT02217475|474046161|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
131661820|NCT02217475|474046159|FG000|Discontinued After Period 1|Adverse Event|1|||
131661821|NCT02217475|474046160|FG001|Discontinued After Period 1|Adverse Event|2|||
131661822|NCT02217475|474046161|FG002|Discontinued After Period 1|Adverse Event|0|||
131661823|NCT02217475|474046159|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
131661824|NCT02217475|474046160|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
131549239|NCT00246337|473634113|FG004|Overall Study|Lack of Qualifying Event|1|||
131549240|NCT00246337|473634114|FG005|Overall Study|Lack of Qualifying Event|3|||
131549241|NCT00246337|473634115|FG006|Overall Study|Lack of Qualifying Event|3|||
131549242|NCT00246337|473634116|FG007|Overall Study|Lack of Qualifying Event|2|||
131549243|NCT00246337|473634117|FG008|Overall Study|Lack of Qualifying Event|5|||
131549244|NCT00246337|473634109|FG000|Overall Study|Site Terminated|10|||
131549245|NCT00246337|473634110|FG001|Overall Study|Site Terminated|0|||
131549246|NCT00246337|473634111|FG002|Overall Study|Site Terminated|0|||
131549247|NCT00246337|473634112|FG003|Overall Study|Site Terminated|0|||
131549248|NCT00246337|473634113|FG004|Overall Study|Site Terminated|0|||
131549249|NCT00246337|473634114|FG005|Overall Study|Site Terminated|7|||
131549250|NCT00246337|473634115|FG006|Overall Study|Site Terminated|1|||
131549251|NCT00246337|473634116|FG007|Overall Study|Site Terminated|6|||
131549252|NCT00246337|473634117|FG008|Overall Study|Site Terminated|2|||
131549253|NCT00246337|473634109|FG000|Overall Study|Abnormal baseline lab values|7|||
131549254|NCT00246337|473634110|FG001|Overall Study|Abnormal baseline lab values|0|||
131549255|NCT00246337|473634111|FG002|Overall Study|Abnormal baseline lab values|2|||
131549256|NCT00246337|473634112|FG003|Overall Study|Abnormal baseline lab values|0|||
131549257|NCT00246337|473634113|FG004|Overall Study|Abnormal baseline lab values|0|||
131549258|NCT00246337|473634114|FG005|Overall Study|Abnormal baseline lab values|2|||
131549259|NCT00246337|473634115|FG006|Overall Study|Abnormal baseline lab values|2|||
131549260|NCT00246337|473634116|FG007|Overall Study|Abnormal baseline lab values|0|||
131549261|NCT00246337|473634117|FG008|Overall Study|Abnormal baseline lab values|4|||
131549262|NCT00246337|473634109|FG000|Overall Study|Overwhelmed|0|||
131549263|NCT00246337|473634110|FG001|Overall Study|Overwhelmed|0|||
131549264|NCT00246337|473634111|FG002|Overall Study|Overwhelmed|0|||
131549265|NCT00246337|473634112|FG003|Overall Study|Overwhelmed|0|||
131549266|NCT00246337|473634113|FG004|Overall Study|Overwhelmed|0|||
131549267|NCT00246337|473634114|FG005|Overall Study|Overwhelmed|1|||
131549268|NCT00246337|473634115|FG006|Overall Study|Overwhelmed|0|||
131549269|NCT00246337|473634116|FG007|Overall Study|Overwhelmed|0|||
131549270|NCT00246337|473634117|FG008|Overall Study|Overwhelmed|0|||
131549271|NCT00246337|473634109|FG000|Overall Study|Protocol Violator|1|||
131549272|NCT00246337|473634110|FG001|Overall Study|Protocol Violator|0|||
131549273|NCT00246337|473634111|FG002|Overall Study|Protocol Violator|0|||
131549274|NCT00246337|473634112|FG003|Overall Study|Protocol Violator|0|||
131549275|NCT00246337|473634113|FG004|Overall Study|Protocol Violator|0|||
131549276|NCT00246337|473634114|FG005|Overall Study|Protocol Violator|0|||
131549277|NCT00246337|473634115|FG006|Overall Study|Protocol Violator|0|||
131549278|NCT00246337|473634116|FG007|Overall Study|Protocol Violator|0|||
131549279|NCT00246337|473634117|FG008|Overall Study|Protocol Violator|0|||
131549280|NCT00246337|473634109|FG000|Overall Study|Reported as completing trial in error|0|||
131549281|NCT00246337|473634110|FG001|Overall Study|Reported as completing trial in error|0|||
131549282|NCT00246337|473634111|FG002|Overall Study|Reported as completing trial in error|0|||
131549283|NCT00246337|473634112|FG003|Overall Study|Reported as completing trial in error|0|||
131549284|NCT00246337|473634113|FG004|Overall Study|Reported as completing trial in error|0|||
131549285|NCT00246337|473634114|FG005|Overall Study|Reported as completing trial in error|0|||
131549286|NCT00246337|473634115|FG006|Overall Study|Reported as completing trial in error|0|||
131549287|NCT00246337|473634116|FG007|Overall Study|Reported as completing trial in error|1|||
131549288|NCT00246337|473634117|FG008|Overall Study|Reported as completing trial in error|0|||
131549289|NCT01226511|473634122|FG000|Acute Treatment Period|Adverse Event|7|||
131549290|NCT01226511|473634123|FG001|Acute Treatment Period|Adverse Event|6|||
131549291|NCT01226511|473634122|FG000|Acute Treatment Period|Lack of Efficacy|2|||
131549292|NCT01226511|473634123|FG001|Acute Treatment Period|Lack of Efficacy|1|||
131549293|NCT01226511|473634122|FG000|Acute Treatment Period|Lost to Follow-up|3|||
131549294|NCT01226511|473634123|FG001|Acute Treatment Period|Lost to Follow-up|6|||
131549295|NCT01226511|473634122|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
131549296|NCT01226511|473634123|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
131549297|NCT01226511|473634122|FG000|Acute Treatment Period|Protocol Violation|5|||
131549298|NCT01226511|473634123|FG001|Acute Treatment Period|Protocol Violation|5|||
131549299|NCT01226511|473634122|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
131549300|NCT01226511|473634123|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
131549301|NCT01226511|473634122|FG000|Extension Treatment Period|Adverse Event|8|||
131549302|NCT01226511|473634123|FG001|Extension Treatment Period|Adverse Event|8|||
131549303|NCT01226511|473634122|FG000|Extension Treatment Period|Lack of Efficacy|3|||
131549304|NCT01226511|473634123|FG001|Extension Treatment Period|Lack of Efficacy|2|||
131549305|NCT01226511|473634122|FG000|Extension Treatment Period|Lost to Follow-up|4|||
131549306|NCT01226511|473634123|FG001|Extension Treatment Period|Lost to Follow-up|3|||
131549307|NCT01226511|473634122|FG000|Extension Treatment Period|Protocol Violation|2|||
131549308|NCT01226511|473634123|FG001|Extension Treatment Period|Protocol Violation|2|||
131549309|NCT01226511|473634122|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
131549310|NCT01226511|473634123|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
131549311|NCT01226511|473634122|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
131549312|NCT01226511|473634123|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
131549313|NCT01226511|473634122|FG000|Extension Treatment Period|Sponsor Decision|1|||
131549314|NCT01226511|473634123|FG001|Extension Treatment Period|Sponsor Decision|1|||
131549315|NCT01226511|473634122|FG000|Taper Period|Adverse Event|1|||
131549316|NCT01226511|473634123|FG001|Taper Period|Adverse Event|0|||
131549317|NCT01226511|473634122|FG000|Taper Period|Lost to Follow-up|2|||
131549318|NCT01226511|473634123|FG001|Taper Period|Lost to Follow-up|2|||
131549319|NCT01226511|473634122|FG000|Taper Period|Protocol Violation|1|||
131549320|NCT01226511|473634123|FG001|Taper Period|Protocol Violation|0|||
131549321|NCT01226511|473634122|FG000|Taper Period|Parent/Caregiver Decision|1|||
131549322|NCT01226511|473634123|FG001|Taper Period|Parent/Caregiver Decision|1|||
131549323|NCT01337986|473634125|FG000|Overall Study|Adverse Event|2|||
131549324|NCT01337986|473634126|FG001|Overall Study|Adverse Event|2|||
131549325|NCT01337986|473634125|FG000|Overall Study|Lost to Follow-up|1|||
131549326|NCT01337986|473634126|FG001|Overall Study|Lost to Follow-up|0|||
131549327|NCT01337986|473634125|FG000|Overall Study|Protocol Violation|0|||
131549328|NCT01337986|473634126|FG001|Overall Study|Protocol Violation|3|||
131549329|NCT01520402|473634127|FG000|Overall Study|Withdrawal by Subject|2|||
131549330|NCT01520402|473634127|FG000|Overall Study|Physician Decision|3|||
131549331|NCT01722162|473634129|FG000|Overall Study|Withdrawal by Subject|1|||
131549332|NCT01722162|473634130|FG001|Overall Study|Withdrawal by Subject|1|||
131549333|NCT01722162|473634129|FG000|Overall Study|Found ineligible|1|||
131549334|NCT01722162|473634130|FG001|Overall Study|Found ineligible|0|||
131549335|NCT01722162|473634129|FG000|Overall Study|Unrelated to study adverse event|2|||
131549336|NCT01722162|473634130|FG001|Overall Study|Unrelated to study adverse event|2|||
131549337|NCT01722162|473634129|FG000|Overall Study|Adverse Event|1|||
131549338|NCT01722162|473634130|FG001|Overall Study|Adverse Event|1|||
131549339|NCT01722162|473634129|FG000|Overall Study|Insurance denial post enrollment|0|||
131549340|NCT01722162|473634130|FG001|Overall Study|Insurance denial post enrollment|1|||
131549341|NCT01722162|473634129|FG000|Overall Study|Noncompliance|0|||
131549342|NCT01722162|473634130|FG001|Overall Study|Noncompliance|1|||
131549343|NCT03124199|473634131|FG000|Overall Study|Lost to Follow-up|4|||
131549344|NCT01538472|473634132|FG000|Overall Study|Disease Progression|3|||
131549345|NCT01538472|473634132|FG000|Overall Study|Death|1|||
131549346|NCT02309112|473634133|FG000|Overall Study|Withdrawal by Subject|1|||
131549347|NCT02309112|473634134|FG001|Overall Study|Withdrawal by Subject|0|||
131549348|NCT02309112|473634135|FG002|Overall Study|Withdrawal by Subject|1|||
131549349|NCT02309112|473634133|FG000|Overall Study|Lost to Follow-up|0|||
131549350|NCT02309112|473634134|FG001|Overall Study|Lost to Follow-up|1|||
131549351|NCT02309112|473634135|FG002|Overall Study|Lost to Follow-up|0|||
131549352|NCT03170375|473634136|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
131549353|NCT03170375|473634137|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
131549354|NCT03170375|473634138|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
131549355|NCT03170375|473634136|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
131549356|NCT03170375|473634137|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
131549357|NCT03170375|473634138|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
131549358|NCT00763958|473634141|FG000|Overall Study|did not meet final criteria|4|||
131549359|NCT00763958|473634142|FG001|Overall Study|did not meet final criteria|4|||
131549360|NCT00763958|473634141|FG000|Overall Study|Lost to Follow-up|10|||
131549361|NCT00763958|473634142|FG001|Overall Study|Lost to Follow-up|2|||
131549362|NCT00763958|473634141|FG000|Overall Study|Believed they were receiving placebo|0|||
131549363|NCT00763958|473634142|FG001|Overall Study|Believed they were receiving placebo|5|||
131549364|NCT02535364|473634150|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
131549365|NCT02535364|473634150|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
131549366|NCT02535364|473634150|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
131549367|NCT02535364|473634150|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
131549368|NCT02535364|473634150|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
131549369|NCT02535364|473634150|FG000|Part B Screening|Death|2|||
131549370|NCT02535364|473634150|FG000|Part B Screening|Physician Decision|1|||
131549371|NCT02535364|473634150|FG000|Part B Screening|Withdrawal by Subject|1|||
131549372|NCT02535364|473634150|FG000|Part B Screening|Adverse Event|1|||
131549373|NCT02535364|473634150|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
131549374|NCT02535364|473634150|FG000|Study Treatment|Death|1|||
131549375|NCT02535364|473634150|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
131549376|NCT02535364|473634150|FG000|12-Month Follow-up Period|Disease progression|22|||
131887890|NCT00236899|474872307|FG002|Overall Study|Death (Study Disease)|0|||
131549377|NCT02535364|473634150|FG000|12-Month Follow-up Period|Death|5|||
131549378|NCT02535364|473634150|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
131549379|NCT02535364|473634150|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
131549380|NCT02535364|473634150|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
131549381|NCT00571701|473634151|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
131549382|NCT00571701|473634152|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
131549383|NCT00571701|473634151|FG000|First Intervention 12 Months|Death|1|||
131549384|NCT00571701|473634152|FG001|First Intervention 12 Months|Death|0|||
131549385|NCT00571701|473634151|FG000|Second Intervention 12 Months|Adverse Event|0|||
131661825|NCT02217475|474046161|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
131661826|NCT02217475|474046159|FG000|Discontinued After Period 1|Physician Decision|0|||
131887891|NCT00236899|474872308|FG003|Overall Study|Death (Study Disease)|0|||
131887892|NCT00236899|474872305|FG000|Overall Study|Death (Not Study Related)|2|||
131887893|NCT00236899|474872306|FG001|Overall Study|Death (Not Study Related)|0|||
131887894|NCT00236899|474872307|FG002|Overall Study|Death (Not Study Related)|0|||
131887895|NCT00236899|474872308|FG003|Overall Study|Death (Not Study Related)|0|||
131887896|NCT00236899|474872305|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
131887897|NCT00236899|474872306|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
131887898|NCT00236899|474872307|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
131887899|NCT00236899|474872308|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
131887900|NCT00236899|474872305|FG000|Overall Study|Lost to Follow-up|0|||
131887901|NCT00236899|474872306|FG001|Overall Study|Lost to Follow-up|1|||
131887902|NCT00236899|474872307|FG002|Overall Study|Lost to Follow-up|0|||
131887903|NCT00236899|474872308|FG003|Overall Study|Lost to Follow-up|0|||
131887904|NCT00236899|474872305|FG000|Overall Study|Entry Criteria Exclusion|0|||
131887905|NCT00236899|474872306|FG001|Overall Study|Entry Criteria Exclusion|1|||
131887906|NCT00236899|474872307|FG002|Overall Study|Entry Criteria Exclusion|1|||
131887907|NCT00236899|474872308|FG003|Overall Study|Entry Criteria Exclusion|0|||
131887908|NCT00236899|474872305|FG000|Overall Study|Protocol Violation|1|||
131887909|NCT00236899|474872306|FG001|Overall Study|Protocol Violation|0|||
131887910|NCT00236899|474872307|FG002|Overall Study|Protocol Violation|0|||
131887911|NCT00236899|474872308|FG003|Overall Study|Protocol Violation|0|||
131887912|NCT00236899|474872305|FG000|Overall Study|Withdrawal by Subject|6|||
131887913|NCT00236899|474872306|FG001|Overall Study|Withdrawal by Subject|4|||
131887914|NCT00236899|474872307|FG002|Overall Study|Withdrawal by Subject|5|||
131887915|NCT00236899|474872308|FG003|Overall Study|Withdrawal by Subject|2|||
131887916|NCT00236899|474872305|FG000|Overall Study|Physician Decision|7|||
131887917|NCT00236899|474872306|FG001|Overall Study|Physician Decision|8|||
131887918|NCT00236899|474872307|FG002|Overall Study|Physician Decision|7|||
131887919|NCT00236899|474872308|FG003|Overall Study|Physician Decision|6|||
131887920|NCT00236899|474872305|FG000|Overall Study|Satisfactory Response|2|||
131887921|NCT00236899|474872306|FG001|Overall Study|Satisfactory Response|0|||
131887922|NCT00236899|474872307|FG002|Overall Study|Satisfactory Response|0|||
131887923|NCT00236899|474872308|FG003|Overall Study|Satisfactory Response|1|||
131887924|NCT00236899|474872305|FG000|Overall Study|Lack of Efficacy|18|||
131887925|NCT00236899|474872306|FG001|Overall Study|Lack of Efficacy|18|||
131887926|NCT00236899|474872307|FG002|Overall Study|Lack of Efficacy|25|||
131887927|NCT00236899|474872308|FG003|Overall Study|Lack of Efficacy|23|||
131887928|NCT02854605|474872311|FG000|Overall Study|Adverse Event|1|||
131887929|NCT02854605|474872312|FG001|Overall Study|Adverse Event|5|||
131887930|NCT02854605|474872313|FG002|Overall Study|Adverse Event|2|||
131887931|NCT02854605|474872311|FG000|Overall Study|Lost to Follow-up|0|||
131887932|NCT02854605|474872312|FG001|Overall Study|Lost to Follow-up|2|||
131887933|NCT02854605|474872313|FG002|Overall Study|Lost to Follow-up|0|||
131887934|NCT02854605|474872311|FG000|Overall Study|Withdrew Consent|1|||
131887935|NCT02854605|474872312|FG001|Overall Study|Withdrew Consent|0|||
131887936|NCT02854605|474872313|FG002|Overall Study|Withdrew Consent|1|||
131887937|NCT02854605|474872311|FG000|Overall Study|Investigator's Discretion|1|||
131887938|NCT02854605|474872312|FG001|Overall Study|Investigator's Discretion|0|||
131887939|NCT02854605|474872313|FG002|Overall Study|Investigator's Discretion|0|||
131887940|NCT02854605|474872311|FG000|Overall Study|Protocol Violation|0|||
131887941|NCT02854605|474872312|FG001|Overall Study|Protocol Violation|0|||
131887942|NCT02854605|474872313|FG002|Overall Study|Protocol Violation|1|||
131887943|NCT01897571|474872316|FG000|Overall Study|Lost to Follow-up|3|||
131887944|NCT01897571|474872317|FG001|Overall Study|Lost to Follow-up|0|||
131887945|NCT01897571|474872318|FG002|Overall Study|Lost to Follow-up|0|||
131887946|NCT01897571|474872319|FG003|Overall Study|Lost to Follow-up|0|||
131887947|NCT01897571|474872320|FG004|Overall Study|Lost to Follow-up|2|||
131887948|NCT01897571|474872321|FG005|Overall Study|Lost to Follow-up|0|||
131887949|NCT01897571|474872322|FG006|Overall Study|Lost to Follow-up|0|||
131887950|NCT01897571|474872323|FG007|Overall Study|Lost to Follow-up|0|||
131887951|NCT01897571|474872324|FG008|Overall Study|Lost to Follow-up|1|||
131887952|NCT01897571|474872325|FG009|Overall Study|Lost to Follow-up|2|||
131887953|NCT01897571|474872326|FG010|Overall Study|Lost to Follow-up|4|||
131887954|NCT01897571|474872316|FG000|Overall Study|Withdrawal by Subject|0|||
131887955|NCT01897571|474872317|FG001|Overall Study|Withdrawal by Subject|0|||
131887956|NCT01897571|474872318|FG002|Overall Study|Withdrawal by Subject|0|||
131887957|NCT01897571|474872319|FG003|Overall Study|Withdrawal by Subject|0|||
131887958|NCT01897571|474872320|FG004|Overall Study|Withdrawal by Subject|0|||
131887959|NCT01897571|474872321|FG005|Overall Study|Withdrawal by Subject|0|||
131887960|NCT01897571|474872322|FG006|Overall Study|Withdrawal by Subject|0|||
131887961|NCT01897571|474872323|FG007|Overall Study|Withdrawal by Subject|1|||
131887962|NCT01897571|474872324|FG008|Overall Study|Withdrawal by Subject|4|||
131887963|NCT01897571|474872325|FG009|Overall Study|Withdrawal by Subject|3|||
131887964|NCT01897571|474872326|FG010|Overall Study|Withdrawal by Subject|1|||
131887965|NCT01897571|474872316|FG000|Overall Study|Other|1|||
131887966|NCT01897571|474872317|FG001|Overall Study|Other|0|||
131435777|NCT02365649|473221860|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435778|NCT02365649|473221861|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435779|NCT02365649|473221862|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435780|NCT02365649|473221863|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435781|NCT02365649|473221864|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435782|NCT02365649|473221865|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435783|NCT02365649|473221866|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
131435784|NCT02365649|473221857|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435785|NCT02365649|473221858|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435786|NCT02365649|473221859|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435787|NCT02365649|473221860|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435788|NCT02365649|473221861|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435789|NCT02365649|473221862|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435790|NCT02365649|473221863|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
131435791|NCT02365649|473221864|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435792|NCT02365649|473221865|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435793|NCT02365649|473221866|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
131435794|NCT02365649|473221857|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435795|NCT02365649|473221858|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435796|NCT02365649|473221859|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435797|NCT02365649|473221860|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435798|NCT02365649|473221861|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435799|NCT02365649|473221862|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435800|NCT02365649|473221863|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
131435801|NCT02365649|473221864|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
131435802|NCT02365649|473221865|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
131435803|NCT02365649|473221866|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
131435804|NCT02365649|473221857|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
131435805|NCT02365649|473221858|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
131435806|NCT02365649|473221859|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
131435807|NCT02365649|473221860|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
131435808|NCT02365649|473221861|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
131435809|NCT02365649|473221862|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
131435810|NCT02365649|473221863|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
131435811|NCT02365649|473221864|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
131435812|NCT02365649|473221865|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
131435813|NCT02365649|473221866|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
131435814|NCT02365649|473221857|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435815|NCT02365649|473221858|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435816|NCT02365649|473221859|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435817|NCT02365649|473221860|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435818|NCT02365649|473221861|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435819|NCT02365649|473221862|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435820|NCT02365649|473221863|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
131435821|NCT02365649|473221864|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
131435822|NCT02365649|473221865|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
131435823|NCT02365649|473221866|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
131435824|NCT02365649|473221857|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435825|NCT02365649|473221858|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435826|NCT02365649|473221859|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435827|NCT02365649|473221860|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435828|NCT02365649|473221861|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435829|NCT02365649|473221862|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435830|NCT02365649|473221863|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
131435831|NCT02365649|473221864|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435832|NCT02365649|473221865|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
131435833|NCT02365649|473221866|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
131435834|NCT01506271|473221867|FG000|Overall Study|Progressive disease|0|||
131435835|NCT01506271|473221868|FG001|Overall Study|Progressive disease|1|||
131435836|NCT01506271|473221869|FG002|Overall Study|Progressive disease|0|||
131435837|NCT01506271|473221867|FG000|Overall Study|Protocol Violation|3|||
131435838|NCT01506271|473221868|FG001|Overall Study|Protocol Violation|1|||
131435839|NCT01506271|473221869|FG002|Overall Study|Protocol Violation|0|||
131435840|NCT01506271|473221867|FG000|Overall Study|Death|0|||
131435841|NCT01506271|473221868|FG001|Overall Study|Death|1|||
131549386|NCT00571701|473634152|FG001|Second Intervention 12 Months|Adverse Event|1|||
131549387|NCT00571701|473634151|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
131549388|NCT00571701|473634152|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
131549389|NCT04766086|473634154|FG000|Overall Study|Lost to Follow-up|3|||
131549390|NCT04766086|473634155|FG001|Overall Study|Lost to Follow-up|5|||
131549391|NCT04766086|473634156|FG002|Overall Study|Lost to Follow-up|3|||
131549392|NCT04766086|473634154|FG000|Overall Study|Withdrawal by Subject|1|||
131549393|NCT04766086|473634155|FG001|Overall Study|Withdrawal by Subject|1|||
131549394|NCT04766086|473634156|FG002|Overall Study|Withdrawal by Subject|2|||
131549395|NCT04766086|473634154|FG000|Overall Study|Other|0|||
131549396|NCT04766086|473634155|FG001|Overall Study|Other|0|||
131549397|NCT04766086|473634156|FG002|Overall Study|Other|1|||
131549398|NCT03815019|473634159|FG000|Overall Study|Withdrawal by Subject|6|||
131549399|NCT03815019|473634160|FG001|Overall Study|Withdrawal by Subject|8|||
131549400|NCT01320943|473634161|FG000|Overall Study|Lost to Follow-up|1|||
131549401|NCT01320943|473634162|FG001|Overall Study|Lost to Follow-up|0|||
131549402|NCT01320943|473634161|FG000|Overall Study|Physician Decision|0|||
131549403|NCT01320943|473634162|FG001|Overall Study|Physician Decision|1|||
131549404|NCT01320943|473634161|FG000|Overall Study|Randomized but not Treated|0|||
131549405|NCT01320943|473634162|FG001|Overall Study|Randomized but not Treated|1|||
131549406|NCT03937219|473634163|FG000|Overall Study|Death|223|||
131549407|NCT03937219|473634164|FG001|Overall Study|Death|211|||
131549408|NCT03937219|473634163|FG000|Overall Study|Withdrawal by Subject|17|||
131549409|NCT03937219|473634164|FG001|Overall Study|Withdrawal by Subject|25|||
131549410|NCT03937219|473634163|FG000|Overall Study|Lost to Follow-up|3|||
131549411|NCT03937219|473634164|FG001|Overall Study|Lost to Follow-up|4|||
131549412|NCT00532155|473634165|FG000|Overall Study|Adverse Event|66|||
131549413|NCT00532155|473634166|FG001|Overall Study|Adverse Event|123|||
131549414|NCT00532155|473634165|FG000|Overall Study|Lack of Efficacy|332|||
131549415|NCT00532155|473634166|FG001|Overall Study|Lack of Efficacy|255|||
131549416|NCT00532155|473634165|FG000|Overall Study|Protocol Violation|1|||
131549417|NCT00532155|473634166|FG001|Overall Study|Protocol Violation|3|||
131549418|NCT00532155|473634165|FG000|Overall Study|Lost to Follow-up|2|||
131549419|NCT00532155|473634166|FG001|Overall Study|Lost to Follow-up|0|||
131549420|NCT00532155|473634165|FG000|Overall Study|Physician Decision|16|||
131549421|NCT00532155|473634166|FG001|Overall Study|Physician Decision|15|||
131549422|NCT00532155|473634165|FG000|Overall Study|Withdrawal by Subject|23|||
131549423|NCT00532155|473634166|FG001|Overall Study|Withdrawal by Subject|44|||
131549424|NCT00532155|473634165|FG000|Overall Study|Consent withdrawn|5|||
131549425|NCT00532155|473634166|FG001|Overall Study|Consent withdrawn|7|||
131549426|NCT00532155|473634165|FG000|Overall Study|Moved|1|||
131549427|NCT00532155|473634166|FG001|Overall Study|Moved|0|||
131549428|NCT00532155|473634165|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
131549429|NCT00532155|473634166|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
131549430|NCT00532155|473634165|FG000|Overall Study|Occurence of a second cancer|0|||
131549431|NCT00532155|473634166|FG001|Overall Study|Occurence of a second cancer|1|||
131549432|NCT00532155|473634165|FG000|Overall Study|Occurence of a secondary cancer|0|||
131549433|NCT00532155|473634166|FG001|Overall Study|Occurence of a secondary cancer|1|||
131549434|NCT00532155|473634165|FG000|Overall Study|Promotor ended study|1|||
131549435|NCT00532155|473634166|FG001|Overall Study|Promotor ended study|0|||
131549436|NCT00532155|473634165|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
131549437|NCT00532155|473634166|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
131549438|NCT00532155|473634165|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
131549439|NCT00532155|473634166|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
131549440|NCT00532155|473634165|FG000|Overall Study|Study stopped|1|||
131549441|NCT00532155|473634166|FG001|Overall Study|Study stopped|0|||
131549442|NCT00532155|473634165|FG000|Overall Study|Study terminated by sponsor|1|||
131549443|NCT00532155|473634166|FG001|Overall Study|Study terminated by sponsor|0|||
131549444|NCT00532155|473634165|FG000|Overall Study|Study termination stop further treatment|4|||
131549445|NCT00532155|473634166|FG001|Overall Study|Study termination stop further treatment|0|||
131549446|NCT00532155|473634165|FG000|Overall Study|Did not receive study medication|2|||
131549447|NCT00532155|473634166|FG001|Overall Study|Did not receive study medication|6|||
131549448|NCT03483038|473634167|FG000|Overall Study|Subjects still in follow-up|18|||
131549449|NCT02134925|473634168|FG000|Overall Study|Withdrawal by Subject|1|||
131549450|NCT02134925|473634169|FG001|Overall Study|Withdrawal by Subject|0|||
131549451|NCT02134925|473634168|FG000|Overall Study|Cancel|1|||
131549452|NCT02134925|473634169|FG001|Overall Study|Cancel|6|||
131549453|NCT04987762|473634170|FG000|Overall Study|Study was Terminated by Sponsor|103|||
131549454|NCT02158884|473634175|FG000|Baseline Assessment|Missed performance assessment|3|||
131549455|NCT02158884|473634175|FG000|Baseline Assessment|Missed SMFA|1|||
131549456|NCT02158884|473634175|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
131549457|NCT02158884|473634175|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
131549458|NCT02158884|473634175|FG000|6 Month Assessment|Missed SMFA|20|||
131549459|NCT02158884|473634175|FG000|12 Month Assessment|Missed SMFA|17|||
131770376|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131887967|NCT01897571|474872318|FG002|Overall Study|Other|0|||
131549460|NCT00504426|473634176|FG000|Overall Study|Adverse Event|0|||
131549461|NCT00504426|473634177|FG001|Overall Study|Adverse Event|0|||
131549462|NCT00504426|473634178|FG002|Overall Study|Adverse Event|2|||
131549463|NCT00504426|473634179|FG003|Overall Study|Adverse Event|0|||
131549464|NCT00504426|473634176|FG000|Overall Study|Protocol Violation|1|||
131549465|NCT00504426|473634177|FG001|Overall Study|Protocol Violation|1|||
131549466|NCT00504426|473634178|FG002|Overall Study|Protocol Violation|2|||
131549467|NCT00504426|473634179|FG003|Overall Study|Protocol Violation|0|||
131549468|NCT00504426|473634176|FG000|Overall Study|Withdrawal by Subject|2|||
131549469|NCT00504426|473634177|FG001|Overall Study|Withdrawal by Subject|0|||
131549470|NCT00504426|473634178|FG002|Overall Study|Withdrawal by Subject|0|||
131549471|NCT00504426|473634179|FG003|Overall Study|Withdrawal by Subject|0|||
131549472|NCT03988166|473634182|FG000|Overall Study|Lost to Follow-up|2|||
131549473|NCT03988166|473634182|FG000|Overall Study|Death|1|||
131549474|NCT03248375|473634183|FG000|Overall Study|Lost to Follow-up|5|||
131549475|NCT00633464|473634184|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
131549476|NCT00633464|473634185|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
131549477|NCT00633464|473634184|FG000|Overall Study|Never Treated (Randomized in error)|0|||
131549478|NCT00633464|473634185|FG001|Overall Study|Never Treated (Randomized in error)|1|||
131549479|NCT02612064|473634186|FG000|Overall Study|Withdrawal by Subject|1|||
131549480|NCT02612064|473634187|FG001|Overall Study|Withdrawal by Subject|1|||
131549481|NCT02612064|473634186|FG000|Overall Study|Other|0|||
131549482|NCT02612064|473634187|FG001|Overall Study|Other|2|||
131549483|NCT01669798|473634190|FG000|Overall Study|Physician Decision|5|||
131549484|NCT00558064|473634192|FG000|Overall Study|Adverse Event|3|||
131549485|NCT00558064|473634193|FG001|Overall Study|Adverse Event|2|||
131549486|NCT00558064|473634192|FG000|Overall Study|Lack of Efficacy|0|||
131549487|NCT00558064|473634193|FG001|Overall Study|Lack of Efficacy|1|||
131549488|NCT00558064|473634192|FG000|Overall Study|Protocol Violation|1|||
131549489|NCT00558064|473634193|FG001|Overall Study|Protocol Violation|0|||
131549490|NCT00558064|473634192|FG000|Overall Study|Lost to Follow-up|0|||
131549491|NCT00558064|473634193|FG001|Overall Study|Lost to Follow-up|1|||
131549492|NCT00558064|473634192|FG000|Overall Study|Withdrawal by Subject|0|||
131549493|NCT00558064|473634193|FG001|Overall Study|Withdrawal by Subject|1|||
131549494|NCT00558064|473634192|FG000|Overall Study|No visit within allowance period|1|||
131549495|NCT00558064|473634193|FG001|Overall Study|No visit within allowance period|0|||
131549496|NCT00982930|473634196|FG000|Overall Study|Adverse Event|1|||
131549497|NCT00982930|473634196|FG000|Overall Study|Withdrawal by Subject|1|||
131549498|NCT00982930|473634196|FG000|Overall Study|Administrative Problems|2|||
131549499|NCT01489189|473634197|FG000|Overall Study|Withdrawal by Subject|20|||
131549500|NCT01489189|473634198|FG001|Overall Study|Withdrawal by Subject|23|||
131549501|NCT01489189|473634197|FG000|Overall Study|Death|10|||
131549502|NCT01489189|473634198|FG001|Overall Study|Death|8|||
131549503|NCT01489189|473634197|FG000|Overall Study|Missed Visit|1|||
131549504|NCT01489189|473634198|FG001|Overall Study|Missed Visit|4|||
131549505|NCT05597722|473634199|FG000|Overall Study|Study was terminated|6|||
131549506|NCT05597722|473634200|FG001|Overall Study|Study was terminated|1|||
131549507|NCT00404495|473634201|FG000|Overall Study|Death|37|||
131549508|NCT00404495|473634202|FG001|Overall Study|Death|11|||
131549509|NCT00404495|473634201|FG000|Overall Study|Lost to Follow-up|5|||
131549510|NCT00404495|473634202|FG001|Overall Study|Lost to Follow-up|0|||
131549511|NCT00404495|473634201|FG000|Overall Study|Other|1|||
131549512|NCT00404495|473634202|FG001|Overall Study|Other|0|||
131549513|NCT00404495|473634201|FG000|Overall Study|Withdrawal by Subject|1|||
131549514|NCT00404495|473634202|FG001|Overall Study|Withdrawal by Subject|0|||
131549515|NCT04108000|473634203|FG000|Overall Study|Death of patient|1|||
131549516|NCT04108000|473634204|FG001|Overall Study|Death of patient|0|||
131549517|NCT04108000|473634205|FG002|Overall Study|Death of patient|1|||
131549518|NCT04108000|473634206|FG003|Overall Study|Death of patient|0|||
131549519|NCT04108000|473634203|FG000|Overall Study|Withdrawal by Subject|2|||
131549520|NCT04108000|473634204|FG001|Overall Study|Withdrawal by Subject|2|||
131549521|NCT04108000|473634205|FG002|Overall Study|Withdrawal by Subject|0|||
131549522|NCT04108000|473634206|FG003|Overall Study|Withdrawal by Subject|0|||
131549523|NCT04108000|473634203|FG000|Overall Study|Death of surrogate partner|0|||
131549524|NCT04108000|473634204|FG001|Overall Study|Death of surrogate partner|1|||
131549525|NCT04108000|473634205|FG002|Overall Study|Death of surrogate partner|0|||
131549526|NCT04108000|473634206|FG003|Overall Study|Death of surrogate partner|1|||
131549527|NCT04739761|473634209|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
131549528|NCT04739761|473634210|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
131549529|NCT04739761|473634209|FG000|Overall Study|By complete response from the participant|1|||
131549530|NCT04739761|473634210|FG001|Overall Study|By complete response from the participant|0|||
131549531|NCT04739761|473634209|FG000|Overall Study|Lost to Follow-up|3|||
131549532|NCT04739761|473634210|FG001|Overall Study|Lost to Follow-up|3|||
131549533|NCT04739761|473634209|FG000|Overall Study|Death|13|||
131549534|NCT04739761|473634210|FG001|Overall Study|Death|13|||
131549535|NCT04739761|473634209|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
131653528|NCT04703192|474018396|FG000|Overall Study|Progressive or Relapsed Disease|46|||
131549536|NCT04739761|473634210|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
131549537|NCT04739761|473634209|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
131549538|NCT04739761|473634210|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
131549539|NCT04739761|473634209|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
131549540|NCT04739761|473634210|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
131549541|NCT04739761|473634209|FG000|Overall Study|Adverse Event|0|||
131549542|NCT04739761|473634210|FG001|Overall Study|Adverse Event|3|||
131549543|NCT04739761|473634209|FG000|Overall Study|Participant decision|1|||
131549544|NCT04739761|473634210|FG001|Overall Study|Participant decision|0|||
131549545|NCT04739761|473634209|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
131549546|NCT04739761|473634210|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
131549547|NCT04739761|473634209|FG000|Overall Study|Participant immediately started next line of treatment|1|||
131549548|NCT04739761|473634210|FG001|Overall Study|Participant immediately started next line of treatment|0|||
131549549|NCT04739761|473634209|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
131549550|NCT04739761|473634210|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
131549551|NCT04739761|473634209|FG000|Overall Study|Lack of clinical benefit|1|||
131549552|NCT04739761|473634210|FG001|Overall Study|Lack of clinical benefit|0|||
131549553|NCT04739761|473634209|FG000|Overall Study|Disease progression|5|||
131549554|NCT04739761|473634210|FG001|Overall Study|Disease progression|5|||
131549555|NCT04739761|473634209|FG000|Overall Study|Withdrawal by Subject|14|||
131549556|NCT04739761|473634210|FG001|Overall Study|Withdrawal by Subject|13|||
131549557|NCT04739761|473634209|FG000|Overall Study|Protocol Violation|1|||
131549558|NCT04739761|473634210|FG001|Overall Study|Protocol Violation|0|||
131549559|NCT04739761|473634209|FG000|Overall Study|Physician Decision|2|||
131549560|NCT04739761|473634210|FG001|Overall Study|Physician Decision|0|||
131549561|NCT03881696|473634211|FG000|Overall Study|Adverse Event|2|||
131549562|NCT03881696|473634212|FG001|Overall Study|Adverse Event|0|||
131549563|NCT03881696|473634211|FG000|Overall Study|Withdrawal by Subject|2|||
131549564|NCT03881696|473634212|FG001|Overall Study|Withdrawal by Subject|0|||
131549565|NCT03881696|473634211|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
131549566|NCT03881696|473634212|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
131549567|NCT03881696|473634211|FG000|Overall Study|Failure to meet continuation criteria|1|||
131549568|NCT03881696|473634212|FG001|Overall Study|Failure to meet continuation criteria|0|||
131549569|NCT02044848|473635497|FG000|Overall Study|Administrative Problems|2|||
131435842|NCT01506271|473221869|FG002|Overall Study|Death|0|||
131435843|NCT01506271|473221867|FG000|Overall Study|Adverse Event|0|||
131435844|NCT01506271|473221868|FG001|Overall Study|Adverse Event|2|||
131435845|NCT01506271|473221869|FG002|Overall Study|Adverse Event|0|||
131435846|NCT01506271|473221867|FG000|Overall Study|Insufficient supply of study drug|1|||
131435847|NCT01506271|473221868|FG001|Overall Study|Insufficient supply of study drug|0|||
131435848|NCT01506271|473221869|FG002|Overall Study|Insufficient supply of study drug|0|||
131435849|NCT01506271|473221867|FG000|Overall Study|Withdrawal by Subject|0|||
131435850|NCT01506271|473221868|FG001|Overall Study|Withdrawal by Subject|1|||
131435851|NCT01506271|473221869|FG002|Overall Study|Withdrawal by Subject|1|||
131435852|NCT01506271|473221867|FG000|Overall Study|Lost to Follow-up|0|||
131435853|NCT01506271|473221868|FG001|Overall Study|Lost to Follow-up|1|||
131435854|NCT01506271|473221869|FG002|Overall Study|Lost to Follow-up|2|||
131435855|NCT03040141|473221879|FG000|Overall Study|Death|1|||
131435856|NCT03040141|473221880|FG001|Overall Study|Death|2|||
131435857|NCT03040141|473221881|FG002|Overall Study|Death|3|||
131435858|NCT03040141|473221879|FG000|Overall Study|Withdrawal by Subject|3|||
131435859|NCT03040141|473221880|FG001|Overall Study|Withdrawal by Subject|1|||
131435860|NCT03040141|473221881|FG002|Overall Study|Withdrawal by Subject|1|||
131435861|NCT03040141|473221879|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
131435862|NCT03040141|473221880|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
131435863|NCT03040141|473221881|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
131435864|NCT03040141|473221879|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
131435865|NCT03040141|473221880|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
131435866|NCT03040141|473221881|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
131435867|NCT00462306|473221882|FG000|Overall Study|insufficient data|0|||
131435868|NCT00462306|473221883|FG001|Overall Study|insufficient data|13|||
131435869|NCT00920855|473221884|FG000|Overall Study|Adverse Event|1|||
131435870|NCT00920855|473221885|FG001|Overall Study|Adverse Event|1|||
131435871|NCT00920855|473221886|FG002|Overall Study|Adverse Event|4|||
131435872|NCT00920855|473221884|FG000|Overall Study|Withdrawal by Subject|2|||
131435873|NCT00920855|473221885|FG001|Overall Study|Withdrawal by Subject|1|||
131435874|NCT00920855|473221886|FG002|Overall Study|Withdrawal by Subject|6|||
131435875|NCT00920855|473221884|FG000|Overall Study|Disease progression|2|||
131549570|NCT02044848|473635498|FG001|Overall Study|Administrative Problems|3|||
131549571|NCT01160484|473635507|FG000|Overall Study|Lack of Efficacy|9|||
131549572|NCT01160484|473635507|FG000|Overall Study|Adverse Event|6|||
131549573|NCT01160484|473635507|FG000|Overall Study|Withdrawal by Subject|2|||
131549574|NCT01160484|473635507|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
131549575|NCT01679301|473635508|FG000|Screening Period|screen failure|3|||
131549576|NCT01679301|473635509|FG001|Screening Period|screen failure|0|||
131549577|NCT01679301|473635510|FG002|Screening Period|screen failure|0|||
131549578|NCT01529008|473635513|FG000|Bone Marrow Harvesting|Physician Decision|1|||
131549579|NCT01529008|473635514|FG001|Bone Marrow Harvesting|Physician Decision|1|||
131549580|NCT01529008|473635513|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
131549581|NCT01529008|473635514|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
131549582|NCT01529008|473635513|FG000|Treatment|Adverse Event|6|||
131549583|NCT01529008|473635514|FG001|Treatment|Adverse Event|0|||
131549584|NCT01529008|473635513|FG000|Treatment|Other|3|||
131549585|NCT01529008|473635514|FG001|Treatment|Other|1|||
131549586|NCT01529008|473635513|FG000|Efficacy Analysis|Protocol Violation|2|||
131549587|NCT01529008|473635514|FG001|Efficacy Analysis|Protocol Violation|0|||
131549588|NCT01529008|473635513|FG000|Efficacy Analysis|Physician Decision|0|||
131549589|NCT01529008|473635514|FG001|Efficacy Analysis|Physician Decision|1|||
131549590|NCT01529008|473635513|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
131549591|NCT01529008|473635514|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
131549592|NCT00332332|473635515|FG000|Overall Study|Adverse Event|13|||
131549593|NCT00332332|473635515|FG000|Overall Study|Death|1|||
131549594|NCT00332332|473635515|FG000|Overall Study|Withdrawal by Subject|8|||
131549595|NCT00332332|473635515|FG000|Overall Study|Physician Decision|1|||
131549596|NCT00332332|473635515|FG000|Overall Study|Lost to Follow-up|3|||
131549597|NCT00332332|473635515|FG000|Overall Study|Protocol deviation|4|||
131549598|NCT00332332|473635515|FG000|Overall Study|Noncompliance|2|||
131549599|NCT00332332|473635515|FG000|Overall Study|Disease progression|2|||
131549600|NCT00332332|473635515|FG000|Overall Study|Other|18|||
131549601|NCT00332332|473635515|FG000|Overall Study|Did not receive study treatment|16|||
131549602|NCT01382602|473635516|FG000|Overall Study|Protocol Violation|0|||
131549603|NCT01382602|473635517|FG001|Overall Study|Protocol Violation|3|||
131549604|NCT01382602|473635516|FG000|Overall Study|Withdrawal by Subject|0|||
131549605|NCT01382602|473635517|FG001|Overall Study|Withdrawal by Subject|1|||
131549606|NCT01392300|473635524|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
131549607|NCT01392300|473635525|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
131549608|NCT01392300|473635526|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
131549609|NCT01392300|473635524|FG000|Main Period (MP)|Withdrawal by Subject|5|||
131549610|NCT01392300|473635525|FG001|Main Period (MP)|Withdrawal by Subject|1|||
131549611|NCT01392300|473635526|FG002|Main Period (MP)|Withdrawal by Subject|0|||
131549612|NCT01392300|473635524|FG000|Main Period (MP)|Lost to Follow-up|3|||
131549613|NCT01392300|473635525|FG001|Main Period (MP)|Lost to Follow-up|3|||
131549614|NCT01392300|473635526|FG002|Main Period (MP)|Lost to Follow-up|0|||
131549615|NCT01392300|473635524|FG000|Main Period (MP)|Non-compliance|1|||
131549616|NCT01392300|473635525|FG001|Main Period (MP)|Non-compliance|0|||
131549617|NCT01392300|473635526|FG002|Main Period (MP)|Non-compliance|0|||
131549618|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
131549619|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
131549620|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
131549621|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
131549622|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
131549623|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
131549624|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
131549625|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
131549626|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
131549627|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Death|0|||
131549628|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Death|0|||
131549629|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Death|4|||
131549630|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
131549631|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
131549632|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
131549633|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
131549634|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
131549635|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
131549636|NCT01392300|473635524|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
131549637|NCT01392300|473635525|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
131549638|NCT01392300|473635526|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
131549639|NCT05056870|473635531|FG000|Period 1|Site COVID-19 Related|3|||
131549640|NCT05056870|473635532|FG001|Period 1|Site COVID-19 Related|3|||
131549641|NCT05056870|473635531|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131549642|NCT05056870|473635532|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
131549643|NCT05056870|473635531|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
131549644|NCT05056870|473635532|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131549645|NCT05056870|473635531|FG000|Period 2|COVID-19 Related|1|||
131549646|NCT05056870|473635532|FG001|Period 2|COVID-19 Related|0|||
131549647|NCT05056870|473635531|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
131549648|NCT05056870|473635532|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
131549649|NCT00676130|473635533|FG000|Overall Study|Lost to Follow-up|0|||
131549650|NCT00676130|473635534|FG001|Overall Study|Lost to Follow-up|1|||
131549651|NCT00676130|473635533|FG000|Overall Study|Found ineligible|3|||
131549652|NCT00676130|473635534|FG001|Overall Study|Found ineligible|2|||
131549653|NCT00676130|473635533|FG000|Overall Study|Withdrawal by Subject|0|||
131549654|NCT00676130|473635534|FG001|Overall Study|Withdrawal by Subject|1|||
131549655|NCT01682213|473635537|FG000|Overall Study|Withdrawal by Subject|2|||
131549656|NCT00742079|473635538|FG000|Overall Study|Lost to Follow-up|0|||
131549657|NCT00742079|473635539|FG001|Overall Study|Lost to Follow-up|1|||
131549658|NCT01181726|473635540|FG000|First Intervention|Adverse Event|1|||
131549659|NCT01181726|473635541|FG001|First Intervention|Adverse Event|0|||
131549660|NCT01114204|473635543|FG000|Overall Study|Adverse Event|3|||
131549661|NCT01114204|473635544|FG001|Overall Study|Adverse Event|2|||
131549662|NCT01114204|473635543|FG000|Overall Study|Lost to Follow-up|1|||
131549663|NCT01114204|473635544|FG001|Overall Study|Lost to Follow-up|0|||
131549664|NCT01114204|473635543|FG000|Overall Study|Withdrawal by Subject|10|||
131549665|NCT01114204|473635544|FG001|Overall Study|Withdrawal by Subject|6|||
131549666|NCT01114204|473635543|FG000|Overall Study|Death|1|||
131549667|NCT01114204|473635544|FG001|Overall Study|Death|0|||
131549668|NCT01114204|473635543|FG000|Overall Study|Other-Personal reasons|2|||
131549669|NCT01114204|473635544|FG001|Overall Study|Other-Personal reasons|0|||
131549670|NCT01114204|473635543|FG000|Overall Study|Other-Medical monitor request|1|||
131549671|NCT01114204|473635544|FG001|Overall Study|Other-Medical monitor request|0|||
131549672|NCT01114204|473635543|FG000|Overall Study|Other-Participant request|2|||
131549673|NCT01114204|473635544|FG001|Overall Study|Other-Participant request|0|||
131549674|NCT01114204|473635543|FG000|Overall Study|Other-Protocol Violation|1|||
131549675|NCT01114204|473635544|FG001|Overall Study|Other-Protocol Violation|0|||
131549676|NCT00674570|473635545|FG000|Overall Study|Withdrawal by Subject|0|||
131549677|NCT00674570|473635546|FG001|Overall Study|Withdrawal by Subject|2|||
131549678|NCT00674570|473635547|FG002|Overall Study|Withdrawal by Subject|0|||
131549679|NCT03633929|473635548|FG000|Overall Study|Lost to Follow-up|1|||
131549680|NCT03633929|473635548|FG000|Overall Study|Did not login to software. Did not participate|3|||
131549681|NCT04461795|473635549|FG000|Overall Study|Lost to Follow-up|2|||
131549682|NCT04461795|473635549|FG000|Overall Study|Withdrawal by Subject|2|||
131549683|NCT04461795|473635549|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
131549684|NCT02798211|473635553|FG000|Period 1|Adverse Event|1|||
131549685|NCT02798211|473635554|FG001|Period 1|Adverse Event|1|||
131549686|NCT02798211|473635555|FG002|Period 1|Adverse Event|0|||
131549687|NCT02798211|473635556|FG003|Period 1|Adverse Event|0|||
131549688|NCT02798211|473635557|FG004|Period 1|Adverse Event|0|||
131549689|NCT02798211|473635558|FG005|Period 1|Adverse Event|0|||
131549690|NCT02798211|473635553|FG000|Period 1|Lost to Follow-up|2|||
131549691|NCT02798211|473635554|FG001|Period 1|Lost to Follow-up|1|||
131549692|NCT02798211|473635555|FG002|Period 1|Lost to Follow-up|0|||
131549693|NCT02798211|473635556|FG003|Period 1|Lost to Follow-up|0|||
131549694|NCT02798211|473635557|FG004|Period 1|Lost to Follow-up|0|||
131549695|NCT02798211|473635558|FG005|Period 1|Lost to Follow-up|0|||
131549696|NCT02798211|473635553|FG000|Period 1|Protocol Violation|0|||
131549697|NCT02798211|473635554|FG001|Period 1|Protocol Violation|0|||
131549698|NCT02798211|473635555|FG002|Period 1|Protocol Violation|2|||
131549699|NCT02798211|473635556|FG003|Period 1|Protocol Violation|0|||
131549700|NCT02798211|473635557|FG004|Period 1|Protocol Violation|0|||
131549701|NCT02798211|473635558|FG005|Period 1|Protocol Violation|0|||
131549702|NCT02798211|473635553|FG000|Period 1|Withdrawal by Subject|1|||
131549703|NCT02798211|473635554|FG001|Period 1|Withdrawal by Subject|1|||
131549704|NCT02798211|473635555|FG002|Period 1|Withdrawal by Subject|0|||
131549705|NCT02798211|473635556|FG003|Period 1|Withdrawal by Subject|0|||
131549706|NCT02798211|473635557|FG004|Period 1|Withdrawal by Subject|0|||
131549707|NCT02798211|473635558|FG005|Period 1|Withdrawal by Subject|0|||
131549708|NCT02798211|473635553|FG000|Period 1|Death|0|||
131549709|NCT02798211|473635554|FG001|Period 1|Death|0|||
131549710|NCT02798211|473635555|FG002|Period 1|Death|1|||
131549711|NCT02798211|473635556|FG003|Period 1|Death|0|||
131549712|NCT02798211|473635557|FG004|Period 1|Death|0|||
131549713|NCT02798211|473635558|FG005|Period 1|Death|0|||
131549714|NCT02798211|473635553|FG000|Period 1|Withdrawal of Informed Consent|2|||
131549715|NCT02798211|473635554|FG001|Period 1|Withdrawal of Informed Consent|7|||
131549716|NCT02798211|473635555|FG002|Period 1|Withdrawal of Informed Consent|3|||
131549717|NCT02798211|473635556|FG003|Period 1|Withdrawal of Informed Consent|0|||
131549718|NCT02798211|473635557|FG004|Period 1|Withdrawal of Informed Consent|0|||
131549719|NCT02798211|473635558|FG005|Period 1|Withdrawal of Informed Consent|0|||
131549720|NCT02798211|473635553|FG000|Period 2|Withdrawal by Subject|2|||
131887968|NCT01897571|474872319|FG003|Overall Study|Other|3|||
131549721|NCT02798211|473635554|FG001|Period 2|Withdrawal by Subject|0|||
131549722|NCT02798211|473635555|FG002|Period 2|Withdrawal by Subject|0|||
131549723|NCT02798211|473635556|FG003|Period 2|Withdrawal by Subject|0|||
131549724|NCT02798211|473635557|FG004|Period 2|Withdrawal by Subject|2|||
131549725|NCT02798211|473635558|FG005|Period 2|Withdrawal by Subject|2|||
131549726|NCT02798211|473635553|FG000|Period 2|Adverse Event|5|||
131549727|NCT02798211|473635554|FG001|Period 2|Adverse Event|0|||
131549728|NCT02798211|473635555|FG002|Period 2|Adverse Event|0|||
131549729|NCT02798211|473635556|FG003|Period 2|Adverse Event|0|||
131549730|NCT02798211|473635557|FG004|Period 2|Adverse Event|1|||
131549731|NCT02798211|473635558|FG005|Period 2|Adverse Event|0|||
131549732|NCT02798211|473635553|FG000|Period 2|Lack of Efficacy|1|||
131549733|NCT02798211|473635554|FG001|Period 2|Lack of Efficacy|0|||
131549734|NCT02798211|473635555|FG002|Period 2|Lack of Efficacy|0|||
131549735|NCT02798211|473635556|FG003|Period 2|Lack of Efficacy|1|||
131549736|NCT02798211|473635557|FG004|Period 2|Lack of Efficacy|0|||
131549737|NCT02798211|473635558|FG005|Period 2|Lack of Efficacy|1|||
131549738|NCT02798211|473635553|FG000|Period 2|Lost to Follow-up|3|||
131549739|NCT02798211|473635554|FG001|Period 2|Lost to Follow-up|0|||
131549740|NCT02798211|473635555|FG002|Period 2|Lost to Follow-up|0|||
131549741|NCT02798211|473635556|FG003|Period 2|Lost to Follow-up|0|||
131549742|NCT02798211|473635557|FG004|Period 2|Lost to Follow-up|2|||
131549743|NCT02798211|473635558|FG005|Period 2|Lost to Follow-up|0|||
131549744|NCT02798211|473635553|FG000|Period 2|Physician Decision|1|||
131549745|NCT02798211|473635554|FG001|Period 2|Physician Decision|0|||
131549746|NCT02798211|473635555|FG002|Period 2|Physician Decision|0|||
131549747|NCT02798211|473635556|FG003|Period 2|Physician Decision|1|||
131549748|NCT02798211|473635557|FG004|Period 2|Physician Decision|1|||
131549749|NCT02798211|473635558|FG005|Period 2|Physician Decision|0|||
131549750|NCT02798211|473635553|FG000|Period 2|Pregnancy|0|||
131549751|NCT02798211|473635554|FG001|Period 2|Pregnancy|0|||
131549752|NCT02798211|473635555|FG002|Period 2|Pregnancy|0|||
131549753|NCT02798211|473635556|FG003|Period 2|Pregnancy|2|||
131549754|NCT02798211|473635557|FG004|Period 2|Pregnancy|0|||
131549755|NCT02798211|473635558|FG005|Period 2|Pregnancy|0|||
131549756|NCT02798211|473635553|FG000|Period 2|Technical problems|1|||
131549757|NCT02798211|473635554|FG001|Period 2|Technical problems|0|||
131549758|NCT02798211|473635555|FG002|Period 2|Technical problems|0|||
131549759|NCT02798211|473635556|FG003|Period 2|Technical problems|1|||
131549760|NCT02798211|473635557|FG004|Period 2|Technical problems|0|||
131549761|NCT02798211|473635558|FG005|Period 2|Technical problems|0|||
131549762|NCT02798211|473635553|FG000|Period 2|Withdrawal of Informed Consent|1|||
131549763|NCT02798211|473635554|FG001|Period 2|Withdrawal of Informed Consent|0|||
131549764|NCT02798211|473635555|FG002|Period 2|Withdrawal of Informed Consent|0|||
131549765|NCT02798211|473635556|FG003|Period 2|Withdrawal of Informed Consent|2|||
131549766|NCT02798211|473635557|FG004|Period 2|Withdrawal of Informed Consent|2|||
131549767|NCT02798211|473635558|FG005|Period 2|Withdrawal of Informed Consent|3|||
131549768|NCT05292534|473635559|FG000|Overall Study|Protocol Violation|3|||
131549769|NCT05292534|473635560|FG001|Overall Study|Protocol Violation|4|||
131549770|NCT05292534|473635559|FG000|Overall Study|Withdrawal by Subject|0|||
131549771|NCT05292534|473635560|FG001|Overall Study|Withdrawal by Subject|1|||
131549772|NCT01982435|473635561|FG000|Overall Study|Adverse Event|1|||
131549773|NCT01982435|473635562|FG001|Overall Study|Adverse Event|0|||
131549774|NCT03086018|473635563|FG000|Final Testing for End of Trial|Adverse Event|1|||
131549775|NCT03086018|473635563|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
131549776|NCT01892345|473635564|FG000|Overall Study|Adverse Event|0|||
131549777|NCT01892345|473635565|FG001|Overall Study|Adverse Event|2|||
131549778|NCT01892345|473635564|FG000|Overall Study|Death|1|||
131549779|NCT01892345|473635565|FG001|Overall Study|Death|0|||
131549780|NCT01892345|473635564|FG000|Overall Study|Lost to Follow-up|3|||
131549781|NCT01892345|473635565|FG001|Overall Study|Lost to Follow-up|0|||
131549782|NCT01892345|473635564|FG000|Overall Study|Withdrawal by Subject|12|||
131549783|NCT01892345|473635565|FG001|Overall Study|Withdrawal by Subject|1|||
131549784|NCT02748694|473635566|FG000|Overall Study|Voluntary Withdrawal|0|||
131549785|NCT02748694|473635567|FG001|Overall Study|Voluntary Withdrawal|0|||
131549786|NCT02748694|473635568|FG002|Overall Study|Voluntary Withdrawal|0|||
131549787|NCT02748694|473635569|FG003|Overall Study|Voluntary Withdrawal|0|||
131549788|NCT02748694|473635570|FG004|Overall Study|Voluntary Withdrawal|0|||
131549789|NCT02748694|473635571|FG005|Overall Study|Voluntary Withdrawal|0|||
131549790|NCT02748694|473635572|FG006|Overall Study|Voluntary Withdrawal|0|||
131549791|NCT02748694|473635573|FG007|Overall Study|Voluntary Withdrawal|0|||
131549792|NCT02748694|473635574|FG008|Overall Study|Voluntary Withdrawal|0|||
131549793|NCT02748694|473635575|FG009|Overall Study|Voluntary Withdrawal|0|||
131549794|NCT02748694|473635576|FG010|Overall Study|Voluntary Withdrawal|0|||
131549795|NCT02748694|473635577|FG011|Overall Study|Voluntary Withdrawal|0|||
131549796|NCT02748694|473635578|FG012|Overall Study|Voluntary Withdrawal|0|||
131549797|NCT02748694|473635579|FG013|Overall Study|Voluntary Withdrawal|0|||
131435876|NCT00920855|473221885|FG001|Overall Study|Disease progression|1|||
131549798|NCT02748694|473635580|FG014|Overall Study|Voluntary Withdrawal|2|||
131549799|NCT01473381|473635581|FG000|Overall Study|Adverse Event|8|||
131549800|NCT01473381|473635582|FG001|Overall Study|Adverse Event|20|||
131549801|NCT01473381|473635583|FG002|Overall Study|Adverse Event|25|||
131549802|NCT01473381|473635584|FG003|Overall Study|Adverse Event|17|||
131549803|NCT01473381|473635581|FG000|Overall Study|Insufficient Therapeutic Response|10|||
131887969|NCT01897571|474872320|FG004|Overall Study|Other|3|||
131887970|NCT01897571|474872321|FG005|Overall Study|Other|4|||
131887971|NCT01897571|474872322|FG006|Overall Study|Other|7|||
131887972|NCT01897571|474872323|FG007|Overall Study|Other|0|||
131887973|NCT01897571|474872324|FG008|Overall Study|Other|0|||
131887974|NCT01897571|474872325|FG009|Overall Study|Other|0|||
131887975|NCT01897571|474872326|FG010|Overall Study|Other|0|||
131887976|NCT01897571|474872316|FG000|Overall Study|Enrolled in rollover study|0|||
131887977|NCT01897571|474872317|FG001|Overall Study|Enrolled in rollover study|0|||
131887978|NCT01897571|474872318|FG002|Overall Study|Enrolled in rollover study|0|||
131887979|NCT01897571|474872319|FG003|Overall Study|Enrolled in rollover study|0|||
131887980|NCT01897571|474872320|FG004|Overall Study|Enrolled in rollover study|0|||
131887981|NCT01897571|474872321|FG005|Overall Study|Enrolled in rollover study|0|||
131887982|NCT01897571|474872322|FG006|Overall Study|Enrolled in rollover study|0|||
131887983|NCT01897571|474872323|FG007|Overall Study|Enrolled in rollover study|9|||
131887984|NCT01897571|474872324|FG008|Overall Study|Enrolled in rollover study|7|||
131887985|NCT01897571|474872325|FG009|Overall Study|Enrolled in rollover study|9|||
131887986|NCT01897571|474872326|FG010|Overall Study|Enrolled in rollover study|1|||
131887987|NCT01897571|474872316|FG000|Overall Study|Death|2|||
131887988|NCT01897571|474872317|FG001|Overall Study|Death|2|||
131887989|NCT01897571|474872318|FG002|Overall Study|Death|3|||
131887990|NCT01897571|474872319|FG003|Overall Study|Death|6|||
131887991|NCT01897571|474872320|FG004|Overall Study|Death|7|||
131887992|NCT01897571|474872321|FG005|Overall Study|Death|9|||
131887993|NCT01897571|474872322|FG006|Overall Study|Death|5|||
131887994|NCT01897571|474872323|FG007|Overall Study|Death|22|||
131887995|NCT01897571|474872324|FG008|Overall Study|Death|23|||
131887996|NCT01897571|474872325|FG009|Overall Study|Death|129|||
131887997|NCT01897571|474872326|FG010|Overall Study|Death|59|||
131887998|NCT04908475|474872328|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
131887999|NCT04908475|474872329|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131888000|NCT04908475|474872330|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131888001|NCT04908475|474872331|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131888002|NCT04908475|474872332|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131888003|NCT04908475|474872333|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131888004|NCT04908475|474872328|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
131888005|NCT04908475|474872329|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
131888006|NCT04908475|474872330|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
131888007|NCT04908475|474872331|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
131888008|NCT04908475|474872332|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
131888009|NCT04908475|474872333|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
131888010|NCT04908475|474872328|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
131888011|NCT04908475|474872329|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
131888012|NCT04908475|474872330|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
131888013|NCT04908475|474872331|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
131888014|NCT04908475|474872332|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
131888015|NCT04908475|474872333|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
131888016|NCT04908475|474872328|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131888017|NCT04908475|474872329|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
131888018|NCT04908475|474872330|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
131888019|NCT04908475|474872331|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
131888020|NCT04908475|474872332|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131888021|NCT04908475|474872333|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131888022|NCT04908475|474872328|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
131888023|NCT04908475|474872329|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
131888024|NCT04908475|474872330|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
131888025|NCT04908475|474872331|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
131888026|NCT04908475|474872332|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
131888027|NCT04908475|474872333|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
131888028|NCT04908475|474872328|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
131888029|NCT04908475|474872329|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
131888030|NCT04908475|474872330|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
131888031|NCT04908475|474872331|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
131888032|NCT04908475|474872332|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
131888033|NCT04908475|474872333|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
131888034|NCT03913104|474872336|FG000|Overall Study|Lost to Follow-up|20|||
131888035|NCT03913104|474872336|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
131888036|NCT03913104|474872336|FG000|Overall Study|Withdrawal by Subject|2|||
131888037|NCT01074255|474872337|FG000|Overall Study|Did not receive EMEND|2|||
131888038|NCT00089635|474872338|FG000|Overall Study|Adverse Event|2|||
131888039|NCT00089635|474872338|FG000|Overall Study|Death|17|||
131888040|NCT00089635|474872338|FG000|Overall Study|Disease Progression|12|||
131888041|NCT00089635|474872338|FG000|Overall Study|Lost to Follow-up|3|||
131888042|NCT00089635|474872338|FG000|Overall Study|Withdrawal by Subject|6|||
131549804|NCT01473381|473635582|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131549805|NCT01473381|473635583|FG002|Overall Study|Insufficient Therapeutic Response|2|||
131549806|NCT01473381|473635584|FG003|Overall Study|Insufficient Therapeutic Response|3|||
131549807|NCT01473381|473635581|FG000|Overall Study|Protocol Violation|17|||
131549808|NCT01473381|473635582|FG001|Overall Study|Protocol Violation|23|||
131549809|NCT01473381|473635583|FG002|Overall Study|Protocol Violation|19|||
131549810|NCT01473381|473635584|FG003|Overall Study|Protocol Violation|17|||
131549811|NCT01473381|473635581|FG000|Overall Study|Withdrawal of Consent|20|||
131549812|NCT01473381|473635582|FG001|Overall Study|Withdrawal of Consent|21|||
131549813|NCT01473381|473635583|FG002|Overall Study|Withdrawal of Consent|20|||
131549814|NCT01473381|473635584|FG003|Overall Study|Withdrawal of Consent|26|||
131549815|NCT01473381|473635581|FG000|Overall Study|Lost to Follow-up|25|||
131549816|NCT01473381|473635582|FG001|Overall Study|Lost to Follow-up|28|||
131549817|NCT01473381|473635583|FG002|Overall Study|Lost to Follow-up|35|||
131549818|NCT01473381|473635584|FG003|Overall Study|Lost to Follow-up|23|||
131549819|NCT01473381|473635581|FG000|Overall Study|Other Reasons|0|||
131549820|NCT01473381|473635582|FG001|Overall Study|Other Reasons|0|||
131549821|NCT01473381|473635583|FG002|Overall Study|Other Reasons|1|||
131549822|NCT01473381|473635584|FG003|Overall Study|Other Reasons|3|||
131549823|NCT02487810|473635585|FG000|Overall Study|Withdrawal by Subject|1|||
131549824|NCT02487810|473635586|FG001|Overall Study|Withdrawal by Subject|0|||
131549825|NCT01889186|473635587|FG000|Overall Study|Adverse event- not related to progression|18|||
131549826|NCT01889186|473635588|FG001|Overall Study|Adverse event- not related to progression|5|||
131549827|NCT01889186|473635587|FG000|Overall Study|Adverse event- related to progression|7|||
131549828|NCT01889186|473635588|FG001|Overall Study|Adverse event- related to progression|2|||
131549829|NCT01889186|473635587|FG000|Overall Study|COVID-19 logistical restrictions|1|||
131549830|NCT01889186|473635588|FG001|Overall Study|COVID-19 logistical restrictions|0|||
131549831|NCT01889186|473635587|FG000|Overall Study|Investigator request|1|||
131549832|NCT01889186|473635588|FG001|Overall Study|Investigator request|1|||
131549833|NCT01889186|473635587|FG000|Overall Study|Progressive disease- Richter's|12|||
131549834|NCT01889186|473635588|FG001|Overall Study|Progressive disease- Richter's|7|||
131549835|NCT01889186|473635587|FG000|Overall Study|Progressive disease per protocol|46|||
131549836|NCT01889186|473635588|FG001|Overall Study|Progressive disease per protocol|17|||
131549837|NCT01889186|473635587|FG000|Overall Study|Stem cell transplant|2|||
131549838|NCT01889186|473635588|FG001|Overall Study|Stem cell transplant|1|||
131549839|NCT01889186|473635587|FG000|Overall Study|Withdrew consent|2|||
131549840|NCT01889186|473635588|FG001|Overall Study|Withdrew consent|3|||
131549841|NCT01889186|473635587|FG000|Overall Study|Other, not specified|18|||
131549842|NCT01889186|473635588|FG001|Overall Study|Other, not specified|15|||
131549843|NCT03056534|473635594|FG000|Overall Study|Participant withdrew consent|8|||
131549844|NCT03056534|473635594|FG000|Overall Study|Participant not able to return|6|||
131549845|NCT03056534|473635594|FG000|Overall Study|Lost to Follow-up|37|||
131549846|NCT03056534|473635594|FG000|Overall Study|Investigator judgment|1|||
131549847|NCT03056534|473635594|FG000|Overall Study|Death|4|||
131549848|NCT03056534|473635594|FG000|Overall Study|Adverse Event|1|||
131549849|NCT03056534|473635594|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
131549850|NCT04241094|473635601|FG000|Overall Study|Dropped out of treatment|4|||
131549851|NCT04241094|473635601|FG000|Overall Study|Ineligible after clinical assessment|2|||
131549852|NCT04241094|473635601|FG000|Overall Study|Lost to Follow-up|2|||
131549853|NCT00316173|473635602|FG000|Run-in Phase|Adverse Event|1|||
131549854|NCT00316173|473635603|FG001|Run-in Phase|Adverse Event|0|||
131549855|NCT00316173|473635602|FG000|Run-in Phase|Protocol Violation|1|||
131549856|NCT00316173|473635603|FG001|Run-in Phase|Protocol Violation|0|||
131549857|NCT00316173|473635602|FG000|Run-in Phase|Study Follow-up Stopped|5|||
131549858|NCT00316173|473635603|FG001|Run-in Phase|Study Follow-up Stopped|0|||
131549859|NCT00316173|473635602|FG000|Treatment Phase|Adverse Event|0|||
131549860|NCT00316173|473635603|FG001|Treatment Phase|Adverse Event|1|||
131549861|NCT00316173|473635602|FG000|Treatment Phase|Lack of Efficacy|0|||
131549862|NCT00316173|473635603|FG001|Treatment Phase|Lack of Efficacy|3|||
131549863|NCT00316173|473635602|FG000|Treatment Phase|Lost to Follow-up|0|||
131549864|NCT00316173|473635603|FG001|Treatment Phase|Lost to Follow-up|3|||
131549865|NCT00316173|473635602|FG000|Treatment Phase|Withdrawal by Subject|0|||
131549866|NCT00316173|473635603|FG001|Treatment Phase|Withdrawal by Subject|1|||
131549867|NCT00316173|473635602|FG000|Treatment Phase|Study Follow-up Stopped|0|||
131549868|NCT00316173|473635603|FG001|Treatment Phase|Study Follow-up Stopped|34|||
131549869|NCT03764072|473635604|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
131549870|NCT03764072|473635605|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
131549871|NCT03764072|473635606|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
131549872|NCT03764072|473635607|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
131549873|NCT03764072|473635608|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
131549874|NCT03764072|473635609|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
131549875|NCT03764072|473635604|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
131549876|NCT03764072|473635605|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
131549877|NCT03764072|473635606|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
131549878|NCT03764072|473635607|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
131549879|NCT03764072|473635608|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
131549880|NCT03764072|473635609|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
131549881|NCT03764072|473635604|FG000|Overall Study|Lost to Follow-up|0|||
131549882|NCT03764072|473635605|FG001|Overall Study|Lost to Follow-up|0|||
131549883|NCT03764072|473635606|FG002|Overall Study|Lost to Follow-up|0|||
131549884|NCT03764072|473635607|FG003|Overall Study|Lost to Follow-up|0|||
131549885|NCT03764072|473635608|FG004|Overall Study|Lost to Follow-up|1|||
131549886|NCT03764072|473635609|FG005|Overall Study|Lost to Follow-up|0|||
131549887|NCT03750006|473635616|FG000|Overall Study|Withdrawal by Subject|8|||
131549888|NCT03750006|473635616|FG000|Overall Study|COVID PANDEMIC|11|||
131549889|NCT01061333|473635624|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
131549890|NCT01061333|473635625|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
131549891|NCT01493960|473637008|FG000|Overall Study|Adverse Event|0|||
131549892|NCT01493960|473637009|FG001|Overall Study|Adverse Event|1|||
131549893|NCT01493960|473637008|FG000|Overall Study|Lack of Efficacy|15|||
131549894|NCT01493960|473637009|FG001|Overall Study|Lack of Efficacy|9|||
131549895|NCT01493960|473637008|FG000|Overall Study|Protocol Violation|3|||
131549896|NCT01493960|473637009|FG001|Overall Study|Protocol Violation|0|||
131549897|NCT01493960|473637008|FG000|Overall Study|Withdrawal by Subject|10|||
131549898|NCT01493960|473637009|FG001|Overall Study|Withdrawal by Subject|4|||
131549899|NCT01493960|473637008|FG000|Overall Study|Non-specified|4|||
131549900|NCT01493960|473637009|FG001|Overall Study|Non-specified|4|||
131549901|NCT00803101|473637010|FG000|Overall Study|Death / Serious Adverse Event|4|||
131549902|NCT00803101|473637011|FG001|Overall Study|Death / Serious Adverse Event|6|||
131549903|NCT00803101|473637010|FG000|Overall Study|Withdrawal by Subject|6|||
131549904|NCT00803101|473637011|FG001|Overall Study|Withdrawal by Subject|4|||
131549905|NCT00803101|473637010|FG000|Overall Study|Lost to Follow-up|2|||
131549906|NCT00803101|473637011|FG001|Overall Study|Lost to Follow-up|2|||
131549907|NCT00803101|473637010|FG000|Overall Study|Protocol Violation|1|||
131549908|NCT00803101|473637011|FG001|Overall Study|Protocol Violation|7|||
131549909|NCT00803101|473637010|FG000|Overall Study|Surgery finished outside protocol window|1|||
131549910|NCT00803101|473637011|FG001|Overall Study|Surgery finished outside protocol window|1|||
131549911|NCT00803101|473637010|FG000|Overall Study|Patient died outside SAE report period|1|||
131549912|NCT00803101|473637011|FG001|Overall Study|Patient died outside SAE report period|0|||
131549913|NCT00803101|473637010|FG000|Overall Study|Patient did not attend scheduled visit|2|||
131549914|NCT00803101|473637011|FG001|Overall Study|Patient did not attend scheduled visit|1|||
131549915|NCT00803101|473637010|FG000|Overall Study|Patient did not have surgery|1|||
131549916|NCT00803101|473637011|FG001|Overall Study|Patient did not have surgery|1|||
131549917|NCT01782742|473637012|FG000|Double-blind Treatment Phase|Adverse Event|1|||
131549918|NCT01782742|473637013|FG001|Double-blind Treatment Phase|Adverse Event|0|||
131549919|NCT02026232|473637016|FG000|Overall Study|incomplete visit/missing data|3|||
131549920|NCT02026232|473637017|FG001|Overall Study|incomplete visit/missing data|2|||
131549921|NCT02790073|473637018|FG000|Overall Study|Death|1|||
131549922|NCT02790073|473637018|FG000|Overall Study|Withdrawal from HD|1|||
131549923|NCT02790073|473637018|FG000|Overall Study|Withdrawal by Subject|1|||
131549924|NCT00058422|473637026|FG000|Overall Study|Not treated|2|||
131549925|NCT00185640|473637027|FG000|Overall Study|Not Eligible|4|||
131549926|NCT00185640|473637027|FG000|Overall Study|Withdrawal by Subject|3|||
131549927|NCT00185640|473637027|FG000|Overall Study|Death|138|||
131549928|NCT02287584|473637028|FG000|the Double-blind Phase|Adverse Event|17|||
131549929|NCT02287584|473637029|FG001|the Double-blind Phase|Adverse Event|17|||
131549930|NCT02287584|473637030|FG002|the Double-blind Phase|Adverse Event|12|||
131549931|NCT02287584|473637031|FG003|the Double-blind Phase|Adverse Event|0|||
131549932|NCT02287584|473637032|FG004|the Double-blind Phase|Adverse Event|0|||
131549933|NCT02287584|473637033|FG005|the Double-blind Phase|Adverse Event|0|||
131549934|NCT02287584|473637028|FG000|the Double-blind Phase|Lack of Efficacy|18|||
131549935|NCT02287584|473637029|FG001|the Double-blind Phase|Lack of Efficacy|8|||
131549936|NCT02287584|473637030|FG002|the Double-blind Phase|Lack of Efficacy|8|||
131549937|NCT02287584|473637031|FG003|the Double-blind Phase|Lack of Efficacy|0|||
131549938|NCT02287584|473637032|FG004|the Double-blind Phase|Lack of Efficacy|0|||
131549939|NCT02287584|473637033|FG005|the Double-blind Phase|Lack of Efficacy|0|||
131549940|NCT02287584|473637028|FG000|the Double-blind Phase|Lost to Follow-up|0|||
131549941|NCT02287584|473637029|FG001|the Double-blind Phase|Lost to Follow-up|1|||
131549942|NCT02287584|473637030|FG002|the Double-blind Phase|Lost to Follow-up|1|||
131549943|NCT02287584|473637031|FG003|the Double-blind Phase|Lost to Follow-up|0|||
131549944|NCT02287584|473637032|FG004|the Double-blind Phase|Lost to Follow-up|0|||
131549945|NCT02287584|473637033|FG005|the Double-blind Phase|Lost to Follow-up|0|||
131658917|NCT01214642|474035466|FG008|Overall Study|Death|0|||
131658918|NCT01214642|474035467|FG009|Overall Study|Death|0|||
131658919|NCT01214642|474035468|FG010|Overall Study|Death|1|||
131658920|NCT01214642|474035469|FG011|Overall Study|Death|0|||
131658921|NCT01214642|474035458|FG000|Overall Study|Withdrawal by Subject|0|||
131658922|NCT01214642|474035459|FG001|Overall Study|Withdrawal by Subject|0|||
131658923|NCT01214642|474035460|FG002|Overall Study|Withdrawal by Subject|1|||
131549946|NCT02287584|473637028|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
131549947|NCT02287584|473637029|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
131549948|NCT02287584|473637030|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
131549949|NCT02287584|473637031|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
131549950|NCT02287584|473637032|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
131549951|NCT02287584|473637033|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
131549952|NCT02287584|473637028|FG000|the Double-blind Phase|Pregnancy|0|||
131549953|NCT02287584|473637029|FG001|the Double-blind Phase|Pregnancy|1|||
131549954|NCT02287584|473637030|FG002|the Double-blind Phase|Pregnancy|0|||
131549955|NCT02287584|473637031|FG003|the Double-blind Phase|Pregnancy|0|||
131549956|NCT02287584|473637032|FG004|the Double-blind Phase|Pregnancy|0|||
131549957|NCT02287584|473637033|FG005|the Double-blind Phase|Pregnancy|0|||
131549958|NCT02287584|473637028|FG000|the Double-blind Phase|Protocol Violation|0|||
131549959|NCT02287584|473637029|FG001|the Double-blind Phase|Protocol Violation|3|||
131549960|NCT02287584|473637030|FG002|the Double-blind Phase|Protocol Violation|0|||
131549961|NCT02287584|473637031|FG003|the Double-blind Phase|Protocol Violation|0|||
131549962|NCT02287584|473637032|FG004|the Double-blind Phase|Protocol Violation|0|||
131549963|NCT02287584|473637033|FG005|the Double-blind Phase|Protocol Violation|0|||
131549964|NCT02287584|473637028|FG000|the Double-blind Phase|other reasons|0|||
131549965|NCT02287584|473637029|FG001|the Double-blind Phase|other reasons|0|||
131549966|NCT02287584|473637030|FG002|the Double-blind Phase|other reasons|1|||
131549967|NCT02287584|473637031|FG003|the Double-blind Phase|other reasons|0|||
131549968|NCT02287584|473637032|FG004|the Double-blind Phase|other reasons|0|||
131549969|NCT02287584|473637033|FG005|the Double-blind Phase|other reasons|0|||
131549970|NCT02287584|473637028|FG000|the Open-label Phase|Did not receive drug|0|||
131549971|NCT02287584|473637029|FG001|the Open-label Phase|Did not receive drug|0|||
131549972|NCT02287584|473637030|FG002|the Open-label Phase|Did not receive drug|0|||
131549973|NCT02287584|473637031|FG003|the Open-label Phase|Did not receive drug|7|||
131549974|NCT02287584|473637032|FG004|the Open-label Phase|Did not receive drug|6|||
131549975|NCT02287584|473637033|FG005|the Open-label Phase|Did not receive drug|4|||
131549976|NCT02287584|473637028|FG000|the Open-label Phase|Adverse Event|0|||
131549977|NCT02287584|473637029|FG001|the Open-label Phase|Adverse Event|0|||
131549978|NCT02287584|473637030|FG002|the Open-label Phase|Adverse Event|0|||
131549979|NCT02287584|473637031|FG003|the Open-label Phase|Adverse Event|15|||
131549980|NCT02287584|473637032|FG004|the Open-label Phase|Adverse Event|12|||
131549981|NCT02287584|473637033|FG005|the Open-label Phase|Adverse Event|16|||
131549982|NCT02287584|473637028|FG000|the Open-label Phase|Lack of Efficacy|0|||
131549983|NCT02287584|473637029|FG001|the Open-label Phase|Lack of Efficacy|0|||
131549984|NCT02287584|473637030|FG002|the Open-label Phase|Lack of Efficacy|0|||
131549985|NCT02287584|473637031|FG003|the Open-label Phase|Lack of Efficacy|8|||
131549986|NCT02287584|473637032|FG004|the Open-label Phase|Lack of Efficacy|3|||
131549987|NCT02287584|473637033|FG005|the Open-label Phase|Lack of Efficacy|7|||
131549988|NCT02287584|473637028|FG000|the Open-label Phase|Lost to Follow-up|0|||
131549989|NCT02287584|473637029|FG001|the Open-label Phase|Lost to Follow-up|0|||
131549990|NCT02287584|473637030|FG002|the Open-label Phase|Lost to Follow-up|0|||
131549991|NCT02287584|473637031|FG003|the Open-label Phase|Lost to Follow-up|4|||
131549992|NCT02287584|473637032|FG004|the Open-label Phase|Lost to Follow-up|1|||
131549993|NCT02287584|473637033|FG005|the Open-label Phase|Lost to Follow-up|2|||
131549994|NCT02287584|473637028|FG000|the Open-label Phase|Withdrawal by Subject|0|||
131549995|NCT02287584|473637029|FG001|the Open-label Phase|Withdrawal by Subject|0|||
131549996|NCT02287584|473637030|FG002|the Open-label Phase|Withdrawal by Subject|0|||
131549997|NCT02287584|473637031|FG003|the Open-label Phase|Withdrawal by Subject|18|||
131549998|NCT02287584|473637032|FG004|the Open-label Phase|Withdrawal by Subject|29|||
131549999|NCT02287584|473637033|FG005|the Open-label Phase|Withdrawal by Subject|21|||
131550000|NCT02287584|473637028|FG000|the Open-label Phase|non-compliance|0|||
131550001|NCT02287584|473637029|FG001|the Open-label Phase|non-compliance|0|||
131550002|NCT02287584|473637030|FG002|the Open-label Phase|non-compliance|0|||
131550003|NCT02287584|473637031|FG003|the Open-label Phase|non-compliance|2|||
131550004|NCT02287584|473637032|FG004|the Open-label Phase|non-compliance|5|||
131550005|NCT02287584|473637033|FG005|the Open-label Phase|non-compliance|1|||
131550006|NCT02287584|473637028|FG000|the Open-label Phase|other reasons|0|||
131550007|NCT02287584|473637029|FG001|the Open-label Phase|other reasons|0|||
131550008|NCT02287584|473637030|FG002|the Open-label Phase|other reasons|0|||
131550009|NCT02287584|473637031|FG003|the Open-label Phase|other reasons|3|||
131550010|NCT02287584|473637032|FG004|the Open-label Phase|other reasons|6|||
131550011|NCT02287584|473637033|FG005|the Open-label Phase|other reasons|6|||
131550012|NCT03430063|473637037|FG000|Overall Study|Adverse Event|0|||
131550013|NCT03430063|473637038|FG001|Overall Study|Adverse Event|1|||
131550014|NCT03430063|473637039|FG002|Overall Study|Adverse Event|0|||
131550015|NCT03430063|473637037|FG000|Overall Study|Death|3|||
131550016|NCT03430063|473637038|FG001|Overall Study|Death|2|||
131550017|NCT03430063|473637039|FG002|Overall Study|Death|3|||
131550018|NCT03430063|473637037|FG000|Overall Study|Lost to Follow-up|0|||
131550019|NCT03430063|473637038|FG001|Overall Study|Lost to Follow-up|1|||
131550020|NCT03430063|473637039|FG002|Overall Study|Lost to Follow-up|0|||
131550021|NCT03430063|473637037|FG000|Overall Study|Withdrawal by Subject|0|||
131550022|NCT03430063|473637038|FG001|Overall Study|Withdrawal by Subject|0|||
131550023|NCT03430063|473637039|FG002|Overall Study|Withdrawal by Subject|1|||
131550024|NCT03430063|473637037|FG000|Overall Study|Withdrawal of consent|3|||
131550025|NCT03430063|473637038|FG001|Overall Study|Withdrawal of consent|1|||
131550026|NCT03430063|473637039|FG002|Overall Study|Withdrawal of consent|2|||
131550027|NCT03430063|473637037|FG000|Overall Study|Progressive disease|1|||
131550028|NCT03430063|473637038|FG001|Overall Study|Progressive disease|2|||
131550029|NCT03430063|473637039|FG002|Overall Study|Progressive disease|1|||
131550030|NCT03430063|473637037|FG000|Overall Study|Other un-specified|1|||
131550031|NCT03430063|473637038|FG001|Overall Study|Other un-specified|1|||
131550032|NCT03430063|473637039|FG002|Overall Study|Other un-specified|0|||
131550033|NCT03430063|473637037|FG000|Overall Study|Randomized, but never treated|0|||
131550034|NCT03430063|473637038|FG001|Overall Study|Randomized, but never treated|0|||
131550035|NCT03430063|473637039|FG002|Overall Study|Randomized, but never treated|1|||
131550036|NCT01782872|473637041|FG000|Overall Study|Protocol Violation|0|||
131550037|NCT01782872|473637042|FG001|Overall Study|Protocol Violation|0|||
131550038|NCT01782872|473637043|FG002|Overall Study|Protocol Violation|0|||
131550039|NCT01782872|473637044|FG003|Overall Study|Protocol Violation|1|||
131550040|NCT01782872|473637041|FG000|Overall Study|Withdrawal by Subject|0|||
131550041|NCT01782872|473637042|FG001|Overall Study|Withdrawal by Subject|1|||
131550042|NCT01782872|473637043|FG002|Overall Study|Withdrawal by Subject|0|||
131550043|NCT01782872|473637044|FG003|Overall Study|Withdrawal by Subject|0|||
131550044|NCT04026165|473637048|FG000|Run-in Placebo Period|Enrollment Error|13|||
131550045|NCT04026165|473637049|FG001|Run-in Placebo Period|Enrollment Error|0|||
131550046|NCT04026165|473637050|FG002|Run-in Placebo Period|Enrollment Error|0|||
131550047|NCT04026165|473637051|FG003|Run-in Placebo Period|Enrollment Error|0|||
131550048|NCT04026165|473637048|FG000|Run-in Placebo Period|Run-in Failure|4|||
131550049|NCT04026165|473637049|FG001|Run-in Placebo Period|Run-in Failure|0|||
131550050|NCT04026165|473637050|FG002|Run-in Placebo Period|Run-in Failure|0|||
131550051|NCT04026165|473637051|FG003|Run-in Placebo Period|Run-in Failure|0|||
131550052|NCT04026165|473637048|FG000|Run-in Placebo Period|Protocol Violation|2|||
131550053|NCT04026165|473637049|FG001|Run-in Placebo Period|Protocol Violation|0|||
131550054|NCT04026165|473637050|FG002|Run-in Placebo Period|Protocol Violation|0|||
131550055|NCT04026165|473637051|FG003|Run-in Placebo Period|Protocol Violation|0|||
131550056|NCT04026165|473637048|FG000|Run-in Placebo Period|Withdrew Consent|2|||
131550057|NCT04026165|473637049|FG001|Run-in Placebo Period|Withdrew Consent|0|||
131550058|NCT04026165|473637050|FG002|Run-in Placebo Period|Withdrew Consent|0|||
131550059|NCT04026165|473637051|FG003|Run-in Placebo Period|Withdrew Consent|0|||
131550060|NCT04026165|473637048|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
131550061|NCT04026165|473637049|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
131550062|NCT04026165|473637050|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
131550063|NCT04026165|473637051|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
131550064|NCT04026165|473637048|FG000|Run-in SEL Period|Run-in Failure|0|||
131550065|NCT04026165|473637049|FG001|Run-in SEL Period|Run-in Failure|26|||
131550066|NCT04026165|473637050|FG002|Run-in SEL Period|Run-in Failure|0|||
131550067|NCT04026165|473637051|FG003|Run-in SEL Period|Run-in Failure|0|||
131550068|NCT04026165|473637048|FG000|Run-in SEL Period|Withdrew Consent|0|||
131550069|NCT04026165|473637049|FG001|Run-in SEL Period|Withdrew Consent|10|||
131550070|NCT04026165|473637050|FG002|Run-in SEL Period|Withdrew Consent|0|||
131550071|NCT04026165|473637051|FG003|Run-in SEL Period|Withdrew Consent|0|||
131550072|NCT04026165|473637048|FG000|Run-in SEL Period|Enrollment Error|0|||
131550073|NCT04026165|473637049|FG001|Run-in SEL Period|Enrollment Error|4|||
131550074|NCT04026165|473637050|FG002|Run-in SEL Period|Enrollment Error|0|||
131550075|NCT04026165|473637051|FG003|Run-in SEL Period|Enrollment Error|0|||
131550076|NCT04026165|473637048|FG000|Run-in SEL Period|Protocol Violation|0|||
131550077|NCT04026165|473637049|FG001|Run-in SEL Period|Protocol Violation|3|||
131550078|NCT04026165|473637050|FG002|Run-in SEL Period|Protocol Violation|0|||
131550079|NCT04026165|473637051|FG003|Run-in SEL Period|Protocol Violation|0|||
131550080|NCT04026165|473637048|FG000|Run-in SEL Period|Investigator's Discretion|0|||
131550081|NCT04026165|473637049|FG001|Run-in SEL Period|Investigator's Discretion|2|||
131550082|NCT04026165|473637050|FG002|Run-in SEL Period|Investigator's Discretion|0|||
131550083|NCT04026165|473637051|FG003|Run-in SEL Period|Investigator's Discretion|0|||
131550084|NCT04026165|473637048|FG000|Run-in SEL Period|Death|0|||
131550085|NCT04026165|473637049|FG001|Run-in SEL Period|Death|1|||
131550086|NCT04026165|473637050|FG002|Run-in SEL Period|Death|0|||
131550087|NCT04026165|473637051|FG003|Run-in SEL Period|Death|0|||
131550088|NCT04026165|473637048|FG000|Randomized Period|Withdrew Consent|0|||
131550089|NCT04026165|473637049|FG001|Randomized Period|Withdrew Consent|0|||
131550090|NCT04026165|473637050|FG002|Randomized Period|Withdrew Consent|5|||
131550091|NCT04026165|473637051|FG003|Randomized Period|Withdrew Consent|8|||
131550092|NCT04026165|473637048|FG000|Randomized Period|Death|0|||
131550093|NCT04026165|473637049|FG001|Randomized Period|Death|0|||
131550094|NCT04026165|473637050|FG002|Randomized Period|Death|5|||
131550095|NCT04026165|473637051|FG003|Randomized Period|Death|7|||
131550096|NCT04026165|473637048|FG000|Randomized Period|Investigator's Discretion|0|||
131550097|NCT04026165|473637049|FG001|Randomized Period|Investigator's Discretion|0|||
131550098|NCT04026165|473637050|FG002|Randomized Period|Investigator's Discretion|2|||
131550099|NCT04026165|473637051|FG003|Randomized Period|Investigator's Discretion|2|||
131550100|NCT04026165|473637048|FG000|Randomized Period|Lost to Follow-up|0|||
131550101|NCT04026165|473637049|FG001|Randomized Period|Lost to Follow-up|0|||
131550102|NCT04026165|473637050|FG002|Randomized Period|Lost to Follow-up|2|||
131550103|NCT04026165|473637051|FG003|Randomized Period|Lost to Follow-up|2|||
131550104|NCT00441701|473637052|FG000|Overall Study|Adverse Event|3|||
131550105|NCT00441701|473637053|FG001|Overall Study|Adverse Event|2|||
131550106|NCT00441701|473637054|FG002|Overall Study|Adverse Event|1|||
131550107|NCT00441701|473637055|FG003|Overall Study|Adverse Event|0|||
131550108|NCT00441701|473637056|FG004|Overall Study|Adverse Event|2|||
131550109|NCT00441701|473637057|FG005|Overall Study|Adverse Event|2|||
131550110|NCT00441701|473637058|FG006|Overall Study|Adverse Event|0|||
131550111|NCT00441701|473637059|FG007|Overall Study|Adverse Event|0|||
131550112|NCT00441701|473637060|FG008|Overall Study|Adverse Event|0|||
131550113|NCT00441701|473637061|FG009|Overall Study|Adverse Event|0|||
131550114|NCT00441701|473637052|FG000|Overall Study|Lack of Efficacy|2|||
131550115|NCT00441701|473637053|FG001|Overall Study|Lack of Efficacy|0|||
131550116|NCT00441701|473637054|FG002|Overall Study|Lack of Efficacy|2|||
131550117|NCT00441701|473637055|FG003|Overall Study|Lack of Efficacy|2|||
131550118|NCT00441701|473637056|FG004|Overall Study|Lack of Efficacy|0|||
131550119|NCT00441701|473637057|FG005|Overall Study|Lack of Efficacy|1|||
131550120|NCT00441701|473637058|FG006|Overall Study|Lack of Efficacy|0|||
131550121|NCT00441701|473637059|FG007|Overall Study|Lack of Efficacy|0|||
131550122|NCT00441701|473637060|FG008|Overall Study|Lack of Efficacy|0|||
131550123|NCT00441701|473637061|FG009|Overall Study|Lack of Efficacy|0|||
131550124|NCT00441701|473637052|FG000|Overall Study|Withdrawal by Subject|0|||
131550125|NCT00441701|473637053|FG001|Overall Study|Withdrawal by Subject|2|||
131550126|NCT00441701|473637054|FG002|Overall Study|Withdrawal by Subject|1|||
131550127|NCT00441701|473637055|FG003|Overall Study|Withdrawal by Subject|1|||
131550128|NCT00441701|473637056|FG004|Overall Study|Withdrawal by Subject|0|||
131550129|NCT00441701|473637057|FG005|Overall Study|Withdrawal by Subject|0|||
131550130|NCT00441701|473637058|FG006|Overall Study|Withdrawal by Subject|0|||
131550131|NCT00441701|473637059|FG007|Overall Study|Withdrawal by Subject|0|||
131550132|NCT00441701|473637060|FG008|Overall Study|Withdrawal by Subject|0|||
131550133|NCT00441701|473637061|FG009|Overall Study|Withdrawal by Subject|0|||
131550134|NCT00077064|473637062|FG000|Overall Study|Adverse Event|0|||
131550135|NCT00077064|473637063|FG001|Overall Study|Adverse Event|4|||
131550136|NCT00077064|473637062|FG000|Overall Study|Patient refusal|0|||
131550137|NCT00077064|473637063|FG001|Overall Study|Patient refusal|2|||
131550138|NCT04710927|473637064|FG000|Overall Study|Lost to Follow-up|7|||
131550139|NCT04710927|473637065|FG001|Overall Study|Lost to Follow-up|6|||
131550140|NCT04710927|473637066|FG002|Overall Study|Lost to Follow-up|5|||
131550141|NCT00621543|473637067|FG000|Overall Study|Lost to Follow-up|23|||
131550142|NCT02007434|473637070|FG000|Overall Study|Lost to Follow-up|0|||
131550143|NCT02007434|473637071|FG001|Overall Study|Lost to Follow-up|1|||
131550144|NCT02007434|473637072|FG002|Overall Study|Lost to Follow-up|0|||
131550145|NCT02007434|473637073|FG003|Overall Study|Lost to Follow-up|0|||
131550146|NCT02007434|473637074|FG004|Overall Study|Lost to Follow-up|0|||
131550147|NCT02007434|473637075|FG005|Overall Study|Lost to Follow-up|0|||
131550148|NCT02007434|473637076|FG006|Overall Study|Lost to Follow-up|0|||
131550149|NCT02007434|473637077|FG007|Overall Study|Lost to Follow-up|0|||
131550150|NCT02007434|473637070|FG000|Overall Study|Non-compliance|1|||
131550151|NCT02007434|473637071|FG001|Overall Study|Non-compliance|0|||
131550152|NCT02007434|473637072|FG002|Overall Study|Non-compliance|1|||
131550153|NCT02007434|473637073|FG003|Overall Study|Non-compliance|0|||
131550154|NCT02007434|473637074|FG004|Overall Study|Non-compliance|0|||
131550155|NCT02007434|473637075|FG005|Overall Study|Non-compliance|0|||
131550156|NCT02007434|473637076|FG006|Overall Study|Non-compliance|0|||
131550157|NCT02007434|473637077|FG007|Overall Study|Non-compliance|0|||
131550158|NCT01287611|473637078|FG000|Overall Study|Lost to Follow-up|29|||
131550159|NCT01287611|473637079|FG001|Overall Study|Lost to Follow-up|16|||
131550160|NCT01287611|473637078|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
131550161|NCT01287611|473637079|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
131550162|NCT02192970|473637080|FG000|Overall Study|Lost to Follow-up|6|||
131550163|NCT02192970|473637081|FG001|Overall Study|Lost to Follow-up|0|||
131550164|NCT04074590|473637084|FG000|Overall Study|Adverse Event|1|||
131550165|NCT04074590|473637085|FG001|Overall Study|Adverse Event|0|||
131550166|NCT04074590|473637084|FG000|Overall Study|Physician Decision|1|||
131550167|NCT04074590|473637085|FG001|Overall Study|Physician Decision|0|||
131550168|NCT04074590|473637084|FG000|Overall Study|Withdrawal by Subject|2|||
131550169|NCT04074590|473637085|FG001|Overall Study|Withdrawal by Subject|0|||
131550170|NCT03745222|473637096|FG000|Overall Study|Withdrawal by Subject|0|||
131550171|NCT03745222|473637097|FG001|Overall Study|Withdrawal by Subject|1|||
131550172|NCT03745222|473637098|FG002|Overall Study|Withdrawal by Subject|0|||
131550173|NCT03299686|473637099|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
131550174|NCT03299686|473637100|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
131550175|NCT03299686|473637099|FG000|Treatment Epoch|Physician Decision|1|||
131550176|NCT03299686|473637100|FG001|Treatment Epoch|Physician Decision|0|||
131888043|NCT00089635|474872338|FG000|Overall Study|Ineligibility determined|1|||
131888044|NCT00089635|474872338|FG000|Overall Study|Other|2|||
131888045|NCT02943785|474872339|FG000|Overall Study|Adverse Event|112|||
131888046|NCT02943785|474872340|FG001|Overall Study|Adverse Event|97|||
131888047|NCT02943785|474872339|FG000|Overall Study|Withdrawal by Subject|63|||
131888048|NCT02943785|474872340|FG001|Overall Study|Withdrawal by Subject|126|||
131888049|NCT02943785|474872339|FG000|Overall Study|Physician Decision|23|||
131888050|NCT02943785|474872340|FG001|Overall Study|Physician Decision|47|||
131888051|NCT02943785|474872339|FG000|Overall Study|Death|46|||
131888052|NCT02943785|474872340|FG001|Overall Study|Death|46|||
131888053|NCT02943785|474872339|FG000|Overall Study|Lost to Follow-up|1|||
131888054|NCT02943785|474872340|FG001|Overall Study|Lost to Follow-up|0|||
131888055|NCT02943785|474872339|FG000|Overall Study|Other|16|||
131888056|NCT02943785|474872340|FG001|Overall Study|Other|19|||
131888057|NCT02943785|474872339|FG000|Overall Study|Did not receive any study medication|21|||
131888058|NCT02943785|474872340|FG001|Overall Study|Did not receive any study medication|28|||
131888059|NCT00821015|474872342|FG000|Overall Study|Lost to Follow-up|12|||
131888060|NCT03170609|474872345|FG000|Overall Study|Death|0|||
131888061|NCT03170609|474872346|FG001|Overall Study|Death|0|||
131888062|NCT03170609|474872347|FG002|Overall Study|Death|1|||
131888063|NCT03170609|474872348|FG003|Overall Study|Death|0|||
131888064|NCT03170609|474872349|FG004|Overall Study|Death|0|||
131888065|NCT03170609|474872350|FG005|Overall Study|Death|0|||
131888066|NCT03170609|474872351|FG006|Overall Study|Death|0|||
131888067|NCT03170609|474872345|FG000|Overall Study|Withdrawal by Subject|1|||
131888068|NCT03170609|474872346|FG001|Overall Study|Withdrawal by Subject|2|||
131888069|NCT03170609|474872347|FG002|Overall Study|Withdrawal by Subject|0|||
131888070|NCT03170609|474872348|FG003|Overall Study|Withdrawal by Subject|0|||
131888071|NCT03170609|474872349|FG004|Overall Study|Withdrawal by Subject|0|||
131888072|NCT03170609|474872350|FG005|Overall Study|Withdrawal by Subject|0|||
131888073|NCT03170609|474872351|FG006|Overall Study|Withdrawal by Subject|1|||
131888074|NCT03170609|474872345|FG000|Overall Study|Lost to Follow-up|1|||
131888075|NCT03170609|474872346|FG001|Overall Study|Lost to Follow-up|0|||
131888076|NCT03170609|474872347|FG002|Overall Study|Lost to Follow-up|5|||
131888077|NCT03170609|474872348|FG003|Overall Study|Lost to Follow-up|2|||
131888078|NCT03170609|474872349|FG004|Overall Study|Lost to Follow-up|1|||
131888079|NCT03170609|474872350|FG005|Overall Study|Lost to Follow-up|1|||
131888080|NCT03170609|474872351|FG006|Overall Study|Lost to Follow-up|0|||
131888081|NCT03170609|474872345|FG000|Overall Study|Other|1|||
131888082|NCT03170609|474872346|FG001|Overall Study|Other|0|||
131888083|NCT03170609|474872347|FG002|Overall Study|Other|0|||
131888084|NCT03170609|474872348|FG003|Overall Study|Other|0|||
131888085|NCT03170609|474872349|FG004|Overall Study|Other|0|||
131888086|NCT03170609|474872350|FG005|Overall Study|Other|1|||
131888087|NCT03170609|474872351|FG006|Overall Study|Other|0|||
131888088|NCT01281956|474872352|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
131888089|NCT01281956|474872353|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
131888090|NCT01593254|474872359|FG000|Overall Study|Disease progression|2|||
131888091|NCT01593254|474872360|FG001|Overall Study|Disease progression|7|||
131888092|NCT01593254|474872359|FG000|Overall Study|Study drug toxicity|6|||
131888093|NCT01593254|474872360|FG001|Overall Study|Study drug toxicity|20|||
131888094|NCT01593254|474872359|FG000|Overall Study|Death|3|||
131888095|NCT01593254|474872360|FG001|Overall Study|Death|3|||
131888096|NCT01593254|474872359|FG000|Overall Study|AE unrelated to study drug|0|||
131888097|NCT01593254|474872360|FG001|Overall Study|AE unrelated to study drug|1|||
131888098|NCT01593254|474872359|FG000|Overall Study|participant request to discontinue study treatment|1|||
131888099|NCT01593254|474872360|FG001|Overall Study|participant request to discontinue study treatment|3|||
131888100|NCT01593254|474872359|FG000|Overall Study|participant withdrew consent|0|||
131888101|NCT01593254|474872360|FG001|Overall Study|participant withdrew consent|9|||
131888102|NCT01593254|474872359|FG000|Overall Study|lost to follow up|1|||
131888103|NCT01593254|474872360|FG001|Overall Study|lost to follow up|6|||
131888104|NCT01593254|474872359|FG000|Overall Study|maximum clinical benefit|1|||
131888105|NCT01593254|474872360|FG001|Overall Study|maximum clinical benefit|2|||
131888106|NCT01593254|474872359|FG000|Overall Study|Poor/non compliance|1|||
131888107|NCT01593254|474872360|FG001|Overall Study|Poor/non compliance|1|||
131888108|NCT01593254|474872359|FG000|Overall Study|Pregnancy|0|||
131888109|NCT01593254|474872360|FG001|Overall Study|Pregnancy|3|||
131888110|NCT01593254|474872359|FG000|Overall Study|participant no longer meets study criteria|1|||
131888111|NCT01593254|474872360|FG001|Overall Study|participant no longer meets study criteria|1|||
131888112|NCT01593254|474872359|FG000|Overall Study|Admin reason by sponsor|7|||
131888113|NCT01593254|474872360|FG001|Overall Study|Admin reason by sponsor|3|||
131888114|NCT01593254|474872359|FG000|Overall Study|Imatinib treatment failure|2|||
131888115|NCT01593254|474872360|FG001|Overall Study|Imatinib treatment failure|0|||
131888116|NCT01593254|474872359|FG000|Overall Study|Other Reasons|61|||
131888117|NCT01593254|474872360|FG001|Overall Study|Other Reasons|115|||
131888118|NCT01887678|474872361|FG000|Overall Study|Adverse Event|4|||
131888119|NCT01887678|474872362|FG001|Overall Study|Adverse Event|6|||
131888120|NCT01887678|474872361|FG000|Overall Study|Exceeded rescue medication dosage|4|||
131888121|NCT01887678|474872362|FG001|Overall Study|Exceeded rescue medication dosage|5|||
131661827|NCT02217475|474046160|FG001|Discontinued After Period 1|Physician Decision|0|||
131661828|NCT02217475|474046161|FG002|Discontinued After Period 1|Physician Decision|1|||
131661829|NCT02217475|474046159|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
131661830|NCT02217475|474046160|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
131661831|NCT02217475|474046161|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
131550177|NCT03299686|473637099|FG000|Treatment Epoch|Adverse Event|8|||
131550178|NCT03299686|473637100|FG001|Treatment Epoch|Adverse Event|4|||
131550179|NCT03299686|473637099|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
131550180|NCT03299686|473637100|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
131550181|NCT02709005|473637101|FG000|Overall Study|Lost to Follow-up|1|||
131550182|NCT02709005|473637102|FG001|Overall Study|Lost to Follow-up|1|||
131550183|NCT02709005|473637101|FG000|Overall Study|Withdrawal by Subject|3|||
131550184|NCT02709005|473637102|FG001|Overall Study|Withdrawal by Subject|0|||
131550185|NCT00691132|473637104|FG000|Overall Study|Adverse Event|2|||
131550186|NCT00691132|473637105|FG001|Overall Study|Adverse Event|3|||
131550187|NCT00691132|473637104|FG000|Overall Study|Withdrawal by Subject|10|||
131550188|NCT00691132|473637105|FG001|Overall Study|Withdrawal by Subject|10|||
131550189|NCT01959347|473637106|FG000|Overall Study|Protocol Violation|9|||
131550190|NCT01959347|473637107|FG001|Overall Study|Protocol Violation|7|||
131550191|NCT03954743|473637108|FG000|Overall Study|Adverse Event|1|||
131550192|NCT03954743|473637109|FG001|Overall Study|Adverse Event|0|||
131550193|NCT03954743|473637108|FG000|Overall Study|Lost to Follow-up|6|||
131550194|NCT03954743|473637109|FG001|Overall Study|Lost to Follow-up|4|||
131550195|NCT03954743|473637108|FG000|Overall Study|Protocol Violation|1|||
131550196|NCT03954743|473637109|FG001|Overall Study|Protocol Violation|0|||
131550197|NCT03954743|473637108|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
131550198|NCT03954743|473637109|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
131550199|NCT03954743|473637108|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
131550200|NCT03954743|473637109|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131550201|NCT01282801|473637112|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
131550202|NCT01282801|473637113|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
131550203|NCT02387996|473637116|FG000|Overall Study|Disease Progression|167|||
131550204|NCT02387996|473637116|FG000|Overall Study|Study Drug Toxicity|31|||
131550205|NCT02387996|473637116|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
131550206|NCT02387996|473637116|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
131550207|NCT02387996|473637116|FG000|Overall Study|Subject Withdrew Consent|5|||
131550208|NCT02387996|473637116|FG000|Overall Study|Lost to Follow-up|1|||
131550209|NCT02387996|473637116|FG000|Overall Study|Poor/Non-Compliance|1|||
131550210|NCT02387996|473637116|FG000|Overall Study|Other Reasons|5|||
131550211|NCT02387996|473637116|FG000|Overall Study|Death|1|||
131550212|NCT01060553|473637117|FG000|Overall Study|Lost to Follow-up|3|||
131550213|NCT01060553|473637118|FG001|Overall Study|Lost to Follow-up|5|||
131550214|NCT01060553|473637117|FG000|Overall Study|Withdrawal by Subject|5|||
131550215|NCT01060553|473637118|FG001|Overall Study|Withdrawal by Subject|5|||
131550216|NCT01060553|473637117|FG000|Overall Study|Lack of Efficacy|1|||
131550217|NCT01060553|473637118|FG001|Overall Study|Lack of Efficacy|0|||
131550218|NCT04707196|473637121|FG000|Overall Study|Withdrawal by Subject|9|||
131550219|NCT04707196|473637122|FG001|Overall Study|Withdrawal by Subject|6|||
131550220|NCT04707196|473637121|FG000|Overall Study|Lost to Follow-up|1|||
131550221|NCT04707196|473637122|FG001|Overall Study|Lost to Follow-up|0|||
131550222|NCT04707196|473637121|FG000|Overall Study|Protocol Violation|4|||
131550223|NCT04707196|473637122|FG001|Overall Study|Protocol Violation|1|||
131550224|NCT04707196|473637121|FG000|Overall Study|Adverse Event|2|||
131550225|NCT04707196|473637122|FG001|Overall Study|Adverse Event|2|||
131550226|NCT04707196|473637121|FG000|Overall Study|Death|3|||
131550227|NCT04707196|473637122|FG001|Overall Study|Death|1|||
131550228|NCT04707196|473637121|FG000|Overall Study|Non-compliance with study drug|1|||
131550229|NCT04707196|473637122|FG001|Overall Study|Non-compliance with study drug|0|||
131550230|NCT04707196|473637121|FG000|Overall Study|Progressive disease|9|||
131550231|NCT04707196|473637122|FG001|Overall Study|Progressive disease|10|||
131550232|NCT01862796|473637123|FG000|Overall Study|Prohibited medications|0|||
131550233|NCT01862796|473637124|FG001|Overall Study|Prohibited medications|0|||
131550234|NCT01862796|473637125|FG002|Overall Study|Prohibited medications|1|||
131550235|NCT05375955|473637133|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
131661832|NCT02217475|474046159|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
131661833|NCT02217475|474046160|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
131550236|NCT05375955|473637134|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
131550237|NCT05375955|473637135|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
131550238|NCT05375955|473637136|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
131550239|NCT05375955|473637137|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
131550240|NCT05375955|473637138|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
131550241|NCT05375955|473637139|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
131550242|NCT05375955|473637133|FG000|Treatment (12 Weeks)|Physician Decision|4|||
131550243|NCT05375955|473637134|FG001|Treatment (12 Weeks)|Physician Decision|1|||
131550244|NCT05375955|473637135|FG002|Treatment (12 Weeks)|Physician Decision|3|||
131550245|NCT05375955|473637136|FG003|Treatment (12 Weeks)|Physician Decision|0|||
131550246|NCT05375955|473637137|FG004|Treatment (12 Weeks)|Physician Decision|0|||
131550247|NCT05375955|473637138|FG005|Treatment (12 Weeks)|Physician Decision|1|||
131550248|NCT05375955|473637139|FG006|Treatment (12 Weeks)|Physician Decision|0|||
131550249|NCT05375955|473637133|FG000|Treatment (12 Weeks)|Other|0|||
131550250|NCT05375955|473637134|FG001|Treatment (12 Weeks)|Other|1|||
131550251|NCT05375955|473637135|FG002|Treatment (12 Weeks)|Other|0|||
131550252|NCT05375955|473637136|FG003|Treatment (12 Weeks)|Other|0|||
131550253|NCT05375955|473637137|FG004|Treatment (12 Weeks)|Other|0|||
131550254|NCT05375955|473637138|FG005|Treatment (12 Weeks)|Other|0|||
131550255|NCT05375955|473637139|FG006|Treatment (12 Weeks)|Other|0|||
131550256|NCT05375955|473637133|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
131550257|NCT05375955|473637134|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
131550258|NCT05375955|473637135|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
131550259|NCT05375955|473637136|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
131550260|NCT05375955|473637137|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
131550261|NCT05375955|473637138|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
131550262|NCT05375955|473637139|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
131550263|NCT05375955|473637133|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
131550264|NCT05375955|473637134|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
131550265|NCT05375955|473637135|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
131550266|NCT05375955|473637136|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
131550267|NCT05375955|473637137|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
131550268|NCT05375955|473637138|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
131550269|NCT05375955|473637139|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
131550270|NCT05375955|473637133|FG000|Treatment (12 Weeks)|Pregnancy|0|||
131550271|NCT05375955|473637134|FG001|Treatment (12 Weeks)|Pregnancy|0|||
131550272|NCT05375955|473637135|FG002|Treatment (12 Weeks)|Pregnancy|1|||
131550273|NCT05375955|473637136|FG003|Treatment (12 Weeks)|Pregnancy|0|||
131550274|NCT05375955|473637137|FG004|Treatment (12 Weeks)|Pregnancy|0|||
131550275|NCT05375955|473637138|FG005|Treatment (12 Weeks)|Pregnancy|0|||
131550276|NCT05375955|473637139|FG006|Treatment (12 Weeks)|Pregnancy|0|||
131550277|NCT05375955|473637133|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
131550278|NCT05375955|473637134|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
131550279|NCT05375955|473637135|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
131550280|NCT05375955|473637136|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
131550281|NCT05375955|473637137|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
131550282|NCT05375955|473637138|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
131550283|NCT05375955|473637139|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
131550284|NCT05375955|473637133|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
131550285|NCT05375955|473637134|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
131550286|NCT05375955|473637135|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
131550287|NCT05375955|473637136|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
131550288|NCT05375955|473637137|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
131550289|NCT05375955|473637138|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
131550290|NCT05375955|473637139|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
131550291|NCT05375955|473637133|FG000|Follow-up (up to 5 Weeks)|Other|0|||
131550292|NCT05375955|473637134|FG001|Follow-up (up to 5 Weeks)|Other|1|||
131550293|NCT05375955|473637135|FG002|Follow-up (up to 5 Weeks)|Other|0|||
131550294|NCT05375955|473637136|FG003|Follow-up (up to 5 Weeks)|Other|0|||
131550295|NCT05375955|473637137|FG004|Follow-up (up to 5 Weeks)|Other|0|||
131550296|NCT05375955|473637138|FG005|Follow-up (up to 5 Weeks)|Other|0|||
131550297|NCT05375955|473637139|FG006|Follow-up (up to 5 Weeks)|Other|0|||
131550298|NCT05375955|473637133|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
131550299|NCT05375955|473637134|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
131550300|NCT05375955|473637135|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
131550301|NCT05375955|473637136|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
131550302|NCT05375955|473637137|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
131550303|NCT05375955|473637138|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
131550304|NCT05375955|473637139|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
131550305|NCT05375955|473637133|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
131550306|NCT05375955|473637134|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
131550307|NCT05375955|473637135|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
131550308|NCT05375955|473637136|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
131550309|NCT05375955|473637137|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
131550310|NCT05375955|473637138|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
131550311|NCT05375955|473637139|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
131550312|NCT00728962|473637145|FG000|Implant Placement Surgery|Adverse Event|8|||
131550313|NCT00728962|473637145|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
131550314|NCT00728962|473637145|FG000|Implant Placement Surgery|Protocol Violation|1|||
131550315|NCT00728962|473637145|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
131550316|NCT00728962|473637145|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
131550317|NCT04954586|473637146|FG000|Overall Study|Withdrawal by Subject|5|||
131550318|NCT02063828|473637147|FG000|Overall Study|Withdrawal by Subject|4|||
131550319|NCT02063828|473637148|FG001|Overall Study|Withdrawal by Subject|6|||
131550320|NCT02063828|473637149|FG002|Overall Study|Withdrawal by Subject|3|||
131550321|NCT02063828|473637147|FG000|Overall Study|Death|0|||
131550322|NCT02063828|473637148|FG001|Overall Study|Death|0|||
131550323|NCT02063828|473637149|FG002|Overall Study|Death|1|||
131550324|NCT01313286|473637154|FG000|Period 1|Withdrawal by Subject|2|||
131550325|NCT01313286|473637155|FG001|Period 1|Withdrawal by Subject|0|||
131550326|NCT00654901|473637156|FG000|Overall Study|Lost to Follow-up|1|||
131550327|NCT00654901|473637157|FG001|Overall Study|Lost to Follow-up|0|||
131550328|NCT00654901|473637158|FG002|Overall Study|Lost to Follow-up|1|||
131550329|NCT00654901|473637159|FG003|Overall Study|Lost to Follow-up|0|||
131550330|NCT00654901|473637156|FG000|Overall Study|Withdrawal by Subject|3|||
131550331|NCT00654901|473637157|FG001|Overall Study|Withdrawal by Subject|0|||
131550332|NCT00654901|473637158|FG002|Overall Study|Withdrawal by Subject|1|||
131550333|NCT00654901|473637159|FG003|Overall Study|Withdrawal by Subject|0|||
131550334|NCT02332590|473637163|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
131550335|NCT02332590|473637164|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
131550336|NCT02332590|473637163|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
131550337|NCT02332590|473637164|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
131550338|NCT02332590|473637163|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
131550339|NCT02332590|473637164|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
131550340|NCT02332590|473637163|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
131550341|NCT02332590|473637164|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
131550342|NCT02332590|473637163|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
131550343|NCT02332590|473637164|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
131550344|NCT02332590|473637163|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
131550345|NCT02332590|473637164|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
131550346|NCT02332590|473637163|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
131550347|NCT02332590|473637164|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
131550348|NCT02332590|473637163|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
131550349|NCT02332590|473637164|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
131550350|NCT02332590|473637163|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
131550351|NCT02332590|473637164|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
131550352|NCT01679236|473639200|FG000|Overall Study|Lost to Follow-up|15|||
131550353|NCT01679236|473639201|FG001|Overall Study|Lost to Follow-up|15|||
131550354|NCT00975221|473639203|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
131550355|NCT00975221|473639204|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
131550356|NCT00975221|473639203|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
131550357|NCT00975221|473639204|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
131550358|NCT00975221|473639203|FG000|Titration Phase (Weeks 1-12)|Other|0|||
131550359|NCT00975221|473639204|FG001|Titration Phase (Weeks 1-12)|Other|1|||
131550360|NCT00975221|473639203|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
131550361|NCT00975221|473639204|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
131550362|NCT00975221|473639203|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
131550363|NCT00975221|473639204|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
131550364|NCT00975221|473639203|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
131550365|NCT00975221|473639204|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
131550366|NCT03935217|473639205|FG000|Overall Study|Adverse Event|1|||
131550367|NCT03935217|473639206|FG001|Overall Study|Adverse Event|0|||
131550368|NCT03935217|473639205|FG000|Overall Study|Lost to Follow-up|0|||
131661834|NCT02217475|474046161|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
131661835|NCT02217475|474046159|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
131661836|NCT02217475|474046160|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
131661837|NCT02217475|474046161|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
131661838|NCT02217475|474046159|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
131661839|NCT02217475|474046160|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
131661840|NCT02217475|474046161|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
131661841|NCT02217475|474046159|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
131661842|NCT02217475|474046160|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
131661843|NCT02217475|474046161|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
131661844|NCT00506441|474046162|FG000|Period 1; Open-label Period|Adverse Event|21|||
131661845|NCT00506441|474046163|FG001|Period 1; Open-label Period|Adverse Event|0|||
131661846|NCT00506441|474046162|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
131661847|NCT00506441|474046163|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
131661848|NCT00506441|474046162|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
131888122|NCT01887678|474872361|FG000|Overall Study|Withdrawal of consent|3|||
131550369|NCT03935217|473639206|FG001|Overall Study|Lost to Follow-up|1|||
131550370|NCT03935217|473639205|FG000|Overall Study|Withdrawal by Subject|0|||
131550371|NCT03935217|473639206|FG001|Overall Study|Withdrawal by Subject|2|||
131550372|NCT03559218|473639207|FG000|Overall Study|Withdrawal by Subject|1|||
131888123|NCT01887678|474872362|FG001|Overall Study|Withdrawal of consent|4|||
131661849|NCT00506441|474046163|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
131661850|NCT00506441|474046162|FG000|Period 1; Open-label Period|Physician Decision|5|||
131661851|NCT00506441|474046163|FG001|Period 1; Open-label Period|Physician Decision|0|||
131661852|NCT00506441|474046162|FG000|Period 1; Open-label Period|Protocol Violation|9|||
131661853|NCT00506441|474046163|FG001|Period 1; Open-label Period|Protocol Violation|0|||
131661854|NCT00506441|474046162|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
131661855|NCT00506441|474046163|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
131550373|NCT03559218|473639208|FG001|Overall Study|Withdrawal by Subject|0|||
131661856|NCT00506441|474046162|FG000|Period 1; Open-label Period|Other Reasons|13|||
131661857|NCT00506441|474046163|FG001|Period 1; Open-label Period|Other Reasons|0|||
131661858|NCT00506441|474046162|FG000|Period 2; Double-blind Period|Adverse Event|0|||
131661859|NCT00506441|474046163|FG001|Period 2; Double-blind Period|Adverse Event|1|||
131661860|NCT00506441|474046162|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
131661861|NCT00506441|474046163|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
131661862|NCT00506441|474046162|FG000|Period 2; Double-blind Period|Physician Decision|1|||
131661863|NCT00506441|474046163|FG001|Period 2; Double-blind Period|Physician Decision|1|||
131661864|NCT00506441|474046162|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
131661865|NCT00506441|474046163|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
131661866|NCT00506441|474046162|FG000|Period 2; Double-blind Period|Other Reason|1|||
131661867|NCT00506441|474046163|FG001|Period 2; Double-blind Period|Other Reason|1|||
131661868|NCT01215188|474046164|FG000|Overall Study|Lost to Follow-up|22|||
131661869|NCT01215188|474046165|FG001|Overall Study|Lost to Follow-up|22|||
131661870|NCT01215188|474046166|FG002|Overall Study|Lost to Follow-up|16|||
131661871|NCT01215188|474046164|FG000|Overall Study|Adverse Event|1|||
131661872|NCT01215188|474046165|FG001|Overall Study|Adverse Event|1|||
131661873|NCT01215188|474046166|FG002|Overall Study|Adverse Event|3|||
131661874|NCT01215188|474046164|FG000|Overall Study|Physician Decision|2|||
131661875|NCT01215188|474046165|FG001|Overall Study|Physician Decision|1|||
131661876|NCT01215188|474046166|FG002|Overall Study|Physician Decision|0|||
131661877|NCT01215188|474046164|FG000|Overall Study|Lack of Efficacy|0|||
131661878|NCT01215188|474046165|FG001|Overall Study|Lack of Efficacy|0|||
131661879|NCT01215188|474046166|FG002|Overall Study|Lack of Efficacy|1|||
131661880|NCT01215188|474046164|FG000|Overall Study|Protocol Violation|1|||
131661881|NCT01215188|474046165|FG001|Overall Study|Protocol Violation|1|||
131661882|NCT01215188|474046166|FG002|Overall Study|Protocol Violation|1|||
131661883|NCT01215188|474046164|FG000|Overall Study|Withdrawal by Subject|32|||
131661884|NCT01215188|474046165|FG001|Overall Study|Withdrawal by Subject|34|||
131661885|NCT01215188|474046166|FG002|Overall Study|Withdrawal by Subject|31|||
131661886|NCT01012414|474046167|FG000|Overall Study|Withdrawal by Subject|2|||
131661887|NCT01012414|474046167|FG000|Overall Study|Lost to Follow-up|1|||
131661888|NCT01012414|474046167|FG000|Overall Study|Trial was stopped before completed|7|||
131661889|NCT02601300|474046168|FG000|Induction Phase|Lack of Efficacy|2|||
131661890|NCT02601300|474046168|FG000|Induction Phase|Protocol Violation|1|||
131661891|NCT02601300|474046168|FG000|Extension Phase|Withdrawal by Subject|3|||
131661892|NCT02601300|474046168|FG000|Extension Phase|Adverse Event|4|||
131661893|NCT02601300|474046168|FG000|Extension Phase|Lack of Efficacy|10|||
131661894|NCT00528931|474046170|FG000|Overall Study|Lost to Follow-up|1|||
131661895|NCT02576587|474046171|FG000|Baseline|Equipment failure|0|||
131661896|NCT02576587|474046172|FG001|Baseline|Equipment failure|1|||
131661897|NCT02576587|474046171|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
131661898|NCT02576587|474046172|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
131661899|NCT02576587|474046171|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
131661900|NCT02576587|474046172|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
131661901|NCT02576587|474046171|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
131661902|NCT02576587|474046172|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
131661903|NCT00532493|474046173|FG000|Overall Study|Death|1|||
131661904|NCT00532493|474046174|FG001|Overall Study|Death|1|||
131661905|NCT00532493|474046173|FG000|Overall Study|Lost to Follow-up|10|||
131661906|NCT00532493|474046174|FG001|Overall Study|Lost to Follow-up|7|||
131661907|NCT00532493|474046173|FG000|Overall Study|Withdrawal by Subject|7|||
131661908|NCT00532493|474046174|FG001|Overall Study|Withdrawal by Subject|9|||
131661909|NCT00532493|474046173|FG000|Overall Study|Physician Decision|1|||
131661910|NCT00532493|474046174|FG001|Overall Study|Physician Decision|6|||
131661911|NCT00532493|474046173|FG000|Overall Study|Adverse Event|6|||
131661912|NCT00532493|474046174|FG001|Overall Study|Adverse Event|5|||
131661913|NCT00532493|474046173|FG000|Overall Study|Protocol Deviation|1|||
131661914|NCT00532493|474046174|FG001|Overall Study|Protocol Deviation|0|||
131661915|NCT00532493|474046173|FG000|Overall Study|Subject Moved Away|3|||
131661916|NCT00532493|474046174|FG001|Overall Study|Subject Moved Away|1|||
131661917|NCT00532493|474046173|FG000|Overall Study|Contraindicative Medication|1|||
131661918|NCT00532493|474046174|FG001|Overall Study|Contraindicative Medication|0|||
131661919|NCT01036438|474046175|FG000|Overall Study|Adverse Event|7|||
131661920|NCT01036438|474046176|FG001|Overall Study|Adverse Event|8|||
131661921|NCT01036438|474046175|FG000|Overall Study|Death|0|||
131661922|NCT01036438|474046176|FG001|Overall Study|Death|1|||
131661923|NCT01036438|474046175|FG000|Overall Study|No effect of study treatment|3|||
131770377|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770378|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
131770379|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131770380|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770381|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
131770382|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770383|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770384|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770385|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770386|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770387|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770388|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770389|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770390|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770391|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131770392|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
131770393|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
131770394|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
131770395|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
131770396|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
131770397|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
131770398|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
131770399|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
131770400|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
131770401|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
131770402|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
131770403|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
131770404|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770405|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770406|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770407|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770408|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770409|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
131770410|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770411|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770412|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770413|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770414|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770415|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131770416|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770417|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770418|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770419|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770420|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770421|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
131770422|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770423|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770424|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770425|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770426|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770427|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131770428|NCT00151775|474437915|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770429|NCT00151775|474437916|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770430|NCT00151775|474437917|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770431|NCT00151775|474437918|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770432|NCT00151775|474437919|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770433|NCT00151775|474437920|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770434|NCT00151775|474437921|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
131770435|NCT00151775|474437922|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770436|NCT00151775|474437923|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770437|NCT00151775|474437924|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770438|NCT00151775|474437925|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770439|NCT00151775|474437926|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131770440|NCT00151775|474437915|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770441|NCT00151775|474437916|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770442|NCT00151775|474437917|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770443|NCT00151775|474437918|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770444|NCT00151775|474437919|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770445|NCT00151775|474437920|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
131770446|NCT00151775|474437921|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770447|NCT00151775|474437922|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770448|NCT00151775|474437923|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770449|NCT00151775|474437924|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770450|NCT00151775|474437925|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770451|NCT00151775|474437926|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131770452|NCT00151775|474437915|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
131770453|NCT00151775|474437916|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
131770454|NCT00151775|474437917|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
131770455|NCT00151775|474437918|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
131770456|NCT00151775|474437919|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
131770457|NCT00151775|474437920|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
131770458|NCT00151775|474437921|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
131770459|NCT00151775|474437922|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
131770460|NCT00151775|474437923|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
131770461|NCT00151775|474437924|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
131770462|NCT00151775|474437925|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
131770463|NCT00151775|474437926|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
131770464|NCT00151775|474437915|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770465|NCT00151775|474437916|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770466|NCT00151775|474437917|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770467|NCT00151775|474437918|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770468|NCT00151775|474437919|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770469|NCT00151775|474437920|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770470|NCT00151775|474437921|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
131770471|NCT00151775|474437922|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770472|NCT00151775|474437923|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770473|NCT00151775|474437924|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770474|NCT00151775|474437925|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770475|NCT00151775|474437926|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131770476|NCT00151775|474437915|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770477|NCT00151775|474437916|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770478|NCT00151775|474437917|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
131770479|NCT00151775|474437918|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770480|NCT00151775|474437919|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770481|NCT00151775|474437920|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770482|NCT00151775|474437921|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770483|NCT00151775|474437922|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770484|NCT00151775|474437923|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770485|NCT00151775|474437924|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770486|NCT00151775|474437925|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770487|NCT00151775|474437926|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131770488|NCT00151775|474437915|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770489|NCT00151775|474437916|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770490|NCT00151775|474437917|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
131770491|NCT00151775|474437918|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770492|NCT00151775|474437919|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770493|NCT00151775|474437920|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770494|NCT00151775|474437921|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770495|NCT00151775|474437922|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770496|NCT00151775|474437923|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770497|NCT00151775|474437924|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770498|NCT00151775|474437925|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770499|NCT00151775|474437926|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131770500|NCT00151775|474437915|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770501|NCT00151775|474437916|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770502|NCT00151775|474437917|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770503|NCT00151775|474437918|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770504|NCT00151775|474437919|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770505|NCT00151775|474437920|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770506|NCT00151775|474437921|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770507|NCT00151775|474437922|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770508|NCT00151775|474437923|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770509|NCT00151775|474437924|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770510|NCT00151775|474437925|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131770511|NCT00151775|474437926|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
131770512|NCT00151775|474437915|FG000|Period 4: Open Label|Increased blood pressure|0|||
131770513|NCT00151775|474437916|FG001|Period 4: Open Label|Increased blood pressure|0|||
131770514|NCT00151775|474437917|FG002|Period 4: Open Label|Increased blood pressure|0|||
131770515|NCT00151775|474437918|FG003|Period 4: Open Label|Increased blood pressure|0|||
131770516|NCT00151775|474437919|FG004|Period 4: Open Label|Increased blood pressure|1|||
131770517|NCT00151775|474437920|FG005|Period 4: Open Label|Increased blood pressure|0|||
131770518|NCT00151775|474437921|FG006|Period 4: Open Label|Increased blood pressure|0|||
131770519|NCT00151775|474437922|FG007|Period 4: Open Label|Increased blood pressure|0|||
131770520|NCT00151775|474437923|FG008|Period 4: Open Label|Increased blood pressure|0|||
131770521|NCT00151775|474437924|FG009|Period 4: Open Label|Increased blood pressure|1|||
131770522|NCT00151775|474437925|FG010|Period 4: Open Label|Increased blood pressure|0|||
131770523|NCT00151775|474437926|FG011|Period 4: Open Label|Increased blood pressure|0|||
131770524|NCT00151775|474437915|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
131770525|NCT00151775|474437916|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
131770526|NCT00151775|474437917|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
131770527|NCT00151775|474437918|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
131770528|NCT00151775|474437919|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
131770529|NCT00151775|474437920|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
131770530|NCT00151775|474437921|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
131770531|NCT00151775|474437922|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
131770532|NCT00151775|474437923|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
131770533|NCT00151775|474437924|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
131770534|NCT00151775|474437925|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
131770535|NCT00151775|474437926|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
131770536|NCT00151775|474437915|FG000|Period 4: Open Label|Adverse Event|0|||
131770537|NCT00151775|474437916|FG001|Period 4: Open Label|Adverse Event|0|||
131770538|NCT00151775|474437917|FG002|Period 4: Open Label|Adverse Event|0|||
131770539|NCT00151775|474437918|FG003|Period 4: Open Label|Adverse Event|0|||
131770540|NCT00151775|474437919|FG004|Period 4: Open Label|Adverse Event|1|||
131770541|NCT00151775|474437920|FG005|Period 4: Open Label|Adverse Event|0|||
131770542|NCT00151775|474437921|FG006|Period 4: Open Label|Adverse Event|0|||
131770543|NCT00151775|474437922|FG007|Period 4: Open Label|Adverse Event|0|||
131770544|NCT00151775|474437923|FG008|Period 4: Open Label|Adverse Event|0|||
131770545|NCT00151775|474437924|FG009|Period 4: Open Label|Adverse Event|2|||
131770546|NCT00151775|474437925|FG010|Period 4: Open Label|Adverse Event|0|||
131770547|NCT00151775|474437926|FG011|Period 4: Open Label|Adverse Event|0|||
131770548|NCT00151775|474437915|FG000|Period 4: Open Label|Lost to Follow-up|0|||
131770549|NCT00151775|474437916|FG001|Period 4: Open Label|Lost to Follow-up|0|||
131770550|NCT00151775|474437917|FG002|Period 4: Open Label|Lost to Follow-up|0|||
131770551|NCT00151775|474437918|FG003|Period 4: Open Label|Lost to Follow-up|0|||
131770552|NCT00151775|474437919|FG004|Period 4: Open Label|Lost to Follow-up|17|||
131770553|NCT00151775|474437920|FG005|Period 4: Open Label|Lost to Follow-up|0|||
131770554|NCT00151775|474437921|FG006|Period 4: Open Label|Lost to Follow-up|0|||
131770555|NCT00151775|474437922|FG007|Period 4: Open Label|Lost to Follow-up|0|||
131770556|NCT00151775|474437923|FG008|Period 4: Open Label|Lost to Follow-up|0|||
131770557|NCT00151775|474437924|FG009|Period 4: Open Label|Lost to Follow-up|7|||
131770558|NCT00151775|474437925|FG010|Period 4: Open Label|Lost to Follow-up|0|||
131770559|NCT00151775|474437926|FG011|Period 4: Open Label|Lost to Follow-up|0|||
131770560|NCT00151775|474437915|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
131770561|NCT00151775|474437916|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
131770562|NCT00151775|474437917|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
131770563|NCT00151775|474437918|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
131770564|NCT00151775|474437919|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
131770565|NCT00151775|474437920|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
131770566|NCT00151775|474437921|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
131770567|NCT00151775|474437922|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
131770568|NCT00151775|474437923|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
131770569|NCT00151775|474437924|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
131770570|NCT00151775|474437925|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
131770571|NCT00151775|474437926|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
131770572|NCT00151775|474437915|FG000|Period 4: Open Label|Other|0|||
131770573|NCT00151775|474437916|FG001|Period 4: Open Label|Other|0|||
131770574|NCT00151775|474437917|FG002|Period 4: Open Label|Other|0|||
131770575|NCT00151775|474437918|FG003|Period 4: Open Label|Other|0|||
131770576|NCT00151775|474437919|FG004|Period 4: Open Label|Other|1|||
131770577|NCT00151775|474437920|FG005|Period 4: Open Label|Other|0|||
131770578|NCT00151775|474437921|FG006|Period 4: Open Label|Other|0|||
131770579|NCT00151775|474437922|FG007|Period 4: Open Label|Other|0|||
131770580|NCT00151775|474437923|FG008|Period 4: Open Label|Other|0|||
131770581|NCT00151775|474437924|FG009|Period 4: Open Label|Other|3|||
131770582|NCT00151775|474437925|FG010|Period 4: Open Label|Other|0|||
131770583|NCT00151775|474437926|FG011|Period 4: Open Label|Other|0|||
131770584|NCT00151775|474437915|FG000|Period 4: Open Label|Physician Decision|0|||
131770585|NCT00151775|474437916|FG001|Period 4: Open Label|Physician Decision|0|||
131770586|NCT00151775|474437917|FG002|Period 4: Open Label|Physician Decision|0|||
131770587|NCT00151775|474437918|FG003|Period 4: Open Label|Physician Decision|0|||
131770588|NCT00151775|474437919|FG004|Period 4: Open Label|Physician Decision|0|||
131770589|NCT00151775|474437920|FG005|Period 4: Open Label|Physician Decision|0|||
131770590|NCT00151775|474437921|FG006|Period 4: Open Label|Physician Decision|0|||
131770591|NCT00151775|474437922|FG007|Period 4: Open Label|Physician Decision|0|||
131770592|NCT00151775|474437923|FG008|Period 4: Open Label|Physician Decision|0|||
131770593|NCT00151775|474437924|FG009|Period 4: Open Label|Physician Decision|2|||
131770594|NCT00151775|474437925|FG010|Period 4: Open Label|Physician Decision|0|||
131770595|NCT00151775|474437926|FG011|Period 4: Open Label|Physician Decision|0|||
131770596|NCT00151775|474437915|FG000|Period 4: Open Label|Protocol Violation|0|||
131770597|NCT00151775|474437916|FG001|Period 4: Open Label|Protocol Violation|0|||
131770598|NCT00151775|474437917|FG002|Period 4: Open Label|Protocol Violation|0|||
131770599|NCT00151775|474437918|FG003|Period 4: Open Label|Protocol Violation|0|||
131770600|NCT00151775|474437919|FG004|Period 4: Open Label|Protocol Violation|1|||
131770601|NCT00151775|474437920|FG005|Period 4: Open Label|Protocol Violation|0|||
131770602|NCT00151775|474437921|FG006|Period 4: Open Label|Protocol Violation|0|||
131770603|NCT00151775|474437922|FG007|Period 4: Open Label|Protocol Violation|0|||
131770604|NCT00151775|474437923|FG008|Period 4: Open Label|Protocol Violation|0|||
131770605|NCT00151775|474437924|FG009|Period 4: Open Label|Protocol Violation|0|||
131770606|NCT00151775|474437925|FG010|Period 4: Open Label|Protocol Violation|0|||
131770607|NCT00151775|474437926|FG011|Period 4: Open Label|Protocol Violation|0|||
131770608|NCT02158949|474437927|FG000|Overall Study|Withdrawal by Subject|1|||
131770609|NCT02158949|474437928|FG001|Overall Study|Withdrawal by Subject|0|||
131770610|NCT02158949|474437927|FG000|Overall Study|Lost to Follow-up|5|||
131770611|NCT02158949|474437928|FG001|Overall Study|Lost to Follow-up|11|||
131770612|NCT02181634|474437929|FG000|Overall Study|Lack of Efficacy|33|||
131770613|NCT02181634|474437929|FG000|Overall Study|Adverse Event|17|||
131770614|NCT02181634|474437929|FG000|Overall Study|Physician Decision|8|||
131770615|NCT02181634|474437929|FG000|Overall Study|Withdrawal by Subject|5|||
131770616|NCT02181634|474437929|FG000|Overall Study|Death|2|||
131770617|NCT02181634|474437929|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
131770618|NCT02181634|474437929|FG000|Overall Study|Ineligible|1|||
131770619|NCT02181634|474437929|FG000|Overall Study|Max number of dose reduction|1|||
131770620|NCT02181634|474437929|FG000|Overall Study|Symptomatic progression|1|||
131770621|NCT02181634|474437929|FG000|Overall Study|Patient opted to proceed to surgery|1|||
131770622|NCT03198559|474437936|FG000|Overall Study|Adverse Event|2|||
131770623|NCT01733758|474437937|FG000|Overall Study|Adverse Event|5|||
131770624|NCT01733758|474437938|FG001|Overall Study|Adverse Event|7|||
131770625|NCT01733758|474437939|FG002|Overall Study|Adverse Event|8|||
131770626|NCT01733758|474437940|FG003|Overall Study|Adverse Event|1|||
131770627|NCT01733758|474437937|FG000|Overall Study|Withdrawal by Subject|1|||
131770628|NCT01733758|474437938|FG001|Overall Study|Withdrawal by Subject|1|||
131770629|NCT01733758|474437939|FG002|Overall Study|Withdrawal by Subject|5|||
131770630|NCT01733758|474437940|FG003|Overall Study|Withdrawal by Subject|3|||
131770631|NCT01733758|474437937|FG000|Overall Study|Persistent Hyperglycemia|3|||
131770632|NCT01733758|474437938|FG001|Overall Study|Persistent Hyperglycemia|2|||
131770633|NCT01733758|474437939|FG002|Overall Study|Persistent Hyperglycemia|0|||
131770634|NCT01733758|474437940|FG003|Overall Study|Persistent Hyperglycemia|0|||
131770635|NCT01733758|474437937|FG000|Overall Study|Protocol Violation|0|||
131770636|NCT01733758|474437938|FG001|Overall Study|Protocol Violation|1|||
131770637|NCT01733758|474437939|FG002|Overall Study|Protocol Violation|2|||
131770638|NCT01733758|474437940|FG003|Overall Study|Protocol Violation|2|||
131770639|NCT01733758|474437937|FG000|Overall Study|Non-compliance|1|||
131770640|NCT01733758|474437938|FG001|Overall Study|Non-compliance|0|||
131770641|NCT01733758|474437939|FG002|Overall Study|Non-compliance|0|||
131770642|NCT01733758|474437940|FG003|Overall Study|Non-compliance|0|||
131770643|NCT01733758|474437937|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
131770644|NCT01733758|474437938|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
131770645|NCT01733758|474437939|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
131770646|NCT01733758|474437940|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
131770647|NCT01733758|474437937|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
131770648|NCT01733758|474437938|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
131770649|NCT01733758|474437939|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
131770650|NCT01733758|474437940|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
131770651|NCT02557308|474437941|FG000|Overall Study|Withdrawal by Subject|11|||
131770652|NCT02557308|474437942|FG001|Overall Study|Withdrawal by Subject|3|||
131770653|NCT02557308|474437943|FG002|Overall Study|Withdrawal by Subject|2|||
131770654|NCT02557308|474437944|FG003|Overall Study|Withdrawal by Subject|0|||
131770655|NCT02557308|474437945|FG004|Overall Study|Withdrawal by Subject|1|||
131550374|NCT04170686|473639212|FG000|Screening|Physician Decision|12|||
131770656|NCT02557308|474437946|FG005|Overall Study|Withdrawal by Subject|0|||
131770657|NCT02557308|474437947|FG006|Overall Study|Withdrawal by Subject|10|||
131770658|NCT02557308|474437948|FG007|Overall Study|Withdrawal by Subject|1|||
131770659|NCT02557308|474437941|FG000|Overall Study|Disease Progression|0|||
131770660|NCT02557308|474437942|FG001|Overall Study|Disease Progression|1|||
131770661|NCT02557308|474437943|FG002|Overall Study|Disease Progression|0|||
131770662|NCT02557308|474437944|FG003|Overall Study|Disease Progression|0|||
131770663|NCT02557308|474437945|FG004|Overall Study|Disease Progression|0|||
131770664|NCT02557308|474437946|FG005|Overall Study|Disease Progression|0|||
131770665|NCT02557308|474437947|FG006|Overall Study|Disease Progression|0|||
131770666|NCT02557308|474437948|FG007|Overall Study|Disease Progression|0|||
131770667|NCT02557308|474437941|FG000|Overall Study|Lack of Efficacy|3|||
131770668|NCT02557308|474437942|FG001|Overall Study|Lack of Efficacy|0|||
131770669|NCT02557308|474437943|FG002|Overall Study|Lack of Efficacy|0|||
131770670|NCT02557308|474437944|FG003|Overall Study|Lack of Efficacy|0|||
131770671|NCT02557308|474437945|FG004|Overall Study|Lack of Efficacy|0|||
131770672|NCT02557308|474437946|FG005|Overall Study|Lack of Efficacy|0|||
131770673|NCT02557308|474437947|FG006|Overall Study|Lack of Efficacy|1|||
131770674|NCT02557308|474437948|FG007|Overall Study|Lack of Efficacy|0|||
131770675|NCT02557308|474437941|FG000|Overall Study|Adverse Event|4|||
131770676|NCT02557308|474437942|FG001|Overall Study|Adverse Event|1|||
131770677|NCT02557308|474437943|FG002|Overall Study|Adverse Event|2|||
131770678|NCT02557308|474437944|FG003|Overall Study|Adverse Event|0|||
131770679|NCT02557308|474437945|FG004|Overall Study|Adverse Event|0|||
131770680|NCT02557308|474437946|FG005|Overall Study|Adverse Event|0|||
131770681|NCT02557308|474437947|FG006|Overall Study|Adverse Event|4|||
131770682|NCT02557308|474437948|FG007|Overall Study|Adverse Event|1|||
131770683|NCT02557308|474437941|FG000|Overall Study|Lost to Follow-up|2|||
131770684|NCT02557308|474437942|FG001|Overall Study|Lost to Follow-up|0|||
131770685|NCT02557308|474437943|FG002|Overall Study|Lost to Follow-up|1|||
131770686|NCT02557308|474437944|FG003|Overall Study|Lost to Follow-up|0|||
131770687|NCT02557308|474437945|FG004|Overall Study|Lost to Follow-up|0|||
131770688|NCT02557308|474437946|FG005|Overall Study|Lost to Follow-up|0|||
131770689|NCT02557308|474437947|FG006|Overall Study|Lost to Follow-up|2|||
131770690|NCT02557308|474437948|FG007|Overall Study|Lost to Follow-up|0|||
131770691|NCT02557308|474437941|FG000|Overall Study|Death|1|||
131770692|NCT02557308|474437942|FG001|Overall Study|Death|0|||
131770693|NCT02557308|474437943|FG002|Overall Study|Death|0|||
131770694|NCT02557308|474437944|FG003|Overall Study|Death|0|||
131770695|NCT02557308|474437945|FG004|Overall Study|Death|0|||
131770696|NCT02557308|474437946|FG005|Overall Study|Death|0|||
131770697|NCT02557308|474437947|FG006|Overall Study|Death|0|||
131770698|NCT02557308|474437948|FG007|Overall Study|Death|0|||
131770699|NCT02557308|474437941|FG000|Overall Study|Study Close|98|||
131770700|NCT02557308|474437942|FG001|Overall Study|Study Close|18|||
131770701|NCT02557308|474437943|FG002|Overall Study|Study Close|5|||
131770702|NCT02557308|474437944|FG003|Overall Study|Study Close|3|||
131770703|NCT02557308|474437945|FG004|Overall Study|Study Close|1|||
131770704|NCT02557308|474437946|FG005|Overall Study|Study Close|0|||
131770705|NCT02557308|474437947|FG006|Overall Study|Study Close|123|||
131770706|NCT02557308|474437948|FG007|Overall Study|Study Close|5|||
131770707|NCT02557308|474437941|FG000|Overall Study|Except for study close|5|||
131770708|NCT02557308|474437942|FG001|Overall Study|Except for study close|0|||
131770709|NCT02557308|474437943|FG002|Overall Study|Except for study close|0|||
131770710|NCT02557308|474437944|FG003|Overall Study|Except for study close|0|||
131770711|NCT02557308|474437945|FG004|Overall Study|Except for study close|3|||
131770712|NCT02557308|474437946|FG005|Overall Study|Except for study close|0|||
131770713|NCT02557308|474437947|FG006|Overall Study|Except for study close|6|||
131770714|NCT02557308|474437948|FG007|Overall Study|Except for study close|10|||
131770715|NCT04594213|474437951|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
131770716|NCT04594213|474437952|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
131770717|NCT04594213|474437953|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
131770718|NCT04594213|474437954|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131770719|NCT04594213|474437955|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131770720|NCT04594213|474437956|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131770721|NCT04594213|474437951|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131770722|NCT04594213|474437952|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
131770723|NCT04594213|474437953|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131770724|NCT04594213|474437954|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131770725|NCT04594213|474437955|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131770726|NCT04594213|474437956|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131770727|NCT04594213|474437951|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
131770728|NCT04594213|474437952|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131770729|NCT04594213|474437953|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
131770730|NCT04594213|474437954|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131770731|NCT04594213|474437955|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131770732|NCT04594213|474437956|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131770733|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131770734|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131770735|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131770736|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131770737|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
131770738|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131770739|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131770740|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131770741|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131770742|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
131770743|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
131770744|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
131770745|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131770746|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131770747|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131770748|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131770749|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131770750|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
131770751|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131770752|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131770753|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131770754|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
131770755|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131770756|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131770757|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131770758|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131770759|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131770760|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
131770761|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131770762|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131770763|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131770764|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131770765|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131770766|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
131770767|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
131770768|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
131770769|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131770770|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131770771|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131770772|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
131770773|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
131770774|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
131770775|NCT04594213|474437951|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
131770776|NCT04594213|474437952|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
131770777|NCT04594213|474437953|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
131770778|NCT04594213|474437954|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
131770779|NCT04594213|474437955|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
131770780|NCT04594213|474437956|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
131770781|NCT03814499|474437962|FG000|Overall Study|Lost to Follow-up|3|||
131770782|NCT01980056|474437963|FG000|Overall Study|Death|1|||
131770783|NCT01980056|474437964|FG001|Overall Study|Death|1|||
131770784|NCT01980056|474437965|FG002|Overall Study|Death|0|||
131770785|NCT02046993|474437966|FG000|Overall Study|Withdrawal by Subject|2|||
131770786|NCT02046993|474437967|FG001|Overall Study|Withdrawal by Subject|10|||
131770787|NCT02046993|474437966|FG000|Overall Study|Lost to Follow-up|1|||
131770788|NCT02046993|474437967|FG001|Overall Study|Lost to Follow-up|1|||
131770789|NCT01589185|474437968|FG000|Overall Study|Death|1|||
131770790|NCT01589185|474437969|FG001|Overall Study|Death|2|||
131770791|NCT01589185|474437970|FG002|Overall Study|Death|2|||
131770792|NCT01589185|474437971|FG003|Overall Study|Death|0|||
131770793|NCT01589185|474437972|FG004|Overall Study|Death|1|||
131770794|NCT01589185|474437968|FG000|Overall Study|Lost to Follow-up|1|||
131770795|NCT01589185|474437969|FG001|Overall Study|Lost to Follow-up|0|||
131770796|NCT01589185|474437970|FG002|Overall Study|Lost to Follow-up|2|||
131770797|NCT01589185|474437971|FG003|Overall Study|Lost to Follow-up|3|||
131770798|NCT01589185|474437972|FG004|Overall Study|Lost to Follow-up|0|||
131770799|NCT00598442|474437975|FG000|Overall Study|Adverse Event|3|||
131770800|NCT00598442|474437976|FG001|Overall Study|Adverse Event|0|||
131770801|NCT00598442|474437977|FG002|Overall Study|Adverse Event|0|||
131770802|NCT00598442|474437975|FG000|Overall Study|Death|19|||
131770803|NCT00598442|474437976|FG001|Overall Study|Death|11|||
131770804|NCT00598442|474437977|FG002|Overall Study|Death|11|||
131770805|NCT00598442|474437975|FG000|Overall Study|Lost to Follow-up|4|||
131770806|NCT00598442|474437976|FG001|Overall Study|Lost to Follow-up|3|||
131770807|NCT00598442|474437977|FG002|Overall Study|Lost to Follow-up|3|||
131770808|NCT00598442|474437975|FG000|Overall Study|Physician Decision|2|||
131770809|NCT00598442|474437976|FG001|Overall Study|Physician Decision|1|||
131770810|NCT00598442|474437977|FG002|Overall Study|Physician Decision|1|||
131770811|NCT00598442|474437975|FG000|Overall Study|Withdrawal by Subject|8|||
131770812|NCT00598442|474437976|FG001|Overall Study|Withdrawal by Subject|16|||
131770813|NCT00598442|474437977|FG002|Overall Study|Withdrawal by Subject|6|||
131770814|NCT00598442|474437975|FG000|Overall Study|Noncompliance|0|||
131770815|NCT00598442|474437976|FG001|Overall Study|Noncompliance|2|||
131770816|NCT00598442|474437977|FG002|Overall Study|Noncompliance|1|||
131770817|NCT00598442|474437975|FG000|Overall Study|Relocation|1|||
131770818|NCT00598442|474437976|FG001|Overall Study|Relocation|4|||
131770819|NCT00598442|474437977|FG002|Overall Study|Relocation|0|||
131770820|NCT00598442|474437975|FG000|Overall Study|Renal transplant|0|||
131770821|NCT00598442|474437976|FG001|Overall Study|Renal transplant|0|||
131770822|NCT00598442|474437977|FG002|Overall Study|Renal transplant|1|||
131770823|NCT00598442|474437975|FG000|Overall Study|Site closed by sponsor|5|||
131770824|NCT00598442|474437976|FG001|Overall Study|Site closed by sponsor|2|||
131770825|NCT00598442|474437977|FG002|Overall Study|Site closed by sponsor|1|||
131770826|NCT00598442|474437975|FG000|Overall Study|Started dialysis|1|||
131770827|NCT00598442|474437976|FG001|Overall Study|Started dialysis|0|||
131770828|NCT00598442|474437977|FG002|Overall Study|Started dialysis|0|||
131770829|NCT01654666|474437978|FG000|Overall Study|Protocol Violation|7|||
131770830|NCT01654666|474437979|FG001|Overall Study|Protocol Violation|4|||
131770831|NCT01654666|474437980|FG002|Overall Study|Protocol Violation|8|||
131770832|NCT01654666|474437978|FG000|Overall Study|Lost to Follow-up|4|||
131770833|NCT01654666|474437979|FG001|Overall Study|Lost to Follow-up|5|||
131770834|NCT01654666|474437980|FG002|Overall Study|Lost to Follow-up|5|||
131770835|NCT01654666|474437978|FG000|Overall Study|Withdrawal by Subject|4|||
131770836|NCT01654666|474437979|FG001|Overall Study|Withdrawal by Subject|4|||
131770837|NCT01654666|474437980|FG002|Overall Study|Withdrawal by Subject|1|||
131770838|NCT00368069|474437983|FG000|Overall Study|Adverse Event|5|||
131770839|NCT00368069|474437984|FG001|Overall Study|Adverse Event|2|||
131770840|NCT00368069|474437983|FG000|Overall Study|Lack of Efficacy|0|||
131770841|NCT00368069|474437984|FG001|Overall Study|Lack of Efficacy|1|||
131770842|NCT00368069|474437983|FG000|Overall Study|Lost to Follow-up|1|||
131770843|NCT00368069|474437984|FG001|Overall Study|Lost to Follow-up|0|||
131770844|NCT00368069|474437983|FG000|Overall Study|Protocol Violation|0|||
131770845|NCT00368069|474437984|FG001|Overall Study|Protocol Violation|2|||
131770846|NCT00368069|474437983|FG000|Overall Study|Withdrawal of Consent|2|||
131770847|NCT00368069|474437984|FG001|Overall Study|Withdrawal of Consent|1|||
131770848|NCT00368069|474437983|FG000|Overall Study|no blood sampling possible|0|||
131770849|NCT00368069|474437984|FG001|Overall Study|no blood sampling possible|1|||
131770850|NCT03907072|474437988|FG000|Overall Study|Study Terminated by Sponsor|2|||
131770851|NCT03907072|474437989|FG001|Overall Study|Study Terminated by Sponsor|2|||
131770852|NCT03907072|474437990|FG002|Overall Study|Study Terminated by Sponsor|2|||
131770853|NCT01430559|474437994|FG000|Overall Study|Adverse Event|7|||
131770854|NCT01430559|474437995|FG001|Overall Study|Adverse Event|3|||
131770855|NCT01430559|474437994|FG000|Overall Study|Entry criteria not met|1|||
131770856|NCT01430559|474437995|FG001|Overall Study|Entry criteria not met|1|||
131770857|NCT01430559|474437994|FG000|Overall Study|Lost to Follow-up|1|||
131770858|NCT01430559|474437995|FG001|Overall Study|Lost to Follow-up|0|||
131770859|NCT01430559|474437994|FG000|Overall Study|Medication error|1|||
131770860|NCT01430559|474437995|FG001|Overall Study|Medication error|0|||
131770861|NCT01430559|474437994|FG000|Overall Study|Withdrawal by Subject|3|||
131770862|NCT01430559|474437995|FG001|Overall Study|Withdrawal by Subject|2|||
131770863|NCT01430559|474437994|FG000|Overall Study|Protocol Violation|1|||
131770864|NCT01430559|474437995|FG001|Overall Study|Protocol Violation|0|||
131770865|NCT01430559|474437994|FG000|Overall Study|Other|3|||
131770866|NCT01430559|474437995|FG001|Overall Study|Other|3|||
131770867|NCT01430559|474437994|FG000|Overall Study|Randomized, Not Treated|3|||
131770868|NCT01430559|474437995|FG001|Overall Study|Randomized, Not Treated|3|||
131770869|NCT01177943|474437996|FG000|First Intervention|Withdrawal by Subject|2|||
131770870|NCT01177943|474437997|FG001|First Intervention|Withdrawal by Subject|0|||
131770871|NCT00672490|474437998|FG000|Overall Study|Withdrawal by Subject|8|||
131770872|NCT00672490|474437999|FG001|Overall Study|Withdrawal by Subject|8|||
131770873|NCT00672490|474437998|FG000|Overall Study|Lack of Compliance|2|||
131770874|NCT00672490|474437999|FG001|Overall Study|Lack of Compliance|7|||
131770875|NCT00672490|474437998|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
131888124|NCT01887678|474872361|FG000|Overall Study|Lost to Follow-up|4|||
131888125|NCT01887678|474872362|FG001|Overall Study|Lost to Follow-up|2|||
131550375|NCT04170686|473639213|FG001|Screening|Physician Decision|13|||
131550376|NCT04170686|473639212|FG000|Randomization and Treatment|Lost to Follow-up|26|||
131550377|NCT04170686|473639213|FG001|Randomization and Treatment|Lost to Follow-up|15|||
131770876|NCT00672490|474437999|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
131770877|NCT00672490|474437998|FG000|Overall Study|Adverse Event|5|||
131770878|NCT00672490|474437999|FG001|Overall Study|Adverse Event|8|||
131770879|NCT00672490|474437998|FG000|Overall Study|Violation of Concomitant Medicine|1|||
131770880|NCT00672490|474437999|FG001|Overall Study|Violation of Concomitant Medicine|0|||
131770881|NCT00672490|474437998|FG000|Overall Study|Intolerance|0|||
131770882|NCT00672490|474437999|FG001|Overall Study|Intolerance|2|||
131770883|NCT00672490|474437998|FG000|Overall Study|Lost to Follow-up|1|||
131770884|NCT00672490|474437999|FG001|Overall Study|Lost to Follow-up|5|||
131770885|NCT00672490|474437998|FG000|Overall Study|No reason was provided|6|||
131770886|NCT00672490|474437999|FG001|Overall Study|No reason was provided|2|||
131770887|NCT03319160|474438002|FG000|Overall Study|Data not available.|7|||
131770888|NCT01005875|474438009|FG000|Overall Study|Death|3|||
131770889|NCT02924129|474438025|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
131770890|NCT02924129|474438026|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
131770891|NCT02924129|474438025|FG000|Overall Study|Withdrawal by Subject|2|||
131770892|NCT02924129|474438026|FG001|Overall Study|Withdrawal by Subject|2|||
131770893|NCT02924129|474438025|FG000|Overall Study|Physician Decision|1|||
131770894|NCT02924129|474438026|FG001|Overall Study|Physician Decision|0|||
131770895|NCT02924129|474438025|FG000|Overall Study|Missed Visit|0|||
131770896|NCT02924129|474438026|FG001|Overall Study|Missed Visit|1|||
131770897|NCT01348828|474438030|FG000|Overall Study|Death|20|||
131770898|NCT01348828|474438030|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
131770899|NCT01348828|474438030|FG000|Overall Study|Conversion|2|||
131770900|NCT01348828|474438030|FG000|Overall Study|missed visit|1|||
131770901|NCT00302731|474438034|FG000|Overall Study|Lost to Follow-up|1|||
131770902|NCT00302731|474438035|FG001|Overall Study|Lost to Follow-up|2|||
131770903|NCT00302731|474438036|FG002|Overall Study|Lost to Follow-up|0|||
131770904|NCT00302731|474438037|FG003|Overall Study|Lost to Follow-up|0|||
131770905|NCT00302731|474438034|FG000|Overall Study|Adverse Event|0|||
131770906|NCT00302731|474438035|FG001|Overall Study|Adverse Event|2|||
131770907|NCT00302731|474438036|FG002|Overall Study|Adverse Event|2|||
131770908|NCT00302731|474438037|FG003|Overall Study|Adverse Event|0|||
131770909|NCT00302731|474438034|FG000|Overall Study|Withdrawal by Subject|1|||
131770910|NCT00302731|474438035|FG001|Overall Study|Withdrawal by Subject|1|||
131770911|NCT00302731|474438036|FG002|Overall Study|Withdrawal by Subject|0|||
131770912|NCT00302731|474438037|FG003|Overall Study|Withdrawal by Subject|0|||
131770913|NCT00302731|474438034|FG000|Overall Study|Protocol Violation|1|||
131770914|NCT00302731|474438035|FG001|Overall Study|Protocol Violation|0|||
131770915|NCT00302731|474438036|FG002|Overall Study|Protocol Violation|0|||
131770916|NCT00302731|474438037|FG003|Overall Study|Protocol Violation|0|||
131770917|NCT00302731|474438034|FG000|Overall Study|cancer unrelated to study discovered|1|||
131770918|NCT00302731|474438035|FG001|Overall Study|cancer unrelated to study discovered|0|||
131770919|NCT00302731|474438036|FG002|Overall Study|cancer unrelated to study discovered|1|||
131770920|NCT00302731|474438037|FG003|Overall Study|cancer unrelated to study discovered|0|||
131770921|NCT01000311|474438038|FG000|Overall Study|Adverse Event|2|||
131770922|NCT01000311|474438039|FG001|Overall Study|Adverse Event|5|||
131770923|NCT01000311|474438038|FG000|Overall Study|Withdrawal by Subject|16|||
131770924|NCT01000311|474438039|FG001|Overall Study|Withdrawal by Subject|24|||
131770925|NCT01000311|474438038|FG000|Overall Study|Lost to Follow-up|15|||
131770926|NCT01000311|474438039|FG001|Overall Study|Lost to Follow-up|24|||
131770927|NCT01000311|474438038|FG000|Overall Study|Protocol Violation|1|||
131770928|NCT01000311|474438039|FG001|Overall Study|Protocol Violation|2|||
131770929|NCT01000311|474438038|FG000|Overall Study|Inappropriate enrollment|2|||
131770930|NCT01000311|474438039|FG001|Overall Study|Inappropriate enrollment|0|||
131770931|NCT01000311|474438038|FG000|Overall Study|Administrative reason|9|||
131770932|NCT01000311|474438039|FG001|Overall Study|Administrative reason|15|||
131770933|NCT01610752|474438042|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
131770934|NCT01610752|474438043|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
131770935|NCT01610752|474438044|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
131770936|NCT02815670|474438045|FG000|Overall Study|Prematurely discontinued of the trial|1|||
131770937|NCT01411917|474438046|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
131770938|NCT01411917|474438047|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
131770939|NCT00242658|474438053|FG000|Overall Study|Lost to Follow-up|22|||
131770940|NCT00242658|474438054|FG001|Overall Study|Lost to Follow-up|19|||
131770941|NCT01815099|474438055|FG000|Overall Study|Lack of Efficacy|1|||
131770942|NCT01815099|474438055|FG000|Overall Study|unable to attend study visits|1|||
131770943|NCT00643851|474438056|FG000|Overall Study|Death|0|||
131770944|NCT00643851|474438057|FG001|Overall Study|Death|1|||
131770945|NCT00643851|474438058|FG002|Overall Study|Death|0|||
131770946|NCT00643851|474438056|FG000|Overall Study|Lack of Efficacy|0|||
131770947|NCT00643851|474438057|FG001|Overall Study|Lack of Efficacy|1|||
131770948|NCT00643851|474438058|FG002|Overall Study|Lack of Efficacy|0|||
131770949|NCT00643851|474438056|FG000|Overall Study|Adverse Event|2|||
131770950|NCT00643851|474438057|FG001|Overall Study|Adverse Event|6|||
131770951|NCT00643851|474438058|FG002|Overall Study|Adverse Event|6|||
131770952|NCT00643851|474438056|FG000|Overall Study|Lost to Follow-up|4|||
131770953|NCT00643851|474438057|FG001|Overall Study|Lost to Follow-up|6|||
131770954|NCT00643851|474438058|FG002|Overall Study|Lost to Follow-up|9|||
131770955|NCT00643851|474438056|FG000|Overall Study|Withdrawal by Subject|8|||
131770956|NCT00643851|474438057|FG001|Overall Study|Withdrawal by Subject|15|||
131770957|NCT00643851|474438058|FG002|Overall Study|Withdrawal by Subject|9|||
131770958|NCT00643851|474438056|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
131770959|NCT00643851|474438057|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
131770960|NCT00643851|474438058|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
131770961|NCT04806334|474438061|FG000|Overall Study|Withdrawal by Subject|1|||
131770962|NCT04557189|474438062|FG000|Overall Study|Adverse Event|0|||
131770963|NCT04557189|474438063|FG001|Overall Study|Adverse Event|1|||
131770964|NCT04557189|474438062|FG000|Overall Study|Lost to Follow-up|1|||
131770965|NCT04557189|474438063|FG001|Overall Study|Lost to Follow-up|1|||
131770966|NCT04557189|474438062|FG000|Overall Study|Withdrawal by Subject|2|||
131770967|NCT04557189|474438063|FG001|Overall Study|Withdrawal by Subject|1|||
131770968|NCT04557189|474438062|FG000|Overall Study|Reason not Specified|3|||
131770969|NCT04557189|474438063|FG001|Overall Study|Reason not Specified|6|||
131770970|NCT01731600|474438066|FG000|Overall Study|Adverse Event|2|||
131770971|NCT01731600|474438067|FG001|Overall Study|Adverse Event|0|||
131770972|NCT01731600|474438066|FG000|Overall Study|Withdrawal criteria|1|||
131770973|NCT01731600|474438067|FG001|Overall Study|Withdrawal criteria|0|||
131770974|NCT01731600|474438066|FG000|Overall Study|Other reasons|3|||
131770975|NCT01731600|474438067|FG001|Overall Study|Other reasons|0|||
131770976|NCT01190839|474438068|FG000|Overall Study|Adverse Event|32|||
131770977|NCT01190839|474438069|FG001|Overall Study|Adverse Event|41|||
131770978|NCT01190839|474438068|FG000|Overall Study|Protocol Violation|2|||
131770979|NCT01190839|474438069|FG001|Overall Study|Protocol Violation|2|||
131770980|NCT01190839|474438068|FG000|Overall Study|Lost to Follow-up|7|||
131770981|NCT01190839|474438069|FG001|Overall Study|Lost to Follow-up|1|||
131770982|NCT01190839|474438068|FG000|Overall Study|Death|1|||
131770983|NCT01190839|474438069|FG001|Overall Study|Death|0|||
131770984|NCT01190839|474438068|FG000|Overall Study|Trial stopped by Sponsor|71|||
131770985|NCT01190839|474438069|FG001|Overall Study|Trial stopped by Sponsor|68|||
131770986|NCT01190839|474438068|FG000|Overall Study|Undefined|35|||
131770987|NCT01190839|474438069|FG001|Overall Study|Undefined|31|||
131770988|NCT01190839|474438068|FG000|Overall Study|Randomized but not treated|2|||
131770989|NCT01190839|474438069|FG001|Overall Study|Randomized but not treated|4|||
131804390|NCT01029353|474568500|FG002|Overall Study|Primary Outcome Indeterminate|2|||
131804391|NCT01029353|474568501|FG003|Overall Study|Primary Outcome Indeterminate|0|||
131804392|NCT01287013|474568502|FG000|Overall Study|Non-evaluable|3|||
131804393|NCT01287013|474568503|FG001|Overall Study|Non-evaluable|5|||
131804394|NCT01287013|474568504|FG002|Overall Study|Non-evaluable|21|||
131804395|NCT00051025|474568505|FG000|Overall Study|Progressive Disease|1|||
131804396|NCT00051025|474568506|FG001|Overall Study|Progressive Disease|1|||
131804397|NCT00051025|474568505|FG000|Overall Study|Adverse Event|1|||
131804398|NCT00051025|474568506|FG001|Overall Study|Adverse Event|1|||
131804399|NCT00051025|474568505|FG000|Overall Study|Withdrawal by Subject|0|||
131804400|NCT00051025|474568506|FG001|Overall Study|Withdrawal by Subject|1|||
131804401|NCT00051025|474568505|FG000|Overall Study|Death|0|||
131804402|NCT00051025|474568506|FG001|Overall Study|Death|1|||
131804403|NCT01900730|474568507|FG000|Overall Study|Withdrawal by Subject|1|||
131804404|NCT01900730|474568508|FG001|Overall Study|Withdrawal by Subject|0|||
131804405|NCT01900730|474568507|FG000|Overall Study|Screen Failure|1|||
131804406|NCT01900730|474568508|FG001|Overall Study|Screen Failure|0|||
131804407|NCT02109042|474568509|FG000|Overall Study|Sponsor Decision|15|||
131804408|NCT03203447|474568510|FG000|Overall Study|Withdrawal by Subject|2|||
131804409|NCT03203447|474568511|FG001|Overall Study|Withdrawal by Subject|1|||
131804410|NCT03203447|474568510|FG000|Overall Study|Lost to Follow-up|1|||
131804411|NCT03203447|474568511|FG001|Overall Study|Lost to Follow-up|10|||
131804412|NCT03203447|474568510|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
131804413|NCT03203447|474568511|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
131804414|NCT02189941|474568512|FG000|Overall Study|Non-compliance|0|||
131804415|NCT02189941|474568513|FG001|Overall Study|Non-compliance|0|||
131804416|NCT02189941|474568514|FG002|Overall Study|Non-compliance|1|||
131804417|NCT00445003|474568515|FG000|Overall Study|Death|1|||
131804418|NCT00445003|474568516|FG001|Overall Study|Death|2|||
131804419|NCT00445003|474568517|FG002|Overall Study|Death|1|||
131804420|NCT00445003|474568515|FG000|Overall Study|Missed Visit|3|||
131804421|NCT00445003|474568516|FG001|Overall Study|Missed Visit|5|||
131804422|NCT00445003|474568517|FG002|Overall Study|Missed Visit|1|||
131804423|NCT00445003|474568515|FG000|Overall Study|Dropped|1|||
131804424|NCT00445003|474568516|FG001|Overall Study|Dropped|3|||
131804425|NCT00445003|474568517|FG002|Overall Study|Dropped|2|||
131888126|NCT01887678|474872361|FG000|Overall Study|Deterioration of clinical condition|0|||
131804426|NCT00528606|474568518|FG000|Overall Study|Withdrew consent|4|||
131804427|NCT00528606|474568519|FG001|Overall Study|Withdrew consent|3|||
131804428|NCT00528606|474568518|FG000|Overall Study|Lost to Follow-up|4|||
131804429|NCT00528606|474568519|FG001|Overall Study|Lost to Follow-up|1|||
131804430|NCT00528606|474568518|FG000|Overall Study|Adverse Event|3|||
131804431|NCT00528606|474568519|FG001|Overall Study|Adverse Event|0|||
131804432|NCT00528606|474568518|FG000|Overall Study|Other|2|||
131804433|NCT00528606|474568519|FG001|Overall Study|Other|0|||
131804434|NCT01196052|474568528|FG000|Overall Study|Adverse Event|9|||
131804435|NCT01196052|474568528|FG000|Overall Study|Lost to Follow-up|1|||
131804436|NCT01196052|474568528|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
131770990|NCT01945866|474440022|FG000|Overall Study|Eyes did not complete or were dropped|2|||
131770991|NCT01945866|474440023|FG001|Overall Study|Eyes did not complete or were dropped|0|||
131770992|NCT04398030|474440024|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
131770993|NCT04398030|474440025|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
131770994|NCT04398030|474440024|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
131770995|NCT04398030|474440025|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
131770996|NCT05056311|474440031|FG000|Overall Study|Lost to Follow-up|14|||
131770997|NCT05056311|474440031|FG000|Overall Study|Withdrawal by Subject|1|||
131770998|NCT05056311|474440031|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
131770999|NCT02713490|474440032|FG000|Overall Study|Withdrawal by Subject|2|||
131771000|NCT02713490|474440033|FG001|Overall Study|Withdrawal by Subject|1|||
131771001|NCT02713490|474440032|FG000|Overall Study|Did not receive study drug|1|||
131771002|NCT02713490|474440033|FG001|Overall Study|Did not receive study drug|0|||
131771003|NCT02713490|474440032|FG000|Overall Study|Met exclusion criteria|0|||
131771004|NCT02713490|474440033|FG001|Overall Study|Met exclusion criteria|1|||
131771005|NCT00346775|474440034|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
131771006|NCT00346775|474440035|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
131771007|NCT00346775|474440034|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
131771008|NCT00346775|474440035|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
131771009|NCT00346775|474440034|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
131771010|NCT00346775|474440035|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
131771011|NCT02946515|474440036|FG000|Overall Study|Lost to Follow-up|2|||
131771012|NCT02946515|474440037|FG001|Overall Study|Lost to Follow-up|1|||
131771013|NCT03799198|474440038|FG000|Overall Study|Lost to Follow-up|4|||
131771014|NCT03799198|474440039|FG001|Overall Study|Lost to Follow-up|8|||
131771015|NCT03799198|474440038|FG000|Overall Study|Death|0|||
131771016|NCT03799198|474440039|FG001|Overall Study|Death|1|||
131771017|NCT01714726|474440040|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
131771018|NCT01714726|474440041|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
131771019|NCT01714726|474440042|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
131771020|NCT01714726|474440043|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
131771021|NCT01714726|474440040|FG000|Double-Blinded Induction Period|Adverse Event|0|||
131771022|NCT01714726|474440041|FG001|Double-Blinded Induction Period|Adverse Event|1|||
131771023|NCT01714726|474440042|FG002|Double-Blinded Induction Period|Adverse Event|0|||
131771024|NCT01714726|474440043|FG003|Double-Blinded Induction Period|Adverse Event|0|||
131771025|NCT01714726|474440040|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
131771026|NCT01714726|474440041|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
131771027|NCT01714726|474440042|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
131771028|NCT01714726|474440043|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
131771029|NCT01714726|474440040|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
131771030|NCT01714726|474440041|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
131771031|NCT01714726|474440042|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
131771032|NCT01714726|474440043|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
131771033|NCT01714726|474440040|FG000|Open-Label Period|Other|0|||
131771034|NCT01714726|474440041|FG001|Open-Label Period|Other|0|||
131771035|NCT01714726|474440042|FG002|Open-Label Period|Other|1|||
131771036|NCT01714726|474440043|FG003|Open-Label Period|Other|3|||
131771037|NCT01714726|474440040|FG000|Open-Label Period|Adverse Event|0|||
131771038|NCT01714726|474440041|FG001|Open-Label Period|Adverse Event|0|||
131771039|NCT01714726|474440042|FG002|Open-Label Period|Adverse Event|1|||
131771040|NCT01714726|474440043|FG003|Open-Label Period|Adverse Event|0|||
131771041|NCT01714726|474440040|FG000|Open-Label Period|Withdrawal by Subject|0|||
131771042|NCT01714726|474440041|FG001|Open-Label Period|Withdrawal by Subject|0|||
131771043|NCT01714726|474440042|FG002|Open-Label Period|Withdrawal by Subject|9|||
131771044|NCT01714726|474440043|FG003|Open-Label Period|Withdrawal by Subject|19|||
131771045|NCT01714726|474440040|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
131771046|NCT01714726|474440041|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
131771047|NCT01714726|474440042|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
131771048|NCT01714726|474440043|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
131771049|NCT01714726|474440040|FG000|Open-Label Period|Lost to Follow-up|0|||
131771050|NCT01714726|474440041|FG001|Open-Label Period|Lost to Follow-up|0|||
131771051|NCT01714726|474440042|FG002|Open-Label Period|Lost to Follow-up|3|||
131771052|NCT01714726|474440043|FG003|Open-Label Period|Lost to Follow-up|4|||
131771053|NCT00665366|474440046|FG000|Overall Study|Lack of Efficacy|11|||
131771054|NCT00665366|474440047|FG001|Overall Study|Lack of Efficacy|10|||
131771055|NCT00665366|474440046|FG000|Overall Study|Adverse Event|25|||
131771056|NCT00665366|474440047|FG001|Overall Study|Adverse Event|23|||
131771057|NCT00665366|474440046|FG000|Overall Study|Withdrawal by Subject|11|||
131771058|NCT00665366|474440047|FG001|Overall Study|Withdrawal by Subject|14|||
131771059|NCT00665366|474440046|FG000|Overall Study|Lost to Follow-up|3|||
131771060|NCT00665366|474440047|FG001|Overall Study|Lost to Follow-up|5|||
131771061|NCT00665366|474440046|FG000|Overall Study|Poor compliance/noncompliance|3|||
131771062|NCT00665366|474440047|FG001|Overall Study|Poor compliance/noncompliance|5|||
131771063|NCT00665366|474440046|FG000|Overall Study|Pregnancy|1|||
131771064|NCT00665366|474440047|FG001|Overall Study|Pregnancy|0|||
131771065|NCT00665366|474440046|FG000|Overall Study|No longer meets study criteria|0|||
131771066|NCT00665366|474440047|FG001|Overall Study|No longer meets study criteria|1|||
131771067|NCT00665366|474440046|FG000|Overall Study|Other reasons|4|||
131771068|NCT00665366|474440047|FG001|Overall Study|Other reasons|1|||
131771069|NCT02687815|474440050|FG000|Overall Study|Lost to Follow-up|2|||
131771070|NCT02687815|474440051|FG001|Overall Study|Lost to Follow-up|4|||
131771071|NCT02687815|474440050|FG000|Overall Study|Withdrawal by Subject|2|||
131771072|NCT02687815|474440051|FG001|Overall Study|Withdrawal by Subject|4|||
131771073|NCT04177862|474440052|FG000|Overall Study|Protocol Violation|2|||
131771074|NCT04177862|474440053|FG001|Overall Study|Protocol Violation|7|||
131771075|NCT03233009|474440054|FG000|Overall Study|Lost to Follow-up|1|||
131771076|NCT00474994|474440064|FG000|Overall Study|Patient Not treated|1|||
131771077|NCT00474994|474440064|FG000|Overall Study|Patient evaluable for toxicity only|3|||
131771078|NCT00474994|474440064|FG000|Overall Study|Patient found to be ineligible|1|||
131771079|NCT00278473|474440065|FG000|Overall Study|drop out|4|||
131771080|NCT00278473|474440066|FG001|Overall Study|drop out|3|||
131771081|NCT02322866|474440068|FG000|Overall Study|Adverse Event|6|||
131771082|NCT02322866|474440069|FG001|Overall Study|Adverse Event|11|||
131771083|NCT02322866|474440068|FG000|Overall Study|Withdrawal of Consent|16|||
131771084|NCT02322866|474440069|FG001|Overall Study|Withdrawal of Consent|25|||
131771085|NCT02322866|474440068|FG000|Overall Study|Lost to Follow-up|36|||
131771086|NCT02322866|474440069|FG001|Overall Study|Lost to Follow-up|39|||
131771087|NCT02322866|474440068|FG000|Overall Study|Protocol Violation|1|||
131771088|NCT02322866|474440069|FG001|Overall Study|Protocol Violation|0|||
131771089|NCT02322866|474440068|FG000|Overall Study|Noncompliance with Treatment|3|||
131771090|NCT02322866|474440069|FG001|Overall Study|Noncompliance with Treatment|4|||
131771091|NCT02322866|474440068|FG000|Overall Study|Lack of Efficacy|3|||
131771092|NCT02322866|474440069|FG001|Overall Study|Lack of Efficacy|1|||
131771093|NCT02322866|474440068|FG000|Overall Study|Other Miscellaneous Reasons|6|||
131771094|NCT02322866|474440069|FG001|Overall Study|Other Miscellaneous Reasons|6|||
131771095|NCT06045026|474440078|FG000|Overall Study|Lost to Follow-up|60|||
131771096|NCT06045026|474440078|FG000|Overall Study|Adverse Event|12|||
131771097|NCT06045026|474440078|FG000|Overall Study|Withdrawal by Subject|3|||
131771098|NCT06045026|474440078|FG000|Overall Study|Enrollment closed|1|||
131771099|NCT01928758|474440084|FG000|Overall Study|Lost to Follow-up|14|||
131771100|NCT01928758|474440085|FG001|Overall Study|Lost to Follow-up|9|||
131771101|NCT01928758|474440084|FG000|Overall Study|Withdrawal by Subject|5|||
131771102|NCT01928758|474440085|FG001|Overall Study|Withdrawal by Subject|2|||
131771103|NCT01928758|474440084|FG000|Overall Study|Adverse Event|3|||
131771104|NCT01928758|474440085|FG001|Overall Study|Adverse Event|5|||
131771105|NCT01928758|474440084|FG000|Overall Study|Protocol Violation|3|||
131771106|NCT01928758|474440085|FG001|Overall Study|Protocol Violation|4|||
131771107|NCT00719706|474440086|FG000|Overall Study|Adverse Event|5|||
131771108|NCT00719706|474440087|FG001|Overall Study|Adverse Event|4|||
131771109|NCT00719706|474440086|FG000|Overall Study|Withdrawal by Subject|1|||
131771110|NCT00719706|474440087|FG001|Overall Study|Withdrawal by Subject|2|||
131771111|NCT00719706|474440086|FG000|Overall Study|Protocol Violation|3|||
131771112|NCT00719706|474440087|FG001|Overall Study|Protocol Violation|0|||
131771113|NCT02452320|474440088|FG000|Overall Study|Adverse Event|0|||
131771114|NCT02452320|474440089|FG001|Overall Study|Adverse Event|1|||
131771115|NCT01072175|474440090|FG000|Part A (Drug-Drug Interaction)|Death|1|||
131771116|NCT01072175|474440091|FG001|Part A (Drug-Drug Interaction)|Death|0|||
131771117|NCT01072175|474440092|FG002|Part A (Drug-Drug Interaction)|Death|0|||
131771118|NCT01072175|474440093|FG003|Part A (Drug-Drug Interaction)|Death|0|||
131771119|NCT01072175|474440094|FG004|Part A (Drug-Drug Interaction)|Death|0|||
131771120|NCT01072175|474440095|FG005|Part A (Drug-Drug Interaction)|Death|0|||
131771121|NCT01072175|474440096|FG006|Part A (Drug-Drug Interaction)|Death|0|||
131771122|NCT01072175|474440097|FG007|Part A (Drug-Drug Interaction)|Death|0|||
131771123|NCT01072175|474440098|FG008|Part A (Drug-Drug Interaction)|Death|0|||
131771124|NCT01072175|474440099|FG009|Part A (Drug-Drug Interaction)|Death|0|||
131771125|NCT01072175|474440100|FG010|Part A (Drug-Drug Interaction)|Death|0|||
131771126|NCT01072175|474440101|FG011|Part A (Drug-Drug Interaction)|Death|0|||
131771127|NCT01072175|474440102|FG012|Part A (Drug-Drug Interaction)|Death|0|||
131771128|NCT01072175|474440090|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
131771129|NCT01072175|474440091|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131888127|NCT01887678|474872362|FG001|Overall Study|Deterioration of clinical condition|4|||
131771130|NCT01072175|474440092|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131888128|NCT01887678|474872361|FG000|Overall Study|Lack of Efficacy|1|||
131888129|NCT01887678|474872362|FG001|Overall Study|Lack of Efficacy|2|||
131771131|NCT01072175|474440093|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771132|NCT01072175|474440094|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771133|NCT01072175|474440095|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771134|NCT01072175|474440096|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771135|NCT01072175|474440097|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771136|NCT01072175|474440098|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771137|NCT01072175|474440099|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771138|NCT01072175|474440100|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771139|NCT01072175|474440101|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771140|NCT01072175|474440102|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131771141|NCT01072175|474440090|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
131771142|NCT01072175|474440091|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771143|NCT01072175|474440092|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771144|NCT01072175|474440093|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771145|NCT01072175|474440094|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771146|NCT01072175|474440095|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771147|NCT01072175|474440096|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771148|NCT01072175|474440097|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771149|NCT01072175|474440098|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771150|NCT01072175|474440099|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771151|NCT01072175|474440100|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771152|NCT01072175|474440101|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771153|NCT01072175|474440102|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131771154|NCT01072175|474440090|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
131771155|NCT01072175|474440091|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
131771156|NCT01072175|474440092|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
131771157|NCT01072175|474440093|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
131771158|NCT01072175|474440094|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
131771159|NCT01072175|474440095|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
131771160|NCT01072175|474440096|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
131771161|NCT01072175|474440097|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
131771162|NCT01072175|474440098|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
131771163|NCT01072175|474440099|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
131771164|NCT01072175|474440100|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
131771165|NCT01072175|474440101|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
131771166|NCT01072175|474440102|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
131771167|NCT01072175|474440090|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771168|NCT01072175|474440091|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771169|NCT01072175|474440092|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
131771170|NCT01072175|474440093|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771171|NCT01072175|474440094|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
131771172|NCT01072175|474440095|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771173|NCT01072175|474440096|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771174|NCT01072175|474440097|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771175|NCT01072175|474440098|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771176|NCT01072175|474440099|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771177|NCT01072175|474440100|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771178|NCT01072175|474440101|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771179|NCT01072175|474440102|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131771180|NCT01072175|474440090|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771181|NCT01072175|474440091|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
131771182|NCT01072175|474440092|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771183|NCT01072175|474440093|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
131771184|NCT01072175|474440094|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
131771185|NCT01072175|474440095|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771186|NCT01072175|474440096|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771187|NCT01072175|474440097|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771188|NCT01072175|474440098|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771189|NCT01072175|474440099|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771190|NCT01072175|474440100|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771191|NCT01072175|474440101|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771192|NCT01072175|474440102|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131771193|NCT01072175|474440090|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771194|NCT01072175|474440091|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771195|NCT01072175|474440092|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
131771196|NCT01072175|474440093|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
131771197|NCT01072175|474440094|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
131771198|NCT01072175|474440095|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771199|NCT01072175|474440096|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771200|NCT01072175|474440097|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771201|NCT01072175|474440098|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771202|NCT01072175|474440099|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771203|NCT01072175|474440100|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771204|NCT01072175|474440101|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771205|NCT01072175|474440102|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131771206|NCT01072175|474440090|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771207|NCT01072175|474440091|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
131771208|NCT01072175|474440092|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771209|NCT01072175|474440093|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
131771210|NCT01072175|474440094|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
131771211|NCT01072175|474440095|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771212|NCT01072175|474440096|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771213|NCT01072175|474440097|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771214|NCT01072175|474440098|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771215|NCT01072175|474440099|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771216|NCT01072175|474440100|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771217|NCT01072175|474440101|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771218|NCT01072175|474440102|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131771219|NCT01072175|474440090|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
131771220|NCT01072175|474440091|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
131771221|NCT01072175|474440092|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
131771222|NCT01072175|474440093|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
131771223|NCT01072175|474440094|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
131771224|NCT01072175|474440095|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
131771225|NCT01072175|474440096|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
131771226|NCT01072175|474440097|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
131771227|NCT01072175|474440098|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
131771228|NCT01072175|474440099|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
131771229|NCT01072175|474440100|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
131771230|NCT01072175|474440101|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
131771231|NCT01072175|474440102|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
131771232|NCT01072175|474440090|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771233|NCT01072175|474440091|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771234|NCT01072175|474440092|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771235|NCT01072175|474440093|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771236|NCT01072175|474440094|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771237|NCT01072175|474440095|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
131771238|NCT01072175|474440096|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
131771239|NCT01072175|474440097|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
131771240|NCT01072175|474440098|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771241|NCT01072175|474440099|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771242|NCT01072175|474440100|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771243|NCT01072175|474440101|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771244|NCT01072175|474440102|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131771245|NCT01072175|474440090|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771246|NCT01072175|474440091|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771247|NCT01072175|474440092|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771248|NCT01072175|474440093|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771249|NCT01072175|474440094|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771250|NCT01072175|474440095|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771251|NCT01072175|474440096|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
131771252|NCT01072175|474440097|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
131771253|NCT01072175|474440098|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771254|NCT01072175|474440099|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771255|NCT01072175|474440100|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771256|NCT01072175|474440101|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771257|NCT01072175|474440102|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131771258|NCT01072175|474440090|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771259|NCT01072175|474440091|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771260|NCT01072175|474440092|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771261|NCT01072175|474440093|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771262|NCT01072175|474440094|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771263|NCT01072175|474440095|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
131771264|NCT01072175|474440096|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
131771265|NCT01072175|474440097|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
131771266|NCT01072175|474440098|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771267|NCT01072175|474440099|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131888130|NCT01887678|474872361|FG000|Overall Study|Non-compliance|0|||
131771268|NCT01072175|474440100|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771269|NCT01072175|474440101|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771270|NCT01072175|474440102|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131771271|NCT01072175|474440090|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771272|NCT01072175|474440091|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771273|NCT01072175|474440092|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771274|NCT01072175|474440093|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771275|NCT01072175|474440094|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771276|NCT01072175|474440095|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
131771277|NCT01072175|474440096|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
131771278|NCT01072175|474440097|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771279|NCT01072175|474440098|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771280|NCT01072175|474440099|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771281|NCT01072175|474440100|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771282|NCT01072175|474440101|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771283|NCT01072175|474440102|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131771284|NCT01072175|474440090|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771285|NCT01072175|474440091|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771286|NCT01072175|474440092|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771287|NCT01072175|474440093|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771288|NCT01072175|474440094|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771289|NCT01072175|474440095|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131550378|NCT02305381|473639214|FG000|Overall Study|Unclassified|5|||
131550379|NCT02305381|473639215|FG001|Overall Study|Unclassified|5|||
131550380|NCT02305381|473639216|FG002|Overall Study|Unclassified|7|||
131550381|NCT02487498|473639217|FG000|Period: Period 1|Adverse Event|2|||
131550382|NCT02487498|473639218|FG001|Period: Period 1|Adverse Event|4|||
131550383|NCT02487498|473639217|FG000|Period: Period 1|Subject/guardian decision|2|||
131550384|NCT02487498|473639218|FG001|Period: Period 1|Subject/guardian decision|4|||
131550385|NCT02487498|473639217|FG000|Period: Period 1|Lost to Follow-up|0|||
131550386|NCT02487498|473639218|FG001|Period: Period 1|Lost to Follow-up|2|||
131550387|NCT02487498|473639217|FG000|Period: Period 1|Lack of Efficacy|1|||
131550388|NCT02487498|473639218|FG001|Period: Period 1|Lack of Efficacy|0|||
131550389|NCT02487498|473639217|FG000|Period: Period 1|Physician Decision|0|||
131550390|NCT02487498|473639218|FG001|Period: Period 1|Physician Decision|1|||
131550391|NCT02487498|473639217|FG000|Period: Period 1|Protocol deviation|1|||
131550392|NCT02487498|473639218|FG001|Period: Period 1|Protocol deviation|0|||
131550393|NCT02487498|473639217|FG000|Period: Washout|Subject/guardian decision|0|||
131550394|NCT02487498|473639218|FG001|Period: Washout|Subject/guardian decision|5|||
131550395|NCT02487498|473639217|FG000|Period: Washout|Lack of Efficacy|1|||
131550396|NCT02487498|473639218|FG001|Period: Washout|Lack of Efficacy|1|||
131550397|NCT02487498|473639217|FG000|Period: Washout|Physician Decision|1|||
131550398|NCT02487498|473639218|FG001|Period: Washout|Physician Decision|0|||
131550399|NCT02487498|473639217|FG000|Period: Washout|Non-compliance with study treatment|0|||
131550400|NCT02487498|473639218|FG001|Period: Washout|Non-compliance with study treatment|1|||
131550401|NCT02487498|473639217|FG000|Period: Period 2|Adverse Event|2|||
131550402|NCT02487498|473639218|FG001|Period: Period 2|Adverse Event|2|||
131550403|NCT02487498|473639217|FG000|Period: Period 2|Subject/guardian decision|2|||
131550404|NCT02487498|473639218|FG001|Period: Period 2|Subject/guardian decision|1|||
131550405|NCT02487498|473639217|FG000|Period: Period 2|Lost to Follow-up|1|||
131550406|NCT02487498|473639218|FG001|Period: Period 2|Lost to Follow-up|1|||
131550407|NCT02487498|473639217|FG000|Period: Period 2|Death|0|||
131550408|NCT02487498|473639218|FG001|Period: Period 2|Death|1|||
131550409|NCT02487498|473639217|FG000|Period: Period 2|Physician Decision|1|||
131550410|NCT02487498|473639218|FG001|Period: Period 2|Physician Decision|0|||
131550411|NCT05044325|473639219|FG000|Part A:Treatment Period 1|Adverse Event|0|||
131550412|NCT05044325|473639220|FG001|Part A:Treatment Period 1|Adverse Event|0|||
131550413|NCT05044325|473639221|FG002|Part A:Treatment Period 1|Adverse Event|0|||
131550414|NCT05044325|473639222|FG003|Part A:Treatment Period 1|Adverse Event|0|||
131550415|NCT05044325|473639223|FG004|Part A:Treatment Period 1|Adverse Event|0|||
131550416|NCT05044325|473639224|FG005|Part A:Treatment Period 1|Adverse Event|1|||
131550417|NCT05044325|473639225|FG006|Part A:Treatment Period 1|Adverse Event|0|||
131550418|NCT05044325|473639226|FG007|Part A:Treatment Period 1|Adverse Event|1|||
131550419|NCT05044325|473639227|FG008|Part A:Treatment Period 1|Adverse Event|0|||
131550420|NCT05044325|473639228|FG009|Part A:Treatment Period 1|Adverse Event|0|||
131550421|NCT05044325|473639219|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131550422|NCT05044325|473639220|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131771290|NCT01072175|474440096|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771291|NCT01072175|474440097|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131550423|NCT05044325|473639221|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131550424|NCT05044325|473639222|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
131771292|NCT01072175|474440098|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
131771293|NCT01072175|474440099|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771294|NCT01072175|474440100|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771295|NCT01072175|474440101|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771296|NCT01072175|474440102|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131771297|NCT01072175|474440090|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771298|NCT01072175|474440091|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771299|NCT01072175|474440092|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771300|NCT01072175|474440093|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771301|NCT01072175|474440094|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771302|NCT01072175|474440095|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771303|NCT01072175|474440096|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771304|NCT01072175|474440097|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771305|NCT01072175|474440098|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
131771306|NCT01072175|474440099|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771307|NCT01072175|474440100|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771308|NCT01072175|474440101|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771309|NCT01072175|474440102|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131771310|NCT01072175|474440090|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771311|NCT01072175|474440091|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771312|NCT01072175|474440092|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771313|NCT01072175|474440093|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771314|NCT01072175|474440094|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771315|NCT01072175|474440095|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771316|NCT01072175|474440096|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771317|NCT01072175|474440097|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771318|NCT01072175|474440098|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
131771319|NCT01072175|474440099|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771320|NCT01072175|474440100|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771321|NCT01072175|474440101|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771322|NCT01072175|474440102|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131771323|NCT01072175|474440090|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771324|NCT01072175|474440091|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771325|NCT01072175|474440092|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771326|NCT01072175|474440093|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771327|NCT01072175|474440094|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771328|NCT01072175|474440095|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771329|NCT01072175|474440096|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771330|NCT01072175|474440097|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771331|NCT01072175|474440098|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
131771332|NCT01072175|474440099|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771333|NCT01072175|474440100|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771334|NCT01072175|474440101|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771335|NCT01072175|474440102|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131771336|NCT01072175|474440090|FG000|Part D (HPMC Capsules)|Death|0|||
131771337|NCT01072175|474440091|FG001|Part D (HPMC Capsules)|Death|0|||
131771338|NCT01072175|474440092|FG002|Part D (HPMC Capsules)|Death|0|||
131771339|NCT01072175|474440093|FG003|Part D (HPMC Capsules)|Death|0|||
131771340|NCT01072175|474440094|FG004|Part D (HPMC Capsules)|Death|0|||
131771341|NCT01072175|474440095|FG005|Part D (HPMC Capsules)|Death|0|||
131771342|NCT01072175|474440096|FG006|Part D (HPMC Capsules)|Death|0|||
131771343|NCT01072175|474440097|FG007|Part D (HPMC Capsules)|Death|0|||
131771344|NCT01072175|474440098|FG008|Part D (HPMC Capsules)|Death|0|||
131771345|NCT01072175|474440099|FG009|Part D (HPMC Capsules)|Death|10|||
131771346|NCT01072175|474440100|FG010|Part D (HPMC Capsules)|Death|12|||
131771347|NCT01072175|474440101|FG011|Part D (HPMC Capsules)|Death|28|||
131771348|NCT01072175|474440102|FG012|Part D (HPMC Capsules)|Death|26|||
131771349|NCT01072175|474440090|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
131771350|NCT01072175|474440091|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
131771351|NCT01072175|474440092|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
131771352|NCT01072175|474440093|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
131771353|NCT01072175|474440094|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
131771354|NCT01072175|474440095|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
131771355|NCT01072175|474440096|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
131771356|NCT01072175|474440097|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
131771357|NCT01072175|474440098|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
131771358|NCT01072175|474440099|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
131771359|NCT01072175|474440100|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
131771360|NCT01072175|474440101|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
131771361|NCT01072175|474440102|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
131771362|NCT01072175|474440090|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771363|NCT01072175|474440091|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771364|NCT01072175|474440092|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771365|NCT01072175|474440093|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771366|NCT01072175|474440094|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771367|NCT01072175|474440095|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771368|NCT01072175|474440096|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771369|NCT01072175|474440097|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771370|NCT01072175|474440098|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771371|NCT01072175|474440099|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131771372|NCT01072175|474440100|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
131771373|NCT01072175|474440101|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
131771374|NCT01072175|474440102|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
131771375|NCT01072175|474440090|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771376|NCT01072175|474440091|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771377|NCT01072175|474440092|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771378|NCT01072175|474440093|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771379|NCT01072175|474440094|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771380|NCT01072175|474440095|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771381|NCT01072175|474440096|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771382|NCT01072175|474440097|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771383|NCT01072175|474440098|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
131771384|NCT01072175|474440099|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
131771385|NCT01072175|474440100|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
131771386|NCT01072175|474440101|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
131771387|NCT01072175|474440102|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
131771388|NCT01072175|474440090|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771389|NCT01072175|474440091|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771390|NCT01072175|474440092|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771391|NCT01072175|474440093|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771392|NCT01072175|474440094|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771393|NCT01072175|474440095|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771394|NCT01072175|474440096|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771395|NCT01072175|474440097|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771396|NCT01072175|474440098|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771397|NCT01072175|474440099|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771398|NCT01072175|474440100|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
131771399|NCT01072175|474440101|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
131771400|NCT01072175|474440102|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131771401|NCT00351611|474440103|FG000|Overall Study|Adverse Event|11|||
131771402|NCT00351611|474440104|FG001|Overall Study|Adverse Event|3|||
131771403|NCT00351611|474440103|FG000|Overall Study|Death|1|||
131771404|NCT00351611|474440104|FG001|Overall Study|Death|0|||
131771405|NCT00351611|474440103|FG000|Overall Study|Lost to Follow-up|1|||
131771406|NCT00351611|474440104|FG001|Overall Study|Lost to Follow-up|0|||
131771407|NCT00351611|474440103|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
131771408|NCT00351611|474440104|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
131771409|NCT00351611|474440103|FG000|Overall Study|Other|1|||
131771410|NCT00351611|474440104|FG001|Overall Study|Other|0|||
131771411|NCT00351611|474440103|FG000|Overall Study|Protocol Violation|0|||
131771412|NCT00351611|474440104|FG001|Overall Study|Protocol Violation|2|||
131771413|NCT00408408|474440105|FG000|Overall Study|No follow up data|2|||
131771414|NCT00408408|474440106|FG001|Overall Study|No follow up data|3|||
131771415|NCT00408408|474440107|FG002|Overall Study|No follow up data|0|||
131771416|NCT00408408|474440108|FG003|Overall Study|No follow up data|7|||
131771417|NCT00408408|474440109|FG004|Overall Study|No follow up data|5|||
131771418|NCT00408408|474440110|FG005|Overall Study|No follow up data|3|||
131771419|NCT00267202|474440111|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
131771420|NCT00267202|474440112|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131771421|NCT00267202|474440111|FG000|Overall Study|Withdrawal by Subject|12|||
131771422|NCT00267202|474440112|FG001|Overall Study|Withdrawal by Subject|15|||
131771423|NCT00267202|474440111|FG000|Overall Study|Adverse Event|13|||
131771424|NCT00267202|474440112|FG001|Overall Study|Adverse Event|7|||
131771425|NCT00267202|474440111|FG000|Overall Study|Protocol Violation|2|||
131771426|NCT00267202|474440112|FG001|Overall Study|Protocol Violation|3|||
131771427|NCT00267202|474440111|FG000|Overall Study|Administrative problems|2|||
131771428|NCT00267202|474440112|FG001|Overall Study|Administrative problems|1|||
131771429|NCT00267202|474440111|FG000|Overall Study|Lost to Follow-up|3|||
131771430|NCT00267202|474440112|FG001|Overall Study|Lost to Follow-up|0|||
131771431|NCT00399542|474440113|FG000|Overall Study|Adverse Event|18|||
131771432|NCT00399542|474440114|FG001|Overall Study|Adverse Event|15|||
131771433|NCT00399542|474440113|FG000|Overall Study|Protocol Violation|13|||
131771434|NCT00399542|474440114|FG001|Overall Study|Protocol Violation|3|||
131771435|NCT00399542|474440113|FG000|Overall Study|Withdrawal by Subject|28|||
131771436|NCT00399542|474440114|FG001|Overall Study|Withdrawal by Subject|10|||
131771437|NCT00399542|474440113|FG000|Overall Study|Lack of Efficacy|18|||
131771438|NCT00399542|474440114|FG001|Overall Study|Lack of Efficacy|8|||
131771439|NCT00399542|474440113|FG000|Overall Study|Lost to Follow-up|6|||
131771440|NCT00399542|474440114|FG001|Overall Study|Lost to Follow-up|6|||
131771441|NCT00399542|474440113|FG000|Overall Study|Other|1|||
131771442|NCT00399542|474440114|FG001|Overall Study|Other|0|||
131771443|NCT00399542|474440113|FG000|Overall Study|Physician Decision|0|||
131771444|NCT00399542|474440114|FG001|Overall Study|Physician Decision|1|||
131771445|NCT00808665|474440115|FG000|Overall Study|Withdrawal by Subject|1|||
131771446|NCT00808665|474440116|FG001|Overall Study|Withdrawal by Subject|0|||
131771447|NCT00808665|474440115|FG000|Overall Study|only required minimally invasive surgery|1|||
131771448|NCT00808665|474440116|FG001|Overall Study|only required minimally invasive surgery|0|||
131771449|NCT00808665|474440115|FG000|Overall Study|surgery cancelled|1|||
131771450|NCT00808665|474440116|FG001|Overall Study|surgery cancelled|0|||
131771451|NCT00808665|474440115|FG000|Overall Study|required an additional procedure|0|||
131771452|NCT00808665|474440116|FG001|Overall Study|required an additional procedure|1|||
131771453|NCT00808665|474440115|FG000|Overall Study|Physician Decision|3|||
131771454|NCT00808665|474440116|FG001|Overall Study|Physician Decision|1|||
131771455|NCT00808665|474440115|FG000|Overall Study|Medication stopped by resident|0|||
131771456|NCT00808665|474440116|FG001|Overall Study|Medication stopped by resident|1|||
131771457|NCT00665002|474440117|FG000|Overall Study|Progression/relapse during treatment|11|||
131771458|NCT00665002|474440117|FG000|Overall Study|Cytogenetic resistance|1|||
131771459|NCT00496782|474440124|FG000|Overall Study|Protocol Violation|1|||
131771460|NCT00496782|474440125|FG001|Overall Study|Protocol Violation|2|||
131771461|NCT01288911|474440130|FG000|Double-blind Period|Death|11|||
131771462|NCT01288911|474440131|FG001|Double-blind Period|Death|7|||
131771463|NCT01288911|474440130|FG000|Double-blind Period|Lost to Follow-up|0|||
131771464|NCT01288911|474440131|FG001|Double-blind Period|Lost to Follow-up|2|||
131771465|NCT01288911|474440130|FG000|Double-blind Period|Progressive Disease|75|||
131771466|NCT01288911|474440131|FG001|Double-blind Period|Progressive Disease|103|||
131771467|NCT01288911|474440130|FG000|Double-blind Period|Protocol Violation|1|||
131771468|NCT01288911|474440131|FG001|Double-blind Period|Protocol Violation|0|||
131771469|NCT01288911|474440130|FG000|Double-blind Period|Withdrawal by Subject|25|||
131771470|NCT01288911|474440131|FG001|Double-blind Period|Withdrawal by Subject|26|||
131771471|NCT01288911|474440130|FG000|Double-blind Period|Miscellaneous Reason|29|||
131771472|NCT01288911|474440131|FG001|Double-blind Period|Miscellaneous Reason|42|||
131771473|NCT01288911|474440130|FG000|Double-blind Period|Randomized but never received study drug|1|||
131771474|NCT01288911|474440131|FG001|Double-blind Period|Randomized but never received study drug|2|||
131771475|NCT01288911|474440130|FG000|Open-label Period (All Enzalutamide)|Death|0|||
131771476|NCT01288911|474440131|FG001|Open-label Period (All Enzalutamide)|Death|1|||
131771477|NCT01288911|474440130|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
131771478|NCT01288911|474440131|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
131771479|NCT01288911|474440130|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
131771480|NCT01288911|474440131|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
131771481|NCT01288911|474440130|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
131771482|NCT01288911|474440131|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
131771483|NCT01288911|474440130|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
131771484|NCT01288911|474440131|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
131771485|NCT01288911|474440130|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
131771486|NCT01288911|474440131|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
131771487|NCT00606931|474440132|FG000|Overall Study|Withdrawal by Subject|3|||
131771488|NCT02354599|474440133|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131771489|NCT02354599|474440134|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131771490|NCT02354599|474440135|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131771491|NCT02354599|474440136|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
131771492|NCT02354599|474440137|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131771493|NCT02354599|474440138|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
131771494|NCT02354599|474440133|FG000|Overall Study|Withdrawal by Subject|1|||
131771495|NCT02354599|474440134|FG001|Overall Study|Withdrawal by Subject|1|||
131771496|NCT02354599|474440135|FG002|Overall Study|Withdrawal by Subject|0|||
131771497|NCT02354599|474440136|FG003|Overall Study|Withdrawal by Subject|0|||
131771498|NCT02354599|474440137|FG004|Overall Study|Withdrawal by Subject|0|||
131771499|NCT02354599|474440138|FG005|Overall Study|Withdrawal by Subject|0|||
131771500|NCT00465894|474440139|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
131771501|NCT00465894|474440140|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
131771502|NCT00465894|474440139|FG000|Treatment For 12 Weeks|Family Issues|1|||
131771503|NCT00465894|474440140|FG001|Treatment For 12 Weeks|Family Issues|1|||
131771504|NCT00465894|474440139|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
131771505|NCT00465894|474440140|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
131888131|NCT01887678|474872362|FG001|Overall Study|Non-compliance|3|||
131771506|NCT01636076|474440141|FG000|Overall Study|Terminated by sponsor|1|||
131771507|NCT01636076|474440142|FG001|Overall Study|Terminated by sponsor|1|||
131771508|NCT01636076|474440141|FG000|Overall Study|Lack of Efficacy|0|||
131771509|NCT01636076|474440142|FG001|Overall Study|Lack of Efficacy|1|||
131771510|NCT01636076|474440141|FG000|Overall Study|Lost to Follow-up|1|||
131771511|NCT01636076|474440142|FG001|Overall Study|Lost to Follow-up|0|||
131771512|NCT01636076|474440141|FG000|Overall Study|Physician Decision|1|||
131771513|NCT01636076|474440142|FG001|Overall Study|Physician Decision|1|||
131771514|NCT01636076|474440141|FG000|Overall Study|Non-compliance with study treatment|1|||
131771515|NCT01636076|474440142|FG001|Overall Study|Non-compliance with study treatment|1|||
131771516|NCT01636076|474440141|FG000|Overall Study|Adverse Event|6|||
131771517|NCT01636076|474440142|FG001|Overall Study|Adverse Event|11|||
131771518|NCT01636076|474440141|FG000|Overall Study|Withdrawal by Subject|7|||
131771519|NCT01636076|474440142|FG001|Overall Study|Withdrawal by Subject|10|||
131771520|NCT01159665|474440143|FG000|Overall Study|Withdrawal by Subject|0|||
131771521|NCT01159665|474440144|FG001|Overall Study|Withdrawal by Subject|1|||
131771522|NCT01159665|474440145|FG002|Overall Study|Withdrawal by Subject|0|||
131771523|NCT01159665|474440146|FG003|Overall Study|Withdrawal by Subject|0|||
131771524|NCT01159665|474440147|FG004|Overall Study|Withdrawal by Subject|0|||
131771525|NCT01159665|474440148|FG005|Overall Study|Withdrawal by Subject|0|||
131771526|NCT02173158|474440150|FG000|Efficacy Phase|Adverse Event|1|||
131771527|NCT01377194|474440162|FG000|Overall Study|Adverse Event|3|||
131771528|NCT01377194|474440163|FG001|Overall Study|Adverse Event|12|||
131771529|NCT01377194|474440164|FG002|Overall Study|Adverse Event|19|||
131771530|NCT01377194|474440162|FG000|Overall Study|Lack of Efficacy|3|||
131771531|NCT01377194|474440163|FG001|Overall Study|Lack of Efficacy|3|||
131771532|NCT01377194|474440164|FG002|Overall Study|Lack of Efficacy|3|||
131771533|NCT01377194|474440162|FG000|Overall Study|Protocol Violation|4|||
131771534|NCT01377194|474440163|FG001|Overall Study|Protocol Violation|10|||
131771535|NCT01377194|474440164|FG002|Overall Study|Protocol Violation|6|||
131771536|NCT01377194|474440162|FG000|Overall Study|Withdrawal by Subject|8|||
131771537|NCT01377194|474440163|FG001|Overall Study|Withdrawal by Subject|10|||
131771538|NCT01377194|474440164|FG002|Overall Study|Withdrawal by Subject|7|||
131771539|NCT01377194|474440162|FG000|Overall Study|Lost to Follow-up|14|||
131771540|NCT01377194|474440163|FG001|Overall Study|Lost to Follow-up|8|||
131771541|NCT01377194|474440164|FG002|Overall Study|Lost to Follow-up|11|||
131771542|NCT01728454|474440165|FG000|Stage 1 and 2|Pregnancy|1|||
131771543|NCT01728454|474440166|FG001|Stage 1 and 2|Pregnancy|0|||
131771544|NCT01728454|474440167|FG002|Stage 1 and 2|Pregnancy|0|||
131771545|NCT01728454|474440165|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
131771546|NCT01728454|474440166|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
131771547|NCT01728454|474440167|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
131771548|NCT01728454|474440165|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
131771549|NCT01728454|474440166|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
131771550|NCT01728454|474440167|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
131771551|NCT01728454|474440165|FG000|Stage 1 and 2|Lost to Follow-up|1|||
131771552|NCT01728454|474440166|FG001|Stage 1 and 2|Lost to Follow-up|1|||
131771553|NCT01728454|474440167|FG002|Stage 1 and 2|Lost to Follow-up|0|||
131771554|NCT01728454|474440165|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
131771555|NCT01728454|474440166|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
131771556|NCT01728454|474440167|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
131771557|NCT01728454|474440165|FG000|Stage 3|Reason Missing|0|||
131771558|NCT01728454|474440166|FG001|Stage 3|Reason Missing|0|||
131771559|NCT01728454|474440167|FG002|Stage 3|Reason Missing|1|||
131771560|NCT01728454|474440165|FG000|Stage 3|Subject Required Other Treatment|0|||
131771561|NCT01728454|474440166|FG001|Stage 3|Subject Required Other Treatment|1|||
131771562|NCT01728454|474440167|FG002|Stage 3|Subject Required Other Treatment|0|||
131771563|NCT01728454|474440165|FG000|Stage 3|Pregnancy|1|||
131771564|NCT01728454|474440166|FG001|Stage 3|Pregnancy|0|||
131771565|NCT01728454|474440167|FG002|Stage 3|Pregnancy|0|||
131771566|NCT01728454|474440165|FG000|Stage 3|Withdrew Consent|1|||
131771567|NCT01728454|474440166|FG001|Stage 3|Withdrew Consent|0|||
131771568|NCT01728454|474440167|FG002|Stage 3|Withdrew Consent|1|||
131771569|NCT01728454|474440165|FG000|Stage 3|Non-compliance with Protocol|0|||
131888132|NCT01887678|474872361|FG000|Overall Study|Specified|1|||
131888133|NCT01887678|474872362|FG001|Overall Study|Specified|2|||
131771570|NCT01728454|474440166|FG001|Stage 3|Non-compliance with Protocol|0|||
131771571|NCT01728454|474440167|FG002|Stage 3|Non-compliance with Protocol|1|||
131771572|NCT01728454|474440165|FG000|Stage 3|Lost to Follow-up|0|||
131771573|NCT01728454|474440166|FG001|Stage 3|Lost to Follow-up|3|||
131771574|NCT01728454|474440167|FG002|Stage 3|Lost to Follow-up|1|||
131771575|NCT01728454|474440165|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
131771576|NCT01728454|474440166|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
131771577|NCT01728454|474440167|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
131771578|NCT03077646|474440173|FG000|Overall Study|Lost to Follow-up|29|||
131771579|NCT03077646|474440174|FG001|Overall Study|Lost to Follow-up|30|||
131771580|NCT03077646|474440175|FG002|Overall Study|Lost to Follow-up|31|||
131771581|NCT00765726|474440176|FG000|Overall Study|Withdrawal by Subject|1|||
131771582|NCT00765726|474440176|FG000|Overall Study|Discontinuation of study by sponsor|8|||
131771583|NCT02058966|474440177|FG000|Open-Label Methamphetamine|Adverse Event|1|||
131771584|NCT02058966|474440177|FG000|First Intervention|Withdrawal by Subject|1|||
131771585|NCT02993731|474440178|FG000|Overall Study|Study Termination|101|||
131771586|NCT02993731|474440179|FG001|Overall Study|Study Termination|105|||
131771587|NCT01265511|474440180|FG000|Overall Study|Lack of Efficacy|2|||
131771588|NCT01265511|474440181|FG001|Overall Study|Lack of Efficacy|1|||
131771589|NCT01265511|474440180|FG000|Overall Study|Met stopping rules|0|||
131771590|NCT01265511|474440181|FG001|Overall Study|Met stopping rules|2|||
131771591|NCT00323479|474440182|FG000|Overall Study|Adverse Event|2|||
131771592|NCT00323479|474440182|FG000|Overall Study|Withdrawal by Subject|2|||
131771593|NCT00323479|474440182|FG000|Overall Study|Protocol Violation|3|||
131771594|NCT00323479|474440182|FG000|Overall Study|house moving|1|||
131771595|NCT01362062|474440184|FG000|Overall Study|Adverse Event|1|||
131771596|NCT01362062|474440185|FG001|Overall Study|Adverse Event|0|||
131771597|NCT01362062|474440184|FG000|Overall Study|Lost to Follow-up|11|||
131771598|NCT01362062|474440185|FG001|Overall Study|Lost to Follow-up|0|||
131771599|NCT01362062|474440184|FG000|Overall Study|Withdrawal by Subject|2|||
131771600|NCT01362062|474440185|FG001|Overall Study|Withdrawal by Subject|0|||
131771601|NCT01362062|474440184|FG000|Overall Study|Non-compliant participant|2|||
131771602|NCT01362062|474440185|FG001|Overall Study|Non-compliant participant|0|||
131771603|NCT01362062|474440184|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
131771604|NCT01362062|474440185|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
131771605|NCT01362062|474440184|FG000|Overall Study|Had significant improvement|9|||
131771606|NCT01362062|474440185|FG001|Overall Study|Had significant improvement|0|||
131771607|NCT02545504|474440186|FG000|Overall Study|Death|174|||
131771608|NCT02545504|474440187|FG001|Overall Study|Death|168|||
131771609|NCT02545504|474440186|FG000|Overall Study|Unknown reason|30|||
131771610|NCT02545504|474440187|FG001|Overall Study|Unknown reason|32|||
131771611|NCT02545504|474440186|FG000|Overall Study|Withdrew consent|9|||
131771612|NCT02545504|474440187|FG001|Overall Study|Withdrew consent|11|||
131771613|NCT02545504|474440186|FG000|Overall Study|Investigator's discretion|3|||
131771614|NCT02545504|474440187|FG001|Overall Study|Investigator's discretion|1|||
131771615|NCT02545504|474440186|FG000|Overall Study|Lost to Follow-up|2|||
131771616|NCT02545504|474440187|FG001|Overall Study|Lost to Follow-up|2|||
131771617|NCT00967343|474440189|FG000|Overall Study|Study termination by sponsor|12|||
131771618|NCT00967343|474440189|FG000|Overall Study|Death|24|||
131771619|NCT00967343|474440189|FG000|Overall Study|Relapse|1|||
131771620|NCT00967343|474440189|FG000|Overall Study|Lost to Follow-up|1|||
131771621|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
131771622|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
131771623|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
131771624|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
131771625|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
131771626|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
131771627|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
131771628|NCT00950755|474440191|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
131771629|NCT00950755|474440191|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
131771630|NCT00950755|474440191|FG000|Long-Term Follow-Up|Death|8|||
131771631|NCT00508820|474440193|FG000|Overall Study|Adverse Event|6|||
131771632|NCT00508820|474440194|FG001|Overall Study|Adverse Event|10|||
131771633|NCT00508820|474440193|FG000|Overall Study|Death|6|||
131771634|NCT00508820|474440194|FG001|Overall Study|Death|8|||
131771635|NCT00508820|474440193|FG000|Overall Study|Lost to Follow-up|1|||
131771636|NCT00508820|474440194|FG001|Overall Study|Lost to Follow-up|1|||
131771637|NCT00508820|474440193|FG000|Overall Study|Physician Decision|8|||
131771638|NCT00508820|474440194|FG001|Overall Study|Physician Decision|2|||
131771639|NCT00508820|474440193|FG000|Overall Study|Pregnancy|0|||
131771640|NCT00508820|474440194|FG001|Overall Study|Pregnancy|2|||
131771641|NCT00508820|474440193|FG000|Overall Study|Protocol Violation|2|||
131771642|NCT00508820|474440194|FG001|Overall Study|Protocol Violation|0|||
131771643|NCT00508820|474440193|FG000|Overall Study|Withdrawal by Subject|10|||
131771644|NCT00508820|474440194|FG001|Overall Study|Withdrawal by Subject|12|||
131771645|NCT00508820|474440193|FG000|Overall Study|Other|11|||
131771646|NCT00508820|474440194|FG001|Overall Study|Other|2|||
131771647|NCT00508820|474440193|FG000|Overall Study|Noncompliance|1|||
131771648|NCT00508820|474440194|FG001|Overall Study|Noncompliance|0|||
131771649|NCT00508820|474440193|FG000|Overall Study|Requirement for alternative therapy|7|||
131771650|NCT00508820|474440194|FG001|Overall Study|Requirement for alternative therapy|15|||
131771651|NCT00508820|474440193|FG000|Overall Study|Protocol-specified Criteria|3|||
131771652|NCT00508820|474440194|FG001|Overall Study|Protocol-specified Criteria|12|||
131771653|NCT01674010|474442069|FG000|Open Treatment Phase 1|Adverse Event|10|||
131771654|NCT01674010|474442070|FG001|Open Treatment Phase 1|Adverse Event|0|||
131771655|NCT01674010|474442071|FG002|Open Treatment Phase 1|Adverse Event|0|||
131888134|NCT00791492|474872363|FG000|Overall Study|Withdrawal by Subject|1|||
131771656|NCT01674010|474442069|FG000|Open Treatment Phase 1|Death|1|||
131771657|NCT01674010|474442070|FG001|Open Treatment Phase 1|Death|0|||
131435877|NCT00920855|473221886|FG002|Overall Study|Disease progression|10|||
131661924|NCT01036438|474046176|FG001|Overall Study|No effect of study treatment|1|||
131661925|NCT00888927|474046177|FG000|Overall Study|Adverse Event|0|||
131661926|NCT00888927|474046178|FG001|Overall Study|Adverse Event|0|||
131661927|NCT00888927|474046179|FG002|Overall Study|Adverse Event|0|||
131661928|NCT00888927|474046180|FG003|Overall Study|Adverse Event|1|||
131661929|NCT00888927|474046177|FG000|Overall Study|Withdrawal of consent|0|||
131661930|NCT00888927|474046178|FG001|Overall Study|Withdrawal of consent|0|||
131661931|NCT00888927|474046179|FG002|Overall Study|Withdrawal of consent|0|||
131661932|NCT00888927|474046180|FG003|Overall Study|Withdrawal of consent|1|||
131661933|NCT03702231|474046181|FG000|Overall Study|Withdrawal by Subject|1|||
131661934|NCT03702231|474046182|FG001|Overall Study|Withdrawal by Subject|0|||
131661935|NCT03702231|474046183|FG002|Overall Study|Withdrawal by Subject|0|||
131661936|NCT03702231|474046181|FG000|Overall Study|Protocol Violation|0|||
131661937|NCT03702231|474046182|FG001|Overall Study|Protocol Violation|0|||
131661938|NCT03702231|474046183|FG002|Overall Study|Protocol Violation|1|||
131661939|NCT03702231|474046181|FG000|Overall Study|Change in CLL Treatment|0|||
131661940|NCT03702231|474046182|FG001|Overall Study|Change in CLL Treatment|0|||
131661941|NCT03702231|474046183|FG002|Overall Study|Change in CLL Treatment|1|||
131661942|NCT03702231|474046181|FG000|Overall Study|COVID Pandemic|1|||
131661943|NCT03702231|474046182|FG001|Overall Study|COVID Pandemic|4|||
131661944|NCT03702231|474046183|FG002|Overall Study|COVID Pandemic|1|||
131661945|NCT03702231|474046181|FG000|Overall Study|Non-compliance|0|||
131661946|NCT03702231|474046182|FG001|Overall Study|Non-compliance|0|||
131661947|NCT03702231|474046183|FG002|Overall Study|Non-compliance|1|||
131661948|NCT03590366|474046184|FG000|Overall Study|Adverse Event|0|||
131661949|NCT03590366|474046185|FG001|Overall Study|Adverse Event|3|||
131661950|NCT03590366|474046184|FG000|Overall Study|Lost to Follow-up|3|||
131661951|NCT03590366|474046185|FG001|Overall Study|Lost to Follow-up|3|||
131661952|NCT03590366|474046184|FG000|Overall Study|Withdrawal by Subject|0|||
131661953|NCT03590366|474046185|FG001|Overall Study|Withdrawal by Subject|2|||
131661954|NCT04927247|474046188|FG000|Overall Study|Other|2|||
131661955|NCT04927247|474046189|FG001|Overall Study|Other|1|||
131661956|NCT04927247|474046188|FG000|Overall Study|Physician Decision|0|||
131661957|NCT04927247|474046189|FG001|Overall Study|Physician Decision|1|||
131661958|NCT04927247|474046188|FG000|Overall Study|Adverse Event|1|||
131661959|NCT04927247|474046189|FG001|Overall Study|Adverse Event|0|||
131661960|NCT00513305|474046193|FG000|Overall Study|Adverse Event|6|||
131661961|NCT00513305|474046194|FG001|Overall Study|Adverse Event|2|||
131661962|NCT00513305|474046193|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
131661963|NCT00513305|474046194|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
131661964|NCT00513305|474046193|FG000|Overall Study|Lack of Efficacy|8|||
131661965|NCT00513305|474046194|FG001|Overall Study|Lack of Efficacy|13|||
131661966|NCT00513305|474046193|FG000|Overall Study|Withdrawal by Subject|1|||
131661967|NCT00513305|474046194|FG001|Overall Study|Withdrawal by Subject|2|||
131661968|NCT00513305|474046193|FG000|Overall Study|Disease progression|8|||
131661969|NCT00513305|474046194|FG001|Overall Study|Disease progression|5|||
131661970|NCT00513305|474046193|FG000|Overall Study|Eligible for stem cell transplant|1|||
131661971|NCT00513305|474046194|FG001|Overall Study|Eligible for stem cell transplant|0|||
131661972|NCT00513305|474046193|FG000|Overall Study|Hematologic counts did not recover|1|||
131661973|NCT00513305|474046194|FG001|Overall Study|Hematologic counts did not recover|0|||
131661974|NCT00513305|474046193|FG000|Overall Study|Physician Decision|1|||
131661975|NCT00513305|474046194|FG001|Overall Study|Physician Decision|0|||
131661976|NCT00513305|474046193|FG000|Overall Study|Persistent hypocellularity|0|||
131661977|NCT00513305|474046194|FG001|Overall Study|Persistent hypocellularity|1|||
131661978|NCT00513305|474046193|FG000|Overall Study|Sponsor Decision|0|||
131661979|NCT00513305|474046194|FG001|Overall Study|Sponsor Decision|2|||
131661980|NCT05453201|474046206|FG000|Overall Study|Withdrawal by Subject|1|||
131661981|NCT03798691|474046207|FG000|Overall Study|Lost to Follow-up|2|||
131661982|NCT03798691|474046208|FG001|Overall Study|Lost to Follow-up|2|||
131661983|NCT02489968|474046212|FG000|Open-label Treatment Period|Adverse Event|14|||
131661984|NCT02489968|474046213|FG001|Open-label Treatment Period|Adverse Event|7|||
131661985|NCT02489968|474046214|FG002|Open-label Treatment Period|Adverse Event|0|||
131661986|NCT02489968|474046215|FG003|Open-label Treatment Period|Adverse Event|0|||
131661987|NCT02489968|474046216|FG004|Open-label Treatment Period|Adverse Event|0|||
131661988|NCT02489968|474046217|FG005|Open-label Treatment Period|Adverse Event|0|||
131661989|NCT02489968|474046212|FG000|Open-label Treatment Period|Protocol Violation|2|||
131661990|NCT02489968|474046213|FG001|Open-label Treatment Period|Protocol Violation|2|||
131661991|NCT02489968|474046214|FG002|Open-label Treatment Period|Protocol Violation|0|||
131661992|NCT02489968|474046215|FG003|Open-label Treatment Period|Protocol Violation|0|||
131661993|NCT02489968|474046216|FG004|Open-label Treatment Period|Protocol Violation|0|||
131661994|NCT02489968|474046217|FG005|Open-label Treatment Period|Protocol Violation|0|||
131661995|NCT02489968|474046212|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131661996|NCT02489968|474046213|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
131661997|NCT02489968|474046214|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
131771658|NCT01674010|474442071|FG002|Open Treatment Phase 1|Death|0|||
131771659|NCT01674010|474442069|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
131771660|NCT01674010|474442070|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
131771661|NCT01674010|474442071|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
131771662|NCT01674010|474442069|FG000|Open Treatment Phase 1|Physician Decision|9|||
131771663|NCT01674010|474442070|FG001|Open Treatment Phase 1|Physician Decision|0|||
131771664|NCT01674010|474442071|FG002|Open Treatment Phase 1|Physician Decision|0|||
131771665|NCT01674010|474442069|FG000|Open Treatment Phase 1|Protocol Violation|7|||
131771666|NCT01674010|474442070|FG001|Open Treatment Phase 1|Protocol Violation|0|||
131771667|NCT01674010|474442071|FG002|Open Treatment Phase 1|Protocol Violation|0|||
131771668|NCT01674010|474442069|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
131771669|NCT01674010|474442070|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
131771670|NCT01674010|474442071|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
131771671|NCT01674010|474442069|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
131771672|NCT01674010|474442070|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
131771673|NCT01674010|474442071|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
131771674|NCT01674010|474442069|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
131771675|NCT01674010|474442070|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
131771676|NCT01674010|474442071|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
131771677|NCT01674010|474442069|FG000|Randomization Phase 2|Adverse Event|0|||
131771678|NCT01674010|474442070|FG001|Randomization Phase 2|Adverse Event|1|||
131771679|NCT01674010|474442071|FG002|Randomization Phase 2|Adverse Event|1|||
131771680|NCT01674010|474442069|FG000|Randomization Phase 2|Lost to Follow-up|0|||
131771681|NCT01674010|474442070|FG001|Randomization Phase 2|Lost to Follow-up|1|||
131771682|NCT01674010|474442071|FG002|Randomization Phase 2|Lost to Follow-up|2|||
131771683|NCT01674010|474442069|FG000|Randomization Phase 2|Mood episode recurrence|0|||
131771684|NCT01674010|474442070|FG001|Randomization Phase 2|Mood episode recurrence|8|||
131771685|NCT01674010|474442071|FG002|Randomization Phase 2|Mood episode recurrence|2|||
131771686|NCT01674010|474442069|FG000|Randomization Phase 2|Physician Decision|0|||
131771687|NCT01674010|474442070|FG001|Randomization Phase 2|Physician Decision|0|||
131771688|NCT01674010|474442071|FG002|Randomization Phase 2|Physician Decision|2|||
131771689|NCT01674010|474442069|FG000|Randomization Phase 2|Pregnancy|0|||
131771690|NCT01674010|474442070|FG001|Randomization Phase 2|Pregnancy|1|||
131771691|NCT01674010|474442071|FG002|Randomization Phase 2|Pregnancy|1|||
131771692|NCT01674010|474442069|FG000|Randomization Phase 2|Protocol Violation|0|||
131771693|NCT01674010|474442070|FG001|Randomization Phase 2|Protocol Violation|1|||
131771694|NCT01674010|474442071|FG002|Randomization Phase 2|Protocol Violation|1|||
131771695|NCT01674010|474442069|FG000|Randomization Phase 2|Sponsor Decision|0|||
131771696|NCT01674010|474442070|FG001|Randomization Phase 2|Sponsor Decision|42|||
131771697|NCT01674010|474442071|FG002|Randomization Phase 2|Sponsor Decision|45|||
131771698|NCT01674010|474442069|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
131771699|NCT01674010|474442070|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
131771700|NCT01674010|474442071|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
131771701|NCT03159455|474442073|FG000|Overall Study|Adverse Event|0|||
131771702|NCT03159455|474442074|FG001|Overall Study|Adverse Event|0|||
131771703|NCT03159455|474442075|FG002|Overall Study|Adverse Event|0|||
131771704|NCT03159455|474442076|FG003|Overall Study|Adverse Event|0|||
131771705|NCT03159455|474442077|FG004|Overall Study|Adverse Event|0|||
131771706|NCT03159455|474442078|FG005|Overall Study|Adverse Event|1|||
131771707|NCT00960869|474442085|FG000|Overall Study|Adverse Event|17|||
131771708|NCT00960869|474442086|FG001|Overall Study|Adverse Event|26|||
131771709|NCT00960869|474442085|FG000|Overall Study|Withdrawal by Subject|16|||
131771710|NCT00960869|474442086|FG001|Overall Study|Withdrawal by Subject|14|||
131771711|NCT00960869|474442085|FG000|Overall Study|Lost to Follow-up|1|||
131771712|NCT00960869|474442086|FG001|Overall Study|Lost to Follow-up|4|||
131771713|NCT00960869|474442085|FG000|Overall Study|Misc|19|||
131771714|NCT00960869|474442086|FG001|Overall Study|Misc|18|||
131771715|NCT02501642|474442087|FG000|Overall Study|Lost to Follow-up|7|||
131771716|NCT02501642|474442088|FG001|Overall Study|Lost to Follow-up|11|||
131771717|NCT00548340|474442089|FG000|Overall Study|Protocol Violation|2|||
131771718|NCT00548340|474442090|FG001|Overall Study|Protocol Violation|3|||
131771719|NCT00548340|474442091|FG002|Overall Study|Protocol Violation|3|||
131771720|NCT00548340|474442089|FG000|Overall Study|Adverse Event|2|||
131771721|NCT00548340|474442090|FG001|Overall Study|Adverse Event|2|||
131771722|NCT00548340|474442091|FG002|Overall Study|Adverse Event|2|||
131771723|NCT00548340|474442089|FG000|Overall Study|Lost to Follow-up|1|||
131771724|NCT00548340|474442090|FG001|Overall Study|Lost to Follow-up|1|||
131771725|NCT00548340|474442091|FG002|Overall Study|Lost to Follow-up|0|||
131771726|NCT00548340|474442089|FG000|Overall Study|Withdrawal by Subject|2|||
131771727|NCT00548340|474442090|FG001|Overall Study|Withdrawal by Subject|4|||
131771728|NCT00548340|474442091|FG002|Overall Study|Withdrawal by Subject|3|||
131771729|NCT00548340|474442089|FG000|Overall Study|Other|1|||
131888135|NCT00791492|474872364|FG001|Overall Study|Withdrawal by Subject|2|||
131888136|NCT00791492|474872363|FG000|Overall Study|Liver transplantation|5|||
131888137|NCT00791492|474872364|FG001|Overall Study|Liver transplantation|1|||
131888138|NCT00076999|474872365|FG000|Overall Study|Adverse Event|2|||
131771730|NCT00548340|474442090|FG001|Overall Study|Other|1|||
131771731|NCT00548340|474442091|FG002|Overall Study|Other|1|||
131771732|NCT01096017|474442092|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
131771733|NCT01096017|474442093|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
131771734|NCT01846442|474442097|FG000|Overall Study|Adverse Event|2|||
131771735|NCT01846442|474442098|FG001|Overall Study|Adverse Event|4|||
131771736|NCT01846442|474442099|FG002|Overall Study|Adverse Event|2|||
131771737|NCT01846442|474442100|FG003|Overall Study|Adverse Event|1|||
131771738|NCT01846442|474442097|FG000|Overall Study|Lost to Follow-up|0|||
131771739|NCT01846442|474442098|FG001|Overall Study|Lost to Follow-up|0|||
131771740|NCT01846442|474442099|FG002|Overall Study|Lost to Follow-up|1|||
131771741|NCT01846442|474442100|FG003|Overall Study|Lost to Follow-up|0|||
131771742|NCT01846442|474442097|FG000|Overall Study|Withdrawal by Subject|3|||
131771743|NCT01846442|474442098|FG001|Overall Study|Withdrawal by Subject|2|||
131771744|NCT01846442|474442099|FG002|Overall Study|Withdrawal by Subject|0|||
131771745|NCT01846442|474442100|FG003|Overall Study|Withdrawal by Subject|1|||
131771746|NCT01846442|474442097|FG000|Overall Study|Left the city/Lost medication|1|||
131771747|NCT01846442|474442098|FG001|Overall Study|Left the city/Lost medication|0|||
131771748|NCT01846442|474442099|FG002|Overall Study|Left the city/Lost medication|1|||
131771749|NCT01846442|474442100|FG003|Overall Study|Left the city/Lost medication|1|||
131771750|NCT02600559|474442111|FG000|Overall Study|Withdrawal by Subject|3|||
131771751|NCT02600559|474442111|FG000|Overall Study|Lost to Follow-up|20|||
131771752|NCT01153971|474442114|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
131771753|NCT01153971|474442114|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
131771754|NCT01153971|474442114|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
131771755|NCT01153971|474442114|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
131771756|NCT01153971|474442114|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
131771757|NCT01153971|474442114|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
131771758|NCT01153971|474442114|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
131771759|NCT03410693|474442115|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
131771760|NCT03410693|474442116|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
131550425|NCT05044325|473639223|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
131550426|NCT05044325|473639224|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
131550427|NCT05044325|473639225|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131550428|NCT05044325|473639226|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131550429|NCT05044325|473639227|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131550430|NCT05044325|473639228|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131550431|NCT05044325|473639219|FG000|Part A:Treatment Period 1|Physician Decision|0|||
131550432|NCT05044325|473639220|FG001|Part A:Treatment Period 1|Physician Decision|0|||
131550433|NCT05044325|473639221|FG002|Part A:Treatment Period 1|Physician Decision|0|||
131550434|NCT05044325|473639222|FG003|Part A:Treatment Period 1|Physician Decision|0|||
131550435|NCT05044325|473639223|FG004|Part A:Treatment Period 1|Physician Decision|0|||
131550436|NCT05044325|473639224|FG005|Part A:Treatment Period 1|Physician Decision|0|||
131550437|NCT05044325|473639225|FG006|Part A:Treatment Period 1|Physician Decision|1|||
131550438|NCT05044325|473639226|FG007|Part A:Treatment Period 1|Physician Decision|0|||
131771761|NCT03410693|474442115|FG000|Overall Study|Disc trt: Lost to follow up|0|||
131771762|NCT03410693|474442116|FG001|Overall Study|Disc trt: Lost to follow up|1|||
131771763|NCT03410693|474442115|FG000|Overall Study|Disc trt: radiological progression|58|||
131771764|NCT03410693|474442116|FG001|Overall Study|Disc trt: radiological progression|50|||
131771765|NCT03410693|474442115|FG000|Overall Study|Disc trt: Other|1|||
131771766|NCT03410693|474442116|FG001|Overall Study|Disc trt: Other|0|||
131771767|NCT03410693|474442115|FG000|Overall Study|Study drug never administered|1|||
131771768|NCT03410693|474442116|FG001|Overall Study|Study drug never administered|6|||
131771769|NCT03410693|474442115|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
131888139|NCT00076999|474872366|FG001|Overall Study|Adverse Event|8|||
131888140|NCT00076999|474872367|FG002|Overall Study|Adverse Event|6|||
131888141|NCT00076999|474872368|FG003|Overall Study|Adverse Event|0|||
131888142|NCT00076999|474872369|FG004|Overall Study|Adverse Event|2|||
131888143|NCT00076999|474872365|FG000|Overall Study|Protocol Violation|0|||
131888144|NCT00076999|474872366|FG001|Overall Study|Protocol Violation|3|||
131888145|NCT00076999|474872367|FG002|Overall Study|Protocol Violation|4|||
131888146|NCT00076999|474872368|FG003|Overall Study|Protocol Violation|0|||
131888147|NCT00076999|474872369|FG004|Overall Study|Protocol Violation|9|||
131888148|NCT00076999|474872365|FG000|Overall Study|Lost to Follow-up|2|||
131888149|NCT00076999|474872366|FG001|Overall Study|Lost to Follow-up|1|||
131888150|NCT00076999|474872367|FG002|Overall Study|Lost to Follow-up|0|||
131888151|NCT00076999|474872368|FG003|Overall Study|Lost to Follow-up|0|||
131888152|NCT00076999|474872369|FG004|Overall Study|Lost to Follow-up|0|||
131888153|NCT00076999|474872365|FG000|Overall Study|Withdrawal by Subject|0|||
131888154|NCT00076999|474872366|FG001|Overall Study|Withdrawal by Subject|4|||
131888155|NCT00076999|474872367|FG002|Overall Study|Withdrawal by Subject|3|||
131550439|NCT05044325|473639227|FG008|Part A:Treatment Period 1|Physician Decision|0|||
131550440|NCT05044325|473639228|FG009|Part A:Treatment Period 1|Physician Decision|0|||
131550441|NCT05044325|473639219|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550442|NCT05044325|473639220|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550443|NCT05044325|473639221|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
131550444|NCT05044325|473639222|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550445|NCT05044325|473639223|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550446|NCT05044325|473639224|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550447|NCT05044325|473639225|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550448|NCT05044325|473639226|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550449|NCT05044325|473639227|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550450|NCT05044325|473639228|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
131550451|NCT05044325|473639219|FG000|Part A:Treatment Period 2|Adverse Event|0|||
131550452|NCT05044325|473639220|FG001|Part A:Treatment Period 2|Adverse Event|1|||
131550453|NCT05044325|473639221|FG002|Part A:Treatment Period 2|Adverse Event|0|||
131550454|NCT05044325|473639222|FG003|Part A:Treatment Period 2|Adverse Event|0|||
131550455|NCT05044325|473639223|FG004|Part A:Treatment Period 2|Adverse Event|1|||
131550456|NCT05044325|473639224|FG005|Part A:Treatment Period 2|Adverse Event|1|||
131550457|NCT05044325|473639225|FG006|Part A:Treatment Period 2|Adverse Event|0|||
131550458|NCT05044325|473639226|FG007|Part A:Treatment Period 2|Adverse Event|0|||
131550459|NCT05044325|473639227|FG008|Part A:Treatment Period 2|Adverse Event|0|||
131550460|NCT05044325|473639228|FG009|Part A:Treatment Period 2|Adverse Event|0|||
131550461|NCT05044325|473639219|FG000|Part A:Treatment Period 2|Physician Decision|0|||
131550462|NCT05044325|473639220|FG001|Part A:Treatment Period 2|Physician Decision|0|||
131550463|NCT05044325|473639221|FG002|Part A:Treatment Period 2|Physician Decision|0|||
131550464|NCT05044325|473639222|FG003|Part A:Treatment Period 2|Physician Decision|0|||
131550465|NCT05044325|473639223|FG004|Part A:Treatment Period 2|Physician Decision|0|||
131550466|NCT05044325|473639224|FG005|Part A:Treatment Period 2|Physician Decision|1|||
131550467|NCT05044325|473639225|FG006|Part A:Treatment Period 2|Physician Decision|0|||
131550468|NCT05044325|473639226|FG007|Part A:Treatment Period 2|Physician Decision|0|||
131550469|NCT05044325|473639227|FG008|Part A:Treatment Period 2|Physician Decision|0|||
131550470|NCT05044325|473639228|FG009|Part A:Treatment Period 2|Physician Decision|0|||
131550471|NCT05044325|473639219|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550472|NCT05044325|473639220|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550473|NCT05044325|473639221|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550474|NCT05044325|473639222|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
131550475|NCT05044325|473639223|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
131550476|NCT05044325|473639224|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550477|NCT05044325|473639225|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550478|NCT05044325|473639226|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550479|NCT05044325|473639227|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550480|NCT05044325|473639228|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
131550481|NCT00755222|473639229|FG000|Overall Study|Withdrawal by Subject|4|||
131550482|NCT00755222|473639230|FG001|Overall Study|Withdrawal by Subject|2|||
131550483|NCT00755222|473639229|FG000|Overall Study|Adverse Event|2|||
131550484|NCT00755222|473639230|FG001|Overall Study|Adverse Event|0|||
131550485|NCT00755222|473639229|FG000|Overall Study|Protocol Violation|2|||
131550486|NCT00755222|473639230|FG001|Overall Study|Protocol Violation|0|||
131550487|NCT02243202|473639231|FG000|Overall Study|Adverse Event|5|||
131550488|NCT02243202|473639232|FG001|Overall Study|Adverse Event|6|||
131550489|NCT02243202|473639233|FG002|Overall Study|Adverse Event|10|||
131550490|NCT02243202|473639234|FG003|Overall Study|Adverse Event|4|||
131550491|NCT02243202|473639231|FG000|Overall Study|Lost to Follow-up|9|||
131550492|NCT02243202|473639232|FG001|Overall Study|Lost to Follow-up|9|||
131550493|NCT02243202|473639233|FG002|Overall Study|Lost to Follow-up|14|||
131550494|NCT02243202|473639234|FG003|Overall Study|Lost to Follow-up|11|||
131550495|NCT02243202|473639231|FG000|Overall Study|Protocol Violation|3|||
131550496|NCT02243202|473639232|FG001|Overall Study|Protocol Violation|1|||
131550497|NCT02243202|473639233|FG002|Overall Study|Protocol Violation|2|||
131550498|NCT02243202|473639234|FG003|Overall Study|Protocol Violation|1|||
131550499|NCT02243202|473639231|FG000|Overall Study|Withdrawal by Subject|7|||
131550500|NCT02243202|473639232|FG001|Overall Study|Withdrawal by Subject|6|||
131550501|NCT02243202|473639233|FG002|Overall Study|Withdrawal by Subject|4|||
131550502|NCT02243202|473639234|FG003|Overall Study|Withdrawal by Subject|4|||
131771770|NCT03410693|474442116|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
131771771|NCT03410693|474442115|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
131771772|NCT03410693|474442116|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
131550503|NCT02243202|473639231|FG000|Overall Study|Other|1|||
131771773|NCT03410693|474442115|FG000|Overall Study|Disc trt: Physician decision|0|||
131550504|NCT02243202|473639232|FG001|Overall Study|Other|3|||
131550505|NCT02243202|473639233|FG002|Overall Study|Other|1|||
131550506|NCT02243202|473639234|FG003|Overall Study|Other|2|||
131550507|NCT02243202|473639231|FG000|Overall Study|Randomized but not received treatment|0|||
131550508|NCT02243202|473639232|FG001|Overall Study|Randomized but not received treatment|0|||
131550509|NCT02243202|473639233|FG002|Overall Study|Randomized but not received treatment|0|||
131550510|NCT02243202|473639234|FG003|Overall Study|Randomized but not received treatment|1|||
131550511|NCT04207840|473639237|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
131550512|NCT04207840|473639238|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
131550513|NCT04207840|473639239|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
131550514|NCT04207840|473639237|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
131550515|NCT04207840|473639238|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
131550516|NCT04207840|473639239|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
131550517|NCT03010462|473639243|FG000|Overall Study|Withdrawal by Subject|3|||
131550518|NCT03010462|473639244|FG001|Overall Study|Withdrawal by Subject|1|||
131550519|NCT02799472|473639245|FG000|Overall Study|Withdrawal by Subject|2|||
131550520|NCT02799472|473639246|FG001|Overall Study|Withdrawal by Subject|4|||
131550521|NCT02799472|473639245|FG000|Overall Study|Lack of Efficacy|2|||
131550522|NCT02799472|473639246|FG001|Overall Study|Lack of Efficacy|0|||
131550523|NCT02799472|473639245|FG000|Overall Study|Lost to Follow-up|0|||
131550524|NCT02799472|473639246|FG001|Overall Study|Lost to Follow-up|1|||
131550525|NCT01492686|473639249|FG000|Double-blind Phase|Adverse Event|0|||
131550526|NCT01492686|473639250|FG001|Double-blind Phase|Adverse Event|2|||
131550527|NCT01492686|473639249|FG000|Double-blind Phase|Physician Decision|0|||
131550528|NCT01492686|473639250|FG001|Double-blind Phase|Physician Decision|1|||
131550529|NCT01492686|473639249|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131550530|NCT01492686|473639250|FG001|Double-blind Phase|Withdrawal by Subject|2|||
131550531|NCT01492686|473639249|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
131550532|NCT01492686|473639250|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
131550533|NCT01492686|473639249|FG000|Open-label Phase|Adverse Event|1|||
131550534|NCT01492686|473639250|FG001|Open-label Phase|Adverse Event|2|||
131550535|NCT01492686|473639249|FG000|Open-label Phase|Physician Decision|1|||
131550536|NCT01492686|473639250|FG001|Open-label Phase|Physician Decision|0|||
131550537|NCT01492686|473639249|FG000|Open-label Phase|Withdrawal by Subject|6|||
131550538|NCT01492686|473639250|FG001|Open-label Phase|Withdrawal by Subject|7|||
131550539|NCT01492686|473639249|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
131550540|NCT01492686|473639250|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
131550541|NCT01153269|473639251|FG000|Overall Study|Withdrawal by Subject|1|||
131550542|NCT01153269|473639251|FG000|Overall Study|Antiretroviral therapy break|1|||
131550543|NCT03541044|473639252|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
131550544|NCT03541044|473639253|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
131550545|NCT03541044|473639252|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
131550546|NCT03541044|473639253|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
131550547|NCT02635724|473639264|FG000|Overall Study|Withdrawal by Subject|0|||
131550548|NCT02635724|473639265|FG001|Overall Study|Withdrawal by Subject|1|||
131550549|NCT02635724|473639266|FG002|Overall Study|Withdrawal by Subject|0|||
131550550|NCT00860067|473639267|FG000|Overall Study|Lost to Follow-up|46|||
131550551|NCT00860067|473639268|FG001|Overall Study|Lost to Follow-up|9|||
131550552|NCT00860067|473639269|FG002|Overall Study|Lost to Follow-up|9|||
131550553|NCT00860067|473639267|FG000|Overall Study|Withdrawal by Subject|4|||
131550554|NCT00860067|473639268|FG001|Overall Study|Withdrawal by Subject|0|||
131550555|NCT00860067|473639269|FG002|Overall Study|Withdrawal by Subject|0|||
131550556|NCT00860067|473639267|FG000|Overall Study|Pregnancy|1|||
131550557|NCT00860067|473639268|FG001|Overall Study|Pregnancy|0|||
131550558|NCT00860067|473639269|FG002|Overall Study|Pregnancy|0|||
131550559|NCT02424591|473639274|FG000|Overall Study|Protocol Violation|2|||
131550560|NCT02424591|473639275|FG001|Overall Study|Protocol Violation|3|||
131550561|NCT01446796|473639276|FG000|Overall Study|Withdrawal by Subject|1|||
131550562|NCT01446796|473639277|FG001|Overall Study|Withdrawal by Subject|0|||
131550563|NCT01498822|473639278|FG000|Overall Study|Protocol Violation|8|||
131550564|NCT01498822|473639279|FG001|Overall Study|Protocol Violation|4|||
131550565|NCT01498822|473639278|FG000|Overall Study|Other Reason|5|||
131550566|NCT01498822|473639279|FG001|Overall Study|Other Reason|2|||
131550567|NCT01498822|473639278|FG000|Overall Study|Lack of Efficacy|7|||
131550568|NCT01498822|473639279|FG001|Overall Study|Lack of Efficacy|2|||
131550569|NCT01498822|473639278|FG000|Overall Study|AE, non-serious non-fatal|8|||
131550570|NCT01498822|473639279|FG001|Overall Study|AE, non-serious non-fatal|17|||
131550571|NCT01498822|473639278|FG000|Overall Study|SAE, non-fatal|2|||
131550572|NCT01498822|473639279|FG001|Overall Study|SAE, non-fatal|2|||
131550573|NCT01498822|473639278|FG000|Overall Study|Adverse Event, serious fatal|1|||
131550574|NCT01498822|473639279|FG001|Overall Study|Adverse Event, serious fatal|1|||
131550575|NCT01498822|473639278|FG000|Overall Study|Withdrawal by Subject|15|||
131550576|NCT01498822|473639279|FG001|Overall Study|Withdrawal by Subject|25|||
131550577|NCT01498822|473639278|FG000|Overall Study|Lost to Follow-up|8|||
131550578|NCT01498822|473639279|FG001|Overall Study|Lost to Follow-up|3|||
131550579|NCT01674621|473639284|FG000|Overall Study|Adverse Event|3|||
131771774|NCT03410693|474442116|FG001|Overall Study|Disc trt: Physician decision|5|||
131550580|NCT01674621|473639285|FG001|Overall Study|Adverse Event|2|||
131550581|NCT01674621|473639286|FG002|Overall Study|Adverse Event|5|||
131550582|NCT01674621|473639287|FG003|Overall Study|Adverse Event|5|||
131550583|NCT01674621|473639288|FG004|Overall Study|Adverse Event|1|||
131550584|NCT01674621|473639284|FG000|Overall Study|Inability to Complete Study Procedures|0|||
131550585|NCT01674621|473639285|FG001|Overall Study|Inability to Complete Study Procedures|0|||
131550586|NCT01674621|473639286|FG002|Overall Study|Inability to Complete Study Procedures|0|||
131550587|NCT01674621|473639287|FG003|Overall Study|Inability to Complete Study Procedures|0|||
131550588|NCT01674621|473639288|FG004|Overall Study|Inability to Complete Study Procedures|2|||
131550589|NCT01674621|473639284|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
131550590|NCT01674621|473639285|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
131550591|NCT01674621|473639286|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
131550592|NCT01674621|473639287|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
131550593|NCT01674621|473639288|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
131550594|NCT01674621|473639284|FG000|Overall Study|Withdrawal by Subject|2|||
131550595|NCT01674621|473639285|FG001|Overall Study|Withdrawal by Subject|5|||
131550596|NCT01674621|473639286|FG002|Overall Study|Withdrawal by Subject|2|||
131550597|NCT01674621|473639287|FG003|Overall Study|Withdrawal by Subject|0|||
131550598|NCT01674621|473639288|FG004|Overall Study|Withdrawal by Subject|1|||
131550599|NCT01674621|473639284|FG000|Overall Study|Other than specified|0|||
131550600|NCT01674621|473639285|FG001|Overall Study|Other than specified|1|||
131550601|NCT01674621|473639286|FG002|Overall Study|Other than specified|0|||
131550602|NCT01674621|473639287|FG003|Overall Study|Other than specified|0|||
131550603|NCT01674621|473639288|FG004|Overall Study|Other than specified|2|||
131550604|NCT01148862|473639291|FG000|Second Intervention|Withdrawal by Subject|0|||
131550605|NCT01148862|473639292|FG001|Second Intervention|Withdrawal by Subject|2|||
131550606|NCT01597505|473639296|FG000|Overall Study|Physician Decision|5|||
131550607|NCT01597505|473639297|FG001|Overall Study|Physician Decision|0|||
131550608|NCT01597505|473639296|FG000|Overall Study|Adverse Event|19|||
131550609|NCT01597505|473639297|FG001|Overall Study|Adverse Event|7|||
131550610|NCT01597505|473639296|FG000|Overall Study|Lost to Follow-up|4|||
131550611|NCT01597505|473639297|FG001|Overall Study|Lost to Follow-up|2|||
131550612|NCT01597505|473639296|FG000|Overall Study|Withdrawal by Subject|10|||
131550613|NCT01597505|473639297|FG001|Overall Study|Withdrawal by Subject|18|||
131550614|NCT01597505|473639296|FG000|Overall Study|Other|5|||
131550615|NCT01597505|473639297|FG001|Overall Study|Other|6|||
131550616|NCT01597505|473639296|FG000|Overall Study|Missing|1|||
131550617|NCT01597505|473639297|FG001|Overall Study|Missing|0|||
131550618|NCT05454410|473639298|FG000|Overall Study|Withdrawal by Subject|0|||
131550619|NCT05454410|473639299|FG001|Overall Study|Withdrawal by Subject|0|||
131550620|NCT05454410|473639300|FG002|Overall Study|Withdrawal by Subject|1|||
131550621|NCT05454410|473639301|FG003|Overall Study|Withdrawal by Subject|1|||
131550622|NCT05004688|473639312|FG000|Overall Study|Protocol Violation|7|||
131550623|NCT05004688|473639312|FG000|Overall Study|Physician Decision|2|||
131550624|NCT05004688|473639312|FG000|Overall Study|Withdrawal by Subject|2|||
131550625|NCT00895622|473639313|FG000|Overall Study|Protocol Violation|5|||
131550626|NCT00895622|473639314|FG001|Overall Study|Protocol Violation|4|||
131550627|NCT00895622|473639315|FG002|Overall Study|Protocol Violation|4|||
131550628|NCT00733980|473639318|FG000|Overall Study|Adverse Event|5|||
131550629|NCT00733980|473639319|FG001|Overall Study|Adverse Event|2|||
131550630|NCT00733980|473639318|FG000|Overall Study|Lack of Efficacy|0|||
131550631|NCT00733980|473639319|FG001|Overall Study|Lack of Efficacy|1|||
131550632|NCT00733980|473639318|FG000|Overall Study|Protocol Violation|2|||
131550633|NCT00733980|473639319|FG001|Overall Study|Protocol Violation|1|||
131550634|NCT00733980|473639318|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
131550635|NCT00733980|473639319|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
131550636|NCT00733980|473639318|FG000|Overall Study|Lost to Follow-up|6|||
131550637|NCT00733980|473639319|FG001|Overall Study|Lost to Follow-up|11|||
131550638|NCT00733980|473639318|FG000|Overall Study|Physician Decision|2|||
131550639|NCT00733980|473639319|FG001|Overall Study|Physician Decision|3|||
131550640|NCT00733980|473639318|FG000|Overall Study|Withdrawal by Subject|6|||
131550641|NCT00733980|473639319|FG001|Overall Study|Withdrawal by Subject|2|||
131550642|NCT00779779|473639322|FG000|Overall Study|Adverse Event|1|||
131550643|NCT00779779|473639322|FG000|Overall Study|Protocol Violation|14|||
131550644|NCT00779779|473639322|FG000|Overall Study|Withdrawal by Subject|4|||
131550645|NCT00779779|473639322|FG000|Overall Study|Lost to Follow-up|5|||
131550646|NCT02552238|473639323|FG000|Overall Study|Withdrawal by Subject|2|||
131550647|NCT02552238|473639323|FG000|Overall Study|Adverse Event|2|||
131550648|NCT05158296|473639326|FG000|Overall Study|Sponsor Decision|2|||
131550649|NCT05158296|473639327|FG001|Overall Study|Sponsor Decision|3|||
131550650|NCT05158296|473639328|FG002|Overall Study|Sponsor Decision|2|||
131550651|NCT02036645|473639331|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550652|NCT02036645|473639332|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550653|NCT02036645|473639333|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550654|NCT02036645|473639334|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131661998|NCT02489968|474046215|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
131661999|NCT02489968|474046216|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
131662000|NCT02489968|474046217|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
131662001|NCT02489968|474046212|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
131662002|NCT02489968|474046213|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
131550655|NCT02036645|473639335|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550656|NCT02036645|473639336|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550657|NCT02036645|473639337|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
131550658|NCT02036645|473639338|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550659|NCT02036645|473639339|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550660|NCT02036645|473639340|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550661|NCT02036645|473639341|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550662|NCT02036645|473639342|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
131550663|NCT02036645|473639331|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550664|NCT02036645|473639332|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550665|NCT02036645|473639333|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550666|NCT02036645|473639334|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
131550667|NCT02036645|473639335|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550668|NCT02036645|473639336|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550669|NCT02036645|473639337|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550670|NCT02036645|473639338|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550671|NCT02036645|473639339|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550672|NCT02036645|473639340|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550673|NCT02036645|473639341|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550674|NCT02036645|473639342|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
131550675|NCT02010632|473639346|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
131550676|NCT02010632|473639347|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
131550677|NCT02404389|473639349|FG000|Overall Study|Adverse Event|1|||
131550678|NCT02404389|473639350|FG001|Overall Study|Adverse Event|0|||
131550679|NCT02404389|473639351|FG002|Overall Study|Adverse Event|1|||
131550680|NCT02404389|473639352|FG003|Overall Study|Adverse Event|0|||
131550681|NCT02404389|473639353|FG004|Overall Study|Adverse Event|2|||
131550682|NCT02404389|473639349|FG000|Overall Study|Subject/guardian decision|1|||
131550683|NCT02404389|473639350|FG001|Overall Study|Subject/guardian decision|0|||
131550684|NCT02404389|473639351|FG002|Overall Study|Subject/guardian decision|0|||
131550685|NCT02404389|473639352|FG003|Overall Study|Subject/guardian decision|1|||
131550686|NCT02404389|473639353|FG004|Overall Study|Subject/guardian decision|1|||
131550687|NCT00652938|473639357|FG000|Overall Study|Adverse Event|1|||
131550688|NCT00652938|473639358|FG001|Overall Study|Adverse Event|0|||
131550689|NCT00652938|473639359|FG002|Overall Study|Adverse Event|2|||
131550690|NCT00652938|473639357|FG000|Overall Study|Withdrawal by Subject|0|||
131550691|NCT00652938|473639358|FG001|Overall Study|Withdrawal by Subject|6|||
131550692|NCT00652938|473639359|FG002|Overall Study|Withdrawal by Subject|1|||
131550693|NCT00652938|473639357|FG000|Overall Study|Lost to Follow-up|0|||
131550694|NCT00652938|473639358|FG001|Overall Study|Lost to Follow-up|0|||
131550695|NCT00652938|473639359|FG002|Overall Study|Lost to Follow-up|2|||
131550696|NCT00652938|473639357|FG000|Overall Study|fear of blood sampling|0|||
131550697|NCT00652938|473639358|FG001|Overall Study|fear of blood sampling|1|||
131550698|NCT00652938|473639359|FG002|Overall Study|fear of blood sampling|0|||
131550699|NCT03324880|473639360|FG000|Overall Study|Adverse Event|0|||
131550700|NCT03324880|473639361|FG001|Overall Study|Adverse Event|2|||
131550701|NCT03324880|473639360|FG000|Overall Study|Withdrawal by Subject|2|||
131550702|NCT03324880|473639361|FG001|Overall Study|Withdrawal by Subject|2|||
131550703|NCT03324880|473639360|FG000|Overall Study|Lost to Follow-up|0|||
131550704|NCT03324880|473639361|FG001|Overall Study|Lost to Follow-up|1|||
131550705|NCT03324880|473639360|FG000|Overall Study|Product Recall|0|||
131550706|NCT03324880|473639361|FG001|Overall Study|Product Recall|1|||
131550707|NCT01412801|473639362|FG000|Overall Study|Death|0|||
131550708|NCT01412801|473639363|FG001|Overall Study|Death|1|||
131550709|NCT01412801|473639364|FG002|Overall Study|Death|0|||
131550710|NCT01412801|473639365|FG003|Overall Study|Death|4|||
131550711|NCT01412801|473639366|FG004|Overall Study|Death|2|||
131550712|NCT01412801|473639367|FG005|Overall Study|Death|2|||
131550713|NCT01412801|473639362|FG000|Overall Study|Lost to Follow-up|1|||
131550714|NCT01412801|473639363|FG001|Overall Study|Lost to Follow-up|2|||
131550715|NCT01412801|473639364|FG002|Overall Study|Lost to Follow-up|4|||
131550716|NCT01412801|473639365|FG003|Overall Study|Lost to Follow-up|0|||
131550717|NCT01412801|473639366|FG004|Overall Study|Lost to Follow-up|1|||
131550718|NCT01412801|473639367|FG005|Overall Study|Lost to Follow-up|1|||
131550719|NCT01412801|473639362|FG000|Overall Study|Withdrawal by Subject|3|||
131550720|NCT01412801|473639363|FG001|Overall Study|Withdrawal by Subject|2|||
131550721|NCT01412801|473639364|FG002|Overall Study|Withdrawal by Subject|1|||
131550722|NCT01412801|473639365|FG003|Overall Study|Withdrawal by Subject|0|||
131550723|NCT01412801|473639366|FG004|Overall Study|Withdrawal by Subject|0|||
131550724|NCT01412801|473639367|FG005|Overall Study|Withdrawal by Subject|0|||
131550725|NCT01412801|473639362|FG000|Overall Study|Relocated to another area|0|||
131550726|NCT01412801|473639363|FG001|Overall Study|Relocated to another area|0|||
131550727|NCT01412801|473639364|FG002|Overall Study|Relocated to another area|2|||
131550728|NCT01412801|473639365|FG003|Overall Study|Relocated to another area|0|||
131550729|NCT01412801|473639366|FG004|Overall Study|Relocated to another area|0|||
131550730|NCT01412801|473639367|FG005|Overall Study|Relocated to another area|0|||
131550731|NCT00116272|473639368|FG000|Overall Study|Lost to Follow-up|11|||
131550732|NCT00116272|473639369|FG001|Overall Study|Lost to Follow-up|6|||
131550733|NCT01547299|473639372|FG000|Overall Study|Withdrawal by Subject|2|||
131550734|NCT01547299|473639373|FG001|Overall Study|Withdrawal by Subject|2|||
131550735|NCT01576718|473639374|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
131550736|NCT01576718|473639375|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131550737|NCT01576718|473639376|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131550738|NCT01576718|473639377|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131550739|NCT01576718|473639378|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131550740|NCT01576718|473639379|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131550741|NCT01576718|473639380|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131550742|NCT01576718|473639374|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
131550743|NCT01576718|473639375|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131550744|NCT01576718|473639376|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131550745|NCT01576718|473639377|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131550746|NCT01576718|473639378|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131550747|NCT01576718|473639379|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131550748|NCT01576718|473639380|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131550749|NCT01576718|473639374|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
131550750|NCT01576718|473639375|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131550751|NCT01576718|473639376|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131550752|NCT01576718|473639377|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131550753|NCT01576718|473639378|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131550754|NCT01576718|473639379|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131550755|NCT01576718|473639380|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131550756|NCT01576718|473639374|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
131550757|NCT01576718|473639375|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131550758|NCT01576718|473639376|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131550759|NCT01576718|473639377|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131550760|NCT01576718|473639378|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131550761|NCT01576718|473639379|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131550762|NCT01576718|473639380|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131550763|NCT01576718|473639374|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
131550764|NCT01576718|473639375|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131550765|NCT01576718|473639376|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131550766|NCT01576718|473639377|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131550767|NCT01576718|473639378|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131550768|NCT01576718|473639379|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131550769|NCT01576718|473639380|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131550770|NCT01576718|473639374|FG000|Treatment Period|Adverse Event|0|||
131550771|NCT01576718|473639375|FG001|Treatment Period|Adverse Event|1|||
131550772|NCT01576718|473639376|FG002|Treatment Period|Adverse Event|1|||
131550773|NCT01576718|473639377|FG003|Treatment Period|Adverse Event|1|||
131550774|NCT01576718|473639378|FG004|Treatment Period|Adverse Event|1|||
131550775|NCT01576718|473639379|FG005|Treatment Period|Adverse Event|1|||
131550776|NCT01576718|473639380|FG006|Treatment Period|Adverse Event|0|||
131550777|NCT01576718|473639374|FG000|Treatment Period|Withdrawal by Subject|0|||
131550778|NCT01576718|473639375|FG001|Treatment Period|Withdrawal by Subject|1|||
131550779|NCT01576718|473639376|FG002|Treatment Period|Withdrawal by Subject|1|||
131550780|NCT01576718|473639377|FG003|Treatment Period|Withdrawal by Subject|0|||
131550781|NCT01576718|473639378|FG004|Treatment Period|Withdrawal by Subject|2|||
131550782|NCT01576718|473639379|FG005|Treatment Period|Withdrawal by Subject|4|||
131550783|NCT01576718|473639380|FG006|Treatment Period|Withdrawal by Subject|2|||
131550784|NCT01576718|473639374|FG000|Treatment Period|Physician Decision|0|||
131550785|NCT01576718|473639375|FG001|Treatment Period|Physician Decision|1|||
131550786|NCT01576718|473639376|FG002|Treatment Period|Physician Decision|1|||
131550787|NCT01576718|473639377|FG003|Treatment Period|Physician Decision|1|||
131550788|NCT01576718|473639378|FG004|Treatment Period|Physician Decision|1|||
131550789|NCT01576718|473639379|FG005|Treatment Period|Physician Decision|0|||
131550790|NCT01576718|473639380|FG006|Treatment Period|Physician Decision|0|||
131550791|NCT01576718|473639374|FG000|Treatment Period|Protocol Violation|0|||
131550792|NCT01576718|473639375|FG001|Treatment Period|Protocol Violation|5|||
131550793|NCT01576718|473639376|FG002|Treatment Period|Protocol Violation|4|||
131550794|NCT01576718|473639377|FG003|Treatment Period|Protocol Violation|10|||
131550795|NCT01576718|473639378|FG004|Treatment Period|Protocol Violation|6|||
131550796|NCT01576718|473639379|FG005|Treatment Period|Protocol Violation|8|||
131550797|NCT01576718|473639380|FG006|Treatment Period|Protocol Violation|12|||
131550798|NCT01576718|473639374|FG000|Treatment Period|Sponsor request|0|||
131550799|NCT01576718|473639375|FG001|Treatment Period|Sponsor request|1|||
131550800|NCT01576718|473639376|FG002|Treatment Period|Sponsor request|0|||
131550801|NCT01576718|473639377|FG003|Treatment Period|Sponsor request|0|||
131550802|NCT01576718|473639378|FG004|Treatment Period|Sponsor request|0|||
131550803|NCT01576718|473639379|FG005|Treatment Period|Sponsor request|1|||
131550804|NCT01576718|473639380|FG006|Treatment Period|Sponsor request|0|||
131550805|NCT01576718|473639374|FG000|Treatment Period|Met stopping criteria|0|||
131550806|NCT01576718|473639375|FG001|Treatment Period|Met stopping criteria|16|||
131550807|NCT01576718|473639376|FG002|Treatment Period|Met stopping criteria|13|||
131550808|NCT01576718|473639377|FG003|Treatment Period|Met stopping criteria|19|||
131550809|NCT01576718|473639378|FG004|Treatment Period|Met stopping criteria|16|||
131550810|NCT01576718|473639379|FG005|Treatment Period|Met stopping criteria|33|||
131550811|NCT01576718|473639380|FG006|Treatment Period|Met stopping criteria|15|||
131550812|NCT01576718|473639374|FG000|Treatment Period|Lost to Follow-up|0|||
131550813|NCT01576718|473639375|FG001|Treatment Period|Lost to Follow-up|0|||
131550814|NCT01576718|473639376|FG002|Treatment Period|Lost to Follow-up|0|||
131550815|NCT01576718|473639377|FG003|Treatment Period|Lost to Follow-up|0|||
131550816|NCT01576718|473639378|FG004|Treatment Period|Lost to Follow-up|1|||
131550817|NCT01576718|473639379|FG005|Treatment Period|Lost to Follow-up|0|||
131550818|NCT01576718|473639380|FG006|Treatment Period|Lost to Follow-up|0|||
131550819|NCT01576718|473639374|FG000|Treatment Period|Noncompliance to study medication|0|||
131550820|NCT01576718|473639375|FG001|Treatment Period|Noncompliance to study medication|0|||
131550821|NCT01576718|473639376|FG002|Treatment Period|Noncompliance to study medication|0|||
131550822|NCT01576718|473639377|FG003|Treatment Period|Noncompliance to study medication|0|||
131550823|NCT01576718|473639378|FG004|Treatment Period|Noncompliance to study medication|0|||
131550824|NCT01576718|473639379|FG005|Treatment Period|Noncompliance to study medication|1|||
131550825|NCT01576718|473639380|FG006|Treatment Period|Noncompliance to study medication|1|||
131550826|NCT06387472|473639387|FG000|Overall Study|Withdrawal by Subject|1|||
131550827|NCT06387472|473639387|FG000|Overall Study|Lost to Follow-up|2|||
131550828|NCT06387472|473639387|FG000|Overall Study|Physician Decision|1|||
131550829|NCT00045708|473641782|FG000|Phase 1|early progressive disease|0|||
131550830|NCT00045708|473641783|FG001|Phase 1|early progressive disease|1|||
131550831|NCT00045708|473641784|FG002|Phase 1|early progressive disease|0|||
131550832|NCT03237858|473641788|FG000|Overall Study|Death|19|||
131550833|NCT03237858|473641788|FG000|Overall Study|Withdrawal by Subject|37|||
131550834|NCT01862991|473641790|FG000|Overall Study|Lost to Follow-up|2|||
131550835|NCT01862991|473641791|FG001|Overall Study|Lost to Follow-up|1|||
131550836|NCT01862991|473641792|FG002|Overall Study|Lost to Follow-up|1|||
131550837|NCT01862991|473641790|FG000|Overall Study|Protocol Violation|1|||
131550838|NCT01862991|473641791|FG001|Overall Study|Protocol Violation|0|||
131550839|NCT01862991|473641792|FG002|Overall Study|Protocol Violation|0|||
131550840|NCT04858802|473641793|FG000|Overall Study|Lost to Follow-up|1|||
131550841|NCT04858802|473641794|FG001|Overall Study|Lost to Follow-up|1|||
131550842|NCT04858802|473641793|FG000|Overall Study|Withdrawal by Subject|1|||
131550843|NCT04858802|473641794|FG001|Overall Study|Withdrawal by Subject|1|||
131550844|NCT01108458|473641795|FG000|Overall Study|Withdrawal by Subject|1|||
131550845|NCT03328143|473641800|FG000|Overall Study|Declined|3|||
131550846|NCT03328143|473641800|FG000|Overall Study|Required increased sedation|4|||
131550847|NCT03328143|473641800|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
131550848|NCT03328143|473641800|FG000|Overall Study|Surgery cancelled|1|||
131550849|NCT02013388|473641808|FG000|Overall Study|work emergency|1|||
131550850|NCT02013388|473641809|FG001|Overall Study|work emergency|0|||
131550851|NCT02013388|473641810|FG002|Overall Study|work emergency|0|||
131550852|NCT02013388|473641811|FG003|Overall Study|work emergency|0|||
131550853|NCT02013388|473641812|FG004|Overall Study|work emergency|1|||
131550854|NCT02013388|473641813|FG005|Overall Study|work emergency|0|||
131550855|NCT02013388|473641814|FG006|Overall Study|work emergency|0|||
131550856|NCT02013388|473641815|FG007|Overall Study|work emergency|0|||
131550857|NCT03243422|473641816|FG000|Overall Study|Death|20|||
131550858|NCT03243422|473641817|FG001|Overall Study|Death|21|||
131550859|NCT03243422|473641816|FG000|Overall Study|Lost to Follow-up|9|||
131550860|NCT03243422|473641817|FG001|Overall Study|Lost to Follow-up|21|||
131550861|NCT03243422|473641816|FG000|Overall Study|Withdrawal by Subject|22|||
131550862|NCT03243422|473641817|FG001|Overall Study|Withdrawal by Subject|8|||
131550863|NCT02173054|473641818|FG000|Overall Study|lack of compliance|1|||
131550864|NCT02173054|473641819|FG001|Overall Study|lack of compliance|0|||
131550865|NCT02173054|473641820|FG002|Overall Study|lack of compliance|0|||
131550866|NCT02173054|473641818|FG000|Overall Study|Withdrawal by Subject|0|||
131550867|NCT02173054|473641819|FG001|Overall Study|Withdrawal by Subject|0|||
131550868|NCT02173054|473641820|FG002|Overall Study|Withdrawal by Subject|1|||
131550869|NCT01559454|473641821|FG000|Overall Study|Lost to Follow-up|3|||
131550870|NCT01559454|473641822|FG001|Overall Study|Lost to Follow-up|2|||
131550871|NCT01559454|473641821|FG000|Overall Study|Withdrawal by Subject|0|||
131550872|NCT01559454|473641822|FG001|Overall Study|Withdrawal by Subject|1|||
131550873|NCT01559454|473641821|FG000|Overall Study|Physician Decision|0|||
131550874|NCT01559454|473641822|FG001|Overall Study|Physician Decision|1|||
131550875|NCT01559454|473641821|FG000|Overall Study|Protocol Violation|0|||
131550876|NCT01559454|473641822|FG001|Overall Study|Protocol Violation|1|||
131550877|NCT01559454|473641821|FG000|Overall Study|Lack of Efficacy|0|||
131550878|NCT01559454|473641822|FG001|Overall Study|Lack of Efficacy|1|||
131550879|NCT00991341|473641829|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
131550880|NCT00991341|473641830|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
131550881|NCT00991341|473641829|FG000|Overall Study|Death|3|||
131550882|NCT00991341|473641830|FG001|Overall Study|Death|0|||
131550883|NCT00991341|473641829|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
131550884|NCT00991341|473641830|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
131550885|NCT00991341|473641829|FG000|Overall Study|Physician Decision|1|||
131550886|NCT00991341|473641830|FG001|Overall Study|Physician Decision|2|||
131550887|NCT00991341|473641829|FG000|Overall Study|Withdrawal by Subject|3|||
131550888|NCT00991341|473641830|FG001|Overall Study|Withdrawal by Subject|4|||
131550889|NCT01330316|473641846|FG000|Overall Study|Adverse Event|2|||
131550890|NCT01330316|473641847|FG001|Overall Study|Adverse Event|2|||
131550891|NCT01330316|473641846|FG000|Overall Study|Lack of Efficacy|0|||
131550892|NCT01330316|473641847|FG001|Overall Study|Lack of Efficacy|10|||
131550893|NCT01330316|473641846|FG000|Overall Study|Lost to Follow-up|0|||
131550894|NCT01330316|473641847|FG001|Overall Study|Lost to Follow-up|1|||
131550895|NCT01330316|473641846|FG000|Overall Study|Withdrawal by Subject|0|||
131550896|NCT01330316|473641847|FG001|Overall Study|Withdrawal by Subject|1|||
131550897|NCT01330316|473641846|FG000|Overall Study|other than above|0|||
131550898|NCT01330316|473641847|FG001|Overall Study|other than above|1|||
131550899|NCT00215540|473641848|FG000|Overall Study|Withdrew from study medication|1|||
131550900|NCT00215540|473641849|FG001|Overall Study|Withdrew from study medication|0|||
131550901|NCT00215540|473641850|FG002|Overall Study|Withdrew from study medication|0|||
131550902|NCT03145766|473641851|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
131550903|NCT03145766|473641852|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
131550904|NCT03145766|473641853|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
131550905|NCT03145766|473641854|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
131550906|NCT03145766|473641855|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
131550907|NCT03145766|473641851|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
131550908|NCT03145766|473641852|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
131550909|NCT03145766|473641853|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
131550910|NCT03145766|473641854|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
131550911|NCT03145766|473641855|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
131550912|NCT03145766|473641851|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
131550913|NCT03145766|473641852|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
131550914|NCT03145766|473641853|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
131550915|NCT03145766|473641854|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
131550916|NCT03145766|473641855|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
131550917|NCT03145766|473641851|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
131550918|NCT03145766|473641852|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
131550919|NCT03145766|473641853|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
131550920|NCT03145766|473641854|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
131550921|NCT03145766|473641855|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
131550922|NCT03145766|473641851|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
131550923|NCT03145766|473641852|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
131550924|NCT03145766|473641853|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
131550925|NCT03145766|473641854|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
131550926|NCT03145766|473641855|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
131550927|NCT03145766|473641851|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
131550928|NCT03145766|473641852|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
131550929|NCT03145766|473641853|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
131550930|NCT03145766|473641854|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
131550931|NCT03145766|473641855|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
131550932|NCT03145766|473641851|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
131550933|NCT03145766|473641852|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
131550934|NCT03145766|473641853|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
131550935|NCT03145766|473641854|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
131550936|NCT03145766|473641855|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
131550937|NCT02801669|473641859|FG000|Overall Study|Death|66|||
131550938|NCT02801669|473641860|FG001|Overall Study|Death|69|||
131771775|NCT03410693|474442115|FG000|Overall Study|Disc trt: clinical progression|1|||
131771776|NCT03410693|474442116|FG001|Overall Study|Disc trt: clinical progression|5|||
131771777|NCT03410693|474442115|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
131550939|NCT02801669|473641859|FG000|Overall Study|Withdrawal by Subject|81|||
131771778|NCT03410693|474442116|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
131771779|NCT00953576|474442117|FG000|Overall Study|Adverse Event|0|||
131550940|NCT02801669|473641860|FG001|Overall Study|Withdrawal by Subject|77|||
131550941|NCT02801669|473641859|FG000|Overall Study|Other|4|||
131550942|NCT02801669|473641860|FG001|Overall Study|Other|6|||
131550943|NCT01966003|473641861|FG000|Overall Study|Death|43|||
131550944|NCT01966003|473641862|FG001|Overall Study|Death|36|||
131550945|NCT01966003|473641861|FG000|Overall Study|Protocol Violation|6|||
131550946|NCT01966003|473641862|FG001|Overall Study|Protocol Violation|4|||
131550947|NCT01966003|473641861|FG000|Overall Study|Lost to Follow-up|4|||
131550948|NCT01966003|473641862|FG001|Overall Study|Lost to Follow-up|3|||
131550949|NCT01966003|473641861|FG000|Overall Study|Physician Decision|12|||
131550950|NCT01966003|473641862|FG001|Overall Study|Physician Decision|13|||
131550951|NCT01966003|473641861|FG000|Overall Study|Withdrawal by Subject|29|||
131550952|NCT01966003|473641862|FG001|Overall Study|Withdrawal by Subject|19|||
131550953|NCT01966003|473641861|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
131550954|NCT01966003|473641862|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
131550955|NCT01966003|473641861|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
131550956|NCT01966003|473641862|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
131550957|NCT01966003|473641861|FG000|Overall Study|Other|1|||
131550958|NCT01966003|473641862|FG001|Overall Study|Other|1|||
131550959|NCT00615264|473641866|FG000|Overall Study|Withdrawal by Subject|17|||
131550960|NCT00615264|473641867|FG001|Overall Study|Withdrawal by Subject|19|||
131550961|NCT00615264|473641866|FG000|Overall Study|Lost to Follow-up|6|||
131550962|NCT00615264|473641867|FG001|Overall Study|Lost to Follow-up|13|||
131550963|NCT00615264|473641866|FG000|Overall Study|Adverse Event|8|||
131550964|NCT00615264|473641867|FG001|Overall Study|Adverse Event|5|||
131550965|NCT00615264|473641866|FG000|Overall Study|Death|1|||
131550966|NCT00615264|473641867|FG001|Overall Study|Death|1|||
131550967|NCT00615264|473641866|FG000|Overall Study|Protocol Violation|11|||
131550968|NCT00615264|473641867|FG001|Overall Study|Protocol Violation|7|||
131550969|NCT00615264|473641866|FG000|Overall Study|Not defined|7|||
131550970|NCT00615264|473641867|FG001|Overall Study|Not defined|4|||
131550971|NCT00615264|473641866|FG000|Overall Study|Dermal Hypersensitivity|0|||
131550972|NCT00615264|473641867|FG001|Overall Study|Dermal Hypersensitivity|3|||
131550973|NCT04415151|473641872|FG000|Overall Study|Death|1|||
131550974|NCT04415151|473641873|FG001|Overall Study|Death|1|||
131550975|NCT04415151|473641872|FG000|Overall Study|Withdrawal by Subject|1|||
131550976|NCT04415151|473641873|FG001|Overall Study|Withdrawal by Subject|0|||
131550977|NCT00638235|473641877|FG000|Overall Study|Lost to Follow-up|31|||
131550978|NCT00638235|473641878|FG001|Overall Study|Lost to Follow-up|3|||
131550979|NCT00638235|473641879|FG002|Overall Study|Lost to Follow-up|18|||
131550980|NCT00638235|473641880|FG003|Overall Study|Lost to Follow-up|10|||
131550981|NCT00638235|473641881|FG004|Overall Study|Lost to Follow-up|13|||
131550982|NCT00638235|473641882|FG005|Overall Study|Lost to Follow-up|26|||
131550983|NCT00638235|473641883|FG006|Overall Study|Lost to Follow-up|0|||
131550984|NCT00638235|473641884|FG007|Overall Study|Lost to Follow-up|1|||
131550985|NCT00638235|473641885|FG008|Overall Study|Lost to Follow-up|18|||
131550986|NCT03505476|473641890|FG000|Overall Study|Physician Decision|18|||
131550987|NCT03505476|473641890|FG000|Overall Study|Device Malfunctioned|101|||
131550988|NCT03505476|473641890|FG000|Overall Study|Data Corrupt|6|||
131550989|NCT03505476|473641890|FG000|Overall Study|Device application insufficiant|3|||
131550990|NCT02228395|473641895|FG000|First Intervention Period|No longer willing to participate|1|||
131550991|NCT02228395|473641896|FG001|First Intervention Period|No longer willing to participate|0|||
131550992|NCT02228395|473641897|FG002|First Intervention Period|No longer willing to participate|0|||
131550993|NCT02228395|473641895|FG000|First Intervention Period|Unable to comply with study dates|0|||
131550994|NCT02228395|473641896|FG001|First Intervention Period|Unable to comply with study dates|1|||
131550995|NCT02228395|473641897|FG002|First Intervention Period|Unable to comply with study dates|1|||
131550996|NCT00659984|473641898|FG000|Overall Study|Adverse Event|1|||
131550997|NCT02569437|473641901|FG000|Overall Study|Lost to Follow-up|12|||
131550998|NCT02569437|473641902|FG001|Overall Study|Lost to Follow-up|14|||
131550999|NCT00985985|473641906|FG000|Overall Study|Adverse Event|4|||
131551000|NCT00985985|473641907|FG001|Overall Study|Adverse Event|2|||
131551001|NCT00985985|473641908|FG002|Overall Study|Adverse Event|2|||
131551002|NCT00985985|473641909|FG003|Overall Study|Adverse Event|2|||
131551003|NCT00985985|473641906|FG000|Overall Study|Lost to Follow-up|4|||
131551004|NCT00985985|473641907|FG001|Overall Study|Lost to Follow-up|11|||
131771780|NCT00953576|474442118|FG001|Overall Study|Adverse Event|1|||
131551005|NCT00985985|473641908|FG002|Overall Study|Lost to Follow-up|2|||
131551006|NCT00985985|473641909|FG003|Overall Study|Lost to Follow-up|3|||
131551007|NCT00985985|473641906|FG000|Overall Study|Protocol Violation|1|||
131551008|NCT00985985|473641907|FG001|Overall Study|Protocol Violation|2|||
131551009|NCT00985985|473641908|FG002|Overall Study|Protocol Violation|0|||
131551010|NCT00985985|473641909|FG003|Overall Study|Protocol Violation|1|||
131551011|NCT00985985|473641906|FG000|Overall Study|Lack of Efficacy|5|||
131551012|NCT00985985|473641907|FG001|Overall Study|Lack of Efficacy|6|||
131551013|NCT00985985|473641908|FG002|Overall Study|Lack of Efficacy|1|||
131551014|NCT00985985|473641909|FG003|Overall Study|Lack of Efficacy|3|||
131551015|NCT00985985|473641906|FG000|Overall Study|Withdrawal by Subject|4|||
131771781|NCT00953576|474442117|FG000|Overall Study|Ineligible after Consent|2|||
131771782|NCT00953576|474442118|FG001|Overall Study|Ineligible after Consent|0|||
131771783|NCT03628781|474442123|FG000|Overall Study|Lost to Follow-up|16|||
131771784|NCT03628781|474442124|FG001|Overall Study|Lost to Follow-up|8|||
131771785|NCT03628781|474442123|FG000|Overall Study|Withdrawal by Subject|16|||
131771786|NCT03628781|474442124|FG001|Overall Study|Withdrawal by Subject|1|||
131771787|NCT00656669|474442125|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
131771788|NCT00656669|474442125|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
131771789|NCT00656669|474442125|FG000|AC (Cycles 6-9)|Adverse Event|1|||
131771790|NCT00656669|474442125|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
131771791|NCT03778021|474442128|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
131771792|NCT03778021|474442129|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
131771793|NCT01545375|474442130|FG000|Overall Study|Adverse Event|2|||
131771794|NCT01545375|474442131|FG001|Overall Study|Adverse Event|1|||
131771795|NCT01545375|474442130|FG000|Overall Study|Lost to Follow-up|34|||
131771796|NCT01545375|474442131|FG001|Overall Study|Lost to Follow-up|31|||
131771797|NCT01545375|474442130|FG000|Overall Study|Protocol Violation|3|||
131771798|NCT01545375|474442131|FG001|Overall Study|Protocol Violation|3|||
131771799|NCT01545375|474442130|FG000|Overall Study|Withdrawal by Subject|58|||
131771800|NCT01545375|474442131|FG001|Overall Study|Withdrawal by Subject|55|||
131771801|NCT00679042|474442132|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
131771802|NCT00679042|474442132|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
131771803|NCT00679042|474442132|FG000|5-Year Follow Up|Death|1|||
131771804|NCT00679042|474442132|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
131771805|NCT00679042|474442132|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
131771806|NCT01846039|474442133|FG000|Overall Study|Protocol Violation|1|||
131771807|NCT01846039|474442133|FG000|Overall Study|Subject Withdrew Consent|1|||
131771808|NCT00247416|474442136|FG000|Overall Study|3 patients were found to be ineligible|1|||
131771809|NCT00247416|474442137|FG001|Overall Study|3 patients were found to be ineligible|2|||
131771810|NCT04854421|474442138|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
131771811|NCT04854421|474442139|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
131771812|NCT00798161|474442140|FG000|Overall Study|Adverse Event|3|||
131771813|NCT00798161|474442141|FG001|Overall Study|Adverse Event|4|||
131771814|NCT00798161|474442142|FG002|Overall Study|Adverse Event|6|||
131771815|NCT00798161|474442143|FG003|Overall Study|Adverse Event|6|||
131771816|NCT00798161|474442144|FG004|Overall Study|Adverse Event|5|||
131771817|NCT00798161|474442145|FG005|Overall Study|Adverse Event|2|||
131771818|NCT00798161|474442146|FG006|Overall Study|Adverse Event|4|||
131771819|NCT00798161|474442140|FG000|Overall Study|Protocol Violation|2|||
131771820|NCT00798161|474442141|FG001|Overall Study|Protocol Violation|1|||
131771821|NCT00798161|474442142|FG002|Overall Study|Protocol Violation|3|||
131771822|NCT00798161|474442143|FG003|Overall Study|Protocol Violation|3|||
131771823|NCT00798161|474442144|FG004|Overall Study|Protocol Violation|3|||
131771824|NCT00798161|474442145|FG005|Overall Study|Protocol Violation|2|||
131771825|NCT00798161|474442146|FG006|Overall Study|Protocol Violation|0|||
131771826|NCT00798161|474442140|FG000|Overall Study|Lost to Follow-up|1|||
131771827|NCT00798161|474442141|FG001|Overall Study|Lost to Follow-up|3|||
131771828|NCT00798161|474442142|FG002|Overall Study|Lost to Follow-up|4|||
131771829|NCT00798161|474442143|FG003|Overall Study|Lost to Follow-up|3|||
131771830|NCT00798161|474442144|FG004|Overall Study|Lost to Follow-up|4|||
131771831|NCT00798161|474442145|FG005|Overall Study|Lost to Follow-up|0|||
131771832|NCT00798161|474442146|FG006|Overall Study|Lost to Follow-up|0|||
131771833|NCT00798161|474442140|FG000|Overall Study|Withdrawal by Subject|5|||
131771834|NCT00798161|474442141|FG001|Overall Study|Withdrawal by Subject|4|||
131771835|NCT00798161|474442142|FG002|Overall Study|Withdrawal by Subject|5|||
131771836|NCT00798161|474442143|FG003|Overall Study|Withdrawal by Subject|4|||
131771837|NCT00798161|474442144|FG004|Overall Study|Withdrawal by Subject|2|||
131771838|NCT00798161|474442145|FG005|Overall Study|Withdrawal by Subject|3|||
131771839|NCT00798161|474442146|FG006|Overall Study|Withdrawal by Subject|1|||
131771840|NCT00798161|474442140|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
131771841|NCT00798161|474442141|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
131771842|NCT00798161|474442142|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
131771843|NCT00798161|474442143|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
131771844|NCT00798161|474442144|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
131771845|NCT00798161|474442145|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
131771846|NCT00798161|474442146|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
131771847|NCT01399619|474442147|FG000|Overall Study|Adverse Event|10|||
131771848|NCT01399619|474442148|FG001|Overall Study|Adverse Event|0|||
131771849|NCT01399619|474442149|FG002|Overall Study|Adverse Event|4|||
131771850|NCT01399619|474442150|FG003|Overall Study|Adverse Event|10|||
131771851|NCT01399619|474442147|FG000|Overall Study|Lack of Efficacy|9|||
131771852|NCT01399619|474442148|FG001|Overall Study|Lack of Efficacy|0|||
131771853|NCT01399619|474442149|FG002|Overall Study|Lack of Efficacy|5|||
131771854|NCT01399619|474442150|FG003|Overall Study|Lack of Efficacy|0|||
131771855|NCT01399619|474442147|FG000|Overall Study|Withdrawal by Subject|6|||
131551016|NCT00985985|473641907|FG001|Overall Study|Withdrawal by Subject|2|||
131551017|NCT00985985|473641908|FG002|Overall Study|Withdrawal by Subject|2|||
131551018|NCT00985985|473641909|FG003|Overall Study|Withdrawal by Subject|2|||
131551019|NCT00985985|473641906|FG000|Overall Study|Other Reason|6|||
131551020|NCT00985985|473641907|FG001|Overall Study|Other Reason|1|||
131551021|NCT00985985|473641908|FG002|Overall Study|Other Reason|4|||
131551022|NCT00985985|473641909|FG003|Overall Study|Other Reason|2|||
131551023|NCT02255357|473641912|FG000|Overall Study|Physician Decision|10|||
131551024|NCT02255357|473641913|FG001|Overall Study|Physician Decision|24|||
131551025|NCT00509236|473641914|FG000|Overall Study|Adverse Event|7|||
131551026|NCT00509236|473641915|FG001|Overall Study|Adverse Event|9|||
131551027|NCT00509236|473641914|FG000|Overall Study|Withdrawal by Subject|5|||
131551028|NCT00509236|473641915|FG001|Overall Study|Withdrawal by Subject|10|||
131551029|NCT00509236|473641914|FG000|Overall Study|Protocol Violation|3|||
131551030|NCT00509236|473641915|FG001|Overall Study|Protocol Violation|0|||
131551031|NCT00509236|473641914|FG000|Overall Study|Excluded Medication|1|||
131551032|NCT00509236|473641915|FG001|Overall Study|Excluded Medication|1|||
131551033|NCT00509236|473641914|FG000|Overall Study|Scheduled Kidney Transplant|1|||
131551034|NCT00509236|473641915|FG001|Overall Study|Scheduled Kidney Transplant|0|||
131551035|NCT00927355|473641916|FG000|Overall Study|Adverse Event|1|||
131551036|NCT00927355|473641917|FG001|Overall Study|Adverse Event|1|||
131551037|NCT00792103|473641918|FG000|Overall Study|Enrolled, not treated|15|||
131551038|NCT00792103|473641918|FG000|Overall Study|Lost to Follow-up|17|||
131551039|NCT00792103|473641918|FG000|Overall Study|Adverse Event|25|||
131551040|NCT00792103|473641918|FG000|Overall Study|Withdrawal by Subject|52|||
131551041|NCT00792103|473641918|FG000|Overall Study|Protocol Violation|10|||
131551042|NCT00792103|473641918|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
131551043|NCT01572389|473641920|FG000|Overall Study|Death|1|||
131551044|NCT01572389|473641921|FG001|Overall Study|Death|3|||
131551045|NCT01572389|473641920|FG000|Overall Study|Withdrawal by Subject|14|||
131551046|NCT01572389|473641921|FG001|Overall Study|Withdrawal by Subject|2|||
131551047|NCT01572389|473641920|FG000|Overall Study|Lost to Follow-up|25|||
131551048|NCT01572389|473641921|FG001|Overall Study|Lost to Follow-up|14|||
131551049|NCT01572389|473641920|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
131551050|NCT01572389|473641921|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
131551051|NCT01287520|473641922|FG000|Overall Study|Adverse Event|2|||
131551052|NCT01287520|473641923|FG001|Overall Study|Adverse Event|2|||
131551053|NCT01287520|473641924|FG002|Overall Study|Adverse Event|2|||
131551054|NCT01287520|473641925|FG003|Overall Study|Adverse Event|1|||
131551055|NCT01287520|473641926|FG004|Overall Study|Adverse Event|1|||
131551056|NCT01287520|473641927|FG005|Overall Study|Adverse Event|2|||
131551057|NCT01287520|473641928|FG006|Overall Study|Adverse Event|0|||
131551058|NCT01287520|473641929|FG007|Overall Study|Adverse Event|2|||
131551059|NCT01287520|473641930|FG008|Overall Study|Adverse Event|0|||
131551060|NCT01287520|473641922|FG000|Overall Study|Physician Decision|1|||
131551061|NCT01287520|473641923|FG001|Overall Study|Physician Decision|1|||
131551062|NCT01287520|473641924|FG002|Overall Study|Physician Decision|2|||
131551063|NCT01287520|473641925|FG003|Overall Study|Physician Decision|0|||
131551064|NCT01287520|473641926|FG004|Overall Study|Physician Decision|1|||
131551065|NCT01287520|473641927|FG005|Overall Study|Physician Decision|1|||
131551066|NCT01287520|473641928|FG006|Overall Study|Physician Decision|0|||
131551067|NCT01287520|473641929|FG007|Overall Study|Physician Decision|1|||
131551068|NCT01287520|473641930|FG008|Overall Study|Physician Decision|0|||
131551069|NCT01287520|473641922|FG000|Overall Study|Progressive disease|0|||
131551070|NCT01287520|473641923|FG001|Overall Study|Progressive disease|4|||
131551071|NCT01287520|473641924|FG002|Overall Study|Progressive disease|1|||
131551072|NCT01287520|473641925|FG003|Overall Study|Progressive disease|6|||
131551073|NCT01287520|473641926|FG004|Overall Study|Progressive disease|1|||
131551074|NCT01287520|473641927|FG005|Overall Study|Progressive disease|0|||
131551075|NCT01287520|473641928|FG006|Overall Study|Progressive disease|2|||
131551076|NCT01287520|473641929|FG007|Overall Study|Progressive disease|2|||
131551077|NCT01287520|473641930|FG008|Overall Study|Progressive disease|4|||
131551078|NCT01287520|473641922|FG000|Overall Study|Withdrawal by Subject|0|||
131888156|NCT00076999|474872368|FG003|Overall Study|Withdrawal by Subject|0|||
131888157|NCT00076999|474872369|FG004|Overall Study|Withdrawal by Subject|1|||
131551079|NCT01287520|473641923|FG001|Overall Study|Withdrawal by Subject|0|||
131551080|NCT01287520|473641924|FG002|Overall Study|Withdrawal by Subject|0|||
131551081|NCT01287520|473641925|FG003|Overall Study|Withdrawal by Subject|0|||
131551082|NCT01287520|473641926|FG004|Overall Study|Withdrawal by Subject|0|||
131551083|NCT01287520|473641927|FG005|Overall Study|Withdrawal by Subject|1|||
131551084|NCT01287520|473641928|FG006|Overall Study|Withdrawal by Subject|0|||
131551085|NCT01287520|473641929|FG007|Overall Study|Withdrawal by Subject|0|||
131551086|NCT01287520|473641930|FG008|Overall Study|Withdrawal by Subject|1|||
131551087|NCT03587142|473641931|FG000|Overall Study|Lost to Follow-up|5|||
131551088|NCT03587142|473641932|FG001|Overall Study|Lost to Follow-up|3|||
131551089|NCT03587142|473641931|FG000|Overall Study|Did not complete the f4 visit|3|||
131551090|NCT03587142|473641932|FG001|Overall Study|Did not complete the f4 visit|7|||
131551091|NCT03673462|473641933|FG000|Overall Study|Adverse Event|11|||
131551092|NCT03673462|473641934|FG001|Overall Study|Adverse Event|1|||
131551093|NCT03673462|473641933|FG000|Overall Study|Protocol Violation|25|||
131551094|NCT03673462|473641934|FG001|Overall Study|Protocol Violation|11|||
131551095|NCT03673462|473641933|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
131551096|NCT03673462|473641934|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
131551097|NCT03673462|473641933|FG000|Overall Study|Lost to Follow-up|102|||
131551098|NCT03673462|473641934|FG001|Overall Study|Lost to Follow-up|19|||
131551099|NCT02768662|473641935|FG000|Overall Study|Adverse Event|1|||
131551100|NCT02768662|473641935|FG000|Overall Study|Lost to Follow-up|4|||
131551101|NCT02768662|473641935|FG000|Overall Study|Withdrawal by Subject|3|||
131551102|NCT02768662|473641935|FG000|Overall Study|Study terminated by Sponsor|78|||
131551103|NCT05061537|473641939|FG000|Treatment Phase|Progressive disease|0|||
131551104|NCT05061537|473641940|FG001|Treatment Phase|Progressive disease|1|||
131551105|NCT05061537|473641941|FG002|Treatment Phase|Progressive disease|2|||
131551106|NCT05061537|473641942|FG003|Treatment Phase|Progressive disease|0|||
131551107|NCT05061537|473641943|FG004|Treatment Phase|Progressive disease|0|||
131551108|NCT05061537|473641939|FG000|Treatment Phase|Adverse Event|0|||
131551109|NCT05061537|473641940|FG001|Treatment Phase|Adverse Event|0|||
131551110|NCT05061537|473641941|FG002|Treatment Phase|Adverse Event|2|||
131551111|NCT05061537|473641942|FG003|Treatment Phase|Adverse Event|0|||
131551112|NCT05061537|473641943|FG004|Treatment Phase|Adverse Event|0|||
131551113|NCT05061537|473641939|FG000|Treatment Phase|Global deterioration of health status|0|||
131551114|NCT05061537|473641940|FG001|Treatment Phase|Global deterioration of health status|1|||
131551115|NCT05061537|473641941|FG002|Treatment Phase|Global deterioration of health status|0|||
131551116|NCT05061537|473641942|FG003|Treatment Phase|Global deterioration of health status|0|||
131551117|NCT05061537|473641943|FG004|Treatment Phase|Global deterioration of health status|0|||
131551118|NCT05061537|473641939|FG000|Follow up|Other|2|||
131551119|NCT05061537|473641940|FG001|Follow up|Other|0|||
131551120|NCT05061537|473641941|FG002|Follow up|Other|2|||
131551121|NCT05061537|473641942|FG003|Follow up|Other|0|||
131551122|NCT05061537|473641943|FG004|Follow up|Other|0|||
131551123|NCT05061537|473641939|FG000|Follow up|Study terminated by sponsor|0|||
131551124|NCT05061537|473641940|FG001|Follow up|Study terminated by sponsor|0|||
131551125|NCT05061537|473641941|FG002|Follow up|Study terminated by sponsor|2|||
131551126|NCT05061537|473641942|FG003|Follow up|Study terminated by sponsor|0|||
131551127|NCT05061537|473641943|FG004|Follow up|Study terminated by sponsor|0|||
131551128|NCT05061537|473641939|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
131551129|NCT05061537|473641940|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
131551130|NCT05061537|473641941|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
131551131|NCT05061537|473641942|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
131551132|NCT05061537|473641943|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
131551133|NCT05061537|473641939|FG000|Long-term Follow-up|Death|0|||
131551134|NCT05061537|473641940|FG001|Long-term Follow-up|Death|1|||
131551135|NCT05061537|473641941|FG002|Long-term Follow-up|Death|0|||
131551136|NCT05061537|473641942|FG003|Long-term Follow-up|Death|0|||
131551137|NCT05061537|473641943|FG004|Long-term Follow-up|Death|0|||
131551138|NCT05807919|473641944|FG000|Overall Study|Received antibiotics - excluded|0|||
131551139|NCT05807919|473641945|FG001|Overall Study|Received antibiotics - excluded|1|||
131551140|NCT05807919|473641944|FG000|Overall Study|Withdrawal by Subject|0|||
131551141|NCT05807919|473641945|FG001|Overall Study|Withdrawal by Subject|3|||
131551142|NCT05807919|473641944|FG000|Overall Study|Adverse Event|1|||
131551143|NCT05807919|473641945|FG001|Overall Study|Adverse Event|1|||
131551144|NCT03489057|473641946|FG000|Overall Study|Lost to Follow-up|16|||
131551145|NCT03489057|473641947|FG001|Overall Study|Lost to Follow-up|16|||
131551146|NCT03489057|473641948|FG002|Overall Study|Lost to Follow-up|14|||
131551147|NCT03489057|473641949|FG003|Overall Study|Lost to Follow-up|14|||
131551148|NCT03489057|473641946|FG000|Overall Study|Withdrawal by Subject|12|||
131551149|NCT03489057|473641947|FG001|Overall Study|Withdrawal by Subject|12|||
131662003|NCT02489968|474046214|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
131551150|NCT03489057|473641948|FG002|Overall Study|Withdrawal by Subject|8|||
131551151|NCT03489057|473641949|FG003|Overall Study|Withdrawal by Subject|8|||
131551152|NCT03489057|473641946|FG000|Overall Study|Protocol Violation|7|||
131551153|NCT03489057|473641947|FG001|Overall Study|Protocol Violation|7|||
131662004|NCT02489968|474046215|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
131662005|NCT02489968|474046216|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
131662006|NCT02489968|474046217|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
131662007|NCT02489968|474046212|FG000|Open-label Treatment Period|Other than specified above|204|||
131662008|NCT02489968|474046213|FG001|Open-label Treatment Period|Other than specified above|189|||
131662009|NCT02489968|474046214|FG002|Open-label Treatment Period|Other than specified above|0|||
131662010|NCT02489968|474046215|FG003|Open-label Treatment Period|Other than specified above|0|||
131662011|NCT02489968|474046216|FG004|Open-label Treatment Period|Other than specified above|0|||
131662012|NCT02489968|474046217|FG005|Open-label Treatment Period|Other than specified above|0|||
131662013|NCT02489968|474046212|FG000|Double-blind Treatment Period|Adverse Event|0|||
131662014|NCT02489968|474046213|FG001|Double-blind Treatment Period|Adverse Event|0|||
131551154|NCT03489057|473641948|FG002|Overall Study|Protocol Violation|2|||
131551155|NCT03489057|473641949|FG003|Overall Study|Protocol Violation|2|||
131551156|NCT04027348|473641952|FG000|Overall Study|Adverse Event|2|||
131551157|NCT02487472|473641953|FG000|Overall Study|Did not complete telephonic interviews|9|||
131551158|NCT02487472|473641953|FG000|Overall Study|Other|2|||
131551159|NCT02034708|473641954|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
131551160|NCT02034708|473641955|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
131551161|NCT02034708|473641954|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
131551162|NCT02034708|473641955|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
131551163|NCT02034708|473641954|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
131551164|NCT02034708|473641955|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
131551165|NCT02034708|473641954|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
131551166|NCT02034708|473641955|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
131551167|NCT04843930|473641956|FG000|Randomization|Withdrawal by Subject|6|||
131551168|NCT04843930|473641957|FG001|Randomization|Withdrawal by Subject|6|||
131551169|NCT04843930|473641958|FG002|Randomization|Withdrawal by Subject|0|||
131551170|NCT04843930|473641959|FG003|Randomization|Withdrawal by Subject|0|||
131551171|NCT04843930|473641956|FG000|Week 6 Assessment|Adverse Event|3|||
131551172|NCT04843930|473641957|FG001|Week 6 Assessment|Adverse Event|0|||
131551173|NCT04843930|473641958|FG002|Week 6 Assessment|Adverse Event|0|||
131551174|NCT04843930|473641959|FG003|Week 6 Assessment|Adverse Event|0|||
131551175|NCT04843930|473641956|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
131551176|NCT04843930|473641957|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
131551177|NCT04843930|473641958|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
131551178|NCT04843930|473641959|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
131551179|NCT04843930|473641956|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
131551180|NCT04843930|473641957|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
131551181|NCT04843930|473641958|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
131551182|NCT04843930|473641959|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
131551183|NCT01987817|473641960|FG000|Overall Study|Adverse Event|4|||
131551184|NCT01987817|473641961|FG001|Overall Study|Adverse Event|0|||
131551185|NCT01987817|473641960|FG000|Overall Study|Withdrawal by Subject|1|||
131551186|NCT01987817|473641961|FG001|Overall Study|Withdrawal by Subject|1|||
131551187|NCT01987817|473641960|FG000|Overall Study|Physician Decision|1|||
131551188|NCT01987817|473641961|FG001|Overall Study|Physician Decision|0|||
131551189|NCT01833143|473641965|FG000|Overall Study|Not Treated|1|||
131551190|NCT03995784|473641966|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
131551191|NCT00284141|473643663|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
131551192|NCT00284141|473643663|FG000|Overall Study|Adverse Event|19|||
131551193|NCT00284141|473643663|FG000|Overall Study|Participant's request|9|||
131551194|NCT00284141|473643663|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
131551195|NCT00284141|473643663|FG000|Overall Study|Clinical deterioration / death|2|||
131551196|NCT00284141|473643663|FG000|Overall Study|General decline|1|||
131551197|NCT00284141|473643663|FG000|Overall Study|Pneumonia|1|||
131551198|NCT00284141|473643663|FG000|Overall Study|Did not take study medication|2|||
131551199|NCT00284141|473643663|FG000|Overall Study|Ongoing treatment|2|||
131551200|NCT02202434|473643664|FG000|Overall Study|Death|70|||
131551201|NCT02202434|473643665|FG001|Overall Study|Death|39|||
131551202|NCT02202434|473643666|FG002|Overall Study|Death|13|||
131551203|NCT02202434|473643667|FG003|Overall Study|Death|27|||
131551204|NCT02202434|473643664|FG000|Overall Study|Lost to Follow-up|1|||
131551205|NCT02202434|473643665|FG001|Overall Study|Lost to Follow-up|1|||
131551206|NCT02202434|473643666|FG002|Overall Study|Lost to Follow-up|1|||
131551207|NCT02202434|473643667|FG003|Overall Study|Lost to Follow-up|0|||
131551208|NCT02202434|473643664|FG000|Overall Study|Physician Decision|2|||
131551209|NCT02202434|473643665|FG001|Overall Study|Physician Decision|3|||
131551210|NCT02202434|473643666|FG002|Overall Study|Physician Decision|0|||
131551211|NCT02202434|473643667|FG003|Overall Study|Physician Decision|0|||
131551212|NCT02202434|473643664|FG000|Overall Study|Withdrawal by Subject|13|||
131551213|NCT02202434|473643665|FG001|Overall Study|Withdrawal by Subject|14|||
131551214|NCT02202434|473643666|FG002|Overall Study|Withdrawal by Subject|1|||
131771856|NCT01399619|474442148|FG001|Overall Study|Withdrawal by Subject|0|||
131771857|NCT01399619|474442149|FG002|Overall Study|Withdrawal by Subject|3|||
131771858|NCT01399619|474442150|FG003|Overall Study|Withdrawal by Subject|4|||
131551215|NCT02202434|473643667|FG003|Overall Study|Withdrawal by Subject|4|||
131551216|NCT02202434|473643664|FG000|Overall Study|Completed Study|1|||
131551217|NCT02202434|473643665|FG001|Overall Study|Completed Study|0|||
131551218|NCT02202434|473643666|FG002|Overall Study|Completed Study|0|||
131551219|NCT02202434|473643667|FG003|Overall Study|Completed Study|0|||
131771859|NCT01399619|474442147|FG000|Overall Study|Protocol Violation|0|||
131551220|NCT02202434|473643664|FG000|Overall Study|Visit Missed|21|||
131551221|NCT02202434|473643665|FG001|Overall Study|Visit Missed|12|||
131551222|NCT02202434|473643666|FG002|Overall Study|Visit Missed|0|||
131551223|NCT02202434|473643667|FG003|Overall Study|Visit Missed|5|||
131551224|NCT02202434|473643664|FG000|Overall Study|Other|1|||
131551225|NCT02202434|473643665|FG001|Overall Study|Other|0|||
131551226|NCT02202434|473643666|FG002|Overall Study|Other|0|||
131551227|NCT02202434|473643667|FG003|Overall Study|Other|1|||
131771860|NCT01399619|474442148|FG001|Overall Study|Protocol Violation|0|||
131551228|NCT03610737|473643670|FG000|Overall Study|Withdrawal by Subject|1|||
131551229|NCT03610737|473643671|FG001|Overall Study|Withdrawal by Subject|5|||
131551230|NCT03610737|473643670|FG000|Overall Study|Death|1|||
131551231|NCT03610737|473643671|FG001|Overall Study|Death|0|||
131551232|NCT03610737|473643670|FG000|Overall Study|Not treated|5|||
131551233|NCT03610737|473643671|FG001|Overall Study|Not treated|2|||
131551234|NCT03610737|473643670|FG000|Overall Study|Missed Visit|1|||
131551235|NCT03610737|473643671|FG001|Overall Study|Missed Visit|2|||
131551236|NCT00369681|473643673|FG000|Overall Study|Death|1|||
131551237|NCT02991482|473643674|FG000|Overall Study|Disease progression|56|||
131551238|NCT02991482|473643675|FG001|Overall Study|Disease progression|47|||
131551239|NCT02991482|473643674|FG000|Overall Study|Death|4|||
131551240|NCT02991482|473643675|FG001|Overall Study|Death|4|||
131551241|NCT02991482|473643674|FG000|Overall Study|Adverse Event|1|||
131551242|NCT02991482|473643675|FG001|Overall Study|Adverse Event|6|||
131551243|NCT02991482|473643674|FG000|Overall Study|Patient decision|1|||
131551244|NCT02991482|473643675|FG001|Overall Study|Patient decision|1|||
131551245|NCT02991482|473643674|FG000|Overall Study|Physician Decision|0|||
131551246|NCT02991482|473643675|FG001|Overall Study|Physician Decision|6|||
131551247|NCT02991482|473643674|FG000|Overall Study|Clinical deterioration|1|||
131551248|NCT02991482|473643675|FG001|Overall Study|Clinical deterioration|0|||
131551249|NCT02991482|473643674|FG000|Overall Study|Patient feeling too unwell|1|||
131551250|NCT02991482|473643675|FG001|Overall Study|Patient feeling too unwell|0|||
131551251|NCT02991482|473643674|FG000|Overall Study|Worsening of performance status|0|||
131551252|NCT02991482|473643675|FG001|Overall Study|Worsening of performance status|1|||
131551253|NCT02991482|473643674|FG000|Overall Study|Death prior to study drug initiation|1|||
131551254|NCT02991482|473643675|FG001|Overall Study|Death prior to study drug initiation|0|||
131551255|NCT02991482|473643674|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
131551256|NCT02991482|473643675|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
131551257|NCT04382924|473643678|FG000|Overall Study|Death|2|||
131551258|NCT04382924|473643679|FG001|Overall Study|Death|5|||
131551259|NCT04382924|473643680|FG002|Overall Study|Death|4|||
131551260|NCT04382924|473643678|FG000|Overall Study|Protocol Violation|0|||
131551261|NCT04382924|473643679|FG001|Overall Study|Protocol Violation|1|||
131551262|NCT04382924|473643680|FG002|Overall Study|Protocol Violation|1|||
131551263|NCT04382924|473643678|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
131551264|NCT04382924|473643679|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
131551265|NCT04382924|473643680|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
131551266|NCT04382924|473643678|FG000|Overall Study|Withdrawal by Subject|6|||
131551267|NCT04382924|473643679|FG001|Overall Study|Withdrawal by Subject|3|||
131551268|NCT04382924|473643680|FG002|Overall Study|Withdrawal by Subject|6|||
131551269|NCT02207725|473643681|FG000|Overall Study|Did Not Receive Treatment|0|||
131551270|NCT02207725|473643682|FG001|Overall Study|Did Not Receive Treatment|1|||
131551271|NCT02207725|473643683|FG002|Overall Study|Did Not Receive Treatment|1|||
131551272|NCT02207725|473643684|FG003|Overall Study|Did Not Receive Treatment|1|||
131551273|NCT02396537|473643689|FG000|Overall Study|Protocol Violation|0|||
131551274|NCT02396537|473643690|FG001|Overall Study|Protocol Violation|1|||
131551275|NCT00871403|473643691|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
131551276|NCT00871403|473643692|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
131551277|NCT00871403|473643693|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
131551278|NCT00871403|473643691|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
131551279|NCT00871403|473643692|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
131551280|NCT00871403|473643693|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
131551281|NCT00871403|473643691|FG000|Combination Treatment Phase|Adverse Event|0|||
131551282|NCT00871403|473643692|FG001|Combination Treatment Phase|Adverse Event|17|||
131551283|NCT00871403|473643693|FG002|Combination Treatment Phase|Adverse Event|2|||
131551284|NCT00871403|473643691|FG000|Combination Treatment Phase|Disease Progression|0|||
131551285|NCT00871403|473643692|FG001|Combination Treatment Phase|Disease Progression|8|||
131551286|NCT00871403|473643693|FG002|Combination Treatment Phase|Disease Progression|5|||
131551287|NCT00871403|473643691|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
131551288|NCT00871403|473643692|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
131551289|NCT00871403|473643693|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
131551290|NCT00871403|473643691|FG000|Combination Treatment Phase|Physician Decision|0|||
131551291|NCT00871403|473643692|FG001|Combination Treatment Phase|Physician Decision|1|||
131551292|NCT00871403|473643693|FG002|Combination Treatment Phase|Physician Decision|3|||
131551293|NCT00871403|473643691|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
131551294|NCT00871403|473643692|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
131771861|NCT01399619|474442149|FG002|Overall Study|Protocol Violation|0|||
131551295|NCT00871403|473643693|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
131551296|NCT00871403|473643691|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
131551297|NCT00871403|473643692|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
131551298|NCT00871403|473643693|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
131551299|NCT04887948|473643694|FG000|Overall Study|Death|1|||
131551300|NCT04887948|473643695|FG001|Overall Study|Death|0|||
131551301|NCT04887948|473643696|FG002|Overall Study|Death|0|||
131551302|NCT04887948|473643694|FG000|Overall Study|Lost to Follow-up|1|||
131551303|NCT04887948|473643695|FG001|Overall Study|Lost to Follow-up|0|||
131551304|NCT04887948|473643696|FG002|Overall Study|Lost to Follow-up|3|||
131551305|NCT04887948|473643694|FG000|Overall Study|Physician Decision|0|||
131551306|NCT04887948|473643695|FG001|Overall Study|Physician Decision|4|||
131551307|NCT04887948|473643696|FG002|Overall Study|Physician Decision|1|||
131551308|NCT04887948|473643694|FG000|Overall Study|Protocol Violation|1|||
131551309|NCT04887948|473643695|FG001|Overall Study|Protocol Violation|1|||
131551310|NCT04887948|473643696|FG002|Overall Study|Protocol Violation|0|||
131551311|NCT04887948|473643694|FG000|Overall Study|Withdrawal by Subject|0|||
131551312|NCT04887948|473643695|FG001|Overall Study|Withdrawal by Subject|6|||
131551313|NCT04887948|473643696|FG002|Overall Study|Withdrawal by Subject|1|||
131551314|NCT04887948|473643694|FG000|Overall Study|No longer met eligibility criteria|1|||
131551315|NCT04887948|473643695|FG001|Overall Study|No longer met eligibility criteria|2|||
131551316|NCT04887948|473643696|FG002|Overall Study|No longer met eligibility criteria|1|||
131551317|NCT04887948|473643694|FG000|Overall Study|Other|2|||
131551318|NCT04887948|473643695|FG001|Overall Study|Other|1|||
131551319|NCT04887948|473643696|FG002|Overall Study|Other|1|||
131551320|NCT00787319|473643700|FG000|Overall Study|Lost to Follow-up|2|||
131551321|NCT00787319|473643700|FG000|Overall Study|Withdrawal by Subject|15|||
131551322|NCT00787319|473643700|FG000|Overall Study|Adverse Event|3|||
131551323|NCT00787319|473643700|FG000|Overall Study|Objective progression or relapse|30|||
131551324|NCT00787319|473643700|FG000|Overall Study|Lack of Efficacy|1|||
131551325|NCT00787319|473643700|FG000|Overall Study|Budget exhausted/exceeded|1|||
131551326|NCT00787319|473643700|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
131551327|NCT00787319|473643700|FG000|Overall Study|No health insurance reimbursement|2|||
131551328|NCT00787319|473643700|FG000|Overall Study|Stabilized disease findings|3|||
131551329|NCT00787319|473643700|FG000|Overall Study|Inactive disease|5|||
131551330|NCT02312856|473643701|FG000|Overall Study|Death|1|||
131551331|NCT02312856|473643701|FG000|Overall Study|Lost to Follow-up|3|||
131551332|NCT01932294|473643702|FG000|Overall Study|Death|43|||
131551333|NCT01932294|473643702|FG000|Overall Study|Lost to Follow-up|8|||
131551334|NCT01932294|473643702|FG000|Overall Study|VAD Implantation|20|||
131551335|NCT01932294|473643702|FG000|Overall Study|Heart Transplantation|16|||
131551336|NCT01932294|473643702|FG000|Overall Study|Transferred to other hospitals|12|||
131551337|NCT03075904|473643704|FG000|Overall Study|Physician Decision|3|||
131551338|NCT03075904|473643704|FG000|Overall Study|Need for Medication not Permitted|1|||
131551339|NCT01800201|473643705|FG000|Overall Study|Withdrawal by Subject|2|||
131551340|NCT01800201|473643706|FG001|Overall Study|Withdrawal by Subject|0|||
131551341|NCT01800201|473643705|FG000|Overall Study|patient privacy concerns|1|||
131551342|NCT01800201|473643706|FG001|Overall Study|patient privacy concerns|1|||
131551343|NCT01800201|473643705|FG000|Overall Study|did not want to use device|0|||
131551344|NCT01800201|473643706|FG001|Overall Study|did not want to use device|1|||
131551345|NCT01800201|473643705|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
131551346|NCT01800201|473643706|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
131551347|NCT00708435|473643707|FG000|Overall Study|Death / Serious Adverse Event|10|||
131551348|NCT00708435|473643708|FG001|Overall Study|Death / Serious Adverse Event|5|||
131551349|NCT00708435|473643707|FG000|Overall Study|Lost to Follow-up|9|||
131551350|NCT00708435|473643708|FG001|Overall Study|Lost to Follow-up|4|||
131551351|NCT00708435|473643707|FG000|Overall Study|Withdrawal by Subject|3|||
131551352|NCT00708435|473643708|FG001|Overall Study|Withdrawal by Subject|7|||
131551353|NCT00708435|473643707|FG000|Overall Study|Adverse Event|1|||
131551354|NCT00708435|473643708|FG001|Overall Study|Adverse Event|0|||
131551355|NCT00708435|473643707|FG000|Overall Study|Protocol Violation|0|||
131551356|NCT00708435|473643708|FG001|Overall Study|Protocol Violation|1|||
131551357|NCT00708435|473643707|FG000|Overall Study|Intervention by primary care physician|1|||
131551358|NCT00708435|473643708|FG001|Overall Study|Intervention by primary care physician|0|||
131551359|NCT00708435|473643707|FG000|Overall Study|Refused hospitalization|1|||
131551360|NCT00708435|473643708|FG001|Overall Study|Refused hospitalization|0|||
131551361|NCT03502616|473643711|FG000|Up to Week 16|Withdrawal by Subject|1|||
131551362|NCT03502616|473643712|FG001|Up to Week 16|Withdrawal by Subject|2|||
131551363|NCT03502616|473643711|FG000|Up to Week 16|Lost to Follow-up|0|||
131551364|NCT03502616|473643712|FG001|Up to Week 16|Lost to Follow-up|1|||
131551365|NCT03502616|473643711|FG000|Up to Week 16|Randomized, but not treated|1|||
131551366|NCT03502616|473643712|FG001|Up to Week 16|Randomized, but not treated|0|||
131551367|NCT03502616|473643711|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
131551368|NCT03502616|473643712|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
131551369|NCT03502616|473643711|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
131551370|NCT03502616|473643712|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
131551371|NCT01691521|473643713|FG000|Overall Study|Adverse Event|4|||
131551372|NCT01691521|473643714|FG001|Overall Study|Adverse Event|0|||
131551373|NCT01691521|473643715|FG002|Overall Study|Adverse Event|1|||
131551374|NCT01691521|473643713|FG000|Overall Study|Lack of Efficacy|1|||
131551375|NCT01691521|473643714|FG001|Overall Study|Lack of Efficacy|1|||
131551376|NCT01691521|473643715|FG002|Overall Study|Lack of Efficacy|2|||
131551377|NCT01691521|473643713|FG000|Overall Study|Protocol Violation|0|||
131551378|NCT01691521|473643714|FG001|Overall Study|Protocol Violation|3|||
131551379|NCT01691521|473643715|FG002|Overall Study|Protocol Violation|0|||
131551380|NCT01691521|473643713|FG000|Overall Study|Lost to Follow-up|0|||
131551381|NCT01691521|473643714|FG001|Overall Study|Lost to Follow-up|2|||
131551382|NCT01691521|473643715|FG002|Overall Study|Lost to Follow-up|2|||
131551383|NCT01691521|473643713|FG000|Overall Study|Physician Decision|2|||
131551384|NCT01691521|473643714|FG001|Overall Study|Physician Decision|1|||
131551385|NCT01691521|473643715|FG002|Overall Study|Physician Decision|0|||
131551386|NCT01691521|473643713|FG000|Overall Study|Withdrawal by Subject|5|||
131551387|NCT01691521|473643714|FG001|Overall Study|Withdrawal by Subject|9|||
131551388|NCT01691521|473643715|FG002|Overall Study|Withdrawal by Subject|4|||
131551389|NCT00770432|473643723|FG000|Overall Study|Other|4|||
131551390|NCT00770432|473643724|FG001|Overall Study|Other|6|||
131551391|NCT00770432|473643723|FG000|Overall Study|Non-compliance|0|||
131551392|NCT00770432|473643724|FG001|Overall Study|Non-compliance|1|||
131551393|NCT00312702|473643725|FG000|Immunization Phase|Lost to Follow-up|0|||
131551394|NCT00312702|473643726|FG001|Immunization Phase|Lost to Follow-up|1|||
131551395|NCT00312702|473643727|FG002|Immunization Phase|Lost to Follow-up|0|||
131551396|NCT00988221|473643728|FG000|Part I|Adverse Event|0|||
131551397|NCT00988221|473643729|FG001|Part I|Adverse Event|1|||
131551398|NCT00988221|473643730|FG002|Part I|Adverse Event|2|||
131551399|NCT00988221|473643731|FG003|Part I|Adverse Event|0|||
131551400|NCT00988221|473643728|FG000|Part I|Insufficient Therapeutic Response|4|||
131551401|NCT00988221|473643729|FG001|Part I|Insufficient Therapeutic Response|6|||
131551402|NCT00988221|473643730|FG002|Part I|Insufficient Therapeutic Response|5|||
131551403|NCT00988221|473643731|FG003|Part I|Insufficient Therapeutic Response|0|||
131551404|NCT00988221|473643728|FG000|Part I|Refused Treatment|0|||
131551405|NCT00988221|473643729|FG001|Part I|Refused Treatment|2|||
131551406|NCT00988221|473643730|FG002|Part I|Refused Treatment|1|||
131551407|NCT00988221|473643731|FG003|Part I|Refused Treatment|0|||
131551408|NCT00988221|473643728|FG000|Part I|Lost to Follow-up|0|||
131551409|NCT00988221|473643729|FG001|Part I|Lost to Follow-up|1|||
131551410|NCT00988221|473643730|FG002|Part I|Lost to Follow-up|0|||
131551411|NCT00988221|473643731|FG003|Part I|Lost to Follow-up|0|||
131551412|NCT00988221|473643728|FG000|Part II|Adverse Event|1|||
131551413|NCT00988221|473643729|FG001|Part II|Adverse Event|0|||
131551414|NCT00988221|473643730|FG002|Part II|Adverse Event|0|||
131551415|NCT00988221|473643731|FG003|Part II|Adverse Event|1|||
131551416|NCT00988221|473643728|FG000|Part II|Withdrawal by Subject|0|||
131551417|NCT00988221|473643729|FG001|Part II|Withdrawal by Subject|0|||
131551418|NCT00988221|473643730|FG002|Part II|Withdrawal by Subject|2|||
131551419|NCT00988221|473643731|FG003|Part II|Withdrawal by Subject|2|||
131551420|NCT00988221|473643728|FG000|Part II|Reason not Specified|0|||
131551421|NCT00988221|473643729|FG001|Part II|Reason not Specified|0|||
131551422|NCT00988221|473643730|FG002|Part II|Reason not Specified|1|||
131551423|NCT00988221|473643731|FG003|Part II|Reason not Specified|0|||
131551424|NCT00988221|473643728|FG000|Part III|Adverse Event|1|||
131551425|NCT00988221|473643729|FG001|Part III|Adverse Event|0|||
131551426|NCT00988221|473643730|FG002|Part III|Adverse Event|1|||
131551427|NCT00988221|473643731|FG003|Part III|Adverse Event|0|||
131551428|NCT00988221|473643728|FG000|Part III|Insufficient Therapeutic Response|0|||
131551429|NCT00988221|473643729|FG001|Part III|Insufficient Therapeutic Response|1|||
131551430|NCT00988221|473643730|FG002|Part III|Insufficient Therapeutic Response|1|||
131551431|NCT00988221|473643731|FG003|Part III|Insufficient Therapeutic Response|0|||
131551432|NCT00988221|473643728|FG000|Part III|Refused Treatment|0|||
131551433|NCT00988221|473643729|FG001|Part III|Refused Treatment|0|||
131551434|NCT00988221|473643730|FG002|Part III|Refused Treatment|1|||
131551435|NCT00988221|473643731|FG003|Part III|Refused Treatment|0|||
131551436|NCT02756832|473643734|FG000|Overall Study|Lost for Observation after Baseline|6|||
131551437|NCT02756832|473643734|FG000|Overall Study|Lost for Observation|13|||
131551438|NCT02756832|473643734|FG000|Overall Study|Patient's Unwillingness|12|||
131551439|NCT02756832|473643734|FG000|Overall Study|Insufficient Efficacy|2|||
131551440|NCT02756832|473643734|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
131551441|NCT02756832|473643734|FG000|Overall Study|Reason not Specified|9|||
131551442|NCT02756832|473643734|FG000|Overall Study|Protocol Deviation|10|||
131551443|NCT03579290|473643744|FG000|Overall Study|Lost to Follow-up|9|||
131551444|NCT04581200|473643747|FG000|Overall Study|Lost to Follow-up|6|||
131551445|NCT04581200|473643748|FG001|Overall Study|Lost to Follow-up|5|||
131551446|NCT01781390|473643749|FG000|Overall Study|Withdrawal of Consent|0|||
131551447|NCT01781390|473643750|FG001|Overall Study|Withdrawal of Consent|3|||
131551448|NCT01781390|473643751|FG002|Overall Study|Withdrawal of Consent|1|||
131551449|NCT01781390|473643749|FG000|Overall Study|Lost to Follow-up|1|||
131551450|NCT01781390|473643750|FG001|Overall Study|Lost to Follow-up|1|||
131551451|NCT01781390|473643751|FG002|Overall Study|Lost to Follow-up|1|||
131662015|NCT02489968|474046214|FG002|Double-blind Treatment Period|Adverse Event|2|||
131551452|NCT01781390|473643749|FG000|Overall Study|Adverse Event|1|||
131551453|NCT01781390|473643750|FG001|Overall Study|Adverse Event|2|||
131551454|NCT01781390|473643751|FG002|Overall Study|Adverse Event|1|||
131551455|NCT01781390|473643749|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
131551456|NCT01781390|473643750|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
131551457|NCT01781390|473643751|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
131551458|NCT03131960|473643752|FG000|Overall Study|Adverse Event|0|||
131551459|NCT03131960|473643753|FG001|Overall Study|Adverse Event|1|||
131551460|NCT00622713|473643756|FG000|Overall Study|Adverse Event|35|||
131551461|NCT00622713|473643756|FG000|Overall Study|Administrative problems|4|||
131551462|NCT00622713|473643756|FG000|Overall Study|Withdrawal by Subject|11|||
131551463|NCT00622713|473643756|FG000|Overall Study|Lost to Follow-up|5|||
131551464|NCT00622713|473643756|FG000|Overall Study|Death|2|||
131551465|NCT00622713|473643756|FG000|Overall Study|Subject no longer required study drug|1|||
131551466|NCT00622713|473643756|FG000|Overall Study|Did not meet eligibility criteria|1|||
131551467|NCT04404478|473643760|FG000|Overall Study|Withdrawal by Subject|1|||
131551468|NCT04404478|473643761|FG001|Overall Study|Withdrawal by Subject|3|||
131551469|NCT03485911|473643762|FG000|Part 1|Perceived lack of efficacy|1|||
131551470|NCT03485911|473643763|FG001|Part 1|Perceived lack of efficacy|1|||
131551471|NCT03485911|473643764|FG002|Part 1|Perceived lack of efficacy|2|||
131551472|NCT03485911|473643765|FG003|Part 1|Perceived lack of efficacy|0|||
131551473|NCT03485911|473643762|FG000|Part 1|Subject withdrew consent|0|||
131551474|NCT03485911|473643763|FG001|Part 1|Subject withdrew consent|1|||
131551475|NCT03485911|473643764|FG002|Part 1|Subject withdrew consent|0|||
131551476|NCT03485911|473643765|FG003|Part 1|Subject withdrew consent|1|||
131551477|NCT03485911|473643762|FG000|Part 1|Lab abnormalities/AEs|3|||
131551478|NCT03485911|473643763|FG001|Part 1|Lab abnormalities/AEs|1|||
131551479|NCT03485911|473643764|FG002|Part 1|Lab abnormalities/AEs|1|||
131551480|NCT03485911|473643765|FG003|Part 1|Lab abnormalities/AEs|0|||
131551481|NCT03485911|473643762|FG000|Part 1|Withdrew Consent prior to dosing|0|||
131551482|NCT03485911|473643763|FG001|Part 1|Withdrew Consent prior to dosing|0|||
131551483|NCT03485911|473643764|FG002|Part 1|Withdrew Consent prior to dosing|0|||
131551484|NCT03485911|473643765|FG003|Part 1|Withdrew Consent prior to dosing|1|||
131551485|NCT03485911|473643762|FG000|Part 1|Other NOS|0|||
131551486|NCT03485911|473643763|FG001|Part 1|Other NOS|0|||
131551487|NCT03485911|473643764|FG002|Part 1|Other NOS|0|||
131551488|NCT03485911|473643765|FG003|Part 1|Other NOS|1|||
131551489|NCT03485911|473643762|FG000|Part 2|Perceived lack of efficacy|5|||
131551490|NCT03485911|473643763|FG001|Part 2|Perceived lack of efficacy|3|||
131551491|NCT03485911|473643764|FG002|Part 2|Perceived lack of efficacy|0|||
131551492|NCT03485911|473643765|FG003|Part 2|Perceived lack of efficacy|2|||
131551493|NCT03485911|473643762|FG000|Part 2|Subject withdrew consent|1|||
131551494|NCT03485911|473643763|FG001|Part 2|Subject withdrew consent|0|||
131551495|NCT03485911|473643764|FG002|Part 2|Subject withdrew consent|2|||
131551496|NCT03485911|473643765|FG003|Part 2|Subject withdrew consent|1|||
131551497|NCT03485911|473643762|FG000|Part 2|Lab abnormalities/AEs|1|||
131551498|NCT03485911|473643763|FG001|Part 2|Lab abnormalities/AEs|2|||
131551499|NCT03485911|473643764|FG002|Part 2|Lab abnormalities/AEs|0|||
131551500|NCT03485911|473643765|FG003|Part 2|Lab abnormalities/AEs|0|||
131551501|NCT03485911|473643762|FG000|Part 2|Other NOS|0|||
131551502|NCT03485911|473643763|FG001|Part 2|Other NOS|1|||
131551503|NCT03485911|473643764|FG002|Part 2|Other NOS|0|||
131551504|NCT03485911|473643765|FG003|Part 2|Other NOS|0|||
131551505|NCT03485911|473643762|FG000|Part 2|Intercurrent illness/new medical condition|1|||
131551506|NCT03485911|473643763|FG001|Part 2|Intercurrent illness/new medical condition|0|||
131551507|NCT03485911|473643764|FG002|Part 2|Intercurrent illness/new medical condition|0|||
131551508|NCT03485911|473643765|FG003|Part 2|Intercurrent illness/new medical condition|0|||
131551509|NCT03485911|473643762|FG000|Part 2|Investigator judgement|1|||
131551510|NCT03485911|473643763|FG001|Part 2|Investigator judgement|0|||
131551511|NCT03485911|473643764|FG002|Part 2|Investigator judgement|0|||
131551512|NCT03485911|473643765|FG003|Part 2|Investigator judgement|0|||
131551513|NCT03485911|473643762|FG000|Part 3|Perceived lack of efficacy|2|||
131551514|NCT03485911|473643763|FG001|Part 3|Perceived lack of efficacy|2|||
131551515|NCT03485911|473643764|FG002|Part 3|Perceived lack of efficacy|2|||
131551516|NCT03485911|473643765|FG003|Part 3|Perceived lack of efficacy|0|||
131551517|NCT03485911|473643762|FG000|Part 3|Subject withdrew consent|1|||
131551518|NCT03485911|473643763|FG001|Part 3|Subject withdrew consent|4|||
131551519|NCT03485911|473643764|FG002|Part 3|Subject withdrew consent|0|||
131551520|NCT03485911|473643765|FG003|Part 3|Subject withdrew consent|1|||
131551521|NCT03485911|473643762|FG000|Part 3|Lab abnormalities/AEs|1|||
131551522|NCT03485911|473643763|FG001|Part 3|Lab abnormalities/AEs|1|||
131551523|NCT03485911|473643764|FG002|Part 3|Lab abnormalities/AEs|0|||
131551524|NCT03485911|473643765|FG003|Part 3|Lab abnormalities/AEs|2|||
131551525|NCT03485911|473643762|FG000|Part 3|Other NOS|1|||
131551526|NCT03485911|473643763|FG001|Part 3|Other NOS|1|||
131551527|NCT03485911|473643764|FG002|Part 3|Other NOS|0|||
131551528|NCT03485911|473643765|FG003|Part 3|Other NOS|0|||
131551529|NCT03485911|473643762|FG000|Part 3|Intercurrent illness/new medical condition|0|||
131551530|NCT03485911|473643763|FG001|Part 3|Intercurrent illness/new medical condition|1|||
131551531|NCT03485911|473643764|FG002|Part 3|Intercurrent illness/new medical condition|1|||
131551532|NCT03485911|473643765|FG003|Part 3|Intercurrent illness/new medical condition|0|||
131551533|NCT03485911|473643762|FG000|Part 3|Sponsor discontinuation|1|||
131551534|NCT03485911|473643763|FG001|Part 3|Sponsor discontinuation|0|||
131551535|NCT03485911|473643764|FG002|Part 3|Sponsor discontinuation|0|||
131551536|NCT03485911|473643765|FG003|Part 3|Sponsor discontinuation|0|||
131771862|NCT01399619|474442150|FG003|Overall Study|Protocol Violation|1|||
131551537|NCT03485911|473643762|FG000|Part 3|Berotralstat provided by alternative means|13|||
131551538|NCT03485911|473643763|FG001|Part 3|Berotralstat provided by alternative means|13|||
131551539|NCT03485911|473643764|FG002|Part 3|Berotralstat provided by alternative means|7|||
131551540|NCT03485911|473643765|FG003|Part 3|Berotralstat provided by alternative means|7|||
131551541|NCT03528174|473643770|FG000|Overall Study|Adverse Event|1|||
131551542|NCT03528174|473643770|FG000|Overall Study|sensors dislodged|1|||
131551543|NCT03002038|473643771|FG000|Overall Study|Adverse Event|3|||
131551544|NCT03002038|473643772|FG001|Overall Study|Adverse Event|1|||
131551545|NCT03002038|473643771|FG000|Overall Study|Withdrawal by Subject|8|||
131551546|NCT03002038|473643772|FG001|Overall Study|Withdrawal by Subject|4|||
131551547|NCT03002038|473643771|FG000|Overall Study|Immigration to another region|0|||
131551548|NCT03002038|473643772|FG001|Overall Study|Immigration to another region|2|||
131551549|NCT01719237|473643779|FG000|Overall Study|Physician Decision|0|||
131551550|NCT01719237|473643780|FG001|Overall Study|Physician Decision|1|||
131551551|NCT03724396|473643785|FG000|Overall Study|Lost to Follow-up|1|||
131551552|NCT03724396|473643786|FG001|Overall Study|Lost to Follow-up|1|||
131551553|NCT03724396|473643785|FG000|Overall Study|Withdrawal by Subject|1|||
131551554|NCT03724396|473643786|FG001|Overall Study|Withdrawal by Subject|0|||
131551555|NCT03879408|473643787|FG000|Overall Study|Lost to Follow-up|0|||
131551556|NCT03879408|473643788|FG001|Overall Study|Lost to Follow-up|3|||
131551557|NCT03879408|473643789|FG002|Overall Study|Lost to Follow-up|2|||
131551558|NCT03879408|473643790|FG003|Overall Study|Lost to Follow-up|1|||
131551559|NCT03879408|473643791|FG004|Overall Study|Lost to Follow-up|0|||
131551560|NCT03879408|473643787|FG000|Overall Study|Withdrawal by Subject|2|||
131551561|NCT03879408|473643788|FG001|Overall Study|Withdrawal by Subject|1|||
131551562|NCT03879408|473643789|FG002|Overall Study|Withdrawal by Subject|1|||
131551563|NCT03879408|473643790|FG003|Overall Study|Withdrawal by Subject|0|||
131551564|NCT03879408|473643791|FG004|Overall Study|Withdrawal by Subject|1|||
131551565|NCT01490125|473643792|FG000|Period I|Adverse Event|4|||
131551566|NCT01490125|473643793|FG001|Period I|Adverse Event|1|||
131551567|NCT01490125|473643794|FG002|Period I|Adverse Event|1|||
131551568|NCT01490125|473643795|FG003|Period I|Adverse Event|3|||
131551569|NCT01490125|473643796|FG004|Period I|Adverse Event|2|||
131551570|NCT01490125|473643797|FG005|Period I|Adverse Event|4|||
131551571|NCT01490125|473643792|FG000|Period I|Protocol Violation|1|||
131551572|NCT01490125|473643793|FG001|Period I|Protocol Violation|1|||
131551573|NCT01490125|473643794|FG002|Period I|Protocol Violation|1|||
131551574|NCT01490125|473643795|FG003|Period I|Protocol Violation|1|||
131551575|NCT01490125|473643796|FG004|Period I|Protocol Violation|0|||
131551576|NCT01490125|473643797|FG005|Period I|Protocol Violation|0|||
131551577|NCT01490125|473643792|FG000|Period I|Withdrawal by Subject|1|||
131551578|NCT01490125|473643793|FG001|Period I|Withdrawal by Subject|3|||
131551579|NCT01490125|473643794|FG002|Period I|Withdrawal by Subject|2|||
131551580|NCT01490125|473643795|FG003|Period I|Withdrawal by Subject|1|||
131551581|NCT01490125|473643796|FG004|Period I|Withdrawal by Subject|2|||
131551582|NCT01490125|473643797|FG005|Period I|Withdrawal by Subject|1|||
131551583|NCT01490125|473643792|FG000|Period II|Adverse Event|2|||
131551584|NCT01490125|473643793|FG001|Period II|Adverse Event|3|||
131551585|NCT01490125|473643794|FG002|Period II|Adverse Event|2|||
131551586|NCT01490125|473643795|FG003|Period II|Adverse Event|2|||
131551587|NCT01490125|473643796|FG004|Period II|Adverse Event|4|||
131551588|NCT01490125|473643797|FG005|Period II|Adverse Event|2|||
131551589|NCT01490125|473643792|FG000|Period II|Protocol Violation|0|||
131551590|NCT01490125|473643793|FG001|Period II|Protocol Violation|0|||
131551591|NCT01490125|473643794|FG002|Period II|Protocol Violation|1|||
131551592|NCT01490125|473643795|FG003|Period II|Protocol Violation|1|||
131551593|NCT01490125|473643796|FG004|Period II|Protocol Violation|0|||
131551594|NCT01490125|473643797|FG005|Period II|Protocol Violation|0|||
131551595|NCT01490125|473643792|FG000|Period II|Lost to Follow-up|0|||
131551596|NCT01490125|473643793|FG001|Period II|Lost to Follow-up|1|||
131551597|NCT01490125|473643794|FG002|Period II|Lost to Follow-up|0|||
131551598|NCT01490125|473643795|FG003|Period II|Lost to Follow-up|0|||
131551599|NCT01490125|473643796|FG004|Period II|Lost to Follow-up|0|||
131551600|NCT01490125|473643797|FG005|Period II|Lost to Follow-up|0|||
131551601|NCT01490125|473643792|FG000|Period II|Withdrawal by Subject|1|||
131551602|NCT01490125|473643793|FG001|Period II|Withdrawal by Subject|0|||
131551603|NCT01490125|473643794|FG002|Period II|Withdrawal by Subject|0|||
131771863|NCT01399619|474442147|FG000|Overall Study|Not treated|0|||
131771864|NCT01399619|474442148|FG001|Overall Study|Not treated|0|||
131771865|NCT01399619|474442149|FG002|Overall Study|Not treated|0|||
131771866|NCT01399619|474442150|FG003|Overall Study|Not treated|2|||
131771867|NCT00462501|474442151|FG000|Overall Study|Not treated|3|||
131551604|NCT01490125|473643795|FG003|Period II|Withdrawal by Subject|0|||
131551605|NCT01490125|473643796|FG004|Period II|Withdrawal by Subject|0|||
131551606|NCT01490125|473643797|FG005|Period II|Withdrawal by Subject|0|||
131551607|NCT01490125|473643792|FG000|Period III|Adverse Event|3|||
131551608|NCT01490125|473643793|FG001|Period III|Adverse Event|1|||
131551609|NCT01490125|473643794|FG002|Period III|Adverse Event|0|||
131551610|NCT01490125|473643795|FG003|Period III|Adverse Event|1|||
131551611|NCT01490125|473643796|FG004|Period III|Adverse Event|0|||
131551612|NCT01490125|473643797|FG005|Period III|Adverse Event|0|||
131551613|NCT01490125|473643792|FG000|Period III|Death|0|||
131551614|NCT01490125|473643793|FG001|Period III|Death|0|||
131551615|NCT01490125|473643794|FG002|Period III|Death|0|||
131551616|NCT01490125|473643795|FG003|Period III|Death|1|||
131551617|NCT01490125|473643796|FG004|Period III|Death|0|||
131551618|NCT01490125|473643797|FG005|Period III|Death|0|||
131551619|NCT01490125|473643792|FG000|Period III|Lack of Efficacy|0|||
131551620|NCT01490125|473643793|FG001|Period III|Lack of Efficacy|0|||
131551621|NCT01490125|473643794|FG002|Period III|Lack of Efficacy|0|||
131551622|NCT01490125|473643795|FG003|Period III|Lack of Efficacy|0|||
131551623|NCT01490125|473643796|FG004|Period III|Lack of Efficacy|1|||
131551624|NCT01490125|473643797|FG005|Period III|Lack of Efficacy|0|||
131551625|NCT02237508|473643799|FG000|Overall Study|Withdrawal by Subject|0|||
131551626|NCT02237508|473643800|FG001|Overall Study|Withdrawal by Subject|2|||
131551627|NCT02237508|473643801|FG002|Overall Study|Withdrawal by Subject|0|||
131551628|NCT02237508|473643802|FG003|Overall Study|Withdrawal by Subject|1|||
131551629|NCT02237508|473643803|FG004|Overall Study|Withdrawal by Subject|0|||
131551630|NCT02237508|473643804|FG005|Overall Study|Withdrawal by Subject|1|||
131551631|NCT02237508|473643805|FG006|Overall Study|Withdrawal by Subject|1|||
131551632|NCT02237508|473643806|FG007|Overall Study|Withdrawal by Subject|0|||
131551633|NCT02237508|473643807|FG008|Overall Study|Withdrawal by Subject|1|||
131551634|NCT02237508|473643808|FG009|Overall Study|Withdrawal by Subject|0|||
131551635|NCT02237508|473643799|FG000|Overall Study|Physician Decision|0|||
131551636|NCT02237508|473643800|FG001|Overall Study|Physician Decision|1|||
131551637|NCT02237508|473643801|FG002|Overall Study|Physician Decision|0|||
131551638|NCT02237508|473643802|FG003|Overall Study|Physician Decision|0|||
131551639|NCT02237508|473643803|FG004|Overall Study|Physician Decision|0|||
131551640|NCT02237508|473643804|FG005|Overall Study|Physician Decision|0|||
131551641|NCT02237508|473643805|FG006|Overall Study|Physician Decision|0|||
131551642|NCT02237508|473643806|FG007|Overall Study|Physician Decision|0|||
131551643|NCT02237508|473643807|FG008|Overall Study|Physician Decision|0|||
131551644|NCT02237508|473643808|FG009|Overall Study|Physician Decision|0|||
131551645|NCT02237508|473643799|FG000|Overall Study|Protocol Violation|0|||
131551646|NCT02237508|473643800|FG001|Overall Study|Protocol Violation|0|||
131551647|NCT02237508|473643801|FG002|Overall Study|Protocol Violation|1|||
131551648|NCT02237508|473643802|FG003|Overall Study|Protocol Violation|0|||
131551649|NCT02237508|473643803|FG004|Overall Study|Protocol Violation|0|||
131551650|NCT02237508|473643804|FG005|Overall Study|Protocol Violation|0|||
131551651|NCT02237508|473643805|FG006|Overall Study|Protocol Violation|0|||
131551652|NCT02237508|473643806|FG007|Overall Study|Protocol Violation|0|||
131551653|NCT02237508|473643807|FG008|Overall Study|Protocol Violation|0|||
131551654|NCT02237508|473643808|FG009|Overall Study|Protocol Violation|0|||
131771868|NCT00462501|474442151|FG000|Overall Study|Adverse Event|2|||
131771869|NCT00998166|474442152|FG000|Overall Study|Early Study Termination|8|||
131771870|NCT03172026|474442166|FG000|Overall Study|Withdrawal by Subject|1|||
131771871|NCT03172026|474442167|FG001|Overall Study|Withdrawal by Subject|0|||
131551655|NCT04000594|473643809|FG000|Overall Study|Withdrawal by Subject|1|||
131551656|NCT04000594|473643810|FG001|Overall Study|Withdrawal by Subject|0|||
131551657|NCT04000594|473643811|FG002|Overall Study|Withdrawal by Subject|0|||
131551658|NCT04522180|473643812|FG000|Overall Study|Investigator judgement|3|||
131551659|NCT04522180|473643813|FG001|Overall Study|Investigator judgement|4|||
131551660|NCT04522180|473643812|FG000|Overall Study|Voluntary withdrawal|1|||
131551661|NCT04522180|473643813|FG001|Overall Study|Voluntary withdrawal|0|||
131551662|NCT04522180|473643812|FG000|Overall Study|Pregnancy|0|||
131551663|NCT04522180|473643813|FG001|Overall Study|Pregnancy|1|||
131551664|NCT04522180|473643812|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
131551665|NCT04522180|473643813|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
131551666|NCT04522180|473643812|FG000|Overall Study|Reason not specified|8|||
131551667|NCT04522180|473643813|FG001|Overall Study|Reason not specified|5|||
131551668|NCT01905046|473643814|FG000|Months 13-24|Withdrawal by Subject|10|||
131551669|NCT01905046|473643815|FG001|Months 13-24|Withdrawal by Subject|10|||
131551670|NCT01905046|473643814|FG000|Months 13-24|Adverse Event|3|||
131551671|NCT01905046|473643815|FG001|Months 13-24|Adverse Event|2|||
131551672|NCT01905046|473643814|FG000|Months 13-24|Protocol Violation|3|||
131551673|NCT01905046|473643815|FG001|Months 13-24|Protocol Violation|3|||
131551674|NCT01905046|473643814|FG000|Months 13-24|Physician Decision|1|||
131551675|NCT01905046|473643815|FG001|Months 13-24|Physician Decision|0|||
131551676|NCT01368900|473643822|FG000|Overall Study|Lost to Follow-up|7|||
131551677|NCT01552954|473643825|FG000|Overall Study|Adverse Event|1|||
131551678|NCT01552954|473643826|FG001|Overall Study|Adverse Event|2|||
131551679|NCT01552954|473643825|FG000|Overall Study|Lost to Follow-up|1|||
131551680|NCT01552954|473643826|FG001|Overall Study|Lost to Follow-up|1|||
131551681|NCT01552954|473643825|FG000|Overall Study|Withdrawal by Subject|1|||
131551682|NCT01552954|473643826|FG001|Overall Study|Withdrawal by Subject|1|||
131551683|NCT01552954|473643825|FG000|Overall Study|Protocol Violation|1|||
131771872|NCT03172026|474442166|FG000|Overall Study|COVID restrictions|1|||
131551684|NCT01552954|473643826|FG001|Overall Study|Protocol Violation|2|||
131551685|NCT01552954|473643825|FG000|Overall Study|diagnosed DM|1|||
131551686|NCT01552954|473643826|FG001|Overall Study|diagnosed DM|0|||
131551687|NCT01931735|473643827|FG000|Randomized Phase|Lost to Follow-up|2|||
131551688|NCT01931735|473643828|FG001|Randomized Phase|Lost to Follow-up|2|||
131551689|NCT01931735|473643829|FG002|Randomized Phase|Lost to Follow-up|5|||
131551690|NCT01931735|473643830|FG003|Randomized Phase|Lost to Follow-up|0|||
131551691|NCT01931735|473643827|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
131551692|NCT01931735|473643828|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
131551693|NCT01931735|473643829|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
131551694|NCT01931735|473643830|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
131551695|NCT01931735|473643827|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
131551696|NCT01931735|473643828|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
131551697|NCT01931735|473643829|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
131551698|NCT01931735|473643830|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
131551699|NCT02719990|473643831|FG000|Overall Study|Physician Decision|2|||
131551700|NCT02719990|473643831|FG000|Overall Study|Withdrawal by Subject|2|||
131551701|NCT02719990|473643831|FG000|Overall Study|Study Terminated By Sponsor|32|||
131551702|NCT02070484|473643832|FG000|Overall Study|Withdrawal by Subject|1|||
131551703|NCT02070484|473643833|FG001|Overall Study|Withdrawal by Subject|0|||
131551704|NCT02130284|473643836|FG000|Overall Study|Withdrawal by Subject|3|||
131551705|NCT02130284|473643836|FG000|Overall Study|Subject Withdrew Consent|1|||
131551706|NCT02130284|473643836|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
131551707|NCT02130284|473643836|FG000|Overall Study|Subject was screened as backup for study|3|||
131551708|NCT02130284|473643836|FG000|Overall Study|Screen Failure|1|||
131551709|NCT01119898|473643837|FG000|Overall Study|Adverse Event|4|||
131551710|NCT01119898|473643838|FG001|Overall Study|Adverse Event|5|||
131551711|NCT01119898|473643837|FG000|Overall Study|Withdrawal by Subject|1|||
131551712|NCT01119898|473643838|FG001|Overall Study|Withdrawal by Subject|4|||
131551713|NCT01119898|473643837|FG000|Overall Study|Lack of Efficacy|0|||
131551714|NCT01119898|473643838|FG001|Overall Study|Lack of Efficacy|2|||
131551715|NCT01119898|473643837|FG000|Overall Study|Protocol Violation|1|||
131551716|NCT01119898|473643838|FG001|Overall Study|Protocol Violation|1|||
131551717|NCT01119898|473643837|FG000|Overall Study|Medical procedure|1|||
131551718|NCT01119898|473643838|FG001|Overall Study|Medical procedure|0|||
131551719|NCT01119898|473643837|FG000|Overall Study|Randomized in error did not participate|1|||
131551720|NCT01119898|473643838|FG001|Overall Study|Randomized in error did not participate|0|||
131551721|NCT01480596|473646002|FG000|Overall Study|Adverse Event|3|||
131551722|NCT01480596|473646003|FG001|Overall Study|Adverse Event|0|||
131551723|NCT01480596|473646002|FG000|Overall Study|MG exacerbation or change in medication|2|||
131551724|NCT01480596|473646003|FG001|Overall Study|MG exacerbation or change in medication|2|||
131551725|NCT04503096|473646004|FG000|Overall Study|Withdrawal by Subject|3|||
131551726|NCT02281760|473646005|FG000|Overall Study|Withdrawal by Subject|1|||
131551727|NCT01576367|473646006|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131551728|NCT01576367|473646006|FG000|Overall Study|Moved to commercial use after 6 months|1|||
131551729|NCT01453348|473646007|FG000|Overall Study|Death|0|||
131551730|NCT01453348|473646008|FG001|Overall Study|Death|0|||
131551731|NCT01453348|473646009|FG002|Overall Study|Death|1|||
131551732|NCT01453348|473646007|FG000|Overall Study|Withdrawal by Subject|0|||
131551733|NCT01453348|473646008|FG001|Overall Study|Withdrawal by Subject|1|||
131551734|NCT01453348|473646009|FG002|Overall Study|Withdrawal by Subject|0|||
131551735|NCT01453348|473646007|FG000|Overall Study|Protocol Violation|1|||
131551736|NCT01453348|473646008|FG001|Overall Study|Protocol Violation|0|||
131551737|NCT01453348|473646009|FG002|Overall Study|Protocol Violation|0|||
131551738|NCT00954733|473646014|FG000|Overall Study|blood gas machine did not work|1|||
131551739|NCT00979602|473646019|FG000|Overall Study|Serious Adverse Event|5|||
131551740|NCT00979602|473646020|FG001|Overall Study|Serious Adverse Event|3|||
131551741|NCT00979602|473646019|FG000|Overall Study|Protocol Violation|3|||
131551742|NCT00979602|473646020|FG001|Overall Study|Protocol Violation|0|||
131551743|NCT00979602|473646019|FG000|Overall Study|Withdrawal by Subject|31|||
131551744|NCT00979602|473646020|FG001|Overall Study|Withdrawal by Subject|25|||
131551745|NCT00979602|473646019|FG000|Overall Study|Lost to Follow-up|100|||
131551746|NCT00979602|473646020|FG001|Overall Study|Lost to Follow-up|96|||
131551747|NCT00979602|473646019|FG000|Overall Study|Migrated/moved from study area|3|||
131551748|NCT00979602|473646020|FG001|Overall Study|Migrated/moved from study area|6|||
131551749|NCT00979602|473646019|FG000|Overall Study|Others|3|||
131551750|NCT00979602|473646020|FG001|Overall Study|Others|3|||
131551751|NCT02904902|473646021|FG000|Overall Study|Withdrawal by Subject|1|||
131551752|NCT02712398|473646022|FG000|Overall Study|Withdrawal by Subject|6|||
131551753|NCT02712398|473646022|FG000|Overall Study|Lost to Follow-up|6|||
131551754|NCT02712398|473646022|FG000|Overall Study|Sponsor Decision|1|||
131551755|NCT02712398|473646022|FG000|Overall Study|Physician Decision|1|||
131551756|NCT02712398|473646022|FG000|Overall Study|Death|2|||
131551757|NCT02712398|473646022|FG000|Overall Study|Re-operation|21|||
131551758|NCT01216163|473646027|FG000|Overall Study|Withdrawal by Subject|1|||
131551759|NCT01216163|473646028|FG001|Overall Study|Withdrawal by Subject|1|||
131551760|NCT01216163|473646029|FG002|Overall Study|Withdrawal by Subject|0|||
131551761|NCT02914314|473646030|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
131551762|NCT02914314|473646031|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
131551763|NCT02914314|473646032|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
131551764|NCT02914314|473646033|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
131551765|NCT02914314|473646030|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
131551766|NCT02914314|473646031|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
131551767|NCT02914314|473646032|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
131551768|NCT02914314|473646033|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
131551769|NCT02914314|473646030|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
131551770|NCT02914314|473646031|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
131551771|NCT02914314|473646032|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
131551772|NCT02914314|473646033|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
131551773|NCT02914314|473646030|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
131551774|NCT02914314|473646031|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
131551775|NCT02914314|473646032|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
131551776|NCT02914314|473646033|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
131551777|NCT02914314|473646030|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
131551778|NCT02914314|473646031|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
131551779|NCT02914314|473646032|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
131551780|NCT02914314|473646033|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
131551781|NCT01735396|473646037|FG000|Overall Study|not evaluable|1|||
131551782|NCT04296890|473646038|FG000|Overall Study|Withdrawal by Subject|1|||
131551783|NCT04296890|473646038|FG000|Overall Study|Death|62|||
131551784|NCT04296890|473646038|FG000|Overall Study|Lost to Follow-up|3|||
131551785|NCT04296890|473646038|FG000|Overall Study|Other than specified|2|||
131551786|NCT05400746|473646039|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
131551787|NCT05400746|473646040|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
131551788|NCT05400746|473646041|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
131551789|NCT01224158|473646046|FG000|Overall Study|Withdrawal by Subject|1|||
131551790|NCT01224158|473646047|FG001|Overall Study|Withdrawal by Subject|0|||
131551791|NCT00733499|473646050|FG000|Pre-operative|Protocol Violation|0|||
131551792|NCT00733499|473646051|FG001|Pre-operative|Protocol Violation|1|||
131551793|NCT00733499|473646050|FG000|3 Months Follow-up|Death|1|||
131551794|NCT00733499|473646051|FG001|3 Months Follow-up|Death|2|||
131551795|NCT00733499|473646050|FG000|6 Months Follow-up|Death|0|||
131551796|NCT00733499|473646051|FG001|6 Months Follow-up|Death|2|||
131551797|NCT00733499|473646050|FG000|6 Months Follow-up|Adverse Event|0|||
131551798|NCT00733499|473646051|FG001|6 Months Follow-up|Adverse Event|1|||
131551799|NCT00733499|473646050|FG000|12 Months Follow-up|Death|2|||
131551800|NCT00733499|473646051|FG001|12 Months Follow-up|Death|1|||
131551801|NCT00733499|473646050|FG000|24 Months Follow-up|Death|0|||
131551802|NCT00733499|473646051|FG001|24 Months Follow-up|Death|1|||
131551803|NCT00733499|473646050|FG000|5 Year Followup|Adverse Event|2|||
131551804|NCT00733499|473646051|FG001|5 Year Followup|Adverse Event|2|||
131551805|NCT00733499|473646050|FG000|5 Year Followup|Non device related AE|0|||
131551806|NCT00733499|473646051|FG001|5 Year Followup|Non device related AE|1|||
131551807|NCT00733499|473646050|FG000|5 Year Followup|Revision of Study Implant|0|||
131551808|NCT00733499|473646051|FG001|5 Year Followup|Revision of Study Implant|1|||
131551809|NCT00733499|473646050|FG000|5 Year Followup|Lost to Follow-up|2|||
131551810|NCT00733499|473646051|FG001|5 Year Followup|Lost to Follow-up|0|||
131551811|NCT00733499|473646050|FG000|5 Year Followup|Death|13|||
131551812|NCT00733499|473646051|FG001|5 Year Followup|Death|19|||
131551813|NCT00733499|473646050|FG000|5 Year Followup|missing, unable to locate|0|||
131551814|NCT00733499|473646051|FG001|5 Year Followup|missing, unable to locate|1|||
131551815|NCT00733499|473646050|FG000|5 Year Followup|Withdrawal by Subject|4|||
131551816|NCT00733499|473646051|FG001|5 Year Followup|Withdrawal by Subject|1|||
131551817|NCT00733499|473646050|FG000|10 Year Followup|Death|9|||
131551818|NCT00733499|473646051|FG001|10 Year Followup|Death|7|||
131551819|NCT00733499|473646050|FG000|10 Year Followup|Adverse Event|3|||
131551820|NCT00733499|473646051|FG001|10 Year Followup|Adverse Event|3|||
131551821|NCT00733499|473646050|FG000|10 Year Followup|Lost to Follow-up|3|||
131551822|NCT00733499|473646051|FG001|10 Year Followup|Lost to Follow-up|2|||
131551823|NCT00733499|473646050|FG000|10 Year Followup|Withdrawal by Subject|5|||
131551824|NCT00733499|473646051|FG001|10 Year Followup|Withdrawal by Subject|5|||
131551825|NCT00733499|473646050|FG000|10 Year Followup|missing, unable to locate|0|||
131771873|NCT03172026|474442167|FG001|Overall Study|COVID restrictions|0|||
131551826|NCT00733499|473646051|FG001|10 Year Followup|missing, unable to locate|2|||
131551827|NCT01778556|473646052|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
131551828|NCT01778556|473646053|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
131551829|NCT01778556|473646052|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
131551830|NCT01778556|473646053|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
131551831|NCT01778556|473646052|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
131551832|NCT01778556|473646053|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
131551833|NCT01778556|473646052|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
131551834|NCT01778556|473646053|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
131551835|NCT01235403|473646057|FG000|Overall Study|Adverse Event|14|||
131551836|NCT01235403|473646057|FG000|Overall Study|Lost to Follow-up|2|||
131551837|NCT01235403|473646057|FG000|Overall Study|Withdrawal by Subject|4|||
131551838|NCT01235403|473646057|FG000|Overall Study|Lack of Efficacy|2|||
131551839|NCT01235403|473646057|FG000|Overall Study|Other reasons for premature termination|4|||
131551840|NCT02296190|473646058|FG000|Overall Study|Lost to Follow-up|0|||
131551841|NCT02296190|473646059|FG001|Overall Study|Lost to Follow-up|0|||
131551842|NCT02296190|473646060|FG002|Overall Study|Lost to Follow-up|0|||
131551843|NCT02296190|473646061|FG003|Overall Study|Lost to Follow-up|0|||
131551844|NCT02296190|473646062|FG004|Overall Study|Lost to Follow-up|1|||
131551845|NCT02296190|473646063|FG005|Overall Study|Lost to Follow-up|0|||
131551846|NCT02296190|473646058|FG000|Overall Study|Failure to induce PSVT|6|||
131551847|NCT02296190|473646059|FG001|Overall Study|Failure to induce PSVT|10|||
131551848|NCT02296190|473646060|FG002|Overall Study|Failure to induce PSVT|5|||
131551849|NCT02296190|473646061|FG003|Overall Study|Failure to induce PSVT|13|||
131551850|NCT02296190|473646062|FG004|Overall Study|Failure to induce PSVT|8|||
131551851|NCT02296190|473646063|FG005|Overall Study|Failure to induce PSVT|0|||
131551852|NCT02296190|473646058|FG000|Overall Study|Physician Decision|1|||
131551853|NCT02296190|473646059|FG001|Overall Study|Physician Decision|1|||
131551854|NCT02296190|473646060|FG002|Overall Study|Physician Decision|0|||
131551855|NCT02296190|473646061|FG003|Overall Study|Physician Decision|1|||
131551856|NCT02296190|473646062|FG004|Overall Study|Physician Decision|2|||
131551857|NCT02296190|473646063|FG005|Overall Study|Physician Decision|0|||
131551858|NCT02296190|473646058|FG000|Overall Study|Withdrawal by Subject|0|||
131551859|NCT02296190|473646059|FG001|Overall Study|Withdrawal by Subject|1|||
131551860|NCT02296190|473646060|FG002|Overall Study|Withdrawal by Subject|0|||
131551861|NCT02296190|473646061|FG003|Overall Study|Withdrawal by Subject|0|||
131551862|NCT02296190|473646062|FG004|Overall Study|Withdrawal by Subject|0|||
131551863|NCT02296190|473646063|FG005|Overall Study|Withdrawal by Subject|0|||
131551864|NCT02296190|473646058|FG000|Overall Study|PSVT < 5 minutes|5|||
131551865|NCT02296190|473646059|FG001|Overall Study|PSVT < 5 minutes|6|||
131551866|NCT02296190|473646060|FG002|Overall Study|PSVT < 5 minutes|6|||
131551867|NCT02296190|473646061|FG003|Overall Study|PSVT < 5 minutes|6|||
131551868|NCT02296190|473646062|FG004|Overall Study|PSVT < 5 minutes|5|||
131551869|NCT02296190|473646063|FG005|Overall Study|PSVT < 5 minutes|0|||
131551870|NCT02296190|473646058|FG000|Overall Study|Patient was given Propofol|0|||
131551871|NCT02296190|473646059|FG001|Overall Study|Patient was given Propofol|1|||
131551872|NCT02296190|473646060|FG002|Overall Study|Patient was given Propofol|0|||
131551873|NCT02296190|473646061|FG003|Overall Study|Patient was given Propofol|1|||
131551874|NCT02296190|473646062|FG004|Overall Study|Patient was given Propofol|0|||
131551875|NCT02296190|473646063|FG005|Overall Study|Patient was given Propofol|0|||
131551876|NCT02296190|473646058|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
131551877|NCT02296190|473646059|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
131551878|NCT02296190|473646060|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
131551879|NCT02296190|473646061|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
131551880|NCT02296190|473646062|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
131551881|NCT02296190|473646063|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
131551882|NCT02296190|473646058|FG000|Overall Study|Blood pressure <100 after sedation|0|||
131551883|NCT02296190|473646059|FG001|Overall Study|Blood pressure <100 after sedation|0|||
131551884|NCT02296190|473646060|FG002|Overall Study|Blood pressure <100 after sedation|0|||
131551885|NCT02296190|473646061|FG003|Overall Study|Blood pressure <100 after sedation|1|||
131551886|NCT02296190|473646062|FG004|Overall Study|Blood pressure <100 after sedation|0|||
131551887|NCT02296190|473646063|FG005|Overall Study|Blood pressure <100 after sedation|0|||
131551888|NCT02296190|473646058|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
131551889|NCT02296190|473646059|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
131551890|NCT02296190|473646060|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
131551891|NCT02296190|473646061|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
131551892|NCT02296190|473646062|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
131551893|NCT02296190|473646063|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
131551894|NCT02296190|473646058|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
131551895|NCT02296190|473646059|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
131551896|NCT02296190|473646060|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
131551897|NCT02296190|473646061|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
131551898|NCT02296190|473646062|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
131551899|NCT02296190|473646063|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
131551900|NCT02296190|473646058|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
131551901|NCT02296190|473646059|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
131771874|NCT00612456|474442168|FG000|Overall Study|Adverse Event|1|||
131551902|NCT02296190|473646060|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
131551903|NCT02296190|473646061|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
131551904|NCT02296190|473646062|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
131551905|NCT02296190|473646063|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
131551906|NCT02296190|473646058|FG000|Overall Study|Lab result not available in time|1|||
131551907|NCT02296190|473646059|FG001|Overall Study|Lab result not available in time|0|||
131771875|NCT00612456|474442169|FG001|Overall Study|Adverse Event|0|||
131551908|NCT02296190|473646060|FG002|Overall Study|Lab result not available in time|0|||
131551909|NCT02296190|473646061|FG003|Overall Study|Lab result not available in time|0|||
131551910|NCT02296190|473646062|FG004|Overall Study|Lab result not available in time|0|||
131551911|NCT02296190|473646063|FG005|Overall Study|Lab result not available in time|0|||
131551912|NCT00782496|473646064|FG000|Overall Study|Lost to Follow-up|14|||
131551913|NCT00782496|473646065|FG001|Overall Study|Lost to Follow-up|15|||
131551914|NCT03682705|473646068|FG000|Overall Study|Adverse Event|1|||
131551915|NCT03682705|473646069|FG001|Overall Study|Adverse Event|1|||
131551916|NCT03682705|473646070|FG002|Overall Study|Adverse Event|1|||
131551917|NCT03682705|473646071|FG003|Overall Study|Adverse Event|0|||
131551918|NCT03682705|473646072|FG004|Overall Study|Adverse Event|1|||
131551919|NCT03682705|473646073|FG005|Overall Study|Adverse Event|1|||
131551920|NCT03682705|473646068|FG000|Overall Study|Withdrawal by Subject|1|||
131551921|NCT03682705|473646069|FG001|Overall Study|Withdrawal by Subject|3|||
131771876|NCT00612456|474442170|FG002|Overall Study|Adverse Event|0|||
131771877|NCT00612456|474442168|FG000|Overall Study|Lack of Efficacy|1|||
131771878|NCT00612456|474442169|FG001|Overall Study|Lack of Efficacy|1|||
131771879|NCT00612456|474442170|FG002|Overall Study|Lack of Efficacy|0|||
131771880|NCT00612456|474442168|FG000|Overall Study|Withdrawal by Subject|0|||
131771881|NCT00612456|474442169|FG001|Overall Study|Withdrawal by Subject|1|||
131771882|NCT00612456|474442170|FG002|Overall Study|Withdrawal by Subject|0|||
131771883|NCT02463097|474442171|FG000|Overall Study|Withdrawal by Subject|1|||
131771884|NCT01757821|474442172|FG000|Overall Study|Adverse Event|1|||
131771885|NCT01552408|474442173|FG000|Overall Study|Lost to Follow-up|2|||
131771886|NCT01552408|474442174|FG001|Overall Study|Lost to Follow-up|0|||
131551922|NCT03682705|473646070|FG002|Overall Study|Withdrawal by Subject|2|||
131551923|NCT03682705|473646071|FG003|Overall Study|Withdrawal by Subject|4|||
131551924|NCT03682705|473646072|FG004|Overall Study|Withdrawal by Subject|0|||
131551925|NCT03682705|473646073|FG005|Overall Study|Withdrawal by Subject|1|||
131551926|NCT03682705|473646068|FG000|Overall Study|Other, not specified|0|||
131551927|NCT03682705|473646069|FG001|Overall Study|Other, not specified|0|||
131551928|NCT03682705|473646070|FG002|Overall Study|Other, not specified|0|||
131551929|NCT03682705|473646071|FG003|Overall Study|Other, not specified|1|||
131551930|NCT03682705|473646072|FG004|Overall Study|Other, not specified|2|||
131551931|NCT03682705|473646073|FG005|Overall Study|Other, not specified|0|||
131551932|NCT03682705|473646068|FG000|Overall Study|Lost to Follow-up|0|||
131551933|NCT03682705|473646069|FG001|Overall Study|Lost to Follow-up|0|||
131551934|NCT03682705|473646070|FG002|Overall Study|Lost to Follow-up|0|||
131551935|NCT03682705|473646071|FG003|Overall Study|Lost to Follow-up|0|||
131551936|NCT03682705|473646072|FG004|Overall Study|Lost to Follow-up|3|||
131551937|NCT03682705|473646073|FG005|Overall Study|Lost to Follow-up|0|||
131551938|NCT00117156|473646074|FG000|Overall Study|Adverse Event|9|||
131551939|NCT00117156|473646074|FG000|Overall Study|Physician Decision|1|||
131551940|NCT00117156|473646074|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
131551941|NCT01919970|473646075|FG000|Overall Study|Withdrawal by Subject|3|||
131551942|NCT01919970|473646076|FG001|Overall Study|Withdrawal by Subject|0|||
131551943|NCT00990340|473646078|FG000|First 14-day Treatment|Not Compliant|2|||
131551944|NCT00990340|473646079|FG001|First 14-day Treatment|Not Compliant|1|||
131551945|NCT00990340|473646078|FG000|First 14-day Treatment|Lost to Follow-up|2|||
131551946|NCT00990340|473646079|FG001|First 14-day Treatment|Lost to Follow-up|1|||
131551947|NCT00990340|473646078|FG000|First 14-day Treatment|Protocol Violation|2|||
131551948|NCT00990340|473646079|FG001|First 14-day Treatment|Protocol Violation|2|||
131551949|NCT04615182|473646080|FG000|Overall Study|Re-transplanted|2|||
131551950|NCT04615182|473646080|FG000|Overall Study|Protocol Violation|6|||
131551951|NCT04615182|473646080|FG000|Overall Study|Death|6|||
131551952|NCT04615182|473646080|FG000|Overall Study|Death and protocol violation|1|||
131551953|NCT00402337|473646086|FG000|Overall Study|Adverse Event|0|||
131551954|NCT00402337|473646087|FG001|Overall Study|Adverse Event|2|||
131551955|NCT00402337|473646088|FG002|Overall Study|Adverse Event|2|||
131551956|NCT00402337|473646089|FG003|Overall Study|Adverse Event|3|||
131551957|NCT00402337|473646090|FG004|Overall Study|Adverse Event|2|||
131551958|NCT00402337|473646086|FG000|Overall Study|Noncompliance|0|||
131551959|NCT00402337|473646087|FG001|Overall Study|Noncompliance|0|||
131551960|NCT00402337|473646088|FG002|Overall Study|Noncompliance|0|||
131771887|NCT01552408|474442173|FG000|Overall Study|Relocation|0|||
131551961|NCT00402337|473646089|FG003|Overall Study|Noncompliance|0|||
131551962|NCT00402337|473646090|FG004|Overall Study|Noncompliance|2|||
131551963|NCT00402337|473646086|FG000|Overall Study|Withdrawal by Subject|5|||
131551964|NCT00402337|473646087|FG001|Overall Study|Withdrawal by Subject|3|||
131551965|NCT00402337|473646088|FG002|Overall Study|Withdrawal by Subject|1|||
131551966|NCT00402337|473646089|FG003|Overall Study|Withdrawal by Subject|6|||
131551967|NCT00402337|473646090|FG004|Overall Study|Withdrawal by Subject|4|||
131771888|NCT01552408|474442174|FG001|Overall Study|Relocation|1|||
131771889|NCT01552408|474442173|FG000|Overall Study|Withdrawal by Subject|2|||
131551968|NCT00402337|473646086|FG000|Overall Study|Lost to Follow-up|0|||
131551969|NCT00402337|473646087|FG001|Overall Study|Lost to Follow-up|0|||
131551970|NCT00402337|473646088|FG002|Overall Study|Lost to Follow-up|1|||
131771890|NCT01552408|474442174|FG001|Overall Study|Withdrawal by Subject|1|||
131551971|NCT00402337|473646089|FG003|Overall Study|Lost to Follow-up|2|||
131551972|NCT00402337|473646090|FG004|Overall Study|Lost to Follow-up|0|||
131551973|NCT00402337|473646086|FG000|Overall Study|Physician Decision|0|||
131551974|NCT00402337|473646087|FG001|Overall Study|Physician Decision|0|||
131551975|NCT00402337|473646088|FG002|Overall Study|Physician Decision|0|||
131551976|NCT00402337|473646089|FG003|Overall Study|Physician Decision|1|||
131551977|NCT00402337|473646090|FG004|Overall Study|Physician Decision|0|||
131551978|NCT00402337|473646086|FG000|Overall Study|Other Reason|0|||
131551979|NCT00402337|473646087|FG001|Overall Study|Other Reason|1|||
131551980|NCT00402337|473646088|FG002|Overall Study|Other Reason|0|||
131551981|NCT00402337|473646089|FG003|Overall Study|Other Reason|0|||
131551982|NCT00402337|473646090|FG004|Overall Study|Other Reason|0|||
131551983|NCT02178566|473646091|FG000|Overall Study|patient did not complete due to noncompliance|0|||
131551984|NCT02178566|473646092|FG001|Overall Study|patient did not complete due to noncompliance|1|||
131551985|NCT04631705|473646093|FG000|Overall Study|Withdrawal by Subject|0|||
131551986|NCT04631705|473646094|FG001|Overall Study|Withdrawal by Subject|0|||
131551987|NCT04631705|473646095|FG002|Overall Study|Withdrawal by Subject|0|||
131551988|NCT04631705|473646096|FG003|Overall Study|Withdrawal by Subject|0|||
131551989|NCT04631705|473646097|FG004|Overall Study|Withdrawal by Subject|0|||
131551990|NCT04631705|473646098|FG005|Overall Study|Withdrawal by Subject|0|||
131551991|NCT04631705|473646099|FG006|Overall Study|Withdrawal by Subject|1|||
131551992|NCT04631705|473646100|FG007|Overall Study|Withdrawal by Subject|0|||
131551993|NCT04631705|473646101|FG008|Overall Study|Withdrawal by Subject|0|||
131551994|NCT02658630|473646102|FG000|Overall Study|Withdrawal by Subject|4|||
131551995|NCT00682643|473646103|FG000|Overall Study|Adverse Event|12|||
131551996|NCT00682643|473646104|FG001|Overall Study|Adverse Event|23|||
131551997|NCT00682643|473646103|FG000|Overall Study|Lack of Efficacy|2|||
131551998|NCT00682643|473646104|FG001|Overall Study|Lack of Efficacy|0|||
131551999|NCT00682643|473646103|FG000|Overall Study|Protocol Violation|38|||
131552000|NCT00682643|473646104|FG001|Overall Study|Protocol Violation|76|||
131552001|NCT00682643|473646103|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
131552002|NCT00682643|473646104|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
131552003|NCT00682643|473646103|FG000|Overall Study|Lost to Follow-up|1|||
131552004|NCT00682643|473646104|FG001|Overall Study|Lost to Follow-up|6|||
131552005|NCT00682643|473646103|FG000|Overall Study|Physician Decision|2|||
131552006|NCT00682643|473646104|FG001|Overall Study|Physician Decision|6|||
131552007|NCT00682643|473646103|FG000|Overall Study|Withdrawal by Subject|19|||
131552008|NCT00682643|473646104|FG001|Overall Study|Withdrawal by Subject|53|||
131552009|NCT00682643|473646103|FG000|Overall Study|Did Not Receive Study Drug|1|||
131552010|NCT00682643|473646104|FG001|Overall Study|Did Not Receive Study Drug|1|||
131552011|NCT00085202|473646105|FG000|Overall Study|Still on therapy|2|||
131552012|NCT00085202|473646106|FG001|Overall Study|Still on therapy|0|||
131552013|NCT00085202|473646105|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
131552014|NCT00085202|473646106|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
131552015|NCT00085202|473646105|FG000|Overall Study|Excessive toxicity|6|||
131552016|NCT00085202|473646106|FG001|Overall Study|Excessive toxicity|5|||
131552017|NCT00085202|473646105|FG000|Overall Study|Non-specified|3|||
131552018|NCT00085202|473646106|FG001|Overall Study|Non-specified|5|||
131552019|NCT00085202|473646105|FG000|Overall Study|Withdrawal by Subject|2|||
131552020|NCT00085202|473646106|FG001|Overall Study|Withdrawal by Subject|1|||
131552021|NCT00085202|473646105|FG000|Overall Study|Physician Decision|4|||
131552022|NCT00085202|473646106|FG001|Overall Study|Physician Decision|1|||
131552023|NCT00085202|473646105|FG000|Overall Study|Progressive disease|1|||
131552024|NCT00085202|473646106|FG001|Overall Study|Progressive disease|11|||
131552025|NCT01436201|473646111|FG000|Overall Study|Adverse Event|2|||
131552026|NCT01436201|473646111|FG000|Overall Study|Withdrawal by Subject|1|||
131552027|NCT01436201|473646111|FG000|Overall Study|Protocol Violation|1|||
131552028|NCT01435655|473646112|FG000|Overall Study|Death|2|||
131552029|NCT01435655|473646112|FG000|Overall Study|Other|1|||
131552030|NCT00110890|473646113|FG000|Overall Study|Adverse Event|30|||
131552031|NCT00110890|473646114|FG001|Overall Study|Adverse Event|7|||
131552032|NCT00110890|473646113|FG000|Overall Study|Death|16|||
131552033|NCT00110890|473646114|FG001|Overall Study|Death|9|||
131552034|NCT00110890|473646113|FG000|Overall Study|Lost to Follow-up|3|||
131552035|NCT00110890|473646114|FG001|Overall Study|Lost to Follow-up|1|||
131552036|NCT00110890|473646113|FG000|Overall Study|Physician Decision|4|||
131552037|NCT00110890|473646114|FG001|Overall Study|Physician Decision|5|||
131552038|NCT00110890|473646113|FG000|Overall Study|Withdrawal by Subject|17|||
131552039|NCT00110890|473646114|FG001|Overall Study|Withdrawal by Subject|5|||
131552040|NCT00110890|473646113|FG000|Overall Study|Protocol Deviation|1|||
131552041|NCT00110890|473646114|FG001|Overall Study|Protocol Deviation|0|||
131552042|NCT00110890|473646113|FG000|Overall Study|Noncompliance|10|||
131552043|NCT00110890|473646114|FG001|Overall Study|Noncompliance|0|||
131552044|NCT00110890|473646113|FG000|Overall Study|Kidney Transplant|16|||
131552045|NCT00110890|473646114|FG001|Overall Study|Kidney Transplant|12|||
131552046|NCT00110890|473646113|FG000|Overall Study|Invest. Product Commercially Available|217|||
131552047|NCT00110890|473646114|FG001|Overall Study|Invest. Product Commercially Available|110|||
131552048|NCT00110890|473646113|FG000|Overall Study|Other|34|||
131552049|NCT00110890|473646114|FG001|Overall Study|Other|23|||
131552050|NCT00110890|473646113|FG000|Overall Study|Ineligibility determined|3|||
131552051|NCT00110890|473646114|FG001|Overall Study|Ineligibility determined|0|||
131552052|NCT00110890|473646113|FG000|Overall Study|Requirement for alternative therapy|0|||
131552053|NCT00110890|473646114|FG001|Overall Study|Requirement for alternative therapy|1|||
131552054|NCT00110890|473646113|FG000|Overall Study|Disease progression|0|||
131552055|NCT00110890|473646114|FG001|Overall Study|Disease progression|1|||
131552056|NCT00110890|473646113|FG000|Overall Study|Parathyroidectomy|0|||
131552057|NCT00110890|473646114|FG001|Overall Study|Parathyroidectomy|1|||
131552058|NCT00110890|473646113|FG000|Overall Study|Did not enter follow-up phase|10|||
131552059|NCT00110890|473646114|FG001|Overall Study|Did not enter follow-up phase|4|||
131552060|NCT01975220|473646115|FG000|Test Period 1|Not treated|0|||
131552061|NCT01975220|473646116|FG001|Test Period 1|Not treated|1|||
131552062|NCT01975220|473646117|FG002|Test Period 1|Not treated|0|||
131552063|NCT01975220|473646118|FG003|Test Period 1|Not treated|0|||
131552064|NCT01975220|473646119|FG004|Test Period 1|Not treated|0|||
131552065|NCT01975220|473646120|FG005|Test Period 1|Not treated|0|||
131552066|NCT02839343|473646121|FG000|Overall Study|Withdrawal by Subject|3|||
131552067|NCT02839343|473646122|FG001|Overall Study|Withdrawal by Subject|1|||
131552068|NCT02839343|473646121|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
131552069|NCT02839343|473646122|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
131552070|NCT02839343|473646121|FG000|Overall Study|Adverse Event|1|||
131552071|NCT02839343|473646122|FG001|Overall Study|Adverse Event|0|||
131552072|NCT01852058|473646125|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
131552073|NCT01852058|473646126|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552074|NCT01852058|473646127|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552075|NCT01852058|473646128|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552076|NCT01852058|473646129|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552077|NCT01852058|473646130|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552078|NCT01852058|473646131|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552079|NCT01852058|473646132|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552080|NCT01852058|473646133|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552081|NCT01852058|473646134|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552082|NCT01852058|473646135|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552083|NCT01852058|473646136|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
131552084|NCT01852058|473646125|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552085|NCT01852058|473646126|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552086|NCT01852058|473646127|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552087|NCT01852058|473646128|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552088|NCT01852058|473646129|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
131552089|NCT01852058|473646130|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552090|NCT01852058|473646131|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552091|NCT01852058|473646132|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552092|NCT01852058|473646133|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552093|NCT01852058|473646134|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552094|NCT01852058|473646135|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552095|NCT01852058|473646136|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
131552096|NCT01852058|473646125|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552097|NCT01852058|473646126|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552098|NCT01852058|473646127|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552099|NCT01852058|473646128|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552100|NCT01852058|473646129|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
131552101|NCT01852058|473646130|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
131552102|NCT01852058|473646131|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552103|NCT01852058|473646132|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552104|NCT01852058|473646133|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552105|NCT01852058|473646134|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552106|NCT01852058|473646135|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552107|NCT01852058|473646136|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
131552108|NCT01852058|473646125|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552109|NCT01852058|473646126|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131771891|NCT01087944|474442197|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
131771892|NCT01087944|474442198|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
131552110|NCT01852058|473646127|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552111|NCT01852058|473646128|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552112|NCT01852058|473646129|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
131552113|NCT01852058|473646130|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131771893|NCT01087944|474442197|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
131771894|NCT01087944|474442198|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
131552114|NCT01852058|473646131|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552115|NCT01852058|473646132|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552116|NCT01852058|473646133|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552117|NCT01852058|473646134|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552118|NCT01852058|473646135|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552119|NCT01852058|473646136|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
131552120|NCT01852058|473646125|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552121|NCT01852058|473646126|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552122|NCT01852058|473646127|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552123|NCT01852058|473646128|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552124|NCT01852058|473646129|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
131552125|NCT01852058|473646130|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
131552126|NCT01852058|473646131|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552127|NCT01852058|473646132|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552128|NCT01852058|473646133|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552129|NCT01852058|473646134|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552130|NCT01852058|473646135|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552131|NCT01852058|473646136|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
131552132|NCT01852058|473646125|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552133|NCT01852058|473646126|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552134|NCT01852058|473646127|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552135|NCT01852058|473646128|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
131552136|NCT01852058|473646129|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552137|NCT01852058|473646130|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552138|NCT01852058|473646131|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552139|NCT01852058|473646132|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552140|NCT01852058|473646133|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552141|NCT01852058|473646134|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552142|NCT01852058|473646135|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552143|NCT01852058|473646136|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
131552144|NCT01852058|473646125|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552145|NCT01852058|473646126|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552146|NCT01852058|473646127|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552147|NCT01852058|473646128|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552148|NCT01852058|473646129|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
131552149|NCT01852058|473646130|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
131552150|NCT01852058|473646131|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552151|NCT01852058|473646132|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552152|NCT01852058|473646133|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552153|NCT01852058|473646134|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552154|NCT01852058|473646135|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552155|NCT01852058|473646136|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
131552156|NCT01852058|473646125|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552157|NCT01852058|473646126|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552158|NCT01852058|473646127|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552159|NCT01852058|473646128|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552160|NCT01852058|473646129|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552161|NCT01852058|473646130|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552162|NCT01852058|473646131|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552163|NCT01852058|473646132|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
131552164|NCT01852058|473646133|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552165|NCT01852058|473646134|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552166|NCT01852058|473646135|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552167|NCT01852058|473646136|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
131552168|NCT01852058|473646125|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552169|NCT01852058|473646126|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552170|NCT01852058|473646127|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552171|NCT01852058|473646128|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552172|NCT01852058|473646129|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131771895|NCT00540228|474442200|FG000|Overall Study|Adverse Event|2|||
131888158|NCT00076999|474872365|FG000|Overall Study|Other reason (not specified)|8|||
131888159|NCT00076999|474872366|FG001|Overall Study|Other reason (not specified)|8|||
131552173|NCT01852058|473646130|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552174|NCT01852058|473646131|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552175|NCT01852058|473646132|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552176|NCT01852058|473646133|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
131552177|NCT01852058|473646134|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552178|NCT01852058|473646135|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552179|NCT01852058|473646136|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
131552180|NCT00263328|473646137|FG000|Overall Study|Death|0|||
131552181|NCT00263328|473646138|FG001|Overall Study|Death|0|||
131552182|NCT00263328|473646139|FG002|Overall Study|Death|1|||
131552183|NCT00263328|473646137|FG000|Overall Study|Lost to Follow-up|1|||
131552184|NCT00263328|473646138|FG001|Overall Study|Lost to Follow-up|1|||
131552185|NCT00263328|473646139|FG002|Overall Study|Lost to Follow-up|0|||
131552186|NCT00263328|473646137|FG000|Overall Study|Withdrawal by Subject|3|||
131552187|NCT00263328|473646138|FG001|Overall Study|Withdrawal by Subject|0|||
131552188|NCT00263328|473646139|FG002|Overall Study|Withdrawal by Subject|1|||
131552189|NCT00263328|473646137|FG000|Overall Study|Other|3|||
131552190|NCT00263328|473646138|FG001|Overall Study|Other|0|||
131552191|NCT00263328|473646139|FG002|Overall Study|Other|1|||
131552192|NCT00263328|473646137|FG000|Overall Study|Adverse Event|1|||
131552193|NCT00263328|473646138|FG001|Overall Study|Adverse Event|1|||
131552194|NCT00263328|473646139|FG002|Overall Study|Adverse Event|4|||
131552195|NCT00622180|473646140|FG000|Overall Study|Lost to Follow-up|1|||
131552196|NCT00622180|473646141|FG001|Overall Study|Lost to Follow-up|2|||
131552197|NCT01301274|473646147|FG000|Overall Study|Physician Decision|2|||
131552198|NCT01301274|473646148|FG001|Overall Study|Physician Decision|1|||
131552199|NCT00661661|473646149|FG000|Overall Study|Adverse Event|99|||
131552200|NCT00661661|473646150|FG001|Overall Study|Adverse Event|24|||
131552201|NCT00661661|473646149|FG000|Overall Study|Lack of Efficacy|3|||
131552202|NCT00661661|473646150|FG001|Overall Study|Lack of Efficacy|2|||
131552203|NCT00661661|473646149|FG000|Overall Study|Lost to Follow-up|0|||
131552204|NCT00661661|473646150|FG001|Overall Study|Lost to Follow-up|1|||
131552205|NCT00661661|473646149|FG000|Overall Study|Withdrawal by Subject|15|||
131552206|NCT00661661|473646150|FG001|Overall Study|Withdrawal by Subject|5|||
131552207|NCT00661661|473646149|FG000|Overall Study|Other|22|||
131552208|NCT00661661|473646150|FG001|Overall Study|Other|7|||
131552209|NCT00661661|473646149|FG000|Overall Study|Not assigned treatment|1|||
131552210|NCT00661661|473646150|FG001|Overall Study|Not assigned treatment|0|||
131552211|NCT04512066|473646153|FG000|Double-blind Treatment Period|Adverse Event|6|||
131552212|NCT04512066|473646154|FG001|Double-blind Treatment Period|Adverse Event|4|||
131552213|NCT04512066|473646155|FG002|Double-blind Treatment Period|Adverse Event|5|||
131552214|NCT04512066|473646156|FG003|Double-blind Treatment Period|Adverse Event|1|||
131552215|NCT04512066|473646157|FG004|Double-blind Treatment Period|Adverse Event|0|||
131552216|NCT04512066|473646158|FG005|Double-blind Treatment Period|Adverse Event|0|||
131552217|NCT04512066|473646153|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
131552218|NCT04512066|473646154|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
131552219|NCT04512066|473646155|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
131552220|NCT04512066|473646156|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
131552221|NCT04512066|473646157|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
131552222|NCT04512066|473646158|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
131552223|NCT04512066|473646153|FG000|Double-blind Treatment Period|Physician Decision|1|||
131552224|NCT04512066|473646154|FG001|Double-blind Treatment Period|Physician Decision|0|||
131552225|NCT04512066|473646155|FG002|Double-blind Treatment Period|Physician Decision|1|||
131552226|NCT04512066|473646156|FG003|Double-blind Treatment Period|Physician Decision|0|||
131552227|NCT04512066|473646157|FG004|Double-blind Treatment Period|Physician Decision|0|||
131552228|NCT04512066|473646158|FG005|Double-blind Treatment Period|Physician Decision|0|||
131552229|NCT04512066|473646153|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
131552230|NCT04512066|473646154|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
131552231|NCT04512066|473646155|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
131552232|NCT04512066|473646156|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
131552233|NCT04512066|473646157|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
131552234|NCT04512066|473646158|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
131552235|NCT04512066|473646153|FG000|Extension Period|Adverse Event|0|||
131552236|NCT04512066|473646154|FG001|Extension Period|Adverse Event|1|||
131552237|NCT04512066|473646155|FG002|Extension Period|Adverse Event|4|||
131552238|NCT04512066|473646156|FG003|Extension Period|Adverse Event|3|||
131552239|NCT04512066|473646157|FG004|Extension Period|Adverse Event|1|||
131552240|NCT04512066|473646158|FG005|Extension Period|Adverse Event|3|||
131552241|NCT04512066|473646153|FG000|Extension Period|Death|0|||
131552242|NCT04512066|473646154|FG001|Extension Period|Death|0|||
131552243|NCT04512066|473646155|FG002|Extension Period|Death|0|||
131552244|NCT04512066|473646156|FG003|Extension Period|Death|0|||
131552245|NCT04512066|473646157|FG004|Extension Period|Death|0|||
131552246|NCT04512066|473646158|FG005|Extension Period|Death|1|||
131552247|NCT04512066|473646153|FG000|Extension Period|Lack of Efficacy|0|||
131552248|NCT04512066|473646154|FG001|Extension Period|Lack of Efficacy|4|||
131552249|NCT04512066|473646155|FG002|Extension Period|Lack of Efficacy|4|||
131552250|NCT04512066|473646156|FG003|Extension Period|Lack of Efficacy|1|||
131552251|NCT04512066|473646157|FG004|Extension Period|Lack of Efficacy|3|||
131552252|NCT04512066|473646158|FG005|Extension Period|Lack of Efficacy|3|||
131552253|NCT04512066|473646153|FG000|Extension Period|Lost to Follow-up|0|||
131552254|NCT04512066|473646154|FG001|Extension Period|Lost to Follow-up|1|||
131552255|NCT04512066|473646155|FG002|Extension Period|Lost to Follow-up|5|||
131552256|NCT04512066|473646156|FG003|Extension Period|Lost to Follow-up|2|||
131771896|NCT00540228|474442201|FG001|Overall Study|Adverse Event|0|||
131771897|NCT00540228|474442202|FG002|Overall Study|Adverse Event|0|||
131771898|NCT00540228|474442203|FG003|Overall Study|Adverse Event|0|||
131771899|NCT00540228|474442204|FG004|Overall Study|Adverse Event|0|||
131552257|NCT04512066|473646157|FG004|Extension Period|Lost to Follow-up|3|||
131552258|NCT04512066|473646158|FG005|Extension Period|Lost to Follow-up|2|||
131552259|NCT04512066|473646153|FG000|Extension Period|Non-compliance with study drug|0|||
131552260|NCT04512066|473646154|FG001|Extension Period|Non-compliance with study drug|1|||
131552261|NCT04512066|473646155|FG002|Extension Period|Non-compliance with study drug|0|||
131552262|NCT04512066|473646156|FG003|Extension Period|Non-compliance with study drug|0|||
131552263|NCT04512066|473646157|FG004|Extension Period|Non-compliance with study drug|0|||
131552264|NCT04512066|473646158|FG005|Extension Period|Non-compliance with study drug|1|||
131552265|NCT04512066|473646153|FG000|Extension Period|Other|0|||
131552266|NCT04512066|473646154|FG001|Extension Period|Other|2|||
131552267|NCT04512066|473646155|FG002|Extension Period|Other|0|||
131552268|NCT04512066|473646156|FG003|Extension Period|Other|0|||
131552269|NCT04512066|473646157|FG004|Extension Period|Other|0|||
131552270|NCT04512066|473646158|FG005|Extension Period|Other|0|||
131552271|NCT04512066|473646153|FG000|Extension Period|Physician Decision|0|||
131552272|NCT04512066|473646154|FG001|Extension Period|Physician Decision|2|||
131552273|NCT04512066|473646155|FG002|Extension Period|Physician Decision|0|||
131552274|NCT04512066|473646156|FG003|Extension Period|Physician Decision|1|||
131552275|NCT04512066|473646157|FG004|Extension Period|Physician Decision|1|||
131552276|NCT04512066|473646158|FG005|Extension Period|Physician Decision|0|||
131552277|NCT04512066|473646153|FG000|Extension Period|Withdrawal by Subject|0|||
131552278|NCT04512066|473646154|FG001|Extension Period|Withdrawal by Subject|3|||
131552279|NCT04512066|473646155|FG002|Extension Period|Withdrawal by Subject|7|||
131552280|NCT04512066|473646156|FG003|Extension Period|Withdrawal by Subject|11|||
131552281|NCT04512066|473646157|FG004|Extension Period|Withdrawal by Subject|8|||
131552282|NCT04512066|473646158|FG005|Extension Period|Withdrawal by Subject|4|||
131552283|NCT03520400|473646159|FG000|Overall Study|Physician Decision|15|||
131552284|NCT03520400|473646160|FG001|Overall Study|Physician Decision|7|||
131552285|NCT00445679|473646163|FG000|Overall Study|Adverse Event|22|||
131552286|NCT00445679|473646164|FG001|Overall Study|Adverse Event|12|||
131552287|NCT00445679|473646165|FG002|Overall Study|Adverse Event|30|||
131552288|NCT00445679|473646166|FG003|Overall Study|Adverse Event|19|||
131552289|NCT00445679|473646163|FG000|Overall Study|Failed to return|1|||
131552290|NCT00445679|473646164|FG001|Overall Study|Failed to return|3|||
131552291|NCT00445679|473646165|FG002|Overall Study|Failed to return|2|||
131552292|NCT00445679|473646166|FG003|Overall Study|Failed to return|2|||
131552293|NCT00445679|473646163|FG000|Overall Study|Physician Decision|0|||
131552294|NCT00445679|473646164|FG001|Overall Study|Physician Decision|0|||
131552295|NCT00445679|473646165|FG002|Overall Study|Physician Decision|1|||
131552296|NCT00445679|473646166|FG003|Overall Study|Physician Decision|0|||
131552297|NCT00445679|473646163|FG000|Overall Study|Lost to Follow-up|10|||
131552298|NCT00445679|473646164|FG001|Overall Study|Lost to Follow-up|6|||
131552299|NCT00445679|473646165|FG002|Overall Study|Lost to Follow-up|6|||
131552300|NCT00445679|473646166|FG003|Overall Study|Lost to Follow-up|5|||
131552301|NCT00445679|473646163|FG000|Overall Study|Compliance|3|||
131552302|NCT00445679|473646164|FG001|Overall Study|Compliance|2|||
131552303|NCT00445679|473646165|FG002|Overall Study|Compliance|1|||
131552304|NCT00445679|473646166|FG003|Overall Study|Compliance|2|||
131552305|NCT00445679|473646163|FG000|Overall Study|Withdrawal of Informed Consent|0|||
131552306|NCT00445679|473646164|FG001|Overall Study|Withdrawal of Informed Consent|0|||
131552307|NCT00445679|473646165|FG002|Overall Study|Withdrawal of Informed Consent|1|||
131552308|NCT00445679|473646166|FG003|Overall Study|Withdrawal of Informed Consent|0|||
131552309|NCT00445679|473646163|FG000|Overall Study|Protocol Violation|2|||
131552310|NCT00445679|473646164|FG001|Overall Study|Protocol Violation|3|||
131552311|NCT00445679|473646165|FG002|Overall Study|Protocol Violation|3|||
131552312|NCT00445679|473646166|FG003|Overall Study|Protocol Violation|1|||
131552313|NCT00445679|473646163|FG000|Overall Study|Withdrawal by Subject|8|||
131552314|NCT00445679|473646164|FG001|Overall Study|Withdrawal by Subject|14|||
131552315|NCT00445679|473646165|FG002|Overall Study|Withdrawal by Subject|20|||
131552316|NCT00445679|473646166|FG003|Overall Study|Withdrawal by Subject|18|||
131552317|NCT00445679|473646163|FG000|Overall Study|Lack of Efficacy|2|||
131552318|NCT00445679|473646164|FG001|Overall Study|Lack of Efficacy|6|||
131552319|NCT00445679|473646165|FG002|Overall Study|Lack of Efficacy|2|||
131771900|NCT00540228|474442200|FG000|Overall Study|Lost to Follow-up|1|||
131771901|NCT00540228|474442201|FG001|Overall Study|Lost to Follow-up|1|||
131552320|NCT00445679|473646166|FG003|Overall Study|Lack of Efficacy|0|||
131552321|NCT01353222|473646168|FG000|Overall Study|Death|30|||
131552322|NCT01353222|473646169|FG001|Overall Study|Death|30|||
131552323|NCT01353222|473646168|FG000|Overall Study|Withdrawal by Subject|8|||
131552324|NCT01353222|473646169|FG001|Overall Study|Withdrawal by Subject|5|||
131552325|NCT01353222|473646168|FG000|Overall Study|Study Terminated|31|||
131552326|NCT01353222|473646169|FG001|Overall Study|Study Terminated|37|||
131552327|NCT01353222|473646168|FG000|Overall Study|Site closed research department|1|||
131552328|NCT01353222|473646169|FG001|Overall Study|Site closed research department|0|||
131552329|NCT01654601|473646172|FG000|1st Administration|Withdrawal by Subject|2|||
131552330|NCT01654601|473646173|FG001|1st Administration|Withdrawal by Subject|0|||
131552331|NCT01654601|473646172|FG000|1st Administration|Protocol Violation|0|||
131552332|NCT01654601|473646173|FG001|1st Administration|Protocol Violation|2|||
131552333|NCT01654601|473646172|FG000|2nd Administration|Adverse Event|1|||
131552334|NCT01654601|473646173|FG001|2nd Administration|Adverse Event|0|||
131552335|NCT01654601|473646172|FG000|2nd Administration|Protocol Violation|0|||
131552336|NCT01654601|473646173|FG001|2nd Administration|Protocol Violation|1|||
131552337|NCT02636270|473646174|FG000|Overall Study|Adverse Event|1|||
131552338|NCT02636270|473646175|FG001|Overall Study|Adverse Event|0|||
131552339|NCT02636270|473646176|FG002|Overall Study|Adverse Event|0|||
131552340|NCT02636270|473646174|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
131552341|NCT02636270|473646175|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
131552342|NCT02636270|473646176|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
131552343|NCT01806584|473646177|FG000|Overall Study|Adverse Event|2|||
131552344|NCT01806584|473646178|FG001|Overall Study|Adverse Event|1|||
131552345|NCT01806584|473646177|FG000|Overall Study|Death|1|||
131552346|NCT01806584|473646178|FG001|Overall Study|Death|0|||
131552347|NCT01806584|473646177|FG000|Overall Study|Lost to Follow-up|0|||
131552348|NCT01806584|473646178|FG001|Overall Study|Lost to Follow-up|2|||
131552349|NCT01806584|473646177|FG000|Overall Study|Study terminated by sponsor|9|||
131552350|NCT01806584|473646178|FG001|Overall Study|Study terminated by sponsor|14|||
131552351|NCT01806584|473646177|FG000|Overall Study|Withdrawal by Subject|1|||
131552352|NCT01806584|473646178|FG001|Overall Study|Withdrawal by Subject|1|||
131552353|NCT01806584|473646177|FG000|Overall Study|Other unspecified|1|||
131552354|NCT01806584|473646178|FG001|Overall Study|Other unspecified|0|||
131552355|NCT04398537|473646187|FG000|Overall Study|Physician Decision|10|||
131552356|NCT04398537|473646188|FG001|Overall Study|Physician Decision|15|||
131552357|NCT03535337|473646189|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
131552358|NCT03535337|473646190|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
131552359|NCT03535337|473646191|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
131552360|NCT03535337|473646192|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
131552361|NCT03535337|473646193|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
131552362|NCT03535337|473646194|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
131552363|NCT03535337|473646195|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
131552364|NCT03535337|473646196|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
131552365|NCT03535337|473646197|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
131552366|NCT03535337|473646198|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
131552367|NCT02272725|473646199|FG000|Overall Study|equipment malfunction|2|||
131552368|NCT02272725|473646200|FG001|Overall Study|equipment malfunction|0|||
131552369|NCT00519896|473647991|FG000|Overall Study|Protocol Violation|1|||
131552370|NCT00519896|473647991|FG000|Overall Study|Adverse Event|1|||
131552371|NCT02367716|473647992|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
131552372|NCT00539643|473647993|FG000|Overall Study|Adverse Event|1|||
131552373|NCT00539643|473647994|FG001|Overall Study|Adverse Event|0|||
131552374|NCT00539643|473647993|FG000|Overall Study|Death|2|||
131552375|NCT00539643|473647994|FG001|Overall Study|Death|1|||
131552376|NCT00539643|473647993|FG000|Overall Study|Physician Decision|3|||
131552377|NCT00539643|473647994|FG001|Overall Study|Physician Decision|1|||
131552378|NCT00539643|473647993|FG000|Overall Study|Withdrawal by Subject|0|||
131552379|NCT00539643|473647994|FG001|Overall Study|Withdrawal by Subject|1|||
131552380|NCT02343003|473647997|FG000|Overall Study|Withdrawal by Subject|9|||
131552381|NCT02343003|473647998|FG001|Overall Study|Withdrawal by Subject|4|||
131552382|NCT02343003|473647997|FG000|Overall Study|Lost to Follow-up|5|||
131552383|NCT02343003|473647998|FG001|Overall Study|Lost to Follow-up|1|||
131552384|NCT02343003|473647997|FG000|Overall Study|Protocol Violation|1|||
131552385|NCT02343003|473647998|FG001|Overall Study|Protocol Violation|0|||
131552386|NCT02343003|473647997|FG000|Overall Study|Death|0|||
131552387|NCT02343003|473647998|FG001|Overall Study|Death|1|||
131552388|NCT02343003|473647997|FG000|Overall Study|exclusion criteria met|1|||
131552389|NCT02343003|473647998|FG001|Overall Study|exclusion criteria met|1|||
131552390|NCT02343003|473647997|FG000|Overall Study|terminated by sponsor|2|||
131552391|NCT02343003|473647998|FG001|Overall Study|terminated by sponsor|0|||
131552392|NCT04359771|473648003|FG000|Overall Study|Lack of Efficacy|2|||
131662016|NCT02489968|474046215|FG003|Double-blind Treatment Period|Adverse Event|6|||
131552393|NCT04359771|473648004|FG001|Overall Study|Lack of Efficacy|2|||
131552394|NCT03592277|473648005|FG000|Overall Study|Withdrawal by Subject|6|||
131552395|NCT03592277|473648006|FG001|Overall Study|Withdrawal by Subject|8|||
131552396|NCT01462162|473648007|FG000|Overall Study|Adverse Event|5|||
131552397|NCT01462162|473648007|FG000|Overall Study|Lack of Efficacy|4|||
131552398|NCT01462162|473648007|FG000|Overall Study|Abnormal laboratory parameters|1|||
131552399|NCT01462162|473648007|FG000|Overall Study|Other|2|||
131552400|NCT01346514|473648008|FG000|Overall Study|Lost to Follow-up|19|||
131552401|NCT01346514|473648009|FG001|Overall Study|Lost to Follow-up|30|||
131552402|NCT01346514|473648008|FG000|Overall Study|Withdrawal by Subject|7|||
131552403|NCT01346514|473648009|FG001|Overall Study|Withdrawal by Subject|3|||
131552404|NCT01346514|473648008|FG000|Overall Study|Death|3|||
131552405|NCT01346514|473648009|FG001|Overall Study|Death|4|||
131552406|NCT00909480|473648010|FG000|Overall Study|Adverse Event|5|||
131552407|NCT00909480|473648011|FG001|Overall Study|Adverse Event|3|||
131552408|NCT00909480|473648010|FG000|Overall Study|Protocol Violation|6|||
131552409|NCT00909480|473648011|FG001|Overall Study|Protocol Violation|8|||
131552410|NCT00909480|473648010|FG000|Overall Study|Withdrawal criteria|9|||
131552411|NCT00909480|473648011|FG001|Overall Study|Withdrawal criteria|11|||
131552412|NCT00909480|473648010|FG000|Overall Study|Unclassified|18|||
131552413|NCT00909480|473648011|FG001|Overall Study|Unclassified|19|||
131552414|NCT01215357|473648012|FG000|Overall Study|Withdrawal by Subject|3|||
131552415|NCT01215357|473648012|FG000|Overall Study|Protocol Violation|9|||
131552416|NCT01859793|473648025|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
131552417|NCT01859793|473648026|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
131552418|NCT01859793|473648025|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
131552419|NCT01859793|473648026|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
131552420|NCT01859793|473648025|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
131552421|NCT01859793|473648026|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
131552422|NCT01859793|473648025|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
131552423|NCT01859793|473648026|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
131552424|NCT02002182|473648029|FG000|Overall Study|Withdraw from study|3|||
131552425|NCT02002182|473648030|FG001|Overall Study|Withdraw from study|1|||
131552426|NCT02002182|473648029|FG000|Overall Study|Health Reasons|1|||
131552427|NCT02002182|473648030|FG001|Overall Study|Health Reasons|0|||
131552428|NCT02002182|473648029|FG000|Overall Study|Death|1|||
131552429|NCT02002182|473648030|FG001|Overall Study|Death|0|||
131552430|NCT04772053|473648035|FG000|Overall Study|Physician Decision|2|||
131552431|NCT04772053|473648035|FG000|Overall Study|Withdrawal by Subject|3|||
131552432|NCT04772053|473648035|FG000|Overall Study|Study Terminated by Sponsor|1|||
131552433|NCT04599101|473648036|FG000|Overall Study|Lost to Follow-up|5|||
131552434|NCT04599101|473648037|FG001|Overall Study|Lost to Follow-up|5|||
131552435|NCT04146896|473648040|FG000|Overall Study|Adverse Event|5|||
131552436|NCT04146896|473648041|FG001|Overall Study|Adverse Event|8|||
131552437|NCT04146896|473648040|FG000|Overall Study|Lack of Efficacy|3|||
131552438|NCT04146896|473648041|FG001|Overall Study|Lack of Efficacy|2|||
131552439|NCT04146896|473648040|FG000|Overall Study|Lost to Follow-up|0|||
131552440|NCT04146896|473648041|FG001|Overall Study|Lost to Follow-up|1|||
131552441|NCT04146896|473648040|FG000|Overall Study|Non-compliance|5|||
131552442|NCT04146896|473648041|FG001|Overall Study|Non-compliance|4|||
131552443|NCT04146896|473648040|FG000|Overall Study|Withdrawal by Subject|3|||
131552444|NCT04146896|473648041|FG001|Overall Study|Withdrawal by Subject|5|||
131552445|NCT04146896|473648040|FG000|Overall Study|Randomized in error|1|||
131552446|NCT04146896|473648041|FG001|Overall Study|Randomized in error|2|||
131552447|NCT02118337|473648042|FG000|Overall Study|Other|1|||
131552448|NCT02118337|473648043|FG001|Overall Study|Other|0|||
131552449|NCT02118337|473648044|FG002|Overall Study|Other|0|||
131552450|NCT02118337|473648045|FG003|Overall Study|Other|0|||
131552451|NCT02118337|473648046|FG004|Overall Study|Other|2|||
131552452|NCT02118337|473648047|FG005|Overall Study|Other|3|||
131552453|NCT02118337|473648048|FG006|Overall Study|Other|1|||
131552454|NCT02118337|473648049|FG007|Overall Study|Other|28|||
131552455|NCT02118337|473648050|FG008|Overall Study|Other|15|||
131552456|NCT02118337|473648042|FG000|Overall Study|Lost to Follow-up|0|||
131552457|NCT02118337|473648043|FG001|Overall Study|Lost to Follow-up|0|||
131552458|NCT02118337|473648044|FG002|Overall Study|Lost to Follow-up|0|||
131552459|NCT02118337|473648045|FG003|Overall Study|Lost to Follow-up|0|||
131552460|NCT02118337|473648046|FG004|Overall Study|Lost to Follow-up|0|||
131552461|NCT02118337|473648047|FG005|Overall Study|Lost to Follow-up|0|||
131552462|NCT02118337|473648048|FG006|Overall Study|Lost to Follow-up|0|||
131552463|NCT02118337|473648049|FG007|Overall Study|Lost to Follow-up|1|||
131552464|NCT02118337|473648050|FG008|Overall Study|Lost to Follow-up|0|||
131552465|NCT02118337|473648042|FG000|Overall Study|Withdrawal by Subject|1|||
131552466|NCT02118337|473648043|FG001|Overall Study|Withdrawal by Subject|3|||
131552467|NCT02118337|473648044|FG002|Overall Study|Withdrawal by Subject|2|||
131552468|NCT02118337|473648045|FG003|Overall Study|Withdrawal by Subject|1|||
131552469|NCT02118337|473648046|FG004|Overall Study|Withdrawal by Subject|2|||
131552470|NCT02118337|473648047|FG005|Overall Study|Withdrawal by Subject|2|||
131552471|NCT02118337|473648048|FG006|Overall Study|Withdrawal by Subject|1|||
131552472|NCT02118337|473648049|FG007|Overall Study|Withdrawal by Subject|4|||
131552473|NCT02118337|473648050|FG008|Overall Study|Withdrawal by Subject|2|||
131552474|NCT02118337|473648042|FG000|Overall Study|Death|2|||
131552475|NCT02118337|473648043|FG001|Overall Study|Death|2|||
131552476|NCT02118337|473648044|FG002|Overall Study|Death|1|||
131552477|NCT02118337|473648045|FG003|Overall Study|Death|2|||
131552478|NCT02118337|473648046|FG004|Overall Study|Death|5|||
131552479|NCT02118337|473648047|FG005|Overall Study|Death|1|||
131552480|NCT02118337|473648048|FG006|Overall Study|Death|2|||
131552481|NCT02118337|473648049|FG007|Overall Study|Death|9|||
131552482|NCT02118337|473648050|FG008|Overall Study|Death|4|||
131552483|NCT02277743|473648055|FG000|Overall Study|Protocol Violation|1|||
131552484|NCT02277743|473648056|FG001|Overall Study|Protocol Violation|1|||
131552485|NCT02277743|473648057|FG002|Overall Study|Protocol Violation|1|||
131552486|NCT02277743|473648055|FG000|Overall Study|Adverse Event|10|||
131552487|NCT02277743|473648056|FG001|Overall Study|Adverse Event|6|||
131552488|NCT02277743|473648057|FG002|Overall Study|Adverse Event|6|||
131552489|NCT02277743|473648055|FG000|Overall Study|Lack of Efficacy|11|||
131552490|NCT02277743|473648056|FG001|Overall Study|Lack of Efficacy|4|||
131552491|NCT02277743|473648057|FG002|Overall Study|Lack of Efficacy|3|||
131552492|NCT02277743|473648055|FG000|Overall Study|Other than specified above|18|||
131552493|NCT02277743|473648056|FG001|Overall Study|Other than specified above|5|||
131552494|NCT02277743|473648057|FG002|Overall Study|Other than specified above|16|||
131552495|NCT02055157|473648058|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
131552496|NCT02055157|473648059|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
131552497|NCT02055157|473648060|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
131552498|NCT02055157|473648061|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
131552499|NCT02055157|473648058|FG000|Initial 6 Months|Adverse Event|0|||
131552500|NCT02055157|473648059|FG001|Initial 6 Months|Adverse Event|0|||
131552501|NCT02055157|473648060|FG002|Initial 6 Months|Adverse Event|0|||
131552502|NCT02055157|473648061|FG003|Initial 6 Months|Adverse Event|1|||
131552503|NCT02055157|473648058|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
131552504|NCT02055157|473648059|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
131552505|NCT02055157|473648060|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
131552506|NCT02055157|473648061|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
131552507|NCT02055157|473648058|FG000|18-month Extension|Investigator decision|0|||
131552508|NCT02055157|473648059|FG001|18-month Extension|Investigator decision|1|||
131552509|NCT02055157|473648060|FG002|18-month Extension|Investigator decision|0|||
131552510|NCT02055157|473648061|FG003|18-month Extension|Investigator decision|0|||
131552511|NCT02055157|473648058|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
131552512|NCT02055157|473648059|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
131552513|NCT02055157|473648060|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
131552514|NCT02055157|473648061|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
131552515|NCT03976466|473648062|FG000|Overall Study|Lost to Follow-up|1|||
131552516|NCT03976466|473648063|FG001|Overall Study|Lost to Follow-up|3|||
131552517|NCT00943306|473648066|FG000|Overall Study|Physician Decision|1|||
131552518|NCT00943306|473648066|FG000|Overall Study|Death|1|||
131552519|NCT00943306|473648066|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
131552520|NCT02739347|473648067|FG000|Overall Study|Adverse Event|3|||
131552521|NCT02739347|473648068|FG001|Overall Study|Adverse Event|0|||
131552522|NCT02739347|473648067|FG000|Overall Study|Protocol Violation|0|||
131552523|NCT02739347|473648068|FG001|Overall Study|Protocol Violation|1|||
131552524|NCT02739347|473648067|FG000|Overall Study|Lost to Follow-up|0|||
131552525|NCT02739347|473648068|FG001|Overall Study|Lost to Follow-up|2|||
131552526|NCT03929562|473648069|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
131552527|NCT03929562|473648070|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
131552528|NCT03929562|473648069|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
131552529|NCT03929562|473648070|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
131552530|NCT03929562|473648069|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
131552531|NCT03929562|473648070|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
131552532|NCT00576732|473648079|FG000|DOUBLE BLIND|Adverse Event|0|||
131552533|NCT00576732|473648080|FG001|DOUBLE BLIND|Adverse Event|0|||
131552534|NCT00576732|473648081|FG002|DOUBLE BLIND|Adverse Event|1|||
131552535|NCT00576732|473648082|FG003|DOUBLE BLIND|Adverse Event|0|||
131552536|NCT00576732|473648083|FG004|DOUBLE BLIND|Adverse Event|0|||
131552537|NCT00576732|473648084|FG005|DOUBLE BLIND|Adverse Event|0|||
131552538|NCT00576732|473648079|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
131552539|NCT00576732|473648080|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
131552540|NCT00576732|473648081|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
131552541|NCT00576732|473648082|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
131552542|NCT00576732|473648083|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
131552543|NCT00576732|473648084|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
131552544|NCT00576732|473648079|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
131552545|NCT00576732|473648080|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
131552546|NCT00576732|473648081|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
131552547|NCT00576732|473648082|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
131552548|NCT00576732|473648083|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
131662017|NCT02489968|474046216|FG004|Double-blind Treatment Period|Adverse Event|4|||
131662018|NCT02489968|474046217|FG005|Double-blind Treatment Period|Adverse Event|5|||
131552549|NCT00576732|473648084|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
131552550|NCT00576732|473648079|FG000|DOUBLE BLIND|OTHER|0|||
131552551|NCT00576732|473648080|FG001|DOUBLE BLIND|OTHER|2|||
131552552|NCT00576732|473648081|FG002|DOUBLE BLIND|OTHER|1|||
131552553|NCT00576732|473648082|FG003|DOUBLE BLIND|OTHER|0|||
131552554|NCT00576732|473648083|FG004|DOUBLE BLIND|OTHER|0|||
131552555|NCT00576732|473648084|FG005|DOUBLE BLIND|OTHER|0|||
131552556|NCT00576732|473648079|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
131552557|NCT00576732|473648080|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
131552558|NCT00576732|473648081|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
131552559|NCT00576732|473648082|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
131552560|NCT00576732|473648083|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
131552561|NCT00576732|473648084|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
131552562|NCT00576732|473648079|FG000|DOUBLE BLIND|Protocol Violation|1|||
131552563|NCT00576732|473648080|FG001|DOUBLE BLIND|Protocol Violation|0|||
131552564|NCT00576732|473648081|FG002|DOUBLE BLIND|Protocol Violation|0|||
131552565|NCT00576732|473648082|FG003|DOUBLE BLIND|Protocol Violation|0|||
131552566|NCT00576732|473648083|FG004|DOUBLE BLIND|Protocol Violation|0|||
131552567|NCT00576732|473648084|FG005|DOUBLE BLIND|Protocol Violation|0|||
131552568|NCT00576732|473648079|FG000|OPEN LABEL|Adverse Event|0|||
131552569|NCT00576732|473648080|FG001|OPEN LABEL|Adverse Event|0|||
131552570|NCT00576732|473648081|FG002|OPEN LABEL|Adverse Event|0|||
131552571|NCT00576732|473648082|FG003|OPEN LABEL|Adverse Event|4|||
131552572|NCT00576732|473648083|FG004|OPEN LABEL|Adverse Event|0|||
131552573|NCT00576732|473648084|FG005|OPEN LABEL|Adverse Event|1|||
131662019|NCT02489968|474046212|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131662020|NCT02489968|474046213|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131662021|NCT02489968|474046214|FG002|Double-blind Treatment Period|Protocol Violation|0|||
131662022|NCT02489968|474046215|FG003|Double-blind Treatment Period|Protocol Violation|0|||
131662023|NCT02489968|474046216|FG004|Double-blind Treatment Period|Protocol Violation|1|||
131662024|NCT02489968|474046217|FG005|Double-blind Treatment Period|Protocol Violation|1|||
131662025|NCT02489968|474046212|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131662026|NCT02489968|474046213|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131662027|NCT02489968|474046214|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131662028|NCT02489968|474046215|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
131662029|NCT02489968|474046216|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
131662030|NCT02489968|474046217|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
131662031|NCT02489968|474046212|FG000|Double-blind Treatment Period|Other than specified above|0|||
131662032|NCT02489968|474046213|FG001|Double-blind Treatment Period|Other than specified above|0|||
131662033|NCT02489968|474046214|FG002|Double-blind Treatment Period|Other than specified above|0|||
131662034|NCT02489968|474046215|FG003|Double-blind Treatment Period|Other than specified above|0|||
131662035|NCT02489968|474046216|FG004|Double-blind Treatment Period|Other than specified above|1|||
131662036|NCT02489968|474046217|FG005|Double-blind Treatment Period|Other than specified above|0|||
131662037|NCT01865747|474046221|FG000|Overall Study (ITT)|Adverse Event|32|||
131662038|NCT01865747|474046222|FG001|Overall Study (ITT)|Adverse Event|31|||
131662039|NCT01865747|474046221|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
131662040|NCT01865747|474046222|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
131662041|NCT01865747|474046221|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
131662042|NCT01865747|474046222|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
131662043|NCT01865747|474046221|FG000|Overall Study (ITT)|Protocol Violation|1|||
131662044|NCT01865747|474046222|FG001|Overall Study (ITT)|Protocol Violation|1|||
131662045|NCT01865747|474046221|FG000|Overall Study (ITT)|Physician Decision|5|||
131662046|NCT01865747|474046222|FG001|Overall Study (ITT)|Physician Decision|2|||
131662047|NCT01865747|474046221|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
131662048|NCT01865747|474046222|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
131662049|NCT01865747|474046221|FG000|Overall Study (ITT)|Sponsor Decision|0|||
131662050|NCT01865747|474046222|FG001|Overall Study (ITT)|Sponsor Decision|1|||
131662051|NCT01865747|474046221|FG000|Overall Study (ITT)|Progressive Disease|122|||
131662052|NCT01865747|474046222|FG001|Overall Study (ITT)|Progressive Disease|158|||
131662053|NCT01865747|474046221|FG000|Overall Study (ITT)|Reason Not Provided|0|||
131662054|NCT01865747|474046222|FG001|Overall Study (ITT)|Reason Not Provided|1|||
131662055|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
131662056|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
131662057|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
131662058|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
131662059|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
131662060|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
131662061|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
131662062|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
131662063|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
131662064|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
131662065|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
131662066|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
131662067|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
131662068|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
131771902|NCT00540228|474442202|FG002|Overall Study|Lost to Follow-up|0|||
131771903|NCT00540228|474442203|FG003|Overall Study|Lost to Follow-up|0|||
131771904|NCT00540228|474442204|FG004|Overall Study|Lost to Follow-up|0|||
131771905|NCT02451137|474442205|FG000|Overall Study|Randomized but not treated|19|||
131771906|NCT02451137|474442206|FG001|Overall Study|Randomized but not treated|27|||
131771907|NCT02451137|474442205|FG000|Overall Study|Adverse Event|43|||
131771908|NCT02451137|474442206|FG001|Overall Study|Adverse Event|42|||
131771909|NCT02451137|474442205|FG000|Overall Study|Lack of Efficacy|4|||
131771910|NCT02451137|474442206|FG001|Overall Study|Lack of Efficacy|9|||
131771911|NCT02451137|474442205|FG000|Overall Study|Participant decision:discontinue insulin|41|||
131771912|NCT02451137|474442206|FG001|Overall Study|Participant decision:discontinue insulin|43|||
131771913|NCT02451137|474442205|FG000|Overall Study|Hypoglycemia|2|||
131771914|NCT02451137|474442206|FG001|Overall Study|Hypoglycemia|1|||
131771915|NCT02451137|474442205|FG000|Overall Study|Investigator's decision|23|||
131771916|NCT02451137|474442206|FG001|Overall Study|Investigator's decision|19|||
131771917|NCT02451137|474442205|FG000|Overall Study|Lost to Follow-up|53|||
131771918|NCT02451137|474442206|FG001|Overall Study|Lost to Follow-up|61|||
131771919|NCT02451137|474442205|FG000|Overall Study|Physician Decision|6|||
131771920|NCT02451137|474442206|FG001|Overall Study|Physician Decision|5|||
131771921|NCT02451137|474442205|FG000|Overall Study|Sponsor decision|13|||
131771922|NCT02451137|474442206|FG001|Overall Study|Sponsor decision|25|||
131771923|NCT02451137|474442205|FG000|Overall Study|Withdrawal by Subject|40|||
131771924|NCT02451137|474442206|FG001|Overall Study|Withdrawal by Subject|63|||
131771925|NCT02451137|474442205|FG000|Overall Study|Other than specified above|2|||
131771926|NCT02451137|474442206|FG001|Overall Study|Other than specified above|3|||
131771927|NCT01977573|474442209|FG000|Overall Study|Adverse Event|7|||
131771928|NCT01977573|474442210|FG001|Overall Study|Adverse Event|0|||
131771929|NCT01977573|474442211|FG002|Overall Study|Adverse Event|2|||
131771930|NCT01977573|474442212|FG003|Overall Study|Adverse Event|1|||
131771931|NCT01977573|474442209|FG000|Overall Study|Lost to Follow-up|1|||
131771932|NCT01977573|474442210|FG001|Overall Study|Lost to Follow-up|0|||
131771933|NCT01977573|474442211|FG002|Overall Study|Lost to Follow-up|0|||
131771934|NCT01977573|474442212|FG003|Overall Study|Lost to Follow-up|1|||
131771935|NCT01977573|474442209|FG000|Overall Study|Physician Decision|1|||
131771936|NCT01977573|474442210|FG001|Overall Study|Physician Decision|0|||
131771937|NCT01977573|474442211|FG002|Overall Study|Physician Decision|0|||
131771938|NCT01977573|474442212|FG003|Overall Study|Physician Decision|0|||
131771939|NCT01977573|474442209|FG000|Overall Study|Protocol Violation|3|||
131771940|NCT01977573|474442210|FG001|Overall Study|Protocol Violation|1|||
131771941|NCT01977573|474442211|FG002|Overall Study|Protocol Violation|0|||
131771942|NCT01977573|474442212|FG003|Overall Study|Protocol Violation|0|||
131771943|NCT01977573|474442209|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
131771944|NCT01977573|474442210|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
131771945|NCT01977573|474442211|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
131771946|NCT01977573|474442212|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
131771947|NCT01977573|474442209|FG000|Overall Study|Withdrawal by Subject|6|||
131771948|NCT01977573|474442210|FG001|Overall Study|Withdrawal by Subject|1|||
131771949|NCT01977573|474442211|FG002|Overall Study|Withdrawal by Subject|1|||
131771950|NCT01977573|474442212|FG003|Overall Study|Withdrawal by Subject|1|||
131771951|NCT01018680|474443713|FG000|Overall Study|Adverse Event|23|||
131771952|NCT01018680|474443714|FG001|Overall Study|Adverse Event|40|||
131771953|NCT01018680|474443713|FG000|Overall Study|Withdrawal by Subject|10|||
131771954|NCT01018680|474443714|FG001|Overall Study|Withdrawal by Subject|10|||
131771955|NCT01018680|474443713|FG000|Overall Study|Protocol Violation|5|||
131771956|NCT01018680|474443714|FG001|Overall Study|Protocol Violation|8|||
131771957|NCT01018680|474443713|FG000|Overall Study|Sponsor Decision|6|||
131771958|NCT01018680|474443714|FG001|Overall Study|Sponsor Decision|7|||
131771959|NCT01018680|474443713|FG000|Overall Study|Lack of Efficacy|8|||
131771960|NCT01018680|474443714|FG001|Overall Study|Lack of Efficacy|2|||
131771961|NCT01018680|474443713|FG000|Overall Study|Lost to Follow-up|5|||
131771962|NCT01018680|474443714|FG001|Overall Study|Lost to Follow-up|3|||
131771963|NCT01018680|474443713|FG000|Overall Study|Entry Criteria Not Met|1|||
131771964|NCT01018680|474443714|FG001|Overall Study|Entry Criteria Not Met|4|||
131771965|NCT01018680|474443713|FG000|Overall Study|Physician Decision|3|||
131771966|NCT01018680|474443714|FG001|Overall Study|Physician Decision|1|||
131771967|NCT02930889|474443715|FG000|Overall Study|Lost to Follow-up|2|||
131771968|NCT02930889|474443715|FG000|Overall Study|Withdrawal by Subject|6|||
131771969|NCT02930889|474443715|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
131771970|NCT00761761|474443716|FG000|Overall Study|Lost to Follow-up|3|||
131771971|NCT00761761|474443717|FG001|Overall Study|Lost to Follow-up|1|||
131771972|NCT00761761|474443716|FG000|Overall Study|Withdrawal by Subject|3|||
131771973|NCT00761761|474443717|FG001|Overall Study|Withdrawal by Subject|0|||
131771974|NCT03472586|474443723|FG000|Overall Study|Physician Decision|6|||
131771975|NCT03472586|474443723|FG000|Overall Study|Death|6|||
131771976|NCT03472586|474443723|FG000|Overall Study|Adverse Event|1|||
131771977|NCT02528331|474443725|FG000|Overall Study|Withdrawal by Subject|2|||
131771978|NCT01224171|474443726|FG000|Overall Study|Adverse Event|8|||
131771979|NCT01224171|474443727|FG001|Overall Study|Adverse Event|4|||
131771980|NCT01224171|474443726|FG000|Overall Study|Protocol Violation|0|||
131771981|NCT01224171|474443727|FG001|Overall Study|Protocol Violation|1|||
131771982|NCT01224171|474443726|FG000|Overall Study|Lack of Efficacy|5|||
131771983|NCT01224171|474443727|FG001|Overall Study|Lack of Efficacy|1|||
131771984|NCT01224171|474443726|FG000|Overall Study|Withdrawal of Consent|2|||
131771985|NCT01224171|474443727|FG001|Overall Study|Withdrawal of Consent|4|||
131771986|NCT01224171|474443726|FG000|Overall Study|Lost to Follow-up|0|||
131771987|NCT01224171|474443727|FG001|Overall Study|Lost to Follow-up|3|||
131771988|NCT03737812|474443728|FG000|Overall Study|Withdrawal by Subject|1|||
131771989|NCT03737812|474443729|FG001|Overall Study|Withdrawal by Subject|2|||
131771990|NCT03737812|474443730|FG002|Overall Study|Withdrawal by Subject|1|||
131771991|NCT03737812|474443728|FG000|Overall Study|Sponsor Discontinued the Study|4|||
131771992|NCT03737812|474443729|FG001|Overall Study|Sponsor Discontinued the Study|3|||
131771993|NCT03737812|474443730|FG002|Overall Study|Sponsor Discontinued the Study|2|||
131771994|NCT03737812|474443728|FG000|Overall Study|Adverse Event|0|||
131771995|NCT03737812|474443729|FG001|Overall Study|Adverse Event|1|||
131771996|NCT03737812|474443730|FG002|Overall Study|Adverse Event|0|||
131771997|NCT03737812|474443728|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
131771998|NCT03737812|474443729|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
131771999|NCT03737812|474443730|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
131772000|NCT02624713|474443731|FG000|Overall Study|Lost to Follow-up|14|||
131772001|NCT02624713|474443732|FG001|Overall Study|Lost to Follow-up|0|||
131772002|NCT00285857|474443736|FG000|Overall Study|Withdrawal by Subject|2|||
131772003|NCT00285857|474443736|FG000|Overall Study|Inadequate initial breast cytology|1|||
131772004|NCT00285857|474443736|FG000|Overall Study|Adverse Event|1|||
131772005|NCT01161173|474443742|FG000|Overall Study|Protocol Violation|13|||
131772006|NCT01161173|474443742|FG000|Overall Study|Lost to Follow-up|7|||
131772007|NCT01161173|474443742|FG000|Overall Study|Progressive Disease|82|||
131772008|NCT01161173|474443742|FG000|Overall Study|Withdrawal of Consent|5|||
131772009|NCT01161173|474443742|FG000|Overall Study|Unacceptable Toxicity|21|||
131772010|NCT01161173|474443742|FG000|Overall Study|Death|194|||
131772011|NCT01161173|474443742|FG000|Overall Study|End of Study|2|||
131772012|NCT01161173|474443742|FG000|Overall Study|Reasons Not Specified|23|||
131772013|NCT00792467|474443745|FG000|Overall Study|progression of disease|17|||
131772014|NCT00792467|474443745|FG000|Overall Study|Adverse Event|1|||
131772015|NCT00792467|474443745|FG000|Overall Study|patient request|1|||
131772016|NCT00792467|474443745|FG000|Overall Study|Lost to Follow-up|1|||
131772017|NCT00792467|474443745|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
131772018|NCT00792467|474443745|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
131772019|NCT03911401|474443746|FG000|Overall Study|Adverse Event|1|||
131772020|NCT03911401|474443747|FG001|Overall Study|Adverse Event|2|||
131772021|NCT03911401|474443748|FG002|Overall Study|Adverse Event|5|||
131772022|NCT03911401|474443746|FG000|Overall Study|Lack of Efficacy|1|||
131772023|NCT03911401|474443747|FG001|Overall Study|Lack of Efficacy|1|||
131772024|NCT03911401|474443748|FG002|Overall Study|Lack of Efficacy|8|||
131772025|NCT03911401|474443746|FG000|Overall Study|Physician Decision|0|||
131772026|NCT03911401|474443747|FG001|Overall Study|Physician Decision|0|||
131772027|NCT03911401|474443748|FG002|Overall Study|Physician Decision|1|||
131772028|NCT03911401|474443746|FG000|Overall Study|Withdrawal by Subject|1|||
131772029|NCT03911401|474443747|FG001|Overall Study|Withdrawal by Subject|2|||
131772030|NCT03911401|474443748|FG002|Overall Study|Withdrawal by Subject|0|||
131772031|NCT03911401|474443746|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131552574|NCT00576732|473648079|FG000|OPEN LABEL|Lost to Follow-up|0|||
131552575|NCT00576732|473648080|FG001|OPEN LABEL|Lost to Follow-up|0|||
131552576|NCT00576732|473648081|FG002|OPEN LABEL|Lost to Follow-up|0|||
131552577|NCT00576732|473648082|FG003|OPEN LABEL|Lost to Follow-up|2|||
131552578|NCT00576732|473648083|FG004|OPEN LABEL|Lost to Follow-up|1|||
131552579|NCT00576732|473648084|FG005|OPEN LABEL|Lost to Follow-up|1|||
131552580|NCT00576732|473648079|FG000|OPEN LABEL|Withdrawal by Subject|0|||
131552581|NCT00576732|473648080|FG001|OPEN LABEL|Withdrawal by Subject|0|||
131552582|NCT00576732|473648081|FG002|OPEN LABEL|Withdrawal by Subject|0|||
131552583|NCT00576732|473648082|FG003|OPEN LABEL|Withdrawal by Subject|1|||
131552584|NCT00576732|473648083|FG004|OPEN LABEL|Withdrawal by Subject|0|||
131552585|NCT00576732|473648084|FG005|OPEN LABEL|Withdrawal by Subject|1|||
131772032|NCT03911401|474443747|FG001|Overall Study|Withdrawal by parent/guardian|4|||
131772033|NCT03911401|474443748|FG002|Overall Study|Withdrawal by parent/guardian|11|||
131772034|NCT02918968|474443749|FG000|1st Line AAT|Progressive disease|9|||
131772035|NCT02918968|474443750|FG001|1st Line AAT|Progressive disease|4|||
131772036|NCT02918968|474443749|FG000|1st Line AAT|Adverse Event|12|||
131772037|NCT02918968|474443750|FG001|1st Line AAT|Adverse Event|3|||
131772038|NCT02918968|474443749|FG000|1st Line AAT|Physician Decision|4|||
131772039|NCT02918968|474443750|FG001|1st Line AAT|Physician Decision|2|||
131552586|NCT00576732|473648079|FG000|OPEN LABEL|OTHER|0|||
131552587|NCT00576732|473648080|FG001|OPEN LABEL|OTHER|0|||
131552588|NCT00576732|473648081|FG002|OPEN LABEL|OTHER|0|||
131552589|NCT00576732|473648082|FG003|OPEN LABEL|OTHER|0|||
131552590|NCT00576732|473648083|FG004|OPEN LABEL|OTHER|0|||
131772040|NCT02918968|474443749|FG000|1st Line AAT|Withdrawal by Subject|2|||
131552591|NCT00576732|473648084|FG005|OPEN LABEL|OTHER|2|||
131552592|NCT00576732|473648079|FG000|OPEN LABEL|Lack of Efficacy|0|||
131552593|NCT00576732|473648080|FG001|OPEN LABEL|Lack of Efficacy|0|||
131772041|NCT02918968|474443750|FG001|1st Line AAT|Withdrawal by Subject|1|||
131772042|NCT02918968|474443749|FG000|1st Line AAT|Lost to Follow-up|0|||
131772043|NCT02918968|474443750|FG001|1st Line AAT|Lost to Follow-up|1|||
131772044|NCT02918968|474443749|FG000|1st Line AAT|Death|1|||
131772045|NCT02918968|474443750|FG001|1st Line AAT|Death|0|||
131772046|NCT02918968|474443749|FG000|1st Line AAT|Miscellaneous|1|||
131772047|NCT02918968|474443750|FG001|1st Line AAT|Miscellaneous|0|||
131772048|NCT02918968|474443749|FG000|2nd Line AAT|Progressive disease|21|||
131772049|NCT02918968|474443750|FG001|2nd Line AAT|Progressive disease|3|||
131888160|NCT00076999|474872367|FG002|Overall Study|Other reason (not specified)|4|||
131888161|NCT00076999|474872368|FG003|Overall Study|Other reason (not specified)|1|||
131888162|NCT00076999|474872369|FG004|Overall Study|Other reason (not specified)|13|||
131888163|NCT01857102|474872371|FG000|Period 1|No longer meets Eligibility Criteria|0|||
131888164|NCT01857102|474872372|FG001|Period 1|No longer meets Eligibility Criteria|2|||
131888165|NCT01857102|474872371|FG000|Period 1|Lost to Follow-up|0|||
131888166|NCT01857102|474872372|FG001|Period 1|Lost to Follow-up|3|||
131888167|NCT01857102|474872371|FG000|Period 1|Unsatisfactory Lens Fit|1|||
131888168|NCT01857102|474872372|FG001|Period 1|Unsatisfactory Lens Fit|0|||
131888169|NCT01857102|474872371|FG000|Period 1|Unsatisfactory Visual Response|1|||
131888170|NCT01857102|474872372|FG001|Period 1|Unsatisfactory Visual Response|0|||
131888171|NCT01857102|474872371|FG000|Period 1|Physician Decision|1|||
131888172|NCT01857102|474872372|FG001|Period 1|Physician Decision|0|||
131888173|NCT01857102|474872371|FG000|Period 2|Lens Discomfort|1|||
131888174|NCT01857102|474872372|FG001|Period 2|Lens Discomfort|0|||
131888175|NCT01857102|474872371|FG000|Period 2|Unsatisfactory Lens Fit|1|||
131888176|NCT01857102|474872372|FG001|Period 2|Unsatisfactory Lens Fit|0|||
131888177|NCT02603562|474872378|FG000|Overall Study|Lost to Follow-up|1|||
131888178|NCT01380691|474872393|FG000|Washout (7 Days)|Protocol Violation|0|||
131888179|NCT01380691|474872394|FG001|Washout (7 Days)|Protocol Violation|0|||
131888180|NCT01380691|474872395|FG002|Washout (7 Days)|Protocol Violation|0|||
131888181|NCT01380691|474872396|FG003|Washout (7 Days)|Protocol Violation|1|||
131888182|NCT01380691|474872393|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
131888183|NCT01380691|474872394|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
131888184|NCT01380691|474872395|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
131888185|NCT01380691|474872396|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
131888186|NCT01987232|474872397|FG000|Overall Study|Ongoing in Study|0|||
131888187|NCT01987232|474872398|FG001|Overall Study|Ongoing in Study|0|||
131888188|NCT01987232|474872399|FG002|Overall Study|Ongoing in Study|0|||
131888189|NCT01987232|474872400|FG003|Overall Study|Ongoing in Study|1|||
131888190|NCT01987232|474872401|FG004|Overall Study|Ongoing in Study|0|||
131888191|NCT02028169|474872402|FG000|Overall Study|Lost to Follow-up|21|||
131888192|NCT02028169|474872402|FG000|Overall Study|Lack of Efficacy|2|||
131552594|NCT00576732|473648081|FG002|OPEN LABEL|Lack of Efficacy|0|||
131552595|NCT00576732|473648082|FG003|OPEN LABEL|Lack of Efficacy|2|||
131552596|NCT00576732|473648083|FG004|OPEN LABEL|Lack of Efficacy|2|||
131552597|NCT00576732|473648084|FG005|OPEN LABEL|Lack of Efficacy|3|||
131552598|NCT00576732|473648079|FG000|OPEN LABEL|Protocol Violation|0|||
131552599|NCT00576732|473648080|FG001|OPEN LABEL|Protocol Violation|0|||
131552600|NCT00576732|473648081|FG002|OPEN LABEL|Protocol Violation|0|||
131552601|NCT00576732|473648082|FG003|OPEN LABEL|Protocol Violation|2|||
131552602|NCT00576732|473648083|FG004|OPEN LABEL|Protocol Violation|1|||
131552603|NCT00576732|473648084|FG005|OPEN LABEL|Protocol Violation|0|||
131552604|NCT03188120|473648085|FG000|Overall Study|Adverse Event|4|||
131552605|NCT03188120|473648085|FG000|Overall Study|Insufficient Effectiveness|8|||
131552606|NCT03188120|473648085|FG000|Overall Study|Improved|12|||
131552607|NCT03188120|473648085|FG000|Overall Study|Lost to Follow-up|7|||
131552608|NCT03188120|473648085|FG000|Overall Study|Other than specified|3|||
131552609|NCT03188120|473648085|FG000|Overall Study|No visit after the first visit|13|||
131552610|NCT02978443|473648087|FG000|Overall Study|Withdrawal by Subject|1|||
131552611|NCT02978443|473648087|FG000|Overall Study|Adverse Event|3|||
131888193|NCT02028169|474872402|FG000|Overall Study|Withdrawal by Subject|2|||
131552612|NCT02978443|473648087|FG000|Overall Study|Disease Progression on study|6|||
131552613|NCT02978443|473648087|FG000|Overall Study|Death|1|||
131552614|NCT02978443|473648087|FG000|Overall Study|Physician Decision|1|||
131552615|NCT02978443|473648087|FG000|Overall Study|Switch to alternative therapy|1|||
131552616|NCT02978443|473648087|FG000|Overall Study|Refused further treatment|1|||
131772050|NCT02918968|474443749|FG000|2nd Line AAT|Adverse Event|2|||
131772051|NCT02918968|474443750|FG001|2nd Line AAT|Adverse Event|5|||
131772052|NCT02918968|474443749|FG000|2nd Line AAT|Physician Decision|0|||
131772053|NCT02918968|474443750|FG001|2nd Line AAT|Physician Decision|1|||
131888194|NCT02028169|474872402|FG000|Overall Study|Adverse Event|1|||
131888195|NCT02028169|474872402|FG000|Overall Study|Cessation of Drug|1|||
131888196|NCT02028169|474872402|FG000|Overall Study|Concomitant Medication Usage|1|||
131888197|NCT00232596|474872408|FG000|6-Week Titration Phase|Adverse Event|6|||
131888198|NCT00232596|474872409|FG001|6-Week Titration Phase|Adverse Event|19|||
131888199|NCT00232596|474872408|FG000|6-Week Titration Phase|Failed to Return|2|||
131888200|NCT00232596|474872409|FG001|6-Week Titration Phase|Failed to Return|1|||
131888201|NCT00232596|474872408|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
131888202|NCT00232596|474872409|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
131888203|NCT00232596|474872408|FG000|6-Week Titration Phase|Protocol Violation|1|||
131888204|NCT00232596|474872409|FG001|6-Week Titration Phase|Protocol Violation|3|||
131888205|NCT00232596|474872408|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
131888206|NCT00232596|474872409|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
131888207|NCT00232596|474872408|FG000|6-Week Titration Phase|Other|3|||
131552617|NCT00717314|473648089|FG000|Overall Study|Adverse Event|3|||
131552618|NCT00717314|473648090|FG001|Overall Study|Adverse Event|2|||
131552619|NCT00717314|473648089|FG000|Overall Study|Protocol Violation|1|||
131552620|NCT00717314|473648090|FG001|Overall Study|Protocol Violation|0|||
131552621|NCT00717314|473648089|FG000|Overall Study|Lost to Follow-up|1|||
131552622|NCT00717314|473648090|FG001|Overall Study|Lost to Follow-up|5|||
131552623|NCT00717314|473648089|FG000|Overall Study|Withdrawal by Subject|1|||
131552624|NCT00717314|473648090|FG001|Overall Study|Withdrawal by Subject|3|||
131552625|NCT04043962|473648092|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
131552626|NCT04043962|473648092|FG000|Post-Treatment|Withdrawal by Subject|5|||
131552627|NCT04043962|473648092|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
131552628|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
131552629|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
131552630|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
131552631|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
131552632|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
131552633|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
131552634|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
131552635|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
131552636|NCT01336621|473648093|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
131552637|NCT01336621|473648093|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
131552638|NCT01336621|473648093|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
131552639|NCT01336621|473648093|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
131552640|NCT01336621|473648093|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
131552641|NCT01336621|473648093|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
131552642|NCT01126060|473648096|FG000|Overall Study|Protocol Violation|0|||
131552643|NCT01126060|473648097|FG001|Overall Study|Protocol Violation|2|||
131552644|NCT01874145|473648098|FG000|Core Period|Non-compliance|1|||
131552645|NCT01874145|473648099|FG001|Core Period|Non-compliance|0|||
131552646|NCT01874145|473648098|FG000|Core Period|Protocol Violation|1|||
131552647|NCT01874145|473648099|FG001|Core Period|Protocol Violation|1|||
131552648|NCT01874145|473648098|FG000|Core Period|Physician Decision|1|||
131552649|NCT01874145|473648099|FG001|Core Period|Physician Decision|1|||
131552650|NCT01874145|473648098|FG000|Core Period|Adverse Event|0|||
131552651|NCT01874145|473648099|FG001|Core Period|Adverse Event|1|||
131552652|NCT01874145|473648098|FG000|Core Period|Withdrawal by Subject|0|||
131552653|NCT01874145|473648099|FG001|Core Period|Withdrawal by Subject|4|||
131552654|NCT01874145|473648098|FG000|Extension Period|Adverse Event|3|||
131552655|NCT01874145|473648099|FG001|Extension Period|Adverse Event|2|||
131552656|NCT01874145|473648098|FG000|Extension Period|Withdrawal by Subject|2|||
131552657|NCT01874145|473648099|FG001|Extension Period|Withdrawal by Subject|1|||
131552658|NCT01874145|473648098|FG000|Extension Period|Lost to Follow-up|1|||
131552659|NCT01874145|473648099|FG001|Extension Period|Lost to Follow-up|1|||
131552660|NCT01521884|473648105|FG000|Overall Study|Non Responders|10|||
131552661|NCT01521884|473648105|FG000|Overall Study|Adverse Event|5|||
131552662|NCT01521884|473648105|FG000|Overall Study|Pregnancy|1|||
131552663|NCT01521884|473648105|FG000|Overall Study|Withdrawal by Subject|1|||
131552664|NCT01521884|473648105|FG000|Overall Study|Physician Decision|2|||
131552665|NCT01521884|473648105|FG000|Overall Study|Protocol Violation|3|||
131552666|NCT01521884|473648105|FG000|Overall Study|Participant non-eligible|1|||
131552667|NCT01521884|473648105|FG000|Overall Study|Lost to Follow-up|4|||
131552668|NCT02821819|473648106|FG000|Overall Study|Protocol Violation|1|||
131552669|NCT03565068|473648107|FG000|Overall Study|Protocol Violation|0|||
131552670|NCT03565068|473648108|FG001|Overall Study|Protocol Violation|0|||
131552671|NCT03565068|473648109|FG002|Overall Study|Protocol Violation|0|||
131552672|NCT03565068|473648110|FG003|Overall Study|Protocol Violation|0|||
131552673|NCT03565068|473648111|FG004|Overall Study|Protocol Violation|1|||
131552674|NCT03565068|473648112|FG005|Overall Study|Protocol Violation|0|||
131552675|NCT03565068|473648113|FG006|Overall Study|Protocol Violation|0|||
131552676|NCT03565068|473648114|FG007|Overall Study|Protocol Violation|1|||
131552677|NCT03565068|473648115|FG008|Overall Study|Protocol Violation|0|||
131552678|NCT03565068|473648107|FG000|Overall Study|Sponsor decision|0|||
131552679|NCT03565068|473648108|FG001|Overall Study|Sponsor decision|0|||
131552680|NCT03565068|473648109|FG002|Overall Study|Sponsor decision|0|||
131552681|NCT03565068|473648110|FG003|Overall Study|Sponsor decision|0|||
131552682|NCT03565068|473648111|FG004|Overall Study|Sponsor decision|1|||
131888208|NCT00232596|474872409|FG001|6-Week Titration Phase|Other|3|||
131888209|NCT00232596|474872408|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
131888210|NCT00232596|474872409|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
131888211|NCT00232596|474872408|FG000|12-Week Maintenance Phase|Adverse Event|7|||
131888212|NCT00232596|474872409|FG001|12-Week Maintenance Phase|Adverse Event|22|||
131888213|NCT00232596|474872408|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
131888214|NCT00232596|474872409|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
131888215|NCT00232596|474872408|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
131888216|NCT00232596|474872409|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
131888217|NCT00232596|474872408|FG000|12-Week Maintenance Phase|Other|1|||
131888218|NCT00232596|474872409|FG001|12-Week Maintenance Phase|Other|3|||
131888219|NCT03426436|474872412|FG000|Overall Study|Incorrect lead placement|12|||
131888220|NCT03426436|474872412|FG000|Overall Study|Withdrawal by Subject|2|||
131888221|NCT03426436|474872412|FG000|Overall Study|Consent issue|1|||
131888222|NCT03426436|474872412|FG000|Overall Study|ECGs not saved|4|||
131888223|NCT00432276|474872413|FG000|Overall Study|Hyperglycemic Rescue|44|||
131888224|NCT00432276|474872414|FG001|Overall Study|Hyperglycemic Rescue|87|||
131888225|NCT00432276|474872413|FG000|Overall Study|Adverse Event|13|||
131888226|NCT00432276|474872414|FG001|Overall Study|Adverse Event|16|||
131888227|NCT00432276|474872413|FG000|Overall Study|Protocol Violation|25|||
131888228|NCT00432276|474872414|FG001|Overall Study|Protocol Violation|20|||
131888229|NCT00432276|474872413|FG000|Overall Study|Lost to Follow-up|6|||
131888230|NCT00432276|474872414|FG001|Overall Study|Lost to Follow-up|2|||
131888231|NCT00432276|474872413|FG000|Overall Study|Withdrawal by Subject|25|||
131888232|NCT00432276|474872414|FG001|Overall Study|Withdrawal by Subject|20|||
131888233|NCT00432276|474872413|FG000|Overall Study|Physician Decision|6|||
131888234|NCT00432276|474872414|FG001|Overall Study|Physician Decision|8|||
131888235|NCT00432276|474872413|FG000|Overall Study|Other|2|||
131888236|NCT00432276|474872414|FG001|Overall Study|Other|3|||
131888237|NCT00467961|474872415|FG000|Overall Study|Technical Failures|5|||
131888238|NCT00467961|474872415|FG000|Overall Study|Disease Progression|2|||
131888239|NCT02360475|474872417|FG000|Overall Study|Lost to Follow-up|4|||
131888240|NCT02360475|474872418|FG001|Overall Study|Lost to Follow-up|12|||
131888241|NCT02360475|474872419|FG002|Overall Study|Lost to Follow-up|6|||
131888242|NCT02360475|474872420|FG003|Overall Study|Lost to Follow-up|4|||
131888243|NCT02360475|474872417|FG000|Overall Study|Withdrawal by Subject|0|||
131888244|NCT02360475|474872418|FG001|Overall Study|Withdrawal by Subject|1|||
131888245|NCT02360475|474872419|FG002|Overall Study|Withdrawal by Subject|2|||
131888246|NCT02360475|474872420|FG003|Overall Study|Withdrawal by Subject|0|||
131888247|NCT02360475|474872417|FG000|Overall Study|Migrated/moved from study area|0|||
131888248|NCT02360475|474872418|FG001|Overall Study|Migrated/moved from study area|0|||
131888249|NCT02360475|474872419|FG002|Overall Study|Migrated/moved from study area|0|||
131552683|NCT03565068|473648112|FG005|Overall Study|Sponsor decision|1|||
131552684|NCT03565068|473648113|FG006|Overall Study|Sponsor decision|0|||
131552685|NCT03565068|473648114|FG007|Overall Study|Sponsor decision|0|||
131552686|NCT03565068|473648115|FG008|Overall Study|Sponsor decision|0|||
131552687|NCT03565068|473648107|FG000|Overall Study|Withdrawal by Subject|0|||
131552688|NCT03565068|473648108|FG001|Overall Study|Withdrawal by Subject|0|||
131552689|NCT03565068|473648109|FG002|Overall Study|Withdrawal by Subject|1|||
131552690|NCT03565068|473648110|FG003|Overall Study|Withdrawal by Subject|0|||
131552691|NCT03565068|473648111|FG004|Overall Study|Withdrawal by Subject|2|||
131552692|NCT03565068|473648112|FG005|Overall Study|Withdrawal by Subject|0|||
131552693|NCT03565068|473648113|FG006|Overall Study|Withdrawal by Subject|1|||
131552694|NCT03565068|473648114|FG007|Overall Study|Withdrawal by Subject|5|||
131552695|NCT03565068|473648115|FG008|Overall Study|Withdrawal by Subject|1|||
131552696|NCT03565068|473648107|FG000|Overall Study|Physician Decision|0|||
131552697|NCT03565068|473648108|FG001|Overall Study|Physician Decision|0|||
131552698|NCT03565068|473648109|FG002|Overall Study|Physician Decision|0|||
131552699|NCT03565068|473648110|FG003|Overall Study|Physician Decision|0|||
131552700|NCT03565068|473648111|FG004|Overall Study|Physician Decision|0|||
131552701|NCT03565068|473648112|FG005|Overall Study|Physician Decision|0|||
131552702|NCT03565068|473648113|FG006|Overall Study|Physician Decision|0|||
131552703|NCT03565068|473648114|FG007|Overall Study|Physician Decision|1|||
131552704|NCT03565068|473648115|FG008|Overall Study|Physician Decision|0|||
131552705|NCT03565068|473648107|FG000|Overall Study|Lost to Follow-up|0|||
131552706|NCT03565068|473648108|FG001|Overall Study|Lost to Follow-up|0|||
131888250|NCT02360475|474872420|FG003|Overall Study|Migrated/moved from study area|1|||
131888251|NCT01764659|474872426|FG000|Overall Study|Death|1|||
131888252|NCT01764659|474872426|FG000|Overall Study|Physician Decision|1|||
131552707|NCT03565068|473648109|FG002|Overall Study|Lost to Follow-up|0|||
131552708|NCT03565068|473648110|FG003|Overall Study|Lost to Follow-up|0|||
131552709|NCT03565068|473648111|FG004|Overall Study|Lost to Follow-up|0|||
131888253|NCT01298141|474872427|FG000|Overall Study|Adverse Event|3|||
131888254|NCT01298141|474872427|FG000|Overall Study|Refusal of Required Study Procedures|1|||
131888255|NCT01298141|474872427|FG000|Overall Study|Withdrawal by Subject|6|||
131888256|NCT01298141|474872427|FG000|Overall Study|Termination of Study by the Investigator|5|||
131888257|NCT01298141|474872427|FG000|Overall Study|Other|5|||
131888258|NCT01298141|474872427|FG000|Overall Study|Lost to Follow-up|1|||
131888259|NCT01298141|474872427|FG000|Overall Study|Death|6|||
131888260|NCT01298141|474872427|FG000|Overall Study|Not treated|4|||
131888261|NCT01854879|474872431|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
131888262|NCT01854879|474872431|FG000|Overall Study|screen fail|3|||
131888263|NCT01854879|474872431|FG000|Overall Study|incomplete data set|1|||
131888264|NCT02824562|474874616|FG000|Overall Study|Lost to Follow-up|3|||
131888265|NCT02824562|474874617|FG001|Overall Study|Lost to Follow-up|4|||
131888266|NCT02824562|474874616|FG000|Overall Study|Death|0|||
131888267|NCT02824562|474874617|FG001|Overall Study|Death|1|||
131888268|NCT02168777|474874618|FG000|Overall Study|Withdrawal by Subject|1|||
131888269|NCT02168777|474874619|FG001|Overall Study|Withdrawal by Subject|0|||
131888270|NCT02168777|474874620|FG002|Overall Study|Withdrawal by Subject|2|||
131888271|NCT02168777|474874618|FG000|Overall Study|Adverse Event|1|||
131888272|NCT02168777|474874619|FG001|Overall Study|Adverse Event|0|||
131888273|NCT02168777|474874620|FG002|Overall Study|Adverse Event|1|||
131888274|NCT02168777|474874618|FG000|Overall Study|Disease recurrence|0|||
131888275|NCT02168777|474874619|FG001|Overall Study|Disease recurrence|0|||
131888276|NCT02168777|474874620|FG002|Overall Study|Disease recurrence|1|||
131888277|NCT02168777|474874618|FG000|Overall Study|Radiological disease progression|0|||
131888278|NCT02168777|474874619|FG001|Overall Study|Radiological disease progression|5|||
131888279|NCT02168777|474874620|FG002|Overall Study|Radiological disease progression|5|||
131888280|NCT02168777|474874618|FG000|Overall Study|Clinical disease progression|0|||
131888281|NCT02168777|474874619|FG001|Overall Study|Clinical disease progression|1|||
131888282|NCT02168777|474874620|FG002|Overall Study|Clinical disease progression|2|||
131888283|NCT02168777|474874618|FG000|Overall Study|Other reason|0|||
131888284|NCT02168777|474874619|FG001|Overall Study|Other reason|1|||
131888285|NCT02168777|474874620|FG002|Overall Study|Other reason|0|||
131888286|NCT05243563|474874621|FG000|Overall Study|Withdrawal by Subject|1|||
131888287|NCT05243563|474874622|FG001|Overall Study|Withdrawal by Subject|0|||
131888288|NCT05243563|474874621|FG000|Overall Study|Physician Decision|1|||
131888289|NCT05243563|474874622|FG001|Overall Study|Physician Decision|0|||
131888290|NCT02474355|474874623|FG000|Overall Study|Other|43|||
131888291|NCT02474355|474874623|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
131888292|NCT02474355|474874623|FG000|Overall Study|Lost to Follow-up|98|||
131888293|NCT02474355|474874623|FG000|Overall Study|Withdrawal by Subject|124|||
131888294|NCT02474355|474874623|FG000|Overall Study|Death|1361|||
131888295|NCT01066793|474874624|FG000|Overall Study|Death|4|||
131888296|NCT01066793|474874625|FG001|Overall Study|Death|1|||
131888297|NCT01066793|474874626|FG002|Overall Study|Death|1|||
131888298|NCT01066793|474874627|FG003|Overall Study|Death|0|||
131888299|NCT01066793|474874628|FG004|Overall Study|Death|0|||
131888300|NCT01066793|474874629|FG005|Overall Study|Death|0|||
131888301|NCT01066793|474874624|FG000|Overall Study|Lack of Efficacy|2|||
131888302|NCT01066793|474874625|FG001|Overall Study|Lack of Efficacy|1|||
131888303|NCT01066793|474874626|FG002|Overall Study|Lack of Efficacy|0|||
131888304|NCT01066793|474874627|FG003|Overall Study|Lack of Efficacy|0|||
131888305|NCT01066793|474874628|FG004|Overall Study|Lack of Efficacy|0|||
131888306|NCT01066793|474874629|FG005|Overall Study|Lack of Efficacy|0|||
131888307|NCT01066793|474874624|FG000|Overall Study|Lost to Follow-up|180|||
131888308|NCT01066793|474874625|FG001|Overall Study|Lost to Follow-up|39|||
131888309|NCT01066793|474874626|FG002|Overall Study|Lost to Follow-up|82|||
131888310|NCT01066793|474874627|FG003|Overall Study|Lost to Follow-up|16|||
131888311|NCT01066793|474874628|FG004|Overall Study|Lost to Follow-up|0|||
131888312|NCT01066793|474874629|FG005|Overall Study|Lost to Follow-up|1|||
131888313|NCT01066793|474874624|FG000|Overall Study|Physician Decision|3|||
131888314|NCT01066793|474874625|FG001|Overall Study|Physician Decision|0|||
131888315|NCT01066793|474874626|FG002|Overall Study|Physician Decision|0|||
131888316|NCT01066793|474874627|FG003|Overall Study|Physician Decision|0|||
131888317|NCT01066793|474874628|FG004|Overall Study|Physician Decision|0|||
131888318|NCT01066793|474874629|FG005|Overall Study|Physician Decision|0|||
131435878|NCT00920855|473221884|FG000|Overall Study|Noncompliance to study medication|0|||
131888319|NCT01066793|474874624|FG000|Overall Study|Protocol Violation|3|||
131888320|NCT01066793|474874625|FG001|Overall Study|Protocol Violation|2|||
131888321|NCT01066793|474874626|FG002|Overall Study|Protocol Violation|2|||
131435879|NCT00920855|473221885|FG001|Overall Study|Noncompliance to study medication|0|||
131435880|NCT00920855|473221886|FG002|Overall Study|Noncompliance to study medication|1|||
131888322|NCT01066793|474874627|FG003|Overall Study|Protocol Violation|0|||
131888323|NCT01066793|474874628|FG004|Overall Study|Protocol Violation|0|||
131888324|NCT01066793|474874629|FG005|Overall Study|Protocol Violation|0|||
131888325|NCT01066793|474874624|FG000|Overall Study|Withdrawal by Subject|7|||
131888326|NCT01066793|474874625|FG001|Overall Study|Withdrawal by Subject|4|||
131888327|NCT01066793|474874626|FG002|Overall Study|Withdrawal by Subject|1|||
131888328|NCT01066793|474874627|FG003|Overall Study|Withdrawal by Subject|0|||
131888329|NCT01066793|474874628|FG004|Overall Study|Withdrawal by Subject|0|||
131888330|NCT01066793|474874629|FG005|Overall Study|Withdrawal by Subject|0|||
131888331|NCT01066793|474874624|FG000|Overall Study|Early Termination|3|||
131888332|NCT01066793|474874625|FG001|Overall Study|Early Termination|0|||
131888333|NCT01066793|474874626|FG002|Overall Study|Early Termination|0|||
131888334|NCT01066793|474874627|FG003|Overall Study|Early Termination|0|||
131552710|NCT03565068|473648112|FG005|Overall Study|Lost to Follow-up|0|||
131772054|NCT02918968|474443749|FG000|2nd Line AAT|Withdrawal by Subject|2|||
131772055|NCT02918968|474443750|FG001|2nd Line AAT|Withdrawal by Subject|2|||
131772056|NCT02918968|474443749|FG000|2nd Line AAT|Death|0|||
131772057|NCT02918968|474443750|FG001|2nd Line AAT|Death|1|||
131772058|NCT03781167|474443760|FG000|Overall Study|Adverse Event|23|||
131772059|NCT03781167|474443761|FG001|Overall Study|Adverse Event|25|||
131772060|NCT03781167|474443760|FG000|Overall Study|Withdrew consent|16|||
131772061|NCT03781167|474443761|FG001|Overall Study|Withdrew consent|12|||
131772062|NCT03781167|474443760|FG000|Overall Study|Lost to Follow-up|0|||
131772063|NCT03781167|474443761|FG001|Overall Study|Lost to Follow-up|1|||
131772064|NCT03781167|474443760|FG000|Overall Study|Lack of Efficacy|4|||
131772065|NCT03781167|474443761|FG001|Overall Study|Lack of Efficacy|5|||
131772066|NCT03781167|474443760|FG000|Overall Study|Difficulty with drug delivery system|2|||
131772067|NCT03781167|474443761|FG001|Overall Study|Difficulty with drug delivery system|3|||
131772068|NCT03781167|474443760|FG000|Overall Study|Other, not specified|2|||
131772069|NCT03781167|474443761|FG001|Overall Study|Other, not specified|2|||
131772070|NCT01590628|474443763|FG000|Overall Study|Death|2|||
131772071|NCT01590628|474443764|FG001|Overall Study|Death|0|||
131772072|NCT00475657|474443765|FG000|Overall Study|Death|1|||
131772073|NCT00475657|474443765|FG000|Overall Study|Sponsor's Decision|3|||
131772074|NCT00381680|474443768|FG000|Overall Study|Adverse Event|9|||
131772075|NCT00381680|474443769|FG001|Overall Study|Adverse Event|3|||
131772076|NCT00381680|474443768|FG000|Overall Study|Death|10|||
131772077|NCT00381680|474443769|FG001|Overall Study|Death|7|||
131772078|NCT00381680|474443768|FG000|Overall Study|Lost to Follow-up|3|||
131772079|NCT00381680|474443769|FG001|Overall Study|Lost to Follow-up|2|||
131772080|NCT00381680|474443768|FG000|Overall Study|Physician Decision|25|||
131772081|NCT00381680|474443769|FG001|Overall Study|Physician Decision|6|||
131772082|NCT00381680|474443768|FG000|Overall Study|Withdrawal by Subject|3|||
131772083|NCT00381680|474443769|FG001|Overall Study|Withdrawal by Subject|1|||
131772084|NCT00381680|474443768|FG000|Overall Study|Entry onto another COG Trial|1|||
131772085|NCT00381680|474443769|FG001|Overall Study|Entry onto another COG Trial|2|||
131772086|NCT00381680|474443768|FG000|Overall Study|Alternative Therapy|11|||
131772087|NCT00381680|474443769|FG001|Overall Study|Alternative Therapy|5|||
131772088|NCT00381680|474443768|FG000|Overall Study|Secondary Malignancy|3|||
131772089|NCT00381680|474443769|FG001|Overall Study|Secondary Malignancy|0|||
131772090|NCT00381680|474443768|FG000|Overall Study|Delay initiation|1|||
131772091|NCT00381680|474443769|FG001|Overall Study|Delay initiation|0|||
131772092|NCT00381680|474443768|FG000|Overall Study|Stem Cell Transplant|26|||
131772093|NCT00381680|474443769|FG001|Overall Study|Stem Cell Transplant|10|||
131772094|NCT00381680|474443768|FG000|Overall Study|Relapse|18|||
131772095|NCT00381680|474443769|FG001|Overall Study|Relapse|9|||
131772096|NCT00381680|474443768|FG000|Overall Study|Induction Failure|4|||
131772097|NCT00381680|474443769|FG001|Overall Study|Induction Failure|1|||
131772098|NCT00381680|474443768|FG000|Overall Study|Progression|1|||
131772099|NCT00381680|474443769|FG001|Overall Study|Progression|1|||
131772100|NCT00381680|474443768|FG000|Overall Study|Other not otherwise specified|7|||
131772101|NCT00381680|474443769|FG001|Overall Study|Other not otherwise specified|2|||
131772102|NCT00381680|474443768|FG000|Overall Study|Ineligible|3|||
131772103|NCT00381680|474443769|FG001|Overall Study|Ineligible|1|||
131772104|NCT00933543|474443774|FG000|Overall Study|Adverse Event|2|||
131772105|NCT00933543|474443775|FG001|Overall Study|Adverse Event|1|||
131772106|NCT00933543|474443774|FG000|Overall Study|Lost to Follow-up|0|||
131772107|NCT00933543|474443775|FG001|Overall Study|Lost to Follow-up|1|||
131772108|NCT00933543|474443774|FG000|Overall Study|Withdrawal by Subject|0|||
131772109|NCT00933543|474443775|FG001|Overall Study|Withdrawal by Subject|1|||
131772110|NCT00933543|474443774|FG000|Overall Study|Lack of Efficacy|0|||
131772111|NCT00933543|474443775|FG001|Overall Study|Lack of Efficacy|3|||
131772112|NCT00933543|474443774|FG000|Overall Study|Other|1|||
131772113|NCT00933543|474443775|FG001|Overall Study|Other|1|||
131772114|NCT04988035|474443776|FG000|Overall Study|Death|19|||
131772115|NCT04988035|474443777|FG001|Overall Study|Death|13|||
131772116|NCT04988035|474443776|FG000|Overall Study|Lost to Follow-up|12|||
131772117|NCT04988035|474443777|FG001|Overall Study|Lost to Follow-up|6|||
131772118|NCT04988035|474443776|FG000|Overall Study|Protocol Violation|0|||
131772119|NCT04988035|474443777|FG001|Overall Study|Protocol Violation|1|||
131772120|NCT04988035|474443776|FG000|Overall Study|Withdrawal by Subject|2|||
131772121|NCT04988035|474443777|FG001|Overall Study|Withdrawal by Subject|4|||
131772122|NCT04988035|474443776|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
131772123|NCT04988035|474443777|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
131772124|NCT04626947|474443778|FG000|Overall Study|Study terminated|14|||
131772125|NCT00265109|474443781|FG000|Overall Study|Withdrawal by Subject|5|||
131772126|NCT00265109|474443781|FG000|Overall Study|Adverse Event|1|||
131772127|NCT03831282|474443782|FG000|Overall Study|Could not place sensor|1|||
131772128|NCT00334893|474443783|FG000|Overall Study|Not Treated|1|||
131772129|NCT00334893|474443784|FG001|Overall Study|Not Treated|0|||
131772130|NCT00920582|474443785|FG000|Overall Study|Lost to Follow-up|5|||
131772131|NCT00920582|474443786|FG001|Overall Study|Lost to Follow-up|1|||
131552711|NCT03565068|473648113|FG006|Overall Study|Lost to Follow-up|0|||
131552712|NCT03565068|473648114|FG007|Overall Study|Lost to Follow-up|1|||
131552713|NCT03565068|473648115|FG008|Overall Study|Lost to Follow-up|0|||
131552714|NCT03238300|473648119|FG000|Baseline (Before Intervention)|Physician Decision|0|||
131552715|NCT03238300|473648120|FG001|Baseline (Before Intervention)|Physician Decision|1|||
131552716|NCT03238300|473648119|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
131552717|NCT03238300|473648120|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
131552718|NCT03238300|473648119|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
131552719|NCT03238300|473648120|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
131552720|NCT03238300|473648119|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
131552721|NCT03238300|473648120|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
131552722|NCT01893827|473648123|FG000|Overall Study|Lost to Follow-up|19|||
131552723|NCT01893827|473648124|FG001|Overall Study|Lost to Follow-up|26|||
131552724|NCT02217280|473648125|FG000|Overall Study|Withdrawal by Subject|2|||
131552725|NCT02217280|473648125|FG000|Overall Study|Post-consent sceen fail|2|||
131552726|NCT02089230|473648127|FG000|Overall Study|Death|0|||
131552727|NCT02089230|473648128|FG001|Overall Study|Death|0|||
131552728|NCT02089230|473648129|FG002|Overall Study|Death|2|||
131552729|NCT02089230|473648127|FG000|Overall Study|Seeking Alternative Therapy|0|||
131552730|NCT02089230|473648128|FG001|Overall Study|Seeking Alternative Therapy|0|||
131552731|NCT02089230|473648129|FG002|Overall Study|Seeking Alternative Therapy|4|||
131552732|NCT02392611|473649732|FG000|Overall Study|Adverse Event|0|||
131552733|NCT02392611|473649733|FG001|Overall Study|Adverse Event|0|||
131552734|NCT02392611|473649734|FG002|Overall Study|Adverse Event|0|||
131552735|NCT02392611|473649735|FG003|Overall Study|Adverse Event|1|||
131552736|NCT02392611|473649736|FG004|Overall Study|Adverse Event|0|||
131662069|NCT01865747|474046221|FG000|Primary Intent to Treat (PITT)|Other|0|||
131662070|NCT01865747|474046222|FG001|Primary Intent to Treat (PITT)|Other|1|||
131662071|NCT02592876|474046223|FG000|Overall Study|Withdrawal by Subject|3|||
131662072|NCT02592876|474046224|FG001|Overall Study|Withdrawal by Subject|3|||
131662073|NCT02592876|474046223|FG000|Overall Study|Study Termination by Sponsor|32|||
131662074|NCT02592876|474046224|FG001|Overall Study|Study Termination by Sponsor|27|||
131662075|NCT02592876|474046223|FG000|Overall Study|Lost to Follow-up|0|||
131662076|NCT02592876|474046224|FG001|Overall Study|Lost to Follow-up|1|||
131662077|NCT02592876|474046223|FG000|Overall Study|Death|6|||
131662078|NCT02592876|474046224|FG001|Overall Study|Death|9|||
131662079|NCT00611975|474046227|FG000|Overall Study|Withdrawal by Subject|3|||
131662080|NCT00611975|474046228|FG001|Overall Study|Withdrawal by Subject|7|||
131662081|NCT00611975|474046227|FG000|Overall Study|Pregnancy|2|||
131662082|NCT00611975|474046228|FG001|Overall Study|Pregnancy|1|||
131662083|NCT03465904|474046229|FG000|Overall Study|Withdrawal by Subject|9|||
131662084|NCT03465904|474046230|FG001|Overall Study|Withdrawal by Subject|5|||
131662085|NCT03465904|474046229|FG000|Overall Study|Lost to Follow-up|11|||
131662086|NCT03465904|474046230|FG001|Overall Study|Lost to Follow-up|9|||
131662087|NCT03465904|474046229|FG000|Overall Study|Protocol Violation|20|||
131662088|NCT03465904|474046230|FG001|Overall Study|Protocol Violation|15|||
131662089|NCT01305200|474046232|FG000|Overall Study|Physician Decision|4|||
131662090|NCT01305200|474046233|FG001|Overall Study|Physician Decision|6|||
131662091|NCT01305200|474046234|FG002|Overall Study|Physician Decision|1|||
131662092|NCT01305200|474046232|FG000|Overall Study|Withdrawal by Subject|24|||
131662093|NCT01305200|474046233|FG001|Overall Study|Withdrawal by Subject|21|||
131662094|NCT01305200|474046234|FG002|Overall Study|Withdrawal by Subject|1|||
131662095|NCT01305200|474046232|FG000|Overall Study|Ineligible|1|||
131888335|NCT01066793|474874628|FG004|Overall Study|Early Termination|0|||
131888336|NCT01066793|474874629|FG005|Overall Study|Early Termination|0|||
131888337|NCT01066793|474874624|FG000|Overall Study|Lab test not done|7|||
131888338|NCT01066793|474874625|FG001|Overall Study|Lab test not done|0|||
131888339|NCT01066793|474874626|FG002|Overall Study|Lab test not done|0|||
131888340|NCT01066793|474874627|FG003|Overall Study|Lab test not done|1|||
131888341|NCT01066793|474874628|FG004|Overall Study|Lab test not done|0|||
131552737|NCT02392611|473649737|FG005|Overall Study|Adverse Event|0|||
131662096|NCT01305200|474046233|FG001|Overall Study|Ineligible|2|||
131662097|NCT01305200|474046234|FG002|Overall Study|Ineligible|1|||
131662098|NCT01305200|474046232|FG000|Overall Study|Death|0|||
131662099|NCT01305200|474046233|FG001|Overall Study|Death|2|||
131662100|NCT01305200|474046234|FG002|Overall Study|Death|0|||
131662101|NCT00925353|474046235|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
131662102|NCT02980731|474047654|FG000|Overall Study|Death|63|||
131662103|NCT02980731|474047654|FG000|Overall Study|Withdrawal by Subject|6|||
131662104|NCT02980731|474047654|FG000|Overall Study|Lost to Follow-up|5|||
131662105|NCT02980731|474047654|FG000|Overall Study|Study terminated by Sponsor|4|||
131662106|NCT02980731|474047654|FG000|Overall Study|Completed survival follow-up period|65|||
131662107|NCT02980731|474047654|FG000|Overall Study|COVID-19 infection|1|||
131662108|NCT02980731|474047654|FG000|Overall Study|Other, not specified|66|||
131662109|NCT01290315|474047655|FG000|Overall Study|Adverse Event|0|||
131662110|NCT01290315|474047656|FG001|Overall Study|Adverse Event|0|||
131552738|NCT02392611|473649738|FG006|Overall Study|Adverse Event|0|||
131662111|NCT01290315|474047657|FG002|Overall Study|Adverse Event|0|||
131888342|NCT01066793|474874629|FG005|Overall Study|Lab test not done|0|||
131772132|NCT00920582|474443787|FG002|Overall Study|Lost to Follow-up|2|||
131772133|NCT00920582|474443788|FG003|Overall Study|Lost to Follow-up|0|||
131772134|NCT00920582|474443785|FG000|Overall Study|Withdrawal by Subject|5|||
131772135|NCT00920582|474443786|FG001|Overall Study|Withdrawal by Subject|4|||
131772136|NCT00920582|474443787|FG002|Overall Study|Withdrawal by Subject|6|||
131772137|NCT00920582|474443788|FG003|Overall Study|Withdrawal by Subject|3|||
131772138|NCT00920582|474443785|FG000|Overall Study|Protocol Violation|1|||
131772139|NCT00920582|474443786|FG001|Overall Study|Protocol Violation|0|||
131772140|NCT00920582|474443787|FG002|Overall Study|Protocol Violation|0|||
131772141|NCT00920582|474443788|FG003|Overall Study|Protocol Violation|0|||
131772142|NCT00920582|474443785|FG000|Overall Study|Other|2|||
131772143|NCT00920582|474443786|FG001|Overall Study|Other|1|||
131772144|NCT00920582|474443787|FG002|Overall Study|Other|3|||
131772145|NCT00920582|474443788|FG003|Overall Study|Other|2|||
131772146|NCT00383292|474443791|FG000|Overall Study|Adverse Event|4|||
131772147|NCT00383292|474443792|FG001|Overall Study|Adverse Event|1|||
131772148|NCT00383292|474443793|FG002|Overall Study|Adverse Event|2|||
131772149|NCT00383292|474443791|FG000|Overall Study|Death|3|||
131772150|NCT00383292|474443792|FG001|Overall Study|Death|3|||
131772151|NCT00383292|474443793|FG002|Overall Study|Death|3|||
131772152|NCT00383292|474443791|FG000|Overall Study|Physician Decision|4|||
131772153|NCT00383292|474443792|FG001|Overall Study|Physician Decision|0|||
131772154|NCT00383292|474443793|FG002|Overall Study|Physician Decision|1|||
131772155|NCT00383292|474443791|FG000|Overall Study|Withdrawal by Subject|3|||
131772156|NCT00383292|474443792|FG001|Overall Study|Withdrawal by Subject|2|||
131772157|NCT00383292|474443793|FG002|Overall Study|Withdrawal by Subject|2|||
131772158|NCT00383292|474443791|FG000|Overall Study|Other|1|||
131772159|NCT00383292|474443792|FG001|Overall Study|Other|0|||
131772160|NCT00383292|474443793|FG002|Overall Study|Other|0|||
131772161|NCT03457701|474443796|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
131772162|NCT03457701|474443797|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
131772163|NCT03457701|474443796|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
131772164|NCT03457701|474443797|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
131772165|NCT02243306|474443798|FG000|Overall Study|Adverse Event|0|||
131772166|NCT02243306|474443799|FG001|Overall Study|Adverse Event|1|||
131772167|NCT02243306|474443798|FG000|Overall Study|Other: Reached stopping criteria|0|||
131772168|NCT02243306|474443799|FG001|Overall Study|Other: Reached stopping criteria|1|||
131772169|NCT02243306|474443798|FG000|Overall Study|Physician Decision|0|||
131772170|NCT02243306|474443799|FG001|Overall Study|Physician Decision|1|||
131772171|NCT01016912|474443800|FG000|End of Treatment Period|Lack of Efficacy|0|||
131772172|NCT01016912|474443801|FG001|End of Treatment Period|Lack of Efficacy|1|||
131772173|NCT01016912|474443802|FG002|End of Treatment Period|Lack of Efficacy|0|||
131772174|NCT01016912|474443803|FG003|End of Treatment Period|Lack of Efficacy|4|||
131772175|NCT01016912|474443804|FG004|End of Treatment Period|Lack of Efficacy|4|||
131772176|NCT01016912|474443800|FG000|End of Treatment Period|Adverse Event|0|||
131772177|NCT01016912|474443801|FG001|End of Treatment Period|Adverse Event|1|||
131772178|NCT01016912|474443802|FG002|End of Treatment Period|Adverse Event|1|||
131772179|NCT01016912|474443803|FG003|End of Treatment Period|Adverse Event|0|||
131772180|NCT01016912|474443804|FG004|End of Treatment Period|Adverse Event|0|||
131772181|NCT01016912|474443800|FG000|End of Treatment Period|Completed double-blind period only|0|||
131772182|NCT01016912|474443801|FG001|End of Treatment Period|Completed double-blind period only|1|||
131772183|NCT01016912|474443802|FG002|End of Treatment Period|Completed double-blind period only|0|||
131772184|NCT01016912|474443803|FG003|End of Treatment Period|Completed double-blind period only|0|||
131772185|NCT01016912|474443804|FG004|End of Treatment Period|Completed double-blind period only|0|||
131772186|NCT01016912|474443800|FG000|Follow-up Period|Other reason|0|||
131772187|NCT01016912|474443801|FG001|Follow-up Period|Other reason|0|||
131772188|NCT01016912|474443802|FG002|Follow-up Period|Other reason|1|||
131772189|NCT01016912|474443803|FG003|Follow-up Period|Other reason|1|||
131772190|NCT01016912|474443804|FG004|Follow-up Period|Other reason|0|||
131772191|NCT02370173|474443811|FG000|Overall Study|Protocol Violation|1|||
131772192|NCT02370173|474443812|FG001|Overall Study|Protocol Violation|1|||
131772193|NCT02370173|474443811|FG000|Overall Study|Withdrawal by Subject|2|||
131772194|NCT02370173|474443812|FG001|Overall Study|Withdrawal by Subject|2|||
131772195|NCT01326481|474443818|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
131772196|NCT00307736|474443819|FG000|Overall Study|Adverse Event|0|||
131772197|NCT00307736|474443820|FG001|Overall Study|Adverse Event|0|||
131772198|NCT00307736|474443821|FG002|Overall Study|Adverse Event|1|||
131772199|NCT00307736|474443822|FG003|Overall Study|Adverse Event|3|||
131772200|NCT00307736|474443819|FG000|Overall Study|Withdrawal by Subject|0|||
131772201|NCT00307736|474443820|FG001|Overall Study|Withdrawal by Subject|0|||
131772202|NCT00307736|474443821|FG002|Overall Study|Withdrawal by Subject|2|||
131772203|NCT00307736|474443822|FG003|Overall Study|Withdrawal by Subject|0|||
131772204|NCT02260791|474443825|FG000|Overall Study|Lost to Follow-up|4|||
131772205|NCT02260791|474443826|FG001|Overall Study|Lost to Follow-up|4|||
131772206|NCT02260791|474443825|FG000|Overall Study|Lack of Efficacy|2|||
131772207|NCT02260791|474443826|FG001|Overall Study|Lack of Efficacy|1|||
131888343|NCT01066793|474874624|FG000|Overall Study|Miscellaneous|4|||
131888344|NCT01066793|474874625|FG001|Overall Study|Miscellaneous|5|||
131888345|NCT01066793|474874626|FG002|Overall Study|Miscellaneous|6|||
131888346|NCT01066793|474874627|FG003|Overall Study|Miscellaneous|0|||
131888347|NCT01066793|474874628|FG004|Overall Study|Miscellaneous|0|||
131888348|NCT01066793|474874629|FG005|Overall Study|Miscellaneous|0|||
131888349|NCT01066793|474874624|FG000|Overall Study|Non-responders|104|||
131888350|NCT01066793|474874625|FG001|Overall Study|Non-responders|5|||
131888351|NCT01066793|474874626|FG002|Overall Study|Non-responders|11|||
131888352|NCT01066793|474874627|FG003|Overall Study|Non-responders|25|||
131888353|NCT01066793|474874628|FG004|Overall Study|Non-responders|0|||
131888354|NCT01066793|474874629|FG005|Overall Study|Non-responders|0|||
131888355|NCT01066793|474874624|FG000|Overall Study|Other|15|||
131888356|NCT01066793|474874625|FG001|Overall Study|Other|5|||
131888357|NCT01066793|474874626|FG002|Overall Study|Other|6|||
131888358|NCT01066793|474874627|FG003|Overall Study|Other|2|||
131888359|NCT01066793|474874628|FG004|Overall Study|Other|0|||
131888360|NCT01066793|474874629|FG005|Overall Study|Other|0|||
131888361|NCT01066793|474874624|FG000|Overall Study|Relapse|20|||
131888362|NCT01066793|474874625|FG001|Overall Study|Relapse|8|||
131888363|NCT01066793|474874626|FG002|Overall Study|Relapse|2|||
131888364|NCT01066793|474874627|FG003|Overall Study|Relapse|3|||
131888365|NCT01066793|474874628|FG004|Overall Study|Relapse|0|||
131888366|NCT01066793|474874629|FG005|Overall Study|Relapse|0|||
131888367|NCT01066793|474874624|FG000|Overall Study|Result Not Available|1|||
131888368|NCT01066793|474874625|FG001|Overall Study|Result Not Available|0|||
131888369|NCT01066793|474874626|FG002|Overall Study|Result Not Available|0|||
131888370|NCT01066793|474874627|FG003|Overall Study|Result Not Available|0|||
131888371|NCT01066793|474874628|FG004|Overall Study|Result Not Available|0|||
131888372|NCT01066793|474874629|FG005|Overall Study|Result Not Available|0|||
131888373|NCT01066793|474874624|FG000|Overall Study|Treatment Interrupted|1|||
131888374|NCT01066793|474874625|FG001|Overall Study|Treatment Interrupted|1|||
131888375|NCT01066793|474874626|FG002|Overall Study|Treatment Interrupted|0|||
131888376|NCT01066793|474874627|FG003|Overall Study|Treatment Interrupted|0|||
131888377|NCT01066793|474874628|FG004|Overall Study|Treatment Interrupted|0|||
131888378|NCT01066793|474874629|FG005|Overall Study|Treatment Interrupted|0|||
131888379|NCT01066793|474874624|FG000|Overall Study|Treatment Never Started|18|||
131888380|NCT01066793|474874625|FG001|Overall Study|Treatment Never Started|5|||
131888381|NCT01066793|474874626|FG002|Overall Study|Treatment Never Started|4|||
131888382|NCT01066793|474874627|FG003|Overall Study|Treatment Never Started|1|||
131888383|NCT01066793|474874628|FG004|Overall Study|Treatment Never Started|0|||
131888384|NCT01066793|474874629|FG005|Overall Study|Treatment Never Started|0|||
131888385|NCT01066793|474874624|FG000|Overall Study|Treatment Stopped|2|||
131888386|NCT01066793|474874625|FG001|Overall Study|Treatment Stopped|1|||
131888387|NCT01066793|474874626|FG002|Overall Study|Treatment Stopped|0|||
131888388|NCT01066793|474874627|FG003|Overall Study|Treatment Stopped|1|||
131888389|NCT01066793|474874628|FG004|Overall Study|Treatment Stopped|0|||
131888390|NCT01066793|474874629|FG005|Overall Study|Treatment Stopped|0|||
131888391|NCT01911793|474874630|FG000|Overall Study|Physician Decision|1|||
131888392|NCT01911793|474874631|FG001|Overall Study|Physician Decision|5|||
131888393|NCT02697916|474874632|FG000|Overall Study|Death|357|||
131888394|NCT02697916|474874633|FG001|Overall Study|Death|315|||
131888395|NCT02697916|474874632|FG000|Overall Study|Withdrawal by Subject|221|||
131888396|NCT02697916|474874633|FG001|Overall Study|Withdrawal by Subject|393|||
131888397|NCT03774394|474874634|FG000|Overall Study|Withdrawal by Subject|2|||
131888398|NCT03774394|474874635|FG001|Overall Study|Withdrawal by Subject|0|||
131888399|NCT03334422|474874636|FG000|Overall Study|Adverse Event|1|||
131888400|NCT03334422|474874637|FG001|Overall Study|Adverse Event|3|||
131888401|NCT03334422|474874638|FG002|Overall Study|Adverse Event|2|||
131888402|NCT03334422|474874639|FG003|Overall Study|Adverse Event|2|||
131888403|NCT03334422|474874636|FG000|Overall Study|Lack of Efficacy|10|||
131888404|NCT03334422|474874637|FG001|Overall Study|Lack of Efficacy|2|||
131888405|NCT03334422|474874638|FG002|Overall Study|Lack of Efficacy|7|||
131888406|NCT03334422|474874639|FG003|Overall Study|Lack of Efficacy|3|||
131888407|NCT03334422|474874636|FG000|Overall Study|Withdrawal by Subject|8|||
131888408|NCT03334422|474874637|FG001|Overall Study|Withdrawal by Subject|3|||
131888409|NCT03334422|474874638|FG002|Overall Study|Withdrawal by Subject|1|||
131888410|NCT03334422|474874639|FG003|Overall Study|Withdrawal by Subject|0|||
131888411|NCT03334422|474874636|FG000|Overall Study|Lost to Follow-up|0|||
131888412|NCT03334422|474874637|FG001|Overall Study|Lost to Follow-up|0|||
131888413|NCT03334422|474874638|FG002|Overall Study|Lost to Follow-up|0|||
131888414|NCT03334422|474874639|FG003|Overall Study|Lost to Follow-up|1|||
131888415|NCT03334422|474874636|FG000|Overall Study|Inability to obtain laboratory samples|0|||
131888416|NCT03334422|474874637|FG001|Overall Study|Inability to obtain laboratory samples|1|||
131888417|NCT03334422|474874638|FG002|Overall Study|Inability to obtain laboratory samples|0|||
131888418|NCT03334422|474874639|FG003|Overall Study|Inability to obtain laboratory samples|0|||
131888419|NCT03334422|474874636|FG000|Overall Study|Pregnancy|0|||
131888420|NCT03334422|474874637|FG001|Overall Study|Pregnancy|1|||
131888421|NCT03334422|474874638|FG002|Overall Study|Pregnancy|0|||
131888422|NCT03334422|474874639|FG003|Overall Study|Pregnancy|0|||
131552739|NCT02392611|473649739|FG007|Overall Study|Adverse Event|0|||
131552740|NCT02392611|473649740|FG008|Overall Study|Adverse Event|0|||
131552741|NCT02392611|473649732|FG000|Overall Study|Progressive disease|0|||
131552742|NCT02392611|473649733|FG001|Overall Study|Progressive disease|0|||
131552743|NCT02392611|473649734|FG002|Overall Study|Progressive disease|0|||
131552744|NCT02392611|473649735|FG003|Overall Study|Progressive disease|2|||
131552745|NCT02392611|473649736|FG004|Overall Study|Progressive disease|1|||
131552746|NCT02392611|473649737|FG005|Overall Study|Progressive disease|0|||
131552747|NCT02392611|473649738|FG006|Overall Study|Progressive disease|0|||
131552748|NCT02392611|473649739|FG007|Overall Study|Progressive disease|0|||
131552749|NCT02392611|473649740|FG008|Overall Study|Progressive disease|0|||
131552750|NCT02392611|473649732|FG000|Overall Study|Death|1|||
131552751|NCT02392611|473649733|FG001|Overall Study|Death|0|||
131552752|NCT02392611|473649734|FG002|Overall Study|Death|0|||
131552753|NCT02392611|473649735|FG003|Overall Study|Death|0|||
131552754|NCT02392611|473649736|FG004|Overall Study|Death|0|||
131552755|NCT02392611|473649737|FG005|Overall Study|Death|1|||
131552756|NCT02392611|473649738|FG006|Overall Study|Death|0|||
131552757|NCT02392611|473649739|FG007|Overall Study|Death|0|||
131552758|NCT02392611|473649740|FG008|Overall Study|Death|0|||
131552759|NCT02392611|473649732|FG000|Overall Study|Withdrawal by Subject|0|||
131552760|NCT02392611|473649733|FG001|Overall Study|Withdrawal by Subject|0|||
131552761|NCT02392611|473649734|FG002|Overall Study|Withdrawal by Subject|0|||
131552762|NCT02392611|473649735|FG003|Overall Study|Withdrawal by Subject|1|||
131552763|NCT02392611|473649736|FG004|Overall Study|Withdrawal by Subject|0|||
131552764|NCT02392611|473649737|FG005|Overall Study|Withdrawal by Subject|0|||
131552765|NCT02392611|473649738|FG006|Overall Study|Withdrawal by Subject|0|||
131552766|NCT02392611|473649739|FG007|Overall Study|Withdrawal by Subject|0|||
131552767|NCT02392611|473649740|FG008|Overall Study|Withdrawal by Subject|0|||
131552768|NCT02392611|473649732|FG000|Overall Study|Lost to Follow-up|0|||
131552769|NCT02392611|473649733|FG001|Overall Study|Lost to Follow-up|0|||
131552770|NCT02392611|473649734|FG002|Overall Study|Lost to Follow-up|0|||
131552771|NCT02392611|473649735|FG003|Overall Study|Lost to Follow-up|0|||
131552772|NCT02392611|473649736|FG004|Overall Study|Lost to Follow-up|0|||
131552773|NCT02392611|473649737|FG005|Overall Study|Lost to Follow-up|0|||
131552774|NCT02392611|473649738|FG006|Overall Study|Lost to Follow-up|1|||
131552775|NCT02392611|473649739|FG007|Overall Study|Lost to Follow-up|0|||
131552776|NCT02392611|473649740|FG008|Overall Study|Lost to Follow-up|0|||
131552777|NCT02392611|473649732|FG000|Overall Study|Enrolled, not treated|0|||
131552778|NCT02392611|473649733|FG001|Overall Study|Enrolled, not treated|0|||
131552779|NCT02392611|473649734|FG002|Overall Study|Enrolled, not treated|0|||
131552780|NCT02392611|473649735|FG003|Overall Study|Enrolled, not treated|2|||
131552781|NCT02392611|473649736|FG004|Overall Study|Enrolled, not treated|0|||
131552782|NCT02392611|473649737|FG005|Overall Study|Enrolled, not treated|0|||
131552783|NCT02392611|473649738|FG006|Overall Study|Enrolled, not treated|0|||
131552784|NCT02392611|473649739|FG007|Overall Study|Enrolled, not treated|0|||
131552785|NCT02392611|473649740|FG008|Overall Study|Enrolled, not treated|0|||
131552786|NCT00462670|473649749|FG000|Overall Study|Adverse Event|3|||
131552787|NCT00462670|473649750|FG001|Overall Study|Adverse Event|5|||
131552788|NCT00462670|473649749|FG000|Overall Study|Lack of Efficacy|1|||
131552789|NCT00462670|473649750|FG001|Overall Study|Lack of Efficacy|0|||
131552790|NCT00462670|473649749|FG000|Overall Study|Protocol Violation|1|||
131552791|NCT00462670|473649750|FG001|Overall Study|Protocol Violation|0|||
131552792|NCT00462670|473649749|FG000|Overall Study|Resolution of signs and symptoms|0|||
131552793|NCT00462670|473649750|FG001|Overall Study|Resolution of signs and symptoms|2|||
131552794|NCT02110732|473649751|FG000|Overall Study|Physician Decision|5|||
131552795|NCT02110732|473649752|FG001|Overall Study|Physician Decision|2|||
131552796|NCT02110732|473649751|FG000|Overall Study|Lost to Follow-up|1|||
131552797|NCT02110732|473649752|FG001|Overall Study|Lost to Follow-up|1|||
131552798|NCT00633932|473649753|FG000|Overall Study|Adverse Event|1|||
131552799|NCT00633932|473649754|FG001|Overall Study|Adverse Event|3|||
131552800|NCT00633932|473649755|FG002|Overall Study|Adverse Event|4|||
131552801|NCT00633932|473649753|FG000|Overall Study|Withdrawal by Subject|3|||
131552802|NCT00633932|473649754|FG001|Overall Study|Withdrawal by Subject|9|||
131552803|NCT00633932|473649755|FG002|Overall Study|Withdrawal by Subject|1|||
131552804|NCT00633932|473649753|FG000|Overall Study|Lost to Follow-up|1|||
131552805|NCT00633932|473649754|FG001|Overall Study|Lost to Follow-up|0|||
131552806|NCT00633932|473649755|FG002|Overall Study|Lost to Follow-up|2|||
131552807|NCT00633932|473649753|FG000|Overall Study|Protocol Violation|5|||
131552808|NCT00633932|473649754|FG001|Overall Study|Protocol Violation|2|||
131552809|NCT00633932|473649755|FG002|Overall Study|Protocol Violation|3|||
131552810|NCT00633932|473649753|FG000|Overall Study|Physician Decision|0|||
131552811|NCT00633932|473649754|FG001|Overall Study|Physician Decision|0|||
131552812|NCT00633932|473649755|FG002|Overall Study|Physician Decision|1|||
131552813|NCT00633932|473649753|FG000|Overall Study|Doctor's judgement|1|||
131552814|NCT00633932|473649754|FG001|Overall Study|Doctor's judgement|0|||
131552815|NCT00633932|473649755|FG002|Overall Study|Doctor's judgement|0|||
131552816|NCT00633932|473649753|FG000|Overall Study|Moved Away|1|||
131552817|NCT00633932|473649754|FG001|Overall Study|Moved Away|0|||
131552818|NCT00633932|473649755|FG002|Overall Study|Moved Away|0|||
131888423|NCT04767529|474874644|FG000|Overall Study|Adverse Event|0|||
131888424|NCT04767529|474874645|FG001|Overall Study|Adverse Event|4|||
131888425|NCT04767529|474874646|FG002|Overall Study|Adverse Event|3|||
131888426|NCT04767529|474874644|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
131888427|NCT04767529|474874645|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
131888428|NCT04767529|474874646|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
131888429|NCT04767529|474874644|FG000|Overall Study|Required use of a prohibited medication|0|||
131888430|NCT04767529|474874645|FG001|Overall Study|Required use of a prohibited medication|1|||
131888431|NCT04767529|474874646|FG002|Overall Study|Required use of a prohibited medication|0|||
131888432|NCT04767529|474874644|FG000|Overall Study|Withdrawal by Subject|7|||
131888433|NCT04767529|474874645|FG001|Overall Study|Withdrawal by Subject|5|||
131888434|NCT04767529|474874646|FG002|Overall Study|Withdrawal by Subject|4|||
131888435|NCT04767529|474874644|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
131888436|NCT04767529|474874645|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
131888437|NCT04767529|474874646|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
131888438|NCT04767529|474874644|FG000|Overall Study|Lost to Follow-up|0|||
131888439|NCT04767529|474874645|FG001|Overall Study|Lost to Follow-up|2|||
131888440|NCT04767529|474874646|FG002|Overall Study|Lost to Follow-up|3|||
131888441|NCT00253370|474874647|FG000|Overall Study|Adverse Event|18|||
131888442|NCT00253370|474874647|FG000|Overall Study|Disease progression|13|||
131888443|NCT00253370|474874647|FG000|Overall Study|Death|2|||
131888444|NCT00253370|474874647|FG000|Overall Study|Withdrawal by Subject|6|||
131888445|NCT00253370|474874647|FG000|Overall Study|Non-protocol therapy|1|||
131888446|NCT00253370|474874647|FG000|Overall Study|Physician Decision|1|||
131888447|NCT00253370|474874647|FG000|Overall Study|Protocol Violation|1|||
131888448|NCT00253370|474874647|FG000|Overall Study|Abdominal pain due to disease|1|||
131888449|NCT05916131|474874648|FG000|Overall Study|Lost to Follow-up|0|||
131888450|NCT05916131|474874649|FG001|Overall Study|Lost to Follow-up|0|||
131888451|NCT05916131|474874650|FG002|Overall Study|Lost to Follow-up|1|||
131888452|NCT05916131|474874651|FG003|Overall Study|Lost to Follow-up|0|||
131888453|NCT00904839|474874654|FG000|Overall Study|Adverse Event|0|||
131888454|NCT00904839|474874655|FG001|Overall Study|Adverse Event|5|||
131888455|NCT00904839|474874656|FG002|Overall Study|Adverse Event|4|||
131888456|NCT00904839|474874654|FG000|Overall Study|Protocol Violation|0|||
131888457|NCT00904839|474874655|FG001|Overall Study|Protocol Violation|1|||
131888458|NCT00904839|474874656|FG002|Overall Study|Protocol Violation|1|||
131888459|NCT00904839|474874654|FG000|Overall Study|Lost to Follow-up|0|||
131888460|NCT00904839|474874655|FG001|Overall Study|Lost to Follow-up|1|||
131888461|NCT00904839|474874656|FG002|Overall Study|Lost to Follow-up|2|||
131888462|NCT00904839|474874654|FG000|Overall Study|Withdrawal by Subject|0|||
131888463|NCT00904839|474874655|FG001|Overall Study|Withdrawal by Subject|2|||
131888464|NCT00904839|474874656|FG002|Overall Study|Withdrawal by Subject|0|||
131888465|NCT00904839|474874654|FG000|Overall Study|Not treated|1|||
131888466|NCT00904839|474874655|FG001|Overall Study|Not treated|0|||
131888467|NCT00904839|474874656|FG002|Overall Study|Not treated|1|||
131888468|NCT00904839|474874654|FG000|Overall Study|Other than above|0|||
131888469|NCT00904839|474874655|FG001|Overall Study|Other than above|9|||
131888470|NCT00904839|474874656|FG002|Overall Study|Other than above|7|||
131888471|NCT00553358|474874659|FG000|Overall Study|Randomized but did not receive treatment|3|||
131888472|NCT00553358|474874660|FG001|Overall Study|Randomized but did not receive treatment|3|||
131888473|NCT00553358|474874661|FG002|Overall Study|Randomized but did not receive treatment|1|||
131888474|NCT00553358|474874659|FG000|Overall Study|Lost to Follow-up|22|||
131888475|NCT00553358|474874660|FG001|Overall Study|Lost to Follow-up|26|||
131888476|NCT00553358|474874661|FG002|Overall Study|Lost to Follow-up|18|||
131888477|NCT00553358|474874659|FG000|Overall Study|Withdrew completely|23|||
131888478|NCT00553358|474874660|FG001|Overall Study|Withdrew completely|33|||
131888479|NCT00553358|474874661|FG002|Overall Study|Withdrew completely|34|||
131888480|NCT00553358|474874659|FG000|Overall Study|Died during clinical follow-up|25|||
131888481|NCT00553358|474874660|FG001|Overall Study|Died during clinical follow-up|29|||
131888482|NCT00553358|474874661|FG002|Overall Study|Died during clinical follow-up|32|||
131888483|NCT00553358|474874659|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
131888484|NCT00553358|474874660|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
131888485|NCT00553358|474874661|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
131888486|NCT00553358|474874659|FG000|Overall Study|Died after clinical follow-up ended|1|||
131888487|NCT00553358|474874660|FG001|Overall Study|Died after clinical follow-up ended|2|||
131888488|NCT00553358|474874661|FG002|Overall Study|Died after clinical follow-up ended|0|||
131888489|NCT00553358|474874659|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
131888490|NCT00553358|474874660|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
131888491|NCT00553358|474874661|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
131888492|NCT01133288|474874662|FG000|Eligibility Assessment|met exclusion criteria|5|||
131888493|NCT01133288|474874662|FG000|Intervention Allocation|study terminated|2|||
131888494|NCT05268016|474874664|FG000|Overall Study|Unacceptable toxicity or AE|2|||
131888495|NCT05268016|474874665|FG001|Overall Study|Unacceptable toxicity or AE|2|||
131888496|NCT05268016|474874666|FG002|Overall Study|Unacceptable toxicity or AE|4|||
131888497|NCT05268016|474874667|FG003|Overall Study|Unacceptable toxicity or AE|3|||
131888498|NCT05268016|474874668|FG004|Overall Study|Unacceptable toxicity or AE|1|||
131888499|NCT05268016|474874664|FG000|Overall Study|Withdrawal by Subject|1|||
131888500|NCT05268016|474874665|FG001|Overall Study|Withdrawal by Subject|3|||
131888501|NCT05268016|474874666|FG002|Overall Study|Withdrawal by Subject|2|||
131888502|NCT05268016|474874667|FG003|Overall Study|Withdrawal by Subject|2|||
131888503|NCT05268016|474874668|FG004|Overall Study|Withdrawal by Subject|1|||
131888504|NCT05268016|474874664|FG000|Overall Study|Lost to Follow-up|4|||
131888505|NCT05268016|474874665|FG001|Overall Study|Lost to Follow-up|7|||
131888506|NCT05268016|474874666|FG002|Overall Study|Lost to Follow-up|1|||
131888507|NCT05268016|474874667|FG003|Overall Study|Lost to Follow-up|3|||
131888508|NCT05268016|474874668|FG004|Overall Study|Lost to Follow-up|5|||
131888509|NCT05268016|474874664|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
131888510|NCT05268016|474874665|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
131888511|NCT05268016|474874666|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
131888512|NCT05268016|474874667|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
131888513|NCT05268016|474874668|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
131888514|NCT05268016|474874664|FG000|Overall Study|Lack of Efficacy|0|||
131888515|NCT05268016|474874665|FG001|Overall Study|Lack of Efficacy|0|||
131888516|NCT05268016|474874666|FG002|Overall Study|Lack of Efficacy|0|||
131888517|NCT05268016|474874667|FG003|Overall Study|Lack of Efficacy|0|||
131888518|NCT05268016|474874668|FG004|Overall Study|Lack of Efficacy|4|||
131888519|NCT05268016|474874664|FG000|Overall Study|Physician Decision|0|||
131888520|NCT05268016|474874665|FG001|Overall Study|Physician Decision|0|||
131888521|NCT05268016|474874666|FG002|Overall Study|Physician Decision|0|||
131888522|NCT05268016|474874667|FG003|Overall Study|Physician Decision|1|||
131888523|NCT05268016|474874668|FG004|Overall Study|Physician Decision|0|||
131888524|NCT05268016|474874664|FG000|Overall Study|Other|1|||
131888525|NCT05268016|474874665|FG001|Overall Study|Other|0|||
131888526|NCT05268016|474874666|FG002|Overall Study|Other|1|||
131888527|NCT05268016|474874667|FG003|Overall Study|Other|2|||
131888528|NCT05268016|474874668|FG004|Overall Study|Other|0|||
131888529|NCT00404924|474874669|FG000|Overall Study|Adverse Event|75|||
131888530|NCT00404924|474874670|FG001|Overall Study|Adverse Event|16|||
131888531|NCT00404924|474874669|FG000|Overall Study|Condition under investigation worsened|475|||
131888532|NCT00404924|474874670|FG001|Overall Study|Condition under investigation worsened|264|||
131888533|NCT00404924|474874669|FG000|Overall Study|Lost to Follow-up|1|||
131888534|NCT00404924|474874670|FG001|Overall Study|Lost to Follow-up|1|||
131888535|NCT00404924|474874669|FG000|Overall Study|Withdrawal by Subject|26|||
131888536|NCT00404924|474874670|FG001|Overall Study|Withdrawal by Subject|13|||
131888537|NCT00404924|474874669|FG000|Overall Study|Other|25|||
131888538|NCT00404924|474874670|FG001|Overall Study|Other|11|||
131888539|NCT00404924|474874669|FG000|Overall Study|Randomised but not received treatment|1|||
131888540|NCT00404924|474874670|FG001|Overall Study|Randomised but not received treatment|1|||
131888541|NCT02603107|474874675|FG000|Randomized Phase|Withdrew consent|8|||
131888542|NCT02603107|474874676|FG001|Randomized Phase|Withdrew consent|15|||
131888543|NCT02603107|474874675|FG000|Randomized Phase|Lost to Follow-up|1|||
131888544|NCT02603107|474874676|FG001|Randomized Phase|Lost to Follow-up|3|||
131888545|NCT02603107|474874675|FG000|Randomized Phase|Adverse Event|2|||
131888546|NCT02603107|474874676|FG001|Randomized Phase|Adverse Event|0|||
131888547|NCT02603107|474874675|FG000|Randomized Phase|Death|1|||
131888548|NCT02603107|474874676|FG001|Randomized Phase|Death|1|||
131888549|NCT02603107|474874675|FG000|Randomized Phase|Non-compliance with study drug|1|||
131888550|NCT02603107|474874676|FG001|Randomized Phase|Non-compliance with study drug|1|||
131888551|NCT02603107|474874675|FG000|Randomized Phase|Investigator's discretion|0|||
131888552|NCT02603107|474874676|FG001|Randomized Phase|Investigator's discretion|1|||
131888553|NCT02603107|474874675|FG000|Randomized Phase|Lack of Efficacy|1|||
131888554|NCT02603107|474874676|FG001|Randomized Phase|Lack of Efficacy|0|||
131888555|NCT02603107|474874675|FG000|Randomized Phase|Protocol Violation|1|||
131888556|NCT02603107|474874676|FG001|Randomized Phase|Protocol Violation|0|||
131888557|NCT02603107|474874675|FG000|Optional Extension Phase|Lost to Follow-up|3|||
131888558|NCT02603107|474874676|FG001|Optional Extension Phase|Lost to Follow-up|3|||
131888559|NCT02603107|474874675|FG000|Optional Extension Phase|Withdrew consent|3|||
131888560|NCT02603107|474874676|FG001|Optional Extension Phase|Withdrew consent|2|||
131888561|NCT02603107|474874675|FG000|Optional Extension Phase|Investigator's discretion|2|||
131888562|NCT02603107|474874676|FG001|Optional Extension Phase|Investigator's discretion|2|||
131888563|NCT02603107|474874675|FG000|Optional Extension Phase|Pregnancy|0|||
131888564|NCT02603107|474874676|FG001|Optional Extension Phase|Pregnancy|3|||
131888565|NCT02603107|474874675|FG000|Optional Extension Phase|Adverse Event|0|||
131888566|NCT02603107|474874676|FG001|Optional Extension Phase|Adverse Event|2|||
131888567|NCT02603107|474874675|FG000|Optional Extension Phase|Not treated in extension phase|0|||
131888568|NCT02603107|474874676|FG001|Optional Extension Phase|Not treated in extension phase|1|||
131888569|NCT02603107|474874675|FG000|Optional Extension Phase|Protocol Violation|1|||
131888570|NCT02603107|474874676|FG001|Optional Extension Phase|Protocol Violation|0|||
131888571|NCT00803205|474874688|FG000|Overall Study|Adverse Event|7|||
131888572|NCT00803205|474874689|FG001|Overall Study|Adverse Event|2|||
131888573|NCT00803205|474874688|FG000|Overall Study|Lost to Follow-up|1|||
131888574|NCT00803205|474874689|FG001|Overall Study|Lost to Follow-up|0|||
131888575|NCT00803205|474874688|FG000|Overall Study|Withdrawal by Subject|9|||
131888576|NCT00803205|474874689|FG001|Overall Study|Withdrawal by Subject|9|||
131888577|NCT00803205|474874688|FG000|Overall Study|Physician Decision|1|||
131888578|NCT00803205|474874689|FG001|Overall Study|Physician Decision|0|||
131888579|NCT00803205|474874688|FG000|Overall Study|Protocol Violation|1|||
131888580|NCT00803205|474874689|FG001|Overall Study|Protocol Violation|1|||
131888581|NCT00803205|474874688|FG000|Overall Study|Medical Monitor Decision|1|||
131888582|NCT00803205|474874689|FG001|Overall Study|Medical Monitor Decision|0|||
131888583|NCT00803205|474874688|FG000|Overall Study|Acquired a Lung Infection|0|||
131888584|NCT00803205|474874689|FG001|Overall Study|Acquired a Lung Infection|1|||
131888585|NCT00803205|474874688|FG000|Overall Study|Sponsor Decision|0|||
131888586|NCT00803205|474874689|FG001|Overall Study|Sponsor Decision|1|||
131888587|NCT01490697|474874696|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
131888588|NCT01490697|474874697|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
131888589|NCT00090584|474874698|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
131888590|NCT00090584|474874699|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
131888591|NCT00090584|474874698|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
131888592|NCT00090584|474874699|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
131888593|NCT02117713|474874708|FG000|Week 48|Adverse Event|4|||
131888594|NCT02117713|474874708|FG000|Week 48|Withdrawal by caregiver|2|||
131888595|NCT02117713|474874708|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
131888596|NCT02117713|474874708|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
131888597|NCT02117713|474874708|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
131888598|NCT02117713|474874708|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
131888599|NCT00957905|474874709|FG000|Part B|Not Treated|0|||
131888600|NCT00957905|474874710|FG001|Part B|Not Treated|1|||
131888601|NCT00957905|474874709|FG000|Part B|Physician Decision|0|||
131888602|NCT00957905|474874710|FG001|Part B|Physician Decision|1|||
131888603|NCT00957905|474874709|FG000|Part B|Death|0|||
131888604|NCT00957905|474874710|FG001|Part B|Death|1|||
131888605|NCT00957905|474874709|FG000|Part B|Protocol Violation|0|||
131888606|NCT00957905|474874710|FG001|Part B|Protocol Violation|1|||
131888607|NCT02069093|474874711|FG000|Overall Study|Disease progression|14|||
131888608|NCT02069093|474874711|FG000|Overall Study|New cancer therapy|1|||
131888609|NCT02069093|474874711|FG000|Overall Study|Death|1|||
131888610|NCT02069093|474874711|FG000|Overall Study|Administrative problems|1|||
131888611|NCT02069093|474874711|FG000|Overall Study|Withdrawal by Subject|2|||
131888612|NCT02069093|474874711|FG000|Overall Study|Abnormal laboratory values|1|||
131888613|NCT02069093|474874711|FG000|Overall Study|Adverse Event|10|||
131888614|NCT01333956|474874713|FG000|Overall Study|Lost to Follow-up|1|||
131888615|NCT01333956|474874714|FG001|Overall Study|Lost to Follow-up|2|||
131888616|NCT01333956|474874715|FG002|Overall Study|Lost to Follow-up|0|||
131888617|NCT01333956|474874716|FG003|Overall Study|Lost to Follow-up|1|||
131888618|NCT01333956|474874713|FG000|Overall Study|Unable to complete study procedure|1|||
131888619|NCT01333956|474874714|FG001|Overall Study|Unable to complete study procedure|0|||
131662112|NCT01290315|474047658|FG003|Overall Study|Adverse Event|3|||
131888620|NCT01333956|474874715|FG002|Overall Study|Unable to complete study procedure|0|||
131888621|NCT01333956|474874716|FG003|Overall Study|Unable to complete study procedure|1|||
131888622|NCT01333956|474874713|FG000|Overall Study|Withdrawal by Subject|0|||
131888623|NCT01333956|474874714|FG001|Overall Study|Withdrawal by Subject|2|||
131888624|NCT01333956|474874715|FG002|Overall Study|Withdrawal by Subject|1|||
131888625|NCT01333956|474874716|FG003|Overall Study|Withdrawal by Subject|0|||
131888626|NCT02240069|474874717|FG000|Overall Study|Withdrawal by Subject|5|||
131888627|NCT02240069|474874718|FG001|Overall Study|Withdrawal by Subject|5|||
131888628|NCT02240069|474874719|FG002|Overall Study|Withdrawal by Subject|2|||
131662113|NCT01290315|474047655|FG000|Overall Study|Selection criteria/compliance|2|||
131662114|NCT01290315|474047656|FG001|Overall Study|Selection criteria/compliance|1|||
131662115|NCT01290315|474047657|FG002|Overall Study|Selection criteria/compliance|0|||
131888629|NCT04907227|474874720|FG000|Overall Study|Death|12|||
131888630|NCT04907227|474874721|FG001|Overall Study|Death|8|||
131888631|NCT04907227|474874720|FG000|Overall Study|Withdrawal by Subject|2|||
131888632|NCT04907227|474874721|FG001|Overall Study|Withdrawal by Subject|2|||
131888633|NCT04907227|474874720|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
131888634|NCT04907227|474874721|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
131888635|NCT04907227|474874720|FG000|Overall Study|Sponsor Decision|25|||
131888636|NCT04907227|474874721|FG001|Overall Study|Sponsor Decision|30|||
131888637|NCT04907227|474874720|FG000|Overall Study|Physician Decision|1|||
131888638|NCT04907227|474874721|FG001|Overall Study|Physician Decision|0|||
131888639|NCT03723070|474874722|FG000|Overall Study|Lost to Follow-up|2|||
131888640|NCT03723070|474874722|FG000|Overall Study|Physician Decision|1|||
131888641|NCT03723070|474874722|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
131888642|NCT02208050|474874723|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
131888643|NCT02208050|474874724|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
131888644|NCT00474786|474874725|FG000|Overall Study|Not Meeting Study Criteria|0|||
131888645|NCT00474786|474874726|FG001|Overall Study|Not Meeting Study Criteria|1|||
131888646|NCT00474786|474874725|FG000|Overall Study|Investigator Request|2|||
131888647|NCT00474786|474874726|FG001|Overall Study|Investigator Request|1|||
131888648|NCT00474786|474874725|FG000|Overall Study|Death|189|||
131888649|NCT00474786|474874726|FG001|Overall Study|Death|170|||
131888650|NCT00474786|474874725|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
131888651|NCT00474786|474874726|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
131888652|NCT00474786|474874725|FG000|Overall Study|Lost to Follow-up|4|||
131888653|NCT00474786|474874726|FG001|Overall Study|Lost to Follow-up|7|||
131888654|NCT00474786|474874725|FG000|Overall Study|Protocol Violation|2|||
131888655|NCT00474786|474874726|FG001|Overall Study|Protocol Violation|0|||
131888656|NCT00474786|474874725|FG000|Overall Study|Withdrawal by Subject|15|||
131888657|NCT00474786|474874726|FG001|Overall Study|Withdrawal by Subject|15|||
131888658|NCT00474786|474874725|FG000|Overall Study|Other|5|||
131888659|NCT00474786|474874726|FG001|Overall Study|Other|0|||
131888660|NCT03646305|474874729|FG000|Overall Study|Lost to Follow-up|4|||
131888661|NCT03646305|474874730|FG001|Overall Study|Lost to Follow-up|2|||
131888662|NCT03646305|474874731|FG002|Overall Study|Lost to Follow-up|2|||
131888663|NCT03646305|474874732|FG003|Overall Study|Lost to Follow-up|1|||
131888664|NCT03646305|474874729|FG000|Overall Study|Withdrawal by Subject|1|||
131888665|NCT03646305|474874730|FG001|Overall Study|Withdrawal by Subject|0|||
131888666|NCT03646305|474874731|FG002|Overall Study|Withdrawal by Subject|0|||
131888667|NCT03646305|474874732|FG003|Overall Study|Withdrawal by Subject|1|||
131888668|NCT03417024|474874735|FG000|Overall Study|Study Termination prior to follow-up|11|||
131888669|NCT03417024|474874735|FG000|Overall Study|Physician Decision|2|||
131888670|NCT03168919|474874736|FG000|Overall Study|Withdrawal by Subject|2|||
131888671|NCT01085136|474874737|FG000|Part A|Other Adverse event|223|||
131888672|NCT01085136|474874738|FG001|Part A|Other Adverse event|0|||
131888673|NCT01085136|474874739|FG002|Part A|Other Adverse event|0|||
131888674|NCT01085136|474874737|FG000|Part A|Protocol Violation|3|||
131888675|NCT01085136|474874738|FG001|Part A|Protocol Violation|0|||
131888676|NCT01085136|474874739|FG002|Part A|Protocol Violation|0|||
131888677|NCT01085136|474874737|FG000|Part A|Lost to Follow-up|3|||
131888678|NCT01085136|474874738|FG001|Part A|Lost to Follow-up|0|||
131888679|NCT01085136|474874739|FG002|Part A|Lost to Follow-up|0|||
131888680|NCT01085136|474874737|FG000|Part A|Refusal to continue trial medication|64|||
131888681|NCT01085136|474874738|FG001|Part A|Refusal to continue trial medication|0|||
131888682|NCT01085136|474874739|FG002|Part A|Refusal to continue trial medication|0|||
131888683|NCT01085136|474874737|FG000|Part A|Other reason not defined above|30|||
131888684|NCT01085136|474874738|FG001|Part A|Other reason not defined above|0|||
131888685|NCT01085136|474874739|FG002|Part A|Other reason not defined above|0|||
131888686|NCT01085136|474874737|FG000|Part B|Other AE|0|||
131888687|NCT01085136|474874738|FG001|Part B|Other AE|29|||
131888688|NCT01085136|474874739|FG002|Part B|Other AE|8|||
131888689|NCT01085136|474874737|FG000|Part B|Refusal to continue trial medication|0|||
131888690|NCT01085136|474874738|FG001|Part B|Refusal to continue trial medication|12|||
131888691|NCT01085136|474874739|FG002|Part B|Refusal to continue trial medication|7|||
131888692|NCT01085136|474874737|FG000|Part B|Not treated|0|||
131888693|NCT01085136|474874738|FG001|Part B|Not treated|4|||
131888694|NCT01085136|474874739|FG002|Part B|Not treated|8|||
131888695|NCT01085136|474874737|FG000|Part B|Other reason not defined above|0|||
131888696|NCT01085136|474874738|FG001|Part B|Other reason not defined above|6|||
131888697|NCT01085136|474874739|FG002|Part B|Other reason not defined above|3|||
131888698|NCT02655419|474874741|FG000|Overall Study|Enrolled but not treated|1|||
131888699|NCT02655419|474874742|FG001|Overall Study|Enrolled but not treated|5|||
131888700|NCT02655419|474874741|FG000|Overall Study|Withdrawal by Subject|4|||
131888701|NCT02655419|474874742|FG001|Overall Study|Withdrawal by Subject|1|||
131888702|NCT02655419|474874741|FG000|Overall Study|Other|0|||
131888703|NCT02655419|474874742|FG001|Overall Study|Other|1|||
131888704|NCT02678000|474874743|FG000|PART 2|Adverse Event|0|||
131888705|NCT02678000|474874744|FG001|PART 2|Adverse Event|0|||
131888706|NCT02678000|474874745|FG002|PART 2|Adverse Event|2|||
131888707|NCT02678000|474874746|FG003|PART 2|Adverse Event|1|||
131888708|NCT02678000|474874747|FG004|PART 2|Adverse Event|0|||
131888709|NCT02678000|474874743|FG000|PART 2|Withdrawal by Subject|0|||
131888710|NCT02678000|474874744|FG001|PART 2|Withdrawal by Subject|0|||
131888711|NCT02678000|474874745|FG002|PART 2|Withdrawal by Subject|1|||
131888712|NCT02678000|474874746|FG003|PART 2|Withdrawal by Subject|0|||
131888713|NCT02678000|474874747|FG004|PART 2|Withdrawal by Subject|0|||
131888714|NCT03759366|474874749|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
131888715|NCT03759366|474874749|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
131888716|NCT03759366|474874749|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
131888717|NCT03759366|474874749|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
131888718|NCT03759366|474874749|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
131888719|NCT03759366|474874749|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
131888720|NCT03759366|474874749|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
131888721|NCT04226495|474874750|FG000|Overall Study|Withdrawal by Subject|3|||
131888722|NCT04226495|474874751|FG001|Overall Study|Withdrawal by Subject|3|||
131888723|NCT04226495|474874750|FG000|Overall Study|PI discretion|3|||
131888724|NCT04226495|474874751|FG001|Overall Study|PI discretion|4|||
131888725|NCT00539032|474874752|FG000|Overall Study|Withdrawal by Subject|2|||
131888726|NCT00539032|474874753|FG001|Overall Study|Withdrawal by Subject|1|||
131888727|NCT00463840|474874758|FG000|Overall Study|Disease progression|7|||
131888728|NCT00463840|474874758|FG000|Overall Study|Withdrawal by Subject|2|||
131888729|NCT00463840|474874758|FG000|Overall Study|Adverse Event|3|||
131888730|NCT01653327|474874759|FG000|Overall Study|Withdrawal by Subject|1|||
131888731|NCT01210352|474874760|FG000|Overall Study|Adverse Event|0|||
131888732|NCT01210352|474874761|FG001|Overall Study|Adverse Event|0|||
131888733|NCT01210352|474874762|FG002|Overall Study|Adverse Event|0|||
131888734|NCT01210352|474874763|FG003|Overall Study|Adverse Event|0|||
131888735|NCT01210352|474874764|FG004|Overall Study|Adverse Event|0|||
131888736|NCT01210352|474874765|FG005|Overall Study|Adverse Event|0|||
131888737|NCT01210352|474874766|FG006|Overall Study|Adverse Event|0|||
131888738|NCT01210352|474874767|FG007|Overall Study|Adverse Event|2|||
131888739|NCT01210352|474874768|FG008|Overall Study|Adverse Event|1|||
131888740|NCT01210352|474874760|FG000|Overall Study|Lack of Efficacy|0|||
131888741|NCT01210352|474874761|FG001|Overall Study|Lack of Efficacy|0|||
131888742|NCT01210352|474874762|FG002|Overall Study|Lack of Efficacy|0|||
131888743|NCT01210352|474874763|FG003|Overall Study|Lack of Efficacy|0|||
131888744|NCT01210352|474874764|FG004|Overall Study|Lack of Efficacy|0|||
131888745|NCT01210352|474874765|FG005|Overall Study|Lack of Efficacy|0|||
131888746|NCT01210352|474874766|FG006|Overall Study|Lack of Efficacy|1|||
131888747|NCT01210352|474874767|FG007|Overall Study|Lack of Efficacy|0|||
131888748|NCT01210352|474874768|FG008|Overall Study|Lack of Efficacy|0|||
131888749|NCT01210352|474874760|FG000|Overall Study|Physician Decision|0|||
131888750|NCT01210352|474874761|FG001|Overall Study|Physician Decision|0|||
131888751|NCT01210352|474874762|FG002|Overall Study|Physician Decision|0|||
131888752|NCT01210352|474874763|FG003|Overall Study|Physician Decision|0|||
131888753|NCT01210352|474874764|FG004|Overall Study|Physician Decision|0|||
131888754|NCT01210352|474874765|FG005|Overall Study|Physician Decision|0|||
131888755|NCT01210352|474874766|FG006|Overall Study|Physician Decision|0|||
131888756|NCT01210352|474874767|FG007|Overall Study|Physician Decision|1|||
131888757|NCT01210352|474874768|FG008|Overall Study|Physician Decision|2|||
131888758|NCT01210352|474874760|FG000|Overall Study|Withdrawal by Subject|0|||
131888759|NCT01210352|474874761|FG001|Overall Study|Withdrawal by Subject|0|||
131888760|NCT01210352|474874762|FG002|Overall Study|Withdrawal by Subject|1|||
131888761|NCT01210352|474874763|FG003|Overall Study|Withdrawal by Subject|0|||
131888762|NCT01210352|474874764|FG004|Overall Study|Withdrawal by Subject|0|||
131888763|NCT01210352|474874765|FG005|Overall Study|Withdrawal by Subject|0|||
131888764|NCT01210352|474874766|FG006|Overall Study|Withdrawal by Subject|1|||
131888765|NCT01210352|474874767|FG007|Overall Study|Withdrawal by Subject|0|||
131888766|NCT01210352|474874768|FG008|Overall Study|Withdrawal by Subject|1|||
131888767|NCT01210352|474874760|FG000|Overall Study|Patient Discharged Early|0|||
131888768|NCT01210352|474874761|FG001|Overall Study|Patient Discharged Early|0|||
131888769|NCT01210352|474874762|FG002|Overall Study|Patient Discharged Early|1|||
131888770|NCT01210352|474874763|FG003|Overall Study|Patient Discharged Early|0|||
131888771|NCT01210352|474874764|FG004|Overall Study|Patient Discharged Early|0|||
131888772|NCT01210352|474874765|FG005|Overall Study|Patient Discharged Early|0|||
131888773|NCT01210352|474874766|FG006|Overall Study|Patient Discharged Early|0|||
131888774|NCT01210352|474874767|FG007|Overall Study|Patient Discharged Early|0|||
131888775|NCT01210352|474874768|FG008|Overall Study|Patient Discharged Early|0|||
131888776|NCT00422292|474874769|FG000|Overall Study|Serious adverse events|1|||
131888777|NCT00422292|474874770|FG001|Overall Study|Serious adverse events|4|||
131888778|NCT00422292|474874771|FG002|Overall Study|Serious adverse events|0|||
131888779|NCT00422292|474874772|FG003|Overall Study|Serious adverse events|0|||
131888780|NCT00422292|474874769|FG000|Overall Study|Adverse Event|1|||
131888781|NCT00422292|474874770|FG001|Overall Study|Adverse Event|0|||
131888782|NCT00422292|474874771|FG002|Overall Study|Adverse Event|1|||
131888783|NCT00422292|474874772|FG003|Overall Study|Adverse Event|0|||
131888784|NCT00422292|474874769|FG000|Overall Study|Protocol Violation|4|||
131888785|NCT00422292|474874770|FG001|Overall Study|Protocol Violation|25|||
131888786|NCT00422292|474874771|FG002|Overall Study|Protocol Violation|8|||
131888787|NCT00422292|474874772|FG003|Overall Study|Protocol Violation|5|||
131888788|NCT00422292|474874769|FG000|Overall Study|Lost to Follow-up|6|||
131888789|NCT00422292|474874770|FG001|Overall Study|Lost to Follow-up|12|||
131888790|NCT00422292|474874771|FG002|Overall Study|Lost to Follow-up|6|||
131888791|NCT00422292|474874772|FG003|Overall Study|Lost to Follow-up|6|||
131888792|NCT00422292|474874769|FG000|Overall Study|Withdrawal by Subject|6|||
131888793|NCT00422292|474874770|FG001|Overall Study|Withdrawal by Subject|25|||
131888794|NCT00422292|474874771|FG002|Overall Study|Withdrawal by Subject|7|||
131888795|NCT00422292|474874772|FG003|Overall Study|Withdrawal by Subject|13|||
131888796|NCT02440854|474874773|FG000|Overall Study|Relocation of patient|1|||
131888797|NCT02440854|474874773|FG000|Overall Study|Death|6|||
131888798|NCT02440854|474874773|FG000|Overall Study|Lost to Follow-up|10|||
131888799|NCT02440854|474874773|FG000|Overall Study|Afatinib discontinuation|46|||
131888800|NCT02440854|474874773|FG000|Overall Study|stopped study at earlier timepoint|14|||
131888801|NCT02440854|474874773|FG000|Overall Study|Study medication not received|1|||
131888802|NCT02440854|474874773|FG000|Overall Study|Violation of inclusion criteria|2|||
131888803|NCT03338569|474874774|FG000|Overall Study|Physician Decision|8|||
131888804|NCT03338569|474874775|FG001|Overall Study|Physician Decision|3|||
131888805|NCT03338569|474874774|FG000|Overall Study|Withdrawal by Subject|0|||
131888806|NCT03338569|474874775|FG001|Overall Study|Withdrawal by Subject|1|||
131888807|NCT03338569|474874774|FG000|Overall Study|Lost to Follow-up|0|||
131888808|NCT03338569|474874775|FG001|Overall Study|Lost to Follow-up|1|||
131888809|NCT02243046|474874776|FG000|Overall Study|Lost to Follow-up|1|||
131888810|NCT02243046|474874777|FG001|Overall Study|Lost to Follow-up|1|||
131888811|NCT02243046|474874778|FG002|Overall Study|Lost to Follow-up|4|||
131888812|NCT04607980|474874779|FG000|Overall Study|Adverse Event|3|||
131888813|NCT04607980|474874780|FG001|Overall Study|Adverse Event|4|||
131888814|NCT04607980|474874779|FG000|Overall Study|Death|0|||
131888815|NCT04607980|474874780|FG001|Overall Study|Death|1|||
131888816|NCT04607980|474874779|FG000|Overall Study|Withdrawal by Subject|2|||
131888817|NCT04607980|474874780|FG001|Overall Study|Withdrawal by Subject|5|||
131888818|NCT04607980|474874779|FG000|Overall Study|Lost to Follow-up|4|||
131888819|NCT04607980|474874780|FG001|Overall Study|Lost to Follow-up|8|||
131888820|NCT04607980|474874779|FG000|Overall Study|Protocol Violation|0|||
131888821|NCT04607980|474874780|FG001|Overall Study|Protocol Violation|3|||
131888822|NCT04607980|474874779|FG000|Overall Study|Other|3|||
131888823|NCT04607980|474874780|FG001|Overall Study|Other|0|||
131888824|NCT02669082|474874781|FG000|Overall Study|Adverse Event|1|||
131888825|NCT04852276|474874782|FG000|Overall Study|Death|2|||
131888826|NCT04852276|474874783|FG001|Overall Study|Death|0|||
131888827|NCT04852276|474874782|FG000|Overall Study|Lost to Follow-up|15|||
131888828|NCT04852276|474874783|FG001|Overall Study|Lost to Follow-up|9|||
131888829|NCT04852276|474874782|FG000|Overall Study|Withdrawal by Subject|26|||
131888830|NCT04852276|474874783|FG001|Overall Study|Withdrawal by Subject|6|||
131888831|NCT00004088|474876093|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
131888832|NCT00004088|474876093|FG000|Overall Study|Withdrawal by Subject|1|||
131888833|NCT00004088|474876093|FG000|Overall Study|Protocol Violation|3|||
131888834|NCT00004088|474876093|FG000|Overall Study|Physician Decision|1|||
131888835|NCT00369161|474876098|FG000|Overall Study|Adverse Event|15|||
131888836|NCT00369161|474876099|FG001|Overall Study|Adverse Event|13|||
131888837|NCT00369161|474876098|FG000|Overall Study|Abnormal laboratory value|0|||
131888838|NCT00369161|474876099|FG001|Overall Study|Abnormal laboratory value|1|||
131888839|NCT00369161|474876098|FG000|Overall Study|Lack of Efficacy|3|||
131888840|NCT00369161|474876099|FG001|Overall Study|Lack of Efficacy|1|||
131888841|NCT00369161|474876098|FG000|Overall Study|Protocol Violation|0|||
131888842|NCT00369161|474876099|FG001|Overall Study|Protocol Violation|2|||
131888843|NCT00369161|474876098|FG000|Overall Study|Withdrawal by Subject|2|||
131888844|NCT00369161|474876099|FG001|Overall Study|Withdrawal by Subject|3|||
131888845|NCT00369161|474876098|FG000|Overall Study|Death|1|||
131888846|NCT00369161|474876099|FG001|Overall Study|Death|2|||
131888847|NCT00369161|474876098|FG000|Overall Study|Graft loss|4|||
131888848|NCT00369161|474876099|FG001|Overall Study|Graft loss|0|||
131888849|NCT00369161|474876098|FG000|Overall Study|Administrative Problem|2|||
131888850|NCT00369161|474876099|FG001|Overall Study|Administrative Problem|2|||
131888851|NCT03411902|474876100|FG000|Overall Study|Lost to Follow-up|3|||
131888852|NCT03411902|474876101|FG001|Overall Study|Lost to Follow-up|0|||
131888853|NCT00419159|474876102|FG000|Overall Study|Adverse Event|7|||
131888854|NCT00419159|474876103|FG001|Overall Study|Adverse Event|15|||
131888855|NCT00419159|474876102|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131888856|NCT00419159|474876103|FG001|Overall Study|Abnormal laboratory value(s)|2|||
131888857|NCT00419159|474876102|FG000|Overall Study|Subject's no longer requires study drug|0|||
131888858|NCT00419159|474876103|FG001|Overall Study|Subject's no longer requires study drug|1|||
131888859|NCT00419159|474876102|FG000|Overall Study|Protocol Violation|1|||
131888860|NCT00419159|474876103|FG001|Overall Study|Protocol Violation|0|||
131888861|NCT00419159|474876102|FG000|Overall Study|Withdrawal by Subject|10|||
131888862|NCT00419159|474876103|FG001|Overall Study|Withdrawal by Subject|3|||
131888863|NCT00419159|474876102|FG000|Overall Study|Lost to Follow-up|0|||
131888864|NCT00419159|474876103|FG001|Overall Study|Lost to Follow-up|1|||
131888865|NCT00419159|474876102|FG000|Overall Study|Death|2|||
131888866|NCT00419159|474876103|FG001|Overall Study|Death|2|||
131888867|NCT00419159|474876102|FG000|Overall Study|Disease progression|79|||
131888868|NCT00419159|474876103|FG001|Overall Study|Disease progression|76|||
131888869|NCT01017601|474876104|FG000|Overall Study|Disease Progression|12|||
131888870|NCT01017601|474876105|FG001|Overall Study|Disease Progression|12|||
131888871|NCT01017601|474876104|FG000|Overall Study|Withdrawal by Subject|0|||
131888872|NCT01017601|474876105|FG001|Overall Study|Withdrawal by Subject|1|||
131888873|NCT00187278|474876106|FG000|Overall Study|Protocol Violation|10|||
131888874|NCT00187278|474876107|FG001|Overall Study|Protocol Violation|13|||
131888875|NCT00270231|474876109|FG000|First Intervention|Lost to Follow-up|1|||
131888876|NCT00270231|474876110|FG001|First Intervention|Lost to Follow-up|1|||
131888877|NCT00270231|474876109|FG000|Washout Period|Lost to Follow-up|1|||
131888878|NCT00270231|474876110|FG001|Washout Period|Lost to Follow-up|0|||
131888879|NCT00270231|474876109|FG000|Second Intervention|Lost to Follow-up|0|||
131888880|NCT00270231|474876110|FG001|Second Intervention|Lost to Follow-up|1|||
131888881|NCT02735096|474876111|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
131888882|NCT00379808|474876112|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
131888883|NCT00379808|474876113|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
131888884|NCT00574795|474876117|FG000|Infant Series|Withdrawal by Subject|2|||
131888885|NCT00574795|474876117|FG000|Infant Series|Protocol Violation|2|||
131888886|NCT00574795|474876117|FG000|Infant Series|Adverse Event|1|||
131888887|NCT00574795|474876117|FG000|After Infant Series|Withdrawal by Subject|1|||
131888888|NCT00574795|474876117|FG000|After Infant Series|Adverse Event|2|||
131888889|NCT00574795|474876117|FG000|Toddler Dose|Withdrawal by Subject|1|||
131888890|NCT02638259|474876120|FG000|Treatment Period 1|Adverse Event|1|||
131888891|NCT02638259|474876121|FG001|Treatment Period 1|Adverse Event|5|||
131888892|NCT02638259|474876120|FG000|Treatment Period 1|Death|0|||
131888893|NCT02638259|474876121|FG001|Treatment Period 1|Death|1|||
131888894|NCT02638259|474876120|FG000|Treatment Period 1|Lack of Efficacy|0|||
131888895|NCT02638259|474876121|FG001|Treatment Period 1|Lack of Efficacy|1|||
131888896|NCT02638259|474876120|FG000|Treatment Period 1|Protocol Violation|0|||
131888897|NCT02638259|474876121|FG001|Treatment Period 1|Protocol Violation|3|||
131888898|NCT02638259|474876120|FG000|Treatment Period 1|Withdrawal by Subject|4|||
131888899|NCT02638259|474876121|FG001|Treatment Period 1|Withdrawal by Subject|6|||
131888900|NCT02638259|474876120|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
131888901|NCT02638259|474876121|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
131888902|NCT02638259|474876120|FG000|Treatment Period 2|Adverse Event|5|||
131888903|NCT02638259|474876121|FG001|Treatment Period 2|Adverse Event|4|||
131888904|NCT02638259|474876120|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131888905|NCT02638259|474876121|FG001|Treatment Period 2|Withdrawal by Subject|7|||
131888906|NCT04299048|474876123|FG000|Overall Study|Death|1|||
131888907|NCT04299048|474876123|FG000|Overall Study|Global deterioration of health status|2|||
131888908|NCT04299048|474876123|FG000|Overall Study|Enrolled and not treated|1|||
131888909|NCT01706575|474876124|FG000|Overall Study|Participant Withdrew Consent|4|||
131888910|NCT01706575|474876124|FG000|Overall Study|Lost to Follow-up|2|||
131888911|NCT01706575|474876124|FG000|Overall Study|Started but not Treated|6|||
131888912|NCT01094782|474876125|FG000|Overall Study|Withdrawal by Subject|5|||
131888913|NCT01094782|474876126|FG001|Overall Study|Withdrawal by Subject|5|||
131888914|NCT01094782|474876127|FG002|Overall Study|Withdrawal by Subject|1|||
131888915|NCT01094782|474876128|FG003|Overall Study|Withdrawal by Subject|5|||
131888916|NCT01094782|474876129|FG004|Overall Study|Withdrawal by Subject|5|||
131888917|NCT01094782|474876130|FG005|Overall Study|Withdrawal by Subject|0|||
131888918|NCT01094782|474876125|FG000|Overall Study|Lost to Follow-up|1|||
131888919|NCT01094782|474876126|FG001|Overall Study|Lost to Follow-up|0|||
131888920|NCT01094782|474876127|FG002|Overall Study|Lost to Follow-up|0|||
131888921|NCT01094782|474876128|FG003|Overall Study|Lost to Follow-up|2|||
131888922|NCT01094782|474876129|FG004|Overall Study|Lost to Follow-up|1|||
131888923|NCT01094782|474876130|FG005|Overall Study|Lost to Follow-up|4|||
131888924|NCT01094782|474876125|FG000|Overall Study|Positive Drug Screen|2|||
131888925|NCT01094782|474876126|FG001|Overall Study|Positive Drug Screen|2|||
131888926|NCT01094782|474876127|FG002|Overall Study|Positive Drug Screen|1|||
131888927|NCT01094782|474876128|FG003|Overall Study|Positive Drug Screen|1|||
131888928|NCT01094782|474876129|FG004|Overall Study|Positive Drug Screen|3|||
131888929|NCT01094782|474876130|FG005|Overall Study|Positive Drug Screen|2|||
131888930|NCT01094782|474876125|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
131888931|NCT01094782|474876126|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
131888932|NCT01094782|474876127|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
131888933|NCT01094782|474876128|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
131888934|NCT01094782|474876129|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
131888935|NCT01094782|474876130|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
131888936|NCT01094782|474876125|FG000|Overall Study|Unable to Complete Questionnaires|0|||
131888937|NCT01094782|474876126|FG001|Overall Study|Unable to Complete Questionnaires|1|||
131888938|NCT01094782|474876127|FG002|Overall Study|Unable to Complete Questionnaires|0|||
131888939|NCT01094782|474876128|FG003|Overall Study|Unable to Complete Questionnaires|0|||
131888940|NCT01094782|474876129|FG004|Overall Study|Unable to Complete Questionnaires|0|||
131888941|NCT01094782|474876130|FG005|Overall Study|Unable to Complete Questionnaires|0|||
131888942|NCT01094782|474876125|FG000|Overall Study|Healthy Subject Had Pain|0|||
131888943|NCT01094782|474876126|FG001|Overall Study|Healthy Subject Had Pain|1|||
131888944|NCT01094782|474876127|FG002|Overall Study|Healthy Subject Had Pain|0|||
131888945|NCT01094782|474876128|FG003|Overall Study|Healthy Subject Had Pain|0|||
131888946|NCT01094782|474876129|FG004|Overall Study|Healthy Subject Had Pain|0|||
131888947|NCT01094782|474876130|FG005|Overall Study|Healthy Subject Had Pain|0|||
131888948|NCT01094782|474876125|FG000|Overall Study|Hypertension|0|||
131888949|NCT01094782|474876126|FG001|Overall Study|Hypertension|0|||
131888950|NCT01094782|474876127|FG002|Overall Study|Hypertension|1|||
131888951|NCT01094782|474876128|FG003|Overall Study|Hypertension|0|||
131888952|NCT01094782|474876129|FG004|Overall Study|Hypertension|0|||
131888953|NCT01094782|474876130|FG005|Overall Study|Hypertension|0|||
131888954|NCT01094782|474876125|FG000|Overall Study|Wrong Pain Condition|0|||
131662116|NCT01290315|474047658|FG003|Overall Study|Selection criteria/compliance|2|||
131662117|NCT01290315|474047655|FG000|Overall Study|Lost to Follow-up|0|||
131662118|NCT01290315|474047656|FG001|Overall Study|Lost to Follow-up|1|||
131662119|NCT01290315|474047657|FG002|Overall Study|Lost to Follow-up|0|||
131662120|NCT01290315|474047658|FG003|Overall Study|Lost to Follow-up|0|||
131662121|NCT01290315|474047655|FG000|Overall Study|Withdrawal by Subject|1|||
131662122|NCT01290315|474047656|FG001|Overall Study|Withdrawal by Subject|1|||
131662123|NCT01290315|474047657|FG002|Overall Study|Withdrawal by Subject|0|||
131662124|NCT01290315|474047658|FG003|Overall Study|Withdrawal by Subject|0|||
131662125|NCT00591721|474047659|FG000|Overall Study|Withdrawal by Subject|10|||
131662126|NCT00591721|474047660|FG001|Overall Study|Withdrawal by Subject|10|||
131662127|NCT00591721|474047659|FG000|Overall Study|Lost to Follow-up|1|||
131662128|NCT00591721|474047660|FG001|Overall Study|Lost to Follow-up|4|||
131662129|NCT00591721|474047659|FG000|Overall Study|Intervention not received|10|||
131662130|NCT00591721|474047660|FG001|Overall Study|Intervention not received|8|||
131662131|NCT03809429|474047663|FG000|Overall Study|Withdrawal by Subject|7|||
131662132|NCT03809429|474047664|FG001|Overall Study|Withdrawal by Subject|3|||
131662133|NCT03809429|474047663|FG000|Overall Study|Adverse Event|6|||
131662134|NCT03809429|474047664|FG001|Overall Study|Adverse Event|9|||
131662135|NCT03809429|474047663|FG000|Overall Study|COVID-19|3|||
131662136|NCT03809429|474047664|FG001|Overall Study|COVID-19|1|||
131662137|NCT03809429|474047663|FG000|Overall Study|Participant was discontinued by investigator|12|||
131662138|NCT03809429|474047664|FG001|Overall Study|Participant was discontinued by investigator|7|||
131662139|NCT03828747|474047665|FG000|Double-Blind Treatment Period|Adverse Event|6|||
131662140|NCT03828747|474047666|FG001|Double-Blind Treatment Period|Adverse Event|6|||
131662141|NCT03828747|474047665|FG000|Double-Blind Treatment Period|Death|1|||
131662142|NCT03828747|474047666|FG001|Double-Blind Treatment Period|Death|1|||
131662143|NCT03828747|474047665|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131662144|NCT03828747|474047666|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131662145|NCT03828747|474047665|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
131662146|NCT03828747|474047666|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
131662147|NCT03828747|474047665|FG000|Double-Blind Treatment Period|Physician Decision|1|||
131662148|NCT03828747|474047666|FG001|Double-Blind Treatment Period|Physician Decision|4|||
131662149|NCT03828747|474047665|FG000|Double-Blind Treatment Period|Various reasons|5|||
131662150|NCT03828747|474047666|FG001|Double-Blind Treatment Period|Various reasons|3|||
131662151|NCT03828747|474047665|FG000|Open-Label Extension|Adverse Event|9|||
131662152|NCT03828747|474047666|FG001|Open-Label Extension|Adverse Event|7|||
131662153|NCT03828747|474047665|FG000|Open-Label Extension|Death|0|||
131662154|NCT03828747|474047666|FG001|Open-Label Extension|Death|2|||
131662155|NCT03828747|474047665|FG000|Open-Label Extension|Lost to Follow-up|4|||
131662156|NCT03828747|474047666|FG001|Open-Label Extension|Lost to Follow-up|0|||
131888955|NCT01094782|474876126|FG001|Overall Study|Wrong Pain Condition|0|||
131888956|NCT01094782|474876127|FG002|Overall Study|Wrong Pain Condition|0|||
131888957|NCT01094782|474876128|FG003|Overall Study|Wrong Pain Condition|2|||
131888958|NCT01094782|474876129|FG004|Overall Study|Wrong Pain Condition|1|||
131662157|NCT03828747|474047665|FG000|Open-Label Extension|Withdrawal by Subject|31|||
131662158|NCT03828747|474047666|FG001|Open-Label Extension|Withdrawal by Subject|30|||
131662159|NCT03828747|474047665|FG000|Open-Label Extension|Various reasons|4|||
131662160|NCT03828747|474047666|FG001|Open-Label Extension|Various reasons|4|||
131662161|NCT03828747|474047665|FG000|Open-Label Extension|Physician Decision|6|||
131662162|NCT03828747|474047666|FG001|Open-Label Extension|Physician Decision|2|||
131662163|NCT01144052|474047667|FG000|Overall Study|Withdrawal by Subject|1|||
131662164|NCT01144052|474047668|FG001|Overall Study|Withdrawal by Subject|1|||
131662165|NCT00424385|474047669|FG000|Cohort 0|Withdrawal by Subject|5|||
131662166|NCT00424385|474047669|FG000|Cohort 0|Physician Decision|1|||
131662167|NCT00424385|474047669|FG000|Cohort 1|Withdrawal by Subject|1|||
131662168|NCT02683876|474047670|FG000|Overall Study|samples damaged during shipping|2|||
131662169|NCT02683876|474047671|FG001|Overall Study|samples damaged during shipping|0|||
131662170|NCT03980808|474047694|FG000|Overall Study|Lost to Follow-up|2|||
131662171|NCT03980808|474047695|FG001|Overall Study|Lost to Follow-up|2|||
131662172|NCT01655693|474047696|FG000|Overall Study|Progression of Disease|92|||
131662173|NCT01655693|474047697|FG001|Overall Study|Progression of Disease|76|||
131662174|NCT01655693|474047698|FG002|Overall Study|Progression of Disease|58|||
131662175|NCT01655693|474047696|FG000|Overall Study|Death|8|||
131888959|NCT01094782|474876130|FG005|Overall Study|Wrong Pain Condition|1|||
131888960|NCT01094782|474876125|FG000|Overall Study|Recent Interventional Injection|0|||
131888961|NCT01094782|474876126|FG001|Overall Study|Recent Interventional Injection|0|||
131888962|NCT01094782|474876127|FG002|Overall Study|Recent Interventional Injection|0|||
131662176|NCT01655693|474047697|FG001|Overall Study|Death|9|||
131662177|NCT01655693|474047698|FG002|Overall Study|Death|12|||
131662178|NCT01655693|474047696|FG000|Overall Study|Serious Adverse Event|3|||
131662179|NCT01655693|474047697|FG001|Overall Study|Serious Adverse Event|15|||
131662180|NCT01655693|474047698|FG002|Overall Study|Serious Adverse Event|11|||
131662181|NCT01655693|474047696|FG000|Overall Study|Withdrawal by Subject|3|||
131662182|NCT01655693|474047697|FG001|Overall Study|Withdrawal by Subject|2|||
131888963|NCT01094782|474876128|FG003|Overall Study|Recent Interventional Injection|0|||
131888964|NCT01094782|474876129|FG004|Overall Study|Recent Interventional Injection|0|||
131888965|NCT01094782|474876130|FG005|Overall Study|Recent Interventional Injection|1|||
131888966|NCT01094782|474876125|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
131888967|NCT01094782|474876126|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
131888968|NCT01094782|474876127|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
131888969|NCT01094782|474876128|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
131888970|NCT01094782|474876129|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
131888971|NCT01094782|474876130|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
131888972|NCT01094782|474876125|FG000|Overall Study|Noncompliance With Study Schedule|0|||
131888973|NCT01094782|474876126|FG001|Overall Study|Noncompliance With Study Schedule|0|||
131888974|NCT01094782|474876127|FG002|Overall Study|Noncompliance With Study Schedule|0|||
131888975|NCT01094782|474876128|FG003|Overall Study|Noncompliance With Study Schedule|1|||
131888976|NCT01094782|474876129|FG004|Overall Study|Noncompliance With Study Schedule|0|||
131888977|NCT01094782|474876130|FG005|Overall Study|Noncompliance With Study Schedule|0|||
131888978|NCT02073656|474876147|FG000|Primary Study|Lost to Follow-up|6|||
131888979|NCT02073656|474876147|FG000|Primary Study|Death|1|||
131888980|NCT02073656|474876147|FG000|Primary Study|Withdrew Consent|1|||
131888981|NCT02536781|474876151|FG000|Overall Study|Lost to Follow-up|2|||
131888982|NCT02536781|474876152|FG001|Overall Study|Lost to Follow-up|0|||
131888983|NCT03423147|474876153|FG000|Overall Study|Lost to Follow-up|5|||
131888984|NCT03423147|474876154|FG001|Overall Study|Lost to Follow-up|8|||
131888985|NCT03423147|474876153|FG000|Overall Study|Withdrawal by Subject|1|||
131888986|NCT03423147|474876154|FG001|Overall Study|Withdrawal by Subject|0|||
131888987|NCT03423147|474876153|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
131888988|NCT03423147|474876154|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
131888989|NCT03423147|474876153|FG000|Overall Study|Age < 18|1|||
131888990|NCT03423147|474876154|FG001|Overall Study|Age < 18|0|||
131888991|NCT03423147|474876153|FG000|Overall Study|No Trial of Labor|0|||
131888992|NCT03423147|474876154|FG001|Overall Study|No Trial of Labor|1|||
131888993|NCT01048099|474876155|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
131888994|NCT01048099|474876155|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
131888995|NCT00508157|474876156|FG000|Overall Study|Adverse Event|0|||
131888996|NCT00508157|474876157|FG001|Overall Study|Adverse Event|1|||
131888997|NCT00508157|474876156|FG000|Overall Study|Subject Withdrew Consent|1|||
131888998|NCT00508157|474876157|FG001|Overall Study|Subject Withdrew Consent|0|||
131888999|NCT00508157|474876156|FG000|Overall Study|Lost to Follow-up|1|||
131889000|NCT00508157|474876157|FG001|Overall Study|Lost to Follow-up|0|||
131889001|NCT00508157|474876156|FG000|Overall Study|Subject no longer met study criteria|0|||
131889002|NCT00508157|474876157|FG001|Overall Study|Subject no longer met study criteria|1|||
131889003|NCT00508157|474876156|FG000|Overall Study|Other known cause|0|||
131889004|NCT00508157|474876157|FG001|Overall Study|Other known cause|1|||
131889005|NCT02258334|474876160|FG000|Overall Study|Adverse Event|1|||
131889006|NCT02258334|474876161|FG001|Overall Study|Adverse Event|0|||
131889007|NCT02258334|474876162|FG002|Overall Study|Adverse Event|0|||
131889008|NCT02258334|474876163|FG003|Overall Study|Adverse Event|0|||
131889009|NCT01969084|474876164|FG000|Overall Study|Adverse Event|0|||
131889010|NCT01969084|474876165|FG001|Overall Study|Adverse Event|1|||
131889011|NCT03564795|474876168|FG000|Overall Study|Withdrawal by Subject|3|||
131889012|NCT03564795|474876168|FG000|Overall Study|Lost to Follow-up|6|||
131889013|NCT03564795|474876168|FG000|Overall Study|Physician Decision|2|||
131889014|NCT00862459|474876169|FG000|Overall Study|Lost to Follow-up|1|||
131889015|NCT00862459|474876170|FG001|Overall Study|Lost to Follow-up|2|||
131889016|NCT00862459|474876171|FG002|Overall Study|Lost to Follow-up|2|||
131889017|NCT00862459|474876169|FG000|Overall Study|Protocol Violation|1|||
131889018|NCT00862459|474876170|FG001|Overall Study|Protocol Violation|0|||
131889019|NCT00862459|474876171|FG002|Overall Study|Protocol Violation|0|||
131889020|NCT00862459|474876169|FG000|Overall Study|Withdrawal by Subject|1|||
131889021|NCT00862459|474876170|FG001|Overall Study|Withdrawal by Subject|1|||
131889022|NCT00862459|474876171|FG002|Overall Study|Withdrawal by Subject|3|||
131889023|NCT00862459|474876169|FG000|Overall Study|Adverse Event|0|||
131889024|NCT00862459|474876170|FG001|Overall Study|Adverse Event|1|||
131889025|NCT00862459|474876171|FG002|Overall Study|Adverse Event|0|||
131889026|NCT00862459|474876169|FG000|Overall Study|Personal reasons|1|||
131889027|NCT00862459|474876170|FG001|Overall Study|Personal reasons|0|||
131889028|NCT00862459|474876171|FG002|Overall Study|Personal reasons|0|||
131889029|NCT00862459|474876169|FG000|Overall Study|Operation|1|||
131889030|NCT00862459|474876170|FG001|Overall Study|Operation|1|||
131889031|NCT00862459|474876171|FG002|Overall Study|Operation|0|||
131889032|NCT00862459|474876169|FG000|Overall Study|Intravenous (IV) site problems|1|||
131889033|NCT00862459|474876170|FG001|Overall Study|Intravenous (IV) site problems|0|||
131889034|NCT00862459|474876171|FG002|Overall Study|Intravenous (IV) site problems|1|||
131889035|NCT00862459|474876169|FG000|Overall Study|Unable to hold still for imaging|0|||
131889036|NCT00862459|474876170|FG001|Overall Study|Unable to hold still for imaging|1|||
131889037|NCT00862459|474876171|FG002|Overall Study|Unable to hold still for imaging|0|||
131889038|NCT00862459|474876169|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
131889039|NCT00862459|474876170|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
131889040|NCT00862459|474876171|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
131889041|NCT00862459|474876169|FG000|Overall Study|Administrative problems|0|||
131889042|NCT00862459|474876170|FG001|Overall Study|Administrative problems|1|||
131889043|NCT00862459|474876171|FG002|Overall Study|Administrative problems|0|||
131889044|NCT02906033|474876172|FG000|Baseline|Protocol Violation|37|||
131889045|NCT02906033|474876173|FG001|Baseline|Protocol Violation|33|||
131889046|NCT02906033|474876172|FG000|Follow-up|Lost to Follow-up|46|||
131889047|NCT02906033|474876173|FG001|Follow-up|Lost to Follow-up|62|||
131889048|NCT02908074|474876188|FG000|Overall Study|sponsor/ICON decision|0|||
131889049|NCT02908074|474876189|FG001|Overall Study|sponsor/ICON decision|0|||
131889050|NCT02908074|474876190|FG002|Overall Study|sponsor/ICON decision|1|||
131889051|NCT02908074|474876191|FG003|Overall Study|sponsor/ICON decision|0|||
131889052|NCT02908074|474876192|FG004|Overall Study|sponsor/ICON decision|0|||
131889053|NCT02908074|474876193|FG005|Overall Study|sponsor/ICON decision|0|||
131889054|NCT02908074|474876188|FG000|Overall Study|Protocol Violation|0|||
131889055|NCT02908074|474876189|FG001|Overall Study|Protocol Violation|1|||
131889056|NCT02908074|474876190|FG002|Overall Study|Protocol Violation|0|||
131889057|NCT02908074|474876191|FG003|Overall Study|Protocol Violation|0|||
131889058|NCT02908074|474876192|FG004|Overall Study|Protocol Violation|0|||
131889059|NCT02908074|474876193|FG005|Overall Study|Protocol Violation|0|||
131889060|NCT02908074|474876188|FG000|Overall Study|Adverse Event|5|||
131889061|NCT02908074|474876189|FG001|Overall Study|Adverse Event|2|||
131889062|NCT02908074|474876190|FG002|Overall Study|Adverse Event|0|||
131889063|NCT02908074|474876191|FG003|Overall Study|Adverse Event|0|||
131889064|NCT02908074|474876192|FG004|Overall Study|Adverse Event|1|||
131889065|NCT02908074|474876193|FG005|Overall Study|Adverse Event|0|||
131889066|NCT02908074|474876188|FG000|Overall Study|AESI|1|||
131889067|NCT02908074|474876189|FG001|Overall Study|AESI|0|||
131889068|NCT02908074|474876190|FG002|Overall Study|AESI|1|||
131889069|NCT02908074|474876191|FG003|Overall Study|AESI|0|||
131889070|NCT02908074|474876192|FG004|Overall Study|AESI|1|||
131889071|NCT02908074|474876193|FG005|Overall Study|AESI|0|||
131889072|NCT02908074|474876188|FG000|Overall Study|Discontinuation criteria per protocol|0|||
131889073|NCT02908074|474876189|FG001|Overall Study|Discontinuation criteria per protocol|0|||
131889074|NCT02908074|474876190|FG002|Overall Study|Discontinuation criteria per protocol|1|||
131889075|NCT02908074|474876191|FG003|Overall Study|Discontinuation criteria per protocol|0|||
131889076|NCT02908074|474876192|FG004|Overall Study|Discontinuation criteria per protocol|0|||
131889077|NCT02908074|474876193|FG005|Overall Study|Discontinuation criteria per protocol|1|||
131889078|NCT02908074|474876188|FG000|Overall Study|Withdrawal by Subject|3|||
131889079|NCT02908074|474876189|FG001|Overall Study|Withdrawal by Subject|2|||
131889080|NCT02908074|474876190|FG002|Overall Study|Withdrawal by Subject|2|||
131889081|NCT02908074|474876191|FG003|Overall Study|Withdrawal by Subject|2|||
131889082|NCT02908074|474876192|FG004|Overall Study|Withdrawal by Subject|2|||
131889083|NCT02908074|474876193|FG005|Overall Study|Withdrawal by Subject|2|||
131889084|NCT02908074|474876188|FG000|Overall Study|Lost to Follow-up|0|||
131889085|NCT02908074|474876189|FG001|Overall Study|Lost to Follow-up|1|||
131889086|NCT02908074|474876190|FG002|Overall Study|Lost to Follow-up|1|||
131889087|NCT02908074|474876191|FG003|Overall Study|Lost to Follow-up|1|||
131889088|NCT02908074|474876192|FG004|Overall Study|Lost to Follow-up|0|||
131889089|NCT02908074|474876193|FG005|Overall Study|Lost to Follow-up|1|||
131889090|NCT02195427|474876196|FG000|Overall Study|Did not consent to study extension|13|||
131889091|NCT02195427|474876197|FG001|Overall Study|Did not consent to study extension|9|||
131889092|NCT02195427|474876196|FG000|Overall Study|Withdrawal by Subject|4|||
131889093|NCT02195427|474876197|FG001|Overall Study|Withdrawal by Subject|2|||
131889094|NCT02195427|474876196|FG000|Overall Study|Lost to Follow-up|0|||
131889095|NCT02195427|474876197|FG001|Overall Study|Lost to Follow-up|1|||
131889096|NCT02195427|474876196|FG000|Overall Study|Protocol Violation|7|||
131889097|NCT02195427|474876197|FG001|Overall Study|Protocol Violation|14|||
131889098|NCT02195427|474876196|FG000|Overall Study|Conditional re-treatment at W52|2|||
131889099|NCT02195427|474876197|FG001|Overall Study|Conditional re-treatment at W52|1|||
131889100|NCT00207727|474876198|FG000|Overall Study|Withdrawal by Subject|0|||
131889101|NCT00207727|474876199|FG001|Overall Study|Withdrawal by Subject|0|||
131889102|NCT00207727|474876200|FG002|Overall Study|Withdrawal by Subject|0|||
131889103|NCT00207727|474876201|FG003|Overall Study|Withdrawal by Subject|0|||
131889104|NCT00207727|474876202|FG004|Overall Study|Withdrawal by Subject|1|||
131889105|NCT00207727|474876198|FG000|Overall Study|Lost to Follow-up|0|||
131889106|NCT00207727|474876199|FG001|Overall Study|Lost to Follow-up|1|||
131889107|NCT00207727|474876200|FG002|Overall Study|Lost to Follow-up|0|||
131889108|NCT00207727|474876201|FG003|Overall Study|Lost to Follow-up|0|||
131889109|NCT00207727|474876202|FG004|Overall Study|Lost to Follow-up|0|||
131889110|NCT00207727|474876198|FG000|Overall Study|Other|38|||
131662183|NCT01655693|474047698|FG002|Overall Study|Withdrawal by Subject|20|||
131889111|NCT00207727|474876199|FG001|Overall Study|Other|41|||
131889112|NCT00207727|474876200|FG002|Overall Study|Other|41|||
131889113|NCT00207727|474876201|FG003|Overall Study|Other|37|||
131889114|NCT00207727|474876202|FG004|Overall Study|Other|33|||
131889115|NCT00505661|474876205|FG000|Overall Study|Not Eligible|4|||
131889116|NCT03611582|474876206|FG000|Overall Study|Adverse Event|26|||
131889117|NCT03611582|474876207|FG001|Overall Study|Adverse Event|6|||
131889118|NCT03611582|474876206|FG000|Overall Study|Protocol Violation|0|||
131889119|NCT03611582|474876207|FG001|Overall Study|Protocol Violation|1|||
131889120|NCT03611582|474876206|FG000|Overall Study|Pregnancy|1|||
131889121|NCT03611582|474876207|FG001|Overall Study|Pregnancy|2|||
131889122|NCT03611582|474876206|FG000|Overall Study|Lack of Efficacy|0|||
131889123|NCT03611582|474876207|FG001|Overall Study|Lack of Efficacy|1|||
131889124|NCT03611582|474876206|FG000|Overall Study|At the discretion of the investigator|1|||
131889125|NCT03611582|474876207|FG001|Overall Study|At the discretion of the investigator|0|||
131889126|NCT03611582|474876206|FG000|Overall Study|Safety concern as judged by the investigator|1|||
131889127|NCT03611582|474876207|FG001|Overall Study|Safety concern as judged by the investigator|2|||
131889128|NCT03611582|474876206|FG000|Overall Study|Withdrawal by Subject|4|||
131889129|NCT03611582|474876207|FG001|Overall Study|Withdrawal by Subject|3|||
131889130|NCT03611582|474876206|FG000|Overall Study|Lost to Follow-up|18|||
131889131|NCT03611582|474876207|FG001|Overall Study|Lost to Follow-up|7|||
131889132|NCT03611582|474876206|FG000|Overall Study|other|17|||
131889133|NCT03611582|474876207|FG001|Overall Study|other|16|||
131889134|NCT01783821|474876208|FG000|Overall Study|Screen Failure|1|||
131889135|NCT01783821|474876209|FG001|Overall Study|Screen Failure|1|||
131889136|NCT03089853|474877386|FG000|Overall Study|Lost to Follow-up|2|||
131889137|NCT03089853|474877387|FG001|Overall Study|Lost to Follow-up|1|||
131889138|NCT00642954|474877388|FG000|Overall Study|Progressive Disease|3|||
131889139|NCT00642954|474877389|FG001|Overall Study|Progressive Disease|3|||
131889140|NCT00642954|474877390|FG002|Overall Study|Progressive Disease|3|||
131889141|NCT00642954|474877391|FG003|Overall Study|Progressive Disease|3|||
131889142|NCT00642954|474877392|FG004|Overall Study|Progressive Disease|9|||
131889143|NCT00642954|474877388|FG000|Overall Study|Withdrawal by Subject|0|||
131889144|NCT00642954|474877389|FG001|Overall Study|Withdrawal by Subject|0|||
131889145|NCT00642954|474877390|FG002|Overall Study|Withdrawal by Subject|0|||
131889146|NCT00642954|474877391|FG003|Overall Study|Withdrawal by Subject|0|||
131889147|NCT00642954|474877392|FG004|Overall Study|Withdrawal by Subject|1|||
131889148|NCT00642954|474877388|FG000|Overall Study|Adverse Event|1|||
131889149|NCT00642954|474877389|FG001|Overall Study|Adverse Event|1|||
131889150|NCT00642954|474877390|FG002|Overall Study|Adverse Event|0|||
131889151|NCT00642954|474877391|FG003|Overall Study|Adverse Event|0|||
131889152|NCT00642954|474877392|FG004|Overall Study|Adverse Event|6|||
131889153|NCT00441363|474877393|FG000|Overall Study|Adverse Event|4|||
131889154|NCT00441363|474877394|FG001|Overall Study|Adverse Event|2|||
131889155|NCT00441363|474877393|FG000|Overall Study|Withdrawal by Subject|3|||
131889156|NCT00441363|474877394|FG001|Overall Study|Withdrawal by Subject|4|||
131889157|NCT00441363|474877393|FG000|Overall Study|Physician Decision|6|||
131889158|NCT00441363|474877394|FG001|Overall Study|Physician Decision|7|||
131889159|NCT00441363|474877393|FG000|Overall Study|Lost to Follow-up|2|||
131889160|NCT00441363|474877394|FG001|Overall Study|Lost to Follow-up|2|||
131889161|NCT00441363|474877393|FG000|Overall Study|Other|2|||
131889162|NCT00441363|474877394|FG001|Overall Study|Other|0|||
131889163|NCT01663857|474877397|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
131889164|NCT01663857|474877398|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
131889165|NCT01663857|474877399|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
131889166|NCT01663857|474877400|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
131889167|NCT01663857|474877397|FG000|Overall Study|Lost to Follow-up|0|||
131889168|NCT01663857|474877398|FG001|Overall Study|Lost to Follow-up|0|||
131889169|NCT01663857|474877399|FG002|Overall Study|Lost to Follow-up|3|||
131889170|NCT01663857|474877400|FG003|Overall Study|Lost to Follow-up|1|||
131889171|NCT04114656|474877401|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
131889172|NCT04114656|474877402|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
131889173|NCT04114656|474877401|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
131889174|NCT04114656|474877402|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
131889175|NCT04114656|474877401|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
131889176|NCT04114656|474877402|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
131889177|NCT04114656|474877401|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
131889178|NCT04114656|474877402|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
131889179|NCT04114656|474877401|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
131889180|NCT04114656|474877402|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
131889181|NCT03052920|474877403|FG000|Overall Study|Withdrawal by Subject|1|||
131889182|NCT02578940|474877404|FG000|Overall Study|Screening failure|5|||
131889183|NCT02578940|474877404|FG000|Overall Study|Lost to Follow-up|1|||
131889184|NCT04591015|474877407|FG000|Overall Study|Death|6|||
131889185|NCT04591015|474877408|FG001|Overall Study|Death|4|||
131889186|NCT04591015|474877407|FG000|Overall Study|Withdrawal by Subject|6|||
131889187|NCT04591015|474877408|FG001|Overall Study|Withdrawal by Subject|3|||
131889188|NCT04591015|474877407|FG000|Overall Study|Lost to Follow-up|16|||
131889189|NCT04591015|474877408|FG001|Overall Study|Lost to Follow-up|11|||
131662184|NCT01655693|474047696|FG000|Overall Study|Adverse Event|3|||
131662185|NCT01655693|474047697|FG001|Overall Study|Adverse Event|11|||
131772208|NCT02260791|474443825|FG000|Overall Study|Adverse Event|13|||
131772209|NCT02260791|474443826|FG001|Overall Study|Adverse Event|9|||
131772210|NCT02260791|474443825|FG000|Overall Study|Death|1|||
131772211|NCT02260791|474443826|FG001|Overall Study|Death|0|||
131772212|NCT02260791|474443825|FG000|Overall Study|Withdrawal by Subject|11|||
131772213|NCT02260791|474443826|FG001|Overall Study|Withdrawal by Subject|16|||
131772214|NCT02260791|474443825|FG000|Overall Study|Screen failure|0|||
131772215|NCT02260791|474443826|FG001|Overall Study|Screen failure|1|||
131772216|NCT02260791|474443825|FG000|Overall Study|Protocol deviation|2|||
131772217|NCT02260791|474443826|FG001|Overall Study|Protocol deviation|3|||
131772218|NCT04246996|474443828|FG000|Overall Study|Physician Decision|1|||
131772219|NCT04246996|474443829|FG001|Overall Study|Physician Decision|1|||
131772220|NCT04246996|474443828|FG000|Overall Study|Did not meet eligibility criteria|1|||
131772221|NCT04246996|474443829|FG001|Overall Study|Did not meet eligibility criteria|4|||
131772222|NCT02442284|474443830|FG000|Overall Study|Adverse Event|1|||
131772223|NCT02442284|474443830|FG000|Overall Study|Withdrew Consent|2|||
131772224|NCT02442284|474443830|FG000|Overall Study|Lost to Follow-up|3|||
131772225|NCT02442284|474443830|FG000|Overall Study|Other|1|||
131772226|NCT03053102|474445018|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
131772227|NCT03053102|474445018|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
131772228|NCT01238861|474445019|FG000|Overall Study|Lost to Follow-up|4|||
131772229|NCT01238861|474445020|FG001|Overall Study|Lost to Follow-up|2|||
131772230|NCT01238861|474445021|FG002|Overall Study|Lost to Follow-up|3|||
131772231|NCT01238861|474445022|FG003|Overall Study|Lost to Follow-up|1|||
131772232|NCT01238861|474445023|FG004|Overall Study|Lost to Follow-up|1|||
131772233|NCT01238861|474445024|FG005|Overall Study|Lost to Follow-up|2|||
131772234|NCT01238861|474445019|FG000|Overall Study|Unplanned surgery|1|||
131772235|NCT01238861|474445020|FG001|Overall Study|Unplanned surgery|0|||
131772236|NCT01238861|474445021|FG002|Overall Study|Unplanned surgery|0|||
131772237|NCT01238861|474445022|FG003|Overall Study|Unplanned surgery|0|||
131772238|NCT01238861|474445023|FG004|Overall Study|Unplanned surgery|0|||
131772239|NCT01238861|474445024|FG005|Overall Study|Unplanned surgery|0|||
131772240|NCT01238861|474445019|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
131772241|NCT01238861|474445020|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
131772242|NCT01238861|474445021|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
131772243|NCT01238861|474445022|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
131772244|NCT01238861|474445023|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
131772245|NCT01238861|474445024|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
131772246|NCT01238861|474445019|FG000|Overall Study|Incorrect enrollment/randomization|0|||
131772247|NCT01238861|474445020|FG001|Overall Study|Incorrect enrollment/randomization|0|||
131772248|NCT01238861|474445021|FG002|Overall Study|Incorrect enrollment/randomization|1|||
131772249|NCT01238861|474445022|FG003|Overall Study|Incorrect enrollment/randomization|0|||
131772250|NCT01238861|474445023|FG004|Overall Study|Incorrect enrollment/randomization|1|||
131772251|NCT01238861|474445024|FG005|Overall Study|Incorrect enrollment/randomization|0|||
131772252|NCT01238861|474445019|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
131772253|NCT01238861|474445020|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
131772254|NCT01238861|474445021|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
131772255|NCT01238861|474445022|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
131772256|NCT01238861|474445023|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
131772257|NCT01238861|474445024|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
131772258|NCT01238861|474445019|FG000|Overall Study|Subject moved out of state/area|0|||
131772259|NCT01238861|474445020|FG001|Overall Study|Subject moved out of state/area|0|||
131772260|NCT01238861|474445021|FG002|Overall Study|Subject moved out of state/area|1|||
131772261|NCT01238861|474445022|FG003|Overall Study|Subject moved out of state/area|1|||
131772262|NCT01238861|474445023|FG004|Overall Study|Subject moved out of state/area|0|||
131772263|NCT01238861|474445024|FG005|Overall Study|Subject moved out of state/area|0|||
131772264|NCT01238861|474445019|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
131772265|NCT01238861|474445020|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
131772266|NCT01238861|474445021|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
131772267|NCT01238861|474445022|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
131772268|NCT01238861|474445023|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
131772269|NCT01238861|474445024|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
131772270|NCT01238861|474445019|FG000|Overall Study|Personal problems|0|||
131772271|NCT01238861|474445020|FG001|Overall Study|Personal problems|0|||
131772272|NCT01238861|474445021|FG002|Overall Study|Personal problems|0|||
131772273|NCT01238861|474445022|FG003|Overall Study|Personal problems|1|||
131772274|NCT01238861|474445023|FG004|Overall Study|Personal problems|0|||
131772275|NCT01238861|474445024|FG005|Overall Study|Personal problems|0|||
131772276|NCT01238861|474445019|FG000|Overall Study|Unable to continue visits|0|||
131772277|NCT01238861|474445020|FG001|Overall Study|Unable to continue visits|0|||
131772278|NCT01238861|474445021|FG002|Overall Study|Unable to continue visits|0|||
131772279|NCT01238861|474445022|FG003|Overall Study|Unable to continue visits|1|||
131889190|NCT02686814|474877409|FG000|Overall Study|Physician Decision|14|||
131889191|NCT02686814|474877409|FG000|Overall Study|Withdrawal by Subject|4|||
131889192|NCT02686814|474877409|FG000|Overall Study|Death|1|||
131889193|NCT00290693|474877410|FG000|Overall Study|Withdrawal by Subject|2|||
131889194|NCT02907619|474877411|FG000|Overall Study|Study terminated by sponsor|18|||
131889195|NCT02907619|474877412|FG001|Overall Study|Study terminated by sponsor|18|||
131889196|NCT02907619|474877413|FG002|Overall Study|Study terminated by sponsor|19|||
131889197|NCT02907619|474877411|FG000|Overall Study|Death|0|||
131889198|NCT02907619|474877412|FG001|Overall Study|Death|0|||
131889199|NCT02907619|474877413|FG002|Overall Study|Death|1|||
131889200|NCT02907619|474877411|FG000|Overall Study|Withdrawal by Subject|1|||
131889201|NCT02907619|474877412|FG001|Overall Study|Withdrawal by Subject|1|||
131889202|NCT02907619|474877413|FG002|Overall Study|Withdrawal by Subject|0|||
131889203|NCT02907619|474877411|FG000|Overall Study|Other|0|||
131889204|NCT02907619|474877412|FG001|Overall Study|Other|1|||
131889205|NCT02907619|474877413|FG002|Overall Study|Other|0|||
131889206|NCT01908582|474877414|FG000|Period 2|Physician Decision|1|||
131889207|NCT01908582|474877414|FG000|Period 2|Withdrawal by Subject|1|||
131889208|NCT03484403|474877416|FG000|Overall Study|Withdrawal by Subject|6|||
131889209|NCT03484403|474877417|FG001|Overall Study|Withdrawal by Subject|4|||
131889210|NCT01716520|474877426|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
131889211|NCT01716520|474877427|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
131889212|NCT01716520|474877428|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
131889213|NCT01716520|474877429|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
131889214|NCT01716520|474877430|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
131889215|NCT01716520|474877431|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
131889216|NCT01716520|474877426|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
131889217|NCT01716520|474877427|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889218|NCT01716520|474877428|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
131889219|NCT01716520|474877429|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
131889220|NCT01716520|474877430|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889221|NCT01716520|474877431|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
131889222|NCT01716520|474877426|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131889223|NCT01716520|474877427|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131889224|NCT01716520|474877428|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131889225|NCT01716520|474877429|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131889226|NCT01716520|474877430|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131889227|NCT01716520|474877431|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131889228|NCT01716520|474877426|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
131889229|NCT01716520|474877427|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
131889230|NCT01716520|474877428|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
131889231|NCT01716520|474877429|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
131889232|NCT01716520|474877430|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
131889233|NCT01716520|474877431|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
131889234|NCT01716520|474877426|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131889235|NCT01716520|474877427|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131889236|NCT01716520|474877428|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131889237|NCT01716520|474877429|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131889238|NCT01716520|474877430|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131889239|NCT01716520|474877431|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
131889240|NCT01716520|474877426|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
131889241|NCT01716520|474877427|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
131889242|NCT01716520|474877428|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
131889243|NCT01716520|474877429|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
131889244|NCT01716520|474877430|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
131889245|NCT01716520|474877431|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
131889246|NCT01716520|474877426|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
131889247|NCT01716520|474877427|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
131889248|NCT01716520|474877428|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
131889249|NCT01716520|474877429|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
131889250|NCT01716520|474877430|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
131889251|NCT01716520|474877431|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
131889252|NCT01716520|474877426|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131889253|NCT01716520|474877427|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131662186|NCT01655693|474047698|FG002|Overall Study|Adverse Event|3|||
131889254|NCT01716520|474877428|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131889255|NCT01716520|474877429|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131889256|NCT01716520|474877430|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
131889257|NCT01716520|474877431|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131889258|NCT01716520|474877426|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889259|NCT01716520|474877427|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889260|NCT01716520|474877428|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889261|NCT01716520|474877429|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
131889262|NCT01716520|474877430|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889263|NCT01716520|474877431|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
131889264|NCT01716520|474877426|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
131889265|NCT01716520|474877427|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
131889266|NCT01716520|474877428|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
131889267|NCT01716520|474877429|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
131889268|NCT01716520|474877430|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
131889269|NCT01716520|474877431|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
131889270|NCT01716520|474877426|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
131889271|NCT01716520|474877427|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
131889272|NCT01716520|474877428|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
131889273|NCT01716520|474877429|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
131889274|NCT01716520|474877430|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
131889275|NCT01716520|474877431|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
131889276|NCT01716520|474877426|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
131889277|NCT01716520|474877427|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
131889278|NCT01716520|474877428|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
131889279|NCT01716520|474877429|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
131889280|NCT01716520|474877430|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
131889281|NCT01716520|474877431|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
131889282|NCT01716520|474877426|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
131889283|NCT01716520|474877427|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
131889284|NCT01716520|474877428|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
131889285|NCT01716520|474877429|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
131889286|NCT01716520|474877430|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
131889287|NCT01716520|474877431|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
131889288|NCT01716520|474877426|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131889289|NCT01716520|474877427|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131889290|NCT01716520|474877428|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131889291|NCT01716520|474877429|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131889292|NCT01716520|474877430|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131889293|NCT01716520|474877431|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
131889294|NCT01716520|474877426|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131889295|NCT01716520|474877427|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131889296|NCT01716520|474877428|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
131889297|NCT01716520|474877429|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131889298|NCT01716520|474877430|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131889299|NCT01716520|474877431|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131889300|NCT01937884|474877435|FG000|Overall Study|Withdrawal by Subject|1|||
131889301|NCT01937884|474877436|FG001|Overall Study|Withdrawal by Subject|0|||
131889302|NCT02636699|474877444|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
131889303|NCT02636699|474877445|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
131889304|NCT02636699|474877446|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
131889305|NCT02636699|474877444|FG000|Screening Period|Withdrawal by Subject|0|||
131889306|NCT02636699|474877445|FG001|Screening Period|Withdrawal by Subject|0|||
131889307|NCT02636699|474877446|FG002|Screening Period|Withdrawal by Subject|23|||
131889308|NCT02636699|474877444|FG000|Screening Period|Adverse Event|0|||
131889309|NCT02636699|474877445|FG001|Screening Period|Adverse Event|0|||
131889310|NCT02636699|474877446|FG002|Screening Period|Adverse Event|1|||
131889311|NCT02636699|474877444|FG000|Screening Period|Other not specified|0|||
131889312|NCT02636699|474877445|FG001|Screening Period|Other not specified|0|||
131889313|NCT02636699|474877446|FG002|Screening Period|Other not specified|3|||
131889314|NCT02636699|474877444|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
131889315|NCT02636699|474877445|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
131889316|NCT02636699|474877446|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
131889317|NCT02636699|474877444|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
131889318|NCT02636699|474877445|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
131889319|NCT02636699|474877446|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
131889320|NCT02636699|474877444|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
131889321|NCT02636699|474877445|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
131889322|NCT02636699|474877446|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
131889323|NCT02636699|474877444|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
131889324|NCT02636699|474877445|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
131889325|NCT02636699|474877446|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
131889326|NCT02636699|474877444|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
131889327|NCT02636699|474877445|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
131889328|NCT02636699|474877446|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
131889329|NCT02636699|474877444|FG000|Treatment and Follow-up Periods|Other|3|||
131889330|NCT02636699|474877445|FG001|Treatment and Follow-up Periods|Other|1|||
131889331|NCT02636699|474877446|FG002|Treatment and Follow-up Periods|Other|0|||
131889332|NCT00981058|474877449|FG000|Overall Study|Progressive Disease|38|||
131889333|NCT00981058|474877450|FG001|Overall Study|Progressive Disease|31|||
131889334|NCT00981058|474877449|FG000|Overall Study|Lost to Follow-up|3|||
131889335|NCT00981058|474877450|FG001|Overall Study|Lost to Follow-up|2|||
131889336|NCT00981058|474877449|FG000|Overall Study|Physician Decision|4|||
131889337|NCT00981058|474877450|FG001|Overall Study|Physician Decision|5|||
131889338|NCT00981058|474877449|FG000|Overall Study|Randomization Error|0|||
131889339|NCT00981058|474877450|FG001|Overall Study|Randomization Error|1|||
131889340|NCT00981058|474877449|FG000|Overall Study|Withdrawal by Subject|24|||
131889341|NCT00981058|474877450|FG001|Overall Study|Withdrawal by Subject|22|||
131889342|NCT02667587|474877451|FG000|Pre-Treatment|Not reported|1|||
131889343|NCT02667587|474877452|FG001|Pre-Treatment|Not reported|0|||
131889344|NCT02667587|474877451|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
131889345|NCT02667587|474877452|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
131889346|NCT02667587|474877451|FG000|Pre-Treatment|Participant withdrew consent|0|||
131889347|NCT02667587|474877452|FG001|Pre-Treatment|Participant withdrew consent|1|||
131889348|NCT02667587|474877451|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
131889349|NCT02667587|474877452|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
131889350|NCT02667587|474877451|FG000|End of Treatment|Disease Progression|193|||
131889351|NCT02667587|474877452|FG001|End of Treatment|Disease Progression|226|||
131889352|NCT02667587|474877451|FG000|End of Treatment|Study Drug Toxicity|75|||
131889353|NCT02667587|474877452|FG001|End of Treatment|Study Drug Toxicity|19|||
131889354|NCT02667587|474877451|FG000|End of Treatment|Death|2|||
131889355|NCT02667587|474877452|FG001|End of Treatment|Death|1|||
131889356|NCT02667587|474877451|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
131889357|NCT02667587|474877452|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
131889358|NCT02667587|474877451|FG000|End of Treatment|participant request to discontinue treatment|33|||
131889359|NCT02667587|474877452|FG001|End of Treatment|participant request to discontinue treatment|35|||
131889360|NCT02667587|474877451|FG000|End of Treatment|participant withdrew consent|5|||
131889361|NCT02667587|474877452|FG001|End of Treatment|participant withdrew consent|6|||
131889362|NCT02667587|474877451|FG000|End of Treatment|Lost to Follow-up|1|||
131889363|NCT02667587|474877452|FG001|End of Treatment|Lost to Follow-up|2|||
131889364|NCT02667587|474877451|FG000|End of Treatment|maximum clinical benefit|4|||
131889365|NCT02667587|474877452|FG001|End of Treatment|maximum clinical benefit|4|||
131889366|NCT02667587|474877451|FG000|End of Treatment|poor or non compliant|0|||
131889367|NCT02667587|474877452|FG001|End of Treatment|poor or non compliant|1|||
131889368|NCT02667587|474877451|FG000|End of Treatment|participant no longer meets study criteria|1|||
131889369|NCT02667587|474877452|FG001|End of Treatment|participant no longer meets study criteria|1|||
131889370|NCT02667587|474877451|FG000|End of Treatment|administrative reason by sponsor|1|||
131889371|NCT02667587|474877452|FG001|End of Treatment|administrative reason by sponsor|29|||
131889372|NCT02667587|474877451|FG000|End of Treatment|other reasonse|21|||
131889373|NCT02667587|474877452|FG001|End of Treatment|other reasonse|10|||
131889374|NCT02305446|474877459|FG000|Overall Study|Adverse Event|1|||
131889375|NCT01636947|474877460|FG000|Overall Study|Not Treated|2|||
131889376|NCT01636947|474877461|FG001|Overall Study|Not Treated|2|||
131889377|NCT01636947|474877460|FG000|Overall Study|Lost to Follow-up|4|||
131889378|NCT01636947|474877461|FG001|Overall Study|Lost to Follow-up|0|||
131889379|NCT01636947|474877460|FG000|Overall Study|Protocol Violation|1|||
131889380|NCT01636947|474877461|FG001|Overall Study|Protocol Violation|1|||
131889381|NCT01636947|474877460|FG000|Overall Study|Withdrawal by Subject|3|||
131889382|NCT01636947|474877461|FG001|Overall Study|Withdrawal by Subject|3|||
131889383|NCT01636947|474877460|FG000|Overall Study|Adverse Event|1|||
131889384|NCT01636947|474877461|FG001|Overall Study|Adverse Event|1|||
131889385|NCT01636947|474877460|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
131889386|NCT01636947|474877461|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
131889387|NCT00957424|474877462|FG000|Overall Study|Lost to Follow-up|19|||
131889388|NCT00957424|474877462|FG000|Overall Study|Protocol Violation|3|||
131889389|NCT00957424|474877462|FG000|Overall Study|Withdrawal by Subject|1|||
131889390|NCT01955109|474877470|FG000|Overall Study|Adverse Event|2|||
131889391|NCT01955109|474877471|FG001|Overall Study|Adverse Event|0|||
131889392|NCT01955109|474877470|FG000|Overall Study|Participant unwilling to continue|35|||
131889393|NCT01955109|474877471|FG001|Overall Study|Participant unwilling to continue|7|||
131889394|NCT01955109|474877470|FG000|Overall Study|Physician Decision|2|||
131889395|NCT01955109|474877471|FG001|Overall Study|Physician Decision|0|||
131889396|NCT01955109|474877470|FG000|Overall Study|Lost to Follow-up|3|||
131552819|NCT00482274|473649757|FG000|Overall Study|Adverse Event|1|||
131552820|NCT00597714|473649760|FG000|Overall Study|Death|56|||
131889397|NCT01955109|474877471|FG001|Overall Study|Lost to Follow-up|1|||
131889398|NCT01955109|474877470|FG000|Overall Study|Non-compliance|3|||
131889399|NCT01955109|474877471|FG001|Overall Study|Non-compliance|1|||
131889400|NCT01167634|474877475|FG000|Overall Study|Lost to Follow-up|1|||
131889401|NCT01167634|474877476|FG001|Overall Study|Lost to Follow-up|3|||
131889402|NCT01167634|474877477|FG002|Overall Study|Lost to Follow-up|3|||
131889403|NCT01167634|474877478|FG003|Overall Study|Lost to Follow-up|4|||
131889404|NCT01167634|474877475|FG000|Overall Study|Withdrawal by Subject|1|||
131889405|NCT01167634|474877476|FG001|Overall Study|Withdrawal by Subject|1|||
131889406|NCT01167634|474877477|FG002|Overall Study|Withdrawal by Subject|0|||
131889407|NCT01167634|474877478|FG003|Overall Study|Withdrawal by Subject|0|||
131889408|NCT00438256|474877481|FG000|Overall Study|Ineligible for Resection|2|||
131889409|NCT00438256|474877482|FG001|Overall Study|Ineligible for Resection|1|||
131889410|NCT00438256|474877483|FG002|Overall Study|Ineligible for Resection|1|||
131889411|NCT00438256|474877484|FG003|Overall Study|Ineligible for Resection|7|||
131889412|NCT00438256|474877481|FG000|Overall Study|Excluded final Diagnosis|0|||
131889413|NCT00438256|474877482|FG001|Overall Study|Excluded final Diagnosis|0|||
131889414|NCT00438256|474877483|FG002|Overall Study|Excluded final Diagnosis|0|||
131889415|NCT00438256|474877484|FG003|Overall Study|Excluded final Diagnosis|2|||
131889416|NCT00750919|474877492|FG000|Overall Study|Adverse Event|9|||
131889417|NCT00750919|474877492|FG000|Overall Study|Withdrawal by Subject|1|||
131889418|NCT00750919|474877492|FG000|Overall Study|Lack of Efficacy|8|||
131889419|NCT00750919|474877492|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
131889420|NCT00750919|474877492|FG000|Overall Study|Other|36|||
131889421|NCT02147067|474877495|FG000|Overall Study|Withdrawal by Subject|2|||
131889422|NCT02147067|474877496|FG001|Overall Study|Withdrawal by Subject|2|||
131889423|NCT01404949|474877498|FG000|Overall Study|Not Treated|1|||
131889424|NCT02912455|474877503|FG000|Overall Study|Withdrawal by Subject|0|||
131889425|NCT02912455|474877504|FG001|Overall Study|Withdrawal by Subject|1|||
131889426|NCT02912455|474877503|FG000|Overall Study|Lack of Efficacy|0|||
131889427|NCT02912455|474877504|FG001|Overall Study|Lack of Efficacy|1|||
131889428|NCT02912455|474877503|FG000|Overall Study|Lost to Follow-up|2|||
131889429|NCT02912455|474877504|FG001|Overall Study|Lost to Follow-up|1|||
131889430|NCT03326518|474879063|FG000|Overall Study|Protocol Violation|1|||
131889431|NCT03326518|474879064|FG001|Overall Study|Protocol Violation|0|||
131889432|NCT03326518|474879065|FG002|Overall Study|Protocol Violation|0|||
131889433|NCT03326518|474879063|FG000|Overall Study|Withdrawal by Subject|1|||
131889434|NCT03326518|474879064|FG001|Overall Study|Withdrawal by Subject|0|||
131889435|NCT03326518|474879065|FG002|Overall Study|Withdrawal by Subject|0|||
131889436|NCT03326518|474879063|FG000|Overall Study|Lost to Follow-up|1|||
131889437|NCT03326518|474879064|FG001|Overall Study|Lost to Follow-up|0|||
131889438|NCT03326518|474879065|FG002|Overall Study|Lost to Follow-up|1|||
131889439|NCT01375374|474879068|FG000|Overall Study|Adverse Event|1|||
131889440|NCT02065518|474879069|FG000|Overall Study|Lost to Follow-up|3|||
131889441|NCT02065518|474879070|FG001|Overall Study|Lost to Follow-up|4|||
131889442|NCT02065518|474879071|FG002|Overall Study|Lost to Follow-up|0|||
131889443|NCT02065518|474879072|FG003|Overall Study|Lost to Follow-up|3|||
131889444|NCT02065518|474879069|FG000|Overall Study|Withdrawal by Subject|3|||
131889445|NCT02065518|474879070|FG001|Overall Study|Withdrawal by Subject|4|||
131889446|NCT02065518|474879071|FG002|Overall Study|Withdrawal by Subject|9|||
131889447|NCT02065518|474879072|FG003|Overall Study|Withdrawal by Subject|2|||
131889448|NCT00564278|474879073|FG000|Overall Study|Lost to Follow-up|35|||
131889449|NCT00564278|474879074|FG001|Overall Study|Lost to Follow-up|33|||
131889450|NCT00564278|474879073|FG000|Overall Study|Physician Decision|1|||
131889451|NCT00564278|474879074|FG001|Overall Study|Physician Decision|2|||
131889452|NCT00564278|474879073|FG000|Overall Study|Withdrawal by Subject|11|||
131889453|NCT00564278|474879074|FG001|Overall Study|Withdrawal by Subject|7|||
131889454|NCT03341936|474879075|FG000|Overall Study|Ineligible|1|||
131889455|NCT03341936|474879075|FG000|Overall Study|Disease Progression|2|||
131889456|NCT03341936|474879075|FG000|Overall Study|Withdrew Consent|4|||
131889457|NCT03341936|474879075|FG000|Overall Study|Non-Compliance|1|||
131889458|NCT03341936|474879075|FG000|Overall Study|Physician Decision|1|||
131889459|NCT03341936|474879075|FG000|Overall Study|Withdrawal by Subject|1|||
131889460|NCT03341936|474879075|FG000|Overall Study|Other|1|||
131889461|NCT04849416|474879076|FG000|Overall Study|Ongoing Treatment|12|||
131889462|NCT04849416|474879077|FG001|Overall Study|Ongoing Treatment|5|||
131889463|NCT04849416|474879078|FG002|Overall Study|Ongoing Treatment|3|||
131889464|NCT04849416|474879076|FG000|Overall Study|On Post-Treatment Follow-up|8|||
131889465|NCT04849416|474879077|FG001|Overall Study|On Post-Treatment Follow-up|9|||
131889466|NCT04849416|474879078|FG002|Overall Study|On Post-Treatment Follow-up|10|||
131889467|NCT04849416|474879076|FG000|Overall Study|Withdrawal by Subject|0|||
131889468|NCT04849416|474879077|FG001|Overall Study|Withdrawal by Subject|0|||
131889469|NCT04849416|474879078|FG002|Overall Study|Withdrawal by Subject|1|||
131552821|NCT00597714|473649761|FG001|Overall Study|Death|46|||
131552822|NCT00597714|473649762|FG002|Overall Study|Death|0|||
131552823|NCT00597714|473649760|FG000|Overall Study|Recipient death|0|||
131552824|NCT00597714|473649761|FG001|Overall Study|Recipient death|0|||
131552825|NCT00597714|473649762|FG002|Overall Study|Recipient death|10|||
131552826|NCT01350141|473649763|FG000|Overall Study|Lost to Follow-up|1|||
131552827|NCT01350141|473649764|FG001|Overall Study|Lost to Follow-up|0|||
131552828|NCT01350141|473649765|FG002|Overall Study|Lost to Follow-up|1|||
131552829|NCT01350141|473649763|FG000|Overall Study|Withdrawal by Subject|1|||
131889470|NCT04849416|474879076|FG000|Overall Study|Lost to Follow-up|1|||
131889471|NCT04849416|474879077|FG001|Overall Study|Lost to Follow-up|0|||
131889472|NCT04849416|474879078|FG002|Overall Study|Lost to Follow-up|0|||
131662187|NCT01655693|474047696|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
131662188|NCT01655693|474047697|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
131662189|NCT01655693|474047698|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
131662190|NCT01655693|474047696|FG000|Overall Study|Non-Compliance|0|||
131662191|NCT01655693|474047697|FG001|Overall Study|Non-Compliance|0|||
131662192|NCT01655693|474047698|FG002|Overall Study|Non-Compliance|7|||
131662193|NCT01655693|474047696|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
131662194|NCT01655693|474047697|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
131662195|NCT01655693|474047698|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
131662196|NCT01655693|474047696|FG000|Overall Study|Protocol Violation|1|||
131662197|NCT01655693|474047697|FG001|Overall Study|Protocol Violation|0|||
131662198|NCT01655693|474047698|FG002|Overall Study|Protocol Violation|3|||
131662199|NCT01655693|474047696|FG000|Overall Study|Lost to Follow-up|1|||
131662200|NCT01655693|474047697|FG001|Overall Study|Lost to Follow-up|0|||
131662201|NCT01655693|474047698|FG002|Overall Study|Lost to Follow-up|1|||
131662202|NCT01655693|474047696|FG000|Overall Study|Screening Failure|1|||
131662203|NCT01655693|474047697|FG001|Overall Study|Screening Failure|0|||
131662204|NCT01655693|474047698|FG002|Overall Study|Screening Failure|0|||
131552830|NCT01350141|473649764|FG001|Overall Study|Withdrawal by Subject|0|||
131552831|NCT01350141|473649765|FG002|Overall Study|Withdrawal by Subject|0|||
131552832|NCT01350141|473649763|FG000|Overall Study|Randomized but not treated|1|||
131552833|NCT01350141|473649764|FG001|Overall Study|Randomized but not treated|0|||
131552834|NCT01350141|473649765|FG002|Overall Study|Randomized but not treated|0|||
131552835|NCT00810082|473649766|FG000|Overall Study|Lost to Follow-up|0|||
131552836|NCT00810082|473649767|FG001|Overall Study|Lost to Follow-up|4|||
131552837|NCT01588990|473649768|FG000|Phase A|Withdrawal by Subject|5|||
131552838|NCT01588990|473649768|FG000|Phase A|Physician Decision|11|||
131552839|NCT01588990|473649768|FG000|Phase A|Other|14|||
131552840|NCT01588990|473649768|FG000|Phase A|Lost to Follow-up|1|||
131552841|NCT01588990|473649768|FG000|Phase A|Death|5|||
131552842|NCT01588990|473649768|FG000|Phase A|Adverse Event|28|||
131889473|NCT01134263|474879087|FG000|Overall Study|Serious adverse event|2|||
131889474|NCT01134263|474879088|FG001|Overall Study|Serious adverse event|1|||
131889475|NCT01134263|474879089|FG002|Overall Study|Serious adverse event|1|||
131889476|NCT01134263|474879090|FG003|Overall Study|Serious adverse event|1|||
131889477|NCT01134263|474879091|FG004|Overall Study|Serious adverse event|1|||
131889478|NCT01134263|474879087|FG000|Overall Study|Other adverse event|1|||
131889479|NCT01134263|474879088|FG001|Overall Study|Other adverse event|2|||
131889480|NCT01134263|474879089|FG002|Overall Study|Other adverse event|5|||
131889481|NCT01134263|474879090|FG003|Overall Study|Other adverse event|3|||
131552843|NCT01588990|473649768|FG000|Phase A|Still on therapy at end of study|6|||
131552844|NCT01588990|473649768|FG000|Phase B|Adverse Event|2|||
131552845|NCT01588990|473649768|FG000|Phase B|Still on therapy at end of study|5|||
131552846|NCT01588990|473649768|FG000|Phase B|Withdrawal by Subject|3|||
131552847|NCT01588990|473649768|FG000|Phase B|Physician Decision|4|||
131552848|NCT01588990|473649768|FG000|Phase B|Other|2|||
131552849|NCT02508532|473649773|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552850|NCT02508532|473649774|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552851|NCT02508532|473649775|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552852|NCT02508532|473649776|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552853|NCT02508532|473649777|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552854|NCT02508532|473649778|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552855|NCT02508532|473649779|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
131552856|NCT02508532|473649780|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552857|NCT02508532|473649781|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131552858|NCT02508532|473649773|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552859|NCT02508532|473649774|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552860|NCT02508532|473649775|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552861|NCT02508532|473649776|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
131889482|NCT01134263|474879091|FG004|Overall Study|Other adverse event|0|||
131889483|NCT01134263|474879087|FG000|Overall Study|Protocol Violation|8|||
131552862|NCT02508532|473649777|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552863|NCT02508532|473649778|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552864|NCT02508532|473649779|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552865|NCT02508532|473649780|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
131552866|NCT02508532|473649781|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
131552867|NCT02508532|473649773|FG000|Part 2 - Treatment|Disease Progression|0|||
131662205|NCT01655693|474047696|FG000|Overall Study|Other|8|||
131662206|NCT01655693|474047697|FG001|Overall Study|Other|6|||
131889484|NCT01134263|474879088|FG001|Overall Study|Protocol Violation|7|||
131889485|NCT01134263|474879089|FG002|Overall Study|Protocol Violation|2|||
131889486|NCT01134263|474879090|FG003|Overall Study|Protocol Violation|4|||
131552868|NCT02508532|473649774|FG001|Part 2 - Treatment|Disease Progression|0|||
131552869|NCT02508532|473649775|FG002|Part 2 - Treatment|Disease Progression|0|||
131552870|NCT02508532|473649776|FG003|Part 2 - Treatment|Disease Progression|0|||
131552871|NCT02508532|473649777|FG004|Part 2 - Treatment|Disease Progression|0|||
131552872|NCT02508532|473649778|FG005|Part 2 - Treatment|Disease Progression|0|||
131552873|NCT02508532|473649779|FG006|Part 2 - Treatment|Disease Progression|0|||
131552874|NCT02508532|473649780|FG007|Part 2 - Treatment|Disease Progression|0|||
131552875|NCT02508532|473649781|FG008|Part 2 - Treatment|Disease Progression|118|||
131552876|NCT02508532|473649773|FG000|Part 2 - Treatment|Adverse Event|0|||
131552877|NCT02508532|473649774|FG001|Part 2 - Treatment|Adverse Event|0|||
131552878|NCT02508532|473649775|FG002|Part 2 - Treatment|Adverse Event|0|||
131552879|NCT02508532|473649776|FG003|Part 2 - Treatment|Adverse Event|0|||
131552880|NCT02508532|473649777|FG004|Part 2 - Treatment|Adverse Event|0|||
131552881|NCT02508532|473649778|FG005|Part 2 - Treatment|Adverse Event|0|||
131552882|NCT02508532|473649779|FG006|Part 2 - Treatment|Adverse Event|0|||
131552883|NCT02508532|473649780|FG007|Part 2 - Treatment|Adverse Event|0|||
131552884|NCT02508532|473649781|FG008|Part 2 - Treatment|Adverse Event|49|||
131552885|NCT02508532|473649773|FG000|Part 2 - Treatment|Physician Decision|0|||
131552886|NCT02508532|473649774|FG001|Part 2 - Treatment|Physician Decision|0|||
131552887|NCT02508532|473649775|FG002|Part 2 - Treatment|Physician Decision|0|||
131552888|NCT02508532|473649776|FG003|Part 2 - Treatment|Physician Decision|0|||
131552889|NCT02508532|473649777|FG004|Part 2 - Treatment|Physician Decision|0|||
131552890|NCT02508532|473649778|FG005|Part 2 - Treatment|Physician Decision|0|||
131552891|NCT02508532|473649779|FG006|Part 2 - Treatment|Physician Decision|0|||
131552892|NCT02508532|473649780|FG007|Part 2 - Treatment|Physician Decision|0|||
131552893|NCT02508532|473649781|FG008|Part 2 - Treatment|Physician Decision|12|||
131552894|NCT02508532|473649773|FG000|Part 2 - Treatment|Administrative|0|||
131552895|NCT02508532|473649774|FG001|Part 2 - Treatment|Administrative|0|||
131552896|NCT02508532|473649775|FG002|Part 2 - Treatment|Administrative|0|||
131552897|NCT02508532|473649776|FG003|Part 2 - Treatment|Administrative|0|||
131552898|NCT02508532|473649777|FG004|Part 2 - Treatment|Administrative|0|||
131552899|NCT02508532|473649778|FG005|Part 2 - Treatment|Administrative|0|||
131552900|NCT02508532|473649779|FG006|Part 2 - Treatment|Administrative|0|||
131552901|NCT02508532|473649780|FG007|Part 2 - Treatment|Administrative|0|||
131552902|NCT02508532|473649781|FG008|Part 2 - Treatment|Administrative|3|||
131552903|NCT02508532|473649773|FG000|Part 2 - Treatment|Sponsor Decision|0|||
131552904|NCT02508532|473649774|FG001|Part 2 - Treatment|Sponsor Decision|0|||
131552905|NCT02508532|473649775|FG002|Part 2 - Treatment|Sponsor Decision|0|||
131552906|NCT02508532|473649776|FG003|Part 2 - Treatment|Sponsor Decision|0|||
131552907|NCT02508532|473649777|FG004|Part 2 - Treatment|Sponsor Decision|0|||
131552908|NCT02508532|473649778|FG005|Part 2 - Treatment|Sponsor Decision|0|||
131552909|NCT02508532|473649779|FG006|Part 2 - Treatment|Sponsor Decision|0|||
131552910|NCT02508532|473649780|FG007|Part 2 - Treatment|Sponsor Decision|0|||
131552911|NCT02508532|473649781|FG008|Part 2 - Treatment|Sponsor Decision|28|||
131552912|NCT02508532|473649773|FG000|Part 2 - Treatment|Death|0|||
131552913|NCT02508532|473649774|FG001|Part 2 - Treatment|Death|0|||
131662207|NCT01655693|474047698|FG002|Overall Study|Other|15|||
131662208|NCT00929110|474047699|FG000|Overall Study|Adverse Event|40|||
131662209|NCT00929110|474047700|FG001|Overall Study|Adverse Event|29|||
131552914|NCT02508532|473649775|FG002|Part 2 - Treatment|Death|0|||
131552915|NCT02508532|473649776|FG003|Part 2 - Treatment|Death|0|||
131552916|NCT02508532|473649777|FG004|Part 2 - Treatment|Death|0|||
131552917|NCT02508532|473649778|FG005|Part 2 - Treatment|Death|0|||
131552918|NCT02508532|473649779|FG006|Part 2 - Treatment|Death|0|||
131552919|NCT02508532|473649780|FG007|Part 2 - Treatment|Death|0|||
131662210|NCT00929110|474047701|FG002|Overall Study|Adverse Event|18|||
131662211|NCT00929110|474047699|FG000|Overall Study|Subject withdrew consent|40|||
131662212|NCT00929110|474047700|FG001|Overall Study|Subject withdrew consent|23|||
131662213|NCT00929110|474047701|FG002|Overall Study|Subject withdrew consent|26|||
131662214|NCT00929110|474047699|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
131662215|NCT00929110|474047700|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
131662216|NCT00929110|474047701|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
131889487|NCT01134263|474879091|FG004|Overall Study|Protocol Violation|2|||
131662217|NCT00929110|474047699|FG000|Overall Study|Lost to Follow-up|7|||
131889488|NCT01134263|474879087|FG000|Overall Study|Lost to Follow-up|4|||
131662218|NCT00929110|474047700|FG001|Overall Study|Lost to Follow-up|7|||
131662219|NCT00929110|474047701|FG002|Overall Study|Lost to Follow-up|3|||
131662220|NCT00929110|474047699|FG000|Overall Study|Protocol deviation|5|||
131552920|NCT02508532|473649781|FG008|Part 2 - Treatment|Death|1|||
131552921|NCT02508532|473649773|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
131552922|NCT02508532|473649774|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
131552923|NCT02508532|473649775|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
131552924|NCT02508532|473649776|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
131552925|NCT02508532|473649777|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
131552926|NCT02508532|473649778|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
131552927|NCT02508532|473649779|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
131552928|NCT02508532|473649780|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
131662221|NCT00929110|474047700|FG001|Overall Study|Protocol deviation|2|||
131662222|NCT00929110|474047701|FG002|Overall Study|Protocol deviation|4|||
131662223|NCT00929110|474047699|FG000|Overall Study|Administrative problems|4|||
131662224|NCT00929110|474047700|FG001|Overall Study|Administrative problems|1|||
131662225|NCT00929110|474047701|FG002|Overall Study|Administrative problems|2|||
131662226|NCT00929110|474047699|FG000|Overall Study|Death|2|||
131662227|NCT00929110|474047700|FG001|Overall Study|Death|2|||
131662228|NCT00929110|474047701|FG002|Overall Study|Death|2|||
131662229|NCT00929110|474047699|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131662230|NCT00929110|474047700|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131662231|NCT00929110|474047701|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131662232|NCT00929110|474047699|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131662233|NCT00929110|474047700|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131662234|NCT00929110|474047701|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131662235|NCT00929110|474047699|FG000|Overall Study|Patient inability to use the device|0|||
131662236|NCT00929110|474047700|FG001|Overall Study|Patient inability to use the device|1|||
131662237|NCT00929110|474047701|FG002|Overall Study|Patient inability to use the device|0|||
131662238|NCT01712659|474047702|FG000|Dose Escalation|Physician Decision|0|||
131662239|NCT01712659|474047703|FG001|Dose Escalation|Physician Decision|1|||
131662240|NCT01712659|474047704|FG002|Dose Escalation|Physician Decision|0|||
131662241|NCT01712659|474047705|FG003|Dose Escalation|Physician Decision|0|||
131662242|NCT01712659|474047706|FG004|Dose Escalation|Physician Decision|0|||
131662243|NCT01712659|474047702|FG000|Dose Escalation|Unable to take study drug|0|||
131662244|NCT01712659|474047703|FG001|Dose Escalation|Unable to take study drug|1|||
131662245|NCT01712659|474047704|FG002|Dose Escalation|Unable to take study drug|0|||
131662246|NCT01712659|474047705|FG003|Dose Escalation|Unable to take study drug|0|||
131662247|NCT01712659|474047706|FG004|Dose Escalation|Unable to take study drug|0|||
131662248|NCT01712659|474047702|FG000|Dose Expansion|Early disease progression|1|||
131662249|NCT01712659|474047703|FG001|Dose Expansion|Early disease progression|0|||
131662250|NCT01712659|474047704|FG002|Dose Expansion|Early disease progression|0|||
131662251|NCT01712659|474047705|FG003|Dose Expansion|Early disease progression|0|||
131662252|NCT01712659|474047706|FG004|Dose Expansion|Early disease progression|0|||
131662253|NCT01712659|474047702|FG000|Dose Expansion|Physician Decision|1|||
131662254|NCT01712659|474047703|FG001|Dose Expansion|Physician Decision|0|||
131662255|NCT01712659|474047704|FG002|Dose Expansion|Physician Decision|0|||
131662256|NCT01712659|474047705|FG003|Dose Expansion|Physician Decision|0|||
131662257|NCT01712659|474047706|FG004|Dose Expansion|Physician Decision|0|||
131662258|NCT02285153|474047707|FG000|Overall Study|Adverse Event|1|||
131662259|NCT02285153|474047708|FG001|Overall Study|Adverse Event|0|||
131662260|NCT00548262|474047709|FG000|Overall Study|Death|21|||
131662261|NCT00548262|474047709|FG000|Overall Study|Adverse Event|2|||
131662262|NCT00548262|474047709|FG000|Overall Study|Lack of Efficacy|4|||
131662263|NCT00548262|474047709|FG000|Overall Study|Lost to Follow-up|1|||
131662264|NCT00548262|474047709|FG000|Overall Study|Other|3|||
131662265|NCT00548262|474047709|FG000|Overall Study|Withdrawal by Subject|1|||
131662266|NCT00948766|474047711|FG000|Core Study|Adverse Event|73|||
131662267|NCT00948766|474047712|FG001|Core Study|Adverse Event|51|||
131662268|NCT00948766|474047711|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
131662269|NCT00948766|474047712|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
131662270|NCT00948766|474047711|FG000|Core Study|Patient Withdrew Consent|27|||
131662271|NCT00948766|474047712|FG001|Core Study|Patient Withdrew Consent|46|||
131662272|NCT00948766|474047711|FG000|Core Study|Lost to Follow-up|3|||
131662273|NCT00948766|474047712|FG001|Core Study|Lost to Follow-up|2|||
131662274|NCT00948766|474047711|FG000|Core Study|Administrative Problems|2|||
131662275|NCT00948766|474047712|FG001|Core Study|Administrative Problems|2|||
131662276|NCT00948766|474047711|FG000|Core Study|Death|1|||
131662277|NCT00948766|474047712|FG001|Core Study|Death|1|||
131662278|NCT00948766|474047711|FG000|Core Study|Protocol Deviation|8|||
131662279|NCT00948766|474047712|FG001|Core Study|Protocol Deviation|10|||
131662280|NCT00948766|474047711|FG000|Extension Study|Adverse Event|43|||
131662281|NCT00948766|474047712|FG001|Extension Study|Adverse Event|0|||
131662282|NCT00948766|474047711|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
131662283|NCT00948766|474047712|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
131662284|NCT00948766|474047711|FG000|Extension Study|Study Drug No Longer Required|1|||
131662285|NCT00948766|474047712|FG001|Extension Study|Study Drug No Longer Required|0|||
131662286|NCT00948766|474047711|FG000|Extension Study|Patient Withdrew Consent|32|||
131662287|NCT00948766|474047712|FG001|Extension Study|Patient Withdrew Consent|0|||
131662288|NCT00948766|474047711|FG000|Extension Study|Lost to Follow-up|8|||
131662289|NCT00948766|474047712|FG001|Extension Study|Lost to Follow-up|0|||
131662290|NCT00948766|474047711|FG000|Extension Study|Administrative Problems|1|||
131662291|NCT00948766|474047712|FG001|Extension Study|Administrative Problems|0|||
131662292|NCT00948766|474047711|FG000|Extension Study|Death|4|||
131662293|NCT00948766|474047712|FG001|Extension Study|Death|0|||
131662294|NCT02153073|474047716|FG000|Overall Study|Case Report Forms Uncollected|230|||
131662295|NCT02153073|474047716|FG000|Overall Study|Protocol Deviation|68|||
131662296|NCT03592745|474047717|FG000|Overall Study|Adverse Event|0|||
131662297|NCT03592745|474047718|FG001|Overall Study|Adverse Event|2|||
131662298|NCT03592745|474047717|FG000|Overall Study|Lost to Follow-up|2|||
131662299|NCT03592745|474047718|FG001|Overall Study|Lost to Follow-up|0|||
131889489|NCT01134263|474879088|FG001|Overall Study|Lost to Follow-up|3|||
131662300|NCT03592745|474047717|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
131662301|NCT03592745|474047718|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
131662302|NCT00738894|474047719|FG000|Overall Study|Lost to Follow-up|23|||
131662303|NCT00738894|474047720|FG001|Overall Study|Lost to Follow-up|13|||
131662304|NCT00738894|474047719|FG000|Overall Study|Withdrawal by Subject|10|||
131662305|NCT00738894|474047720|FG001|Overall Study|Withdrawal by Subject|15|||
131662306|NCT00738894|474047719|FG000|Overall Study|Physician Decision|4|||
131662307|NCT00738894|474047720|FG001|Overall Study|Physician Decision|5|||
131662308|NCT00738894|474047719|FG000|Overall Study|Death|2|||
131662309|NCT00738894|474047720|FG001|Overall Study|Death|0|||
131662310|NCT01081665|474047721|FG000|Overall Study|Death|41|||
131662311|NCT01081665|474047721|FG000|Overall Study|Lost to Follow-up|18|||
131662312|NCT01081665|474047721|FG000|Overall Study|Withdrawal by Subject|17|||
131662313|NCT01081665|474047721|FG000|Overall Study|Change of dialysis unit|10|||
131662314|NCT01081665|474047721|FG000|Overall Study|Regulation of iPTH|5|||
131662315|NCT01081665|474047721|FG000|Overall Study|Change in renal replacement therapy|2|||
131662316|NCT01081665|474047721|FG000|Overall Study|Adverse Event|1|||
131662317|NCT01081665|474047721|FG000|Overall Study|Lack of Efficacy|1|||
131662318|NCT02546921|474047730|FG000|Overall Study|Adverse Event|0|||
131662319|NCT02546921|474047731|FG001|Overall Study|Adverse Event|5|||
131662320|NCT02546921|474047732|FG002|Overall Study|Adverse Event|2|||
131662321|NCT02546921|474047733|FG003|Overall Study|Adverse Event|0|||
131662322|NCT02546921|474047734|FG004|Overall Study|Adverse Event|0|||
131662323|NCT02546921|474047735|FG005|Overall Study|Adverse Event|0|||
131662324|NCT02546921|474047736|FG006|Overall Study|Adverse Event|0|||
131662325|NCT02546921|474047730|FG000|Overall Study|Evidence of Disease Progression|1|||
131662326|NCT02546921|474047731|FG001|Overall Study|Evidence of Disease Progression|0|||
131662327|NCT02546921|474047732|FG002|Overall Study|Evidence of Disease Progression|0|||
131662328|NCT02546921|474047733|FG003|Overall Study|Evidence of Disease Progression|0|||
131662329|NCT02546921|474047734|FG004|Overall Study|Evidence of Disease Progression|1|||
131662330|NCT02546921|474047735|FG005|Overall Study|Evidence of Disease Progression|0|||
131662331|NCT02546921|474047736|FG006|Overall Study|Evidence of Disease Progression|0|||
131662332|NCT02546921|474047730|FG000|Overall Study|Patient Choice|0|||
131662333|NCT02546921|474047731|FG001|Overall Study|Patient Choice|1|||
131662334|NCT02546921|474047732|FG002|Overall Study|Patient Choice|0|||
131662335|NCT02546921|474047733|FG003|Overall Study|Patient Choice|0|||
131662336|NCT02546921|474047734|FG004|Overall Study|Patient Choice|0|||
131662337|NCT02546921|474047735|FG005|Overall Study|Patient Choice|1|||
131662338|NCT02546921|474047736|FG006|Overall Study|Patient Choice|0|||
131662339|NCT01413503|474047737|FG000|Overall Study|Lost to Follow-up|1|||
131662340|NCT01373151|474047738|FG000|Period 1|Lack of Efficacy|3|||
131662341|NCT01373151|474047739|FG001|Period 1|Lack of Efficacy|0|||
131662342|NCT01373151|474047740|FG002|Period 1|Lack of Efficacy|0|||
131662343|NCT01373151|474047741|FG003|Period 1|Lack of Efficacy|0|||
131662344|NCT01373151|474047742|FG004|Period 1|Lack of Efficacy|1|||
131662345|NCT01373151|474047743|FG005|Period 1|Lack of Efficacy|0|||
131662346|NCT01373151|474047744|FG006|Period 1|Lack of Efficacy|0|||
131662347|NCT01373151|474047738|FG000|Period 1|Adverse Event|0|||
131662348|NCT01373151|474047739|FG001|Period 1|Adverse Event|0|||
131662349|NCT01373151|474047740|FG002|Period 1|Adverse Event|1|||
131662350|NCT01373151|474047741|FG003|Period 1|Adverse Event|0|||
131662351|NCT01373151|474047742|FG004|Period 1|Adverse Event|4|||
131662352|NCT01373151|474047743|FG005|Period 1|Adverse Event|3|||
131662353|NCT01373151|474047744|FG006|Period 1|Adverse Event|0|||
131662354|NCT01373151|474047738|FG000|Period 1|Withdrawal by Subject|2|||
131662355|NCT01373151|474047739|FG001|Period 1|Withdrawal by Subject|0|||
131662356|NCT01373151|474047740|FG002|Period 1|Withdrawal by Subject|3|||
131662357|NCT01373151|474047741|FG003|Period 1|Withdrawal by Subject|1|||
131662358|NCT01373151|474047742|FG004|Period 1|Withdrawal by Subject|0|||
131662359|NCT01373151|474047743|FG005|Period 1|Withdrawal by Subject|1|||
131662360|NCT01373151|474047744|FG006|Period 1|Withdrawal by Subject|0|||
131662361|NCT01373151|474047738|FG000|Period 2|Lack of Efficacy|9|||
131889490|NCT01134263|474879089|FG002|Overall Study|Lost to Follow-up|5|||
131889491|NCT01134263|474879090|FG003|Overall Study|Lost to Follow-up|3|||
131662362|NCT01373151|474047739|FG001|Period 2|Lack of Efficacy|0|||
131662363|NCT01373151|474047740|FG002|Period 2|Lack of Efficacy|0|||
131662364|NCT01373151|474047741|FG003|Period 2|Lack of Efficacy|1|||
131889492|NCT01134263|474879091|FG004|Overall Study|Lost to Follow-up|1|||
131662365|NCT01373151|474047742|FG004|Period 2|Lack of Efficacy|2|||
131662366|NCT01373151|474047743|FG005|Period 2|Lack of Efficacy|0|||
131662367|NCT01373151|474047744|FG006|Period 2|Lack of Efficacy|3|||
131662368|NCT01373151|474047738|FG000|Period 2|Adverse Event|0|||
131662369|NCT01373151|474047739|FG001|Period 2|Adverse Event|0|||
131662370|NCT01373151|474047740|FG002|Period 2|Adverse Event|3|||
131662371|NCT01373151|474047741|FG003|Period 2|Adverse Event|3|||
131662372|NCT01373151|474047742|FG004|Period 2|Adverse Event|0|||
131889493|NCT01134263|474879087|FG000|Overall Study|Withdrawal by Subject|8|||
131662373|NCT01373151|474047743|FG005|Period 2|Adverse Event|0|||
131662374|NCT01373151|474047744|FG006|Period 2|Adverse Event|1|||
131662375|NCT01373151|474047738|FG000|Period 2|subject request to discontinue|0|||
131662376|NCT01373151|474047739|FG001|Period 2|subject request to discontinue|1|||
131662377|NCT01373151|474047740|FG002|Period 2|subject request to discontinue|0|||
131662378|NCT01373151|474047741|FG003|Period 2|subject request to discontinue|0|||
131662379|NCT01373151|474047742|FG004|Period 2|subject request to discontinue|0|||
131662380|NCT01373151|474047743|FG005|Period 2|subject request to discontinue|0|||
131662381|NCT01373151|474047744|FG006|Period 2|subject request to discontinue|0|||
131662382|NCT01373151|474047738|FG000|Period 2|Withdrawal by Subject|0|||
131662383|NCT01373151|474047739|FG001|Period 2|Withdrawal by Subject|0|||
131662384|NCT01373151|474047740|FG002|Period 2|Withdrawal by Subject|0|||
131662385|NCT01373151|474047741|FG003|Period 2|Withdrawal by Subject|1|||
131662386|NCT01373151|474047742|FG004|Period 2|Withdrawal by Subject|0|||
131662387|NCT01373151|474047743|FG005|Period 2|Withdrawal by Subject|0|||
131662388|NCT01373151|474047744|FG006|Period 2|Withdrawal by Subject|0|||
131662389|NCT01373151|474047738|FG000|Period 2|Other|0|||
131662390|NCT01373151|474047739|FG001|Period 2|Other|0|||
131662391|NCT01373151|474047740|FG002|Period 2|Other|1|||
131662392|NCT01373151|474047741|FG003|Period 2|Other|0|||
131662393|NCT01373151|474047742|FG004|Period 2|Other|0|||
131662394|NCT01373151|474047743|FG005|Period 2|Other|0|||
131662395|NCT01373151|474047744|FG006|Period 2|Other|1|||
131662396|NCT03026075|474047748|FG000|Overall Study|Physician Decision|1|||
131662397|NCT03381339|474047749|FG000|Overall Study|Protocol Violation|4|||
131662398|NCT03381339|474047750|FG001|Overall Study|Protocol Violation|3|||
131662399|NCT03381339|474047749|FG000|Overall Study|Lost to Follow-up|0|||
131662400|NCT03381339|474047750|FG001|Overall Study|Lost to Follow-up|1|||
131662401|NCT00293059|474047752|FG000|Overall Study|Adverse Event|12|||
131662402|NCT00293059|474047753|FG001|Overall Study|Adverse Event|4|||
131662403|NCT00293059|474047752|FG000|Overall Study|Lack of Efficacy|2|||
131662404|NCT00293059|474047753|FG001|Overall Study|Lack of Efficacy|0|||
131662405|NCT00293059|474047752|FG000|Overall Study|Lost to Follow-up|2|||
131662406|NCT00293059|474047753|FG001|Overall Study|Lost to Follow-up|3|||
131662407|NCT00293059|474047752|FG000|Overall Study|Pregnancy|1|||
131662408|NCT00293059|474047753|FG001|Overall Study|Pregnancy|1|||
131662409|NCT00293059|474047752|FG000|Overall Study|Protocol Violation|2|||
131662410|NCT00293059|474047753|FG001|Overall Study|Protocol Violation|0|||
131662411|NCT00293059|474047752|FG000|Overall Study|Withdrawal by Subject|11|||
131662412|NCT00293059|474047753|FG001|Overall Study|Withdrawal by Subject|5|||
131662413|NCT00293059|474047752|FG000|Overall Study|Participant moved out of state|1|||
131662414|NCT00293059|474047753|FG001|Overall Study|Participant moved out of state|0|||
131662415|NCT00293059|474047752|FG000|Overall Study|Participant stopped study drug|1|||
131662416|NCT00293059|474047753|FG001|Overall Study|Participant stopped study drug|0|||
131662417|NCT00293059|474047752|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
131662418|NCT00293059|474047753|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
131662419|NCT00293059|474047752|FG000|Overall Study|missing|3|||
131662420|NCT00293059|474047753|FG001|Overall Study|missing|5|||
131662421|NCT02297139|474047755|FG000|Overall Study|Disease progression|0|||
131662422|NCT02297139|474047756|FG001|Overall Study|Disease progression|1|||
131662423|NCT02297139|474047755|FG000|Overall Study|Study drug toxicity|0|||
131662424|NCT02297139|474047756|FG001|Overall Study|Study drug toxicity|4|||
131662425|NCT02297139|474047755|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131662426|NCT02297139|474047756|FG001|Overall Study|Participant request to discontinue study treatment|1|||
131662427|NCT02297139|474047755|FG000|Overall Study|Maximum clinical benefit|1|||
131662428|NCT02297139|474047756|FG001|Overall Study|Maximum clinical benefit|0|||
131662429|NCT02297139|474047755|FG000|Overall Study|Administrative reason by sponsor|0|||
131662430|NCT02297139|474047756|FG001|Overall Study|Administrative reason by sponsor|2|||
131662431|NCT02297139|474047755|FG000|Overall Study|Other reasons|0|||
131662432|NCT02297139|474047756|FG001|Overall Study|Other reasons|8|||
131662433|NCT02101385|474047757|FG000|Study Treatment|Disease Progression|9|||
131662434|NCT02101385|474047758|FG001|Study Treatment|Disease Progression|3|||
131662435|NCT02101385|474047757|FG000|Study Treatment|Alternative therapy|0|||
131662436|NCT02101385|474047758|FG001|Study Treatment|Alternative therapy|1|||
131662437|NCT02101385|474047757|FG000|Study Treatment|No treatment, per protocol criteria|0|||
131662438|NCT02101385|474047758|FG001|Study Treatment|No treatment, per protocol criteria|4|||
131662439|NCT02101385|474047757|FG000|Study Treatment|Patient Non compliance|0|||
131662440|NCT02101385|474047758|FG001|Study Treatment|Patient Non compliance|2|||
131662441|NCT02101385|474047757|FG000|Study Treatment|Withdrawal by Subject|5|||
131662442|NCT02101385|474047758|FG001|Study Treatment|Withdrawal by Subject|2|||
131662443|NCT02101385|474047757|FG000|Study Treatment|screen failure|1|||
131662444|NCT02101385|474047758|FG001|Study Treatment|screen failure|0|||
131662445|NCT02101385|474047757|FG000|Study Treatment|AE/Side Effects/Complications|8|||
131662446|NCT02101385|474047758|FG001|Study Treatment|AE/Side Effects/Complications|0|||
131662447|NCT02101385|474047757|FG000|Study Treatment|Lost to Follow-up|1|||
131662448|NCT02101385|474047758|FG001|Study Treatment|Lost to Follow-up|0|||
131662449|NCT02101385|474047757|FG000|Study Treatment|Disease Progression before treatment|1|||
131662450|NCT02101385|474047758|FG001|Study Treatment|Disease Progression before treatment|0|||
131662451|NCT02101385|474047757|FG000|Study Treatment|Death|1|||
131662452|NCT02101385|474047758|FG001|Study Treatment|Death|0|||
131662453|NCT02101385|474047757|FG000|Follow up|Lost to Follow-up|4|||
131662454|NCT02101385|474047758|FG001|Follow up|Lost to Follow-up|9|||
131662455|NCT02101385|474047757|FG000|Follow up|Refused to follow up|5|||
131662456|NCT02101385|474047758|FG001|Follow up|Refused to follow up|4|||
131662457|NCT02101385|474047757|FG000|Follow up|Death|21|||
131662458|NCT02101385|474047758|FG001|Follow up|Death|39|||
131662459|NCT02101385|474047757|FG000|Follow up|study completed|33|||
131662460|NCT02101385|474047758|FG001|Follow up|study completed|52|||
131662461|NCT02101385|474047757|FG000|Follow up|screen failure|2|||
131662462|NCT02101385|474047758|FG001|Follow up|screen failure|0|||
131662463|NCT02101385|474047757|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
131662464|NCT02101385|474047758|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
131662465|NCT02101385|474047757|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
131662466|NCT02101385|474047758|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
131662467|NCT02101385|474047757|FG000|Follow up|Withdrawal by Subject|2|||
131662468|NCT02101385|474047758|FG001|Follow up|Withdrawal by Subject|2|||
131662469|NCT02101385|474047757|FG000|Follow up|PI requested closure of site|0|||
131662470|NCT02101385|474047758|FG001|Follow up|PI requested closure of site|5|||
131662471|NCT02432196|474047759|FG000|Overall Study|Exit - did not receive study device|1|||
131662472|NCT02432196|474047759|FG000|Overall Study|Death|2|||
131662473|NCT02432196|474047759|FG000|Overall Study|Reoperation|3|||
131662474|NCT02227199|474047762|FG000|Overall Study|Physician Decision|0|||
131662475|NCT02227199|474047763|FG001|Overall Study|Physician Decision|0|||
131662476|NCT02227199|474047764|FG002|Overall Study|Physician Decision|1|||
131662477|NCT02227199|474047762|FG000|Overall Study|Adverse Event|0|||
131662478|NCT02227199|474047763|FG001|Overall Study|Adverse Event|0|||
131662479|NCT02227199|474047764|FG002|Overall Study|Adverse Event|3|||
131662480|NCT01905150|474047765|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
131662481|NCT01905150|474047766|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
131662482|NCT01934790|474047767|FG000|Treatment|Adverse Event|3|||
131662483|NCT01934790|474047767|FG000|Treatment|Clinical progression|6|||
131662484|NCT01934790|474047767|FG000|Treatment|Radiological progression|4|||
131662485|NCT01934790|474047767|FG000|Treatment|Withdrawal by Subject|2|||
131662486|NCT01934790|474047767|FG000|Treatment|Study drug never administered|1|||
131662487|NCT01934790|474047767|FG000|Active Follow up|Death|20|||
131662488|NCT01934790|474047767|FG000|Active Follow up|Physician Decision|2|||
131662489|NCT01934790|474047767|FG000|Active Follow up|Progressive disease|1|||
131662490|NCT01934790|474047767|FG000|Active Follow up|Other reason|1|||
131662491|NCT00552929|474047772|FG000|Overall Study|Lost to Follow-up|0|||
131662492|NCT00552929|474047773|FG001|Overall Study|Lost to Follow-up|0|||
131662493|NCT00552929|474047774|FG002|Overall Study|Lost to Follow-up|0|||
131662494|NCT00552929|474047775|FG003|Overall Study|Lost to Follow-up|0|||
131662495|NCT00552929|474047776|FG004|Overall Study|Lost to Follow-up|0|||
131662496|NCT00552929|474047777|FG005|Overall Study|Lost to Follow-up|0|||
131662497|NCT00552929|474047778|FG006|Overall Study|Lost to Follow-up|0|||
131662498|NCT00552929|474047779|FG007|Overall Study|Lost to Follow-up|0|||
131662499|NCT00552929|474047780|FG008|Overall Study|Lost to Follow-up|1|||
131662500|NCT00552929|474047781|FG009|Overall Study|Lost to Follow-up|0|||
131662501|NCT00552929|474047772|FG000|Overall Study|Not Eligible|0|||
131662502|NCT00552929|474047773|FG001|Overall Study|Not Eligible|0|||
131662503|NCT00552929|474047774|FG002|Overall Study|Not Eligible|0|||
131662504|NCT00552929|474047775|FG003|Overall Study|Not Eligible|0|||
131662505|NCT00552929|474047776|FG004|Overall Study|Not Eligible|0|||
131662506|NCT00552929|474047777|FG005|Overall Study|Not Eligible|1|||
131662507|NCT00552929|474047778|FG006|Overall Study|Not Eligible|0|||
131662508|NCT00552929|474047779|FG007|Overall Study|Not Eligible|0|||
131662509|NCT00552929|474047780|FG008|Overall Study|Not Eligible|0|||
131662510|NCT00552929|474047781|FG009|Overall Study|Not Eligible|0|||
131662511|NCT01147536|474047787|FG000|Overall Study|Administrative study close|2|||
131662512|NCT01147536|474047787|FG000|Overall Study|Death|1|||
131662513|NCT04577001|474047791|FG000|Overall Study|Subject became ineligible|0|||
131662514|NCT04577001|474047792|FG001|Overall Study|Subject became ineligible|1|||
131662515|NCT01241604|474047793|FG000|Screening Period|Screen Failure|3|||
131662516|NCT01241604|474047794|FG001|Screening Period|Screen Failure|0|||
131662517|NCT01241604|474047795|FG002|Screening Period|Screen Failure|0|||
131662518|NCT05110690|474047796|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
131662519|NCT05110690|474047796|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
131662520|NCT05110690|474047796|FG000|Completion of Intervention|Lost to Follow-up|1|||
131662521|NCT05110690|474047796|FG000|Completion of Intervention|Death|1|||
131662522|NCT05110690|474047796|FG000|Completion of Intervention|Withdrawal by Subject|2|||
131662523|NCT03973931|474047799|FG000|Overall Study|Lost to Follow-up|47|||
131662524|NCT03973931|474047800|FG001|Overall Study|Lost to Follow-up|63|||
131662525|NCT03973931|474047801|FG002|Overall Study|Lost to Follow-up|51|||
131662526|NCT03973931|474047802|FG003|Overall Study|Lost to Follow-up|54|||
131662527|NCT03973931|474047799|FG000|Overall Study|opted out|6|||
131772280|NCT01238861|474445023|FG004|Overall Study|Unable to continue visits|0|||
131662528|NCT03973931|474047800|FG001|Overall Study|opted out|5|||
131662529|NCT03973931|474047801|FG002|Overall Study|opted out|5|||
131662530|NCT03973931|474047802|FG003|Overall Study|opted out|1|||
131662531|NCT03507777|474049300|FG000|Overall Study|Lost to Follow-up|5|||
131662532|NCT03507777|474049301|FG001|Overall Study|Lost to Follow-up|7|||
131889494|NCT01134263|474879088|FG001|Overall Study|Withdrawal by Subject|6|||
131889495|NCT01134263|474879089|FG002|Overall Study|Withdrawal by Subject|16|||
131889496|NCT01134263|474879090|FG003|Overall Study|Withdrawal by Subject|7|||
131889497|NCT01134263|474879091|FG004|Overall Study|Withdrawal by Subject|5|||
131889498|NCT01134263|474879087|FG000|Overall Study|Enrolled, but not treated|1|||
131889499|NCT01134263|474879088|FG001|Overall Study|Enrolled, but not treated|1|||
131889500|NCT01134263|474879089|FG002|Overall Study|Enrolled, but not treated|0|||
131889501|NCT01134263|474879090|FG003|Overall Study|Enrolled, but not treated|1|||
131889502|NCT01134263|474879091|FG004|Overall Study|Enrolled, but not treated|0|||
131889503|NCT01038752|474879093|FG000|Overall Study|Tumor Progression|2|||
131889504|NCT01038752|474879094|FG001|Overall Study|Tumor Progression|2|||
131889505|NCT01038752|474879093|FG000|Overall Study|Lost to Follow-up|3|||
131552929|NCT02508532|473649781|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
131552930|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
131552931|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
131552932|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
131552933|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
131552934|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
131552935|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
131552936|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
131552937|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
131552938|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
131552939|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
131552940|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
131552941|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
131552942|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
131552943|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
131552944|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
131552945|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
131552946|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
131552947|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
131552948|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Death|0|||
131552949|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Death|4|||
131552950|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Death|2|||
131552951|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Death|4|||
131552952|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Death|3|||
131552953|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Death|0|||
131552954|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Death|0|||
131552955|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Death|1|||
131552956|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Death|111|||
131552957|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
131552958|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
131552959|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
131552960|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
131552961|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
131552962|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
131552963|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
131552964|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
131552965|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
131552966|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552967|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552968|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552969|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552970|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552971|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552972|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552973|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
131552974|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
131552975|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
131552976|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
131552977|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
131552978|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
131552979|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
131552980|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
131552981|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
131552982|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
131552983|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
131552984|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131889506|NCT01038752|474879094|FG001|Overall Study|Lost to Follow-up|3|||
131889507|NCT04165135|474879095|FG000|Overall Study|Protocol Violation|10|||
131889508|NCT04165135|474879095|FG000|Overall Study|Participants withdrawal of consent|5|||
131889509|NCT01618916|474879096|FG000|Overall Study|Adverse Event|1|||
131889510|NCT01618916|474879097|FG001|Overall Study|Adverse Event|0|||
131889511|NCT01618916|474879098|FG002|Overall Study|Adverse Event|0|||
131889512|NCT01618916|474879099|FG003|Overall Study|Adverse Event|0|||
131889513|NCT01618916|474879100|FG004|Overall Study|Adverse Event|0|||
131662533|NCT03507777|474049300|FG000|Overall Study|Withdrawal by Subject|6|||
131662534|NCT03507777|474049301|FG001|Overall Study|Withdrawal by Subject|11|||
131662535|NCT03507777|474049300|FG000|Overall Study|Death|30|||
131662536|NCT03507777|474049301|FG001|Overall Study|Death|44|||
131662537|NCT03507777|474049300|FG000|Overall Study|Other Reasons|3|||
131662538|NCT03507777|474049301|FG001|Overall Study|Other Reasons|8|||
131662539|NCT01879722|474049302|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131662540|NCT01879722|474049303|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131662541|NCT01879722|474049304|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131889514|NCT01618916|474879101|FG005|Overall Study|Adverse Event|0|||
131889515|NCT01618916|474879096|FG000|Overall Study|Withdrawal by Subject|0|||
131889516|NCT01618916|474879097|FG001|Overall Study|Withdrawal by Subject|1|||
131889517|NCT01618916|474879098|FG002|Overall Study|Withdrawal by Subject|1|||
131662542|NCT01879722|474049305|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
131662543|NCT01879722|474049306|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
131662544|NCT01879722|474049307|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
131662545|NCT01879722|474049308|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
131662546|NCT01879722|474049309|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
131662547|NCT01879722|474049310|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
131662548|NCT01879722|474049311|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
131662549|NCT01879722|474049302|FG000|Overall Study|Voluntary Withdrawal|0|||
131662550|NCT01879722|474049303|FG001|Overall Study|Voluntary Withdrawal|0|||
131662551|NCT01879722|474049304|FG002|Overall Study|Voluntary Withdrawal|0|||
131662552|NCT01879722|474049305|FG003|Overall Study|Voluntary Withdrawal|0|||
131662553|NCT01879722|474049306|FG004|Overall Study|Voluntary Withdrawal|0|||
131662554|NCT01879722|474049307|FG005|Overall Study|Voluntary Withdrawal|0|||
131662555|NCT01879722|474049308|FG006|Overall Study|Voluntary Withdrawal|0|||
131662556|NCT01879722|474049309|FG007|Overall Study|Voluntary Withdrawal|0|||
131662557|NCT01879722|474049310|FG008|Overall Study|Voluntary Withdrawal|1|||
131662558|NCT01879722|474049311|FG009|Overall Study|Voluntary Withdrawal|0|||
131662559|NCT01253304|474049312|FG000|Overall Study|Adverse Event|0|||
131662560|NCT01253304|474049313|FG001|Overall Study|Adverse Event|0|||
131662561|NCT01253304|474049314|FG002|Overall Study|Adverse Event|0|||
131662562|NCT01253304|474049315|FG003|Overall Study|Adverse Event|1|||
131662563|NCT01327495|474049316|FG000|Overall Study|Adverse Event|2|||
131662564|NCT01327495|474049317|FG001|Overall Study|Adverse Event|1|||
131662565|NCT01327495|474049318|FG002|Overall Study|Adverse Event|1|||
131662566|NCT01327495|474049319|FG003|Overall Study|Adverse Event|0|||
131662567|NCT01327495|474049320|FG004|Overall Study|Adverse Event|0|||
131662568|NCT01327495|474049321|FG005|Overall Study|Adverse Event|2|||
131662569|NCT01327495|474049316|FG000|Overall Study|Withdrawal by Subject|0|||
131662570|NCT01327495|474049317|FG001|Overall Study|Withdrawal by Subject|1|||
131662571|NCT01327495|474049318|FG002|Overall Study|Withdrawal by Subject|1|||
131662572|NCT01327495|474049319|FG003|Overall Study|Withdrawal by Subject|0|||
131662573|NCT01327495|474049320|FG004|Overall Study|Withdrawal by Subject|1|||
131662574|NCT01327495|474049321|FG005|Overall Study|Withdrawal by Subject|0|||
131662575|NCT01327495|474049316|FG000|Overall Study|Physician Decision|0|||
131662576|NCT01327495|474049317|FG001|Overall Study|Physician Decision|0|||
131662577|NCT01327495|474049318|FG002|Overall Study|Physician Decision|0|||
131662578|NCT01327495|474049319|FG003|Overall Study|Physician Decision|0|||
131662579|NCT01327495|474049320|FG004|Overall Study|Physician Decision|2|||
131662580|NCT01327495|474049321|FG005|Overall Study|Physician Decision|0|||
131662581|NCT00006011|474049322|FG000|Overall Study|Disease progression|13|||
131889518|NCT01618916|474879099|FG003|Overall Study|Withdrawal by Subject|0|||
131889519|NCT01618916|474879100|FG004|Overall Study|Withdrawal by Subject|1|||
131889520|NCT01618916|474879101|FG005|Overall Study|Withdrawal by Subject|0|||
131662582|NCT00006011|474049323|FG001|Overall Study|Disease progression|6|||
131662583|NCT00006011|474049324|FG002|Overall Study|Disease progression|26|||
131662584|NCT00006011|474049322|FG000|Overall Study|Refused further treatment|15|||
131889521|NCT01618916|474879096|FG000|Overall Study|Lost to Follow-up|1|||
131889522|NCT01618916|474879097|FG001|Overall Study|Lost to Follow-up|0|||
131889523|NCT01618916|474879098|FG002|Overall Study|Lost to Follow-up|0|||
131662585|NCT00006011|474049323|FG001|Overall Study|Refused further treatment|13|||
131662586|NCT00006011|474049324|FG002|Overall Study|Refused further treatment|26|||
131662587|NCT00006011|474049322|FG000|Overall Study|Adverse Event|15|||
131662588|NCT00006011|474049323|FG001|Overall Study|Adverse Event|39|||
131662589|NCT00006011|474049324|FG002|Overall Study|Adverse Event|5|||
131662590|NCT00006011|474049322|FG000|Overall Study|Death|0|||
131889524|NCT01618916|474879099|FG003|Overall Study|Lost to Follow-up|2|||
131889525|NCT01618916|474879100|FG004|Overall Study|Lost to Follow-up|0|||
131662591|NCT00006011|474049323|FG001|Overall Study|Death|1|||
131662592|NCT00006011|474049324|FG002|Overall Study|Death|2|||
131662593|NCT00006011|474049322|FG000|Overall Study|Other|4|||
131662594|NCT00006011|474049323|FG001|Overall Study|Other|2|||
131662595|NCT00006011|474049324|FG002|Overall Study|Other|5|||
131662596|NCT00006011|474049322|FG000|Overall Study|Ineligible|18|||
131662597|NCT00006011|474049323|FG001|Overall Study|Ineligible|16|||
131662598|NCT00006011|474049324|FG002|Overall Study|Ineligible|9|||
131662599|NCT03212989|474049326|FG000|Overall Study|Physician Decision|8|||
131662600|NCT03047395|474049329|FG000|Overall Study|Adverse Event|142|||
131662601|NCT03047395|474049329|FG000|Overall Study|Withdrawal by Subject|155|||
131662602|NCT03047395|474049329|FG000|Overall Study|Lost to Follow-up|144|||
131662603|NCT03047395|474049329|FG000|Overall Study|COVID-19 Infection|2|||
131662604|NCT03047395|474049329|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
131662605|NCT03047395|474049329|FG000|Overall Study|Other, Not Specified|117|||
131662606|NCT00560066|474049332|FG000|Overall Study|Death|2|||
131662607|NCT00560066|474049333|FG001|Overall Study|Death|1|||
131662608|NCT00560066|474049332|FG000|Overall Study|Withdrawal by Subject|0|||
131662609|NCT00560066|474049333|FG001|Overall Study|Withdrawal by Subject|3|||
131662610|NCT00560066|474049332|FG000|Overall Study|Lost to Follow-up|4|||
131662611|NCT00560066|474049333|FG001|Overall Study|Lost to Follow-up|10|||
131662612|NCT00560066|474049332|FG000|Overall Study|Protocol Violation|0|||
131662613|NCT00560066|474049333|FG001|Overall Study|Protocol Violation|1|||
131662614|NCT00560066|474049332|FG000|Overall Study|Administrative reason|0|||
131662615|NCT00560066|474049333|FG001|Overall Study|Administrative reason|5|||
131662616|NCT00560066|474049332|FG000|Overall Study|Missing primary reason|0|||
131662617|NCT00560066|474049333|FG001|Overall Study|Missing primary reason|2|||
131662618|NCT00620282|474049340|FG000|Overall Study|Adverse Event|0|||
131662619|NCT00620282|474049341|FG001|Overall Study|Adverse Event|1|||
131662620|NCT00620282|474049342|FG002|Overall Study|Adverse Event|0|||
131662621|NCT00620282|474049340|FG000|Overall Study|Arterial line unable to be placed|0|||
131662622|NCT00620282|474049341|FG001|Overall Study|Arterial line unable to be placed|0|||
131662623|NCT00620282|474049342|FG002|Overall Study|Arterial line unable to be placed|1|||
131662624|NCT00620282|474049340|FG000|Overall Study|Withdrawal by Subject|0|||
131662625|NCT00620282|474049341|FG001|Overall Study|Withdrawal by Subject|1|||
131662626|NCT00620282|474049342|FG002|Overall Study|Withdrawal by Subject|0|||
131662627|NCT01258595|474049343|FG000|Overall Study|Lost to Follow-up|1|||
131662628|NCT01258595|474049344|FG001|Overall Study|Lost to Follow-up|0|||
131662629|NCT01258595|474049343|FG000|Overall Study|Withdrawal by Subject|0|||
131662630|NCT01258595|474049344|FG001|Overall Study|Withdrawal by Subject|1|||
131662631|NCT02703259|474049345|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
131662632|NCT02703259|474049346|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
131662633|NCT02703259|474049345|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
131662634|NCT02703259|474049346|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
131662635|NCT02703259|474049345|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
131662636|NCT02703259|474049346|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
131662637|NCT04738292|474049351|FG000|Overall Study|Death|1|||
131662638|NCT03122223|474049352|FG000|Overall Study|Withdrawal by Subject|2|||
131662639|NCT03122223|474049353|FG001|Overall Study|Withdrawal by Subject|2|||
131662640|NCT03122223|474049354|FG002|Overall Study|Withdrawal by Subject|1|||
131662641|NCT03122223|474049355|FG003|Overall Study|Withdrawal by Subject|0|||
131662642|NCT03122223|474049352|FG000|Overall Study|Lost to Follow-up|0|||
131662643|NCT03122223|474049353|FG001|Overall Study|Lost to Follow-up|2|||
131662644|NCT03122223|474049354|FG002|Overall Study|Lost to Follow-up|2|||
131662645|NCT03122223|474049355|FG003|Overall Study|Lost to Follow-up|0|||
131662646|NCT03122223|474049352|FG000|Overall Study|Participant unable to adhere|1|||
131662647|NCT03122223|474049353|FG001|Overall Study|Participant unable to adhere|1|||
131662648|NCT03122223|474049354|FG002|Overall Study|Participant unable to adhere|1|||
131662649|NCT03122223|474049355|FG003|Overall Study|Participant unable to adhere|0|||
131662650|NCT01820585|474049357|FG000|Overall Study|Adverse Event|9|||
131662651|NCT01820585|474049358|FG001|Overall Study|Adverse Event|13|||
131662652|NCT01820585|474049359|FG002|Overall Study|Adverse Event|23|||
131662653|NCT01820585|474049360|FG003|Overall Study|Adverse Event|34|||
131662654|NCT01820585|474049357|FG000|Overall Study|Lack of Efficacy|9|||
131662655|NCT01820585|474049358|FG001|Overall Study|Lack of Efficacy|7|||
131662656|NCT01820585|474049359|FG002|Overall Study|Lack of Efficacy|5|||
131662657|NCT01820585|474049360|FG003|Overall Study|Lack of Efficacy|1|||
131662658|NCT01820585|474049357|FG000|Overall Study|Withdrawal by Subject|3|||
131662659|NCT01820585|474049358|FG001|Overall Study|Withdrawal by Subject|7|||
131662660|NCT01820585|474049359|FG002|Overall Study|Withdrawal by Subject|3|||
131662661|NCT01820585|474049360|FG003|Overall Study|Withdrawal by Subject|8|||
131662662|NCT01820585|474049357|FG000|Overall Study|Lost to Follow-up|3|||
131662663|NCT01820585|474049358|FG001|Overall Study|Lost to Follow-up|3|||
131662664|NCT01820585|474049359|FG002|Overall Study|Lost to Follow-up|0|||
131662665|NCT01820585|474049360|FG003|Overall Study|Lost to Follow-up|3|||
131662666|NCT01820585|474049357|FG000|Overall Study|Protocol Violation|3|||
131662667|NCT01820585|474049358|FG001|Overall Study|Protocol Violation|1|||
131662668|NCT01820585|474049359|FG002|Overall Study|Protocol Violation|1|||
131662669|NCT01820585|474049360|FG003|Overall Study|Protocol Violation|1|||
131662670|NCT01820585|474049357|FG000|Overall Study|Subject non-compliance|0|||
131662671|NCT01820585|474049358|FG001|Overall Study|Subject non-compliance|0|||
131662672|NCT01820585|474049359|FG002|Overall Study|Subject non-compliance|1|||
131662673|NCT01820585|474049360|FG003|Overall Study|Subject non-compliance|2|||
131662674|NCT01820585|474049357|FG000|Overall Study|at sponsor request|0|||
131662675|NCT01820585|474049358|FG001|Overall Study|at sponsor request|0|||
131662676|NCT01820585|474049359|FG002|Overall Study|at sponsor request|1|||
131662677|NCT01820585|474049360|FG003|Overall Study|at sponsor request|0|||
131662678|NCT01820585|474049357|FG000|Overall Study|Pregnancy|0|||
131662679|NCT01820585|474049358|FG001|Overall Study|Pregnancy|1|||
131662680|NCT01820585|474049359|FG002|Overall Study|Pregnancy|0|||
131662681|NCT01820585|474049360|FG003|Overall Study|Pregnancy|0|||
131662682|NCT02544451|474049361|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
131662683|NCT02544451|474049362|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
131662684|NCT02544451|474049363|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
131662685|NCT02544451|474049364|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
131662686|NCT02544451|474049361|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
131662687|NCT02544451|474049362|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
131662688|NCT02544451|474049363|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
131662689|NCT02544451|474049364|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
131662690|NCT02544451|474049361|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
131662691|NCT02544451|474049362|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
131662692|NCT02544451|474049363|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
131662693|NCT02544451|474049364|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
131662694|NCT02544451|474049361|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
131662695|NCT02544451|474049362|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
131662696|NCT02544451|474049363|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
131662697|NCT02544451|474049364|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
131662698|NCT02544451|474049361|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
131662699|NCT02544451|474049362|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
131662700|NCT02544451|474049363|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
131662701|NCT02544451|474049364|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
131662702|NCT02544451|474049361|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
131662703|NCT02544451|474049362|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
131662704|NCT02544451|474049363|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
131662705|NCT02544451|474049364|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
131662706|NCT02442336|474049368|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
131662707|NCT02442336|474049368|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
131662708|NCT02442336|474049368|FG000|Overall Study|Lost to Follow-up|11|||
131662709|NCT01489891|474049369|FG000|Overall Study|Endoscopy failure|1|||
131662710|NCT01489891|474049370|FG001|Overall Study|Endoscopy failure|0|||
131662711|NCT00998790|474049371|FG000|Overall Study|Withdrawal by Subject|21|||
131662712|NCT03001076|474049372|FG000|Overall Study|Withdrawal by patient|2|||
131662713|NCT03001076|474049373|FG001|Overall Study|Withdrawal by patient|0|||
131662714|NCT03001076|474049372|FG000|Overall Study|Other|1|||
131662715|NCT03001076|474049373|FG001|Overall Study|Other|0|||
131662716|NCT03001076|474049372|FG000|Overall Study|Adverse Event|3|||
131662717|NCT03001076|474049373|FG001|Overall Study|Adverse Event|3|||
131662718|NCT03001076|474049372|FG000|Overall Study|Sponsor decision|1|||
131662719|NCT03001076|474049373|FG001|Overall Study|Sponsor decision|0|||
131662720|NCT03001076|474049372|FG000|Overall Study|Lost to Follow-up|0|||
131662721|NCT03001076|474049373|FG001|Overall Study|Lost to Follow-up|2|||
131662722|NCT00844532|474049375|FG000|Overall Study|Death|16|||
131662723|NCT00844532|474049375|FG000|Overall Study|Withdrawal by Subject|16|||
131662724|NCT00844532|474049375|FG000|Overall Study|Lost to Follow-up|7|||
131662725|NCT03189745|474049376|FG000|Overall Study|Conflict in work schedule of participant|1|||
131662726|NCT03189745|474049377|FG001|Overall Study|Conflict in work schedule of participant|1|||
131662727|NCT01993927|474049378|FG000|Overall Study|Case Report Forms Uncollected|18|||
131662728|NCT01993927|474049378|FG000|Overall Study|Protocol Violation|11|||
131662729|NCT00895154|474049379|FG000|Overall Study|Lost to Follow-up|1|||
131662730|NCT00895154|474049380|FG001|Overall Study|Lost to Follow-up|1|||
131662731|NCT00895154|474049379|FG000|Overall Study|Withdrawal by Subject|0|||
131662732|NCT00895154|474049380|FG001|Overall Study|Withdrawal by Subject|1|||
131662733|NCT00777088|474049381|FG000|Overall Study|PED Treatment not attempted|1|||
131662734|NCT02729831|474049383|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
131662735|NCT02729831|474049384|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
131662736|NCT02729831|474049385|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
131662737|NCT02729831|474049386|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
131662738|NCT02729831|474049383|FG000|1 Week Post-visit|Lost to Follow-up|43|||
131889526|NCT01618916|474879101|FG005|Overall Study|Lost to Follow-up|0|||
131662739|NCT02729831|474049384|FG001|1 Week Post-visit|Lost to Follow-up|40|||
131662740|NCT02729831|474049385|FG002|1 Week Post-visit|Lost to Follow-up|38|||
131662741|NCT02729831|474049386|FG003|1 Week Post-visit|Lost to Follow-up|36|||
131662742|NCT02729831|474049383|FG000|6 Month Follow-up|Lost to Follow-up|54|||
131662743|NCT02729831|474049384|FG001|6 Month Follow-up|Lost to Follow-up|51|||
131662744|NCT02729831|474049385|FG002|6 Month Follow-up|Lost to Follow-up|48|||
131662745|NCT02729831|474049386|FG003|6 Month Follow-up|Lost to Follow-up|42|||
131662746|NCT02729831|474049383|FG000|6 Month Follow-up|Death|1|||
131662747|NCT02729831|474049384|FG001|6 Month Follow-up|Death|3|||
131662748|NCT02729831|474049385|FG002|6 Month Follow-up|Death|0|||
131662749|NCT02729831|474049386|FG003|6 Month Follow-up|Death|1|||
131662750|NCT03117998|474049387|FG000|Overall Study|Adverse Event|1|||
131662751|NCT03117998|474049388|FG001|Overall Study|Adverse Event|0|||
131662752|NCT03117998|474049389|FG002|Overall Study|Adverse Event|0|||
131662753|NCT03117998|474049390|FG003|Overall Study|Adverse Event|0|||
131662754|NCT03117998|474049391|FG004|Overall Study|Adverse Event|0|||
131662755|NCT03117998|474049392|FG005|Overall Study|Adverse Event|0|||
131662756|NCT03117998|474049387|FG000|Overall Study|Withdrawal by Subject|0|||
131662757|NCT03117998|474049388|FG001|Overall Study|Withdrawal by Subject|0|||
131662758|NCT03117998|474049389|FG002|Overall Study|Withdrawal by Subject|2|||
131662759|NCT03117998|474049390|FG003|Overall Study|Withdrawal by Subject|3|||
131662760|NCT03117998|474049391|FG004|Overall Study|Withdrawal by Subject|3|||
131662761|NCT03117998|474049392|FG005|Overall Study|Withdrawal by Subject|0|||
131662762|NCT03117998|474049387|FG000|Overall Study|Physician Decision|0|||
131662763|NCT03117998|474049388|FG001|Overall Study|Physician Decision|1|||
131662764|NCT03117998|474049389|FG002|Overall Study|Physician Decision|1|||
131662765|NCT03117998|474049390|FG003|Overall Study|Physician Decision|0|||
131662766|NCT03117998|474049391|FG004|Overall Study|Physician Decision|0|||
131662767|NCT03117998|474049392|FG005|Overall Study|Physician Decision|0|||
131662768|NCT03117998|474049387|FG000|Overall Study|Lost to Follow-up|0|||
131662769|NCT03117998|474049388|FG001|Overall Study|Lost to Follow-up|0|||
131662770|NCT03117998|474049389|FG002|Overall Study|Lost to Follow-up|0|||
131662771|NCT03117998|474049390|FG003|Overall Study|Lost to Follow-up|1|||
131662772|NCT03117998|474049391|FG004|Overall Study|Lost to Follow-up|4|||
131662773|NCT03117998|474049392|FG005|Overall Study|Lost to Follow-up|0|||
131662774|NCT03117998|474049387|FG000|Overall Study|Subject noncompliance|0|||
131662775|NCT03117998|474049388|FG001|Overall Study|Subject noncompliance|0|||
131662776|NCT03117998|474049389|FG002|Overall Study|Subject noncompliance|1|||
131662777|NCT03117998|474049390|FG003|Overall Study|Subject noncompliance|0|||
131662778|NCT03117998|474049391|FG004|Overall Study|Subject noncompliance|0|||
131662779|NCT03117998|474049392|FG005|Overall Study|Subject noncompliance|2|||
131662780|NCT03117998|474049387|FG000|Overall Study|Protocol Violation|0|||
131662781|NCT03117998|474049388|FG001|Overall Study|Protocol Violation|0|||
131662782|NCT03117998|474049389|FG002|Overall Study|Protocol Violation|0|||
131662783|NCT03117998|474049390|FG003|Overall Study|Protocol Violation|0|||
131662784|NCT03117998|474049391|FG004|Overall Study|Protocol Violation|0|||
131662785|NCT03117998|474049392|FG005|Overall Study|Protocol Violation|1|||
131662786|NCT00438672|474049393|FG000|Overall Study|Lost to Follow-up|7|||
131662787|NCT00438672|474049394|FG001|Overall Study|Lost to Follow-up|9|||
131662788|NCT01468181|474049398|FG000|Overall Study|Adverse Event|8|||
131662789|NCT01468181|474049399|FG001|Overall Study|Adverse Event|1|||
131662790|NCT01468181|474049400|FG002|Overall Study|Adverse Event|6|||
131662791|NCT01468181|474049401|FG003|Overall Study|Adverse Event|2|||
131662792|NCT01468181|474049402|FG004|Overall Study|Adverse Event|2|||
131662793|NCT01468181|474049398|FG000|Overall Study|Protocol Violation|2|||
131662794|NCT01468181|474049399|FG001|Overall Study|Protocol Violation|0|||
131662795|NCT01468181|474049400|FG002|Overall Study|Protocol Violation|1|||
131662796|NCT01468181|474049401|FG003|Overall Study|Protocol Violation|0|||
131662797|NCT01468181|474049402|FG004|Overall Study|Protocol Violation|1|||
131662798|NCT01468181|474049398|FG000|Overall Study|Physician Decision|0|||
131662799|NCT01468181|474049399|FG001|Overall Study|Physician Decision|0|||
131662800|NCT01468181|474049400|FG002|Overall Study|Physician Decision|0|||
131662801|NCT01468181|474049401|FG003|Overall Study|Physician Decision|1|||
131889527|NCT04521114|474879102|FG000|Overall Study|Lost to Follow-up|1|||
131889528|NCT04521114|474879103|FG001|Overall Study|Lost to Follow-up|2|||
131889529|NCT04521114|474879104|FG002|Overall Study|Lost to Follow-up|0|||
131889530|NCT04521114|474879102|FG000|Overall Study|Withdrawal by Subject|1|||
131662802|NCT01468181|474049402|FG004|Overall Study|Physician Decision|1|||
131662803|NCT01468181|474049398|FG000|Overall Study|Lost to Follow-up|0|||
131662804|NCT01468181|474049399|FG001|Overall Study|Lost to Follow-up|0|||
131662805|NCT01468181|474049400|FG002|Overall Study|Lost to Follow-up|1|||
131662806|NCT01468181|474049401|FG003|Overall Study|Lost to Follow-up|0|||
131662807|NCT01468181|474049402|FG004|Overall Study|Lost to Follow-up|1|||
131662808|NCT01468181|474049398|FG000|Overall Study|Withdrawal by Subject|0|||
131662809|NCT01468181|474049399|FG001|Overall Study|Withdrawal by Subject|1|||
131662810|NCT01468181|474049400|FG002|Overall Study|Withdrawal by Subject|0|||
131662811|NCT01468181|474049401|FG003|Overall Study|Withdrawal by Subject|0|||
131662812|NCT01468181|474049402|FG004|Overall Study|Withdrawal by Subject|0|||
131662813|NCT04828837|474049403|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
131662814|NCT04828837|474049404|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
131662815|NCT04828837|474049403|FG000|Overall Study|Lost to Follow-up|2|||
131662816|NCT04828837|474049404|FG001|Overall Study|Lost to Follow-up|6|||
131662817|NCT04828837|474049403|FG000|Overall Study|Lack of Efficacy|1|||
131662818|NCT04828837|474049404|FG001|Overall Study|Lack of Efficacy|0|||
131662819|NCT04828837|474049403|FG000|Overall Study|Admitted due to pneumothorax.|1|||
131662820|NCT04828837|474049404|FG001|Overall Study|Admitted due to pneumothorax.|0|||
131662821|NCT04828837|474049403|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
131662822|NCT04828837|474049404|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
131662823|NCT00320528|474049405|FG000|Study Period II|Adverse Event|3|||
131662824|NCT00320528|474049406|FG001|Study Period II|Adverse Event|4|||
131662825|NCT00320528|474049407|FG002|Study Period II|Adverse Event|8|||
131662826|NCT00320528|474049405|FG000|Study Period II|Parent/Caregiver Decision|8|||
131662827|NCT00320528|474049406|FG001|Study Period II|Parent/Caregiver Decision|3|||
131662828|NCT00320528|474049407|FG002|Study Period II|Parent/Caregiver Decision|11|||
131662829|NCT00320528|474049405|FG000|Study Period II|Withdrawal by Subject|0|||
131662830|NCT00320528|474049406|FG001|Study Period II|Withdrawal by Subject|1|||
131662831|NCT00320528|474049407|FG002|Study Period II|Withdrawal by Subject|1|||
131662832|NCT00320528|474049405|FG000|Study Period II|Entry Criteria Exclusion|0|||
131662833|NCT00320528|474049406|FG001|Study Period II|Entry Criteria Exclusion|2|||
131662834|NCT00320528|474049407|FG002|Study Period II|Entry Criteria Exclusion|2|||
131662835|NCT00320528|474049405|FG000|Study Period III|Adverse Event|1|||
131662836|NCT00320528|474049406|FG001|Study Period III|Adverse Event|0|||
131662837|NCT00320528|474049407|FG002|Study Period III|Adverse Event|0|||
131662838|NCT00320528|474049405|FG000|Study Period III|Lost to Follow-up|1|||
131662839|NCT00320528|474049406|FG001|Study Period III|Lost to Follow-up|0|||
131662840|NCT00320528|474049407|FG002|Study Period III|Lost to Follow-up|0|||
131662841|NCT00320528|474049405|FG000|Study Period III|Withdrawal by Subject|1|||
131662842|NCT00320528|474049406|FG001|Study Period III|Withdrawal by Subject|1|||
131662843|NCT00320528|474049407|FG002|Study Period III|Withdrawal by Subject|2|||
131662844|NCT00320528|474049405|FG000|Study Period III|Lack of Efficacy|2|||
131662845|NCT00320528|474049406|FG001|Study Period III|Lack of Efficacy|0|||
131662846|NCT00320528|474049407|FG002|Study Period III|Lack of Efficacy|0|||
131662847|NCT00320528|474049405|FG000|Study Period III|Parent/Caregiver Decision|14|||
131662848|NCT00320528|474049406|FG001|Study Period III|Parent/Caregiver Decision|3|||
131662849|NCT00320528|474049407|FG002|Study Period III|Parent/Caregiver Decision|11|||
131662850|NCT00320528|474049405|FG000|Study Period III|Protocol Violation|0|||
131662851|NCT00320528|474049406|FG001|Study Period III|Protocol Violation|1|||
131662852|NCT00320528|474049407|FG002|Study Period III|Protocol Violation|0|||
131662853|NCT00320528|474049405|FG000|Study Period III|Physician Decision|0|||
131662854|NCT00320528|474049406|FG001|Study Period III|Physician Decision|1|||
131662855|NCT00320528|474049407|FG002|Study Period III|Physician Decision|2|||
131662856|NCT00320528|474049405|FG000|Study Period III|Sponsor Decision|0|||
131662857|NCT00320528|474049406|FG001|Study Period III|Sponsor Decision|0|||
131662858|NCT00320528|474049407|FG002|Study Period III|Sponsor Decision|1|||
131662859|NCT00320528|474049405|FG000|Study Period III|Atomoxetine Commercially Available|68|||
131662860|NCT00320528|474049406|FG001|Study Period III|Atomoxetine Commercially Available|25|||
131662861|NCT00320528|474049407|FG002|Study Period III|Atomoxetine Commercially Available|90|||
131662862|NCT00545753|474049408|FG000|Overall Study|Withdrawal by Subject|0|||
131662863|NCT00545753|474049409|FG001|Overall Study|Withdrawal by Subject|1|||
131662864|NCT00545753|474049410|FG002|Overall Study|Withdrawal by Subject|10|||
131662865|NCT00545753|474049408|FG000|Overall Study|Lost to Follow-up|13|||
131662866|NCT00545753|474049409|FG001|Overall Study|Lost to Follow-up|3|||
131662867|NCT00545753|474049410|FG002|Overall Study|Lost to Follow-up|12|||
131662868|NCT00545753|474049408|FG000|Overall Study|Protocol Violation|3|||
131662869|NCT00545753|474049409|FG001|Overall Study|Protocol Violation|1|||
131662870|NCT00545753|474049410|FG002|Overall Study|Protocol Violation|4|||
131662871|NCT01942785|474049417|FG000|Overall Study|Adverse Event|2|||
131662872|NCT01942785|474049417|FG000|Overall Study|Withdrawal by Subject|1|||
131662873|NCT01942785|474049417|FG000|Overall Study|Protocol Violation|1|||
131662874|NCT03762200|474049420|FG000|Overall Study|Death|2|||
131662875|NCT02631577|474049421|FG000|Overall Study|Death|1|||
131662876|NCT02631577|474049422|FG001|Overall Study|Death|7|||
131889531|NCT04521114|474879103|FG001|Overall Study|Withdrawal by Subject|2|||
131889532|NCT04521114|474879104|FG002|Overall Study|Withdrawal by Subject|2|||
131662877|NCT02631577|474049421|FG000|Overall Study|Withdrawal by Subject|0|||
131662878|NCT02631577|474049422|FG001|Overall Study|Withdrawal by Subject|3|||
131662879|NCT01593787|474049423|FG000|Overall Study|Adverse Event|1|||
131662880|NCT01593787|474049424|FG001|Overall Study|Adverse Event|0|||
131889533|NCT04521114|474879102|FG000|Overall Study|Adverse Event|1|||
131662881|NCT01593787|474049425|FG002|Overall Study|Adverse Event|0|||
131662882|NCT03981861|474049431|FG000|Overall Study|Withdrawal by Subject|3|||
131662883|NCT05618912|474049432|FG000|Overall Study|Lost to Follow-up|14|||
131662884|NCT05618912|474049433|FG001|Overall Study|Lost to Follow-up|19|||
131662885|NCT01022112|474049434|FG000|Overall Study|Adverse Event|1|||
131662886|NCT01022112|474049435|FG001|Overall Study|Adverse Event|2|||
131662887|NCT01022112|474049436|FG002|Overall Study|Adverse Event|0|||
131662888|NCT01022112|474049437|FG003|Overall Study|Adverse Event|1|||
131662889|NCT01022112|474049438|FG004|Overall Study|Adverse Event|0|||
131662890|NCT01022112|474049434|FG000|Overall Study|Lack of Efficacy|1|||
131662891|NCT01022112|474049435|FG001|Overall Study|Lack of Efficacy|0|||
131662892|NCT01022112|474049436|FG002|Overall Study|Lack of Efficacy|0|||
131662893|NCT01022112|474049437|FG003|Overall Study|Lack of Efficacy|0|||
131662894|NCT01022112|474049438|FG004|Overall Study|Lack of Efficacy|1|||
131662895|NCT01022112|474049434|FG000|Overall Study|Physician Decision|0|||
131662896|NCT01022112|474049435|FG001|Overall Study|Physician Decision|0|||
131662897|NCT01022112|474049436|FG002|Overall Study|Physician Decision|1|||
131662898|NCT01022112|474049437|FG003|Overall Study|Physician Decision|0|||
131662899|NCT01022112|474049438|FG004|Overall Study|Physician Decision|1|||
131662900|NCT01022112|474049434|FG000|Overall Study|Withdrawal by Subject|0|||
131662901|NCT01022112|474049435|FG001|Overall Study|Withdrawal by Subject|1|||
131662902|NCT01022112|474049436|FG002|Overall Study|Withdrawal by Subject|2|||
131662903|NCT01022112|474049437|FG003|Overall Study|Withdrawal by Subject|2|||
131662904|NCT01022112|474049438|FG004|Overall Study|Withdrawal by Subject|1|||
131662905|NCT01022112|474049434|FG000|Overall Study|Fasting plasma glucose level increased|1|||
131662906|NCT01022112|474049435|FG001|Overall Study|Fasting plasma glucose level increased|0|||
131662907|NCT01022112|474049436|FG002|Overall Study|Fasting plasma glucose level increased|0|||
131662908|NCT01022112|474049437|FG003|Overall Study|Fasting plasma glucose level increased|0|||
131662909|NCT01022112|474049438|FG004|Overall Study|Fasting plasma glucose level increased|7|||
131662910|NCT00978627|474051153|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
131662911|NCT00978627|474051154|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
131662912|NCT00978627|474051153|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
131662913|NCT00978627|474051154|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
131662914|NCT00978627|474051153|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
131662915|NCT00978627|474051154|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
131662916|NCT00978627|474051153|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
131662917|NCT00978627|474051154|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
131662918|NCT00978627|474051153|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
131662919|NCT00978627|474051154|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
131662920|NCT00978627|474051153|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
131662921|NCT00978627|474051154|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
131662922|NCT00978627|474051153|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
131662923|NCT00978627|474051154|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
131662924|NCT00978627|474051153|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
131662925|NCT00978627|474051154|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
131662926|NCT00978627|474051153|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
131662927|NCT00978627|474051154|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
131662928|NCT03695237|474051155|FG000|Overall Study|Withdrawal by Subject|1|||
131662929|NCT03695237|474051156|FG001|Overall Study|Withdrawal by Subject|3|||
131662930|NCT03695237|474051155|FG000|Overall Study|Lost to Follow-up|1|||
131662931|NCT03695237|474051156|FG001|Overall Study|Lost to Follow-up|2|||
131662932|NCT03695237|474051155|FG000|Overall Study|Other, Not Specified|8|||
131662933|NCT03695237|474051156|FG001|Overall Study|Other, Not Specified|2|||
131662934|NCT02516332|474051157|FG000|Overall Study|Withdrawal by Subject|2|||
131662935|NCT02516332|474051158|FG001|Overall Study|Withdrawal by Subject|1|||
131662936|NCT02516332|474051159|FG002|Overall Study|Withdrawal by Subject|2|||
131662937|NCT03037931|474051160|FG000|Overall Study|Death|354|||
131662938|NCT03037931|474051161|FG001|Overall Study|Death|367|||
131662939|NCT03037931|474051160|FG000|Overall Study|Lost to Follow-up|7|||
131662940|NCT03037931|474051161|FG001|Overall Study|Lost to Follow-up|4|||
131662941|NCT03037931|474051160|FG000|Overall Study|Withdrawal by Subject|48|||
131662942|NCT03037931|474051161|FG001|Overall Study|Withdrawal by Subject|41|||
131662943|NCT00605215|474051164|FG000|Overall Study|Death|0|||
131662944|NCT00605215|474051165|FG001|Overall Study|Death|0|||
131662945|NCT00605215|474051166|FG002|Overall Study|Death|1|||
131662946|NCT00605215|474051164|FG000|Overall Study|Adverse Event|19|||
131662947|NCT00605215|474051165|FG001|Overall Study|Adverse Event|21|||
131662948|NCT00605215|474051166|FG002|Overall Study|Adverse Event|26|||
131662949|NCT00605215|474051164|FG000|Overall Study|Refusal to sign the re-consent form|8|||
131662950|NCT00605215|474051165|FG001|Overall Study|Refusal to sign the re-consent form|3|||
131662951|NCT00605215|474051166|FG002|Overall Study|Refusal to sign the re-consent form|3|||
131662952|NCT00605215|474051164|FG000|Overall Study|Withdrawal by Subject|39|||
131889534|NCT04521114|474879103|FG001|Overall Study|Adverse Event|0|||
131662953|NCT00605215|474051165|FG001|Overall Study|Withdrawal by Subject|37|||
131662954|NCT00605215|474051166|FG002|Overall Study|Withdrawal by Subject|27|||
131662955|NCT00605215|474051164|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
131662956|NCT00605215|474051165|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
131662957|NCT00605215|474051166|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
131662958|NCT00605215|474051164|FG000|Overall Study|Protocol Violation|3|||
131662959|NCT00605215|474051165|FG001|Overall Study|Protocol Violation|4|||
131662960|NCT00605215|474051166|FG002|Overall Study|Protocol Violation|1|||
131662961|NCT00605215|474051164|FG000|Overall Study|Pregnancy|8|||
131662962|NCT00605215|474051165|FG001|Overall Study|Pregnancy|5|||
131662963|NCT00605215|474051166|FG002|Overall Study|Pregnancy|4|||
131662964|NCT00605215|474051164|FG000|Overall Study|Lost to Follow-up|8|||
131662965|NCT00605215|474051165|FG001|Overall Study|Lost to Follow-up|5|||
131662966|NCT00605215|474051166|FG002|Overall Study|Lost to Follow-up|2|||
131662967|NCT00605215|474051164|FG000|Overall Study|Other than specified|0|||
131662968|NCT00605215|474051165|FG001|Overall Study|Other than specified|2|||
131662969|NCT00605215|474051166|FG002|Overall Study|Other than specified|1|||
131662970|NCT02704754|474051170|FG000|Overall Study|Lost to Follow-up|1|||
131662971|NCT02704754|474051171|FG001|Overall Study|Lost to Follow-up|1|||
131662972|NCT02704754|474051170|FG000|Overall Study|Lack of Efficacy|1|||
131662973|NCT02704754|474051171|FG001|Overall Study|Lack of Efficacy|0|||
131662974|NCT02704754|474051170|FG000|Overall Study|Withdrawal by Subject|1|||
131662975|NCT02704754|474051171|FG001|Overall Study|Withdrawal by Subject|0|||
131662976|NCT00657020|474051172|FG000|PERIOD 1|Adverse Event|0|||
131662977|NCT00657020|474051173|FG001|PERIOD 1|Adverse Event|1|||
131662978|NCT00774930|474051177|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
131662979|NCT00774930|474051178|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
131662980|NCT00774930|474051177|FG000|DB Phase|Adverse Event|1|||
131662981|NCT00774930|474051178|FG001|DB Phase|Adverse Event|2|||
131662982|NCT00774930|474051177|FG000|DB Phase|Subject Decision|1|||
131662983|NCT00774930|474051178|FG001|DB Phase|Subject Decision|5|||
131662984|NCT00774930|474051177|FG000|DB Phase|Sponsor Decision|0|||
131662985|NCT00774930|474051178|FG001|DB Phase|Sponsor Decision|1|||
131662986|NCT00774930|474051177|FG000|DB Phase|Disease Progression|1|||
131662987|NCT00774930|474051178|FG001|DB Phase|Disease Progression|1|||
131662988|NCT00774930|474051177|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
131662989|NCT00774930|474051178|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
131662990|NCT00774930|474051177|FG000|IOL Phase|Adverse Event|1|||
131662991|NCT00774930|474051178|FG001|IOL Phase|Adverse Event|1|||
131662992|NCT00774930|474051177|FG000|IOL Phase|Subject Decision|4|||
131662993|NCT00774930|474051178|FG001|IOL Phase|Subject Decision|3|||
131662994|NCT00774930|474051177|FG000|IOL Phase|Physician Decision|3|||
131662995|NCT00774930|474051178|FG001|IOL Phase|Physician Decision|2|||
131662996|NCT00774930|474051177|FG000|IOL Phase|Sponsor Decision|1|||
131662997|NCT00774930|474051178|FG001|IOL Phase|Sponsor Decision|0|||
131662998|NCT00774930|474051177|FG000|IOL Phase|Disease Progression|2|||
131662999|NCT00774930|474051178|FG001|IOL Phase|Disease Progression|1|||
131663000|NCT00774930|474051177|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
131663001|NCT00774930|474051178|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
131663002|NCT00774930|474051177|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
131663003|NCT00774930|474051178|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
131663004|NCT00774930|474051177|FG000|IOL Phase|Other|1|||
131663005|NCT00774930|474051178|FG001|IOL Phase|Other|0|||
131663006|NCT00774930|474051177|FG000|IOL Phase|Brain radiation|0|||
131663007|NCT00774930|474051178|FG001|IOL Phase|Brain radiation|1|||
131663008|NCT00774930|474051177|FG000|LTOLE Phase|Adverse Event|7|||
131663009|NCT00774930|474051178|FG001|LTOLE Phase|Adverse Event|3|||
131663010|NCT00774930|474051177|FG000|LTOLE Phase|Subject decision|0|||
131663011|NCT00774930|474051178|FG001|LTOLE Phase|Subject decision|5|||
131663012|NCT00774930|474051177|FG000|LTOLE Phase|Physician Decision|4|||
131663013|NCT00774930|474051178|FG001|LTOLE Phase|Physician Decision|1|||
131663014|NCT00774930|474051177|FG000|LTOLE Phase|Sponsor decision|2|||
131663015|NCT00774930|474051178|FG001|LTOLE Phase|Sponsor decision|1|||
131663016|NCT00774930|474051177|FG000|LTOLE Phase|Disease Progression|2|||
131663017|NCT00774930|474051178|FG001|LTOLE Phase|Disease Progression|5|||
131663018|NCT00774930|474051177|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
131663019|NCT00774930|474051178|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
131663020|NCT00774930|474051177|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
131663021|NCT00774930|474051178|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
131663022|NCT00766363|474051179|FG000|Overall Study|Withdrawal by Subject|1|||
131663023|NCT00766363|474051180|FG001|Overall Study|Withdrawal by Subject|0|||
131663024|NCT00766363|474051181|FG002|Overall Study|Withdrawal by Subject|0|||
131889535|NCT04521114|474879104|FG002|Overall Study|Adverse Event|0|||
131889536|NCT04521114|474879102|FG000|Overall Study|Sponsor Wish|1|||
131889537|NCT04521114|474879103|FG001|Overall Study|Sponsor Wish|0|||
131663025|NCT00766363|474051182|FG003|Overall Study|Withdrawal by Subject|0|||
131663026|NCT00766363|474051179|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
131663027|NCT00766363|474051180|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
131663028|NCT00766363|474051181|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
131663029|NCT00766363|474051182|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
131663030|NCT01153321|474051187|FG000|Overall Study|Development of study withdrawal criteria|0|||
131663031|NCT01153321|474051188|FG001|Overall Study|Development of study withdrawal criteria|1|||
131663032|NCT01153321|474051187|FG000|Overall Study|Withdrawal by Subject|0|||
131663033|NCT01153321|474051188|FG001|Overall Study|Withdrawal by Subject|1|||
131663034|NCT01153321|474051187|FG000|Overall Study|Adverse Event|1|||
131663035|NCT01153321|474051188|FG001|Overall Study|Adverse Event|1|||
131663036|NCT03020576|474051189|FG000|Overall Study|Withdrawal by Subject|1|||
131663037|NCT03020576|474051190|FG001|Overall Study|Withdrawal by Subject|2|||
131663038|NCT01177800|474051192|FG000|Overall Study|Adverse Event|9|||
131663039|NCT01177800|474051193|FG001|Overall Study|Adverse Event|3|||
131663040|NCT01177800|474051192|FG000|Overall Study|Protocol Violation|0|||
131663041|NCT01177800|474051193|FG001|Overall Study|Protocol Violation|1|||
131663042|NCT01177800|474051192|FG000|Overall Study|Physician Decision|1|||
131663043|NCT01177800|474051193|FG001|Overall Study|Physician Decision|0|||
131663044|NCT01177800|474051192|FG000|Overall Study|Withdrawal of informed consent|0|||
131663045|NCT01177800|474051193|FG001|Overall Study|Withdrawal of informed consent|1|||
131663046|NCT03527550|474051194|FG000|Overall Study|Lost to Follow-up|4|||
131663047|NCT03527550|474051195|FG001|Overall Study|Lost to Follow-up|2|||
131663048|NCT03527550|474051194|FG000|Overall Study|Withdrawal by Subject|4|||
131663049|NCT03527550|474051195|FG001|Overall Study|Withdrawal by Subject|1|||
131663050|NCT03527550|474051194|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
131663051|NCT03527550|474051195|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
131663052|NCT00911937|474051196|FG000|Overall Study|Death|1|||
131663053|NCT00911937|474051197|FG001|Overall Study|Death|0|||
131663054|NCT00911937|474051196|FG000|Overall Study|Lost to Follow-up|8|||
131663055|NCT00911937|474051197|FG001|Overall Study|Lost to Follow-up|5|||
131663056|NCT00911937|474051196|FG000|Overall Study|Withdrawal by Subject|10|||
131663057|NCT00911937|474051197|FG001|Overall Study|Withdrawal by Subject|7|||
131663058|NCT00911937|474051196|FG000|Overall Study|Withdrawn due to pregnancy|1|||
131663059|NCT00911937|474051197|FG001|Overall Study|Withdrawn due to pregnancy|0|||
131663060|NCT00911937|474051196|FG000|Overall Study|Adverse Event|11|||
131663061|NCT00911937|474051197|FG001|Overall Study|Adverse Event|25|||
131663062|NCT00911937|474051196|FG000|Overall Study|Lack of Efficacy|11|||
131663063|NCT00911937|474051197|FG001|Overall Study|Lack of Efficacy|6|||
131663064|NCT00911937|474051196|FG000|Overall Study|Did not meet inclusion criteria|9|||
131663065|NCT00911937|474051197|FG001|Overall Study|Did not meet inclusion criteria|11|||
131663066|NCT00911937|474051196|FG000|Overall Study|Protocol Violation|14|||
131663067|NCT00911937|474051197|FG001|Overall Study|Protocol Violation|23|||
131663068|NCT00911937|474051196|FG000|Overall Study|Randomized but not treated|13|||
131663069|NCT00911937|474051197|FG001|Overall Study|Randomized but not treated|13|||
131663070|NCT00911937|474051196|FG000|Overall Study|Other|9|||
131663071|NCT00911937|474051197|FG001|Overall Study|Other|5|||
131663072|NCT01498679|474051198|FG000|Overall Study|Adverse Event|1|||
131663073|NCT01498679|474051199|FG001|Overall Study|Adverse Event|4|||
131663074|NCT01498679|474051198|FG000|Overall Study|Lack of Efficacy|72|||
131663075|NCT01498679|474051199|FG001|Overall Study|Lack of Efficacy|12|||
131663076|NCT01498679|474051198|FG000|Overall Study|Protocol Violation|4|||
131663077|NCT01498679|474051199|FG001|Overall Study|Protocol Violation|0|||
131663078|NCT01498679|474051198|FG000|Overall Study|Physician Decision|0|||
131663079|NCT01498679|474051199|FG001|Overall Study|Physician Decision|2|||
131663080|NCT01498679|474051198|FG000|Overall Study|Withdrawal by Subject|12|||
131663081|NCT01498679|474051199|FG001|Overall Study|Withdrawal by Subject|4|||
131663082|NCT01844687|474051204|FG000|Visit 1|Protocol Violation|3|||
131663083|NCT01844687|474051204|FG000|Visit 1|Lost to Follow-up|5|||
131663084|NCT01844687|474051204|FG000|Visit 2|Withdrawal by Subject|1|||
131663085|NCT01844687|474051204|FG000|Visit 2|Protocol Violation|1|||
131663086|NCT01844687|474051204|FG000|Visit 3|Lost to Follow-up|1|||
131663087|NCT01844687|474051204|FG000|Visit 3|Withdrawal by Subject|3|||
131663088|NCT01844687|474051204|FG000|Visit 3|child care problems|1|||
131663089|NCT01844687|474051204|FG000|Visit 4|Pregnancy|1|||
131663090|NCT01844687|474051204|FG000|Visit 4|Lost to Follow-up|1|||
131663091|NCT01844687|474051204|FG000|Visit 4|Withdrawal by Subject|2|||
131663092|NCT03484273|474051211|FG000|Overall Study|Equipment Malfunction|1|||
131663093|NCT03484273|474051211|FG000|Overall Study|Data excluded from analysis|1|||
131663094|NCT02706899|474051214|FG000|Overall Study|Withdrawal by Subject|1|||
131663095|NCT02706899|474051215|FG001|Overall Study|Withdrawal by Subject|0|||
131663096|NCT02706899|474051214|FG000|Overall Study|Death|8|||
131663097|NCT02706899|474051215|FG001|Overall Study|Death|0|||
131663098|NCT02706899|474051214|FG000|Overall Study|Study Termination by Sponsor|4|||
131663099|NCT02706899|474051215|FG001|Overall Study|Study Termination by Sponsor|6|||
131663100|NCT01056718|474051216|FG000|Overall Study|Withdrawal by Subject|2|||
131663101|NCT01056718|474051216|FG000|Overall Study|Ischemia on baseline stress test|1|||
131663102|NCT00287690|474051217|FG000|Overall Study|Protocol Violation|20|||
131663103|NCT00287690|474051218|FG001|Overall Study|Protocol Violation|26|||
131663104|NCT02270515|474051219|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
131663105|NCT02270515|474051219|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
131435881|NCT00920855|473221884|FG000|Overall Study|Response plateau; started maintenance|0|||
131435882|NCT00920855|473221885|FG001|Overall Study|Response plateau; started maintenance|0|||
131663106|NCT02270515|474051219|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
131663107|NCT02270515|474051219|FG000|Intervention Period 1: 0-6 Months|Death|7|||
131663108|NCT02270515|474051219|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
131663109|NCT02270515|474051219|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
131889538|NCT04521114|474879104|FG002|Overall Study|Sponsor Wish|0|||
131663110|NCT02270515|474051219|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
131663111|NCT02270515|474051219|FG000|Intervention Period 2: 6-12 Months|Death|5|||
131663112|NCT02270515|474051219|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
131663113|NCT02270515|474051219|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
131663114|NCT02270515|474051219|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
131663115|NCT02270515|474051219|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
131663116|NCT02270515|474051219|FG000|Intervention Period 3: 12-18 Months|Death|3|||
131663117|NCT02270515|474051219|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
131663118|NCT01237587|474051222|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
131663119|NCT01237587|474051223|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
131663120|NCT01237587|474051222|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
131663121|NCT01237587|474051223|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
131663122|NCT01237587|474051222|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
131663123|NCT01237587|474051223|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
131663124|NCT01237587|474051222|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
131663125|NCT01237587|474051223|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
131663126|NCT01237587|474051222|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
131663127|NCT01237587|474051223|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
131663128|NCT01237587|474051222|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
131663129|NCT01237587|474051223|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
131663130|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
131663131|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
131663132|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
131663133|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
131663134|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
131663135|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
131889539|NCT04521114|474879102|FG000|Overall Study|Withdrawal of Consent|2|||
131889540|NCT04521114|474879103|FG001|Overall Study|Withdrawal of Consent|2|||
131889541|NCT04521114|474879104|FG002|Overall Study|Withdrawal of Consent|0|||
131889542|NCT01084538|474879111|FG000|Overall Study|Drug not available|30|||
131889543|NCT01084538|474879111|FG000|Overall Study|Adverse Event|9|||
131889544|NCT01084538|474879111|FG000|Overall Study|Kidney transplant|6|||
131889545|NCT01084538|474879111|FG000|Overall Study|Serious Adverse Event|3|||
131889546|NCT01084538|474879111|FG000|Overall Study|Lack of effectiveness|2|||
131889547|NCT01084538|474879111|FG000|Overall Study|Patient noncompliance|2|||
131889548|NCT01084538|474879111|FG000|Overall Study|Hyperphosphatemia|2|||
131889549|NCT01084538|474879111|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
131889550|NCT01084538|474879111|FG000|Overall Study|Change of residence|2|||
131889551|NCT01084538|474879111|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
131435883|NCT00920855|473221886|FG002|Overall Study|Response plateau; started maintenance|1|||
131435884|NCT00510835|473221887|FG000|Overall Study|Withdrawal by Subject|6|||
131435885|NCT00510835|473221888|FG001|Overall Study|Withdrawal by Subject|2|||
131435886|NCT00510835|473221889|FG002|Overall Study|Withdrawal by Subject|2|||
131435887|NCT03084796|473221890|FG000|Overall Study|Adverse Event|4|||
131435888|NCT03084796|473221891|FG001|Overall Study|Adverse Event|5|||
131435889|NCT03084796|473221892|FG002|Overall Study|Adverse Event|6|||
131435890|NCT03084796|473221893|FG003|Overall Study|Adverse Event|2|||
131435891|NCT03084796|473221894|FG004|Overall Study|Adverse Event|3|||
131435892|NCT03084796|473221895|FG005|Overall Study|Adverse Event|5|||
131435893|NCT03084796|473221890|FG000|Overall Study|Withdrawal by Subject|3|||
131435894|NCT03084796|473221891|FG001|Overall Study|Withdrawal by Subject|5|||
131435895|NCT03084796|473221892|FG002|Overall Study|Withdrawal by Subject|2|||
131435896|NCT03084796|473221893|FG003|Overall Study|Withdrawal by Subject|1|||
131435897|NCT03084796|473221894|FG004|Overall Study|Withdrawal by Subject|3|||
131435898|NCT03084796|473221895|FG005|Overall Study|Withdrawal by Subject|0|||
131435899|NCT03084796|473221890|FG000|Overall Study|Protocol Violation|0|||
131435900|NCT03084796|473221891|FG001|Overall Study|Protocol Violation|0|||
131435901|NCT03084796|473221892|FG002|Overall Study|Protocol Violation|1|||
131435902|NCT03084796|473221893|FG003|Overall Study|Protocol Violation|0|||
131435903|NCT03084796|473221894|FG004|Overall Study|Protocol Violation|1|||
131435904|NCT03084796|473221895|FG005|Overall Study|Protocol Violation|1|||
131435905|NCT03084796|473221890|FG000|Overall Study|Lack of Efficacy|0|||
131435906|NCT03084796|473221891|FG001|Overall Study|Lack of Efficacy|0|||
131435907|NCT03084796|473221892|FG002|Overall Study|Lack of Efficacy|1|||
131435908|NCT03084796|473221893|FG003|Overall Study|Lack of Efficacy|0|||
131435909|NCT03084796|473221894|FG004|Overall Study|Lack of Efficacy|1|||
131435910|NCT03084796|473221895|FG005|Overall Study|Lack of Efficacy|0|||
131435911|NCT03084796|473221890|FG000|Overall Study|Lost to Follow-up|0|||
131435912|NCT03084796|473221891|FG001|Overall Study|Lost to Follow-up|0|||
131889552|NCT01084538|474879111|FG000|Overall Study|Reason unknown|8|||
131889553|NCT02083653|474879116|FG000|Overall Study|Randomized but not Treated|0|||
131889554|NCT02083653|474879117|FG001|Overall Study|Randomized but not Treated|2|||
131663136|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
131663137|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
131663138|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
131663139|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
131663140|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
131663141|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
131663142|NCT01237587|474051222|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
131663143|NCT01237587|474051223|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
131663144|NCT01237587|474051222|FG000|Taper Phase|Adverse Event|0|||
131663145|NCT01237587|474051223|FG001|Taper Phase|Adverse Event|2|||
131663146|NCT01237587|474051222|FG000|Taper Phase|Protocol Violation|2|||
131663147|NCT01237587|474051223|FG001|Taper Phase|Protocol Violation|0|||
131663148|NCT01237587|474051222|FG000|Taper Phase|Lack of Efficacy|2|||
131663149|NCT01237587|474051223|FG001|Taper Phase|Lack of Efficacy|5|||
131663150|NCT01237587|474051222|FG000|Taper Phase|Parent/Guardian Decision|0|||
131663151|NCT01237587|474051223|FG001|Taper Phase|Parent/Guardian Decision|2|||
131663152|NCT01237587|474051222|FG000|Taper Phase|Sponsor Decision|1|||
131663153|NCT01237587|474051223|FG001|Taper Phase|Sponsor Decision|0|||
131663154|NCT01237587|474051222|FG000|Taper Phase|Withdrawal by Subject|0|||
131663155|NCT01237587|474051223|FG001|Taper Phase|Withdrawal by Subject|1|||
131663156|NCT05017103|474051224|FG000|Overall Study|Death|2|||
131663157|NCT01747551|474051229|FG000|Overall Study|Progressive Disease|24|||
131663158|NCT01747551|474051230|FG001|Overall Study|Progressive Disease|17|||
131663159|NCT01747551|474051229|FG000|Overall Study|Death|3|||
131663160|NCT01747551|474051230|FG001|Overall Study|Death|1|||
131663161|NCT01747551|474051229|FG000|Overall Study|Adverse Event|7|||
131663162|NCT01747551|474051230|FG001|Overall Study|Adverse Event|1|||
131663163|NCT01747551|474051229|FG000|Overall Study|Prolonged Treatment Delay|2|||
131663164|NCT01747551|474051230|FG001|Overall Study|Prolonged Treatment Delay|0|||
131663165|NCT01747551|474051229|FG000|Overall Study|Withdrawal by Subject|3|||
131663166|NCT01747551|474051230|FG001|Overall Study|Withdrawal by Subject|1|||
131663167|NCT01747551|474051229|FG000|Overall Study|Physician Decision|2|||
131663168|NCT01747551|474051230|FG001|Overall Study|Physician Decision|1|||
131663169|NCT01747551|474051229|FG000|Overall Study|Other|2|||
131663170|NCT01747551|474051230|FG001|Overall Study|Other|0|||
131663171|NCT01142115|474051231|FG000|First Intervention|Lack of Efficacy|1|||
131663172|NCT01142115|474051232|FG001|First Intervention|Lack of Efficacy|1|||
131663173|NCT01142115|474051231|FG000|First Intervention|Adverse Event|1|||
131663174|NCT01142115|474051232|FG001|First Intervention|Adverse Event|0|||
131663175|NCT00633880|474051233|FG000|Open Label Titration|Lack of Efficacy|1|||
131663176|NCT00633880|474051234|FG001|Open Label Titration|Lack of Efficacy|0|||
131663177|NCT00633880|474051235|FG002|Open Label Titration|Lack of Efficacy|0|||
131663178|NCT00633880|474051233|FG000|Open Label Titration|Adverse Event|13|||
131663179|NCT00633880|474051234|FG001|Open Label Titration|Adverse Event|0|||
131663180|NCT00633880|474051235|FG002|Open Label Titration|Adverse Event|0|||
131663181|NCT00633880|474051233|FG000|Open Label Titration|Treatment Failure|55|||
131663182|NCT00633880|474051234|FG001|Open Label Titration|Treatment Failure|0|||
131663183|NCT00633880|474051235|FG002|Open Label Titration|Treatment Failure|0|||
131663184|NCT00633880|474051233|FG000|Open Label Titration|Protocol Violation|6|||
131663185|NCT00633880|474051234|FG001|Open Label Titration|Protocol Violation|0|||
131663186|NCT00633880|474051235|FG002|Open Label Titration|Protocol Violation|0|||
131663187|NCT00633880|474051233|FG000|Open Label Titration|Physician Decision|1|||
131663188|NCT00633880|474051234|FG001|Open Label Titration|Physician Decision|0|||
131663189|NCT00633880|474051235|FG002|Open Label Titration|Physician Decision|0|||
131663190|NCT00633880|474051233|FG000|Open Label Titration|Withdrawal by Subject|4|||
131663191|NCT00633880|474051234|FG001|Open Label Titration|Withdrawal by Subject|0|||
131663192|NCT00633880|474051235|FG002|Open Label Titration|Withdrawal by Subject|0|||
131663193|NCT03208036|474051236|FG000|Baseline Assessment|Withdrawal by Subject|1|||
131663194|NCT03208036|474051237|FG001|Baseline Assessment|Withdrawal by Subject|1|||
131663195|NCT03208036|474051236|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
131889555|NCT02083653|474879118|FG002|Overall Study|Randomized but not Treated|7|||
131889556|NCT02083653|474879116|FG000|Overall Study|Adverse Event|12|||
131889557|NCT02083653|474879117|FG001|Overall Study|Adverse Event|5|||
131889558|NCT02083653|474879118|FG002|Overall Study|Adverse Event|4|||
131889559|NCT02083653|474879116|FG000|Overall Study|Lost to Follow-up|1|||
131889560|NCT02083653|474879117|FG001|Overall Study|Lost to Follow-up|0|||
131435913|NCT03084796|473221892|FG002|Overall Study|Lost to Follow-up|1|||
131663196|NCT03208036|474051237|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
131663197|NCT03208036|474051236|FG000|Intervention|Withdrawal by Subject|3|||
131663198|NCT03208036|474051237|FG001|Intervention|Withdrawal by Subject|2|||
131663199|NCT03208036|474051236|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
131663200|NCT03208036|474051237|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
131663201|NCT03406078|474051238|FG000|Overall Study|Death|1|||
131663202|NCT03406078|474051239|FG001|Overall Study|Death|0|||
131435914|NCT03084796|473221893|FG003|Overall Study|Lost to Follow-up|1|||
131663203|NCT03406078|474051238|FG000|Overall Study|Lost to Follow-up|0|||
131663204|NCT03406078|474051239|FG001|Overall Study|Lost to Follow-up|1|||
131663205|NCT03406078|474051238|FG000|Overall Study|Withdrawal by Subject|5|||
131663206|NCT03406078|474051239|FG001|Overall Study|Withdrawal by Subject|2|||
131663207|NCT02091206|474051240|FG000|Treatment Period|Adverse Event|0|||
131663208|NCT02091206|474051241|FG001|Treatment Period|Adverse Event|1|||
131663209|NCT02091206|474051242|FG002|Treatment Period|Adverse Event|0|||
131663210|NCT02091206|474051243|FG003|Treatment Period|Adverse Event|0|||
131663211|NCT02091206|474051240|FG000|Treatment Period|Met withdrawal criteria|0|||
131663212|NCT02091206|474051241|FG001|Treatment Period|Met withdrawal criteria|0|||
131663213|NCT02091206|474051242|FG002|Treatment Period|Met withdrawal criteria|1|||
131663214|NCT02091206|474051243|FG003|Treatment Period|Met withdrawal criteria|0|||
131663215|NCT02091206|474051240|FG000|Taper Period|Participant refused study drug|1|||
131663216|NCT02091206|474051241|FG001|Taper Period|Participant refused study drug|0|||
131663217|NCT02091206|474051242|FG002|Taper Period|Participant refused study drug|0|||
131663218|NCT02091206|474051243|FG003|Taper Period|Participant refused study drug|1|||
131663219|NCT02091206|474051240|FG000|Taper Period|Lost to Follow-up|0|||
131663220|NCT02091206|474051241|FG001|Taper Period|Lost to Follow-up|0|||
131663221|NCT02091206|474051242|FG002|Taper Period|Lost to Follow-up|0|||
131663222|NCT02091206|474051243|FG003|Taper Period|Lost to Follow-up|1|||
131663223|NCT00700778|474051244|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
131663224|NCT00350103|474051248|FG000|Overall Study|Adverse Event|12|||
131552985|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552986|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552987|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552988|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552989|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552990|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552991|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
131552992|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
131552993|NCT02508532|473649773|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
131552994|NCT02508532|473649774|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
131552995|NCT02508532|473649775|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
131552996|NCT02508532|473649776|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
131552997|NCT02508532|473649777|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
131552998|NCT02508532|473649778|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
131552999|NCT02508532|473649779|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
131553000|NCT02508532|473649780|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
131553001|NCT02508532|473649781|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
131553002|NCT03097861|473649784|FG000|Overall Study|Adverse Event|3|||
131553003|NCT03097861|473649785|FG001|Overall Study|Adverse Event|8|||
131553004|NCT03097861|473649786|FG002|Overall Study|Adverse Event|4|||
131553005|NCT03097861|473649784|FG000|Overall Study|Investigator Decision|0|||
131553006|NCT03097861|473649785|FG001|Overall Study|Investigator Decision|1|||
131553007|NCT03097861|473649786|FG002|Overall Study|Investigator Decision|0|||
131553008|NCT03097861|473649784|FG000|Overall Study|Lost to Follow-up|0|||
131553009|NCT03097861|473649785|FG001|Overall Study|Lost to Follow-up|7|||
131553010|NCT03097861|473649786|FG002|Overall Study|Lost to Follow-up|1|||
131663225|NCT00350103|474051249|FG001|Overall Study|Adverse Event|29|||
131663226|NCT00350103|474051250|FG002|Overall Study|Adverse Event|17|||
131663227|NCT00350103|474051248|FG000|Overall Study|Lack of Efficacy|5|||
131772281|NCT01238861|474445024|FG005|Overall Study|Unable to continue visits|1|||
131772282|NCT01238861|474445019|FG000|Overall Study|Serious adverse event|0|||
131772283|NCT01238861|474445020|FG001|Overall Study|Serious adverse event|0|||
131772284|NCT01238861|474445021|FG002|Overall Study|Serious adverse event|0|||
131772285|NCT01238861|474445022|FG003|Overall Study|Serious adverse event|0|||
131772286|NCT01238861|474445023|FG004|Overall Study|Serious adverse event|0|||
131772287|NCT01238861|474445024|FG005|Overall Study|Serious adverse event|1|||
131772288|NCT01238861|474445019|FG000|Overall Study|Lack of compliance|0|||
131772289|NCT01238861|474445020|FG001|Overall Study|Lack of compliance|0|||
131772290|NCT01238861|474445021|FG002|Overall Study|Lack of compliance|0|||
131772291|NCT01238861|474445022|FG003|Overall Study|Lack of compliance|0|||
131772292|NCT01238861|474445023|FG004|Overall Study|Lack of compliance|0|||
131772293|NCT01238861|474445024|FG005|Overall Study|Lack of compliance|1|||
131772294|NCT01238861|474445019|FG000|Overall Study|Adverse Event|0|||
131772295|NCT01238861|474445020|FG001|Overall Study|Adverse Event|1|||
131772296|NCT01238861|474445021|FG002|Overall Study|Adverse Event|0|||
131772297|NCT01238861|474445022|FG003|Overall Study|Adverse Event|0|||
131772298|NCT01238861|474445023|FG004|Overall Study|Adverse Event|0|||
131772299|NCT01238861|474445024|FG005|Overall Study|Adverse Event|0|||
131772300|NCT01238861|474445019|FG000|Overall Study|Withdrawal by Subject|6|||
131553011|NCT03097861|473649784|FG000|Overall Study|Withdrawal by Subject|1|||
131663228|NCT00350103|474051249|FG001|Overall Study|Lack of Efficacy|1|||
131663229|NCT00350103|474051250|FG002|Overall Study|Lack of Efficacy|3|||
131772301|NCT01238861|474445020|FG001|Overall Study|Withdrawal by Subject|5|||
131663230|NCT00350103|474051248|FG000|Overall Study|Withdrawal by Subject|6|||
131663231|NCT00350103|474051249|FG001|Overall Study|Withdrawal by Subject|6|||
131663232|NCT00350103|474051250|FG002|Overall Study|Withdrawal by Subject|8|||
131663233|NCT00350103|474051248|FG000|Overall Study|Protocol Violation|0|||
131663234|NCT00350103|474051249|FG001|Overall Study|Protocol Violation|0|||
131663235|NCT00350103|474051250|FG002|Overall Study|Protocol Violation|1|||
131663236|NCT00350103|474051248|FG000|Overall Study|Unsatisfactory Compliance|2|||
131663237|NCT00350103|474051249|FG001|Overall Study|Unsatisfactory Compliance|2|||
131663238|NCT00350103|474051250|FG002|Overall Study|Unsatisfactory Compliance|1|||
131663239|NCT00350103|474051248|FG000|Overall Study|Investigator´s decision|1|||
131663240|NCT00350103|474051249|FG001|Overall Study|Investigator´s decision|1|||
131889561|NCT02083653|474879118|FG002|Overall Study|Lost to Follow-up|0|||
131889562|NCT02083653|474879116|FG000|Overall Study|Death|2|||
131889563|NCT02083653|474879117|FG001|Overall Study|Death|2|||
131889564|NCT02083653|474879118|FG002|Overall Study|Death|2|||
131889565|NCT02083653|474879116|FG000|Overall Study|Progressive Disease|65|||
131889566|NCT02083653|474879117|FG001|Overall Study|Progressive Disease|73|||
131889567|NCT02083653|474879118|FG002|Overall Study|Progressive Disease|63|||
131889568|NCT02083653|474879116|FG000|Overall Study|Withdrawal by Subject|2|||
131889569|NCT02083653|474879117|FG001|Overall Study|Withdrawal by Subject|1|||
131889570|NCT02083653|474879118|FG002|Overall Study|Withdrawal by Subject|2|||
131889571|NCT02083653|474879116|FG000|Overall Study|Other Events|0|||
131889572|NCT02083653|474879117|FG001|Overall Study|Other Events|2|||
131889573|NCT02083653|474879118|FG002|Overall Study|Other Events|2|||
131889574|NCT02083653|474879116|FG000|Overall Study|Reason Missing|0|||
131889575|NCT02083653|474879117|FG001|Overall Study|Reason Missing|0|||
131889576|NCT02083653|474879118|FG002|Overall Study|Reason Missing|4|||
131889577|NCT01625689|474879119|FG000|Overall Study|Migration|2|||
131889578|NCT01625689|474879120|FG001|Overall Study|Migration|1|||
131889579|NCT00106639|474879121|FG000|Overall Study|Adverse Event|3|||
131889580|NCT00106639|474879122|FG001|Overall Study|Adverse Event|4|||
131889581|NCT00106639|474879123|FG002|Overall Study|Adverse Event|1|||
131889582|NCT00106639|474879121|FG000|Overall Study|Protocol Violation|0|||
131889583|NCT00106639|474879122|FG001|Overall Study|Protocol Violation|1|||
131889584|NCT00106639|474879123|FG002|Overall Study|Protocol Violation|0|||
131889585|NCT00106639|474879121|FG000|Overall Study|Withdrawal by Subject|0|||
131889586|NCT00106639|474879122|FG001|Overall Study|Withdrawal by Subject|1|||
131889587|NCT00106639|474879123|FG002|Overall Study|Withdrawal by Subject|0|||
131889588|NCT00106639|474879121|FG000|Overall Study|Participant defaulted|0|||
131889589|NCT00106639|474879122|FG001|Overall Study|Participant defaulted|1|||
131889590|NCT00106639|474879123|FG002|Overall Study|Participant defaulted|1|||
131889591|NCT01810783|474879124|FG000|Overall Study|Adverse Event|32|||
131889592|NCT01810783|474879124|FG000|Overall Study|Withdrawal by Subject|22|||
131889593|NCT01810783|474879124|FG000|Overall Study|Lack of Efficacy|12|||
131889594|NCT01810783|474879124|FG000|Overall Study|Lost to Follow-up|10|||
131889595|NCT01810783|474879124|FG000|Overall Study|Protocol Violation|5|||
131889596|NCT01810783|474879124|FG000|Overall Study|Non-compliance with IMP|4|||
131889597|NCT01810783|474879124|FG000|Overall Study|Adminstrative or other reason(s)|23|||
131889598|NCT01810783|474879124|FG000|Overall Study|Enrolled, not treated|1|||
131889599|NCT02134353|474879127|FG000|Overall Study|Adverse Event|10|||
131889600|NCT02134353|474879128|FG001|Overall Study|Adverse Event|6|||
131889601|NCT02134353|474879127|FG000|Overall Study|Lost to Follow-up|1|||
131889602|NCT02134353|474879128|FG001|Overall Study|Lost to Follow-up|1|||
131889603|NCT02134353|474879127|FG000|Overall Study|Lack of Efficacy|2|||
131889604|NCT02134353|474879128|FG001|Overall Study|Lack of Efficacy|1|||
131889605|NCT02134353|474879127|FG000|Overall Study|Withdrawal by Subject|12|||
131889606|NCT02134353|474879128|FG001|Overall Study|Withdrawal by Subject|13|||
131889607|NCT02134353|474879127|FG000|Overall Study|Death|0|||
131889608|NCT02134353|474879128|FG001|Overall Study|Death|1|||
131889609|NCT02134353|474879127|FG000|Overall Study|Pregnancy|0|||
131889610|NCT02134353|474879128|FG001|Overall Study|Pregnancy|1|||
131889611|NCT02134353|474879127|FG000|Overall Study|Relocation|1|||
131889612|NCT02134353|474879128|FG001|Overall Study|Relocation|0|||
131663241|NCT00350103|474051250|FG002|Overall Study|Investigator´s decision|0|||
131663242|NCT00350103|474051248|FG000|Overall Study|Exclusion criteria met|0|||
131663243|NCT00350103|474051249|FG001|Overall Study|Exclusion criteria met|0|||
131889613|NCT02134353|474879127|FG000|Overall Study|Other - Patient's Choice|0|||
131889614|NCT02134353|474879128|FG001|Overall Study|Other - Patient's Choice|1|||
131889615|NCT00477607|474879129|FG000|Overall Study|Lost to Follow-up|7|||
131889616|NCT00477607|474879130|FG001|Overall Study|Lost to Follow-up|7|||
131889617|NCT00358956|474879131|FG000|Overall Study|Adverse Event|3|||
131889618|NCT00358956|474879131|FG000|Overall Study|condition under investigation worsened|4|||
131889619|NCT00358956|474879131|FG000|Overall Study|Withdrawal by Subject|1|||
131889620|NCT04776018|474879133|FG000|Overall Study|Death|0|||
131889621|NCT04776018|474879134|FG001|Overall Study|Death|1|||
131889622|NCT04776018|474879135|FG002|Overall Study|Death|4|||
131889623|NCT04776018|474879136|FG003|Overall Study|Death|1|||
131889624|NCT04776018|474879137|FG004|Overall Study|Death|4|||
131663244|NCT00350103|474051250|FG002|Overall Study|Exclusion criteria met|1|||
131663245|NCT00350103|474051248|FG000|Overall Study|Patient relocated|0|||
131889625|NCT04776018|474879138|FG005|Overall Study|Death|0|||
131889626|NCT04776018|474879139|FG006|Overall Study|Death|0|||
131889627|NCT04776018|474879133|FG000|Overall Study|Study terminated by sponsor|2|||
131889628|NCT04776018|474879134|FG001|Overall Study|Study terminated by sponsor|1|||
131889629|NCT04776018|474879135|FG002|Overall Study|Study terminated by sponsor|4|||
131889630|NCT04776018|474879136|FG003|Overall Study|Study terminated by sponsor|0|||
131889631|NCT04776018|474879137|FG004|Overall Study|Study terminated by sponsor|3|||
131889632|NCT04776018|474879138|FG005|Overall Study|Study terminated by sponsor|0|||
131663246|NCT00350103|474051249|FG001|Overall Study|Patient relocated|0|||
131663247|NCT00350103|474051250|FG002|Overall Study|Patient relocated|1|||
131663248|NCT00350103|474051248|FG000|Overall Study|Need for prohibited medication|1|||
131663249|NCT00350103|474051249|FG001|Overall Study|Need for prohibited medication|0|||
131663250|NCT00350103|474051250|FG002|Overall Study|Need for prohibited medication|0|||
131663251|NCT00350103|474051248|FG000|Overall Study|Personal reasons|0|||
131663252|NCT00350103|474051249|FG001|Overall Study|Personal reasons|0|||
131663253|NCT00350103|474051250|FG002|Overall Study|Personal reasons|1|||
131663254|NCT00350103|474051248|FG000|Overall Study|Patient stopped feeling pain|1|||
131663255|NCT00350103|474051249|FG001|Overall Study|Patient stopped feeling pain|0|||
131663256|NCT00350103|474051250|FG002|Overall Study|Patient stopped feeling pain|0|||
131663257|NCT00350103|474051248|FG000|Overall Study|PR greater than 250ms|0|||
131663258|NCT00350103|474051249|FG001|Overall Study|PR greater than 250ms|0|||
131663259|NCT00350103|474051250|FG002|Overall Study|PR greater than 250ms|1|||
131663260|NCT00350103|474051248|FG000|Overall Study|Wrong calculation of QT interval|0|||
131663261|NCT00350103|474051249|FG001|Overall Study|Wrong calculation of QT interval|0|||
131663262|NCT00350103|474051250|FG002|Overall Study|Wrong calculation of QT interval|1|||
131663263|NCT00350103|474051248|FG000|Overall Study|Sponsor mistake|1|||
131663264|NCT00350103|474051249|FG001|Overall Study|Sponsor mistake|0|||
131663265|NCT00350103|474051250|FG002|Overall Study|Sponsor mistake|0|||
131663266|NCT00350103|474051248|FG000|Overall Study|Randomization mistake|0|||
131663267|NCT00350103|474051249|FG001|Overall Study|Randomization mistake|1|||
131663268|NCT00350103|474051250|FG002|Overall Study|Randomization mistake|1|||
131663269|NCT00350103|474051248|FG000|Overall Study|Sponsor´s decision|0|||
131663270|NCT00350103|474051249|FG001|Overall Study|Sponsor´s decision|1|||
131663271|NCT00350103|474051250|FG002|Overall Study|Sponsor´s decision|0|||
131663272|NCT00350103|474051248|FG000|Overall Study|Lost, Reason unknown|1|||
131663273|NCT00350103|474051249|FG001|Overall Study|Lost, Reason unknown|1|||
131663274|NCT00350103|474051250|FG002|Overall Study|Lost, Reason unknown|0|||
131663275|NCT01879553|474051251|FG000|Overall Study|Withdrawal by Subject|1|||
131663276|NCT01879553|474051252|FG001|Overall Study|Withdrawal by Subject|0|||
131663277|NCT02712905|474051253|FG000|Monotherapy|Death|2|||
131663278|NCT02712905|474051254|FG001|Monotherapy|Death|5|||
131663279|NCT02712905|474051255|FG002|Monotherapy|Death|0|||
131663280|NCT02712905|474051256|FG003|Monotherapy|Death|3|||
131663281|NCT02712905|474051257|FG004|Monotherapy|Death|15|||
131663282|NCT02712905|474051258|FG005|Monotherapy|Death|1|||
131663283|NCT02712905|474051259|FG006|Monotherapy|Death|3|||
131663284|NCT02712905|474051260|FG007|Monotherapy|Death|3|||
131663285|NCT02712905|474051261|FG008|Monotherapy|Death|0|||
131663286|NCT02712905|474051262|FG009|Monotherapy|Death|27|||
131663287|NCT02712905|474051263|FG010|Monotherapy|Death|2|||
131663288|NCT02712905|474051264|FG011|Monotherapy|Death|5|||
131663289|NCT02712905|474051265|FG012|Monotherapy|Death|0|||
131663290|NCT02712905|474051266|FG013|Monotherapy|Death|0|||
131663291|NCT02712905|474051267|FG014|Monotherapy|Death|0|||
131663292|NCT02712905|474051268|FG015|Monotherapy|Death|0|||
131663293|NCT02712905|474051269|FG016|Monotherapy|Death|0|||
131663294|NCT02712905|474051270|FG017|Monotherapy|Death|0|||
131663295|NCT02712905|474051253|FG000|Monotherapy|Lost to Follow-up|0|||
131663296|NCT02712905|474051254|FG001|Monotherapy|Lost to Follow-up|1|||
131663297|NCT02712905|474051255|FG002|Monotherapy|Lost to Follow-up|0|||
131663298|NCT02712905|474051256|FG003|Monotherapy|Lost to Follow-up|1|||
131663299|NCT02712905|474051257|FG004|Monotherapy|Lost to Follow-up|0|||
131663300|NCT02712905|474051258|FG005|Monotherapy|Lost to Follow-up|0|||
131663301|NCT02712905|474051259|FG006|Monotherapy|Lost to Follow-up|0|||
131663302|NCT02712905|474051260|FG007|Monotherapy|Lost to Follow-up|0|||
131435915|NCT03084796|473221894|FG004|Overall Study|Lost to Follow-up|3|||
131663303|NCT02712905|474051261|FG008|Monotherapy|Lost to Follow-up|0|||
131663304|NCT02712905|474051262|FG009|Monotherapy|Lost to Follow-up|2|||
131663305|NCT02712905|474051263|FG010|Monotherapy|Lost to Follow-up|0|||
131663306|NCT02712905|474051264|FG011|Monotherapy|Lost to Follow-up|0|||
131663307|NCT02712905|474051265|FG012|Monotherapy|Lost to Follow-up|0|||
131663308|NCT02712905|474051266|FG013|Monotherapy|Lost to Follow-up|0|||
131663309|NCT02712905|474051267|FG014|Monotherapy|Lost to Follow-up|0|||
131663310|NCT02712905|474051268|FG015|Monotherapy|Lost to Follow-up|0|||
131663311|NCT02712905|474051269|FG016|Monotherapy|Lost to Follow-up|0|||
131663312|NCT02712905|474051270|FG017|Monotherapy|Lost to Follow-up|0|||
131663313|NCT02712905|474051253|FG000|Monotherapy|Physician Decision|1|||
131663314|NCT02712905|474051254|FG001|Monotherapy|Physician Decision|0|||
131663315|NCT02712905|474051255|FG002|Monotherapy|Physician Decision|0|||
131663316|NCT02712905|474051256|FG003|Monotherapy|Physician Decision|1|||
131889633|NCT04776018|474879139|FG006|Overall Study|Study terminated by sponsor|0|||
131663317|NCT02712905|474051257|FG004|Monotherapy|Physician Decision|0|||
131663318|NCT02712905|474051258|FG005|Monotherapy|Physician Decision|0|||
131663319|NCT02712905|474051259|FG006|Monotherapy|Physician Decision|0|||
131663320|NCT02712905|474051260|FG007|Monotherapy|Physician Decision|0|||
131663321|NCT02712905|474051261|FG008|Monotherapy|Physician Decision|0|||
131663322|NCT02712905|474051262|FG009|Monotherapy|Physician Decision|1|||
131663323|NCT02712905|474051263|FG010|Monotherapy|Physician Decision|0|||
131663324|NCT02712905|474051264|FG011|Monotherapy|Physician Decision|0|||
131663325|NCT02712905|474051265|FG012|Monotherapy|Physician Decision|0|||
131663326|NCT02712905|474051266|FG013|Monotherapy|Physician Decision|0|||
131663327|NCT02712905|474051267|FG014|Monotherapy|Physician Decision|0|||
131663328|NCT02712905|474051268|FG015|Monotherapy|Physician Decision|0|||
131663329|NCT02712905|474051269|FG016|Monotherapy|Physician Decision|0|||
131663330|NCT02712905|474051270|FG017|Monotherapy|Physician Decision|0|||
131663331|NCT02712905|474051253|FG000|Monotherapy|Study Terminated by Sponsor|0|||
131663332|NCT02712905|474051254|FG001|Monotherapy|Study Terminated by Sponsor|0|||
131663333|NCT02712905|474051255|FG002|Monotherapy|Study Terminated by Sponsor|0|||
131663334|NCT02712905|474051256|FG003|Monotherapy|Study Terminated by Sponsor|0|||
131663335|NCT02712905|474051257|FG004|Monotherapy|Study Terminated by Sponsor|1|||
131663336|NCT02712905|474051258|FG005|Monotherapy|Study Terminated by Sponsor|0|||
131663337|NCT02712905|474051259|FG006|Monotherapy|Study Terminated by Sponsor|0|||
131663338|NCT02712905|474051260|FG007|Monotherapy|Study Terminated by Sponsor|0|||
131663339|NCT02712905|474051261|FG008|Monotherapy|Study Terminated by Sponsor|0|||
131663340|NCT02712905|474051262|FG009|Monotherapy|Study Terminated by Sponsor|2|||
131663341|NCT02712905|474051263|FG010|Monotherapy|Study Terminated by Sponsor|0|||
131663342|NCT02712905|474051264|FG011|Monotherapy|Study Terminated by Sponsor|0|||
131663343|NCT02712905|474051265|FG012|Monotherapy|Study Terminated by Sponsor|0|||
131663344|NCT02712905|474051266|FG013|Monotherapy|Study Terminated by Sponsor|0|||
131663345|NCT02712905|474051267|FG014|Monotherapy|Study Terminated by Sponsor|0|||
131663346|NCT02712905|474051268|FG015|Monotherapy|Study Terminated by Sponsor|0|||
131663347|NCT02712905|474051269|FG016|Monotherapy|Study Terminated by Sponsor|0|||
131663348|NCT02712905|474051270|FG017|Monotherapy|Study Terminated by Sponsor|0|||
131663349|NCT02712905|474051253|FG000|Monotherapy|Withdrawal by Subject|0|||
131663350|NCT02712905|474051254|FG001|Monotherapy|Withdrawal by Subject|0|||
131663351|NCT02712905|474051255|FG002|Monotherapy|Withdrawal by Subject|1|||
131663352|NCT02712905|474051256|FG003|Monotherapy|Withdrawal by Subject|0|||
131663353|NCT02712905|474051257|FG004|Monotherapy|Withdrawal by Subject|2|||
131663354|NCT02712905|474051258|FG005|Monotherapy|Withdrawal by Subject|0|||
131663355|NCT02712905|474051259|FG006|Monotherapy|Withdrawal by Subject|0|||
131663356|NCT02712905|474051260|FG007|Monotherapy|Withdrawal by Subject|0|||
131663357|NCT02712905|474051261|FG008|Monotherapy|Withdrawal by Subject|0|||
131663358|NCT02712905|474051262|FG009|Monotherapy|Withdrawal by Subject|4|||
131663359|NCT02712905|474051263|FG010|Monotherapy|Withdrawal by Subject|1|||
131663360|NCT02712905|474051264|FG011|Monotherapy|Withdrawal by Subject|2|||
131889634|NCT04776018|474879133|FG000|Overall Study|Withdrawal by Subject|1|||
131889635|NCT04776018|474879134|FG001|Overall Study|Withdrawal by Subject|0|||
131889636|NCT04776018|474879135|FG002|Overall Study|Withdrawal by Subject|0|||
131889637|NCT04776018|474879136|FG003|Overall Study|Withdrawal by Subject|2|||
131889638|NCT04776018|474879137|FG004|Overall Study|Withdrawal by Subject|1|||
131889639|NCT04776018|474879138|FG005|Overall Study|Withdrawal by Subject|0|||
131889640|NCT04776018|474879139|FG006|Overall Study|Withdrawal by Subject|0|||
131889641|NCT04776018|474879133|FG000|Overall Study|Other|0|||
131889642|NCT04776018|474879134|FG001|Overall Study|Other|1|||
131889643|NCT04776018|474879135|FG002|Overall Study|Other|1|||
131889644|NCT04776018|474879136|FG003|Overall Study|Other|0|||
131889645|NCT04776018|474879137|FG004|Overall Study|Other|0|||
131889646|NCT04776018|474879138|FG005|Overall Study|Other|0|||
131889647|NCT04776018|474879139|FG006|Overall Study|Other|0|||
131663361|NCT02712905|474051265|FG012|Monotherapy|Withdrawal by Subject|0|||
131663362|NCT02712905|474051266|FG013|Monotherapy|Withdrawal by Subject|0|||
131663363|NCT02712905|474051267|FG014|Monotherapy|Withdrawal by Subject|0|||
131663364|NCT02712905|474051268|FG015|Monotherapy|Withdrawal by Subject|0|||
131889648|NCT04776018|474879133|FG000|Overall Study|Lost to Follow-up|0|||
131663365|NCT02712905|474051269|FG016|Monotherapy|Withdrawal by Subject|0|||
131663366|NCT02712905|474051270|FG017|Monotherapy|Withdrawal by Subject|0|||
131663367|NCT02712905|474051253|FG000|Monotherapy|Started New Cancer Drug|0|||
131663368|NCT02712905|474051254|FG001|Monotherapy|Started New Cancer Drug|0|||
131663369|NCT02712905|474051255|FG002|Monotherapy|Started New Cancer Drug|0|||
131663370|NCT02712905|474051256|FG003|Monotherapy|Started New Cancer Drug|0|||
131663371|NCT02712905|474051257|FG004|Monotherapy|Started New Cancer Drug|0|||
131663372|NCT02712905|474051258|FG005|Monotherapy|Started New Cancer Drug|1|||
131663373|NCT02712905|474051259|FG006|Monotherapy|Started New Cancer Drug|0|||
131889649|NCT04776018|474879134|FG001|Overall Study|Lost to Follow-up|0|||
131889650|NCT04776018|474879135|FG002|Overall Study|Lost to Follow-up|1|||
131663374|NCT02712905|474051260|FG007|Monotherapy|Started New Cancer Drug|0|||
131663375|NCT02712905|474051261|FG008|Monotherapy|Started New Cancer Drug|0|||
131889651|NCT04776018|474879136|FG003|Overall Study|Lost to Follow-up|0|||
131889652|NCT04776018|474879137|FG004|Overall Study|Lost to Follow-up|0|||
131889653|NCT04776018|474879138|FG005|Overall Study|Lost to Follow-up|0|||
131663376|NCT02712905|474051262|FG009|Monotherapy|Started New Cancer Drug|0|||
131663377|NCT02712905|474051263|FG010|Monotherapy|Started New Cancer Drug|0|||
131663378|NCT02712905|474051264|FG011|Monotherapy|Started New Cancer Drug|0|||
131663379|NCT02712905|474051265|FG012|Monotherapy|Started New Cancer Drug|0|||
131889654|NCT04776018|474879139|FG006|Overall Study|Lost to Follow-up|0|||
131889655|NCT01210144|474879140|FG000|Overall Study|Lack of ovarian response|1|||
131889656|NCT01210144|474879141|FG001|Overall Study|Lack of ovarian response|0|||
131889657|NCT01210144|474879140|FG000|Overall Study|No fertilization|1|||
131663380|NCT02712905|474051266|FG013|Monotherapy|Started New Cancer Drug|0|||
131663381|NCT02712905|474051267|FG014|Monotherapy|Started New Cancer Drug|0|||
131663382|NCT02712905|474051268|FG015|Monotherapy|Started New Cancer Drug|0|||
131663383|NCT02712905|474051269|FG016|Monotherapy|Started New Cancer Drug|0|||
131663384|NCT02712905|474051270|FG017|Monotherapy|Started New Cancer Drug|0|||
131663385|NCT02712905|474051253|FG000|Monotherapy|Adverse Event|0|||
131663386|NCT02712905|474051254|FG001|Monotherapy|Adverse Event|0|||
131663387|NCT02712905|474051255|FG002|Monotherapy|Adverse Event|0|||
131663388|NCT02712905|474051256|FG003|Monotherapy|Adverse Event|0|||
131663389|NCT02712905|474051257|FG004|Monotherapy|Adverse Event|0|||
131663390|NCT02712905|474051258|FG005|Monotherapy|Adverse Event|0|||
131663391|NCT02712905|474051259|FG006|Monotherapy|Adverse Event|0|||
131663392|NCT02712905|474051260|FG007|Monotherapy|Adverse Event|0|||
131663393|NCT02712905|474051261|FG008|Monotherapy|Adverse Event|1|||
131663394|NCT02712905|474051262|FG009|Monotherapy|Adverse Event|0|||
131663395|NCT02712905|474051263|FG010|Monotherapy|Adverse Event|0|||
131663396|NCT02712905|474051264|FG011|Monotherapy|Adverse Event|0|||
131663397|NCT02712905|474051265|FG012|Monotherapy|Adverse Event|0|||
131889658|NCT01210144|474879141|FG001|Overall Study|No fertilization|0|||
131889659|NCT01210144|474879140|FG000|Overall Study|No transfer|1|||
131889660|NCT01210144|474879141|FG001|Overall Study|No transfer|0|||
131889661|NCT00494221|474879148|FG000|Overall Study|Death|15|||
131889662|NCT00494221|474879149|FG001|Overall Study|Death|9|||
131889663|NCT00494221|474879150|FG002|Overall Study|Death|14|||
131889664|NCT00494221|474879148|FG000|Overall Study|Withdrawal by Subject|1|||
131889665|NCT00494221|474879149|FG001|Overall Study|Withdrawal by Subject|2|||
131889666|NCT00494221|474879150|FG002|Overall Study|Withdrawal by Subject|0|||
131889667|NCT01900431|474879152|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
131889668|NCT01900431|474879153|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
131889669|NCT01900431|474879154|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
131889670|NCT01900431|474879152|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
131889671|NCT01900431|474879153|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
131889672|NCT01900431|474879154|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
131889673|NCT01900431|474879152|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
131889674|NCT01900431|474879153|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
131889675|NCT01900431|474879154|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
131889676|NCT01900431|474879152|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
131889677|NCT01900431|474879153|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
131889678|NCT01900431|474879154|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
131889679|NCT01900431|474879152|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
131889680|NCT01900431|474879153|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
131889681|NCT01900431|474879154|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
131889682|NCT01900431|474879152|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
131889683|NCT01900431|474879153|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
131889684|NCT01900431|474879154|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
131889685|NCT01900431|474879152|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
131889686|NCT01900431|474879153|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
131889687|NCT01900431|474879154|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
131889688|NCT01900431|474879152|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
131889689|NCT01900431|474879153|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
131889690|NCT01900431|474879154|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
131889691|NCT01900431|474879152|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
131889692|NCT01900431|474879153|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
131889693|NCT01900431|474879154|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
131889694|NCT03755518|474879155|FG000|Overall Study|Lack of Efficacy|10|||
131889695|NCT03755518|474879155|FG000|Overall Study|Adverse Event|7|||
131663398|NCT02712905|474051266|FG013|Monotherapy|Adverse Event|0|||
131663399|NCT02712905|474051267|FG014|Monotherapy|Adverse Event|0|||
131663400|NCT02712905|474051268|FG015|Monotherapy|Adverse Event|0|||
131663401|NCT02712905|474051269|FG016|Monotherapy|Adverse Event|0|||
131663402|NCT02712905|474051270|FG017|Monotherapy|Adverse Event|0|||
131663403|NCT02712905|474051253|FG000|Combination Therapy|Death|0|||
131663404|NCT02712905|474051254|FG001|Combination Therapy|Death|0|||
131663405|NCT02712905|474051255|FG002|Combination Therapy|Death|0|||
131889696|NCT03755518|474879155|FG000|Overall Study|Study Terminated by Sponsor|5|||
131889697|NCT03755518|474879155|FG000|Overall Study|Death|1|||
131889698|NCT03755518|474879155|FG000|Overall Study|Withdrawal by Subject|3|||
131889699|NCT03755518|474879155|FG000|Overall Study|Progressive Disease|4|||
131889700|NCT03755518|474879155|FG000|Overall Study|Bone Marrow Transplant|4|||
131889701|NCT03755518|474879155|FG000|Overall Study|Physicians Decision|1|||
131889702|NCT03755518|474879155|FG000|Overall Study|Relapse|1|||
131889703|NCT03755518|474879155|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
131889704|NCT03755518|474879155|FG000|Overall Study|Withdrawal by PI|1|||
131889705|NCT03172364|474879156|FG000|Overall Study|Adverse Event|1|||
131889706|NCT03172364|474879157|FG001|Overall Study|Adverse Event|1|||
131889707|NCT03172364|474879156|FG000|Overall Study|Protocol Violation|1|||
131889708|NCT03172364|474879157|FG001|Overall Study|Protocol Violation|0|||
131889709|NCT01714609|474879158|FG000|Overall Study|Protocol Violation|1|||
131889710|NCT01714609|474879159|FG001|Overall Study|Protocol Violation|0|||
131663406|NCT02712905|474051256|FG003|Combination Therapy|Death|0|||
131663407|NCT02712905|474051257|FG004|Combination Therapy|Death|0|||
131663408|NCT02712905|474051258|FG005|Combination Therapy|Death|0|||
131663409|NCT02712905|474051259|FG006|Combination Therapy|Death|0|||
131663410|NCT02712905|474051260|FG007|Combination Therapy|Death|0|||
131663411|NCT02712905|474051261|FG008|Combination Therapy|Death|0|||
131663412|NCT02712905|474051262|FG009|Combination Therapy|Death|0|||
131663413|NCT02712905|474051263|FG010|Combination Therapy|Death|0|||
131663414|NCT02712905|474051264|FG011|Combination Therapy|Death|0|||
131889711|NCT00630747|474879160|FG000|Overall Study|Death|1|||
131889712|NCT00630747|474879160|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
131663415|NCT02712905|474051265|FG012|Combination Therapy|Death|5|||
131889713|NCT00630747|474879160|FG000|Overall Study|Returned to country of origin|1|||
131889714|NCT02732327|474879161|FG000|Overall Study|Protocol Violation|0|||
131663416|NCT02712905|474051266|FG013|Combination Therapy|Death|6|||
131663417|NCT02712905|474051267|FG014|Combination Therapy|Death|1|||
131663418|NCT02712905|474051268|FG015|Combination Therapy|Death|3|||
131663419|NCT02712905|474051269|FG016|Combination Therapy|Death|1|||
131663420|NCT02712905|474051270|FG017|Combination Therapy|Death|3|||
131663421|NCT02712905|474051253|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
131663422|NCT02712905|474051254|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
131663423|NCT02712905|474051255|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
131663424|NCT02712905|474051256|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
131663425|NCT02712905|474051257|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
131663426|NCT02712905|474051258|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
131663427|NCT02712905|474051259|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
131663428|NCT02712905|474051260|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
131663429|NCT02712905|474051261|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
131663430|NCT02712905|474051262|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
131663431|NCT02712905|474051263|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
131889715|NCT02732327|474879162|FG001|Overall Study|Protocol Violation|1|||
131889716|NCT04503668|474879163|FG000|Overall Study|Incomplete data|4|||
131889717|NCT04503668|474879164|FG001|Overall Study|Incomplete data|3|||
131889718|NCT04503668|474879163|FG000|Overall Study|Withdrawal by Subject|1|||
131663432|NCT02712905|474051264|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
131663433|NCT02712905|474051265|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
131663434|NCT02712905|474051266|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
131663435|NCT02712905|474051267|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
131663436|NCT02712905|474051268|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
131663437|NCT02712905|474051269|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
131889719|NCT04503668|474879164|FG001|Overall Study|Withdrawal by Subject|1|||
131889720|NCT04503668|474879163|FG000|Overall Study|Adverse Event|2|||
131889721|NCT04503668|474879164|FG001|Overall Study|Adverse Event|0|||
131889722|NCT02306694|474879165|FG000|Overall Study|Withdrawal by Subject|3|||
131889723|NCT02306694|474879165|FG000|Overall Study|Lost to Follow-up|1|||
131889724|NCT00603382|474879166|FG000|Overall Study|Adverse Event|0|||
131889725|NCT00603382|474879167|FG001|Overall Study|Adverse Event|1|||
131889726|NCT00603382|474879168|FG002|Overall Study|Adverse Event|1|||
131889727|NCT00603382|474879169|FG003|Overall Study|Adverse Event|2|||
131889728|NCT00603382|474879170|FG004|Overall Study|Adverse Event|1|||
131663438|NCT02712905|474051270|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
131663439|NCT02712905|474051253|FG000|Combination Therapy|Withdrawal by Subject|0|||
131663440|NCT02712905|474051254|FG001|Combination Therapy|Withdrawal by Subject|0|||
131663441|NCT02712905|474051255|FG002|Combination Therapy|Withdrawal by Subject|0|||
131663442|NCT02712905|474051256|FG003|Combination Therapy|Withdrawal by Subject|0|||
131663443|NCT02712905|474051257|FG004|Combination Therapy|Withdrawal by Subject|0|||
131663444|NCT02712905|474051258|FG005|Combination Therapy|Withdrawal by Subject|0|||
131663445|NCT02712905|474051259|FG006|Combination Therapy|Withdrawal by Subject|0|||
131663446|NCT02712905|474051260|FG007|Combination Therapy|Withdrawal by Subject|0|||
131889729|NCT00603382|474879171|FG005|Overall Study|Adverse Event|2|||
131889730|NCT00603382|474879166|FG000|Overall Study|Lack of Efficacy|14|||
131889731|NCT00603382|474879167|FG001|Overall Study|Lack of Efficacy|9|||
131889732|NCT00603382|474879168|FG002|Overall Study|Lack of Efficacy|3|||
131889733|NCT00603382|474879169|FG003|Overall Study|Lack of Efficacy|6|||
131889734|NCT00603382|474879170|FG004|Overall Study|Lack of Efficacy|6|||
131889735|NCT00603382|474879171|FG005|Overall Study|Lack of Efficacy|11|||
131889736|NCT00603382|474879166|FG000|Overall Study|Protocol Violation|1|||
131889737|NCT00603382|474879167|FG001|Overall Study|Protocol Violation|0|||
131889738|NCT00603382|474879168|FG002|Overall Study|Protocol Violation|1|||
131889739|NCT00603382|474879169|FG003|Overall Study|Protocol Violation|2|||
131889740|NCT00603382|474879170|FG004|Overall Study|Protocol Violation|1|||
131889741|NCT00603382|474879171|FG005|Overall Study|Protocol Violation|0|||
131663447|NCT02712905|474051261|FG008|Combination Therapy|Withdrawal by Subject|0|||
131663448|NCT02712905|474051262|FG009|Combination Therapy|Withdrawal by Subject|0|||
131889742|NCT00603382|474879166|FG000|Overall Study|Lost to Follow-up|0|||
131889743|NCT00603382|474879167|FG001|Overall Study|Lost to Follow-up|1|||
131889744|NCT00603382|474879168|FG002|Overall Study|Lost to Follow-up|1|||
131889745|NCT00603382|474879169|FG003|Overall Study|Lost to Follow-up|1|||
131663449|NCT02712905|474051263|FG010|Combination Therapy|Withdrawal by Subject|0|||
131663450|NCT02712905|474051264|FG011|Combination Therapy|Withdrawal by Subject|0|||
131663451|NCT02712905|474051265|FG012|Combination Therapy|Withdrawal by Subject|0|||
131663452|NCT02712905|474051266|FG013|Combination Therapy|Withdrawal by Subject|0|||
131663453|NCT02712905|474051267|FG014|Combination Therapy|Withdrawal by Subject|0|||
131663454|NCT02712905|474051268|FG015|Combination Therapy|Withdrawal by Subject|1|||
131663455|NCT02712905|474051269|FG016|Combination Therapy|Withdrawal by Subject|0|||
131663456|NCT02712905|474051270|FG017|Combination Therapy|Withdrawal by Subject|2|||
131663457|NCT02712905|474051253|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663458|NCT02712905|474051254|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663459|NCT02712905|474051255|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663460|NCT02712905|474051256|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663461|NCT02712905|474051257|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663462|NCT02712905|474051258|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663463|NCT02712905|474051259|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663464|NCT02712905|474051260|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663465|NCT02712905|474051261|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663466|NCT02712905|474051262|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663467|NCT02712905|474051263|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663468|NCT02712905|474051264|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663469|NCT02712905|474051265|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663470|NCT02712905|474051266|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663471|NCT02712905|474051267|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131889746|NCT00603382|474879170|FG004|Overall Study|Lost to Follow-up|0|||
131889747|NCT00603382|474879171|FG005|Overall Study|Lost to Follow-up|1|||
131889748|NCT00603382|474879166|FG000|Overall Study|Physician Decision|0|||
131889749|NCT00603382|474879167|FG001|Overall Study|Physician Decision|0|||
131889750|NCT00603382|474879168|FG002|Overall Study|Physician Decision|2|||
131889751|NCT00603382|474879169|FG003|Overall Study|Physician Decision|0|||
131889752|NCT00603382|474879170|FG004|Overall Study|Physician Decision|1|||
131889753|NCT00603382|474879171|FG005|Overall Study|Physician Decision|3|||
131889754|NCT00603382|474879166|FG000|Overall Study|Withdrawal by Subject|3|||
131889755|NCT00603382|474879167|FG001|Overall Study|Withdrawal by Subject|3|||
131889756|NCT00603382|474879168|FG002|Overall Study|Withdrawal by Subject|1|||
131889757|NCT00603382|474879169|FG003|Overall Study|Withdrawal by Subject|1|||
131889758|NCT00603382|474879170|FG004|Overall Study|Withdrawal by Subject|0|||
131889759|NCT00603382|474879171|FG005|Overall Study|Withdrawal by Subject|1|||
131889760|NCT03782974|474879172|FG000|Overall Study|Withdrawal by Subject|7|||
131889761|NCT03782974|474879173|FG001|Overall Study|Withdrawal by Subject|7|||
131889762|NCT03782974|474879172|FG000|Overall Study|Pregnancy|1|||
131889763|NCT03782974|474879173|FG001|Overall Study|Pregnancy|0|||
131889764|NCT00583102|474879174|FG000|Overall Study|Adverse Event|3|||
131889765|NCT03403621|474879175|FG000|Overall Study|Withdrawal by Subject|2|||
131663472|NCT02712905|474051268|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
131663473|NCT02712905|474051269|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131663474|NCT02712905|474051270|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131889766|NCT03403621|474879176|FG001|Overall Study|Withdrawal by Subject|2|||
131889767|NCT00395642|474879177|FG000|Overall Study|Death|4|||
131889768|NCT00395642|474879177|FG000|Overall Study|Lost to Follow-up|1|||
131889769|NCT00395642|474879177|FG000|Overall Study|Physician Decision|7|||
131889770|NCT00395642|474879177|FG000|Overall Study|Withdrawal by Subject|1|||
131889771|NCT02333383|474879180|FG000|Overall Study|Adalimumab discontinuation|21|||
131889772|NCT02333383|474879180|FG000|Overall Study|Lost to Follow-up|15|||
131889773|NCT02333383|474879180|FG000|Overall Study|Withdrawal by Subject|3|||
131889774|NCT02333383|474879180|FG000|Overall Study|Transfer to another hospital|2|||
131889775|NCT04459598|474879181|FG000|Overall Study|Adverse Event|1|||
131663475|NCT04664400|474051273|FG000|Overall Study|Withdrawal by Subject|2|||
131663476|NCT01011153|474051274|FG000|Overall Study|Less than 78 cases completed|8|||
131663477|NCT01011153|474051275|FG001|Overall Study|Less than 78 cases completed|11|||
131663478|NCT01011153|474051276|FG002|Overall Study|Less than 78 cases completed|9|||
131663479|NCT03014479|474051277|FG000|Overall Study|Adverse Event|0|||
131663480|NCT03014479|474051278|FG001|Overall Study|Adverse Event|1|||
131663481|NCT03014479|474051277|FG000|Overall Study|Voluntary Withdrawal|0|||
131663482|NCT03014479|474051278|FG001|Overall Study|Voluntary Withdrawal|2|||
131663483|NCT03014479|474051277|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
131663484|NCT03014479|474051278|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
131663485|NCT01394978|474051282|FG000|Overall Study|Withdrawal by Subject|2|||
131663486|NCT01394978|474051283|FG001|Overall Study|Withdrawal by Subject|4|||
131663487|NCT01394978|474051282|FG000|Overall Study|Lost to Follow-up|13|||
131663488|NCT01394978|474051283|FG001|Overall Study|Lost to Follow-up|20|||
131663489|NCT01394978|474051282|FG000|Overall Study|Death|6|||
131663490|NCT01394978|474051283|FG001|Overall Study|Death|7|||
131663491|NCT01081132|474051284|FG000|Overall Study|Lack of Efficacy|25|||
131663492|NCT01081132|474051285|FG001|Overall Study|Lack of Efficacy|9|||
131663493|NCT01081132|474051284|FG000|Overall Study|Withdrawal by Subject|13|||
131663494|NCT01081132|474051285|FG001|Overall Study|Withdrawal by Subject|16|||
131663495|NCT01081132|474051284|FG000|Overall Study|Lost to Follow-up|4|||
131663496|NCT01081132|474051285|FG001|Overall Study|Lost to Follow-up|11|||
131663497|NCT01081132|474051284|FG000|Overall Study|Adverse Event|3|||
131663498|NCT01081132|474051285|FG001|Overall Study|Adverse Event|9|||
131663499|NCT01081132|474051284|FG000|Overall Study|Non Compliance|4|||
131663500|NCT01081132|474051285|FG001|Overall Study|Non Compliance|2|||
131663501|NCT01081132|474051284|FG000|Overall Study|Lack Of Compliance|0|||
131663502|NCT01081132|474051285|FG001|Overall Study|Lack Of Compliance|1|||
131663503|NCT01081132|474051284|FG000|Overall Study|Missed Visits|1|||
131663504|NCT01081132|474051285|FG001|Overall Study|Missed Visits|1|||
131663505|NCT01081132|474051284|FG000|Overall Study|Stopped Taking Meds|2|||
131663506|NCT01081132|474051285|FG001|Overall Study|Stopped Taking Meds|0|||
131663507|NCT01081132|474051284|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
131663508|NCT01081132|474051285|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
131663509|NCT01081132|474051284|FG000|Overall Study|Declined Taper Phase|0|||
131663510|NCT01081132|474051285|FG001|Overall Study|Declined Taper Phase|1|||
131663511|NCT01081132|474051284|FG000|Overall Study|Protocol Violation|3|||
131663512|NCT01081132|474051285|FG001|Overall Study|Protocol Violation|1|||
131663513|NCT02019667|474051286|FG000|First Intervention (6 Months)|Adverse Event|0|||
131663514|NCT02019667|474051287|FG001|First Intervention (6 Months)|Adverse Event|1|||
131663515|NCT02019667|474051286|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
131663516|NCT02019667|474051287|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
131663517|NCT02019667|474051286|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
131663518|NCT02019667|474051287|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
131663519|NCT05038163|474051290|FG000|Stage 1|Did not complete survey|374|||
131663520|NCT05038163|474051291|FG001|Stage 1|Did not complete survey|0|||
131663521|NCT05038163|474051292|FG002|Stage 1|Did not complete survey|0|||
131663522|NCT05038163|474051293|FG003|Stage 1|Did not complete survey|0|||
131663523|NCT05038163|474051294|FG004|Stage 1|Did not complete survey|0|||
131663524|NCT05038163|474051295|FG005|Stage 1|Did not complete survey|0|||
131663525|NCT05038163|474051290|FG000|Stage 2|Did not complete Stage 2 survey|0|||
131663526|NCT05038163|474051291|FG001|Stage 2|Did not complete Stage 2 survey|29|||
131663527|NCT05038163|474051292|FG002|Stage 2|Did not complete Stage 2 survey|30|||
131663528|NCT05038163|474051293|FG003|Stage 2|Did not complete Stage 2 survey|24|||
131663529|NCT05038163|474051294|FG004|Stage 2|Did not complete Stage 2 survey|21|||
131663530|NCT05038163|474051295|FG005|Stage 2|Did not complete Stage 2 survey|100|||
131663531|NCT00432666|474052966|FG000|Main Period|Adverse Event|1|||
131663532|NCT00432666|474052967|FG001|Main Period|Adverse Event|1|||
131663533|NCT00432666|474052966|FG000|Main Period|Consent Withdrawn|1|||
131663534|NCT00432666|474052967|FG001|Main Period|Consent Withdrawn|0|||
131663535|NCT00432666|474052966|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
131663536|NCT00432666|474052967|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
131663537|NCT00432666|474052966|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
131663538|NCT00432666|474052967|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
131663539|NCT00432666|474052966|FG000|Open-Label Extension Period|Adverse Event|5|||
131663540|NCT00432666|474052967|FG001|Open-Label Extension Period|Adverse Event|0|||
131663541|NCT00432666|474052966|FG000|Open-Label Extension Period|Consent withdrawn|10|||
131663542|NCT00432666|474052967|FG001|Open-Label Extension Period|Consent withdrawn|0|||
131663543|NCT00432666|474052966|FG000|Open-Label Extension Period|Physician Decision|3|||
131663544|NCT00432666|474052967|FG001|Open-Label Extension Period|Physician Decision|0|||
131663545|NCT00565851|474052968|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
131663546|NCT00565851|474052969|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
131663547|NCT00565851|474052970|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
131663548|NCT00565851|474052971|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
131663549|NCT00565851|474052972|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
131663550|NCT00565851|474052973|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
131663551|NCT00565851|474052974|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
131663552|NCT00565851|474052975|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
131663553|NCT00565851|474052968|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
131663554|NCT00565851|474052969|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
131663555|NCT00565851|474052970|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
131663556|NCT00565851|474052971|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
131663557|NCT00565851|474052972|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
131663558|NCT00565851|474052973|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
131663559|NCT00565851|474052974|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
131663560|NCT00565851|474052975|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
131663561|NCT00969709|474052980|FG000|Overall Study|Adverse Event|3|||
131663562|NCT00969709|474052981|FG001|Overall Study|Adverse Event|13|||
131663563|NCT00969709|474052982|FG002|Overall Study|Adverse Event|26|||
131663564|NCT00969709|474052983|FG003|Overall Study|Adverse Event|12|||
131663565|NCT00969709|474052980|FG000|Overall Study|Lack of Efficacy|7|||
131663566|NCT00969709|474052981|FG001|Overall Study|Lack of Efficacy|4|||
131663567|NCT00969709|474052982|FG002|Overall Study|Lack of Efficacy|1|||
131663568|NCT00969709|474052983|FG003|Overall Study|Lack of Efficacy|3|||
131663569|NCT00969709|474052980|FG000|Overall Study|Protocol Violation|9|||
131663570|NCT00969709|474052981|FG001|Overall Study|Protocol Violation|5|||
131663571|NCT00969709|474052982|FG002|Overall Study|Protocol Violation|9|||
131663572|NCT00969709|474052983|FG003|Overall Study|Protocol Violation|10|||
131663573|NCT00969709|474052980|FG000|Overall Study|Withdrawal by Subject|9|||
131663574|NCT00969709|474052981|FG001|Overall Study|Withdrawal by Subject|12|||
131663575|NCT00969709|474052982|FG002|Overall Study|Withdrawal by Subject|11|||
131663576|NCT00969709|474052983|FG003|Overall Study|Withdrawal by Subject|23|||
131663577|NCT00969709|474052980|FG000|Overall Study|Lost to Follow-up|10|||
131663578|NCT00969709|474052981|FG001|Overall Study|Lost to Follow-up|14|||
131663579|NCT00969709|474052982|FG002|Overall Study|Lost to Follow-up|8|||
131663580|NCT00969709|474052983|FG003|Overall Study|Lost to Follow-up|15|||
131663581|NCT00969709|474052980|FG000|Overall Study|Other reasons|0|||
131663582|NCT00969709|474052981|FG001|Overall Study|Other reasons|0|||
131663583|NCT00969709|474052982|FG002|Overall Study|Other reasons|3|||
131663584|NCT00969709|474052983|FG003|Overall Study|Other reasons|0|||
131663585|NCT01342341|474052984|FG000|Overall Study|Lost to Follow-up|4|||
131663586|NCT01342341|474052985|FG001|Overall Study|Lost to Follow-up|4|||
131663587|NCT01789567|474052986|FG000|Overall Study|Death|6|||
131663588|NCT02914275|474052987|FG000|Overall Study|Lost to Follow-up|84|||
131663589|NCT02914275|474052988|FG001|Overall Study|Lost to Follow-up|29|||
131663590|NCT02914275|474052987|FG000|Overall Study|Withdrawal by Subject|26|||
131663591|NCT02914275|474052988|FG001|Overall Study|Withdrawal by Subject|10|||
131663592|NCT02914275|474052987|FG000|Overall Study|Protocol Violation|1|||
131663593|NCT02914275|474052988|FG001|Overall Study|Protocol Violation|1|||
131663594|NCT02914275|474052987|FG000|Overall Study|Physician Decision|3|||
131663595|NCT02914275|474052988|FG001|Overall Study|Physician Decision|1|||
131663596|NCT02914275|474052987|FG000|Overall Study|Other|4|||
131663597|NCT02914275|474052988|FG001|Overall Study|Other|1|||
131663598|NCT02914275|474052987|FG000|Overall Study|Excluded due to invalid informed consent|3|||
131663599|NCT02914275|474052988|FG001|Overall Study|Excluded due to invalid informed consent|0|||
131663600|NCT00091169|474052989|FG000|Overall Study|Disease progression|3|||
131663601|NCT00091169|474052990|FG001|Overall Study|Disease progression|1|||
131663602|NCT00091169|474052989|FG000|Overall Study|Adverse Event|11|||
131663603|NCT00091169|474052990|FG001|Overall Study|Adverse Event|17|||
131663604|NCT00091169|474052989|FG000|Overall Study|Death|4|||
131663605|NCT00091169|474052990|FG001|Overall Study|Death|1|||
131663606|NCT00091169|474052989|FG000|Overall Study|Withdrawal by Subject|10|||
131663607|NCT00091169|474052990|FG001|Overall Study|Withdrawal by Subject|13|||
131663608|NCT00091169|474052989|FG000|Overall Study|Other|3|||
131663609|NCT00091169|474052990|FG001|Overall Study|Other|4|||
131663610|NCT00091169|474052989|FG000|Overall Study|Not start protocol therapy|26|||
131663611|NCT00091169|474052990|FG001|Overall Study|Not start protocol therapy|17|||
131663612|NCT00872989|474052991|FG000|Overall Study|Adverse Event|7|||
131889776|NCT04459598|474879182|FG001|Overall Study|Adverse Event|1|||
131889777|NCT01907217|474879183|FG000|Overall Study|Withdrawal by Subject|0|||
131663613|NCT00872989|474052992|FG001|Overall Study|Adverse Event|15|||
131889778|NCT01907217|474879184|FG001|Overall Study|Withdrawal by Subject|2|||
131663614|NCT00872989|474052991|FG000|Overall Study|Withdrawal by Subject|8|||
131663615|NCT00872989|474052992|FG001|Overall Study|Withdrawal by Subject|5|||
131663616|NCT00872989|474052991|FG000|Overall Study|Progression/relapse|47|||
131663617|NCT00872989|474052992|FG001|Overall Study|Progression/relapse|35|||
131663618|NCT00872989|474052991|FG000|Overall Study|Not protocol specified|3|||
131663619|NCT00872989|474052992|FG001|Overall Study|Not protocol specified|8|||
131663620|NCT01302067|474052999|FG000|Overall Study|Death|0|||
131663621|NCT01302067|474053000|FG001|Overall Study|Death|0|||
131663622|NCT01302067|474053001|FG002|Overall Study|Death|1|||
131663623|NCT01302067|474052999|FG000|Overall Study|Physician Decision|9|||
131663624|NCT01302067|474053000|FG001|Overall Study|Physician Decision|5|||
131663625|NCT01302067|474053001|FG002|Overall Study|Physician Decision|14|||
131663626|NCT01302067|474052999|FG000|Overall Study|Lack of Efficacy|8|||
131663627|NCT01302067|474053000|FG001|Overall Study|Lack of Efficacy|4|||
131663628|NCT01302067|474053001|FG002|Overall Study|Lack of Efficacy|2|||
131663629|NCT01302067|474052999|FG000|Overall Study|Lost to Follow-up|9|||
131663630|NCT01302067|474053000|FG001|Overall Study|Lost to Follow-up|4|||
131663631|NCT01302067|474053001|FG002|Overall Study|Lost to Follow-up|15|||
131663632|NCT01302067|474052999|FG000|Overall Study|Withdrawal by Subject|13|||
131663633|NCT01302067|474053000|FG001|Overall Study|Withdrawal by Subject|6|||
131663634|NCT01302067|474053001|FG002|Overall Study|Withdrawal by Subject|10|||
131663635|NCT01302067|474052999|FG000|Overall Study|Other|1|||
131663636|NCT01302067|474053000|FG001|Overall Study|Other|1|||
131663637|NCT01302067|474053001|FG002|Overall Study|Other|3|||
131663638|NCT01302067|474052999|FG000|Overall Study|Protocol Violation|11|||
131663639|NCT01302067|474053000|FG001|Overall Study|Protocol Violation|0|||
131663640|NCT01302067|474053001|FG002|Overall Study|Protocol Violation|8|||
131663641|NCT01302067|474052999|FG000|Overall Study|Adverse Event|27|||
131663642|NCT01302067|474053000|FG001|Overall Study|Adverse Event|14|||
131663643|NCT01302067|474053001|FG002|Overall Study|Adverse Event|45|||
131663644|NCT02738203|474053002|FG000|Overall Study|Failed IUD Insertion|2|||
131663645|NCT02738203|474053003|FG001|Overall Study|Failed IUD Insertion|2|||
131663646|NCT02738203|474053002|FG000|Overall Study|Protocol Violation|0|||
131663647|NCT02738203|474053003|FG001|Overall Study|Protocol Violation|1|||
131663648|NCT00266227|474053004|FG000|Initial Treatment|Adverse Event|0|||
131663649|NCT00266227|474053005|FG001|Initial Treatment|Adverse Event|0|||
131663650|NCT00266227|474053006|FG002|Initial Treatment|Adverse Event|13|||
131663651|NCT00266227|474053004|FG000|Initial Treatment|Lost to Follow-up|0|||
131663652|NCT00266227|474053005|FG001|Initial Treatment|Lost to Follow-up|0|||
131663653|NCT00266227|474053006|FG002|Initial Treatment|Lost to Follow-up|6|||
131663654|NCT00266227|474053004|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
131663655|NCT00266227|474053005|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
131663656|NCT00266227|474053006|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
131663657|NCT00266227|474053004|FG000|Initial Treatment|Physician decision to withdraw|0|||
131663658|NCT00266227|474053005|FG001|Initial Treatment|Physician decision to withdraw|0|||
131663659|NCT00266227|474053006|FG002|Initial Treatment|Physician decision to withdraw|12|||
131663660|NCT00266227|474053004|FG000|Initial Treatment|Pregnancy|0|||
131663661|NCT00266227|474053005|FG001|Initial Treatment|Pregnancy|0|||
131663662|NCT00266227|474053006|FG002|Initial Treatment|Pregnancy|1|||
131663663|NCT00266227|474053004|FG000|Retreatment: Up to Week 48|Death|1|||
131663664|NCT00266227|474053005|FG001|Retreatment: Up to Week 48|Death|0|||
131663665|NCT00266227|474053006|FG002|Retreatment: Up to Week 48|Death|0|||
131663666|NCT00266227|474053004|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
131663667|NCT00266227|474053005|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
131663668|NCT00266227|474053006|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
131663669|NCT00266227|474053004|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
131663670|NCT00266227|474053005|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
131663671|NCT00266227|474053006|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
131663672|NCT00266227|474053004|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
131663673|NCT00266227|474053005|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
131663674|NCT00266227|474053006|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
131663675|NCT00266227|474053004|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
131663676|NCT00266227|474053005|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
131663677|NCT00266227|474053006|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
131663678|NCT00266227|474053004|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
131663679|NCT00266227|474053005|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
131663680|NCT00266227|474053006|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
131663681|NCT00266227|474053004|FG000|Retreatment: Week 48 to Week 72|Death|1|||
131663682|NCT00266227|474053005|FG001|Retreatment: Week 48 to Week 72|Death|1|||
131663683|NCT00266227|474053006|FG002|Retreatment: Week 48 to Week 72|Death|0|||
131663684|NCT00266227|474053004|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
131663685|NCT00266227|474053005|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
131663686|NCT00266227|474053006|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
131889779|NCT01078298|474879186|FG000|Overall Study|Lost to Follow-up|12|||
131663687|NCT00266227|474053004|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
131663688|NCT00266227|474053005|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
131663689|NCT00266227|474053006|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
131663690|NCT00266227|474053004|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
131663691|NCT00266227|474053005|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
131663692|NCT00266227|474053006|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
131663693|NCT00266227|474053004|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
131663694|NCT00266227|474053005|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
131663695|NCT00266227|474053006|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
131663696|NCT03241927|474053007|FG000|Overall Study|study terminated|1|||
131663697|NCT03241927|474053008|FG001|Overall Study|study terminated|0|||
131663698|NCT03725085|474053013|FG000|Overall Study|Lost to Follow-up|2|||
131889780|NCT01078298|474879187|FG001|Overall Study|Lost to Follow-up|13|||
131889781|NCT01078298|474879186|FG000|Overall Study|Withdrawal by Subject|31|||
131889782|NCT01078298|474879187|FG001|Overall Study|Withdrawal by Subject|33|||
131889783|NCT01078298|474879186|FG000|Overall Study|Protocol Violation|6|||
131889784|NCT01078298|474879187|FG001|Overall Study|Protocol Violation|6|||
131889785|NCT01078298|474879186|FG000|Overall Study|Adverse Event|6|||
131889786|NCT01078298|474879187|FG001|Overall Study|Adverse Event|5|||
131889787|NCT01078298|474879186|FG000|Overall Study|Death|2|||
131889788|NCT01078298|474879187|FG001|Overall Study|Death|0|||
131889789|NCT01078298|474879186|FG000|Overall Study|Did not meet entrance criteria|0|||
131889790|NCT01078298|474879187|FG001|Overall Study|Did not meet entrance criteria|1|||
131889791|NCT01078298|474879186|FG000|Overall Study|Other|24|||
131889792|NCT01078298|474879187|FG001|Overall Study|Other|32|||
131889793|NCT00866333|474879189|FG000|Overall Study|Withdrawal of consent|0|||
131663699|NCT00423943|474053014|FG000|Overall Study|Withdrawal by Subject|3|||
131663700|NCT00423943|474053015|FG001|Overall Study|Withdrawal by Subject|1|||
131663701|NCT02383056|474053019|FG000|Overall Study|Adverse Event|1|||
131663702|NCT02383056|474053020|FG001|Overall Study|Adverse Event|0|||
131663703|NCT02383056|474053019|FG000|Overall Study|Lost to Follow-up|0|||
131663704|NCT02383056|474053020|FG001|Overall Study|Lost to Follow-up|2|||
131663705|NCT04214600|474053021|FG000|Overall Study|Lost to Follow-up|9|||
131663706|NCT04214600|474053022|FG001|Overall Study|Lost to Follow-up|14|||
131663707|NCT03245151|474053028|FG000|Overall Study|Withdrawal by Subject|2|||
131663708|NCT03245151|474053029|FG001|Overall Study|Withdrawal by Subject|0|||
131663709|NCT03245151|474053030|FG002|Overall Study|Withdrawal by Subject|0|||
131663710|NCT03245151|474053031|FG003|Overall Study|Withdrawal by Subject|2|||
131663711|NCT03245151|474053032|FG004|Overall Study|Withdrawal by Subject|1|||
131663712|NCT03245151|474053028|FG000|Overall Study|Death|3|||
131663713|NCT03245151|474053029|FG001|Overall Study|Death|14|||
131663714|NCT03245151|474053030|FG002|Overall Study|Death|9|||
131663715|NCT03245151|474053031|FG003|Overall Study|Death|16|||
131663716|NCT03245151|474053032|FG004|Overall Study|Death|7|||
131663717|NCT03245151|474053028|FG000|Overall Study|Sponsor's decision|0|||
131663718|NCT03245151|474053029|FG001|Overall Study|Sponsor's decision|1|||
131663719|NCT03245151|474053030|FG002|Overall Study|Sponsor's decision|0|||
131663720|NCT03245151|474053031|FG003|Overall Study|Sponsor's decision|0|||
131663721|NCT03245151|474053032|FG004|Overall Study|Sponsor's decision|0|||
131663722|NCT02245737|474053034|FG000|Overall Study|Adverse Event|23|||
131663723|NCT02245737|474053035|FG001|Overall Study|Adverse Event|26|||
131663724|NCT02245737|474053036|FG002|Overall Study|Adverse Event|33|||
131663725|NCT02245737|474053034|FG000|Overall Study|Condition Worsened|9|||
131663726|NCT02245737|474053035|FG001|Overall Study|Condition Worsened|10|||
131663727|NCT02245737|474053036|FG002|Overall Study|Condition Worsened|9|||
131663728|NCT02245737|474053034|FG000|Overall Study|Death|2|||
131663729|NCT02245737|474053035|FG001|Overall Study|Death|4|||
131663730|NCT02245737|474053036|FG002|Overall Study|Death|4|||
131663731|NCT02245737|474053034|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
131663732|NCT02245737|474053035|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
131663733|NCT02245737|474053036|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
131663734|NCT02245737|474053034|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
131663735|NCT02245737|474053035|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
131889794|NCT00866333|474879190|FG001|Overall Study|Withdrawal of consent|1|||
131889795|NCT00866333|474879191|FG002|Overall Study|Withdrawal of consent|2|||
131889796|NCT00866333|474879189|FG000|Overall Study|Reason not Specified|3|||
131889797|NCT00866333|474879190|FG001|Overall Study|Reason not Specified|1|||
131889798|NCT00866333|474879191|FG002|Overall Study|Reason not Specified|1|||
131889799|NCT00866333|474879189|FG000|Overall Study|Study Terminated by Sponsor|2|||
131889800|NCT00866333|474879190|FG001|Overall Study|Study Terminated by Sponsor|5|||
131889801|NCT00866333|474879191|FG002|Overall Study|Study Terminated by Sponsor|9|||
131889802|NCT01738191|474879193|FG000|Overall Study|Withdrawal by Subject|4|||
131889803|NCT01738191|474879194|FG001|Overall Study|Withdrawal by Subject|1|||
131889804|NCT00350779|474879195|FG000|Overall Study|Adverse Event|4|||
131889805|NCT00350779|474879196|FG001|Overall Study|Adverse Event|2|||
131889806|NCT00350779|474879195|FG000|Overall Study|Lack of Efficacy|0|||
131663736|NCT02245737|474053036|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
131663737|NCT02245737|474053034|FG000|Overall Study|Lost to Follow-up|2|||
131663738|NCT02245737|474053035|FG001|Overall Study|Lost to Follow-up|5|||
131663739|NCT02245737|474053036|FG002|Overall Study|Lost to Follow-up|4|||
131889807|NCT00350779|474879196|FG001|Overall Study|Lack of Efficacy|4|||
131889808|NCT00350779|474879195|FG000|Overall Study|Lost to Follow-up|2|||
131889809|NCT00350779|474879196|FG001|Overall Study|Lost to Follow-up|0|||
131889810|NCT00350779|474879195|FG000|Overall Study|Physician Decision|2|||
131663740|NCT02245737|474053034|FG000|Overall Study|Other-determined by Investigator|9|||
131663741|NCT02245737|474053035|FG001|Overall Study|Other-determined by Investigator|10|||
131663742|NCT02245737|474053036|FG002|Overall Study|Other-determined by Investigator|10|||
131663743|NCT02245737|474053034|FG000|Overall Study|Physician Decision|6|||
131889811|NCT00350779|474879196|FG001|Overall Study|Physician Decision|4|||
131663744|NCT02245737|474053035|FG001|Overall Study|Physician Decision|3|||
131663745|NCT02245737|474053036|FG002|Overall Study|Physician Decision|6|||
131663746|NCT02245737|474053034|FG000|Overall Study|Protocol Violation|3|||
131663747|NCT02245737|474053035|FG001|Overall Study|Protocol Violation|2|||
131663748|NCT02245737|474053036|FG002|Overall Study|Protocol Violation|3|||
131663749|NCT02245737|474053034|FG000|Overall Study|Withdrawal by Subject|40|||
131663750|NCT02245737|474053035|FG001|Overall Study|Withdrawal by Subject|41|||
131663751|NCT02245737|474053036|FG002|Overall Study|Withdrawal by Subject|44|||
131663752|NCT02245737|474053034|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
131663753|NCT02245737|474053035|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
131663754|NCT02245737|474053036|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
131663755|NCT02245737|474053034|FG000|Overall Study|Sponsor Decision|445|||
131663756|NCT02245737|474053035|FG001|Overall Study|Sponsor Decision|430|||
131663757|NCT02245737|474053036|FG002|Overall Study|Sponsor Decision|432|||
131663758|NCT02366468|474053037|FG000|Overall Study|Adverse Event|2|||
131663759|NCT02366468|474053038|FG001|Overall Study|Adverse Event|0|||
131663760|NCT02366468|474053037|FG000|Overall Study|Withdrawal by Subject|1|||
131663761|NCT02366468|474053038|FG001|Overall Study|Withdrawal by Subject|5|||
131663762|NCT02366468|474053037|FG000|Overall Study|Lost to Follow-up|2|||
131663763|NCT02366468|474053038|FG001|Overall Study|Lost to Follow-up|0|||
131663764|NCT02366468|474053037|FG000|Overall Study|Death|1|||
131663765|NCT02366468|474053038|FG001|Overall Study|Death|2|||
131663766|NCT02366468|474053037|FG000|Overall Study|Other|0|||
131663767|NCT02366468|474053038|FG001|Overall Study|Other|2|||
131663768|NCT01552603|474053039|FG000|Overall Study|Physician Decision|1|||
131663769|NCT04797650|474053044|FG000|Overall Study|Reason Not Specified|5|||
131663770|NCT04797650|474053045|FG001|Overall Study|Reason Not Specified|12|||
131663771|NCT04797650|474053046|FG002|Overall Study|Reason Not Specified|5|||
131663772|NCT04797650|474053044|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
131663773|NCT04797650|474053045|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
131663774|NCT04797650|474053046|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
131663775|NCT04797650|474053044|FG000|Overall Study|Lack of Efficacy|1|||
131663776|NCT04797650|474053045|FG001|Overall Study|Lack of Efficacy|0|||
131663777|NCT04797650|474053046|FG002|Overall Study|Lack of Efficacy|1|||
131663778|NCT04797650|474053044|FG000|Overall Study|Non-compliance with Study Drug|0|||
131663779|NCT04797650|474053045|FG001|Overall Study|Non-compliance with Study Drug|0|||
131663780|NCT04797650|474053046|FG002|Overall Study|Non-compliance with Study Drug|2|||
131663781|NCT04797650|474053044|FG000|Overall Study|Lost to Follow-up|4|||
131663782|NCT04797650|474053045|FG001|Overall Study|Lost to Follow-up|6|||
131663783|NCT04797650|474053046|FG002|Overall Study|Lost to Follow-up|1|||
131663784|NCT00446043|474053047|FG000|Overall Study|Adverse Event|9|||
131663785|NCT00446043|474053047|FG000|Overall Study|Withdrawal by Subject|70|||
131663786|NCT00446043|474053047|FG000|Overall Study|Protocol Violation|2|||
131663787|NCT00446043|474053047|FG000|Overall Study|Lost to Follow-up|42|||
131663788|NCT00446043|474053047|FG000|Overall Study|Pregnancy|2|||
131663789|NCT04772898|474053050|FG000|Overall Study|Withdrawal by Subject|0|||
131663790|NCT04772898|474053051|FG001|Overall Study|Withdrawal by Subject|1|||
131663791|NCT02947087|474053052|FG000|Overall Study|Withdrawal by Subject|3|||
131663792|NCT02947087|474053053|FG001|Overall Study|Withdrawal by Subject|2|||
131663793|NCT01983254|474053057|FG000|Overall Study|Death|6|||
131663794|NCT01983254|474053058|FG001|Overall Study|Death|6|||
131663795|NCT01983254|474053057|FG000|Overall Study|Lost to Follow-up|17|||
131663796|NCT01983254|474053058|FG001|Overall Study|Lost to Follow-up|16|||
131663797|NCT01983254|474053057|FG000|Overall Study|too ill|11|||
131663798|NCT01983254|474053058|FG001|Overall Study|too ill|8|||
131663799|NCT04988867|474053063|FG000|Overall Study|Study terminated by Sponsor|12|||
131663800|NCT04988867|474053063|FG000|Overall Study|Adverse Event|2|||
131663801|NCT04988867|474053063|FG000|Overall Study|Study drug noncompliance|1|||
131663802|NCT01699503|474053064|FG000|Overall Study|Death|31|||
131663803|NCT01699503|474053065|FG001|Overall Study|Death|40|||
131663804|NCT01699503|474053064|FG000|Overall Study|Withdrawal by Subject|65|||
131663805|NCT01699503|474053065|FG001|Overall Study|Withdrawal by Subject|57|||
131663806|NCT01699503|474053064|FG000|Overall Study|Lost to Follow-up|121|||
131663807|NCT01699503|474053065|FG001|Overall Study|Lost to Follow-up|117|||
131889812|NCT00350779|474879195|FG000|Overall Study|Protocol Violation|3|||
131663808|NCT01699503|474053064|FG000|Overall Study|Excluded due to quality|783|||
131663809|NCT01699503|474053065|FG001|Overall Study|Excluded due to quality|791|||
131663810|NCT01871805|474053079|FG000|Phase I|Death|7|||
131663811|NCT01871805|474053080|FG001|Phase I|Death|4|||
131663812|NCT01871805|474053081|FG002|Phase I|Death|6|||
131663813|NCT01871805|474053082|FG003|Phase I|Death|2|||
131889813|NCT00350779|474879196|FG001|Overall Study|Protocol Violation|1|||
131663814|NCT01871805|474053083|FG004|Phase I|Death|9|||
131663815|NCT01871805|474053084|FG005|Phase I|Death|0|||
131663816|NCT01871805|474053079|FG000|Phase I|Alive in Survival Follow-up|0|||
131663817|NCT01871805|474053080|FG001|Phase I|Alive in Survival Follow-up|2|||
131663818|NCT01871805|474053081|FG002|Phase I|Alive in Survival Follow-up|4|||
131663819|NCT01871805|474053082|FG003|Phase I|Alive in Survival Follow-up|5|||
131663820|NCT01871805|474053083|FG004|Phase I|Alive in Survival Follow-up|4|||
131663821|NCT01871805|474053084|FG005|Phase I|Alive in Survival Follow-up|0|||
131663822|NCT01871805|474053079|FG000|Phase I|Lost to Follow-up|0|||
131663823|NCT01871805|474053080|FG001|Phase I|Lost to Follow-up|1|||
131663824|NCT01871805|474053081|FG002|Phase I|Lost to Follow-up|3|||
131663825|NCT01871805|474053082|FG003|Phase I|Lost to Follow-up|0|||
131663826|NCT01871805|474053083|FG004|Phase I|Lost to Follow-up|0|||
131663827|NCT01871805|474053084|FG005|Phase I|Lost to Follow-up|0|||
131663828|NCT01871805|474053079|FG000|Phase II|Death|0|||
131663829|NCT01871805|474053080|FG001|Phase II|Death|0|||
131663830|NCT01871805|474053081|FG002|Phase II|Death|0|||
131663831|NCT01871805|474053082|FG003|Phase II|Death|0|||
131663832|NCT01871805|474053083|FG004|Phase II|Death|0|||
131663833|NCT01871805|474053084|FG005|Phase II|Death|45|||
131663834|NCT01871805|474053079|FG000|Phase II|Alive in Survival Follow-up|0|||
131663835|NCT01871805|474053080|FG001|Phase II|Alive in Survival Follow-up|0|||
131663836|NCT01871805|474053081|FG002|Phase II|Alive in Survival Follow-up|0|||
131663837|NCT01871805|474053082|FG003|Phase II|Alive in Survival Follow-up|0|||
131663838|NCT01871805|474053083|FG004|Phase II|Alive in Survival Follow-up|0|||
131663839|NCT01871805|474053084|FG005|Phase II|Alive in Survival Follow-up|29|||
131663840|NCT01871805|474053079|FG000|Phase II|Lost to Follow-up|0|||
131663841|NCT01871805|474053080|FG001|Phase II|Lost to Follow-up|0|||
131663842|NCT01871805|474053081|FG002|Phase II|Lost to Follow-up|0|||
131663843|NCT01871805|474053082|FG003|Phase II|Lost to Follow-up|0|||
131663844|NCT01871805|474053083|FG004|Phase II|Lost to Follow-up|0|||
131663845|NCT01871805|474053084|FG005|Phase II|Lost to Follow-up|13|||
131663846|NCT00635427|474053087|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131663847|NCT00635427|474053088|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131663848|NCT00635427|474053089|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
131663849|NCT00635427|474053090|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131663850|NCT00635427|474053091|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131663851|NCT00635427|474053087|FG000|Overall Study|Death|0|||
131663852|NCT00635427|474053088|FG001|Overall Study|Death|0|||
131663853|NCT00635427|474053089|FG002|Overall Study|Death|0|||
131663854|NCT00635427|474053090|FG003|Overall Study|Death|1|||
131663855|NCT00635427|474053091|FG004|Overall Study|Death|0|||
131663856|NCT00635427|474053087|FG000|Overall Study|Termination Of Study By Sponsor|12|||
131663857|NCT00635427|474053088|FG001|Overall Study|Termination Of Study By Sponsor|6|||
131663858|NCT00635427|474053089|FG002|Overall Study|Termination Of Study By Sponsor|10|||
131663859|NCT00635427|474053090|FG003|Overall Study|Termination Of Study By Sponsor|6|||
131663860|NCT00635427|474053091|FG004|Overall Study|Termination Of Study By Sponsor|6|||
131663861|NCT00635427|474053087|FG000|Overall Study|Withdrawal Of Consent|0|||
131663862|NCT00635427|474053088|FG001|Overall Study|Withdrawal Of Consent|0|||
131663863|NCT00635427|474053089|FG002|Overall Study|Withdrawal Of Consent|0|||
131663864|NCT00635427|474053090|FG003|Overall Study|Withdrawal Of Consent|2|||
131663865|NCT00635427|474053091|FG004|Overall Study|Withdrawal Of Consent|2|||
131663866|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
131663867|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
131663868|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
131663869|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
131663870|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
131663871|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
131663872|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
131663873|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
131663874|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
131663875|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
131663876|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
131663877|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
131663878|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
131663879|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
131663880|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
131663881|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
131663882|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
131663883|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
131663884|NCT03412747|474053092|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
131663885|NCT03412747|474053093|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
131663886|NCT03412747|474053094|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
131663887|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
131663888|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
131663889|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
131663890|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
131663891|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
131663892|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
131663893|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
131663894|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
131663895|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
131663896|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
131663897|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
131663898|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
131889814|NCT00350779|474879195|FG000|Overall Study|Withdrawal by Subject|9|||
131889815|NCT00350779|474879196|FG001|Overall Study|Withdrawal by Subject|8|||
131889816|NCT00350779|474879195|FG000|Overall Study|Patient Moved|2|||
131889817|NCT00350779|474879196|FG001|Overall Study|Patient Moved|1|||
131889818|NCT00350779|474879195|FG000|Overall Study|Non-compliance with study procedures|0|||
131889819|NCT00350779|474879196|FG001|Overall Study|Non-compliance with study procedures|1|||
131889820|NCT02109445|474879199|FG000|Overall Study|Symptomatic deterioration|2|||
131889821|NCT02109445|474879199|FG000|Overall Study|Adverse Event|1|||
131889822|NCT02012959|474879202|FG000|Treatment Phase A|Adverse Event|2|||
131889823|NCT02012959|474879203|FG001|Treatment Phase A|Adverse Event|0|||
131889824|NCT02012959|474879204|FG002|Treatment Phase A|Adverse Event|0|||
131889825|NCT02012959|474879205|FG003|Treatment Phase A|Adverse Event|0|||
131663899|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
131663900|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
131663901|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
131663902|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
131663903|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
131663904|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
131663905|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
131663906|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
131663907|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
131663908|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
131663909|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
131663910|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
131663911|NCT03412747|474053092|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
131663912|NCT03412747|474053093|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
131663913|NCT03412747|474053094|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
131663914|NCT02081417|474053095|FG000|Overall Study|Lost to Follow-up|26|||
131663915|NCT02081417|474053096|FG001|Overall Study|Lost to Follow-up|23|||
131663916|NCT02081417|474053095|FG000|Overall Study|Moved Away|1|||
131663917|NCT02081417|474053096|FG001|Overall Study|Moved Away|2|||
131663918|NCT02081417|474053095|FG000|Overall Study|Incarcerated|2|||
131663919|NCT02081417|474053096|FG001|Overall Study|Incarcerated|2|||
131663920|NCT02081417|474053095|FG000|Overall Study|Death|4|||
131663921|NCT02081417|474053096|FG001|Overall Study|Death|3|||
131663922|NCT02081417|474053095|FG000|Overall Study|Withdrawal by Subject|4|||
131663923|NCT02081417|474053096|FG001|Overall Study|Withdrawal by Subject|0|||
131663924|NCT02081417|474053095|FG000|Overall Study|Admitted to Residential Treatment|2|||
131663925|NCT02081417|474053096|FG001|Overall Study|Admitted to Residential Treatment|0|||
131663926|NCT02081417|474053095|FG000|Overall Study|Did not start treatment|17|||
131663927|NCT02081417|474053096|FG001|Overall Study|Did not start treatment|21|||
131663928|NCT01263665|474053100|FG000|Overall Study|Withdrew Consent|1|||
131663929|NCT01263665|474053100|FG000|Overall Study|Lost to Follow-up|3|||
131663930|NCT01263665|474053100|FG000|Overall Study|Death|2|||
131663931|NCT01263665|474053100|FG000|Overall Study|Amputation above the ankle|1|||
131663932|NCT01263665|474053100|FG000|Overall Study|Surgical Bypass|2|||
131663933|NCT00324675|474053102|FG000|Overall Study|Adverse Event|1|||
131663934|NCT00324675|474053103|FG001|Overall Study|Adverse Event|0|||
131663935|NCT00381615|474053104|FG000|Overall Study|Withdrawal by Subject|1|||
131663936|NCT00381615|474053105|FG001|Overall Study|Withdrawal by Subject|3|||
131663937|NCT00381615|474053106|FG002|Overall Study|Withdrawal by Subject|0|||
131663938|NCT00381615|474053107|FG003|Overall Study|Withdrawal by Subject|1|||
131663939|NCT00381615|474053104|FG000|Overall Study|Lost to Follow-up|3|||
131663940|NCT00381615|474053105|FG001|Overall Study|Lost to Follow-up|2|||
131663941|NCT00381615|474053106|FG002|Overall Study|Lost to Follow-up|0|||
131889826|NCT02012959|474879206|FG004|Treatment Phase A|Adverse Event|0|||
131663942|NCT00381615|474053107|FG003|Overall Study|Lost to Follow-up|1|||
131889827|NCT02732015|474880688|FG000|Overall Study|Lost to Follow-up|0|||
131889828|NCT02732015|474880689|FG001|Overall Study|Lost to Follow-up|1|||
131889829|NCT01980628|474880690|FG000|Overall Study|Adverse Event|12|||
131889830|NCT01980628|474880690|FG000|Overall Study|Physician Decision|5|||
131663943|NCT00381615|474053104|FG000|Overall Study|Protocol Violation|0|||
131663944|NCT00381615|474053105|FG001|Overall Study|Protocol Violation|0|||
131663945|NCT00381615|474053106|FG002|Overall Study|Protocol Violation|1|||
131663946|NCT00381615|474053107|FG003|Overall Study|Protocol Violation|0|||
131663947|NCT01801735|474053110|FG000|Overall Study|Adverse Event|79|||
131663948|NCT01801735|474053110|FG000|Overall Study|Lack of Efficacy|28|||
131663949|NCT01801735|474053110|FG000|Overall Study|Withdrawal by Subject|27|||
131663950|NCT01801735|474053110|FG000|Overall Study|Protocol Violation|25|||
131889831|NCT01980628|474880690|FG000|Overall Study|Withdrawal by Subject|4|||
131553012|NCT03097861|473649785|FG001|Overall Study|Withdrawal by Subject|5|||
131553013|NCT03097861|473649786|FG002|Overall Study|Withdrawal by Subject|3|||
131553014|NCT03097861|473649784|FG000|Overall Study|Reason not provided|3|||
131553015|NCT03097861|473649785|FG001|Overall Study|Reason not provided|1|||
131553016|NCT03097861|473649786|FG002|Overall Study|Reason not provided|1|||
131553017|NCT04251065|473649788|FG000|Overall Study|Death|2|||
131553018|NCT04251065|473649788|FG000|Overall Study|Lack of Efficacy|3|||
131553019|NCT04251065|473649788|FG000|Overall Study|Death|1|||
131553020|NCT05266963|473649792|FG000|Drug Period A|Withdrawal by Subject|0|||
131553021|NCT05266963|473649793|FG001|Drug Period A|Withdrawal by Subject|1|||
131553022|NCT01725386|473649794|FG000|Overall Study|Death|84|||
131553023|NCT01725386|473649795|FG001|Overall Study|Death|40|||
131553024|NCT01725386|473649794|FG000|Overall Study|Lost to Follow-up|81|||
131553025|NCT01725386|473649795|FG001|Overall Study|Lost to Follow-up|6|||
131553026|NCT01725386|473649794|FG000|Overall Study|Withdrawal by Subject|10|||
131553027|NCT01725386|473649795|FG001|Overall Study|Withdrawal by Subject|0|||
131553028|NCT03812536|473649796|FG000|Overall Study|Protocol Violation|2|||
131553029|NCT03812536|473649797|FG001|Overall Study|Protocol Violation|0|||
131553030|NCT03812536|473649796|FG000|Overall Study|Withdrawal by Subject|1|||
131553031|NCT03812536|473649797|FG001|Overall Study|Withdrawal by Subject|1|||
131553032|NCT00152009|473649798|FG000|Overall Study|Adverse Event|9|||
131553033|NCT00152009|473649799|FG001|Overall Study|Adverse Event|13|||
131553034|NCT00152009|473649800|FG002|Overall Study|Adverse Event|20|||
131553035|NCT00152009|473649801|FG003|Overall Study|Adverse Event|1|||
131553036|NCT00152009|473649798|FG000|Overall Study|Protocol Violation|3|||
131553037|NCT00152009|473649799|FG001|Overall Study|Protocol Violation|0|||
131553038|NCT00152009|473649800|FG002|Overall Study|Protocol Violation|0|||
131553039|NCT00152009|473649801|FG003|Overall Study|Protocol Violation|1|||
131553040|NCT00152009|473649798|FG000|Overall Study|Withdrawal by Subject|2|||
131553041|NCT00152009|473649799|FG001|Overall Study|Withdrawal by Subject|3|||
131553042|NCT00152009|473649800|FG002|Overall Study|Withdrawal by Subject|4|||
131553043|NCT00152009|473649801|FG003|Overall Study|Withdrawal by Subject|9|||
131553044|NCT00152009|473649798|FG000|Overall Study|Lost to Follow-up|2|||
131553045|NCT00152009|473649799|FG001|Overall Study|Lost to Follow-up|4|||
131553046|NCT00152009|473649800|FG002|Overall Study|Lost to Follow-up|3|||
131553047|NCT00152009|473649801|FG003|Overall Study|Lost to Follow-up|3|||
131553048|NCT00152009|473649798|FG000|Overall Study|Lack of Efficacy|8|||
131553049|NCT00152009|473649799|FG001|Overall Study|Lack of Efficacy|6|||
131553050|NCT00152009|473649800|FG002|Overall Study|Lack of Efficacy|7|||
131553051|NCT00152009|473649801|FG003|Overall Study|Lack of Efficacy|15|||
131553052|NCT00152009|473649798|FG000|Overall Study|ECG abnormalities|2|||
131553053|NCT00152009|473649799|FG001|Overall Study|ECG abnormalities|2|||
131553054|NCT00152009|473649800|FG002|Overall Study|ECG abnormalities|2|||
131553055|NCT00152009|473649801|FG003|Overall Study|ECG abnormalities|1|||
131553056|NCT00152009|473649798|FG000|Overall Study|Sponsor's decision|3|||
131553057|NCT00152009|473649799|FG001|Overall Study|Sponsor's decision|3|||
131553058|NCT00152009|473649800|FG002|Overall Study|Sponsor's decision|1|||
131553059|NCT00152009|473649801|FG003|Overall Study|Sponsor's decision|3|||
131553060|NCT00393523|473649803|FG000|Overall Study|Lost to Follow-up|0|||
131553061|NCT00393523|473649804|FG001|Overall Study|Lost to Follow-up|0|||
131553062|NCT00393523|473649805|FG002|Overall Study|Lost to Follow-up|0|||
131553063|NCT00393523|473649806|FG003|Overall Study|Lost to Follow-up|2|||
131553064|NCT00393523|473649807|FG004|Overall Study|Lost to Follow-up|1|||
131553065|NCT00393523|473649803|FG000|Overall Study|Protocol Violation|6|||
131553066|NCT00393523|473649804|FG001|Overall Study|Protocol Violation|2|||
131553067|NCT00393523|473649805|FG002|Overall Study|Protocol Violation|0|||
131553068|NCT00393523|473649806|FG003|Overall Study|Protocol Violation|1|||
131553069|NCT00393523|473649807|FG004|Overall Study|Protocol Violation|0|||
131553070|NCT00393523|473649803|FG000|Overall Study|Withdrawal by Subject|6|||
131553071|NCT00393523|473649804|FG001|Overall Study|Withdrawal by Subject|7|||
131553072|NCT00393523|473649805|FG002|Overall Study|Withdrawal by Subject|2|||
131553073|NCT00393523|473649806|FG003|Overall Study|Withdrawal by Subject|3|||
131553074|NCT00393523|473649807|FG004|Overall Study|Withdrawal by Subject|0|||
131553075|NCT00393523|473649803|FG000|Overall Study|Difficulties in specimen collection|0|||
131553076|NCT00393523|473649804|FG001|Overall Study|Difficulties in specimen collection|0|||
131553077|NCT00393523|473649805|FG002|Overall Study|Difficulties in specimen collection|1|||
131553078|NCT00393523|473649806|FG003|Overall Study|Difficulties in specimen collection|0|||
131553079|NCT00393523|473649807|FG004|Overall Study|Difficulties in specimen collection|0|||
131553080|NCT00393523|473649803|FG000|Overall Study|Vaccine supply issue|0|||
131553081|NCT00393523|473649804|FG001|Overall Study|Vaccine supply issue|0|||
131553082|NCT00393523|473649805|FG002|Overall Study|Vaccine supply issue|1|||
131553083|NCT00393523|473649806|FG003|Overall Study|Vaccine supply issue|0|||
131553084|NCT00393523|473649807|FG004|Overall Study|Vaccine supply issue|0|||
131553085|NCT00098254|473649812|FG000|Overall Study|Adverse Event|2|||
131553086|NCT00098254|473649812|FG000|Overall Study|Death|1|||
131553087|NCT05672680|473649813|FG000|Overall Study|Patient Did Not Complete the Form|5|||
131553088|NCT05672680|473649814|FG001|Overall Study|Patient Did Not Complete the Form|4|||
131553089|NCT05672680|473649813|FG000|Overall Study|Procedure Aborted|1|||
131663951|NCT01801735|474053110|FG000|Overall Study|Lost to Follow-up|15|||
131663952|NCT01801735|474053110|FG000|Overall Study|Non-compliance with Trial Drug|13|||
131663953|NCT01801735|474053110|FG000|Overall Study|Physician Decision|3|||
131663954|NCT01801735|474053110|FG000|Overall Study|Death|1|||
131663955|NCT01801735|474053110|FG000|Overall Study|Other, including site closure|19|||
131663956|NCT01435616|474053111|FG000|Overall Study|Adverse Event|39|||
131663957|NCT01435616|474053112|FG001|Overall Study|Adverse Event|21|||
131663958|NCT01435616|474053111|FG000|Overall Study|Death|7|||
131663959|NCT01435616|474053112|FG001|Overall Study|Death|2|||
131663960|NCT01435616|474053111|FG000|Overall Study|Lost to Follow-up|22|||
131663961|NCT01435616|474053112|FG001|Overall Study|Lost to Follow-up|13|||
131663962|NCT01435616|474053111|FG000|Overall Study|Protocol Violation|16|||
131663963|NCT01435616|474053112|FG001|Overall Study|Protocol Violation|13|||
131663964|NCT01435616|474053111|FG000|Overall Study|Withdrawal by Subject|66|||
131663965|NCT01435616|474053112|FG001|Overall Study|Withdrawal by Subject|24|||
131663966|NCT01435616|474053111|FG000|Overall Study|Physician Decision|20|||
131663967|NCT01435616|474053112|FG001|Overall Study|Physician Decision|7|||
131663968|NCT01435616|474053111|FG000|Overall Study|Sponsor Decision|1|||
131663969|NCT01435616|474053112|FG001|Overall Study|Sponsor Decision|0|||
131663970|NCT01528345|474053113|FG000|Overall Study|Adverse Event|10|||
131663971|NCT01528345|474053114|FG001|Overall Study|Adverse Event|1|||
131663972|NCT01528345|474053113|FG000|Overall Study|Death|1|||
131663973|NCT01528345|474053114|FG001|Overall Study|Death|1|||
131663974|NCT01528345|474053113|FG000|Overall Study|Non-compliance with study treatment|1|||
131663975|NCT01528345|474053114|FG001|Overall Study|Non-compliance with study treatment|0|||
131663976|NCT01528345|474053113|FG000|Overall Study|Progressive Disease|26|||
131663977|NCT01528345|474053114|FG001|Overall Study|Progressive Disease|40|||
131663978|NCT01528345|474053113|FG000|Overall Study|Study Terminated by Sponsor|4|||
131663979|NCT01528345|474053114|FG001|Overall Study|Study Terminated by Sponsor|8|||
131663980|NCT01528345|474053113|FG000|Overall Study|Subject/Guardian Decision|5|||
131663981|NCT01528345|474053114|FG001|Overall Study|Subject/Guardian Decision|0|||
131663982|NCT01151410|474053116|FG000|Overall Study|Withdrawal by Subject|3|||
131663983|NCT01151410|474053117|FG001|Overall Study|Withdrawal by Subject|5|||
131663984|NCT01151410|474053116|FG000|Overall Study|Lost to Follow-up|3|||
131663985|NCT01151410|474053117|FG001|Overall Study|Lost to Follow-up|4|||
131889832|NCT01980628|474880690|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
131889833|NCT03015194|474880691|FG000|Overall Study|Death|10|||
131889834|NCT03015194|474880691|FG000|Overall Study|Withdrawal by Subject|2|||
131889835|NCT02469168|474880694|FG000|Overall Study|Trial closed|1|||
131889836|NCT02469168|474880695|FG001|Overall Study|Trial closed|0|||
131889837|NCT00433017|474880696|FG000|Overall Study|Adverse Event|5|||
131889838|NCT00433017|474880697|FG001|Overall Study|Adverse Event|3|||
131889839|NCT00433017|474880696|FG000|Overall Study|Withdrawal by Subject|4|||
131889840|NCT00433017|474880697|FG001|Overall Study|Withdrawal by Subject|5|||
131889841|NCT00433017|474880696|FG000|Overall Study|Lost to Follow-up|3|||
131889842|NCT00433017|474880697|FG001|Overall Study|Lost to Follow-up|4|||
131889843|NCT00433017|474880696|FG000|Overall Study|Administrative problems|80|||
131889844|NCT00433017|474880697|FG001|Overall Study|Administrative problems|86|||
131889845|NCT00433017|474880696|FG000|Overall Study|Protocol Violation|1|||
131889846|NCT00433017|474880697|FG001|Overall Study|Protocol Violation|0|||
131889847|NCT00433017|474880696|FG000|Overall Study|Death|2|||
131889848|NCT00433017|474880697|FG001|Overall Study|Death|2|||
131889849|NCT00433017|474880696|FG000|Overall Study|Subject no longer requires study drug|1|||
131889850|NCT00433017|474880697|FG001|Overall Study|Subject no longer requires study drug|1|||
131889851|NCT03959488|474880700|FG000|Season 1|Other|6|||
131889852|NCT03959488|474880701|FG001|Season 1|Other|7|||
131889853|NCT03959488|474880702|FG002|Season 1|Other|0|||
131889854|NCT03959488|474880703|FG003|Season 1|Other|0|||
131889855|NCT03959488|474880704|FG004|Season 1|Other|0|||
131889856|NCT03959488|474880700|FG000|Season 1|Withdrawal by parent/guardian|43|||
131889857|NCT03959488|474880701|FG001|Season 1|Withdrawal by parent/guardian|28|||
131889858|NCT03959488|474880702|FG002|Season 1|Withdrawal by parent/guardian|0|||
131889859|NCT03959488|474880703|FG003|Season 1|Withdrawal by parent/guardian|0|||
131889860|NCT03959488|474880704|FG004|Season 1|Withdrawal by parent/guardian|0|||
131889861|NCT03959488|474880700|FG000|Season 1|Due to COVID-19 pandemic|2|||
131663986|NCT01151410|474053116|FG000|Overall Study|Adverse Event|1|||
131663987|NCT01151410|474053117|FG001|Overall Study|Adverse Event|2|||
131663988|NCT01151410|474053116|FG000|Overall Study|Protocol deviation|2|||
131663989|NCT01151410|474053117|FG001|Overall Study|Protocol deviation|1|||
131663990|NCT01151410|474053116|FG000|Overall Study|Administrative problems|1|||
131663991|NCT01151410|474053117|FG001|Overall Study|Administrative problems|1|||
131663992|NCT01151410|474053116|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131889862|NCT03959488|474880701|FG001|Season 1|Due to COVID-19 pandemic|3|||
131889863|NCT03959488|474880702|FG002|Season 1|Due to COVID-19 pandemic|0|||
131889864|NCT03959488|474880703|FG003|Season 1|Due to COVID-19 pandemic|0|||
131889865|NCT03959488|474880704|FG004|Season 1|Due to COVID-19 pandemic|0|||
131889866|NCT03959488|474880700|FG000|Season 1|Lost to Follow-up|17|||
131663993|NCT01151410|474053117|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131663994|NCT01151410|474053116|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131889867|NCT03959488|474880701|FG001|Season 1|Lost to Follow-up|7|||
131889868|NCT03959488|474880702|FG002|Season 1|Lost to Follow-up|0|||
131889869|NCT03959488|474880703|FG003|Season 1|Lost to Follow-up|0|||
131889870|NCT03959488|474880704|FG004|Season 1|Lost to Follow-up|0|||
131889871|NCT03959488|474880700|FG000|Season 1|Death|5|||
131889872|NCT03959488|474880701|FG001|Season 1|Death|1|||
131889873|NCT03959488|474880702|FG002|Season 1|Death|0|||
131889874|NCT03959488|474880703|FG003|Season 1|Death|0|||
131889875|NCT03959488|474880704|FG004|Season 1|Death|0|||
131889876|NCT03959488|474880700|FG000|Season 2|Other|0|||
131889877|NCT03959488|474880701|FG001|Season 2|Other|0|||
131889878|NCT03959488|474880702|FG002|Season 2|Other|2|||
131889879|NCT03959488|474880703|FG003|Season 2|Other|0|||
131889880|NCT03959488|474880704|FG004|Season 2|Other|0|||
131889881|NCT03959488|474880700|FG000|Season 2|Withdrawal by parent/guardian|0|||
131889882|NCT03959488|474880701|FG001|Season 2|Withdrawal by parent/guardian|0|||
131889883|NCT03959488|474880702|FG002|Season 2|Withdrawal by parent/guardian|3|||
131889884|NCT03959488|474880703|FG003|Season 2|Withdrawal by parent/guardian|1|||
131889885|NCT03959488|474880704|FG004|Season 2|Withdrawal by parent/guardian|1|||
131889886|NCT03959488|474880700|FG000|Season 2|Lost to Follow-up|0|||
131889887|NCT03959488|474880701|FG001|Season 2|Lost to Follow-up|0|||
131889888|NCT03959488|474880702|FG002|Season 2|Lost to Follow-up|1|||
131889889|NCT03959488|474880703|FG003|Season 2|Lost to Follow-up|0|||
131889890|NCT03959488|474880704|FG004|Season 2|Lost to Follow-up|1|||
131889891|NCT01760447|474880705|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
131889892|NCT01760447|474880706|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
131889893|NCT01760447|474880707|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
131889894|NCT01760447|474880708|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
131889895|NCT01760447|474880705|FG000|Weeks 0-20|Withdrawal by Subject|2|||
131889896|NCT01760447|474880706|FG001|Weeks 0-20|Withdrawal by Subject|0|||
131889897|NCT01760447|474880707|FG002|Weeks 0-20|Withdrawal by Subject|1|||
131889898|NCT01760447|474880708|FG003|Weeks 0-20|Withdrawal by Subject|0|||
131889899|NCT01760447|474880705|FG000|Weeks 0-20|Lost to Follow-up|1|||
131889900|NCT01760447|474880706|FG001|Weeks 0-20|Lost to Follow-up|0|||
131889901|NCT01760447|474880707|FG002|Weeks 0-20|Lost to Follow-up|1|||
131889902|NCT01760447|474880708|FG003|Weeks 0-20|Lost to Follow-up|1|||
131435916|NCT03084796|473221895|FG005|Overall Study|Lost to Follow-up|1|||
131553090|NCT05672680|473649814|FG001|Overall Study|Procedure Aborted|0|||
131553091|NCT01395823|473649819|FG000|Overall Study|Death|4|||
131553092|NCT01395823|473649820|FG001|Overall Study|Death|4|||
131553093|NCT01395823|473649819|FG000|Overall Study|Physician Decision|3|||
131553094|NCT01395823|473649820|FG001|Overall Study|Physician Decision|1|||
131553095|NCT01395823|473649819|FG000|Overall Study|Lost to Follow-up|1|||
131553096|NCT01395823|473649820|FG001|Overall Study|Lost to Follow-up|0|||
131553097|NCT01395823|473649819|FG000|Overall Study|Transplant|1|||
131553098|NCT01395823|473649820|FG001|Overall Study|Transplant|0|||
131553099|NCT01395823|473649819|FG000|Overall Study|GI symptoms|1|||
131553100|NCT01395823|473649820|FG001|Overall Study|GI symptoms|0|||
131553101|NCT01395823|473649819|FG000|Overall Study|Withdrawal by Subject|5|||
131553102|NCT01395823|473649820|FG001|Overall Study|Withdrawal by Subject|4|||
131553103|NCT01036022|473649821|FG000|Overall Study|Adverse Event|1|||
131553104|NCT01036022|473649822|FG001|Overall Study|Adverse Event|3|||
131553105|NCT01036022|473649823|FG002|Overall Study|Adverse Event|2|||
131553106|NCT01036022|473649824|FG003|Overall Study|Adverse Event|1|||
131553107|NCT01036022|473649825|FG004|Overall Study|Adverse Event|0|||
131553108|NCT01036022|473649826|FG005|Overall Study|Adverse Event|2|||
131553109|NCT01036022|473649821|FG000|Overall Study|Lack of Efficacy|1|||
131553110|NCT01036022|473649822|FG001|Overall Study|Lack of Efficacy|1|||
131553111|NCT01036022|473649823|FG002|Overall Study|Lack of Efficacy|1|||
131553112|NCT01036022|473649824|FG003|Overall Study|Lack of Efficacy|0|||
131553113|NCT01036022|473649825|FG004|Overall Study|Lack of Efficacy|1|||
131553114|NCT01036022|473649826|FG005|Overall Study|Lack of Efficacy|1|||
131553115|NCT01036022|473649821|FG000|Overall Study|Physician Decision|0|||
131553116|NCT01036022|473649822|FG001|Overall Study|Physician Decision|0|||
131553117|NCT01036022|473649823|FG002|Overall Study|Physician Decision|1|||
131553118|NCT01036022|473649824|FG003|Overall Study|Physician Decision|0|||
131553119|NCT01036022|473649825|FG004|Overall Study|Physician Decision|0|||
131553120|NCT01036022|473649826|FG005|Overall Study|Physician Decision|0|||
131553121|NCT01036022|473649821|FG000|Overall Study|Withdrawal by Subject|0|||
131553122|NCT01036022|473649822|FG001|Overall Study|Withdrawal by Subject|0|||
131553123|NCT01036022|473649823|FG002|Overall Study|Withdrawal by Subject|0|||
131553124|NCT01036022|473649824|FG003|Overall Study|Withdrawal by Subject|1|||
131553125|NCT01036022|473649825|FG004|Overall Study|Withdrawal by Subject|2|||
131553126|NCT01036022|473649826|FG005|Overall Study|Withdrawal by Subject|0|||
131889903|NCT01760447|474880705|FG000|Weeks 0-20|Randomized but not treated|0|||
131889904|NCT01760447|474880706|FG001|Weeks 0-20|Randomized but not treated|0|||
131889905|NCT01760447|474880707|FG002|Weeks 0-20|Randomized but not treated|2|||
131889906|NCT01760447|474880708|FG003|Weeks 0-20|Randomized but not treated|0|||
131889907|NCT01760447|474880705|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
131889908|NCT01760447|474880706|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
131889909|NCT01760447|474880707|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
131663995|NCT01151410|474053117|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131663996|NCT00735475|474053118|FG000|Overall Study|Adverse Event|0|||
131663997|NCT00735475|474053119|FG001|Overall Study|Adverse Event|1|||
131663998|NCT00735475|474053118|FG000|Overall Study|Death|1|||
131663999|NCT00735475|474053119|FG001|Overall Study|Death|1|||
131664000|NCT00735475|474053118|FG000|Overall Study|Lost to Follow-up|3|||
131664001|NCT00735475|474053119|FG001|Overall Study|Lost to Follow-up|3|||
131664002|NCT00735475|474053118|FG000|Overall Study|Physician Decision|0|||
131664003|NCT00735475|474053119|FG001|Overall Study|Physician Decision|1|||
131664004|NCT00735475|474053118|FG000|Overall Study|Withdrawal by Subject|4|||
131664005|NCT00735475|474053119|FG001|Overall Study|Withdrawal by Subject|5|||
131664006|NCT01080716|474053121|FG000|Part 1|Physician Decision|1|||
131664007|NCT01080716|474053122|FG001|Part 1|Physician Decision|0|||
131664008|NCT01080716|474053123|FG002|Part 1|Physician Decision|0|||
131664009|NCT01080716|474053124|FG003|Part 1|Physician Decision|0|||
131664010|NCT05086276|474053125|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
131664011|NCT05086276|474053126|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
131664012|NCT00760474|474053133|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
131664013|NCT00760474|474053134|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
131664014|NCT00760474|474053133|FG000|Placebo Washout Period|Other|0|||
131664015|NCT00760474|474053134|FG001|Placebo Washout Period|Other|1|||
131664016|NCT00760474|474053133|FG000|Period 2 (P2)|Lost to Follow-up|1|||
131664017|NCT00760474|474053134|FG001|Period 2 (P2)|Lost to Follow-up|0|||
131664018|NCT00760474|474053133|FG000|Period 2 (P2)|Adverse Event|0|||
131664019|NCT00760474|474053134|FG001|Period 2 (P2)|Adverse Event|1|||
131664020|NCT02217501|474053140|FG000|Overall Study|Death|3|||
131664021|NCT02217501|474053141|FG001|Overall Study|Death|4|||
131664022|NCT00775463|474054786|FG000|Overall Study|Withdrawal by Subject|0|||
131664023|NCT00775463|474054787|FG001|Overall Study|Withdrawal by Subject|1|||
131664024|NCT00775463|474054786|FG000|Overall Study|Adverse Event|7|||
131664025|NCT00775463|474054787|FG001|Overall Study|Adverse Event|9|||
131664026|NCT00775463|474054786|FG000|Overall Study|Protocol Violation|2|||
131664027|NCT00775463|474054787|FG001|Overall Study|Protocol Violation|2|||
131664028|NCT00775463|474054786|FG000|Overall Study|Lost to Follow-up|1|||
131664029|NCT00775463|474054787|FG001|Overall Study|Lost to Follow-up|0|||
131664030|NCT00775463|474054786|FG000|Overall Study|Lack of Efficacy|1|||
131664031|NCT00775463|474054787|FG001|Overall Study|Lack of Efficacy|1|||
131664032|NCT01238900|474054788|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
131664033|NCT01238900|474054788|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
131664034|NCT00852540|474054791|FG000|Overall Study|Adverse Event|10|||
131664035|NCT00852540|474054792|FG001|Overall Study|Adverse Event|3|||
131664036|NCT00852540|474054791|FG000|Overall Study|Lack of Efficacy|15|||
131664037|NCT00852540|474054792|FG001|Overall Study|Lack of Efficacy|3|||
131664038|NCT00852540|474054791|FG000|Overall Study|Protocol Violation|1|||
131664039|NCT00852540|474054792|FG001|Overall Study|Protocol Violation|2|||
131664040|NCT00852540|474054791|FG000|Overall Study|Lost to Follow-up|2|||
131664041|NCT00852540|474054792|FG001|Overall Study|Lost to Follow-up|3|||
131664042|NCT00852540|474054791|FG000|Overall Study|Investigator Discretion|2|||
131664043|NCT00852540|474054792|FG001|Overall Study|Investigator Discretion|3|||
131664044|NCT00852540|474054791|FG000|Overall Study|Withdrawal by Subject|3|||
131664045|NCT00852540|474054792|FG001|Overall Study|Withdrawal by Subject|1|||
131664046|NCT00852540|474054791|FG000|Overall Study|Did Not Receive Study Drug|3|||
131664047|NCT00852540|474054792|FG001|Overall Study|Did Not Receive Study Drug|3|||
131664048|NCT01119105|474054793|FG000|Overall Study|Withdrawal by Subject|1|||
131664049|NCT01119105|474054794|FG001|Overall Study|Withdrawal by Subject|1|||
131664050|NCT01119105|474054795|FG002|Overall Study|Withdrawal by Subject|1|||
131664051|NCT01119105|474054793|FG000|Overall Study|Lost to Follow-up|0|||
131664052|NCT01119105|474054794|FG001|Overall Study|Lost to Follow-up|2|||
131664053|NCT01119105|474054795|FG002|Overall Study|Lost to Follow-up|5|||
131664054|NCT01119105|474054793|FG000|Overall Study|Adverse Event|1|||
131664055|NCT01119105|474054794|FG001|Overall Study|Adverse Event|0|||
131664056|NCT01119105|474054795|FG002|Overall Study|Adverse Event|1|||
131664057|NCT01119105|474054793|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
131664058|NCT01119105|474054794|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
131664059|NCT01119105|474054795|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
131664060|NCT01119105|474054793|FG000|Overall Study|Other|1|||
131664061|NCT01119105|474054794|FG001|Overall Study|Other|1|||
131664062|NCT01119105|474054795|FG002|Overall Study|Other|0|||
131664063|NCT00618618|474054796|FG000|Overall Study|Patient Request|0|||
131664064|NCT00618618|474054797|FG001|Overall Study|Patient Request|0|||
131664065|NCT00618618|474054798|FG002|Overall Study|Patient Request|2|||
131664066|NCT00618618|474054799|FG003|Overall Study|Patient Request|0|||
131664067|NCT00618618|474054796|FG000|Overall Study|Inability to Complete Study Procedures|0|||
131664068|NCT00618618|474054797|FG001|Overall Study|Inability to Complete Study Procedures|1|||
131664069|NCT00618618|474054798|FG002|Overall Study|Inability to Complete Study Procedures|0|||
131664070|NCT00618618|474054799|FG003|Overall Study|Inability to Complete Study Procedures|0|||
131664071|NCT00618618|474054796|FG000|Overall Study|Lost to Follow-up|3|||
131664072|NCT00618618|474054797|FG001|Overall Study|Lost to Follow-up|0|||
131664073|NCT00618618|474054798|FG002|Overall Study|Lost to Follow-up|0|||
131664074|NCT00618618|474054799|FG003|Overall Study|Lost to Follow-up|1|||
131664075|NCT00618618|474054796|FG000|Overall Study|Non-compliance|1|||
131664076|NCT00618618|474054797|FG001|Overall Study|Non-compliance|1|||
131889910|NCT01760447|474880708|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
131553127|NCT03300570|473649827|FG000|Overall Study|Adverse Event|0|||
131553128|NCT03300570|473649828|FG001|Overall Study|Adverse Event|1|||
131553129|NCT03300570|473649827|FG000|Overall Study|Withdrawal by Subject|1|||
131553130|NCT03300570|473649828|FG001|Overall Study|Withdrawal by Subject|0|||
131553131|NCT03300570|473649827|FG000|Overall Study|Inadequate bowel prep|1|||
131553132|NCT03300570|473649828|FG001|Overall Study|Inadequate bowel prep|0|||
131553133|NCT05076149|473649831|FG000|Overall Study|Adverse Event|3|||
131553134|NCT05076149|473649832|FG001|Overall Study|Adverse Event|9|||
131553135|NCT05076149|473649831|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
131553136|NCT05076149|473649832|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
131553137|NCT05076149|473649831|FG000|Overall Study|Lost to Follow-up|0|||
131553138|NCT05076149|473649832|FG001|Overall Study|Lost to Follow-up|1|||
131553139|NCT05076149|473649831|FG000|Overall Study|Commercial drug is available for participant|0|||
131553140|NCT05076149|473649832|FG001|Overall Study|Commercial drug is available for participant|1|||
131553141|NCT05076149|473649831|FG000|Overall Study|Other non compliance|1|||
131553142|NCT05076149|473649832|FG001|Overall Study|Other non compliance|1|||
131553143|NCT05076149|473649831|FG000|Overall Study|Physician Decision|0|||
131553144|NCT05076149|473649832|FG001|Overall Study|Physician Decision|1|||
131553145|NCT05076149|473649831|FG000|Overall Study|Other|5|||
131553146|NCT05076149|473649832|FG001|Overall Study|Other|4|||
131553147|NCT05096208|473649833|FG000|Overall Study|Lost to Follow-up|3|||
131553148|NCT05096208|473649834|FG001|Overall Study|Lost to Follow-up|5|||
131553149|NCT05096208|473649835|FG002|Overall Study|Lost to Follow-up|5|||
131553150|NCT05096208|473649836|FG003|Overall Study|Lost to Follow-up|2|||
131553151|NCT05096208|473649833|FG000|Overall Study|Withdrawal by Subject|0|||
131553152|NCT05096208|473649834|FG001|Overall Study|Withdrawal by Subject|1|||
131553153|NCT05096208|473649835|FG002|Overall Study|Withdrawal by Subject|2|||
131553154|NCT05096208|473649836|FG003|Overall Study|Withdrawal by Subject|3|||
131553155|NCT05096208|473649833|FG000|Overall Study|No longer met eligibility criteria|1|||
131553156|NCT05096208|473649834|FG001|Overall Study|No longer met eligibility criteria|0|||
131553157|NCT05096208|473649835|FG002|Overall Study|No longer met eligibility criteria|0|||
131553158|NCT05096208|473649836|FG003|Overall Study|No longer met eligibility criteria|0|||
131553159|NCT05096208|473649833|FG000|Overall Study|Other|0|||
131553160|NCT05096208|473649834|FG001|Overall Study|Other|0|||
131553161|NCT05096208|473649835|FG002|Overall Study|Other|1|||
131553162|NCT05096208|473649836|FG003|Overall Study|Other|0|||
131553163|NCT02087501|473649837|FG000|Overall Study|Death|7|||
131553164|NCT02087501|473649837|FG000|Overall Study|Open repair of aneurysm|1|||
131553165|NCT02087501|473649837|FG000|Overall Study|Lost to Follow-up|2|||
131553166|NCT00094328|473649838|FG000|Overall Study|Lost to Follow-up|1|||
131553167|NCT01483937|473649839|FG000|Overall Study|Withdrawal by Subject|4|||
131553168|NCT01483937|473649840|FG001|Overall Study|Withdrawal by Subject|3|||
131553169|NCT01875185|473649842|FG000|Overall Study|study was terminated|52|||
131553170|NCT01875185|473649843|FG001|Overall Study|study was terminated|48|||
131553171|NCT01686581|473649844|FG000|Overall Study|Side-effects or Health Problems|15|||
131553172|NCT01686581|473649844|FG000|Overall Study|Lack of Efficacy|90|||
131553173|NCT01686581|473649844|FG000|Overall Study|Participant Concerned about Risks|6|||
131553174|NCT01686581|473649844|FG000|Overall Study|Thinks Injections Too Painful|8|||
131553175|NCT01686581|473649844|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
131553176|NCT01686581|473649844|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
131553177|NCT01686581|473649844|FG000|Overall Study|Thinks it is Inconvenient|17|||
131553178|NCT01686581|473649844|FG000|Overall Study|Other Miscellaneous Reasons|36|||
131553179|NCT01686581|473649844|FG000|Overall Study|Reason Missing|1|||
131553180|NCT00399763|473649845|FG000|Overall Study|Lost to Follow-up|2|||
131553181|NCT00399763|473649846|FG001|Overall Study|Lost to Follow-up|3|||
131553182|NCT04182880|473649847|FG000|Overall Study|Pregnancy|1|||
131553183|NCT04182880|473649848|FG001|Overall Study|Pregnancy|0|||
131553184|NCT03389477|473649849|FG000|Step 1|Withdrawal by Subject|1|||
131553185|NCT03389477|473649850|FG001|Step 1|Withdrawal by Subject|0|||
131553186|NCT03389477|473649849|FG000|Step 2|Withdrawal by Subject|1|||
131553187|NCT03389477|473649850|FG001|Step 2|Withdrawal by Subject|2|||
131553188|NCT03389477|473649849|FG000|Step 2|Disease progression|1|||
131553189|NCT03389477|473649850|FG001|Step 2|Disease progression|0|||
131553190|NCT03389477|473649849|FG000|Step 2|Death|0|||
131553191|NCT03389477|473649850|FG001|Step 2|Death|1|||
131553192|NCT03389477|473649849|FG000|Step 2|Poor performance status and nutrition|0|||
131553193|NCT03389477|473649850|FG001|Step 2|Poor performance status and nutrition|1|||
131553194|NCT03389477|473649849|FG000|Step 3|Withdrawal after 3 cycles|0|||
131664077|NCT00618618|474054798|FG002|Overall Study|Non-compliance|0|||
131664078|NCT00618618|474054799|FG003|Overall Study|Non-compliance|0|||
131553195|NCT03389477|473649850|FG001|Step 3|Withdrawal after 3 cycles|1|||
131553196|NCT03389477|473649849|FG000|Step 3|Still receiving active treatment|4|||
131889911|NCT01760447|474880705|FG000|Weeks 20-54|Withdrawal by Subject|2|||
131664079|NCT00618618|474054796|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
131664080|NCT00618618|474054797|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
131664081|NCT00618618|474054798|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
131664082|NCT00618618|474054799|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
131664083|NCT00618618|474054796|FG000|Overall Study|Death|0|||
131664084|NCT00618618|474054797|FG001|Overall Study|Death|1|||
131664085|NCT00618618|474054798|FG002|Overall Study|Death|0|||
131889912|NCT01760447|474880706|FG001|Weeks 20-54|Withdrawal by Subject|1|||
131889913|NCT01760447|474880707|FG002|Weeks 20-54|Withdrawal by Subject|1|||
131889914|NCT01760447|474880708|FG003|Weeks 20-54|Withdrawal by Subject|2|||
131889915|NCT01760447|474880705|FG000|Weeks 20-54|Lost to Follow-up|0|||
131889916|NCT01760447|474880706|FG001|Weeks 20-54|Lost to Follow-up|0|||
131889917|NCT01760447|474880707|FG002|Weeks 20-54|Lost to Follow-up|1|||
131889918|NCT01760447|474880708|FG003|Weeks 20-54|Lost to Follow-up|2|||
131889919|NCT06439095|474880710|FG000|Overall Study|Lost to Follow-up|2|||
131889920|NCT02368886|474880711|FG000|Overall Study|Cancel|1|||
131889921|NCT02368886|474880712|FG001|Overall Study|Cancel|1|||
131889922|NCT02368886|474880713|FG002|Overall Study|Cancel|1|||
131889923|NCT02368886|474880714|FG003|Overall Study|Cancel|3|||
131889924|NCT02368886|474880711|FG000|Overall Study|Ineligible|0|||
131889925|NCT02368886|474880712|FG001|Overall Study|Ineligible|0|||
131889926|NCT02368886|474880713|FG002|Overall Study|Ineligible|0|||
131889927|NCT02368886|474880714|FG003|Overall Study|Ineligible|1|||
131889928|NCT02131636|474880717|FG000|Overall Study|Personal Reasons|4|||
131889929|NCT02131636|474880718|FG001|Overall Study|Personal Reasons|4|||
131889930|NCT02131636|474880717|FG000|Overall Study|Lost to Follow-up|4|||
131889931|NCT02131636|474880718|FG001|Overall Study|Lost to Follow-up|0|||
131889932|NCT02131636|474880717|FG000|Overall Study|Adverse Event|4|||
131889933|NCT02131636|474880718|FG001|Overall Study|Adverse Event|1|||
131889934|NCT02173379|474880719|FG000|Overall Study|Lost to Follow-up|89|||
131889935|NCT02173379|474880720|FG001|Overall Study|Lost to Follow-up|81|||
131889936|NCT02173379|474880719|FG000|Overall Study|Withdrawal by Subject|24|||
131889937|NCT02173379|474880720|FG001|Overall Study|Withdrawal by Subject|29|||
131889938|NCT02173379|474880719|FG000|Overall Study|Physician Decision|8|||
131889939|NCT02173379|474880720|FG001|Overall Study|Physician Decision|8|||
131889940|NCT02173379|474880719|FG000|Overall Study|Death|75|||
131889941|NCT02173379|474880720|FG001|Overall Study|Death|72|||
131889942|NCT02173379|474880719|FG000|Overall Study|Other Reason|1|||
131889943|NCT02173379|474880720|FG001|Overall Study|Other Reason|0|||
131889944|NCT00715520|474880723|FG000|Overall Study|Screen failure|8|||
131889945|NCT00715520|474880724|FG001|Overall Study|Screen failure|1|||
131889946|NCT00715520|474880725|FG002|Overall Study|Screen failure|1|||
131889947|NCT00715520|474880723|FG000|Overall Study|Withdrawal by Subject|2|||
131889948|NCT00715520|474880724|FG001|Overall Study|Withdrawal by Subject|0|||
131889949|NCT00715520|474880725|FG002|Overall Study|Withdrawal by Subject|1|||
131889950|NCT02290925|474880731|FG000|First Period of Three Months|Lost to Follow-up|2|||
131889951|NCT02290925|474880732|FG001|First Period of Three Months|Lost to Follow-up|1|||
131889952|NCT02290925|474880731|FG000|First Period of Three Months|Death|1|||
131889953|NCT02290925|474880732|FG001|First Period of Three Months|Death|0|||
131889954|NCT02290925|474880731|FG000|First Period of Three Months|Insulin Started|1|||
131889955|NCT02290925|474880732|FG001|First Period of Three Months|Insulin Started|1|||
131889956|NCT02290925|474880731|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
131664086|NCT00618618|474054799|FG003|Overall Study|Death|0|||
131664087|NCT03836716|474054803|FG000|Overall Study|Adverse Event|3|||
131664088|NCT03836716|474054803|FG000|Overall Study|Death|22|||
131664089|NCT03836716|474054803|FG000|Overall Study|Withdrawal by Subject|8|||
131664090|NCT03836716|474054803|FG000|Overall Study|Study terminated by sponsor|87|||
131664091|NCT00434213|474054804|FG000|Overall Study|Adverse Event|12|||
131664092|NCT00434213|474054804|FG000|Overall Study|Lack of Efficacy|9|||
131889957|NCT02290925|474880732|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
131889958|NCT02290925|474880731|FG000|Second Period of 3 Months|insulin started|0|||
131889959|NCT02290925|474880732|FG001|Second Period of 3 Months|insulin started|1|||
131889960|NCT04942210|474880733|FG000|Overall Study|Adverse Event|0|||
131664093|NCT00434213|474054804|FG000|Overall Study|Lost to Follow-up|14|||
131664094|NCT00434213|474054804|FG000|Overall Study|Withdrawal by Subject|7|||
131664095|NCT00434213|474054804|FG000|Overall Study|Protocol Violation|3|||
131664096|NCT00434213|474054804|FG000|Overall Study|Unable to comply with study visit window|2|||
131664097|NCT00434213|474054804|FG000|Overall Study|Application site reaction|1|||
131664098|NCT00434213|474054804|FG000|Overall Study|Non-compliant to study schedule|1|||
131664099|NCT01631227|474054806|FG000|Overall Study|withdrawn consent|27|||
131889961|NCT04942210|474880734|FG001|Overall Study|Adverse Event|1|||
131889962|NCT04942210|474880733|FG000|Overall Study|Protocol Deviation|4|||
131889963|NCT04942210|474880734|FG001|Overall Study|Protocol Deviation|1|||
131889964|NCT04942210|474880733|FG000|Overall Study|Withdrawal by Subject|5|||
131889965|NCT04942210|474880734|FG001|Overall Study|Withdrawal by Subject|2|||
131889966|NCT04942210|474880733|FG000|Overall Study|Lost to Follow-up|16|||
131889967|NCT04942210|474880734|FG001|Overall Study|Lost to Follow-up|7|||
131889968|NCT04942210|474880733|FG000|Overall Study|Ongoing at the time of DBL date|60|||
131889969|NCT04942210|474880734|FG001|Overall Study|Ongoing at the time of DBL date|25|||
131889970|NCT04942210|474880733|FG000|Overall Study|Randomized but did not receive vaccination|3|||
131889971|NCT04942210|474880734|FG001|Overall Study|Randomized but did not receive vaccination|0|||
131889972|NCT05697627|474880735|FG000|Overall Study|Adverse Event|1|||
131889973|NCT02570750|474880736|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
131889974|NCT02570750|474880737|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
131889975|NCT02570750|474880736|FG000|Overall Study|Protocol deviation|4|||
131889976|NCT02570750|474880737|FG001|Overall Study|Protocol deviation|2|||
131889977|NCT02570750|474880736|FG000|Overall Study|Withdrawal by Subject|5|||
131889978|NCT02570750|474880737|FG001|Overall Study|Withdrawal by Subject|0|||
131889979|NCT02570750|474880736|FG000|Overall Study|Lost to Follow-up|2|||
131889980|NCT02570750|474880737|FG001|Overall Study|Lost to Follow-up|2|||
131889981|NCT02570750|474880736|FG000|Overall Study|Adverse Event|2|||
131889982|NCT02570750|474880737|FG001|Overall Study|Adverse Event|1|||
131889983|NCT04122625|474880738|FG000|Part A (up to 2.92 Years)|Death|2|||
131889984|NCT04122625|474880739|FG001|Part A (up to 2.92 Years)|Death|4|||
131889985|NCT04122625|474880740|FG002|Part A (up to 2.92 Years)|Death|0|||
131889986|NCT04122625|474880741|FG003|Part A (up to 2.92 Years)|Death|0|||
131889987|NCT04122625|474880742|FG004|Part A (up to 2.92 Years)|Death|0|||
131889988|NCT04122625|474880743|FG005|Part A (up to 2.92 Years)|Death|0|||
131889989|NCT04122625|474880738|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
131889990|NCT04122625|474880739|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
131889991|NCT04122625|474880740|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
131889992|NCT04122625|474880741|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
131889993|NCT04122625|474880742|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
131889994|NCT04122625|474880743|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
131889995|NCT04122625|474880738|FG000|Part B (up to 2.33 Years)|Death|0|||
131889996|NCT04122625|474880739|FG001|Part B (up to 2.33 Years)|Death|0|||
131889997|NCT04122625|474880740|FG002|Part B (up to 2.33 Years)|Death|5|||
131889998|NCT04122625|474880741|FG003|Part B (up to 2.33 Years)|Death|7|||
131889999|NCT04122625|474880742|FG004|Part B (up to 2.33 Years)|Death|6|||
131890000|NCT04122625|474880743|FG005|Part B (up to 2.33 Years)|Death|7|||
131890001|NCT01410240|474880744|FG000|Overall Study|Physician Decision|0|||
131890002|NCT01410240|474880745|FG001|Overall Study|Physician Decision|0|||
131890003|NCT01410240|474880746|FG002|Overall Study|Physician Decision|1|||
131890004|NCT01410240|474880744|FG000|Overall Study|Missed week 6 assessments|1|||
131890005|NCT01410240|474880745|FG001|Overall Study|Missed week 6 assessments|1|||
131890006|NCT01410240|474880746|FG002|Overall Study|Missed week 6 assessments|1|||
131890007|NCT02776670|474880747|FG000|Overall Study|Adverse Event|0|||
131890008|NCT02776670|474880748|FG001|Overall Study|Adverse Event|2|||
131890009|NCT02776670|474880747|FG000|Overall Study|Protocol Violation|0|||
131890010|NCT02776670|474880748|FG001|Overall Study|Protocol Violation|2|||
131890011|NCT02776670|474880747|FG000|Overall Study|Withdrawal by Subject|0|||
131890012|NCT02776670|474880748|FG001|Overall Study|Withdrawal by Subject|1|||
131890013|NCT02776670|474880747|FG000|Overall Study|Other - Reason not given|0|||
131890014|NCT02776670|474880748|FG001|Overall Study|Other - Reason not given|1|||
131890015|NCT02697591|474880751|FG000|Overall Study|Lost to Follow-up|0|||
131890016|NCT02697591|474880752|FG001|Overall Study|Lost to Follow-up|0|||
131890017|NCT02697591|474880753|FG002|Overall Study|Lost to Follow-up|0|||
131890018|NCT02697591|474880754|FG003|Overall Study|Lost to Follow-up|0|||
131890019|NCT02697591|474880755|FG004|Overall Study|Lost to Follow-up|0|||
131890020|NCT02697591|474880756|FG005|Overall Study|Lost to Follow-up|1|||
131890021|NCT02697591|474880757|FG006|Overall Study|Lost to Follow-up|1|||
131890022|NCT02697591|474880758|FG007|Overall Study|Lost to Follow-up|0|||
131890023|NCT02697591|474880759|FG008|Overall Study|Lost to Follow-up|0|||
131890024|NCT02697591|474880760|FG009|Overall Study|Lost to Follow-up|1|||
131890025|NCT02697591|474880751|FG000|Overall Study|Withdrawal by Subject|1|||
131890026|NCT02697591|474880752|FG001|Overall Study|Withdrawal by Subject|1|||
131890027|NCT02697591|474880753|FG002|Overall Study|Withdrawal by Subject|2|||
131890028|NCT02697591|474880754|FG003|Overall Study|Withdrawal by Subject|1|||
131890029|NCT02697591|474880755|FG004|Overall Study|Withdrawal by Subject|7|||
131890030|NCT02697591|474880756|FG005|Overall Study|Withdrawal by Subject|6|||
131890031|NCT02697591|474880757|FG006|Overall Study|Withdrawal by Subject|9|||
131553197|NCT03389477|473649850|FG001|Step 3|Still receiving active treatment|0|||
131553198|NCT03389477|473649849|FG000|Step 3|Progressive disease after 2 cycles|1|||
131890032|NCT02697591|474880758|FG007|Overall Study|Withdrawal by Subject|1|||
131890033|NCT02697591|474880759|FG008|Overall Study|Withdrawal by Subject|6|||
131890034|NCT02697591|474880760|FG009|Overall Study|Withdrawal by Subject|10|||
131890035|NCT02697591|474880751|FG000|Overall Study|Physician Decision|1|||
131890036|NCT02697591|474880752|FG001|Overall Study|Physician Decision|0|||
131890037|NCT02697591|474880753|FG002|Overall Study|Physician Decision|0|||
131890038|NCT02697591|474880754|FG003|Overall Study|Physician Decision|0|||
131890039|NCT02697591|474880755|FG004|Overall Study|Physician Decision|1|||
131890040|NCT02697591|474880756|FG005|Overall Study|Physician Decision|2|||
131553199|NCT03389477|473649850|FG001|Step 3|Progressive disease after 2 cycles|0|||
131890041|NCT02697591|474880757|FG006|Overall Study|Physician Decision|0|||
131890042|NCT02697591|474880758|FG007|Overall Study|Physician Decision|0|||
131890043|NCT02697591|474880759|FG008|Overall Study|Physician Decision|1|||
131890044|NCT02697591|474880760|FG009|Overall Study|Physician Decision|1|||
131890045|NCT02697591|474880751|FG000|Overall Study|Death|2|||
131890046|NCT02697591|474880752|FG001|Overall Study|Death|3|||
131890047|NCT02697591|474880753|FG002|Overall Study|Death|1|||
131890048|NCT02697591|474880754|FG003|Overall Study|Death|1|||
131890049|NCT02697591|474880755|FG004|Overall Study|Death|4|||
131890050|NCT02697591|474880756|FG005|Overall Study|Death|5|||
131890051|NCT02697591|474880757|FG006|Overall Study|Death|3|||
131890052|NCT02697591|474880758|FG007|Overall Study|Death|1|||
131890053|NCT02697591|474880759|FG008|Overall Study|Death|1|||
131890054|NCT02697591|474880760|FG009|Overall Study|Death|5|||
131890055|NCT02697591|474880751|FG000|Overall Study|Reason not Specified|0|||
131890056|NCT02697591|474880752|FG001|Overall Study|Reason not Specified|0|||
131890057|NCT02697591|474880753|FG002|Overall Study|Reason not Specified|0|||
131890058|NCT02697591|474880754|FG003|Overall Study|Reason not Specified|1|||
131890059|NCT02697591|474880755|FG004|Overall Study|Reason not Specified|1|||
131890060|NCT02697591|474880756|FG005|Overall Study|Reason not Specified|2|||
131890061|NCT02697591|474880757|FG006|Overall Study|Reason not Specified|3|||
131890062|NCT02697591|474880758|FG007|Overall Study|Reason not Specified|1|||
131890063|NCT02697591|474880759|FG008|Overall Study|Reason not Specified|1|||
131890064|NCT02697591|474880760|FG009|Overall Study|Reason not Specified|3|||
131890065|NCT02722746|474880761|FG000|Overall Study|Withdrawal by Subject|0|||
131890066|NCT02722746|474880762|FG001|Overall Study|Withdrawal by Subject|1|||
131890067|NCT02722746|474880763|FG002|Overall Study|Withdrawal by Subject|0|||
131890068|NCT02722746|474880761|FG000|Overall Study|Protocol Violation|8|||
131890069|NCT02722746|474880762|FG001|Overall Study|Protocol Violation|4|||
131890070|NCT02722746|474880763|FG002|Overall Study|Protocol Violation|6|||
131890071|NCT00624832|474880768|FG000|Overall Study|Adverse Event|0|||
131890072|NCT00624832|474880769|FG001|Overall Study|Adverse Event|1|||
131890073|NCT00624832|474880770|FG002|Overall Study|Adverse Event|0|||
131890074|NCT00624832|474880771|FG003|Overall Study|Adverse Event|1|||
131890075|NCT00624832|474880768|FG000|Overall Study|Abnormal Laboratory Value|2|||
131890076|NCT00624832|474880769|FG001|Overall Study|Abnormal Laboratory Value|0|||
131890077|NCT00624832|474880770|FG002|Overall Study|Abnormal Laboratory Value|0|||
131890078|NCT00624832|474880771|FG003|Overall Study|Abnormal Laboratory Value|0|||
131890079|NCT04379700|474880772|FG000|Overall Study|Withdrawal by Subject|10|||
131890080|NCT04379700|474880772|FG000|Overall Study|Screen Fail|4|||
131890081|NCT04379700|474880772|FG000|Overall Study|Lost to Follow-up|3|||
131890082|NCT00592592|474880773|FG000|Overall Study|Patient found ineligible upon chart review|1|||
131890083|NCT02700698|474880774|FG000|Overall Study|Withdrawal by Subject|1|||
131890084|NCT02700698|474880775|FG001|Overall Study|Withdrawal by Subject|0|||
131890085|NCT00530790|474880776|FG000|Overall Study|Adverse Event|2|||
131890086|NCT00530790|474880776|FG000|Overall Study|Withdrawal by Subject|2|||
131890087|NCT00530790|474880776|FG000|Overall Study|Physician Decision|1|||
131890088|NCT05053035|474880779|FG000|Overall Study|Withdrawal by Subject|1|||
131890089|NCT05053035|474880780|FG001|Overall Study|Withdrawal by Subject|0|||
131890090|NCT03084315|474880782|FG000|Overall Study|Lost to Follow-up|8|||
131890091|NCT03084315|474880783|FG001|Overall Study|Lost to Follow-up|7|||
131890092|NCT03084315|474880782|FG000|Overall Study|Withdrawal by Subject|2|||
131890093|NCT03084315|474880783|FG001|Overall Study|Withdrawal by Subject|2|||
131890094|NCT01952080|474880785|FG000|Overall Study|Withdrawal by Subject|0|||
131890095|NCT01952080|474880786|FG001|Overall Study|Withdrawal by Subject|0|||
131890096|NCT01952080|474880787|FG002|Overall Study|Withdrawal by Subject|0|||
131890097|NCT01952080|474880788|FG003|Overall Study|Withdrawal by Subject|1|||
131890098|NCT01952080|474880785|FG000|Overall Study|Protocol Non-compliance|0|||
131890099|NCT01952080|474880786|FG001|Overall Study|Protocol Non-compliance|1|||
131890100|NCT01952080|474880787|FG002|Overall Study|Protocol Non-compliance|0|||
131890101|NCT01952080|474880788|FG003|Overall Study|Protocol Non-compliance|0|||
131890102|NCT00564395|474880789|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
131890103|NCT00564395|474880790|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
131890104|NCT00564395|474880789|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
131890105|NCT00564395|474880790|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
131890106|NCT00659776|474880804|FG000|Overall Study|Withdrawal by Subject|12|||
131890107|NCT00659776|474880805|FG001|Overall Study|Withdrawal by Subject|2|||
131890108|NCT00659776|474880806|FG002|Overall Study|Withdrawal by Subject|0|||
131890109|NCT01180049|474880807|FG000|Overall Study|Other|9|||
131890110|NCT01180049|474880808|FG001|Overall Study|Other|7|||
131664100|NCT01631227|474054807|FG001|Overall Study|withdrawn consent|21|||
131890111|NCT01180049|474880807|FG000|Overall Study|Lost to Follow-up|8|||
131890112|NCT01180049|474880808|FG001|Overall Study|Lost to Follow-up|6|||
131890113|NCT01180049|474880807|FG000|Overall Study|Death|36|||
131890114|NCT01180049|474880808|FG001|Overall Study|Death|35|||
131890115|NCT01905592|474880812|FG000|Overall Study|Disease Progression|51|||
131890116|NCT01905592|474880813|FG001|Overall Study|Disease Progression|110|||
131890117|NCT01905592|474880812|FG000|Overall Study|Toxicity|1|||
131890118|NCT01905592|474880813|FG001|Overall Study|Toxicity|16|||
131890119|NCT01905592|474880812|FG000|Overall Study|Physician Decision|0|||
131664101|NCT01631227|474054806|FG000|Overall Study|Adverse Event|1|||
131890120|NCT01905592|474880813|FG001|Overall Study|Physician Decision|2|||
131890121|NCT01905592|474880812|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
131890122|NCT01905592|474880813|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
131890123|NCT01905592|474880812|FG000|Overall Study|Protocol Violation|0|||
131890124|NCT01905592|474880813|FG001|Overall Study|Protocol Violation|1|||
131890125|NCT01905592|474880812|FG000|Overall Study|Sponsor's decision|1|||
131890126|NCT01905592|474880813|FG001|Overall Study|Sponsor's decision|1|||
131890127|NCT01905592|474880812|FG000|Overall Study|Not treated|7|||
131890128|NCT01905592|474880813|FG001|Overall Study|Not treated|3|||
131890129|NCT01905592|474880812|FG000|Overall Study|Withdrawal by Subject|10|||
131890130|NCT01905592|474880813|FG001|Overall Study|Withdrawal by Subject|2|||
131890131|NCT04003623|474882273|FG000|Overall Study|Withdrawal by Subject|1|||
131890132|NCT04003623|474882274|FG001|Overall Study|Withdrawal by Subject|0|||
131890133|NCT00703326|474882276|FG000|Overall Study|Lost to Follow-up|47|||
131890134|NCT00703326|474882277|FG001|Overall Study|Lost to Follow-up|18|||
131890135|NCT00703326|474882276|FG000|Overall Study|Withdrawal by Subject|54|||
131890136|NCT00703326|474882277|FG001|Overall Study|Withdrawal by Subject|20|||
131890137|NCT00703326|474882276|FG000|Overall Study|Adverse Event|1|||
131890138|NCT00703326|474882277|FG001|Overall Study|Adverse Event|0|||
131890139|NCT01393106|474882280|FG000|Overall Study|Adverse Event|3|||
131890140|NCT01393106|474882280|FG000|Overall Study|Withdrawal by Subject|1|||
131890141|NCT01393106|474882280|FG000|Overall Study|Lack of Efficacy|1|||
131890142|NCT01744483|474882281|FG000|Overall Study|Death|9|||
131890143|NCT01744483|474882282|FG001|Overall Study|Death|4|||
131890144|NCT01744483|474882283|FG002|Overall Study|Death|11|||
131890145|NCT01744483|474882281|FG000|Overall Study|Lost to Follow-up|8|||
131890146|NCT01744483|474882282|FG001|Overall Study|Lost to Follow-up|9|||
131890147|NCT01744483|474882283|FG002|Overall Study|Lost to Follow-up|11|||
131890148|NCT01744483|474882281|FG000|Overall Study|Protocol Violation|1|||
131890149|NCT01744483|474882282|FG001|Overall Study|Protocol Violation|2|||
131890150|NCT01744483|474882283|FG002|Overall Study|Protocol Violation|1|||
131890151|NCT01744483|474882281|FG000|Overall Study|Withdrawal by Subject|4|||
131890152|NCT01744483|474882282|FG001|Overall Study|Withdrawal by Subject|6|||
131890153|NCT01744483|474882283|FG002|Overall Study|Withdrawal by Subject|2|||
131890154|NCT01744483|474882281|FG000|Overall Study|No ICU Admit|5|||
131890155|NCT01744483|474882282|FG001|Overall Study|No ICU Admit|1|||
131890156|NCT01744483|474882283|FG002|Overall Study|No ICU Admit|2|||
131890157|NCT01744483|474882281|FG000|Overall Study|Routed to OSH|2|||
131890158|NCT01744483|474882282|FG001|Overall Study|Routed to OSH|0|||
131890159|NCT01744483|474882283|FG002|Overall Study|Routed to OSH|1|||
131890160|NCT03041467|474882284|FG000|Overall Study|Death|46|||
131890161|NCT03041467|474882285|FG001|Overall Study|Death|39|||
131890162|NCT03041467|474882284|FG000|Overall Study|Withdrawal by Subject|36|||
131890163|NCT03041467|474882285|FG001|Overall Study|Withdrawal by Subject|37|||
131890164|NCT03041467|474882284|FG000|Overall Study|Lost to Follow-up|6|||
131890165|NCT03041467|474882285|FG001|Overall Study|Lost to Follow-up|8|||
131890166|NCT03041467|474882284|FG000|Overall Study|Declined consent for study extension|21|||
131890167|NCT03041467|474882285|FG001|Overall Study|Declined consent for study extension|33|||
131890168|NCT03041467|474882284|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
131890169|NCT03041467|474882285|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
131890170|NCT01190189|474882286|FG000|Overall Study|Lost to Follow-up|4|||
131890171|NCT01190189|474882286|FG000|Overall Study|Withdrawal by Subject|1|||
131890172|NCT01190189|474882286|FG000|Overall Study|Migrated/moved from study area|1|||
131890173|NCT04348500|474882290|FG000|Overall Study|Death|2|||
131890174|NCT04348500|474882291|FG001|Overall Study|Death|2|||
131890175|NCT04348500|474882290|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
131890176|NCT04348500|474882291|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
131890177|NCT03517449|474882296|FG000|Overall Study|Death|184|||
131890178|NCT03517449|474882297|FG001|Overall Study|Death|236|||
131890179|NCT03517449|474882296|FG000|Overall Study|Lost to Follow-up|0|||
131890180|NCT03517449|474882297|FG001|Overall Study|Lost to Follow-up|2|||
131890181|NCT03517449|474882296|FG000|Overall Study|Withdrawal by Subject|7|||
131890182|NCT03517449|474882297|FG001|Overall Study|Withdrawal by Subject|26|||
131890183|NCT03517449|474882296|FG000|Overall Study|Participants Ongoing|220|||
131890184|NCT03517449|474882297|FG001|Overall Study|Participants Ongoing|152|||
131890185|NCT02005627|474882304|FG000|Overall Study|Lost to Follow-up|1|||
131890186|NCT02005627|474882305|FG001|Overall Study|Lost to Follow-up|2|||
131890187|NCT02005627|474882304|FG000|Overall Study|Withdrawal by Subject|1|||
131890188|NCT02005627|474882305|FG001|Overall Study|Withdrawal by Subject|2|||
131890189|NCT00548249|474882306|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
131890190|NCT00548249|474882307|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
131890191|NCT00548249|474882308|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
131890192|NCT00548249|474882309|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
131890193|NCT00548249|474882310|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
131890194|NCT00548249|474882306|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
131890195|NCT00548249|474882307|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
131890196|NCT00548249|474882308|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
131890197|NCT00548249|474882309|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
131890198|NCT00548249|474882310|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
131890199|NCT00548249|474882306|FG000|Overall Study|Protocol Violation|1|||
131890200|NCT00548249|474882307|FG001|Overall Study|Protocol Violation|1|||
131890201|NCT00548249|474882308|FG002|Overall Study|Protocol Violation|4|||
131890202|NCT00548249|474882309|FG003|Overall Study|Protocol Violation|0|||
131890203|NCT00548249|474882310|FG004|Overall Study|Protocol Violation|3|||
131890204|NCT00548249|474882306|FG000|Overall Study|Miscellaneous|2|||
131890205|NCT00548249|474882307|FG001|Overall Study|Miscellaneous|3|||
131890206|NCT00548249|474882308|FG002|Overall Study|Miscellaneous|2|||
131890207|NCT00548249|474882309|FG003|Overall Study|Miscellaneous|0|||
131890208|NCT00548249|474882310|FG004|Overall Study|Miscellaneous|2|||
131890209|NCT00548249|474882306|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
131890210|NCT00548249|474882307|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
131890211|NCT00548249|474882308|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
131890212|NCT00548249|474882309|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
131890213|NCT00548249|474882310|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
131890214|NCT00548249|474882306|FG000|Overall Study|Adverse Event|2|||
131890215|NCT00548249|474882307|FG001|Overall Study|Adverse Event|2|||
131890216|NCT00548249|474882308|FG002|Overall Study|Adverse Event|0|||
131890217|NCT00548249|474882309|FG003|Overall Study|Adverse Event|1|||
131890218|NCT00548249|474882310|FG004|Overall Study|Adverse Event|1|||
131890219|NCT00548249|474882306|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
131890220|NCT00548249|474882307|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
131890221|NCT00548249|474882308|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
131890222|NCT00548249|474882309|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
131890223|NCT00548249|474882310|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
131890224|NCT00548249|474882306|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
131890225|NCT00548249|474882307|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
131890226|NCT00548249|474882308|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
131890227|NCT00548249|474882309|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
131890228|NCT00548249|474882310|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
131890229|NCT00548249|474882306|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
131890230|NCT00548249|474882307|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
131890231|NCT00548249|474882308|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
131890232|NCT00548249|474882309|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
131890233|NCT00548249|474882310|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
131890234|NCT00548249|474882306|FG000|Overall Study|Prolonged hospitalization|0|||
131890235|NCT00548249|474882307|FG001|Overall Study|Prolonged hospitalization|0|||
131890236|NCT00548249|474882308|FG002|Overall Study|Prolonged hospitalization|2|||
131890237|NCT00548249|474882309|FG003|Overall Study|Prolonged hospitalization|1|||
131890238|NCT00548249|474882310|FG004|Overall Study|Prolonged hospitalization|0|||
131890239|NCT00548249|474882306|FG000|Overall Study|Withdrawal by Subject|2|||
131890240|NCT00548249|474882307|FG001|Overall Study|Withdrawal by Subject|0|||
131890241|NCT00548249|474882308|FG002|Overall Study|Withdrawal by Subject|0|||
131890242|NCT00548249|474882309|FG003|Overall Study|Withdrawal by Subject|0|||
131890243|NCT00548249|474882310|FG004|Overall Study|Withdrawal by Subject|0|||
131890244|NCT00548249|474882306|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
131890245|NCT00548249|474882307|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
131890246|NCT00548249|474882308|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
131890247|NCT00548249|474882309|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
131890248|NCT00548249|474882310|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
131890249|NCT00548249|474882306|FG000|Overall Study|Sponsor's request|0|||
131890250|NCT00548249|474882307|FG001|Overall Study|Sponsor's request|0|||
131890251|NCT00548249|474882308|FG002|Overall Study|Sponsor's request|0|||
131890252|NCT00548249|474882309|FG003|Overall Study|Sponsor's request|1|||
131890253|NCT00548249|474882310|FG004|Overall Study|Sponsor's request|0|||
131890254|NCT00938587|474882311|FG000|Overall Study|Adverse Event|2|||
131553200|NCT03403426|473649853|FG000|Overall Study|Death|1|||
131553201|NCT03403426|473649853|FG000|Overall Study|Lost to Follow-up|2|||
131553202|NCT01657266|473649856|FG000|Overall Study|Lost to Follow-up|2|||
131553203|NCT01657266|473649857|FG001|Overall Study|Lost to Follow-up|2|||
131553204|NCT01657266|473649856|FG000|Overall Study|Adverse Event|2|||
131553205|NCT01657266|473649857|FG001|Overall Study|Adverse Event|3|||
131553206|NCT00116844|473649860|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
131890255|NCT00938587|474882312|FG001|Overall Study|Adverse Event|0|||
131890256|NCT00938587|474882313|FG002|Overall Study|Adverse Event|0|||
131553207|NCT00116844|473649861|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
131890257|NCT00938587|474882314|FG003|Overall Study|Adverse Event|2|||
131890258|NCT00938587|474882311|FG000|Overall Study|Did not meet entrance criteria|0|||
131890259|NCT00938587|474882312|FG001|Overall Study|Did not meet entrance criteria|0|||
131890260|NCT00938587|474882313|FG002|Overall Study|Did not meet entrance criteria|1|||
131553208|NCT00116844|473649860|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
131890261|NCT00938587|474882314|FG003|Overall Study|Did not meet entrance criteria|0|||
131890262|NCT00938587|474882311|FG000|Overall Study|Withdrawal by Subject|1|||
131890263|NCT00938587|474882312|FG001|Overall Study|Withdrawal by Subject|1|||
131890264|NCT00938587|474882313|FG002|Overall Study|Withdrawal by Subject|0|||
131890265|NCT00938587|474882314|FG003|Overall Study|Withdrawal by Subject|0|||
131890266|NCT03003000|474882315|FG000|Overall Study|Adverse Event|1|||
131890267|NCT03003000|474882316|FG001|Overall Study|Adverse Event|2|||
131890268|NCT03003000|474882317|FG002|Overall Study|Adverse Event|3|||
131890269|NCT03003000|474882315|FG000|Overall Study|Lack of Efficacy|1|||
131890270|NCT03003000|474882316|FG001|Overall Study|Lack of Efficacy|0|||
131890271|NCT03003000|474882317|FG002|Overall Study|Lack of Efficacy|0|||
131890272|NCT03003000|474882315|FG000|Overall Study|Non-compliant with protocol|0|||
131890273|NCT03003000|474882316|FG001|Overall Study|Non-compliant with protocol|1|||
131890274|NCT03003000|474882317|FG002|Overall Study|Non-compliant with protocol|1|||
131890275|NCT03003000|474882315|FG000|Overall Study|Refused to continue medication|2|||
131890276|NCT03003000|474882316|FG001|Overall Study|Refused to continue medication|0|||
131890277|NCT03003000|474882317|FG002|Overall Study|Refused to continue medication|0|||
131890278|NCT03003000|474882315|FG000|Overall Study|Other than listed|1|||
131890279|NCT03003000|474882316|FG001|Overall Study|Other than listed|1|||
131890280|NCT03003000|474882317|FG002|Overall Study|Other than listed|1|||
131890281|NCT02191046|474882321|FG000|Overall Study|low compliance|5|||
131890282|NCT02191046|474882322|FG001|Overall Study|low compliance|1|||
131890283|NCT00048997|474882325|FG000|Overall Study|Protocol Violation|7|||
131890284|NCT00048997|474882326|FG001|Overall Study|Protocol Violation|2|||
131890285|NCT00048997|474882325|FG000|Overall Study|Withdrawal by Subject|6|||
131890286|NCT00048997|474882326|FG001|Overall Study|Withdrawal by Subject|1|||
131890287|NCT02819440|474882327|FG000|Overall Study|Adverse Event|3|||
131890288|NCT02819440|474882328|FG001|Overall Study|Adverse Event|1|||
131890289|NCT02819440|474882327|FG000|Overall Study|Lost to Follow-up|1|||
131890290|NCT02819440|474882328|FG001|Overall Study|Lost to Follow-up|3|||
131890291|NCT02819440|474882327|FG000|Overall Study|Withdrawal by Subject|9|||
131890292|NCT02819440|474882328|FG001|Overall Study|Withdrawal by Subject|8|||
131890293|NCT00002525|474882334|FG000|Overall Study|Adverse Event|36|||
131890294|NCT00002525|474882335|FG001|Overall Study|Adverse Event|0|||
131890295|NCT00002525|474882334|FG000|Overall Study|Death|5|||
131890296|NCT00002525|474882335|FG001|Overall Study|Death|0|||
131890297|NCT00002525|474882334|FG000|Overall Study|Withdrawal by Subject|11|||
131890298|NCT00002525|474882335|FG001|Overall Study|Withdrawal by Subject|0|||
131890299|NCT00002525|474882334|FG000|Overall Study|Start non-protocol therapy|1|||
131890300|NCT00002525|474882335|FG001|Overall Study|Start non-protocol therapy|0|||
131890301|NCT00002525|474882334|FG000|Overall Study|Other complicating disease|1|||
131890302|NCT00002525|474882335|FG001|Overall Study|Other complicating disease|0|||
131890303|NCT00002525|474882334|FG000|Overall Study|Duke's A, B1, D disease|92|||
131890304|NCT00002525|474882335|FG001|Overall Study|Duke's A, B1, D disease|0|||
131890305|NCT00002525|474882334|FG000|Overall Study|Error|6|||
131890306|NCT00002525|474882335|FG001|Overall Study|Error|0|||
131890307|NCT00002525|474882334|FG000|Overall Study|Other|26|||
131890308|NCT00002525|474882335|FG001|Overall Study|Other|0|||
131890309|NCT00002525|474882334|FG000|Overall Study|Never start protocol therapy|8|||
131890310|NCT00002525|474882335|FG001|Overall Study|Never start protocol therapy|0|||
131890311|NCT03230838|474882336|FG000|Overall Study|Withdrawal by Subject|3|||
131890312|NCT03230838|474882337|FG001|Overall Study|Withdrawal by Subject|0|||
131890313|NCT03230838|474882336|FG000|Overall Study|Temperature excursion|1|||
131890314|NCT03230838|474882337|FG001|Overall Study|Temperature excursion|0|||
131890315|NCT02886884|474882338|FG000|Follow-up|Withdrawal by Subject|0|||
131890316|NCT02886884|474882339|FG001|Follow-up|Withdrawal by Subject|0|||
131890317|NCT02886884|474882340|FG002|Follow-up|Withdrawal by Subject|0|||
131890318|NCT02886884|474882341|FG003|Follow-up|Withdrawal by Subject|1|||
131890319|NCT00435188|474882347|FG000|Overall Study|Death|1|||
131890320|NCT00435188|474882348|FG001|Overall Study|Death|6|||
131890321|NCT00435188|474882347|FG000|Overall Study|Withdrawal by Subject|16|||
131890322|NCT00435188|474882348|FG001|Overall Study|Withdrawal by Subject|11|||
131890323|NCT00435188|474882347|FG000|Overall Study|Lost to Follow-up|5|||
131890324|NCT00435188|474882348|FG001|Overall Study|Lost to Follow-up|6|||
131890325|NCT01915771|474882349|FG000|Day 1|Withdrawal by Subject|1|||
131890326|NCT01915771|474882349|FG000|Day 15|Withdrawal by Subject|1|||
131890327|NCT00575510|474882352|FG000|Overall Study|Lost to Follow-up|4|||
131890328|NCT00575510|474882353|FG001|Overall Study|Lost to Follow-up|6|||
131890329|NCT00575510|474882354|FG002|Overall Study|Lost to Follow-up|9|||
131890330|NCT00575510|474882352|FG000|Overall Study|Withdrawal by Subject|1|||
131890331|NCT00575510|474882353|FG001|Overall Study|Withdrawal by Subject|0|||
131890332|NCT00575510|474882354|FG002|Overall Study|Withdrawal by Subject|0|||
131890333|NCT00575510|474882352|FG000|Overall Study|Clinic Called Patient|7|||
131890334|NCT00575510|474882353|FG001|Overall Study|Clinic Called Patient|7|||
131890335|NCT00575510|474882354|FG002|Overall Study|Clinic Called Patient|7|||
131890336|NCT00575510|474882352|FG000|Overall Study|Pregnancy|0|||
131890337|NCT00575510|474882353|FG001|Overall Study|Pregnancy|0|||
131890338|NCT00575510|474882354|FG002|Overall Study|Pregnancy|1|||
131890339|NCT03420222|474882357|FG000|Overall Study|Withdrawal by Subject|5|||
131890340|NCT03420222|474882358|FG001|Overall Study|Withdrawal by Subject|0|||
131890341|NCT03420222|474882357|FG000|Overall Study|Physician Decision|0|||
131890342|NCT03420222|474882358|FG001|Overall Study|Physician Decision|1|||
131890343|NCT02697734|474882359|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
131890344|NCT02697734|474882360|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
131890345|NCT02697734|474882359|FG000|Core Phase - up to Week 48|Adverse Event|1|||
131890346|NCT02697734|474882360|FG001|Core Phase - up to Week 48|Adverse Event|2|||
131890347|NCT02697734|474882359|FG000|Core Phase - up to Week 48|Physician Decision|1|||
131890348|NCT02697734|474882360|FG001|Core Phase - up to Week 48|Physician Decision|0|||
131890349|NCT02697734|474882359|FG000|Optional Extension Phase|Adverse Event|5|||
131890350|NCT02697734|474882360|FG001|Optional Extension Phase|Adverse Event|1|||
131890351|NCT02697734|474882359|FG000|Optional Extension Phase|Physician Decision|0|||
131890352|NCT02697734|474882360|FG001|Optional Extension Phase|Physician Decision|1|||
131890353|NCT02334384|474882363|FG000|Overall Study|Lost to Follow-up|1|||
131890354|NCT02334384|474882364|FG001|Overall Study|Lost to Follow-up|1|||
131890355|NCT02651688|474882365|FG000|Overall Study|Non-compliance|0|||
131890356|NCT02651688|474882366|FG001|Overall Study|Non-compliance|0|||
131890357|NCT02651688|474882367|FG002|Overall Study|Non-compliance|1|||
131890358|NCT02651688|474882365|FG000|Overall Study|Principal Investigator (PI) decision|0|||
131890359|NCT02651688|474882366|FG001|Overall Study|Principal Investigator (PI) decision|2|||
131890360|NCT02651688|474882367|FG002|Overall Study|Principal Investigator (PI) decision|0|||
131890361|NCT02651688|474882365|FG000|Overall Study|Lost to Follow-up|1|||
131890362|NCT02651688|474882366|FG001|Overall Study|Lost to Follow-up|3|||
131890363|NCT02651688|474882367|FG002|Overall Study|Lost to Follow-up|0|||
131890364|NCT02651688|474882365|FG000|Overall Study|Withdrawal by Subject|1|||
131890365|NCT02651688|474882366|FG001|Overall Study|Withdrawal by Subject|0|||
131890366|NCT02651688|474882367|FG002|Overall Study|Withdrawal by Subject|2|||
131890367|NCT00055497|474882368|FG000|Overall Study|Adverse Event|1|||
131890368|NCT00055497|474882369|FG001|Overall Study|Adverse Event|1|||
131890369|NCT00055497|474882370|FG002|Overall Study|Adverse Event|1|||
131890370|NCT00055497|474882371|FG003|Overall Study|Adverse Event|28|||
131890371|NCT00055497|474882368|FG000|Overall Study|Withdrawal by Subject|3|||
131890372|NCT00055497|474882369|FG001|Overall Study|Withdrawal by Subject|1|||
131890373|NCT00055497|474882370|FG002|Overall Study|Withdrawal by Subject|1|||
131890374|NCT00055497|474882371|FG003|Overall Study|Withdrawal by Subject|15|||
131890375|NCT00055497|474882368|FG000|Overall Study|Lost to Follow-up|0|||
131890376|NCT00055497|474882369|FG001|Overall Study|Lost to Follow-up|1|||
131890377|NCT00055497|474882370|FG002|Overall Study|Lost to Follow-up|0|||
131890378|NCT00055497|474882371|FG003|Overall Study|Lost to Follow-up|5|||
131890379|NCT00055497|474882368|FG000|Overall Study|Protocol Violation|0|||
131890380|NCT00055497|474882369|FG001|Overall Study|Protocol Violation|0|||
131890381|NCT00055497|474882370|FG002|Overall Study|Protocol Violation|0|||
131890382|NCT00055497|474882371|FG003|Overall Study|Protocol Violation|3|||
131890383|NCT00055497|474882368|FG000|Overall Study|Lack of Efficacy|1|||
131890384|NCT00055497|474882369|FG001|Overall Study|Lack of Efficacy|0|||
131890385|NCT00055497|474882370|FG002|Overall Study|Lack of Efficacy|0|||
131890386|NCT00055497|474882371|FG003|Overall Study|Lack of Efficacy|27|||
131890387|NCT00055497|474882368|FG000|Overall Study|Administrative Reasons|0|||
131890388|NCT00055497|474882369|FG001|Overall Study|Administrative Reasons|0|||
131890389|NCT00055497|474882370|FG002|Overall Study|Administrative Reasons|0|||
131890390|NCT00055497|474882371|FG003|Overall Study|Administrative Reasons|1|||
131890391|NCT00055497|474882368|FG000|Overall Study|Other|0|||
131890392|NCT00055497|474882369|FG001|Overall Study|Other|0|||
131890393|NCT00055497|474882370|FG002|Overall Study|Other|0|||
131890394|NCT00055497|474882371|FG003|Overall Study|Other|11|||
131890395|NCT00048165|474882372|FG000|Completed 6 Months Study|Administration/Other|8|||
131890396|NCT00048165|474882373|FG001|Completed 6 Months Study|Administration/Other|8|||
131890397|NCT00048165|474882372|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
131890398|NCT00048165|474882373|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
131890399|NCT00048165|474882372|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
131890400|NCT00048165|474882373|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
131890401|NCT00048165|474882372|FG000|Completed 6 Months Study|Death|12|||
131890402|NCT00048165|474882373|FG001|Completed 6 Months Study|Death|6|||
131890403|NCT00048165|474882372|FG000|Completed 6 Months Study|Insufficient therapy|1|||
131664102|NCT01631227|474054807|FG001|Overall Study|Adverse Event|0|||
131664103|NCT01631227|474054806|FG000|Overall Study|administrative|2|||
131890404|NCT00048165|474882373|FG001|Completed 6 Months Study|Insufficient therapy|4|||
131890405|NCT00048165|474882372|FG000|Completed 6 Months Study|Other violation|4|||
131890406|NCT00048165|474882373|FG001|Completed 6 Months Study|Other violation|6|||
131890407|NCT00048165|474882372|FG000|Completed 6 Months Study|Refused treatment|5|||
131890408|NCT00048165|474882373|FG001|Completed 6 Months Study|Refused treatment|5|||
131890409|NCT00048165|474882372|FG000|Completed 6 Months Study|Violation criteria|0|||
131890410|NCT00048165|474882373|FG001|Completed 6 Months Study|Violation criteria|2|||
131890411|NCT00048165|474882372|FG000|Completed 6 Months Study|Did not receive study drug|6|||
131890412|NCT00048165|474882373|FG001|Completed 6 Months Study|Did not receive study drug|6|||
131890413|NCT00048165|474882372|FG000|Completed 12 Months Study|Administration/Other|0|||
131890414|NCT00048165|474882373|FG001|Completed 12 Months Study|Administration/Other|2|||
131890415|NCT00048165|474882372|FG000|Completed 12 Months Study|Death|2|||
131890416|NCT00048165|474882373|FG001|Completed 12 Months Study|Death|1|||
131890417|NCT00048165|474882372|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
131890418|NCT00048165|474882373|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
131890419|NCT00731731|474882374|FG000|Overall Study|Protocol Violation|0|||
131890420|NCT00731731|474882375|FG001|Overall Study|Protocol Violation|0|||
131890421|NCT00731731|474882376|FG002|Overall Study|Protocol Violation|1|||
131890422|NCT00731731|474882374|FG000|Overall Study|Cancel prior to treatment|0|||
131890423|NCT00731731|474882375|FG001|Overall Study|Cancel prior to treatment|0|||
131890424|NCT00731731|474882376|FG002|Overall Study|Cancel prior to treatment|2|||
131890425|NCT03970200|474882377|FG000|Overall Study|Death|2|||
131890426|NCT03970200|474882378|FG001|Overall Study|Death|2|||
131890427|NCT03970200|474882379|FG002|Overall Study|Death|1|||
131890428|NCT03970200|474882377|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
131890429|NCT03970200|474882378|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
131890430|NCT03970200|474882379|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
131890431|NCT02112877|474882380|FG000|Overall Study|Withdrawal by Subject|1|||
131890432|NCT02112877|474882381|FG001|Overall Study|Withdrawal by Subject|7|||
131890433|NCT02112877|474882380|FG000|Overall Study|Visit Missed|1|||
131890434|NCT02112877|474882381|FG001|Overall Study|Visit Missed|6|||
131890435|NCT01693185|474882382|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
131890436|NCT01693185|474882383|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
131890437|NCT01429441|474882384|FG000|Overall Study|Adverse Event|5|||
131890438|NCT01429441|474882385|FG001|Overall Study|Adverse Event|1|||
131890439|NCT01429441|474882384|FG000|Overall Study|Death|0|||
131890440|NCT01429441|474882385|FG001|Overall Study|Death|2|||
131890441|NCT01429441|474882384|FG000|Overall Study|Lost to Follow-up|5|||
131890442|NCT01429441|474882385|FG001|Overall Study|Lost to Follow-up|2|||
131890443|NCT01429441|474882384|FG000|Overall Study|Physician Decision|1|||
131890444|NCT01429441|474882385|FG001|Overall Study|Physician Decision|0|||
131890445|NCT01429441|474882384|FG000|Overall Study|Withdrawal by Subject|27|||
131890446|NCT01429441|474882385|FG001|Overall Study|Withdrawal by Subject|18|||
131890447|NCT02279745|474882390|FG000|Overall Study|Adverse Event|7|||
131890448|NCT02279745|474882390|FG000|Overall Study|Death|6|||
131890449|NCT02279745|474882390|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
131890450|NCT02279745|474882390|FG000|Overall Study|Withdrawal by Subject|2|||
131890451|NCT02279745|474882390|FG000|Overall Study|Pregnancy|1|||
131890452|NCT02279745|474882390|FG000|Overall Study|Study Non-compliance|1|||
131890453|NCT02279745|474882390|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
131890454|NCT00380718|474882391|FG000|Overall Study|Adverse Event|1|||
131890455|NCT00380718|474882391|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
131890456|NCT01606748|474882396|FG000|Overall Study|Adverse Event|1|||
131890457|NCT01606748|474882397|FG001|Overall Study|Adverse Event|0|||
131890458|NCT01606748|474882396|FG000|Overall Study|Progressive Disease|1|||
131890459|NCT01606748|474882397|FG001|Overall Study|Progressive Disease|0|||
131890460|NCT01606748|474882396|FG000|Overall Study|Withdrawal by Subject|1|||
131890461|NCT01606748|474882397|FG001|Overall Study|Withdrawal by Subject|0|||
131890462|NCT03742258|474882401|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
131890463|NCT03742258|474882402|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
131890464|NCT03742258|474882403|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
131890465|NCT03742258|474882401|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
131890466|NCT03742258|474882402|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
131890467|NCT03742258|474882403|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
131890468|NCT03742258|474882401|FG000|Survival Follow-Up|Still in Follow-up|0|||
131890469|NCT03742258|474882402|FG001|Survival Follow-Up|Still in Follow-up|0|||
131890470|NCT03742258|474882403|FG002|Survival Follow-Up|Still in Follow-up|2|||
131890471|NCT02839876|474882406|FG000|Overall Study|Protocol Violation|10|||
131890472|NCT02839876|474882407|FG001|Overall Study|Protocol Violation|11|||
131890473|NCT00594386|474882414|FG000|Overall Study|Major protocol violation|2|||
131890474|NCT00594386|474882414|FG000|Overall Study|Lack of Efficacy|12|||
131890475|NCT00594386|474882414|FG000|Overall Study|Adverse Event|68|||
131890476|NCT00594386|474882414|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
131890477|NCT00594386|474882414|FG000|Overall Study|Subject withdrew consent|35|||
131890478|NCT00594386|474882414|FG000|Overall Study|Study ended per sponsor|115|||
131890479|NCT00594386|474882414|FG000|Overall Study|Lost to Follow-up|6|||
131890480|NCT00594386|474882414|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
131890481|NCT00594386|474882414|FG000|Overall Study|Other: Subject moved to Seattle|1|||
131890482|NCT00594386|474882414|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
131890483|NCT00594386|474882414|FG000|Overall Study|Other: Study terminated per investigator|2|||
131890484|NCT00594386|474882414|FG000|Overall Study|Other: Sponsor closure of study|1|||
131435917|NCT03084796|473221890|FG000|Overall Study|Randomization error|0|||
131890485|NCT00594386|474882414|FG000|Overall Study|Other: Site terminated participation|1|||
131890486|NCT00594386|474882414|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
131890487|NCT00594386|474882414|FG000|Overall Study|Other: Loss of drivers license|1|||
131890488|NCT00094536|474882415|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
131890489|NCT00094536|474882415|FG000|Treatment and Follow-up|Adverse Event|4|||
131890490|NCT00094536|474882415|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
131890491|NCT00094536|474882415|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
131890492|NCT00094536|474882415|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
131890493|NCT00094536|474882415|FG000|Treatment and Follow-up|Subject non-compliance|9|||
131890494|NCT00094536|474882415|FG000|Treatment and Follow-up|Unable to attend visits|1|||
131890495|NCT02071082|474882416|FG000|Overall Study|Enrolled and Never Treated|1|||
131890496|NCT02071082|474882417|FG001|Overall Study|Enrolled and Never Treated|1|||
131890497|NCT02071082|474882416|FG000|Overall Study|Adverse Event|0|||
131890498|NCT02071082|474882417|FG001|Overall Study|Adverse Event|1|||
131890499|NCT02071082|474882416|FG000|Overall Study|Withdrew Consent|0|||
131890500|NCT02071082|474882417|FG001|Overall Study|Withdrew Consent|4|||
131890501|NCT02071082|474882416|FG000|Overall Study|Lost to Follow-up|1|||
131890502|NCT02071082|474882417|FG001|Overall Study|Lost to Follow-up|1|||
131890503|NCT00958412|474882421|FG000|Overall Study|Study prematurely terminated|18|||
131890504|NCT02227368|474884364|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
131890505|NCT02227368|474884365|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
131890506|NCT02227368|474884364|FG000|Overall Study|Lost to Follow-up|1|||
131890507|NCT02227368|474884365|FG001|Overall Study|Lost to Follow-up|0|||
131890508|NCT02227368|474884364|FG000|Overall Study|Adverse Event|1|||
131890509|NCT02227368|474884365|FG001|Overall Study|Adverse Event|0|||
131890510|NCT02510820|474884369|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131890511|NCT02510820|474884370|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131890512|NCT02510820|474884369|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131890513|NCT02510820|474884370|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
131890514|NCT01687283|474884371|FG000|Overall Study|Adverse Event|11|||
131890515|NCT01687283|474884372|FG001|Overall Study|Adverse Event|4|||
131890516|NCT01687283|474884371|FG000|Overall Study|Lack of Efficacy|3|||
131890517|NCT01687283|474884372|FG001|Overall Study|Lack of Efficacy|1|||
131890518|NCT01687283|474884371|FG000|Overall Study|Protocol Violation|1|||
131890519|NCT01687283|474884372|FG001|Overall Study|Protocol Violation|3|||
131890520|NCT01687283|474884371|FG000|Overall Study|protocol defined stopping criteria|8|||
131890521|NCT01687283|474884372|FG001|Overall Study|protocol defined stopping criteria|10|||
131890522|NCT01687283|474884371|FG000|Overall Study|Lost to Follow-up|1|||
131890523|NCT01687283|474884372|FG001|Overall Study|Lost to Follow-up|1|||
131890524|NCT01687283|474884371|FG000|Overall Study|Investigator discretion|2|||
131890525|NCT01687283|474884372|FG001|Overall Study|Investigator discretion|0|||
131890526|NCT01687283|474884371|FG000|Overall Study|Withdrawal by Subject|9|||
131890527|NCT01687283|474884372|FG001|Overall Study|Withdrawal by Subject|8|||
131890528|NCT03046056|474884373|FG000|Overall Study|Non-responder at Week 10|6|||
131890529|NCT03046056|474884374|FG001|Overall Study|Non-responder at Week 10|6|||
131890530|NCT03046056|474884375|FG002|Overall Study|Non-responder at Week 10|4|||
131890531|NCT03046056|474884373|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
131890532|NCT03046056|474884374|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
131890533|NCT03046056|474884375|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
131890534|NCT03046056|474884373|FG000|Overall Study|Adverse Event|1|||
131890535|NCT03046056|474884374|FG001|Overall Study|Adverse Event|5|||
131890536|NCT03046056|474884375|FG002|Overall Study|Adverse Event|0|||
131890537|NCT03046056|474884373|FG000|Overall Study|Non-compliance With Study Drug|0|||
131890538|NCT03046056|474884374|FG001|Overall Study|Non-compliance With Study Drug|0|||
131890539|NCT03046056|474884375|FG002|Overall Study|Non-compliance With Study Drug|2|||
131890540|NCT03046056|474884373|FG000|Overall Study|Protocol Violation|1|||
131890541|NCT03046056|474884374|FG001|Overall Study|Protocol Violation|1|||
131890542|NCT03046056|474884375|FG002|Overall Study|Protocol Violation|0|||
131890543|NCT03046056|474884373|FG000|Overall Study|Investigator's Discretion|0|||
131890544|NCT03046056|474884374|FG001|Overall Study|Investigator's Discretion|1|||
131890545|NCT03046056|474884375|FG002|Overall Study|Investigator's Discretion|0|||
131890546|NCT03046056|474884373|FG000|Overall Study|Withdrew Consent|1|||
131890547|NCT03046056|474884374|FG001|Overall Study|Withdrew Consent|0|||
131890548|NCT03046056|474884375|FG002|Overall Study|Withdrew Consent|0|||
131890549|NCT02913105|474884376|FG000|Overall Study|Adverse Event|11|||
131890550|NCT02913105|474884377|FG001|Overall Study|Adverse Event|0|||
131890551|NCT02913105|474884378|FG002|Overall Study|Adverse Event|4|||
131890552|NCT02913105|474884376|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131890553|NCT02913105|474884377|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131890554|NCT02913105|474884378|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131890555|NCT02913105|474884376|FG000|Overall Study|Reason Not Specified|3|||
131890556|NCT02913105|474884377|FG001|Overall Study|Reason Not Specified|1|||
131890557|NCT02913105|474884378|FG002|Overall Study|Reason Not Specified|1|||
131890558|NCT02913105|474884376|FG000|Overall Study|Physician Decision|1|||
131890559|NCT02913105|474884377|FG001|Overall Study|Physician Decision|1|||
131890560|NCT02913105|474884378|FG002|Overall Study|Physician Decision|0|||
131890561|NCT02913105|474884376|FG000|Overall Study|Withdrawal by Subject|0|||
131890562|NCT02913105|474884377|FG001|Overall Study|Withdrawal by Subject|3|||
131890563|NCT02913105|474884378|FG002|Overall Study|Withdrawal by Subject|1|||
131890564|NCT01317004|474884379|FG000|Overall Study|Withdrawal by Subject|1|||
131890565|NCT01317004|474884380|FG001|Overall Study|Withdrawal by Subject|4|||
131890566|NCT01317004|474884379|FG000|Overall Study|Protocol Violation|0|||
131890567|NCT01317004|474884380|FG001|Overall Study|Protocol Violation|2|||
131890568|NCT01317004|474884379|FG000|Overall Study|Adverse Event|3|||
131890569|NCT01317004|474884380|FG001|Overall Study|Adverse Event|3|||
131890570|NCT01859949|474884386|FG000|Overall Study|Family Matters|0|||
131890571|NCT01859949|474884387|FG001|Overall Study|Family Matters|1|||
131890572|NCT01859949|474884386|FG000|Overall Study|Physician Decision|2|||
131890573|NCT01859949|474884387|FG001|Overall Study|Physician Decision|4|||
131890574|NCT01859949|474884386|FG000|Overall Study|Withdrawal by Subject|11|||
131890575|NCT01859949|474884387|FG001|Overall Study|Withdrawal by Subject|10|||
131890576|NCT01859949|474884386|FG000|Overall Study|Protocol Violation|1|||
131890577|NCT01859949|474884387|FG001|Overall Study|Protocol Violation|1|||
131890578|NCT01859949|474884386|FG000|Overall Study|Adverse Event|0|||
131890579|NCT01859949|474884387|FG001|Overall Study|Adverse Event|1|||
131890580|NCT01344759|474884388|FG000|Overall Study|Patients failed to reach sedation level|0|||
131890581|NCT01344759|474884389|FG001|Overall Study|Patients failed to reach sedation level|2|||
131890582|NCT01890759|474884390|FG000|Overall Study|Protocol Violation|0|||
131890583|NCT01890759|474884391|FG001|Overall Study|Protocol Violation|2|||
131890584|NCT01890759|474884390|FG000|Overall Study|Lost to Follow-up|0|||
131890585|NCT01890759|474884391|FG001|Overall Study|Lost to Follow-up|2|||
131890586|NCT01890759|474884390|FG000|Overall Study|Withdrawal by Subject|2|||
131890587|NCT01890759|474884391|FG001|Overall Study|Withdrawal by Subject|8|||
131890588|NCT01153009|474884392|FG000|Overall Study|Adverse Event|4|||
131890589|NCT01153009|474884393|FG001|Overall Study|Adverse Event|14|||
131890590|NCT01153009|474884394|FG002|Overall Study|Adverse Event|14|||
131890591|NCT01153009|474884395|FG003|Overall Study|Adverse Event|10|||
131890592|NCT01153009|474884392|FG000|Overall Study|Lack of Efficacy|9|||
131890593|NCT01153009|474884393|FG001|Overall Study|Lack of Efficacy|0|||
131890594|NCT01153009|474884394|FG002|Overall Study|Lack of Efficacy|2|||
131890595|NCT01153009|474884395|FG003|Overall Study|Lack of Efficacy|1|||
131890596|NCT01153009|474884392|FG000|Overall Study|Noncompliance with Study Medication|1|||
131890597|NCT01153009|474884393|FG001|Overall Study|Noncompliance with Study Medication|3|||
131890598|NCT01153009|474884394|FG002|Overall Study|Noncompliance with Study Medication|4|||
131890599|NCT01153009|474884395|FG003|Overall Study|Noncompliance with Study Medication|1|||
131890600|NCT01153009|474884392|FG000|Overall Study|Protocol Deviations|4|||
131890601|NCT01153009|474884393|FG001|Overall Study|Protocol Deviations|3|||
131890602|NCT01153009|474884394|FG002|Overall Study|Protocol Deviations|3|||
131890603|NCT01153009|474884395|FG003|Overall Study|Protocol Deviations|2|||
131890604|NCT01153009|474884392|FG000|Overall Study|Withdrawal of Consent|5|||
131890605|NCT01153009|474884393|FG001|Overall Study|Withdrawal of Consent|5|||
131890606|NCT01153009|474884394|FG002|Overall Study|Withdrawal of Consent|4|||
131890607|NCT01153009|474884395|FG003|Overall Study|Withdrawal of Consent|6|||
131890608|NCT01153009|474884392|FG000|Overall Study|Lost to Follow-up|8|||
131890609|NCT01153009|474884393|FG001|Overall Study|Lost to Follow-up|8|||
131890610|NCT01153009|474884394|FG002|Overall Study|Lost to Follow-up|11|||
131890611|NCT01153009|474884395|FG003|Overall Study|Lost to Follow-up|15|||
131890612|NCT01153009|474884392|FG000|Overall Study|Other|1|||
131890613|NCT01153009|474884393|FG001|Overall Study|Other|1|||
131890614|NCT01153009|474884394|FG002|Overall Study|Other|3|||
131890615|NCT01153009|474884395|FG003|Overall Study|Other|2|||
131890616|NCT04494425|474884400|FG000|Overall Study|Death|160|||
131890617|NCT04494425|474884401|FG001|Overall Study|Death|166|||
131890618|NCT04494425|474884400|FG000|Overall Study|Withdrawal by Subject|10|||
131890619|NCT04494425|474884401|FG001|Overall Study|Withdrawal by Subject|40|||
131890620|NCT04494425|474884400|FG000|Overall Study|Other|1|||
131890621|NCT04494425|474884401|FG001|Overall Study|Other|1|||
131890622|NCT04494425|474884400|FG000|Overall Study|Ongoing at the time of PCD|265|||
131890623|NCT04494425|474884401|FG001|Overall Study|Ongoing at the time of PCD|223|||
131890624|NCT01270321|474884403|FG000|Overall Study|Death|3|||
131890625|NCT01270321|474884404|FG001|Overall Study|Death|1|||
131890626|NCT01270321|474884405|FG002|Overall Study|Death|4|||
131890627|NCT01270321|474884403|FG000|Overall Study|Adverse Event|7|||
131890628|NCT01270321|474884404|FG001|Overall Study|Adverse Event|9|||
131890629|NCT01270321|474884405|FG002|Overall Study|Adverse Event|5|||
131890630|NCT05437640|474884406|FG000|Washout (1 Week)|Adverse Event|1|||
131890631|NCT05437640|474884407|FG001|Washout (1 Week)|Adverse Event|0|||
131890632|NCT04228965|474884410|FG000|Overall Study|Lost to Follow-up|26|||
131890633|NCT04228965|474884411|FG001|Overall Study|Lost to Follow-up|11|||
131890634|NCT04228965|474884410|FG000|Overall Study|Withdrawal by Subject|18|||
131890635|NCT04228965|474884411|FG001|Overall Study|Withdrawal by Subject|5|||
131890636|NCT00734656|474884414|FG000|Lab Session 1|Withdrawal by Subject|2|||
131890637|NCT00734656|474884415|FG001|Lab Session 1|Withdrawal by Subject|0|||
131890638|NCT00734656|474884416|FG002|Lab Session 1|Withdrawal by Subject|0|||
131890639|NCT00734656|474884417|FG003|Lab Session 1|Withdrawal by Subject|0|||
131890640|NCT00734656|474884414|FG000|Washout 1|Withdrawal by Subject|1|||
131890641|NCT00734656|474884415|FG001|Washout 1|Withdrawal by Subject|5|||
131890642|NCT00734656|474884416|FG002|Washout 1|Withdrawal by Subject|2|||
131890643|NCT00734656|474884417|FG003|Washout 1|Withdrawal by Subject|3|||
131890644|NCT00734656|474884414|FG000|Lab Session 2|Withdrawal by Subject|1|||
131890645|NCT00734656|474884415|FG001|Lab Session 2|Withdrawal by Subject|0|||
131890646|NCT00734656|474884416|FG002|Lab Session 2|Withdrawal by Subject|0|||
131890647|NCT00734656|474884417|FG003|Lab Session 2|Withdrawal by Subject|1|||
131890648|NCT00734656|474884414|FG000|Washout 2|Withdrawal by Subject|1|||
131890649|NCT00734656|474884415|FG001|Washout 2|Withdrawal by Subject|1|||
131890650|NCT00734656|474884416|FG002|Washout 2|Withdrawal by Subject|1|||
131890651|NCT00734656|474884417|FG003|Washout 2|Withdrawal by Subject|0|||
131890652|NCT00734656|474884414|FG000|Washout 3|Withdrawal by Subject|1|||
131890653|NCT00734656|474884415|FG001|Washout 3|Withdrawal by Subject|0|||
131890654|NCT00734656|474884416|FG002|Washout 3|Withdrawal by Subject|0|||
131890655|NCT00734656|474884417|FG003|Washout 3|Withdrawal by Subject|1|||
131890656|NCT00734656|474884414|FG000|Lab Session 4|Withdrawal by Subject|0|||
131890657|NCT00734656|474884415|FG001|Lab Session 4|Withdrawal by Subject|0|||
131890658|NCT00734656|474884416|FG002|Lab Session 4|Withdrawal by Subject|0|||
131890659|NCT00734656|474884417|FG003|Lab Session 4|Withdrawal by Subject|1|||
131890660|NCT03214679|474884419|FG000|Overall Study|Lost to Follow-up|12|||
131890661|NCT03214679|474884420|FG001|Overall Study|Lost to Follow-up|14|||
131890662|NCT03214679|474884419|FG000|Overall Study|not eligible|2|||
131890663|NCT03214679|474884420|FG001|Overall Study|not eligible|0|||
131890664|NCT01754766|474884426|FG000|Overall Study|Personal reasons|1|||
131890665|NCT01754766|474884427|FG001|Overall Study|Personal reasons|1|||
131890666|NCT01754766|474884428|FG002|Overall Study|Personal reasons|0|||
131890667|NCT01709409|474884433|FG000|Overall Study|Protocol Violation|1|||
131890668|NCT01709409|474884434|FG001|Overall Study|Protocol Violation|0|||
131890669|NCT02412878|474884435|FG000|Overall Study|Withdrawal by Subject|19|||
131890670|NCT02412878|474884436|FG001|Overall Study|Withdrawal by Subject|10|||
131890671|NCT02412878|474884435|FG000|Overall Study|Lost to Follow-up|2|||
131890672|NCT02412878|474884436|FG001|Overall Study|Lost to Follow-up|3|||
131890673|NCT04571385|474884437|FG000|Overall Study|Participant non-compliance|1|||
131890674|NCT04571385|474884438|FG001|Overall Study|Participant non-compliance|0|||
131890675|NCT04571385|474884439|FG002|Overall Study|Participant non-compliance|0|||
131890676|NCT04571385|474884437|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
131890677|NCT04571385|474884438|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
131890678|NCT04571385|474884439|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
131890679|NCT04571385|474884437|FG000|Overall Study|Screen failure|0|||
131890680|NCT04571385|474884438|FG001|Overall Study|Screen failure|0|||
131890681|NCT04571385|474884439|FG002|Overall Study|Screen failure|1|||
131890682|NCT02263729|474884440|FG000|Overall Study|Lost to Follow-up|1|||
131890683|NCT02263729|474884441|FG001|Overall Study|Lost to Follow-up|1|||
131890684|NCT01212159|474884442|FG000|Overall Study|Withdrawal by Subject|12|||
131890685|NCT01212159|474884443|FG001|Overall Study|Withdrawal by Subject|12|||
131890686|NCT01306214|474884444|FG000|Overall Study|Death|0|||
131890687|NCT01306214|474884445|FG001|Overall Study|Death|0|||
131890688|NCT01306214|474884446|FG002|Overall Study|Death|1|||
131890689|NCT01306214|474884444|FG000|Overall Study|Lost to Follow-up|3|||
131890690|NCT01306214|474884445|FG001|Overall Study|Lost to Follow-up|5|||
131553209|NCT00116844|473649861|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
131553210|NCT00116844|473649860|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
131553211|NCT00116844|473649861|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
131553212|NCT00116844|473649860|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
131553213|NCT00116844|473649861|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
131553214|NCT00116844|473649860|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
131553215|NCT00116844|473649861|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
131553216|NCT00116844|473649860|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
131553217|NCT00116844|473649861|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
131553218|NCT00116844|473649860|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
131553219|NCT00116844|473649861|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
131553220|NCT00116844|473649860|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
131664104|NCT01631227|474054807|FG001|Overall Study|administrative|1|||
131890691|NCT01306214|474884446|FG002|Overall Study|Lost to Follow-up|4|||
131890692|NCT01306214|474884444|FG000|Overall Study|Withdrawal by Subject|24|||
131890693|NCT01306214|474884445|FG001|Overall Study|Withdrawal by Subject|22|||
131890694|NCT01306214|474884446|FG002|Overall Study|Withdrawal by Subject|16|||
131890695|NCT01306214|474884444|FG000|Overall Study|Not treated|1|||
131890696|NCT01306214|474884445|FG001|Overall Study|Not treated|1|||
131890697|NCT01306214|474884446|FG002|Overall Study|Not treated|1|||
131890698|NCT01031004|474884447|FG000|Overall Study|Protocol Violation|0|||
131890699|NCT01031004|474884448|FG001|Overall Study|Protocol Violation|1|||
131890700|NCT01031004|474884447|FG000|Overall Study|Lost to Follow-up|1|||
131890701|NCT01031004|474884448|FG001|Overall Study|Lost to Follow-up|0|||
131553221|NCT00116844|473649861|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
131890702|NCT01641471|474884449|FG000|Overall Study|Withdrawal by Subject|19|||
131890703|NCT01641471|474884450|FG001|Overall Study|Withdrawal by Subject|19|||
131890704|NCT01641471|474884449|FG000|Overall Study|Lost to Follow-up|2|||
131890705|NCT01641471|474884450|FG001|Overall Study|Lost to Follow-up|4|||
131890706|NCT01641471|474884449|FG000|Overall Study|Protocol Violation|2|||
131890707|NCT01641471|474884450|FG001|Overall Study|Protocol Violation|4|||
131890708|NCT01108237|474884451|FG000|Overall Study|No alignment data|2|||
131890709|NCT01108237|474884452|FG001|Overall Study|No alignment data|15|||
131890710|NCT01108237|474884451|FG000|Overall Study|Did not meet criteria for analysis|7|||
131890711|NCT01108237|474884452|FG001|Overall Study|Did not meet criteria for analysis|0|||
131890712|NCT00255840|474884455|FG000|Overall Study|Lost to Follow-up|10|||
131890713|NCT00255840|474884456|FG001|Overall Study|Lost to Follow-up|14|||
131890714|NCT00255840|474884455|FG000|Overall Study|Discontinued intervention|53|||
131890715|NCT00255840|474884456|FG001|Overall Study|Discontinued intervention|56|||
131890716|NCT04278924|474884457|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
131890717|NCT04278924|474884458|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
131890718|NCT04278924|474884459|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
131890719|NCT04278924|474884460|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
131890720|NCT04278924|474884461|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
131890721|NCT04278924|474884462|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
131890722|NCT04278924|474884463|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
131890723|NCT04278924|474884457|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
131890724|NCT04278924|474884458|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
131890725|NCT04278924|474884459|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
131890726|NCT04278924|474884460|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
131890727|NCT04278924|474884461|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
131890728|NCT04278924|474884462|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
131890729|NCT04278924|474884463|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
131890730|NCT06226649|474884464|FG000|Overall Study|Withdrawal by Subject|4|||
131890731|NCT06226649|474884465|FG001|Overall Study|Withdrawal by Subject|1|||
131890732|NCT04847232|474884466|FG000|Overall Study|Death|123|||
131890733|NCT04847232|474884467|FG001|Overall Study|Death|115|||
131890734|NCT04847232|474884466|FG000|Overall Study|Lost to Follow-up|3|||
131890735|NCT04847232|474884467|FG001|Overall Study|Lost to Follow-up|10|||
131890736|NCT04847232|474884466|FG000|Overall Study|Withdrawal by Subject|73|||
131890737|NCT04847232|474884467|FG001|Overall Study|Withdrawal by Subject|101|||
131890738|NCT04847232|474884466|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
131890739|NCT04847232|474884467|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
131890740|NCT00631163|474884468|FG000|Number of Participants in Year 1|Adverse Event|12|||
131890741|NCT00631163|474884468|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
131890742|NCT00631163|474884468|FG000|Number of Participants in Year 1|Death|6|||
131890743|NCT00631163|474884468|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
131890744|NCT00631163|474884468|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
131890745|NCT00631163|474884468|FG000|Number of Participants in Year 1|Administrative problems|6|||
131890746|NCT00631163|474884468|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
131890747|NCT00631163|474884468|FG000|Number of Participants in Year 2|Adverse Event|1|||
131890748|NCT00631163|474884468|FG000|Number of Participants in Year 2|Protocol Violation|1|||
131890749|NCT00631163|474884468|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
131890750|NCT01006590|474884469|FG000|Overall Study|Adverse Event|2|||
131890751|NCT01006590|474884470|FG001|Overall Study|Adverse Event|3|||
131890752|NCT01006590|474884469|FG000|Overall Study|Death|1|||
131890753|NCT01006590|474884470|FG001|Overall Study|Death|1|||
131890754|NCT01006590|474884469|FG000|Overall Study|Lost to Follow-up|1|||
131890755|NCT01006590|474884470|FG001|Overall Study|Lost to Follow-up|1|||
131890756|NCT01006590|474884469|FG000|Overall Study|Protocol Violation|1|||
131890757|NCT01006590|474884470|FG001|Overall Study|Protocol Violation|0|||
131890758|NCT01006590|474884469|FG000|Overall Study|Withdrawal by Subject|4|||
131890759|NCT01006590|474884470|FG001|Overall Study|Withdrawal by Subject|2|||
131890760|NCT01006590|474884469|FG000|Overall Study|Study specific discontinuation criteria|16|||
131890761|NCT01006590|474884470|FG001|Overall Study|Study specific discontinuation criteria|23|||
131890762|NCT01006590|474884469|FG000|Overall Study|Other|3|||
131890763|NCT01006590|474884470|FG001|Overall Study|Other|2|||
131890764|NCT03332095|474884471|FG000|Overall Study|Lost to Follow-up|1|||
131890765|NCT03332095|474884472|FG001|Overall Study|Lost to Follow-up|0|||
131890766|NCT03332095|474884471|FG000|Overall Study|Pregnancy|0|||
131890767|NCT03332095|474884472|FG001|Overall Study|Pregnancy|1|||
131890768|NCT03699540|474884475|FG000|Overall Study|Lost to Follow-up|1|||
131890769|NCT01939223|474884478|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
131890770|NCT01939223|474884479|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
131435918|NCT03084796|473221891|FG001|Overall Study|Randomization error|0|||
131553222|NCT00116844|473649860|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
131553223|NCT00116844|473649861|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
131890771|NCT01939223|474884478|FG000|Overall Study|Disease recurrence (radiological)|1|||
131890772|NCT01939223|474884479|FG001|Overall Study|Disease recurrence (radiological)|3|||
131890773|NCT01939223|474884478|FG000|Overall Study|Study stopped by Sponsor|5|||
131890774|NCT01939223|474884479|FG001|Overall Study|Study stopped by Sponsor|7|||
131890775|NCT01939223|474884478|FG000|Overall Study|Withdrawal by Subject|6|||
131890776|NCT01939223|474884479|FG001|Overall Study|Withdrawal by Subject|0|||
131890777|NCT00703118|474884480|FG000|Overall Study|Adverse Event|1|||
131890778|NCT00703118|474884481|FG001|Overall Study|Adverse Event|2|||
131890779|NCT00703118|474884482|FG002|Overall Study|Adverse Event|2|||
131890780|NCT00703118|474884480|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
131890781|NCT00703118|474884481|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
131890782|NCT00703118|474884482|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
131890783|NCT00703118|474884480|FG000|Overall Study|Lost to Follow-up|6|||
131890784|NCT00703118|474884481|FG001|Overall Study|Lost to Follow-up|4|||
131890785|NCT00703118|474884482|FG002|Overall Study|Lost to Follow-up|4|||
131890786|NCT00703118|474884480|FG000|Overall Study|Withdrawal by Subject|8|||
131890787|NCT00703118|474884481|FG001|Overall Study|Withdrawal by Subject|7|||
131890788|NCT00703118|474884482|FG002|Overall Study|Withdrawal by Subject|13|||
131890789|NCT00703118|474884480|FG000|Overall Study|Other|0|||
131890790|NCT00703118|474884481|FG001|Overall Study|Other|0|||
131890791|NCT00703118|474884482|FG002|Overall Study|Other|1|||
131890792|NCT01853696|474884485|FG000|Overall Study|Withdrawal by Subject|1|||
131890793|NCT01853696|474884486|FG001|Overall Study|Withdrawal by Subject|1|||
131890794|NCT01853696|474884485|FG000|Overall Study|Lost to Follow-up|5|||
131890795|NCT01853696|474884486|FG001|Overall Study|Lost to Follow-up|4|||
131890796|NCT00431067|474884487|FG000|Overall Study|Other Adverse Event|9|||
131890797|NCT00431067|474884487|FG000|Overall Study|Progressive disease|30|||
131890798|NCT00431067|474884487|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
131890799|NCT04933617|474884489|FG000|Dose Escalation|Early closure of study|0|||
131890800|NCT04933617|474884490|FG001|Dose Escalation|Early closure of study|3|||
131890801|NCT04933617|474884491|FG002|Dose Escalation|Early closure of study|0|||
131890802|NCT04933617|474884492|FG003|Dose Escalation|Early closure of study|0|||
131890803|NCT04933617|474884493|FG004|Dose Escalation|Early closure of study|0|||
131890804|NCT03760458|474884494|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
131890805|NCT03760458|474884495|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
131890806|NCT03760458|474884496|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
131890807|NCT03760458|474884497|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
131890808|NCT03760458|474884498|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
131890809|NCT02007278|474884509|FG000|Overall Study|Failure to comply with an eligibility|0|||
131890810|NCT02007278|474884510|FG001|Overall Study|Failure to comply with an eligibility|1|||
131890811|NCT02007278|474884509|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
131890812|NCT02007278|474884510|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
131890813|NCT02007278|474884509|FG000|Overall Study|Incorrect medication administration|1|||
131890814|NCT02007278|474884510|FG001|Overall Study|Incorrect medication administration|0|||
131890815|NCT02007278|474884509|FG000|Overall Study|Mis-randomization|1|||
131890816|NCT02007278|474884510|FG001|Overall Study|Mis-randomization|1|||
131890817|NCT00830518|474884520|FG000|Overall Study|Progressive Disease|18|||
131890818|NCT00830518|474884521|FG001|Overall Study|Progressive Disease|8|||
131890819|NCT00830518|474884520|FG000|Overall Study|Symptomatic Deterioration|4|||
131890820|NCT00830518|474884521|FG001|Overall Study|Symptomatic Deterioration|1|||
131890821|NCT00830518|474884520|FG000|Overall Study|Adverse Event|14|||
131890822|NCT00830518|474884521|FG001|Overall Study|Adverse Event|1|||
131890823|NCT00830518|474884520|FG000|Overall Study|Withdrawal by Patient|2|||
131890824|NCT00830518|474884521|FG001|Overall Study|Withdrawal by Patient|0|||
131890825|NCT00830518|474884520|FG000|Overall Study|Reason not Specified|8|||
131890826|NCT00830518|474884521|FG001|Overall Study|Reason not Specified|1|||
131890827|NCT00621517|474884522|FG000|Overall Study|Lost to Follow-up|3|||
131890828|NCT00621517|474884523|FG001|Overall Study|Lost to Follow-up|3|||
131890829|NCT00621517|474884522|FG000|Overall Study|Withdrawal by Subject|3|||
131890830|NCT00621517|474884523|FG001|Overall Study|Withdrawal by Subject|4|||
131890831|NCT00621517|474884522|FG000|Overall Study|Adverse Event|1|||
131890832|NCT00621517|474884523|FG001|Overall Study|Adverse Event|0|||
131890833|NCT02155322|474884528|FG000|Overall Study|Adverse Event|1|||
131890834|NCT02155322|474884528|FG000|Overall Study|Physician Decision|1|||
131890835|NCT02155322|474884528|FG000|Overall Study|Relapse/Recurrence|8|||
131890836|NCT02155322|474884528|FG000|Overall Study|Withdrawal by Subject|4|||
131890837|NCT00073008|474884529|FG000|Overall Study|Missing|6|||
131890838|NCT00073008|474884530|FG001|Overall Study|Missing|6|||
131890839|NCT00073008|474884529|FG000|Overall Study|Withdrawal by Subject|2|||
131890840|NCT00073008|474884530|FG001|Overall Study|Withdrawal by Subject|2|||
131890841|NCT00073008|474884529|FG000|Overall Study|Lost to Follow-up|1|||
131890842|NCT00073008|474884530|FG001|Overall Study|Lost to Follow-up|3|||
131890843|NCT00073008|474884529|FG000|Overall Study|Death|46|||
131890844|NCT00073008|474884530|FG001|Overall Study|Death|47|||
131890845|NCT00073008|474884529|FG000|Overall Study|"Other selected on Case Report Form"|7|||
131890846|NCT00073008|474884530|FG001|Overall Study|"Other selected on Case Report Form"|5|||
131890847|NCT02669667|474884531|FG000|Overall Study|Lost to Follow-up|0|||
131890848|NCT02669667|474884532|FG001|Overall Study|Lost to Follow-up|0|||
131890849|NCT02669667|474884533|FG002|Overall Study|Lost to Follow-up|0|||
131890850|NCT02669667|474884534|FG003|Overall Study|Lost to Follow-up|0|||
131890851|NCT02669667|474884535|FG004|Overall Study|Lost to Follow-up|0|||
131890852|NCT02669667|474884536|FG005|Overall Study|Lost to Follow-up|1|||
131890853|NCT02669667|474884537|FG006|Overall Study|Lost to Follow-up|0|||
131890854|NCT01156051|474884538|FG000|Overall Study|Lost to Follow-up|1|||
131890855|NCT01156051|474884539|FG001|Overall Study|Lost to Follow-up|0|||
131890856|NCT01156051|474884538|FG000|Overall Study|patient not compliant with protocol|0|||
131890857|NCT01156051|474884539|FG001|Overall Study|patient not compliant with protocol|1|||
131890858|NCT03915626|474886382|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
131664105|NCT00768079|474054810|FG000|Overall Study|Lost to Follow-up|2|||
131890859|NCT05025332|474886386|FG000|Screening|Screen failure|12|||
131890860|NCT05025332|474886386|FG000|Treatment & Follow Up|Protocol Violation|1|||
131890861|NCT05025332|474886386|FG000|Treatment & Follow Up|Adverse Event|4|||
131890862|NCT01928199|474886387|FG000|Overall Study|Lost to Follow-up|2|||
131890863|NCT01928199|474886388|FG001|Overall Study|Lost to Follow-up|1|||
131890864|NCT01928199|474886387|FG000|Overall Study|Withdrawal by Subject|3|||
131890865|NCT01928199|474886388|FG001|Overall Study|Withdrawal by Subject|5|||
131890866|NCT01502956|474886389|FG000|Overall Study|Death|0|||
131890867|NCT01502956|474886390|FG001|Overall Study|Death|2|||
131890868|NCT01502956|474886389|FG000|Overall Study|Lost to Follow-up|14|||
131890869|NCT01502956|474886390|FG001|Overall Study|Lost to Follow-up|11|||
131890870|NCT01502956|474886389|FG000|Overall Study|Physician Decision|2|||
131890871|NCT01502956|474886390|FG001|Overall Study|Physician Decision|3|||
131890872|NCT01502956|474886389|FG000|Overall Study|Withdrawal by Subject|8|||
131890873|NCT01502956|474886390|FG001|Overall Study|Withdrawal by Subject|10|||
131890874|NCT01026818|474886391|FG000|Screening Period|Entry Criteria Not Met|105|||
131890875|NCT01026818|474886392|FG001|Screening Period|Entry Criteria Not Met|0|||
131890876|NCT01026818|474886393|FG002|Screening Period|Entry Criteria Not Met|0|||
131890877|NCT01026818|474886394|FG003|Screening Period|Entry Criteria Not Met|0|||
131890878|NCT01026818|474886391|FG000|Screening Period|Withdrawal by Subject|49|||
131890879|NCT01026818|474886392|FG001|Screening Period|Withdrawal by Subject|0|||
131890880|NCT01026818|474886393|FG002|Screening Period|Withdrawal by Subject|0|||
131890881|NCT01026818|474886394|FG003|Screening Period|Withdrawal by Subject|0|||
131890882|NCT01026818|474886391|FG000|Screening Period|Protocol Deviation|3|||
131890883|NCT01026818|474886392|FG001|Screening Period|Protocol Deviation|0|||
131890884|NCT01026818|474886393|FG002|Screening Period|Protocol Deviation|0|||
131890885|NCT01026818|474886394|FG003|Screening Period|Protocol Deviation|0|||
131890886|NCT01026818|474886391|FG000|Screening Period|Adverse Event|2|||
131890887|NCT01026818|474886392|FG001|Screening Period|Adverse Event|0|||
131890888|NCT01026818|474886393|FG002|Screening Period|Adverse Event|0|||
131890889|NCT01026818|474886394|FG003|Screening Period|Adverse Event|0|||
131890890|NCT01026818|474886391|FG000|Screening Period|Physician Decision|1|||
131890891|NCT01026818|474886392|FG001|Screening Period|Physician Decision|0|||
131890892|NCT01026818|474886393|FG002|Screening Period|Physician Decision|0|||
131890893|NCT01026818|474886394|FG003|Screening Period|Physician Decision|0|||
131890894|NCT01026818|474886391|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
131890895|NCT01026818|474886392|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
131890896|NCT01026818|474886393|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
131890897|NCT01026818|474886394|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
131890898|NCT01026818|474886391|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
131890899|NCT01026818|474886392|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
131890900|NCT01026818|474886393|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
131890901|NCT01026818|474886394|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
131890902|NCT01026818|474886391|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
131890903|NCT01026818|474886392|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
131890904|NCT01026818|474886393|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
131890905|NCT01026818|474886394|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
131890906|NCT01026818|474886391|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
131890907|NCT01026818|474886392|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
131890908|NCT01026818|474886393|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
131890909|NCT01026818|474886394|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
131890910|NCT01026818|474886391|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
131890911|NCT01026818|474886392|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
131890912|NCT01026818|474886393|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
131890913|NCT01026818|474886394|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
131890914|NCT01026818|474886391|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
131890915|NCT01026818|474886392|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
131890916|NCT01026818|474886393|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
131890917|NCT01026818|474886394|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
131664106|NCT00768079|474054811|FG001|Overall Study|Lost to Follow-up|0|||
131890918|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
131890919|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
131890920|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
131890921|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
131890922|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
131890923|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
131890924|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
131890925|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
131890926|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
131890927|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
131890928|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
131890929|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
131890930|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
131890931|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
131890932|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
131890933|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
131890934|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
131890935|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
131890936|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
131890937|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
131890938|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
131890939|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
131890940|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
131890941|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
131890942|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
131890943|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
131890944|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
131890945|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
131890946|NCT01026818|474886391|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
131890947|NCT01026818|474886392|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
131890948|NCT01026818|474886393|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
131890949|NCT01026818|474886394|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
131890950|NCT01026818|474886391|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
131890951|NCT01026818|474886392|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
131890952|NCT01026818|474886393|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
131890953|NCT01026818|474886394|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
131890954|NCT01026818|474886391|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
131890955|NCT01026818|474886392|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
131890956|NCT01026818|474886393|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
131890957|NCT01026818|474886394|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
131890958|NCT01026818|474886391|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
131890959|NCT01026818|474886392|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
131890960|NCT01026818|474886393|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
131890961|NCT01026818|474886394|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
131890962|NCT01026818|474886391|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
131890963|NCT01026818|474886392|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
131890964|NCT01026818|474886393|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
131890965|NCT01026818|474886394|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
131890966|NCT01026818|474886391|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
131890967|NCT01026818|474886392|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
131890968|NCT01026818|474886393|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
131890969|NCT01026818|474886394|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
131890970|NCT04575584|474886400|FG000|Overall Study|Death|6|||
131890971|NCT04575584|474886401|FG001|Overall Study|Death|4|||
131890972|NCT04575584|474886402|FG002|Overall Study|Death|6|||
131890973|NCT04575584|474886403|FG003|Overall Study|Death|2|||
131890974|NCT04575584|474886404|FG004|Overall Study|Death|0|||
131890975|NCT04575584|474886405|FG005|Overall Study|Death|0|||
131890976|NCT04575584|474886400|FG000|Overall Study|Lost to Follow-up|1|||
131890977|NCT04575584|474886401|FG001|Overall Study|Lost to Follow-up|1|||
131890978|NCT04575584|474886402|FG002|Overall Study|Lost to Follow-up|1|||
131890979|NCT04575584|474886403|FG003|Overall Study|Lost to Follow-up|1|||
131890980|NCT04575584|474886404|FG004|Overall Study|Lost to Follow-up|0|||
131890981|NCT04575584|474886405|FG005|Overall Study|Lost to Follow-up|0|||
131890982|NCT04575584|474886400|FG000|Overall Study|Physician Decision|0|||
131890983|NCT04575584|474886401|FG001|Overall Study|Physician Decision|1|||
131890984|NCT04575584|474886402|FG002|Overall Study|Physician Decision|1|||
131890985|NCT04575584|474886403|FG003|Overall Study|Physician Decision|1|||
131890986|NCT04575584|474886404|FG004|Overall Study|Physician Decision|0|||
131890987|NCT04575584|474886405|FG005|Overall Study|Physician Decision|0|||
131664107|NCT00768079|474054812|FG002|Overall Study|Lost to Follow-up|4|||
131664108|NCT00768079|474054810|FG000|Overall Study|Participant incarcerated|0|||
131664109|NCT00768079|474054811|FG001|Overall Study|Participant incarcerated|1|||
131664110|NCT00768079|474054812|FG002|Overall Study|Participant incarcerated|0|||
131664111|NCT01097707|474054813|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131664112|NCT01097707|474054814|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131664113|NCT01097707|474054815|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131664114|NCT01097707|474054816|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131664115|NCT01097707|474054817|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131664116|NCT01097707|474054813|FG000|Overall Study|Adverse Event|4|||
131664117|NCT01097707|474054814|FG001|Overall Study|Adverse Event|2|||
131664118|NCT01097707|474054815|FG002|Overall Study|Adverse Event|3|||
131664119|NCT01097707|474054816|FG003|Overall Study|Adverse Event|1|||
131664120|NCT01097707|474054817|FG004|Overall Study|Adverse Event|3|||
131664121|NCT01097707|474054813|FG000|Overall Study|Entry Criteria Not Met|2|||
131664122|NCT01097707|474054814|FG001|Overall Study|Entry Criteria Not Met|1|||
131664123|NCT01097707|474054815|FG002|Overall Study|Entry Criteria Not Met|1|||
131664124|NCT01097707|474054816|FG003|Overall Study|Entry Criteria Not Met|0|||
131664125|NCT01097707|474054817|FG004|Overall Study|Entry Criteria Not Met|1|||
131664126|NCT01097707|474054813|FG000|Overall Study|Lack of Efficacy|1|||
131664127|NCT01097707|474054814|FG001|Overall Study|Lack of Efficacy|0|||
131664128|NCT01097707|474054815|FG002|Overall Study|Lack of Efficacy|0|||
131664129|NCT01097707|474054816|FG003|Overall Study|Lack of Efficacy|1|||
131664130|NCT01097707|474054817|FG004|Overall Study|Lack of Efficacy|0|||
131664131|NCT01097707|474054813|FG000|Overall Study|Lost to Follow-up|1|||
131664132|NCT01097707|474054814|FG001|Overall Study|Lost to Follow-up|1|||
131664133|NCT01097707|474054815|FG002|Overall Study|Lost to Follow-up|2|||
131664134|NCT01097707|474054816|FG003|Overall Study|Lost to Follow-up|0|||
131664135|NCT01097707|474054817|FG004|Overall Study|Lost to Follow-up|3|||
131664136|NCT01097707|474054813|FG000|Overall Study|Protocol Violation|2|||
131664137|NCT01097707|474054814|FG001|Overall Study|Protocol Violation|2|||
131664138|NCT01097707|474054815|FG002|Overall Study|Protocol Violation|3|||
131664139|NCT01097707|474054816|FG003|Overall Study|Protocol Violation|2|||
131664140|NCT01097707|474054817|FG004|Overall Study|Protocol Violation|2|||
131664141|NCT01097707|474054813|FG000|Overall Study|Sponsor Decision|31|||
131664142|NCT01097707|474054814|FG001|Overall Study|Sponsor Decision|31|||
131664143|NCT01097707|474054815|FG002|Overall Study|Sponsor Decision|34|||
131664144|NCT01097707|474054816|FG003|Overall Study|Sponsor Decision|35|||
131664145|NCT01097707|474054817|FG004|Overall Study|Sponsor Decision|36|||
131664146|NCT01097707|474054813|FG000|Overall Study|Withdrawal by Subject|3|||
131664147|NCT01097707|474054814|FG001|Overall Study|Withdrawal by Subject|6|||
131664148|NCT01097707|474054815|FG002|Overall Study|Withdrawal by Subject|1|||
131664149|NCT01097707|474054816|FG003|Overall Study|Withdrawal by Subject|4|||
131664150|NCT01097707|474054817|FG004|Overall Study|Withdrawal by Subject|3|||
131664151|NCT01097707|474054813|FG000|Overall Study|Reason unknown|0|||
131664152|NCT01097707|474054814|FG001|Overall Study|Reason unknown|0|||
131664153|NCT01097707|474054815|FG002|Overall Study|Reason unknown|0|||
131664154|NCT01097707|474054816|FG003|Overall Study|Reason unknown|0|||
131664155|NCT01097707|474054817|FG004|Overall Study|Reason unknown|1|||
131664156|NCT02207569|474054821|FG000|1-Month|Death|6|||
131664157|NCT02207569|474054821|FG000|1-Month|Withdrawal by Subject|2|||
131664158|NCT02207569|474054821|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
131664159|NCT02207569|474054821|FG000|6-Month|Death|8|||
131664160|NCT02207569|474054821|FG000|6-Month|Withdrawal by Subject|2|||
131664161|NCT02207569|474054821|FG000|12-Month|Death|14|||
131664162|NCT02207569|474054821|FG000|12-Month|Withdrawal by Subject|2|||
131664163|NCT02207569|474054821|FG000|24-Month|Death|23|||
131664164|NCT02207569|474054821|FG000|24-Month|Withdrawal by Subject|3|||
131664165|NCT02207569|474054821|FG000|36-Month|Death|23|||
131664166|NCT02207569|474054821|FG000|36-Month|Withdrawal by Subject|4|||
131664167|NCT02207569|474054821|FG000|48-Month|Death|25|||
131664168|NCT02207569|474054821|FG000|48-Month|Withdrawal by Subject|2|||
131664169|NCT02207569|474054821|FG000|48-Month|Lost to Follow-up|4|||
131664170|NCT02207569|474054821|FG000|60-Month|Death|1|||
131664171|NCT02207569|474054821|FG000|60-Month|Lost to Follow-up|1|||
131664172|NCT02207569|474054821|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
131664173|NCT02207569|474054821|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
131664174|NCT01236534|474054822|FG000|Overall Study|Adverse Event|3|||
131664175|NCT01236534|474054823|FG001|Overall Study|Adverse Event|0|||
131890988|NCT04575584|474886400|FG000|Overall Study|Withdrawal by Subject|7|||
131890989|NCT04575584|474886401|FG001|Overall Study|Withdrawal by Subject|9|||
131890990|NCT04575584|474886402|FG002|Overall Study|Withdrawal by Subject|5|||
131890991|NCT04575584|474886403|FG003|Overall Study|Withdrawal by Subject|3|||
131664176|NCT05383508|474054832|FG000|Overall Study|Withdrawal by Subject|1|||
131664177|NCT05383508|474054833|FG001|Overall Study|Withdrawal by Subject|0|||
131664178|NCT05383508|474054834|FG002|Overall Study|Withdrawal by Subject|1|||
131664179|NCT05383508|474054835|FG003|Overall Study|Withdrawal by Subject|1|||
131664180|NCT05383508|474054836|FG004|Overall Study|Withdrawal by Subject|2|||
131890992|NCT04575584|474886404|FG004|Overall Study|Withdrawal by Subject|0|||
131890993|NCT04575584|474886405|FG005|Overall Study|Withdrawal by Subject|0|||
131890994|NCT04575584|474886400|FG000|Overall Study|Not recorded|0|||
131890995|NCT04575584|474886401|FG001|Overall Study|Not recorded|0|||
131890996|NCT04575584|474886402|FG002|Overall Study|Not recorded|0|||
131890997|NCT04575584|474886403|FG003|Overall Study|Not recorded|1|||
131890998|NCT04575584|474886404|FG004|Overall Study|Not recorded|0|||
131890999|NCT04575584|474886405|FG005|Overall Study|Not recorded|0|||
131891000|NCT02634801|474886406|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
131891001|NCT02634801|474886407|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
131891002|NCT02634801|474886408|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
131891003|NCT02634801|474886406|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
131891004|NCT02634801|474886407|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
131891005|NCT02634801|474886408|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
131891006|NCT02634801|474886406|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
131891007|NCT02634801|474886407|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
131891008|NCT02634801|474886408|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
131891009|NCT02634801|474886406|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
131891010|NCT02634801|474886407|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
131891011|NCT02634801|474886408|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
131891012|NCT02634801|474886406|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
131891013|NCT02634801|474886407|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
131891014|NCT02634801|474886408|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
131891015|NCT02634801|474886406|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
131891016|NCT02634801|474886407|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
131891017|NCT02634801|474886408|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
131891018|NCT02634801|474886406|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
131891019|NCT02634801|474886407|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
131891020|NCT02634801|474886408|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
131891021|NCT02634801|474886406|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
131891022|NCT02634801|474886407|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
131891023|NCT02634801|474886408|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
131891024|NCT02634801|474886406|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
131891025|NCT02634801|474886407|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
131891026|NCT02634801|474886408|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
131891027|NCT02634801|474886406|FG000|Follow-up Period|Lost to Follow-up|3|||
131891028|NCT02634801|474886407|FG001|Follow-up Period|Lost to Follow-up|1|||
131891029|NCT02634801|474886408|FG002|Follow-up Period|Lost to Follow-up|2|||
131891030|NCT02634801|474886406|FG000|Follow-up Period|Physician Decision|0|||
131891031|NCT02634801|474886407|FG001|Follow-up Period|Physician Decision|0|||
131891032|NCT02634801|474886408|FG002|Follow-up Period|Physician Decision|1|||
131891033|NCT02634801|474886406|FG000|Follow-up Period|Withdrawal by Subject|1|||
131891034|NCT02634801|474886407|FG001|Follow-up Period|Withdrawal by Subject|2|||
131891035|NCT02634801|474886408|FG002|Follow-up Period|Withdrawal by Subject|5|||
131891036|NCT02634801|474886406|FG000|Follow-up Period|Adverse Event|1|||
131891037|NCT02634801|474886407|FG001|Follow-up Period|Adverse Event|5|||
131891038|NCT02634801|474886408|FG002|Follow-up Period|Adverse Event|0|||
131891039|NCT03488563|474886409|FG000|Overall Study|Lost to Follow-up|7|||
131891040|NCT03488563|474886410|FG001|Overall Study|Lost to Follow-up|6|||
131891041|NCT03488563|474886411|FG002|Overall Study|Lost to Follow-up|7|||
131891042|NCT03488563|474886409|FG000|Overall Study|Withdrawal by Subject|8|||
131891043|NCT03488563|474886410|FG001|Overall Study|Withdrawal by Subject|7|||
131891044|NCT03488563|474886411|FG002|Overall Study|Withdrawal by Subject|7|||
131891045|NCT03488563|474886409|FG000|Overall Study|Physician Decision|0|||
131891046|NCT03488563|474886410|FG001|Overall Study|Physician Decision|0|||
131891047|NCT03488563|474886411|FG002|Overall Study|Physician Decision|1|||
131891048|NCT03488563|474886409|FG000|Overall Study|Protocol Violation|3|||
131891049|NCT03488563|474886410|FG001|Overall Study|Protocol Violation|2|||
131891050|NCT03488563|474886411|FG002|Overall Study|Protocol Violation|6|||
131891051|NCT03488563|474886409|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
131891052|NCT03488563|474886410|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
131891053|NCT03488563|474886411|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
131891054|NCT03488563|474886409|FG000|Overall Study|Use of prohibited medication|2|||
131891055|NCT03488563|474886410|FG001|Overall Study|Use of prohibited medication|0|||
131891056|NCT03488563|474886411|FG002|Overall Study|Use of prohibited medication|0|||
131891057|NCT03488563|474886409|FG000|Overall Study|Adverse Event|1|||
131891058|NCT03488563|474886410|FG001|Overall Study|Adverse Event|0|||
131891059|NCT03488563|474886411|FG002|Overall Study|Adverse Event|1|||
131891060|NCT03488563|474886409|FG000|Overall Study|Subject returned for ET visit|0|||
131891061|NCT03488563|474886410|FG001|Overall Study|Subject returned for ET visit|1|||
131891062|NCT03488563|474886411|FG002|Overall Study|Subject returned for ET visit|0|||
131435919|NCT03084796|473221892|FG002|Overall Study|Randomization error|1|||
131891063|NCT03488563|474886409|FG000|Overall Study|Sponsor's decision|0|||
131891064|NCT03488563|474886410|FG001|Overall Study|Sponsor's decision|0|||
131891065|NCT03488563|474886411|FG002|Overall Study|Sponsor's decision|1|||
131891066|NCT02626000|474886419|FG000|Overall Study|Decision by Sponsor|1|||
131891067|NCT02626000|474886419|FG000|Overall Study|Death|29|||
131891068|NCT02815267|474886425|FG000|Double-Blind Phase|Adverse Event|0|||
131891069|NCT02815267|474886426|FG001|Double-Blind Phase|Adverse Event|3|||
131891070|NCT02815267|474886425|FG000|Double-Blind Phase|Lost to Follow-up|17|||
131891071|NCT02815267|474886426|FG001|Double-Blind Phase|Lost to Follow-up|9|||
131891072|NCT02815267|474886425|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
131891073|NCT02815267|474886426|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
131891074|NCT02815267|474886425|FG000|Double-Blind Phase|Protocol Violation|3|||
131891075|NCT02815267|474886426|FG001|Double-Blind Phase|Protocol Violation|2|||
131891076|NCT02815267|474886425|FG000|Double-Blind Phase|Site withdrawal|1|||
131891077|NCT02815267|474886426|FG001|Double-Blind Phase|Site withdrawal|6|||
131891078|NCT02815267|474886425|FG000|Double-Blind Phase|Received a disallowed medication|1|||
131891079|NCT02815267|474886426|FG001|Double-Blind Phase|Received a disallowed medication|1|||
131891080|NCT02815267|474886425|FG000|Open-Label Phase|Adverse Event|1|||
131891081|NCT02815267|474886426|FG001|Open-Label Phase|Adverse Event|1|||
131891082|NCT02815267|474886425|FG000|Open-Label Phase|Lost to Follow-up|23|||
131891083|NCT02815267|474886426|FG001|Open-Label Phase|Lost to Follow-up|9|||
131891084|NCT02815267|474886425|FG000|Open-Label Phase|Withdrawal by Subject|24|||
131891085|NCT02815267|474886426|FG001|Open-Label Phase|Withdrawal by Subject|13|||
131891086|NCT02815267|474886425|FG000|Open-Label Phase|Protocol Violation|0|||
131891087|NCT02815267|474886426|FG001|Open-Label Phase|Protocol Violation|1|||
131891088|NCT02815267|474886425|FG000|Open-Label Phase|Administrative|21|||
131891089|NCT02815267|474886426|FG001|Open-Label Phase|Administrative|12|||
131891090|NCT02815267|474886425|FG000|Open-Label Phase|Other|2|||
131891091|NCT02815267|474886426|FG001|Open-Label Phase|Other|5|||
131891092|NCT02769312|474886427|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
131891093|NCT02769312|474886428|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
131891094|NCT02769312|474886427|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
131891095|NCT02769312|474886428|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
131891096|NCT02769312|474886427|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
131891097|NCT02769312|474886428|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
131891098|NCT02769312|474886427|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
131891099|NCT02769312|474886428|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
131891100|NCT02769312|474886427|FG000|Follow-up|Lost to Follow-up|1|||
131891101|NCT02769312|474886428|FG001|Follow-up|Lost to Follow-up|1|||
131891102|NCT03594955|474886431|FG000|Overall Study|Adverse Event|1|||
131891103|NCT03594955|474886431|FG000|Overall Study|Progressive disease|5|||
131891104|NCT03594955|474886431|FG000|Overall Study|Sponsor's decision|1|||
131891105|NCT03539484|474886432|FG000|Overall Study|Death|1|||
131891106|NCT03539484|474886433|FG001|Overall Study|Death|0|||
131891107|NCT03539484|474886434|FG002|Overall Study|Death|0|||
131891108|NCT03539484|474886435|FG003|Overall Study|Death|2|||
131891109|NCT03539484|474886436|FG004|Overall Study|Death|8|||
131891110|NCT03539484|474886437|FG005|Overall Study|Death|3|||
131891111|NCT03539484|474886438|FG006|Overall Study|Death|0|||
131891112|NCT03539484|474886432|FG000|Overall Study|Lost to Follow-up|0|||
131891113|NCT03539484|474886433|FG001|Overall Study|Lost to Follow-up|1|||
131891114|NCT03539484|474886434|FG002|Overall Study|Lost to Follow-up|0|||
131891115|NCT03539484|474886435|FG003|Overall Study|Lost to Follow-up|0|||
131891116|NCT03539484|474886436|FG004|Overall Study|Lost to Follow-up|1|||
131891117|NCT03539484|474886437|FG005|Overall Study|Lost to Follow-up|0|||
131891118|NCT03539484|474886438|FG006|Overall Study|Lost to Follow-up|0|||
131891119|NCT03539484|474886432|FG000|Overall Study|Withdrawal by Subject|0|||
131891120|NCT03539484|474886433|FG001|Overall Study|Withdrawal by Subject|0|||
131891121|NCT03539484|474886434|FG002|Overall Study|Withdrawal by Subject|0|||
131891122|NCT03539484|474886435|FG003|Overall Study|Withdrawal by Subject|0|||
131891123|NCT03539484|474886436|FG004|Overall Study|Withdrawal by Subject|2|||
131891124|NCT03539484|474886437|FG005|Overall Study|Withdrawal by Subject|0|||
131891125|NCT03539484|474886438|FG006|Overall Study|Withdrawal by Subject|1|||
131891126|NCT03539484|474886432|FG000|Overall Study|Study Terminated by Sponsor|0|||
131891127|NCT03539484|474886433|FG001|Overall Study|Study Terminated by Sponsor|0|||
131891128|NCT03539484|474886434|FG002|Overall Study|Study Terminated by Sponsor|1|||
131891129|NCT03539484|474886435|FG003|Overall Study|Study Terminated by Sponsor|1|||
131891130|NCT03539484|474886436|FG004|Overall Study|Study Terminated by Sponsor|2|||
131891131|NCT03539484|474886437|FG005|Overall Study|Study Terminated by Sponsor|2|||
131891132|NCT03539484|474886438|FG006|Overall Study|Study Terminated by Sponsor|1|||
131891133|NCT02476916|474886439|FG000|Core Period|Adverse Event|2|||
131891134|NCT02476916|474886440|FG001|Core Period|Adverse Event|2|||
131891135|NCT02476916|474886439|FG000|Core Period|Investigator decision|1|||
131891136|NCT02476916|474886440|FG001|Core Period|Investigator decision|1|||
131891137|NCT02476916|474886439|FG000|Core Period|Withdrawal by Subject|3|||
131891138|NCT02476916|474886440|FG001|Core Period|Withdrawal by Subject|0|||
131891139|NCT02476916|474886439|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
131891140|NCT02476916|474886440|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
131891141|NCT02476916|474886439|FG000|Extension Period|On Treatment|12|||
131891142|NCT02476916|474886440|FG001|Extension Period|On Treatment|17|||
131891143|NCT05600036|474886441|FG000|Overall Study|Adverse Event|0|||
131891144|NCT05600036|474886442|FG001|Overall Study|Adverse Event|2|||
131891145|NCT05600036|474886443|FG002|Overall Study|Adverse Event|1|||
131891146|NCT05600036|474886444|FG003|Overall Study|Adverse Event|0|||
131891147|NCT05600036|474886445|FG004|Overall Study|Adverse Event|1|||
131891148|NCT05600036|474886446|FG005|Overall Study|Adverse Event|0|||
131891149|NCT05600036|474886441|FG000|Overall Study|Lost to Follow-up|0|||
131891150|NCT05600036|474886442|FG001|Overall Study|Lost to Follow-up|2|||
131891151|NCT05600036|474886443|FG002|Overall Study|Lost to Follow-up|1|||
131891152|NCT05600036|474886444|FG003|Overall Study|Lost to Follow-up|1|||
131891153|NCT05600036|474886445|FG004|Overall Study|Lost to Follow-up|0|||
131891154|NCT05600036|474886446|FG005|Overall Study|Lost to Follow-up|0|||
131891155|NCT05600036|474886441|FG000|Overall Study|Protocol Violation|0|||
131891156|NCT05600036|474886442|FG001|Overall Study|Protocol Violation|0|||
131891157|NCT05600036|474886443|FG002|Overall Study|Protocol Violation|2|||
131891158|NCT05600036|474886444|FG003|Overall Study|Protocol Violation|0|||
131891159|NCT05600036|474886445|FG004|Overall Study|Protocol Violation|0|||
131891160|NCT05600036|474886446|FG005|Overall Study|Protocol Violation|0|||
131891161|NCT05600036|474886441|FG000|Overall Study|Withdrawal by Subject|0|||
131891162|NCT05600036|474886442|FG001|Overall Study|Withdrawal by Subject|1|||
131891163|NCT05600036|474886443|FG002|Overall Study|Withdrawal by Subject|2|||
131891164|NCT05600036|474886444|FG003|Overall Study|Withdrawal by Subject|0|||
131891165|NCT05600036|474886445|FG004|Overall Study|Withdrawal by Subject|3|||
131891166|NCT05600036|474886446|FG005|Overall Study|Withdrawal by Subject|5|||
131891167|NCT05600036|474886441|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
131891168|NCT05600036|474886442|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
131891169|NCT05600036|474886443|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
131891170|NCT05600036|474886444|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
131891171|NCT05600036|474886445|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
131891172|NCT05600036|474886446|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
131891173|NCT05600036|474886441|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
131891174|NCT05600036|474886442|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
131891175|NCT05600036|474886443|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
131891176|NCT05600036|474886444|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
131891177|NCT05600036|474886445|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
131891178|NCT05600036|474886446|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
131891179|NCT05600036|474886441|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
131891180|NCT05600036|474886442|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
131891181|NCT05600036|474886443|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
131891182|NCT05600036|474886444|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
131891183|NCT05600036|474886445|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
131891184|NCT05600036|474886446|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
131891185|NCT06010732|474886447|FG000|Crossover Period 1|Protocol Violation|0|||
131891186|NCT06010732|474886448|FG001|Crossover Period 1|Protocol Violation|0|||
131891187|NCT06010732|474886449|FG002|Crossover Period 1|Protocol Violation|1|||
131891188|NCT06010732|474886450|FG003|Crossover Period 1|Protocol Violation|0|||
131891189|NCT06010732|474886451|FG004|Crossover Period 1|Protocol Violation|1|||
131891190|NCT06010732|474886452|FG005|Crossover Period 1|Protocol Violation|0|||
131891191|NCT06010732|474886447|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
131891192|NCT06010732|474886448|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
131891193|NCT06010732|474886449|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
131891194|NCT06010732|474886450|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
131891195|NCT06010732|474886451|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
131891196|NCT06010732|474886452|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
131891197|NCT06010732|474886447|FG000|Crossover Period 2|Adverse Event|0|||
131891198|NCT06010732|474886448|FG001|Crossover Period 2|Adverse Event|1|||
131891199|NCT06010732|474886449|FG002|Crossover Period 2|Adverse Event|0|||
131891200|NCT06010732|474886450|FG003|Crossover Period 2|Adverse Event|0|||
131891201|NCT06010732|474886451|FG004|Crossover Period 2|Adverse Event|0|||
131891202|NCT06010732|474886452|FG005|Crossover Period 2|Adverse Event|0|||
131553224|NCT01933880|473649862|FG000|Overall Study|Withdrawal by Subject|5|||
131553225|NCT01933880|473649863|FG001|Overall Study|Withdrawal by Subject|0|||
131553226|NCT01933880|473649862|FG000|Overall Study|Lack of Efficacy|1|||
131553227|NCT01933880|473649863|FG001|Overall Study|Lack of Efficacy|0|||
131553228|NCT01933880|473649862|FG000|Overall Study|Concomitant medication Interference|0|||
131553229|NCT01933880|473649863|FG001|Overall Study|Concomitant medication Interference|1|||
131553230|NCT01933880|473649862|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
131553231|NCT01933880|473649863|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
131891203|NCT06010732|474886447|FG000|Crossover Period 2|broken denture|0|||
131891204|NCT06010732|474886448|FG001|Crossover Period 2|broken denture|0|||
131891205|NCT06010732|474886449|FG002|Crossover Period 2|broken denture|1|||
131891206|NCT06010732|474886450|FG003|Crossover Period 2|broken denture|0|||
131891207|NCT06010732|474886451|FG004|Crossover Period 2|broken denture|0|||
131891208|NCT06010732|474886452|FG005|Crossover Period 2|broken denture|0|||
131891209|NCT04401202|474886453|FG000|Overall Study|Lost to Follow-up|2|||
131891210|NCT04401202|474886454|FG001|Overall Study|Lost to Follow-up|2|||
131891211|NCT04401202|474886453|FG000|Overall Study|Adverse Event|0|||
131891212|NCT04401202|474886454|FG001|Overall Study|Adverse Event|1|||
131891213|NCT04401202|474886453|FG000|Overall Study|Hospitalized|4|||
131891214|NCT04401202|474886454|FG001|Overall Study|Hospitalized|1|||
131891215|NCT02714036|474886456|FG000|Overall Study|Adverse Event|9|||
131891216|NCT02714036|474886457|FG001|Overall Study|Adverse Event|2|||
131891217|NCT02714036|474886456|FG000|Overall Study|Withdrawal by Subject|3|||
131891218|NCT02714036|474886457|FG001|Overall Study|Withdrawal by Subject|2|||
131891219|NCT00329745|474886459|FG000|Overall Study|Protocol Violation|1|||
131891220|NCT00329745|474886460|FG001|Overall Study|Protocol Violation|0|||
131891221|NCT00329745|474886459|FG000|Overall Study|Withdrawal by Subject|0|||
131891222|NCT00329745|474886460|FG001|Overall Study|Withdrawal by Subject|1|||
131891223|NCT00329745|474886459|FG000|Overall Study|Lost to Follow-up|86|||
131891224|NCT00329745|474886460|FG001|Overall Study|Lost to Follow-up|101|||
131891225|NCT01597492|474886461|FG000|Overall Study|Withdrawal by Subject|1|||
131891226|NCT01597492|474886462|FG001|Overall Study|Withdrawal by Subject|2|||
131891227|NCT01597492|474886461|FG000|Overall Study|Adverse Event|3|||
131891228|NCT01597492|474886462|FG001|Overall Study|Adverse Event|0|||
131891229|NCT01597492|474886461|FG000|Overall Study|Lost to Follow-up|0|||
131891230|NCT01597492|474886462|FG001|Overall Study|Lost to Follow-up|2|||
131891231|NCT01597492|474886461|FG000|Overall Study|Other Reason|2|||
131891232|NCT01597492|474886462|FG001|Overall Study|Other Reason|0|||
131891233|NCT03624569|474886466|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131891234|NCT03624569|474886467|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
131891235|NCT03624569|474886466|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
131891236|NCT03624569|474886467|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
131891237|NCT01557517|474886468|FG000|Overall Study|Death|1|||
131891238|NCT01557517|474886469|FG001|Overall Study|Death|0|||
131891239|NCT01557517|474886468|FG000|Overall Study|Refused further treatment|0|||
131891240|NCT01557517|474886469|FG001|Overall Study|Refused further treatment|2|||
131891241|NCT01557517|474886468|FG000|Overall Study|Adverse Event|0|||
131891242|NCT01557517|474886469|FG001|Overall Study|Adverse Event|2|||
131891243|NCT01557517|474886468|FG000|Overall Study|Pt declined before treatment started|1|||
131891244|NCT01557517|474886469|FG001|Overall Study|Pt declined before treatment started|0|||
131891245|NCT01204918|474886480|FG000|Overall Study|Withdrawal by Subject|4|||
131891246|NCT01204918|474886481|FG001|Overall Study|Withdrawal by Subject|10|||
131891247|NCT01204918|474886482|FG002|Overall Study|Withdrawal by Subject|5|||
131891248|NCT00849290|474886485|FG000|Overall Study|Adverse Event|3|||
131891249|NCT00849290|474886485|FG000|Overall Study|Death|14|||
131891250|NCT00849290|474886485|FG000|Overall Study|Withdrawal by Subject|11|||
131891251|NCT00849290|474886485|FG000|Overall Study|Lost to Follow-up|2|||
131891252|NCT00849290|474886485|FG000|Overall Study|Protocol Violation|5|||
131891253|NCT00849290|474886485|FG000|Overall Study|Disease Progression|20|||
131891254|NCT00080483|474886494|FG000|Overall Study|Lost to Follow-up|1|||
131891255|NCT00080483|474886495|FG001|Overall Study|Lost to Follow-up|1|||
131891256|NCT00080483|474886494|FG000|Overall Study|Physician Decision|1|||
131891257|NCT00080483|474886495|FG001|Overall Study|Physician Decision|1|||
131891258|NCT01119846|474886496|FG000|Overall Study|Adverse Event|1|||
131891259|NCT01119846|474886497|FG001|Overall Study|Adverse Event|0|||
131891260|NCT01119846|474886498|FG002|Overall Study|Adverse Event|6|||
131891261|NCT01119846|474886496|FG000|Overall Study|Physician Decision|1|||
131891262|NCT01119846|474886497|FG001|Overall Study|Physician Decision|0|||
131891263|NCT01119846|474886498|FG002|Overall Study|Physician Decision|0|||
131891264|NCT01119846|474886496|FG000|Overall Study|Protocol Violation|0|||
131891265|NCT01119846|474886497|FG001|Overall Study|Protocol Violation|0|||
131891266|NCT01119846|474886498|FG002|Overall Study|Protocol Violation|1|||
131891267|NCT01119846|474886496|FG000|Overall Study|Withdrawal by Subject|0|||
131891268|NCT01119846|474886497|FG001|Overall Study|Withdrawal by Subject|0|||
131891269|NCT01119846|474886498|FG002|Overall Study|Withdrawal by Subject|4|||
131891270|NCT03304184|474886503|FG000|Overall Study|Withdrawal by Subject|1|||
131891271|NCT03304184|474886504|FG001|Overall Study|Withdrawal by Subject|2|||
131891272|NCT04527978|474886505|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
131891273|NCT04527978|474886506|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
131891274|NCT01370616|474886507|FG000|Overall Study|Adverse Event|11|||
131891275|NCT01370616|474886508|FG001|Overall Study|Adverse Event|16|||
131891276|NCT01370616|474886507|FG000|Overall Study|Death|1|||
131891277|NCT01370616|474886508|FG001|Overall Study|Death|0|||
131891278|NCT01370616|474886507|FG000|Overall Study|Lack of Efficacy|6|||
131891279|NCT01370616|474886508|FG001|Overall Study|Lack of Efficacy|2|||
131891280|NCT01370616|474886507|FG000|Overall Study|Lost to Follow-up|0|||
131891281|NCT01370616|474886508|FG001|Overall Study|Lost to Follow-up|3|||
131891282|NCT01370616|474886507|FG000|Overall Study|Physician Decision|6|||
131891283|NCT01370616|474886508|FG001|Overall Study|Physician Decision|6|||
131891284|NCT01370616|474886507|FG000|Overall Study|Progressive Disease|0|||
131891285|NCT01370616|474886508|FG001|Overall Study|Progressive Disease|1|||
131891286|NCT01370616|474886507|FG000|Overall Study|Recovery|1|||
131891287|NCT01370616|474886508|FG001|Overall Study|Recovery|0|||
131891288|NCT01370616|474886507|FG000|Overall Study|Technical Problems|3|||
131891289|NCT01370616|474886508|FG001|Overall Study|Technical Problems|5|||
131891290|NCT01370616|474886507|FG000|Overall Study|Withdrawal by Subject|34|||
131891291|NCT01370616|474886508|FG001|Overall Study|Withdrawal by Subject|34|||
131891292|NCT02324699|474886509|FG000|Overall Study|study terminated|1|||
131891293|NCT03337048|474886519|FG000|Overall Study|Withdrawal by Subject|2|||
131891294|NCT03337048|474886520|FG001|Overall Study|Withdrawal by Subject|0|||
131891295|NCT03337048|474886521|FG002|Overall Study|Withdrawal by Subject|0|||
131891296|NCT02791438|474886522|FG000|Treatment Period|Adverse Event|1|||
131891297|NCT02791438|474886523|FG001|Treatment Period|Adverse Event|0|||
131891298|NCT02791438|474886522|FG000|Treatment Period|Withdrawal by Subject|0|||
131891299|NCT02791438|474886523|FG001|Treatment Period|Withdrawal by Subject|1|||
131891300|NCT02791438|474886522|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
131891301|NCT02791438|474886523|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
131891302|NCT00394771|474886524|FG000|Overall Study|Did not meet protocol requirements|1|||
131891303|NCT00394771|474886525|FG001|Overall Study|Did not meet protocol requirements|0|||
131891304|NCT00394771|474886526|FG002|Overall Study|Did not meet protocol requirements|2|||
131891305|NCT00394771|474886527|FG003|Overall Study|Did not meet protocol requirements|0|||
131891306|NCT00394771|474886524|FG000|Overall Study|Protocol Violation|2|||
131891307|NCT00394771|474886525|FG001|Overall Study|Protocol Violation|4|||
131891308|NCT00394771|474886526|FG002|Overall Study|Protocol Violation|9|||
131891309|NCT00394771|474886527|FG003|Overall Study|Protocol Violation|7|||
131891310|NCT00394771|474886524|FG000|Overall Study|Withdrawal by Subject|10|||
131891311|NCT00394771|474886525|FG001|Overall Study|Withdrawal by Subject|6|||
131891312|NCT00394771|474886526|FG002|Overall Study|Withdrawal by Subject|8|||
131891313|NCT00394771|474886527|FG003|Overall Study|Withdrawal by Subject|12|||
131891314|NCT00394771|474886524|FG000|Overall Study|Adverse Event|10|||
131891315|NCT00394771|474886525|FG001|Overall Study|Adverse Event|5|||
131891316|NCT00394771|474886526|FG002|Overall Study|Adverse Event|12|||
131891317|NCT00394771|474886527|FG003|Overall Study|Adverse Event|8|||
131891318|NCT00394771|474886524|FG000|Overall Study|Participant pregnant|0|||
131891319|NCT00394771|474886525|FG001|Overall Study|Participant pregnant|1|||
131891320|NCT00394771|474886526|FG002|Overall Study|Participant pregnant|2|||
131891321|NCT00394771|474886527|FG003|Overall Study|Participant pregnant|2|||
131891322|NCT00394771|474886524|FG000|Overall Study|Lost to Follow-up|15|||
131891323|NCT00394771|474886525|FG001|Overall Study|Lost to Follow-up|15|||
131891324|NCT00394771|474886526|FG002|Overall Study|Lost to Follow-up|13|||
131891325|NCT00394771|474886527|FG003|Overall Study|Lost to Follow-up|10|||
131891326|NCT00394771|474886524|FG000|Overall Study|Other|3|||
131891327|NCT00394771|474886525|FG001|Overall Study|Other|3|||
131891328|NCT00394771|474886526|FG002|Overall Study|Other|1|||
131891329|NCT00394771|474886527|FG003|Overall Study|Other|0|||
131891330|NCT00586898|474886532|FG000|Overall Study|Adverse Event|1|||
131891331|NCT00586898|474886532|FG000|Overall Study|Patiemt Non-compliance|1|||
131891332|NCT00586898|474886532|FG000|Overall Study|Evaluable for Toxicity Only|5|||
131891333|NCT02101359|474886534|FG000|Overall Study|Not included|23|||
131891334|NCT02101359|474886535|FG001|Overall Study|Not included|13|||
131891335|NCT02101359|474886534|FG000|Overall Study|Withdrawal by Subject|5|||
131891336|NCT02101359|474886535|FG001|Overall Study|Withdrawal by Subject|4|||
131891337|NCT02101359|474886534|FG000|Overall Study|Lost to Follow-up|1|||
131891338|NCT02101359|474886535|FG001|Overall Study|Lost to Follow-up|0|||
131891339|NCT02101359|474886534|FG000|Overall Study|Protocol Violation|0|||
131891340|NCT02101359|474886535|FG001|Overall Study|Protocol Violation|2|||
131891341|NCT00742027|474886537|FG000|Overall Study|Disease Progression|76|||
131891342|NCT00742027|474886537|FG000|Overall Study|New Cancer Therapy|19|||
131891343|NCT00742027|474886537|FG000|Overall Study|Withdrawal by Subject|18|||
131891344|NCT00742027|474886537|FG000|Overall Study|Death|7|||
131891345|NCT00742027|474886537|FG000|Overall Study|Lost to Follow-up|4|||
131891346|NCT00742027|474886537|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
131891347|NCT00742027|474886537|FG000|Overall Study|Missing|2|||
131891348|NCT00742027|474886537|FG000|Overall Study|Administrative Problems|1|||
131891349|NCT01483599|474886539|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
131891350|NCT01483599|474886540|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891351|NCT01483599|474886541|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891352|NCT01483599|474886542|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
131891353|NCT01483599|474886543|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
131891354|NCT01483599|474886544|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
131891355|NCT01483599|474886545|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
131891356|NCT01483599|474886546|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891357|NCT01483599|474886547|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891358|NCT01483599|474886548|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891359|NCT01483599|474886549|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891360|NCT01483599|474886550|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891361|NCT01483599|474886551|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891362|NCT01483599|474886552|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
131891363|NCT01483599|474886539|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891364|NCT01483599|474886540|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
131891365|NCT01483599|474886541|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891366|NCT01483599|474886542|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
131891367|NCT01483599|474886543|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891368|NCT01483599|474886544|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891369|NCT01483599|474886545|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
131891370|NCT01483599|474886546|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891371|NCT01483599|474886547|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891372|NCT01483599|474886548|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891373|NCT01483599|474886549|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891374|NCT01483599|474886550|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891375|NCT01483599|474886551|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891376|NCT01483599|474886552|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
131891377|NCT01483599|474886539|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
131891378|NCT01483599|474886540|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891379|NCT01483599|474886541|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891380|NCT01483599|474886542|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891381|NCT01483599|474886543|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891382|NCT01483599|474886544|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891383|NCT01483599|474886545|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891384|NCT01483599|474886546|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891385|NCT01483599|474886547|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891386|NCT01483599|474886548|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891387|NCT01483599|474886549|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891388|NCT01483599|474886550|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891389|NCT01483599|474886551|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891390|NCT01483599|474886552|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131891391|NCT01483599|474886539|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
131891392|NCT01483599|474886540|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
131891393|NCT01483599|474886541|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
131891394|NCT01483599|474886542|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
131891395|NCT01483599|474886543|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
131891396|NCT01483599|474886544|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
131891397|NCT01483599|474886545|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
131891398|NCT01483599|474886546|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
131891399|NCT01483599|474886547|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
131891400|NCT01483599|474886548|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
131891401|NCT01483599|474886549|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
131891402|NCT01483599|474886550|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
131891403|NCT01483599|474886551|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
131891404|NCT01483599|474886552|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
131891405|NCT01483599|474886539|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
131891406|NCT01483599|474886540|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
131891407|NCT01483599|474886541|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
131891408|NCT01483599|474886542|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
131891409|NCT01483599|474886543|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
131891410|NCT01483599|474886544|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
131891411|NCT01483599|474886545|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
131891412|NCT01483599|474886546|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
131891413|NCT01483599|474886547|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
131891414|NCT01483599|474886548|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
131891415|NCT01483599|474886549|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
131891416|NCT01483599|474886550|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
131891417|NCT01483599|474886551|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
131891418|NCT01483599|474886552|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
131891419|NCT01483599|474886539|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891420|NCT01483599|474886540|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891421|NCT01483599|474886541|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891422|NCT01483599|474886542|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891423|NCT01483599|474886543|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891424|NCT01483599|474886544|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891425|NCT01483599|474886545|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891426|NCT01483599|474886546|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
131891427|NCT01483599|474886547|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
131891428|NCT01483599|474886548|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891429|NCT01483599|474886549|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891430|NCT01483599|474886550|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
131891431|NCT01483599|474886551|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
131891432|NCT01483599|474886552|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
131891433|NCT01483599|474886539|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891434|NCT01483599|474886540|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891435|NCT01483599|474886541|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891436|NCT01483599|474886542|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891437|NCT01483599|474886543|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891438|NCT01483599|474886544|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891439|NCT01483599|474886545|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131664181|NCT05383508|474054837|FG005|Overall Study|Withdrawal by Subject|0|||
131664182|NCT01157676|474054842|FG000|Randomization|Death|1|||
131664183|NCT01157676|474054843|FG001|Randomization|Death|1|||
131664184|NCT01157676|474054842|FG000|Randomization|unresectable|2|||
131664185|NCT01157676|474054843|FG001|Randomization|unresectable|3|||
131664186|NCT01157676|474054842|FG000|Randomization|Withdrawal by Subject|17|||
131664187|NCT01157676|474054843|FG001|Randomization|Withdrawal by Subject|13|||
131891440|NCT01483599|474886546|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891441|NCT01483599|474886547|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
131891442|NCT01483599|474886548|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891443|NCT01483599|474886549|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891444|NCT01483599|474886550|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
131891445|NCT01483599|474886551|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
131891446|NCT01483599|474886552|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
131891447|NCT01483599|474886539|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891448|NCT01483599|474886540|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891449|NCT01483599|474886541|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891450|NCT01483599|474886542|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891451|NCT01483599|474886543|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891452|NCT01483599|474886544|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891453|NCT01483599|474886545|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891454|NCT01483599|474886546|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891455|NCT01483599|474886547|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
131891456|NCT01483599|474886548|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891457|NCT01483599|474886549|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
131891458|NCT01483599|474886550|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891459|NCT01483599|474886551|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
131891460|NCT01483599|474886552|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
131891461|NCT01483599|474886539|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891462|NCT01483599|474886540|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891463|NCT01483599|474886541|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891464|NCT01483599|474886542|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891465|NCT01483599|474886543|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891466|NCT01483599|474886544|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891467|NCT01483599|474886545|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891468|NCT01483599|474886546|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891469|NCT01483599|474886547|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
131891470|NCT01483599|474886548|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891471|NCT01483599|474886549|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891472|NCT01483599|474886550|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
131891473|NCT01483599|474886551|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
131891474|NCT01483599|474886552|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
131891475|NCT01483599|474886539|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
131891476|NCT01483599|474886540|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
131891477|NCT01483599|474886541|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
131891478|NCT01483599|474886542|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
131891479|NCT01483599|474886543|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
131435920|NCT03084796|473221893|FG003|Overall Study|Randomization error|0|||
131664188|NCT01157676|474054842|FG000|Randomization|Physician Decision|1|||
131664189|NCT01157676|474054843|FG001|Randomization|Physician Decision|0|||
131664190|NCT01157676|474054842|FG000|Surgery|underwent open cystectomy|0|||
131664191|NCT01157676|474054843|FG001|Surgery|underwent open cystectomy|4|||
131891480|NCT01483599|474886544|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
131891481|NCT01483599|474886545|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
131891482|NCT01483599|474886546|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
131891483|NCT01483599|474886547|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
131891484|NCT01483599|474886548|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
131891485|NCT01483599|474886549|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
131891486|NCT01483599|474886550|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
131891487|NCT01483599|474886551|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
131891488|NCT01483599|474886552|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
131891489|NCT02494401|474886553|FG000|Overall Study|Lost to Follow-up|22|||
131891490|NCT02494401|474886554|FG001|Overall Study|Lost to Follow-up|25|||
131891491|NCT02494401|474886553|FG000|Overall Study|Withdrawal by Subject|3|||
131891492|NCT02494401|474886554|FG001|Overall Study|Withdrawal by Subject|2|||
131891493|NCT00966355|474886555|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
131891494|NCT00966355|474886556|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
131891495|NCT00966355|474886557|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
131891496|NCT00966355|474886555|FG000|Overall Study|newly diagnosed advanced HCC|11|||
131891497|NCT00966355|474886556|FG001|Overall Study|newly diagnosed advanced HCC|12|||
131891498|NCT00966355|474886557|FG002|Overall Study|newly diagnosed advanced HCC|10|||
131891499|NCT00966355|474886555|FG000|Overall Study|Lost to Follow-up|5|||
131891500|NCT00966355|474886556|FG001|Overall Study|Lost to Follow-up|4|||
131891501|NCT00966355|474886557|FG002|Overall Study|Lost to Follow-up|3|||
131891502|NCT00385827|474888056|FG000|Part 1|Adverse Event|1|||
131891503|NCT00385827|474888057|FG001|Part 1|Adverse Event|0|||
131891504|NCT00385827|474888058|FG002|Part 1|Adverse Event|0|||
131891505|NCT00385827|474888056|FG000|Part 1|Death|2|||
131891506|NCT00385827|474888057|FG001|Part 1|Death|0|||
131891507|NCT00385827|474888058|FG002|Part 1|Death|0|||
131891508|NCT00385827|474888056|FG000|Part 1|Lack of Efficacy|5|||
131891509|NCT00385827|474888057|FG001|Part 1|Lack of Efficacy|0|||
131891510|NCT00385827|474888058|FG002|Part 1|Lack of Efficacy|0|||
131891511|NCT00385827|474888056|FG000|Part 1|Other|1|||
131891512|NCT00385827|474888057|FG001|Part 1|Other|0|||
131891513|NCT00385827|474888058|FG002|Part 1|Other|0|||
131891514|NCT00385827|474888056|FG000|Part 2|Adverse Event|0|||
131891515|NCT00385827|474888057|FG001|Part 2|Adverse Event|6|||
131891516|NCT00385827|474888058|FG002|Part 2|Adverse Event|10|||
131891517|NCT00385827|474888056|FG000|Part 2|Death|0|||
131891518|NCT00385827|474888057|FG001|Part 2|Death|0|||
131891519|NCT00385827|474888058|FG002|Part 2|Death|2|||
131891520|NCT00385827|474888056|FG000|Part 2|Lack of Efficacy|0|||
131891521|NCT00385827|474888057|FG001|Part 2|Lack of Efficacy|14|||
131891522|NCT00385827|474888058|FG002|Part 2|Lack of Efficacy|13|||
131891523|NCT00385827|474888056|FG000|Part 2|Randomized but not treated|0|||
131891524|NCT00385827|474888057|FG001|Part 2|Randomized but not treated|2|||
131891525|NCT00385827|474888058|FG002|Part 2|Randomized but not treated|2|||
131891526|NCT00385827|474888056|FG000|Part 2|Other|0|||
131891527|NCT00385827|474888057|FG001|Part 2|Other|11|||
131891528|NCT00385827|474888058|FG002|Part 2|Other|21|||
131891529|NCT00410072|474888059|FG000|Day 1 to Week 48|Adverse Event|1|||
131891530|NCT00410072|474888060|FG001|Day 1 to Week 48|Adverse Event|2|||
131891531|NCT00410072|474888059|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
131891532|NCT00410072|474888060|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
131891533|NCT00410072|474888059|FG000|Day 1 to Week 48|Other|0|||
131891534|NCT00410072|474888060|FG001|Day 1 to Week 48|Other|1|||
131891535|NCT00410072|474888059|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
131891536|NCT00410072|474888060|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
131891537|NCT00410072|474888059|FG000|Day 1 to Week 48|Pregnancy|0|||
131891538|NCT00410072|474888060|FG001|Day 1 to Week 48|Pregnancy|2|||
131891539|NCT00410072|474888059|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
131664192|NCT01157676|474054842|FG000|Surgery|converted to open procedure|0|||
131664193|NCT01157676|474054843|FG001|Surgery|converted to open procedure|5|||
131664194|NCT01157676|474054842|FG000|Surgery|underwent robotic cystectomy|1|||
131664195|NCT01157676|474054843|FG001|Surgery|underwent robotic cystectomy|0|||
131891540|NCT00410072|474888060|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
131891541|NCT00410072|474888059|FG000|After Week 48 to Week 96|Adverse Event|1|||
131664196|NCT00468104|474054844|FG000|First Intervention|Protocol Violation|2|||
131664197|NCT00468104|474054845|FG001|First Intervention|Protocol Violation|1|||
131891542|NCT00410072|474888060|FG001|After Week 48 to Week 96|Adverse Event|2|||
131891543|NCT00410072|474888059|FG000|After Week 48 to Week 96|Death|0|||
131891544|NCT00410072|474888060|FG001|After Week 48 to Week 96|Death|1|||
131891545|NCT00410072|474888059|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
131664198|NCT00468104|474054844|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
131891546|NCT00410072|474888060|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
131891547|NCT00410072|474888059|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
131891548|NCT00410072|474888060|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
131891549|NCT00410072|474888059|FG000|After Week 48 to Week 96|Other|2|||
131891550|NCT00410072|474888060|FG001|After Week 48 to Week 96|Other|0|||
131891551|NCT00410072|474888059|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
131891552|NCT00410072|474888060|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
131891553|NCT00410072|474888059|FG000|After Week 48 to Week 96|Pregnancy|0|||
131891554|NCT00410072|474888060|FG001|After Week 48 to Week 96|Pregnancy|2|||
131891555|NCT00410072|474888059|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
131891556|NCT00410072|474888060|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
131891557|NCT01421147|474888061|FG000|Treatment Period|Adverse Event|2|||
131891558|NCT01421147|474888062|FG001|Treatment Period|Adverse Event|3|||
131891559|NCT01421147|474888061|FG000|Treatment Period|Lost to Follow-up|2|||
131891560|NCT01421147|474888062|FG001|Treatment Period|Lost to Follow-up|1|||
131891561|NCT01421147|474888061|FG000|Treatment Period|Physician Decision|2|||
131891562|NCT01421147|474888062|FG001|Treatment Period|Physician Decision|2|||
131891563|NCT01421147|474888061|FG000|Treatment Period|Withdrawal by Subject|10|||
131891564|NCT01421147|474888062|FG001|Treatment Period|Withdrawal by Subject|5|||
131891565|NCT01421147|474888061|FG000|Extension Period|Adverse Event|0|||
131891566|NCT01421147|474888062|FG001|Extension Period|Adverse Event|2|||
131891567|NCT01421147|474888061|FG000|Extension Period|Death|0|||
131891568|NCT01421147|474888062|FG001|Extension Period|Death|1|||
131891569|NCT01421147|474888061|FG000|Extension Period|Lost to Follow-up|2|||
131891570|NCT01421147|474888062|FG001|Extension Period|Lost to Follow-up|5|||
131891571|NCT01421147|474888061|FG000|Extension Period|Physician Decision|1|||
131891572|NCT01421147|474888062|FG001|Extension Period|Physician Decision|0|||
131891573|NCT01421147|474888061|FG000|Extension Period|Withdrawal by Subject|5|||
131891574|NCT01421147|474888062|FG001|Extension Period|Withdrawal by Subject|3|||
131891575|NCT03307837|474888064|FG000|Overall Study|Withdrawal by Subject|0|||
131891576|NCT03307837|474888065|FG001|Overall Study|Withdrawal by Subject|0|||
131891577|NCT03307837|474888066|FG002|Overall Study|Withdrawal by Subject|1|||
131891578|NCT03307837|474888067|FG003|Overall Study|Withdrawal by Subject|0|||
131891579|NCT03307837|474888068|FG004|Overall Study|Withdrawal by Subject|0|||
131891580|NCT03307837|474888069|FG005|Overall Study|Withdrawal by Subject|1|||
131891581|NCT03307837|474888064|FG000|Overall Study|Lost to Follow-up|1|||
131891582|NCT03307837|474888065|FG001|Overall Study|Lost to Follow-up|1|||
131891583|NCT03307837|474888066|FG002|Overall Study|Lost to Follow-up|0|||
131891584|NCT03307837|474888067|FG003|Overall Study|Lost to Follow-up|0|||
131891585|NCT03307837|474888068|FG004|Overall Study|Lost to Follow-up|0|||
131891586|NCT03307837|474888069|FG005|Overall Study|Lost to Follow-up|1|||
131891587|NCT00171158|474888070|FG000|Core Study|Death|27|||
131891588|NCT00171158|474888070|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
131891589|NCT00171158|474888070|FG000|Core Study|Protocol Violation|4|||
131891590|NCT00171158|474888070|FG000|Core Study|Administrative problems|1|||
131891591|NCT00171158|474888070|FG000|Core Study|Adverse event, non-fatal|21|||
131891592|NCT00171158|474888070|FG000|Core Study|Consent withdrawn by subject|6|||
131891593|NCT00171158|474888070|FG000|Core Study|No longer required drug (BMT)|14|||
131891594|NCT00171158|474888070|FG000|Core Study|Abnormal Laboratory Values|2|||
131891595|NCT00171158|474888070|FG000|Core Study|Lost to Follow-up|1|||
131891596|NCT00171158|474888070|FG000|E2 Extension|Other|7|||
131891597|NCT03536663|474888073|FG000|Endexo|Protocol Violation|1|||
131891598|NCT00904917|474888075|FG000|Overall Study|Lost to Follow-up|2|||
131891599|NCT00904917|474888076|FG001|Overall Study|Lost to Follow-up|2|||
131891600|NCT00904917|474888077|FG002|Overall Study|Lost to Follow-up|2|||
131891601|NCT00904917|474888078|FG003|Overall Study|Lost to Follow-up|2|||
131891602|NCT02442206|474888079|FG000|Period 1|Adverse Event|1|||
131891603|NCT02442206|474888080|FG001|Period 1|Adverse Event|1|||
131891604|NCT02442206|474888079|FG000|Period 1|withdrew consent|0|||
131891605|NCT02442206|474888080|FG001|Period 1|withdrew consent|1|||
131891606|NCT02442206|474888079|FG000|Period 1|COPD exacerbation|0|||
131891607|NCT02442206|474888080|FG001|Period 1|COPD exacerbation|1|||
131891608|NCT02442206|474888079|FG000|Period 2|Adverse Event|1|||
131891609|NCT02442206|474888080|FG001|Period 2|Adverse Event|0|||
131891610|NCT01471444|474888081|FG000|Overall Study|Physician Decision|3|||
131891611|NCT01471444|474888082|FG001|Overall Study|Physician Decision|2|||
131891612|NCT01471444|474888081|FG000|Overall Study|Withdrawal by Subject|0|||
131891613|NCT01471444|474888082|FG001|Overall Study|Withdrawal by Subject|1|||
131891614|NCT02155309|474888085|FG000|Overall Study|Protocol Violation|0|||
131891615|NCT02155309|474888086|FG001|Overall Study|Protocol Violation|0|||
131891616|NCT02155309|474888087|FG002|Overall Study|Protocol Violation|1|||
131891617|NCT02190721|474888093|FG000|Overall Study|Patient was out of the city|0|||
131891618|NCT02190721|474888094|FG001|Overall Study|Patient was out of the city|1|||
131891619|NCT02190721|474888095|FG002|Overall Study|Patient was out of the city|0|||
131891620|NCT04676152|474888096|FG000|Overall Study|screen fail|9|||
131891621|NCT00662311|474888108|FG000|Overall Study|Respiratory Infection|1|||
131891622|NCT00662311|474888109|FG001|Overall Study|Respiratory Infection|0|||
131891623|NCT00662311|474888110|FG002|Overall Study|Respiratory Infection|0|||
131891624|NCT01467271|474888111|FG000|Overall Study|Death|84|||
131891625|NCT01467271|474888111|FG000|Overall Study|Lost to Follow-up|83|||
131891626|NCT01467271|474888111|FG000|Overall Study|Retraction of patient's consent|21|||
131891627|NCT01467271|474888111|FG000|Overall Study|Other reason|14|||
131891628|NCT02335346|474888130|FG000|Overall Study|Adverse Event|11|||
131891629|NCT02335346|474888130|FG000|Overall Study|Withdrawal by Subject|1|||
131891630|NCT01548768|474888131|FG000|Overall Study|Withdrawal by Subject|0|||
131891631|NCT01548768|474888132|FG001|Overall Study|Withdrawal by Subject|2|||
131891632|NCT01548768|474888133|FG002|Overall Study|Withdrawal by Subject|1|||
131891633|NCT01548768|474888134|FG003|Overall Study|Withdrawal by Subject|0|||
131891634|NCT01548768|474888131|FG000|Overall Study|Physician Decision|1|||
131891635|NCT01548768|474888132|FG001|Overall Study|Physician Decision|0|||
131891636|NCT01548768|474888133|FG002|Overall Study|Physician Decision|0|||
131891637|NCT01548768|474888134|FG003|Overall Study|Physician Decision|0|||
131891638|NCT01548768|474888131|FG000|Overall Study|Adverse Event|0|||
131891639|NCT01548768|474888132|FG001|Overall Study|Adverse Event|0|||
131891640|NCT01548768|474888133|FG002|Overall Study|Adverse Event|0|||
131891641|NCT01548768|474888134|FG003|Overall Study|Adverse Event|1|||
131891642|NCT01548768|474888131|FG000|Overall Study|Non-Compliance|0|||
131891643|NCT01548768|474888132|FG001|Overall Study|Non-Compliance|0|||
131891644|NCT01548768|474888133|FG002|Overall Study|Non-Compliance|0|||
131891645|NCT01548768|474888134|FG003|Overall Study|Non-Compliance|3|||
131891646|NCT00482170|474888135|FG000|Overall Study|Adverse Event|5|||
131891647|NCT00482170|474888136|FG001|Overall Study|Adverse Event|14|||
131891648|NCT00482170|474888135|FG000|Overall Study|Withdrawal by Subject|6|||
131891649|NCT00482170|474888136|FG001|Overall Study|Withdrawal by Subject|1|||
131891650|NCT00482170|474888135|FG000|Overall Study|Protocol Violation|2|||
131891651|NCT00482170|474888136|FG001|Overall Study|Protocol Violation|3|||
131891652|NCT00482170|474888135|FG000|Overall Study|Lost to Follow-up|2|||
131891653|NCT00482170|474888136|FG001|Overall Study|Lost to Follow-up|0|||
131891654|NCT00482170|474888135|FG000|Overall Study|Unspecified reason|0|||
131891655|NCT00482170|474888136|FG001|Overall Study|Unspecified reason|2|||
131891656|NCT00162097|474888137|FG000|Overall Study|Participant no longer met study criteria|0|||
131891657|NCT00162097|474888138|FG001|Overall Study|Participant no longer met study criteria|0|||
131891658|NCT00162097|474888139|FG002|Overall Study|Participant no longer met study criteria|0|||
131891659|NCT00162097|474888140|FG003|Overall Study|Participant no longer met study criteria|1|||
131891660|NCT03585712|474888145|FG000|Treatment Period 1|Protocol Violation|1|||
131891661|NCT03585712|474888146|FG001|Treatment Period 1|Protocol Violation|0|||
131891662|NCT03585712|474888147|FG002|Treatment Period 1|Protocol Violation|0|||
131891663|NCT03585712|474888145|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
131891664|NCT03585712|474888146|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
131891665|NCT03585712|474888147|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
131891666|NCT03585712|474888145|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
131891667|NCT03585712|474888146|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
131891668|NCT03585712|474888147|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
131891669|NCT03585712|474888145|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
131891670|NCT03585712|474888146|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
131891671|NCT03585712|474888147|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
131891672|NCT03004924|474888148|FG000|Overall Study|Adverse Event|6|||
131891673|NCT03004924|474888149|FG001|Overall Study|Adverse Event|5|||
131891674|NCT03004924|474888150|FG002|Overall Study|Adverse Event|10|||
131891675|NCT03004924|474888148|FG000|Overall Study|Protocol Violation|4|||
131891676|NCT03004924|474888149|FG001|Overall Study|Protocol Violation|0|||
131891677|NCT03004924|474888150|FG002|Overall Study|Protocol Violation|1|||
131891678|NCT03004924|474888148|FG000|Overall Study|Withdrawal by Subject|5|||
131891679|NCT03004924|474888149|FG001|Overall Study|Withdrawal by Subject|3|||
131891680|NCT03004924|474888150|FG002|Overall Study|Withdrawal by Subject|5|||
131891681|NCT03004924|474888148|FG000|Overall Study|Lost to Follow-up|6|||
131891682|NCT03004924|474888149|FG001|Overall Study|Lost to Follow-up|1|||
131891683|NCT03004924|474888150|FG002|Overall Study|Lost to Follow-up|4|||
131891684|NCT03004924|474888148|FG000|Overall Study|Lack of Efficacy|2|||
131891685|NCT03004924|474888149|FG001|Overall Study|Lack of Efficacy|4|||
131891686|NCT03004924|474888150|FG002|Overall Study|Lack of Efficacy|2|||
131891687|NCT03004924|474888148|FG000|Overall Study|Physician Decision|1|||
131891688|NCT03004924|474888149|FG001|Overall Study|Physician Decision|0|||
131891689|NCT03004924|474888150|FG002|Overall Study|Physician Decision|1|||
131891690|NCT03004924|474888148|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131891691|NCT03004924|474888149|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131891692|NCT03004924|474888150|FG002|Overall Study|Withdrawal by parent/guardian|2|||
131891693|NCT03004924|474888148|FG000|Overall Study|Screen Failure|1|||
131891694|NCT03004924|474888149|FG001|Overall Study|Screen Failure|0|||
131891695|NCT03004924|474888150|FG002|Overall Study|Screen Failure|0|||
131891696|NCT03004924|474888148|FG000|Overall Study|Pregnancy|0|||
131891697|NCT03004924|474888149|FG001|Overall Study|Pregnancy|1|||
131891698|NCT03004924|474888150|FG002|Overall Study|Pregnancy|0|||
131891699|NCT03004924|474888148|FG000|Overall Study|Terminated by Sponsor|0|||
131891700|NCT03004924|474888149|FG001|Overall Study|Terminated by Sponsor|0|||
131891701|NCT03004924|474888150|FG002|Overall Study|Terminated by Sponsor|1|||
131891702|NCT03004924|474888148|FG000|Overall Study|Missed Study Visit|0|||
131891703|NCT03004924|474888149|FG001|Overall Study|Missed Study Visit|0|||
131891704|NCT03004924|474888150|FG002|Overall Study|Missed Study Visit|2|||
131891705|NCT03004924|474888148|FG000|Overall Study|HSV1 Positive|1|||
131891706|NCT03004924|474888149|FG001|Overall Study|HSV1 Positive|0|||
131891707|NCT03004924|474888150|FG002|Overall Study|HSV1 Positive|0|||
131891708|NCT01280682|474888151|FG000|Overall Study|Lost to Follow-up|0|||
131891709|NCT01280682|474888152|FG001|Overall Study|Lost to Follow-up|6|||
131891710|NCT01280682|474888151|FG000|Overall Study|Withdrawal by Subject|0|||
131891711|NCT01280682|474888152|FG001|Overall Study|Withdrawal by Subject|7|||
131891712|NCT00269477|474888155|FG000|Overall Study|Protocol Violation|5|||
131891713|NCT00269477|474888156|FG001|Overall Study|Protocol Violation|5|||
131891714|NCT00269477|474888157|FG002|Overall Study|Protocol Violation|1|||
131891715|NCT00269477|474888158|FG003|Overall Study|Protocol Violation|0|||
131891716|NCT00269477|474888155|FG000|Overall Study|Missed post-vaccination blood draw|0|||
131891717|NCT00269477|474888156|FG001|Overall Study|Missed post-vaccination blood draw|1|||
131891718|NCT00269477|474888157|FG002|Overall Study|Missed post-vaccination blood draw|0|||
131891719|NCT00269477|474888158|FG003|Overall Study|Missed post-vaccination blood draw|0|||
131891720|NCT01964716|474888165|FG000|Overall Study|Withdrawal by Subject|2|||
131891721|NCT01964716|474888166|FG001|Overall Study|Withdrawal by Subject|3|||
131891722|NCT01964716|474888165|FG000|Overall Study|Lost to Follow-up|1|||
131891723|NCT01964716|474888166|FG001|Overall Study|Lost to Follow-up|2|||
131891724|NCT01964716|474888165|FG000|Overall Study|No longer met eligibility criteria|1|||
131891725|NCT01964716|474888166|FG001|Overall Study|No longer met eligibility criteria|1|||
131891726|NCT01964716|474888165|FG000|Overall Study|Death|1|||
131891727|NCT01964716|474888166|FG001|Overall Study|Death|0|||
131891728|NCT01464619|474888167|FG000|Overall Study|Lost to Follow-up|3|||
131891729|NCT01464619|474888168|FG001|Overall Study|Lost to Follow-up|4|||
131891730|NCT01605825|474888171|FG000|Overall Study|Adverse Event|4|||
131891731|NCT01605825|474888172|FG001|Overall Study|Adverse Event|2|||
131891732|NCT01605825|474888171|FG000|Overall Study|Withdrawal by Subject|0|||
131891733|NCT01605825|474888172|FG001|Overall Study|Withdrawal by Subject|1|||
131891734|NCT01605825|474888171|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
131891735|NCT01605825|474888172|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
131891736|NCT01605825|474888171|FG000|Overall Study|Non-Compliance with Protocol|3|||
131891737|NCT01605825|474888172|FG001|Overall Study|Non-Compliance with Protocol|0|||
131891738|NCT01578499|474888175|FG000|Overall Study|Reason not Specified|0|||
131891739|NCT01578499|474888176|FG001|Overall Study|Reason not Specified|1|||
131891740|NCT01578499|474888175|FG000|Overall Study|Lost to Follow-up|2|||
131891741|NCT01578499|474888176|FG001|Overall Study|Lost to Follow-up|1|||
131891742|NCT01578499|474888175|FG000|Overall Study|Withdrawal by Subject|10|||
131891743|NCT01578499|474888176|FG001|Overall Study|Withdrawal by Subject|16|||
131891744|NCT01578499|474888175|FG000|Overall Study|Death|20|||
131891745|NCT01578499|474888176|FG001|Overall Study|Death|25|||
131891746|NCT01578499|474888175|FG000|Overall Study|Died and End of Study Page not Completed|2|||
131891747|NCT01578499|474888176|FG001|Overall Study|Died and End of Study Page not Completed|0|||
131891748|NCT02670382|474888177|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
131891749|NCT02670382|474888178|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
131891750|NCT03244618|474888179|FG000|Overall Study|Lost to Follow-up|3|||
131891751|NCT03244618|474888180|FG001|Overall Study|Lost to Follow-up|4|||
131891752|NCT03244618|474888179|FG000|Overall Study|Protocol Violation|4|||
131891753|NCT03244618|474888180|FG001|Overall Study|Protocol Violation|3|||
131891754|NCT03244618|474888179|FG000|Overall Study|Withdrawal by Subject|0|||
131891755|NCT03244618|474888180|FG001|Overall Study|Withdrawal by Subject|2|||
131891756|NCT01863732|474888184|FG000|Overall Study|Adverse Event|2|||
131891757|NCT01863732|474888185|FG001|Overall Study|Adverse Event|0|||
131891758|NCT01863732|474888186|FG002|Overall Study|Adverse Event|3|||
131891759|NCT01863732|474888187|FG003|Overall Study|Adverse Event|3|||
131891760|NCT01863732|474888184|FG000|Overall Study|Lack of Efficacy|1|||
131891761|NCT01863732|474888185|FG001|Overall Study|Lack of Efficacy|0|||
131891762|NCT01863732|474888186|FG002|Overall Study|Lack of Efficacy|2|||
131891763|NCT01863732|474888187|FG003|Overall Study|Lack of Efficacy|1|||
131891764|NCT01863732|474888184|FG000|Overall Study|Lost to Follow-up|2|||
131891765|NCT01863732|474888185|FG001|Overall Study|Lost to Follow-up|2|||
131891766|NCT01863732|474888186|FG002|Overall Study|Lost to Follow-up|1|||
131891767|NCT01863732|474888187|FG003|Overall Study|Lost to Follow-up|1|||
131891768|NCT01863732|474888184|FG000|Overall Study|Physician Decision|1|||
131891769|NCT01863732|474888185|FG001|Overall Study|Physician Decision|0|||
131891770|NCT01863732|474888186|FG002|Overall Study|Physician Decision|1|||
131891771|NCT01863732|474888187|FG003|Overall Study|Physician Decision|0|||
131891772|NCT01863732|474888184|FG000|Overall Study|Pregnancy|0|||
131891773|NCT01863732|474888185|FG001|Overall Study|Pregnancy|0|||
131891774|NCT01863732|474888186|FG002|Overall Study|Pregnancy|0|||
131435921|NCT03084796|473221894|FG004|Overall Study|Randomization error|0|||
131891775|NCT01863732|474888187|FG003|Overall Study|Pregnancy|1|||
131891776|NCT01863732|474888184|FG000|Overall Study|Technical problems|0|||
131891777|NCT01863732|474888185|FG001|Overall Study|Technical problems|1|||
131891778|NCT01863732|474888186|FG002|Overall Study|Technical problems|1|||
131891779|NCT01863732|474888187|FG003|Overall Study|Technical problems|0|||
131891780|NCT01863732|474888184|FG000|Overall Study|Subject/guardian decision|6|||
131891781|NCT01863732|474888185|FG001|Overall Study|Subject/guardian decision|9|||
131891782|NCT01863732|474888186|FG002|Overall Study|Subject/guardian decision|3|||
131891783|NCT01863732|474888187|FG003|Overall Study|Subject/guardian decision|1|||
131891784|NCT01863732|474888184|FG000|Overall Study|Death|1|||
131891785|NCT01863732|474888185|FG001|Overall Study|Death|0|||
131891786|NCT01863732|474888186|FG002|Overall Study|Death|0|||
131891787|NCT01863732|474888187|FG003|Overall Study|Death|1|||
131891788|NCT00460746|474888188|FG000|Overall Study|Adverse Event|1|||
131891789|NCT00460746|474888188|FG000|Overall Study|Lost to Follow-up|1|||
131891790|NCT00913770|474888189|FG000|Overall Study|Unable to contact|24|||
131891791|NCT00913770|474888190|FG001|Overall Study|Unable to contact|19|||
131891792|NCT00913770|474888191|FG002|Overall Study|Unable to contact|13|||
131891793|NCT00913770|474888189|FG000|Overall Study|Refused|11|||
131891794|NCT00913770|474888190|FG001|Overall Study|Refused|10|||
131891795|NCT00913770|474888191|FG002|Overall Study|Refused|8|||
131891796|NCT00636961|474888197|FG000|Period 1|Administrative problems|1|||
131891797|NCT00636961|474888198|FG001|Period 1|Administrative problems|1|||
131891798|NCT00636961|474888197|FG000|Period 2|Adverse Event|1|||
131891799|NCT00636961|474888198|FG001|Period 2|Adverse Event|0|||
131891800|NCT03816007|474888199|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
131891801|NCT03816007|474888200|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
131891802|NCT03816007|474888199|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
131891803|NCT03816007|474888200|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
131891804|NCT03816007|474888199|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
131891805|NCT03816007|474888200|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
131891806|NCT01926197|474888201|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
131891807|NCT01926197|474888202|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
131891808|NCT01926197|474888201|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
131891809|NCT01926197|474888202|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
131891810|NCT01428115|474888204|FG000|Overall Study|Lack of Efficacy|3|||
131891811|NCT01428115|474888204|FG000|Overall Study|Lost to Follow-up|10|||
131891812|NCT01428115|474888204|FG000|Overall Study|Pregnancy|1|||
131891813|NCT01428115|474888204|FG000|Overall Study|Protocol Violation|3|||
131891814|NCT01428115|474888204|FG000|Overall Study|Withdrawal by Subject|4|||
131891815|NCT02223364|474888206|FG000|Overall Study|Protocol Violation|3|||
131891816|NCT02223364|474888207|FG001|Overall Study|Protocol Violation|0|||
131891817|NCT02223364|474888208|FG002|Overall Study|Protocol Violation|3|||
131891818|NCT02223364|474888206|FG000|Overall Study|subject expired before surgery|1|||
131891819|NCT02223364|474888207|FG001|Overall Study|subject expired before surgery|0|||
131891820|NCT02223364|474888208|FG002|Overall Study|subject expired before surgery|0|||
131891821|NCT02223364|474888206|FG000|Overall Study|Physician Decision|1|||
131891822|NCT02223364|474888207|FG001|Overall Study|Physician Decision|0|||
131891823|NCT02223364|474888208|FG002|Overall Study|Physician Decision|0|||
131891824|NCT00793546|474888209|FG000|Overall Study|Death|3|||
131891825|NCT00793546|474888210|FG001|Overall Study|Death|0|||
131891826|NCT00793546|474888209|FG000|Overall Study|Lost to Follow-up|1|||
131891827|NCT00793546|474888210|FG001|Overall Study|Lost to Follow-up|0|||
131891828|NCT00793546|474888209|FG000|Overall Study|Withdrawal by Subject|1|||
131891829|NCT00793546|474888210|FG001|Overall Study|Withdrawal by Subject|1|||
131891830|NCT00793546|474888209|FG000|Overall Study|Study Terminated by Sponsor|8|||
131891831|NCT00793546|474888210|FG001|Overall Study|Study Terminated by Sponsor|27|||
131891832|NCT00793546|474888209|FG000|Overall Study|Other|1|||
131891833|NCT00793546|474888210|FG001|Overall Study|Other|0|||
131891834|NCT02620384|474888211|FG000|Overall Study|Adverse Event|2|||
131891835|NCT02620384|474888212|FG001|Overall Study|Adverse Event|1|||
131891836|NCT02620384|474888211|FG000|Overall Study|Discharged prior to 2nd dose|2|||
131891837|NCT02620384|474888212|FG001|Overall Study|Discharged prior to 2nd dose|5|||
131891838|NCT02620384|474888211|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
131891839|NCT02620384|474888212|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
131891840|NCT01841567|474888213|FG000|Overall Study|Adverse Event|3|||
131891841|NCT00762034|474889846|FG000|Induction Period|Protocol Violation|1|||
131891842|NCT00762034|474889847|FG001|Induction Period|Protocol Violation|2|||
131891843|NCT00762034|474889846|FG000|Induction Period|Entry Criterion Not Met|12|||
131891844|NCT00762034|474889847|FG001|Induction Period|Entry Criterion Not Met|11|||
131891845|NCT00762034|474889846|FG000|Induction Period|Adverse Event|27|||
131891846|NCT00762034|474889847|FG001|Induction Period|Adverse Event|38|||
131891847|NCT00762034|474889846|FG000|Induction Period|Lost to Follow-up|1|||
131891848|NCT00762034|474889847|FG001|Induction Period|Lost to Follow-up|1|||
131891849|NCT00762034|474889846|FG000|Induction Period|Progressive Disease|73|||
131891850|NCT00762034|474889847|FG001|Induction Period|Progressive Disease|55|||
131891851|NCT00762034|474889846|FG000|Induction Period|Physician Decision|21|||
131891852|NCT00762034|474889847|FG001|Induction Period|Physician Decision|20|||
131891853|NCT00762034|474889846|FG000|Induction Period|Withdrawal by Subject|15|||
131891854|NCT00762034|474889847|FG001|Induction Period|Withdrawal by Subject|19|||
131891855|NCT00762034|474889846|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
131891856|NCT00762034|474889847|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
131891857|NCT00762034|474889846|FG000|Induction Period|Deaths Due to Study Disease|9|||
131891858|NCT00762034|474889847|FG001|Induction Period|Deaths Due to Study Disease|9|||
131891859|NCT00762034|474889846|FG000|Maintenance Period|Protocol Violation|1|||
131891860|NCT00762034|474889847|FG001|Maintenance Period|Protocol Violation|3|||
131891861|NCT00762034|474889846|FG000|Maintenance Period|Entry Criterion Not Met|0|||
131891862|NCT00762034|474889847|FG001|Maintenance Period|Entry Criterion Not Met|2|||
131891863|NCT00762034|474889846|FG000|Maintenance Period|Adverse Event|42|||
131891864|NCT00762034|474889847|FG001|Maintenance Period|Adverse Event|26|||
131891865|NCT00762034|474889846|FG000|Maintenance Period|Progressive Disease|186|||
131891866|NCT00762034|474889847|FG001|Maintenance Period|Progressive Disease|224|||
131891867|NCT00762034|474889846|FG000|Maintenance Period|Physician Decision|25|||
131891868|NCT00762034|474889847|FG001|Maintenance Period|Physician Decision|20|||
131891869|NCT00762034|474889846|FG000|Maintenance Period|Withdrawal by Subject|34|||
131891870|NCT00762034|474889847|FG001|Maintenance Period|Withdrawal by Subject|14|||
131891871|NCT00762034|474889846|FG000|Maintenance Period|Death not due to study disease|2|||
131891872|NCT00762034|474889847|FG001|Maintenance Period|Death not due to study disease|5|||
131891873|NCT00762034|474889846|FG000|Maintenance Period|Death due to study disease|3|||
131891874|NCT00762034|474889847|FG001|Maintenance Period|Death due to study disease|3|||
131891875|NCT00762034|474889846|FG000|Maintenance Period|Other|1|||
131891876|NCT00762034|474889847|FG001|Maintenance Period|Other|1|||
131891877|NCT00497146|474889848|FG000|Treatment Period|Adverse Event|6|||
131891878|NCT00497146|474889849|FG001|Treatment Period|Adverse Event|2|||
131891879|NCT00497146|474889848|FG000|Treatment Period|Withdrawal by Subject|5|||
131891880|NCT00497146|474889849|FG001|Treatment Period|Withdrawal by Subject|9|||
131891881|NCT00497146|474889848|FG000|Treatment Period|Lost to Follow-up|1|||
131891882|NCT00497146|474889849|FG001|Treatment Period|Lost to Follow-up|3|||
131891883|NCT00497146|474889848|FG000|Treatment Period|Required dialysis|4|||
131891884|NCT00497146|474889849|FG001|Treatment Period|Required dialysis|1|||
131891885|NCT00497146|474889848|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
131891886|NCT00497146|474889849|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
131891887|NCT00497146|474889848|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
131891888|NCT00497146|474889849|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
131891889|NCT00497146|474889848|FG000|Treatment Period|Other Reason|2|||
131891890|NCT00497146|474889849|FG001|Treatment Period|Other Reason|3|||
131891891|NCT00497146|474889848|FG000|Long-term Follow-up Period|Adverse Event|2|||
131891892|NCT00497146|474889849|FG001|Long-term Follow-up Period|Adverse Event|2|||
131891893|NCT00497146|474889848|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
131891894|NCT00497146|474889849|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
131891895|NCT00497146|474889848|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
131891896|NCT00497146|474889849|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
131891897|NCT00497146|474889848|FG000|Long-term Follow-up Period|Other|0|||
131891898|NCT00497146|474889849|FG001|Long-term Follow-up Period|Other|1|||
131891899|NCT01299896|474889850|FG000|Overall Study|Withdrawal by Subject|1|||
131891900|NCT01299896|474889851|FG001|Overall Study|Withdrawal by Subject|7|||
131891901|NCT01299896|474889850|FG000|Overall Study|Lost to Follow-up|0|||
131891902|NCT01299896|474889851|FG001|Overall Study|Lost to Follow-up|11|||
131891903|NCT02107313|474889852|FG000|Overall Study|One participant did not do the FED cohor|0|||
131891904|NCT02107313|474889853|FG001|Overall Study|One participant did not do the FED cohor|1|||
131891905|NCT00582426|474889864|FG000|Overall Study|Lost to Follow-up|0|||
131891906|NCT00582426|474889865|FG001|Overall Study|Lost to Follow-up|2|||
131891907|NCT00582426|474889864|FG000|Overall Study|Adverse Event|4|||
131891908|NCT00582426|474889865|FG001|Overall Study|Adverse Event|2|||
131891909|NCT00582426|474889864|FG000|Overall Study|Protocol Violation|6|||
131891910|NCT00582426|474889865|FG001|Overall Study|Protocol Violation|2|||
131891911|NCT00582426|474889864|FG000|Overall Study|Death|4|||
131891912|NCT00582426|474889865|FG001|Overall Study|Death|3|||
131891913|NCT00582426|474889864|FG000|Overall Study|Withdrawal by Subject|3|||
131891914|NCT00582426|474889865|FG001|Overall Study|Withdrawal by Subject|2|||
131891915|NCT00582426|474889864|FG000|Overall Study|Disease Progression|2|||
131891916|NCT00582426|474889865|FG001|Overall Study|Disease Progression|2|||
131891917|NCT00582426|474889864|FG000|Overall Study|Use of illicit drugs|1|||
131891918|NCT00582426|474889865|FG001|Overall Study|Use of illicit drugs|0|||
131891919|NCT02164318|474889866|FG000|Overall Study|Withdrawal by Subject|0|||
131891920|NCT02164318|474889867|FG001|Overall Study|Withdrawal by Subject|1|||
131891921|NCT02164318|474889868|FG002|Overall Study|Withdrawal by Subject|0|||
131891922|NCT02164318|474889869|FG003|Overall Study|Withdrawal by Subject|1|||
131891923|NCT03300050|474889870|FG000|Overall Study|Lost to Follow-up|2|||
131891924|NCT03300050|474889871|FG001|Overall Study|Lost to Follow-up|1|||
131891925|NCT03300050|474889872|FG002|Overall Study|Lost to Follow-up|0|||
131891926|NCT03300050|474889873|FG003|Overall Study|Lost to Follow-up|0|||
131891927|NCT03300050|474889874|FG004|Overall Study|Lost to Follow-up|1|||
131891928|NCT03300050|474889870|FG000|Overall Study|Withdrawal by Subject|1|||
131891929|NCT03300050|474889871|FG001|Overall Study|Withdrawal by Subject|1|||
131891930|NCT03300050|474889872|FG002|Overall Study|Withdrawal by Subject|1|||
131891931|NCT03300050|474889873|FG003|Overall Study|Withdrawal by Subject|0|||
131891932|NCT03300050|474889874|FG004|Overall Study|Withdrawal by Subject|0|||
131891933|NCT03300050|474889870|FG000|Overall Study|Death|0|||
131891934|NCT03300050|474889871|FG001|Overall Study|Death|0|||
131891935|NCT03300050|474889872|FG002|Overall Study|Death|1|||
131891936|NCT03300050|474889873|FG003|Overall Study|Death|0|||
131891937|NCT03300050|474889874|FG004|Overall Study|Death|0|||
131891938|NCT03300050|474889870|FG000|Overall Study|Not Eligible at Randomization|0|||
131891939|NCT03300050|474889871|FG001|Overall Study|Not Eligible at Randomization|0|||
131891940|NCT03300050|474889872|FG002|Overall Study|Not Eligible at Randomization|1|||
131891941|NCT03300050|474889873|FG003|Overall Study|Not Eligible at Randomization|1|||
131891942|NCT03300050|474889874|FG004|Overall Study|Not Eligible at Randomization|0|||
131891943|NCT04126317|474889891|FG000|Overall Study|Adverse Event|0|||
131891944|NCT04126317|474889892|FG001|Overall Study|Adverse Event|1|||
131891945|NCT04126317|474889891|FG000|Overall Study|Withdrawal by Subject|4|||
131891946|NCT04126317|474889892|FG001|Overall Study|Withdrawal by Subject|1|||
131891947|NCT02178358|474889893|FG000|Overall Study|Withdrawal by Subject|0|||
131891948|NCT02178358|474889894|FG001|Overall Study|Withdrawal by Subject|2|||
131891949|NCT02178358|474889895|FG002|Overall Study|Withdrawal by Subject|2|||
131891950|NCT02178358|474889893|FG000|Overall Study|Lost to Follow-up|1|||
131891951|NCT02178358|474889894|FG001|Overall Study|Lost to Follow-up|0|||
131891952|NCT02178358|474889895|FG002|Overall Study|Lost to Follow-up|0|||
131891953|NCT01066663|474889897|FG000|Overall Study|Adverse Event|0|||
131891954|NCT01066663|474889898|FG001|Overall Study|Adverse Event|0|||
131891955|NCT01066663|474889899|FG002|Overall Study|Adverse Event|1|||
131891956|NCT02985021|474889900|FG000|Overall Study|Inability to comply with study procedures|1|||
131891957|NCT01090050|474889901|FG000|Overall Study|Lost to Follow-up|0|||
131891958|NCT01090050|474889902|FG001|Overall Study|Lost to Follow-up|1|||
131891959|NCT01090050|474889901|FG000|Overall Study|Lack of Efficacy|1|||
131891960|NCT01090050|474889902|FG001|Overall Study|Lack of Efficacy|5|||
131891961|NCT01090050|474889901|FG000|Overall Study|Physician Decision|0|||
131891962|NCT01090050|474889902|FG001|Overall Study|Physician Decision|1|||
131891963|NCT02232061|474889903|FG000|Overall Study|Administrative problems|1|||
131891964|NCT02232061|474889903|FG000|Overall Study|Withdrawal by Subject|1|||
131891965|NCT03297021|474889904|FG000|Overall Study|Incomplete/illegible data sheet|4|||
131891966|NCT03297021|474889905|FG001|Overall Study|Incomplete/illegible data sheet|2|||
131891967|NCT03297021|474889906|FG002|Overall Study|Incomplete/illegible data sheet|3|||
131891968|NCT03297021|474889904|FG000|Overall Study|Missing Post-Op Data|1|||
131891969|NCT03297021|474889905|FG001|Overall Study|Missing Post-Op Data|2|||
131891970|NCT03297021|474889906|FG002|Overall Study|Missing Post-Op Data|1|||
131891971|NCT00948922|474889909|FG000|Overall Study|Did not start study treatment|2|||
131891972|NCT00948922|474889910|FG001|Overall Study|Did not start study treatment|5|||
131891973|NCT00948922|474889911|FG002|Overall Study|Did not start study treatment|0|||
131891974|NCT00948922|474889909|FG000|Overall Study|Withdrawal by Subject|0|||
131891975|NCT00948922|474889910|FG001|Overall Study|Withdrawal by Subject|2|||
131891976|NCT00948922|474889911|FG002|Overall Study|Withdrawal by Subject|1|||
131891977|NCT00948922|474889909|FG000|Overall Study|Death|3|||
131891978|NCT00948922|474889910|FG001|Overall Study|Death|0|||
131891979|NCT00948922|474889911|FG002|Overall Study|Death|0|||
131891980|NCT00948922|474889909|FG000|Overall Study|Disease progression|0|||
131891981|NCT00948922|474889910|FG001|Overall Study|Disease progression|1|||
131891982|NCT00948922|474889911|FG002|Overall Study|Disease progression|0|||
131891983|NCT00948922|474889909|FG000|Overall Study|Insurance issues|1|||
131891984|NCT00948922|474889910|FG001|Overall Study|Insurance issues|0|||
131891985|NCT00948922|474889911|FG002|Overall Study|Insurance issues|0|||
131891986|NCT00948922|474889909|FG000|Overall Study|Transplant eligibility issues|2|||
131891987|NCT00948922|474889910|FG001|Overall Study|Transplant eligibility issues|3|||
131891988|NCT00948922|474889911|FG002|Overall Study|Transplant eligibility issues|0|||
131891989|NCT00948922|474889909|FG000|Overall Study|Not evaluable at time of analysis|0|||
131891990|NCT00948922|474889910|FG001|Overall Study|Not evaluable at time of analysis|3|||
131891991|NCT00948922|474889911|FG002|Overall Study|Not evaluable at time of analysis|0|||
131891992|NCT00560703|474889912|FG000|Overall Study|Adverse Event|0|||
131891993|NCT00560703|474889913|FG001|Overall Study|Adverse Event|2|||
131891994|NCT00560703|474889912|FG000|Overall Study|Protocol Violation|0|||
131891995|NCT00560703|474889913|FG001|Overall Study|Protocol Violation|2|||
131891996|NCT00560703|474889912|FG000|Overall Study|Withdrawal by Subject|0|||
131891997|NCT00560703|474889913|FG001|Overall Study|Withdrawal by Subject|1|||
131891998|NCT00560703|474889912|FG000|Overall Study|non-compliance|0|||
131891999|NCT00560703|474889913|FG001|Overall Study|non-compliance|1|||
131892000|NCT02095197|474889914|FG000|Overall Study|Lost to Follow-up|0|||
131892001|NCT02095197|474889915|FG001|Overall Study|Lost to Follow-up|3|||
131892002|NCT00790556|474889917|FG000|Treatment Period 1|Physician Decision|1|||
131892003|NCT00790556|474889918|FG001|Treatment Period 1|Physician Decision|0|||
131772302|NCT01238861|474445021|FG002|Overall Study|Withdrawal by Subject|4|||
131892004|NCT00790556|474889917|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131892005|NCT00790556|474889918|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131892006|NCT00339833|474889921|FG000|Overall Study|Withdrawal by Subject|1|||
131892007|NCT00339833|474889922|FG001|Overall Study|Withdrawal by Subject|2|||
131892008|NCT00339833|474889921|FG000|Overall Study|toothache|0|||
131892009|NCT00339833|474889922|FG001|Overall Study|toothache|1|||
131892010|NCT00339833|474889921|FG000|Overall Study|indigestion|0|||
131892011|NCT00339833|474889922|FG001|Overall Study|indigestion|1|||
131892012|NCT00339833|474889921|FG000|Overall Study|Chest pain|0|||
131892013|NCT00339833|474889922|FG001|Overall Study|Chest pain|1|||
131892014|NCT00339833|474889921|FG000|Overall Study|minor infection|0|||
131892015|NCT00339833|474889922|FG001|Overall Study|minor infection|1|||
131892016|NCT00339833|474889921|FG000|Overall Study|Poor venous access|2|||
131892017|NCT00339833|474889922|FG001|Overall Study|Poor venous access|2|||
131892018|NCT00339833|474889921|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
131892019|NCT00339833|474889922|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
131892020|NCT00339833|474889921|FG000|Overall Study|Error in data records|1|||
131892021|NCT00339833|474889922|FG001|Overall Study|Error in data records|0|||
131892022|NCT02829047|474889926|FG000|Overall Study|Withdrawal by Subject|1|||
131892023|NCT03077607|474889928|FG000|Period 1 (15 Days)|Adverse Event|1|||
131892024|NCT03077607|474889929|FG001|Period 1 (15 Days)|Adverse Event|0|||
131892025|NCT03077607|474889928|FG000|Period 1 (15 Days)|Death|1|||
131892026|NCT03077607|474889929|FG001|Period 1 (15 Days)|Death|0|||
131892027|NCT03077607|474889928|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
131892028|NCT03077607|474889929|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
131892029|NCT03077607|474889928|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
131892030|NCT03077607|474889929|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
131892031|NCT03469999|474889935|FG000|Overall Study|Lost to Follow-up|2|||
131892032|NCT02756364|474889944|FG000|Overall Study|Site Terminated by Sponsor|24|||
131892033|NCT02756364|474889945|FG001|Overall Study|Site Terminated by Sponsor|30|||
131892034|NCT02756364|474889946|FG002|Overall Study|Site Terminated by Sponsor|21|||
131892035|NCT02756364|474889944|FG000|Overall Study|Death|20|||
131892036|NCT02756364|474889945|FG001|Overall Study|Death|15|||
131892037|NCT02756364|474889946|FG002|Overall Study|Death|18|||
131892038|NCT02756364|474889944|FG000|Overall Study|Withdrawal by Patient|2|||
131892039|NCT02756364|474889945|FG001|Overall Study|Withdrawal by Patient|1|||
131892040|NCT02756364|474889946|FG002|Overall Study|Withdrawal by Patient|8|||
131892041|NCT02756364|474889944|FG000|Overall Study|Lost to Follow-up|0|||
131892042|NCT02756364|474889945|FG001|Overall Study|Lost to Follow-up|1|||
131892043|NCT02756364|474889946|FG002|Overall Study|Lost to Follow-up|1|||
131892044|NCT01416155|474889947|FG000|Overall Study|Adverse Event|8|||
131892045|NCT01416155|474889947|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
131892046|NCT01416155|474889947|FG000|Overall Study|Withdrawal by Subject|33|||
131892047|NCT01416155|474889947|FG000|Overall Study|Investigator decision|8|||
131892048|NCT01416155|474889947|FG000|Overall Study|Other|7|||
131892049|NCT01249833|474889948|FG000|Overall Study|Lost to Follow-up|0|||
131892050|NCT01249833|474889949|FG001|Overall Study|Lost to Follow-up|1|||
131892051|NCT03796676|474889950|FG000|Overall Study|Adverse Event|2|||
131892052|NCT03796676|474889951|FG001|Overall Study|Adverse Event|1|||
131892053|NCT03796676|474889952|FG002|Overall Study|Adverse Event|2|||
131892054|NCT03796676|474889950|FG000|Overall Study|Lost to Follow-up|2|||
131892055|NCT03796676|474889951|FG001|Overall Study|Lost to Follow-up|1|||
131892056|NCT03796676|474889952|FG002|Overall Study|Lost to Follow-up|0|||
131892057|NCT03796676|474889950|FG000|Overall Study|Protocol Violation|0|||
131892058|NCT03796676|474889951|FG001|Overall Study|Protocol Violation|0|||
131892059|NCT03796676|474889952|FG002|Overall Study|Protocol Violation|1|||
131892060|NCT03796676|474889950|FG000|Overall Study|Withdrawal by Subject|1|||
131892061|NCT03796676|474889951|FG001|Overall Study|Withdrawal by Subject|1|||
131892062|NCT03796676|474889952|FG002|Overall Study|Withdrawal by Subject|0|||
131892063|NCT03796676|474889950|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
131892064|NCT03796676|474889951|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
131892065|NCT03796676|474889952|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
131892066|NCT00248833|474889956|FG000|Overall Study|Adverse Event|2|||
131892067|NCT00248833|474889957|FG001|Overall Study|Adverse Event|0|||
131892068|NCT00248833|474889958|FG002|Overall Study|Adverse Event|0|||
131892069|NCT00248833|474889956|FG000|Overall Study|Withdrawal by Subject|0|||
131892070|NCT00248833|474889957|FG001|Overall Study|Withdrawal by Subject|1|||
131892071|NCT00248833|474889958|FG002|Overall Study|Withdrawal by Subject|1|||
131892072|NCT00248833|474889956|FG000|Overall Study|Lost to Follow-up|1|||
131892073|NCT00248833|474889957|FG001|Overall Study|Lost to Follow-up|1|||
131892074|NCT00248833|474889958|FG002|Overall Study|Lost to Follow-up|1|||
131892075|NCT00248833|474889956|FG000|Overall Study|Other|0|||
131892076|NCT00248833|474889957|FG001|Overall Study|Other|1|||
131892077|NCT00248833|474889958|FG002|Overall Study|Other|0|||
131892078|NCT01900899|474889959|FG000|Overall Study|Withdrawal by Subject|7|||
131892079|NCT01900899|474889960|FG001|Overall Study|Withdrawal by Subject|1|||
131892080|NCT01900899|474889959|FG000|Overall Study|Migrated from study area|2|||
131892081|NCT01900899|474889960|FG001|Overall Study|Migrated from study area|0|||
131892082|NCT00723697|474889963|FG000|Overall Study|Physician questionnaires not received|2|||
131892083|NCT00723697|474889963|FG000|Overall Study|Missing Informed Consent Form|10|||
131892084|NCT00723697|474889963|FG000|Overall Study|Other exclusion criteria applied|6|||
131892085|NCT00448812|474889966|FG000|Year 2|Missed visit but remained in study|4|||
131892086|NCT00448812|474889967|FG001|Year 2|Missed visit but remained in study|1|||
131892087|NCT00448812|474889966|FG000|Year 3|Withdrawal by Subject|1|||
131435922|NCT03084796|473221895|FG005|Overall Study|Randomization error|0|||
131892088|NCT00448812|474889967|FG001|Year 3|Withdrawal by Subject|3|||
131892089|NCT00448812|474889966|FG000|Year 3|Lost to Follow-up|1|||
131892090|NCT00448812|474889967|FG001|Year 3|Lost to Follow-up|0|||
131892091|NCT00448812|474889966|FG000|Year 3|Missed visit but remained in study|2|||
131892092|NCT00448812|474889967|FG001|Year 3|Missed visit but remained in study|0|||
131892093|NCT00448812|474889966|FG000|Year 5|Missed visit but remained in study|1|||
131892094|NCT00448812|474889967|FG001|Year 5|Missed visit but remained in study|0|||
131892095|NCT03885999|474889968|FG000|Overall Study|Adverse Event|1|||
131892096|NCT02452554|474889969|FG000|Overall Study|Death|2|||
131892097|NCT02452554|474889970|FG001|Overall Study|Death|1|||
131892098|NCT02452554|474889971|FG002|Overall Study|Death|0|||
131892099|NCT02452554|474889972|FG003|Overall Study|Death|0|||
131892100|NCT02452554|474889973|FG004|Overall Study|Death|0|||
131892101|NCT02452554|474889974|FG005|Overall Study|Death|0|||
131892102|NCT02452554|474889969|FG000|Overall Study|Lack of Efficacy|13|||
131892103|NCT02452554|474889970|FG001|Overall Study|Lack of Efficacy|14|||
131892104|NCT02452554|474889971|FG002|Overall Study|Lack of Efficacy|9|||
131892105|NCT02452554|474889972|FG003|Overall Study|Lack of Efficacy|1|||
131892106|NCT02452554|474889973|FG004|Overall Study|Lack of Efficacy|5|||
131892107|NCT02452554|474889974|FG005|Overall Study|Lack of Efficacy|8|||
131892108|NCT02452554|474889969|FG000|Overall Study|Physician Decision|0|||
131892109|NCT02452554|474889970|FG001|Overall Study|Physician Decision|1|||
131892110|NCT02452554|474889971|FG002|Overall Study|Physician Decision|0|||
131892111|NCT02452554|474889972|FG003|Overall Study|Physician Decision|0|||
131892112|NCT02452554|474889973|FG004|Overall Study|Physician Decision|0|||
131892113|NCT02452554|474889974|FG005|Overall Study|Physician Decision|0|||
131892114|NCT02452554|474889969|FG000|Overall Study|Withdrawal by Subject|1|||
131892115|NCT02452554|474889970|FG001|Overall Study|Withdrawal by Subject|0|||
131892116|NCT02452554|474889971|FG002|Overall Study|Withdrawal by Subject|2|||
131892117|NCT02452554|474889972|FG003|Overall Study|Withdrawal by Subject|0|||
131892118|NCT02452554|474889973|FG004|Overall Study|Withdrawal by Subject|0|||
131892119|NCT02452554|474889974|FG005|Overall Study|Withdrawal by Subject|1|||
131892120|NCT02452554|474889969|FG000|Overall Study|Ineligible|0|||
131892121|NCT02452554|474889970|FG001|Overall Study|Ineligible|1|||
131892122|NCT02452554|474889971|FG002|Overall Study|Ineligible|0|||
131892123|NCT02452554|474889972|FG003|Overall Study|Ineligible|0|||
131892124|NCT02452554|474889973|FG004|Overall Study|Ineligible|0|||
131892125|NCT02452554|474889974|FG005|Overall Study|Ineligible|0|||
131892126|NCT02452554|474889969|FG000|Overall Study|Never Received Treatment|1|||
131892127|NCT02452554|474889970|FG001|Overall Study|Never Received Treatment|0|||
131892128|NCT02452554|474889971|FG002|Overall Study|Never Received Treatment|0|||
131892129|NCT02452554|474889972|FG003|Overall Study|Never Received Treatment|0|||
131892130|NCT02452554|474889973|FG004|Overall Study|Never Received Treatment|0|||
131892131|NCT02452554|474889974|FG005|Overall Study|Never Received Treatment|0|||
131892132|NCT00467558|474889975|FG000|Overall Study|Lost to Follow-up|2|||
131892133|NCT00467558|474889976|FG001|Overall Study|Lost to Follow-up|0|||
131892134|NCT02636439|474889977|FG000|Overall Study|Adverse Event|2|||
131892135|NCT02636439|474889978|FG001|Overall Study|Adverse Event|2|||
131892136|NCT02636439|474889977|FG000|Overall Study|Lost to Follow-up|1|||
131892137|NCT02636439|474889978|FG001|Overall Study|Lost to Follow-up|0|||
131892138|NCT02636439|474889977|FG000|Overall Study|Non-compliance|1|||
131892139|NCT02636439|474889978|FG001|Overall Study|Non-compliance|1|||
131892140|NCT02636439|474889977|FG000|Overall Study|Personal reasons|2|||
131892141|NCT02636439|474889978|FG001|Overall Study|Personal reasons|0|||
131892142|NCT05188729|474889980|FG000|Overall Study|Withdrawal by Subject|0|||
131892143|NCT05188729|474889981|FG001|Overall Study|Withdrawal by Subject|0|||
131892144|NCT05188729|474889982|FG002|Overall Study|Withdrawal by Subject|0|||
131892145|NCT05188729|474889983|FG003|Overall Study|Withdrawal by Subject|0|||
131892146|NCT05188729|474889984|FG004|Overall Study|Withdrawal by Subject|0|||
131892147|NCT05188729|474889985|FG005|Overall Study|Withdrawal by Subject|0|||
131892148|NCT05188729|474889986|FG006|Overall Study|Withdrawal by Subject|0|||
131892149|NCT05188729|474889987|FG007|Overall Study|Withdrawal by Subject|0|||
131892150|NCT05188729|474889988|FG008|Overall Study|Withdrawal by Subject|0|||
131892151|NCT05188729|474889989|FG009|Overall Study|Withdrawal by Subject|1|||
131892152|NCT05188729|474889990|FG010|Overall Study|Withdrawal by Subject|0|||
131892153|NCT05188729|474889991|FG011|Overall Study|Withdrawal by Subject|0|||
131892154|NCT05188729|474889992|FG012|Overall Study|Withdrawal by Subject|0|||
131892155|NCT05188729|474889980|FG000|Overall Study|Lost to Follow-up|0|||
131892156|NCT05188729|474889981|FG001|Overall Study|Lost to Follow-up|0|||
131892157|NCT05188729|474889982|FG002|Overall Study|Lost to Follow-up|0|||
131892158|NCT05188729|474889983|FG003|Overall Study|Lost to Follow-up|0|||
131892159|NCT05188729|474889984|FG004|Overall Study|Lost to Follow-up|0|||
131892160|NCT05188729|474889985|FG005|Overall Study|Lost to Follow-up|0|||
131892161|NCT05188729|474889986|FG006|Overall Study|Lost to Follow-up|0|||
131892162|NCT05188729|474889987|FG007|Overall Study|Lost to Follow-up|0|||
131892163|NCT05188729|474889988|FG008|Overall Study|Lost to Follow-up|0|||
131892164|NCT05188729|474889989|FG009|Overall Study|Lost to Follow-up|0|||
131892165|NCT05188729|474889990|FG010|Overall Study|Lost to Follow-up|1|||
131435923|NCT00650767|473221897|FG000|Overall Study|Adverse Event|0|||
131892166|NCT05188729|474889991|FG011|Overall Study|Lost to Follow-up|1|||
131892167|NCT05188729|474889992|FG012|Overall Study|Lost to Follow-up|0|||
131892168|NCT02784288|474891921|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
131892169|NCT02734862|474891922|FG000|Part A|Death|3|||
131892170|NCT02734862|474891923|FG001|Part A|Death|4|||
131892171|NCT02734862|474891924|FG002|Part A|Death|6|||
131892172|NCT02734862|474891922|FG000|Part A|Lost to Follow-up|2|||
131892173|NCT02734862|474891923|FG001|Part A|Lost to Follow-up|1|||
131892174|NCT02734862|474891924|FG002|Part A|Lost to Follow-up|1|||
131892175|NCT02734862|474891922|FG000|Part A|Withdrawal by Subject|1|||
131892176|NCT02734862|474891923|FG001|Part A|Withdrawal by Subject|1|||
131892177|NCT02734862|474891924|FG002|Part A|Withdrawal by Subject|2|||
131892178|NCT02734862|474891922|FG000|Part A|Physician Decision|2|||
131892179|NCT02734862|474891923|FG001|Part A|Physician Decision|0|||
131892180|NCT02734862|474891924|FG002|Part A|Physician Decision|1|||
131892181|NCT02734862|474891922|FG000|Part A|Adverse Event|2|||
131892182|NCT02734862|474891923|FG001|Part A|Adverse Event|0|||
131892183|NCT02734862|474891924|FG002|Part A|Adverse Event|1|||
131892184|NCT02734862|474891922|FG000|Part A|Noncompliance|1|||
131892185|NCT02734862|474891923|FG001|Part A|Noncompliance|1|||
131892186|NCT02734862|474891924|FG002|Part A|Noncompliance|0|||
131892187|NCT02734862|474891922|FG000|Part A|Other|1|||
131892188|NCT02734862|474891923|FG001|Part A|Other|1|||
131892189|NCT02734862|474891924|FG002|Part A|Other|3|||
131892190|NCT02734862|474891922|FG000|Part B|Death|8|||
131892191|NCT02734862|474891923|FG001|Part B|Death|3|||
131892192|NCT02734862|474891924|FG002|Part B|Death|5|||
131892193|NCT02734862|474891922|FG000|Part B|Lost to Follow-up|2|||
131892194|NCT02734862|474891923|FG001|Part B|Lost to Follow-up|2|||
131892195|NCT02734862|474891924|FG002|Part B|Lost to Follow-up|0|||
131892196|NCT02734862|474891922|FG000|Part B|Withdrawal by Subject|3|||
131892197|NCT02734862|474891923|FG001|Part B|Withdrawal by Subject|1|||
131892198|NCT02734862|474891924|FG002|Part B|Withdrawal by Subject|0|||
131892199|NCT02734862|474891922|FG000|Part B|Other|0|||
131892200|NCT02734862|474891923|FG001|Part B|Other|1|||
131892201|NCT02734862|474891924|FG002|Part B|Other|0|||
131892202|NCT02131233|474891925|FG000|Overall Study|Not Treated|2|||
131892203|NCT02131233|474891926|FG001|Overall Study|Not Treated|3|||
131892204|NCT02131233|474891925|FG000|Overall Study|Adverse Event|7|||
131892205|NCT02131233|474891926|FG001|Overall Study|Adverse Event|6|||
131892206|NCT02131233|474891925|FG000|Overall Study|Death|0|||
131892207|NCT02131233|474891926|FG001|Overall Study|Death|1|||
131892208|NCT02131233|474891925|FG000|Overall Study|Lack of Efficacy|6|||
131892209|NCT02131233|474891926|FG001|Overall Study|Lack of Efficacy|3|||
131892210|NCT02131233|474891925|FG000|Overall Study|Lost to Follow-up|14|||
131892211|NCT02131233|474891926|FG001|Overall Study|Lost to Follow-up|13|||
131892212|NCT02131233|474891925|FG000|Overall Study|Non-Compliance With Study Drug|8|||
131892213|NCT02131233|474891926|FG001|Overall Study|Non-Compliance With Study Drug|5|||
131892214|NCT02131233|474891925|FG000|Overall Study|Physician Decision|7|||
131892215|NCT02131233|474891926|FG001|Overall Study|Physician Decision|0|||
131892216|NCT02131233|474891925|FG000|Overall Study|Pregnancy|4|||
131892217|NCT02131233|474891926|FG001|Overall Study|Pregnancy|0|||
131892218|NCT02131233|474891925|FG000|Overall Study|Withdrawal by Subject|18|||
131892219|NCT02131233|474891926|FG001|Overall Study|Withdrawal by Subject|11|||
131892220|NCT04399889|474891935|FG000|Overall Study|Death|5|||
131892221|NCT04399889|474891936|FG001|Overall Study|Death|1|||
131892222|NCT04399889|474891937|FG002|Overall Study|Death|1|||
131892223|NCT00217581|474891938|FG000|Overall Study|Withdrawal by Subject|1|||
131892224|NCT01005901|474891940|FG000|Overall Study|Withdrawal by Subject|38|||
131892225|NCT01005901|474891941|FG001|Overall Study|Withdrawal by Subject|14|||
131892226|NCT01005901|474891940|FG000|Overall Study|Adverse Event|30|||
131892227|NCT01005901|474891941|FG001|Overall Study|Adverse Event|16|||
131892228|NCT01005901|474891940|FG000|Overall Study|Administrative problems|21|||
131892229|NCT01005901|474891941|FG001|Overall Study|Administrative problems|13|||
131892230|NCT01005901|474891940|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131892231|NCT01005901|474891941|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
131892232|NCT01005901|474891940|FG000|Overall Study|Protocol Violation|4|||
131435924|NCT00650767|473221898|FG001|Overall Study|Adverse Event|3|||
131892233|NCT01005901|474891941|FG001|Overall Study|Protocol Violation|3|||
131892234|NCT01005901|474891940|FG000|Overall Study|Death|2|||
131892235|NCT01005901|474891941|FG001|Overall Study|Death|3|||
131892236|NCT01005901|474891940|FG000|Overall Study|Lost to Follow-up|1|||
131892237|NCT01005901|474891941|FG001|Overall Study|Lost to Follow-up|2|||
131892238|NCT01005901|474891940|FG000|Overall Study|Patient's inability to use the device|1|||
131892239|NCT01005901|474891941|FG001|Overall Study|Patient's inability to use the device|1|||
131892240|NCT01005901|474891940|FG000|Overall Study|No longer requires study drug|0|||
131892241|NCT01005901|474891941|FG001|Overall Study|No longer requires study drug|1|||
131892242|NCT00760487|474891942|FG000|Overall Study|Unilateral implantation|3|||
131892243|NCT06360588|474891943|FG000|Overall Study|Adverse Event|3|||
131892244|NCT06360588|474891943|FG000|Overall Study|Death|2|||
131892245|NCT06360588|474891943|FG000|Overall Study|Disease Progression|14|||
131892246|NCT06360588|474891943|FG000|Overall Study|Withdrawal by Subject|1|||
131892247|NCT06360588|474891943|FG000|Overall Study|Lack of Efficacy|1|||
131892248|NCT06360588|474891943|FG000|Overall Study|Ineligible|1|||
131892249|NCT01690299|474891945|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
131892250|NCT01690299|474891946|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
131892251|NCT01690299|474891947|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
131892252|NCT01690299|474891948|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
131892253|NCT01690299|474891949|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
131892254|NCT01690299|474891950|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
131892255|NCT01690299|474891945|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
131892256|NCT01690299|474891946|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131892257|NCT01690299|474891947|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131892258|NCT01690299|474891948|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131892259|NCT01690299|474891949|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131892260|NCT01690299|474891950|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131892261|NCT01690299|474891945|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
131892262|NCT01690299|474891946|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
131892263|NCT01690299|474891947|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131892264|NCT01690299|474891948|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131892265|NCT01690299|474891949|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131892266|NCT01690299|474891950|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131892267|NCT01690299|474891945|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
131892268|NCT01690299|474891946|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
131892269|NCT01690299|474891947|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
131892270|NCT01690299|474891948|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
131892271|NCT01690299|474891949|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
131892272|NCT01690299|474891950|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
131892273|NCT01690299|474891945|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
131892274|NCT01690299|474891946|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
131892275|NCT01690299|474891947|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
131892276|NCT01690299|474891948|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
131892277|NCT01690299|474891949|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
131892278|NCT01690299|474891950|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
131892279|NCT01690299|474891945|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
131892280|NCT01690299|474891946|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
131892281|NCT01690299|474891947|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
131892282|NCT01690299|474891948|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
131892283|NCT01690299|474891949|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
131892284|NCT01690299|474891950|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
131892285|NCT01690299|474891945|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
131892286|NCT01690299|474891946|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
131892287|NCT01690299|474891947|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
131892288|NCT01690299|474891948|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
131892289|NCT01690299|474891949|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
131892290|NCT01690299|474891950|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
131892291|NCT01690299|474891945|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
131892292|NCT01690299|474891946|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
131892293|NCT01690299|474891947|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
131892294|NCT01690299|474891948|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
131892295|NCT01690299|474891949|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
131892296|NCT01690299|474891950|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
131892297|NCT01690299|474891945|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
131892298|NCT01690299|474891946|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
131892299|NCT01690299|474891947|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
131892300|NCT01690299|474891948|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
131892301|NCT01690299|474891949|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
131892302|NCT01690299|474891950|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
131892303|NCT01690299|474891945|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
131892304|NCT01690299|474891946|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
131892305|NCT01690299|474891947|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
131892306|NCT01690299|474891948|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
131664199|NCT00468104|474054845|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
131664200|NCT00468104|474054844|FG000|First Intervention|died within 3 weeks|1|||
131664201|NCT00468104|474054845|FG001|First Intervention|died within 3 weeks|0|||
131664202|NCT00468104|474054844|FG000|First Intervention|malposition/blocked chest tube tube|2|||
131664203|NCT00468104|474054845|FG001|First Intervention|malposition/blocked chest tube tube|0|||
131664204|NCT00468104|474054844|FG000|First Intervention|large lung mass with minimal effusion|1|||
131664205|NCT00468104|474054845|FG001|First Intervention|large lung mass with minimal effusion|0|||
131892307|NCT01690299|474891949|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
131892308|NCT01690299|474891950|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
131892309|NCT03836209|474891951|FG000|Overall Study|Adverse Event|5|||
131892310|NCT03836209|474891952|FG001|Overall Study|Adverse Event|2|||
131892311|NCT03836209|474891951|FG000|Overall Study|Death|4|||
131892312|NCT03836209|474891952|FG001|Overall Study|Death|1|||
131892313|NCT03836209|474891951|FG000|Overall Study|Lack of Efficacy|7|||
131892314|NCT03836209|474891952|FG001|Overall Study|Lack of Efficacy|10|||
131892315|NCT03836209|474891951|FG000|Overall Study|Physician Decision|7|||
131892316|NCT03836209|474891952|FG001|Overall Study|Physician Decision|11|||
131892317|NCT03836209|474891951|FG000|Overall Study|Protocol Violation|0|||
131892318|NCT03836209|474891952|FG001|Overall Study|Protocol Violation|3|||
131892319|NCT03836209|474891951|FG000|Overall Study|Withdrawal by Subject|2|||
131892320|NCT03836209|474891952|FG001|Overall Study|Withdrawal by Subject|10|||
131892321|NCT03836209|474891951|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
131892322|NCT03836209|474891952|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
131892323|NCT03739710|474891953|FG000|Overall Study|Screen Failed|81|||
131892324|NCT01753115|474891954|FG000|Overall Study|Lost to Follow-up|3|||
131892325|NCT01753115|474891955|FG001|Overall Study|Lost to Follow-up|6|||
131892326|NCT01753115|474891956|FG002|Overall Study|Lost to Follow-up|8|||
131892327|NCT01753115|474891954|FG000|Overall Study|Withdrawal by Subject|6|||
131892328|NCT01753115|474891955|FG001|Overall Study|Withdrawal by Subject|5|||
131892329|NCT01753115|474891956|FG002|Overall Study|Withdrawal by Subject|6|||
131892330|NCT01753115|474891954|FG000|Overall Study|Subject non-compliant|3|||
131892331|NCT01753115|474891955|FG001|Overall Study|Subject non-compliant|3|||
131892332|NCT01753115|474891956|FG002|Overall Study|Subject non-compliant|0|||
131892333|NCT01753115|474891954|FG000|Overall Study|Used excluded drug|0|||
131892334|NCT01753115|474891955|FG001|Overall Study|Used excluded drug|1|||
131892335|NCT01753115|474891956|FG002|Overall Study|Used excluded drug|0|||
131892336|NCT05259917|474891964|FG000|Overall Study|Protocol Violation|0|||
131892337|NCT05259917|474891965|FG001|Overall Study|Protocol Violation|0|||
131892338|NCT05259917|474891966|FG002|Overall Study|Protocol Violation|1|||
131892339|NCT05259917|474891967|FG003|Overall Study|Protocol Violation|0|||
131892340|NCT05259917|474891968|FG004|Overall Study|Protocol Violation|0|||
131892341|NCT05259917|474891969|FG005|Overall Study|Protocol Violation|0|||
131892342|NCT05259917|474891964|FG000|Overall Study|Lost to Follow-up|0|||
131892343|NCT05259917|474891965|FG001|Overall Study|Lost to Follow-up|0|||
131892344|NCT05259917|474891966|FG002|Overall Study|Lost to Follow-up|1|||
131892345|NCT05259917|474891967|FG003|Overall Study|Lost to Follow-up|0|||
131892346|NCT05259917|474891968|FG004|Overall Study|Lost to Follow-up|0|||
131892347|NCT05259917|474891969|FG005|Overall Study|Lost to Follow-up|1|||
131892348|NCT05259917|474891964|FG000|Overall Study|Physician Decision|0|||
131892349|NCT05259917|474891965|FG001|Overall Study|Physician Decision|1|||
131892350|NCT05259917|474891966|FG002|Overall Study|Physician Decision|0|||
131892351|NCT05259917|474891967|FG003|Overall Study|Physician Decision|0|||
131892352|NCT05259917|474891968|FG004|Overall Study|Physician Decision|0|||
131892353|NCT05259917|474891969|FG005|Overall Study|Physician Decision|0|||
131892354|NCT05259917|474891964|FG000|Overall Study|Withdrawal by Subject|0|||
131892355|NCT05259917|474891965|FG001|Overall Study|Withdrawal by Subject|1|||
131892356|NCT05259917|474891966|FG002|Overall Study|Withdrawal by Subject|0|||
131892357|NCT05259917|474891967|FG003|Overall Study|Withdrawal by Subject|0|||
131892358|NCT05259917|474891968|FG004|Overall Study|Withdrawal by Subject|1|||
131892359|NCT05259917|474891969|FG005|Overall Study|Withdrawal by Subject|1|||
131892360|NCT05259917|474891964|FG000|Overall Study|Trial Termination by Sponsor|7|||
131892361|NCT05259917|474891965|FG001|Overall Study|Trial Termination by Sponsor|2|||
131892362|NCT05259917|474891966|FG002|Overall Study|Trial Termination by Sponsor|3|||
131892363|NCT05259917|474891967|FG003|Overall Study|Trial Termination by Sponsor|5|||
131892364|NCT05259917|474891968|FG004|Overall Study|Trial Termination by Sponsor|11|||
131892365|NCT05259917|474891969|FG005|Overall Study|Trial Termination by Sponsor|4|||
131892366|NCT05259917|474891964|FG000|Overall Study|Other|1|||
131892367|NCT05259917|474891965|FG001|Overall Study|Other|0|||
131892368|NCT05259917|474891966|FG002|Overall Study|Other|2|||
131892369|NCT05259917|474891967|FG003|Overall Study|Other|0|||
131892370|NCT05259917|474891968|FG004|Overall Study|Other|0|||
131892371|NCT05259917|474891969|FG005|Overall Study|Other|0|||
131892372|NCT01658904|474891975|FG000|Overall Study|Principal Investigator discretion|2|||
131892373|NCT01658904|474891976|FG001|Overall Study|Principal Investigator discretion|0|||
131435925|NCT00650767|473221899|FG002|Overall Study|Adverse Event|10|||
131892374|NCT01658904|474891977|FG002|Overall Study|Principal Investigator discretion|0|||
131892375|NCT01808222|474891978|FG000|Overall Study|mpMR scan was not performed|1|||
131892376|NCT02383355|474891980|FG000|Overall Study|Adverse Event|2|||
131892377|NCT02383355|474891981|FG001|Overall Study|Adverse Event|0|||
131892378|NCT01146561|474891982|FG000|Overall Study|Withdrawal by Subject|1|||
131892379|NCT01146561|474891982|FG000|Overall Study|Lost to Follow-up|1|||
131892380|NCT01778751|474891986|FG000|Overall Study|Lost to Follow-up|1|||
131892381|NCT01778751|474891987|FG001|Overall Study|Lost to Follow-up|0|||
131892382|NCT01778751|474891986|FG000|Overall Study|Withdrawal by Subject|0|||
131892383|NCT01778751|474891987|FG001|Overall Study|Withdrawal by Subject|2|||
131892384|NCT01778751|474891986|FG000|Overall Study|Transfered care|1|||
131892385|NCT01778751|474891987|FG001|Overall Study|Transfered care|0|||
131892386|NCT01603394|474891989|FG000|Overall Study|Adverse Event|1|||
131892387|NCT04399538|474891991|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
131892388|NCT04399538|474891992|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
131892389|NCT04399538|474891993|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
131892390|NCT04399538|474891994|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
131892391|NCT04399538|474891995|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
131892392|NCT04399538|474891991|FG000|Double-Blind Treatment|Adverse Event|0|||
131892393|NCT04399538|474891992|FG001|Double-Blind Treatment|Adverse Event|0|||
131892394|NCT04399538|474891993|FG002|Double-Blind Treatment|Adverse Event|0|||
131892395|NCT04399538|474891994|FG003|Double-Blind Treatment|Adverse Event|0|||
131892396|NCT04399538|474891995|FG004|Double-Blind Treatment|Adverse Event|1|||
131892397|NCT04399538|474891991|FG000|Follow-Up|Adverse Event|0|||
131892398|NCT04399538|474891992|FG001|Follow-Up|Adverse Event|0|||
131892399|NCT04399538|474891993|FG002|Follow-Up|Adverse Event|0|||
131892400|NCT04399538|474891994|FG003|Follow-Up|Adverse Event|0|||
131892401|NCT04399538|474891995|FG004|Follow-Up|Adverse Event|1|||
131892402|NCT04399538|474891991|FG000|Follow-Up|Withdrawal by Subject|0|||
131892403|NCT04399538|474891992|FG001|Follow-Up|Withdrawal by Subject|0|||
131892404|NCT04399538|474891993|FG002|Follow-Up|Withdrawal by Subject|0|||
131892405|NCT04399538|474891994|FG003|Follow-Up|Withdrawal by Subject|2|||
131892406|NCT04399538|474891995|FG004|Follow-Up|Withdrawal by Subject|0|||
131892407|NCT00840034|474891996|FG000|Acute Treatment Phase|Adverse Event|6|||
131892408|NCT00840034|474891997|FG001|Acute Treatment Phase|Adverse Event|8|||
131892409|NCT00840034|474891996|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
131892410|NCT00840034|474891997|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
131892411|NCT00840034|474891996|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
131892412|NCT00840034|474891997|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
131892413|NCT00840034|474891996|FG000|Acute Treatment Phase|Physician Decision|0|||
131892414|NCT00840034|474891997|FG001|Acute Treatment Phase|Physician Decision|1|||
131892415|NCT00840034|474891996|FG000|Acute Treatment Phase|Protocol Violation|2|||
131892416|NCT00840034|474891997|FG001|Acute Treatment Phase|Protocol Violation|4|||
131892417|NCT00840034|474891996|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
131892418|NCT00840034|474891997|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
131892419|NCT00840034|474891996|FG000|Taper Phase|Adverse Event|1|||
131892420|NCT00840034|474891997|FG001|Taper Phase|Adverse Event|0|||
131892421|NCT00840034|474891996|FG000|Taper Phase|Lost to Follow-up|1|||
131892422|NCT00840034|474891997|FG001|Taper Phase|Lost to Follow-up|1|||
131892423|NCT00840034|474891996|FG000|Taper Phase|Withdrawal by Subject|1|||
131892424|NCT00840034|474891997|FG001|Taper Phase|Withdrawal by Subject|1|||
131892425|NCT01215435|474891998|FG000|Overall Study|Adverse Event|1|||
131892426|NCT01215435|474891999|FG001|Overall Study|Adverse Event|0|||
131892427|NCT01215435|474891998|FG000|Overall Study|Protocol Violation|2|||
131892428|NCT01215435|474891999|FG001|Overall Study|Protocol Violation|0|||
131892429|NCT01215435|474891998|FG000|Overall Study|Withdrawal Criteria|8|||
131892430|NCT01215435|474891999|FG001|Overall Study|Withdrawal Criteria|11|||
131892431|NCT01215435|474891998|FG000|Overall Study|Lost to Follow-up|3|||
131892432|NCT01215435|474891999|FG001|Overall Study|Lost to Follow-up|0|||
131892433|NCT01215435|474891998|FG000|Overall Study|Unclassified|5|||
131892434|NCT01215435|474891999|FG001|Overall Study|Unclassified|5|||
131892435|NCT03628716|474892008|FG000|Overall Study|Adverse Event|1|||
131892436|NCT03628716|474892009|FG001|Overall Study|Adverse Event|1|||
131892437|NCT03628716|474892008|FG000|Overall Study|Death|1|||
131892438|NCT03628716|474892009|FG001|Overall Study|Death|0|||
131892439|NCT03628716|474892008|FG000|Overall Study|Lack of Efficacy|15|||
131892440|NCT03628716|474892009|FG001|Overall Study|Lack of Efficacy|20|||
131892441|NCT03628716|474892008|FG000|Overall Study|Withdrawal by Subject|1|||
131892442|NCT03628716|474892009|FG001|Overall Study|Withdrawal by Subject|2|||
131892443|NCT03628716|474892008|FG000|Overall Study|Study Terminated by Sponsor|1|||
131892444|NCT03628716|474892009|FG001|Overall Study|Study Terminated by Sponsor|0|||
131892445|NCT00856843|474892011|FG000|Overall Study|Withdrawal by Subject|1|||
131435926|NCT00650767|473221900|FG003|Overall Study|Adverse Event|8|||
131892446|NCT00856843|474892012|FG001|Overall Study|Withdrawal by Subject|5|||
131892447|NCT00856843|474892011|FG000|Overall Study|Lack of Efficacy|1|||
131892448|NCT00856843|474892012|FG001|Overall Study|Lack of Efficacy|0|||
131892449|NCT02179749|474892013|FG000|Overall Study|Adverse Event|0|||
131892450|NCT02179749|474892014|FG001|Overall Study|Adverse Event|0|||
131892451|NCT02179749|474892015|FG002|Overall Study|Adverse Event|1|||
131892452|NCT02179749|474892013|FG000|Overall Study|Withdrawal by Subject|0|||
131892453|NCT02179749|474892014|FG001|Overall Study|Withdrawal by Subject|0|||
131892454|NCT02179749|474892015|FG002|Overall Study|Withdrawal by Subject|1|||
131892455|NCT01573754|474892020|FG000|Overall Study|Noncompliance or remission not achieved|3|||
131892456|NCT01573754|474892021|FG001|Overall Study|Noncompliance or remission not achieved|15|||
131892457|NCT00829829|474892023|FG000|Overall Study|Protocol Violation|0|||
131892458|NCT00829829|474892024|FG001|Overall Study|Protocol Violation|3|||
131892459|NCT00829829|474892025|FG002|Overall Study|Protocol Violation|0|||
131892460|NCT00829829|474892023|FG000|Overall Study|Adverse Event|4|||
131892461|NCT00829829|474892024|FG001|Overall Study|Adverse Event|4|||
131892462|NCT00829829|474892025|FG002|Overall Study|Adverse Event|3|||
131892463|NCT00829829|474892023|FG000|Overall Study|Withdrawal by Subject|8|||
131892464|NCT00829829|474892024|FG001|Overall Study|Withdrawal by Subject|4|||
131892465|NCT00829829|474892025|FG002|Overall Study|Withdrawal by Subject|2|||
131892466|NCT00829829|474892023|FG000|Overall Study|Decision by the Sponsor|1|||
131892467|NCT00829829|474892024|FG001|Overall Study|Decision by the Sponsor|0|||
131892468|NCT00829829|474892025|FG002|Overall Study|Decision by the Sponsor|2|||
131892469|NCT00829829|474892023|FG000|Overall Study|Lost to Follow-up|7|||
131892470|NCT00829829|474892024|FG001|Overall Study|Lost to Follow-up|3|||
131892471|NCT00829829|474892025|FG002|Overall Study|Lost to Follow-up|3|||
131892472|NCT00829829|474892023|FG000|Overall Study|Other than specified above|2|||
131892473|NCT00829829|474892024|FG001|Overall Study|Other than specified above|2|||
131892474|NCT00829829|474892025|FG002|Overall Study|Other than specified above|1|||
131892475|NCT02984267|474892026|FG000|Overall Study|Protocol Violation|1|||
131892476|NCT02984267|474892027|FG001|Overall Study|Protocol Violation|0|||
131892477|NCT02984267|474892026|FG000|Overall Study|Withdrawal by Subject|0|||
131892478|NCT02984267|474892027|FG001|Overall Study|Withdrawal by Subject|1|||
131892479|NCT01994902|474892028|FG000|Test Period 1|Withdrawal by Subject|3|||
131892480|NCT01994902|474892029|FG001|Test Period 1|Withdrawal by Subject|0|||
131892481|NCT01994902|474892028|FG000|Test Period 1|device deficiency with adverse event|0|||
131892482|NCT01994902|474892029|FG001|Test Period 1|device deficiency with adverse event|1|||
131892483|NCT01994902|474892028|FG000|Test Period 1|Adverse Event|2|||
131892484|NCT01994902|474892029|FG001|Test Period 1|Adverse Event|1|||
131892485|NCT01994902|474892028|FG000|Test Period 1|Lack of Efficacy|0|||
131892486|NCT01994902|474892029|FG001|Test Period 1|Lack of Efficacy|1|||
131892487|NCT01994902|474892028|FG000|Test Period 1|bag too small|1|||
131892488|NCT01994902|474892029|FG001|Test Period 1|bag too small|0|||
131892489|NCT01994902|474892028|FG000|Test Period 2|Withdrawal by Subject|0|||
131892490|NCT01994902|474892029|FG001|Test Period 2|Withdrawal by Subject|2|||
131664206|NCT00468104|474054844|FG000|First Intervention|associated prolonged pneumothorax|1|||
131892491|NCT01994902|474892028|FG000|Test Period 2|Lack of Efficacy|0|||
131892492|NCT01994902|474892029|FG001|Test Period 2|Lack of Efficacy|1|||
131892493|NCT01994902|474892028|FG000|Test Period 2|Other|0|||
131892494|NCT01994902|474892029|FG001|Test Period 2|Other|3|||
131892495|NCT00520767|474892031|FG000|Overall Study|Death|2|||
131892496|NCT03597139|474892032|FG000|Overall Study|Adverse Event|3|||
131892497|NCT03597139|474892033|FG001|Overall Study|Adverse Event|0|||
131892498|NCT03597139|474892032|FG000|Overall Study|Protocol Non-compliance|1|||
131892499|NCT03597139|474892033|FG001|Overall Study|Protocol Non-compliance|0|||
131892500|NCT00382109|474892036|FG000|Overall Study|Adverse Event|3|||
131892501|NCT00382109|474892037|FG001|Overall Study|Adverse Event|0|||
131892502|NCT00382109|474892036|FG000|Overall Study|Physician Decision|6|||
131892503|NCT00382109|474892037|FG001|Overall Study|Physician Decision|1|||
131892504|NCT00382109|474892036|FG000|Overall Study|Withdrawal by Subject|1|||
131892505|NCT00382109|474892037|FG001|Overall Study|Withdrawal by Subject|0|||
131892506|NCT00382109|474892036|FG000|Overall Study|ineligible|2|||
131892507|NCT00382109|474892037|FG001|Overall Study|ineligible|0|||
131892508|NCT00382109|474892036|FG000|Overall Study|Other|0|||
131892509|NCT00382109|474892037|FG001|Overall Study|Other|2|||
131892510|NCT00382109|474892036|FG000|Overall Study|consent withdrawal|0|||
131892511|NCT00382109|474892037|FG001|Overall Study|consent withdrawal|1|||
131892512|NCT02717442|474892038|FG000|Overall Study|Study Terminated by Sponsor|31|||
131892513|NCT02717442|474892039|FG001|Overall Study|Study Terminated by Sponsor|29|||
131892514|NCT02717442|474892038|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
131892515|NCT02717442|474892039|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
131892516|NCT02717442|474892038|FG000|Overall Study|Other - Not Specified|2|||
131892517|NCT02717442|474892039|FG001|Overall Study|Other - Not Specified|0|||
131892518|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
131892519|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892520|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892521|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892522|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892523|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892524|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892525|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892526|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
131892527|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
131892528|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
131892529|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
131892530|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
131892531|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
131892532|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
131892533|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
131892534|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
131892535|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
131892536|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
131892537|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
131892538|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
131892539|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
131892540|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
131892541|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
131892542|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
131892543|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
131892544|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
131892545|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
131892546|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
131892547|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
131892548|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
131892549|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
131892550|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
131892551|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
131892552|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
131892553|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
131892554|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892555|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892556|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892557|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
131892558|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892559|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
131892560|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892561|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892562|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
131892563|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
131892564|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
131892565|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
131892566|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
131892567|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
131892568|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
131892569|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
131892570|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
131892571|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
131892572|NCT00528372|474892043|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
131892573|NCT00528372|474892044|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131892574|NCT00528372|474892045|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131892575|NCT00528372|474892046|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
131892576|NCT00528372|474892047|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131892577|NCT00528372|474892048|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131892578|NCT00528372|474892049|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131892579|NCT00528372|474892050|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
131892580|NCT00528372|474892051|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131892581|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
131892582|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
131892583|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
131892584|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
131892585|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
131892586|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
131892587|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
131892588|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
131892589|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
131892590|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
131892591|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
131892592|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
131892593|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
131892594|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
131892595|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
131892596|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
131892597|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
131892598|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
131892599|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
131892600|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
131892601|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
131892602|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
131892603|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
131892604|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
131892605|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
131892606|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
131892607|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
131892608|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
131892609|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
131892610|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
131892611|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
131892612|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
131892613|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
131892614|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
131892615|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
131892616|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
131892617|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131892618|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
131892619|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
131892620|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
131892621|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131892622|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131892623|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
131892624|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131892625|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131892626|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892627|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892628|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892629|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892630|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
131892631|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
131892632|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892633|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892634|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
131892635|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
131892636|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
131892637|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
131892638|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
131892639|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
131892640|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
131892641|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
131892642|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
131892643|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
131892644|NCT00528372|474892043|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
131892645|NCT00528372|474892044|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
131892646|NCT00528372|474892045|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
131892647|NCT00528372|474892046|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
131892648|NCT00528372|474892047|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
131892649|NCT00528372|474892048|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
131892650|NCT00528372|474892049|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
131892651|NCT00528372|474892050|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
131892652|NCT00528372|474892051|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
131892653|NCT02772809|474892052|FG000|Overall Study|not completed some tasks|6|||
131892654|NCT02774005|474892055|FG000|Overall Study|Adverse Event|8|||
131892655|NCT02774005|474892055|FG000|Overall Study|Withdrawal by Subject|23|||
131892656|NCT02774005|474892055|FG000|Overall Study|Lost to Follow-up|7|||
131892657|NCT02774005|474892055|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
131892658|NCT02774005|474892055|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
131892659|NCT02774005|474892055|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
131892660|NCT02774005|474892055|FG000|Overall Study|Death|1|||
131892661|NCT02774005|474892055|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
131892662|NCT02774005|474892055|FG000|Overall Study|Lack of compliance with study medication|4|||
131892663|NCT02774005|474892055|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
131892664|NCT02774005|474892055|FG000|Overall Study|another study|1|||
131892665|NCT02774005|474892055|FG000|Overall Study|cardiologist imposed travel restriction|1|||
131892666|NCT00534105|474892056|FG000|Overall Study|Lost to Follow-up|23|||
131892667|NCT00534105|474892057|FG001|Overall Study|Lost to Follow-up|39|||
131892668|NCT03275389|474892058|FG000|Overall Study|Lost to Follow-up|10|||
131892669|NCT03275389|474892059|FG001|Overall Study|Lost to Follow-up|10|||
131892670|NCT03275389|474892060|FG002|Overall Study|Lost to Follow-up|19|||
131892671|NCT03275389|474892061|FG003|Overall Study|Lost to Follow-up|12|||
131892672|NCT03275389|474892062|FG004|Overall Study|Lost to Follow-up|11|||
131892673|NCT03275389|474892063|FG005|Overall Study|Lost to Follow-up|12|||
131892674|NCT03275389|474892064|FG006|Overall Study|Lost to Follow-up|21|||
131892675|NCT03275389|474892065|FG007|Overall Study|Lost to Follow-up|15|||
131892676|NCT03275389|474892066|FG008|Overall Study|Lost to Follow-up|12|||
131892677|NCT03275389|474892067|FG009|Overall Study|Lost to Follow-up|14|||
131892678|NCT03275389|474892058|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892679|NCT03275389|474892059|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892680|NCT03275389|474892060|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892681|NCT03275389|474892061|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892682|NCT03275389|474892062|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892683|NCT03275389|474892063|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
131892684|NCT03275389|474892064|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892685|NCT03275389|474892065|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892686|NCT03275389|474892066|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
131892687|NCT03275389|474892067|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
131892688|NCT03275389|474892058|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
131892689|NCT03275389|474892059|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131892690|NCT03275389|474892060|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131892691|NCT03275389|474892061|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
131892692|NCT03275389|474892062|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
131892693|NCT03275389|474892063|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
131892694|NCT03275389|474892064|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
131892695|NCT03275389|474892065|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
131892696|NCT03275389|474892066|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
131892697|NCT03275389|474892067|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
131892698|NCT03275389|474892058|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892699|NCT03275389|474892059|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131892700|NCT03275389|474892060|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892701|NCT03275389|474892061|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
131892702|NCT03275389|474892062|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892703|NCT03275389|474892063|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892704|NCT03275389|474892064|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131892705|NCT03275389|474892065|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892706|NCT03275389|474892066|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892707|NCT03275389|474892067|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131892708|NCT03275389|474892058|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892709|NCT03275389|474892059|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892710|NCT03275389|474892060|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
131892711|NCT03275389|474892061|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892712|NCT03275389|474892062|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892713|NCT03275389|474892063|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892714|NCT03275389|474892064|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892715|NCT03275389|474892065|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892716|NCT03275389|474892066|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131892717|NCT03275389|474892067|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
131892718|NCT03275389|474892058|FG000|Overall Study|Other|0|||
131892719|NCT03275389|474892059|FG001|Overall Study|Other|4|||
131892720|NCT03275389|474892060|FG002|Overall Study|Other|3|||
131664207|NCT00468104|474054845|FG001|First Intervention|associated prolonged pneumothorax|0|||
131892721|NCT03275389|474892061|FG003|Overall Study|Other|2|||
131892722|NCT03275389|474892062|FG004|Overall Study|Other|2|||
131892723|NCT03275389|474892063|FG005|Overall Study|Other|2|||
131892724|NCT03275389|474892064|FG006|Overall Study|Other|0|||
131892725|NCT03275389|474892065|FG007|Overall Study|Other|0|||
131892726|NCT03275389|474892066|FG008|Overall Study|Other|1|||
131892727|NCT03275389|474892067|FG009|Overall Study|Other|0|||
131664208|NCT00468104|474054844|FG000|First Intervention|trapped lung|1|||
131664209|NCT00468104|474054845|FG001|First Intervention|trapped lung|0|||
131892728|NCT00978341|474892071|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
131892729|NCT00978341|474892072|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
131892730|NCT03035916|474892073|FG000|Overall Study|Puncture failed|0|||
131892731|NCT03035916|474892074|FG001|Overall Study|Puncture failed|2|||
131892732|NCT03035916|474892075|FG002|Overall Study|Puncture failed|0|||
131892733|NCT02749799|474892076|FG000|Overall Study|Adverse Event|2|||
131892734|NCT02749799|474892076|FG000|Overall Study|Lost to Follow-up|4|||
131892735|NCT02749799|474892076|FG000|Overall Study|Protocol Violation|1|||
131892736|NCT02749799|474892076|FG000|Overall Study|Withdrawal by Subject|1|||
131892737|NCT03749109|474892077|FG000|Overall Study|Adverse Event|2|||
131892738|NCT03749109|474892078|FG001|Overall Study|Adverse Event|0|||
131892739|NCT03084302|474894703|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
131892740|NCT03084302|474894703|FG000|Overall Study|No valid objective monitor data|6|||
131892741|NCT00929994|474894704|FG000|Overall Study|Withdrawal by Subject|1|||
131892742|NCT00929994|474894704|FG000|Overall Study|medical issue unrelated to intervention|4|||
131892743|NCT00929994|474894704|FG000|Overall Study|employment|1|||
131892744|NCT01214668|474894705|FG000|Overall Study|Adverse Event|0|||
131892745|NCT01214668|474894706|FG001|Overall Study|Adverse Event|1|||
131892746|NCT01214668|474894707|FG002|Overall Study|Adverse Event|0|||
131892747|NCT01214668|474894708|FG003|Overall Study|Adverse Event|2|||
131892748|NCT01214668|474894709|FG004|Overall Study|Adverse Event|1|||
131892749|NCT01214668|474894710|FG005|Overall Study|Adverse Event|1|||
131892750|NCT01214668|474894705|FG000|Overall Study|Death|0|||
131892751|NCT01214668|474894706|FG001|Overall Study|Death|0|||
131892752|NCT01214668|474894707|FG002|Overall Study|Death|1|||
131892753|NCT01214668|474894708|FG003|Overall Study|Death|0|||
131892754|NCT01214668|474894709|FG004|Overall Study|Death|0|||
131892755|NCT01214668|474894710|FG005|Overall Study|Death|0|||
131892756|NCT01214668|474894705|FG000|Overall Study|Progressive Disease|4|||
131892757|NCT01214668|474894706|FG001|Overall Study|Progressive Disease|2|||
131892758|NCT01214668|474894707|FG002|Overall Study|Progressive Disease|5|||
131892759|NCT01214668|474894708|FG003|Overall Study|Progressive Disease|4|||
131892760|NCT01214668|474894709|FG004|Overall Study|Progressive Disease|4|||
131892761|NCT01214668|474894710|FG005|Overall Study|Progressive Disease|5|||
131892762|NCT01214668|474894705|FG000|Overall Study|Withdrawal by Subject|0|||
131892763|NCT01214668|474894706|FG001|Overall Study|Withdrawal by Subject|0|||
131892764|NCT01214668|474894707|FG002|Overall Study|Withdrawal by Subject|0|||
131892765|NCT01214668|474894708|FG003|Overall Study|Withdrawal by Subject|0|||
131892766|NCT01214668|474894709|FG004|Overall Study|Withdrawal by Subject|1|||
131892767|NCT01214668|474894710|FG005|Overall Study|Withdrawal by Subject|0|||
131892768|NCT01964989|474894711|FG000|Overall Study|Protocol Violation|3|||
131892769|NCT01964989|474894712|FG001|Overall Study|Protocol Violation|4|||
131892770|NCT01964989|474894711|FG000|Overall Study|Administrative Reason|103|||
131892771|NCT01964989|474894712|FG001|Overall Study|Administrative Reason|95|||
131892772|NCT01964989|474894711|FG000|Overall Study|Adverse Event|0|||
131892773|NCT01964989|474894712|FG001|Overall Study|Adverse Event|1|||
131892774|NCT01964989|474894711|FG000|Overall Study|Death|1|||
131892775|NCT01964989|474894712|FG001|Overall Study|Death|3|||
131892776|NCT01964989|474894711|FG000|Overall Study|Withdrawal by Subject|156|||
131892777|NCT01964989|474894712|FG001|Overall Study|Withdrawal by Subject|160|||
131892778|NCT01964989|474894711|FG000|Overall Study|Lost to Follow-up|254|||
131892779|NCT01964989|474894712|FG001|Overall Study|Lost to Follow-up|232|||
131892780|NCT01964989|474894711|FG000|Overall Study|Other|267|||
131892781|NCT01964989|474894712|FG001|Overall Study|Other|252|||
131892782|NCT00424593|474894713|FG000|Acute Double-Blind Period|Adverse Event|16|||
131892783|NCT00424593|474894714|FG001|Acute Double-Blind Period|Adverse Event|7|||
131892784|NCT00424593|474894713|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
131892785|NCT00424593|474894714|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
131892786|NCT00424593|474894713|FG000|Acute Double-Blind Period|Protocol Violation|2|||
131892787|NCT00424593|474894714|FG001|Acute Double-Blind Period|Protocol Violation|2|||
131892788|NCT00424593|474894713|FG000|Acute Double-Blind Period|Physician Decision|1|||
131892789|NCT00424593|474894714|FG001|Acute Double-Blind Period|Physician Decision|2|||
131892790|NCT00424593|474894713|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
131892791|NCT00424593|474894714|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
131892792|NCT00424593|474894713|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
131892793|NCT00424593|474894714|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
131892794|NCT00424593|474894713|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
131892795|NCT00424593|474894714|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
131892796|NCT00424593|474894713|FG000|Dose-Blind Extension Period|Adverse Event|18|||
131892797|NCT00424593|474894714|FG001|Dose-Blind Extension Period|Adverse Event|0|||
131892798|NCT00424593|474894713|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
131892799|NCT00424593|474894714|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
131892800|NCT00424593|474894713|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
131892801|NCT00424593|474894714|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
131892802|NCT00424593|474894713|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
131892803|NCT00424593|474894714|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
131892804|NCT00424593|474894713|FG000|Dose-Blind Extension Period|Physician Decision|3|||
131892805|NCT00424593|474894714|FG001|Dose-Blind Extension Period|Physician Decision|0|||
131892806|NCT01796301|474894715|FG000|Overall Study|Withdrawal by Subject|15|||
131892807|NCT01796301|474894716|FG001|Overall Study|Withdrawal by Subject|15|||
131892808|NCT01796301|474894715|FG000|Overall Study|Lost to Follow-up|3|||
131892809|NCT01796301|474894716|FG001|Overall Study|Lost to Follow-up|3|||
131892810|NCT01796301|474894715|FG000|Overall Study|Death|0|||
131892811|NCT01796301|474894716|FG001|Overall Study|Death|1|||
131892812|NCT01796301|474894715|FG000|Overall Study|Decision by Sponsor|0|||
131892813|NCT01796301|474894716|FG001|Overall Study|Decision by Sponsor|1|||
131892814|NCT00667563|474894717|FG000|Overall Study|Protocol Violation|24|||
131892815|NCT02187029|474894719|FG000|Overall Study|Adverse Event|0|||
131892816|NCT02187029|474894720|FG001|Overall Study|Adverse Event|1|||
131892817|NCT02187029|474894721|FG002|Overall Study|Adverse Event|1|||
131892818|NCT02187029|474894722|FG003|Overall Study|Adverse Event|0|||
131892819|NCT02187029|474894719|FG000|Overall Study|Study Terminated by Sponsor|0|||
131892820|NCT02187029|474894720|FG001|Overall Study|Study Terminated by Sponsor|0|||
131892821|NCT02187029|474894721|FG002|Overall Study|Study Terminated by Sponsor|10|||
131892822|NCT02187029|474894722|FG003|Overall Study|Study Terminated by Sponsor|3|||
131892823|NCT02187029|474894719|FG000|Overall Study|Withdrawal by Subject|1|||
131892824|NCT02187029|474894720|FG001|Overall Study|Withdrawal by Subject|0|||
131892825|NCT02187029|474894721|FG002|Overall Study|Withdrawal by Subject|0|||
131892826|NCT02187029|474894722|FG003|Overall Study|Withdrawal by Subject|0|||
131892827|NCT03042910|474894723|FG000|Overall Study|Adverse Event|1|||
131892828|NCT03042910|474894723|FG000|Overall Study|Disease Progression|2|||
131892829|NCT03042910|474894723|FG000|Overall Study|Withdrawal by Subject|3|||
131892830|NCT03042910|474894723|FG000|Overall Study|Enrolled but not treated|1|||
131892831|NCT01763203|474894724|FG000|Overall Study|Death|4|||
131892832|NCT01763203|474894725|FG001|Overall Study|Death|7|||
131892833|NCT01763203|474894724|FG000|Overall Study|Lost to Follow-up|12|||
131892834|NCT01763203|474894725|FG001|Overall Study|Lost to Follow-up|12|||
131892835|NCT01763203|474894724|FG000|Overall Study|Withdrawal by Subject|8|||
131892836|NCT01763203|474894725|FG001|Overall Study|Withdrawal by Subject|12|||
131892837|NCT01763203|474894724|FG000|Overall Study|Moved out of study region|7|||
131892838|NCT01763203|474894725|FG001|Overall Study|Moved out of study region|10|||
131892839|NCT01763203|474894724|FG000|Overall Study|Physician Decision|2|||
131892840|NCT01763203|474894725|FG001|Overall Study|Physician Decision|1|||
131892841|NCT02187861|474894729|FG000|Overall Study|Adverse Event|2|||
131892842|NCT02187861|474894730|FG001|Overall Study|Adverse Event|1|||
131892843|NCT02187861|474894731|FG002|Overall Study|Adverse Event|2|||
131892844|NCT02187861|474894732|FG003|Overall Study|Adverse Event|1|||
131892845|NCT02187861|474894729|FG000|Overall Study|Death|0|||
131892846|NCT02187861|474894730|FG001|Overall Study|Death|3|||
131892847|NCT02187861|474894731|FG002|Overall Study|Death|1|||
131892848|NCT02187861|474894732|FG003|Overall Study|Death|2|||
131892849|NCT02187861|474894729|FG000|Overall Study|Physician Decision|0|||
131892850|NCT02187861|474894730|FG001|Overall Study|Physician Decision|1|||
131892851|NCT02187861|474894731|FG002|Overall Study|Physician Decision|0|||
131892852|NCT02187861|474894732|FG003|Overall Study|Physician Decision|3|||
131892853|NCT02187861|474894729|FG000|Overall Study|Progressive Disease|4|||
131892854|NCT02187861|474894730|FG001|Overall Study|Progressive Disease|42|||
131892855|NCT02187861|474894731|FG002|Overall Study|Progressive Disease|19|||
131892856|NCT02187861|474894732|FG003|Overall Study|Progressive Disease|22|||
131892857|NCT02187861|474894729|FG000|Overall Study|Withdrawal by Subject|0|||
131892858|NCT02187861|474894730|FG001|Overall Study|Withdrawal by Subject|0|||
131892859|NCT02187861|474894731|FG002|Overall Study|Withdrawal by Subject|3|||
131892860|NCT02187861|474894732|FG003|Overall Study|Withdrawal by Subject|3|||
131892861|NCT02187861|474894729|FG000|Overall Study|Other|0|||
131892862|NCT02187861|474894730|FG001|Overall Study|Other|1|||
131892863|NCT02187861|474894731|FG002|Overall Study|Other|7|||
131892864|NCT02187861|474894732|FG003|Overall Study|Other|1|||
131892865|NCT02756819|474894733|FG000|Overall Study|Lost for observation|23|||
131892866|NCT02756819|474894733|FG000|Overall Study|Patient's unwillingness|16|||
131892867|NCT02756819|474894733|FG000|Overall Study|Insufficient efficacy|2|||
131892868|NCT02756819|474894733|FG000|Overall Study|Adverse Event|2|||
131892869|NCT02756819|474894733|FG000|Overall Study|Reason not Specified|9|||
131892870|NCT01491841|474894735|FG000|Overall Study|Screen Failure|10|||
131892871|NCT01491841|474894735|FG000|Overall Study|Withdrawal by Subject|1|||
131892872|NCT02933528|474894736|FG000|Overall Study|Lost to Follow-up|2|||
131892873|NCT01301079|474894739|FG000|Overall Study|Lost to Follow-up|2|||
131892874|NCT01301079|474894740|FG001|Overall Study|Lost to Follow-up|2|||
131892875|NCT00264290|474894742|FG000|Intervention (8 Weeks)|Adverse Event|1|||
131892876|NCT00264290|474894743|FG001|Intervention (8 Weeks)|Adverse Event|0|||
131892877|NCT02496039|474894744|FG000|Overall Study|Adverse Event|3|||
131892878|NCT02496039|474894744|FG000|Overall Study|Protocol Violation|1|||
131892879|NCT04472494|474894745|FG000|Pre-treatment|Other reasons|2|||
131892880|NCT04472494|474894746|FG001|Pre-treatment|Other reasons|0|||
131892881|NCT04472494|474894745|FG000|Treatment|Death|5|||
131892882|NCT04472494|474894746|FG001|Treatment|Death|2|||
131892883|NCT04472494|474894745|FG000|Treatment|Hospital discharge|1|||
131892884|NCT04472494|474894746|FG001|Treatment|Hospital discharge|1|||
131892885|NCT00571103|474894747|FG000|Overall Study|Withdrawal by Subject|1|||
131892886|NCT00571103|474894747|FG000|Overall Study|Lost to Follow-up|1|||
131892887|NCT01951573|474894749|FG000|Washout Period|Adverse Event|0|||
131892888|NCT01951573|474894750|FG001|Washout Period|Adverse Event|1|||
131892889|NCT00707980|474894751|FG000|Overall Study|Adverse Event|49|||
131892890|NCT00707980|474894751|FG000|Overall Study|Lack of Efficacy|35|||
131892891|NCT00707980|474894751|FG000|Overall Study|Non-Compliance with Study Drug|28|||
131892892|NCT00707980|474894751|FG000|Overall Study|Protocol Deviations|19|||
131892893|NCT00707980|474894751|FG000|Overall Study|Withdrawal of Consent|81|||
131892894|NCT00707980|474894751|FG000|Overall Study|Lost to Follow-up|59|||
131892895|NCT00707980|474894751|FG000|Overall Study|Other|39|||
131892896|NCT01909973|474894752|FG000|Overall Study|Lost to Follow-up|1|||
131892897|NCT01909973|474894753|FG001|Overall Study|Lost to Follow-up|0|||
131892898|NCT01152996|474894754|FG000|Overall Study|Withdrawal by Subject|142|||
131892899|NCT01152996|474894754|FG000|Overall Study|Adverse Event|115|||
131892900|NCT01152996|474894754|FG000|Overall Study|Lost to Follow-up|112|||
131892901|NCT01152996|474894754|FG000|Overall Study|Lack of Efficacy|68|||
131892902|NCT01152996|474894754|FG000|Overall Study|Noncompliance|41|||
131892903|NCT01152996|474894754|FG000|Overall Study|Other|36|||
131892904|NCT01152996|474894754|FG000|Overall Study|Protocol Violation|22|||
131892905|NCT01152996|474894754|FG000|Overall Study|Elevated liver enzymes|1|||
131892906|NCT02072941|474894755|FG000|Overall Study|Withdrawal by Subject|29|||
131892907|NCT02072941|474894756|FG001|Overall Study|Withdrawal by Subject|21|||
131892908|NCT02072941|474894755|FG000|Overall Study|Lost to Follow-up|4|||
131892909|NCT02072941|474894756|FG001|Overall Study|Lost to Follow-up|4|||
131892910|NCT02072941|474894755|FG000|Overall Study|Death|3|||
131664210|NCT00468104|474054844|FG000|Second Intervention|Withdrawal by Subject|5|||
131664211|NCT00468104|474054845|FG001|Second Intervention|Withdrawal by Subject|2|||
131664212|NCT00468104|474054844|FG000|Second Intervention|discarded for malposition of chest tube|0|||
131664213|NCT00468104|474054845|FG001|Second Intervention|discarded for malposition of chest tube|2|||
131664214|NCT04860297|474054850|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
131664215|NCT04860297|474054851|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
131892911|NCT02072941|474894756|FG001|Overall Study|Death|2|||
131892912|NCT02072941|474894755|FG000|Overall Study|Removed by Study Staff|2|||
131892913|NCT02072941|474894756|FG001|Overall Study|Removed by Study Staff|2|||
131892914|NCT00460239|474894757|FG000|Overall Study|Physician Decision|0|||
131892915|NCT00460239|474894758|FG001|Overall Study|Physician Decision|1|||
131892916|NCT00460239|474894759|FG002|Overall Study|Physician Decision|0|||
131892917|NCT00460239|474894760|FG003|Overall Study|Physician Decision|0|||
131892918|NCT00460239|474894761|FG004|Overall Study|Physician Decision|0|||
131892919|NCT00460239|474894762|FG005|Overall Study|Physician Decision|2|||
131892920|NCT00460239|474894763|FG006|Overall Study|Physician Decision|0|||
131892921|NCT00460239|474894764|FG007|Overall Study|Physician Decision|0|||
131892922|NCT00460239|474894765|FG008|Overall Study|Physician Decision|0|||
131892923|NCT00460239|474894757|FG000|Overall Study|Withdrawal by Subject|0|||
131892924|NCT00460239|474894758|FG001|Overall Study|Withdrawal by Subject|0|||
131892925|NCT00460239|474894759|FG002|Overall Study|Withdrawal by Subject|0|||
131892926|NCT00460239|474894760|FG003|Overall Study|Withdrawal by Subject|0|||
131892927|NCT00460239|474894761|FG004|Overall Study|Withdrawal by Subject|0|||
131892928|NCT00460239|474894762|FG005|Overall Study|Withdrawal by Subject|1|||
131892929|NCT00460239|474894763|FG006|Overall Study|Withdrawal by Subject|0|||
131892930|NCT00460239|474894764|FG007|Overall Study|Withdrawal by Subject|0|||
131892931|NCT00460239|474894765|FG008|Overall Study|Withdrawal by Subject|0|||
131892932|NCT02087943|474894793|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
131892933|NCT02087943|474894794|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
131892934|NCT02087943|474894795|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
131892935|NCT02087943|474894796|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
131892936|NCT02087943|474894797|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
131892937|NCT02087943|474894793|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
131892938|NCT02087943|474894794|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
131892939|NCT02087943|474894795|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
131892940|NCT02087943|474894796|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
131892941|NCT02087943|474894797|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
131892942|NCT02087943|474894793|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
131892943|NCT02087943|474894794|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
131892944|NCT02087943|474894795|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
131892945|NCT02087943|474894796|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
131892946|NCT02087943|474894797|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
131664216|NCT04860297|474054852|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
131664217|NCT04860297|474054853|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
131664218|NCT04860297|474054854|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
131892947|NCT02087943|474894793|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
131892948|NCT02087943|474894794|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
131892949|NCT02087943|474894795|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
131892950|NCT02087943|474894796|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
131892951|NCT02087943|474894797|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
131892952|NCT02087943|474894793|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
131892953|NCT02087943|474894794|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
131892954|NCT02087943|474894795|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
131892955|NCT02087943|474894796|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
131892956|NCT02087943|474894797|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
131892957|NCT02087943|474894793|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
131892958|NCT02087943|474894794|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
131892959|NCT02087943|474894795|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
131892960|NCT02087943|474894796|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
131892961|NCT02087943|474894797|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
131892962|NCT02087943|474894793|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
131892963|NCT02087943|474894794|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
131892964|NCT02087943|474894795|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
131892965|NCT02087943|474894796|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
131892966|NCT02087943|474894797|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
131892967|NCT02087943|474894793|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
131892968|NCT02087943|474894794|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
131892969|NCT02087943|474894795|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
131892970|NCT02087943|474894796|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
131892971|NCT02087943|474894797|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
131892972|NCT02087943|474894793|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
131892973|NCT02087943|474894794|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
131892974|NCT02087943|474894795|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
131892975|NCT02087943|474894796|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
131892976|NCT02087943|474894797|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
131892977|NCT02087943|474894793|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
131892978|NCT02087943|474894794|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
131892979|NCT02087943|474894795|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
131892980|NCT02087943|474894796|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
131892981|NCT02087943|474894797|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
131892982|NCT01424241|474894803|FG000|Overall Study|Withdrawal by Subject|1|||
131892983|NCT01424241|474894803|FG000|Overall Study|Time constraints|2|||
131892984|NCT00496587|474894804|FG000|Overall Study|Adverse Event|2|||
131892985|NCT00496587|474894804|FG000|Overall Study|Progressive Disease|24|||
131892986|NCT00496587|474894804|FG000|Overall Study|Withdrawal by Subject|2|||
131892987|NCT00496587|474894804|FG000|Overall Study|Death|1|||
131892988|NCT00496587|474894804|FG000|Overall Study|Complications unrelated|2|||
131892989|NCT00770913|474894805|FG000|Overall Study|Adverse Event|1|||
131892990|NCT00770913|474894806|FG001|Overall Study|Adverse Event|3|||
131892991|NCT00770913|474894807|FG002|Overall Study|Adverse Event|6|||
131892992|NCT00770913|474894805|FG000|Overall Study|Refusal to continue participation|6|||
131892993|NCT00770913|474894806|FG001|Overall Study|Refusal to continue participation|4|||
131892994|NCT00770913|474894807|FG002|Overall Study|Refusal to continue participation|5|||
131892995|NCT00770913|474894805|FG000|Overall Study|Physician Decision|0|||
131892996|NCT00770913|474894806|FG001|Overall Study|Physician Decision|1|||
131892997|NCT00770913|474894807|FG002|Overall Study|Physician Decision|1|||
131892998|NCT00770913|474894805|FG000|Overall Study|Protocol Violation|3|||
131892999|NCT00770913|474894806|FG001|Overall Study|Protocol Violation|0|||
131893000|NCT00770913|474894807|FG002|Overall Study|Protocol Violation|1|||
131893001|NCT00770913|474894805|FG000|Overall Study|Incorrect drug was allocated|1|||
131893002|NCT00770913|474894806|FG001|Overall Study|Incorrect drug was allocated|0|||
131893003|NCT00770913|474894807|FG002|Overall Study|Incorrect drug was allocated|0|||
131893004|NCT00359294|474894808|FG000|Overall Study|Progressive disease|1|||
131893005|NCT00359294|474894809|FG001|Overall Study|Progressive disease|1|||
131893006|NCT00359294|474894810|FG002|Overall Study|Progressive disease|2|||
131893007|NCT00359294|474894811|FG003|Overall Study|Progressive disease|3|||
131893008|NCT00359294|474894812|FG004|Overall Study|Progressive disease|2|||
131893009|NCT00359294|474894808|FG000|Overall Study|Withdrawal by Subject|0|||
131893010|NCT00359294|474894809|FG001|Overall Study|Withdrawal by Subject|0|||
131893011|NCT00359294|474894810|FG002|Overall Study|Withdrawal by Subject|0|||
131893012|NCT00359294|474894811|FG003|Overall Study|Withdrawal by Subject|0|||
131893013|NCT00359294|474894812|FG004|Overall Study|Withdrawal by Subject|1|||
131893014|NCT00359294|474894808|FG000|Overall Study|Not treated|0|||
131893015|NCT00359294|474894809|FG001|Overall Study|Not treated|0|||
131893016|NCT00359294|474894810|FG002|Overall Study|Not treated|0|||
131893017|NCT00359294|474894811|FG003|Overall Study|Not treated|1|||
131893018|NCT00359294|474894812|FG004|Overall Study|Not treated|0|||
131893019|NCT00359294|474894808|FG000|Overall Study|Physician Decision|0|||
131893020|NCT00359294|474894809|FG001|Overall Study|Physician Decision|0|||
131893021|NCT00359294|474894810|FG002|Overall Study|Physician Decision|1|||
131893022|NCT00359294|474894811|FG003|Overall Study|Physician Decision|0|||
131893023|NCT00359294|474894812|FG004|Overall Study|Physician Decision|0|||
131893024|NCT00524680|474894814|FG000|Overall Study|progression|0|||
131893025|NCT00524680|474894815|FG001|Overall Study|progression|0|||
131893026|NCT00524680|474894816|FG002|Overall Study|progression|0|||
131893027|NCT00524680|474894817|FG003|Overall Study|progression|1|||
131893028|NCT00524680|474894814|FG000|Overall Study|Adverse Event|2|||
131893029|NCT00524680|474894815|FG001|Overall Study|Adverse Event|0|||
131893030|NCT00524680|474894816|FG002|Overall Study|Adverse Event|0|||
131893031|NCT00524680|474894817|FG003|Overall Study|Adverse Event|1|||
131893032|NCT00524680|474894814|FG000|Overall Study|Other|0|||
131893033|NCT00524680|474894815|FG001|Overall Study|Other|1|||
131893034|NCT00524680|474894816|FG002|Overall Study|Other|2|||
131893035|NCT00524680|474894817|FG003|Overall Study|Other|3|||
131893036|NCT00524680|474894814|FG000|Overall Study|Withdrawal by Subject|1|||
131893037|NCT00524680|474894815|FG001|Overall Study|Withdrawal by Subject|0|||
131893038|NCT00524680|474894816|FG002|Overall Study|Withdrawal by Subject|1|||
131893039|NCT00524680|474894817|FG003|Overall Study|Withdrawal by Subject|1|||
131893040|NCT03124537|474894818|FG000|Overall Study|Lost to Follow-up|3|||
131893041|NCT03124537|474894819|FG001|Overall Study|Lost to Follow-up|5|||
131893042|NCT03124537|474894818|FG000|Overall Study|App Crash, Incomplete Data|7|||
131893043|NCT03124537|474894819|FG001|Overall Study|App Crash, Incomplete Data|8|||
131893044|NCT01607346|474894822|FG000|Overall Study|Adverse Event|3|||
131893045|NCT04424914|474894823|FG000|Overall Study|Other|0|||
131893046|NCT04424914|474894824|FG001|Overall Study|Other|0|||
131893047|NCT04424914|474894825|FG002|Overall Study|Other|28|||
131893048|NCT04424914|474894823|FG000|Overall Study|Withdrawal by Subject|3|||
131893049|NCT04424914|474894824|FG001|Overall Study|Withdrawal by Subject|0|||
131893050|NCT04424914|474894825|FG002|Overall Study|Withdrawal by Subject|0|||
131893051|NCT04424914|474894823|FG000|Overall Study|Study terminated by sponsor|23|||
131893052|NCT04424914|474894824|FG001|Overall Study|Study terminated by sponsor|7|||
131893053|NCT04424914|474894825|FG002|Overall Study|Study terminated by sponsor|0|||
131893054|NCT04424914|474894823|FG000|Overall Study|Lost to Follow-up|0|||
131893055|NCT04424914|474894824|FG001|Overall Study|Lost to Follow-up|0|||
131893056|NCT04424914|474894825|FG002|Overall Study|Lost to Follow-up|1|||
131893057|NCT04424914|474894823|FG000|Overall Study|Death|3|||
131893058|NCT04424914|474894824|FG001|Overall Study|Death|1|||
131893059|NCT04424914|474894825|FG002|Overall Study|Death|0|||
131893060|NCT02685072|474894836|FG000|Treatment Period|Lost to Follow-up|12|||
131893061|NCT02685072|474894837|FG001|Treatment Period|Lost to Follow-up|6|||
131893062|NCT02685072|474894836|FG000|Treatment Period|Withdrawal by Subject|1|||
131893063|NCT02685072|474894837|FG001|Treatment Period|Withdrawal by Subject|3|||
131893064|NCT02685072|474894836|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
131893065|NCT02685072|474894837|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
131893066|NCT02634710|474894838|FG000|Overall Study|Death|4|||
131893067|NCT02483572|474894839|FG000|Overall Study|Withdrawal by Subject|1|||
131893068|NCT02483572|474894840|FG001|Overall Study|Withdrawal by Subject|0|||
131893069|NCT02483572|474894839|FG000|Overall Study|Lost to Follow-up|1|||
131893070|NCT02483572|474894840|FG001|Overall Study|Lost to Follow-up|0|||
131893071|NCT02483572|474894839|FG000|Overall Study|Physician Decision|0|||
131893072|NCT02483572|474894840|FG001|Overall Study|Physician Decision|1|||
131893073|NCT04811664|474894841|FG000|Overall Study|Lost to Follow-up|78|||
131893074|NCT04811664|474894842|FG001|Overall Study|Lost to Follow-up|125|||
131893075|NCT04811664|474894843|FG002|Overall Study|Lost to Follow-up|46|||
131893076|NCT04811664|474894841|FG000|Overall Study|Withdrawal by Subject|39|||
131893077|NCT04811664|474894842|FG001|Overall Study|Withdrawal by Subject|76|||
131893078|NCT04811664|474894843|FG002|Overall Study|Withdrawal by Subject|12|||
131893079|NCT04811664|474894841|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
131893080|NCT04811664|474894842|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
131893081|NCT04811664|474894843|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
131893082|NCT04811664|474894841|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
131893083|NCT04811664|474894842|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
131893084|NCT04811664|474894843|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
131893085|NCT04811664|474894841|FG000|Overall Study|Protocol Violation|0|||
131893086|NCT04811664|474894842|FG001|Overall Study|Protocol Violation|5|||
131893087|NCT04811664|474894843|FG002|Overall Study|Protocol Violation|11|||
131893088|NCT04811664|474894841|FG000|Overall Study|Study Terminated by Sponsor|4|||
131893089|NCT04811664|474894842|FG001|Overall Study|Study Terminated by Sponsor|3|||
131893090|NCT04811664|474894843|FG002|Overall Study|Study Terminated by Sponsor|34|||
131893091|NCT04811664|474894841|FG000|Overall Study|Early Study Closure|3|||
131893092|NCT04811664|474894842|FG001|Overall Study|Early Study Closure|7|||
131893093|NCT04811664|474894843|FG002|Overall Study|Early Study Closure|79|||
131893094|NCT04811664|474894841|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
131893095|NCT04811664|474894842|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
131893096|NCT04811664|474894843|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
131893097|NCT05052697|474894844|FG000|Substudy A|Lost to Follow-up|0|||
131893098|NCT05052697|474894845|FG001|Substudy A|Lost to Follow-up|0|||
131893099|NCT05052697|474894846|FG002|Substudy A|Lost to Follow-up|0|||
131893100|NCT05052697|474894847|FG003|Substudy A|Lost to Follow-up|0|||
131893101|NCT05052697|474894848|FG004|Substudy A|Lost to Follow-up|0|||
131893102|NCT05052697|474894849|FG005|Substudy A|Lost to Follow-up|1|||
131893103|NCT05052697|474894850|FG006|Substudy A|Lost to Follow-up|0|||
131893104|NCT05052697|474894851|FG007|Substudy A|Lost to Follow-up|0|||
131893105|NCT05052697|474894852|FG008|Substudy A|Lost to Follow-up|0|||
131893106|NCT05052697|474894853|FG009|Substudy A|Lost to Follow-up|0|||
131893107|NCT05052697|474894854|FG010|Substudy A|Lost to Follow-up|0|||
131893108|NCT05052697|474894855|FG011|Substudy A|Lost to Follow-up|0|||
131893109|NCT05052697|474894856|FG012|Substudy A|Lost to Follow-up|0|||
131893110|NCT05052697|474894857|FG013|Substudy A|Lost to Follow-up|0|||
131893111|NCT05052697|474894858|FG014|Substudy A|Lost to Follow-up|0|||
131893112|NCT05052697|474894859|FG015|Substudy A|Lost to Follow-up|2|||
131893113|NCT05052697|474894860|FG016|Substudy A|Lost to Follow-up|0|||
131893114|NCT05052697|474894861|FG017|Substudy A|Lost to Follow-up|0|||
131893115|NCT05052697|474894862|FG018|Substudy A|Lost to Follow-up|0|||
131893116|NCT05052697|474894863|FG019|Substudy A|Lost to Follow-up|0|||
131893117|NCT05052697|474894864|FG020|Substudy A|Lost to Follow-up|0|||
131893118|NCT05052697|474894865|FG021|Substudy A|Lost to Follow-up|0|||
131893119|NCT05052697|474894866|FG022|Substudy A|Lost to Follow-up|0|||
131893120|NCT05052697|474894867|FG023|Substudy A|Lost to Follow-up|0|||
131893121|NCT05052697|474894868|FG024|Substudy A|Lost to Follow-up|0|||
131893122|NCT05052697|474894869|FG025|Substudy A|Lost to Follow-up|0|||
131893123|NCT05052697|474894870|FG026|Substudy A|Lost to Follow-up|0|||
131893124|NCT05052697|474894871|FG027|Substudy A|Lost to Follow-up|0|||
131893125|NCT05052697|474894872|FG028|Substudy A|Lost to Follow-up|0|||
131893126|NCT05052697|474894873|FG029|Substudy A|Lost to Follow-up|0|||
131893127|NCT05052697|474894874|FG030|Substudy A|Lost to Follow-up|0|||
131893128|NCT05052697|474894875|FG031|Substudy A|Lost to Follow-up|0|||
131893129|NCT05052697|474894876|FG032|Substudy A|Lost to Follow-up|0|||
131893130|NCT05052697|474894877|FG033|Substudy A|Lost to Follow-up|0|||
131893131|NCT05052697|474894844|FG000|Substudy A|No longer met eligibility criteria|0|||
131893132|NCT05052697|474894845|FG001|Substudy A|No longer met eligibility criteria|0|||
131893133|NCT05052697|474894846|FG002|Substudy A|No longer met eligibility criteria|0|||
131893134|NCT05052697|474894847|FG003|Substudy A|No longer met eligibility criteria|0|||
131893135|NCT05052697|474894848|FG004|Substudy A|No longer met eligibility criteria|0|||
131893136|NCT05052697|474894849|FG005|Substudy A|No longer met eligibility criteria|0|||
131893137|NCT05052697|474894850|FG006|Substudy A|No longer met eligibility criteria|0|||
131893138|NCT05052697|474894851|FG007|Substudy A|No longer met eligibility criteria|0|||
131893139|NCT05052697|474894852|FG008|Substudy A|No longer met eligibility criteria|0|||
131893140|NCT05052697|474894853|FG009|Substudy A|No longer met eligibility criteria|0|||
131893141|NCT05052697|474894854|FG010|Substudy A|No longer met eligibility criteria|0|||
131893142|NCT05052697|474894855|FG011|Substudy A|No longer met eligibility criteria|0|||
131893143|NCT05052697|474894856|FG012|Substudy A|No longer met eligibility criteria|0|||
131893144|NCT05052697|474894857|FG013|Substudy A|No longer met eligibility criteria|1|||
131893145|NCT05052697|474894858|FG014|Substudy A|No longer met eligibility criteria|0|||
131893146|NCT05052697|474894859|FG015|Substudy A|No longer met eligibility criteria|0|||
131893147|NCT05052697|474894860|FG016|Substudy A|No longer met eligibility criteria|0|||
131893148|NCT05052697|474894861|FG017|Substudy A|No longer met eligibility criteria|0|||
131893149|NCT05052697|474894862|FG018|Substudy A|No longer met eligibility criteria|0|||
131893150|NCT05052697|474894863|FG019|Substudy A|No longer met eligibility criteria|0|||
131893151|NCT05052697|474894864|FG020|Substudy A|No longer met eligibility criteria|0|||
131893152|NCT05052697|474894865|FG021|Substudy A|No longer met eligibility criteria|0|||
131893153|NCT05052697|474894866|FG022|Substudy A|No longer met eligibility criteria|0|||
131893154|NCT05052697|474894867|FG023|Substudy A|No longer met eligibility criteria|0|||
131893155|NCT05052697|474894868|FG024|Substudy A|No longer met eligibility criteria|0|||
131893156|NCT05052697|474894869|FG025|Substudy A|No longer met eligibility criteria|0|||
131893157|NCT05052697|474894870|FG026|Substudy A|No longer met eligibility criteria|0|||
131893158|NCT05052697|474894871|FG027|Substudy A|No longer met eligibility criteria|0|||
131893159|NCT05052697|474894872|FG028|Substudy A|No longer met eligibility criteria|0|||
131893160|NCT05052697|474894873|FG029|Substudy A|No longer met eligibility criteria|0|||
131893161|NCT05052697|474894874|FG030|Substudy A|No longer met eligibility criteria|0|||
131893162|NCT05052697|474894875|FG031|Substudy A|No longer met eligibility criteria|0|||
131893163|NCT05052697|474894876|FG032|Substudy A|No longer met eligibility criteria|0|||
131893164|NCT05052697|474894877|FG033|Substudy A|No longer met eligibility criteria|0|||
131893165|NCT05052697|474894844|FG000|Substudy A|Not vaccinated|0|||
131893166|NCT05052697|474894845|FG001|Substudy A|Not vaccinated|0|||
131893167|NCT05052697|474894846|FG002|Substudy A|Not vaccinated|0|||
131893168|NCT05052697|474894847|FG003|Substudy A|Not vaccinated|1|||
131893169|NCT05052697|474894848|FG004|Substudy A|Not vaccinated|0|||
131893170|NCT05052697|474894849|FG005|Substudy A|Not vaccinated|0|||
131893171|NCT05052697|474894850|FG006|Substudy A|Not vaccinated|0|||
131893172|NCT05052697|474894851|FG007|Substudy A|Not vaccinated|0|||
131893173|NCT05052697|474894852|FG008|Substudy A|Not vaccinated|1|||
131893174|NCT05052697|474894853|FG009|Substudy A|Not vaccinated|0|||
131893175|NCT05052697|474894854|FG010|Substudy A|Not vaccinated|0|||
131893176|NCT05052697|474894855|FG011|Substudy A|Not vaccinated|0|||
131893177|NCT05052697|474894856|FG012|Substudy A|Not vaccinated|0|||
131893178|NCT05052697|474894857|FG013|Substudy A|Not vaccinated|0|||
131893179|NCT05052697|474894858|FG014|Substudy A|Not vaccinated|0|||
131893180|NCT05052697|474894859|FG015|Substudy A|Not vaccinated|0|||
131893181|NCT05052697|474894860|FG016|Substudy A|Not vaccinated|0|||
131893182|NCT05052697|474894861|FG017|Substudy A|Not vaccinated|0|||
131893183|NCT05052697|474894862|FG018|Substudy A|Not vaccinated|0|||
131893184|NCT05052697|474894863|FG019|Substudy A|Not vaccinated|0|||
131893185|NCT05052697|474894864|FG020|Substudy A|Not vaccinated|0|||
131893186|NCT05052697|474894865|FG021|Substudy A|Not vaccinated|0|||
131893187|NCT05052697|474894866|FG022|Substudy A|Not vaccinated|0|||
131893188|NCT05052697|474894867|FG023|Substudy A|Not vaccinated|0|||
131893189|NCT05052697|474894868|FG024|Substudy A|Not vaccinated|0|||
131893190|NCT05052697|474894869|FG025|Substudy A|Not vaccinated|0|||
131893191|NCT05052697|474894870|FG026|Substudy A|Not vaccinated|0|||
131893192|NCT05052697|474894871|FG027|Substudy A|Not vaccinated|0|||
131893193|NCT05052697|474894872|FG028|Substudy A|Not vaccinated|0|||
131893194|NCT05052697|474894873|FG029|Substudy A|Not vaccinated|0|||
131893195|NCT05052697|474894874|FG030|Substudy A|Not vaccinated|0|||
131893196|NCT05052697|474894875|FG031|Substudy A|Not vaccinated|0|||
131893197|NCT05052697|474894876|FG032|Substudy A|Not vaccinated|0|||
131893198|NCT05052697|474894877|FG033|Substudy A|Not vaccinated|0|||
131893199|NCT05052697|474894844|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893200|NCT05052697|474894845|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893201|NCT05052697|474894846|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893202|NCT05052697|474894847|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893203|NCT05052697|474894848|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893204|NCT05052697|474894849|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893205|NCT05052697|474894850|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893206|NCT05052697|474894851|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893207|NCT05052697|474894852|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893208|NCT05052697|474894853|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893209|NCT05052697|474894854|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893210|NCT05052697|474894855|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893211|NCT05052697|474894856|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893212|NCT05052697|474894857|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893213|NCT05052697|474894858|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893214|NCT05052697|474894859|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893215|NCT05052697|474894860|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893216|NCT05052697|474894861|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893217|NCT05052697|474894862|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
131893218|NCT05052697|474894863|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
131893219|NCT05052697|474894864|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893220|NCT05052697|474894865|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
131893221|NCT05052697|474894866|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
131893222|NCT05052697|474894867|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893223|NCT05052697|474894868|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893224|NCT05052697|474894869|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893225|NCT05052697|474894870|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893226|NCT05052697|474894871|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893227|NCT05052697|474894872|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893228|NCT05052697|474894873|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893229|NCT05052697|474894874|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893230|NCT05052697|474894875|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893231|NCT05052697|474894876|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893232|NCT05052697|474894877|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131893233|NCT05052697|474894844|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893234|NCT05052697|474894845|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893235|NCT05052697|474894846|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893236|NCT05052697|474894847|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893237|NCT05052697|474894848|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893238|NCT05052697|474894849|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893239|NCT05052697|474894850|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893240|NCT05052697|474894851|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
131664219|NCT04860297|474054855|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
131893241|NCT05052697|474894852|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
131664220|NCT04860297|474054856|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
131893242|NCT05052697|474894853|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893243|NCT05052697|474894854|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893244|NCT05052697|474894855|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893245|NCT05052697|474894856|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893246|NCT05052697|474894857|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893247|NCT05052697|474894858|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893248|NCT05052697|474894859|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893249|NCT05052697|474894860|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893250|NCT05052697|474894861|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
131893251|NCT05052697|474894862|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893252|NCT05052697|474894863|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893253|NCT05052697|474894864|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893254|NCT05052697|474894865|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893255|NCT05052697|474894866|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893256|NCT05052697|474894867|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893257|NCT05052697|474894868|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893258|NCT05052697|474894869|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893259|NCT05052697|474894870|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893260|NCT05052697|474894871|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893261|NCT05052697|474894872|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893262|NCT05052697|474894873|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893263|NCT05052697|474894874|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893264|NCT05052697|474894875|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893265|NCT05052697|474894876|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893266|NCT05052697|474894877|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
131893267|NCT05052697|474894844|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893268|NCT05052697|474894845|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893269|NCT05052697|474894846|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893270|NCT05052697|474894847|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893271|NCT05052697|474894848|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893272|NCT05052697|474894849|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893273|NCT05052697|474894850|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893274|NCT05052697|474894851|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893275|NCT05052697|474894852|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893276|NCT05052697|474894853|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893277|NCT05052697|474894854|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893278|NCT05052697|474894855|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893279|NCT05052697|474894856|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893280|NCT05052697|474894857|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893281|NCT05052697|474894858|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893282|NCT05052697|474894859|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893283|NCT05052697|474894860|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893284|NCT05052697|474894861|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893285|NCT05052697|474894862|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893286|NCT05052697|474894863|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
131893287|NCT05052697|474894864|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893288|NCT05052697|474894865|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893289|NCT05052697|474894866|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893290|NCT05052697|474894867|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893291|NCT05052697|474894868|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893292|NCT05052697|474894869|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893293|NCT05052697|474894870|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893294|NCT05052697|474894871|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893295|NCT05052697|474894872|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893296|NCT05052697|474894873|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893297|NCT05052697|474894874|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893298|NCT05052697|474894875|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893299|NCT05052697|474894876|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893300|NCT05052697|474894877|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
131893301|NCT05052697|474894844|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893302|NCT05052697|474894845|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893303|NCT05052697|474894846|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893304|NCT05052697|474894847|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893305|NCT05052697|474894848|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893306|NCT05052697|474894849|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893307|NCT05052697|474894850|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893308|NCT05052697|474894851|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893309|NCT05052697|474894852|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893310|NCT05052697|474894853|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893311|NCT05052697|474894854|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893312|NCT05052697|474894855|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893313|NCT05052697|474894856|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893314|NCT05052697|474894857|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893315|NCT05052697|474894858|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893316|NCT05052697|474894859|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131664221|NCT04860297|474054857|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
131664222|NCT04860297|474054850|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
131664223|NCT04860297|474054851|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
131664224|NCT04860297|474054852|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
131664225|NCT04860297|474054853|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
131664226|NCT04860297|474054854|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
131664227|NCT04860297|474054855|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
131664228|NCT04860297|474054856|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
131664229|NCT04860297|474054857|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
131664230|NCT04860297|474054850|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
131893317|NCT05052697|474894860|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131664231|NCT04860297|474054851|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
131664232|NCT04860297|474054852|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
131664233|NCT04860297|474054853|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
131664234|NCT04860297|474054854|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
131664235|NCT04860297|474054855|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
131664236|NCT04860297|474054856|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
131664237|NCT04860297|474054857|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
131664238|NCT04860297|474054850|FG000|Part B (Booster Dose)|Other Than Specified|0|||
131664239|NCT04860297|474054851|FG001|Part B (Booster Dose)|Other Than Specified|0|||
131664240|NCT04860297|474054852|FG002|Part B (Booster Dose)|Other Than Specified|0|||
131664241|NCT04860297|474054853|FG003|Part B (Booster Dose)|Other Than Specified|0|||
131664242|NCT04860297|474054854|FG004|Part B (Booster Dose)|Other Than Specified|0|||
131664243|NCT04860297|474054855|FG005|Part B (Booster Dose)|Other Than Specified|1|||
131664244|NCT04860297|474054856|FG006|Part B (Booster Dose)|Other Than Specified|1|||
131664245|NCT04860297|474054857|FG007|Part B (Booster Dose)|Other Than Specified|0|||
131664246|NCT04860297|474054850|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
131664247|NCT04860297|474054851|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
131664248|NCT04860297|474054852|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
131664249|NCT04860297|474054853|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
131664250|NCT04860297|474054854|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
131664251|NCT04860297|474054855|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
131664252|NCT04860297|474054856|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
131664253|NCT04860297|474054857|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
131664254|NCT04860297|474054850|FG000|Part B (Booster Dose)|Death|0|||
131664255|NCT04860297|474054851|FG001|Part B (Booster Dose)|Death|0|||
131664256|NCT04860297|474054852|FG002|Part B (Booster Dose)|Death|0|||
131664257|NCT04860297|474054853|FG003|Part B (Booster Dose)|Death|0|||
131664258|NCT04860297|474054854|FG004|Part B (Booster Dose)|Death|1|||
131664259|NCT04860297|474054855|FG005|Part B (Booster Dose)|Death|2|||
131664260|NCT04860297|474054856|FG006|Part B (Booster Dose)|Death|1|||
131664261|NCT04860297|474054857|FG007|Part B (Booster Dose)|Death|0|||
131664262|NCT04860297|474054850|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
131664263|NCT04860297|474054851|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
131664264|NCT04860297|474054852|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
131664265|NCT04860297|474054853|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
131664266|NCT04860297|474054854|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
131664267|NCT04860297|474054855|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
131664268|NCT04860297|474054856|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
131664269|NCT04860297|474054857|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
131664270|NCT04811131|474054864|FG000|Overall Study|Adverse Event|0|||
131664271|NCT04811131|474054865|FG001|Overall Study|Adverse Event|0|||
131664272|NCT04811131|474054866|FG002|Overall Study|Adverse Event|1|||
131664273|NCT04811131|474054867|FG003|Overall Study|Adverse Event|0|||
131664274|NCT04811131|474054864|FG000|Overall Study|Lack of Efficacy|0|||
131664275|NCT04811131|474054865|FG001|Overall Study|Lack of Efficacy|0|||
131893318|NCT05052697|474894861|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
131893319|NCT05052697|474894862|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893320|NCT05052697|474894863|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893321|NCT05052697|474894864|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893322|NCT05052697|474894865|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893323|NCT05052697|474894866|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893324|NCT05052697|474894867|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893325|NCT05052697|474894868|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893326|NCT05052697|474894869|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
131893327|NCT05052697|474894870|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893328|NCT05052697|474894871|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
131664276|NCT04811131|474054866|FG002|Overall Study|Lack of Efficacy|0|||
131664277|NCT04811131|474054867|FG003|Overall Study|Lack of Efficacy|1|||
131664278|NCT04811131|474054864|FG000|Overall Study|Lost to Follow-up|0|||
131664279|NCT04811131|474054865|FG001|Overall Study|Lost to Follow-up|1|||
131664280|NCT04811131|474054866|FG002|Overall Study|Lost to Follow-up|0|||
131664281|NCT04811131|474054867|FG003|Overall Study|Lost to Follow-up|0|||
131664282|NCT04811131|474054864|FG000|Overall Study|Sponsor request|31|||
131893329|NCT05052697|474894872|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893330|NCT05052697|474894873|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893331|NCT05052697|474894874|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893332|NCT05052697|474894875|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893333|NCT05052697|474894876|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893334|NCT05052697|474894877|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
131893335|NCT05052697|474894844|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893336|NCT05052697|474894845|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893337|NCT05052697|474894846|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893338|NCT05052697|474894847|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893339|NCT05052697|474894848|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893340|NCT05052697|474894849|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893341|NCT05052697|474894850|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893342|NCT05052697|474894851|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893343|NCT05052697|474894852|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893344|NCT05052697|474894853|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893345|NCT05052697|474894854|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893346|NCT05052697|474894855|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893347|NCT05052697|474894856|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893348|NCT05052697|474894857|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893349|NCT05052697|474894858|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893350|NCT05052697|474894859|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893351|NCT05052697|474894860|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893352|NCT05052697|474894861|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893353|NCT05052697|474894862|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893354|NCT05052697|474894863|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893355|NCT05052697|474894864|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893356|NCT05052697|474894865|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893357|NCT05052697|474894866|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893358|NCT05052697|474894867|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893359|NCT05052697|474894868|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893360|NCT05052697|474894869|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893361|NCT05052697|474894870|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893362|NCT05052697|474894871|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893363|NCT05052697|474894872|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
131893364|NCT05052697|474894873|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893365|NCT05052697|474894874|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
131893366|NCT05052697|474894875|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
131893367|NCT05052697|474894876|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
131893368|NCT05052697|474894877|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131893369|NCT05052697|474894844|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893370|NCT05052697|474894845|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893371|NCT05052697|474894846|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893372|NCT05052697|474894847|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893373|NCT05052697|474894848|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893374|NCT05052697|474894849|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893375|NCT05052697|474894850|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893376|NCT05052697|474894851|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893377|NCT05052697|474894852|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893378|NCT05052697|474894853|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893379|NCT05052697|474894854|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893380|NCT05052697|474894855|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893381|NCT05052697|474894856|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893382|NCT05052697|474894857|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893383|NCT05052697|474894858|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893384|NCT05052697|474894859|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893385|NCT05052697|474894860|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893386|NCT05052697|474894861|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893387|NCT05052697|474894862|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893388|NCT05052697|474894863|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893389|NCT05052697|474894864|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893390|NCT05052697|474894865|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893391|NCT05052697|474894866|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893392|NCT05052697|474894867|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893393|NCT05052697|474894868|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893394|NCT05052697|474894869|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893395|NCT05052697|474894870|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893396|NCT05052697|474894871|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893397|NCT05052697|474894872|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
131893398|NCT05052697|474894873|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
131893399|NCT05052697|474894874|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
131893400|NCT05052697|474894875|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
131893401|NCT05052697|474894876|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
131893402|NCT05052697|474894877|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131893403|NCT05052697|474894844|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893404|NCT05052697|474894845|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131664283|NCT04811131|474054865|FG001|Overall Study|Sponsor request|35|||
131664284|NCT04811131|474054866|FG002|Overall Study|Sponsor request|27|||
131664285|NCT04811131|474054867|FG003|Overall Study|Sponsor request|10|||
131664286|NCT04811131|474054864|FG000|Overall Study|Withdrawal by Subject|3|||
131664287|NCT04811131|474054865|FG001|Overall Study|Withdrawal by Subject|1|||
131664288|NCT04811131|474054866|FG002|Overall Study|Withdrawal by Subject|3|||
131664289|NCT04811131|474054867|FG003|Overall Study|Withdrawal by Subject|1|||
131664290|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|Death|1|||
131664291|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|Death|1|||
131664292|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
131664293|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
131664294|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
131664295|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
131664296|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
131664297|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
131664298|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
131664299|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
131664300|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
131664301|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
131664302|NCT00371683|474054869|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
131664303|NCT00371683|474054870|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
131664304|NCT00371683|474054869|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
131664305|NCT00371683|474054870|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
131664306|NCT00371683|474054869|FG000|Follow-Up Period - Randomized Patients|Death|0|||
131664307|NCT00371683|474054870|FG001|Follow-Up Period - Randomized Patients|Death|2|||
131664308|NCT00371683|474054869|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
131664309|NCT00371683|474054870|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
131664310|NCT00371683|474054869|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
131664311|NCT00371683|474054870|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
131664312|NCT03181789|474054871|FG000|Overall Study|Withdrawal by Subject|0|||
131664313|NCT03181789|474054872|FG001|Overall Study|Withdrawal by Subject|1|||
131664314|NCT03181789|474054873|FG002|Overall Study|Withdrawal by Subject|1|||
131664315|NCT03181789|474054874|FG003|Overall Study|Withdrawal by Subject|0|||
131664316|NCT03181789|474054871|FG000|Overall Study|Lost to Follow-up|7|||
131664317|NCT03181789|474054872|FG001|Overall Study|Lost to Follow-up|1|||
131664318|NCT03181789|474054873|FG002|Overall Study|Lost to Follow-up|0|||
131664319|NCT03181789|474054874|FG003|Overall Study|Lost to Follow-up|0|||
131664320|NCT03181789|474054871|FG000|Overall Study|Participant unable to adhere to visit|0|||
131664321|NCT03181789|474054872|FG001|Overall Study|Participant unable to adhere to visit|1|||
131664322|NCT03181789|474054873|FG002|Overall Study|Participant unable to adhere to visit|0|||
131664323|NCT03181789|474054874|FG003|Overall Study|Participant unable to adhere to visit|0|||
131664324|NCT02624791|474054875|FG000|Overall Study|Withdrawal by Subject|2|||
131664325|NCT02624791|474054876|FG001|Overall Study|Withdrawal by Subject|0|||
131664326|NCT02624791|474054877|FG002|Overall Study|Withdrawal by Subject|0|||
131664327|NCT02624791|474054878|FG003|Overall Study|Withdrawal by Subject|0|||
131893405|NCT05052697|474894846|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893406|NCT05052697|474894847|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893407|NCT05052697|474894848|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893408|NCT05052697|474894849|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893409|NCT05052697|474894850|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893410|NCT05052697|474894851|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893411|NCT05052697|474894852|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893412|NCT05052697|474894853|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893413|NCT05052697|474894854|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893414|NCT05052697|474894855|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893415|NCT05052697|474894856|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893416|NCT05052697|474894857|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893417|NCT05052697|474894858|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131664328|NCT02624791|474054879|FG004|Overall Study|Withdrawal by Subject|0|||
131664329|NCT02624791|474054880|FG005|Overall Study|Withdrawal by Subject|0|||
131664330|NCT01146782|474054886|FG000|Screening Cohort|Screen Failure|187|||
131893418|NCT05052697|474894859|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893419|NCT05052697|474894860|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893420|NCT05052697|474894861|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893421|NCT05052697|474894862|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893422|NCT05052697|474894863|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893423|NCT05052697|474894864|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893424|NCT05052697|474894865|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893425|NCT05052697|474894866|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893426|NCT05052697|474894867|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893427|NCT05052697|474894868|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893428|NCT05052697|474894869|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893429|NCT05052697|474894870|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893430|NCT05052697|474894871|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893431|NCT05052697|474894872|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893432|NCT05052697|474894873|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893433|NCT05052697|474894874|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893434|NCT05052697|474894875|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893435|NCT05052697|474894876|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
131893436|NCT05052697|474894877|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131893437|NCT05052697|474894844|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893438|NCT05052697|474894845|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893439|NCT05052697|474894846|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893440|NCT05052697|474894847|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893441|NCT05052697|474894848|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893442|NCT05052697|474894849|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893443|NCT05052697|474894850|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893444|NCT05052697|474894851|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893445|NCT05052697|474894852|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893446|NCT05052697|474894853|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893447|NCT05052697|474894854|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893448|NCT05052697|474894855|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893449|NCT05052697|474894856|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893450|NCT05052697|474894857|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893451|NCT05052697|474894858|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893452|NCT05052697|474894859|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893453|NCT05052697|474894860|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893454|NCT05052697|474894861|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893455|NCT05052697|474894862|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893456|NCT05052697|474894863|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893457|NCT05052697|474894864|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893458|NCT05052697|474894865|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893459|NCT05052697|474894866|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893460|NCT05052697|474894867|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893461|NCT05052697|474894868|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893462|NCT05052697|474894869|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893463|NCT05052697|474894870|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893464|NCT05052697|474894871|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893465|NCT05052697|474894872|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
131893466|NCT05052697|474894873|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
131893467|NCT05052697|474894874|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
131893468|NCT05052697|474894875|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893469|NCT05052697|474894876|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893470|NCT05052697|474894877|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
131893471|NCT01289574|474894878|FG000|Overall Study|Lack of Efficacy|4|||
131893472|NCT01289574|474894879|FG001|Overall Study|Lack of Efficacy|0|||
131893473|NCT01289574|474894880|FG002|Overall Study|Lack of Efficacy|1|||
131893474|NCT01289574|474894878|FG000|Overall Study|Lost to Follow-up|2|||
131893475|NCT01289574|474894879|FG001|Overall Study|Lost to Follow-up|0|||
131893476|NCT01289574|474894880|FG002|Overall Study|Lost to Follow-up|1|||
131893477|NCT01289574|474894878|FG000|Overall Study|Withdrawal by Subject|1|||
131893478|NCT01289574|474894879|FG001|Overall Study|Withdrawal by Subject|1|||
131893479|NCT01289574|474894880|FG002|Overall Study|Withdrawal by Subject|1|||
131893480|NCT01289574|474894878|FG000|Overall Study|Adverse Event|0|||
131893481|NCT01289574|474894879|FG001|Overall Study|Adverse Event|1|||
131893482|NCT01289574|474894880|FG002|Overall Study|Adverse Event|0|||
131893483|NCT01289574|474894878|FG000|Overall Study|Subject wanted alternate treatment|0|||
131893484|NCT01289574|474894879|FG001|Overall Study|Subject wanted alternate treatment|1|||
131893485|NCT01289574|474894880|FG002|Overall Study|Subject wanted alternate treatment|0|||
131893486|NCT02432144|474894881|FG000|Overall Study|Participant Non-Compliance|1|||
131553232|NCT01933880|473649862|FG000|Overall Study|Other|4|||
131893487|NCT00262002|474894882|FG000|Overall Study|Adverse Event|2|||
131893488|NCT00262002|474894883|FG001|Overall Study|Adverse Event|1|||
131893489|NCT00262002|474894884|FG002|Overall Study|Adverse Event|0|||
131893490|NCT00262002|474894885|FG003|Overall Study|Adverse Event|0|||
131893491|NCT00262002|474894886|FG004|Overall Study|Adverse Event|0|||
131893492|NCT00262002|474894887|FG005|Overall Study|Adverse Event|1|||
131893493|NCT00262002|474894888|FG006|Overall Study|Adverse Event|0|||
131893494|NCT00262002|474894882|FG000|Overall Study|Withdrawal by Subject|4|||
131893495|NCT00262002|474894883|FG001|Overall Study|Withdrawal by Subject|2|||
131893496|NCT00262002|474894884|FG002|Overall Study|Withdrawal by Subject|0|||
131893497|NCT00262002|474894885|FG003|Overall Study|Withdrawal by Subject|1|||
131893498|NCT00262002|474894886|FG004|Overall Study|Withdrawal by Subject|2|||
131893499|NCT00262002|474894887|FG005|Overall Study|Withdrawal by Subject|2|||
131893500|NCT00262002|474894888|FG006|Overall Study|Withdrawal by Subject|2|||
131893501|NCT00262002|474894882|FG000|Overall Study|Lost to Follow-up|2|||
131893502|NCT00262002|474894883|FG001|Overall Study|Lost to Follow-up|0|||
131893503|NCT00262002|474894884|FG002|Overall Study|Lost to Follow-up|0|||
131893504|NCT00262002|474894885|FG003|Overall Study|Lost to Follow-up|2|||
131893505|NCT00262002|474894886|FG004|Overall Study|Lost to Follow-up|0|||
131893506|NCT00262002|474894887|FG005|Overall Study|Lost to Follow-up|1|||
131893507|NCT00262002|474894888|FG006|Overall Study|Lost to Follow-up|0|||
131893508|NCT00262002|474894882|FG000|Overall Study|Inapropriate enrollment|0|||
131893509|NCT00262002|474894883|FG001|Overall Study|Inapropriate enrollment|1|||
131893510|NCT00262002|474894884|FG002|Overall Study|Inapropriate enrollment|0|||
131893511|NCT00262002|474894885|FG003|Overall Study|Inapropriate enrollment|0|||
131893512|NCT00262002|474894886|FG004|Overall Study|Inapropriate enrollment|0|||
131893513|NCT00262002|474894887|FG005|Overall Study|Inapropriate enrollment|0|||
131893514|NCT00262002|474894888|FG006|Overall Study|Inapropriate enrollment|0|||
131893515|NCT00262002|474894882|FG000|Overall Study|Protocol Violation|3|||
131893516|NCT00262002|474894883|FG001|Overall Study|Protocol Violation|2|||
131893517|NCT00262002|474894884|FG002|Overall Study|Protocol Violation|0|||
131893518|NCT00262002|474894885|FG003|Overall Study|Protocol Violation|2|||
131893519|NCT00262002|474894886|FG004|Overall Study|Protocol Violation|5|||
131893520|NCT00262002|474894887|FG005|Overall Study|Protocol Violation|3|||
131893521|NCT00262002|474894888|FG006|Overall Study|Protocol Violation|2|||
131893522|NCT00262002|474894882|FG000|Overall Study|Unable to classify|0|||
131893523|NCT00262002|474894883|FG001|Overall Study|Unable to classify|0|||
131893524|NCT00262002|474894884|FG002|Overall Study|Unable to classify|0|||
131893525|NCT00262002|474894885|FG003|Overall Study|Unable to classify|0|||
131893526|NCT00262002|474894886|FG004|Overall Study|Unable to classify|0|||
131893527|NCT00262002|474894887|FG005|Overall Study|Unable to classify|0|||
131893528|NCT00262002|474894888|FG006|Overall Study|Unable to classify|2|||
131893529|NCT01451554|474894889|FG000|Overall Study|Withdrawal by Subject|14|||
131893530|NCT01451554|474894890|FG001|Overall Study|Withdrawal by Subject|9|||
131893531|NCT01402986|474894891|FG000|Overall Study|Withdrawal by Subject|7|||
131893532|NCT01402986|474894892|FG001|Overall Study|Withdrawal by Subject|10|||
131893533|NCT01402986|474894893|FG002|Overall Study|Withdrawal by Subject|7|||
131893534|NCT01402986|474894894|FG003|Overall Study|Withdrawal by Subject|13|||
131893535|NCT01402986|474894891|FG000|Overall Study|Death|0|||
131893536|NCT01402986|474894892|FG001|Overall Study|Death|0|||
131893537|NCT01402986|474894893|FG002|Overall Study|Death|0|||
131893538|NCT01402986|474894894|FG003|Overall Study|Death|2|||
131893539|NCT01402986|474894891|FG000|Overall Study|Lost to Follow-up|0|||
131893540|NCT01402986|474894892|FG001|Overall Study|Lost to Follow-up|0|||
131893541|NCT01402986|474894893|FG002|Overall Study|Lost to Follow-up|0|||
131893542|NCT01402986|474894894|FG003|Overall Study|Lost to Follow-up|1|||
131893543|NCT01402986|474894891|FG000|Overall Study|Other|2|||
131893544|NCT01402986|474894892|FG001|Overall Study|Other|5|||
131893545|NCT01402986|474894893|FG002|Overall Study|Other|1|||
131893546|NCT01402986|474894894|FG003|Overall Study|Other|6|||
131893547|NCT01085084|474894895|FG000|Overall Study|Withdrawal by Subject|1|||
131893548|NCT01085084|474894896|FG001|Overall Study|Withdrawal by Subject|0|||
131893549|NCT01085084|474894897|FG002|Overall Study|Withdrawal by Subject|0|||
131893550|NCT01085084|474894895|FG000|Overall Study|Lost to Follow-up|2|||
131893551|NCT01085084|474894896|FG001|Overall Study|Lost to Follow-up|1|||
131893552|NCT01085084|474894897|FG002|Overall Study|Lost to Follow-up|1|||
131893553|NCT01085084|474894895|FG000|Overall Study|Adverse Event|4|||
131893554|NCT01085084|474894896|FG001|Overall Study|Adverse Event|3|||
131893555|NCT01085084|474894897|FG002|Overall Study|Adverse Event|6|||
131893556|NCT01085084|474894895|FG000|Overall Study|Treatment Failure|0|||
131893557|NCT01085084|474894896|FG001|Overall Study|Treatment Failure|1|||
131893558|NCT01085084|474894897|FG002|Overall Study|Treatment Failure|2|||
131893559|NCT02427802|474894898|FG000|Overall Study|Adverse Event|11|||
131893560|NCT02427802|474894899|FG001|Overall Study|Adverse Event|3|||
131893561|NCT02427802|474894900|FG002|Overall Study|Adverse Event|7|||
131893562|NCT02427802|474894898|FG000|Overall Study|Death|0|||
131893563|NCT02427802|474894899|FG001|Overall Study|Death|4|||
131893564|NCT02427802|474894900|FG002|Overall Study|Death|1|||
131893565|NCT02427802|474894898|FG000|Overall Study|Lost to Follow-up|13|||
131893566|NCT02427802|474894899|FG001|Overall Study|Lost to Follow-up|8|||
131893567|NCT02427802|474894900|FG002|Overall Study|Lost to Follow-up|8|||
131893568|NCT02427802|474894898|FG000|Overall Study|Physician Decision|4|||
131893569|NCT02427802|474894899|FG001|Overall Study|Physician Decision|2|||
131893570|NCT02427802|474894900|FG002|Overall Study|Physician Decision|4|||
131893571|NCT02427802|474894898|FG000|Overall Study|Withdrawal by Subject|10|||
131893572|NCT02427802|474894899|FG001|Overall Study|Withdrawal by Subject|5|||
131893573|NCT02427802|474894900|FG002|Overall Study|Withdrawal by Subject|11|||
131893574|NCT02427802|474894898|FG000|Overall Study|Protocol Violation|3|||
131893575|NCT02427802|474894899|FG001|Overall Study|Protocol Violation|1|||
131893576|NCT02427802|474894900|FG002|Overall Study|Protocol Violation|1|||
131893577|NCT02427802|474894898|FG000|Overall Study|protocol specific treatment unrelated|18|||
131893578|NCT02427802|474894899|FG001|Overall Study|protocol specific treatment unrelated|11|||
131893579|NCT02427802|474894900|FG002|Overall Study|protocol specific treatment unrelated|11|||
131893580|NCT02634983|474894901|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
131893581|NCT02634983|474894902|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
131893582|NCT03951753|474894903|FG000|Overall Study|Adverse Event|1|||
131893583|NCT03951753|474894904|FG001|Overall Study|Adverse Event|0|||
131893584|NCT03951753|474894905|FG002|Overall Study|Adverse Event|3|||
131893585|NCT03951753|474894903|FG000|Overall Study|Withdrawal by Subject|3|||
131893586|NCT03951753|474894904|FG001|Overall Study|Withdrawal by Subject|1|||
131893587|NCT03951753|474894905|FG002|Overall Study|Withdrawal by Subject|0|||
131893588|NCT03951753|474894903|FG000|Overall Study|Lost to Follow-up|0|||
131893589|NCT03951753|474894904|FG001|Overall Study|Lost to Follow-up|0|||
131893590|NCT03951753|474894905|FG002|Overall Study|Lost to Follow-up|1|||
131893591|NCT03178851|474894906|FG000|Overall Study|Death|48|||
131893592|NCT03178851|474894907|FG001|Overall Study|Death|2|||
131893593|NCT03178851|474894908|FG002|Overall Study|Death|25|||
131893594|NCT03178851|474894906|FG000|Overall Study|Withdrawal by Subject|8|||
131893595|NCT03178851|474894907|FG001|Overall Study|Withdrawal by Subject|0|||
131893596|NCT03178851|474894908|FG002|Overall Study|Withdrawal by Subject|0|||
131893597|NCT03178851|474894906|FG000|Overall Study|Lost to Follow-up|5|||
131893598|NCT03178851|474894907|FG001|Overall Study|Lost to Follow-up|2|||
131893599|NCT03178851|474894908|FG002|Overall Study|Lost to Follow-up|0|||
131893600|NCT03178851|474894906|FG000|Overall Study|Adverse Event|0|||
131893601|NCT03178851|474894907|FG001|Overall Study|Adverse Event|0|||
131893602|NCT03178851|474894908|FG002|Overall Study|Adverse Event|1|||
131893603|NCT03178851|474894906|FG000|Overall Study|Study Termination by Sponsor|31|||
131893604|NCT03178851|474894907|FG001|Overall Study|Study Termination by Sponsor|7|||
131893605|NCT03178851|474894908|FG002|Overall Study|Study Termination by Sponsor|26|||
131893606|NCT02669043|474894913|FG000|Overall Study|Didn't meet I/E criteria|4|||
131893607|NCT02552888|474894916|FG000|Overall Study|Lost to Follow-up|1|||
131893608|NCT02552888|474894917|FG001|Overall Study|Lost to Follow-up|1|||
131893609|NCT00401193|474896859|FG000|Overall Study|Adverse Event|1|||
131893610|NCT00401193|474896860|FG001|Overall Study|Adverse Event|3|||
131893611|NCT00401193|474896861|FG002|Overall Study|Adverse Event|1|||
131893612|NCT00401193|474896859|FG000|Overall Study|Protocol Violation|3|||
131893613|NCT00401193|474896860|FG001|Overall Study|Protocol Violation|1|||
131893614|NCT00401193|474896861|FG002|Overall Study|Protocol Violation|1|||
131893615|NCT00401193|474896859|FG000|Overall Study|Lost to Follow-up|6|||
131893616|NCT00401193|474896860|FG001|Overall Study|Lost to Follow-up|5|||
131893617|NCT00401193|474896861|FG002|Overall Study|Lost to Follow-up|1|||
131893618|NCT00401193|474896859|FG000|Overall Study|Withdrawal by Subject|2|||
131893619|NCT00401193|474896860|FG001|Overall Study|Withdrawal by Subject|0|||
131893620|NCT00401193|474896861|FG002|Overall Study|Withdrawal by Subject|1|||
131893621|NCT00401193|474896859|FG000|Overall Study|Other Event|3|||
131893622|NCT00401193|474896860|FG001|Overall Study|Other Event|2|||
131893623|NCT00401193|474896861|FG002|Overall Study|Other Event|2|||
131893624|NCT00398216|474896862|FG000|Overall Study|Adverse Event|4|||
131893625|NCT00398216|474896863|FG001|Overall Study|Adverse Event|2|||
131893626|NCT00398216|474896864|FG002|Overall Study|Adverse Event|5|||
131893627|NCT00398216|474896865|FG003|Overall Study|Adverse Event|7|||
131893628|NCT00398216|474896866|FG004|Overall Study|Adverse Event|2|||
131893629|NCT00398216|474896862|FG000|Overall Study|Protocol Violation|2|||
131893630|NCT00398216|474896863|FG001|Overall Study|Protocol Violation|4|||
131893631|NCT00398216|474896864|FG002|Overall Study|Protocol Violation|5|||
131893632|NCT00398216|474896865|FG003|Overall Study|Protocol Violation|7|||
131893633|NCT00398216|474896866|FG004|Overall Study|Protocol Violation|5|||
131893634|NCT00398216|474896862|FG000|Overall Study|Lost to Follow-up|1|||
131893635|NCT00398216|474896863|FG001|Overall Study|Lost to Follow-up|6|||
131893636|NCT00398216|474896864|FG002|Overall Study|Lost to Follow-up|4|||
131893637|NCT00398216|474896865|FG003|Overall Study|Lost to Follow-up|4|||
131893638|NCT00398216|474896866|FG004|Overall Study|Lost to Follow-up|1|||
131893639|NCT00398216|474896862|FG000|Overall Study|Death|0|||
131893640|NCT00398216|474896863|FG001|Overall Study|Death|3|||
131893641|NCT00398216|474896864|FG002|Overall Study|Death|0|||
131893642|NCT00398216|474896865|FG003|Overall Study|Death|0|||
131893643|NCT00398216|474896866|FG004|Overall Study|Death|0|||
131893644|NCT00398216|474896862|FG000|Overall Study|Withdrawal by Subject|1|||
131893645|NCT00398216|474896863|FG001|Overall Study|Withdrawal by Subject|0|||
131893646|NCT00398216|474896864|FG002|Overall Study|Withdrawal by Subject|3|||
131893647|NCT00398216|474896865|FG003|Overall Study|Withdrawal by Subject|1|||
131664331|NCT01146782|474054886|FG000|Screening Cohort|Lost to Follow-up|4|||
131664332|NCT01146782|474054886|FG000|Screening Cohort|Physician Decision|1|||
131664333|NCT01146782|474054886|FG000|Screening Cohort|Withdrawal by Subject|29|||
131664334|NCT01146782|474054886|FG000|Safety Cohort|Screen Failure|61|||
131664335|NCT01146782|474054886|FG000|Safety Cohort|Withdrawal by Subject|4|||
131664336|NCT01146782|474054886|FG000|Safety Cohort|Control AHI <5|4|||
131664337|NCT01146782|474054886|FG000|Safety Cohort|TST <4 hrs|14|||
131664338|NCT01146782|474054886|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
131664339|NCT01146782|474054886|FG000|Primary Endpoint Cohort|Physician Decision|1|||
131664340|NCT02656329|474054887|FG000|Overall Study|Lost to Follow-up|2|||
131664341|NCT02656329|474054888|FG001|Overall Study|Lost to Follow-up|3|||
131664342|NCT02656329|474054887|FG000|Overall Study|Withdrawal by Subject|7|||
131664343|NCT02656329|474054888|FG001|Overall Study|Withdrawal by Subject|6|||
131664344|NCT02656329|474054887|FG000|Overall Study|Study termination by Sponsor|150|||
131664345|NCT02656329|474054888|FG001|Overall Study|Study termination by Sponsor|142|||
131664346|NCT02656329|474054887|FG000|Overall Study|Other than specified above|5|||
131664347|NCT02656329|474054888|FG001|Overall Study|Other than specified above|6|||
131664348|NCT01139580|474054889|FG000|Overall Study|Adverse Event|5|||
131664349|NCT01139580|474054890|FG001|Overall Study|Adverse Event|4|||
131664350|NCT01139580|474054889|FG000|Overall Study|Lost to Follow-up|9|||
131664351|NCT01139580|474054890|FG001|Overall Study|Lost to Follow-up|1|||
131664352|NCT01139580|474054889|FG000|Overall Study|Lack of Efficacy|0|||
131664353|NCT01139580|474054890|FG001|Overall Study|Lack of Efficacy|2|||
131664354|NCT01139580|474054889|FG000|Overall Study|Withdrawal by Subject|6|||
131664355|NCT01139580|474054890|FG001|Overall Study|Withdrawal by Subject|9|||
131664356|NCT01139580|474054889|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
131664357|NCT01139580|474054890|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
131664358|NCT01139580|474054889|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
131664359|NCT01139580|474054890|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
131664360|NCT01139580|474054889|FG000|Overall Study|Misrandomized|1|||
131664361|NCT01139580|474054890|FG001|Overall Study|Misrandomized|0|||
131664362|NCT01139580|474054889|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
131664363|NCT01139580|474054890|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
131664364|NCT01139580|474054889|FG000|Overall Study|Participant Randomization in Error|0|||
131664365|NCT01139580|474054890|FG001|Overall Study|Participant Randomization in Error|1|||
131664366|NCT00911768|474054891|FG000|Overall Study|Protocol Violation|5|||
131664367|NCT00911768|474054892|FG001|Overall Study|Protocol Violation|4|||
131664368|NCT00911768|474054891|FG000|Overall Study|Withdrawal by Subject|1|||
131664369|NCT00911768|474054892|FG001|Overall Study|Withdrawal by Subject|0|||
131893648|NCT00398216|474896866|FG004|Overall Study|Withdrawal by Subject|2|||
131893649|NCT00398216|474896862|FG000|Overall Study|administrative reasons|3|||
131553233|NCT01933880|473649863|FG001|Overall Study|Other|0|||
131553234|NCT01933880|473649862|FG000|Overall Study|Protocol Violation|1|||
131553235|NCT01933880|473649863|FG001|Overall Study|Protocol Violation|0|||
131553236|NCT02395133|473649864|FG000|Overall Study|Adverse Event|4|||
131553237|NCT02395133|473649865|FG001|Overall Study|Adverse Event|1|||
131553238|NCT02395133|473649866|FG002|Overall Study|Adverse Event|3|||
131553239|NCT02395133|473649867|FG003|Overall Study|Adverse Event|0|||
131553240|NCT02395133|473649864|FG000|Overall Study|Lack of Efficacy|1|||
131553241|NCT02395133|473649865|FG001|Overall Study|Lack of Efficacy|0|||
131553242|NCT02395133|473649866|FG002|Overall Study|Lack of Efficacy|1|||
131553243|NCT02395133|473649867|FG003|Overall Study|Lack of Efficacy|1|||
131553244|NCT02395133|473649864|FG000|Overall Study|Protocol Violation|1|||
131553245|NCT02395133|473649865|FG001|Overall Study|Protocol Violation|1|||
131553246|NCT02395133|473649866|FG002|Overall Study|Protocol Violation|0|||
131553247|NCT02395133|473649867|FG003|Overall Study|Protocol Violation|3|||
131553248|NCT02395133|473649864|FG000|Overall Study|Lost to Follow-up|0|||
131553249|NCT02395133|473649865|FG001|Overall Study|Lost to Follow-up|1|||
131553250|NCT02395133|473649866|FG002|Overall Study|Lost to Follow-up|1|||
131553251|NCT02395133|473649867|FG003|Overall Study|Lost to Follow-up|0|||
131553252|NCT02395133|473649864|FG000|Overall Study|Pregnancy|0|||
131553253|NCT02395133|473649865|FG001|Overall Study|Pregnancy|0|||
131553254|NCT02395133|473649866|FG002|Overall Study|Pregnancy|3|||
131553255|NCT02395133|473649867|FG003|Overall Study|Pregnancy|0|||
131664370|NCT02842151|474054896|FG000|Overall Study|Adverse Event|1|||
131664371|NCT02842151|474054896|FG000|Overall Study|Subject moved too far away|1|||
131664372|NCT00591851|474054897|FG000|Overall Study|Withdrawal by Subject|3|||
131664373|NCT00591851|474054897|FG000|Overall Study|Adverse Event|2|||
131664374|NCT00591851|474054897|FG000|Overall Study|Progressive Disease|1|||
131664375|NCT02559895|474054898|FG000|Overall Study|Adverse Event|3|||
131664376|NCT02559895|474054899|FG001|Overall Study|Adverse Event|3|||
131664377|NCT02559895|474054900|FG002|Overall Study|Adverse Event|2|||
131664378|NCT02559895|474054901|FG003|Overall Study|Adverse Event|1|||
131893650|NCT00398216|474896863|FG001|Overall Study|administrative reasons|4|||
131553256|NCT02395133|473649864|FG000|Overall Study|Consent withdrawn with no reason given|1|||
131553257|NCT02395133|473649865|FG001|Overall Study|Consent withdrawn with no reason given|3|||
131664379|NCT02559895|474054898|FG000|Overall Study|Lack of Efficacy|2|||
131664380|NCT02559895|474054899|FG001|Overall Study|Lack of Efficacy|3|||
131664381|NCT02559895|474054900|FG002|Overall Study|Lack of Efficacy|2|||
131664382|NCT02559895|474054901|FG003|Overall Study|Lack of Efficacy|8|||
131664383|NCT02559895|474054898|FG000|Overall Study|Lost to Follow-up|22|||
131664384|NCT02559895|474054899|FG001|Overall Study|Lost to Follow-up|16|||
131664385|NCT02559895|474054900|FG002|Overall Study|Lost to Follow-up|12|||
131664386|NCT02559895|474054901|FG003|Overall Study|Lost to Follow-up|17|||
131664387|NCT02559895|474054898|FG000|Overall Study|Physician Decision|1|||
131664388|NCT02559895|474054899|FG001|Overall Study|Physician Decision|1|||
131664389|NCT02559895|474054900|FG002|Overall Study|Physician Decision|3|||
131664390|NCT02559895|474054901|FG003|Overall Study|Physician Decision|0|||
131664391|NCT02559895|474054898|FG000|Overall Study|Withdrawal by Subject|16|||
131664392|NCT02559895|474054899|FG001|Overall Study|Withdrawal by Subject|9|||
131664393|NCT02559895|474054900|FG002|Overall Study|Withdrawal by Subject|20|||
131664394|NCT02559895|474054901|FG003|Overall Study|Withdrawal by Subject|9|||
131664395|NCT02559895|474054898|FG000|Overall Study|Study Burden|10|||
131664396|NCT02559895|474054899|FG001|Overall Study|Study Burden|16|||
131664397|NCT02559895|474054900|FG002|Overall Study|Study Burden|12|||
131664398|NCT02559895|474054901|FG003|Overall Study|Study Burden|22|||
131664399|NCT02559895|474054898|FG000|Overall Study|Other|1|||
131664400|NCT02559895|474054899|FG001|Overall Study|Other|5|||
131664401|NCT02559895|474054900|FG002|Overall Study|Other|3|||
131664402|NCT02559895|474054901|FG003|Overall Study|Other|3|||
131664403|NCT00867308|474054912|FG000|Overall Study|Death|1|||
131664404|NCT00867308|474054913|FG001|Overall Study|Death|0|||
131664405|NCT00867308|474054912|FG000|Overall Study|Adverse Event|1|||
131664406|NCT00867308|474054913|FG001|Overall Study|Adverse Event|4|||
131664407|NCT00867308|474054912|FG000|Overall Study|Lack of Efficacy|6|||
131664408|NCT00867308|474054913|FG001|Overall Study|Lack of Efficacy|12|||
131664409|NCT00867308|474054912|FG000|Overall Study|Withdrawal by Subject|1|||
131664410|NCT00867308|474054913|FG001|Overall Study|Withdrawal by Subject|2|||
131664411|NCT00604825|474054914|FG000|Overall Study|Adverse Event|2|||
131664412|NCT00604825|474054915|FG001|Overall Study|Adverse Event|6|||
131664413|NCT00604825|474054916|FG002|Overall Study|Adverse Event|7|||
131664414|NCT00604825|474054917|FG003|Overall Study|Adverse Event|4|||
131664415|NCT00604825|474054914|FG000|Overall Study|Lost to Follow-up|0|||
131664416|NCT00604825|474054915|FG001|Overall Study|Lost to Follow-up|3|||
131664417|NCT00604825|474054916|FG002|Overall Study|Lost to Follow-up|1|||
131664418|NCT00604825|474054917|FG003|Overall Study|Lost to Follow-up|0|||
131664419|NCT00604825|474054914|FG000|Overall Study|Protocol Violation|0|||
131664420|NCT00604825|474054915|FG001|Overall Study|Protocol Violation|1|||
131664421|NCT00604825|474054916|FG002|Overall Study|Protocol Violation|0|||
131664422|NCT00604825|474054917|FG003|Overall Study|Protocol Violation|0|||
131664423|NCT00604825|474054914|FG000|Overall Study|Withdrawal by Subject|4|||
131664424|NCT00604825|474054915|FG001|Overall Study|Withdrawal by Subject|3|||
131664425|NCT00604825|474054916|FG002|Overall Study|Withdrawal by Subject|5|||
131664426|NCT00604825|474054917|FG003|Overall Study|Withdrawal by Subject|5|||
131664427|NCT00604825|474054914|FG000|Overall Study|Lack of Efficacy|3|||
131664428|NCT00604825|474054915|FG001|Overall Study|Lack of Efficacy|2|||
131664429|NCT00604825|474054916|FG002|Overall Study|Lack of Efficacy|1|||
131664430|NCT00604825|474054917|FG003|Overall Study|Lack of Efficacy|0|||
131664431|NCT00604825|474054914|FG000|Overall Study|Did not meet eligibility criteria|0|||
131664432|NCT00604825|474054915|FG001|Overall Study|Did not meet eligibility criteria|0|||
131664433|NCT00604825|474054916|FG002|Overall Study|Did not meet eligibility criteria|2|||
131664434|NCT00604825|474054917|FG003|Overall Study|Did not meet eligibility criteria|0|||
131664435|NCT00604825|474054914|FG000|Overall Study|Physician Decision|0|||
131664436|NCT00604825|474054915|FG001|Overall Study|Physician Decision|0|||
131664437|NCT00604825|474054916|FG002|Overall Study|Physician Decision|0|||
131664438|NCT00604825|474054917|FG003|Overall Study|Physician Decision|1|||
131664439|NCT00604825|474054914|FG000|Overall Study|Exclusion criterion met|0|||
131664440|NCT00604825|474054915|FG001|Overall Study|Exclusion criterion met|0|||
131664441|NCT00604825|474054916|FG002|Overall Study|Exclusion criterion met|0|||
131664442|NCT00604825|474054917|FG003|Overall Study|Exclusion criterion met|1|||
131664443|NCT03647488|474056228|FG000|Overall Study|Progressive disease|10|||
131664444|NCT03647488|474056229|FG001|Overall Study|Progressive disease|0|||
131664445|NCT03647488|474056230|FG002|Overall Study|Progressive disease|0|||
131664446|NCT03647488|474056228|FG000|Overall Study|Adverse Event|5|||
131664447|NCT03647488|474056229|FG001|Overall Study|Adverse Event|0|||
131664448|NCT03647488|474056230|FG002|Overall Study|Adverse Event|0|||
131664449|NCT03647488|474056228|FG000|Overall Study|Clinical progression|2|||
131664450|NCT03647488|474056229|FG001|Overall Study|Clinical progression|0|||
131664451|NCT03647488|474056230|FG002|Overall Study|Clinical progression|0|||
131664452|NCT03647488|474056228|FG000|Overall Study|Participant refused to take investigational product|1|||
131664453|NCT03647488|474056229|FG001|Overall Study|Participant refused to take investigational product|0|||
131664454|NCT03647488|474056230|FG002|Overall Study|Participant refused to take investigational product|0|||
131664455|NCT03694275|474056231|FG000|Overall Study|Adverse Event|0|||
131664456|NCT03694275|474056232|FG001|Overall Study|Adverse Event|1|||
131664457|NCT03694275|474056231|FG000|Overall Study|Reason not Specified|0|||
131664458|NCT03694275|474056232|FG001|Overall Study|Reason not Specified|1|||
131664459|NCT03541174|474056233|FG000|Part 1 Double-Blind|Adverse Event|6|||
131664460|NCT03541174|474056234|FG001|Part 1 Double-Blind|Adverse Event|5|||
131664461|NCT03541174|474056235|FG002|Part 1 Double-Blind|Adverse Event|2|||
131664462|NCT03541174|474056236|FG003|Part 1 Double-Blind|Adverse Event|0|||
131664463|NCT03541174|474056237|FG004|Part 1 Double-Blind|Adverse Event|0|||
131664464|NCT03541174|474056238|FG005|Part 1 Double-Blind|Adverse Event|0|||
131664465|NCT03541174|474056233|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
131664466|NCT03541174|474056234|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
131664467|NCT03541174|474056235|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
131664468|NCT03541174|474056236|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
131664469|NCT03541174|474056237|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
131664470|NCT03541174|474056238|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
131664471|NCT03541174|474056233|FG000|Part 1 Double-Blind|Other reasons|3|||
131664472|NCT03541174|474056234|FG001|Part 1 Double-Blind|Other reasons|2|||
131664473|NCT03541174|474056235|FG002|Part 1 Double-Blind|Other reasons|3|||
131664474|NCT03541174|474056236|FG003|Part 1 Double-Blind|Other reasons|0|||
131664475|NCT03541174|474056237|FG004|Part 1 Double-Blind|Other reasons|0|||
131664476|NCT03541174|474056238|FG005|Part 1 Double-Blind|Other reasons|0|||
131664477|NCT03541174|474056233|FG000|Part 2 Single-Blind|Adverse Event|0|||
131664478|NCT03541174|474056234|FG001|Part 2 Single-Blind|Adverse Event|0|||
131664479|NCT03541174|474056235|FG002|Part 2 Single-Blind|Adverse Event|0|||
131664480|NCT03541174|474056236|FG003|Part 2 Single-Blind|Adverse Event|25|||
131664481|NCT03541174|474056237|FG004|Part 2 Single-Blind|Adverse Event|0|||
131664482|NCT03541174|474056238|FG005|Part 2 Single-Blind|Adverse Event|0|||
131664483|NCT03541174|474056233|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
131664484|NCT03541174|474056234|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
131664485|NCT03541174|474056235|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
131664486|NCT03541174|474056236|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
131664487|NCT03541174|474056237|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
131664488|NCT03541174|474056238|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
131664489|NCT03541174|474056233|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
131664490|NCT03541174|474056234|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
131664491|NCT03541174|474056235|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
131664492|NCT03541174|474056236|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
131664493|NCT03541174|474056237|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
131664494|NCT03541174|474056238|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
131664495|NCT03541174|474056233|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
131664496|NCT03541174|474056234|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
131664497|NCT03541174|474056235|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
131664498|NCT03541174|474056236|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
131664499|NCT03541174|474056237|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
131664500|NCT03541174|474056238|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
131664501|NCT03541174|474056233|FG000|Part 2 Single-Blind|Death|0|||
131664502|NCT03541174|474056234|FG001|Part 2 Single-Blind|Death|0|||
131664503|NCT03541174|474056235|FG002|Part 2 Single-Blind|Death|0|||
131664504|NCT03541174|474056236|FG003|Part 2 Single-Blind|Death|5|||
131664505|NCT03541174|474056237|FG004|Part 2 Single-Blind|Death|0|||
131664506|NCT03541174|474056238|FG005|Part 2 Single-Blind|Death|0|||
131893651|NCT00398216|474896864|FG002|Overall Study|administrative reasons|4|||
131893652|NCT00398216|474896865|FG003|Overall Study|administrative reasons|3|||
131893653|NCT00398216|474896866|FG004|Overall Study|administrative reasons|3|||
131893654|NCT00398216|474896862|FG000|Overall Study|entrance criteria|0|||
131893655|NCT00398216|474896863|FG001|Overall Study|entrance criteria|0|||
131893656|NCT00398216|474896864|FG002|Overall Study|entrance criteria|0|||
131893657|NCT00398216|474896865|FG003|Overall Study|entrance criteria|0|||
131893658|NCT00398216|474896866|FG004|Overall Study|entrance criteria|2|||
131893659|NCT00376532|474896867|FG000|Overall Study|Lack sufficient blood sample|6|||
131893660|NCT00376532|474896868|FG001|Overall Study|Lack sufficient blood sample|6|||
131893661|NCT04227405|474896869|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
131893662|NCT04227405|474896870|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
131893663|NCT04227405|474896869|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
131893664|NCT04227405|474896870|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
131893665|NCT04227405|474896869|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
131893666|NCT04227405|474896870|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
131893667|NCT02207400|474896871|FG000|Overall Study|Adverse Event|1|||
131893668|NCT02207400|474896872|FG001|Overall Study|Adverse Event|1|||
131893669|NCT02207400|474896871|FG000|Overall Study|Lost to Follow-up|6|||
131893670|NCT02207400|474896872|FG001|Overall Study|Lost to Follow-up|7|||
131893671|NCT02207400|474896871|FG000|Overall Study|Protocol Violation|1|||
131435927|NCT00650767|473221897|FG000|Overall Study|Death|1|||
131664507|NCT03541174|474056233|FG000|Part 2 Single-Blind|Pregnancy|0|||
131664508|NCT03541174|474056234|FG001|Part 2 Single-Blind|Pregnancy|0|||
131664509|NCT03541174|474056235|FG002|Part 2 Single-Blind|Pregnancy|0|||
131664510|NCT03541174|474056236|FG003|Part 2 Single-Blind|Pregnancy|1|||
131893672|NCT02207400|474896872|FG001|Overall Study|Protocol Violation|1|||
131893673|NCT02207400|474896871|FG000|Overall Study|Withdrawal by Subject|8|||
131664511|NCT03541174|474056237|FG004|Part 2 Single-Blind|Pregnancy|0|||
131664512|NCT03541174|474056238|FG005|Part 2 Single-Blind|Pregnancy|0|||
131664513|NCT03541174|474056233|FG000|Part 2 Single-Blind|Other reasons|0|||
131664514|NCT03541174|474056234|FG001|Part 2 Single-Blind|Other reasons|0|||
131664515|NCT03541174|474056235|FG002|Part 2 Single-Blind|Other reasons|0|||
131664516|NCT03541174|474056236|FG003|Part 2 Single-Blind|Other reasons|32|||
131664517|NCT03541174|474056237|FG004|Part 2 Single-Blind|Other reasons|0|||
131664518|NCT03541174|474056238|FG005|Part 2 Single-Blind|Other reasons|0|||
131664519|NCT03541174|474056233|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131664520|NCT03541174|474056234|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131664521|NCT03541174|474056235|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131664522|NCT03541174|474056236|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131664523|NCT03541174|474056237|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
131664524|NCT03541174|474056238|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
131664525|NCT03541174|474056233|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131664526|NCT03541174|474056234|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131664527|NCT03541174|474056235|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131664528|NCT03541174|474056236|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131664529|NCT03541174|474056237|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
131664530|NCT03541174|474056238|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
131664531|NCT03541174|474056233|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131664532|NCT03541174|474056234|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131664533|NCT03541174|474056235|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131664534|NCT03541174|474056236|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131664535|NCT03541174|474056237|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131664536|NCT03541174|474056238|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
131664537|NCT03541174|474056233|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131664538|NCT03541174|474056234|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131664539|NCT03541174|474056235|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131664540|NCT03541174|474056236|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131664541|NCT03541174|474056237|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
131664542|NCT03541174|474056238|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
131664543|NCT03541174|474056233|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131664544|NCT03541174|474056234|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131664545|NCT03541174|474056235|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131664546|NCT03541174|474056236|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131664547|NCT03541174|474056237|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
131664548|NCT03541174|474056238|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131893674|NCT02207400|474896872|FG001|Overall Study|Withdrawal by Subject|4|||
131893675|NCT02207400|474896871|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
131893676|NCT02207400|474896872|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
131893677|NCT02849704|474896875|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
131893678|NCT02849704|474896876|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
131893679|NCT02849704|474896875|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
131893680|NCT02849704|474896876|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
131893681|NCT02849704|474896875|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
131893682|NCT02849704|474896876|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
131893683|NCT02757352|474896877|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
131893684|NCT02757352|474896878|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893685|NCT02757352|474896879|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
131893686|NCT02757352|474896880|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893687|NCT02757352|474896881|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893688|NCT02757352|474896882|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893689|NCT02757352|474896883|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893690|NCT02757352|474896884|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893691|NCT02757352|474896885|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893692|NCT02757352|474896886|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
131893693|NCT02757352|474896877|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131893694|NCT02757352|474896878|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131893695|NCT02757352|474896879|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
131893696|NCT02757352|474896880|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131664549|NCT02217332|474056241|FG000|Overall Study|Adverse Event|3|||
131664550|NCT02217332|474056241|FG000|Overall Study|Dose interruption >1 month|1|||
131664551|NCT02217332|474056241|FG000|Overall Study|Protocol Violation (eligibility)|1|||
131664552|NCT02217332|474056241|FG000|Overall Study|Withdrawal by Subject|1|||
131664553|NCT02217332|474056241|FG000|Overall Study|Lost to Follow-up|1|||
131893697|NCT02757352|474896881|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131664554|NCT02407990|474056242|FG000|Overall Study|Death|2|||
131664555|NCT02407990|474056243|FG001|Overall Study|Death|22|||
131664556|NCT02407990|474056244|FG002|Overall Study|Death|23|||
131664557|NCT02407990|474056245|FG003|Overall Study|Death|7|||
131664558|NCT02407990|474056246|FG004|Overall Study|Death|17|||
131664559|NCT02407990|474056247|FG005|Overall Study|Death|16|||
131664560|NCT02407990|474056248|FG006|Overall Study|Death|10|||
131664561|NCT02407990|474056249|FG007|Overall Study|Death|248|||
131664562|NCT02407990|474056242|FG000|Overall Study|Lost to Follow-up|0|||
131664563|NCT02407990|474056243|FG001|Overall Study|Lost to Follow-up|1|||
131664564|NCT02407990|474056244|FG002|Overall Study|Lost to Follow-up|0|||
131664565|NCT02407990|474056245|FG003|Overall Study|Lost to Follow-up|0|||
131664566|NCT02407990|474056246|FG004|Overall Study|Lost to Follow-up|0|||
131664567|NCT02407990|474056247|FG005|Overall Study|Lost to Follow-up|0|||
131664568|NCT02407990|474056248|FG006|Overall Study|Lost to Follow-up|0|||
131664569|NCT02407990|474056249|FG007|Overall Study|Lost to Follow-up|17|||
131664570|NCT02407990|474056242|FG000|Overall Study|Progressive Disease|0|||
131664571|NCT02407990|474056243|FG001|Overall Study|Progressive Disease|0|||
131664572|NCT02407990|474056244|FG002|Overall Study|Progressive Disease|0|||
131664573|NCT02407990|474056245|FG003|Overall Study|Progressive Disease|0|||
131664574|NCT02407990|474056246|FG004|Overall Study|Progressive Disease|0|||
131664575|NCT02407990|474056247|FG005|Overall Study|Progressive Disease|0|||
131664576|NCT02407990|474056248|FG006|Overall Study|Progressive Disease|0|||
131664577|NCT02407990|474056249|FG007|Overall Study|Progressive Disease|1|||
131664578|NCT02407990|474056242|FG000|Overall Study|Withdrawal by Subject|0|||
131664579|NCT02407990|474056243|FG001|Overall Study|Withdrawal by Subject|0|||
131664580|NCT02407990|474056244|FG002|Overall Study|Withdrawal by Subject|0|||
131664581|NCT02407990|474056245|FG003|Overall Study|Withdrawal by Subject|0|||
131664582|NCT02407990|474056246|FG004|Overall Study|Withdrawal by Subject|1|||
131664583|NCT02407990|474056247|FG005|Overall Study|Withdrawal by Subject|0|||
131664584|NCT02407990|474056248|FG006|Overall Study|Withdrawal by Subject|0|||
131664585|NCT02407990|474056249|FG007|Overall Study|Withdrawal by Subject|30|||
131664586|NCT02407990|474056242|FG000|Overall Study|Study Terminated by Sponsor|1|||
131664587|NCT02407990|474056243|FG001|Overall Study|Study Terminated by Sponsor|3|||
131664588|NCT02407990|474056244|FG002|Overall Study|Study Terminated by Sponsor|3|||
131664589|NCT02407990|474056245|FG003|Overall Study|Study Terminated by Sponsor|0|||
131664590|NCT02407990|474056246|FG004|Overall Study|Study Terminated by Sponsor|3|||
131664591|NCT02407990|474056247|FG005|Overall Study|Study Terminated by Sponsor|4|||
131664592|NCT02407990|474056248|FG006|Overall Study|Study Terminated by Sponsor|3|||
131664593|NCT02407990|474056249|FG007|Overall Study|Study Terminated by Sponsor|37|||
131664594|NCT02407990|474056242|FG000|Overall Study|Logistics|0|||
131664595|NCT02407990|474056243|FG001|Overall Study|Logistics|0|||
131664596|NCT02407990|474056244|FG002|Overall Study|Logistics|0|||
131664597|NCT02407990|474056245|FG003|Overall Study|Logistics|0|||
131664598|NCT02407990|474056246|FG004|Overall Study|Logistics|0|||
131664599|NCT02407990|474056247|FG005|Overall Study|Logistics|0|||
131664600|NCT02407990|474056248|FG006|Overall Study|Logistics|0|||
131664601|NCT02407990|474056249|FG007|Overall Study|Logistics|1|||
131664602|NCT02407990|474056242|FG000|Overall Study|Rolled into long-term extension study|0|||
131664603|NCT02407990|474056243|FG001|Overall Study|Rolled into long-term extension study|0|||
131664604|NCT02407990|474056244|FG002|Overall Study|Rolled into long-term extension study|0|||
131664605|NCT02407990|474056245|FG003|Overall Study|Rolled into long-term extension study|0|||
131664606|NCT02407990|474056246|FG004|Overall Study|Rolled into long-term extension study|0|||
131664607|NCT02407990|474056247|FG005|Overall Study|Rolled into long-term extension study|0|||
131664608|NCT02407990|474056248|FG006|Overall Study|Rolled into long-term extension study|0|||
131664609|NCT02407990|474056249|FG007|Overall Study|Rolled into long-term extension study|1|||
131664610|NCT02929329|474056250|FG000|Overall Study|Withdrawal by Subject|24|||
131664611|NCT02929329|474056251|FG001|Overall Study|Withdrawal by Subject|21|||
131664612|NCT02929329|474056250|FG000|Overall Study|Lost to Follow-up|26|||
131664613|NCT02929329|474056251|FG001|Overall Study|Lost to Follow-up|20|||
131664614|NCT02929329|474056250|FG000|Overall Study|Death|1054|||
131664615|NCT02929329|474056251|FG001|Overall Study|Death|1051|||
131664616|NCT01183234|474056252|FG000|First Intervention|Adverse Event|1|||
131664617|NCT01183234|474056253|FG001|First Intervention|Adverse Event|0|||
131664618|NCT02937454|474056258|FG000|Overall Study|Adverse Event|0|||
131664619|NCT02937454|474056259|FG001|Overall Study|Adverse Event|1|||
131664620|NCT02937454|474056258|FG000|Overall Study|Death|98|||
131664621|NCT02937454|474056259|FG001|Overall Study|Death|95|||
131664622|NCT02937454|474056258|FG000|Overall Study|Lost to Follow-up|1|||
131664623|NCT02937454|474056259|FG001|Overall Study|Lost to Follow-up|1|||
131664624|NCT02937454|474056258|FG000|Overall Study|Physician Decision|0|||
131664625|NCT02937454|474056259|FG001|Overall Study|Physician Decision|1|||
131664626|NCT02937454|474056258|FG000|Overall Study|Protocol Violation|6|||
131664627|NCT02937454|474056259|FG001|Overall Study|Protocol Violation|10|||
131664628|NCT02937454|474056258|FG000|Overall Study|Withdrawal by Subject|27|||
131664629|NCT02937454|474056259|FG001|Overall Study|Withdrawal by Subject|15|||
131664630|NCT02937454|474056258|FG000|Overall Study|Other|8|||
131664631|NCT02937454|474056259|FG001|Overall Study|Other|5|||
131664632|NCT00037830|474056262|FG000|Overall Study|Adverse Event|2|||
131664633|NCT00037830|474056263|FG001|Overall Study|Adverse Event|0|||
131664634|NCT00037830|474056264|FG002|Overall Study|Adverse Event|0|||
131664635|NCT00037830|474056262|FG000|Overall Study|Withdrawal by Subject|4|||
131664636|NCT00037830|474056263|FG001|Overall Study|Withdrawal by Subject|5|||
131664637|NCT00037830|474056264|FG002|Overall Study|Withdrawal by Subject|1|||
131664638|NCT00037830|474056262|FG000|Overall Study|Protocol Violation|2|||
131664639|NCT00037830|474056263|FG001|Overall Study|Protocol Violation|2|||
131664640|NCT00037830|474056264|FG002|Overall Study|Protocol Violation|0|||
131664641|NCT00037830|474056262|FG000|Overall Study|Unrelated Medical Problem|2|||
131664642|NCT00037830|474056263|FG001|Overall Study|Unrelated Medical Problem|0|||
131664643|NCT00037830|474056264|FG002|Overall Study|Unrelated Medical Problem|0|||
131664644|NCT03292432|474056265|FG000|Overall Study|Lost to Follow-up|11|||
131664645|NCT03292432|474056266|FG001|Overall Study|Lost to Follow-up|8|||
131664646|NCT03292432|474056265|FG000|Overall Study|Death|2|||
131664647|NCT03292432|474056266|FG001|Overall Study|Death|1|||
131664648|NCT03292432|474056265|FG000|Overall Study|Withdrawal by Subject|1|||
131664649|NCT03292432|474056266|FG001|Overall Study|Withdrawal by Subject|2|||
131664650|NCT03292432|474056265|FG000|Overall Study|Site closed before any data collected|1|||
131664651|NCT03292432|474056266|FG001|Overall Study|Site closed before any data collected|0|||
131664652|NCT01014143|474056268|FG000|Second Intervention|Lost to Follow-up|2|||
131664653|NCT01014143|474056269|FG001|Second Intervention|Lost to Follow-up|0|||
131664654|NCT01014143|474056270|FG002|Second Intervention|Lost to Follow-up|0|||
131664655|NCT02038543|474056271|FG000|Overall Study|Screen Failure|0|||
131664656|NCT02038543|474056272|FG001|Overall Study|Screen Failure|0|||
131664657|NCT02038543|474056273|FG002|Overall Study|Screen Failure|0|||
131664658|NCT02038543|474056274|FG003|Overall Study|Screen Failure|1|||
131664659|NCT02038543|474056271|FG000|Overall Study|Withdrawal by Subject|0|||
131664660|NCT02038543|474056272|FG001|Overall Study|Withdrawal by Subject|0|||
131664661|NCT02038543|474056273|FG002|Overall Study|Withdrawal by Subject|0|||
131664662|NCT02038543|474056274|FG003|Overall Study|Withdrawal by Subject|1|||
131664663|NCT00158860|474056275|FG000|Overall Study|Adverse Event|3|||
131664664|NCT00158860|474056276|FG001|Overall Study|Adverse Event|6|||
131664665|NCT00158860|474056275|FG000|Overall Study|Lost to Follow-up|11|||
131664666|NCT00158860|474056276|FG001|Overall Study|Lost to Follow-up|17|||
131664667|NCT00158860|474056275|FG000|Overall Study|Protocol Violation|8|||
131664668|NCT00158860|474056276|FG001|Overall Study|Protocol Violation|23|||
131664669|NCT00158860|474056275|FG000|Overall Study|Withdrawal by Subject|7|||
131664670|NCT00158860|474056276|FG001|Overall Study|Withdrawal by Subject|17|||
131664671|NCT00158860|474056275|FG000|Overall Study|MOVING OUT OF STATE|1|||
131664672|NCT00158860|474056276|FG001|Overall Study|MOVING OUT OF STATE|0|||
131664673|NCT00158860|474056275|FG000|Overall Study|Pregnancy|3|||
131664674|NCT00158860|474056276|FG001|Overall Study|Pregnancy|3|||
131664675|NCT00158860|474056275|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
131664676|NCT00158860|474056276|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
131664677|NCT00158860|474056275|FG000|Overall Study|SPONSOR REQUEST|0|||
131664678|NCT00158860|474056276|FG001|Overall Study|SPONSOR REQUEST|1|||
131664679|NCT00158860|474056275|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
131664680|NCT00158860|474056276|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
131664681|NCT00158860|474056275|FG000|Overall Study|Closed per sponsor|0|||
131664682|NCT00158860|474056276|FG001|Overall Study|Closed per sponsor|1|||
131664683|NCT01029652|474056277|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
131664684|NCT01029652|474056278|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
131664685|NCT01029652|474056277|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
131664686|NCT01029652|474056278|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
131664687|NCT01029652|474056277|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
131664688|NCT01029652|474056278|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
131664689|NCT01029652|474056277|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
131664690|NCT01029652|474056278|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
131664691|NCT01029652|474056277|FG000|Core Study (0-12 Weeks)|Death|0|||
131664692|NCT01029652|474056278|FG001|Core Study (0-12 Weeks)|Death|1|||
131664693|NCT01029652|474056277|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
131664694|NCT01029652|474056278|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
131893698|NCT02757352|474896882|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131893699|NCT02757352|474896883|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131435928|NCT00650767|473221898|FG001|Overall Study|Death|0|||
131435929|NCT00650767|473221899|FG002|Overall Study|Death|0|||
131664695|NCT01029652|474056277|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
131664696|NCT01029652|474056278|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
131664697|NCT01029652|474056277|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
131664698|NCT01029652|474056278|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
131664699|NCT01029652|474056277|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
131664700|NCT01029652|474056278|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
131664701|NCT01029652|474056277|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
131664702|NCT01029652|474056278|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
131664703|NCT01029652|474056277|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
131664704|NCT01029652|474056278|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
131664705|NCT01029652|474056277|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
131664706|NCT01029652|474056278|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
131664707|NCT02095951|474056279|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
131664708|NCT02095951|474056280|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
131664709|NCT03618823|474056281|FG000|Overall Study|Lost to Follow-up|63|||
131664710|NCT03618823|474056282|FG001|Overall Study|Lost to Follow-up|61|||
131664711|NCT04638920|474056283|FG000|Overall Study|Withdrawal by Subject|5|||
131664712|NCT00523640|474056285|FG000|Overall Study|Death|1|||
131664713|NCT03775434|474056287|FG000|Overall Study|Adverse Event|2|||
131664714|NCT03775434|474056287|FG000|Overall Study|Withdrawal by Subject|1|||
131664715|NCT01859988|474056288|FG000|Overall Study|Withdrawal by Subject|6|||
131664716|NCT01859988|474056289|FG001|Overall Study|Withdrawal by Subject|3|||
131664717|NCT01859988|474056290|FG002|Overall Study|Withdrawal by Subject|4|||
131664718|NCT01859988|474056291|FG003|Overall Study|Withdrawal by Subject|3|||
131664719|NCT01859988|474056292|FG004|Overall Study|Withdrawal by Subject|2|||
131664720|NCT01859988|474056293|FG005|Overall Study|Withdrawal by Subject|2|||
131664721|NCT01859988|474056288|FG000|Overall Study|Lack of Efficacy|1|||
131664722|NCT01859988|474056289|FG001|Overall Study|Lack of Efficacy|1|||
131664723|NCT01859988|474056290|FG002|Overall Study|Lack of Efficacy|5|||
131664724|NCT01859988|474056291|FG003|Overall Study|Lack of Efficacy|0|||
131664725|NCT01859988|474056292|FG004|Overall Study|Lack of Efficacy|7|||
131664726|NCT01859988|474056293|FG005|Overall Study|Lack of Efficacy|9|||
131664727|NCT01859988|474056288|FG000|Overall Study|Physician Decision|1|||
131664728|NCT01859988|474056289|FG001|Overall Study|Physician Decision|3|||
131664729|NCT01859988|474056290|FG002|Overall Study|Physician Decision|1|||
131664730|NCT01859988|474056291|FG003|Overall Study|Physician Decision|3|||
131664731|NCT01859988|474056292|FG004|Overall Study|Physician Decision|4|||
131664732|NCT01859988|474056293|FG005|Overall Study|Physician Decision|1|||
131664733|NCT01859988|474056288|FG000|Overall Study|Adverse Event|2|||
131664734|NCT01859988|474056289|FG001|Overall Study|Adverse Event|1|||
131664735|NCT01859988|474056290|FG002|Overall Study|Adverse Event|3|||
131664736|NCT01859988|474056291|FG003|Overall Study|Adverse Event|1|||
131664737|NCT01859988|474056292|FG004|Overall Study|Adverse Event|2|||
131664738|NCT01859988|474056293|FG005|Overall Study|Adverse Event|2|||
131664739|NCT01859988|474056288|FG000|Overall Study|Lost to Follow-up|1|||
131664740|NCT01859988|474056289|FG001|Overall Study|Lost to Follow-up|2|||
131664741|NCT01859988|474056290|FG002|Overall Study|Lost to Follow-up|3|||
131664742|NCT01859988|474056291|FG003|Overall Study|Lost to Follow-up|0|||
131664743|NCT01859988|474056292|FG004|Overall Study|Lost to Follow-up|3|||
131664744|NCT01859988|474056293|FG005|Overall Study|Lost to Follow-up|2|||
131664745|NCT01859988|474056288|FG000|Overall Study|Protocol Violation|0|||
131664746|NCT01859988|474056289|FG001|Overall Study|Protocol Violation|0|||
131664747|NCT01859988|474056290|FG002|Overall Study|Protocol Violation|1|||
131664748|NCT01859988|474056291|FG003|Overall Study|Protocol Violation|0|||
131664749|NCT01859988|474056292|FG004|Overall Study|Protocol Violation|0|||
131664750|NCT01859988|474056293|FG005|Overall Study|Protocol Violation|0|||
131664751|NCT01859988|474056288|FG000|Overall Study|Other than specified above|0|||
131664752|NCT01859988|474056289|FG001|Overall Study|Other than specified above|2|||
131664753|NCT01859988|474056290|FG002|Overall Study|Other than specified above|11|||
131664754|NCT01859988|474056291|FG003|Overall Study|Other than specified above|3|||
131664755|NCT01859988|474056292|FG004|Overall Study|Other than specified above|5|||
131664756|NCT01859988|474056293|FG005|Overall Study|Other than specified above|3|||
131664757|NCT03500159|474056298|FG000|Overall Study|Study Terminated|2|||
131664758|NCT03500159|474056299|FG001|Overall Study|Study Terminated|1|||
131664759|NCT00468559|474056300|FG000|Open-label Treatment Phase|Adverse Event|5|||
131664760|NCT00468559|474056301|FG001|Open-label Treatment Phase|Adverse Event|0|||
131664761|NCT00468559|474056302|FG002|Open-label Treatment Phase|Adverse Event|0|||
131893700|NCT02757352|474896884|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131893701|NCT02757352|474896885|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131893702|NCT02757352|474896886|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
131893703|NCT02757352|474896877|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
131893704|NCT02757352|474896878|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
131893705|NCT02757352|474896879|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
131893706|NCT02757352|474896880|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131893707|NCT02757352|474896881|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131893708|NCT02757352|474896882|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131893709|NCT02757352|474896883|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131664762|NCT00468559|474056300|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
131664763|NCT00468559|474056301|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
131664764|NCT00468559|474056302|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
131664765|NCT00468559|474056300|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
131664766|NCT00468559|474056301|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
131664767|NCT00468559|474056302|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
131664768|NCT00468559|474056300|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
131664769|NCT00468559|474056301|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
131893710|NCT02757352|474896884|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131893711|NCT02757352|474896885|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131893712|NCT02757352|474896886|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
131893713|NCT02757352|474896877|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893714|NCT02757352|474896878|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
131893715|NCT02757352|474896879|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893716|NCT02757352|474896880|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893717|NCT02757352|474896881|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893718|NCT02757352|474896882|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893719|NCT02757352|474896883|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893720|NCT02757352|474896884|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893721|NCT02757352|474896885|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893722|NCT02757352|474896886|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
131893723|NCT02757352|474896877|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893724|NCT02757352|474896878|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
131893725|NCT02757352|474896879|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893726|NCT02757352|474896880|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893727|NCT02757352|474896881|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893728|NCT02757352|474896882|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893729|NCT02757352|474896883|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893730|NCT02757352|474896884|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893731|NCT02757352|474896885|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893732|NCT02757352|474896886|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893733|NCT02757352|474896877|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
131893734|NCT02757352|474896878|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
131893735|NCT02757352|474896879|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
131893736|NCT02757352|474896880|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893737|NCT02757352|474896881|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893738|NCT02757352|474896882|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893739|NCT02757352|474896883|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893740|NCT02757352|474896884|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893741|NCT02757352|474896885|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893742|NCT02757352|474896886|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893743|NCT02757352|474896877|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
131893744|NCT02757352|474896878|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
131893745|NCT02757352|474896879|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
131893746|NCT02757352|474896880|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893747|NCT02757352|474896881|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893748|NCT02757352|474896882|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893749|NCT02757352|474896883|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893750|NCT02757352|474896884|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893751|NCT02757352|474896885|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893752|NCT02757352|474896886|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
131893753|NCT02757352|474896877|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131553258|NCT02395133|473649866|FG002|Overall Study|Consent withdrawn with no reason given|0|||
131553259|NCT02395133|473649867|FG003|Overall Study|Consent withdrawn with no reason given|2|||
131893754|NCT02757352|474896878|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893755|NCT02757352|474896879|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893756|NCT02757352|474896880|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
131893757|NCT02757352|474896881|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893758|NCT02757352|474896882|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
131893759|NCT02757352|474896883|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893760|NCT02757352|474896884|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893761|NCT02757352|474896885|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893762|NCT02757352|474896886|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
131893763|NCT02757352|474896877|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893764|NCT02757352|474896878|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893765|NCT02757352|474896879|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131435930|NCT00650767|473221900|FG003|Overall Study|Death|0|||
131553260|NCT02395133|473649864|FG000|Overall Study|Consent withdrawn with personal reason|0|||
131893766|NCT02757352|474896880|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
131893767|NCT02757352|474896881|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
131893768|NCT02757352|474896882|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
131893769|NCT02757352|474896883|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893770|NCT02757352|474896884|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893771|NCT02757352|474896885|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893772|NCT02757352|474896886|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131893773|NCT02757352|474896877|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893774|NCT02757352|474896878|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893775|NCT02757352|474896879|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893776|NCT02757352|474896880|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893777|NCT02757352|474896881|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
131893778|NCT02757352|474896882|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893779|NCT02757352|474896883|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893780|NCT02757352|474896884|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893781|NCT02757352|474896885|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893782|NCT02757352|474896886|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
131893783|NCT02757352|474896877|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893784|NCT02757352|474896878|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893785|NCT02757352|474896879|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893786|NCT02757352|474896880|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893787|NCT02757352|474896881|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893788|NCT02757352|474896882|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
131893789|NCT02757352|474896883|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893790|NCT02757352|474896884|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893791|NCT02757352|474896885|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893792|NCT02757352|474896886|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131893793|NCT02757352|474896877|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893794|NCT02757352|474896878|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893795|NCT02757352|474896879|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893796|NCT02757352|474896880|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
131893797|NCT02757352|474896881|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
131893798|NCT02757352|474896882|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
131893799|NCT02757352|474896883|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893800|NCT02757352|474896884|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893801|NCT02757352|474896885|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893802|NCT02757352|474896886|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131893803|NCT02757352|474896877|FG000|Follow-Up Period|Adverse Event|0|||
131893804|NCT02757352|474896878|FG001|Follow-Up Period|Adverse Event|0|||
131893805|NCT02757352|474896879|FG002|Follow-Up Period|Adverse Event|0|||
131893806|NCT02757352|474896880|FG003|Follow-Up Period|Adverse Event|0|||
131893807|NCT02757352|474896881|FG004|Follow-Up Period|Adverse Event|0|||
131893808|NCT02757352|474896882|FG005|Follow-Up Period|Adverse Event|0|||
131893809|NCT02757352|474896883|FG006|Follow-Up Period|Adverse Event|1|||
131893810|NCT02757352|474896884|FG007|Follow-Up Period|Adverse Event|0|||
131893811|NCT02757352|474896885|FG008|Follow-Up Period|Adverse Event|2|||
131893812|NCT02757352|474896886|FG009|Follow-Up Period|Adverse Event|0|||
131893813|NCT02757352|474896877|FG000|Follow-Up Period|Lost to Follow-up|0|||
131893814|NCT02757352|474896878|FG001|Follow-Up Period|Lost to Follow-up|0|||
131893815|NCT02757352|474896879|FG002|Follow-Up Period|Lost to Follow-up|0|||
131893816|NCT02757352|474896880|FG003|Follow-Up Period|Lost to Follow-up|0|||
131893817|NCT02757352|474896881|FG004|Follow-Up Period|Lost to Follow-up|0|||
131893818|NCT02757352|474896882|FG005|Follow-Up Period|Lost to Follow-up|0|||
131893819|NCT02757352|474896883|FG006|Follow-Up Period|Lost to Follow-up|0|||
131893820|NCT02757352|474896884|FG007|Follow-Up Period|Lost to Follow-up|0|||
131893821|NCT02757352|474896885|FG008|Follow-Up Period|Lost to Follow-up|1|||
131893822|NCT02757352|474896886|FG009|Follow-Up Period|Lost to Follow-up|0|||
131893823|NCT02757352|474896877|FG000|Follow-Up Period|Lack of Efficacy|0|||
131893824|NCT02757352|474896878|FG001|Follow-Up Period|Lack of Efficacy|0|||
131893825|NCT02757352|474896879|FG002|Follow-Up Period|Lack of Efficacy|0|||
131893826|NCT02757352|474896880|FG003|Follow-Up Period|Lack of Efficacy|0|||
131893827|NCT02757352|474896881|FG004|Follow-Up Period|Lack of Efficacy|0|||
131893828|NCT02757352|474896882|FG005|Follow-Up Period|Lack of Efficacy|0|||
131893829|NCT02757352|474896883|FG006|Follow-Up Period|Lack of Efficacy|0|||
131893830|NCT02757352|474896884|FG007|Follow-Up Period|Lack of Efficacy|0|||
131893831|NCT02757352|474896885|FG008|Follow-Up Period|Lack of Efficacy|1|||
131893832|NCT02757352|474896886|FG009|Follow-Up Period|Lack of Efficacy|1|||
131893833|NCT02757352|474896877|FG000|Follow-Up Period|Withdrawal by Subject|0|||
131893834|NCT02757352|474896878|FG001|Follow-Up Period|Withdrawal by Subject|0|||
131893835|NCT02757352|474896879|FG002|Follow-Up Period|Withdrawal by Subject|0|||
131893836|NCT02757352|474896880|FG003|Follow-Up Period|Withdrawal by Subject|0|||
131893837|NCT02757352|474896881|FG004|Follow-Up Period|Withdrawal by Subject|0|||
131893838|NCT02757352|474896882|FG005|Follow-Up Period|Withdrawal by Subject|0|||
131664770|NCT00468559|474056302|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
131664771|NCT00468559|474056300|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
131664772|NCT00468559|474056301|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
131664773|NCT00468559|474056302|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
131664774|NCT01131182|474056303|FG000|Overall Study|Withdrawal by Subject|1|||
131664775|NCT01131182|474056304|FG001|Overall Study|Withdrawal by Subject|1|||
131893839|NCT02757352|474896883|FG006|Follow-Up Period|Withdrawal by Subject|0|||
131893840|NCT02757352|474896884|FG007|Follow-Up Period|Withdrawal by Subject|1|||
131893841|NCT02757352|474896885|FG008|Follow-Up Period|Withdrawal by Subject|6|||
131893842|NCT02757352|474896886|FG009|Follow-Up Period|Withdrawal by Subject|2|||
131893843|NCT03638466|474896887|FG000|Overall Study|Early Termination|0|||
131893844|NCT03638466|474896888|FG001|Overall Study|Early Termination|1|||
131893845|NCT01128400|474896889|FG000|Overall Study|Lost to Follow-up|1|||
131893846|NCT01128400|474896890|FG001|Overall Study|Lost to Follow-up|0|||
131893847|NCT01128400|474896891|FG002|Overall Study|Lost to Follow-up|1|||
131893848|NCT01128400|474896889|FG000|Overall Study|Screening failure|1|||
131893849|NCT01128400|474896890|FG001|Overall Study|Screening failure|0|||
131893850|NCT01128400|474896891|FG002|Overall Study|Screening failure|0|||
131893851|NCT01128400|474896889|FG000|Overall Study|were not invited to participate on taste|0|||
131893852|NCT01128400|474896890|FG001|Overall Study|were not invited to participate on taste|0|||
131893853|NCT01128400|474896891|FG002|Overall Study|were not invited to participate on taste|15|||
131893854|NCT01128400|474896889|FG000|Overall Study|Excluded due to sinus problems|0|||
131893855|NCT01128400|474896890|FG001|Overall Study|Excluded due to sinus problems|1|||
131893856|NCT01128400|474896891|FG002|Overall Study|Excluded due to sinus problems|0|||
131893857|NCT02362425|474896892|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
131893858|NCT02362425|474896893|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
131893859|NCT02362425|474896894|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
131893860|NCT02362425|474896895|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
131893861|NCT02362425|474896892|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
131893862|NCT02362425|474896893|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
131893863|NCT02362425|474896894|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
131893864|NCT02362425|474896895|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
131893865|NCT02362425|474896892|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
131893866|NCT02362425|474896893|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
131893867|NCT02362425|474896894|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
131893868|NCT02362425|474896895|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
131893869|NCT02362425|474896892|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
131893870|NCT02362425|474896893|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
131893871|NCT02362425|474896894|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
131893872|NCT02362425|474896895|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
131893873|NCT02362425|474896892|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
131893874|NCT02362425|474896893|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
131893875|NCT02362425|474896894|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
131893876|NCT02362425|474896895|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
131893877|NCT02362425|474896892|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
131893878|NCT02362425|474896893|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
131893879|NCT02362425|474896894|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
131893880|NCT02362425|474896895|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
131893881|NCT02362425|474896892|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
131893882|NCT02362425|474896893|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
131893883|NCT02362425|474896894|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
131893884|NCT02362425|474896895|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
131893885|NCT02362425|474896892|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
131893886|NCT02362425|474896893|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
131893887|NCT02362425|474896894|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
131893888|NCT02362425|474896895|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
131893889|NCT00802672|474896902|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
131893890|NCT00802672|474896903|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
131893891|NCT00802672|474896904|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
131893892|NCT00802672|474896902|FG000|Overall Study|Adverse Event|1|||
131893893|NCT00802672|474896903|FG001|Overall Study|Adverse Event|1|||
131893894|NCT00802672|474896904|FG002|Overall Study|Adverse Event|1|||
131893895|NCT00802672|474896902|FG000|Overall Study|Protocol Violation|2|||
131664776|NCT01131182|474056303|FG000|Overall Study|Lost to Follow-up|14|||
131664777|NCT01131182|474056304|FG001|Overall Study|Lost to Follow-up|15|||
131893896|NCT00802672|474896903|FG001|Overall Study|Protocol Violation|1|||
131893897|NCT00802672|474896904|FG002|Overall Study|Protocol Violation|1|||
131893898|NCT00802672|474896902|FG000|Overall Study|Lost to Follow-up|5|||
131893899|NCT00802672|474896903|FG001|Overall Study|Lost to Follow-up|5|||
131893900|NCT00802672|474896904|FG002|Overall Study|Lost to Follow-up|3|||
131893901|NCT00802672|474896902|FG000|Overall Study|Withdrawal by Subject|1|||
131893902|NCT00802672|474896903|FG001|Overall Study|Withdrawal by Subject|1|||
131893903|NCT00802672|474896904|FG002|Overall Study|Withdrawal by Subject|2|||
131893904|NCT00802672|474896902|FG000|Overall Study|other|3|||
131893905|NCT00802672|474896903|FG001|Overall Study|other|1|||
131893906|NCT00802672|474896904|FG002|Overall Study|other|2|||
131893907|NCT01616758|474896906|FG000|Overall Study|Adverse Event|1|||
131893908|NCT01616758|474896906|FG000|Overall Study|Withdrawal by Subject|2|||
131893909|NCT01616758|474896906|FG000|Overall Study|Disease progression|18|||
131893910|NCT01616758|474896906|FG000|Overall Study|Study termination by Sponsor|1|||
131893911|NCT03026283|474896907|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
131893912|NCT03026283|474896908|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
131893913|NCT03026283|474896909|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
131893914|NCT03026283|474896910|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
131893915|NCT03026283|474896911|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
131893916|NCT03026283|474896912|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
131893917|NCT03026283|474896913|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
131893918|NCT03026283|474896914|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
131893919|NCT03026283|474896907|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
131893920|NCT03026283|474896908|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
131893921|NCT03026283|474896909|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
131893922|NCT03026283|474896910|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
131893923|NCT03026283|474896911|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
131893924|NCT03026283|474896912|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
131893925|NCT03026283|474896913|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
131893926|NCT03026283|474896914|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
131893927|NCT03026283|474896907|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893928|NCT03026283|474896908|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
131893929|NCT03026283|474896909|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893930|NCT03026283|474896910|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893931|NCT03026283|474896911|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893932|NCT03026283|474896912|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893933|NCT03026283|474896913|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893934|NCT03026283|474896914|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
131893935|NCT03026283|474896907|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131893936|NCT03026283|474896908|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131893937|NCT03026283|474896909|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
131893938|NCT03026283|474896910|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131664778|NCT01131182|474056303|FG000|Overall Study|Other Reason|1|||
131664779|NCT01131182|474056304|FG001|Overall Study|Other Reason|0|||
131664780|NCT04602221|474056305|FG000|Overall Study|Discontinuation of trial treatment|0|||
131893939|NCT03026283|474896911|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131893940|NCT03026283|474896912|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131664781|NCT04602221|474056306|FG001|Overall Study|Discontinuation of trial treatment|0|||
131664782|NCT04602221|474056307|FG002|Overall Study|Discontinuation of trial treatment|1|||
131893941|NCT03026283|474896913|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131893942|NCT03026283|474896914|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
131893943|NCT03026283|474896907|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
131893944|NCT03026283|474896908|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
131893945|NCT03026283|474896909|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
131893946|NCT03026283|474896910|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
131893947|NCT03026283|474896911|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
131893948|NCT03026283|474896912|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
131893949|NCT03026283|474896913|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
131893950|NCT03026283|474896914|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
131893951|NCT03026283|474896907|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
131664783|NCT04602221|474056308|FG003|Overall Study|Discontinuation of trial treatment|0|||
131664784|NCT04602221|474056309|FG004|Overall Study|Discontinuation of trial treatment|0|||
131664785|NCT04602221|474056310|FG005|Overall Study|Discontinuation of trial treatment|0|||
131664786|NCT04602221|474056311|FG006|Overall Study|Discontinuation of trial treatment|0|||
131664787|NCT04602221|474056312|FG007|Overall Study|Discontinuation of trial treatment|0|||
131664788|NCT04602221|474056313|FG008|Overall Study|Discontinuation of trial treatment|0|||
131893952|NCT03026283|474896908|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
131435931|NCT00650767|473221897|FG000|Overall Study|Withdrawal by Subject|2|||
131435932|NCT00650767|473221898|FG001|Overall Study|Withdrawal by Subject|4|||
131435933|NCT00650767|473221899|FG002|Overall Study|Withdrawal by Subject|3|||
131664789|NCT04602221|474056314|FG009|Overall Study|Discontinuation of trial treatment|0|||
131893953|NCT03026283|474896909|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
131893954|NCT03026283|474896910|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
131893955|NCT03026283|474896911|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
131893956|NCT03026283|474896912|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
131893957|NCT03026283|474896913|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
131893958|NCT03026283|474896914|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
131893959|NCT03026283|474896907|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
131893960|NCT03026283|474896908|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
131893961|NCT03026283|474896909|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
131893962|NCT03026283|474896910|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
131893963|NCT03026283|474896911|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
131893964|NCT03026283|474896912|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
131893965|NCT03026283|474896913|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
131893966|NCT03026283|474896914|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
131893967|NCT03026283|474896907|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893968|NCT03026283|474896908|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893969|NCT03026283|474896909|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893970|NCT03026283|474896910|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
131893971|NCT03026283|474896911|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893972|NCT03026283|474896912|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893973|NCT03026283|474896913|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893974|NCT03026283|474896914|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
131893975|NCT03026283|474896907|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
131893976|NCT03026283|474896908|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
131893977|NCT03026283|474896909|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
131893978|NCT03026283|474896910|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
131893979|NCT03026283|474896911|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
131893980|NCT03026283|474896912|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
131893981|NCT03026283|474896913|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
131553261|NCT02395133|473649865|FG001|Overall Study|Consent withdrawn with personal reason|1|||
131553262|NCT02395133|473649866|FG002|Overall Study|Consent withdrawn with personal reason|0|||
131553263|NCT02395133|473649867|FG003|Overall Study|Consent withdrawn with personal reason|3|||
131553264|NCT02395133|473649864|FG000|Overall Study|Sponsor decision|2|||
131553265|NCT02395133|473649865|FG001|Overall Study|Sponsor decision|0|||
131553266|NCT02395133|473649866|FG002|Overall Study|Sponsor decision|0|||
131553267|NCT02395133|473649867|FG003|Overall Study|Sponsor decision|1|||
131553268|NCT02395133|473649864|FG000|Overall Study|Other than specified above|5|||
131553269|NCT02395133|473649865|FG001|Overall Study|Other than specified above|2|||
131553270|NCT02395133|473649866|FG002|Overall Study|Other than specified above|2|||
131553271|NCT02395133|473649867|FG003|Overall Study|Other than specified above|4|||
131553272|NCT00962247|473649868|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
131553273|NCT00962247|473649868|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
131553274|NCT00738101|473649873|FG000|Overall Study|Physician Decision|5|||
131553275|NCT00738101|473649873|FG000|Overall Study|Death|1|||
131553276|NCT00738101|473649873|FG000|Overall Study|Repeat enrollment|1|||
131553277|NCT00709059|473649879|FG000|Overall Study|Lost to Follow-up|34|||
131553278|NCT00709059|473649879|FG000|Overall Study|Withdrawal by Subject|19|||
131553279|NCT00709059|473649879|FG000|Overall Study|Physician Decision|7|||
131553280|NCT00709059|473649879|FG000|Overall Study|Disease complication|3|||
131553281|NCT00709059|473649879|FG000|Overall Study|Side effects|20|||
131553282|NCT00709059|473649879|FG000|Overall Study|Serious side effects|11|||
131553283|NCT01786330|473649880|FG000|Overall Study|Withdrawal by Subject|0|||
131553284|NCT01786330|473649881|FG001|Overall Study|Withdrawal by Subject|1|||
131553285|NCT01786330|473649880|FG000|Overall Study|Lost to Follow-up|0|||
131553286|NCT01786330|473649881|FG001|Overall Study|Lost to Follow-up|1|||
131553287|NCT01786330|473649880|FG000|Overall Study|Excluded intraoperatively|0|||
131553288|NCT01786330|473649881|FG001|Overall Study|Excluded intraoperatively|1|||
131553289|NCT01786330|473649880|FG000|Overall Study|Protocol Violation|1|||
131553290|NCT01786330|473649881|FG001|Overall Study|Protocol Violation|0|||
131553291|NCT02969525|473649886|FG000|Double-Blind Period|Adverse Event|0|||
131553292|NCT02969525|473649887|FG001|Double-Blind Period|Adverse Event|0|||
131553293|NCT02969525|473649888|FG002|Double-Blind Period|Adverse Event|1|||
131553294|NCT02969525|473649889|FG003|Double-Blind Period|Adverse Event|1|||
131435934|NCT00650767|473221900|FG003|Overall Study|Withdrawal by Subject|3|||
131435935|NCT00650767|473221897|FG000|Overall Study|Lost to Follow-up|1|||
131553295|NCT02969525|473649890|FG004|Double-Blind Period|Adverse Event|0|||
131553296|NCT02969525|473649891|FG005|Double-Blind Period|Adverse Event|0|||
131553297|NCT02969525|473649892|FG006|Double-Blind Period|Adverse Event|0|||
131553298|NCT02969525|473649893|FG007|Double-Blind Period|Adverse Event|0|||
131553299|NCT02969525|473649894|FG008|Double-Blind Period|Adverse Event|0|||
131553300|NCT02969525|473649895|FG009|Double-Blind Period|Adverse Event|0|||
131553301|NCT02969525|473649896|FG010|Double-Blind Period|Adverse Event|0|||
131435936|NCT00650767|473221898|FG001|Overall Study|Lost to Follow-up|1|||
131893982|NCT03026283|474896914|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
131893983|NCT04076319|474896919|FG000|Overall Study|Withdrawal by Subject|2|||
131893984|NCT04076319|474896920|FG001|Overall Study|Withdrawal by Subject|0|||
131893985|NCT04076319|474896919|FG000|Overall Study|Death|1|||
131893986|NCT04076319|474896920|FG001|Overall Study|Death|0|||
131893987|NCT01054222|474896921|FG000|Overall Study|Lack of Efficacy|1|||
131893988|NCT01054222|474896921|FG000|Overall Study|Lost to Follow-up|4|||
131893989|NCT01054222|474896921|FG000|Overall Study|Withdrawal by Subject|6|||
131893990|NCT03782571|474896922|FG000|Period 1|Withdrawal by Subject|1|||
131893991|NCT03782571|474896923|FG001|Period 1|Withdrawal by Subject|0|||
131893992|NCT03782571|474896924|FG002|Period 1|Withdrawal by Subject|0|||
131893993|NCT03782571|474896925|FG003|Period 1|Withdrawal by Subject|0|||
131893994|NCT03782571|474896922|FG000|Period 3|Subject Unable to Attend V5|1|||
131893995|NCT03782571|474896923|FG001|Period 3|Subject Unable to Attend V5|0|||
131893996|NCT03782571|474896924|FG002|Period 3|Subject Unable to Attend V5|0|||
131893997|NCT03782571|474896925|FG003|Period 3|Subject Unable to Attend V5|0|||
131893998|NCT03782571|474896922|FG000|Period 3|Adverse Event|1|||
131893999|NCT03782571|474896923|FG001|Period 3|Adverse Event|0|||
131894000|NCT03782571|474896924|FG002|Period 3|Adverse Event|0|||
131894001|NCT03782571|474896925|FG003|Period 3|Adverse Event|0|||
131894002|NCT03091738|474896926|FG000|Overall Study|Adverse Event|1|||
131894003|NCT03091738|474896926|FG000|Overall Study|Lost to Follow-up|1|||
131894004|NCT02090283|474896936|FG000|Overall Study|Withdrawal by Subject|6|||
131894005|NCT02090283|474896937|FG001|Overall Study|Withdrawal by Subject|6|||
131894006|NCT02090283|474896938|FG002|Overall Study|Withdrawal by Subject|6|||
131894007|NCT02090283|474896936|FG000|Overall Study|Sponsor Terminated Study|6|||
131894008|NCT02090283|474896937|FG001|Overall Study|Sponsor Terminated Study|6|||
131894009|NCT02090283|474896938|FG002|Overall Study|Sponsor Terminated Study|1|||
131894010|NCT02090283|474896936|FG000|Overall Study|Lost to Follow-up|2|||
131894011|NCT02090283|474896937|FG001|Overall Study|Lost to Follow-up|2|||
131894012|NCT02090283|474896938|FG002|Overall Study|Lost to Follow-up|3|||
131894013|NCT02090283|474896936|FG000|Overall Study|Adverse Event|1|||
131894014|NCT02090283|474896937|FG001|Overall Study|Adverse Event|1|||
131894015|NCT02090283|474896938|FG002|Overall Study|Adverse Event|0|||
131894016|NCT02090283|474896936|FG000|Overall Study|Protocol Violation|2|||
131894017|NCT02090283|474896937|FG001|Overall Study|Protocol Violation|0|||
131894018|NCT02090283|474896938|FG002|Overall Study|Protocol Violation|0|||
131894019|NCT01411319|474896946|FG000|Overall Study|Lost to Follow-up|1|||
131894020|NCT02499263|474896947|FG000|Overall Study|Lost to Follow-up|9|||
131894021|NCT02499263|474896947|FG000|Overall Study|Participant's withdrawal of consent|4|||
131894022|NCT02499263|474896947|FG000|Overall Study|Lack of Efficacy|22|||
131894023|NCT02499263|474896947|FG000|Overall Study|investigator's judgment|12|||
131894024|NCT02499263|474896947|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
131894025|NCT02499263|474896947|FG000|Overall Study|Participant's decision|3|||
131894026|NCT02499263|474896947|FG000|Overall Study|Pregnancy|1|||
131894027|NCT02075008|474896954|FG000|Overall Study|Technical problems|1|||
131894028|NCT02075008|474896954|FG000|Overall Study|Pregnancy|1|||
131894029|NCT02075008|474896954|FG000|Overall Study|Physician Decision|1|||
131894030|NCT02075008|474896954|FG000|Overall Study|Lost to Follow-up|1|||
131894031|NCT02075008|474896954|FG000|Overall Study|Lack of Efficacy|1|||
131894032|NCT02075008|474896954|FG000|Overall Study|Death|1|||
131894033|NCT02075008|474896954|FG000|Overall Study|Adverse Event|5|||
131894034|NCT02075008|474896954|FG000|Overall Study|Withdrawal by Subject|6|||
131894035|NCT02075008|474896954|FG000|Overall Study|Study terminated by Sponsor|159|||
131894036|NCT00660595|474896955|FG000|Overall Study|Lost to Follow-up|0|||
131894037|NCT00660595|474896956|FG001|Overall Study|Lost to Follow-up|1|||
131894038|NCT00660595|474896955|FG000|Overall Study|Did not consent to participate in study|12|||
131894039|NCT00660595|474896956|FG001|Overall Study|Did not consent to participate in study|8|||
131894040|NCT00660595|474896955|FG000|Overall Study|Participant left hospital|1|||
131894041|NCT00660595|474896956|FG001|Overall Study|Participant left hospital|0|||
131894042|NCT00660595|474896955|FG000|Overall Study|Non Specified reasons|5|||
131894043|NCT00660595|474896956|FG001|Overall Study|Non Specified reasons|0|||
131894044|NCT05205005|474896971|FG000|Overall Study|Withdrawal by Subject|1|||
131894045|NCT05205005|474896972|FG001|Overall Study|Withdrawal by Subject|0|||
131894046|NCT05205005|474896971|FG000|Overall Study|Adverse Event|1|||
131894047|NCT05205005|474896972|FG001|Overall Study|Adverse Event|0|||
131894048|NCT01148459|474896975|FG000|Overall Study|Serious Adverse Event|5|||
131894049|NCT01148459|474896976|FG001|Overall Study|Serious Adverse Event|4|||
131894050|NCT01148459|474896975|FG000|Overall Study|Withdrawal by Subject|1|||
131894051|NCT01148459|474896976|FG001|Overall Study|Withdrawal by Subject|0|||
131894052|NCT01148459|474896975|FG000|Overall Study|Migrated/moved from study area|3|||
131894053|NCT01148459|474896976|FG001|Overall Study|Migrated/moved from study area|6|||
131894054|NCT01148459|474896975|FG000|Overall Study|Lost to Follow-up|2|||
131553302|NCT02969525|473649897|FG011|Double-Blind Period|Adverse Event|0|||
131894055|NCT01148459|474896976|FG001|Overall Study|Lost to Follow-up|0|||
131894056|NCT01148459|474896975|FG000|Overall Study|Refusal|1|||
131894057|NCT01148459|474896976|FG001|Overall Study|Refusal|0|||
131894058|NCT01148459|474896975|FG000|Overall Study|Failure to comply with study procedures|0|||
131894059|NCT01148459|474896976|FG001|Overall Study|Failure to comply with study procedures|1|||
131894060|NCT00694356|474896977|FG000|Overall Study|Adverse Event|1|||
131894061|NCT00694356|474896978|FG001|Overall Study|Adverse Event|0|||
131894062|NCT00694356|474896979|FG002|Overall Study|Adverse Event|0|||
131894063|NCT00694356|474896977|FG000|Overall Study|Progressive Disease|2|||
131894064|NCT00694356|474896978|FG001|Overall Study|Progressive Disease|6|||
131894065|NCT00694356|474896979|FG002|Overall Study|Progressive Disease|6|||
131894066|NCT01308463|474896986|FG000|Overall Study|Study Discontinued|23|||
131894067|NCT01308463|474896986|FG000|Overall Study|Death|4|||
131894068|NCT01308463|474896986|FG000|Overall Study|Revision|2|||
131894069|NCT02757625|474896987|FG000|Overall Study|Investigator's discretion|0|||
131894070|NCT02757625|474896988|FG001|Overall Study|Investigator's discretion|0|||
131894071|NCT02757625|474896989|FG002|Overall Study|Investigator's discretion|1|||
131894072|NCT02757625|474896990|FG003|Overall Study|Investigator's discretion|0|||
131894073|NCT02757625|474896987|FG000|Overall Study|Adverse Event|0|||
131894074|NCT02757625|474896988|FG001|Overall Study|Adverse Event|0|||
131894075|NCT02757625|474896989|FG002|Overall Study|Adverse Event|1|||
131894076|NCT02757625|474896990|FG003|Overall Study|Adverse Event|0|||
131894077|NCT04854057|474896991|FG000|Overall Study|Adverse Event|0|||
131894078|NCT04854057|474896992|FG001|Overall Study|Adverse Event|1|||
131894079|NCT03519919|474896993|FG000|Overall Study|Withdrawal by Subject|1|||
131894080|NCT03519919|474896993|FG000|Overall Study|Lack of Efficacy|1|||
131894081|NCT03519919|474896993|FG000|Overall Study|Screen Failure|1|||
131894082|NCT00645671|474896994|FG000|Overall Study|Protocol Violation|1|||
131894083|NCT00645671|474896995|FG001|Overall Study|Protocol Violation|0|||
131894084|NCT00645671|474896994|FG000|Overall Study|Withdrawal by Subject|0|||
131894085|NCT00645671|474896995|FG001|Overall Study|Withdrawal by Subject|4|||
131894086|NCT00645671|474896994|FG000|Overall Study|Adverse Event|0|||
131894087|NCT00645671|474896995|FG001|Overall Study|Adverse Event|1|||
131894088|NCT00645671|474896994|FG000|Overall Study|Physician Decision|0|||
131894089|NCT00645671|474896995|FG001|Overall Study|Physician Decision|1|||
131894090|NCT05114564|474896996|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
131894091|NCT05114564|474896997|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
131894092|NCT05114564|474896996|FG000|First Intervention|Adverse Event|0|||
131894093|NCT05114564|474896997|FG001|First Intervention|Adverse Event|1|||
131894094|NCT00493311|474896998|FG000|Overall Study|Need for rescue medication|2|||
131894095|NCT00493311|474896999|FG001|Overall Study|Need for rescue medication|2|||
131894096|NCT02779075|474897000|FG000|Overall Study|Withdrawal by Subject|1|||
131894097|NCT02779075|474897001|FG001|Overall Study|Withdrawal by Subject|3|||
131894098|NCT02779075|474897000|FG000|Overall Study|IV lost during 2nd study|1|||
131894099|NCT02779075|474897001|FG001|Overall Study|IV lost during 2nd study|0|||
131894100|NCT04217317|474897005|FG000|Overall Study|Lack of Efficacy|4|||
131894101|NCT04217317|474897005|FG000|Overall Study|Physician Decision|1|||
131894102|NCT04313400|474897008|FG000|Overall Study|Withdrawal by Subject|0|||
131894103|NCT04313400|474897009|FG001|Overall Study|Withdrawal by Subject|0|||
131894104|NCT04313400|474897010|FG002|Overall Study|Withdrawal by Subject|0|||
131894105|NCT04313400|474897011|FG003|Overall Study|Withdrawal by Subject|0|||
131894106|NCT04313400|474897012|FG004|Overall Study|Withdrawal by Subject|0|||
131894107|NCT04313400|474897013|FG005|Overall Study|Withdrawal by Subject|4|||
131894108|NCT04313400|474897014|FG006|Overall Study|Withdrawal by Subject|1|||
131894109|NCT04313400|474897008|FG000|Overall Study|Adverse Event|0|||
131894110|NCT04313400|474897009|FG001|Overall Study|Adverse Event|0|||
131894111|NCT04313400|474897010|FG002|Overall Study|Adverse Event|0|||
131894112|NCT04313400|474897011|FG003|Overall Study|Adverse Event|0|||
131894113|NCT04313400|474897012|FG004|Overall Study|Adverse Event|0|||
131894114|NCT04313400|474897013|FG005|Overall Study|Adverse Event|1|||
131894115|NCT04313400|474897014|FG006|Overall Study|Adverse Event|0|||
131894116|NCT04313400|474897008|FG000|Overall Study|Lost to Follow-up|0|||
131894117|NCT04313400|474897009|FG001|Overall Study|Lost to Follow-up|0|||
131894118|NCT04313400|474897010|FG002|Overall Study|Lost to Follow-up|0|||
131894119|NCT04313400|474897011|FG003|Overall Study|Lost to Follow-up|0|||
131894120|NCT04313400|474897012|FG004|Overall Study|Lost to Follow-up|0|||
131894121|NCT04313400|474897013|FG005|Overall Study|Lost to Follow-up|1|||
131894122|NCT04313400|474897014|FG006|Overall Study|Lost to Follow-up|0|||
131894123|NCT03224624|474897019|FG000|Overall Study|Lost to Follow-up|9|||
131894124|NCT03224624|474897020|FG001|Overall Study|Lost to Follow-up|4|||
131894125|NCT03224624|474897019|FG000|Overall Study|Death|1|||
131894126|NCT03224624|474897020|FG001|Overall Study|Death|0|||
131894127|NCT01884545|474897021|FG000|Overall Study|Lost to Follow-up|6|||
131894128|NCT01884545|474897022|FG001|Overall Study|Lost to Follow-up|4|||
131894129|NCT01884545|474897023|FG002|Overall Study|Lost to Follow-up|9|||
131894130|NCT01884545|474897024|FG003|Overall Study|Lost to Follow-up|4|||
131894131|NCT01884545|474897021|FG000|Overall Study|Patient withdrawn|7|||
131894132|NCT01884545|474897022|FG001|Overall Study|Patient withdrawn|12|||
131894133|NCT01884545|474897023|FG002|Overall Study|Patient withdrawn|5|||
131894134|NCT01884545|474897024|FG003|Overall Study|Patient withdrawn|5|||
131894135|NCT01884545|474897021|FG000|Overall Study|Non-adherence|0|||
131894136|NCT01884545|474897022|FG001|Overall Study|Non-adherence|2|||
131894137|NCT01884545|474897023|FG002|Overall Study|Non-adherence|0|||
131664790|NCT04602221|474056315|FG010|Overall Study|Discontinuation of trial treatment|0|||
131894138|NCT01884545|474897024|FG003|Overall Study|Non-adherence|0|||
131894139|NCT02782377|474897025|FG000|Overall Study|Physician Decision|5|||
131894140|NCT02521792|474897026|FG000|Overall Study|Study Terminated|6|||
131894141|NCT01188668|474897027|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
131894142|NCT01188668|474897027|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
131894143|NCT01188668|474897027|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
131894144|NCT00303472|474897028|FG000|Treatment Period|Adverse Event|0|||
131894145|NCT00303472|474897029|FG001|Treatment Period|Adverse Event|0|||
131894146|NCT00303472|474897030|FG002|Treatment Period|Adverse Event|0|||
131894147|NCT00303472|474897031|FG003|Treatment Period|Adverse Event|0|||
131894148|NCT00303472|474897032|FG004|Treatment Period|Adverse Event|1|||
131894149|NCT00303472|474897033|FG005|Treatment Period|Adverse Event|0|||
131894150|NCT00303472|474897034|FG006|Treatment Period|Adverse Event|0|||
131894151|NCT00303472|474897028|FG000|Treatment Period|Death|0|||
131894152|NCT00303472|474897029|FG001|Treatment Period|Death|0|||
131894153|NCT00303472|474897030|FG002|Treatment Period|Death|0|||
131894154|NCT00303472|474897031|FG003|Treatment Period|Death|1|||
131894155|NCT00303472|474897032|FG004|Treatment Period|Death|0|||
131894156|NCT00303472|474897033|FG005|Treatment Period|Death|0|||
131894157|NCT00303472|474897034|FG006|Treatment Period|Death|1|||
131894158|NCT00303472|474897028|FG000|Treatment Period|Withdrawal by Subject|0|||
131894159|NCT00303472|474897029|FG001|Treatment Period|Withdrawal by Subject|0|||
131894160|NCT00303472|474897030|FG002|Treatment Period|Withdrawal by Subject|0|||
131894161|NCT00303472|474897031|FG003|Treatment Period|Withdrawal by Subject|1|||
131894162|NCT00303472|474897032|FG004|Treatment Period|Withdrawal by Subject|0|||
131894163|NCT00303472|474897033|FG005|Treatment Period|Withdrawal by Subject|1|||
131894164|NCT00303472|474897034|FG006|Treatment Period|Withdrawal by Subject|0|||
131894165|NCT00303472|474897028|FG000|Treatment Period|Other|0|||
131894166|NCT00303472|474897029|FG001|Treatment Period|Other|0|||
131894167|NCT00303472|474897030|FG002|Treatment Period|Other|0|||
131894168|NCT00303472|474897031|FG003|Treatment Period|Other|0|||
131894169|NCT00303472|474897032|FG004|Treatment Period|Other|1|||
131894170|NCT00303472|474897033|FG005|Treatment Period|Other|0|||
131894171|NCT00303472|474897034|FG006|Treatment Period|Other|1|||
131894172|NCT00303472|474897028|FG000|Treatment Period|Disease Progression (to AML)|0|||
131894173|NCT00303472|474897029|FG001|Treatment Period|Disease Progression (to AML)|0|||
131894174|NCT00303472|474897030|FG002|Treatment Period|Disease Progression (to AML)|0|||
131894175|NCT00303472|474897031|FG003|Treatment Period|Disease Progression (to AML)|0|||
131894176|NCT00303472|474897032|FG004|Treatment Period|Disease Progression (to AML)|1|||
131894177|NCT00303472|474897033|FG005|Treatment Period|Disease Progression (to AML)|0|||
131894178|NCT00303472|474897034|FG006|Treatment Period|Disease Progression (to AML)|0|||
131894179|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Adverse Event|1|||
131894180|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Adverse Event|0|||
131894181|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Adverse Event|1|||
131894182|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Adverse Event|0|||
131894183|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Adverse Event|0|||
131894184|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Adverse Event|0|||
131894185|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Adverse Event|0|||
131894186|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Death|2|||
131894187|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Death|0|||
131894188|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Death|1|||
131894189|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Death|0|||
131894190|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Death|0|||
131894191|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Death|0|||
131894192|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Death|0|||
131894193|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
131894194|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
131894195|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
131664791|NCT04602221|474056316|FG011|Overall Study|Discontinuation of trial treatment|0|||
131664792|NCT04602221|474056317|FG012|Overall Study|Discontinuation of trial treatment|0|||
131664793|NCT04602221|474056318|FG013|Overall Study|Discontinuation of trial treatment|0|||
131894196|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
131664794|NCT04602221|474056319|FG014|Overall Study|Discontinuation of trial treatment|0|||
131894197|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
131894198|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
131894199|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
131894200|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Physician Decision|0|||
131894201|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Physician Decision|4|||
131894202|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Physician Decision|2|||
131894203|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Physician Decision|3|||
131664795|NCT04602221|474056320|FG015|Overall Study|Discontinuation of trial treatment|0|||
131894204|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Physician Decision|2|||
131894205|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Physician Decision|0|||
131894206|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Physician Decision|0|||
131894207|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
131894208|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
131894209|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
131894210|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
131894211|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
131894212|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
131894213|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
131894214|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Other|0|||
131894215|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Other|2|||
131894216|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Other|4|||
131894217|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Other|2|||
131894218|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Other|1|||
131894219|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Other|0|||
131894220|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Other|0|||
131894221|NCT00303472|474897028|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
131894222|NCT00303472|474897029|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
131894223|NCT00303472|474897030|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
131894224|NCT00303472|474897031|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
131894225|NCT00303472|474897032|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
131894226|NCT00303472|474897033|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
131894227|NCT00303472|474897034|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
131894228|NCT02937636|474897035|FG000|Overall Study|Other (Not specified)|3|||
131894229|NCT02937636|474897036|FG001|Overall Study|Other (Not specified)|2|||
131894230|NCT03681184|474897044|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
131894231|NCT03681184|474897045|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
131894232|NCT01098162|474897046|FG000|Overall Study|Adverse Event|37|||
131894233|NCT01098162|474897046|FG000|Overall Study|Lack of Efficacy|4|||
131894234|NCT01098162|474897046|FG000|Overall Study|Wish of Patient|7|||
131894235|NCT01098162|474897046|FG000|Overall Study|Lost to Follow-up|9|||
131894236|NCT01098162|474897046|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
131894237|NCT01098162|474897046|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
131894238|NCT01098162|474897046|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
131894239|NCT01098162|474897046|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
131894240|NCT01098162|474897046|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
131894241|NCT01098162|474897046|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
131894242|NCT01098162|474897046|FG000|Overall Study|Other Reason|1|||
131894243|NCT01098162|474897046|FG000|Overall Study|Reason Unknown|26|||
131894244|NCT00625183|474897047|FG000|Overall Study|Disease Progression|1|||
131894245|NCT04318132|474897048|FG000|Overall Study|Protocol Violation|0|||
131894246|NCT04318132|474897049|FG001|Overall Study|Protocol Violation|0|||
131894247|NCT04318132|474897050|FG002|Overall Study|Protocol Violation|3|||
131894248|NCT04318132|474897051|FG003|Overall Study|Protocol Violation|0|||
131894249|NCT02526160|474898811|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
131894250|NCT02526160|474898812|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
131894251|NCT02526160|474898811|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
131894252|NCT02526160|474898812|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
131894253|NCT02526160|474898811|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
131894254|NCT02526160|474898812|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
131894255|NCT02526160|474898811|FG000|Open-Label Treatment Extension Period I|Death|0|||
131894256|NCT02526160|474898812|FG001|Open-Label Treatment Extension Period I|Death|1|||
131894257|NCT02526160|474898811|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
131894258|NCT02526160|474898812|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
131894259|NCT02526160|474898811|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
131894260|NCT02526160|474898812|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
131894261|NCT02526160|474898811|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
131894262|NCT02526160|474898812|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
131894263|NCT02526160|474898811|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
131894264|NCT02526160|474898812|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
131894265|NCT01048944|474898815|FG000|Overall Study|Protocol Violation|8|||
131894266|NCT01048944|474898816|FG001|Overall Study|Protocol Violation|10|||
131894267|NCT01048944|474898817|FG002|Overall Study|Protocol Violation|10|||
131894268|NCT01048944|474898818|FG003|Overall Study|Protocol Violation|2|||
131894269|NCT01844817|474898819|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
131894270|NCT01844817|474898820|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
131894271|NCT01844817|474898819|FG000|Treatment|Progressive Disease|27|||
131894272|NCT01844817|474898820|FG001|Treatment|Progressive Disease|36|||
131894273|NCT01844817|474898819|FG000|Treatment|Adverse Event|17|||
131894274|NCT01844817|474898820|FG001|Treatment|Adverse Event|9|||
131894275|NCT01844817|474898819|FG000|Treatment|Withdrawal by Subject|10|||
131894276|NCT01844817|474898820|FG001|Treatment|Withdrawal by Subject|6|||
131894277|NCT01844817|474898819|FG000|Treatment|Death|10|||
131894278|NCT01844817|474898820|FG001|Treatment|Death|8|||
131894279|NCT01844817|474898819|FG000|Treatment|Lost to Follow-up|0|||
131894280|NCT01844817|474898820|FG001|Treatment|Lost to Follow-up|1|||
131894281|NCT01844817|474898819|FG000|Treatment|Other|0|||
131894282|NCT01844817|474898820|FG001|Treatment|Other|3|||
131894283|NCT01133704|474898821|FG000|Overall Study|Death|44|||
131894284|NCT01133704|474898822|FG001|Overall Study|Death|26|||
131894285|NCT01133704|474898821|FG000|Overall Study|Patient refused to continue|4|||
131894286|NCT01133704|474898822|FG001|Overall Study|Patient refused to continue|0|||
131894287|NCT01133704|474898821|FG000|Overall Study|Study Closure|1|||
131894288|NCT01133704|474898822|FG001|Overall Study|Study Closure|0|||
131894289|NCT03396822|474898825|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
131894290|NCT03396822|474898825|FG000|Overall Study|Physician Decision|1|||
131894291|NCT04985942|474898826|FG000|Overall Study|Adverse Event|14|||
131894292|NCT04985942|474898827|FG001|Overall Study|Adverse Event|2|||
131894293|NCT04985942|474898826|FG000|Overall Study|Lack of Efficacy|0|||
131894294|NCT04985942|474898827|FG001|Overall Study|Lack of Efficacy|3|||
131894295|NCT04985942|474898826|FG000|Overall Study|Lost to Follow-up|1|||
131894296|NCT04985942|474898827|FG001|Overall Study|Lost to Follow-up|1|||
131894297|NCT04985942|474898826|FG000|Overall Study|Protocol Violation|1|||
131894298|NCT04985942|474898827|FG001|Overall Study|Protocol Violation|1|||
131894299|NCT04985942|474898826|FG000|Overall Study|Withdrawal by Subject|5|||
131664796|NCT04602221|474056321|FG016|Overall Study|Discontinuation of trial treatment|0|||
131894300|NCT04985942|474898827|FG001|Overall Study|Withdrawal by Subject|4|||
131894301|NCT03630705|474898828|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
131894302|NCT03630705|474898829|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
131894303|NCT03630705|474898830|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
131894304|NCT03630705|474898831|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131894305|NCT03630705|474898828|FG000|Overall Study|Lost to Follow-up|1|||
131894306|NCT03630705|474898829|FG001|Overall Study|Lost to Follow-up|2|||
131894307|NCT03630705|474898830|FG002|Overall Study|Lost to Follow-up|0|||
131894308|NCT03630705|474898831|FG003|Overall Study|Lost to Follow-up|0|||
131894309|NCT02576977|474898835|FG000|Overall Study|Adverse Event|13|||
131894310|NCT02576977|474898836|FG001|Overall Study|Adverse Event|2|||
131894311|NCT02576977|474898835|FG000|Overall Study|Death|73|||
131894312|NCT02576977|474898836|FG001|Overall Study|Death|60|||
131894313|NCT02576977|474898835|FG000|Overall Study|Screen failure|1|||
131894314|NCT02576977|474898836|FG001|Overall Study|Screen failure|0|||
131894315|NCT02576977|474898835|FG000|Overall Study|Study Terminated at Selected Sites|27|||
131894316|NCT02576977|474898836|FG001|Overall Study|Study Terminated at Selected Sites|50|||
131894317|NCT02576977|474898835|FG000|Overall Study|Withdrawal by Subject|11|||
131894318|NCT02576977|474898836|FG001|Overall Study|Withdrawal by Subject|11|||
131894319|NCT02576977|474898835|FG000|Overall Study|Final Disposition Unknown|0|||
131894320|NCT02576977|474898836|FG001|Overall Study|Final Disposition Unknown|1|||
131894321|NCT02576977|474898835|FG000|Overall Study|Lost to Follow-up|1|||
131894322|NCT02576977|474898836|FG001|Overall Study|Lost to Follow-up|0|||
131894323|NCT02576977|474898835|FG000|Overall Study|Progressive Disease|0|||
131894324|NCT02576977|474898836|FG001|Overall Study|Progressive Disease|1|||
131894325|NCT03251482|474898837|FG000|Overall Study|Withdrawal by Subject|0|||
131894326|NCT03251482|474898838|FG001|Overall Study|Withdrawal by Subject|1|||
131894327|NCT03251482|474898839|FG002|Overall Study|Withdrawal by Subject|0|||
131894328|NCT03251482|474898840|FG003|Overall Study|Withdrawal by Subject|0|||
131894329|NCT03251482|474898841|FG004|Overall Study|Withdrawal by Subject|0|||
131894330|NCT02447328|474898844|FG000|Overall Study|Withdrawal by Subject|1|||
131894331|NCT00314808|474898850|FG000|Overall Study|Disease Progression without AE|4|||
131894332|NCT00314808|474898850|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
131894333|NCT04304508|474898851|FG000|Overall Study|Subject Decision|29|||
131894334|NCT04304508|474898852|FG001|Overall Study|Subject Decision|39|||
131894335|NCT04304508|474898853|FG002|Overall Study|Subject Decision|37|||
131894336|NCT04304508|474898854|FG003|Overall Study|Subject Decision|48|||
131894337|NCT04304508|474898851|FG000|Overall Study|Death|6|||
131894338|NCT04304508|474898852|FG001|Overall Study|Death|1|||
131894339|NCT04304508|474898853|FG002|Overall Study|Death|8|||
131894340|NCT04304508|474898854|FG003|Overall Study|Death|5|||
131894341|NCT04304508|474898851|FG000|Overall Study|Non-compliance With Study Drug|3|||
131894342|NCT04304508|474898852|FG001|Overall Study|Non-compliance With Study Drug|1|||
131894343|NCT04304508|474898853|FG002|Overall Study|Non-compliance With Study Drug|2|||
131894344|NCT04304508|474898854|FG003|Overall Study|Non-compliance With Study Drug|0|||
131894345|NCT04304508|474898851|FG000|Overall Study|Switching To Other Therapy|1|||
131894346|NCT04304508|474898852|FG001|Overall Study|Switching To Other Therapy|1|||
131894347|NCT04304508|474898853|FG002|Overall Study|Switching To Other Therapy|1|||
131894348|NCT04304508|474898854|FG003|Overall Study|Switching To Other Therapy|2|||
131894349|NCT04304508|474898851|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
131894350|NCT04304508|474898852|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
131894351|NCT04304508|474898853|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
131894352|NCT04304508|474898854|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
131894353|NCT04304508|474898851|FG000|Overall Study|Withdrawal by Subject|7|||
131894354|NCT04304508|474898852|FG001|Overall Study|Withdrawal by Subject|5|||
131894355|NCT04304508|474898853|FG002|Overall Study|Withdrawal by Subject|11|||
131894356|NCT04304508|474898854|FG003|Overall Study|Withdrawal by Subject|6|||
131894357|NCT04304508|474898851|FG000|Overall Study|Logistical Difficulties|2|||
131894358|NCT04304508|474898852|FG001|Overall Study|Logistical Difficulties|2|||
131894359|NCT04304508|474898853|FG002|Overall Study|Logistical Difficulties|3|||
131894360|NCT04304508|474898854|FG003|Overall Study|Logistical Difficulties|2|||
131894361|NCT04304508|474898851|FG000|Overall Study|Missing Information|1|||
131894362|NCT04304508|474898852|FG001|Overall Study|Missing Information|2|||
131894363|NCT04304508|474898853|FG002|Overall Study|Missing Information|1|||
131894364|NCT04304508|474898854|FG003|Overall Study|Missing Information|3|||
131894365|NCT04304508|474898851|FG000|Overall Study|Other|7|||
131894366|NCT04304508|474898852|FG001|Overall Study|Other|6|||
131894367|NCT04304508|474898853|FG002|Overall Study|Other|5|||
131894368|NCT04304508|474898854|FG003|Overall Study|Other|4|||
131894369|NCT04304508|474898851|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
131894370|NCT04304508|474898852|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
131894371|NCT04304508|474898853|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
131894372|NCT04304508|474898854|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
131894373|NCT04304508|474898851|FG000|Overall Study|Physician Decision|3|||
131894374|NCT04304508|474898852|FG001|Overall Study|Physician Decision|4|||
131894375|NCT04304508|474898853|FG002|Overall Study|Physician Decision|9|||
131894376|NCT04304508|474898854|FG003|Overall Study|Physician Decision|7|||
131894377|NCT04304508|474898851|FG000|Overall Study|Study drug never administered|10|||
131894378|NCT04304508|474898852|FG001|Overall Study|Study drug never administered|4|||
131894379|NCT04304508|474898853|FG002|Overall Study|Study drug never administered|4|||
131894380|NCT04304508|474898854|FG003|Overall Study|Study drug never administered|4|||
131894381|NCT04304508|474898851|FG000|Overall Study|Adverse Event|49|||
131894382|NCT04304508|474898852|FG001|Overall Study|Adverse Event|50|||
131894383|NCT04304508|474898853|FG002|Overall Study|Adverse Event|51|||
131894384|NCT04304508|474898854|FG003|Overall Study|Adverse Event|56|||
131894385|NCT04304508|474898851|FG000|Overall Study|Lost to Follow-up|1|||
131894386|NCT04304508|474898852|FG001|Overall Study|Lost to Follow-up|5|||
131894387|NCT04304508|474898853|FG002|Overall Study|Lost to Follow-up|2|||
131894388|NCT04304508|474898854|FG003|Overall Study|Lost to Follow-up|3|||
131894389|NCT02688764|474898855|FG000|Overall Study|Adverse Event|3|||
131894390|NCT02688764|474898856|FG001|Overall Study|Adverse Event|3|||
131894391|NCT02688764|474898855|FG000|Overall Study|AE/Kidney transplant|1|||
131894392|NCT02688764|474898856|FG001|Overall Study|AE/Kidney transplant|0|||
131894393|NCT02688764|474898855|FG000|Overall Study|AE/Lack of efficacy|1|||
131894394|NCT02688764|474898856|FG001|Overall Study|AE/Lack of efficacy|0|||
131894395|NCT02688764|474898855|FG000|Overall Study|AE/Non-compl.|1|||
131894396|NCT02688764|474898856|FG001|Overall Study|AE/Non-compl.|0|||
131894397|NCT02688764|474898855|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
131894398|NCT02688764|474898856|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
131894399|NCT02688764|474898855|FG000|Overall Study|AE/Other|0|||
131894400|NCT02688764|474898856|FG001|Overall Study|AE/Other|1|||
131894401|NCT02688764|474898855|FG000|Overall Study|AE/Physician decision|1|||
131894402|NCT02688764|474898856|FG001|Overall Study|AE/Physician decision|0|||
131894403|NCT02688764|474898855|FG000|Overall Study|AE/Withd. parent|3|||
131894404|NCT02688764|474898856|FG001|Overall Study|AE/Withd. parent|0|||
131894405|NCT02688764|474898855|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
131894406|NCT02688764|474898856|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
131894407|NCT02688764|474898855|FG000|Overall Study|AE/Withd. subject|1|||
131894408|NCT02688764|474898856|FG001|Overall Study|AE/Withd. subject|0|||
131894409|NCT02688764|474898855|FG000|Overall Study|Kidney transplant|10|||
131894410|NCT02688764|474898856|FG001|Overall Study|Kidney transplant|4|||
131894411|NCT02688764|474898855|FG000|Overall Study|Lack of Efficacy|3|||
131894412|NCT02688764|474898856|FG001|Overall Study|Lack of Efficacy|2|||
131894413|NCT02688764|474898855|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
131894414|NCT02688764|474898856|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
131894415|NCT02688764|474898855|FG000|Overall Study|Non-compliance with study drug|4|||
131894416|NCT02688764|474898856|FG001|Overall Study|Non-compliance with study drug|0|||
131894417|NCT02688764|474898855|FG000|Overall Study|Non-compl./Physician decision|2|||
131894418|NCT02688764|474898856|FG001|Overall Study|Non-compl./Physician decision|0|||
131894419|NCT02688764|474898855|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
131894420|NCT02688764|474898856|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
131894421|NCT02688764|474898855|FG000|Overall Study|Non-compl./Withd. subject|0|||
131894422|NCT02688764|474898856|FG001|Overall Study|Non-compl./Withd. subject|2|||
131894423|NCT02688764|474898855|FG000|Overall Study|Phosphorus level outside safe range|0|||
131894424|NCT02688764|474898856|FG001|Overall Study|Phosphorus level outside safe range|1|||
131894425|NCT02688764|474898855|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
131894426|NCT02688764|474898856|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
131894427|NCT02688764|474898855|FG000|Overall Study|Study drug taste/Withd. parent|1|||
131894428|NCT02688764|474898856|FG001|Overall Study|Study drug taste/Withd. parent|0|||
131894429|NCT02688764|474898855|FG000|Overall Study|Subject moving out|2|||
131664797|NCT04602221|474056322|FG017|Overall Study|Discontinuation of trial treatment|0|||
131664798|NCT04602221|474056305|FG000|Overall Study|Other than listed|0|||
131664799|NCT04602221|474056306|FG001|Overall Study|Other than listed|0|||
131664800|NCT04602221|474056307|FG002|Overall Study|Other than listed|0|||
131664801|NCT04602221|474056308|FG003|Overall Study|Other than listed|0|||
131664802|NCT04602221|474056309|FG004|Overall Study|Other than listed|0|||
131664803|NCT04602221|474056310|FG005|Overall Study|Other than listed|0|||
131664804|NCT04602221|474056311|FG006|Overall Study|Other than listed|0|||
131664805|NCT04602221|474056312|FG007|Overall Study|Other than listed|0|||
131664806|NCT04602221|474056313|FG008|Overall Study|Other than listed|0|||
131664807|NCT04602221|474056314|FG009|Overall Study|Other than listed|0|||
131664808|NCT04602221|474056315|FG010|Overall Study|Other than listed|0|||
131664809|NCT04602221|474056316|FG011|Overall Study|Other than listed|0|||
131664810|NCT04602221|474056317|FG012|Overall Study|Other than listed|0|||
131894430|NCT02688764|474898856|FG001|Overall Study|Subject moving out|0|||
131894431|NCT02688764|474898855|FG000|Overall Study|Subject taken off dialysis|1|||
131894432|NCT02688764|474898856|FG001|Overall Study|Subject taken off dialysis|0|||
131894433|NCT02688764|474898855|FG000|Overall Study|Withdrawal by parent|3|||
131894434|NCT02688764|474898856|FG001|Overall Study|Withdrawal by parent|0|||
131894435|NCT02113007|474898857|FG000|Overall Study|Progressive disease|2|||
131894436|NCT00885378|474898858|FG000|Overall Study|Lack of Efficacy|2|||
131894437|NCT00885378|474898859|FG001|Overall Study|Lack of Efficacy|2|||
131894438|NCT00885378|474898858|FG000|Overall Study|Withdrawal by Subject|1|||
131894439|NCT00885378|474898859|FG001|Overall Study|Withdrawal by Subject|2|||
131894440|NCT00885378|474898858|FG000|Overall Study|Lost to Follow-up|1|||
131894441|NCT00885378|474898859|FG001|Overall Study|Lost to Follow-up|2|||
131894442|NCT00885378|474898858|FG000|Overall Study|Poor/Noncompliance|2|||
131894443|NCT00885378|474898859|FG001|Overall Study|Poor/Noncompliance|2|||
131894444|NCT00885378|474898858|FG000|Overall Study|Protocol Violation|2|||
131894445|NCT00885378|474898859|FG001|Overall Study|Protocol Violation|0|||
131894446|NCT04750278|474898860|FG000|Overall Study|Death|9|||
131894447|NCT04750278|474898861|FG001|Overall Study|Death|10|||
131894448|NCT04750278|474898862|FG002|Overall Study|Death|10|||
131894449|NCT04750278|474898860|FG000|Overall Study|Withdrawal by Subject|4|||
131894450|NCT04750278|474898861|FG001|Overall Study|Withdrawal by Subject|1|||
131894451|NCT04750278|474898862|FG002|Overall Study|Withdrawal by Subject|2|||
131894452|NCT04750278|474898860|FG000|Overall Study|Lost to Follow-up|1|||
131894453|NCT04750278|474898861|FG001|Overall Study|Lost to Follow-up|1|||
131894454|NCT04750278|474898862|FG002|Overall Study|Lost to Follow-up|1|||
131435937|NCT00650767|473221899|FG002|Overall Study|Lost to Follow-up|1|||
131553303|NCT02969525|473649886|FG000|Double-Blind Period|LOW EGFR|0|||
131553304|NCT02969525|473649887|FG001|Double-Blind Period|LOW EGFR|0|||
131553305|NCT02969525|473649888|FG002|Double-Blind Period|LOW EGFR|0|||
131553306|NCT02969525|473649889|FG003|Double-Blind Period|LOW EGFR|1|||
131553307|NCT02969525|473649890|FG004|Double-Blind Period|LOW EGFR|0|||
131553308|NCT02969525|473649891|FG005|Double-Blind Period|LOW EGFR|0|||
131553309|NCT02969525|473649892|FG006|Double-Blind Period|LOW EGFR|0|||
131553310|NCT02969525|473649893|FG007|Double-Blind Period|LOW EGFR|0|||
131553311|NCT02969525|473649894|FG008|Double-Blind Period|LOW EGFR|0|||
131553312|NCT02969525|473649895|FG009|Double-Blind Period|LOW EGFR|0|||
131553313|NCT02969525|473649896|FG010|Double-Blind Period|LOW EGFR|0|||
131553314|NCT02969525|473649897|FG011|Double-Blind Period|LOW EGFR|0|||
131553315|NCT02969525|473649886|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
131553316|NCT02969525|473649887|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553317|NCT02969525|473649888|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553318|NCT02969525|473649889|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
131553319|NCT02969525|473649890|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553320|NCT02969525|473649891|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553321|NCT02969525|473649892|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553322|NCT02969525|473649893|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553323|NCT02969525|473649894|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553324|NCT02969525|473649895|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553325|NCT02969525|473649896|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553326|NCT02969525|473649897|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
131553327|NCT02969525|473649886|FG000|Dose-Blind Period|Adverse Event|0|||
131553328|NCT02969525|473649887|FG001|Dose-Blind Period|Adverse Event|0|||
131553329|NCT02969525|473649888|FG002|Dose-Blind Period|Adverse Event|0|||
131553330|NCT02969525|473649889|FG003|Dose-Blind Period|Adverse Event|0|||
131553331|NCT02969525|473649890|FG004|Dose-Blind Period|Adverse Event|0|||
131553332|NCT02969525|473649891|FG005|Dose-Blind Period|Adverse Event|0|||
131553333|NCT02969525|473649892|FG006|Dose-Blind Period|Adverse Event|0|||
131553334|NCT02969525|473649893|FG007|Dose-Blind Period|Adverse Event|0|||
131553335|NCT02969525|473649894|FG008|Dose-Blind Period|Adverse Event|0|||
131553336|NCT02969525|473649895|FG009|Dose-Blind Period|Adverse Event|1|||
131894455|NCT04750278|474898860|FG000|Overall Study|Pregnancy|1|||
131894456|NCT04750278|474898861|FG001|Overall Study|Pregnancy|0|||
131894457|NCT04750278|474898862|FG002|Overall Study|Pregnancy|0|||
131894458|NCT04750278|474898860|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
131894459|NCT04750278|474898861|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
131894460|NCT04750278|474898862|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
131894461|NCT04750278|474898860|FG000|Overall Study|Non-compliance|0|||
131894462|NCT04750278|474898861|FG001|Overall Study|Non-compliance|0|||
131894463|NCT04750278|474898862|FG002|Overall Study|Non-compliance|1|||
131894464|NCT04750278|474898860|FG000|Overall Study|Transfer to Outside Facility|0|||
131894465|NCT04750278|474898861|FG001|Overall Study|Transfer to Outside Facility|2|||
131894466|NCT04750278|474898862|FG002|Overall Study|Transfer to Outside Facility|1|||
131894467|NCT04750278|474898860|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
131894468|NCT04750278|474898861|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
131894469|NCT04750278|474898862|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
131894470|NCT04750278|474898860|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
131894471|NCT04750278|474898861|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
131894472|NCT04750278|474898862|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
131894473|NCT02579382|474898865|FG000|Main Study Phase|Lost to Follow-up|0|||
131894474|NCT02579382|474898866|FG001|Main Study Phase|Lost to Follow-up|0|||
131894475|NCT02579382|474898867|FG002|Main Study Phase|Lost to Follow-up|2|||
131894476|NCT02579382|474898868|FG003|Main Study Phase|Lost to Follow-up|0|||
131894477|NCT02579382|474898865|FG000|Main Study Phase|Withdrew Consent|0|||
131894478|NCT02579382|474898866|FG001|Main Study Phase|Withdrew Consent|0|||
131894479|NCT02579382|474898867|FG002|Main Study Phase|Withdrew Consent|0|||
131894480|NCT02579382|474898868|FG003|Main Study Phase|Withdrew Consent|2|||
131894481|NCT02579382|474898865|FG000|Main Study Phase|Lack of Efficacy|0|||
131894482|NCT02579382|474898866|FG001|Main Study Phase|Lack of Efficacy|0|||
131894483|NCT02579382|474898867|FG002|Main Study Phase|Lack of Efficacy|0|||
131894484|NCT02579382|474898868|FG003|Main Study Phase|Lack of Efficacy|1|||
131894485|NCT02579382|474898865|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
131894486|NCT02579382|474898866|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
131894487|NCT02579382|474898867|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
131894488|NCT02579382|474898868|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
131894489|NCT02579382|474898865|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
131894490|NCT02579382|474898866|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
131894491|NCT02579382|474898867|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
131894492|NCT02579382|474898868|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
131553337|NCT02969525|473649896|FG010|Dose-Blind Period|Adverse Event|1|||
131553338|NCT02969525|473649897|FG011|Dose-Blind Period|Adverse Event|1|||
131553339|NCT02969525|473649886|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
131553340|NCT02969525|473649887|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
131553341|NCT02969525|473649888|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
131553342|NCT02969525|473649889|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
131553343|NCT02969525|473649890|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
131553344|NCT02969525|473649891|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
131553345|NCT02969525|473649892|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
131553346|NCT02969525|473649893|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
131553347|NCT02969525|473649894|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
131553348|NCT02969525|473649895|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
131553349|NCT02969525|473649896|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
131553350|NCT02969525|473649897|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
131553351|NCT02969525|473649886|FG000|Dose-Blind Period|Non-cooperating patient|0|||
131553352|NCT02969525|473649887|FG001|Dose-Blind Period|Non-cooperating patient|0|||
131553353|NCT02969525|473649888|FG002|Dose-Blind Period|Non-cooperating patient|0|||
131553354|NCT02969525|473649889|FG003|Dose-Blind Period|Non-cooperating patient|0|||
131553355|NCT02969525|473649890|FG004|Dose-Blind Period|Non-cooperating patient|0|||
131553356|NCT02969525|473649891|FG005|Dose-Blind Period|Non-cooperating patient|0|||
131553357|NCT02969525|473649892|FG006|Dose-Blind Period|Non-cooperating patient|0|||
131553358|NCT02969525|473649893|FG007|Dose-Blind Period|Non-cooperating patient|0|||
131553359|NCT02969525|473649894|FG008|Dose-Blind Period|Non-cooperating patient|0|||
131553360|NCT02969525|473649895|FG009|Dose-Blind Period|Non-cooperating patient|0|||
131553361|NCT02969525|473649896|FG010|Dose-Blind Period|Non-cooperating patient|0|||
131553362|NCT02969525|473649897|FG011|Dose-Blind Period|Non-cooperating patient|1|||
131553363|NCT02969525|473649886|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553364|NCT02969525|473649887|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553365|NCT02969525|473649888|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553366|NCT02969525|473649889|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553367|NCT02969525|473649890|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553368|NCT02969525|473649891|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131664811|NCT04602221|474056318|FG013|Overall Study|Other than listed|0|||
131894493|NCT02579382|474898865|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
131894494|NCT02579382|474898866|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
131894495|NCT02579382|474898867|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
131894496|NCT02579382|474898868|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
131894497|NCT02579382|474898865|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
131894498|NCT02579382|474898866|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
131894499|NCT02579382|474898867|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
131894500|NCT02579382|474898868|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
131894501|NCT02579382|474898865|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
131894502|NCT02579382|474898866|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
131894503|NCT02579382|474898867|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
131894504|NCT02579382|474898868|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
131894505|NCT02579382|474898865|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
131894506|NCT02579382|474898866|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
131894507|NCT02579382|474898867|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
131894508|NCT02579382|474898868|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
131894509|NCT01775787|474898869|FG000|First 7-10 Days|Adverse Event|0|||
131894510|NCT01775787|474898870|FG001|First 7-10 Days|Adverse Event|1|||
131894511|NCT01775787|474898869|FG000|First 7-10 Days|family emergency|0|||
131894512|NCT01775787|474898870|FG001|First 7-10 Days|family emergency|1|||
131894513|NCT01775787|474898869|FG000|First 7-10 Days|time commitment|0|||
131894514|NCT01775787|474898870|FG001|First 7-10 Days|time commitment|2|||
131894515|NCT01775787|474898869|FG000|First 7-10 Days|concerns with using IV|1|||
131894516|NCT01775787|474898870|FG001|First 7-10 Days|concerns with using IV|2|||
131894517|NCT01775787|474898869|FG000|Second 7-10 Days|time commitment|0|||
131894518|NCT01775787|474898870|FG001|Second 7-10 Days|time commitment|1|||
131894519|NCT01775787|474898869|FG000|Second 7-10 Days|concerns with using IV|0|||
131894520|NCT01775787|474898870|FG001|Second 7-10 Days|concerns with using IV|1|||
131894521|NCT00824655|474898876|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
131894522|NCT00824655|474898877|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
131894523|NCT00824655|474898876|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
131894524|NCT00824655|474898877|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
131894525|NCT03252145|474898878|FG000|Overall Study|Withdrawal by Subject|1|||
131894526|NCT03252145|474898879|FG001|Overall Study|Withdrawal by Subject|0|||
131894527|NCT03252145|474898878|FG000|Overall Study|Complicating Disease|1|||
131894528|NCT03252145|474898879|FG001|Overall Study|Complicating Disease|2|||
131894529|NCT03504189|474898880|FG000|Overall Study|Withdrawal by Subject|1|||
131894530|NCT03504189|474898880|FG000|Overall Study|Screening Failure|1|||
131894531|NCT03504189|474898880|FG000|Overall Study|Device Failure|2|||
131894532|NCT04336475|474898881|FG000|Overall Study|pain|1|||
131894533|NCT04336475|474898882|FG001|Overall Study|pain|0|||
131894534|NCT04336475|474898881|FG000|Overall Study|upper respiratory infection|1|||
131894535|NCT04336475|474898882|FG001|Overall Study|upper respiratory infection|0|||
131894536|NCT04336475|474898881|FG000|Overall Study|Lost to Follow-up|0|||
131894537|NCT04336475|474898882|FG001|Overall Study|Lost to Follow-up|2|||
131894538|NCT01826981|474898894|FG000|Overall Study|Lack of Efficacy|0|||
131894539|NCT01826981|474898895|FG001|Overall Study|Lack of Efficacy|1|||
131894540|NCT01826981|474898896|FG002|Overall Study|Lack of Efficacy|0|||
131894541|NCT01826981|474898897|FG003|Overall Study|Lack of Efficacy|0|||
131894542|NCT01826981|474898898|FG004|Overall Study|Lack of Efficacy|5|||
131894543|NCT01826981|474898899|FG005|Overall Study|Lack of Efficacy|0|||
131894544|NCT01826981|474898900|FG006|Overall Study|Lack of Efficacy|0|||
131894545|NCT01826981|474898901|FG007|Overall Study|Lack of Efficacy|8|||
131894546|NCT01826981|474898902|FG008|Overall Study|Lack of Efficacy|7|||
131894547|NCT01826981|474898903|FG009|Overall Study|Lack of Efficacy|0|||
131894548|NCT01826981|474898904|FG010|Overall Study|Lack of Efficacy|1|||
131894549|NCT01826981|474898905|FG011|Overall Study|Lack of Efficacy|0|||
131894550|NCT01826981|474898906|FG012|Overall Study|Lack of Efficacy|0|||
131894551|NCT01826981|474898907|FG013|Overall Study|Lack of Efficacy|3|||
131894552|NCT01826981|474898908|FG014|Overall Study|Lack of Efficacy|0|||
131894553|NCT01826981|474898894|FG000|Overall Study|Lost to Follow-up|0|||
131894554|NCT01826981|474898895|FG001|Overall Study|Lost to Follow-up|0|||
131894555|NCT01826981|474898896|FG002|Overall Study|Lost to Follow-up|0|||
131894556|NCT01826981|474898897|FG003|Overall Study|Lost to Follow-up|0|||
131894557|NCT01826981|474898898|FG004|Overall Study|Lost to Follow-up|1|||
131894558|NCT01826981|474898899|FG005|Overall Study|Lost to Follow-up|1|||
131664812|NCT04602221|474056319|FG014|Overall Study|Other than listed|0|||
131894559|NCT01826981|474898900|FG006|Overall Study|Lost to Follow-up|0|||
131894560|NCT01826981|474898901|FG007|Overall Study|Lost to Follow-up|1|||
131894561|NCT01826981|474898902|FG008|Overall Study|Lost to Follow-up|0|||
131894562|NCT01826981|474898903|FG009|Overall Study|Lost to Follow-up|1|||
131894563|NCT01826981|474898904|FG010|Overall Study|Lost to Follow-up|1|||
131894564|NCT01826981|474898905|FG011|Overall Study|Lost to Follow-up|1|||
131894565|NCT01826981|474898906|FG012|Overall Study|Lost to Follow-up|1|||
131894566|NCT01826981|474898907|FG013|Overall Study|Lost to Follow-up|0|||
131894567|NCT01826981|474898908|FG014|Overall Study|Lost to Follow-up|0|||
131894568|NCT01826981|474898894|FG000|Overall Study|Withdrew Consent|0|||
131894569|NCT01826981|474898895|FG001|Overall Study|Withdrew Consent|0|||
131894570|NCT01826981|474898896|FG002|Overall Study|Withdrew Consent|0|||
131894571|NCT01826981|474898897|FG003|Overall Study|Withdrew Consent|0|||
131894572|NCT01826981|474898898|FG004|Overall Study|Withdrew Consent|0|||
131894573|NCT01826981|474898899|FG005|Overall Study|Withdrew Consent|0|||
131894574|NCT01826981|474898900|FG006|Overall Study|Withdrew Consent|1|||
131894575|NCT01826981|474898901|FG007|Overall Study|Withdrew Consent|1|||
131894576|NCT01826981|474898902|FG008|Overall Study|Withdrew Consent|0|||
131894577|NCT01826981|474898903|FG009|Overall Study|Withdrew Consent|0|||
131894578|NCT01826981|474898904|FG010|Overall Study|Withdrew Consent|0|||
131894579|NCT01826981|474898905|FG011|Overall Study|Withdrew Consent|1|||
131894580|NCT01826981|474898906|FG012|Overall Study|Withdrew Consent|0|||
131894581|NCT01826981|474898907|FG013|Overall Study|Withdrew Consent|1|||
131894582|NCT01826981|474898908|FG014|Overall Study|Withdrew Consent|0|||
131894583|NCT01826981|474898894|FG000|Overall Study|Adverse Event|0|||
131894584|NCT01826981|474898895|FG001|Overall Study|Adverse Event|0|||
131894585|NCT01826981|474898896|FG002|Overall Study|Adverse Event|0|||
131664813|NCT04602221|474056320|FG015|Overall Study|Other than listed|1|||
131894586|NCT01826981|474898897|FG003|Overall Study|Adverse Event|0|||
131894587|NCT01826981|474898898|FG004|Overall Study|Adverse Event|1|||
131894588|NCT01826981|474898899|FG005|Overall Study|Adverse Event|0|||
131894589|NCT01826981|474898900|FG006|Overall Study|Adverse Event|0|||
131894590|NCT01826981|474898901|FG007|Overall Study|Adverse Event|0|||
131894591|NCT01826981|474898902|FG008|Overall Study|Adverse Event|0|||
131894592|NCT01826981|474898903|FG009|Overall Study|Adverse Event|0|||
131894593|NCT01826981|474898904|FG010|Overall Study|Adverse Event|0|||
131894594|NCT01826981|474898905|FG011|Overall Study|Adverse Event|0|||
131894595|NCT01826981|474898906|FG012|Overall Study|Adverse Event|0|||
131894596|NCT01826981|474898907|FG013|Overall Study|Adverse Event|0|||
131894597|NCT01826981|474898908|FG014|Overall Study|Adverse Event|0|||
131894598|NCT01826981|474898894|FG000|Overall Study|Upper G-I Haemorrhage|0|||
131894599|NCT01826981|474898895|FG001|Overall Study|Upper G-I Haemorrhage|0|||
131894600|NCT01826981|474898896|FG002|Overall Study|Upper G-I Haemorrhage|0|||
131894601|NCT01826981|474898897|FG003|Overall Study|Upper G-I Haemorrhage|0|||
131894602|NCT01826981|474898898|FG004|Overall Study|Upper G-I Haemorrhage|0|||
131894603|NCT01826981|474898899|FG005|Overall Study|Upper G-I Haemorrhage|0|||
131894604|NCT01826981|474898900|FG006|Overall Study|Upper G-I Haemorrhage|0|||
131894605|NCT01826981|474898901|FG007|Overall Study|Upper G-I Haemorrhage|0|||
131894606|NCT01826981|474898902|FG008|Overall Study|Upper G-I Haemorrhage|0|||
131894607|NCT01826981|474898903|FG009|Overall Study|Upper G-I Haemorrhage|0|||
131894608|NCT01826981|474898904|FG010|Overall Study|Upper G-I Haemorrhage|0|||
131894609|NCT01826981|474898905|FG011|Overall Study|Upper G-I Haemorrhage|0|||
131894610|NCT01826981|474898906|FG012|Overall Study|Upper G-I Haemorrhage|0|||
131894611|NCT01826981|474898907|FG013|Overall Study|Upper G-I Haemorrhage|1|||
131894612|NCT01826981|474898908|FG014|Overall Study|Upper G-I Haemorrhage|0|||
131894613|NCT01826981|474898894|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894614|NCT01826981|474898895|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894615|NCT01826981|474898896|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894616|NCT01826981|474898897|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
131664814|NCT04602221|474056321|FG016|Overall Study|Other than listed|0|||
131664815|NCT04602221|474056322|FG017|Overall Study|Other than listed|1|||
131664816|NCT04602221|474056305|FG000|Overall Study|Withdrawal by Subject|0|||
131664817|NCT04602221|474056306|FG001|Overall Study|Withdrawal by Subject|0|||
131664818|NCT04602221|474056307|FG002|Overall Study|Withdrawal by Subject|0|||
131664819|NCT04602221|474056308|FG003|Overall Study|Withdrawal by Subject|0|||
131664820|NCT04602221|474056309|FG004|Overall Study|Withdrawal by Subject|0|||
131664821|NCT04602221|474056310|FG005|Overall Study|Withdrawal by Subject|0|||
131664822|NCT04602221|474056311|FG006|Overall Study|Withdrawal by Subject|0|||
131664823|NCT04602221|474056312|FG007|Overall Study|Withdrawal by Subject|0|||
131664824|NCT04602221|474056313|FG008|Overall Study|Withdrawal by Subject|0|||
131664825|NCT04602221|474056314|FG009|Overall Study|Withdrawal by Subject|0|||
131664826|NCT04602221|474056315|FG010|Overall Study|Withdrawal by Subject|0|||
131894617|NCT01826981|474898898|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894618|NCT01826981|474898899|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894619|NCT01826981|474898900|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894620|NCT01826981|474898901|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
131894621|NCT01826981|474898902|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894622|NCT01826981|474898903|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894623|NCT01826981|474898904|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894624|NCT01826981|474898905|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894625|NCT01826981|474898906|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
131435938|NCT00650767|473221900|FG003|Overall Study|Lost to Follow-up|0|||
131664827|NCT04602221|474056316|FG011|Overall Study|Withdrawal by Subject|0|||
131664828|NCT04602221|474056317|FG012|Overall Study|Withdrawal by Subject|1|||
131894626|NCT01826981|474898907|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
131435939|NCT00650767|473221897|FG000|Overall Study|Other|1|||
131894627|NCT01826981|474898908|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
131894628|NCT01310127|474898909|FG000|Overall Study|Protocol Violation|1|||
131894629|NCT01310127|474898910|FG001|Overall Study|Protocol Violation|1|||
131894630|NCT01310127|474898909|FG000|Overall Study|advanced psc cataract outlier|1|||
131894631|NCT01310127|474898910|FG001|Overall Study|advanced psc cataract outlier|0|||
131894632|NCT03498313|474898911|FG000|Experimental Period 1|Adverse Event|1|||
131894633|NCT03498313|474898912|FG001|Experimental Period 1|Adverse Event|0|||
131894634|NCT03498313|474898913|FG002|Experimental Period 1|Adverse Event|0|||
131894635|NCT03498313|474898914|FG003|Experimental Period 1|Adverse Event|1|||
131894636|NCT03498313|474898915|FG004|Experimental Period 1|Adverse Event|0|||
131894637|NCT03498313|474898916|FG005|Experimental Period 1|Adverse Event|0|||
131894638|NCT03498313|474898911|FG000|Experimental Period 1|Withdrawal by Subject|0|||
131894639|NCT03498313|474898912|FG001|Experimental Period 1|Withdrawal by Subject|1|||
131894640|NCT03498313|474898913|FG002|Experimental Period 1|Withdrawal by Subject|0|||
131894641|NCT03498313|474898914|FG003|Experimental Period 1|Withdrawal by Subject|0|||
131894642|NCT03498313|474898915|FG004|Experimental Period 1|Withdrawal by Subject|0|||
131894643|NCT03498313|474898916|FG005|Experimental Period 1|Withdrawal by Subject|0|||
131894644|NCT03498313|474898911|FG000|Washout Period 1|Anovulation|1|||
131894645|NCT03498313|474898912|FG001|Washout Period 1|Anovulation|0|||
131894646|NCT03498313|474898913|FG002|Washout Period 1|Anovulation|0|||
131894647|NCT03498313|474898914|FG003|Washout Period 1|Anovulation|0|||
131894648|NCT03498313|474898915|FG004|Washout Period 1|Anovulation|0|||
131894649|NCT03498313|474898916|FG005|Washout Period 1|Anovulation|0|||
131894650|NCT03498313|474898911|FG000|Washout Period 1|Withdrawal by Subject|0|||
131894651|NCT03498313|474898912|FG001|Washout Period 1|Withdrawal by Subject|3|||
131894652|NCT03498313|474898913|FG002|Washout Period 1|Withdrawal by Subject|0|||
131894653|NCT03498313|474898914|FG003|Washout Period 1|Withdrawal by Subject|1|||
131664829|NCT04602221|474056318|FG013|Overall Study|Withdrawal by Subject|0|||
131664830|NCT04602221|474056319|FG014|Overall Study|Withdrawal by Subject|0|||
131664831|NCT04602221|474056320|FG015|Overall Study|Withdrawal by Subject|0|||
131664832|NCT04602221|474056321|FG016|Overall Study|Withdrawal by Subject|0|||
131664833|NCT04602221|474056322|FG017|Overall Study|Withdrawal by Subject|0|||
131664834|NCT04602221|474056305|FG000|Overall Study|Lost to Follow-up|0|||
131664835|NCT04602221|474056306|FG001|Overall Study|Lost to Follow-up|0|||
131664836|NCT04602221|474056307|FG002|Overall Study|Lost to Follow-up|0|||
131664837|NCT04602221|474056308|FG003|Overall Study|Lost to Follow-up|0|||
131664838|NCT04602221|474056309|FG004|Overall Study|Lost to Follow-up|0|||
131894654|NCT03498313|474898915|FG004|Washout Period 1|Withdrawal by Subject|0|||
131894655|NCT03498313|474898916|FG005|Washout Period 1|Withdrawal by Subject|1|||
131894656|NCT03498313|474898911|FG000|Experimental Period 2|Adverse Event|0|||
131894657|NCT03498313|474898912|FG001|Experimental Period 2|Adverse Event|0|||
131894658|NCT03498313|474898913|FG002|Experimental Period 2|Adverse Event|0|||
131894659|NCT03498313|474898914|FG003|Experimental Period 2|Adverse Event|0|||
131894660|NCT03498313|474898915|FG004|Experimental Period 2|Adverse Event|1|||
131894661|NCT03498313|474898916|FG005|Experimental Period 2|Adverse Event|2|||
131894662|NCT03498313|474898911|FG000|Washout Period 2|Physician Decision|1|||
131894663|NCT03498313|474898912|FG001|Washout Period 2|Physician Decision|0|||
131894664|NCT03498313|474898913|FG002|Washout Period 2|Physician Decision|0|||
131894665|NCT03498313|474898914|FG003|Washout Period 2|Physician Decision|1|||
131894666|NCT03498313|474898915|FG004|Washout Period 2|Physician Decision|0|||
131894667|NCT03498313|474898916|FG005|Washout Period 2|Physician Decision|1|||
131894668|NCT03498313|474898911|FG000|Washout Period 2|Withdrawal by Subject|3|||
131894669|NCT03498313|474898912|FG001|Washout Period 2|Withdrawal by Subject|2|||
131894670|NCT03498313|474898913|FG002|Washout Period 2|Withdrawal by Subject|0|||
131894671|NCT03498313|474898914|FG003|Washout Period 2|Withdrawal by Subject|0|||
131894672|NCT03498313|474898915|FG004|Washout Period 2|Withdrawal by Subject|2|||
131894673|NCT03498313|474898916|FG005|Washout Period 2|Withdrawal by Subject|0|||
131894674|NCT03498313|474898911|FG000|Washout Period 2|Anovulation|0|||
131894675|NCT03498313|474898912|FG001|Washout Period 2|Anovulation|0|||
131894676|NCT03498313|474898913|FG002|Washout Period 2|Anovulation|0|||
131894677|NCT03498313|474898914|FG003|Washout Period 2|Anovulation|0|||
131894678|NCT03498313|474898915|FG004|Washout Period 2|Anovulation|0|||
131894679|NCT03498313|474898916|FG005|Washout Period 2|Anovulation|1|||
131894680|NCT00184002|474898917|FG000|Overall Study|Adverse Event|9|||
131894681|NCT00184002|474898917|FG000|Overall Study|Death|3|||
131894682|NCT00184002|474898917|FG000|Overall Study|Physician Decision|1|||
131894683|NCT00184002|474898917|FG000|Overall Study|Withdrawal by Subject|4|||
131894684|NCT02020889|474898919|FG000|Overall Study|Adverse Event|0|||
131894685|NCT02020889|474898920|FG001|Overall Study|Adverse Event|1|||
131664839|NCT04602221|474056310|FG005|Overall Study|Lost to Follow-up|1|||
131664840|NCT04602221|474056311|FG006|Overall Study|Lost to Follow-up|0|||
131664841|NCT04602221|474056312|FG007|Overall Study|Lost to Follow-up|0|||
131894686|NCT02020889|474898919|FG000|Overall Study|Lack of Efficacy|1|||
131664842|NCT04602221|474056313|FG008|Overall Study|Lost to Follow-up|0|||
131894687|NCT02020889|474898920|FG001|Overall Study|Lack of Efficacy|0|||
131894688|NCT02020889|474898919|FG000|Overall Study|Lost to Follow-up|1|||
131664843|NCT04602221|474056314|FG009|Overall Study|Lost to Follow-up|0|||
131664844|NCT04602221|474056315|FG010|Overall Study|Lost to Follow-up|0|||
131664845|NCT04602221|474056316|FG011|Overall Study|Lost to Follow-up|0|||
131664846|NCT04602221|474056317|FG012|Overall Study|Lost to Follow-up|0|||
131664847|NCT04602221|474056318|FG013|Overall Study|Lost to Follow-up|0|||
131664848|NCT04602221|474056319|FG014|Overall Study|Lost to Follow-up|0|||
131664849|NCT04602221|474056320|FG015|Overall Study|Lost to Follow-up|0|||
131664850|NCT04602221|474056321|FG016|Overall Study|Lost to Follow-up|0|||
131664851|NCT04602221|474056322|FG017|Overall Study|Lost to Follow-up|0|||
131664852|NCT01226095|474056325|FG000|Overall Study|Poor compliance|1|||
131664853|NCT03538301|474056326|FG000|Overall Study|Adverse Event|1|||
131664854|NCT03538301|474056327|FG001|Overall Study|Adverse Event|4|||
131664855|NCT03538301|474056328|FG002|Overall Study|Adverse Event|4|||
131664856|NCT03538301|474056326|FG000|Overall Study|Death|1|||
131664857|NCT03538301|474056327|FG001|Overall Study|Death|1|||
131664858|NCT03538301|474056328|FG002|Overall Study|Death|0|||
131664859|NCT03538301|474056326|FG000|Overall Study|Physician Decision|0|||
131664860|NCT03538301|474056327|FG001|Overall Study|Physician Decision|1|||
131664861|NCT03538301|474056328|FG002|Overall Study|Physician Decision|0|||
131664862|NCT03538301|474056326|FG000|Overall Study|Protocol Violation|0|||
131894689|NCT02020889|474898920|FG001|Overall Study|Lost to Follow-up|0|||
131894690|NCT02020889|474898919|FG000|Overall Study|Physician Decision|2|||
131894691|NCT02020889|474898920|FG001|Overall Study|Physician Decision|0|||
131894692|NCT02020889|474898919|FG000|Overall Study|Withdrawal by Subject|3|||
131894693|NCT02020889|474898920|FG001|Overall Study|Withdrawal by Subject|2|||
131894694|NCT02768792|474898921|FG000|Overall Study|Adverse Event|1|||
131894695|NCT05980013|474898922|FG000|Overall Study|Withdrawal by Subject|0|||
131894696|NCT05980013|474898923|FG001|Overall Study|Withdrawal by Subject|1|||
131894697|NCT05980013|474898922|FG000|Overall Study|Device Error|0|||
131894698|NCT05980013|474898923|FG001|Overall Study|Device Error|1|||
131894699|NCT00398047|474898926|FG000|Overall Study|all patient progressed before completion|3|||
131894700|NCT00902746|474898927|FG000|Overall Study|Protocol Violation|7|||
131894701|NCT00902746|474898927|FG000|Overall Study|Withdrawal by Subject|16|||
131894702|NCT00902746|474898927|FG000|Overall Study|Adverse Event|8|||
131894703|NCT00902746|474898927|FG000|Overall Study|Lost to Follow-up|3|||
131894704|NCT00902746|474898927|FG000|Overall Study|Physician Decision|2|||
131894705|NCT03383692|474898938|FG000|Overall Study|Progressive disease as per RECIST|3|||
131894706|NCT03383692|474898939|FG001|Overall Study|Progressive disease as per RECIST|3|||
131894707|NCT03383692|474898938|FG000|Overall Study|Clinical progression|0|||
131894708|NCT03383692|474898939|FG001|Overall Study|Clinical progression|1|||
131894709|NCT03383692|474898938|FG000|Overall Study|Adverse Event|3|||
131894710|NCT03383692|474898939|FG001|Overall Study|Adverse Event|0|||
131894711|NCT00893971|474898940|FG000|Overall Study|Physician Decision|3|||
131894712|NCT02453256|474898941|FG000|Double Blind Period|Death|1|||
131894713|NCT02453256|474898942|FG001|Double Blind Period|Death|1|||
131894714|NCT02453256|474898941|FG000|Double Blind Period|Adverse Event|3|||
131894715|NCT02453256|474898942|FG001|Double Blind Period|Adverse Event|2|||
131894716|NCT02453256|474898941|FG000|Double Blind Period|Withdrawal by Subject|9|||
131894717|NCT02453256|474898942|FG001|Double Blind Period|Withdrawal by Subject|5|||
131894718|NCT02453256|474898941|FG000|Double Blind Period|Other|0|||
131894719|NCT02453256|474898942|FG001|Double Blind Period|Other|1|||
131894720|NCT02453256|474898941|FG000|Open Label Period|Adverse Event|1|||
131894721|NCT02453256|474898942|FG001|Open Label Period|Adverse Event|3|||
131894722|NCT02453256|474898941|FG000|Open Label Period|Death|0|||
131894723|NCT02453256|474898942|FG001|Open Label Period|Death|1|||
131894724|NCT02453256|474898941|FG000|Open Label Period|Lost to Follow-up|1|||
131894725|NCT02453256|474898942|FG001|Open Label Period|Lost to Follow-up|0|||
131894726|NCT02453256|474898941|FG000|Open Label Period|Other|0|||
131894727|NCT02453256|474898942|FG001|Open Label Period|Other|2|||
131894728|NCT02453256|474898941|FG000|Open Label Period|Withdrawal by Subject|5|||
131894729|NCT02453256|474898942|FG001|Open Label Period|Withdrawal by Subject|1|||
131894730|NCT01366638|474898943|FG000|Overall Study|Withdrawal by Subject|0|||
131894731|NCT01366638|474898944|FG001|Overall Study|Withdrawal by Subject|0|||
131894732|NCT01366638|474898945|FG002|Overall Study|Withdrawal by Subject|6|||
131894733|NCT01366638|474898943|FG000|Overall Study|Other|1|||
131435940|NCT00650767|473221898|FG001|Overall Study|Other|1|||
131664863|NCT03538301|474056327|FG001|Overall Study|Protocol Violation|0|||
131664864|NCT03538301|474056328|FG002|Overall Study|Protocol Violation|1|||
131664865|NCT03538301|474056326|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
131894734|NCT01366638|474898944|FG001|Overall Study|Other|0|||
131894735|NCT01366638|474898945|FG002|Overall Study|Other|0|||
131894736|NCT01237327|474898946|FG000|Overall Study|Protocol Violation: Core Study|1|||
131894737|NCT01237327|474898947|FG001|Overall Study|Protocol Violation: Core Study|0|||
131894738|NCT01237327|474898946|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
131435941|NCT00650767|473221899|FG002|Overall Study|Other|0|||
131664866|NCT03538301|474056327|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
131719347|NCT05309668|474253261|FG000|Overall Study|Ongoing at data cut-off|14|||
131894739|NCT01237327|474898947|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
131894740|NCT01237327|474898946|FG000|Overall Study|Progression of Disease: Core Study|18|||
131894741|NCT01237327|474898947|FG001|Overall Study|Progression of Disease: Core Study|22|||
131664867|NCT03538301|474056328|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
131664868|NCT04540887|474056330|FG000|Overall Study|Withdrawal by Subject|2|||
131664869|NCT00515853|474056331|FG000|Overall Study|Lost to Follow-up|9|||
131664870|NCT00515853|474056332|FG001|Overall Study|Lost to Follow-up|13|||
131664871|NCT00515853|474056331|FG000|Overall Study|Withdrawal by Subject|6|||
131664872|NCT00515853|474056332|FG001|Overall Study|Withdrawal by Subject|4|||
131664873|NCT01262027|474056333|FG000|Overall Study|Adverse Event|1|||
131664874|NCT01262027|474056333|FG000|Overall Study|Withdrawal by Subject|3|||
131664875|NCT01262027|474056333|FG000|Overall Study|Protocol Violation|1|||
131664876|NCT00589121|474056334|FG000|Overall Study|Protocol Violation|2|||
131664877|NCT00589121|474056335|FG001|Overall Study|Protocol Violation|6|||
131664878|NCT00589121|474056334|FG000|Overall Study|No protocol treatment received|0|||
131664879|NCT00589121|474056335|FG001|Overall Study|No protocol treatment received|1|||
131664880|NCT01758900|474056339|FG000|Overall Study|difficulty for further intubation|7|||
131664881|NCT01758900|474056340|FG001|Overall Study|difficulty for further intubation|8|||
131664882|NCT01892540|474056341|FG000|Overall Study|Did not complete PET/MRI|0|||
131664883|NCT01892540|474056342|FG001|Overall Study|Did not complete PET/MRI|0|||
131664884|NCT01892540|474056343|FG002|Overall Study|Did not complete PET/MRI|2|||
131664885|NCT01892540|474056341|FG000|Overall Study|Did not fit in scanner|0|||
131664886|NCT01892540|474056342|FG001|Overall Study|Did not fit in scanner|0|||
131664887|NCT01892540|474056343|FG002|Overall Study|Did not fit in scanner|1|||
131664888|NCT01370590|474056344|FG000|Period 1|Adverse Event|8|||
131664889|NCT01370590|474056345|FG001|Period 1|Adverse Event|4|||
131664890|NCT01370590|474056344|FG000|Period 1|Lost to Follow-up|2|||
131664891|NCT01370590|474056345|FG001|Period 1|Lost to Follow-up|2|||
131664892|NCT01370590|474056344|FG000|Period 1|Protocol Violation|2|||
131664893|NCT01370590|474056345|FG001|Period 1|Protocol Violation|2|||
131664894|NCT01370590|474056344|FG000|Period 1|Withdrawal by Subject|4|||
131664895|NCT01370590|474056345|FG001|Period 1|Withdrawal by Subject|2|||
131664896|NCT01370590|474056344|FG000|Period 1|Could not access randomization system|0|||
131664897|NCT01370590|474056345|FG001|Period 1|Could not access randomization system|1|||
131664898|NCT01370590|474056344|FG000|Crossover Washout Period|Adverse Event|1|||
131664899|NCT01370590|474056345|FG001|Crossover Washout Period|Adverse Event|4|||
131664900|NCT01370590|474056344|FG000|Crossover Washout Period|Lost to Follow-up|2|||
131664901|NCT01370590|474056345|FG001|Crossover Washout Period|Lost to Follow-up|0|||
131664902|NCT01370590|474056344|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
131664903|NCT01370590|474056345|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
131664904|NCT01370590|474056344|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
131664905|NCT01370590|474056345|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
131664906|NCT01370590|474056344|FG000|Period 2|Adverse Event|0|||
131664907|NCT01370590|474056345|FG001|Period 2|Adverse Event|1|||
131664908|NCT01370590|474056344|FG000|Period 2|Withdrawal by Subject|1|||
131664909|NCT01370590|474056345|FG001|Period 2|Withdrawal by Subject|1|||
131664910|NCT05172050|474056346|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
131664911|NCT05172050|474056347|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
131664912|NCT05172050|474056348|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
131664913|NCT05172050|474056346|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
131664914|NCT05172050|474056347|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
131664915|NCT05172050|474056348|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
131664916|NCT05172050|474056346|FG000|Overall Study|Other|2|||
131664917|NCT05172050|474056347|FG001|Overall Study|Other|2|||
131664918|NCT05172050|474056348|FG002|Overall Study|Other|1|||
131664919|NCT05180500|474056349|FG000|Overall Study|Adverse Event|1|||
131664920|NCT05180500|474056350|FG001|Overall Study|Adverse Event|0|||
131664921|NCT05180500|474056349|FG000|Overall Study|Withdrawal by Subject|2|||
131664922|NCT05180500|474056350|FG001|Overall Study|Withdrawal by Subject|0|||
131664923|NCT04617275|474056351|FG000|Treatment Period|Adverse Event|1|||
131664924|NCT04617275|474056352|FG001|Treatment Period|Adverse Event|6|||
131664925|NCT04617275|474056353|FG002|Treatment Period|Adverse Event|4|||
131664926|NCT04617275|474056354|FG003|Treatment Period|Adverse Event|6|||
131664927|NCT04617275|474056355|FG004|Treatment Period|Adverse Event|7|||
131664928|NCT04617275|474056356|FG005|Treatment Period|Adverse Event|8|||
131664929|NCT04617275|474056357|FG006|Treatment Period|Adverse Event|0|||
131664930|NCT04617275|474056358|FG007|Treatment Period|Adverse Event|12|||
131664931|NCT04617275|474056351|FG000|Treatment Period|Lost to Follow-up|0|||
131664932|NCT04617275|474056352|FG001|Treatment Period|Lost to Follow-up|0|||
131664933|NCT04617275|474056353|FG002|Treatment Period|Lost to Follow-up|2|||
131664934|NCT04617275|474056354|FG003|Treatment Period|Lost to Follow-up|0|||
131664935|NCT04617275|474056355|FG004|Treatment Period|Lost to Follow-up|0|||
131664936|NCT04617275|474056356|FG005|Treatment Period|Lost to Follow-up|3|||
131664937|NCT04617275|474056357|FG006|Treatment Period|Lost to Follow-up|0|||
131664938|NCT04617275|474056358|FG007|Treatment Period|Lost to Follow-up|2|||
131664939|NCT04617275|474056351|FG000|Treatment Period|No longer meets eligibility criteria|0|||
131664940|NCT04617275|474056352|FG001|Treatment Period|No longer meets eligibility criteria|0|||
131664941|NCT04617275|474056353|FG002|Treatment Period|No longer meets eligibility criteria|0|||
131894742|NCT01237327|474898946|FG000|Overall Study|Progression of Disease: Extension Study|15|||
131894743|NCT01237327|474898947|FG001|Overall Study|Progression of Disease: Extension Study|13|||
131894744|NCT01237327|474898946|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
131894745|NCT01237327|474898947|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
131894746|NCT01237327|474898946|FG000|Overall Study|Withdrawal by Subject|1|||
131894747|NCT01237327|474898947|FG001|Overall Study|Withdrawal by Subject|3|||
131894748|NCT01237327|474898946|FG000|Overall Study|Lost to Follow-up|3|||
131894749|NCT01237327|474898947|FG001|Overall Study|Lost to Follow-up|0|||
131894750|NCT01790516|474898950|FG000|Overall Study|Physician Decision|1|||
131894751|NCT01790516|474898951|FG001|Overall Study|Physician Decision|0|||
131894752|NCT01554163|474898952|FG000|Overall Study|Adverse Event|3|||
131894753|NCT01554163|474898953|FG001|Overall Study|Adverse Event|0|||
131894754|NCT01554163|474898952|FG000|Overall Study|Lack of Efficacy|1|||
131894755|NCT01554163|474898953|FG001|Overall Study|Lack of Efficacy|0|||
131894756|NCT01554163|474898952|FG000|Overall Study|Lost to Follow-up|1|||
131894757|NCT01554163|474898953|FG001|Overall Study|Lost to Follow-up|0|||
131894758|NCT01554163|474898952|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131894759|NCT01554163|474898953|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131894760|NCT01554163|474898952|FG000|Overall Study|Protocol Violation|0|||
131894761|NCT01554163|474898953|FG001|Overall Study|Protocol Violation|4|||
131894762|NCT01554163|474898952|FG000|Overall Study|Withdrawal by Subject|1|||
131894763|NCT01554163|474898953|FG001|Overall Study|Withdrawal by Subject|5|||
131894764|NCT01554163|474898952|FG000|Overall Study|Not Treated|1|||
131894765|NCT01554163|474898953|FG001|Overall Study|Not Treated|0|||
131894766|NCT02070978|474898954|FG000|Overall Study|Adverse Event|6|||
131894767|NCT02070978|474898955|FG001|Overall Study|Adverse Event|2|||
131894768|NCT02070978|474898956|FG002|Overall Study|Adverse Event|0|||
131894769|NCT02070978|474898954|FG000|Overall Study|Lost to Follow-up|1|||
131894770|NCT02070978|474898955|FG001|Overall Study|Lost to Follow-up|3|||
131894771|NCT02070978|474898956|FG002|Overall Study|Lost to Follow-up|4|||
131894772|NCT02070978|474898954|FG000|Overall Study|Withdrawal by Subject|3|||
131894773|NCT02070978|474898955|FG001|Overall Study|Withdrawal by Subject|5|||
131894774|NCT02070978|474898956|FG002|Overall Study|Withdrawal by Subject|3|||
131894775|NCT02070978|474898954|FG000|Overall Study|Protocol Violation|1|||
131894776|NCT02070978|474898955|FG001|Overall Study|Protocol Violation|0|||
131894777|NCT02070978|474898956|FG002|Overall Study|Protocol Violation|3|||
131894778|NCT02070978|474898954|FG000|Overall Study|Lack of Efficacy|0|||
131894779|NCT02070978|474898955|FG001|Overall Study|Lack of Efficacy|1|||
131894780|NCT02070978|474898956|FG002|Overall Study|Lack of Efficacy|0|||
131894781|NCT02070978|474898954|FG000|Overall Study|Death|0|||
131894782|NCT02070978|474898955|FG001|Overall Study|Death|0|||
131894783|NCT02070978|474898956|FG002|Overall Study|Death|2|||
131894784|NCT02070978|474898954|FG000|Overall Study|Un-specified|3|||
131894785|NCT02070978|474898955|FG001|Overall Study|Un-specified|2|||
131894786|NCT02070978|474898956|FG002|Overall Study|Un-specified|2|||
131553369|NCT02969525|473649892|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553370|NCT02969525|473649893|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553371|NCT02969525|473649894|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553372|NCT02969525|473649895|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553373|NCT02969525|473649896|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
131553374|NCT02969525|473649897|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
131553375|NCT02172625|473649898|FG000|Overall Study|Adverse Event|0|||
131553376|NCT02172625|473649899|FG001|Overall Study|Adverse Event|1|||
131553377|NCT02172625|473649898|FG000|Overall Study|Pregnancy|0|||
131553378|NCT02172625|473649899|FG001|Overall Study|Pregnancy|1|||
131553379|NCT02172625|473649898|FG000|Overall Study|car accident|0|||
131553380|NCT02172625|473649899|FG001|Overall Study|car accident|1|||
131553381|NCT03315130|473649900|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
131553382|NCT03315130|473649901|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
131553383|NCT03315130|473649902|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
131553384|NCT03315130|473649903|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
131553385|NCT03315130|473649900|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
131553386|NCT03315130|473649901|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
131664942|NCT04617275|474056354|FG003|Treatment Period|No longer meets eligibility criteria|1|||
131894787|NCT02070978|474898954|FG000|Overall Study|Terminated by Sponsor|33|||
131894788|NCT02070978|474898955|FG001|Overall Study|Terminated by Sponsor|40|||
131894789|NCT02070978|474898956|FG002|Overall Study|Terminated by Sponsor|39|||
131894790|NCT02226120|474898957|FG000|Overall Study|Adverse Event|60|||
131894791|NCT02226120|474898957|FG000|Overall Study|Death|172|||
131894792|NCT02226120|474898957|FG000|Overall Study|Study terminated by sponsor|1|||
131894793|NCT02226120|474898957|FG000|Overall Study|Technical problems|4|||
131894794|NCT02226120|474898957|FG000|Overall Study|Lost to Follow-up|13|||
131894795|NCT02226120|474898957|FG000|Overall Study|Physician Decision|21|||
131894796|NCT02226120|474898957|FG000|Overall Study|Withdrawal by parent/guardian|36|||
131553387|NCT03315130|473649902|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
131894797|NCT02226120|474898957|FG000|Overall Study|Non-compliance with study drug|10|||
131894798|NCT02226120|474898957|FG000|Overall Study|Protocol deviation|1|||
131894799|NCT02226120|474898957|FG000|Overall Study|missing treatment disposition pages|2|||
131664943|NCT04617275|474056355|FG004|Treatment Period|No longer meets eligibility criteria|0|||
131664944|NCT04617275|474056356|FG005|Treatment Period|No longer meets eligibility criteria|0|||
131664945|NCT04617275|474056357|FG006|Treatment Period|No longer meets eligibility criteria|0|||
131664946|NCT04617275|474056358|FG007|Treatment Period|No longer meets eligibility criteria|0|||
131894800|NCT03034135|474898958|FG000|Overall Study|Withdrawal by Subject|2|||
131894801|NCT00199849|474900709|FG000|Overall Study|Unrelated illness or complication|0|||
131894802|NCT00199849|474900710|FG001|Overall Study|Unrelated illness or complication|1|||
131894803|NCT00199849|474900711|FG002|Overall Study|Unrelated illness or complication|0|||
131894804|NCT00199849|474900709|FG000|Overall Study|Progressive disease requiring intervention|0|||
131894805|NCT00199849|474900710|FG001|Overall Study|Progressive disease requiring intervention|0|||
131894806|NCT00199849|474900711|FG002|Overall Study|Progressive disease requiring intervention|1|||
131894807|NCT00199849|474900709|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
131894808|NCT00199849|474900710|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
131894809|NCT00199849|474900711|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
131894810|NCT04727528|474900712|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
131894811|NCT04727528|474900713|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
131894812|NCT04727528|474900712|FG000|Open-label Period|Randomized who did not receive treatment|1|||
131894813|NCT04727528|474900713|FG001|Open-label Period|Randomized who did not receive treatment|0|||
131894814|NCT04727528|474900712|FG000|Double-blind Treatment Phase|Adverse Event|0|||
131894815|NCT04727528|474900713|FG001|Double-blind Treatment Phase|Adverse Event|1|||
131894816|NCT04727528|474900712|FG000|Double-blind Treatment Phase|Death|0|||
131894817|NCT04727528|474900713|FG001|Double-blind Treatment Phase|Death|1|||
131894818|NCT04727528|474900712|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
131894819|NCT04727528|474900713|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
131894820|NCT04727528|474900712|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
131894821|NCT04727528|474900713|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
131894822|NCT04727528|474900712|FG000|Double-blind Treatment Phase|Physician Decision|0|||
131894823|NCT04727528|474900713|FG001|Double-blind Treatment Phase|Physician Decision|1|||
131894824|NCT04727528|474900712|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
131894825|NCT04727528|474900713|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131894826|NCT01763827|474900720|FG000|Overall Study|Withdrawal by Subject|1|||
131894827|NCT01763827|474900721|FG001|Overall Study|Withdrawal by Subject|0|||
131894828|NCT01763827|474900722|FG002|Overall Study|Withdrawal by Subject|0|||
131894829|NCT01763827|474900723|FG003|Overall Study|Withdrawal by Subject|0|||
131894830|NCT01763827|474900724|FG004|Overall Study|Withdrawal by Subject|2|||
131894831|NCT01763827|474900725|FG005|Overall Study|Withdrawal by Subject|0|||
131894832|NCT01763827|474900720|FG000|Overall Study|Decision by sponsor|2|||
131894833|NCT01763827|474900721|FG001|Overall Study|Decision by sponsor|0|||
131894834|NCT01763827|474900722|FG002|Overall Study|Decision by sponsor|3|||
131894835|NCT01763827|474900723|FG003|Overall Study|Decision by sponsor|0|||
131894836|NCT01763827|474900724|FG004|Overall Study|Decision by sponsor|2|||
131894837|NCT01763827|474900725|FG005|Overall Study|Decision by sponsor|1|||
131894838|NCT01763827|474900720|FG000|Overall Study|Lost to Follow-up|0|||
131894839|NCT01763827|474900721|FG001|Overall Study|Lost to Follow-up|1|||
131894840|NCT01763827|474900722|FG002|Overall Study|Lost to Follow-up|1|||
131894841|NCT01763827|474900723|FG003|Overall Study|Lost to Follow-up|1|||
131894842|NCT01763827|474900724|FG004|Overall Study|Lost to Follow-up|2|||
131894843|NCT01763827|474900725|FG005|Overall Study|Lost to Follow-up|1|||
131894844|NCT02906579|474900726|FG000|Overall Study|Adverse Event|1|||
131894845|NCT02906579|474900726|FG000|Overall Study|Physician Decision|1|||
131894846|NCT02030119|474900731|FG000|Overall Study|Withdrawal by Subject|3|||
131664947|NCT04617275|474056351|FG000|Treatment Period|Other|0|||
131664948|NCT04617275|474056352|FG001|Treatment Period|Other|1|||
131664949|NCT04617275|474056353|FG002|Treatment Period|Other|0|||
131664950|NCT04617275|474056354|FG003|Treatment Period|Other|0|||
131664951|NCT04617275|474056355|FG004|Treatment Period|Other|0|||
131664952|NCT04617275|474056356|FG005|Treatment Period|Other|0|||
131664953|NCT04617275|474056357|FG006|Treatment Period|Other|0|||
131664954|NCT04617275|474056358|FG007|Treatment Period|Other|0|||
131664955|NCT04617275|474056351|FG000|Treatment Period|Withdrawal by Subject|2|||
131664956|NCT04617275|474056352|FG001|Treatment Period|Withdrawal by Subject|0|||
131664957|NCT04617275|474056353|FG002|Treatment Period|Withdrawal by Subject|0|||
131664958|NCT04617275|474056354|FG003|Treatment Period|Withdrawal by Subject|2|||
131664959|NCT04617275|474056355|FG004|Treatment Period|Withdrawal by Subject|2|||
131664960|NCT04617275|474056356|FG005|Treatment Period|Withdrawal by Subject|0|||
131894847|NCT02030119|474900732|FG001|Overall Study|Withdrawal by Subject|1|||
131894848|NCT02030119|474900733|FG002|Overall Study|Withdrawal by Subject|5|||
131894849|NCT02030119|474900734|FG003|Overall Study|Withdrawal by Subject|3|||
131894850|NCT02030119|474900731|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
131664961|NCT04617275|474056357|FG006|Treatment Period|Withdrawal by Subject|1|||
131664962|NCT04617275|474056358|FG007|Treatment Period|Withdrawal by Subject|2|||
131664963|NCT04617275|474056351|FG000|Follow-up Period|Adverse Event|1|||
131664964|NCT04617275|474056352|FG001|Follow-up Period|Adverse Event|1|||
131664965|NCT04617275|474056353|FG002|Follow-up Period|Adverse Event|2|||
131664966|NCT04617275|474056354|FG003|Follow-up Period|Adverse Event|3|||
131664967|NCT04617275|474056355|FG004|Follow-up Period|Adverse Event|4|||
131664968|NCT04617275|474056356|FG005|Follow-up Period|Adverse Event|3|||
131664969|NCT04617275|474056357|FG006|Follow-up Period|Adverse Event|0|||
131664970|NCT04617275|474056358|FG007|Follow-up Period|Adverse Event|3|||
131664971|NCT04617275|474056351|FG000|Follow-up Period|Lost to Follow-up|0|||
131664972|NCT04617275|474056352|FG001|Follow-up Period|Lost to Follow-up|1|||
131664973|NCT04617275|474056353|FG002|Follow-up Period|Lost to Follow-up|2|||
131664974|NCT04617275|474056354|FG003|Follow-up Period|Lost to Follow-up|0|||
131664975|NCT04617275|474056355|FG004|Follow-up Period|Lost to Follow-up|0|||
131664976|NCT04617275|474056356|FG005|Follow-up Period|Lost to Follow-up|4|||
131664977|NCT04617275|474056357|FG006|Follow-up Period|Lost to Follow-up|0|||
131664978|NCT04617275|474056358|FG007|Follow-up Period|Lost to Follow-up|3|||
131664979|NCT04617275|474056351|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
131664980|NCT04617275|474056352|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
131664981|NCT04617275|474056353|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
131664982|NCT04617275|474056354|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
131664983|NCT04617275|474056355|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
131664984|NCT04617275|474056356|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
131664985|NCT04617275|474056357|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
131664986|NCT04617275|474056358|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
131664987|NCT04617275|474056351|FG000|Follow-up Period|Other|0|||
131664988|NCT04617275|474056352|FG001|Follow-up Period|Other|1|||
131664989|NCT04617275|474056353|FG002|Follow-up Period|Other|0|||
131894851|NCT02030119|474900732|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
131894852|NCT02030119|474900733|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
131894853|NCT02030119|474900734|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
131894854|NCT00759655|474900735|FG000|Overall Study|Termination of the study by sponsor|1|||
131894855|NCT02213380|474900745|FG000|Underwent Randomization|Withdrawal by Subject|2|||
131894856|NCT02213380|474900746|FG001|Underwent Randomization|Withdrawal by Subject|0|||
131894857|NCT02213380|474900745|FG000|Underwent Randomization|Not treated|3|||
131894858|NCT02213380|474900746|FG001|Underwent Randomization|Not treated|3|||
131894859|NCT02213380|474900745|FG000|Per-protocol Analysis|Protocol Violation|32|||
131894860|NCT02213380|474900746|FG001|Per-protocol Analysis|Protocol Violation|36|||
131894861|NCT03746405|474900747|FG000|Overall Study|Withdrawal by Subject|3|||
131894862|NCT03746405|474900748|FG001|Overall Study|Withdrawal by Subject|0|||
131894863|NCT03746405|474900747|FG000|Overall Study|technical difficulties|0|||
131894864|NCT03746405|474900748|FG001|Overall Study|technical difficulties|2|||
131894865|NCT03479008|474900749|FG000|Overall Study|Withdrawal by Subject|3|||
131894866|NCT00412932|474900750|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
131894867|NCT00412932|474900750|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
131894868|NCT00412932|474900750|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
131894869|NCT00412932|474900750|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
131894870|NCT00412932|474900750|FG000|Olmesartan (Olm) 20 mg|Other|1|||
131894871|NCT00412932|474900750|FG000|Olmesartan 40 mg|Adverse Event|4|||
131894872|NCT00412932|474900750|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
131894873|NCT00412932|474900750|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
131894874|NCT00412932|474900750|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
131894875|NCT00412932|474900750|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
131894876|NCT00412932|474900750|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
131894877|NCT00412932|474900750|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
131553388|NCT03315130|473649903|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
131553389|NCT03315130|473649900|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
131553390|NCT03315130|473649901|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
131553391|NCT03315130|473649902|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
131553392|NCT03315130|473649903|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
131553393|NCT03315130|473649900|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
131553394|NCT03315130|473649901|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
131553395|NCT03315130|473649902|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
131553396|NCT03315130|473649903|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
131553397|NCT03315130|473649900|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
131553398|NCT03315130|473649901|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
131553399|NCT03315130|473649902|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
131553400|NCT03315130|473649903|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
131553401|NCT03315130|473649900|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
131553402|NCT03315130|473649901|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
131553403|NCT03315130|473649902|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
131894878|NCT01490840|474900754|FG000|Phase 1|Lost to Follow-up|1|||
131894879|NCT01490840|474900755|FG001|Phase 1|Lost to Follow-up|0|||
131894880|NCT01490840|474900754|FG000|Phase 1|Adverse Event|2|||
131894881|NCT01490840|474900755|FG001|Phase 1|Adverse Event|1|||
131894882|NCT01490840|474900754|FG000|Phase 1|Withdrawal by Subject|6|||
131894883|NCT01490840|474900755|FG001|Phase 1|Withdrawal by Subject|5|||
131894884|NCT01490840|474900754|FG000|Phase 1|Visit 6a omitted|1|||
131894885|NCT01490840|474900755|FG001|Phase 1|Visit 6a omitted|0|||
131894886|NCT01490840|474900754|FG000|Phase 2|Withdrawal by Subject|4|||
131894887|NCT01490840|474900755|FG001|Phase 2|Withdrawal by Subject|3|||
131894888|NCT01490840|474900754|FG000|Phase 2|Permanent interruption of fingolimod|0|||
131894889|NCT01490840|474900755|FG001|Phase 2|Permanent interruption of fingolimod|1|||
131894890|NCT01490840|474900754|FG000|Phase 2|Lost to Follow-up|1|||
131894891|NCT01490840|474900755|FG001|Phase 2|Lost to Follow-up|1|||
131894892|NCT01490840|474900754|FG000|Phase 2|Adverse Event|1|||
131894893|NCT01490840|474900755|FG001|Phase 2|Adverse Event|1|||
131894894|NCT02171429|474900756|FG000|Overall Study|Other|0|||
131894895|NCT02171429|474900757|FG001|Overall Study|Other|1|||
131894896|NCT02171429|474900758|FG002|Overall Study|Other|1|||
131894897|NCT02171429|474900756|FG000|Overall Study|Non-Compliance|0|||
131894898|NCT02171429|474900757|FG001|Overall Study|Non-Compliance|0|||
131894899|NCT02171429|474900758|FG002|Overall Study|Non-Compliance|1|||
131894900|NCT02171429|474900756|FG000|Overall Study|Physician Decision|0|||
131894901|NCT02171429|474900757|FG001|Overall Study|Physician Decision|0|||
131894902|NCT02171429|474900758|FG002|Overall Study|Physician Decision|1|||
131894903|NCT02171429|474900756|FG000|Overall Study|Withdrawal by Subject|1|||
131894904|NCT02171429|474900757|FG001|Overall Study|Withdrawal by Subject|1|||
131894905|NCT02171429|474900758|FG002|Overall Study|Withdrawal by Subject|1|||
131894906|NCT02171429|474900756|FG000|Overall Study|Lost to Follow-up|0|||
131894907|NCT02171429|474900757|FG001|Overall Study|Lost to Follow-up|1|||
131894908|NCT02171429|474900758|FG002|Overall Study|Lost to Follow-up|0|||
131894909|NCT02171429|474900756|FG000|Overall Study|Death|0|||
131894910|NCT02171429|474900757|FG001|Overall Study|Death|0|||
131894911|NCT02171429|474900758|FG002|Overall Study|Death|1|||
131894912|NCT01704755|474900759|FG000|Overall Study|Adverse Event|4|||
131894913|NCT01704755|474900760|FG001|Overall Study|Adverse Event|1|||
131894914|NCT01704755|474900759|FG000|Overall Study|Lost to Follow-up|3|||
131894915|NCT01704755|474900760|FG001|Overall Study|Lost to Follow-up|4|||
131894916|NCT01704755|474900759|FG000|Overall Study|Withdrew consent|1|||
131894917|NCT01704755|474900760|FG001|Overall Study|Withdrew consent|1|||
131894918|NCT01704755|474900759|FG000|Overall Study|Other (not specified)|3|||
131894919|NCT01704755|474900760|FG001|Overall Study|Other (not specified)|1|||
131894920|NCT01704755|474900759|FG000|Overall Study|Withdrew consent and personal issues|1|||
131894921|NCT01704755|474900760|FG001|Overall Study|Withdrew consent and personal issues|0|||
131894922|NCT04105842|474900761|FG000|Overall Study|Withdrawal by Subject|2|||
131894923|NCT01639703|474900762|FG000|Overall Study|Withdrawal by Subject|5|||
131894924|NCT01639703|474900762|FG000|Overall Study|Other reason|7|||
131894925|NCT02087670|474900763|FG000|Overall Study|Withdrawal by Subject|3|||
131894926|NCT02087670|474900764|FG001|Overall Study|Withdrawal by Subject|2|||
131894927|NCT01768559|474900767|FG000|Overall Study|Randomized but not treated|0|||
131894928|NCT01768559|474900768|FG001|Overall Study|Randomized but not treated|0|||
131894929|NCT01768559|474900769|FG002|Overall Study|Randomized but not treated|1|||
131894930|NCT01768559|474900767|FG000|Overall Study|Adverse Event|15|||
131894931|NCT01768559|474900768|FG001|Overall Study|Adverse Event|2|||
131894932|NCT01768559|474900769|FG002|Overall Study|Adverse Event|5|||
131894933|NCT01768559|474900767|FG000|Overall Study|Lack of Efficacy|6|||
131894934|NCT01768559|474900768|FG001|Overall Study|Lack of Efficacy|4|||
131894935|NCT01768559|474900769|FG002|Overall Study|Lack of Efficacy|0|||
131894936|NCT01768559|474900767|FG000|Overall Study|Poor compliance to protocol|0|||
131894937|NCT01768559|474900768|FG001|Overall Study|Poor compliance to protocol|3|||
131894938|NCT01768559|474900769|FG002|Overall Study|Poor compliance to protocol|2|||
131894939|NCT01768559|474900767|FG000|Overall Study|Other than specified|9|||
131894940|NCT01768559|474900768|FG001|Overall Study|Other than specified|8|||
131894941|NCT01768559|474900769|FG002|Overall Study|Other than specified|5|||
131894942|NCT00837967|474900770|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
131894943|NCT00837967|474900771|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
131894944|NCT00551525|474900774|FG000|Overall Study|Protocol Violation|5|||
131894945|NCT04676724|474900775|FG000|Overall Study|Adverse Event|2|||
131894946|NCT04676724|474900776|FG001|Overall Study|Adverse Event|0|||
131894947|NCT04676724|474900775|FG000|Overall Study|Lost to Follow-up|1|||
131894948|NCT04676724|474900776|FG001|Overall Study|Lost to Follow-up|0|||
131894949|NCT04676724|474900775|FG000|Overall Study|Physician Decision|0|||
131894950|NCT04676724|474900776|FG001|Overall Study|Physician Decision|1|||
131894951|NCT04676724|474900775|FG000|Overall Study|Withdrawal by Subject|3|||
131894952|NCT04676724|474900776|FG001|Overall Study|Withdrawal by Subject|2|||
131894953|NCT02081001|474900780|FG000|Overall Study|Adverse Event|0|||
131894954|NCT02081001|474900781|FG001|Overall Study|Adverse Event|0|||
131894955|NCT02081001|474900782|FG002|Overall Study|Adverse Event|0|||
131894956|NCT02081001|474900783|FG003|Overall Study|Adverse Event|0|||
131894957|NCT02081001|474900784|FG004|Overall Study|Adverse Event|1|||
131894958|NCT02081001|474900785|FG005|Overall Study|Adverse Event|0|||
131894959|NCT02081001|474900786|FG006|Overall Study|Adverse Event|0|||
131894960|NCT02081001|474900787|FG007|Overall Study|Adverse Event|0|||
131894961|NCT02081001|474900788|FG008|Overall Study|Adverse Event|0|||
131894962|NCT02081001|474900789|FG009|Overall Study|Adverse Event|0|||
131894963|NCT02081001|474900790|FG010|Overall Study|Adverse Event|0|||
131894964|NCT02081001|474900791|FG011|Overall Study|Adverse Event|0|||
131894965|NCT02588092|474900798|FG000|Overall Study|Death|4|||
131894966|NCT02588092|474900799|FG001|Overall Study|Death|3|||
131894967|NCT02588092|474900800|FG002|Overall Study|Death|3|||
131664990|NCT04617275|474056354|FG003|Follow-up Period|Other|0|||
131664991|NCT04617275|474056355|FG004|Follow-up Period|Other|0|||
131664992|NCT04617275|474056356|FG005|Follow-up Period|Other|0|||
131664993|NCT04617275|474056357|FG006|Follow-up Period|Other|0|||
131664994|NCT04617275|474056358|FG007|Follow-up Period|Other|0|||
131664995|NCT04617275|474056351|FG000|Follow-up Period|Withdrawal by Subject|2|||
131664996|NCT04617275|474056352|FG001|Follow-up Period|Withdrawal by Subject|0|||
131664997|NCT04617275|474056353|FG002|Follow-up Period|Withdrawal by Subject|0|||
131664998|NCT04617275|474056354|FG003|Follow-up Period|Withdrawal by Subject|2|||
131664999|NCT04617275|474056355|FG004|Follow-up Period|Withdrawal by Subject|2|||
131665000|NCT04617275|474056356|FG005|Follow-up Period|Withdrawal by Subject|0|||
131665001|NCT04617275|474056357|FG006|Follow-up Period|Withdrawal by Subject|1|||
131665002|NCT04617275|474056358|FG007|Follow-up Period|Withdrawal by Subject|2|||
131665003|NCT04927884|474056362|FG000|Overall Study|Progressive Disease|2|||
131665004|NCT02317432|474056363|FG000|Overall Study|Death|4|||
131665005|NCT02317432|474056364|FG001|Overall Study|Death|1|||
131665006|NCT02317432|474056363|FG000|Overall Study|Lost to Follow-up|0|||
131665007|NCT02317432|474056364|FG001|Overall Study|Lost to Follow-up|5|||
131665008|NCT02317432|474056363|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
131665009|NCT02317432|474056364|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
131665010|NCT05593445|474056365|FG000|12-Week DBVC Period|Adverse Event|1|||
131665011|NCT05593445|474056366|FG001|12-Week DBVC Period|Adverse Event|0|||
131665012|NCT05593445|474056367|FG002|12-Week DBVC Period|Adverse Event|0|||
131665013|NCT05593445|474056368|FG003|12-Week DBVC Period|Adverse Event|0|||
131665014|NCT05593445|474056365|FG000|12-Week DBVC Period|Physician Decision|0|||
131665015|NCT05593445|474056366|FG001|12-Week DBVC Period|Physician Decision|1|||
131665016|NCT05593445|474056367|FG002|12-Week DBVC Period|Physician Decision|0|||
131665017|NCT05593445|474056368|FG003|12-Week DBVC Period|Physician Decision|0|||
131665018|NCT05593445|474056365|FG000|12-Week DBVC Period|Protocol Violation|0|||
131665019|NCT05593445|474056366|FG001|12-Week DBVC Period|Protocol Violation|1|||
131665020|NCT05593445|474056367|FG002|12-Week DBVC Period|Protocol Violation|0|||
131665021|NCT05593445|474056368|FG003|12-Week DBVC Period|Protocol Violation|0|||
131665022|NCT05593445|474056365|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
131665023|NCT05593445|474056366|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
131665024|NCT05593445|474056367|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
131665025|NCT05593445|474056368|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
131665026|NCT05593445|474056365|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
131665027|NCT05593445|474056366|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
131665028|NCT05593445|474056367|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
131665029|NCT05593445|474056368|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
131665030|NCT05593445|474056365|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
131665031|NCT05593445|474056366|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
131665032|NCT05593445|474056367|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
131665033|NCT05593445|474056368|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
131665034|NCT05593445|474056365|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
131665035|NCT05593445|474056366|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
131665036|NCT05593445|474056367|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
131665037|NCT05593445|474056368|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
131665038|NCT05593445|474056365|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131665039|NCT05593445|474056366|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131665040|NCT05593445|474056367|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
131665041|NCT05593445|474056368|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131665042|NCT05559476|474056371|FG000|Overall Study|Adverse Event|2|||
131894968|NCT02588092|474900801|FG003|Overall Study|Death|3|||
131894969|NCT02588092|474900802|FG004|Overall Study|Death|2|||
131665043|NCT05559476|474056372|FG001|Overall Study|Adverse Event|0|||
131665044|NCT05559476|474056371|FG000|Overall Study|Lost to Follow-up|13|||
131665045|NCT05559476|474056372|FG001|Overall Study|Lost to Follow-up|12|||
131665046|NCT05559476|474056371|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
131665047|NCT05559476|474056372|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
131894970|NCT02588092|474900803|FG005|Overall Study|Death|2|||
131665048|NCT05559476|474056371|FG000|Overall Study|Other|0|||
131665049|NCT05559476|474056372|FG001|Overall Study|Other|2|||
131665050|NCT00727311|474056373|FG000|Overall Study|Did not receive drug|316|||
131894971|NCT02588092|474900804|FG006|Overall Study|Death|2|||
131894972|NCT02588092|474900805|FG007|Overall Study|Death|1|||
131894973|NCT02588092|474900806|FG008|Overall Study|Death|5|||
131894974|NCT02588092|474900807|FG009|Overall Study|Death|2|||
131894975|NCT02588092|474900798|FG000|Overall Study|Withdrawal by Subject|0|||
131894976|NCT02588092|474900799|FG001|Overall Study|Withdrawal by Subject|0|||
131894977|NCT02588092|474900800|FG002|Overall Study|Withdrawal by Subject|0|||
131894978|NCT02588092|474900801|FG003|Overall Study|Withdrawal by Subject|0|||
131894979|NCT02588092|474900802|FG004|Overall Study|Withdrawal by Subject|0|||
131894980|NCT02588092|474900803|FG005|Overall Study|Withdrawal by Subject|1|||
131894981|NCT02588092|474900804|FG006|Overall Study|Withdrawal by Subject|1|||
131894982|NCT02588092|474900805|FG007|Overall Study|Withdrawal by Subject|2|||
131894983|NCT02588092|474900806|FG008|Overall Study|Withdrawal by Subject|0|||
131894984|NCT02588092|474900807|FG009|Overall Study|Withdrawal by Subject|0|||
131894985|NCT02588092|474900798|FG000|Overall Study|Started Another Treatment|0|||
131894986|NCT02588092|474900799|FG001|Overall Study|Started Another Treatment|0|||
131894987|NCT02588092|474900800|FG002|Overall Study|Started Another Treatment|0|||
131894988|NCT02588092|474900801|FG003|Overall Study|Started Another Treatment|0|||
131894989|NCT02588092|474900802|FG004|Overall Study|Started Another Treatment|1|||
131894990|NCT02588092|474900803|FG005|Overall Study|Started Another Treatment|0|||
131894991|NCT02588092|474900804|FG006|Overall Study|Started Another Treatment|0|||
131894992|NCT02588092|474900805|FG007|Overall Study|Started Another Treatment|1|||
131894993|NCT02588092|474900806|FG008|Overall Study|Started Another Treatment|0|||
131894994|NCT02588092|474900807|FG009|Overall Study|Started Another Treatment|0|||
131894995|NCT02588092|474900798|FG000|Overall Study|Sponsor Decision|0|||
131894996|NCT02588092|474900799|FG001|Overall Study|Sponsor Decision|0|||
131894997|NCT02588092|474900800|FG002|Overall Study|Sponsor Decision|0|||
131894998|NCT02588092|474900801|FG003|Overall Study|Sponsor Decision|0|||
131894999|NCT02588092|474900802|FG004|Overall Study|Sponsor Decision|0|||
131895000|NCT02588092|474900803|FG005|Overall Study|Sponsor Decision|0|||
131895001|NCT02588092|474900804|FG006|Overall Study|Sponsor Decision|0|||
131895002|NCT02588092|474900805|FG007|Overall Study|Sponsor Decision|0|||
131895003|NCT02588092|474900806|FG008|Overall Study|Sponsor Decision|1|||
131895004|NCT02588092|474900807|FG009|Overall Study|Sponsor Decision|1|||
131895005|NCT02347072|474900808|FG000|Overall Study|Adverse Event|2|||
131895006|NCT02347072|474900808|FG000|Overall Study|Withdrawal by Subject|6|||
131895007|NCT02347072|474900808|FG000|Overall Study|Physician Decision|1|||
131895008|NCT02347072|474900808|FG000|Overall Study|Lost to Follow-up|2|||
131895009|NCT02347072|474900808|FG000|Overall Study|Protocol Violation|1|||
131895010|NCT02347072|474900808|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
131895011|NCT03762681|474900810|FG000|Part 1|Withdrawal by Subject|0|||
131895012|NCT03762681|474900811|FG001|Part 1|Withdrawal by Subject|0|||
131895013|NCT03762681|474900812|FG002|Part 1|Withdrawal by Subject|0|||
131895014|NCT03762681|474900813|FG003|Part 1|Withdrawal by Subject|1|||
131895015|NCT03762681|474900814|FG004|Part 1|Withdrawal by Subject|0|||
131895016|NCT03762681|474900815|FG005|Part 1|Withdrawal by Subject|0|||
131553404|NCT03315130|473649903|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
131553405|NCT00524030|473649904|FG000|Overall Study|Lack of Efficacy|10|||
131553406|NCT00524030|473649905|FG001|Overall Study|Lack of Efficacy|24|||
131553407|NCT00524030|473649904|FG000|Overall Study|Lost to Follow-up|0|||
131553408|NCT00524030|473649905|FG001|Overall Study|Lost to Follow-up|2|||
131553409|NCT00524030|473649904|FG000|Overall Study|Withdrawal by Subject|3|||
131553410|NCT00524030|473649905|FG001|Overall Study|Withdrawal by Subject|8|||
131553411|NCT00524030|473649904|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
131553412|NCT00524030|473649905|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
131553413|NCT00524030|473649904|FG000|Overall Study|Protocol Violation|0|||
131553414|NCT00524030|473649905|FG001|Overall Study|Protocol Violation|1|||
131553415|NCT00524030|473649904|FG000|Overall Study|Pregnancy|1|||
131553416|NCT00524030|473649905|FG001|Overall Study|Pregnancy|0|||
131553417|NCT00524030|473649904|FG000|Overall Study|Adverse Event|3|||
131553418|NCT00524030|473649905|FG001|Overall Study|Adverse Event|21|||
131553419|NCT00524030|473649904|FG000|Overall Study|Death|0|||
131553420|NCT00524030|473649905|FG001|Overall Study|Death|1|||
131553421|NCT00118898|473649906|FG000|Overall Study|Death|6|||
131553422|NCT00118898|473649907|FG001|Overall Study|Death|11|||
131553423|NCT00118898|473649908|FG002|Overall Study|Death|6|||
131553424|NCT00118898|473649909|FG003|Overall Study|Death|8|||
131553425|NCT00118898|473649906|FG000|Overall Study|Lost to Follow-up|26|||
131553426|NCT00118898|473649907|FG001|Overall Study|Lost to Follow-up|34|||
131553427|NCT00118898|473649908|FG002|Overall Study|Lost to Follow-up|33|||
131553428|NCT00118898|473649909|FG003|Overall Study|Lost to Follow-up|33|||
131665051|NCT00727311|474056373|FG000|Overall Study|Missing end of therapy data|205|||
131895017|NCT03762681|474900816|FG006|Part 1|Withdrawal by Subject|0|||
131895018|NCT03762681|474900817|FG007|Part 1|Withdrawal by Subject|0|||
131895019|NCT03762681|474900810|FG000|Part 2a|Pandemic Travel Restrictions|0|||
131895020|NCT03762681|474900811|FG001|Part 2a|Pandemic Travel Restrictions|0|||
131895021|NCT03762681|474900812|FG002|Part 2a|Pandemic Travel Restrictions|0|||
131895022|NCT03762681|474900813|FG003|Part 2a|Pandemic Travel Restrictions|0|||
131895023|NCT03762681|474900814|FG004|Part 2a|Pandemic Travel Restrictions|0|||
131895024|NCT03762681|474900815|FG005|Part 2a|Pandemic Travel Restrictions|0|||
131553429|NCT00118898|473649906|FG000|Overall Study|Withdrawal by Subject|10|||
131553430|NCT00118898|473649907|FG001|Overall Study|Withdrawal by Subject|5|||
131895025|NCT03762681|474900816|FG006|Part 2a|Pandemic Travel Restrictions|0|||
131895026|NCT03762681|474900817|FG007|Part 2a|Pandemic Travel Restrictions|1|||
131895027|NCT03148067|474900818|FG000|Overall Study|Lost to Follow-up|3|||
131895028|NCT03148067|474900818|FG000|Overall Study|Death|1|||
131895029|NCT05305989|474900823|FG000|Overall Study|Other|3|||
131895030|NCT05305989|474900824|FG001|Overall Study|Other|2|||
131895031|NCT05305989|474900825|FG002|Overall Study|Other|0|||
131895032|NCT05305989|474900823|FG000|Overall Study|Sponsor decision|2|||
131895033|NCT05305989|474900824|FG001|Overall Study|Sponsor decision|1|||
131895034|NCT05305989|474900825|FG002|Overall Study|Sponsor decision|0|||
131895035|NCT05305989|474900823|FG000|Overall Study|Protocol Violation|0|||
131895036|NCT05305989|474900824|FG001|Overall Study|Protocol Violation|1|||
131895037|NCT05305989|474900825|FG002|Overall Study|Protocol Violation|0|||
131895038|NCT05305989|474900823|FG000|Overall Study|Investigator decision|1|||
131895039|NCT05305989|474900824|FG001|Overall Study|Investigator decision|2|||
131895040|NCT05305989|474900825|FG002|Overall Study|Investigator decision|0|||
131895041|NCT05305989|474900823|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
131895042|NCT05305989|474900824|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
131665052|NCT00727311|474056373|FG000|Overall Study|Adverse Event|58|||
131665053|NCT00727311|474056373|FG000|Overall Study|Lack of Efficacy|242|||
131665054|NCT00727311|474056373|FG000|Overall Study|Lost to Follow-up|73|||
131665055|NCT00727311|474056373|FG000|Overall Study|Withdrawal by Subject|77|||
131665056|NCT00727311|474056373|FG000|Overall Study|Other|97|||
131665057|NCT00727311|474056373|FG000|Overall Study|Multiple reasons|39|||
131665058|NCT03992846|474056374|FG000|Overall Study|Adverse Event|8|||
131665059|NCT03992846|474056375|FG001|Overall Study|Adverse Event|6|||
131665060|NCT03992846|474056376|FG002|Overall Study|Adverse Event|3|||
131665061|NCT03992846|474056374|FG000|Overall Study|Lost to Follow-up|0|||
131665062|NCT03992846|474056375|FG001|Overall Study|Lost to Follow-up|1|||
131665063|NCT03992846|474056376|FG002|Overall Study|Lost to Follow-up|1|||
131665064|NCT03992846|474056374|FG000|Overall Study|Pregnancy|2|||
131665065|NCT03992846|474056375|FG001|Overall Study|Pregnancy|0|||
131665066|NCT03992846|474056376|FG002|Overall Study|Pregnancy|1|||
131665067|NCT03992846|474056374|FG000|Overall Study|Protocol Violation|1|||
131665068|NCT03992846|474056375|FG001|Overall Study|Protocol Violation|2|||
131665069|NCT03992846|474056376|FG002|Overall Study|Protocol Violation|0|||
131665070|NCT03992846|474056374|FG000|Overall Study|Withdrawal by Subject|8|||
131665071|NCT03992846|474056375|FG001|Overall Study|Withdrawal by Subject|10|||
131665072|NCT03992846|474056376|FG002|Overall Study|Withdrawal by Subject|20|||
131665073|NCT03992846|474056374|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
131665074|NCT03992846|474056375|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
131665075|NCT03992846|474056376|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
131665076|NCT04058366|474058040|FG000|Overall Study|Adverse Event|14|||
131665077|NCT04058366|474058040|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
131665078|NCT04058366|474058040|FG000|Overall Study|Commercial drug is available for participants|6|||
131665079|NCT04058366|474058040|FG000|Overall Study|Death|1|||
131665080|NCT04058366|474058040|FG000|Overall Study|Other non-compliance|2|||
131665081|NCT04058366|474058040|FG000|Overall Study|Other|6|||
131665082|NCT00734097|474058041|FG000|Screening|Protocol Violation|12|||
131665083|NCT00734097|474058041|FG000|Screening|Withdrawal by Subject|5|||
131665084|NCT00734097|474058041|FG000|Screening|Lost to Follow-up|2|||
131665085|NCT00734097|474058041|FG000|Screening|Unconfirmed pregnancy|1|||
131665086|NCT00734097|474058041|FG000|Open Label|Lost to Follow-up|7|||
131665087|NCT00734097|474058041|FG000|Open Label|Withdrawal by Subject|5|||
131665088|NCT00734097|474058041|FG000|Open Label|Protocol Violation|4|||
131665089|NCT02233543|474058044|FG000|Period 1|Withdrawal by Subject|1|||
131665090|NCT02233543|474058045|FG001|Period 1|Withdrawal by Subject|0|||
131665091|NCT02233543|474058044|FG000|Period 1|Participants required other treatment.|2|||
131665092|NCT02233543|474058045|FG001|Period 1|Participants required other treatment.|3|||
131665093|NCT02233543|474058044|FG000|Period 2|Adverse Event|1|||
131665094|NCT02233543|474058045|FG001|Period 2|Adverse Event|0|||
131665095|NCT02233543|474058044|FG000|Period 2|Participant required other treatment.|0|||
131665096|NCT02233543|474058045|FG001|Period 2|Participant required other treatment.|1|||
131665097|NCT02233543|474058044|FG000|Period 2|COPD exacerbation|1|||
131665098|NCT02233543|474058045|FG001|Period 2|COPD exacerbation|0|||
131665099|NCT00603304|474058046|FG000|Overall Study|Lost to Follow-up|5|||
131665100|NCT00603304|474058047|FG001|Overall Study|Lost to Follow-up|7|||
131895043|NCT05305989|474900825|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
131895044|NCT05305989|474900823|FG000|Overall Study|Adverse Event|1|||
131895045|NCT05305989|474900824|FG001|Overall Study|Adverse Event|1|||
131895046|NCT05305989|474900825|FG002|Overall Study|Adverse Event|0|||
131665101|NCT00603304|474058046|FG000|Overall Study|Withdrawal by Subject|8|||
131665102|NCT00603304|474058047|FG001|Overall Study|Withdrawal by Subject|5|||
131665103|NCT00603304|474058046|FG000|Overall Study|Protocol Violation|1|||
131435942|NCT00650767|473221900|FG003|Overall Study|Other|0|||
131665104|NCT00603304|474058047|FG001|Overall Study|Protocol Violation|0|||
131665105|NCT00603304|474058046|FG000|Overall Study|Adverse Event|4|||
131895047|NCT05305989|474900823|FG000|Overall Study|Enrolled but never dosed|3|||
131895048|NCT05305989|474900824|FG001|Overall Study|Enrolled but never dosed|2|||
131895049|NCT05305989|474900825|FG002|Overall Study|Enrolled but never dosed|1|||
131895050|NCT03162328|474900826|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
131895051|NCT03162328|474900827|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
131895052|NCT03162328|474900828|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
131895053|NCT03162328|474900826|FG000|Screening Period|Withdrawal by Subject|1|||
131895054|NCT03162328|474900827|FG001|Screening Period|Withdrawal by Subject|0|||
131895055|NCT03162328|474900828|FG002|Screening Period|Withdrawal by Subject|0|||
131895056|NCT03162328|474900826|FG000|Study Period|Withdrawal by Subject|0|||
131895057|NCT03162328|474900827|FG001|Study Period|Withdrawal by Subject|0|||
131895058|NCT03162328|474900828|FG002|Study Period|Withdrawal by Subject|1|||
131895059|NCT00792116|474900829|FG000|Overall Study|Lost to Follow-up|0|||
131895060|NCT00792116|474900830|FG001|Overall Study|Lost to Follow-up|1|||
131895061|NCT00792116|474900829|FG000|Overall Study|Discontnued intervention|1|||
131895062|NCT00792116|474900830|FG001|Overall Study|Discontnued intervention|0|||
131895063|NCT00492232|474900831|FG000|Placebo Run-in|Adverse Event|0|||
131895064|NCT00492232|474900832|FG001|Placebo Run-in|Adverse Event|2|||
131895065|NCT00492232|474900831|FG000|Placebo Run-in|Protocol Violation|0|||
131895066|NCT00492232|474900832|FG001|Placebo Run-in|Protocol Violation|3|||
131895067|NCT00492232|474900831|FG000|Placebo Run-in|Lost to Follow-up|0|||
131895068|NCT00492232|474900832|FG001|Placebo Run-in|Lost to Follow-up|3|||
131895069|NCT00492232|474900831|FG000|Placebo Run-in|Withdrawal by Subject|0|||
131895070|NCT00492232|474900832|FG001|Placebo Run-in|Withdrawal by Subject|8|||
131895071|NCT00492232|474900831|FG000|Placebo Run-in|Pregnancy|0|||
131895072|NCT00492232|474900832|FG001|Placebo Run-in|Pregnancy|1|||
131895073|NCT00492232|474900831|FG000|Placebo Run-in|Entrance criteria not met|0|||
131895074|NCT00492232|474900832|FG001|Placebo Run-in|Entrance criteria not met|45|||
131895075|NCT00492232|474900831|FG000|Placebo Run-in|Other|0|||
131895076|NCT00492232|474900832|FG001|Placebo Run-in|Other|6|||
131895077|NCT00492232|474900831|FG000|Placebo Run-in|Missing|0|||
131895078|NCT00492232|474900832|FG001|Placebo Run-in|Missing|2|||
131895079|NCT00492232|474900831|FG000|Double-Blind Treatment|Adverse Event|1|||
131895080|NCT00492232|474900832|FG001|Double-Blind Treatment|Adverse Event|2|||
131895081|NCT00492232|474900831|FG000|Double-Blind Treatment|Protocol Violation|3|||
131895082|NCT00492232|474900832|FG001|Double-Blind Treatment|Protocol Violation|7|||
131895083|NCT00492232|474900831|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
131895084|NCT00492232|474900832|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
131895085|NCT00492232|474900831|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
131895086|NCT00492232|474900832|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
131895087|NCT00492232|474900831|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
131895088|NCT00492232|474900832|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
131895089|NCT00492232|474900831|FG000|Double-Blind Treatment|Other|6|||
131895090|NCT00492232|474900832|FG001|Double-Blind Treatment|Other|5|||
131895091|NCT00492232|474900831|FG000|Double-Blind Treatment|Randomized not treated|1|||
131895092|NCT00492232|474900832|FG001|Double-Blind Treatment|Randomized not treated|0|||
131895093|NCT00492232|474900831|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
131895094|NCT00492232|474900832|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
131895095|NCT01216332|474900833|FG000|Overall Study|Withdrawal by Subject|4|||
131895096|NCT01216332|474900834|FG001|Overall Study|Withdrawal by Subject|0|||
131895097|NCT00481767|474900836|FG000|Overall Study|Withdrawal by Subject|16|||
131895098|NCT00481767|474900837|FG001|Overall Study|Withdrawal by Subject|11|||
131895099|NCT00481767|474900836|FG000|Overall Study|Lost to Follow-up|16|||
131895100|NCT00481767|474900837|FG001|Overall Study|Lost to Follow-up|10|||
131895101|NCT00636636|474900838|FG000|Overall Study|Other reason|4|||
131553431|NCT00118898|473649908|FG002|Overall Study|Withdrawal by Subject|8|||
131553432|NCT00118898|473649909|FG003|Overall Study|Withdrawal by Subject|8|||
131553433|NCT00118898|473649906|FG000|Overall Study|Site Closure|33|||
131895102|NCT00636636|474900839|FG001|Overall Study|Other reason|6|||
131895103|NCT00636636|474900838|FG000|Overall Study|Adverse Event|19|||
131553434|NCT00118898|473649907|FG001|Overall Study|Site Closure|31|||
131553435|NCT00118898|473649908|FG002|Overall Study|Site Closure|28|||
131553436|NCT00118898|473649909|FG003|Overall Study|Site Closure|37|||
131553437|NCT00118898|473649906|FG000|Overall Study|Severe debilitation|1|||
131553438|NCT00118898|473649907|FG001|Overall Study|Severe debilitation|4|||
131553439|NCT00118898|473649908|FG002|Overall Study|Severe debilitation|6|||
131553440|NCT00118898|473649909|FG003|Overall Study|Severe debilitation|4|||
131553441|NCT00118898|473649906|FG000|Overall Study|Not compliant with requirements|11|||
131553442|NCT00118898|473649907|FG001|Overall Study|Not compliant with requirements|13|||
131553443|NCT00118898|473649908|FG002|Overall Study|Not compliant with requirements|11|||
131553444|NCT00118898|473649909|FG003|Overall Study|Not compliant with requirements|11|||
131553445|NCT00118898|473649906|FG000|Overall Study|Not able to get to clinic|34|||
131895104|NCT00636636|474900839|FG001|Overall Study|Adverse Event|8|||
131895105|NCT00636636|474900838|FG000|Overall Study|Lack of Efficacy|7|||
131895106|NCT00636636|474900839|FG001|Overall Study|Lack of Efficacy|12|||
131895107|NCT00636636|474900838|FG000|Overall Study|Protocol Violation|2|||
131895108|NCT00636636|474900839|FG001|Overall Study|Protocol Violation|2|||
131895109|NCT00636636|474900838|FG000|Overall Study|Lost to Follow-up|0|||
131895110|NCT00636636|474900839|FG001|Overall Study|Lost to Follow-up|1|||
131553446|NCT00118898|473649907|FG001|Overall Study|Not able to get to clinic|43|||
131553447|NCT00118898|473649908|FG002|Overall Study|Not able to get to clinic|31|||
131553448|NCT00118898|473649909|FG003|Overall Study|Not able to get to clinic|40|||
131553449|NCT00976703|473651102|FG000|Overall Study|Physician Decision|1|||
131553450|NCT00976703|473651103|FG001|Overall Study|Physician Decision|1|||
131553451|NCT00976703|473651102|FG000|Overall Study|ineligible for study|2|||
131553452|NCT00976703|473651103|FG001|Overall Study|ineligible for study|2|||
131553453|NCT03075501|473651106|FG000|Overall Study|Scheduling difficulties|15|||
131553454|NCT03075501|473651107|FG001|Overall Study|Scheduling difficulties|9|||
131553455|NCT00957931|473651110|FG000|Overall Study|Death|4|||
131553456|NCT00857805|473651111|FG000|Overall Study|Withdrawal by Subject|1|||
131553457|NCT00857805|473651112|FG001|Overall Study|Withdrawal by Subject|1|||
131553458|NCT04867785|473651113|FG000|Overall Study|Adverse Event|1|||
131553459|NCT04867785|473651114|FG001|Overall Study|Adverse Event|0|||
131553460|NCT04867785|473651115|FG002|Overall Study|Adverse Event|1|||
131553461|NCT04867785|473651116|FG003|Overall Study|Adverse Event|0|||
131553462|NCT04867785|473651117|FG004|Overall Study|Adverse Event|0|||
131553463|NCT04867785|473651118|FG005|Overall Study|Adverse Event|0|||
131553464|NCT04867785|473651119|FG006|Overall Study|Adverse Event|0|||
131553465|NCT04867785|473651120|FG007|Overall Study|Adverse Event|2|||
131553466|NCT04867785|473651113|FG000|Overall Study|Lost to Follow-up|4|||
131553467|NCT04867785|473651114|FG001|Overall Study|Lost to Follow-up|4|||
131553468|NCT04867785|473651115|FG002|Overall Study|Lost to Follow-up|3|||
131553469|NCT04867785|473651116|FG003|Overall Study|Lost to Follow-up|2|||
131553470|NCT04867785|473651117|FG004|Overall Study|Lost to Follow-up|0|||
131553471|NCT04867785|473651118|FG005|Overall Study|Lost to Follow-up|1|||
131553472|NCT04867785|473651119|FG006|Overall Study|Lost to Follow-up|0|||
131553473|NCT04867785|473651120|FG007|Overall Study|Lost to Follow-up|1|||
131553474|NCT04867785|473651113|FG000|Overall Study|Withdrawal by Subject|6|||
131553475|NCT04867785|473651114|FG001|Overall Study|Withdrawal by Subject|2|||
131553476|NCT04867785|473651115|FG002|Overall Study|Withdrawal by Subject|2|||
131553477|NCT04867785|473651116|FG003|Overall Study|Withdrawal by Subject|1|||
131553478|NCT04867785|473651117|FG004|Overall Study|Withdrawal by Subject|2|||
131553479|NCT04867785|473651118|FG005|Overall Study|Withdrawal by Subject|0|||
131553480|NCT04867785|473651119|FG006|Overall Study|Withdrawal by Subject|2|||
131553481|NCT04867785|473651120|FG007|Overall Study|Withdrawal by Subject|5|||
131553482|NCT04867785|473651113|FG000|Overall Study|Physician Decision|0|||
131553483|NCT04867785|473651114|FG001|Overall Study|Physician Decision|0|||
131553484|NCT04867785|473651115|FG002|Overall Study|Physician Decision|0|||
131553485|NCT04867785|473651116|FG003|Overall Study|Physician Decision|0|||
131553486|NCT04867785|473651117|FG004|Overall Study|Physician Decision|0|||
131553487|NCT04867785|473651118|FG005|Overall Study|Physician Decision|0|||
131553488|NCT04867785|473651119|FG006|Overall Study|Physician Decision|0|||
131553489|NCT04867785|473651120|FG007|Overall Study|Physician Decision|1|||
131553490|NCT04867785|473651113|FG000|Overall Study|Inadvertent Enrollment|0|||
131553491|NCT04867785|473651114|FG001|Overall Study|Inadvertent Enrollment|0|||
131553492|NCT04867785|473651115|FG002|Overall Study|Inadvertent Enrollment|0|||
131553493|NCT04867785|473651116|FG003|Overall Study|Inadvertent Enrollment|1|||
131553494|NCT04867785|473651117|FG004|Overall Study|Inadvertent Enrollment|1|||
131553495|NCT04867785|473651118|FG005|Overall Study|Inadvertent Enrollment|0|||
131553496|NCT04867785|473651119|FG006|Overall Study|Inadvertent Enrollment|0|||
131553497|NCT04867785|473651120|FG007|Overall Study|Inadvertent Enrollment|1|||
131553498|NCT04867785|473651113|FG000|Overall Study|Eligibility Criteria Not Met|0|||
131553499|NCT04867785|473651114|FG001|Overall Study|Eligibility Criteria Not Met|0|||
131553500|NCT04867785|473651115|FG002|Overall Study|Eligibility Criteria Not Met|0|||
131553501|NCT04867785|473651116|FG003|Overall Study|Eligibility Criteria Not Met|0|||
131553502|NCT04867785|473651117|FG004|Overall Study|Eligibility Criteria Not Met|0|||
131553503|NCT04867785|473651118|FG005|Overall Study|Eligibility Criteria Not Met|0|||
131553504|NCT04867785|473651119|FG006|Overall Study|Eligibility Criteria Not Met|0|||
131553505|NCT04867785|473651120|FG007|Overall Study|Eligibility Criteria Not Met|1|||
131553506|NCT01289041|473651121|FG000|Overall Study|Adverse Event|24|||
131553507|NCT01289041|473651121|FG000|Overall Study|Physician Decision|1|||
131553508|NCT01289041|473651121|FG000|Overall Study|Progressive Disease|41|||
131553509|NCT01289041|473651121|FG000|Overall Study|Withdrawal by Subject|3|||
131553510|NCT01289041|473651121|FG000|Overall Study|Death|1|||
131553511|NCT01062763|473651122|FG000|Overall Study|Adverse Event|3|||
131553512|NCT01062763|473651123|FG001|Overall Study|Adverse Event|4|||
131553513|NCT02494921|473651125|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
131553514|NCT02494921|473651126|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
131553515|NCT02494921|473651127|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
131553516|NCT02494921|473651128|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
131553517|NCT02494921|473651129|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
131553518|NCT02494921|473651125|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
131553519|NCT02494921|473651126|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
131553520|NCT02494921|473651127|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
131665106|NCT00603304|474058047|FG001|Overall Study|Adverse Event|2|||
131665107|NCT00603304|474058046|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
131665108|NCT00603304|474058047|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
131665109|NCT00603304|474058046|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
131665110|NCT00603304|474058047|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
131665111|NCT00603304|474058046|FG000|Overall Study|Exclusionary Medication|2|||
131665112|NCT00603304|474058047|FG001|Overall Study|Exclusionary Medication|3|||
131665113|NCT00603304|474058046|FG000|Overall Study|Non-Compliant|0|||
131665114|NCT00603304|474058047|FG001|Overall Study|Non-Compliant|1|||
131665115|NCT00603304|474058046|FG000|Overall Study|Moved Away|0|||
131665116|NCT00603304|474058047|FG001|Overall Study|Moved Away|2|||
131665117|NCT00603304|474058046|FG000|Overall Study|Other|2|||
131665118|NCT00603304|474058047|FG001|Overall Study|Other|0|||
131665119|NCT00603304|474058046|FG000|Overall Study|Patient Decision|2|||
131665120|NCT00603304|474058047|FG001|Overall Study|Patient Decision|0|||
131665121|NCT00616902|474058048|FG000|Overall Study|Termination of study|6|||
131665122|NCT00616902|474058049|FG001|Overall Study|Termination of study|6|||
131665123|NCT03573583|474058050|FG000|Overall Study|Lost to Follow-up|1|||
131665124|NCT03573583|474058051|FG001|Overall Study|Lost to Follow-up|0|||
131665125|NCT03573583|474058050|FG000|Overall Study|Withdrawal by Subject|1|||
131665126|NCT03573583|474058051|FG001|Overall Study|Withdrawal by Subject|1|||
131665127|NCT04343872|474058056|FG000|Overall Study|Lost to Follow-up|6|||
131665128|NCT04343872|474058057|FG001|Overall Study|Lost to Follow-up|3|||
131665129|NCT01850446|474058058|FG000|Overall Study|Lack of Efficacy|1|||
131665130|NCT01850446|474058059|FG001|Overall Study|Lack of Efficacy|0|||
131665131|NCT01850446|474058058|FG000|Overall Study|Withdrawal by Subject|4|||
131665132|NCT01850446|474058059|FG001|Overall Study|Withdrawal by Subject|0|||
131665133|NCT01850446|474058058|FG000|Overall Study|Protocol Violation|0|||
131665134|NCT01850446|474058059|FG001|Overall Study|Protocol Violation|2|||
131665135|NCT00759915|474058060|FG000|Overall Study|Withdrawal by Subject|1|||
131665136|NCT00759915|474058061|FG001|Overall Study|Withdrawal by Subject|0|||
131665137|NCT00759915|474058060|FG000|Overall Study|Adverse Event|0|||
131665138|NCT00759915|474058061|FG001|Overall Study|Adverse Event|1|||
131665139|NCT03730480|474058062|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
131665140|NCT01227577|474058063|FG000|Overall Study|Protocol deviation|3|||
131665141|NCT01227577|474058063|FG000|Overall Study|Death|3|||
131665142|NCT01227577|474058063|FG000|Overall Study|Administrative problems|2|||
131665143|NCT01227577|474058063|FG000|Overall Study|Lost to Follow-up|1|||
131665144|NCT01227577|474058063|FG000|Overall Study|Withdrawal by Subject|4|||
131665145|NCT01227577|474058063|FG000|Overall Study|Lack of Efficacy|5|||
131665146|NCT01227577|474058063|FG000|Overall Study|Adverse Event|17|||
131665147|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
131665148|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
131665149|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
131665150|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
131665151|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
131665152|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
131665153|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
131665154|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
131665155|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
131665156|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
131665157|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
131665158|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
131665159|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
131665160|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
131665161|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
131665162|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
131665163|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
131665164|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
131665165|NCT02480153|474058064|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
131665166|NCT02480153|474058065|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
131665167|NCT02480153|474058066|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
131665168|NCT02480153|474058064|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
131895111|NCT00636636|474900838|FG000|Overall Study|Death|0|||
131665169|NCT02480153|474058065|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
131665170|NCT02480153|474058066|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
131665171|NCT02480153|474058064|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
131665172|NCT02480153|474058065|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
131665173|NCT02480153|474058066|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
131665174|NCT02480153|474058064|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
131895112|NCT00636636|474900839|FG001|Overall Study|Death|1|||
131895113|NCT00636636|474900838|FG000|Overall Study|Withdrawal by Subject|4|||
131895114|NCT00636636|474900839|FG001|Overall Study|Withdrawal by Subject|9|||
131895115|NCT00524173|474900840|FG000|Overall Study|Lost to Follow-up|0|||
131895116|NCT00524173|474900841|FG001|Overall Study|Lost to Follow-up|1|||
131895117|NCT00524173|474900840|FG000|Overall Study|Death|1|||
131895118|NCT00524173|474900841|FG001|Overall Study|Death|0|||
131895119|NCT00524173|474900840|FG000|Overall Study|Had not reached endpoint at study close|4|||
131895120|NCT00524173|474900841|FG001|Overall Study|Had not reached endpoint at study close|1|||
131895121|NCT01972464|474900845|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
131895122|NCT01972464|474900846|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
131895123|NCT01972464|474900845|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
131895124|NCT01972464|474900846|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
131895125|NCT01972464|474900845|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
131895126|NCT01972464|474900846|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
131895127|NCT01972464|474900845|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
131665175|NCT02480153|474058065|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
131665176|NCT02480153|474058066|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
131665177|NCT02480153|474058064|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
131895128|NCT01972464|474900846|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
131895129|NCT02793947|474902704|FG000|Overall Study|Death|1|||
131895130|NCT02793947|474902705|FG001|Overall Study|Death|0|||
131895131|NCT02793947|474902704|FG000|Overall Study|Physician Decision|1|||
131895132|NCT02793947|474902705|FG001|Overall Study|Physician Decision|5|||
131895133|NCT01025284|474902709|FG000|Overall Study|Investigator Decision|0|||
131895134|NCT01025284|474902710|FG001|Overall Study|Investigator Decision|1|||
131895135|NCT01025284|474902711|FG002|Overall Study|Investigator Decision|0|||
131895136|NCT01025284|474902709|FG000|Overall Study|Withdrawal by Subject|0|||
131895137|NCT01025284|474902710|FG001|Overall Study|Withdrawal by Subject|1|||
131895138|NCT01025284|474902711|FG002|Overall Study|Withdrawal by Subject|0|||
131895139|NCT00905567|474902713|FG000|Washout|Withdrawal by Subject|0|||
131895140|NCT00905567|474902714|FG001|Washout|Withdrawal by Subject|1|||
131895141|NCT01465230|474902715|FG000|Overall Study|Withdrawal by Subject|2|||
131895142|NCT02753816|474902716|FG000|Overall Study|Protocol Violation|0|||
131895143|NCT02753816|474902717|FG001|Overall Study|Protocol Violation|1|||
131895144|NCT02753816|474902718|FG002|Overall Study|Protocol Violation|0|||
131895145|NCT02542397|474902720|FG000|Overall Study|Death|2|||
131895146|NCT02542397|474902720|FG000|Overall Study|Physician Decision|6|||
131895147|NCT02542397|474902720|FG000|Overall Study|Withdrawal by Subject|6|||
131895148|NCT02542397|474902720|FG000|Overall Study|Lost to Follow-up|2|||
131895149|NCT01738919|474902726|FG000|Overall Study|Lost to Follow-up|1|||
131895150|NCT01738919|474902727|FG001|Overall Study|Lost to Follow-up|0|||
131895151|NCT01738919|474902726|FG000|Overall Study|Immigrated|0|||
131895152|NCT01738919|474902727|FG001|Overall Study|Immigrated|1|||
131895153|NCT01738919|474902726|FG000|Overall Study|Withdrawal by Subject|0|||
131895154|NCT01738919|474902727|FG001|Overall Study|Withdrawal by Subject|1|||
131895155|NCT01738919|474902726|FG000|Overall Study|Not treated in accordance to guidelines|0|||
131895156|NCT01738919|474902727|FG001|Overall Study|Not treated in accordance to guidelines|1|||
131895157|NCT01473940|474902731|FG000|Induction Therapy|Death|0|||
131435943|NCT01774799|473221901|FG000|Overall Study|Lost to Follow-up|1|||
131435944|NCT01774799|473221902|FG001|Overall Study|Lost to Follow-up|1|||
131665178|NCT02480153|474058065|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
131665179|NCT02480153|474058066|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
131665180|NCT02480153|474058064|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
131665181|NCT02480153|474058065|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
131665182|NCT02480153|474058066|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
131665183|NCT02480153|474058064|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
131665184|NCT02480153|474058065|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
131665185|NCT02480153|474058066|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
131665186|NCT02480153|474058064|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
131665187|NCT02480153|474058065|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
131665188|NCT02480153|474058066|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
131665189|NCT02480153|474058064|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
131665190|NCT02480153|474058065|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
131895158|NCT01473940|474902732|FG001|Induction Therapy|Death|0|||
131895159|NCT01473940|474902733|FG002|Induction Therapy|Death|1|||
131895160|NCT01473940|474902734|FG003|Induction Therapy|Death|1|||
131895161|NCT01473940|474902731|FG000|Induction Therapy|Progressive Disease|0|||
131895162|NCT01473940|474902732|FG001|Induction Therapy|Progressive Disease|1|||
131895163|NCT01473940|474902733|FG002|Induction Therapy|Progressive Disease|1|||
131895164|NCT01473940|474902734|FG003|Induction Therapy|Progressive Disease|0|||
131895165|NCT01473940|474902731|FG000|Maintenance Therapy|Progressive Disease|1|||
131895166|NCT01473940|474902732|FG001|Maintenance Therapy|Progressive Disease|2|||
131435945|NCT01774799|473221903|FG002|Overall Study|Lost to Follow-up|0|||
131895167|NCT01473940|474902733|FG002|Maintenance Therapy|Progressive Disease|1|||
131895168|NCT01473940|474902734|FG003|Maintenance Therapy|Progressive Disease|4|||
131895169|NCT00547248|474902735|FG000|Overall Study|Protocol Violation|0|||
131895170|NCT00547248|474902736|FG001|Overall Study|Protocol Violation|0|||
131895171|NCT00547248|474902737|FG002|Overall Study|Protocol Violation|1|||
131895172|NCT00547248|474902738|FG003|Overall Study|Protocol Violation|1|||
131895173|NCT00547248|474902735|FG000|Overall Study|Migrated/moved from study area|0|||
131895174|NCT00547248|474902736|FG001|Overall Study|Migrated/moved from study area|0|||
131895175|NCT00547248|474902737|FG002|Overall Study|Migrated/moved from study area|2|||
131895176|NCT00547248|474902738|FG003|Overall Study|Migrated/moved from study area|0|||
131895177|NCT00547248|474902735|FG000|Overall Study|Withdrawal by Subject|0|||
131895178|NCT00547248|474902736|FG001|Overall Study|Withdrawal by Subject|0|||
131895179|NCT00547248|474902737|FG002|Overall Study|Withdrawal by Subject|7|||
131895180|NCT00547248|474902738|FG003|Overall Study|Withdrawal by Subject|1|||
131895181|NCT00534248|474902741|FG000|Overall Study|Adverse Event|19|||
131895182|NCT00534248|474902742|FG001|Overall Study|Adverse Event|29|||
131895183|NCT00534248|474902741|FG000|Overall Study|Lost to Follow-up|353|||
131895184|NCT00534248|474902742|FG001|Overall Study|Lost to Follow-up|375|||
131895185|NCT00534248|474902741|FG000|Overall Study|Other protocol specified criteria|13|||
131895186|NCT00534248|474902742|FG001|Overall Study|Other protocol specified criteria|3|||
131895187|NCT00534248|474902741|FG000|Overall Study|Physician Decision|10|||
131895188|NCT00534248|474902742|FG001|Overall Study|Physician Decision|7|||
131895189|NCT00534248|474902741|FG000|Overall Study|Protocol Violation|3|||
131895190|NCT00534248|474902742|FG001|Overall Study|Protocol Violation|4|||
131895191|NCT00534248|474902741|FG000|Overall Study|Withdrawal by Subject|263|||
131895192|NCT00534248|474902742|FG001|Overall Study|Withdrawal by Subject|255|||
131895193|NCT02532257|474902743|FG000|Overall Study|Adverse Event|2|||
131895194|NCT02532257|474902743|FG000|Overall Study|Physician Decision|4|||
131895195|NCT02532257|474902743|FG000|Overall Study|Withdrawal by Subject|3|||
131895196|NCT02532257|474902743|FG000|Overall Study|Progressive Disease|10|||
131895197|NCT02849171|474902744|FG000|Overall Study|Withdrawal by Subject|1|||
131895198|NCT02849171|474902744|FG000|Overall Study|Not treated|1|||
131895199|NCT02259400|474902747|FG000|Overall Study|Death|0|||
131895200|NCT02259400|474902748|FG001|Overall Study|Death|2|||
131895201|NCT00697593|474902752|FG000|Overall Study|Adverse Event|3|||
131895202|NCT00697593|474902752|FG000|Overall Study|Protocol Violation|1|||
131895203|NCT00697593|474902752|FG000|Overall Study|Lack of Efficacy|3|||
131895204|NCT00697593|474902752|FG000|Overall Study|Suspension of the study by sponsor|12|||
131895205|NCT02964338|474902753|FG000|Overall Study|Sponsor terminated study for futility|12|||
131895206|NCT02964338|474902754|FG001|Overall Study|Sponsor terminated study for futility|15|||
131895207|NCT02964338|474902755|FG002|Overall Study|Sponsor terminated study for futility|14|||
131895208|NCT02964338|474902753|FG000|Overall Study|Lack of Efficacy|0|||
131895209|NCT02964338|474902754|FG001|Overall Study|Lack of Efficacy|3|||
131895210|NCT02964338|474902755|FG002|Overall Study|Lack of Efficacy|0|||
131895211|NCT02964338|474902753|FG000|Overall Study|Lost to Follow-up|1|||
131895212|NCT02964338|474902754|FG001|Overall Study|Lost to Follow-up|0|||
131895213|NCT02964338|474902755|FG002|Overall Study|Lost to Follow-up|3|||
131895214|NCT02964338|474902753|FG000|Overall Study|Protocol Violation|0|||
131895215|NCT02964338|474902754|FG001|Overall Study|Protocol Violation|1|||
131895216|NCT02964338|474902755|FG002|Overall Study|Protocol Violation|0|||
131895217|NCT02964338|474902753|FG000|Overall Study|Withdrawal by Subject|1|||
131895218|NCT02964338|474902754|FG001|Overall Study|Withdrawal by Subject|3|||
131895219|NCT02964338|474902755|FG002|Overall Study|Withdrawal by Subject|1|||
131895220|NCT02964338|474902753|FG000|Overall Study|Adverse Event|2|||
131895221|NCT02964338|474902754|FG001|Overall Study|Adverse Event|1|||
131895222|NCT02964338|474902755|FG002|Overall Study|Adverse Event|1|||
131895223|NCT02964338|474902753|FG000|Overall Study|Non-compliant with e-diary|0|||
131895224|NCT02964338|474902754|FG001|Overall Study|Non-compliant with e-diary|1|||
131895225|NCT02964338|474902755|FG002|Overall Study|Non-compliant with e-diary|0|||
131895226|NCT02964338|474902753|FG000|Overall Study|Did not meet criteria|1|||
131895227|NCT02964338|474902754|FG001|Overall Study|Did not meet criteria|0|||
131895228|NCT02964338|474902755|FG002|Overall Study|Did not meet criteria|0|||
131895229|NCT02372383|474902759|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
131895230|NCT02372383|474902760|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
131895231|NCT02372383|474902761|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
131895232|NCT02239640|474902762|FG000|Overall Study|Withdrawal by Subject|3|||
131895233|NCT02239640|474902762|FG000|Overall Study|Lost to Follow-up|72|||
131895234|NCT02239640|474902762|FG000|Overall Study|Death|142|||
131895235|NCT02630563|474902763|FG000|Overall Study|Administrative|1|||
131895236|NCT00621257|474902766|FG000|Overall Study|Lost to Follow-up|4|||
131895237|NCT00621257|474902767|FG001|Overall Study|Lost to Follow-up|0|||
131895238|NCT00621257|474902768|FG002|Overall Study|Lost to Follow-up|2|||
131895239|NCT00621257|474902769|FG003|Overall Study|Lost to Follow-up|4|||
131895240|NCT00621257|474902770|FG004|Overall Study|Lost to Follow-up|7|||
131895241|NCT00621257|474902766|FG000|Overall Study|Adverse Event|0|||
131553521|NCT02494921|473651128|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
131895242|NCT00621257|474902767|FG001|Overall Study|Adverse Event|1|||
131895243|NCT00621257|474902768|FG002|Overall Study|Adverse Event|1|||
131895244|NCT00621257|474902769|FG003|Overall Study|Adverse Event|0|||
131895245|NCT00621257|474902770|FG004|Overall Study|Adverse Event|0|||
131895246|NCT00621257|474902766|FG000|Overall Study|Physician Decision|0|||
131895247|NCT00621257|474902767|FG001|Overall Study|Physician Decision|2|||
131895248|NCT00621257|474902768|FG002|Overall Study|Physician Decision|0|||
131895249|NCT00621257|474902769|FG003|Overall Study|Physician Decision|1|||
131895250|NCT00621257|474902770|FG004|Overall Study|Physician Decision|1|||
131895251|NCT00621257|474902766|FG000|Overall Study|Withdrawal by Subject|0|||
131895252|NCT00621257|474902767|FG001|Overall Study|Withdrawal by Subject|0|||
131895253|NCT00621257|474902768|FG002|Overall Study|Withdrawal by Subject|0|||
131895254|NCT00621257|474902769|FG003|Overall Study|Withdrawal by Subject|1|||
131895255|NCT00621257|474902770|FG004|Overall Study|Withdrawal by Subject|1|||
131895256|NCT01255904|474902771|FG000|Overall Study|Physician Decision|1|||
131895257|NCT01255904|474902772|FG001|Overall Study|Physician Decision|4|||
131895258|NCT02061813|474902776|FG000|Overall Study|Withdrawal by Subject|1|||
131895259|NCT02061813|474902776|FG000|Overall Study|Protocol Violation|2|||
131895260|NCT01705080|474902779|FG000|Overall Study|Missed visit|10|||
131895261|NCT01705080|474902780|FG001|Overall Study|Missed visit|4|||
131895262|NCT01705080|474902781|FG002|Overall Study|Missed visit|1|||
131895263|NCT01705080|474902779|FG000|Overall Study|Death|4|||
131895264|NCT01705080|474902780|FG001|Overall Study|Death|4|||
131895265|NCT01705080|474902781|FG002|Overall Study|Death|6|||
131895266|NCT01705080|474902779|FG000|Overall Study|Withdrawal by Subject|61|||
131895267|NCT01705080|474902780|FG001|Overall Study|Withdrawal by Subject|44|||
131895268|NCT01705080|474902781|FG002|Overall Study|Withdrawal by Subject|9|||
131895269|NCT00206427|474902783|FG000|Overall Study|Adverse Event|2|||
131895270|NCT00632125|474902787|FG000|Overall Study|Death|82|||
131895271|NCT00632125|474902787|FG000|Overall Study|Withdrawal by Subject|44|||
131895272|NCT00632125|474902787|FG000|Overall Study|Adverse Event|36|||
131895273|NCT00632125|474902787|FG000|Overall Study|Renal transplantation|17|||
131895274|NCT00632125|474902787|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
131895275|NCT00632125|474902787|FG000|Overall Study|Non-compliance|8|||
131895276|NCT00632125|474902787|FG000|Overall Study|Development of uncontrolled hypertension|5|||
131895277|NCT00632125|474902787|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
131895278|NCT03130959|474902794|FG000|Overall Study|Disease progression|19|||
131895279|NCT03130959|474902795|FG001|Overall Study|Disease progression|7|||
131895280|NCT03130959|474902796|FG002|Overall Study|Disease progression|12|||
131895281|NCT03130959|474902797|FG003|Overall Study|Disease progression|7|||
131895282|NCT03130959|474902798|FG004|Overall Study|Disease progression|12|||
131895283|NCT03130959|474902799|FG005|Overall Study|Disease progression|3|||
131895284|NCT03130959|474902800|FG006|Overall Study|Disease progression|6|||
131895285|NCT03130959|474902801|FG007|Overall Study|Disease progression|3|||
131895286|NCT03130959|474902802|FG008|Overall Study|Disease progression|15|||
131895287|NCT03130959|474902803|FG009|Overall Study|Disease progression|8|||
131895288|NCT03130959|474902794|FG000|Overall Study|Study drug toxicity|2|||
131895289|NCT03130959|474902795|FG001|Overall Study|Study drug toxicity|2|||
131895290|NCT03130959|474902796|FG002|Overall Study|Study drug toxicity|1|||
131895291|NCT03130959|474902797|FG003|Overall Study|Study drug toxicity|2|||
131895292|NCT03130959|474902798|FG004|Overall Study|Study drug toxicity|1|||
131553522|NCT02494921|473651129|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
131553523|NCT02494921|473651125|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
131553524|NCT02494921|473651126|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
131553525|NCT02494921|473651127|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
131553526|NCT02494921|473651128|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
131553527|NCT02494921|473651129|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
131553528|NCT02714868|473651137|FG000|Overall Study|Withdrawal by Subject|3|||
131553529|NCT02714868|473651138|FG001|Overall Study|Withdrawal by Subject|0|||
131553530|NCT02714868|473651137|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
131553531|NCT02714868|473651138|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
131553532|NCT02714868|473651137|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
131553533|NCT02714868|473651138|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
131553534|NCT00255346|473651142|FG000|Overall Study|Adverse Event|1|||
131553535|NCT00255346|473651143|FG001|Overall Study|Adverse Event|0|||
131553536|NCT00255346|473651144|FG002|Overall Study|Adverse Event|0|||
131553537|NCT00255346|473651145|FG003|Overall Study|Adverse Event|0|||
131553538|NCT00255346|473651146|FG004|Overall Study|Adverse Event|0|||
131553539|NCT00674323|473651147|FG000|Overall Study|Adverse Event|0|||
131553540|NCT00674323|473651148|FG001|Overall Study|Adverse Event|1|||
131553541|NCT00674323|473651149|FG002|Overall Study|Adverse Event|0|||
131553542|NCT00674323|473651147|FG000|Overall Study|Protocol Violation|1|||
131553543|NCT00674323|473651148|FG001|Overall Study|Protocol Violation|0|||
131665191|NCT02480153|474058066|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
131895293|NCT03130959|474902799|FG005|Overall Study|Study drug toxicity|1|||
131895294|NCT03130959|474902800|FG006|Overall Study|Study drug toxicity|3|||
131895295|NCT03130959|474902801|FG007|Overall Study|Study drug toxicity|0|||
131895296|NCT03130959|474902802|FG008|Overall Study|Study drug toxicity|3|||
131895297|NCT03130959|474902803|FG009|Overall Study|Study drug toxicity|3|||
131895298|NCT03130959|474902794|FG000|Overall Study|Other reasons|0|||
131895299|NCT03130959|474902795|FG001|Overall Study|Other reasons|0|||
131895300|NCT03130959|474902796|FG002|Overall Study|Other reasons|0|||
131895301|NCT03130959|474902797|FG003|Overall Study|Other reasons|0|||
131895302|NCT03130959|474902798|FG004|Overall Study|Other reasons|0|||
131895303|NCT03130959|474902799|FG005|Overall Study|Other reasons|1|||
131895304|NCT03130959|474902800|FG006|Overall Study|Other reasons|1|||
131895305|NCT03130959|474902801|FG007|Overall Study|Other reasons|0|||
131895306|NCT03130959|474902802|FG008|Overall Study|Other reasons|0|||
131895307|NCT03130959|474902803|FG009|Overall Study|Other reasons|0|||
131895308|NCT03130959|474902794|FG000|Overall Study|Subject request to discontinue therapy|0|||
131895309|NCT03130959|474902795|FG001|Overall Study|Subject request to discontinue therapy|0|||
131895310|NCT03130959|474902796|FG002|Overall Study|Subject request to discontinue therapy|1|||
131895311|NCT03130959|474902797|FG003|Overall Study|Subject request to discontinue therapy|1|||
131895312|NCT03130959|474902798|FG004|Overall Study|Subject request to discontinue therapy|0|||
131895313|NCT03130959|474902799|FG005|Overall Study|Subject request to discontinue therapy|0|||
131895314|NCT03130959|474902800|FG006|Overall Study|Subject request to discontinue therapy|1|||
131895315|NCT03130959|474902801|FG007|Overall Study|Subject request to discontinue therapy|1|||
131895316|NCT03130959|474902802|FG008|Overall Study|Subject request to discontinue therapy|0|||
131895317|NCT03130959|474902803|FG009|Overall Study|Subject request to discontinue therapy|0|||
131895318|NCT03130959|474902794|FG000|Overall Study|Not reported|0|||
131895319|NCT03130959|474902795|FG001|Overall Study|Not reported|0|||
131895320|NCT03130959|474902796|FG002|Overall Study|Not reported|0|||
131895321|NCT03130959|474902797|FG003|Overall Study|Not reported|1|||
131895322|NCT03130959|474902798|FG004|Overall Study|Not reported|0|||
131895323|NCT03130959|474902799|FG005|Overall Study|Not reported|1|||
131895324|NCT03130959|474902800|FG006|Overall Study|Not reported|0|||
131895325|NCT03130959|474902801|FG007|Overall Study|Not reported|0|||
131895326|NCT03130959|474902802|FG008|Overall Study|Not reported|0|||
131895327|NCT03130959|474902803|FG009|Overall Study|Not reported|1|||
131895328|NCT03130959|474902794|FG000|Overall Study|Adverse Event unrelated to drug|0|||
131895329|NCT03130959|474902795|FG001|Overall Study|Adverse Event unrelated to drug|0|||
131895330|NCT03130959|474902796|FG002|Overall Study|Adverse Event unrelated to drug|1|||
131895331|NCT03130959|474902797|FG003|Overall Study|Adverse Event unrelated to drug|1|||
131895332|NCT03130959|474902798|FG004|Overall Study|Adverse Event unrelated to drug|1|||
131895333|NCT03130959|474902799|FG005|Overall Study|Adverse Event unrelated to drug|0|||
131895334|NCT03130959|474902800|FG006|Overall Study|Adverse Event unrelated to drug|1|||
131895335|NCT03130959|474902801|FG007|Overall Study|Adverse Event unrelated to drug|0|||
131895336|NCT03130959|474902802|FG008|Overall Study|Adverse Event unrelated to drug|1|||
131895337|NCT03130959|474902803|FG009|Overall Study|Adverse Event unrelated to drug|1|||
131895338|NCT03130959|474902794|FG000|Overall Study|Participant withdrew consent|0|||
131895339|NCT03130959|474902795|FG001|Overall Study|Participant withdrew consent|1|||
131895340|NCT03130959|474902796|FG002|Overall Study|Participant withdrew consent|0|||
131895341|NCT03130959|474902797|FG003|Overall Study|Participant withdrew consent|2|||
131895342|NCT03130959|474902798|FG004|Overall Study|Participant withdrew consent|1|||
131895343|NCT03130959|474902799|FG005|Overall Study|Participant withdrew consent|0|||
131895344|NCT03130959|474902800|FG006|Overall Study|Participant withdrew consent|0|||
131895345|NCT03130959|474902801|FG007|Overall Study|Participant withdrew consent|0|||
131895346|NCT03130959|474902802|FG008|Overall Study|Participant withdrew consent|0|||
131895347|NCT03130959|474902803|FG009|Overall Study|Participant withdrew consent|2|||
131895348|NCT03130959|474902794|FG000|Overall Study|Administrative reason by sponsor|1|||
131895349|NCT03130959|474902795|FG001|Overall Study|Administrative reason by sponsor|0|||
131895350|NCT03130959|474902796|FG002|Overall Study|Administrative reason by sponsor|1|||
131895351|NCT03130959|474902797|FG003|Overall Study|Administrative reason by sponsor|0|||
131553544|NCT00674323|473651149|FG002|Overall Study|Protocol Violation|0|||
131553545|NCT02045433|473651159|FG000|Overall Study|Withdrawal by Subject|1|||
131553546|NCT03585296|473651160|FG000|Overall Study|Adverse Event|1|||
131553547|NCT03585296|473651160|FG000|Overall Study|Lost to Follow-up|2|||
131553548|NCT03585296|473651160|FG000|Overall Study|Withdrawal by Subject|2|||
131553549|NCT04836858|473651162|FG000|Overall Study|Adverse Event|0|||
131553550|NCT04836858|473651163|FG001|Overall Study|Adverse Event|0|||
131553551|NCT04836858|473651164|FG002|Overall Study|Adverse Event|0|||
131895352|NCT03130959|474902798|FG004|Overall Study|Administrative reason by sponsor|0|||
131895353|NCT03130959|474902799|FG005|Overall Study|Administrative reason by sponsor|0|||
131895354|NCT03130959|474902800|FG006|Overall Study|Administrative reason by sponsor|0|||
131895355|NCT03130959|474902801|FG007|Overall Study|Administrative reason by sponsor|0|||
131895356|NCT03130959|474902802|FG008|Overall Study|Administrative reason by sponsor|0|||
131895357|NCT03130959|474902803|FG009|Overall Study|Administrative reason by sponsor|0|||
131895358|NCT03130959|474902794|FG000|Overall Study|Lost to Follow-up|1|||
131895359|NCT03130959|474902795|FG001|Overall Study|Lost to Follow-up|0|||
131895360|NCT03130959|474902796|FG002|Overall Study|Lost to Follow-up|0|||
131895361|NCT03130959|474902797|FG003|Overall Study|Lost to Follow-up|0|||
131553552|NCT04836858|473651165|FG003|Overall Study|Adverse Event|1|||
131553553|NCT04836858|473651162|FG000|Overall Study|Lost to Follow-up|1|||
131895362|NCT03130959|474902798|FG004|Overall Study|Lost to Follow-up|0|||
131895363|NCT03130959|474902799|FG005|Overall Study|Lost to Follow-up|0|||
131895364|NCT03130959|474902800|FG006|Overall Study|Lost to Follow-up|0|||
131895365|NCT03130959|474902801|FG007|Overall Study|Lost to Follow-up|0|||
131895366|NCT03130959|474902802|FG008|Overall Study|Lost to Follow-up|0|||
131895367|NCT03130959|474902803|FG009|Overall Study|Lost to Follow-up|0|||
131895368|NCT02384538|474902804|FG000|Overall Study|Adverse Event|1|||
131895369|NCT02384538|474902805|FG001|Overall Study|Adverse Event|4|||
131895370|NCT02384538|474902804|FG000|Overall Study|Lack of Efficacy|4|||
131895371|NCT02384538|474902805|FG001|Overall Study|Lack of Efficacy|4|||
131895372|NCT02384538|474902804|FG000|Overall Study|Withdrew Consent|0|||
131895373|NCT02384538|474902805|FG001|Overall Study|Withdrew Consent|4|||
131895374|NCT02384538|474902804|FG000|Overall Study|Other|1|||
131895375|NCT02384538|474902805|FG001|Overall Study|Other|3|||
131895376|NCT00741598|474902808|FG000|Overall Study|Lost to Follow-up|3|||
131895377|NCT00741598|474902809|FG001|Overall Study|Lost to Follow-up|4|||
131895378|NCT00741598|474902808|FG000|Overall Study|Lack of Efficacy|1|||
131895379|NCT00741598|474902809|FG001|Overall Study|Lack of Efficacy|2|||
131895380|NCT00741598|474902808|FG000|Overall Study|Physician Decision|1|||
131895381|NCT00741598|474902809|FG001|Overall Study|Physician Decision|1|||
131895382|NCT00741598|474902808|FG000|Overall Study|Pregnancy|1|||
131895383|NCT00741598|474902809|FG001|Overall Study|Pregnancy|0|||
131895384|NCT00741598|474902808|FG000|Overall Study|Withdrawal by Subject|3|||
131895385|NCT00741598|474902809|FG001|Overall Study|Withdrawal by Subject|2|||
131895386|NCT00313586|474902810|FG000|Overall Study|Disease progression|14|||
131895387|NCT00313586|474902811|FG001|Overall Study|Disease progression|19|||
131895388|NCT00313586|474902812|FG002|Overall Study|Disease progression|10|||
131895389|NCT00313586|474902813|FG003|Overall Study|Disease progression|3|||
131895390|NCT00313586|474902810|FG000|Overall Study|Adverse Event|12|||
131895391|NCT00313586|474902811|FG001|Overall Study|Adverse Event|18|||
131895392|NCT00313586|474902812|FG002|Overall Study|Adverse Event|3|||
131895393|NCT00313586|474902813|FG003|Overall Study|Adverse Event|10|||
131895394|NCT00313586|474902810|FG000|Overall Study|Death|11|||
131895395|NCT00313586|474902811|FG001|Overall Study|Death|8|||
131895396|NCT00313586|474902812|FG002|Overall Study|Death|1|||
131895397|NCT00313586|474902813|FG003|Overall Study|Death|7|||
131895398|NCT00313586|474902810|FG000|Overall Study|Withdrawal by Subject|13|||
131895399|NCT00313586|474902811|FG001|Overall Study|Withdrawal by Subject|6|||
131895400|NCT00313586|474902812|FG002|Overall Study|Withdrawal by Subject|6|||
131895401|NCT00313586|474902813|FG003|Overall Study|Withdrawal by Subject|2|||
131895402|NCT00313586|474902810|FG000|Overall Study|Alternative therapy|3|||
131895403|NCT00313586|474902811|FG001|Overall Study|Alternative therapy|6|||
131895404|NCT00313586|474902812|FG002|Overall Study|Alternative therapy|2|||
131895405|NCT00313586|474902813|FG003|Overall Study|Alternative therapy|0|||
131895406|NCT00313586|474902810|FG000|Overall Study|Other complicating disease|2|||
131895407|NCT00313586|474902811|FG001|Overall Study|Other complicating disease|2|||
131895408|NCT00313586|474902812|FG002|Overall Study|Other complicating disease|0|||
131895409|NCT00313586|474902813|FG003|Overall Study|Other complicating disease|0|||
131895410|NCT00313586|474902810|FG000|Overall Study|Did not achieve HI-major/better response|10|||
131895411|NCT00313586|474902811|FG001|Overall Study|Did not achieve HI-major/better response|7|||
131895412|NCT00313586|474902812|FG002|Overall Study|Did not achieve HI-major/better response|2|||
131895413|NCT00313586|474902813|FG003|Overall Study|Did not achieve HI-major/better response|1|||
131895414|NCT00313586|474902810|FG000|Overall Study|Physician Decision|2|||
131895415|NCT00313586|474902811|FG001|Overall Study|Physician Decision|1|||
131895416|NCT00313586|474902812|FG002|Overall Study|Physician Decision|0|||
131895417|NCT00313586|474902813|FG003|Overall Study|Physician Decision|0|||
131895418|NCT00313586|474902810|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
131895419|NCT00313586|474902811|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
131895420|NCT00313586|474902812|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
131895421|NCT00313586|474902813|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
131895422|NCT00313586|474902810|FG000|Overall Study|Lost insurance|0|||
131895423|NCT00313586|474902811|FG001|Overall Study|Lost insurance|1|||
131895424|NCT00313586|474902812|FG002|Overall Study|Lost insurance|0|||
131895425|NCT00313586|474902813|FG003|Overall Study|Lost insurance|0|||
131895426|NCT00313586|474902810|FG000|Overall Study|Moved|0|||
131895427|NCT00313586|474902811|FG001|Overall Study|Moved|1|||
131895428|NCT00313586|474902812|FG002|Overall Study|Moved|0|||
131895429|NCT00313586|474902813|FG003|Overall Study|Moved|0|||
131895430|NCT00313586|474902810|FG000|Overall Study|Death before starting treatment|1|||
131895431|NCT00313586|474902811|FG001|Overall Study|Death before starting treatment|0|||
131895432|NCT00313586|474902812|FG002|Overall Study|Death before starting treatment|0|||
131895433|NCT00313586|474902813|FG003|Overall Study|Death before starting treatment|0|||
131895434|NCT01042392|474902814|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
131895435|NCT01042392|474902815|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
131895436|NCT01042392|474902816|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
131895437|NCT01042392|474902817|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
131895438|NCT01042392|474902814|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
131895439|NCT01042392|474902815|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
131895440|NCT01042392|474902816|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
131895441|NCT01042392|474902817|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
131895442|NCT01042392|474902814|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
131895443|NCT01042392|474902815|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
131895444|NCT01042392|474902816|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
131895445|NCT01042392|474902817|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
131895446|NCT01042392|474902814|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
131895447|NCT01042392|474902815|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
131895448|NCT01042392|474902816|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
131895449|NCT01042392|474902817|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
131895450|NCT01042392|474902814|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
131895451|NCT01042392|474902815|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
131895452|NCT01042392|474902816|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
131895453|NCT01042392|474902817|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
131895454|NCT01042392|474902814|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
131895455|NCT01042392|474902815|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
131895456|NCT01042392|474902816|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
131895457|NCT01042392|474902817|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
131895458|NCT01042392|474902814|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
131895459|NCT01042392|474902815|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
131895460|NCT01042392|474902816|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
131895461|NCT01042392|474902817|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
131895462|NCT01042392|474902814|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
131895463|NCT01042392|474902815|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
131895464|NCT01042392|474902816|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
131895465|NCT01042392|474902817|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
131895466|NCT01042392|474902814|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
131895467|NCT01042392|474902815|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
131895468|NCT01042392|474902816|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
131895469|NCT01042392|474902817|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
131895470|NCT03076996|474902818|FG000|Overall Study|Withdrawal by Subject|2|||
131895471|NCT03076996|474902818|FG000|Overall Study|Lost to Follow-up|3|||
131895472|NCT03076996|474902818|FG000|Overall Study|Literacy precluded participation|1|||
131895473|NCT00587795|474902819|FG000|Overall Study|Withdrawal by Subject|1|||
131895474|NCT00587795|474902820|FG001|Overall Study|Withdrawal by Subject|0|||
131895475|NCT01247350|474902821|FG000|Overall Study|Adverse Event|0|||
131895476|NCT01247350|474902822|FG001|Overall Study|Adverse Event|0|||
131895477|NCT01247350|474902823|FG002|Overall Study|Adverse Event|1|||
131895478|NCT01247350|474902824|FG003|Overall Study|Adverse Event|0|||
131895479|NCT01247350|474902825|FG004|Overall Study|Adverse Event|0|||
131895480|NCT01247350|474902821|FG000|Overall Study|Withdrawal by Subject|0|||
131895481|NCT01247350|474902822|FG001|Overall Study|Withdrawal by Subject|0|||
131895482|NCT01247350|474902823|FG002|Overall Study|Withdrawal by Subject|0|||
131895483|NCT01247350|474902824|FG003|Overall Study|Withdrawal by Subject|1|||
131895484|NCT01247350|474902825|FG004|Overall Study|Withdrawal by Subject|0|||
131895485|NCT01247350|474902821|FG000|Overall Study|Entry criteria not met|0|||
131895486|NCT01247350|474902822|FG001|Overall Study|Entry criteria not met|0|||
131895487|NCT01247350|474902823|FG002|Overall Study|Entry criteria not met|0|||
131895488|NCT01247350|474902824|FG003|Overall Study|Entry criteria not met|0|||
131895489|NCT01247350|474902825|FG004|Overall Study|Entry criteria not met|1|||
131895490|NCT02869893|474902828|FG000|Overall Study|participant aversion to IV|5|||
131895491|NCT02869893|474902828|FG000|Overall Study|participant fear of MRI scanner|2|||
131895492|NCT03146741|474902829|FG000|Overall Study|Txp with non-HCV+ heart|4|||
131895493|NCT03146741|474902829|FG000|Overall Study|Listeted for MOT|2|||
131895494|NCT03146741|474902829|FG000|Overall Study|Physician Decision|2|||
131895495|NCT03146741|474902829|FG000|Overall Study|Awaiting txp|2|||
131895496|NCT01030718|474902846|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
131895497|NCT01030718|474902847|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
131895498|NCT01030718|474902848|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
131895499|NCT01030718|474902846|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
131895500|NCT01030718|474902847|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
131895501|NCT01030718|474902848|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
131895502|NCT01030718|474902846|FG000|Studies CA180-031 and -036 Combined|Death|0|||
131895503|NCT01030718|474902847|FG001|Studies CA180-031 and -036 Combined|Death|1|||
131895504|NCT01030718|474902848|FG002|Studies CA180-031 and -036 Combined|Death|0|||
131895505|NCT01030718|474902846|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
131895506|NCT01030718|474902847|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
131895507|NCT01030718|474902848|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
131895508|NCT01030718|474902846|FG000|Study CA180-036 Only|insufficient effect|1|||
131895509|NCT01030718|474902847|FG001|Study CA180-036 Only|insufficient effect|1|||
131895510|NCT01030718|474902848|FG002|Study CA180-036 Only|insufficient effect|5|||
131895511|NCT01030718|474902846|FG000|Study CA180-036 Only|Adverse Event|2|||
131895512|NCT01030718|474902847|FG001|Study CA180-036 Only|Adverse Event|3|||
131895513|NCT01030718|474902848|FG002|Study CA180-036 Only|Adverse Event|0|||
131895514|NCT01030718|474902846|FG000|Study CA180-036 Only|Death|0|||
131895515|NCT01030718|474902847|FG001|Study CA180-036 Only|Death|1|||
131895516|NCT01030718|474902848|FG002|Study CA180-036 Only|Death|0|||
131895517|NCT01030718|474902846|FG000|Study CA180-036 Only|Other Reasons|0|||
131895518|NCT01030718|474902847|FG001|Study CA180-036 Only|Other Reasons|2|||
131895519|NCT01030718|474902848|FG002|Study CA180-036 Only|Other Reasons|0|||
131895520|NCT00099632|474902849|FG000|Overall Study|Lost to Follow-up|1|||
131895521|NCT00099632|474902850|FG001|Overall Study|Lost to Follow-up|0|||
131895522|NCT00099632|474902851|FG002|Overall Study|Lost to Follow-up|3|||
131895523|NCT00099632|474902852|FG003|Overall Study|Lost to Follow-up|1|||
131895524|NCT00099632|474902853|FG004|Overall Study|Lost to Follow-up|1|||
131895525|NCT00099632|474902854|FG005|Overall Study|Lost to Follow-up|0|||
131895526|NCT00099632|474902849|FG000|Overall Study|Withdrawal by Subject|0|||
131895527|NCT00099632|474902850|FG001|Overall Study|Withdrawal by Subject|1|||
131895528|NCT00099632|474902851|FG002|Overall Study|Withdrawal by Subject|0|||
131895529|NCT00099632|474902852|FG003|Overall Study|Withdrawal by Subject|0|||
131895530|NCT00099632|474902853|FG004|Overall Study|Withdrawal by Subject|0|||
131895531|NCT00099632|474902854|FG005|Overall Study|Withdrawal by Subject|1|||
131895532|NCT00099632|474902849|FG000|Overall Study|Protocol Violation|0|||
131895533|NCT00099632|474902850|FG001|Overall Study|Protocol Violation|0|||
131895534|NCT00099632|474902851|FG002|Overall Study|Protocol Violation|0|||
131895535|NCT00099632|474902852|FG003|Overall Study|Protocol Violation|0|||
131895536|NCT00099632|474902853|FG004|Overall Study|Protocol Violation|0|||
131895537|NCT00099632|474902854|FG005|Overall Study|Protocol Violation|1|||
131895538|NCT00423813|474902855|FG000|Overall Study|Adverse Event|11|||
131895539|NCT00423813|474902856|FG001|Overall Study|Adverse Event|30|||
131895540|NCT00423813|474902857|FG002|Overall Study|Adverse Event|40|||
131895541|NCT00423813|474902855|FG000|Overall Study|Withdrawal by Subject|6|||
131895542|NCT00423813|474902856|FG001|Overall Study|Withdrawal by Subject|8|||
131895543|NCT00423813|474902857|FG002|Overall Study|Withdrawal by Subject|5|||
131895544|NCT00423813|474902855|FG000|Overall Study|Lost to Follow-up|5|||
131895545|NCT00423813|474902856|FG001|Overall Study|Lost to Follow-up|4|||
131895546|NCT00423813|474902857|FG002|Overall Study|Lost to Follow-up|4|||
131895547|NCT00423813|474902855|FG000|Overall Study|Lack of Efficacy|23|||
131895548|NCT00423813|474902856|FG001|Overall Study|Lack of Efficacy|18|||
131895549|NCT00423813|474902857|FG002|Overall Study|Lack of Efficacy|19|||
131895550|NCT00423813|474902855|FG000|Overall Study|Physician Decision|2|||
131895551|NCT00423813|474902856|FG001|Overall Study|Physician Decision|0|||
131895552|NCT00423813|474902857|FG002|Overall Study|Physician Decision|0|||
131895553|NCT00423813|474902855|FG000|Overall Study|Sponsor Decision|0|||
131895554|NCT00423813|474902856|FG001|Overall Study|Sponsor Decision|1|||
131895555|NCT00423813|474902857|FG002|Overall Study|Sponsor Decision|0|||
131895556|NCT00423813|474902855|FG000|Overall Study|Protocol Violation|9|||
131895557|NCT00423813|474902856|FG001|Overall Study|Protocol Violation|4|||
131895558|NCT00423813|474902857|FG002|Overall Study|Protocol Violation|4|||
131895559|NCT00423813|474902855|FG000|Overall Study|Pregnancy|0|||
131895560|NCT00423813|474902856|FG001|Overall Study|Pregnancy|0|||
131895561|NCT00423813|474902857|FG002|Overall Study|Pregnancy|1|||
131895562|NCT00423813|474902855|FG000|Overall Study|Subject started night shift work|1|||
131895563|NCT00423813|474902856|FG001|Overall Study|Subject started night shift work|0|||
131895564|NCT00423813|474902857|FG002|Overall Study|Subject started night shift work|0|||
131895565|NCT00423813|474902855|FG000|Overall Study|Will start exclusionary medications|0|||
131895566|NCT00423813|474902856|FG001|Overall Study|Will start exclusionary medications|1|||
131895567|NCT00423813|474902857|FG002|Overall Study|Will start exclusionary medications|0|||
131895568|NCT00423813|474902855|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
131895569|NCT00423813|474902856|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
131895570|NCT00423813|474902857|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
131895571|NCT01386944|474902859|FG000|Overall Study|Adverse Event|26|||
131895572|NCT01386944|474902859|FG000|Overall Study|Lack of Efficacy|14|||
131895573|NCT01386944|474902859|FG000|Overall Study|Lost to Follow-up|8|||
131895574|NCT01386944|474902859|FG000|Overall Study|Unspecified reason|8|||
131895575|NCT03853291|474902860|FG000|Overall Study|Lost to Follow-up|1|||
131895576|NCT03853291|474902861|FG001|Overall Study|Lost to Follow-up|2|||
131895577|NCT03853291|474902862|FG002|Overall Study|Lost to Follow-up|0|||
131895578|NCT03853291|474902863|FG003|Overall Study|Lost to Follow-up|0|||
131895579|NCT03853291|474902864|FG004|Overall Study|Lost to Follow-up|0|||
131895580|NCT03853291|474902865|FG005|Overall Study|Lost to Follow-up|0|||
131895581|NCT03853291|474902860|FG000|Overall Study|Determined to be ineligible|1|||
131895582|NCT03853291|474902861|FG001|Overall Study|Determined to be ineligible|1|||
131895583|NCT03853291|474902862|FG002|Overall Study|Determined to be ineligible|0|||
131895584|NCT03853291|474902863|FG003|Overall Study|Determined to be ineligible|0|||
131895585|NCT03853291|474902864|FG004|Overall Study|Determined to be ineligible|0|||
131895586|NCT03853291|474902865|FG005|Overall Study|Determined to be ineligible|0|||
131895587|NCT03883477|474902866|FG000|Overall Study|Death|1|||
131895588|NCT03883477|474902867|FG001|Overall Study|Death|0|||
131895589|NCT03883477|474902866|FG000|Overall Study|Protocol Violation|0|||
131895590|NCT03883477|474902867|FG001|Overall Study|Protocol Violation|1|||
131895591|NCT02137226|474902875|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
131895592|NCT02137226|474902876|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
131895593|NCT02137226|474902877|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
131895594|NCT02137226|474902878|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
131895595|NCT02137226|474902879|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
131895596|NCT02137226|474902875|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
131895597|NCT02137226|474902876|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
131895598|NCT02137226|474902877|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
131895599|NCT02137226|474902878|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
131895600|NCT02137226|474902879|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
131895601|NCT02137226|474902875|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
131895602|NCT02137226|474902876|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
131895603|NCT02137226|474902877|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
131895604|NCT02137226|474902878|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
131895605|NCT02137226|474902879|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
131895606|NCT02137226|474902875|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
131895607|NCT02137226|474902876|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
131895608|NCT02137226|474902877|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
131895609|NCT02137226|474902878|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
131895610|NCT02137226|474902879|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
131895611|NCT02137226|474902875|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
131895612|NCT02137226|474902876|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
131895613|NCT02137226|474902877|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
131895614|NCT02137226|474902878|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
131895615|NCT02137226|474902879|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
131895616|NCT02137226|474902875|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
131553554|NCT04836858|473651163|FG001|Overall Study|Lost to Follow-up|0|||
131553555|NCT04836858|473651164|FG002|Overall Study|Lost to Follow-up|0|||
131553556|NCT04836858|473651165|FG003|Overall Study|Lost to Follow-up|0|||
131553557|NCT04836858|473651162|FG000|Overall Study|Subject/Guardian decision|3|||
131553558|NCT04836858|473651163|FG001|Overall Study|Subject/Guardian decision|0|||
131553559|NCT04836858|473651164|FG002|Overall Study|Subject/Guardian decision|0|||
131553560|NCT04836858|473651165|FG003|Overall Study|Subject/Guardian decision|1|||
131553561|NCT04836858|473651162|FG000|Overall Study|Randomized but not treated|4|||
131553562|NCT04836858|473651163|FG001|Overall Study|Randomized but not treated|0|||
131553563|NCT04836858|473651164|FG002|Overall Study|Randomized but not treated|0|||
131553564|NCT04836858|473651165|FG003|Overall Study|Randomized but not treated|0|||
131553565|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
131553566|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
131553567|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Adverse Event|2|||
131553568|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Adverse Event|5|||
131553569|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
131553570|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
131553571|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
131553572|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
131553573|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Randomized by error|0|||
131553574|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Randomized by error|5|||
131553575|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
131553576|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
131553577|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
131553578|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
131553579|NCT02948959|473651166|FG000|52 Weeks Treatment Period|Change of residence location|0|||
131553580|NCT02948959|473651167|FG001|52 Weeks Treatment Period|Change of residence location|1|||
131553581|NCT02948959|473651166|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
131895617|NCT02137226|474902876|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
131895618|NCT02137226|474902877|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
131895619|NCT02137226|474902878|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
131895620|NCT02137226|474902879|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
131895621|NCT02137226|474902875|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
131553582|NCT02948959|473651167|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
131553583|NCT02948959|473651166|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
131553584|NCT02948959|473651167|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
131553585|NCT02948959|473651166|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
131553586|NCT02948959|473651167|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
131895622|NCT02137226|474902876|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
131895623|NCT02137226|474902877|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
131895624|NCT02137226|474902878|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
131895625|NCT02137226|474902879|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
131895626|NCT02137226|474902875|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
131895627|NCT02137226|474902876|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
131895628|NCT02137226|474902877|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
131895629|NCT02137226|474902878|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
131895630|NCT02137226|474902879|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
131895631|NCT02137226|474902875|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
131895632|NCT02137226|474902876|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
131895633|NCT02137226|474902877|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
131895634|NCT02137226|474902878|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
131895635|NCT02137226|474902879|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
131895636|NCT02137226|474902875|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
131895637|NCT02137226|474902876|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
131895638|NCT02137226|474902877|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
131895639|NCT02137226|474902878|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
131895640|NCT02137226|474902879|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
131895641|NCT02137226|474902875|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
131895642|NCT02137226|474902876|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
131895643|NCT02137226|474902877|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
131895644|NCT02137226|474902878|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
131895645|NCT02137226|474902879|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
131895646|NCT02137226|474902875|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
131895647|NCT02137226|474902876|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
131895648|NCT02137226|474902877|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
131895649|NCT02137226|474902878|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
131895650|NCT02137226|474902879|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
131895651|NCT01398358|474902886|FG000|Overall Study|Lost to Follow-up|11|||
131895652|NCT01398358|474902887|FG001|Overall Study|Lost to Follow-up|21|||
131895653|NCT01398358|474902888|FG002|Overall Study|Lost to Follow-up|18|||
131895654|NCT01398358|474902886|FG000|Overall Study|Withdrawal by Subject|3|||
131895655|NCT01398358|474902887|FG001|Overall Study|Withdrawal by Subject|2|||
131895656|NCT01398358|474902888|FG002|Overall Study|Withdrawal by Subject|2|||
131895657|NCT01398358|474902886|FG000|Overall Study|no longer eligible|1|||
131895658|NCT01398358|474902887|FG001|Overall Study|no longer eligible|0|||
131895659|NCT01398358|474902888|FG002|Overall Study|no longer eligible|1|||
131895660|NCT00985686|474902889|FG000|Overall Study|Lost to Follow-up|1|||
131895661|NCT00985686|474902890|FG001|Overall Study|Lost to Follow-up|1|||
131895662|NCT00985686|474902891|FG002|Overall Study|Lost to Follow-up|0|||
131895663|NCT00985686|474902892|FG003|Overall Study|Lost to Follow-up|2|||
131895664|NCT02559570|474902893|FG000|Overall Study|Adverse Event|0|||
131895665|NCT02559570|474902894|FG001|Overall Study|Adverse Event|2|||
131895666|NCT02559570|474902895|FG002|Overall Study|Adverse Event|0|||
131895667|NCT02559570|474902896|FG003|Overall Study|Adverse Event|1|||
131895668|NCT02559570|474902897|FG004|Overall Study|Adverse Event|0|||
131895669|NCT02559570|474902893|FG000|Overall Study|Withdrawal of Consent|0|||
131895670|NCT02559570|474902894|FG001|Overall Study|Withdrawal of Consent|0|||
131895671|NCT02559570|474902895|FG002|Overall Study|Withdrawal of Consent|1|||
131895672|NCT02559570|474902896|FG003|Overall Study|Withdrawal of Consent|2|||
131895673|NCT02559570|474902897|FG004|Overall Study|Withdrawal of Consent|1|||
131895674|NCT02559570|474902893|FG000|Overall Study|Lost to Follow-up|1|||
131895675|NCT02559570|474902894|FG001|Overall Study|Lost to Follow-up|0|||
131895676|NCT02559570|474902895|FG002|Overall Study|Lost to Follow-up|0|||
131895677|NCT02559570|474902896|FG003|Overall Study|Lost to Follow-up|0|||
131895678|NCT02559570|474902897|FG004|Overall Study|Lost to Follow-up|0|||
131895679|NCT02559570|474902893|FG000|Overall Study|Protocol Violation|1|||
131895680|NCT02559570|474902894|FG001|Overall Study|Protocol Violation|0|||
131895681|NCT02559570|474902895|FG002|Overall Study|Protocol Violation|0|||
131895682|NCT02559570|474902896|FG003|Overall Study|Protocol Violation|0|||
131895683|NCT02559570|474902897|FG004|Overall Study|Protocol Violation|1|||
131895684|NCT02559570|474902893|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131895685|NCT02559570|474902894|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131895686|NCT02559570|474902895|FG002|Overall Study|Other Miscellaneous Reasons|1|||
131895687|NCT02559570|474902896|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131895688|NCT02559570|474902897|FG004|Overall Study|Other Miscellaneous Reasons|0|||
131895689|NCT00420628|474902903|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
131895690|NCT00420628|474902904|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
131895691|NCT00420628|474902903|FG000|Overall Study|Lost to Follow-up|3|||
131895692|NCT00420628|474902904|FG001|Overall Study|Lost to Follow-up|2|||
131895693|NCT00420628|474902903|FG000|Overall Study|Adverse Event|1|||
131895694|NCT00420628|474902904|FG001|Overall Study|Adverse Event|0|||
131895695|NCT00396383|474902909|FG000|Overall Study|Death|2|||
131895696|NCT00396383|474902909|FG000|Overall Study|Lost to Follow-up|1|||
131895697|NCT02787083|474902910|FG000|Overall Study|Adverse Event|1|||
131895698|NCT02787083|474902911|FG001|Overall Study|Adverse Event|0|||
131895699|NCT02787083|474902910|FG000|Overall Study|Withdrawal by Subject|2|||
131895700|NCT02787083|474902911|FG001|Overall Study|Withdrawal by Subject|2|||
131895701|NCT01941537|474902912|FG000|Overall Study|Lack of Efficacy|1|||
131895702|NCT01941537|474902913|FG001|Overall Study|Lack of Efficacy|2|||
131895703|NCT01941537|474902912|FG000|Overall Study|Lost to Follow-up|1|||
131895704|NCT01941537|474902913|FG001|Overall Study|Lost to Follow-up|0|||
131895705|NCT01941537|474902912|FG000|Overall Study|Pregnancy|1|||
131895706|NCT01941537|474902913|FG001|Overall Study|Pregnancy|0|||
131895707|NCT01941537|474902912|FG000|Overall Study|Adverse Event|1|||
131895708|NCT01941537|474902913|FG001|Overall Study|Adverse Event|0|||
131895709|NCT01941537|474902912|FG000|Overall Study|Withdrawal by Subject|0|||
131895710|NCT01941537|474902913|FG001|Overall Study|Withdrawal by Subject|1|||
131895711|NCT02557516|474902915|FG000|Overall Study|Adverse Event|1|||
131895712|NCT02557516|474902916|FG001|Overall Study|Adverse Event|0|||
131895713|NCT02557516|474902917|FG002|Overall Study|Adverse Event|2|||
131895714|NCT02557516|474902918|FG003|Overall Study|Adverse Event|1|||
131895715|NCT02557516|474902915|FG000|Overall Study|Disease progression|0|||
131895716|NCT02557516|474902916|FG001|Overall Study|Disease progression|2|||
131895717|NCT02557516|474902917|FG002|Overall Study|Disease progression|0|||
131895718|NCT02557516|474902918|FG003|Overall Study|Disease progression|0|||
131895719|NCT02557516|474902915|FG000|Overall Study|Physician Decision|0|||
131895720|NCT02557516|474902916|FG001|Overall Study|Physician Decision|2|||
131895721|NCT02557516|474902917|FG002|Overall Study|Physician Decision|0|||
131895722|NCT02557516|474902918|FG003|Overall Study|Physician Decision|0|||
131895723|NCT02557516|474902915|FG000|Overall Study|Sponsor decision|0|||
131895724|NCT02557516|474902916|FG001|Overall Study|Sponsor decision|1|||
131895725|NCT02557516|474902917|FG002|Overall Study|Sponsor decision|2|||
131895726|NCT02557516|474902918|FG003|Overall Study|Sponsor decision|8|||
131895727|NCT03117361|474904372|FG000|Overall Study|Progressive disease|5|||
131895728|NCT03117361|474904372|FG000|Overall Study|Death|1|||
131895729|NCT03117361|474904372|FG000|Overall Study|Physician Decision|2|||
131895730|NCT03117361|474904372|FG000|Overall Study|On study treatment at the end of study|1|||
131895731|NCT03117361|474904372|FG000|Overall Study|Treatment-related adverse event|1|||
131895732|NCT00540644|474904377|FG000|Overall Study|Adverse Event|3|||
131895733|NCT00540644|474904378|FG001|Overall Study|Adverse Event|1|||
131895734|NCT00540644|474904377|FG000|Overall Study|Disease Progression|3|||
131895735|NCT00540644|474904378|FG001|Overall Study|Disease Progression|1|||
131895736|NCT00540644|474904377|FG000|Overall Study|Physician Decision|0|||
131895737|NCT00540644|474904378|FG001|Overall Study|Physician Decision|5|||
131895738|NCT00540644|474904377|FG000|Overall Study|Withdrawal by Subject|2|||
131895739|NCT00540644|474904378|FG001|Overall Study|Withdrawal by Subject|2|||
131895740|NCT00540644|474904377|FG000|Overall Study|Noncomplilance|1|||
131895741|NCT00540644|474904378|FG001|Overall Study|Noncomplilance|0|||
131895742|NCT03280056|474904379|FG000|Overall Study|Withdrawal by Subject|12|||
131895743|NCT03280056|474904380|FG001|Overall Study|Withdrawal by Subject|14|||
131895744|NCT03280056|474904379|FG000|Overall Study|Death|9|||
131895745|NCT03280056|474904380|FG001|Overall Study|Death|2|||
131895746|NCT03280056|474904379|FG000|Overall Study|Adverse Event|1|||
131895747|NCT03280056|474904380|FG001|Overall Study|Adverse Event|3|||
131895748|NCT03280056|474904379|FG000|Overall Study|Lost to Follow-up|1|||
131895749|NCT03280056|474904380|FG001|Overall Study|Lost to Follow-up|1|||
131895750|NCT03280056|474904379|FG000|Overall Study|Physician Decision|0|||
131895751|NCT03280056|474904380|FG001|Overall Study|Physician Decision|1|||
131895752|NCT03280056|474904379|FG000|Overall Study|Early Discontinuation|1|||
131895753|NCT03280056|474904380|FG001|Overall Study|Early Discontinuation|0|||
131895754|NCT02144077|474904381|FG000|Overall Study|Withdrawal by Subject|3|||
131895755|NCT02144077|474904382|FG001|Overall Study|Withdrawal by Subject|3|||
131895756|NCT02144077|474904381|FG000|Overall Study|Adverse Event|2|||
131895757|NCT02144077|474904382|FG001|Overall Study|Adverse Event|3|||
131895758|NCT02144077|474904381|FG000|Overall Study|Lost to Follow-up|2|||
131895759|NCT02144077|474904382|FG001|Overall Study|Lost to Follow-up|2|||
131895760|NCT02144077|474904381|FG000|Overall Study|Protocol Violation|1|||
131895761|NCT02144077|474904382|FG001|Overall Study|Protocol Violation|2|||
131895762|NCT02144077|474904381|FG000|Overall Study|Death|0|||
131895763|NCT02144077|474904382|FG001|Overall Study|Death|1|||
131895764|NCT02144077|474904381|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
131895765|NCT02144077|474904382|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
131895766|NCT00610168|474904383|FG000|Overall Study|Withdrawal by Subject|2|||
131895767|NCT00610168|474904384|FG001|Overall Study|Withdrawal by Subject|0|||
131895768|NCT00943592|474904385|FG000|Overall Study|Death|3|||
131895769|NCT00169104|474904386|FG000|Overall Study|Withdrawal by Subject|2|||
131895770|NCT00169104|474904387|FG001|Overall Study|Withdrawal by Subject|0|||
131895771|NCT00169104|474904386|FG000|Overall Study|Protocol Violation|0|||
131435946|NCT01774799|473221904|FG003|Overall Study|Lost to Follow-up|0|||
131895772|NCT00169104|474904387|FG001|Overall Study|Protocol Violation|1|||
131895773|NCT00169104|474904386|FG000|Overall Study|Physician Decision|0|||
131895774|NCT00169104|474904387|FG001|Overall Study|Physician Decision|1|||
131895775|NCT00715299|474904393|FG000|Overall Study|Withdrawal by Subject|1|||
131553587|NCT02948959|473651166|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
131553588|NCT02948959|473651167|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
131553589|NCT02948959|473651166|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
131553590|NCT02948959|473651167|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
131553591|NCT02948959|473651166|FG000|12 Weeks Follow-up Period|Study site closure|1|||
131895776|NCT00715299|474904393|FG000|Overall Study|Adverse Event|3|||
131553592|NCT02948959|473651167|FG001|12 Weeks Follow-up Period|Study site closure|0|||
131553593|NCT00154310|473651168|FG000|Overall Study|Adverse Event|19|||
131553594|NCT00154310|473651169|FG001|Overall Study|Adverse Event|9|||
131553595|NCT00154310|473651168|FG000|Overall Study|Lack of Efficacy|5|||
131553596|NCT00154310|473651169|FG001|Overall Study|Lack of Efficacy|4|||
131553597|NCT00154310|473651168|FG000|Overall Study|Protocol Violation|4|||
131553598|NCT00154310|473651169|FG001|Overall Study|Protocol Violation|2|||
131553599|NCT00154310|473651168|FG000|Overall Study|Withdrawal by Subject|9|||
131553600|NCT00154310|473651169|FG001|Overall Study|Withdrawal by Subject|3|||
131553601|NCT00154310|473651168|FG000|Overall Study|Lost to Follow-up|0|||
131553602|NCT00154310|473651169|FG001|Overall Study|Lost to Follow-up|8|||
131553603|NCT00154310|473651168|FG000|Overall Study|Administrative problems|0|||
131553604|NCT00154310|473651169|FG001|Overall Study|Administrative problems|1|||
131553605|NCT00154310|473651168|FG000|Overall Study|Death|0|||
131553606|NCT00154310|473651169|FG001|Overall Study|Death|1|||
131553607|NCT04399356|473651170|FG000|Overall Study|Lost to Follow-up|1|||
131553608|NCT04399356|473651171|FG001|Overall Study|Lost to Follow-up|1|||
131553609|NCT04399356|473651170|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
131553610|NCT04399356|473651171|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
131553611|NCT04399356|473651170|FG000|Overall Study|Withdrawal by Subject|1|||
131553612|NCT04399356|473651171|FG001|Overall Study|Withdrawal by Subject|0|||
131553613|NCT01678820|473651172|FG000|Overall Study|Study Terminated by Sponsor|45|||
131553614|NCT01678820|473651173|FG001|Overall Study|Study Terminated by Sponsor|43|||
131553615|NCT01678820|473651174|FG002|Overall Study|Study Terminated by Sponsor|43|||
131553616|NCT01678820|473651172|FG000|Overall Study|Withdrawal by Subject|2|||
131553617|NCT01678820|473651173|FG001|Overall Study|Withdrawal by Subject|5|||
131553618|NCT01678820|473651174|FG002|Overall Study|Withdrawal by Subject|2|||
131553619|NCT01678820|473651172|FG000|Overall Study|Protocol Specified Criteria|2|||
131553620|NCT01678820|473651173|FG001|Overall Study|Protocol Specified Criteria|3|||
131553621|NCT01678820|473651174|FG002|Overall Study|Protocol Specified Criteria|1|||
131553622|NCT01678820|473651172|FG000|Overall Study|Adverse Event|2|||
131553623|NCT01678820|473651173|FG001|Overall Study|Adverse Event|2|||
131553624|NCT01678820|473651174|FG002|Overall Study|Adverse Event|2|||
131553625|NCT01678820|473651172|FG000|Overall Study|Lost to Follow-up|7|||
131553626|NCT01678820|473651173|FG001|Overall Study|Lost to Follow-up|2|||
131553627|NCT01678820|473651174|FG002|Overall Study|Lost to Follow-up|2|||
131553628|NCT01678820|473651172|FG000|Overall Study|Non-compliance with study drug|0|||
131553629|NCT01678820|473651173|FG001|Overall Study|Non-compliance with study drug|1|||
131553630|NCT01678820|473651174|FG002|Overall Study|Non-compliance with study drug|0|||
131553631|NCT01678820|473651172|FG000|Overall Study|Physician Decision|0|||
131553632|NCT01678820|473651173|FG001|Overall Study|Physician Decision|0|||
131553633|NCT01678820|473651174|FG002|Overall Study|Physician Decision|1|||
131553634|NCT01678820|473651172|FG000|Overall Study|Protocol Violation|4|||
131553635|NCT01678820|473651173|FG001|Overall Study|Protocol Violation|5|||
131553636|NCT01678820|473651174|FG002|Overall Study|Protocol Violation|4|||
131553637|NCT01678820|473651172|FG000|Overall Study|Not treated with double-blind study drug|0|||
131553638|NCT01678820|473651173|FG001|Overall Study|Not treated with double-blind study drug|2|||
131553639|NCT01678820|473651174|FG002|Overall Study|Not treated with double-blind study drug|2|||
131553640|NCT03447730|473651175|FG000|Overall Study|Adverse Event|0|||
131553641|NCT03447730|473651176|FG001|Overall Study|Adverse Event|2|||
131553642|NCT03447730|473651177|FG002|Overall Study|Adverse Event|0|||
131553643|NCT01350505|473651183|FG000|Overall Study|Lost to Follow-up|4|||
131553644|NCT01834222|473651187|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
131553645|NCT01054573|473651188|FG000|Overall Study|Adverse Event|1|||
131553646|NCT01054573|473651189|FG001|Overall Study|Adverse Event|0|||
131553647|NCT01054573|473651190|FG002|Overall Study|Adverse Event|1|||
131553648|NCT01054573|473651191|FG003|Overall Study|Adverse Event|1|||
131895777|NCT00715299|474904393|FG000|Overall Study|failed the pre-screen exercise test|2|||
131895778|NCT01540981|474904394|FG000|Overall Study|Withdrawal by Subject|1|||
131895779|NCT01540981|474904395|FG001|Overall Study|Withdrawal by Subject|0|||
131895780|NCT00809094|474904397|FG000|Overall Study|Lost to Follow-up|0|||
131895781|NCT00809094|474904398|FG001|Overall Study|Lost to Follow-up|1|||
131895782|NCT00397189|474904399|FG000|3 Weeks Period|Lost to Follow-up|5|||
131895783|NCT00397189|474904400|FG001|3 Weeks Period|Lost to Follow-up|4|||
131895784|NCT00397189|474904399|FG000|3 Weeks Period|Adverse Event|3|||
131553649|NCT01054573|473651188|FG000|Overall Study|Lost to Follow-up|0|||
131553650|NCT01054573|473651189|FG001|Overall Study|Lost to Follow-up|2|||
131553651|NCT01054573|473651190|FG002|Overall Study|Lost to Follow-up|0|||
131553652|NCT01054573|473651191|FG003|Overall Study|Lost to Follow-up|0|||
131553653|NCT01054573|473651188|FG000|Overall Study|Withdrawal by Subject|0|||
131553654|NCT01054573|473651189|FG001|Overall Study|Withdrawal by Subject|2|||
131895785|NCT00397189|474904400|FG001|3 Weeks Period|Adverse Event|2|||
131895786|NCT00397189|474904399|FG000|3 Weeks Period|Withdrawal by Subject|13|||
131895787|NCT00397189|474904400|FG001|3 Weeks Period|Withdrawal by Subject|9|||
131895788|NCT00397189|474904399|FG000|3 Weeks Period|Physician Decision|0|||
131895789|NCT00397189|474904400|FG001|3 Weeks Period|Physician Decision|2|||
131895790|NCT00397189|474904399|FG000|3 Weeks Period|Protocol Violation|0|||
131895791|NCT00397189|474904400|FG001|3 Weeks Period|Protocol Violation|3|||
131895792|NCT00397189|474904399|FG000|3 Weeks Period|Other|0|||
131895793|NCT00397189|474904400|FG001|3 Weeks Period|Other|2|||
131895794|NCT01535443|474904401|FG000|Overall Study|Physician Decision|3|||
131895795|NCT00232557|474904404|FG000|Overall Study|Lost to Follow-up|3|||
131895796|NCT00232557|474904405|FG001|Overall Study|Lost to Follow-up|5|||
131895797|NCT01059773|474904406|FG000|Overall Study|Adverse Event|2|||
131895798|NCT01059773|474904407|FG001|Overall Study|Adverse Event|2|||
131895799|NCT01059773|474904406|FG000|Overall Study|Withdrawal by Subject|1|||
131895800|NCT01059773|474904407|FG001|Overall Study|Withdrawal by Subject|5|||
131895801|NCT01059773|474904406|FG000|Overall Study|Lost to Follow-up|1|||
131895802|NCT01059773|474904407|FG001|Overall Study|Lost to Follow-up|1|||
131895803|NCT01059773|474904406|FG000|Overall Study|Pregnancy|1|||
131895804|NCT01059773|474904407|FG001|Overall Study|Pregnancy|1|||
131895805|NCT01059773|474904406|FG000|Overall Study|Protocol Violation|6|||
131895806|NCT01059773|474904407|FG001|Overall Study|Protocol Violation|2|||
131895807|NCT01059773|474904406|FG000|Overall Study|Physician Decision|5|||
131895808|NCT01059773|474904407|FG001|Overall Study|Physician Decision|4|||
131553655|NCT01054573|473651190|FG002|Overall Study|Withdrawal by Subject|2|||
131553656|NCT01054573|473651191|FG003|Overall Study|Withdrawal by Subject|1|||
131553657|NCT01306201|473651192|FG000|Overall Study|Arrhythmia|4|||
131553658|NCT01306201|473651192|FG000|Overall Study|Files could not be processed|3|||
131553659|NCT01306201|473651192|FG000|Overall Study|Files unreadable|3|||
131553660|NCT00423852|473651193|FG000|Overall Study|Removed pior to the high-dose portion|3|||
131553661|NCT00744263|473651194|FG000|Overall Study|Death|3006|||
131553662|NCT00744263|473651195|FG001|Overall Study|Death|3005|||
131553663|NCT00744263|473651194|FG000|Overall Study|Lost to Follow-up|2038|||
131553664|NCT00744263|473651195|FG001|Overall Study|Lost to Follow-up|2135|||
131553665|NCT00744263|473651194|FG000|Overall Study|Withdrawal by Subject|166|||
131553666|NCT00744263|473651195|FG001|Overall Study|Withdrawal by Subject|150|||
131553667|NCT00744263|473651194|FG000|Overall Study|Physician Decision|20|||
131553668|NCT00744263|473651195|FG001|Overall Study|Physician Decision|23|||
131553669|NCT00744263|473651194|FG000|Overall Study|Protocol Violation|3|||
131553670|NCT00744263|473651195|FG001|Overall Study|Protocol Violation|5|||
131553671|NCT00744263|473651194|FG000|Overall Study|Adverse Event|1|||
131553672|NCT00744263|473651195|FG001|Overall Study|Adverse Event|0|||
131553673|NCT00744263|473651194|FG000|Overall Study|Other|2|||
131553674|NCT00744263|473651195|FG001|Overall Study|Other|2|||
131553675|NCT01515189|473651197|FG000|Induction|Disease Progression|109|||
131553676|NCT01515189|473651198|FG001|Induction|Disease Progression|155|||
131553677|NCT01515189|473651197|FG000|Induction|Study drug toxicity|86|||
131553678|NCT01515189|473651198|FG001|Induction|Study drug toxicity|36|||
131553679|NCT01515189|473651197|FG000|Induction|Death|24|||
131553680|NCT01515189|473651198|FG001|Induction|Death|17|||
131553681|NCT01515189|473651197|FG000|Induction|Adverse Event|14|||
131553682|NCT01515189|473651198|FG001|Induction|Adverse Event|9|||
131553683|NCT01515189|473651197|FG000|Induction|Withdrawal by Subject|3|||
131553684|NCT01515189|473651198|FG001|Induction|Withdrawal by Subject|9|||
131553685|NCT01515189|473651197|FG000|Induction|No longer meets study criteria|0|||
131553686|NCT01515189|473651198|FG001|Induction|No longer meets study criteria|2|||
131553687|NCT01515189|473651197|FG000|Induction|Lost to Follow-up|1|||
131553688|NCT01515189|473651198|FG001|Induction|Lost to Follow-up|0|||
131553689|NCT01515189|473651197|FG000|Induction|Other|0|||
131553690|NCT01515189|473651198|FG001|Induction|Other|4|||
131553691|NCT01515189|473651197|FG000|First Re-Induction Phase|Disease progression|6|||
131553692|NCT01515189|473651198|FG001|First Re-Induction Phase|Disease progression|14|||
131553693|NCT01515189|473651197|FG000|First Re-Induction Phase|Study drug toxicity|5|||
131553694|NCT01515189|473651198|FG001|First Re-Induction Phase|Study drug toxicity|0|||
131553695|NCT01515189|473651197|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
131553696|NCT01515189|473651198|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
131553697|NCT01515189|473651197|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
131553698|NCT01515189|473651198|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
131895809|NCT01059773|474904406|FG000|Overall Study|Lack of Efficacy|3|||
131895810|NCT01059773|474904407|FG001|Overall Study|Lack of Efficacy|3|||
131895811|NCT01059773|474904406|FG000|Overall Study|Death|0|||
131553699|NCT01515189|473651197|FG000|First Re-Induction Phase|Other|1|||
131553700|NCT01515189|473651198|FG001|First Re-Induction Phase|Other|0|||
131553701|NCT03787680|473651199|FG000|Overall Study|Physician Decision|2|||
131895812|NCT01059773|474904407|FG001|Overall Study|Death|1|||
131895813|NCT01059773|474904406|FG000|Overall Study|Malignancy including squamous cell skin|0|||
131895814|NCT01059773|474904407|FG001|Overall Study|Malignancy including squamous cell skin|1|||
131553702|NCT03787680|473651200|FG001|Overall Study|Physician Decision|3|||
131895815|NCT01059773|474904406|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
131895816|NCT01059773|474904407|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
131895817|NCT01059773|474904406|FG000|Overall Study|Other|1|||
131895818|NCT01059773|474904407|FG001|Overall Study|Other|3|||
131895819|NCT00141518|474904411|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
131895820|NCT00141518|474904412|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
131895821|NCT00141518|474904413|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
131895822|NCT00141518|474904411|FG000|Overall Study|Adverse Event|7|||
131895823|NCT00141518|474904412|FG001|Overall Study|Adverse Event|5|||
131895824|NCT00141518|474904413|FG002|Overall Study|Adverse Event|2|||
131895825|NCT00141518|474904411|FG000|Overall Study|Withdrawal by Subject|2|||
131895826|NCT00141518|474904412|FG001|Overall Study|Withdrawal by Subject|0|||
131895827|NCT00141518|474904413|FG002|Overall Study|Withdrawal by Subject|2|||
131895828|NCT00141518|474904411|FG000|Overall Study|Protocol Violation|1|||
131895829|NCT00141518|474904412|FG001|Overall Study|Protocol Violation|1|||
131895830|NCT00141518|474904413|FG002|Overall Study|Protocol Violation|2|||
131895831|NCT00141518|474904411|FG000|Overall Study|Lack of Efficacy|5|||
131895832|NCT00141518|474904412|FG001|Overall Study|Lack of Efficacy|0|||
131895833|NCT00141518|474904413|FG002|Overall Study|Lack of Efficacy|0|||
131895834|NCT01882803|474904414|FG000|Overall Study|Disease Progression|1|||
131895835|NCT01882803|474904414|FG000|Overall Study|Withdrawal by Subject|9|||
131895836|NCT01882803|474904414|FG000|Overall Study|Death|68|||
131895837|NCT01882803|474904414|FG000|Overall Study|Physician Decision|3|||
131895838|NCT01882803|474904414|FG000|Overall Study|Lost to Follow-up|3|||
131895839|NCT01882803|474904414|FG000|Overall Study|Follow-up Completed|39|||
131895840|NCT01882803|474904414|FG000|Overall Study|Study Terminated by the Sponsor|6|||
131895841|NCT01563913|474904415|FG000|Overall Study|Physician Decision|1|||
131895842|NCT01563913|474904416|FG001|Overall Study|Physician Decision|0|||
131895843|NCT01563913|474904415|FG000|Overall Study|Spouse Passed Away|1|||
131895844|NCT01563913|474904416|FG001|Overall Study|Spouse Passed Away|0|||
131895845|NCT03665077|474904417|FG000|Overall Study|Lost to Follow-up|2|||
131895846|NCT03665077|474904417|FG000|Overall Study|Physician Decision|2|||
131895847|NCT00435461|474904420|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
131895848|NCT00435461|474904421|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
131895849|NCT00435461|474904422|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
131895850|NCT00435461|474904420|FG000|Overall Study|Protocol Violation|6|||
131895851|NCT00435461|474904421|FG001|Overall Study|Protocol Violation|9|||
131895852|NCT00435461|474904422|FG002|Overall Study|Protocol Violation|10|||
131895853|NCT00435461|474904420|FG000|Overall Study|Participant randomized(inadequate score)|1|||
131895854|NCT00435461|474904421|FG001|Overall Study|Participant randomized(inadequate score)|0|||
131895855|NCT00435461|474904422|FG002|Overall Study|Participant randomized(inadequate score)|0|||
131895856|NCT00435461|474904420|FG000|Overall Study|Compliance less than 80 percent|1|||
131895857|NCT00435461|474904421|FG001|Overall Study|Compliance less than 80 percent|0|||
131895858|NCT00435461|474904422|FG002|Overall Study|Compliance less than 80 percent|0|||
131895859|NCT00435461|474904420|FG000|Overall Study|In error, two study medications switched|1|||
131895860|NCT00435461|474904421|FG001|Overall Study|In error, two study medications switched|0|||
131895861|NCT00435461|474904422|FG002|Overall Study|In error, two study medications switched|0|||
131895862|NCT00435461|474904420|FG000|Overall Study|Lack of Efficacy|2|||
131895863|NCT00435461|474904421|FG001|Overall Study|Lack of Efficacy|1|||
131895864|NCT00435461|474904422|FG002|Overall Study|Lack of Efficacy|0|||
131895865|NCT00435461|474904420|FG000|Overall Study|Withdrawal by Subject|1|||
131895866|NCT00435461|474904421|FG001|Overall Study|Withdrawal by Subject|0|||
131895867|NCT00435461|474904422|FG002|Overall Study|Withdrawal by Subject|2|||
131895868|NCT00435461|474904420|FG000|Overall Study|Randomized in error|1|||
131895869|NCT00435461|474904421|FG001|Overall Study|Randomized in error|0|||
131895870|NCT00435461|474904422|FG002|Overall Study|Randomized in error|0|||
131895871|NCT00435461|474904420|FG000|Overall Study|Participant could not tolerate symptoms|0|||
131895872|NCT00435461|474904421|FG001|Overall Study|Participant could not tolerate symptoms|0|||
131895873|NCT00435461|474904422|FG002|Overall Study|Participant could not tolerate symptoms|1|||
131895874|NCT00435461|474904420|FG000|Overall Study|Participant could not swallow capsule|0|||
131895875|NCT00435461|474904421|FG001|Overall Study|Participant could not swallow capsule|0|||
131895876|NCT00435461|474904422|FG002|Overall Study|Participant could not swallow capsule|1|||
131895877|NCT00435461|474904420|FG000|Overall Study|Pregnancy|2|||
131895878|NCT00435461|474904421|FG001|Overall Study|Pregnancy|0|||
131895879|NCT00435461|474904422|FG002|Overall Study|Pregnancy|0|||
131895880|NCT00435461|474904420|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
131895881|NCT00435461|474904421|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
131895882|NCT00435461|474904422|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
131895883|NCT00435461|474904420|FG000|Overall Study|Participant ended study one day early|1|||
131895884|NCT00435461|474904421|FG001|Overall Study|Participant ended study one day early|0|||
131895885|NCT00435461|474904422|FG002|Overall Study|Participant ended study one day early|0|||
131895886|NCT00435461|474904420|FG000|Overall Study|Noncompliance with study requirements|1|||
131895887|NCT00435461|474904421|FG001|Overall Study|Noncompliance with study requirements|1|||
131895888|NCT00435461|474904422|FG002|Overall Study|Noncompliance with study requirements|1|||
131895889|NCT00435461|474904420|FG000|Overall Study|Adverse Event|1|||
131895890|NCT00435461|474904421|FG001|Overall Study|Adverse Event|2|||
131895891|NCT00435461|474904422|FG002|Overall Study|Adverse Event|6|||
131895892|NCT00435461|474904420|FG000|Overall Study|Non-Compliance of diary|2|||
131895893|NCT00435461|474904421|FG001|Overall Study|Non-Compliance of diary|0|||
131895894|NCT00435461|474904422|FG002|Overall Study|Non-Compliance of diary|1|||
131895895|NCT00435461|474904420|FG000|Overall Study|Lost to Follow-up|1|||
131895896|NCT00435461|474904421|FG001|Overall Study|Lost to Follow-up|1|||
131895897|NCT00435461|474904422|FG002|Overall Study|Lost to Follow-up|2|||
131895898|NCT00237692|474904423|FG000|Overall Study|Lost to Follow-up|9|||
131895899|NCT00237692|474904424|FG001|Overall Study|Lost to Follow-up|3|||
131895900|NCT00237692|474904425|FG002|Overall Study|Lost to Follow-up|5|||
131895901|NCT00237692|474904426|FG003|Overall Study|Lost to Follow-up|3|||
131895902|NCT00237692|474904423|FG000|Overall Study|Death|1|||
131895903|NCT00237692|474904424|FG001|Overall Study|Death|2|||
131895904|NCT00237692|474904425|FG002|Overall Study|Death|2|||
131895905|NCT00237692|474904426|FG003|Overall Study|Death|3|||
131895906|NCT00237692|474904423|FG000|Overall Study|Excluded - did not meet criteria|4|||
131895907|NCT00237692|474904424|FG001|Overall Study|Excluded - did not meet criteria|3|||
131895908|NCT00237692|474904425|FG002|Overall Study|Excluded - did not meet criteria|5|||
131895909|NCT00237692|474904426|FG003|Overall Study|Excluded - did not meet criteria|9|||
131895910|NCT00237692|474904423|FG000|Overall Study|Withdrawal by Subject|4|||
131895911|NCT00237692|474904424|FG001|Overall Study|Withdrawal by Subject|6|||
131895912|NCT00237692|474904425|FG002|Overall Study|Withdrawal by Subject|10|||
131895913|NCT00237692|474904426|FG003|Overall Study|Withdrawal by Subject|4|||
131895914|NCT01151345|474904437|FG000|First Intervention Period|Protocol Violation|0|||
131895915|NCT01151345|474904438|FG001|First Intervention Period|Protocol Violation|1|||
131895916|NCT03882957|474904440|FG000|Overall Study|Did not complete all three arms|1|||
131895917|NCT00003896|474904442|FG000|Overall Study|Adverse Event|16|||
131895918|NCT00003896|474904442|FG000|Overall Study|Withdrawal by Subject|1|||
131895919|NCT00003896|474904442|FG000|Overall Study|Lack of Efficacy|1|||
131895920|NCT00003896|474904442|FG000|Overall Study|Death|3|||
131895921|NCT00003896|474904442|FG000|Overall Study|not protocol specified|3|||
131895922|NCT00003896|474904442|FG000|Overall Study|ineligible|5|||
131895923|NCT03134911|474904444|FG000|Overall Study|Screen failure|31|||
131895924|NCT03134911|474904444|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
131895925|NCT01670045|474904445|FG000|Overall Study|Withdrawal by Subject|3|||
131895926|NCT01670045|474904445|FG000|Overall Study|Adverse Event|1|||
131895927|NCT01670045|474904445|FG000|Overall Study|Death|1|||
131895928|NCT01670045|474904445|FG000|Overall Study|Lost to Follow-up|11|||
131895929|NCT02710084|474904451|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
131895930|NCT02710084|474904452|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
131895931|NCT00282152|474904453|FG000|Overall Study|Withdrawal by Subject|1|||
131895932|NCT00282152|474904454|FG001|Overall Study|Withdrawal by Subject|0|||
131895933|NCT03301831|474904455|FG000|Overall Study|Lost to Follow-up|5|||
131895934|NCT03301831|474904456|FG001|Overall Study|Lost to Follow-up|3|||
131895935|NCT03301831|474904455|FG000|Overall Study|Protocol Violation|4|||
131895936|NCT03301831|474904456|FG001|Overall Study|Protocol Violation|0|||
131895937|NCT03301831|474904455|FG000|Overall Study|Withdrawal by Subject|11|||
131895938|NCT03301831|474904456|FG001|Overall Study|Withdrawal by Subject|0|||
131895939|NCT00585325|474904457|FG000|Overall Study|Withdrawal by Subject|1|||
131895940|NCT00585325|474904458|FG001|Overall Study|Withdrawal by Subject|1|||
131435947|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
131553703|NCT03787680|473651199|FG000|Overall Study|Adverse Event|7|||
131553704|NCT03787680|473651200|FG001|Overall Study|Adverse Event|3|||
131553705|NCT03787680|473651199|FG000|Overall Study|Withdrawal by Subject|2|||
131553706|NCT03787680|473651200|FG001|Overall Study|Withdrawal by Subject|1|||
131553707|NCT05458024|473651201|FG000|Overall Study|Withdrawal by Subject|1|||
131553708|NCT05458024|473651202|FG001|Overall Study|Withdrawal by Subject|1|||
131895941|NCT03092791|474904459|FG000|Overall Study|Lost to Follow-up|0|||
131895942|NCT03092791|474904460|FG001|Overall Study|Lost to Follow-up|0|||
131895943|NCT03092791|474904461|FG002|Overall Study|Lost to Follow-up|0|||
131895944|NCT03092791|474904462|FG003|Overall Study|Lost to Follow-up|0|||
131895945|NCT03092791|474904463|FG004|Overall Study|Lost to Follow-up|0|||
131895946|NCT03092791|474904464|FG005|Overall Study|Lost to Follow-up|0|||
131895947|NCT03092791|474904465|FG006|Overall Study|Lost to Follow-up|1|||
131895948|NCT03092791|474904466|FG007|Overall Study|Lost to Follow-up|0|||
131895949|NCT03092791|474904459|FG000|Overall Study|Withdrawal of Consent|0|||
131895950|NCT03092791|474904460|FG001|Overall Study|Withdrawal of Consent|0|||
131895951|NCT03092791|474904461|FG002|Overall Study|Withdrawal of Consent|0|||
131895952|NCT03092791|474904462|FG003|Overall Study|Withdrawal of Consent|0|||
131895953|NCT03092791|474904463|FG004|Overall Study|Withdrawal of Consent|4|||
131895954|NCT03092791|474904464|FG005|Overall Study|Withdrawal of Consent|12|||
131895955|NCT03092791|474904465|FG006|Overall Study|Withdrawal of Consent|6|||
131895956|NCT03092791|474904466|FG007|Overall Study|Withdrawal of Consent|4|||
131895957|NCT03092791|474904459|FG000|Overall Study|Study Termination|0|||
131895958|NCT03092791|474904460|FG001|Overall Study|Study Termination|0|||
131895959|NCT03092791|474904461|FG002|Overall Study|Study Termination|0|||
131895960|NCT03092791|474904462|FG003|Overall Study|Study Termination|0|||
131895961|NCT03092791|474904463|FG004|Overall Study|Study Termination|55|||
131895962|NCT03092791|474904464|FG005|Overall Study|Study Termination|46|||
131895963|NCT03092791|474904465|FG006|Overall Study|Study Termination|53|||
131895964|NCT03092791|474904466|FG007|Overall Study|Study Termination|55|||
131895965|NCT03092791|474904459|FG000|Overall Study|Death|0|||
131895966|NCT03092791|474904460|FG001|Overall Study|Death|0|||
131895967|NCT03092791|474904461|FG002|Overall Study|Death|0|||
131895968|NCT03092791|474904462|FG003|Overall Study|Death|0|||
131895969|NCT03092791|474904463|FG004|Overall Study|Death|0|||
131895970|NCT03092791|474904464|FG005|Overall Study|Death|1|||
131895971|NCT03092791|474904465|FG006|Overall Study|Death|0|||
131895972|NCT03092791|474904466|FG007|Overall Study|Death|1|||
131895973|NCT03092791|474904459|FG000|Overall Study|Reason Not Specified|0|||
131895974|NCT03092791|474904460|FG001|Overall Study|Reason Not Specified|0|||
131895975|NCT03092791|474904461|FG002|Overall Study|Reason Not Specified|0|||
131895976|NCT03092791|474904462|FG003|Overall Study|Reason Not Specified|0|||
131895977|NCT03092791|474904463|FG004|Overall Study|Reason Not Specified|1|||
131895978|NCT03092791|474904464|FG005|Overall Study|Reason Not Specified|1|||
131895979|NCT03092791|474904465|FG006|Overall Study|Reason Not Specified|0|||
131895980|NCT03092791|474904466|FG007|Overall Study|Reason Not Specified|0|||
131895981|NCT02182830|474904468|FG000|Overall Study|Not Treated|1|||
131895982|NCT02182830|474904469|FG001|Overall Study|Not Treated|1|||
131895983|NCT02182830|474904468|FG000|Overall Study|Trial stopped, reason missing|3|||
131895984|NCT02182830|474904469|FG001|Overall Study|Trial stopped, reason missing|3|||
131895985|NCT02182830|474904468|FG000|Overall Study|Consent withdrawn|8|||
131895986|NCT02182830|474904469|FG001|Overall Study|Consent withdrawn|8|||
131895987|NCT02182830|474904468|FG000|Overall Study|Lost to Follow-up|3|||
131895988|NCT02182830|474904469|FG001|Overall Study|Lost to Follow-up|3|||
131895989|NCT00154375|474904470|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
131895990|NCT00154375|474904471|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
131895991|NCT00154375|474904470|FG000|Overall Study|Adverse Event|18|||
131895992|NCT00154375|474904471|FG001|Overall Study|Adverse Event|20|||
131895993|NCT00154375|474904470|FG000|Overall Study|Withdrawal by Subject|14|||
131895994|NCT00154375|474904471|FG001|Overall Study|Withdrawal by Subject|10|||
131895995|NCT00154375|474904470|FG000|Overall Study|Death|5|||
131895996|NCT00154375|474904471|FG001|Overall Study|Death|13|||
131895997|NCT00154375|474904470|FG000|Overall Study|Study drug no longer required|5|||
131895998|NCT00154375|474904471|FG001|Overall Study|Study drug no longer required|3|||
131895999|NCT00154375|474904470|FG000|Overall Study|Lost to Follow-up|2|||
131896000|NCT00154375|474904471|FG001|Overall Study|Lost to Follow-up|1|||
131896001|NCT00154375|474904470|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131896002|NCT00154375|474904471|FG001|Overall Study|Abnormal laboratory value(s)|2|||
131896003|NCT00154375|474904470|FG000|Overall Study|Protocol Violation|0|||
131896004|NCT00154375|474904471|FG001|Overall Study|Protocol Violation|1|||
131896005|NCT00154375|474904470|FG000|Overall Study|Suspected progression of disease|44|||
131896006|NCT00154375|474904471|FG001|Overall Study|Suspected progression of disease|30|||
131896007|NCT02348008|474904472|FG000|Overall Study|Adverse Event|2|||
131896008|NCT02348008|474904473|FG001|Overall Study|Adverse Event|3|||
131896009|NCT02348008|474904474|FG002|Overall Study|Adverse Event|3|||
131896010|NCT02348008|474904472|FG000|Overall Study|Disease Progression|1|||
131896011|NCT02348008|474904473|FG001|Overall Study|Disease Progression|5|||
131896012|NCT02348008|474904474|FG002|Overall Study|Disease Progression|16|||
131896013|NCT02348008|474904472|FG000|Overall Study|Withdrawal by Subject|0|||
131896014|NCT02348008|474904473|FG001|Overall Study|Withdrawal by Subject|1|||
131896015|NCT02348008|474904474|FG002|Overall Study|Withdrawal by Subject|0|||
131896016|NCT02348008|474904472|FG000|Overall Study|Symptomatic Deterioration|0|||
131896017|NCT02348008|474904473|FG001|Overall Study|Symptomatic Deterioration|1|||
131896018|NCT02348008|474904474|FG002|Overall Study|Symptomatic Deterioration|0|||
131896019|NCT03268005|474904479|FG000|Overall Study|Death|2|||
131896020|NCT03268005|474904480|FG001|Overall Study|Death|1|||
131896021|NCT03268005|474904479|FG000|Overall Study|Lost to Follow-up|2|||
131896022|NCT03268005|474904480|FG001|Overall Study|Lost to Follow-up|2|||
131896023|NCT03268005|474904479|FG000|Overall Study|Withdrawal by Subject|11|||
131896024|NCT03268005|474904480|FG001|Overall Study|Withdrawal by Subject|11|||
131896025|NCT00980655|474904483|FG000|Overall Study|Adverse Event|13|||
131896026|NCT00980655|474904484|FG001|Overall Study|Adverse Event|31|||
131896027|NCT00980655|474904483|FG000|Overall Study|Death|0|||
131896028|NCT00980655|474904484|FG001|Overall Study|Death|7|||
131896029|NCT00980655|474904483|FG000|Overall Study|Protocol Violation|2|||
131896030|NCT00980655|474904484|FG001|Overall Study|Protocol Violation|7|||
131896031|NCT00980655|474904483|FG000|Overall Study|Withdrawal by Subject|0|||
131896032|NCT00980655|474904484|FG001|Overall Study|Withdrawal by Subject|4|||
131896033|NCT00980655|474904483|FG000|Overall Study|Lost to Follow-up|0|||
131896034|NCT00980655|474904484|FG001|Overall Study|Lost to Follow-up|1|||
131896035|NCT00980655|474904483|FG000|Overall Study|Parent/legal guardian request|1|||
131896036|NCT00980655|474904484|FG001|Overall Study|Parent/legal guardian request|0|||
131896037|NCT00980655|474904483|FG000|Overall Study|Other|0|||
131896038|NCT00980655|474904484|FG001|Overall Study|Other|1|||
131896039|NCT00845676|474904490|FG000|Overall Study|Virologic breakthrough at week 20|1|||
131665192|NCT02480153|474058064|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
131665193|NCT02480153|474058065|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
131665194|NCT02480153|474058066|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
131665195|NCT02480153|474058064|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
131896040|NCT00845676|474904490|FG000|Overall Study|Adverse Event|1|||
131896041|NCT04378569|474906782|FG000|Overall Study|Adverse Event|0|||
131896042|NCT04378569|474906783|FG001|Overall Study|Adverse Event|0|||
131896043|NCT04378569|474906784|FG002|Overall Study|Adverse Event|2|||
131665196|NCT02480153|474058065|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
131665197|NCT02480153|474058066|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
131665198|NCT02480153|474058064|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
131665199|NCT02480153|474058065|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
131665200|NCT02480153|474058066|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
131665201|NCT00512317|474058067|FG000|Overall Study|Insufficient clinical response|36|||
131665202|NCT00512317|474058067|FG000|Overall Study|Withdrawal by Subject|23|||
131665203|NCT00512317|474058067|FG000|Overall Study|Sponsor closure of study|21|||
131665204|NCT00512317|474058067|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
131665205|NCT00512317|474058067|FG000|Overall Study|Adverse Event|13|||
131665206|NCT00512317|474058067|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
131665207|NCT00512317|474058067|FG000|Overall Study|Lost to Follow-up|2|||
131665208|NCT00512317|474058067|FG000|Overall Study|Other|2|||
131665209|NCT01639495|474058068|FG000|Overall Study|Lost to Follow-up|6|||
131665210|NCT01639495|474058068|FG000|Overall Study|Consented but didn't have study catheter|4|||
131665211|NCT01639495|474058068|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
131665212|NCT01639495|474058068|FG000|Overall Study|No radiofrequency energy applied|2|||
131665213|NCT01775475|474058069|FG000|Overall Study|Death|3|||
131896044|NCT04378569|474906785|FG003|Overall Study|Adverse Event|0|||
131896045|NCT04378569|474906786|FG004|Overall Study|Adverse Event|3|||
131896046|NCT04378569|474906787|FG005|Overall Study|Adverse Event|3|||
131896047|NCT04378569|474906782|FG000|Overall Study|Lost to Follow-up|0|||
131896048|NCT04378569|474906783|FG001|Overall Study|Lost to Follow-up|3|||
131896049|NCT04378569|474906784|FG002|Overall Study|Lost to Follow-up|1|||
131896050|NCT04378569|474906785|FG003|Overall Study|Lost to Follow-up|0|||
131896051|NCT04378569|474906786|FG004|Overall Study|Lost to Follow-up|1|||
131896052|NCT04378569|474906787|FG005|Overall Study|Lost to Follow-up|1|||
131896053|NCT04378569|474906782|FG000|Overall Study|Protocol Violation|0|||
131665214|NCT01775475|474058070|FG001|Overall Study|Death|3|||
131665215|NCT01813929|474058071|FG000|Overall Study|Withdrawal by Subject|0|||
131665216|NCT01813929|474058072|FG001|Overall Study|Withdrawal by Subject|1|||
131665217|NCT00007345|474058073|FG000|Overall Study|Refused further treatment|0|||
131896054|NCT04378569|474906783|FG001|Overall Study|Protocol Violation|0|||
131896055|NCT04378569|474906784|FG002|Overall Study|Protocol Violation|0|||
131896056|NCT04378569|474906785|FG003|Overall Study|Protocol Violation|0|||
131896057|NCT04378569|474906786|FG004|Overall Study|Protocol Violation|0|||
131896058|NCT04378569|474906787|FG005|Overall Study|Protocol Violation|1|||
131896059|NCT04378569|474906782|FG000|Overall Study|Withdrawal by Subject|0|||
131896060|NCT04378569|474906783|FG001|Overall Study|Withdrawal by Subject|6|||
131896061|NCT04378569|474906784|FG002|Overall Study|Withdrawal by Subject|7|||
131896062|NCT04378569|474906785|FG003|Overall Study|Withdrawal by Subject|4|||
131896063|NCT04378569|474906786|FG004|Overall Study|Withdrawal by Subject|5|||
131896064|NCT04378569|474906787|FG005|Overall Study|Withdrawal by Subject|4|||
131896065|NCT04378569|474906782|FG000|Overall Study|Lack of response|0|||
131896066|NCT04378569|474906783|FG001|Overall Study|Lack of response|0|||
131896067|NCT04378569|474906784|FG002|Overall Study|Lack of response|1|||
131896068|NCT04378569|474906785|FG003|Overall Study|Lack of response|0|||
131896069|NCT04378569|474906786|FG004|Overall Study|Lack of response|1|||
131896070|NCT04378569|474906787|FG005|Overall Study|Lack of response|1|||
131896071|NCT01962948|474906788|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
131896072|NCT01962948|474906789|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
131896073|NCT01962948|474906790|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
131896074|NCT01962948|474906791|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
131896075|NCT01806168|474906797|FG000|Overall Study|Adverse Event|1|||
131896076|NCT01806168|474906798|FG001|Overall Study|Adverse Event|0|||
131896077|NCT01806168|474906799|FG002|Overall Study|Adverse Event|0|||
131896078|NCT01806168|474906797|FG000|Overall Study|Withdrawal by Subject|0|||
131896079|NCT01806168|474906798|FG001|Overall Study|Withdrawal by Subject|1|||
131896080|NCT01806168|474906799|FG002|Overall Study|Withdrawal by Subject|2|||
131896081|NCT01806168|474906797|FG000|Overall Study|Protocol Violation|0|||
131896082|NCT01806168|474906798|FG001|Overall Study|Protocol Violation|0|||
131896083|NCT01806168|474906799|FG002|Overall Study|Protocol Violation|1|||
131896084|NCT01029262|474906802|FG000|Overall Study|Adverse Event|9|||
131896085|NCT01029262|474906803|FG001|Overall Study|Adverse Event|52|||
131896086|NCT01029262|474906802|FG000|Overall Study|Lack of therapeutic effect|57|||
131896087|NCT01029262|474906803|FG001|Overall Study|Lack of therapeutic effect|76|||
131896088|NCT01029262|474906802|FG000|Overall Study|Withdrawal by Subject|10|||
131896089|NCT01029262|474906803|FG001|Overall Study|Withdrawal by Subject|17|||
131896090|NCT01029262|474906802|FG000|Overall Study|Protocol Violation|2|||
131896091|NCT01029262|474906803|FG001|Overall Study|Protocol Violation|3|||
131896092|NCT01029262|474906802|FG000|Overall Study|Miscellaneous|1|||
131896093|NCT01029262|474906803|FG001|Overall Study|Miscellaneous|9|||
131896094|NCT01029262|474906802|FG000|Overall Study|Death|0|||
131896095|NCT01029262|474906803|FG001|Overall Study|Death|3|||
131896096|NCT03410992|474906804|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896097|NCT03410992|474906805|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
131896098|NCT03410992|474906806|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896099|NCT03410992|474906807|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896100|NCT03410992|474906808|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896101|NCT03410992|474906809|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896102|NCT03410992|474906810|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896103|NCT03410992|474906811|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896104|NCT03410992|474906812|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896105|NCT03410992|474906813|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896106|NCT03410992|474906814|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
131896107|NCT03410992|474906804|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
131896108|NCT03410992|474906805|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
131896109|NCT03410992|474906806|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896110|NCT03410992|474906807|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896111|NCT03410992|474906808|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896112|NCT03410992|474906809|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896113|NCT03410992|474906810|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896114|NCT03410992|474906811|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896115|NCT03410992|474906812|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896116|NCT03410992|474906813|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896117|NCT03410992|474906814|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
131896118|NCT03410992|474906804|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
131896119|NCT03410992|474906805|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
131896120|NCT03410992|474906806|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896121|NCT03410992|474906807|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896122|NCT03410992|474906808|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896123|NCT03410992|474906809|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896124|NCT03410992|474906810|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896125|NCT03410992|474906811|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896126|NCT03410992|474906812|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896127|NCT03410992|474906813|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896128|NCT03410992|474906814|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
131896129|NCT03410992|474906804|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
131896130|NCT03410992|474906805|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896131|NCT03410992|474906806|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896132|NCT03410992|474906807|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896133|NCT03410992|474906808|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896134|NCT03410992|474906809|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896135|NCT03410992|474906810|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896136|NCT03410992|474906811|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896137|NCT03410992|474906812|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896138|NCT03410992|474906813|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896139|NCT03410992|474906814|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131896140|NCT03410992|474906804|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
131896141|NCT03410992|474906805|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
131896142|NCT03410992|474906806|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896143|NCT03410992|474906807|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896144|NCT03410992|474906808|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896145|NCT03410992|474906809|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896146|NCT03410992|474906810|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896147|NCT03410992|474906811|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896148|NCT03410992|474906812|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896149|NCT03410992|474906813|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896150|NCT03410992|474906814|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
131896151|NCT03410992|474906804|FG000|Week 16 Assessment|Incorrect escapers|0|||
131896152|NCT03410992|474906805|FG001|Week 16 Assessment|Incorrect escapers|6|||
131896153|NCT03410992|474906806|FG002|Week 16 Assessment|Incorrect escapers|0|||
131896154|NCT03410992|474906807|FG003|Week 16 Assessment|Incorrect escapers|0|||
131896155|NCT03410992|474906808|FG004|Week 16 Assessment|Incorrect escapers|0|||
131896156|NCT03410992|474906809|FG005|Week 16 Assessment|Incorrect escapers|0|||
131896157|NCT03410992|474906810|FG006|Week 16 Assessment|Incorrect escapers|0|||
131896158|NCT03410992|474906811|FG007|Week 16 Assessment|Incorrect escapers|0|||
131896159|NCT03410992|474906812|FG008|Week 16 Assessment|Incorrect escapers|0|||
131896160|NCT03410992|474906813|FG009|Week 16 Assessment|Incorrect escapers|0|||
131896161|NCT03410992|474906814|FG010|Week 16 Assessment|Incorrect escapers|0|||
131896162|NCT03410992|474906804|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896163|NCT03410992|474906805|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896164|NCT03410992|474906806|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896165|NCT03410992|474906807|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
131896166|NCT03410992|474906808|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
131896167|NCT03410992|474906809|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896168|NCT03410992|474906810|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896169|NCT03410992|474906811|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896170|NCT03410992|474906812|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896171|NCT03410992|474906813|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896172|NCT03410992|474906814|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
131896173|NCT03410992|474906804|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896174|NCT03410992|474906805|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896175|NCT03410992|474906806|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896176|NCT03410992|474906807|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
131896177|NCT03410992|474906808|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
131896178|NCT03410992|474906809|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
131896179|NCT03410992|474906810|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896180|NCT03410992|474906811|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896181|NCT03410992|474906812|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896182|NCT03410992|474906813|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896183|NCT03410992|474906814|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131896184|NCT03410992|474906804|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896185|NCT03410992|474906805|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896186|NCT03410992|474906806|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896187|NCT03410992|474906807|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896188|NCT03410992|474906808|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896189|NCT03410992|474906809|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
131896190|NCT03410992|474906810|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896191|NCT03410992|474906811|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896192|NCT03410992|474906812|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896193|NCT03410992|474906813|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896194|NCT03410992|474906814|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
131896195|NCT03410992|474906804|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896196|NCT03410992|474906805|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896197|NCT03410992|474906806|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896198|NCT03410992|474906807|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
131896199|NCT03410992|474906808|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
131896200|NCT03410992|474906809|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
131665218|NCT00007345|474058074|FG001|Overall Study|Refused further treatment|7|||
131665219|NCT00007345|474058073|FG000|Overall Study|Switched to alternative treatment|0|||
131665220|NCT00007345|474058074|FG001|Overall Study|Switched to alternative treatment|3|||
131665221|NCT00007345|474058073|FG000|Overall Study|Intercurrent illness|1|||
131896201|NCT03410992|474906810|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131553709|NCT02213328|473651203|FG000|Overall Study|Withdrawal by Subject|10|||
131553710|NCT02213328|473651203|FG000|Overall Study|Physician Decision|2|||
131553711|NCT02213328|473651203|FG000|Overall Study|Lost to Follow-up|16|||
131553712|NCT03287414|473651206|FG000|Treatment Epoch|Adverse Event|0|||
131553713|NCT03287414|473651207|FG001|Treatment Epoch|Adverse Event|1|||
131553714|NCT03287414|473651206|FG000|Treatment Epoch|Study terminated by sponsor|2|||
131553715|NCT03287414|473651207|FG001|Treatment Epoch|Study terminated by sponsor|2|||
131553716|NCT03287414|473651206|FG000|Treatment Epoch|Subject/Guardian decision|4|||
131553717|NCT03287414|473651207|FG001|Treatment Epoch|Subject/Guardian decision|0|||
131553718|NCT03287414|473651206|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
131553719|NCT03287414|473651207|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
131553720|NCT03287414|473651206|FG000|Treatment Epoch|Withdrawal by Subject|1|||
131553721|NCT03287414|473651207|FG001|Treatment Epoch|Withdrawal by Subject|0|||
131553722|NCT03287414|473651206|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
131553723|NCT03287414|473651207|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
131665222|NCT00007345|474058074|FG001|Overall Study|Intercurrent illness|0|||
131896202|NCT03410992|474906811|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896203|NCT03410992|474906812|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896204|NCT03410992|474906813|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896205|NCT03410992|474906814|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
131896206|NCT03410992|474906804|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896207|NCT03410992|474906805|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896208|NCT03410992|474906806|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896209|NCT03410992|474906807|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896210|NCT03410992|474906808|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896211|NCT03410992|474906809|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896212|NCT03410992|474906810|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
131553724|NCT03287414|473651206|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
131553725|NCT03287414|473651207|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
131553726|NCT00909428|473651214|FG000|Overall Study|Lost to Follow-up|13|||
131553727|NCT00909428|473651215|FG001|Overall Study|Lost to Follow-up|10|||
131553728|NCT00909428|473651216|FG002|Overall Study|Lost to Follow-up|9|||
131553729|NCT03021668|473651217|FG000|Overall Study|Physician Decision|0|||
131553730|NCT03021668|473651218|FG001|Overall Study|Physician Decision|1|||
131553731|NCT01122381|473651219|FG000|Overall Study|study terminated early|0|||
131553732|NCT01122381|473651220|FG001|Overall Study|study terminated early|1|||
131553733|NCT01125722|473651221|FG000|Overall Study|Withdrawal by Subject|2|||
131553734|NCT01125722|473651222|FG001|Overall Study|Withdrawal by Subject|1|||
131553735|NCT01125722|473651221|FG000|Overall Study|Lost to Follow-up|1|||
131553736|NCT01125722|473651222|FG001|Overall Study|Lost to Follow-up|0|||
131553737|NCT03474549|473651223|FG000|Overall Study|Death|31|||
131553738|NCT03474549|473651223|FG000|Overall Study|Lost to Follow-up|4|||
131553739|NCT03474549|473651223|FG000|Overall Study|Withdrawal by Subject|2|||
131553740|NCT03445065|473651225|FG000|Overall Study|Withdrawal by Subject|3|||
131553741|NCT03445065|473651226|FG001|Overall Study|Withdrawal by Subject|6|||
131553742|NCT03445065|473651227|FG002|Overall Study|Withdrawal by Subject|2|||
131553743|NCT03445065|473651228|FG003|Overall Study|Withdrawal by Subject|2|||
131553744|NCT03445065|473651225|FG000|Overall Study|Other|4|||
131553745|NCT03445065|473651226|FG001|Overall Study|Other|3|||
131553746|NCT03445065|473651227|FG002|Overall Study|Other|3|||
131553747|NCT03445065|473651228|FG003|Overall Study|Other|1|||
131553748|NCT01816763|473652847|FG000|Overall Study|The main reason for an incomplete survey|4|||
131553749|NCT01816763|473652848|FG001|Overall Study|The main reason for an incomplete survey|15|||
131553750|NCT01816763|473652849|FG002|Overall Study|The main reason for an incomplete survey|11|||
131553751|NCT00311155|473652850|FG000|Overall Study|Adverse Event|21|||
131553752|NCT00311155|473652850|FG000|Overall Study|Withdrawal by Subject|17|||
131553753|NCT00311155|473652850|FG000|Overall Study|Did not meet entry criteria|55|||
131553754|NCT00429494|473652851|FG000|Overall Study|Withdrawal by Subject|9|||
131553755|NCT00429494|473652851|FG000|Overall Study|Death|6|||
131553756|NCT02746575|473652852|FG000|Overall Study|Surgery cancelled or time chaned|13|||
131553757|NCT02746575|473652852|FG000|Overall Study|Received epidural|10|||
131553758|NCT02746575|473652852|FG000|Overall Study|Withdrawal by Subject|3|||
131553759|NCT02746575|473652852|FG000|Overall Study|Bradycardia/hypotension|9|||
131553760|NCT02746575|473652852|FG000|Overall Study|Study paused|8|||
131553761|NCT02746575|473652852|FG000|Overall Study|put on beta-blocker|3|||
131553762|NCT02746575|473652852|FG000|Overall Study|type of surgery|1|||
131553763|NCT02746575|473652852|FG000|Overall Study|typ of surgery|1|||
131553764|NCT02746575|473652852|FG000|Overall Study|PI unavailable|1|||
131553765|NCT02746575|473652852|FG000|Overall Study|Unknown history of CVA|1|||
131553766|NCT05648357|473652853|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
131553767|NCT00409786|473652857|FG000|Overall Study|Withdrawal by Subject|3|||
131553768|NCT02341456|473652858|FG000|Overall Study|Disease progression|2|||
131553769|NCT02341456|473652859|FG001|Overall Study|Disease progression|3|||
131553770|NCT02341456|473652860|FG002|Overall Study|Disease progression|1|||
131553771|NCT02341456|473652858|FG000|Overall Study|Death|1|||
131553772|NCT02341456|473652859|FG001|Overall Study|Death|1|||
131553773|NCT02341456|473652860|FG002|Overall Study|Death|1|||
131553774|NCT02341456|473652858|FG000|Overall Study|Withdrawal by Subject|0|||
131553775|NCT02341456|473652859|FG001|Overall Study|Withdrawal by Subject|1|||
131553776|NCT02341456|473652860|FG002|Overall Study|Withdrawal by Subject|1|||
131553777|NCT02341456|473652858|FG000|Overall Study|Moved to local access programme.|0|||
131553778|NCT02341456|473652859|FG001|Overall Study|Moved to local access programme.|1|||
131553779|NCT02341456|473652860|FG002|Overall Study|Moved to local access programme.|1|||
131553780|NCT02341456|473652858|FG000|Overall Study|Physician Decision|1|||
131553781|NCT02341456|473652859|FG001|Overall Study|Physician Decision|0|||
131553782|NCT02341456|473652860|FG002|Overall Study|Physician Decision|0|||
131553783|NCT02306265|473652861|FG000|Overall Study|Withdrawal by Subject|1|||
131553784|NCT04702568|473652862|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
131553785|NCT04702568|473652863|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
131553786|NCT04702568|473652862|FG000|Overall Study|Pregnancy|1|||
131896213|NCT03410992|474906811|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
131896214|NCT03410992|474906812|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896215|NCT03410992|474906813|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896216|NCT03410992|474906814|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
131896217|NCT03410992|474906804|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896218|NCT03410992|474906805|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896219|NCT03410992|474906806|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896220|NCT03410992|474906807|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896221|NCT03410992|474906808|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896222|NCT03410992|474906809|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896223|NCT03410992|474906810|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896224|NCT03410992|474906811|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896225|NCT03410992|474906812|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
131896226|NCT03410992|474906813|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896227|NCT03410992|474906814|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131896228|NCT02438280|474906815|FG000|Overall Study|Physician Decision|1|||
131435948|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
131553787|NCT04702568|473652863|FG001|Overall Study|Pregnancy|0|||
131553788|NCT04702568|473652862|FG000|Overall Study|Bone marrow transplant|1|||
131553789|NCT04702568|473652863|FG001|Overall Study|Bone marrow transplant|0|||
131553790|NCT04702568|473652862|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
131553791|NCT04702568|473652863|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
131553792|NCT04702568|473652862|FG000|Overall Study|Withdrawal by Subject|0|||
131553793|NCT04702568|473652863|FG001|Overall Study|Withdrawal by Subject|2|||
131553794|NCT04091360|473652864|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553795|NCT04091360|473652865|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553796|NCT04091360|473652866|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553797|NCT04091360|473652867|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553798|NCT04091360|473652868|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553799|NCT04091360|473652869|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553800|NCT04091360|473652870|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553801|NCT04091360|473652871|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131553802|NCT04091360|473652872|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
131553803|NCT04091360|473652873|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
131553804|NCT04091360|473652864|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553805|NCT04091360|473652865|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553806|NCT04091360|473652866|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553807|NCT04091360|473652867|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553808|NCT04091360|473652868|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553809|NCT04091360|473652869|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553810|NCT04091360|473652870|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
131553811|NCT04091360|473652871|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
131553812|NCT04091360|473652872|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553813|NCT04091360|473652873|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
131553814|NCT04091360|473652864|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553815|NCT04091360|473652865|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553816|NCT04091360|473652866|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553817|NCT04091360|473652867|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553818|NCT04091360|473652868|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553819|NCT04091360|473652869|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553820|NCT04091360|473652870|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
131553821|NCT04091360|473652871|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553822|NCT04091360|473652872|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
131553823|NCT04091360|473652873|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
131553824|NCT00572624|473652874|FG000|Overall Study|Lost to Follow-up|10|||
131553825|NCT00572624|473652875|FG001|Overall Study|Lost to Follow-up|4|||
131553826|NCT00572624|473652874|FG000|Overall Study|Wanted to do a different diet program|1|||
131553827|NCT00572624|473652875|FG001|Overall Study|Wanted to do a different diet program|0|||
131553828|NCT00572624|473652874|FG000|Overall Study|Medication change|1|||
131553829|NCT00572624|473652875|FG001|Overall Study|Medication change|0|||
131553830|NCT00572624|473652874|FG000|Overall Study|Started a new job-- no time for study|1|||
131553831|NCT00572624|473652875|FG001|Overall Study|Started a new job-- no time for study|0|||
131553832|NCT00572624|473652874|FG000|Overall Study|Admitted to being a smoker|1|||
131553833|NCT00572624|473652875|FG001|Overall Study|Admitted to being a smoker|0|||
131553834|NCT00572624|473652874|FG000|Overall Study|Refused to do the stress test|1|||
131553835|NCT00572624|473652875|FG001|Overall Study|Refused to do the stress test|0|||
131896229|NCT02438280|474906816|FG001|Overall Study|Physician Decision|0|||
131896230|NCT02260817|474906817|FG000|Overall Study|Lost to Follow-up|0|||
131896231|NCT02260817|474906818|FG001|Overall Study|Lost to Follow-up|14|||
131896232|NCT02260817|474906817|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
131896233|NCT02260817|474906818|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
131896234|NCT02260817|474906817|FG000|Overall Study|Observation, no biopsy|0|||
131896235|NCT02260817|474906818|FG001|Overall Study|Observation, no biopsy|1|||
131896236|NCT02260817|474906817|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
131896237|NCT02260817|474906818|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
131896238|NCT02260817|474906817|FG000|Overall Study|Protocol Violation|0|||
131896239|NCT02260817|474906818|FG001|Overall Study|Protocol Violation|14|||
131896240|NCT03299101|474906819|FG000|Overall Study|Lost to Follow-up|1|||
131896241|NCT03299101|474906819|FG000|Overall Study|Withdrawal by Subject|5|||
131896242|NCT03299101|474906819|FG000|Overall Study|Surgery was changed|3|||
131896243|NCT03299101|474906819|FG000|Overall Study|Not enough time to complete prehab|1|||
131896244|NCT05359952|474906821|FG000|Overall Study|Lost to Follow-up|1|||
131896245|NCT05359952|474906822|FG001|Overall Study|Lost to Follow-up|0|||
131896246|NCT03066778|474906823|FG000|Overall Study|Death|195|||
131896247|NCT03066778|474906824|FG001|Overall Study|Death|205|||
131896248|NCT03066778|474906823|FG000|Overall Study|Withdrawal by Subject|5|||
131896249|NCT03066778|474906824|FG001|Overall Study|Withdrawal by Subject|7|||
131896250|NCT02091414|474906825|FG000|Overall Study|Withdrawal by Subject|2|||
131896251|NCT02091414|474906825|FG000|Overall Study|Death|2|||
131896252|NCT03231306|474906828|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
131896253|NCT03231306|474906828|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
131896254|NCT03231306|474906828|FG000|Overall Study|Treatment delay > 21 days|2|||
131896255|NCT03231306|474906828|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
131896256|NCT03231306|474906828|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
131896257|NCT03231306|474906828|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
131896258|NCT03231306|474906828|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
131896259|NCT03231306|474906828|FG000|Overall Study|More than 1 Reason|2|||
131896260|NCT02306850|474906829|FG000|Overall Study|Lack of Efficacy|2|||
131896261|NCT02420262|474906830|FG000|Overall Study|Adverse Event|1|||
131896262|NCT02420262|474906831|FG001|Overall Study|Adverse Event|0|||
131896263|NCT02420262|474906830|FG000|Overall Study|Withdrawal by Subject|1|||
131896264|NCT02420262|474906831|FG001|Overall Study|Withdrawal by Subject|4|||
131896265|NCT02420262|474906830|FG000|Overall Study|Unclassified|0|||
131896266|NCT02420262|474906831|FG001|Overall Study|Unclassified|1|||
131896267|NCT00685360|474906832|FG000|Overall Study|Lost to Follow-up|0|||
131896268|NCT00685360|474906833|FG001|Overall Study|Lost to Follow-up|1|||
131896269|NCT00685360|474906834|FG002|Overall Study|Lost to Follow-up|2|||
131896270|NCT00685360|474906832|FG000|Overall Study|Adverse Event|4|||
131896271|NCT00685360|474906833|FG001|Overall Study|Adverse Event|6|||
131896272|NCT00685360|474906834|FG002|Overall Study|Adverse Event|4|||
131896273|NCT00685360|474906832|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
131896274|NCT00685360|474906833|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
131896275|NCT00685360|474906834|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
131896276|NCT00685360|474906832|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
131896277|NCT00685360|474906833|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
131896278|NCT00685360|474906834|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
131896279|NCT00685360|474906832|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
131896280|NCT00685360|474906833|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
131896281|NCT00685360|474906834|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
131896282|NCT00685360|474906832|FG000|Overall Study|Protocol Deviation|0|||
131896283|NCT00685360|474906833|FG001|Overall Study|Protocol Deviation|1|||
131896284|NCT00685360|474906834|FG002|Overall Study|Protocol Deviation|1|||
131896285|NCT05446142|474906842|FG000|Period 2|Adverse Event|1|||
131896286|NCT05446142|474906843|FG001|Period 2|Adverse Event|0|||
131896287|NCT05446142|474906844|FG002|Period 2|Adverse Event|0|||
131896288|NCT05446142|474906845|FG003|Period 2|Adverse Event|0|||
131896289|NCT05446142|474906846|FG004|Period 2|Adverse Event|0|||
131896290|NCT05446142|474906847|FG005|Period 2|Adverse Event|0|||
131896291|NCT02098395|474906848|FG000|Overall Study|Protocol Violation|2|||
131896292|NCT02098395|474906849|FG001|Overall Study|Protocol Violation|2|||
131896293|NCT02098395|474906850|FG002|Overall Study|Protocol Violation|0|||
131896294|NCT02098395|474906851|FG003|Overall Study|Protocol Violation|7|||
131896295|NCT02098395|474906848|FG000|Overall Study|Withdrawal by Subject|10|||
131896296|NCT02098395|474906849|FG001|Overall Study|Withdrawal by Subject|10|||
131896297|NCT02098395|474906850|FG002|Overall Study|Withdrawal by Subject|5|||
131896298|NCT02098395|474906851|FG003|Overall Study|Withdrawal by Subject|13|||
131896299|NCT02098395|474906848|FG000|Overall Study|Adverse Event|12|||
131896300|NCT02098395|474906849|FG001|Overall Study|Adverse Event|19|||
131896301|NCT02098395|474906850|FG002|Overall Study|Adverse Event|34|||
131896302|NCT02098395|474906851|FG003|Overall Study|Adverse Event|2|||
131896303|NCT02098395|474906848|FG000|Overall Study|Lost to Follow-up|2|||
131896304|NCT02098395|474906849|FG001|Overall Study|Lost to Follow-up|1|||
131896305|NCT02098395|474906850|FG002|Overall Study|Lost to Follow-up|0|||
131896306|NCT02098395|474906851|FG003|Overall Study|Lost to Follow-up|3|||
131896307|NCT02098395|474906848|FG000|Overall Study|Unclassified|0|||
131896308|NCT02098395|474906849|FG001|Overall Study|Unclassified|0|||
131896309|NCT02098395|474906850|FG002|Overall Study|Unclassified|3|||
131896310|NCT02098395|474906851|FG003|Overall Study|Unclassified|2|||
131896311|NCT00547157|474906852|FG000|Overall Study|Other|1|||
131896312|NCT00547157|474906853|FG001|Overall Study|Other|0|||
131896313|NCT00547157|474906852|FG000|Overall Study|Death|38|||
131896314|NCT00547157|474906853|FG001|Overall Study|Death|18|||
131896315|NCT00547157|474906852|FG000|Overall Study|Withdrawal by Subject|3|||
131896316|NCT00547157|474906853|FG001|Overall Study|Withdrawal by Subject|1|||
131896317|NCT00547157|474906852|FG000|Overall Study|Administrative decision|3|||
131896318|NCT00547157|474906853|FG001|Overall Study|Administrative decision|2|||
131896319|NCT00547157|474906852|FG000|Overall Study|Lost to Follow-up|4|||
131896320|NCT00547157|474906853|FG001|Overall Study|Lost to Follow-up|2|||
131896321|NCT00110357|474906854|FG000|Overall Study|Deterioration without progression|2|||
131896322|NCT00110357|474906855|FG001|Overall Study|Deterioration without progression|0|||
131896323|NCT00110357|474906854|FG000|Overall Study|Disease progression/relapse|20|||
131896324|NCT00110357|474906855|FG001|Overall Study|Disease progression/relapse|15|||
131896325|NCT00110357|474906854|FG000|Overall Study|Study Closure|1|||
131896326|NCT00110357|474906855|FG001|Overall Study|Study Closure|0|||
131896327|NCT00110357|474906854|FG000|Overall Study|Study Drug Toxicity|1|||
131896328|NCT00110357|474906855|FG001|Overall Study|Study Drug Toxicity|3|||
131896329|NCT00110357|474906854|FG000|Overall Study|Withdrawal by Subject|3|||
131896330|NCT00110357|474906855|FG001|Overall Study|Withdrawal by Subject|1|||
131896331|NCT03382418|474906856|FG000|Overall Study|Withdrawal by Subject|1|||
131896332|NCT03382418|474906857|FG001|Overall Study|Withdrawal by Subject|0|||
131896333|NCT03382418|474906858|FG002|Overall Study|Withdrawal by Subject|0|||
131896334|NCT03382418|474906856|FG000|Overall Study|Lost to Follow-up|2|||
131896335|NCT03382418|474906857|FG001|Overall Study|Lost to Follow-up|3|||
131896336|NCT03382418|474906858|FG002|Overall Study|Lost to Follow-up|0|||
131896337|NCT05464420|474906859|FG000|Overall Study|Death|0|||
131896338|NCT05464420|474906860|FG001|Overall Study|Death|0|||
131435949|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
131665223|NCT00007345|474058073|FG000|Overall Study|Death on study|1|||
131665224|NCT00007345|474058074|FG001|Overall Study|Death on study|1|||
131665225|NCT04433585|474058075|FG000|Overall Study|Withdrawal by Subject|15|||
131665226|NCT04433585|474058076|FG001|Overall Study|Withdrawal by Subject|3|||
131665227|NCT04433585|474058077|FG002|Overall Study|Withdrawal by Subject|15|||
131665228|NCT04433585|474058078|FG003|Overall Study|Withdrawal by Subject|6|||
131665229|NCT04433585|474058075|FG000|Overall Study|Adverse Event|10|||
131665230|NCT04433585|474058076|FG001|Overall Study|Adverse Event|4|||
131665231|NCT04433585|474058077|FG002|Overall Study|Adverse Event|1|||
131665232|NCT04433585|474058078|FG003|Overall Study|Adverse Event|0|||
131896339|NCT05464420|474906861|FG002|Overall Study|Death|0|||
131896340|NCT05464420|474906862|FG003|Overall Study|Death|1|||
131896341|NCT05464420|474906859|FG000|Overall Study|Lost to Follow-up|16|||
131896342|NCT05464420|474906860|FG001|Overall Study|Lost to Follow-up|11|||
131896343|NCT05464420|474906861|FG002|Overall Study|Lost to Follow-up|11|||
131896344|NCT05464420|474906862|FG003|Overall Study|Lost to Follow-up|11|||
131665233|NCT04433585|474058075|FG000|Overall Study|Due to the conflict in Ukraine|2|||
131665234|NCT04433585|474058076|FG001|Overall Study|Due to the conflict in Ukraine|1|||
131896345|NCT05464420|474906859|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
131665235|NCT04433585|474058077|FG002|Overall Study|Due to the conflict in Ukraine|1|||
131896346|NCT05464420|474906860|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
131896347|NCT05464420|474906861|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
131896348|NCT05464420|474906862|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
131896349|NCT05464420|474906859|FG000|Overall Study|Withdrawal by Subject|4|||
131665236|NCT04433585|474058078|FG003|Overall Study|Due to the conflict in Ukraine|2|||
131665237|NCT04433585|474058075|FG000|Overall Study|Physician Decision|1|||
131665238|NCT04433585|474058076|FG001|Overall Study|Physician Decision|2|||
131665239|NCT04433585|474058077|FG002|Overall Study|Physician Decision|0|||
131665240|NCT04433585|474058078|FG003|Overall Study|Physician Decision|0|||
131665241|NCT04433585|474058075|FG000|Overall Study|Lost to Follow-up|1|||
131665242|NCT04433585|474058076|FG001|Overall Study|Lost to Follow-up|1|||
131665243|NCT04433585|474058077|FG002|Overall Study|Lost to Follow-up|1|||
131665244|NCT04433585|474058078|FG003|Overall Study|Lost to Follow-up|0|||
131665245|NCT04433585|474058075|FG000|Overall Study|Lack of Efficacy|0|||
131665246|NCT04433585|474058076|FG001|Overall Study|Lack of Efficacy|1|||
131665247|NCT04433585|474058077|FG002|Overall Study|Lack of Efficacy|1|||
131665248|NCT04433585|474058078|FG003|Overall Study|Lack of Efficacy|1|||
131665249|NCT04433585|474058075|FG000|Overall Study|Death|0|||
131665250|NCT04433585|474058076|FG001|Overall Study|Death|1|||
131665251|NCT04433585|474058077|FG002|Overall Study|Death|0|||
131896350|NCT05464420|474906860|FG001|Overall Study|Withdrawal by Subject|8|||
131896351|NCT05464420|474906861|FG002|Overall Study|Withdrawal by Subject|3|||
131896352|NCT05464420|474906862|FG003|Overall Study|Withdrawal by Subject|1|||
131896353|NCT05464420|474906859|FG000|Overall Study|Protocol Violation|0|||
131665252|NCT04433585|474058078|FG003|Overall Study|Death|0|||
131665253|NCT02074553|474058079|FG000|Intervention Period 1|Family Emergency|0|||
131665254|NCT02074553|474058080|FG001|Intervention Period 1|Family Emergency|0|||
131665255|NCT02074553|474058081|FG002|Intervention Period 1|Family Emergency|0|||
131665256|NCT02074553|474058082|FG003|Intervention Period 1|Family Emergency|1|||
131665257|NCT02074553|474058083|FG004|Intervention Period 1|Family Emergency|0|||
131665258|NCT02074553|474058084|FG005|Intervention Period 1|Family Emergency|0|||
131896354|NCT05464420|474906860|FG001|Overall Study|Protocol Violation|0|||
131896355|NCT05464420|474906861|FG002|Overall Study|Protocol Violation|1|||
131896356|NCT05464420|474906862|FG003|Overall Study|Protocol Violation|1|||
131896357|NCT05464420|474906859|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
131896358|NCT05464420|474906860|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
131896359|NCT05464420|474906861|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
131896360|NCT05464420|474906862|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
131896361|NCT01383018|474906863|FG000|Overall Study|Adverse Event|14|||
131896362|NCT01383018|474906863|FG000|Overall Study|Death|10|||
131896363|NCT01383018|474906863|FG000|Overall Study|Lost to Follow-up|5|||
131896364|NCT01383018|474906863|FG000|Overall Study|Physician Decision|5|||
131896365|NCT01383018|474906863|FG000|Overall Study|Withdrawal by Subject|9|||
131896366|NCT01383018|474906863|FG000|Overall Study|Subject not implanted|76|||
131896367|NCT01383018|474906863|FG000|Overall Study|Missed Visit|247|||
131896368|NCT01383018|474906863|FG000|Overall Study|Site closed early-not compliance related|7|||
131896369|NCT01383018|474906863|FG000|Overall Study|Patient moved away from site|1|||
131896370|NCT01383018|474906863|FG000|Overall Study|Subject Incarcerated|1|||
131896371|NCT04633226|474906864|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131896372|NCT04633226|474906864|FG000|Overall Study|Randomized by mistake without study treatment|1|||
131896373|NCT01765569|474906867|FG000|Period B|Withdrawal by Subject|1|||
131896374|NCT01765569|474906867|FG000|Period C|Death|1|||
131896375|NCT04533438|474906868|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
131896376|NCT04533438|474906869|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
131896377|NCT04208412|474906870|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
131896378|NCT04208412|474906871|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
131896379|NCT04208412|474906870|FG000|Overall Study|Withdrawal by Subject|1|||
131896380|NCT04208412|474906871|FG001|Overall Study|Withdrawal by Subject|0|||
131896381|NCT04208412|474906870|FG000|Overall Study|Lost to Follow-up|0|||
131896382|NCT04208412|474906871|FG001|Overall Study|Lost to Follow-up|1|||
131896383|NCT05415462|474906874|FG000|Overall Study|Death|18|||
131896384|NCT05415462|474906875|FG001|Overall Study|Death|10|||
131896385|NCT05415462|474906874|FG000|Overall Study|Lost to Follow-up|72|||
131896386|NCT05415462|474906875|FG001|Overall Study|Lost to Follow-up|64|||
131896387|NCT05415462|474906874|FG000|Overall Study|Physician Decision|5|||
131896388|NCT05415462|474906875|FG001|Overall Study|Physician Decision|5|||
131896389|NCT05415462|474906874|FG000|Overall Study|Protocol Deviation|1|||
131896390|NCT05415462|474906875|FG001|Overall Study|Protocol Deviation|0|||
131896391|NCT05415462|474906874|FG000|Overall Study|Withdrawal by Subject|129|||
131896392|NCT05415462|474906875|FG001|Overall Study|Withdrawal by Subject|101|||
131896393|NCT05415462|474906874|FG000|Overall Study|Other Than Specified|8|||
131896394|NCT05415462|474906875|FG001|Overall Study|Other Than Specified|8|||
131896395|NCT01348100|474906876|FG000|Overall Study|Subject Withdrew Consent|0|||
131553836|NCT00572624|473652874|FG000|Overall Study|Problem with vascular access|1|||
131553837|NCT00572624|473652875|FG001|Overall Study|Problem with vascular access|0|||
131553838|NCT00572624|473652874|FG000|Overall Study|Health issues unrelated to the study|1|||
131553839|NCT00572624|473652875|FG001|Overall Study|Health issues unrelated to the study|0|||
131553840|NCT00130793|473652878|FG000|Overall Study|Lost to Follow-up|1|||
131553841|NCT00130793|473652879|FG001|Overall Study|Lost to Follow-up|4|||
131553842|NCT00130793|473652878|FG000|Overall Study|Withdrew consent|2|||
131553843|NCT00130793|473652879|FG001|Overall Study|Withdrew consent|0|||
131553844|NCT00453102|473652882|FG000|Overall Study|Withdrawal by Subject|2|||
131553845|NCT03500640|473652890|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
131553846|NCT03500640|473652891|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
131553847|NCT03500640|473652892|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
131553848|NCT03500640|473652890|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
131553849|NCT03500640|473652891|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
131553850|NCT03500640|473652892|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
131553851|NCT03500640|473652890|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
131553852|NCT03500640|473652891|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
131553853|NCT03500640|473652892|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
131553854|NCT03500640|473652890|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
131553855|NCT03500640|473652891|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
131553856|NCT03500640|473652892|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
131553857|NCT03500640|473652890|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
131553858|NCT03500640|473652891|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
131553859|NCT03500640|473652892|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
131553860|NCT03500640|473652890|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
131553861|NCT03500640|473652891|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
131553862|NCT03500640|473652892|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
131553863|NCT03500640|473652890|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
131553864|NCT03500640|473652891|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
131553865|NCT03500640|473652892|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
131553866|NCT03500640|473652890|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
131553867|NCT03500640|473652891|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
131553868|NCT03500640|473652892|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
131553869|NCT03500640|473652890|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
131553870|NCT03500640|473652891|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
131553871|NCT03500640|473652892|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
131553872|NCT03500640|473652890|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
131553873|NCT03500640|473652891|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
131553874|NCT03500640|473652892|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
131553875|NCT01650519|473652893|FG000|Overall Study|Withdrawal by Subject|1|||
131553876|NCT01650519|473652894|FG001|Overall Study|Withdrawal by Subject|0|||
131553877|NCT05229653|473652900|FG000|Overall Study|Lost to Follow-up|1|||
131553878|NCT05229653|473652901|FG001|Overall Study|Lost to Follow-up|0|||
131553879|NCT02667886|473652902|FG000|Dose Escalation (Part A)|Adverse Event|1|||
131553880|NCT02667886|473652903|FG001|Dose Escalation (Part A)|Adverse Event|3|||
131553881|NCT02667886|473652904|FG002|Dose Escalation (Part A)|Adverse Event|1|||
131553882|NCT02667886|473652905|FG003|Dose Escalation (Part A)|Adverse Event|0|||
131553883|NCT02667886|473652906|FG004|Dose Escalation (Part A)|Adverse Event|0|||
131553884|NCT02667886|473652902|FG000|Dose Escalation (Part A)|Disease Progression|1|||
131553885|NCT02667886|473652903|FG001|Dose Escalation (Part A)|Disease Progression|4|||
131553886|NCT02667886|473652904|FG002|Dose Escalation (Part A)|Disease Progression|3|||
131553887|NCT02667886|473652905|FG003|Dose Escalation (Part A)|Disease Progression|0|||
131553888|NCT02667886|473652906|FG004|Dose Escalation (Part A)|Disease Progression|0|||
131553889|NCT02667886|473652902|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
131553890|NCT02667886|473652903|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
131553891|NCT02667886|473652904|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
131553892|NCT02667886|473652905|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
131553893|NCT02667886|473652906|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
131553894|NCT02667886|473652902|FG000|Dose Expansion (Part B)|Adverse Event|0|||
131553895|NCT02667886|473652903|FG001|Dose Expansion (Part B)|Adverse Event|0|||
131553896|NCT02667886|473652904|FG002|Dose Expansion (Part B)|Adverse Event|0|||
131553897|NCT02667886|473652905|FG003|Dose Expansion (Part B)|Adverse Event|9|||
131553898|NCT02667886|473652906|FG004|Dose Expansion (Part B)|Adverse Event|0|||
131553899|NCT02667886|473652902|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
131553900|NCT02667886|473652903|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
131896396|NCT01348100|474906877|FG001|Overall Study|Subject Withdrew Consent|0|||
131896397|NCT01348100|474906878|FG002|Overall Study|Subject Withdrew Consent|2|||
131896398|NCT01348100|474906879|FG003|Overall Study|Subject Withdrew Consent|0|||
131896399|NCT01348100|474906880|FG004|Overall Study|Subject Withdrew Consent|1|||
131896400|NCT01348100|474906881|FG005|Overall Study|Subject Withdrew Consent|0|||
131665259|NCT02074553|474058085|FG006|Intervention Period 1|Family Emergency|0|||
131665260|NCT02074553|474058086|FG007|Intervention Period 1|Family Emergency|0|||
131665261|NCT02074553|474058079|FG000|Washout Period 1|Adverse Event|1|||
131665262|NCT02074553|474058080|FG001|Washout Period 1|Adverse Event|0|||
131665263|NCT02074553|474058081|FG002|Washout Period 1|Adverse Event|0|||
131665264|NCT02074553|474058082|FG003|Washout Period 1|Adverse Event|0|||
131665265|NCT02074553|474058083|FG004|Washout Period 1|Adverse Event|0|||
131665266|NCT02074553|474058084|FG005|Washout Period 1|Adverse Event|0|||
131665267|NCT02074553|474058085|FG006|Washout Period 1|Adverse Event|0|||
131665268|NCT02074553|474058086|FG007|Washout Period 1|Adverse Event|0|||
131665269|NCT02074553|474058079|FG000|Washout Period 1|Physician Decision|0|||
131896401|NCT01348100|474906882|FG006|Overall Study|Subject Withdrew Consent|1|||
131896402|NCT01348100|474906876|FG000|Overall Study|Protocol Deviation|0|||
131896403|NCT01348100|474906877|FG001|Overall Study|Protocol Deviation|0|||
131896404|NCT01348100|474906878|FG002|Overall Study|Protocol Deviation|0|||
131896405|NCT01348100|474906879|FG003|Overall Study|Protocol Deviation|1|||
131896406|NCT01348100|474906880|FG004|Overall Study|Protocol Deviation|0|||
131896407|NCT01348100|474906881|FG005|Overall Study|Protocol Deviation|0|||
131896408|NCT01348100|474906882|FG006|Overall Study|Protocol Deviation|0|||
131896409|NCT01348100|474906876|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131896410|NCT01348100|474906877|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131896411|NCT01348100|474906878|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131896412|NCT01348100|474906879|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131896413|NCT01348100|474906880|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131896414|NCT01348100|474906881|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131896415|NCT01348100|474906882|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131896416|NCT01348100|474906876|FG000|Overall Study|Lost to Follow-up|0|||
131896417|NCT01348100|474906877|FG001|Overall Study|Lost to Follow-up|0|||
131896418|NCT01348100|474906878|FG002|Overall Study|Lost to Follow-up|0|||
131896419|NCT01348100|474906879|FG003|Overall Study|Lost to Follow-up|0|||
131896420|NCT01348100|474906880|FG004|Overall Study|Lost to Follow-up|0|||
131896421|NCT01348100|474906881|FG005|Overall Study|Lost to Follow-up|0|||
131896422|NCT01348100|474906882|FG006|Overall Study|Lost to Follow-up|1|||
131896423|NCT01348100|474906876|FG000|Overall Study|Administrative Problems|0|||
131896424|NCT01348100|474906877|FG001|Overall Study|Administrative Problems|0|||
131896425|NCT01348100|474906878|FG002|Overall Study|Administrative Problems|0|||
131896426|NCT01348100|474906879|FG003|Overall Study|Administrative Problems|0|||
131896427|NCT01348100|474906880|FG004|Overall Study|Administrative Problems|0|||
131896428|NCT01348100|474906881|FG005|Overall Study|Administrative Problems|1|||
131896429|NCT01348100|474906882|FG006|Overall Study|Administrative Problems|1|||
131896430|NCT04186221|474906885|FG000|Overall Study|Death|1|||
131896431|NCT01134393|474906888|FG000|Overall Study|Adverse Event|18|||
131896432|NCT01134393|474906888|FG000|Overall Study|Lack of Efficacy|2|||
131896433|NCT01134393|474906888|FG000|Overall Study|Protocol Violation|12|||
131896434|NCT01134393|474906888|FG000|Overall Study|Lost to Follow-up|3|||
131896435|NCT01134393|474906888|FG000|Overall Study|Withdrawal by Subject|11|||
131896436|NCT01134393|474906888|FG000|Overall Study|Other|6|||
131896437|NCT01904032|474906889|FG000|Overall Study|Adverse Event|3|||
131896438|NCT01904032|474906890|FG001|Overall Study|Adverse Event|1|||
131896439|NCT01904032|474906889|FG000|Overall Study|Lost to Follow-up|4|||
131896440|NCT01904032|474906890|FG001|Overall Study|Lost to Follow-up|2|||
131896441|NCT00531947|474906897|FG000|Overall Study|Adverse Event|5|||
131896442|NCT00531947|474906898|FG001|Overall Study|Adverse Event|10|||
131896443|NCT00531947|474906897|FG000|Overall Study|Lost to Follow-up|12|||
131896444|NCT00531947|474906898|FG001|Overall Study|Lost to Follow-up|9|||
131896445|NCT00531947|474906897|FG000|Overall Study|Withdrawal by Subject|14|||
131896446|NCT00531947|474906898|FG001|Overall Study|Withdrawal by Subject|19|||
131896447|NCT00531947|474906897|FG000|Overall Study|Protocol Violation|2|||
131896448|NCT00531947|474906898|FG001|Overall Study|Protocol Violation|1|||
131896449|NCT00531947|474906897|FG000|Overall Study|Non-Compliance|4|||
131896450|NCT00531947|474906898|FG001|Overall Study|Non-Compliance|7|||
131896451|NCT00531947|474906897|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
131896452|NCT00531947|474906898|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
131896453|NCT01087203|474906903|FG000|Overall Study|Lost to Follow-up|2|||
131896454|NCT01087203|474906904|FG001|Overall Study|Lost to Follow-up|0|||
131896455|NCT01087203|474906903|FG000|Overall Study|Withdrawal by Subject|2|||
131896456|NCT01087203|474906904|FG001|Overall Study|Withdrawal by Subject|6|||
131896457|NCT01087203|474906903|FG000|Overall Study|Lack of Efficacy|1|||
131896458|NCT01087203|474906904|FG001|Overall Study|Lack of Efficacy|2|||
131896459|NCT01087203|474906903|FG000|Overall Study|Study terminated by sponsor|27|||
131896460|NCT01087203|474906904|FG001|Overall Study|Study terminated by sponsor|27|||
131896461|NCT04074330|474906920|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
131896462|NCT04074330|474906921|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
131896463|NCT04074330|474906922|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
131896464|NCT04074330|474906923|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
131896465|NCT04074330|474906924|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
131896466|NCT04074330|474906925|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
131665270|NCT02074553|474058080|FG001|Washout Period 1|Physician Decision|0|||
131665271|NCT02074553|474058081|FG002|Washout Period 1|Physician Decision|0|||
131665272|NCT02074553|474058082|FG003|Washout Period 1|Physician Decision|1|||
131665273|NCT02074553|474058083|FG004|Washout Period 1|Physician Decision|0|||
131665274|NCT02074553|474058084|FG005|Washout Period 1|Physician Decision|0|||
131665275|NCT02074553|474058085|FG006|Washout Period 1|Physician Decision|0|||
131448252|NCT00554216|473272629|FG001|Overall Study|Lack of Efficacy|3|||
131665276|NCT02074553|474058086|FG007|Washout Period 1|Physician Decision|0|||
131665277|NCT02074553|474058079|FG000|Washout Period 1|Other|0|||
131435950|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
131435951|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
131435952|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
131435953|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
131435954|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
131435955|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
131435956|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
131435957|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
131435958|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
131435959|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
131435960|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
131665278|NCT02074553|474058080|FG001|Washout Period 1|Other|0|||
131665279|NCT02074553|474058081|FG002|Washout Period 1|Other|0|||
131435961|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
131435962|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
131435963|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
131435964|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
131435965|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
131665280|NCT02074553|474058082|FG003|Washout Period 1|Other|0|||
131665281|NCT02074553|474058083|FG004|Washout Period 1|Other|0|||
131665282|NCT02074553|474058084|FG005|Washout Period 1|Other|1|||
131665283|NCT02074553|474058085|FG006|Washout Period 1|Other|0|||
131665284|NCT02074553|474058086|FG007|Washout Period 1|Other|0|||
131665285|NCT02074553|474058079|FG000|Washout Period 2|Adverse Event|0|||
131665286|NCT02074553|474058080|FG001|Washout Period 2|Adverse Event|0|||
131665287|NCT02074553|474058081|FG002|Washout Period 2|Adverse Event|0|||
131665288|NCT02074553|474058082|FG003|Washout Period 2|Adverse Event|0|||
131665289|NCT02074553|474058083|FG004|Washout Period 2|Adverse Event|0|||
131665290|NCT02074553|474058084|FG005|Washout Period 2|Adverse Event|0|||
131665291|NCT02074553|474058085|FG006|Washout Period 2|Adverse Event|1|||
131665292|NCT02074553|474058086|FG007|Washout Period 2|Adverse Event|0|||
131665293|NCT02074553|474058079|FG000|Washout Period 2|Physician Decision|0|||
131665294|NCT02074553|474058080|FG001|Washout Period 2|Physician Decision|0|||
131665295|NCT02074553|474058081|FG002|Washout Period 2|Physician Decision|0|||
131665296|NCT02074553|474058082|FG003|Washout Period 2|Physician Decision|0|||
131665297|NCT02074553|474058083|FG004|Washout Period 2|Physician Decision|0|||
131665298|NCT02074553|474058084|FG005|Washout Period 2|Physician Decision|1|||
131665299|NCT02074553|474058085|FG006|Washout Period 2|Physician Decision|0|||
131665300|NCT02074553|474058086|FG007|Washout Period 2|Physician Decision|0|||
131665301|NCT02074553|474058079|FG000|Washout Period 2|Lost to Follow-up|0|||
131665302|NCT02074553|474058080|FG001|Washout Period 2|Lost to Follow-up|0|||
131665303|NCT02074553|474058081|FG002|Washout Period 2|Lost to Follow-up|1|||
131665304|NCT02074553|474058082|FG003|Washout Period 2|Lost to Follow-up|0|||
131665305|NCT02074553|474058083|FG004|Washout Period 2|Lost to Follow-up|0|||
131665306|NCT02074553|474058084|FG005|Washout Period 2|Lost to Follow-up|0|||
131665307|NCT02074553|474058085|FG006|Washout Period 2|Lost to Follow-up|0|||
131665308|NCT02074553|474058086|FG007|Washout Period 2|Lost to Follow-up|0|||
131665309|NCT02074553|474058079|FG000|Washout Period 3|Physician Decision|0|||
131665310|NCT02074553|474058080|FG001|Washout Period 3|Physician Decision|0|||
131665311|NCT02074553|474058081|FG002|Washout Period 3|Physician Decision|0|||
131665312|NCT02074553|474058082|FG003|Washout Period 3|Physician Decision|0|||
131665313|NCT02074553|474058083|FG004|Washout Period 3|Physician Decision|0|||
131665314|NCT02074553|474058084|FG005|Washout Period 3|Physician Decision|0|||
131665315|NCT02074553|474058085|FG006|Washout Period 3|Physician Decision|0|||
131665316|NCT02074553|474058086|FG007|Washout Period 3|Physician Decision|1|||
131665317|NCT01658150|474058087|FG000|Overall Study|Withdrawal by Subject|1|||
131665318|NCT02342743|474058088|FG000|Baseline Period|Withdrawal by Subject|3|||
131665319|NCT02342743|474058088|FG000|Baseline Period|Lost to Follow-up|2|||
131665320|NCT02342743|474058088|FG000|Baseline Period|Change in prophylactic medication|3|||
131665321|NCT02342743|474058088|FG000|Baseline Period|Screening failure regarding baseline|7|||
131665322|NCT02342743|474058088|FG000|Treatment Period|Withdrawal by Subject|2|||
131665323|NCT02342743|474058088|FG000|Treatment Period|Lost to Follow-up|8|||
131665324|NCT02342743|474058088|FG000|Treatment Period|Change in prophylactic medication|1|||
131665325|NCT04875676|474058089|FG000|Overall Study|Lost to Follow-up|1|||
131665326|NCT04875676|474058090|FG001|Overall Study|Lost to Follow-up|0|||
131665327|NCT04875676|474058091|FG002|Overall Study|Lost to Follow-up|0|||
131665328|NCT04187989|474058092|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
131665329|NCT04187989|474058093|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
131665330|NCT04187989|474058092|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
131665331|NCT04187989|474058093|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
131665332|NCT03646656|474058094|FG000|Overall Study|Lost to Follow-up|1|||
131665333|NCT03646656|474058095|FG001|Overall Study|Lost to Follow-up|0|||
131665334|NCT03646656|474058094|FG000|Overall Study|Withdrawal by Subject|2|||
131665335|NCT03646656|474058095|FG001|Overall Study|Withdrawal by Subject|0|||
131665336|NCT03602066|474058096|FG000|Overall Study|Withdrawal by Subject|2|||
131665337|NCT03602066|474058097|FG001|Overall Study|Withdrawal by Subject|0|||
131665338|NCT03602066|474058096|FG000|Overall Study|Physician Decision|1|||
131665339|NCT03602066|474058097|FG001|Overall Study|Physician Decision|0|||
131665340|NCT00092495|474058098|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
131665341|NCT00092495|474058099|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
131553901|NCT02667886|473652904|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
131553902|NCT02667886|473652905|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
131553903|NCT02667886|473652906|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
131553904|NCT02667886|473652902|FG000|Dose Expansion (Part B)|Disease Progression|0|||
131553905|NCT02667886|473652903|FG001|Dose Expansion (Part B)|Disease Progression|0|||
131553906|NCT02667886|473652904|FG002|Dose Expansion (Part B)|Disease Progression|0|||
131553907|NCT02667886|473652905|FG003|Dose Expansion (Part B)|Disease Progression|38|||
131553908|NCT02667886|473652906|FG004|Dose Expansion (Part B)|Disease Progression|0|||
131553909|NCT02667886|473652902|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
131553910|NCT02667886|473652903|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
131553911|NCT02667886|473652904|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
131553912|NCT02667886|473652905|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
131553913|NCT02667886|473652906|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
131553914|NCT02667886|473652902|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
131553915|NCT02667886|473652903|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
131553916|NCT02667886|473652904|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
131553917|NCT02667886|473652905|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
131553918|NCT02667886|473652906|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
131553919|NCT02667886|473652902|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
131553920|NCT02667886|473652903|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
131553921|NCT02667886|473652904|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
131553922|NCT02667886|473652905|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
131553923|NCT02667886|473652906|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
131553924|NCT00594217|473652907|FG000|Overall Study|Withdrawal by Subject|1|||
131553925|NCT00594217|473652908|FG001|Overall Study|Withdrawal by Subject|3|||
131553926|NCT00747123|473652909|FG000|Overall Study|Investigator's request|0|||
131553927|NCT00747123|473652910|FG001|Overall Study|Investigator's request|0|||
131553928|NCT00747123|473652911|FG002|Overall Study|Investigator's request|1|||
131553929|NCT00747123|473652912|FG003|Overall Study|Investigator's request|0|||
131553930|NCT00747123|473652909|FG000|Overall Study|Withdrew consent|0|||
131665342|NCT00092495|474058100|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131665343|NCT00092495|474058101|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
131665344|NCT00092495|474058102|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131665345|NCT00092495|474058098|FG000|Base Study Vaccination Period|Extended|0|||
131665346|NCT00092495|474058099|FG001|Base Study Vaccination Period|Extended|0|||
131665347|NCT00092495|474058100|FG002|Base Study Vaccination Period|Extended|0|||
131665348|NCT00092495|474058101|FG003|Base Study Vaccination Period|Extended|1|||
131665349|NCT00092495|474058102|FG004|Base Study Vaccination Period|Extended|0|||
131665350|NCT00092495|474058098|FG000|Base Study Vaccination Period|*Clinical AE|1|||
131665351|NCT00092495|474058099|FG001|Base Study Vaccination Period|*Clinical AE|0|||
131665352|NCT00092495|474058100|FG002|Base Study Vaccination Period|*Clinical AE|1|||
131665353|NCT00092495|474058101|FG003|Base Study Vaccination Period|*Clinical AE|2|||
131665354|NCT00092495|474058102|FG004|Base Study Vaccination Period|*Clinical AE|0|||
131665355|NCT00092495|474058098|FG000|Base Study Vaccination Period|*Other reasons|1|||
131665356|NCT00092495|474058099|FG001|Base Study Vaccination Period|*Other reasons|0|||
131665357|NCT00092495|474058100|FG002|Base Study Vaccination Period|*Other reasons|0|||
131665358|NCT00092495|474058101|FG003|Base Study Vaccination Period|*Other reasons|1|||
131665359|NCT00092495|474058102|FG004|Base Study Vaccination Period|*Other reasons|0|||
131665360|NCT00092495|474058098|FG000|Base Study Vaccination Period|*Pregnancy|0|||
131665361|NCT00092495|474058099|FG001|Base Study Vaccination Period|*Pregnancy|2|||
131665362|NCT00092495|474058100|FG002|Base Study Vaccination Period|*Pregnancy|5|||
131665363|NCT00092495|474058101|FG003|Base Study Vaccination Period|*Pregnancy|7|||
131665364|NCT00092495|474058102|FG004|Base Study Vaccination Period|*Pregnancy|0|||
131665365|NCT00092495|474058098|FG000|Base Study Vaccination Period|Adverse Event|1|||
131665366|NCT00092495|474058099|FG001|Base Study Vaccination Period|Adverse Event|0|||
131665367|NCT00092495|474058100|FG002|Base Study Vaccination Period|Adverse Event|0|||
131665368|NCT00092495|474058101|FG003|Base Study Vaccination Period|Adverse Event|3|||
131665369|NCT00092495|474058102|FG004|Base Study Vaccination Period|Adverse Event|0|||
131665370|NCT00092495|474058098|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
131665371|NCT00092495|474058099|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
131665372|NCT00092495|474058100|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
131665373|NCT00092495|474058101|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
131665374|NCT00092495|474058102|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131665375|NCT00092495|474058098|FG000|Base Study Vaccination Period|Moved|3|||
131665376|NCT00092495|474058099|FG001|Base Study Vaccination Period|Moved|1|||
131665377|NCT00092495|474058100|FG002|Base Study Vaccination Period|Moved|2|||
131665378|NCT00092495|474058101|FG003|Base Study Vaccination Period|Moved|2|||
131665379|NCT00092495|474058102|FG004|Base Study Vaccination Period|Moved|0|||
131665380|NCT00092495|474058098|FG000|Base Study Vaccination Period|Other|1|||
131665381|NCT00092495|474058099|FG001|Base Study Vaccination Period|Other|1|||
131665382|NCT00092495|474058100|FG002|Base Study Vaccination Period|Other|0|||
131665383|NCT00092495|474058101|FG003|Base Study Vaccination Period|Other|2|||
131665384|NCT00092495|474058102|FG004|Base Study Vaccination Period|Other|0|||
131665385|NCT00092495|474058098|FG000|Base Study Vaccination Period|Pregnancy|2|||
131665386|NCT00092495|474058099|FG001|Base Study Vaccination Period|Pregnancy|0|||
131665387|NCT00092495|474058100|FG002|Base Study Vaccination Period|Pregnancy|0|||
131665388|NCT00092495|474058101|FG003|Base Study Vaccination Period|Pregnancy|0|||
131665389|NCT00092495|474058102|FG004|Base Study Vaccination Period|Pregnancy|0|||
131665390|NCT00092495|474058098|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
131665391|NCT00092495|474058099|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
131665392|NCT00092495|474058100|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
131665393|NCT00092495|474058101|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
131665394|NCT00092495|474058102|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
131665395|NCT00092495|474058098|FG000|Base Study Vaccination Period|Protocol Violation|1|||
131665396|NCT00092495|474058099|FG001|Base Study Vaccination Period|Protocol Violation|0|||
131665397|NCT00092495|474058100|FG002|Base Study Vaccination Period|Protocol Violation|0|||
131665398|NCT00092495|474058101|FG003|Base Study Vaccination Period|Protocol Violation|0|||
131665399|NCT00092495|474058102|FG004|Base Study Vaccination Period|Protocol Violation|0|||
131665400|NCT00092495|474058098|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
131665401|NCT00092495|474058099|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
131665402|NCT00092495|474058100|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
131665403|NCT00092495|474058101|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
131665404|NCT00092495|474058102|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131665405|NCT00092495|474058098|FG000|Base Study Follow-up Period|Extended|0|||
131665406|NCT00092495|474058099|FG001|Base Study Follow-up Period|Extended|0|||
131665407|NCT00092495|474058100|FG002|Base Study Follow-up Period|Extended|1|||
131665408|NCT00092495|474058101|FG003|Base Study Follow-up Period|Extended|2|||
131665409|NCT00092495|474058102|FG004|Base Study Follow-up Period|Extended|0|||
131665410|NCT00092495|474058098|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
131665411|NCT00092495|474058099|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
131665412|NCT00092495|474058100|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
131665413|NCT00092495|474058101|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
131665414|NCT00092495|474058102|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
131665415|NCT00092495|474058098|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
131665416|NCT00092495|474058099|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
131665417|NCT00092495|474058100|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
131665418|NCT00092495|474058101|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
131665419|NCT00092495|474058102|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
131665420|NCT00938470|474058109|FG000|Overall Study|Disease Progression|3|||
131665421|NCT00938470|474058110|FG001|Overall Study|Disease Progression|0|||
131665422|NCT00938470|474058109|FG000|Overall Study|Alternate Treatment|1|||
131665423|NCT00938470|474058110|FG001|Overall Study|Alternate Treatment|0|||
131665424|NCT00938470|474058109|FG000|Overall Study|Death|3|||
131665425|NCT00938470|474058110|FG001|Overall Study|Death|2|||
131665426|NCT00938470|474058109|FG000|Overall Study|Other Reason|0|||
131665427|NCT00938470|474058110|FG001|Overall Study|Other Reason|1|||
131665428|NCT00309959|474058115|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
131665429|NCT01004848|474058116|FG000|Overall Study|Lost to Follow-up|55|||
131665430|NCT01004848|474058117|FG001|Overall Study|Lost to Follow-up|45|||
131665431|NCT01639560|474058118|FG000|Overall Study|Withdrawal by Subject|9|||
131665432|NCT01639560|474058119|FG001|Overall Study|Withdrawal by Subject|14|||
131665433|NCT01639560|474058118|FG000|Overall Study|Lack of Efficacy|1|||
131665434|NCT01639560|474058119|FG001|Overall Study|Lack of Efficacy|2|||
131665435|NCT01639560|474058118|FG000|Overall Study|Lost to Follow-up|9|||
131665436|NCT01639560|474058119|FG001|Overall Study|Lost to Follow-up|11|||
131665437|NCT01639560|474058118|FG000|Overall Study|Adverse Event|0|||
131665438|NCT01639560|474058119|FG001|Overall Study|Adverse Event|2|||
131665439|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
131665440|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131665441|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131665442|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131665443|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131665444|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131665445|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
131665446|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131665447|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131665448|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131665449|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131665450|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131665451|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
131665452|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131665453|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131665454|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131665455|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131665456|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131665457|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
131665458|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131665459|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131665460|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131665461|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131665462|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131665463|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
131665464|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131665465|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131665466|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131665467|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131665468|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131665469|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
131665470|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131665471|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131448253|NCT00554216|473272630|FG002|Overall Study|Lack of Efficacy|0|||
131665472|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131665473|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131665474|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131665475|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
131665476|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131665477|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131665478|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131665479|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131665480|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131665481|NCT01160289|474058120|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
131665482|NCT01160289|474058121|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131665483|NCT01160289|474058122|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131665484|NCT01160289|474058123|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131665485|NCT01160289|474058124|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131665486|NCT01160289|474058125|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131665487|NCT01160289|474058120|FG000|Post-Randomization Period|Adverse Event|0|||
131665488|NCT01160289|474058121|FG001|Post-Randomization Period|Adverse Event|4|||
131665489|NCT01160289|474058122|FG002|Post-Randomization Period|Adverse Event|4|||
131665490|NCT01160289|474058123|FG003|Post-Randomization Period|Adverse Event|2|||
131665491|NCT01160289|474058124|FG004|Post-Randomization Period|Adverse Event|0|||
131665492|NCT01160289|474058125|FG005|Post-Randomization Period|Adverse Event|0|||
131665493|NCT01160289|474058120|FG000|Post-Randomization Period|Death|0|||
131665494|NCT01160289|474058121|FG001|Post-Randomization Period|Death|0|||
131665495|NCT01160289|474058122|FG002|Post-Randomization Period|Death|0|||
131665496|NCT01160289|474058123|FG003|Post-Randomization Period|Death|1|||
131665497|NCT01160289|474058124|FG004|Post-Randomization Period|Death|0|||
131665498|NCT01160289|474058125|FG005|Post-Randomization Period|Death|0|||
131665499|NCT01160289|474058120|FG000|Post-Randomization Period|Lack of Efficacy|0|||
131665500|NCT01160289|474058121|FG001|Post-Randomization Period|Lack of Efficacy|1|||
131665501|NCT01160289|474058122|FG002|Post-Randomization Period|Lack of Efficacy|0|||
131665502|NCT01160289|474058123|FG003|Post-Randomization Period|Lack of Efficacy|3|||
131665503|NCT01160289|474058124|FG004|Post-Randomization Period|Lack of Efficacy|0|||
131665504|NCT01160289|474058125|FG005|Post-Randomization Period|Lack of Efficacy|0|||
131665505|NCT01160289|474058120|FG000|Post-Randomization Period|Lost to Follow-up|0|||
131665506|NCT01160289|474058121|FG001|Post-Randomization Period|Lost to Follow-up|3|||
131665507|NCT01160289|474058122|FG002|Post-Randomization Period|Lost to Follow-up|2|||
131665508|NCT01160289|474058123|FG003|Post-Randomization Period|Lost to Follow-up|5|||
131665509|NCT01160289|474058124|FG004|Post-Randomization Period|Lost to Follow-up|3|||
131665510|NCT01160289|474058125|FG005|Post-Randomization Period|Lost to Follow-up|4|||
131896467|NCT04074330|474906926|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
131896468|NCT04074330|474906927|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
131896469|NCT04074330|474906928|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
131896470|NCT04074330|474906929|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
131896471|NCT04074330|474906920|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
131896472|NCT04074330|474906921|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
131896473|NCT04074330|474906922|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
131896474|NCT04074330|474906923|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
131665511|NCT01160289|474058120|FG000|Post-Randomization Period|Physician Decision|0|||
131665512|NCT01160289|474058121|FG001|Post-Randomization Period|Physician Decision|0|||
131665513|NCT01160289|474058122|FG002|Post-Randomization Period|Physician Decision|1|||
131665514|NCT01160289|474058123|FG003|Post-Randomization Period|Physician Decision|0|||
131665515|NCT01160289|474058124|FG004|Post-Randomization Period|Physician Decision|0|||
131665516|NCT01160289|474058125|FG005|Post-Randomization Period|Physician Decision|0|||
131665517|NCT01160289|474058120|FG000|Post-Randomization Period|Protocol Violation|0|||
131665518|NCT01160289|474058121|FG001|Post-Randomization Period|Protocol Violation|4|||
131665519|NCT01160289|474058122|FG002|Post-Randomization Period|Protocol Violation|2|||
131665520|NCT01160289|474058123|FG003|Post-Randomization Period|Protocol Violation|0|||
131896475|NCT04074330|474906924|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
131896476|NCT04074330|474906925|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
131448254|NCT02079246|473272631|FG000|OLEX|Withdrawal before treatment|1|||
131448255|NCT02079246|473272632|FG001|OLEX|Withdrawal before treatment|0|||
131448256|NCT02079246|473272631|FG000|OLEX|Death|11|||
131448257|NCT02079246|473272632|FG001|OLEX|Death|0|||
131448258|NCT02079246|473272631|FG000|OLEX|Adverse Event|66|||
131448259|NCT02079246|473272632|FG001|OLEX|Adverse Event|0|||
131448260|NCT02079246|473272631|FG000|OLEX|Withdrawal by Subject|60|||
131448261|NCT02079246|473272632|FG001|OLEX|Withdrawal by Subject|0|||
131448262|NCT02079246|473272631|FG000|OLEX|Lost to Follow-up|6|||
131448263|NCT02079246|473272632|FG001|OLEX|Lost to Follow-up|0|||
131448264|NCT02079246|473272631|FG000|OLEX|Protocol Violation|6|||
131448265|NCT02079246|473272632|FG001|OLEX|Protocol Violation|0|||
131448266|NCT02079246|473272631|FG000|OLEX|Lack of Efficacy|3|||
131448267|NCT02079246|473272632|FG001|OLEX|Lack of Efficacy|0|||
131665521|NCT01160289|474058124|FG004|Post-Randomization Period|Protocol Violation|1|||
131665522|NCT01160289|474058125|FG005|Post-Randomization Period|Protocol Violation|3|||
131772303|NCT01238861|474445022|FG003|Overall Study|Withdrawal by Subject|8|||
131772304|NCT01238861|474445023|FG004|Overall Study|Withdrawal by Subject|10|||
131772305|NCT01238861|474445024|FG005|Overall Study|Withdrawal by Subject|9|||
131772306|NCT01269346|474445025|FG000|Treatment Phase|Disease progression|3|||
131772307|NCT01269346|474445025|FG000|Treatment Phase|Adverse Event|3|||
131772308|NCT01269346|474445025|FG000|Treatment Phase|Withdrawal by Subject|1|||
131772309|NCT01269346|474445025|FG000|Treatment Phase|Other|2|||
131772310|NCT01269346|474445025|FG000|Extension Phase|Adverse Event|6|||
131772311|NCT01269346|474445025|FG000|Extension Phase|Withdrawal by Subject|4|||
131772312|NCT01269346|474445025|FG000|Extension Phase|Disease progression|22|||
131772313|NCT01269346|474445025|FG000|Extension Phase|Physician decision or participant choice|9|||
131772314|NCT01269346|474445025|FG000|Extension Phase|Clinical progression|1|||
131772315|NCT01269346|474445025|FG000|Extension Phase|Started a prohibited con med|1|||
131772316|NCT01855607|474445026|FG000|Overall Study|Withdrawal by Subject|1|||
131772317|NCT01855607|474445026|FG000|Overall Study|Study was terminated|11|||
131772318|NCT04963231|474445032|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
131772319|NCT04963231|474445033|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
131772320|NCT04963231|474445034|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
131772321|NCT04963231|474445032|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
131772322|NCT04963231|474445033|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
131665523|NCT01160289|474058120|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
131665524|NCT01160289|474058121|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
131665525|NCT01160289|474058122|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
131665526|NCT01160289|474058123|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
131665527|NCT01160289|474058124|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
131665528|NCT01160289|474058125|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
131665529|NCT01160289|474058120|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
131665530|NCT01160289|474058121|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
131665531|NCT01160289|474058122|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
131665532|NCT01160289|474058123|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
131665533|NCT01160289|474058124|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
131665534|NCT01160289|474058125|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
131665535|NCT01160289|474058120|FG000|Post-Randomization Period|Sponsor Decision|0|||
131665536|NCT01160289|474058121|FG001|Post-Randomization Period|Sponsor Decision|1|||
131665537|NCT01160289|474058122|FG002|Post-Randomization Period|Sponsor Decision|0|||
131665538|NCT01160289|474058123|FG003|Post-Randomization Period|Sponsor Decision|0|||
131665539|NCT01160289|474058124|FG004|Post-Randomization Period|Sponsor Decision|0|||
131665540|NCT01160289|474058125|FG005|Post-Randomization Period|Sponsor Decision|0|||
131665541|NCT01156792|474058127|FG000|Overall Study|Adverse Event|1|||
131665542|NCT01156792|474058127|FG000|Overall Study|Lack of Efficacy|36|||
131665543|NCT01156792|474058127|FG000|Overall Study|Protocol Violation|6|||
131772323|NCT04963231|474445034|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
131665544|NCT01156792|474058127|FG000|Overall Study|Lost to Follow-up|3|||
131665545|NCT01156792|474058127|FG000|Overall Study|Physician Decision|3|||
131665546|NCT01156792|474058127|FG000|Overall Study|Withdrawal by Subject|9|||
131665547|NCT01156792|474058127|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
131665548|NCT00495586|474058128|FG000|Overall Study|Withdrawal by Subject|4|||
131665549|NCT00495586|474058129|FG001|Overall Study|Withdrawal by Subject|4|||
131665550|NCT00964886|474058130|FG000|Overall Study|Lost to Follow-up|2|||
131553931|NCT00747123|473652910|FG001|Overall Study|Withdrew consent|1|||
131665551|NCT00964886|474058131|FG001|Overall Study|Lost to Follow-up|2|||
131665552|NCT00964886|474058132|FG002|Overall Study|Lost to Follow-up|6|||
131665553|NCT00964886|474058133|FG003|Overall Study|Lost to Follow-up|4|||
131665554|NCT00964886|474058130|FG000|Overall Study|Withdrawal by Subject|6|||
131665555|NCT00964886|474058131|FG001|Overall Study|Withdrawal by Subject|2|||
131665556|NCT00964886|474058132|FG002|Overall Study|Withdrawal by Subject|5|||
131665557|NCT00964886|474058133|FG003|Overall Study|Withdrawal by Subject|3|||
131665558|NCT00964886|474058130|FG000|Overall Study|Adverse Event|3|||
131665559|NCT00964886|474058131|FG001|Overall Study|Adverse Event|1|||
131665560|NCT00964886|474058132|FG002|Overall Study|Adverse Event|5|||
131665561|NCT00964886|474058133|FG003|Overall Study|Adverse Event|2|||
131665562|NCT00964886|474058130|FG000|Overall Study|Protocol Violation|0|||
131665563|NCT00964886|474058131|FG001|Overall Study|Protocol Violation|2|||
131665564|NCT00964886|474058132|FG002|Overall Study|Protocol Violation|0|||
131665565|NCT00964886|474058133|FG003|Overall Study|Protocol Violation|0|||
131665566|NCT01621568|474058135|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
131665567|NCT01621568|474058136|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
131665568|NCT01621568|474058135|FG000|Week 5-6 No Treatment|Death|1|||
131665569|NCT01621568|474058136|FG001|Week 5-6 No Treatment|Death|0|||
131665570|NCT02334423|474058137|FG000|Overall Study|Protocol Violation|10|||
131665571|NCT02334423|474058138|FG001|Overall Study|Protocol Violation|3|||
131665572|NCT02930226|474058139|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
131665573|NCT02930226|474058140|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
131665574|NCT02930226|474058141|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
131665575|NCT02930226|474058142|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
131665576|NCT02930226|474058143|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
131665577|NCT02930226|474058144|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
131665578|NCT00652327|474058145|FG000|Overall Study|Adverse Event|0|||
131665579|NCT00652327|474058146|FG001|Overall Study|Adverse Event|2|||
131665580|NCT00652327|474058145|FG000|Overall Study|Lost to Follow-up|0|||
131665581|NCT00652327|474058146|FG001|Overall Study|Lost to Follow-up|3|||
131665582|NCT01076647|474058147|FG000|Overall Study|Adverse Event|4|||
131665583|NCT01076647|474058148|FG001|Overall Study|Adverse Event|1|||
131665584|NCT01076647|474058147|FG000|Overall Study|Lack of Efficacy|0|||
131665585|NCT01076647|474058148|FG001|Overall Study|Lack of Efficacy|1|||
131665586|NCT01076647|474058147|FG000|Overall Study|Protocol Violation|7|||
131665587|NCT01076647|474058148|FG001|Overall Study|Protocol Violation|9|||
131665588|NCT01076647|474058147|FG000|Overall Study|Withdrawal criteria|2|||
131665589|NCT01076647|474058148|FG001|Overall Study|Withdrawal criteria|2|||
131665590|NCT01076647|474058147|FG000|Overall Study|Unclassified|12|||
131665591|NCT01076647|474058148|FG001|Overall Study|Unclassified|12|||
131665592|NCT00564889|474058154|FG000|Overall Study|Death|7|||
131665593|NCT00564889|474058154|FG000|Overall Study|Adverse Event|12|||
131665594|NCT00564889|474058154|FG000|Overall Study|Alternative treatment|3|||
131665595|NCT00564889|474058154|FG000|Overall Study|Disease progression|3|||
131665596|NCT00564889|474058154|FG000|Overall Study|Other, not specified|4|||
131665597|NCT01021215|474058159|FG000|Overall Study|Lost to Follow-up|3|||
131665598|NCT01021215|474058160|FG001|Overall Study|Lost to Follow-up|0|||
131665599|NCT02751320|474058161|FG000|Overall Study|Adverse Event|2|||
131665600|NCT02751320|474058161|FG000|Overall Study|Withdrawal by Subject|1|||
131665601|NCT01103362|474058162|FG000|Overall Study|study terminated|596|||
131665602|NCT02047903|474058163|FG000|Overall Study|Adverse Event|14|||
131665603|NCT02047903|474058163|FG000|Overall Study|Serious adverse event|10|||
131665604|NCT02047903|474058163|FG000|Overall Study|Withdrawal by Subject|16|||
131665605|NCT02047903|474058163|FG000|Overall Study|Lost to Follow-up|4|||
131665606|NCT02047903|474058163|FG000|Overall Study|Reason not listed|6|||
131665607|NCT02047903|474058163|FG000|Overall Study|Not Treated|9|||
131665608|NCT01011387|474058164|FG000|Overall Study|Withdrawal by Subject|3|||
131665609|NCT01011387|474058164|FG000|Overall Study|Adverse Event|2|||
131665610|NCT01011387|474058164|FG000|Overall Study|Protocol Violation|1|||
131665611|NCT02665338|474058166|FG000|Overall Study|Withdrawal by Subject|0|||
131896477|NCT04074330|474906926|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
131896478|NCT04074330|474906927|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
131896479|NCT04074330|474906928|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
131896480|NCT04074330|474906929|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
131896481|NCT04074330|474906920|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896482|NCT04074330|474906921|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896483|NCT04074330|474906922|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
131896484|NCT04074330|474906923|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896485|NCT04074330|474906924|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896486|NCT04074330|474906925|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896487|NCT04074330|474906926|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896488|NCT04074330|474906927|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131665612|NCT02665338|474058167|FG001|Overall Study|Withdrawal by Subject|1|||
131665613|NCT00847808|474058170|FG000|Overall Study|Adverse Event|7|||
131665614|NCT00847808|474058170|FG000|Overall Study|Protocol Violation|1|||
131665615|NCT00847808|474058170|FG000|Overall Study|Lost to Follow-up|1|||
131665616|NCT00847808|474058170|FG000|Overall Study|Withdrawal by Subject|4|||
131665617|NCT00847808|474058170|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
131665618|NCT00847808|474058170|FG000|Overall Study|Participant Took Excluded Medication|1|||
131665619|NCT05326815|474058172|FG000|Overall Study|Withdrawal by Subject|3|||
131665620|NCT05326815|474058172|FG000|Overall Study|Did not complete required labs|6|||
131665621|NCT05326815|474058172|FG000|Overall Study|Screen fail- abnormal labs|5|||
131665622|NCT03562975|474058173|FG000|Overall Study|Death|1|||
131665623|NCT03562975|474058173|FG000|Overall Study|Lost to Follow-up|1|||
131665624|NCT03562975|474058173|FG000|Overall Study|Withdrawal by Subject|1|||
131665625|NCT02545933|474058174|FG000|Overall Study|Adverse Event|3|||
131665626|NCT02545933|474058175|FG001|Overall Study|Adverse Event|0|||
131665627|NCT02545933|474058176|FG002|Overall Study|Adverse Event|0|||
131665628|NCT02545933|474058174|FG000|Overall Study|Withdrawal by Subject|2|||
131665629|NCT02545933|474058175|FG001|Overall Study|Withdrawal by Subject|3|||
131665630|NCT02545933|474058176|FG002|Overall Study|Withdrawal by Subject|3|||
131665631|NCT02545933|474058174|FG000|Overall Study|Protocol Violation|1|||
131665632|NCT02545933|474058175|FG001|Overall Study|Protocol Violation|0|||
131665633|NCT02545933|474058176|FG002|Overall Study|Protocol Violation|1|||
131665634|NCT00935818|474058179|FG000|Overall Study|Withdrawal by Subject|45|||
131665635|NCT00935818|474058180|FG001|Overall Study|Withdrawal by Subject|50|||
131665636|NCT00935818|474058179|FG000|Overall Study|Lost to Follow-up|40|||
131665637|NCT00935818|474058180|FG001|Overall Study|Lost to Follow-up|42|||
131665638|NCT00935818|474058179|FG000|Overall Study|Adverse Event|6|||
131665639|NCT00935818|474058180|FG001|Overall Study|Adverse Event|7|||
131665640|NCT00935818|474058179|FG000|Overall Study|Physician Decision|0|||
131665641|NCT00935818|474058180|FG001|Overall Study|Physician Decision|1|||
131665642|NCT00979134|474058181|FG000|Overall Study|Disease progression|18|||
131665643|NCT00979134|474058182|FG001|Overall Study|Disease progression|2|||
131665644|NCT00979134|474058183|FG002|Overall Study|Disease progression|5|||
131665645|NCT00979134|474058181|FG000|Overall Study|Adverse Event|0|||
131665646|NCT00979134|474058182|FG001|Overall Study|Adverse Event|0|||
131665647|NCT00979134|474058183|FG002|Overall Study|Adverse Event|2|||
131665648|NCT00979134|474058181|FG000|Overall Study|Withdrawal by Subject|1|||
131665649|NCT00979134|474058182|FG001|Overall Study|Withdrawal by Subject|1|||
131665650|NCT00979134|474058183|FG002|Overall Study|Withdrawal by Subject|2|||
131665651|NCT00979134|474058181|FG000|Overall Study|Lost to Follow-up|2|||
131665652|NCT00979134|474058182|FG001|Overall Study|Lost to Follow-up|2|||
131665653|NCT00979134|474058183|FG002|Overall Study|Lost to Follow-up|0|||
131665654|NCT00979134|474058181|FG000|Overall Study|Death|4|||
131665655|NCT00979134|474058182|FG001|Overall Study|Death|0|||
131665656|NCT00979134|474058183|FG002|Overall Study|Death|26|||
131665657|NCT00979134|474058181|FG000|Overall Study|Other|8|||
131665658|NCT00979134|474058182|FG001|Overall Study|Other|1|||
131665659|NCT00979134|474058183|FG002|Overall Study|Other|5|||
131665660|NCT05917470|474058184|FG000|Overall Study|Progressive Disease|1|||
131665661|NCT05917470|474058185|FG001|Overall Study|Progressive Disease|1|||
131665662|NCT05917470|474058186|FG002|Overall Study|Progressive Disease|2|||
131665663|NCT05917470|474058187|FG003|Overall Study|Progressive Disease|3|||
131665664|NCT05917470|474058188|FG004|Overall Study|Progressive Disease|1|||
131665665|NCT05917470|474058189|FG005|Overall Study|Progressive Disease|1|||
131665666|NCT05917470|474058190|FG006|Overall Study|Progressive Disease|0|||
131665667|NCT05917470|474058191|FG007|Overall Study|Progressive Disease|0|||
131665668|NCT05917470|474058184|FG000|Overall Study|Withdrawal by Subject|0|||
131665669|NCT05917470|474058185|FG001|Overall Study|Withdrawal by Subject|0|||
131665670|NCT05917470|474058186|FG002|Overall Study|Withdrawal by Subject|1|||
131665671|NCT05917470|474058187|FG003|Overall Study|Withdrawal by Subject|0|||
131665672|NCT05917470|474058188|FG004|Overall Study|Withdrawal by Subject|0|||
131665673|NCT05917470|474058189|FG005|Overall Study|Withdrawal by Subject|0|||
131665674|NCT05917470|474058190|FG006|Overall Study|Withdrawal by Subject|0|||
131665675|NCT05917470|474058191|FG007|Overall Study|Withdrawal by Subject|0|||
131665676|NCT05917470|474058184|FG000|Overall Study|Sponsor Decision|0|||
131665677|NCT05917470|474058185|FG001|Overall Study|Sponsor Decision|0|||
131665678|NCT05917470|474058186|FG002|Overall Study|Sponsor Decision|1|||
131665679|NCT05917470|474058187|FG003|Overall Study|Sponsor Decision|0|||
131665680|NCT05917470|474058188|FG004|Overall Study|Sponsor Decision|2|||
131665681|NCT05917470|474058189|FG005|Overall Study|Sponsor Decision|1|||
131665682|NCT05917470|474058190|FG006|Overall Study|Sponsor Decision|3|||
131665683|NCT05917470|474058191|FG007|Overall Study|Sponsor Decision|3|||
131665684|NCT05917470|474058184|FG000|Overall Study|Adverse Event|0|||
131665685|NCT05917470|474058185|FG001|Overall Study|Adverse Event|0|||
131665686|NCT05917470|474058186|FG002|Overall Study|Adverse Event|0|||
131665687|NCT05917470|474058187|FG003|Overall Study|Adverse Event|0|||
131665688|NCT05917470|474058188|FG004|Overall Study|Adverse Event|0|||
131665689|NCT05917470|474058189|FG005|Overall Study|Adverse Event|1|||
131665690|NCT05917470|474058190|FG006|Overall Study|Adverse Event|0|||
131665691|NCT05917470|474058191|FG007|Overall Study|Adverse Event|0|||
131665692|NCT01076192|474060573|FG000|Overall Study|Other|197|||
131665693|NCT01034176|474060574|FG000|Overall Study|Physician Decision|2|||
131665694|NCT01034176|474060575|FG001|Overall Study|Physician Decision|0|||
131665695|NCT01034176|474060574|FG000|Overall Study|Withdrawal by Subject|0|||
131665696|NCT01034176|474060575|FG001|Overall Study|Withdrawal by Subject|1|||
131665697|NCT01034176|474060574|FG000|Overall Study|Lost to Follow-up|0|||
131665698|NCT01034176|474060575|FG001|Overall Study|Lost to Follow-up|1|||
131665699|NCT05087979|474060578|FG000|Overall Study|Converted to general anesthesia|1|||
131665700|NCT05087979|474060579|FG001|Overall Study|Converted to general anesthesia|0|||
131665701|NCT02915302|474060580|FG000|Overall Study|Adverse Event|3|||
131553932|NCT00747123|473652911|FG002|Overall Study|Withdrew consent|0|||
131553933|NCT00747123|473652912|FG003|Overall Study|Withdrew consent|0|||
131553934|NCT00747123|473652909|FG000|Overall Study|Adverse Event|0|||
131553935|NCT00747123|473652910|FG001|Overall Study|Adverse Event|1|||
131553936|NCT00747123|473652911|FG002|Overall Study|Adverse Event|0|||
131553937|NCT00747123|473652912|FG003|Overall Study|Adverse Event|1|||
131553938|NCT03635489|473652913|FG000|Overall Study|Death|19|||
131553939|NCT03635489|473652914|FG001|Overall Study|Death|13|||
131553940|NCT03635489|473652913|FG000|Overall Study|Lost to Follow-up|1|||
131553941|NCT03635489|473652914|FG001|Overall Study|Lost to Follow-up|2|||
131553942|NCT03635489|473652913|FG000|Overall Study|Withdrawal by Subject|1|||
131553943|NCT03635489|473652914|FG001|Overall Study|Withdrawal by Subject|2|||
131553944|NCT03635489|473652913|FG000|Overall Study|Study Ended by Sponsor|28|||
131553945|NCT03635489|473652914|FG001|Overall Study|Study Ended by Sponsor|34|||
131553946|NCT02487095|473652919|FG000|Dose Expansion|Unable to scan/restage participant|0|||
131553947|NCT02487095|473652920|FG001|Dose Expansion|Unable to scan/restage participant|0|||
131553948|NCT02487095|473652921|FG002|Dose Expansion|Unable to scan/restage participant|0|||
131553949|NCT02487095|473652922|FG003|Dose Expansion|Unable to scan/restage participant|0|||
131553950|NCT02487095|473652923|FG004|Dose Expansion|Unable to scan/restage participant|1|||
131553951|NCT05778526|473652926|FG000|Overall Study|Lost to Follow-up|0|||
131553952|NCT05778526|473652927|FG001|Overall Study|Lost to Follow-up|1|||
131553953|NCT05778526|473652928|FG002|Overall Study|Lost to Follow-up|3|||
131553954|NCT05778526|473652926|FG000|Overall Study|Protocol Violation|0|||
131553955|NCT05778526|473652927|FG001|Overall Study|Protocol Violation|0|||
131553956|NCT05778526|473652928|FG002|Overall Study|Protocol Violation|8|||
131553957|NCT03108157|473652929|FG000|Overall Study|Protocol Violation|15|||
131553958|NCT03108157|473652930|FG001|Overall Study|Protocol Violation|4|||
131553959|NCT01279343|473652933|FG000|Overall Study|Did not receive treatment|2|||
131553960|NCT01279343|473652934|FG001|Overall Study|Did not receive treatment|6|||
131553961|NCT04534114|473652935|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
131553962|NCT04534114|473652936|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
131553963|NCT04534114|473652937|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
131553964|NCT04534114|473652938|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
131553965|NCT04534114|473652935|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
131553966|NCT04534114|473652936|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
131553967|NCT04534114|473652937|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
131553968|NCT04534114|473652938|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
131553969|NCT04534114|473652935|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
131553970|NCT04534114|473652936|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
131553971|NCT04534114|473652937|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
131553972|NCT04534114|473652938|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
131553973|NCT04534114|473652935|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
131553974|NCT04534114|473652936|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
131553975|NCT04534114|473652937|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
131553976|NCT04534114|473652938|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
131553977|NCT04534114|473652935|FG000|Main Treatment Period|Physician Decision|0|||
131553978|NCT04534114|473652936|FG001|Main Treatment Period|Physician Decision|0|||
131553979|NCT04534114|473652937|FG002|Main Treatment Period|Physician Decision|0|||
131553980|NCT04534114|473652938|FG003|Main Treatment Period|Physician Decision|1|||
131553981|NCT04534114|473652935|FG000|Main Treatment Period|Death|1|||
131553982|NCT04534114|473652936|FG001|Main Treatment Period|Death|0|||
131553983|NCT04534114|473652937|FG002|Main Treatment Period|Death|0|||
131553984|NCT04534114|473652938|FG003|Main Treatment Period|Death|1|||
131553985|NCT04534114|473652935|FG000|Main Treatment Period|Other reason|1|||
131553986|NCT04534114|473652936|FG001|Main Treatment Period|Other reason|1|||
131553987|NCT04534114|473652937|FG002|Main Treatment Period|Other reason|0|||
131665702|NCT02915302|474060581|FG001|Overall Study|Adverse Event|0|||
131665703|NCT02915302|474060580|FG000|Overall Study|Protocol Violation|20|||
131665704|NCT02915302|474060581|FG001|Overall Study|Protocol Violation|27|||
131665705|NCT02915302|474060580|FG000|Overall Study|Lost to Follow-up|19|||
131665706|NCT02915302|474060581|FG001|Overall Study|Lost to Follow-up|22|||
131665707|NCT02915302|474060580|FG000|Overall Study|Withdrawal by Subject|22|||
131665708|NCT02915302|474060581|FG001|Overall Study|Withdrawal by Subject|29|||
131665709|NCT02915302|474060580|FG000|Overall Study|Other|1|||
131665710|NCT02915302|474060581|FG001|Overall Study|Other|0|||
131665711|NCT03527173|474060582|FG000|Overall Study|Lost to Follow-up|4|||
131665712|NCT03527173|474060583|FG001|Overall Study|Lost to Follow-up|2|||
131665713|NCT03527173|474060582|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
131665714|NCT03527173|474060583|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
131665715|NCT03527173|474060582|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
131665716|NCT03527173|474060583|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
131665717|NCT03527173|474060582|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
131665718|NCT03527173|474060583|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131665719|NCT02134977|474060584|FG000|Overall Study|Protocol Deviation|102|||
131665720|NCT04097301|474060585|FG000|Overall Study|Death|1|||
131665721|NCT04097301|474060585|FG000|Overall Study|Withdrawal by Subject|1|||
131665722|NCT04097301|474060585|FG000|Overall Study|Screening Failure|5|||
131665723|NCT00107120|474060587|FG000|Overall Study|Adverse Event|4|||
131665724|NCT00107120|474060588|FG001|Overall Study|Adverse Event|1|||
131665725|NCT00107120|474060587|FG000|Overall Study|Lack of Efficacy|5|||
131665726|NCT00107120|474060588|FG001|Overall Study|Lack of Efficacy|5|||
131665727|NCT00107120|474060587|FG000|Overall Study|Protocol Violation|3|||
131665728|NCT00107120|474060588|FG001|Overall Study|Protocol Violation|0|||
131665729|NCT00107120|474060587|FG000|Overall Study|Withdrawal by Subject|8|||
131896489|NCT04074330|474906928|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896490|NCT04074330|474906929|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
131896491|NCT04074330|474906920|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896492|NCT04074330|474906921|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896493|NCT04074330|474906922|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896494|NCT04074330|474906923|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896495|NCT04074330|474906924|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896496|NCT04074330|474906925|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
131896497|NCT04074330|474906926|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896498|NCT04074330|474906927|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
131896499|NCT04074330|474906928|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896500|NCT04074330|474906929|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
131896501|NCT04074330|474906920|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
131896502|NCT04074330|474906921|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
131896503|NCT04074330|474906922|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
131896504|NCT04074330|474906923|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
131896505|NCT04074330|474906924|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
131665730|NCT00107120|474060588|FG001|Overall Study|Withdrawal by Subject|9|||
131896506|NCT04074330|474906925|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
131665731|NCT00107120|474060587|FG000|Overall Study|Lost to Follow-up|8|||
131665732|NCT00107120|474060588|FG001|Overall Study|Lost to Follow-up|6|||
131665733|NCT00107120|474060587|FG000|Overall Study|Pregnancy|0|||
131665734|NCT00107120|474060588|FG001|Overall Study|Pregnancy|1|||
131665735|NCT00107120|474060587|FG000|Overall Study|moving away from site|1|||
131665736|NCT00107120|474060588|FG001|Overall Study|moving away from site|1|||
131665737|NCT00107120|474060587|FG000|Overall Study|death of parent|0|||
131665738|NCT00107120|474060588|FG001|Overall Study|death of parent|1|||
131665739|NCT01635920|474060589|FG000|Overall Study|Adverse Event|1|||
131665740|NCT01635920|474060590|FG001|Overall Study|Adverse Event|0|||
131665741|NCT01635920|474060589|FG000|Overall Study|Lost to Follow-up|0|||
131665742|NCT01635920|474060590|FG001|Overall Study|Lost to Follow-up|1|||
131665743|NCT01635920|474060589|FG000|Overall Study|Subject decision|2|||
131665744|NCT01635920|474060590|FG001|Overall Study|Subject decision|0|||
131665745|NCT00194987|474060591|FG000|Overall Study|Withdrawal by Subject|0|||
131665746|NCT00194987|474060592|FG001|Overall Study|Withdrawal by Subject|3|||
131665747|NCT01664598|474060593|FG000|Overall Study|Sponsor Decision|1|||
131665748|NCT01664598|474060593|FG000|Overall Study|Withdrawal of Informed Consent|4|||
131665749|NCT01664598|474060593|FG000|Overall Study|Adverse Event|1|||
131665750|NCT00686725|474060594|FG000|Overall Study|Adverse Event|1|||
131665751|NCT00686725|474060595|FG001|Overall Study|Adverse Event|1|||
131665752|NCT00686725|474060594|FG000|Overall Study|Progressive Disease|17|||
131665753|NCT00686725|474060595|FG001|Overall Study|Progressive Disease|23|||
131665754|NCT00686725|474060594|FG000|Overall Study|Lost to Follow-up|7|||
131665755|NCT00686725|474060595|FG001|Overall Study|Lost to Follow-up|5|||
131665756|NCT00686725|474060594|FG000|Overall Study|Death|6|||
131665757|NCT00686725|474060595|FG001|Overall Study|Death|3|||
131665758|NCT00686725|474060594|FG000|Overall Study|Withdrawal by Subject|13|||
131665759|NCT00686725|474060595|FG001|Overall Study|Withdrawal by Subject|4|||
131665760|NCT00686725|474060594|FG000|Overall Study|Protocol Violation|1|||
131665761|NCT00686725|474060595|FG001|Overall Study|Protocol Violation|3|||
131665762|NCT00686725|474060594|FG000|Overall Study|Other|1|||
131665763|NCT00686725|474060595|FG001|Overall Study|Other|3|||
131665764|NCT02630693|474060599|FG000|Overall Study|No receive treatment|0|||
131665765|NCT02630693|474060600|FG001|Overall Study|No receive treatment|1|||
131665766|NCT01474434|474060601|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
131665767|NCT01474434|474060602|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
131665768|NCT01474434|474060603|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
131665769|NCT01474434|474060604|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
131665770|NCT01474434|474060601|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
131665771|NCT01474434|474060602|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
131665772|NCT01474434|474060603|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
131665773|NCT01474434|474060604|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
131665774|NCT01474434|474060601|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
131665775|NCT01474434|474060602|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
131665776|NCT01474434|474060603|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
131665777|NCT01474434|474060604|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
131665778|NCT00993668|474060605|FG000|Single-Blind Period|Adverse Event|1|||
131665779|NCT00993668|474060606|FG001|Single-Blind Period|Adverse Event|1|||
131665780|NCT00993668|474060605|FG000|Single-Blind Period|Lack of Efficacy|0|||
131665781|NCT00993668|474060606|FG001|Single-Blind Period|Lack of Efficacy|1|||
131665782|NCT00993668|474060605|FG000|Single-Blind Period|Lost to Follow-up|3|||
131665783|NCT00993668|474060606|FG001|Single-Blind Period|Lost to Follow-up|1|||
131665784|NCT00993668|474060605|FG000|Open-Label Period|Adverse Event|9|||
131665785|NCT00993668|474060606|FG001|Open-Label Period|Adverse Event|8|||
131665786|NCT00993668|474060605|FG000|Open-Label Period|Lack of Efficacy|4|||
131665787|NCT00993668|474060606|FG001|Open-Label Period|Lack of Efficacy|3|||
131665788|NCT00993668|474060605|FG000|Open-Label Period|Withdrawal by Subject|4|||
131665789|NCT00993668|474060606|FG001|Open-Label Period|Withdrawal by Subject|3|||
131665790|NCT00993668|474060605|FG000|Open-Label Period|Lost to Follow-up|6|||
131665791|NCT00993668|474060606|FG001|Open-Label Period|Lost to Follow-up|1|||
131665792|NCT03606668|474060609|FG000|Overall Study|Screen Failure|1|||
131665793|NCT03606668|474060609|FG000|Overall Study|Lost to Follow-up|1|||
131665794|NCT02057523|474060613|FG000|Overall Study|Withdrawal by Subject|1|||
131665795|NCT02057523|474060613|FG000|Overall Study|Lack of Efficacy|1|||
131665796|NCT02399254|474060617|FG000|Overall Study|Physician Decision|2|||
131665797|NCT02292927|474060618|FG000|Overall Study|Protocol Violation|13|||
131665798|NCT02292927|474060619|FG001|Overall Study|Protocol Violation|7|||
131665799|NCT01656733|474060623|FG000|Overall Study|No permission to collect birth outcomes|0|||
131665800|NCT01656733|474060624|FG001|Overall Study|No permission to collect birth outcomes|1|||
131665801|NCT01656733|474060623|FG000|Overall Study|Delivery at another hospital|0|||
131665802|NCT01656733|474060624|FG001|Overall Study|Delivery at another hospital|2|||
131665803|NCT01656733|474060623|FG000|Overall Study|Spontaneous abortion|0|||
131665804|NCT01656733|474060624|FG001|Overall Study|Spontaneous abortion|1|||
131665805|NCT00141219|474060627|FG000|Overall Study|Protocol violations|5|||
131665806|NCT00141219|474060628|FG001|Overall Study|Protocol violations|4|||
131665807|NCT00141219|474060627|FG000|Overall Study|Adverse Event|8|||
131665808|NCT00141219|474060628|FG001|Overall Study|Adverse Event|6|||
131665809|NCT00141219|474060627|FG000|Overall Study|Lack of Efficacy|5|||
131665810|NCT00141219|474060628|FG001|Overall Study|Lack of Efficacy|4|||
131665811|NCT00141219|474060627|FG000|Overall Study|Withdrawal by Subject|6|||
131665812|NCT00141219|474060628|FG001|Overall Study|Withdrawal by Subject|2|||
131665813|NCT00122460|474060630|FG000|Overall Study|investigational study phase ongoing|7|||
131665814|NCT00122460|474060631|FG001|Overall Study|investigational study phase ongoing|1|||
131665815|NCT02595073|474060632|FG000|Overall Study|Progressive Disease|0|||
131665816|NCT02595073|474060633|FG001|Overall Study|Progressive Disease|1|||
131665817|NCT02595073|474060632|FG000|Overall Study|Protocol Violation|2|||
131665818|NCT02595073|474060633|FG001|Overall Study|Protocol Violation|0|||
131665819|NCT02962960|474060634|FG000|Overall Study|Withdrawal by Subject|1|||
131665820|NCT02962960|474060635|FG001|Overall Study|Withdrawal by Subject|1|||
131665821|NCT02962960|474060636|FG002|Overall Study|Withdrawal by Subject|0|||
131665822|NCT02962960|474060634|FG000|Overall Study|Adverse Event|1|||
131665823|NCT02962960|474060635|FG001|Overall Study|Adverse Event|1|||
131665824|NCT02962960|474060636|FG002|Overall Study|Adverse Event|0|||
131665825|NCT02962960|474060634|FG000|Overall Study|Protocol Violation|1|||
131665826|NCT02962960|474060635|FG001|Overall Study|Protocol Violation|0|||
131665827|NCT02962960|474060636|FG002|Overall Study|Protocol Violation|0|||
131665828|NCT01605019|474060637|FG000|Overall Study|pt did not meet transplant endpoint|3|||
131665829|NCT01605019|474060638|FG001|Overall Study|pt did not meet transplant endpoint|0|||
131665830|NCT01451827|474060639|FG000|Overall Study|Adverse Event|2|||
131665831|NCT01451827|474060640|FG001|Overall Study|Adverse Event|0|||
131665832|NCT01451827|474060641|FG002|Overall Study|Adverse Event|1|||
131665833|NCT01451827|474060642|FG003|Overall Study|Adverse Event|1|||
131665834|NCT01451827|474060639|FG000|Overall Study|Protocol deviation|1|||
131665835|NCT01451827|474060640|FG001|Overall Study|Protocol deviation|0|||
131665836|NCT01451827|474060641|FG002|Overall Study|Protocol deviation|0|||
131665837|NCT01451827|474060642|FG003|Overall Study|Protocol deviation|0|||
131665838|NCT01451827|474060639|FG000|Overall Study|Lost to Follow-up|0|||
131665839|NCT01451827|474060640|FG001|Overall Study|Lost to Follow-up|3|||
131665840|NCT01451827|474060641|FG002|Overall Study|Lost to Follow-up|0|||
131665841|NCT01451827|474060642|FG003|Overall Study|Lost to Follow-up|2|||
131665842|NCT01451827|474060639|FG000|Overall Study|Participant met withdrawal criteria|0|||
131665843|NCT01451827|474060640|FG001|Overall Study|Participant met withdrawal criteria|2|||
131665844|NCT01451827|474060641|FG002|Overall Study|Participant met withdrawal criteria|0|||
131665845|NCT01451827|474060642|FG003|Overall Study|Participant met withdrawal criteria|0|||
131665846|NCT01451827|474060639|FG000|Overall Study|Withdrawal by Subject|0|||
131665847|NCT01451827|474060640|FG001|Overall Study|Withdrawal by Subject|0|||
131665848|NCT01451827|474060641|FG002|Overall Study|Withdrawal by Subject|1|||
131665849|NCT01451827|474060642|FG003|Overall Study|Withdrawal by Subject|1|||
131665850|NCT02424734|474060643|FG000|Overall Study|Treatment stopped to be discharged home|2|||
131665851|NCT02424734|474060644|FG001|Overall Study|Treatment stopped to be discharged home|2|||
131665852|NCT02424734|474060645|FG002|Overall Study|Treatment stopped to be discharged home|0|||
131665853|NCT01642251|474060646|FG000|Overall Study|Progressive disease|0|||
131665854|NCT01642251|474060647|FG001|Overall Study|Progressive disease|0|||
131665855|NCT01642251|474060648|FG002|Overall Study|Progressive disease|3|||
131665856|NCT01642251|474060649|FG003|Overall Study|Progressive disease|3|||
131665857|NCT01642251|474060646|FG000|Overall Study|Adverse Event|0|||
131665858|NCT01642251|474060647|FG001|Overall Study|Adverse Event|0|||
131665859|NCT01642251|474060648|FG002|Overall Study|Adverse Event|5|||
131665860|NCT01642251|474060649|FG003|Overall Study|Adverse Event|4|||
131665861|NCT01642251|474060646|FG000|Overall Study|Death|0|||
131665862|NCT01642251|474060647|FG001|Overall Study|Death|0|||
131665863|NCT01642251|474060648|FG002|Overall Study|Death|1|||
131665864|NCT01642251|474060649|FG003|Overall Study|Death|3|||
131665865|NCT01642251|474060646|FG000|Overall Study|Withdrawal by Subject|0|||
131665866|NCT01642251|474060647|FG001|Overall Study|Withdrawal by Subject|0|||
131665867|NCT01642251|474060648|FG002|Overall Study|Withdrawal by Subject|1|||
131665868|NCT01642251|474060649|FG003|Overall Study|Withdrawal by Subject|3|||
131665869|NCT01642251|474060646|FG000|Overall Study|Alternative therapy|0|||
131665870|NCT01642251|474060647|FG001|Overall Study|Alternative therapy|0|||
131665871|NCT01642251|474060648|FG002|Overall Study|Alternative therapy|0|||
131665872|NCT01642251|474060649|FG003|Overall Study|Alternative therapy|2|||
131896507|NCT04074330|474906926|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
131896508|NCT04074330|474906927|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
131896509|NCT04074330|474906928|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
131665873|NCT01642251|474060646|FG000|Overall Study|Other complicating disease|0|||
131665874|NCT01642251|474060647|FG001|Overall Study|Other complicating disease|0|||
131665875|NCT01642251|474060648|FG002|Overall Study|Other complicating disease|1|||
131665876|NCT01642251|474060649|FG003|Overall Study|Other complicating disease|0|||
131665877|NCT01642251|474060646|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
131665878|NCT01642251|474060647|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
131665879|NCT01642251|474060648|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
131665880|NCT01642251|474060649|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
131665881|NCT00470366|474060650|FG000|Overall Study|Adverse Event|3|||
131665882|NCT00470366|474060650|FG000|Overall Study|Poor compliance|1|||
131665883|NCT02996474|474060651|FG000|Overall Study|Physician Decision|5|||
131665884|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
131665885|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
131665886|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
131665887|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
131665888|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
131665889|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
131665890|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
131665891|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
131665892|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
131665893|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
131665894|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
131665895|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
131665896|NCT04493502|474060652|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
131665897|NCT04493502|474060653|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
131665898|NCT04493502|474060652|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
131665899|NCT04493502|474060653|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
131665900|NCT04493502|474060652|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
131665901|NCT04493502|474060653|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
131665902|NCT04493502|474060652|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
131665903|NCT04493502|474060653|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
131665904|NCT04493502|474060652|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
131665905|NCT04493502|474060653|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
131665906|NCT04493502|474060652|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
131665907|NCT04493502|474060653|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
131665908|NCT04493502|474060652|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
131665909|NCT04493502|474060653|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
131665910|NCT00540046|474060654|FG000|Overall Study|Lost to Follow-up|33|||
131665911|NCT00540046|474060655|FG001|Overall Study|Lost to Follow-up|23|||
131665912|NCT02549196|474060657|FG000|Overall Study|Protocol Violation|0|||
131665913|NCT02549196|474060658|FG001|Overall Study|Protocol Violation|0|||
131665914|NCT02549196|474060659|FG002|Overall Study|Protocol Violation|0|||
131665915|NCT02549196|474060660|FG003|Overall Study|Protocol Violation|1|||
131665916|NCT02549196|474060657|FG000|Overall Study|Withdrawal by Subject|1|||
131665917|NCT02549196|474060658|FG001|Overall Study|Withdrawal by Subject|0|||
131665918|NCT02549196|474060659|FG002|Overall Study|Withdrawal by Subject|1|||
131665919|NCT02549196|474060660|FG003|Overall Study|Withdrawal by Subject|0|||
131665920|NCT00296400|474060661|FG000|Overall Study|Adverse Event|7|||
131665921|NCT00296400|474060662|FG001|Overall Study|Adverse Event|7|||
131665922|NCT00296400|474060663|FG002|Overall Study|Adverse Event|7|||
131665923|NCT00296400|474060661|FG000|Overall Study|Withdrawal by Subject|5|||
131665924|NCT00296400|474060662|FG001|Overall Study|Withdrawal by Subject|6|||
131665925|NCT00296400|474060663|FG002|Overall Study|Withdrawal by Subject|2|||
131665926|NCT00296400|474060661|FG000|Overall Study|Incorrect enrollment|2|||
131665927|NCT00296400|474060662|FG001|Overall Study|Incorrect enrollment|0|||
131665928|NCT00296400|474060663|FG002|Overall Study|Incorrect enrollment|0|||
131665929|NCT00296400|474060661|FG000|Overall Study|Protocol Violation|1|||
131665930|NCT00296400|474060662|FG001|Overall Study|Protocol Violation|1|||
131665931|NCT00296400|474060663|FG002|Overall Study|Protocol Violation|1|||
131665932|NCT00296400|474060661|FG000|Overall Study|Lost to Follow-up|1|||
131665933|NCT00296400|474060662|FG001|Overall Study|Lost to Follow-up|1|||
131665934|NCT00296400|474060663|FG002|Overall Study|Lost to Follow-up|2|||
131665935|NCT00296400|474060661|FG000|Overall Study|Study specific discontinuation criteria|0|||
131665936|NCT00296400|474060662|FG001|Overall Study|Study specific discontinuation criteria|0|||
131665937|NCT00296400|474060663|FG002|Overall Study|Study specific discontinuation criteria|1|||
131665938|NCT00296400|474060661|FG000|Overall Study|Visit 10 was performed earlier|0|||
131665939|NCT00296400|474060662|FG001|Overall Study|Visit 10 was performed earlier|1|||
131665940|NCT00296400|474060663|FG002|Overall Study|Visit 10 was performed earlier|0|||
131665941|NCT00296400|474060661|FG000|Overall Study|Pregnancy|1|||
131665942|NCT00296400|474060662|FG001|Overall Study|Pregnancy|2|||
131665943|NCT00296400|474060663|FG002|Overall Study|Pregnancy|0|||
131665944|NCT00412061|474060669|FG000|Double Blind Phase|Disease Progression|101|||
131665945|NCT00412061|474060670|FG001|Double Blind Phase|Disease Progression|154|||
131665946|NCT00412061|474060669|FG000|Double Blind Phase|Adverse Event|61|||
131665947|NCT00412061|474060670|FG001|Double Blind Phase|Adverse Event|16|||
131665948|NCT00412061|474060669|FG000|Double Blind Phase|Final Primary Analysis|26|||
131665949|NCT00412061|474060670|FG001|Double Blind Phase|Final Primary Analysis|14|||
131665950|NCT00412061|474060669|FG000|Double Blind Phase|Withdrawal by Subject|18|||
131665951|NCT00412061|474060670|FG001|Double Blind Phase|Withdrawal by Subject|20|||
131665952|NCT00412061|474060669|FG000|Double Blind Phase|Death|6|||
131665953|NCT00412061|474060670|FG001|Double Blind Phase|Death|3|||
131665954|NCT00412061|474060669|FG000|Double Blind Phase|Protocol Violation|3|||
131665955|NCT00412061|474060670|FG001|Double Blind Phase|Protocol Violation|4|||
131665956|NCT00412061|474060669|FG000|Double Blind Phase|New Cander Therapy|1|||
131665957|NCT00412061|474060670|FG001|Double Blind Phase|New Cander Therapy|1|||
131665958|NCT00412061|474060669|FG000|Double Blind Phase|Lost to Follow-up|0|||
131665959|NCT00412061|474060670|FG001|Double Blind Phase|Lost to Follow-up|1|||
131665960|NCT00412061|474060669|FG000|Open Label Phase|Disease Progression|0|||
131665961|NCT00412061|474060670|FG001|Open Label Phase|Disease Progression|86|||
131665962|NCT00412061|474060669|FG000|Open Label Phase|Adverse Event|0|||
131665963|NCT00412061|474060670|FG001|Open Label Phase|Adverse Event|46|||
131665964|NCT00412061|474060669|FG000|Open Label Phase|Withdrawal by Subject|0|||
131665965|NCT00412061|474060670|FG001|Open Label Phase|Withdrawal by Subject|15|||
131665966|NCT00412061|474060669|FG000|Open Label Phase|Administrative Problems|0|||
131665967|NCT00412061|474060670|FG001|Open Label Phase|Administrative Problems|13|||
131665968|NCT00412061|474060669|FG000|Open Label Phase|Death|0|||
131665969|NCT00412061|474060670|FG001|Open Label Phase|Death|7|||
131665970|NCT00412061|474060669|FG000|Open Label Phase|Lost to Follow-up|0|||
131665971|NCT00412061|474060670|FG001|Open Label Phase|Lost to Follow-up|2|||
131665972|NCT00412061|474060669|FG000|Open Label Phase|New Cancer Therapy|0|||
131665973|NCT00412061|474060670|FG001|Open Label Phase|New Cancer Therapy|1|||
131665974|NCT01942590|474060671|FG000|Overall Study|Withdrawal by Subject|0|||
131665975|NCT01942590|474060672|FG001|Overall Study|Withdrawal by Subject|1|||
131665976|NCT01942590|474060671|FG000|Overall Study|Adverse Event|1|||
131665977|NCT01942590|474060672|FG001|Overall Study|Adverse Event|0|||
131665978|NCT02433340|474060676|FG000|Overall Study|Adverse Event|0|||
131665979|NCT02433340|474060677|FG001|Overall Study|Adverse Event|0|||
131665980|NCT02433340|474060678|FG002|Overall Study|Adverse Event|1|||
131665981|NCT02433340|474060679|FG003|Overall Study|Adverse Event|0|||
131665982|NCT02433340|474060676|FG000|Overall Study|Withdrawal by Subject|1|||
131665983|NCT02433340|474060677|FG001|Overall Study|Withdrawal by Subject|0|||
131665984|NCT02433340|474060678|FG002|Overall Study|Withdrawal by Subject|1|||
131665985|NCT02433340|474060679|FG003|Overall Study|Withdrawal by Subject|2|||
131665986|NCT02433340|474060676|FG000|Overall Study|Lost to Follow-up|0|||
131665987|NCT02433340|474060677|FG001|Overall Study|Lost to Follow-up|1|||
131665988|NCT02433340|474060678|FG002|Overall Study|Lost to Follow-up|0|||
131665989|NCT02433340|474060679|FG003|Overall Study|Lost to Follow-up|0|||
131665990|NCT02433340|474060676|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
131665991|NCT02433340|474060677|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
131665992|NCT02433340|474060678|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
131665993|NCT02433340|474060679|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
131665994|NCT02433340|474060676|FG000|Overall Study|Other|0|||
131665995|NCT02433340|474060677|FG001|Overall Study|Other|1|||
131665996|NCT02433340|474060678|FG002|Overall Study|Other|0|||
131448268|NCT02079246|473272631|FG000|OLEX|Results of the lead-in studies|58|||
131665997|NCT02433340|474060679|FG003|Overall Study|Other|0|||
131665998|NCT01178385|474060680|FG000|Overall Study|Withdrawal by Subject|2|||
131665999|NCT01178385|474060681|FG001|Overall Study|Withdrawal by Subject|0|||
131666000|NCT01688830|474060684|FG000|Overall Study|Lost to Follow-up|0|||
131666001|NCT01688830|474060685|FG001|Overall Study|Lost to Follow-up|0|||
131666002|NCT01688830|474060686|FG002|Overall Study|Lost to Follow-up|0|||
131666003|NCT01688830|474060687|FG003|Overall Study|Lost to Follow-up|0|||
131666004|NCT01688830|474060688|FG004|Overall Study|Lost to Follow-up|0|||
131666005|NCT01688830|474060689|FG005|Overall Study|Lost to Follow-up|0|||
131666006|NCT01688830|474060690|FG006|Overall Study|Lost to Follow-up|0|||
131666007|NCT01688830|474060691|FG007|Overall Study|Lost to Follow-up|0|||
131666008|NCT01688830|474060692|FG008|Overall Study|Lost to Follow-up|0|||
131666009|NCT01688830|474060693|FG009|Overall Study|Lost to Follow-up|0|||
131666010|NCT01688830|474060694|FG010|Overall Study|Lost to Follow-up|1|||
131666011|NCT01688830|474060695|FG011|Overall Study|Lost to Follow-up|0|||
131666012|NCT01688830|474060696|FG012|Overall Study|Lost to Follow-up|0|||
131666013|NCT01688830|474060697|FG013|Overall Study|Lost to Follow-up|0|||
131666014|NCT01688830|474060698|FG014|Overall Study|Lost to Follow-up|0|||
131666015|NCT01688830|474060699|FG015|Overall Study|Lost to Follow-up|0|||
131666016|NCT01688830|474060700|FG016|Overall Study|Lost to Follow-up|0|||
131666017|NCT01688830|474060701|FG017|Overall Study|Lost to Follow-up|0|||
131666018|NCT01688830|474060702|FG018|Overall Study|Lost to Follow-up|0|||
131666019|NCT01688830|474060703|FG019|Overall Study|Lost to Follow-up|0|||
131666020|NCT01688830|474060704|FG020|Overall Study|Lost to Follow-up|0|||
131666021|NCT01285609|474060705|FG000|Randomized|Progressive Disease|41|||
131666022|NCT01285609|474060706|FG001|Randomized|Progressive Disease|61|||
131666023|NCT01285609|474060705|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
131666024|NCT01285609|474060706|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
131666025|NCT01285609|474060705|FG000|Randomized|Study Drug Toxicity|13|||
131666026|NCT01285609|474060706|FG001|Randomized|Study Drug Toxicity|14|||
131666027|NCT01285609|474060705|FG000|Randomized|Death|5|||
131666028|NCT01285609|474060706|FG001|Randomized|Death|7|||
131666029|NCT01285609|474060705|FG000|Randomized|Withdrawal by Subject|8|||
131666030|NCT01285609|474060706|FG001|Randomized|Withdrawal by Subject|11|||
131666031|NCT01285609|474060705|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
131666032|NCT01285609|474060706|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
131666033|NCT01285609|474060705|FG000|Randomized|Undisclosed Reasons|1|||
131666034|NCT01285609|474060706|FG001|Randomized|Undisclosed Reasons|0|||
131666035|NCT01285609|474060705|FG000|Randomized|Randomized but not Treated|4|||
131666036|NCT01285609|474060706|FG001|Randomized|Randomized but not Treated|4|||
131666037|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
131666038|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
131666039|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
131666040|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
131666041|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
131666042|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
131666043|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
131666044|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
131666045|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Death|11|||
131666046|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Death|3|||
131666047|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
131666048|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
131666049|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Not Reported|0|||
131666050|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Not Reported|2|||
131666051|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
131666052|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
131666053|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
131666054|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
131666055|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
131666056|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
131666057|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
131666058|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
131666059|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
131896510|NCT04074330|474906929|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
131896511|NCT04074330|474906920|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
131896512|NCT04074330|474906921|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
131896513|NCT04074330|474906922|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
131896514|NCT04074330|474906923|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
131896515|NCT04074330|474906924|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
131896516|NCT04074330|474906925|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
131896517|NCT04074330|474906926|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
131896518|NCT04074330|474906927|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
131896519|NCT04074330|474906928|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
131896520|NCT04074330|474906929|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
131666060|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
131666061|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
131666062|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
131666063|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
131666064|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
131666065|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
131666066|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
131666067|NCT01285609|474060705|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
131666068|NCT01285609|474060706|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
131666069|NCT01285609|474060705|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
131666070|NCT01285609|474060706|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
131666071|NCT04822597|474060707|FG000|Overall Study|Withdrawal by Subject|0|||
131666072|NCT04822597|474060708|FG001|Overall Study|Withdrawal by Subject|1|||
131666073|NCT04822597|474060709|FG002|Overall Study|Withdrawal by Subject|1|||
131666074|NCT04822597|474060710|FG003|Overall Study|Withdrawal by Subject|0|||
131666075|NCT04822597|474060707|FG000|Overall Study|Physician Decision|0|||
131666076|NCT04822597|474060708|FG001|Overall Study|Physician Decision|0|||
131666077|NCT04822597|474060709|FG002|Overall Study|Physician Decision|1|||
131666078|NCT04822597|474060710|FG003|Overall Study|Physician Decision|1|||
131666079|NCT04822597|474060707|FG000|Overall Study|Subject withdrawn after enrollment|0|||
131666080|NCT04822597|474060708|FG001|Overall Study|Subject withdrawn after enrollment|1|||
131666081|NCT04822597|474060709|FG002|Overall Study|Subject withdrawn after enrollment|0|||
131666082|NCT04822597|474060710|FG003|Overall Study|Subject withdrawn after enrollment|1|||
131666083|NCT04822597|474060707|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
131666084|NCT04822597|474060708|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
131666085|NCT04822597|474060709|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
131666086|NCT04822597|474060710|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
131666087|NCT03616977|474060717|FG000|Period 1|Physician Decision|0|||
131666088|NCT03616977|474060718|FG001|Period 1|Physician Decision|1|||
131666089|NCT03616977|474060717|FG000|Period 3|Adverse Event|1|||
131666090|NCT03616977|474060718|FG001|Period 3|Adverse Event|1|||
131666091|NCT00925132|474060719|FG000|Overall Study|Withdrawal by Subject|2|||
131666092|NCT00925132|474060720|FG001|Overall Study|Withdrawal by Subject|0|||
131666093|NCT00925132|474060721|FG002|Overall Study|Withdrawal by Subject|0|||
131666094|NCT00925132|474060722|FG003|Overall Study|Withdrawal by Subject|0|||
131666095|NCT00925132|474060723|FG004|Overall Study|Withdrawal by Subject|1|||
131666096|NCT00925132|474060719|FG000|Overall Study|Removed due to disease progression|0|||
131666097|NCT00925132|474060720|FG001|Overall Study|Removed due to disease progression|0|||
131666098|NCT00925132|474060721|FG002|Overall Study|Removed due to disease progression|0|||
131666099|NCT00925132|474060722|FG003|Overall Study|Removed due to disease progression|0|||
131666100|NCT00925132|474060723|FG004|Overall Study|Removed due to disease progression|4|||
131666101|NCT01773291|474062574|FG000|Overall Study|Protocol Violation|1|||
131666102|NCT01773291|474062575|FG001|Overall Study|Protocol Violation|0|||
131666103|NCT01773291|474062576|FG002|Overall Study|Protocol Violation|0|||
131666104|NCT01773291|474062574|FG000|Overall Study|Withdrawal by Subject|0|||
131666105|NCT01773291|474062575|FG001|Overall Study|Withdrawal by Subject|0|||
131666106|NCT01773291|474062576|FG002|Overall Study|Withdrawal by Subject|1|||
131666107|NCT00203476|474062577|FG000|Overall Study|Lost to Follow-up|1|||
131666108|NCT00203476|474062578|FG001|Overall Study|Lost to Follow-up|0|||
131666109|NCT00203476|474062579|FG002|Overall Study|Lost to Follow-up|0|||
131666110|NCT00203476|474062577|FG000|Overall Study|Withdrawal by Subject|0|||
131666111|NCT00203476|474062578|FG001|Overall Study|Withdrawal by Subject|1|||
131666112|NCT00203476|474062579|FG002|Overall Study|Withdrawal by Subject|0|||
131666113|NCT01190514|474062580|FG000|First Intervention (Period 1)|Adverse Event|1|||
131666114|NCT01190514|474062581|FG001|First Intervention (Period 1)|Adverse Event|0|||
131666115|NCT01190514|474062582|FG002|First Intervention (Period 1)|Adverse Event|0|||
131666116|NCT01190514|474062583|FG003|First Intervention (Period 1)|Adverse Event|0|||
131666117|NCT01190514|474062580|FG000|Third Intervention (Period 3)|Adverse Event|1|||
131666118|NCT01190514|474062581|FG001|Third Intervention (Period 3)|Adverse Event|0|||
131666119|NCT01190514|474062582|FG002|Third Intervention (Period 3)|Adverse Event|0|||
131666120|NCT01190514|474062583|FG003|Third Intervention (Period 3)|Adverse Event|0|||
131666121|NCT03241225|474062586|FG000|Overall Study|Lost to Follow-up|2|||
131666122|NCT03241225|474062587|FG001|Overall Study|Lost to Follow-up|1|||
131666123|NCT03241225|474062586|FG000|Overall Study|Protocol Violation|4|||
131666124|NCT03241225|474062587|FG001|Overall Study|Protocol Violation|1|||
131666125|NCT03241225|474062586|FG000|Overall Study|Withdrawal by Subject|1|||
131666126|NCT03241225|474062587|FG001|Overall Study|Withdrawal by Subject|0|||
131666127|NCT01970345|474062590|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
131666128|NCT01970345|474062591|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
131666129|NCT01970345|474062590|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
131666130|NCT01970345|474062591|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
131666131|NCT00545051|474062595|FG000|Overall Study|Adverse Event|7|||
131666132|NCT00545051|474062596|FG001|Overall Study|Adverse Event|3|||
131666133|NCT00545051|474062595|FG000|Overall Study|Death|1|||
131666134|NCT00545051|474062596|FG001|Overall Study|Death|0|||
131666135|NCT00545051|474062595|FG000|Overall Study|Violation of inclusion/exclusion|0|||
131666136|NCT00545051|474062596|FG001|Overall Study|Violation of inclusion/exclusion|2|||
131666137|NCT00545051|474062595|FG000|Overall Study|Protocol Violation|1|||
131666138|NCT00545051|474062596|FG001|Overall Study|Protocol Violation|0|||
131666139|NCT00545051|474062595|FG000|Overall Study|Withdrawal by Subject|0|||
131666140|NCT00545051|474062596|FG001|Overall Study|Withdrawal by Subject|1|||
131666141|NCT00545051|474062595|FG000|Overall Study|Administrative reasons|0|||
131666142|NCT00545051|474062596|FG001|Overall Study|Administrative reasons|1|||
131666143|NCT03932812|474062601|FG000|Overall Study|Lost to Follow-up|12|||
131666144|NCT03932812|474062602|FG001|Overall Study|Lost to Follow-up|14|||
131666145|NCT03932812|474062601|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
131666146|NCT03932812|474062602|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
131666147|NCT03271021|474062610|FG000|Overall Study|Adverse Event|3|||
131666148|NCT03271021|474062611|FG001|Overall Study|Adverse Event|2|||
131666149|NCT03271021|474062610|FG000|Overall Study|Withdrawal by Subject|36|||
131666150|NCT03271021|474062611|FG001|Overall Study|Withdrawal by Subject|53|||
131666151|NCT03271021|474062610|FG000|Overall Study|Lost to Follow-up|34|||
131666152|NCT03271021|474062611|FG001|Overall Study|Lost to Follow-up|39|||
131666153|NCT03271021|474062610|FG000|Overall Study|Protocol Violation|6|||
131666154|NCT03271021|474062611|FG001|Overall Study|Protocol Violation|4|||
131666155|NCT03271021|474062610|FG000|Overall Study|Abnormal Lab Results|1|||
131666156|NCT03271021|474062611|FG001|Overall Study|Abnormal Lab Results|0|||
131896521|NCT04074330|474906920|FG000|Dose Expansion (up to 42 Months)|Death|0|||
131896522|NCT04074330|474906921|FG001|Dose Expansion (up to 42 Months)|Death|0|||
131896523|NCT04074330|474906922|FG002|Dose Expansion (up to 42 Months)|Death|0|||
131896524|NCT04074330|474906923|FG003|Dose Expansion (up to 42 Months)|Death|0|||
131896525|NCT04074330|474906924|FG004|Dose Expansion (up to 42 Months)|Death|0|||
131666157|NCT03271021|474062610|FG000|Overall Study|Miscellaneous|9|||
131666158|NCT03271021|474062611|FG001|Overall Study|Miscellaneous|8|||
131666159|NCT02585232|474062615|FG000|Overall Study|Lost to Follow-up|8|||
131666160|NCT02585232|474062616|FG001|Overall Study|Lost to Follow-up|8|||
131666161|NCT02585232|474062615|FG000|Overall Study|Withdrawal by Subject|4|||
131666162|NCT02585232|474062616|FG001|Overall Study|Withdrawal by Subject|8|||
131666163|NCT03215810|474062619|FG000|Overall Study|Still responding to nivolumab|1|||
131666164|NCT03215810|474062619|FG000|Overall Study|Insufficient TIL growth|1|||
131666165|NCT03215810|474062619|FG000|Overall Study|Decline in performance status|1|||
131666166|NCT03215810|474062619|FG000|Overall Study|Withdrawal by Subject|1|||
131666167|NCT02313233|474062620|FG000|Overall Study|Withdrawal by Subject|1|||
131666168|NCT02313233|474062621|FG001|Overall Study|Withdrawal by Subject|2|||
131666169|NCT02313233|474062620|FG000|Overall Study|Administrative reason|1|||
131666170|NCT02313233|474062621|FG001|Overall Study|Administrative reason|1|||
131666171|NCT02679573|474062627|FG000|Overall Study|Adverse Event|13|||
131666172|NCT02679573|474062628|FG001|Overall Study|Adverse Event|6|||
131666173|NCT02679573|474062627|FG000|Overall Study|Lack of Efficacy|12|||
131666174|NCT02679573|474062628|FG001|Overall Study|Lack of Efficacy|15|||
131666175|NCT02679573|474062627|FG000|Overall Study|Could not complete required study visits|6|||
131666176|NCT02679573|474062628|FG001|Overall Study|Could not complete required study visits|2|||
131666177|NCT02679573|474062627|FG000|Overall Study|Withdrawal by Subject|2|||
131666178|NCT02679573|474062628|FG001|Overall Study|Withdrawal by Subject|9|||
131666179|NCT02679573|474062627|FG000|Overall Study|Death|2|||
131666180|NCT02679573|474062628|FG001|Overall Study|Death|0|||
131666181|NCT02679573|474062627|FG000|Overall Study|Physician Decision|2|||
131666182|NCT02679573|474062628|FG001|Overall Study|Physician Decision|4|||
131666183|NCT02679573|474062627|FG000|Overall Study|Lost to Follow-up|0|||
131666184|NCT02679573|474062628|FG001|Overall Study|Lost to Follow-up|3|||
131666185|NCT03545503|474062629|FG000|Overall Study|Protocol Violation|14|||
131666186|NCT03545503|474062630|FG001|Overall Study|Protocol Violation|16|||
131666187|NCT00682890|474062631|FG000|Overall Study|Lost to Follow-up|1|||
131666188|NCT00682890|474062632|FG001|Overall Study|Lost to Follow-up|1|||
131666189|NCT00682890|474062631|FG000|Overall Study|subject moved away|0|||
131666190|NCT00682890|474062632|FG001|Overall Study|subject moved away|1|||
131666191|NCT00682890|474062631|FG000|Overall Study|heavy menstrual bleeding|1|||
131666192|NCT00682890|474062632|FG001|Overall Study|heavy menstrual bleeding|0|||
131666193|NCT02224690|474062633|FG000|Overall Study|Adverse Event|8|||
131666194|NCT02224690|474062634|FG001|Overall Study|Adverse Event|1|||
131666195|NCT02224690|474062633|FG000|Overall Study|Met Withdrawal Criteria|4|||
131666196|NCT02224690|474062634|FG001|Overall Study|Met Withdrawal Criteria|0|||
131666197|NCT02224690|474062633|FG000|Overall Study|Use of G-tube|1|||
131666198|NCT02224690|474062634|FG001|Overall Study|Use of G-tube|0|||
131666199|NCT02224690|474062633|FG000|Overall Study|Did not meet eligibility criteria|1|||
131666200|NCT02224690|474062634|FG001|Overall Study|Did not meet eligibility criteria|0|||
131666201|NCT01506609|474062635|FG000|Overall Study|Adverse Event Related to Progression|0|||
131666202|NCT01506609|474062636|FG001|Overall Study|Adverse Event Related to Progression|0|||
131666203|NCT01506609|474062637|FG002|Overall Study|Adverse Event Related to Progression|0|||
131666204|NCT01506609|474062638|FG003|Overall Study|Adverse Event Related to Progression|3|||
131666205|NCT01506609|474062639|FG004|Overall Study|Adverse Event Related to Progression|7|||
131666206|NCT01506609|474062640|FG005|Overall Study|Adverse Event Related to Progression|3|||
131666207|NCT01506609|474062635|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
131666208|NCT01506609|474062636|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
131666209|NCT01506609|474062637|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
131666210|NCT01506609|474062638|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
131666211|NCT01506609|474062639|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
131666212|NCT01506609|474062640|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
131666213|NCT01506609|474062635|FG000|Overall Study|Withdrawal by Subject|0|||
131666214|NCT01506609|474062636|FG001|Overall Study|Withdrawal by Subject|0|||
131666215|NCT01506609|474062637|FG002|Overall Study|Withdrawal by Subject|0|||
131666216|NCT01506609|474062638|FG003|Overall Study|Withdrawal by Subject|9|||
131666217|NCT01506609|474062639|FG004|Overall Study|Withdrawal by Subject|7|||
131666218|NCT01506609|474062640|FG005|Overall Study|Withdrawal by Subject|7|||
131666219|NCT01506609|474062635|FG000|Overall Study|Lost to Follow-up|0|||
131666220|NCT01506609|474062636|FG001|Overall Study|Lost to Follow-up|0|||
131666221|NCT01506609|474062637|FG002|Overall Study|Lost to Follow-up|0|||
131666222|NCT01506609|474062638|FG003|Overall Study|Lost to Follow-up|1|||
131666223|NCT01506609|474062639|FG004|Overall Study|Lost to Follow-up|2|||
131666224|NCT01506609|474062640|FG005|Overall Study|Lost to Follow-up|0|||
131666225|NCT01506609|474062635|FG000|Overall Study|Sponsor Discontinued Study|0|||
131896526|NCT04074330|474906925|FG005|Dose Expansion (up to 42 Months)|Death|0|||
131896527|NCT04074330|474906926|FG006|Dose Expansion (up to 42 Months)|Death|0|||
131896528|NCT04074330|474906927|FG007|Dose Expansion (up to 42 Months)|Death|0|||
131896529|NCT04074330|474906928|FG008|Dose Expansion (up to 42 Months)|Death|1|||
131896530|NCT04074330|474906929|FG009|Dose Expansion (up to 42 Months)|Death|0|||
131896531|NCT04074330|474906920|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131896532|NCT04074330|474906921|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131666226|NCT01506609|474062636|FG001|Overall Study|Sponsor Discontinued Study|0|||
131896533|NCT04074330|474906922|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131666227|NCT01506609|474062637|FG002|Overall Study|Sponsor Discontinued Study|0|||
131666228|NCT01506609|474062638|FG003|Overall Study|Sponsor Discontinued Study|2|||
131666229|NCT01506609|474062639|FG004|Overall Study|Sponsor Discontinued Study|2|||
131666230|NCT01506609|474062640|FG005|Overall Study|Sponsor Discontinued Study|0|||
131666231|NCT01506609|474062635|FG000|Overall Study|Progressive Disease per Protocol|1|||
131666232|NCT01506609|474062636|FG001|Overall Study|Progressive Disease per Protocol|0|||
131666233|NCT01506609|474062637|FG002|Overall Study|Progressive Disease per Protocol|0|||
131666234|NCT01506609|474062638|FG003|Overall Study|Progressive Disease per Protocol|64|||
131666235|NCT01506609|474062639|FG004|Overall Study|Progressive Disease per Protocol|57|||
131666236|NCT01506609|474062640|FG005|Overall Study|Progressive Disease per Protocol|74|||
131666237|NCT01506609|474062635|FG000|Overall Study|Other, Not Specified|0|||
131666238|NCT01506609|474062636|FG001|Overall Study|Other, Not Specified|0|||
131666239|NCT01506609|474062637|FG002|Overall Study|Other, Not Specified|0|||
131666240|NCT01506609|474062638|FG003|Overall Study|Other, Not Specified|10|||
131666241|NCT01506609|474062639|FG004|Overall Study|Other, Not Specified|7|||
131666242|NCT01506609|474062640|FG005|Overall Study|Other, Not Specified|3|||
131666243|NCT01506609|474062635|FG000|Overall Study|Missing / Unknown Reason|1|||
131666244|NCT01506609|474062636|FG001|Overall Study|Missing / Unknown Reason|0|||
131666245|NCT01506609|474062637|FG002|Overall Study|Missing / Unknown Reason|1|||
131666246|NCT01506609|474062638|FG003|Overall Study|Missing / Unknown Reason|4|||
131896534|NCT04074330|474906923|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131896535|NCT04074330|474906924|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131896536|NCT04074330|474906925|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131896537|NCT04074330|474906926|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131896538|NCT04074330|474906927|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
131896539|NCT04074330|474906928|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
131896540|NCT04074330|474906929|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
131896541|NCT00184093|474906932|FG000|Overall Study|Adverse Event|3|||
131896542|NCT00184093|474906932|FG000|Overall Study|Lost to Follow-up|3|||
131896543|NCT00184093|474906932|FG000|Overall Study|Physician Decision|1|||
131896544|NCT00184093|474906932|FG000|Overall Study|Withdrawal by Subject|2|||
131896545|NCT05095311|474906933|FG000|Overall Study|Lost to Follow-up|7|||
131896546|NCT05095311|474906934|FG001|Overall Study|Lost to Follow-up|0|||
131896547|NCT05095311|474906935|FG002|Overall Study|Lost to Follow-up|0|||
131896548|NCT00972283|474906936|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
131896549|NCT00972283|474906937|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
131896550|NCT00972283|474906936|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
131896551|NCT00972283|474906937|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
131896552|NCT00972283|474906936|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
131896553|NCT00972283|474906937|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
131896554|NCT00972283|474906936|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
131896555|NCT00972283|474906937|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
131896556|NCT00972283|474906936|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
131896557|NCT00972283|474906937|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
131896558|NCT00972283|474906936|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
131896559|NCT00972283|474906937|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
131896560|NCT00972283|474906936|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
131896561|NCT00972283|474906937|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
131896562|NCT00972283|474906936|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
131896563|NCT00972283|474906937|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
131896564|NCT00972283|474906936|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
131896565|NCT00972283|474906937|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
131896566|NCT00972283|474906936|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
131896567|NCT00972283|474906937|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
131896568|NCT01868165|474906941|FG000|Overall Study|Withdrawal by Subject|36|||
131896569|NCT01868165|474906941|FG000|Overall Study|Physician Decision|2|||
131896570|NCT01868165|474906941|FG000|Overall Study|Lost to Follow-up|3|||
131896571|NCT01868165|474906941|FG000|Overall Study|Death|4|||
131896572|NCT02588664|474906944|FG000|Overall Study|Death|56|||
131896573|NCT02588664|474906945|FG001|Overall Study|Death|55|||
131896574|NCT02588664|474906944|FG000|Overall Study|Lost to Follow-up|1305|||
131896575|NCT02588664|474906945|FG001|Overall Study|Lost to Follow-up|990|||
131896576|NCT01429298|474906946|FG000|Overall Study|Protocol Violation|4|||
131896577|NCT01429298|474906947|FG001|Overall Study|Protocol Violation|6|||
131896578|NCT02903420|474906948|FG000|Overall Study|Death|3|||
131896579|NCT00334295|474906951|FG000|Overall Study|Patients received fewer than 3 injection|5|||
131896580|NCT01588405|474906952|FG000|Overall Study|Adverse Event|1|||
131666247|NCT01506609|474062639|FG004|Overall Study|Missing / Unknown Reason|4|||
131896581|NCT01588405|474906952|FG000|Overall Study|Clinical Worsening|1|||
131896582|NCT01124292|474906953|FG000|Overall Study|Lost to Follow-up|2|||
131666248|NCT01506609|474062640|FG005|Overall Study|Missing / Unknown Reason|2|||
131896583|NCT01124292|474906954|FG001|Overall Study|Lost to Follow-up|4|||
131896584|NCT01124292|474906955|FG002|Overall Study|Lost to Follow-up|3|||
131666249|NCT01502631|474062641|FG000|Overall Study|Adverse Event|5|||
131666250|NCT01502631|474062642|FG001|Overall Study|Adverse Event|8|||
131666251|NCT01502631|474062641|FG000|Overall Study|Lost to Follow-up|2|||
131666252|NCT01502631|474062642|FG001|Overall Study|Lost to Follow-up|2|||
131666253|NCT01502631|474062641|FG000|Overall Study|Participant withdrew consent|2|||
131666254|NCT01502631|474062642|FG001|Overall Study|Participant withdrew consent|4|||
131666255|NCT01502631|474062641|FG000|Overall Study|Participant non-compliant|1|||
131666256|NCT01502631|474062642|FG001|Overall Study|Participant non-compliant|0|||
131666257|NCT01502631|474062641|FG000|Overall Study|Investigator's decision|0|||
131666258|NCT01502631|474062642|FG001|Overall Study|Investigator's decision|1|||
131666259|NCT01502631|474062641|FG000|Overall Study|Other|10|||
131666260|NCT01502631|474062642|FG001|Overall Study|Other|5|||
131666261|NCT01293487|474062643|FG000|Overall Study|Lost to Follow-up|0|||
131666262|NCT01293487|474062644|FG001|Overall Study|Lost to Follow-up|0|||
131666263|NCT01293487|474062645|FG002|Overall Study|Lost to Follow-up|0|||
131666264|NCT01293487|474062646|FG003|Overall Study|Lost to Follow-up|1|||
131666265|NCT01293487|474062647|FG004|Overall Study|Lost to Follow-up|0|||
131666266|NCT01293487|474062648|FG005|Overall Study|Lost to Follow-up|0|||
131666267|NCT01293487|474062649|FG006|Overall Study|Lost to Follow-up|0|||
131666268|NCT01293487|474062650|FG007|Overall Study|Lost to Follow-up|0|||
131666269|NCT01293487|474062643|FG000|Overall Study|Withdrawal by Subject|0|||
131666270|NCT01293487|474062644|FG001|Overall Study|Withdrawal by Subject|0|||
131666271|NCT01293487|474062645|FG002|Overall Study|Withdrawal by Subject|0|||
131666272|NCT01293487|474062646|FG003|Overall Study|Withdrawal by Subject|0|||
131666273|NCT01293487|474062647|FG004|Overall Study|Withdrawal by Subject|0|||
131666274|NCT01293487|474062648|FG005|Overall Study|Withdrawal by Subject|0|||
131666275|NCT01293487|474062649|FG006|Overall Study|Withdrawal by Subject|0|||
131666276|NCT01293487|474062650|FG007|Overall Study|Withdrawal by Subject|2|||
131666277|NCT00395460|474062651|FG000|Overall Study|Withdrawal by Subject|1|||
131666278|NCT00395460|474062652|FG001|Overall Study|Withdrawal by Subject|0|||
131666279|NCT04223830|474062659|FG000|Overall Study|Lost to Follow-up|9|||
131666280|NCT04223830|474062659|FG000|Overall Study|Adverse Event|1|||
131666281|NCT00862719|474062660|FG000|Overall Study|Disease Progression|5|||
131666282|NCT00862719|474062661|FG001|Overall Study|Disease Progression|0|||
131666283|NCT00862719|474062662|FG002|Overall Study|Disease Progression|1|||
131666284|NCT00862719|474062663|FG003|Overall Study|Disease Progression|0|||
131666285|NCT00862719|474062660|FG000|Overall Study|Death|5|||
131666286|NCT00862719|474062661|FG001|Overall Study|Death|6|||
131666287|NCT00862719|474062662|FG002|Overall Study|Death|1|||
131666288|NCT00862719|474062663|FG003|Overall Study|Death|1|||
131666289|NCT00862719|474062660|FG000|Overall Study|Engraftment failure|0|||
131666290|NCT00862719|474062661|FG001|Overall Study|Engraftment failure|0|||
131666291|NCT00862719|474062662|FG002|Overall Study|Engraftment failure|1|||
131666292|NCT00862719|474062663|FG003|Overall Study|Engraftment failure|0|||
131666293|NCT00862719|474062660|FG000|Overall Study|Veno-Occlusive Disease|0|||
131666294|NCT00862719|474062661|FG001|Overall Study|Veno-Occlusive Disease|0|||
131666295|NCT00862719|474062662|FG002|Overall Study|Veno-Occlusive Disease|1|||
131666296|NCT00862719|474062663|FG003|Overall Study|Veno-Occlusive Disease|0|||
131666297|NCT00324116|474062664|FG000|Overall Study|Adverse Event|5|||
131666298|NCT00324116|474062664|FG000|Overall Study|Lack of Efficacy|17|||
131666299|NCT00324116|474062664|FG000|Overall Study|Withdrawal by Subject|5|||
131666300|NCT00324116|474062664|FG000|Overall Study|Other|5|||
131666301|NCT01806623|474062665|FG000|Overall Study|Withdrawal by Subject|1|||
131666302|NCT01806623|474062665|FG000|Overall Study|Adverse Event|1|||
131666303|NCT01806623|474062665|FG000|Overall Study|Did not meet the inclusion criteria|56|||
131666304|NCT01737827|474062666|FG000|Overall Study|Adverse Event|3|||
131666305|NCT01737827|474062667|FG001|Overall Study|Adverse Event|6|||
131666306|NCT01737827|474062668|FG002|Overall Study|Adverse Event|0|||
131666307|NCT01737827|474062666|FG000|Overall Study|Lost to Follow-up|0|||
131666308|NCT01737827|474062667|FG001|Overall Study|Lost to Follow-up|1|||
131666309|NCT01737827|474062668|FG002|Overall Study|Lost to Follow-up|0|||
131666310|NCT01737827|474062666|FG000|Overall Study|Physician Decision|0|||
131666311|NCT01737827|474062667|FG001|Overall Study|Physician Decision|2|||
131666312|NCT01737827|474062668|FG002|Overall Study|Physician Decision|0|||
131666313|NCT01737827|474062666|FG000|Overall Study|Progressive Disease|5|||
131666314|NCT01737827|474062667|FG001|Overall Study|Progressive Disease|16|||
131666315|NCT01737827|474062668|FG002|Overall Study|Progressive Disease|2|||
131666316|NCT01737827|474062666|FG000|Overall Study|Study Terminated by Sponsor|0|||
131666317|NCT01737827|474062667|FG001|Overall Study|Study Terminated by Sponsor|1|||
131666318|NCT01737827|474062668|FG002|Overall Study|Study Terminated by Sponsor|0|||
131666319|NCT01737827|474062666|FG000|Overall Study|Subject/Guardian Decision|0|||
131666320|NCT01737827|474062667|FG001|Overall Study|Subject/Guardian Decision|2|||
131666321|NCT01737827|474062668|FG002|Overall Study|Subject/Guardian Decision|0|||
131666322|NCT01964924|474062669|FG000|Trametinib Monotherapy|Progression|19|||
131666323|NCT01964924|474062670|FG001|Trametinib Monotherapy|Progression|0|||
131666324|NCT01153958|474062671|FG000|Overall Study|Study Terminated|36|||
131666325|NCT01153958|474062672|FG001|Overall Study|Study Terminated|32|||
131666326|NCT02971761|474062673|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
131666327|NCT01034163|474062674|FG000|Overall Study|Treatment completed as per protocol|8|||
131896585|NCT01124292|474906953|FG000|Overall Study|Physician Decision|0|||
131553988|NCT04534114|473652938|FG003|Main Treatment Period|Other reason|0|||
131553989|NCT04534114|473652935|FG000|Main Treatment Period|Participant decision|1|||
131553990|NCT04534114|473652936|FG001|Main Treatment Period|Participant decision|3|||
131553991|NCT04534114|473652937|FG002|Main Treatment Period|Participant decision|3|||
131553992|NCT04534114|473652938|FG003|Main Treatment Period|Participant decision|1|||
131553993|NCT04534114|473652935|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
131553994|NCT04534114|473652936|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
131553995|NCT04534114|473652937|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
131553996|NCT04534114|473652938|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
131553997|NCT04534114|473652935|FG000|Main Treatment Period|Adverse Event|4|||
131553998|NCT04534114|473652936|FG001|Main Treatment Period|Adverse Event|2|||
131553999|NCT04534114|473652937|FG002|Main Treatment Period|Adverse Event|1|||
131554000|NCT04534114|473652938|FG003|Main Treatment Period|Adverse Event|2|||
131554001|NCT04534114|473652935|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
131554002|NCT04534114|473652936|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
131554003|NCT04534114|473652937|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
131554004|NCT04534114|473652938|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
131554005|NCT04534114|473652935|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
131554006|NCT04534114|473652936|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
131554007|NCT04534114|473652937|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
131554008|NCT04534114|473652938|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
131554009|NCT04534114|473652935|FG000|Extension Treatment Period|Other reason|0|||
131554010|NCT04534114|473652936|FG001|Extension Treatment Period|Other reason|1|||
131554011|NCT04534114|473652937|FG002|Extension Treatment Period|Other reason|0|||
131554012|NCT04534114|473652938|FG003|Extension Treatment Period|Other reason|0|||
131554013|NCT04534114|473652935|FG000|Extension Treatment Period|Death|0|||
131554014|NCT04534114|473652936|FG001|Extension Treatment Period|Death|0|||
131554015|NCT04534114|473652937|FG002|Extension Treatment Period|Death|1|||
131554016|NCT04534114|473652938|FG003|Extension Treatment Period|Death|2|||
131554017|NCT04534114|473652935|FG000|Extension Treatment Period|Adverse Event|0|||
131554018|NCT04534114|473652936|FG001|Extension Treatment Period|Adverse Event|1|||
131554019|NCT04534114|473652937|FG002|Extension Treatment Period|Adverse Event|0|||
131554020|NCT04534114|473652938|FG003|Extension Treatment Period|Adverse Event|1|||
131554021|NCT04534114|473652935|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
131554022|NCT04534114|473652936|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
131554023|NCT04534114|473652937|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
131554024|NCT04534114|473652938|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
131554025|NCT02759185|473652939|FG000|Stage 1|Adverse Event|0|||
131554026|NCT02759185|473652940|FG001|Stage 1|Adverse Event|1|||
131554027|NCT02759185|473652941|FG002|Stage 1|Adverse Event|3|||
131554028|NCT02759185|473652942|FG003|Stage 1|Adverse Event|0|||
131554029|NCT02759185|473652943|FG004|Stage 1|Adverse Event|0|||
131554030|NCT02759185|473652944|FG005|Stage 1|Adverse Event|0|||
131554031|NCT02759185|473652945|FG006|Stage 1|Adverse Event|0|||
131554032|NCT02759185|473652939|FG000|Stage 1|Withdrawal by Subject|1|||
131554033|NCT02759185|473652940|FG001|Stage 1|Withdrawal by Subject|0|||
131554034|NCT02759185|473652941|FG002|Stage 1|Withdrawal by Subject|0|||
131554035|NCT02759185|473652942|FG003|Stage 1|Withdrawal by Subject|0|||
131554036|NCT02759185|473652943|FG004|Stage 1|Withdrawal by Subject|0|||
131554037|NCT02759185|473652944|FG005|Stage 1|Withdrawal by Subject|0|||
131554038|NCT02759185|473652945|FG006|Stage 1|Withdrawal by Subject|0|||
131554039|NCT02759185|473652939|FG000|Stage 2|Adverse Event|0|||
131554040|NCT02759185|473652940|FG001|Stage 2|Adverse Event|0|||
131554041|NCT02759185|473652941|FG002|Stage 2|Adverse Event|0|||
131554042|NCT02759185|473652942|FG003|Stage 2|Adverse Event|0|||
131554043|NCT02759185|473652943|FG004|Stage 2|Adverse Event|1|||
131554044|NCT02759185|473652944|FG005|Stage 2|Adverse Event|2|||
131554045|NCT02759185|473652945|FG006|Stage 2|Adverse Event|0|||
131554046|NCT02759185|473652939|FG000|Stage 2|Withdrawal by Subject|0|||
131554047|NCT02759185|473652940|FG001|Stage 2|Withdrawal by Subject|0|||
131896586|NCT01124292|474906954|FG001|Overall Study|Physician Decision|3|||
131554048|NCT02759185|473652941|FG002|Stage 2|Withdrawal by Subject|0|||
131554049|NCT02759185|473652942|FG003|Stage 2|Withdrawal by Subject|0|||
131554050|NCT02759185|473652943|FG004|Stage 2|Withdrawal by Subject|1|||
131554051|NCT02759185|473652944|FG005|Stage 2|Withdrawal by Subject|1|||
131554052|NCT02759185|473652945|FG006|Stage 2|Withdrawal by Subject|1|||
131554053|NCT02613221|473652951|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
131554054|NCT02613221|473652951|FG000|Overall Study|Adverse Event|2|||
131554055|NCT02613221|473652951|FG000|Overall Study|Voluntary Discontinuation|1|||
131896587|NCT01124292|474906955|FG002|Overall Study|Physician Decision|2|||
131554056|NCT02613221|473652951|FG000|Overall Study|Delayed Treatment|1|||
131554057|NCT02613221|473652951|FG000|Overall Study|Enrolled but Not Treated|1|||
131554058|NCT01008475|473652954|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
131666328|NCT01034163|474062675|FG001|Overall Study|Treatment completed as per protocol|7|||
131666329|NCT01034163|474062674|FG000|Overall Study|Withdrawal by Subject|8|||
131666330|NCT01034163|474062675|FG001|Overall Study|Withdrawal by Subject|2|||
131666331|NCT01034163|474062674|FG000|Overall Study|Protocol deviation|1|||
131666332|NCT01034163|474062675|FG001|Overall Study|Protocol deviation|0|||
131666333|NCT01034163|474062674|FG000|Overall Study|Disease progression|3|||
131666334|NCT01034163|474062675|FG001|Overall Study|Disease progression|4|||
131666335|NCT01034163|474062674|FG000|Overall Study|Adverse Event|6|||
131666336|NCT01034163|474062675|FG001|Overall Study|Adverse Event|0|||
131896588|NCT01124292|474906953|FG000|Overall Study|Withdrawal by Subject|0|||
131896589|NCT01124292|474906954|FG001|Overall Study|Withdrawal by Subject|6|||
131896590|NCT01124292|474906955|FG002|Overall Study|Withdrawal by Subject|2|||
131896591|NCT01124292|474906953|FG000|Overall Study|medical issue unrelated to the study|0|||
131896592|NCT01124292|474906954|FG001|Overall Study|medical issue unrelated to the study|0|||
131896593|NCT01124292|474906955|FG002|Overall Study|medical issue unrelated to the study|2|||
131896594|NCT01124292|474906953|FG000|Overall Study|piercing track closed|0|||
131896595|NCT01124292|474906954|FG001|Overall Study|piercing track closed|2|||
131896596|NCT01124292|474906955|FG002|Overall Study|piercing track closed|1|||
131554059|NCT01008475|473652955|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
131554060|NCT01008475|473652956|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
131554061|NCT01008475|473652957|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
131554062|NCT01008475|473652958|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
131554063|NCT01008475|473652959|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
131554064|NCT01008475|473652960|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
131554065|NCT02668016|473652961|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
131554066|NCT02668016|473652961|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
131554067|NCT02668016|473652961|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
131554068|NCT02668016|473652961|FG000|Month 4|Withdrawal due to severe symptoms|1|||
131554069|NCT02668016|473652961|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
131554070|NCT02668016|473652961|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
131554071|NCT02668016|473652961|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
131554072|NCT02668016|473652961|FG000|Month 6|Withdrawal due to severe symptoms|2|||
131554073|NCT02668016|473652961|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
131554074|NCT02668016|473652961|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
131554075|NCT02668016|473652961|FG000|Month 8|Withdrawal due to severe symptoms|1|||
131554076|NCT02668016|473652961|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
131554077|NCT02668016|473652961|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
131554078|NCT02668016|473652961|FG000|Month 10|Withdrawal due to severe symptoms|1|||
131554079|NCT02668016|473652961|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
131554080|NCT02917941|473652963|FG000|Treatment Period|Adverse Event|11|||
131554081|NCT02917941|473652963|FG000|Treatment Period|Progressive Disease|11|||
131554082|NCT02917941|473652963|FG000|Treatment Period|Reason not Specified|2|||
131554083|NCT02917941|473652963|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
131554084|NCT02917941|473652963|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
131554085|NCT05067933|473652972|FG000|Overall Study|Withdrawal by Subject|2|||
131554086|NCT05067933|473652973|FG001|Overall Study|Withdrawal by Subject|0|||
131554087|NCT05067933|473652974|FG002|Overall Study|Withdrawal by Subject|0|||
131554088|NCT05067933|473652975|FG003|Overall Study|Withdrawal by Subject|0|||
131554089|NCT05067933|473652976|FG004|Overall Study|Withdrawal by Subject|0|||
131554090|NCT05067933|473652977|FG005|Overall Study|Withdrawal by Subject|0|||
131554091|NCT05067933|473652972|FG000|Overall Study|Lost to Follow-up|1|||
131554092|NCT05067933|473652973|FG001|Overall Study|Lost to Follow-up|1|||
131554093|NCT05067933|473652974|FG002|Overall Study|Lost to Follow-up|1|||
131554094|NCT05067933|473652975|FG003|Overall Study|Lost to Follow-up|2|||
131554095|NCT05067933|473652976|FG004|Overall Study|Lost to Follow-up|1|||
131554096|NCT05067933|473652977|FG005|Overall Study|Lost to Follow-up|0|||
131554097|NCT05067933|473652972|FG000|Overall Study|Miscellaneous|1|||
131554098|NCT05067933|473652973|FG001|Overall Study|Miscellaneous|0|||
131554099|NCT05067933|473652974|FG002|Overall Study|Miscellaneous|0|||
131554100|NCT05067933|473652975|FG003|Overall Study|Miscellaneous|0|||
131666337|NCT01034163|474062674|FG000|Overall Study|Administrative problems|0|||
131666338|NCT01034163|474062675|FG001|Overall Study|Administrative problems|1|||
131554101|NCT05067933|473652976|FG004|Overall Study|Miscellaneous|0|||
131666339|NCT01034163|474062674|FG000|Overall Study|Abnormal laboratory value|1|||
131666340|NCT01034163|474062675|FG001|Overall Study|Abnormal laboratory value|0|||
131666341|NCT00528645|474062676|FG000|Overall Study|Adverse Event|3|||
131666342|NCT00116753|474062677|FG000|Overall Study|Adverse Event|16|||
131666343|NCT00116753|474062678|FG001|Overall Study|Adverse Event|10|||
131666344|NCT00116753|474062679|FG002|Overall Study|Adverse Event|7|||
131666345|NCT00116753|474062677|FG000|Overall Study|Withdrawal by Subject|11|||
131666346|NCT00116753|474062678|FG001|Overall Study|Withdrawal by Subject|12|||
131666347|NCT00116753|474062679|FG002|Overall Study|Withdrawal by Subject|8|||
131666348|NCT00116753|474062677|FG000|Overall Study|Lost to Follow-up|0|||
131666349|NCT00116753|474062678|FG001|Overall Study|Lost to Follow-up|2|||
131666350|NCT00116753|474062679|FG002|Overall Study|Lost to Follow-up|1|||
131666351|NCT00116753|474062677|FG000|Overall Study|Protocol Violation|0|||
131666352|NCT00116753|474062678|FG001|Overall Study|Protocol Violation|0|||
131666353|NCT00116753|474062679|FG002|Overall Study|Protocol Violation|1|||
131666354|NCT00116753|474062677|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
131666355|NCT00116753|474062678|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
131666356|NCT00116753|474062679|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
131666357|NCT00116753|474062677|FG000|Overall Study|Disease Progression|3|||
131666358|NCT00116753|474062678|FG001|Overall Study|Disease Progression|4|||
131666359|NCT00116753|474062679|FG002|Overall Study|Disease Progression|3|||
131666360|NCT00116753|474062677|FG000|Overall Study|Abnormal Echocardiogram|0|||
131666361|NCT00116753|474062678|FG001|Overall Study|Abnormal Echocardiogram|0|||
131666362|NCT00116753|474062679|FG002|Overall Study|Abnormal Echocardiogram|1|||
131666363|NCT00116753|474062677|FG000|Overall Study|Progressive Parkinson's Disease|1|||
131666364|NCT00116753|474062678|FG001|Overall Study|Progressive Parkinson's Disease|0|||
131666365|NCT00116753|474062679|FG002|Overall Study|Progressive Parkinson's Disease|0|||
131666366|NCT00116753|474062677|FG000|Overall Study|Dosing Error|0|||
131666367|NCT00116753|474062678|FG001|Overall Study|Dosing Error|1|||
131666368|NCT00116753|474062679|FG002|Overall Study|Dosing Error|0|||
131666369|NCT01445301|474062680|FG000|Overall Study|Adverse Event|15|||
131666370|NCT01445301|474062681|FG001|Overall Study|Adverse Event|25|||
131666371|NCT01445301|474062682|FG002|Overall Study|Adverse Event|4|||
131666372|NCT01445301|474062680|FG000|Overall Study|Lack of Efficacy|0|||
131666373|NCT01445301|474062681|FG001|Overall Study|Lack of Efficacy|1|||
131666374|NCT01445301|474062682|FG002|Overall Study|Lack of Efficacy|0|||
131666375|NCT01445301|474062680|FG000|Overall Study|Protocol Violation|1|||
131666376|NCT01445301|474062681|FG001|Overall Study|Protocol Violation|0|||
131666377|NCT01445301|474062682|FG002|Overall Study|Protocol Violation|0|||
131772324|NCT04963231|474445032|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
131772325|NCT04963231|474445033|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
131772326|NCT04963231|474445034|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
131772327|NCT04963231|474445032|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
131772328|NCT04963231|474445033|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
131772329|NCT04963231|474445034|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
131772330|NCT04963231|474445032|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
131772331|NCT04963231|474445033|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
131772332|NCT04963231|474445034|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
131772333|NCT04963231|474445032|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
131772334|NCT04963231|474445033|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
131772335|NCT04963231|474445034|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
131772336|NCT04963231|474445032|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
131772337|NCT04963231|474445033|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
131896597|NCT03373461|474906956|FG000|Part 2|Adverse Event|0|||
131896598|NCT03373461|474906957|FG001|Part 2|Adverse Event|1|||
131896599|NCT03373461|474906958|FG002|Part 2|Adverse Event|0|||
131896600|NCT03373461|474906959|FG003|Part 2|Adverse Event|0|||
131896601|NCT03373461|474906960|FG004|Part 2|Adverse Event|1|||
131896602|NCT03300180|474906961|FG000|Baseline|Withdrawal by Subject|4|||
131896603|NCT03300180|474906962|FG001|Baseline|Withdrawal by Subject|6|||
131896604|NCT03300180|474906963|FG002|Baseline|Withdrawal by Subject|4|||
131896605|NCT03300180|474906961|FG000|6 Month Outcome|Withdrawal by Subject|12|||
131666378|NCT01445301|474062680|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
131896606|NCT03300180|474906962|FG001|6 Month Outcome|Withdrawal by Subject|12|||
131554102|NCT05067933|473652977|FG005|Overall Study|Miscellaneous|0|||
131554103|NCT05067933|473652972|FG000|Overall Study|Death|0|||
131554104|NCT05067933|473652973|FG001|Overall Study|Death|0|||
131554105|NCT05067933|473652974|FG002|Overall Study|Death|0|||
131554106|NCT05067933|473652975|FG003|Overall Study|Death|1|||
131554107|NCT05067933|473652976|FG004|Overall Study|Death|0|||
131554108|NCT05067933|473652977|FG005|Overall Study|Death|0|||
131554109|NCT01807650|473652984|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
131554110|NCT01807650|473652984|FG000|Overall Study|Adverse Event|5|||
131554111|NCT01807650|473652984|FG000|Overall Study|Other|2|||
131554112|NCT00736489|473652985|FG000|Period 1|Lost to Follow-up|1|||
131554113|NCT00736489|473652986|FG001|Period 1|Lost to Follow-up|0|||
131554114|NCT00736489|473652987|FG002|Period 1|Lost to Follow-up|0|||
131554115|NCT00736489|473652988|FG003|Period 1|Lost to Follow-up|0|||
131554116|NCT00736489|473652989|FG004|Period 1|Lost to Follow-up|0|||
131554117|NCT00736489|473652990|FG005|Period 1|Lost to Follow-up|0|||
131554118|NCT00736489|473652985|FG000|Period 1|Withdrawal by Subject|0|||
131554119|NCT00736489|473652986|FG001|Period 1|Withdrawal by Subject|0|||
131554120|NCT00736489|473652987|FG002|Period 1|Withdrawal by Subject|0|||
131554121|NCT00736489|473652988|FG003|Period 1|Withdrawal by Subject|0|||
131554122|NCT00736489|473652989|FG004|Period 1|Withdrawal by Subject|0|||
131554123|NCT00736489|473652990|FG005|Period 1|Withdrawal by Subject|1|||
131554124|NCT02946918|473652993|FG000|Overall Study|Patient unblinded himself|1|||
131554125|NCT02946918|473652994|FG001|Overall Study|Patient unblinded himself|0|||
131554126|NCT02946918|473652993|FG000|Overall Study|Physician Decision|0|||
131554127|NCT02946918|473652994|FG001|Overall Study|Physician Decision|2|||
131554128|NCT02946918|473652993|FG000|Overall Study|Ran out of study medication|0|||
131554129|NCT02946918|473652994|FG001|Overall Study|Ran out of study medication|1|||
131554130|NCT00069784|473652995|FG000|Overall Study|Adverse Event|105|||
131554131|NCT00069784|473652996|FG001|Overall Study|Adverse Event|0|||
131554132|NCT00069784|473652995|FG000|Overall Study|Withdrawal by Subject|1090|||
131554133|NCT00069784|473652996|FG001|Overall Study|Withdrawal by Subject|0|||
131554134|NCT00069784|473652995|FG000|Overall Study|Other|17|||
131554135|NCT00069784|473652996|FG001|Overall Study|Other|0|||
131554136|NCT01672853|473653001|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
131554137|NCT01672853|473653002|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
131554138|NCT01672853|473653003|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
131554139|NCT01672853|473653001|FG000|Overall Study|Pregnancy|0|||
131554140|NCT01672853|473653002|FG001|Overall Study|Pregnancy|1|||
131554141|NCT01672853|473653003|FG002|Overall Study|Pregnancy|0|||
131554142|NCT01672853|473653001|FG000|Overall Study|Investigator's Discretion|1|||
131554143|NCT01672853|473653002|FG001|Overall Study|Investigator's Discretion|0|||
131554144|NCT01672853|473653003|FG002|Overall Study|Investigator's Discretion|0|||
131554145|NCT01672853|473653001|FG000|Overall Study|Withdrew Consent|5|||
131554146|NCT01672853|473653002|FG001|Overall Study|Withdrew Consent|5|||
131554147|NCT01672853|473653003|FG002|Overall Study|Withdrew Consent|5|||
131554148|NCT01672853|473653001|FG000|Overall Study|Adverse Event|4|||
131554149|NCT01672853|473653002|FG001|Overall Study|Adverse Event|6|||
131554150|NCT01672853|473653003|FG002|Overall Study|Adverse Event|8|||
131554151|NCT01672853|473653001|FG000|Overall Study|Lost to Follow-up|0|||
131554152|NCT01672853|473653002|FG001|Overall Study|Lost to Follow-up|1|||
131554153|NCT01672853|473653003|FG002|Overall Study|Lost to Follow-up|0|||
131554154|NCT01672853|473653001|FG000|Overall Study|Randomized but Never Treated|0|||
131554155|NCT01672853|473653002|FG001|Overall Study|Randomized but Never Treated|0|||
131554156|NCT01672853|473653003|FG002|Overall Study|Randomized but Never Treated|1|||
131554157|NCT00663117|473654641|FG000|Overall Study|Lack of Efficacy|1|||
131554158|NCT00663117|473654642|FG001|Overall Study|Lack of Efficacy|0|||
131554159|NCT02243631|473654645|FG000|Overall Study|no synovial fluid on second aspirate|0|||
131554160|NCT02243631|473654646|FG001|Overall Study|no synovial fluid on second aspirate|1|||
131554161|NCT01992549|473654654|FG000|Overall Study|Lost to Follow-up|2|||
131554162|NCT01992549|473654654|FG000|Overall Study|Serious Adverse Event|1|||
131554163|NCT01992549|473654654|FG000|Overall Study|Product Switch to Extend Half Life|1|||
131554164|NCT01590771|473654655|FG000|Overall Study|Other Protocol Specified Criteria|5|||
131554165|NCT01590771|473654656|FG001|Overall Study|Other Protocol Specified Criteria|14|||
131554166|NCT01590771|473654655|FG000|Overall Study|Withdrawal by Subject|8|||
131554167|NCT01590771|473654656|FG001|Overall Study|Withdrawal by Subject|15|||
131554168|NCT01590771|473654655|FG000|Overall Study|Protocol Violation|1|||
131554169|NCT01590771|473654656|FG001|Overall Study|Protocol Violation|2|||
131554170|NCT01590771|473654655|FG000|Overall Study|Lost to Follow-up|1|||
131554171|NCT01590771|473654656|FG001|Overall Study|Lost to Follow-up|1|||
131554172|NCT01590771|473654655|FG000|Overall Study|Lack of Efficacy|1|||
131554173|NCT01590771|473654656|FG001|Overall Study|Lack of Efficacy|0|||
131554174|NCT01590771|473654655|FG000|Overall Study|Adverse Event|3|||
131554175|NCT01590771|473654656|FG001|Overall Study|Adverse Event|7|||
131554176|NCT01785628|473654660|FG000|Overall Study|Lost to Follow-up|2|||
131554177|NCT01785628|473654661|FG001|Overall Study|Lost to Follow-up|3|||
131554178|NCT00767104|473654664|FG000|Overall Study|Lost to Follow-up|1|||
131554179|NCT00767104|473654665|FG001|Overall Study|Lost to Follow-up|2|||
131554180|NCT00840996|473654666|FG000|Overall Study|Withdrawal by Subject|1|||
131554181|NCT00840996|473654667|FG001|Overall Study|Withdrawal by Subject|0|||
131554182|NCT01900054|473654675|FG000|Overall Study|Physician Decision|1|||
131554183|NCT01900054|473654675|FG000|Overall Study|Withdrawal by Subject|1|||
131554184|NCT01186328|473654676|FG000|Overall Study|Death|1|||
131554185|NCT01186328|473654677|FG001|Overall Study|Death|0|||
131554186|NCT01186328|473654678|FG002|Overall Study|Death|0|||
131554187|NCT03285295|473654683|FG000|Alinity s HBsAg|Protocol Violation|11|||
131554188|NCT03285295|473654684|FG001|Alinity s HBsAg|Protocol Violation|0|||
131554189|NCT03285295|473654685|FG002|Alinity s HBsAg|Protocol Violation|0|||
131554190|NCT03285295|473654686|FG003|Alinity s HBsAg|Protocol Violation|0|||
131554191|NCT03285295|473654687|FG004|Alinity s HBsAg|Protocol Violation|0|||
131666379|NCT01445301|474062681|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
131666380|NCT01445301|474062682|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
131666381|NCT01445301|474062680|FG000|Overall Study|Physician Decision|0|||
131666382|NCT01445301|474062681|FG001|Overall Study|Physician Decision|2|||
131666383|NCT01445301|474062682|FG002|Overall Study|Physician Decision|0|||
131666384|NCT01445301|474062680|FG000|Overall Study|Withdrawal by Subject|5|||
131666385|NCT01445301|474062681|FG001|Overall Study|Withdrawal by Subject|6|||
131666386|NCT01445301|474062682|FG002|Overall Study|Withdrawal by Subject|4|||
131666387|NCT00752557|474062683|FG000|Overall Study|Withdrawal by Subject|4|||
131666388|NCT00752557|474062684|FG001|Overall Study|Withdrawal by Subject|3|||
131666389|NCT00752557|474062685|FG002|Overall Study|Withdrawal by Subject|3|||
131666390|NCT00752557|474062683|FG000|Overall Study|Unspecified resaons|0|||
131666391|NCT00752557|474062684|FG001|Overall Study|Unspecified resaons|2|||
131666392|NCT00752557|474062685|FG002|Overall Study|Unspecified resaons|2|||
131666393|NCT00752557|474062683|FG000|Overall Study|Lost to Follow-up|1|||
131666394|NCT00752557|474062684|FG001|Overall Study|Lost to Follow-up|0|||
131666395|NCT00752557|474062685|FG002|Overall Study|Lost to Follow-up|1|||
131666396|NCT02150343|474062690|FG000|Overall Study|Adverse Event|2|||
131666397|NCT02150343|474062691|FG001|Overall Study|Adverse Event|0|||
131666398|NCT02150343|474062692|FG002|Overall Study|Adverse Event|1|||
131666399|NCT02150343|474062693|FG003|Overall Study|Adverse Event|1|||
131666400|NCT02150343|474062690|FG000|Overall Study|Withdrawal by Subject|13|||
131666401|NCT02150343|474062691|FG001|Overall Study|Withdrawal by Subject|10|||
131666402|NCT02150343|474062692|FG002|Overall Study|Withdrawal by Subject|9|||
131666403|NCT02150343|474062693|FG003|Overall Study|Withdrawal by Subject|4|||
131666404|NCT02150343|474062690|FG000|Overall Study|Lost to Follow-up|4|||
131666405|NCT02150343|474062691|FG001|Overall Study|Lost to Follow-up|4|||
131666406|NCT02150343|474062692|FG002|Overall Study|Lost to Follow-up|2|||
131666407|NCT02150343|474062693|FG003|Overall Study|Lost to Follow-up|3|||
131666408|NCT02150343|474062690|FG000|Overall Study|Other|2|||
131666409|NCT02150343|474062691|FG001|Overall Study|Other|6|||
131666410|NCT02150343|474062692|FG002|Overall Study|Other|0|||
131666411|NCT02150343|474062693|FG003|Overall Study|Other|2|||
131666412|NCT02729753|474062694|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
131666413|NCT02729753|474062695|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
131666414|NCT01090427|474062696|FG000|After Controlled Period|Death|0|||
131666415|NCT01090427|474062697|FG001|After Controlled Period|Death|0|||
131666416|NCT01090427|474062698|FG002|After Controlled Period|Death|0|||
131666417|NCT01090427|474062699|FG003|After Controlled Period|Death|0|||
131666418|NCT01090427|474062700|FG004|After Controlled Period|Death|0|||
131666419|NCT01090427|474062701|FG005|After Controlled Period|Death|1|||
131666420|NCT01090427|474062702|FG006|After Controlled Period|Death|0|||
131666421|NCT01090427|474062696|FG000|After Controlled Period|Lack of Efficacy|0|||
131666422|NCT01090427|474062697|FG001|After Controlled Period|Lack of Efficacy|0|||
131666423|NCT01090427|474062698|FG002|After Controlled Period|Lack of Efficacy|0|||
131666424|NCT01090427|474062699|FG003|After Controlled Period|Lack of Efficacy|0|||
131666425|NCT01090427|474062700|FG004|After Controlled Period|Lack of Efficacy|0|||
131666426|NCT01090427|474062701|FG005|After Controlled Period|Lack of Efficacy|3|||
131666427|NCT01090427|474062702|FG006|After Controlled Period|Lack of Efficacy|2|||
131666428|NCT01090427|474062696|FG000|After Controlled Period|Adverse Event|0|||
131666429|NCT01090427|474062697|FG001|After Controlled Period|Adverse Event|0|||
131666430|NCT01090427|474062698|FG002|After Controlled Period|Adverse Event|0|||
131666431|NCT01090427|474062699|FG003|After Controlled Period|Adverse Event|2|||
131666432|NCT01090427|474062700|FG004|After Controlled Period|Adverse Event|0|||
131666433|NCT01090427|474062701|FG005|After Controlled Period|Adverse Event|1|||
131666434|NCT01090427|474062702|FG006|After Controlled Period|Adverse Event|0|||
131666435|NCT01200589|474062703|FG000|Overall Study|Withdrawal by Subject|13|||
131666436|NCT01200589|474062704|FG001|Overall Study|Withdrawal by Subject|11|||
131666437|NCT01200589|474062703|FG000|Overall Study|Physician Decision|2|||
131666438|NCT01200589|474062704|FG001|Overall Study|Physician Decision|2|||
131666439|NCT01200589|474062703|FG000|Overall Study|Lost to Follow-up|5|||
131666440|NCT01200589|474062704|FG001|Overall Study|Lost to Follow-up|4|||
131896607|NCT03300180|474906963|FG002|6 Month Outcome|Withdrawal by Subject|19|||
131666441|NCT01200589|474062703|FG000|Overall Study|Study terminated|170|||
131666442|NCT01200589|474062704|FG001|Overall Study|Study terminated|172|||
131666443|NCT01605916|474062705|FG000|Overall Study|Adverse Event|1|||
131666444|NCT01605916|474062706|FG001|Overall Study|Adverse Event|0|||
131666445|NCT01605916|474062707|FG002|Overall Study|Adverse Event|0|||
131666446|NCT01605916|474062708|FG003|Overall Study|Adverse Event|1|||
131666447|NCT01605916|474062709|FG004|Overall Study|Adverse Event|0|||
131666448|NCT01605916|474062705|FG000|Overall Study|Lack of Efficacy|2|||
131666449|NCT01605916|474062706|FG001|Overall Study|Lack of Efficacy|3|||
131666450|NCT01605916|474062707|FG002|Overall Study|Lack of Efficacy|3|||
131666451|NCT01605916|474062708|FG003|Overall Study|Lack of Efficacy|5|||
131666452|NCT01605916|474062709|FG004|Overall Study|Lack of Efficacy|4|||
131666453|NCT01605916|474062705|FG000|Overall Study|Withdrawal by Subject|1|||
131666454|NCT01605916|474062706|FG001|Overall Study|Withdrawal by Subject|1|||
131896608|NCT03300180|474906961|FG000|6 Month Outcome|Death|2|||
131896609|NCT03300180|474906962|FG001|6 Month Outcome|Death|4|||
131666455|NCT01605916|474062707|FG002|Overall Study|Withdrawal by Subject|0|||
131666456|NCT01605916|474062708|FG003|Overall Study|Withdrawal by Subject|0|||
131666457|NCT01605916|474062709|FG004|Overall Study|Withdrawal by Subject|2|||
131666458|NCT02891837|474062712|FG000|Overall Study|Lost to Follow-up|2|||
131666459|NCT02891837|474062713|FG001|Overall Study|Lost to Follow-up|0|||
131666460|NCT02891837|474062712|FG000|Overall Study|Withdrawal by Subject|1|||
131666461|NCT02891837|474062713|FG001|Overall Study|Withdrawal by Subject|0|||
131666462|NCT00185965|474062722|FG000|Overall Study|Adverse Event|0|||
131666463|NCT00185965|474062723|FG001|Overall Study|Adverse Event|1|||
131666464|NCT02533531|474062724|FG000|Overall Study|Device did not turn on|1|||
131666465|NCT01014533|474062725|FG000|Overall Study|Protocol Violation|3|||
131666466|NCT01014533|474062726|FG001|Overall Study|Protocol Violation|2|||
131666467|NCT01014533|474062725|FG000|Overall Study|Withdrawal by Subject|2|||
131666468|NCT01014533|474062726|FG001|Overall Study|Withdrawal by Subject|0|||
131666469|NCT01014533|474062725|FG000|Overall Study|unable to come to appointment|0|||
131666470|NCT01014533|474062726|FG001|Overall Study|unable to come to appointment|3|||
131666471|NCT02689518|474062727|FG000|Overall Study|Withdrawal by Subject|3|||
131666472|NCT03265938|474062730|FG000|Overall Study|Withdrawal by Subject|1|||
131666473|NCT03265938|474062730|FG000|Overall Study|Physician Decision|1|||
131666474|NCT03265938|474062730|FG000|Overall Study|friable mass|6|||
131666475|NCT02679508|474062731|FG000|Healing Phase|Protocol Violation|1|||
131666476|NCT02679508|474062732|FG001|Healing Phase|Protocol Violation|1|||
131666477|NCT02679508|474062731|FG000|Healing Phase|Lost to Follow-up|1|||
131666478|NCT02679508|474062732|FG001|Healing Phase|Lost to Follow-up|0|||
131666479|NCT02679508|474062731|FG000|Maintenance Phase|Adverse Event|12|||
131666480|NCT02679508|474062732|FG001|Maintenance Phase|Adverse Event|2|||
131666481|NCT02679508|474062731|FG000|Maintenance Phase|Lost to Follow-up|0|||
131666482|NCT02679508|474062732|FG001|Maintenance Phase|Lost to Follow-up|1|||
131666483|NCT02679508|474062731|FG000|Maintenance Phase|Withdrawal by Subject|15|||
131666484|NCT02679508|474062732|FG001|Maintenance Phase|Withdrawal by Subject|8|||
131666485|NCT02679508|474062731|FG000|Maintenance Phase|Other|5|||
131666486|NCT02679508|474062732|FG001|Maintenance Phase|Other|4|||
131666487|NCT03143166|474062733|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
131666488|NCT03683823|474062734|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
131666489|NCT03683823|474062735|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
131666490|NCT03683823|474062734|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
131666491|NCT03683823|474062735|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
131666492|NCT03683823|474062734|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
131666493|NCT03683823|474062735|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
131666494|NCT01323972|474062737|FG000|Overall Study|Withdrawal by Subject|1|||
131666495|NCT01323972|474062738|FG001|Overall Study|Withdrawal by Subject|0|||
131666496|NCT01323972|474062739|FG002|Overall Study|Withdrawal by Subject|1|||
131666497|NCT01323972|474062740|FG003|Overall Study|Withdrawal by Subject|0|||
131666498|NCT01323972|474062737|FG000|Overall Study|Migrated/moved from study area|1|||
131666499|NCT01323972|474062738|FG001|Overall Study|Migrated/moved from study area|2|||
131666500|NCT01323972|474062739|FG002|Overall Study|Migrated/moved from study area|0|||
131666501|NCT01323972|474062740|FG003|Overall Study|Migrated/moved from study area|0|||
131666502|NCT01323972|474062737|FG000|Overall Study|Lost to Follow-up|0|||
131666503|NCT01323972|474062738|FG001|Overall Study|Lost to Follow-up|1|||
131666504|NCT01323972|474062739|FG002|Overall Study|Lost to Follow-up|1|||
131666505|NCT01323972|474062740|FG003|Overall Study|Lost to Follow-up|1|||
131666506|NCT05000931|474062749|FG000|Overall Study|Lost to Follow-up|1|||
131666507|NCT03141905|474062750|FG000|Overall Study|Death|3|||
131666508|NCT03141905|474062751|FG001|Overall Study|Death|2|||
131666509|NCT03141905|474062750|FG000|Overall Study|Withdrawal by Subject|1|||
131666510|NCT03141905|474062751|FG001|Overall Study|Withdrawal by Subject|0|||
131435966|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
131554192|NCT03285295|473654683|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
131554193|NCT03285295|473654684|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
131554194|NCT03285295|473654685|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
131554195|NCT03285295|473654686|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
131554196|NCT03285295|473654687|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
131554197|NCT03285295|473654683|FG000|Alinity s HBsAg|No Results Generated|74|||
131554198|NCT03285295|473654684|FG001|Alinity s HBsAg|No Results Generated|6|||
131554199|NCT03285295|473654685|FG002|Alinity s HBsAg|No Results Generated|0|||
131554200|NCT03285295|473654686|FG003|Alinity s HBsAg|No Results Generated|0|||
131554201|NCT03285295|473654687|FG004|Alinity s HBsAg|No Results Generated|0|||
131554202|NCT03285295|473654683|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
131554203|NCT03285295|473654684|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
131666511|NCT03141905|474062750|FG000|Overall Study|Lost to Follow-up|3|||
131666512|NCT03141905|474062751|FG001|Overall Study|Lost to Follow-up|7|||
131666513|NCT03141905|474062750|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
131666514|NCT03141905|474062751|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
131666515|NCT00812331|474064563|FG000|Overall Study|Adverse Event|1|||
131666516|NCT00812331|474064564|FG001|Overall Study|Adverse Event|0|||
131666517|NCT00812331|474064565|FG002|Overall Study|Adverse Event|0|||
131666518|NCT00812331|474064566|FG003|Overall Study|Adverse Event|0|||
131666519|NCT00812331|474064567|FG004|Overall Study|Adverse Event|0|||
131666520|NCT01506453|474064568|FG000|Overall Study|Withdrawal prior to treatment|0|||
131666521|NCT01506453|474064569|FG001|Overall Study|Withdrawal prior to treatment|2|||
131666522|NCT02502799|474064570|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
131666523|NCT02502799|474064571|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
131666524|NCT02502799|474064572|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
131666525|NCT02502799|474064573|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
131666526|NCT02502799|474064570|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
131666527|NCT02502799|474064571|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
131666528|NCT02502799|474064572|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
131666529|NCT02502799|474064573|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
131666530|NCT02502799|474064570|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
131666531|NCT02502799|474064571|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
131666532|NCT02502799|474064572|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
131666533|NCT02502799|474064573|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
131666534|NCT02502799|474064570|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
131666535|NCT02502799|474064571|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
131666536|NCT02502799|474064572|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
131666537|NCT02502799|474064573|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
131666538|NCT02502799|474064570|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
131666539|NCT02502799|474064571|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
131666540|NCT02502799|474064572|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
131666541|NCT02502799|474064573|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
131666542|NCT00055601|474064576|FG000|Overall Study|Protocol Violation|1|||
131666543|NCT00055601|474064577|FG001|Overall Study|Protocol Violation|1|||
131666544|NCT00055601|474064576|FG000|Overall Study|No protocol treatment received|1|||
131666545|NCT00055601|474064577|FG001|Overall Study|No protocol treatment received|1|||
131666546|NCT00117845|474064578|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
131666547|NCT01022268|474064579|FG000|Overall Study|Withdrawal by Subject|1|||
131666548|NCT01022268|474064580|FG001|Overall Study|Withdrawal by Subject|0|||
131666549|NCT01022268|474064579|FG000|Overall Study|Withdrawal by Subject|1|||
131666550|NCT01022268|474064580|FG001|Overall Study|Withdrawal by Subject|0|||
131666551|NCT00910689|474064581|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
131666552|NCT00910689|474064582|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
131666553|NCT00910689|474064583|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
131666554|NCT00910689|474064584|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
131666555|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
131666556|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
131666557|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
131666558|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
131435967|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
131554204|NCT03285295|473654685|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
131554205|NCT03285295|473654686|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
131554206|NCT03285295|473654687|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
131554207|NCT03285295|473654683|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
131554208|NCT03285295|473654684|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
131554209|NCT03285295|473654685|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
131554210|NCT03285295|473654686|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
131554211|NCT03285295|473654687|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
131554212|NCT03285295|473654683|FG000|Alinity s HTLV I/II|No Results Generated|70|||
131554213|NCT03285295|473654684|FG001|Alinity s HTLV I/II|No Results Generated|0|||
131554214|NCT03285295|473654685|FG002|Alinity s HTLV I/II|No Results Generated|0|||
131554215|NCT03285295|473654686|FG003|Alinity s HTLV I/II|No Results Generated|0|||
131554216|NCT03285295|473654687|FG004|Alinity s HTLV I/II|No Results Generated|0|||
131554217|NCT03285295|473654683|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
131554218|NCT03285295|473654684|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
131554219|NCT03285295|473654685|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
131554220|NCT03285295|473654686|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
131554221|NCT03285295|473654687|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
131554222|NCT03285295|473654683|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
131554223|NCT03285295|473654684|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
131554224|NCT03285295|473654685|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
131554225|NCT03285295|473654686|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
131554226|NCT03285295|473654687|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
131554227|NCT03285295|473654683|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
131554228|NCT03285295|473654684|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
131554229|NCT03285295|473654685|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
131666559|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
131666560|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
131666561|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
131666562|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
131666563|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
131666564|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
131666565|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
131666566|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
131666567|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
131666568|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
131666569|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
131666570|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
131666571|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
131666572|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
131666573|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
131666574|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
131666575|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
131666576|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
131666577|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
131666578|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
131666579|NCT00910689|474064581|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
131666580|NCT00910689|474064582|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
131666581|NCT00910689|474064583|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
131666582|NCT00910689|474064584|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
131666583|NCT00910689|474064581|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
131666584|NCT00910689|474064582|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
131666585|NCT00910689|474064583|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
131666586|NCT00910689|474064584|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
131666587|NCT00910689|474064581|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
131666588|NCT00910689|474064582|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
131666589|NCT00910689|474064583|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
131666590|NCT00910689|474064584|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
131666591|NCT00910689|474064581|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
131666592|NCT00910689|474064582|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
131666593|NCT00910689|474064583|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
131666594|NCT00910689|474064584|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
131666595|NCT00910689|474064581|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
131666596|NCT00910689|474064582|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
131666597|NCT00910689|474064583|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
131666598|NCT00910689|474064584|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
131435968|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
131554230|NCT03285295|473654686|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
131554231|NCT03285295|473654687|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
131554232|NCT03285295|473654683|FG000|Alinity s Anti-HCV|No Results Generated|71|||
131554233|NCT03285295|473654684|FG001|Alinity s Anti-HCV|No Results Generated|0|||
131554234|NCT03285295|473654685|FG002|Alinity s Anti-HCV|No Results Generated|0|||
131554235|NCT03285295|473654686|FG003|Alinity s Anti-HCV|No Results Generated|0|||
131554236|NCT03285295|473654687|FG004|Alinity s Anti-HCV|No Results Generated|0|||
131554237|NCT03285295|473654683|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
131554238|NCT03285295|473654684|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
131554239|NCT03285295|473654685|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
131554240|NCT03285295|473654686|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
131554241|NCT03285295|473654687|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
131554242|NCT03285295|473654683|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
131554243|NCT03285295|473654684|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
131554244|NCT03285295|473654685|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
131554245|NCT03285295|473654686|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
131554246|NCT03285295|473654687|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
131554247|NCT03285295|473654683|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
131554248|NCT03285295|473654684|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
131554249|NCT03285295|473654685|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
131554250|NCT03285295|473654686|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
131554251|NCT03285295|473654687|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
131554252|NCT03285295|473654683|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
131554253|NCT03285295|473654684|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
131554254|NCT03285295|473654685|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
131554255|NCT03285295|473654686|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
131554256|NCT03285295|473654687|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
131554257|NCT03285295|473654683|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
131666599|NCT00910689|474064581|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
131666600|NCT00910689|474064582|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
131666601|NCT00910689|474064583|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
131666602|NCT00910689|474064584|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
131666603|NCT00910689|474064581|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
131666604|NCT00910689|474064582|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
131666605|NCT00910689|474064583|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
131666606|NCT00910689|474064584|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
131666607|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
131666608|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
131666609|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
131666610|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
131666611|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
131666612|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
131666613|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
131666614|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
131666615|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
131666616|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
131666617|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
131666618|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
131666619|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
131666620|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
131666621|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
131666622|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
131666623|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
131666624|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
131666625|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
131666626|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
131666627|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
131666628|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
131666629|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
131666630|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
131666631|NCT00910689|474064581|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
131666632|NCT00910689|474064582|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
131666633|NCT00910689|474064583|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
131666634|NCT00910689|474064584|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
131666635|NCT03207009|474064585|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
131666636|NCT02924428|474064586|FG000|Overall Study|Adverse Event|1|||
131666637|NCT02924428|474064587|FG001|Overall Study|Adverse Event|0|||
131666638|NCT02924428|474064586|FG000|Overall Study|Physician Decision|1|||
131666639|NCT02924428|474064587|FG001|Overall Study|Physician Decision|0|||
131666640|NCT02924428|474064586|FG000|Overall Study|Lost to Follow-up|2|||
131666641|NCT02924428|474064587|FG001|Overall Study|Lost to Follow-up|4|||
131666642|NCT02924428|474064586|FG000|Overall Study|Pregnancy|0|||
131666643|NCT02924428|474064587|FG001|Overall Study|Pregnancy|1|||
131666644|NCT01877837|474064588|FG000|Overall Study|Lost to Follow-up|1|||
131666645|NCT01877837|474064588|FG000|Overall Study|Ineligible|4|||
131666646|NCT02680002|474064589|FG000|Overall Study|Lost to Follow-up|5|||
131666647|NCT02680002|474064590|FG001|Overall Study|Lost to Follow-up|1|||
131666648|NCT02680002|474064591|FG002|Overall Study|Lost to Follow-up|4|||
131666649|NCT02680002|474064592|FG003|Overall Study|Lost to Follow-up|2|||
131666650|NCT02680002|474064593|FG004|Overall Study|Lost to Follow-up|0|||
131666651|NCT02680002|474064594|FG005|Overall Study|Lost to Follow-up|2|||
131666652|NCT02680002|474064589|FG000|Overall Study|Physician Decision|5|||
131666653|NCT02680002|474064590|FG001|Overall Study|Physician Decision|1|||
131666654|NCT02680002|474064591|FG002|Overall Study|Physician Decision|1|||
131666655|NCT02680002|474064592|FG003|Overall Study|Physician Decision|1|||
131666656|NCT02680002|474064593|FG004|Overall Study|Physician Decision|1|||
131666657|NCT02680002|474064594|FG005|Overall Study|Physician Decision|1|||
131666658|NCT02680002|474064589|FG000|Overall Study|Protocol Violation|1|||
131666659|NCT02680002|474064590|FG001|Overall Study|Protocol Violation|0|||
131666660|NCT02680002|474064591|FG002|Overall Study|Protocol Violation|1|||
131666661|NCT02680002|474064592|FG003|Overall Study|Protocol Violation|0|||
131666662|NCT02680002|474064593|FG004|Overall Study|Protocol Violation|1|||
131666663|NCT02680002|474064594|FG005|Overall Study|Protocol Violation|2|||
131666664|NCT02680002|474064589|FG000|Overall Study|Withdrawal by Subject|0|||
131666665|NCT02680002|474064590|FG001|Overall Study|Withdrawal by Subject|0|||
131666666|NCT02680002|474064591|FG002|Overall Study|Withdrawal by Subject|1|||
131666667|NCT02680002|474064592|FG003|Overall Study|Withdrawal by Subject|0|||
131666668|NCT02680002|474064593|FG004|Overall Study|Withdrawal by Subject|2|||
131666669|NCT02680002|474064594|FG005|Overall Study|Withdrawal by Subject|2|||
131666670|NCT02680002|474064589|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
131666671|NCT02680002|474064590|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
131666672|NCT02680002|474064591|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
131666673|NCT02680002|474064592|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
131666674|NCT02680002|474064593|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
131666675|NCT02680002|474064594|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
131666676|NCT02680002|474064589|FG000|Overall Study|Other|0|||
131666677|NCT02680002|474064590|FG001|Overall Study|Other|1|||
131666678|NCT02680002|474064591|FG002|Overall Study|Other|0|||
131666679|NCT02680002|474064592|FG003|Overall Study|Other|0|||
131666680|NCT02680002|474064593|FG004|Overall Study|Other|1|||
131666681|NCT02680002|474064594|FG005|Overall Study|Other|0|||
131666682|NCT02680002|474064589|FG000|Overall Study|Adverse Event|0|||
131666683|NCT02680002|474064590|FG001|Overall Study|Adverse Event|0|||
131666684|NCT02680002|474064591|FG002|Overall Study|Adverse Event|0|||
131666685|NCT02680002|474064592|FG003|Overall Study|Adverse Event|0|||
131666686|NCT02680002|474064593|FG004|Overall Study|Adverse Event|1|||
131666687|NCT02680002|474064594|FG005|Overall Study|Adverse Event|2|||
131666688|NCT00705679|474064595|FG000|Overall Study|Adverse Event|1|||
131666689|NCT00705679|474064596|FG001|Overall Study|Adverse Event|1|||
131666690|NCT00705679|474064597|FG002|Overall Study|Adverse Event|0|||
131666691|NCT00705679|474064598|FG003|Overall Study|Adverse Event|0|||
131666692|NCT00705679|474064599|FG004|Overall Study|Adverse Event|0|||
131666693|NCT00705679|474064595|FG000|Overall Study|Death|0|||
131666694|NCT00705679|474064596|FG001|Overall Study|Death|0|||
131666695|NCT00705679|474064597|FG002|Overall Study|Death|3|||
131666696|NCT00705679|474064598|FG003|Overall Study|Death|2|||
131666697|NCT00705679|474064599|FG004|Overall Study|Death|1|||
131666698|NCT00705679|474064595|FG000|Overall Study|Lost to Follow-up|32|||
131666699|NCT00705679|474064596|FG001|Overall Study|Lost to Follow-up|60|||
131666700|NCT00705679|474064597|FG002|Overall Study|Lost to Follow-up|44|||
131666701|NCT00705679|474064598|FG003|Overall Study|Lost to Follow-up|30|||
131666702|NCT00705679|474064599|FG004|Overall Study|Lost to Follow-up|35|||
131666703|NCT00705679|474064595|FG000|Overall Study|Physician Decision|0|||
131666704|NCT00705679|474064596|FG001|Overall Study|Physician Decision|1|||
131666705|NCT00705679|474064597|FG002|Overall Study|Physician Decision|0|||
131666706|NCT00705679|474064598|FG003|Overall Study|Physician Decision|1|||
131666707|NCT00705679|474064599|FG004|Overall Study|Physician Decision|0|||
131666708|NCT00705679|474064595|FG000|Overall Study|Withdrawal by Subject|32|||
131666709|NCT00705679|474064596|FG001|Overall Study|Withdrawal by Subject|77|||
131666710|NCT00705679|474064597|FG002|Overall Study|Withdrawal by Subject|68|||
131666711|NCT00705679|474064598|FG003|Overall Study|Withdrawal by Subject|47|||
131666712|NCT00705679|474064599|FG004|Overall Study|Withdrawal by Subject|33|||
131666713|NCT01248780|474064606|FG000|Overall Study|Lack of Efficacy|2|||
131666714|NCT01248780|474064607|FG001|Overall Study|Lack of Efficacy|0|||
131666715|NCT01248780|474064606|FG000|Overall Study|Lost to Follow-up|0|||
131666716|NCT01248780|474064607|FG001|Overall Study|Lost to Follow-up|1|||
131666717|NCT01248780|474064606|FG000|Overall Study|Death|0|||
131666718|NCT01248780|474064607|FG001|Overall Study|Death|1|||
131666719|NCT01248780|474064606|FG000|Overall Study|Adverse Event|2|||
131666720|NCT01248780|474064607|FG001|Overall Study|Adverse Event|7|||
131666721|NCT01248780|474064606|FG000|Overall Study|Protocol Violation|1|||
131666722|NCT01248780|474064607|FG001|Overall Study|Protocol Violation|1|||
131666723|NCT01248780|474064606|FG000|Overall Study|Withdrawal by Subject|4|||
131666724|NCT01248780|474064607|FG001|Overall Study|Withdrawal by Subject|4|||
131666725|NCT01248780|474064606|FG000|Overall Study|Not treated|0|||
131666726|NCT01248780|474064607|FG001|Overall Study|Not treated|1|||
131666727|NCT03064035|474064608|FG000|Overall Study|Did not receive allocated intervention|4|||
131666728|NCT03064035|474064609|FG001|Overall Study|Did not receive allocated intervention|2|||
131666729|NCT03064035|474064608|FG000|Overall Study|Lost to Follow-up|1|||
131666730|NCT03064035|474064609|FG001|Overall Study|Lost to Follow-up|1|||
131666731|NCT03103763|474064610|FG000|Overall Study|Death|15|||
131666732|NCT03103763|474064611|FG001|Overall Study|Death|5|||
131666733|NCT03103763|474064612|FG002|Overall Study|Death|5|||
131666734|NCT03103763|474064610|FG000|Overall Study|Withdrawal by Subject|0|||
131666735|NCT03103763|474064611|FG001|Overall Study|Withdrawal by Subject|3|||
131666736|NCT03103763|474064612|FG002|Overall Study|Withdrawal by Subject|2|||
131554258|NCT03285295|473654684|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
131554259|NCT03285295|473654685|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
131554260|NCT03285295|473654686|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
131554261|NCT03285295|473654687|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
131554262|NCT03285295|473654683|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
131554263|NCT03285295|473654684|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
131554264|NCT03285295|473654685|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
131554265|NCT03285295|473654686|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
131554266|NCT03285295|473654687|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
131554267|NCT03285295|473654683|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
131554268|NCT03285295|473654684|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
131554269|NCT03285295|473654685|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
131554270|NCT03285295|473654686|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
131554271|NCT03285295|473654687|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
131554272|NCT03285295|473654683|FG000|Alinity s Anti-HBc|No Results Generated|70|||
131554273|NCT03285295|473654684|FG001|Alinity s Anti-HBc|No Results Generated|0|||
131554274|NCT03285295|473654685|FG002|Alinity s Anti-HBc|No Results Generated|0|||
131554275|NCT03285295|473654686|FG003|Alinity s Anti-HBc|No Results Generated|0|||
131554276|NCT03285295|473654687|FG004|Alinity s Anti-HBc|No Results Generated|0|||
131554277|NCT03285295|473654683|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
131554278|NCT03285295|473654684|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
131554279|NCT03285295|473654685|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
131554280|NCT03285295|473654686|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
131554281|NCT03285295|473654687|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
131554282|NCT03285295|473654683|FG000|Alinity s Chagas|Protocol Violation|76|||
131554283|NCT03285295|473654684|FG001|Alinity s Chagas|Protocol Violation|0|||
131554284|NCT03285295|473654685|FG002|Alinity s Chagas|Protocol Violation|0|||
131554285|NCT03285295|473654686|FG003|Alinity s Chagas|Protocol Violation|0|||
131554286|NCT03285295|473654687|FG004|Alinity s Chagas|Protocol Violation|0|||
131554287|NCT03285295|473654683|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
131554288|NCT03285295|473654684|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
131554289|NCT03285295|473654685|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
131554290|NCT03285295|473654686|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
131554291|NCT03285295|473654687|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
131554292|NCT03285295|473654683|FG000|Alinity s Chagas|No Results Generated|105|||
131554293|NCT03285295|473654684|FG001|Alinity s Chagas|No Results Generated|0|||
131554294|NCT03285295|473654685|FG002|Alinity s Chagas|No Results Generated|0|||
131554295|NCT03285295|473654686|FG003|Alinity s Chagas|No Results Generated|0|||
131554296|NCT03285295|473654687|FG004|Alinity s Chagas|No Results Generated|0|||
131554297|NCT03285295|473654683|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
131554298|NCT03285295|473654684|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
131554299|NCT03285295|473654685|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
131554300|NCT03285295|473654686|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
131554301|NCT03285295|473654687|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
131554302|NCT03015116|473654688|FG000|Overall Study|Lost to Follow-up|3|||
131554303|NCT03015116|473654689|FG001|Overall Study|Lost to Follow-up|0|||
131554304|NCT03015116|473654690|FG002|Overall Study|Lost to Follow-up|2|||
131554305|NCT03015116|473654688|FG000|Overall Study|Withdrawal by Subject|3|||
131554306|NCT03015116|473654689|FG001|Overall Study|Withdrawal by Subject|1|||
131554307|NCT03015116|473654690|FG002|Overall Study|Withdrawal by Subject|0|||
131554308|NCT03015116|473654688|FG000|Overall Study|Subject has New Medical Status|1|||
131554309|NCT03015116|473654689|FG001|Overall Study|Subject has New Medical Status|0|||
131554310|NCT03015116|473654690|FG002|Overall Study|Subject has New Medical Status|0|||
131666737|NCT01346475|474064613|FG000|First Intervention|Lost to Follow-up|4|||
131666738|NCT01346475|474064614|FG001|First Intervention|Lost to Follow-up|3|||
131554311|NCT03015116|473654688|FG000|Overall Study|Physician Decision|0|||
131554312|NCT03015116|473654689|FG001|Overall Study|Physician Decision|1|||
131554313|NCT03015116|473654690|FG002|Overall Study|Physician Decision|0|||
131554314|NCT02200939|473654695|FG000|Overall Study|Participant withdrew consent|0|||
131554315|NCT02200939|473654696|FG001|Overall Study|Participant withdrew consent|1|||
131554316|NCT02200939|473654695|FG000|Overall Study|Lost to Follow-up|2|||
131666739|NCT04279392|474064615|FG000|Overall Study|Physician Decision|1|||
131666740|NCT04279392|474064616|FG001|Overall Study|Physician Decision|0|||
131666741|NCT04101318|474064623|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
131666742|NCT04101318|474064624|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
131666743|NCT04101318|474064623|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
131666744|NCT04101318|474064624|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
131666745|NCT04101318|474064623|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
131666746|NCT04101318|474064624|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
131666747|NCT00558259|474064625|FG000|Overall Study|Adverse Event|50|||
131666748|NCT00558259|474064626|FG001|Overall Study|Adverse Event|81|||
131666749|NCT00558259|474064625|FG000|Overall Study|Protocol Violation|9|||
131666750|NCT00558259|474064626|FG001|Overall Study|Protocol Violation|5|||
131666751|NCT00558259|474064625|FG000|Overall Study|Withdrawal by Subject|12|||
131666752|NCT00558259|474064626|FG001|Overall Study|Withdrawal by Subject|13|||
131666753|NCT04289051|474064627|FG000|Overall Study|Lost to Follow-up|0|||
131666754|NCT04289051|474064628|FG001|Overall Study|Lost to Follow-up|0|||
131666755|NCT04289051|474064629|FG002|Overall Study|Lost to Follow-up|2|||
131666756|NCT01901341|474064630|FG000|Overall Study|Adverse Event|4|||
131666757|NCT01901341|474064631|FG001|Overall Study|Adverse Event|2|||
131666758|NCT01901341|474064630|FG000|Overall Study|Lack of Efficacy|0|||
131666759|NCT01901341|474064631|FG001|Overall Study|Lack of Efficacy|2|||
131666760|NCT01901341|474064630|FG000|Overall Study|Lost to Follow-up|0|||
131666761|NCT01901341|474064631|FG001|Overall Study|Lost to Follow-up|1|||
131666762|NCT01901341|474064630|FG000|Overall Study|Protocol Violation|2|||
131666763|NCT01901341|474064631|FG001|Overall Study|Protocol Violation|0|||
131666764|NCT01901341|474064630|FG000|Overall Study|Study Terminated by Sponsor|13|||
131666765|NCT01901341|474064631|FG001|Overall Study|Study Terminated by Sponsor|15|||
131666766|NCT01901341|474064630|FG000|Overall Study|Withdrawal by Subject|1|||
131666767|NCT01901341|474064631|FG001|Overall Study|Withdrawal by Subject|1|||
131666768|NCT02966301|474064632|FG000|Overall Study|Death|2|||
131666769|NCT02966301|474064632|FG000|Overall Study|Withdrawal by Subject|1|||
131666770|NCT00370331|474064634|FG000|Overall Study|Adverse Event|4|||
131666771|NCT00370331|474064635|FG001|Overall Study|Adverse Event|13|||
131666772|NCT00370331|474064634|FG000|Overall Study|Withdrawal by Subject|2|||
131666773|NCT00370331|474064635|FG001|Overall Study|Withdrawal by Subject|4|||
131666774|NCT00370331|474064634|FG000|Overall Study|Lost to Follow-up|0|||
131666775|NCT00370331|474064635|FG001|Overall Study|Lost to Follow-up|3|||
131666776|NCT00370331|474064634|FG000|Overall Study|Lack of Efficacy|0|||
131666777|NCT00370331|474064635|FG001|Overall Study|Lack of Efficacy|1|||
131666778|NCT00370331|474064634|FG000|Overall Study|Non-compliance|0|||
131666779|NCT00370331|474064635|FG001|Overall Study|Non-compliance|1|||
131666780|NCT00370331|474064634|FG000|Overall Study|Protocol Violation|1|||
131666781|NCT00370331|474064635|FG001|Overall Study|Protocol Violation|1|||
131666782|NCT01874431|474064636|FG000|Overall Study|Physician Decision|0|||
131666783|NCT01874431|474064637|FG001|Overall Study|Physician Decision|0|||
131666784|NCT01874431|474064638|FG002|Overall Study|Physician Decision|1|||
131666785|NCT01874431|474064639|FG003|Overall Study|Physician Decision|0|||
131666786|NCT01874431|474064640|FG004|Overall Study|Physician Decision|0|||
131666787|NCT01874431|474064641|FG005|Overall Study|Physician Decision|0|||
131666788|NCT01874431|474064642|FG006|Overall Study|Physician Decision|0|||
131666789|NCT01874431|474064643|FG007|Overall Study|Physician Decision|0|||
131666790|NCT01874431|474064636|FG000|Overall Study|Adverse Event|5|||
131666791|NCT01874431|474064637|FG001|Overall Study|Adverse Event|4|||
131666792|NCT01874431|474064638|FG002|Overall Study|Adverse Event|6|||
131666793|NCT01874431|474064639|FG003|Overall Study|Adverse Event|5|||
131666794|NCT01874431|474064640|FG004|Overall Study|Adverse Event|2|||
131666795|NCT01874431|474064641|FG005|Overall Study|Adverse Event|8|||
131666796|NCT01874431|474064642|FG006|Overall Study|Adverse Event|2|||
131666797|NCT01874431|474064643|FG007|Overall Study|Adverse Event|3|||
131666798|NCT01874431|474064636|FG000|Overall Study|Protocol Violation|1|||
131666799|NCT01874431|474064637|FG001|Overall Study|Protocol Violation|1|||
131666800|NCT01874431|474064638|FG002|Overall Study|Protocol Violation|1|||
131666801|NCT01874431|474064639|FG003|Overall Study|Protocol Violation|0|||
131666802|NCT01874431|474064640|FG004|Overall Study|Protocol Violation|3|||
131666803|NCT01874431|474064641|FG005|Overall Study|Protocol Violation|2|||
131666804|NCT01874431|474064642|FG006|Overall Study|Protocol Violation|1|||
131666805|NCT01874431|474064643|FG007|Overall Study|Protocol Violation|1|||
131666806|NCT01874431|474064636|FG000|Overall Study|Non-compliance|0|||
131666807|NCT01874431|474064637|FG001|Overall Study|Non-compliance|0|||
131666808|NCT01874431|474064638|FG002|Overall Study|Non-compliance|0|||
131666809|NCT01874431|474064639|FG003|Overall Study|Non-compliance|0|||
131666810|NCT01874431|474064640|FG004|Overall Study|Non-compliance|1|||
131666811|NCT01874431|474064641|FG005|Overall Study|Non-compliance|0|||
131666812|NCT01874431|474064642|FG006|Overall Study|Non-compliance|1|||
131666813|NCT01874431|474064643|FG007|Overall Study|Non-compliance|0|||
131666814|NCT01874431|474064636|FG000|Overall Study|Logistical difficulties|0|||
131666815|NCT01874431|474064637|FG001|Overall Study|Logistical difficulties|0|||
131666816|NCT01874431|474064638|FG002|Overall Study|Logistical difficulties|0|||
131666817|NCT01874431|474064639|FG003|Overall Study|Logistical difficulties|0|||
131666818|NCT01874431|474064640|FG004|Overall Study|Logistical difficulties|0|||
131666819|NCT01874431|474064641|FG005|Overall Study|Logistical difficulties|0|||
131666820|NCT01874431|474064642|FG006|Overall Study|Logistical difficulties|1|||
131666821|NCT01874431|474064643|FG007|Overall Study|Logistical difficulties|0|||
131666822|NCT01874431|474064636|FG000|Overall Study|Withdrawal by Subject|0|||
131666823|NCT01874431|474064637|FG001|Overall Study|Withdrawal by Subject|0|||
131666824|NCT01874431|474064638|FG002|Overall Study|Withdrawal by Subject|1|||
131666825|NCT01874431|474064639|FG003|Overall Study|Withdrawal by Subject|2|||
131666826|NCT01874431|474064640|FG004|Overall Study|Withdrawal by Subject|1|||
131666827|NCT01874431|474064641|FG005|Overall Study|Withdrawal by Subject|1|||
131666828|NCT01874431|474064642|FG006|Overall Study|Withdrawal by Subject|3|||
131666829|NCT01874431|474064643|FG007|Overall Study|Withdrawal by Subject|0|||
131666830|NCT01874431|474064636|FG000|Overall Study|Sponsor decision|0|||
131666831|NCT01874431|474064637|FG001|Overall Study|Sponsor decision|0|||
131666832|NCT01874431|474064638|FG002|Overall Study|Sponsor decision|0|||
131666833|NCT01874431|474064639|FG003|Overall Study|Sponsor decision|0|||
131666834|NCT01874431|474064640|FG004|Overall Study|Sponsor decision|1|||
131666835|NCT01874431|474064641|FG005|Overall Study|Sponsor decision|0|||
131666836|NCT01874431|474064642|FG006|Overall Study|Sponsor decision|0|||
131666837|NCT01874431|474064643|FG007|Overall Study|Sponsor decision|0|||
131666838|NCT01874431|474064636|FG000|Overall Study|Lost to Follow-up|0|||
131666839|NCT01874431|474064637|FG001|Overall Study|Lost to Follow-up|0|||
131666840|NCT01874431|474064638|FG002|Overall Study|Lost to Follow-up|1|||
131666841|NCT01874431|474064639|FG003|Overall Study|Lost to Follow-up|0|||
131666842|NCT01874431|474064640|FG004|Overall Study|Lost to Follow-up|0|||
131666843|NCT01874431|474064641|FG005|Overall Study|Lost to Follow-up|0|||
131666844|NCT01874431|474064642|FG006|Overall Study|Lost to Follow-up|0|||
131666845|NCT01874431|474064643|FG007|Overall Study|Lost to Follow-up|0|||
131666846|NCT01981473|474064644|FG000|Overall Study|Incorrect diagnosis of RA|0|||
131666847|NCT01981473|474064645|FG001|Overall Study|Incorrect diagnosis of RA|0|||
131666848|NCT01981473|474064646|FG002|Overall Study|Incorrect diagnosis of RA|1|||
131666849|NCT01981473|474064644|FG000|Overall Study|Received treatment for < 6 months|0|||
131666850|NCT01981473|474064645|FG001|Overall Study|Received treatment for < 6 months|0|||
131666851|NCT01981473|474064646|FG002|Overall Study|Received treatment for < 6 months|1|||
131666852|NCT01981473|474064644|FG000|Overall Study|Received treatment for >24 months|2|||
131554317|NCT02200939|473654696|FG001|Overall Study|Lost to Follow-up|9|||
131554318|NCT02200939|473654695|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
131554319|NCT02200939|473654696|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
131554320|NCT02762981|473654697|FG000|Overall Study|Adverse Event|2|||
131554321|NCT02762981|473654698|FG001|Overall Study|Adverse Event|3|||
131554322|NCT02762981|473654699|FG002|Overall Study|Adverse Event|1|||
131554323|NCT02762981|473654700|FG003|Overall Study|Adverse Event|1|||
131554324|NCT02762981|473654701|FG004|Overall Study|Adverse Event|3|||
131554325|NCT02762981|473654697|FG000|Overall Study|Physician Decision|0|||
131554326|NCT02762981|473654698|FG001|Overall Study|Physician Decision|1|||
131554327|NCT02762981|473654699|FG002|Overall Study|Physician Decision|0|||
131554328|NCT02762981|473654700|FG003|Overall Study|Physician Decision|0|||
131554329|NCT02762981|473654701|FG004|Overall Study|Physician Decision|1|||
131554330|NCT02762981|473654697|FG000|Overall Study|Disease progression|11|||
131554331|NCT02762981|473654698|FG001|Overall Study|Disease progression|23|||
131554332|NCT02762981|473654699|FG002|Overall Study|Disease progression|4|||
131554333|NCT02762981|473654700|FG003|Overall Study|Disease progression|10|||
131554334|NCT02762981|473654701|FG004|Overall Study|Disease progression|1|||
131554335|NCT02762981|473654697|FG000|Overall Study|Enrolled not treated|1|||
131554336|NCT02762981|473654698|FG001|Overall Study|Enrolled not treated|5|||
131554337|NCT02762981|473654699|FG002|Overall Study|Enrolled not treated|0|||
131554338|NCT02762981|473654700|FG003|Overall Study|Enrolled not treated|2|||
131554339|NCT02762981|473654701|FG004|Overall Study|Enrolled not treated|0|||
131554340|NCT02762981|473654697|FG000|Overall Study|Other|2|||
131554341|NCT02762981|473654698|FG001|Overall Study|Other|3|||
131554342|NCT02762981|473654699|FG002|Overall Study|Other|1|||
131554343|NCT02762981|473654700|FG003|Overall Study|Other|0|||
131554344|NCT02762981|473654701|FG004|Overall Study|Other|0|||
131666853|NCT01981473|474064645|FG001|Overall Study|Received treatment for >24 months|0|||
131666854|NCT01981473|474064646|FG002|Overall Study|Received treatment for >24 months|6|||
131666855|NCT01888900|474064649|FG000|Overall Study|failed treatment|0|||
131666856|NCT01888900|474064650|FG001|Overall Study|failed treatment|2|||
131666857|NCT02257567|474064652|FG000|Overall Study|Adverse Event|0|||
131554345|NCT02762981|473654697|FG000|Overall Study|Missing|1|||
131554346|NCT02762981|473654698|FG001|Overall Study|Missing|0|||
131554347|NCT02762981|473654699|FG002|Overall Study|Missing|0|||
131896610|NCT03300180|474906963|FG002|6 Month Outcome|Death|3|||
131896611|NCT03300180|474906961|FG000|6 Month Outcome|Missed Assessment|43|||
131554348|NCT02762981|473654700|FG003|Overall Study|Missing|0|||
131554349|NCT02762981|473654701|FG004|Overall Study|Missing|0|||
131554350|NCT02762981|473654697|FG000|Overall Study|Withdrawal by Subject|0|||
131554351|NCT02762981|473654698|FG001|Overall Study|Withdrawal by Subject|5|||
131554352|NCT02762981|473654699|FG002|Overall Study|Withdrawal by Subject|1|||
131554353|NCT02762981|473654700|FG003|Overall Study|Withdrawal by Subject|3|||
131554354|NCT02762981|473654701|FG004|Overall Study|Withdrawal by Subject|0|||
131554355|NCT03239873|473654702|FG000|Overall Study|Lost to Follow-up|15|||
131554356|NCT03239873|473654703|FG001|Overall Study|Lost to Follow-up|16|||
131554357|NCT03239873|473654702|FG000|Overall Study|Physician Decision|1|||
131554358|NCT03239873|473654703|FG001|Overall Study|Physician Decision|0|||
131554359|NCT03239873|473654702|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
131554360|NCT03239873|473654703|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
131554361|NCT03239873|473654702|FG000|Overall Study|Withdrawal by Subject|2|||
131554362|NCT03239873|473654703|FG001|Overall Study|Withdrawal by Subject|0|||
131554363|NCT03239873|473654702|FG000|Overall Study|Contraindication to study medication|1|||
131554364|NCT03239873|473654703|FG001|Overall Study|Contraindication to study medication|0|||
131554365|NCT03239873|473654702|FG000|Overall Study|Protocol Violation|1|||
131554366|NCT03239873|473654703|FG001|Overall Study|Protocol Violation|0|||
131554367|NCT00605319|473654708|FG000|Overall Study|Adverse Event|6|||
131554368|NCT01250119|473654709|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
131554369|NCT01250119|473654710|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
131554370|NCT01250119|473654709|FG000|Diagnostic Phase|Participants Not Tested|44|||
131554371|NCT01250119|473654710|FG001|Diagnostic Phase|Participants Not Tested|0|||
131554372|NCT01250119|473654709|FG000|Treatment Phase|Progressive Disease|0|||
131554373|NCT01250119|473654710|FG001|Treatment Phase|Progressive Disease|32|||
131554374|NCT01250119|473654709|FG000|Treatment Phase|Death|0|||
131554375|NCT01250119|473654710|FG001|Treatment Phase|Death|2|||
131554376|NCT01250119|473654709|FG000|Treatment Phase|Withdrawal by Subject|0|||
131554377|NCT01250119|473654710|FG001|Treatment Phase|Withdrawal by Subject|1|||
131554378|NCT01250119|473654709|FG000|Treatment Phase|Adverse Event|0|||
131554379|NCT01250119|473654710|FG001|Treatment Phase|Adverse Event|2|||
131554380|NCT01250119|473654709|FG000|Treatment Phase|Unknown reason|0|||
131554381|NCT01250119|473654710|FG001|Treatment Phase|Unknown reason|4|||
131554382|NCT02670538|473654711|FG000|Overall Study|Withdrawal of Consent|8|||
131554383|NCT02670538|473654712|FG001|Overall Study|Withdrawal of Consent|6|||
131554384|NCT02670538|473654713|FG002|Overall Study|Withdrawal of Consent|5|||
131554385|NCT02670538|473654711|FG000|Overall Study|Lost to Follow-up|8|||
131554386|NCT02670538|473654712|FG001|Overall Study|Lost to Follow-up|12|||
131554387|NCT02670538|473654713|FG002|Overall Study|Lost to Follow-up|7|||
131554388|NCT02670538|473654711|FG000|Overall Study|Adverse Event|5|||
131554389|NCT02670538|473654712|FG001|Overall Study|Adverse Event|5|||
131554390|NCT02670538|473654713|FG002|Overall Study|Adverse Event|11|||
131554391|NCT02670538|473654711|FG000|Overall Study|Lack of Efficacy|7|||
131554392|NCT02670538|473654712|FG001|Overall Study|Lack of Efficacy|1|||
131554393|NCT02670538|473654713|FG002|Overall Study|Lack of Efficacy|2|||
131554394|NCT02670538|473654711|FG000|Overall Study|Protocol Violation|3|||
131554395|NCT02670538|473654712|FG001|Overall Study|Protocol Violation|4|||
131554396|NCT02670538|473654713|FG002|Overall Study|Protocol Violation|1|||
131554397|NCT02670538|473654711|FG000|Overall Study|Noncompliance with Study Drug|1|||
131554398|NCT02670538|473654712|FG001|Overall Study|Noncompliance with Study Drug|3|||
131554399|NCT02670538|473654713|FG002|Overall Study|Noncompliance with Study Drug|2|||
131554400|NCT02670538|473654711|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131554401|NCT02670538|473654712|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131554402|NCT02670538|473654713|FG002|Overall Study|Other Miscellaneous Reasons|2|||
131554403|NCT02887989|473654717|FG000|Overall Study|Withdrawal by Subject|8|||
131554404|NCT02887989|473654718|FG001|Overall Study|Withdrawal by Subject|11|||
131554405|NCT02887989|473654717|FG000|Overall Study|Death|1|||
131554406|NCT02887989|473654718|FG001|Overall Study|Death|0|||
131554407|NCT02176421|473654719|FG000|Overall Study|Lost to Follow-up|4|||
131554408|NCT02176421|473654719|FG000|Overall Study|Adverse Event|1|||
131554409|NCT00584805|473654722|FG000|Overall Study|No longer at risk of exposure|39|||
131554410|NCT00584805|473654722|FG000|Overall Study|Relocation|36|||
131554411|NCT00584805|473654722|FG000|Overall Study|Withdrawal by Subject|18|||
131554412|NCT00584805|473654722|FG000|Overall Study|Non-compliance|1|||
131554413|NCT00584805|473654722|FG000|Overall Study|Lost to follow up|3|||
131554414|NCT00584805|473654722|FG000|Overall Study|Screen failures|2|||
131554415|NCT01077362|473654726|FG000|Overall Study|Lack of Efficacy|13|||
131554416|NCT01077362|473654727|FG001|Overall Study|Lack of Efficacy|8|||
131554417|NCT01077362|473654728|FG002|Overall Study|Lack of Efficacy|10|||
131554418|NCT01077362|473654726|FG000|Overall Study|Lost to Follow-up|1|||
131554419|NCT01077362|473654727|FG001|Overall Study|Lost to Follow-up|0|||
131554420|NCT01077362|473654728|FG002|Overall Study|Lost to Follow-up|3|||
131554421|NCT01077362|473654726|FG000|Overall Study|Adverse Event|12|||
131554422|NCT01077362|473654727|FG001|Overall Study|Adverse Event|7|||
131554423|NCT01077362|473654728|FG002|Overall Study|Adverse Event|4|||
131666858|NCT02257567|474064653|FG001|Overall Study|Adverse Event|0|||
131666859|NCT02257567|474064654|FG002|Overall Study|Adverse Event|0|||
131666860|NCT02257567|474064655|FG003|Overall Study|Adverse Event|1|||
131666861|NCT02257567|474064656|FG004|Overall Study|Adverse Event|1|||
131666862|NCT02257567|474064657|FG005|Overall Study|Adverse Event|0|||
131666863|NCT02257567|474064658|FG006|Overall Study|Adverse Event|0|||
131666864|NCT02257567|474064659|FG007|Overall Study|Adverse Event|0|||
131666865|NCT02257567|474064660|FG008|Overall Study|Adverse Event|1|||
131666866|NCT02257567|474064661|FG009|Overall Study|Adverse Event|0|||
131666867|NCT02257567|474064662|FG010|Overall Study|Adverse Event|0|||
131666868|NCT02257567|474064652|FG000|Overall Study|Death|2|||
131666869|NCT02257567|474064653|FG001|Overall Study|Death|2|||
131666870|NCT02257567|474064654|FG002|Overall Study|Death|2|||
131666871|NCT02257567|474064655|FG003|Overall Study|Death|4|||
131666872|NCT02257567|474064656|FG004|Overall Study|Death|15|||
131666873|NCT02257567|474064657|FG005|Overall Study|Death|11|||
131666874|NCT02257567|474064658|FG006|Overall Study|Death|26|||
131666875|NCT02257567|474064659|FG007|Overall Study|Death|30|||
131666876|NCT02257567|474064660|FG008|Overall Study|Death|2|||
131666877|NCT02257567|474064661|FG009|Overall Study|Death|18|||
131666878|NCT02257567|474064662|FG010|Overall Study|Death|65|||
131666879|NCT02257567|474064652|FG000|Overall Study|Lost to Follow-up|0|||
131666880|NCT02257567|474064653|FG001|Overall Study|Lost to Follow-up|0|||
131666881|NCT02257567|474064654|FG002|Overall Study|Lost to Follow-up|0|||
131666882|NCT02257567|474064655|FG003|Overall Study|Lost to Follow-up|0|||
131666883|NCT02257567|474064656|FG004|Overall Study|Lost to Follow-up|2|||
131666884|NCT02257567|474064657|FG005|Overall Study|Lost to Follow-up|2|||
131666885|NCT02257567|474064658|FG006|Overall Study|Lost to Follow-up|0|||
131666886|NCT02257567|474064659|FG007|Overall Study|Lost to Follow-up|0|||
131666887|NCT02257567|474064660|FG008|Overall Study|Lost to Follow-up|0|||
131666888|NCT02257567|474064661|FG009|Overall Study|Lost to Follow-up|1|||
131666889|NCT02257567|474064662|FG010|Overall Study|Lost to Follow-up|1|||
131666890|NCT02257567|474064652|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666891|NCT02257567|474064653|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666892|NCT02257567|474064654|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666893|NCT02257567|474064655|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666894|NCT02257567|474064656|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
131666895|NCT02257567|474064657|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666896|NCT02257567|474064658|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
131666897|NCT02257567|474064659|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666898|NCT02257567|474064660|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666899|NCT02257567|474064661|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666900|NCT02257567|474064662|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131666901|NCT02257567|474064652|FG000|Overall Study|Physician Decision|0|||
131666902|NCT02257567|474064653|FG001|Overall Study|Physician Decision|0|||
131666903|NCT02257567|474064654|FG002|Overall Study|Physician Decision|0|||
131666904|NCT02257567|474064655|FG003|Overall Study|Physician Decision|0|||
131666905|NCT02257567|474064656|FG004|Overall Study|Physician Decision|0|||
131666906|NCT02257567|474064657|FG005|Overall Study|Physician Decision|0|||
131666907|NCT02257567|474064658|FG006|Overall Study|Physician Decision|0|||
131666908|NCT02257567|474064659|FG007|Overall Study|Physician Decision|2|||
131666909|NCT02257567|474064660|FG008|Overall Study|Physician Decision|0|||
131666910|NCT02257567|474064661|FG009|Overall Study|Physician Decision|1|||
131666911|NCT02257567|474064662|FG010|Overall Study|Physician Decision|0|||
131666912|NCT02257567|474064652|FG000|Overall Study|Withdrawal by Subject|0|||
131666913|NCT02257567|474064653|FG001|Overall Study|Withdrawal by Subject|0|||
131666914|NCT02257567|474064654|FG002|Overall Study|Withdrawal by Subject|2|||
131666915|NCT02257567|474064655|FG003|Overall Study|Withdrawal by Subject|0|||
131666916|NCT02257567|474064656|FG004|Overall Study|Withdrawal by Subject|0|||
131666917|NCT02257567|474064657|FG005|Overall Study|Withdrawal by Subject|6|||
131666918|NCT02257567|474064658|FG006|Overall Study|Withdrawal by Subject|6|||
131666919|NCT02257567|474064659|FG007|Overall Study|Withdrawal by Subject|6|||
131666920|NCT02257567|474064660|FG008|Overall Study|Withdrawal by Subject|1|||
131666921|NCT02257567|474064661|FG009|Overall Study|Withdrawal by Subject|1|||
131666922|NCT02257567|474064662|FG010|Overall Study|Withdrawal by Subject|10|||
131666923|NCT01065844|474064671|FG000|Overall Study|Adverse Event|5|||
131666924|NCT00190749|474064677|FG000|Overall Study|Lost to Follow-up|8|||
131666925|NCT00190749|474064678|FG001|Overall Study|Lost to Follow-up|11|||
131666926|NCT00190749|474064677|FG000|Overall Study|Withdrawal by Subject|10|||
131666927|NCT00190749|474064678|FG001|Overall Study|Withdrawal by Subject|6|||
131666928|NCT00190749|474064677|FG000|Overall Study|Protocol Violation|5|||
131666929|NCT00190749|474064678|FG001|Overall Study|Protocol Violation|4|||
131666930|NCT00190749|474064677|FG000|Overall Study|Adverse Event|0|||
131666931|NCT00190749|474064678|FG001|Overall Study|Adverse Event|5|||
131666932|NCT00190749|474064677|FG000|Overall Study|Lack of Efficacy|2|||
131666933|NCT00190749|474064678|FG001|Overall Study|Lack of Efficacy|3|||
131666934|NCT00190749|474064677|FG000|Overall Study|Reason Not Specified|0|||
131666935|NCT00190749|474064678|FG001|Overall Study|Reason Not Specified|2|||
131666936|NCT00190749|474064677|FG000|Overall Study|Sponsor Decision|1|||
131666937|NCT00190749|474064678|FG001|Overall Study|Sponsor Decision|0|||
131666938|NCT01154010|474064679|FG000|Overall Study|Lost to Follow-up|0|||
131666939|NCT01154010|474064680|FG001|Overall Study|Lost to Follow-up|1|||
131666940|NCT00439231|474064681|FG000|Overall Study|Lack of Efficacy|28|||
131666941|NCT01465347|474064682|FG000|Overall Study|Withdrawal by Subject|1|||
131666942|NCT01465347|474064683|FG001|Overall Study|Withdrawal by Subject|1|||
131666943|NCT01465347|474064682|FG000|Overall Study|Physician Decision|0|||
131666944|NCT01465347|474064683|FG001|Overall Study|Physician Decision|1|||
131666945|NCT01465347|474064682|FG000|Overall Study|Admitted to hospice|0|||
131666946|NCT01465347|474064683|FG001|Overall Study|Admitted to hospice|1|||
131666947|NCT03814187|474064684|FG000|Overall Study|Sponsor's Administrative Decision|0|||
131666948|NCT03814187|474064685|FG001|Overall Study|Sponsor's Administrative Decision|0|||
131666949|NCT03814187|474064686|FG002|Overall Study|Sponsor's Administrative Decision|272|||
131666950|NCT03814187|474064684|FG000|Overall Study|Death|80|||
131666951|NCT03814187|474064685|FG001|Overall Study|Death|81|||
131666952|NCT03814187|474064686|FG002|Overall Study|Death|4|||
131666953|NCT03814187|474064684|FG000|Overall Study|Withdrew Consent|77|||
131666954|NCT03814187|474064685|FG001|Overall Study|Withdrew Consent|78|||
131666955|NCT03814187|474064686|FG002|Overall Study|Withdrew Consent|2|||
131666956|NCT03814187|474064684|FG000|Overall Study|Lost to Follow-up|47|||
131666957|NCT03814187|474064685|FG001|Overall Study|Lost to Follow-up|52|||
131666958|NCT03814187|474064686|FG002|Overall Study|Lost to Follow-up|1|||
131666959|NCT03814187|474064684|FG000|Overall Study|Adverse Event|22|||
131666960|NCT03814187|474064685|FG001|Overall Study|Adverse Event|23|||
131666961|NCT03814187|474064686|FG002|Overall Study|Adverse Event|0|||
131666962|NCT03814187|474064684|FG000|Overall Study|Physician Decision|7|||
131666963|NCT03814187|474064685|FG001|Overall Study|Physician Decision|4|||
131666964|NCT03814187|474064686|FG002|Overall Study|Physician Decision|2|||
131666965|NCT03814187|474064684|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
131666966|NCT03814187|474064685|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
131666967|NCT03814187|474064686|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
131666968|NCT03814187|474064684|FG000|Overall Study|Other reasons|34|||
131666969|NCT03814187|474064685|FG001|Overall Study|Other reasons|40|||
131666970|NCT03814187|474064686|FG002|Overall Study|Other reasons|2|||
131666971|NCT00825825|474064688|FG000|First Medication Period (14 Days)|Adverse Event|1|||
131666972|NCT00825825|474064689|FG001|First Medication Period (14 Days)|Adverse Event|0|||
131666973|NCT00825825|474064690|FG002|First Medication Period (14 Days)|Adverse Event|0|||
131666974|NCT00825825|474064691|FG003|First Medication Period (14 Days)|Adverse Event|0|||
131666975|NCT00825825|474064692|FG004|First Medication Period (14 Days)|Adverse Event|0|||
131666976|NCT00825825|474064693|FG005|First Medication Period (14 Days)|Adverse Event|1|||
131666977|NCT00825825|474064688|FG000|First Medication Period (14 Days)|Physician Decision|2|||
131666978|NCT00825825|474064689|FG001|First Medication Period (14 Days)|Physician Decision|0|||
131666979|NCT00825825|474064690|FG002|First Medication Period (14 Days)|Physician Decision|1|||
131666980|NCT00825825|474064691|FG003|First Medication Period (14 Days)|Physician Decision|0|||
131666981|NCT00825825|474064692|FG004|First Medication Period (14 Days)|Physician Decision|0|||
131666982|NCT00825825|474064693|FG005|First Medication Period (14 Days)|Physician Decision|1|||
131666983|NCT00825825|474064688|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
131666984|NCT00825825|474064689|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
131666985|NCT00825825|474064690|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
131666986|NCT00825825|474064691|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
131666987|NCT00825825|474064692|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
131666988|NCT00825825|474064693|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
131666989|NCT00825825|474064688|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
131666990|NCT00825825|474064689|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
131666991|NCT00825825|474064690|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
131666992|NCT00825825|474064691|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
131666993|NCT00825825|474064692|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
131666994|NCT00825825|474064693|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
131666995|NCT00825825|474064688|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
131666996|NCT00825825|474064689|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
131666997|NCT00825825|474064690|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
131435969|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
131554424|NCT01077362|473654726|FG000|Overall Study|Withdrawal by Subject|5|||
131554425|NCT01077362|473654727|FG001|Overall Study|Withdrawal by Subject|3|||
131554426|NCT01077362|473654728|FG002|Overall Study|Withdrawal by Subject|5|||
131554427|NCT01077362|473654726|FG000|Overall Study|Other|0|||
131554428|NCT01077362|473654727|FG001|Overall Study|Other|1|||
131554429|NCT01077362|473654728|FG002|Overall Study|Other|2|||
131554430|NCT00301080|473654729|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
131554431|NCT00301080|473654730|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
131554432|NCT00301080|473654731|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
131554433|NCT00301080|473654732|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
131554434|NCT00301080|473654733|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
131554435|NCT01641926|473654734|FG000|Overall Study|Adverse Event|5|||
131554436|NCT01641926|473654735|FG001|Overall Study|Adverse Event|2|||
131554437|NCT01641926|473654736|FG002|Overall Study|Adverse Event|3|||
131554438|NCT01641926|473654737|FG003|Overall Study|Adverse Event|1|||
131554439|NCT01641926|473654734|FG000|Overall Study|Lost to Follow-up|2|||
131554440|NCT01641926|473654735|FG001|Overall Study|Lost to Follow-up|2|||
131554441|NCT01641926|473654736|FG002|Overall Study|Lost to Follow-up|1|||
131554442|NCT01641926|473654737|FG003|Overall Study|Lost to Follow-up|0|||
131554443|NCT01641926|473654734|FG000|Overall Study|Physician Decision|6|||
131554444|NCT01641926|473654735|FG001|Overall Study|Physician Decision|5|||
131554445|NCT01641926|473654736|FG002|Overall Study|Physician Decision|0|||
131554446|NCT01641926|473654737|FG003|Overall Study|Physician Decision|1|||
131554447|NCT01641926|473654734|FG000|Overall Study|Protocol Violation|1|||
131554448|NCT01641926|473654735|FG001|Overall Study|Protocol Violation|0|||
131554449|NCT01641926|473654736|FG002|Overall Study|Protocol Violation|0|||
131554450|NCT01641926|473654737|FG003|Overall Study|Protocol Violation|1|||
131554451|NCT01641926|473654734|FG000|Overall Study|Withdrawal by Subject|13|||
131554452|NCT01641926|473654735|FG001|Overall Study|Withdrawal by Subject|5|||
131554453|NCT01641926|473654736|FG002|Overall Study|Withdrawal by Subject|6|||
131554454|NCT01641926|473654737|FG003|Overall Study|Withdrawal by Subject|1|||
131554455|NCT01641926|473654734|FG000|Overall Study|Not Treated|1|||
131554456|NCT01641926|473654735|FG001|Overall Study|Not Treated|1|||
131554457|NCT01641926|473654736|FG002|Overall Study|Not Treated|1|||
131554458|NCT01641926|473654737|FG003|Overall Study|Not Treated|0|||
131554459|NCT02567825|473654744|FG000|Overall Study|No follow-up post-randomization|5|||
131554460|NCT02567825|473654745|FG001|Overall Study|No follow-up post-randomization|1|||
131554461|NCT02567825|473654744|FG000|Overall Study|Follow-up less than 23 months|16|||
131554462|NCT02567825|473654745|FG001|Overall Study|Follow-up less than 23 months|20|||
131554463|NCT01540565|473654747|FG000|Overall Study|Ineligible|2|||
131554464|NCT04041440|473654748|FG000|Overall Study|Withdrawal by Subject|0|||
131554465|NCT04041440|473654749|FG001|Overall Study|Withdrawal by Subject|1|||
131554466|NCT04041440|473654748|FG000|Overall Study|Lost to Follow-up|0|||
131554467|NCT04041440|473654749|FG001|Overall Study|Lost to Follow-up|1|||
131554468|NCT02247804|473654754|FG000|Treatment Period 1|Adverse Event|9|||
131554469|NCT02247804|473654755|FG001|Treatment Period 1|Adverse Event|2|||
131554470|NCT02247804|473654756|FG002|Treatment Period 1|Adverse Event|0|||
131554471|NCT02247804|473654754|FG000|Treatment Period 1|Lack of Efficacy|0|||
131554472|NCT02247804|473654755|FG001|Treatment Period 1|Lack of Efficacy|0|||
131554473|NCT02247804|473654756|FG002|Treatment Period 1|Lack of Efficacy|2|||
131554474|NCT02247804|473654754|FG000|Treatment Period 1|Lost to Follow-up|1|||
131554475|NCT02247804|473654755|FG001|Treatment Period 1|Lost to Follow-up|0|||
131554476|NCT02247804|473654756|FG002|Treatment Period 1|Lost to Follow-up|2|||
131554477|NCT02247804|473654754|FG000|Treatment Period 1|Personal Reasons|7|||
131554478|NCT02247804|473654755|FG001|Treatment Period 1|Personal Reasons|1|||
131554479|NCT02247804|473654756|FG002|Treatment Period 1|Personal Reasons|2|||
131554480|NCT02247804|473654754|FG000|Treatment Period 1|Protocol Deviation|0|||
131554481|NCT02247804|473654755|FG001|Treatment Period 1|Protocol Deviation|0|||
131554482|NCT02247804|473654756|FG002|Treatment Period 1|Protocol Deviation|1|||
131554483|NCT02247804|473654754|FG000|Treatment Period 1|Randomized but not Treated|5|||
131554484|NCT02247804|473654755|FG001|Treatment Period 1|Randomized but not Treated|1|||
131554485|NCT02247804|473654756|FG002|Treatment Period 1|Randomized but not Treated|1|||
131554486|NCT02247804|473654754|FG000|Treatment Period 2|Adverse Event|6|||
131554487|NCT02247804|473654755|FG001|Treatment Period 2|Adverse Event|3|||
131554488|NCT02247804|473654756|FG002|Treatment Period 2|Adverse Event|3|||
131554489|NCT02247804|473654754|FG000|Treatment Period 2|Lack of Efficacy|0|||
131554490|NCT02247804|473654755|FG001|Treatment Period 2|Lack of Efficacy|0|||
131554491|NCT02247804|473654756|FG002|Treatment Period 2|Lack of Efficacy|1|||
131554492|NCT02247804|473654754|FG000|Treatment Period 2|Lost to Follow-up|0|||
131554493|NCT02247804|473654755|FG001|Treatment Period 2|Lost to Follow-up|1|||
131554494|NCT02247804|473654756|FG002|Treatment Period 2|Lost to Follow-up|1|||
131554495|NCT02247804|473654754|FG000|Treatment Period 2|Personal Reasons|2|||
131554496|NCT02247804|473654755|FG001|Treatment Period 2|Personal Reasons|1|||
131666998|NCT00825825|474064691|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
131666999|NCT00825825|474064692|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
131667000|NCT00825825|474064693|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
131667001|NCT00825825|474064688|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
131667002|NCT00825825|474064689|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
131667003|NCT00825825|474064690|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
131667004|NCT00825825|474064691|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
131667005|NCT00825825|474064692|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
131667006|NCT00825825|474064693|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
131667007|NCT00825825|474064688|FG000|Third Medication Period (14 Days)|poor data quality|0|||
131667008|NCT00825825|474064689|FG001|Third Medication Period (14 Days)|poor data quality|1|||
131667009|NCT00825825|474064690|FG002|Third Medication Period (14 Days)|poor data quality|0|||
131667010|NCT00825825|474064691|FG003|Third Medication Period (14 Days)|poor data quality|0|||
131667011|NCT00825825|474064692|FG004|Third Medication Period (14 Days)|poor data quality|0|||
131667012|NCT00825825|474064693|FG005|Third Medication Period (14 Days)|poor data quality|0|||
131667013|NCT01920854|474064695|FG000|Overall Study|Withdrawal by Subject|1|||
131667014|NCT01920854|474064696|FG001|Overall Study|Withdrawal by Subject|0|||
131667015|NCT01920854|474064697|FG002|Overall Study|Withdrawal by Subject|0|||
131667016|NCT01920854|474064698|FG003|Overall Study|Withdrawal by Subject|0|||
131667017|NCT01920854|474064699|FG004|Overall Study|Withdrawal by Subject|1|||
131667018|NCT01920854|474064700|FG005|Overall Study|Withdrawal by Subject|0|||
131667019|NCT01920854|474064701|FG006|Overall Study|Withdrawal by Subject|1|||
131667020|NCT00757783|474064702|FG000|Overall Study|Adverse Event|0|||
131667021|NCT00757783|474064703|FG001|Overall Study|Adverse Event|2|||
131667022|NCT00757783|474064702|FG000|Overall Study|Lost to Follow-up|1|||
131667023|NCT00757783|474064703|FG001|Overall Study|Lost to Follow-up|1|||
131667024|NCT00757783|474064702|FG000|Overall Study|Protocol Violation|1|||
131667025|NCT00757783|474064703|FG001|Overall Study|Protocol Violation|0|||
131667026|NCT00757783|474064702|FG000|Overall Study|Withdrawal by Subject|2|||
131667027|NCT00757783|474064703|FG001|Overall Study|Withdrawal by Subject|1|||
131667028|NCT00757783|474064702|FG000|Overall Study|Other|1|||
131667029|NCT00757783|474064703|FG001|Overall Study|Other|2|||
131667030|NCT02008877|474064709|FG000|Overall Study|Inevaluable|0|||
131667031|NCT02008877|474064710|FG001|Overall Study|Inevaluable|1|||
131667032|NCT02008877|474064711|FG002|Overall Study|Inevaluable|0|||
131667033|NCT01049217|474064712|FG000|Overall Study|Adverse Event|2|||
131667034|NCT01049217|474064713|FG001|Overall Study|Adverse Event|1|||
131667035|NCT01049217|474064712|FG000|Overall Study|Lack of Efficacy|1|||
131667036|NCT01049217|474064713|FG001|Overall Study|Lack of Efficacy|1|||
131667037|NCT01049217|474064712|FG000|Overall Study|Lost to Follow-up|3|||
131667038|NCT01049217|474064713|FG001|Overall Study|Lost to Follow-up|8|||
131667039|NCT01049217|474064712|FG000|Overall Study|Withdrawal by Subject|4|||
131667040|NCT01049217|474064713|FG001|Overall Study|Withdrawal by Subject|3|||
131667041|NCT01049217|474064712|FG000|Overall Study|Protocol Violation|1|||
131667042|NCT01049217|474064713|FG001|Overall Study|Protocol Violation|3|||
131667043|NCT01049217|474064712|FG000|Overall Study|Pregnancy|1|||
131667044|NCT01049217|474064713|FG001|Overall Study|Pregnancy|0|||
131667045|NCT01049217|474064712|FG000|Overall Study|Study Terminated by Sponsor|43|||
131667046|NCT01049217|474064713|FG001|Overall Study|Study Terminated by Sponsor|43|||
131667047|NCT01049217|474064712|FG000|Overall Study|Other|1|||
131667048|NCT01049217|474064713|FG001|Overall Study|Other|2|||
131667049|NCT01049217|474064712|FG000|Overall Study|Randomized but not Treated|0|||
131667050|NCT01049217|474064713|FG001|Overall Study|Randomized but not Treated|2|||
131667051|NCT02412371|474064714|FG000|Overall Study|Withdrawal by Subject|0|||
131667052|NCT02412371|474064715|FG001|Overall Study|Withdrawal by Subject|2|||
131667053|NCT02412371|474064716|FG002|Overall Study|Withdrawal by Subject|0|||
131667054|NCT02412371|474064717|FG003|Overall Study|Withdrawal by Subject|1|||
131667055|NCT02412371|474064718|FG004|Overall Study|Withdrawal by Subject|1|||
131667056|NCT02412371|474064719|FG005|Overall Study|Withdrawal by Subject|0|||
131667057|NCT02412371|474064714|FG000|Overall Study|Sponsor Discontinued Study|1|||
131667058|NCT02412371|474064715|FG001|Overall Study|Sponsor Discontinued Study|4|||
131667059|NCT02412371|474064716|FG002|Overall Study|Sponsor Discontinued Study|6|||
131667060|NCT02412371|474064717|FG003|Overall Study|Sponsor Discontinued Study|4|||
131667061|NCT02412371|474064718|FG004|Overall Study|Sponsor Discontinued Study|5|||
131667062|NCT02412371|474064719|FG005|Overall Study|Sponsor Discontinued Study|0|||
131667063|NCT02412371|474064714|FG000|Overall Study|Death|4|||
131667064|NCT02412371|474064715|FG001|Overall Study|Death|2|||
131667065|NCT02412371|474064716|FG002|Overall Study|Death|1|||
131667066|NCT02412371|474064717|FG003|Overall Study|Death|3|||
131667067|NCT02412371|474064718|FG004|Overall Study|Death|5|||
131667068|NCT02412371|474064719|FG005|Overall Study|Death|2|||
131667069|NCT02412371|474064714|FG000|Overall Study|Other|2|||
131667070|NCT02412371|474064715|FG001|Overall Study|Other|1|||
131667071|NCT02412371|474064716|FG002|Overall Study|Other|0|||
131667072|NCT02412371|474064717|FG003|Overall Study|Other|0|||
131667073|NCT02412371|474064718|FG004|Overall Study|Other|1|||
131667074|NCT02412371|474064719|FG005|Overall Study|Other|3|||
131667075|NCT02495792|474064720|FG000|Overall Study|Lost to Follow-up|5|||
131667076|NCT02495792|474064721|FG001|Overall Study|Lost to Follow-up|9|||
131667077|NCT02495792|474064720|FG000|Overall Study|Protocol Violation|32|||
131667078|NCT02495792|474064721|FG001|Overall Study|Protocol Violation|31|||
131667079|NCT02053792|474064722|FG000|Overall Study|Physician Decision|0|||
131667080|NCT02053792|474064723|FG001|Overall Study|Physician Decision|1|||
131667081|NCT02053792|474064722|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
131667082|NCT02053792|474064723|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
131667083|NCT02053792|474064722|FG000|Overall Study|Lack of Efficacy|1|||
131667084|NCT02053792|474064723|FG001|Overall Study|Lack of Efficacy|0|||
131667085|NCT02053792|474064722|FG000|Overall Study|Adverse Event|1|||
131667086|NCT02053792|474064723|FG001|Overall Study|Adverse Event|0|||
131667087|NCT02053792|474064722|FG000|Overall Study|Withdrawal by Subject|2|||
131667088|NCT02053792|474064723|FG001|Overall Study|Withdrawal by Subject|2|||
131667089|NCT02053792|474064722|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
131667090|NCT02053792|474064723|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
131667091|NCT02053792|474064722|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
131667092|NCT02053792|474064723|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
131667093|NCT01028027|474064724|FG000|Overall Study|Lost to Follow-up|4|||
131667094|NCT01028027|474064725|FG001|Overall Study|Lost to Follow-up|1|||
131667095|NCT01028027|474064724|FG000|Overall Study|Withdrawal by Subject|5|||
131667096|NCT01028027|474064725|FG001|Overall Study|Withdrawal by Subject|3|||
131667097|NCT01028027|474064724|FG000|Overall Study|Adverse Event|4|||
131667098|NCT01028027|474064725|FG001|Overall Study|Adverse Event|7|||
131667099|NCT01028027|474064724|FG000|Overall Study|Protocol Violation|3|||
131667100|NCT01028027|474064725|FG001|Overall Study|Protocol Violation|1|||
131667101|NCT01028027|474064724|FG000|Overall Study|Lack of Efficacy|0|||
131667102|NCT01028027|474064725|FG001|Overall Study|Lack of Efficacy|1|||
131667103|NCT03149549|474064726|FG000|Study Discontinuation--Treatment Period|Death|0|||
131667104|NCT03149549|474064727|FG001|Study Discontinuation--Treatment Period|Death|0|||
131667105|NCT03149549|474064728|FG002|Study Discontinuation--Treatment Period|Death|0|||
131667106|NCT03149549|474064729|FG003|Study Discontinuation--Treatment Period|Death|1|||
131667107|NCT03149549|474064730|FG004|Study Discontinuation--Treatment Period|Death|2|||
131667108|NCT03149549|474064731|FG005|Study Discontinuation--Treatment Period|Death|1|||
131667109|NCT03149549|474064732|FG006|Study Discontinuation--Treatment Period|Death|1|||
131667110|NCT03149549|474064733|FG007|Study Discontinuation--Treatment Period|Death|2|||
131667111|NCT03149549|474064734|FG008|Study Discontinuation--Treatment Period|Death|4|||
131667112|NCT03149549|474064735|FG009|Study Discontinuation--Treatment Period|Death|1|||
131667113|NCT03149549|474064736|FG010|Study Discontinuation--Treatment Period|Death|0|||
131667114|NCT03149549|474064737|FG011|Study Discontinuation--Treatment Period|Death|0|||
131554497|NCT02247804|473654756|FG002|Treatment Period 2|Personal Reasons|1|||
131554498|NCT02247804|473654754|FG000|Treatment Period 2|Reason not Specified|0|||
131554499|NCT02247804|473654755|FG001|Treatment Period 2|Reason not Specified|0|||
131554500|NCT02247804|473654756|FG002|Treatment Period 2|Reason not Specified|2|||
131554501|NCT02247804|473654754|FG000|Treatment Period 3|Adverse Event|4|||
131554502|NCT02247804|473654755|FG001|Treatment Period 3|Adverse Event|3|||
131554503|NCT02247804|473654756|FG002|Treatment Period 3|Adverse Event|3|||
131554504|NCT02247804|473654754|FG000|Treatment Period 3|Lack of Efficacy|0|||
131554505|NCT02247804|473654755|FG001|Treatment Period 3|Lack of Efficacy|1|||
131554506|NCT02247804|473654756|FG002|Treatment Period 3|Lack of Efficacy|0|||
131554507|NCT02247804|473654754|FG000|Treatment Period 3|Lost to Follow-up|1|||
131554508|NCT02247804|473654755|FG001|Treatment Period 3|Lost to Follow-up|2|||
131554509|NCT02247804|473654756|FG002|Treatment Period 3|Lost to Follow-up|2|||
131554510|NCT02247804|473654754|FG000|Treatment Period 3|Personal Reasons|4|||
131554511|NCT02247804|473654755|FG001|Treatment Period 3|Personal Reasons|3|||
131554512|NCT02247804|473654756|FG002|Treatment Period 3|Personal Reasons|2|||
131667115|NCT03149549|474064738|FG012|Study Discontinuation--Treatment Period|Death|1|||
131554513|NCT02247804|473654754|FG000|Treatment Period 3|Reason not Specified|2|||
131554514|NCT02247804|473654755|FG001|Treatment Period 3|Reason not Specified|1|||
131667116|NCT03149549|474064726|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667117|NCT03149549|474064727|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667118|NCT03149549|474064728|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667119|NCT03149549|474064729|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667120|NCT03149549|474064730|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667121|NCT03149549|474064731|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667122|NCT03149549|474064732|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667123|NCT03149549|474064733|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
131667124|NCT03149549|474064734|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667125|NCT03149549|474064735|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667126|NCT03149549|474064736|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667127|NCT03149549|474064737|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131667128|NCT03149549|474064738|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
131667129|NCT03149549|474064726|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667130|NCT03149549|474064727|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667131|NCT03149549|474064728|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667132|NCT03149549|474064729|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
131667133|NCT03149549|474064730|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
131667134|NCT03149549|474064731|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
131667135|NCT03149549|474064732|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
131667136|NCT03149549|474064733|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667137|NCT03149549|474064734|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
131667138|NCT03149549|474064735|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667139|NCT03149549|474064736|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667140|NCT03149549|474064737|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667141|NCT03149549|474064738|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131667142|NCT03149549|474064726|FG000|Study Discontinuation--Treatment Period|Other|0|||
131667143|NCT03149549|474064727|FG001|Study Discontinuation--Treatment Period|Other|0|||
131667144|NCT03149549|474064728|FG002|Study Discontinuation--Treatment Period|Other|0|||
131667145|NCT03149549|474064729|FG003|Study Discontinuation--Treatment Period|Other|0|||
131667146|NCT03149549|474064730|FG004|Study Discontinuation--Treatment Period|Other|0|||
131667147|NCT03149549|474064731|FG005|Study Discontinuation--Treatment Period|Other|0|||
131667148|NCT03149549|474064732|FG006|Study Discontinuation--Treatment Period|Other|0|||
131667149|NCT03149549|474064733|FG007|Study Discontinuation--Treatment Period|Other|1|||
131667150|NCT03149549|474064734|FG008|Study Discontinuation--Treatment Period|Other|0|||
131667151|NCT03149549|474064735|FG009|Study Discontinuation--Treatment Period|Other|1|||
131667152|NCT03149549|474064736|FG010|Study Discontinuation--Treatment Period|Other|0|||
131667153|NCT03149549|474064737|FG011|Study Discontinuation--Treatment Period|Other|0|||
131667154|NCT03149549|474064738|FG012|Study Discontinuation--Treatment Period|Other|0|||
131667155|NCT03149549|474064726|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667156|NCT03149549|474064727|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667157|NCT03149549|474064728|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667158|NCT03149549|474064729|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667159|NCT03149549|474064730|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667160|NCT03149549|474064731|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
131667161|NCT03149549|474064732|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
131667162|NCT03149549|474064733|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667163|NCT03149549|474064734|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
131667164|NCT03149549|474064735|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667165|NCT03149549|474064736|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667166|NCT03149549|474064737|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667167|NCT03149549|474064738|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131667168|NCT03149549|474064726|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667169|NCT03149549|474064727|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667170|NCT03149549|474064728|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667171|NCT03149549|474064729|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667172|NCT03149549|474064730|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
131667173|NCT03149549|474064731|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667174|NCT03149549|474064732|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667175|NCT03149549|474064733|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
131667176|NCT03149549|474064734|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
131667177|NCT03149549|474064735|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667178|NCT03149549|474064736|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131667179|NCT03149549|474064737|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
131667180|NCT03149549|474064738|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
131667181|NCT03149549|474064726|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667182|NCT03149549|474064727|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667183|NCT03149549|474064728|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667184|NCT03149549|474064729|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667185|NCT03149549|474064730|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131667186|NCT03149549|474064731|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667187|NCT03149549|474064732|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667188|NCT03149549|474064733|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
131667189|NCT03149549|474064734|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131667190|NCT03149549|474064735|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131667191|NCT03149549|474064736|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
131667192|NCT03149549|474064737|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131667193|NCT03149549|474064738|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131667194|NCT03149549|474064726|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
131667195|NCT03149549|474064727|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
131667196|NCT03149549|474064728|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
131667197|NCT03149549|474064729|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
131667198|NCT03149549|474064730|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
131667199|NCT03149549|474064731|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
131667200|NCT03149549|474064732|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
131667201|NCT03149549|474064733|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
131667202|NCT03149549|474064734|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
131667203|NCT03149549|474064735|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
131667204|NCT03149549|474064736|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
131667205|NCT03149549|474064737|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
131667206|NCT03149549|474064738|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
131667207|NCT03149549|474064726|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
131896612|NCT03300180|474906962|FG001|6 Month Outcome|Missed Assessment|52|||
131554515|NCT02247804|473654756|FG002|Treatment Period 3|Reason not Specified|3|||
131554516|NCT02917265|473654757|FG000|Overall Study|Physician Decision|1|||
131554517|NCT02917265|473654758|FG001|Overall Study|Physician Decision|0|||
131554518|NCT02917265|473654757|FG000|Overall Study|Withdrawal by Subject|1|||
131554519|NCT02917265|473654758|FG001|Overall Study|Withdrawal by Subject|0|||
131554520|NCT04488003|473654759|FG000|Assessed for Eligibility|Screen Failure|24|||
131554521|NCT04488003|473654760|FG001|Assessed for Eligibility|Screen Failure|0|||
131554522|NCT04488003|473654761|FG002|Assessed for Eligibility|Screen Failure|0|||
131554523|NCT04488003|473654759|FG000|Assessed for Eligibility|Adverse Event|1|||
131554524|NCT04488003|473654760|FG001|Assessed for Eligibility|Adverse Event|0|||
131554525|NCT04488003|473654761|FG002|Assessed for Eligibility|Adverse Event|0|||
131554526|NCT04488003|473654759|FG000|Assessed for Eligibility|Death|1|||
131554527|NCT04488003|473654760|FG001|Assessed for Eligibility|Death|0|||
131554528|NCT04488003|473654761|FG002|Assessed for Eligibility|Death|0|||
131554529|NCT04488003|473654759|FG000|Assessed for Eligibility|Physician Decision|1|||
131554530|NCT04488003|473654760|FG001|Assessed for Eligibility|Physician Decision|0|||
131554531|NCT04488003|473654761|FG002|Assessed for Eligibility|Physician Decision|0|||
131554532|NCT04488003|473654759|FG000|Allocated to Treatment|Progressive Disease|51|||
131554533|NCT04488003|473654760|FG001|Allocated to Treatment|Progressive Disease|0|||
131554534|NCT04488003|473654761|FG002|Allocated to Treatment|Progressive Disease|0|||
131554535|NCT04488003|473654759|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
131554536|NCT04488003|473654760|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
131554537|NCT04488003|473654761|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
131554538|NCT04488003|473654759|FG000|Allocated to Treatment|Adverse Event|6|||
131554539|NCT04488003|473654760|FG001|Allocated to Treatment|Adverse Event|0|||
131554540|NCT04488003|473654761|FG002|Allocated to Treatment|Adverse Event|0|||
131554541|NCT04488003|473654759|FG000|Allocated to Treatment|Other|5|||
131554542|NCT04488003|473654760|FG001|Allocated to Treatment|Other|0|||
131554543|NCT04488003|473654761|FG002|Allocated to Treatment|Other|0|||
131554544|NCT04488003|473654759|FG000|Allocated to Treatment|Physician Decision|4|||
131554545|NCT04488003|473654760|FG001|Allocated to Treatment|Physician Decision|0|||
131554546|NCT04488003|473654761|FG002|Allocated to Treatment|Physician Decision|0|||
131554547|NCT04488003|473654759|FG000|Allocated to Treatment|Death|4|||
131554548|NCT04488003|473654760|FG001|Allocated to Treatment|Death|0|||
131554549|NCT04488003|473654761|FG002|Allocated to Treatment|Death|0|||
131554550|NCT00980005|473654767|FG000|Overall Study|Withdrawal by Subject|6|||
131554551|NCT00980005|473654768|FG001|Overall Study|Withdrawal by Subject|17|||
131554552|NCT00980005|473654767|FG000|Overall Study|Lost to Follow-up|37|||
131554553|NCT00980005|473654768|FG001|Overall Study|Lost to Follow-up|43|||
131554554|NCT00980005|473654767|FG000|Overall Study|Other|4|||
131554555|NCT00980005|473654768|FG001|Overall Study|Other|3|||
131554556|NCT00692406|473654769|FG000|Overall Study|PI dropped, bad data|57|||
131554557|NCT01617005|473654770|FG000|Overall Study|Pregnancy|1|||
131667208|NCT03149549|474064727|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
131667209|NCT03149549|474064728|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
131667210|NCT03149549|474064729|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
131667211|NCT03149549|474064730|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
131667212|NCT03149549|474064731|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
131667213|NCT03149549|474064732|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
131667214|NCT03149549|474064733|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
131667215|NCT03149549|474064734|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
131667216|NCT03149549|474064735|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
131667217|NCT03149549|474064736|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
131667218|NCT03149549|474064737|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
131667219|NCT03149549|474064738|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
131667220|NCT00153062|474067187|FG000|Overall Study|Death|360|||
131667221|NCT00153062|474067188|FG001|Overall Study|Death|352|||
131667222|NCT00153062|474067189|FG002|Overall Study|Death|369|||
131667223|NCT00153062|474067190|FG003|Overall Study|Death|365|||
131667224|NCT00153062|474067187|FG000|Overall Study|Withdrawal by Subject|14|||
131667225|NCT00153062|474067188|FG001|Overall Study|Withdrawal by Subject|30|||
131667226|NCT00153062|474067189|FG002|Overall Study|Withdrawal by Subject|27|||
131667227|NCT00153062|474067190|FG003|Overall Study|Withdrawal by Subject|28|||
131667228|NCT00153062|474067187|FG000|Overall Study|Lost to Follow-up|12|||
131667229|NCT00153062|474067188|FG001|Overall Study|Lost to Follow-up|20|||
131667230|NCT00153062|474067189|FG002|Overall Study|Lost to Follow-up|15|||
131667231|NCT00153062|474067190|FG003|Overall Study|Lost to Follow-up|16|||
131667232|NCT00153062|474067187|FG000|Overall Study|Adverse Event|0|||
131667233|NCT00153062|474067188|FG001|Overall Study|Adverse Event|1|||
131667234|NCT00153062|474067189|FG002|Overall Study|Adverse Event|1|||
131667235|NCT00153062|474067190|FG003|Overall Study|Adverse Event|0|||
131667236|NCT00153062|474067187|FG000|Overall Study|Protocol Violation|0|||
131667237|NCT00153062|474067188|FG001|Overall Study|Protocol Violation|2|||
131667238|NCT00153062|474067189|FG002|Overall Study|Protocol Violation|1|||
131667239|NCT00153062|474067190|FG003|Overall Study|Protocol Violation|1|||
131667240|NCT00153062|474067187|FG000|Overall Study|No disposition data available|1|||
131667241|NCT00153062|474067188|FG001|Overall Study|No disposition data available|1|||
131667242|NCT00153062|474067189|FG002|Overall Study|No disposition data available|1|||
131667243|NCT00153062|474067190|FG003|Overall Study|No disposition data available|1|||
131667244|NCT00153062|474067187|FG000|Overall Study|Other|0|||
131667245|NCT00153062|474067188|FG001|Overall Study|Other|0|||
131667246|NCT00153062|474067189|FG002|Overall Study|Other|1|||
131667247|NCT00153062|474067190|FG003|Overall Study|Other|0|||
131667248|NCT00275262|474067197|FG000|Overall Study|Adverse Event|2|||
131667249|NCT00275262|474067198|FG001|Overall Study|Adverse Event|0|||
131667250|NCT00275262|474067197|FG000|Overall Study|Disease progression|2|||
131667251|NCT00275262|474067198|FG001|Overall Study|Disease progression|5|||
131667252|NCT00275262|474067197|FG000|Overall Study|Lost to Follow-up|0|||
131667253|NCT00275262|474067198|FG001|Overall Study|Lost to Follow-up|2|||
131667254|NCT00275262|474067197|FG000|Overall Study|Protocol Violation|0|||
131667255|NCT00275262|474067198|FG001|Overall Study|Protocol Violation|2|||
131667256|NCT00275262|474067197|FG000|Overall Study|Death|1|||
131667257|NCT00275262|474067198|FG001|Overall Study|Death|0|||
131667258|NCT00275262|474067197|FG000|Overall Study|Started Chemotherapy|1|||
131667259|NCT00275262|474067198|FG001|Overall Study|Started Chemotherapy|0|||
131667260|NCT01589237|474067211|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
131667261|NCT01589237|474067212|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
131667262|NCT01589237|474067213|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
131667263|NCT01589237|474067214|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
131667264|NCT01589237|474067211|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
131667265|NCT01589237|474067212|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
131667266|NCT01589237|474067213|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
131667267|NCT01589237|474067214|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
131667268|NCT01589237|474067211|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
131667269|NCT01589237|474067212|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
131667270|NCT01589237|474067213|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
131667271|NCT01589237|474067214|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
131667272|NCT01589237|474067211|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
131667273|NCT01589237|474067212|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
131667274|NCT01589237|474067213|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
131667275|NCT01589237|474067214|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
131667276|NCT02594163|474067215|FG000|Treatment Period|Progressive disease|2|||
131667277|NCT02594163|474067216|FG001|Treatment Period|Progressive disease|3|||
131667278|NCT02594163|474067215|FG000|Treatment Period|Adverse Event|1|||
131667279|NCT02594163|474067216|FG001|Treatment Period|Adverse Event|5|||
131667280|NCT02594163|474067215|FG000|Treatment Period|Physician Decision|1|||
131667281|NCT02594163|474067216|FG001|Treatment Period|Physician Decision|3|||
131667282|NCT02594163|474067215|FG000|Treatment Period|Study termination by sponsor|2|||
131667283|NCT02594163|474067216|FG001|Treatment Period|Study termination by sponsor|1|||
131667284|NCT02594163|474067215|FG000|Treatment Period|Other, Non-AE|1|||
131667285|NCT02594163|474067216|FG001|Treatment Period|Other, Non-AE|0|||
131667286|NCT02594163|474067215|FG000|Follow-up Period|Withdrawal by Subject|0|||
131667287|NCT02594163|474067216|FG001|Follow-up Period|Withdrawal by Subject|1|||
131667288|NCT02594163|474067215|FG000|Follow-up Period|Study Termination by Sponsor|6|||
131667289|NCT02594163|474067216|FG001|Follow-up Period|Study Termination by Sponsor|4|||
131667290|NCT02594163|474067215|FG000|Follow-up Period|Lost to Follow-up|1|||
131667291|NCT02594163|474067216|FG001|Follow-up Period|Lost to Follow-up|0|||
131667292|NCT02594163|474067215|FG000|Follow-up Period|Death|2|||
131667293|NCT02594163|474067216|FG001|Follow-up Period|Death|5|||
131667294|NCT02594163|474067215|FG000|Follow-up Period|Adverse Event|0|||
131667295|NCT02594163|474067216|FG001|Follow-up Period|Adverse Event|1|||
131667296|NCT02594163|474067215|FG000|Follow-up Period|Progressive Disease|2|||
131667297|NCT02594163|474067216|FG001|Follow-up Period|Progressive Disease|0|||
131667298|NCT02594163|474067215|FG000|Follow-up Period|Physician Decision|0|||
131667299|NCT02594163|474067216|FG001|Follow-up Period|Physician Decision|1|||
131667300|NCT01290029|474067219|FG000|Overall Study|Other|2|||
131667301|NCT00189488|474067220|FG000|Overall Study|Ineligibility determined|1|||
131667302|NCT00189488|474067221|FG001|Overall Study|Ineligibility determined|0|||
131667303|NCT00189488|474067220|FG000|Overall Study|Protocol deviation|2|||
131667304|NCT00189488|474067221|FG001|Overall Study|Protocol deviation|1|||
131667305|NCT00189488|474067220|FG000|Overall Study|Adverse Event|2|||
131667306|NCT00189488|474067221|FG001|Overall Study|Adverse Event|1|||
131667307|NCT00189488|474067220|FG000|Overall Study|Withdrawal by Subject|2|||
131667308|NCT00189488|474067221|FG001|Overall Study|Withdrawal by Subject|6|||
131667309|NCT00189488|474067220|FG000|Overall Study|Disease progression|2|||
131667310|NCT00189488|474067221|FG001|Overall Study|Disease progression|4|||
131667311|NCT00189488|474067220|FG000|Overall Study|Administrative Decision|0|||
131667312|NCT00189488|474067221|FG001|Overall Study|Administrative Decision|2|||
131667313|NCT00189488|474067220|FG000|Overall Study|Death|5|||
131667314|NCT00189488|474067221|FG001|Overall Study|Death|8|||
131667315|NCT00189488|474067220|FG000|Overall Study|Other|1|||
131667316|NCT00189488|474067221|FG001|Overall Study|Other|0|||
131667317|NCT00484289|474067227|FG000|Long Term Phase|Adverse Event|1|||
131667318|NCT00484289|474067228|FG001|Long Term Phase|Adverse Event|17|||
131667319|NCT00484289|474067229|FG002|Long Term Phase|Adverse Event|5|||
131667320|NCT00484289|474067227|FG000|Long Term Phase|Withdrawal by Subject|0|||
131667321|NCT00484289|474067228|FG001|Long Term Phase|Withdrawal by Subject|7|||
131667322|NCT00484289|474067229|FG002|Long Term Phase|Withdrawal by Subject|6|||
131667323|NCT00484289|474067227|FG000|Long Term Phase|Inadequate response|2|||
131667324|NCT00484289|474067228|FG001|Long Term Phase|Inadequate response|7|||
131667325|NCT00484289|474067229|FG002|Long Term Phase|Inadequate response|4|||
131667326|NCT00484289|474067227|FG000|Long Term Phase|Other Reason|0|||
131667327|NCT00484289|474067228|FG001|Long Term Phase|Other Reason|5|||
131667328|NCT00484289|474067229|FG002|Long Term Phase|Other Reason|1|||
131667329|NCT00484289|474067227|FG000|Post Marketing Phase|Adverse Event|0|||
131667330|NCT00484289|474067228|FG001|Post Marketing Phase|Adverse Event|1|||
131667331|NCT00484289|474067229|FG002|Post Marketing Phase|Adverse Event|0|||
131667332|NCT02349425|474067230|FG000|Period 1|Adverse Event|1|||
131667333|NCT02349425|474067231|FG001|Period 1|Adverse Event|1|||
131667334|NCT02349425|474067232|FG002|Period 1|Adverse Event|0|||
131667335|NCT02349425|474067233|FG003|Period 1|Adverse Event|0|||
131667336|NCT02349425|474067230|FG000|Period 2|Adverse Event|0|||
131667337|NCT02349425|474067231|FG001|Period 2|Adverse Event|1|||
131667338|NCT02349425|474067232|FG002|Period 2|Adverse Event|1|||
131667339|NCT02349425|474067233|FG003|Period 2|Adverse Event|0|||
131667340|NCT00645801|474067235|FG000|Overall Study|unclear if patient took all the medication.|1|||
131667341|NCT00645801|474067236|FG001|Overall Study|unclear if patient took all the medication.|0|||
131667342|NCT00645801|474067235|FG000|Overall Study|Lost to Follow-up|19|||
131667343|NCT00645801|474067236|FG001|Overall Study|Lost to Follow-up|15|||
131667344|NCT00932113|474067237|FG000|Overall Study|Lost to Follow-up|1|||
131667345|NCT00932113|474067238|FG001|Overall Study|Lost to Follow-up|0|||
131667346|NCT01403610|474067239|FG000|Overall Study|Withdrawal by Subject|2|||
131667347|NCT01403610|474067240|FG001|Overall Study|Withdrawal by Subject|0|||
131667348|NCT01403610|474067241|FG002|Overall Study|Withdrawal by Subject|0|||
131667349|NCT01403610|474067242|FG003|Overall Study|Withdrawal by Subject|0|||
131667350|NCT01403610|474067239|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
131667351|NCT01403610|474067240|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
131667352|NCT01403610|474067241|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
131667353|NCT01403610|474067242|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
131667354|NCT01143038|474067247|FG000|Overall Study|Withdrawal by Subject|4|||
131667355|NCT01143038|474067247|FG000|Overall Study|Requirement for alternative therapy|5|||
131667356|NCT01143038|474067247|FG000|Overall Study|Adverse Event|3|||
131667357|NCT01143038|474067247|FG000|Overall Study|Lost to Follow-up|2|||
131667358|NCT01143038|474067247|FG000|Overall Study|Protocol Deviation|1|||
131667359|NCT01143038|474067247|FG000|Overall Study|Death|1|||
131667360|NCT01171807|474067251|FG000|Overall Study|Treatment failure|2|||
131667361|NCT01171807|474067252|FG001|Overall Study|Treatment failure|4|||
131667362|NCT01171807|474067251|FG000|Overall Study|Non compliance|1|||
131667363|NCT01171807|474067252|FG001|Overall Study|Non compliance|0|||
131667364|NCT01171807|474067251|FG000|Overall Study|Lost to Follow-up|3|||
131667365|NCT01171807|474067252|FG001|Overall Study|Lost to Follow-up|0|||
131667366|NCT02874924|474067253|FG000|Overall Study|Adverse Event|2|||
131667367|NCT02874924|474067254|FG001|Overall Study|Adverse Event|0|||
131667368|NCT02874924|474067255|FG002|Overall Study|Adverse Event|0|||
131667369|NCT02874924|474067253|FG000|Overall Study|Withdrawal by Subject|1|||
131667370|NCT02874924|474067254|FG001|Overall Study|Withdrawal by Subject|0|||
131667371|NCT02874924|474067255|FG002|Overall Study|Withdrawal by Subject|0|||
131667372|NCT02029846|474067258|FG000|Overall Study|n=1 each arm|1|||
131667373|NCT02029846|474067259|FG001|Overall Study|n=1 each arm|1|||
131667374|NCT00642772|474067263|FG000|Overall Study|Lost to Follow-up|3|||
131667375|NCT00642772|474067263|FG000|Overall Study|Withdrawal by Subject|7|||
131667376|NCT00903006|474067265|FG000|Overall Study|Withdrawal by Subject|2|||
131667377|NCT00903006|474067266|FG001|Overall Study|Withdrawal by Subject|0|||
131667378|NCT00903006|474067267|FG002|Overall Study|Withdrawal by Subject|0|||
131667379|NCT00903006|474067268|FG003|Overall Study|Withdrawal by Subject|0|||
131667380|NCT00903006|474067265|FG000|Overall Study|Progressive Disease|0|||
131667381|NCT00903006|474067266|FG001|Overall Study|Progressive Disease|3|||
131667382|NCT00903006|474067267|FG002|Overall Study|Progressive Disease|1|||
131667383|NCT00903006|474067268|FG003|Overall Study|Progressive Disease|0|||
131667384|NCT00321373|474067269|FG000|Overall Study|Adverse Event|0|||
131667385|NCT00321373|474067270|FG001|Overall Study|Adverse Event|0|||
131667386|NCT00321373|474067271|FG002|Overall Study|Adverse Event|1|||
131667387|NCT00321373|474067269|FG000|Overall Study|Lost to Follow-up|1|||
131667388|NCT00321373|474067270|FG001|Overall Study|Lost to Follow-up|0|||
131667389|NCT00321373|474067271|FG002|Overall Study|Lost to Follow-up|1|||
131667390|NCT00321373|474067269|FG000|Overall Study|Withdrawal by Subject|1|||
131667391|NCT00321373|474067270|FG001|Overall Study|Withdrawal by Subject|0|||
131667392|NCT00321373|474067271|FG002|Overall Study|Withdrawal by Subject|0|||
131667393|NCT00321373|474067269|FG000|Overall Study|Other|0|||
131667394|NCT00321373|474067270|FG001|Overall Study|Other|0|||
131667395|NCT00321373|474067271|FG002|Overall Study|Other|1|||
131667396|NCT04275089|474067272|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
131667397|NCT00946101|474067275|FG000|Overall Study|Lost to Follow-up|2|||
131667398|NCT00946101|474067276|FG001|Overall Study|Lost to Follow-up|1|||
131667399|NCT00946101|474067275|FG000|Overall Study|Withdrawal of consent|2|||
131667400|NCT00946101|474067276|FG001|Overall Study|Withdrawal of consent|0|||
131667401|NCT00946101|474067275|FG000|Overall Study|Physician Decision|0|||
131667402|NCT00946101|474067276|FG001|Overall Study|Physician Decision|1|||
131667403|NCT03038438|474067277|FG000|Overall Study|Death|3|||
131667404|NCT03038438|474067277|FG000|Overall Study|Lost to Follow-up|8|||
131667405|NCT03038438|474067277|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
131667406|NCT03038438|474067277|FG000|Overall Study|Withdrawal by Subject|5|||
131667407|NCT03038438|474067277|FG000|Overall Study|No 36-Month Follow-Up|18|||
131667408|NCT03625895|474067283|FG000|Overall Study|Protocol Violation|585|||
131667409|NCT00577473|474067286|FG000|Overall Study|Protocol Violation|1|||
131667410|NCT00577473|474067287|FG001|Overall Study|Protocol Violation|4|||
131667411|NCT00577473|474067286|FG000|Overall Study|Adverse Event|8|||
131667412|NCT00577473|474067287|FG001|Overall Study|Adverse Event|5|||
131667413|NCT00577473|474067286|FG000|Overall Study|Withdrawal by Subject|2|||
131667414|NCT00577473|474067287|FG001|Overall Study|Withdrawal by Subject|6|||
131667415|NCT00577473|474067286|FG000|Overall Study|Physician Decision|2|||
131667416|NCT00577473|474067287|FG001|Overall Study|Physician Decision|2|||
131667417|NCT00577473|474067286|FG000|Overall Study|Lack of Efficacy|8|||
131667418|NCT00577473|474067287|FG001|Overall Study|Lack of Efficacy|7|||
131667419|NCT02884908|474067290|FG000|Overall Study|Lost to Follow-up|13|||
131667420|NCT02884908|474067291|FG001|Overall Study|Lost to Follow-up|18|||
131667421|NCT02084056|474067297|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
131667422|NCT02084056|474067298|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131667423|NCT02084056|474067299|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131667424|NCT02084056|474067300|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131667425|NCT02084056|474067297|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
131667426|NCT02084056|474067298|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131667427|NCT02084056|474067299|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131554558|NCT01617005|473654770|FG000|Overall Study|Lack of motivation for treatment|1|||
131554559|NCT04145037|473654774|FG000|Overall Study|Study terminated|2|||
131554560|NCT04145037|473654775|FG001|Overall Study|Study terminated|0|||
131554561|NCT04145037|473654774|FG000|Overall Study|Withdrawal by Subject|1|||
131554562|NCT04145037|473654775|FG001|Overall Study|Withdrawal by Subject|0|||
131554563|NCT04145037|473654774|FG000|Overall Study|Lost to Follow-up|1|||
131554564|NCT04145037|473654775|FG001|Overall Study|Lost to Follow-up|0|||
131554565|NCT02307513|473654778|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
131554566|NCT02307513|473654779|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
131554567|NCT02307513|473654778|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
131554568|NCT02307513|473654779|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
131554569|NCT02307513|473654778|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
131554570|NCT02307513|473654779|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
131554571|NCT02307513|473654778|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
131554572|NCT02307513|473654779|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
131554573|NCT02307513|473654778|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
131554574|NCT02307513|473654779|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
131554575|NCT02307513|473654778|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
131554576|NCT02307513|473654779|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
131554577|NCT02307513|473654778|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
131554578|NCT02307513|473654779|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
131554579|NCT02307513|473654778|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
131554580|NCT02307513|473654779|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
131554581|NCT02307513|473654778|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
131554582|NCT02307513|473654779|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
131554583|NCT02307513|473654778|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
131554584|NCT02307513|473654779|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
131554585|NCT02307513|473654778|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
131554586|NCT02307513|473654779|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
131554587|NCT02307513|473654778|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
131554588|NCT02307513|473654779|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
131554589|NCT02307513|473654778|FG000|Long-term Extension|Physician Decision|1|||
131554590|NCT02307513|473654779|FG001|Long-term Extension|Physician Decision|0|||
131554591|NCT00525265|473654782|FG000|Overall Study|Protocol Violation|1|||
131554592|NCT00525265|473654783|FG001|Overall Study|Protocol Violation|0|||
131554593|NCT03107377|473654784|FG000|Overall Study|Adverse Event|3|||
131554594|NCT03107377|473654785|FG001|Overall Study|Adverse Event|3|||
131554595|NCT03107377|473654784|FG000|Overall Study|Protocol Violation|9|||
131554596|NCT03107377|473654785|FG001|Overall Study|Protocol Violation|12|||
131554597|NCT03107377|473654784|FG000|Overall Study|Physician Decision|3|||
131554598|NCT03107377|473654785|FG001|Overall Study|Physician Decision|6|||
131554599|NCT03107377|473654784|FG000|Overall Study|Pregnancy|7|||
131554600|NCT03107377|473654785|FG001|Overall Study|Pregnancy|7|||
131554601|NCT03107377|473654784|FG000|Overall Study|Withdrawal by Subject|16|||
131554602|NCT03107377|473654785|FG001|Overall Study|Withdrawal by Subject|22|||
131554603|NCT03107377|473654784|FG000|Overall Study|Lost to Follow-up|37|||
131554604|NCT03107377|473654785|FG001|Overall Study|Lost to Follow-up|34|||
131554605|NCT03107377|473654784|FG000|Overall Study|Other reason not specified|16|||
131554606|NCT03107377|473654785|FG001|Overall Study|Other reason not specified|15|||
131554607|NCT00211237|473654786|FG000|Baseline|Withdrew|1|||
131554608|NCT00211237|473654787|FG001|Baseline|Withdrew|3|||
131554609|NCT00211237|473654788|FG002|Baseline|Withdrew|0|||
131554610|NCT00211237|473654786|FG000|Baseline|Refused random assignment|1|||
131554611|NCT00211237|473654787|FG001|Baseline|Refused random assignment|0|||
131554612|NCT00211237|473654788|FG002|Baseline|Refused random assignment|0|||
131554613|NCT00211237|473654786|FG000|1 Month|Death|2|||
131554614|NCT00211237|473654787|FG001|1 Month|Death|1|||
131554615|NCT00211237|473654788|FG002|1 Month|Death|0|||
131554616|NCT00211237|473654786|FG000|1 Month|Lost to Follow-up|0|||
131554617|NCT00211237|473654787|FG001|1 Month|Lost to Follow-up|2|||
131554618|NCT00211237|473654788|FG002|1 Month|Lost to Follow-up|0|||
131554619|NCT00211237|473654786|FG000|1 Month|Withdrew|0|||
131554620|NCT00211237|473654787|FG001|1 Month|Withdrew|4|||
131554621|NCT00211237|473654788|FG002|1 Month|Withdrew|0|||
131554622|NCT00211237|473654786|FG000|1 Month|Additional surgery needed|1|||
131554623|NCT00211237|473654787|FG001|1 Month|Additional surgery needed|0|||
131554624|NCT00211237|473654788|FG002|1 Month|Additional surgery needed|0|||
131667428|NCT02084056|474067300|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131667429|NCT00232544|474067302|FG000|Overall Study|Lost to Follow-up|20|||
131667430|NCT00232544|474067303|FG001|Overall Study|Lost to Follow-up|15|||
131667431|NCT00986973|474067307|FG000|Overall Study|Withdrawn by study team|1|||
131667432|NCT02413333|474067308|FG000|Period 1|Adverse Event|1|||
131667433|NCT02413333|474067309|FG001|Period 1|Adverse Event|0|||
131667434|NCT02413333|474067308|FG000|Period 1|Reason Not Specified|0|||
131667435|NCT02413333|474067309|FG001|Period 1|Reason Not Specified|1|||
131667436|NCT02413333|474067308|FG000|Period 2|Protocol Deviation|1|||
131667437|NCT02413333|474067309|FG001|Period 2|Protocol Deviation|0|||
131667438|NCT01590082|474067310|FG000|Overall Study|Withdrawal by Subject|1|||
131667439|NCT01590082|474067311|FG001|Overall Study|Withdrawal by Subject|0|||
131667440|NCT01590082|474067310|FG000|Overall Study|Ineligible|1|||
131667441|NCT01590082|474067311|FG001|Overall Study|Ineligible|0|||
131667442|NCT02414932|474067312|FG000|Overall Study|Withdrawal by Subject|2|||
131667443|NCT02414932|474067313|FG001|Overall Study|Withdrawal by Subject|3|||
131667444|NCT02414932|474067312|FG000|Overall Study|Adverse Event|1|||
131667445|NCT02414932|474067313|FG001|Overall Study|Adverse Event|0|||
131667446|NCT01210664|474067315|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
131667447|NCT01210664|474067316|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
131667448|NCT01210664|474067317|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
131667449|NCT01210664|474067318|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
131667450|NCT01210664|474067315|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
131667451|NCT01210664|474067316|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
131667452|NCT01210664|474067317|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
131667453|NCT01210664|474067318|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
131667454|NCT01210664|474067315|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
131667455|NCT01210664|474067316|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
131667456|NCT01210664|474067317|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
131667457|NCT01210664|474067318|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
131667458|NCT01853644|474067319|FG000|Registration and Treatment Start|Did not start treatment|1|||
131667459|NCT01853644|474067319|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
131667460|NCT01853644|474067319|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
131667461|NCT01853644|474067319|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
131667462|NCT01853644|474067319|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
131667463|NCT01853644|474067319|FG000|Continued Treatment After First Response|Adverse Event|2|||
131667464|NCT01853644|474067319|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
131667465|NCT02891408|474067320|FG000|Overall Study|Lost to Follow-up|0|||
131667466|NCT02891408|474067321|FG001|Overall Study|Lost to Follow-up|0|||
131667467|NCT02891408|474067322|FG002|Overall Study|Lost to Follow-up|1|||
131667468|NCT02891408|474067323|FG003|Overall Study|Lost to Follow-up|0|||
131667469|NCT02891408|474067324|FG004|Overall Study|Lost to Follow-up|0|||
131667470|NCT02891408|474067325|FG005|Overall Study|Lost to Follow-up|0|||
131667471|NCT02891408|474067326|FG006|Overall Study|Lost to Follow-up|0|||
131667472|NCT01054170|474067327|FG000|Overall Study|Protocol Violation|1|||
131667473|NCT01054170|474067328|FG001|Overall Study|Protocol Violation|0|||
131667474|NCT01054170|474067327|FG000|Overall Study|Withdrawal by Subject|3|||
131667475|NCT01054170|474067328|FG001|Overall Study|Withdrawal by Subject|2|||
131667476|NCT01054170|474067327|FG000|Overall Study|Adverse Event|0|||
131667477|NCT01054170|474067328|FG001|Overall Study|Adverse Event|4|||
131667478|NCT02951767|474067329|FG000|Overall Study|Study Terminated By Sponsor|9|||
131667479|NCT02951767|474067329|FG000|Overall Study|Withdrawal by Subject|11|||
131667480|NCT02951767|474067329|FG000|Overall Study|Death|96|||
131667481|NCT02951767|474067329|FG000|Overall Study|Lost to Follow-up|2|||
131667482|NCT02951767|474067329|FG000|Overall Study|Physician Decision|1|||
131667483|NCT00709852|474067330|FG000|Period 1|Adverse Event|2|||
131667484|NCT00709852|474067331|FG001|Period 1|Adverse Event|0|||
131667485|NCT00709852|474067330|FG000|Period 1|Withdrawal by Subject|4|||
131667486|NCT00709852|474067331|FG001|Period 1|Withdrawal by Subject|2|||
131667487|NCT00709852|474067330|FG000|Period 1|Protocol Violation|1|||
131667488|NCT00709852|474067331|FG001|Period 1|Protocol Violation|0|||
131667489|NCT00709852|474067330|FG000|Period 1|Defective scanner|0|||
131667490|NCT00709852|474067331|FG001|Period 1|Defective scanner|1|||
131667491|NCT00709852|474067330|FG000|Period 1|Lost to Follow-up|1|||
131667492|NCT00709852|474067331|FG001|Period 1|Lost to Follow-up|0|||
131667493|NCT00709852|474067330|FG000|Period 2|Protocol Violation|4|||
131667494|NCT00709852|474067331|FG001|Period 2|Protocol Violation|1|||
131667495|NCT00709852|474067330|FG000|Period 2|Adverse Event|1|||
131667496|NCT00709852|474067331|FG001|Period 2|Adverse Event|1|||
131667497|NCT00709852|474067330|FG000|Period 2|Lost to Follow-up|1|||
131667498|NCT00709852|474067331|FG001|Period 2|Lost to Follow-up|0|||
131667499|NCT00709852|474067330|FG000|Period 2|No 72-hour follow-up|3|||
131667500|NCT00709852|474067331|FG001|Period 2|No 72-hour follow-up|0|||
131667501|NCT01442779|474067332|FG000|Overall Study|Withdrawal by Subject|3|||
131667502|NCT01442779|474067332|FG000|Overall Study|Death|3|||
131667503|NCT01442779|474067332|FG000|Overall Study|Non-compliance|1|||
131667504|NCT01048671|474067333|FG000|Overall Study|Protocol Violation|0|||
131667505|NCT01048671|474067334|FG001|Overall Study|Protocol Violation|1|||
131896613|NCT03300180|474906963|FG002|6 Month Outcome|Missed Assessment|46|||
131554625|NCT00211237|473654786|FG000|1 Month|Non-medical problem|0|||
131554626|NCT00211237|473654787|FG001|1 Month|Non-medical problem|2|||
131554627|NCT00211237|473654788|FG002|1 Month|Non-medical problem|0|||
131554628|NCT00211237|473654786|FG000|3 Months|Death|7|||
131554629|NCT00211237|473654787|FG001|3 Months|Death|3|||
131554630|NCT00211237|473654788|FG002|3 Months|Death|0|||
131554631|NCT00211237|473654786|FG000|3 Months|Could not comply with protocol|1|||
131554632|NCT00211237|473654787|FG001|3 Months|Could not comply with protocol|0|||
131554633|NCT00211237|473654788|FG002|3 Months|Could not comply with protocol|0|||
131554634|NCT00211237|473654786|FG000|3 Months|Withdrew|0|||
131554635|NCT00211237|473654787|FG001|3 Months|Withdrew|1|||
131554636|NCT00211237|473654788|FG002|3 Months|Withdrew|0|||
131554637|NCT00211237|473654786|FG000|3 Months|Non-medical problem|0|||
131554638|NCT00211237|473654787|FG001|3 Months|Non-medical problem|0|||
131554639|NCT00211237|473654788|FG002|3 Months|Non-medical problem|1|||
131554640|NCT00211237|473654786|FG000|6 Months|Death|6|||
131554641|NCT00211237|473654787|FG001|6 Months|Death|0|||
131554642|NCT00211237|473654788|FG002|6 Months|Death|3|||
131554643|NCT00211237|473654786|FG000|6 Months|Lost to Follow-up|2|||
131554644|NCT00211237|473654787|FG001|6 Months|Lost to Follow-up|0|||
131554645|NCT00211237|473654788|FG002|6 Months|Lost to Follow-up|0|||
131554646|NCT00211237|473654786|FG000|6 Months|Could not comply with protocol|0|||
131554647|NCT00211237|473654787|FG001|6 Months|Could not comply with protocol|2|||
131554648|NCT00211237|473654788|FG002|6 Months|Could not comply with protocol|0|||
131554649|NCT00211237|473654786|FG000|12 Months|Death|8|||
131554650|NCT00211237|473654787|FG001|12 Months|Death|2|||
131554651|NCT00211237|473654788|FG002|12 Months|Death|3|||
131554652|NCT00211237|473654786|FG000|12 Months|Lost to Follow-up|1|||
131554653|NCT00211237|473654787|FG001|12 Months|Lost to Follow-up|0|||
131554654|NCT00211237|473654788|FG002|12 Months|Lost to Follow-up|1|||
131554655|NCT00211237|473654786|FG000|12 Months|Withdrew|0|||
131554656|NCT00211237|473654787|FG001|12 Months|Withdrew|0|||
131554657|NCT00211237|473654788|FG002|12 Months|Withdrew|1|||
131554658|NCT00211237|473654786|FG000|12 Months|unrelated medical problem|0|||
131554659|NCT00211237|473654787|FG001|12 Months|unrelated medical problem|0|||
131554660|NCT00211237|473654788|FG002|12 Months|unrelated medical problem|1|||
131554661|NCT02954458|473654793|FG000|Overall Study|Adverse Event|0|||
131554662|NCT02954458|473654794|FG001|Overall Study|Adverse Event|0|||
131554663|NCT02954458|473654795|FG002|Overall Study|Adverse Event|0|||
131554664|NCT02954458|473654796|FG003|Overall Study|Adverse Event|1|||
131554665|NCT02954458|473654793|FG000|Overall Study|Withdrawal by Subject|0|||
131554666|NCT02954458|473654794|FG001|Overall Study|Withdrawal by Subject|0|||
131554667|NCT02954458|473654795|FG002|Overall Study|Withdrawal by Subject|0|||
131554668|NCT02954458|473654796|FG003|Overall Study|Withdrawal by Subject|1|||
131554669|NCT02954458|473654793|FG000|Overall Study|Physician Decision|0|||
131554670|NCT02954458|473654794|FG001|Overall Study|Physician Decision|0|||
131554671|NCT02954458|473654795|FG002|Overall Study|Physician Decision|1|||
131554672|NCT02954458|473654796|FG003|Overall Study|Physician Decision|1|||
131554673|NCT02954458|473654793|FG000|Overall Study|Lost to Follow-up|1|||
131554674|NCT02954458|473654794|FG001|Overall Study|Lost to Follow-up|0|||
131554675|NCT02954458|473654795|FG002|Overall Study|Lost to Follow-up|0|||
131554676|NCT02954458|473654796|FG003|Overall Study|Lost to Follow-up|1|||
131554677|NCT02954458|473654793|FG000|Overall Study|Death|0|||
131554678|NCT02954458|473654794|FG001|Overall Study|Death|0|||
131554679|NCT02954458|473654795|FG002|Overall Study|Death|0|||
131554680|NCT02954458|473654796|FG003|Overall Study|Death|1|||
131554681|NCT02954458|473654793|FG000|Overall Study|Other|0|||
131554682|NCT02954458|473654794|FG001|Overall Study|Other|0|||
131554683|NCT02954458|473654795|FG002|Overall Study|Other|0|||
131554684|NCT02954458|473654796|FG003|Overall Study|Other|7|||
131554685|NCT01845974|473654797|FG000|Overall Study|screen failure|1|||
131554686|NCT01845974|473654798|FG001|Overall Study|screen failure|0|||
131554687|NCT04186403|473654799|FG000|Overall Study|Adverse Event|1|||
131554688|NCT04186403|473654800|FG001|Overall Study|Adverse Event|8|||
131554689|NCT04186403|473654799|FG000|Overall Study|Lost to Follow-up|7|||
131554690|NCT04186403|473654800|FG001|Overall Study|Lost to Follow-up|3|||
131554691|NCT04186403|473654799|FG000|Overall Study|Physician Decision|1|||
131554692|NCT04186403|473654800|FG001|Overall Study|Physician Decision|0|||
131896614|NCT03300180|474906961|FG000|12 Month Outcome|Withdrawal by Subject|3|||
131554693|NCT04186403|473654799|FG000|Overall Study|Withdrawal by Subject|7|||
131554694|NCT04186403|473654800|FG001|Overall Study|Withdrawal by Subject|8|||
131554695|NCT04186403|473654799|FG000|Overall Study|Other: Not Related to Covid-19|3|||
131554696|NCT04186403|473654800|FG001|Overall Study|Other: Not Related to Covid-19|0|||
131554697|NCT00405639|473654802|FG000|Overall Study|Withdrawal by Subject|1|||
131554698|NCT00405639|473654803|FG001|Overall Study|Withdrawal by Subject|0|||
131554699|NCT00405639|473654802|FG000|Overall Study|Adverse Event|1|||
131554700|NCT00405639|473654803|FG001|Overall Study|Adverse Event|0|||
131554701|NCT00405639|473654802|FG000|Overall Study|Seizure prior to receiving BNP|1|||
131554702|NCT00405639|473654803|FG001|Overall Study|Seizure prior to receiving BNP|0|||
131554703|NCT00265330|473654804|FG000|Overall Study|Adverse Event|41|||
131554704|NCT00265330|473654804|FG000|Overall Study|Lost to Follow-up|8|||
131667506|NCT01048671|474067335|FG002|Overall Study|Protocol Violation|1|||
131667507|NCT05249829|474067336|FG000|Overall Study|Participant Relocation|0|||
131667508|NCT05249829|474067337|FG001|Overall Study|Participant Relocation|1|||
131667509|NCT05249829|474067338|FG002|Overall Study|Participant Relocation|2|||
131667510|NCT05249829|474067339|FG003|Overall Study|Participant Relocation|2|||
131667511|NCT05249829|474067336|FG000|Overall Study|Withdrawal by Subject|9|||
131667512|NCT05249829|474067337|FG001|Overall Study|Withdrawal by Subject|17|||
131667513|NCT05249829|474067338|FG002|Overall Study|Withdrawal by Subject|40|||
131667514|NCT05249829|474067339|FG003|Overall Study|Withdrawal by Subject|35|||
131667515|NCT05249829|474067336|FG000|Overall Study|Physician Decision|1|||
131667516|NCT05249829|474067337|FG001|Overall Study|Physician Decision|0|||
131667517|NCT05249829|474067338|FG002|Overall Study|Physician Decision|0|||
131667518|NCT05249829|474067339|FG003|Overall Study|Physician Decision|0|||
131667519|NCT05249829|474067336|FG000|Overall Study|Lost to Follow-up|16|||
131667520|NCT05249829|474067337|FG001|Overall Study|Lost to Follow-up|16|||
131667521|NCT05249829|474067338|FG002|Overall Study|Lost to Follow-up|57|||
131667522|NCT05249829|474067339|FG003|Overall Study|Lost to Follow-up|60|||
131667523|NCT05249829|474067336|FG000|Overall Study|Adverse Event|2|||
131667524|NCT05249829|474067337|FG001|Overall Study|Adverse Event|2|||
131667525|NCT05249829|474067338|FG002|Overall Study|Adverse Event|2|||
131667526|NCT05249829|474067339|FG003|Overall Study|Adverse Event|2|||
131667527|NCT05249829|474067336|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
131667528|NCT05249829|474067337|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
131667529|NCT05249829|474067338|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
131667530|NCT05249829|474067339|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
131667531|NCT05249829|474067336|FG000|Overall Study|Protocol Violation|2|||
131667532|NCT05249829|474067337|FG001|Overall Study|Protocol Violation|0|||
131667533|NCT05249829|474067338|FG002|Overall Study|Protocol Violation|5|||
131667534|NCT05249829|474067339|FG003|Overall Study|Protocol Violation|3|||
131667535|NCT05249829|474067336|FG000|Overall Study|Death|0|||
131667536|NCT05249829|474067337|FG001|Overall Study|Death|1|||
131667537|NCT05249829|474067338|FG002|Overall Study|Death|2|||
131667538|NCT05249829|474067339|FG003|Overall Study|Death|4|||
131667539|NCT00513604|474067340|FG000|Overall Study|Not treated|2|||
131667540|NCT00513604|474067341|FG001|Overall Study|Not treated|0|||
131667541|NCT00513604|474067342|FG002|Overall Study|Not treated|1|||
131667542|NCT00513604|474067343|FG003|Overall Study|Not treated|0|||
131667543|NCT00513604|474067344|FG004|Overall Study|Not treated|0|||
131667544|NCT00513604|474067340|FG000|Overall Study|Death during treatment|0|||
131667545|NCT00513604|474067341|FG001|Overall Study|Death during treatment|3|||
131667546|NCT00513604|474067342|FG002|Overall Study|Death during treatment|2|||
131667547|NCT00513604|474067343|FG003|Overall Study|Death during treatment|0|||
131667548|NCT00513604|474067344|FG004|Overall Study|Death during treatment|0|||
131667549|NCT00196976|474067345|FG000|Primary Study|Migrated from study area|0|||
131667550|NCT00196976|474067346|FG001|Primary Study|Migrated from study area|0|||
131667551|NCT00196976|474067347|FG002|Primary Study|Migrated from study area|0|||
131667552|NCT00196976|474067348|FG003|Primary Study|Migrated from study area|0|||
131667553|NCT00196976|474067349|FG004|Primary Study|Migrated from study area|0|||
131667554|NCT00196976|474067350|FG005|Primary Study|Migrated from study area|0|||
131667555|NCT00196976|474067351|FG006|Primary Study|Migrated from study area|0|||
131667556|NCT00196976|474067352|FG007|Primary Study|Migrated from study area|1|||
131667557|NCT00196976|474067353|FG008|Primary Study|Migrated from study area|0|||
131667558|NCT00196976|474067354|FG009|Primary Study|Migrated from study area|0|||
131667559|NCT00196976|474067355|FG010|Primary Study|Migrated from study area|0|||
131667560|NCT00196976|474067356|FG011|Primary Study|Migrated from study area|0|||
131667561|NCT00196976|474067357|FG012|Primary Study|Migrated from study area|0|||
131667562|NCT00196976|474067358|FG013|Primary Study|Migrated from study area|0|||
131667563|NCT00196976|474067345|FG000|Primary Study|Protocol Violation|0|||
131667564|NCT00196976|474067346|FG001|Primary Study|Protocol Violation|1|||
131667565|NCT00196976|474067347|FG002|Primary Study|Protocol Violation|1|||
131667566|NCT00196976|474067348|FG003|Primary Study|Protocol Violation|0|||
131667567|NCT00196976|474067349|FG004|Primary Study|Protocol Violation|0|||
131667568|NCT00196976|474067350|FG005|Primary Study|Protocol Violation|0|||
131667569|NCT00196976|474067351|FG006|Primary Study|Protocol Violation|0|||
131667570|NCT00196976|474067352|FG007|Primary Study|Protocol Violation|0|||
131667571|NCT00196976|474067353|FG008|Primary Study|Protocol Violation|0|||
131667572|NCT00196976|474067354|FG009|Primary Study|Protocol Violation|0|||
131667573|NCT00196976|474067355|FG010|Primary Study|Protocol Violation|0|||
131667574|NCT00196976|474067356|FG011|Primary Study|Protocol Violation|0|||
131667575|NCT00196976|474067357|FG012|Primary Study|Protocol Violation|0|||
131667576|NCT00196976|474067358|FG013|Primary Study|Protocol Violation|0|||
131667577|NCT00196976|474067345|FG000|Primary Study|Withdrawal by Subject|1|||
131667578|NCT00196976|474067346|FG001|Primary Study|Withdrawal by Subject|0|||
131667579|NCT00196976|474067347|FG002|Primary Study|Withdrawal by Subject|1|||
131667580|NCT00196976|474067348|FG003|Primary Study|Withdrawal by Subject|1|||
131667581|NCT00196976|474067349|FG004|Primary Study|Withdrawal by Subject|2|||
131667582|NCT00196976|474067350|FG005|Primary Study|Withdrawal by Subject|1|||
131667583|NCT00196976|474067351|FG006|Primary Study|Withdrawal by Subject|0|||
131667584|NCT00196976|474067352|FG007|Primary Study|Withdrawal by Subject|0|||
131667585|NCT00196976|474067353|FG008|Primary Study|Withdrawal by Subject|0|||
131667586|NCT00196976|474067354|FG009|Primary Study|Withdrawal by Subject|1|||
131667587|NCT00196976|474067355|FG010|Primary Study|Withdrawal by Subject|0|||
131667588|NCT00196976|474067356|FG011|Primary Study|Withdrawal by Subject|0|||
131667589|NCT00196976|474067357|FG012|Primary Study|Withdrawal by Subject|0|||
131667590|NCT00196976|474067358|FG013|Primary Study|Withdrawal by Subject|0|||
131667591|NCT00196976|474067345|FG000|Primary Study|Lost to Follow-up|0|||
131667592|NCT00196976|474067346|FG001|Primary Study|Lost to Follow-up|0|||
131667593|NCT00196976|474067347|FG002|Primary Study|Lost to Follow-up|0|||
131667594|NCT00196976|474067348|FG003|Primary Study|Lost to Follow-up|0|||
131667595|NCT00196976|474067349|FG004|Primary Study|Lost to Follow-up|1|||
131667596|NCT00196976|474067350|FG005|Primary Study|Lost to Follow-up|1|||
131667597|NCT00196976|474067351|FG006|Primary Study|Lost to Follow-up|0|||
131667598|NCT00196976|474067352|FG007|Primary Study|Lost to Follow-up|2|||
131667599|NCT00196976|474067353|FG008|Primary Study|Lost to Follow-up|0|||
131667600|NCT00196976|474067354|FG009|Primary Study|Lost to Follow-up|0|||
131667601|NCT00196976|474067355|FG010|Primary Study|Lost to Follow-up|0|||
131667602|NCT00196976|474067356|FG011|Primary Study|Lost to Follow-up|0|||
131667603|NCT00196976|474067357|FG012|Primary Study|Lost to Follow-up|0|||
131667604|NCT00196976|474067358|FG013|Primary Study|Lost to Follow-up|0|||
131667605|NCT00196976|474067345|FG000|Primary Study|Other|0|||
131667606|NCT00196976|474067346|FG001|Primary Study|Other|0|||
131667607|NCT00196976|474067347|FG002|Primary Study|Other|2|||
131667608|NCT00196976|474067348|FG003|Primary Study|Other|0|||
131667609|NCT00196976|474067349|FG004|Primary Study|Other|0|||
131667610|NCT00196976|474067350|FG005|Primary Study|Other|0|||
131667611|NCT00196976|474067351|FG006|Primary Study|Other|0|||
131667612|NCT00196976|474067352|FG007|Primary Study|Other|0|||
131667613|NCT00196976|474067353|FG008|Primary Study|Other|0|||
131667614|NCT00196976|474067354|FG009|Primary Study|Other|0|||
131667615|NCT00196976|474067355|FG010|Primary Study|Other|0|||
131667616|NCT00196976|474067356|FG011|Primary Study|Other|0|||
131667617|NCT00196976|474067357|FG012|Primary Study|Other|0|||
131667618|NCT00196976|474067358|FG013|Primary Study|Other|0|||
131667619|NCT00196976|474067345|FG000|Booster Study|Withdrawal by Subject|0|||
131667620|NCT00196976|474067346|FG001|Booster Study|Withdrawal by Subject|0|||
131667621|NCT00196976|474067347|FG002|Booster Study|Withdrawal by Subject|0|||
131667622|NCT00196976|474067348|FG003|Booster Study|Withdrawal by Subject|0|||
131667623|NCT00196976|474067349|FG004|Booster Study|Withdrawal by Subject|0|||
131667624|NCT00196976|474067350|FG005|Booster Study|Withdrawal by Subject|0|||
131667625|NCT00196976|474067351|FG006|Booster Study|Withdrawal by Subject|0|||
131667626|NCT00196976|474067352|FG007|Booster Study|Withdrawal by Subject|0|||
131667627|NCT00196976|474067353|FG008|Booster Study|Withdrawal by Subject|0|||
131667628|NCT00196976|474067354|FG009|Booster Study|Withdrawal by Subject|0|||
131667629|NCT00196976|474067355|FG010|Booster Study|Withdrawal by Subject|1|||
131667630|NCT00196976|474067356|FG011|Booster Study|Withdrawal by Subject|0|||
131667631|NCT00196976|474067357|FG012|Booster Study|Withdrawal by Subject|0|||
131667632|NCT00196976|474067358|FG013|Booster Study|Withdrawal by Subject|0|||
131667633|NCT00196976|474067345|FG000|Booster Study|Lost to Follow-up|0|||
131667634|NCT00196976|474067346|FG001|Booster Study|Lost to Follow-up|0|||
131667635|NCT00196976|474067347|FG002|Booster Study|Lost to Follow-up|0|||
131667636|NCT00196976|474067348|FG003|Booster Study|Lost to Follow-up|0|||
131667637|NCT00196976|474067349|FG004|Booster Study|Lost to Follow-up|0|||
131667638|NCT00196976|474067350|FG005|Booster Study|Lost to Follow-up|0|||
131667639|NCT00196976|474067351|FG006|Booster Study|Lost to Follow-up|0|||
131667640|NCT00196976|474067352|FG007|Booster Study|Lost to Follow-up|0|||
131667641|NCT00196976|474067353|FG008|Booster Study|Lost to Follow-up|0|||
131667642|NCT00196976|474067354|FG009|Booster Study|Lost to Follow-up|0|||
131667643|NCT00196976|474067355|FG010|Booster Study|Lost to Follow-up|1|||
131667644|NCT00196976|474067356|FG011|Booster Study|Lost to Follow-up|2|||
131667645|NCT00196976|474067357|FG012|Booster Study|Lost to Follow-up|0|||
131667646|NCT00196976|474067358|FG013|Booster Study|Lost to Follow-up|0|||
131667647|NCT01535560|474067359|FG000|Overall Study|Adverse Event|12|||
131667648|NCT01535560|474067360|FG001|Overall Study|Adverse Event|7|||
131667649|NCT01535560|474067359|FG000|Overall Study|Lost to Follow-up|1|||
131667650|NCT01535560|474067360|FG001|Overall Study|Lost to Follow-up|3|||
131667651|NCT01535560|474067359|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
131896615|NCT03300180|474906962|FG001|12 Month Outcome|Withdrawal by Subject|6|||
131896616|NCT03300180|474906963|FG002|12 Month Outcome|Withdrawal by Subject|6|||
131896617|NCT03300180|474906961|FG000|12 Month Outcome|Death|9|||
131896618|NCT03300180|474906962|FG001|12 Month Outcome|Death|6|||
131896619|NCT03300180|474906963|FG002|12 Month Outcome|Death|6|||
131896620|NCT03300180|474906961|FG000|12 Month Outcome|Missed Assessment|62|||
131667652|NCT01535560|474067360|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
131667653|NCT01535560|474067359|FG000|Overall Study|Treatment Failure|21|||
131667654|NCT01535560|474067360|FG001|Overall Study|Treatment Failure|83|||
131667655|NCT01535560|474067359|FG000|Overall Study|Other|0|||
131667656|NCT01535560|474067360|FG001|Overall Study|Other|1|||
131667657|NCT01535560|474067359|FG000|Overall Study|Randomized in Error|0|||
131667658|NCT01535560|474067360|FG001|Overall Study|Randomized in Error|1|||
131667659|NCT02009761|474067361|FG000|Overall Study|Adverse Event|4|||
131667660|NCT02842827|474067364|FG000|Overall Study|Adverse Event|0|||
131667661|NCT02842827|474067365|FG001|Overall Study|Adverse Event|1|||
131667662|NCT02842827|474067366|FG002|Overall Study|Adverse Event|0|||
131667663|NCT02842827|474067367|FG003|Overall Study|Adverse Event|1|||
131667664|NCT02842827|474067368|FG004|Overall Study|Adverse Event|0|||
131667665|NCT02842827|474067369|FG005|Overall Study|Adverse Event|1|||
131667666|NCT02842827|474067370|FG006|Overall Study|Adverse Event|0|||
131667667|NCT02842827|474067371|FG007|Overall Study|Adverse Event|0|||
131667668|NCT02842827|474067364|FG000|Overall Study|Death|1|||
131667669|NCT02842827|474067365|FG001|Overall Study|Death|0|||
131667670|NCT02842827|474067366|FG002|Overall Study|Death|2|||
131667671|NCT02842827|474067367|FG003|Overall Study|Death|3|||
131667672|NCT02842827|474067368|FG004|Overall Study|Death|2|||
131667673|NCT02842827|474067369|FG005|Overall Study|Death|1|||
131667674|NCT02842827|474067370|FG006|Overall Study|Death|0|||
131667675|NCT02842827|474067371|FG007|Overall Study|Death|4|||
131667676|NCT02842827|474067364|FG000|Overall Study|Physician Decision|1|||
131667677|NCT02842827|474067365|FG001|Overall Study|Physician Decision|3|||
131667678|NCT02842827|474067366|FG002|Overall Study|Physician Decision|0|||
131667679|NCT02842827|474067367|FG003|Overall Study|Physician Decision|0|||
131667680|NCT02842827|474067368|FG004|Overall Study|Physician Decision|1|||
131667681|NCT02842827|474067369|FG005|Overall Study|Physician Decision|4|||
131667682|NCT02842827|474067370|FG006|Overall Study|Physician Decision|2|||
131667683|NCT02842827|474067371|FG007|Overall Study|Physician Decision|1|||
131667684|NCT02842827|474067364|FG000|Overall Study|Protocol Defined Disease Progression|0|||
131667685|NCT02842827|474067365|FG001|Overall Study|Protocol Defined Disease Progression|0|||
131667686|NCT02842827|474067366|FG002|Overall Study|Protocol Defined Disease Progression|0|||
131667687|NCT02842827|474067367|FG003|Overall Study|Protocol Defined Disease Progression|0|||
131667688|NCT02842827|474067368|FG004|Overall Study|Protocol Defined Disease Progression|0|||
131667689|NCT02842827|474067369|FG005|Overall Study|Protocol Defined Disease Progression|1|||
131667690|NCT02842827|474067370|FG006|Overall Study|Protocol Defined Disease Progression|0|||
131667691|NCT02842827|474067371|FG007|Overall Study|Protocol Defined Disease Progression|0|||
131667692|NCT02842827|474067364|FG000|Overall Study|Participant Withdrawal of Consent|1|||
131667693|NCT02842827|474067365|FG001|Overall Study|Participant Withdrawal of Consent|2|||
131667694|NCT02842827|474067366|FG002|Overall Study|Participant Withdrawal of Consent|2|||
131667695|NCT02842827|474067367|FG003|Overall Study|Participant Withdrawal of Consent|2|||
131667696|NCT02842827|474067368|FG004|Overall Study|Participant Withdrawal of Consent|2|||
131667697|NCT02842827|474067369|FG005|Overall Study|Participant Withdrawal of Consent|1|||
131667698|NCT02842827|474067370|FG006|Overall Study|Participant Withdrawal of Consent|2|||
131667699|NCT02842827|474067371|FG007|Overall Study|Participant Withdrawal of Consent|1|||
131667700|NCT02372136|474067376|FG000|Overall Study|Death|3|||
131667701|NCT02372136|474067377|FG001|Overall Study|Death|1|||
131667702|NCT00985946|474067378|FG000|Overall Study|Lost to Follow-up|6|||
131667703|NCT00985946|474067378|FG000|Overall Study|Withdrawal by Subject|1|||
131667704|NCT02471833|474067379|FG000|Overall Study|Lost to Follow-up|1|||
131667705|NCT02471833|474067380|FG001|Overall Study|Lost to Follow-up|0|||
131667706|NCT02471833|474067381|FG002|Overall Study|Lost to Follow-up|0|||
131667707|NCT02471833|474067379|FG000|Overall Study|Withdrawal by Subject|2|||
131667708|NCT02471833|474067380|FG001|Overall Study|Withdrawal by Subject|1|||
131667709|NCT02471833|474067381|FG002|Overall Study|Withdrawal by Subject|5|||
131667710|NCT02673515|474067382|FG000|Overall Study|Lack of motivation|2|||
131667711|NCT02673515|474067383|FG001|Overall Study|Lack of motivation|1|||
131667712|NCT00490724|474067385|FG000|Period I|Physician Decision|0|||
131667713|NCT00490724|474067386|FG001|Period I|Physician Decision|0|||
131667714|NCT00490724|474067387|FG002|Period I|Physician Decision|1|||
131667715|NCT00490724|474067385|FG000|Period II|Treatment Discontinuation|3|||
131667716|NCT00490724|474067386|FG001|Period II|Treatment Discontinuation|1|||
131667717|NCT00490724|474067387|FG002|Period II|Treatment Discontinuation|3|||
131667718|NCT03432260|474067388|FG000|Overall Study|Lost to Follow-up|1|||
131667719|NCT03432260|474067389|FG001|Overall Study|Lost to Follow-up|1|||
131667720|NCT03432260|474067390|FG002|Overall Study|Lost to Follow-up|0|||
131667721|NCT03432260|474067391|FG003|Overall Study|Lost to Follow-up|0|||
131667722|NCT03432260|474067392|FG004|Overall Study|Lost to Follow-up|1|||
131667723|NCT01775124|474067393|FG000|Core Period|Disease Progression|0|||
131667724|NCT01775124|474067394|FG001|Core Period|Disease Progression|1|||
131667725|NCT01775124|474067393|FG000|Core Period|Physician Decision|1|||
131667726|NCT01775124|474067394|FG001|Core Period|Physician Decision|1|||
131667727|NCT01775124|474067393|FG000|Core Period|Death|0|||
131667728|NCT01775124|474067394|FG001|Core Period|Death|1|||
131667729|NCT01775124|474067393|FG000|Core Period|Administrative problems|1|||
131667730|NCT01775124|474067394|FG001|Core Period|Administrative problems|0|||
131667731|NCT01775124|474067393|FG000|Core Period|Withdrawal by Subject|4|||
131554705|NCT00265330|473654804|FG000|Overall Study|Withdrawal by Subject|34|||
131554706|NCT00265330|473654804|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
131554707|NCT00265330|473654804|FG000|Overall Study|Lack of Efficacy|4|||
131554708|NCT00265330|473654804|FG000|Overall Study|Family Scheduling Conflicts|1|||
131554709|NCT00265330|473654804|FG000|Overall Study|Began Taking Formulary Geodon|1|||
131554710|NCT00265330|473654804|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
131554711|NCT00265330|473654804|FG000|Overall Study|Site Closed by Sponsor|1|||
131554712|NCT00265330|473654804|FG000|Overall Study|Principal Investigators Request|1|||
131554713|NCT00265330|473654804|FG000|Overall Study|Withdrew Consent|1|||
131554714|NCT00265330|473654804|FG000|Overall Study|Protocol Violation|1|||
131554715|NCT01396317|473654809|FG000|Overall Study|Adverse Event|1|||
131554716|NCT01396317|473654810|FG001|Overall Study|Adverse Event|0|||
131554717|NCT02294474|473654811|FG000|Overall Study|Adverse Event|7|||
131554718|NCT02294474|473654812|FG001|Overall Study|Adverse Event|7|||
131554719|NCT02294474|473654811|FG000|Overall Study|Lack of Efficacy|2|||
131554720|NCT02294474|473654812|FG001|Overall Study|Lack of Efficacy|1|||
131554721|NCT02294474|473654811|FG000|Overall Study|Protocol Violation|4|||
131554722|NCT02294474|473654812|FG001|Overall Study|Protocol Violation|2|||
131554723|NCT02294474|473654811|FG000|Overall Study|Other than specified above|12|||
131554724|NCT02294474|473654812|FG001|Overall Study|Other than specified above|12|||
131554725|NCT03443713|473654813|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
131554726|NCT03443713|473654814|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
131554727|NCT03443713|473654815|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
131554728|NCT02944656|473654817|FG000|Overall Study|No longer eligible|3|||
131554729|NCT02944656|473654818|FG001|Overall Study|No longer eligible|0|||
131554730|NCT02944656|473654817|FG000|Overall Study|Lost to Follow-up|7|||
131554731|NCT02944656|473654818|FG001|Overall Study|Lost to Follow-up|10|||
131554732|NCT05879198|473654821|FG000|Overall Study|Lost to Follow-up|1|||
131554733|NCT02073097|473654822|FG000|Overall Study|Adverse Event|0|||
131554734|NCT02073097|473654823|FG001|Overall Study|Adverse Event|0|||
131554735|NCT02073097|473654824|FG002|Overall Study|Adverse Event|0|||
131554736|NCT02073097|473654825|FG003|Overall Study|Adverse Event|0|||
131554737|NCT02073097|473654826|FG004|Overall Study|Adverse Event|0|||
131554738|NCT02073097|473654827|FG005|Overall Study|Adverse Event|0|||
131554739|NCT02073097|473654828|FG006|Overall Study|Adverse Event|0|||
131554740|NCT02073097|473654829|FG007|Overall Study|Adverse Event|2|||
131554741|NCT02073097|473654822|FG000|Overall Study|Withdrawal by Subject|0|||
131554742|NCT02073097|473654823|FG001|Overall Study|Withdrawal by Subject|0|||
131554743|NCT02073097|473654824|FG002|Overall Study|Withdrawal by Subject|0|||
131554744|NCT02073097|473654825|FG003|Overall Study|Withdrawal by Subject|0|||
131554745|NCT02073097|473654826|FG004|Overall Study|Withdrawal by Subject|0|||
131554746|NCT02073097|473654827|FG005|Overall Study|Withdrawal by Subject|0|||
131554747|NCT02073097|473654828|FG006|Overall Study|Withdrawal by Subject|0|||
131554748|NCT02073097|473654829|FG007|Overall Study|Withdrawal by Subject|2|||
131554749|NCT02073097|473654822|FG000|Overall Study|Death|0|||
131554750|NCT02073097|473654823|FG001|Overall Study|Death|0|||
131554751|NCT02073097|473654824|FG002|Overall Study|Death|0|||
131554752|NCT02073097|473654825|FG003|Overall Study|Death|0|||
131554753|NCT02073097|473654826|FG004|Overall Study|Death|0|||
131554754|NCT02073097|473654827|FG005|Overall Study|Death|0|||
131554755|NCT02073097|473654828|FG006|Overall Study|Death|0|||
131554756|NCT02073097|473654829|FG007|Overall Study|Death|1|||
131554757|NCT02073097|473654822|FG000|Overall Study|Physician Decision|0|||
131554758|NCT02073097|473654823|FG001|Overall Study|Physician Decision|0|||
131554759|NCT02073097|473654824|FG002|Overall Study|Physician Decision|0|||
131554760|NCT02073097|473654825|FG003|Overall Study|Physician Decision|0|||
131554761|NCT02073097|473654826|FG004|Overall Study|Physician Decision|0|||
131554762|NCT02073097|473654827|FG005|Overall Study|Physician Decision|0|||
131554763|NCT02073097|473654828|FG006|Overall Study|Physician Decision|0|||
131554764|NCT02073097|473654829|FG007|Overall Study|Physician Decision|1|||
131554765|NCT04022889|473656291|FG000|Stage 1: Period 1|Adverse Event|1|||
131554766|NCT04022889|473656292|FG001|Stage 1: Period 1|Adverse Event|0|||
131554767|NCT04022889|473656293|FG002|Stage 1: Period 1|Adverse Event|0|||
131554768|NCT04022889|473656291|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
131554769|NCT04022889|473656292|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
131554770|NCT04022889|473656293|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
131667732|NCT01775124|474067394|FG001|Core Period|Withdrawal by Subject|2|||
131667733|NCT01775124|474067393|FG000|Core Period|Adverse Event|5|||
131896621|NCT03300180|474906962|FG001|12 Month Outcome|Missed Assessment|59|||
131554771|NCT04022889|473656291|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
131667734|NCT01775124|474067394|FG001|Core Period|Adverse Event|5|||
131896622|NCT03300180|474906963|FG002|12 Month Outcome|Missed Assessment|58|||
131896623|NCT03300180|474906961|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
131896624|NCT03300180|474906962|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
131896625|NCT03300180|474906963|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
131896626|NCT03300180|474906961|FG000|18 Month Outcome Assessment|Death|8|||
131896627|NCT03300180|474906962|FG001|18 Month Outcome Assessment|Death|5|||
131667735|NCT01775124|474067393|FG000|Extension Period|Adverse Event|3|||
131667736|NCT01775124|474067394|FG001|Extension Period|Adverse Event|2|||
131667737|NCT01775124|474067393|FG000|Extension Period|Physician Decision|0|||
131667738|NCT01775124|474067394|FG001|Extension Period|Physician Decision|2|||
131667739|NCT01775124|474067393|FG000|Extension Period|Administrative problems|0|||
131667740|NCT01775124|474067394|FG001|Extension Period|Administrative problems|1|||
131667741|NCT01775124|474067393|FG000|Extension Period|Lost to Follow-up|0|||
131667742|NCT01775124|474067394|FG001|Extension Period|Lost to Follow-up|1|||
131667743|NCT01775124|474067393|FG000|Extension Period|Withdrawal by Subject|9|||
131667744|NCT01775124|474067394|FG001|Extension Period|Withdrawal by Subject|12|||
131667745|NCT02164383|474069519|FG000|Overall Study|Lost to Follow-up|1|||
131667746|NCT02164383|474069520|FG001|Overall Study|Lost to Follow-up|0|||
131667747|NCT02831387|474069521|FG000|Overall Study|Withdrawal by Subject|1|||
131667748|NCT02831387|474069522|FG001|Overall Study|Withdrawal by Subject|1|||
131667749|NCT02831387|474069521|FG000|Overall Study|Discontinued due to stock recovery|0|||
131667750|NCT02831387|474069522|FG001|Overall Study|Discontinued due to stock recovery|1|||
131667751|NCT00192647|474069523|FG000|Overall Study|Death|1|||
131667752|NCT00192647|474069524|FG001|Overall Study|Death|1|||
131667753|NCT00192647|474069523|FG000|Overall Study|Adverse Event|35|||
131667754|NCT00192647|474069524|FG001|Overall Study|Adverse Event|29|||
131667755|NCT00192647|474069523|FG000|Overall Study|Laboratory Test Abnormality|4|||
131667756|NCT00192647|474069524|FG001|Overall Study|Laboratory Test Abnormality|2|||
131667757|NCT00192647|474069523|FG000|Overall Study|Insufficient Therapeutic Response|53|||
131667758|NCT00192647|474069524|FG001|Overall Study|Insufficient Therapeutic Response|83|||
131667759|NCT00192647|474069523|FG000|Overall Study|Entry Criteria Violation|6|||
131667760|NCT00192647|474069524|FG001|Overall Study|Entry Criteria Violation|6|||
131667761|NCT00192647|474069523|FG000|Overall Study|Protocol Violation|3|||
131667762|NCT00192647|474069524|FG001|Overall Study|Protocol Violation|1|||
131667763|NCT00192647|474069523|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
131667764|NCT00192647|474069524|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
131667765|NCT00192647|474069523|FG000|Overall Study|Failure to Return|11|||
131667766|NCT00192647|474069524|FG001|Overall Study|Failure to Return|13|||
131667767|NCT00192647|474069523|FG000|Overall Study|Other/Administrative|5|||
131667768|NCT00192647|474069524|FG001|Overall Study|Other/Administrative|3|||
131667769|NCT00690443|474069525|FG000|Overall Study|Adverse Event|1|||
131667770|NCT00690443|474069526|FG001|Overall Study|Adverse Event|2|||
131667771|NCT01350336|474069527|FG000|Overall Study|Lost to Follow-up|31|||
131667772|NCT01350336|474069527|FG000|Overall Study|Withdrawal by Subject|14|||
131667773|NCT01350336|474069527|FG000|Overall Study|Physician Decision|8|||
131667774|NCT01350336|474069527|FG000|Overall Study|Death|4|||
131667775|NCT00896051|474069531|FG000|Overall Study|Adverse Event|2|||
131667776|NCT00896051|474069532|FG001|Overall Study|Adverse Event|1|||
131667777|NCT00896051|474069531|FG000|Overall Study|Lost to Follow-up|3|||
131667778|NCT00896051|474069532|FG001|Overall Study|Lost to Follow-up|2|||
131667779|NCT00896051|474069531|FG000|Overall Study|Withdrawal by Subject|3|||
131667780|NCT00896051|474069532|FG001|Overall Study|Withdrawal by Subject|2|||
131667781|NCT00896051|474069531|FG000|Overall Study|Subject noncompliant|1|||
131667782|NCT00896051|474069532|FG001|Overall Study|Subject noncompliant|3|||
131667783|NCT00896051|474069531|FG000|Overall Study|Other|1|||
131667784|NCT00896051|474069532|FG001|Overall Study|Other|1|||
131667785|NCT02935452|474069533|FG000|Overall Study|work and life commintment|3|||
131667786|NCT02935452|474069534|FG001|Overall Study|work and life commintment|1|||
131667787|NCT00876928|474069535|FG000|Overall Study|Lost to Follow-up|2|||
131667788|NCT00876928|474069536|FG001|Overall Study|Lost to Follow-up|5|||
131667789|NCT00876928|474069535|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
131667790|NCT00876928|474069536|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
131667791|NCT02336178|474069537|FG000|Overall Study|Lost to Follow-up|1|||
131667792|NCT02336178|474069537|FG000|Overall Study|Protocol Violation|1|||
131667793|NCT02336178|474069537|FG000|Overall Study|Withdrawal by Subject|1|||
131667794|NCT02336178|474069537|FG000|Overall Study|Other|1|||
131667795|NCT00618982|474069538|FG000|Overall Study|Adverse Event|23|||
131667796|NCT00618982|474069538|FG000|Overall Study|Withdrawal by Subject|1|||
131667797|NCT00618982|474069538|FG000|Overall Study|Protocol Violation|1|||
131667798|NCT00618982|474069538|FG000|Overall Study|ongoing, still treated with study med.|25|||
131667799|NCT01776541|474069541|FG000|Overall Study|Administrative Reason|6|||
131667800|NCT01776541|474069542|FG001|Overall Study|Administrative Reason|2|||
131667801|NCT01776541|474069541|FG000|Overall Study|Death|4|||
131667802|NCT01776541|474069542|FG001|Overall Study|Death|0|||
131667803|NCT01776541|474069541|FG000|Overall Study|Lost to Follow-up|27|||
131667804|NCT01776541|474069542|FG001|Overall Study|Lost to Follow-up|48|||
131667805|NCT01776541|474069541|FG000|Overall Study|Unclassified|5|||
131667806|NCT01776541|474069542|FG001|Overall Study|Unclassified|4|||
131667807|NCT01776541|474069541|FG000|Overall Study|Protocol Violation|2|||
131667808|NCT01776541|474069542|FG001|Overall Study|Protocol Violation|1|||
131667809|NCT01776541|474069541|FG000|Overall Study|Withdrawal by Subject|12|||
131667810|NCT01776541|474069542|FG001|Overall Study|Withdrawal by Subject|20|||
131667811|NCT00156819|474069543|FG000|Overall Study|Lost to Follow-up|1|||
131667812|NCT00156819|474069544|FG001|Overall Study|Lost to Follow-up|1|||
131667813|NCT00156819|474069545|FG002|Overall Study|Lost to Follow-up|3|||
131667814|NCT02090959|474069546|FG000|Overall Study|Withdrawal by Subject|10|||
131667815|NCT02090959|474069546|FG000|Overall Study|Adverse Event|1|||
131667816|NCT02090959|474069546|FG000|Overall Study|Investigator decision|2|||
131667817|NCT02090959|474069546|FG000|Overall Study|Study termination|6|||
131667818|NCT02090959|474069546|FG000|Overall Study|Enrolled but not treated|1|||
131667819|NCT02090959|474069546|FG000|Overall Study|Transfer for compassionate use medicine|4|||
131667820|NCT02090959|474069546|FG000|Overall Study|Move to medical need program|3|||
131667821|NCT02090959|474069546|FG000|Overall Study|Entered in to other study|34|||
131667822|NCT02090959|474069546|FG000|Overall Study|Switched to commercial supply|88|||
131667823|NCT02090959|474069546|FG000|Overall Study|Other than specified|2|||
131667824|NCT00522873|474069549|FG000|Overall Study|Adverse Event|41|||
131667825|NCT00522873|474069550|FG001|Overall Study|Adverse Event|26|||
131667826|NCT00522873|474069549|FG000|Overall Study|Withdrawal by Subject|20|||
131667827|NCT00522873|474069550|FG001|Overall Study|Withdrawal by Subject|9|||
131667828|NCT00522873|474069549|FG000|Overall Study|Protocol Violation|14|||
131667829|NCT00522873|474069550|FG001|Overall Study|Protocol Violation|4|||
131667830|NCT00522873|474069549|FG000|Overall Study|Lost to Follow-up|11|||
131667831|NCT00522873|474069550|FG001|Overall Study|Lost to Follow-up|3|||
131667832|NCT00522873|474069549|FG000|Overall Study|Personal Reasons|8|||
131667833|NCT00522873|474069550|FG001|Overall Study|Personal Reasons|1|||
131667834|NCT00522873|474069549|FG000|Overall Study|Medication Errors|1|||
131667835|NCT00522873|474069550|FG001|Overall Study|Medication Errors|1|||
131667836|NCT00522873|474069549|FG000|Overall Study|Never Received Medication|1|||
131667837|NCT00522873|474069550|FG001|Overall Study|Never Received Medication|0|||
131667838|NCT00822172|474069553|FG000|Overall Study|Adverse Event|10|||
131667839|NCT00822172|474069554|FG001|Overall Study|Adverse Event|12|||
131667840|NCT00822172|474069553|FG000|Overall Study|Death|1|||
131667841|NCT00822172|474069554|FG001|Overall Study|Death|0|||
131667842|NCT00822172|474069553|FG000|Overall Study|Lost to Follow-up|3|||
131667843|NCT00822172|474069554|FG001|Overall Study|Lost to Follow-up|1|||
131667844|NCT00822172|474069553|FG000|Overall Study|Withdrawal by Subject|1|||
131667845|NCT00822172|474069554|FG001|Overall Study|Withdrawal by Subject|4|||
131667846|NCT00822172|474069553|FG000|Overall Study|site closed|0|||
131667847|NCT00822172|474069554|FG001|Overall Study|site closed|1|||
131667848|NCT00822172|474069553|FG000|Overall Study|Other|0|||
131667849|NCT00822172|474069554|FG001|Overall Study|Other|1|||
131667850|NCT00700258|474069555|FG000|Overall Study|Premature discontinuation of documentation|136|||
131667851|NCT00700258|474069555|FG000|Overall Study|Type of study end not documented|1|||
131667852|NCT00700258|474069555|FG000|Overall Study|Lost to Follow-up|81|||
131667853|NCT00700258|474069555|FG000|Overall Study|Premature discontinuation of therapy|1013|||
131667854|NCT00738582|474069559|FG000|Combination Therapy|Completed Combination Therapy|1|||
131667855|NCT00738582|474069560|FG001|Combination Therapy|Completed Combination Therapy|0|||
131667856|NCT00738582|474069559|FG000|Combination Therapy|Physician Decision|1|||
131667857|NCT00738582|474069560|FG001|Combination Therapy|Physician Decision|0|||
131667858|NCT00738582|474069559|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
131667859|NCT00738582|474069560|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
131667860|NCT00738582|474069559|FG000|Combination Therapy|Other|5|||
131667861|NCT00738582|474069560|FG001|Combination Therapy|Other|0|||
131667862|NCT00738582|474069559|FG000|Combination Therapy|Adverse Event|16|||
131667863|NCT00738582|474069560|FG001|Combination Therapy|Adverse Event|0|||
131667864|NCT00738582|474069559|FG000|Combination Therapy|Progressive Disease|9|||
131667865|NCT00738582|474069560|FG001|Combination Therapy|Progressive Disease|0|||
131667866|NCT00738582|474069559|FG000|Maintenance Therapy|Other|0|||
131667867|NCT00738582|474069560|FG001|Maintenance Therapy|Other|2|||
131667868|NCT00738582|474069559|FG000|Maintenance Therapy|Adverse Event|0|||
131667869|NCT00738582|474069560|FG001|Maintenance Therapy|Adverse Event|6|||
131667870|NCT00738582|474069559|FG000|Maintenance Therapy|Progressive Disease|0|||
131667871|NCT00738582|474069560|FG001|Maintenance Therapy|Progressive Disease|47|||
131667872|NCT00738582|474069559|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
131667873|NCT00738582|474069560|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
131667874|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
131667875|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
131667876|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
131667877|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
131667878|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
131667879|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
131667880|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
131667881|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
131667882|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
131667883|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
131667884|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
131667885|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
131667886|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
131667887|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
131667888|NCT00757588|474069561|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
131667889|NCT00757588|474069562|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
131667890|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
131667891|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
131667892|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
131896628|NCT03300180|474906963|FG002|18 Month Outcome Assessment|Death|5|||
131896629|NCT03300180|474906961|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
131896630|NCT03300180|474906962|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
131896631|NCT03300180|474906963|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
131896632|NCT03300180|474906961|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
131896633|NCT03300180|474906962|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
131896634|NCT03300180|474906963|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
131896635|NCT03300180|474906961|FG000|24 Month Outcome Assessment|Death|13|||
131896636|NCT03300180|474906962|FG001|24 Month Outcome Assessment|Death|13|||
131896637|NCT03300180|474906963|FG002|24 Month Outcome Assessment|Death|3|||
131896638|NCT03300180|474906961|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
131896639|NCT03300180|474906962|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
131896640|NCT03300180|474906963|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
131896641|NCT03654729|474908532|FG000|Overall Study|Death|9|||
131896642|NCT03654729|474908533|FG001|Overall Study|Death|9|||
131896643|NCT03654729|474908534|FG002|Overall Study|Death|16|||
131896644|NCT03654729|474908532|FG000|Overall Study|Withdrawal by Subject|8|||
131896645|NCT03654729|474908533|FG001|Overall Study|Withdrawal by Subject|6|||
131896646|NCT03654729|474908534|FG002|Overall Study|Withdrawal by Subject|4|||
131896647|NCT03654729|474908532|FG000|Overall Study|Study terminated by Sponsor|3|||
131896648|NCT03654729|474908533|FG001|Overall Study|Study terminated by Sponsor|5|||
131896649|NCT03654729|474908534|FG002|Overall Study|Study terminated by Sponsor|4|||
131896650|NCT03654729|474908532|FG000|Overall Study|Not reported|2|||
131896651|NCT03654729|474908533|FG001|Overall Study|Not reported|4|||
131896652|NCT03654729|474908534|FG002|Overall Study|Not reported|5|||
131896653|NCT03654729|474908532|FG000|Overall Study|Progressive disease|3|||
131896654|NCT03654729|474908533|FG001|Overall Study|Progressive disease|0|||
131896655|NCT03654729|474908534|FG002|Overall Study|Progressive disease|0|||
131896656|NCT03654729|474908532|FG000|Overall Study|Lost to Follow-up|2|||
131896657|NCT03654729|474908533|FG001|Overall Study|Lost to Follow-up|0|||
131896658|NCT03654729|474908534|FG002|Overall Study|Lost to Follow-up|0|||
131896659|NCT03654729|474908532|FG000|Overall Study|Physician Decision|2|||
131896660|NCT03654729|474908533|FG001|Overall Study|Physician Decision|0|||
131896661|NCT03654729|474908534|FG002|Overall Study|Physician Decision|0|||
131667893|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
131667894|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
131667895|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
131667896|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
131667897|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
131667898|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
131667899|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
131667900|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
131667901|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
131667902|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
131667903|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
131667904|NCT00757588|474069561|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
131667905|NCT00757588|474069562|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
131667906|NCT01052103|474069563|FG000|Overall Study|Adverse Event|10|||
131667907|NCT01052103|474069564|FG001|Overall Study|Adverse Event|6|||
131667908|NCT01052103|474069563|FG000|Overall Study|Entry Criteria Not Met|3|||
131667909|NCT01052103|474069564|FG001|Overall Study|Entry Criteria Not Met|1|||
131667910|NCT01052103|474069563|FG000|Overall Study|Lost to Follow-up|3|||
131667911|NCT01052103|474069564|FG001|Overall Study|Lost to Follow-up|5|||
131667912|NCT01052103|474069563|FG000|Overall Study|Protocol Violation|10|||
131667913|NCT01052103|474069564|FG001|Overall Study|Protocol Violation|4|||
131667914|NCT01052103|474069563|FG000|Overall Study|Scheduling conflict|2|||
131667915|NCT01052103|474069564|FG001|Overall Study|Scheduling conflict|1|||
131667916|NCT01052103|474069563|FG000|Overall Study|Sponsor Decision|2|||
131667917|NCT01052103|474069564|FG001|Overall Study|Sponsor Decision|0|||
131667918|NCT01052103|474069563|FG000|Overall Study|Withdrawal by Subject|3|||
131667919|NCT01052103|474069564|FG001|Overall Study|Withdrawal by Subject|6|||
131667920|NCT01052103|474069563|FG000|Overall Study|Perceived Lack of Efficacy|1|||
131667921|NCT01052103|474069564|FG001|Overall Study|Perceived Lack of Efficacy|0|||
131667922|NCT00799513|474069570|FG000|Overall Study|Physician Decision|1|||
131667923|NCT00799513|474069570|FG000|Overall Study|Adverse Event|1|||
131667924|NCT05398237|474069571|FG000|Overall Study|Withdrawal by Subject|1|||
131667925|NCT05062759|474069576|FG000|Overall Study|Death|0|||
131667926|NCT05062759|474069577|FG001|Overall Study|Death|1|||
131667927|NCT05062759|474069576|FG000|Overall Study|Lost to Follow-up|1|||
131667928|NCT05062759|474069577|FG001|Overall Study|Lost to Follow-up|0|||
131667929|NCT01248065|474069578|FG000|Overall Study|Lost to Follow-up|3|||
131667930|NCT01248065|474069579|FG001|Overall Study|Lost to Follow-up|5|||
131667931|NCT01248065|474069578|FG000|Overall Study|Withdrawal by Subject|14|||
131667932|NCT01248065|474069579|FG001|Overall Study|Withdrawal by Subject|11|||
131667933|NCT01248065|474069578|FG000|Overall Study|Adverse Event|3|||
131667934|NCT01248065|474069579|FG001|Overall Study|Adverse Event|0|||
131667935|NCT01248065|474069578|FG000|Overall Study|Third treatment failure event|3|||
131667936|NCT01248065|474069579|FG001|Overall Study|Third treatment failure event|1|||
131667937|NCT01248065|474069578|FG000|Overall Study|Other|3|||
131667938|NCT01248065|474069579|FG001|Overall Study|Other|5|||
131667939|NCT02781844|474069581|FG000|Treatment Period 1|Adverse Event|0|||
131667940|NCT02781844|474069582|FG001|Treatment Period 1|Adverse Event|0|||
131667941|NCT02781844|474069583|FG002|Treatment Period 1|Adverse Event|0|||
131667942|NCT02781844|474069584|FG003|Treatment Period 1|Adverse Event|0|||
131667943|NCT02781844|474069585|FG004|Treatment Period 1|Adverse Event|0|||
131667944|NCT02781844|474069586|FG005|Treatment Period 1|Adverse Event|1|||
131667945|NCT02781844|474069587|FG006|Treatment Period 1|Adverse Event|0|||
131667946|NCT02781844|474069588|FG007|Treatment Period 1|Adverse Event|0|||
131667947|NCT02518490|474069589|FG000|Overall Study|Withdrawal by Subject|1|||
131667948|NCT02518490|474069590|FG001|Overall Study|Withdrawal by Subject|1|||
131667949|NCT03010176|474069591|FG000|Overall Study|Death|21|||
131554772|NCT04022889|473656292|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
131554773|NCT04022889|473656293|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
131554774|NCT04022889|473656291|FG000|Stage 2|Screen Failure|0|||
131554775|NCT04022889|473656292|FG001|Stage 2|Screen Failure|0|||
131554776|NCT04022889|473656293|FG002|Stage 2|Screen Failure|3|||
131554777|NCT04022889|473656291|FG000|Stage 2|Ineligible for apheresis donation|0|||
131554778|NCT04022889|473656292|FG001|Stage 2|Ineligible for apheresis donation|0|||
131554779|NCT04022889|473656293|FG002|Stage 2|Ineligible for apheresis donation|2|||
131554780|NCT04022889|473656291|FG000|Stage 2|Adverse Event|0|||
131554781|NCT04022889|473656292|FG001|Stage 2|Adverse Event|0|||
131554782|NCT04022889|473656293|FG002|Stage 2|Adverse Event|2|||
131554783|NCT04022889|473656291|FG000|Stage 2|Protocol Violation|0|||
131554784|NCT04022889|473656292|FG001|Stage 2|Protocol Violation|0|||
131554785|NCT04022889|473656293|FG002|Stage 2|Protocol Violation|1|||
131554786|NCT04022889|473656291|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
131554787|NCT04022889|473656292|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
131554788|NCT04022889|473656293|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
131554789|NCT04741802|473656295|FG000|Overall Study|Death|1|||
131554790|NCT04741802|473656295|FG000|Overall Study|Lost to Follow-up|11|||
131554791|NCT01785563|473656297|FG000|Overall Study|Physician Decision|10|||
131554792|NCT01785563|473656297|FG000|Overall Study|Withdrawal by Subject|1|||
131554793|NCT01785563|473656297|FG000|Overall Study|Protocol Violation|2|||
131554794|NCT01872910|473656298|FG000|Overall Study|Lost to Follow-up|2|||
131554795|NCT01872910|473656299|FG001|Overall Study|Lost to Follow-up|0|||
131554796|NCT01872910|473656300|FG002|Overall Study|Lost to Follow-up|2|||
131554797|NCT01872910|473656301|FG003|Overall Study|Lost to Follow-up|0|||
131554798|NCT01872910|473656302|FG004|Overall Study|Lost to Follow-up|0|||
131554799|NCT01872910|473656303|FG005|Overall Study|Lost to Follow-up|0|||
131554800|NCT01616771|473656304|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
131554801|NCT00100932|473656305|FG000|Overall Study|Adverse Event|11|||
131554802|NCT00100932|473656306|FG001|Overall Study|Adverse Event|2|||
131554803|NCT00100932|473656305|FG000|Overall Study|Withdrawal by Subject|6|||
131554804|NCT00100932|473656306|FG001|Overall Study|Withdrawal by Subject|0|||
131554805|NCT00100932|473656305|FG000|Overall Study|Progressive Disease|44|||
131554806|NCT00100932|473656306|FG001|Overall Study|Progressive Disease|18|||
131554807|NCT00100932|473656305|FG000|Overall Study|Physician Decision|7|||
131554808|NCT00100932|473656306|FG001|Overall Study|Physician Decision|5|||
131554809|NCT00100932|473656305|FG000|Overall Study|Other|5|||
131554810|NCT00100932|473656306|FG001|Overall Study|Other|2|||
131554811|NCT00744328|473656307|FG000|Overall Study|Lost to Follow-up|2|||
131554812|NCT00744328|473656308|FG001|Overall Study|Lost to Follow-up|5|||
131554813|NCT00744328|473656309|FG002|Overall Study|Lost to Follow-up|3|||
131554814|NCT00744328|473656307|FG000|Overall Study|Withdrawal by Subject|5|||
131554815|NCT00744328|473656308|FG001|Overall Study|Withdrawal by Subject|3|||
131554816|NCT00744328|473656309|FG002|Overall Study|Withdrawal by Subject|4|||
131554817|NCT00744328|473656307|FG000|Overall Study|Found ineligible after randomization|0|||
131554818|NCT00744328|473656308|FG001|Overall Study|Found ineligible after randomization|0|||
131554819|NCT00744328|473656309|FG002|Overall Study|Found ineligible after randomization|1|||
131554820|NCT02387216|473656314|FG000|Overall Study|Progressive disease|2|||
131554821|NCT02387216|473656315|FG001|Overall Study|Progressive disease|0|||
131554822|NCT02387216|473656314|FG000|Overall Study|Withdrawal by Subject|3|||
131554823|NCT02387216|473656315|FG001|Overall Study|Withdrawal by Subject|5|||
131554824|NCT02387216|473656314|FG000|Overall Study|Physician Decision|2|||
131554825|NCT02387216|473656315|FG001|Overall Study|Physician Decision|0|||
131554826|NCT02387216|473656314|FG000|Overall Study|Sponsor Decision|28|||
131554827|NCT02387216|473656315|FG001|Overall Study|Sponsor Decision|12|||
131554828|NCT02387216|473656314|FG000|Overall Study|Death|60|||
131554829|NCT02387216|473656315|FG001|Overall Study|Death|23|||
131554830|NCT02387216|473656314|FG000|Overall Study|Other|5|||
131554831|NCT02387216|473656315|FG001|Overall Study|Other|4|||
131554832|NCT02387216|473656314|FG000|Overall Study|Lost to Follow-up|0|||
131554833|NCT02387216|473656315|FG001|Overall Study|Lost to Follow-up|3|||
131554834|NCT05952297|473656317|FG000|Overall Study|Withdrawal by Subject|1|||
131554835|NCT05952297|473656318|FG001|Overall Study|Withdrawal by Subject|0|||
131554836|NCT04078035|473656319|FG000|Session 2|Lost to Follow-up|3|||
131554837|NCT04078035|473656320|FG001|Session 2|Lost to Follow-up|1|||
131554838|NCT04078035|473656319|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
131554839|NCT04078035|473656320|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
131554840|NCT01013792|473656321|FG000|Overall Study|Study suspended|2|||
131554841|NCT01013792|473656322|FG001|Overall Study|Study suspended|1|||
131554842|NCT01013792|473656321|FG000|Overall Study|Adverse Event|0|||
131554843|NCT01013792|473656322|FG001|Overall Study|Adverse Event|3|||
131554844|NCT01013792|473656321|FG000|Overall Study|Lost to Follow-up|0|||
131554845|NCT01013792|473656322|FG001|Overall Study|Lost to Follow-up|1|||
131554846|NCT02100722|473656323|FG000|Overall Study|Withdrawal pre-procedure|4|||
131667950|NCT03010176|474069592|FG001|Overall Study|Death|35|||
131667951|NCT03010176|474069593|FG002|Overall Study|Death|19|||
131667952|NCT03010176|474069594|FG003|Overall Study|Death|19|||
131667953|NCT03010176|474069595|FG004|Overall Study|Death|14|||
131667954|NCT03010176|474069596|FG005|Overall Study|Death|0|||
131667955|NCT03010176|474069591|FG000|Overall Study|Lost to Follow-up|0|||
131667956|NCT03010176|474069592|FG001|Overall Study|Lost to Follow-up|0|||
131667957|NCT03010176|474069593|FG002|Overall Study|Lost to Follow-up|0|||
131667958|NCT03010176|474069594|FG003|Overall Study|Lost to Follow-up|0|||
131667959|NCT03010176|474069595|FG004|Overall Study|Lost to Follow-up|1|||
131667960|NCT03010176|474069596|FG005|Overall Study|Lost to Follow-up|0|||
131667961|NCT03010176|474069591|FG000|Overall Study|Physician Decision|0|||
131667962|NCT03010176|474069592|FG001|Overall Study|Physician Decision|4|||
131667963|NCT03010176|474069593|FG002|Overall Study|Physician Decision|0|||
131667964|NCT03010176|474069594|FG003|Overall Study|Physician Decision|1|||
131667965|NCT03010176|474069595|FG004|Overall Study|Physician Decision|0|||
131667966|NCT03010176|474069596|FG005|Overall Study|Physician Decision|0|||
131667967|NCT03010176|474069591|FG000|Overall Study|Sponsor Decision|0|||
131667968|NCT03010176|474069592|FG001|Overall Study|Sponsor Decision|4|||
131667969|NCT03010176|474069593|FG002|Overall Study|Sponsor Decision|4|||
131667970|NCT03010176|474069594|FG003|Overall Study|Sponsor Decision|1|||
131667971|NCT03010176|474069595|FG004|Overall Study|Sponsor Decision|6|||
131667972|NCT03010176|474069596|FG005|Overall Study|Sponsor Decision|0|||
131667973|NCT03010176|474069591|FG000|Overall Study|Withdrawal by Subject|11|||
131667974|NCT03010176|474069592|FG001|Overall Study|Withdrawal by Subject|9|||
131667975|NCT03010176|474069593|FG002|Overall Study|Withdrawal by Subject|3|||
131667976|NCT03010176|474069594|FG003|Overall Study|Withdrawal by Subject|0|||
131667977|NCT03010176|474069595|FG004|Overall Study|Withdrawal by Subject|4|||
131667978|NCT03010176|474069596|FG005|Overall Study|Withdrawal by Subject|0|||
131667979|NCT04256629|474069597|FG000|Overall Study|Adverse Event|0|||
131667980|NCT04256629|474069598|FG001|Overall Study|Adverse Event|0|||
131667981|NCT04256629|474069599|FG002|Overall Study|Adverse Event|0|||
131667982|NCT04256629|474069600|FG003|Overall Study|Adverse Event|0|||
131667983|NCT04256629|474069601|FG004|Overall Study|Adverse Event|0|||
131667984|NCT04256629|474069602|FG005|Overall Study|Adverse Event|1|||
131667985|NCT04256629|474069597|FG000|Overall Study|Protocol Violation|0|||
131667986|NCT04256629|474069598|FG001|Overall Study|Protocol Violation|1|||
131667987|NCT04256629|474069599|FG002|Overall Study|Protocol Violation|0|||
131667988|NCT04256629|474069600|FG003|Overall Study|Protocol Violation|0|||
131667989|NCT04256629|474069601|FG004|Overall Study|Protocol Violation|0|||
131667990|NCT04256629|474069602|FG005|Overall Study|Protocol Violation|0|||
131667991|NCT01383499|474069603|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
131667992|NCT01383499|474069604|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131667993|NCT01383499|474069605|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131667994|NCT01383499|474069606|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131667995|NCT01774487|474069607|FG000|Overall Study|Did not tolerate taste|4|||
131667996|NCT01774487|474069608|FG001|Overall Study|Did not tolerate taste|4|||
131667997|NCT00346632|474069609|FG000|Overall Study|Progressive Disease|2|||
131667998|NCT00346632|474069610|FG001|Overall Study|Progressive Disease|2|||
131667999|NCT00346632|474069611|FG002|Overall Study|Progressive Disease|4|||
131668000|NCT00346632|474069612|FG003|Overall Study|Progressive Disease|3|||
131668001|NCT00346632|474069613|FG004|Overall Study|Progressive Disease|3|||
131668002|NCT00346632|474069614|FG005|Overall Study|Progressive Disease|1|||
131668003|NCT00346632|474069615|FG006|Overall Study|Progressive Disease|2|||
131668004|NCT00346632|474069616|FG007|Overall Study|Progressive Disease|2|||
131668005|NCT00346632|474069617|FG008|Overall Study|Progressive Disease|2|||
131668006|NCT00346632|474069618|FG009|Overall Study|Progressive Disease|2|||
131668007|NCT00346632|474069609|FG000|Overall Study|Adverse Event|0|||
131668008|NCT00346632|474069610|FG001|Overall Study|Adverse Event|0|||
131668009|NCT00346632|474069611|FG002|Overall Study|Adverse Event|0|||
131668010|NCT00346632|474069612|FG003|Overall Study|Adverse Event|0|||
131668011|NCT00346632|474069613|FG004|Overall Study|Adverse Event|1|||
131668012|NCT00346632|474069614|FG005|Overall Study|Adverse Event|1|||
131668013|NCT00346632|474069615|FG006|Overall Study|Adverse Event|1|||
131668014|NCT00346632|474069616|FG007|Overall Study|Adverse Event|0|||
131668015|NCT00346632|474069617|FG008|Overall Study|Adverse Event|0|||
131668016|NCT00346632|474069618|FG009|Overall Study|Adverse Event|0|||
131668017|NCT00346632|474069609|FG000|Overall Study|Death|0|||
131668018|NCT00346632|474069610|FG001|Overall Study|Death|0|||
131668019|NCT00346632|474069611|FG002|Overall Study|Death|1|||
131668020|NCT00346632|474069612|FG003|Overall Study|Death|0|||
131668021|NCT00346632|474069613|FG004|Overall Study|Death|0|||
131668022|NCT00346632|474069614|FG005|Overall Study|Death|0|||
131668023|NCT00346632|474069615|FG006|Overall Study|Death|0|||
131668024|NCT00346632|474069616|FG007|Overall Study|Death|0|||
131668025|NCT00346632|474069617|FG008|Overall Study|Death|0|||
131668026|NCT00346632|474069618|FG009|Overall Study|Death|0|||
131668027|NCT00346632|474069609|FG000|Overall Study|Protocol Violation|0|||
131668028|NCT00346632|474069610|FG001|Overall Study|Protocol Violation|0|||
131668029|NCT00346632|474069611|FG002|Overall Study|Protocol Violation|0|||
131668030|NCT00346632|474069612|FG003|Overall Study|Protocol Violation|0|||
131668031|NCT00346632|474069613|FG004|Overall Study|Protocol Violation|0|||
131668032|NCT00346632|474069614|FG005|Overall Study|Protocol Violation|0|||
131668033|NCT00346632|474069615|FG006|Overall Study|Protocol Violation|1|||
131668034|NCT00346632|474069616|FG007|Overall Study|Protocol Violation|0|||
131668035|NCT00346632|474069617|FG008|Overall Study|Protocol Violation|0|||
131668036|NCT00346632|474069618|FG009|Overall Study|Protocol Violation|0|||
131668037|NCT00346632|474069609|FG000|Overall Study|Withdrawal by Subject|0|||
131668038|NCT00346632|474069610|FG001|Overall Study|Withdrawal by Subject|0|||
131896662|NCT03654729|474908532|FG000|Overall Study|Protocol Violation|1|||
131896663|NCT03654729|474908533|FG001|Overall Study|Protocol Violation|1|||
131896664|NCT03654729|474908534|FG002|Overall Study|Protocol Violation|0|||
131896665|NCT03654729|474908532|FG000|Overall Study|Non-compliance with study drug|0|||
131896666|NCT03654729|474908533|FG001|Overall Study|Non-compliance with study drug|1|||
131896667|NCT03654729|474908534|FG002|Overall Study|Non-compliance with study drug|0|||
131896668|NCT03654729|474908532|FG000|Overall Study|Site terminated by Sponsor|1|||
131896669|NCT03654729|474908533|FG001|Overall Study|Site terminated by Sponsor|0|||
131896670|NCT03654729|474908534|FG002|Overall Study|Site terminated by Sponsor|0|||
131668039|NCT00346632|474069611|FG002|Overall Study|Withdrawal by Subject|0|||
131668040|NCT00346632|474069612|FG003|Overall Study|Withdrawal by Subject|0|||
131896671|NCT04530838|474908535|FG000|Overall Study|Other|2|||
131668041|NCT00346632|474069613|FG004|Overall Study|Withdrawal by Subject|0|||
131896672|NCT04530838|474908536|FG001|Overall Study|Other|1|||
131896673|NCT04530838|474908537|FG002|Overall Study|Other|0|||
131668042|NCT00346632|474069614|FG005|Overall Study|Withdrawal by Subject|0|||
131668043|NCT00346632|474069615|FG006|Overall Study|Withdrawal by Subject|1|||
131668044|NCT00346632|474069616|FG007|Overall Study|Withdrawal by Subject|0|||
131668045|NCT00346632|474069617|FG008|Overall Study|Withdrawal by Subject|0|||
131668046|NCT00346632|474069618|FG009|Overall Study|Withdrawal by Subject|0|||
131668047|NCT00346632|474069609|FG000|Overall Study|Switched to alternative treatment|0|||
131668048|NCT00346632|474069610|FG001|Overall Study|Switched to alternative treatment|0|||
131554847|NCT02100722|473656324|FG001|Overall Study|Withdrawal pre-procedure|9|||
131554848|NCT02100722|473656323|FG000|Overall Study|Withdrawal post-procedure|0|||
131554849|NCT02100722|473656324|FG001|Overall Study|Withdrawal post-procedure|3|||
131554850|NCT02100722|473656323|FG000|Overall Study|Lost to Follow-up|2|||
131554851|NCT02100722|473656324|FG001|Overall Study|Lost to Follow-up|2|||
131554852|NCT02100722|473656323|FG000|Overall Study|Continuing on study|751|||
131554853|NCT02100722|473656324|FG001|Overall Study|Continuing on study|729|||
131554854|NCT02541383|473656328|FG000|Overall Study|Death|50|||
131554855|NCT02541383|473656329|FG001|Overall Study|Death|37|||
131554856|NCT02541383|473656330|FG002|Overall Study|Death|48|||
131554857|NCT02541383|473656331|FG003|Overall Study|Death|41|||
131554858|NCT02541383|473656332|FG004|Overall Study|Death|21|||
131554859|NCT02541383|473656333|FG005|Overall Study|Death|25|||
131554860|NCT02541383|473656328|FG000|Overall Study|Lost to Follow-up|5|||
131554861|NCT02541383|473656329|FG001|Overall Study|Lost to Follow-up|3|||
131554862|NCT02541383|473656330|FG002|Overall Study|Lost to Follow-up|1|||
131554863|NCT02541383|473656331|FG003|Overall Study|Lost to Follow-up|1|||
131554864|NCT02541383|473656332|FG004|Overall Study|Lost to Follow-up|3|||
131554865|NCT02541383|473656333|FG005|Overall Study|Lost to Follow-up|0|||
131554866|NCT02541383|473656328|FG000|Overall Study|Consent withdrawn|5|||
131554867|NCT02541383|473656329|FG001|Overall Study|Consent withdrawn|6|||
131554868|NCT02541383|473656330|FG002|Overall Study|Consent withdrawn|1|||
131554869|NCT02541383|473656331|FG003|Overall Study|Consent withdrawn|1|||
131554870|NCT02541383|473656332|FG004|Overall Study|Consent withdrawn|0|||
131554871|NCT02541383|473656333|FG005|Overall Study|Consent withdrawn|0|||
131554872|NCT02541383|473656328|FG000|Overall Study|Sponsor's decision|1|||
131554873|NCT02541383|473656329|FG001|Overall Study|Sponsor's decision|1|||
131554874|NCT02541383|473656330|FG002|Overall Study|Sponsor's decision|0|||
131554875|NCT02541383|473656331|FG003|Overall Study|Sponsor's decision|0|||
131554876|NCT02541383|473656332|FG004|Overall Study|Sponsor's decision|0|||
131554877|NCT02541383|473656333|FG005|Overall Study|Sponsor's decision|0|||
131554878|NCT05796518|473656334|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
131554879|NCT02690077|473656335|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
131554880|NCT02690077|473656336|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
131554881|NCT02690077|473656335|FG000|Overall Study|Withdrawal by Subject|0|||
131554882|NCT02690077|473656336|FG001|Overall Study|Withdrawal by Subject|5|||
131554883|NCT02690077|473656335|FG000|Overall Study|Excluded by IRB|0|||
131554884|NCT02690077|473656336|FG001|Overall Study|Excluded by IRB|2|||
131554885|NCT05408468|473656337|FG000|Overall Study|Lost to Follow-up|3|||
131554886|NCT05408468|473656338|FG001|Overall Study|Lost to Follow-up|1|||
131554887|NCT05408468|473656337|FG000|Overall Study|Physician Decision|1|||
131554888|NCT05408468|473656338|FG001|Overall Study|Physician Decision|0|||
131554889|NCT05408468|473656337|FG000|Overall Study|Overwhelmed by clinical situation|3|||
131554890|NCT05408468|473656338|FG001|Overall Study|Overwhelmed by clinical situation|0|||
131554891|NCT05408468|473656337|FG000|Overall Study|Personal illness precluding participation|1|||
131554892|NCT05408468|473656338|FG001|Overall Study|Personal illness precluding participation|0|||
131554893|NCT05408468|473656337|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
131554894|NCT05408468|473656338|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
131554895|NCT00612534|473656340|FG000|Overall Study|Adverse Event|0|||
131554896|NCT00612534|473656341|FG001|Overall Study|Adverse Event|4|||
131554897|NCT00612534|473656342|FG002|Overall Study|Adverse Event|2|||
131668049|NCT00346632|474069611|FG002|Overall Study|Switched to alternative treatment|1|||
131668050|NCT00346632|474069612|FG003|Overall Study|Switched to alternative treatment|0|||
131668051|NCT00346632|474069613|FG004|Overall Study|Switched to alternative treatment|0|||
131668052|NCT00346632|474069614|FG005|Overall Study|Switched to alternative treatment|0|||
131668053|NCT00346632|474069615|FG006|Overall Study|Switched to alternative treatment|0|||
131668054|NCT00346632|474069616|FG007|Overall Study|Switched to alternative treatment|0|||
131668055|NCT00346632|474069617|FG008|Overall Study|Switched to alternative treatment|0|||
131668056|NCT00346632|474069618|FG009|Overall Study|Switched to alternative treatment|0|||
131668057|NCT00346632|474069609|FG000|Overall Study|Not Stated|1|||
131668058|NCT00346632|474069610|FG001|Overall Study|Not Stated|1|||
131668059|NCT00346632|474069611|FG002|Overall Study|Not Stated|0|||
131896674|NCT04530838|474908535|FG000|Overall Study|Physician Decision|0|||
131896675|NCT04530838|474908536|FG001|Overall Study|Physician Decision|0|||
131896676|NCT04530838|474908537|FG002|Overall Study|Physician Decision|1|||
131896677|NCT04530838|474908535|FG000|Overall Study|Death|0|||
131896678|NCT04530838|474908536|FG001|Overall Study|Death|0|||
131896679|NCT04530838|474908537|FG002|Overall Study|Death|1|||
131896680|NCT04530838|474908535|FG000|Overall Study|Adverse Event|0|||
131896681|NCT04530838|474908536|FG001|Overall Study|Adverse Event|1|||
131896682|NCT04530838|474908537|FG002|Overall Study|Adverse Event|0|||
131896683|NCT04530838|474908535|FG000|Overall Study|No longer meets eligibility criteria|1|||
131896684|NCT04530838|474908536|FG001|Overall Study|No longer meets eligibility criteria|0|||
131896685|NCT04530838|474908537|FG002|Overall Study|No longer meets eligibility criteria|2|||
131896686|NCT04530838|474908535|FG000|Overall Study|Withdrawal by parent/guardian|5|||
131896687|NCT04530838|474908536|FG001|Overall Study|Withdrawal by parent/guardian|2|||
131896688|NCT04530838|474908537|FG002|Overall Study|Withdrawal by parent/guardian|2|||
131896689|NCT00803712|474908538|FG000|Overall Study|Noncompliance|3|||
131896690|NCT00803712|474908539|FG001|Overall Study|Noncompliance|0|||
131896691|NCT00803712|474908538|FG000|Overall Study|Adverse Event|5|||
131896692|NCT00803712|474908539|FG001|Overall Study|Adverse Event|0|||
131896693|NCT00803712|474908538|FG000|Overall Study|Death|8|||
131896694|NCT00803712|474908539|FG001|Overall Study|Death|7|||
131896695|NCT00803712|474908538|FG000|Overall Study|Lost to Follow-up|3|||
131896696|NCT00803712|474908539|FG001|Overall Study|Lost to Follow-up|1|||
131896697|NCT00803712|474908538|FG000|Overall Study|Withdrawal by Subject|2|||
131896698|NCT00803712|474908539|FG001|Overall Study|Withdrawal by Subject|4|||
131896699|NCT00803712|474908538|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
131896700|NCT00803712|474908539|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
131896701|NCT00803712|474908538|FG000|Overall Study|Protocol criteria (other)|0|||
131896702|NCT00803712|474908539|FG001|Overall Study|Protocol criteria (other)|2|||
131896703|NCT00803712|474908538|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
131896704|NCT00803712|474908539|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
131896705|NCT00803712|474908538|FG000|Overall Study|Administrative decision|2|||
131896706|NCT00803712|474908539|FG001|Overall Study|Administrative decision|3|||
131896707|NCT00803712|474908538|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
131896708|NCT00803712|474908539|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
131896709|NCT01919164|474908550|FG000|Overall Study|Adverse Event|6|||
131896710|NCT01919164|474908551|FG001|Overall Study|Adverse Event|4|||
131896711|NCT01919164|474908552|FG002|Overall Study|Adverse Event|9|||
131896712|NCT01919164|474908553|FG003|Overall Study|Adverse Event|3|||
131896713|NCT01919164|474908554|FG004|Overall Study|Adverse Event|2|||
131896714|NCT01919164|474908550|FG000|Overall Study|Lost to Follow-up|2|||
131896715|NCT01919164|474908551|FG001|Overall Study|Lost to Follow-up|2|||
131896716|NCT01919164|474908552|FG002|Overall Study|Lost to Follow-up|2|||
131896717|NCT01919164|474908553|FG003|Overall Study|Lost to Follow-up|0|||
131896718|NCT01919164|474908554|FG004|Overall Study|Lost to Follow-up|4|||
131896719|NCT01919164|474908550|FG000|Overall Study|Death|1|||
131896720|NCT01919164|474908551|FG001|Overall Study|Death|0|||
131896721|NCT01919164|474908552|FG002|Overall Study|Death|0|||
131896722|NCT01919164|474908553|FG003|Overall Study|Death|0|||
131668060|NCT00346632|474069612|FG003|Overall Study|Not Stated|0|||
131668061|NCT00346632|474069613|FG004|Overall Study|Not Stated|0|||
131668062|NCT00346632|474069614|FG005|Overall Study|Not Stated|0|||
131896723|NCT01919164|474908554|FG004|Overall Study|Death|0|||
131896724|NCT01919164|474908550|FG000|Overall Study|Protocol Violation|6|||
131896725|NCT01919164|474908551|FG001|Overall Study|Protocol Violation|0|||
131896726|NCT01919164|474908552|FG002|Overall Study|Protocol Violation|3|||
131896727|NCT01919164|474908553|FG003|Overall Study|Protocol Violation|2|||
131896728|NCT01919164|474908554|FG004|Overall Study|Protocol Violation|2|||
131896729|NCT01919164|474908550|FG000|Overall Study|Disease progression|2|||
131896730|NCT01919164|474908551|FG001|Overall Study|Disease progression|2|||
131896731|NCT01919164|474908552|FG002|Overall Study|Disease progression|1|||
131896732|NCT01919164|474908553|FG003|Overall Study|Disease progression|2|||
131896733|NCT01919164|474908554|FG004|Overall Study|Disease progression|1|||
131896734|NCT01919164|474908550|FG000|Overall Study|Withdrew consent|13|||
131896735|NCT01919164|474908551|FG001|Overall Study|Withdrew consent|13|||
131896736|NCT01919164|474908552|FG002|Overall Study|Withdrew consent|14|||
131896737|NCT01919164|474908553|FG003|Overall Study|Withdrew consent|14|||
131896738|NCT01919164|474908554|FG004|Overall Study|Withdrew consent|9|||
131896739|NCT01919164|474908550|FG000|Overall Study|Other Un-specified|13|||
131896740|NCT01919164|474908551|FG001|Overall Study|Other Un-specified|9|||
131896741|NCT01919164|474908552|FG002|Overall Study|Other Un-specified|8|||
131896742|NCT01919164|474908553|FG003|Overall Study|Other Un-specified|7|||
131896743|NCT01919164|474908554|FG004|Overall Study|Other Un-specified|15|||
131896744|NCT00588146|474908556|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
131896745|NCT00588146|474908557|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
131896746|NCT02100839|474908558|FG000|Multiple Ascending Dose|Adverse Event|2|||
131896747|NCT02100839|474908559|FG001|Multiple Ascending Dose|Adverse Event|0|||
131896748|NCT02100839|474908558|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
131896749|NCT02100839|474908559|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
131896750|NCT02823470|474908560|FG000|Overall Study|Adverse Event|1|||
131896751|NCT02823470|474908561|FG001|Overall Study|Adverse Event|0|||
131896752|NCT02823470|474908560|FG000|Overall Study|Study terminated by sponsor|8|||
131896753|NCT02823470|474908561|FG001|Overall Study|Study terminated by sponsor|15|||
131896754|NCT00463801|474908566|FG000|Overall Study|Protocol Violation|1|||
131896755|NCT00463801|474908566|FG000|Overall Study|Lack of Efficacy|2|||
131896756|NCT00463801|474908566|FG000|Overall Study|Adverse Event|4|||
131896757|NCT00463801|474908566|FG000|Overall Study|Lost to Follow-up|5|||
131896758|NCT00463801|474908566|FG000|Overall Study|No longer require therapy|1|||
131896759|NCT01073163|474908567|FG000|Overall Study|Adverse Event|1|||
131896760|NCT01073163|474908567|FG000|Overall Study|Disease Progression|1|||
131896761|NCT01073163|474908567|FG000|Overall Study|Early termination|1|||
131896762|NCT00703677|474908568|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
131896763|NCT00940888|474908569|FG000|Overall Study|Unsuccessful Implant|4|||
131896764|NCT00940888|474908569|FG000|Overall Study|Death|461|||
131896765|NCT00940888|474908569|FG000|Overall Study|Withdrawn - Non-Death|364|||
131896766|NCT00940888|474908569|FG000|Overall Study|Lost to Follow-up|6|||
131896767|NCT04441788|474908570|FG000|Overall Study|Voluntary Withdrawl|0|||
131896768|NCT04441788|474908571|FG001|Overall Study|Voluntary Withdrawl|1|||
131896769|NCT04441788|474908572|FG002|Overall Study|Voluntary Withdrawl|0|||
131896770|NCT04441788|474908570|FG000|Overall Study|Ineligibility|1|||
131896771|NCT04441788|474908571|FG001|Overall Study|Ineligibility|0|||
131668063|NCT00346632|474069615|FG006|Overall Study|Not Stated|0|||
131668064|NCT00346632|474069616|FG007|Overall Study|Not Stated|2|||
131668065|NCT00346632|474069617|FG008|Overall Study|Not Stated|2|||
131668066|NCT00346632|474069618|FG009|Overall Study|Not Stated|1|||
131668067|NCT00297232|474069619|FG000|Overall Study|Lack of Efficacy|7|||
131668068|NCT00297232|474069619|FG000|Overall Study|Lost to Follow-up|10|||
131668069|NCT00297232|474069619|FG000|Overall Study|Adverse Event|63|||
131668070|NCT00297232|474069619|FG000|Overall Study|Voluntary Withdrawal|120|||
131668071|NCT00297232|474069619|FG000|Overall Study|Subject was Noncompliant|9|||
131668072|NCT00297232|474069619|FG000|Overall Study|Death|9|||
131668073|NCT00297232|474069619|FG000|Overall Study|Anti-natalizumab Positive|8|||
131668074|NCT00297232|474069619|FG000|Overall Study|Switched to Commercial Tysabri|22|||
131668075|NCT00297232|474069619|FG000|Overall Study|Disease Progression|8|||
131668076|NCT00297232|474069619|FG000|Overall Study|Fear of PML|10|||
131668077|NCT00297232|474069619|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
131668078|NCT00297232|474069619|FG000|Overall Study|Miscellaneous|5|||
131668079|NCT00297232|474069619|FG000|Overall Study|Sponsor Decision|34|||
131668080|NCT00297232|474069619|FG000|Overall Study|Subject Relocated|7|||
131668081|NCT00297232|474069619|FG000|Overall Study|Subject Withdrew Consent|37|||
131668082|NCT00297232|474069619|FG000|Overall Study|Persistently Positive Antibodies|11|||
131668083|NCT00297232|474069619|FG000|Overall Study|Investigator Withdrew From Program|19|||
131668084|NCT00297232|474069619|FG000|Overall Study|Did Not Enroll to Week 264|34|||
131668085|NCT00297232|474069619|FG000|Overall Study|Did Not Enroll to Week 480|17|||
131668086|NCT00297232|474069619|FG000|Overall Study|No data available after Week 264|161|||
131668087|NCT00297232|474069619|FG000|Overall Study|Other|1|||
131668088|NCT00552240|474069620|FG000|Overall Study|Adverse Event|9|||
131668089|NCT00552240|474069621|FG001|Overall Study|Adverse Event|9|||
131668090|NCT00552240|474069620|FG000|Overall Study|Protocol Violation|1|||
131668091|NCT00552240|474069621|FG001|Overall Study|Protocol Violation|1|||
131668092|NCT00552240|474069620|FG000|Overall Study|Lost to Follow-up|5|||
131668093|NCT00552240|474069621|FG001|Overall Study|Lost to Follow-up|6|||
131668094|NCT00552240|474069620|FG000|Overall Study|Withdrawal by Subject|2|||
131668095|NCT00552240|474069621|FG001|Overall Study|Withdrawal by Subject|2|||
131668096|NCT00552240|474069620|FG000|Overall Study|Lack of Efficacy|6|||
131668097|NCT00552240|474069621|FG001|Overall Study|Lack of Efficacy|0|||
131668098|NCT00552240|474069620|FG000|Overall Study|Other|1|||
131668099|NCT00552240|474069621|FG001|Overall Study|Other|0|||
131668100|NCT02783768|474069623|FG000|Overall Study|Lost to Follow-up|1|||
131668101|NCT02783768|474069624|FG001|Overall Study|Lost to Follow-up|0|||
131668102|NCT02476279|474069625|FG000|Overall Study|Lost to Follow-up|1|||
131668103|NCT02476279|474069626|FG001|Overall Study|Lost to Follow-up|1|||
131668104|NCT01323647|474069627|FG000|Overall Study|Migrated/moved from study area|2|||
131668105|NCT01323647|474069628|FG001|Overall Study|Migrated/moved from study area|0|||
131668106|NCT01323647|474069627|FG000|Overall Study|Withdrawal by Subject|5|||
131668107|NCT01323647|474069628|FG001|Overall Study|Withdrawal by Subject|0|||
131668108|NCT01323647|474069627|FG000|Overall Study|Lost to Follow-up|2|||
131668109|NCT01323647|474069628|FG001|Overall Study|Lost to Follow-up|0|||
131668110|NCT01236339|474069631|FG000|Overall Study|Termination of study by sponsor|11|||
131668111|NCT01236339|474069632|FG001|Overall Study|Termination of study by sponsor|13|||
131896772|NCT04441788|474908572|FG002|Overall Study|Ineligibility|0|||
131896773|NCT04441788|474908570|FG000|Overall Study|Adverse Event|0|||
131896774|NCT04441788|474908571|FG001|Overall Study|Adverse Event|0|||
131896775|NCT04441788|474908572|FG002|Overall Study|Adverse Event|4|||
131896776|NCT04441788|474908570|FG000|Overall Study|Study Terminated by Sponsor|16|||
131896777|NCT04441788|474908571|FG001|Overall Study|Study Terminated by Sponsor|16|||
131896778|NCT04441788|474908572|FG002|Overall Study|Study Terminated by Sponsor|12|||
131896779|NCT03859648|474908577|FG000|Overall Study|Lost to Follow-up|1|||
131896780|NCT03859648|474908577|FG000|Overall Study|Adverse Event|1|||
131896781|NCT02315664|474908578|FG000|Overall Study|Lost to Follow-up|1|||
131896782|NCT02315664|474908579|FG001|Overall Study|Lost to Follow-up|1|||
131896783|NCT02315664|474908578|FG000|Overall Study|Withdrawal by Subject|0|||
131896784|NCT02315664|474908579|FG001|Overall Study|Withdrawal by Subject|3|||
131896785|NCT01677182|474908580|FG000|Overall Study|Adverse Event|2|||
131896786|NCT01677182|474908581|FG001|Overall Study|Adverse Event|1|||
131896787|NCT01677182|474908582|FG002|Overall Study|Adverse Event|8|||
131896788|NCT01677182|474908580|FG000|Overall Study|Protocol Violation|5|||
131668112|NCT02054741|474069633|FG000|Overall Study|Protocol Violation|13|||
131668113|NCT02054741|474069634|FG001|Overall Study|Protocol Violation|2|||
131668114|NCT02054741|474069633|FG000|Overall Study|Withdrawal by Subject|10|||
131668115|NCT02054741|474069634|FG001|Overall Study|Withdrawal by Subject|5|||
131668116|NCT02054741|474069633|FG000|Overall Study|Death|94|||
131668117|NCT02054741|474069634|FG001|Overall Study|Death|90|||
131668118|NCT02054741|474069633|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
131668119|NCT02054741|474069634|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
131668120|NCT01945060|474069635|FG000|Overall Study|Lost to follow up|1|||
131896789|NCT01677182|474908581|FG001|Overall Study|Protocol Violation|1|||
131668121|NCT01945060|474069636|FG001|Overall Study|Lost to follow up|0|||
131668122|NCT01945060|474069635|FG000|Overall Study|Distress related to IV access|0|||
131668123|NCT01945060|474069636|FG001|Overall Study|Distress related to IV access|1|||
131668124|NCT00402597|474069637|FG000|Overall Study|Death|15|||
131668125|NCT00402597|474069638|FG001|Overall Study|Death|7|||
131668126|NCT00402597|474069639|FG002|Overall Study|Death|6|||
131668127|NCT00402597|474069640|FG003|Overall Study|Death|4|||
131668128|NCT00402597|474069641|FG004|Overall Study|Death|6|||
131668129|NCT00402597|474069637|FG000|Overall Study|Adverse Event|81|||
131668130|NCT00402597|474069638|FG001|Overall Study|Adverse Event|18|||
131668131|NCT00402597|474069639|FG002|Overall Study|Adverse Event|106|||
131668132|NCT00402597|474069640|FG003|Overall Study|Adverse Event|39|||
131668133|NCT00402597|474069641|FG004|Overall Study|Adverse Event|71|||
131668134|NCT00402597|474069637|FG000|Overall Study|Lost to Follow-up|8|||
131668135|NCT00402597|474069638|FG001|Overall Study|Lost to Follow-up|1|||
131668136|NCT00402597|474069639|FG002|Overall Study|Lost to Follow-up|8|||
131668137|NCT00402597|474069640|FG003|Overall Study|Lost to Follow-up|2|||
131668138|NCT00402597|474069641|FG004|Overall Study|Lost to Follow-up|3|||
131668139|NCT00402597|474069637|FG000|Overall Study|Withdrawal by Subject|57|||
131668140|NCT00402597|474069638|FG001|Overall Study|Withdrawal by Subject|16|||
131668141|NCT00402597|474069639|FG002|Overall Study|Withdrawal by Subject|65|||
131668142|NCT00402597|474069640|FG003|Overall Study|Withdrawal by Subject|15|||
131668143|NCT00402597|474069641|FG004|Overall Study|Withdrawal by Subject|24|||
131668144|NCT00402597|474069637|FG000|Overall Study|reason not specified|30|||
131668145|NCT00402597|474069638|FG001|Overall Study|reason not specified|4|||
131668146|NCT00402597|474069639|FG002|Overall Study|reason not specified|27|||
131668147|NCT00402597|474069640|FG003|Overall Study|reason not specified|14|||
131668148|NCT00402597|474069641|FG004|Overall Study|reason not specified|20|||
131668149|NCT02319525|474069643|FG000|Overall Study|Withdrawal by Subject|2|||
131668150|NCT02319525|474069644|FG001|Overall Study|Withdrawal by Subject|1|||
131668151|NCT00938860|474069645|FG000|Overall Study|Adverse Event|2|||
131668152|NCT00938860|474069646|FG001|Overall Study|Adverse Event|1|||
131668153|NCT00938860|474069645|FG000|Overall Study|Abnormal laboratory values|2|||
131668154|NCT00938860|474069646|FG001|Overall Study|Abnormal laboratory values|2|||
131668155|NCT00938860|474069645|FG000|Overall Study|Withdrawal by Subject|11|||
131668156|NCT00938860|474069646|FG001|Overall Study|Withdrawal by Subject|8|||
131668157|NCT00938860|474069645|FG000|Overall Study|Lost to Follow-up|4|||
131668158|NCT00938860|474069646|FG001|Overall Study|Lost to Follow-up|4|||
131668159|NCT00938860|474069645|FG000|Overall Study|Administration problems|2|||
131668160|NCT00938860|474069646|FG001|Overall Study|Administration problems|0|||
131668161|NCT00938860|474069645|FG000|Overall Study|Death|1|||
131668162|NCT00938860|474069646|FG001|Overall Study|Death|1|||
131668163|NCT00938860|474069645|FG000|Overall Study|Protocol Violation|3|||
131668164|NCT00938860|474069646|FG001|Overall Study|Protocol Violation|1|||
131668165|NCT00577577|474069648|FG000|Overall Study|Adverse Event|3|||
131668166|NCT00577577|474069649|FG001|Overall Study|Adverse Event|2|||
131668167|NCT00577577|474069648|FG000|Overall Study|Lost to Follow-up|1|||
131668168|NCT00577577|474069649|FG001|Overall Study|Lost to Follow-up|0|||
131668169|NCT00577577|474069648|FG000|Overall Study|Protocol Violation|0|||
131668170|NCT00577577|474069649|FG001|Overall Study|Protocol Violation|3|||
131668171|NCT00577577|474069648|FG000|Overall Study|Transportation|1|||
131668172|NCT00577577|474069649|FG001|Overall Study|Transportation|0|||
131668173|NCT00906945|474069654|FG000|Overall Study|Found to be not eligible|0|||
131668174|NCT00906945|474069655|FG001|Overall Study|Found to be not eligible|0|||
131668175|NCT00906945|474069656|FG002|Overall Study|Found to be not eligible|0|||
131668176|NCT00906945|474069657|FG003|Overall Study|Found to be not eligible|1|||
131668177|NCT00906945|474069658|FG004|Overall Study|Found to be not eligible|1|||
131668178|NCT00906945|474069659|FG005|Overall Study|Found to be not eligible|1|||
131668179|NCT00906945|474069654|FG000|Overall Study|Physician Decision|0|||
131668180|NCT00906945|474069655|FG001|Overall Study|Physician Decision|0|||
131668181|NCT00906945|474069656|FG002|Overall Study|Physician Decision|0|||
131668182|NCT00906945|474069657|FG003|Overall Study|Physician Decision|0|||
131668183|NCT00906945|474069658|FG004|Overall Study|Physician Decision|0|||
131668184|NCT00906945|474069659|FG005|Overall Study|Physician Decision|1|||
131668185|NCT03965351|474069665|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131668186|NCT03965351|474069666|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
131668187|NCT03965351|474069665|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
131668188|NCT03965351|474069666|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
131668189|NCT00994682|474069667|FG000|Double Bilnd|Withdrawal by Subject|5|||
131668190|NCT00994682|474069668|FG001|Double Bilnd|Withdrawal by Subject|6|||
131668191|NCT00994682|474069667|FG000|Double Bilnd|Lost to Follow-up|3|||
131668192|NCT00994682|474069668|FG001|Double Bilnd|Lost to Follow-up|3|||
131668193|NCT00994682|474069667|FG000|Double Bilnd|Adverse Event|1|||
131668194|NCT00994682|474069668|FG001|Double Bilnd|Adverse Event|0|||
131668195|NCT00994682|474069667|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
131668196|NCT00994682|474069668|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
131668197|NCT00994682|474069667|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
131668198|NCT00994682|474069668|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
131668199|NCT00994682|474069667|FG000|Pioglitazone Open Label|Physician Decision|6|||
131668200|NCT00994682|474069668|FG001|Pioglitazone Open Label|Physician Decision|1|||
131668201|NCT00943111|474069671|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
131668202|NCT00943111|474069672|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
131668203|NCT00943111|474069673|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
131668204|NCT00943111|474069671|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
131668205|NCT00943111|474069672|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
131668206|NCT00943111|474069673|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
131668207|NCT00943111|474069671|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
131668208|NCT00943111|474069672|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
131668209|NCT00943111|474069673|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
131668210|NCT00943111|474069671|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
131668211|NCT00943111|474069672|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
131668212|NCT00943111|474069673|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
131668213|NCT00943111|474069671|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
131668214|NCT00943111|474069672|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
131668215|NCT00943111|474069673|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
131668216|NCT00943111|474069671|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
131668217|NCT00943111|474069672|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
131668218|NCT00943111|474069673|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
131668219|NCT00943111|474069671|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
131668220|NCT00943111|474069672|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
131668221|NCT00943111|474069673|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
131668222|NCT00943111|474069671|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
131668223|NCT00943111|474069672|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
131668224|NCT00943111|474069673|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
131668225|NCT00903682|474069674|FG000|Overall Study|Adverse Event|6|||
131668226|NCT00903682|474069675|FG001|Overall Study|Adverse Event|13|||
131668227|NCT00903682|474069674|FG000|Overall Study|Lost to Follow-up|1|||
131668228|NCT00903682|474069675|FG001|Overall Study|Lost to Follow-up|0|||
131668229|NCT00903682|474069674|FG000|Overall Study|Withdrawal by Subject|5|||
131668230|NCT00903682|474069675|FG001|Overall Study|Withdrawal by Subject|0|||
131668231|NCT00903682|474069674|FG000|Overall Study|Pregnancy|0|||
131668232|NCT00903682|474069675|FG001|Overall Study|Pregnancy|1|||
131668233|NCT00903682|474069674|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
131668234|NCT00903682|474069675|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
131668235|NCT00903682|474069674|FG000|Overall Study|Subject Non-Compliant|1|||
131668236|NCT00903682|474069675|FG001|Overall Study|Subject Non-Compliant|0|||
131668237|NCT00903682|474069674|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
131668238|NCT00903682|474069675|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
131668239|NCT00903682|474069674|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
131668240|NCT00903682|474069675|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
131668241|NCT04227704|474069679|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
131668242|NCT04227704|474069680|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
131668243|NCT04227704|474069681|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
131668244|NCT04227704|474069679|FG000|Overall Study|due to C/S being cancelled|1|||
131668245|NCT04227704|474069680|FG001|Overall Study|due to C/S being cancelled|0|||
131668246|NCT04227704|474069681|FG002|Overall Study|due to C/S being cancelled|0|||
131668247|NCT01828073|474071784|FG000|Overall Study|Lost to Follow-up|1|||
131668248|NCT01828073|474071785|FG001|Overall Study|Lost to Follow-up|2|||
131668249|NCT02079610|474071788|FG000|Overall Study|Withdrawal by Subject|1|||
131668250|NCT02079610|474071789|FG001|Overall Study|Withdrawal by Subject|1|||
131668251|NCT01111474|474071793|FG000|Overall Study|Lost to Follow-up|12|||
131668252|NCT01016977|474071794|FG000|Overall Study|Lost to Follow-up|1|||
131668253|NCT01016977|474071795|FG001|Overall Study|Lost to Follow-up|0|||
131668254|NCT01016977|474071794|FG000|Overall Study|Withdrawal by Subject|2|||
131668255|NCT01016977|474071795|FG001|Overall Study|Withdrawal by Subject|2|||
131668256|NCT00666679|474071796|FG000|First Intervention|Lost to Follow-up|1|||
131668257|NCT00666679|474071797|FG001|First Intervention|Lost to Follow-up|0|||
131668258|NCT00666679|474071796|FG000|First Intervention|Protocol Violation|1|||
131668259|NCT00666679|474071797|FG001|First Intervention|Protocol Violation|0|||
131668260|NCT00666679|474071796|FG000|First Intervention|Withdrawal by Subject|1|||
131668261|NCT00666679|474071797|FG001|First Intervention|Withdrawal by Subject|0|||
131668262|NCT00666679|474071796|FG000|First Intervention|Randomized did not start treatment|1|||
131668263|NCT00666679|474071797|FG001|First Intervention|Randomized did not start treatment|1|||
131668264|NCT00666679|474071796|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
131668265|NCT00666679|474071797|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
131668266|NCT00666679|474071796|FG000|Washout Period of 1 Week|Protocol Violation|0|||
131668267|NCT00666679|474071797|FG001|Washout Period of 1 Week|Protocol Violation|1|||
131668268|NCT00666679|474071796|FG000|Second Intervention|Adverse Event|1|||
131668269|NCT00666679|474071797|FG001|Second Intervention|Adverse Event|0|||
131668270|NCT00666679|474071796|FG000|Second Intervention|Death|0|||
131668271|NCT00666679|474071797|FG001|Second Intervention|Death|1|||
131668272|NCT00918580|474071804|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
131668273|NCT00918580|474071804|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
131668274|NCT00918580|474071804|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
131668275|NCT00918580|474071804|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
131668276|NCT00918580|474071804|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
131668277|NCT00918580|474071804|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
131668278|NCT00918580|474071804|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
131668279|NCT00477334|474071805|FG000|Overall Study|Discontinued prior to taking study drug|106|||
131668280|NCT00477334|474071806|FG001|Overall Study|Discontinued prior to taking study drug|53|||
131668281|NCT00477334|474071805|FG000|Overall Study|Adverse Event|1|||
131668282|NCT00477334|474071806|FG001|Overall Study|Adverse Event|2|||
131668283|NCT00477334|474071805|FG000|Overall Study|Withdrawal by Subject|2|||
131668284|NCT00477334|474071806|FG001|Overall Study|Withdrawal by Subject|1|||
131668285|NCT00477334|474071805|FG000|Overall Study|Lost to Follow-up|15|||
131668286|NCT00477334|474071806|FG001|Overall Study|Lost to Follow-up|4|||
131668287|NCT00477334|474071805|FG000|Overall Study|Administrative Problems|39|||
131668288|NCT00477334|474071806|FG001|Overall Study|Administrative Problems|15|||
131668289|NCT00477334|474071805|FG000|Overall Study|Protocol Violation|7|||
131668290|NCT00477334|474071806|FG001|Overall Study|Protocol Violation|1|||
131668291|NCT01079663|474071807|FG000|Overall Study|Adverse Event|0|||
131668292|NCT01079663|474071808|FG001|Overall Study|Adverse Event|2|||
131668293|NCT01079663|474071807|FG000|Overall Study|Protocol Violation|0|||
131668294|NCT01079663|474071808|FG001|Overall Study|Protocol Violation|2|||
131668295|NCT02354508|474071809|FG000|Period 1: Core Phase|Adverse Event|1|||
131668296|NCT02354508|474071810|FG001|Period 1: Core Phase|Adverse Event|1|||
131668297|NCT02354508|474071811|FG002|Period 1: Core Phase|Adverse Event|2|||
131668298|NCT02354508|474071809|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
131668299|NCT02354508|474071810|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
131668300|NCT02354508|474071811|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
131668301|NCT02354508|474071809|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
131668302|NCT02354508|474071810|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
131668303|NCT02354508|474071811|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
131668304|NCT02354508|474071809|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
131668305|NCT02354508|474071810|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
131668306|NCT02354508|474071811|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
131668307|NCT02354508|474071809|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
131668308|NCT02354508|474071810|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
131668309|NCT02354508|474071811|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
131668310|NCT02354508|474071809|FG000|Period 2: Extension Phase|Physician Decision|5|||
131668311|NCT02354508|474071810|FG001|Period 2: Extension Phase|Physician Decision|0|||
131668312|NCT02354508|474071811|FG002|Period 2: Extension Phase|Physician Decision|1|||
131668313|NCT02354508|474071809|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
131668314|NCT02354508|474071810|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
131668315|NCT02354508|474071811|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
131668316|NCT02354508|474071809|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
131668317|NCT02354508|474071810|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
131668318|NCT02354508|474071811|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
131668319|NCT02354508|474071809|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
131668320|NCT02354508|474071810|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
131668321|NCT02354508|474071811|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
131668322|NCT03587974|474071812|FG000|Overall Study|caregiver demented, care recipient died|3|||
131668323|NCT03587974|474071813|FG001|Overall Study|caregiver demented, care recipient died|3|||
131668324|NCT03587974|474071812|FG000|Overall Study|Withdrawal by Subject|2|||
131668325|NCT03587974|474071813|FG001|Overall Study|Withdrawal by Subject|1|||
131668326|NCT00461032|474071815|FG000|Overall Study|Adverse Event|5|||
131668327|NCT00461032|474071816|FG001|Overall Study|Adverse Event|6|||
131668328|NCT00461032|474071815|FG000|Overall Study|Lack of Efficacy|5|||
131668329|NCT00461032|474071816|FG001|Overall Study|Lack of Efficacy|1|||
131668330|NCT00461032|474071815|FG000|Overall Study|Lost to Follow-up|7|||
131668331|NCT00461032|474071816|FG001|Overall Study|Lost to Follow-up|12|||
131668332|NCT00461032|474071815|FG000|Overall Study|Protocol Violation|4|||
131668333|NCT00461032|474071816|FG001|Overall Study|Protocol Violation|4|||
131668334|NCT00461032|474071815|FG000|Overall Study|Withdrawal by Subject|7|||
131668335|NCT00461032|474071816|FG001|Overall Study|Withdrawal by Subject|15|||
131668336|NCT00461032|474071815|FG000|Overall Study|Patient Moved or Relocated|2|||
131668337|NCT00461032|474071816|FG001|Overall Study|Patient Moved or Relocated|1|||
131668338|NCT00461032|474071815|FG000|Overall Study|Other|7|||
131668339|NCT00461032|474071816|FG001|Overall Study|Other|5|||
131668340|NCT04447846|474071817|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
131668341|NCT03486457|474071820|FG000|Up to Month 3|Adverse Event|2|||
131668342|NCT03486457|474071821|FG001|Up to Month 3|Adverse Event|5|||
131668343|NCT03486457|474071820|FG000|Up to Month 3|Lack of Efficacy|1|||
131668344|NCT03486457|474071821|FG001|Up to Month 3|Lack of Efficacy|0|||
131668345|NCT03486457|474071820|FG000|Up to Month 3|Withdrawal by Subject|1|||
131668346|NCT03486457|474071821|FG001|Up to Month 3|Withdrawal by Subject|0|||
131668347|NCT03486457|474071820|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
131668348|NCT03486457|474071821|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
131668349|NCT03486457|474071820|FG000|Up to Month 3|Other|1|||
131668350|NCT03486457|474071821|FG001|Up to Month 3|Other|0|||
131668351|NCT03486457|474071820|FG000|Month 3 to Month 6|Adverse Event|2|||
131668352|NCT03486457|474071821|FG001|Month 3 to Month 6|Adverse Event|0|||
131668353|NCT03486457|474071820|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
131668354|NCT03486457|474071821|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
131668355|NCT03486457|474071820|FG000|Month 3 to Month 6|Pregnancy|0|||
131668356|NCT03486457|474071821|FG001|Month 3 to Month 6|Pregnancy|1|||
131668357|NCT03486457|474071820|FG000|Month 3 to Month 6|Other|1|||
131668358|NCT03486457|474071821|FG001|Month 3 to Month 6|Other|0|||
131668359|NCT00372229|474071822|FG000|Study Phase|Graft loss|0|||
131668360|NCT00372229|474071823|FG001|Study Phase|Graft loss|3|||
131668361|NCT00372229|474071822|FG000|Study Phase|Protocol Violation|3|||
131668362|NCT00372229|474071823|FG001|Study Phase|Protocol Violation|4|||
131668363|NCT00372229|474071822|FG000|Study Phase|Consent withdrawn|16|||
131668364|NCT00372229|474071823|FG001|Study Phase|Consent withdrawn|14|||
131668365|NCT00372229|474071822|FG000|Study Phase|Refused treatment/did not cooperate|3|||
131668366|NCT00372229|474071823|FG001|Study Phase|Refused treatment/did not cooperate|1|||
131668367|NCT00372229|474071822|FG000|Study Phase|Death|3|||
131668368|NCT00372229|474071823|FG001|Study Phase|Death|2|||
131668369|NCT00372229|474071822|FG000|Study Phase|Reason not specified|3|||
131668370|NCT00372229|474071823|FG001|Study Phase|Reason not specified|2|||
131668371|NCT00372229|474071822|FG000|Study Phase|Lost to Follow-up|3|||
131668372|NCT00372229|474071823|FG001|Study Phase|Lost to Follow-up|3|||
131668373|NCT00372229|474071822|FG000|Follow-Up Phase|Graft loss|8|||
131668374|NCT00372229|474071823|FG001|Follow-Up Phase|Graft loss|7|||
131668375|NCT00372229|474071822|FG000|Follow-Up Phase|Consent withdrawn|13|||
131668376|NCT00372229|474071823|FG001|Follow-Up Phase|Consent withdrawn|19|||
131668377|NCT00372229|474071822|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
131668378|NCT00372229|474071823|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
131668379|NCT00372229|474071822|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
131668380|NCT00372229|474071823|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
131668381|NCT00372229|474071822|FG000|Follow-Up Phase|Death|9|||
131668382|NCT00372229|474071823|FG001|Follow-Up Phase|Death|12|||
131668383|NCT00372229|474071822|FG000|Follow-Up Phase|Administrative|1|||
131668384|NCT00372229|474071823|FG001|Follow-Up Phase|Administrative|0|||
131668385|NCT00372229|474071822|FG000|Follow-Up Phase|Reason not specified|2|||
131668386|NCT00372229|474071823|FG001|Follow-Up Phase|Reason not specified|3|||
131668387|NCT00372229|474071822|FG000|Follow-Up Phase|Lost to Follow-up|12|||
131668388|NCT00372229|474071823|FG001|Follow-Up Phase|Lost to Follow-up|10|||
131668389|NCT01878214|474071824|FG000|Overall Study|Withdrawal by Subject|18|||
131668390|NCT01878214|474071825|FG001|Overall Study|Withdrawal by Subject|7|||
131668391|NCT01878214|474071824|FG000|Overall Study|Death|0|||
131668392|NCT01878214|474071825|FG001|Overall Study|Death|1|||
131668393|NCT01878214|474071824|FG000|Overall Study|Lost to Follow-up|35|||
131668394|NCT01878214|474071825|FG001|Overall Study|Lost to Follow-up|36|||
131668395|NCT00093808|474071828|FG000|Overall Study|Cancel participation before receiving tx|1|||
131668396|NCT00093808|474071828|FG000|Overall Study|Protocol Violation|1|||
131668397|NCT02647866|474071829|FG000|Overall Study|Adverse Event|0|||
131668398|NCT02647866|474071830|FG001|Overall Study|Adverse Event|0|||
131668399|NCT02647866|474071831|FG002|Overall Study|Adverse Event|2|||
131668400|NCT02647866|474071832|FG003|Overall Study|Adverse Event|2|||
131668401|NCT02647866|474071833|FG004|Overall Study|Adverse Event|1|||
131668402|NCT02647866|474071829|FG000|Overall Study|Disease Worsening|3|||
131668403|NCT02647866|474071830|FG001|Overall Study|Disease Worsening|1|||
131668404|NCT02647866|474071831|FG002|Overall Study|Disease Worsening|0|||
131668405|NCT02647866|474071832|FG003|Overall Study|Disease Worsening|0|||
131668406|NCT02647866|474071833|FG004|Overall Study|Disease Worsening|1|||
131668407|NCT02647866|474071829|FG000|Overall Study|Withdrawal by Subject|1|||
131668408|NCT02647866|474071830|FG001|Overall Study|Withdrawal by Subject|1|||
131668409|NCT02647866|474071831|FG002|Overall Study|Withdrawal by Subject|2|||
131668410|NCT02647866|474071832|FG003|Overall Study|Withdrawal by Subject|4|||
131668411|NCT02647866|474071833|FG004|Overall Study|Withdrawal by Subject|4|||
131668412|NCT02647866|474071829|FG000|Overall Study|Physician Decision|0|||
131668413|NCT02647866|474071830|FG001|Overall Study|Physician Decision|1|||
131668414|NCT02647866|474071831|FG002|Overall Study|Physician Decision|1|||
131668415|NCT02647866|474071832|FG003|Overall Study|Physician Decision|0|||
131668416|NCT02647866|474071833|FG004|Overall Study|Physician Decision|2|||
131668417|NCT02647866|474071829|FG000|Overall Study|Death|0|||
131668418|NCT02647866|474071830|FG001|Overall Study|Death|1|||
131668419|NCT02647866|474071831|FG002|Overall Study|Death|0|||
131668420|NCT02647866|474071832|FG003|Overall Study|Death|0|||
131668421|NCT02647866|474071833|FG004|Overall Study|Death|0|||
131668422|NCT02647866|474071829|FG000|Overall Study|Subject moved to different country|1|||
131668423|NCT02647866|474071830|FG001|Overall Study|Subject moved to different country|0|||
131668424|NCT02647866|474071831|FG002|Overall Study|Subject moved to different country|0|||
131668425|NCT02647866|474071832|FG003|Overall Study|Subject moved to different country|0|||
131668426|NCT02647866|474071833|FG004|Overall Study|Subject moved to different country|0|||
131668427|NCT01415531|474071837|FG000|Overall Study|Adverse Event|7|||
131668428|NCT01415531|474071838|FG001|Overall Study|Adverse Event|10|||
131668429|NCT01415531|474071837|FG000|Overall Study|Lack of Efficacy|3|||
131668430|NCT01415531|474071838|FG001|Overall Study|Lack of Efficacy|2|||
131668431|NCT01415531|474071837|FG000|Overall Study|Protocol Violation|0|||
131668432|NCT01415531|474071838|FG001|Overall Study|Protocol Violation|1|||
131668433|NCT01415531|474071837|FG000|Overall Study|Withdrawal by Subject|5|||
131668434|NCT01415531|474071838|FG001|Overall Study|Withdrawal by Subject|4|||
131668435|NCT01415531|474071837|FG000|Overall Study|Lost to Follow-up|6|||
131668436|NCT01415531|474071838|FG001|Overall Study|Lost to Follow-up|14|||
131668437|NCT01415531|474071837|FG000|Overall Study|Lack of Compliance|1|||
131668438|NCT01415531|474071838|FG001|Overall Study|Lack of Compliance|4|||
131668439|NCT01415531|474071837|FG000|Overall Study|Other Reasons|3|||
131668440|NCT01415531|474071838|FG001|Overall Study|Other Reasons|2|||
131668441|NCT01577745|474071839|FG000|Overall Study|Withdrawal by Subject|0|||
131668442|NCT01577745|474071840|FG001|Overall Study|Withdrawal by Subject|1|||
131668443|NCT01577745|474071841|FG002|Overall Study|Withdrawal by Subject|0|||
131668444|NCT01577745|474071842|FG003|Overall Study|Withdrawal by Subject|3|||
131668445|NCT01577745|474071843|FG004|Overall Study|Withdrawal by Subject|2|||
131668446|NCT01577745|474071844|FG005|Overall Study|Withdrawal by Subject|0|||
131668447|NCT01577745|474071839|FG000|Overall Study|Death|3|||
131668448|NCT01577745|474071840|FG001|Overall Study|Death|2|||
131668449|NCT01577745|474071841|FG002|Overall Study|Death|2|||
131668450|NCT01577745|474071842|FG003|Overall Study|Death|1|||
131668451|NCT01577745|474071843|FG004|Overall Study|Death|1|||
131668452|NCT01577745|474071844|FG005|Overall Study|Death|3|||
131668453|NCT01577745|474071839|FG000|Overall Study|Physician Decision|0|||
131668454|NCT01577745|474071840|FG001|Overall Study|Physician Decision|0|||
131668455|NCT01577745|474071841|FG002|Overall Study|Physician Decision|0|||
131668456|NCT01577745|474071842|FG003|Overall Study|Physician Decision|1|||
131668457|NCT01577745|474071843|FG004|Overall Study|Physician Decision|1|||
131668458|NCT01577745|474071844|FG005|Overall Study|Physician Decision|0|||
131668459|NCT01577745|474071839|FG000|Overall Study|Lost to Follow-up|0|||
131668460|NCT01577745|474071840|FG001|Overall Study|Lost to Follow-up|0|||
131668461|NCT01577745|474071841|FG002|Overall Study|Lost to Follow-up|0|||
131668462|NCT01577745|474071842|FG003|Overall Study|Lost to Follow-up|0|||
131896790|NCT01677182|474908582|FG002|Overall Study|Protocol Violation|4|||
131896791|NCT01677182|474908580|FG000|Overall Study|Lost to Follow-up|4|||
131896792|NCT01677182|474908581|FG001|Overall Study|Lost to Follow-up|0|||
131896793|NCT01677182|474908582|FG002|Overall Study|Lost to Follow-up|3|||
131896794|NCT01677182|474908580|FG000|Overall Study|Withdrawal by Subject|7|||
131896795|NCT01677182|474908581|FG001|Overall Study|Withdrawal by Subject|12|||
131896796|NCT01677182|474908582|FG002|Overall Study|Withdrawal by Subject|10|||
131668463|NCT01577745|474071843|FG004|Overall Study|Lost to Follow-up|0|||
131668464|NCT01577745|474071844|FG005|Overall Study|Lost to Follow-up|1|||
131668465|NCT01577745|474071839|FG000|Overall Study|Alternative Therapy|0|||
131668466|NCT01577745|474071840|FG001|Overall Study|Alternative Therapy|0|||
131668467|NCT01577745|474071841|FG002|Overall Study|Alternative Therapy|0|||
131668468|NCT01577745|474071842|FG003|Overall Study|Alternative Therapy|1|||
131668469|NCT01577745|474071843|FG004|Overall Study|Alternative Therapy|1|||
131668470|NCT01577745|474071844|FG005|Overall Study|Alternative Therapy|0|||
131668471|NCT02483585|474071845|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
131668472|NCT02483585|474071846|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
131668473|NCT02483585|474071845|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
131668474|NCT02483585|474071846|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
131668475|NCT02483585|474071845|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
131668476|NCT02483585|474071846|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
131668477|NCT02483585|474071845|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
131668478|NCT02483585|474071846|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
131668479|NCT02483585|474071845|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
131668480|NCT02483585|474071846|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
131668481|NCT02483585|474071845|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
131896797|NCT01677182|474908580|FG000|Overall Study|Study termination|12|||
131668482|NCT02483585|474071846|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
131668483|NCT02483585|474071845|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
131668484|NCT02483585|474071846|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
131668485|NCT00825916|474071848|FG000|Overall Study|Lost to Follow-up|4|||
131668486|NCT00825916|474071849|FG001|Overall Study|Lost to Follow-up|2|||
131668487|NCT00825916|474071850|FG002|Overall Study|Lost to Follow-up|1|||
131668488|NCT01324440|474071854|FG000|Overall Study|Subject moved|0|||
131668489|NCT01324440|474071855|FG001|Overall Study|Subject moved|1|||
131668490|NCT02325557|474071857|FG000|Overall Study|Progressive disease|1|||
131668491|NCT02325557|474071858|FG001|Overall Study|Progressive disease|0|||
131668492|NCT02325557|474071859|FG002|Overall Study|Progressive disease|0|||
131668493|NCT02325557|474071860|FG003|Overall Study|Progressive disease|0|||
131668494|NCT02325557|474071857|FG000|Overall Study|Withdrawal by Subject|4|||
131668495|NCT02325557|474071858|FG001|Overall Study|Withdrawal by Subject|0|||
131668496|NCT02325557|474071859|FG002|Overall Study|Withdrawal by Subject|0|||
131668497|NCT02325557|474071860|FG003|Overall Study|Withdrawal by Subject|15|||
131668498|NCT02325557|474071857|FG000|Overall Study|Death|5|||
131668499|NCT02325557|474071858|FG001|Overall Study|Death|1|||
131668500|NCT02325557|474071859|FG002|Overall Study|Death|1|||
131668501|NCT02325557|474071860|FG003|Overall Study|Death|16|||
131668502|NCT02325557|474071857|FG000|Overall Study|Lost to Follow-up|0|||
131668503|NCT02325557|474071858|FG001|Overall Study|Lost to Follow-up|0|||
131668504|NCT02325557|474071859|FG002|Overall Study|Lost to Follow-up|1|||
131668505|NCT02325557|474071860|FG003|Overall Study|Lost to Follow-up|1|||
131668506|NCT02325557|474071857|FG000|Overall Study|Other|0|||
131668507|NCT02325557|474071858|FG001|Overall Study|Other|0|||
131668508|NCT02325557|474071859|FG002|Overall Study|Other|0|||
131668509|NCT02325557|474071860|FG003|Overall Study|Other|5|||
131668510|NCT02344004|474071861|FG000|Overall Study|Adverse Event|11|||
131668511|NCT02344004|474071862|FG001|Overall Study|Adverse Event|1|||
131668512|NCT02344004|474071861|FG000|Overall Study|Death|9|||
131668513|NCT02344004|474071862|FG001|Overall Study|Death|7|||
131668514|NCT02344004|474071861|FG000|Overall Study|Physician Decision|4|||
131668515|NCT02344004|474071862|FG001|Overall Study|Physician Decision|1|||
131668516|NCT02344004|474071861|FG000|Overall Study|Withdrawal by Subject|22|||
131668517|NCT02344004|474071862|FG001|Overall Study|Withdrawal by Subject|5|||
131668518|NCT02344004|474071861|FG000|Overall Study|Rescue Medication|2|||
131668519|NCT02344004|474071862|FG001|Overall Study|Rescue Medication|0|||
131668520|NCT02344004|474071861|FG000|Overall Study|Other Not Specified|12|||
131668521|NCT02344004|474071862|FG001|Overall Study|Other Not Specified|0|||
131668522|NCT02344004|474071861|FG000|Overall Study|Protocol Violation|1|||
131668523|NCT02344004|474071862|FG001|Overall Study|Protocol Violation|0|||
131668524|NCT03426605|474071863|FG000|Overall Study|AML relapse or progression|2|||
131668525|NCT03426605|474071864|FG001|Overall Study|AML relapse or progression|1|||
131668526|NCT03426605|474071865|FG002|Overall Study|AML relapse or progression|2|||
131668527|NCT03426605|474071866|FG003|Overall Study|AML relapse or progression|2|||
131668528|NCT03426605|474071863|FG000|Overall Study|Treatment failure|3|||
131668529|NCT03426605|474071864|FG001|Overall Study|Treatment failure|2|||
131668530|NCT03426605|474071865|FG002|Overall Study|Treatment failure|0|||
131668531|NCT03426605|474071866|FG003|Overall Study|Treatment failure|0|||
131668532|NCT03426605|474071863|FG000|Overall Study|Adverse Event|1|||
131668533|NCT03426605|474071864|FG001|Overall Study|Adverse Event|0|||
131668534|NCT03426605|474071865|FG002|Overall Study|Adverse Event|1|||
131668535|NCT03426605|474071866|FG003|Overall Study|Adverse Event|1|||
131668536|NCT03426605|474071863|FG000|Overall Study|Withdrawal by Subject|0|||
131668537|NCT03426605|474071864|FG001|Overall Study|Withdrawal by Subject|0|||
131668538|NCT03426605|474071865|FG002|Overall Study|Withdrawal by Subject|1|||
131668539|NCT03426605|474071866|FG003|Overall Study|Withdrawal by Subject|1|||
131668540|NCT00609765|474071872|FG000|Overall Study|Study ended prior to 12 months|1|||
131668541|NCT02649946|474071879|FG000|Overall Study|Withdrawal by Subject|1|||
131668542|NCT02649946|474071880|FG001|Overall Study|Withdrawal by Subject|1|||
131668543|NCT02649946|474071879|FG000|Overall Study|Death|7|||
131668544|NCT02649946|474071880|FG001|Overall Study|Death|9|||
131668545|NCT02649946|474071879|FG000|Overall Study|Physician Decision|1|||
131668546|NCT02649946|474071880|FG001|Overall Study|Physician Decision|0|||
131668547|NCT02649946|474071879|FG000|Overall Study|Lost to Follow-up|2|||
131668548|NCT02649946|474071880|FG001|Overall Study|Lost to Follow-up|1|||
131668549|NCT02649946|474071879|FG000|Overall Study|Erroneously enrolled|1|||
131668550|NCT02649946|474071880|FG001|Overall Study|Erroneously enrolled|0|||
131668551|NCT02649946|474071879|FG000|Overall Study|Missed 6-month follow-up visit|0|||
131668552|NCT02649946|474071880|FG001|Overall Study|Missed 6-month follow-up visit|4|||
131668553|NCT00950950|474071881|FG000|Overall Study|Adverse Event|1|||
131668554|NCT00950950|474071882|FG001|Overall Study|Adverse Event|0|||
131668555|NCT00950950|474071881|FG000|Overall Study|Withdrawal by Subject|0|||
131668556|NCT00950950|474071882|FG001|Overall Study|Withdrawal by Subject|1|||
131668557|NCT01047293|474071883|FG000|Overall Study|DLT criteria not fulfilled|1|||
131668558|NCT01047293|474071884|FG001|Overall Study|DLT criteria not fulfilled|1|||
131668559|NCT01047293|474071885|FG002|Overall Study|DLT criteria not fulfilled|0|||
131668560|NCT01047293|474071886|FG003|Overall Study|DLT criteria not fulfilled|0|||
131668561|NCT02054520|474071892|FG000|Overall Study|Adverse Event|1|||
131668562|NCT02054520|474071893|FG001|Overall Study|Adverse Event|4|||
131668563|NCT02054520|474071894|FG002|Overall Study|Adverse Event|2|||
131668564|NCT02054520|474071895|FG003|Overall Study|Adverse Event|1|||
131668565|NCT02054520|474071896|FG004|Overall Study|Adverse Event|1|||
131668566|NCT02054520|474071897|FG005|Overall Study|Adverse Event|0|||
131668567|NCT02054520|474071892|FG000|Overall Study|Lack of Efficacy|7|||
131668568|NCT02054520|474071893|FG001|Overall Study|Lack of Efficacy|0|||
131668569|NCT02054520|474071894|FG002|Overall Study|Lack of Efficacy|2|||
131668570|NCT02054520|474071895|FG003|Overall Study|Lack of Efficacy|1|||
131668571|NCT02054520|474071896|FG004|Overall Study|Lack of Efficacy|3|||
131668572|NCT02054520|474071897|FG005|Overall Study|Lack of Efficacy|2|||
131668573|NCT02054520|474071892|FG000|Overall Study|Withdrawal by Subject|1|||
131668574|NCT02054520|474071893|FG001|Overall Study|Withdrawal by Subject|0|||
131668575|NCT02054520|474071894|FG002|Overall Study|Withdrawal by Subject|0|||
131668576|NCT02054520|474071895|FG003|Overall Study|Withdrawal by Subject|2|||
131668577|NCT02054520|474071896|FG004|Overall Study|Withdrawal by Subject|1|||
131668578|NCT02054520|474071897|FG005|Overall Study|Withdrawal by Subject|0|||
131668579|NCT02054520|474071892|FG000|Overall Study|Physician Decision|0|||
131668580|NCT02054520|474071893|FG001|Overall Study|Physician Decision|1|||
131668581|NCT02054520|474071894|FG002|Overall Study|Physician Decision|0|||
131668582|NCT02054520|474071895|FG003|Overall Study|Physician Decision|1|||
131668583|NCT02054520|474071896|FG004|Overall Study|Physician Decision|0|||
131668584|NCT02054520|474071897|FG005|Overall Study|Physician Decision|1|||
131668585|NCT02054520|474071892|FG000|Overall Study|Study terminated by Sponsor|0|||
131668586|NCT02054520|474071893|FG001|Overall Study|Study terminated by Sponsor|0|||
131668587|NCT02054520|474071894|FG002|Overall Study|Study terminated by Sponsor|2|||
131668588|NCT02054520|474071895|FG003|Overall Study|Study terminated by Sponsor|1|||
131668589|NCT02054520|474071896|FG004|Overall Study|Study terminated by Sponsor|0|||
131668590|NCT02054520|474071897|FG005|Overall Study|Study terminated by Sponsor|0|||
131668591|NCT01272804|474071898|FG000|Overall Study|Adverse Event|1|||
131668592|NCT01272804|474071899|FG001|Overall Study|Adverse Event|0|||
131668593|NCT01272804|474071900|FG002|Overall Study|Adverse Event|0|||
131668594|NCT01272804|474071901|FG003|Overall Study|Adverse Event|0|||
131668595|NCT01272804|474071902|FG004|Overall Study|Adverse Event|2|||
131668596|NCT01272804|474071903|FG005|Overall Study|Adverse Event|1|||
131668597|NCT02318797|474071904|FG000|Overall Study|Death|3|||
131668598|NCT02318797|474071905|FG001|Overall Study|Death|6|||
131668599|NCT02318797|474071904|FG000|Overall Study|Lost to Follow-up|85|||
131668600|NCT02318797|474071905|FG001|Overall Study|Lost to Follow-up|96|||
131668601|NCT02308020|474071908|FG000|Overall Study|Lost to Follow-up|1|||
131668602|NCT02308020|474071909|FG001|Overall Study|Lost to Follow-up|7|||
131668603|NCT02308020|474071910|FG002|Overall Study|Lost to Follow-up|0|||
131668604|NCT02308020|474071911|FG003|Overall Study|Lost to Follow-up|0|||
131668605|NCT02308020|474071912|FG004|Overall Study|Lost to Follow-up|1|||
131668606|NCT02308020|474071913|FG005|Overall Study|Lost to Follow-up|2|||
131668607|NCT02308020|474071908|FG000|Overall Study|Sponsor Decision|0|||
131668608|NCT02308020|474071909|FG001|Overall Study|Sponsor Decision|8|||
131668609|NCT02308020|474071910|FG002|Overall Study|Sponsor Decision|0|||
131668610|NCT02308020|474071911|FG003|Overall Study|Sponsor Decision|2|||
131668611|NCT02308020|474071912|FG004|Overall Study|Sponsor Decision|2|||
131668612|NCT02308020|474071913|FG005|Overall Study|Sponsor Decision|1|||
131668613|NCT02308020|474071908|FG000|Overall Study|Withdrawal by Subject|3|||
131668614|NCT02308020|474071909|FG001|Overall Study|Withdrawal by Subject|5|||
131668615|NCT02308020|474071910|FG002|Overall Study|Withdrawal by Subject|3|||
131668616|NCT02308020|474071911|FG003|Overall Study|Withdrawal by Subject|2|||
131668617|NCT02308020|474071912|FG004|Overall Study|Withdrawal by Subject|1|||
131668618|NCT02308020|474071913|FG005|Overall Study|Withdrawal by Subject|2|||
131668619|NCT03333837|474071914|FG000|Overall Study|Adverse Event|2|||
131668620|NCT03333837|474071915|FG001|Overall Study|Adverse Event|1|||
131668621|NCT03333837|474071916|FG002|Overall Study|Adverse Event|1|||
131668622|NCT03333837|474071917|FG003|Overall Study|Adverse Event|1|||
131668623|NCT03333837|474071918|FG004|Overall Study|Adverse Event|0|||
131668624|NCT03333837|474071914|FG000|Overall Study|Caregiver withdrew|0|||
131668625|NCT03333837|474071915|FG001|Overall Study|Caregiver withdrew|2|||
131668626|NCT03333837|474071916|FG002|Overall Study|Caregiver withdrew|1|||
131668627|NCT03333837|474071917|FG003|Overall Study|Caregiver withdrew|0|||
131668628|NCT03333837|474071918|FG004|Overall Study|Caregiver withdrew|0|||
131668629|NCT03333837|474071914|FG000|Overall Study|Withdrawal by Subject|0|||
131668630|NCT03333837|474071915|FG001|Overall Study|Withdrawal by Subject|0|||
131668631|NCT03333837|474071916|FG002|Overall Study|Withdrawal by Subject|1|||
131668632|NCT03333837|474071917|FG003|Overall Study|Withdrawal by Subject|1|||
131668633|NCT03333837|474071918|FG004|Overall Study|Withdrawal by Subject|3|||
131668634|NCT03333837|474071914|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131668635|NCT03333837|474071915|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131668636|NCT03333837|474071916|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
131668637|NCT03333837|474071917|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131668638|NCT03333837|474071918|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131668639|NCT04217590|474071919|FG000|Overall Study|Other|1|||
131668640|NCT04217590|474071920|FG001|Overall Study|Other|1|||
131668641|NCT04217590|474071919|FG000|Overall Study|Withdrawal by Subject|3|||
131668642|NCT04217590|474071920|FG001|Overall Study|Withdrawal by Subject|1|||
131668643|NCT04217590|474071919|FG000|Overall Study|Death|0|||
131668644|NCT04217590|474071920|FG001|Overall Study|Death|1|||
131668645|NCT02232243|474071921|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
131668646|NCT02232243|474071922|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
131668647|NCT02232243|474071923|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
131668648|NCT00704405|474071924|FG000|Overall Study (NC Population)|Adverse Event|1|||
131668649|NCT00704405|474071925|FG001|Overall Study (NC Population)|Adverse Event|0|||
131668650|NCT00704405|474071926|FG002|Overall Study (NC Population)|Adverse Event|0|||
131668651|NCT00704405|474071927|FG003|Overall Study (NC Population)|Adverse Event|0|||
131668652|NCT00704405|474071928|FG004|Overall Study (NC Population)|Adverse Event|0|||
131668653|NCT00704405|474071924|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
131668654|NCT00704405|474071925|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
131668655|NCT00704405|474071926|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
131668656|NCT00704405|474071927|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
131668657|NCT00704405|474071928|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
131668658|NCT00704405|474071924|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
131668659|NCT00704405|474071925|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
131668660|NCT00704405|474071926|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
131668661|NCT00704405|474071927|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
131668662|NCT00704405|474071928|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
131668663|NCT00704405|474071924|FG000|Overall Study (NC Population)|Other|0|||
131668664|NCT00704405|474071925|FG001|Overall Study (NC Population)|Other|0|||
131668665|NCT00704405|474071926|FG002|Overall Study (NC Population)|Other|0|||
131668666|NCT00704405|474071927|FG003|Overall Study (NC Population)|Other|0|||
131668667|NCT00704405|474071928|FG004|Overall Study (NC Population)|Other|1|||
131668668|NCT00704405|474071924|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
131668669|NCT00704405|474071925|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
131668670|NCT00704405|474071926|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
131668671|NCT00704405|474071927|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
131668672|NCT00704405|474071928|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
131668673|NCT00704405|474071924|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
131668674|NCT00704405|474071925|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
131668675|NCT00704405|474071926|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
131668676|NCT00704405|474071927|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
131668677|NCT00704405|474071928|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
131668678|NCT01395888|474071929|FG000|2-week Run-in Period|Adverse Event|2|||
131668679|NCT01395888|474071930|FG001|2-week Run-in Period|Adverse Event|0|||
131668680|NCT01395888|474071931|FG002|2-week Run-in Period|Adverse Event|0|||
131668681|NCT01395888|474071929|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
131668682|NCT01395888|474071930|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
131668683|NCT01395888|474071931|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
131668684|NCT01395888|474071929|FG000|2-week Run-in Period|Lost to Follow-up|1|||
131668685|NCT01395888|474071930|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131668686|NCT01395888|474071931|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131668687|NCT01395888|474071929|FG000|2-week Run-in Period|Protocol Violation|2|||
131668688|NCT01395888|474071930|FG001|2-week Run-in Period|Protocol Violation|0|||
131668689|NCT01395888|474071931|FG002|2-week Run-in Period|Protocol Violation|0|||
131668690|NCT01395888|474071929|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
131668691|NCT01395888|474071930|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131668692|NCT01395888|474071931|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131668693|NCT01395888|474071929|FG000|Treatment Period (TP)|Adverse Event|0|||
131668694|NCT01395888|474071930|FG001|Treatment Period (TP)|Adverse Event|7|||
131668695|NCT01395888|474071931|FG002|Treatment Period (TP)|Adverse Event|6|||
131668696|NCT01395888|474071929|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
131668697|NCT01395888|474071930|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
131668698|NCT01395888|474071931|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
131668699|NCT01395888|474071929|FG000|Treatment Period (TP)|Protocol Violation|0|||
131668700|NCT01395888|474071930|FG001|Treatment Period (TP)|Protocol Violation|1|||
131668701|NCT01395888|474071931|FG002|Treatment Period (TP)|Protocol Violation|5|||
131668702|NCT01395888|474071929|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
131554898|NCT00612534|473656343|FG003|Overall Study|Adverse Event|1|||
131554899|NCT00612534|473656340|FG000|Overall Study|Lack of Efficacy|13|||
131554900|NCT00612534|473656341|FG001|Overall Study|Lack of Efficacy|12|||
131554901|NCT00612534|473656342|FG002|Overall Study|Lack of Efficacy|5|||
131554902|NCT00612534|473656343|FG003|Overall Study|Lack of Efficacy|16|||
131554903|NCT00612534|473656340|FG000|Overall Study|Other Reason|0|||
131554904|NCT00612534|473656341|FG001|Overall Study|Other Reason|1|||
131554905|NCT00612534|473656342|FG002|Overall Study|Other Reason|0|||
131554906|NCT00612534|473656343|FG003|Overall Study|Other Reason|0|||
131554907|NCT01065350|473656348|FG000|Overall Study|Received incorrect drug allocation|0|||
131554908|NCT01065350|473656349|FG001|Overall Study|Received incorrect drug allocation|1|||
131554909|NCT02234063|473656362|FG000|Overall Study|Lost to Follow-up|235|||
131554910|NCT02234063|473656363|FG001|Overall Study|Lost to Follow-up|42|||
131554911|NCT02234063|473656362|FG000|Overall Study|Withdrawal by Subject|20|||
131554912|NCT02234063|473656363|FG001|Overall Study|Withdrawal by Subject|1|||
131554913|NCT00510458|473656364|FG000|Overall Study|5 year not evaluable/missed|21|||
131554914|NCT00510458|473656364|FG000|Overall Study|Death|1|||
131554915|NCT00510458|473656364|FG000|Overall Study|Terminated|14|||
131554916|NCT00510458|473656364|FG000|Overall Study|Lost to Follow-up|6|||
131554917|NCT00510458|473656364|FG000|Overall Study|Withdrawal by Subject|3|||
131554918|NCT00510458|473656364|FG000|Overall Study|Revision|2|||
131554919|NCT02569710|473656365|FG000|Overall Study|Adverse Event|1|||
131554920|NCT02569710|473656366|FG001|Overall Study|Adverse Event|0|||
131554921|NCT02569710|473656367|FG002|Overall Study|Adverse Event|0|||
131554922|NCT02569710|473656368|FG003|Overall Study|Adverse Event|0|||
131554923|NCT02569710|473656369|FG004|Overall Study|Adverse Event|0|||
131554924|NCT02569710|473656370|FG005|Overall Study|Adverse Event|0|||
131554925|NCT02569710|473656371|FG006|Overall Study|Adverse Event|0|||
131554926|NCT02569710|473656372|FG007|Overall Study|Adverse Event|0|||
131554927|NCT02569710|473656373|FG008|Overall Study|Adverse Event|0|||
131554928|NCT02569710|473656374|FG009|Overall Study|Adverse Event|0|||
131554929|NCT02569710|473656365|FG000|Overall Study|Lost to Follow-up|0|||
131554930|NCT02569710|473656366|FG001|Overall Study|Lost to Follow-up|0|||
131554931|NCT02569710|473656367|FG002|Overall Study|Lost to Follow-up|0|||
131554932|NCT02569710|473656368|FG003|Overall Study|Lost to Follow-up|0|||
131554933|NCT02569710|473656369|FG004|Overall Study|Lost to Follow-up|0|||
131554934|NCT02569710|473656370|FG005|Overall Study|Lost to Follow-up|0|||
131554935|NCT02569710|473656371|FG006|Overall Study|Lost to Follow-up|1|||
131554936|NCT02569710|473656372|FG007|Overall Study|Lost to Follow-up|0|||
131554937|NCT02569710|473656373|FG008|Overall Study|Lost to Follow-up|1|||
131554938|NCT02569710|473656374|FG009|Overall Study|Lost to Follow-up|0|||
131554939|NCT02569710|473656365|FG000|Overall Study|Virologic failure|0|||
131554940|NCT02569710|473656366|FG001|Overall Study|Virologic failure|0|||
131554941|NCT02569710|473656367|FG002|Overall Study|Virologic failure|0|||
131554942|NCT02569710|473656368|FG003|Overall Study|Virologic failure|0|||
131554943|NCT02569710|473656369|FG004|Overall Study|Virologic failure|1|||
131554944|NCT02569710|473656370|FG005|Overall Study|Virologic failure|0|||
131554945|NCT02569710|473656371|FG006|Overall Study|Virologic failure|1|||
131554946|NCT02569710|473656372|FG007|Overall Study|Virologic failure|0|||
131554947|NCT02569710|473656373|FG008|Overall Study|Virologic failure|0|||
131554948|NCT02569710|473656374|FG009|Overall Study|Virologic failure|0|||
131554949|NCT02569710|473656365|FG000|Overall Study|Withdrawal by Subject|0|||
131554950|NCT02569710|473656366|FG001|Overall Study|Withdrawal by Subject|0|||
131554951|NCT02569710|473656367|FG002|Overall Study|Withdrawal by Subject|0|||
131554952|NCT02569710|473656368|FG003|Overall Study|Withdrawal by Subject|0|||
131554953|NCT02569710|473656369|FG004|Overall Study|Withdrawal by Subject|0|||
131554954|NCT02569710|473656370|FG005|Overall Study|Withdrawal by Subject|1|||
131554955|NCT02569710|473656371|FG006|Overall Study|Withdrawal by Subject|0|||
131554956|NCT02569710|473656372|FG007|Overall Study|Withdrawal by Subject|0|||
131554957|NCT02569710|473656373|FG008|Overall Study|Withdrawal by Subject|0|||
131554958|NCT02569710|473656374|FG009|Overall Study|Withdrawal by Subject|0|||
131554959|NCT02716038|473656375|FG000|Overall Study|Not evaluable|1|||
131554960|NCT02716038|473656375|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
131554961|NCT02716038|473656375|FG000|Overall Study|Unresectable|3|||
131554962|NCT03573908|473656376|FG000|Treatment Period|Adverse Event|4|||
131554963|NCT03573908|473656377|FG001|Treatment Period|Adverse Event|9|||
131554964|NCT03573908|473656378|FG002|Treatment Period|Adverse Event|0|||
131554965|NCT03573908|473656379|FG003|Treatment Period|Adverse Event|0|||
131554966|NCT03573908|473656380|FG004|Treatment Period|Adverse Event|0|||
131554967|NCT03573908|473656376|FG000|Treatment Period|Protocol Violation|1|||
131554968|NCT03573908|473656377|FG001|Treatment Period|Protocol Violation|0|||
131554969|NCT03573908|473656378|FG002|Treatment Period|Protocol Violation|0|||
131554970|NCT03573908|473656379|FG003|Treatment Period|Protocol Violation|0|||
131554971|NCT03573908|473656380|FG004|Treatment Period|Protocol Violation|0|||
131554972|NCT03573908|473656376|FG000|Treatment Period|Withdrawal by Subject|7|||
131554973|NCT03573908|473656377|FG001|Treatment Period|Withdrawal by Subject|5|||
131554974|NCT03573908|473656378|FG002|Treatment Period|Withdrawal by Subject|0|||
131554975|NCT03573908|473656379|FG003|Treatment Period|Withdrawal by Subject|0|||
131554976|NCT03573908|473656380|FG004|Treatment Period|Withdrawal by Subject|0|||
131668703|NCT01395888|474071930|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
131668704|NCT01395888|474071931|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
131668705|NCT01395888|474071929|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
131668706|NCT01395888|474071930|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
131668707|NCT01395888|474071931|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
131668708|NCT03218397|474071932|FG000|Overall Study|Prior positive blood culture|8|||
131668709|NCT03218397|474071933|FG001|Overall Study|Prior positive blood culture|13|||
131668710|NCT03218397|474071932|FG000|Overall Study|Comfort care|8|||
131668711|NCT03218397|474071933|FG001|Overall Study|Comfort care|5|||
131668712|NCT03218397|474071932|FG000|Overall Study|Comfort care and positive blood culture|1|||
131668713|NCT03218397|474071933|FG001|Overall Study|Comfort care and positive blood culture|0|||
131668714|NCT03218397|474071932|FG000|Overall Study|Comfort care and mixed culture|0|||
131668715|NCT03218397|474071933|FG001|Overall Study|Comfort care and mixed culture|1|||
131668716|NCT03218397|474071932|FG000|Overall Study|Mixed culture|2|||
131668717|NCT03218397|474071933|FG001|Overall Study|Mixed culture|2|||
131668718|NCT03218397|474071932|FG000|Overall Study|Inaccessible hospital records|2|||
131668719|NCT03218397|474071933|FG001|Overall Study|Inaccessible hospital records|5|||
131668720|NCT03218397|474071932|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
131668721|NCT03218397|474071933|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
131668722|NCT03218397|474071932|FG000|Overall Study|Randomized during laboratory off hours|2|||
131668723|NCT03218397|474071933|FG001|Overall Study|Randomized during laboratory off hours|1|||
131668724|NCT01796548|474071934|FG000|Overall Study|Lost to Follow-up|1|||
131668725|NCT01796548|474071934|FG000|Overall Study|Other|2|||
131668726|NCT02859324|474071935|FG000|Overall Study|Death|4|||
131668727|NCT02859324|474071936|FG001|Overall Study|Death|6|||
131668728|NCT02859324|474071937|FG002|Overall Study|Death|5|||
131668729|NCT02859324|474071935|FG000|Overall Study|Other reasons|3|||
131668730|NCT02859324|474071936|FG001|Overall Study|Other reasons|3|||
131668731|NCT02859324|474071937|FG002|Overall Study|Other reasons|0|||
131668732|NCT01946438|474071938|FG000|Overall Study|Adverse Event|0|||
131668733|NCT01946438|474071939|FG001|Overall Study|Adverse Event|0|||
131668734|NCT01946438|474071940|FG002|Overall Study|Adverse Event|0|||
131668735|NCT01946438|474071941|FG003|Overall Study|Adverse Event|1|||
131668736|NCT01946438|474071938|FG000|Overall Study|Serious Adverse event|1|||
131668737|NCT01946438|474071939|FG001|Overall Study|Serious Adverse event|0|||
131668738|NCT01946438|474071940|FG002|Overall Study|Serious Adverse event|0|||
131668739|NCT01946438|474071941|FG003|Overall Study|Serious Adverse event|0|||
131668740|NCT01946438|474071938|FG000|Overall Study|Protocol Violation|0|||
131668741|NCT01946438|474071939|FG001|Overall Study|Protocol Violation|0|||
131668742|NCT01946438|474071940|FG002|Overall Study|Protocol Violation|1|||
131668743|NCT01946438|474071941|FG003|Overall Study|Protocol Violation|0|||
131668744|NCT01946438|474071938|FG000|Overall Study|Withdrawal by Subject|1|||
131668745|NCT01946438|474071939|FG001|Overall Study|Withdrawal by Subject|0|||
131668746|NCT01946438|474071940|FG002|Overall Study|Withdrawal by Subject|0|||
131668747|NCT01946438|474071941|FG003|Overall Study|Withdrawal by Subject|0|||
131668748|NCT03169101|474071944|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
131668749|NCT03169101|474071945|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
131668750|NCT03169101|474071946|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
131668751|NCT03169101|474071947|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
131668752|NCT02641496|474071948|FG000|Overall Study|Lost to Follow-up|13|||
131668753|NCT02641496|474071949|FG001|Overall Study|Lost to Follow-up|12|||
131668754|NCT02641496|474071948|FG000|Overall Study|Withdrawal by Subject|1|||
131668755|NCT02641496|474071949|FG001|Overall Study|Withdrawal by Subject|0|||
131668756|NCT02523599|474071950|FG000|Overall Study|Adverse Event|1|||
131668757|NCT02523599|474071951|FG001|Overall Study|Adverse Event|0|||
131668758|NCT02523599|474071950|FG000|Overall Study|Physician Decision|1|||
131668759|NCT02523599|474071951|FG001|Overall Study|Physician Decision|0|||
131668760|NCT02523599|474071950|FG000|Overall Study|Lost to Follow-up|4|||
131668761|NCT02523599|474071951|FG001|Overall Study|Lost to Follow-up|1|||
131668762|NCT02523599|474071950|FG000|Overall Study|Did not return for Day 30 visit|2|||
131668763|NCT02523599|474071951|FG001|Overall Study|Did not return for Day 30 visit|0|||
131668764|NCT00790751|474071954|FG000|Overall Study|Protocol non-compliance|16|||
131668765|NCT00790751|474071955|FG001|Overall Study|Protocol non-compliance|16|||
131668766|NCT00790751|474071956|FG002|Overall Study|Protocol non-compliance|10|||
131668767|NCT00790751|474071957|FG003|Overall Study|Protocol non-compliance|11|||
131668768|NCT00790751|474071954|FG000|Overall Study|Lost to Follow-up|4|||
131668769|NCT00790751|474071955|FG001|Overall Study|Lost to Follow-up|9|||
131668770|NCT00790751|474071956|FG002|Overall Study|Lost to Follow-up|4|||
131668771|NCT00790751|474071957|FG003|Overall Study|Lost to Follow-up|5|||
131668772|NCT00790751|474071954|FG000|Overall Study|Adverse Event|5|||
131668773|NCT00790751|474071955|FG001|Overall Study|Adverse Event|3|||
131668774|NCT00790751|474071956|FG002|Overall Study|Adverse Event|5|||
131668775|NCT00790751|474071957|FG003|Overall Study|Adverse Event|4|||
131668776|NCT00790751|474071954|FG000|Overall Study|Requirement for restricted medication|0|||
131668777|NCT00790751|474071955|FG001|Overall Study|Requirement for restricted medication|2|||
131668778|NCT00790751|474071956|FG002|Overall Study|Requirement for restricted medication|0|||
131668779|NCT00790751|474071957|FG003|Overall Study|Requirement for restricted medication|0|||
131668780|NCT00790751|474071954|FG000|Overall Study|Death|0|||
131668781|NCT00790751|474071955|FG001|Overall Study|Death|0|||
131668782|NCT00790751|474071956|FG002|Overall Study|Death|1|||
131668783|NCT00790751|474071957|FG003|Overall Study|Death|0|||
131668784|NCT00790751|474071954|FG000|Overall Study|Physician Decision|0|||
131668785|NCT00790751|474071955|FG001|Overall Study|Physician Decision|0|||
131668786|NCT00790751|474071956|FG002|Overall Study|Physician Decision|0|||
131668787|NCT00790751|474071957|FG003|Overall Study|Physician Decision|1|||
131668788|NCT00112047|474071958|FG000|Randomized Phase|Lost to Follow-up|26|||
131668789|NCT00112047|474071959|FG001|Randomized Phase|Lost to Follow-up|33|||
131668790|NCT00112047|474071958|FG000|Randomized Phase|Adverse Event|10|||
131668791|NCT00112047|474071959|FG001|Randomized Phase|Adverse Event|10|||
131668792|NCT00112047|474071958|FG000|Randomized Phase|Withrawal of consent|10|||
131668793|NCT00112047|474071959|FG001|Randomized Phase|Withrawal of consent|18|||
131668794|NCT00112047|474071958|FG000|Randomized Phase|Sub-optimal virological response|3|||
131668795|NCT00112047|474071959|FG001|Randomized Phase|Sub-optimal virological response|13|||
131668796|NCT00112047|474071958|FG000|Randomized Phase|Noncompliance|8|||
131668797|NCT00112047|474071959|FG001|Randomized Phase|Noncompliance|4|||
131668798|NCT00112047|474071958|FG000|Randomized Phase|Protocol Violation|2|||
131668799|NCT00112047|474071959|FG001|Randomized Phase|Protocol Violation|0|||
131668800|NCT00112047|474071958|FG000|Randomized Phase|Pregnancy|3|||
131668801|NCT00112047|474071959|FG001|Randomized Phase|Pregnancy|1|||
131668802|NCT00112047|474071958|FG000|Randomized Phase|Death|1|||
131668803|NCT00112047|474071959|FG001|Randomized Phase|Death|3|||
131668804|NCT00112047|474071958|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
131668805|NCT00112047|474071959|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
131668806|NCT00112047|474071958|FG000|Randomized Phase|Inability to swallow pills|0|||
131668807|NCT00112047|474071959|FG001|Randomized Phase|Inability to swallow pills|1|||
131668808|NCT00112047|474071958|FG000|Randomized Phase|Incarceration|3|||
131668809|NCT00112047|474071959|FG001|Randomized Phase|Incarceration|2|||
131668810|NCT00112047|474071958|FG000|Randomized Phase|Moved out of State|0|||
131668811|NCT00112047|474071959|FG001|Randomized Phase|Moved out of State|1|||
131668812|NCT00112047|474071958|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
131668813|NCT00112047|474071959|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
131668814|NCT00112047|474071958|FG000|Randomized Phase|High Hepatitis B DNA|0|||
131668815|NCT00112047|474071959|FG001|Randomized Phase|High Hepatitis B DNA|1|||
131668816|NCT00112047|474071958|FG000|Atripla Phase|Adverse Event|2|||
131668817|NCT00112047|474071959|FG001|Atripla Phase|Adverse Event|1|||
131668818|NCT00112047|474071958|FG000|Atripla Phase|Lost to Follow-up|5|||
131668819|NCT00112047|474071959|FG001|Atripla Phase|Lost to Follow-up|7|||
131668820|NCT00112047|474071958|FG000|Atripla Phase|Pregnancy|0|||
131668821|NCT00112047|474071959|FG001|Atripla Phase|Pregnancy|1|||
131668822|NCT00112047|474071958|FG000|Atripla Phase|Death|0|||
131668823|NCT00112047|474071959|FG001|Atripla Phase|Death|2|||
131668824|NCT00112047|474071958|FG000|Atripla Phase|Withdrew consent|7|||
131668825|NCT00112047|474071959|FG001|Atripla Phase|Withdrew consent|7|||
131668826|NCT00112047|474071958|FG000|Atripla Phase|Sub-optimal virological response|0|||
131668827|NCT00112047|474071959|FG001|Atripla Phase|Sub-optimal virological response|1|||
131668828|NCT00112047|474071958|FG000|Atripla Phase|Non-compliance|1|||
131668829|NCT00112047|474071959|FG001|Atripla Phase|Non-compliance|0|||
131668830|NCT00112047|474071958|FG000|Atripla Phase|Other|3|||
131668831|NCT00112047|474071959|FG001|Atripla Phase|Other|1|||
131668832|NCT01307579|474071960|FG000|Overall Study|Death|3|||
131668833|NCT01307579|474071961|FG001|Overall Study|Death|6|||
131668834|NCT01307579|474071960|FG000|Overall Study|Physician Decision|26|||
131668835|NCT01307579|474071961|FG001|Overall Study|Physician Decision|29|||
131668836|NCT01307579|474071960|FG000|Overall Study|Withdrawal by Subject|7|||
131668837|NCT01307579|474071961|FG001|Overall Study|Withdrawal by Subject|3|||
131668838|NCT01307579|474071960|FG000|Overall Study|Institutional diagnosis of IFD|21|||
131668839|NCT01307579|474071961|FG001|Overall Study|Institutional diagnosis of IFD|36|||
131668840|NCT01307579|474071960|FG000|Overall Study|Begin conditioning for HSCT|42|||
131668841|NCT01307579|474071961|FG001|Overall Study|Begin conditioning for HSCT|44|||
131668842|NCT01307579|474071960|FG000|Overall Study|Refractory or relapsed AML|38|||
131668843|NCT01307579|474071961|FG001|Overall Study|Refractory or relapsed AML|23|||
131668844|NCT01307579|474071960|FG000|Overall Study|Ineligible|3|||
131668845|NCT01307579|474071961|FG001|Overall Study|Ineligible|4|||
131668846|NCT00031551|474074007|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
131668847|NCT00031551|474074008|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
131668848|NCT00409773|474074009|FG000|Overall Study|Adverse Event|3|||
131668849|NCT00409773|474074010|FG001|Overall Study|Adverse Event|4|||
131668850|NCT00409773|474074011|FG002|Overall Study|Adverse Event|4|||
131668851|NCT00409773|474074012|FG003|Overall Study|Adverse Event|2|||
131668852|NCT00409773|474074013|FG004|Overall Study|Adverse Event|6|||
131668853|NCT00409773|474074009|FG000|Overall Study|Lost to Follow-up|6|||
131668854|NCT00409773|474074010|FG001|Overall Study|Lost to Follow-up|1|||
131668855|NCT00409773|474074011|FG002|Overall Study|Lost to Follow-up|2|||
131668856|NCT00409773|474074012|FG003|Overall Study|Lost to Follow-up|3|||
131668857|NCT00409773|474074013|FG004|Overall Study|Lost to Follow-up|1|||
131668858|NCT00409773|474074009|FG000|Overall Study|Physician Decision|0|||
131668859|NCT00409773|474074010|FG001|Overall Study|Physician Decision|0|||
131668860|NCT00409773|474074011|FG002|Overall Study|Physician Decision|0|||
131668861|NCT00409773|474074012|FG003|Overall Study|Physician Decision|2|||
131668862|NCT00409773|474074013|FG004|Overall Study|Physician Decision|0|||
131668863|NCT00409773|474074009|FG000|Overall Study|Protocol Violation|0|||
131668864|NCT00409773|474074010|FG001|Overall Study|Protocol Violation|2|||
131668865|NCT00409773|474074011|FG002|Overall Study|Protocol Violation|3|||
131668866|NCT00409773|474074012|FG003|Overall Study|Protocol Violation|3|||
131668867|NCT00409773|474074013|FG004|Overall Study|Protocol Violation|1|||
131668868|NCT00409773|474074009|FG000|Overall Study|Withdrawal by Subject|0|||
131668869|NCT00409773|474074010|FG001|Overall Study|Withdrawal by Subject|0|||
131668870|NCT00409773|474074011|FG002|Overall Study|Withdrawal by Subject|0|||
131668871|NCT00409773|474074012|FG003|Overall Study|Withdrawal by Subject|2|||
131668872|NCT00409773|474074013|FG004|Overall Study|Withdrawal by Subject|1|||
131668873|NCT00409773|474074009|FG000|Overall Study|Lack of Eligibility|0|||
131668874|NCT00409773|474074010|FG001|Overall Study|Lack of Eligibility|0|||
131668875|NCT00409773|474074011|FG002|Overall Study|Lack of Eligibility|0|||
131668876|NCT00409773|474074012|FG003|Overall Study|Lack of Eligibility|0|||
131668877|NCT00409773|474074013|FG004|Overall Study|Lack of Eligibility|1|||
131668878|NCT02359877|474074014|FG000|Overall Study|Withdrawal by Subject|1|||
131668879|NCT02359877|474074015|FG001|Overall Study|Withdrawal by Subject|0|||
131668880|NCT02359877|474074016|FG002|Overall Study|Withdrawal by Subject|0|||
131668881|NCT02359877|474074017|FG003|Overall Study|Withdrawal by Subject|2|||
131668882|NCT02359877|474074014|FG000|Overall Study|Adverse Event|0|||
131668883|NCT02359877|474074015|FG001|Overall Study|Adverse Event|0|||
131668884|NCT02359877|474074016|FG002|Overall Study|Adverse Event|0|||
131668885|NCT02359877|474074017|FG003|Overall Study|Adverse Event|1|||
131668886|NCT01919814|474074018|FG000|Overall Study|Adverse Event|1|||
131668887|NCT01919814|474074019|FG001|Overall Study|Adverse Event|0|||
131668888|NCT01919814|474074018|FG000|Overall Study|Protocol Violation|1|||
131668889|NCT01919814|474074019|FG001|Overall Study|Protocol Violation|0|||
131668890|NCT01919814|474074018|FG000|Overall Study|Withdrawal by Subject|1|||
131668891|NCT01919814|474074019|FG001|Overall Study|Withdrawal by Subject|0|||
131668892|NCT02502097|474074025|FG000|Period 1|Adverse Event|0|||
131668893|NCT02502097|474074026|FG001|Period 1|Adverse Event|0|||
131668894|NCT02502097|474074027|FG002|Period 1|Adverse Event|1|||
131668895|NCT02502097|474074028|FG003|Period 1|Adverse Event|0|||
131668896|NCT02502097|474074025|FG000|Wash Out Period|Adverse Event|0|||
131668897|NCT02502097|474074026|FG001|Wash Out Period|Adverse Event|1|||
131668898|NCT02502097|474074027|FG002|Wash Out Period|Adverse Event|1|||
131668899|NCT02502097|474074028|FG003|Wash Out Period|Adverse Event|1|||
131668900|NCT02502097|474074025|FG000|Period 2|Adverse Event|0|||
131668901|NCT02502097|474074026|FG001|Period 2|Adverse Event|0|||
131668902|NCT02502097|474074027|FG002|Period 2|Adverse Event|1|||
131668903|NCT02502097|474074028|FG003|Period 2|Adverse Event|0|||
131668904|NCT02186223|474074029|FG000|Overall Study|Not eligible for device placement|6|||
131668905|NCT02186223|474074029|FG000|Overall Study|Unable to obtain femoral access|3|||
131668906|NCT02186223|474074029|FG000|Overall Study|Death|3|||
131668907|NCT02186223|474074029|FG000|Overall Study|Device in place less than 48 hours|9|||
131668908|NCT01201317|474074030|FG000|Overall Study|Withdrawal by Subject|5|||
131668909|NCT01201317|474074031|FG001|Overall Study|Withdrawal by Subject|0|||
131668910|NCT01201317|474074032|FG002|Overall Study|Withdrawal by Subject|3|||
131668911|NCT01201317|474074030|FG000|Overall Study|Adverse Event|2|||
131668912|NCT01201317|474074031|FG001|Overall Study|Adverse Event|2|||
131668913|NCT01201317|474074032|FG002|Overall Study|Adverse Event|2|||
131668914|NCT01201317|474074030|FG000|Overall Study|Screen failure|1|||
131668915|NCT01201317|474074031|FG001|Overall Study|Screen failure|1|||
131668916|NCT01201317|474074032|FG002|Overall Study|Screen failure|0|||
131668917|NCT01201317|474074030|FG000|Overall Study|Protocol Violation|0|||
131668918|NCT01201317|474074031|FG001|Overall Study|Protocol Violation|1|||
131668919|NCT01201317|474074032|FG002|Overall Study|Protocol Violation|1|||
131668920|NCT01201317|474074030|FG000|Overall Study|Death|0|||
131668921|NCT01201317|474074031|FG001|Overall Study|Death|1|||
131668922|NCT01201317|474074032|FG002|Overall Study|Death|0|||
131668923|NCT01201317|474074030|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131668924|NCT01201317|474074031|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131668925|NCT01201317|474074032|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131668926|NCT01201317|474074030|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
131668927|NCT01201317|474074031|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
131668928|NCT01201317|474074032|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
131668929|NCT01201317|474074030|FG000|Overall Study|Decrease in renal function|0|||
131668930|NCT01201317|474074031|FG001|Overall Study|Decrease in renal function|1|||
131668931|NCT01201317|474074032|FG002|Overall Study|Decrease in renal function|0|||
131668932|NCT01201317|474074030|FG000|Overall Study|Lack of Efficacy|1|||
131668933|NCT01201317|474074031|FG001|Overall Study|Lack of Efficacy|0|||
131668934|NCT01201317|474074032|FG002|Overall Study|Lack of Efficacy|0|||
131668935|NCT01201317|474074030|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
131668936|NCT01201317|474074031|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
131668937|NCT01201317|474074032|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
131668938|NCT00252733|474074033|FG000|Overall Study|Withdrawal by Subject|73|||
131668939|NCT00252733|474074034|FG001|Overall Study|Withdrawal by Subject|67|||
131668940|NCT00252733|474074033|FG000|Overall Study|Death|7|||
131668941|NCT00252733|474074034|FG001|Overall Study|Death|5|||
131668942|NCT00252733|474074033|FG000|Overall Study|Lost to Follow-up|12|||
131668943|NCT00252733|474074034|FG001|Overall Study|Lost to Follow-up|6|||
131668944|NCT00252733|474074033|FG000|Overall Study|Multiple Reasons|14|||
131668945|NCT00252733|474074034|FG001|Overall Study|Multiple Reasons|14|||
131668946|NCT01491672|474074035|FG000|Overall Study|Lost to Follow-up|0|||
131668947|NCT01491672|474074036|FG001|Overall Study|Lost to Follow-up|4|||
131668948|NCT01491672|474074037|FG002|Overall Study|Lost to Follow-up|1|||
131668949|NCT01491672|474074035|FG000|Overall Study|Withdrawal by Subject|6|||
131668950|NCT01491672|474074036|FG001|Overall Study|Withdrawal by Subject|7|||
131668951|NCT01491672|474074037|FG002|Overall Study|Withdrawal by Subject|0|||
131668952|NCT01491672|474074035|FG000|Overall Study|Adverse Event|8|||
131668953|NCT01491672|474074036|FG001|Overall Study|Adverse Event|10|||
131668954|NCT01491672|474074037|FG002|Overall Study|Adverse Event|4|||
131668955|NCT01491672|474074035|FG000|Overall Study|Disease progression|42|||
131668956|NCT01491672|474074036|FG001|Overall Study|Disease progression|34|||
131668957|NCT01491672|474074037|FG002|Overall Study|Disease progression|6|||
131668958|NCT01491672|474074035|FG000|Overall Study|Protocol deviation|0|||
131668959|NCT01491672|474074036|FG001|Overall Study|Protocol deviation|1|||
131668960|NCT01491672|474074037|FG002|Overall Study|Protocol deviation|0|||
131668961|NCT01491672|474074035|FG000|Overall Study|Death|0|||
131668962|NCT01491672|474074036|FG001|Overall Study|Death|4|||
131668963|NCT01491672|474074037|FG002|Overall Study|Death|0|||
131668964|NCT03310268|474074041|FG000|Overall Study|(Not specified)|1|||
131668965|NCT03310268|474074042|FG001|Overall Study|(Not specified)|5|||
131668966|NCT03310268|474074043|FG002|Overall Study|(Not specified)|0|||
131668967|NCT00706433|474074046|FG000|Overall Study|Lost to Follow-up|3|||
131668968|NCT00706433|474074047|FG001|Overall Study|Lost to Follow-up|1|||
131668969|NCT00706433|474074048|FG002|Overall Study|Lost to Follow-up|6|||
131668970|NCT00706433|474074049|FG003|Overall Study|Lost to Follow-up|0|||
131668971|NCT00706433|474074046|FG000|Overall Study|Withdrawal by Subject|1|||
131668972|NCT00706433|474074047|FG001|Overall Study|Withdrawal by Subject|2|||
131668973|NCT00706433|474074048|FG002|Overall Study|Withdrawal by Subject|3|||
131668974|NCT00706433|474074049|FG003|Overall Study|Withdrawal by Subject|1|||
131668975|NCT00706433|474074046|FG000|Overall Study|Adverse Event|0|||
131668976|NCT00706433|474074047|FG001|Overall Study|Adverse Event|0|||
131668977|NCT00706433|474074048|FG002|Overall Study|Adverse Event|1|||
131668978|NCT00706433|474074049|FG003|Overall Study|Adverse Event|0|||
131668979|NCT00706433|474074046|FG000|Overall Study|Protocol Violation|1|||
131668980|NCT00706433|474074047|FG001|Overall Study|Protocol Violation|0|||
131668981|NCT00706433|474074048|FG002|Overall Study|Protocol Violation|0|||
131668982|NCT00706433|474074049|FG003|Overall Study|Protocol Violation|0|||
131668983|NCT00706433|474074046|FG000|Overall Study|new job|0|||
131668984|NCT00706433|474074047|FG001|Overall Study|new job|0|||
131668985|NCT00706433|474074048|FG002|Overall Study|new job|0|||
131668986|NCT00706433|474074049|FG003|Overall Study|new job|1|||
131668987|NCT01236365|474074050|FG000|Overall Study|Lost to Follow-up|0|||
131668988|NCT01236365|474074051|FG001|Overall Study|Lost to Follow-up|2|||
131668989|NCT01236365|474074050|FG000|Overall Study|Moved Out of State|1|||
131668990|NCT01236365|474074051|FG001|Overall Study|Moved Out of State|0|||
131668991|NCT01236365|474074050|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
131668992|NCT01236365|474074051|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
131668993|NCT00717067|474074052|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131668994|NCT00717067|474074053|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131668995|NCT00717067|474074054|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
131668996|NCT00717067|474074055|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131668997|NCT00717067|474074056|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131668998|NCT02808143|474074057|FG000|Maintenance Phase|Disease recurrence|1|||
131668999|NCT02808143|474074058|FG001|Maintenance Phase|Disease recurrence|3|||
131669000|NCT02808143|474074057|FG000|Maintenance Phase|Disease progression|1|||
131669001|NCT02808143|474074058|FG001|Maintenance Phase|Disease progression|2|||
131669002|NCT02808143|474074057|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
131669003|NCT02808143|474074058|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
131669004|NCT02808143|474074057|FG000|Survival Follow-Up|Disease recurrence|0|||
131669005|NCT02808143|474074058|FG001|Survival Follow-Up|Disease recurrence|2|||
131669006|NCT02808143|474074057|FG000|Survival Follow-Up|Adverse Event|0|||
131669007|NCT02808143|474074058|FG001|Survival Follow-Up|Adverse Event|1|||
131669008|NCT02808143|474074057|FG000|Survival Follow-Up|Death|1|||
131669009|NCT02808143|474074058|FG001|Survival Follow-Up|Death|0|||
131669010|NCT04964388|474074059|FG000|Overall Study|Lost to Follow-up|3|||
131669011|NCT04964388|474074060|FG001|Overall Study|Lost to Follow-up|2|||
131669012|NCT01689337|474074061|FG000|Overall Study|Study Discontinuation|1|||
131669013|NCT00871780|474074062|FG000|Overall Study|Enrolled But Not Treated|6|||
131669014|NCT00871780|474074062|FG000|Overall Study|Withdrawal by Subject|9|||
131669015|NCT00871780|474074062|FG000|Overall Study|Adverse Event|6|||
131669016|NCT00871780|474074062|FG000|Overall Study|Voluntary Discontinuation|4|||
131669017|NCT00871780|474074062|FG000|Overall Study|Death|1|||
131669018|NCT00871780|474074062|FG000|Overall Study|Physician Decision|1|||
131669019|NCT03406260|474074063|FG000|Period 1|Adverse Event|0|||
131669020|NCT03406260|474074064|FG001|Period 1|Adverse Event|0|||
131669021|NCT03406260|474074065|FG002|Period 1|Adverse Event|0|||
131669022|NCT03406260|474074066|FG003|Period 1|Adverse Event|0|||
131669023|NCT03406260|474074067|FG004|Period 1|Adverse Event|1|||
131669024|NCT03406260|474074068|FG005|Period 1|Adverse Event|0|||
131669025|NCT00069108|474074073|FG000|Overall Study|Withdrawal by Subject|5|||
131669026|NCT00069108|474074074|FG001|Overall Study|Withdrawal by Subject|9|||
131669027|NCT00069108|474074073|FG000|Overall Study|Adverse Event|64|||
131669028|NCT00069108|474074074|FG001|Overall Study|Adverse Event|42|||
131669029|NCT00069108|474074073|FG000|Overall Study|Death|6|||
131669030|NCT00069108|474074074|FG001|Overall Study|Death|6|||
131669031|NCT00069108|474074073|FG000|Overall Study|Administration|15|||
131669032|NCT00069108|474074074|FG001|Overall Study|Administration|4|||
131669033|NCT00069108|474074073|FG000|Overall Study|Insufficient therapy|117|||
131669034|NCT00069108|474074074|FG001|Overall Study|Insufficient therapy|144|||
131669035|NCT00069108|474074073|FG000|Overall Study|Violation criteria|1|||
131669036|NCT00069108|474074074|FG001|Overall Study|Violation criteria|4|||
131669037|NCT00069108|474074073|FG000|Overall Study|Refused treatment|5|||
131669038|NCT00069108|474074074|FG001|Overall Study|Refused treatment|10|||
131669039|NCT02208999|474074076|FG000|Overall Study|Lost to Follow-up|1|||
131669040|NCT00319839|474074077|FG000|Overall Study|Adverse Event|5|||
131669041|NCT00319839|474074077|FG000|Overall Study|Withdrawal by Subject|1|||
131669042|NCT00262951|474074078|FG000|Overall Study|Progressive disease/relapse|3|||
131669043|NCT00262951|474074078|FG000|Overall Study|Adverse Event|7|||
131669044|NCT00262951|474074078|FG000|Overall Study|Death|1|||
131669045|NCT00262951|474074078|FG000|Overall Study|Withdrawal by Subject|1|||
131669046|NCT00262951|474074078|FG000|Overall Study|Alternative treatment|3|||
131669047|NCT00262951|474074078|FG000|Overall Study|Off treatment for other disease|1|||
131669048|NCT00394082|474074081|FG000|Overall Study|Unacceptable toxicity|15|||
131669049|NCT00394082|474074081|FG000|Overall Study|Adverse Event|4|||
131669050|NCT00394082|474074081|FG000|Overall Study|Physician Decision|4|||
131669051|NCT00394082|474074081|FG000|Overall Study|Withdrawal by Subject|2|||
131669052|NCT00394082|474074081|FG000|Overall Study|Other|1|||
131669053|NCT00903630|474074082|FG000|Phase 2|Adverse Event|0|||
131669054|NCT00903630|474074083|FG001|Phase 2|Adverse Event|0|||
131669055|NCT00903630|474074084|FG002|Phase 2|Adverse Event|1|||
131669056|NCT01136772|474074089|FG000|Overall Study|Adverse Event|15|||
131669057|NCT01136772|474074090|FG001|Overall Study|Adverse Event|14|||
131669058|NCT01136772|474074089|FG000|Overall Study|Lack of Efficacy|42|||
131669059|NCT01136772|474074090|FG001|Overall Study|Lack of Efficacy|39|||
131669060|NCT01136772|474074089|FG000|Overall Study|Administrative|14|||
131669061|NCT01136772|474074090|FG001|Overall Study|Administrative|12|||
131669062|NCT01136772|474074089|FG000|Overall Study|Withdrawal by Subject|33|||
131669063|NCT01136772|474074090|FG001|Overall Study|Withdrawal by Subject|36|||
131669064|NCT01136772|474074089|FG000|Overall Study|Did not receive injection|10|||
131669065|NCT01136772|474074090|FG001|Overall Study|Did not receive injection|7|||
131669066|NCT01136772|474074089|FG000|Overall Study|Did not follow up after first injection|2|||
131669067|NCT01136772|474074090|FG001|Overall Study|Did not follow up after first injection|2|||
131669068|NCT01602562|474074096|FG000|Overall Study|Adverse Event|3|||
131669069|NCT01602562|474074097|FG001|Overall Study|Adverse Event|1|||
131669070|NCT01602562|474074096|FG000|Overall Study|Physician Decision|1|||
131669071|NCT01602562|474074097|FG001|Overall Study|Physician Decision|1|||
131669072|NCT01602562|474074096|FG000|Overall Study|Withdrawal by Subject|1|||
131669073|NCT01602562|474074097|FG001|Overall Study|Withdrawal by Subject|1|||
131669074|NCT03881553|474074098|FG000|Overall Study|Discharged prior to participation|1|||
131669075|NCT03881553|474074099|FG001|Overall Study|Discharged prior to participation|1|||
131669076|NCT03881553|474074100|FG002|Overall Study|Discharged prior to participation|0|||
131669077|NCT03881553|474074098|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
131669078|NCT03881553|474074099|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
131669079|NCT03881553|474074100|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
131669080|NCT01477333|474074101|FG000|Overall Study|Adverse Event|1|||
131669081|NCT01477333|474074101|FG000|Overall Study|Withdrawal by Subject|1|||
131669082|NCT01477333|474074101|FG000|Overall Study|Clinical Deterioration|1|||
131669083|NCT00928746|474074104|FG000|Overall Study|Adverse Event|2|||
131669084|NCT00928746|474074104|FG000|Overall Study|Protocol Violation|1|||
131669085|NCT00928746|474074104|FG000|Overall Study|Withdrawal by Subject|1|||
131669086|NCT00928746|474074104|FG000|Overall Study|Other|2|||
131669087|NCT02004353|474074109|FG000|Overall Study|Voluntary participation|1334|||
131669088|NCT02581631|474074110|FG000|Overall Study|Disease progression|29|||
131669089|NCT02581631|474074111|FG001|Overall Study|Disease progression|19|||
131669090|NCT02581631|474074112|FG002|Overall Study|Disease progression|13|||
131669091|NCT02581631|474074113|FG003|Overall Study|Disease progression|5|||
131669092|NCT02581631|474074114|FG004|Overall Study|Disease progression|8|||
131669093|NCT02581631|474074110|FG000|Overall Study|Study drug toxicity|4|||
131669094|NCT02581631|474074111|FG001|Overall Study|Study drug toxicity|6|||
131669095|NCT02581631|474074112|FG002|Overall Study|Study drug toxicity|7|||
131669096|NCT02581631|474074113|FG003|Overall Study|Study drug toxicity|0|||
131669097|NCT02581631|474074114|FG004|Overall Study|Study drug toxicity|3|||
131669098|NCT02581631|474074110|FG000|Overall Study|AE unrelated to study drug|3|||
131669099|NCT02581631|474074111|FG001|Overall Study|AE unrelated to study drug|1|||
131669100|NCT02581631|474074112|FG002|Overall Study|AE unrelated to study drug|1|||
131669101|NCT02581631|474074113|FG003|Overall Study|AE unrelated to study drug|0|||
131669102|NCT02581631|474074114|FG004|Overall Study|AE unrelated to study drug|2|||
131669103|NCT02581631|474074110|FG000|Overall Study|Request to discontinue|1|||
131669104|NCT02581631|474074111|FG001|Overall Study|Request to discontinue|0|||
131669105|NCT02581631|474074112|FG002|Overall Study|Request to discontinue|3|||
131669106|NCT02581631|474074113|FG003|Overall Study|Request to discontinue|0|||
131669107|NCT02581631|474074114|FG004|Overall Study|Request to discontinue|1|||
131669108|NCT02581631|474074110|FG000|Overall Study|participant withdrew consent|3|||
131669109|NCT02581631|474074111|FG001|Overall Study|participant withdrew consent|0|||
131669110|NCT02581631|474074112|FG002|Overall Study|participant withdrew consent|1|||
131669111|NCT02581631|474074113|FG003|Overall Study|participant withdrew consent|0|||
131669112|NCT02581631|474074114|FG004|Overall Study|participant withdrew consent|0|||
131669113|NCT02581631|474074110|FG000|Overall Study|Maximum clinical benefit|1|||
131669114|NCT02581631|474074111|FG001|Overall Study|Maximum clinical benefit|7|||
131669115|NCT02581631|474074112|FG002|Overall Study|Maximum clinical benefit|1|||
131669116|NCT02581631|474074113|FG003|Overall Study|Maximum clinical benefit|3|||
131669117|NCT02581631|474074114|FG004|Overall Study|Maximum clinical benefit|13|||
131669118|NCT02581631|474074110|FG000|Overall Study|Other Reasons|1|||
131669119|NCT02581631|474074111|FG001|Overall Study|Other Reasons|0|||
131669120|NCT02581631|474074112|FG002|Overall Study|Other Reasons|2|||
131669121|NCT02581631|474074113|FG003|Overall Study|Other Reasons|2|||
131669122|NCT02581631|474074114|FG004|Overall Study|Other Reasons|3|||
131669123|NCT02581631|474074110|FG000|Overall Study|Poor/Non-Compliance|0|||
131669124|NCT02581631|474074111|FG001|Overall Study|Poor/Non-Compliance|0|||
131669125|NCT02581631|474074112|FG002|Overall Study|Poor/Non-Compliance|1|||
131669126|NCT02581631|474074113|FG003|Overall Study|Poor/Non-Compliance|0|||
131669127|NCT02581631|474074114|FG004|Overall Study|Poor/Non-Compliance|0|||
131669128|NCT00819390|474074115|FG000|Overall Study|Lost to Follow-up|1|||
131669129|NCT00819390|474074116|FG001|Overall Study|Lost to Follow-up|1|||
131669130|NCT00819390|474074117|FG002|Overall Study|Lost to Follow-up|0|||
131669131|NCT00819390|474074118|FG003|Overall Study|Lost to Follow-up|0|||
131669132|NCT00819390|474074115|FG000|Overall Study|Withdrawal by Subject|2|||
131669133|NCT00819390|474074116|FG001|Overall Study|Withdrawal by Subject|0|||
131669134|NCT00819390|474074117|FG002|Overall Study|Withdrawal by Subject|0|||
131669135|NCT00819390|474074118|FG003|Overall Study|Withdrawal by Subject|0|||
131669136|NCT00819390|474074115|FG000|Overall Study|Adverse Event|0|||
131669137|NCT00819390|474074116|FG001|Overall Study|Adverse Event|0|||
131669138|NCT00819390|474074117|FG002|Overall Study|Adverse Event|1|||
131669139|NCT00819390|474074118|FG003|Overall Study|Adverse Event|0|||
131669140|NCT00336895|474074125|FG000|Overall Study|diarrhea|1|||
131669141|NCT00336895|474074125|FG000|Overall Study|nausea and upset stomach|1|||
131669142|NCT00336895|474074125|FG000|Overall Study|Physician Decision|1|||
131669143|NCT00336895|474074125|FG000|Overall Study|screen failed|1|||
131669144|NCT00598273|474074126|FG000|Overall Study|Adverse Event|4|||
131669145|NCT00598273|474074127|FG001|Overall Study|Adverse Event|5|||
131669146|NCT00598273|474074128|FG002|Overall Study|Adverse Event|2|||
131669147|NCT00598273|474074126|FG000|Overall Study|Death|6|||
131669148|NCT00598273|474074127|FG001|Overall Study|Death|12|||
131669149|NCT00598273|474074128|FG002|Overall Study|Death|8|||
131669150|NCT00598273|474074126|FG000|Overall Study|Lost to Follow-up|8|||
131669151|NCT00598273|474074127|FG001|Overall Study|Lost to Follow-up|3|||
131669152|NCT00598273|474074128|FG002|Overall Study|Lost to Follow-up|5|||
131669153|NCT00598273|474074126|FG000|Overall Study|Physician Decision|0|||
131669154|NCT00598273|474074127|FG001|Overall Study|Physician Decision|0|||
131669155|NCT00598273|474074128|FG002|Overall Study|Physician Decision|1|||
131669156|NCT00598273|474074126|FG000|Overall Study|Withdrawal by Subject|12|||
131669157|NCT00598273|474074127|FG001|Overall Study|Withdrawal by Subject|10|||
131669158|NCT00598273|474074128|FG002|Overall Study|Withdrawal by Subject|10|||
131669159|NCT00598273|474074126|FG000|Overall Study|Noncompliance|3|||
131669160|NCT00598273|474074127|FG001|Overall Study|Noncompliance|2|||
131669161|NCT00598273|474074128|FG002|Overall Study|Noncompliance|3|||
131669162|NCT00598273|474074126|FG000|Overall Study|Relocation|0|||
131554977|NCT03573908|473656376|FG000|Treatment Period|Lost to Follow-up|7|||
131554978|NCT03573908|473656377|FG001|Treatment Period|Lost to Follow-up|6|||
131554979|NCT03573908|473656378|FG002|Treatment Period|Lost to Follow-up|0|||
131669163|NCT00598273|474074127|FG001|Overall Study|Relocation|2|||
131669164|NCT00598273|474074128|FG002|Overall Study|Relocation|4|||
131669165|NCT00598273|474074126|FG000|Overall Study|Renal transplant|1|||
131669166|NCT00598273|474074127|FG001|Overall Study|Renal transplant|0|||
131669167|NCT00598273|474074128|FG002|Overall Study|Renal transplant|1|||
131669168|NCT00598273|474074126|FG000|Overall Study|Site elected to close|1|||
131669169|NCT00598273|474074127|FG001|Overall Study|Site elected to close|0|||
131554980|NCT03573908|473656379|FG003|Treatment Period|Lost to Follow-up|0|||
131669170|NCT00598273|474074128|FG002|Overall Study|Site elected to close|0|||
131669171|NCT00598273|474074126|FG000|Overall Study|Started dialysis|6|||
131669172|NCT00598273|474074127|FG001|Overall Study|Started dialysis|4|||
131669173|NCT00598273|474074128|FG002|Overall Study|Started dialysis|5|||
131669174|NCT02481947|474074129|FG000|Overall Study|Withdrawal by Subject|24|||
131669175|NCT02481947|474074130|FG001|Overall Study|Withdrawal by Subject|10|||
131554981|NCT03573908|473656380|FG004|Treatment Period|Lost to Follow-up|0|||
131669176|NCT02481947|474074129|FG000|Overall Study|Lost to Follow-up|11|||
131669177|NCT02481947|474074130|FG001|Overall Study|Lost to Follow-up|5|||
131669178|NCT02481947|474074129|FG000|Overall Study|Adverse Event|6|||
131669179|NCT02481947|474074130|FG001|Overall Study|Adverse Event|11|||
131669180|NCT02481947|474074129|FG000|Overall Study|Physician Decision|4|||
131669181|NCT02481947|474074130|FG001|Overall Study|Physician Decision|5|||
131669182|NCT02481947|474074129|FG000|Overall Study|Protocol Violation|1|||
131669183|NCT02481947|474074130|FG001|Overall Study|Protocol Violation|5|||
131669184|NCT03426267|474074131|FG000|Overall Study|Physician Decision|1|||
131669185|NCT03426267|474074132|FG001|Overall Study|Physician Decision|4|||
131669186|NCT03426267|474074131|FG000|Overall Study|Lost to Follow-up|1|||
131669187|NCT03426267|474074132|FG001|Overall Study|Lost to Follow-up|0|||
131669188|NCT03426267|474074131|FG000|Overall Study|Withdrawal by Subject|4|||
131669189|NCT03426267|474074132|FG001|Overall Study|Withdrawal by Subject|10|||
131669190|NCT03426267|474074131|FG000|Overall Study|Protocol Violation|1|||
131669191|NCT03426267|474074132|FG001|Overall Study|Protocol Violation|3|||
131669192|NCT03426267|474074131|FG000|Overall Study|Adverse Event|9|||
131669193|NCT03426267|474074132|FG001|Overall Study|Adverse Event|27|||
131669194|NCT03426267|474074131|FG000|Overall Study|Prohibited Treatment Intake|2|||
131669195|NCT03426267|474074132|FG001|Overall Study|Prohibited Treatment Intake|3|||
131669196|NCT03426267|474074131|FG000|Overall Study|Lack of Efficacy|0|||
131669197|NCT03426267|474074132|FG001|Overall Study|Lack of Efficacy|25|||
131669198|NCT03426267|474074131|FG000|Overall Study|other|3|||
131669199|NCT03426267|474074132|FG001|Overall Study|other|0|||
131669200|NCT03801915|474074133|FG000|Overall Study|Screen failure|0|||
131669201|NCT03801915|474074134|FG001|Overall Study|Screen failure|0|||
131669202|NCT03801915|474074135|FG002|Overall Study|Screen failure|1|||
131669203|NCT03801915|474074133|FG000|Overall Study|Ineligible|1|||
131669204|NCT03801915|474074134|FG001|Overall Study|Ineligible|0|||
131669205|NCT03801915|474074135|FG002|Overall Study|Ineligible|0|||
131669206|NCT03801915|474074133|FG000|Overall Study|Physician Decision|2|||
131669207|NCT03801915|474074134|FG001|Overall Study|Physician Decision|1|||
131669208|NCT03801915|474074135|FG002|Overall Study|Physician Decision|0|||
131669209|NCT02003573|474074148|FG000|Overall Study|Progressive disease|2|||
131669210|NCT02003573|474074149|FG001|Overall Study|Progressive disease|0|||
131669211|NCT02003573|474074150|FG002|Overall Study|Progressive disease|1|||
131669212|NCT02003573|474074148|FG000|Overall Study|Other Adverse event|0|||
131669213|NCT02003573|474074149|FG001|Overall Study|Other Adverse event|1|||
131669214|NCT02003573|474074150|FG002|Overall Study|Other Adverse event|1|||
131669215|NCT02003573|474074148|FG000|Overall Study|Refuse to take trial medication|0|||
131669216|NCT02003573|474074149|FG001|Overall Study|Refuse to take trial medication|1|||
131669217|NCT02003573|474074150|FG002|Overall Study|Refuse to take trial medication|1|||
131669218|NCT02003573|474074148|FG000|Overall Study|Other than specified|1|||
131669219|NCT02003573|474074149|FG001|Overall Study|Other than specified|2|||
131669220|NCT02003573|474074150|FG002|Overall Study|Other than specified|3|||
131669221|NCT00928018|474074157|FG000|Overall Study|Withdrawal by Subject|1|||
131669222|NCT00928018|474074158|FG001|Overall Study|Withdrawal by Subject|0|||
131669223|NCT00126503|474074159|FG000|Overall Study|disease progression|23|||
131669224|NCT00126503|474074160|FG001|Overall Study|disease progression|14|||
131669225|NCT00126503|474074159|FG000|Overall Study|Withdrawal by Subject|0|||
131669226|NCT00126503|474074160|FG001|Overall Study|Withdrawal by Subject|1|||
131669227|NCT00126503|474074159|FG000|Overall Study|alternative therapy|1|||
131669228|NCT00126503|474074160|FG001|Overall Study|alternative therapy|1|||
131669229|NCT00126503|474074159|FG000|Overall Study|other complicating disease|4|||
131669230|NCT00126503|474074160|FG001|Overall Study|other complicating disease|1|||
131669231|NCT00126503|474074159|FG000|Overall Study|Death|3|||
131669232|NCT00126503|474074160|FG001|Overall Study|Death|0|||
131669233|NCT00126503|474074159|FG000|Overall Study|Adverse Event|13|||
131669234|NCT00126503|474074160|FG001|Overall Study|Adverse Event|3|||
131669235|NCT00126503|474074159|FG000|Overall Study|non-compliant|1|||
131669236|NCT00126503|474074160|FG001|Overall Study|non-compliant|0|||
131669237|NCT00126503|474074159|FG000|Overall Study|Physician Decision|2|||
131669238|NCT00126503|474074160|FG001|Overall Study|Physician Decision|1|||
131669239|NCT02457559|474074161|FG000|Overall Study|Progressive Disease|1|||
131669240|NCT02457559|474074162|FG001|Overall Study|Progressive Disease|2|||
131669241|NCT02457559|474074163|FG002|Overall Study|Progressive Disease|3|||
131669242|NCT02457559|474074164|FG003|Overall Study|Progressive Disease|0|||
131669243|NCT02457559|474074165|FG004|Overall Study|Progressive Disease|0|||
131669244|NCT02457559|474074166|FG005|Overall Study|Progressive Disease|2|||
131669245|NCT02457559|474074167|FG006|Overall Study|Progressive Disease|1|||
131669246|NCT02457559|474074168|FG007|Overall Study|Progressive Disease|0|||
131669247|NCT02457559|474074169|FG008|Overall Study|Progressive Disease|1|||
131669248|NCT02457559|474074170|FG009|Overall Study|Progressive Disease|1|||
131669249|NCT02457559|474074171|FG010|Overall Study|Progressive Disease|1|||
131669250|NCT02457559|474074161|FG000|Overall Study|Investigator's Discretion|0|||
131669251|NCT02457559|474074162|FG001|Overall Study|Investigator's Discretion|0|||
131669252|NCT02457559|474074163|FG002|Overall Study|Investigator's Discretion|2|||
131669253|NCT02457559|474074164|FG003|Overall Study|Investigator's Discretion|0|||
131669254|NCT02457559|474074165|FG004|Overall Study|Investigator's Discretion|1|||
131669255|NCT02457559|474074166|FG005|Overall Study|Investigator's Discretion|0|||
131669256|NCT02457559|474074167|FG006|Overall Study|Investigator's Discretion|1|||
131669257|NCT02457559|474074168|FG007|Overall Study|Investigator's Discretion|0|||
131669258|NCT02457559|474074169|FG008|Overall Study|Investigator's Discretion|1|||
131669259|NCT02457559|474074170|FG009|Overall Study|Investigator's Discretion|0|||
131669260|NCT02457559|474074171|FG010|Overall Study|Investigator's Discretion|1|||
131669261|NCT02457559|474074161|FG000|Overall Study|Adverse Event|0|||
131669262|NCT02457559|474074162|FG001|Overall Study|Adverse Event|1|||
131669263|NCT02457559|474074163|FG002|Overall Study|Adverse Event|2|||
131669264|NCT02457559|474074164|FG003|Overall Study|Adverse Event|0|||
131669265|NCT02457559|474074165|FG004|Overall Study|Adverse Event|0|||
131669266|NCT02457559|474074166|FG005|Overall Study|Adverse Event|0|||
131669267|NCT02457559|474074167|FG006|Overall Study|Adverse Event|0|||
131669268|NCT02457559|474074168|FG007|Overall Study|Adverse Event|0|||
131669269|NCT02457559|474074169|FG008|Overall Study|Adverse Event|0|||
131669270|NCT02457559|474074170|FG009|Overall Study|Adverse Event|0|||
131669271|NCT02457559|474074171|FG010|Overall Study|Adverse Event|0|||
131669272|NCT02457559|474074161|FG000|Overall Study|Reason not Specified|1|||
131669273|NCT02457559|474074162|FG001|Overall Study|Reason not Specified|0|||
131669274|NCT02457559|474074163|FG002|Overall Study|Reason not Specified|0|||
131669275|NCT02457559|474074164|FG003|Overall Study|Reason not Specified|0|||
131669276|NCT02457559|474074165|FG004|Overall Study|Reason not Specified|0|||
131669277|NCT02457559|474074166|FG005|Overall Study|Reason not Specified|0|||
131669278|NCT02457559|474074167|FG006|Overall Study|Reason not Specified|0|||
131669279|NCT02457559|474074168|FG007|Overall Study|Reason not Specified|0|||
131669280|NCT02457559|474074169|FG008|Overall Study|Reason not Specified|0|||
131669281|NCT02457559|474074170|FG009|Overall Study|Reason not Specified|2|||
131669282|NCT02457559|474074171|FG010|Overall Study|Reason not Specified|0|||
131669283|NCT02457559|474074161|FG000|Overall Study|Death|0|||
131669284|NCT02457559|474074162|FG001|Overall Study|Death|0|||
131669285|NCT02457559|474074163|FG002|Overall Study|Death|0|||
131669286|NCT02457559|474074164|FG003|Overall Study|Death|0|||
131669287|NCT02457559|474074165|FG004|Overall Study|Death|0|||
131669288|NCT02457559|474074166|FG005|Overall Study|Death|0|||
131669289|NCT02457559|474074167|FG006|Overall Study|Death|0|||
131669290|NCT02457559|474074168|FG007|Overall Study|Death|0|||
131669291|NCT02457559|474074169|FG008|Overall Study|Death|1|||
131669292|NCT02457559|474074170|FG009|Overall Study|Death|1|||
131669293|NCT02457559|474074171|FG010|Overall Study|Death|0|||
131669294|NCT00998335|474074172|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
131669295|NCT00998335|474074173|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
131669296|NCT02374671|474074174|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
131669297|NCT02374671|474074175|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
131669298|NCT02374671|474074176|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
131669299|NCT02374671|474074174|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
131669300|NCT02374671|474074175|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
131669301|NCT02374671|474074176|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
131669302|NCT02374671|474074174|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
131669303|NCT02374671|474074175|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
131669304|NCT02374671|474074176|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
131669305|NCT02374671|474074174|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
131669306|NCT02374671|474074175|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
131669307|NCT02374671|474074176|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
131669308|NCT02374671|474074174|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
131669309|NCT02374671|474074175|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
131669310|NCT02374671|474074176|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
131669311|NCT05330312|474074181|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
131669312|NCT05330312|474074182|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
131669313|NCT05330312|474074183|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
131669314|NCT05330312|474074181|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
131669315|NCT05330312|474074182|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
131669316|NCT05330312|474074183|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
131669317|NCT05330312|474074181|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
131669318|NCT05330312|474074182|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
131669319|NCT05330312|474074183|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
131669320|NCT05330312|474074181|FG000|Pivotal Investigation - Part 2|Death|1|||
131669321|NCT05330312|474074182|FG001|Pivotal Investigation - Part 2|Death|4|||
131669322|NCT05330312|474074183|FG002|Pivotal Investigation - Part 2|Death|0|||
131669323|NCT01078454|474074186|FG000|Overall Study|Adverse Event|1|||
131669324|NCT01078454|474074187|FG001|Overall Study|Adverse Event|1|||
131669325|NCT01078454|474074186|FG000|Overall Study|Death|0|||
131669326|NCT01078454|474074187|FG001|Overall Study|Death|1|||
131669327|NCT00346268|474075713|FG000|Overall Study|Adverse Event|1|||
131669328|NCT00346268|474075714|FG001|Overall Study|Adverse Event|0|||
131669329|NCT00346268|474075713|FG000|Overall Study|Protocol Violation|1|||
131669330|NCT00346268|474075714|FG001|Overall Study|Protocol Violation|0|||
131669331|NCT00346268|474075713|FG000|Overall Study|Participant refused|0|||
131669332|NCT00346268|474075714|FG001|Overall Study|Participant refused|3|||
131669333|NCT01036763|474075715|FG000|Overall Study|Adverse Event|25|||
131669334|NCT01036763|474075715|FG000|Overall Study|Lost to Follow-up|28|||
131669335|NCT01036763|474075715|FG000|Overall Study|Other reason (not specified)|40|||
131669336|NCT00743275|474075716|FG000|Overall Study|Protocol Violation|0|||
131669337|NCT00743275|474075717|FG001|Overall Study|Protocol Violation|1|||
131669338|NCT01672723|474075718|FG000|First Intervention|Adverse Event|3|||
131669339|NCT01672723|474075719|FG001|First Intervention|Adverse Event|0|||
131669340|NCT03536143|474075728|FG000|Overall Study|Early termination, Sponsor decision|1|||
131669341|NCT01174160|474075729|FG000|Overall Study|Adverse Event|1|||
131669342|NCT01174160|474075730|FG001|Overall Study|Adverse Event|0|||
131669343|NCT01174160|474075729|FG000|Overall Study|Lost to Follow-up|1|||
131669344|NCT01174160|474075730|FG001|Overall Study|Lost to Follow-up|0|||
131669345|NCT01174160|474075729|FG000|Overall Study|Physician Decision|1|||
131669346|NCT01174160|474075730|FG001|Overall Study|Physician Decision|0|||
131669347|NCT01174160|474075729|FG000|Overall Study|Protocol Violation|4|||
131669348|NCT01174160|474075730|FG001|Overall Study|Protocol Violation|6|||
131669349|NCT01174160|474075729|FG000|Overall Study|Withdrawal by Subject|1|||
131669350|NCT01174160|474075730|FG001|Overall Study|Withdrawal by Subject|0|||
131669351|NCT02527343|474075731|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
131669352|NCT02527343|474075732|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131669353|NCT02527343|474075733|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131669354|NCT02527343|474075734|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131669355|NCT02527343|474075735|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131669356|NCT02527343|474075736|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131669357|NCT02527343|474075731|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
131669358|NCT02527343|474075732|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131669359|NCT02527343|474075733|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131669360|NCT02527343|474075734|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131669361|NCT02527343|474075735|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131669362|NCT02527343|474075736|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131669363|NCT02527343|474075731|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131669364|NCT02527343|474075732|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
131669365|NCT02527343|474075733|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131669366|NCT02527343|474075734|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131669367|NCT02527343|474075735|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131669368|NCT02527343|474075736|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131669369|NCT02527343|474075731|FG000|RT Period: Weeks 1 to 52|Other|4|||
131669370|NCT02527343|474075732|FG001|RT Period: Weeks 1 to 52|Other|3|||
131669371|NCT02527343|474075733|FG002|RT Period: Weeks 1 to 52|Other|0|||
131669372|NCT02527343|474075734|FG003|RT Period: Weeks 1 to 52|Other|0|||
131669373|NCT02527343|474075735|FG004|RT Period: Weeks 1 to 52|Other|0|||
131669374|NCT02527343|474075736|FG005|RT Period: Weeks 1 to 52|Other|0|||
131669375|NCT02527343|474075731|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131669376|NCT02527343|474075732|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131669377|NCT02527343|474075733|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
131669378|NCT02527343|474075734|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131669379|NCT02527343|474075735|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131669380|NCT02527343|474075736|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131669381|NCT02527343|474075731|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131669382|NCT02527343|474075732|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131669383|NCT02527343|474075733|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131669384|NCT02527343|474075734|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
131669385|NCT02527343|474075735|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131669386|NCT02527343|474075736|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131669387|NCT02527343|474075731|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131669388|NCT02527343|474075732|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131669389|NCT02527343|474075733|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131669390|NCT02527343|474075734|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131669391|NCT02527343|474075735|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
131669392|NCT02527343|474075736|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131669393|NCT02527343|474075731|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131669394|NCT02527343|474075732|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131669395|NCT02527343|474075733|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131669396|NCT02527343|474075734|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131669397|NCT02527343|474075735|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
131669398|NCT02527343|474075736|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
131669399|NCT02527343|474075731|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131669400|NCT02527343|474075732|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131669401|NCT02527343|474075733|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131669402|NCT02527343|474075734|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131669403|NCT02527343|474075735|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
131669404|NCT02527343|474075736|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
131554982|NCT03573908|473656376|FG000|Treatment Period|Pregnancy|1|||
131554983|NCT03573908|473656377|FG001|Treatment Period|Pregnancy|0|||
131554984|NCT03573908|473656378|FG002|Treatment Period|Pregnancy|0|||
131554985|NCT03573908|473656379|FG003|Treatment Period|Pregnancy|0|||
131554986|NCT03573908|473656380|FG004|Treatment Period|Pregnancy|0|||
131554987|NCT03573908|473656376|FG000|Treatment Period|Other, Not Specified|4|||
131554988|NCT03573908|473656377|FG001|Treatment Period|Other, Not Specified|6|||
131669405|NCT02527343|474075731|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
131669406|NCT02527343|474075732|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
131669407|NCT02527343|474075733|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
131669408|NCT02527343|474075734|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
131669409|NCT02527343|474075735|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
131669410|NCT02527343|474075736|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
131669411|NCT02527343|474075731|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
131669412|NCT02527343|474075732|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
131669413|NCT02527343|474075733|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
131669414|NCT02527343|474075734|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
131669415|NCT02527343|474075735|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
131669416|NCT02527343|474075736|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
131669417|NCT02527343|474075731|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131669418|NCT02527343|474075732|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131669419|NCT02527343|474075733|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131669420|NCT02527343|474075734|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131669421|NCT02527343|474075735|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
131669422|NCT02527343|474075736|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131669423|NCT02527343|474075731|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
131669424|NCT02527343|474075732|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
131669425|NCT02527343|474075733|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
131669426|NCT02527343|474075734|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
131669427|NCT02527343|474075735|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
131669428|NCT02527343|474075736|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
131669429|NCT00701220|474075737|FG000|Overall Study|Withdrawal by Subject|0|||
131669430|NCT00701220|474075738|FG001|Overall Study|Withdrawal by Subject|2|||
131669431|NCT00701220|474075737|FG000|Overall Study|Protocol Violation|2|||
131669432|NCT00701220|474075738|FG001|Overall Study|Protocol Violation|0|||
131669433|NCT00440999|474075739|FG000|Overall Study|Adverse Event|0|||
131669434|NCT00440999|474075740|FG001|Overall Study|Adverse Event|2|||
131669435|NCT00440999|474075739|FG000|Overall Study|Lack of Efficacy|6|||
131669436|NCT00440999|474075740|FG001|Overall Study|Lack of Efficacy|7|||
131669437|NCT00440999|474075739|FG000|Overall Study|Lost to Follow-up|19|||
131669438|NCT00440999|474075740|FG001|Overall Study|Lost to Follow-up|12|||
131669439|NCT00440999|474075739|FG000|Overall Study|Protocol Violation|1|||
131669440|NCT00440999|474075740|FG001|Overall Study|Protocol Violation|0|||
131669441|NCT00440999|474075739|FG000|Overall Study|Withdrawal by Subject|2|||
131669442|NCT00440999|474075740|FG001|Overall Study|Withdrawal by Subject|5|||
131669443|NCT00440999|474075739|FG000|Overall Study|Subjets missed the visit|1|||
131669444|NCT00440999|474075740|FG001|Overall Study|Subjets missed the visit|0|||
131669445|NCT00440999|474075739|FG000|Overall Study|Mixed infection at entry|1|||
131669446|NCT00440999|474075740|FG001|Overall Study|Mixed infection at entry|0|||
131896798|NCT01677182|474908581|FG001|Overall Study|Study termination|9|||
131896799|NCT01677182|474908582|FG002|Overall Study|Study termination|11|||
131896800|NCT01677182|474908580|FG000|Overall Study|Lack of Efficacy|3|||
131896801|NCT01677182|474908581|FG001|Overall Study|Lack of Efficacy|0|||
131896802|NCT01677182|474908582|FG002|Overall Study|Lack of Efficacy|1|||
131896803|NCT01677182|474908580|FG000|Overall Study|Other reasons|1|||
131896804|NCT01677182|474908581|FG001|Overall Study|Other reasons|5|||
131896805|NCT01677182|474908582|FG002|Overall Study|Other reasons|2|||
131896806|NCT02501161|474908583|FG000|Overall Study|Adverse Event|2|||
131896807|NCT02501161|474908584|FG001|Overall Study|Adverse Event|6|||
131896808|NCT02501161|474908583|FG000|Overall Study|Lost to Follow-up|7|||
131896809|NCT02501161|474908584|FG001|Overall Study|Lost to Follow-up|4|||
131896810|NCT02501161|474908583|FG000|Overall Study|Withdrawal by Subject|10|||
131896811|NCT02501161|474908584|FG001|Overall Study|Withdrawal by Subject|15|||
131896812|NCT02501161|474908583|FG000|Overall Study|Other|3|||
131896813|NCT02501161|474908584|FG001|Overall Study|Other|0|||
131896814|NCT00667992|474908589|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
131896815|NCT00667992|474908590|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
131896816|NCT00667992|474908589|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
131896817|NCT00667992|474908590|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
131896818|NCT00667992|474908589|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
131896819|NCT00667992|474908590|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
131896820|NCT00667992|474908589|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
131896821|NCT00667992|474908590|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
131896822|NCT00667992|474908589|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
131896823|NCT00667992|474908590|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
131896824|NCT00667992|474908589|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
131896825|NCT00667992|474908590|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
131896826|NCT00667992|474908589|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
131896827|NCT00667992|474908590|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
131896828|NCT00667992|474908589|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
131896829|NCT00667992|474908590|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
131896830|NCT00667992|474908589|FG000|Wash-out|Not within one doubling dilution|4|||
131896831|NCT00667992|474908590|FG001|Wash-out|Not within one doubling dilution|3|||
131896832|NCT00667992|474908589|FG000|Wash-out|Failure to wash-out|2|||
131896833|NCT00667992|474908590|FG001|Wash-out|Failure to wash-out|2|||
131896834|NCT00667992|474908589|FG000|Wash-out|Withdrawal by Subject|1|||
131896835|NCT00667992|474908590|FG001|Wash-out|Withdrawal by Subject|0|||
131669447|NCT00440999|474075739|FG000|Overall Study|P. falciparum malaria|5|||
131669448|NCT00440999|474075740|FG001|Overall Study|P. falciparum malaria|14|||
131669449|NCT00440999|474075739|FG000|Overall Study|Subj left hosp without inform staff|0|||
131669450|NCT00440999|474075740|FG001|Overall Study|Subj left hosp without inform staff|1|||
131669451|NCT04745026|474075741|FG000|Overall Study|Physician Decision|1|||
131669452|NCT04745026|474075742|FG001|Overall Study|Physician Decision|0|||
131669453|NCT04745026|474075741|FG000|Overall Study|Adverse Event|2|||
131669454|NCT04745026|474075742|FG001|Overall Study|Adverse Event|2|||
131669455|NCT04745026|474075741|FG000|Overall Study|Protocol Violation|1|||
131669456|NCT04745026|474075742|FG001|Overall Study|Protocol Violation|3|||
131669457|NCT04745026|474075741|FG000|Overall Study|Lost to Follow-up|4|||
131669458|NCT04745026|474075742|FG001|Overall Study|Lost to Follow-up|3|||
131669459|NCT04745026|474075741|FG000|Overall Study|Withdrawal by Subject|5|||
131669460|NCT04745026|474075742|FG001|Overall Study|Withdrawal by Subject|5|||
131669461|NCT04426851|474075743|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
131669462|NCT04426851|474075744|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
131669463|NCT04426851|474075743|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
131669464|NCT04426851|474075744|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
131669465|NCT03256851|474075745|FG000|Overall Study|Withdrawal by Subject|1|||
131669466|NCT03256851|474075746|FG001|Overall Study|Withdrawal by Subject|0|||
131669467|NCT01778023|474075747|FG000|Overall Study|Withdrawal by Subject|0|||
131669468|NCT01778023|474075748|FG001|Overall Study|Withdrawal by Subject|3|||
131669469|NCT01990560|474075749|FG000|Overall Study|Withdrawal by Subject|1|||
131669470|NCT01098097|474075750|FG000|Overall Study|Adverse Event|17|||
131669471|NCT01098097|474075750|FG000|Overall Study|Lost to Follow-up|18|||
131669472|NCT01098097|474075750|FG000|Overall Study|Status unknown|16|||
131669473|NCT01098097|474075750|FG000|Overall Study|No reason reported|31|||
131669474|NCT00966277|474075753|FG000|Overall Study|Withdrawal by Subject|3|||
131669475|NCT00966277|474075754|FG001|Overall Study|Withdrawal by Subject|0|||
131669476|NCT00966277|474075753|FG000|Overall Study|Ineligible|1|||
131669477|NCT00966277|474075754|FG001|Overall Study|Ineligible|3|||
131669478|NCT00966277|474075753|FG000|Overall Study|Treatment Plan Changed|0|||
131669479|NCT00966277|474075754|FG001|Overall Study|Treatment Plan Changed|1|||
131669480|NCT01488487|474075755|FG000|Overall Study|Adverse Event|6|||
131669481|NCT01488487|474075755|FG000|Overall Study|Death|1|||
131669482|NCT01488487|474075755|FG000|Overall Study|Withdrawal by Subject|2|||
131669483|NCT01959516|474075756|FG000|Epoch 1|Adverse Event|4|||
131669484|NCT01959516|474075757|FG001|Epoch 1|Adverse Event|1|||
131669485|NCT01959516|474075756|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
131669486|NCT01959516|474075757|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
131669487|NCT01959516|474075756|FG000|Epoch 1|Subject withdrew consent|3|||
131669488|NCT01959516|474075757|FG001|Epoch 1|Subject withdrew consent|2|||
131669489|NCT01959516|474075756|FG000|Epoch 1|Administrative problems|1|||
131669490|NCT01959516|474075757|FG001|Epoch 1|Administrative problems|0|||
131669491|NCT01959516|474075756|FG000|Epoch 1|Use of prohibited treatment|1|||
131669492|NCT01959516|474075757|FG001|Epoch 1|Use of prohibited treatment|0|||
131669493|NCT01959516|474075756|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
131669494|NCT01959516|474075757|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
131669495|NCT01959516|474075756|FG000|Epoch 1|Protocol deviation|0|||
131669496|NCT01959516|474075757|FG001|Epoch 1|Protocol deviation|1|||
131669497|NCT01959516|474075756|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
131669498|NCT01959516|474075757|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
131669499|NCT01959516|474075756|FG000|Epoch 2|Subject withdrew consent|1|||
131669500|NCT01959516|474075757|FG001|Epoch 2|Subject withdrew consent|0|||
131669501|NCT01959516|474075756|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
131669502|NCT01959516|474075757|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
131669503|NCT01815138|474075760|FG000|Overall Study|Withdrawal by Subject|0|||
131669504|NCT01815138|474075761|FG001|Overall Study|Withdrawal by Subject|1|||
131669505|NCT01815138|474075760|FG000|Overall Study|Physician Decision|8|||
131669506|NCT01815138|474075761|FG001|Overall Study|Physician Decision|5|||
131669507|NCT01211288|474075763|FG000|Overall Study|Lost to Follow-up|1|||
131669508|NCT01211288|474075764|FG001|Overall Study|Lost to Follow-up|1|||
131669509|NCT01270971|474075765|FG000|Overall Study|Withdrawal by Subject|24|||
131669510|NCT01270971|474075766|FG001|Overall Study|Withdrawal by Subject|11|||
131669511|NCT01270971|474075765|FG000|Overall Study|Lost to Follow-up|18|||
131669512|NCT01270971|474075766|FG001|Overall Study|Lost to Follow-up|5|||
131669513|NCT01270971|474075765|FG000|Overall Study|Adverse Event|1|||
131669514|NCT01270971|474075766|FG001|Overall Study|Adverse Event|2|||
131669515|NCT01270971|474075765|FG000|Overall Study|Non compliance|2|||
131669516|NCT01270971|474075766|FG001|Overall Study|Non compliance|2|||
131669517|NCT01270971|474075765|FG000|Overall Study|Non-specific|7|||
131669518|NCT01270971|474075766|FG001|Overall Study|Non-specific|3|||
131669519|NCT01588496|474075770|FG000|Overall Study|Withdrawal by Subject|0|||
131669520|NCT01588496|474075771|FG001|Overall Study|Withdrawal by Subject|1|||
131669521|NCT01588496|474075772|FG002|Overall Study|Withdrawal by Subject|0|||
131669522|NCT01551212|474075773|FG000|Overall Study|Graft loss/Retransplantation|0|||
131669523|NCT01551212|474075774|FG001|Overall Study|Graft loss/Retransplantation|1|||
131669524|NCT01551212|474075773|FG000|Overall Study|Administrative problems|1|||
131669525|NCT01551212|474075774|FG001|Overall Study|Administrative problems|2|||
131669526|NCT01551212|474075773|FG000|Overall Study|Lost to Follow-up|0|||
131669527|NCT01551212|474075774|FG001|Overall Study|Lost to Follow-up|1|||
131669528|NCT01551212|474075773|FG000|Overall Study|Protocol Violation|0|||
131669529|NCT01551212|474075774|FG001|Overall Study|Protocol Violation|1|||
131669530|NCT01551212|474075773|FG000|Overall Study|Withdrawal by Subject|0|||
131669531|NCT01551212|474075774|FG001|Overall Study|Withdrawal by Subject|7|||
131669532|NCT01551212|474075773|FG000|Overall Study|Death|2|||
131669533|NCT01551212|474075774|FG001|Overall Study|Death|4|||
131669534|NCT01551212|474075773|FG000|Overall Study|Never Received Study Treatment|2|||
131669535|NCT01551212|474075774|FG001|Overall Study|Never Received Study Treatment|4|||
131669536|NCT00705523|474075775|FG000|Overall Study|Lost to Follow-up|2|||
131669537|NCT00705523|474075776|FG001|Overall Study|Lost to Follow-up|3|||
131669538|NCT01013285|474075778|FG000|Overall Study|Death|48|||
131669539|NCT01013285|474075779|FG001|Overall Study|Death|89|||
131669540|NCT02112708|474075782|FG000|Baseline|Physician Decision|16|||
131669541|NCT02112708|474075783|FG001|Baseline|Physician Decision|11|||
131669542|NCT02112708|474075782|FG000|Baseline|Lost to Follow-up|12|||
131669543|NCT02112708|474075783|FG001|Baseline|Lost to Follow-up|0|||
131669544|NCT02112708|474075782|FG000|4 Month|Death|0|||
131669545|NCT02112708|474075783|FG001|4 Month|Death|1|||
131669546|NCT02112708|474075782|FG000|4 Month|Withdrawal by Subject|12|||
131669547|NCT02112708|474075783|FG001|4 Month|Withdrawal by Subject|0|||
131669548|NCT01242800|474075784|FG000|Overall Study|Patient refusal|0|||
131669549|NCT01242800|474075785|FG001|Overall Study|Patient refusal|10|||
131669550|NCT01242800|474075784|FG000|Overall Study|Physician Decision|0|||
131669551|NCT01242800|474075785|FG001|Overall Study|Physician Decision|1|||
131669552|NCT01242800|474075784|FG000|Overall Study|Disease progression|0|||
131669553|NCT01242800|474075785|FG001|Overall Study|Disease progression|3|||
131669554|NCT01242800|474075784|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
131669555|NCT01242800|474075785|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
131669556|NCT01242800|474075784|FG000|Overall Study|Reasons not reported|0|||
131669557|NCT01242800|474075785|FG001|Overall Study|Reasons not reported|4|||
131669558|NCT00953745|474075786|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
131669559|NCT00953745|474075787|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
131669560|NCT00953745|474075786|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
131669561|NCT00953745|474075787|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
131669562|NCT00953745|474075786|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
131669563|NCT00953745|474075787|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
131669564|NCT00953745|474075786|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
131669565|NCT00953745|474075787|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
131669566|NCT00953745|474075786|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
131669567|NCT00953745|474075787|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
131669568|NCT00953745|474075786|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
131669569|NCT00953745|474075787|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
131669570|NCT02640157|474075791|FG000|Overall Study|Adverse Event|2|||
131669571|NCT02640157|474075792|FG001|Overall Study|Adverse Event|2|||
131669572|NCT02640157|474075793|FG002|Overall Study|Adverse Event|1|||
131669573|NCT02640157|474075791|FG000|Overall Study|Withdrew consent|2|||
131669574|NCT02640157|474075792|FG001|Overall Study|Withdrew consent|0|||
131669575|NCT02640157|474075793|FG002|Overall Study|Withdrew consent|2|||
131669576|NCT02640157|474075791|FG000|Overall Study|Lost to Follow-up|9|||
131669577|NCT02640157|474075792|FG001|Overall Study|Lost to Follow-up|2|||
131669578|NCT02640157|474075793|FG002|Overall Study|Lost to Follow-up|7|||
131669579|NCT02640157|474075791|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
131669580|NCT02640157|474075792|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
131669581|NCT02640157|474075793|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
131669582|NCT01679405|474075795|FG000|Overall Study|Death|2|||
131669583|NCT01679405|474075796|FG001|Overall Study|Death|5|||
131669584|NCT04677179|474075797|FG000|Induction Treatment Period|Adverse Event|1|||
131669585|NCT04677179|474075798|FG001|Induction Treatment Period|Adverse Event|0|||
131669586|NCT04677179|474075799|FG002|Induction Treatment Period|Adverse Event|0|||
131669587|NCT04677179|474075800|FG003|Induction Treatment Period|Adverse Event|0|||
131669588|NCT04677179|474075801|FG004|Induction Treatment Period|Adverse Event|0|||
131669589|NCT04677179|474075802|FG005|Induction Treatment Period|Adverse Event|0|||
131669590|NCT04677179|474075803|FG006|Induction Treatment Period|Adverse Event|0|||
131669591|NCT04677179|474075804|FG007|Induction Treatment Period|Adverse Event|0|||
131669592|NCT04677179|474075805|FG008|Induction Treatment Period|Adverse Event|0|||
131896836|NCT00667992|474908589|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
131896837|NCT00667992|474908590|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
131896838|NCT00667992|474908589|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
131896839|NCT00667992|474908590|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
131896840|NCT00762762|474908593|FG000|Overall Study|Did not return for appointments|6|||
131896841|NCT00762762|474908594|FG001|Overall Study|Did not return for appointments|8|||
131896842|NCT02489448|474908595|FG000|Overall Study|Death|3|||
131896843|NCT02489448|474908595|FG000|Overall Study|Withdrawal by Subject|2|||
131896844|NCT02748057|474908596|FG000|Overall Study|Adverse Event|1|||
131896845|NCT02748057|474908597|FG001|Overall Study|Adverse Event|0|||
131896846|NCT02748057|474908596|FG000|Overall Study|Physician Decision|0|||
131896847|NCT02748057|474908597|FG001|Overall Study|Physician Decision|1|||
131896848|NCT02748057|474908596|FG000|Overall Study|Protocol Violation|2|||
131896849|NCT02748057|474908597|FG001|Overall Study|Protocol Violation|1|||
131896850|NCT02748057|474908596|FG000|Overall Study|Participant Moved|1|||
131896851|NCT02748057|474908597|FG001|Overall Study|Participant Moved|0|||
131896852|NCT02748057|474908596|FG000|Overall Study|Withdrawal by Subject|1|||
131896853|NCT02748057|474908597|FG001|Overall Study|Withdrawal by Subject|0|||
131896854|NCT01990573|474908598|FG000|Overall Study|Physician Decision|0|||
131896855|NCT01990573|474908599|FG001|Overall Study|Physician Decision|0|||
131896856|NCT01990573|474908600|FG002|Overall Study|Physician Decision|1|||
131896857|NCT03335813|474908611|FG000|Overall Study|Withdrawal by Subject|1|||
131896858|NCT00524771|474908614|FG000|Overall Study|Protocol Violation|220|||
131896859|NCT00524771|474908615|FG001|Overall Study|Protocol Violation|585|||
131896860|NCT02492165|474908616|FG000|Overall Study|Withdrawal by Subject|0|||
131896861|NCT02492165|474908617|FG001|Overall Study|Withdrawal by Subject|1|||
131896862|NCT02492165|474908618|FG002|Overall Study|Withdrawal by Subject|0|||
131896863|NCT02492165|474908619|FG003|Overall Study|Withdrawal by Subject|0|||
131896864|NCT01957579|474908621|FG000|Overall Study|Withdrawal of concent|0|||
131896865|NCT01957579|474908622|FG001|Overall Study|Withdrawal of concent|1|||
131896866|NCT01957579|474908623|FG002|Overall Study|Withdrawal of concent|0|||
131896867|NCT01957579|474908624|FG003|Overall Study|Withdrawal of concent|0|||
131896868|NCT01957579|474908621|FG000|Overall Study|Death|0|||
131896869|NCT01957579|474908622|FG001|Overall Study|Death|0|||
131896870|NCT01957579|474908623|FG002|Overall Study|Death|2|||
131554989|NCT03573908|473656378|FG002|Treatment Period|Other, Not Specified|0|||
131669593|NCT04677179|474075806|FG009|Induction Treatment Period|Adverse Event|0|||
131669594|NCT04677179|474075797|FG000|Induction Treatment Period|Physician Decision|1|||
131896871|NCT01957579|474908624|FG003|Overall Study|Death|0|||
131896872|NCT01639144|474908627|FG000|Overall Study|Withdrawal by Subject|4|||
131896873|NCT01639144|474908628|FG001|Overall Study|Withdrawal by Subject|2|||
131896874|NCT01639144|474908627|FG000|Overall Study|Physician Decision|2|||
131896875|NCT01639144|474908628|FG001|Overall Study|Physician Decision|0|||
131669595|NCT04677179|474075798|FG001|Induction Treatment Period|Physician Decision|0|||
131896876|NCT01639144|474908627|FG000|Overall Study|Met postoperative exclusion criteria|4|||
131669596|NCT04677179|474075799|FG002|Induction Treatment Period|Physician Decision|1|||
131669597|NCT04677179|474075800|FG003|Induction Treatment Period|Physician Decision|0|||
131669598|NCT04677179|474075801|FG004|Induction Treatment Period|Physician Decision|0|||
131669599|NCT04677179|474075802|FG005|Induction Treatment Period|Physician Decision|0|||
131669600|NCT04677179|474075803|FG006|Induction Treatment Period|Physician Decision|0|||
131669601|NCT04677179|474075804|FG007|Induction Treatment Period|Physician Decision|0|||
131669602|NCT04677179|474075805|FG008|Induction Treatment Period|Physician Decision|0|||
131669603|NCT04677179|474075806|FG009|Induction Treatment Period|Physician Decision|0|||
131669604|NCT04677179|474075797|FG000|Induction Treatment Period|Protocol Violation|0|||
131669605|NCT04677179|474075798|FG001|Induction Treatment Period|Protocol Violation|1|||
131669606|NCT04677179|474075799|FG002|Induction Treatment Period|Protocol Violation|0|||
131669607|NCT04677179|474075800|FG003|Induction Treatment Period|Protocol Violation|0|||
131669608|NCT04677179|474075801|FG004|Induction Treatment Period|Protocol Violation|0|||
131669609|NCT04677179|474075802|FG005|Induction Treatment Period|Protocol Violation|0|||
131669610|NCT04677179|474075803|FG006|Induction Treatment Period|Protocol Violation|0|||
131669611|NCT04677179|474075804|FG007|Induction Treatment Period|Protocol Violation|0|||
131669612|NCT04677179|474075805|FG008|Induction Treatment Period|Protocol Violation|0|||
131669613|NCT04677179|474075806|FG009|Induction Treatment Period|Protocol Violation|0|||
131669614|NCT04677179|474075797|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
131669615|NCT04677179|474075798|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
131669616|NCT04677179|474075799|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
131669617|NCT04677179|474075800|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
131669618|NCT04677179|474075801|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
131669619|NCT04677179|474075802|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
131669620|NCT04677179|474075803|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
131669621|NCT04677179|474075804|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
131669622|NCT04677179|474075805|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
131669623|NCT04677179|474075806|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
131669624|NCT04677179|474075797|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
131669625|NCT04677179|474075798|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
131669626|NCT04677179|474075799|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
131669627|NCT04677179|474075800|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
131669628|NCT04677179|474075801|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
131669629|NCT04677179|474075802|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
131669630|NCT04677179|474075803|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
131669631|NCT04677179|474075804|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
131669632|NCT04677179|474075805|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
131669633|NCT04677179|474075806|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
131669634|NCT04677179|474075797|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
131669635|NCT04677179|474075798|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
131669636|NCT04677179|474075799|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
131669637|NCT04677179|474075800|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
131669638|NCT04677179|474075801|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
131669639|NCT04677179|474075802|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
131669640|NCT04677179|474075803|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
131669641|NCT04677179|474075804|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
131669642|NCT04677179|474075805|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
131669643|NCT04677179|474075806|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
131669644|NCT04677179|474075797|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669645|NCT04677179|474075798|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669646|NCT04677179|474075799|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669647|NCT04677179|474075800|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
131669648|NCT04677179|474075801|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669649|NCT04677179|474075802|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669650|NCT04677179|474075803|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669651|NCT04677179|474075804|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669652|NCT04677179|474075805|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669653|NCT04677179|474075806|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
131669654|NCT04677179|474075797|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669655|NCT04677179|474075798|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669656|NCT04677179|474075799|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669657|NCT04677179|474075800|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
131669658|NCT04677179|474075801|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
131669659|NCT04677179|474075802|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
131669660|NCT04677179|474075803|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669661|NCT04677179|474075804|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669662|NCT04677179|474075805|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669663|NCT04677179|474075806|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
131669664|NCT04677179|474075797|FG000|Extension Treatment Period|Lack of Efficacy|0|||
131669665|NCT04677179|474075798|FG001|Extension Treatment Period|Lack of Efficacy|0|||
131669666|NCT04677179|474075799|FG002|Extension Treatment Period|Lack of Efficacy|0|||
131669667|NCT04677179|474075800|FG003|Extension Treatment Period|Lack of Efficacy|0|||
131669668|NCT04677179|474075801|FG004|Extension Treatment Period|Lack of Efficacy|0|||
131669669|NCT04677179|474075802|FG005|Extension Treatment Period|Lack of Efficacy|0|||
131669670|NCT04677179|474075803|FG006|Extension Treatment Period|Lack of Efficacy|6|||
131669671|NCT04677179|474075804|FG007|Extension Treatment Period|Lack of Efficacy|0|||
131669672|NCT04677179|474075805|FG008|Extension Treatment Period|Lack of Efficacy|0|||
131669673|NCT04677179|474075806|FG009|Extension Treatment Period|Lack of Efficacy|0|||
131669674|NCT04677179|474075797|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
131669675|NCT04677179|474075798|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131669676|NCT04677179|474075799|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
131669677|NCT04677179|474075800|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
131669678|NCT04677179|474075801|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
131669679|NCT04677179|474075802|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
131669680|NCT04677179|474075803|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
131669681|NCT04677179|474075804|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
131669682|NCT04677179|474075805|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
131669683|NCT04677179|474075806|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
131669684|NCT04677179|474075797|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
131669685|NCT04677179|474075798|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
131669686|NCT04677179|474075799|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
131669687|NCT04677179|474075800|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
131669688|NCT04677179|474075801|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
131669689|NCT04677179|474075802|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
131669690|NCT04677179|474075803|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
131669691|NCT04677179|474075804|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
131669692|NCT04677179|474075805|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
131669693|NCT04677179|474075806|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
131669694|NCT04677179|474075797|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
131669695|NCT04677179|474075798|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
131669696|NCT04677179|474075799|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
131669697|NCT04677179|474075800|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
131669698|NCT04677179|474075801|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
131669699|NCT04677179|474075802|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
131669700|NCT04677179|474075803|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
131669701|NCT04677179|474075804|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
131669702|NCT04677179|474075805|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
131669703|NCT04677179|474075806|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
131669704|NCT04677179|474075797|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669705|NCT04677179|474075798|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669706|NCT04677179|474075799|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669707|NCT04677179|474075800|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669708|NCT04677179|474075801|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669709|NCT04677179|474075802|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669710|NCT04677179|474075803|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669711|NCT04677179|474075804|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
131669712|NCT04677179|474075805|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
131669713|NCT04677179|474075806|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131669714|NCT04677179|474075797|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131554990|NCT03573908|473656379|FG003|Treatment Period|Other, Not Specified|0|||
131669715|NCT04677179|474075798|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669716|NCT04677179|474075799|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669717|NCT04677179|474075800|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669718|NCT04677179|474075801|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669719|NCT04677179|474075802|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669720|NCT04677179|474075803|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669721|NCT04677179|474075804|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
131669722|NCT04677179|474075805|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669723|NCT04677179|474075806|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131669724|NCT04677179|474075797|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669725|NCT04677179|474075798|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669726|NCT04677179|474075799|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669727|NCT04677179|474075800|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669728|NCT04677179|474075801|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669729|NCT04677179|474075802|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669730|NCT04677179|474075803|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669731|NCT04677179|474075804|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
131669732|NCT04677179|474075805|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
131669733|NCT04677179|474075806|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131669734|NCT04677179|474075797|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669735|NCT04677179|474075798|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669736|NCT04677179|474075799|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669737|NCT04677179|474075800|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669738|NCT04677179|474075801|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669739|NCT04677179|474075802|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669740|NCT04677179|474075803|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131669741|NCT04677179|474075804|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
131669742|NCT04677179|474075805|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
131669743|NCT04677179|474075806|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
131669744|NCT03866473|474075810|FG000|Phase 1|Death|1|||
131669745|NCT03866473|474075811|FG001|Phase 1|Death|0|||
131669746|NCT03866473|474075810|FG000|Phase 2|Death|0|||
131669747|NCT03866473|474075811|FG001|Phase 2|Death|2|||
131669748|NCT03866473|474075810|FG000|Phase 2|Dropped|1|||
131669749|NCT03866473|474075811|FG001|Phase 2|Dropped|1|||
131669750|NCT03866473|474075810|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
131669751|NCT03866473|474075811|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
131669752|NCT03110185|474075813|FG000|Overall Study|Death|0|||
131669753|NCT03110185|474075814|FG001|Overall Study|Death|1|||
131669754|NCT03110185|474075813|FG000|Overall Study|Withdrawal by Subject|2|||
131669755|NCT03110185|474075814|FG001|Overall Study|Withdrawal by Subject|7|||
131669756|NCT03110185|474075813|FG000|Overall Study|Time Constraints|0|||
131669757|NCT03110185|474075814|FG001|Overall Study|Time Constraints|6|||
131669758|NCT03110185|474075813|FG000|Overall Study|Conflict with care|5|||
131669759|NCT03110185|474075814|FG001|Overall Study|Conflict with care|12|||
131669760|NCT03110185|474075813|FG000|Overall Study|Protocol Violation|1|||
131669761|NCT03110185|474075814|FG001|Overall Study|Protocol Violation|4|||
131669762|NCT03110185|474075813|FG000|Overall Study|MRI Incompatible|2|||
131669763|NCT03110185|474075814|FG001|Overall Study|MRI Incompatible|0|||
131669764|NCT03110185|474075813|FG000|Overall Study|Patient Refusal|0|||
131772338|NCT04963231|474445034|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
131669765|NCT03110185|474075814|FG001|Overall Study|Patient Refusal|1|||
131669766|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
131669767|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
131669768|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
131669769|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
131669770|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
131669771|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
131669772|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
131669773|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
131669774|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
131772339|NCT04511533|474445035|FG000|Treatment|Other|2|||
131772340|NCT04511533|474445035|FG000|Treatment|Withdrawal by Subject|11|||
131896877|NCT01639144|474908628|FG001|Overall Study|Met postoperative exclusion criteria|3|||
131669775|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
131669776|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
131669777|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
131669778|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
131669779|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
131669780|NCT00600886|474075815|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
131669781|NCT00600886|474075816|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
131772341|NCT04511533|474445035|FG000|Treatment|Death|5|||
131896878|NCT01000974|474908629|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
131896879|NCT01000974|474908630|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
131896880|NCT01000974|474908631|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
131896881|NCT01000974|474908629|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
131896882|NCT01000974|474908630|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
131896883|NCT01000974|474908631|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
131896884|NCT01000974|474908629|FG000|Primary Vaccination Phase|Protocol Violation|40|||
131896885|NCT01000974|474908630|FG001|Primary Vaccination Phase|Protocol Violation|3|||
131896886|NCT01000974|474908631|FG002|Primary Vaccination Phase|Protocol Violation|2|||
131896887|NCT01000974|474908629|FG000|Primary Vaccination Phase|Adverse Event|14|||
131896888|NCT01000974|474908630|FG001|Primary Vaccination Phase|Adverse Event|2|||
131896889|NCT01000974|474908631|FG002|Primary Vaccination Phase|Adverse Event|2|||
131896890|NCT01000974|474908629|FG000|Primary Vaccination Phase|Other|4|||
131896891|NCT01000974|474908630|FG001|Primary Vaccination Phase|Other|9|||
131896892|NCT01000974|474908631|FG002|Primary Vaccination Phase|Other|12|||
131896893|NCT01000974|474908629|FG000|Booster Vaccination Phase|Protocol Violation|0|||
131896894|NCT01000974|474908630|FG001|Booster Vaccination Phase|Protocol Violation|0|||
131896895|NCT01000974|474908631|FG002|Booster Vaccination Phase|Protocol Violation|2|||
131896896|NCT01000974|474908629|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
131896897|NCT01000974|474908630|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
131896898|NCT01000974|474908631|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
131896899|NCT01000974|474908629|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
131896900|NCT01000974|474908630|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
131896901|NCT01000974|474908631|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
131896902|NCT01000974|474908629|FG000|Booster Vaccination Phase|Other|24|||
131896903|NCT01000974|474908630|FG001|Booster Vaccination Phase|Other|6|||
131896904|NCT01000974|474908631|FG002|Booster Vaccination Phase|Other|4|||
131896905|NCT02750332|474908632|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131896906|NCT02750332|474908633|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131896907|NCT02485483|474908638|FG000|Overall Study|Depression at baseline|15|||
131896908|NCT02485483|474908639|FG001|Overall Study|Depression at baseline|0|||
131896909|NCT02485483|474908638|FG000|Overall Study|Discontinued after baseline|39|||
131896910|NCT02485483|474908639|FG001|Overall Study|Discontinued after baseline|0|||
131669782|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
131669783|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
131669784|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
131669785|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
131669786|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
131669787|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
131669788|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
131669789|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
131669790|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
131669791|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
131669792|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
131669793|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
131669794|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Death|1|||
131669795|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Death|1|||
131669796|NCT00600886|474075815|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
131669797|NCT00600886|474075816|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
131669798|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
131669799|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
131669800|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
131669801|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
131669802|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
131669803|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
131669804|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
131669805|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
131669806|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
131669807|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
131669808|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
131669809|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
131669810|NCT00600886|474075815|FG000|Extension - After Crossover (CAS)|Death|1|||
131669811|NCT00600886|474075816|FG001|Extension - After Crossover (CAS)|Death|0|||
131669812|NCT03075410|474075817|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
131669813|NCT03075410|474075818|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669814|NCT03075410|474075819|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
131669815|NCT03075410|474075820|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669816|NCT03075410|474075821|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669817|NCT03075410|474075822|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669818|NCT03075410|474075823|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669819|NCT03075410|474075824|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669820|NCT03075410|474075825|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
131669821|NCT03075410|474075817|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
131669822|NCT03075410|474075818|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669823|NCT03075410|474075819|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669824|NCT03075410|474075820|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669825|NCT03075410|474075821|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669826|NCT03075410|474075822|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669827|NCT03075410|474075823|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669828|NCT03075410|474075824|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669829|NCT03075410|474075825|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131669830|NCT01427751|474075826|FG000|Overall Study|Adverse Event|18|||
131669831|NCT01427751|474075827|FG001|Overall Study|Adverse Event|2|||
131669832|NCT01427751|474075826|FG000|Overall Study|No further treatment benefit expected|5|||
131669833|NCT01427751|474075827|FG001|Overall Study|No further treatment benefit expected|1|||
131669834|NCT01427751|474075826|FG000|Overall Study|Lost to Follow-up|3|||
131669835|NCT01427751|474075827|FG001|Overall Study|Lost to Follow-up|1|||
131669836|NCT01427751|474075826|FG000|Overall Study|Withdrawal of consent|2|||
131669837|NCT01427751|474075827|FG001|Overall Study|Withdrawal of consent|2|||
131669838|NCT01427751|474075826|FG000|Overall Study|Protocol Violation|6|||
131669839|NCT01427751|474075827|FG001|Overall Study|Protocol Violation|4|||
131669840|NCT01427751|474075826|FG000|Overall Study|Death|2|||
131669841|NCT01427751|474075827|FG001|Overall Study|Death|0|||
131669842|NCT01427751|474075826|FG000|Overall Study|Other miscellaneous reasons|6|||
131669843|NCT01427751|474075827|FG001|Overall Study|Other miscellaneous reasons|4|||
131669844|NCT05182125|474075838|FG000|Overall Study|Withdrawal by Subject|0|||
131669845|NCT05182125|474075839|FG001|Overall Study|Withdrawal by Subject|0|||
131669846|NCT05182125|474075840|FG002|Overall Study|Withdrawal by Subject|0|||
131669847|NCT05182125|474075841|FG003|Overall Study|Withdrawal by Subject|0|||
131669848|NCT05182125|474075842|FG004|Overall Study|Withdrawal by Subject|2|||
131669849|NCT05182125|474075843|FG005|Overall Study|Withdrawal by Subject|0|||
131669850|NCT05182125|474075838|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
131669851|NCT05182125|474075839|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
131669852|NCT05182125|474075840|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
131669853|NCT05182125|474075841|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
131669854|NCT05182125|474075842|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
131669855|NCT05182125|474075843|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
131669856|NCT05182125|474075838|FG000|Overall Study|Death|0|||
131669857|NCT05182125|474075839|FG001|Overall Study|Death|0|||
131669858|NCT05182125|474075840|FG002|Overall Study|Death|0|||
131669859|NCT05182125|474075841|FG003|Overall Study|Death|0|||
131669860|NCT05182125|474075842|FG004|Overall Study|Death|1|||
131669861|NCT05182125|474075843|FG005|Overall Study|Death|0|||
131669862|NCT03534284|474075844|FG000|Overall Study|Death|2|||
131669863|NCT03534284|474075845|FG001|Overall Study|Death|3|||
131669864|NCT03534284|474075846|FG002|Overall Study|Death|3|||
131669865|NCT03534284|474075844|FG000|Overall Study|Withdrawal by Subject|5|||
131669866|NCT03534284|474075845|FG001|Overall Study|Withdrawal by Subject|0|||
131669867|NCT03534284|474075846|FG002|Overall Study|Withdrawal by Subject|0|||
131669868|NCT04737187|474075847|FG000|Overall Study|Switched to marketed drug|32|||
131669869|NCT04737187|474075848|FG001|Overall Study|Switched to marketed drug|4|||
131669870|NCT04737187|474075847|FG000|Overall Study|Radiological Progressive Disease|145|||
131669871|NCT04737187|474075848|FG001|Overall Study|Radiological Progressive Disease|146|||
131669872|NCT04737187|474075847|FG000|Overall Study|Clinical Progressive Disease|20|||
131669873|NCT04737187|474075848|FG001|Overall Study|Clinical Progressive Disease|20|||
131669874|NCT04737187|474075847|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
131669875|NCT04737187|474075848|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
131669876|NCT04737187|474075847|FG000|Overall Study|Adverse Event|16|||
131669877|NCT04737187|474075848|FG001|Overall Study|Adverse Event|16|||
131669878|NCT04737187|474075847|FG000|Overall Study|Physician Decision|2|||
131669879|NCT04737187|474075848|FG001|Overall Study|Physician Decision|0|||
131669880|NCT04737187|474075847|FG000|Overall Study|Withdrawal by Subject|5|||
131669881|NCT04737187|474075848|FG001|Overall Study|Withdrawal by Subject|8|||
131669882|NCT03756129|474075853|FG000|Overall Study|Adverse Event|1|||
131669883|NCT03756129|474075854|FG001|Overall Study|Adverse Event|1|||
131669884|NCT03756129|474075855|FG002|Overall Study|Adverse Event|0|||
131669885|NCT03756129|474075856|FG003|Overall Study|Adverse Event|2|||
131669886|NCT03756129|474075857|FG004|Overall Study|Adverse Event|0|||
131669887|NCT03756129|474075858|FG005|Overall Study|Adverse Event|0|||
131669888|NCT03756129|474075853|FG000|Overall Study|Withdrawal by Subject|2|||
131669889|NCT03756129|474075854|FG001|Overall Study|Withdrawal by Subject|1|||
131669890|NCT03756129|474075855|FG002|Overall Study|Withdrawal by Subject|3|||
131669891|NCT03756129|474075856|FG003|Overall Study|Withdrawal by Subject|1|||
131669892|NCT03756129|474075857|FG004|Overall Study|Withdrawal by Subject|1|||
131669893|NCT03756129|474075858|FG005|Overall Study|Withdrawal by Subject|3|||
131669894|NCT03756129|474075853|FG000|Overall Study|Lost to Follow-up|0|||
131669895|NCT03756129|474075854|FG001|Overall Study|Lost to Follow-up|0|||
131669896|NCT03756129|474075855|FG002|Overall Study|Lost to Follow-up|0|||
131669897|NCT03756129|474075856|FG003|Overall Study|Lost to Follow-up|0|||
131669898|NCT03756129|474075857|FG004|Overall Study|Lost to Follow-up|0|||
131669899|NCT03756129|474075858|FG005|Overall Study|Lost to Follow-up|1|||
131669900|NCT03756129|474075853|FG000|Overall Study|Physician Decision|0|||
131669901|NCT03756129|474075854|FG001|Overall Study|Physician Decision|0|||
131669902|NCT03756129|474075855|FG002|Overall Study|Physician Decision|0|||
131669903|NCT03756129|474075856|FG003|Overall Study|Physician Decision|0|||
131896911|NCT01724177|474908641|FG000|Overall Study|Adverse Event|8|||
131896912|NCT01724177|474908641|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
131896913|NCT01724177|474908641|FG000|Overall Study|Nervous participant|1|||
131896914|NCT01724177|474908641|FG000|Overall Study|Serious Adverse Event Related|1|||
131896915|NCT00281697|474908646|FG000|Overall Study|> 60 days since last dose of study drug|4|||
131896916|NCT00281697|474908647|FG001|Overall Study|> 60 days since last dose of study drug|4|||
131896917|NCT00281697|474908646|FG000|Overall Study|Adverse Event|54|||
131896918|NCT00281697|474908647|FG001|Overall Study|Adverse Event|15|||
131896919|NCT00281697|474908646|FG000|Overall Study|Death|8|||
131896920|NCT00281697|474908647|FG001|Overall Study|Death|3|||
131896921|NCT00281697|474908646|FG000|Overall Study|Disease progression|279|||
131896922|NCT00281697|474908647|FG001|Overall Study|Disease progression|149|||
131896923|NCT00281697|474908646|FG000|Overall Study|Other|5|||
131896924|NCT00281697|474908647|FG001|Overall Study|Other|6|||
131896925|NCT00281697|474908646|FG000|Overall Study|Physician's decision to withdraw|15|||
131896926|NCT00281697|474908647|FG001|Overall Study|Physician's decision to withdraw|12|||
131896927|NCT00281697|474908646|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
131896928|NCT00281697|474908647|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
131896929|NCT00281697|474908646|FG000|Overall Study|Did not receive study drug|3|||
131896930|NCT00281697|474908647|FG001|Overall Study|Did not receive study drug|2|||
131896931|NCT04446429|474908648|FG000|Overall Study|Lost to Follow-up|6|||
131896932|NCT04446429|474908649|FG001|Overall Study|Lost to Follow-up|0|||
131896933|NCT02256917|474908650|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
131896934|NCT02256917|474908650|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
131896935|NCT02256917|474908650|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
131896936|NCT02256917|474908650|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
131896937|NCT02256917|474908650|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
131896938|NCT02982863|474908654|FG000|Overall Study|Not eligible patients|809|||
131896939|NCT02982863|474908655|FG001|Overall Study|Not eligible patients|4261|||
131896940|NCT02982863|474908656|FG002|Overall Study|Not eligible patients|1852|||
131896941|NCT02982863|474908657|FG003|Overall Study|Not eligible patients|1400|||
131896942|NCT02982863|474908658|FG004|Overall Study|Not eligible patients|492|||
131896943|NCT02457195|474908659|FG000|Overall Study|Adverse Event|3|||
131896944|NCT02457195|474908659|FG000|Overall Study|Protocol Violation|2|||
131896945|NCT02457195|474908659|FG000|Overall Study|Withdrawal by Subject|4|||
131896946|NCT01896193|474908661|FG000|Overall Study|Lack of Efficacy|20|||
131896947|NCT01896193|474908662|FG001|Overall Study|Lack of Efficacy|11|||
131896948|NCT01896193|474908661|FG000|Overall Study|Protocol Violation|0|||
131896949|NCT01896193|474908662|FG001|Overall Study|Protocol Violation|1|||
131896950|NCT01896193|474908661|FG000|Overall Study|Withdrew Consent|1|||
131896951|NCT01896193|474908662|FG001|Overall Study|Withdrew Consent|0|||
131896952|NCT01300247|474908664|FG000|Overall Study|Death|1|||
131896953|NCT01300247|474908665|FG001|Overall Study|Death|1|||
131896954|NCT01300247|474908664|FG000|Overall Study|Lost to Follow-up|2|||
131896955|NCT01300247|474908665|FG001|Overall Study|Lost to Follow-up|0|||
131896956|NCT01300247|474908664|FG000|Overall Study|Withdrawal by Subject|1|||
131896957|NCT01300247|474908665|FG001|Overall Study|Withdrawal by Subject|0|||
131896958|NCT01300247|474908664|FG000|Overall Study|Non-Compliance|0|||
131896959|NCT01300247|474908665|FG001|Overall Study|Non-Compliance|1|||
131896960|NCT01556932|474908666|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
131896961|NCT01556932|474908667|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
131896962|NCT02328937|474908668|FG000|Period 1|Lost to Follow-up|0|||
131896963|NCT02328937|474908669|FG001|Period 1|Lost to Follow-up|0|||
131896964|NCT02328937|474908670|FG002|Period 1|Lost to Follow-up|0|||
131896965|NCT02328937|474908671|FG003|Period 1|Lost to Follow-up|1|||
131896966|NCT02328937|474908672|FG004|Period 1|Lost to Follow-up|0|||
131896967|NCT02328937|474908673|FG005|Period 1|Lost to Follow-up|0|||
131896968|NCT02328937|474908668|FG000|Period 2|Adverse Event|0|||
131896969|NCT02328937|474908669|FG001|Period 2|Adverse Event|0|||
131896970|NCT02328937|474908670|FG002|Period 2|Adverse Event|1|||
131896971|NCT02328937|474908671|FG003|Period 2|Adverse Event|0|||
131896972|NCT02328937|474908672|FG004|Period 2|Adverse Event|0|||
131896973|NCT02328937|474908673|FG005|Period 2|Adverse Event|0|||
131896974|NCT00996034|474908676|FG000|Overall Study|Lost to Follow-up|2|||
131896975|NCT00996034|474908676|FG000|Overall Study|withdrawn by PI|1|||
131896976|NCT04865419|474908677|FG000|Overall Study|Other|1|||
131896977|NCT04865419|474908678|FG001|Overall Study|Other|2|||
131896978|NCT04865419|474908679|FG002|Overall Study|Other|2|||
131896979|NCT04865419|474908680|FG003|Overall Study|Other|1|||
131896980|NCT04865419|474908681|FG004|Overall Study|Other|3|||
131896981|NCT04865419|474908682|FG005|Overall Study|Other|0|||
131896982|NCT04865419|474908683|FG006|Overall Study|Other|0|||
131896983|NCT04865419|474908684|FG007|Overall Study|Other|1|||
131896984|NCT04865419|474908685|FG008|Overall Study|Other|0|||
131896985|NCT04865419|474908686|FG009|Overall Study|Other|0|||
131896986|NCT04865419|474908687|FG010|Overall Study|Other|0|||
131896987|NCT04865419|474908677|FG000|Overall Study|Withdrawal by Subject|0|||
131896988|NCT04865419|474908678|FG001|Overall Study|Withdrawal by Subject|1|||
131896989|NCT04865419|474908679|FG002|Overall Study|Withdrawal by Subject|1|||
131554991|NCT03573908|473656380|FG004|Treatment Period|Other, Not Specified|0|||
131669904|NCT03756129|474075857|FG004|Overall Study|Physician Decision|0|||
131669905|NCT03756129|474075858|FG005|Overall Study|Physician Decision|1|||
131669906|NCT03035201|474075859|FG000|Overall Study|Death|9|||
131669907|NCT03035201|474075860|FG001|Overall Study|Death|12|||
131896990|NCT04865419|474908680|FG003|Overall Study|Withdrawal by Subject|0|||
131896991|NCT04865419|474908681|FG004|Overall Study|Withdrawal by Subject|0|||
131896992|NCT04865419|474908682|FG005|Overall Study|Withdrawal by Subject|0|||
131896993|NCT04865419|474908683|FG006|Overall Study|Withdrawal by Subject|0|||
131896994|NCT04865419|474908684|FG007|Overall Study|Withdrawal by Subject|1|||
131896995|NCT04865419|474908685|FG008|Overall Study|Withdrawal by Subject|2|||
131896996|NCT04865419|474908686|FG009|Overall Study|Withdrawal by Subject|1|||
131896997|NCT04865419|474908687|FG010|Overall Study|Withdrawal by Subject|0|||
131896998|NCT04865419|474908677|FG000|Overall Study|Study terminated by Sponsor|0|||
131896999|NCT04865419|474908678|FG001|Overall Study|Study terminated by Sponsor|0|||
131897000|NCT04865419|474908679|FG002|Overall Study|Study terminated by Sponsor|0|||
131897001|NCT04865419|474908680|FG003|Overall Study|Study terminated by Sponsor|2|||
131897002|NCT04865419|474908681|FG004|Overall Study|Study terminated by Sponsor|2|||
131897003|NCT04865419|474908682|FG005|Overall Study|Study terminated by Sponsor|0|||
131897004|NCT04865419|474908683|FG006|Overall Study|Study terminated by Sponsor|0|||
131897005|NCT04865419|474908684|FG007|Overall Study|Study terminated by Sponsor|0|||
131897006|NCT04865419|474908685|FG008|Overall Study|Study terminated by Sponsor|0|||
131897007|NCT04865419|474908686|FG009|Overall Study|Study terminated by Sponsor|0|||
131897008|NCT04865419|474908687|FG010|Overall Study|Study terminated by Sponsor|1|||
131897009|NCT04865419|474908677|FG000|Overall Study|Death|3|||
131897010|NCT04865419|474908678|FG001|Overall Study|Death|1|||
131897011|NCT04865419|474908679|FG002|Overall Study|Death|4|||
131897012|NCT04865419|474908680|FG003|Overall Study|Death|2|||
131897013|NCT04865419|474908681|FG004|Overall Study|Death|5|||
131897014|NCT04865419|474908682|FG005|Overall Study|Death|2|||
131897015|NCT04865419|474908683|FG006|Overall Study|Death|1|||
131897016|NCT04865419|474908684|FG007|Overall Study|Death|1|||
131897017|NCT04865419|474908685|FG008|Overall Study|Death|2|||
131897018|NCT04865419|474908686|FG009|Overall Study|Death|2|||
131897019|NCT04865419|474908687|FG010|Overall Study|Death|1|||
131897020|NCT04865419|474908677|FG000|Overall Study|Lost to Follow-up|0|||
131897021|NCT04865419|474908678|FG001|Overall Study|Lost to Follow-up|0|||
131897022|NCT04865419|474908679|FG002|Overall Study|Lost to Follow-up|0|||
131897023|NCT04865419|474908680|FG003|Overall Study|Lost to Follow-up|0|||
131897024|NCT04865419|474908681|FG004|Overall Study|Lost to Follow-up|0|||
131897025|NCT04865419|474908682|FG005|Overall Study|Lost to Follow-up|0|||
131897026|NCT04865419|474908683|FG006|Overall Study|Lost to Follow-up|0|||
131897027|NCT04865419|474908684|FG007|Overall Study|Lost to Follow-up|0|||
131897028|NCT04865419|474908685|FG008|Overall Study|Lost to Follow-up|0|||
131897029|NCT04865419|474908686|FG009|Overall Study|Lost to Follow-up|1|||
131897030|NCT04865419|474908687|FG010|Overall Study|Lost to Follow-up|0|||
131897031|NCT05251233|474910330|FG000|Overall Study|Disease progression - did not start treatment|0|||
131897032|NCT05251233|474910331|FG001|Overall Study|Disease progression - did not start treatment|0|||
131897033|NCT05251233|474910332|FG002|Overall Study|Disease progression - did not start treatment|5|||
131897034|NCT05251233|474910330|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
131897035|NCT05251233|474910331|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
131897036|NCT05251233|474910332|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
131897037|NCT05251233|474910330|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
131897038|NCT05251233|474910331|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
131897039|NCT05251233|474910332|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
131897040|NCT05251233|474910330|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
131897041|NCT05251233|474910331|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
131897042|NCT05251233|474910332|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
131897043|NCT05251233|474910330|FG000|Overall Study|Death - did not start treatment|3|||
131897044|NCT05251233|474910331|FG001|Overall Study|Death - did not start treatment|0|||
131897045|NCT05251233|474910332|FG002|Overall Study|Death - did not start treatment|0|||
131897046|NCT05251233|474910330|FG000|Overall Study|Withdrawal by Subject|2|||
131897047|NCT05251233|474910331|FG001|Overall Study|Withdrawal by Subject|2|||
131897048|NCT05251233|474910332|FG002|Overall Study|Withdrawal by Subject|0|||
131897049|NCT05251233|474910330|FG000|Overall Study|Other complicating disease|2|||
131669908|NCT03035201|474075861|FG002|Overall Study|Death|9|||
131669909|NCT03035201|474075862|FG003|Overall Study|Death|10|||
131669910|NCT03035201|474075859|FG000|Overall Study|Withdrawal by Subject|51|||
131669911|NCT03035201|474075860|FG001|Overall Study|Withdrawal by Subject|49|||
131669912|NCT03035201|474075861|FG002|Overall Study|Withdrawal by Subject|37|||
131669913|NCT03035201|474075862|FG003|Overall Study|Withdrawal by Subject|46|||
131669914|NCT03035201|474075859|FG000|Overall Study|Lost to Follow-up|67|||
131669915|NCT03035201|474075860|FG001|Overall Study|Lost to Follow-up|51|||
131669916|NCT03035201|474075861|FG002|Overall Study|Lost to Follow-up|64|||
131669917|NCT03035201|474075862|FG003|Overall Study|Lost to Follow-up|69|||
131669918|NCT05195489|474077672|FG000|Overall Study|Lost to Follow-up|1|||
131669919|NCT05195489|474077673|FG001|Overall Study|Lost to Follow-up|0|||
131669920|NCT05195489|474077672|FG000|Overall Study|Protocol Violation|0|||
131669921|NCT05195489|474077673|FG001|Overall Study|Protocol Violation|2|||
131669922|NCT05195489|474077672|FG000|Overall Study|Withdrawal by Subject|1|||
131669923|NCT05195489|474077673|FG001|Overall Study|Withdrawal by Subject|1|||
131669924|NCT05195489|474077672|FG000|Overall Study|Removed|0|||
131669925|NCT05195489|474077673|FG001|Overall Study|Removed|1|||
131669926|NCT04812548|474077675|FG000|Overall Study|Adverse Event|2|||
131669927|NCT04812548|474077676|FG001|Overall Study|Adverse Event|7|||
131669928|NCT04812548|474077675|FG000|Overall Study|HSCT Planned|2|||
131669929|NCT04812548|474077676|FG001|Overall Study|HSCT Planned|3|||
131669930|NCT04812548|474077675|FG000|Overall Study|Progressive Disease|0|||
131669931|NCT04812548|474077676|FG001|Overall Study|Progressive Disease|2|||
131669932|NCT04812548|474077675|FG000|Overall Study|Death|0|||
131669933|NCT04812548|474077676|FG001|Overall Study|Death|1|||
131669934|NCT04812548|474077675|FG000|Overall Study|Post Study Access to Treatment|0|||
131669935|NCT04812548|474077676|FG001|Overall Study|Post Study Access to Treatment|1|||
131669936|NCT04812548|474077675|FG000|Overall Study|Withdrawal by Subject|0|||
131669937|NCT04812548|474077676|FG001|Overall Study|Withdrawal by Subject|1|||
131669938|NCT04812548|474077675|FG000|Overall Study|Physician Decision|1|||
131669939|NCT04812548|474077676|FG001|Overall Study|Physician Decision|0|||
131669940|NCT03184870|474077677|FG000|Initial Treatment|Death|6|||
131669941|NCT03184870|474077678|FG001|Initial Treatment|Death|6|||
131669942|NCT03184870|474077679|FG002|Initial Treatment|Death|8|||
131669943|NCT03184870|474077680|FG003|Initial Treatment|Death|8|||
131669944|NCT03184870|474077681|FG004|Initial Treatment|Death|6|||
131669945|NCT03184870|474077682|FG005|Initial Treatment|Death|6|||
131669946|NCT03184870|474077683|FG006|Initial Treatment|Death|6|||
131669947|NCT03184870|474077684|FG007|Initial Treatment|Death|7|||
131669948|NCT03184870|474077685|FG008|Initial Treatment|Death|1|||
131669949|NCT03184870|474077686|FG009|Initial Treatment|Death|2|||
131669950|NCT03184870|474077687|FG010|Initial Treatment|Death|26|||
131669951|NCT03184870|474077688|FG011|Initial Treatment|Death|28|||
131669952|NCT03184870|474077689|FG012|Initial Treatment|Death|10|||
131669953|NCT03184870|474077690|FG013|Initial Treatment|Death|33|||
131669954|NCT03184870|474077691|FG014|Initial Treatment|Death|34|||
131669955|NCT03184870|474077692|FG015|Initial Treatment|Death|26|||
131669956|NCT03184870|474077693|FG016|Initial Treatment|Death|20|||
131669957|NCT03184870|474077694|FG017|Initial Treatment|Death|18|||
131669958|NCT03184870|474077677|FG000|Initial Treatment|Other Reasons|2|||
131669959|NCT03184870|474077678|FG001|Initial Treatment|Other Reasons|2|||
131669960|NCT03184870|474077679|FG002|Initial Treatment|Other Reasons|0|||
131669961|NCT03184870|474077680|FG003|Initial Treatment|Other Reasons|1|||
131669962|NCT03184870|474077681|FG004|Initial Treatment|Other Reasons|0|||
131669963|NCT03184870|474077682|FG005|Initial Treatment|Other Reasons|0|||
131669964|NCT03184870|474077683|FG006|Initial Treatment|Other Reasons|0|||
131669965|NCT03184870|474077684|FG007|Initial Treatment|Other Reasons|2|||
131669966|NCT03184870|474077685|FG008|Initial Treatment|Other Reasons|0|||
131669967|NCT03184870|474077686|FG009|Initial Treatment|Other Reasons|0|||
131669968|NCT03184870|474077687|FG010|Initial Treatment|Other Reasons|4|||
131669969|NCT03184870|474077688|FG011|Initial Treatment|Other Reasons|2|||
131669970|NCT03184870|474077689|FG012|Initial Treatment|Other Reasons|2|||
131669971|NCT03184870|474077690|FG013|Initial Treatment|Other Reasons|0|||
131669972|NCT03184870|474077691|FG014|Initial Treatment|Other Reasons|0|||
131669973|NCT03184870|474077692|FG015|Initial Treatment|Other Reasons|1|||
131669974|NCT03184870|474077693|FG016|Initial Treatment|Other Reasons|0|||
131669975|NCT03184870|474077694|FG017|Initial Treatment|Other Reasons|2|||
131669976|NCT03184870|474077677|FG000|Initial Treatment|Lost to Follow-up|2|||
131669977|NCT03184870|474077678|FG001|Initial Treatment|Lost to Follow-up|0|||
131669978|NCT03184870|474077679|FG002|Initial Treatment|Lost to Follow-up|0|||
131669979|NCT03184870|474077680|FG003|Initial Treatment|Lost to Follow-up|1|||
131669980|NCT03184870|474077681|FG004|Initial Treatment|Lost to Follow-up|1|||
131669981|NCT03184870|474077682|FG005|Initial Treatment|Lost to Follow-up|1|||
131669982|NCT03184870|474077683|FG006|Initial Treatment|Lost to Follow-up|0|||
131669983|NCT03184870|474077684|FG007|Initial Treatment|Lost to Follow-up|2|||
131669984|NCT03184870|474077685|FG008|Initial Treatment|Lost to Follow-up|0|||
131669985|NCT03184870|474077686|FG009|Initial Treatment|Lost to Follow-up|0|||
131669986|NCT03184870|474077687|FG010|Initial Treatment|Lost to Follow-up|2|||
131669987|NCT03184870|474077688|FG011|Initial Treatment|Lost to Follow-up|0|||
131669988|NCT03184870|474077689|FG012|Initial Treatment|Lost to Follow-up|2|||
131669989|NCT03184870|474077690|FG013|Initial Treatment|Lost to Follow-up|2|||
131669990|NCT03184870|474077691|FG014|Initial Treatment|Lost to Follow-up|0|||
131669991|NCT03184870|474077692|FG015|Initial Treatment|Lost to Follow-up|0|||
131669992|NCT03184870|474077693|FG016|Initial Treatment|Lost to Follow-up|2|||
131669993|NCT03184870|474077694|FG017|Initial Treatment|Lost to Follow-up|2|||
131669994|NCT03184870|474077677|FG000|Initial Treatment|Withdrawal by Subject|0|||
131669995|NCT03184870|474077678|FG001|Initial Treatment|Withdrawal by Subject|0|||
131669996|NCT03184870|474077679|FG002|Initial Treatment|Withdrawal by Subject|2|||
131669997|NCT03184870|474077680|FG003|Initial Treatment|Withdrawal by Subject|1|||
131669998|NCT03184870|474077681|FG004|Initial Treatment|Withdrawal by Subject|1|||
131669999|NCT03184870|474077682|FG005|Initial Treatment|Withdrawal by Subject|0|||
131670000|NCT03184870|474077683|FG006|Initial Treatment|Withdrawal by Subject|1|||
131670001|NCT03184870|474077684|FG007|Initial Treatment|Withdrawal by Subject|0|||
131670002|NCT03184870|474077685|FG008|Initial Treatment|Withdrawal by Subject|0|||
131670003|NCT03184870|474077686|FG009|Initial Treatment|Withdrawal by Subject|0|||
131670004|NCT03184870|474077687|FG010|Initial Treatment|Withdrawal by Subject|0|||
131670005|NCT03184870|474077688|FG011|Initial Treatment|Withdrawal by Subject|2|||
131670006|NCT03184870|474077689|FG012|Initial Treatment|Withdrawal by Subject|3|||
131670007|NCT03184870|474077690|FG013|Initial Treatment|Withdrawal by Subject|0|||
131670008|NCT03184870|474077691|FG014|Initial Treatment|Withdrawal by Subject|1|||
131670009|NCT03184870|474077692|FG015|Initial Treatment|Withdrawal by Subject|5|||
131670010|NCT03184870|474077693|FG016|Initial Treatment|Withdrawal by Subject|2|||
131670011|NCT03184870|474077694|FG017|Initial Treatment|Withdrawal by Subject|2|||
131670012|NCT03184870|474077677|FG000|Initial Treatment|Moved to crossover treatment|0|||
131670013|NCT03184870|474077678|FG001|Initial Treatment|Moved to crossover treatment|0|||
131670014|NCT03184870|474077679|FG002|Initial Treatment|Moved to crossover treatment|0|||
131670015|NCT03184870|474077680|FG003|Initial Treatment|Moved to crossover treatment|0|||
131670016|NCT03184870|474077681|FG004|Initial Treatment|Moved to crossover treatment|0|||
131670017|NCT03184870|474077682|FG005|Initial Treatment|Moved to crossover treatment|0|||
131670018|NCT03184870|474077683|FG006|Initial Treatment|Moved to crossover treatment|0|||
131670019|NCT03184870|474077684|FG007|Initial Treatment|Moved to crossover treatment|0|||
131670020|NCT03184870|474077685|FG008|Initial Treatment|Moved to crossover treatment|0|||
131670021|NCT03184870|474077686|FG009|Initial Treatment|Moved to crossover treatment|0|||
131670022|NCT03184870|474077687|FG010|Initial Treatment|Moved to crossover treatment|0|||
131670023|NCT03184870|474077688|FG011|Initial Treatment|Moved to crossover treatment|0|||
131670024|NCT03184870|474077689|FG012|Initial Treatment|Moved to crossover treatment|9|||
131670025|NCT03184870|474077690|FG013|Initial Treatment|Moved to crossover treatment|0|||
131670026|NCT03184870|474077691|FG014|Initial Treatment|Moved to crossover treatment|0|||
131670027|NCT03184870|474077692|FG015|Initial Treatment|Moved to crossover treatment|0|||
131670028|NCT03184870|474077693|FG016|Initial Treatment|Moved to crossover treatment|0|||
131670029|NCT03184870|474077694|FG017|Initial Treatment|Moved to crossover treatment|0|||
131670030|NCT03184870|474077677|FG000|Crossover Treatment|Other reasons|0|||
131670031|NCT03184870|474077678|FG001|Crossover Treatment|Other reasons|0|||
131670032|NCT03184870|474077679|FG002|Crossover Treatment|Other reasons|0|||
131670033|NCT03184870|474077680|FG003|Crossover Treatment|Other reasons|0|||
131670034|NCT03184870|474077681|FG004|Crossover Treatment|Other reasons|0|||
131670035|NCT03184870|474077682|FG005|Crossover Treatment|Other reasons|0|||
131670036|NCT03184870|474077683|FG006|Crossover Treatment|Other reasons|0|||
131670037|NCT03184870|474077684|FG007|Crossover Treatment|Other reasons|0|||
131670038|NCT03184870|474077685|FG008|Crossover Treatment|Other reasons|0|||
131670039|NCT03184870|474077686|FG009|Crossover Treatment|Other reasons|0|||
131670040|NCT03184870|474077687|FG010|Crossover Treatment|Other reasons|0|||
131670041|NCT03184870|474077688|FG011|Crossover Treatment|Other reasons|0|||
131670042|NCT03184870|474077689|FG012|Crossover Treatment|Other reasons|0|||
131670043|NCT03184870|474077690|FG013|Crossover Treatment|Other reasons|0|||
131670044|NCT03184870|474077691|FG014|Crossover Treatment|Other reasons|0|||
131670045|NCT03184870|474077692|FG015|Crossover Treatment|Other reasons|0|||
131670046|NCT03184870|474077693|FG016|Crossover Treatment|Other reasons|0|||
131670047|NCT03184870|474077694|FG017|Crossover Treatment|Other reasons|2|||
131670048|NCT03184870|474077677|FG000|Crossover Treatment|Death|0|||
131670049|NCT03184870|474077678|FG001|Crossover Treatment|Death|0|||
131670050|NCT03184870|474077679|FG002|Crossover Treatment|Death|0|||
131670051|NCT03184870|474077680|FG003|Crossover Treatment|Death|0|||
131670052|NCT03184870|474077681|FG004|Crossover Treatment|Death|0|||
131670053|NCT03184870|474077682|FG005|Crossover Treatment|Death|0|||
131554992|NCT03573908|473656376|FG000|Randomized Withdrawal Period|Adverse Event|0|||
131554993|NCT03573908|473656377|FG001|Randomized Withdrawal Period|Adverse Event|0|||
131670054|NCT03184870|474077683|FG006|Crossover Treatment|Death|0|||
131670055|NCT03184870|474077684|FG007|Crossover Treatment|Death|0|||
131670056|NCT03184870|474077685|FG008|Crossover Treatment|Death|0|||
131670057|NCT03184870|474077686|FG009|Crossover Treatment|Death|0|||
131554994|NCT03573908|473656378|FG002|Randomized Withdrawal Period|Adverse Event|3|||
131670058|NCT03184870|474077687|FG010|Crossover Treatment|Death|0|||
131670059|NCT03184870|474077688|FG011|Crossover Treatment|Death|0|||
131670060|NCT03184870|474077689|FG012|Crossover Treatment|Death|0|||
131670061|NCT03184870|474077690|FG013|Crossover Treatment|Death|0|||
131670062|NCT03184870|474077691|FG014|Crossover Treatment|Death|0|||
131670063|NCT03184870|474077692|FG015|Crossover Treatment|Death|0|||
131670064|NCT03184870|474077693|FG016|Crossover Treatment|Death|0|||
131670065|NCT03184870|474077694|FG017|Crossover Treatment|Death|7|||
131670066|NCT03786783|474077696|FG000|Overall Study|Death|1|||
131670067|NCT03786783|474077696|FG000|Overall Study|Physician Decision|6|||
131670068|NCT03786783|474077696|FG000|Overall Study|Withdrawal by Subject|2|||
131670069|NCT03786783|474077696|FG000|Overall Study|Disease Progression|7|||
131670070|NCT03786783|474077696|FG000|Overall Study|Patient/Parent Refusal|4|||
131670071|NCT04363801|474077697|FG000|Overall Study|Death|18|||
131670072|NCT04363801|474077698|FG001|Overall Study|Death|14|||
131670073|NCT04363801|474077699|FG002|Overall Study|Death|16|||
131670074|NCT04363801|474077700|FG003|Overall Study|Death|48|||
131670075|NCT04363801|474077701|FG004|Overall Study|Death|38|||
131670076|NCT04363801|474077697|FG000|Overall Study|Withdrawal by Subject|1|||
131670077|NCT04363801|474077698|FG001|Overall Study|Withdrawal by Subject|6|||
131670078|NCT04363801|474077699|FG002|Overall Study|Withdrawal by Subject|1|||
131670079|NCT04363801|474077700|FG003|Overall Study|Withdrawal by Subject|4|||
131670080|NCT04363801|474077701|FG004|Overall Study|Withdrawal by Subject|14|||
131670081|NCT04363801|474077697|FG000|Overall Study|Sponsor Decision|6|||
131670082|NCT04363801|474077698|FG001|Overall Study|Sponsor Decision|4|||
131670083|NCT04363801|474077699|FG002|Overall Study|Sponsor Decision|10|||
131670084|NCT04363801|474077700|FG003|Overall Study|Sponsor Decision|33|||
131670085|NCT04363801|474077701|FG004|Overall Study|Sponsor Decision|32|||
131670086|NCT04363801|474077697|FG000|Overall Study|Lost to Follow-up|0|||
131670087|NCT04363801|474077698|FG001|Overall Study|Lost to Follow-up|0|||
131670088|NCT04363801|474077699|FG002|Overall Study|Lost to Follow-up|1|||
131670089|NCT04363801|474077700|FG003|Overall Study|Lost to Follow-up|0|||
131670090|NCT04363801|474077701|FG004|Overall Study|Lost to Follow-up|1|||
131670091|NCT06336603|474077704|FG000|Overall Study|Withdrawal by Subject|1|||
131670092|NCT06336603|474077704|FG000|Overall Study|Lost to Follow-up|2|||
131670093|NCT00250679|474077705|FG000|Overall Study|Adverse Event|12|||
131670094|NCT00250679|474077706|FG001|Overall Study|Adverse Event|15|||
131670095|NCT00250679|474077707|FG002|Overall Study|Adverse Event|16|||
131670096|NCT00250679|474077705|FG000|Overall Study|Protocol Violation|2|||
131670097|NCT00250679|474077706|FG001|Overall Study|Protocol Violation|4|||
131670098|NCT00250679|474077707|FG002|Overall Study|Protocol Violation|3|||
131670099|NCT00250679|474077705|FG000|Overall Study|Withdrawal by Subject|15|||
131670100|NCT00250679|474077706|FG001|Overall Study|Withdrawal by Subject|18|||
131670101|NCT00250679|474077707|FG002|Overall Study|Withdrawal by Subject|15|||
131670102|NCT00250679|474077705|FG000|Overall Study|Lost to Follow-up|3|||
131670103|NCT00250679|474077706|FG001|Overall Study|Lost to Follow-up|4|||
131670104|NCT00250679|474077707|FG002|Overall Study|Lost to Follow-up|2|||
131670105|NCT00250679|474077705|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
131670106|NCT00250679|474077706|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
131670107|NCT00250679|474077707|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
131670108|NCT00250679|474077705|FG000|Overall Study|Lack of Efficacy|0|||
131670109|NCT00250679|474077706|FG001|Overall Study|Lack of Efficacy|1|||
131670110|NCT00250679|474077707|FG002|Overall Study|Lack of Efficacy|3|||
131670111|NCT00250679|474077705|FG000|Overall Study|Technical Holter issues|1|||
131670112|NCT00250679|474077706|FG001|Overall Study|Technical Holter issues|0|||
131670113|NCT00250679|474077707|FG002|Overall Study|Technical Holter issues|2|||
131670114|NCT00250679|474077705|FG000|Overall Study|Moved|1|||
131670115|NCT00250679|474077706|FG001|Overall Study|Moved|1|||
131670116|NCT00250679|474077707|FG002|Overall Study|Moved|0|||
131670117|NCT00250679|474077705|FG000|Overall Study|Non-compliance|1|||
131670118|NCT00250679|474077706|FG001|Overall Study|Non-compliance|1|||
131670119|NCT00250679|474077707|FG002|Overall Study|Non-compliance|0|||
131670120|NCT00250679|474077705|FG000|Overall Study|various single events: hip surgery,diary|3|||
131670121|NCT00250679|474077706|FG001|Overall Study|various single events: hip surgery,diary|1|||
131670122|NCT00250679|474077707|FG002|Overall Study|various single events: hip surgery,diary|1|||
131670123|NCT04776148|474077709|FG000|Overall Study|Death|249|||
131670124|NCT04776148|474077710|FG001|Overall Study|Death|260|||
131670125|NCT04776148|474077709|FG000|Overall Study|Lost to Follow-up|0|||
131670126|NCT04776148|474077710|FG001|Overall Study|Lost to Follow-up|1|||
131670127|NCT04776148|474077709|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131670128|NCT04776148|474077710|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131670129|NCT04776148|474077709|FG000|Overall Study|Withdrawal by Subject|3|||
131670130|NCT04776148|474077710|FG001|Overall Study|Withdrawal by Subject|4|||
131670131|NCT04776148|474077709|FG000|Overall Study|Sponsor Decision|30|||
131670132|NCT04776148|474077710|FG001|Overall Study|Sponsor Decision|15|||
131670133|NCT02563522|474077711|FG000|Overall Study|Adverse Event|2|||
131670134|NCT02563522|474077712|FG001|Overall Study|Adverse Event|3|||
131670135|NCT02563522|474077711|FG000|Overall Study|Lost to Follow-up|1|||
131670136|NCT02563522|474077712|FG001|Overall Study|Lost to Follow-up|0|||
131670137|NCT02563522|474077711|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
131670138|NCT02563522|474077712|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
131670139|NCT03718533|474077713|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
131670140|NCT03718533|474077713|FG000|Overall Study|Protocol deviation|1|||
131670141|NCT03718533|474077713|FG000|Overall Study|Disease progression|1|||
131670142|NCT03718533|474077713|FG000|Overall Study|Relapse|1|||
131670143|NCT03718533|474077713|FG000|Overall Study|Physician Decision|2|||
131670144|NCT03718533|474077713|FG000|Overall Study|Physician Decision and Adverse Event|1|||
131670145|NCT05754333|474077714|FG000|Overall Study|Miscellaneous|3|||
131670146|NCT05754333|474077715|FG001|Overall Study|Miscellaneous|0|||
131670147|NCT05754333|474077716|FG002|Overall Study|Miscellaneous|0|||
131670148|NCT05754333|474077717|FG003|Overall Study|Miscellaneous|0|||
131670149|NCT05754333|474077714|FG000|Overall Study|Lost to Follow-up|2|||
131670150|NCT05754333|474077715|FG001|Overall Study|Lost to Follow-up|1|||
131670151|NCT05754333|474077716|FG002|Overall Study|Lost to Follow-up|0|||
131670152|NCT05754333|474077717|FG003|Overall Study|Lost to Follow-up|1|||
131670153|NCT00824161|474077720|FG000|Overall Study|Withdrawal by Subject|1|||
131670154|NCT00824161|474077720|FG000|Overall Study|Screen Failure|1|||
131670155|NCT04874415|474077721|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670156|NCT04874415|474077722|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670157|NCT04874415|474077723|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670158|NCT04874415|474077724|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670159|NCT04874415|474077725|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670160|NCT04874415|474077726|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670161|NCT04874415|474077727|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131772342|NCT04511533|474445035|FG000|Treatment|Physician Decision|1|||
131670162|NCT04874415|474077728|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670163|NCT04874415|474077729|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
131670164|NCT04874415|474077730|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131670165|NCT04874415|474077731|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670166|NCT04874415|474077732|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131670167|NCT04874415|474077733|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131670168|NCT04874415|474077734|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131670169|NCT04874415|474077735|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
131670170|NCT04874415|474077736|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131670171|NCT04874415|474077721|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670172|NCT04874415|474077722|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670173|NCT04874415|474077723|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670174|NCT04874415|474077724|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670175|NCT04874415|474077725|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670176|NCT04874415|474077726|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670177|NCT04874415|474077727|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670178|NCT04874415|474077728|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670179|NCT04874415|474077729|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670180|NCT04874415|474077730|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
131670181|NCT04874415|474077731|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670182|NCT04874415|474077732|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670183|NCT04874415|474077733|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670184|NCT04874415|474077734|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670185|NCT04874415|474077735|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
131670186|NCT04874415|474077736|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
131670187|NCT04874415|474077721|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670188|NCT04874415|474077722|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670189|NCT04874415|474077723|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670190|NCT04874415|474077724|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670191|NCT04874415|474077725|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
131670192|NCT04874415|474077726|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670193|NCT04874415|474077727|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670194|NCT04874415|474077728|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670195|NCT04874415|474077729|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670196|NCT04874415|474077730|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670197|NCT04874415|474077731|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670198|NCT04874415|474077732|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670199|NCT04874415|474077733|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670200|NCT04874415|474077734|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670201|NCT04874415|474077735|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670202|NCT04874415|474077736|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131670203|NCT01312857|474077737|FG000|Overall Study|Adverse Event|1|||
131670204|NCT01312857|474077738|FG001|Overall Study|Adverse Event|1|||
131670205|NCT01312857|474077737|FG000|Overall Study|Lost to Follow-up|2|||
131670206|NCT01312857|474077738|FG001|Overall Study|Lost to Follow-up|0|||
131670207|NCT01312857|474077737|FG000|Overall Study|Physician Decision|3|||
131670208|NCT01312857|474077738|FG001|Overall Study|Physician Decision|0|||
131670209|NCT01312857|474077737|FG000|Overall Study|Withdrawal by Subject|2|||
131670210|NCT01312857|474077738|FG001|Overall Study|Withdrawal by Subject|0|||
131670211|NCT04882995|474077739|FG000|Overall Study|Withdrawal by Subject|1|||
131670212|NCT04882995|474077740|FG001|Overall Study|Withdrawal by Subject|2|||
131670213|NCT04882995|474077739|FG000|Overall Study|Protocol Violation|4|||
131670214|NCT04882995|474077740|FG001|Overall Study|Protocol Violation|4|||
131670215|NCT04882995|474077739|FG000|Overall Study|Surgery postponed due to COVID|1|||
131670216|NCT04882995|474077740|FG001|Overall Study|Surgery postponed due to COVID|1|||
131670217|NCT02572882|474077741|FG000|Overall Study|Withdrawal by Subject|1|||
131670218|NCT02572882|474077741|FG000|Overall Study|Participant received kidney transplant|1|||
131670219|NCT04371198|474077742|FG000|Overall Study|inadequate sample|4|||
131670220|NCT04754477|474077743|FG000|Overall Study|Withdrawal by Subject|1|||
131670221|NCT01590017|474077744|FG000|Overall Study|Adverse Event|1|||
131670222|NCT01590017|474077744|FG000|Overall Study|Withdrawal by Subject|1|||
131670223|NCT01590017|474077744|FG000|Overall Study|Lack of Efficacy|1|||
131670224|NCT01590017|474077744|FG000|Overall Study|Physician Decision|1|||
131670225|NCT01347762|474077745|FG000|Overall Study|Lost to Follow-up|0|||
131670226|NCT01347762|474077746|FG001|Overall Study|Lost to Follow-up|1|||
131670227|NCT01347762|474077747|FG002|Overall Study|Lost to Follow-up|6|||
131670228|NCT01347762|474077748|FG003|Overall Study|Lost to Follow-up|5|||
131670229|NCT01347762|474077745|FG000|Overall Study|Withdrawal by Subject|4|||
131670230|NCT01347762|474077746|FG001|Overall Study|Withdrawal by Subject|1|||
131670231|NCT01347762|474077747|FG002|Overall Study|Withdrawal by Subject|3|||
131670232|NCT01347762|474077748|FG003|Overall Study|Withdrawal by Subject|3|||
131670233|NCT03235284|474077749|FG000|Overall Study|Adverse Event|1|||
131670234|NCT03235284|474077750|FG001|Overall Study|Adverse Event|2|||
131670235|NCT03235284|474077751|FG002|Overall Study|Adverse Event|1|||
131670236|NCT01382706|474077754|FG000|Overall Study|Adverse Event|1|||
131670237|NCT01382706|474077754|FG000|Overall Study|Withdrawal by Subject|1|||
131670238|NCT05559099|474077755|FG000|Overall Study|Death|5|||
131670239|NCT05559099|474077756|FG001|Overall Study|Death|4|||
131670240|NCT05559099|474077755|FG000|Overall Study|Lost to Follow-up|0|||
131670241|NCT05559099|474077756|FG001|Overall Study|Lost to Follow-up|2|||
131670242|NCT05559099|474077755|FG000|Overall Study|Adverse Event|1|||
131670243|NCT05559099|474077756|FG001|Overall Study|Adverse Event|1|||
131670244|NCT04018092|474077757|FG000|Overall Study|Withdrawal by Subject|1|||
131670245|NCT04018092|474077758|FG001|Overall Study|Withdrawal by Subject|1|||
131670246|NCT04018092|474077757|FG000|Overall Study|Withdrawal by Subject|1|||
131670247|NCT04018092|474077758|FG001|Overall Study|Withdrawal by Subject|1|||
131670248|NCT04055090|474077759|FG000|Overall Study|screen failure|1|||
131670249|NCT04055090|474077760|FG001|Overall Study|screen failure|0|||
131670250|NCT04055090|474077759|FG000|Overall Study|Withdrawal by Subject|1|||
131670251|NCT04055090|474077760|FG001|Overall Study|Withdrawal by Subject|0|||
131670252|NCT04572841|474077761|FG000|Overall Study|Adverse Event|1|||
131670253|NCT04572841|474077762|FG001|Overall Study|Adverse Event|1|||
131670254|NCT04572841|474077761|FG000|Overall Study|Withdrawal by Subject|2|||
131670255|NCT04572841|474077762|FG001|Overall Study|Withdrawal by Subject|1|||
131670256|NCT06469242|474077763|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
131670257|NCT06469242|474077764|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
131670258|NCT06469242|474077763|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
131554995|NCT03573908|473656379|FG003|Randomized Withdrawal Period|Adverse Event|0|||
131554996|NCT03573908|473656380|FG004|Randomized Withdrawal Period|Adverse Event|0|||
131554997|NCT03573908|473656376|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131670259|NCT06469242|474077764|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
131670260|NCT05041101|474077765|FG000|Overall Study|Adverse Event|1|||
131670261|NCT05041101|474077766|FG001|Overall Study|Adverse Event|0|||
131670262|NCT05041101|474077767|FG002|Overall Study|Adverse Event|0|||
131670263|NCT05041101|474077765|FG000|Overall Study|Diease Progression|5|||
131670264|NCT05041101|474077766|FG001|Overall Study|Diease Progression|0|||
131670265|NCT05041101|474077767|FG002|Overall Study|Diease Progression|0|||
131670266|NCT01205152|474077768|FG000|Overall Study|Death|1|||
131670267|NCT00249002|474077769|FG000|Overall Study|Adverse Event|2|||
131670268|NCT00249002|474077769|FG000|Overall Study|Study cancellation|3|||
131670269|NCT00249002|474077769|FG000|Overall Study|Other|2|||
131670270|NCT04494256|474077770|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
131670271|NCT04494256|474077771|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
131670272|NCT04494256|474077772|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
131670273|NCT04494256|474077773|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
131554998|NCT03573908|473656377|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131670274|NCT04494256|474077774|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
131670275|NCT04494256|474077775|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
131554999|NCT03573908|473656378|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131555000|NCT03573908|473656379|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131555001|NCT03573908|473656380|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
131555002|NCT03573908|473656376|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
131555003|NCT03573908|473656377|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
131555004|NCT03573908|473656378|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
131555005|NCT03573908|473656379|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
131555006|NCT03573908|473656380|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
131555007|NCT03573908|473656376|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
131555008|NCT03573908|473656377|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
131555009|NCT03573908|473656378|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
131555010|NCT03573908|473656379|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
131555011|NCT03573908|473656380|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
131555012|NCT04006925|473656381|FG000|Overall Study|Side effects|2|||
131555013|NCT04006925|473656382|FG001|Overall Study|Side effects|0|||
131555014|NCT02669095|473656387|FG000|Overall Study|Adverse Event|1|||
131555015|NCT02669095|473656388|FG001|Overall Study|Adverse Event|0|||
131555016|NCT02669095|473656387|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
131555017|NCT02669095|473656388|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
131555018|NCT02669095|473656387|FG000|Overall Study|Torn Lens|0|||
131555019|NCT02669095|473656388|FG001|Overall Study|Torn Lens|1|||
131555020|NCT02669095|473656387|FG000|Overall Study|Visit 5 assessments not completed|0|||
131555021|NCT02669095|473656388|FG001|Overall Study|Visit 5 assessments not completed|1|||
131555022|NCT01555164|473656390|FG000|Overall Study|Adverse Event|5|||
131555023|NCT01555164|473656391|FG001|Overall Study|Adverse Event|7|||
131555024|NCT01555164|473656390|FG000|Overall Study|Hyperglycemia|0|||
131555025|NCT01555164|473656391|FG001|Overall Study|Hyperglycemia|1|||
131555026|NCT01555164|473656390|FG000|Overall Study|Investigator's Discretion|2|||
131555027|NCT01555164|473656391|FG001|Overall Study|Investigator's Discretion|2|||
131555028|NCT01555164|473656390|FG000|Overall Study|Lost to Follow-up|4|||
131555029|NCT01555164|473656391|FG001|Overall Study|Lost to Follow-up|3|||
131555030|NCT01555164|473656390|FG000|Overall Study|Protocol Violation|9|||
131555031|NCT01555164|473656391|FG001|Overall Study|Protocol Violation|5|||
131555032|NCT01555164|473656390|FG000|Overall Study|Subject Non-compliance|14|||
131555033|NCT01555164|473656391|FG001|Overall Study|Subject Non-compliance|6|||
131555034|NCT01555164|473656390|FG000|Overall Study|Subject Withdrew Consent|6|||
131555035|NCT01555164|473656391|FG001|Overall Study|Subject Withdrew Consent|11|||
131555036|NCT00926003|473656392|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
131555037|NCT00926003|473656393|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
131555038|NCT00926003|473656394|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
131555039|NCT00926003|473656392|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
131555040|NCT00926003|473656393|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
131555041|NCT00926003|473656394|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
131555042|NCT01709305|473656397|FG000|Phase 1|Clinical Adverse Event|80|||
131555043|NCT01709305|473656398|FG001|Phase 1|Clinical Adverse Event|0|||
131555044|NCT01709305|473656399|FG002|Phase 1|Clinical Adverse Event|0|||
131555045|NCT01709305|473656400|FG003|Phase 1|Clinical Adverse Event|0|||
131555046|NCT01709305|473656401|FG004|Phase 1|Clinical Adverse Event|0|||
131555047|NCT01709305|473656397|FG000|Phase 1|Death|2|||
131555048|NCT01709305|473656398|FG001|Phase 1|Death|0|||
131555049|NCT01709305|473656399|FG002|Phase 1|Death|0|||
131555050|NCT01709305|473656400|FG003|Phase 1|Death|0|||
131555051|NCT01709305|473656401|FG004|Phase 1|Death|0|||
131555052|NCT01709305|473656397|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
131555053|NCT01709305|473656398|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
131555054|NCT01709305|473656399|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
131555055|NCT01709305|473656400|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
131555056|NCT01709305|473656401|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
131555057|NCT01709305|473656397|FG000|Phase 1|Laboratory Adverse Event|16|||
131555058|NCT01709305|473656398|FG001|Phase 1|Laboratory Adverse Event|0|||
131555059|NCT01709305|473656399|FG002|Phase 1|Laboratory Adverse Event|0|||
131555060|NCT01709305|473656400|FG003|Phase 1|Laboratory Adverse Event|0|||
131555061|NCT01709305|473656401|FG004|Phase 1|Laboratory Adverse Event|0|||
131555062|NCT01709305|473656397|FG000|Phase 1|Lost to Follow-up|147|||
131555063|NCT01709305|473656398|FG001|Phase 1|Lost to Follow-up|0|||
131555064|NCT01709305|473656399|FG002|Phase 1|Lost to Follow-up|0|||
131555065|NCT01709305|473656400|FG003|Phase 1|Lost to Follow-up|0|||
131555066|NCT01709305|473656401|FG004|Phase 1|Lost to Follow-up|0|||
131555067|NCT01709305|473656397|FG000|Phase 1|Travel, moving, etc.|30|||
131555068|NCT01709305|473656398|FG001|Phase 1|Travel, moving, etc.|0|||
131555069|NCT01709305|473656399|FG002|Phase 1|Travel, moving, etc.|0|||
131555070|NCT01709305|473656400|FG003|Phase 1|Travel, moving, etc.|0|||
131670276|NCT04494256|474077776|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
131555071|NCT01709305|473656401|FG004|Phase 1|Travel, moving, etc.|0|||
131555072|NCT01709305|473656397|FG000|Phase 1|Physician Decision|13|||
131670277|NCT04494256|474077770|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131670278|NCT04494256|474077771|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131670279|NCT04494256|474077772|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131670280|NCT04494256|474077773|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131670281|NCT04494256|474077774|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
131670282|NCT04494256|474077775|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131670283|NCT04494256|474077776|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131670284|NCT04494256|474077770|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
131670285|NCT04494256|474077771|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
131670286|NCT04494256|474077772|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
131670287|NCT04494256|474077773|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
131670288|NCT04494256|474077774|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
131670289|NCT04494256|474077775|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
131670290|NCT04494256|474077776|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
131670291|NCT04494256|474077770|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670292|NCT04494256|474077771|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670293|NCT04494256|474077772|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670294|NCT04494256|474077773|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
131670295|NCT04494256|474077774|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
131670296|NCT04494256|474077775|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670297|NCT04494256|474077776|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670298|NCT04494256|474077770|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131670299|NCT04494256|474077771|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
131670300|NCT04494256|474077772|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131670301|NCT04494256|474077773|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131670302|NCT04494256|474077774|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131670303|NCT04494256|474077775|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
131670304|NCT04494256|474077776|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
131670305|NCT04494256|474077770|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
131670306|NCT04494256|474077771|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
131670307|NCT04494256|474077772|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
131670308|NCT04494256|474077773|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
131670309|NCT04494256|474077774|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
131670310|NCT04494256|474077775|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
131670311|NCT04494256|474077776|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
131670312|NCT04494256|474077770|FG000|Part 2: Open Label Period|Death|0|||
131670313|NCT04494256|474077771|FG001|Part 2: Open Label Period|Death|0|||
131670314|NCT04494256|474077772|FG002|Part 2: Open Label Period|Death|0|||
131670315|NCT04494256|474077773|FG003|Part 2: Open Label Period|Death|0|||
131670316|NCT04494256|474077774|FG004|Part 2: Open Label Period|Death|0|||
131670317|NCT04494256|474077775|FG005|Part 2: Open Label Period|Death|4|||
131670318|NCT04494256|474077776|FG006|Part 2: Open Label Period|Death|2|||
131670319|NCT04494256|474077770|FG000|Part 2: Open Label Period|Adverse Event|0|||
131670320|NCT04494256|474077771|FG001|Part 2: Open Label Period|Adverse Event|0|||
131670321|NCT04494256|474077772|FG002|Part 2: Open Label Period|Adverse Event|0|||
131670322|NCT04494256|474077773|FG003|Part 2: Open Label Period|Adverse Event|0|||
131670323|NCT04494256|474077774|FG004|Part 2: Open Label Period|Adverse Event|0|||
131670324|NCT04494256|474077775|FG005|Part 2: Open Label Period|Adverse Event|0|||
131670325|NCT04494256|474077776|FG006|Part 2: Open Label Period|Adverse Event|2|||
131670326|NCT04494256|474077770|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131670327|NCT04494256|474077771|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131670328|NCT04494256|474077772|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131670329|NCT04494256|474077773|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131670330|NCT04494256|474077774|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131670331|NCT04494256|474077775|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
131670332|NCT04494256|474077776|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
131772343|NCT04511533|474445035|FG000|Treatment|Progressive Disease|61|||
131670333|NCT04494256|474077770|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131670334|NCT04494256|474077771|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131670335|NCT04494256|474077772|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131670336|NCT04494256|474077773|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131670337|NCT04494256|474077774|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131670338|NCT04494256|474077775|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131670339|NCT04494256|474077776|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
131670340|NCT04494256|474077770|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131670341|NCT04494256|474077771|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131670342|NCT04494256|474077772|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131670343|NCT04494256|474077773|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131670344|NCT04494256|474077774|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131670345|NCT04494256|474077775|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
131670346|NCT04494256|474077776|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
131670347|NCT04494256|474077770|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670348|NCT04494256|474077771|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670349|NCT04494256|474077772|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670350|NCT04494256|474077773|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670351|NCT04494256|474077774|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131670352|NCT04494256|474077775|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
131670353|NCT04494256|474077776|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
131670354|NCT04494256|474077770|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131670355|NCT04494256|474077771|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131555073|NCT01709305|473656398|FG001|Phase 1|Physician Decision|0|||
131670356|NCT04494256|474077772|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131670357|NCT04494256|474077773|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131670358|NCT04494256|474077774|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131670359|NCT04494256|474077775|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
131670360|NCT04494256|474077776|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
131670361|NCT00986674|474077777|FG000|Overall Study|Lack of Efficacy|28|||
131670362|NCT00986674|474077778|FG001|Overall Study|Lack of Efficacy|25|||
131670363|NCT00986674|474077779|FG002|Overall Study|Lack of Efficacy|23|||
131670364|NCT00986674|474077777|FG000|Overall Study|Adverse Event|4|||
131670365|NCT00986674|474077778|FG001|Overall Study|Adverse Event|8|||
131670366|NCT00986674|474077779|FG002|Overall Study|Adverse Event|9|||
131670367|NCT00986674|474077777|FG000|Overall Study|Death|5|||
131670368|NCT00986674|474077778|FG001|Overall Study|Death|0|||
131670369|NCT00986674|474077779|FG002|Overall Study|Death|4|||
131670370|NCT00986674|474077777|FG000|Overall Study|Withdrawal by Subject|6|||
131670371|NCT00986674|474077778|FG001|Overall Study|Withdrawal by Subject|2|||
131670372|NCT00986674|474077779|FG002|Overall Study|Withdrawal by Subject|1|||
131670373|NCT00986674|474077777|FG000|Overall Study|alternative therapy|0|||
131670374|NCT00986674|474077778|FG001|Overall Study|alternative therapy|0|||
131670375|NCT00986674|474077779|FG002|Overall Study|alternative therapy|1|||
131670376|NCT00986674|474077777|FG000|Overall Study|not start protocol therapy|4|||
131670377|NCT00986674|474077778|FG001|Overall Study|not start protocol therapy|3|||
131670378|NCT00986674|474077779|FG002|Overall Study|not start protocol therapy|1|||
131670379|NCT00986674|474077777|FG000|Overall Study|unknown/not specify|0|||
131670380|NCT00986674|474077778|FG001|Overall Study|unknown/not specify|7|||
131670381|NCT00986674|474077779|FG002|Overall Study|unknown/not specify|9|||
131670382|NCT02128542|474077780|FG000|Overall Study|Lost to Follow-up|3|||
131670383|NCT02128542|474077781|FG001|Overall Study|Lost to Follow-up|0|||
131670384|NCT02128542|474077780|FG000|Overall Study|Withdrew Consent|1|||
131670385|NCT02128542|474077781|FG001|Overall Study|Withdrew Consent|0|||
131670386|NCT02513303|474077782|FG000|Overall Study|Withdrawal by Subject|9|||
131670387|NCT02513303|474077783|FG001|Overall Study|Withdrawal by Subject|7|||
131670388|NCT02513303|474077784|FG002|Overall Study|Withdrawal by Subject|2|||
131670389|NCT02513303|474077782|FG000|Overall Study|Lost to Follow-up|2|||
131670390|NCT02513303|474077783|FG001|Overall Study|Lost to Follow-up|4|||
131670391|NCT02513303|474077784|FG002|Overall Study|Lost to Follow-up|0|||
131670392|NCT02513303|474077782|FG000|Overall Study|Adverse Event|0|||
131670393|NCT02513303|474077783|FG001|Overall Study|Adverse Event|1|||
131670394|NCT02513303|474077784|FG002|Overall Study|Adverse Event|0|||
131670395|NCT02513303|474077782|FG000|Overall Study|Physician Decision|1|||
131670396|NCT02513303|474077783|FG001|Overall Study|Physician Decision|1|||
131670397|NCT02513303|474077784|FG002|Overall Study|Physician Decision|0|||
131670398|NCT02513303|474077782|FG000|Overall Study|Death|8|||
131670399|NCT02513303|474077783|FG001|Overall Study|Death|4|||
131670400|NCT02513303|474077784|FG002|Overall Study|Death|2|||
131670401|NCT06338462|474077788|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
131670402|NCT03816332|474077789|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
131670403|NCT03816332|474077789|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
131670404|NCT03464097|474077792|FG000|Overall Study|Withdrawal by Subject|15|||
131670405|NCT03464097|474077793|FG001|Overall Study|Withdrawal by Subject|13|||
131670406|NCT03464097|474077794|FG002|Overall Study|Withdrawal by Subject|11|||
131670407|NCT03464097|474077792|FG000|Overall Study|Study terminated by sponsor|47|||
131670408|NCT03464097|474077793|FG001|Overall Study|Study terminated by sponsor|44|||
131670409|NCT03464097|474077794|FG002|Overall Study|Study terminated by sponsor|40|||
131670410|NCT03464097|474077792|FG000|Overall Study|Pregnancy|0|||
131670411|NCT03464097|474077793|FG001|Overall Study|Pregnancy|1|||
131670412|NCT03464097|474077794|FG002|Overall Study|Pregnancy|0|||
131670413|NCT03464097|474077792|FG000|Overall Study|Other reasons|5|||
131670414|NCT03464097|474077793|FG001|Overall Study|Other reasons|12|||
131670415|NCT03464097|474077794|FG002|Overall Study|Other reasons|14|||
131670416|NCT03464097|474077792|FG000|Overall Study|Lost to Follow-up|0|||
131670417|NCT03464097|474077793|FG001|Overall Study|Lost to Follow-up|1|||
131670418|NCT03464097|474077794|FG002|Overall Study|Lost to Follow-up|1|||
131670419|NCT03464097|474077792|FG000|Overall Study|Lack of Efficacy|11|||
131670420|NCT03464097|474077793|FG001|Overall Study|Lack of Efficacy|18|||
131670421|NCT03464097|474077794|FG002|Overall Study|Lack of Efficacy|30|||
131670422|NCT03464097|474077792|FG000|Overall Study|Death|1|||
131670423|NCT03464097|474077793|FG001|Overall Study|Death|0|||
131670424|NCT03464097|474077794|FG002|Overall Study|Death|0|||
131670425|NCT03464097|474077792|FG000|Overall Study|Adverse Event|13|||
131670426|NCT03464097|474077793|FG001|Overall Study|Adverse Event|6|||
131670427|NCT03464097|474077794|FG002|Overall Study|Adverse Event|8|||
131670428|NCT05445843|474077795|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
131670429|NCT05445843|474077796|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
131670430|NCT05445843|474077795|FG000|Overall Study|Progressive disease|17|||
131670431|NCT05445843|474077796|FG001|Overall Study|Progressive disease|9|||
131670432|NCT05445843|474077795|FG000|Overall Study|Physician Decision|16|||
131670433|NCT05445843|474077796|FG001|Overall Study|Physician Decision|4|||
131670434|NCT05445843|474077795|FG000|Overall Study|Death|6|||
131670435|NCT05445843|474077796|FG001|Overall Study|Death|3|||
131670436|NCT05445843|474077795|FG000|Overall Study|Subject decision|6|||
131670437|NCT05445843|474077796|FG001|Overall Study|Subject decision|2|||
131555074|NCT01709305|473656399|FG002|Phase 1|Physician Decision|0|||
131555075|NCT01709305|473656400|FG003|Phase 1|Physician Decision|0|||
131555076|NCT01709305|473656401|FG004|Phase 1|Physician Decision|0|||
131555077|NCT01709305|473656397|FG000|Phase 1|Protocol Violation|118|||
131555078|NCT01709305|473656398|FG001|Phase 1|Protocol Violation|0|||
131555079|NCT01709305|473656399|FG002|Phase 1|Protocol Violation|0|||
131555080|NCT01709305|473656400|FG003|Phase 1|Protocol Violation|0|||
131555081|NCT01709305|473656401|FG004|Phase 1|Protocol Violation|0|||
131555082|NCT01709305|473656397|FG000|Phase 1|Withdrawal by Subject|218|||
131670438|NCT05445843|474077795|FG000|Overall Study|Adverse Event|2|||
131670439|NCT05445843|474077796|FG001|Overall Study|Adverse Event|0|||
131670440|NCT04469270|474077797|FG000|Overall Study|Adverse Event|2|||
131670441|NCT04469270|474077798|FG001|Overall Study|Adverse Event|0|||
131670442|NCT04469270|474077797|FG000|Overall Study|Lost to Follow-up|4|||
131670443|NCT04469270|474077798|FG001|Overall Study|Lost to Follow-up|3|||
131670444|NCT04469270|474077797|FG000|Overall Study|Withdrawal by Subject|7|||
131670445|NCT04469270|474077798|FG001|Overall Study|Withdrawal by Subject|3|||
131670446|NCT04469270|474077797|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
131670447|NCT04469270|474077798|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
131670448|NCT04469270|474077797|FG000|Overall Study|missing|1|||
131670449|NCT04469270|474077798|FG001|Overall Study|missing|0|||
131670450|NCT04576455|474077799|FG000|Overall Study|Ongoing in the Study|48|||
131670451|NCT04576455|474077800|FG001|Overall Study|Ongoing in the Study|58|||
131670452|NCT04576455|474077799|FG000|Overall Study|Death|83|||
131670453|NCT04576455|474077800|FG001|Overall Study|Death|77|||
131670454|NCT04576455|474077799|FG000|Overall Study|Lost to Follow-up|4|||
131670455|NCT04576455|474077800|FG001|Overall Study|Lost to Follow-up|5|||
131670456|NCT04576455|474077799|FG000|Overall Study|Withdrawal by Subject|16|||
131670457|NCT04576455|474077800|FG001|Overall Study|Withdrawal by Subject|12|||
131670458|NCT02186847|474077801|FG000|Overall Study|Protocol Violation|3|||
131670459|NCT02186847|474077802|FG001|Overall Study|Protocol Violation|0|||
131670460|NCT03319849|474077803|FG000|Overall Study|Adverse Event|1|||
131670461|NCT03319849|474077804|FG001|Overall Study|Adverse Event|0|||
131670462|NCT03319849|474077803|FG000|Overall Study|Physician Decision|0|||
131670463|NCT03319849|474077804|FG001|Overall Study|Physician Decision|1|||
131670464|NCT03319849|474077803|FG000|Overall Study|Withdrawal by Subject|0|||
131670465|NCT03319849|474077804|FG001|Overall Study|Withdrawal by Subject|1|||
131670466|NCT03319849|474077803|FG000|Overall Study|COVID-19|0|||
131670467|NCT03319849|474077804|FG001|Overall Study|COVID-19|1|||
131670468|NCT03319849|474077803|FG000|Overall Study|Other|1|||
131670469|NCT03319849|474077804|FG001|Overall Study|Other|2|||
131670470|NCT03319849|474077803|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
131670471|NCT03319849|474077804|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
131670472|NCT03319849|474077803|FG000|Overall Study|Lost to Follow-up|0|||
131670473|NCT03319849|474077804|FG001|Overall Study|Lost to Follow-up|2|||
131670474|NCT02254278|474077805|FG000|Overall Study|Protocol Violation|1|||
131670475|NCT02254278|474077806|FG001|Overall Study|Protocol Violation|1|||
131670476|NCT05774197|474077809|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
131670477|NCT03727438|474077814|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
131670478|NCT03727438|474077815|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
131670479|NCT03727438|474077814|FG000|Intervention Period|Excluded (health)|1|||
131670480|NCT03727438|474077815|FG001|Intervention Period|Excluded (health)|0|||
131670481|NCT03727438|474077814|FG000|Intervention Period|Withdrawal by Subject|3|||
131670482|NCT03727438|474077815|FG001|Intervention Period|Withdrawal by Subject|1|||
131670483|NCT03727438|474077814|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
131670484|NCT03727438|474077815|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
131670485|NCT03727438|474077814|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
131670486|NCT03727438|474077815|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
131670487|NCT03727438|474077814|FG000|8 Week Assessment|Withdrawal by Subject|6|||
131670488|NCT03727438|474077815|FG001|8 Week Assessment|Withdrawal by Subject|1|||
131670489|NCT03727438|474077814|FG000|6 mo Assessment|did not complete assessment|10|||
131670490|NCT03727438|474077815|FG001|6 mo Assessment|did not complete assessment|11|||
131670491|NCT04647253|474077816|FG000|Overall Study|Death ≤ 365 Days|16|||
131670492|NCT04647253|474077817|FG001|Overall Study|Death ≤ 365 Days|7|||
131670493|NCT04647253|474077816|FG000|Overall Study|Physician Decision|0|||
131670494|NCT04647253|474077817|FG001|Overall Study|Physician Decision|1|||
131670495|NCT04647253|474077816|FG000|Overall Study|Withdrawal by Subject|7|||
131670496|NCT04647253|474077817|FG001|Overall Study|Withdrawal by Subject|2|||
131670497|NCT04647253|474077816|FG000|Overall Study|Missed 12-Month Visit|9|||
131670498|NCT04647253|474077817|FG001|Overall Study|Missed 12-Month Visit|7|||
131670499|NCT04647253|474077816|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
131670500|NCT04647253|474077817|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
131670501|NCT06729606|474077820|FG000|Overall Study|Adverse Event|0|||
131670502|NCT06729606|474077821|FG001|Overall Study|Adverse Event|2|||
131670503|NCT06729606|474077820|FG000|Overall Study|Death|1|||
131670504|NCT06729606|474077821|FG001|Overall Study|Death|0|||
131670505|NCT06729606|474077820|FG000|Overall Study|Physician Decision|0|||
131670506|NCT06729606|474077821|FG001|Overall Study|Physician Decision|1|||
131670507|NCT06729606|474077820|FG000|Overall Study|Withdrawal by Subject|2|||
131670508|NCT06729606|474077821|FG001|Overall Study|Withdrawal by Subject|4|||
131670509|NCT04873232|474077822|FG000|Overall Study|Lost to Follow-up|1|||
131670510|NCT04873232|474077823|FG001|Overall Study|Lost to Follow-up|4|||
131670511|NCT04873232|474077822|FG000|Overall Study|Withdrawal by Subject|1|||
131670512|NCT04873232|474077823|FG001|Overall Study|Withdrawal by Subject|0|||
131670513|NCT05437510|474077824|FG000|Overall Study|Adverse Event|2|||
131670514|NCT05437510|474077825|FG001|Overall Study|Adverse Event|1|||
131670515|NCT05437510|474077824|FG000|Overall Study|Protocol Deviation|1|||
131670516|NCT05437510|474077825|FG001|Overall Study|Protocol Deviation|6|||
131670517|NCT05437510|474077824|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
131670518|NCT05437510|474077825|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
131670519|NCT05437510|474077824|FG000|Overall Study|Lost to Follow-up|265|||
131670520|NCT05437510|474077825|FG001|Overall Study|Lost to Follow-up|358|||
131670521|NCT01640054|474078993|FG000|Overall Study|Study-specific disc criteria|1|||
131670522|NCT01640054|474078993|FG000|Overall Study|Lack of Efficacy|3|||
131670523|NCT01640054|474078993|FG000|Overall Study|Adverse Event|2|||
131670524|NCT05220254|474078995|FG000|Overall Study|Withdrawal by Subject|4|||
131670525|NCT05220254|474078995|FG000|Overall Study|Removed due to ineligibility|1|||
131670526|NCT05220254|474078995|FG000|Overall Study|Lost to Follow-up|7|||
131670527|NCT01557283|474078996|FG000|Overall Study|Lost to Follow-up|7|||
131670528|NCT01557283|474078996|FG000|Overall Study|Non-responder|19|||
131670529|NCT01557283|474078996|FG000|Overall Study|Adverse Event|7|||
131670530|NCT01557283|474078996|FG000|Overall Study|Lack of Efficacy|1|||
131670531|NCT01557283|474078996|FG000|Overall Study|Non-compliance|1|||
131670532|NCT01557283|474078996|FG000|Overall Study|Withdrawal by Subject|1|||
131670533|NCT01557283|474078996|FG000|Overall Study|Participant's weight too high for dose|1|||
131670534|NCT01557283|474078996|FG000|Overall Study|Worsening of psoriasis|1|||
131670535|NCT01557283|474078996|FG000|Overall Study|Other|6|||
131670536|NCT00448279|474078997|FG000|Overall Study|Lost to Follow-up|2|||
131670537|NCT00448279|474078998|FG001|Overall Study|Lost to Follow-up|2|||
131670538|NCT00448279|474078997|FG000|Overall Study|Adverse Event|1|||
131670539|NCT00448279|474078998|FG001|Overall Study|Adverse Event|1|||
131670540|NCT00448279|474078997|FG000|Overall Study|Disease progression|16|||
131670541|NCT00448279|474078998|FG001|Overall Study|Disease progression|18|||
131670542|NCT00448279|474078997|FG000|Overall Study|Withdrawal by Subject|4|||
131670543|NCT00448279|474078998|FG001|Overall Study|Withdrawal by Subject|3|||
131670544|NCT00448279|474078997|FG000|Overall Study|Other|6|||
131670545|NCT00448279|474078998|FG001|Overall Study|Other|4|||
131670546|NCT00448279|474078997|FG000|Overall Study|Protocol Violation|0|||
131670547|NCT00448279|474078998|FG001|Overall Study|Protocol Violation|1|||
131670548|NCT03907410|474078999|FG000|Overall Study|Lost to Follow-up|4|||
131670549|NCT03907410|474079000|FG001|Overall Study|Lost to Follow-up|1|||
131670550|NCT03907410|474079001|FG002|Overall Study|Lost to Follow-up|1|||
131670551|NCT03907410|474078999|FG000|Overall Study|Lost to follow-up and research burden|0|||
131670552|NCT03907410|474079000|FG001|Overall Study|Lost to follow-up and research burden|0|||
131670553|NCT03907410|474079001|FG002|Overall Study|Lost to follow-up and research burden|1|||
131670554|NCT01853137|474079002|FG000|Overall Study|Lost to Follow-up|4|||
131670555|NCT01853137|474079003|FG001|Overall Study|Lost to Follow-up|1|||
131670556|NCT01037244|474079004|FG000|Overall Study|Adverse Event|3|||
131670557|NCT01037244|474079005|FG001|Overall Study|Adverse Event|2|||
131670558|NCT01037244|474079006|FG002|Overall Study|Adverse Event|6|||
131670559|NCT01037244|474079007|FG003|Overall Study|Adverse Event|3|||
131670560|NCT01037244|474079004|FG000|Overall Study|Lack of Efficacy|1|||
131670561|NCT01037244|474079005|FG001|Overall Study|Lack of Efficacy|1|||
131670562|NCT01037244|474079006|FG002|Overall Study|Lack of Efficacy|0|||
131670563|NCT01037244|474079007|FG003|Overall Study|Lack of Efficacy|1|||
131670564|NCT01037244|474079004|FG000|Overall Study|Lost to Follow-up|3|||
131670565|NCT01037244|474079005|FG001|Overall Study|Lost to Follow-up|3|||
131670566|NCT01037244|474079006|FG002|Overall Study|Lost to Follow-up|4|||
131670567|NCT01037244|474079007|FG003|Overall Study|Lost to Follow-up|4|||
131670568|NCT01037244|474079004|FG000|Overall Study|Withdrawal by Subject|1|||
131670569|NCT01037244|474079005|FG001|Overall Study|Withdrawal by Subject|5|||
131670570|NCT01037244|474079006|FG002|Overall Study|Withdrawal by Subject|3|||
131670571|NCT01037244|474079007|FG003|Overall Study|Withdrawal by Subject|5|||
131670572|NCT01037244|474079004|FG000|Overall Study|Partner Withdrew Consent|2|||
131670573|NCT01037244|474079005|FG001|Overall Study|Partner Withdrew Consent|1|||
131670574|NCT01037244|474079006|FG002|Overall Study|Partner Withdrew Consent|0|||
131670575|NCT01037244|474079007|FG003|Overall Study|Partner Withdrew Consent|0|||
131670576|NCT01037244|474079004|FG000|Overall Study|Various|3|||
131670577|NCT01037244|474079005|FG001|Overall Study|Various|2|||
131670578|NCT01037244|474079006|FG002|Overall Study|Various|1|||
131670579|NCT01037244|474079007|FG003|Overall Study|Various|1|||
131670580|NCT01411215|474079008|FG000|Overall Study|Adverse Event|1|||
131670581|NCT01411215|474079009|FG001|Overall Study|Adverse Event|2|||
131670582|NCT01411215|474079008|FG000|Overall Study|Lack of Efficacy|2|||
131670583|NCT01411215|474079009|FG001|Overall Study|Lack of Efficacy|4|||
131670584|NCT01411215|474079008|FG000|Overall Study|Lost to Follow-up|12|||
131670585|NCT01411215|474079009|FG001|Overall Study|Lost to Follow-up|18|||
131670586|NCT01411215|474079008|FG000|Overall Study|Did not meet entrance criteria|0|||
131670587|NCT01411215|474079009|FG001|Overall Study|Did not meet entrance criteria|1|||
131670588|NCT01411215|474079008|FG000|Overall Study|Study terminated by sponsor|2|||
131670589|NCT01411215|474079009|FG001|Overall Study|Study terminated by sponsor|15|||
131670590|NCT01411215|474079008|FG000|Overall Study|Protocol Violation|3|||
131670591|NCT01411215|474079009|FG001|Overall Study|Protocol Violation|5|||
131670592|NCT01411215|474079008|FG000|Overall Study|Withdrawal by Subject|34|||
131670593|NCT01411215|474079009|FG001|Overall Study|Withdrawal by Subject|21|||
131670594|NCT01411215|474079008|FG000|Overall Study|Other|12|||
131670595|NCT01411215|474079009|FG001|Overall Study|Other|17|||
131670596|NCT01411215|474079008|FG000|Overall Study|Screen failure|0|||
131670597|NCT01411215|474079009|FG001|Overall Study|Screen failure|1|||
131670598|NCT00848926|474079010|FG000|Treatment Period|Progressive disease|45|||
131670599|NCT00848926|474079010|FG000|Treatment Period|Adverse Event|20|||
131670600|NCT00848926|474079010|FG000|Treatment Period|Physician Decision|12|||
131670601|NCT00848926|474079010|FG000|Treatment Period|Withdrawal by Subject|7|||
131670602|NCT00848926|474079010|FG000|Follow-up Period|Lost to Follow-up|7|||
131670603|NCT00848926|474079010|FG000|Follow-up Period|Withdrawal by Subject|3|||
131670604|NCT00848926|474079010|FG000|Follow-up Period|Other|2|||
131670605|NCT04025580|474079011|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
131670606|NCT04025580|474079012|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
131670607|NCT04025580|474079013|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
131670608|NCT04507126|474079014|FG000|Overall Study|Withdrawal by Subject|1|||
131670609|NCT04507126|474079014|FG000|Overall Study|Protocol Violation|2|||
131670610|NCT04507126|474079014|FG000|Overall Study|Physician Decision|1|||
131670611|NCT02924064|474079015|FG000|Overall Study|Adverse Event|2|||
131670612|NCT02924064|474079016|FG001|Overall Study|Adverse Event|2|||
131670613|NCT02924064|474079015|FG000|Overall Study|Lost to Follow-up|0|||
131670614|NCT02924064|474079016|FG001|Overall Study|Lost to Follow-up|2|||
131670615|NCT02924064|474079015|FG000|Overall Study|Physician Decision|0|||
131670616|NCT02924064|474079016|FG001|Overall Study|Physician Decision|2|||
131670617|NCT02924064|474079015|FG000|Overall Study|Protocol Violation|1|||
131670618|NCT02924064|474079016|FG001|Overall Study|Protocol Violation|3|||
131670619|NCT02924064|474079015|FG000|Overall Study|Withdrawal by Subject|4|||
131670620|NCT02924064|474079016|FG001|Overall Study|Withdrawal by Subject|5|||
131670621|NCT02924064|474079015|FG000|Overall Study|Other|17|||
131670622|NCT02924064|474079016|FG001|Overall Study|Other|29|||
131670623|NCT01249274|474079019|FG000|Overall Study|Lost to Follow-up|3|||
131670624|NCT01249274|474079020|FG001|Overall Study|Lost to Follow-up|4|||
131670625|NCT01249274|474079019|FG000|Overall Study|Received inpatient substance treatment|1|||
131670626|NCT01249274|474079020|FG001|Overall Study|Received inpatient substance treatment|2|||
131670627|NCT01000636|474079021|FG000|Overall Study|Withdrawal by Subject|1|||
131670628|NCT01000636|474079021|FG000|Overall Study|Adverse Event|1|||
131670629|NCT00138671|474079022|FG000|Overall Study|Death|0|||
131670630|NCT00138671|474079023|FG001|Overall Study|Death|3|||
131670631|NCT00138671|474079022|FG000|Overall Study|Adverse Event|6|||
131670632|NCT00138671|474079023|FG001|Overall Study|Adverse Event|3|||
131670633|NCT00138671|474079022|FG000|Overall Study|Lost to Follow-up|1|||
131670634|NCT00138671|474079023|FG001|Overall Study|Lost to Follow-up|2|||
131670635|NCT00138671|474079022|FG000|Overall Study|Withdrawal by Subject|3|||
131670636|NCT00138671|474079023|FG001|Overall Study|Withdrawal by Subject|5|||
131670637|NCT00138671|474079022|FG000|Overall Study|Other|3|||
131670638|NCT00138671|474079023|FG001|Overall Study|Other|3|||
131670639|NCT03451162|474079024|FG000|Overall Study|Lost to Follow-up|1|||
131670640|NCT03451162|474079025|FG001|Overall Study|Lost to Follow-up|0|||
131670641|NCT03451162|474079026|FG002|Overall Study|Lost to Follow-up|0|||
131670642|NCT03451162|474079027|FG003|Overall Study|Lost to Follow-up|0|||
131670643|NCT03451162|474079028|FG004|Overall Study|Lost to Follow-up|0|||
131670644|NCT03451162|474079024|FG000|Overall Study|Physician Decision|0|||
131670645|NCT03451162|474079025|FG001|Overall Study|Physician Decision|1|||
131670646|NCT03451162|474079026|FG002|Overall Study|Physician Decision|0|||
131670647|NCT03451162|474079027|FG003|Overall Study|Physician Decision|0|||
131670648|NCT03451162|474079028|FG004|Overall Study|Physician Decision|0|||
131670649|NCT03451162|474079024|FG000|Overall Study|Withdrawal by Subject|1|||
131670650|NCT03451162|474079025|FG001|Overall Study|Withdrawal by Subject|1|||
131670651|NCT03451162|474079026|FG002|Overall Study|Withdrawal by Subject|0|||
131670652|NCT03451162|474079027|FG003|Overall Study|Withdrawal by Subject|0|||
131670653|NCT03451162|474079028|FG004|Overall Study|Withdrawal by Subject|0|||
131670654|NCT03658668|474079029|FG000|Overall Study|Time Commitment|1|||
131670655|NCT03658668|474079030|FG001|Overall Study|Time Commitment|1|||
131670656|NCT03305731|474079031|FG000|Overall Study|Protocol Violation|1|||
131670657|NCT01952054|474079032|FG000|Overall Study|Physician Decision|1|||
131670658|NCT01127139|474079033|FG000|Overall Study|Adverse Event|40|||
131670659|NCT01127139|474079033|FG000|Overall Study|Incompliance|12|||
131670660|NCT01127139|474079033|FG000|Overall Study|Lack of Efficacy|4|||
131670661|NCT01127139|474079033|FG000|Overall Study|Reason not specified|1|||
131670662|NCT01100034|474079034|FG000|Overall Study|Lost to Follow-up|11|||
131670663|NCT01100034|474079034|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
131670664|NCT01100034|474079034|FG000|Overall Study|Withdrawal by Subject|4|||
131670665|NCT01100034|474079034|FG000|Overall Study|Sponsor decision|21|||
131670666|NCT01100034|474079034|FG000|Overall Study|Participated in another clinical trial|1|||
131670667|NCT01100034|474079034|FG000|Overall Study|Participants moved to another hospital|4|||
131670668|NCT01100034|474079034|FG000|Overall Study|Site closed due to non-responsiveness|1|||
131670669|NCT01831856|474079035|FG000|Overall Study|Adverse Event|5|||
131670670|NCT01831856|474079036|FG001|Overall Study|Adverse Event|8|||
131670671|NCT01831856|474079035|FG000|Overall Study|Lack of Efficacy|13|||
131670672|NCT01831856|474079036|FG001|Overall Study|Lack of Efficacy|11|||
131670673|NCT01831856|474079035|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
131670674|NCT01831856|474079036|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
131670675|NCT01498653|474079038|FG000|Overall Study|Adverse Event|2|||
131670676|NCT01498653|474079039|FG001|Overall Study|Adverse Event|2|||
131670677|NCT01498653|474079038|FG000|Overall Study|Lack of Efficacy|12|||
131670678|NCT01498653|474079039|FG001|Overall Study|Lack of Efficacy|26|||
131670679|NCT01498653|474079038|FG000|Overall Study|Protocol Violation|0|||
131670680|NCT01498653|474079039|FG001|Overall Study|Protocol Violation|4|||
131670681|NCT01498653|474079038|FG000|Overall Study|Lost to Follow-up|1|||
131670682|NCT01498653|474079039|FG001|Overall Study|Lost to Follow-up|0|||
131670683|NCT01498653|474079038|FG000|Overall Study|Physician Decision|2|||
131670684|NCT01498653|474079039|FG001|Overall Study|Physician Decision|0|||
131670685|NCT01498653|474079038|FG000|Overall Study|Withdrawal by Subject|2|||
131670686|NCT01498653|474079039|FG001|Overall Study|Withdrawal by Subject|3|||
131670687|NCT05208866|474079040|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
131670688|NCT02070588|474079041|FG000|Overall Study|Withdrawal by Subject|29|||
131670689|NCT02070588|474079042|FG001|Overall Study|Withdrawal by Subject|1|||
131897050|NCT05251233|474910331|FG001|Overall Study|Other complicating disease|1|||
131897051|NCT05251233|474910332|FG002|Overall Study|Other complicating disease|0|||
131897052|NCT05251233|474910330|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
131897053|NCT05251233|474910331|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
131670690|NCT02070588|474079043|FG002|Overall Study|Withdrawal by Subject|0|||
131670691|NCT02070588|474079041|FG000|Overall Study|Writhdrawal due to early termination|9|||
131670692|NCT02070588|474079042|FG001|Overall Study|Writhdrawal due to early termination|0|||
131670693|NCT02070588|474079043|FG002|Overall Study|Writhdrawal due to early termination|0|||
131670694|NCT02070588|474079041|FG000|Overall Study|Adverse Event|1|||
131670695|NCT02070588|474079042|FG001|Overall Study|Adverse Event|0|||
131670696|NCT02070588|474079043|FG002|Overall Study|Adverse Event|0|||
131670697|NCT02216357|474079047|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
131670698|NCT02216357|474079048|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
131670699|NCT00836095|474079049|FG000|Overall Study|Physician Decision|0|||
131670700|NCT00836095|474079050|FG001|Overall Study|Physician Decision|3|||
131670701|NCT04964414|474079052|FG000|Overall Study|Lost to Follow-up|10|||
131670702|NCT04964414|474079053|FG001|Overall Study|Lost to Follow-up|8|||
131670703|NCT04964414|474079052|FG000|Overall Study|Withdrawal by Subject|1|||
131670704|NCT04964414|474079053|FG001|Overall Study|Withdrawal by Subject|1|||
131670705|NCT01718353|474079054|FG000|Overall Study|Lost to Follow-up|0|||
131670706|NCT01718353|474079055|FG001|Overall Study|Lost to Follow-up|1|||
131670707|NCT01718353|474079054|FG000|Overall Study|Principal Investigator's Decision|10|||
131670708|NCT01718353|474079055|FG001|Overall Study|Principal Investigator's Decision|4|||
131555083|NCT01709305|473656398|FG001|Phase 1|Withdrawal by Subject|0|||
131555084|NCT01709305|473656399|FG002|Phase 1|Withdrawal by Subject|0|||
131555085|NCT01709305|473656400|FG003|Phase 1|Withdrawal by Subject|0|||
131555086|NCT01709305|473656401|FG004|Phase 1|Withdrawal by Subject|0|||
131555087|NCT01709305|473656397|FG000|Phase 2|Clinical Adverse Event|0|||
131555088|NCT01709305|473656398|FG001|Phase 2|Clinical Adverse Event|10|||
131555089|NCT01709305|473656399|FG002|Phase 2|Clinical Adverse Event|10|||
131555090|NCT01709305|473656400|FG003|Phase 2|Clinical Adverse Event|6|||
131555091|NCT01709305|473656401|FG004|Phase 2|Clinical Adverse Event|11|||
131555092|NCT01709305|473656397|FG000|Phase 2|Death|0|||
131555093|NCT01709305|473656398|FG001|Phase 2|Death|0|||
131555094|NCT01709305|473656399|FG002|Phase 2|Death|1|||
131555095|NCT01709305|473656400|FG003|Phase 2|Death|0|||
131555096|NCT01709305|473656401|FG004|Phase 2|Death|0|||
131555097|NCT01709305|473656397|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
131555098|NCT01709305|473656398|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
131555099|NCT01709305|473656399|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
131555100|NCT01709305|473656400|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
131555101|NCT01709305|473656401|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
131555102|NCT01709305|473656397|FG000|Phase 2|Laboratory Adverse Event|0|||
131555103|NCT01709305|473656398|FG001|Phase 2|Laboratory Adverse Event|1|||
131555104|NCT01709305|473656399|FG002|Phase 2|Laboratory Adverse Event|0|||
131555105|NCT01709305|473656400|FG003|Phase 2|Laboratory Adverse Event|1|||
131555106|NCT01709305|473656401|FG004|Phase 2|Laboratory Adverse Event|1|||
131555107|NCT01709305|473656397|FG000|Phase 2|Lost to Follow-up|0|||
131555108|NCT01709305|473656398|FG001|Phase 2|Lost to Follow-up|10|||
131555109|NCT01709305|473656399|FG002|Phase 2|Lost to Follow-up|6|||
131555110|NCT01709305|473656400|FG003|Phase 2|Lost to Follow-up|9|||
131555111|NCT01709305|473656401|FG004|Phase 2|Lost to Follow-up|5|||
131555112|NCT01709305|473656397|FG000|Phase 2|Travel, moving, etc.|0|||
131555113|NCT01709305|473656398|FG001|Phase 2|Travel, moving, etc.|2|||
131555114|NCT01709305|473656399|FG002|Phase 2|Travel, moving, etc.|3|||
131555115|NCT01709305|473656400|FG003|Phase 2|Travel, moving, etc.|3|||
131555116|NCT01709305|473656401|FG004|Phase 2|Travel, moving, etc.|5|||
131555117|NCT01709305|473656397|FG000|Phase 2|Physician Decision|0|||
131555118|NCT01709305|473656398|FG001|Phase 2|Physician Decision|2|||
131555119|NCT01709305|473656399|FG002|Phase 2|Physician Decision|0|||
131555120|NCT01709305|473656400|FG003|Phase 2|Physician Decision|1|||
131555121|NCT01709305|473656401|FG004|Phase 2|Physician Decision|2|||
131555122|NCT01709305|473656397|FG000|Phase 2|Protocol Violation|0|||
131555123|NCT01709305|473656398|FG001|Phase 2|Protocol Violation|19|||
131555124|NCT01709305|473656399|FG002|Phase 2|Protocol Violation|19|||
131555125|NCT01709305|473656400|FG003|Phase 2|Protocol Violation|13|||
131555126|NCT01709305|473656401|FG004|Phase 2|Protocol Violation|9|||
131555127|NCT01709305|473656397|FG000|Phase 2|Withdrawal by Subject|0|||
131555128|NCT01709305|473656398|FG001|Phase 2|Withdrawal by Subject|8|||
131555129|NCT01709305|473656399|FG002|Phase 2|Withdrawal by Subject|6|||
131555130|NCT01709305|473656400|FG003|Phase 2|Withdrawal by Subject|15|||
131555131|NCT01709305|473656401|FG004|Phase 2|Withdrawal by Subject|12|||
131555132|NCT00171873|473656407|FG000|Overall Study|Withdrawal by Subject|4|||
131555133|NCT00171873|473656408|FG001|Overall Study|Withdrawal by Subject|2|||
131555134|NCT00171873|473656407|FG000|Overall Study|Adverse Event|5|||
131555135|NCT00171873|473656408|FG001|Overall Study|Adverse Event|0|||
131555136|NCT00171873|473656407|FG000|Overall Study|Switched to Octreotide|0|||
131555137|NCT00171873|473656408|FG001|Overall Study|Switched to Octreotide|1|||
131555138|NCT05200936|473656410|FG000|Overall Study|Withdrawal by Subject|2|||
131555139|NCT05200936|473656411|FG001|Overall Study|Withdrawal by Subject|2|||
131555140|NCT05200936|473656410|FG000|Overall Study|Lost to Follow-up|2|||
131555141|NCT05200936|473656411|FG001|Overall Study|Lost to Follow-up|0|||
131555142|NCT05200936|473656410|FG000|Overall Study|Pregnancy|0|||
131555143|NCT05200936|473656411|FG001|Overall Study|Pregnancy|1|||
131555144|NCT00539279|473656412|FG000|Treatment|Withdrawal by Subject|10|||
131555145|NCT00539279|473656413|FG001|Treatment|Withdrawal by Subject|8|||
131555146|NCT00539279|473656412|FG000|Treatment|Death|1|||
131555147|NCT00539279|473656413|FG001|Treatment|Death|0|||
131555148|NCT00539279|473656412|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
131555149|NCT00539279|473656413|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
131555150|NCT00539279|473656412|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
131555151|NCT00539279|473656413|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
131555152|NCT01338012|473656416|FG000|Overall Study|Death|4|||
131555153|NCT01338012|473656416|FG000|Overall Study|Study terminated|4|||
131555154|NCT02714205|473656417|FG000|Overall Study|Cannot tolerate medication|1|||
131555155|NCT02714205|473656418|FG001|Overall Study|Cannot tolerate medication|0|||
131555156|NCT02714205|473656417|FG000|Overall Study|Adverse Event|2|||
131555157|NCT02714205|473656418|FG001|Overall Study|Adverse Event|0|||
131555158|NCT02714205|473656417|FG000|Overall Study|Too busy|1|||
131555159|NCT02714205|473656418|FG001|Overall Study|Too busy|0|||
131555160|NCT02714205|473656417|FG000|Overall Study|Incomplete outcome data|0|||
131555161|NCT02714205|473656418|FG001|Overall Study|Incomplete outcome data|1|||
131555162|NCT02769065|473658101|FG000|Overall Study|Voluntary Withdrawal|1|||
131555163|NCT02769065|473658102|FG001|Overall Study|Voluntary Withdrawal|0|||
131555164|NCT02769065|473658103|FG002|Overall Study|Voluntary Withdrawal|0|||
131555165|NCT02769065|473658104|FG003|Overall Study|Voluntary Withdrawal|0|||
131555166|NCT02769065|473658105|FG004|Overall Study|Voluntary Withdrawal|0|||
131555167|NCT02769065|473658106|FG005|Overall Study|Voluntary Withdrawal|0|||
131555168|NCT02769065|473658107|FG006|Overall Study|Voluntary Withdrawal|0|||
131555169|NCT02769065|473658108|FG007|Overall Study|Voluntary Withdrawal|0|||
131555170|NCT02769065|473658109|FG008|Overall Study|Voluntary Withdrawal|0|||
131555171|NCT02769065|473658110|FG009|Overall Study|Voluntary Withdrawal|0|||
131555172|NCT02769065|473658111|FG010|Overall Study|Voluntary Withdrawal|0|||
131555173|NCT02769065|473658112|FG011|Overall Study|Voluntary Withdrawal|0|||
131555174|NCT02769065|473658113|FG012|Overall Study|Voluntary Withdrawal|0|||
131555175|NCT02769065|473658114|FG013|Overall Study|Voluntary Withdrawal|0|||
131555176|NCT02769065|473658115|FG014|Overall Study|Voluntary Withdrawal|0|||
131555177|NCT02769065|473658116|FG015|Overall Study|Voluntary Withdrawal|0|||
131555178|NCT02769065|473658117|FG016|Overall Study|Voluntary Withdrawal|0|||
131555179|NCT02769065|473658118|FG017|Overall Study|Voluntary Withdrawal|0|||
131555180|NCT02769065|473658119|FG018|Overall Study|Voluntary Withdrawal|0|||
131555181|NCT02769065|473658120|FG019|Overall Study|Voluntary Withdrawal|0|||
131555182|NCT02769065|473658121|FG020|Overall Study|Voluntary Withdrawal|0|||
131772344|NCT04511533|474445035|FG000|Follow-Up|Other|7|||
131772345|NCT04511533|474445035|FG000|Follow-Up|Withdrawal by Subject|5|||
131772346|NCT04511533|474445035|FG000|Follow-Up|Lost to Follow-up|2|||
131772347|NCT04511533|474445035|FG000|Follow-Up|Death|4|||
131772348|NCT04576702|474445036|FG000|Overall Study|Death|1|||
131772349|NCT04576702|474445037|FG001|Overall Study|Death|0|||
131772350|NCT04576702|474445038|FG002|Overall Study|Death|0|||
131772351|NCT04576702|474445039|FG003|Overall Study|Death|0|||
131772352|NCT04576702|474445036|FG000|Overall Study|Withdrawal by Subject|0|||
131772353|NCT04576702|474445037|FG001|Overall Study|Withdrawal by Subject|2|||
131772354|NCT04576702|474445038|FG002|Overall Study|Withdrawal by Subject|1|||
131772355|NCT04576702|474445039|FG003|Overall Study|Withdrawal by Subject|0|||
131772356|NCT04576702|474445036|FG000|Overall Study|Lost to Follow-up|3|||
131772357|NCT04576702|474445037|FG001|Overall Study|Lost to Follow-up|3|||
131772358|NCT04576702|474445038|FG002|Overall Study|Lost to Follow-up|3|||
131772359|NCT04576702|474445039|FG003|Overall Study|Lost to Follow-up|4|||
131772360|NCT01319422|474445042|FG000|Overall Study|Withdrawal by Subject|1|||
131772361|NCT01319422|474445043|FG001|Overall Study|Withdrawal by Subject|0|||
131772362|NCT06104423|474445046|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
131772363|NCT06104423|474445047|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
131772364|NCT06104423|474445048|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
131772365|NCT06104423|474445046|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
131772366|NCT06104423|474445047|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
131772367|NCT06104423|474445048|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
131772368|NCT00727246|474445049|FG000|Overall Study|could not complete MRI|0|||
131772369|NCT00727246|474445050|FG001|Overall Study|could not complete MRI|1|||
131772370|NCT00727246|474445051|FG002|Overall Study|could not complete MRI|0|||
131772371|NCT00727246|474445052|FG003|Overall Study|could not complete MRI|1|||
131772372|NCT00727246|474445049|FG000|Overall Study|incidental finding|0|||
131772373|NCT00727246|474445050|FG001|Overall Study|incidental finding|0|||
131772374|NCT00727246|474445051|FG002|Overall Study|incidental finding|0|||
131772375|NCT00727246|474445052|FG003|Overall Study|incidental finding|1|||
131772376|NCT00727246|474445049|FG000|Overall Study|withdrawn|0|||
131772377|NCT00727246|474445050|FG001|Overall Study|withdrawn|0|||
131772378|NCT00727246|474445051|FG002|Overall Study|withdrawn|1|||
131772379|NCT00727246|474445052|FG003|Overall Study|withdrawn|0|||
131772380|NCT01258803|474445059|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
131555183|NCT02769065|473658122|FG021|Overall Study|Voluntary Withdrawal|0|||
131555184|NCT02769065|473658123|FG022|Overall Study|Voluntary Withdrawal|0|||
131555185|NCT02769065|473658124|FG023|Overall Study|Voluntary Withdrawal|0|||
131555186|NCT02769065|473658125|FG024|Overall Study|Voluntary Withdrawal|0|||
131555187|NCT02769065|473658126|FG025|Overall Study|Voluntary Withdrawal|0|||
131555188|NCT02769065|473658127|FG026|Overall Study|Voluntary Withdrawal|0|||
131555189|NCT02769065|473658128|FG027|Overall Study|Voluntary Withdrawal|0|||
131555190|NCT02769065|473658129|FG028|Overall Study|Voluntary Withdrawal|0|||
131555191|NCT02769065|473658130|FG029|Overall Study|Voluntary Withdrawal|0|||
131555192|NCT02769065|473658101|FG000|Overall Study|Reason Not Specified|0|||
131555193|NCT02769065|473658102|FG001|Overall Study|Reason Not Specified|0|||
131555194|NCT02769065|473658103|FG002|Overall Study|Reason Not Specified|0|||
131555195|NCT02769065|473658104|FG003|Overall Study|Reason Not Specified|0|||
131555196|NCT02769065|473658105|FG004|Overall Study|Reason Not Specified|0|||
131555197|NCT02769065|473658106|FG005|Overall Study|Reason Not Specified|0|||
131555198|NCT02769065|473658107|FG006|Overall Study|Reason Not Specified|1|||
131555199|NCT02769065|473658108|FG007|Overall Study|Reason Not Specified|0|||
131772381|NCT01258803|474445060|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
131772382|NCT01258803|474445061|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
131670709|NCT01718353|474079054|FG000|Overall Study|Randomized but not treated|2|||
131670710|NCT01718353|474079055|FG001|Overall Study|Randomized but not treated|0|||
131670711|NCT00455325|474079057|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
131670712|NCT00455325|474079058|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
131670713|NCT00455325|474079059|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
131670714|NCT00455325|474079060|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
131670715|NCT00455325|474079057|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
131670716|NCT00455325|474079058|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
131670717|NCT00455325|474079059|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
131670718|NCT00455325|474079060|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
131670719|NCT00455325|474079057|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
131670720|NCT00455325|474079058|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
131670721|NCT00455325|474079059|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
131670722|NCT00455325|474079060|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
131670723|NCT00455325|474079057|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
131670724|NCT00455325|474079058|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
131670725|NCT00455325|474079059|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
131670726|NCT00455325|474079060|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
131670727|NCT00455325|474079057|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
131670728|NCT00455325|474079058|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
131670729|NCT00455325|474079059|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
131670730|NCT00455325|474079060|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
131670731|NCT00455325|474079057|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
131670732|NCT00455325|474079058|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
131670733|NCT00455325|474079059|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
131670734|NCT00455325|474079060|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
131670735|NCT00455325|474079057|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
131670736|NCT00455325|474079058|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
131670737|NCT00455325|474079059|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
131670738|NCT00455325|474079060|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
131670739|NCT04620811|474079061|FG000|Overall Study|Withdrawal by Subject|18|||
131670740|NCT04620811|474079062|FG001|Overall Study|Withdrawal by Subject|15|||
131670741|NCT04620811|474079061|FG000|Overall Study|Adverse Event|6|||
131670742|NCT04620811|474079062|FG001|Overall Study|Adverse Event|11|||
131670743|NCT04620811|474079061|FG000|Overall Study|Lost to Follow-up|4|||
131670744|NCT04620811|474079062|FG001|Overall Study|Lost to Follow-up|8|||
131670745|NCT04620811|474079061|FG000|Overall Study|Physician Decision|1|||
131670746|NCT04620811|474079062|FG001|Overall Study|Physician Decision|4|||
131670747|NCT04620811|474079061|FG000|Overall Study|Sponsor Decision|0|||
131670748|NCT04620811|474079062|FG001|Overall Study|Sponsor Decision|1|||
131670749|NCT04620811|474079061|FG000|Overall Study|Elevation of ALT or AST|1|||
131670750|NCT04620811|474079062|FG001|Overall Study|Elevation of ALT or AST|0|||
131670751|NCT04620811|474079061|FG000|Overall Study|Other|3|||
131670752|NCT04620811|474079062|FG001|Overall Study|Other|5|||
131670753|NCT01078675|474079063|FG000|Overall Study|Withdrawal by Subject|7|||
131670754|NCT01078675|474079064|FG001|Overall Study|Withdrawal by Subject|3|||
131670755|NCT01078675|474079063|FG000|Overall Study|Protocol Violation|56|||
131670756|NCT01078675|474079064|FG001|Overall Study|Protocol Violation|0|||
131670757|NCT01078675|474079063|FG000|Overall Study|Provided in CRF for specific reasons|2|||
131670758|NCT01078675|474079064|FG001|Overall Study|Provided in CRF for specific reasons|3|||
131670759|NCT01078675|474079063|FG000|Overall Study|Adverse Event|3|||
131670760|NCT01078675|474079064|FG001|Overall Study|Adverse Event|0|||
131670761|NCT01759368|474079072|FG000|Overall Study|Lost to Follow-up|1|||
131670762|NCT01759368|474079073|FG001|Overall Study|Lost to Follow-up|0|||
131670763|NCT01191268|474079074|FG000|Overall Study|Withdrawal by Subject|19|||
131670764|NCT01191268|474079075|FG001|Overall Study|Withdrawal by Subject|25|||
131670765|NCT01191268|474079076|FG002|Overall Study|Withdrawal by Subject|21|||
131670766|NCT01191268|474079074|FG000|Overall Study|Adverse Event|21|||
131670767|NCT01191268|474079075|FG001|Overall Study|Adverse Event|13|||
131670768|NCT01191268|474079076|FG002|Overall Study|Adverse Event|8|||
131670769|NCT01191268|474079074|FG000|Overall Study|Physician Decision|6|||
131670770|NCT01191268|474079075|FG001|Overall Study|Physician Decision|8|||
131670771|NCT01191268|474079076|FG002|Overall Study|Physician Decision|9|||
131670772|NCT01191268|474079074|FG000|Overall Study|Lost to Follow-up|8|||
131670773|NCT01191268|474079075|FG001|Overall Study|Lost to Follow-up|5|||
131670774|NCT01191268|474079076|FG002|Overall Study|Lost to Follow-up|9|||
131670775|NCT01191268|474079074|FG000|Overall Study|Entry Criteria Not Met|3|||
131670776|NCT01191268|474079075|FG001|Overall Study|Entry Criteria Not Met|1|||
131670777|NCT01191268|474079076|FG002|Overall Study|Entry Criteria Not Met|1|||
131670778|NCT01191268|474079074|FG000|Overall Study|Death|0|||
131670779|NCT01191268|474079075|FG001|Overall Study|Death|1|||
131670780|NCT01191268|474079076|FG002|Overall Study|Death|3|||
131670781|NCT01191268|474079074|FG000|Overall Study|Protocol Violation|1|||
131670782|NCT01191268|474079075|FG001|Overall Study|Protocol Violation|0|||
131670783|NCT01191268|474079076|FG002|Overall Study|Protocol Violation|1|||
131670784|NCT01191268|474079074|FG000|Overall Study|Sponsor Decision|0|||
131670785|NCT01191268|474079075|FG001|Overall Study|Sponsor Decision|2|||
131670786|NCT01191268|474079076|FG002|Overall Study|Sponsor Decision|0|||
131670787|NCT02294227|474079081|FG000|Overall Study|Death|0|||
131670788|NCT02294227|474079082|FG001|Overall Study|Death|0|||
131670789|NCT02294227|474079083|FG002|Overall Study|Death|1|||
131670790|NCT02294227|474079081|FG000|Overall Study|Subject/Guardian Decision|6|||
131670791|NCT02294227|474079082|FG001|Overall Study|Subject/Guardian Decision|3|||
131670792|NCT02294227|474079083|FG002|Overall Study|Subject/Guardian Decision|7|||
131670793|NCT02294227|474079081|FG000|Overall Study|Physician Decision|1|||
131670794|NCT02294227|474079082|FG001|Overall Study|Physician Decision|2|||
131670795|NCT02294227|474079083|FG002|Overall Study|Physician Decision|1|||
131670796|NCT02294227|474079081|FG000|Overall Study|Lost to Follow-up|1|||
131670797|NCT02294227|474079082|FG001|Overall Study|Lost to Follow-up|0|||
131670798|NCT02294227|474079083|FG002|Overall Study|Lost to Follow-up|0|||
131670799|NCT02294227|474079081|FG000|Overall Study|Lack of Efficacy|11|||
131670800|NCT02294227|474079082|FG001|Overall Study|Lack of Efficacy|12|||
131670801|NCT02294227|474079083|FG002|Overall Study|Lack of Efficacy|8|||
131670802|NCT02294227|474079081|FG000|Overall Study|Adverse Event|6|||
131670803|NCT02294227|474079082|FG001|Overall Study|Adverse Event|8|||
131670804|NCT02294227|474079083|FG002|Overall Study|Adverse Event|2|||
131670805|NCT01768637|474079084|FG000|Overall Study|Lost to Follow-up|2|||
131670806|NCT01768637|474079085|FG001|Overall Study|Lost to Follow-up|7|||
131670807|NCT01768637|474079084|FG000|Overall Study|Difficult blood draw|1|||
131670808|NCT01768637|474079085|FG001|Overall Study|Difficult blood draw|0|||
131670809|NCT00899548|474079086|FG000|Overall Study|Physician Decision|3|||
131670810|NCT00511472|474079087|FG000|Overall Study|Clinical Adverse Event|1|||
131670811|NCT00511472|474079088|FG001|Overall Study|Clinical Adverse Event|2|||
131670812|NCT00511472|474079087|FG000|Overall Study|Laboratory Adverse Event|0|||
131670813|NCT00511472|474079088|FG001|Overall Study|Laboratory Adverse Event|2|||
131670814|NCT00511472|474079087|FG000|Overall Study|Not reported|2|||
131670815|NCT00511472|474079088|FG001|Overall Study|Not reported|2|||
131670816|NCT02709096|474079089|FG000|Overall Study|non-compliance|1|||
131670817|NCT02709096|474079090|FG001|Overall Study|non-compliance|1|||
131670818|NCT02427464|474079092|FG000|Overall Study|Adverse Event|6|||
131670819|NCT02427464|474079093|FG001|Overall Study|Adverse Event|1|||
131670820|NCT02427464|474079092|FG000|Overall Study|Lost to Follow-up|16|||
131670821|NCT02427464|474079093|FG001|Overall Study|Lost to Follow-up|5|||
131670822|NCT02427464|474079092|FG000|Overall Study|Physician Decision|2|||
131670823|NCT02427464|474079093|FG001|Overall Study|Physician Decision|0|||
131670824|NCT02427464|474079092|FG000|Overall Study|Withdrawal by Subject|10|||
131670825|NCT02427464|474079093|FG001|Overall Study|Withdrawal by Subject|8|||
131670826|NCT02427464|474079092|FG000|Overall Study|Noncompliance|16|||
131670827|NCT02427464|474079093|FG001|Overall Study|Noncompliance|10|||
131670828|NCT03164564|474079097|FG000|Overall Study|Death|3|||
131670829|NCT03164564|474079098|FG001|Overall Study|Death|0|||
131670830|NCT03164564|474079097|FG000|Overall Study|Withdrawal by Subject|20|||
131670831|NCT03164564|474079098|FG001|Overall Study|Withdrawal by Subject|15|||
131670832|NCT03164564|474079097|FG000|Overall Study|Lost to Follow-up|2|||
131670833|NCT03164564|474079098|FG001|Overall Study|Lost to Follow-up|0|||
131670834|NCT03164564|474079097|FG000|Overall Study|Physician Decision|0|||
131670835|NCT03164564|474079098|FG001|Overall Study|Physician Decision|1|||
131670836|NCT03164564|474079097|FG000|Overall Study|Adverse Event|0|||
131670837|NCT03164564|474079098|FG001|Overall Study|Adverse Event|1|||
131670838|NCT03164564|474079097|FG000|Overall Study|Ongoing|1586|||
131670839|NCT03164564|474079098|FG001|Overall Study|Ongoing|1586|||
131670840|NCT05959629|474079101|FG000|Overall Study|partially necrotic/technical issues|2|||
131670841|NCT05959629|474079102|FG001|Overall Study|partially necrotic/technical issues|2|||
131670842|NCT03573401|474079103|FG000|Overall Study|Withdrawal by Subject|2|||
131670843|NCT03573401|474079104|FG001|Overall Study|Withdrawal by Subject|0|||
131670844|NCT03573401|474079103|FG000|Overall Study|Subject non-compliance with study schedule|1|||
131670845|NCT03573401|474079104|FG001|Overall Study|Subject non-compliance with study schedule|0|||
131670846|NCT03573401|474079103|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
131670847|NCT03573401|474079104|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
131670848|NCT03573401|474079103|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
131670849|NCT03573401|474079104|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
131670850|NCT01328717|474080640|FG000|Overall Study|Adverse Event|1|||
131670851|NCT03440320|474080641|FG000|Overall Study|Withdrawal by Subject|0|||
131670852|NCT03440320|474080642|FG001|Overall Study|Withdrawal by Subject|1|||
131670853|NCT01912456|474080643|FG000|Period 1|Physician Decision|0|||
131670854|NCT01912456|474080644|FG001|Period 1|Physician Decision|0|||
131670855|NCT01912456|474080645|FG002|Period 1|Physician Decision|1|||
131670856|NCT01912456|474080646|FG003|Period 1|Physician Decision|0|||
131670857|NCT01912456|474080643|FG000|Period 1|non-compliance|1|||
131670858|NCT01912456|474080644|FG001|Period 1|non-compliance|0|||
131670859|NCT01912456|474080645|FG002|Period 1|non-compliance|0|||
131670860|NCT01912456|474080646|FG003|Period 1|non-compliance|1|||
131670861|NCT01912456|474080643|FG000|Period 1|Adverse Event|1|||
131670862|NCT01912456|474080644|FG001|Period 1|Adverse Event|0|||
131670863|NCT01912456|474080645|FG002|Period 1|Adverse Event|0|||
131670864|NCT01912456|474080646|FG003|Period 1|Adverse Event|1|||
131670865|NCT01912456|474080643|FG000|Period 1|Withdrawal by Subject|0|||
131670866|NCT01912456|474080644|FG001|Period 1|Withdrawal by Subject|1|||
131670867|NCT01912456|474080645|FG002|Period 1|Withdrawal by Subject|1|||
131670868|NCT01912456|474080646|FG003|Period 1|Withdrawal by Subject|1|||
131670869|NCT01912456|474080643|FG000|Period 2|Lack of Efficacy|0|||
131670870|NCT01912456|474080644|FG001|Period 2|Lack of Efficacy|2|||
131670871|NCT01912456|474080645|FG002|Period 2|Lack of Efficacy|0|||
131670872|NCT01912456|474080646|FG003|Period 2|Lack of Efficacy|0|||
131670873|NCT01912456|474080643|FG000|Period 2|Adverse Event|0|||
131670874|NCT01912456|474080644|FG001|Period 2|Adverse Event|0|||
131670875|NCT01912456|474080645|FG002|Period 2|Adverse Event|0|||
131670876|NCT01912456|474080646|FG003|Period 2|Adverse Event|1|||
131670877|NCT01201343|474080647|FG000|Overall Study|Adverse Event|6|||
131670878|NCT01201343|474080647|FG000|Overall Study|Withdrawal by Subject|5|||
131670879|NCT01201343|474080647|FG000|Overall Study|Lost to Follow-up|2|||
131670880|NCT01201343|474080647|FG000|Overall Study|Lack of Efficacy|2|||
131670881|NCT01201343|474080647|FG000|Overall Study|Participant wrongly included in trial|1|||
131670882|NCT01201343|474080647|FG000|Overall Study|Randomized, not treated|3|||
131670883|NCT00001962|474080648|FG000|Overall Study|Lack of Efficacy|18|||
131670884|NCT00001962|474080648|FG000|Overall Study|Lack of Accrual|6|||
131670885|NCT00001962|474080648|FG000|Overall Study|Death|1|||
131670886|NCT00001962|474080648|FG000|Overall Study|Lost to Follow-up|2|||
131670887|NCT00001962|474080648|FG000|Overall Study|Adverse Event|1|||
131670888|NCT01440374|474080649|FG000|Part 1: Open-label Phase|Adverse Event|5|||
131670889|NCT01440374|474080650|FG001|Part 1: Open-label Phase|Adverse Event|0|||
131670890|NCT01440374|474080651|FG002|Part 1: Open-label Phase|Adverse Event|0|||
131670891|NCT01440374|474080652|FG003|Part 1: Open-label Phase|Adverse Event|0|||
131670892|NCT01440374|474080649|FG000|Part 1: Open-label Phase|Physician Decision|1|||
131670893|NCT01440374|474080650|FG001|Part 1: Open-label Phase|Physician Decision|0|||
131670894|NCT01440374|474080651|FG002|Part 1: Open-label Phase|Physician Decision|0|||
131670895|NCT01440374|474080652|FG003|Part 1: Open-label Phase|Physician Decision|0|||
131670896|NCT01440374|474080649|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
131670897|NCT01440374|474080650|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
131670898|NCT01440374|474080651|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
131670899|NCT01440374|474080652|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
131670900|NCT01440374|474080649|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
131670901|NCT01440374|474080650|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
131670902|NCT01440374|474080651|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
131670903|NCT01440374|474080652|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
131670904|NCT01440374|474080649|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
131670905|NCT01440374|474080650|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
131670906|NCT01440374|474080651|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
131670907|NCT01440374|474080652|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
131670908|NCT01440374|474080649|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
131555200|NCT02769065|473658109|FG008|Overall Study|Reason Not Specified|0|||
131555201|NCT02769065|473658110|FG009|Overall Study|Reason Not Specified|0|||
131555202|NCT02769065|473658111|FG010|Overall Study|Reason Not Specified|0|||
131555203|NCT02769065|473658112|FG011|Overall Study|Reason Not Specified|0|||
131555204|NCT02769065|473658113|FG012|Overall Study|Reason Not Specified|0|||
131555205|NCT02769065|473658114|FG013|Overall Study|Reason Not Specified|0|||
131555206|NCT02769065|473658115|FG014|Overall Study|Reason Not Specified|0|||
131555207|NCT02769065|473658116|FG015|Overall Study|Reason Not Specified|0|||
131555208|NCT02769065|473658117|FG016|Overall Study|Reason Not Specified|0|||
131555209|NCT02769065|473658118|FG017|Overall Study|Reason Not Specified|0|||
131555210|NCT02769065|473658119|FG018|Overall Study|Reason Not Specified|0|||
131555211|NCT02769065|473658120|FG019|Overall Study|Reason Not Specified|0|||
131555212|NCT02769065|473658121|FG020|Overall Study|Reason Not Specified|0|||
131555213|NCT02769065|473658122|FG021|Overall Study|Reason Not Specified|0|||
131555214|NCT02769065|473658123|FG022|Overall Study|Reason Not Specified|0|||
131670909|NCT01440374|474080650|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
131670910|NCT01440374|474080651|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
131670911|NCT01440374|474080652|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
131670912|NCT01440374|474080649|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
131670913|NCT01440374|474080650|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
131670914|NCT01440374|474080651|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
131670915|NCT01440374|474080652|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
131670916|NCT01440374|474080649|FG000|Part 2; Double-blind Phase|Not treated|0|||
131670917|NCT01440374|474080650|FG001|Part 2; Double-blind Phase|Not treated|0|||
131670918|NCT01440374|474080651|FG002|Part 2; Double-blind Phase|Not treated|1|||
131670919|NCT01440374|474080652|FG003|Part 2; Double-blind Phase|Not treated|0|||
131670920|NCT01440374|474080649|FG000|Part 3: Extension|Withdrawal by Subject|0|||
131670921|NCT01440374|474080650|FG001|Part 3: Extension|Withdrawal by Subject|0|||
131670922|NCT01440374|474080651|FG002|Part 3: Extension|Withdrawal by Subject|0|||
131670923|NCT01440374|474080652|FG003|Part 3: Extension|Withdrawal by Subject|5|||
131670924|NCT01440374|474080649|FG000|Part 3: Extension|Adverse Event|0|||
131670925|NCT01440374|474080650|FG001|Part 3: Extension|Adverse Event|0|||
131670926|NCT01440374|474080651|FG002|Part 3: Extension|Adverse Event|0|||
131670927|NCT01440374|474080652|FG003|Part 3: Extension|Adverse Event|13|||
131670928|NCT01440374|474080649|FG000|Part 3: Extension|Physician Decision|0|||
131670929|NCT01440374|474080650|FG001|Part 3: Extension|Physician Decision|0|||
131670930|NCT01440374|474080651|FG002|Part 3: Extension|Physician Decision|0|||
131670931|NCT01440374|474080652|FG003|Part 3: Extension|Physician Decision|14|||
131670932|NCT01177722|474080659|FG000|Overall Study|Serious Adverse Event|0|||
131670933|NCT01177722|474080660|FG001|Overall Study|Serious Adverse Event|0|||
131670934|NCT01177722|474080661|FG002|Overall Study|Serious Adverse Event|1|||
131670935|NCT01177722|474080662|FG003|Overall Study|Serious Adverse Event|0|||
131670936|NCT01177722|474080659|FG000|Overall Study|Protocol Violation|0|||
131670937|NCT01177722|474080660|FG001|Overall Study|Protocol Violation|0|||
131670938|NCT01177722|474080661|FG002|Overall Study|Protocol Violation|1|||
131670939|NCT01177722|474080662|FG003|Overall Study|Protocol Violation|0|||
131670940|NCT01177722|474080659|FG000|Overall Study|Lost to Follow-up|3|||
131670941|NCT01177722|474080660|FG001|Overall Study|Lost to Follow-up|4|||
131670942|NCT01177722|474080661|FG002|Overall Study|Lost to Follow-up|3|||
131670943|NCT01177722|474080662|FG003|Overall Study|Lost to Follow-up|1|||
131670944|NCT01177722|474080659|FG000|Overall Study|Withdrawal by Subject|10|||
131670945|NCT01177722|474080660|FG001|Overall Study|Withdrawal by Subject|6|||
131670946|NCT01177722|474080661|FG002|Overall Study|Withdrawal by Subject|4|||
131670947|NCT01177722|474080662|FG003|Overall Study|Withdrawal by Subject|6|||
131670948|NCT03938545|474080663|FG000|Overall Study|Lost to Follow-up|0|||
131670949|NCT03938545|474080664|FG001|Overall Study|Lost to Follow-up|0|||
131670950|NCT03938545|474080665|FG002|Overall Study|Lost to Follow-up|0|||
131670951|NCT03938545|474080666|FG003|Overall Study|Lost to Follow-up|1|||
131670952|NCT03938545|474080663|FG000|Overall Study|Non-compliance with study drug|0|||
131670953|NCT03938545|474080664|FG001|Overall Study|Non-compliance with study drug|0|||
131670954|NCT03938545|474080665|FG002|Overall Study|Non-compliance with study drug|1|||
131670955|NCT03938545|474080666|FG003|Overall Study|Non-compliance with study drug|0|||
131670956|NCT03938545|474080663|FG000|Overall Study|Pregnancy|1|||
131670957|NCT03938545|474080664|FG001|Overall Study|Pregnancy|0|||
131670958|NCT03938545|474080665|FG002|Overall Study|Pregnancy|0|||
131670959|NCT03938545|474080666|FG003|Overall Study|Pregnancy|0|||
131670960|NCT03938545|474080663|FG000|Overall Study|Study terminated by sponsor|6|||
131670961|NCT03938545|474080664|FG001|Overall Study|Study terminated by sponsor|4|||
131670962|NCT03938545|474080665|FG002|Overall Study|Study terminated by sponsor|2|||
131670963|NCT03938545|474080666|FG003|Overall Study|Study terminated by sponsor|4|||
131670964|NCT03938545|474080663|FG000|Overall Study|Withdrawal by Subject|0|||
131670965|NCT03938545|474080664|FG001|Overall Study|Withdrawal by Subject|1|||
131670966|NCT03938545|474080665|FG002|Overall Study|Withdrawal by Subject|0|||
131670967|NCT03938545|474080666|FG003|Overall Study|Withdrawal by Subject|0|||
131670968|NCT03938545|474080663|FG000|Overall Study|Adverse Event|1|||
131670969|NCT03938545|474080664|FG001|Overall Study|Adverse Event|0|||
131670970|NCT03938545|474080665|FG002|Overall Study|Adverse Event|0|||
131670971|NCT03938545|474080666|FG003|Overall Study|Adverse Event|0|||
131670972|NCT01060540|474080667|FG000|Overall Study|Withdrawal by Subject|10|||
131670973|NCT01060540|474080668|FG001|Overall Study|Withdrawal by Subject|20|||
131670974|NCT01060540|474080667|FG000|Overall Study|Lost to Follow-up|52|||
131670975|NCT01060540|474080668|FG001|Overall Study|Lost to Follow-up|43|||
131670976|NCT01060540|474080667|FG000|Overall Study|Death|2|||
131670977|NCT01060540|474080668|FG001|Overall Study|Death|1|||
131670978|NCT01060540|474080667|FG000|Overall Study|Physician Decision|0|||
131670979|NCT01060540|474080668|FG001|Overall Study|Physician Decision|1|||
131670980|NCT01222507|474080669|FG000|Overall Study|Physician Decision|1|||
131670981|NCT01222507|474080669|FG000|Overall Study|Withdrawal by Subject|1|||
131670982|NCT02647320|474080670|FG000|Overall Study|Adverse Event|0|||
131670983|NCT02647320|474080671|FG001|Overall Study|Adverse Event|1|||
131670984|NCT02647320|474080672|FG002|Overall Study|Adverse Event|3|||
131670985|NCT02647320|474080673|FG003|Overall Study|Adverse Event|2|||
131670986|NCT02647320|474080674|FG004|Overall Study|Adverse Event|1|||
131670987|NCT02647320|474080670|FG000|Overall Study|Protocol Violation|0|||
131670988|NCT02647320|474080671|FG001|Overall Study|Protocol Violation|0|||
131670989|NCT02647320|474080672|FG002|Overall Study|Protocol Violation|3|||
131670990|NCT02647320|474080673|FG003|Overall Study|Protocol Violation|0|||
131670991|NCT02647320|474080674|FG004|Overall Study|Protocol Violation|0|||
131670992|NCT02647320|474080670|FG000|Overall Study|Withdrawal by Subject|7|||
131670993|NCT02647320|474080671|FG001|Overall Study|Withdrawal by Subject|4|||
131670994|NCT02647320|474080672|FG002|Overall Study|Withdrawal by Subject|2|||
131670995|NCT02647320|474080673|FG003|Overall Study|Withdrawal by Subject|2|||
131670996|NCT02647320|474080674|FG004|Overall Study|Withdrawal by Subject|7|||
131670997|NCT02647320|474080670|FG000|Overall Study|Persistent hyperglycemia|0|||
131670998|NCT02647320|474080671|FG001|Overall Study|Persistent hyperglycemia|1|||
131670999|NCT02647320|474080672|FG002|Overall Study|Persistent hyperglycemia|1|||
131671000|NCT02647320|474080673|FG003|Overall Study|Persistent hyperglycemia|1|||
131671001|NCT02647320|474080674|FG004|Overall Study|Persistent hyperglycemia|1|||
131671002|NCT02647320|474080670|FG000|Overall Study|Study terminated by sponsor|1|||
131671003|NCT02647320|474080671|FG001|Overall Study|Study terminated by sponsor|1|||
131671004|NCT02647320|474080672|FG002|Overall Study|Study terminated by sponsor|1|||
131671005|NCT02647320|474080673|FG003|Overall Study|Study terminated by sponsor|1|||
131671006|NCT02647320|474080674|FG004|Overall Study|Study terminated by sponsor|2|||
131671007|NCT02647320|474080670|FG000|Overall Study|Reason not provided|0|||
131671008|NCT02647320|474080671|FG001|Overall Study|Reason not provided|0|||
131671009|NCT02647320|474080672|FG002|Overall Study|Reason not provided|1|||
131671010|NCT02647320|474080673|FG003|Overall Study|Reason not provided|0|||
131671011|NCT02647320|474080674|FG004|Overall Study|Reason not provided|2|||
131671012|NCT02647320|474080670|FG000|Overall Study|Lost to Follow-up|1|||
131671013|NCT02647320|474080671|FG001|Overall Study|Lost to Follow-up|1|||
131671014|NCT02647320|474080672|FG002|Overall Study|Lost to Follow-up|0|||
131671015|NCT02647320|474080673|FG003|Overall Study|Lost to Follow-up|0|||
131671016|NCT02647320|474080674|FG004|Overall Study|Lost to Follow-up|0|||
131671017|NCT02647320|474080670|FG000|Overall Study|Develop anemia|1|||
131671018|NCT02647320|474080671|FG001|Overall Study|Develop anemia|0|||
131671019|NCT02647320|474080672|FG002|Overall Study|Develop anemia|0|||
131671020|NCT02647320|474080673|FG003|Overall Study|Develop anemia|0|||
131671021|NCT02647320|474080674|FG004|Overall Study|Develop anemia|0|||
131671022|NCT02647320|474080670|FG000|Overall Study|Lack of Efficacy|0|||
131671023|NCT02647320|474080671|FG001|Overall Study|Lack of Efficacy|0|||
131671024|NCT02647320|474080672|FG002|Overall Study|Lack of Efficacy|0|||
131671025|NCT02647320|474080673|FG003|Overall Study|Lack of Efficacy|1|||
131671026|NCT02647320|474080674|FG004|Overall Study|Lack of Efficacy|0|||
131671027|NCT02647320|474080670|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
131671028|NCT02647320|474080671|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
131435970|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
131435971|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
131435972|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
131435973|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
131671029|NCT02647320|474080672|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
131671030|NCT02647320|474080673|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
131671031|NCT02647320|474080674|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
131435974|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
131435975|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
131435976|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
131435977|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
131671032|NCT00596427|474080678|FG000|Overall Study|Withdrawal by Subject|2|||
131671033|NCT00596427|474080679|FG001|Overall Study|Withdrawal by Subject|2|||
131671034|NCT00596427|474080678|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
131671035|NCT00596427|474080679|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
131435978|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
131435979|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
131671036|NCT00596427|474080678|FG000|Overall Study|Protocol Violation|1|||
131671037|NCT00596427|474080679|FG001|Overall Study|Protocol Violation|0|||
131671038|NCT00320541|474080680|FG000|Overall Study|Adverse Event|21|||
131671039|NCT00320541|474080681|FG001|Overall Study|Adverse Event|19|||
131671040|NCT00320541|474080680|FG000|Overall Study|Protocol Violation|0|||
131671041|NCT00320541|474080681|FG001|Overall Study|Protocol Violation|1|||
131671042|NCT00320541|474080680|FG000|Overall Study|Withdrawal by Subject|12|||
131671043|NCT00320541|474080681|FG001|Overall Study|Withdrawal by Subject|16|||
131671044|NCT00320541|474080680|FG000|Overall Study|Physician Decision|9|||
131671045|NCT00320541|474080681|FG001|Overall Study|Physician Decision|13|||
131671046|NCT00320541|474080680|FG000|Overall Study|Other|3|||
131671047|NCT00320541|474080681|FG001|Overall Study|Other|4|||
131671048|NCT00320541|474080680|FG000|Overall Study|Sponsor Decision|2|||
131671049|NCT00320541|474080681|FG001|Overall Study|Sponsor Decision|1|||
131671050|NCT00320541|474080680|FG000|Overall Study|Death due to Study Disease|1|||
131671051|NCT00320541|474080681|FG001|Overall Study|Death due to Study Disease|3|||
131671052|NCT00320541|474080680|FG000|Overall Study|Death due to Adverse Event(s)|1|||
131671053|NCT00320541|474080681|FG001|Overall Study|Death due to Adverse Event(s)|0|||
131671054|NCT00320541|474080680|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
131671055|NCT00320541|474080681|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
131671056|NCT03057977|474080684|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
131671057|NCT03057977|474080685|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
131671058|NCT03057977|474080684|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
131671059|NCT03057977|474080685|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
131671060|NCT03057977|474080684|FG000|Discontinuation From Treatment|Protocol Violation|6|||
131671061|NCT03057977|474080685|FG001|Discontinuation From Treatment|Protocol Violation|5|||
131671062|NCT03057977|474080684|FG000|Discontinuation From Treatment|Not treated|4|||
131671063|NCT03057977|474080685|FG001|Discontinuation From Treatment|Not treated|0|||
131671064|NCT03057977|474080684|FG000|Discontinuation From Treatment|Adverse Event|343|||
131671065|NCT03057977|474080685|FG001|Discontinuation From Treatment|Adverse Event|337|||
131671066|NCT03057977|474080684|FG000|Discontinuation From Treatment|Reason Unknown|0|||
131671067|NCT03057977|474080685|FG001|Discontinuation From Treatment|Reason Unknown|1|||
131671068|NCT03057977|474080684|FG000|Discontinuation From Treatment|Personal Reasons|1|||
131671069|NCT03057977|474080685|FG001|Discontinuation From Treatment|Personal Reasons|1|||
131671070|NCT03057977|474080684|FG000|Discontinuation From Treatment|Unblinded medication|1|||
131671071|NCT03057977|474080685|FG001|Discontinuation From Treatment|Unblinded medication|0|||
131671072|NCT03057977|474080684|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
131671073|NCT03057977|474080685|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
131671074|NCT03057977|474080684|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
131671075|NCT03057977|474080685|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
131671076|NCT03057977|474080684|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
131671077|NCT03057977|474080685|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
131671078|NCT03057977|474080684|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
131671079|NCT03057977|474080685|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
131671080|NCT03057977|474080684|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
131671081|NCT03057977|474080685|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
131671082|NCT03057977|474080684|FG000|Discontinuation From Treatment|Not attending study visit|3|||
131671083|NCT03057977|474080685|FG001|Discontinuation From Treatment|Not attending study visit|10|||
131671084|NCT03057977|474080684|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
131671085|NCT03057977|474080685|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
131671086|NCT03057977|474080684|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
131671087|NCT03057977|474080685|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
131671088|NCT03057977|474080684|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
131671089|NCT03057977|474080685|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
131671090|NCT03057977|474080684|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
131671091|NCT03057977|474080685|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
131671092|NCT03057977|474080684|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
131671093|NCT03057977|474080685|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
131671094|NCT02401867|474080688|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
131671095|NCT02401867|474080688|FG000|Analysis|Cervical assay could not be conducted|9|||
131671096|NCT01650246|474080689|FG000|Overall Study|Adverse Event|23|||
131671097|NCT01650246|474080689|FG000|Overall Study|Protocol Violation|5|||
131671098|NCT01650246|474080689|FG000|Overall Study|Sponsor terminated study|53|||
131671099|NCT01650246|474080689|FG000|Overall Study|Lost to Follow-up|5|||
131671100|NCT01650246|474080689|FG000|Overall Study|Withdrawal by Subject|26|||
131671101|NCT01650246|474080689|FG000|Overall Study|Death|1|||
131671102|NCT01650246|474080689|FG000|Overall Study|Lack of Efficacy|30|||
131671103|NCT00953407|474080690|FG000|Overall Study|Failed inclusion criteria|1|||
131671104|NCT00953407|474080691|FG001|Overall Study|Failed inclusion criteria|1|||
131671105|NCT00953407|474080692|FG002|Overall Study|Failed inclusion criteria|1|||
131671106|NCT00953407|474080693|FG003|Overall Study|Failed inclusion criteria|1|||
131671107|NCT00953407|474080694|FG004|Overall Study|Failed inclusion criteria|1|||
131671108|NCT00953407|474080690|FG000|Overall Study|Lost to Follow-up|0|||
131671109|NCT00953407|474080691|FG001|Overall Study|Lost to Follow-up|0|||
131671110|NCT00953407|474080692|FG002|Overall Study|Lost to Follow-up|0|||
131671111|NCT00953407|474080693|FG003|Overall Study|Lost to Follow-up|1|||
131671112|NCT00953407|474080694|FG004|Overall Study|Lost to Follow-up|0|||
131671113|NCT03435497|474080696|FG000|Overall Study|Lost to Follow-up|1|||
131671114|NCT03435497|474080697|FG001|Overall Study|Lost to Follow-up|0|||
131671115|NCT03435497|474080696|FG000|Overall Study|Death|1|||
131671116|NCT03435497|474080697|FG001|Overall Study|Death|0|||
131671117|NCT03435497|474080696|FG000|Overall Study|Withdrawal by Subject|0|||
131671118|NCT03435497|474080697|FG001|Overall Study|Withdrawal by Subject|4|||
131671119|NCT03435497|474080696|FG000|Overall Study|Wrong survey administered|0|||
131671120|NCT03435497|474080697|FG001|Overall Study|Wrong survey administered|2|||
131671121|NCT02795429|474080699|FG000|Overall Study|Adverse Event|1|||
131671122|NCT02795429|474080700|FG001|Overall Study|Adverse Event|2|||
131671123|NCT02795429|474080701|FG002|Overall Study|Adverse Event|1|||
131671124|NCT02795429|474080702|FG003|Overall Study|Adverse Event|2|||
131671125|NCT02795429|474080703|FG004|Overall Study|Adverse Event|1|||
131671126|NCT02795429|474080699|FG000|Overall Study|Death|1|||
131671127|NCT02795429|474080700|FG001|Overall Study|Death|0|||
131671128|NCT02795429|474080701|FG002|Overall Study|Death|1|||
131671129|NCT02795429|474080702|FG003|Overall Study|Death|2|||
131671130|NCT02795429|474080703|FG004|Overall Study|Death|1|||
131671131|NCT02795429|474080699|FG000|Overall Study|Physician Decision|0|||
131671132|NCT02795429|474080700|FG001|Overall Study|Physician Decision|0|||
131671133|NCT02795429|474080701|FG002|Overall Study|Physician Decision|2|||
131671134|NCT02795429|474080702|FG003|Overall Study|Physician Decision|1|||
131671135|NCT02795429|474080703|FG004|Overall Study|Physician Decision|5|||
131671136|NCT02795429|474080699|FG000|Overall Study|Progressive disease|3|||
131671137|NCT02795429|474080700|FG001|Overall Study|Progressive disease|7|||
131671138|NCT02795429|474080701|FG002|Overall Study|Progressive disease|6|||
131671139|NCT02795429|474080702|FG003|Overall Study|Progressive disease|26|||
131671140|NCT02795429|474080703|FG004|Overall Study|Progressive disease|20|||
131671141|NCT02795429|474080699|FG000|Overall Study|Subject/guardian decision|1|||
131671142|NCT02795429|474080700|FG001|Overall Study|Subject/guardian decision|1|||
131671143|NCT02795429|474080701|FG002|Overall Study|Subject/guardian decision|1|||
131671144|NCT02795429|474080702|FG003|Overall Study|Subject/guardian decision|1|||
131671145|NCT02795429|474080703|FG004|Overall Study|Subject/guardian decision|3|||
131671146|NCT00701779|474080704|FG000|Overall Study|Adverse Event|6|||
131671147|NCT00701779|474080704|FG000|Overall Study|Lost to Follow-up|1|||
131671148|NCT00701779|474080704|FG000|Overall Study|Withdrawal by Subject|2|||
131671149|NCT03645057|474080705|FG000|Randomization to Baseline|Lost to Follow-up|1|||
131671150|NCT03645057|474080706|FG001|Randomization to Baseline|Lost to Follow-up|0|||
131671151|NCT03645057|474080707|FG002|Randomization to Baseline|Lost to Follow-up|1|||
131671152|NCT03645057|474080708|FG003|Randomization to Baseline|Lost to Follow-up|0|||
131671153|NCT03645057|474080705|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
131671154|NCT03645057|474080706|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
131671155|NCT03645057|474080707|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
131671156|NCT03645057|474080708|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
131671157|NCT03645057|474080705|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
131671158|NCT03645057|474080706|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
131671159|NCT03645057|474080707|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
131671160|NCT03645057|474080708|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
131671161|NCT03645057|474080705|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
131671162|NCT03645057|474080706|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
131671163|NCT03645057|474080707|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
131671164|NCT03645057|474080708|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
131671165|NCT01873495|474080709|FG000|Overall Study|Withdrawal by Subject|1|||
131671166|NCT01873495|474080709|FG000|Overall Study|Physician Decision|3|||
131671167|NCT01873495|474080709|FG000|Overall Study|Adverse Event|1|||
131671168|NCT01873495|474080709|FG000|Overall Study|Removed for Transplantation|1|||
131671169|NCT01873495|474080709|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
131671170|NCT01206777|474080710|FG000|Overall Study|Death|1|||
131671171|NCT01206777|474080710|FG000|Overall Study|Adverse Event|1|||
131671172|NCT02080221|474080711|FG000|Overall Study|Withdrawal by Subject|1|||
131671173|NCT02080221|474080711|FG000|Overall Study|Clinical Progression of Disease|1|||
131671174|NCT00842985|474080716|FG000|Screening|Did not meet entrance requirements|27|||
131671175|NCT00842985|474080716|FG000|First Intervention|Withdrawal by Subject|3|||
131671176|NCT00842985|474080716|FG000|First Intervention|Protocol Violation|3|||
131671177|NCT00842985|474080716|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
131671178|NCT00842985|474080716|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
131671179|NCT02745392|474080723|FG000|Overall Study|Lost to Follow-up|0|||
131671180|NCT02745392|474080724|FG001|Overall Study|Lost to Follow-up|1|||
131671181|NCT02745392|474080725|FG002|Overall Study|Lost to Follow-up|0|||
131671182|NCT02745392|474080726|FG003|Overall Study|Lost to Follow-up|0|||
131671183|NCT01691768|474080727|FG000|Overall Study|Death|0|||
131671184|NCT01691768|474080728|FG001|Overall Study|Death|2|||
131671185|NCT01691768|474080727|FG000|Overall Study|Lost to Follow-up|4|||
131671186|NCT01691768|474080728|FG001|Overall Study|Lost to Follow-up|3|||
131671187|NCT01691768|474080727|FG000|Overall Study|Withdrawal by Subject|10|||
131671188|NCT01691768|474080728|FG001|Overall Study|Withdrawal by Subject|9|||
131671189|NCT01691768|474080727|FG000|Overall Study|Relocated|0|||
131671190|NCT01691768|474080728|FG001|Overall Study|Relocated|1|||
131671191|NCT01691768|474080727|FG000|Overall Study|Investigator decision|1|||
131671192|NCT01691768|474080728|FG001|Overall Study|Investigator decision|1|||
131671193|NCT01959334|474080729|FG000|Second Dose|Adverse Event|1|||
131671194|NCT01959334|474080730|FG001|Second Dose|Adverse Event|0|||
131671195|NCT01959334|474080729|FG000|Third Dose|Adverse Event|0|||
131671196|NCT01959334|474080730|FG001|Third Dose|Adverse Event|1|||
131671197|NCT00887432|474080731|FG000|Overall Study|Start Excluded Therapy|3|||
131671198|NCT00887432|474080732|FG001|Overall Study|Start Excluded Therapy|0|||
131671199|NCT00887432|474080731|FG000|Overall Study|Did not complete treatment|6|||
131671200|NCT00887432|474080732|FG001|Overall Study|Did not complete treatment|8|||
131671201|NCT00887432|474080731|FG000|Overall Study|Protocol Violation|2|||
131671202|NCT00887432|474080732|FG001|Overall Study|Protocol Violation|3|||
131671203|NCT00887432|474080731|FG000|Overall Study|Withdrawal by Subject|3|||
131671204|NCT00887432|474080732|FG001|Overall Study|Withdrawal by Subject|2|||
131671205|NCT00887432|474080731|FG000|Overall Study|Lost to Follow-up|1|||
131671206|NCT00887432|474080732|FG001|Overall Study|Lost to Follow-up|0|||
131671207|NCT00887432|474080731|FG000|Overall Study|No reason provided|0|||
131671208|NCT00887432|474080732|FG001|Overall Study|No reason provided|1|||
131671209|NCT04781387|474080733|FG000|Overall Study|Withdrawal by Subject|1|||
131671210|NCT04781387|474080734|FG001|Overall Study|Withdrawal by Subject|0|||
131671211|NCT04781387|474080735|FG002|Overall Study|Withdrawal by Subject|1|||
131671212|NCT04781387|474080733|FG000|Overall Study|Lost to Follow-up|1|||
131671213|NCT04781387|474080734|FG001|Overall Study|Lost to Follow-up|0|||
131671214|NCT04781387|474080735|FG002|Overall Study|Lost to Follow-up|0|||
131671215|NCT01636960|474080736|FG000|Induction Phase|Adverse Event|2|||
131671216|NCT01636960|474080736|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
131671217|NCT01636960|474080736|FG000|Maintenance Phase|Adverse Event|3|||
131671218|NCT01636960|474080736|FG000|Maintenance Phase|Progressive disease|1|||
131671219|NCT01209780|474080739|FG000|Overall Study|Adverse Event|0|||
131671220|NCT01209780|474080740|FG001|Overall Study|Adverse Event|1|||
131671221|NCT01209780|474080741|FG002|Overall Study|Adverse Event|0|||
131671222|NCT01209780|474080742|FG003|Overall Study|Adverse Event|0|||
131671223|NCT01209780|474080743|FG004|Overall Study|Adverse Event|0|||
131671224|NCT01209780|474080739|FG000|Overall Study|Withdrawal by Subject|9|||
131671225|NCT01209780|474080740|FG001|Overall Study|Withdrawal by Subject|2|||
131671226|NCT01209780|474080741|FG002|Overall Study|Withdrawal by Subject|1|||
131671227|NCT01209780|474080742|FG003|Overall Study|Withdrawal by Subject|1|||
131671228|NCT01209780|474080743|FG004|Overall Study|Withdrawal by Subject|0|||
131671229|NCT01209780|474080739|FG000|Overall Study|Lost to Follow-up|17|||
131671230|NCT01209780|474080740|FG001|Overall Study|Lost to Follow-up|12|||
131671231|NCT01209780|474080741|FG002|Overall Study|Lost to Follow-up|3|||
131671232|NCT01209780|474080742|FG003|Overall Study|Lost to Follow-up|9|||
131671233|NCT01209780|474080743|FG004|Overall Study|Lost to Follow-up|4|||
131671234|NCT01209780|474080739|FG000|Overall Study|Protocol Violation|0|||
131671235|NCT01209780|474080740|FG001|Overall Study|Protocol Violation|1|||
131671236|NCT01209780|474080741|FG002|Overall Study|Protocol Violation|0|||
131671237|NCT01209780|474080742|FG003|Overall Study|Protocol Violation|0|||
131671238|NCT01209780|474080743|FG004|Overall Study|Protocol Violation|0|||
131671239|NCT01209780|474080739|FG000|Overall Study|Inappropriate enrollment|0|||
131671240|NCT01209780|474080740|FG001|Overall Study|Inappropriate enrollment|2|||
131671241|NCT01209780|474080741|FG002|Overall Study|Inappropriate enrollment|0|||
131671242|NCT01209780|474080742|FG003|Overall Study|Inappropriate enrollment|0|||
131671243|NCT01209780|474080743|FG004|Overall Study|Inappropriate enrollment|1|||
131671244|NCT00505284|474080749|FG000|Overall Study|Adverse Event|3|||
131671245|NCT00505284|474080750|FG001|Overall Study|Adverse Event|7|||
131671246|NCT00505284|474080751|FG002|Overall Study|Adverse Event|9|||
131671247|NCT00505284|474080752|FG003|Overall Study|Adverse Event|14|||
131671248|NCT00505284|474080753|FG004|Overall Study|Adverse Event|22|||
131671249|NCT00505284|474080749|FG000|Overall Study|Protocol Violation|0|||
131671250|NCT00505284|474080750|FG001|Overall Study|Protocol Violation|1|||
131671251|NCT00505284|474080751|FG002|Overall Study|Protocol Violation|1|||
131671252|NCT00505284|474080752|FG003|Overall Study|Protocol Violation|0|||
131671253|NCT00505284|474080753|FG004|Overall Study|Protocol Violation|0|||
131671254|NCT00505284|474080749|FG000|Overall Study|Withdrawal by Subject|2|||
131671255|NCT00505284|474080750|FG001|Overall Study|Withdrawal by Subject|6|||
131671256|NCT00505284|474080751|FG002|Overall Study|Withdrawal by Subject|1|||
131671257|NCT00505284|474080752|FG003|Overall Study|Withdrawal by Subject|0|||
131671258|NCT00505284|474080753|FG004|Overall Study|Withdrawal by Subject|6|||
131671259|NCT00505284|474080749|FG000|Overall Study|Lack of Efficacy|0|||
131671260|NCT00505284|474080750|FG001|Overall Study|Lack of Efficacy|1|||
131671261|NCT00505284|474080751|FG002|Overall Study|Lack of Efficacy|1|||
131671262|NCT00505284|474080752|FG003|Overall Study|Lack of Efficacy|1|||
131671263|NCT00505284|474080753|FG004|Overall Study|Lack of Efficacy|1|||
131671264|NCT00505284|474080749|FG000|Overall Study|Physician Decision|0|||
131671265|NCT00505284|474080750|FG001|Overall Study|Physician Decision|1|||
131671266|NCT00505284|474080751|FG002|Overall Study|Physician Decision|0|||
131671267|NCT00505284|474080752|FG003|Overall Study|Physician Decision|0|||
131671268|NCT00505284|474080753|FG004|Overall Study|Physician Decision|0|||
131671269|NCT00505284|474080749|FG000|Overall Study|Other|5|||
131671270|NCT00505284|474080750|FG001|Overall Study|Other|0|||
131671271|NCT00505284|474080751|FG002|Overall Study|Other|0|||
131671272|NCT00505284|474080752|FG003|Overall Study|Other|4|||
131671273|NCT00505284|474080753|FG004|Overall Study|Other|4|||
131671274|NCT01275131|474080754|FG000|Period 1|Withdrawal by Subject|1|||
131671275|NCT01275131|474080755|FG001|Period 1|Withdrawal by Subject|0|||
131671276|NCT01275131|474080756|FG002|Period 1|Withdrawal by Subject|3|||
131671277|NCT01275131|474080757|FG003|Period 1|Withdrawal by Subject|2|||
131671278|NCT01275131|474080754|FG000|Period 1|Physician Decision|1|||
131671279|NCT01275131|474080755|FG001|Period 1|Physician Decision|0|||
131671280|NCT01275131|474080756|FG002|Period 1|Physician Decision|0|||
131671281|NCT01275131|474080757|FG003|Period 1|Physician Decision|0|||
131671282|NCT01275131|474080754|FG000|Period 2 (Crossover)|Adverse Event|0|||
131671283|NCT01275131|474080755|FG001|Period 2 (Crossover)|Adverse Event|1|||
131671284|NCT01275131|474080756|FG002|Period 2 (Crossover)|Adverse Event|0|||
131671285|NCT01275131|474080757|FG003|Period 2 (Crossover)|Adverse Event|0|||
131671286|NCT01275131|474080754|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
131671287|NCT01275131|474080755|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
131671288|NCT01275131|474080756|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
131671289|NCT01275131|474080757|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
131671290|NCT00731120|474080758|FG000|Overall Study|Adverse Event|7|||
131671291|NCT00731120|474080759|FG001|Overall Study|Adverse Event|6|||
131671292|NCT00731120|474080760|FG002|Overall Study|Adverse Event|8|||
131671293|NCT00731120|474080758|FG000|Overall Study|Lack of Efficacy|4|||
131671294|NCT00731120|474080759|FG001|Overall Study|Lack of Efficacy|5|||
131671295|NCT00731120|474080760|FG002|Overall Study|Lack of Efficacy|4|||
131671296|NCT00731120|474080758|FG000|Overall Study|Noncompliance with Study Drug|3|||
131671297|NCT00731120|474080759|FG001|Overall Study|Noncompliance with Study Drug|3|||
131671298|NCT00731120|474080760|FG002|Overall Study|Noncompliance with Study Drug|1|||
131671299|NCT00731120|474080758|FG000|Overall Study|Protocol Deviations|1|||
131671300|NCT00731120|474080759|FG001|Overall Study|Protocol Deviations|6|||
131671301|NCT00731120|474080760|FG002|Overall Study|Protocol Deviations|1|||
131671302|NCT00731120|474080758|FG000|Overall Study|Withdrawal of Consent|13|||
131671303|NCT00731120|474080759|FG001|Overall Study|Withdrawal of Consent|8|||
131671304|NCT00731120|474080760|FG002|Overall Study|Withdrawal of Consent|4|||
131671305|NCT00731120|474080758|FG000|Overall Study|Lost to Follow-up|10|||
131671306|NCT00731120|474080759|FG001|Overall Study|Lost to Follow-up|15|||
131671307|NCT00731120|474080760|FG002|Overall Study|Lost to Follow-up|17|||
131671308|NCT00731120|474080758|FG000|Overall Study|Other|4|||
131671309|NCT00731120|474080759|FG001|Overall Study|Other|0|||
131671310|NCT00731120|474080760|FG002|Overall Study|Other|1|||
131671311|NCT02434939|474080764|FG000|Overall Study|Lack of Efficacy|34|||
131671312|NCT02434939|474080765|FG001|Overall Study|Lack of Efficacy|48|||
131671313|NCT02434939|474080764|FG000|Overall Study|Withdrawal by Subject|3|||
131671314|NCT02434939|474080765|FG001|Overall Study|Withdrawal by Subject|0|||
131671315|NCT02434939|474080764|FG000|Overall Study|Adverse Event|0|||
131671316|NCT02434939|474080765|FG001|Overall Study|Adverse Event|1|||
131671317|NCT00069238|474080768|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
131671318|NCT00069238|474080769|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
131671319|NCT00069238|474080770|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
131671320|NCT00069238|474080768|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
131671321|NCT00069238|474080769|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
131671322|NCT00069238|474080770|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
131671323|NCT00069238|474080768|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
131671324|NCT00069238|474080769|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
131671325|NCT00069238|474080770|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
131671326|NCT01001832|474080771|FG000|Short-term Period|Adverse Event|2|||
131671327|NCT01001832|474080772|FG001|Short-term Period|Adverse Event|3|||
131671328|NCT01001832|474080771|FG000|Long-term Period|Adverse Event|2|||
131671329|NCT01001832|474080772|FG001|Long-term Period|Adverse Event|1|||
131671330|NCT01001832|474080771|FG000|Long-term Period|Withdrawal by Subject|1|||
131671331|NCT01001832|474080772|FG001|Long-term Period|Withdrawal by Subject|0|||
131671332|NCT01001832|474080771|FG000|Long-term Period|Lack of Efficacy|0|||
131671333|NCT01001832|474080772|FG001|Long-term Period|Lack of Efficacy|2|||
131671334|NCT01001832|474080771|FG000|Long-term Period|Other|1|||
131671335|NCT01001832|474080772|FG001|Long-term Period|Other|2|||
131671336|NCT01001832|474080771|FG000|Follow-up Period|Withdrawal by Subject|1|||
131671337|NCT01001832|474080772|FG001|Follow-up Period|Withdrawal by Subject|0|||
131671338|NCT01001832|474080771|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
131671339|NCT01001832|474080772|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
131671340|NCT01001832|474080771|FG000|Follow-up Period|Other|2|||
131671341|NCT01001832|474080772|FG001|Follow-up Period|Other|1|||
131671342|NCT01575028|474080779|FG000|Overall Study|Physician Decision|0|||
131671343|NCT01575028|474080780|FG001|Overall Study|Physician Decision|1|||
131671344|NCT03442985|474081953|FG000|Overall Study|Sponsor Request|55|||
131671345|NCT03442985|474081954|FG001|Overall Study|Sponsor Request|60|||
131671346|NCT03442985|474081955|FG002|Overall Study|Sponsor Request|54|||
131671347|NCT03442985|474081953|FG000|Overall Study|Lost to Follow-up|5|||
131671348|NCT03442985|474081954|FG001|Overall Study|Lost to Follow-up|2|||
131671349|NCT03442985|474081955|FG002|Overall Study|Lost to Follow-up|7|||
131671350|NCT03442985|474081953|FG000|Overall Study|Withdrawal by Subject|2|||
131671351|NCT03442985|474081954|FG001|Overall Study|Withdrawal by Subject|3|||
131671352|NCT03442985|474081955|FG002|Overall Study|Withdrawal by Subject|4|||
131671353|NCT03442985|474081953|FG000|Overall Study|Adverse Event|0|||
131671354|NCT03442985|474081954|FG001|Overall Study|Adverse Event|1|||
131671355|NCT03442985|474081955|FG002|Overall Study|Adverse Event|0|||
131671356|NCT01716117|474081956|FG000|Overall Study|Death|5|||
131671357|NCT01716117|474081957|FG001|Overall Study|Death|2|||
131671358|NCT01716117|474081956|FG000|Overall Study|Withdrawal by Subject|2|||
131671359|NCT01716117|474081957|FG001|Overall Study|Withdrawal by Subject|0|||
131671360|NCT01386788|474081963|FG000|Overall Study|Lost to Follow-up|2|||
131671361|NCT02986334|474081966|FG000|Overall Study|Withdrawal by Subject|0|||
131671362|NCT02986334|474081967|FG001|Overall Study|Withdrawal by Subject|1|||
131671363|NCT02986334|474081968|FG002|Overall Study|Withdrawal by Subject|2|||
131671364|NCT02986334|474081966|FG000|Overall Study|Lost to Follow-up|1|||
131671365|NCT02986334|474081967|FG001|Overall Study|Lost to Follow-up|2|||
131671366|NCT02986334|474081968|FG002|Overall Study|Lost to Follow-up|1|||
131671367|NCT02986334|474081966|FG000|Overall Study|Adverse Event|0|||
131671368|NCT02986334|474081967|FG001|Overall Study|Adverse Event|2|||
131671369|NCT02986334|474081968|FG002|Overall Study|Adverse Event|1|||
131671370|NCT02986334|474081966|FG000|Overall Study|non compliance in phone ratings|2|||
131671371|NCT02986334|474081967|FG001|Overall Study|non compliance in phone ratings|1|||
131671372|NCT02986334|474081968|FG002|Overall Study|non compliance in phone ratings|2|||
131671373|NCT02986334|474081966|FG000|Overall Study|undisclosed comorbidities|0|||
131671374|NCT02986334|474081967|FG001|Overall Study|undisclosed comorbidities|1|||
131671375|NCT02986334|474081968|FG002|Overall Study|undisclosed comorbidities|1|||
131671376|NCT00120406|474081969|FG000|Overall Study|Death|9|||
131671377|NCT00120406|474081970|FG001|Overall Study|Death|4|||
131671378|NCT00120406|474081969|FG000|Overall Study|Withdrawal by Subject|5|||
131671379|NCT00120406|474081970|FG001|Overall Study|Withdrawal by Subject|7|||
131671380|NCT00120406|474081969|FG000|Overall Study|Lost to Follow-up|5|||
131671381|NCT00120406|474081970|FG001|Overall Study|Lost to Follow-up|2|||
131671382|NCT00120406|474081969|FG000|Overall Study|received non-study stent|0|||
131671383|NCT00120406|474081970|FG001|Overall Study|received non-study stent|2|||
131671384|NCT00120406|474081969|FG000|Overall Study|patient moved but has not withdrawn|0|||
131671385|NCT00120406|474081970|FG001|Overall Study|patient moved but has not withdrawn|1|||
131671386|NCT01295034|474081971|FG000|Overall Study|Lost to Follow-up|5|||
131671387|NCT01295034|474081972|FG001|Overall Study|Lost to Follow-up|5|||
131671388|NCT03818204|474081973|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671389|NCT03818204|474081974|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671390|NCT03818204|474081975|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671391|NCT03818204|474081976|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671392|NCT03818204|474081977|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
131671393|NCT03818204|474081978|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671394|NCT03818204|474081979|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671395|NCT03818204|474081980|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671396|NCT03818204|474081981|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671397|NCT03818204|474081982|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671398|NCT03818204|474081983|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671399|NCT03818204|474081984|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671400|NCT03818204|474081985|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671401|NCT03818204|474081986|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
131671402|NCT03818204|474081987|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671403|NCT03818204|474081988|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671404|NCT03818204|474081989|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671405|NCT03818204|474081990|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671406|NCT03818204|474081991|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131671407|NCT03818204|474081973|FG000|Overall Study|Physician Decision|0|||
131671408|NCT03818204|474081974|FG001|Overall Study|Physician Decision|0|||
131671409|NCT03818204|474081975|FG002|Overall Study|Physician Decision|0|||
131671410|NCT03818204|474081976|FG003|Overall Study|Physician Decision|0|||
131671411|NCT03818204|474081977|FG004|Overall Study|Physician Decision|0|||
131671412|NCT03818204|474081978|FG005|Overall Study|Physician Decision|0|||
131671413|NCT03818204|474081979|FG006|Overall Study|Physician Decision|0|||
131671414|NCT03818204|474081980|FG007|Overall Study|Physician Decision|0|||
131671415|NCT03818204|474081981|FG008|Overall Study|Physician Decision|0|||
131671416|NCT03818204|474081982|FG009|Overall Study|Physician Decision|0|||
131671417|NCT03818204|474081983|FG010|Overall Study|Physician Decision|0|||
131671418|NCT03818204|474081984|FG011|Overall Study|Physician Decision|0|||
131671419|NCT03818204|474081985|FG012|Overall Study|Physician Decision|0|||
131671420|NCT03818204|474081986|FG013|Overall Study|Physician Decision|0|||
131671421|NCT03818204|474081987|FG014|Overall Study|Physician Decision|1|||
131671422|NCT03818204|474081988|FG015|Overall Study|Physician Decision|0|||
131671423|NCT03818204|474081989|FG016|Overall Study|Physician Decision|0|||
131671424|NCT03818204|474081990|FG017|Overall Study|Physician Decision|0|||
131671425|NCT03818204|474081991|FG018|Overall Study|Physician Decision|0|||
131671426|NCT03864146|474081992|FG000|Overall Study|Lost to Follow-up|14|||
131671427|NCT03864146|474081993|FG001|Overall Study|Lost to Follow-up|23|||
131671428|NCT03864146|474081992|FG000|Overall Study|Withdrawal by Subject|3|||
131671429|NCT03864146|474081993|FG001|Overall Study|Withdrawal by Subject|2|||
131671430|NCT01313637|474081999|FG000|Overall Study|Adverse Event|17|||
131671431|NCT01313637|474082000|FG001|Overall Study|Adverse Event|24|||
131671432|NCT01313637|474082001|FG002|Overall Study|Adverse Event|25|||
131671433|NCT01313637|474082002|FG003|Overall Study|Adverse Event|18|||
131671434|NCT01313637|474081999|FG000|Overall Study|Lack of Efficacy|44|||
131671435|NCT01313637|474082000|FG001|Overall Study|Lack of Efficacy|38|||
131671436|NCT01313637|474082001|FG002|Overall Study|Lack of Efficacy|37|||
131671437|NCT01313637|474082002|FG003|Overall Study|Lack of Efficacy|24|||
131671438|NCT01313637|474081999|FG000|Overall Study|Protocol Violation|4|||
131671439|NCT01313637|474082000|FG001|Overall Study|Protocol Violation|3|||
131671440|NCT01313637|474082001|FG002|Overall Study|Protocol Violation|11|||
131671441|NCT01313637|474082002|FG003|Overall Study|Protocol Violation|5|||
131671442|NCT01313637|474081999|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
131671443|NCT01313637|474082000|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
131671444|NCT01313637|474082001|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
131671445|NCT01313637|474082002|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
131671446|NCT01313637|474081999|FG000|Overall Study|Lost to Follow-up|0|||
131671447|NCT01313637|474082000|FG001|Overall Study|Lost to Follow-up|2|||
131671448|NCT01313637|474082001|FG002|Overall Study|Lost to Follow-up|1|||
131671449|NCT01313637|474082002|FG003|Overall Study|Lost to Follow-up|3|||
131671450|NCT01313637|474081999|FG000|Overall Study|Withdrawal by Subject|11|||
131671451|NCT01313637|474082000|FG001|Overall Study|Withdrawal by Subject|13|||
131671452|NCT01313637|474082001|FG002|Overall Study|Withdrawal by Subject|18|||
131671453|NCT01313637|474082002|FG003|Overall Study|Withdrawal by Subject|15|||
131671454|NCT04218084|474082004|FG000|Overall Study|Adverse Event|7|||
131671455|NCT04218084|474082005|FG001|Overall Study|Adverse Event|2|||
131671456|NCT04218084|474082004|FG000|Overall Study|Withdrawal of Consent|4|||
131671457|NCT04218084|474082005|FG001|Overall Study|Withdrawal of Consent|5|||
131671458|NCT04218084|474082004|FG000|Overall Study|Physician Decision|1|||
131671459|NCT04218084|474082005|FG001|Overall Study|Physician Decision|1|||
131671460|NCT04218084|474082004|FG000|Overall Study|Lost to Follow-up|1|||
131671461|NCT04218084|474082005|FG001|Overall Study|Lost to Follow-up|1|||
131671462|NCT04218084|474082004|FG000|Overall Study|Non-compliance with study drug|1|||
131671463|NCT04218084|474082005|FG001|Overall Study|Non-compliance with study drug|1|||
131671464|NCT04218084|474082004|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
131671465|NCT04218084|474082005|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
131671466|NCT04218084|474082004|FG000|Overall Study|Other|0|||
131671467|NCT04218084|474082005|FG001|Overall Study|Other|1|||
131671468|NCT04218084|474082004|FG000|Overall Study|Ongoing at data cut-off date|62|||
131671469|NCT04218084|474082005|FG001|Overall Study|Ongoing at data cut-off date|58|||
131671470|NCT05580588|474082006|FG000|Overall Study|Lack of Efficacy|12|||
131671471|NCT00211185|474082009|FG000|Overall Study|Death|2|||
131671472|NCT00211185|474082009|FG000|Overall Study|Disease progression|7|||
131671473|NCT00211185|474082009|FG000|Overall Study|Withdrawal by Subject|6|||
131671474|NCT00211185|474082009|FG000|Overall Study|Physician Decision|5|||
131671475|NCT00712673|474082010|FG000|Overall Study|Adverse Event|3|||
131671476|NCT00712673|474082011|FG001|Overall Study|Adverse Event|3|||
131671477|NCT00712673|474082012|FG002|Overall Study|Adverse Event|21|||
131671478|NCT00712673|474082013|FG003|Overall Study|Adverse Event|26|||
131671479|NCT00712673|474082010|FG000|Overall Study|Lack of Efficacy|2|||
131671480|NCT00712673|474082011|FG001|Overall Study|Lack of Efficacy|8|||
131671481|NCT00712673|474082012|FG002|Overall Study|Lack of Efficacy|8|||
131671482|NCT00712673|474082013|FG003|Overall Study|Lack of Efficacy|6|||
131671483|NCT00712673|474082010|FG000|Overall Study|Poor Compliance to Protocol|3|||
131671484|NCT00712673|474082011|FG001|Overall Study|Poor Compliance to Protocol|3|||
131671485|NCT00712673|474082012|FG002|Overall Study|Poor Compliance to Protocol|4|||
131671486|NCT00712673|474082013|FG003|Overall Study|Poor Compliance to Protocol|16|||
131671487|NCT00712673|474082010|FG000|Overall Study|Lost to Follow-up|1|||
131671488|NCT00712673|474082011|FG001|Overall Study|Lost to Follow-up|0|||
131671489|NCT00712673|474082012|FG002|Overall Study|Lost to Follow-up|2|||
131671490|NCT00712673|474082013|FG003|Overall Study|Lost to Follow-up|0|||
131671491|NCT00712673|474082010|FG000|Overall Study|Withdrawal by Subject|6|||
131671492|NCT00712673|474082011|FG001|Overall Study|Withdrawal by Subject|7|||
131671493|NCT00712673|474082012|FG002|Overall Study|Withdrawal by Subject|15|||
131671494|NCT00712673|474082013|FG003|Overall Study|Withdrawal by Subject|20|||
131671495|NCT00712673|474082010|FG000|Overall Study|Familial and Personal Reasons|5|||
131671496|NCT00712673|474082011|FG001|Overall Study|Familial and Personal Reasons|0|||
131671497|NCT00712673|474082012|FG002|Overall Study|Familial and Personal Reasons|5|||
131671498|NCT00712673|474082013|FG003|Overall Study|Familial and Personal Reasons|2|||
131671499|NCT00712673|474082010|FG000|Overall Study|Investigator's Decision|1|||
131671500|NCT00712673|474082011|FG001|Overall Study|Investigator's Decision|0|||
131671501|NCT00712673|474082012|FG002|Overall Study|Investigator's Decision|0|||
131671502|NCT00712673|474082013|FG003|Overall Study|Investigator's Decision|0|||
131671503|NCT00712673|474082010|FG000|Overall Study|Protocol Violation|0|||
131671504|NCT00712673|474082011|FG001|Overall Study|Protocol Violation|0|||
131671505|NCT00712673|474082012|FG002|Overall Study|Protocol Violation|2|||
131671506|NCT00712673|474082013|FG003|Overall Study|Protocol Violation|0|||
131671507|NCT03603028|474082014|FG000|Overall Study|Withdrawal by Subject|1|||
131671508|NCT01768117|474082019|FG000|Overall Study|Lost to Follow-up|1|||
131671509|NCT01768117|474082019|FG000|Overall Study|Withdrawal by Subject|2|||
131671510|NCT01768117|474082019|FG000|Overall Study|Protocol Violation|3|||
131671511|NCT01580969|474082020|FG000|Overall Study|Physician Decision|3|||
131671512|NCT01580969|474082021|FG001|Overall Study|Physician Decision|0|||
131671513|NCT01580969|474082022|FG002|Overall Study|Physician Decision|0|||
131671514|NCT01745848|474082023|FG000|Overall Study|Adverse Event|6|||
131671515|NCT02076178|474082030|FG000|Oral Phase|Adverse Event|0|||
131671516|NCT02076178|474082031|FG001|Oral Phase|Adverse Event|7|||
131671517|NCT02076178|474082030|FG000|Oral Phase|Withdrawal by Subject|0|||
131671518|NCT02076178|474082031|FG001|Oral Phase|Withdrawal by Subject|4|||
131671519|NCT02076178|474082030|FG000|Oral Phase|Physician Decision|0|||
131671520|NCT02076178|474082031|FG001|Oral Phase|Physician Decision|1|||
131671521|NCT02076178|474082030|FG000|Injection Phase|Protocol defined stopping criteria|1|||
131671522|NCT02076178|474082031|FG001|Injection Phase|Protocol defined stopping criteria|0|||
131671523|NCT02076178|474082030|FG000|Injection Phase|Withdrawal by Subject|0|||
131671524|NCT02076178|474082031|FG001|Injection Phase|Withdrawal by Subject|3|||
131671525|NCT02076178|474082030|FG000|Injection Phase|Physician Decision|0|||
131671526|NCT02076178|474082031|FG001|Injection Phase|Physician Decision|3|||
131671527|NCT02076178|474082030|FG000|Injection Phase|Lost to Follow-up|0|||
131671528|NCT02076178|474082031|FG001|Injection Phase|Lost to Follow-up|1|||
131671529|NCT03021954|474082036|FG000|Overall Study|Lost to Follow-up|10|||
131671530|NCT03021954|474082037|FG001|Overall Study|Lost to Follow-up|43|||
131671531|NCT03021954|474082036|FG000|Overall Study|Subjects had avulsion trauma|4|||
131671532|NCT03021954|474082037|FG001|Overall Study|Subjects had avulsion trauma|1|||
131671533|NCT00710021|474082042|FG000|Overall Study|Lost to Follow-up|1|||
131671534|NCT00710021|474082043|FG001|Overall Study|Lost to Follow-up|0|||
131671535|NCT00710021|474082044|FG002|Overall Study|Lost to Follow-up|0|||
131671536|NCT00710021|474082042|FG000|Overall Study|Subject's Decision|0|||
131671537|NCT00710021|474082043|FG001|Overall Study|Subject's Decision|1|||
131671538|NCT00710021|474082044|FG002|Overall Study|Subject's Decision|0|||
131671539|NCT00710021|474082042|FG000|Overall Study|Subject misrandomized|0|||
131671540|NCT00710021|474082043|FG001|Overall Study|Subject misrandomized|1|||
131671541|NCT00710021|474082044|FG002|Overall Study|Subject misrandomized|1|||
131671542|NCT00710021|474082042|FG000|Overall Study|Physician Decision|0|||
131671543|NCT00710021|474082043|FG001|Overall Study|Physician Decision|1|||
131671544|NCT00710021|474082044|FG002|Overall Study|Physician Decision|0|||
131671545|NCT03581825|474082045|FG000|Period 1|Lens Discomfort|1|||
131671546|NCT03581825|474082046|FG001|Period 1|Lens Discomfort|0|||
131671547|NCT03581825|474082045|FG000|Period 2|Unsatisfactory Vision to Test|0|||
131671548|NCT03581825|474082046|FG001|Period 2|Unsatisfactory Vision to Test|1|||
131671549|NCT00511901|474082047|FG000|Overall Study|Withdrawal by Subject|1|||
131671550|NCT00511901|474082048|FG001|Overall Study|Withdrawal by Subject|3|||
131671551|NCT02447172|474082049|FG000|Overall Study|Adverse Event|11|||
131671552|NCT02447172|474082050|FG001|Overall Study|Adverse Event|8|||
131671553|NCT02447172|474082051|FG002|Overall Study|Adverse Event|7|||
131671554|NCT02447172|474082049|FG000|Overall Study|Death|3|||
131671555|NCT02447172|474082050|FG001|Overall Study|Death|1|||
131671556|NCT02447172|474082051|FG002|Overall Study|Death|0|||
131671557|NCT02447172|474082049|FG000|Overall Study|Protocol Violation|2|||
131671558|NCT02447172|474082050|FG001|Overall Study|Protocol Violation|1|||
131671559|NCT02447172|474082051|FG002|Overall Study|Protocol Violation|2|||
131671560|NCT02447172|474082049|FG000|Overall Study|Lost to Follow-up|7|||
131671561|NCT02447172|474082050|FG001|Overall Study|Lost to Follow-up|4|||
131671562|NCT02447172|474082051|FG002|Overall Study|Lost to Follow-up|4|||
131671563|NCT02447172|474082049|FG000|Overall Study|Withdrawal by Subject|5|||
131671564|NCT02447172|474082050|FG001|Overall Study|Withdrawal by Subject|1|||
131671565|NCT02447172|474082051|FG002|Overall Study|Withdrawal by Subject|3|||
131671566|NCT02447172|474082049|FG000|Overall Study|protocol specific treatment unrelated|3|||
131671567|NCT02447172|474082050|FG001|Overall Study|protocol specific treatment unrelated|0|||
131671568|NCT02447172|474082051|FG002|Overall Study|protocol specific treatment unrelated|2|||
131671569|NCT01013597|474082060|FG000|Overall Study|Withdrawal by Subject|1|||
131671570|NCT02796560|474082061|FG000|Overall Study|Adverse Event|2|||
131671571|NCT02796560|474082062|FG001|Overall Study|Adverse Event|0|||
131671572|NCT02796560|474082061|FG000|Overall Study|Withdrawal by Subject|2|||
131671573|NCT02796560|474082062|FG001|Overall Study|Withdrawal by Subject|2|||
131671574|NCT02533570|474082063|FG000|Overall Study|Adverse Event|0|||
131671575|NCT02533570|474082064|FG001|Overall Study|Adverse Event|1|||
131671576|NCT02533570|474082065|FG002|Overall Study|Adverse Event|1|||
131671577|NCT00529958|474082066|FG000|2-Year Follow-up|Lost to Follow-up|1|||
131671578|NCT00529958|474082067|FG001|2-Year Follow-up|Lost to Follow-up|2|||
131671579|NCT00529958|474082068|FG002|2-Year Follow-up|Lost to Follow-up|2|||
131671580|NCT00529958|474082066|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
131671581|NCT00529958|474082067|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
131671582|NCT00529958|474082068|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
131671583|NCT00529958|474082066|FG000|5-Year Follow-up|Lost to Follow-up|2|||
131671584|NCT00529958|474082067|FG001|5-Year Follow-up|Lost to Follow-up|3|||
131671585|NCT00529958|474082068|FG002|5-Year Follow-up|Lost to Follow-up|1|||
131671586|NCT00529958|474082066|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
131671587|NCT00529958|474082067|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
131671588|NCT00529958|474082068|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
131671589|NCT03316300|474082069|FG000|Overall Study|Withdrawal by Subject|3|||
131671590|NCT03316300|474082070|FG001|Overall Study|Withdrawal by Subject|2|||
131671591|NCT03316300|474082069|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
131671592|NCT03316300|474082070|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
131671593|NCT03316300|474082069|FG000|Overall Study|Adverse Event|1|||
131671594|NCT03316300|474082070|FG001|Overall Study|Adverse Event|0|||
131671595|NCT03316300|474082069|FG000|Overall Study|COVID-19|0|||
131671596|NCT03316300|474082070|FG001|Overall Study|COVID-19|1|||
131671597|NCT01315353|474082071|FG000|Overall Study|Death|2|||
131671598|NCT01315353|474082072|FG001|Overall Study|Death|1|||
131671599|NCT01315353|474082073|FG002|Overall Study|Death|0|||
131671600|NCT01315353|474082071|FG000|Overall Study|Withdrawal by Subject|2|||
131671601|NCT01315353|474082072|FG001|Overall Study|Withdrawal by Subject|6|||
131671602|NCT01315353|474082073|FG002|Overall Study|Withdrawal by Subject|1|||
131671603|NCT01315353|474082071|FG000|Overall Study|Lost to Follow-up|13|||
131671604|NCT01315353|474082072|FG001|Overall Study|Lost to Follow-up|6|||
131671605|NCT01315353|474082073|FG002|Overall Study|Lost to Follow-up|6|||
131671606|NCT01315353|474082071|FG000|Overall Study|Unwilling to adhere to requirements|5|||
131671607|NCT01315353|474082072|FG001|Overall Study|Unwilling to adhere to requirements|5|||
131671608|NCT01315353|474082073|FG002|Overall Study|Unwilling to adhere to requirements|4|||
131671609|NCT01315353|474082071|FG000|Overall Study|Site closing|7|||
131671610|NCT01315353|474082072|FG001|Overall Study|Site closing|4|||
131671611|NCT01315353|474082073|FG002|Overall Study|Site closing|0|||
131671612|NCT01315353|474082071|FG000|Overall Study|Taken off study by site in error|0|||
131671613|NCT01315353|474082072|FG001|Overall Study|Taken off study by site in error|1|||
131671614|NCT01315353|474082073|FG002|Overall Study|Taken off study by site in error|0|||
131671615|NCT01315353|474082071|FG000|Overall Study|Inadvertent randomization/assignment|0|||
131671616|NCT01315353|474082072|FG001|Overall Study|Inadvertent randomization/assignment|0|||
131671617|NCT01315353|474082073|FG002|Overall Study|Inadvertent randomization/assignment|2|||
131671618|NCT03567434|474082074|FG000|Overall Study|Lost to Follow-up|1|||
131897054|NCT05251233|474910332|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
131897055|NCT05251233|474910330|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
131671619|NCT03567434|474082075|FG001|Overall Study|Lost to Follow-up|3|||
131671620|NCT02881957|474082078|FG000|Overall Study|Comfort care|0|||
131671621|NCT02881957|474082079|FG001|Overall Study|Comfort care|1|||
131671622|NCT02881957|474082078|FG000|Overall Study|Concurrent trial enrollment|0|||
131671623|NCT02881957|474082079|FG001|Overall Study|Concurrent trial enrollment|1|||
131671624|NCT02881957|474082078|FG000|Overall Study|Discharged within 48 hours|0|||
131671625|NCT02881957|474082079|FG001|Overall Study|Discharged within 48 hours|1|||
131671626|NCT02881957|474082078|FG000|Overall Study|Withdrawal by Subject|2|||
131671627|NCT02881957|474082079|FG001|Overall Study|Withdrawal by Subject|1|||
131671628|NCT02881957|474082078|FG000|Overall Study|Protocol Violation|1|||
131671629|NCT02881957|474082079|FG001|Overall Study|Protocol Violation|0|||
131671630|NCT01050790|474082081|FG000|Overall Study|Adverse Event|1|||
131671631|NCT03705832|474082082|FG000|Overall Study|Physician Decision|0|||
131671632|NCT03705832|474082083|FG001|Overall Study|Physician Decision|1|||
131671633|NCT03705832|474082082|FG000|Overall Study|Withdrawal by Subject|1|||
131671634|NCT03705832|474082083|FG001|Overall Study|Withdrawal by Subject|0|||
131671635|NCT01880528|474082084|FG000|Overall Study|Other|1|||
131671636|NCT01880528|474082085|FG001|Overall Study|Other|1|||
131671637|NCT01439360|474082086|FG000|Overall Study|Adverse Event|4|||
131671638|NCT01439360|474082087|FG001|Overall Study|Adverse Event|16|||
131671639|NCT01439360|474082086|FG000|Overall Study|Lost to Follow-up|43|||
131671640|NCT01439360|474082087|FG001|Overall Study|Lost to Follow-up|58|||
131671641|NCT01439360|474082086|FG000|Overall Study|Others|10|||
131671642|NCT01439360|474082087|FG001|Overall Study|Others|5|||
131671643|NCT01439360|474082086|FG000|Overall Study|Protocol Violation|1|||
131671644|NCT01439360|474082087|FG001|Overall Study|Protocol Violation|0|||
131671645|NCT01439360|474082086|FG000|Overall Study|Withdrawal by Subject|140|||
131671646|NCT01439360|474082087|FG001|Overall Study|Withdrawal by Subject|129|||
131671647|NCT00345293|474082088|FG000|Overall Study|Unable to access line for sample|1|||
131671648|NCT00345293|474082089|FG001|Overall Study|Unable to access line for sample|0|||
131671649|NCT00345293|474082088|FG000|Overall Study|Withdrawal by Subject|1|||
131671650|NCT00345293|474082089|FG001|Overall Study|Withdrawal by Subject|0|||
131671651|NCT01786174|474083558|FG000|Overall Study|Discontinued Study Drug|2|||
131671652|NCT01786174|474083559|FG001|Overall Study|Discontinued Study Drug|0|||
131671653|NCT04281004|474083568|FG000|Overall Study|Physician Decision|1|||
131671654|NCT04281004|474083569|FG001|Overall Study|Physician Decision|0|||
131671655|NCT03628898|474083570|FG000|Overall Study|Device deficiency|1|||
131671656|NCT01217957|474083571|FG000|Phase 1|Withdrawal by Patient|1|||
131671657|NCT01217957|474083572|FG001|Phase 1|Withdrawal by Patient|0|||
131671658|NCT01217957|474083573|FG002|Phase 1|Withdrawal by Patient|1|||
131671659|NCT01217957|474083574|FG003|Phase 1|Withdrawal by Patient|1|||
131671660|NCT01217957|474083575|FG004|Phase 1|Withdrawal by Patient|0|||
131671661|NCT01217957|474083571|FG000|Phase 2|Withdrawal by Patient|0|||
131671662|NCT01217957|474083572|FG001|Phase 2|Withdrawal by Patient|0|||
131671663|NCT01217957|474083573|FG002|Phase 2|Withdrawal by Patient|0|||
131671664|NCT01217957|474083574|FG003|Phase 2|Withdrawal by Patient|0|||
131671665|NCT01217957|474083575|FG004|Phase 2|Withdrawal by Patient|1|||
131671666|NCT01620255|474083581|FG000|Overall Study|Withdrawal by Subject|4|||
131671667|NCT01620255|474083582|FG001|Overall Study|Withdrawal by Subject|1|||
131671668|NCT01620255|474083583|FG002|Overall Study|Withdrawal by Subject|1|||
131671669|NCT01620255|474083584|FG003|Overall Study|Withdrawal by Subject|2|||
131671670|NCT01620255|474083585|FG004|Overall Study|Withdrawal by Subject|4|||
131671671|NCT01620255|474083581|FG000|Overall Study|Participant underwent fecal transplant|0|||
131671672|NCT01620255|474083582|FG001|Overall Study|Participant underwent fecal transplant|0|||
131671673|NCT01620255|474083583|FG002|Overall Study|Participant underwent fecal transplant|1|||
131671674|NCT01620255|474083584|FG003|Overall Study|Participant underwent fecal transplant|0|||
131671675|NCT01620255|474083585|FG004|Overall Study|Participant underwent fecal transplant|0|||
131671676|NCT01620255|474083581|FG000|Overall Study|Non-compliance|0|||
131671677|NCT01620255|474083582|FG001|Overall Study|Non-compliance|1|||
131671678|NCT01620255|474083583|FG002|Overall Study|Non-compliance|0|||
131671679|NCT01620255|474083584|FG003|Overall Study|Non-compliance|0|||
131671680|NCT01620255|474083585|FG004|Overall Study|Non-compliance|0|||
131671681|NCT01620255|474083581|FG000|Overall Study|Adverse Event|0|||
131671682|NCT01620255|474083582|FG001|Overall Study|Adverse Event|4|||
131671683|NCT01620255|474083583|FG002|Overall Study|Adverse Event|0|||
131671684|NCT01620255|474083584|FG003|Overall Study|Adverse Event|1|||
131671685|NCT01620255|474083585|FG004|Overall Study|Adverse Event|1|||
131671686|NCT01620255|474083581|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
131671687|NCT01620255|474083582|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
131671688|NCT01620255|474083583|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
131671689|NCT01620255|474083584|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
131671690|NCT01620255|474083585|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
131671691|NCT01155375|474083590|FG000|Overall Study|Adverse Event|1|||
131671692|NCT01155375|474083591|FG001|Overall Study|Adverse Event|0|||
131671693|NCT00762970|474083595|FG000|Overall Study|Withdrawal by Subject|7|||
131671694|NCT00762970|474083596|FG001|Overall Study|Withdrawal by Subject|4|||
131671695|NCT00762970|474083597|FG002|Overall Study|Withdrawal by Subject|0|||
131671696|NCT00762970|474083595|FG000|Overall Study|Protocol Violation|3|||
131671697|NCT00762970|474083596|FG001|Overall Study|Protocol Violation|1|||
131671698|NCT00762970|474083597|FG002|Overall Study|Protocol Violation|1|||
131671699|NCT00762970|474083595|FG000|Overall Study|Lost to Follow-up|1|||
131671700|NCT00762970|474083596|FG001|Overall Study|Lost to Follow-up|2|||
131671701|NCT00762970|474083597|FG002|Overall Study|Lost to Follow-up|0|||
131671702|NCT00762970|474083595|FG000|Overall Study|Difficulty of handling lens|1|||
131671703|NCT00762970|474083596|FG001|Overall Study|Difficulty of handling lens|2|||
131671704|NCT00762970|474083597|FG002|Overall Study|Difficulty of handling lens|0|||
131671705|NCT01480674|474083598|FG000|Overall Study|Death|23|||
131671706|NCT01480674|474083598|FG000|Overall Study|Lost to Follow-up|2|||
131671707|NCT01480674|474083598|FG000|Overall Study|visit not done|10|||
131671708|NCT00887250|474083599|FG000|Overall Study|Adverse Event|3|||
131671709|NCT00887250|474083600|FG001|Overall Study|Adverse Event|0|||
131671710|NCT00887250|474083601|FG002|Overall Study|Adverse Event|7|||
131671711|NCT00887250|474083599|FG000|Overall Study|Lack of Efficacy|9|||
131671712|NCT00887250|474083600|FG001|Overall Study|Lack of Efficacy|6|||
131671713|NCT00887250|474083601|FG002|Overall Study|Lack of Efficacy|1|||
131671714|NCT00887250|474083599|FG000|Overall Study|Lost to Follow-up|2|||
131671715|NCT00887250|474083600|FG001|Overall Study|Lost to Follow-up|3|||
131671716|NCT00887250|474083601|FG002|Overall Study|Lost to Follow-up|1|||
131671717|NCT00887250|474083599|FG000|Overall Study|Protocol Violation|2|||
131671718|NCT00887250|474083600|FG001|Overall Study|Protocol Violation|2|||
131671719|NCT00887250|474083601|FG002|Overall Study|Protocol Violation|1|||
131671720|NCT00887250|474083599|FG000|Overall Study|Withdrawal by Subject|2|||
131671721|NCT00887250|474083600|FG001|Overall Study|Withdrawal by Subject|1|||
131671722|NCT00887250|474083601|FG002|Overall Study|Withdrawal by Subject|2|||
131671723|NCT00887250|474083599|FG000|Overall Study|Patient uncooperative|0|||
131671724|NCT00887250|474083600|FG001|Overall Study|Patient uncooperative|0|||
131671725|NCT00887250|474083601|FG002|Overall Study|Patient uncooperative|1|||
131671726|NCT01933113|474083602|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
131671727|NCT00879762|474083603|FG000|Overall Study|Lost to Follow-up|3|||
131671728|NCT00879762|474083604|FG001|Overall Study|Lost to Follow-up|1|||
131671729|NCT04981366|474083605|FG000|Overall Study|Withdrawal by Subject|5|||
131671730|NCT04981366|474083606|FG001|Overall Study|Withdrawal by Subject|4|||
131671731|NCT04981366|474083607|FG002|Overall Study|Withdrawal by Subject|8|||
131671732|NCT04981366|474083605|FG000|Overall Study|Health issues unrelated to the trial|1|||
131671733|NCT04981366|474083606|FG001|Overall Study|Health issues unrelated to the trial|2|||
131671734|NCT04981366|474083607|FG002|Overall Study|Health issues unrelated to the trial|0|||
131671735|NCT00881608|474083608|FG000|Overall Study|Study prematurely terminated|11|||
131671736|NCT03214094|474083609|FG000|Overall Study|Case Report Forms Uncollected|14|||
131671737|NCT03214094|474083609|FG000|Overall Study|Protocol Deviation|46|||
131671738|NCT00795951|474083615|FG000|Overall Study|Lost to Follow-up|1|||
131671739|NCT00795951|474083615|FG000|Overall Study|Withdrawal by Subject|1|||
131671740|NCT00690820|474083616|FG000|Period 1|Withdrawal by Subject|0|||
131671741|NCT00690820|474083617|FG001|Period 1|Withdrawal by Subject|1|||
131671742|NCT00846391|474083619|FG000|Overall Study|Physician Decision|0|||
131671743|NCT00846391|474083620|FG001|Overall Study|Physician Decision|0|||
131671744|NCT00846391|474083621|FG002|Overall Study|Physician Decision|1|||
131671745|NCT00846391|474083619|FG000|Overall Study|Study Terminated by Sponsor|1|||
131671746|NCT00846391|474083620|FG001|Overall Study|Study Terminated by Sponsor|2|||
131671747|NCT00846391|474083621|FG002|Overall Study|Study Terminated by Sponsor|2|||
131671748|NCT04634825|474083623|FG000|Overall Study|Death|10|||
131671749|NCT04634825|474083624|FG001|Overall Study|Death|3|||
131671750|NCT04634825|474083623|FG000|Overall Study|Lost to Follow-up|1|||
131671751|NCT04634825|474083624|FG001|Overall Study|Lost to Follow-up|0|||
131671752|NCT04634825|474083623|FG000|Overall Study|Study terminated by sponsor|35|||
131671753|NCT04634825|474083624|FG001|Overall Study|Study terminated by sponsor|11|||
131671754|NCT04634825|474083623|FG000|Overall Study|Withdrawal by Subject|2|||
131671755|NCT04634825|474083624|FG001|Overall Study|Withdrawal by Subject|0|||
131671756|NCT01337115|474083631|FG000|Overall Study|Protocol Violation|2|||
131671757|NCT01337115|474083632|FG001|Overall Study|Protocol Violation|0|||
131671758|NCT00551460|474083638|FG000|Overall Study|Adverse Event|1|||
131671759|NCT00551460|474083638|FG000|Overall Study|Withdrawal by Subject|1|||
131671760|NCT00551460|474083638|FG000|Overall Study|Physician Decision|1|||
131671761|NCT00551460|474083638|FG000|Overall Study|Death|7|||
131671762|NCT00551460|474083638|FG000|Overall Study|Ineligible|4|||
131671763|NCT00551460|474083638|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
131671764|NCT00679627|474083639|FG000|Overall Study|Death|41|||
131671765|NCT00679627|474083640|FG001|Overall Study|Death|29|||
131671766|NCT00679627|474083639|FG000|Overall Study|Adverse Event|43|||
131671767|NCT00679627|474083640|FG001|Overall Study|Adverse Event|53|||
131671768|NCT00679627|474083639|FG000|Overall Study|Withdrawal by Subject|168|||
131671769|NCT00679627|474083640|FG001|Overall Study|Withdrawal by Subject|172|||
131671770|NCT00679627|474083639|FG000|Overall Study|Lost to Follow-up|22|||
131671771|NCT00679627|474083640|FG001|Overall Study|Lost to Follow-up|26|||
131671772|NCT00679627|474083639|FG000|Overall Study|Early Study Closure|425|||
131671773|NCT00679627|474083640|FG001|Overall Study|Early Study Closure|405|||
131671774|NCT00448123|474083641|FG000|Overall Study|Lost to Follow-up|9|||
131671775|NCT00448123|474083642|FG001|Overall Study|Lost to Follow-up|6|||
131671776|NCT00448123|474083641|FG000|Overall Study|Physician Decision|6|||
131671777|NCT00448123|474083642|FG001|Overall Study|Physician Decision|6|||
131671778|NCT02027623|474083643|FG000|Overall Study|Lost to Follow-up|3|||
131671779|NCT02027623|474083644|FG001|Overall Study|Lost to Follow-up|3|||
131671780|NCT02027623|474083643|FG000|Overall Study|Withdrawal by Subject|6|||
131671781|NCT02027623|474083644|FG001|Overall Study|Withdrawal by Subject|9|||
131671782|NCT01886378|474083645|FG000|Overall Study|Adverse Event|1|||
131671783|NCT01886378|474083645|FG000|Overall Study|Withdrawal by Subject|4|||
131671784|NCT01079741|474083646|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131671785|NCT01079741|474083647|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
131671786|NCT01079741|474083648|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131671787|NCT01079741|474083649|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131671788|NCT01079741|474083650|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131671789|NCT01079741|474083646|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131671790|NCT01079741|474083647|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131671791|NCT01079741|474083648|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131671792|NCT01079741|474083649|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131671793|NCT01079741|474083650|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
131671794|NCT00446992|474083651|FG000|Overall Study|Adverse Event|11|||
131671795|NCT00446992|474083651|FG000|Overall Study|Lost to Follow-up|5|||
131671796|NCT01536015|474083652|FG000|Overall Study|Adverse Event|1|||
131671797|NCT01536015|474083653|FG001|Overall Study|Adverse Event|4|||
131671798|NCT01536015|474083652|FG000|Overall Study|Lost to Follow-up|0|||
131671799|NCT01536015|474083653|FG001|Overall Study|Lost to Follow-up|1|||
131671800|NCT01536015|474083652|FG000|Overall Study|Inclusion Criterion not met|2|||
131671801|NCT01536015|474083653|FG001|Overall Study|Inclusion Criterion not met|0|||
131671802|NCT01536015|474083652|FG000|Overall Study|Study closure|5|||
131671803|NCT01536015|474083653|FG001|Overall Study|Study closure|5|||
131671804|NCT01668667|474083655|FG000|Overall Study|Adverse Event|3|||
131671805|NCT01668667|474083656|FG001|Overall Study|Adverse Event|6|||
131671806|NCT01668667|474083657|FG002|Overall Study|Adverse Event|4|||
131671807|NCT01668667|474083658|FG003|Overall Study|Adverse Event|4|||
131671808|NCT01668667|474083655|FG000|Overall Study|Lack of Efficacy|3|||
131671809|NCT01668667|474083656|FG001|Overall Study|Lack of Efficacy|2|||
131671810|NCT01668667|474083657|FG002|Overall Study|Lack of Efficacy|2|||
131671811|NCT01668667|474083658|FG003|Overall Study|Lack of Efficacy|3|||
131671812|NCT01668667|474083655|FG000|Overall Study|Protocol Violation|6|||
131671813|NCT01668667|474083656|FG001|Overall Study|Protocol Violation|10|||
131671814|NCT01668667|474083657|FG002|Overall Study|Protocol Violation|12|||
131671815|NCT01668667|474083658|FG003|Overall Study|Protocol Violation|5|||
131671816|NCT01668667|474083655|FG000|Overall Study|Lost to Follow-up|9|||
131671817|NCT01668667|474083656|FG001|Overall Study|Lost to Follow-up|4|||
131671818|NCT01668667|474083657|FG002|Overall Study|Lost to Follow-up|7|||
131671819|NCT01668667|474083658|FG003|Overall Study|Lost to Follow-up|6|||
131671820|NCT01668667|474083655|FG000|Overall Study|Physician Decision|3|||
131671821|NCT01668667|474083656|FG001|Overall Study|Physician Decision|0|||
131671822|NCT01668667|474083657|FG002|Overall Study|Physician Decision|1|||
131671823|NCT01668667|474083658|FG003|Overall Study|Physician Decision|0|||
131671824|NCT01668667|474083655|FG000|Overall Study|Withdrawal by Subject|7|||
131671825|NCT01668667|474083656|FG001|Overall Study|Withdrawal by Subject|4|||
131671826|NCT01668667|474083657|FG002|Overall Study|Withdrawal by Subject|5|||
131671827|NCT01668667|474083658|FG003|Overall Study|Withdrawal by Subject|5|||
131671828|NCT03343301|474083659|FG000|Overall Study|Withdrawal by Subject|1|||
131671829|NCT03343301|474083660|FG001|Overall Study|Withdrawal by Subject|1|||
131671830|NCT03343301|474083659|FG000|Overall Study|Death|0|||
131671831|NCT03343301|474083660|FG001|Overall Study|Death|2|||
131671832|NCT03343301|474083659|FG000|Overall Study|Other|0|||
131671833|NCT03343301|474083660|FG001|Overall Study|Other|6|||
131671834|NCT03343301|474083659|FG000|Overall Study|Missing|2|||
131671835|NCT03343301|474083660|FG001|Overall Study|Missing|0|||
131671836|NCT00427895|474083663|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671837|NCT00427895|474083664|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671838|NCT00427895|474083665|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671839|NCT00427895|474083666|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
131671840|NCT00427895|474083667|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671841|NCT00427895|474083668|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671842|NCT00427895|474083669|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671843|NCT00427895|474083670|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131671844|NCT00427895|474083663|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671845|NCT00427895|474083664|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671846|NCT00427895|474083665|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671847|NCT00427895|474083666|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671848|NCT00427895|474083667|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671849|NCT00427895|474083668|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671850|NCT00427895|474083669|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131671851|NCT00427895|474083670|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
131671852|NCT00427895|474083663|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671853|NCT00427895|474083664|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671854|NCT00427895|474083665|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671855|NCT00427895|474083666|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671856|NCT00427895|474083667|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671857|NCT00427895|474083668|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671858|NCT00427895|474083669|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
131671859|NCT00427895|474083670|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
131671860|NCT00427895|474083663|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
131671861|NCT00427895|474083664|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
131671862|NCT00427895|474083665|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
131671863|NCT00427895|474083666|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
131671864|NCT00427895|474083667|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
131671865|NCT00427895|474083668|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
131671866|NCT00427895|474083669|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
131671867|NCT00427895|474083670|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
131671868|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131671869|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
131671870|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
131671871|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
131671872|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131671873|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131671874|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131671875|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131671876|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
131671877|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131671878|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
131671879|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
131671880|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131671881|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131671882|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131671883|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131671884|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
131671885|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
131671886|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131671887|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131671888|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131671889|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131671890|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131671891|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131671892|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
131671893|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
131671894|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
131671895|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
131671896|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131671897|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131671898|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131671899|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131671900|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671901|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671902|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671903|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
131671904|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671905|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671906|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671907|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131671908|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
131671909|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
131671910|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
131671911|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
131671912|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131671913|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131671914|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131671915|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131671916|NCT00427895|474083663|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131671917|NCT00427895|474083664|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131671918|NCT00427895|474083665|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
131671919|NCT00427895|474083666|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
131671920|NCT00427895|474083667|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131671921|NCT00427895|474083668|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131671922|NCT00427895|474083669|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131671923|NCT00427895|474083670|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131671924|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131671925|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
131671926|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
131671927|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
131671928|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131671929|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131671930|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131671931|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131671932|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
131671933|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
131671934|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131671935|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
131671936|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131671937|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131671938|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131671939|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131671940|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
131671941|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
131671942|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
131671943|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
131671944|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131671945|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131671946|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131671947|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131671948|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671949|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
131671950|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671951|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671952|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671953|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671954|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671955|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131671956|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Death|1|||
131671957|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Death|0|||
131671958|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Death|0|||
131671959|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Death|0|||
131671960|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Death|0|||
131671961|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Death|0|||
131671962|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Death|0|||
131671963|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Death|0|||
131671964|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131671965|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131671966|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
131671967|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
131671968|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131671969|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131671970|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131671971|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131671972|NCT00427895|474083663|FG000|Vax 1/Year 1 Follow-up|Other|0|||
131671973|NCT00427895|474083664|FG001|Vax 1/Year 1 Follow-up|Other|0|||
131671974|NCT00427895|474083665|FG002|Vax 1/Year 1 Follow-up|Other|0|||
131671975|NCT00427895|474083666|FG003|Vax 1/Year 1 Follow-up|Other|2|||
131671976|NCT00427895|474083667|FG004|Vax 1/Year 1 Follow-up|Other|0|||
131671977|NCT00427895|474083668|FG005|Vax 1/Year 1 Follow-up|Other|0|||
131671978|NCT00427895|474083669|FG006|Vax 1/Year 1 Follow-up|Other|0|||
131671979|NCT00427895|474083670|FG007|Vax 1/Year 1 Follow-up|Other|0|||
131671980|NCT00427895|474083663|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
131671981|NCT00427895|474083664|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
131671982|NCT00427895|474083665|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
131671983|NCT00427895|474083666|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
131671984|NCT00427895|474083667|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131671985|NCT00427895|474083668|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131671986|NCT00427895|474083669|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131671987|NCT00427895|474083670|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131671988|NCT00423930|474083671|FG000|Overall Study|Withdrawal by Subject|2|||
131671989|NCT02656823|474083672|FG000|Overall Study|Adverse Event|3|||
131671990|NCT02656823|474083672|FG000|Overall Study|Lost to Follow-up|2|||
131671991|NCT01009580|474083677|FG000|Overall Study|Adverse Event|4|||
131671992|NCT01009580|474083678|FG001|Overall Study|Adverse Event|4|||
131671993|NCT01009580|474083677|FG000|Overall Study|Lack of Efficacy|0|||
131671994|NCT01009580|474083678|FG001|Overall Study|Lack of Efficacy|1|||
131671995|NCT01009580|474083677|FG000|Overall Study|Protocol Violation|2|||
131671996|NCT01009580|474083678|FG001|Overall Study|Protocol Violation|3|||
131671997|NCT01009580|474083677|FG000|Overall Study|Withdrawal Criteria|4|||
131671998|NCT01009580|474083678|FG001|Overall Study|Withdrawal Criteria|6|||
131671999|NCT01009580|474083677|FG000|Overall Study|Unclassified|17|||
131672000|NCT01009580|474083678|FG001|Overall Study|Unclassified|21|||
131672001|NCT00081497|474083680|FG000|Overall Study|Adverse Event|2|||
131672002|NCT00081497|474083681|FG001|Overall Study|Adverse Event|0|||
131672003|NCT00081497|474083680|FG000|Overall Study|Death|0|||
131672004|NCT00081497|474083681|FG001|Overall Study|Death|1|||
131672005|NCT00081497|474083680|FG000|Overall Study|Withdrawal by Subject|1|||
131672006|NCT00081497|474083681|FG001|Overall Study|Withdrawal by Subject|0|||
131672007|NCT00081497|474083680|FG000|Overall Study|Non-compliance|0|||
131672008|NCT00081497|474083681|FG001|Overall Study|Non-compliance|1|||
131672009|NCT02390245|474083682|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
131672010|NCT02390245|474083683|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
131672011|NCT02390245|474083684|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
131672012|NCT02390245|474083682|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
131672013|NCT02390245|474083683|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
131672014|NCT02390245|474083684|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
131672015|NCT00959647|474083686|FG000|Overall Study|Adverse Event|2|||
131672016|NCT00959647|474083686|FG000|Overall Study|Progressive disease|6|||
131672017|NCT00959647|474083686|FG000|Overall Study|Study terminated by sponsor|4|||
131672018|NCT00959647|474083686|FG000|Overall Study|Withdrawal by Subject|7|||
131672019|NCT02141984|474085678|FG000|Overall Study|Lack of Efficacy|2|||
131672020|NCT00816400|474085682|FG000|Overall Study|Death|2|||
131672021|NCT00816400|474085683|FG001|Overall Study|Death|3|||
131672022|NCT00816400|474085684|FG002|Overall Study|Death|3|||
131897056|NCT05251233|474910331|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
131897057|NCT05251233|474910332|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
131897058|NCT00669318|474910338|FG000|Overall Study|Withdrawal by Subject|2|||
131897059|NCT03272347|474910339|FG000|Overall Study|Death|0|||
131897060|NCT03272347|474910340|FG001|Overall Study|Death|0|||
131897061|NCT03272347|474910341|FG002|Overall Study|Death|0|||
131897062|NCT03272347|474910342|FG003|Overall Study|Death|1|||
131672023|NCT00816400|474085685|FG003|Overall Study|Death|3|||
131672024|NCT00816400|474085686|FG004|Overall Study|Death|2|||
131672025|NCT00816400|474085687|FG005|Overall Study|Death|3|||
131672026|NCT00816400|474085688|FG006|Overall Study|Death|2|||
131672027|NCT00816400|474085689|FG007|Overall Study|Death|5|||
131672028|NCT00816400|474085690|FG008|Overall Study|Death|6|||
131672029|NCT00816400|474085682|FG000|Overall Study|In hospice care at the end of the study|0|||
131672030|NCT00816400|474085683|FG001|Overall Study|In hospice care at the end of the study|0|||
131672031|NCT00816400|474085684|FG002|Overall Study|In hospice care at the end of the study|2|||
131672032|NCT00816400|474085685|FG003|Overall Study|In hospice care at the end of the study|0|||
131672033|NCT00816400|474085686|FG004|Overall Study|In hospice care at the end of the study|0|||
131672034|NCT00816400|474085687|FG005|Overall Study|In hospice care at the end of the study|0|||
131672035|NCT00816400|474085688|FG006|Overall Study|In hospice care at the end of the study|0|||
131672036|NCT00816400|474085689|FG007|Overall Study|In hospice care at the end of the study|0|||
131672037|NCT00816400|474085690|FG008|Overall Study|In hospice care at the end of the study|0|||
131672038|NCT00081770|474085691|FG000|Overall Study|Adverse Event|130|||
131672039|NCT00081770|474085692|FG001|Overall Study|Adverse Event|98|||
131672040|NCT00081770|474085693|FG002|Overall Study|Adverse Event|136|||
131672041|NCT00081770|474085691|FG000|Overall Study|Lack of Efficacy|262|||
131672042|NCT00081770|474085692|FG001|Overall Study|Lack of Efficacy|357|||
131672043|NCT00081770|474085693|FG002|Overall Study|Lack of Efficacy|211|||
131672044|NCT00081770|474085691|FG000|Overall Study|Lost to Follow-up|45|||
131672045|NCT00081770|474085692|FG001|Overall Study|Lost to Follow-up|34|||
131672046|NCT00081770|474085693|FG002|Overall Study|Lost to Follow-up|45|||
131672047|NCT00081770|474085691|FG000|Overall Study|Protocol Violation|15|||
131672048|NCT00081770|474085692|FG001|Overall Study|Protocol Violation|10|||
131672049|NCT00081770|474085693|FG002|Overall Study|Protocol Violation|10|||
131672050|NCT00081770|474085691|FG000|Overall Study|Withdrawal by Subject|45|||
131672051|NCT00081770|474085692|FG001|Overall Study|Withdrawal by Subject|40|||
131672052|NCT00081770|474085693|FG002|Overall Study|Withdrawal by Subject|42|||
131672053|NCT00081770|474085691|FG000|Overall Study|Did not meet protocol eligibility|2|||
131672054|NCT00081770|474085692|FG001|Overall Study|Did not meet protocol eligibility|0|||
131672055|NCT00081770|474085693|FG002|Overall Study|Did not meet protocol eligibility|3|||
131672056|NCT00081770|474085691|FG000|Overall Study|Administrative|1|||
131672057|NCT00081770|474085692|FG001|Overall Study|Administrative|0|||
131672058|NCT00081770|474085693|FG002|Overall Study|Administrative|1|||
131672059|NCT00081770|474085691|FG000|Overall Study|Other|2|||
131672060|NCT00081770|474085692|FG001|Overall Study|Other|7|||
131672061|NCT00081770|474085693|FG002|Overall Study|Other|8|||
131672062|NCT00655486|474085699|FG000|Overall Study|Adverse Event|10|||
131672063|NCT00655486|474085699|FG000|Overall Study|Lack of Efficacy|8|||
131672064|NCT00655486|474085699|FG000|Overall Study|Withdrawal by Subject|4|||
131672065|NCT00655486|474085699|FG000|Overall Study|Protocol Violation|1|||
131672066|NCT00655486|474085699|FG000|Overall Study|Unsatisfactory compliance|2|||
131672067|NCT00655486|474085699|FG000|Overall Study|Other: Pregnancy|1|||
131672068|NCT00655486|474085699|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
131672069|NCT00655486|474085699|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
131672070|NCT02768870|474085710|FG000|Overall Study|Death|1|||
131672071|NCT02768870|474085710|FG000|Overall Study|Reoperation|6|||
131672072|NCT02768870|474085710|FG000|Overall Study|Lost to Follow-up|1|||
131672073|NCT02768870|474085710|FG000|Overall Study|Exit|4|||
131672074|NCT03401229|474085711|FG000|Overall Study|Lost to Follow-up|2|||
131672075|NCT03401229|474085712|FG001|Overall Study|Lost to Follow-up|1|||
131672076|NCT03401229|474085711|FG000|Overall Study|Other|1|||
131672077|NCT03401229|474085712|FG001|Overall Study|Other|3|||
131672078|NCT03401229|474085711|FG000|Overall Study|Adverse Event|8|||
131672079|NCT03401229|474085712|FG001|Overall Study|Adverse Event|6|||
131672080|NCT03401229|474085711|FG000|Overall Study|Withdrawal by Subject|29|||
131672081|NCT03401229|474085712|FG001|Overall Study|Withdrawal by Subject|26|||
131672082|NCT03401229|474085711|FG000|Overall Study|COVID-19|0|||
131672083|NCT03401229|474085712|FG001|Overall Study|COVID-19|1|||
131672084|NCT02963610|474085713|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
131672085|NCT01774110|474085714|FG000|Overall Study|Lost to Follow-up|7|||
131672086|NCT01122862|474085715|FG000|Period 1|Protocol Violation|0|||
131897063|NCT03272347|474910339|FG000|Overall Study|Lost to Follow-up|1|||
131897064|NCT03272347|474910340|FG001|Overall Study|Lost to Follow-up|3|||
131897065|NCT03272347|474910341|FG002|Overall Study|Lost to Follow-up|5|||
131897066|NCT03272347|474910342|FG003|Overall Study|Lost to Follow-up|1|||
131897067|NCT03272347|474910339|FG000|Overall Study|Physician Decision|4|||
131897068|NCT03272347|474910340|FG001|Overall Study|Physician Decision|2|||
131897069|NCT03272347|474910341|FG002|Overall Study|Physician Decision|5|||
131897070|NCT03272347|474910342|FG003|Overall Study|Physician Decision|4|||
131897071|NCT03272347|474910339|FG000|Overall Study|Screen Failure|1|||
131897072|NCT03272347|474910340|FG001|Overall Study|Screen Failure|0|||
131897073|NCT03272347|474910341|FG002|Overall Study|Screen Failure|0|||
131897074|NCT03272347|474910342|FG003|Overall Study|Screen Failure|0|||
131897075|NCT03272347|474910339|FG000|Overall Study|Withdrawal by Subject|5|||
131897076|NCT03272347|474910340|FG001|Overall Study|Withdrawal by Subject|1|||
131897077|NCT03272347|474910341|FG002|Overall Study|Withdrawal by Subject|2|||
131897078|NCT03272347|474910342|FG003|Overall Study|Withdrawal by Subject|1|||
131897079|NCT01239394|474910348|FG000|Overall Study|Adverse Event|1|||
131897080|NCT02861664|474910349|FG000|Overall Study|Withdrawal of Consent|0|||
131672087|NCT01122862|474085716|FG001|Period 1|Protocol Violation|1|||
131672088|NCT01122862|474085717|FG002|Period 1|Protocol Violation|0|||
131672089|NCT01122862|474085715|FG000|Period 2|Adverse Event|0|||
131672090|NCT01122862|474085716|FG001|Period 2|Adverse Event|0|||
131672091|NCT01122862|474085717|FG002|Period 2|Adverse Event|1|||
131672092|NCT00640016|474085718|FG000|Overall Study|Withdrawal by Subject|0|||
131672093|NCT00640016|474085719|FG001|Overall Study|Withdrawal by Subject|1|||
131672094|NCT00640016|474085720|FG002|Overall Study|Withdrawal by Subject|0|||
131672095|NCT00640016|474085721|FG003|Overall Study|Withdrawal by Subject|0|||
131672096|NCT00640016|474085718|FG000|Overall Study|Study termination|2|||
131672097|NCT00640016|474085719|FG001|Overall Study|Study termination|1|||
131672098|NCT00640016|474085720|FG002|Overall Study|Study termination|3|||
131672099|NCT00640016|474085721|FG003|Overall Study|Study termination|2|||
131672100|NCT00640016|474085718|FG000|Overall Study|Adverse Event|0|||
131672101|NCT00640016|474085719|FG001|Overall Study|Adverse Event|0|||
131672102|NCT00640016|474085720|FG002|Overall Study|Adverse Event|0|||
131672103|NCT00640016|474085721|FG003|Overall Study|Adverse Event|1|||
131672104|NCT02699983|474085724|FG000|Overall Study|Withdrawal by Subject|1|||
131672105|NCT02699983|474085725|FG001|Overall Study|Withdrawal by Subject|0|||
131672106|NCT03575143|474085726|FG000|Overall Study|Lost to Follow-up|0|||
131672107|NCT03575143|474085727|FG001|Overall Study|Lost to Follow-up|0|||
131672108|NCT03575143|474085728|FG002|Overall Study|Lost to Follow-up|4|||
131672109|NCT03575143|474085726|FG000|Overall Study|Withdrawal by Subject|0|||
131672110|NCT03575143|474085727|FG001|Overall Study|Withdrawal by Subject|0|||
131672111|NCT03575143|474085728|FG002|Overall Study|Withdrawal by Subject|5|||
131672112|NCT03575143|474085726|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
131672113|NCT03575143|474085727|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
131672114|NCT03575143|474085728|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
131672115|NCT01287065|474085729|FG000|Treatment Period 1|Adverse Event|0|||
131672116|NCT01287065|474085730|FG001|Treatment Period 1|Adverse Event|0|||
131672117|NCT01287065|474085731|FG002|Treatment Period 1|Adverse Event|0|||
131672118|NCT01287065|474085732|FG003|Treatment Period 1|Adverse Event|0|||
131672119|NCT01287065|474085733|FG004|Treatment Period 1|Adverse Event|1|||
131672120|NCT01287065|474085734|FG005|Treatment Period 1|Adverse Event|0|||
131672121|NCT01287065|474085729|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131672122|NCT01287065|474085730|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131672123|NCT01287065|474085731|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131672124|NCT01287065|474085732|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131672125|NCT01287065|474085733|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131672126|NCT01287065|474085734|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131672127|NCT02875977|474085737|FG000|Overall Study|Lost to Follow-up|42|||
131672128|NCT02875977|474085738|FG001|Overall Study|Lost to Follow-up|29|||
131672129|NCT01259726|474085739|FG000|Overall Study|Death|1|||
131672130|NCT01259726|474085740|FG001|Overall Study|Death|0|||
131672131|NCT01259726|474085741|FG002|Overall Study|Death|0|||
131672132|NCT01259726|474085742|FG003|Overall Study|Death|0|||
131672133|NCT01259726|474085739|FG000|Overall Study|Physician Decision|2|||
131672134|NCT01259726|474085740|FG001|Overall Study|Physician Decision|0|||
131672135|NCT01259726|474085741|FG002|Overall Study|Physician Decision|1|||
131672136|NCT01259726|474085742|FG003|Overall Study|Physician Decision|1|||
131672137|NCT01259726|474085739|FG000|Overall Study|Withdrawal by Subject|1|||
131672138|NCT01259726|474085740|FG001|Overall Study|Withdrawal by Subject|3|||
131672139|NCT01259726|474085741|FG002|Overall Study|Withdrawal by Subject|2|||
131672140|NCT01259726|474085742|FG003|Overall Study|Withdrawal by Subject|1|||
131672141|NCT01259726|474085739|FG000|Overall Study|Lost to Follow-up|1|||
131672142|NCT01259726|474085740|FG001|Overall Study|Lost to Follow-up|1|||
131672143|NCT01259726|474085741|FG002|Overall Study|Lost to Follow-up|1|||
131672144|NCT01259726|474085742|FG003|Overall Study|Lost to Follow-up|3|||
131672145|NCT03421431|474085750|FG000|Overall Study|Adverse Event|2|||
131672146|NCT03421431|474085751|FG001|Overall Study|Adverse Event|1|||
131672147|NCT03421431|474085752|FG002|Overall Study|Adverse Event|12|||
131672148|NCT03421431|474085750|FG000|Overall Study|Lost to Follow-up|1|||
131672149|NCT03421431|474085751|FG001|Overall Study|Lost to Follow-up|1|||
131672150|NCT03421431|474085752|FG002|Overall Study|Lost to Follow-up|1|||
131672151|NCT03421431|474085750|FG000|Overall Study|Withdrawal by Subject|3|||
131672152|NCT03421431|474085751|FG001|Overall Study|Withdrawal by Subject|2|||
131672153|NCT03421431|474085752|FG002|Overall Study|Withdrawal by Subject|1|||
131672154|NCT03421431|474085750|FG000|Overall Study|Protocol Violation|0|||
131672155|NCT03421431|474085751|FG001|Overall Study|Protocol Violation|1|||
131672156|NCT03421431|474085752|FG002|Overall Study|Protocol Violation|0|||
131672157|NCT03421431|474085750|FG000|Overall Study|Participant met Stopping Rules|0|||
131672158|NCT03421431|474085751|FG001|Overall Study|Participant met Stopping Rules|1|||
131672159|NCT03421431|474085752|FG002|Overall Study|Participant met Stopping Rules|0|||
131672160|NCT00141726|474085756|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
131672161|NCT00235326|474085761|FG000|Overall Study|Lost to Follow-up|746|||
131672162|NCT00235326|474085762|FG001|Overall Study|Lost to Follow-up|1400|||
131672163|NCT01790126|474085763|FG000|Overall Study|PSA Progression|12|||
131672164|NCT01790126|474085764|FG001|Overall Study|PSA Progression|16|||
131672165|NCT01790126|474085765|FG002|Overall Study|PSA Progression|16|||
131672166|NCT01790126|474085763|FG000|Overall Study|Other|5|||
131672167|NCT01790126|474085764|FG001|Overall Study|Other|4|||
131672168|NCT01790126|474085765|FG002|Overall Study|Other|8|||
131672169|NCT01790126|474085763|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
131672170|NCT01790126|474085764|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
131672171|NCT01790126|474085765|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
131672172|NCT01790126|474085763|FG000|Overall Study|Withdrawal by Physician|1|||
131672173|NCT01790126|474085764|FG001|Overall Study|Withdrawal by Physician|1|||
131672174|NCT01790126|474085765|FG002|Overall Study|Withdrawal by Physician|2|||
131672175|NCT01790126|474085763|FG000|Overall Study|Withdrawal by Subject|3|||
131672176|NCT01790126|474085764|FG001|Overall Study|Withdrawal by Subject|1|||
131672177|NCT01790126|474085765|FG002|Overall Study|Withdrawal by Subject|2|||
131672178|NCT01790126|474085763|FG000|Overall Study|Lost to Follow-up|1|||
131672179|NCT01790126|474085764|FG001|Overall Study|Lost to Follow-up|0|||
131672180|NCT01790126|474085765|FG002|Overall Study|Lost to Follow-up|1|||
131672181|NCT01790126|474085763|FG000|Overall Study|Adverse Event|0|||
131672182|NCT01790126|474085764|FG001|Overall Study|Adverse Event|2|||
131672183|NCT01790126|474085765|FG002|Overall Study|Adverse Event|0|||
131672184|NCT01790126|474085763|FG000|Overall Study|Death|2|||
131672185|NCT01790126|474085764|FG001|Overall Study|Death|0|||
131672186|NCT01790126|474085765|FG002|Overall Study|Death|0|||
131672187|NCT01790126|474085763|FG000|Overall Study|Radiographic Progression|3|||
131672188|NCT01790126|474085764|FG001|Overall Study|Radiographic Progression|1|||
131672189|NCT01790126|474085765|FG002|Overall Study|Radiographic Progression|0|||
131672190|NCT01128738|474085766|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
131672191|NCT01128738|474085767|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
131672192|NCT01128738|474085766|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
131555215|NCT02769065|473658124|FG023|Overall Study|Reason Not Specified|0|||
131555216|NCT02769065|473658125|FG024|Overall Study|Reason Not Specified|0|||
131555217|NCT02769065|473658126|FG025|Overall Study|Reason Not Specified|0|||
131555218|NCT02769065|473658127|FG026|Overall Study|Reason Not Specified|0|||
131555219|NCT02769065|473658128|FG027|Overall Study|Reason Not Specified|0|||
131555220|NCT02769065|473658129|FG028|Overall Study|Reason Not Specified|0|||
131555221|NCT02769065|473658130|FG029|Overall Study|Reason Not Specified|0|||
131672193|NCT01128738|474085767|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
131672194|NCT01128738|474085766|FG000|Second TP|Lost to Follow-up|0|||
131672195|NCT01128738|474085767|FG001|Second TP|Lost to Follow-up|1|||
131672196|NCT01128738|474085766|FG000|Second TP|Withdrawal by Subject|0|||
131672197|NCT01128738|474085767|FG001|Second TP|Withdrawal by Subject|2|||
131672198|NCT01178671|474085768|FG000|Overall Study|Adverse Event|4|||
131672199|NCT01178671|474085769|FG001|Overall Study|Adverse Event|6|||
131672200|NCT01178671|474085768|FG000|Overall Study|Protocol Violation|1|||
131555222|NCT02769065|473658101|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555223|NCT02769065|473658102|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672201|NCT01178671|474085769|FG001|Overall Study|Protocol Violation|1|||
131672202|NCT01178671|474085768|FG000|Overall Study|Lack of Efficacy|0|||
131672203|NCT01178671|474085769|FG001|Overall Study|Lack of Efficacy|1|||
131672204|NCT01178671|474085768|FG000|Overall Study|Lost to Follow-up|3|||
131672205|NCT01178671|474085769|FG001|Overall Study|Lost to Follow-up|1|||
131672206|NCT01178671|474085768|FG000|Overall Study|Physician Decision|4|||
131672207|NCT01178671|474085769|FG001|Overall Study|Physician Decision|6|||
131672208|NCT02435966|474085770|FG000|Overall Study|Withdrawal by Subject|0|||
131672209|NCT02435966|474085771|FG001|Overall Study|Withdrawal by Subject|1|||
131672210|NCT02435966|474085772|FG002|Overall Study|Withdrawal by Subject|0|||
131672211|NCT01211197|474085776|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131672212|NCT01211197|474085777|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131672213|NCT01211197|474085778|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131672214|NCT01211197|474085779|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131672215|NCT01211197|474085780|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131672216|NCT01211197|474085781|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131672217|NCT01211197|474085776|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
131672218|NCT01211197|474085777|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
131672219|NCT01211197|474085778|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
131672220|NCT01211197|474085779|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
131672221|NCT01211197|474085780|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
131672222|NCT01211197|474085781|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
131672223|NCT00406653|474085786|FG000|Induction Period|Adverse Event|1|||
131672224|NCT00406653|474085787|FG001|Induction Period|Adverse Event|10|||
131672225|NCT00406653|474085788|FG002|Induction Period|Adverse Event|4|||
131672226|NCT00406653|474085789|FG003|Induction Period|Adverse Event|11|||
131672227|NCT00406653|474085790|FG004|Induction Period|Adverse Event|0|||
131672228|NCT00406653|474085791|FG005|Induction Period|Adverse Event|0|||
131672229|NCT00406653|474085792|FG006|Induction Period|Adverse Event|0|||
131672230|NCT00406653|474085786|FG000|Induction Period|Lack of Efficacy|11|||
131672231|NCT00406653|474085787|FG001|Induction Period|Lack of Efficacy|14|||
131672232|NCT00406653|474085788|FG002|Induction Period|Lack of Efficacy|8|||
131672233|NCT00406653|474085789|FG003|Induction Period|Lack of Efficacy|10|||
131672234|NCT00406653|474085790|FG004|Induction Period|Lack of Efficacy|0|||
131672235|NCT00406653|474085791|FG005|Induction Period|Lack of Efficacy|0|||
131672236|NCT00406653|474085792|FG006|Induction Period|Lack of Efficacy|0|||
131672237|NCT00406653|474085786|FG000|Induction Period|Lost to Follow-up|0|||
131672238|NCT00406653|474085787|FG001|Induction Period|Lost to Follow-up|2|||
131672239|NCT00406653|474085788|FG002|Induction Period|Lost to Follow-up|0|||
131672240|NCT00406653|474085789|FG003|Induction Period|Lost to Follow-up|0|||
131672241|NCT00406653|474085790|FG004|Induction Period|Lost to Follow-up|0|||
131672242|NCT00406653|474085791|FG005|Induction Period|Lost to Follow-up|0|||
131672243|NCT00406653|474085792|FG006|Induction Period|Lost to Follow-up|0|||
131672244|NCT00406653|474085786|FG000|Induction Period|Withdrawal of Consent|2|||
131672245|NCT00406653|474085787|FG001|Induction Period|Withdrawal of Consent|5|||
131672246|NCT00406653|474085788|FG002|Induction Period|Withdrawal of Consent|1|||
131672247|NCT00406653|474085789|FG003|Induction Period|Withdrawal of Consent|2|||
131672248|NCT00406653|474085790|FG004|Induction Period|Withdrawal of Consent|0|||
131672249|NCT00406653|474085791|FG005|Induction Period|Withdrawal of Consent|0|||
131672250|NCT00406653|474085792|FG006|Induction Period|Withdrawal of Consent|0|||
131672251|NCT00406653|474085786|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
131672252|NCT00406653|474085787|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
131672253|NCT00406653|474085788|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
131672254|NCT00406653|474085789|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
131672255|NCT00406653|474085790|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
131672256|NCT00406653|474085791|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
131672257|NCT00406653|474085792|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
131672258|NCT00406653|474085786|FG000|Induction Period|Pregnancy|1|||
131672259|NCT00406653|474085787|FG001|Induction Period|Pregnancy|0|||
131672260|NCT00406653|474085788|FG002|Induction Period|Pregnancy|0|||
131672261|NCT00406653|474085789|FG003|Induction Period|Pregnancy|0|||
131672262|NCT00406653|474085790|FG004|Induction Period|Pregnancy|0|||
131672263|NCT00406653|474085791|FG005|Induction Period|Pregnancy|0|||
131672264|NCT00406653|474085792|FG006|Induction Period|Pregnancy|0|||
131672265|NCT00406653|474085786|FG000|Induction Period|Declined participation but followup done|0|||
131672266|NCT00406653|474085787|FG001|Induction Period|Declined participation but followup done|2|||
131672267|NCT00406653|474085788|FG002|Induction Period|Declined participation but followup done|1|||
131672268|NCT00406653|474085789|FG003|Induction Period|Declined participation but followup done|1|||
131672269|NCT00406653|474085790|FG004|Induction Period|Declined participation but followup done|0|||
131672270|NCT00406653|474085791|FG005|Induction Period|Declined participation but followup done|0|||
131672271|NCT00406653|474085792|FG006|Induction Period|Declined participation but followup done|0|||
131672272|NCT00406653|474085786|FG000|Induction Period|Given prohibited drug|0|||
131672273|NCT00406653|474085787|FG001|Induction Period|Given prohibited drug|1|||
131672274|NCT00406653|474085788|FG002|Induction Period|Given prohibited drug|2|||
131672275|NCT00406653|474085789|FG003|Induction Period|Given prohibited drug|0|||
131672276|NCT00406653|474085790|FG004|Induction Period|Given prohibited drug|0|||
131672277|NCT00406653|474085791|FG005|Induction Period|Given prohibited drug|0|||
131672278|NCT00406653|474085792|FG006|Induction Period|Given prohibited drug|0|||
131672279|NCT00406653|474085786|FG000|Induction Period|Incarcerated|0|||
131672280|NCT00406653|474085787|FG001|Induction Period|Incarcerated|0|||
131672281|NCT00406653|474085788|FG002|Induction Period|Incarcerated|1|||
131672282|NCT00406653|474085789|FG003|Induction Period|Incarcerated|0|||
131672283|NCT00406653|474085790|FG004|Induction Period|Incarcerated|0|||
131672284|NCT00406653|474085791|FG005|Induction Period|Incarcerated|0|||
131672285|NCT00406653|474085792|FG006|Induction Period|Incarcerated|0|||
131672286|NCT00406653|474085786|FG000|Induction Period|Patient relocated|0|||
131672287|NCT00406653|474085787|FG001|Induction Period|Patient relocated|0|||
131672288|NCT00406653|474085788|FG002|Induction Period|Patient relocated|1|||
131672289|NCT00406653|474085789|FG003|Induction Period|Patient relocated|0|||
131672290|NCT00406653|474085790|FG004|Induction Period|Patient relocated|0|||
131672291|NCT00406653|474085791|FG005|Induction Period|Patient relocated|0|||
131672292|NCT00406653|474085792|FG006|Induction Period|Patient relocated|0|||
131672293|NCT00406653|474085786|FG000|Maintenance Period|Adverse Event|0|||
131672294|NCT00406653|474085787|FG001|Maintenance Period|Adverse Event|0|||
131672295|NCT00406653|474085788|FG002|Maintenance Period|Adverse Event|0|||
131672296|NCT00406653|474085789|FG003|Maintenance Period|Adverse Event|0|||
131672297|NCT00406653|474085790|FG004|Maintenance Period|Adverse Event|1|||
131672298|NCT00406653|474085791|FG005|Maintenance Period|Adverse Event|1|||
131672299|NCT00406653|474085792|FG006|Maintenance Period|Adverse Event|0|||
131672300|NCT00406653|474085786|FG000|Maintenance Period|Lack of Efficacy|0|||
131672301|NCT00406653|474085787|FG001|Maintenance Period|Lack of Efficacy|0|||
131672302|NCT00406653|474085788|FG002|Maintenance Period|Lack of Efficacy|0|||
131672303|NCT00406653|474085789|FG003|Maintenance Period|Lack of Efficacy|0|||
131672304|NCT00406653|474085790|FG004|Maintenance Period|Lack of Efficacy|20|||
131672305|NCT00406653|474085791|FG005|Maintenance Period|Lack of Efficacy|26|||
131672306|NCT00406653|474085792|FG006|Maintenance Period|Lack of Efficacy|0|||
131672307|NCT00406653|474085786|FG000|Maintenance Period|Lost to Follow-up|0|||
131672308|NCT00406653|474085787|FG001|Maintenance Period|Lost to Follow-up|0|||
131672309|NCT00406653|474085788|FG002|Maintenance Period|Lost to Follow-up|0|||
131672310|NCT00406653|474085789|FG003|Maintenance Period|Lost to Follow-up|0|||
131672311|NCT00406653|474085790|FG004|Maintenance Period|Lost to Follow-up|2|||
131672312|NCT00406653|474085791|FG005|Maintenance Period|Lost to Follow-up|1|||
131672313|NCT00406653|474085792|FG006|Maintenance Period|Lost to Follow-up|0|||
131672314|NCT00406653|474085786|FG000|Maintenance Period|Withdrawal of Consent|0|||
131672315|NCT00406653|474085787|FG001|Maintenance Period|Withdrawal of Consent|0|||
131672316|NCT00406653|474085788|FG002|Maintenance Period|Withdrawal of Consent|0|||
131672317|NCT00406653|474085789|FG003|Maintenance Period|Withdrawal of Consent|0|||
131672318|NCT00406653|474085790|FG004|Maintenance Period|Withdrawal of Consent|2|||
131672319|NCT00406653|474085791|FG005|Maintenance Period|Withdrawal of Consent|0|||
131672320|NCT00406653|474085792|FG006|Maintenance Period|Withdrawal of Consent|0|||
131672321|NCT00406653|474085786|FG000|Maintenance Period|Pregnancy|0|||
131672322|NCT00406653|474085787|FG001|Maintenance Period|Pregnancy|0|||
131672323|NCT00406653|474085788|FG002|Maintenance Period|Pregnancy|0|||
131672324|NCT00406653|474085789|FG003|Maintenance Period|Pregnancy|0|||
131672325|NCT00406653|474085790|FG004|Maintenance Period|Pregnancy|0|||
131672326|NCT00406653|474085791|FG005|Maintenance Period|Pregnancy|1|||
131672327|NCT00406653|474085792|FG006|Maintenance Period|Pregnancy|0|||
131672328|NCT00406653|474085786|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
131672329|NCT00406653|474085787|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
131672330|NCT00406653|474085788|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
131672331|NCT00406653|474085789|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
131672332|NCT00406653|474085790|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
131672333|NCT00406653|474085791|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
131672334|NCT00406653|474085792|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
131672335|NCT00406653|474085786|FG000|Maintenance Period|Error in disease score evaluation|0|||
131672336|NCT00406653|474085787|FG001|Maintenance Period|Error in disease score evaluation|0|||
131672337|NCT00406653|474085788|FG002|Maintenance Period|Error in disease score evaluation|0|||
131672338|NCT00406653|474085789|FG003|Maintenance Period|Error in disease score evaluation|0|||
131672339|NCT00406653|474085790|FG004|Maintenance Period|Error in disease score evaluation|1|||
131672340|NCT00406653|474085791|FG005|Maintenance Period|Error in disease score evaluation|0|||
131672341|NCT00406653|474085792|FG006|Maintenance Period|Error in disease score evaluation|0|||
131672342|NCT00406653|474085786|FG000|Open-Label Period|Death|0|||
131672343|NCT00406653|474085787|FG001|Open-Label Period|Death|0|||
131672344|NCT00406653|474085788|FG002|Open-Label Period|Death|0|||
131672345|NCT00406653|474085789|FG003|Open-Label Period|Death|0|||
131672346|NCT00406653|474085790|FG004|Open-Label Period|Death|0|||
131672347|NCT00406653|474085791|FG005|Open-Label Period|Death|0|||
131672348|NCT00406653|474085792|FG006|Open-Label Period|Death|1|||
131672349|NCT00406653|474085786|FG000|Open-Label Period|Adverse Event|0|||
131672350|NCT00406653|474085787|FG001|Open-Label Period|Adverse Event|0|||
131672351|NCT00406653|474085788|FG002|Open-Label Period|Adverse Event|0|||
131672352|NCT00406653|474085789|FG003|Open-Label Period|Adverse Event|0|||
131672353|NCT00406653|474085790|FG004|Open-Label Period|Adverse Event|0|||
131672354|NCT00406653|474085791|FG005|Open-Label Period|Adverse Event|0|||
131672355|NCT00406653|474085792|FG006|Open-Label Period|Adverse Event|18|||
131672356|NCT00406653|474085786|FG000|Open-Label Period|Lack of Efficacy|0|||
131672357|NCT00406653|474085787|FG001|Open-Label Period|Lack of Efficacy|0|||
131672358|NCT00406653|474085788|FG002|Open-Label Period|Lack of Efficacy|0|||
131672359|NCT00406653|474085789|FG003|Open-Label Period|Lack of Efficacy|0|||
131672360|NCT00406653|474085790|FG004|Open-Label Period|Lack of Efficacy|0|||
131672361|NCT00406653|474085791|FG005|Open-Label Period|Lack of Efficacy|0|||
131672362|NCT00406653|474085792|FG006|Open-Label Period|Lack of Efficacy|160|||
131672363|NCT00406653|474085786|FG000|Open-Label Period|Lost to Follow-up|0|||
131672364|NCT00406653|474085787|FG001|Open-Label Period|Lost to Follow-up|0|||
131672365|NCT00406653|474085788|FG002|Open-Label Period|Lost to Follow-up|0|||
131672366|NCT00406653|474085789|FG003|Open-Label Period|Lost to Follow-up|0|||
131672367|NCT00406653|474085790|FG004|Open-Label Period|Lost to Follow-up|0|||
131672368|NCT00406653|474085791|FG005|Open-Label Period|Lost to Follow-up|0|||
131672369|NCT00406653|474085792|FG006|Open-Label Period|Lost to Follow-up|6|||
131672370|NCT00406653|474085786|FG000|Open-Label Period|Withdrawal of Consent|0|||
131672371|NCT00406653|474085787|FG001|Open-Label Period|Withdrawal of Consent|0|||
131672372|NCT00406653|474085788|FG002|Open-Label Period|Withdrawal of Consent|0|||
131672373|NCT00406653|474085789|FG003|Open-Label Period|Withdrawal of Consent|0|||
131672374|NCT00406653|474085790|FG004|Open-Label Period|Withdrawal of Consent|0|||
131672375|NCT00406653|474085791|FG005|Open-Label Period|Withdrawal of Consent|0|||
131672376|NCT00406653|474085792|FG006|Open-Label Period|Withdrawal of Consent|11|||
131672377|NCT00406653|474085786|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131672378|NCT00406653|474085787|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131672379|NCT00406653|474085788|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131672380|NCT00406653|474085789|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131555224|NCT02769065|473658103|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672381|NCT00406653|474085790|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131672382|NCT00406653|474085791|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131672383|NCT00406653|474085792|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
131672384|NCT00406653|474085786|FG000|Open-Label Period|Pregnancy|0|||
131672385|NCT00406653|474085787|FG001|Open-Label Period|Pregnancy|0|||
131672386|NCT00406653|474085788|FG002|Open-Label Period|Pregnancy|0|||
131672387|NCT00406653|474085789|FG003|Open-Label Period|Pregnancy|0|||
131672388|NCT00406653|474085790|FG004|Open-Label Period|Pregnancy|0|||
131672389|NCT00406653|474085791|FG005|Open-Label Period|Pregnancy|0|||
131672390|NCT00406653|474085792|FG006|Open-Label Period|Pregnancy|2|||
131672391|NCT00406653|474085786|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
131672392|NCT00406653|474085787|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
131672393|NCT00406653|474085788|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
131672394|NCT00406653|474085789|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
131672395|NCT00406653|474085790|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
131672396|NCT00406653|474085791|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
131448269|NCT02079246|473272632|FG001|OLEX|Results of the lead-in studies|0|||
131672397|NCT00406653|474085792|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
131672398|NCT00406653|474085786|FG000|Open-Label Period|Declined participation but followup done|0|||
131672399|NCT00406653|474085787|FG001|Open-Label Period|Declined participation but followup done|0|||
131672400|NCT00406653|474085788|FG002|Open-Label Period|Declined participation but followup done|0|||
131672401|NCT00406653|474085789|FG003|Open-Label Period|Declined participation but followup done|0|||
131672402|NCT00406653|474085790|FG004|Open-Label Period|Declined participation but followup done|0|||
131672403|NCT00406653|474085791|FG005|Open-Label Period|Declined participation but followup done|0|||
131672404|NCT00406653|474085792|FG006|Open-Label Period|Declined participation but followup done|8|||
131672405|NCT00406653|474085786|FG000|Open-Label Period|Discontinued by Sponsor|0|||
131672406|NCT00406653|474085787|FG001|Open-Label Period|Discontinued by Sponsor|0|||
131672407|NCT00406653|474085788|FG002|Open-Label Period|Discontinued by Sponsor|0|||
131672408|NCT00406653|474085789|FG003|Open-Label Period|Discontinued by Sponsor|0|||
131672409|NCT00406653|474085790|FG004|Open-Label Period|Discontinued by Sponsor|0|||
131672410|NCT00406653|474085791|FG005|Open-Label Period|Discontinued by Sponsor|0|||
131672411|NCT00406653|474085792|FG006|Open-Label Period|Discontinued by Sponsor|1|||
131672412|NCT00406653|474085786|FG000|Open-Label Period|Refused followup|0|||
131672413|NCT00406653|474085787|FG001|Open-Label Period|Refused followup|0|||
131672414|NCT00406653|474085788|FG002|Open-Label Period|Refused followup|0|||
131672415|NCT00406653|474085789|FG003|Open-Label Period|Refused followup|0|||
131672416|NCT00406653|474085790|FG004|Open-Label Period|Refused followup|0|||
131672417|NCT00406653|474085791|FG005|Open-Label Period|Refused followup|0|||
131672418|NCT00406653|474085792|FG006|Open-Label Period|Refused followup|1|||
131672419|NCT00818649|474085793|FG000|Overall Study|Declining performance status|2|||
131672420|NCT00818649|474085793|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
131672421|NCT00818649|474085793|FG000|Overall Study|Adverse Event|1|||
131672422|NCT03513588|474085794|FG000|Overall Study|Lost to Follow-up|0|||
131672423|NCT03513588|474085795|FG001|Overall Study|Lost to Follow-up|1|||
131672424|NCT03513588|474085796|FG002|Overall Study|Lost to Follow-up|1|||
131672425|NCT03513588|474085794|FG000|Overall Study|Study dosing paused by sponsor|1|||
131672426|NCT03513588|474085795|FG001|Overall Study|Study dosing paused by sponsor|1|||
131672427|NCT03513588|474085796|FG002|Overall Study|Study dosing paused by sponsor|0|||
131672428|NCT03513588|474085794|FG000|Overall Study|Death|0|||
131672429|NCT03513588|474085795|FG001|Overall Study|Death|0|||
131672430|NCT03513588|474085796|FG002|Overall Study|Death|1|||
131672431|NCT00940108|474085800|FG000|Overall Study|Adverse Event|2|||
131672432|NCT00940108|474085801|FG001|Overall Study|Adverse Event|4|||
131672433|NCT00940108|474085802|FG002|Overall Study|Adverse Event|0|||
131672434|NCT00940108|474085803|FG003|Overall Study|Adverse Event|2|||
131672435|NCT00940108|474085800|FG000|Overall Study|Withdrew Consent|2|||
131555225|NCT02769065|473658104|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672436|NCT00940108|474085801|FG001|Overall Study|Withdrew Consent|1|||
131672437|NCT00940108|474085802|FG002|Overall Study|Withdrew Consent|0|||
131672438|NCT00940108|474085803|FG003|Overall Study|Withdrew Consent|1|||
131672439|NCT00940108|474085800|FG000|Overall Study|Dose 2 contraindicated|1|||
131672440|NCT00940108|474085801|FG001|Overall Study|Dose 2 contraindicated|1|||
131672441|NCT00940108|474085802|FG002|Overall Study|Dose 2 contraindicated|0|||
131672442|NCT00940108|474085803|FG003|Overall Study|Dose 2 contraindicated|1|||
131672443|NCT00940108|474085800|FG000|Overall Study|Declined further vaccination|0|||
131672444|NCT00940108|474085801|FG001|Overall Study|Declined further vaccination|1|||
131672445|NCT00940108|474085802|FG002|Overall Study|Declined further vaccination|3|||
131672446|NCT00940108|474085803|FG003|Overall Study|Declined further vaccination|0|||
131555226|NCT02769065|473658105|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555227|NCT02769065|473658106|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555228|NCT02769065|473658107|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555229|NCT02769065|473658108|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555230|NCT02769065|473658109|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555231|NCT02769065|473658110|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555232|NCT02769065|473658111|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
131448270|NCT02079246|473272631|FG000|OLEX|Other: Disallowed medication|8|||
131555233|NCT02769065|473658112|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555234|NCT02769065|473658113|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555235|NCT02769065|473658114|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555236|NCT02769065|473658115|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672447|NCT00940108|474085800|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
131672448|NCT00940108|474085801|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
131672449|NCT00940108|474085802|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
131672450|NCT00940108|474085803|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
131672451|NCT00940108|474085800|FG000|Overall Study|Viral illness after Dose 1|0|||
131672452|NCT00940108|474085801|FG001|Overall Study|Viral illness after Dose 1|1|||
131672453|NCT00940108|474085802|FG002|Overall Study|Viral illness after Dose 1|0|||
131672454|NCT00940108|474085803|FG003|Overall Study|Viral illness after Dose 1|0|||
131672455|NCT00940108|474085800|FG000|Overall Study|Diagnosed with H1N1|0|||
131672456|NCT00940108|474085801|FG001|Overall Study|Diagnosed with H1N1|0|||
131672457|NCT00940108|474085802|FG002|Overall Study|Diagnosed with H1N1|0|||
131672458|NCT00940108|474085803|FG003|Overall Study|Diagnosed with H1N1|1|||
131672459|NCT02075541|474085804|FG000|Overall Study|Serious Adverse Event|1|||
131772383|NCT01258803|474445062|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
131672460|NCT02075541|474085805|FG001|Overall Study|Serious Adverse Event|4|||
131672461|NCT02075541|474085804|FG000|Overall Study|Protocol Violation|1|||
131672462|NCT02075541|474085805|FG001|Overall Study|Protocol Violation|0|||
131672463|NCT02075541|474085804|FG000|Overall Study|Withdrawal by Subject|1|||
131672464|NCT02075541|474085805|FG001|Overall Study|Withdrawal by Subject|3|||
131672465|NCT02075541|474085804|FG000|Overall Study|Sponsor study termination|0|||
131672466|NCT02075541|474085805|FG001|Overall Study|Sponsor study termination|1|||
131672467|NCT02075541|474085804|FG000|Overall Study|Other- unable to perform study procedure|1|||
131672468|NCT02075541|474085805|FG001|Overall Study|Other- unable to perform study procedure|0|||
131772384|NCT01258803|474445063|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
131772385|NCT01258803|474445064|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
131772386|NCT01258803|474445059|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131772387|NCT01258803|474445060|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
131772388|NCT01258803|474445061|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131772389|NCT01258803|474445062|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131772390|NCT01258803|474445063|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131772391|NCT01258803|474445064|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131772392|NCT01258803|474445059|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131772393|NCT01258803|474445060|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131772394|NCT01258803|474445061|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
131772395|NCT01258803|474445062|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131672469|NCT01142596|474085807|FG000|Overall Study|Withdrawal by Subject|9|||
131672470|NCT01142596|474085808|FG001|Overall Study|Withdrawal by Subject|35|||
131672471|NCT01142596|474085807|FG000|Overall Study|Adverse Event|8|||
131672472|NCT01142596|474085808|FG001|Overall Study|Adverse Event|35|||
131672473|NCT01142596|474085807|FG000|Overall Study|Lack of Efficacy|5|||
131448271|NCT02079246|473272632|FG001|OLEX|Other: Disallowed medication|0|||
131672474|NCT01142596|474085808|FG001|Overall Study|Lack of Efficacy|9|||
131672475|NCT01142596|474085807|FG000|Overall Study|Lost to Follow-up|2|||
131672476|NCT01142596|474085808|FG001|Overall Study|Lost to Follow-up|3|||
131672477|NCT01142596|474085807|FG000|Overall Study|Other reason (not specified)|5|||
131672478|NCT01142596|474085808|FG001|Overall Study|Other reason (not specified)|4|||
131672479|NCT01971203|474085809|FG000|Overall Study|Protocol Violation|3|||
131672480|NCT01971203|474085810|FG001|Overall Study|Protocol Violation|2|||
131672481|NCT01971203|474085809|FG000|Overall Study|Withdrawal by Subject|5|||
131672482|NCT01971203|474085810|FG001|Overall Study|Withdrawal by Subject|6|||
131672483|NCT01971203|474085809|FG000|Overall Study|Adverse Event|1|||
131672484|NCT01971203|474085810|FG001|Overall Study|Adverse Event|0|||
131672485|NCT01012713|474085811|FG000|Overall Study|Lack of Efficacy|3|||
131672486|NCT00985153|474085812|FG000|Overall Study|Lost to Follow-up|16|||
131672487|NCT00985153|474085813|FG001|Overall Study|Lost to Follow-up|19|||
131672488|NCT00985153|474085814|FG002|Overall Study|Lost to Follow-up|17|||
131672489|NCT00985153|474085815|FG003|Overall Study|Lost to Follow-up|20|||
131672490|NCT00985153|474085812|FG000|Overall Study|Protocol Violation|3|||
131672491|NCT00985153|474085813|FG001|Overall Study|Protocol Violation|2|||
131672492|NCT00985153|474085814|FG002|Overall Study|Protocol Violation|4|||
131672493|NCT00985153|474085815|FG003|Overall Study|Protocol Violation|3|||
131672494|NCT00985153|474085812|FG000|Overall Study|Withdrawal by Subject|6|||
131435980|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
131435981|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
131435982|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
131435983|NCT02586623|473221905|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
131435984|NCT02586623|473221906|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
131435985|NCT02586623|473221907|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
131435986|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
131672495|NCT00985153|474085813|FG001|Overall Study|Withdrawal by Subject|11|||
131435987|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
131672496|NCT00985153|474085814|FG002|Overall Study|Withdrawal by Subject|11|||
131672497|NCT00985153|474085815|FG003|Overall Study|Withdrawal by Subject|10|||
131672498|NCT00985153|474085812|FG000|Overall Study|Missed One or More Bleeds|7|||
131672499|NCT00985153|474085813|FG001|Overall Study|Missed One or More Bleeds|7|||
131672500|NCT00985153|474085814|FG002|Overall Study|Missed One or More Bleeds|8|||
131555237|NCT02769065|473658116|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672501|NCT00985153|474085815|FG003|Overall Study|Missed One or More Bleeds|10|||
131672502|NCT00985153|474085812|FG000|Overall Study|Incomplete Safety Follow-up|3|||
131672503|NCT00985153|474085813|FG001|Overall Study|Incomplete Safety Follow-up|5|||
131672504|NCT00985153|474085814|FG002|Overall Study|Incomplete Safety Follow-up|4|||
131672505|NCT00985153|474085815|FG003|Overall Study|Incomplete Safety Follow-up|4|||
131672506|NCT00585195|474085822|FG000|Overall Study|Adverse Event|0|||
131672507|NCT00585195|474085823|FG001|Overall Study|Adverse Event|0|||
131672508|NCT00585195|474085824|FG002|Overall Study|Adverse Event|0|||
131672509|NCT00585195|474085825|FG003|Overall Study|Adverse Event|0|||
131672510|NCT00585195|474085826|FG004|Overall Study|Adverse Event|2|||
131672511|NCT00585195|474085827|FG005|Overall Study|Adverse Event|1|||
131672512|NCT00585195|474085828|FG006|Overall Study|Adverse Event|0|||
131672513|NCT00585195|474085829|FG007|Overall Study|Adverse Event|1|||
131672514|NCT00585195|474085830|FG008|Overall Study|Adverse Event|0|||
131672515|NCT00585195|474085831|FG009|Overall Study|Adverse Event|0|||
131672516|NCT00585195|474085832|FG010|Overall Study|Adverse Event|3|||
131672517|NCT00585195|474085833|FG011|Overall Study|Adverse Event|0|||
131672518|NCT00585195|474085834|FG012|Overall Study|Adverse Event|8|||
131672519|NCT00585195|474085835|FG013|Overall Study|Adverse Event|6|||
131672520|NCT00585195|474085836|FG014|Overall Study|Adverse Event|4|||
131672521|NCT00585195|474085837|FG015|Overall Study|Adverse Event|1|||
131672522|NCT00585195|474085838|FG016|Overall Study|Adverse Event|14|||
131672523|NCT00585195|474085839|FG017|Overall Study|Adverse Event|9|||
131672524|NCT00585195|474085840|FG018|Overall Study|Adverse Event|2|||
131672525|NCT00585195|474085841|FG019|Overall Study|Adverse Event|3|||
131672526|NCT00585195|474085842|FG020|Overall Study|Adverse Event|1|||
131672527|NCT00585195|474085822|FG000|Overall Study|Progressive Disease|2|||
131672528|NCT00585195|474085823|FG001|Overall Study|Progressive Disease|2|||
131672529|NCT00585195|474085824|FG002|Overall Study|Progressive Disease|5|||
131672530|NCT00585195|474085825|FG003|Overall Study|Progressive Disease|4|||
131672531|NCT00585195|474085826|FG004|Overall Study|Progressive Disease|6|||
131672532|NCT00585195|474085827|FG005|Overall Study|Progressive Disease|4|||
131672533|NCT00585195|474085828|FG006|Overall Study|Progressive Disease|6|||
131672534|NCT00585195|474085829|FG007|Overall Study|Progressive Disease|3|||
131672535|NCT00585195|474085830|FG008|Overall Study|Progressive Disease|0|||
131672536|NCT00585195|474085831|FG009|Overall Study|Progressive Disease|5|||
131672537|NCT00585195|474085832|FG010|Overall Study|Progressive Disease|2|||
131672538|NCT00585195|474085833|FG011|Overall Study|Progressive Disease|25|||
131672539|NCT00585195|474085834|FG012|Overall Study|Progressive Disease|29|||
131672540|NCT00585195|474085835|FG013|Overall Study|Progressive Disease|26|||
131672541|NCT00585195|474085836|FG014|Overall Study|Progressive Disease|21|||
131672542|NCT00585195|474085837|FG015|Overall Study|Progressive Disease|12|||
131672543|NCT00585195|474085838|FG016|Overall Study|Progressive Disease|94|||
131672544|NCT00585195|474085839|FG017|Overall Study|Progressive Disease|42|||
131672545|NCT00585195|474085840|FG018|Overall Study|Progressive Disease|4|||
131672546|NCT00585195|474085841|FG019|Overall Study|Progressive Disease|9|||
131672547|NCT00585195|474085842|FG020|Overall Study|Progressive Disease|8|||
131672548|NCT00585195|474085822|FG000|Overall Study|Withdrawal by Subject|1|||
131672549|NCT00585195|474085823|FG001|Overall Study|Withdrawal by Subject|1|||
131672550|NCT00585195|474085824|FG002|Overall Study|Withdrawal by Subject|2|||
131672551|NCT00585195|474085825|FG003|Overall Study|Withdrawal by Subject|2|||
131672552|NCT00585195|474085826|FG004|Overall Study|Withdrawal by Subject|0|||
131672553|NCT00585195|474085827|FG005|Overall Study|Withdrawal by Subject|0|||
131672554|NCT00585195|474085828|FG006|Overall Study|Withdrawal by Subject|0|||
131672555|NCT00585195|474085829|FG007|Overall Study|Withdrawal by Subject|1|||
131672556|NCT00585195|474085830|FG008|Overall Study|Withdrawal by Subject|0|||
131672557|NCT00585195|474085831|FG009|Overall Study|Withdrawal by Subject|0|||
131672558|NCT00585195|474085832|FG010|Overall Study|Withdrawal by Subject|3|||
131672559|NCT00585195|474085833|FG011|Overall Study|Withdrawal by Subject|8|||
131672560|NCT00585195|474085834|FG012|Overall Study|Withdrawal by Subject|15|||
131672561|NCT00585195|474085835|FG013|Overall Study|Withdrawal by Subject|0|||
131672562|NCT00585195|474085836|FG014|Overall Study|Withdrawal by Subject|3|||
131672563|NCT00585195|474085837|FG015|Overall Study|Withdrawal by Subject|0|||
131672564|NCT00585195|474085838|FG016|Overall Study|Withdrawal by Subject|7|||
131672565|NCT00585195|474085839|FG017|Overall Study|Withdrawal by Subject|1|||
131672566|NCT00585195|474085840|FG018|Overall Study|Withdrawal by Subject|2|||
131672567|NCT00585195|474085841|FG019|Overall Study|Withdrawal by Subject|2|||
131672568|NCT00585195|474085842|FG020|Overall Study|Withdrawal by Subject|0|||
131672569|NCT00585195|474085822|FG000|Overall Study|Other|0|||
131672570|NCT00585195|474085823|FG001|Overall Study|Other|1|||
131672571|NCT00585195|474085824|FG002|Overall Study|Other|1|||
131672572|NCT00585195|474085825|FG003|Overall Study|Other|1|||
131672573|NCT00585195|474085826|FG004|Overall Study|Other|0|||
131672574|NCT00585195|474085827|FG005|Overall Study|Other|1|||
131672575|NCT00585195|474085828|FG006|Overall Study|Other|0|||
131672576|NCT00585195|474085829|FG007|Overall Study|Other|0|||
131672577|NCT00585195|474085830|FG008|Overall Study|Other|2|||
131672578|NCT00585195|474085831|FG009|Overall Study|Other|1|||
131672579|NCT00585195|474085832|FG010|Overall Study|Other|0|||
131672580|NCT00585195|474085833|FG011|Overall Study|Other|19|||
131672581|NCT00585195|474085834|FG012|Overall Study|Other|24|||
131672582|NCT00585195|474085835|FG013|Overall Study|Other|7|||
131672583|NCT00585195|474085836|FG014|Overall Study|Other|11|||
131672584|NCT00585195|474085837|FG015|Overall Study|Other|3|||
131672585|NCT00585195|474085838|FG016|Overall Study|Other|28|||
131672586|NCT00585195|474085839|FG017|Overall Study|Other|12|||
131672587|NCT00585195|474085840|FG018|Overall Study|Other|10|||
131672588|NCT00585195|474085841|FG019|Overall Study|Other|4|||
131672589|NCT00585195|474085842|FG020|Overall Study|Other|2|||
131555238|NCT02769065|473658117|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672590|NCT00585195|474085822|FG000|Overall Study|Randomized not treated|0|||
131672591|NCT00585195|474085823|FG001|Overall Study|Randomized not treated|0|||
131672592|NCT00585195|474085824|FG002|Overall Study|Randomized not treated|1|||
131672593|NCT00585195|474085825|FG003|Overall Study|Randomized not treated|0|||
131672594|NCT00585195|474085826|FG004|Overall Study|Randomized not treated|1|||
131672595|NCT00585195|474085827|FG005|Overall Study|Randomized not treated|0|||
131672596|NCT00585195|474085828|FG006|Overall Study|Randomized not treated|1|||
131672597|NCT00585195|474085829|FG007|Overall Study|Randomized not treated|0|||
131672598|NCT00585195|474085830|FG008|Overall Study|Randomized not treated|0|||
131672599|NCT00585195|474085831|FG009|Overall Study|Randomized not treated|0|||
131672600|NCT00585195|474085832|FG010|Overall Study|Randomized not treated|2|||
131672601|NCT00585195|474085833|FG011|Overall Study|Randomized not treated|0|||
131672602|NCT00585195|474085834|FG012|Overall Study|Randomized not treated|0|||
131672603|NCT00585195|474085835|FG013|Overall Study|Randomized not treated|0|||
131672604|NCT00585195|474085836|FG014|Overall Study|Randomized not treated|0|||
131672605|NCT00585195|474085837|FG015|Overall Study|Randomized not treated|1|||
131672606|NCT00585195|474085838|FG016|Overall Study|Randomized not treated|0|||
131672607|NCT00585195|474085839|FG017|Overall Study|Randomized not treated|1|||
131672608|NCT00585195|474085840|FG018|Overall Study|Randomized not treated|3|||
131672609|NCT00585195|474085841|FG019|Overall Study|Randomized not treated|0|||
131672610|NCT00585195|474085842|FG020|Overall Study|Randomized not treated|2|||
131672611|NCT00585195|474085822|FG000|Overall Study|Death|0|||
131672612|NCT00585195|474085823|FG001|Overall Study|Death|0|||
131672613|NCT00585195|474085824|FG002|Overall Study|Death|0|||
131672614|NCT00585195|474085825|FG003|Overall Study|Death|0|||
131672615|NCT00585195|474085826|FG004|Overall Study|Death|0|||
131672616|NCT00585195|474085827|FG005|Overall Study|Death|0|||
131672617|NCT00585195|474085828|FG006|Overall Study|Death|0|||
131672618|NCT00585195|474085829|FG007|Overall Study|Death|0|||
131672619|NCT00585195|474085830|FG008|Overall Study|Death|1|||
131672620|NCT00585195|474085831|FG009|Overall Study|Death|0|||
131672621|NCT00585195|474085832|FG010|Overall Study|Death|1|||
131672622|NCT00585195|474085833|FG011|Overall Study|Death|1|||
131672623|NCT00585195|474085834|FG012|Overall Study|Death|7|||
131672624|NCT00585195|474085835|FG013|Overall Study|Death|2|||
131672625|NCT00585195|474085836|FG014|Overall Study|Death|8|||
131672626|NCT00585195|474085837|FG015|Overall Study|Death|2|||
131672627|NCT00585195|474085838|FG016|Overall Study|Death|11|||
131672628|NCT00585195|474085839|FG017|Overall Study|Death|0|||
131672629|NCT00585195|474085840|FG018|Overall Study|Death|0|||
131672630|NCT00585195|474085841|FG019|Overall Study|Death|0|||
131672631|NCT00585195|474085842|FG020|Overall Study|Death|1|||
131672632|NCT00585195|474085822|FG000|Overall Study|Lost to Follow-up|0|||
131672633|NCT00585195|474085823|FG001|Overall Study|Lost to Follow-up|0|||
131672634|NCT00585195|474085824|FG002|Overall Study|Lost to Follow-up|0|||
131672635|NCT00585195|474085825|FG003|Overall Study|Lost to Follow-up|0|||
131672636|NCT00585195|474085826|FG004|Overall Study|Lost to Follow-up|0|||
131672637|NCT00585195|474085827|FG005|Overall Study|Lost to Follow-up|0|||
131672638|NCT00585195|474085828|FG006|Overall Study|Lost to Follow-up|0|||
131672639|NCT00585195|474085829|FG007|Overall Study|Lost to Follow-up|0|||
131672640|NCT00585195|474085830|FG008|Overall Study|Lost to Follow-up|0|||
131672641|NCT00585195|474085831|FG009|Overall Study|Lost to Follow-up|0|||
131672642|NCT00585195|474085832|FG010|Overall Study|Lost to Follow-up|0|||
131672643|NCT00585195|474085833|FG011|Overall Study|Lost to Follow-up|0|||
131672644|NCT00585195|474085834|FG012|Overall Study|Lost to Follow-up|1|||
131672645|NCT00585195|474085835|FG013|Overall Study|Lost to Follow-up|0|||
131672646|NCT00585195|474085836|FG014|Overall Study|Lost to Follow-up|0|||
131672647|NCT00585195|474085837|FG015|Overall Study|Lost to Follow-up|0|||
131672648|NCT00585195|474085838|FG016|Overall Study|Lost to Follow-up|0|||
131672649|NCT00585195|474085839|FG017|Overall Study|Lost to Follow-up|2|||
131672650|NCT00585195|474085840|FG018|Overall Study|Lost to Follow-up|0|||
131672651|NCT00585195|474085841|FG019|Overall Study|Lost to Follow-up|0|||
131672652|NCT00585195|474085842|FG020|Overall Study|Lost to Follow-up|0|||
131672653|NCT00585195|474085822|FG000|Overall Study|Site Terminated by Sponsor|0|||
131672654|NCT00585195|474085823|FG001|Overall Study|Site Terminated by Sponsor|0|||
131672655|NCT00585195|474085824|FG002|Overall Study|Site Terminated by Sponsor|0|||
131672656|NCT00585195|474085825|FG003|Overall Study|Site Terminated by Sponsor|0|||
131672657|NCT00585195|474085826|FG004|Overall Study|Site Terminated by Sponsor|0|||
131672658|NCT00585195|474085827|FG005|Overall Study|Site Terminated by Sponsor|0|||
131672659|NCT00585195|474085828|FG006|Overall Study|Site Terminated by Sponsor|0|||
131672660|NCT00585195|474085829|FG007|Overall Study|Site Terminated by Sponsor|0|||
131672661|NCT00585195|474085830|FG008|Overall Study|Site Terminated by Sponsor|0|||
131672662|NCT00585195|474085831|FG009|Overall Study|Site Terminated by Sponsor|0|||
131672663|NCT00585195|474085832|FG010|Overall Study|Site Terminated by Sponsor|0|||
131672664|NCT00585195|474085833|FG011|Overall Study|Site Terminated by Sponsor|0|||
131672665|NCT00585195|474085834|FG012|Overall Study|Site Terminated by Sponsor|1|||
131672666|NCT00585195|474085835|FG013|Overall Study|Site Terminated by Sponsor|0|||
131672667|NCT00585195|474085836|FG014|Overall Study|Site Terminated by Sponsor|0|||
131672668|NCT00585195|474085837|FG015|Overall Study|Site Terminated by Sponsor|0|||
131672669|NCT00585195|474085838|FG016|Overall Study|Site Terminated by Sponsor|0|||
131672670|NCT00585195|474085839|FG017|Overall Study|Site Terminated by Sponsor|0|||
131672671|NCT00585195|474085840|FG018|Overall Study|Site Terminated by Sponsor|0|||
131672672|NCT00585195|474085841|FG019|Overall Study|Site Terminated by Sponsor|0|||
131672673|NCT00585195|474085842|FG020|Overall Study|Site Terminated by Sponsor|0|||
131672674|NCT00585195|474085822|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
131672675|NCT00585195|474085823|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
131672676|NCT00585195|474085824|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
131672677|NCT00585195|474085825|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
131672678|NCT00585195|474085826|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
131672679|NCT00585195|474085827|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
131672680|NCT00585195|474085828|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
131672681|NCT00585195|474085829|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
131672682|NCT00585195|474085830|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
131672683|NCT00585195|474085831|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
131672684|NCT00585195|474085832|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
131672685|NCT00585195|474085833|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
131672686|NCT00585195|474085834|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
131672687|NCT00585195|474085835|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
131672688|NCT00585195|474085836|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
131672689|NCT00585195|474085837|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
131672690|NCT00585195|474085838|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
131672691|NCT00585195|474085839|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
131672692|NCT00585195|474085840|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
131672693|NCT00585195|474085841|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
131672694|NCT00585195|474085842|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
131672695|NCT00770341|474085843|FG000|Overall Study|Did not meet eligibility criteria|1|||
131672696|NCT00770341|474085844|FG001|Overall Study|Did not meet eligibility criteria|0|||
131672697|NCT00770341|474085845|FG002|Overall Study|Did not meet eligibility criteria|0|||
131672698|NCT00770341|474085843|FG000|Overall Study|Withdrawal by Subject|0|||
131672699|NCT00770341|474085844|FG001|Overall Study|Withdrawal by Subject|1|||
131672700|NCT00770341|474085845|FG002|Overall Study|Withdrawal by Subject|0|||
131672701|NCT00770341|474085843|FG000|Overall Study|Clinical Adverse Event|3|||
131672702|NCT00770341|474085844|FG001|Overall Study|Clinical Adverse Event|1|||
131672703|NCT00770341|474085845|FG002|Overall Study|Clinical Adverse Event|2|||
131672704|NCT00770341|474085843|FG000|Overall Study|Laboratory adverse event|3|||
131672705|NCT00770341|474085844|FG001|Overall Study|Laboratory adverse event|3|||
131672706|NCT00770341|474085845|FG002|Overall Study|Laboratory adverse event|0|||
131672707|NCT00770341|474085843|FG000|Overall Study|Lack of Efficacy|3|||
131672708|NCT00770341|474085844|FG001|Overall Study|Lack of Efficacy|0|||
131672709|NCT00770341|474085845|FG002|Overall Study|Lack of Efficacy|1|||
131672710|NCT00770341|474085843|FG000|Overall Study|Other|1|||
131672711|NCT00770341|474085844|FG001|Overall Study|Other|0|||
131672712|NCT00770341|474085845|FG002|Overall Study|Other|0|||
131672713|NCT00770341|474085843|FG000|Overall Study|Not treated|1|||
131672714|NCT00770341|474085844|FG001|Overall Study|Not treated|0|||
131672715|NCT00770341|474085845|FG002|Overall Study|Not treated|0|||
131672716|NCT00960531|474085851|FG000|Overall Study|Lack of Efficacy|1|||
131672717|NCT00960531|474085852|FG001|Overall Study|Lack of Efficacy|0|||
131672718|NCT00960531|474085853|FG002|Overall Study|Lack of Efficacy|0|||
131672719|NCT00960531|474085854|FG003|Overall Study|Lack of Efficacy|0|||
131672720|NCT00960531|474085855|FG004|Overall Study|Lack of Efficacy|0|||
131672721|NCT00960531|474085856|FG005|Overall Study|Lack of Efficacy|0|||
131672722|NCT00960531|474085857|FG006|Overall Study|Lack of Efficacy|0|||
131672723|NCT00960531|474085858|FG007|Overall Study|Lack of Efficacy|0|||
131672724|NCT00960531|474085859|FG008|Overall Study|Lack of Efficacy|0|||
131672725|NCT00960531|474085860|FG009|Overall Study|Lack of Efficacy|0|||
131672726|NCT00960531|474085851|FG000|Overall Study|Withdrawal by Subject|1|||
131672727|NCT00960531|474085852|FG001|Overall Study|Withdrawal by Subject|0|||
131672728|NCT00960531|474085853|FG002|Overall Study|Withdrawal by Subject|5|||
131672729|NCT00960531|474085854|FG003|Overall Study|Withdrawal by Subject|2|||
131672730|NCT00960531|474085855|FG004|Overall Study|Withdrawal by Subject|0|||
131672731|NCT00960531|474085856|FG005|Overall Study|Withdrawal by Subject|0|||
131672732|NCT00960531|474085857|FG006|Overall Study|Withdrawal by Subject|2|||
131672733|NCT00960531|474085858|FG007|Overall Study|Withdrawal by Subject|0|||
131672734|NCT00960531|474085859|FG008|Overall Study|Withdrawal by Subject|1|||
131672735|NCT00960531|474085860|FG009|Overall Study|Withdrawal by Subject|0|||
131672736|NCT00960531|474085851|FG000|Overall Study|Caregiver Request|2|||
131672737|NCT00960531|474085852|FG001|Overall Study|Caregiver Request|0|||
131672738|NCT00960531|474085853|FG002|Overall Study|Caregiver Request|6|||
131672739|NCT00960531|474085854|FG003|Overall Study|Caregiver Request|5|||
131672740|NCT00960531|474085855|FG004|Overall Study|Caregiver Request|0|||
131672741|NCT00960531|474085856|FG005|Overall Study|Caregiver Request|2|||
131672742|NCT00960531|474085857|FG006|Overall Study|Caregiver Request|3|||
131672743|NCT00960531|474085858|FG007|Overall Study|Caregiver Request|1|||
131672744|NCT00960531|474085859|FG008|Overall Study|Caregiver Request|3|||
131672745|NCT00960531|474085860|FG009|Overall Study|Caregiver Request|0|||
131672746|NCT00960531|474085851|FG000|Overall Study|Investigator Request|0|||
131672747|NCT00960531|474085852|FG001|Overall Study|Investigator Request|0|||
131672748|NCT00960531|474085853|FG002|Overall Study|Investigator Request|1|||
131672749|NCT00960531|474085854|FG003|Overall Study|Investigator Request|0|||
131672750|NCT00960531|474085855|FG004|Overall Study|Investigator Request|0|||
131672751|NCT00960531|474085856|FG005|Overall Study|Investigator Request|0|||
131672752|NCT00960531|474085857|FG006|Overall Study|Investigator Request|0|||
131672753|NCT00960531|474085858|FG007|Overall Study|Investigator Request|0|||
131672754|NCT00960531|474085859|FG008|Overall Study|Investigator Request|0|||
131672755|NCT00960531|474085860|FG009|Overall Study|Investigator Request|0|||
131672756|NCT00960531|474085851|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
131672757|NCT00960531|474085852|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131672758|NCT00960531|474085853|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
131672759|NCT00960531|474085854|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
131672760|NCT00960531|474085855|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
131672761|NCT00960531|474085856|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
131672762|NCT00960531|474085857|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
131672763|NCT00960531|474085858|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
131672764|NCT00960531|474085859|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
131672765|NCT00960531|474085860|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
131672766|NCT00960531|474085851|FG000|Overall Study|Lost to Follow-up|0|||
131672767|NCT00960531|474085852|FG001|Overall Study|Lost to Follow-up|0|||
131672768|NCT00960531|474085853|FG002|Overall Study|Lost to Follow-up|1|||
131672769|NCT00960531|474085854|FG003|Overall Study|Lost to Follow-up|0|||
131672770|NCT00960531|474085855|FG004|Overall Study|Lost to Follow-up|0|||
131672771|NCT00960531|474085856|FG005|Overall Study|Lost to Follow-up|0|||
131672772|NCT00960531|474085857|FG006|Overall Study|Lost to Follow-up|1|||
131672773|NCT00960531|474085858|FG007|Overall Study|Lost to Follow-up|0|||
131672774|NCT00960531|474085859|FG008|Overall Study|Lost to Follow-up|0|||
131672775|NCT00960531|474085860|FG009|Overall Study|Lost to Follow-up|0|||
131672776|NCT00960531|474085851|FG000|Overall Study|Failed to Return|2|||
131672777|NCT00960531|474085852|FG001|Overall Study|Failed to Return|0|||
131672778|NCT00960531|474085853|FG002|Overall Study|Failed to Return|0|||
131672779|NCT00960531|474085854|FG003|Overall Study|Failed to Return|0|||
131672780|NCT00960531|474085855|FG004|Overall Study|Failed to Return|0|||
131672781|NCT00960531|474085856|FG005|Overall Study|Failed to Return|0|||
131672782|NCT00960531|474085857|FG006|Overall Study|Failed to Return|0|||
131672783|NCT00960531|474085858|FG007|Overall Study|Failed to Return|2|||
131672784|NCT00960531|474085859|FG008|Overall Study|Failed to Return|0|||
131672785|NCT00960531|474085860|FG009|Overall Study|Failed to Return|0|||
131672786|NCT00960531|474085851|FG000|Overall Study|Adverse Event (AE)|2|||
131672787|NCT00960531|474085852|FG001|Overall Study|Adverse Event (AE)|0|||
131672788|NCT00960531|474085853|FG002|Overall Study|Adverse Event (AE)|0|||
131672789|NCT00960531|474085854|FG003|Overall Study|Adverse Event (AE)|0|||
131672790|NCT00960531|474085855|FG004|Overall Study|Adverse Event (AE)|0|||
131672791|NCT00960531|474085856|FG005|Overall Study|Adverse Event (AE)|1|||
131672792|NCT00960531|474085857|FG006|Overall Study|Adverse Event (AE)|2|||
131672793|NCT00960531|474085858|FG007|Overall Study|Adverse Event (AE)|0|||
131672794|NCT00960531|474085859|FG008|Overall Study|Adverse Event (AE)|2|||
131672795|NCT00960531|474085860|FG009|Overall Study|Adverse Event (AE)|0|||
131672796|NCT00960531|474085851|FG000|Overall Study|Reason not Specified|2|||
131672797|NCT00960531|474085852|FG001|Overall Study|Reason not Specified|1|||
131672798|NCT00960531|474085853|FG002|Overall Study|Reason not Specified|13|||
131672799|NCT00960531|474085854|FG003|Overall Study|Reason not Specified|1|||
131672800|NCT00960531|474085855|FG004|Overall Study|Reason not Specified|2|||
131672801|NCT00960531|474085856|FG005|Overall Study|Reason not Specified|0|||
131672802|NCT00960531|474085857|FG006|Overall Study|Reason not Specified|16|||
131672803|NCT00960531|474085858|FG007|Overall Study|Reason not Specified|0|||
131672804|NCT00960531|474085859|FG008|Overall Study|Reason not Specified|8|||
131672805|NCT00960531|474085860|FG009|Overall Study|Reason not Specified|1|||
131672806|NCT01163916|474085864|FG000|Overall Study|Withdrawal by Subject|2|||
131672807|NCT01163916|474085865|FG001|Overall Study|Withdrawal by Subject|0|||
131672808|NCT01163916|474085866|FG002|Overall Study|Withdrawal by Subject|2|||
131672809|NCT01163916|474085864|FG000|Overall Study|Adverse Event|2|||
131672810|NCT01163916|474085865|FG001|Overall Study|Adverse Event|0|||
131672811|NCT01163916|474085866|FG002|Overall Study|Adverse Event|1|||
131672812|NCT01163916|474085864|FG000|Overall Study|Lack of Efficacy|2|||
131672813|NCT01163916|474085865|FG001|Overall Study|Lack of Efficacy|0|||
131672814|NCT01163916|474085866|FG002|Overall Study|Lack of Efficacy|1|||
131672815|NCT01163916|474085864|FG000|Overall Study|Other|24|||
131672816|NCT01163916|474085865|FG001|Overall Study|Other|4|||
131672817|NCT01163916|474085866|FG002|Overall Study|Other|16|||
131672818|NCT04002401|474085867|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
131672819|NCT04002401|474085867|FG000|Overall Study|Death|10|||
131672820|NCT04002401|474085867|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
131672821|NCT04002401|474085867|FG000|Overall Study|Enrolled but Never Treated|1|||
131672822|NCT04002401|474085867|FG000|Overall Study|Lost to Follow-up|1|||
131672823|NCT01910181|474085868|FG000|Overall Study|Death|37|||
131672824|NCT01910181|474085868|FG000|Overall Study|Lost to Follow-up|3|||
131672825|NCT01910181|474085868|FG000|Overall Study|Study Terminated by Sponsor|6|||
131555239|NCT02769065|473658118|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672826|NCT05269355|474085871|FG000|Overall Study|Progressive Disease|104|||
131672827|NCT05269355|474085872|FG001|Overall Study|Progressive Disease|68|||
131672828|NCT05269355|474085871|FG000|Overall Study|Study Terminated by Sponsor|87|||
131672829|NCT05269355|474085872|FG001|Overall Study|Study Terminated by Sponsor|29|||
131672830|NCT05269355|474085871|FG000|Overall Study|Adverse Event|15|||
131672831|NCT05269355|474085872|FG001|Overall Study|Adverse Event|8|||
131672832|NCT05269355|474085871|FG000|Overall Study|Withdrawal by Subject|18|||
131672833|NCT05269355|474085872|FG001|Overall Study|Withdrawal by Subject|5|||
131672834|NCT05269355|474085871|FG000|Overall Study|Physician Decision|6|||
131672835|NCT05269355|474085872|FG001|Overall Study|Physician Decision|4|||
131672836|NCT05269355|474085871|FG000|Overall Study|Death|3|||
131672837|NCT05269355|474085872|FG001|Overall Study|Death|5|||
131672838|NCT05269355|474085871|FG000|Overall Study|Other Than Specified|5|||
131672839|NCT05269355|474085872|FG001|Overall Study|Other Than Specified|1|||
131672840|NCT05269355|474085871|FG000|Overall Study|Randomized But Not Treated|1|||
131672841|NCT05269355|474085872|FG001|Overall Study|Randomized But Not Treated|0|||
131672842|NCT01340196|474088045|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
131672843|NCT00171704|474088048|FG000|Overall Study|Adverse Event|24|||
131672844|NCT00171704|474088049|FG001|Overall Study|Adverse Event|33|||
131672845|NCT00171704|474088048|FG000|Overall Study|Disease Progression|14|||
131672846|NCT00171704|474088049|FG001|Overall Study|Disease Progression|9|||
131672847|NCT00171704|474088048|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
131672848|NCT00171704|474088049|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
131672849|NCT00171704|474088048|FG000|Overall Study|Administrative Problems|2|||
131672850|NCT00171704|474088049|FG001|Overall Study|Administrative Problems|1|||
131672851|NCT00171704|474088048|FG000|Overall Study|Death|2|||
131672852|NCT00171704|474088049|FG001|Overall Study|Death|2|||
131672853|NCT00171704|474088048|FG000|Overall Study|Withdrawal by Subject|1|||
131672854|NCT00171704|474088049|FG001|Overall Study|Withdrawal by Subject|3|||
131672855|NCT00171704|474088048|FG000|Overall Study|Protocol Violation|0|||
131672856|NCT00171704|474088049|FG001|Overall Study|Protocol Violation|1|||
131672857|NCT00601419|474088050|FG000|Overall Study|Lost to Follow-up|3|||
131672858|NCT00601419|474088050|FG000|Overall Study|Missed Visits|1|||
131672859|NCT01614197|474088051|FG000|Overall Study|Withdrawal by Subject|0|||
131672860|NCT01614197|474088052|FG001|Overall Study|Withdrawal by Subject|1|||
131672861|NCT01614197|474088053|FG002|Overall Study|Withdrawal by Subject|0|||
131672862|NCT01614197|474088054|FG003|Overall Study|Withdrawal by Subject|0|||
131672863|NCT02245672|474088055|FG000|Overall Study|Adverse Event|4|||
131672864|NCT02245672|474088056|FG001|Overall Study|Adverse Event|4|||
131672865|NCT02245672|474088057|FG002|Overall Study|Adverse Event|4|||
131672866|NCT02245672|474088055|FG000|Overall Study|Lost to Follow-up|3|||
131672867|NCT02245672|474088056|FG001|Overall Study|Lost to Follow-up|5|||
131672868|NCT02245672|474088057|FG002|Overall Study|Lost to Follow-up|1|||
131672869|NCT02245672|474088055|FG000|Overall Study|Withdrawal by Subject|6|||
131672870|NCT02245672|474088056|FG001|Overall Study|Withdrawal by Subject|3|||
131672871|NCT02245672|474088057|FG002|Overall Study|Withdrawal by Subject|0|||
131672872|NCT02245672|474088055|FG000|Overall Study|Randomized in error (not treated)|0|||
131672873|NCT02245672|474088056|FG001|Overall Study|Randomized in error (not treated)|1|||
131672874|NCT02245672|474088057|FG002|Overall Study|Randomized in error (not treated)|0|||
131672875|NCT00971932|474088058|FG000|Overall Study|Withdrawal by Subject|1|||
131672876|NCT00971932|474088058|FG000|Overall Study|Investigator's decision|2|||
131672877|NCT00971932|474088058|FG000|Overall Study|Ongoing|4|||
131672878|NCT01765192|474088061|FG000|Treatment Period 1|Adverse Event|0|||
131672879|NCT01765192|474088062|FG001|Treatment Period 1|Adverse Event|1|||
131672880|NCT01765192|474088061|FG000|Washout Period|Voluntary Withdrawal|1|||
131672881|NCT01765192|474088062|FG001|Washout Period|Voluntary Withdrawal|1|||
131672882|NCT01765192|474088061|FG000|Washout Period|Reason not specified|1|||
131672883|NCT01765192|474088062|FG001|Washout Period|Reason not specified|0|||
131672884|NCT01765192|474088061|FG000|Treatment Period 2|Reason not specified|0|||
131672885|NCT01765192|474088062|FG001|Treatment Period 2|Reason not specified|2|||
131672886|NCT01765192|474088061|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
131672887|NCT01765192|474088062|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
131672888|NCT00876694|474088067|FG000|Overall Study|Adverse Event|10|||
131672889|NCT00876694|474088068|FG001|Overall Study|Adverse Event|7|||
131672890|NCT00876694|474088067|FG000|Overall Study|Subject withdrew consent|6|||
131672891|NCT00876694|474088068|FG001|Overall Study|Subject withdrew consent|4|||
131672892|NCT00876694|474088067|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131672893|NCT00876694|474088068|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131672894|NCT00876694|474088067|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131672895|NCT00876694|474088068|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131672896|NCT00876694|474088067|FG000|Overall Study|Administrative problems|1|||
131672897|NCT00876694|474088068|FG001|Overall Study|Administrative problems|1|||
131672898|NCT00876694|474088067|FG000|Overall Study|Death|1|||
131672899|NCT00876694|474088068|FG001|Overall Study|Death|0|||
131672900|NCT00288509|474088069|FG000|Treatment Cycle 1|Adverse Event|1|||
131672901|NCT00288509|474088069|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
131672902|NCT00288509|474088069|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
131672903|NCT00288509|474088069|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
131672904|NCT00288509|474088069|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
131672905|NCT00288509|474088069|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
131672906|NCT00288509|474088069|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
131672907|NCT00288509|474088069|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
131672908|NCT00288509|474088069|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
131672909|NCT00288509|474088069|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
131672910|NCT00288509|474088069|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
131672911|NCT00288509|474088069|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
131672912|NCT00288509|474088069|FG000|Treatment Cycle 4|Physician Decision|4|||
131672913|NCT00288509|474088069|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
131672914|NCT03249714|474088074|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
131672915|NCT03249714|474088075|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
131672916|NCT03249714|474088074|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
131672917|NCT03249714|474088075|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
131672918|NCT03249714|474088074|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
131672919|NCT03249714|474088075|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
131672920|NCT03249714|474088074|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
131672921|NCT03249714|474088075|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
131672922|NCT04442737|474088085|FG000|Overall Study|Lost to Follow-up|1|||
131672923|NCT04442737|474088086|FG001|Overall Study|Lost to Follow-up|3|||
131672924|NCT04442737|474088085|FG000|Overall Study|Withdrawal by Subject|3|||
131672925|NCT04442737|474088086|FG001|Overall Study|Withdrawal by Subject|2|||
131672926|NCT04442737|474088085|FG000|Overall Study|Adverse Event|3|||
131672927|NCT04442737|474088086|FG001|Overall Study|Adverse Event|2|||
131672928|NCT04442737|474088085|FG000|Overall Study|Death|0|||
131672929|NCT04442737|474088086|FG001|Overall Study|Death|1|||
131672930|NCT04442737|474088085|FG000|Overall Study|Protocol Violation|0|||
131672931|NCT04442737|474088086|FG001|Overall Study|Protocol Violation|2|||
131672932|NCT04442737|474088085|FG000|Overall Study|Other|1|||
131672933|NCT04442737|474088086|FG001|Overall Study|Other|1|||
131672934|NCT05333224|474088087|FG000|Overall Study - Infants|Lost to Follow-up|1|||
131672935|NCT05333224|474088088|FG001|Overall Study - Infants|Lost to Follow-up|1|||
131672936|NCT00063154|474088089|FG000|Overall Study|Disease progression|27|||
131672937|NCT00063154|474088089|FG000|Overall Study|Adverse Event|2|||
131672938|NCT00063154|474088089|FG000|Overall Study|Physician Decision|10|||
131672939|NCT00063154|474088089|FG000|Overall Study|Death|3|||
131672940|NCT00063154|474088089|FG000|Overall Study|Reason unspecified|1|||
131672941|NCT00063154|474088089|FG000|Overall Study|Did not receive treatment|8|||
131672942|NCT01978262|474088090|FG000|Overall Study|Withdrawal by Subject|9|||
131672943|NCT01978262|474088090|FG000|Overall Study|Lost to Follow-up|2|||
131672944|NCT02349451|474088091|FG000|Overall Study|Withdrawal by Subject|0|||
131672945|NCT02349451|474088092|FG001|Overall Study|Withdrawal by Subject|1|||
131672946|NCT02349451|474088093|FG002|Overall Study|Withdrawal by Subject|2|||
131672947|NCT02349451|474088094|FG003|Overall Study|Withdrawal by Subject|1|||
131672948|NCT05116046|474088097|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131672949|NCT05116046|474088098|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131672950|NCT05116046|474088099|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131672951|NCT05116046|474088097|FG000|Overall Study|Study terminated by sponsor|14|||
131672952|NCT05116046|474088098|FG001|Overall Study|Study terminated by sponsor|16|||
131672953|NCT05116046|474088099|FG002|Overall Study|Study terminated by sponsor|1|||
131672954|NCT02683941|474088100|FG000|Double-blind Phase|Adverse Event|0|||
131672955|NCT02683941|474088101|FG001|Double-blind Phase|Adverse Event|1|||
131672956|NCT02683941|474088100|FG000|Double-blind Phase|Withdrawal by Subject|4|||
131672957|NCT02683941|474088101|FG001|Double-blind Phase|Withdrawal by Subject|2|||
131672958|NCT02683941|474088100|FG000|Double-blind Phase|Lost to Follow-up|1|||
131672959|NCT02683941|474088101|FG001|Double-blind Phase|Lost to Follow-up|0|||
131672960|NCT02683941|474088100|FG000|Double-blind Phase|Disease Progression|5|||
131672961|NCT02683941|474088101|FG001|Double-blind Phase|Disease Progression|2|||
131672962|NCT02683941|474088100|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
131672963|NCT02683941|474088101|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
131672964|NCT02683941|474088100|FG000|Open-label Treatment Phase|Disease Progression|1|||
131672965|NCT02683941|474088101|FG001|Open-label Treatment Phase|Disease Progression|2|||
131672966|NCT02683941|474088100|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
131672967|NCT02683941|474088101|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
131672968|NCT02683941|474088100|FG000|Open-label Treatment Phase|Other|1|||
131672969|NCT02683941|474088101|FG001|Open-label Treatment Phase|Other|0|||
131672970|NCT02683941|474088100|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
131672971|NCT02683941|474088101|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
131672972|NCT02683941|474088100|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
131672973|NCT02683941|474088101|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
131555240|NCT02769065|473658119|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555241|NCT02769065|473658120|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555242|NCT02769065|473658121|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555243|NCT02769065|473658122|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672974|NCT02683941|474088100|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
131672975|NCT02683941|474088101|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
131672976|NCT02683941|474088100|FG000|Open-label Follow-up Phase|Other|8|||
131672977|NCT02683941|474088101|FG001|Open-label Follow-up Phase|Other|1|||
131672978|NCT00261846|474088102|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
131672979|NCT00261846|474088103|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
131672980|NCT00261846|474088104|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
131672981|NCT00261846|474088105|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131555244|NCT02769065|473658123|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555245|NCT02769065|473658124|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
131672982|NCT00261846|474088106|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672983|NCT00261846|474088107|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672984|NCT00261846|474088108|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672985|NCT00261846|474088109|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672986|NCT00261846|474088110|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672987|NCT00261846|474088111|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672988|NCT00261846|474088112|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672989|NCT00261846|474088113|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131672990|NCT00261846|474088102|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672991|NCT00261846|474088103|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672992|NCT00261846|474088104|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672993|NCT00261846|474088105|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
131672994|NCT00261846|474088106|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672995|NCT00261846|474088107|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672996|NCT00261846|474088108|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672997|NCT00261846|474088109|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131672998|NCT00261846|474088110|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
131672999|NCT00261846|474088111|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131673000|NCT00261846|474088112|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131673001|NCT00261846|474088113|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131673002|NCT00261846|474088102|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131673003|NCT00261846|474088103|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131673004|NCT00261846|474088104|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131673005|NCT00261846|474088105|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
131673006|NCT00261846|474088106|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
131673007|NCT00261846|474088107|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
131673008|NCT00261846|474088108|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
131673009|NCT00261846|474088109|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
131673010|NCT00261846|474088110|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131673011|NCT00261846|474088111|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
131673012|NCT00261846|474088112|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131673013|NCT00261846|474088113|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131673014|NCT00261846|474088102|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131673015|NCT00261846|474088103|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131673016|NCT00261846|474088104|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131673017|NCT00261846|474088105|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
131673018|NCT00261846|474088106|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131673019|NCT00261846|474088107|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131673020|NCT00261846|474088108|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131673021|NCT00261846|474088109|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131673022|NCT00261846|474088110|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
131673023|NCT00261846|474088111|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131673024|NCT00261846|474088112|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131673025|NCT00261846|474088113|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131673026|NCT00261846|474088102|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
131673027|NCT00261846|474088103|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
131673028|NCT00261846|474088104|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
131673029|NCT00261846|474088105|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
131673030|NCT00261846|474088106|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
131673031|NCT00261846|474088107|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
131673032|NCT00261846|474088108|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
131673033|NCT00261846|474088109|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
131673034|NCT00261846|474088110|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
131673035|NCT00261846|474088111|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
131673036|NCT00261846|474088112|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
131673037|NCT00261846|474088113|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
131673038|NCT00261846|474088102|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
131673039|NCT00261846|474088103|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
131673040|NCT00261846|474088104|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
131673041|NCT00261846|474088105|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
131673042|NCT00261846|474088106|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
131673043|NCT00261846|474088107|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
131673044|NCT00261846|474088108|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
131673045|NCT00261846|474088109|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
131673046|NCT00261846|474088110|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
131673047|NCT00261846|474088111|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
131673048|NCT00261846|474088112|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
131673049|NCT00261846|474088113|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
131673050|NCT00261846|474088102|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
131673051|NCT00261846|474088103|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
131673052|NCT00261846|474088104|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
131673053|NCT00261846|474088105|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
131673054|NCT00261846|474088106|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
131673055|NCT00261846|474088107|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
131673056|NCT00261846|474088108|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
131673057|NCT00261846|474088109|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
131673058|NCT00261846|474088110|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
131673059|NCT00261846|474088111|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
131673060|NCT00261846|474088112|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
131673061|NCT00261846|474088113|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
131673062|NCT01313689|474088114|FG000|24-Week Randomization 1|Adverse Event|10|||
131673063|NCT01313689|474088115|FG001|24-Week Randomization 1|Adverse Event|5|||
131673064|NCT01313689|474088116|FG002|24-Week Randomization 1|Adverse Event|0|||
131673065|NCT01313689|474088117|FG003|24-Week Randomization 1|Adverse Event|0|||
131673066|NCT01313689|474088118|FG004|24-Week Randomization 1|Adverse Event|0|||
131673067|NCT01313689|474088114|FG000|24-Week Randomization 1|Physician Decision|4|||
131673068|NCT01313689|474088115|FG001|24-Week Randomization 1|Physician Decision|5|||
131673069|NCT01313689|474088116|FG002|24-Week Randomization 1|Physician Decision|0|||
131673070|NCT01313689|474088117|FG003|24-Week Randomization 1|Physician Decision|0|||
131673071|NCT01313689|474088118|FG004|24-Week Randomization 1|Physician Decision|0|||
131673072|NCT01313689|474088114|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
131673073|NCT01313689|474088115|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
131673074|NCT01313689|474088116|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
131673075|NCT01313689|474088117|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
131673076|NCT01313689|474088118|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
131673077|NCT01313689|474088114|FG000|24-Week Randomization 2|Adverse Event|0|||
131673078|NCT01313689|474088115|FG001|24-Week Randomization 2|Adverse Event|0|||
131673079|NCT01313689|474088116|FG002|24-Week Randomization 2|Adverse Event|2|||
131673080|NCT01313689|474088117|FG003|24-Week Randomization 2|Adverse Event|0|||
131673081|NCT01313689|474088118|FG004|24-Week Randomization 2|Adverse Event|8|||
131673082|NCT01313689|474088114|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
131673083|NCT01313689|474088115|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
131673084|NCT01313689|474088116|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
131673085|NCT01313689|474088117|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
131673086|NCT01313689|474088118|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
131673087|NCT01313689|474088114|FG000|24-Week Randomization 2|Physician Decision|0|||
131673088|NCT01313689|474088115|FG001|24-Week Randomization 2|Physician Decision|0|||
131673089|NCT01313689|474088116|FG002|24-Week Randomization 2|Physician Decision|0|||
131673090|NCT01313689|474088117|FG003|24-Week Randomization 2|Physician Decision|0|||
131673091|NCT01313689|474088118|FG004|24-Week Randomization 2|Physician Decision|4|||
131673092|NCT00687973|474088119|FG000|Overall Study|Adverse Event|18|||
131772396|NCT01258803|474445063|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131772397|NCT01258803|474445064|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131772398|NCT04652245|474445071|FG000|Wash-Out Period|Adverse Event|0|||
131772399|NCT04652245|474445072|FG001|Wash-Out Period|Adverse Event|2|||
131772400|NCT04652245|474445071|FG000|Wash-Out Period|Withdrawal by Subject|0|||
131772401|NCT04652245|474445072|FG001|Wash-Out Period|Withdrawal by Subject|2|||
131772402|NCT03556202|474445075|FG000|Extension Treatment Period|Adverse Event|18|||
131772403|NCT03556202|474445076|FG001|Extension Treatment Period|Adverse Event|14|||
131673093|NCT00687973|474088120|FG001|Overall Study|Adverse Event|28|||
131673094|NCT00687973|474088119|FG000|Overall Study|Lack of Efficacy|2|||
131673095|NCT00687973|474088120|FG001|Overall Study|Lack of Efficacy|3|||
131673096|NCT00687973|474088119|FG000|Overall Study|Protocol Violation|1|||
131772404|NCT03556202|474445077|FG002|Extension Treatment Period|Adverse Event|9|||
131772405|NCT03556202|474445075|FG000|Extension Treatment Period|Death|2|||
131772406|NCT03556202|474445076|FG001|Extension Treatment Period|Death|6|||
131772407|NCT03556202|474445077|FG002|Extension Treatment Period|Death|0|||
131673097|NCT00687973|474088120|FG001|Overall Study|Protocol Violation|2|||
131673098|NCT00687973|474088119|FG000|Overall Study|Administrative Reasons|0|||
131673099|NCT00687973|474088120|FG001|Overall Study|Administrative Reasons|2|||
131673100|NCT00687973|474088119|FG000|Overall Study|Withdrawal by Subject|3|||
131673101|NCT00687973|474088120|FG001|Overall Study|Withdrawal by Subject|3|||
131772408|NCT03556202|474445075|FG000|Extension Treatment Period|Lack of Efficacy|5|||
131772409|NCT03556202|474445076|FG001|Extension Treatment Period|Lack of Efficacy|12|||
131673102|NCT01007448|474088121|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
131673103|NCT01007448|474088122|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
131673104|NCT01007448|474088121|FG000|Overall Study|Staph Skin Infection Flare|1|||
131673105|NCT01007448|474088122|FG001|Overall Study|Staph Skin Infection Flare|0|||
131673106|NCT01007448|474088121|FG000|Overall Study|Participant Leaving the Country|1|||
131673107|NCT01007448|474088122|FG001|Overall Study|Participant Leaving the Country|0|||
131673108|NCT01007448|474088121|FG000|Overall Study|Participant Given Prohibited Medication|1|||
131673109|NCT01007448|474088122|FG001|Overall Study|Participant Given Prohibited Medication|0|||
131673110|NCT01007448|474088121|FG000|Overall Study|Progressive Disease|1|||
131673111|NCT01007448|474088122|FG001|Overall Study|Progressive Disease|2|||
131673112|NCT01007448|474088121|FG000|Overall Study|Lack of Efficacy|2|||
131673113|NCT01007448|474088122|FG001|Overall Study|Lack of Efficacy|0|||
131673114|NCT01007448|474088121|FG000|Overall Study|Withdrawal by Subject|2|||
131673115|NCT01007448|474088122|FG001|Overall Study|Withdrawal by Subject|3|||
131673116|NCT01007448|474088121|FG000|Overall Study|Adverse Event|1|||
131673117|NCT01007448|474088122|FG001|Overall Study|Adverse Event|4|||
131673118|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
131673119|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
131673120|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Death|0|||
131673121|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Death|2|||
131673122|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131673123|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
131673124|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
131673125|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
131673126|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
131673127|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
131673128|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
131673129|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
131673130|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
131673131|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
131673132|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
131673133|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
131772410|NCT03556202|474445077|FG002|Extension Treatment Period|Lack of Efficacy|18|||
131772411|NCT03556202|474445075|FG000|Extension Treatment Period|Lost to Follow-up|9|||
131772412|NCT03556202|474445076|FG001|Extension Treatment Period|Lost to Follow-up|20|||
131673134|NCT00343252|474088124|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
131673135|NCT00343252|474088125|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
131673136|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
131673137|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
131673138|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Death|3|||
131673139|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Death|3|||
131673140|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131673141|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131673142|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
131673143|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
131673144|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
131673145|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
131673146|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
131673147|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
131673148|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
131673149|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
131673150|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
131673151|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
131673152|NCT00343252|474088124|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
131673153|NCT00343252|474088125|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
131673154|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
131673155|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
131673156|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Death|4|||
131673157|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Death|5|||
131673158|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
131673159|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131673160|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
131673161|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
131673162|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
131673163|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
131673164|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
131673165|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
131673166|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
131673167|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
131673168|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
131673169|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
131673170|NCT00343252|474088124|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
131673171|NCT00343252|474088125|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
131673172|NCT01740323|474088126|FG000|Overall Study|Adverse Event|1|||
131673173|NCT01740323|474088127|FG001|Overall Study|Adverse Event|0|||
131673174|NCT01740323|474088126|FG000|Overall Study|Randomized but did not take study drug|1|||
131673175|NCT01740323|474088127|FG001|Overall Study|Randomized but did not take study drug|0|||
131673176|NCT01054846|474088128|FG000|Overall Study|Lost to Follow-up|76|||
131673177|NCT01054846|474088129|FG001|Overall Study|Lost to Follow-up|17|||
131673178|NCT02446886|474088130|FG000|Overall Study|Adverse Event|1|||
131673179|NCT02446886|474088131|FG001|Overall Study|Adverse Event|3|||
131673180|NCT02446886|474088130|FG000|Overall Study|Withdrawal by Subject|1|||
131673181|NCT02446886|474088131|FG001|Overall Study|Withdrawal by Subject|1|||
131673182|NCT00928447|474088132|FG000|Overall Study|Withdrawal by Subject|1|||
131673183|NCT00928447|474088132|FG000|Overall Study|Investigator's decision|1|||
131673184|NCT01259284|474088135|FG000|Overall Study|Study Termination|2|||
131673185|NCT01259284|474088136|FG001|Overall Study|Study Termination|0|||
131673186|NCT01259284|474088137|FG002|Overall Study|Study Termination|0|||
131673187|NCT03353350|474088143|FG000|30-week Core Treatment Period|Protocol Violation|1|||
131673188|NCT03353350|474088144|FG001|30-week Core Treatment Period|Protocol Violation|1|||
131673189|NCT03353350|474088145|FG002|30-week Core Treatment Period|Protocol Violation|1|||
131673190|NCT03353350|474088146|FG003|30-week Core Treatment Period|Protocol Violation|0|||
131673191|NCT03353350|474088143|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
131673192|NCT03353350|474088144|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
131673193|NCT03353350|474088145|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
131673194|NCT03353350|474088146|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
131673195|NCT03353350|474088143|FG000|30-week Core Treatment Period|Adverse Event|0|||
131673196|NCT03353350|474088144|FG001|30-week Core Treatment Period|Adverse Event|4|||
131673197|NCT03353350|474088145|FG002|30-week Core Treatment Period|Adverse Event|2|||
131673198|NCT03353350|474088146|FG003|30-week Core Treatment Period|Adverse Event|3|||
131673199|NCT03353350|474088143|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
131673200|NCT03353350|474088144|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
131673201|NCT03353350|474088145|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
131673202|NCT03353350|474088146|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
131673203|NCT03353350|474088143|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
131673204|NCT03353350|474088144|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
131673205|NCT03353350|474088145|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
131673206|NCT03353350|474088146|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
131673207|NCT03353350|474088143|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
131673208|NCT03353350|474088144|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
131673209|NCT03353350|474088145|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
131673210|NCT03353350|474088146|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
131673211|NCT03353350|474088143|FG000|26-week Treatment Extension Period|Adverse Event|1|||
131673212|NCT03353350|474088144|FG001|26-week Treatment Extension Period|Adverse Event|0|||
131673213|NCT03353350|474088145|FG002|26-week Treatment Extension Period|Adverse Event|0|||
131673214|NCT03353350|474088146|FG003|26-week Treatment Extension Period|Adverse Event|1|||
131673215|NCT03353350|474088143|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
131673216|NCT03353350|474088144|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
131673217|NCT03353350|474088145|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
131673218|NCT03353350|474088146|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
131673219|NCT00051363|474088147|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
131673220|NCT00051363|474088148|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
131673221|NCT00051363|474088147|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
131673222|NCT00051363|474088148|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
131673223|NCT00051363|474088147|FG000|Overall Study|Death|2|||
131555246|NCT02769065|473658125|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555247|NCT02769065|473658126|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555248|NCT02769065|473658127|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555249|NCT02769065|473658128|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555250|NCT02769065|473658129|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555251|NCT02769065|473658130|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
131555252|NCT02764775|473658131|FG000|Overall Study|Death|1|||
131555253|NCT02764775|473658131|FG000|Overall Study|Lost to Follow-up|2|||
131555254|NCT02764775|473658131|FG000|Overall Study|Withdrawal by Subject|3|||
131555255|NCT04567693|473658132|FG000|Overall Study|Death|0|||
131555256|NCT04567693|473658133|FG001|Overall Study|Death|0|||
131555257|NCT04567693|473658134|FG002|Overall Study|Death|2|||
131555258|NCT04567693|473658132|FG000|Overall Study|Lost to Follow-up|1|||
131555259|NCT04567693|473658133|FG001|Overall Study|Lost to Follow-up|0|||
131555260|NCT04567693|473658134|FG002|Overall Study|Lost to Follow-up|2|||
131555261|NCT04567693|473658132|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
131555262|NCT04567693|473658133|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
131555263|NCT04567693|473658134|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
131555264|NCT01382940|473658135|FG000|Overall Study|Adverse Event|19|||
131555265|NCT01382940|473658135|FG000|Overall Study|Lost to Follow-up|4|||
131555266|NCT01382940|473658135|FG000|Overall Study|Physician Decision|7|||
131555267|NCT01382940|473658135|FG000|Overall Study|Withdrawal by Subject|23|||
131555268|NCT01382940|473658135|FG000|Overall Study|Protocol Violation|20|||
131555269|NCT00976482|473658138|FG000|Overall Study|Death|208|||
131555270|NCT00976482|473658138|FG000|Overall Study|Withdrawal by Subject|45|||
131555271|NCT00976482|473658138|FG000|Overall Study|Center terminated|1|||
131555272|NCT00976482|473658138|FG000|Overall Study|Protocol Violation|5|||
131555273|NCT03722264|473658141|FG000|Overall Study|Physician Decision|3|||
131555274|NCT00720902|473658142|FG000|Overall Study|Withdrawal by Subject|1|||
131555275|NCT00720902|473658143|FG001|Overall Study|Withdrawal by Subject|0|||
131555276|NCT00720902|473658142|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
131555277|NCT00720902|473658143|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
131555278|NCT01486758|473658144|FG000|Overall Study|Lost to Follow-up|0|||
131555279|NCT01486758|473658145|FG001|Overall Study|Lost to Follow-up|1|||
131555280|NCT02959671|473658146|FG000|Overall Study|Adverse Event|2|||
131555281|NCT02959671|473658146|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
131555282|NCT02254408|473658158|FG000|Overall Study|Randomized But Not Treated|1|||
131555283|NCT02254408|473658159|FG001|Overall Study|Randomized But Not Treated|3|||
131555284|NCT02254408|473658158|FG000|Overall Study|Adverse Event|1|||
131555285|NCT02254408|473658159|FG001|Overall Study|Adverse Event|0|||
131555286|NCT02254408|473658158|FG000|Overall Study|Death|2|||
131555287|NCT02254408|473658159|FG001|Overall Study|Death|3|||
131555288|NCT02254408|473658158|FG000|Overall Study|Investigator's Discretion|0|||
131673224|NCT00051363|474088148|FG001|Overall Study|Death|2|||
131772413|NCT03556202|474445077|FG002|Extension Treatment Period|Lost to Follow-up|2|||
131555289|NCT02254408|473658159|FG001|Overall Study|Investigator's Discretion|1|||
131555290|NCT02254408|473658158|FG000|Overall Study|Withdrawal by Subject|3|||
131555291|NCT02254408|473658159|FG001|Overall Study|Withdrawal by Subject|3|||
131555292|NCT02254408|473658158|FG000|Overall Study|Lost to Follow-up|1|||
131673225|NCT00051363|474088147|FG000|Overall Study|Excluded Pre-Randomization|2|||
131673226|NCT00051363|474088148|FG001|Overall Study|Excluded Pre-Randomization|5|||
131673227|NCT00807235|474088149|FG000|Overall Study|Adverse Event|1|||
131673228|NCT00807235|474088150|FG001|Overall Study|Adverse Event|0|||
131673229|NCT03370471|474088151|FG000|Overall Study|Withdrawal by Subject|6|||
131673230|NCT03370471|474088152|FG001|Overall Study|Withdrawal by Subject|1|||
131673231|NCT03370471|474088151|FG000|Overall Study|Unable to access veins for blood draw|0|||
131673232|NCT03370471|474088152|FG001|Overall Study|Unable to access veins for blood draw|1|||
131673233|NCT03370471|474088151|FG000|Overall Study|Screen fail|1|||
131673234|NCT03370471|474088152|FG001|Overall Study|Screen fail|0|||
131673235|NCT01765179|474088154|FG000|Overall Study|Adverse Event|3|||
131673236|NCT01765179|474088154|FG000|Overall Study|Lost to Follow-up|5|||
131673237|NCT01765179|474088154|FG000|Overall Study|Non-compliance with study drug|2|||
131673238|NCT01765179|474088154|FG000|Overall Study|Protocol Violation|1|||
131673239|NCT01765179|474088154|FG000|Overall Study|Withdrawal by Subject|8|||
131673240|NCT01765179|474088154|FG000|Overall Study|Hematocrit >54%|3|||
131673241|NCT01765179|474088154|FG000|Overall Study|prohibited med|1|||
131673242|NCT01765179|474088154|FG000|Overall Study|Out of country unable to finish study|1|||
131673243|NCT01765179|474088154|FG000|Overall Study|lack of venous access|1|||
131555293|NCT02254408|473658159|FG001|Overall Study|Lost to Follow-up|0|||
131555294|NCT02914184|473658161|FG000|Overall Study|Lost to Follow-up|7|||
131555295|NCT02914184|473658162|FG001|Overall Study|Lost to Follow-up|10|||
131555296|NCT02914184|473658163|FG002|Overall Study|Lost to Follow-up|8|||
131555297|NCT02914184|473658164|FG003|Overall Study|Lost to Follow-up|7|||
131555298|NCT02914184|473658161|FG000|Overall Study|Withdrawal by Subject|4|||
131555299|NCT02914184|473658162|FG001|Overall Study|Withdrawal by Subject|2|||
131555300|NCT02914184|473658163|FG002|Overall Study|Withdrawal by Subject|7|||
131555301|NCT02914184|473658164|FG003|Overall Study|Withdrawal by Subject|3|||
131555302|NCT02914184|473658161|FG000|Overall Study|Other|1|||
131555303|NCT02914184|473658162|FG001|Overall Study|Other|0|||
131555304|NCT02914184|473658163|FG002|Overall Study|Other|0|||
131555305|NCT02914184|473658164|FG003|Overall Study|Other|0|||
131555306|NCT02914184|473658161|FG000|Overall Study|Migrated/moved from the study area|2|||
131555307|NCT02914184|473658162|FG001|Overall Study|Migrated/moved from the study area|1|||
131555308|NCT02914184|473658163|FG002|Overall Study|Migrated/moved from the study area|2|||
131555309|NCT02914184|473658164|FG003|Overall Study|Migrated/moved from the study area|1|||
131555310|NCT00798174|473658165|FG000|Overall Study|inability to implant azygos coil|3|||
131555311|NCT00798174|473658166|FG001|Overall Study|inability to implant azygos coil|3|||
131555312|NCT00798174|473658165|FG000|Overall Study|Inability to sedate for DFT testing|1|||
131555313|NCT00798174|473658166|FG001|Overall Study|Inability to sedate for DFT testing|0|||
131555314|NCT01478113|473658170|FG000|Overall Study|Withdrawal by Subject|0|||
131555315|NCT01478113|473658171|FG001|Overall Study|Withdrawal by Subject|1|||
131555316|NCT01478113|473658170|FG000|Overall Study|Physician Decision|1|||
131555317|NCT01478113|473658171|FG001|Overall Study|Physician Decision|0|||
131555318|NCT03093428|473658174|FG000|Overall Study|Not eligible for treatment|2|||
131555319|NCT03093428|473658175|FG001|Overall Study|Not eligible for treatment|1|||
131555320|NCT03093428|473658174|FG000|Overall Study|Progression|14|||
131555321|NCT03093428|473658175|FG001|Overall Study|Progression|4|||
131555322|NCT03093428|473658174|FG000|Overall Study|Death|1|||
131555323|NCT03093428|473658175|FG001|Overall Study|Death|0|||
131555324|NCT03093428|473658174|FG000|Overall Study|Adverse Event|1|||
131555325|NCT03093428|473658175|FG001|Overall Study|Adverse Event|0|||
131555326|NCT03093428|473658174|FG000|Overall Study|Withdrawal by Subject|1|||
131555327|NCT03093428|473658175|FG001|Overall Study|Withdrawal by Subject|1|||
131555328|NCT00041756|473658176|FG000|Overall Study|Adverse Event|4|||
131555329|NCT00041756|473658177|FG001|Overall Study|Adverse Event|10|||
131555330|NCT00041756|473658178|FG002|Overall Study|Adverse Event|6|||
131555331|NCT00041756|473658179|FG003|Overall Study|Adverse Event|11|||
131555332|NCT00041756|473658180|FG004|Overall Study|Adverse Event|34|||
131555333|NCT00041756|473658176|FG000|Overall Study|Protocol Violation|1|||
131555334|NCT00041756|473658177|FG001|Overall Study|Protocol Violation|1|||
131555335|NCT00041756|473658178|FG002|Overall Study|Protocol Violation|2|||
131555336|NCT00041756|473658179|FG003|Overall Study|Protocol Violation|2|||
131555337|NCT00041756|473658180|FG004|Overall Study|Protocol Violation|1|||
131555338|NCT00041756|473658176|FG000|Overall Study|Withdrawal by Subject|3|||
131555339|NCT00041756|473658177|FG001|Overall Study|Withdrawal by Subject|3|||
131555340|NCT00041756|473658178|FG002|Overall Study|Withdrawal by Subject|4|||
131555341|NCT00041756|473658179|FG003|Overall Study|Withdrawal by Subject|2|||
131555342|NCT00041756|473658180|FG004|Overall Study|Withdrawal by Subject|3|||
131555343|NCT00041756|473658176|FG000|Overall Study|Lost to Follow-up|0|||
131555344|NCT00041756|473658177|FG001|Overall Study|Lost to Follow-up|1|||
131555345|NCT00041756|473658178|FG002|Overall Study|Lost to Follow-up|0|||
131555346|NCT00041756|473658179|FG003|Overall Study|Lost to Follow-up|1|||
131555347|NCT00041756|473658180|FG004|Overall Study|Lost to Follow-up|0|||
131555348|NCT00041756|473658176|FG000|Overall Study|Unable to meet protocol criteria|0|||
131673244|NCT01765179|474088154|FG000|Overall Study|work conflict|1|||
131673245|NCT01765179|474088154|FG000|Overall Study|Ca elevated 10.6|1|||
131673246|NCT01596621|474088155|FG000|Overall Study|Death|4|||
131673247|NCT01596621|474088155|FG000|Overall Study|Withdrawal by Subject|9|||
131673248|NCT01596621|474088155|FG000|Overall Study|Disease Progression|49|||
131673249|NCT01596621|474088155|FG000|Overall Study|Lost to Follow-up|3|||
131673250|NCT01596621|474088155|FG000|Overall Study|Other than specified|13|||
131673251|NCT00392327|474088158|FG000|Overall Study|Death|1|||
131673252|NCT00392327|474088159|FG001|Overall Study|Death|0|||
131673253|NCT00392327|474088160|FG002|Overall Study|Death|1|||
131673254|NCT00392327|474088161|FG003|Overall Study|Death|0|||
131673255|NCT00392327|474088162|FG004|Overall Study|Death|0|||
131673256|NCT00392327|474088163|FG005|Overall Study|Death|0|||
131673257|NCT00392327|474088164|FG006|Overall Study|Death|0|||
131673258|NCT00392327|474088165|FG007|Overall Study|Death|0|||
131673259|NCT00392327|474088158|FG000|Overall Study|Lack of Efficacy|8|||
131673260|NCT00392327|474088159|FG001|Overall Study|Lack of Efficacy|8|||
131673261|NCT00392327|474088160|FG002|Overall Study|Lack of Efficacy|9|||
131673262|NCT00392327|474088161|FG003|Overall Study|Lack of Efficacy|6|||
131673263|NCT00392327|474088162|FG004|Overall Study|Lack of Efficacy|3|||
131673264|NCT00392327|474088163|FG005|Overall Study|Lack of Efficacy|3|||
131673265|NCT00392327|474088164|FG006|Overall Study|Lack of Efficacy|3|||
131673266|NCT00392327|474088165|FG007|Overall Study|Lack of Efficacy|3|||
131673267|NCT00392327|474088158|FG000|Overall Study|Physician Decision|3|||
131673268|NCT00392327|474088159|FG001|Overall Study|Physician Decision|5|||
131673269|NCT00392327|474088160|FG002|Overall Study|Physician Decision|2|||
131673270|NCT00392327|474088161|FG003|Overall Study|Physician Decision|2|||
131673271|NCT00392327|474088162|FG004|Overall Study|Physician Decision|0|||
131673272|NCT00392327|474088163|FG005|Overall Study|Physician Decision|1|||
131673273|NCT00392327|474088164|FG006|Overall Study|Physician Decision|5|||
131673274|NCT00392327|474088165|FG007|Overall Study|Physician Decision|3|||
131673275|NCT00392327|474088158|FG000|Overall Study|Protocol Violation|0|||
131673276|NCT00392327|474088159|FG001|Overall Study|Protocol Violation|0|||
131673277|NCT00392327|474088160|FG002|Overall Study|Protocol Violation|1|||
131673278|NCT00392327|474088161|FG003|Overall Study|Protocol Violation|0|||
131673279|NCT00392327|474088162|FG004|Overall Study|Protocol Violation|0|||
131673280|NCT00392327|474088163|FG005|Overall Study|Protocol Violation|0|||
131673281|NCT00392327|474088164|FG006|Overall Study|Protocol Violation|0|||
131673282|NCT00392327|474088165|FG007|Overall Study|Protocol Violation|0|||
131673283|NCT00392327|474088158|FG000|Overall Study|Withdrawal by Subject|3|||
131673284|NCT00392327|474088159|FG001|Overall Study|Withdrawal by Subject|2|||
131673285|NCT00392327|474088160|FG002|Overall Study|Withdrawal by Subject|4|||
131673286|NCT00392327|474088161|FG003|Overall Study|Withdrawal by Subject|6|||
131673287|NCT00392327|474088162|FG004|Overall Study|Withdrawal by Subject|0|||
131673288|NCT00392327|474088163|FG005|Overall Study|Withdrawal by Subject|1|||
131673289|NCT00392327|474088164|FG006|Overall Study|Withdrawal by Subject|1|||
131673290|NCT00392327|474088165|FG007|Overall Study|Withdrawal by Subject|5|||
131673291|NCT00392327|474088158|FG000|Overall Study|Ineligible|0|||
131673292|NCT00392327|474088159|FG001|Overall Study|Ineligible|4|||
131673293|NCT00392327|474088160|FG002|Overall Study|Ineligible|3|||
131673294|NCT00392327|474088161|FG003|Overall Study|Ineligible|2|||
131673295|NCT00392327|474088162|FG004|Overall Study|Ineligible|0|||
131673296|NCT00392327|474088163|FG005|Overall Study|Ineligible|0|||
131673297|NCT00392327|474088164|FG006|Overall Study|Ineligible|0|||
131673298|NCT00392327|474088165|FG007|Overall Study|Ineligible|0|||
131673299|NCT04508023|474088166|FG000|Overall Study|Withdrawal by Subject|1|||
131673300|NCT04508023|474088167|FG001|Overall Study|Withdrawal by Subject|2|||
131673301|NCT00178126|474088174|FG000|Overall Study|Lost to Follow-up|21|||
131673302|NCT00178126|474088175|FG001|Overall Study|Lost to Follow-up|21|||
131673303|NCT00178126|474088174|FG000|Overall Study|did not receive intervention|4|||
131673304|NCT00178126|474088175|FG001|Overall Study|did not receive intervention|6|||
131673305|NCT02988622|474088176|FG000|Overall Study|Lost to Follow-up|17|||
131673306|NCT01204398|474088180|FG000|Overall Study|Adverse Event|1|||
131673307|NCT03562247|474088181|FG000|Overall Study|Lost to Follow-up|3|||
131673308|NCT03562247|474088182|FG001|Overall Study|Lost to Follow-up|1|||
131673309|NCT03562247|474088183|FG002|Overall Study|Lost to Follow-up|1|||
131673310|NCT00983931|474088184|FG000|14 Day Washout Period|Physician Decision|1|||
131673311|NCT01281969|474088187|FG000|Overall Study|not randomized didn't meet criteria|0|||
131673312|NCT01281969|474088188|FG001|Overall Study|not randomized didn't meet criteria|0|||
131673313|NCT01281969|474088189|FG002|Overall Study|not randomized didn't meet criteria|7|||
131673314|NCT01281969|474088187|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
131673315|NCT01281969|474088188|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
131673316|NCT01281969|474088189|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
131673317|NCT01281969|474088187|FG000|Overall Study|not randomized, child consent not given|0|||
131673318|NCT01281969|474088188|FG001|Overall Study|not randomized, child consent not given|0|||
131673319|NCT01281969|474088189|FG002|Overall Study|not randomized, child consent not given|2|||
131673320|NCT01201265|474088190|FG000|Overall Study|Death|14|||
131673321|NCT01201265|474088190|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131673322|NCT01201265|474088190|FG000|Overall Study|Lost to Follow-up|10|||
131673323|NCT01201265|474088190|FG000|Overall Study|Withdrawal by Subject|7|||
131673324|NCT01201265|474088190|FG000|Overall Study|Disease Progression|4|||
131673325|NCT04640077|474088191|FG000|Period 1|Withdrawal by Subject|4|||
131673326|NCT04640077|474088192|FG001|Period 1|Withdrawal by Subject|5|||
131673327|NCT04640077|474088193|FG002|Period 1|Withdrawal by Subject|0|||
131673328|NCT04640077|474088191|FG000|Period 1|Adverse Event|1|||
131673329|NCT04640077|474088192|FG001|Period 1|Adverse Event|1|||
131673330|NCT04640077|474088193|FG002|Period 1|Adverse Event|0|||
131673331|NCT04640077|474088191|FG000|Period 1|Screen Failure|2|||
131673332|NCT04640077|474088192|FG001|Period 1|Screen Failure|0|||
131673333|NCT04640077|474088193|FG002|Period 1|Screen Failure|0|||
131673334|NCT04640077|474088191|FG000|Period 2|Withdrawal by Subject|0|||
131673335|NCT04640077|474088192|FG001|Period 2|Withdrawal by Subject|0|||
131673336|NCT04640077|474088193|FG002|Period 2|Withdrawal by Subject|18|||
131673337|NCT04640077|474088191|FG000|Period 2|Adverse Event|0|||
131673338|NCT04640077|474088192|FG001|Period 2|Adverse Event|0|||
131673339|NCT04640077|474088193|FG002|Period 2|Adverse Event|6|||
131673340|NCT04640077|474088191|FG000|Period 2|Lost to Follow-up|0|||
131673341|NCT04640077|474088192|FG001|Period 2|Lost to Follow-up|0|||
131673342|NCT04640077|474088193|FG002|Period 2|Lost to Follow-up|2|||
131673343|NCT04640077|474088191|FG000|Period 2|Death|0|||
131673344|NCT04640077|474088192|FG001|Period 2|Death|0|||
131673345|NCT04640077|474088193|FG002|Period 2|Death|2|||
131673346|NCT04640077|474088191|FG000|Period 2|Progressive Disease|0|||
131673347|NCT04640077|474088192|FG001|Period 2|Progressive Disease|0|||
131673348|NCT04640077|474088193|FG002|Period 2|Progressive Disease|1|||
131673349|NCT04640077|474088191|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
131673350|NCT04640077|474088192|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
131673351|NCT04640077|474088193|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
131673352|NCT01257425|474088194|FG000|Overall Study|Lack of Efficacy|3|||
131673353|NCT01257425|474088195|FG001|Overall Study|Lack of Efficacy|3|||
131673354|NCT01257425|474088194|FG000|Overall Study|Adverse Event|1|||
131673355|NCT01257425|474088195|FG001|Overall Study|Adverse Event|1|||
131673356|NCT01257425|474088194|FG000|Overall Study|Protocol Violation|1|||
131673357|NCT01257425|474088195|FG001|Overall Study|Protocol Violation|1|||
131673358|NCT01257425|474088194|FG000|Overall Study|Withdrawal by Subject|0|||
131673359|NCT01257425|474088195|FG001|Overall Study|Withdrawal by Subject|1|||
131673360|NCT01257425|474088194|FG000|Overall Study|Death|1|||
131673361|NCT01257425|474088195|FG001|Overall Study|Death|0|||
131673362|NCT01182194|474088197|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
131673363|NCT01182194|474088198|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
131673364|NCT00368992|474088199|FG000|Overall Study|Ineligible|5|||
131673365|NCT00368992|474088199|FG000|Overall Study|Refused treatment|3|||
131673366|NCT00368992|474088199|FG000|Overall Study|Lack of Efficacy|63|||
131673367|NCT00368992|474088199|FG000|Overall Study|Adverse Event|26|||
131673368|NCT00368992|474088199|FG000|Overall Study|Death|4|||
131673369|NCT00368992|474088199|FG000|Overall Study|Other|9|||
131673370|NCT02668185|474088200|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
131673371|NCT02668185|474088201|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
131673372|NCT02668185|474088200|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
131673373|NCT02668185|474088201|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
131673374|NCT02668185|474088200|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
131673375|NCT02668185|474088201|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
131673376|NCT02668185|474088200|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
131673377|NCT02668185|474088201|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
131673378|NCT00723021|474088206|FG000|Intervention Period 4|Adverse Event|0|||
131673379|NCT00723021|474088207|FG001|Intervention Period 4|Adverse Event|0|||
131673380|NCT00723021|474088208|FG002|Intervention Period 4|Adverse Event|0|||
131673381|NCT00723021|474088209|FG003|Intervention Period 4|Adverse Event|0|||
131673382|NCT00723021|474088210|FG004|Intervention Period 4|Adverse Event|1|||
131673383|NCT00883051|474088212|FG000|Overall Study|Lost to Follow-up|0|||
131673384|NCT00883051|474088213|FG001|Overall Study|Lost to Follow-up|0|||
131673385|NCT00883051|474088214|FG002|Overall Study|Lost to Follow-up|0|||
131673386|NCT00883051|474088215|FG003|Overall Study|Lost to Follow-up|0|||
131673387|NCT00883051|474088216|FG004|Overall Study|Lost to Follow-up|1|||
131673388|NCT00883051|474088212|FG000|Overall Study|Did not use study medication|24|||
131673389|NCT00883051|474088213|FG001|Overall Study|Did not use study medication|22|||
131673390|NCT00883051|474088214|FG002|Overall Study|Did not use study medication|29|||
131673391|NCT00883051|474088215|FG003|Overall Study|Did not use study medication|29|||
131673392|NCT00883051|474088216|FG004|Overall Study|Did not use study medication|17|||
131673393|NCT02337751|474088217|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
131673394|NCT02337751|474088218|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
131673395|NCT02337751|474088217|FG000|Overall Study|Voluntary Withdrawal|6|||
131673396|NCT02337751|474088218|FG001|Overall Study|Voluntary Withdrawal|8|||
131673397|NCT02337751|474088217|FG000|Overall Study|Lack of Efficacy|2|||
131673398|NCT02337751|474088218|FG001|Overall Study|Lack of Efficacy|5|||
131673399|NCT02337751|474088217|FG000|Overall Study|Investigator's Judgement|1|||
131673400|NCT02337751|474088218|FG001|Overall Study|Investigator's Judgement|0|||
131673401|NCT01215422|474090639|FG000|Overall Study|Relocation|1|||
131673402|NCT01215422|474090640|FG001|Overall Study|Relocation|0|||
131673403|NCT01215422|474090641|FG002|Overall Study|Relocation|0|||
131673404|NCT01215422|474090642|FG003|Overall Study|Relocation|0|||
131673405|NCT01215422|474090639|FG000|Overall Study|Failed intubations|0|||
131673406|NCT01215422|474090640|FG001|Overall Study|Failed intubations|0|||
131673407|NCT01215422|474090641|FG002|Overall Study|Failed intubations|3|||
131673408|NCT01215422|474090642|FG003|Overall Study|Failed intubations|8|||
131673409|NCT01215422|474090639|FG000|Overall Study|Did not complete all intubations|7|||
131673410|NCT01215422|474090640|FG001|Overall Study|Did not complete all intubations|0|||
131673411|NCT01215422|474090641|FG002|Overall Study|Did not complete all intubations|0|||
131673412|NCT01215422|474090642|FG003|Overall Study|Did not complete all intubations|0|||
131673413|NCT04142450|474090647|FG000|Overall Study|Screen Failure|1|||
131673414|NCT04142450|474090647|FG000|Overall Study|Lost to Follow-up|1|||
131673415|NCT02544217|474090648|FG000|Overall Study|Withdrawal by Subject|1|||
131673416|NCT02544217|474090649|FG001|Overall Study|Withdrawal by Subject|1|||
131673417|NCT02544217|474090650|FG002|Overall Study|Withdrawal by Subject|0|||
131673418|NCT02544217|474090651|FG003|Overall Study|Withdrawal by Subject|0|||
131673419|NCT02544217|474090652|FG004|Overall Study|Withdrawal by Subject|0|||
131673420|NCT02544217|474090653|FG005|Overall Study|Withdrawal by Subject|0|||
131673421|NCT04335812|474090654|FG000|Overall Study|Withdrawal by Subject|1|||
131673422|NCT04335812|474090655|FG001|Overall Study|Withdrawal by Subject|3|||
131673423|NCT04335812|474090654|FG000|Overall Study|Lost to Follow-up|12|||
131673424|NCT04335812|474090655|FG001|Overall Study|Lost to Follow-up|12|||
131673425|NCT04335812|474090654|FG000|Overall Study|Did not engage in the intervention|22|||
131673426|NCT04335812|474090655|FG001|Overall Study|Did not engage in the intervention|18|||
131673427|NCT02901041|474090666|FG000|Overall Study|Withdrawal by PI|4|||
131673428|NCT02901041|474090667|FG001|Overall Study|Withdrawal by PI|8|||
131673429|NCT02901041|474090666|FG000|Overall Study|Withdrawal by Subject|7|||
131673430|NCT02901041|474090667|FG001|Overall Study|Withdrawal by Subject|3|||
131673431|NCT00975507|474090671|FG000|Overall Study|Adverse Event|1|||
131673432|NCT00975507|474090672|FG001|Overall Study|Adverse Event|0|||
131673433|NCT00975507|474090671|FG000|Overall Study|Lost to Follow-up|7|||
131673434|NCT00975507|474090672|FG001|Overall Study|Lost to Follow-up|1|||
131673435|NCT00975507|474090671|FG000|Overall Study|Protocol Violation|2|||
131673436|NCT00975507|474090672|FG001|Overall Study|Protocol Violation|0|||
131673437|NCT00975507|474090671|FG000|Overall Study|Withdrawal by Subject|10|||
131673438|NCT00975507|474090672|FG001|Overall Study|Withdrawal by Subject|3|||
131673439|NCT01112306|474090673|FG000|Overall Study|Death|175|||
131673440|NCT01112306|474090673|FG000|Overall Study|Lost to Follow-up|9|||
131673441|NCT01112306|474090673|FG000|Overall Study|Withdrawal by Subject|31|||
131673442|NCT01112306|474090673|FG000|Overall Study|Other|70|||
131673443|NCT01607554|474090677|FG000|Overall Study|Disease progression|2|||
131673444|NCT03952806|474090678|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
131673445|NCT03952806|474090679|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
131673446|NCT03952806|474090678|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
131673447|NCT03952806|474090679|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
131673448|NCT03952806|474090678|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
131673449|NCT03952806|474090679|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
131673450|NCT03952806|474090678|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
131673451|NCT03952806|474090679|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
131673452|NCT03952806|474090678|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
131673453|NCT03952806|474090679|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
131673454|NCT03952806|474090678|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
131673455|NCT03952806|474090679|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
131673456|NCT03952806|474090678|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
131673457|NCT03952806|474090679|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
131673458|NCT03952806|474090678|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
131673459|NCT03952806|474090679|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
131673460|NCT03952806|474090678|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
131673461|NCT03952806|474090679|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
131673462|NCT03952806|474090678|FG000|OLE Phase (48 Weeks)|Other|16|||
131673463|NCT03952806|474090679|FG001|OLE Phase (48 Weeks)|Other|13|||
131673464|NCT00655863|474090680|FG000|Overall Study|Lost to Follow-up|0|||
131673465|NCT00655863|474090681|FG001|Overall Study|Lost to Follow-up|0|||
131673466|NCT00655863|474090682|FG002|Overall Study|Lost to Follow-up|1|||
131673467|NCT01138007|474090683|FG000|Overall Study|Adverse Event|4|||
131673468|NCT01138007|474090684|FG001|Overall Study|Adverse Event|12|||
131673469|NCT01138007|474090685|FG002|Overall Study|Adverse Event|9|||
131673470|NCT01138007|474090683|FG000|Overall Study|Lack of Efficacy|2|||
131673471|NCT01138007|474090684|FG001|Overall Study|Lack of Efficacy|0|||
131673472|NCT01138007|474090685|FG002|Overall Study|Lack of Efficacy|6|||
131673473|NCT01138007|474090683|FG000|Overall Study|Protocol Violation|2|||
131673474|NCT01138007|474090684|FG001|Overall Study|Protocol Violation|3|||
131673475|NCT01138007|474090685|FG002|Overall Study|Protocol Violation|2|||
131673476|NCT01138007|474090683|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
131673477|NCT01138007|474090684|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
131673478|NCT01138007|474090685|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
131673479|NCT01138007|474090683|FG000|Overall Study|Lost to Follow-up|3|||
131673480|NCT01138007|474090684|FG001|Overall Study|Lost to Follow-up|3|||
131673481|NCT01138007|474090685|FG002|Overall Study|Lost to Follow-up|5|||
131673482|NCT01138007|474090683|FG000|Overall Study|Physician Decision|0|||
131673483|NCT01138007|474090684|FG001|Overall Study|Physician Decision|5|||
131673484|NCT01138007|474090685|FG002|Overall Study|Physician Decision|3|||
131673485|NCT01138007|474090683|FG000|Overall Study|Withdrawal by Subject|5|||
131673486|NCT01138007|474090684|FG001|Overall Study|Withdrawal by Subject|6|||
131673487|NCT01138007|474090685|FG002|Overall Study|Withdrawal by Subject|15|||
131673488|NCT04661878|474090686|FG000|Overall Study|Lost to Follow-up|6|||
131673489|NCT04661878|474090687|FG001|Overall Study|Lost to Follow-up|5|||
131673490|NCT00744523|474090690|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
131673491|NCT00744523|474090691|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
131673492|NCT00325039|474090693|FG000|Overall Study|Lost to Follow-up|18|||
131673493|NCT00325039|474090694|FG001|Overall Study|Lost to Follow-up|14|||
131673494|NCT01009203|474090695|FG000|Overall Study|Withdrawal by Subject|1|||
131673495|NCT01009203|474090695|FG000|Overall Study|Adverse Event|5|||
131673496|NCT01009203|474090695|FG000|Overall Study|Treatment-unrelated death|1|||
131673497|NCT02974088|474090696|FG000|Overall Study|Lost to Follow-up|0|||
131673498|NCT02974088|474090697|FG001|Overall Study|Lost to Follow-up|2|||
131673499|NCT02974088|474090696|FG000|Overall Study|Adverse Event|0|||
131673500|NCT02974088|474090697|FG001|Overall Study|Adverse Event|1|||
131673501|NCT00892723|474090698|FG000|Overall Study|Lost to Follow-up|1|||
131673502|NCT00892723|474090699|FG001|Overall Study|Lost to Follow-up|3|||
131673503|NCT00892723|474090700|FG002|Overall Study|Lost to Follow-up|1|||
131673504|NCT00892723|474090698|FG000|Overall Study|Withdrawal by Subject|1|||
131673505|NCT00892723|474090699|FG001|Overall Study|Withdrawal by Subject|1|||
131673506|NCT00892723|474090700|FG002|Overall Study|Withdrawal by Subject|1|||
131673507|NCT00150969|474090703|FG000|24 Month Main Study|Adverse Event|3|||
131673508|NCT00150969|474090704|FG001|24 Month Main Study|Adverse Event|4|||
131673509|NCT00150969|474090703|FG000|24 Month Main Study|Death|1|||
131673510|NCT00150969|474090704|FG001|24 Month Main Study|Death|1|||
131673511|NCT00150969|474090703|FG000|24 Month Main Study|Lack of Efficacy|1|||
131673512|NCT00150969|474090704|FG001|24 Month Main Study|Lack of Efficacy|8|||
131673513|NCT00150969|474090703|FG000|24 Month Main Study|Lost to Follow-up|3|||
131673514|NCT00150969|474090704|FG001|24 Month Main Study|Lost to Follow-up|2|||
131673515|NCT00150969|474090703|FG000|24 Month Main Study|Protocol Violation|4|||
131673516|NCT00150969|474090704|FG001|24 Month Main Study|Protocol Violation|2|||
131673517|NCT00150969|474090703|FG000|24 Month Main Study|Withdrawal by Subject|7|||
131673518|NCT00150969|474090704|FG001|24 Month Main Study|Withdrawal by Subject|4|||
131673519|NCT00150969|474090703|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
131673520|NCT00150969|474090704|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
131673521|NCT00150969|474090703|FG000|24-48 Month Extension|Lack of Efficacy|0|||
131673522|NCT00150969|474090704|FG001|24-48 Month Extension|Lack of Efficacy|1|||
131673523|NCT00150969|474090703|FG000|24-48 Month Extension|Adverse Event|1|||
131673524|NCT00150969|474090704|FG001|24-48 Month Extension|Adverse Event|3|||
131673525|NCT00150969|474090703|FG000|24-48 Month Extension|Other Reason|81|||
131673526|NCT00150969|474090704|FG001|24-48 Month Extension|Other Reason|91|||
131673527|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
131673528|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
131673529|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
131673530|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
131673531|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
131673532|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
131673533|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
131673534|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
131673535|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
131673536|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
131673537|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
131673538|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
131673539|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
131673540|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
131555349|NCT00041756|473658177|FG001|Overall Study|Unable to meet protocol criteria|0|||
131673541|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
131673542|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
131673543|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
131673544|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
131673545|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
131673546|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
131673547|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
131673548|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
131673549|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
131555350|NCT00041756|473658178|FG002|Overall Study|Unable to meet protocol criteria|1|||
131673550|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
131673551|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
131673552|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
131673553|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
131673554|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
131673555|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
131673556|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
131673557|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Other|10|||
131673558|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Other|7|||
131673559|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Other|8|||
131673560|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Other|8|||
131673561|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Other|0|||
131673562|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
131673563|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
131673564|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
131673565|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
131673566|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
131673567|NCT00615836|474090705|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
131673568|NCT00615836|474090706|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131673569|NCT00615836|474090707|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131673570|NCT00615836|474090708|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131673571|NCT00615836|474090709|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131673572|NCT02121834|474090710|FG000|Overall Study|Protocol Violation|0|||
131673573|NCT02121834|474090711|FG001|Overall Study|Protocol Violation|1|||
131673574|NCT02121834|474090712|FG002|Overall Study|Protocol Violation|0|||
131673575|NCT02121834|474090713|FG003|Overall Study|Protocol Violation|0|||
131673576|NCT02121834|474090714|FG004|Overall Study|Protocol Violation|0|||
131673577|NCT02121834|474090715|FG005|Overall Study|Protocol Violation|0|||
131673578|NCT02121834|474090716|FG006|Overall Study|Protocol Violation|0|||
131673579|NCT02121834|474090710|FG000|Overall Study|Withdrawal by Subject|0|||
131673580|NCT02121834|474090711|FG001|Overall Study|Withdrawal by Subject|1|||
131673581|NCT02121834|474090712|FG002|Overall Study|Withdrawal by Subject|1|||
131673582|NCT02121834|474090713|FG003|Overall Study|Withdrawal by Subject|0|||
131673583|NCT02121834|474090714|FG004|Overall Study|Withdrawal by Subject|0|||
131673584|NCT02121834|474090715|FG005|Overall Study|Withdrawal by Subject|0|||
131673585|NCT02121834|474090716|FG006|Overall Study|Withdrawal by Subject|0|||
131673586|NCT02121834|474090710|FG000|Overall Study|Lost to Follow-up|0|||
131673587|NCT02121834|474090711|FG001|Overall Study|Lost to Follow-up|0|||
131673588|NCT02121834|474090712|FG002|Overall Study|Lost to Follow-up|1|||
131673589|NCT02121834|474090713|FG003|Overall Study|Lost to Follow-up|0|||
131673590|NCT02121834|474090714|FG004|Overall Study|Lost to Follow-up|0|||
131673591|NCT02121834|474090715|FG005|Overall Study|Lost to Follow-up|0|||
131673592|NCT02121834|474090716|FG006|Overall Study|Lost to Follow-up|0|||
131673593|NCT02019927|474090719|FG000|Overall Study|Lost to Follow-up|2|||
131673594|NCT02019927|474090720|FG001|Overall Study|Lost to Follow-up|4|||
131673595|NCT02019927|474090721|FG002|Overall Study|Lost to Follow-up|1|||
131673596|NCT02019927|474090722|FG003|Overall Study|Lost to Follow-up|2|||
131673597|NCT02019927|474090723|FG004|Overall Study|Lost to Follow-up|3|||
131673598|NCT02019927|474090724|FG005|Overall Study|Lost to Follow-up|1|||
131673599|NCT01423253|474090737|FG000|Overall Study|Adverse Event|2|||
131673600|NCT01423253|474090737|FG000|Overall Study|Lack of Efficacy|2|||
131673601|NCT01423253|474090737|FG000|Overall Study|Lost to Follow-up|1|||
131673602|NCT01423253|474090737|FG000|Overall Study|Protocol Violation|2|||
131673603|NCT01423253|474090737|FG000|Overall Study|Withdrawal by Subject|2|||
131673604|NCT00307125|474090740|FG000|Screening Phase|Adverse Event|1|||
131673605|NCT00307125|474090741|FG001|Screening Phase|Adverse Event|0|||
131673606|NCT00307125|474090742|FG002|Screening Phase|Adverse Event|0|||
131673607|NCT00307125|474090740|FG000|Screening Phase|Protocol Violation|27|||
131673608|NCT00307125|474090741|FG001|Screening Phase|Protocol Violation|0|||
131673609|NCT00307125|474090742|FG002|Screening Phase|Protocol Violation|0|||
131673610|NCT00307125|474090740|FG000|Screening Phase|Lost to Follow-up|87|||
131673611|NCT00307125|474090741|FG001|Screening Phase|Lost to Follow-up|0|||
131673612|NCT00307125|474090742|FG002|Screening Phase|Lost to Follow-up|0|||
131673613|NCT00307125|474090740|FG000|Screening Phase|Death|10|||
131673614|NCT00307125|474090741|FG001|Screening Phase|Death|0|||
131673615|NCT00307125|474090742|FG002|Screening Phase|Death|0|||
131673616|NCT00307125|474090740|FG000|Screening Phase|Withdrawal by Subject|77|||
131673617|NCT00307125|474090741|FG001|Screening Phase|Withdrawal by Subject|0|||
131673618|NCT00307125|474090742|FG002|Screening Phase|Withdrawal by Subject|0|||
131673619|NCT00307125|474090740|FG000|Screening Phase|Physician Decision|26|||
131673620|NCT00307125|474090741|FG001|Screening Phase|Physician Decision|0|||
131673621|NCT00307125|474090742|FG002|Screening Phase|Physician Decision|0|||
131673622|NCT00307125|474090740|FG000|Screening Phase|Sponsor Decision|4|||
131673623|NCT00307125|474090741|FG001|Screening Phase|Sponsor Decision|0|||
131673624|NCT00307125|474090742|FG002|Screening Phase|Sponsor Decision|0|||
131673625|NCT00307125|474090740|FG000|Screening Phase|Study Terminated|17|||
131673626|NCT00307125|474090741|FG001|Screening Phase|Study Terminated|0|||
131673627|NCT00307125|474090742|FG002|Screening Phase|Study Terminated|0|||
131673628|NCT00307125|474090740|FG000|Screening Phase|Graft Loss|3|||
131673629|NCT00307125|474090741|FG001|Screening Phase|Graft Loss|0|||
131673630|NCT00307125|474090742|FG002|Screening Phase|Graft Loss|0|||
131673631|NCT00307125|474090740|FG000|Screening Phase|Graft Failure|8|||
131673632|NCT00307125|474090741|FG001|Screening Phase|Graft Failure|0|||
131673633|NCT00307125|474090742|FG002|Screening Phase|Graft Failure|0|||
131673634|NCT00307125|474090740|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
131673635|NCT00307125|474090741|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
131673636|NCT00307125|474090742|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
131673637|NCT00307125|474090740|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
131673638|NCT00307125|474090741|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
131673639|NCT00307125|474090742|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
131673640|NCT00307125|474090740|FG000|Screening Phase|Moved or transferred facilities|34|||
131673641|NCT00307125|474090741|FG001|Screening Phase|Moved or transferred facilities|0|||
131673642|NCT00307125|474090742|FG002|Screening Phase|Moved or transferred facilities|0|||
131673643|NCT00307125|474090740|FG000|Screening Phase|Received Pancreas Transplant|8|||
131673644|NCT00307125|474090741|FG001|Screening Phase|Received Pancreas Transplant|0|||
131673645|NCT00307125|474090742|FG002|Screening Phase|Received Pancreas Transplant|0|||
131673646|NCT00307125|474090740|FG000|Screening Phase|Ineligible for pilot|4|||
131673647|NCT00307125|474090741|FG001|Screening Phase|Ineligible for pilot|0|||
131673648|NCT00307125|474090742|FG002|Screening Phase|Ineligible for pilot|0|||
131673649|NCT00307125|474090740|FG000|Screening Phase|Try to get pregnant|1|||
131673650|NCT00307125|474090741|FG001|Screening Phase|Try to get pregnant|0|||
131673651|NCT00307125|474090742|FG002|Screening Phase|Try to get pregnant|0|||
131673652|NCT00307125|474090740|FG000|Screening Phase|Developed acute leukemia|1|||
131673653|NCT00307125|474090741|FG001|Screening Phase|Developed acute leukemia|0|||
131673654|NCT00307125|474090742|FG002|Screening Phase|Developed acute leukemia|0|||
131673655|NCT00307125|474090740|FG000|Screening Phase|Metastatic colon cancer|1|||
131673656|NCT00307125|474090741|FG001|Screening Phase|Metastatic colon cancer|0|||
131673657|NCT00307125|474090742|FG002|Screening Phase|Metastatic colon cancer|0|||
131673658|NCT00307125|474090740|FG000|Screening Phase|Malignancy|1|||
131673659|NCT00307125|474090741|FG001|Screening Phase|Malignancy|0|||
131673660|NCT00307125|474090742|FG002|Screening Phase|Malignancy|0|||
131673661|NCT00307125|474090740|FG000|Screening Phase|PAK|1|||
131673662|NCT00307125|474090741|FG001|Screening Phase|PAK|0|||
131673663|NCT00307125|474090742|FG002|Screening Phase|PAK|0|||
131673664|NCT00307125|474090740|FG000|Screening Phase|Ineligible|1|||
131673665|NCT00307125|474090741|FG001|Screening Phase|Ineligible|0|||
131673666|NCT00307125|474090742|FG002|Screening Phase|Ineligible|0|||
131673667|NCT00307125|474090740|FG000|Screening Phase|Screen Error|1|||
131673668|NCT00307125|474090741|FG001|Screening Phase|Screen Error|0|||
131673669|NCT00307125|474090742|FG002|Screening Phase|Screen Error|0|||
131673670|NCT00307125|474090740|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
131673671|NCT00307125|474090741|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
131673672|NCT00307125|474090742|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
131673673|NCT00307125|474090740|FG000|Screening Phase|AMR and treated with rituximab|1|||
131673674|NCT00307125|474090741|FG001|Screening Phase|AMR and treated with rituximab|0|||
131673675|NCT00307125|474090742|FG002|Screening Phase|AMR and treated with rituximab|0|||
131673676|NCT00307125|474090740|FG000|Screening Phase|Coronary artery bypass|1|||
131673677|NCT00307125|474090741|FG001|Screening Phase|Coronary artery bypass|0|||
131673678|NCT00307125|474090742|FG002|Screening Phase|Coronary artery bypass|0|||
131673679|NCT00307125|474090740|FG000|Pilot Phase|Lost to Follow-up|0|||
131673680|NCT00307125|474090741|FG001|Pilot Phase|Lost to Follow-up|1|||
131673681|NCT00307125|474090742|FG002|Pilot Phase|Lost to Follow-up|0|||
131673682|NCT00307125|474090740|FG000|Pilot Phase|Withdrawal by Subject|0|||
131673683|NCT00307125|474090741|FG001|Pilot Phase|Withdrawal by Subject|1|||
131673684|NCT00307125|474090742|FG002|Pilot Phase|Withdrawal by Subject|1|||
131673685|NCT00147823|474090745|FG000|Overall Study|Lost to Follow-up|6|||
131673686|NCT00147823|474090746|FG001|Overall Study|Lost to Follow-up|12|||
131673687|NCT00147823|474090745|FG000|Overall Study|Physician Decision|1|||
131673688|NCT00147823|474090746|FG001|Overall Study|Physician Decision|0|||
131673689|NCT00147823|474090745|FG000|Overall Study|Withdrawal by Subject|0|||
131673690|NCT00147823|474090746|FG001|Overall Study|Withdrawal by Subject|1|||
131673691|NCT00147823|474090745|FG000|Overall Study|Did not receive vitoss due to infection|6|||
131673692|NCT00147823|474090746|FG001|Overall Study|Did not receive vitoss due to infection|2|||
131673693|NCT01032382|474090747|FG000|Overall Study|Disease dissemination|1|||
131673694|NCT01032382|474090748|FG001|Overall Study|Disease dissemination|1|||
131673695|NCT01032382|474090747|FG000|Overall Study|Treatment failure|3|||
131673696|NCT01032382|474090748|FG001|Overall Study|Treatment failure|1|||
131673697|NCT01032382|474090747|FG000|Overall Study|Index lesion relapse|1|||
131673698|NCT01032382|474090748|FG001|Overall Study|Index lesion relapse|3|||
131673699|NCT00412971|474090749|FG000|Overall Study|Lost to Follow-up|17|||
131673700|NCT00412971|474090750|FG001|Overall Study|Lost to Follow-up|9|||
131673701|NCT00412971|474090749|FG000|Overall Study|Protocol Violation|13|||
131673702|NCT00412971|474090750|FG001|Overall Study|Protocol Violation|1|||
131673703|NCT02571049|474090751|FG000|Screening|Did not meet entry criteria|2|||
131673704|NCT02571049|474090752|FG001|Screening|Did not meet entry criteria|2|||
131673705|NCT02571049|474090751|FG000|Randomization|No migraine attack|0|||
131673706|NCT02571049|474090752|FG001|Randomization|No migraine attack|1|||
131673707|NCT02571049|474090751|FG000|Randomization|Adverse Event|0|||
131673708|NCT02571049|474090752|FG001|Randomization|Adverse Event|1|||
131673709|NCT01055262|474090753|FG000|Overall Study|Adverse Event|5|||
131673710|NCT01055262|474090753|FG000|Overall Study|Protocol Violation|3|||
131673711|NCT01055262|474090753|FG000|Overall Study|Uncooperativeness|1|||
131673712|NCT00561951|474090754|FG000|Overall Study|Adverse Event|11|||
131673713|NCT00561951|474090755|FG001|Overall Study|Adverse Event|14|||
131673714|NCT00561951|474090756|FG002|Overall Study|Adverse Event|14|||
131673715|NCT00561951|474090754|FG000|Overall Study|Lack of Efficacy|5|||
131673716|NCT00561951|474090755|FG001|Overall Study|Lack of Efficacy|3|||
131673717|NCT00561951|474090756|FG002|Overall Study|Lack of Efficacy|2|||
131673718|NCT00561951|474090754|FG000|Overall Study|Lost to Follow-up|1|||
131673719|NCT00561951|474090755|FG001|Overall Study|Lost to Follow-up|1|||
131673720|NCT00561951|474090756|FG002|Overall Study|Lost to Follow-up|0|||
131673721|NCT00561951|474090754|FG000|Overall Study|Withdrawal by Subject|10|||
131673722|NCT00561951|474090755|FG001|Overall Study|Withdrawal by Subject|9|||
131673723|NCT00561951|474090756|FG002|Overall Study|Withdrawal by Subject|10|||
131673724|NCT00561951|474090754|FG000|Overall Study|Protocol Violation|4|||
131673725|NCT00561951|474090755|FG001|Overall Study|Protocol Violation|3|||
131673726|NCT00561951|474090756|FG002|Overall Study|Protocol Violation|4|||
131673727|NCT00561951|474090754|FG000|Overall Study|Physician Decision|1|||
131673728|NCT00561951|474090755|FG001|Overall Study|Physician Decision|0|||
131673729|NCT00561951|474090756|FG002|Overall Study|Physician Decision|0|||
131673730|NCT00561951|474090754|FG000|Overall Study|Pregnancy|0|||
131673731|NCT00561951|474090755|FG001|Overall Study|Pregnancy|1|||
131673732|NCT00561951|474090756|FG002|Overall Study|Pregnancy|0|||
131673733|NCT00561951|474090754|FG000|Overall Study|Meet Withdrawal Criterion|0|||
131673734|NCT00561951|474090755|FG001|Overall Study|Meet Withdrawal Criterion|1|||
131673735|NCT00561951|474090756|FG002|Overall Study|Meet Withdrawal Criterion|1|||
131673736|NCT00561951|474090754|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
131673737|NCT00561951|474090755|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
131673738|NCT00561951|474090756|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
131673739|NCT00421707|474090768|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
131673740|NCT00421707|474090769|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
131555351|NCT00041756|473658179|FG003|Overall Study|Unable to meet protocol criteria|0|||
131555352|NCT00041756|473658180|FG004|Overall Study|Unable to meet protocol criteria|1|||
131555353|NCT00041756|473658176|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
131555354|NCT00041756|473658177|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
131555355|NCT00041756|473658178|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
131555356|NCT00041756|473658179|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
131555357|NCT00041756|473658180|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
131555358|NCT03980184|473658181|FG000|Overall Study|Dropped out before treatment|2|||
131555359|NCT03980184|473658182|FG001|Overall Study|Dropped out before treatment|2|||
131555360|NCT03980184|473658181|FG000|Overall Study|Lost to Follow-up|11|||
131555361|NCT03980184|473658182|FG001|Overall Study|Lost to Follow-up|13|||
131555362|NCT00603265|473658183|FG000|Overall Study|Adverse Event|2|||
131555363|NCT00603265|473658184|FG001|Overall Study|Adverse Event|11|||
131555364|NCT00603265|473658185|FG002|Overall Study|Adverse Event|1|||
131555365|NCT00603265|473658183|FG000|Overall Study|Withdrawal by Subject|1|||
131555366|NCT00603265|473658184|FG001|Overall Study|Withdrawal by Subject|2|||
131555367|NCT00603265|473658185|FG002|Overall Study|Withdrawal by Subject|1|||
131555368|NCT00603265|473658183|FG000|Overall Study|Lack of Efficacy|3|||
131555369|NCT00603265|473658184|FG001|Overall Study|Lack of Efficacy|0|||
131555370|NCT00603265|473658185|FG002|Overall Study|Lack of Efficacy|3|||
131555371|NCT00603265|473658183|FG000|Overall Study|Lost to Follow-up|0|||
131555372|NCT00603265|473658184|FG001|Overall Study|Lost to Follow-up|1|||
131555373|NCT00603265|473658185|FG002|Overall Study|Lost to Follow-up|0|||
131555374|NCT00603265|473658183|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
131555375|NCT00603265|473658184|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
131555376|NCT00603265|473658185|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
131673741|NCT00421707|474090768|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
131673742|NCT00421707|474090769|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
131673743|NCT00421707|474090768|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
131673744|NCT00421707|474090769|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
131555377|NCT00603265|473658183|FG000|Overall Study|Participant Left Country, No Responses|0|||
131555378|NCT00603265|473658184|FG001|Overall Study|Participant Left Country, No Responses|1|||
131555379|NCT00603265|473658185|FG002|Overall Study|Participant Left Country, No Responses|0|||
131555380|NCT00603265|473658183|FG000|Overall Study|Protocol Violation|1|||
131673745|NCT00421707|474090768|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
131673746|NCT00421707|474090769|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
131673747|NCT00421707|474090768|FG000|Period 2: Washout|Adverse Event|1|||
131673748|NCT00421707|474090769|FG001|Period 2: Washout|Adverse Event|1|||
131673749|NCT00421707|474090768|FG000|Period 2: Washout|Withdrawal by Subject|0|||
131673750|NCT00421707|474090769|FG001|Period 2: Washout|Withdrawal by Subject|1|||
131673751|NCT00421707|474090768|FG000|Period 2: Washout|Lost to Follow-up|0|||
131673752|NCT00421707|474090769|FG001|Period 2: Washout|Lost to Follow-up|1|||
131673753|NCT00421707|474090768|FG000|Period 2: Washout|Other: Pregnancy|0|||
131673754|NCT00421707|474090769|FG001|Period 2: Washout|Other: Pregnancy|1|||
131673755|NCT00421707|474090768|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
131673756|NCT00421707|474090769|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
131673757|NCT00421707|474090768|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
131673758|NCT00421707|474090769|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
131673759|NCT00421707|474090768|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
131673760|NCT00421707|474090769|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
131673761|NCT03261700|474090770|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
131673762|NCT03261700|474090771|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
131673763|NCT01723254|474090772|FG000|Overall Study|Conflict with work schedule|0|||
131673764|NCT01723254|474090773|FG001|Overall Study|Conflict with work schedule|0|||
131673765|NCT01723254|474090774|FG002|Overall Study|Conflict with work schedule|0|||
131673766|NCT01723254|474090775|FG003|Overall Study|Conflict with work schedule|0|||
131673767|NCT01723254|474090776|FG004|Overall Study|Conflict with work schedule|0|||
131673768|NCT01723254|474090777|FG005|Overall Study|Conflict with work schedule|0|||
131673769|NCT01723254|474090778|FG006|Overall Study|Conflict with work schedule|0|||
131673770|NCT01723254|474090779|FG007|Overall Study|Conflict with work schedule|1|||
131673771|NCT01723254|474090772|FG000|Overall Study|Personal issues|0|||
131673772|NCT01723254|474090773|FG001|Overall Study|Personal issues|0|||
131673773|NCT01723254|474090774|FG002|Overall Study|Personal issues|0|||
131673774|NCT01723254|474090775|FG003|Overall Study|Personal issues|0|||
131673775|NCT01723254|474090776|FG004|Overall Study|Personal issues|0|||
131673776|NCT01723254|474090777|FG005|Overall Study|Personal issues|1|||
131673777|NCT01723254|474090778|FG006|Overall Study|Personal issues|0|||
131673778|NCT01723254|474090779|FG007|Overall Study|Personal issues|0|||
131673779|NCT01723254|474090772|FG000|Overall Study|No longer have time to participate|0|||
131673780|NCT01723254|474090773|FG001|Overall Study|No longer have time to participate|0|||
131673781|NCT01723254|474090774|FG002|Overall Study|No longer have time to participate|0|||
131673782|NCT01723254|474090775|FG003|Overall Study|No longer have time to participate|1|||
131673783|NCT01723254|474090776|FG004|Overall Study|No longer have time to participate|0|||
131673784|NCT01723254|474090777|FG005|Overall Study|No longer have time to participate|0|||
131673785|NCT01723254|474090778|FG006|Overall Study|No longer have time to participate|0|||
131673786|NCT01723254|474090779|FG007|Overall Study|No longer have time to participate|0|||
131673787|NCT01723254|474090772|FG000|Overall Study|Move/Left to another country/city|0|||
131673788|NCT01723254|474090773|FG001|Overall Study|Move/Left to another country/city|0|||
131673789|NCT01723254|474090774|FG002|Overall Study|Move/Left to another country/city|2|||
131673790|NCT01723254|474090775|FG003|Overall Study|Move/Left to another country/city|1|||
131673791|NCT01723254|474090776|FG004|Overall Study|Move/Left to another country/city|1|||
131673792|NCT01723254|474090777|FG005|Overall Study|Move/Left to another country/city|0|||
131673793|NCT01723254|474090778|FG006|Overall Study|Move/Left to another country/city|0|||
131673794|NCT01723254|474090779|FG007|Overall Study|Move/Left to another country/city|0|||
131673795|NCT01723254|474090772|FG000|Overall Study|Protocol Violation|0|||
131673796|NCT01723254|474090773|FG001|Overall Study|Protocol Violation|1|||
131673797|NCT01723254|474090774|FG002|Overall Study|Protocol Violation|0|||
131673798|NCT01723254|474090775|FG003|Overall Study|Protocol Violation|0|||
131673799|NCT01723254|474090776|FG004|Overall Study|Protocol Violation|0|||
131673800|NCT01723254|474090777|FG005|Overall Study|Protocol Violation|0|||
131673801|NCT01723254|474090778|FG006|Overall Study|Protocol Violation|0|||
131673802|NCT01723254|474090779|FG007|Overall Study|Protocol Violation|0|||
131673803|NCT01723254|474090772|FG000|Overall Study|Withdrawal by Subject|1|||
131673804|NCT01723254|474090773|FG001|Overall Study|Withdrawal by Subject|2|||
131673805|NCT01723254|474090774|FG002|Overall Study|Withdrawal by Subject|1|||
131673806|NCT01723254|474090775|FG003|Overall Study|Withdrawal by Subject|0|||
131673807|NCT01723254|474090776|FG004|Overall Study|Withdrawal by Subject|1|||
131673808|NCT01723254|474090777|FG005|Overall Study|Withdrawal by Subject|1|||
131673809|NCT01723254|474090778|FG006|Overall Study|Withdrawal by Subject|1|||
131673810|NCT01723254|474090779|FG007|Overall Study|Withdrawal by Subject|2|||
131673811|NCT01074216|474090780|FG000|Overall Study|Physician Decision|1|||
131673812|NCT01074216|474090780|FG000|Overall Study|Not Treated|12|||
131673813|NCT01323634|474090781|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
131673814|NCT01323634|474090782|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
131673815|NCT01323634|474090783|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
131673816|NCT01323634|474090781|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
131673817|NCT01323634|474090782|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
131673818|NCT01323634|474090783|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
131673819|NCT01323634|474090781|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
131673820|NCT01323634|474090782|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131673821|NCT01323634|474090783|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131673822|NCT01323634|474090781|FG000|2-week Run-in Period|Physician Decision|5|||
131673823|NCT01323634|474090782|FG001|2-week Run-in Period|Physician Decision|0|||
131673824|NCT01323634|474090783|FG002|2-week Run-in Period|Physician Decision|0|||
131673825|NCT01323634|474090781|FG000|2-week Run-in Period|Protocol Violation|1|||
131673826|NCT01323634|474090782|FG001|2-week Run-in Period|Protocol Violation|0|||
131673827|NCT01323634|474090783|FG002|2-week Run-in Period|Protocol Violation|0|||
131673828|NCT01323634|474090781|FG000|2-week Run-in Period|Adverse Event|1|||
131673829|NCT01323634|474090782|FG001|2-week Run-in Period|Adverse Event|0|||
131673830|NCT01323634|474090783|FG002|2-week Run-in Period|Adverse Event|0|||
131673831|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131673832|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
131673833|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
131673834|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131673835|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131673836|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
131673837|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131673838|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
131673839|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
131673840|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131673841|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
131673842|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
131673843|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
131673844|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
131673845|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
131673846|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131673847|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
131673848|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
131673849|NCT01323634|474090781|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
131673850|NCT01323634|474090782|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
131673851|NCT01323634|474090783|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
131673852|NCT02409368|474090784|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
131673853|NCT02409368|474090785|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
131673854|NCT02409368|474090786|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
131673855|NCT02409368|474090787|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
131673856|NCT02409368|474090784|FG000|ECOG Reclassification|Death|1|||
131673857|NCT02409368|474090785|FG001|ECOG Reclassification|Death|5|||
131673858|NCT02409368|474090786|FG002|ECOG Reclassification|Death|0|||
131673859|NCT02409368|474090787|FG003|ECOG Reclassification|Death|0|||
131673860|NCT02409368|474090784|FG000|ECOG Reclassification|Disease Progression|113|||
131673861|NCT02409368|474090785|FG001|ECOG Reclassification|Disease Progression|382|||
131673862|NCT02409368|474090786|FG002|ECOG Reclassification|Disease Progression|70|||
131673863|NCT02409368|474090787|FG003|ECOG Reclassification|Disease Progression|1|||
131673864|NCT02409368|474090784|FG000|ECOG Reclassification|Lost to Follow-up|1|||
131673865|NCT02409368|474090785|FG001|ECOG Reclassification|Lost to Follow-up|5|||
131673866|NCT02409368|474090786|FG002|ECOG Reclassification|Lost to Follow-up|0|||
131673867|NCT02409368|474090787|FG003|ECOG Reclassification|Lost to Follow-up|0|||
131673868|NCT02409368|474090784|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
131673869|NCT02409368|474090785|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
131673870|NCT02409368|474090786|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
131673871|NCT02409368|474090787|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
131673872|NCT02409368|474090784|FG000|ECOG Reclassification|Poor/non-compliance|0|||
131673873|NCT02409368|474090785|FG001|ECOG Reclassification|Poor/non-compliance|3|||
131673874|NCT02409368|474090786|FG002|ECOG Reclassification|Poor/non-compliance|2|||
131673875|NCT02409368|474090787|FG003|ECOG Reclassification|Poor/non-compliance|0|||
131673876|NCT02409368|474090784|FG000|ECOG Reclassification|Study drug toxicity|17|||
131673877|NCT02409368|474090785|FG001|ECOG Reclassification|Study drug toxicity|42|||
131673878|NCT02409368|474090786|FG002|ECOG Reclassification|Study drug toxicity|7|||
131673879|NCT02409368|474090787|FG003|ECOG Reclassification|Study drug toxicity|0|||
131673880|NCT02409368|474090784|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
131673881|NCT02409368|474090785|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
131673882|NCT02409368|474090786|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
131673883|NCT02409368|474090787|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
131673884|NCT02409368|474090784|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
131673885|NCT02409368|474090785|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
131673886|NCT02409368|474090786|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
131673887|NCT02409368|474090787|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
131673888|NCT02409368|474090784|FG000|ECOG Reclassification|Participant withdrew consent|2|||
131673889|NCT02409368|474090785|FG001|ECOG Reclassification|Participant withdrew consent|3|||
131673890|NCT02409368|474090786|FG002|ECOG Reclassification|Participant withdrew consent|4|||
131673891|NCT02409368|474090787|FG003|ECOG Reclassification|Participant withdrew consent|0|||
131673892|NCT02409368|474090784|FG000|ECOG Reclassification|Other Reasons|5|||
131673893|NCT02409368|474090785|FG001|ECOG Reclassification|Other Reasons|26|||
131673894|NCT02409368|474090786|FG002|ECOG Reclassification|Other Reasons|2|||
131673895|NCT02409368|474090787|FG003|ECOG Reclassification|Other Reasons|0|||
131673896|NCT02409368|474090784|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
131673897|NCT02409368|474090785|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
131673898|NCT02409368|474090786|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
131673899|NCT02409368|474090787|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
131673900|NCT02041520|474090788|FG000|Overall Study|Adverse Event|2|||
131673901|NCT02041520|474090789|FG001|Overall Study|Adverse Event|1|||
131673902|NCT02041520|474090788|FG000|Overall Study|Withdrawal by Subject|3|||
131673903|NCT02041520|474090789|FG001|Overall Study|Withdrawal by Subject|4|||
131673904|NCT02041520|474090788|FG000|Overall Study|Protocol Violation|1|||
131673905|NCT02041520|474090789|FG001|Overall Study|Protocol Violation|0|||
131673906|NCT02041520|474090788|FG000|Overall Study|Lost to Follow-up|0|||
131673907|NCT02041520|474090789|FG001|Overall Study|Lost to Follow-up|1|||
131673908|NCT02041520|474090788|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
131673909|NCT02041520|474090789|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
131673910|NCT00413972|474090792|FG000|Overall Study|Adverse Event|2|||
131673911|NCT00413972|474090793|FG001|Overall Study|Adverse Event|1|||
131673912|NCT00413972|474090794|FG002|Overall Study|Adverse Event|0|||
131673913|NCT00413972|474090795|FG003|Overall Study|Adverse Event|0|||
131673914|NCT00413972|474090792|FG000|Overall Study|Lost to Follow-up|1|||
131673915|NCT00413972|474090793|FG001|Overall Study|Lost to Follow-up|2|||
131673916|NCT00413972|474090794|FG002|Overall Study|Lost to Follow-up|1|||
131673917|NCT00413972|474090795|FG003|Overall Study|Lost to Follow-up|0|||
131673918|NCT00413972|474090792|FG000|Overall Study|Withdrawal by Subject|4|||
131673919|NCT00413972|474090793|FG001|Overall Study|Withdrawal by Subject|5|||
131673920|NCT00413972|474090794|FG002|Overall Study|Withdrawal by Subject|7|||
131673921|NCT00413972|474090795|FG003|Overall Study|Withdrawal by Subject|2|||
131673922|NCT00413972|474090792|FG000|Overall Study|Protocol Violation|0|||
131673923|NCT00413972|474090793|FG001|Overall Study|Protocol Violation|0|||
131673924|NCT00413972|474090794|FG002|Overall Study|Protocol Violation|2|||
131673925|NCT00413972|474090795|FG003|Overall Study|Protocol Violation|0|||
131673926|NCT00413972|474090792|FG000|Overall Study|Other|0|||
131673927|NCT00413972|474090793|FG001|Overall Study|Other|0|||
131673928|NCT00413972|474090794|FG002|Overall Study|Other|0|||
131673929|NCT00413972|474090795|FG003|Overall Study|Other|1|||
131673930|NCT01145755|474090796|FG000|Overall Study|Adverse Event|2|||
131673931|NCT01145755|474090797|FG001|Overall Study|Adverse Event|4|||
131673932|NCT01145755|474090798|FG002|Overall Study|Adverse Event|2|||
131673933|NCT01145755|474090796|FG000|Overall Study|Withdrawal by Subject|2|||
131673934|NCT01145755|474090797|FG001|Overall Study|Withdrawal by Subject|2|||
131673935|NCT01145755|474090798|FG002|Overall Study|Withdrawal by Subject|2|||
131673936|NCT01145755|474090796|FG000|Overall Study|Lost to Follow-up|2|||
131673937|NCT01145755|474090797|FG001|Overall Study|Lost to Follow-up|3|||
131673938|NCT01145755|474090798|FG002|Overall Study|Lost to Follow-up|1|||
131673939|NCT01145755|474090796|FG000|Overall Study|Protocol Violation|0|||
131673940|NCT01145755|474090797|FG001|Overall Study|Protocol Violation|3|||
131673941|NCT01145755|474090798|FG002|Overall Study|Protocol Violation|1|||
131673942|NCT01145755|474090796|FG000|Overall Study|Study Closure|14|||
131673943|NCT01145755|474090797|FG001|Overall Study|Study Closure|14|||
131673944|NCT01145755|474090798|FG002|Overall Study|Study Closure|17|||
131673945|NCT01145755|474090796|FG000|Overall Study|Lack of Efficacy|0|||
131673946|NCT01145755|474090797|FG001|Overall Study|Lack of Efficacy|1|||
131673947|NCT01145755|474090798|FG002|Overall Study|Lack of Efficacy|0|||
131673948|NCT01145755|474090796|FG000|Overall Study|Patient could not swollow medication|0|||
131673949|NCT01145755|474090797|FG001|Overall Study|Patient could not swollow medication|0|||
131673950|NCT01145755|474090798|FG002|Overall Study|Patient could not swollow medication|1|||
131673951|NCT01145755|474090796|FG000|Overall Study|Withdrawal by Subject|0|||
131673952|NCT01145755|474090797|FG001|Overall Study|Withdrawal by Subject|0|||
131673953|NCT01145755|474090798|FG002|Overall Study|Withdrawal by Subject|1|||
131673954|NCT01145755|474090796|FG000|Overall Study|Positive urine ethanol|0|||
131673955|NCT01145755|474090797|FG001|Overall Study|Positive urine ethanol|1|||
131673956|NCT01145755|474090798|FG002|Overall Study|Positive urine ethanol|0|||
131673957|NCT00753272|474090808|FG000|Overall Study|Adverse Event|878|||
131673958|NCT00753272|474090809|FG001|Overall Study|Adverse Event|869|||
131673959|NCT00753272|474090808|FG000|Overall Study|Protocol Violation|28|||
131673960|NCT00753272|474090809|FG001|Overall Study|Protocol Violation|46|||
131673961|NCT00753272|474090808|FG000|Overall Study|Withdrawal by Subject|2481|||
131673962|NCT00753272|474090809|FG001|Overall Study|Withdrawal by Subject|2407|||
131673963|NCT00753272|474090808|FG000|Overall Study|Lost to Follow-up|491|||
131673964|NCT00753272|474090809|FG001|Overall Study|Lost to Follow-up|497|||
131673965|NCT00753272|474090808|FG000|Overall Study|Other|1104|||
131673966|NCT00753272|474090809|FG001|Overall Study|Other|1088|||
131673967|NCT04223856|474090812|FG000|Overall Study|Progressive disease|153|||
131673968|NCT04223856|474090813|FG001|Overall Study|Progressive disease|73|||
131673969|NCT04223856|474090812|FG000|Overall Study|Adverse Event|97|||
131673970|NCT04223856|474090813|FG001|Overall Study|Adverse Event|62|||
131673971|NCT04223856|474090812|FG000|Overall Study|Physician Decision|9|||
131673972|NCT04223856|474090813|FG001|Overall Study|Physician Decision|28|||
131673973|NCT04223856|474090812|FG000|Overall Study|Withdrawal by Subject|22|||
131673974|NCT04223856|474090813|FG001|Overall Study|Withdrawal by Subject|24|||
131673975|NCT04223856|474090812|FG000|Overall Study|Other|7|||
131673976|NCT04223856|474090813|FG001|Overall Study|Other|2|||
131673977|NCT04223856|474090812|FG000|Overall Study|Randomized but not treated|2|||
131673978|NCT04223856|474090813|FG001|Overall Study|Randomized but not treated|11|||
131673979|NCT04223856|474090812|FG000|Overall Study|On-treatment|144|||
131673980|NCT04223856|474090813|FG001|Overall Study|On-treatment|0|||
131673981|NCT03226275|474090814|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
131673982|NCT03226275|474090815|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
131673983|NCT03226275|474090816|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
131673984|NCT03226275|474090817|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
131673985|NCT03226275|474090814|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
131673986|NCT03226275|474090815|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
131673987|NCT03226275|474090816|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
131673988|NCT03226275|474090817|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
131673989|NCT03442114|474090818|FG000|Overall Study|Lost to Follow-up|13|||
131673990|NCT03442114|474090819|FG001|Overall Study|Lost to Follow-up|13|||
131673991|NCT03442114|474090818|FG000|Overall Study|Physician Decision|2|||
131673992|NCT03442114|474090819|FG001|Overall Study|Physician Decision|2|||
131673993|NCT03442114|474090818|FG000|Overall Study|Protocol Violation|0|||
131673994|NCT03442114|474090819|FG001|Overall Study|Protocol Violation|2|||
131673995|NCT03442114|474090818|FG000|Overall Study|Withdrawal by Subject|1|||
131673996|NCT03442114|474090819|FG001|Overall Study|Withdrawal by Subject|3|||
131673997|NCT03442114|474090818|FG000|Overall Study|Guardianship Change|0|||
131673998|NCT03442114|474090819|FG001|Overall Study|Guardianship Change|1|||
131673999|NCT02382016|474092300|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
131674000|NCT02382016|474092301|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
131674001|NCT02382016|474092300|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
131674002|NCT02382016|474092301|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
131674003|NCT02382016|474092300|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
131674004|NCT02382016|474092301|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
131674005|NCT02382016|474092300|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
131674006|NCT02382016|474092301|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
131674007|NCT02382016|474092300|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
131674008|NCT02382016|474092301|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
131674009|NCT02382016|474092300|FG000|Open-label (OL) Treatment Period|Death|4|||
131674010|NCT02382016|474092301|FG001|Open-label (OL) Treatment Period|Death|0|||
131674011|NCT02382016|474092300|FG000|OL Extension Period|Physician Decision|3|||
131674012|NCT02382016|474092301|FG001|OL Extension Period|Physician Decision|0|||
131674013|NCT02382016|474092300|FG000|OL Extension Period|Death|2|||
131674014|NCT02382016|474092301|FG001|OL Extension Period|Death|0|||
131674015|NCT02382016|474092300|FG000|OL Extension Period|Withdrawal by Subject|1|||
131674016|NCT02382016|474092301|FG001|OL Extension Period|Withdrawal by Subject|0|||
131674017|NCT00084266|474092302|FG000|Overall Study|Death|42|||
131674018|NCT00084266|474092303|FG001|Overall Study|Death|39|||
131674019|NCT00084266|474092302|FG000|Overall Study|Adverse Event|8|||
131674020|NCT00084266|474092303|FG001|Overall Study|Adverse Event|5|||
131674021|NCT00084266|474092302|FG000|Overall Study|Lack of Efficacy|2|||
131674022|NCT00084266|474092303|FG001|Overall Study|Lack of Efficacy|4|||
131674023|NCT00084266|474092302|FG000|Overall Study|Lost to Follow-up|5|||
131674024|NCT00084266|474092303|FG001|Overall Study|Lost to Follow-up|3|||
131674025|NCT00084266|474092302|FG000|Overall Study|Participant not willing to participate|3|||
131674026|NCT00084266|474092303|FG001|Overall Study|Participant not willing to participate|8|||
131674027|NCT00084266|474092302|FG000|Overall Study|Other|360|||
131674028|NCT00084266|474092303|FG001|Overall Study|Other|344|||
131674029|NCT00084266|474092302|FG000|Overall Study|Randomized not treated|21|||
131674030|NCT00084266|474092303|FG001|Overall Study|Randomized not treated|20|||
131674031|NCT00730171|474092304|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
131674032|NCT00730171|474092304|FG000|Overall Study|Adverse Event|193|||
131674033|NCT00730171|474092304|FG000|Overall Study|Protocol Violation|48|||
131674034|NCT00730171|474092304|FG000|Overall Study|Withdrawal by Subject|202|||
131674035|NCT00730171|474092304|FG000|Overall Study|Lost to Follow-up|121|||
131674036|NCT00730171|474092304|FG000|Overall Study|Insufficient Therapeutic Response|141|||
131674037|NCT00730171|474092304|FG000|Overall Study|Other|61|||
131674038|NCT01729156|474092305|FG000|Overall Study|Withdrawal by Subject|1|||
131674039|NCT01729156|474092306|FG001|Overall Study|Withdrawal by Subject|0|||
131674040|NCT01729156|474092307|FG002|Overall Study|Withdrawal by Subject|0|||
131674041|NCT00294554|474092310|FG000|Overall Study|Lack of Efficacy|0|||
131674042|NCT00294554|474092311|FG001|Overall Study|Lack of Efficacy|1|||
131674043|NCT00294554|474092310|FG000|Overall Study|Physician Decision|0|||
131674044|NCT00294554|474092311|FG001|Overall Study|Physician Decision|1|||
131674045|NCT00462865|474092312|FG000|Overall Study|Adverse Event|1|||
131674046|NCT02864381|474092313|FG000|Overall Study|Death|58|||
131674047|NCT02864381|474092314|FG001|Overall Study|Death|61|||
131674048|NCT02864381|474092313|FG000|Overall Study|Withdrew Consent|5|||
131674049|NCT02864381|474092314|FG001|Overall Study|Withdrew Consent|6|||
131674050|NCT02864381|474092313|FG000|Overall Study|Reason Unknown|7|||
131674051|NCT02864381|474092314|FG001|Overall Study|Reason Unknown|3|||
131674052|NCT02864381|474092313|FG000|Overall Study|Lost to Follow-up|1|||
131674053|NCT02864381|474092314|FG001|Overall Study|Lost to Follow-up|1|||
131674054|NCT02864381|474092313|FG000|Overall Study|Investigator's Discretion|1|||
131674055|NCT02864381|474092314|FG001|Overall Study|Investigator's Discretion|0|||
131674056|NCT02864381|474092313|FG000|Overall Study|Protocol Violation|0|||
131674057|NCT02864381|474092314|FG001|Overall Study|Protocol Violation|1|||
131674058|NCT01146054|474092317|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
131674059|NCT01146054|474092317|FG000|Overall Study|Rapid tumor progression|2|||
131674060|NCT01146054|474092317|FG000|Overall Study|Other illness precluded treatment|2|||
131674061|NCT01146054|474092317|FG000|Overall Study|Lost to Follow-up|1|||
131674062|NCT03840486|474092318|FG000|Overall Study|Withdrawal by Subject|0|||
131674063|NCT03840486|474092319|FG001|Overall Study|Withdrawal by Subject|1|||
131674064|NCT03840486|474092320|FG002|Overall Study|Withdrawal by Subject|0|||
131674065|NCT03840486|474092321|FG003|Overall Study|Withdrawal by Subject|0|||
131674066|NCT03840486|474092322|FG004|Overall Study|Withdrawal by Subject|0|||
131674067|NCT03840486|474092323|FG005|Overall Study|Withdrawal by Subject|0|||
131674068|NCT03840486|474092324|FG006|Overall Study|Withdrawal by Subject|0|||
131674069|NCT03840486|474092325|FG007|Overall Study|Withdrawal by Subject|0|||
131674070|NCT03840486|474092326|FG008|Overall Study|Withdrawal by Subject|0|||
131674071|NCT03840486|474092327|FG009|Overall Study|Withdrawal by Subject|0|||
131674072|NCT03840486|474092328|FG010|Overall Study|Withdrawal by Subject|0|||
131674073|NCT03840486|474092329|FG011|Overall Study|Withdrawal by Subject|0|||
131674074|NCT01139021|474092334|FG000|Overall Study|Adverse Event|0|||
131674075|NCT01139021|474092335|FG001|Overall Study|Adverse Event|0|||
131674076|NCT01139021|474092336|FG002|Overall Study|Adverse Event|0|||
131674077|NCT01139021|474092337|FG003|Overall Study|Adverse Event|0|||
131674078|NCT01139021|474092338|FG004|Overall Study|Adverse Event|1|||
131674079|NCT01139021|474092339|FG005|Overall Study|Adverse Event|0|||
131674080|NCT01139021|474092334|FG000|Overall Study|Lost to Follow-up|0|||
131674081|NCT01139021|474092335|FG001|Overall Study|Lost to Follow-up|0|||
131674082|NCT01139021|474092336|FG002|Overall Study|Lost to Follow-up|0|||
131674083|NCT01139021|474092337|FG003|Overall Study|Lost to Follow-up|0|||
131674084|NCT01139021|474092338|FG004|Overall Study|Lost to Follow-up|2|||
131674085|NCT01139021|474092339|FG005|Overall Study|Lost to Follow-up|0|||
131674086|NCT01139021|474092334|FG000|Overall Study|Protocol Violation|1|||
131674087|NCT01139021|474092335|FG001|Overall Study|Protocol Violation|0|||
131674088|NCT01139021|474092336|FG002|Overall Study|Protocol Violation|0|||
131674089|NCT01139021|474092337|FG003|Overall Study|Protocol Violation|0|||
131674090|NCT01139021|474092338|FG004|Overall Study|Protocol Violation|2|||
131674091|NCT01139021|474092339|FG005|Overall Study|Protocol Violation|0|||
131674092|NCT01139021|474092334|FG000|Overall Study|Withdrawal by Subject|0|||
131674093|NCT01139021|474092335|FG001|Overall Study|Withdrawal by Subject|0|||
131674094|NCT01139021|474092336|FG002|Overall Study|Withdrawal by Subject|0|||
131674095|NCT01139021|474092337|FG003|Overall Study|Withdrawal by Subject|1|||
131674096|NCT01139021|474092338|FG004|Overall Study|Withdrawal by Subject|4|||
131674097|NCT01139021|474092339|FG005|Overall Study|Withdrawal by Subject|0|||
131674098|NCT03588728|474092340|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
131674099|NCT03588728|474092341|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
131674100|NCT03588728|474092342|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
131674101|NCT03588728|474092343|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
131674102|NCT03588728|474092340|FG000|Overall Study|Lab shut down due to COVID-19|0|||
131674103|NCT03588728|474092341|FG001|Overall Study|Lab shut down due to COVID-19|0|||
131674104|NCT03588728|474092342|FG002|Overall Study|Lab shut down due to COVID-19|0|||
131674105|NCT03588728|474092343|FG003|Overall Study|Lab shut down due to COVID-19|1|||
131674106|NCT03588728|474092340|FG000|Overall Study|multiple technical issues|1|||
131674107|NCT03588728|474092341|FG001|Overall Study|multiple technical issues|0|||
131674108|NCT03588728|474092342|FG002|Overall Study|multiple technical issues|0|||
131674109|NCT03588728|474092343|FG003|Overall Study|multiple technical issues|0|||
131674110|NCT03588728|474092340|FG000|Overall Study|Hospitalized for COVID|1|||
131674111|NCT03588728|474092341|FG001|Overall Study|Hospitalized for COVID|0|||
131674112|NCT03588728|474092342|FG002|Overall Study|Hospitalized for COVID|0|||
131674113|NCT03588728|474092343|FG003|Overall Study|Hospitalized for COVID|0|||
131674114|NCT03588728|474092340|FG000|Overall Study|Schedule change unable to attend sessions|1|||
131674115|NCT03588728|474092341|FG001|Overall Study|Schedule change unable to attend sessions|0|||
131674116|NCT03588728|474092342|FG002|Overall Study|Schedule change unable to attend sessions|0|||
131674117|NCT03588728|474092343|FG003|Overall Study|Schedule change unable to attend sessions|0|||
131674118|NCT02027701|474092344|FG000|Overall Study|Adverse Event|3|||
131674119|NCT02027701|474092344|FG000|Overall Study|Lack of Efficacy|8|||
131674120|NCT02027701|474092344|FG000|Overall Study|Physician Decision|2|||
131674121|NCT02027701|474092344|FG000|Overall Study|Withdrawal by Subject|3|||
131674122|NCT02982187|474092345|FG000|Overall Study|Withdrawal by Subject|0|||
131674123|NCT02982187|474092346|FG001|Overall Study|Withdrawal by Subject|0|||
131674124|NCT02982187|474092347|FG002|Overall Study|Withdrawal by Subject|0|||
131674125|NCT02982187|474092348|FG003|Overall Study|Withdrawal by Subject|0|||
131555381|NCT00603265|473658184|FG001|Overall Study|Protocol Violation|0|||
131555382|NCT00603265|473658185|FG002|Overall Study|Protocol Violation|0|||
131555383|NCT02966002|473658186|FG000|Overall Study|Withdrawal by Subject|2|||
131555384|NCT02966002|473658186|FG000|Overall Study|Adverse Event|1|||
131555385|NCT02966002|473658186|FG000|Overall Study|Lost to Follow-up|1|||
131555386|NCT02291432|473658189|FG000|Overall Study|Withdrawal by Subject|2|||
131555387|NCT03377790|473658190|FG000|Overall Study|Withdrawal by Subject|1|||
131555388|NCT03377790|473658191|FG001|Overall Study|Withdrawal by Subject|0|||
131555389|NCT03377790|473658190|FG000|Overall Study|Adverse Event|1|||
131555390|NCT03377790|473658191|FG001|Overall Study|Adverse Event|0|||
131555391|NCT03377790|473658190|FG000|Overall Study|Lost to Follow-up|0|||
131555392|NCT03377790|473658191|FG001|Overall Study|Lost to Follow-up|2|||
131555393|NCT03377790|473658190|FG000|Overall Study|Randomized but not treated|1|||
131555394|NCT03377790|473658191|FG001|Overall Study|Randomized but not treated|0|||
131555395|NCT03377790|473658190|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
131555396|NCT03377790|473658191|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
131555397|NCT02145078|473658192|FG000|Overall Study|Death|1|||
131555398|NCT02145078|473658192|FG000|Overall Study|Reason not given|3|||
131555399|NCT03327402|473658193|FG000|Overall Study|Withdrawal by Subject|1|||
131555400|NCT03327402|473658193|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
131555401|NCT02440594|473658197|FG000|Overall Study|Lost to Follow-up|34|||
131555402|NCT02440594|473658198|FG001|Overall Study|Lost to Follow-up|33|||
131555403|NCT02440594|473658199|FG002|Overall Study|Lost to Follow-up|54|||
131555404|NCT02440594|473658200|FG003|Overall Study|Lost to Follow-up|47|||
131555405|NCT02440594|473658201|FG004|Overall Study|Lost to Follow-up|5|||
131555406|NCT02440594|473658202|FG005|Overall Study|Lost to Follow-up|4|||
131555407|NCT02440594|473658203|FG006|Overall Study|Lost to Follow-up|28|||
131555408|NCT02440594|473658204|FG007|Overall Study|Lost to Follow-up|48|||
131555409|NCT02440594|473658197|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
131555410|NCT02440594|473658198|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
131555411|NCT02440594|473658199|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
131555412|NCT02440594|473658200|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
131555413|NCT02440594|473658201|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
131555414|NCT02440594|473658202|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
131555415|NCT02440594|473658203|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
131555416|NCT02440594|473658204|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
131555417|NCT02440594|473658197|FG000|Overall Study|Withdrawal by Subject|81|||
131555418|NCT02440594|473658198|FG001|Overall Study|Withdrawal by Subject|67|||
131555419|NCT02440594|473658199|FG002|Overall Study|Withdrawal by Subject|59|||
131555420|NCT02440594|473658200|FG003|Overall Study|Withdrawal by Subject|38|||
131555421|NCT02440594|473658201|FG004|Overall Study|Withdrawal by Subject|2|||
131555422|NCT02440594|473658202|FG005|Overall Study|Withdrawal by Subject|2|||
131555423|NCT02440594|473658203|FG006|Overall Study|Withdrawal by Subject|7|||
131555424|NCT02440594|473658204|FG007|Overall Study|Withdrawal by Subject|7|||
131555425|NCT02440594|473658197|FG000|Overall Study|Administratively w/drawn|3|||
131555426|NCT02440594|473658198|FG001|Overall Study|Administratively w/drawn|2|||
131555427|NCT02440594|473658199|FG002|Overall Study|Administratively w/drawn|0|||
131555428|NCT02440594|473658200|FG003|Overall Study|Administratively w/drawn|0|||
131555429|NCT02440594|473658201|FG004|Overall Study|Administratively w/drawn|0|||
131555430|NCT02440594|473658202|FG005|Overall Study|Administratively w/drawn|0|||
131555431|NCT02440594|473658203|FG006|Overall Study|Administratively w/drawn|2|||
131555432|NCT02440594|473658204|FG007|Overall Study|Administratively w/drawn|1|||
131674126|NCT02982187|474092349|FG004|Overall Study|Withdrawal by Subject|0|||
131897081|NCT02861664|474910350|FG001|Overall Study|Withdrawal of Consent|1|||
131555433|NCT03810313|473658205|FG000|Overall Study|Study terminated by sponsor|164|||
131555434|NCT03810313|473658206|FG001|Overall Study|Study terminated by sponsor|159|||
131555435|NCT03810313|473658205|FG000|Overall Study|Subject decision|10|||
131555436|NCT03810313|473658206|FG001|Overall Study|Subject decision|11|||
131555437|NCT03810313|473658205|FG000|Overall Study|Lost to Follow-up|3|||
131555438|NCT03810313|473658206|FG001|Overall Study|Lost to Follow-up|3|||
131555439|NCT03810313|473658205|FG000|Overall Study|Adverse Event|2|||
131555440|NCT03810313|473658206|FG001|Overall Study|Adverse Event|1|||
131555441|NCT03810313|473658205|FG000|Overall Study|Death|2|||
131674127|NCT02982187|474092350|FG005|Overall Study|Withdrawal by Subject|0|||
131674128|NCT02982187|474092351|FG006|Overall Study|Withdrawal by Subject|1|||
131555442|NCT03810313|473658206|FG001|Overall Study|Death|1|||
131555443|NCT03810313|473658205|FG000|Overall Study|Physician Decision|0|||
131674129|NCT02982187|474092352|FG007|Overall Study|Withdrawal by Subject|0|||
131674130|NCT00887679|474092353|FG000|Overall Study|Withdrawal by Subject|1|||
131674131|NCT00887679|474092353|FG000|Overall Study|Lost to Follow-up|4|||
131674132|NCT00887679|474092353|FG000|Overall Study|Physician Decision|5|||
131674133|NCT02168842|474092354|FG000|Overall Study|Withdrawal by Subject|5|||
131674134|NCT02168842|474092355|FG001|Overall Study|Withdrawal by Subject|3|||
131674135|NCT02168842|474092354|FG000|Overall Study|Lost to Follow-up|0|||
131674136|NCT02168842|474092355|FG001|Overall Study|Lost to Follow-up|2|||
131674137|NCT02168842|474092354|FG000|Overall Study|Death|2|||
131674138|NCT02168842|474092355|FG001|Overall Study|Death|1|||
131674139|NCT02168842|474092354|FG000|Overall Study|Physician Decision|1|||
131674140|NCT02168842|474092355|FG001|Overall Study|Physician Decision|2|||
131674141|NCT01026454|474092358|FG000|Second Intervention|Pregnancy|1|||
131674142|NCT01026454|474092359|FG001|Second Intervention|Pregnancy|1|||
131674143|NCT00394953|474092362|FG000|First Treatment Period|Adverse Event|1|||
131674144|NCT00394953|474092363|FG001|First Treatment Period|Adverse Event|2|||
131674145|NCT00394953|474092362|FG000|First Treatment Period|Death|6|||
131674146|NCT00394953|474092363|FG001|First Treatment Period|Death|7|||
131674147|NCT00394953|474092362|FG000|First Treatment Period|Lack of Efficacy|1|||
131674148|NCT00394953|474092363|FG001|First Treatment Period|Lack of Efficacy|1|||
131674149|NCT00394953|474092362|FG000|First Treatment Period|Withdrawal by Subject|6|||
131674150|NCT00394953|474092363|FG001|First Treatment Period|Withdrawal by Subject|3|||
131674151|NCT00394953|474092362|FG000|First Treatment Period|Lost to Follow-up|0|||
131674152|NCT00394953|474092363|FG001|First Treatment Period|Lost to Follow-up|1|||
131674153|NCT00394953|474092362|FG000|First Treatment Period|Renal transplant|11|||
131674154|NCT00394953|474092363|FG001|First Treatment Period|Renal transplant|7|||
131674155|NCT00394953|474092362|FG000|First Treatment Period|Not defined|4|||
131674156|NCT00394953|474092363|FG001|First Treatment Period|Not defined|1|||
131674157|NCT00394953|474092362|FG000|Second Treatment Period|Adverse Event|2|||
131674158|NCT00394953|474092363|FG001|Second Treatment Period|Adverse Event|5|||
131674159|NCT00394953|474092362|FG000|Second Treatment Period|Death|8|||
131674160|NCT00394953|474092363|FG001|Second Treatment Period|Death|4|||
131674161|NCT00394953|474092362|FG000|Second Treatment Period|Lack of Efficacy|9|||
131674162|NCT00394953|474092363|FG001|Second Treatment Period|Lack of Efficacy|47|||
131674163|NCT00394953|474092362|FG000|Second Treatment Period|Withdrawal by Subject|3|||
131674164|NCT00394953|474092363|FG001|Second Treatment Period|Withdrawal by Subject|3|||
131674165|NCT00394953|474092362|FG000|Second Treatment Period|Lost to Follow-up|0|||
131674166|NCT00394953|474092363|FG001|Second Treatment Period|Lost to Follow-up|1|||
131674167|NCT00394953|474092362|FG000|Second Treatment Period|Renal transplant|4|||
131674168|NCT00394953|474092363|FG001|Second Treatment Period|Renal transplant|6|||
131674169|NCT00394953|474092362|FG000|Second Treatment Period|Not defined|3|||
131674170|NCT00394953|474092363|FG001|Second Treatment Period|Not defined|8|||
131674171|NCT03181451|474092367|FG000|Overall Study|Adverse Event|0|||
131674172|NCT03181451|474092368|FG001|Overall Study|Adverse Event|1|||
131674173|NCT03181451|474092369|FG002|Overall Study|Adverse Event|0|||
131674174|NCT03181451|474092367|FG000|Overall Study|Withdrawal by Subject|0|||
131674175|NCT03181451|474092368|FG001|Overall Study|Withdrawal by Subject|1|||
131674176|NCT03181451|474092369|FG002|Overall Study|Withdrawal by Subject|0|||
131674177|NCT02196714|474092373|FG000|Overall Study|Protocol Violation|0|||
131674178|NCT02196714|474092374|FG001|Overall Study|Protocol Violation|0|||
131674179|NCT02196714|474092375|FG002|Overall Study|Protocol Violation|1|||
131674180|NCT02196714|474092376|FG003|Overall Study|Protocol Violation|0|||
131674181|NCT01592864|474092378|FG000|Overall Study|Withdrawal by Subject|0|||
131674182|NCT01592864|474092379|FG001|Overall Study|Withdrawal by Subject|1|||
131674183|NCT01326533|474092381|FG000|Overall Study|Lost to Follow-up|2|||
131674184|NCT01326533|474092382|FG001|Overall Study|Lost to Follow-up|0|||
131674185|NCT01326533|474092381|FG000|Overall Study|Withdrawal by Subject|1|||
131674186|NCT01326533|474092382|FG001|Overall Study|Withdrawal by Subject|0|||
131674187|NCT01326533|474092381|FG000|Overall Study|Adverse Event|1|||
131674188|NCT01326533|474092382|FG001|Overall Study|Adverse Event|0|||
131674189|NCT04079803|474092383|FG000|Overall Study|Withdrawal by Subject|0|||
131674190|NCT04079803|474092384|FG001|Overall Study|Withdrawal by Subject|0|||
131674191|NCT04079803|474092385|FG002|Overall Study|Withdrawal by Subject|1|||
131674192|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
131674193|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
131674194|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
131674195|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
131674196|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
131674197|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
131674198|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
131674199|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
131674200|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
131674201|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
131674202|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
131674203|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
131674204|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
131674205|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
131674206|NCT01294683|474092386|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
131674207|NCT01294683|474092387|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
131674208|NCT01294683|474092386|FG000|Post Crossover (Period III)|Adverse Event|6|||
131674209|NCT01294683|474092387|FG001|Post Crossover (Period III)|Adverse Event|6|||
131674210|NCT01294683|474092386|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
131674211|NCT01294683|474092387|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
131674212|NCT01294683|474092386|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
131674213|NCT01294683|474092387|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
131674214|NCT01294683|474092386|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
131674215|NCT01294683|474092387|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
131674216|NCT01881750|474092388|FG000|Overall Study|Changes in concomitant therapies|2|||
131674217|NCT01881750|474092389|FG001|Overall Study|Changes in concomitant therapies|3|||
131674218|NCT01881750|474092388|FG000|Overall Study|Lost to Follow-up|0|||
131674219|NCT01881750|474092389|FG001|Overall Study|Lost to Follow-up|1|||
131674220|NCT00926211|474092391|FG000|Overall Study|Lost to Follow-up|1|||
131674221|NCT05056987|474092394|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
131674222|NCT05056987|474092395|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
131674223|NCT05056987|474092394|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
131674224|NCT05056987|474092395|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
131674225|NCT01585987|474092396|FG000|Randomized|Withdrawal by Subject|0|||
131674226|NCT01585987|474092397|FG001|Randomized|Withdrawal by Subject|4|||
131674227|NCT01585987|474092396|FG000|Randomized|No longer met criteria|0|||
131674228|NCT01585987|474092397|FG001|Randomized|No longer met criteria|2|||
131674229|NCT01585987|474092396|FG000|Treated|Disease Progression|39|||
131674230|NCT01585987|474092397|FG001|Treated|Disease Progression|36|||
131674231|NCT01585987|474092396|FG000|Treated|Study Drug Toxicity|9|||
131674232|NCT01585987|474092397|FG001|Treated|Study Drug Toxicity|5|||
131674233|NCT01585987|474092396|FG000|Treated|Adverse Event|3|||
131674234|NCT01585987|474092397|FG001|Treated|Adverse Event|0|||
131674235|NCT01585987|474092396|FG000|Treated|Withdrawal by Subject|1|||
131674236|NCT01585987|474092397|FG001|Treated|Withdrawal by Subject|2|||
131674237|NCT01585987|474092396|FG000|Treated|Death|1|||
131674238|NCT01585987|474092397|FG001|Treated|Death|0|||
131674239|NCT01585987|474092396|FG000|Treated|Lost to Follow-up|0|||
131674240|NCT01585987|474092397|FG001|Treated|Lost to Follow-up|1|||
131674241|NCT01585987|474092396|FG000|Treated|Maximum Clinical Benefit|0|||
131674242|NCT01585987|474092397|FG001|Treated|Maximum Clinical Benefit|1|||
131674243|NCT01585987|474092396|FG000|Treated|Non-Specified|1|||
131674244|NCT01585987|474092397|FG001|Treated|Non-Specified|2|||
131674245|NCT01585987|474092396|FG000|Treated|Subject Request|0|||
131674246|NCT01585987|474092397|FG001|Treated|Subject Request|1|||
131674247|NCT01585987|474092396|FG000|Treated|Poor/Non-Compliance|0|||
131674248|NCT01585987|474092397|FG001|Treated|Poor/Non-Compliance|1|||
131674249|NCT01759407|474092401|FG000|Overall Study|Protocol Violation|0|||
131674250|NCT01759407|474092402|FG001|Overall Study|Protocol Violation|2|||
131674251|NCT03737474|474092403|FG000|Overall Study|Adverse Event|18|||
131674252|NCT03737474|474092404|FG001|Overall Study|Adverse Event|48|||
131674253|NCT03737474|474092403|FG000|Overall Study|Lack of Efficacy|1|||
131674254|NCT03737474|474092404|FG001|Overall Study|Lack of Efficacy|3|||
131674255|NCT03737474|474092403|FG000|Overall Study|Protocol Violation|0|||
131674256|NCT03737474|474092404|FG001|Overall Study|Protocol Violation|8|||
131674257|NCT03737474|474092403|FG000|Overall Study|Withdrawal by Subject|5|||
131674258|NCT03737474|474092404|FG001|Overall Study|Withdrawal by Subject|20|||
131674259|NCT03737474|474092403|FG000|Overall Study|Non-compliance With Study Drug|0|||
131674260|NCT03737474|474092404|FG001|Overall Study|Non-compliance With Study Drug|1|||
131674261|NCT03737474|474092403|FG000|Overall Study|Physician Decision|1|||
131674262|NCT03737474|474092404|FG001|Overall Study|Physician Decision|4|||
131674263|NCT02513745|474092405|FG000|Overall Study|Criteria at time of surgery not met.|3|||
131674264|NCT02513745|474092406|FG001|Overall Study|Criteria at time of surgery not met.|3|||
131674265|NCT01209143|474092407|FG000|Overall Study|Adverse Event|2|||
131674266|NCT01209143|474092408|FG001|Overall Study|Adverse Event|1|||
131674267|NCT01209143|474092407|FG000|Overall Study|Death|0|||
131674268|NCT01209143|474092408|FG001|Overall Study|Death|1|||
131674269|NCT01209143|474092407|FG000|Overall Study|Physician Decision|3|||
131674270|NCT01209143|474092408|FG001|Overall Study|Physician Decision|1|||
131674271|NCT01209143|474092407|FG000|Overall Study|Lost to Follow-up|1|||
131674272|NCT01209143|474092408|FG001|Overall Study|Lost to Follow-up|0|||
131674273|NCT01209143|474092407|FG000|Overall Study|Withdrawal by Subject|2|||
131674274|NCT01209143|474092408|FG001|Overall Study|Withdrawal by Subject|1|||
131674275|NCT01209143|474092407|FG000|Overall Study|Disease progression|11|||
131674276|NCT01209143|474092408|FG001|Overall Study|Disease progression|16|||
131674277|NCT02678247|474092409|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
131674278|NCT02678247|474092410|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
131674279|NCT02678247|474092409|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
131674280|NCT02678247|474092410|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
131674281|NCT02678247|474092409|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
131674282|NCT02678247|474092410|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
131674283|NCT02678247|474092409|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
131674284|NCT02678247|474092410|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
131674285|NCT02678247|474092409|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
131674286|NCT02678247|474092410|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
131674287|NCT02678247|474092409|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
131674288|NCT02678247|474092410|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
131674289|NCT01139658|474092411|FG000|Overall Study|Adverse Event|10|||
131674290|NCT01139658|474092412|FG001|Overall Study|Adverse Event|27|||
131674291|NCT01139658|474092411|FG000|Overall Study|Lack of Efficacy|15|||
131674292|NCT01139658|474092412|FG001|Overall Study|Lack of Efficacy|7|||
131674293|NCT01139658|474092411|FG000|Overall Study|Withdrawal by Subject|2|||
131674294|NCT01139658|474092412|FG001|Overall Study|Withdrawal by Subject|4|||
131674295|NCT01139658|474092411|FG000|Overall Study|No documentation of treatment|1|||
131674296|NCT01139658|474092412|FG001|Overall Study|No documentation of treatment|0|||
131674297|NCT01139658|474092411|FG000|Overall Study|Other|28|||
131674298|NCT01139658|474092412|FG001|Overall Study|Other|75|||
131674299|NCT00026208|474092416|FG000|Overall Study|Complications of auto accident|1|||
131674300|NCT00026208|474092417|FG001|Overall Study|Complications of auto accident|0|||
131674301|NCT02225353|474092418|FG000|Overall Study|Lost to Follow-up|0|||
131674302|NCT02225353|474092419|FG001|Overall Study|Lost to Follow-up|1|||
131674303|NCT02225353|474092420|FG002|Overall Study|Lost to Follow-up|3|||
131674304|NCT02225353|474092418|FG000|Overall Study|Protocol Violation|4|||
131674305|NCT02225353|474092419|FG001|Overall Study|Protocol Violation|5|||
131674306|NCT02225353|474092420|FG002|Overall Study|Protocol Violation|12|||
131674307|NCT00607022|474092426|FG000|Overall Study|Withdrawal by Subject|1|||
131674308|NCT00607022|474092427|FG001|Overall Study|Withdrawal by Subject|0|||
131674309|NCT00607022|474092428|FG002|Overall Study|Withdrawal by Subject|0|||
131674310|NCT03604523|474092429|FG000|Overall Study|Physician Decision|1|||
131674311|NCT03604523|474092430|FG001|Overall Study|Physician Decision|0|||
131674312|NCT01696942|474092438|FG000|Overall Study|Withdrawal by Subject|1|||
131674313|NCT01696942|474092439|FG001|Overall Study|Withdrawal by Subject|0|||
131674314|NCT01696942|474092438|FG000|Overall Study|Protocol Violation|1|||
131674315|NCT01696942|474092439|FG001|Overall Study|Protocol Violation|2|||
131674316|NCT01696942|474092438|FG000|Overall Study|screen failure|0|||
131674317|NCT01696942|474092439|FG001|Overall Study|screen failure|1|||
131674318|NCT01313117|474092440|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
131674319|NCT01313117|474092440|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
131674320|NCT02903368|474092441|FG000|Part 1|Adverse Event|3|||
131674321|NCT02903368|474092442|FG001|Part 1|Adverse Event|0|||
131674322|NCT02903368|474092443|FG002|Part 1|Adverse Event|0|||
131674323|NCT02903368|474092444|FG003|Part 1|Adverse Event|0|||
131674324|NCT02903368|474092441|FG000|Part 1|Withdrawal by Subject|1|||
131674325|NCT02903368|474092442|FG001|Part 1|Withdrawal by Subject|0|||
131674326|NCT02903368|474092443|FG002|Part 1|Withdrawal by Subject|0|||
131674327|NCT02903368|474092444|FG003|Part 1|Withdrawal by Subject|0|||
131674328|NCT02903368|474092441|FG000|Part 2|Adverse Event|0|||
131674329|NCT02903368|474092442|FG001|Part 2|Adverse Event|0|||
131674330|NCT02903368|474092443|FG002|Part 2|Adverse Event|5|||
131674331|NCT02903368|474092444|FG003|Part 2|Adverse Event|0|||
131674332|NCT02903368|474092441|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
131674333|NCT02903368|474092442|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
131674334|NCT02903368|474092443|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
131674335|NCT02903368|474092444|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
131674336|NCT02903368|474092441|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
131674337|NCT02903368|474092442|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
131674338|NCT02903368|474092443|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
131674339|NCT02903368|474092444|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
131674340|NCT02903368|474092441|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
131674341|NCT02903368|474092442|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
131674342|NCT02903368|474092443|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
131674343|NCT02903368|474092444|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
131674344|NCT00720941|474094477|FG000|Overall Study|Protocol Violation|1|||
131674345|NCT00720941|474094478|FG001|Overall Study|Protocol Violation|2|||
131674346|NCT00720941|474094477|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
131674347|NCT00720941|474094478|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
131674348|NCT00720941|474094477|FG000|Overall Study|Lost to Follow-up|20|||
131674349|NCT00720941|474094478|FG001|Overall Study|Lost to Follow-up|15|||
131674350|NCT00720941|474094477|FG000|Overall Study|Physician Decision|14|||
131674351|NCT00720941|474094478|FG001|Overall Study|Physician Decision|12|||
131674352|NCT00720941|474094477|FG000|Overall Study|Withdrawal by Subject|29|||
131674353|NCT00720941|474094478|FG001|Overall Study|Withdrawal by Subject|36|||
131674354|NCT00604279|474094479|FG000|Overall Study|Lack of Efficacy|22|||
131674355|NCT00604279|474094480|FG001|Overall Study|Lack of Efficacy|9|||
131674356|NCT00604279|474094479|FG000|Overall Study|Lost to Follow-up|9|||
131674357|NCT00604279|474094480|FG001|Overall Study|Lost to Follow-up|14|||
131674358|NCT00604279|474094479|FG000|Overall Study|Pregnancy|2|||
131674359|NCT00604279|474094480|FG001|Overall Study|Pregnancy|0|||
131674360|NCT00604279|474094479|FG000|Overall Study|Protocol Violation|3|||
131674361|NCT00604279|474094480|FG001|Overall Study|Protocol Violation|1|||
131674362|NCT00604279|474094479|FG000|Overall Study|Withdrawal by Subject|16|||
131674363|NCT00604279|474094480|FG001|Overall Study|Withdrawal by Subject|5|||
131674364|NCT00604279|474094479|FG000|Overall Study|Adverse Event|4|||
131674365|NCT00604279|474094480|FG001|Overall Study|Adverse Event|5|||
131674366|NCT00604279|474094479|FG000|Overall Study|Other|8|||
131674367|NCT00604279|474094480|FG001|Overall Study|Other|4|||
131674368|NCT00355056|474094481|FG000|Randomization Period|Early Termination|4|||
131674369|NCT00355056|474094482|FG001|Randomization Period|Early Termination|6|||
131674370|NCT00719563|474094487|FG000|Overall Study|Adverse Event|16|||
131674371|NCT00719563|474094488|FG001|Overall Study|Adverse Event|13|||
131674372|NCT00719563|474094487|FG000|Overall Study|Medical condition changed|3|||
131674373|NCT00719563|474094488|FG001|Overall Study|Medical condition changed|5|||
131674374|NCT00719563|474094487|FG000|Overall Study|Lack of Efficacy|3|||
131674375|NCT00719563|474094488|FG001|Overall Study|Lack of Efficacy|7|||
131674376|NCT00719563|474094487|FG000|Overall Study|Personal reasons|6|||
131674377|NCT00719563|474094488|FG001|Overall Study|Personal reasons|7|||
131674378|NCT00719563|474094487|FG000|Overall Study|Unknown reasons|4|||
131674379|NCT00719563|474094488|FG001|Overall Study|Unknown reasons|6|||
131674380|NCT00719563|474094487|FG000|Overall Study|Noncompliant|1|||
131674381|NCT00719563|474094488|FG001|Overall Study|Noncompliant|1|||
131674382|NCT00719563|474094487|FG000|Overall Study|Lost to Follow-up|5|||
131674383|NCT00719563|474094488|FG001|Overall Study|Lost to Follow-up|3|||
131674384|NCT00792805|474094491|FG000|Overall Study|Adverse Event|12|||
131674385|NCT00792805|474094492|FG001|Overall Study|Adverse Event|10|||
131674386|NCT00792805|474094493|FG002|Overall Study|Adverse Event|10|||
131674387|NCT00792805|474094491|FG000|Overall Study|Subject withdrew consent|5|||
131674388|NCT00792805|474094492|FG001|Overall Study|Subject withdrew consent|6|||
131674389|NCT00792805|474094493|FG002|Overall Study|Subject withdrew consent|5|||
131674390|NCT00792805|474094491|FG000|Overall Study|Administrative problems|2|||
131674391|NCT00792805|474094492|FG001|Overall Study|Administrative problems|0|||
131674392|NCT00792805|474094493|FG002|Overall Study|Administrative problems|4|||
131674393|NCT00792805|474094491|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131674394|NCT00792805|474094492|FG001|Overall Study|Abnormal test procedure result(s)|2|||
131674395|NCT00792805|474094493|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131674396|NCT00792805|474094491|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131674397|NCT00792805|474094492|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131674398|NCT00792805|474094493|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
131674399|NCT00792805|474094491|FG000|Overall Study|Lost to Follow-up|1|||
131674400|NCT00792805|474094492|FG001|Overall Study|Lost to Follow-up|1|||
131674401|NCT00792805|474094493|FG002|Overall Study|Lost to Follow-up|6|||
131674402|NCT00792805|474094491|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131674403|NCT00792805|474094492|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131674404|NCT00792805|474094493|FG002|Overall Study|Abnormal laboratory value(s)|1|||
131674405|NCT00792805|474094491|FG000|Overall Study|Protocol deviation|0|||
131674406|NCT00792805|474094492|FG001|Overall Study|Protocol deviation|1|||
131674407|NCT00792805|474094493|FG002|Overall Study|Protocol deviation|1|||
131674408|NCT03224325|474094494|FG000|Overall Study|Adverse Event|1|||
131674409|NCT03224325|474094495|FG001|Overall Study|Adverse Event|0|||
131674410|NCT03224325|474094496|FG002|Overall Study|Adverse Event|0|||
131674411|NCT03224325|474094497|FG003|Overall Study|Adverse Event|0|||
131674412|NCT03224325|474094498|FG004|Overall Study|Adverse Event|0|||
131674413|NCT03224325|474094499|FG005|Overall Study|Adverse Event|0|||
131674414|NCT03224325|474094500|FG006|Overall Study|Adverse Event|1|||
131674415|NCT03224325|474094494|FG000|Overall Study|Withdrawal by Subject|0|||
131674416|NCT03224325|474094495|FG001|Overall Study|Withdrawal by Subject|0|||
131674417|NCT03224325|474094496|FG002|Overall Study|Withdrawal by Subject|0|||
131674418|NCT03224325|474094497|FG003|Overall Study|Withdrawal by Subject|1|||
131674419|NCT03224325|474094498|FG004|Overall Study|Withdrawal by Subject|0|||
131674420|NCT03224325|474094499|FG005|Overall Study|Withdrawal by Subject|0|||
131674421|NCT03224325|474094500|FG006|Overall Study|Withdrawal by Subject|0|||
131674422|NCT02120625|474094502|FG000|Overall Study|Physician Decision|2|||
131674423|NCT02952001|474094505|FG000|Overall Study|Adverse Event|3|||
131674424|NCT02952001|474094506|FG001|Overall Study|Adverse Event|0|||
131674425|NCT02952001|474094505|FG000|Overall Study|Prohibited therapy|10|||
131674426|NCT02952001|474094506|FG001|Overall Study|Prohibited therapy|3|||
131674427|NCT02952001|474094505|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
131674428|NCT02952001|474094506|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
131674429|NCT00937833|474094509|FG000|Overall Study|Protocol Violation|1|||
131674430|NCT00937833|474094510|FG001|Overall Study|Protocol Violation|2|||
131674431|NCT00937833|474094509|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
131674432|NCT00937833|474094510|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
131674433|NCT00937833|474094509|FG000|Overall Study|Lost to Follow-up|10|||
131674434|NCT00937833|474094510|FG001|Overall Study|Lost to Follow-up|8|||
131674435|NCT00937833|474094509|FG000|Overall Study|Withdrawal by Subject|4|||
131674436|NCT00937833|474094510|FG001|Overall Study|Withdrawal by Subject|6|||
131674437|NCT03278106|474094512|FG000|Overall Study|No protocol treatment|1|||
131674438|NCT00818389|474094513|FG000|Overall Study|Death|1|||
131674439|NCT00818389|474094514|FG001|Overall Study|Death|3|||
131674440|NCT00818389|474094513|FG000|Overall Study|ALS Disease Progression|1|||
131674441|NCT00818389|474094514|FG001|Overall Study|ALS Disease Progression|0|||
131674442|NCT00818389|474094513|FG000|Overall Study|Withdrawal by Subject|2|||
131674443|NCT00818389|474094514|FG001|Overall Study|Withdrawal by Subject|2|||
131674444|NCT00818389|474094513|FG000|Overall Study|Adverse Event|0|||
131674445|NCT00818389|474094514|FG001|Overall Study|Adverse Event|1|||
131674446|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
131674447|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
131674448|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
131674449|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
131674450|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
131674451|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
131674452|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
131674453|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
131674454|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
131674455|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
131674456|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
131674457|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
131674458|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
131674459|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
131674460|NCT03548987|474094515|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
131674461|NCT03548987|474094516|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
131674462|NCT03548987|474094515|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
131674463|NCT03548987|474094516|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
131674464|NCT03548987|474094515|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
131674465|NCT03548987|474094516|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
131674466|NCT03548987|474094515|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
131674467|NCT03548987|474094516|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
131674468|NCT03548987|474094515|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
131674469|NCT03548987|474094516|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
131674470|NCT03548987|474094515|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
131674471|NCT03548987|474094516|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
131674472|NCT03548987|474094515|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
131674473|NCT03548987|474094516|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
131674474|NCT00756470|474094518|FG000|Overall Study|Withdrawal by Subject|1|||
131674475|NCT00756470|474094518|FG000|Overall Study|Adverse Event|4|||
131674476|NCT00820027|474094519|FG000|Overall Study|Adverse Event|15|||
131674477|NCT00820027|474094520|FG001|Overall Study|Adverse Event|8|||
131674478|NCT00820027|474094521|FG002|Overall Study|Adverse Event|10|||
131674479|NCT00820027|474094522|FG003|Overall Study|Adverse Event|5|||
131674480|NCT00820027|474094519|FG000|Overall Study|Lack of Efficacy|2|||
131674481|NCT00820027|474094520|FG001|Overall Study|Lack of Efficacy|1|||
131674482|NCT00820027|474094521|FG002|Overall Study|Lack of Efficacy|2|||
131674483|NCT00820027|474094522|FG003|Overall Study|Lack of Efficacy|2|||
131674484|NCT00820027|474094519|FG000|Overall Study|Physician Decision|0|||
131674485|NCT00820027|474094520|FG001|Overall Study|Physician Decision|1|||
131674486|NCT00820027|474094521|FG002|Overall Study|Physician Decision|1|||
131674487|NCT00820027|474094522|FG003|Overall Study|Physician Decision|0|||
131674488|NCT00820027|474094519|FG000|Overall Study|Protocol Violation|3|||
131674489|NCT00820027|474094520|FG001|Overall Study|Protocol Violation|0|||
131674490|NCT00820027|474094521|FG002|Overall Study|Protocol Violation|4|||
131674491|NCT00820027|474094522|FG003|Overall Study|Protocol Violation|0|||
131674492|NCT00820027|474094519|FG000|Overall Study|Withdrawal by Subject|6|||
131674493|NCT00820027|474094520|FG001|Overall Study|Withdrawal by Subject|4|||
131674494|NCT00820027|474094521|FG002|Overall Study|Withdrawal by Subject|4|||
131674495|NCT00820027|474094522|FG003|Overall Study|Withdrawal by Subject|6|||
131674496|NCT03285178|474094523|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
131674497|NCT03285178|474094524|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131719348|NCT05309668|474253262|FG001|Overall Study|Ongoing at data cut-off|17|||
131719349|NCT05309668|474253263|FG002|Overall Study|Ongoing at data cut-off|4|||
131719350|NCT02401256|474253264|FG000|Overall Study|Adverse Event|5|||
131719351|NCT02401256|474253264|FG000|Overall Study|Withdrawal by Subject|12|||
131719352|NCT00345605|474253268|FG000|Arm 1|Adverse Event|0|||
131719353|NCT00345605|474253269|FG001|Arm 1|Adverse Event|1|||
131674498|NCT03285178|474094525|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131674499|NCT03285178|474094526|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131674500|NCT03285178|474094527|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131674501|NCT03285178|474094528|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131674502|NCT03285178|474094529|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131674503|NCT03285178|474094523|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
131674504|NCT03285178|474094524|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131674505|NCT03285178|474094525|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131674506|NCT03285178|474094526|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131674507|NCT03285178|474094527|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131674508|NCT03285178|474094528|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131674509|NCT03285178|474094529|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131674510|NCT03285178|474094523|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
131674511|NCT03285178|474094524|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
131674512|NCT03285178|474094525|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
131674513|NCT03285178|474094526|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
131674514|NCT03285178|474094527|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
131674515|NCT03285178|474094528|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
131674516|NCT03285178|474094529|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
131674517|NCT03285178|474094523|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
131674518|NCT03285178|474094524|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131674519|NCT03285178|474094525|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131674520|NCT03285178|474094526|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131674521|NCT03285178|474094527|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131674522|NCT03285178|474094528|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131674523|NCT03285178|474094529|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131674524|NCT03285178|474094523|FG000|Single-Blind Run-In Period|Physician Decision|2|||
131674525|NCT03285178|474094524|FG001|Single-Blind Run-In Period|Physician Decision|0|||
131674526|NCT03285178|474094525|FG002|Single-Blind Run-In Period|Physician Decision|0|||
131674527|NCT03285178|474094526|FG003|Single-Blind Run-In Period|Physician Decision|0|||
131674528|NCT03285178|474094527|FG004|Single-Blind Run-In Period|Physician Decision|0|||
131674529|NCT03285178|474094528|FG005|Single-Blind Run-In Period|Physician Decision|0|||
131674530|NCT03285178|474094529|FG006|Single-Blind Run-In Period|Physician Decision|0|||
131674531|NCT03285178|474094523|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131674532|NCT03285178|474094524|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
131674533|NCT03285178|474094525|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
131674534|NCT03285178|474094526|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131674535|NCT03285178|474094527|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131674536|NCT03285178|474094528|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131674537|NCT03285178|474094529|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131674538|NCT03285178|474094523|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131674539|NCT03285178|474094524|FG001|Double-Blind Treatment Period|Adverse Event|0|||
131674540|NCT03285178|474094525|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131674541|NCT03285178|474094526|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131674542|NCT03285178|474094527|FG004|Double-Blind Treatment Period|Adverse Event|0|||
131674543|NCT03285178|474094528|FG005|Double-Blind Treatment Period|Adverse Event|0|||
131674544|NCT03285178|474094529|FG006|Double-Blind Treatment Period|Adverse Event|2|||
131674545|NCT03285178|474094523|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131674546|NCT03285178|474094524|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131674547|NCT03285178|474094525|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
131674548|NCT03285178|474094526|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
131674549|NCT03285178|474094527|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
131674550|NCT03285178|474094528|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
131674551|NCT03285178|474094529|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
131674552|NCT03285178|474094523|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131674553|NCT03285178|474094524|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131674554|NCT03285178|474094525|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131674555|NCT03285178|474094526|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131674556|NCT03285178|474094527|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131674557|NCT03285178|474094528|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131674558|NCT03285178|474094529|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131674559|NCT03285178|474094523|FG000|Double-Blind Treatment Period|COVID-19|0|||
131674560|NCT03285178|474094524|FG001|Double-Blind Treatment Period|COVID-19|0|||
131674561|NCT03285178|474094525|FG002|Double-Blind Treatment Period|COVID-19|1|||
131674562|NCT03285178|474094526|FG003|Double-Blind Treatment Period|COVID-19|0|||
131674563|NCT03285178|474094527|FG004|Double-Blind Treatment Period|COVID-19|0|||
131674564|NCT03285178|474094528|FG005|Double-Blind Treatment Period|COVID-19|0|||
131674565|NCT03285178|474094529|FG006|Double-Blind Treatment Period|COVID-19|0|||
131674566|NCT01388790|474094530|FG000|Overall Study|Ongoing at data cut-off date|8|||
131674567|NCT01128894|474094531|FG000|Overall Study|Adverse Event|31|||
131674568|NCT01128894|474094532|FG001|Overall Study|Adverse Event|41|||
131674569|NCT01128894|474094531|FG000|Overall Study|Protocol Violation|2|||
131674570|NCT01128894|474094532|FG001|Overall Study|Protocol Violation|1|||
131674571|NCT01128894|474094531|FG000|Overall Study|Noncompliance|4|||
131674572|NCT01128894|474094532|FG001|Overall Study|Noncompliance|5|||
131674573|NCT01128894|474094531|FG000|Overall Study|Lost to Follow-up|8|||
131674574|NCT01128894|474094532|FG001|Overall Study|Lost to Follow-up|8|||
131674575|NCT01128894|474094531|FG000|Overall Study|Withdrawal by Subject|10|||
131674576|NCT01128894|474094532|FG001|Overall Study|Withdrawal by Subject|12|||
131674577|NCT01128894|474094531|FG000|Overall Study|Physician Decision|2|||
131674578|NCT01128894|474094532|FG001|Overall Study|Physician Decision|1|||
131674579|NCT01128894|474094531|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
131674580|NCT01128894|474094532|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
131674581|NCT00195507|474094533|FG000|Overall Study|Adverse Event|24|||
131674582|NCT00195507|474094534|FG001|Overall Study|Adverse Event|13|||
131674583|NCT00195507|474094533|FG000|Overall Study|Death|0|||
131674584|NCT00195507|474094534|FG001|Overall Study|Death|1|||
131674585|NCT00195507|474094533|FG000|Overall Study|Failed to Return|4|||
131674586|NCT00195507|474094534|FG001|Overall Study|Failed to Return|3|||
131674587|NCT00195507|474094533|FG000|Overall Study|Physician Decision|1|||
131674588|NCT00195507|474094534|FG001|Overall Study|Physician Decision|2|||
131674589|NCT00195507|474094533|FG000|Overall Study|Lost to Follow-up|3|||
131674590|NCT00195507|474094534|FG001|Overall Study|Lost to Follow-up|2|||
131674591|NCT00195507|474094533|FG000|Overall Study|Protocol Violation|5|||
131674592|NCT00195507|474094534|FG001|Overall Study|Protocol Violation|4|||
131674593|NCT00195507|474094533|FG000|Overall Study|Lack of Efficacy|40|||
131674594|NCT00195507|474094534|FG001|Overall Study|Lack of Efficacy|67|||
131674595|NCT00195507|474094533|FG000|Overall Study|Withdrawal by Subject|16|||
131674596|NCT00195507|474094534|FG001|Overall Study|Withdrawal by Subject|23|||
131674597|NCT00195507|474094533|FG000|Overall Study|Protocol Deviation|6|||
131674598|NCT00195507|474094534|FG001|Overall Study|Protocol Deviation|3|||
131674599|NCT00973362|474094535|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
131674600|NCT00973362|474094536|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
131674601|NCT00973362|474094535|FG000|Baseline Evaluation|No colposcopy visit|62|||
131674602|NCT00973362|474094536|FG001|Baseline Evaluation|No colposcopy visit|0|||
131674603|NCT00973362|474094535|FG000|Baseline Evaluation|Inevaluable|686|||
131674604|NCT00973362|474094536|FG001|Baseline Evaluation|Inevaluable|223|||
131674605|NCT00973362|474094535|FG000|3-Year Follow-up|Lost to Follow-up|17|||
131674606|NCT00973362|474094536|FG001|3-Year Follow-up|Lost to Follow-up|0|||
131674607|NCT01630434|474094543|FG000|Overall Study|Donor lungs turned down|1|||
131674608|NCT01630434|474094544|FG001|Overall Study|Donor lungs turned down|0|||
131674609|NCT01630434|474094543|FG000|Overall Study|Protocol Violation|9|||
131674610|NCT01630434|474094544|FG001|Overall Study|Protocol Violation|4|||
131674611|NCT01630434|474094543|FG000|Overall Study|Death|20|||
131674612|NCT01630434|474094544|FG001|Overall Study|Death|26|||
131674613|NCT02804178|474094547|FG000|Overall Study|Adverse Event|1|||
131674614|NCT01106404|474094548|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
131674615|NCT01106404|474094549|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
131674616|NCT01106404|474094548|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
131674617|NCT01106404|474094549|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
131674618|NCT01106404|474094548|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
131674619|NCT01106404|474094549|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
131674620|NCT01106404|474094548|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
131674621|NCT01106404|474094549|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
131674622|NCT01290601|474094550|FG000|Overall Study|Adverse Event|0|||
131674623|NCT01290601|474094551|FG001|Overall Study|Adverse Event|2|||
131674624|NCT01290601|474094552|FG002|Overall Study|Adverse Event|0|||
131674625|NCT01290601|474094553|FG003|Overall Study|Adverse Event|0|||
131674626|NCT01290601|474094550|FG000|Overall Study|Lack of Efficacy|2|||
131674627|NCT01290601|474094551|FG001|Overall Study|Lack of Efficacy|1|||
131674628|NCT01290601|474094552|FG002|Overall Study|Lack of Efficacy|0|||
131674629|NCT01290601|474094553|FG003|Overall Study|Lack of Efficacy|0|||
131674630|NCT01290601|474094550|FG000|Overall Study|Lost to Follow-up|7|||
131674631|NCT01290601|474094551|FG001|Overall Study|Lost to Follow-up|2|||
131674632|NCT01290601|474094552|FG002|Overall Study|Lost to Follow-up|0|||
131674633|NCT01290601|474094553|FG003|Overall Study|Lost to Follow-up|0|||
131674634|NCT01290601|474094550|FG000|Overall Study|Other|1|||
131674635|NCT01290601|474094551|FG001|Overall Study|Other|0|||
131674636|NCT01290601|474094552|FG002|Overall Study|Other|0|||
131674637|NCT01290601|474094553|FG003|Overall Study|Other|0|||
131674638|NCT01290601|474094550|FG000|Overall Study|Protocol Violation|1|||
131674639|NCT01290601|474094551|FG001|Overall Study|Protocol Violation|0|||
131674640|NCT01290601|474094552|FG002|Overall Study|Protocol Violation|0|||
131674641|NCT01290601|474094553|FG003|Overall Study|Protocol Violation|0|||
131674642|NCT00775450|474094554|FG000|Overall Study|Serious Adverse Event|2|||
131674643|NCT00775450|474094555|FG001|Overall Study|Serious Adverse Event|0|||
131674644|NCT00775450|474094556|FG002|Overall Study|Serious Adverse Event|0|||
131674645|NCT00775450|474094557|FG003|Overall Study|Serious Adverse Event|0|||
131674646|NCT00775450|474094558|FG004|Overall Study|Serious Adverse Event|0|||
131674647|NCT00775450|474094554|FG000|Overall Study|Protocol Violation|0|||
131674648|NCT00775450|474094555|FG001|Overall Study|Protocol Violation|0|||
131674649|NCT00775450|474094556|FG002|Overall Study|Protocol Violation|0|||
131674650|NCT00775450|474094557|FG003|Overall Study|Protocol Violation|0|||
131674651|NCT00775450|474094558|FG004|Overall Study|Protocol Violation|1|||
131674652|NCT00775450|474094554|FG000|Overall Study|Withdrawal by Subject|1|||
131674653|NCT00775450|474094555|FG001|Overall Study|Withdrawal by Subject|0|||
131674654|NCT00775450|474094556|FG002|Overall Study|Withdrawal by Subject|0|||
131674655|NCT00775450|474094557|FG003|Overall Study|Withdrawal by Subject|0|||
131674656|NCT00775450|474094558|FG004|Overall Study|Withdrawal by Subject|1|||
131674657|NCT01749540|474094564|FG000|Overall Study|Protocol Violation|0|||
131674658|NCT01749540|474094565|FG001|Overall Study|Protocol Violation|0|||
131674659|NCT01749540|474094566|FG002|Overall Study|Protocol Violation|0|||
131674660|NCT01749540|474094567|FG003|Overall Study|Protocol Violation|0|||
131674661|NCT01749540|474094568|FG004|Overall Study|Protocol Violation|0|||
131674662|NCT01749540|474094569|FG005|Overall Study|Protocol Violation|1|||
131674663|NCT01749540|474094570|FG006|Overall Study|Protocol Violation|1|||
131674664|NCT01749540|474094564|FG000|Overall Study|Withdrawal by Subject|0|||
131674665|NCT01749540|474094565|FG001|Overall Study|Withdrawal by Subject|0|||
131674666|NCT01749540|474094566|FG002|Overall Study|Withdrawal by Subject|0|||
131674667|NCT01749540|474094567|FG003|Overall Study|Withdrawal by Subject|1|||
131674668|NCT01749540|474094568|FG004|Overall Study|Withdrawal by Subject|0|||
131674669|NCT01749540|474094569|FG005|Overall Study|Withdrawal by Subject|0|||
131674670|NCT01749540|474094570|FG006|Overall Study|Withdrawal by Subject|0|||
131674671|NCT01749540|474094564|FG000|Overall Study|Initiated into extension study A536-06|0|||
131674672|NCT01749540|474094565|FG001|Overall Study|Initiated into extension study A536-06|0|||
131674673|NCT01749540|474094566|FG002|Overall Study|Initiated into extension study A536-06|0|||
131674674|NCT01749540|474094567|FG003|Overall Study|Initiated into extension study A536-06|0|||
131674675|NCT01749540|474094568|FG004|Overall Study|Initiated into extension study A536-06|0|||
131674676|NCT01749540|474094569|FG005|Overall Study|Initiated into extension study A536-06|2|||
131674677|NCT01749540|474094570|FG006|Overall Study|Initiated into extension study A536-06|24|||
131674678|NCT00576836|474094571|FG000|Overall Study|Death|0|||
131674679|NCT00576836|474094572|FG001|Overall Study|Death|1|||
131674680|NCT00576836|474094571|FG000|Overall Study|Physician Decision|0|||
131674681|NCT00576836|474094572|FG001|Overall Study|Physician Decision|1|||
131674682|NCT01296347|474094573|FG000|Allocation|Withdrawal by Subject|1|||
131674683|NCT01296347|474094574|FG001|Allocation|Withdrawal by Subject|2|||
131674684|NCT01296347|474094573|FG000|Allocation|Lack of Efficacy|1|||
131674685|NCT01296347|474094574|FG001|Allocation|Lack of Efficacy|2|||
131674686|NCT01296347|474094573|FG000|Allocation|not received infusion|1|||
131674687|NCT01296347|474094574|FG001|Allocation|not received infusion|0|||
131674688|NCT01296347|474094573|FG000|6 Week Follow up|Death|0|||
131674689|NCT01296347|474094574|FG001|6 Week Follow up|Death|1|||
131674690|NCT01296347|474094573|FG000|3 Month Follow up|Death|1|||
131674691|NCT01296347|474094574|FG001|3 Month Follow up|Death|0|||
131674692|NCT01296347|474094573|FG000|3 Month Follow up|Lost to Follow-up|0|||
131674693|NCT01296347|474094574|FG001|3 Month Follow up|Lost to Follow-up|1|||
131674694|NCT01296347|474094573|FG000|6 Month Follow up|Death|2|||
131674695|NCT01296347|474094574|FG001|6 Month Follow up|Death|1|||
131674696|NCT01296347|474094573|FG000|6 Month Follow up|Lost to Follow-up|0|||
131674697|NCT01296347|474094574|FG001|6 Month Follow up|Lost to Follow-up|1|||
131674698|NCT01296347|474094573|FG000|12 Month Follow up|Lost to Follow-up|3|||
131674699|NCT01296347|474094574|FG001|12 Month Follow up|Lost to Follow-up|1|||
131674700|NCT01296347|474094573|FG000|12 Month Follow up|Death|1|||
131674701|NCT01296347|474094574|FG001|12 Month Follow up|Death|1|||
131674702|NCT01296347|474094573|FG000|12 Month Follow up|Withdrawal by Subject|0|||
131674703|NCT01296347|474094574|FG001|12 Month Follow up|Withdrawal by Subject|1|||
131674704|NCT02240693|474094575|FG000|Overall Study|Adverse Event|0|||
131674705|NCT02240693|474094576|FG001|Overall Study|Adverse Event|0|||
131674706|NCT02240693|474094577|FG002|Overall Study|Adverse Event|0|||
131674707|NCT02240693|474094578|FG003|Overall Study|Adverse Event|0|||
131674708|NCT02240693|474094579|FG004|Overall Study|Adverse Event|1|||
131674709|NCT02240693|474094575|FG000|Overall Study|Withdrawal by Subject|0|||
131772414|NCT03556202|474445075|FG000|Extension Treatment Period|Pregnancy|2|||
131674710|NCT02240693|474094576|FG001|Overall Study|Withdrawal by Subject|0|||
131772415|NCT03556202|474445076|FG001|Extension Treatment Period|Pregnancy|4|||
131674711|NCT02240693|474094577|FG002|Overall Study|Withdrawal by Subject|2|||
131674712|NCT02240693|474094578|FG003|Overall Study|Withdrawal by Subject|1|||
131674713|NCT02240693|474094579|FG004|Overall Study|Withdrawal by Subject|0|||
131674714|NCT02240693|474094575|FG000|Overall Study|Other than specified|0|||
131674715|NCT02240693|474094576|FG001|Overall Study|Other than specified|0|||
131674716|NCT02240693|474094577|FG002|Overall Study|Other than specified|2|||
131674717|NCT02240693|474094578|FG003|Overall Study|Other than specified|0|||
131674718|NCT02240693|474094579|FG004|Overall Study|Other than specified|0|||
131674719|NCT01116882|474094580|FG000|30-day|Lost to Follow-up|50|||
131674720|NCT01116882|474094581|FG001|30-day|Lost to Follow-up|21|||
131674721|NCT01116882|474094580|FG000|30-day|Withdrawal by Subject|2|||
131674722|NCT01116882|474094581|FG001|30-day|Withdrawal by Subject|4|||
131674723|NCT01116882|474094580|FG000|30-day|Other Reasons|16|||
131674724|NCT01116882|474094581|FG001|30-day|Other Reasons|6|||
131674725|NCT01116882|474094580|FG000|12-month|Lost to Follow-up|111|||
131674726|NCT01116882|474094581|FG001|12-month|Lost to Follow-up|42|||
131674727|NCT01116882|474094580|FG000|12-month|Other Reasons|151|||
131674728|NCT01116882|474094581|FG001|12-month|Other Reasons|49|||
131674729|NCT01116882|474094580|FG000|12-month|Withdrawal by Subject|5|||
131674730|NCT01116882|474094581|FG001|12-month|Withdrawal by Subject|8|||
131674731|NCT00971243|474094584|FG000|Double Blind Period|Adverse Event|2|||
131674732|NCT00971243|474094585|FG001|Double Blind Period|Adverse Event|3|||
131674733|NCT00971243|474094586|FG002|Double Blind Period|Adverse Event|2|||
131674734|NCT00971243|474094587|FG003|Double Blind Period|Adverse Event|2|||
131674735|NCT00971243|474094588|FG004|Double Blind Period|Adverse Event|3|||
131674736|NCT00971243|474094584|FG000|Double Blind Period|Lost to Follow-up|0|||
131674737|NCT00971243|474094585|FG001|Double Blind Period|Lost to Follow-up|1|||
131772416|NCT03556202|474445077|FG002|Extension Treatment Period|Pregnancy|3|||
131772417|NCT03556202|474445075|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
131674738|NCT00971243|474094586|FG002|Double Blind Period|Lost to Follow-up|1|||
131674739|NCT00971243|474094587|FG003|Double Blind Period|Lost to Follow-up|0|||
131674740|NCT00971243|474094588|FG004|Double Blind Period|Lost to Follow-up|1|||
131674741|NCT00971243|474094584|FG000|Double Blind Period|Physician Decision|10|||
131674742|NCT00971243|474094585|FG001|Double Blind Period|Physician Decision|6|||
131674743|NCT00971243|474094586|FG002|Double Blind Period|Physician Decision|7|||
131674744|NCT00971243|474094587|FG003|Double Blind Period|Physician Decision|6|||
131674745|NCT00971243|474094588|FG004|Double Blind Period|Physician Decision|7|||
131674746|NCT00971243|474094584|FG000|Double Blind Period|Protocol Violation|2|||
131674747|NCT00971243|474094585|FG001|Double Blind Period|Protocol Violation|0|||
131674748|NCT00971243|474094586|FG002|Double Blind Period|Protocol Violation|3|||
131674749|NCT00971243|474094587|FG003|Double Blind Period|Protocol Violation|2|||
131674750|NCT00971243|474094588|FG004|Double Blind Period|Protocol Violation|2|||
131674751|NCT00971243|474094584|FG000|Double Blind Period|Withdrawal by Subject|4|||
131674752|NCT00971243|474094585|FG001|Double Blind Period|Withdrawal by Subject|1|||
131674753|NCT00971243|474094586|FG002|Double Blind Period|Withdrawal by Subject|4|||
131674754|NCT00971243|474094587|FG003|Double Blind Period|Withdrawal by Subject|4|||
131674755|NCT00971243|474094588|FG004|Double Blind Period|Withdrawal by Subject|4|||
131674756|NCT00971243|474094584|FG000|Double Blind Period|Other reasons|1|||
131674757|NCT00971243|474094585|FG001|Double Blind Period|Other reasons|0|||
131674758|NCT00971243|474094586|FG002|Double Blind Period|Other reasons|2|||
131674759|NCT00971243|474094587|FG003|Double Blind Period|Other reasons|0|||
131674760|NCT00971243|474094588|FG004|Double Blind Period|Other reasons|1|||
131674761|NCT00971243|474094584|FG000|Open-label Period|Adverse Event|1|||
131674762|NCT00971243|474094585|FG001|Open-label Period|Adverse Event|0|||
131674763|NCT00971243|474094586|FG002|Open-label Period|Adverse Event|1|||
131674764|NCT00971243|474094587|FG003|Open-label Period|Adverse Event|1|||
131674765|NCT00971243|474094588|FG004|Open-label Period|Adverse Event|0|||
131674766|NCT00971243|474094584|FG000|Open-label Period|Physician Decision|5|||
131674767|NCT00971243|474094585|FG001|Open-label Period|Physician Decision|9|||
131674768|NCT00971243|474094586|FG002|Open-label Period|Physician Decision|3|||
131674769|NCT00971243|474094587|FG003|Open-label Period|Physician Decision|7|||
131674770|NCT00971243|474094588|FG004|Open-label Period|Physician Decision|2|||
131674771|NCT00971243|474094584|FG000|Open-label Period|Protocol Violation|1|||
131674772|NCT00971243|474094585|FG001|Open-label Period|Protocol Violation|1|||
131674773|NCT00971243|474094586|FG002|Open-label Period|Protocol Violation|1|||
131674774|NCT00971243|474094587|FG003|Open-label Period|Protocol Violation|0|||
131674775|NCT00971243|474094588|FG004|Open-label Period|Protocol Violation|1|||
131674776|NCT00971243|474094584|FG000|Open-label Period|Withdrawal by Subject|1|||
131674777|NCT00971243|474094585|FG001|Open-label Period|Withdrawal by Subject|0|||
131674778|NCT00971243|474094586|FG002|Open-label Period|Withdrawal by Subject|0|||
131674779|NCT00971243|474094587|FG003|Open-label Period|Withdrawal by Subject|2|||
131674780|NCT00971243|474094588|FG004|Open-label Period|Withdrawal by Subject|1|||
131674781|NCT00971243|474094584|FG000|Open-label Period|Other reason|0|||
131674782|NCT00971243|474094585|FG001|Open-label Period|Other reason|0|||
131674783|NCT00971243|474094586|FG002|Open-label Period|Other reason|0|||
131674784|NCT00971243|474094587|FG003|Open-label Period|Other reason|0|||
131674785|NCT00971243|474094588|FG004|Open-label Period|Other reason|2|||
131674786|NCT02092220|474094590|FG000|Period 1|Unrelated Illness|0|||
131674787|NCT02092220|474094591|FG001|Period 1|Unrelated Illness|2|||
131674788|NCT02092220|474094590|FG000|Period 2|Severe Hypoglycaemia|1|||
131674789|NCT02092220|474094591|FG001|Period 2|Severe Hypoglycaemia|0|||
131674790|NCT02092220|474094590|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
131674791|NCT02092220|474094591|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
131674792|NCT02739360|474094592|FG000|Overall Study|Adverse Event|1|||
131674793|NCT02739360|474094592|FG000|Overall Study|Study terminated by Sponsor|2|||
131674794|NCT01193920|474094593|FG000|Overall Study|Withdrawal by Subject|1|||
131674795|NCT01193920|474094594|FG001|Overall Study|Withdrawal by Subject|0|||
131674796|NCT01193920|474094595|FG002|Overall Study|Withdrawal by Subject|5|||
131674797|NCT01193920|474094596|FG003|Overall Study|Withdrawal by Subject|1|||
131674798|NCT01193920|474094597|FG004|Overall Study|Withdrawal by Subject|3|||
131674799|NCT01193920|474094598|FG005|Overall Study|Withdrawal by Subject|1|||
131674800|NCT01193920|474094599|FG006|Overall Study|Withdrawal by Subject|3|||
131674801|NCT01193920|474094600|FG007|Overall Study|Withdrawal by Subject|0|||
131674802|NCT01193920|474094601|FG008|Overall Study|Withdrawal by Subject|1|||
131674803|NCT01193920|474094602|FG009|Overall Study|Withdrawal by Subject|0|||
131674804|NCT01193920|474094593|FG000|Overall Study|Lost to Follow-up|1|||
131674805|NCT01193920|474094594|FG001|Overall Study|Lost to Follow-up|0|||
131674806|NCT01193920|474094595|FG002|Overall Study|Lost to Follow-up|1|||
131674807|NCT01193920|474094596|FG003|Overall Study|Lost to Follow-up|1|||
131674808|NCT01193920|474094597|FG004|Overall Study|Lost to Follow-up|3|||
131674809|NCT01193920|474094598|FG005|Overall Study|Lost to Follow-up|3|||
131674810|NCT01193920|474094599|FG006|Overall Study|Lost to Follow-up|1|||
131674811|NCT01193920|474094600|FG007|Overall Study|Lost to Follow-up|0|||
131674812|NCT01193920|474094601|FG008|Overall Study|Lost to Follow-up|2|||
131674813|NCT01193920|474094602|FG009|Overall Study|Lost to Follow-up|3|||
131674814|NCT01193920|474094593|FG000|Overall Study|Protocol Violation|1|||
131674815|NCT01193920|474094594|FG001|Overall Study|Protocol Violation|0|||
131674816|NCT01193920|474094595|FG002|Overall Study|Protocol Violation|0|||
131674817|NCT01193920|474094596|FG003|Overall Study|Protocol Violation|0|||
131674818|NCT01193920|474094597|FG004|Overall Study|Protocol Violation|0|||
131674819|NCT01193920|474094598|FG005|Overall Study|Protocol Violation|0|||
131674820|NCT01193920|474094599|FG006|Overall Study|Protocol Violation|0|||
131674821|NCT01193920|474094600|FG007|Overall Study|Protocol Violation|0|||
131674822|NCT01193920|474094601|FG008|Overall Study|Protocol Violation|0|||
131772418|NCT03556202|474445076|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
131772419|NCT03556202|474445077|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
131772420|NCT03556202|474445075|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
131772421|NCT03556202|474445076|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
131772422|NCT03556202|474445077|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
131674823|NCT01193920|474094602|FG009|Overall Study|Protocol Violation|0|||
131674824|NCT01193920|474094593|FG000|Overall Study|Death|0|||
131674825|NCT01193920|474094594|FG001|Overall Study|Death|0|||
131674826|NCT01193920|474094595|FG002|Overall Study|Death|0|||
131674827|NCT01193920|474094596|FG003|Overall Study|Death|1|||
131674828|NCT01193920|474094597|FG004|Overall Study|Death|0|||
131674829|NCT01193920|474094598|FG005|Overall Study|Death|0|||
131674830|NCT01193920|474094599|FG006|Overall Study|Death|2|||
131674831|NCT01193920|474094600|FG007|Overall Study|Death|3|||
131674832|NCT01193920|474094601|FG008|Overall Study|Death|2|||
131674833|NCT01193920|474094602|FG009|Overall Study|Death|4|||
131674834|NCT01193920|474094593|FG000|Overall Study|Unable to classify|0|||
131674835|NCT01193920|474094594|FG001|Overall Study|Unable to classify|0|||
131674836|NCT01193920|474094595|FG002|Overall Study|Unable to classify|0|||
131674837|NCT01193920|474094596|FG003|Overall Study|Unable to classify|1|||
131674838|NCT01193920|474094597|FG004|Overall Study|Unable to classify|0|||
131674839|NCT01193920|474094598|FG005|Overall Study|Unable to classify|0|||
131674840|NCT01193920|474094599|FG006|Overall Study|Unable to classify|0|||
131674841|NCT01193920|474094600|FG007|Overall Study|Unable to classify|1|||
131674842|NCT01193920|474094601|FG008|Overall Study|Unable to classify|0|||
131674843|NCT01193920|474094602|FG009|Overall Study|Unable to classify|0|||
131674844|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
131674845|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
131674846|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
131674847|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
131674848|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
131897082|NCT02781818|474910352|FG000|Overall Study|Lost to Follow-up|4|||
131897083|NCT02781818|474910353|FG001|Overall Study|Lost to Follow-up|2|||
131897084|NCT02781818|474910354|FG002|Overall Study|Lost to Follow-up|1|||
131897085|NCT01223404|474910355|FG000|First Intervention (1 Day)|Adverse Event|0|||
131897086|NCT01223404|474910356|FG001|First Intervention (1 Day)|Adverse Event|0|||
131897087|NCT01223404|474910357|FG002|First Intervention (1 Day)|Adverse Event|0|||
131897088|NCT01223404|474910358|FG003|First Intervention (1 Day)|Adverse Event|1|||
131897089|NCT01223404|474910359|FG004|First Intervention (1 Day)|Adverse Event|0|||
131674849|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
131674850|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
131674851|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
131674852|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
131674853|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
131674854|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
131674855|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
131674856|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
131674857|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
131674858|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
131674859|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
131674860|NCT01231516|474094605|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
131674861|NCT01231516|474094606|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
131674862|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
131674863|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
131674864|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
131674865|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
131674866|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
131674867|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
131674868|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
131674869|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
131674870|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
131674871|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
131674872|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
131674873|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
131674874|NCT01231516|474094605|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
131674875|NCT01231516|474094606|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
131674876|NCT03170154|474094607|FG000|Overall Study|Lost to Follow-up|4|||
131674877|NCT03170154|474094607|FG000|Overall Study|Death|2|||
131674878|NCT03170154|474094607|FG000|Overall Study|Withdrawal by Subject|2|||
131674879|NCT05266586|474094608|FG000|Overall Study|Adverse Event|2|||
131674880|NCT05266586|474094609|FG001|Overall Study|Adverse Event|2|||
131674881|NCT05266586|474094610|FG002|Overall Study|Adverse Event|1|||
131674882|NCT05266586|474094608|FG000|Overall Study|Withdrawal by Subject|1|||
131674883|NCT05266586|474094609|FG001|Overall Study|Withdrawal by Subject|0|||
131674884|NCT05266586|474094610|FG002|Overall Study|Withdrawal by Subject|1|||
131674885|NCT05266586|474094608|FG000|Overall Study|Non-compliance with study drug|0|||
131674886|NCT05266586|474094609|FG001|Overall Study|Non-compliance with study drug|1|||
131674887|NCT05266586|474094610|FG002|Overall Study|Non-compliance with study drug|0|||
131674888|NCT05266586|474094608|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
131674889|NCT05266586|474094609|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
131674890|NCT05266586|474094610|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
131674891|NCT01117857|474094611|FG000|Overall Study|Lost to Follow-up|4|||
131674892|NCT01117857|474094611|FG000|Overall Study|Withdrawal by Subject|4|||
131674893|NCT01117857|474094611|FG000|Overall Study|Physician Decision|1|||
131674894|NCT00633061|474094612|FG000|Overall Study|Study closed|86|||
131674895|NCT00633061|474094613|FG001|Overall Study|Study closed|0|||
131674896|NCT05245097|474094614|FG000|Overall Study|Adverse Event|13|||
131674897|NCT05245097|474094615|FG001|Overall Study|Adverse Event|2|||
131674898|NCT05245097|474094614|FG000|Overall Study|Protocol Violation|8|||
131674899|NCT05245097|474094615|FG001|Overall Study|Protocol Violation|6|||
131674900|NCT05245097|474094614|FG000|Overall Study|Withdrawal by Subject|18|||
131674901|NCT05245097|474094615|FG001|Overall Study|Withdrawal by Subject|0|||
131674902|NCT05245097|474094614|FG000|Overall Study|Death|6|||
131674903|NCT05245097|474094615|FG001|Overall Study|Death|7|||
131674904|NCT05245097|474094614|FG000|Overall Study|Physician Decision|6|||
131674905|NCT05245097|474094615|FG001|Overall Study|Physician Decision|0|||
131674906|NCT05245097|474094614|FG000|Overall Study|Relocation|4|||
131674907|NCT05245097|474094615|FG001|Overall Study|Relocation|3|||
131674908|NCT02730598|474094620|FG000|Overall Study|Withdrawal by Subject|3|||
131674909|NCT02730598|474094621|FG001|Overall Study|Withdrawal by Subject|3|||
131674910|NCT02730598|474094620|FG000|Overall Study|Protocol Violation|0|||
131674911|NCT02730598|474094621|FG001|Overall Study|Protocol Violation|1|||
131674912|NCT02730598|474094620|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
131674913|NCT02730598|474094621|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
131674914|NCT03282240|474094622|FG000|Overall Study|Adverse Event|2|||
131674915|NCT03282240|474094623|FG001|Overall Study|Adverse Event|2|||
131674916|NCT03282240|474094624|FG002|Overall Study|Adverse Event|0|||
131674917|NCT03282240|474094622|FG000|Overall Study|Lost to Follow-up|3|||
131674918|NCT03282240|474094623|FG001|Overall Study|Lost to Follow-up|0|||
131674919|NCT03282240|474094624|FG002|Overall Study|Lost to Follow-up|0|||
131674920|NCT03282240|474094622|FG000|Overall Study|Protocol Deviation|4|||
131674921|NCT03282240|474094623|FG001|Overall Study|Protocol Deviation|1|||
131674922|NCT03282240|474094624|FG002|Overall Study|Protocol Deviation|2|||
131674923|NCT03282240|474094622|FG000|Overall Study|Withdrawal by Subject|1|||
131674924|NCT03282240|474094623|FG001|Overall Study|Withdrawal by Subject|0|||
131674925|NCT03282240|474094624|FG002|Overall Study|Withdrawal by Subject|1|||
131674926|NCT01675479|474094625|FG000|Overall Study|Lost to Follow-up|11|||
131674927|NCT03254485|474094626|FG000|Overall Study|Adverse Event|3|||
131674928|NCT03254485|474094627|FG001|Overall Study|Adverse Event|0|||
131674929|NCT03254485|474094628|FG002|Overall Study|Adverse Event|0|||
131674930|NCT03254485|474094629|FG003|Overall Study|Adverse Event|6|||
131674931|NCT03254485|474094626|FG000|Overall Study|Protocol Violation|6|||
131674932|NCT03254485|474094627|FG001|Overall Study|Protocol Violation|0|||
131674933|NCT03254485|474094628|FG002|Overall Study|Protocol Violation|0|||
131674934|NCT03254485|474094629|FG003|Overall Study|Protocol Violation|2|||
131674935|NCT03254485|474094626|FG000|Overall Study|Withdrawal by Subject|1|||
131674936|NCT03254485|474094627|FG001|Overall Study|Withdrawal by Subject|0|||
131674937|NCT03254485|474094628|FG002|Overall Study|Withdrawal by Subject|0|||
131674938|NCT03254485|474094629|FG003|Overall Study|Withdrawal by Subject|4|||
131674939|NCT03254485|474094626|FG000|Overall Study|Death|0|||
131674940|NCT03254485|474094627|FG001|Overall Study|Death|0|||
131674941|NCT03254485|474094628|FG002|Overall Study|Death|0|||
131674942|NCT03254485|474094629|FG003|Overall Study|Death|1|||
131674943|NCT03254485|474094626|FG000|Overall Study|Lost to Follow-up|1|||
131674944|NCT03254485|474094627|FG001|Overall Study|Lost to Follow-up|0|||
131674945|NCT03254485|474094628|FG002|Overall Study|Lost to Follow-up|0|||
131674946|NCT03254485|474094629|FG003|Overall Study|Lost to Follow-up|0|||
131674947|NCT03254485|474094626|FG000|Overall Study|Other|1|||
131674948|NCT03254485|474094627|FG001|Overall Study|Other|0|||
131674949|NCT03254485|474094628|FG002|Overall Study|Other|0|||
131674950|NCT03254485|474094629|FG003|Overall Study|Other|2|||
131674951|NCT02146326|474094630|FG000|Overall Study|Lost to Follow-up|3|||
131674952|NCT02146326|474094631|FG001|Overall Study|Lost to Follow-up|3|||
131674953|NCT02146326|474094632|FG002|Overall Study|Lost to Follow-up|11|||
131674954|NCT02146326|474094633|FG003|Overall Study|Lost to Follow-up|19|||
131674955|NCT02146326|474094630|FG000|Overall Study|Withdrawal by Subject|2|||
131674956|NCT02146326|474094631|FG001|Overall Study|Withdrawal by Subject|1|||
131674957|NCT02146326|474094632|FG002|Overall Study|Withdrawal by Subject|15|||
131674958|NCT02146326|474094633|FG003|Overall Study|Withdrawal by Subject|11|||
131674959|NCT02146326|474094630|FG000|Overall Study|Separated from mental health center|23|||
131674960|NCT02146326|474094631|FG001|Overall Study|Separated from mental health center|33|||
131674961|NCT02146326|474094632|FG002|Overall Study|Separated from mental health center|0|||
131674962|NCT02146326|474094633|FG003|Overall Study|Separated from mental health center|0|||
131674963|NCT02146326|474094630|FG000|Overall Study|Incarcerated|0|||
131674964|NCT02146326|474094631|FG001|Overall Study|Incarcerated|0|||
131674965|NCT02146326|474094632|FG002|Overall Study|Incarcerated|3|||
131674966|NCT02146326|474094633|FG003|Overall Study|Incarcerated|8|||
131674967|NCT02146326|474094630|FG000|Overall Study|Death|0|||
131674968|NCT02146326|474094631|FG001|Overall Study|Death|0|||
131674969|NCT02146326|474094632|FG002|Overall Study|Death|4|||
131674970|NCT02146326|474094633|FG003|Overall Study|Death|4|||
131674971|NCT02146326|474094630|FG000|Overall Study|Unable to complete interview|0|||
131674972|NCT02146326|474094631|FG001|Overall Study|Unable to complete interview|0|||
131674973|NCT02146326|474094632|FG002|Overall Study|Unable to complete interview|10|||
131674974|NCT02146326|474094633|FG003|Overall Study|Unable to complete interview|6|||
131674975|NCT02910739|474094634|FG000|Overall Study|Adverse Event|1|||
131674976|NCT02910739|474094635|FG001|Overall Study|Adverse Event|0|||
131674977|NCT02910739|474094636|FG002|Overall Study|Adverse Event|0|||
131674978|NCT02910739|474094637|FG003|Overall Study|Adverse Event|0|||
131674979|NCT01340651|474094639|FG000|Overall Study|Adverse Event|3|||
131674980|NCT01340651|474094639|FG000|Overall Study|Consent Withdrawn|2|||
131674981|NCT01340651|474094639|FG000|Overall Study|Commercial Supply per Sponsor|12|||
131674982|NCT01598311|474094644|FG000|Overall Study|Physician Decision|4|||
131674983|NCT01598311|474094645|FG001|Overall Study|Physician Decision|5|||
131674984|NCT01598311|474094644|FG000|Overall Study|Adverse Event|9|||
131674985|NCT01598311|474094645|FG001|Overall Study|Adverse Event|13|||
131674986|NCT01598311|474094644|FG000|Overall Study|Lost to Follow-up|7|||
131674987|NCT01598311|474094645|FG001|Overall Study|Lost to Follow-up|12|||
131674988|NCT01598311|474094644|FG000|Overall Study|Withdrawal by Subject|9|||
131674989|NCT01598311|474094645|FG001|Overall Study|Withdrawal by Subject|13|||
131674990|NCT01598311|474094644|FG000|Overall Study|No reason provided.|0|||
131674991|NCT01598311|474094645|FG001|Overall Study|No reason provided.|5|||
131674992|NCT01598311|474094644|FG000|Overall Study|Randomized but never treated|8|||
131674993|NCT01598311|474094645|FG001|Overall Study|Randomized but never treated|5|||
131674994|NCT01598311|474094644|FG000|Overall Study|Treated but no confirmed CDAD|9|||
131674995|NCT01598311|474094645|FG001|Overall Study|Treated but no confirmed CDAD|8|||
131674996|NCT01598311|474094644|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
131674997|NCT01598311|474094645|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
131674998|NCT00688103|474094646|FG000|Overall Study|Adverse Event|4|||
131674999|NCT00688103|474094647|FG001|Overall Study|Adverse Event|1|||
131675000|NCT00688103|474094646|FG000|Overall Study|Lack of Efficacy|11|||
131675001|NCT00688103|474094647|FG001|Overall Study|Lack of Efficacy|1|||
131675002|NCT00688103|474094646|FG000|Overall Study|Withdrawal by Subject|4|||
131675003|NCT00688103|474094647|FG001|Overall Study|Withdrawal by Subject|2|||
131675004|NCT00688103|474094646|FG000|Overall Study|complex reasons|11|||
131675005|NCT00688103|474094647|FG001|Overall Study|complex reasons|9|||
131675006|NCT03602261|474094650|FG000|Overall Study|Adverse Event|5|||
131675007|NCT03602261|474094651|FG001|Overall Study|Adverse Event|1|||
131675008|NCT03602261|474094650|FG000|Overall Study|Physician Decision|1|||
131675009|NCT03602261|474094651|FG001|Overall Study|Physician Decision|0|||
131675010|NCT03602261|474094650|FG000|Overall Study|Withdrawal by Subject|1|||
131675011|NCT03602261|474094651|FG001|Overall Study|Withdrawal by Subject|1|||
131675012|NCT03602261|474094650|FG000|Overall Study|Lack of Efficacy|0|||
131675013|NCT03602261|474094651|FG001|Overall Study|Lack of Efficacy|1|||
131675014|NCT03602261|474094650|FG000|Overall Study|Subject moving out of state|1|||
131675015|NCT03602261|474094651|FG001|Overall Study|Subject moving out of state|0|||
131675016|NCT05677893|474095764|FG000|Overall Study|Withdrawal by Subject|0|||
131675017|NCT05677893|474095765|FG001|Overall Study|Withdrawal by Subject|0|||
131675018|NCT05677893|474095766|FG002|Overall Study|Withdrawal by Subject|0|||
131675019|NCT05677893|474095767|FG003|Overall Study|Withdrawal by Subject|0|||
131675020|NCT05677893|474095768|FG004|Overall Study|Withdrawal by Subject|1|||
131675021|NCT05677893|474095769|FG005|Overall Study|Withdrawal by Subject|1|||
131675022|NCT05677893|474095770|FG006|Overall Study|Withdrawal by Subject|0|||
131675023|NCT05677893|474095764|FG000|Overall Study|Others|1|||
131675024|NCT05677893|474095765|FG001|Overall Study|Others|0|||
131772423|NCT03556202|474445075|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
131772424|NCT03556202|474445076|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
131772425|NCT03556202|474445077|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
131772426|NCT03556202|474445075|FG000|Extension Treatment Period|Physician Decision|0|||
131772427|NCT03556202|474445076|FG001|Extension Treatment Period|Physician Decision|8|||
131772428|NCT03556202|474445077|FG002|Extension Treatment Period|Physician Decision|2|||
131772429|NCT03556202|474445075|FG000|Extension Treatment Period|Protocol Violation|0|||
131772430|NCT03556202|474445076|FG001|Extension Treatment Period|Protocol Violation|1|||
131772431|NCT03556202|474445077|FG002|Extension Treatment Period|Protocol Violation|1|||
131772432|NCT03556202|474445075|FG000|Extension Treatment Period|Sponsor Decision|0|||
131772433|NCT03556202|474445076|FG001|Extension Treatment Period|Sponsor Decision|1|||
131675025|NCT05677893|474095766|FG002|Overall Study|Others|0|||
131675026|NCT05677893|474095767|FG003|Overall Study|Others|0|||
131675027|NCT05677893|474095768|FG004|Overall Study|Others|0|||
131675028|NCT05677893|474095769|FG005|Overall Study|Others|0|||
131675029|NCT05677893|474095770|FG006|Overall Study|Others|0|||
131675030|NCT01485354|474095773|FG000|Overall Study|Withdrawal by Subject|5|||
131675031|NCT02101034|474095774|FG000|Overall Study|Enrolled but did not start treatment|0|||
131675032|NCT02101034|474095775|FG001|Overall Study|Enrolled but did not start treatment|0|||
131675033|NCT02101034|474095776|FG002|Overall Study|Enrolled but did not start treatment|1|||
131675034|NCT02101034|474095777|FG003|Overall Study|Enrolled but did not start treatment|0|||
131675035|NCT02101034|474095778|FG004|Overall Study|Enrolled but did not start treatment|0|||
131675036|NCT01103245|474095783|FG000|Overall Study|Withdrawal by Subject|1|||
131675037|NCT01103245|474095784|FG001|Overall Study|Withdrawal by Subject|0|||
131675038|NCT01103245|474095785|FG002|Overall Study|Withdrawal by Subject|3|||
131675039|NCT01103245|474095786|FG003|Overall Study|Withdrawal by Subject|0|||
131675040|NCT01103245|474095783|FG000|Overall Study|Inadequate IV access|1|||
131675041|NCT01103245|474095784|FG001|Overall Study|Inadequate IV access|0|||
131675042|NCT01103245|474095785|FG002|Overall Study|Inadequate IV access|0|||
131772434|NCT03556202|474445077|FG002|Extension Treatment Period|Sponsor Decision|0|||
131772435|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
131772436|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
131675043|NCT01103245|474095786|FG003|Overall Study|Inadequate IV access|0|||
131772437|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
131675044|NCT01103245|474095783|FG000|Overall Study|Adverse Event|0|||
131675045|NCT01103245|474095784|FG001|Overall Study|Adverse Event|2|||
131675046|NCT01103245|474095785|FG002|Overall Study|Adverse Event|1|||
131675047|NCT01103245|474095786|FG003|Overall Study|Adverse Event|0|||
131675048|NCT01103245|474095783|FG000|Overall Study|Physician Decision|1|||
131675049|NCT01103245|474095784|FG001|Overall Study|Physician Decision|0|||
131675050|NCT01103245|474095785|FG002|Overall Study|Physician Decision|0|||
131675051|NCT01103245|474095786|FG003|Overall Study|Physician Decision|0|||
131675052|NCT01101477|474095788|FG000|Overall Study|Protocol Violation|5|||
131675053|NCT01101477|474095789|FG001|Overall Study|Protocol Violation|3|||
131675054|NCT01101477|474095790|FG002|Overall Study|Protocol Violation|1|||
131675055|NCT01072877|474095793|FG000|Overall Study|Lost to Follow-up|1|||
131675056|NCT01072877|474095794|FG001|Overall Study|Lost to Follow-up|1|||
131675057|NCT01072877|474095795|FG002|Overall Study|Lost to Follow-up|0|||
131772438|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Death|1|||
131675058|NCT01072877|474095796|FG003|Overall Study|Lost to Follow-up|2|||
131772439|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Death|0|||
131772440|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Death|0|||
131772441|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
131772442|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
131772443|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
131772444|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
131772445|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
131772446|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
131772447|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
131675059|NCT01072877|474095797|FG004|Overall Study|Lost to Follow-up|0|||
131675060|NCT00995020|474095798|FG000|Overall Study|margin analysis not performed|2|||
131675061|NCT00995020|474095799|FG001|Overall Study|margin analysis not performed|5|||
131675062|NCT00995020|474095798|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
131675063|NCT00995020|474095799|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
131675064|NCT02720536|474095800|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
131675065|NCT02720536|474095800|FG000|Overall Study|PR - pregnancy|2|||
131675066|NCT02720536|474095800|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
131675067|NCT02720536|474095800|FG000|Overall Study|PR - death|1|||
131675068|NCT02720536|474095800|FG000|Overall Study|PR - adverse event|1|||
131675069|NCT02720536|474095800|FG000|Overall Study|PR - abnormal lab value(s)|1|||
131675070|NCT02720536|474095800|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
131675071|NCT01794520|474095801|FG000|Overall Study|Adverse events- related to progression|0|||
131675072|NCT01794520|474095802|FG001|Overall Study|Adverse events- related to progression|0|||
131675073|NCT01794520|474095803|FG002|Overall Study|Adverse events- related to progression|1|||
131675074|NCT01794520|474095804|FG003|Overall Study|Adverse events- related to progression|2|||
131675075|NCT01794520|474095805|FG004|Overall Study|Adverse events- related to progression|0|||
131675076|NCT01794520|474095806|FG005|Overall Study|Adverse events- related to progression|1|||
131675077|NCT01794520|474095807|FG006|Overall Study|Adverse events- related to progression|0|||
131675078|NCT01794520|474095801|FG000|Overall Study|Adverse event- not related to progression|1|||
131675079|NCT01794520|474095802|FG001|Overall Study|Adverse event- not related to progression|1|||
131675080|NCT01794520|474095803|FG002|Overall Study|Adverse event- not related to progression|0|||
131675081|NCT01794520|474095804|FG003|Overall Study|Adverse event- not related to progression|0|||
131675082|NCT01794520|474095805|FG004|Overall Study|Adverse event- not related to progression|2|||
131675083|NCT01794520|474095806|FG005|Overall Study|Adverse event- not related to progression|0|||
131675084|NCT01794520|474095807|FG006|Overall Study|Adverse event- not related to progression|0|||
131675085|NCT01794520|474095801|FG000|Overall Study|Progressive disease|5|||
131675086|NCT01794520|474095802|FG001|Overall Study|Progressive disease|6|||
131675087|NCT01794520|474095803|FG002|Overall Study|Progressive disease|2|||
131675088|NCT01794520|474095804|FG003|Overall Study|Progressive disease|5|||
131675089|NCT01794520|474095805|FG004|Overall Study|Progressive disease|27|||
131675090|NCT01794520|474095806|FG005|Overall Study|Progressive disease|18|||
131675091|NCT01794520|474095807|FG006|Overall Study|Progressive disease|0|||
131675092|NCT01794520|474095801|FG000|Overall Study|Withdrew consent|0|||
131675093|NCT01794520|474095802|FG001|Overall Study|Withdrew consent|0|||
131675094|NCT01794520|474095803|FG002|Overall Study|Withdrew consent|1|||
131675095|NCT01794520|474095804|FG003|Overall Study|Withdrew consent|1|||
131675096|NCT01794520|474095805|FG004|Overall Study|Withdrew consent|0|||
131675097|NCT01794520|474095806|FG005|Overall Study|Withdrew consent|0|||
131675098|NCT01794520|474095807|FG006|Overall Study|Withdrew consent|0|||
131675099|NCT01794520|474095801|FG000|Overall Study|Lost to Follow-up|0|||
131675100|NCT01794520|474095802|FG001|Overall Study|Lost to Follow-up|0|||
131675101|NCT01794520|474095803|FG002|Overall Study|Lost to Follow-up|0|||
131675102|NCT01794520|474095804|FG003|Overall Study|Lost to Follow-up|0|||
131675103|NCT01794520|474095805|FG004|Overall Study|Lost to Follow-up|1|||
131675104|NCT01794520|474095806|FG005|Overall Study|Lost to Follow-up|0|||
131675105|NCT01794520|474095807|FG006|Overall Study|Lost to Follow-up|0|||
131675106|NCT01794520|474095801|FG000|Overall Study|Toxicity|0|||
131675107|NCT01794520|474095802|FG001|Overall Study|Toxicity|2|||
131675108|NCT01794520|474095803|FG002|Overall Study|Toxicity|0|||
131675109|NCT01794520|474095804|FG003|Overall Study|Toxicity|0|||
131772448|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
131772449|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
131675110|NCT01794520|474095805|FG004|Overall Study|Toxicity|0|||
131675111|NCT01794520|474095806|FG005|Overall Study|Toxicity|0|||
131675112|NCT01794520|474095807|FG006|Overall Study|Toxicity|0|||
131675113|NCT01794520|474095801|FG000|Overall Study|Study terminated by sponsor|0|||
131675114|NCT01794520|474095802|FG001|Overall Study|Study terminated by sponsor|0|||
131675115|NCT01794520|474095803|FG002|Overall Study|Study terminated by sponsor|1|||
131675116|NCT01794520|474095804|FG003|Overall Study|Study terminated by sponsor|0|||
131675117|NCT01794520|474095805|FG004|Overall Study|Study terminated by sponsor|1|||
131675118|NCT01794520|474095806|FG005|Overall Study|Study terminated by sponsor|0|||
131675119|NCT01794520|474095807|FG006|Overall Study|Study terminated by sponsor|7|||
131675120|NCT01794520|474095801|FG000|Overall Study|Death|0|||
131772450|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
131675121|NCT01794520|474095802|FG001|Overall Study|Death|0|||
131675122|NCT01794520|474095803|FG002|Overall Study|Death|0|||
131675123|NCT01794520|474095804|FG003|Overall Study|Death|0|||
131675124|NCT01794520|474095805|FG004|Overall Study|Death|1|||
131675125|NCT01794520|474095806|FG005|Overall Study|Death|0|||
131675126|NCT01794520|474095807|FG006|Overall Study|Death|22|||
131675127|NCT01794520|474095801|FG000|Overall Study|Other, not specified|0|||
131675128|NCT01794520|474095802|FG001|Overall Study|Other, not specified|0|||
131772451|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
131772452|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
131772453|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
131772454|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
131772455|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
131772456|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
131772457|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
131772458|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
131772459|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
131772460|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
131772461|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
131772462|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
131772463|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
131772464|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
131772465|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
131772466|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
131772467|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
131772468|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
131772469|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
131772470|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
131772471|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
131772472|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
131772473|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
131675129|NCT01794520|474095803|FG002|Overall Study|Other, not specified|1|||
131675130|NCT01794520|474095804|FG003|Overall Study|Other, not specified|1|||
131675131|NCT01794520|474095805|FG004|Overall Study|Other, not specified|4|||
131675132|NCT01794520|474095806|FG005|Overall Study|Other, not specified|1|||
131675133|NCT01794520|474095807|FG006|Overall Study|Other, not specified|2|||
131675134|NCT05193500|474095808|FG000|Overall Study|Withdrawal by Subject|7|||
131675135|NCT05193500|474095809|FG001|Overall Study|Withdrawal by Subject|4|||
131675136|NCT05193500|474095810|FG002|Overall Study|Withdrawal by Subject|3|||
131675137|NCT05193500|474095811|FG003|Overall Study|Withdrawal by Subject|5|||
131675138|NCT03437278|474095814|FG000|Overall Study|Adverse Event|0|||
131675139|NCT03437278|474095815|FG001|Overall Study|Adverse Event|0|||
131675140|NCT03437278|474095816|FG002|Overall Study|Adverse Event|1|||
131675141|NCT03437278|474095814|FG000|Overall Study|Progressive disease|1|||
131675142|NCT03437278|474095815|FG001|Overall Study|Progressive disease|0|||
131675143|NCT03437278|474095816|FG002|Overall Study|Progressive disease|0|||
131675144|NCT03437278|474095814|FG000|Overall Study|Physician Decision|1|||
131675145|NCT03437278|474095815|FG001|Overall Study|Physician Decision|0|||
131675146|NCT03437278|474095816|FG002|Overall Study|Physician Decision|1|||
131675147|NCT02202551|474095817|FG000|Overall Study|Adverse Event|8|||
131675148|NCT02202551|474095818|FG001|Overall Study|Adverse Event|19|||
131675149|NCT02202551|474095819|FG002|Overall Study|Adverse Event|5|||
131675150|NCT02202551|474095820|FG003|Overall Study|Adverse Event|9|||
131675151|NCT02202551|474095817|FG000|Overall Study|Death|3|||
131675152|NCT02202551|474095818|FG001|Overall Study|Death|2|||
131675153|NCT02202551|474095819|FG002|Overall Study|Death|1|||
131675154|NCT02202551|474095820|FG003|Overall Study|Death|1|||
131675155|NCT02202551|474095817|FG000|Overall Study|Lost to Follow-up|0|||
131675156|NCT02202551|474095818|FG001|Overall Study|Lost to Follow-up|1|||
131675157|NCT02202551|474095819|FG002|Overall Study|Lost to Follow-up|0|||
131675158|NCT02202551|474095820|FG003|Overall Study|Lost to Follow-up|1|||
131675159|NCT02202551|474095817|FG000|Overall Study|Needed to take excluded medication|0|||
131675160|NCT02202551|474095818|FG001|Overall Study|Needed to take excluded medication|2|||
131675161|NCT02202551|474095819|FG002|Overall Study|Needed to take excluded medication|0|||
131675162|NCT02202551|474095820|FG003|Overall Study|Needed to take excluded medication|1|||
131675163|NCT02202551|474095817|FG000|Overall Study|Subject moved away|0|||
131675164|NCT02202551|474095818|FG001|Overall Study|Subject moved away|1|||
131675165|NCT02202551|474095819|FG002|Overall Study|Subject moved away|0|||
131675166|NCT02202551|474095820|FG003|Overall Study|Subject moved away|0|||
131675167|NCT02202551|474095817|FG000|Overall Study|DBS surgery|3|||
131675168|NCT02202551|474095818|FG001|Overall Study|DBS surgery|0|||
131675169|NCT02202551|474095819|FG002|Overall Study|DBS surgery|0|||
131675170|NCT02202551|474095820|FG003|Overall Study|DBS surgery|0|||
131675171|NCT02202551|474095817|FG000|Overall Study|Dyskinesia upon taper|1|||
131675172|NCT02202551|474095818|FG001|Overall Study|Dyskinesia upon taper|0|||
131675173|NCT02202551|474095819|FG002|Overall Study|Dyskinesia upon taper|0|||
131675174|NCT02202551|474095820|FG003|Overall Study|Dyskinesia upon taper|0|||
131675175|NCT02202551|474095817|FG000|Overall Study|Lack of Efficacy|0|||
131675176|NCT02202551|474095818|FG001|Overall Study|Lack of Efficacy|1|||
131675177|NCT02202551|474095819|FG002|Overall Study|Lack of Efficacy|0|||
131675178|NCT02202551|474095820|FG003|Overall Study|Lack of Efficacy|0|||
131675179|NCT02202551|474095817|FG000|Overall Study|Physician Decision|1|||
131675180|NCT02202551|474095818|FG001|Overall Study|Physician Decision|0|||
131675181|NCT02202551|474095819|FG002|Overall Study|Physician Decision|0|||
131675182|NCT02202551|474095820|FG003|Overall Study|Physician Decision|0|||
131675183|NCT02202551|474095817|FG000|Overall Study|Site closure|3|||
131675184|NCT02202551|474095818|FG001|Overall Study|Site closure|0|||
131675185|NCT02202551|474095819|FG002|Overall Study|Site closure|0|||
131675186|NCT02202551|474095820|FG003|Overall Study|Site closure|1|||
131675187|NCT02202551|474095817|FG000|Overall Study|Unable to complete visits per protocol|1|||
131675188|NCT02202551|474095818|FG001|Overall Study|Unable to complete visits per protocol|0|||
131675189|NCT02202551|474095819|FG002|Overall Study|Unable to complete visits per protocol|0|||
131675190|NCT02202551|474095820|FG003|Overall Study|Unable to complete visits per protocol|0|||
131675191|NCT02202551|474095817|FG000|Overall Study|Worsening Dyskinesia|0|||
131675192|NCT02202551|474095818|FG001|Overall Study|Worsening Dyskinesia|0|||
131675193|NCT02202551|474095819|FG002|Overall Study|Worsening Dyskinesia|0|||
131675194|NCT02202551|474095820|FG003|Overall Study|Worsening Dyskinesia|1|||
131675195|NCT02202551|474095817|FG000|Overall Study|Protocol Violation|0|||
131675196|NCT02202551|474095818|FG001|Overall Study|Protocol Violation|1|||
131675197|NCT02202551|474095819|FG002|Overall Study|Protocol Violation|0|||
131675198|NCT02202551|474095820|FG003|Overall Study|Protocol Violation|0|||
131675199|NCT02202551|474095817|FG000|Overall Study|Sponsor's decision|2|||
131675200|NCT02202551|474095818|FG001|Overall Study|Sponsor's decision|0|||
131675201|NCT02202551|474095819|FG002|Overall Study|Sponsor's decision|0|||
131675202|NCT02202551|474095820|FG003|Overall Study|Sponsor's decision|0|||
131675203|NCT02202551|474095817|FG000|Overall Study|Subject unwilling to proceed|1|||
131675204|NCT02202551|474095818|FG001|Overall Study|Subject unwilling to proceed|5|||
131675205|NCT02202551|474095819|FG002|Overall Study|Subject unwilling to proceed|3|||
131675206|NCT02202551|474095820|FG003|Overall Study|Subject unwilling to proceed|5|||
131675207|NCT02202551|474095817|FG000|Overall Study|Subject consent withdrawn|0|||
131675208|NCT02202551|474095818|FG001|Overall Study|Subject consent withdrawn|3|||
131675209|NCT02202551|474095819|FG002|Overall Study|Subject consent withdrawn|1|||
131675210|NCT02202551|474095820|FG003|Overall Study|Subject consent withdrawn|2|||
131675211|NCT02202551|474095817|FG000|Overall Study|eGFR<50mL/min/m2|2|||
131675212|NCT02202551|474095818|FG001|Overall Study|eGFR<50mL/min/m2|2|||
131675213|NCT02202551|474095819|FG002|Overall Study|eGFR<50mL/min/m2|0|||
131675214|NCT02202551|474095820|FG003|Overall Study|eGFR<50mL/min/m2|1|||
131675215|NCT01776424|474095824|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
131675216|NCT01776424|474095825|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
131675217|NCT01776424|474095826|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
131675218|NCT01776424|474095824|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
131675219|NCT01776424|474095825|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
131675220|NCT01776424|474095826|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
131675221|NCT01776424|474095824|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
131675222|NCT01776424|474095825|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
131675223|NCT01776424|474095826|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
131675224|NCT01776424|474095824|FG000|LTOLE Part (Open Label)|Refused|5|||
131675225|NCT01776424|474095825|FG001|LTOLE Part (Open Label)|Refused|2|||
131772474|NCT03556202|474445075|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
131772475|NCT03556202|474445076|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
131772476|NCT03556202|474445077|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
131675226|NCT01776424|474095826|FG002|LTOLE Part (Open Label)|Refused|11|||
131675227|NCT01776424|474095824|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
131675228|NCT01776424|474095825|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
131675229|NCT01776424|474095826|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
131675230|NCT00146757|474095827|FG000|Overall Study|Death|1|||
131675231|NCT00146757|474095828|FG001|Overall Study|Death|0|||
131675232|NCT00146757|474095827|FG000|Overall Study|Adverse Event|1|||
131772477|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Adverse Event|6|||
131675233|NCT00146757|474095828|FG001|Overall Study|Adverse Event|0|||
131675234|NCT02578862|474095836|FG000|Overall Study|Withdrawal by Subject|0|||
131675235|NCT02578862|474095837|FG001|Overall Study|Withdrawal by Subject|1|||
131675236|NCT02578862|474095836|FG000|Overall Study|Unplanned unilateral procedure|0|||
131675237|NCT02578862|474095837|FG001|Overall Study|Unplanned unilateral procedure|1|||
131675238|NCT02893930|474095840|FG000|Overall Study|Adverse Event|3|||
131675239|NCT02893930|474095840|FG000|Overall Study|Death|1|||
131675240|NCT02893930|474095840|FG000|Overall Study|Disease progression|5|||
131675241|NCT02893930|474095840|FG000|Overall Study|Withdrawal by Subject|2|||
131675242|NCT02893930|474095840|FG000|Overall Study|Physician Decision|1|||
131675243|NCT02893930|474095840|FG000|Overall Study|Ineligible|1|||
131675244|NCT02349360|474095841|FG000|Overall Study|Withdrawal by Subject|0|||
131675245|NCT02349360|474095842|FG001|Overall Study|Withdrawal by Subject|1|||
131675246|NCT01176773|474095843|FG000|Overall Study|Screen Failure|2|||
131675247|NCT01176773|474095843|FG000|Overall Study|Withdrew consent|1|||
131675248|NCT03037619|474095860|FG000|Overall Study|Lost to Follow-up|0|||
131675249|NCT03037619|474095861|FG001|Overall Study|Lost to Follow-up|1|||
131675250|NCT01498289|474095862|FG000|Overall Study|Adverse Event|16|||
131675251|NCT01498289|474095863|FG001|Overall Study|Adverse Event|18|||
131675252|NCT01498289|474095862|FG000|Overall Study|Death|6|||
131675253|NCT01498289|474095863|FG001|Overall Study|Death|8|||
131675254|NCT01498289|474095862|FG000|Overall Study|Withdrawal unrelated to AE|16|||
131675255|NCT01498289|474095863|FG001|Overall Study|Withdrawal unrelated to AE|16|||
131675256|NCT01498289|474095862|FG000|Overall Study|Progression/relapse|53|||
131675257|NCT01498289|474095863|FG001|Overall Study|Progression/relapse|59|||
131675258|NCT01498289|474095862|FG000|Overall Study|Not protocol specified|7|||
131675259|NCT01498289|474095863|FG001|Overall Study|Not protocol specified|2|||
131675260|NCT01498289|474095862|FG000|Overall Study|Reason under review|0|||
131675261|NCT01498289|474095863|FG001|Overall Study|Reason under review|1|||
131675262|NCT01794923|474095864|FG000|Overall Study|Adverse Event|0|||
131675263|NCT01794923|474095865|FG001|Overall Study|Adverse Event|0|||
131675264|NCT01794923|474095866|FG002|Overall Study|Adverse Event|1|||
131675265|NCT00752622|474095877|FG000|Induction Phase|Adverse Event|3|||
131675266|NCT00752622|474095877|FG000|Induction Phase|Other|3|||
131675267|NCT00752622|474095877|FG000|Induction Phase|Non-responder|14|||
131675268|NCT00752622|474095877|FG000|Induction Phase|Withdrawal by Subject|1|||
131675269|NCT00752622|474095877|FG000|Induction Phase|Premature study termination|14|||
131675270|NCT00752622|474095877|FG000|Observational Phase|Premature Study Termination|36|||
131675271|NCT00752622|474095877|FG000|Observational Phase|Non-responder|2|||
131675272|NCT00752622|474095877|FG000|Observational Phase|Withdrawal by Subject|2|||
131675273|NCT00752622|474095877|FG000|Observational Phase|Adverse Event|1|||
131675274|NCT00752622|474095877|FG000|Observational Phase|Other|2|||
131675275|NCT00752622|474095877|FG000|Interventional Phase|Non-responder|2|||
131675276|NCT00752622|474095877|FG000|Interventional Phase|Physician Decision|1|||
131675277|NCT00752622|474095877|FG000|Interventional Phase|Premature Study Termination|5|||
131675278|NCT00894686|474095878|FG000|Overall Study|Withdrawal by Subject|50|||
131675279|NCT00894686|474095878|FG000|Overall Study|Physician Decision|1|||
131675280|NCT00894686|474095878|FG000|Overall Study|Other|5|||
131675281|NCT00564018|474095881|FG000|Overall Study|Withdrawal by Subject|2|||
131675282|NCT00564018|474095882|FG001|Overall Study|Withdrawal by Subject|3|||
131675283|NCT00564018|474095883|FG002|Overall Study|Withdrawal by Subject|1|||
131675284|NCT03291587|474095892|FG000|Overall Study|Lost to Follow-up|62|||
131675285|NCT03291587|474095893|FG001|Overall Study|Lost to Follow-up|43|||
131675286|NCT03291587|474095892|FG000|Overall Study|Refused to Answer|5|||
131675287|NCT03291587|474095893|FG001|Overall Study|Refused to Answer|2|||
131675288|NCT03291587|474095892|FG000|Overall Study|Death|2|||
131675289|NCT03291587|474095893|FG001|Overall Study|Death|4|||
131675290|NCT03291587|474095892|FG000|Overall Study|Not interested in participating|8|||
131675291|NCT03291587|474095893|FG001|Overall Study|Not interested in participating|6|||
131675292|NCT03291587|474095892|FG000|Overall Study|Too busy to participate|4|||
131675293|NCT03291587|474095893|FG001|Overall Study|Too busy to participate|2|||
131675294|NCT00796120|474095894|FG000|Overall Study|Death|3|||
131675295|NCT00796120|474095895|FG001|Overall Study|Death|0|||
131675296|NCT00796120|474095894|FG000|Overall Study|Adverse Event|11|||
131675297|NCT00796120|474095895|FG001|Overall Study|Adverse Event|6|||
131675298|NCT00796120|474095894|FG000|Overall Study|Progressive disease|22|||
131675299|NCT00796120|474095895|FG001|Overall Study|Progressive disease|13|||
131675300|NCT00796120|474095894|FG000|Overall Study|Participant refusal|3|||
131675301|NCT00796120|474095895|FG001|Overall Study|Participant refusal|4|||
131675302|NCT00796120|474095894|FG000|Overall Study|Other|6|||
131675303|NCT00796120|474095895|FG001|Overall Study|Other|17|||
131675304|NCT00796120|474095894|FG000|Overall Study|Physician Decision|16|||
131675305|NCT00796120|474095895|FG001|Overall Study|Physician Decision|17|||
131675306|NCT00796120|474095894|FG000|Overall Study|Randomized but not treated|0|||
131675307|NCT00796120|474095895|FG001|Overall Study|Randomized but not treated|3|||
131675308|NCT02520284|474095897|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
131675309|NCT02520284|474095898|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
131675310|NCT02520284|474095899|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
131675311|NCT02520284|474095897|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
131675312|NCT02520284|474095898|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
131675313|NCT02520284|474095899|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
131675314|NCT02520284|474095897|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
131675315|NCT02520284|474095898|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
131675316|NCT02520284|474095899|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
131675317|NCT02520284|474095897|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
131675318|NCT02520284|474095898|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
131675319|NCT02520284|474095899|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
131675320|NCT02520284|474095897|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
131675321|NCT02520284|474095898|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
131675322|NCT02520284|474095899|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
131675323|NCT02520284|474095897|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
131675324|NCT02520284|474095898|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
131675325|NCT02520284|474095899|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
131675326|NCT02520284|474095897|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
131675327|NCT02520284|474095898|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
131675328|NCT02520284|474095899|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
131675329|NCT02520284|474095897|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
131772478|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Adverse Event|6|||
131772479|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Death|14|||
131772480|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Death|11|||
131772481|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
131772482|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
131675330|NCT02520284|474095898|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
131675331|NCT02520284|474095899|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
131675332|NCT02520284|474095897|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
131675333|NCT02520284|474095898|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
131675334|NCT02520284|474095899|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
131675335|NCT02520284|474095897|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
131675336|NCT02520284|474095898|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
131675337|NCT02520284|474095899|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
131675338|NCT02520284|474095897|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
131675339|NCT02520284|474095898|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
131675340|NCT02520284|474095899|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
131675341|NCT01898923|474095902|FG000|Overall Study|Lack of Efficacy|5|||
131675342|NCT01898923|474095903|FG001|Overall Study|Lack of Efficacy|6|||
131675343|NCT01898923|474095902|FG000|Overall Study|Adverse Event|3|||
131675344|NCT01898923|474095903|FG001|Overall Study|Adverse Event|1|||
131675345|NCT01898923|474095902|FG000|Overall Study|Lost to Follow-up|0|||
131675346|NCT01898923|474095903|FG001|Overall Study|Lost to Follow-up|1|||
131675347|NCT01898923|474095902|FG000|Overall Study|Withdrawal by Subject|4|||
131675348|NCT01898923|474095903|FG001|Overall Study|Withdrawal by Subject|7|||
131675349|NCT01898923|474095902|FG000|Overall Study|Physician Decision|3|||
131675350|NCT01898923|474095903|FG001|Overall Study|Physician Decision|4|||
131675351|NCT01898923|474095902|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
131675352|NCT01898923|474095903|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
131675353|NCT00547365|474095906|FG000|Overall Study|Physician Decision|1|||
131675354|NCT00547365|474095906|FG000|Overall Study|Lost to Follow-up|1|||
131675355|NCT00547365|474095906|FG000|Overall Study|Protocol Violation|2|||
131675356|NCT00547365|474095906|FG000|Overall Study|death (not related to study)|4|||
131675357|NCT00504881|474095907|FG000|Overall Study|Lack of Efficacy|1|||
131675358|NCT00504881|474095908|FG001|Overall Study|Lack of Efficacy|5|||
131675359|NCT00504881|474095907|FG000|Overall Study|Lost to Follow-up|0|||
131675360|NCT00504881|474095908|FG001|Overall Study|Lost to Follow-up|2|||
131675361|NCT00504881|474095907|FG000|Overall Study|Withdrawal by Subject|1|||
131675362|NCT00504881|474095908|FG001|Overall Study|Withdrawal by Subject|4|||
131675363|NCT00504881|474095907|FG000|Overall Study|Non-Compliance|1|||
131675364|NCT00504881|474095908|FG001|Overall Study|Non-Compliance|0|||
131675365|NCT00504881|474095907|FG000|Overall Study|No Birth Control|0|||
131675366|NCT00504881|474095908|FG001|Overall Study|No Birth Control|1|||
131675367|NCT00504881|474095907|FG000|Overall Study|Safety Visit not performed|0|||
131675368|NCT00504881|474095908|FG001|Overall Study|Safety Visit not performed|1|||
131675369|NCT00504881|474095907|FG000|Overall Study|AE, serious fatal|0|||
131675370|NCT00504881|474095908|FG001|Overall Study|AE, serious fatal|1|||
131675371|NCT00504881|474095907|FG000|Overall Study|SAE, non-fatal|2|||
131675372|NCT00504881|474095908|FG001|Overall Study|SAE, non-fatal|6|||
131555444|NCT03810313|473658206|FG001|Overall Study|Physician Decision|1|||
131675373|NCT00504881|474095907|FG000|Overall Study|AE, non-serious non-fatal|4|||
131675374|NCT00504881|474095908|FG001|Overall Study|AE, non-serious non-fatal|14|||
131675375|NCT00504881|474095907|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131675376|NCT00504881|474095908|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
131675377|NCT00504881|474095907|FG000|Overall Study|AE of unknown type|1|||
131675378|NCT00504881|474095908|FG001|Overall Study|AE of unknown type|0|||
131675379|NCT00810394|474095909|FG000|Overall Study|Withdrawal by Subject|3|||
131675380|NCT03217266|474097616|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
131675381|NCT03217266|474097617|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
131675382|NCT03217266|474097618|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
131675383|NCT03217266|474097619|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
131675384|NCT03217266|474097616|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
131675385|NCT03217266|474097617|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
131675386|NCT03217266|474097618|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
131675387|NCT03217266|474097619|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
131675388|NCT03217266|474097616|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
131675389|NCT03217266|474097617|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
131675390|NCT03217266|474097618|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
131675391|NCT03217266|474097619|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
131675392|NCT01390181|474097620|FG000|Overall Study|Lost to Follow-up|1|||
131675393|NCT01390181|474097620|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
131675394|NCT02805725|474097621|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
131675395|NCT02805725|474097622|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
131675396|NCT02805725|474097623|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
131675397|NCT02805725|474097624|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
131675398|NCT02805725|474097625|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
131675399|NCT02805725|474097621|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
131675400|NCT02805725|474097622|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
131675401|NCT02805725|474097623|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
131675402|NCT02805725|474097624|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
131675403|NCT02805725|474097625|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
131675404|NCT02805725|474097621|FG000|Phase II|Protocol Violation|0|||
131675405|NCT02805725|474097622|FG001|Phase II|Protocol Violation|0|||
131675406|NCT02805725|474097623|FG002|Phase II|Protocol Violation|0|||
131675407|NCT02805725|474097624|FG003|Phase II|Protocol Violation|0|||
131675408|NCT02805725|474097625|FG004|Phase II|Protocol Violation|6|||
131675409|NCT01195545|474097626|FG000|Overall Study|Protocol Violation|4|||
131675410|NCT02425644|474097628|FG000|Overall Study|Lost to Follow-up|2|||
131675411|NCT02425644|474097629|FG001|Overall Study|Lost to Follow-up|3|||
131675412|NCT02425644|474097628|FG000|Overall Study|Withdrawal by Subject|41|||
131675413|NCT02425644|474097629|FG001|Overall Study|Withdrawal by Subject|36|||
131675414|NCT02425644|474097628|FG000|Overall Study|Lack of Efficacy|3|||
131675415|NCT02425644|474097629|FG001|Overall Study|Lack of Efficacy|10|||
131675416|NCT02425644|474097628|FG000|Overall Study|Adverse Event|13|||
131675417|NCT02425644|474097629|FG001|Overall Study|Adverse Event|3|||
131675418|NCT02425644|474097628|FG000|Overall Study|Death|0|||
131675419|NCT02425644|474097629|FG001|Overall Study|Death|2|||
131675420|NCT02425644|474097628|FG000|Overall Study|Other|18|||
131675421|NCT02425644|474097629|FG001|Overall Study|Other|17|||
131675422|NCT01256658|474097630|FG000|Period 1|Lost to Follow-up|837|||
131675423|NCT01256658|474097631|FG001|Period 1|Lost to Follow-up|661|||
131675424|NCT01256658|474097630|FG000|Period 1|Withdrawal by Subject|35|||
131675425|NCT01256658|474097631|FG001|Period 1|Withdrawal by Subject|43|||
131675426|NCT01256658|474097630|FG000|Period 1|Death|48|||
131675427|NCT01256658|474097631|FG001|Period 1|Death|44|||
131675428|NCT00909792|474097632|FG000|Period 1|Did not meet inclusion criteria|0|||
131675429|NCT00909792|474097633|FG001|Period 1|Did not meet inclusion criteria|1|||
131675430|NCT00909792|474097632|FG000|Period 2|Biomicroscopy|1|||
131675431|NCT00909792|474097633|FG001|Period 2|Biomicroscopy|0|||
131675432|NCT00909792|474097632|FG000|Period 2|Lost to Follow-up|0|||
131675433|NCT00909792|474097633|FG001|Period 2|Lost to Follow-up|1|||
131675434|NCT00567268|474097634|FG000|Overall Study|Protocol Violation|7|||
131675435|NCT00567268|474097634|FG000|Overall Study|Lost to Follow-up|36|||
131675436|NCT00567268|474097634|FG000|Overall Study|No Visit After First Day of Treatment|2|||
131675437|NCT00567268|474097634|FG000|Overall Study|No Drug Administration|4|||
131675438|NCT00567268|474097634|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
131675439|NCT01717989|474097635|FG000|Overall Study|Ineligibility determined|6|||
131675440|NCT01717989|474097635|FG000|Overall Study|Protocol deviation|6|||
131675441|NCT01717989|474097635|FG000|Overall Study|Withdrawal by Subject|11|||
131675442|NCT01717989|474097635|FG000|Overall Study|Physician Decision|2|||
131675443|NCT01717989|474097635|FG000|Overall Study|Lost to Follow-up|11|||
131675444|NCT01717989|474097635|FG000|Overall Study|Death|439|||
131675445|NCT01717989|474097635|FG000|Overall Study|Protocol-specified criteria|551|||
131675446|NCT01717989|474097635|FG000|Overall Study|Other|40|||
131675447|NCT02525861|474097641|FG000|Overall Study|Adverse Event|1|||
131675448|NCT02525861|474097642|FG001|Overall Study|Adverse Event|0|||
131675449|NCT02525861|474097641|FG000|Overall Study|Withdrawal by Subject|0|||
131675450|NCT02525861|474097642|FG001|Overall Study|Withdrawal by Subject|1|||
131675451|NCT02525861|474097641|FG000|Overall Study|Physician Decision|0|||
131675452|NCT02525861|474097642|FG001|Overall Study|Physician Decision|1|||
131675453|NCT04796896|474097644|FG000|Overall Study|Adverse Event|1|||
131675454|NCT04796896|474097645|FG001|Overall Study|Adverse Event|0|||
131675455|NCT04796896|474097646|FG002|Overall Study|Adverse Event|0|||
131675456|NCT04796896|474097647|FG003|Overall Study|Adverse Event|0|||
131675457|NCT04796896|474097648|FG004|Overall Study|Adverse Event|0|||
131675458|NCT04796896|474097649|FG005|Overall Study|Adverse Event|1|||
131675459|NCT04796896|474097650|FG006|Overall Study|Adverse Event|1|||
131675460|NCT04796896|474097651|FG007|Overall Study|Adverse Event|0|||
131675461|NCT04796896|474097652|FG008|Overall Study|Adverse Event|1|||
131675462|NCT04796896|474097653|FG009|Overall Study|Adverse Event|1|||
131675463|NCT04796896|474097654|FG010|Overall Study|Adverse Event|1|||
131675464|NCT04796896|474097655|FG011|Overall Study|Adverse Event|0|||
131675465|NCT04796896|474097644|FG000|Overall Study|Lost to Follow-up|24|||
131675466|NCT04796896|474097645|FG001|Overall Study|Lost to Follow-up|15|||
131675467|NCT04796896|474097646|FG002|Overall Study|Lost to Follow-up|6|||
131675468|NCT04796896|474097647|FG003|Overall Study|Lost to Follow-up|4|||
131675469|NCT04796896|474097648|FG004|Overall Study|Lost to Follow-up|21|||
131675470|NCT04796896|474097649|FG005|Overall Study|Lost to Follow-up|55|||
131675471|NCT04796896|474097650|FG006|Overall Study|Lost to Follow-up|237|||
131675472|NCT04796896|474097651|FG007|Overall Study|Lost to Follow-up|52|||
131675473|NCT04796896|474097652|FG008|Overall Study|Lost to Follow-up|221|||
131675474|NCT04796896|474097653|FG009|Overall Study|Lost to Follow-up|43|||
131675475|NCT04796896|474097654|FG010|Overall Study|Lost to Follow-up|142|||
131675476|NCT04796896|474097655|FG011|Overall Study|Lost to Follow-up|18|||
131675477|NCT04796896|474097644|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
131675478|NCT04796896|474097645|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
131675479|NCT04796896|474097646|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
131675480|NCT04796896|474097647|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
131675481|NCT04796896|474097648|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
131675482|NCT04796896|474097649|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
131675483|NCT04796896|474097650|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
131675484|NCT04796896|474097651|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
131675485|NCT04796896|474097652|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
131675486|NCT04796896|474097653|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
131675487|NCT04796896|474097654|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
131675488|NCT04796896|474097655|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
131675489|NCT04796896|474097644|FG000|Overall Study|Physician Decision|1|||
131675490|NCT04796896|474097645|FG001|Overall Study|Physician Decision|0|||
131675491|NCT04796896|474097646|FG002|Overall Study|Physician Decision|0|||
131675492|NCT04796896|474097647|FG003|Overall Study|Physician Decision|0|||
131675493|NCT04796896|474097648|FG004|Overall Study|Physician Decision|0|||
131675494|NCT04796896|474097649|FG005|Overall Study|Physician Decision|3|||
131675495|NCT04796896|474097650|FG006|Overall Study|Physician Decision|18|||
131675496|NCT04796896|474097651|FG007|Overall Study|Physician Decision|1|||
131675497|NCT04796896|474097652|FG008|Overall Study|Physician Decision|7|||
131675498|NCT04796896|474097653|FG009|Overall Study|Physician Decision|0|||
131675499|NCT04796896|474097654|FG010|Overall Study|Physician Decision|5|||
131675500|NCT04796896|474097655|FG011|Overall Study|Physician Decision|0|||
131675501|NCT04796896|474097644|FG000|Overall Study|Withdrawal by Subject|36|||
131675502|NCT04796896|474097645|FG001|Overall Study|Withdrawal by Subject|31|||
131675503|NCT04796896|474097646|FG002|Overall Study|Withdrawal by Subject|11|||
131675504|NCT04796896|474097647|FG003|Overall Study|Withdrawal by Subject|8|||
131675505|NCT04796896|474097648|FG004|Overall Study|Withdrawal by Subject|16|||
131675506|NCT04796896|474097649|FG005|Overall Study|Withdrawal by Subject|162|||
131675507|NCT04796896|474097650|FG006|Overall Study|Withdrawal by Subject|299|||
131675508|NCT04796896|474097651|FG007|Overall Study|Withdrawal by Subject|149|||
131675509|NCT04796896|474097652|FG008|Overall Study|Withdrawal by Subject|303|||
131675510|NCT04796896|474097653|FG009|Overall Study|Withdrawal by Subject|94|||
131675511|NCT04796896|474097654|FG010|Overall Study|Withdrawal by Subject|192|||
131675512|NCT04796896|474097655|FG011|Overall Study|Withdrawal by Subject|16|||
131675513|NCT04796896|474097644|FG000|Overall Study|Other Than Specified|6|||
131675514|NCT04796896|474097645|FG001|Overall Study|Other Than Specified|5|||
131675515|NCT04796896|474097646|FG002|Overall Study|Other Than Specified|3|||
131675516|NCT04796896|474097647|FG003|Overall Study|Other Than Specified|2|||
131675517|NCT04796896|474097648|FG004|Overall Study|Other Than Specified|6|||
131675518|NCT04796896|474097649|FG005|Overall Study|Other Than Specified|31|||
131675519|NCT04796896|474097650|FG006|Overall Study|Other Than Specified|86|||
131675520|NCT04796896|474097651|FG007|Overall Study|Other Than Specified|66|||
131675521|NCT04796896|474097652|FG008|Overall Study|Other Than Specified|388|||
131675522|NCT04796896|474097653|FG009|Overall Study|Other Than Specified|48|||
131675523|NCT04796896|474097654|FG010|Overall Study|Other Than Specified|258|||
131675524|NCT04796896|474097655|FG011|Overall Study|Other Than Specified|4|||
131675525|NCT04796896|474097644|FG000|Overall Study|Protocol Deviation|0|||
131675526|NCT04796896|474097645|FG001|Overall Study|Protocol Deviation|0|||
131675527|NCT04796896|474097646|FG002|Overall Study|Protocol Deviation|0|||
131675528|NCT04796896|474097647|FG003|Overall Study|Protocol Deviation|1|||
131675529|NCT04796896|474097648|FG004|Overall Study|Protocol Deviation|1|||
131675530|NCT04796896|474097649|FG005|Overall Study|Protocol Deviation|2|||
131675531|NCT04796896|474097650|FG006|Overall Study|Protocol Deviation|2|||
131675532|NCT04796896|474097651|FG007|Overall Study|Protocol Deviation|2|||
131675533|NCT04796896|474097652|FG008|Overall Study|Protocol Deviation|2|||
131675534|NCT04796896|474097653|FG009|Overall Study|Protocol Deviation|1|||
131675535|NCT04796896|474097654|FG010|Overall Study|Protocol Deviation|0|||
131675536|NCT04796896|474097655|FG011|Overall Study|Protocol Deviation|0|||
131675537|NCT04796896|474097644|FG000|Overall Study|Missing|0|||
131675538|NCT04796896|474097645|FG001|Overall Study|Missing|0|||
131675539|NCT04796896|474097646|FG002|Overall Study|Missing|0|||
131675540|NCT04796896|474097647|FG003|Overall Study|Missing|0|||
131675541|NCT04796896|474097648|FG004|Overall Study|Missing|0|||
131675542|NCT04796896|474097649|FG005|Overall Study|Missing|0|||
131675543|NCT04796896|474097650|FG006|Overall Study|Missing|2|||
131675544|NCT04796896|474097651|FG007|Overall Study|Missing|1|||
131675545|NCT04796896|474097652|FG008|Overall Study|Missing|2|||
131675546|NCT04796896|474097653|FG009|Overall Study|Missing|1|||
131675547|NCT04796896|474097654|FG010|Overall Study|Missing|1|||
131675548|NCT04796896|474097655|FG011|Overall Study|Missing|0|||
131675549|NCT04796896|474097644|FG000|Overall Study|Death|0|||
131675550|NCT04796896|474097645|FG001|Overall Study|Death|0|||
131675551|NCT04796896|474097646|FG002|Overall Study|Death|0|||
131675552|NCT04796896|474097647|FG003|Overall Study|Death|0|||
131675553|NCT04796896|474097648|FG004|Overall Study|Death|0|||
131675554|NCT04796896|474097649|FG005|Overall Study|Death|0|||
131675555|NCT04796896|474097650|FG006|Overall Study|Death|0|||
131675556|NCT04796896|474097651|FG007|Overall Study|Death|0|||
131675557|NCT04796896|474097652|FG008|Overall Study|Death|1|||
131675558|NCT04796896|474097653|FG009|Overall Study|Death|0|||
131675559|NCT04796896|474097654|FG010|Overall Study|Death|0|||
131675560|NCT04796896|474097655|FG011|Overall Study|Death|0|||
131675561|NCT04356183|474097656|FG000|Overall Study|Lost to Follow-up|1|||
131675562|NCT04356183|474097657|FG001|Overall Study|Lost to Follow-up|0|||
131675563|NCT04356183|474097656|FG000|Overall Study|Withdrawal by Subject|1|||
131675564|NCT04356183|474097657|FG001|Overall Study|Withdrawal by Subject|1|||
131675565|NCT01177787|474097658|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
131675566|NCT01177787|474097658|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
131675567|NCT01177787|474097658|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
131675568|NCT00402363|474097661|FG000|Overall Study|Adverse Event|9|||
131675569|NCT00402363|474097662|FG001|Overall Study|Adverse Event|14|||
131675570|NCT00402363|474097663|FG002|Overall Study|Adverse Event|2|||
131675571|NCT00402363|474097664|FG003|Overall Study|Adverse Event|2|||
131675572|NCT00402363|474097661|FG000|Overall Study|Withdrew Consent|10|||
131675573|NCT00402363|474097662|FG001|Overall Study|Withdrew Consent|5|||
131675574|NCT00402363|474097663|FG002|Overall Study|Withdrew Consent|2|||
131675575|NCT00402363|474097664|FG003|Overall Study|Withdrew Consent|1|||
131675576|NCT00402363|474097661|FG000|Overall Study|Protocol Violation|3|||
131675577|NCT00402363|474097662|FG001|Overall Study|Protocol Violation|5|||
131675578|NCT00402363|474097663|FG002|Overall Study|Protocol Violation|0|||
131675579|NCT00402363|474097664|FG003|Overall Study|Protocol Violation|3|||
131675580|NCT00402363|474097661|FG000|Overall Study|Lost to Follow-up|5|||
131675581|NCT00402363|474097662|FG001|Overall Study|Lost to Follow-up|4|||
131675582|NCT00402363|474097663|FG002|Overall Study|Lost to Follow-up|0|||
131675583|NCT00402363|474097664|FG003|Overall Study|Lost to Follow-up|2|||
131675584|NCT00402363|474097661|FG000|Overall Study|"Captured as Other"|6|||
131675585|NCT00402363|474097662|FG001|Overall Study|"Captured as Other"|2|||
131675586|NCT00402363|474097663|FG002|Overall Study|"Captured as Other"|2|||
131675587|NCT00402363|474097664|FG003|Overall Study|"Captured as Other"|2|||
131675588|NCT00293722|474097665|FG000|Overall Study|Other|427|||
131675589|NCT02824263|474097666|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
131675590|NCT02824263|474097667|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
131675591|NCT02824263|474097666|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
131675592|NCT02824263|474097667|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
131675593|NCT00667355|474097668|FG000|Overall Study|Adverse Event|5|||
131675594|NCT00667355|474097668|FG000|Overall Study|Lost to Follow-up|1|||
131675595|NCT00667355|474097668|FG000|Overall Study|Other reason was not specified|5|||
131675596|NCT00068588|474097675|FG000|Overall Study|Adverse Event|0|||
131675597|NCT00068588|474097676|FG001|Overall Study|Adverse Event|0|||
131675598|NCT00068588|474097677|FG002|Overall Study|Adverse Event|2|||
131675599|NCT00068588|474097675|FG000|Overall Study|Withdrawal by Subject|0|||
131675600|NCT00068588|474097676|FG001|Overall Study|Withdrawal by Subject|0|||
131675601|NCT00068588|474097677|FG002|Overall Study|Withdrawal by Subject|1|||
131675602|NCT00068588|474097675|FG000|Overall Study|Poor KPS|0|||
131675603|NCT00068588|474097676|FG001|Overall Study|Poor KPS|0|||
131675604|NCT00068588|474097677|FG002|Overall Study|Poor KPS|1|||
131675605|NCT02604433|474097678|FG000|Overall Study|Withdrawal by Subject|37|||
131675606|NCT02604433|474097679|FG001|Overall Study|Withdrawal by Subject|16|||
131675607|NCT02604433|474097678|FG000|Overall Study|Adverse Event|4|||
131675608|NCT02604433|474097679|FG001|Overall Study|Adverse Event|0|||
131675609|NCT02604433|474097678|FG000|Overall Study|Other reasons|3|||
131675610|NCT02604433|474097679|FG001|Overall Study|Other reasons|5|||
131675611|NCT02604433|474097678|FG000|Overall Study|Death|4|||
131675612|NCT02604433|474097679|FG001|Overall Study|Death|1|||
131675613|NCT02604433|474097678|FG000|Overall Study|Transition to Rollover Protocol|169|||
131675614|NCT02604433|474097679|FG001|Overall Study|Transition to Rollover Protocol|82|||
131675615|NCT02604433|474097678|FG000|Overall Study|Physician Decision|1|||
131675616|NCT02604433|474097679|FG001|Overall Study|Physician Decision|1|||
131675617|NCT02604433|474097678|FG000|Overall Study|Lack of Efficacy|0|||
131675618|NCT02604433|474097679|FG001|Overall Study|Lack of Efficacy|1|||
131675619|NCT02147353|474097680|FG000|Overall Study|Lost to Follow-up|2|||
131675620|NCT02147353|474097681|FG001|Overall Study|Lost to Follow-up|0|||
131675621|NCT02147353|474097680|FG000|Overall Study|unable to make visits|4|||
131675622|NCT02147353|474097681|FG001|Overall Study|unable to make visits|0|||
131675623|NCT02147353|474097680|FG000|Overall Study|medication noncompliance|3|||
131675624|NCT02147353|474097681|FG001|Overall Study|medication noncompliance|0|||
131675625|NCT03267940|474097683|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
131675626|NCT03267940|474097684|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
131675627|NCT03267940|474097685|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131675628|NCT03267940|474097686|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131675629|NCT03267940|474097687|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131675630|NCT03267940|474097688|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131675631|NCT03267940|474097683|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131675632|NCT03267940|474097684|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
131675633|NCT03267940|474097685|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131675634|NCT03267940|474097686|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131675635|NCT03267940|474097687|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131675636|NCT03267940|474097688|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131675637|NCT03267940|474097683|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131675638|NCT03267940|474097684|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
131675639|NCT03267940|474097685|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131675640|NCT03267940|474097686|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131675641|NCT03267940|474097687|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131675642|NCT03267940|474097688|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131675643|NCT03267940|474097683|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
131675644|NCT03267940|474097684|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
131675645|NCT03267940|474097685|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131675646|NCT03267940|474097686|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131675647|NCT03267940|474097687|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131675648|NCT03267940|474097688|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131675649|NCT03267940|474097683|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131675650|NCT03267940|474097684|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131675651|NCT03267940|474097685|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131675652|NCT03267940|474097686|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
131675653|NCT03267940|474097687|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
131675654|NCT03267940|474097688|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131675655|NCT03267940|474097683|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
131675656|NCT03267940|474097684|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
131675657|NCT03267940|474097685|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
131675658|NCT03267940|474097686|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
131675659|NCT03267940|474097687|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
131675660|NCT03267940|474097688|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
131675661|NCT03267940|474097683|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
131675662|NCT03267940|474097684|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
131675663|NCT03267940|474097685|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
131675664|NCT03267940|474097686|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
131675665|NCT03267940|474097687|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
131675666|NCT03267940|474097688|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
131675667|NCT03267940|474097683|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
131675668|NCT03267940|474097684|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
131675669|NCT03267940|474097685|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
131675670|NCT03267940|474097686|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
131675671|NCT03267940|474097687|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
131675672|NCT03267940|474097688|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
131675673|NCT03267940|474097683|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
131675674|NCT03267940|474097684|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
131675675|NCT03267940|474097685|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
131675676|NCT03267940|474097686|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
131675677|NCT03267940|474097687|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
131675678|NCT03267940|474097688|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
131675679|NCT00388154|474097689|FG000|Overall Study|Withdrawal by Subject|1|||
131675680|NCT01948908|474097690|FG000|Overall Study|Protocol Violation|1|||
131675681|NCT01948908|474097691|FG001|Overall Study|Protocol Violation|0|||
131675682|NCT01948908|474097692|FG002|Overall Study|Protocol Violation|2|||
131675683|NCT00381303|474097693|FG000|Overall Study|Lost to Follow-up|25|||
131675684|NCT00381303|474097694|FG001|Overall Study|Lost to Follow-up|9|||
131675685|NCT00381303|474097693|FG000|Overall Study|AE/HIV-related event|22|||
131675686|NCT00381303|474097694|FG001|Overall Study|AE/HIV-related event|6|||
131675687|NCT00381303|474097693|FG000|Overall Study|Non-Adherence|13|||
131675688|NCT00381303|474097694|FG001|Overall Study|Non-Adherence|6|||
131675689|NCT00381303|474097693|FG000|Overall Study|Withdrawal by Subject|13|||
131675690|NCT00381303|474097694|FG001|Overall Study|Withdrawal by Subject|6|||
131675691|NCT00381303|474097693|FG000|Overall Study|Virologic failure|6|||
131675692|NCT00381303|474097694|FG001|Overall Study|Virologic failure|4|||
131675693|NCT00381303|474097693|FG000|Overall Study|Ineligible to continue the trial|2|||
131675694|NCT00381303|474097694|FG001|Overall Study|Ineligible to continue the trial|1|||
131675695|NCT00381303|474097693|FG000|Overall Study|Pregnancy|2|||
131675696|NCT00381303|474097694|FG001|Overall Study|Pregnancy|0|||
131675697|NCT00381303|474097693|FG000|Overall Study|Physician Decision|1|||
131675698|NCT00381303|474097694|FG001|Overall Study|Physician Decision|0|||
131675699|NCT00381303|474097693|FG000|Overall Study|Physician's decision to close the site|3|||
131675700|NCT00381303|474097694|FG001|Overall Study|Physician's decision to close the site|1|||
131675701|NCT00381303|474097693|FG000|Overall Study|Subject moved out of state|2|||
131675702|NCT00381303|474097694|FG001|Overall Study|Subject moved out of state|0|||
131675703|NCT00381303|474097693|FG000|Overall Study|Subject taking too many different meds|1|||
131675704|NCT00381303|474097694|FG001|Overall Study|Subject taking too many different meds|0|||
131675705|NCT00381303|474097693|FG000|Overall Study|No virologic response by week 12|1|||
131675706|NCT00381303|474097694|FG001|Overall Study|No virologic response by week 12|0|||
131675707|NCT00381303|474097693|FG000|Overall Study|Subject was too busy for appointments|1|||
131675708|NCT00381303|474097694|FG001|Overall Study|Subject was too busy for appointments|0|||
131675709|NCT00381303|474097693|FG000|Overall Study|Subject did not continue visits|1|||
131675710|NCT00381303|474097694|FG001|Overall Study|Subject did not continue visits|0|||
131675711|NCT00381303|474097693|FG000|Overall Study|Subject primary physician's decision|1|||
131675712|NCT00381303|474097694|FG001|Overall Study|Subject primary physician's decision|0|||
131675713|NCT01211522|474097696|FG000|Overall Study|Withdrawal by Subject|3|||
131675714|NCT01211522|474097697|FG001|Overall Study|Withdrawal by Subject|7|||
131675715|NCT01211522|474097698|FG002|Overall Study|Withdrawal by Subject|5|||
131675716|NCT01777269|474097699|FG000|Overall Study|Adverse Event|24|||
131675717|NCT01777269|474097700|FG001|Overall Study|Adverse Event|33|||
131675718|NCT01777269|474097699|FG000|Overall Study|Lack of Efficacy|8|||
131675719|NCT01777269|474097700|FG001|Overall Study|Lack of Efficacy|10|||
131675720|NCT01777269|474097699|FG000|Overall Study|Protocol Violation|4|||
131675721|NCT01777269|474097700|FG001|Overall Study|Protocol Violation|4|||
131675722|NCT01777269|474097699|FG000|Overall Study|Participants reached stopping criteria|1|||
131675723|NCT01777269|474097700|FG001|Overall Study|Participants reached stopping criteria|1|||
131675724|NCT01777269|474097699|FG000|Overall Study|Lost to Follow-up|4|||
131675725|NCT01777269|474097700|FG001|Overall Study|Lost to Follow-up|0|||
131675726|NCT01777269|474097699|FG000|Overall Study|Physician Decision|5|||
131675727|NCT01777269|474097700|FG001|Overall Study|Physician Decision|2|||
131675728|NCT01777269|474097699|FG000|Overall Study|Withdrawal by Subject|9|||
131675729|NCT01777269|474097700|FG001|Overall Study|Withdrawal by Subject|9|||
131675730|NCT00803270|474097702|FG000|Overall Study|Lost to Follow-up|1|||
131675731|NCT00803270|474097703|FG001|Overall Study|Lost to Follow-up|2|||
131675732|NCT01966471|474097706|FG000|Overall Study|Death|44|||
131675733|NCT01966471|474097707|FG001|Overall Study|Death|56|||
131675734|NCT01966471|474097706|FG000|Overall Study|Lost to Follow-up|46|||
131675735|NCT01966471|474097707|FG001|Overall Study|Lost to Follow-up|39|||
131675736|NCT01966471|474097706|FG000|Overall Study|Various reasons|4|||
131675737|NCT01966471|474097707|FG001|Overall Study|Various reasons|4|||
131675738|NCT01966471|474097706|FG000|Overall Study|Physician Decision|7|||
131675739|NCT01966471|474097707|FG001|Overall Study|Physician Decision|5|||
131675740|NCT01966471|474097706|FG000|Overall Study|Study Terminated By Sponsor|758|||
131675741|NCT01966471|474097707|FG001|Overall Study|Study Terminated By Sponsor|773|||
131675742|NCT01966471|474097706|FG000|Overall Study|Withdrawal by Subject|59|||
131675743|NCT01966471|474097707|FG001|Overall Study|Withdrawal by Subject|51|||
131675744|NCT00593957|474097708|FG000|Overall Study|Physician Decision|0|||
131675745|NCT00593957|474097709|FG001|Overall Study|Physician Decision|1|||
131675746|NCT00593957|474097710|FG002|Overall Study|Physician Decision|2|||
131675747|NCT01030198|474097711|FG000|Overall Study|Could not measure efficacy accurately|0|||
131675748|NCT01030198|474097712|FG001|Overall Study|Could not measure efficacy accurately|7|||
131675749|NCT02370043|474097713|FG000|Overall Study|Withdrawal by Subject|0|||
131675750|NCT02370043|474097714|FG001|Overall Study|Withdrawal by Subject|0|||
131675751|NCT02370043|474097715|FG002|Overall Study|Withdrawal by Subject|0|||
131675752|NCT02370043|474097716|FG003|Overall Study|Withdrawal by Subject|0|||
131675753|NCT02370043|474097717|FG004|Overall Study|Withdrawal by Subject|1|||
131675754|NCT02370043|474097718|FG005|Overall Study|Withdrawal by Subject|1|||
131675755|NCT01163721|474097719|FG000|Overall Study|Adverse Event|5|||
131675756|NCT01163721|474097720|FG001|Overall Study|Adverse Event|6|||
131675757|NCT01163721|474097719|FG000|Overall Study|Withdrawal by Subject|3|||
131675758|NCT01163721|474097720|FG001|Overall Study|Withdrawal by Subject|4|||
131675759|NCT01163721|474097719|FG000|Overall Study|Lost to Follow-up|0|||
131675760|NCT01163721|474097720|FG001|Overall Study|Lost to Follow-up|1|||
131675761|NCT01163721|474097719|FG000|Overall Study|Physician Decision|0|||
131675762|NCT01163721|474097720|FG001|Overall Study|Physician Decision|1|||
131675763|NCT00688181|474097721|FG000|Overall Study|Lost to Follow-up|17|||
131675764|NCT00688181|474097721|FG000|Overall Study|Unknown Reason|4|||
131675765|NCT00688181|474097721|FG000|Overall Study|Non-clinical Reason|2|||
131675766|NCT01050205|474097722|FG000|Overall Study|Lost to Follow-up|7|||
131675767|NCT01050205|474097723|FG001|Overall Study|Lost to Follow-up|1|||
131675768|NCT01050205|474097722|FG000|Overall Study|Withdrawal by Subject|1|||
131675769|NCT01050205|474097723|FG001|Overall Study|Withdrawal by Subject|1|||
131675770|NCT01050205|474097722|FG000|Overall Study|Relocated from area|1|||
131675771|NCT01050205|474097723|FG001|Overall Study|Relocated from area|2|||
131675772|NCT01050205|474097722|FG000|Overall Study|Discontinued Intervention|2|||
131675773|NCT01050205|474097723|FG001|Overall Study|Discontinued Intervention|0|||
131675774|NCT01295281|474097724|FG000|First Intervention (7 Days)|Death|0|||
131675775|NCT01295281|474097725|FG001|First Intervention (7 Days)|Death|1|||
131675776|NCT01119001|474097729|FG000|Overall Study|Withdrawal by Subject|2|||
131675777|NCT00954421|474097730|FG000|Screening|screen failures|3|||
131675778|NCT00954421|474097730|FG000|6 Months of DBS|Withdrawal by Subject|1|||
131675779|NCT00954421|474097730|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
131675780|NCT00777946|474097731|FG000|Overall Study|Adverse Event|11|||
131675781|NCT00777946|474097732|FG001|Overall Study|Adverse Event|1|||
131675782|NCT00777946|474097733|FG002|Overall Study|Adverse Event|3|||
131675783|NCT00777946|474097731|FG000|Overall Study|Lack of Efficacy|0|||
131675784|NCT00777946|474097732|FG001|Overall Study|Lack of Efficacy|0|||
131675785|NCT00777946|474097733|FG002|Overall Study|Lack of Efficacy|9|||
131675786|NCT00777946|474097731|FG000|Overall Study|Condition no longer required study drug|1|||
131675787|NCT00777946|474097732|FG001|Overall Study|Condition no longer required study drug|0|||
131675788|NCT00777946|474097733|FG002|Overall Study|Condition no longer required study drug|0|||
131555445|NCT03029780|473658211|FG000|Overall Study|Disease Progression|20|||
131675789|NCT00777946|474097731|FG000|Overall Study|Patient withdrew consent|3|||
131675790|NCT00777946|474097732|FG001|Overall Study|Patient withdrew consent|2|||
131675791|NCT00777946|474097733|FG002|Overall Study|Patient withdrew consent|3|||
131675792|NCT00777946|474097731|FG000|Overall Study|Lost to Follow-up|3|||
131675793|NCT00777946|474097732|FG001|Overall Study|Lost to Follow-up|1|||
131675794|NCT00777946|474097733|FG002|Overall Study|Lost to Follow-up|0|||
131675795|NCT00777946|474097731|FG000|Overall Study|Protocol deviation|2|||
131675796|NCT00777946|474097732|FG001|Overall Study|Protocol deviation|1|||
131675797|NCT00777946|474097733|FG002|Overall Study|Protocol deviation|1|||
131772483|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
131772484|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
131772485|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
131772486|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
131772487|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Disease Progression|1|||
131772488|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Disease Progression|0|||
131772489|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
131772490|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
131772491|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
131772492|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
131772493|NCT04419558|474445078|FG000|DB Period (48 Weeks)|Participant Decision|4|||
131772494|NCT04419558|474445079|FG001|DB Period (48 Weeks)|Participant Decision|3|||
131675798|NCT00777946|474097731|FG000|Overall Study|Randomized in error|1|||
131675799|NCT00777946|474097732|FG001|Overall Study|Randomized in error|1|||
131675800|NCT00777946|474097733|FG002|Overall Study|Randomized in error|0|||
131675801|NCT01853982|474097734|FG000|Overall Study|Withdrawal by Subject|1|||
131675802|NCT01853982|474097735|FG001|Overall Study|Withdrawal by Subject|0|||
131675803|NCT01853982|474097734|FG000|Overall Study|Death|1|||
131675804|NCT01853982|474097735|FG001|Overall Study|Death|0|||
131675805|NCT01853982|474097734|FG000|Overall Study|Lost to Follow-up|0|||
131772495|NCT04419558|474445078|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
131675806|NCT01853982|474097735|FG001|Overall Study|Lost to Follow-up|1|||
131772496|NCT04419558|474445079|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
131772497|NCT04419558|474445078|FG000|OLE Period (48 Weeks)|Death|4|||
131772498|NCT04419558|474445079|FG001|OLE Period (48 Weeks)|Death|6|||
131675807|NCT05066724|474097738|FG000|Overall Study|Adverse Event|1|||
131675808|NCT05066724|474097738|FG000|Overall Study|Non-Compliance With Study Drug|5|||
131675809|NCT05066724|474097738|FG000|Overall Study|Withdrawal by Subject|6|||
131675810|NCT05066724|474097738|FG000|Overall Study|Physician Decision|2|||
131675811|NCT00475033|474097741|FG000|Infant Series|Failed to return|3|||
131675812|NCT00475033|474097742|FG001|Infant Series|Failed to return|4|||
131675813|NCT00475033|474097741|FG000|Infant Series|Parent or legal guardian request|1|||
131675814|NCT00475033|474097742|FG001|Infant Series|Parent or legal guardian request|5|||
131675815|NCT00475033|474097741|FG000|Infant Series|Protocol Violation|1|||
131675816|NCT00475033|474097742|FG001|Infant Series|Protocol Violation|2|||
131675817|NCT00475033|474097741|FG000|Infant Series|Lost to Follow-up|2|||
131675818|NCT00475033|474097742|FG001|Infant Series|Lost to Follow-up|0|||
131675819|NCT00475033|474097741|FG000|Infant Series|Adverse Event|0|||
131772499|NCT04419558|474445078|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
131772500|NCT04419558|474445079|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
131772501|NCT04419558|474445078|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
131772502|NCT04419558|474445079|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
131772503|NCT00903357|474445080|FG000|First Intervention|Withdrawal by Subject|5|||
131675820|NCT00475033|474097742|FG001|Infant Series|Adverse Event|2|||
131675821|NCT00475033|474097741|FG000|After the Infant Series|Adverse Event|0|||
131772504|NCT00903357|474445081|FG001|First Intervention|Withdrawal by Subject|3|||
131772505|NCT00903357|474445080|FG000|First Intervention|Flu|0|||
131772506|NCT00903357|474445081|FG001|First Intervention|Flu|1|||
131772507|NCT00903357|474445080|FG000|Wash Out Period of 2 Weeks|Flu|0|||
131772508|NCT00903357|474445081|FG001|Wash Out Period of 2 Weeks|Flu|1|||
131772509|NCT00903357|474445080|FG000|Second Intervention|Lost to Follow-up|1|||
131772510|NCT00903357|474445081|FG001|Second Intervention|Lost to Follow-up|0|||
131772511|NCT05146999|474445082|FG000|Overall Study|Withdrew consent|6|||
131772512|NCT05146999|474445083|FG001|Overall Study|Withdrew consent|1|||
131772513|NCT05146999|474445082|FG000|Overall Study|Lost to Follow-up|3|||
131772514|NCT05146999|474445083|FG001|Overall Study|Lost to Follow-up|2|||
131772515|NCT05146999|474445082|FG000|Overall Study|Other|1|||
131772516|NCT05146999|474445083|FG001|Overall Study|Other|3|||
131675822|NCT00475033|474097742|FG001|After the Infant Series|Adverse Event|4|||
131675823|NCT00475033|474097741|FG000|After the Infant Series|Parent or legal guardian request|2|||
131675824|NCT00475033|474097742|FG001|After the Infant Series|Parent or legal guardian request|2|||
131675825|NCT00475033|474097741|FG000|After the Infant Series|Failed to return|2|||
131675826|NCT00475033|474097742|FG001|After the Infant Series|Failed to return|1|||
131772517|NCT02221882|474445084|FG000|Overall Study|Withdrawal by Subject|0|||
131772518|NCT02221882|474445085|FG001|Overall Study|Withdrawal by Subject|0|||
131772519|NCT02221882|474445086|FG002|Overall Study|Withdrawal by Subject|4|||
131772520|NCT02221882|474445087|FG003|Overall Study|Withdrawal by Subject|2|||
131772521|NCT02221882|474445088|FG004|Overall Study|Withdrawal by Subject|2|||
131772522|NCT02221882|474445089|FG005|Overall Study|Withdrawal by Subject|2|||
131772523|NCT02221882|474445084|FG000|Overall Study|Death|0|||
131772524|NCT02221882|474445085|FG001|Overall Study|Death|1|||
131675827|NCT00475033|474097741|FG000|After the Infant Series|Protocol Violation|1|||
131772525|NCT02221882|474445086|FG002|Overall Study|Death|0|||
131772526|NCT02221882|474445087|FG003|Overall Study|Death|0|||
131772527|NCT02221882|474445088|FG004|Overall Study|Death|0|||
131675828|NCT00475033|474097742|FG001|After the Infant Series|Protocol Violation|0|||
131772528|NCT02221882|474445089|FG005|Overall Study|Death|0|||
131772529|NCT05664672|474445090|FG000|Overall Study|Adverse Event|0|||
131772530|NCT05664672|474445091|FG001|Overall Study|Adverse Event|0|||
131675829|NCT00475033|474097741|FG000|After the Infant Series|Lost to Follow-up|1|||
131675830|NCT00475033|474097742|FG001|After the Infant Series|Lost to Follow-up|0|||
131675831|NCT00475033|474097741|FG000|After the Infant Series|Other|0|||
131675832|NCT00475033|474097742|FG001|After the Infant Series|Other|1|||
131675833|NCT00475033|474097741|FG000|Toddler Dose|Parent or legal guardian request|2|||
131675834|NCT00475033|474097742|FG001|Toddler Dose|Parent or legal guardian request|0|||
131675835|NCT00475033|474097741|FG000|Toddler Dose|Failed to return|1|||
131675836|NCT00475033|474097742|FG001|Toddler Dose|Failed to return|0|||
131675837|NCT00475033|474097741|FG000|Toddler Dose|Lost to Follow-up|1|||
131675838|NCT00475033|474097742|FG001|Toddler Dose|Lost to Follow-up|0|||
131675839|NCT03444324|474097744|FG000|Overall Study|Withdrawal by Subject|0|||
131675840|NCT03444324|474097745|FG001|Overall Study|Withdrawal by Subject|1|||
131772531|NCT05664672|474445092|FG002|Overall Study|Adverse Event|0|||
131772532|NCT05664672|474445093|FG003|Overall Study|Adverse Event|0|||
131772533|NCT05664672|474445094|FG004|Overall Study|Adverse Event|0|||
131772534|NCT05664672|474445095|FG005|Overall Study|Adverse Event|1|||
131772535|NCT05664672|474445090|FG000|Overall Study|Withdrawal by Subject|0|||
131772536|NCT05664672|474445091|FG001|Overall Study|Withdrawal by Subject|1|||
131772537|NCT05664672|474445092|FG002|Overall Study|Withdrawal by Subject|3|||
131772538|NCT05664672|474445093|FG003|Overall Study|Withdrawal by Subject|0|||
131772539|NCT05664672|474445094|FG004|Overall Study|Withdrawal by Subject|5|||
131772540|NCT05664672|474445095|FG005|Overall Study|Withdrawal by Subject|6|||
131772541|NCT05664672|474445090|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
131772542|NCT05664672|474445091|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131772543|NCT05664672|474445092|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
131772544|NCT05664672|474445093|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
131772545|NCT05664672|474445094|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
131772546|NCT05664672|474445095|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
131772547|NCT05664672|474445090|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
131675841|NCT03444324|474097744|FG000|Overall Study|Lost to Follow-up|4|||
131675842|NCT03444324|474097745|FG001|Overall Study|Lost to Follow-up|2|||
131675843|NCT03444324|474097744|FG000|Overall Study|Protocol Violation|0|||
131772548|NCT05664672|474445091|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131772549|NCT05664672|474445092|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131772550|NCT05664672|474445093|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131772551|NCT05664672|474445094|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131772552|NCT05664672|474445095|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131772553|NCT04236986|474445100|FG000|Overall Study|Withdrawal by Subject|3|||
131772554|NCT04236986|474445101|FG001|Overall Study|Withdrawal by Subject|1|||
131772555|NCT04034225|474445102|FG000|Overall Study|Death|3|||
131772556|NCT04034225|474445102|FG000|Overall Study|Withdrawal by Subject|2|||
131772557|NCT04034225|474445102|FG000|Overall Study|Study termination by Sponsor|18|||
131772558|NCT04034225|474445102|FG000|Overall Study|Physician Decision|1|||
131772559|NCT04034225|474445102|FG000|Overall Study|Lack of Efficacy|1|||
131772560|NCT01365182|474445103|FG000|Overall Study|Withdrawal by Subject|10|||
131772561|NCT01365182|474445104|FG001|Overall Study|Withdrawal by Subject|13|||
131772562|NCT01365182|474445105|FG002|Overall Study|Withdrawal by Subject|12|||
131772563|NCT02129192|474445112|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
131772564|NCT02129192|474445113|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
131772565|NCT01231620|474445114|FG000|Overall Study|Physician Decision|3|||
131772566|NCT01231620|474445115|FG001|Overall Study|Physician Decision|5|||
131772567|NCT01231620|474445116|FG002|Overall Study|Physician Decision|10|||
131772568|NCT01231620|474445114|FG000|Overall Study|Death|12|||
131675844|NCT03444324|474097745|FG001|Overall Study|Protocol Violation|1|||
131675845|NCT03444324|474097744|FG000|Overall Study|Lack of Trial Compliance|1|||
131675846|NCT03444324|474097745|FG001|Overall Study|Lack of Trial Compliance|1|||
131675847|NCT03444324|474097744|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
131675848|NCT03444324|474097745|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
131675849|NCT06515483|474097748|FG000|Overall Study|Subject withdraw due to family issues|1|||
131675850|NCT06515483|474097749|FG001|Overall Study|Subject withdraw due to family issues|0|||
131675851|NCT00146328|474099168|FG000|Overall Study|Adverse Event|39|||
131675852|NCT00146328|474099169|FG001|Overall Study|Adverse Event|48|||
131675853|NCT00146328|474099170|FG002|Overall Study|Adverse Event|79|||
131675854|NCT00146328|474099168|FG000|Overall Study|Protocol Violation|11|||
131675855|NCT00146328|474099169|FG001|Overall Study|Protocol Violation|6|||
131675856|NCT00146328|474099170|FG002|Overall Study|Protocol Violation|12|||
131675857|NCT00146328|474099168|FG000|Overall Study|Lost to Follow-up|7|||
131675858|NCT00146328|474099169|FG001|Overall Study|Lost to Follow-up|4|||
131675859|NCT00146328|474099170|FG002|Overall Study|Lost to Follow-up|7|||
131675860|NCT00146328|474099168|FG000|Overall Study|Withdrawal by Subject|16|||
131675861|NCT00146328|474099169|FG001|Overall Study|Withdrawal by Subject|16|||
131675862|NCT00146328|474099170|FG002|Overall Study|Withdrawal by Subject|22|||
131675863|NCT00146328|474099168|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
131675864|NCT00146328|474099169|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
131675865|NCT00146328|474099170|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
131675866|NCT00146328|474099168|FG000|Overall Study|Trial ended/site closed|8|||
131675867|NCT00146328|474099169|FG001|Overall Study|Trial ended/site closed|2|||
131675868|NCT00146328|474099170|FG002|Overall Study|Trial ended/site closed|19|||
131675869|NCT00146328|474099168|FG000|Overall Study|Patient decision to end|0|||
131675870|NCT00146328|474099169|FG001|Overall Study|Patient decision to end|1|||
131675871|NCT00146328|474099170|FG002|Overall Study|Patient decision to end|6|||
131675872|NCT00146328|474099168|FG000|Overall Study|Enroll into other trial|2|||
131675873|NCT00146328|474099169|FG001|Overall Study|Enroll into other trial|4|||
131675874|NCT00146328|474099170|FG002|Overall Study|Enroll into other trial|2|||
131675875|NCT00146328|474099168|FG000|Overall Study|Death|0|||
131675876|NCT00146328|474099169|FG001|Overall Study|Death|1|||
131675877|NCT00146328|474099170|FG002|Overall Study|Death|1|||
131675878|NCT00146328|474099168|FG000|Overall Study|Moved|2|||
131675879|NCT00146328|474099169|FG001|Overall Study|Moved|0|||
131675880|NCT00146328|474099170|FG002|Overall Study|Moved|0|||
131675881|NCT00146328|474099168|FG000|Overall Study|Interaction with other medication|2|||
131675882|NCT00146328|474099169|FG001|Overall Study|Interaction with other medication|0|||
131675883|NCT00146328|474099170|FG002|Overall Study|Interaction with other medication|1|||
131675884|NCT00300781|474099171|FG000|Overall Study|Disease Progression|55|||
131675885|NCT00300781|474099172|FG001|Overall Study|Disease Progression|52|||
131675886|NCT00300781|474099171|FG000|Overall Study|Adverse Event|5|||
131675887|NCT00300781|474099172|FG001|Overall Study|Adverse Event|6|||
131675888|NCT00300781|474099171|FG000|Overall Study|Withdrawal by Subject|1|||
131675889|NCT00300781|474099172|FG001|Overall Study|Withdrawal by Subject|2|||
131675890|NCT00300781|474099171|FG000|Overall Study|Physician Decision|1|||
131675891|NCT00300781|474099172|FG001|Overall Study|Physician Decision|0|||
131675892|NCT00300781|474099171|FG000|Overall Study|Not Recorded|0|||
131675893|NCT00300781|474099172|FG001|Overall Study|Not Recorded|1|||
131675894|NCT00300781|474099171|FG000|Overall Study|Symptomatic Deterioration|1|||
131675895|NCT00300781|474099172|FG001|Overall Study|Symptomatic Deterioration|0|||
131675896|NCT00300781|474099171|FG000|Overall Study|Lost to Follow-up|0|||
131675897|NCT00300781|474099172|FG001|Overall Study|Lost to Follow-up|1|||
131675898|NCT00568321|474099178|FG000|Overall Study|Adverse Event|1|||
131675899|NCT00568321|474099179|FG001|Overall Study|Adverse Event|0|||
131675900|NCT00568321|474099180|FG002|Overall Study|Adverse Event|0|||
131675901|NCT00568321|474099178|FG000|Overall Study|Lack of Efficacy|8|||
131675902|NCT00568321|474099179|FG001|Overall Study|Lack of Efficacy|5|||
131675903|NCT00568321|474099180|FG002|Overall Study|Lack of Efficacy|6|||
131675904|NCT00568321|474099178|FG000|Overall Study|Lost to Follow-up|0|||
131675905|NCT00568321|474099179|FG001|Overall Study|Lost to Follow-up|0|||
131675906|NCT00568321|474099180|FG002|Overall Study|Lost to Follow-up|1|||
131675907|NCT00568321|474099178|FG000|Overall Study|Withdrawal by Subject|2|||
131675908|NCT00568321|474099179|FG001|Overall Study|Withdrawal by Subject|0|||
131675909|NCT00568321|474099180|FG002|Overall Study|Withdrawal by Subject|0|||
131675910|NCT00568321|474099178|FG000|Overall Study|Protocol Violation|0|||
131675911|NCT00568321|474099179|FG001|Overall Study|Protocol Violation|0|||
131675912|NCT00568321|474099180|FG002|Overall Study|Protocol Violation|1|||
131675913|NCT00568321|474099178|FG000|Overall Study|Randomized, not treated|2|||
131675914|NCT00568321|474099179|FG001|Overall Study|Randomized, not treated|0|||
131675915|NCT00568321|474099180|FG002|Overall Study|Randomized, not treated|1|||
131675916|NCT01676909|474099181|FG000|Overall Study|Withdrawal by Subject|3|||
131675917|NCT01676909|474099182|FG001|Overall Study|Withdrawal by Subject|5|||
131675918|NCT01676909|474099181|FG000|Overall Study|Lost to Follow-up|15|||
131675919|NCT01676909|474099182|FG001|Overall Study|Lost to Follow-up|9|||
131675920|NCT01180998|474099184|FG000|Overall Study|Poor Vision|0|||
131675921|NCT01180998|474099185|FG001|Overall Study|Poor Vision|2|||
131675922|NCT01180998|474099186|FG002|Overall Study|Poor Vision|2|||
131675923|NCT01180998|474099184|FG000|Overall Study|Lost to Follow-up|0|||
131675924|NCT01180998|474099185|FG001|Overall Study|Lost to Follow-up|0|||
131675925|NCT01180998|474099186|FG002|Overall Study|Lost to Follow-up|1|||
131675926|NCT01180998|474099184|FG000|Overall Study|Protocol Violation|1|||
131675927|NCT01180998|474099185|FG001|Overall Study|Protocol Violation|2|||
131675928|NCT01180998|474099186|FG002|Overall Study|Protocol Violation|0|||
131675929|NCT01180998|474099184|FG000|Overall Study|Withdrawal by Subject|0|||
131675930|NCT01180998|474099185|FG001|Overall Study|Withdrawal by Subject|0|||
131675931|NCT01180998|474099186|FG002|Overall Study|Withdrawal by Subject|1|||
131675932|NCT01180998|474099184|FG000|Overall Study|Poor comfort|3|||
131675933|NCT01180998|474099185|FG001|Overall Study|Poor comfort|0|||
131675934|NCT01180998|474099186|FG002|Overall Study|Poor comfort|4|||
131675935|NCT01180998|474099184|FG000|Overall Study|Poor lens handling|0|||
131675936|NCT01180998|474099185|FG001|Overall Study|Poor lens handling|0|||
131675937|NCT01180998|474099186|FG002|Overall Study|Poor lens handling|2|||
131675938|NCT01376349|474099187|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
131675939|NCT01376349|474099188|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
131555446|NCT03029780|473658212|FG001|Overall Study|Disease Progression|22|||
131555447|NCT03029780|473658211|FG000|Overall Study|Study Drug Toxicity|15|||
131555448|NCT03029780|473658212|FG001|Overall Study|Study Drug Toxicity|11|||
131555449|NCT03029780|473658211|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
131555450|NCT03029780|473658212|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
131675940|NCT01376349|474099189|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
131675941|NCT01376349|474099187|FG000|Raondomized Treatment|Adverse Event|13|||
131675942|NCT01376349|474099188|FG001|Raondomized Treatment|Adverse Event|17|||
131555451|NCT03029780|473658211|FG000|Overall Study|Participant request to discontinue study treatment|4|||
131555452|NCT03029780|473658212|FG001|Overall Study|Participant request to discontinue study treatment|1|||
131675943|NCT01376349|474099189|FG002|Raondomized Treatment|Adverse Event|14|||
131675944|NCT01376349|474099187|FG000|Raondomized Treatment|Unkown|1|||
131675945|NCT01376349|474099188|FG001|Raondomized Treatment|Unkown|2|||
131675946|NCT01376349|474099189|FG002|Raondomized Treatment|Unkown|1|||
131675947|NCT01376349|474099187|FG000|Raondomized Treatment|Alternative Treatment|0|||
131675948|NCT01376349|474099188|FG001|Raondomized Treatment|Alternative Treatment|0|||
131675949|NCT01376349|474099189|FG002|Raondomized Treatment|Alternative Treatment|1|||
131675950|NCT00162032|474099190|FG000|Overall Study|Lost to Follow-up|4|||
131675951|NCT00162032|474099191|FG001|Overall Study|Lost to Follow-up|2|||
131675952|NCT00162032|474099190|FG000|Overall Study|Reason not specified|1|||
131675953|NCT00162032|474099191|FG001|Overall Study|Reason not specified|0|||
131555453|NCT03029780|473658211|FG000|Overall Study|Maximum clinical benefit|1|||
131555454|NCT03029780|473658212|FG001|Overall Study|Maximum clinical benefit|0|||
131555455|NCT03029780|473658211|FG000|Overall Study|Participant no longer meets study criteria|0|||
131555456|NCT03029780|473658212|FG001|Overall Study|Participant no longer meets study criteria|1|||
131555457|NCT03029780|473658211|FG000|Overall Study|Other reasons|6|||
131555458|NCT03029780|473658212|FG001|Overall Study|Other reasons|6|||
131555459|NCT03029780|473658211|FG000|Overall Study|Not reported|1|||
131555460|NCT03029780|473658212|FG001|Overall Study|Not reported|1|||
131555461|NCT03029780|473658211|FG000|Overall Study|Death|2|||
131555462|NCT03029780|473658212|FG001|Overall Study|Death|6|||
131555463|NCT03066622|473658213|FG000|Overall Study|Lost to Follow-up|24|||
131555464|NCT03066622|473658214|FG001|Overall Study|Lost to Follow-up|25|||
131555465|NCT03066622|473658213|FG000|Overall Study|Withdrawal by Subject|2|||
131555466|NCT03066622|473658214|FG001|Overall Study|Withdrawal by Subject|1|||
131555467|NCT01111838|473658215|FG000|Overall Study|Patient Ineligible|2|||
131555468|NCT01111838|473658215|FG000|Overall Study|Not Treated|3|||
131555469|NCT01111838|473658215|FG000|Overall Study|Clinical deterioration|1|||
131675954|NCT01176968|474099192|FG000|Overall Study|Adverse Event|10|||
131675955|NCT01176968|474099193|FG001|Overall Study|Adverse Event|11|||
131675956|NCT01176968|474099192|FG000|Overall Study|Death|2|||
131675957|NCT01176968|474099193|FG001|Overall Study|Death|3|||
131675958|NCT01176968|474099192|FG000|Overall Study|Lack of Efficacy|0|||
131675959|NCT01176968|474099193|FG001|Overall Study|Lack of Efficacy|1|||
131675960|NCT01176968|474099192|FG000|Overall Study|Lost to Follow-up|16|||
131675961|NCT01176968|474099193|FG001|Overall Study|Lost to Follow-up|14|||
131675962|NCT01176968|474099192|FG000|Overall Study|Withdrawal by Subject|48|||
131675963|NCT01176968|474099193|FG001|Overall Study|Withdrawal by Subject|48|||
131675964|NCT01176968|474099192|FG000|Overall Study|Protocol Violation|2|||
131675965|NCT01176968|474099193|FG001|Overall Study|Protocol Violation|1|||
131675966|NCT01176968|474099192|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131675967|NCT01176968|474099193|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
131675968|NCT01176968|474099192|FG000|Overall Study|Study terminated by sponsor|0|||
131675969|NCT01176968|474099193|FG001|Overall Study|Study terminated by sponsor|1|||
131675970|NCT01176968|474099192|FG000|Overall Study|Reason not defined|5|||
131675971|NCT01176968|474099193|FG001|Overall Study|Reason not defined|3|||
131675972|NCT00833911|474099194|FG000|Titration|Adverse Event|18|||
131675973|NCT00833911|474099194|FG000|Titration|Withdrawal by Subject|3|||
131675974|NCT00833911|474099194|FG000|Maintenance Phase I|Adverse Event|73|||
131675975|NCT00833911|474099194|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
131675976|NCT00833911|474099194|FG000|Maintenance Phase I|Physician Decision|10|||
131675977|NCT00833911|474099194|FG000|Maintenance Phase I|Lack of Efficacy|4|||
131675978|NCT00833911|474099194|FG000|Maintenance Phase II|Adverse Event|6|||
131675979|NCT00833911|474099194|FG000|Maintenance Phase II|Physician Decision|2|||
131675980|NCT00833911|474099194|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
131675981|NCT00833911|474099194|FG000|Maintenance Phase II|Lack of Efficacy|1|||
131675982|NCT00718640|474099195|FG000|Overall Study|Adverse Event|4|||
131675983|NCT00718640|474099195|FG000|Overall Study|Death|1|||
131675984|NCT00718640|474099195|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
131675985|NCT01137955|474099198|FG000|Overall Study|Withdrawal by Subject|5|||
131675986|NCT01137955|474099199|FG001|Overall Study|Withdrawal by Subject|4|||
131675987|NCT01207596|474099200|FG000|Overall Study|Physician Decision|4|||
131675988|NCT01207596|474099200|FG000|Overall Study|Lack of Efficacy|1|||
131555470|NCT01111838|473658215|FG000|Overall Study|Other Complicating Disease|1|||
131675989|NCT01207596|474099200|FG000|Overall Study|Adverse Event|3|||
131675990|NCT01207596|474099200|FG000|Overall Study|Withdrawal by Subject|1|||
131675991|NCT00216203|474099201|FG000|Overall Study|Withdrawal by Subject|2|||
131675992|NCT04098068|474099202|FG000|Overall Study|Disease Progression|7|||
131675993|NCT04098068|474099202|FG000|Overall Study|Withdrawal by Subject|2|||
131675994|NCT04098068|474099202|FG000|Overall Study|New Cancer Diagnosis|1|||
131675995|NCT03871829|474099203|FG000|Overall Study|Lost to Follow-up|0|||
131675996|NCT03871829|474099204|FG001|Overall Study|Lost to Follow-up|1|||
131675997|NCT03871829|474099203|FG000|Overall Study|Withdrawal by Subject|1|||
131555471|NCT00641719|473658216|FG000|Overall Study|Lack of Efficacy|1|||
131555472|NCT00641719|473658217|FG001|Overall Study|Lack of Efficacy|2|||
131555473|NCT00641719|473658216|FG000|Overall Study|Adverse Event|24|||
131555474|NCT00641719|473658217|FG001|Overall Study|Adverse Event|29|||
131675998|NCT03871829|474099204|FG001|Overall Study|Withdrawal by Subject|1|||
131675999|NCT03871829|474099203|FG000|Overall Study|Death|12|||
131676000|NCT03871829|474099204|FG001|Overall Study|Death|8|||
131676001|NCT03871829|474099203|FG000|Overall Study|Study terminated by sponsor|31|||
131676002|NCT03871829|474099204|FG001|Overall Study|Study terminated by sponsor|34|||
131676003|NCT01106014|474099205|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
131676004|NCT01106014|474099206|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
131676005|NCT01106014|474099205|FG000|Overall Study|Adverse Event|78|||
131676006|NCT01106014|474099206|FG001|Overall Study|Adverse Event|42|||
131676007|NCT01106014|474099205|FG000|Overall Study|Withdrawal by Subject|43|||
131676008|NCT01106014|474099206|FG001|Overall Study|Withdrawal by Subject|37|||
131676009|NCT01106014|474099205|FG000|Overall Study|Administrative reason|7|||
131676010|NCT01106014|474099206|FG001|Overall Study|Administrative reason|6|||
131676011|NCT01106014|474099205|FG000|Overall Study|Lost to Follow-up|2|||
131676012|NCT01106014|474099206|FG001|Overall Study|Lost to Follow-up|3|||
131676013|NCT05458479|474099211|FG000|Overall Study|Lost to Follow-up|1|||
131676014|NCT04209621|474099219|FG000|Overall Study|Death|1|||
131676015|NCT04209621|474099219|FG000|Overall Study|Study Terminated Early|2|||
131676016|NCT02030405|474099227|FG000|Overall Study|Withdrawal by Subject|1|||
131676017|NCT02030405|474099227|FG000|Overall Study|Lost to Follow-up|1|||
131555475|NCT00641719|473658216|FG000|Overall Study|Withdrawal by Subject|4|||
131555476|NCT00641719|473658217|FG001|Overall Study|Withdrawal by Subject|4|||
131676018|NCT00986440|474099228|FG000|Overall Study|Progressive disease|27|||
131676019|NCT00986440|474099229|FG001|Overall Study|Progressive disease|37|||
131676020|NCT00986440|474099228|FG000|Overall Study|Serious adverse event or adverse event|9|||
131676021|NCT00986440|474099229|FG001|Overall Study|Serious adverse event or adverse event|2|||
131676022|NCT00986440|474099228|FG000|Overall Study|Withdrawal by Subject|1|||
131676023|NCT00986440|474099229|FG001|Overall Study|Withdrawal by Subject|2|||
131676024|NCT00986440|474099228|FG000|Overall Study|Screen failure (not dosed)|4|||
131676025|NCT00986440|474099229|FG001|Overall Study|Screen failure (not dosed)|2|||
131676026|NCT00494481|474099233|FG000|Overall Study|Condition under investigation worsened|11|||
131676027|NCT00494481|474099234|FG001|Overall Study|Condition under investigation worsened|13|||
131676028|NCT00494481|474099233|FG000|Overall Study|Adverse Event|15|||
131676029|NCT00494481|474099234|FG001|Overall Study|Adverse Event|11|||
131676030|NCT00494481|474099233|FG000|Overall Study|Other|1|||
131676031|NCT00494481|474099234|FG001|Overall Study|Other|0|||
131676032|NCT00494481|474099233|FG000|Overall Study|Never received IP|2|||
131676033|NCT00494481|474099234|FG001|Overall Study|Never received IP|0|||
131676034|NCT02973048|474099235|FG000|Overall Study|Epidural catheter insertion failure|1|||
131676035|NCT02973048|474099236|FG001|Overall Study|Epidural catheter insertion failure|0|||
131676036|NCT02973048|474099235|FG000|Overall Study|Withdrawal by Subject|0|||
131676037|NCT02973048|474099236|FG001|Overall Study|Withdrawal by Subject|3|||
131676038|NCT00332189|474099237|FG000|Overall Study|Adverse Event|3|||
131676039|NCT00332189|474099237|FG000|Overall Study|Uncooperative/Noncompliant|3|||
131676040|NCT00332189|474099237|FG000|Overall Study|Withdrawal by Subject|9|||
131676041|NCT00332189|474099237|FG000|Overall Study|Lack of Efficacy|4|||
131676042|NCT00332189|474099237|FG000|Overall Study|Moved out of country|2|||
131676043|NCT02279862|474099239|FG000|Overall Study|Study drug toxicity|3|||
131676044|NCT02279862|474099240|FG001|Overall Study|Study drug toxicity|6|||
131676045|NCT02279862|474099239|FG000|Overall Study|No longer meets criteria|0|||
131897090|NCT01223404|474910360|FG005|First Intervention (1 Day)|Adverse Event|0|||
131897091|NCT01223404|474910355|FG000|Second Intervention (1 Day)|Adverse Event|1|||
131897092|NCT01223404|474910356|FG001|Second Intervention (1 Day)|Adverse Event|0|||
131897093|NCT01223404|474910357|FG002|Second Intervention (1 Day)|Adverse Event|0|||
131897094|NCT01223404|474910358|FG003|Second Intervention (1 Day)|Adverse Event|0|||
131897095|NCT01223404|474910359|FG004|Second Intervention (1 Day)|Adverse Event|0|||
131897096|NCT01223404|474910360|FG005|Second Intervention (1 Day)|Adverse Event|0|||
131897097|NCT01223404|474910355|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
131897098|NCT01223404|474910356|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
131897099|NCT01223404|474910357|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
131897100|NCT01223404|474910358|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
131897101|NCT01223404|474910359|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
131897102|NCT01223404|474910360|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
131897103|NCT00707057|474910361|FG000|Overall Study|Withdrawal by Subject|8|||
131897104|NCT00707057|474910362|FG001|Overall Study|Withdrawal by Subject|3|||
131897105|NCT00707057|474910361|FG000|Overall Study|Dosed incorrectly|0|||
131897106|NCT00707057|474910362|FG001|Overall Study|Dosed incorrectly|1|||
131897107|NCT00577772|474910368|FG000|Overall Study|Lost to Follow-up|0|||
131897108|NCT00577772|474910369|FG001|Overall Study|Lost to Follow-up|1|||
131897109|NCT00572455|474910370|FG000|Stage I (14 Days)|Adverse Event|0|||
131897110|NCT00572455|474910371|FG001|Stage I (14 Days)|Adverse Event|0|||
131897111|NCT00572455|474910372|FG002|Stage I (14 Days)|Adverse Event|0|||
131897112|NCT00572455|474910373|FG003|Stage I (14 Days)|Adverse Event|0|||
131897113|NCT00572455|474910374|FG004|Stage I (14 Days)|Adverse Event|0|||
131897114|NCT00572455|474910375|FG005|Stage I (14 Days)|Adverse Event|3|||
131897115|NCT00572455|474910376|FG006|Stage I (14 Days)|Adverse Event|0|||
131897116|NCT00572455|474910377|FG007|Stage I (14 Days)|Adverse Event|0|||
131897117|NCT00572455|474910378|FG008|Stage I (14 Days)|Adverse Event|0|||
131897118|NCT00572455|474910379|FG009|Stage I (14 Days)|Adverse Event|0|||
131897119|NCT00572455|474910380|FG010|Stage I (14 Days)|Adverse Event|0|||
131897120|NCT00572455|474910381|FG011|Stage I (14 Days)|Adverse Event|0|||
131897121|NCT00572455|474910382|FG012|Stage I (14 Days)|Adverse Event|0|||
131897122|NCT00572455|474910383|FG013|Stage I (14 Days)|Adverse Event|0|||
131897123|NCT00572455|474910370|FG000|Stage I (14 Days)|Other|0|||
131897124|NCT00572455|474910371|FG001|Stage I (14 Days)|Other|0|||
131897125|NCT00572455|474910372|FG002|Stage I (14 Days)|Other|0|||
131897126|NCT00572455|474910373|FG003|Stage I (14 Days)|Other|0|||
131897127|NCT00572455|474910374|FG004|Stage I (14 Days)|Other|1|||
131897128|NCT00572455|474910375|FG005|Stage I (14 Days)|Other|0|||
131897129|NCT00572455|474910376|FG006|Stage I (14 Days)|Other|0|||
131897130|NCT00572455|474910377|FG007|Stage I (14 Days)|Other|0|||
131897131|NCT00572455|474910378|FG008|Stage I (14 Days)|Other|0|||
131897132|NCT00572455|474910379|FG009|Stage I (14 Days)|Other|0|||
131897133|NCT00572455|474910380|FG010|Stage I (14 Days)|Other|0|||
131897134|NCT00572455|474910381|FG011|Stage I (14 Days)|Other|0|||
131897135|NCT00572455|474910382|FG012|Stage I (14 Days)|Other|0|||
131897136|NCT00572455|474910383|FG013|Stage I (14 Days)|Other|0|||
131897137|NCT00572455|474910370|FG000|Stage II (28 Days)|Adverse Event|0|||
131897138|NCT00572455|474910371|FG001|Stage II (28 Days)|Adverse Event|0|||
131897139|NCT00572455|474910372|FG002|Stage II (28 Days)|Adverse Event|0|||
131897140|NCT00572455|474910373|FG003|Stage II (28 Days)|Adverse Event|0|||
131897141|NCT00572455|474910374|FG004|Stage II (28 Days)|Adverse Event|0|||
131897142|NCT00572455|474910375|FG005|Stage II (28 Days)|Adverse Event|0|||
131897143|NCT00572455|474910376|FG006|Stage II (28 Days)|Adverse Event|0|||
131897144|NCT00572455|474910377|FG007|Stage II (28 Days)|Adverse Event|0|||
131897145|NCT00572455|474910378|FG008|Stage II (28 Days)|Adverse Event|1|||
131897146|NCT00572455|474910379|FG009|Stage II (28 Days)|Adverse Event|3|||
131676046|NCT02279862|474099240|FG001|Overall Study|No longer meets criteria|1|||
131676047|NCT02279862|474099239|FG000|Overall Study|Administrative reason by sponsor|0|||
131897147|NCT00572455|474910380|FG010|Stage II (28 Days)|Adverse Event|3|||
131897148|NCT00572455|474910381|FG011|Stage II (28 Days)|Adverse Event|4|||
131897149|NCT00572455|474910382|FG012|Stage II (28 Days)|Adverse Event|5|||
131897150|NCT00572455|474910383|FG013|Stage II (28 Days)|Adverse Event|1|||
131897151|NCT00572455|474910370|FG000|Stage II (28 Days)|Death|0|||
131897152|NCT00572455|474910371|FG001|Stage II (28 Days)|Death|0|||
131897153|NCT00572455|474910372|FG002|Stage II (28 Days)|Death|0|||
131897154|NCT00572455|474910373|FG003|Stage II (28 Days)|Death|0|||
131897155|NCT00572455|474910374|FG004|Stage II (28 Days)|Death|0|||
131897156|NCT00572455|474910375|FG005|Stage II (28 Days)|Death|0|||
131897157|NCT00572455|474910376|FG006|Stage II (28 Days)|Death|0|||
131897158|NCT00572455|474910377|FG007|Stage II (28 Days)|Death|0|||
131897159|NCT00572455|474910378|FG008|Stage II (28 Days)|Death|1|||
131897160|NCT00572455|474910379|FG009|Stage II (28 Days)|Death|0|||
131897161|NCT00572455|474910380|FG010|Stage II (28 Days)|Death|0|||
131897162|NCT00572455|474910381|FG011|Stage II (28 Days)|Death|0|||
131897163|NCT00572455|474910382|FG012|Stage II (28 Days)|Death|0|||
131897164|NCT00572455|474910383|FG013|Stage II (28 Days)|Death|0|||
131897165|NCT00572455|474910370|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
131897166|NCT00572455|474910371|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
131897167|NCT00572455|474910372|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
131897168|NCT00572455|474910373|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
131676048|NCT02279862|474099240|FG001|Overall Study|Administrative reason by sponsor|1|||
131676049|NCT02279862|474099239|FG000|Overall Study|Disease progression|5|||
131676050|NCT02279862|474099240|FG001|Overall Study|Disease progression|2|||
131676051|NCT02279862|474099239|FG000|Overall Study|Study closed by sponsor|16|||
131676052|NCT02279862|474099240|FG001|Overall Study|Study closed by sponsor|13|||
131676053|NCT02279862|474099239|FG000|Overall Study|Other|1|||
131676054|NCT02279862|474099240|FG001|Overall Study|Other|2|||
131676055|NCT02279862|474099239|FG000|Overall Study|Withdrawal by Subject|1|||
131676056|NCT02279862|474099240|FG001|Overall Study|Withdrawal by Subject|0|||
131676057|NCT03707925|474099242|FG000|Overall Study|Inevaluable|1|||
131676058|NCT03431857|474099244|FG000|Overall Study|Death|6|||
131676059|NCT03431857|474099244|FG000|Overall Study|Lost to Follow-up|41|||
131676060|NCT03431857|474099244|FG000|Overall Study|Adverse Event|6|||
131676061|NCT03431857|474099244|FG000|Overall Study|Withdrawal by Subject|1|||
131676062|NCT00651157|474099246|FG000|Overall Study|Death|1|||
131676063|NCT00651157|474099246|FG000|Overall Study|Protocol Violation|1|||
131676064|NCT01472380|474099250|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
131676065|NCT01472380|474099250|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
131676066|NCT02511678|474099251|FG000|Overall Study|Withdrawal by Subject|2|||
131676067|NCT02511678|474099251|FG000|Overall Study|Lost to Follow-up|4|||
131676068|NCT02511678|474099251|FG000|Overall Study|Death|19|||
131676069|NCT02511678|474099251|FG000|Overall Study|Adverse Event|1|||
131676070|NCT02511678|474099251|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
131676071|NCT02511678|474099251|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
131676072|NCT02511678|474099251|FG000|Overall Study|Required Radiofrequency Ablation|1|||
131676073|NCT02511678|474099251|FG000|Overall Study|Biopsy was Negative|1|||
131897169|NCT00572455|474910374|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
131676074|NCT02511678|474099251|FG000|Overall Study|Protocol Violation|1|||
131676075|NCT02511678|474099251|FG000|Overall Study|Received Radiation Treatment|1|||
131676076|NCT00292461|474099252|FG000|Overall Study|Adverse Event|4|||
131897170|NCT00572455|474910375|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
131676077|NCT00292461|474099253|FG001|Overall Study|Adverse Event|2|||
131676078|NCT00292461|474099252|FG000|Overall Study|Lack of Efficacy|1|||
131676079|NCT00292461|474099253|FG001|Overall Study|Lack of Efficacy|0|||
131555477|NCT00641719|473658216|FG000|Overall Study|Reason Not Specified|1|||
131555478|NCT00641719|473658217|FG001|Overall Study|Reason Not Specified|2|||
131772569|NCT01231620|474445115|FG001|Overall Study|Death|14|||
131555479|NCT03303469|473658218|FG000|Overall Study|Lost to Follow-up|2|||
131676080|NCT00292461|474099252|FG000|Overall Study|Withdrawal by Subject|0|||
131676081|NCT00292461|474099253|FG001|Overall Study|Withdrawal by Subject|1|||
131676082|NCT00292461|474099252|FG000|Overall Study|Protocol Violation|4|||
131676083|NCT00292461|474099253|FG001|Overall Study|Protocol Violation|3|||
131676084|NCT00292461|474099252|FG000|Overall Study|Lost to Follow-up|1|||
131897171|NCT00572455|474910376|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
131897172|NCT00572455|474910377|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
131897173|NCT00572455|474910378|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
131897174|NCT00572455|474910379|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
131897175|NCT00572455|474910380|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
131897176|NCT00572455|474910381|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
131897177|NCT00572455|474910382|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
131897178|NCT00572455|474910383|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
131897179|NCT00572455|474910370|FG000|Stage II (28 Days)|Other|0|||
131897180|NCT00572455|474910371|FG001|Stage II (28 Days)|Other|0|||
131897181|NCT00572455|474910372|FG002|Stage II (28 Days)|Other|0|||
131897182|NCT00572455|474910373|FG003|Stage II (28 Days)|Other|0|||
131897183|NCT00572455|474910374|FG004|Stage II (28 Days)|Other|0|||
131897184|NCT00572455|474910375|FG005|Stage II (28 Days)|Other|0|||
131897185|NCT00572455|474910376|FG006|Stage II (28 Days)|Other|0|||
131897186|NCT00572455|474910377|FG007|Stage II (28 Days)|Other|0|||
131897187|NCT00572455|474910378|FG008|Stage II (28 Days)|Other|1|||
131897188|NCT00572455|474910379|FG009|Stage II (28 Days)|Other|0|||
131897189|NCT00572455|474910380|FG010|Stage II (28 Days)|Other|0|||
131897190|NCT00572455|474910381|FG011|Stage II (28 Days)|Other|0|||
131897191|NCT00572455|474910382|FG012|Stage II (28 Days)|Other|0|||
131897192|NCT00572455|474910383|FG013|Stage II (28 Days)|Other|0|||
131897193|NCT00572455|474910370|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
131897194|NCT00572455|474910371|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
131897195|NCT00572455|474910372|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
131897196|NCT00572455|474910373|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
131897197|NCT00572455|474910374|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
131897198|NCT00572455|474910375|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
131897199|NCT00572455|474910376|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
131897200|NCT00572455|474910377|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
131897201|NCT00572455|474910378|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
131897202|NCT00572455|474910379|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
131897203|NCT00572455|474910380|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
131897204|NCT00572455|474910381|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
131897205|NCT00572455|474910382|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
131897206|NCT00572455|474910383|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
131897207|NCT02821416|474910386|FG000|Overall Study|Adverse Event|0|||
131897208|NCT02821416|474910387|FG001|Overall Study|Adverse Event|1|||
131897209|NCT02821416|474910386|FG000|Overall Study|Withdrawal by Subject|2|||
131897210|NCT02821416|474910387|FG001|Overall Study|Withdrawal by Subject|0|||
131897211|NCT02821416|474910386|FG000|Overall Study|Lost to Follow-up|1|||
131897212|NCT02821416|474910387|FG001|Overall Study|Lost to Follow-up|0|||
131897213|NCT04152083|474910388|FG000|Overall Study|Lost to Follow-up|2|||
131897214|NCT04152083|474910389|FG001|Overall Study|Lost to Follow-up|1|||
131897215|NCT04152083|474910388|FG000|Overall Study|Adverse Event|1|||
131897216|NCT04152083|474910389|FG001|Overall Study|Adverse Event|0|||
131897217|NCT04152083|474910388|FG000|Overall Study|Randomized but not treated|3|||
131897218|NCT04152083|474910389|FG001|Overall Study|Randomized but not treated|2|||
131897219|NCT00856999|474910390|FG000|Overall Study|Withdrawal by Subject|5|||
131897220|NCT00872521|474910391|FG000|Completed PAD Induction|Patient choice|0|||
131897221|NCT00872521|474910392|FG001|Completed PAD Induction|Patient choice|1|||
131897222|NCT00872521|474910393|FG002|Completed PAD Induction|Patient choice|0|||
131897223|NCT00872521|474910391|FG000|Completed PAD Induction|Disease progression|0|||
131897224|NCT00872521|474910392|FG001|Completed PAD Induction|Disease progression|2|||
131897225|NCT00872521|474910393|FG002|Completed PAD Induction|Disease progression|0|||
131897226|NCT00872521|474910391|FG000|Completed PAD Induction|Adverse Event|4|||
131897227|NCT00872521|474910392|FG001|Completed PAD Induction|Adverse Event|0|||
131897228|NCT00872521|474910393|FG002|Completed PAD Induction|Adverse Event|0|||
131897229|NCT00872521|474910391|FG000|Completed PAD Induction|Death|1|||
131897230|NCT00872521|474910392|FG001|Completed PAD Induction|Death|1|||
131897231|NCT00872521|474910393|FG002|Completed PAD Induction|Death|0|||
131897232|NCT00872521|474910391|FG000|Primary Endpoint Analysis|Other|1|||
131897233|NCT00872521|474910392|FG001|Primary Endpoint Analysis|Other|2|||
131897234|NCT00872521|474910393|FG002|Primary Endpoint Analysis|Other|0|||
131897235|NCT00872521|474910391|FG000|Primary Endpoint Analysis|Patient choice|0|||
131897236|NCT00872521|474910392|FG001|Primary Endpoint Analysis|Patient choice|1|||
131897237|NCT00872521|474910393|FG002|Primary Endpoint Analysis|Patient choice|0|||
131897238|NCT00872521|474910391|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
131897239|NCT00872521|474910392|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
131897240|NCT00872521|474910393|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
131897241|NCT00872521|474910391|FG000|Primary Endpoint Analysis|Patient response missing|0|||
131897242|NCT00872521|474910392|FG001|Primary Endpoint Analysis|Patient response missing|0|||
131897243|NCT00872521|474910393|FG002|Primary Endpoint Analysis|Patient response missing|1|||
131897244|NCT00872521|474910391|FG000|Completed 3-month Follow up|Other|0|||
131897245|NCT00872521|474910392|FG001|Completed 3-month Follow up|Other|2|||
131897246|NCT00872521|474910393|FG002|Completed 3-month Follow up|Other|0|||
131897247|NCT00872521|474910391|FG000|Completed 3-month Follow up|Physician Decision|0|||
131897248|NCT00872521|474910392|FG001|Completed 3-month Follow up|Physician Decision|1|||
131897249|NCT00872521|474910393|FG002|Completed 3-month Follow up|Physician Decision|0|||
131897250|NCT00872521|474910391|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
131897251|NCT00872521|474910392|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
131897252|NCT00872521|474910393|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
131897253|NCT04819438|474910394|FG000|Overall Study|Withdrawal by Subject|1|||
131897254|NCT04819438|474910395|FG001|Overall Study|Withdrawal by Subject|0|||
131897255|NCT04819438|474910394|FG000|Overall Study|Adverse Event|0|||
131897256|NCT04819438|474910395|FG001|Overall Study|Adverse Event|1|||
131897257|NCT04819438|474910394|FG000|Overall Study|Protocol Violation|0|||
131897258|NCT04819438|474910395|FG001|Overall Study|Protocol Violation|1|||
131897259|NCT03465709|474910396|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
131897260|NCT03465709|474910396|FG000|Overall Study|Withdrawal by Subject|3|||
131897261|NCT03060291|474910397|FG000|3-month Follow-up|Declined to respond|8|||
131897262|NCT03060291|474910398|FG001|3-month Follow-up|Declined to respond|10|||
131897263|NCT03060291|474910399|FG002|3-month Follow-up|Declined to respond|2|||
131897264|NCT03060291|474910397|FG000|6-month Follow-up|Declined to respond|7|||
131897265|NCT03060291|474910398|FG001|6-month Follow-up|Declined to respond|13|||
131897266|NCT03060291|474910399|FG002|6-month Follow-up|Declined to respond|4|||
131897267|NCT03060291|474910397|FG000|12-month Follow-up|Declined to respond|7|||
131897268|NCT03060291|474910398|FG001|12-month Follow-up|Declined to respond|16|||
131897269|NCT03060291|474910399|FG002|12-month Follow-up|Declined to respond|6|||
131897270|NCT01720524|474910403|FG000|Part A|Insufficient Clinical Response|2|||
131897271|NCT01720524|474910404|FG001|Part A|Insufficient Clinical Response|4|||
131897272|NCT01720524|474910403|FG000|Part A|Adverse Event|2|||
131897273|NCT01720524|474910404|FG001|Part A|Adverse Event|2|||
131897274|NCT01720524|474910403|FG000|Part A|Death|2|||
131897275|NCT01720524|474910404|FG001|Part A|Death|1|||
131897276|NCT01720524|474910403|FG000|Part A|Lost to Follow-up|0|||
131897277|NCT01720524|474910404|FG001|Part A|Lost to Follow-up|1|||
131897278|NCT01720524|474910403|FG000|Part A|Missed 28 day follow-up visit|1|||
131897279|NCT01720524|474910404|FG001|Part A|Missed 28 day follow-up visit|1|||
131897280|NCT01720524|474910403|FG000|Part A|Withdrawal by Subject|0|||
131897281|NCT01720524|474910404|FG001|Part A|Withdrawal by Subject|1|||
131897282|NCT01720524|474910403|FG000|Part A|Other|0|||
131897283|NCT01720524|474910404|FG001|Part A|Other|1|||
131897284|NCT01720524|474910403|FG000|Part A|Lost to Follow-up|0|||
131897285|NCT01720524|474910404|FG001|Part A|Lost to Follow-up|1|||
131897286|NCT01720524|474910403|FG000|Part B|No longer willing to participate in study|1|||
131897287|NCT01720524|474910404|FG001|Part B|No longer willing to participate in study|4|||
131897288|NCT01720524|474910403|FG000|Part B|Other|2|||
131897289|NCT01720524|474910404|FG001|Part B|Other|0|||
131897290|NCT01720524|474910403|FG000|Part B|Lost to Follow-up|2|||
131897291|NCT01720524|474910404|FG001|Part B|Lost to Follow-up|3|||
131897292|NCT01720524|474910403|FG000|Part B|Death|0|||
131897293|NCT01720524|474910404|FG001|Part B|Death|2|||
131897294|NCT00158262|474910408|FG000|Overall Study|Lost to Follow-up|1|||
131897295|NCT00158262|474910409|FG001|Overall Study|Lost to Follow-up|1|||
131897296|NCT02105285|474910412|FG000|Overall Study|Adverse Event|1|||
131897297|NCT02105285|474910413|FG001|Overall Study|Adverse Event|1|||
131897298|NCT02105285|474910414|FG002|Overall Study|Adverse Event|0|||
131897299|NCT02105285|474910412|FG000|Overall Study|Protocol Violation|0|||
131897300|NCT02105285|474910413|FG001|Overall Study|Protocol Violation|1|||
131897301|NCT02105285|474910414|FG002|Overall Study|Protocol Violation|0|||
131897302|NCT02105285|474910412|FG000|Overall Study|Withdrawal by Subject|1|||
131897303|NCT02105285|474910413|FG001|Overall Study|Withdrawal by Subject|0|||
131897304|NCT02105285|474910414|FG002|Overall Study|Withdrawal by Subject|0|||
131897305|NCT01421641|474910415|FG000|Overall Study|Protocol Violation|2|||
131897306|NCT01421641|474910416|FG001|Overall Study|Protocol Violation|2|||
131897307|NCT02959918|474910418|FG000|Overall Study|Adverse Event|1|||
131897308|NCT02959918|474910419|FG001|Overall Study|Adverse Event|1|||
131897309|NCT02959918|474910420|FG002|Overall Study|Adverse Event|2|||
131897310|NCT02959918|474910421|FG003|Overall Study|Adverse Event|0|||
131897311|NCT02959918|474910422|FG004|Overall Study|Adverse Event|0|||
131897312|NCT02959918|474910423|FG005|Overall Study|Adverse Event|2|||
131897313|NCT02959918|474910424|FG006|Overall Study|Adverse Event|2|||
131897314|NCT02959918|474910425|FG007|Overall Study|Adverse Event|1|||
131897315|NCT02959918|474910426|FG008|Overall Study|Adverse Event|2|||
131897316|NCT02959918|474910427|FG009|Overall Study|Adverse Event|1|||
131897317|NCT02959918|474910428|FG010|Overall Study|Adverse Event|1|||
131897318|NCT02959918|474910429|FG011|Overall Study|Adverse Event|3|||
131897319|NCT02959918|474910430|FG012|Overall Study|Adverse Event|2|||
131897320|NCT02959918|474910431|FG013|Overall Study|Adverse Event|4|||
131897321|NCT02959918|474910418|FG000|Overall Study|Lost to Follow-up|0|||
131897322|NCT02959918|474910419|FG001|Overall Study|Lost to Follow-up|0|||
131897323|NCT02959918|474910420|FG002|Overall Study|Lost to Follow-up|0|||
131897324|NCT02959918|474910421|FG003|Overall Study|Lost to Follow-up|0|||
131897325|NCT02959918|474910422|FG004|Overall Study|Lost to Follow-up|0|||
131897326|NCT02959918|474910423|FG005|Overall Study|Lost to Follow-up|0|||
131897327|NCT02959918|474910424|FG006|Overall Study|Lost to Follow-up|0|||
131897328|NCT02959918|474910425|FG007|Overall Study|Lost to Follow-up|0|||
131897329|NCT02959918|474910426|FG008|Overall Study|Lost to Follow-up|0|||
131897330|NCT02959918|474910427|FG009|Overall Study|Lost to Follow-up|1|||
131897331|NCT02959918|474910428|FG010|Overall Study|Lost to Follow-up|0|||
131897332|NCT02959918|474910429|FG011|Overall Study|Lost to Follow-up|0|||
131897333|NCT02959918|474910430|FG012|Overall Study|Lost to Follow-up|1|||
131897334|NCT02959918|474910431|FG013|Overall Study|Lost to Follow-up|0|||
131897335|NCT02959918|474910418|FG000|Overall Study|Withdrawal by Subject|0|||
131897336|NCT02959918|474910419|FG001|Overall Study|Withdrawal by Subject|0|||
131897337|NCT02959918|474910420|FG002|Overall Study|Withdrawal by Subject|1|||
131897338|NCT02959918|474910421|FG003|Overall Study|Withdrawal by Subject|2|||
131897339|NCT02959918|474910422|FG004|Overall Study|Withdrawal by Subject|0|||
131897340|NCT02959918|474910423|FG005|Overall Study|Withdrawal by Subject|0|||
131897341|NCT02959918|474910424|FG006|Overall Study|Withdrawal by Subject|1|||
131897342|NCT02959918|474910425|FG007|Overall Study|Withdrawal by Subject|0|||
131897343|NCT02959918|474910426|FG008|Overall Study|Withdrawal by Subject|1|||
131897344|NCT02959918|474910427|FG009|Overall Study|Withdrawal by Subject|1|||
131897345|NCT02959918|474910428|FG010|Overall Study|Withdrawal by Subject|2|||
131897346|NCT02959918|474910429|FG011|Overall Study|Withdrawal by Subject|3|||
131897347|NCT02959918|474910430|FG012|Overall Study|Withdrawal by Subject|1|||
131897348|NCT02959918|474910431|FG013|Overall Study|Withdrawal by Subject|1|||
131897349|NCT02959918|474910418|FG000|Overall Study|Protocol Violation|0|||
131897350|NCT02959918|474910419|FG001|Overall Study|Protocol Violation|0|||
131897351|NCT02959918|474910420|FG002|Overall Study|Protocol Violation|1|||
131897352|NCT02959918|474910421|FG003|Overall Study|Protocol Violation|0|||
131897353|NCT02959918|474910422|FG004|Overall Study|Protocol Violation|0|||
131897354|NCT02959918|474910423|FG005|Overall Study|Protocol Violation|1|||
131676085|NCT00292461|474099253|FG001|Overall Study|Lost to Follow-up|0|||
131676086|NCT05125679|474099254|FG000|Overall Study|Study Terminated by Sponsor|2|||
131897355|NCT02959918|474910424|FG006|Overall Study|Protocol Violation|0|||
131897356|NCT02959918|474910425|FG007|Overall Study|Protocol Violation|0|||
131897357|NCT02959918|474910426|FG008|Overall Study|Protocol Violation|2|||
131897358|NCT02959918|474910427|FG009|Overall Study|Protocol Violation|1|||
131897359|NCT02959918|474910428|FG010|Overall Study|Protocol Violation|0|||
131897360|NCT02959918|474910429|FG011|Overall Study|Protocol Violation|1|||
131897361|NCT02959918|474910430|FG012|Overall Study|Protocol Violation|1|||
131897362|NCT02959918|474910431|FG013|Overall Study|Protocol Violation|0|||
131897363|NCT02959918|474910418|FG000|Overall Study|Stopping Rule Met|1|||
131897364|NCT02959918|474910419|FG001|Overall Study|Stopping Rule Met|0|||
131897365|NCT02959918|474910420|FG002|Overall Study|Stopping Rule Met|3|||
131897366|NCT02959918|474910421|FG003|Overall Study|Stopping Rule Met|4|||
131897367|NCT02959918|474910422|FG004|Overall Study|Stopping Rule Met|5|||
131897368|NCT02959918|474910423|FG005|Overall Study|Stopping Rule Met|3|||
131897369|NCT02959918|474910424|FG006|Overall Study|Stopping Rule Met|2|||
131897370|NCT02959918|474910425|FG007|Overall Study|Stopping Rule Met|4|||
131897371|NCT02959918|474910426|FG008|Overall Study|Stopping Rule Met|1|||
131897372|NCT02959918|474910427|FG009|Overall Study|Stopping Rule Met|1|||
131897373|NCT02959918|474910428|FG010|Overall Study|Stopping Rule Met|3|||
131897374|NCT02959918|474910429|FG011|Overall Study|Stopping Rule Met|5|||
131897375|NCT02959918|474910430|FG012|Overall Study|Stopping Rule Met|2|||
131897376|NCT02959918|474910431|FG013|Overall Study|Stopping Rule Met|1|||
131897377|NCT02959918|474910418|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
131897378|NCT02959918|474910419|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
131897379|NCT02959918|474910420|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
131897380|NCT02959918|474910421|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
131897381|NCT02959918|474910422|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897382|NCT02959918|474910423|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897383|NCT02959918|474910424|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897384|NCT02959918|474910425|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897385|NCT02959918|474910426|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897386|NCT02959918|474910427|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897387|NCT02959918|474910428|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897388|NCT02959918|474910429|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897389|NCT02959918|474910430|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897390|NCT02959918|474910431|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
131897391|NCT02959918|474910418|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897392|NCT02959918|474910419|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897393|NCT02959918|474910420|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897394|NCT02959918|474910421|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897395|NCT02959918|474910422|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897396|NCT02959918|474910423|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897397|NCT02959918|474910424|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897398|NCT02959918|474910425|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
131897399|NCT02959918|474910426|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897400|NCT02959918|474910427|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897401|NCT02959918|474910428|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897402|NCT02959918|474910429|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897403|NCT02959918|474910430|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897404|NCT02959918|474910431|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
131897405|NCT02959918|474910418|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897406|NCT02959918|474910419|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897407|NCT02959918|474910420|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897408|NCT02959918|474910421|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897409|NCT02959918|474910422|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897410|NCT02959918|474910423|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897411|NCT02959918|474910424|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897412|NCT02959918|474910425|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897413|NCT02959918|474910426|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
131897414|NCT02959918|474910427|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897415|NCT02959918|474910428|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897416|NCT02959918|474910429|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897417|NCT02959918|474910430|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897418|NCT02959918|474910431|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
131897419|NCT02959918|474910418|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897420|NCT02959918|474910419|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897421|NCT02959918|474910420|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131676087|NCT05125679|474099255|FG001|Overall Study|Study Terminated by Sponsor|5|||
131676088|NCT04484259|474099272|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131676089|NCT04484259|474099273|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131676090|NCT04484259|474099274|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131676091|NCT04484259|474099275|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
131676092|NCT04484259|474099276|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131676093|NCT04484259|474099272|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131676094|NCT04484259|474099273|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131676095|NCT04484259|474099274|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131676096|NCT04484259|474099275|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
131676097|NCT04484259|474099276|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131676098|NCT04484259|474099272|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131676099|NCT04484259|474099273|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131676100|NCT04484259|474099274|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131676101|NCT04484259|474099275|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
131676102|NCT04484259|474099276|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131676103|NCT04484259|474099272|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
131676104|NCT04484259|474099273|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
131676105|NCT04484259|474099274|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
131676106|NCT04484259|474099275|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
131676107|NCT04484259|474099276|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
131897422|NCT02959918|474910421|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897423|NCT02959918|474910422|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897424|NCT02959918|474910423|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897425|NCT02959918|474910424|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897426|NCT02959918|474910425|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897427|NCT02959918|474910426|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897428|NCT02959918|474910427|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
131897429|NCT02959918|474910428|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897430|NCT02959918|474910429|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897431|NCT02959918|474910430|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897432|NCT02959918|474910431|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
131897433|NCT02585713|474910433|FG000|Overall Study|Withdrew prior to treatment|2|||
131897434|NCT02585713|474910434|FG001|Overall Study|Withdrew prior to treatment|7|||
131897435|NCT02585713|474910433|FG000|Overall Study|Other|3|||
131897436|NCT02585713|474910434|FG001|Overall Study|Other|1|||
131897437|NCT03173456|474910439|FG000|Baseline|Medication dispensing system malfunction'|0|||
131897438|NCT03173456|474910440|FG001|Baseline|Medication dispensing system malfunction'|1|||
131897439|NCT03173456|474910441|FG002|Baseline|Medication dispensing system malfunction'|0|||
131897440|NCT03173456|474910442|FG003|Baseline|Medication dispensing system malfunction'|0|||
131897441|NCT03173456|474910443|FG004|Baseline|Medication dispensing system malfunction'|2|||
131897442|NCT03173456|474910439|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
131897443|NCT03173456|474910440|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
131897444|NCT03173456|474910441|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
131897445|NCT03173456|474910442|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
131897446|NCT03173456|474910443|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
131897447|NCT01733121|474910444|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
131897448|NCT01733121|474910445|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
131897449|NCT01733121|474910444|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
131897450|NCT01733121|474910445|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
131897451|NCT01733121|474910444|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
131897452|NCT01733121|474910445|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
131897453|NCT01733121|474910444|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
131897454|NCT01733121|474910445|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
131897455|NCT03061188|474910454|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
131897456|NCT03061188|474910455|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
131897457|NCT03061188|474910456|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
131897458|NCT03061188|474910457|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
131897459|NCT03061188|474910454|FG000|On Follow-up for 3 Years|Death|0|||
131897460|NCT03061188|474910455|FG001|On Follow-up for 3 Years|Death|3|||
131897461|NCT03061188|474910456|FG002|On Follow-up for 3 Years|Death|5|||
131897462|NCT03061188|474910457|FG003|On Follow-up for 3 Years|Death|4|||
131897463|NCT03061188|474910454|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
131897464|NCT03061188|474910455|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
131897465|NCT03061188|474910456|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
131897466|NCT03061188|474910457|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
131897467|NCT04501952|474910458|FG000|Overall Study|Adverse Event|0|||
131897468|NCT04501952|474910459|FG001|Overall Study|Adverse Event|3|||
131897469|NCT04501952|474910458|FG000|Overall Study|Investigator's Discretion|0|||
131897470|NCT04501952|474910459|FG001|Overall Study|Investigator's Discretion|1|||
131897471|NCT04501952|474910458|FG000|Overall Study|Protocol Violation|1|||
131897472|NCT04501952|474910459|FG001|Overall Study|Protocol Violation|1|||
131897473|NCT04501952|474910458|FG000|Overall Study|Withdrew Consent|5|||
131897474|NCT04501952|474910459|FG001|Overall Study|Withdrew Consent|4|||
131897475|NCT04501952|474910458|FG000|Overall Study|Lost to Follow-up|7|||
131897476|NCT04501952|474910459|FG001|Overall Study|Lost to Follow-up|2|||
131897477|NCT04501952|474910458|FG000|Overall Study|Randomized and Never Treated|13|||
131676108|NCT04484259|474099272|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
131676109|NCT04484259|474099273|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
131676110|NCT04484259|474099274|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
131676111|NCT04484259|474099275|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
131772570|NCT01231620|474445116|FG002|Overall Study|Death|11|||
131897478|NCT04501952|474910459|FG001|Overall Study|Randomized and Never Treated|9|||
131897479|NCT02609984|474910460|FG000|Overall Study|Death|29|||
131897480|NCT02609984|474910461|FG001|Overall Study|Death|26|||
131897481|NCT02609984|474910460|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
131897482|NCT02609984|474910461|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
131897483|NCT02609984|474910460|FG000|Overall Study|Lost to Follow-up|1|||
131897484|NCT02609984|474910461|FG001|Overall Study|Lost to Follow-up|2|||
131897485|NCT02609984|474910460|FG000|Overall Study|Withdrawal by Subject|0|||
131897486|NCT02609984|474910461|FG001|Overall Study|Withdrawal by Subject|1|||
131897487|NCT02609984|474910460|FG000|Overall Study|Disease Progression|2|||
131897488|NCT02609984|474910461|FG001|Overall Study|Disease Progression|0|||
131897489|NCT02504320|474910462|FG000|Treatment Period 1|Positive Drug Screen|0|||
131897490|NCT02504320|474910463|FG001|Treatment Period 1|Positive Drug Screen|0|||
131897491|NCT02504320|474910464|FG002|Treatment Period 1|Positive Drug Screen|1|||
131897492|NCT02504320|474910465|FG003|Treatment Period 1|Positive Drug Screen|0|||
131897493|NCT02504320|474910462|FG000|Treatment Period 2|Positive Drug Screen|0|||
131897494|NCT02504320|474910463|FG001|Treatment Period 2|Positive Drug Screen|1|||
131897495|NCT02504320|474910464|FG002|Treatment Period 2|Positive Drug Screen|0|||
131897496|NCT02504320|474910465|FG003|Treatment Period 2|Positive Drug Screen|0|||
131897497|NCT02504320|474910462|FG000|Treatment Period 3|Positive Drug Screen|0|||
131897498|NCT02504320|474910463|FG001|Treatment Period 3|Positive Drug Screen|0|||
131897499|NCT02504320|474910464|FG002|Treatment Period 3|Positive Drug Screen|0|||
131897500|NCT02504320|474910465|FG003|Treatment Period 3|Positive Drug Screen|1|||
131897501|NCT02504320|474910462|FG000|Treatment Period 3|Adverse Event|0|||
131897502|NCT02504320|474910463|FG001|Treatment Period 3|Adverse Event|0|||
131897503|NCT02504320|474910464|FG002|Treatment Period 3|Adverse Event|1|||
131897504|NCT02504320|474910465|FG003|Treatment Period 3|Adverse Event|0|||
131897505|NCT01210222|474910466|FG000|Overall Study|Ineligible|2|||
131897506|NCT01210222|474910466|FG000|Overall Study|Never treated|1|||
131897507|NCT00941304|474910467|FG000|Overall Study|Lost to Follow-up|1|||
131897508|NCT00941304|474910468|FG001|Overall Study|Lost to Follow-up|0|||
131897509|NCT00941304|474910469|FG002|Overall Study|Lost to Follow-up|0|||
131897510|NCT00941304|474910470|FG003|Overall Study|Lost to Follow-up|0|||
131897511|NCT00941304|474910471|FG004|Overall Study|Lost to Follow-up|0|||
131897512|NCT03293394|474910472|FG000|Follow-up (6 Months)|Adverse Event|4|||
131897513|NCT03293394|474910473|FG001|Follow-up (6 Months)|Adverse Event|2|||
131897514|NCT00436826|474910476|FG000|Double Blind Period (DBP)|Adverse Event|2|||
131897515|NCT00436826|474910477|FG001|Double Blind Period (DBP)|Adverse Event|0|||
131897516|NCT00436826|474910478|FG002|Double Blind Period (DBP)|Adverse Event|0|||
131897517|NCT00436826|474910479|FG003|Double Blind Period (DBP)|Adverse Event|0|||
131897518|NCT00436826|474910480|FG004|Double Blind Period (DBP)|Adverse Event|0|||
131897519|NCT00436826|474910481|FG005|Double Blind Period (DBP)|Adverse Event|0|||
131897520|NCT00436826|474910476|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
131897521|NCT00436826|474910477|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
131897522|NCT00436826|474910478|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
131897523|NCT00436826|474910479|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
131897524|NCT00436826|474910480|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
131897525|NCT00436826|474910481|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
131897526|NCT00436826|474910476|FG000|Double Blind Period (DBP)|Other|10|||
131897527|NCT00436826|474910477|FG001|Double Blind Period (DBP)|Other|11|||
131897528|NCT00436826|474910478|FG002|Double Blind Period (DBP)|Other|0|||
131897529|NCT00436826|474910479|FG003|Double Blind Period (DBP)|Other|0|||
131897530|NCT00436826|474910480|FG004|Double Blind Period (DBP)|Other|0|||
131897531|NCT00436826|474910481|FG005|Double Blind Period (DBP)|Other|0|||
131897532|NCT00436826|474910476|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
131897533|NCT00436826|474910477|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
131897534|NCT00436826|474910478|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
131897535|NCT00436826|474910479|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
131897536|NCT00436826|474910480|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
131897537|NCT00436826|474910481|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
131897538|NCT00436826|474910476|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
131897539|NCT00436826|474910477|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
131897540|NCT00436826|474910478|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
131897541|NCT00436826|474910479|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
131653529|NCT04703192|474018397|FG001|Overall Study|Progressive or Relapsed Disease|7|||
131653530|NCT04703192|474018396|FG000|Overall Study|Clinical Progression|19|||
131653531|NCT04703192|474018397|FG001|Overall Study|Clinical Progression|8|||
131653532|NCT04703192|474018396|FG000|Overall Study|Lost to Follow-up|1|||
131653533|NCT04703192|474018397|FG001|Overall Study|Lost to Follow-up|0|||
131653534|NCT04703192|474018396|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
131653535|NCT04703192|474018397|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
131653536|NCT04703192|474018396|FG000|Overall Study|Other|5|||
131653537|NCT04703192|474018397|FG001|Overall Study|Other|1|||
131676112|NCT04484259|474099276|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
131676113|NCT04484259|474099272|FG000|Randomized Treatment|Withdrawal by Subject|1|||
131676114|NCT04484259|474099273|FG001|Randomized Treatment|Withdrawal by Subject|0|||
131676115|NCT04484259|474099274|FG002|Randomized Treatment|Withdrawal by Subject|0|||
131676116|NCT04484259|474099275|FG003|Randomized Treatment|Withdrawal by Subject|0|||
131676117|NCT04484259|474099276|FG004|Randomized Treatment|Withdrawal by Subject|0|||
131676118|NCT04908189|474099277|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
131676119|NCT04908189|474099278|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
131676120|NCT04908189|474099279|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
131676121|NCT04908189|474099277|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
131676122|NCT04908189|474099278|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
131676123|NCT04908189|474099279|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
131676124|NCT04908189|474099277|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
131676125|NCT04908189|474099278|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
131676126|NCT04908189|474099279|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
131676127|NCT04908189|474099277|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
131676128|NCT04908189|474099278|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
131676129|NCT04908189|474099279|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
131676130|NCT04908189|474099277|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
131676131|NCT04908189|474099278|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
131676132|NCT04908189|474099279|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
131676133|NCT04908189|474099277|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
131676134|NCT04908189|474099278|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
131676135|NCT04908189|474099279|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
131676136|NCT04908189|474099277|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
131676137|NCT04908189|474099278|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
131435988|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
131676138|NCT04908189|474099279|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
131676139|NCT04908189|474099277|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
131676140|NCT04908189|474099278|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
131676141|NCT04908189|474099279|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
131676142|NCT04908189|474099277|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
131676143|NCT04908189|474099278|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
131676144|NCT04908189|474099279|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
131676145|NCT04908189|474099277|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
131676146|NCT04908189|474099278|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
131676147|NCT04908189|474099279|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
131676148|NCT04908189|474099277|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
131676149|NCT04908189|474099278|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
131676150|NCT04908189|474099279|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
131676151|NCT04908189|474099277|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
131676152|NCT04908189|474099278|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
131676153|NCT04908189|474099279|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
131676154|NCT04683731|474099280|FG000|Overall Study|Withdrawal by Subject|1|||
131676155|NCT04683731|474099281|FG001|Overall Study|Withdrawal by Subject|0|||
131676156|NCT04683731|474099282|FG002|Overall Study|Withdrawal by Subject|3|||
131676157|NCT04683731|474099283|FG003|Overall Study|Withdrawal by Subject|2|||
131676158|NCT04683731|474099280|FG000|Overall Study|Determined patient was not eligible|3|||
131676159|NCT04683731|474099281|FG001|Overall Study|Determined patient was not eligible|3|||
131676160|NCT04683731|474099282|FG002|Overall Study|Determined patient was not eligible|12|||
131676161|NCT04683731|474099283|FG003|Overall Study|Determined patient was not eligible|3|||
131676162|NCT01411839|474099285|FG000|Overall Study|Lost to Follow-up|4|||
131676163|NCT01411839|474099286|FG001|Overall Study|Lost to Follow-up|3|||
131676164|NCT00458341|474099287|FG000|Cycle 1|Adverse Event|1|||
131676165|NCT00458341|474099288|FG001|Cycle 1|Adverse Event|0|||
131676166|NCT05461794|474099291|FG000|Overall Study|Withdrawal by Subject|1|||
131676167|NCT05461794|474099292|FG001|Overall Study|Withdrawal by Subject|1|||
131676168|NCT05461794|474099293|FG002|Overall Study|Withdrawal by Subject|3|||
131676169|NCT05461794|474099291|FG000|Overall Study|Study Terminated By Sponsor|18|||
131676170|NCT05461794|474099292|FG001|Overall Study|Study Terminated By Sponsor|13|||
131676171|NCT05461794|474099293|FG002|Overall Study|Study Terminated By Sponsor|16|||
131676172|NCT05461794|474099291|FG000|Overall Study|Death|20|||
131676173|NCT05461794|474099292|FG001|Overall Study|Death|5|||
131676174|NCT05461794|474099293|FG002|Overall Study|Death|19|||
131676175|NCT00467285|474099294|FG000|Overall Study|Lost to Follow-up|4|||
131676176|NCT00467285|474099295|FG001|Overall Study|Lost to Follow-up|4|||
131676177|NCT01658826|474099307|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
131676178|NCT01658826|474099308|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
131772571|NCT01231620|474445114|FG000|Overall Study|Adverse Event|2|||
131676179|NCT01658826|474099307|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
131676180|NCT01658826|474099308|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
131676181|NCT01658826|474099307|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
131676182|NCT01658826|474099308|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
131676183|NCT01658826|474099307|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
131676184|NCT01658826|474099308|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
131676185|NCT01658826|474099307|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
131676186|NCT01658826|474099308|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
131676187|NCT01658826|474099307|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
131676188|NCT01658826|474099308|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
131676189|NCT01658826|474099307|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
131676190|NCT01658826|474099308|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
131676191|NCT01658826|474099307|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
131676192|NCT01658826|474099308|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
131719354|NCT00345605|474253268|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
131676193|NCT01658826|474099307|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
131676194|NCT01658826|474099308|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
131676195|NCT01422850|474099311|FG000|Overall Study|Physician Decision|3|||
131676196|NCT04484831|474099312|FG000|Overall Study|Withdrawal by Subject|1|||
131676197|NCT04484831|474099313|FG001|Overall Study|Withdrawal by Subject|0|||
131676198|NCT02244996|474099314|FG000|Overall Study|Lack of Efficacy|2|||
131676199|NCT02244996|474099315|FG001|Overall Study|Lack of Efficacy|6|||
131676200|NCT01335009|474099316|FG000|Overall Study|Too ill to travel to study sites|1|||
131676201|NCT01335009|474099317|FG001|Overall Study|Too ill to travel to study sites|0|||
131676202|NCT01335009|474099316|FG000|Overall Study|Death|28|||
131676203|NCT01335009|474099317|FG001|Overall Study|Death|32|||
131676204|NCT01335009|474099316|FG000|Overall Study|Withdrawal by Subject|1|||
131676205|NCT01335009|474099317|FG001|Overall Study|Withdrawal by Subject|1|||
131676206|NCT01335009|474099316|FG000|Overall Study|Lost to Follow-up|1|||
131676207|NCT01335009|474099317|FG001|Overall Study|Lost to Follow-up|0|||
131676208|NCT04821869|474099318|FG000|Overall Study|Adverse Event|4|||
131676209|NCT04821869|474099318|FG000|Overall Study|Withdrawal by Subject|2|||
131676210|NCT04821869|474099318|FG000|Overall Study|Did not meet FEV1 criteria|1|||
131676211|NCT00658684|474099319|FG000|Overall Study|Adverse Event|10|||
131676212|NCT00658684|474099320|FG001|Overall Study|Adverse Event|8|||
131676213|NCT00658684|474099321|FG002|Overall Study|Adverse Event|2|||
131676214|NCT00658684|474099322|FG003|Overall Study|Adverse Event|0|||
131676215|NCT00658684|474099319|FG000|Overall Study|Withdrawal by Subject|6|||
131676216|NCT00658684|474099320|FG001|Overall Study|Withdrawal by Subject|4|||
131676217|NCT00658684|474099321|FG002|Overall Study|Withdrawal by Subject|1|||
131676218|NCT00658684|474099322|FG003|Overall Study|Withdrawal by Subject|1|||
131676219|NCT00658684|474099319|FG000|Overall Study|Lack of Efficacy|1|||
131676220|NCT00658684|474099320|FG001|Overall Study|Lack of Efficacy|1|||
131676221|NCT00658684|474099321|FG002|Overall Study|Lack of Efficacy|0|||
131676222|NCT00658684|474099322|FG003|Overall Study|Lack of Efficacy|0|||
131676223|NCT00658684|474099319|FG000|Overall Study|Protocol Violation|1|||
131676224|NCT00658684|474099320|FG001|Overall Study|Protocol Violation|1|||
131676225|NCT00658684|474099321|FG002|Overall Study|Protocol Violation|0|||
131676226|NCT00658684|474099322|FG003|Overall Study|Protocol Violation|0|||
131676227|NCT00658684|474099319|FG000|Overall Study|Pregnancy|1|||
131676228|NCT00658684|474099320|FG001|Overall Study|Pregnancy|1|||
131676229|NCT00658684|474099321|FG002|Overall Study|Pregnancy|0|||
131676230|NCT00658684|474099322|FG003|Overall Study|Pregnancy|0|||
131676231|NCT00985166|474100759|FG000|Overall Study|Lost to Follow-up|3|||
131676232|NCT00985166|474100760|FG001|Overall Study|Lost to Follow-up|2|||
131676233|NCT00985166|474100761|FG002|Overall Study|Lost to Follow-up|2|||
131676234|NCT00985166|474100759|FG000|Overall Study|Withdrawal by Subject|3|||
131676235|NCT00985166|474100760|FG001|Overall Study|Withdrawal by Subject|2|||
131676236|NCT00985166|474100761|FG002|Overall Study|Withdrawal by Subject|0|||
131676237|NCT00985166|474100759|FG000|Overall Study|Test not done|2|||
131676238|NCT00985166|474100760|FG001|Overall Study|Test not done|0|||
131676239|NCT00985166|474100761|FG002|Overall Study|Test not done|4|||
131676240|NCT00985166|474100759|FG000|Overall Study|Other|1|||
131676241|NCT00985166|474100760|FG001|Overall Study|Other|0|||
131676242|NCT00985166|474100761|FG002|Overall Study|Other|1|||
131676243|NCT01028222|474100762|FG000|Overall Study|Protocol deviation|1|||
131676244|NCT01028222|474100763|FG001|Overall Study|Protocol deviation|0|||
131676245|NCT01028222|474100762|FG000|Overall Study|Disease progression|33|||
131676246|NCT01028222|474100763|FG001|Overall Study|Disease progression|9|||
131676247|NCT01028222|474100762|FG000|Overall Study|Administrative problems|1|||
131676248|NCT01028222|474100763|FG001|Overall Study|Administrative problems|1|||
131676249|NCT01028222|474100762|FG000|Overall Study|Lost to Follow-up|0|||
131676250|NCT01028222|474100763|FG001|Overall Study|Lost to Follow-up|1|||
131676251|NCT01028222|474100762|FG000|Overall Study|Withdrawal by Subject|1|||
131676252|NCT01028222|474100763|FG001|Overall Study|Withdrawal by Subject|0|||
131676253|NCT01028222|474100762|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
131676254|NCT01028222|474100763|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
131676255|NCT01028222|474100762|FG000|Overall Study|Adverse Event|2|||
131676256|NCT01028222|474100763|FG001|Overall Study|Adverse Event|0|||
131676257|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
131676258|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
131676259|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
131676260|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
131676261|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
131676262|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
131676263|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
131676264|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
131676265|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
131676266|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
131676267|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
131676268|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
131676269|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Death|3|||
131676270|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Death|1|||
131676271|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
131676272|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
131676273|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Adverse Event|7|||
131676274|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Adverse Event|8|||
131676275|NCT03236246|474100766|FG000|24-Week Dose Titration Period|Captured as Other|1|||
131676276|NCT03236246|474100767|FG001|24-Week Dose Titration Period|Captured as Other|2|||
131676277|NCT03236246|474100766|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
131676278|NCT03236246|474100767|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
131676279|NCT03236246|474100766|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
131676280|NCT03236246|474100767|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
131676281|NCT03236246|474100766|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
131676282|NCT03236246|474100767|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
131676283|NCT03236246|474100766|FG000|24-Week Dose Maintenance Period|Death|0|||
131676284|NCT03236246|474100767|FG001|24-Week Dose Maintenance Period|Death|1|||
131676285|NCT03236246|474100766|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
131676286|NCT03236246|474100767|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
131676287|NCT02072434|474100768|FG000|Overall Study|Protocol Violation|10|||
131676288|NCT02072434|474100769|FG001|Overall Study|Protocol Violation|9|||
131676289|NCT02072434|474100768|FG000|Overall Study|Physician Decision|5|||
131676290|NCT02072434|474100769|FG001|Overall Study|Physician Decision|10|||
131676291|NCT02072434|474100768|FG000|Overall Study|Adverse event, serious fatal|1|||
131676292|NCT02072434|474100769|FG001|Overall Study|Adverse event, serious fatal|6|||
131676293|NCT02072434|474100768|FG000|Overall Study|Adverse Event|7|||
131676294|NCT02072434|474100769|FG001|Overall Study|Adverse Event|6|||
131676295|NCT02072434|474100768|FG000|Overall Study|Withdrawal by Subject|17|||
131676296|NCT02072434|474100769|FG001|Overall Study|Withdrawal by Subject|29|||
131676297|NCT02072434|474100768|FG000|Overall Study|Other|14|||
131676298|NCT02072434|474100769|FG001|Overall Study|Other|29|||
131676299|NCT02072434|474100768|FG000|Overall Study|Lost to Follow-up|0|||
131676300|NCT02072434|474100769|FG001|Overall Study|Lost to Follow-up|1|||
131676301|NCT02634346|474100770|FG000|Overall Study|Withdrawal by Subject|8|||
131676302|NCT02634346|474100771|FG001|Overall Study|Withdrawal by Subject|9|||
131676303|NCT02634346|474100772|FG002|Overall Study|Withdrawal by Subject|8|||
131676304|NCT02634346|474100770|FG000|Overall Study|Adverse Event|2|||
131676305|NCT02634346|474100771|FG001|Overall Study|Adverse Event|2|||
131676306|NCT02634346|474100772|FG002|Overall Study|Adverse Event|7|||
131676307|NCT02634346|474100770|FG000|Overall Study|Lack of Efficacy|1|||
131676308|NCT02634346|474100771|FG001|Overall Study|Lack of Efficacy|2|||
131676309|NCT02634346|474100772|FG002|Overall Study|Lack of Efficacy|8|||
131676310|NCT02634346|474100770|FG000|Overall Study|Lost to Follow-up|1|||
131676311|NCT02634346|474100771|FG001|Overall Study|Lost to Follow-up|0|||
131676312|NCT02634346|474100772|FG002|Overall Study|Lost to Follow-up|0|||
131676313|NCT02634346|474100770|FG000|Overall Study|Protocol Violation|0|||
131676314|NCT02634346|474100771|FG001|Overall Study|Protocol Violation|1|||
131676315|NCT02634346|474100772|FG002|Overall Study|Protocol Violation|0|||
131676316|NCT01008696|474100773|FG000|Overall Study|Participant's evasion of hospital visit|5|||
131676317|NCT01008696|474100774|FG001|Overall Study|Participant's evasion of hospital visit|4|||
131676318|NCT01008696|474100773|FG000|Overall Study|Withdrawal by Subject|2|||
131676319|NCT01008696|474100774|FG001|Overall Study|Withdrawal by Subject|4|||
131676320|NCT01008696|474100773|FG000|Overall Study|Physician Decision|5|||
131676321|NCT01008696|474100774|FG001|Overall Study|Physician Decision|1|||
131676322|NCT01008696|474100773|FG000|Overall Study|Adverse Event|1|||
131676323|NCT01008696|474100774|FG001|Overall Study|Adverse Event|0|||
131676324|NCT01008696|474100773|FG000|Overall Study|Participants' non-cooperation|2|||
131676325|NCT01008696|474100774|FG001|Overall Study|Participants' non-cooperation|3|||
131676326|NCT01008696|474100773|FG000|Overall Study|Other|2|||
131676327|NCT01008696|474100774|FG001|Overall Study|Other|3|||
131676328|NCT01008696|474100773|FG000|Overall Study|Other|0|||
131676329|NCT01008696|474100774|FG001|Overall Study|Other|2|||
131676330|NCT02076113|474100775|FG000|Overall Study|Lost to Follow-up|4|||
131676331|NCT02076113|474100776|FG001|Overall Study|Lost to Follow-up|1|||
131676332|NCT02076113|474100775|FG000|Overall Study|Withdrawal by Subject|2|||
131676333|NCT02076113|474100776|FG001|Overall Study|Withdrawal by Subject|3|||
131676334|NCT02076113|474100775|FG000|Overall Study|Death|1|||
131676335|NCT02076113|474100776|FG001|Overall Study|Death|3|||
131676336|NCT02175004|474100777|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
131676337|NCT02175004|474100778|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
131676338|NCT02175004|474100777|FG000|Overall Study|Investigator Judgment|1|||
131676339|NCT02175004|474100778|FG001|Overall Study|Investigator Judgment|4|||
131676340|NCT02175004|474100777|FG000|Overall Study|Voluntary Withdrawal|6|||
131676341|NCT02175004|474100778|FG001|Overall Study|Voluntary Withdrawal|19|||
131676342|NCT02175004|474100777|FG000|Overall Study|Liver Transplant|1|||
131676343|NCT02175004|474100778|FG001|Overall Study|Liver Transplant|0|||
131676344|NCT02175004|474100777|FG000|Overall Study|Disease Progression|1|||
131676345|NCT02175004|474100778|FG001|Overall Study|Disease Progression|0|||
131676346|NCT02175004|474100777|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
131676347|NCT02175004|474100778|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
131676348|NCT02960854|474100779|FG000|Overall Study|Not Disclosed|2|||
131676349|NCT02960854|474100780|FG001|Overall Study|Not Disclosed|2|||
131676350|NCT02960854|474100779|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
131676351|NCT02960854|474100780|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
131676352|NCT02960854|474100779|FG000|Overall Study|Subject Withdrew Consent|0|||
131676353|NCT02960854|474100780|FG001|Overall Study|Subject Withdrew Consent|1|||
131676354|NCT02960854|474100779|FG000|Overall Study|Death|4|||
131676355|NCT02960854|474100780|FG001|Overall Study|Death|6|||
131676356|NCT00221195|474100781|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
131676357|NCT00221195|474100782|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
131676358|NCT00221195|474100781|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
131676359|NCT00221195|474100782|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
131676360|NCT00221195|474100781|FG000|Washout Period (Months 7-9)|Death|0|||
131676361|NCT00221195|474100782|FG001|Washout Period (Months 7-9)|Death|1|||
131676362|NCT00221195|474100781|FG000|Therapy 2 (Months 10-15)|Death|1|||
131676363|NCT00221195|474100782|FG001|Therapy 2 (Months 10-15)|Death|0|||
131676364|NCT00221195|474100781|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
131676365|NCT00221195|474100782|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
131676366|NCT00823901|474100783|FG000|Overall Study|Adverse Event|1|||
131676367|NCT00823901|474100784|FG001|Overall Study|Adverse Event|1|||
131676368|NCT00823901|474100783|FG000|Overall Study|Lack of Efficacy|1|||
131676369|NCT00823901|474100784|FG001|Overall Study|Lack of Efficacy|0|||
131676370|NCT00823901|474100783|FG000|Overall Study|Lost to Follow-up|2|||
131676371|NCT00823901|474100784|FG001|Overall Study|Lost to Follow-up|1|||
131676372|NCT01369511|474100786|FG000|Overall Study|Adverse Event|1|||
131676373|NCT01369511|474100787|FG001|Overall Study|Adverse Event|1|||
131676374|NCT01369511|474100788|FG002|Overall Study|Adverse Event|5|||
131676375|NCT01369511|474100789|FG003|Overall Study|Adverse Event|0|||
131676376|NCT01369511|474100786|FG000|Overall Study|Entry criteria not met|2|||
131676377|NCT01369511|474100787|FG001|Overall Study|Entry criteria not met|0|||
131676378|NCT01369511|474100788|FG002|Overall Study|Entry criteria not met|0|||
131676379|NCT01369511|474100789|FG003|Overall Study|Entry criteria not met|1|||
131676380|NCT01369511|474100786|FG000|Overall Study|Lost to Follow-up|0|||
131676381|NCT01369511|474100787|FG001|Overall Study|Lost to Follow-up|1|||
131676382|NCT01369511|474100788|FG002|Overall Study|Lost to Follow-up|1|||
131676383|NCT01369511|474100789|FG003|Overall Study|Lost to Follow-up|2|||
131676384|NCT01369511|474100786|FG000|Overall Study|Protocol Violation|0|||
131676385|NCT01369511|474100787|FG001|Overall Study|Protocol Violation|1|||
131676386|NCT01369511|474100788|FG002|Overall Study|Protocol Violation|0|||
131676387|NCT01369511|474100789|FG003|Overall Study|Protocol Violation|2|||
131676388|NCT01369511|474100786|FG000|Overall Study|Physician Decision|3|||
131676389|NCT01369511|474100787|FG001|Overall Study|Physician Decision|4|||
131676390|NCT01369511|474100788|FG002|Overall Study|Physician Decision|0|||
131676391|NCT01369511|474100789|FG003|Overall Study|Physician Decision|0|||
131676392|NCT01369511|474100786|FG000|Overall Study|Sponsor decision|2|||
131676393|NCT01369511|474100787|FG001|Overall Study|Sponsor decision|0|||
131676394|NCT01369511|474100788|FG002|Overall Study|Sponsor decision|1|||
131676395|NCT01369511|474100789|FG003|Overall Study|Sponsor decision|0|||
131676396|NCT01369511|474100786|FG000|Overall Study|Withdrawal by Subject|5|||
131676397|NCT01369511|474100787|FG001|Overall Study|Withdrawal by Subject|6|||
131676398|NCT01369511|474100788|FG002|Overall Study|Withdrawal by Subject|4|||
131676399|NCT01369511|474100789|FG003|Overall Study|Withdrawal by Subject|6|||
131676400|NCT04263909|474100790|FG000|Overall Study|Physician Decision|1|||
131676401|NCT04263909|474100791|FG001|Overall Study|Physician Decision|0|||
131676402|NCT04263909|474100792|FG002|Overall Study|Physician Decision|0|||
131676403|NCT04263909|474100790|FG000|Overall Study|Adverse Event|3|||
131676404|NCT04263909|474100791|FG001|Overall Study|Adverse Event|0|||
131676405|NCT04263909|474100792|FG002|Overall Study|Adverse Event|0|||
131676406|NCT04263909|474100790|FG000|Overall Study|Protocol Violation|5|||
131676407|NCT04263909|474100791|FG001|Overall Study|Protocol Violation|0|||
131676408|NCT04263909|474100792|FG002|Overall Study|Protocol Violation|0|||
131676409|NCT00784693|474100794|FG000|Overall Study|Lost to Follow-up|0|||
131676410|NCT00784693|474100795|FG001|Overall Study|Lost to Follow-up|1|||
131676411|NCT00784693|474100794|FG000|Overall Study|Lack of Efficacy|1|||
131676412|NCT00784693|474100795|FG001|Overall Study|Lack of Efficacy|1|||
131676413|NCT00784693|474100794|FG000|Overall Study|Withdrawal by Subject|0|||
131676414|NCT00784693|474100795|FG001|Overall Study|Withdrawal by Subject|4|||
131676415|NCT00784693|474100794|FG000|Overall Study|Randomized but not Treated|1|||
131676416|NCT00784693|474100795|FG001|Overall Study|Randomized but not Treated|0|||
131676417|NCT00784693|474100794|FG000|Overall Study|Other|1|||
131676418|NCT00784693|474100795|FG001|Overall Study|Other|0|||
131897542|NCT00436826|474910480|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
131897543|NCT00436826|474910481|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
131897544|NCT00436826|474910476|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
131897545|NCT00436826|474910477|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
131897546|NCT00436826|474910478|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
131897547|NCT00436826|474910479|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
131897548|NCT00436826|474910480|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
131897549|NCT00436826|474910481|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
131897550|NCT00784719|474910482|FG000|Overall Study|Adverse Event|0|||
131897551|NCT00784719|474910483|FG001|Overall Study|Adverse Event|2|||
131897552|NCT00784719|474910484|FG002|Overall Study|Adverse Event|0|||
131897553|NCT00784719|474910485|FG003|Overall Study|Adverse Event|0|||
131897554|NCT00784719|474910486|FG004|Overall Study|Adverse Event|1|||
131897555|NCT00784719|474910487|FG005|Overall Study|Adverse Event|1|||
131897556|NCT00784719|474910488|FG006|Overall Study|Adverse Event|1|||
131897557|NCT00784719|474910482|FG000|Overall Study|Lost to Follow-up|0|||
131897558|NCT00784719|474910483|FG001|Overall Study|Lost to Follow-up|0|||
131897559|NCT00784719|474910484|FG002|Overall Study|Lost to Follow-up|0|||
131897560|NCT00784719|474910485|FG003|Overall Study|Lost to Follow-up|0|||
131897561|NCT00784719|474910486|FG004|Overall Study|Lost to Follow-up|1|||
131897562|NCT00784719|474910487|FG005|Overall Study|Lost to Follow-up|1|||
131897563|NCT00784719|474910488|FG006|Overall Study|Lost to Follow-up|0|||
131897564|NCT00784719|474910482|FG000|Overall Study|Other|2|||
131897565|NCT00784719|474910483|FG001|Overall Study|Other|1|||
131897566|NCT00784719|474910484|FG002|Overall Study|Other|1|||
131897567|NCT00784719|474910485|FG003|Overall Study|Other|0|||
131897568|NCT00784719|474910486|FG004|Overall Study|Other|2|||
131897569|NCT00784719|474910487|FG005|Overall Study|Other|1|||
131897570|NCT00784719|474910488|FG006|Overall Study|Other|3|||
131897571|NCT00784719|474910482|FG000|Overall Study|Withdrawal by Subject|1|||
131897572|NCT00784719|474910483|FG001|Overall Study|Withdrawal by Subject|0|||
131897573|NCT00784719|474910484|FG002|Overall Study|Withdrawal by Subject|0|||
131897574|NCT00784719|474910485|FG003|Overall Study|Withdrawal by Subject|0|||
131897575|NCT00784719|474910486|FG004|Overall Study|Withdrawal by Subject|2|||
131897576|NCT00784719|474910487|FG005|Overall Study|Withdrawal by Subject|0|||
131897577|NCT00784719|474910488|FG006|Overall Study|Withdrawal by Subject|1|||
131897578|NCT01408901|474910489|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
131897579|NCT01408901|474910490|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
131897580|NCT01408901|474910491|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
131897581|NCT01408901|474910492|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
131897582|NCT01408901|474910489|FG000|6-Week Follow-Up|Death|1|||
131897583|NCT01408901|474910490|FG001|6-Week Follow-Up|Death|0|||
131897584|NCT01408901|474910491|FG002|6-Week Follow-Up|Death|0|||
131897585|NCT01408901|474910492|FG003|6-Week Follow-Up|Death|0|||
131897586|NCT01408901|474910489|FG000|6-Week Follow-Up|Cancelled visit|0|||
131897587|NCT01408901|474910490|FG001|6-Week Follow-Up|Cancelled visit|1|||
131897588|NCT01408901|474910491|FG002|6-Week Follow-Up|Cancelled visit|0|||
131897589|NCT01408901|474910492|FG003|6-Week Follow-Up|Cancelled visit|2|||
131897590|NCT01408901|474910489|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
131897591|NCT01408901|474910490|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
131897592|NCT01408901|474910491|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
131897593|NCT01408901|474910492|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
131897594|NCT01408901|474910489|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
131897595|NCT01408901|474910490|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
131897596|NCT01408901|474910491|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
131897597|NCT01408901|474910492|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
131897598|NCT01408901|474910489|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
131897599|NCT01408901|474910490|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
131897600|NCT01408901|474910491|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
131897601|NCT01408901|474910492|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
131897602|NCT01408901|474910489|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
131897603|NCT01408901|474910490|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
131897604|NCT01408901|474910491|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
131897605|NCT01408901|474910492|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
131897606|NCT01408901|474910489|FG000|26-Week Follow-Up|Death|0|||
131897607|NCT01408901|474910490|FG001|26-Week Follow-Up|Death|1|||
131897608|NCT01408901|474910491|FG002|26-Week Follow-Up|Death|0|||
131897609|NCT01408901|474910492|FG003|26-Week Follow-Up|Death|0|||
131897610|NCT04978337|474910493|FG000|Overall Study|Withdrawal by Subject|0|||
131897611|NCT04978337|474910494|FG001|Overall Study|Withdrawal by Subject|1|||
131897612|NCT01436227|474910500|FG000|Overall Study|Adverse Event|7|||
131897613|NCT01436227|474910500|FG000|Overall Study|Death|1|||
131897614|NCT01436227|474910500|FG000|Overall Study|Lack of Efficacy|1|||
131676419|NCT00908232|474100796|FG000|Cycle 1 to 4|Death|5|||
131676420|NCT00908232|474100797|FG001|Cycle 1 to 4|Death|0|||
131676421|NCT00908232|474100798|FG002|Cycle 1 to 4|Death|0|||
131676422|NCT00908232|474100799|FG003|Cycle 1 to 4|Death|0|||
131676423|NCT00908232|474100796|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
131676424|NCT00908232|474100797|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
131676425|NCT00908232|474100798|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
131676426|NCT00908232|474100799|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
131676427|NCT00908232|474100796|FG000|Cycle 1 to 4|Progressive Disease|6|||
131676428|NCT00908232|474100797|FG001|Cycle 1 to 4|Progressive Disease|0|||
131676429|NCT00908232|474100798|FG002|Cycle 1 to 4|Progressive Disease|0|||
131676430|NCT00908232|474100799|FG003|Cycle 1 to 4|Progressive Disease|0|||
131676431|NCT00908232|474100796|FG000|Cycle 1 to 4|Adverse Event|12|||
131676432|NCT00908232|474100797|FG001|Cycle 1 to 4|Adverse Event|0|||
131676433|NCT00908232|474100798|FG002|Cycle 1 to 4|Adverse Event|0|||
131676434|NCT00908232|474100799|FG003|Cycle 1 to 4|Adverse Event|0|||
131676435|NCT00908232|474100796|FG000|Cycle 1 to 4|Other|1|||
131676436|NCT00908232|474100797|FG001|Cycle 1 to 4|Other|0|||
131676437|NCT00908232|474100798|FG002|Cycle 1 to 4|Other|0|||
131676438|NCT00908232|474100799|FG003|Cycle 1 to 4|Other|0|||
131676439|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
131676440|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
131676441|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
131676442|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
131676443|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
131676444|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
131897615|NCT01436227|474910500|FG000|Overall Study|Lost to Follow-up|3|||
131897616|NCT01436227|474910500|FG000|Overall Study|Physician Decision|1|||
131897617|NCT01436227|474910500|FG000|Overall Study|Withdrawal by Subject|7|||
131897618|NCT01436227|474910500|FG000|Overall Study|Disease progression, relapse|6|||
131897619|NCT04004260|474910503|FG000|Overall Study|Withdrawal by Subject|7|||
131897620|NCT04004260|474910504|FG001|Overall Study|Withdrawal by Subject|3|||
131897621|NCT04004260|474910503|FG000|Overall Study|Lost to Follow-up|22|||
131897622|NCT04004260|474910504|FG001|Overall Study|Lost to Follow-up|12|||
131897623|NCT04004260|474910503|FG000|Overall Study|Did not engage in intervention|13|||
131897624|NCT04004260|474910504|FG001|Overall Study|Did not engage in intervention|17|||
131897625|NCT03414229|474910505|FG000|Overall Study|Adverse Event|1|||
131897626|NCT03414229|474910506|FG001|Overall Study|Adverse Event|0|||
131897627|NCT03414229|474910507|FG002|Overall Study|Adverse Event|2|||
131897628|NCT03414229|474910508|FG003|Overall Study|Adverse Event|1|||
131897629|NCT03414229|474910505|FG000|Overall Study|Lack of Efficacy|7|||
131897630|NCT03414229|474910506|FG001|Overall Study|Lack of Efficacy|4|||
131897631|NCT03414229|474910507|FG002|Overall Study|Lack of Efficacy|1|||
131897632|NCT03414229|474910508|FG003|Overall Study|Lack of Efficacy|9|||
131897633|NCT03414229|474910505|FG000|Overall Study|Change in therapy|1|||
131897634|NCT03414229|474910506|FG001|Overall Study|Change in therapy|0|||
131897635|NCT03414229|474910507|FG002|Overall Study|Change in therapy|0|||
131897636|NCT03414229|474910508|FG003|Overall Study|Change in therapy|0|||
131897637|NCT03414229|474910505|FG000|Overall Study|Pregnancy|0|||
131897638|NCT03414229|474910506|FG001|Overall Study|Pregnancy|0|||
131897639|NCT03414229|474910507|FG002|Overall Study|Pregnancy|1|||
131897640|NCT03414229|474910508|FG003|Overall Study|Pregnancy|0|||
131897641|NCT03414229|474910505|FG000|Overall Study|Withdrawal by Subject|0|||
131897642|NCT03414229|474910506|FG001|Overall Study|Withdrawal by Subject|1|||
131897643|NCT03414229|474910507|FG002|Overall Study|Withdrawal by Subject|1|||
131897644|NCT03414229|474910508|FG003|Overall Study|Withdrawal by Subject|0|||
131555480|NCT03101241|473658221|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
131555481|NCT03101241|473658222|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
131555482|NCT03101241|473658221|FG000|Overall Study|Participant withdrew consent|3|||
131676445|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
131676446|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
131676447|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
131676448|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
131772572|NCT01231620|474445115|FG001|Overall Study|Adverse Event|2|||
131772573|NCT01231620|474445116|FG002|Overall Study|Adverse Event|1|||
131772574|NCT01231620|474445114|FG000|Overall Study|Withdrawal by Subject|6|||
131772575|NCT01231620|474445115|FG001|Overall Study|Withdrawal by Subject|6|||
131772576|NCT01231620|474445116|FG002|Overall Study|Withdrawal by Subject|8|||
131772577|NCT01231620|474445114|FG000|Overall Study|Lost to Follow-up|3|||
131772578|NCT01231620|474445115|FG001|Overall Study|Lost to Follow-up|4|||
131772579|NCT01231620|474445116|FG002|Overall Study|Lost to Follow-up|9|||
131772580|NCT02400281|474445118|FG000|Overall Study|Adverse Event|0|||
131772581|NCT02400281|474445119|FG001|Overall Study|Adverse Event|0|||
131772582|NCT02400281|474445120|FG002|Overall Study|Adverse Event|1|||
131772583|NCT02400281|474445121|FG003|Overall Study|Adverse Event|0|||
131772584|NCT02400281|474445122|FG004|Overall Study|Adverse Event|1|||
131772585|NCT02400281|474445123|FG005|Overall Study|Adverse Event|0|||
131772586|NCT02400281|474445118|FG000|Overall Study|Physician Decision|0|||
131772587|NCT02400281|474445119|FG001|Overall Study|Physician Decision|0|||
131772588|NCT02400281|474445120|FG002|Overall Study|Physician Decision|1|||
131772589|NCT02400281|474445121|FG003|Overall Study|Physician Decision|0|||
131555483|NCT03101241|473658222|FG001|Overall Study|Participant withdrew consent|1|||
131555484|NCT03101241|473658221|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
131555485|NCT03101241|473658222|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
131897645|NCT02716584|474910513|FG000|Overall Study|Lost to Follow-up|8|||
131897646|NCT02716584|474910514|FG001|Overall Study|Lost to Follow-up|5|||
131897647|NCT01903993|474910515|FG000|Overall Study|Death|118|||
131897648|NCT01903993|474910516|FG001|Overall Study|Death|121|||
131897649|NCT01903993|474910515|FG000|Overall Study|Withdrawal by Subject|15|||
131897650|NCT01903993|474910516|FG001|Overall Study|Withdrawal by Subject|4|||
131897651|NCT01903993|474910515|FG000|Overall Study|Lost to Follow-up|2|||
131897652|NCT01903993|474910516|FG001|Overall Study|Lost to Follow-up|3|||
131897653|NCT01903993|474910515|FG000|Overall Study|Study Terminated by Sponsor|8|||
131897654|NCT01903993|474910516|FG001|Overall Study|Study Terminated by Sponsor|14|||
131897655|NCT01903993|474910515|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
131897656|NCT01903993|474910516|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
131897657|NCT01243177|474910519|FG000|Overall Study|Lack of Efficacy|47|||
131676449|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
131676450|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
131676451|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
131772590|NCT02400281|474445122|FG004|Overall Study|Physician Decision|0|||
131897658|NCT01243177|474910520|FG001|Overall Study|Lack of Efficacy|31|||
131897659|NCT01243177|474910519|FG000|Overall Study|Protocol Violation|11|||
131897660|NCT01243177|474910520|FG001|Overall Study|Protocol Violation|10|||
131897661|NCT01243177|474910519|FG000|Overall Study|Lost to Follow-up|15|||
131897662|NCT01243177|474910520|FG001|Overall Study|Lost to Follow-up|18|||
131897663|NCT01243177|474910519|FG000|Overall Study|Withdrawal by Subject|46|||
131897664|NCT01243177|474910520|FG001|Overall Study|Withdrawal by Subject|38|||
131897665|NCT01243177|474910519|FG000|Overall Study|AE, serious fatal|0|||
131897666|NCT01243177|474910520|FG001|Overall Study|AE, serious fatal|1|||
131897667|NCT01243177|474910519|FG000|Overall Study|SAE, non-fatal|7|||
131897668|NCT01243177|474910520|FG001|Overall Study|SAE, non-fatal|9|||
131897669|NCT01243177|474910519|FG000|Overall Study|AE, non-serious non-fatal|40|||
131897670|NCT01243177|474910520|FG001|Overall Study|AE, non-serious non-fatal|58|||
131897671|NCT01243177|474910519|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
131897672|NCT01243177|474910520|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
131897673|NCT01243177|474910519|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131897674|NCT01243177|474910520|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
131897675|NCT01243177|474910519|FG000|Overall Study|Other Reason|11|||
131897676|NCT01243177|474910520|FG001|Overall Study|Other Reason|12|||
131897677|NCT00391872|474912427|FG000|Overall Study|Protocol Violation|7|||
131897678|NCT00391872|474912428|FG001|Overall Study|Protocol Violation|2|||
131897679|NCT00391872|474912427|FG000|Overall Study|Withdrawal by Subject|296|||
131897680|NCT00391872|474912428|FG001|Overall Study|Withdrawal by Subject|249|||
131897681|NCT00391872|474912427|FG000|Overall Study|Reason unknown|2|||
131897682|NCT00391872|474912428|FG001|Overall Study|Reason unknown|4|||
131897683|NCT00391872|474912427|FG000|Overall Study|Lost to Follow-up|2|||
131897684|NCT00391872|474912428|FG001|Overall Study|Lost to Follow-up|0|||
131897685|NCT00905632|474912430|FG000|Overall Study|Adverse Event|0|||
131897686|NCT00905632|474912431|FG001|Overall Study|Adverse Event|0|||
131897687|NCT00905632|474912432|FG002|Overall Study|Adverse Event|0|||
131897688|NCT00905632|474912433|FG003|Overall Study|Adverse Event|0|||
131897689|NCT00905632|474912434|FG004|Overall Study|Adverse Event|0|||
131897690|NCT00905632|474912435|FG005|Overall Study|Adverse Event|1|||
131897691|NCT00905632|474912436|FG006|Overall Study|Adverse Event|4|||
131897692|NCT03365934|474912439|FG000|Overall Study|Adverse Event|1|||
131897693|NCT03365934|474912439|FG000|Overall Study|Withdrawal by Subject|1|||
131897694|NCT01307891|474912440|FG000|Overall Study|Progressive Disease|3|||
131897695|NCT01307891|474912441|FG001|Overall Study|Progressive Disease|1|||
131897696|NCT02937740|474912442|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
131897697|NCT02937740|474912443|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
131897698|NCT02937740|474912442|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
131897699|NCT02937740|474912443|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
131897700|NCT02937740|474912442|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
131897701|NCT02937740|474912443|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
131897702|NCT02937740|474912442|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
131897703|NCT02937740|474912443|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
131897704|NCT02937740|474912442|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
131897705|NCT02937740|474912443|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
131897706|NCT02937740|474912442|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
131897707|NCT02937740|474912443|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
131897708|NCT04085601|474912444|FG000|Overall Study|Lost to Follow-up|1|||
131897709|NCT04085601|474912445|FG001|Overall Study|Lost to Follow-up|0|||
131897710|NCT04085601|474912444|FG000|Overall Study|Death|1|||
131897711|NCT04085601|474912445|FG001|Overall Study|Death|1|||
131897712|NCT03492437|474912446|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131897713|NCT03492437|474912447|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131897714|NCT03872843|474912448|FG000|Overall Study|Lost to Follow-up|5|||
131897715|NCT03872843|474912449|FG001|Overall Study|Lost to Follow-up|7|||
131897716|NCT00823264|474912450|FG000|Overall Study|Protocol Violation|2|||
131897717|NCT00823264|474912451|FG001|Overall Study|Protocol Violation|0|||
131897718|NCT00113295|474912452|FG000|Overall Study|Adverse Event|4|||
131897719|NCT00113295|474912453|FG001|Overall Study|Adverse Event|1|||
131897720|NCT00113295|474912452|FG000|Overall Study|Unrelated Medical Illness|1|||
131897721|NCT00113295|474912453|FG001|Overall Study|Unrelated Medical Illness|0|||
131897722|NCT00003483|474912456|FG000|Overall Study|Not evaluable|1|||
131897723|NCT02609386|474912457|FG000|Overall Study|Withdrawal by Subject|6|||
131897724|NCT02609386|474912458|FG001|Overall Study|Withdrawal by Subject|1|||
131897725|NCT02609386|474912457|FG000|Overall Study|Lost to Follow-up|3|||
131897726|NCT02609386|474912458|FG001|Overall Study|Lost to Follow-up|5|||
131897727|NCT02609386|474912457|FG000|Overall Study|Death|19|||
131897728|NCT02609386|474912458|FG001|Overall Study|Death|9|||
131897729|NCT02609386|474912457|FG000|Overall Study|Physician Decision|0|||
131897730|NCT02609386|474912458|FG001|Overall Study|Physician Decision|2|||
131897731|NCT01869777|474912470|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
131897732|NCT00878800|474912479|FG000|Overall Study|Adverse Event|0|||
131897733|NCT00878800|474912480|FG001|Overall Study|Adverse Event|0|||
131897734|NCT00878800|474912481|FG002|Overall Study|Adverse Event|2|||
131676452|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
131676453|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
131676454|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
131676455|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
131676456|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
131676457|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
131676458|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
131676459|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
131676460|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
131676461|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
131676462|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
131676463|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
131676464|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
131676465|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
131676466|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
131676467|NCT00908232|474100796|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
131676468|NCT00908232|474100797|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
131676469|NCT00908232|474100798|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
131676470|NCT00908232|474100799|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
131676471|NCT00528866|474100800|FG000|Overall Study|Protocol Violation|6|||
131676472|NCT02260882|474100801|FG000|Overall Study|Protocol Violation|0|||
131676473|NCT02260882|474100802|FG001|Overall Study|Protocol Violation|1|||
131676474|NCT02119325|474100803|FG000|Washout Period 1|Adverse Event|0|||
131676475|NCT02119325|474100804|FG001|Washout Period 1|Adverse Event|1|||
131676476|NCT01386658|474100805|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
131676477|NCT01386658|474100806|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
131676478|NCT01386658|474100805|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
131676479|NCT01386658|474100806|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
131676480|NCT00954174|474100807|FG000|Overall Study|Adverse Event|28|||
131676481|NCT00954174|474100808|FG001|Overall Study|Adverse Event|23|||
131676482|NCT00954174|474100809|FG002|Overall Study|Adverse Event|4|||
131676483|NCT00954174|474100810|FG003|Overall Study|Adverse Event|9|||
131676484|NCT00954174|474100807|FG000|Overall Study|Death|4|||
131676485|NCT00954174|474100808|FG001|Overall Study|Death|2|||
131676486|NCT00954174|474100809|FG002|Overall Study|Death|0|||
131676487|NCT00954174|474100810|FG003|Overall Study|Death|0|||
131676488|NCT00954174|474100807|FG000|Overall Study|Lack of Efficacy|32|||
131676489|NCT00954174|474100808|FG001|Overall Study|Lack of Efficacy|22|||
131676490|NCT00954174|474100809|FG002|Overall Study|Lack of Efficacy|8|||
131676491|NCT00954174|474100810|FG003|Overall Study|Lack of Efficacy|6|||
131676492|NCT00954174|474100807|FG000|Overall Study|Withdrawal by Subject|14|||
131676493|NCT00954174|474100808|FG001|Overall Study|Withdrawal by Subject|10|||
131676494|NCT00954174|474100809|FG002|Overall Study|Withdrawal by Subject|4|||
131676495|NCT00954174|474100810|FG003|Overall Study|Withdrawal by Subject|3|||
131676496|NCT00954174|474100807|FG000|Overall Study|Medical Reason|4|||
131897735|NCT00878800|474912482|FG003|Overall Study|Adverse Event|0|||
131897736|NCT00878800|474912483|FG004|Overall Study|Adverse Event|1|||
131897737|NCT00878800|474912479|FG000|Overall Study|Progressive disease|1|||
131897738|NCT00878800|474912480|FG001|Overall Study|Progressive disease|5|||
131897739|NCT00878800|474912481|FG002|Overall Study|Progressive disease|6|||
131897740|NCT00878800|474912482|FG003|Overall Study|Progressive disease|5|||
131897741|NCT00878800|474912483|FG004|Overall Study|Progressive disease|13|||
131897742|NCT00878800|474912479|FG000|Overall Study|Withdrew consent|1|||
131897743|NCT00878800|474912480|FG001|Overall Study|Withdrew consent|1|||
131897744|NCT00878800|474912481|FG002|Overall Study|Withdrew consent|0|||
131897745|NCT00878800|474912482|FG003|Overall Study|Withdrew consent|1|||
131897746|NCT00878800|474912483|FG004|Overall Study|Withdrew consent|1|||
131897747|NCT00878800|474912479|FG000|Overall Study|Death|0|||
131676497|NCT00954174|474100808|FG001|Overall Study|Medical Reason|2|||
131676498|NCT00954174|474100809|FG002|Overall Study|Medical Reason|1|||
131676499|NCT00954174|474100810|FG003|Overall Study|Medical Reason|0|||
131676500|NCT00954174|474100807|FG000|Overall Study|Ineligible|40|||
131676501|NCT00954174|474100808|FG001|Overall Study|Ineligible|47|||
131676502|NCT00954174|474100809|FG002|Overall Study|Ineligible|7|||
131676503|NCT00954174|474100810|FG003|Overall Study|Ineligible|4|||
131676504|NCT00954174|474100807|FG000|Overall Study|Never Treated|4|||
131676505|NCT00954174|474100808|FG001|Overall Study|Never Treated|17|||
131676506|NCT00954174|474100809|FG002|Overall Study|Never Treated|0|||
131676507|NCT00954174|474100810|FG003|Overall Study|Never Treated|3|||
131676508|NCT02249767|474100811|FG000|Overall Study|Did not use medication|8|||
131676509|NCT02249767|474100812|FG001|Overall Study|Did not use medication|9|||
131676510|NCT02249767|474100813|FG002|Overall Study|Did not use medication|8|||
131676511|NCT01372410|474100814|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
131676512|NCT01372410|474100815|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
131676513|NCT01372410|474100816|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131897748|NCT00878800|474912480|FG001|Overall Study|Death|0|||
131897749|NCT00878800|474912481|FG002|Overall Study|Death|1|||
131897750|NCT00878800|474912482|FG003|Overall Study|Death|0|||
131897751|NCT00878800|474912483|FG004|Overall Study|Death|0|||
131897752|NCT00878800|474912479|FG000|Overall Study|Other|1|||
131897753|NCT00878800|474912480|FG001|Overall Study|Other|1|||
131897754|NCT00878800|474912481|FG002|Overall Study|Other|0|||
131897755|NCT00878800|474912482|FG003|Overall Study|Other|0|||
131897756|NCT00878800|474912483|FG004|Overall Study|Other|1|||
131897757|NCT00613821|474912484|FG000|Overall Study|Withdrawal by Subject|1|||
131897758|NCT00613821|474912485|FG001|Overall Study|Withdrawal by Subject|0|||
131897759|NCT00613821|474912484|FG000|Overall Study|Physician Decision|1|||
131897760|NCT00613821|474912485|FG001|Overall Study|Physician Decision|1|||
131897761|NCT03318003|474912486|FG000|Overall Study|Withdrawal by Subject|1|||
131897762|NCT03318003|474912487|FG001|Overall Study|Withdrawal by Subject|1|||
131897763|NCT03318003|474912486|FG000|Overall Study|fetal loss|0|||
131897764|NCT03318003|474912487|FG001|Overall Study|fetal loss|1|||
131897765|NCT02302846|474912489|FG000|Overall Study|Withdrawal by Subject|1|||
131897766|NCT01468454|474912490|FG000|Overall Study|Did not have surgery after PET|9|||
131897767|NCT04435808|474912491|FG000|Overall Study|Study stopped by DSMB|0|||
131897768|NCT04435808|474912492|FG001|Overall Study|Study stopped by DSMB|1|||
131897769|NCT02620787|474912493|FG000|Overall Study|Adverse Event|1|||
131897770|NCT02620787|474912494|FG001|Overall Study|Adverse Event|0|||
131897771|NCT02620787|474912493|FG000|Overall Study|Eligibility Criteria Not Met|1|||
131897772|NCT02620787|474912494|FG001|Overall Study|Eligibility Criteria Not Met|0|||
131897773|NCT00807612|474912499|FG000|Overall Study|Death|8|||
131676514|NCT01372410|474100817|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131676515|NCT01372410|474100818|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
131676516|NCT01372410|474100819|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131676517|NCT01372410|474100820|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131676518|NCT01372410|474100821|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131676519|NCT01372410|474100814|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
131676520|NCT01372410|474100815|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
131676521|NCT01372410|474100816|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
131676522|NCT01372410|474100817|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
131676523|NCT01372410|474100818|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
131676524|NCT01372410|474100819|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
131676525|NCT01372410|474100820|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
131676526|NCT01372410|474100821|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
131676527|NCT01372410|474100814|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131676528|NCT01372410|474100815|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131772591|NCT02400281|474445123|FG005|Overall Study|Physician Decision|0|||
131676529|NCT01372410|474100816|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131676530|NCT01372410|474100817|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131897774|NCT00807612|474912499|FG000|Overall Study|Study early termination|5|||
131897775|NCT00807612|474912499|FG000|Overall Study|Withdrawal by Subject|1|||
131897776|NCT02258659|474912501|FG000|Overall Study|Withdrawal by Subject|1|||
131897777|NCT04892446|474912502|FG000|Overall Study|Death|4|||
131897778|NCT04892446|474912503|FG001|Overall Study|Death|4|||
131897779|NCT04892446|474912504|FG002|Overall Study|Death|0|||
131897780|NCT04892446|474912502|FG000|Overall Study|Withdrew consent|3|||
131897781|NCT04892446|474912503|FG001|Overall Study|Withdrew consent|0|||
131897782|NCT04892446|474912504|FG002|Overall Study|Withdrew consent|1|||
131897783|NCT04892446|474912502|FG000|Overall Study|Investigator's discretion|1|||
131897784|NCT04892446|474912503|FG001|Overall Study|Investigator's discretion|1|||
131897785|NCT04892446|474912504|FG002|Overall Study|Investigator's discretion|0|||
131897786|NCT04892446|474912502|FG000|Overall Study|Study terminated by sponsor|0|||
131897787|NCT04892446|474912503|FG001|Overall Study|Study terminated by sponsor|0|||
131897788|NCT04892446|474912504|FG002|Overall Study|Study terminated by sponsor|2|||
131897789|NCT00272844|474912505|FG000|Overall Study|Withdrawal by Subject|5|||
131897790|NCT00791700|474912508|FG000|Overall Study|Insufficient clinical response|1|||
131897791|NCT00791700|474912509|FG001|Overall Study|Insufficient clinical response|4|||
131897792|NCT00791700|474912510|FG002|Overall Study|Insufficient clinical response|1|||
131897793|NCT00791700|474912511|FG003|Overall Study|Insufficient clinical response|8|||
131897794|NCT00791700|474912508|FG000|Overall Study|No longer willing to participate|1|||
131897795|NCT00791700|474912509|FG001|Overall Study|No longer willing to participate|1|||
131897796|NCT00791700|474912510|FG002|Overall Study|No longer willing to participate|0|||
131897797|NCT00791700|474912511|FG003|Overall Study|No longer willing to participate|8|||
131897798|NCT00791700|474912508|FG000|Overall Study|Non-compliance with study treatment|0|||
131897799|NCT00791700|474912509|FG001|Overall Study|Non-compliance with study treatment|2|||
131897800|NCT00791700|474912510|FG002|Overall Study|Non-compliance with study treatment|0|||
131897801|NCT00791700|474912511|FG003|Overall Study|Non-compliance with study treatment|4|||
131897802|NCT00791700|474912508|FG000|Overall Study|Withdrawn due to pregnancy|0|||
131897803|NCT00791700|474912509|FG001|Overall Study|Withdrawn due to pregnancy|0|||
131897804|NCT00791700|474912510|FG002|Overall Study|Withdrawn due to pregnancy|0|||
131897805|NCT00791700|474912511|FG003|Overall Study|Withdrawn due to pregnancy|1|||
131897806|NCT00791700|474912508|FG000|Overall Study|Other|0|||
131897807|NCT00791700|474912509|FG001|Overall Study|Other|1|||
131897808|NCT00791700|474912510|FG002|Overall Study|Other|0|||
131897809|NCT00791700|474912511|FG003|Overall Study|Other|1|||
131897810|NCT00791700|474912508|FG000|Overall Study|Death|0|||
131897811|NCT00791700|474912509|FG001|Overall Study|Death|0|||
131897812|NCT00791700|474912510|FG002|Overall Study|Death|0|||
131897813|NCT00791700|474912511|FG003|Overall Study|Death|1|||
131897814|NCT00791700|474912508|FG000|Overall Study|Lost to Follow-up|4|||
131897815|NCT00791700|474912509|FG001|Overall Study|Lost to Follow-up|3|||
131897816|NCT00791700|474912510|FG002|Overall Study|Lost to Follow-up|4|||
131897817|NCT00791700|474912511|FG003|Overall Study|Lost to Follow-up|6|||
131897818|NCT00791700|474912508|FG000|Overall Study|Adverse Event|0|||
131897819|NCT00791700|474912509|FG001|Overall Study|Adverse Event|0|||
131897820|NCT00791700|474912510|FG002|Overall Study|Adverse Event|1|||
131897821|NCT00791700|474912511|FG003|Overall Study|Adverse Event|1|||
131897822|NCT00527826|474912512|FG000|Overall Study|Adverse Event|10|||
131897823|NCT00527826|474912513|FG001|Overall Study|Adverse Event|10|||
131897824|NCT00527826|474912512|FG000|Overall Study|Lost to Follow-up|3|||
131897825|NCT00527826|474912513|FG001|Overall Study|Lost to Follow-up|2|||
131897826|NCT00527826|474912512|FG000|Overall Study|Withdrawal by Subject|5|||
131897827|NCT00527826|474912513|FG001|Overall Study|Withdrawal by Subject|8|||
131897828|NCT00527826|474912512|FG000|Overall Study|Inclusion Criteria Not Met|3|||
131897829|NCT00527826|474912513|FG001|Overall Study|Inclusion Criteria Not Met|3|||
131897830|NCT00527826|474912512|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
131897831|NCT00527826|474912513|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
131897832|NCT00527826|474912512|FG000|Overall Study|Additional Intake of Viani forte|0|||
131897833|NCT00527826|474912513|FG001|Overall Study|Additional Intake of Viani forte|1|||
131897834|NCT00527826|474912512|FG000|Overall Study|Participant moved away|0|||
131897835|NCT00527826|474912513|FG001|Overall Study|Participant moved away|1|||
131897836|NCT01808261|474912514|FG000|Overall Study|Physician Decision|0|||
131897837|NCT01808261|474912515|FG001|Overall Study|Physician Decision|2|||
131897838|NCT01808261|474912514|FG000|Overall Study|Study Closed/Terminated|25|||
131897839|NCT01808261|474912515|FG001|Overall Study|Study Closed/Terminated|23|||
131897840|NCT01808261|474912514|FG000|Overall Study|Adverse event, non-fatal|2|||
131897841|NCT01808261|474912515|FG001|Overall Study|Adverse event, non-fatal|0|||
131897842|NCT01808261|474912514|FG000|Overall Study|Consent withdrawn by subject|6|||
131897843|NCT01808261|474912515|FG001|Overall Study|Consent withdrawn by subject|7|||
131897844|NCT01808261|474912514|FG000|Overall Study|Lost to Follow-up|3|||
131897845|NCT01808261|474912515|FG001|Overall Study|Lost to Follow-up|1|||
131897846|NCT01737879|474912520|FG000|Overall Study|Death|1|||
131676531|NCT01372410|474100818|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
131676532|NCT01372410|474100819|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131676533|NCT01372410|474100820|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131676534|NCT01372410|474100821|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131676535|NCT01372410|474100814|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131676536|NCT01372410|474100815|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131676537|NCT01372410|474100816|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131676538|NCT01372410|474100817|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131676539|NCT01372410|474100818|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131897847|NCT01737879|474912520|FG000|Overall Study|Sponsor decision|40|||
131897848|NCT02497404|474912521|FG000|Overall Study|Adverse Event|1|||
131897849|NCT05568797|474912526|FG000|Overall Study|Adverse Event|0|||
131897850|NCT05568797|474912527|FG001|Overall Study|Adverse Event|8|||
131897851|NCT05568797|474912526|FG000|Overall Study|Lost to Follow-up|2|||
131897852|NCT05568797|474912527|FG001|Overall Study|Lost to Follow-up|3|||
131897853|NCT05568797|474912526|FG000|Overall Study|Withdrawal by Subject|1|||
131897854|NCT05568797|474912527|FG001|Overall Study|Withdrawal by Subject|10|||
131897855|NCT05568797|474912526|FG000|Overall Study|Other|2|||
131897856|NCT05568797|474912527|FG001|Overall Study|Other|2|||
131897857|NCT03131687|474912528|FG000|Overall Study|Adverse Event|0|||
131897858|NCT03131687|474912529|FG001|Overall Study|Adverse Event|1|||
131897859|NCT03131687|474912530|FG002|Overall Study|Adverse Event|0|||
131897860|NCT03131687|474912531|FG003|Overall Study|Adverse Event|1|||
131897861|NCT03131687|474912532|FG004|Overall Study|Adverse Event|2|||
131897862|NCT03131687|474912533|FG005|Overall Study|Adverse Event|2|||
131897863|NCT03131687|474912528|FG000|Overall Study|Death|1|||
131897864|NCT03131687|474912529|FG001|Overall Study|Death|0|||
131897865|NCT03131687|474912530|FG002|Overall Study|Death|0|||
131897866|NCT03131687|474912531|FG003|Overall Study|Death|0|||
131897867|NCT03131687|474912532|FG004|Overall Study|Death|0|||
131897868|NCT03131687|474912533|FG005|Overall Study|Death|0|||
131897869|NCT03131687|474912528|FG000|Overall Study|Withdrawal by Subject|3|||
131897870|NCT03131687|474912529|FG001|Overall Study|Withdrawal by Subject|3|||
131897871|NCT03131687|474912530|FG002|Overall Study|Withdrawal by Subject|3|||
131897872|NCT03131687|474912531|FG003|Overall Study|Withdrawal by Subject|1|||
131897873|NCT03131687|474912532|FG004|Overall Study|Withdrawal by Subject|2|||
131897874|NCT03131687|474912533|FG005|Overall Study|Withdrawal by Subject|1|||
131897875|NCT03131687|474912528|FG000|Overall Study|Lost to Follow-up|1|||
131897876|NCT03131687|474912529|FG001|Overall Study|Lost to Follow-up|4|||
131897877|NCT03131687|474912530|FG002|Overall Study|Lost to Follow-up|0|||
131897878|NCT03131687|474912531|FG003|Overall Study|Lost to Follow-up|1|||
131897879|NCT03131687|474912532|FG004|Overall Study|Lost to Follow-up|4|||
131897880|NCT03131687|474912533|FG005|Overall Study|Lost to Follow-up|2|||
131897881|NCT03131687|474912528|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
131897882|NCT03131687|474912529|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
131897883|NCT03131687|474912530|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
131897884|NCT03131687|474912531|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
131897885|NCT03131687|474912532|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
131897886|NCT03131687|474912533|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
131897887|NCT03131687|474912528|FG000|Overall Study|Principle Investigator Decision|0|||
131897888|NCT03131687|474912529|FG001|Overall Study|Principle Investigator Decision|1|||
131897889|NCT03131687|474912530|FG002|Overall Study|Principle Investigator Decision|0|||
131897890|NCT03131687|474912531|FG003|Overall Study|Principle Investigator Decision|0|||
131897891|NCT03131687|474912532|FG004|Overall Study|Principle Investigator Decision|0|||
131897892|NCT03131687|474912533|FG005|Overall Study|Principle Investigator Decision|0|||
131897893|NCT03131687|474912528|FG000|Overall Study|Inadvertent Enrollment|0|||
131897894|NCT03131687|474912529|FG001|Overall Study|Inadvertent Enrollment|0|||
131897895|NCT03131687|474912530|FG002|Overall Study|Inadvertent Enrollment|0|||
131897896|NCT03131687|474912531|FG003|Overall Study|Inadvertent Enrollment|1|||
131897897|NCT03131687|474912532|FG004|Overall Study|Inadvertent Enrollment|0|||
131897898|NCT03131687|474912533|FG005|Overall Study|Inadvertent Enrollment|0|||
131897899|NCT00869128|474912538|FG000|Overall Study|lack of Compliance|6|||
131897900|NCT00869128|474912539|FG001|Overall Study|lack of Compliance|6|||
131897901|NCT01118663|474912545|FG000|Overall Study|Adverse Event|2|||
131897902|NCT01118663|474912546|FG001|Overall Study|Adverse Event|1|||
131897903|NCT01118663|474912545|FG000|Overall Study|Withdrawal by Subject|0|||
131897904|NCT01118663|474912546|FG001|Overall Study|Withdrawal by Subject|1|||
131897905|NCT05279131|474912547|FG000|Overall Study|Lost to Follow-up|1|||
131897906|NCT05279131|474912547|FG000|Overall Study|Death|1|||
131897907|NCT05279131|474912547|FG000|Overall Study|Physician Decision|1|||
131897908|NCT02282163|474912554|FG000|Overall Study|Protocol Violation|1|||
131897909|NCT01603407|474912555|FG000|Overall Study|Adverse Event|1|||
131897910|NCT01603407|474912556|FG001|Overall Study|Adverse Event|1|||
131897911|NCT01603407|474912557|FG002|Overall Study|Adverse Event|1|||
131897912|NCT01603407|474912555|FG000|Overall Study|Protocol Violation|2|||
131897913|NCT01603407|474912556|FG001|Overall Study|Protocol Violation|2|||
131676540|NCT01372410|474100819|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131676541|NCT01372410|474100820|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
131676542|NCT01372410|474100821|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131897914|NCT01603407|474912557|FG002|Overall Study|Protocol Violation|0|||
131897915|NCT01603407|474912555|FG000|Overall Study|Withdrawal by Subject|8|||
131897916|NCT01603407|474912556|FG001|Overall Study|Withdrawal by Subject|5|||
131897917|NCT01603407|474912557|FG002|Overall Study|Withdrawal by Subject|7|||
131897918|NCT01603407|474912555|FG000|Overall Study|Lost to Follow-up|0|||
131897919|NCT01603407|474912556|FG001|Overall Study|Lost to Follow-up|3|||
131897920|NCT01603407|474912557|FG002|Overall Study|Lost to Follow-up|2|||
131897921|NCT02500719|474912558|FG000|Overall Study|Lost to Follow-up|2|||
131897922|NCT02500719|474912559|FG001|Overall Study|Lost to Follow-up|3|||
131897923|NCT02500719|474912558|FG000|Overall Study|Trauma history|1|||
131897924|NCT02500719|474912559|FG001|Overall Study|Trauma history|0|||
131897925|NCT02500719|474912558|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
131897926|NCT02500719|474912559|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
131897927|NCT02500719|474912558|FG000|Overall Study|Did not meet criteria for PTSD|0|||
131897928|NCT02500719|474912559|FG001|Overall Study|Did not meet criteria for PTSD|1|||
131897929|NCT02500719|474912558|FG000|Overall Study|Claustrophobia|0|||
131897930|NCT02500719|474912559|FG001|Overall Study|Claustrophobia|1|||
131897931|NCT02500719|474912558|FG000|Overall Study|History of head trauma|0|||
131897932|NCT02500719|474912559|FG001|Overall Study|History of head trauma|1|||
131897933|NCT01990768|474912562|FG000|Intervention Started|Found to be ineligible|14|||
131897934|NCT01990768|474912563|FG001|Intervention Started|Found to be ineligible|13|||
131897935|NCT01990768|474912564|FG002|Intervention Started|Found to be ineligible|11|||
131897936|NCT01990768|474912562|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
131897937|NCT01990768|474912563|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
131897938|NCT01990768|474912564|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
131897939|NCT01990768|474912562|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
131897940|NCT01990768|474912563|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
131897941|NCT01990768|474912564|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
131897942|NCT01990768|474912562|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
131897943|NCT01990768|474912563|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
131897944|NCT01990768|474912564|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
131897945|NCT01990768|474912562|FG000|Intervention Started|Patient care priority|1|||
131897946|NCT01990768|474912563|FG001|Intervention Started|Patient care priority|2|||
131897947|NCT01990768|474912564|FG002|Intervention Started|Patient care priority|3|||
131897948|NCT01990768|474912562|FG000|Intervention Started|IV lost|2|||
131897949|NCT01990768|474912563|FG001|Intervention Started|IV lost|2|||
131897950|NCT01990768|474912564|FG002|Intervention Started|IV lost|2|||
131897951|NCT01990768|474912562|FG000|Intervention Started|Required CPR|1|||
131897952|NCT01990768|474912563|FG001|Intervention Started|Required CPR|1|||
131897953|NCT01990768|474912564|FG002|Intervention Started|Required CPR|0|||
131897954|NCT01990768|474912562|FG000|Intervention Started|Seizure or hx of seizure|0|||
131897955|NCT01990768|474912563|FG001|Intervention Started|Seizure or hx of seizure|0|||
131897956|NCT01990768|474912564|FG002|Intervention Started|Seizure or hx of seizure|2|||
131897957|NCT01990768|474912562|FG000|Intervention Started|Discovered to be pregnant|0|||
131897958|NCT01990768|474912563|FG001|Intervention Started|Discovered to be pregnant|1|||
131897959|NCT01990768|474912564|FG002|Intervention Started|Discovered to be pregnant|0|||
131897960|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
131897961|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
131897962|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
131897963|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
131897964|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
131897965|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
131897966|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
131897967|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
131897968|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
131897969|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
131897970|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
131897971|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
131897972|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Death|3|||
131897973|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Death|1|||
131897974|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Death|1|||
131897975|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Discharged|2|||
131897976|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Discharged|1|||
131897977|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Discharged|0|||
131897978|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
131676543|NCT01372410|474100814|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
131676544|NCT01372410|474100815|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131676545|NCT01372410|474100816|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131676546|NCT01372410|474100817|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131676547|NCT01372410|474100818|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131676548|NCT01372410|474100819|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131676549|NCT01372410|474100820|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131676550|NCT01372410|474100821|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
131676551|NCT01372410|474100814|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676552|NCT01372410|474100815|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676553|NCT01372410|474100816|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676554|NCT01372410|474100817|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676555|NCT01372410|474100818|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
131676556|NCT01372410|474100819|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676557|NCT01372410|474100820|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676558|NCT01372410|474100821|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131676559|NCT01372410|474100814|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131676560|NCT01372410|474100815|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131676561|NCT01372410|474100816|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131676562|NCT01372410|474100817|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131676563|NCT01372410|474100818|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
131676564|NCT01372410|474100819|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131676565|NCT01372410|474100820|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
131676566|NCT01372410|474100821|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
131676567|NCT01372410|474100814|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676568|NCT01372410|474100815|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676569|NCT01372410|474100816|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676570|NCT01372410|474100817|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676571|NCT01372410|474100818|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676572|NCT01372410|474100819|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676573|NCT01372410|474100820|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131676574|NCT01372410|474100821|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
131676575|NCT01372410|474100814|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676576|NCT01372410|474100815|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676577|NCT01372410|474100816|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
131676578|NCT01372410|474100817|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676579|NCT01372410|474100818|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676580|NCT01372410|474100819|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676581|NCT01372410|474100820|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676582|NCT01372410|474100821|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
131676583|NCT01372410|474100814|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676584|NCT01372410|474100815|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676585|NCT01372410|474100816|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676586|NCT01372410|474100817|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676587|NCT01372410|474100818|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676588|NCT01372410|474100819|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
131676589|NCT01372410|474100820|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676590|NCT01372410|474100821|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131676591|NCT04585646|474100822|FG000|First Intervention|Physician Decision|1|||
131676592|NCT04585646|474100823|FG001|First Intervention|Physician Decision|0|||
131676593|NCT04585646|474100822|FG000|First Intervention|Lost to Follow-up|0|||
131676594|NCT04585646|474100823|FG001|First Intervention|Lost to Follow-up|3|||
131676595|NCT04585646|474100822|FG000|First Intervention|Withdrawal by Subject|0|||
131676596|NCT04585646|474100823|FG001|First Intervention|Withdrawal by Subject|1|||
131676597|NCT02465463|474100825|FG000|Overall Study|Lost to Follow-up|2|||
131676598|NCT02465463|474100826|FG001|Overall Study|Lost to Follow-up|1|||
131676599|NCT02465463|474100825|FG000|Overall Study|Death|1|||
131676600|NCT02465463|474100826|FG001|Overall Study|Death|0|||
131676601|NCT02465463|474100825|FG000|Overall Study|Protocol Violation|1|||
131676602|NCT02465463|474100826|FG001|Overall Study|Protocol Violation|0|||
131676603|NCT01067326|474100829|FG000|Overall Study|Adverse Event|0|||
131676604|NCT01067326|474100830|FG001|Overall Study|Adverse Event|2|||
131676605|NCT01067326|474100829|FG000|Overall Study|Withdrawal by Subject|1|||
131676606|NCT01067326|474100830|FG001|Overall Study|Withdrawal by Subject|0|||
131676607|NCT01067326|474100829|FG000|Overall Study|Early Study Termination|1|||
131676608|NCT01067326|474100830|FG001|Overall Study|Early Study Termination|1|||
131676609|NCT01230788|474100835|FG000|Overall Study|Prescribed exclusion drug|1|||
131676610|NCT02411578|474100843|FG000|Crossover Trial Phase|Pregnancy|0|||
131676611|NCT02411578|474100844|FG001|Crossover Trial Phase|Pregnancy|1|||
131676612|NCT01557348|474100847|FG000|Overall Study|Adverse Event|6|||
131676613|NCT01557348|474100848|FG001|Overall Study|Adverse Event|16|||
131676614|NCT01557348|474100847|FG000|Overall Study|Infusion reaction event|5|||
131676615|NCT01557348|474100848|FG001|Overall Study|Infusion reaction event|5|||
131676616|NCT01557348|474100847|FG000|Overall Study|Death|7|||
131676617|NCT01557348|474100848|FG001|Overall Study|Death|4|||
131676618|NCT01557348|474100847|FG000|Overall Study|Insufficient Therapeutic Response|13|||
131676619|NCT01557348|474100848|FG001|Overall Study|Insufficient Therapeutic Response|28|||
131676620|NCT01557348|474100847|FG000|Overall Study|Withdrawal by Subject|5|||
131676621|NCT01557348|474100848|FG001|Overall Study|Withdrawal by Subject|4|||
131676622|NCT01557348|474100847|FG000|Overall Study|Lost to Follow-up|26|||
131676623|NCT01557348|474100848|FG001|Overall Study|Lost to Follow-up|22|||
131676624|NCT01557348|474100847|FG000|Overall Study|Administrative|18|||
131676625|NCT01557348|474100848|FG001|Overall Study|Administrative|11|||
131676626|NCT02000427|474100853|FG000|Overall Study|Death|22|||
131676627|NCT02708095|474100856|FG000|Overall Study|Adverse Event|4|||
131676628|NCT02708095|474100857|FG001|Overall Study|Adverse Event|10|||
131676629|NCT02708095|474100858|FG002|Overall Study|Adverse Event|11|||
131676630|NCT02708095|474100856|FG000|Overall Study|Lack of Efficacy|9|||
131676631|NCT02708095|474100857|FG001|Overall Study|Lack of Efficacy|3|||
131676632|NCT02708095|474100858|FG002|Overall Study|Lack of Efficacy|0|||
131897979|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
131897980|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
131676633|NCT02708095|474100856|FG000|Overall Study|Lost to Follow-up|2|||
131897981|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
131897982|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
131897983|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
131897984|NCT01990768|474912562|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
131897985|NCT01990768|474912563|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
131897986|NCT01990768|474912564|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
131897987|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
131897988|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
131897989|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
131897990|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
131897991|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
131897992|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
131897993|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
131897994|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
131897995|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
131897996|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
131897997|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
131897998|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
131897999|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
131898000|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
131898001|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
131898002|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
131898003|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
131898004|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
131898005|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
131898006|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
131898007|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
131898008|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
131898009|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
131898010|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
131898011|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
131898012|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
131898013|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
131898014|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
131898015|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
131898016|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
131898017|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
131898018|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
131898019|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
131898020|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
131898021|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
131898022|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
131898023|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
131898024|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
131898025|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
131898026|NCT01990768|474912562|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
131898027|NCT01990768|474912563|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
131898028|NCT01990768|474912564|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
131898029|NCT01990768|474912562|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
131898030|NCT01990768|474912563|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
131898031|NCT01990768|474912564|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
131898032|NCT01990768|474912562|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
131898033|NCT01990768|474912563|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
131898034|NCT01990768|474912564|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
131555486|NCT03101241|473658221|FG000|Overall Study|Lost to Follow-up|2|||
131676634|NCT02708095|474100857|FG001|Overall Study|Lost to Follow-up|0|||
131676635|NCT02708095|474100858|FG002|Overall Study|Lost to Follow-up|0|||
131676636|NCT02708095|474100856|FG000|Overall Study|Physician Decision|2|||
131676637|NCT02708095|474100857|FG001|Overall Study|Physician Decision|3|||
131676638|NCT02708095|474100858|FG002|Overall Study|Physician Decision|2|||
131676639|NCT02708095|474100856|FG000|Overall Study|Protocol Violation|0|||
131676640|NCT02708095|474100857|FG001|Overall Study|Protocol Violation|0|||
131676641|NCT02708095|474100858|FG002|Overall Study|Protocol Violation|1|||
131676642|NCT02708095|474100856|FG000|Overall Study|Withdrawal by Subject|5|||
131676643|NCT02708095|474100857|FG001|Overall Study|Withdrawal by Subject|3|||
131676644|NCT02708095|474100858|FG002|Overall Study|Withdrawal by Subject|4|||
131676645|NCT03891524|474100863|FG000|Overall Study|Death|0|||
131676646|NCT03891524|474100864|FG001|Overall Study|Death|0|||
131676647|NCT03891524|474100865|FG002|Overall Study|Death|0|||
131676648|NCT03891524|474100866|FG003|Overall Study|Death|0|||
131676649|NCT03891524|474100867|FG004|Overall Study|Death|0|||
131676650|NCT03891524|474100868|FG005|Overall Study|Death|0|||
131676651|NCT03891524|474100869|FG006|Overall Study|Death|0|||
131676652|NCT03891524|474100870|FG007|Overall Study|Death|1|||
131676653|NCT03891524|474100863|FG000|Overall Study|Withdrawal by Subject|0|||
131676654|NCT03891524|474100864|FG001|Overall Study|Withdrawal by Subject|1|||
131676655|NCT03891524|474100865|FG002|Overall Study|Withdrawal by Subject|2|||
131676656|NCT03891524|474100866|FG003|Overall Study|Withdrawal by Subject|1|||
131676657|NCT03891524|474100867|FG004|Overall Study|Withdrawal by Subject|2|||
131676658|NCT03891524|474100868|FG005|Overall Study|Withdrawal by Subject|2|||
131676659|NCT03891524|474100869|FG006|Overall Study|Withdrawal by Subject|2|||
131676660|NCT03891524|474100870|FG007|Overall Study|Withdrawal by Subject|1|||
131676661|NCT02958267|474100873|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
131676662|NCT02958267|474100874|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
131676663|NCT02958267|474100873|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
131676664|NCT02958267|474100874|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
131676665|NCT02958267|474100873|FG000|Follow-up Visits|Additional treatment pursued|2|||
131676666|NCT02958267|474100874|FG001|Follow-up Visits|Additional treatment pursued|1|||
131676667|NCT01210118|474100875|FG000|Overall Study|Lost to Follow-up|1|||
131676668|NCT01210118|474100876|FG001|Overall Study|Lost to Follow-up|1|||
131676669|NCT01210118|474100875|FG000|Overall Study|Protocol Violation|1|||
131676670|NCT01210118|474100876|FG001|Overall Study|Protocol Violation|1|||
131676671|NCT01210118|474100875|FG000|Overall Study|Spontaneous abortion|1|||
131676672|NCT01210118|474100876|FG001|Overall Study|Spontaneous abortion|3|||
131676673|NCT02684357|474100877|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
131676674|NCT02684357|474100878|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
131676675|NCT02684357|474100879|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
131676676|NCT02684357|474100880|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
131676677|NCT02684357|474100881|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
131676678|NCT02684357|474100882|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
131676679|NCT02684357|474100877|FG000|Part A|Lost to Follow-up|0|||
131676680|NCT02684357|474100878|FG001|Part A|Lost to Follow-up|2|||
131676681|NCT02684357|474100879|FG002|Part A|Lost to Follow-up|2|||
131676682|NCT02684357|474100880|FG003|Part A|Lost to Follow-up|0|||
131898035|NCT01990768|474912562|FG000|6-Month Follow-up|No contact information|5|||
131898036|NCT01990768|474912563|FG001|6-Month Follow-up|No contact information|6|||
131898037|NCT01990768|474912564|FG002|6-Month Follow-up|No contact information|5|||
131898038|NCT01990768|474912562|FG000|6-Month Follow-up|Homeless|4|||
131898039|NCT01990768|474912563|FG001|6-Month Follow-up|Homeless|3|||
131898040|NCT01990768|474912564|FG002|6-Month Follow-up|Homeless|6|||
131898041|NCT01990768|474912562|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
131898042|NCT01990768|474912563|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
131898043|NCT01990768|474912564|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
131898044|NCT01990768|474912562|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
131898045|NCT01990768|474912563|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
131898046|NCT01990768|474912564|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
131898047|NCT01990768|474912562|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
131898048|NCT01990768|474912563|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
131898049|NCT01990768|474912564|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
131898050|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
131898051|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
131898052|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
131898053|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
131898054|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
131898055|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
131898056|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
131898057|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
131898058|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
131898059|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
131898060|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
131898061|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
131898062|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
131898063|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
131898064|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
131898065|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
131898066|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
131898067|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
131898068|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
131898069|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
131898070|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
131898071|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
131898072|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
131898073|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
131898074|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
131898075|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
131898076|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
131898077|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
131898078|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
131898079|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
131898080|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
131898081|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
131898082|NCT03538691|474912565|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
131898083|NCT03538691|474912566|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
131898084|NCT03538691|474912567|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
131898085|NCT03538691|474912568|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
131898086|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
131898087|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
131898088|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
131898089|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
131898090|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
131898091|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
131898092|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
131898093|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
131676683|NCT02684357|474100881|FG004|Part A|Lost to Follow-up|0|||
131676684|NCT02684357|474100882|FG005|Part A|Lost to Follow-up|0|||
131676685|NCT02684357|474100877|FG000|Part A|Withdrawal by Subject|3|||
131676686|NCT02684357|474100878|FG001|Part A|Withdrawal by Subject|0|||
131676687|NCT02684357|474100879|FG002|Part A|Withdrawal by Subject|0|||
131676688|NCT02684357|474100880|FG003|Part A|Withdrawal by Subject|0|||
131676689|NCT02684357|474100881|FG004|Part A|Withdrawal by Subject|0|||
131676690|NCT02684357|474100882|FG005|Part A|Withdrawal by Subject|0|||
131676691|NCT02684357|474100877|FG000|Part A|Other|0|||
131676692|NCT02684357|474100878|FG001|Part A|Other|1|||
131676693|NCT02684357|474100879|FG002|Part A|Other|0|||
131676694|NCT02684357|474100880|FG003|Part A|Other|0|||
131676695|NCT02684357|474100881|FG004|Part A|Other|0|||
131676696|NCT02684357|474100882|FG005|Part A|Other|0|||
131676697|NCT02684357|474100877|FG000|Part B|Adverse Event (Other)|0|||
131676698|NCT02684357|474100878|FG001|Part B|Adverse Event (Other)|0|||
131676699|NCT02684357|474100879|FG002|Part B|Adverse Event (Other)|0|||
131676700|NCT02684357|474100880|FG003|Part B|Adverse Event (Other)|1|||
131676701|NCT02684357|474100881|FG004|Part B|Adverse Event (Other)|1|||
131676702|NCT02684357|474100882|FG005|Part B|Adverse Event (Other)|1|||
131676703|NCT02684357|474100877|FG000|Part B|Lost to Follow-up|0|||
131676704|NCT02684357|474100878|FG001|Part B|Lost to Follow-up|0|||
131676705|NCT02684357|474100879|FG002|Part B|Lost to Follow-up|0|||
131676706|NCT02684357|474100880|FG003|Part B|Lost to Follow-up|1|||
131676707|NCT02684357|474100881|FG004|Part B|Lost to Follow-up|1|||
131676708|NCT02684357|474100882|FG005|Part B|Lost to Follow-up|7|||
131676709|NCT02684357|474100877|FG000|Part B|Withdrawal by Subject|0|||
131676710|NCT02684357|474100878|FG001|Part B|Withdrawal by Subject|0|||
131676711|NCT02684357|474100879|FG002|Part B|Withdrawal by Subject|0|||
131676712|NCT02684357|474100880|FG003|Part B|Withdrawal by Subject|0|||
131676713|NCT02684357|474100881|FG004|Part B|Withdrawal by Subject|2|||
131676714|NCT02684357|474100882|FG005|Part B|Withdrawal by Subject|4|||
131676715|NCT02684357|474100877|FG000|Part B|Other|0|||
131676716|NCT02684357|474100878|FG001|Part B|Other|0|||
131676717|NCT02684357|474100879|FG002|Part B|Other|0|||
131676718|NCT02684357|474100880|FG003|Part B|Other|1|||
131676719|NCT02684357|474100881|FG004|Part B|Other|0|||
131676720|NCT02684357|474100882|FG005|Part B|Other|1|||
131676721|NCT01079130|474100883|FG000|Overall Study|Adverse Event|1|||
131676722|NCT01079130|474100884|FG001|Overall Study|Adverse Event|1|||
131676723|NCT01079130|474100885|FG002|Overall Study|Adverse Event|0|||
131676724|NCT01079130|474100886|FG003|Overall Study|Adverse Event|1|||
131676725|NCT01079130|474100887|FG004|Overall Study|Adverse Event|5|||
131676726|NCT01079130|474100888|FG005|Overall Study|Adverse Event|1|||
131676727|NCT01079130|474100883|FG000|Overall Study|Administrative problems|1|||
131676728|NCT01079130|474100884|FG001|Overall Study|Administrative problems|3|||
131676729|NCT01079130|474100885|FG002|Overall Study|Administrative problems|0|||
131676730|NCT01079130|474100886|FG003|Overall Study|Administrative problems|0|||
131676731|NCT01079130|474100887|FG004|Overall Study|Administrative problems|0|||
131676732|NCT01079130|474100888|FG005|Overall Study|Administrative problems|1|||
131676733|NCT01079130|474100883|FG000|Overall Study|Withdrawal by Subject|0|||
131676734|NCT01079130|474100884|FG001|Overall Study|Withdrawal by Subject|1|||
131676735|NCT01079130|474100885|FG002|Overall Study|Withdrawal by Subject|0|||
131676736|NCT01079130|474100886|FG003|Overall Study|Withdrawal by Subject|0|||
131676737|NCT01079130|474100887|FG004|Overall Study|Withdrawal by Subject|1|||
131898094|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
131898095|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
131676738|NCT01079130|474100888|FG005|Overall Study|Withdrawal by Subject|3|||
131676739|NCT01079130|474100883|FG000|Overall Study|Protocol deviation|0|||
131676740|NCT01079130|474100884|FG001|Overall Study|Protocol deviation|2|||
131676741|NCT01079130|474100885|FG002|Overall Study|Protocol deviation|1|||
131676742|NCT01079130|474100886|FG003|Overall Study|Protocol deviation|2|||
131676743|NCT01079130|474100887|FG004|Overall Study|Protocol deviation|0|||
131898096|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
131898097|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
131898098|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
131898099|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
131898100|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
131898101|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
131898102|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
131898103|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
131898104|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
131898105|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
131898106|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
131898107|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
131898108|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
131898109|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
131898110|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
131676744|NCT01079130|474100888|FG005|Overall Study|Protocol deviation|0|||
131676745|NCT01079130|474100883|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131676746|NCT01079130|474100884|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131676747|NCT01079130|474100885|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131676748|NCT01079130|474100886|FG003|Overall Study|Abnormal test procedure result(s)|0|||
131676749|NCT01079130|474100887|FG004|Overall Study|Abnormal test procedure result(s)|1|||
131676750|NCT01079130|474100888|FG005|Overall Study|Abnormal test procedure result(s)|0|||
131676751|NCT01079130|474100883|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131676752|NCT01079130|474100884|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131676753|NCT01079130|474100885|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131676754|NCT01079130|474100886|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131676755|NCT01079130|474100887|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
131676756|NCT01079130|474100888|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
131676757|NCT01079130|474100883|FG000|Overall Study|Lost to Follow-up|0|||
131676758|NCT01079130|474100884|FG001|Overall Study|Lost to Follow-up|0|||
131676759|NCT01079130|474100885|FG002|Overall Study|Lost to Follow-up|0|||
131676760|NCT01079130|474100886|FG003|Overall Study|Lost to Follow-up|0|||
131676761|NCT01079130|474100887|FG004|Overall Study|Lost to Follow-up|1|||
131676762|NCT01079130|474100888|FG005|Overall Study|Lost to Follow-up|0|||
131676763|NCT01839487|474100889|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
131676764|NCT01839487|474100890|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131676765|NCT01839487|474100891|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131676766|NCT01839487|474100892|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131676767|NCT01839487|474100893|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131676768|NCT01839487|474100894|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131676769|NCT01839487|474100889|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
131676770|NCT01839487|474100890|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
131676771|NCT01839487|474100891|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131676772|NCT01839487|474100892|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131676773|NCT01839487|474100893|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131676774|NCT01839487|474100894|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131676775|NCT01839487|474100889|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131676776|NCT01839487|474100890|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
131676777|NCT01839487|474100891|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131676778|NCT01839487|474100892|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131676779|NCT01839487|474100893|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131676780|NCT01839487|474100894|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131676781|NCT01839487|474100889|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
131676782|NCT01839487|474100890|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131676783|NCT01839487|474100891|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131676784|NCT01839487|474100892|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131676785|NCT01839487|474100893|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131676786|NCT01839487|474100894|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131676787|NCT01839487|474100889|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
131676788|NCT01839487|474100890|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
131676789|NCT01839487|474100891|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
131676790|NCT01839487|474100892|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
131676791|NCT01839487|474100893|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
131676792|NCT01839487|474100894|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
131676793|NCT01839487|474100889|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
131676794|NCT01839487|474100890|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
131676795|NCT01839487|474100891|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
131676796|NCT01839487|474100892|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
131676797|NCT01839487|474100893|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
131676798|NCT01839487|474100894|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
131676799|NCT01839487|474100889|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131676800|NCT01839487|474100890|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131676801|NCT01839487|474100891|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
131676802|NCT01839487|474100892|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131676803|NCT01839487|474100893|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
131676804|NCT01839487|474100894|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131676805|NCT01839487|474100889|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
131676806|NCT01839487|474100890|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
131676807|NCT01839487|474100891|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
131676808|NCT01839487|474100892|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
131676809|NCT01839487|474100893|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
131676810|NCT01839487|474100894|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
131676811|NCT01839487|474100889|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
131676812|NCT01839487|474100890|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
131676813|NCT01839487|474100891|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
131676814|NCT01839487|474100892|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
131676815|NCT01839487|474100893|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
131676816|NCT01839487|474100894|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
131676817|NCT03471871|474100895|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131676818|NCT03471871|474100896|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131676819|NCT03471871|474100897|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
131676820|NCT03471871|474100898|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131676821|NCT03471871|474100899|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131676822|NCT03471871|474100895|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
131676823|NCT03471871|474100896|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
131676824|NCT03471871|474100897|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
131676825|NCT03471871|474100898|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
131676826|NCT03471871|474100899|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
131676827|NCT03471871|474100895|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131676828|NCT03471871|474100896|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131676829|NCT03471871|474100897|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131676830|NCT03471871|474100898|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131676831|NCT03471871|474100899|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
131676832|NCT03471871|474100895|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131676833|NCT03471871|474100896|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131676834|NCT03471871|474100897|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131676835|NCT03471871|474100898|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131676836|NCT03471871|474100899|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
131676837|NCT03471871|474100895|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131676838|NCT03471871|474100896|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131676839|NCT03471871|474100897|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131676840|NCT03471871|474100898|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
131676841|NCT03471871|474100899|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131676842|NCT03144804|474100901|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
131676843|NCT03971422|474102659|FG000|Overall Study|Lost to Follow-up|0|||
131676844|NCT03971422|474102660|FG001|Overall Study|Lost to Follow-up|1|||
131676845|NCT03971422|474102661|FG002|Overall Study|Lost to Follow-up|0|||
131676846|NCT03971422|474102659|FG000|Overall Study|Lack of Efficacy|5|||
131676847|NCT03971422|474102660|FG001|Overall Study|Lack of Efficacy|1|||
131676848|NCT03971422|474102661|FG002|Overall Study|Lack of Efficacy|1|||
131676849|NCT03971422|474102659|FG000|Overall Study|Adverse event, not fatal|2|||
131676850|NCT03971422|474102660|FG001|Overall Study|Adverse event, not fatal|2|||
131676851|NCT03971422|474102661|FG002|Overall Study|Adverse event, not fatal|5|||
131676852|NCT03971422|474102659|FG000|Overall Study|Worsening of MG Symptoms|1|||
131676853|NCT03971422|474102660|FG001|Overall Study|Worsening of MG Symptoms|4|||
131676854|NCT03971422|474102661|FG002|Overall Study|Worsening of MG Symptoms|2|||
131676855|NCT03971422|474102659|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
131676856|NCT03971422|474102660|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
131676857|NCT03971422|474102661|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
131676858|NCT03971422|474102659|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
131676859|NCT03971422|474102660|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
131676860|NCT03971422|474102661|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
131676861|NCT03971422|474102659|FG000|Overall Study|Due to COVID-19 pandemic|0|||
131676862|NCT03971422|474102660|FG001|Overall Study|Due to COVID-19 pandemic|1|||
131676863|NCT03971422|474102661|FG002|Overall Study|Due to COVID-19 pandemic|1|||
131676864|NCT04751656|474102664|FG000|Overall Study|Lost to Follow-up|1|||
131676865|NCT03566810|474102665|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
131676866|NCT03566810|474102666|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
131676867|NCT03566810|474102667|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
131676868|NCT03566810|474102668|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
131676869|NCT01955122|474102676|FG000|Overall Study|Physician Decision|5|||
131676870|NCT01955122|474102677|FG001|Overall Study|Physician Decision|5|||
131676871|NCT00826111|474102678|FG000|Overall Study|Lost to Follow-up|0|||
131676872|NCT00826111|474102679|FG001|Overall Study|Lost to Follow-up|1|||
131676873|NCT00826111|474102678|FG000|Overall Study|Protocol Violation|1|||
131676874|NCT00826111|474102679|FG001|Overall Study|Protocol Violation|0|||
131676875|NCT00826111|474102678|FG000|Overall Study|Withdrawal by Subject|5|||
131676876|NCT00826111|474102679|FG001|Overall Study|Withdrawal by Subject|0|||
131676877|NCT00826111|474102678|FG000|Overall Study|Physician Decision|1|||
131676878|NCT00826111|474102679|FG001|Overall Study|Physician Decision|1|||
131676879|NCT01672788|474102680|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
131676880|NCT01672788|474102681|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
131676881|NCT01672788|474102682|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
131676882|NCT01672788|474102683|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
131676883|NCT03511053|474102686|FG000|Overall Study|Withdrawal by Subject|1|||
131676884|NCT01128361|474102687|FG000|Overall Study|Lost to Follow-up|0|||
131676885|NCT01128361|474102688|FG001|Overall Study|Lost to Follow-up|1|||
131676886|NCT01128361|474102687|FG000|Overall Study|Withdrawal by Subject|5|||
131676887|NCT01128361|474102688|FG001|Overall Study|Withdrawal by Subject|2|||
131676888|NCT01929980|474102689|FG000|Overall Study|Physician Decision|1|||
131676889|NCT04288778|474102690|FG000|Overall Study|Withdrawal by Subject|2|||
131676890|NCT04288778|474102690|FG000|Overall Study|Adverse Event|5|||
131676891|NCT04288778|474102690|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131676892|NCT04288778|474102690|FG000|Overall Study|Other|1|||
131676893|NCT04288778|474102690|FG000|Overall Study|Started but not treated|2|||
131676894|NCT01324323|474102691|FG000|Overall Study|Withdrawal by Subject|1|||
131676895|NCT03153137|474102692|FG000|Overall Study|Lost to Follow-up|1|||
131676896|NCT03153137|474102693|FG001|Overall Study|Lost to Follow-up|0|||
131676897|NCT03153137|474102692|FG000|Overall Study|Withdrawal by Subject|2|||
131676898|NCT03153137|474102693|FG001|Overall Study|Withdrawal by Subject|1|||
131676899|NCT03153137|474102692|FG000|Overall Study|Physician Decision|0|||
131676900|NCT03153137|474102693|FG001|Overall Study|Physician Decision|3|||
131676901|NCT00993915|474102700|FG000|Overall Study|Insufficient clinical response|3|||
131676902|NCT00993915|474102700|FG000|Overall Study|Withdrawal by Subject|2|||
131676903|NCT00993915|474102700|FG000|Overall Study|Other|1|||
131676904|NCT00993915|474102700|FG000|Overall Study|Ongoing|3|||
131676905|NCT04614662|474102701|FG000|Overall Study|Withdrawal by Subject|0|||
131676906|NCT04614662|474102702|FG001|Overall Study|Withdrawal by Subject|1|||
131676907|NCT00769860|474102703|FG000|Overall Study|Withdrawal by Subject|2|||
131676908|NCT00769860|474102704|FG001|Overall Study|Withdrawal by Subject|0|||
131676909|NCT01603082|474102705|FG000|Overall Study|Adverse Event|0|||
131676910|NCT01603082|474102706|FG001|Overall Study|Adverse Event|1|||
131676911|NCT01603082|474102705|FG000|Overall Study|Withdrawal by Subject|1|||
131676912|NCT01603082|474102706|FG001|Overall Study|Withdrawal by Subject|0|||
131676913|NCT01603082|474102705|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
131676914|NCT01603082|474102706|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
131676915|NCT01019317|474102710|FG000|Overall Study|Not Eligible|4|||
131676916|NCT03294109|474102712|FG000|Overall Study|Withdrawal by Subject|6|||
131676917|NCT03294109|474102713|FG001|Overall Study|Withdrawal by Subject|5|||
131676918|NCT04744285|474102714|FG000|Overall Study|Withdrawal by Subject|1|||
131676919|NCT04744285|474102715|FG001|Overall Study|Withdrawal by Subject|1|||
131676920|NCT04744285|474102716|FG002|Overall Study|Withdrawal by Subject|2|||
131676921|NCT04744285|474102717|FG003|Overall Study|Withdrawal by Subject|1|||
131676922|NCT01774084|474102718|FG000|Overall Study|Personal reasons|1|||
131676923|NCT01774084|474102719|FG001|Overall Study|Personal reasons|0|||
131676924|NCT00821431|474102720|FG000|Overall Study|Adverse Event|6|||
131676925|NCT00821431|474102721|FG001|Overall Study|Adverse Event|3|||
131676926|NCT00821431|474102720|FG000|Overall Study|Withdrawal by Subject|5|||
131676927|NCT00821431|474102721|FG001|Overall Study|Withdrawal by Subject|0|||
131676928|NCT00821431|474102720|FG000|Overall Study|Lost to Follow-up|1|||
131676929|NCT00821431|474102721|FG001|Overall Study|Lost to Follow-up|0|||
131676930|NCT00821431|474102720|FG000|Overall Study|Protocol Violation|3|||
131676931|NCT00821431|474102721|FG001|Overall Study|Protocol Violation|1|||
131676932|NCT00821431|474102720|FG000|Overall Study|Physician Decision|0|||
131676933|NCT00821431|474102721|FG001|Overall Study|Physician Decision|1|||
131676934|NCT01843218|474102724|FG000|Overall Study|Withdrawal by Subject|5|||
131676935|NCT04526197|474102725|FG000|Period 1|Adverse Event|0|||
131676936|NCT04526197|474102726|FG001|Period 1|Adverse Event|1|||
131676937|NCT04526197|474102725|FG000|Period 1|Withdrawal by Subject|1|||
131676938|NCT04526197|474102726|FG001|Period 1|Withdrawal by Subject|0|||
131676939|NCT04526197|474102725|FG000|Period 2|Adverse Event|0|||
131676940|NCT04526197|474102726|FG001|Period 2|Adverse Event|1|||
131676941|NCT04526197|474102725|FG000|Period 2|Withdrawal by Subject|0|||
131676942|NCT04526197|474102726|FG001|Period 2|Withdrawal by Subject|1|||
131676943|NCT00372385|474102727|FG000|Overall Study|Adverse Event|6|||
131676944|NCT00372385|474102728|FG001|Overall Study|Adverse Event|11|||
131676945|NCT00372385|474102729|FG002|Overall Study|Adverse Event|9|||
131676946|NCT00372385|474102730|FG003|Overall Study|Adverse Event|7|||
131676947|NCT00372385|474102727|FG000|Overall Study|Noncompliance|0|||
131676948|NCT00372385|474102728|FG001|Overall Study|Noncompliance|1|||
131676949|NCT00372385|474102729|FG002|Overall Study|Noncompliance|1|||
131676950|NCT00372385|474102730|FG003|Overall Study|Noncompliance|1|||
131676951|NCT00372385|474102727|FG000|Overall Study|Physician Decision|1|||
131676952|NCT00372385|474102728|FG001|Overall Study|Physician Decision|0|||
131676953|NCT00372385|474102729|FG002|Overall Study|Physician Decision|0|||
131676954|NCT00372385|474102730|FG003|Overall Study|Physician Decision|0|||
131676955|NCT00372385|474102727|FG000|Overall Study|Lost to Follow-up|2|||
131676956|NCT00372385|474102728|FG001|Overall Study|Lost to Follow-up|0|||
131676957|NCT00372385|474102729|FG002|Overall Study|Lost to Follow-up|0|||
131676958|NCT00372385|474102730|FG003|Overall Study|Lost to Follow-up|0|||
131676959|NCT00372385|474102727|FG000|Overall Study|Withdrawal by Subject|2|||
131676960|NCT00372385|474102728|FG001|Overall Study|Withdrawal by Subject|1|||
131676961|NCT00372385|474102729|FG002|Overall Study|Withdrawal by Subject|0|||
131676962|NCT00372385|474102730|FG003|Overall Study|Withdrawal by Subject|0|||
131676963|NCT00372385|474102727|FG000|Overall Study|Refusal of Treatment|3|||
131676964|NCT00372385|474102728|FG001|Overall Study|Refusal of Treatment|6|||
131676965|NCT00372385|474102729|FG002|Overall Study|Refusal of Treatment|0|||
131676966|NCT00372385|474102730|FG003|Overall Study|Refusal of Treatment|0|||
131676967|NCT00372385|474102727|FG000|Overall Study|No Response|1|||
131676968|NCT00372385|474102728|FG001|Overall Study|No Response|1|||
131676969|NCT00372385|474102729|FG002|Overall Study|No Response|0|||
131676970|NCT00372385|474102730|FG003|Overall Study|No Response|0|||
131676971|NCT00372385|474102727|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
131676972|NCT00372385|474102728|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
131676973|NCT00372385|474102729|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
131676974|NCT00372385|474102730|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
131676975|NCT00372385|474102727|FG000|Overall Study|Virologic Stopping Rule|17|||
131676976|NCT00372385|474102728|FG001|Overall Study|Virologic Stopping Rule|0|||
131676977|NCT00372385|474102729|FG002|Overall Study|Virologic Stopping Rule|0|||
131676978|NCT00372385|474102730|FG003|Overall Study|Virologic Stopping Rule|0|||
131676979|NCT01699789|474102731|FG000|Overall Study|Withdrawal by Subject|18|||
131676980|NCT01699789|474102732|FG001|Overall Study|Withdrawal by Subject|23|||
131676981|NCT01699789|474102731|FG000|Overall Study|Death|1|||
131676982|NCT01699789|474102732|FG001|Overall Study|Death|2|||
131676983|NCT01699789|474102731|FG000|Overall Study|Lost to Follow-up|83|||
131676984|NCT01699789|474102732|FG001|Overall Study|Lost to Follow-up|101|||
131676985|NCT01906346|474102733|FG000|Overall Study|AEs|1|||
131676986|NCT01323621|474102736|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
131676987|NCT01323621|474102737|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
131676988|NCT01323621|474102738|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
131676989|NCT01323621|474102736|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
131676990|NCT01323621|474102737|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
131676991|NCT01323621|474102738|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
131676992|NCT01323621|474102736|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
131676993|NCT01323621|474102737|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
131676994|NCT01323621|474102738|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
131676995|NCT01323621|474102736|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
131676996|NCT01323621|474102737|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
131676997|NCT01323621|474102738|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
131676998|NCT01323621|474102736|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
131676999|NCT01323621|474102737|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
131677000|NCT01323621|474102738|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
131677001|NCT01323621|474102736|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
131677002|NCT01323621|474102737|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
131555487|NCT03101241|473658222|FG001|Overall Study|Lost to Follow-up|0|||
131677003|NCT01323621|474102738|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
131677004|NCT01323621|474102736|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
131677005|NCT01323621|474102737|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
131677006|NCT01323621|474102738|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
131677007|NCT01323621|474102736|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131677008|NCT01323621|474102737|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
131677009|NCT01323621|474102738|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
131677010|NCT01323621|474102736|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
131677011|NCT01323621|474102737|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
131677012|NCT01323621|474102738|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
131677013|NCT01323621|474102736|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131677014|NCT01323621|474102737|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131677015|NCT01323621|474102738|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131677016|NCT01323621|474102736|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
131677017|NCT01323621|474102737|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
131677018|NCT01323621|474102738|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
131677019|NCT01323621|474102736|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131677020|NCT01323621|474102737|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
131677021|NCT01323621|474102738|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
131677022|NCT04226833|474102739|FG000|Overall Study|Death|0|||
131677023|NCT04226833|474102740|FG001|Overall Study|Death|0|||
131677024|NCT04226833|474102741|FG002|Overall Study|Death|1|||
131677025|NCT04226833|474102742|FG003|Overall Study|Death|0|||
131677026|NCT02876835|474102745|FG000|Treatment Period (51.1 Month)|Other|1|||
131677027|NCT02876835|474102746|FG001|Treatment Period (51.1 Month)|Other|0|||
131677028|NCT02876835|474102745|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
131677029|NCT02876835|474102746|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
131677030|NCT02876835|474102745|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
131677031|NCT02876835|474102746|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
131677032|NCT02876835|474102745|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
131677033|NCT02876835|474102746|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
131677034|NCT02540538|474102748|FG000|Overall Study|Pregnancy|0|||
131677035|NCT02540538|474102749|FG001|Overall Study|Pregnancy|1|||
131677036|NCT02540538|474102750|FG002|Overall Study|Pregnancy|0|||
131677037|NCT00364156|474102754|FG000|Overall Study|Withdrawal by Subject|73|||
131677038|NCT00364156|474102755|FG001|Overall Study|Withdrawal by Subject|80|||
131677039|NCT00364156|474102754|FG000|Overall Study|Protocol Violation|6|||
131677040|NCT00364156|474102755|FG001|Overall Study|Protocol Violation|1|||
131677041|NCT01891721|474102756|FG000|Overall Study|Lost to Follow-up|10|||
131677042|NCT01891721|474102757|FG001|Overall Study|Lost to Follow-up|5|||
131677043|NCT01891721|474102758|FG002|Overall Study|Lost to Follow-up|1|||
131677044|NCT04343248|474102759|FG000|Overall Study|Withdrawal by Subject|5|||
131677045|NCT04343248|474102760|FG001|Overall Study|Withdrawal by Subject|6|||
131677046|NCT04343248|474102759|FG000|Overall Study|Death|1|||
131677047|NCT04343248|474102760|FG001|Overall Study|Death|2|||
131677048|NCT04343248|474102759|FG000|Overall Study|Lost to Follow-up|9|||
131677049|NCT04343248|474102760|FG001|Overall Study|Lost to Follow-up|6|||
131677050|NCT04343248|474102759|FG000|Overall Study|Physician Decision|0|||
131677051|NCT04343248|474102760|FG001|Overall Study|Physician Decision|1|||
131677052|NCT04343248|474102759|FG000|Overall Study|Adverse Event|1|||
131677053|NCT04343248|474102760|FG001|Overall Study|Adverse Event|0|||
131677054|NCT01313650|474102763|FG000|Overall Study|Adverse Event|9|||
131677055|NCT01313650|474102764|FG001|Overall Study|Adverse Event|34|||
131677056|NCT01313650|474102765|FG002|Overall Study|Adverse Event|24|||
131677057|NCT01313650|474102766|FG003|Overall Study|Adverse Event|23|||
131677058|NCT01313650|474102763|FG000|Overall Study|Lack of Efficacy|37|||
131677059|NCT01313650|474102764|FG001|Overall Study|Lack of Efficacy|20|||
131677060|NCT01313650|474102765|FG002|Overall Study|Lack of Efficacy|32|||
131677061|NCT01313650|474102766|FG003|Overall Study|Lack of Efficacy|20|||
131677062|NCT01313650|474102763|FG000|Overall Study|Lost to Follow-up|1|||
131677063|NCT01313650|474102764|FG001|Overall Study|Lost to Follow-up|0|||
131677064|NCT01313650|474102765|FG002|Overall Study|Lost to Follow-up|3|||
131677065|NCT01313650|474102766|FG003|Overall Study|Lost to Follow-up|2|||
131677066|NCT01313650|474102763|FG000|Overall Study|Withdrawal by Subject|16|||
131677067|NCT01313650|474102764|FG001|Overall Study|Withdrawal by Subject|20|||
131677068|NCT01313650|474102765|FG002|Overall Study|Withdrawal by Subject|15|||
131677069|NCT01313650|474102766|FG003|Overall Study|Withdrawal by Subject|15|||
131677070|NCT01313650|474102763|FG000|Overall Study|Protocol Violation|4|||
131677071|NCT01313650|474102764|FG001|Overall Study|Protocol Violation|7|||
131677072|NCT01313650|474102765|FG002|Overall Study|Protocol Violation|5|||
131677073|NCT01313650|474102766|FG003|Overall Study|Protocol Violation|6|||
131677074|NCT01313650|474102763|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
131677075|NCT01313650|474102764|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
131677076|NCT01313650|474102765|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
131677077|NCT01313650|474102766|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
131677078|NCT05393037|474102767|FG000|Part A|Death|1|||
131677079|NCT05393037|474102768|FG001|Part A|Death|0|||
131677080|NCT05393037|474102767|FG000|Part A|Lost to Follow-up|1|||
131677081|NCT05393037|474102768|FG001|Part A|Lost to Follow-up|1|||
131677082|NCT05393037|474102767|FG000|Part A|Withdrawal by Subject|2|||
131677083|NCT05393037|474102768|FG001|Part A|Withdrawal by Subject|4|||
131677084|NCT05393037|474102767|FG000|Part B|Lost to Follow-up|1|||
131677085|NCT05393037|474102768|FG001|Part B|Lost to Follow-up|0|||
131677086|NCT04540133|474102769|FG000|Overall Study|Lost to Follow-up|1|||
131677087|NCT04540133|474102770|FG001|Overall Study|Lost to Follow-up|0|||
131677088|NCT03153111|474102771|FG000|Overall Study|Death|2|||
131677089|NCT03153111|474102772|FG001|Overall Study|Death|5|||
131677090|NCT03153111|474102771|FG000|Overall Study|Lost to Follow-up|1|||
131677091|NCT03153111|474102772|FG001|Overall Study|Lost to Follow-up|0|||
131677092|NCT03153111|474102771|FG000|Overall Study|Physician Decision|5|||
131677093|NCT03153111|474102772|FG001|Overall Study|Physician Decision|1|||
131677094|NCT03153111|474102771|FG000|Overall Study|Withdrawal by Subject|3|||
131677095|NCT03153111|474102772|FG001|Overall Study|Withdrawal by Subject|3|||
131677096|NCT00390910|474102773|FG000|Overall Study|Adverse Event|1|||
131677097|NCT00390910|474102774|FG001|Overall Study|Adverse Event|0|||
131677098|NCT00390910|474102775|FG002|Overall Study|Adverse Event|0|||
131677099|NCT00390910|474102773|FG000|Overall Study|Lost to Follow-up|0|||
131677100|NCT00390910|474102774|FG001|Overall Study|Lost to Follow-up|1|||
131677101|NCT00390910|474102775|FG002|Overall Study|Lost to Follow-up|5|||
131677102|NCT00390910|474102773|FG000|Overall Study|Withdrawal by Subject|1|||
131677103|NCT00390910|474102774|FG001|Overall Study|Withdrawal by Subject|3|||
131677104|NCT00390910|474102775|FG002|Overall Study|Withdrawal by Subject|2|||
131677105|NCT00390910|474102773|FG000|Overall Study|Migrated/moved from study area|0|||
131677106|NCT00390910|474102774|FG001|Overall Study|Migrated/moved from study area|0|||
131677107|NCT00390910|474102775|FG002|Overall Study|Migrated/moved from study area|3|||
131677108|NCT00174265|474102780|FG000|Overall Study|Adverse Event|7|||
131677109|NCT00174265|474102781|FG001|Overall Study|Adverse Event|4|||
131677110|NCT00174265|474102780|FG000|Overall Study|Lack of Efficacy|2|||
131677111|NCT00174265|474102781|FG001|Overall Study|Lack of Efficacy|2|||
131677112|NCT00174265|474102780|FG000|Overall Study|Withdrawal by Subject|3|||
131898111|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
131898112|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
131898113|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
131898114|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
131898115|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
131898116|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
131898117|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
131898118|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
131677113|NCT00174265|474102781|FG001|Overall Study|Withdrawal by Subject|5|||
131677114|NCT00174265|474102780|FG000|Overall Study|Lost to Follow-up|1|||
131677115|NCT00174265|474102781|FG001|Overall Study|Lost to Follow-up|0|||
131677116|NCT00174265|474102780|FG000|Overall Study|Other (Not specified)|16|||
131677117|NCT00174265|474102781|FG001|Overall Study|Other (Not specified)|10|||
131677118|NCT03231943|474102783|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677119|NCT03231943|474102784|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
131677120|NCT03231943|474102785|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
131677121|NCT03231943|474102786|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677122|NCT03231943|474102787|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677123|NCT03231943|474102788|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677124|NCT03231943|474102789|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677125|NCT03231943|474102790|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677126|NCT03231943|474102791|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677127|NCT03231943|474102792|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677128|NCT03231943|474102793|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677129|NCT03231943|474102794|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677130|NCT03231943|474102795|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131677131|NCT03231943|474102783|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677132|NCT03231943|474102784|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
131677133|NCT03231943|474102785|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677134|NCT03231943|474102786|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677135|NCT03231943|474102787|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677136|NCT03231943|474102788|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677137|NCT03231943|474102789|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677138|NCT03231943|474102790|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131898119|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
131898120|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
131898121|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
131898122|NCT03538691|474912565|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
131898123|NCT03538691|474912566|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
131898124|NCT03538691|474912567|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
131898125|NCT03538691|474912568|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
131898126|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
131898127|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
131898128|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
131677139|NCT03231943|474102791|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677140|NCT03231943|474102792|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677141|NCT03231943|474102793|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677142|NCT03231943|474102794|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677143|NCT03231943|474102795|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131677144|NCT03231943|474102783|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
131677145|NCT03231943|474102784|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677146|NCT03231943|474102785|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131772592|NCT01078974|474445126|FG000|Overall Study|Adverse Event|3|||
131677147|NCT03231943|474102786|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677148|NCT03231943|474102787|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677149|NCT03231943|474102788|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677150|NCT03231943|474102789|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677151|NCT03231943|474102790|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677152|NCT03231943|474102791|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677153|NCT03231943|474102792|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677154|NCT03231943|474102793|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677155|NCT03231943|474102794|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677156|NCT03231943|474102795|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131677157|NCT03231943|474102783|FG000|Part 2|Adverse Event|0|||
131677158|NCT03231943|474102784|FG001|Part 2|Adverse Event|0|||
131677159|NCT03231943|474102785|FG002|Part 2|Adverse Event|0|||
131677160|NCT03231943|474102786|FG003|Part 2|Adverse Event|0|||
131677161|NCT03231943|474102787|FG004|Part 2|Adverse Event|0|||
131677162|NCT03231943|474102788|FG005|Part 2|Adverse Event|0|||
131677163|NCT03231943|474102789|FG006|Part 2|Adverse Event|0|||
131677164|NCT03231943|474102790|FG007|Part 2|Adverse Event|0|||
131677165|NCT03231943|474102791|FG008|Part 2|Adverse Event|0|||
131677166|NCT03231943|474102792|FG009|Part 2|Adverse Event|0|||
131677167|NCT03231943|474102793|FG010|Part 2|Adverse Event|1|||
131677168|NCT03231943|474102794|FG011|Part 2|Adverse Event|0|||
131677169|NCT03231943|474102795|FG012|Part 2|Adverse Event|0|||
131677170|NCT03231943|474102783|FG000|Part 2|Withdrawal by Subject|0|||
131677171|NCT03231943|474102784|FG001|Part 2|Withdrawal by Subject|0|||
131677172|NCT03231943|474102785|FG002|Part 2|Withdrawal by Subject|0|||
131677173|NCT03231943|474102786|FG003|Part 2|Withdrawal by Subject|0|||
131677174|NCT03231943|474102787|FG004|Part 2|Withdrawal by Subject|0|||
131677175|NCT03231943|474102788|FG005|Part 2|Withdrawal by Subject|0|||
131677176|NCT03231943|474102789|FG006|Part 2|Withdrawal by Subject|0|||
131677177|NCT03231943|474102790|FG007|Part 2|Withdrawal by Subject|0|||
131677178|NCT03231943|474102791|FG008|Part 2|Withdrawal by Subject|0|||
131677179|NCT03231943|474102792|FG009|Part 2|Withdrawal by Subject|0|||
131677180|NCT03231943|474102793|FG010|Part 2|Withdrawal by Subject|0|||
131677181|NCT03231943|474102794|FG011|Part 2|Withdrawal by Subject|1|||
131677182|NCT03231943|474102795|FG012|Part 2|Withdrawal by Subject|0|||
131677183|NCT03040622|474102797|FG000|Overall Study|unable to implant device|3|||
131677184|NCT01572922|474102798|FG000|Overall Study|Adverse Event|1|||
131677185|NCT01572922|474102798|FG000|Overall Study|Protocol Violation|1|||
131677186|NCT01572922|474102798|FG000|Overall Study|Death|1|||
131677187|NCT00445068|474102799|FG000|Overall Study|Disease progression|26|||
131677188|NCT00445068|474102799|FG000|Overall Study|Adverse Event|5|||
131677189|NCT00445068|474102799|FG000|Overall Study|Abnormal laboratory value|2|||
131677190|NCT00445068|474102799|FG000|Overall Study|Withdrawal by Subject|2|||
131677191|NCT00445068|474102799|FG000|Overall Study|Death|1|||
131677192|NCT04091451|474102803|FG000|Overall Study|Adverse Event|15|||
131677193|NCT04091451|474102804|FG001|Overall Study|Adverse Event|10|||
131677194|NCT04091451|474102803|FG000|Overall Study|Lost to Follow-up|8|||
131677195|NCT04091451|474102804|FG001|Overall Study|Lost to Follow-up|8|||
131677196|NCT04091451|474102803|FG000|Overall Study|Protocol Violation|5|||
131677197|NCT04091451|474102804|FG001|Overall Study|Protocol Violation|4|||
131677198|NCT04091451|474102803|FG000|Overall Study|Withdrawal by Subject|21|||
131677199|NCT04091451|474102804|FG001|Overall Study|Withdrawal by Subject|27|||
131677200|NCT04091451|474102803|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
131677201|NCT04091451|474102804|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
131677202|NCT04091451|474102803|FG000|Overall Study|Migrated/moved from the study area|3|||
131677203|NCT04091451|474102804|FG001|Overall Study|Migrated/moved from the study area|5|||
131677204|NCT04091451|474102803|FG000|Overall Study|Suspected HZ episode|1|||
131677205|NCT04091451|474102804|FG001|Overall Study|Suspected HZ episode|0|||
131677206|NCT02598557|474104134|FG000|Overall Study|Withdrawal by Subject|1|||
131677207|NCT02598557|474104135|FG001|Overall Study|Withdrawal by Subject|0|||
131677208|NCT02598557|474104136|FG002|Overall Study|Withdrawal by Subject|1|||
131677209|NCT02598557|474104134|FG000|Overall Study|Participant did not start treatment|2|||
131677210|NCT02598557|474104135|FG001|Overall Study|Participant did not start treatment|1|||
131677211|NCT02598557|474104136|FG002|Overall Study|Participant did not start treatment|1|||
131677212|NCT02598557|474104134|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
131677213|NCT02598557|474104135|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
131677214|NCT02598557|474104136|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
131677215|NCT02598557|474104134|FG000|Overall Study|Adverse Event|1|||
131677216|NCT02598557|474104135|FG001|Overall Study|Adverse Event|1|||
131677217|NCT02598557|474104136|FG002|Overall Study|Adverse Event|0|||
131677218|NCT01117454|474104139|FG000|Overall Study|Pregnancy|0|||
131677219|NCT01117454|474104140|FG001|Overall Study|Pregnancy|1|||
131677220|NCT00888433|474104141|FG000|Overall Study|Withdrawal by Subject|1|||
131677221|NCT00888433|474104142|FG001|Overall Study|Withdrawal by Subject|2|||
131677222|NCT00888433|474104141|FG000|Overall Study|Missed Visit|2|||
131677223|NCT00888433|474104142|FG001|Overall Study|Missed Visit|1|||
131677224|NCT01831544|474104143|FG000|Overall Study|Death|1|||
131677225|NCT01831544|474104143|FG000|Overall Study|Still on original MVAD device|2|||
131677226|NCT01681628|474104144|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
131677227|NCT01681628|474104145|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
131677228|NCT01681628|474104144|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
131677229|NCT01681628|474104145|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
131677230|NCT01681628|474104144|FG000|19 Months Follow-up|Death|1|||
131677231|NCT01681628|474104145|FG001|19 Months Follow-up|Death|0|||
131677232|NCT01681628|474104144|FG000|19 Months Follow-up|Lost to Follow-up|61|||
131677233|NCT01681628|474104145|FG001|19 Months Follow-up|Lost to Follow-up|43|||
131677234|NCT01637623|474104154|FG000|Overall Study|Lost to Follow-up|0|||
131677235|NCT01637623|474104155|FG001|Overall Study|Lost to Follow-up|0|||
131677236|NCT01637623|474104156|FG002|Overall Study|Lost to Follow-up|2|||
131677237|NCT01637623|474104154|FG000|Overall Study|Physician Decision|1|||
131677238|NCT01637623|474104155|FG001|Overall Study|Physician Decision|0|||
131677239|NCT01637623|474104156|FG002|Overall Study|Physician Decision|1|||
131677240|NCT02170389|474104159|FG000|Overall Study|Study terminated prior to start of treat|1|||
131677241|NCT01054144|474104165|FG000|Overall Study|Death|2|||
131677242|NCT03801902|474104166|FG000|Overall Study|Did not receive protocol treatment.|1|||
131677243|NCT03801902|474104167|FG001|Overall Study|Did not receive protocol treatment.|0|||
131677244|NCT03801902|474104168|FG002|Overall Study|Did not receive protocol treatment.|0|||
131677245|NCT03801902|474104169|FG003|Overall Study|Did not receive protocol treatment.|0|||
131677246|NCT02993523|474104172|FG000|Overall Study|Withdrew Consent|0|||
131677247|NCT02993523|474104173|FG001|Overall Study|Withdrew Consent|0|||
131677248|NCT02993523|474104174|FG002|Overall Study|Withdrew Consent|2|||
131677249|NCT02993523|474104175|FG003|Overall Study|Withdrew Consent|9|||
131677250|NCT02993523|474104176|FG004|Overall Study|Withdrew Consent|0|||
131677251|NCT02993523|474104172|FG000|Overall Study|Lost to Follow-up|0|||
131677252|NCT02993523|474104173|FG001|Overall Study|Lost to Follow-up|0|||
131677253|NCT02993523|474104174|FG002|Overall Study|Lost to Follow-up|3|||
131677254|NCT02993523|474104175|FG003|Overall Study|Lost to Follow-up|6|||
131677255|NCT02993523|474104176|FG004|Overall Study|Lost to Follow-up|0|||
131677256|NCT02993523|474104172|FG000|Overall Study|Death|1|||
131677257|NCT02993523|474104173|FG001|Overall Study|Death|1|||
131677258|NCT02993523|474104174|FG002|Overall Study|Death|138|||
131677259|NCT02993523|474104175|FG003|Overall Study|Death|222|||
131677260|NCT02993523|474104176|FG004|Overall Study|Death|6|||
131677261|NCT02993523|474104172|FG000|Overall Study|Reason not Specified|0|||
131677262|NCT02993523|474104173|FG001|Overall Study|Reason not Specified|0|||
131677263|NCT02993523|474104174|FG002|Overall Study|Reason not Specified|1|||
131677264|NCT02993523|474104175|FG003|Overall Study|Reason not Specified|1|||
131555488|NCT03101241|473658221|FG000|Overall Study|Lack of Efficacy|0|||
131677265|NCT02993523|474104176|FG004|Overall Study|Reason not Specified|0|||
131677266|NCT03118674|474104177|FG000|Overall Study|Lost to Follow-up|2|||
131677267|NCT03118674|474104177|FG000|Overall Study|Screen Faliure|8|||
131677268|NCT03118674|474104177|FG000|Overall Study|Withdrawal by Subject|5|||
131677269|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
131677270|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
131677271|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
131677272|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
131677273|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
131677274|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
131677275|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
131677276|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
131677277|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Death|1|||
131677278|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Death|1|||
131677279|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
131677280|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
131677281|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
131677282|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
131677283|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
131677284|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
131677285|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
131677286|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
131677287|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
131677288|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
131677289|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
131677290|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
131677291|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
131677292|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
131677293|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
131677294|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
131677295|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
131677296|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
131677297|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
131677298|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
131677299|NCT00559585|474104178|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
131772593|NCT03575975|474445127|FG000|Overall Study|Lost to Follow-up|1|||
131555489|NCT03101241|473658222|FG001|Overall Study|Lack of Efficacy|1|||
131677300|NCT00559585|474104179|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
131677301|NCT00559585|474104178|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
131677302|NCT00559585|474104179|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
131677303|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
131677304|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
131677305|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
131677306|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
131677307|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
131677308|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
131677309|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
131677310|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
131677311|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
131677312|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
131677313|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
131898129|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
131898130|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
131898131|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
131898132|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
131898133|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
131898134|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
131898135|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
131898136|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
131898137|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
131898138|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
131898139|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
131898140|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
131898141|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
131898142|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
131898143|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
131898144|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
131898145|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
131898146|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
131898147|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
131898148|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
131898149|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
131898150|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
131898151|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
131898152|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
131898153|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
131898154|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
131898155|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
131898156|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
131898157|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
131898158|NCT03538691|474912565|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
131898159|NCT03538691|474912566|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
131898160|NCT03538691|474912567|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
131898161|NCT03538691|474912568|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
131898162|NCT06597084|474912569|FG000|Overall Study|Withdrawal by Subject|4|||
131898163|NCT06597084|474912570|FG001|Overall Study|Withdrawal by Subject|9|||
131898164|NCT06597084|474912569|FG000|Overall Study|Consent was not given by the patient until V2|0|||
131898165|NCT06597084|474912570|FG001|Overall Study|Consent was not given by the patient until V2|3|||
131898166|NCT06597084|474912569|FG000|Overall Study|Physician Decision|1|||
131898167|NCT06597084|474912570|FG001|Overall Study|Physician Decision|0|||
131898168|NCT06597084|474912569|FG000|Overall Study|Adverse Event|3|||
131898169|NCT06597084|474912570|FG001|Overall Study|Adverse Event|2|||
131898170|NCT06597084|474912569|FG000|Overall Study|Death|4|||
131898171|NCT06597084|474912570|FG001|Overall Study|Death|0|||
131898172|NCT06597084|474912569|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
131898173|NCT06597084|474912570|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
131898174|NCT06597084|474912569|FG000|Overall Study|Lost to Follow-up|4|||
131898175|NCT06597084|474912570|FG001|Overall Study|Lost to Follow-up|2|||
131898176|NCT06597084|474912569|FG000|Overall Study|Other. Not specified|1|||
131898177|NCT06597084|474912570|FG001|Overall Study|Other. Not specified|0|||
131677314|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
131677315|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
131677316|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
131677317|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
131677318|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
131677319|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
131677320|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
131677321|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
131677322|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
131677323|NCT00559585|474104178|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
131677324|NCT00559585|474104179|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
131677325|NCT02644941|474104180|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
131677326|NCT02644941|474104181|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
131677327|NCT01717768|474104191|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677328|NCT01717768|474104192|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
131677329|NCT01717768|474104193|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677330|NCT01717768|474104194|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677331|NCT01717768|474104195|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677332|NCT01717768|474104196|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677333|NCT01717768|474104197|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677334|NCT01717768|474104198|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677335|NCT01717768|474104199|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677336|NCT01717768|474104200|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677337|NCT01717768|474104201|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677338|NCT01717768|474104202|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131677339|NCT01717768|474104191|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677340|NCT01717768|474104192|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677341|NCT01717768|474104193|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677342|NCT01717768|474104194|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677343|NCT01717768|474104195|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677344|NCT01717768|474104196|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677345|NCT01717768|474104197|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677346|NCT01717768|474104198|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677347|NCT01717768|474104199|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677348|NCT01717768|474104200|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677349|NCT01717768|474104201|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131677350|NCT01717768|474104202|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
131677351|NCT01717768|474104191|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131898178|NCT01066871|474912572|FG000|Overall Study|Lost to Follow-up|0|||
131772594|NCT03575975|474445128|FG001|Overall Study|Lost to Follow-up|0|||
131898179|NCT01066871|474912573|FG001|Overall Study|Lost to Follow-up|2|||
131898180|NCT01066871|474912574|FG002|Overall Study|Lost to Follow-up|2|||
131898181|NCT01066871|474912575|FG003|Overall Study|Lost to Follow-up|0|||
131898182|NCT01066871|474912572|FG000|Overall Study|Protocol Violation|1|||
131898183|NCT01066871|474912573|FG001|Overall Study|Protocol Violation|0|||
131898184|NCT01066871|474912574|FG002|Overall Study|Protocol Violation|3|||
131898185|NCT01066871|474912575|FG003|Overall Study|Protocol Violation|2|||
131898186|NCT01066871|474912572|FG000|Overall Study|Lack of Efficacy|0|||
131898187|NCT01066871|474912573|FG001|Overall Study|Lack of Efficacy|0|||
131898188|NCT01066871|474912574|FG002|Overall Study|Lack of Efficacy|0|||
131898189|NCT01066871|474912575|FG003|Overall Study|Lack of Efficacy|1|||
131898190|NCT01066871|474912572|FG000|Overall Study|Withdrawal by Subject|3|||
131898191|NCT01066871|474912573|FG001|Overall Study|Withdrawal by Subject|1|||
131898192|NCT01066871|474912574|FG002|Overall Study|Withdrawal by Subject|0|||
131898193|NCT01066871|474912575|FG003|Overall Study|Withdrawal by Subject|0|||
131898194|NCT01066871|474912572|FG000|Overall Study|Other|0|||
131898195|NCT01066871|474912573|FG001|Overall Study|Other|2|||
131898196|NCT01066871|474912574|FG002|Overall Study|Other|1|||
131898197|NCT01066871|474912575|FG003|Overall Study|Other|2|||
131898198|NCT02029274|474912580|FG000|Overall Study|Adverse Event|1|||
131898199|NCT02029274|474912581|FG001|Overall Study|Adverse Event|0|||
131898200|NCT02029274|474912582|FG002|Overall Study|Adverse Event|2|||
131898201|NCT02029274|474912583|FG003|Overall Study|Adverse Event|2|||
131898202|NCT00954122|474913988|FG000|Overall Study|Withdrawal by Subject|5|||
131898203|NCT00954122|474913988|FG000|Overall Study|Adverse Event|1|||
131898204|NCT00954122|474913988|FG000|Overall Study|Safety Reason|1|||
131898205|NCT00305227|474913999|FG000|Overall Study|Lost to Follow-up|7|||
131898206|NCT00305227|474914000|FG001|Overall Study|Lost to Follow-up|6|||
131898207|NCT02915159|474914002|FG000|Overall Study|Participant no longer meets criteria|2|||
131898208|NCT02915159|474914003|FG001|Overall Study|Participant no longer meets criteria|0|||
131898209|NCT02915159|474914002|FG000|Overall Study|poor/non-compliance|1|||
131898210|NCT02915159|474914003|FG001|Overall Study|poor/non-compliance|0|||
131898211|NCT02915159|474914002|FG000|Overall Study|Participant withdrew consent|5|||
131898212|NCT02915159|474914003|FG001|Overall Study|Participant withdrew consent|1|||
131898213|NCT02915159|474914002|FG000|Overall Study|Request to discontinue treatment|1|||
131898214|NCT02915159|474914003|FG001|Overall Study|Request to discontinue treatment|2|||
131898215|NCT02915159|474914002|FG000|Overall Study|Adverse Event|2|||
131898216|NCT02915159|474914003|FG001|Overall Study|Adverse Event|2|||
131898217|NCT02915159|474914002|FG000|Overall Study|Lack of Efficacy|0|||
131898218|NCT02915159|474914003|FG001|Overall Study|Lack of Efficacy|3|||
131898219|NCT04534517|474914004|FG000|Overall Study|Adverse Event|1|||
131898220|NCT04534517|474914004|FG000|Overall Study|Withdrawal by Subject|1|||
131898221|NCT04534517|474914004|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
131898222|NCT04534517|474914004|FG000|Overall Study|COVID-19 Related|1|||
131898223|NCT02121795|474914005|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
131898224|NCT02121795|474914006|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
131898225|NCT02121795|474914005|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
131898226|NCT02121795|474914006|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
131898227|NCT02121795|474914005|FG000|Double-Blind Phase|Lost to Follow-up|7|||
131898228|NCT02121795|474914006|FG001|Double-Blind Phase|Lost to Follow-up|4|||
131898229|NCT02121795|474914005|FG000|Double-Blind Phase|Physician Decision|2|||
131898230|NCT02121795|474914006|FG001|Double-Blind Phase|Physician Decision|5|||
131898231|NCT02121795|474914005|FG000|Double-Blind Phase|Adverse Event|5|||
131898232|NCT02121795|474914006|FG001|Double-Blind Phase|Adverse Event|0|||
131898233|NCT02121795|474914005|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
131898234|NCT02121795|474914006|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
131898235|NCT02121795|474914005|FG000|Double-Blind Phase|Protocol Violation|0|||
131898236|NCT02121795|474914006|FG001|Double-Blind Phase|Protocol Violation|3|||
131898237|NCT02121795|474914005|FG000|Double-Blind Phase|Death|1|||
131898238|NCT02121795|474914006|FG001|Double-Blind Phase|Death|1|||
131898239|NCT02121795|474914005|FG000|Open-Label Phase|Physician Decision|8|||
131898240|NCT02121795|474914006|FG001|Open-Label Phase|Physician Decision|8|||
131898241|NCT02121795|474914005|FG000|Open-Label Phase|Withdrawal by Subject|3|||
131898242|NCT02121795|474914006|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131898243|NCT02121795|474914005|FG000|Open-Label Phase|Lost to Follow-up|1|||
131898244|NCT02121795|474914006|FG001|Open-Label Phase|Lost to Follow-up|0|||
131898245|NCT05133323|474914007|FG000|Overall Study|Lack of Efficacy|0|||
131677352|NCT01717768|474104192|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131898246|NCT05133323|474914008|FG001|Overall Study|Lack of Efficacy|0|||
131898247|NCT05133323|474914009|FG002|Overall Study|Lack of Efficacy|1|||
131898248|NCT05133323|474914007|FG000|Overall Study|Withdrawal by Subject|2|||
131898249|NCT05133323|474914008|FG001|Overall Study|Withdrawal by Subject|1|||
131898250|NCT05133323|474914009|FG002|Overall Study|Withdrawal by Subject|0|||
131898251|NCT01714544|474914010|FG000|Overall Study|Lost to Follow-up|1|||
131898252|NCT01714544|474914010|FG000|Overall Study|Physician Decision|1|||
131898253|NCT01714544|474914010|FG000|Overall Study|Withdrawal by Subject|1|||
131898254|NCT00666211|474914017|FG000|Overall Study|Withdrawal by Subject|10|||
131898255|NCT00666211|474914018|FG001|Overall Study|Withdrawal by Subject|13|||
131898256|NCT00666211|474914017|FG000|Overall Study|went off medication, no more pain|1|||
131898257|NCT00666211|474914018|FG001|Overall Study|went off medication, no more pain|0|||
131898258|NCT00666211|474914017|FG000|Overall Study|patient non-compliant|6|||
131898259|NCT00666211|474914018|FG001|Overall Study|patient non-compliant|6|||
131898260|NCT00666211|474914017|FG000|Overall Study|disease progression|1|||
131898261|NCT00666211|474914018|FG001|Overall Study|disease progression|8|||
131898262|NCT00666211|474914017|FG000|Overall Study|Lost to Follow-up|2|||
131898263|NCT00666211|474914018|FG001|Overall Study|Lost to Follow-up|0|||
131898264|NCT00666211|474914017|FG000|Overall Study|toxicity|0|||
131898265|NCT00666211|474914018|FG001|Overall Study|toxicity|2|||
131898266|NCT00666211|474914017|FG000|Overall Study|hospital admission|0|||
131898267|NCT00666211|474914018|FG001|Overall Study|hospital admission|5|||
131898268|NCT00666211|474914017|FG000|Overall Study|Death|0|||
131898269|NCT00666211|474914018|FG001|Overall Study|Death|2|||
131898270|NCT00666211|474914017|FG000|Overall Study|off tx for other complicating disease|0|||
131898271|NCT00666211|474914018|FG001|Overall Study|off tx for other complicating disease|1|||
131898272|NCT00666211|474914017|FG000|Overall Study|Physician Decision|0|||
131898273|NCT00666211|474914018|FG001|Overall Study|Physician Decision|1|||
131898274|NCT02824224|474914019|FG000|Overall Study|Discontinued, IUS expulsion|0|||
131898275|NCT02824224|474914020|FG001|Overall Study|Discontinued, IUS expulsion|1|||
131898276|NCT02824224|474914019|FG000|Overall Study|Did not show up for allocation visit|2|||
131898277|NCT02824224|474914020|FG001|Overall Study|Did not show up for allocation visit|0|||
131898278|NCT02465437|474914027|FG000|Overall Study|Physician Decision|0|||
131898279|NCT02465437|474914028|FG001|Overall Study|Physician Decision|0|||
131898280|NCT02465437|474914029|FG002|Overall Study|Physician Decision|1|||
131898281|NCT02465437|474914030|FG003|Overall Study|Physician Decision|0|||
131898282|NCT02465437|474914027|FG000|Overall Study|Withdrawal by Subject|1|||
131677353|NCT01717768|474104193|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677354|NCT01717768|474104194|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677355|NCT01717768|474104195|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677356|NCT01717768|474104196|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677357|NCT01717768|474104197|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677358|NCT01717768|474104198|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
131677359|NCT01717768|474104199|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677360|NCT01717768|474104200|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131555490|NCT03101241|473658221|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
131677361|NCT01717768|474104201|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677362|NCT01717768|474104202|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131677363|NCT01717768|474104191|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677364|NCT01717768|474104192|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677365|NCT01717768|474104193|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677366|NCT01717768|474104194|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677367|NCT01717768|474104195|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677368|NCT01717768|474104196|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677369|NCT01717768|474104197|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677370|NCT01717768|474104198|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677371|NCT01717768|474104199|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677372|NCT01717768|474104200|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
131677373|NCT01717768|474104201|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677374|NCT01717768|474104202|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131677375|NCT00448435|474104203|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
131677376|NCT00448435|474104204|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
131677377|NCT04195581|474104207|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
131677378|NCT04195581|474104207|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
131677379|NCT04195581|474104207|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
131435989|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
131677380|NCT04195581|474104207|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
131898283|NCT02465437|474914028|FG001|Overall Study|Withdrawal by Subject|0|||
131898284|NCT02465437|474914029|FG002|Overall Study|Withdrawal by Subject|0|||
131898285|NCT02465437|474914030|FG003|Overall Study|Withdrawal by Subject|1|||
131898286|NCT02465437|474914027|FG000|Overall Study|Adverse Event|0|||
131898287|NCT02465437|474914028|FG001|Overall Study|Adverse Event|1|||
131898288|NCT02465437|474914029|FG002|Overall Study|Adverse Event|0|||
131898289|NCT02465437|474914030|FG003|Overall Study|Adverse Event|0|||
131898290|NCT02299388|474914035|FG000|Overall Study|Withdrawal by Subject|0|||
131898291|NCT02299388|474914036|FG001|Overall Study|Withdrawal by Subject|1|||
131898292|NCT00103662|474914037|FG000|Overall Study|Entered Rescue Procedure|0|||
131898293|NCT00103662|474914038|FG001|Overall Study|Entered Rescue Procedure|7|||
131898294|NCT00103662|474914037|FG000|Overall Study|Death|7|||
131898295|NCT00103662|474914038|FG001|Overall Study|Death|7|||
131898296|NCT00103662|474914037|FG000|Overall Study|Elective Withdrawal|5|||
131898297|NCT00103662|474914038|FG001|Overall Study|Elective Withdrawal|5|||
131898298|NCT00103662|474914037|FG000|Overall Study|Lost to Follow-up|0|||
131898299|NCT00103662|474914038|FG001|Overall Study|Lost to Follow-up|1|||
131898300|NCT00103662|474914037|FG000|Overall Study|Other|6|||
131898301|NCT00103662|474914038|FG001|Overall Study|Other|9|||
131898302|NCT00103662|474914037|FG000|Overall Study|Failed mobilization|0|||
131898303|NCT00103662|474914038|FG001|Overall Study|Failed mobilization|4|||
131898304|NCT00103662|474914037|FG000|Overall Study|Intercurrent illness|1|||
131898305|NCT00103662|474914038|FG001|Overall Study|Intercurrent illness|0|||
131898306|NCT03334188|474914041|FG000|Overall Study|Withdrawal by Subject|0|||
131898307|NCT03334188|474914042|FG001|Overall Study|Withdrawal by Subject|1|||
131898308|NCT03334188|474914041|FG000|Overall Study|Death|1|||
131898309|NCT03334188|474914042|FG001|Overall Study|Death|0|||
131898310|NCT03334188|474914041|FG000|Overall Study|Never had qualifying clinic visit|7|||
131898311|NCT03334188|474914042|FG001|Overall Study|Never had qualifying clinic visit|7|||
131898312|NCT03373760|474914043|FG000|Overall Study|Adverse Event|8|||
131898313|NCT03373760|474914043|FG000|Overall Study|Disease Progression|46|||
131898314|NCT03373760|474914043|FG000|Overall Study|Death|4|||
131898315|NCT01093586|474914050|FG000|Overall Study|Failed to engraft|3|||
131898316|NCT03442088|474914051|FG000|Overall Study|Adverse Event|1|||
131898317|NCT03442088|474914051|FG000|Overall Study|Lack of Efficacy|2|||
131898318|NCT03442088|474914051|FG000|Overall Study|Lost to Follow-up|2|||
131898319|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
131898320|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
131898321|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
131898322|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
131898323|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
131898324|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
131898325|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
131898326|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
131898327|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
131898328|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
131898329|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
131898330|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
131898331|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
131898332|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
131898333|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Death|1|||
131898334|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Death|0|||
131898335|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
131898336|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
131898337|NCT00105989|474914052|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
131898338|NCT00105989|474914053|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
131898339|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
131898340|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
131898341|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
131898342|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
131898343|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
131898344|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
131898345|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
131898346|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
131898347|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
131898348|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
131898349|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
131898350|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
131898351|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
131898352|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
131677381|NCT04195581|474104207|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
131677382|NCT04195581|474104207|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
131677383|NCT01387230|474104208|FG000|Overall Study|Adverse Event|0|||
131677384|NCT01387230|474104209|FG001|Overall Study|Adverse Event|1|||
131677385|NCT01387230|474104210|FG002|Overall Study|Adverse Event|3|||
131677386|NCT01387230|474104208|FG000|Overall Study|Lack of Efficacy|8|||
131677387|NCT01387230|474104209|FG001|Overall Study|Lack of Efficacy|5|||
131677388|NCT01387230|474104210|FG002|Overall Study|Lack of Efficacy|4|||
131677389|NCT01387230|474104208|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
131677390|NCT01387230|474104209|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
131677391|NCT01387230|474104210|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
131677392|NCT01387230|474104208|FG000|Overall Study|Lost to Follow-up|0|||
131677393|NCT01387230|474104209|FG001|Overall Study|Lost to Follow-up|0|||
131677394|NCT01387230|474104210|FG002|Overall Study|Lost to Follow-up|1|||
131677395|NCT01387230|474104208|FG000|Overall Study|Withdrawal by Subject|4|||
131677396|NCT01387230|474104209|FG001|Overall Study|Withdrawal by Subject|1|||
131677397|NCT01387230|474104210|FG002|Overall Study|Withdrawal by Subject|0|||
131677398|NCT01237340|474104213|FG000|Overall Study|Adverse Event|3|||
131677399|NCT01237340|474104213|FG000|Overall Study|Withdrawal by Subject|1|||
131677400|NCT01237340|474104213|FG000|Overall Study|Early termination of the trial|36|||
131677401|NCT01136811|474104214|FG000|Overall Study|Physician Decision|11|||
131677402|NCT03829319|474104219|FG000|Overall Study|Sponsor's Decision|4|||
131677403|NCT03829319|474104220|FG001|Overall Study|Sponsor's Decision|90|||
131677404|NCT03829319|474104221|FG002|Overall Study|Sponsor's Decision|102|||
131677405|NCT03829319|474104219|FG000|Overall Study|Withdrawal by Subject|1|||
131677406|NCT03829319|474104220|FG001|Overall Study|Withdrawal by Subject|5|||
131677407|NCT03829319|474104221|FG002|Overall Study|Withdrawal by Subject|4|||
131677408|NCT03829319|474104219|FG000|Overall Study|Physician Decision|0|||
131677409|NCT03829319|474104220|FG001|Overall Study|Physician Decision|3|||
131677410|NCT03829319|474104221|FG002|Overall Study|Physician Decision|0|||
131677411|NCT03829319|474104219|FG000|Overall Study|Lost to Follow-up|0|||
131677412|NCT03829319|474104220|FG001|Overall Study|Lost to Follow-up|0|||
131677413|NCT03829319|474104221|FG002|Overall Study|Lost to Follow-up|1|||
131677414|NCT03829319|474104219|FG000|Overall Study|Death|8|||
131677415|NCT03829319|474104220|FG001|Overall Study|Death|277|||
131677416|NCT03829319|474104221|FG002|Overall Study|Death|266|||
131677417|NCT04498832|474104222|FG000|Overall Study|Adverse Event|1|||
131677418|NCT04498832|474104223|FG001|Overall Study|Adverse Event|3|||
131677419|NCT04498832|474104222|FG000|Overall Study|Withdrawal by Subject|0|||
131677420|NCT04498832|474104223|FG001|Overall Study|Withdrawal by Subject|1|||
131677421|NCT01012739|474104224|FG000|Treatment Period 1|Adverse Event|0|||
131677422|NCT01012739|474104225|FG001|Treatment Period 1|Adverse Event|0|||
131677423|NCT01012739|474104226|FG002|Treatment Period 1|Adverse Event|0|||
131677424|NCT01012739|474104227|FG003|Treatment Period 1|Adverse Event|1|||
131677425|NCT01012739|474104224|FG000|Treatment Period 2|Abnormal test procedure results|0|||
131677426|NCT01012739|474104225|FG001|Treatment Period 2|Abnormal test procedure results|0|||
131677427|NCT01012739|474104226|FG002|Treatment Period 2|Abnormal test procedure results|0|||
131677428|NCT01012739|474104227|FG003|Treatment Period 2|Abnormal test procedure results|1|||
131677429|NCT03049735|474104232|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
131677430|NCT03049735|474104233|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
131677431|NCT03049735|474104234|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
131677432|NCT03049735|474104232|FG000|Overall Study|Other|5|||
131677433|NCT03049735|474104233|FG001|Overall Study|Other|3|||
131677434|NCT03049735|474104234|FG002|Overall Study|Other|1|||
131677435|NCT03049735|474104232|FG000|Overall Study|Lack of Efficacy|4|||
131677436|NCT03049735|474104233|FG001|Overall Study|Lack of Efficacy|0|||
131677437|NCT03049735|474104234|FG002|Overall Study|Lack of Efficacy|3|||
131677438|NCT03049735|474104232|FG000|Overall Study|Protocol deviation|1|||
131677439|NCT03049735|474104233|FG001|Overall Study|Protocol deviation|0|||
131677440|NCT03049735|474104234|FG002|Overall Study|Protocol deviation|0|||
131677441|NCT03049735|474104232|FG000|Overall Study|Pregnancy|0|||
131677442|NCT03049735|474104233|FG001|Overall Study|Pregnancy|0|||
131677443|NCT03049735|474104234|FG002|Overall Study|Pregnancy|1|||
131677444|NCT03049735|474104232|FG000|Overall Study|Adverse Event|7|||
131677445|NCT03049735|474104233|FG001|Overall Study|Adverse Event|18|||
131677446|NCT03049735|474104234|FG002|Overall Study|Adverse Event|5|||
131677447|NCT03049735|474104232|FG000|Overall Study|Withdrawal by Subject|10|||
131677448|NCT03049735|474104233|FG001|Overall Study|Withdrawal by Subject|3|||
131677449|NCT03049735|474104234|FG002|Overall Study|Withdrawal by Subject|7|||
131677450|NCT03049735|474104232|FG000|Overall Study|Lost to Follow-up|1|||
131677451|NCT03049735|474104233|FG001|Overall Study|Lost to Follow-up|5|||
131677452|NCT03049735|474104234|FG002|Overall Study|Lost to Follow-up|5|||
131677453|NCT00047320|474104238|FG000|Overall Study|Lack of Efficacy|8|||
131677454|NCT00047320|474104238|FG000|Overall Study|Lost to Follow-up|1|||
131677455|NCT00047320|474104238|FG000|Overall Study|Physician Decision|8|||
131677456|NCT00047320|474104238|FG000|Overall Study|Withdrawal by Subject|9|||
131677457|NCT00047320|474104238|FG000|Overall Study|Ineligible|2|||
131677458|NCT02906787|474104239|FG000|Overall Study|Withdrawal by Subject|12|||
131677459|NCT02906787|474104240|FG001|Overall Study|Withdrawal by Subject|10|||
131677460|NCT02906787|474104239|FG000|Overall Study|Missed|24|||
131677461|NCT02906787|474104240|FG001|Overall Study|Missed|22|||
131677462|NCT04275297|474104241|FG000|Overall Study|Lost to Follow-up|1|||
131677463|NCT04275297|474104242|FG001|Overall Study|Lost to Follow-up|1|||
131677464|NCT02818920|474104243|FG000|Overall Study|Unresectable|4|||
131677465|NCT02818920|474104243|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
131677466|NCT02818920|474104243|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
131677467|NCT02818920|474104243|FG000|Overall Study|Adverse Event|3|||
131677468|NCT02818920|474104243|FG000|Overall Study|Developed Other Disease|1|||
131677469|NCT02818920|474104243|FG000|Overall Study|Refused Further Treatment|1|||
131677470|NCT04824521|474104246|FG000|Overall Study|Lost to Follow-up|1|||
131677471|NCT00447382|474104247|FG000|Overall Study|Adverse Event|1|||
131677472|NCT00447382|474104248|FG001|Overall Study|Adverse Event|1|||
131677473|NCT00447382|474104247|FG000|Overall Study|Lack of Efficacy|1|||
131677474|NCT00447382|474104248|FG001|Overall Study|Lack of Efficacy|0|||
131677475|NCT00447382|474104247|FG000|Overall Study|Protocol Violation|2|||
131677476|NCT00447382|474104248|FG001|Overall Study|Protocol Violation|0|||
131677477|NCT00447382|474104247|FG000|Overall Study|Unclassified|2|||
131677478|NCT00447382|474104248|FG001|Overall Study|Unclassified|5|||
131677479|NCT02673619|474104249|FG000|Overall Study|Lost to Follow-up|1|||
131677480|NCT02673619|474104250|FG001|Overall Study|Lost to Follow-up|0|||
131677481|NCT02673619|474104251|FG002|Overall Study|Lost to Follow-up|0|||
131677482|NCT02673619|474104252|FG003|Overall Study|Lost to Follow-up|0|||
131677483|NCT02673619|474104249|FG000|Overall Study|Withdrawal by Subject|1|||
131677484|NCT02673619|474104250|FG001|Overall Study|Withdrawal by Subject|1|||
131677485|NCT02673619|474104251|FG002|Overall Study|Withdrawal by Subject|1|||
131677486|NCT02673619|474104252|FG003|Overall Study|Withdrawal by Subject|0|||
131677487|NCT02673619|474104249|FG000|Overall Study|Adverse Event|0|||
131677488|NCT02673619|474104250|FG001|Overall Study|Adverse Event|0|||
131677489|NCT02673619|474104251|FG002|Overall Study|Adverse Event|1|||
131677490|NCT02673619|474104252|FG003|Overall Study|Adverse Event|0|||
131677491|NCT02673619|474104249|FG000|Overall Study|Lack of Efficacy|0|||
131677492|NCT02673619|474104250|FG001|Overall Study|Lack of Efficacy|0|||
131677493|NCT02673619|474104251|FG002|Overall Study|Lack of Efficacy|1|||
131677494|NCT02673619|474104252|FG003|Overall Study|Lack of Efficacy|0|||
131677495|NCT03769181|474105703|FG000|Overall Study|Adverse Event|1|||
131677496|NCT03769181|474105704|FG001|Overall Study|Adverse Event|0|||
131677497|NCT03769181|474105705|FG002|Overall Study|Adverse Event|2|||
131677498|NCT03769181|474105706|FG003|Overall Study|Adverse Event|4|||
131677499|NCT03769181|474105703|FG000|Overall Study|Withdrawal by Subject|1|||
131677500|NCT03769181|474105704|FG001|Overall Study|Withdrawal by Subject|0|||
131677501|NCT03769181|474105705|FG002|Overall Study|Withdrawal by Subject|2|||
131677502|NCT03769181|474105706|FG003|Overall Study|Withdrawal by Subject|1|||
131677503|NCT03769181|474105703|FG000|Overall Study|Progressive disease|9|||
131677504|NCT03769181|474105704|FG001|Overall Study|Progressive disease|7|||
131677505|NCT03769181|474105705|FG002|Overall Study|Progressive disease|13|||
131677506|NCT03769181|474105706|FG003|Overall Study|Progressive disease|6|||
131677507|NCT03769181|474105703|FG000|Overall Study|Other - Unspecified|2|||
131677508|NCT03769181|474105704|FG001|Overall Study|Other - Unspecified|1|||
131677509|NCT03769181|474105705|FG002|Overall Study|Other - Unspecified|0|||
131677510|NCT03769181|474105706|FG003|Overall Study|Other - Unspecified|0|||
131677511|NCT03078907|474105709|FG000|Overall Study|Adverse Event|2|||
131677512|NCT03078907|474105710|FG001|Overall Study|Adverse Event|0|||
131677513|NCT03078907|474105709|FG000|Overall Study|Other|1|||
131677514|NCT03078907|474105710|FG001|Overall Study|Other|0|||
131677515|NCT03078907|474105709|FG000|Overall Study|Protocol Violation|0|||
131677516|NCT03078907|474105710|FG001|Overall Study|Protocol Violation|1|||
131677517|NCT03338192|474105711|FG000|Year One to Year Two|High Blood Pressure|7|||
131677518|NCT03338192|474105712|FG001|Year One to Year Two|High Blood Pressure|1|||
131677519|NCT03338192|474105711|FG000|Year One to Year Two|HIV +|1|||
131677520|NCT03338192|474105712|FG001|Year One to Year Two|HIV +|0|||
131677521|NCT03338192|474105711|FG000|Year Two to Year Four|High Blood Pressure|1|||
131677522|NCT03338192|474105712|FG001|Year Two to Year Four|High Blood Pressure|0|||
131677523|NCT03338192|474105711|FG000|Year Two to Year Four|HIV +|2|||
131677524|NCT03338192|474105712|FG001|Year Two to Year Four|HIV +|0|||
131677525|NCT03338192|474105711|FG000|Year Four to Year Six|High Blood Pressure|2|||
131677526|NCT03338192|474105712|FG001|Year Four to Year Six|High Blood Pressure|1|||
131677527|NCT03808688|474105713|FG000|Overall Study|Adverse Event|13|||
131677528|NCT03808688|474105714|FG001|Overall Study|Adverse Event|17|||
131677529|NCT03808688|474105713|FG000|Overall Study|Lack of Efficacy|2|||
131677530|NCT03808688|474105714|FG001|Overall Study|Lack of Efficacy|0|||
131677531|NCT03808688|474105713|FG000|Overall Study|Lost to Follow-up|0|||
131677532|NCT03808688|474105714|FG001|Overall Study|Lost to Follow-up|2|||
131677533|NCT03808688|474105713|FG000|Overall Study|Withdrawal by Subject|1|||
131677534|NCT03808688|474105714|FG001|Overall Study|Withdrawal by Subject|0|||
131772595|NCT03575975|474445129|FG002|Overall Study|Lost to Follow-up|0|||
131677535|NCT03808688|474105713|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
131677536|NCT03808688|474105714|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
131677537|NCT03808688|474105713|FG000|Overall Study|IOP Too High|1|||
131677538|NCT03808688|474105714|FG001|Overall Study|IOP Too High|1|||
131677539|NCT03808688|474105713|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
131677540|NCT03808688|474105714|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
131677541|NCT03808688|474105713|FG000|Overall Study|Visit Out of Window|0|||
131677542|NCT03808688|474105714|FG001|Overall Study|Visit Out of Window|1|||
131677543|NCT03808688|474105713|FG000|Overall Study|Medication Non-Compliance|0|||
131677544|NCT03808688|474105714|FG001|Overall Study|Medication Non-Compliance|1|||
131677545|NCT03329196|474105715|FG000|Overall Study|Adverse Event|10|||
131677546|NCT03329196|474105716|FG001|Overall Study|Adverse Event|5|||
131677547|NCT03329196|474105715|FG000|Overall Study|Physician Decision|2|||
131677548|NCT03329196|474105716|FG001|Overall Study|Physician Decision|2|||
131677549|NCT03329196|474105715|FG000|Overall Study|Withdrawal by Subject|11|||
131677550|NCT03329196|474105716|FG001|Overall Study|Withdrawal by Subject|3|||
131677551|NCT03329196|474105715|FG000|Overall Study|Hepatic function abnormalities|0|||
131677552|NCT03329196|474105716|FG001|Overall Study|Hepatic function abnormalities|1|||
131677553|NCT03329196|474105715|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
131677554|NCT03329196|474105716|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
131677555|NCT03329196|474105715|FG000|Overall Study|Difficult to control Hb|2|||
131677556|NCT03329196|474105716|FG001|Overall Study|Difficult to control Hb|3|||
131677557|NCT03329196|474105715|FG000|Overall Study|Dialysis or renal transplant|13|||
131677558|NCT03329196|474105716|FG001|Overall Study|Dialysis or renal transplant|15|||
131677559|NCT03434353|474105723|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
131677560|NCT03434353|474105724|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
131677561|NCT03434353|474105725|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
131677562|NCT03434353|474105726|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
131677563|NCT03434353|474105727|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
131677564|NCT03434353|474105723|FG000|Overall Study|Withdrew consent|1|||
131677565|NCT03434353|474105724|FG001|Overall Study|Withdrew consent|0|||
131677566|NCT03434353|474105725|FG002|Overall Study|Withdrew consent|3|||
131677567|NCT03434353|474105726|FG003|Overall Study|Withdrew consent|0|||
131677568|NCT03434353|474105727|FG004|Overall Study|Withdrew consent|0|||
131677569|NCT03434353|474105723|FG000|Overall Study|Adverse Event|1|||
131677570|NCT03434353|474105724|FG001|Overall Study|Adverse Event|0|||
131677571|NCT03434353|474105725|FG002|Overall Study|Adverse Event|0|||
131677572|NCT03434353|474105726|FG003|Overall Study|Adverse Event|0|||
131677573|NCT03434353|474105727|FG004|Overall Study|Adverse Event|1|||
131677574|NCT03434353|474105723|FG000|Overall Study|Lost to Follow-up|2|||
131677575|NCT03434353|474105724|FG001|Overall Study|Lost to Follow-up|0|||
131677576|NCT03434353|474105725|FG002|Overall Study|Lost to Follow-up|0|||
131677577|NCT03434353|474105726|FG003|Overall Study|Lost to Follow-up|0|||
131677578|NCT03434353|474105727|FG004|Overall Study|Lost to Follow-up|0|||
131677579|NCT01990534|474105730|FG000|Overall Study|Death|22|||
131677580|NCT01990534|474105730|FG000|Overall Study|Progressive disease|3|||
131898353|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Death|0|||
131898354|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Death|0|||
131898355|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
131898356|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
131898357|NCT00105989|474914052|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
131898358|NCT00105989|474914053|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
131898359|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
131898360|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
131898361|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
131898362|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
131898363|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
131898364|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
131898365|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
131898366|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
131898367|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
131898368|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
131898369|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
131898370|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
131898371|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
131898372|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
131898373|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
131898374|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
131898375|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
131898376|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
131898377|NCT00105989|474914052|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
131898378|NCT00105989|474914053|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
131898379|NCT01001520|474914054|FG000|Medication Period 1|Withdrawal by Subject|2|||
131898380|NCT01001520|474914055|FG001|Medication Period 1|Withdrawal by Subject|2|||
131898381|NCT01001520|474914054|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
131898382|NCT01001520|474914055|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
131898383|NCT01001520|474914054|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
131898384|NCT01001520|474914055|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
131898385|NCT01001520|474914054|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
131898386|NCT01001520|474914055|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
131898387|NCT01001520|474914054|FG000|Washout Period|Withdrawal by Subject|2|||
131898388|NCT01001520|474914055|FG001|Washout Period|Withdrawal by Subject|1|||
131898389|NCT01001520|474914054|FG000|Medication Period 2|Withdrawal by Subject|0|||
131898390|NCT01001520|474914055|FG001|Medication Period 2|Withdrawal by Subject|3|||
131898391|NCT00357877|474914056|FG000|Overall Study|Death|2|||
131898392|NCT00357877|474914057|FG001|Overall Study|Death|1|||
131898393|NCT00357877|474914056|FG000|Overall Study|Lost to Follow-up|20|||
131898394|NCT00357877|474914057|FG001|Overall Study|Lost to Follow-up|23|||
131898395|NCT00357877|474914056|FG000|Overall Study|Withdrawal by Subject|3|||
131898396|NCT00357877|474914057|FG001|Overall Study|Withdrawal by Subject|3|||
131898397|NCT00357877|474914056|FG000|Overall Study|Administrative withdrawal|1|||
131898398|NCT00357877|474914057|FG001|Overall Study|Administrative withdrawal|1|||
131898399|NCT00357877|474914056|FG000|Overall Study|Other|0|||
131898400|NCT00357877|474914057|FG001|Overall Study|Other|2|||
131898401|NCT04668209|474914060|FG000|Overall Study|Withdrawal by Subject|2|||
131898402|NCT04668209|474914061|FG001|Overall Study|Withdrawal by Subject|2|||
131898403|NCT04668209|474914060|FG000|Overall Study|Lost to Follow-up|3|||
131898404|NCT04668209|474914061|FG001|Overall Study|Lost to Follow-up|4|||
131898405|NCT04668209|474914060|FG000|Overall Study|Subject Expired|2|||
131898406|NCT04668209|474914061|FG001|Overall Study|Subject Expired|0|||
131898407|NCT04668209|474914060|FG000|Overall Study|Withdrawn from study|0|||
131898408|NCT04668209|474914061|FG001|Overall Study|Withdrawn from study|1|||
131898409|NCT04668209|474914060|FG000|Overall Study|Adverse Event|0|||
131677581|NCT01990534|474105730|FG000|Overall Study|Protocol Violation|1|||
131677582|NCT01990534|474105730|FG000|Overall Study|Withdrawal of Informed Consent|2|||
131677583|NCT01990534|474105730|FG000|Overall Study|Symptomatic Deterioration|1|||
131677584|NCT01990534|474105730|FG000|Overall Study|Withdrawal by Subject|3|||
131677585|NCT01990534|474105730|FG000|Overall Study|Reason not Specified|2|||
131677586|NCT01990534|474105730|FG000|Overall Study|Lost to Follow-up|1|||
131677587|NCT00234494|474105731|FG000|Overall Study|Protocol Violation|2|||
131677588|NCT02276872|474105736|FG000|Overall Study|Adverse Event|1|||
131677589|NCT02276872|474105737|FG001|Overall Study|Adverse Event|0|||
131677590|NCT02276872|474105738|FG002|Overall Study|Adverse Event|0|||
131677591|NCT04175808|474105739|FG000|Part A|Miscellaneous|2|||
131677592|NCT04175808|474105740|FG001|Part A|Miscellaneous|0|||
131677593|NCT04175808|474105741|FG002|Part A|Miscellaneous|0|||
131677594|NCT04175808|474105742|FG003|Part A|Miscellaneous|0|||
131677595|NCT04175808|474105743|FG004|Part A|Miscellaneous|0|||
131677596|NCT04175808|474105744|FG005|Part A|Miscellaneous|0|||
131677597|NCT04175808|474105745|FG006|Part A|Miscellaneous|0|||
131677598|NCT02021292|474105749|FG000|Overall Study|Physician Decision|0|||
131677599|NCT02021292|474105750|FG001|Overall Study|Physician Decision|1|||
131677600|NCT02021292|474105749|FG000|Overall Study|Lost to Follow-up|0|||
131677601|NCT02021292|474105750|FG001|Overall Study|Lost to Follow-up|1|||
131677602|NCT02021292|474105749|FG000|Overall Study|Death|0|||
131677603|NCT02021292|474105750|FG001|Overall Study|Death|1|||
131677604|NCT04147234|474105751|FG000|Overall Study|Clinical deterioration|0|||
131677605|NCT04147234|474105752|FG001|Overall Study|Clinical deterioration|0|||
131677606|NCT04147234|474105753|FG002|Overall Study|Clinical deterioration|1|||
131677607|NCT04147234|474105754|FG003|Overall Study|Clinical deterioration|0|||
131677608|NCT04147234|474105755|FG004|Overall Study|Clinical deterioration|0|||
131677609|NCT04147234|474105756|FG005|Overall Study|Clinical deterioration|0|||
131677610|NCT04147234|474105757|FG006|Overall Study|Clinical deterioration|0|||
131677611|NCT04147234|474105751|FG000|Overall Study|Withdrawal by Subject|0|||
131677612|NCT04147234|474105752|FG001|Overall Study|Withdrawal by Subject|1|||
131677613|NCT04147234|474105753|FG002|Overall Study|Withdrawal by Subject|1|||
131677614|NCT04147234|474105754|FG003|Overall Study|Withdrawal by Subject|0|||
131677615|NCT04147234|474105755|FG004|Overall Study|Withdrawal by Subject|0|||
131677616|NCT04147234|474105756|FG005|Overall Study|Withdrawal by Subject|0|||
131677617|NCT04147234|474105757|FG006|Overall Study|Withdrawal by Subject|0|||
131677618|NCT04147234|474105751|FG000|Overall Study|Clinical disease progression|1|||
131677619|NCT04147234|474105752|FG001|Overall Study|Clinical disease progression|3|||
131677620|NCT04147234|474105753|FG002|Overall Study|Clinical disease progression|1|||
131677621|NCT04147234|474105754|FG003|Overall Study|Clinical disease progression|1|||
131677622|NCT04147234|474105755|FG004|Overall Study|Clinical disease progression|0|||
131677623|NCT04147234|474105756|FG005|Overall Study|Clinical disease progression|1|||
131677624|NCT04147234|474105757|FG006|Overall Study|Clinical disease progression|0|||
131677625|NCT04147234|474105751|FG000|Overall Study|Objective disease progression|6|||
131677626|NCT04147234|474105752|FG001|Overall Study|Objective disease progression|4|||
131677627|NCT04147234|474105753|FG002|Overall Study|Objective disease progression|3|||
131677628|NCT04147234|474105754|FG003|Overall Study|Objective disease progression|3|||
131677629|NCT04147234|474105755|FG004|Overall Study|Objective disease progression|5|||
131677630|NCT04147234|474105756|FG005|Overall Study|Objective disease progression|2|||
131677631|NCT04147234|474105757|FG006|Overall Study|Objective disease progression|3|||
131677632|NCT04147234|474105751|FG000|Overall Study|Adverse Event|0|||
131677633|NCT04147234|474105752|FG001|Overall Study|Adverse Event|0|||
131677634|NCT04147234|474105753|FG002|Overall Study|Adverse Event|0|||
131677635|NCT04147234|474105754|FG003|Overall Study|Adverse Event|0|||
131677636|NCT04147234|474105755|FG004|Overall Study|Adverse Event|1|||
131677637|NCT04147234|474105756|FG005|Overall Study|Adverse Event|0|||
131677638|NCT04147234|474105757|FG006|Overall Study|Adverse Event|0|||
131677639|NCT05972733|474105758|FG000|Overall Study|Lost to Follow-up|2|||
131677640|NCT05972733|474105758|FG000|Overall Study|Withdrawal by Subject|1|||
131677641|NCT04982588|474105761|FG000|Overall Study|Withdrawal by Subject|2|||
131677642|NCT02366728|474105763|FG000|Overall Study|Death|0|||
131677643|NCT02366728|474105764|FG001|Overall Study|Death|0|||
131677644|NCT02366728|474105765|FG002|Overall Study|Death|1|||
131677645|NCT02366728|474105763|FG000|Overall Study|Adverse Event|1|||
131677646|NCT02366728|474105764|FG001|Overall Study|Adverse Event|0|||
131677647|NCT02366728|474105765|FG002|Overall Study|Adverse Event|0|||
131677648|NCT02366728|474105763|FG000|Overall Study|Screen Failure|2|||
131677649|NCT02366728|474105764|FG001|Overall Study|Screen Failure|1|||
131677650|NCT02366728|474105765|FG002|Overall Study|Screen Failure|0|||
131677651|NCT02366728|474105763|FG000|Overall Study|Only yielded 2 vaccines|1|||
131677652|NCT02366728|474105764|FG001|Overall Study|Only yielded 2 vaccines|0|||
131677653|NCT02366728|474105765|FG002|Overall Study|Only yielded 2 vaccines|0|||
131677654|NCT00992511|474105766|FG000|Overall Study|Migrated/moved from study area|1|||
131677655|NCT00992511|474105767|FG001|Overall Study|Migrated/moved from study area|0|||
131677656|NCT00992511|474105768|FG002|Overall Study|Migrated/moved from study area|1|||
131677657|NCT00992511|474105769|FG003|Overall Study|Migrated/moved from study area|2|||
131677658|NCT00992511|474105766|FG000|Overall Study|Lost to Follow-up|1|||
131677659|NCT00992511|474105767|FG001|Overall Study|Lost to Follow-up|0|||
131677660|NCT00992511|474105768|FG002|Overall Study|Lost to Follow-up|0|||
131677661|NCT00992511|474105769|FG003|Overall Study|Lost to Follow-up|2|||
131677662|NCT00992511|474105766|FG000|Overall Study|Withdrawal by Subject|0|||
131677663|NCT00992511|474105767|FG001|Overall Study|Withdrawal by Subject|0|||
131677664|NCT00992511|474105768|FG002|Overall Study|Withdrawal by Subject|1|||
131677665|NCT00992511|474105769|FG003|Overall Study|Withdrawal by Subject|1|||
131677666|NCT04498169|474105770|FG000|Study Completion|Adverse Event|1|||
131677667|NCT04498169|474105771|FG001|Study Completion|Adverse Event|1|||
131677668|NCT04615247|474105772|FG000|Overall Study|Adverse Event|0|||
131677669|NCT04615247|474105773|FG001|Overall Study|Adverse Event|2|||
131677670|NCT04615247|474105772|FG000|Overall Study|Withdrawal by Subject|1|||
131677671|NCT04615247|474105773|FG001|Overall Study|Withdrawal by Subject|1|||
131677672|NCT01383161|474105778|FG000|Overall Study|Adverse Event|5|||
131677673|NCT01383161|474105779|FG001|Overall Study|Adverse Event|1|||
131677674|NCT01383161|474105778|FG000|Overall Study|Withdrawal by Subject|0|||
131677675|NCT01383161|474105779|FG001|Overall Study|Withdrawal by Subject|2|||
131677676|NCT01383161|474105778|FG000|Overall Study|Lack of Efficacy|0|||
131677677|NCT01383161|474105779|FG001|Overall Study|Lack of Efficacy|1|||
131677678|NCT03942406|474105786|FG000|Overall Study|Lost to Follow-up|4|||
131677679|NCT03942406|474105787|FG001|Overall Study|Lost to Follow-up|5|||
131677680|NCT03942406|474105788|FG002|Overall Study|Lost to Follow-up|3|||
131677681|NCT03942406|474105789|FG003|Overall Study|Lost to Follow-up|7|||
131677682|NCT03942406|474105790|FG004|Overall Study|Lost to Follow-up|1|||
131677683|NCT03942406|474105791|FG005|Overall Study|Lost to Follow-up|0|||
131677684|NCT03942406|474105792|FG006|Overall Study|Lost to Follow-up|0|||
131677685|NCT03942406|474105786|FG000|Overall Study|Withdrawal by Subject|3|||
131677686|NCT03942406|474105787|FG001|Overall Study|Withdrawal by Subject|1|||
131677687|NCT03942406|474105788|FG002|Overall Study|Withdrawal by Subject|1|||
131677688|NCT03942406|474105789|FG003|Overall Study|Withdrawal by Subject|3|||
131677689|NCT03942406|474105790|FG004|Overall Study|Withdrawal by Subject|0|||
131677690|NCT03942406|474105791|FG005|Overall Study|Withdrawal by Subject|0|||
131677691|NCT03942406|474105792|FG006|Overall Study|Withdrawal by Subject|0|||
131677692|NCT03942406|474105786|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
131677693|NCT03942406|474105787|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
131677694|NCT03942406|474105788|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
131677695|NCT03942406|474105789|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
131677696|NCT03942406|474105790|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
131677697|NCT03942406|474105791|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
131677698|NCT03942406|474105792|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
131677699|NCT02596620|474105793|FG000|Overall Study|Lost to Follow-up|1|||
131677700|NCT02596620|474105794|FG001|Overall Study|Lost to Follow-up|1|||
131677701|NCT05628285|474105795|FG000|Overall Study|Lost to Follow-up|1|||
131677702|NCT03694418|474105796|FG000|Overall Study|Lost to Follow-up|115|||
131677703|NCT03694418|474105797|FG001|Overall Study|Lost to Follow-up|23|||
131677704|NCT03694418|474105798|FG002|Overall Study|Lost to Follow-up|12|||
131677705|NCT03694418|474105799|FG003|Overall Study|Lost to Follow-up|12|||
131677706|NCT03694418|474105800|FG004|Overall Study|Lost to Follow-up|13|||
131677707|NCT02310672|474105801|FG000|Overall Study|Death|1|||
131677708|NCT02310672|474105801|FG000|Overall Study|Lost to Follow-up|1|||
131677709|NCT02310672|474105801|FG000|Overall Study|Withdrawal by Subject|1|||
131677710|NCT02310672|474105801|FG000|Overall Study|Sponsor's decision|12|||
131677711|NCT01601847|474105809|FG000|Overall Study|Death|1|||
131677712|NCT01601847|474105810|FG001|Overall Study|Death|0|||
131677713|NCT01601847|474105809|FG000|Overall Study|Withdrawal by Subject|11|||
131677714|NCT01601847|474105810|FG001|Overall Study|Withdrawal by Subject|7|||
131677715|NCT01601847|474105809|FG000|Overall Study|Lost to Follow-up|1|||
131677716|NCT01601847|474105810|FG001|Overall Study|Lost to Follow-up|3|||
131677717|NCT01284062|474105811|FG000|Overall Study|Adverse Event|4|||
131677718|NCT01284062|474105812|FG001|Overall Study|Adverse Event|5|||
131677719|NCT01284062|474105813|FG002|Overall Study|Adverse Event|0|||
131677720|NCT01284062|474105814|FG003|Overall Study|Adverse Event|5|||
131677721|NCT01284062|474105811|FG000|Overall Study|Lack of Efficacy|3|||
131677722|NCT01284062|474105812|FG001|Overall Study|Lack of Efficacy|2|||
131677723|NCT01284062|474105813|FG002|Overall Study|Lack of Efficacy|2|||
131677724|NCT01284062|474105814|FG003|Overall Study|Lack of Efficacy|1|||
131677725|NCT01284062|474105811|FG000|Overall Study|Medication error without adverse event|0|||
131677726|NCT01284062|474105812|FG001|Overall Study|Medication error without adverse event|0|||
131677727|NCT01284062|474105813|FG002|Overall Study|Medication error without adverse event|1|||
131677728|NCT01284062|474105814|FG003|Overall Study|Medication error without adverse event|0|||
131677729|NCT01284062|474105811|FG000|Overall Study|Protocol Violation|1|||
131677730|NCT01284062|474105812|FG001|Overall Study|Protocol Violation|0|||
131677731|NCT01284062|474105813|FG002|Overall Study|Protocol Violation|0|||
131677732|NCT01284062|474105814|FG003|Overall Study|Protocol Violation|2|||
131677733|NCT01284062|474105811|FG000|Overall Study|Withdrawal by Subject|3|||
131677734|NCT01284062|474105812|FG001|Overall Study|Withdrawal by Subject|1|||
131677735|NCT01284062|474105813|FG002|Overall Study|Withdrawal by Subject|2|||
131677736|NCT01284062|474105814|FG003|Overall Study|Withdrawal by Subject|5|||
131677737|NCT01284062|474105811|FG000|Overall Study|Other|0|||
131677738|NCT01284062|474105812|FG001|Overall Study|Other|0|||
131677739|NCT01284062|474105813|FG002|Overall Study|Other|0|||
131677740|NCT01284062|474105814|FG003|Overall Study|Other|1|||
131677741|NCT01284062|474105811|FG000|Overall Study|Site Closed|0|||
131677742|NCT01284062|474105812|FG001|Overall Study|Site Closed|0|||
131677743|NCT01284062|474105813|FG002|Overall Study|Site Closed|1|||
131677744|NCT01284062|474105814|FG003|Overall Study|Site Closed|0|||
131677745|NCT02234323|474105815|FG000|All Enrolled|Not Treated: Completed study in database|2|||
131677746|NCT02234323|474105815|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
131677747|NCT02234323|474105815|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
131677748|NCT02234323|474105815|FG000|All Treated|Death|1|||
131677749|NCT02234323|474105815|FG000|All Treated|Physician Decision|5|||
131677750|NCT02234323|474105815|FG000|All Treated|Lack of Efficacy|3|||
131677751|NCT02234323|474105815|FG000|All Treated|Exceeded lab value limit|2|||
131677752|NCT02234323|474105815|FG000|All Treated|Other|7|||
131677753|NCT00867113|474105816|FG000|Treatment Period|Adverse Event|15|||
131677754|NCT00867113|474105816|FG000|Treatment Period|Death|2|||
131677755|NCT00867113|474105816|FG000|Treatment Period|Withdrawal by Subject|19|||
131677756|NCT00867113|474105816|FG000|Treatment Period|Lost to Follow-up|3|||
131677757|NCT00867113|474105816|FG000|Treatment Period|Administrative problems|1|||
131677758|NCT00867113|474105816|FG000|Treatment Period|Disease progression/relapse|1|||
131677759|NCT00867113|474105816|FG000|Treatment Period|Protocol Violation|4|||
131677760|NCT00867113|474105816|FG000|Post Treatment After Survival Follow-up|Death|1|||
131677761|NCT00867113|474105816|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
131677762|NCT00867113|474105816|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
131677763|NCT00867113|474105816|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
131677764|NCT01886313|474105817|FG000|Overall Study|Adverse Event|1|||
131677765|NCT01886313|474105818|FG001|Overall Study|Adverse Event|1|||
131677766|NCT00403754|474105819|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
131677767|NCT00403754|474105820|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
131677768|NCT00403754|474105821|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
131677769|NCT00403754|474105822|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
131677770|NCT00403754|474105819|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
131677771|NCT00403754|474105820|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
131677772|NCT00403754|474105821|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
131677773|NCT00403754|474105822|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
131677774|NCT02499770|474105823|FG000|Overall Study|Death|17|||
131677775|NCT02499770|474105824|FG001|Overall Study|Death|56|||
131677776|NCT02499770|474105823|FG000|Overall Study|Study completion|1|||
131677777|NCT02499770|474105824|FG001|Overall Study|Study completion|10|||
131677778|NCT02499770|474105823|FG000|Overall Study|Withdrawal by Subject|0|||
131677779|NCT02499770|474105824|FG001|Overall Study|Withdrawal by Subject|7|||
131677780|NCT02499770|474105823|FG000|Overall Study|Lost to Follow-up|0|||
131677781|NCT02499770|474105824|FG001|Overall Study|Lost to Follow-up|2|||
131677782|NCT02499770|474105823|FG000|Overall Study|Subject declined further treatment|1|||
131677783|NCT02499770|474105824|FG001|Overall Study|Subject declined further treatment|0|||
131677784|NCT02499770|474105823|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
131677785|NCT02499770|474105824|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
131677786|NCT02499770|474105823|FG000|Overall Study|Randomized but not enrolled|0|||
131677787|NCT02499770|474105824|FG001|Overall Study|Randomized but not enrolled|1|||
131677788|NCT04600336|474105827|FG000|Initial Treatment|Withdrawal by Subject|1|||
131677789|NCT04600336|474105828|FG001|Initial Treatment|Withdrawal by Subject|2|||
131677790|NCT04600336|474105829|FG002|Initial Treatment|Withdrawal by Subject|0|||
131677791|NCT04600336|474105830|FG003|Initial Treatment|Withdrawal by Subject|0|||
131677792|NCT04600336|474105827|FG000|Initial Treatment|Adverse Event|0|||
131677793|NCT04600336|474105828|FG001|Initial Treatment|Adverse Event|2|||
131677794|NCT04600336|474105829|FG002|Initial Treatment|Adverse Event|0|||
131677795|NCT04600336|474105830|FG003|Initial Treatment|Adverse Event|0|||
131677796|NCT04600336|474105827|FG000|Initial Treatment|Other complicating disease|0|||
131677797|NCT04600336|474105828|FG001|Initial Treatment|Other complicating disease|0|||
131677798|NCT04600336|474105829|FG002|Initial Treatment|Other complicating disease|1|||
131677799|NCT04600336|474105830|FG003|Initial Treatment|Other complicating disease|0|||
131677800|NCT04600336|474105827|FG000|Crossover Treatment|Withdrawal by Subject|0|||
131677801|NCT04600336|474105828|FG001|Crossover Treatment|Withdrawal by Subject|0|||
131677802|NCT04600336|474105829|FG002|Crossover Treatment|Withdrawal by Subject|2|||
131677803|NCT04600336|474105830|FG003|Crossover Treatment|Withdrawal by Subject|1|||
131677804|NCT04600336|474105827|FG000|Crossover Treatment|Adverse Event|0|||
131677805|NCT04600336|474105828|FG001|Crossover Treatment|Adverse Event|0|||
131677806|NCT04600336|474105829|FG002|Crossover Treatment|Adverse Event|1|||
131677807|NCT04600336|474105830|FG003|Crossover Treatment|Adverse Event|1|||
131677808|NCT01521897|474107737|FG000|Overall Study|Protocol Violation|18|||
131677809|NCT01521897|474107737|FG000|Overall Study|Lost to Follow-up|5|||
131677810|NCT02194062|474107744|FG000|Overall Study|Lost to Follow-up|2|||
131677811|NCT02194062|474107745|FG001|Overall Study|Lost to Follow-up|2|||
131677812|NCT02194062|474107746|FG002|Overall Study|Lost to Follow-up|5|||
131677813|NCT00537485|474107747|FG000|Overall Study|Adverse Event|10|||
131677814|NCT00537485|474107748|FG001|Overall Study|Adverse Event|5|||
131677815|NCT00537485|474107747|FG000|Overall Study|Withdrawal by Subject|3|||
131677816|NCT00537485|474107748|FG001|Overall Study|Withdrawal by Subject|2|||
131677817|NCT00537485|474107747|FG000|Overall Study|Withdrawal by Subject|1|||
131677818|NCT00537485|474107748|FG001|Overall Study|Withdrawal by Subject|3|||
131677819|NCT00537485|474107747|FG000|Overall Study|Physician Decision|1|||
131677820|NCT00537485|474107748|FG001|Overall Study|Physician Decision|0|||
131677821|NCT00634010|474107754|FG000|Overall Study|Adverse Event|2|||
131677822|NCT00634010|474107755|FG001|Overall Study|Adverse Event|5|||
131677823|NCT00634010|474107754|FG000|Overall Study|Withdrawal by Subject|5|||
131677824|NCT00634010|474107755|FG001|Overall Study|Withdrawal by Subject|6|||
131677825|NCT00634010|474107754|FG000|Overall Study|Physician Decision|1|||
131677826|NCT00634010|474107755|FG001|Overall Study|Physician Decision|1|||
131677827|NCT00634010|474107754|FG000|Overall Study|Disease Progression|1|||
131677828|NCT00634010|474107755|FG001|Overall Study|Disease Progression|1|||
131677829|NCT00634010|474107754|FG000|Overall Study|Non-Compliant|1|||
131677830|NCT00634010|474107755|FG001|Overall Study|Non-Compliant|1|||
131677831|NCT01641809|474107757|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
131677832|NCT01641809|474107758|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
131677833|NCT01641809|474107759|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
131677834|NCT01641809|474107760|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
131677835|NCT01641809|474107757|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
131677836|NCT01641809|474107758|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
131677837|NCT01641809|474107759|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
131677838|NCT01641809|474107760|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
131677839|NCT01641809|474107757|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
131677840|NCT01641809|474107758|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
131677841|NCT01641809|474107759|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
131677842|NCT01641809|474107760|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
131677843|NCT01641809|474107757|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
131677844|NCT01641809|474107758|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
131677845|NCT01641809|474107759|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
131677846|NCT01641809|474107760|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
131677847|NCT01641809|474107757|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
131677848|NCT01641809|474107758|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
131677849|NCT01641809|474107759|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
131677850|NCT01641809|474107760|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
131677851|NCT01641809|474107757|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
131677852|NCT01641809|474107758|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
131677853|NCT01641809|474107759|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
131677854|NCT01641809|474107760|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
131677855|NCT01641809|474107757|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
131677856|NCT01641809|474107758|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
131677857|NCT01641809|474107759|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
131677858|NCT01641809|474107760|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
131677859|NCT01641809|474107757|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
131677860|NCT01641809|474107758|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
131677861|NCT01641809|474107759|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
131677862|NCT01641809|474107760|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
131677863|NCT01641809|474107757|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
131677864|NCT01641809|474107758|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
131677865|NCT01641809|474107759|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
131677866|NCT01641809|474107760|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
131677867|NCT01641809|474107757|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
131677868|NCT01641809|474107758|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
131677869|NCT01641809|474107759|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
131677870|NCT01641809|474107760|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
131677871|NCT01641809|474107757|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
131677872|NCT01641809|474107758|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
131677873|NCT01641809|474107759|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
131677874|NCT01641809|474107760|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
131677875|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
131677876|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
131677877|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
131677878|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
131677879|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
131677880|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
131677881|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
131677882|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
131677883|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
131677884|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
131677885|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
131677886|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
131677887|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
131677888|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
131677889|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
131677890|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
131677891|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
131677892|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
131677893|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
131677894|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
131677895|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
131677896|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
131677897|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
131677898|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
131677899|NCT01641809|474107757|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
131677900|NCT01641809|474107758|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
131677901|NCT01641809|474107759|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
131677902|NCT01641809|474107760|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
131677903|NCT03690141|474107763|FG000|Overall Study|Adverse Event|5|||
131677904|NCT03690141|474107763|FG000|Overall Study|Withdrawal by Subject|3|||
131677905|NCT03690141|474107763|FG000|Overall Study|Physician Decision|4|||
131677906|NCT03690141|474107763|FG000|Overall Study|Disease progression|4|||
131677907|NCT02066051|474107767|FG000|Overall Study|Subject developed active GVHD|1|||
131677908|NCT03027557|474107771|FG000|Overall Study|Adverse Event|1|||
131677909|NCT03027557|474107772|FG001|Overall Study|Adverse Event|0|||
131677910|NCT03027557|474107773|FG002|Overall Study|Adverse Event|0|||
131677911|NCT01610687|474107778|FG000|Overall Study|Lack of Efficacy|26|||
131677912|NCT01610687|474107778|FG000|Overall Study|Adverse Event|18|||
131677913|NCT01610687|474107778|FG000|Overall Study|Moved out of area|6|||
131677914|NCT01610687|474107778|FG000|Overall Study|Withdrawal by Subject|7|||
131677915|NCT01610687|474107778|FG000|Overall Study|Lost to Follow-up|4|||
131677916|NCT01610687|474107778|FG000|Overall Study|Symptom control without study medication|2|||
131677917|NCT01610687|474107778|FG000|Overall Study|Unable to make journey|1|||
131677918|NCT01610687|474107778|FG000|Overall Study|Death|1|||
131677919|NCT01610687|474107778|FG000|Overall Study|Cannabis affecting job|1|||
131677920|NCT01610687|474107778|FG000|Overall Study|Felt more alter without study medication|1|||
131677921|NCT03836807|474107779|FG000|Overall Study|Physician Decision|1|||
131677922|NCT03836807|474107780|FG001|Overall Study|Physician Decision|0|||
131677923|NCT02430051|474107781|FG000|Overall Study|Withdrawal by Subject|6|||
131677924|NCT02430051|474107782|FG001|Overall Study|Withdrawal by Subject|3|||
131677925|NCT02430051|474107781|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
131677926|NCT02430051|474107782|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
131677927|NCT02430051|474107781|FG000|Overall Study|Protocol Violation|1|||
131677928|NCT02430051|474107782|FG001|Overall Study|Protocol Violation|0|||
131677929|NCT01272947|474107783|FG000|Overall Study|Abnormal Laboratory Value|2|||
131677930|NCT01272947|474107784|FG001|Overall Study|Abnormal Laboratory Value|2|||
131677931|NCT02019420|474107788|FG000|Overall Study|Did not receive study drug|2|||
131677932|NCT02019420|474107789|FG001|Overall Study|Did not receive study drug|2|||
131677933|NCT02019420|474107788|FG000|Overall Study|Withdrawal by Subject|1|||
131677934|NCT02019420|474107789|FG001|Overall Study|Withdrawal by Subject|3|||
131677935|NCT02019420|474107788|FG000|Overall Study|At request of sponsor or investigator|0|||
131677936|NCT02019420|474107789|FG001|Overall Study|At request of sponsor or investigator|1|||
131677937|NCT02019420|474107788|FG000|Overall Study|Death|104|||
131677938|NCT02019420|474107789|FG001|Overall Study|Death|99|||
131677939|NCT02019420|474107788|FG000|Overall Study|Transferred to other care facility|1|||
131677940|NCT02019420|474107789|FG001|Overall Study|Transferred to other care facility|1|||
131677941|NCT02510560|474107790|FG000|Overall Study|Discontinued from Treatment|27|||
131677942|NCT02510560|474107791|FG001|Overall Study|Discontinued from Treatment|18|||
131677943|NCT02510560|474107792|FG002|Overall Study|Discontinued from Treatment|19|||
131677944|NCT02510560|474107790|FG000|Overall Study|Other|4|||
131677945|NCT02510560|474107791|FG001|Overall Study|Other|4|||
131677946|NCT02510560|474107792|FG002|Overall Study|Other|3|||
131677947|NCT00132496|474107793|FG000|Overall Study|Withdrawal by Subject|1|||
131677948|NCT00132496|474107794|FG001|Overall Study|Withdrawal by Subject|2|||
131677949|NCT00132496|474107793|FG000|Overall Study|Physician Decision|1|||
131677950|NCT00132496|474107794|FG001|Overall Study|Physician Decision|0|||
131677951|NCT01093625|474107799|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
131677952|NCT01093625|474107800|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
131677953|NCT01093625|474107799|FG000|2-Week Visit|Withdrawal by Subject|1|||
131677954|NCT01093625|474107800|FG001|2-Week Visit|Withdrawal by Subject|0|||
131677955|NCT01093625|474107799|FG000|1-Month Visit|Lost to Follow-up|2|||
131677956|NCT01093625|474107800|FG001|1-Month Visit|Lost to Follow-up|0|||
131677957|NCT01093625|474107799|FG000|3-Month Visit|Lost to Follow-up|2|||
131677958|NCT01093625|474107800|FG001|3-Month Visit|Lost to Follow-up|0|||
131677959|NCT01093625|474107799|FG000|6-Month Visit|Withdrawal by Subject|6|||
131677960|NCT01093625|474107800|FG001|6-Month Visit|Withdrawal by Subject|7|||
131677961|NCT01093625|474107799|FG000|6-Month Visit|Lost to Follow-up|2|||
131677962|NCT01093625|474107800|FG001|6-Month Visit|Lost to Follow-up|2|||
131677963|NCT01093625|474107799|FG000|1-Year Visit|Lost to Follow-up|5|||
131677964|NCT01093625|474107800|FG001|1-Year Visit|Lost to Follow-up|3|||
131677965|NCT02014740|474107803|FG000|Overall Study|Lost to Follow-up|4|||
131677966|NCT02014740|474107804|FG001|Overall Study|Lost to Follow-up|4|||
131677967|NCT02014740|474107803|FG000|Overall Study|Withdrawal by Subject|2|||
131677968|NCT02014740|474107804|FG001|Overall Study|Withdrawal by Subject|1|||
131677969|NCT01431534|474107805|FG000|Treatment Phase|Adverse Event|0|||
131677970|NCT01431534|474107806|FG001|Treatment Phase|Adverse Event|0|||
131677971|NCT01431534|474107807|FG002|Treatment Phase|Adverse Event|1|||
131677972|NCT01431534|474107805|FG000|Treatment Phase|Progressive Disease|4|||
131677973|NCT01431534|474107806|FG001|Treatment Phase|Progressive Disease|3|||
131677974|NCT01431534|474107807|FG002|Treatment Phase|Progressive Disease|10|||
131677975|NCT01009554|474107810|FG000|Overall Study|Adverse Event|1|||
131677976|NCT01009554|474107811|FG001|Overall Study|Adverse Event|1|||
131677977|NCT01009554|474107810|FG000|Overall Study|Withdrawal by Subject|1|||
131677978|NCT01009554|474107811|FG001|Overall Study|Withdrawal by Subject|3|||
131677979|NCT01009554|474107810|FG000|Overall Study|Noncompliant with Study Product|0|||
131677980|NCT01009554|474107811|FG001|Overall Study|Noncompliant with Study Product|3|||
131677981|NCT01605253|474107812|FG000|Overall Study|Physician Decision|3|||
131677982|NCT01605253|474107813|FG001|Overall Study|Physician Decision|2|||
131677983|NCT01605253|474107812|FG000|Overall Study|Lost to Follow-up|3|||
131677984|NCT01605253|474107813|FG001|Overall Study|Lost to Follow-up|1|||
131677985|NCT02554903|474107816|FG000|Overall Study|Death|1|||
131677986|NCT02554903|474107817|FG001|Overall Study|Death|1|||
131677987|NCT02554903|474107816|FG000|Overall Study|Physician Decision|2|||
131677988|NCT02554903|474107817|FG001|Overall Study|Physician Decision|2|||
131677989|NCT02554903|474107816|FG000|Overall Study|Heart Transplant|1|||
131677990|NCT02554903|474107817|FG001|Overall Study|Heart Transplant|2|||
131677991|NCT02742766|474107818|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677992|NCT02742766|474107819|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677993|NCT02742766|474107820|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677994|NCT02742766|474107821|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677995|NCT02742766|474107822|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677996|NCT02742766|474107823|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677997|NCT02742766|474107824|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677998|NCT02742766|474107825|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131677999|NCT02742766|474107826|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678000|NCT02742766|474107827|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131898410|NCT04668209|474914061|FG001|Overall Study|Adverse Event|1|||
131898411|NCT00613366|474914065|FG000|Overall Study|Withdrawal by Subject|3|||
131898412|NCT00613366|474914066|FG001|Overall Study|Withdrawal by Subject|2|||
131898413|NCT01135524|474914069|FG000|Overall Study|Withdrawal by Subject|14|||
131898414|NCT01135524|474914069|FG000|Overall Study|Adverse Event|20|||
131898415|NCT01135524|474914069|FG000|Overall Study|Lost to Follow-up|3|||
131898416|NCT01135524|474914069|FG000|Overall Study|Administrative|151|||
131898417|NCT01135524|474914069|FG000|Overall Study|Lack of Efficacy|8|||
131898418|NCT01266824|474914070|FG000|Overall Study|Study terminated prior to completion|2|||
131898419|NCT01266824|474914071|FG001|Overall Study|Study terminated prior to completion|3|||
131898420|NCT02254772|474914072|FG000|Overall Study|Ineligible|1|||
131898421|NCT02254772|474914072|FG000|Overall Study|Withdrawal by Subject|1|||
131898422|NCT05225558|474914073|FG000|Overall Study|Withdrawal by Subject|4|||
131898423|NCT05225558|474914074|FG001|Overall Study|Withdrawal by Subject|3|||
131898424|NCT05225558|474914073|FG000|Overall Study|Adverse Event|1|||
131898425|NCT05225558|474914074|FG001|Overall Study|Adverse Event|0|||
131898426|NCT05225558|474914073|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
131898427|NCT05225558|474914074|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
131898428|NCT05225558|474914073|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
131898429|NCT05225558|474914074|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
131898430|NCT02028507|474914075|FG000|Overall Study|Progressive Disease|122|||
131898431|NCT02028507|474914076|FG001|Overall Study|Progressive Disease|90|||
131898432|NCT02028507|474914077|FG002|Overall Study|Progressive Disease|102|||
131898433|NCT02028507|474914078|FG003|Overall Study|Progressive Disease|89|||
131898434|NCT02028507|474914075|FG000|Overall Study|Adverse Event|8|||
131898435|NCT02028507|474914076|FG001|Overall Study|Adverse Event|25|||
131898436|NCT02028507|474914077|FG002|Overall Study|Adverse Event|3|||
131898437|NCT02028507|474914078|FG003|Overall Study|Adverse Event|16|||
131898438|NCT02028507|474914075|FG000|Overall Study|Withdrawal by Subject|6|||
131898439|NCT02028507|474914076|FG001|Overall Study|Withdrawal by Subject|8|||
131898440|NCT02028507|474914077|FG002|Overall Study|Withdrawal by Subject|5|||
131898441|NCT02028507|474914078|FG003|Overall Study|Withdrawal by Subject|9|||
131898442|NCT02028507|474914075|FG000|Overall Study|Protocol Violation|2|||
131898443|NCT02028507|474914076|FG001|Overall Study|Protocol Violation|4|||
131898444|NCT02028507|474914077|FG002|Overall Study|Protocol Violation|1|||
131898445|NCT02028507|474914078|FG003|Overall Study|Protocol Violation|3|||
131898446|NCT02028507|474914075|FG000|Overall Study|Physician Decision|0|||
131898447|NCT02028507|474914076|FG001|Overall Study|Physician Decision|4|||
131898448|NCT02028507|474914077|FG002|Overall Study|Physician Decision|0|||
131898449|NCT02028507|474914078|FG003|Overall Study|Physician Decision|0|||
131898450|NCT02028507|474914075|FG000|Overall Study|Death|1|||
131898451|NCT02028507|474914076|FG001|Overall Study|Death|0|||
131898452|NCT02028507|474914077|FG002|Overall Study|Death|1|||
131898453|NCT02028507|474914078|FG003|Overall Study|Death|3|||
131898454|NCT02028507|474914075|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
131898455|NCT02028507|474914076|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
131898456|NCT02028507|474914077|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
131898457|NCT02028507|474914078|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
131898458|NCT02028507|474914075|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
131898459|NCT02028507|474914076|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
131898460|NCT02028507|474914077|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
131898461|NCT02028507|474914078|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
131898462|NCT02028507|474914075|FG000|Overall Study|Randomized But Not Treated|3|||
131898463|NCT02028507|474914076|FG001|Overall Study|Randomized But Not Treated|6|||
131898464|NCT02028507|474914077|FG002|Overall Study|Randomized But Not Treated|0|||
131898465|NCT02028507|474914078|FG003|Overall Study|Randomized But Not Treated|4|||
131898466|NCT02028507|474914075|FG000|Overall Study|Enzyme defect|0|||
131898467|NCT02028507|474914076|FG001|Overall Study|Enzyme defect|0|||
131898468|NCT02028507|474914077|FG002|Overall Study|Enzyme defect|0|||
131898469|NCT02028507|474914078|FG003|Overall Study|Enzyme defect|1|||
131898470|NCT02028507|474914075|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
131898471|NCT02028507|474914076|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
131898472|NCT02028507|474914077|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
131898473|NCT02028507|474914078|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
131898474|NCT02028507|474914075|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
131898475|NCT02028507|474914076|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
131898476|NCT02028507|474914077|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
131898477|NCT02028507|474914078|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
131898478|NCT00705341|474914079|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
131898479|NCT00705341|474914080|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
131678001|NCT02742766|474107828|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678002|NCT02742766|474107829|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678003|NCT02742766|474107830|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678004|NCT02742766|474107831|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
131678005|NCT02742766|474107832|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678006|NCT02742766|474107833|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678007|NCT02742766|474107834|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678008|NCT02742766|474107835|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678009|NCT02742766|474107836|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131678010|NCT02742766|474107818|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678011|NCT02742766|474107819|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678012|NCT02742766|474107820|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678013|NCT02742766|474107821|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678014|NCT02742766|474107822|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678015|NCT02742766|474107823|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678016|NCT02742766|474107824|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678017|NCT02742766|474107825|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678018|NCT02742766|474107826|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678019|NCT02742766|474107827|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678020|NCT02742766|474107828|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678021|NCT02742766|474107829|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678022|NCT02742766|474107830|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
131678023|NCT02742766|474107831|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
131678024|NCT02742766|474107832|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678025|NCT02742766|474107833|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
131678026|NCT02742766|474107834|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678027|NCT02742766|474107835|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678028|NCT02742766|474107836|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
131678029|NCT03951220|474107842|FG000|Overall Study|Withdrawal by Subject|9|||
131678030|NCT03951220|474107843|FG001|Overall Study|Withdrawal by Subject|2|||
131678031|NCT03951220|474107844|FG002|Overall Study|Withdrawal by Subject|0|||
131678032|NCT04598477|474107846|FG000|Overall Study|Adverse Event|2|||
131678033|NCT04598477|474107847|FG001|Overall Study|Adverse Event|0|||
131678034|NCT04598477|474107846|FG000|Overall Study|Death|0|||
131678035|NCT04598477|474107847|FG001|Overall Study|Death|1|||
131678036|NCT04598477|474107846|FG000|Overall Study|Lost to Follow-up|1|||
131678037|NCT04598477|474107847|FG001|Overall Study|Lost to Follow-up|0|||
131678038|NCT04598477|474107846|FG000|Overall Study|Physician Decision|7|||
131678039|NCT04598477|474107847|FG001|Overall Study|Physician Decision|2|||
131678040|NCT04598477|474107846|FG000|Overall Study|Pregnancy|0|||
131678041|NCT04598477|474107847|FG001|Overall Study|Pregnancy|1|||
131678042|NCT04598477|474107846|FG000|Overall Study|Requires Prohibited Medication|0|||
131678043|NCT04598477|474107847|FG001|Overall Study|Requires Prohibited Medication|1|||
131678044|NCT04598477|474107846|FG000|Overall Study|Study Terminated by Sponsor|18|||
131678045|NCT04598477|474107847|FG001|Overall Study|Study Terminated by Sponsor|12|||
131678046|NCT04598477|474107846|FG000|Overall Study|Withdrawal by Subject|16|||
131678047|NCT04598477|474107847|FG001|Overall Study|Withdrawal by Subject|12|||
131678048|NCT04598477|474107846|FG000|Overall Study|Other|15|||
131678049|NCT04598477|474107847|FG001|Overall Study|Other|8|||
131678050|NCT05579990|474107850|FG000|Overall Study|Lost to Follow-up|3|||
131678051|NCT02038920|474107861|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
131678052|NCT02038920|474107862|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
131678053|NCT02038920|474107863|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131678054|NCT02038920|474107864|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131678055|NCT02038920|474107865|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131678056|NCT02038920|474107866|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131678057|NCT02038920|474107861|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
131678058|NCT02038920|474107862|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131678059|NCT02038920|474107863|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131678060|NCT02038920|474107864|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131678061|NCT02038920|474107865|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131678062|NCT02038920|474107866|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131678063|NCT02038920|474107861|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
131678064|NCT02038920|474107862|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
131678065|NCT02038920|474107863|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131678066|NCT02038920|474107864|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131678067|NCT02038920|474107865|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131678068|NCT02038920|474107866|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131678069|NCT02038920|474107861|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
131678070|NCT02038920|474107862|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
131678071|NCT02038920|474107863|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
131678072|NCT02038920|474107864|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
131678073|NCT02038920|474107865|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
131678074|NCT02038920|474107866|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
131678075|NCT02038920|474107861|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131678076|NCT02038920|474107862|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131678077|NCT02038920|474107863|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
131678078|NCT02038920|474107864|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131678079|NCT02038920|474107865|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131678080|NCT02038920|474107866|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131678081|NCT02038920|474107861|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
131678082|NCT02038920|474107862|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
131678083|NCT02038920|474107863|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
131678084|NCT02038920|474107864|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
131678085|NCT02038920|474107865|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
131678086|NCT02038920|474107866|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
131678087|NCT02038920|474107861|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131678088|NCT02038920|474107862|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131678089|NCT02038920|474107863|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131678090|NCT02038920|474107864|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131678091|NCT02038920|474107865|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131678092|NCT02038920|474107866|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
131678093|NCT02038920|474107861|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131678094|NCT02038920|474107862|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131678095|NCT02038920|474107863|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131678096|NCT02038920|474107864|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131678097|NCT02038920|474107865|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131678098|NCT02038920|474107866|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
131678099|NCT02038920|474107861|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131678100|NCT02038920|474107862|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131678101|NCT02038920|474107863|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131678102|NCT02038920|474107864|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131678103|NCT02038920|474107865|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131678104|NCT02038920|474107866|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
131678105|NCT02038920|474107861|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131678106|NCT02038920|474107862|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131678107|NCT02038920|474107863|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131678108|NCT02038920|474107864|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131678109|NCT02038920|474107865|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131678110|NCT02038920|474107866|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
131678111|NCT02038920|474107861|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131678112|NCT02038920|474107862|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131678113|NCT02038920|474107863|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131678114|NCT02038920|474107864|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131678115|NCT02038920|474107865|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131678116|NCT02038920|474107866|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
131678117|NCT02038920|474107861|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131678118|NCT02038920|474107862|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131678119|NCT02038920|474107863|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131678120|NCT02038920|474107864|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131678121|NCT02038920|474107865|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131678122|NCT02038920|474107866|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
131678123|NCT00866697|474107867|FG000|Overall Study|Study closed/terminated|156|||
131678124|NCT00866697|474107868|FG001|Overall Study|Study closed/terminated|138|||
131678125|NCT00866697|474107867|FG000|Overall Study|Lost to Follow-up|22|||
131678126|NCT00866697|474107868|FG001|Overall Study|Lost to Follow-up|28|||
131678127|NCT00866697|474107867|FG000|Overall Study|Physician Decision|3|||
131678128|NCT00866697|474107868|FG001|Overall Study|Physician Decision|5|||
131678129|NCT00866697|474107867|FG000|Overall Study|Withdrawal by Subject|33|||
131678130|NCT00866697|474107868|FG001|Overall Study|Withdrawal by Subject|57|||
131678131|NCT04376060|474107869|FG000|Overall Study|Physician Decision|1|||
131678132|NCT04124614|474107870|FG000|Placebo Run-in Period|Not Randomized|34|||
131678133|NCT04124614|474107871|FG001|Placebo Run-in Period|Not Randomized|0|||
131678134|NCT04124614|474107872|FG002|Placebo Run-in Period|Not Randomized|0|||
131678135|NCT04124614|474107870|FG000|Double Blind Treatment Period|Adverse Event|0|||
131678136|NCT04124614|474107871|FG001|Double Blind Treatment Period|Adverse Event|7|||
131678137|NCT04124614|474107872|FG002|Double Blind Treatment Period|Adverse Event|22|||
131678138|NCT04124614|474107870|FG000|Double Blind Treatment Period|Death|0|||
131678139|NCT04124614|474107871|FG001|Double Blind Treatment Period|Death|0|||
131678140|NCT04124614|474107872|FG002|Double Blind Treatment Period|Death|1|||
131678141|NCT04124614|474107870|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
131678142|NCT04124614|474107871|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
131678143|NCT04124614|474107872|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
131678144|NCT04124614|474107870|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
131678145|NCT04124614|474107871|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
131678146|NCT04124614|474107872|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
131678147|NCT04124614|474107870|FG000|Double Blind Treatment Period|Physician Decision|0|||
131678148|NCT04124614|474107871|FG001|Double Blind Treatment Period|Physician Decision|0|||
131678149|NCT04124614|474107872|FG002|Double Blind Treatment Period|Physician Decision|3|||
131678150|NCT04124614|474107870|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
131678151|NCT04124614|474107871|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
131678152|NCT04124614|474107872|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
131678153|NCT04124614|474107870|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131678154|NCT04124614|474107871|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
131678155|NCT04124614|474107872|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
131678156|NCT04124614|474107870|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
131678157|NCT04124614|474107871|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
131678158|NCT04124614|474107872|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
131678159|NCT01306890|474108975|FG000|Overall Study|Adverse Event|2|||
131678160|NCT01306890|474108975|FG000|Overall Study|Death|1223|||
131678161|NCT01306890|474108975|FG000|Overall Study|Lost to Follow-up|58|||
131678162|NCT01306890|474108975|FG000|Overall Study|Withdrawal by Subject|88|||
131678163|NCT01306890|474108975|FG000|Overall Study|Unspecified reasons|104|||
131678164|NCT01306890|474108975|FG000|Overall Study|Study Termination|3|||
131678165|NCT01306890|474108975|FG000|Overall Study|No discontinuation documentation|41|||
131678166|NCT01096342|474108980|FG000|Overall Study|Protocol Violation|1|||
131678167|NCT04906616|474108981|FG000|Overall Study|Divorce|3|||
131678168|NCT04906616|474108982|FG001|Overall Study|Divorce|2|||
131678169|NCT03739762|474108983|FG000|Overall Study|Lost to Follow-up|1|||
131678170|NCT03739762|474108984|FG001|Overall Study|Lost to Follow-up|1|||
131678171|NCT03739762|474108983|FG000|Overall Study|Withdrawal by Subject|2|||
131678172|NCT03739762|474108984|FG001|Overall Study|Withdrawal by Subject|6|||
131678173|NCT02464228|474108985|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
131678174|NCT02464228|474108986|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
131678175|NCT02464228|474108987|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
131678176|NCT02464228|474108988|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
131678177|NCT02464228|474108985|FG000|Overall Study|Physician Decision|2|||
131678178|NCT02464228|474108986|FG001|Overall Study|Physician Decision|0|||
131678179|NCT02464228|474108987|FG002|Overall Study|Physician Decision|1|||
131678180|NCT02464228|474108988|FG003|Overall Study|Physician Decision|0|||
131678181|NCT02464228|474108985|FG000|Overall Study|Miscellaneous|1|||
131678182|NCT02464228|474108986|FG001|Overall Study|Miscellaneous|0|||
131678183|NCT02464228|474108987|FG002|Overall Study|Miscellaneous|1|||
131678184|NCT02464228|474108988|FG003|Overall Study|Miscellaneous|0|||
131678185|NCT02464228|474108985|FG000|Overall Study|Adverse Event|9|||
131678186|NCT02464228|474108986|FG001|Overall Study|Adverse Event|0|||
131678187|NCT02464228|474108987|FG002|Overall Study|Adverse Event|3|||
131678188|NCT02464228|474108988|FG003|Overall Study|Adverse Event|0|||
131678189|NCT02464228|474108985|FG000|Overall Study|Withdrawal by Subject|1|||
131678190|NCT02464228|474108986|FG001|Overall Study|Withdrawal by Subject|1|||
131678191|NCT02464228|474108987|FG002|Overall Study|Withdrawal by Subject|1|||
131678192|NCT02464228|474108988|FG003|Overall Study|Withdrawal by Subject|0|||
131678193|NCT02464228|474108985|FG000|Overall Study|Disease Progression|22|||
131678194|NCT02464228|474108986|FG001|Overall Study|Disease Progression|12|||
131678195|NCT02464228|474108987|FG002|Overall Study|Disease Progression|5|||
131678196|NCT02464228|474108988|FG003|Overall Study|Disease Progression|2|||
131678197|NCT00385203|474108991|FG000|Overall Study|Adverse Event|5|||
131678198|NCT00385203|474108992|FG001|Overall Study|Adverse Event|4|||
131678199|NCT00385203|474108991|FG000|Overall Study|Death|1|||
131678200|NCT00385203|474108992|FG001|Overall Study|Death|0|||
131678201|NCT00385203|474108991|FG000|Overall Study|Condition under investigation worsened|18|||
131678202|NCT00385203|474108992|FG001|Overall Study|Condition under investigation worsened|3|||
131678203|NCT00385203|474108991|FG000|Overall Study|Incorrect enrollment|2|||
131678204|NCT00385203|474108992|FG001|Overall Study|Incorrect enrollment|0|||
131678205|NCT03308942|474108993|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
131678206|NCT03308942|474108994|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
131678207|NCT03308942|474108995|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
131678208|NCT03308942|474108996|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
131678209|NCT03308942|474108997|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
131678210|NCT03308942|474108993|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
131678211|NCT03308942|474108994|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
131678212|NCT03308942|474108995|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
131678213|NCT03308942|474108996|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
131678214|NCT03308942|474108997|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
131678215|NCT03308942|474108993|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131678216|NCT03308942|474108994|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
131678217|NCT03308942|474108995|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131678218|NCT03308942|474108996|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131678219|NCT03308942|474108997|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131678220|NCT03308942|474108993|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
131678221|NCT03308942|474108994|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
131678222|NCT03308942|474108995|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
131678223|NCT03308942|474108996|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
131678224|NCT03308942|474108997|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
131678225|NCT03308942|474108993|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131678226|NCT03308942|474108994|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131678227|NCT03308942|474108995|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131678228|NCT03308942|474108996|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
131678229|NCT03308942|474108997|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131678230|NCT03308942|474108993|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131678231|NCT03308942|474108994|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131678232|NCT03308942|474108995|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131678233|NCT03308942|474108996|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
131678234|NCT03308942|474108997|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131678235|NCT03308942|474108993|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131678236|NCT03308942|474108994|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131678237|NCT03308942|474108995|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131678238|NCT03308942|474108996|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
131678239|NCT03308942|474108997|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131678240|NCT03422172|474108998|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
131678241|NCT03422172|474108998|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
131678242|NCT03422172|474108998|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
131678243|NCT01423812|474108999|FG000|Overall Study|Lost to Follow-up|2|||
131678244|NCT01423812|474109000|FG001|Overall Study|Lost to Follow-up|2|||
131678245|NCT01423812|474108999|FG000|Overall Study|Withdrawal by Subject|1|||
131678246|NCT01423812|474109000|FG001|Overall Study|Withdrawal by Subject|2|||
131678247|NCT02748018|474109001|FG000|Study Period|Adverse Event|1|||
131678248|NCT02748018|474109002|FG001|Study Period|Adverse Event|3|||
131678249|NCT02748018|474109003|FG002|Study Period|Adverse Event|4|||
131678250|NCT02748018|474109004|FG003|Study Period|Adverse Event|0|||
131678251|NCT02748018|474109005|FG004|Study Period|Adverse Event|3|||
131678252|NCT02748018|474109006|FG005|Study Period|Adverse Event|3|||
131678253|NCT02748018|474109001|FG000|Study Period|Withdrawal by Subject|7|||
131678254|NCT02748018|474109002|FG001|Study Period|Withdrawal by Subject|4|||
131678255|NCT02748018|474109003|FG002|Study Period|Withdrawal by Subject|4|||
131678256|NCT02748018|474109004|FG003|Study Period|Withdrawal by Subject|11|||
131678257|NCT02748018|474109005|FG004|Study Period|Withdrawal by Subject|12|||
131678258|NCT02748018|474109006|FG005|Study Period|Withdrawal by Subject|10|||
131678259|NCT02748018|474109001|FG000|Study Period|Pregnancy|0|||
131678260|NCT02748018|474109002|FG001|Study Period|Pregnancy|1|||
131678261|NCT02748018|474109003|FG002|Study Period|Pregnancy|0|||
131678262|NCT02748018|474109004|FG003|Study Period|Pregnancy|0|||
131678263|NCT02748018|474109005|FG004|Study Period|Pregnancy|1|||
131678264|NCT02748018|474109006|FG005|Study Period|Pregnancy|0|||
131678265|NCT02748018|474109001|FG000|Study Period|Physician Decision|2|||
131678266|NCT02748018|474109002|FG001|Study Period|Physician Decision|2|||
131678267|NCT02748018|474109003|FG002|Study Period|Physician Decision|1|||
131678268|NCT02748018|474109004|FG003|Study Period|Physician Decision|0|||
131678269|NCT02748018|474109005|FG004|Study Period|Physician Decision|2|||
131678270|NCT02748018|474109006|FG005|Study Period|Physician Decision|0|||
131678271|NCT02748018|474109001|FG000|Study Period|Lost to Follow-up|0|||
131678272|NCT02748018|474109002|FG001|Study Period|Lost to Follow-up|0|||
131678273|NCT02748018|474109003|FG002|Study Period|Lost to Follow-up|0|||
131678274|NCT02748018|474109004|FG003|Study Period|Lost to Follow-up|2|||
131678275|NCT02748018|474109005|FG004|Study Period|Lost to Follow-up|0|||
131678276|NCT02748018|474109006|FG005|Study Period|Lost to Follow-up|1|||
131678277|NCT02748018|474109001|FG000|Continuation Period|Adverse Event|2|||
131678278|NCT02748018|474109002|FG001|Continuation Period|Adverse Event|0|||
131678279|NCT02748018|474109003|FG002|Continuation Period|Adverse Event|1|||
131678280|NCT02748018|474109004|FG003|Continuation Period|Adverse Event|1|||
131678281|NCT02748018|474109005|FG004|Continuation Period|Adverse Event|1|||
131678282|NCT02748018|474109006|FG005|Continuation Period|Adverse Event|4|||
131678283|NCT02748018|474109001|FG000|Continuation Period|Withdrawal by Subject|3|||
131678284|NCT02748018|474109002|FG001|Continuation Period|Withdrawal by Subject|5|||
131678285|NCT02748018|474109003|FG002|Continuation Period|Withdrawal by Subject|3|||
131678286|NCT02748018|474109004|FG003|Continuation Period|Withdrawal by Subject|9|||
131678287|NCT02748018|474109005|FG004|Continuation Period|Withdrawal by Subject|11|||
131678288|NCT02748018|474109006|FG005|Continuation Period|Withdrawal by Subject|1|||
131678289|NCT02748018|474109001|FG000|Continuation Period|Lost to Follow-up|0|||
131678290|NCT02748018|474109002|FG001|Continuation Period|Lost to Follow-up|2|||
131678291|NCT02748018|474109003|FG002|Continuation Period|Lost to Follow-up|1|||
131678292|NCT02748018|474109004|FG003|Continuation Period|Lost to Follow-up|0|||
131678293|NCT02748018|474109005|FG004|Continuation Period|Lost to Follow-up|1|||
131678294|NCT02748018|474109006|FG005|Continuation Period|Lost to Follow-up|0|||
131678295|NCT02748018|474109001|FG000|Continuation Period|Pregnancy|1|||
131678296|NCT02748018|474109002|FG001|Continuation Period|Pregnancy|2|||
131678297|NCT02748018|474109003|FG002|Continuation Period|Pregnancy|0|||
131678298|NCT02748018|474109004|FG003|Continuation Period|Pregnancy|0|||
131678299|NCT02748018|474109005|FG004|Continuation Period|Pregnancy|0|||
131678300|NCT02748018|474109006|FG005|Continuation Period|Pregnancy|0|||
131678301|NCT02748018|474109001|FG000|Continuation Period|Physician Decision|0|||
131678302|NCT02748018|474109002|FG001|Continuation Period|Physician Decision|1|||
131678303|NCT02748018|474109003|FG002|Continuation Period|Physician Decision|2|||
131678304|NCT02748018|474109004|FG003|Continuation Period|Physician Decision|0|||
131678305|NCT02748018|474109005|FG004|Continuation Period|Physician Decision|2|||
131678306|NCT02748018|474109006|FG005|Continuation Period|Physician Decision|1|||
131678307|NCT02748018|474109001|FG000|Continuation Period|Protocol Violation|0|||
131678308|NCT02748018|474109002|FG001|Continuation Period|Protocol Violation|1|||
131678309|NCT02748018|474109003|FG002|Continuation Period|Protocol Violation|0|||
131678310|NCT02748018|474109004|FG003|Continuation Period|Protocol Violation|0|||
131678311|NCT02748018|474109005|FG004|Continuation Period|Protocol Violation|0|||
131678312|NCT02748018|474109006|FG005|Continuation Period|Protocol Violation|0|||
131678313|NCT00312221|474109007|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
131678314|NCT00312221|474109008|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
131678315|NCT00312221|474109009|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
131678316|NCT00312221|474109010|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
131678317|NCT00312221|474109007|FG000|Open-label Run-in Period|Adverse Event|74|||
131678318|NCT00312221|474109008|FG001|Open-label Run-in Period|Adverse Event|0|||
131678319|NCT00312221|474109009|FG002|Open-label Run-in Period|Adverse Event|0|||
131678320|NCT00312221|474109010|FG003|Open-label Run-in Period|Adverse Event|0|||
131678321|NCT00312221|474109007|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
131678322|NCT00312221|474109008|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
131678323|NCT00312221|474109009|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
131678324|NCT00312221|474109010|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
131678325|NCT00312221|474109007|FG000|Open-label Run-in Period|Administrative|42|||
131678326|NCT00312221|474109008|FG001|Open-label Run-in Period|Administrative|0|||
131678327|NCT00312221|474109009|FG002|Open-label Run-in Period|Administrative|0|||
131678328|NCT00312221|474109010|FG003|Open-label Run-in Period|Administrative|0|||
131678329|NCT00312221|474109007|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
131678330|NCT00312221|474109008|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
131678331|NCT00312221|474109009|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
131678332|NCT00312221|474109010|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
131678333|NCT00312221|474109007|FG000|Open-label Run-in Period|Did not qualify|5|||
131678334|NCT00312221|474109008|FG001|Open-label Run-in Period|Did not qualify|0|||
131678335|NCT00312221|474109009|FG002|Open-label Run-in Period|Did not qualify|0|||
131678336|NCT00312221|474109010|FG003|Open-label Run-in Period|Did not qualify|0|||
131678337|NCT00312221|474109007|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131678338|NCT00312221|474109008|FG001|Double-blind Phase|Withdrawal by Subject|6|||
131678339|NCT00312221|474109009|FG002|Double-blind Phase|Withdrawal by Subject|8|||
131678340|NCT00312221|474109010|FG003|Double-blind Phase|Withdrawal by Subject|7|||
131678341|NCT00312221|474109007|FG000|Double-blind Phase|Adverse Event|0|||
131678342|NCT00312221|474109008|FG001|Double-blind Phase|Adverse Event|10|||
131678343|NCT00312221|474109009|FG002|Double-blind Phase|Adverse Event|19|||
131678344|NCT00312221|474109010|FG003|Double-blind Phase|Adverse Event|18|||
131678345|NCT00312221|474109007|FG000|Double-blind Phase|Lost to Follow-up|0|||
131678346|NCT00312221|474109008|FG001|Double-blind Phase|Lost to Follow-up|0|||
131678347|NCT00312221|474109009|FG002|Double-blind Phase|Lost to Follow-up|2|||
131678348|NCT00312221|474109010|FG003|Double-blind Phase|Lost to Follow-up|2|||
131678349|NCT00312221|474109007|FG000|Double-blind Phase|Administrative|0|||
131678350|NCT00312221|474109008|FG001|Double-blind Phase|Administrative|26|||
131678351|NCT00312221|474109009|FG002|Double-blind Phase|Administrative|37|||
131678352|NCT00312221|474109010|FG003|Double-blind Phase|Administrative|33|||
131678353|NCT00312221|474109007|FG000|Double-blind Phase|Lack of Efficacy|0|||
131678354|NCT00312221|474109008|FG001|Double-blind Phase|Lack of Efficacy|17|||
131678355|NCT00312221|474109009|FG002|Double-blind Phase|Lack of Efficacy|6|||
131678356|NCT00312221|474109010|FG003|Double-blind Phase|Lack of Efficacy|10|||
131678357|NCT00323297|474109011|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
131678358|NCT00323297|474109012|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
131678359|NCT00323297|474109011|FG000|Part A (Double Blind Randomized)|Death|0|||
131678360|NCT00323297|474109012|FG001|Part A (Double Blind Randomized)|Death|1|||
131678361|NCT00323297|474109011|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
131678362|NCT00323297|474109012|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
131678363|NCT00323297|474109011|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
131678364|NCT00323297|474109012|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
131678365|NCT00323297|474109011|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
131678366|NCT00323297|474109012|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
131678367|NCT00323297|474109011|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
131678368|NCT00323297|474109012|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
131678369|NCT00323297|474109011|FG000|Part B (Open-label)|Death|0|||
131678370|NCT00323297|474109012|FG001|Part B (Open-label)|Death|1|||
131678371|NCT00323297|474109011|FG000|Part B (Open-label)|Reason unspecified|0|||
131678372|NCT00323297|474109012|FG001|Part B (Open-label)|Reason unspecified|1|||
131678373|NCT00323297|474109011|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
131678374|NCT00323297|474109012|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
131678375|NCT00323297|474109011|FG000|Part B (Open-label)|Lack of Efficacy|3|||
131678376|NCT00323297|474109012|FG001|Part B (Open-label)|Lack of Efficacy|1|||
131678377|NCT00323297|474109011|FG000|Part B (Open-label)|Adverse Event|5|||
131678378|NCT00323297|474109012|FG001|Part B (Open-label)|Adverse Event|5|||
131678379|NCT00323297|474109011|FG000|Part B (Open-label)|Protocol Violation|0|||
131678380|NCT00323297|474109012|FG001|Part B (Open-label)|Protocol Violation|1|||
131678381|NCT01003990|474109013|FG000|Overall Study|Adverse Event|8|||
131678382|NCT01003990|474109014|FG001|Overall Study|Adverse Event|5|||
131678383|NCT01003990|474109015|FG002|Overall Study|Adverse Event|11|||
131678384|NCT01003990|474109013|FG000|Overall Study|Death|0|||
131678385|NCT01003990|474109014|FG001|Overall Study|Death|8|||
131678386|NCT01003990|474109015|FG002|Overall Study|Death|1|||
131678387|NCT01003990|474109013|FG000|Overall Study|Lack of Efficacy|10|||
131678388|NCT01003990|474109014|FG001|Overall Study|Lack of Efficacy|2|||
131678389|NCT01003990|474109015|FG002|Overall Study|Lack of Efficacy|3|||
131678390|NCT01003990|474109013|FG000|Overall Study|Lost to Follow-up|30|||
131678391|NCT01003990|474109014|FG001|Overall Study|Lost to Follow-up|12|||
131678392|NCT01003990|474109015|FG002|Overall Study|Lost to Follow-up|7|||
131678393|NCT01003990|474109013|FG000|Overall Study|Reasons Not Identified|14|||
131678394|NCT01003990|474109014|FG001|Overall Study|Reasons Not Identified|13|||
131678395|NCT01003990|474109015|FG002|Overall Study|Reasons Not Identified|8|||
131678396|NCT01003990|474109013|FG000|Overall Study|Poor/Non-compliance|4|||
131678397|NCT01003990|474109014|FG001|Overall Study|Poor/Non-compliance|3|||
131678398|NCT01003990|474109015|FG002|Overall Study|Poor/Non-compliance|2|||
131678399|NCT01003990|474109013|FG000|Overall Study|Pregnancy|10|||
131678400|NCT01003990|474109014|FG001|Overall Study|Pregnancy|2|||
131678401|NCT01003990|474109015|FG002|Overall Study|Pregnancy|4|||
131678402|NCT01003990|474109013|FG000|Overall Study|No Longer Met Study Criteria|4|||
131678403|NCT01003990|474109014|FG001|Overall Study|No Longer Met Study Criteria|1|||
131678404|NCT01003990|474109015|FG002|Overall Study|No Longer Met Study Criteria|0|||
131678405|NCT01003990|474109013|FG000|Overall Study|Subject Withdrew Consent|12|||
131678406|NCT01003990|474109014|FG001|Overall Study|Subject Withdrew Consent|5|||
131678407|NCT01003990|474109015|FG002|Overall Study|Subject Withdrew Consent|7|||
131678408|NCT01807923|474109016|FG000|Overall Study|Adverse Event|2|||
131678409|NCT01807923|474109017|FG001|Overall Study|Adverse Event|1|||
131678410|NCT01807923|474109018|FG002|Overall Study|Adverse Event|2|||
131678411|NCT01807923|474109016|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
131678412|NCT01807923|474109017|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
131678413|NCT01807923|474109018|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
131678414|NCT01807923|474109016|FG000|Overall Study|Physician Decision|0|||
131678415|NCT01807923|474109017|FG001|Overall Study|Physician Decision|0|||
131678416|NCT01807923|474109018|FG002|Overall Study|Physician Decision|1|||
131678417|NCT01807923|474109016|FG000|Overall Study|Not Eligible (Genotype)|0|||
131678418|NCT01807923|474109017|FG001|Overall Study|Not Eligible (Genotype)|0|||
131678419|NCT01807923|474109018|FG002|Overall Study|Not Eligible (Genotype)|1|||
131678420|NCT01807923|474109016|FG000|Overall Study|Randomized But Not Treated|3|||
131678421|NCT01807923|474109017|FG001|Overall Study|Randomized But Not Treated|2|||
131678422|NCT01807923|474109018|FG002|Overall Study|Randomized But Not Treated|5|||
131678423|NCT04427501|474109019|FG000|Overall Study|Death|0|||
131678424|NCT04427501|474109020|FG001|Overall Study|Death|0|||
131678425|NCT04427501|474109021|FG002|Overall Study|Death|0|||
131678426|NCT04427501|474109022|FG003|Overall Study|Death|0|||
131678427|NCT04427501|474109023|FG004|Overall Study|Death|0|||
131678428|NCT04427501|474109024|FG005|Overall Study|Death|15|||
131678429|NCT04427501|474109025|FG006|Overall Study|Death|0|||
131678430|NCT04427501|474109026|FG007|Overall Study|Death|0|||
131678431|NCT04427501|474109027|FG008|Overall Study|Death|0|||
131678432|NCT04427501|474109028|FG009|Overall Study|Death|0|||
131678433|NCT04427501|474109029|FG010|Overall Study|Death|0|||
131678434|NCT04427501|474109030|FG011|Overall Study|Death|0|||
131678435|NCT04427501|474109019|FG000|Overall Study|Lost to Follow-up|5|||
131678436|NCT04427501|474109020|FG001|Overall Study|Lost to Follow-up|1|||
131678437|NCT04427501|474109021|FG002|Overall Study|Lost to Follow-up|2|||
131678438|NCT04427501|474109022|FG003|Overall Study|Lost to Follow-up|0|||
131678439|NCT04427501|474109023|FG004|Overall Study|Lost to Follow-up|2|||
131678440|NCT04427501|474109024|FG005|Overall Study|Lost to Follow-up|11|||
131678441|NCT04427501|474109025|FG006|Overall Study|Lost to Follow-up|10|||
131678442|NCT04427501|474109026|FG007|Overall Study|Lost to Follow-up|10|||
131678443|NCT04427501|474109027|FG008|Overall Study|Lost to Follow-up|2|||
131678444|NCT04427501|474109028|FG009|Overall Study|Lost to Follow-up|5|||
131678445|NCT04427501|474109029|FG010|Overall Study|Lost to Follow-up|2|||
131678446|NCT04427501|474109030|FG011|Overall Study|Lost to Follow-up|0|||
131678447|NCT04427501|474109019|FG000|Overall Study|Physician Decision|0|||
131678448|NCT04427501|474109020|FG001|Overall Study|Physician Decision|3|||
131678449|NCT04427501|474109021|FG002|Overall Study|Physician Decision|0|||
131678450|NCT04427501|474109022|FG003|Overall Study|Physician Decision|0|||
131678451|NCT04427501|474109023|FG004|Overall Study|Physician Decision|0|||
131678452|NCT04427501|474109024|FG005|Overall Study|Physician Decision|0|||
131678453|NCT04427501|474109025|FG006|Overall Study|Physician Decision|2|||
131678454|NCT04427501|474109026|FG007|Overall Study|Physician Decision|0|||
131678455|NCT04427501|474109027|FG008|Overall Study|Physician Decision|0|||
131678456|NCT04427501|474109028|FG009|Overall Study|Physician Decision|0|||
131678457|NCT04427501|474109029|FG010|Overall Study|Physician Decision|0|||
131678458|NCT04427501|474109030|FG011|Overall Study|Physician Decision|0|||
131678459|NCT04427501|474109019|FG000|Overall Study|Withdrawal by Subject|9|||
131678460|NCT04427501|474109020|FG001|Overall Study|Withdrawal by Subject|2|||
131678461|NCT04427501|474109021|FG002|Overall Study|Withdrawal by Subject|2|||
131678462|NCT04427501|474109022|FG003|Overall Study|Withdrawal by Subject|3|||
131678463|NCT04427501|474109023|FG004|Overall Study|Withdrawal by Subject|7|||
131678464|NCT04427501|474109024|FG005|Overall Study|Withdrawal by Subject|25|||
131678465|NCT04427501|474109025|FG006|Overall Study|Withdrawal by Subject|15|||
131678466|NCT04427501|474109026|FG007|Overall Study|Withdrawal by Subject|7|||
131678467|NCT04427501|474109027|FG008|Overall Study|Withdrawal by Subject|4|||
131678468|NCT04427501|474109028|FG009|Overall Study|Withdrawal by Subject|1|||
131678469|NCT04427501|474109029|FG010|Overall Study|Withdrawal by Subject|4|||
131678470|NCT04427501|474109030|FG011|Overall Study|Withdrawal by Subject|0|||
131678471|NCT04427501|474109019|FG000|Overall Study|Other - as reported by the investigator|1|||
131678472|NCT04427501|474109020|FG001|Overall Study|Other - as reported by the investigator|0|||
131678473|NCT04427501|474109021|FG002|Overall Study|Other - as reported by the investigator|0|||
131678474|NCT04427501|474109022|FG003|Overall Study|Other - as reported by the investigator|0|||
131678475|NCT04427501|474109023|FG004|Overall Study|Other - as reported by the investigator|0|||
131678476|NCT04427501|474109024|FG005|Overall Study|Other - as reported by the investigator|6|||
131678477|NCT04427501|474109025|FG006|Overall Study|Other - as reported by the investigator|6|||
131678478|NCT04427501|474109026|FG007|Overall Study|Other - as reported by the investigator|0|||
131678479|NCT04427501|474109027|FG008|Overall Study|Other - as reported by the investigator|0|||
131678480|NCT04427501|474109028|FG009|Overall Study|Other - as reported by the investigator|0|||
131678481|NCT04427501|474109029|FG010|Overall Study|Other - as reported by the investigator|0|||
131678482|NCT04427501|474109030|FG011|Overall Study|Other - as reported by the investigator|0|||
131678483|NCT04427501|474109019|FG000|Overall Study|Other|0|||
131678484|NCT04427501|474109020|FG001|Overall Study|Other|0|||
131678485|NCT04427501|474109021|FG002|Overall Study|Other|0|||
131678486|NCT04427501|474109022|FG003|Overall Study|Other|0|||
131678487|NCT04427501|474109023|FG004|Overall Study|Other|0|||
131678488|NCT04427501|474109024|FG005|Overall Study|Other|0|||
131678489|NCT04427501|474109025|FG006|Overall Study|Other|0|||
131678490|NCT04427501|474109026|FG007|Overall Study|Other|0|||
131678491|NCT04427501|474109027|FG008|Overall Study|Other|0|||
131678492|NCT04427501|474109028|FG009|Overall Study|Other|0|||
131678493|NCT04427501|474109029|FG010|Overall Study|Other|0|||
131678494|NCT04427501|474109030|FG011|Overall Study|Other|1|||
131678495|NCT00999713|474109031|FG000|Overall Study|Physician Decision|2|||
131678496|NCT00999713|474109032|FG001|Overall Study|Physician Decision|0|||
131678497|NCT00639223|474109033|FG000|Overall Study|Lost to Follow-up|0|||
131678498|NCT00639223|474109034|FG001|Overall Study|Lost to Follow-up|2|||
131678499|NCT04936841|474109035|FG000|Overall Study|Death|1|||
131678500|NCT03739437|474109037|FG000|Overall Study|Lost to Follow-up|2|||
131678501|NCT03739437|474109038|FG001|Overall Study|Lost to Follow-up|5|||
131678502|NCT01395316|474109041|FG000|Overall Study|Lost to Follow-up|2|||
131678503|NCT01395316|474109041|FG000|Overall Study|poor MRI quality|1|||
131678504|NCT03359590|474109042|FG000|First Intervention|Withdrawal by Subject|1|||
131678505|NCT03359590|474109043|FG001|First Intervention|Withdrawal by Subject|1|||
131678506|NCT03359590|474109042|FG000|First Intervention|Protocol Violation|0|||
131678507|NCT03359590|474109043|FG001|First Intervention|Protocol Violation|1|||
131678508|NCT02846532|474109044|FG000|Overall Study|Lost to Follow-up|0|||
131678509|NCT02846532|474109045|FG001|Overall Study|Lost to Follow-up|1|||
131678510|NCT02846532|474109046|FG002|Overall Study|Lost to Follow-up|1|||
131678511|NCT02846532|474109044|FG000|Overall Study|Withdrawal by Subject|1|||
131678512|NCT02846532|474109045|FG001|Overall Study|Withdrawal by Subject|2|||
131678513|NCT02846532|474109046|FG002|Overall Study|Withdrawal by Subject|0|||
131678514|NCT06132425|474109047|FG000|Overall Study|Withdrawal by Subject|3|||
131678515|NCT06132425|474109048|FG001|Overall Study|Withdrawal by Subject|0|||
131678516|NCT06132425|474109047|FG000|Overall Study|Did not follow study instructions|0|||
131678517|NCT06132425|474109048|FG001|Overall Study|Did not follow study instructions|2|||
131678518|NCT06132425|474109047|FG000|Overall Study|Lost to Follow-up|3|||
131678519|NCT06132425|474109048|FG001|Overall Study|Lost to Follow-up|5|||
131678520|NCT01019980|474109054|FG000|Overall Study|Drug not available.|2|||
131678521|NCT01019980|474109055|FG001|Overall Study|Drug not available.|0|||
131678522|NCT02383589|474109065|FG000|Treatment Period|Adverse Event|1|||
131678523|NCT02383589|474109066|FG001|Treatment Period|Adverse Event|3|||
131678524|NCT02383589|474109065|FG000|Treatment Period|Lost to Follow-up|0|||
131678525|NCT02383589|474109066|FG001|Treatment Period|Lost to Follow-up|1|||
131678526|NCT02383589|474109065|FG000|Treatment Period|Withdrawal by Subject|0|||
131678527|NCT02383589|474109066|FG001|Treatment Period|Withdrawal by Subject|5|||
131678528|NCT02383589|474109065|FG000|Treatment Period|Non-compliance with study drug|0|||
131678529|NCT02383589|474109066|FG001|Treatment Period|Non-compliance with study drug|1|||
131678530|NCT02383589|474109065|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
131678531|NCT02383589|474109066|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
131678532|NCT02383589|474109065|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
131678533|NCT02383589|474109066|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
131678534|NCT02383589|474109065|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
131678535|NCT02383589|474109066|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
131678536|NCT03672461|474109067|FG000|Overall Study|COVID Related|4|||
131678537|NCT03672461|474109068|FG001|Overall Study|COVID Related|2|||
131678538|NCT03672461|474109067|FG000|Overall Study|Adverse Event|2|||
131678539|NCT03672461|474109068|FG001|Overall Study|Adverse Event|0|||
131678540|NCT03672461|474109067|FG000|Overall Study|Serious Adverse Event|0|||
131678541|NCT03672461|474109068|FG001|Overall Study|Serious Adverse Event|1|||
131678542|NCT03672461|474109067|FG000|Overall Study|Too Busy|3|||
131678543|NCT03672461|474109068|FG001|Overall Study|Too Busy|1|||
131678544|NCT03672461|474109067|FG000|Overall Study|Lost to Follow-up|1|||
131678545|NCT03672461|474109068|FG001|Overall Study|Lost to Follow-up|2|||
131678546|NCT03672461|474109067|FG000|Overall Study|Family|2|||
131678547|NCT03672461|474109068|FG001|Overall Study|Family|2|||
131678548|NCT03672461|474109067|FG000|Overall Study|No remote technology access|0|||
131678549|NCT03672461|474109068|FG001|Overall Study|No remote technology access|1|||
131678550|NCT03672461|474109067|FG000|Overall Study|Withdrawal by Subject|1|||
131678551|NCT03672461|474109068|FG001|Overall Study|Withdrawal by Subject|0|||
131678552|NCT03672461|474109067|FG000|Overall Study|Cannot tolerate intervention|1|||
131678553|NCT03672461|474109068|FG001|Overall Study|Cannot tolerate intervention|0|||
131678554|NCT03672461|474109067|FG000|Overall Study|Incomplete outcome data|6|||
131678555|NCT03672461|474109068|FG001|Overall Study|Incomplete outcome data|1|||
131678556|NCT04225806|474109069|FG000|Overall Study|Trial termination|15|||
131678557|NCT02408861|474109072|FG000|Overall Study|Death|0|||
131678558|NCT02408861|474109073|FG001|Overall Study|Death|3|||
131678559|NCT02408861|474109074|FG002|Overall Study|Death|1|||
131678560|NCT02408861|474109075|FG003|Overall Study|Death|2|||
131678561|NCT02408861|474109076|FG004|Overall Study|Death|4|||
131678562|NCT02408861|474109077|FG005|Overall Study|Death|1|||
131678563|NCT02408861|474109078|FG006|Overall Study|Death|0|||
131678564|NCT02408861|474109072|FG000|Overall Study|Lost to Follow-up|0|||
131678565|NCT02408861|474109073|FG001|Overall Study|Lost to Follow-up|0|||
131678566|NCT02408861|474109074|FG002|Overall Study|Lost to Follow-up|1|||
131678567|NCT02408861|474109075|FG003|Overall Study|Lost to Follow-up|1|||
131678568|NCT02408861|474109076|FG004|Overall Study|Lost to Follow-up|4|||
131678569|NCT02408861|474109077|FG005|Overall Study|Lost to Follow-up|2|||
131678570|NCT02408861|474109078|FG006|Overall Study|Lost to Follow-up|1|||
131678571|NCT02408861|474109072|FG000|Overall Study|Disease Progression|0|||
131678572|NCT02408861|474109073|FG001|Overall Study|Disease Progression|0|||
131678573|NCT02408861|474109074|FG002|Overall Study|Disease Progression|1|||
131678574|NCT02408861|474109075|FG003|Overall Study|Disease Progression|0|||
131678575|NCT02408861|474109076|FG004|Overall Study|Disease Progression|3|||
131678576|NCT02408861|474109077|FG005|Overall Study|Disease Progression|1|||
131678577|NCT02408861|474109078|FG006|Overall Study|Disease Progression|1|||
131678578|NCT02408861|474109072|FG000|Overall Study|Adverse Event|1|||
131678579|NCT02408861|474109073|FG001|Overall Study|Adverse Event|0|||
131678580|NCT02408861|474109074|FG002|Overall Study|Adverse Event|1|||
131678581|NCT02408861|474109075|FG003|Overall Study|Adverse Event|0|||
131678582|NCT02408861|474109076|FG004|Overall Study|Adverse Event|2|||
131678583|NCT02408861|474109077|FG005|Overall Study|Adverse Event|0|||
131678584|NCT02408861|474109078|FG006|Overall Study|Adverse Event|0|||
131678585|NCT02408861|474109072|FG000|Overall Study|Physician Decision|1|||
131678586|NCT02408861|474109073|FG001|Overall Study|Physician Decision|1|||
131678587|NCT02408861|474109074|FG002|Overall Study|Physician Decision|1|||
131678588|NCT02408861|474109075|FG003|Overall Study|Physician Decision|0|||
131678589|NCT02408861|474109076|FG004|Overall Study|Physician Decision|0|||
131678590|NCT02408861|474109077|FG005|Overall Study|Physician Decision|1|||
131678591|NCT02408861|474109078|FG006|Overall Study|Physician Decision|0|||
131678592|NCT02408861|474109072|FG000|Overall Study|Protocol Violation|1|||
131678593|NCT02408861|474109073|FG001|Overall Study|Protocol Violation|0|||
131678594|NCT02408861|474109074|FG002|Overall Study|Protocol Violation|0|||
131678595|NCT02408861|474109075|FG003|Overall Study|Protocol Violation|0|||
131678596|NCT02408861|474109076|FG004|Overall Study|Protocol Violation|0|||
131678597|NCT02408861|474109077|FG005|Overall Study|Protocol Violation|0|||
131678598|NCT02408861|474109078|FG006|Overall Study|Protocol Violation|0|||
131678599|NCT02408861|474109072|FG000|Overall Study|Withdrawal by Subject|0|||
131678600|NCT02408861|474109073|FG001|Overall Study|Withdrawal by Subject|0|||
131678601|NCT02408861|474109074|FG002|Overall Study|Withdrawal by Subject|0|||
131678602|NCT02408861|474109075|FG003|Overall Study|Withdrawal by Subject|0|||
131678603|NCT02408861|474109076|FG004|Overall Study|Withdrawal by Subject|1|||
131678604|NCT02408861|474109077|FG005|Overall Study|Withdrawal by Subject|1|||
131678605|NCT02408861|474109078|FG006|Overall Study|Withdrawal by Subject|0|||
131678606|NCT02408861|474109072|FG000|Overall Study|Other Treatment|0|||
131678607|NCT02408861|474109073|FG001|Overall Study|Other Treatment|0|||
131678608|NCT02408861|474109074|FG002|Overall Study|Other Treatment|0|||
131678609|NCT02408861|474109075|FG003|Overall Study|Other Treatment|0|||
131678610|NCT02408861|474109076|FG004|Overall Study|Other Treatment|0|||
131678611|NCT02408861|474109077|FG005|Overall Study|Other Treatment|1|||
131678612|NCT02408861|474109078|FG006|Overall Study|Other Treatment|1|||
131678613|NCT07052682|474109079|FG000|Overall Study|Withdrawal by Subject|4|||
131678614|NCT05460273|474109080|FG000|Overall Study|Death|43|||
131678615|NCT05460273|474109081|FG001|Overall Study|Death|9|||
131678616|NCT05460273|474109080|FG000|Overall Study|Lost to Follow-up|7|||
131678617|NCT05460273|474109081|FG001|Overall Study|Lost to Follow-up|0|||
131678618|NCT05460273|474109080|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
131678619|NCT05460273|474109081|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
131678620|NCT04890054|474110572|FG000|Overall Study|Lost to Follow-up|202|||
131678621|NCT04890054|474110573|FG001|Overall Study|Lost to Follow-up|219|||
131678622|NCT01310803|474110574|FG000|Overall Study|Subject terminated by Sponsor|1|||
131678623|NCT01310803|474110575|FG001|Overall Study|Subject terminated by Sponsor|0|||
131678624|NCT01444651|474110576|FG000|Overall Study|Adverse Event|3|||
131678625|NCT01444651|474110577|FG001|Overall Study|Adverse Event|2|||
131678626|NCT01444651|474110576|FG000|Overall Study|Lost to Follow-up|5|||
131678627|NCT01444651|474110577|FG001|Overall Study|Lost to Follow-up|5|||
131678628|NCT01444651|474110576|FG000|Overall Study|Non-fasting|2|||
131678629|NCT01444651|474110577|FG001|Overall Study|Non-fasting|1|||
131678630|NCT01444651|474110576|FG000|Overall Study|Missing data|1|||
131678631|NCT01444651|474110577|FG001|Overall Study|Missing data|1|||
131678632|NCT03047551|474110578|FG000|Overall Study|Did not receive TAS|1|||
131678633|NCT03047551|474110579|FG001|Overall Study|Did not receive TAS|0|||
131678634|NCT03047551|474110578|FG000|Overall Study|Physician Decision|1|||
131678635|NCT03047551|474110579|FG001|Overall Study|Physician Decision|0|||
131678636|NCT03047551|474110578|FG000|Overall Study|Withdrawal by Subject|0|||
131678637|NCT03047551|474110579|FG001|Overall Study|Withdrawal by Subject|1|||
131678638|NCT03047551|474110578|FG000|Overall Study|Probe malfunction|0|||
131678639|NCT03047551|474110579|FG001|Overall Study|Probe malfunction|1|||
131678640|NCT03047551|474110578|FG000|Overall Study|Ineligible|0|||
131678641|NCT03047551|474110579|FG001|Overall Study|Ineligible|1|||
131678642|NCT00726622|474110580|FG000|Overall Study|Withdrawal by Subject|16|||
131678643|NCT00726622|474110581|FG001|Overall Study|Withdrawal by Subject|2|||
131678644|NCT00726622|474110580|FG000|Overall Study|Physician Decision|0|||
131678645|NCT00726622|474110581|FG001|Overall Study|Physician Decision|1|||
131678646|NCT00726622|474110580|FG000|Overall Study|Metastasis|2|||
131678647|NCT00726622|474110581|FG001|Overall Study|Metastasis|0|||
131678648|NCT01940354|474110582|FG000|Overall Study|Withdrawal by Subject|4|||
131678649|NCT01940354|474110583|FG001|Overall Study|Withdrawal by Subject|2|||
131678650|NCT01215175|474110584|FG000|Overall Study|Lost to Follow-up|0|||
131678651|NCT01215175|474110585|FG001|Overall Study|Lost to Follow-up|1|||
131678652|NCT01215175|474110586|FG002|Overall Study|Lost to Follow-up|0|||
131678653|NCT01215175|474110587|FG003|Overall Study|Lost to Follow-up|1|||
131678654|NCT01215175|474110588|FG004|Overall Study|Lost to Follow-up|0|||
131678655|NCT03872453|474110589|FG000|Overall Study|Adverse Event|1|||
131678656|NCT03872453|474110590|FG001|Overall Study|Adverse Event|1|||
131678657|NCT03872453|474110591|FG002|Overall Study|Adverse Event|0|||
131678658|NCT03872453|474110592|FG003|Overall Study|Adverse Event|0|||
131678659|NCT03872453|474110589|FG000|Overall Study|Lost to Follow-up|8|||
131678660|NCT03872453|474110590|FG001|Overall Study|Lost to Follow-up|7|||
131678661|NCT03872453|474110591|FG002|Overall Study|Lost to Follow-up|4|||
131678662|NCT03872453|474110592|FG003|Overall Study|Lost to Follow-up|4|||
131678663|NCT03872453|474110589|FG000|Overall Study|Never Treated Migraine|19|||
131678664|NCT03872453|474110590|FG001|Overall Study|Never Treated Migraine|17|||
131678665|NCT03872453|474110591|FG002|Overall Study|Never Treated Migraine|13|||
131678666|NCT03872453|474110592|FG003|Overall Study|Never Treated Migraine|12|||
131678667|NCT03872453|474110589|FG000|Overall Study|Pregnancy|1|||
131678668|NCT03872453|474110590|FG001|Overall Study|Pregnancy|0|||
131678669|NCT03872453|474110591|FG002|Overall Study|Pregnancy|0|||
131678670|NCT03872453|474110592|FG003|Overall Study|Pregnancy|0|||
131678671|NCT03872453|474110589|FG000|Overall Study|Protocol Deviation|2|||
131678672|NCT03872453|474110590|FG001|Overall Study|Protocol Deviation|0|||
131678673|NCT03872453|474110591|FG002|Overall Study|Protocol Deviation|0|||
131678674|NCT03872453|474110592|FG003|Overall Study|Protocol Deviation|2|||
131678675|NCT03872453|474110589|FG000|Overall Study|Withdrawal by Subject|0|||
131678676|NCT03872453|474110590|FG001|Overall Study|Withdrawal by Subject|1|||
131678677|NCT03872453|474110591|FG002|Overall Study|Withdrawal by Subject|2|||
131678678|NCT03872453|474110592|FG003|Overall Study|Withdrawal by Subject|0|||
131678679|NCT03872453|474110589|FG000|Overall Study|Other Than Specified|1|||
131678680|NCT03872453|474110590|FG001|Overall Study|Other Than Specified|0|||
131678681|NCT03872453|474110591|FG002|Overall Study|Other Than Specified|0|||
131678682|NCT03872453|474110592|FG003|Overall Study|Other Than Specified|0|||
131678683|NCT00352885|474110593|FG000|Overall Study|Withdrawal by Subject|0|||
131678684|NCT00352885|474110594|FG001|Overall Study|Withdrawal by Subject|3|||
131678685|NCT00352885|474110593|FG000|Overall Study|Development of major depression|0|||
131678686|NCT00352885|474110594|FG001|Overall Study|Development of major depression|1|||
131678687|NCT00352885|474110593|FG000|Overall Study|Progression of metastatic melanoma|5|||
131678688|NCT00352885|474110594|FG001|Overall Study|Progression of metastatic melanoma|3|||
131678689|NCT00352885|474110593|FG000|Overall Study|Side effects of IL-2 administration|1|||
131678690|NCT00352885|474110594|FG001|Overall Study|Side effects of IL-2 administration|0|||
131678691|NCT03873493|474110595|FG000|Overall Study|Withdrawal by Subject|1|||
131678692|NCT03873493|474110595|FG000|Overall Study|Death|9|||
131678693|NCT03873493|474110595|FG000|Overall Study|Lost to Follow-up|1|||
131678694|NCT03873493|474110595|FG000|Overall Study|Study Terminated by Sponsor|1|||
131678695|NCT03873493|474110595|FG000|Overall Study|Other|2|||
131678696|NCT03756350|474110597|FG000|Overall Study|Lost to Follow-up|1|||
131678697|NCT00440700|474110600|FG000|Overall Study|Withdrawal by Subject|8|||
131678698|NCT00440700|474110601|FG001|Overall Study|Withdrawal by Subject|8|||
131678699|NCT00440700|474110602|FG002|Overall Study|Withdrawal by Subject|4|||
131678700|NCT01131351|474110605|FG000|Overall Study|Adverse Event|0|||
131678701|NCT01131351|474110606|FG001|Overall Study|Adverse Event|2|||
131678702|NCT01131351|474110605|FG000|Overall Study|Protocol Deviation|0|||
131678703|NCT01131351|474110606|FG001|Overall Study|Protocol Deviation|1|||
131678704|NCT02294682|474110607|FG000|Overall Study|Could not swallow pills|1|||
131678705|NCT02294682|474110608|FG001|Overall Study|Could not swallow pills|0|||
131678706|NCT00404066|474110614|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
131678707|NCT00404066|474110614|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
131678708|NCT01179672|474110615|FG000|Overall Study|Adverse Event|17|||
131678709|NCT01179672|474110616|FG001|Overall Study|Adverse Event|8|||
131678710|NCT01179672|474110615|FG000|Overall Study|Withdrawal by Subject|10|||
131678711|NCT01179672|474110616|FG001|Overall Study|Withdrawal by Subject|12|||
131678712|NCT01179672|474110615|FG000|Overall Study|Entry Criteria Not Met|0|||
131678713|NCT01179672|474110616|FG001|Overall Study|Entry Criteria Not Met|2|||
131678714|NCT01179672|474110615|FG000|Overall Study|Lost to Follow-up|0|||
131678715|NCT01179672|474110616|FG001|Overall Study|Lost to Follow-up|1|||
131678716|NCT01179672|474110615|FG000|Overall Study|Protocol Violation|2|||
131678717|NCT01179672|474110616|FG001|Overall Study|Protocol Violation|2|||
131678718|NCT01179672|474110615|FG000|Overall Study|Physician Decision|1|||
131678719|NCT01179672|474110616|FG001|Overall Study|Physician Decision|1|||
131678720|NCT01187550|474110619|FG000|Overall Study|Protocol Violation|3|||
131678721|NCT01187550|474110620|FG001|Overall Study|Protocol Violation|1|||
131678722|NCT01187550|474110619|FG000|Overall Study|Other|3|||
131678723|NCT01187550|474110620|FG001|Overall Study|Other|0|||
131678724|NCT01187550|474110619|FG000|Overall Study|Randomized but not treated|8|||
131678725|NCT01187550|474110620|FG001|Overall Study|Randomized but not treated|0|||
131678726|NCT00129623|474110621|FG000|Overall Study|Adverse Event|3|||
131678727|NCT00129623|474110622|FG001|Overall Study|Adverse Event|7|||
131678728|NCT00129623|474110621|FG000|Overall Study|Refused Treatment|5|||
131678729|NCT00129623|474110622|FG001|Overall Study|Refused Treatment|3|||
131678730|NCT00129623|474110621|FG000|Overall Study|Failure to Return|1|||
131678731|NCT00129623|474110622|FG001|Overall Study|Failure to Return|1|||
131678732|NCT00129623|474110621|FG000|Overall Study|Relocated job out of state|1|||
131678733|NCT00129623|474110622|FG001|Overall Study|Relocated job out of state|0|||
131678734|NCT00129623|474110621|FG000|Overall Study|Uncertainty to return|0|||
131678735|NCT00129623|474110622|FG001|Overall Study|Uncertainty to return|1|||
131678736|NCT02616614|474110623|FG000|Overall Study|Withdrawal by Subject|10|||
131678737|NCT02616614|474110624|FG001|Overall Study|Withdrawal by Subject|5|||
131678738|NCT02616614|474110625|FG002|Overall Study|Withdrawal by Subject|6|||
131678739|NCT02616614|474110623|FG000|Overall Study|Physician Decision|2|||
131678740|NCT02616614|474110624|FG001|Overall Study|Physician Decision|1|||
131678741|NCT02616614|474110625|FG002|Overall Study|Physician Decision|0|||
131678742|NCT02616614|474110623|FG000|Overall Study|Adverse Event|1|||
131678743|NCT02616614|474110624|FG001|Overall Study|Adverse Event|4|||
131678744|NCT02616614|474110625|FG002|Overall Study|Adverse Event|1|||
131678745|NCT02616614|474110623|FG000|Overall Study|Protocol Violation|0|||
131678746|NCT02616614|474110624|FG001|Overall Study|Protocol Violation|3|||
131678747|NCT02616614|474110625|FG002|Overall Study|Protocol Violation|1|||
131678748|NCT02616614|474110623|FG000|Overall Study|Prohibited Medication|12|||
131678749|NCT02616614|474110624|FG001|Overall Study|Prohibited Medication|9|||
131678750|NCT02616614|474110625|FG002|Overall Study|Prohibited Medication|5|||
131678751|NCT02616614|474110623|FG000|Overall Study|More than 3 applications missed|6|||
131678752|NCT02616614|474110624|FG001|Overall Study|More than 3 applications missed|8|||
131678753|NCT02616614|474110625|FG002|Overall Study|More than 3 applications missed|1|||
131678754|NCT02616614|474110623|FG000|Overall Study|Lost to Follow-up|31|||
131678755|NCT02616614|474110624|FG001|Overall Study|Lost to Follow-up|28|||
131678756|NCT02616614|474110625|FG002|Overall Study|Lost to Follow-up|13|||
131678757|NCT02616614|474110623|FG000|Overall Study|Pregnancy|2|||
131678758|NCT02616614|474110624|FG001|Overall Study|Pregnancy|0|||
131678759|NCT02616614|474110625|FG002|Overall Study|Pregnancy|1|||
131678760|NCT02616614|474110623|FG000|Overall Study|Other|1|||
131678761|NCT02616614|474110624|FG001|Overall Study|Other|2|||
131678762|NCT02616614|474110625|FG002|Overall Study|Other|1|||
131678763|NCT02315898|474110626|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
131678764|NCT02315898|474110627|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
131678765|NCT02315898|474110628|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
131678766|NCT02315898|474110629|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
131678767|NCT02445755|474110630|FG000|Overall Study|Withdrawal by Subject|2|||
131678768|NCT02445755|474110630|FG000|Overall Study|Protocol Violation|6|||
131678769|NCT02445755|474110630|FG000|Overall Study|Screen Failure|5|||
131678770|NCT03239483|474110631|FG000|Overall Study|Lost to Follow-up|1|||
131678771|NCT03239483|474110632|FG001|Overall Study|Lost to Follow-up|0|||
131678772|NCT03239483|474110631|FG000|Overall Study|Withdrawal by Subject|1|||
131678773|NCT03239483|474110632|FG001|Overall Study|Withdrawal by Subject|0|||
131678774|NCT05352048|474110633|FG000|Overall Study|Lost to Follow-up|1|||
131678775|NCT05352048|474110633|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
131678776|NCT01233869|474110647|FG000|Initial Treatment Period (24 Months)|Death|1|||
131678777|NCT01233869|474110648|FG001|Initial Treatment Period (24 Months)|Death|0|||
131678778|NCT01233869|474110649|FG002|Initial Treatment Period (24 Months)|Death|0|||
131678779|NCT01233869|474110650|FG003|Initial Treatment Period (24 Months)|Death|0|||
131678780|NCT01233869|474110647|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
131678781|NCT01233869|474110648|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
131678782|NCT01233869|474110649|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
131678783|NCT01233869|474110650|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
131678784|NCT01233869|474110647|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
131678785|NCT01233869|474110648|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
131678786|NCT01233869|474110649|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
131678787|NCT01233869|474110650|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
131678788|NCT01233869|474110647|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
131678789|NCT01233869|474110648|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
131678790|NCT01233869|474110649|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
131678791|NCT01233869|474110650|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
131678792|NCT01233869|474110647|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
131678793|NCT01233869|474110648|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
131678794|NCT01233869|474110649|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
131678795|NCT01233869|474110650|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
131678796|NCT01233869|474110647|FG000|Extended Treatment Period (46 Months)|Other|3|||
131678797|NCT01233869|474110648|FG001|Extended Treatment Period (46 Months)|Other|0|||
131678798|NCT01233869|474110649|FG002|Extended Treatment Period (46 Months)|Other|0|||
131678799|NCT01233869|474110650|FG003|Extended Treatment Period (46 Months)|Other|3|||
131678800|NCT01233869|474110647|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
131678801|NCT01233869|474110648|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
131678802|NCT01233869|474110649|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
131678803|NCT01233869|474110650|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
131678804|NCT04464265|474110657|FG000|Overall Study|Physician Decision|2|||
131678805|NCT00974090|474110664|FG000|Period 1: Double Blind Period|Adverse Event|2|||
131678806|NCT00974090|474110665|FG001|Period 1: Double Blind Period|Adverse Event|1|||
131678807|NCT00974090|474110664|FG000|Period 1: Double Blind Period|Physician Decision|1|||
131678808|NCT00974090|474110665|FG001|Period 1: Double Blind Period|Physician Decision|0|||
131678809|NCT00974090|474110664|FG000|Period 2: Open-label Period|Adverse Event|4|||
131678810|NCT00974090|474110665|FG001|Period 2: Open-label Period|Adverse Event|6|||
131678811|NCT00974090|474110664|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
131678812|NCT00974090|474110665|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
131678813|NCT00974090|474110664|FG000|Period 2: Open-label Period|Physician Decision|0|||
131678814|NCT00974090|474110665|FG001|Period 2: Open-label Period|Physician Decision|3|||
131678815|NCT00974090|474110664|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
131678816|NCT00974090|474110665|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
131678817|NCT03189862|474110666|FG000|Overall Study|Withdrawal by Subject|1|||
131678818|NCT03189862|474110667|FG001|Overall Study|Withdrawal by Subject|0|||
131678819|NCT03189862|474110666|FG000|Overall Study|Lost to Follow-up|54|||
131678820|NCT03189862|474110667|FG001|Overall Study|Lost to Follow-up|62|||
131678821|NCT05696236|474110670|FG000|Overall Study|Lost to Follow-up|1|||
131678822|NCT05696236|474110671|FG001|Overall Study|Lost to Follow-up|0|||
131678823|NCT05696236|474110670|FG000|Overall Study|Later determined to not be eligible for participation|0|||
131678824|NCT05696236|474110671|FG001|Overall Study|Later determined to not be eligible for participation|1|||
131678825|NCT05696236|474110670|FG000|Overall Study|Withdrawal by Subject|2|||
131678826|NCT05696236|474110671|FG001|Overall Study|Withdrawal by Subject|2|||
131678827|NCT01829360|474110672|FG000|Overall Study|Protocol Violation|0|||
131678828|NCT01829360|474110673|FG001|Overall Study|Protocol Violation|0|||
131678829|NCT01829360|474110674|FG002|Overall Study|Protocol Violation|1|||
131678830|NCT01829360|474110675|FG003|Overall Study|Protocol Violation|0|||
131678831|NCT01145495|474110678|FG000|Overall Study|Adverse Event|6|||
131678832|NCT01145495|474110678|FG000|Overall Study|Withdrawal by Subject|6|||
131678833|NCT01145495|474110678|FG000|Overall Study|Disease progression after respone|2|||
131678834|NCT02378220|474110681|FG000|Overall Study|Death|6|||
131678835|NCT02378220|474110682|FG001|Overall Study|Death|1|||
131678836|NCT00578786|474110683|FG000|Overall Study|Adverse Event|27|||
131678837|NCT00578786|474110684|FG001|Overall Study|Adverse Event|37|||
131678838|NCT00578786|474110685|FG002|Overall Study|Adverse Event|17|||
131678839|NCT00578786|474110683|FG000|Overall Study|Lack of Efficacy|2|||
131678840|NCT00578786|474110684|FG001|Overall Study|Lack of Efficacy|5|||
131678841|NCT00578786|474110685|FG002|Overall Study|Lack of Efficacy|2|||
131678842|NCT00578786|474110683|FG000|Overall Study|Early Escape from Prior Study|2|||
131678843|NCT00578786|474110684|FG001|Overall Study|Early Escape from Prior Study|1|||
131678844|NCT00578786|474110685|FG002|Overall Study|Early Escape from Prior Study|2|||
131678845|NCT00578786|474110683|FG000|Overall Study|Withdrawal by Subject|7|||
131678846|NCT00578786|474110684|FG001|Overall Study|Withdrawal by Subject|8|||
131678847|NCT00578786|474110685|FG002|Overall Study|Withdrawal by Subject|5|||
131678848|NCT00578786|474110683|FG000|Overall Study|Protocol Violation|0|||
131678849|NCT00578786|474110684|FG001|Overall Study|Protocol Violation|3|||
131678850|NCT00578786|474110685|FG002|Overall Study|Protocol Violation|1|||
131678851|NCT00578786|474110683|FG000|Overall Study|Physician Decision|1|||
131678852|NCT00578786|474110684|FG001|Overall Study|Physician Decision|0|||
131678853|NCT00578786|474110685|FG002|Overall Study|Physician Decision|1|||
131678854|NCT00578786|474110683|FG000|Overall Study|Sponsor Decision|0|||
131678855|NCT00578786|474110684|FG001|Overall Study|Sponsor Decision|0|||
131678856|NCT00578786|474110685|FG002|Overall Study|Sponsor Decision|1|||
131678857|NCT00578786|474110683|FG000|Overall Study|Lost to Follow-up|0|||
131678858|NCT00578786|474110684|FG001|Overall Study|Lost to Follow-up|4|||
131678859|NCT00578786|474110685|FG002|Overall Study|Lost to Follow-up|0|||
131678860|NCT00578786|474110683|FG000|Overall Study|Pregnancy|0|||
131678861|NCT00578786|474110684|FG001|Overall Study|Pregnancy|1|||
131678862|NCT00578786|474110685|FG002|Overall Study|Pregnancy|0|||
131678863|NCT00578786|474110683|FG000|Overall Study|Not Otherwise Specified|0|||
131678864|NCT00578786|474110684|FG001|Overall Study|Not Otherwise Specified|4|||
131678865|NCT00578786|474110685|FG002|Overall Study|Not Otherwise Specified|1|||
131678866|NCT00578786|474110683|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
131678867|NCT00578786|474110684|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
131678868|NCT00578786|474110685|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
131678869|NCT02060721|474110686|FG000|Overall Study|Lost to Follow-up|1|||
131678870|NCT02060721|474110686|FG000|Overall Study|Physician Decision|2|||
131678871|NCT02060721|474110686|FG000|Overall Study|Death|14|||
131678872|NCT02060721|474110686|FG000|Overall Study|Withdrawal by Subject|2|||
131678873|NCT02060721|474110686|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
131678874|NCT00117507|474110687|FG000|Overall Study|Adverse Event|4|||
131678875|NCT00117507|474110687|FG000|Overall Study|Abnormal laboratory values|3|||
131678876|NCT00117507|474110687|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131678877|NCT00117507|474110687|FG000|Overall Study|Patient withdrew consent|4|||
131678878|NCT00117507|474110687|FG000|Overall Study|Death|3|||
131678879|NCT05105789|474110688|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
131678880|NCT01271803|474110691|FG000|Overall Study|Progressive disease|0|||
131678881|NCT01271803|474110692|FG001|Overall Study|Progressive disease|0|||
131678882|NCT01271803|474110693|FG002|Overall Study|Progressive disease|2|||
131678883|NCT01271803|474110691|FG000|Overall Study|Death|53|||
131678884|NCT01271803|474110692|FG001|Overall Study|Death|34|||
131678885|NCT01271803|474110693|FG002|Overall Study|Death|0|||
131678886|NCT01271803|474110691|FG000|Overall Study|Withdrawal by Subject|1|||
131678887|NCT01271803|474110692|FG001|Overall Study|Withdrawal by Subject|5|||
131678888|NCT01271803|474110693|FG002|Overall Study|Withdrawal by Subject|0|||
131678889|NCT01271803|474110691|FG000|Overall Study|Lost to Follow-up|1|||
131678890|NCT01271803|474110692|FG001|Overall Study|Lost to Follow-up|0|||
131678891|NCT01271803|474110693|FG002|Overall Study|Lost to Follow-up|0|||
131678892|NCT00890929|474110696|FG000|Overall Study|Death before treatment|2|||
131678893|NCT00890929|474110696|FG000|Overall Study|Withdrawal by Subject|3|||
131678894|NCT00890929|474110696|FG000|Overall Study|Physician Decision|1|||
131678895|NCT04233164|474110697|FG000|Overall Study|Unable to obtain specimen|0|||
131678896|NCT04233164|474110698|FG001|Overall Study|Unable to obtain specimen|1|||
131678897|NCT04667247|474110703|FG000|Overall Study|Withdrawal by Subject|0|||
131678898|NCT04667247|474110704|FG001|Overall Study|Withdrawal by Subject|1|||
131678899|NCT01436071|474112223|FG000|Overall Study|Adverse Event|1|||
131678900|NCT01436071|474112224|FG001|Overall Study|Adverse Event|0|||
131678901|NCT01436071|474112223|FG000|Overall Study|Lack of Efficacy|16|||
131678902|NCT01436071|474112224|FG001|Overall Study|Lack of Efficacy|7|||
131678903|NCT01436071|474112223|FG000|Overall Study|Protocol Violation|0|||
131678904|NCT01436071|474112224|FG001|Overall Study|Protocol Violation|1|||
131678905|NCT01436071|474112223|FG000|Overall Study|Lost to Follow-up|3|||
131678906|NCT01436071|474112224|FG001|Overall Study|Lost to Follow-up|1|||
131678907|NCT01436071|474112223|FG000|Overall Study|Physician Decision|1|||
131678908|NCT01436071|474112224|FG001|Overall Study|Physician Decision|0|||
131678909|NCT01436071|474112223|FG000|Overall Study|Withdrawal by Subject|2|||
131678910|NCT01436071|474112224|FG001|Overall Study|Withdrawal by Subject|2|||
131678911|NCT01436071|474112223|FG000|Overall Study|Did Not Receive Trial Medication|3|||
131678912|NCT01436071|474112224|FG001|Overall Study|Did Not Receive Trial Medication|3|||
131678913|NCT01296035|474112227|FG000|Overall Study|Withdrawal by Subject|1|||
131678914|NCT00056862|474112228|FG000|Overall Study|Protocol Violation|1|||
131678915|NCT00056862|474112229|FG001|Overall Study|Protocol Violation|0|||
131678916|NCT03838198|474112230|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
131678917|NCT03838198|474112231|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
131678918|NCT03838198|474112232|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
131678919|NCT03838198|474112233|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
131678920|NCT03838198|474112230|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
131678921|NCT03838198|474112231|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
131678922|NCT03838198|474112232|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
131678923|NCT03838198|474112233|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
131678924|NCT00866723|474112237|FG000|Overall Study|Withdrawal by Subject|1|||
131678925|NCT00866723|474112237|FG000|Overall Study|Disease Progression|4|||
131678926|NCT01026142|474112241|FG000|Overall Study|Death|136|||
131678927|NCT01026142|474112242|FG001|Overall Study|Death|134|||
131678928|NCT01026142|474112241|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
131678929|NCT01026142|474112242|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
131678930|NCT02178553|474112248|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
131678931|NCT02178553|474112249|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
131678932|NCT02178553|474112248|FG000|Overall Study|Physician Decision|0|||
131678933|NCT02178553|474112249|FG001|Overall Study|Physician Decision|4|||
131678934|NCT02178553|474112248|FG000|Overall Study|Technical problem with injection|1|||
131678935|NCT02178553|474112249|FG001|Overall Study|Technical problem with injection|3|||
131678936|NCT02187809|474112250|FG000|Overall Study|The study was terminated|3|||
131678937|NCT05085665|474112251|FG000|Overall Study|Physician Decision|2|||
131678938|NCT00628251|474112252|FG000|Randomised Part|Withdrawal by Subject|0|||
131678939|NCT00628251|474112253|FG001|Randomised Part|Withdrawal by Subject|0|||
131678940|NCT00628251|474112254|FG002|Randomised Part|Withdrawal by Subject|1|||
131678941|NCT00628251|474112252|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
131678942|NCT00628251|474112253|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
131678943|NCT00628251|474112254|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
131678944|NCT00628251|474112252|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
131678945|NCT00628251|474112253|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
131678946|NCT00628251|474112254|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
131678947|NCT00628251|474112252|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
131678948|NCT00628251|474112253|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
131678949|NCT00628251|474112254|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
131678950|NCT00628251|474112252|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
131678951|NCT00628251|474112253|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
131678952|NCT00628251|474112254|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
131678953|NCT00628251|474112252|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
131678954|NCT00628251|474112253|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
131678955|NCT00628251|474112254|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
131678956|NCT02545322|474112255|FG000|Overall Study|Withdrawal by Subject|3|||
131678957|NCT00041067|474112256|FG000|Overall Study|Adverse Event|20|||
131678958|NCT00041067|474112256|FG000|Overall Study|Progression|19|||
131678959|NCT00041067|474112256|FG000|Overall Study|Patient refusal|12|||
131678960|NCT00041067|474112256|FG000|Overall Study|Other reasons|23|||
131678961|NCT00041067|474112256|FG000|Overall Study|Ineligible|2|||
131678962|NCT00778622|474112257|FG000|Overall Study|Adverse Event|5|||
131678963|NCT00778622|474112258|FG001|Overall Study|Adverse Event|4|||
131678964|NCT00778622|474112259|FG002|Overall Study|Adverse Event|7|||
131678965|NCT00778622|474112257|FG000|Overall Study|Withdrawal by Subject|4|||
131678966|NCT00778622|474112258|FG001|Overall Study|Withdrawal by Subject|5|||
131678967|NCT00778622|474112259|FG002|Overall Study|Withdrawal by Subject|5|||
131678968|NCT00778622|474112257|FG000|Overall Study|Lost to Follow-up|3|||
131678969|NCT00778622|474112258|FG001|Overall Study|Lost to Follow-up|3|||
131678970|NCT00778622|474112259|FG002|Overall Study|Lost to Follow-up|2|||
131678971|NCT00778622|474112257|FG000|Overall Study|Protocol Violation|0|||
131678972|NCT00778622|474112258|FG001|Overall Study|Protocol Violation|3|||
131678973|NCT00778622|474112259|FG002|Overall Study|Protocol Violation|0|||
131678974|NCT00778622|474112257|FG000|Overall Study|Lack of Efficacy|2|||
131678975|NCT00778622|474112258|FG001|Overall Study|Lack of Efficacy|0|||
131678976|NCT00778622|474112259|FG002|Overall Study|Lack of Efficacy|0|||
131678977|NCT00778622|474112257|FG000|Overall Study|immigration|1|||
131678978|NCT00778622|474112258|FG001|Overall Study|immigration|0|||
131678979|NCT00778622|474112259|FG002|Overall Study|immigration|0|||
131678980|NCT00778622|474112257|FG000|Overall Study|Other|1|||
131678981|NCT00778622|474112258|FG001|Overall Study|Other|0|||
131678982|NCT00778622|474112259|FG002|Overall Study|Other|1|||
131678983|NCT01251120|474112261|FG000|Overall Study|Lack of Efficacy|0|||
131678984|NCT01251120|474112262|FG001|Overall Study|Lack of Efficacy|1|||
131678985|NCT01822522|474112263|FG000|Overall Study|Adverse Event|1|||
131678986|NCT01822522|474112264|FG001|Overall Study|Adverse Event|1|||
131678987|NCT01822522|474112265|FG002|Overall Study|Adverse Event|1|||
131678988|NCT01822522|474112266|FG003|Overall Study|Adverse Event|0|||
131678989|NCT01822522|474112267|FG004|Overall Study|Adverse Event|0|||
131678990|NCT01822522|474112268|FG005|Overall Study|Adverse Event|1|||
131678991|NCT01822522|474112263|FG000|Overall Study|Death|3|||
131678992|NCT01822522|474112264|FG001|Overall Study|Death|0|||
131678993|NCT01822522|474112265|FG002|Overall Study|Death|2|||
131678994|NCT01822522|474112266|FG003|Overall Study|Death|0|||
131678995|NCT01822522|474112267|FG004|Overall Study|Death|0|||
131678996|NCT01822522|474112268|FG005|Overall Study|Death|0|||
131678997|NCT01822522|474112263|FG000|Overall Study|Lost to Follow-up|0|||
131678998|NCT01822522|474112264|FG001|Overall Study|Lost to Follow-up|0|||
131678999|NCT01822522|474112265|FG002|Overall Study|Lost to Follow-up|1|||
131679000|NCT01822522|474112266|FG003|Overall Study|Lost to Follow-up|1|||
131679001|NCT01822522|474112267|FG004|Overall Study|Lost to Follow-up|0|||
131679002|NCT01822522|474112268|FG005|Overall Study|Lost to Follow-up|1|||
131679003|NCT01822522|474112263|FG000|Overall Study|Withdrawal by Subject|0|||
131679004|NCT01822522|474112264|FG001|Overall Study|Withdrawal by Subject|0|||
131679005|NCT01822522|474112265|FG002|Overall Study|Withdrawal by Subject|0|||
131679006|NCT01822522|474112266|FG003|Overall Study|Withdrawal by Subject|1|||
131679007|NCT01822522|474112267|FG004|Overall Study|Withdrawal by Subject|0|||
131679008|NCT01822522|474112268|FG005|Overall Study|Withdrawal by Subject|0|||
131679009|NCT01822522|474112263|FG000|Overall Study|Lack of Efficacy|0|||
131679010|NCT01822522|474112264|FG001|Overall Study|Lack of Efficacy|0|||
131679011|NCT01822522|474112265|FG002|Overall Study|Lack of Efficacy|0|||
131679012|NCT01822522|474112266|FG003|Overall Study|Lack of Efficacy|0|||
131679013|NCT01822522|474112267|FG004|Overall Study|Lack of Efficacy|0|||
131679014|NCT01822522|474112268|FG005|Overall Study|Lack of Efficacy|2|||
131679015|NCT02558231|474112269|FG000|Overall Study|Death|4|||
131679016|NCT02558231|474112270|FG001|Overall Study|Death|12|||
131679017|NCT02558231|474112269|FG000|Overall Study|Lost to Follow-up|7|||
131679018|NCT02558231|474112270|FG001|Overall Study|Lost to Follow-up|4|||
131679019|NCT02558231|474112269|FG000|Overall Study|Withdrawal by Subject|7|||
131679020|NCT02558231|474112270|FG001|Overall Study|Withdrawal by Subject|4|||
131679021|NCT02558231|474112269|FG000|Overall Study|Physician Decision|7|||
131679022|NCT02558231|474112270|FG001|Overall Study|Physician Decision|5|||
131679023|NCT02558231|474112269|FG000|Overall Study|Sponsor Decision|0|||
131679024|NCT02558231|474112270|FG001|Overall Study|Sponsor Decision|1|||
131679025|NCT01006265|474112271|FG000|Overall Study|Lost to Follow-up|1|||
131679026|NCT01006265|474112272|FG001|Overall Study|Lost to Follow-up|0|||
131679027|NCT01006265|474112273|FG002|Overall Study|Lost to Follow-up|1|||
131679028|NCT01006265|474112274|FG003|Overall Study|Lost to Follow-up|0|||
131679029|NCT01006265|474112271|FG000|Overall Study|Withdrawal by Subject|4|||
131679030|NCT01006265|474112272|FG001|Overall Study|Withdrawal by Subject|7|||
131679031|NCT01006265|474112273|FG002|Overall Study|Withdrawal by Subject|5|||
131679032|NCT01006265|474112274|FG003|Overall Study|Withdrawal by Subject|5|||
131679033|NCT01006265|474112271|FG000|Overall Study|Administrative reason|1|||
131679034|NCT01006265|474112272|FG001|Overall Study|Administrative reason|2|||
131679035|NCT01006265|474112273|FG002|Overall Study|Administrative reason|3|||
131679036|NCT01006265|474112274|FG003|Overall Study|Administrative reason|0|||
131679037|NCT01840605|474112277|FG000|Overall Study|Adverse Event|0|||
131679038|NCT01840605|474112278|FG001|Overall Study|Adverse Event|1|||
131679039|NCT01840605|474112277|FG000|Overall Study|Physician Decision|2|||
131679040|NCT01840605|474112278|FG001|Overall Study|Physician Decision|1|||
131679041|NCT01351623|474112279|FG000|Overall Study|Protocol Violation|2|||
131679042|NCT01351623|474112279|FG000|Overall Study|Adverse Event|4|||
131679043|NCT01351623|474112279|FG000|Overall Study|Withdrawal by Subject|1|||
131679044|NCT01351623|474112279|FG000|Overall Study|Death|2|||
131679045|NCT04201821|474112280|FG000|Overall Study|Withdrawal by Subject|2|||
131679046|NCT01130974|474112281|FG000|Overall Study|Protocol Violation|10|||
131679047|NCT01130974|474112282|FG001|Overall Study|Protocol Violation|10|||
131679048|NCT01130974|474112281|FG000|Overall Study|Withdrawal by Subject|0|||
131679049|NCT01130974|474112282|FG001|Overall Study|Withdrawal by Subject|1|||
131679050|NCT01130974|474112281|FG000|Overall Study|Ineligibility criteria|5|||
131679051|NCT01130974|474112282|FG001|Overall Study|Ineligibility criteria|2|||
131679052|NCT00387764|474112283|FG000|Overall Study|Adverse Event|12|||
131679053|NCT00387764|474112283|FG000|Overall Study|Withdrawal by Subject|8|||
131679054|NCT00387764|474112283|FG000|Overall Study|Sponsor Terminated Study|1|||
131679055|NCT00387764|474112283|FG000|Overall Study|Physician Decision|1|||
131679056|NCT00387764|474112283|FG000|Overall Study|Other|2|||
131679057|NCT00387764|474112283|FG000|Overall Study|Death|7|||
131679058|NCT01184053|474112284|FG000|Overall Study|progression while on treatment|3|||
131679059|NCT03065023|474112286|FG000|Overall Study|Progressive Disease|0|||
131679060|NCT03065023|474112287|FG001|Overall Study|Progressive Disease|1|||
131679061|NCT03065023|474112288|FG002|Overall Study|Progressive Disease|0|||
131679062|NCT03065023|474112289|FG003|Overall Study|Progressive Disease|0|||
131679063|NCT03065023|474112290|FG004|Overall Study|Progressive Disease|0|||
131679064|NCT03065023|474112286|FG000|Overall Study|Death|2|||
131679065|NCT03065023|474112287|FG001|Overall Study|Death|0|||
131679066|NCT03065023|474112288|FG002|Overall Study|Death|1|||
131679067|NCT03065023|474112289|FG003|Overall Study|Death|1|||
131679068|NCT03065023|474112290|FG004|Overall Study|Death|0|||
131679069|NCT03065023|474112286|FG000|Overall Study|Lost to Follow-up|0|||
131679070|NCT03065023|474112287|FG001|Overall Study|Lost to Follow-up|1|||
131679071|NCT03065023|474112288|FG002|Overall Study|Lost to Follow-up|0|||
131679072|NCT03065023|474112289|FG003|Overall Study|Lost to Follow-up|0|||
131679073|NCT03065023|474112290|FG004|Overall Study|Lost to Follow-up|0|||
131679074|NCT03065023|474112286|FG000|Overall Study|Participant Decision|0|||
131679075|NCT03065023|474112287|FG001|Overall Study|Participant Decision|0|||
131679076|NCT03065023|474112288|FG002|Overall Study|Participant Decision|0|||
131679077|NCT03065023|474112289|FG003|Overall Study|Participant Decision|1|||
131679078|NCT03065023|474112290|FG004|Overall Study|Participant Decision|0|||
131679079|NCT03065023|474112286|FG000|Overall Study|Withdrawal by Subject|0|||
131679080|NCT03065023|474112287|FG001|Overall Study|Withdrawal by Subject|0|||
131679081|NCT03065023|474112288|FG002|Overall Study|Withdrawal by Subject|0|||
131679082|NCT03065023|474112289|FG003|Overall Study|Withdrawal by Subject|1|||
131679083|NCT03065023|474112290|FG004|Overall Study|Withdrawal by Subject|0|||
131679084|NCT01102803|474112291|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
131679085|NCT01102803|474112292|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
131679086|NCT01102803|474112291|FG000|Post to Follow-Up|Lost to Follow-up|1|||
131679087|NCT01102803|474112292|FG001|Post to Follow-Up|Lost to Follow-up|3|||
131679088|NCT04029961|474112293|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
131679089|NCT04029961|474112294|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
131679090|NCT04029961|474112293|FG000|Overall Study|Change in Treatment Course|0|||
131679091|NCT04029961|474112294|FG001|Overall Study|Change in Treatment Course|1|||
131679092|NCT03427125|474112295|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
131679093|NCT03427125|474112296|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
131679094|NCT03427125|474112297|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
131679095|NCT02684279|474112298|FG000|Overall Study|Adverse Event|87|||
131679096|NCT02684279|474112298|FG000|Overall Study|Lack of Efficacy|4|||
131679097|NCT02684279|474112298|FG000|Overall Study|Lost to Follow-up|61|||
131679098|NCT02684279|474112298|FG000|Overall Study|Protocol Violation|6|||
131679099|NCT02684279|474112298|FG000|Overall Study|Pregnancy|8|||
131679100|NCT02684279|474112298|FG000|Overall Study|Withdrawal by Subject|92|||
131679101|NCT02684279|474112298|FG000|Overall Study|non-compliance with study drug|9|||
131679102|NCT02684279|474112298|FG000|Overall Study|non compliance with study visits|2|||
131679103|NCT02684279|474112298|FG000|Overall Study|subject to have surgery|1|||
131679104|NCT02684279|474112298|FG000|Overall Study|family emergency|1|||
131679105|NCT02684279|474112298|FG000|Overall Study|Site closures|7|||
131679106|NCT02684279|474112298|FG000|Overall Study|Physician Decision|1|||
131679107|NCT05975840|474112299|FG000|Overall Study|Other|1|||
131679108|NCT05975840|474112300|FG001|Overall Study|Other|0|||
131679109|NCT05975840|474112301|FG002|Overall Study|Other|0|||
131679110|NCT05975840|474112302|FG003|Overall Study|Other|0|||
131679111|NCT05975840|474112303|FG004|Overall Study|Other|1|||
131679112|NCT05975840|474112304|FG005|Overall Study|Other|0|||
131679113|NCT05975840|474112305|FG006|Overall Study|Other|0|||
131679114|NCT05975840|474112306|FG007|Overall Study|Other|0|||
131679115|NCT05975840|474112299|FG000|Overall Study|Lost to Follow-up|3|||
131679116|NCT05975840|474112300|FG001|Overall Study|Lost to Follow-up|6|||
131679117|NCT05975840|474112301|FG002|Overall Study|Lost to Follow-up|3|||
131679118|NCT05975840|474112302|FG003|Overall Study|Lost to Follow-up|1|||
131679119|NCT05975840|474112303|FG004|Overall Study|Lost to Follow-up|4|||
131679120|NCT05975840|474112304|FG005|Overall Study|Lost to Follow-up|1|||
131679121|NCT05975840|474112305|FG006|Overall Study|Lost to Follow-up|2|||
131679122|NCT05975840|474112306|FG007|Overall Study|Lost to Follow-up|4|||
131679123|NCT05975840|474112299|FG000|Overall Study|Migrated/moved from the study area|1|||
131679124|NCT05975840|474112300|FG001|Overall Study|Migrated/moved from the study area|0|||
131679125|NCT05975840|474112301|FG002|Overall Study|Migrated/moved from the study area|0|||
131679126|NCT05975840|474112302|FG003|Overall Study|Migrated/moved from the study area|0|||
131679127|NCT05975840|474112303|FG004|Overall Study|Migrated/moved from the study area|0|||
131679128|NCT05975840|474112304|FG005|Overall Study|Migrated/moved from the study area|0|||
131679129|NCT05975840|474112305|FG006|Overall Study|Migrated/moved from the study area|0|||
131679130|NCT05975840|474112306|FG007|Overall Study|Migrated/moved from the study area|0|||
131679131|NCT05975840|474112299|FG000|Overall Study|Withdrawal by Subject|0|||
131679132|NCT05975840|474112300|FG001|Overall Study|Withdrawal by Subject|5|||
131679133|NCT05975840|474112301|FG002|Overall Study|Withdrawal by Subject|2|||
131679134|NCT05975840|474112302|FG003|Overall Study|Withdrawal by Subject|2|||
131679135|NCT05975840|474112303|FG004|Overall Study|Withdrawal by Subject|0|||
131679136|NCT05975840|474112304|FG005|Overall Study|Withdrawal by Subject|2|||
131679137|NCT05975840|474112305|FG006|Overall Study|Withdrawal by Subject|2|||
131679138|NCT05975840|474112306|FG007|Overall Study|Withdrawal by Subject|1|||
131679139|NCT05975840|474112299|FG000|Overall Study|Protocol Violation|0|||
131679140|NCT05975840|474112300|FG001|Overall Study|Protocol Violation|1|||
131679141|NCT05975840|474112301|FG002|Overall Study|Protocol Violation|0|||
131679142|NCT05975840|474112302|FG003|Overall Study|Protocol Violation|0|||
131679143|NCT05975840|474112303|FG004|Overall Study|Protocol Violation|0|||
131679144|NCT05975840|474112304|FG005|Overall Study|Protocol Violation|0|||
131679145|NCT05975840|474112305|FG006|Overall Study|Protocol Violation|0|||
131679146|NCT05975840|474112306|FG007|Overall Study|Protocol Violation|0|||
131679147|NCT05975840|474112299|FG000|Overall Study|Adverse Event|0|||
131679148|NCT05975840|474112300|FG001|Overall Study|Adverse Event|0|||
131679149|NCT05975840|474112301|FG002|Overall Study|Adverse Event|0|||
131679150|NCT05975840|474112302|FG003|Overall Study|Adverse Event|1|||
131679151|NCT05975840|474112303|FG004|Overall Study|Adverse Event|0|||
131679152|NCT05975840|474112304|FG005|Overall Study|Adverse Event|0|||
131679153|NCT05975840|474112305|FG006|Overall Study|Adverse Event|0|||
131679154|NCT05975840|474112306|FG007|Overall Study|Adverse Event|0|||
131679155|NCT05975840|474112299|FG000|Overall Study|Death|0|||
131679156|NCT05975840|474112300|FG001|Overall Study|Death|1|||
131679157|NCT05975840|474112301|FG002|Overall Study|Death|0|||
131679158|NCT05975840|474112302|FG003|Overall Study|Death|0|||
131679159|NCT05975840|474112303|FG004|Overall Study|Death|0|||
131679160|NCT05975840|474112304|FG005|Overall Study|Death|0|||
131679161|NCT05975840|474112305|FG006|Overall Study|Death|0|||
131679162|NCT05975840|474112306|FG007|Overall Study|Death|1|||
131679163|NCT04014361|474112309|FG000|Period 2|Physician Decision|0|||
131679164|NCT04014361|474112310|FG001|Period 2|Physician Decision|0|||
131679165|NCT04014361|474112311|FG002|Period 2|Physician Decision|0|||
131679166|NCT04014361|474112312|FG003|Period 2|Physician Decision|1|||
131679167|NCT04014361|474112313|FG004|Period 2|Physician Decision|0|||
131679168|NCT04014361|474112314|FG005|Period 2|Physician Decision|0|||
131679169|NCT04014361|474112315|FG006|Period 2|Physician Decision|0|||
131679170|NCT04014361|474112316|FG007|Period 2|Physician Decision|0|||
131679171|NCT02593786|474112318|FG000|Overall Study|Disease progression|12|||
131679172|NCT02593786|474112319|FG001|Overall Study|Disease progression|16|||
131679173|NCT02593786|474112320|FG002|Overall Study|Disease progression|10|||
131679174|NCT02593786|474112321|FG003|Overall Study|Disease progression|7|||
131679175|NCT02593786|474112318|FG000|Overall Study|Study drug toxicity|1|||
131679176|NCT02593786|474112319|FG001|Overall Study|Study drug toxicity|0|||
131679177|NCT02593786|474112320|FG002|Overall Study|Study drug toxicity|0|||
131679178|NCT02593786|474112321|FG003|Overall Study|Study drug toxicity|0|||
131679179|NCT02593786|474112318|FG000|Overall Study|Adverse event unrelated to study drug|1|||
131679180|NCT02593786|474112319|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131679181|NCT02593786|474112320|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131679182|NCT02593786|474112321|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131679183|NCT02593786|474112318|FG000|Overall Study|Participant request to discontinue study therapy|0|||
131679184|NCT02593786|474112319|FG001|Overall Study|Participant request to discontinue study therapy|2|||
131679185|NCT02593786|474112320|FG002|Overall Study|Participant request to discontinue study therapy|0|||
131679186|NCT02593786|474112321|FG003|Overall Study|Participant request to discontinue study therapy|0|||
131679187|NCT02593786|474112318|FG000|Overall Study|Other reasons|1|||
131679188|NCT02593786|474112319|FG001|Overall Study|Other reasons|1|||
131679189|NCT02593786|474112320|FG002|Overall Study|Other reasons|0|||
131679190|NCT02593786|474112321|FG003|Overall Study|Other reasons|5|||
131679191|NCT01130051|474112322|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
131679192|NCT01130051|474112323|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
131679193|NCT01130051|474112322|FG000|Washout Period of 14 Days|Protocol Violation|1|||
131679194|NCT01130051|474112323|FG001|Washout Period of 14 Days|Protocol Violation|1|||
131679195|NCT04252287|474112327|FG000|Overall Study|Death|5|||
131679196|NCT04252287|474112328|FG001|Overall Study|Death|3|||
131679197|NCT04252287|474112327|FG000|Overall Study|Lost to Follow-up|4|||
131679198|NCT04252287|474112328|FG001|Overall Study|Lost to Follow-up|6|||
131679199|NCT04252287|474112327|FG000|Overall Study|Withdrawal by Subject|19|||
131679200|NCT04252287|474112328|FG001|Overall Study|Withdrawal by Subject|16|||
131679201|NCT04252287|474112327|FG000|Overall Study|Protocol Violation|3|||
131679202|NCT04252287|474112328|FG001|Overall Study|Protocol Violation|4|||
131679203|NCT00835120|474112334|FG000|Overall Study|Lack of Efficacy|1|||
131679204|NCT00835120|474112334|FG000|Overall Study|Lost to Follow-up|3|||
131679205|NCT00835120|474112334|FG000|Overall Study|Adverse Event|2|||
131679206|NCT00835120|474112334|FG000|Overall Study|Withdrawal by Subject|2|||
131679207|NCT01298518|474112336|FG000|Overall Study|Withdrawal by Subject|0|||
131679208|NCT01298518|474112337|FG001|Overall Study|Withdrawal by Subject|0|||
131679209|NCT01298518|474112338|FG002|Overall Study|Withdrawal by Subject|1|||
131679210|NCT02273726|474112339|FG000|Overall Study|Death|70|||
131679211|NCT02273726|474112340|FG001|Overall Study|Death|62|||
131679212|NCT02273726|474112339|FG000|Overall Study|Withdrawal by Subject|41|||
131679213|NCT02273726|474112340|FG001|Overall Study|Withdrawal by Subject|29|||
131679214|NCT02273726|474112339|FG000|Overall Study|Kidney transplant|31|||
131679215|NCT02273726|474112340|FG001|Overall Study|Kidney transplant|39|||
131679216|NCT02273726|474112339|FG000|Overall Study|Physician Decision|30|||
131679217|NCT02273726|474112340|FG001|Overall Study|Physician Decision|15|||
131679218|NCT02273726|474112339|FG000|Overall Study|Adverse Event|27|||
131679219|NCT02273726|474112340|FG001|Overall Study|Adverse Event|9|||
131679220|NCT02273726|474112339|FG000|Overall Study|Lost to Follow-up|6|||
131679221|NCT02273726|474112340|FG001|Overall Study|Lost to Follow-up|3|||
131679222|NCT02273726|474112339|FG000|Overall Study|Lack of Efficacy|6|||
131679223|NCT02273726|474112340|FG001|Overall Study|Lack of Efficacy|1|||
131679224|NCT02273726|474112339|FG000|Overall Study|Protocol Violation|4|||
131679225|NCT02273726|474112340|FG001|Overall Study|Protocol Violation|0|||
131679226|NCT02273726|474112339|FG000|Overall Study|Other than specified|28|||
131679227|NCT02273726|474112340|FG001|Overall Study|Other than specified|30|||
131679228|NCT03610165|474112341|FG000|Overall Study|Device didn't work|0|||
131679229|NCT03610165|474112342|FG001|Overall Study|Device didn't work|1|||
131679230|NCT00671554|474112343|FG000|Overall Study|Disease progression|3|||
131679231|NCT02129205|474112344|FG000|Overall Study|Withdrawal by Subject|0|||
131679232|NCT02129205|474112345|FG001|Overall Study|Withdrawal by Subject|0|||
131679233|NCT02129205|474112346|FG002|Overall Study|Withdrawal by Subject|0|||
131679234|NCT02129205|474112347|FG003|Overall Study|Withdrawal by Subject|0|||
131679235|NCT02129205|474112348|FG004|Overall Study|Withdrawal by Subject|1|||
131679236|NCT02129205|474112349|FG005|Overall Study|Withdrawal by Subject|1|||
131679237|NCT02129205|474112350|FG006|Overall Study|Withdrawal by Subject|1|||
131679238|NCT02129205|474112351|FG007|Overall Study|Withdrawal by Subject|0|||
131679239|NCT02129205|474112352|FG008|Overall Study|Withdrawal by Subject|1|||
131679240|NCT02129205|474112353|FG009|Overall Study|Withdrawal by Subject|0|||
131679241|NCT02129205|474112344|FG000|Overall Study|Other|1|||
131679242|NCT02129205|474112345|FG001|Overall Study|Other|0|||
131679243|NCT02129205|474112346|FG002|Overall Study|Other|0|||
131679244|NCT02129205|474112347|FG003|Overall Study|Other|0|||
131679245|NCT02129205|474112348|FG004|Overall Study|Other|2|||
131679246|NCT02129205|474112349|FG005|Overall Study|Other|3|||
131679247|NCT02129205|474112350|FG006|Overall Study|Other|3|||
131679248|NCT02129205|474112351|FG007|Overall Study|Other|2|||
131679249|NCT02129205|474112352|FG008|Overall Study|Other|1|||
131679250|NCT02129205|474112353|FG009|Overall Study|Other|0|||
131679251|NCT02877927|474112354|FG000|Overall Study|Adverse Event|1|||
131679252|NCT02877927|474112355|FG001|Overall Study|Adverse Event|0|||
131679253|NCT02877927|474112354|FG000|Overall Study|Lost to Follow-up|37|||
131679254|NCT02877927|474112355|FG001|Overall Study|Lost to Follow-up|38|||
131679255|NCT02877927|474112354|FG000|Overall Study|Withdrawal by Subject|11|||
131679256|NCT02877927|474112355|FG001|Overall Study|Withdrawal by Subject|12|||
131679257|NCT02877927|474112354|FG000|Overall Study|Physician Decision|0|||
131679258|NCT02877927|474112355|FG001|Overall Study|Physician Decision|1|||
131679259|NCT02877927|474112354|FG000|Overall Study|Missed EOT/PTE Visit|5|||
131679260|NCT02877927|474112355|FG001|Overall Study|Missed EOT/PTE Visit|6|||
131679261|NCT01810016|474112356|FG000|Overall Study|Progressive disease|1|||
131679262|NCT01810016|474112357|FG001|Overall Study|Progressive disease|1|||
131679263|NCT01810016|474112358|FG002|Overall Study|Progressive disease|0|||
131679264|NCT01810016|474112356|FG000|Overall Study|Death|0|||
131679265|NCT01810016|474112357|FG001|Overall Study|Death|0|||
131679266|NCT01810016|474112358|FG002|Overall Study|Death|1|||
131679267|NCT00708175|474112359|FG000|Overall Study|Adverse Event|4|||
131679268|NCT00708175|474112360|FG001|Overall Study|Adverse Event|5|||
131679269|NCT00708175|474112359|FG000|Overall Study|Protocol Violation|2|||
131679270|NCT00708175|474112360|FG001|Overall Study|Protocol Violation|3|||
131679271|NCT00708175|474112359|FG000|Overall Study|Lost to Follow-up|5|||
131679272|NCT00708175|474112360|FG001|Overall Study|Lost to Follow-up|3|||
131679273|NCT00708175|474112359|FG000|Overall Study|Withdrawal by Subject|5|||
131679274|NCT00708175|474112360|FG001|Overall Study|Withdrawal by Subject|7|||
131679275|NCT00708175|474112359|FG000|Overall Study|BMD loss >7%|2|||
131679276|NCT00708175|474112360|FG001|Overall Study|BMD loss >7%|3|||
131679277|NCT04435782|474112368|FG000|Overall Study|Study terminated by sponsor|4|||
131679278|NCT06950879|474112370|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
131679279|NCT04752475|474114264|FG000|Overall Study|Withdrawal by Subject|1|||
131679280|NCT04752475|474114265|FG001|Overall Study|Withdrawal by Subject|1|||
131679281|NCT02113579|474114273|FG000|Overall Study|Adverse Event|1|||
131679282|NCT02113579|474114274|FG001|Overall Study|Adverse Event|0|||
131679283|NCT02113579|474114273|FG000|Overall Study|Withdrawal by Subject|3|||
131679284|NCT02113579|474114274|FG001|Overall Study|Withdrawal by Subject|2|||
131679285|NCT02113579|474114273|FG000|Overall Study|Lost to Follow-up|6|||
131679286|NCT02113579|474114274|FG001|Overall Study|Lost to Follow-up|2|||
131679287|NCT00594516|474114280|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
131679288|NCT00594516|474114281|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
131679289|NCT00594516|474114282|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
131679290|NCT00594516|474114280|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
131679291|NCT00594516|474114281|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
131679292|NCT00594516|474114282|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
131679293|NCT00594516|474114280|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
131555491|NCT03101241|473658222|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
131555492|NCT04498247|473658223|FG000|Overall Study|Lost to Follow-up|0|||
131555493|NCT04498247|473658224|FG001|Overall Study|Lost to Follow-up|0|||
131555494|NCT04498247|473658225|FG002|Overall Study|Lost to Follow-up|0|||
131555495|NCT04498247|473658226|FG003|Overall Study|Lost to Follow-up|1|||
131555496|NCT04498247|473658227|FG004|Overall Study|Lost to Follow-up|0|||
131555497|NCT04498247|473658228|FG005|Overall Study|Lost to Follow-up|0|||
131555498|NCT04498247|473658229|FG006|Overall Study|Lost to Follow-up|0|||
131555499|NCT04498247|473658230|FG007|Overall Study|Lost to Follow-up|0|||
131555500|NCT04498247|473658223|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
131555501|NCT04498247|473658224|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555502|NCT04498247|473658225|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555503|NCT04498247|473658226|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555504|NCT04498247|473658227|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555505|NCT04498247|473658228|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555506|NCT04498247|473658229|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555507|NCT04498247|473658230|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
131555508|NCT04498247|473658223|FG000|Overall Study|Withdrawal by Subject|0|||
131555509|NCT04498247|473658224|FG001|Overall Study|Withdrawal by Subject|8|||
131555510|NCT04498247|473658225|FG002|Overall Study|Withdrawal by Subject|0|||
131555511|NCT04498247|473658226|FG003|Overall Study|Withdrawal by Subject|7|||
131555512|NCT04498247|473658227|FG004|Overall Study|Withdrawal by Subject|0|||
131555513|NCT04498247|473658228|FG005|Overall Study|Withdrawal by Subject|0|||
131555514|NCT04498247|473658229|FG006|Overall Study|Withdrawal by Subject|1|||
131555515|NCT04498247|473658230|FG007|Overall Study|Withdrawal by Subject|0|||
131555516|NCT04498247|473658223|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
131555517|NCT04498247|473658224|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
131555518|NCT04498247|473658225|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
131555519|NCT04498247|473658226|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
131555520|NCT04498247|473658227|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
131555521|NCT04498247|473658228|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
131555522|NCT04498247|473658229|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
131555523|NCT04498247|473658230|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
131555524|NCT03469349|473658231|FG000|Overall Study|Withdrawal by Subject|1|||
131555525|NCT03469349|473658232|FG001|Overall Study|Withdrawal by Subject|3|||
131555526|NCT03469349|473658231|FG000|Overall Study|Progressive Disease|0|||
131555527|NCT03469349|473658232|FG001|Overall Study|Progressive Disease|1|||
131555528|NCT03469349|473658231|FG000|Overall Study|Lost to Follow-up|2|||
131555529|NCT03469349|473658232|FG001|Overall Study|Lost to Follow-up|2|||
131555530|NCT03469349|473658231|FG000|Overall Study|Adverse Event|2|||
131555531|NCT03469349|473658232|FG001|Overall Study|Adverse Event|4|||
131555532|NCT00879996|473658234|FG000|Overall Study|Lost to Follow-up|7|||
131555533|NCT00879996|473658235|FG001|Overall Study|Lost to Follow-up|6|||
131555534|NCT00879996|473658234|FG000|Overall Study|non-compliance|6|||
131555535|NCT00879996|473658235|FG001|Overall Study|non-compliance|4|||
131555536|NCT00879996|473658234|FG000|Overall Study|Physician Decision|1|||
131555537|NCT00879996|473658235|FG001|Overall Study|Physician Decision|2|||
131555538|NCT00879996|473658234|FG000|Overall Study|psychiatric problem|0|||
131555539|NCT00879996|473658235|FG001|Overall Study|psychiatric problem|1|||
131555540|NCT00879996|473658234|FG000|Overall Study|put on parole|1|||
131555541|NCT00879996|473658235|FG001|Overall Study|put on parole|0|||
131555542|NCT02912468|473658240|FG000|Overall Study|Adverse Event|3|||
131555543|NCT02912468|473658241|FG001|Overall Study|Adverse Event|2|||
131555544|NCT02912468|473658240|FG000|Overall Study|Withdrawal by Subject|6|||
131555545|NCT02912468|473658241|FG001|Overall Study|Withdrawal by Subject|2|||
131555546|NCT02912468|473658240|FG000|Overall Study|Randomized and not treated|0|||
131555547|NCT02912468|473658241|FG001|Overall Study|Randomized and not treated|1|||
131555548|NCT02597933|473658243|FG000|Overall Study|Withdrawal by Subject|7|||
131555549|NCT02597933|473658244|FG001|Overall Study|Withdrawal by Subject|5|||
131555550|NCT02597933|473658243|FG000|Overall Study|Protocol Violation|2|||
131555551|NCT02597933|473658244|FG001|Overall Study|Protocol Violation|2|||
131555552|NCT02597933|473658243|FG000|Overall Study|Adverse Event|20|||
131555553|NCT02597933|473658244|FG001|Overall Study|Adverse Event|28|||
131555554|NCT02597933|473658243|FG000|Overall Study|Not treated|2|||
131555555|NCT02597933|473658244|FG001|Overall Study|Not treated|2|||
131555556|NCT02597933|473658243|FG000|Overall Study|Other than stated above|7|||
131555557|NCT02597933|473658244|FG001|Overall Study|Other than stated above|14|||
131679294|NCT00594516|474114281|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
131679295|NCT00594516|474114282|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
131679296|NCT00594516|474114280|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
131679297|NCT00594516|474114281|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
131679298|NCT00594516|474114282|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
131679299|NCT00594516|474114280|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
131679300|NCT00594516|474114281|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
131679301|NCT00594516|474114282|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
131679302|NCT00594516|474114280|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
131679303|NCT00594516|474114281|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
131679304|NCT00594516|474114282|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
131679305|NCT00594516|474114280|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
131679306|NCT00594516|474114281|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
131679307|NCT00594516|474114282|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
131679308|NCT00594516|474114280|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
131679309|NCT00594516|474114281|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
131679310|NCT00594516|474114282|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
131679311|NCT00594516|474114280|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
131679312|NCT00594516|474114281|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
131679313|NCT00594516|474114282|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
131679314|NCT02462928|474114283|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
131679315|NCT02462928|474114284|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
131679316|NCT02462928|474114285|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
131679317|NCT02462928|474114283|FG000|Overall Study|Adverse Event|47|||
131679318|NCT02462928|474114284|FG001|Overall Study|Adverse Event|51|||
131679319|NCT02462928|474114285|FG002|Overall Study|Adverse Event|25|||
131679320|NCT02462928|474114283|FG000|Overall Study|Lack of Efficacy|3|||
131679321|NCT02462928|474114284|FG001|Overall Study|Lack of Efficacy|8|||
131679322|NCT02462928|474114285|FG002|Overall Study|Lack of Efficacy|3|||
131679323|NCT02462928|474114283|FG000|Overall Study|Lost to Follow-up|4|||
131679324|NCT02462928|474114284|FG001|Overall Study|Lost to Follow-up|4|||
131679325|NCT02462928|474114285|FG002|Overall Study|Lost to Follow-up|1|||
131679326|NCT02462928|474114283|FG000|Overall Study|Withdrawal by Patient|31|||
131679327|NCT02462928|474114284|FG001|Overall Study|Withdrawal by Patient|21|||
131679328|NCT02462928|474114285|FG002|Overall Study|Withdrawal by Patient|21|||
131679329|NCT02462928|474114283|FG000|Overall Study|Protocol Violation|0|||
131679330|NCT02462928|474114284|FG001|Overall Study|Protocol Violation|1|||
131679331|NCT02462928|474114285|FG002|Overall Study|Protocol Violation|0|||
131679332|NCT02462928|474114283|FG000|Overall Study|Reason not Specified|4|||
131679333|NCT02462928|474114284|FG001|Overall Study|Reason not Specified|6|||
131555558|NCT01320735|473658247|FG000|Overall Study|Adverse Event|3|||
131679334|NCT02462928|474114285|FG002|Overall Study|Reason not Specified|5|||
131679335|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
131679336|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
131679337|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
131679338|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
131679339|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
131679340|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
131679341|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
131679342|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
131679343|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
131679344|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
131679345|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
131679346|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
131679347|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
131679348|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
131679349|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
131679350|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
131679351|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
131679352|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
131679353|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Early termination|0|||
131679354|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Early termination|0|||
131679355|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Early termination|34|||
131679356|NCT01493557|474114286|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
131679357|NCT01493557|474114287|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
131679358|NCT01493557|474114288|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
131679359|NCT01493557|474114286|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
131679360|NCT01493557|474114287|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
131679361|NCT01493557|474114288|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
131679362|NCT01493557|474114286|FG000|Randomized to Management Strategies|Other adverse event|8|||
131679363|NCT01493557|474114287|FG001|Randomized to Management Strategies|Other adverse event|5|||
131679364|NCT01493557|474114288|FG002|Randomized to Management Strategies|Other adverse event|0|||
131679365|NCT01493557|474114286|FG000|Randomized to Management Strategies|Protocol Violation|3|||
131679366|NCT01493557|474114287|FG001|Randomized to Management Strategies|Protocol Violation|0|||
131679367|NCT01493557|474114288|FG002|Randomized to Management Strategies|Protocol Violation|0|||
131679368|NCT01493557|474114286|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
131679369|NCT01493557|474114287|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
131679370|NCT01493557|474114288|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
131679371|NCT01493557|474114286|FG000|Randomized to Management Strategies|Other than stated above|1|||
131679372|NCT01493557|474114287|FG001|Randomized to Management Strategies|Other than stated above|3|||
131679373|NCT01493557|474114288|FG002|Randomized to Management Strategies|Other than stated above|0|||
131679374|NCT01493557|474114286|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
131679375|NCT01493557|474114287|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
131679376|NCT01493557|474114288|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
131679377|NCT01493557|474114286|FG000|Adding the Second Strategy|Other adverse event|1|||
131679378|NCT01493557|474114287|FG001|Adding the Second Strategy|Other adverse event|2|||
131679379|NCT01493557|474114288|FG002|Adding the Second Strategy|Other adverse event|0|||
131679380|NCT01493557|474114286|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
131679381|NCT01493557|474114287|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
131679382|NCT01493557|474114288|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
131679383|NCT02217436|474114289|FG000|Overall Study|Protocol Violation|1|||
131679384|NCT02217436|474114290|FG001|Overall Study|Protocol Violation|1|||
131679385|NCT02217436|474114289|FG000|Overall Study|Incomplete data|0|||
131679386|NCT02217436|474114290|FG001|Overall Study|Incomplete data|1|||
131679387|NCT01890148|474114305|FG000|Overall Study|Adverse Event|1|||
131679388|NCT01016964|474114306|FG000|Overall Study|Lost to Follow-up|3|||
131679389|NCT01016964|474114307|FG001|Overall Study|Lost to Follow-up|3|||
131679390|NCT01678209|474114308|FG000|Overall Study|could not scan twice|1|||
131555559|NCT01320735|473658247|FG000|Overall Study|Withdrawal by Subject|3|||
131679391|NCT01678209|474114309|FG001|Overall Study|could not scan twice|1|||
131679392|NCT01678209|474114310|FG002|Overall Study|could not scan twice|1|||
131679393|NCT01678209|474114308|FG000|Overall Study|scheduling conflicts|0|||
131679394|NCT01678209|474114309|FG001|Overall Study|scheduling conflicts|0|||
131679395|NCT01678209|474114310|FG002|Overall Study|scheduling conflicts|1|||
131679396|NCT01678209|474114308|FG000|Overall Study|screen fail|16|||
131679397|NCT01678209|474114309|FG001|Overall Study|screen fail|17|||
131679398|NCT01678209|474114310|FG002|Overall Study|screen fail|16|||
131679399|NCT00702845|474114311|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
131679400|NCT00702845|474114312|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
131679401|NCT00702845|474114311|FG000|Overall Study|Too high ovarian response|5|||
131679402|NCT00702845|474114312|FG001|Overall Study|Too high ovarian response|1|||
131679403|NCT00702845|474114311|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
131679404|NCT00702845|474114312|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
131679405|NCT00702845|474114311|FG000|Overall Study|Insufficient ovarian response|1|||
131679406|NCT00702845|474114312|FG001|Overall Study|Insufficient ovarian response|0|||
131679407|NCT00702845|474114311|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
131679408|NCT00702845|474114312|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
131679409|NCT00702845|474114311|FG000|Overall Study|No or abnormal fertilization|4|||
131679410|NCT00702845|474114312|FG001|Overall Study|No or abnormal fertilization|2|||
131679411|NCT00702845|474114311|FG000|Overall Study|Patient's decision|2|||
131679412|NCT00702845|474114312|FG001|Overall Study|Patient's decision|1|||
131679413|NCT00702845|474114311|FG000|Overall Study|Not randomized|0|||
131679414|NCT00702845|474114312|FG001|Overall Study|Not randomized|1|||
131679415|NCT00928564|474114316|FG000|Overall Study|Lost to Follow-up|6|||
131679416|NCT00928564|474114317|FG001|Overall Study|Lost to Follow-up|0|||
131679417|NCT02973425|474114319|FG000|Overall Study|Lost to Follow-up|49|||
131679418|NCT02973425|474114320|FG001|Overall Study|Lost to Follow-up|53|||
131679419|NCT03876171|474114321|FG000|Overall Study|Withdrawal by Subject|3|||
131679420|NCT03876171|474114322|FG001|Overall Study|Withdrawal by Subject|3|||
131679421|NCT03876171|474114321|FG000|Overall Study|Re-arrest|0|||
131679422|NCT03876171|474114322|FG001|Overall Study|Re-arrest|4|||
131679423|NCT03503513|474114327|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
131679424|NCT03503513|474114327|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
131679425|NCT03503513|474114327|FG000|Overall Study|Physician Decision|3|||
131679426|NCT03503513|474114327|FG000|Overall Study|Withdrawal by Subject|2|||
131679427|NCT03503513|474114327|FG000|Overall Study|Lost to Follow-up|1|||
131679428|NCT00929656|474114328|FG000|Overall Study|Lost to Follow-up|0|||
131679429|NCT00929656|474114329|FG001|Overall Study|Lost to Follow-up|1|||
131679430|NCT00607880|474114330|FG000|Overall Study|Unable to place port due to occlusion|1|||
131679431|NCT00607880|474114331|FG001|Overall Study|Unable to place port due to occlusion|0|||
131679432|NCT01170039|474114332|FG000|Overall Study|Withdrawal by Subject|5|||
131679433|NCT01170039|474114333|FG001|Overall Study|Withdrawal by Subject|3|||
131679434|NCT01170039|474114332|FG000|Overall Study|Lack of funding, drug not available|3|||
131679435|NCT01170039|474114333|FG001|Overall Study|Lack of funding, drug not available|3|||
131679436|NCT00908583|474114334|FG000|Phase 1|Withdrawal by Subject|1|||
131679437|NCT00908583|474114334|FG000|Phase 1|Adverse Event|4|||
131679438|NCT00908583|474114334|FG000|Phase 2|Physician Decision|1|||
131679439|NCT00908583|474114334|FG000|Phase 2|Adverse Event|1|||
131679440|NCT00908583|474114334|FG000|Phase 3|Adverse Event|2|||
131679441|NCT00908583|474114334|FG000|Phase 4|Adverse Event|1|||
131679442|NCT00908583|474114334|FG000|Phase 4|Physician Decision|1|||
131679443|NCT00908583|474114334|FG000|Phase 5|Adverse Event|3|||
131679444|NCT00993954|474114335|FG000|Overall Study|Protocol Violation|21|||
131679445|NCT00993954|474114336|FG001|Overall Study|Protocol Violation|2|||
131679446|NCT00860951|474114337|FG000|Overall Study|Withdrawal by Subject|2|||
131679447|NCT00860951|474114337|FG000|Overall Study|Lost to Follow-up|5|||
131679448|NCT00727649|474114338|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
131679449|NCT00727649|474114339|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
131679450|NCT00727649|474114338|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
131679451|NCT00727649|474114339|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
131679452|NCT00727649|474114338|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
131679453|NCT00727649|474114339|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
131679454|NCT00727649|474114338|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
131679455|NCT00727649|474114339|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
131679456|NCT00727649|474114338|FG000|Second Intervention (4-weeks)|Death|1|||
131679457|NCT00727649|474114339|FG001|Second Intervention (4-weeks)|Death|0|||
131679458|NCT00727649|474114338|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
131679459|NCT00727649|474114339|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
131679460|NCT00727649|474114338|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
131679461|NCT00727649|474114339|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
131679462|NCT01667081|474114341|FG000|Overall Study|Death|43|||
131679463|NCT01667081|474114342|FG001|Overall Study|Death|3|||
131679464|NCT01667081|474114341|FG000|Overall Study|Lost to Follow-up|99|||
131679465|NCT01667081|474114342|FG001|Overall Study|Lost to Follow-up|48|||
131679466|NCT01667081|474114341|FG000|Overall Study|Physician Decision|16|||
131679467|NCT01667081|474114342|FG001|Overall Study|Physician Decision|2|||
131679468|NCT01667081|474114341|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
131679469|NCT01667081|474114342|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
131679470|NCT01667081|474114341|FG000|Overall Study|Withdrawal by Subject|90|||
131679471|NCT01667081|474114342|FG001|Overall Study|Withdrawal by Subject|35|||
131679472|NCT03034460|474114343|FG000|Overall Study|Adverse Event|0|||
131679473|NCT03034460|474114344|FG001|Overall Study|Adverse Event|1|||
131679474|NCT03034460|474114343|FG000|Overall Study|Withdrawal by Subject|2|||
131679475|NCT03034460|474114344|FG001|Overall Study|Withdrawal by Subject|2|||
131679476|NCT03034460|474114343|FG000|Overall Study|Personal Reasons|1|||
131679477|NCT03034460|474114344|FG001|Overall Study|Personal Reasons|0|||
131679478|NCT01798992|474114345|FG000|Overall Study|Administrative withdrawal|0|||
131679479|NCT01798992|474114346|FG001|Overall Study|Administrative withdrawal|1|||
131679480|NCT01798992|474114347|FG002|Overall Study|Administrative withdrawal|0|||
131679481|NCT01798992|474114348|FG003|Overall Study|Administrative withdrawal|1|||
131679482|NCT01798992|474114345|FG000|Overall Study|Lost to Follow-up|0|||
131679483|NCT01798992|474114346|FG001|Overall Study|Lost to Follow-up|1|||
131679484|NCT01798992|474114347|FG002|Overall Study|Lost to Follow-up|1|||
131679485|NCT01798992|474114348|FG003|Overall Study|Lost to Follow-up|0|||
131679486|NCT01798992|474114345|FG000|Overall Study|Insufficient biopsy tissue|0|||
131679487|NCT01798992|474114346|FG001|Overall Study|Insufficient biopsy tissue|0|||
131555560|NCT01320735|473658247|FG000|Overall Study|Lost to Follow-up|13|||
131679488|NCT01798992|474114347|FG002|Overall Study|Insufficient biopsy tissue|1|||
131679489|NCT01798992|474114348|FG003|Overall Study|Insufficient biopsy tissue|0|||
131679490|NCT03823404|474114349|FG000|Overall Study|Lost to Follow-up|1|||
131679491|NCT03823404|474114350|FG001|Overall Study|Lost to Follow-up|2|||
131679492|NCT03823404|474114351|FG002|Overall Study|Lost to Follow-up|3|||
131679493|NCT03823404|474114349|FG000|Overall Study|Protocol Violation|2|||
131679494|NCT03823404|474114350|FG001|Overall Study|Protocol Violation|0|||
131679495|NCT03823404|474114351|FG002|Overall Study|Protocol Violation|2|||
131679496|NCT03823404|474114349|FG000|Overall Study|Adverse Event|35|||
131679497|NCT03823404|474114350|FG001|Overall Study|Adverse Event|38|||
131679498|NCT03823404|474114351|FG002|Overall Study|Adverse Event|8|||
131679499|NCT03823404|474114349|FG000|Overall Study|Withdrawal by Subject|38|||
131679500|NCT03823404|474114350|FG001|Overall Study|Withdrawal by Subject|40|||
131679501|NCT03823404|474114351|FG002|Overall Study|Withdrawal by Subject|35|||
131679502|NCT03823404|474114349|FG000|Overall Study|Death|4|||
131679503|NCT03823404|474114350|FG001|Overall Study|Death|0|||
131679504|NCT03823404|474114351|FG002|Overall Study|Death|0|||
131679505|NCT03823404|474114349|FG000|Overall Study|Other: Various reasons provided|5|||
131679506|NCT03823404|474114350|FG001|Overall Study|Other: Various reasons provided|5|||
131679507|NCT03823404|474114351|FG002|Overall Study|Other: Various reasons provided|6|||
131679508|NCT03383289|474114362|FG000|Overall Study|Death|83|||
131679509|NCT03383289|474114363|FG001|Overall Study|Death|78|||
131679510|NCT03383289|474114362|FG000|Overall Study|discharge from facility|84|||
131679511|NCT03383289|474114363|FG001|Overall Study|discharge from facility|84|||
131679512|NCT03383289|474114362|FG000|Overall Study|Withdrawal by Subject|4|||
131679513|NCT03383289|474114363|FG001|Overall Study|Withdrawal by Subject|1|||
131679514|NCT04439071|474114364|FG000|Overall Study|Lost to Follow-up|0|||
131679515|NCT04439071|474114365|FG001|Overall Study|Lost to Follow-up|3|||
131679516|NCT04439071|474114364|FG000|Overall Study|Withdrawal by Subject|3|||
131679517|NCT04439071|474114365|FG001|Overall Study|Withdrawal by Subject|8|||
131679518|NCT04439071|474114364|FG000|Overall Study|Death|6|||
131679519|NCT04439071|474114365|FG001|Overall Study|Death|4|||
131679520|NCT04439071|474114364|FG000|Overall Study|Other than specified|3|||
131679521|NCT04439071|474114365|FG001|Overall Study|Other than specified|3|||
131679522|NCT04439071|474114364|FG000|Overall Study|Randomized but not treated|2|||
131679523|NCT04439071|474114365|FG001|Overall Study|Randomized but not treated|0|||
131679524|NCT00832117|474114366|FG000|Overall Study|Death|1|||
131679525|NCT00832117|474114366|FG000|Overall Study|Disease Progression|11|||
131679526|NCT01524133|474114371|FG000|Treatment Phase|Withdrawal by Subject|13|||
131679527|NCT01524133|474114372|FG001|Treatment Phase|Withdrawal by Subject|28|||
131679528|NCT01524133|474114373|FG002|Treatment Phase|Withdrawal by Subject|31|||
131679529|NCT01524133|474114371|FG000|Treatment Phase|Physician Decision|6|||
131679530|NCT01524133|474114372|FG001|Treatment Phase|Physician Decision|3|||
131679531|NCT01524133|474114373|FG002|Treatment Phase|Physician Decision|3|||
131679532|NCT01524133|474114371|FG000|Treatment Phase|Lost to Follow-up|0|||
131679533|NCT01524133|474114372|FG001|Treatment Phase|Lost to Follow-up|1|||
131679534|NCT01524133|474114373|FG002|Treatment Phase|Lost to Follow-up|2|||
131679535|NCT01524133|474114371|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
131679536|NCT01524133|474114372|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
131679537|NCT01524133|474114373|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
131679538|NCT01524133|474114371|FG000|Overall Study 52 Weeks|Physician Decision|1|||
131679539|NCT01524133|474114372|FG001|Overall Study 52 Weeks|Physician Decision|0|||
131679540|NCT01524133|474114373|FG002|Overall Study 52 Weeks|Physician Decision|2|||
131679541|NCT01524133|474114371|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
131679542|NCT01524133|474114372|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
131555561|NCT01320735|473658247|FG000|Overall Study|Administrative Reason|6|||
131555562|NCT01320735|473658247|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
131555563|NCT01320735|473658247|FG000|Overall Study|Protocol Violation|1|||
131555564|NCT01320735|473658247|FG000|Overall Study|Other|1|||
131555565|NCT01320735|473658247|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
131555566|NCT01320735|473658247|FG000|Overall Study|Investigator Unable to be Contacted|17|||
131555567|NCT01913639|473658250|FG000|Overall Study|Not Eligible|3|||
131555568|NCT01225822|473658260|FG000|Overall Study|Adverse Event|13|||
131555569|NCT01225822|473658261|FG001|Overall Study|Adverse Event|31|||
131555570|NCT01225822|473658262|FG002|Overall Study|Adverse Event|18|||
131555571|NCT01225822|473658263|FG003|Overall Study|Adverse Event|23|||
131555572|NCT01225822|473658264|FG004|Overall Study|Adverse Event|14|||
131555573|NCT01225822|473658260|FG000|Overall Study|Protocol Violation|6|||
131555574|NCT01225822|473658261|FG001|Overall Study|Protocol Violation|8|||
131555575|NCT01225822|473658262|FG002|Overall Study|Protocol Violation|6|||
131555576|NCT01225822|473658263|FG003|Overall Study|Protocol Violation|7|||
131555577|NCT01225822|473658264|FG004|Overall Study|Protocol Violation|4|||
131555578|NCT01225822|473658260|FG000|Overall Study|Lost to Follow-up|0|||
131555579|NCT01225822|473658261|FG001|Overall Study|Lost to Follow-up|0|||
131555580|NCT01225822|473658262|FG002|Overall Study|Lost to Follow-up|0|||
131555581|NCT01225822|473658263|FG003|Overall Study|Lost to Follow-up|1|||
131555582|NCT01225822|473658264|FG004|Overall Study|Lost to Follow-up|0|||
131555583|NCT01225822|473658260|FG000|Overall Study|Withdrawal by Subject|6|||
131555584|NCT01225822|473658261|FG001|Overall Study|Withdrawal by Subject|7|||
131555585|NCT01225822|473658262|FG002|Overall Study|Withdrawal by Subject|7|||
131555586|NCT01225822|473658263|FG003|Overall Study|Withdrawal by Subject|11|||
131555587|NCT01225822|473658264|FG004|Overall Study|Withdrawal by Subject|6|||
131555588|NCT01225822|473658260|FG000|Overall Study|Other|13|||
131555589|NCT01225822|473658261|FG001|Overall Study|Other|10|||
131555590|NCT01225822|473658262|FG002|Overall Study|Other|7|||
131555591|NCT01225822|473658263|FG003|Overall Study|Other|10|||
131555592|NCT01225822|473658264|FG004|Overall Study|Other|7|||
131555593|NCT01290822|473658265|FG000|Overall Study|Withdrawal by Subject|1|||
131555594|NCT01290822|473658265|FG000|Overall Study|Physician Decision|10|||
131555595|NCT02223754|473658269|FG000|Period 1|Adverse Event|1|||
131555596|NCT02223754|473658270|FG001|Period 1|Adverse Event|0|||
131555597|NCT02223754|473658269|FG000|Period 1|Lost to Follow-up|0|||
131555598|NCT02223754|473658270|FG001|Period 1|Lost to Follow-up|1|||
131555599|NCT02223754|473658269|FG000|Period 1|Protocol Violation|2|||
131555600|NCT02223754|473658270|FG001|Period 1|Protocol Violation|4|||
131555601|NCT02223754|473658269|FG000|Period 1|Withdrawal by Subject|0|||
131555602|NCT02223754|473658270|FG001|Period 1|Withdrawal by Subject|4|||
131555603|NCT02223754|473658269|FG000|Period 1|Test Article No Longer Available|1|||
131555604|NCT02223754|473658270|FG001|Period 1|Test Article No Longer Available|5|||
131555605|NCT02223754|473658269|FG000|Period 1|Unsatisfactory Visual Response|0|||
131555606|NCT02223754|473658270|FG001|Period 1|Unsatisfactory Visual Response|1|||
131555607|NCT02223754|473658269|FG000|Period 2|Adverse Event|0|||
131555608|NCT02223754|473658270|FG001|Period 2|Adverse Event|1|||
131555609|NCT02223754|473658269|FG000|Period 2|Protocol Violation|1|||
131555610|NCT02223754|473658270|FG001|Period 2|Protocol Violation|0|||
131555611|NCT02223754|473658269|FG000|Period 2|Lens Discomfort|1|||
131555612|NCT02223754|473658270|FG001|Period 2|Lens Discomfort|1|||
131555613|NCT02223754|473658269|FG000|Period 2|Lost to Follow-up|1|||
131555614|NCT02223754|473658270|FG001|Period 2|Lost to Follow-up|0|||
131555615|NCT02223754|473658269|FG000|Period 2|Test Article No Longer Available|0|||
131555616|NCT02223754|473658270|FG001|Period 2|Test Article No Longer Available|1|||
131555617|NCT04395183|473658271|FG000|Overall Study|Withdrawal by Subject|1|||
131555618|NCT04395183|473658272|FG001|Overall Study|Withdrawal by Subject|0|||
131555619|NCT04395183|473658273|FG002|Overall Study|Withdrawal by Subject|2|||
131555620|NCT04395183|473658274|FG003|Overall Study|Withdrawal by Subject|2|||
131555621|NCT01693692|473658278|FG000|Overall Study|Withdrawal by Subject|12|||
131555622|NCT01693692|473658279|FG001|Overall Study|Withdrawal by Subject|10|||
131555623|NCT01693692|473658280|FG002|Overall Study|Withdrawal by Subject|11|||
131555624|NCT01693692|473658278|FG000|Overall Study|Adverse Event|7|||
131555625|NCT01693692|473658279|FG001|Overall Study|Adverse Event|14|||
131555626|NCT01693692|473658280|FG002|Overall Study|Adverse Event|9|||
131555627|NCT01693692|473658278|FG000|Overall Study|Physician Decision|0|||
131555628|NCT01693692|473658279|FG001|Overall Study|Physician Decision|0|||
131555629|NCT01693692|473658280|FG002|Overall Study|Physician Decision|1|||
131555630|NCT01693692|473658278|FG000|Overall Study|Protocol Violation|5|||
131555631|NCT01693692|473658279|FG001|Overall Study|Protocol Violation|4|||
131555632|NCT01693692|473658280|FG002|Overall Study|Protocol Violation|6|||
131555633|NCT01693692|473658278|FG000|Overall Study|Lost to Follow-up|2|||
131555634|NCT01693692|473658279|FG001|Overall Study|Lost to Follow-up|2|||
131555635|NCT01693692|473658280|FG002|Overall Study|Lost to Follow-up|3|||
131555636|NCT01693692|473658278|FG000|Overall Study|Other|4|||
131679543|NCT01524133|474114373|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
131679544|NCT00059839|474114380|FG000|Overall Study|Death|1|||
131555637|NCT01693692|473658279|FG001|Overall Study|Other|4|||
131679545|NCT00059839|474114381|FG001|Overall Study|Death|1|||
131679546|NCT00059839|474114380|FG000|Overall Study|Lack of Efficacy|6|||
131679547|NCT00059839|474114381|FG001|Overall Study|Lack of Efficacy|5|||
131679548|NCT00059839|474114380|FG000|Overall Study|Lost to Follow-up|2|||
131679549|NCT00059839|474114381|FG001|Overall Study|Lost to Follow-up|0|||
131679550|NCT00059839|474114380|FG000|Overall Study|Physician Decision|1|||
131679551|NCT00059839|474114381|FG001|Overall Study|Physician Decision|2|||
131679552|NCT00059839|474114380|FG000|Overall Study|Withdrawal by Subject|1|||
131679553|NCT00059839|474114381|FG001|Overall Study|Withdrawal by Subject|6|||
131679554|NCT00059839|474114380|FG000|Overall Study|Ineligible|1|||
131679555|NCT00059839|474114381|FG001|Overall Study|Ineligible|3|||
131679556|NCT03842163|474114382|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
131679557|NCT03842163|474114382|FG000|Overall Study|Scintigraphy was not performed|44|||
131679558|NCT03829241|474114383|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
131679559|NCT03829241|474114384|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
131679560|NCT03829241|474114383|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
131679561|NCT03829241|474114384|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
131679562|NCT03829241|474114383|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
131679563|NCT03829241|474114384|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
131679564|NCT03829241|474114383|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
131679565|NCT03829241|474114384|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
131679566|NCT03829241|474114383|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
131679567|NCT03829241|474114384|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
131679568|NCT03829241|474114383|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
131679569|NCT03829241|474114384|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
131679570|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
131679571|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
131679572|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
131679573|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
131679574|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
131679575|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
131679576|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
131679577|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
131679578|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
131679579|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
131679580|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
131679581|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
131679582|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
131679583|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
131679584|NCT03829241|474114383|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
131679585|NCT03829241|474114384|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
131679586|NCT00698451|474114385|FG000|Overall Study|Adverse Event|22|||
131679587|NCT00698451|474114385|FG000|Overall Study|Physician Decision|2|||
131679588|NCT00698451|474114385|FG000|Overall Study|Protocol Violation|6|||
131679589|NCT00698451|474114385|FG000|Overall Study|Withdrawal by Subject|6|||
131679590|NCT00698451|474114385|FG000|Overall Study|Disease progression|3|||
131679591|NCT02224599|474114386|FG000|Overall Study|Physician Decision|1|||
131679592|NCT02224599|474114386|FG000|Overall Study|Progression of Disease|1|||
131679593|NCT00733304|474114387|FG000|Overall Study|Adverse Event|3|||
131679594|NCT00733304|474114388|FG001|Overall Study|Adverse Event|0|||
131679595|NCT00733304|474114389|FG002|Overall Study|Adverse Event|0|||
131679596|NCT00733304|474114387|FG000|Overall Study|Lack of Efficacy|0|||
131679597|NCT00733304|474114388|FG001|Overall Study|Lack of Efficacy|0|||
131679598|NCT00733304|474114389|FG002|Overall Study|Lack of Efficacy|2|||
131679599|NCT00733304|474114387|FG000|Overall Study|Lost to Follow-up|0|||
131679600|NCT00733304|474114388|FG001|Overall Study|Lost to Follow-up|1|||
131679601|NCT00733304|474114389|FG002|Overall Study|Lost to Follow-up|0|||
131679602|NCT00733304|474114387|FG000|Overall Study|Physician Decision|3|||
131679603|NCT00733304|474114388|FG001|Overall Study|Physician Decision|1|||
131679604|NCT00733304|474114389|FG002|Overall Study|Physician Decision|3|||
131679605|NCT00733304|474114387|FG000|Overall Study|Withdrawal by Subject|1|||
131679606|NCT00733304|474114388|FG001|Overall Study|Withdrawal by Subject|1|||
131679607|NCT00733304|474114389|FG002|Overall Study|Withdrawal by Subject|0|||
131679608|NCT03155373|474114399|FG000|Overall Study|No longer required surgery|1|||
131679609|NCT03155373|474114399|FG000|Overall Study|Protocol Violation|1|||
131679610|NCT03155373|474114399|FG000|Overall Study|Death|2|||
131679611|NCT03155373|474114399|FG000|Overall Study|Withdrawal by Subject|3|||
131679612|NCT00596934|474114402|FG000|Overall Study|Protocol Violation|1|||
131679613|NCT00596934|474114402|FG000|Overall Study|Withdrawal by Subject|1|||
131679614|NCT01214187|474114405|FG000|Overall Study|Adverse Event|6|||
131679615|NCT01214187|474114406|FG001|Overall Study|Adverse Event|2|||
131679616|NCT01214187|474114405|FG000|Overall Study|Death|1|||
131679617|NCT01214187|474114406|FG001|Overall Study|Death|1|||
131679618|NCT01214187|474114405|FG000|Overall Study|Withdrawal by Subject|0|||
131679619|NCT01214187|474114406|FG001|Overall Study|Withdrawal by Subject|3|||
131679620|NCT02308007|474114410|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
131679621|NCT02308007|474114411|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
131679622|NCT02308007|474114412|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
131679623|NCT02308007|474114410|FG000|Overall Study|Positive for STD at Baseline|7|||
131679624|NCT02308007|474114411|FG001|Overall Study|Positive for STD at Baseline|11|||
131679625|NCT02308007|474114412|FG002|Overall Study|Positive for STD at Baseline|7|||
131679626|NCT02308007|474114410|FG000|Overall Study|Lost to Follow-up|3|||
131679627|NCT02308007|474114411|FG001|Overall Study|Lost to Follow-up|0|||
131679628|NCT02308007|474114412|FG002|Overall Study|Lost to Follow-up|1|||
131679629|NCT03678103|474114413|FG000|Overall Study|Withdrawn prior to completion|4|||
131679630|NCT01241552|474114418|FG000|Overall Study|Lack of Efficacy|1|||
131679631|NCT01241552|474114419|FG001|Overall Study|Lack of Efficacy|0|||
131679632|NCT01241552|474114420|FG002|Overall Study|Lack of Efficacy|0|||
131679633|NCT01241552|474114421|FG003|Overall Study|Lack of Efficacy|0|||
131679634|NCT01241552|474114418|FG000|Overall Study|Death|26|||
131679635|NCT01241552|474114419|FG001|Overall Study|Death|30|||
131679636|NCT01241552|474114420|FG002|Overall Study|Death|20|||
131679637|NCT01241552|474114421|FG003|Overall Study|Death|25|||
131679638|NCT01241552|474114418|FG000|Overall Study|Adverse Event|1|||
131679639|NCT01241552|474114419|FG001|Overall Study|Adverse Event|1|||
131679640|NCT01241552|474114420|FG002|Overall Study|Adverse Event|0|||
131679641|NCT01241552|474114421|FG003|Overall Study|Adverse Event|0|||
131679642|NCT01241552|474114418|FG000|Overall Study|Technical Problems|2|||
131679643|NCT01241552|474114419|FG001|Overall Study|Technical Problems|0|||
131679644|NCT01241552|474114420|FG002|Overall Study|Technical Problems|2|||
131679645|NCT01241552|474114421|FG003|Overall Study|Technical Problems|2|||
131679646|NCT01241552|474114418|FG000|Overall Study|Progressive Disease|0|||
131679647|NCT01241552|474114419|FG001|Overall Study|Progressive Disease|0|||
131679648|NCT01241552|474114420|FG002|Overall Study|Progressive Disease|1|||
131679649|NCT01241552|474114421|FG003|Overall Study|Progressive Disease|2|||
131679650|NCT01241552|474114418|FG000|Overall Study|Protocol Violation|0|||
131679651|NCT01241552|474114419|FG001|Overall Study|Protocol Violation|2|||
131679652|NCT01241552|474114420|FG002|Overall Study|Protocol Violation|6|||
131679653|NCT01241552|474114421|FG003|Overall Study|Protocol Violation|1|||
131679654|NCT01241552|474114418|FG000|Overall Study|Withdrawal by Subject|7|||
131679655|NCT01241552|474114419|FG001|Overall Study|Withdrawal by Subject|15|||
131679656|NCT01241552|474114420|FG002|Overall Study|Withdrawal by Subject|14|||
131679657|NCT01241552|474114421|FG003|Overall Study|Withdrawal by Subject|15|||
131679658|NCT01241552|474114418|FG000|Overall Study|Physician Decision|2|||
131679659|NCT01241552|474114419|FG001|Overall Study|Physician Decision|4|||
131679660|NCT01241552|474114420|FG002|Overall Study|Physician Decision|2|||
131679661|NCT01241552|474114421|FG003|Overall Study|Physician Decision|3|||
131679662|NCT01241552|474114418|FG000|Overall Study|Lost to Follow-up|2|||
131679663|NCT01241552|474114419|FG001|Overall Study|Lost to Follow-up|11|||
131679664|NCT01241552|474114420|FG002|Overall Study|Lost to Follow-up|15|||
131679665|NCT01241552|474114421|FG003|Overall Study|Lost to Follow-up|16|||
131679666|NCT00528567|474114422|FG000|Overall Study|Death|4|||
131679667|NCT00528567|474114423|FG001|Overall Study|Death|5|||
131679668|NCT00528567|474114422|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
131679669|NCT00528567|474114423|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
131679670|NCT00528567|474114422|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
131679671|NCT00528567|474114423|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
131679672|NCT00528567|474114422|FG000|Overall Study|Violation Criteria at Entry|3|||
131679673|NCT00528567|474114423|FG001|Overall Study|Violation Criteria at Entry|17|||
131679674|NCT00528567|474114422|FG000|Overall Study|Withdrew Consent|59|||
131679675|NCT00528567|474114423|FG001|Overall Study|Withdrew Consent|55|||
131679676|NCT00528567|474114422|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
131679677|NCT00528567|474114423|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
131679678|NCT00528567|474114422|FG000|Overall Study|Failure to Return|1|||
131679679|NCT00528567|474114423|FG001|Overall Study|Failure to Return|4|||
131679680|NCT00528567|474114422|FG000|Overall Study|Other Protocol Violation|5|||
131679681|NCT00528567|474114423|FG001|Overall Study|Other Protocol Violation|21|||
131679682|NCT00528567|474114422|FG000|Overall Study|Administrative/Other|22|||
131679683|NCT00528567|474114423|FG001|Overall Study|Administrative/Other|75|||
131679684|NCT00631189|474114426|FG000|Initial Phase|Protocol Violation|347|||
131679685|NCT00631189|474114427|FG001|Initial Phase|Protocol Violation|0|||
131679686|NCT00631189|474114428|FG002|Initial Phase|Protocol Violation|0|||
131679687|NCT00631189|474114429|FG003|Initial Phase|Protocol Violation|0|||
131679688|NCT00631189|474114426|FG000|Initial Phase|Withdrawal by Subject|4|||
131679689|NCT00631189|474114427|FG001|Initial Phase|Withdrawal by Subject|0|||
131679690|NCT00631189|474114428|FG002|Initial Phase|Withdrawal by Subject|0|||
131679691|NCT00631189|474114429|FG003|Initial Phase|Withdrawal by Subject|0|||
131679692|NCT00631189|474114426|FG000|Treatment Phase|Withdrawal by Subject|0|||
131679693|NCT00631189|474114427|FG001|Treatment Phase|Withdrawal by Subject|2|||
131679694|NCT00631189|474114428|FG002|Treatment Phase|Withdrawal by Subject|1|||
131679695|NCT00631189|474114429|FG003|Treatment Phase|Withdrawal by Subject|1|||
131679696|NCT00631189|474114426|FG000|Treatment Phase|Protocol Violation|0|||
131679697|NCT00631189|474114427|FG001|Treatment Phase|Protocol Violation|1|||
131679698|NCT00631189|474114428|FG002|Treatment Phase|Protocol Violation|6|||
131679699|NCT00631189|474114429|FG003|Treatment Phase|Protocol Violation|2|||
131679700|NCT00631189|474114426|FG000|Treatment Phase|Adverse Event|0|||
131679701|NCT00631189|474114427|FG001|Treatment Phase|Adverse Event|3|||
131679702|NCT00631189|474114428|FG002|Treatment Phase|Adverse Event|2|||
131679703|NCT00631189|474114429|FG003|Treatment Phase|Adverse Event|4|||
131679704|NCT00631189|474114426|FG000|Treatment Phase|Lost to Follow-up|0|||
131679705|NCT00631189|474114427|FG001|Treatment Phase|Lost to Follow-up|1|||
131679706|NCT00631189|474114428|FG002|Treatment Phase|Lost to Follow-up|0|||
131679707|NCT00631189|474114429|FG003|Treatment Phase|Lost to Follow-up|0|||
131679708|NCT00631189|474114426|FG000|Treatment Phase|Pregnancy|0|||
131679709|NCT00631189|474114427|FG001|Treatment Phase|Pregnancy|0|||
131679710|NCT00631189|474114428|FG002|Treatment Phase|Pregnancy|1|||
131679711|NCT00631189|474114429|FG003|Treatment Phase|Pregnancy|0|||
131679712|NCT00631189|474114426|FG000|Treatment Phase|patient did not take pravastatin|0|||
131679713|NCT00631189|474114427|FG001|Treatment Phase|patient did not take pravastatin|0|||
131679714|NCT00631189|474114428|FG002|Treatment Phase|patient did not take pravastatin|1|||
131679715|NCT00631189|474114429|FG003|Treatment Phase|patient did not take pravastatin|0|||
131679716|NCT01132612|474114430|FG000|Overall Study|Death|0|||
131679717|NCT01132612|474114431|FG001|Overall Study|Death|0|||
131679718|NCT01132612|474114432|FG002|Overall Study|Death|1|||
131679719|NCT01132612|474114430|FG000|Overall Study|Protocol deviation|0|||
131679720|NCT01132612|474114431|FG001|Overall Study|Protocol deviation|0|||
131679721|NCT01132612|474114432|FG002|Overall Study|Protocol deviation|3|||
131679722|NCT01132612|474114430|FG000|Overall Study|Lost to Follow-up|2|||
131679723|NCT01132612|474114431|FG001|Overall Study|Lost to Follow-up|2|||
131679724|NCT01132612|474114432|FG002|Overall Study|Lost to Follow-up|7|||
131679725|NCT01132612|474114430|FG000|Overall Study|Adverse Event|5|||
131679726|NCT01132612|474114431|FG001|Overall Study|Adverse Event|2|||
131679727|NCT01132612|474114432|FG002|Overall Study|Adverse Event|15|||
131679728|NCT01132612|474114430|FG000|Overall Study|Withdrawal by Subject|5|||
131679729|NCT01132612|474114431|FG001|Overall Study|Withdrawal by Subject|8|||
131679730|NCT01132612|474114432|FG002|Overall Study|Withdrawal by Subject|19|||
131679731|NCT01132612|474114430|FG000|Overall Study|Administrative problems|5|||
131679732|NCT01132612|474114431|FG001|Overall Study|Administrative problems|1|||
131679733|NCT01132612|474114432|FG002|Overall Study|Administrative problems|52|||
131679734|NCT01132612|474114430|FG000|Overall Study|Lack of Efficacy|23|||
131679735|NCT01132612|474114431|FG001|Overall Study|Lack of Efficacy|22|||
131679736|NCT01132612|474114432|FG002|Overall Study|Lack of Efficacy|73|||
131679737|NCT02252536|474114433|FG000|Overall Study|Lost to Follow-up|5|||
131679738|NCT02252536|474114434|FG001|Overall Study|Lost to Follow-up|3|||
131679739|NCT01438151|474114438|FG000|Overall Study|study terminated|8|||
131679740|NCT01862640|474114443|FG000|Overall Study|Adverse Event|4|||
131679741|NCT01862640|474114444|FG001|Overall Study|Adverse Event|10|||
131679742|NCT01862640|474114445|FG002|Overall Study|Adverse Event|6|||
131679743|NCT01862640|474114446|FG003|Overall Study|Adverse Event|8|||
131679744|NCT01862640|474114443|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
131679745|NCT01862640|474114444|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
131679746|NCT01862640|474114445|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
131679747|NCT01862640|474114446|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
131679748|NCT01862640|474114443|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
131679749|NCT01862640|474114444|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
131679750|NCT01862640|474114445|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
131679751|NCT01862640|474114446|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
131679752|NCT01862640|474114443|FG000|Overall Study|Withdrawal by Subject|2|||
131679753|NCT01862640|474114444|FG001|Overall Study|Withdrawal by Subject|4|||
131679754|NCT01862640|474114445|FG002|Overall Study|Withdrawal by Subject|8|||
131679755|NCT01862640|474114446|FG003|Overall Study|Withdrawal by Subject|5|||
131679756|NCT01862640|474114443|FG000|Overall Study|Protocol Deviation|0|||
131679757|NCT01862640|474114444|FG001|Overall Study|Protocol Deviation|0|||
131679758|NCT01862640|474114445|FG002|Overall Study|Protocol Deviation|1|||
131679759|NCT01862640|474114446|FG003|Overall Study|Protocol Deviation|0|||
131679760|NCT04178967|474114447|FG000|Induction Period|Adverse Event|4|||
131679761|NCT04178967|474114448|FG001|Induction Period|Adverse Event|6|||
131679762|NCT04178967|474114449|FG002|Induction Period|Adverse Event|0|||
131679763|NCT04178967|474114450|FG003|Induction Period|Adverse Event|0|||
131679764|NCT04178967|474114451|FG004|Induction Period|Adverse Event|0|||
131679765|NCT04178967|474114452|FG005|Induction Period|Adverse Event|0|||
131679766|NCT04178967|474114453|FG006|Induction Period|Adverse Event|0|||
131679767|NCT04178967|474114454|FG007|Induction Period|Adverse Event|0|||
131679768|NCT04178967|474114455|FG008|Induction Period|Adverse Event|0|||
131679769|NCT04178967|474114456|FG009|Induction Period|Adverse Event|0|||
131679770|NCT04178967|474114457|FG010|Induction Period|Adverse Event|0|||
131679771|NCT04178967|474114447|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
131679772|NCT04178967|474114448|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
131679773|NCT04178967|474114449|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
131679774|NCT04178967|474114450|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
131679775|NCT04178967|474114451|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
131679776|NCT04178967|474114452|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
131679777|NCT04178967|474114453|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
131679778|NCT04178967|474114454|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
131679779|NCT04178967|474114455|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
131679780|NCT04178967|474114456|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
131679781|NCT04178967|474114457|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
131679782|NCT04178967|474114447|FG000|Induction Period|Lack of Efficacy|4|||
131679783|NCT04178967|474114448|FG001|Induction Period|Lack of Efficacy|1|||
131679784|NCT04178967|474114449|FG002|Induction Period|Lack of Efficacy|0|||
131679785|NCT04178967|474114450|FG003|Induction Period|Lack of Efficacy|0|||
131679786|NCT04178967|474114451|FG004|Induction Period|Lack of Efficacy|0|||
131679787|NCT04178967|474114452|FG005|Induction Period|Lack of Efficacy|0|||
131679788|NCT04178967|474114453|FG006|Induction Period|Lack of Efficacy|0|||
131679789|NCT04178967|474114454|FG007|Induction Period|Lack of Efficacy|0|||
131555638|NCT01693692|473658280|FG002|Overall Study|Other|6|||
131555639|NCT03462706|473660145|FG000|Overall Study|Polyp was pedunculated|1|||
131555640|NCT03462706|473660146|FG001|Overall Study|Polyp was pedunculated|0|||
131555641|NCT03462706|473660147|FG002|Overall Study|Polyp was pedunculated|1|||
131555642|NCT03462706|473660148|FG003|Overall Study|Polyp was pedunculated|0|||
131555643|NCT03462706|473660145|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
131555644|NCT03462706|473660146|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
131555645|NCT03462706|473660147|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
131555646|NCT03462706|473660148|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
131555647|NCT04105972|473660153|FG000|Overall Study|Adverse Event|2|||
131555648|NCT04105972|473660154|FG001|Overall Study|Adverse Event|1|||
131555649|NCT00553202|473660159|FG000|Overall Study|Death|16|||
131555650|NCT00553202|473660159|FG000|Overall Study|Lost to Follow-up|1|||
131555651|NCT00553202|473660159|FG000|Overall Study|Physician Decision|28|||
131555652|NCT00553202|473660159|FG000|Overall Study|Withdrawal by Subject|1|||
131555653|NCT00553202|473660159|FG000|Overall Study|No donor identified|16|||
131555654|NCT00553202|473660159|FG000|Overall Study|Fails to meet organ function|6|||
131555655|NCT02593305|473660162|FG000|Post 1|Comparison only group. No intervention.|0|||
131555656|NCT02593305|473660163|FG001|Post 1|Comparison only group. No intervention.|0|||
131555657|NCT02593305|473660164|FG002|Post 1|Comparison only group. No intervention.|10|||
131555658|NCT01190215|473660165|FG000|Up to Month 6|Lost to Follow-up|2|||
131555659|NCT01190215|473660166|FG001|Up to Month 6|Lost to Follow-up|0|||
131555660|NCT01161472|473660168|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
131555661|NCT01161472|473660169|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
131555662|NCT01161472|473660170|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
131555663|NCT01161472|473660171|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
131555664|NCT00768430|473660191|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
131555665|NCT00768430|473660192|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
131555666|NCT02002884|473660199|FG000|Main Period (MP)|Other|0|||
131555667|NCT02002884|473660200|FG001|Main Period (MP)|Other|3|||
131555668|NCT02002884|473660201|FG002|Main Period (MP)|Other|3|||
131555669|NCT02002884|473660202|FG003|Main Period (MP)|Other|0|||
131555670|NCT02002884|473660199|FG000|Main Period (MP)|Adverse Event|0|||
131555671|NCT02002884|473660200|FG001|Main Period (MP)|Adverse Event|1|||
131555672|NCT02002884|473660201|FG002|Main Period (MP)|Adverse Event|1|||
131555673|NCT02002884|473660202|FG003|Main Period (MP)|Adverse Event|0|||
131555674|NCT02002884|473660199|FG000|Main Period (MP)|Withdrawal by Subject|6|||
131555675|NCT02002884|473660200|FG001|Main Period (MP)|Withdrawal by Subject|2|||
131555676|NCT02002884|473660201|FG002|Main Period (MP)|Withdrawal by Subject|2|||
131555677|NCT02002884|473660202|FG003|Main Period (MP)|Withdrawal by Subject|0|||
131555678|NCT02002884|473660199|FG000|Main Period (MP)|Lost to Follow-up|0|||
131555679|NCT02002884|473660200|FG001|Main Period (MP)|Lost to Follow-up|0|||
131555680|NCT02002884|473660201|FG002|Main Period (MP)|Lost to Follow-up|2|||
131555681|NCT02002884|473660202|FG003|Main Period (MP)|Lost to Follow-up|0|||
131555682|NCT02002884|473660199|FG000|Open-Label Extension Period (OLEX)|Other|0|||
131555683|NCT02002884|473660200|FG001|Open-Label Extension Period (OLEX)|Other|0|||
131555684|NCT02002884|473660201|FG002|Open-Label Extension Period (OLEX)|Other|0|||
131555685|NCT02002884|473660202|FG003|Open-Label Extension Period (OLEX)|Other|24|||
131555686|NCT02002884|473660199|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
131555687|NCT02002884|473660200|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
131555688|NCT02002884|473660201|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
131555689|NCT02002884|473660202|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
131555690|NCT02002884|473660199|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
131555691|NCT02002884|473660200|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
131555692|NCT02002884|473660201|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
131555693|NCT02002884|473660202|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
131555694|NCT02002884|473660199|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
131555695|NCT02002884|473660200|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
131555696|NCT02002884|473660201|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
131555697|NCT02002884|473660202|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
131555698|NCT02002884|473660199|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
131555699|NCT02002884|473660200|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
131555700|NCT02002884|473660201|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
131555701|NCT02002884|473660202|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
131555702|NCT01642602|473660203|FG000|Overall Study|Adverse Event|2|||
131555703|NCT02632786|473660207|FG000|Overall Study|Adverse Event|2|||
131679790|NCT04178967|474114455|FG008|Induction Period|Lack of Efficacy|0|||
131555704|NCT02632786|473660208|FG001|Overall Study|Adverse Event|1|||
131555705|NCT02632786|473660207|FG000|Overall Study|Death|3|||
131555706|NCT02632786|473660208|FG001|Overall Study|Death|2|||
131555707|NCT02632786|473660207|FG000|Overall Study|Physician Decision|5|||
131555708|NCT02632786|473660208|FG001|Overall Study|Physician Decision|4|||
131679791|NCT04178967|474114456|FG009|Induction Period|Lack of Efficacy|0|||
131679792|NCT04178967|474114457|FG010|Induction Period|Lack of Efficacy|0|||
131679793|NCT04178967|474114447|FG000|Induction Period|Protocol Violation|0|||
131679794|NCT04178967|474114448|FG001|Induction Period|Protocol Violation|6|||
131679795|NCT04178967|474114449|FG002|Induction Period|Protocol Violation|0|||
131679796|NCT04178967|474114450|FG003|Induction Period|Protocol Violation|0|||
131679797|NCT04178967|474114451|FG004|Induction Period|Protocol Violation|0|||
131679798|NCT04178967|474114452|FG005|Induction Period|Protocol Violation|0|||
131679799|NCT04178967|474114453|FG006|Induction Period|Protocol Violation|0|||
131679800|NCT04178967|474114454|FG007|Induction Period|Protocol Violation|0|||
131679801|NCT04178967|474114455|FG008|Induction Period|Protocol Violation|0|||
131679802|NCT04178967|474114456|FG009|Induction Period|Protocol Violation|0|||
131679803|NCT04178967|474114457|FG010|Induction Period|Protocol Violation|0|||
131679804|NCT04178967|474114447|FG000|Induction Period|Withdrawal by Subject|6|||
131679805|NCT04178967|474114448|FG001|Induction Period|Withdrawal by Subject|4|||
131679806|NCT04178967|474114449|FG002|Induction Period|Withdrawal by Subject|0|||
131679807|NCT04178967|474114450|FG003|Induction Period|Withdrawal by Subject|0|||
131679808|NCT04178967|474114451|FG004|Induction Period|Withdrawal by Subject|0|||
131679809|NCT04178967|474114452|FG005|Induction Period|Withdrawal by Subject|0|||
131679810|NCT04178967|474114453|FG006|Induction Period|Withdrawal by Subject|0|||
131679811|NCT04178967|474114454|FG007|Induction Period|Withdrawal by Subject|0|||
131679812|NCT04178967|474114455|FG008|Induction Period|Withdrawal by Subject|0|||
131679813|NCT04178967|474114456|FG009|Induction Period|Withdrawal by Subject|0|||
131679814|NCT04178967|474114457|FG010|Induction Period|Withdrawal by Subject|0|||
131679815|NCT04178967|474114447|FG000|Induction Period|Lost to Follow-up|2|||
131679816|NCT04178967|474114448|FG001|Induction Period|Lost to Follow-up|0|||
131679817|NCT04178967|474114449|FG002|Induction Period|Lost to Follow-up|0|||
131679818|NCT04178967|474114450|FG003|Induction Period|Lost to Follow-up|0|||
131679819|NCT04178967|474114451|FG004|Induction Period|Lost to Follow-up|0|||
131679820|NCT04178967|474114452|FG005|Induction Period|Lost to Follow-up|0|||
131679821|NCT04178967|474114453|FG006|Induction Period|Lost to Follow-up|0|||
131679822|NCT04178967|474114454|FG007|Induction Period|Lost to Follow-up|0|||
131679823|NCT04178967|474114455|FG008|Induction Period|Lost to Follow-up|0|||
131679824|NCT04178967|474114456|FG009|Induction Period|Lost to Follow-up|0|||
131679825|NCT04178967|474114457|FG010|Induction Period|Lost to Follow-up|0|||
131679826|NCT04178967|474114447|FG000|Induction Period|Participant Missed Study Visits|0|||
131679827|NCT04178967|474114448|FG001|Induction Period|Participant Missed Study Visits|1|||
131679828|NCT04178967|474114449|FG002|Induction Period|Participant Missed Study Visits|0|||
131679829|NCT04178967|474114450|FG003|Induction Period|Participant Missed Study Visits|0|||
131679830|NCT04178967|474114451|FG004|Induction Period|Participant Missed Study Visits|0|||
131679831|NCT04178967|474114452|FG005|Induction Period|Participant Missed Study Visits|0|||
131679832|NCT04178967|474114453|FG006|Induction Period|Participant Missed Study Visits|0|||
131679833|NCT04178967|474114454|FG007|Induction Period|Participant Missed Study Visits|0|||
131679834|NCT04178967|474114455|FG008|Induction Period|Participant Missed Study Visits|0|||
131679835|NCT04178967|474114456|FG009|Induction Period|Participant Missed Study Visits|0|||
131679836|NCT04178967|474114457|FG010|Induction Period|Participant Missed Study Visits|0|||
131679837|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679838|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679839|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679840|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679841|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679842|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
131679843|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
131679844|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
131679845|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679846|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679847|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
131679848|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679849|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679850|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679851|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679852|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679853|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
131679854|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679855|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679856|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679857|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679858|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131679859|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679860|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679861|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679862|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
131679863|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679864|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679865|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679866|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679867|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679868|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679869|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131679870|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679871|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679872|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679873|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679874|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679875|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679876|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
131679877|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679878|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679879|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679880|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
131679881|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679882|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679883|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679884|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679885|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
131679886|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
131679887|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679888|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
131679889|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679890|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679891|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131679892|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131679893|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131679894|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
131679895|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
131679896|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
131679897|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
131679898|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
131679899|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
131679900|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131679901|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131679902|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131679903|NCT04178967|474114447|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679904|NCT04178967|474114448|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679905|NCT04178967|474114449|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679906|NCT04178967|474114450|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
131679907|NCT04178967|474114451|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679908|NCT04178967|474114452|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
131679909|NCT04178967|474114453|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
131679910|NCT04178967|474114454|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
131679911|NCT04178967|474114455|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679912|NCT04178967|474114456|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679913|NCT04178967|474114457|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131679914|NCT04178967|474114447|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679915|NCT04178967|474114448|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679916|NCT04178967|474114449|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679917|NCT04178967|474114450|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679918|NCT04178967|474114451|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679919|NCT04178967|474114452|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679920|NCT04178967|474114453|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679921|NCT04178967|474114454|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679922|NCT04178967|474114455|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
131679923|NCT04178967|474114456|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
131679924|NCT04178967|474114457|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
131679925|NCT04178967|474114447|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679926|NCT04178967|474114448|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679927|NCT04178967|474114449|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131898480|NCT00705341|474914081|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
131898481|NCT00705341|474914082|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
131679928|NCT04178967|474114450|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679929|NCT04178967|474114451|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679930|NCT04178967|474114452|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679931|NCT04178967|474114453|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679932|NCT04178967|474114454|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131679933|NCT04178967|474114455|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
131679934|NCT04178967|474114456|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
131679935|NCT04178967|474114457|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
131679936|NCT04178967|474114447|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679937|NCT04178967|474114448|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679938|NCT04178967|474114449|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679939|NCT04178967|474114450|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679940|NCT04178967|474114451|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679941|NCT04178967|474114452|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679942|NCT04178967|474114453|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679943|NCT04178967|474114454|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679944|NCT04178967|474114455|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679945|NCT04178967|474114456|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
131679946|NCT04178967|474114457|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131679947|NCT04178967|474114447|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679948|NCT04178967|474114448|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679949|NCT04178967|474114449|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679950|NCT04178967|474114450|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679951|NCT04178967|474114451|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679952|NCT04178967|474114452|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679953|NCT04178967|474114453|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679954|NCT04178967|474114454|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131679955|NCT04178967|474114455|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
131679956|NCT04178967|474114456|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
131679957|NCT04178967|474114457|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131679958|NCT04178967|474114447|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679959|NCT04178967|474114448|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679960|NCT04178967|474114449|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679961|NCT04178967|474114450|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679962|NCT04178967|474114451|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679963|NCT04178967|474114452|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679964|NCT04178967|474114453|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679965|NCT04178967|474114454|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679966|NCT04178967|474114455|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679967|NCT04178967|474114456|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
131679968|NCT04178967|474114457|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131679969|NCT04178967|474114447|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679970|NCT04178967|474114448|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679971|NCT04178967|474114449|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679972|NCT04178967|474114450|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679973|NCT04178967|474114451|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679974|NCT04178967|474114452|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679975|NCT04178967|474114453|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679976|NCT04178967|474114454|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679977|NCT04178967|474114455|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679978|NCT04178967|474114456|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
131679979|NCT04178967|474114457|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131679980|NCT01020448|474114458|FG000|Pre-assignment|Adverse Event|6|||
131679981|NCT01020448|474114458|FG000|Pre-assignment|Withdrawal by Subject|5|||
131679982|NCT01020448|474114458|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
131679983|NCT01020448|474114458|FG000|Treatment|Adverse Event|11|||
131679984|NCT01020448|474114458|FG000|Treatment|Consent Withdrawn|3|||
131679985|NCT01020448|474114458|FG000|Treatment|Disease Progression|2|||
131679986|NCT01020448|474114458|FG000|Treatment|Lack of Efficacy|8|||
131679987|NCT01020448|474114458|FG000|Treatment|Lost to Follow-up|2|||
131679988|NCT00728481|474114459|FG000|Overall Study|Withdrawal by Subject|0|||
131679989|NCT00728481|474114460|FG001|Overall Study|Withdrawal by Subject|1|||
131679990|NCT00728481|474114459|FG000|Overall Study|Adverse Event|0|||
131679991|NCT00728481|474114460|FG001|Overall Study|Adverse Event|1|||
131679992|NCT00728481|474114459|FG000|Overall Study|Study medication non-compliance|0|||
131679993|NCT00728481|474114460|FG001|Overall Study|Study medication non-compliance|2|||
131679994|NCT00728481|474114459|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
131679995|NCT00728481|474114460|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
131679996|NCT04399122|474114462|FG000|Overall Study|Lost to Follow-up|2|||
131679997|NCT04399122|474114463|FG001|Overall Study|Lost to Follow-up|0|||
131679998|NCT04399122|474114462|FG000|Overall Study|Withdrawal by Subject|1|||
131679999|NCT04399122|474114463|FG001|Overall Study|Withdrawal by Subject|0|||
131680000|NCT02536755|474114466|FG000|Overall Study|Adverse Event|4|||
131680001|NCT01174238|474114467|FG000|Overall Study|Lost to Follow-up|2|||
131680002|NCT02301936|474114468|FG000|Overall Study|Lost to Follow-up|1|||
131680003|NCT02301936|474114469|FG001|Overall Study|Lost to Follow-up|0|||
131680004|NCT03085758|474116178|FG000|Overall Study|Death|26|||
131680005|NCT03085758|474116179|FG001|Overall Study|Death|24|||
131680006|NCT03085758|474116180|FG002|Overall Study|Death|53|||
131680007|NCT03085758|474116178|FG000|Overall Study|Lost to Follow-up|1|||
131680008|NCT03085758|474116179|FG001|Overall Study|Lost to Follow-up|1|||
131680009|NCT03085758|474116180|FG002|Overall Study|Lost to Follow-up|1|||
131680010|NCT03085758|474116178|FG000|Overall Study|Withdrawal by Subject|2|||
131680011|NCT03085758|474116179|FG001|Overall Study|Withdrawal by Subject|2|||
131680012|NCT03085758|474116180|FG002|Overall Study|Withdrawal by Subject|1|||
131680013|NCT03085758|474116178|FG000|Overall Study|Refusal to recall it up to day 90|0|||
131680014|NCT03085758|474116179|FG001|Overall Study|Refusal to recall it up to day 90|0|||
131680015|NCT03085758|474116180|FG002|Overall Study|Refusal to recall it up to day 90|1|||
131680016|NCT03085758|474116178|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
131680017|NCT03085758|474116179|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
131680018|NCT03085758|474116180|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
131680019|NCT04004429|474116181|FG000|Overall Study|Protocol Violation|1|||
131680020|NCT04004429|474116182|FG001|Overall Study|Protocol Violation|0|||
131680021|NCT04004429|474116183|FG002|Overall Study|Protocol Violation|0|||
131680022|NCT04004429|474116181|FG000|Overall Study|Physician Decision|0|||
131680023|NCT04004429|474116182|FG001|Overall Study|Physician Decision|1|||
131680024|NCT04004429|474116183|FG002|Overall Study|Physician Decision|1|||
131680025|NCT04004429|474116181|FG000|Overall Study|Withdrawal by Subject|1|||
131680026|NCT04004429|474116182|FG001|Overall Study|Withdrawal by Subject|1|||
131680027|NCT04004429|474116183|FG002|Overall Study|Withdrawal by Subject|1|||
131680028|NCT01122576|474116184|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
131680029|NCT01122576|474116185|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
131680030|NCT01122576|474116186|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
131680031|NCT01122576|474116184|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
131680032|NCT01122576|474116185|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
131680033|NCT01122576|474116186|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
131680034|NCT01122576|474116184|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
131680035|NCT01122576|474116185|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
131680036|NCT01122576|474116186|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
131680037|NCT00931944|474116187|FG000|Overall Study|Adverse Event|4|||
131680038|NCT00931944|474116187|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
131680039|NCT00931944|474116187|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
131680040|NCT00931944|474116187|FG000|Overall Study|Death|28|||
131680041|NCT00931944|474116187|FG000|Overall Study|Other|2|||
131680042|NCT02459769|474116191|FG000|Overall Study|Withdrawal by Subject|7|||
131680043|NCT02459769|474116192|FG001|Overall Study|Withdrawal by Subject|4|||
131680044|NCT02459769|474116193|FG002|Overall Study|Withdrawal by Subject|8|||
131680045|NCT02459769|474116194|FG003|Overall Study|Withdrawal by Subject|5|||
131680046|NCT02459769|474116191|FG000|Overall Study|Lost to Follow-up|1|||
131680047|NCT02459769|474116192|FG001|Overall Study|Lost to Follow-up|0|||
131680048|NCT02459769|474116193|FG002|Overall Study|Lost to Follow-up|1|||
131680049|NCT02459769|474116194|FG003|Overall Study|Lost to Follow-up|0|||
131680050|NCT01287364|474116195|FG000|Overall Study|Adverse Event|0|||
131680051|NCT01287364|474116196|FG001|Overall Study|Adverse Event|3|||
131680052|NCT01287364|474116195|FG000|Overall Study|Protocol Violation|5|||
131680053|NCT01287364|474116196|FG001|Overall Study|Protocol Violation|5|||
131680054|NCT01287364|474116195|FG000|Overall Study|Other Reason|4|||
131435990|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
131680055|NCT01287364|474116196|FG001|Overall Study|Other Reason|2|||
131680056|NCT05372653|474116203|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
131680057|NCT05372653|474116204|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
131680058|NCT05372653|474116203|FG000|Overall Study|Adverse Event|0|||
131680059|NCT05372653|474116204|FG001|Overall Study|Adverse Event|1|||
131680060|NCT00711529|474116205|FG000|Overall Study|Protocol Violation|2|||
131680061|NCT00711529|474116206|FG001|Overall Study|Protocol Violation|0|||
131680062|NCT00711529|474116205|FG000|Overall Study|Withdrawal by Subject|2|||
131680063|NCT00711529|474116206|FG001|Overall Study|Withdrawal by Subject|6|||
131898482|NCT00705341|474914079|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
131680064|NCT03740997|474116209|FG000|Overall Study|Withdrawal by Subject|1|||
131680065|NCT03740997|474116210|FG001|Overall Study|Withdrawal by Subject|0|||
131680066|NCT03740997|474116209|FG000|Overall Study|Participant was unable to complete study procedures|1|||
131680067|NCT03740997|474116210|FG001|Overall Study|Participant was unable to complete study procedures|0|||
131680068|NCT01829425|474116211|FG000|Overall Study|Withdrawal by Subject|4|||
131680069|NCT01829425|474116212|FG001|Overall Study|Withdrawal by Subject|3|||
131680070|NCT01829425|474116211|FG000|Overall Study|Lost to Follow-up|2|||
131680071|NCT01829425|474116212|FG001|Overall Study|Lost to Follow-up|1|||
131680072|NCT05211739|474116213|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
131680073|NCT05211739|474116214|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
131680074|NCT05211739|474116213|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
131680075|NCT05211739|474116214|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
131680076|NCT05211739|474116213|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
131680077|NCT05211739|474116214|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
131680078|NCT05211739|474116213|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
131680079|NCT05211739|474116214|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
131680080|NCT03681951|474116215|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
131680081|NCT03681951|474116216|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680082|NCT03681951|474116217|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680083|NCT03681951|474116218|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680084|NCT03681951|474116219|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680085|NCT03681951|474116220|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680086|NCT03681951|474116221|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680087|NCT03681951|474116222|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131680088|NCT03681951|474116215|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
131680089|NCT03681951|474116216|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680090|NCT03681951|474116217|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680091|NCT03681951|474116218|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680092|NCT03681951|474116219|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680093|NCT03681951|474116220|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680094|NCT03681951|474116221|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680095|NCT03681951|474116222|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131680096|NCT03681951|474116215|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
131680097|NCT03681951|474116216|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680098|NCT03681951|474116217|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680099|NCT03681951|474116218|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680100|NCT03681951|474116219|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680101|NCT03681951|474116220|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680102|NCT03681951|474116221|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680103|NCT03681951|474116222|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131680104|NCT01975428|474116223|FG000|Overall Study|Lost to Follow-up|17|||
131680105|NCT01975428|474116224|FG001|Overall Study|Lost to Follow-up|4|||
131680106|NCT01975428|474116223|FG000|Overall Study|Withdrawal by Subject|3|||
131680107|NCT01975428|474116224|FG001|Overall Study|Withdrawal by Subject|10|||
131680108|NCT01505010|474116225|FG000|Overall Study|Protocol Violation|0|||
131680109|NCT01505010|474116226|FG001|Overall Study|Protocol Violation|1|||
131680110|NCT01505010|474116225|FG000|Overall Study|Lost to Follow-up|0|||
131680111|NCT01505010|474116226|FG001|Overall Study|Lost to Follow-up|1|||
131680112|NCT01968070|474116233|FG000|Period 1|Withdrawal by Subject|0|||
131680113|NCT01968070|474116234|FG001|Period 1|Withdrawal by Subject|1|||
131680114|NCT01968070|474116235|FG002|Period 1|Withdrawal by Subject|0|||
131680115|NCT01968070|474116236|FG003|Period 1|Withdrawal by Subject|0|||
131680116|NCT01968070|474116237|FG004|Period 1|Withdrawal by Subject|0|||
131680117|NCT01968070|474116238|FG005|Period 1|Withdrawal by Subject|0|||
131680118|NCT01968070|474116239|FG006|Period 1|Withdrawal by Subject|1|||
131680119|NCT01968070|474116240|FG007|Period 1|Withdrawal by Subject|0|||
131680120|NCT01968070|474116241|FG008|Period 1|Withdrawal by Subject|0|||
131680121|NCT01968070|474116242|FG009|Period 1|Withdrawal by Subject|0|||
131680122|NCT01968070|474116243|FG010|Period 1|Withdrawal by Subject|0|||
131680123|NCT01968070|474116244|FG011|Period 1|Withdrawal by Subject|0|||
131680124|NCT01968070|474116245|FG012|Period 1|Withdrawal by Subject|0|||
131680125|NCT01968070|474116246|FG013|Period 1|Withdrawal by Subject|0|||
131680126|NCT01968070|474116247|FG014|Period 1|Withdrawal by Subject|0|||
131680127|NCT01968070|474116248|FG015|Period 1|Withdrawal by Subject|1|||
131680128|NCT01968070|474116249|FG016|Period 1|Withdrawal by Subject|0|||
131680129|NCT01968070|474116250|FG017|Period 1|Withdrawal by Subject|0|||
131680130|NCT01968070|474116233|FG000|Period 1|Protocol Violation|0|||
131680131|NCT01968070|474116234|FG001|Period 1|Protocol Violation|0|||
131680132|NCT01968070|474116235|FG002|Period 1|Protocol Violation|0|||
131680133|NCT01968070|474116236|FG003|Period 1|Protocol Violation|1|||
131680134|NCT01968070|474116237|FG004|Period 1|Protocol Violation|1|||
131680135|NCT01968070|474116238|FG005|Period 1|Protocol Violation|0|||
131680136|NCT01968070|474116239|FG006|Period 1|Protocol Violation|0|||
131680137|NCT01968070|474116240|FG007|Period 1|Protocol Violation|0|||
131680138|NCT01968070|474116241|FG008|Period 1|Protocol Violation|0|||
131680139|NCT01968070|474116242|FG009|Period 1|Protocol Violation|0|||
131680140|NCT01968070|474116243|FG010|Period 1|Protocol Violation|0|||
131680141|NCT01968070|474116244|FG011|Period 1|Protocol Violation|0|||
131898483|NCT00705341|474914080|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
131680142|NCT01968070|474116245|FG012|Period 1|Protocol Violation|0|||
131680143|NCT01968070|474116246|FG013|Period 1|Protocol Violation|0|||
131680144|NCT01968070|474116247|FG014|Period 1|Protocol Violation|0|||
131680145|NCT01968070|474116248|FG015|Period 1|Protocol Violation|0|||
131680146|NCT01968070|474116249|FG016|Period 1|Protocol Violation|0|||
131680147|NCT01968070|474116250|FG017|Period 1|Protocol Violation|0|||
131680148|NCT01968070|474116233|FG000|Period 1|Lost to Follow-up|0|||
131680149|NCT01968070|474116234|FG001|Period 1|Lost to Follow-up|0|||
131680150|NCT01968070|474116235|FG002|Period 1|Lost to Follow-up|0|||
131680151|NCT01968070|474116236|FG003|Period 1|Lost to Follow-up|1|||
131680152|NCT01968070|474116237|FG004|Period 1|Lost to Follow-up|0|||
131680153|NCT01968070|474116238|FG005|Period 1|Lost to Follow-up|0|||
131680154|NCT01968070|474116239|FG006|Period 1|Lost to Follow-up|0|||
131680155|NCT01968070|474116240|FG007|Period 1|Lost to Follow-up|0|||
131680156|NCT01968070|474116241|FG008|Period 1|Lost to Follow-up|0|||
131680157|NCT01968070|474116242|FG009|Period 1|Lost to Follow-up|0|||
131680158|NCT01968070|474116243|FG010|Period 1|Lost to Follow-up|0|||
131680159|NCT01968070|474116244|FG011|Period 1|Lost to Follow-up|0|||
131680160|NCT01968070|474116245|FG012|Period 1|Lost to Follow-up|0|||
131680161|NCT01968070|474116246|FG013|Period 1|Lost to Follow-up|0|||
131680162|NCT01968070|474116247|FG014|Period 1|Lost to Follow-up|0|||
131680163|NCT01968070|474116248|FG015|Period 1|Lost to Follow-up|0|||
131680164|NCT01968070|474116249|FG016|Period 1|Lost to Follow-up|0|||
131680165|NCT01968070|474116250|FG017|Period 1|Lost to Follow-up|0|||
131680166|NCT01968070|474116233|FG000|Period 1|Adverse Event|0|||
131680167|NCT01968070|474116234|FG001|Period 1|Adverse Event|0|||
131680168|NCT01968070|474116235|FG002|Period 1|Adverse Event|0|||
131680169|NCT01968070|474116236|FG003|Period 1|Adverse Event|0|||
131680170|NCT01968070|474116237|FG004|Period 1|Adverse Event|0|||
131680171|NCT01968070|474116238|FG005|Period 1|Adverse Event|0|||
131680172|NCT01968070|474116239|FG006|Period 1|Adverse Event|1|||
131680173|NCT01968070|474116240|FG007|Period 1|Adverse Event|0|||
131680174|NCT01968070|474116241|FG008|Period 1|Adverse Event|0|||
131680175|NCT01968070|474116242|FG009|Period 1|Adverse Event|0|||
131680176|NCT01968070|474116243|FG010|Period 1|Adverse Event|0|||
131680177|NCT01968070|474116244|FG011|Period 1|Adverse Event|0|||
131680178|NCT01968070|474116245|FG012|Period 1|Adverse Event|0|||
131680179|NCT01968070|474116246|FG013|Period 1|Adverse Event|0|||
131680180|NCT01968070|474116247|FG014|Period 1|Adverse Event|0|||
131680181|NCT01968070|474116248|FG015|Period 1|Adverse Event|0|||
131680182|NCT01968070|474116249|FG016|Period 1|Adverse Event|0|||
131680183|NCT01968070|474116250|FG017|Period 1|Adverse Event|0|||
131680184|NCT01968070|474116233|FG000|Period 1|Physician Decision|0|||
131680185|NCT01968070|474116234|FG001|Period 1|Physician Decision|0|||
131680186|NCT01968070|474116235|FG002|Period 1|Physician Decision|0|||
131680187|NCT01968070|474116236|FG003|Period 1|Physician Decision|0|||
131680188|NCT01968070|474116237|FG004|Period 1|Physician Decision|0|||
131680189|NCT01968070|474116238|FG005|Period 1|Physician Decision|0|||
131680190|NCT01968070|474116239|FG006|Period 1|Physician Decision|0|||
131680191|NCT01968070|474116240|FG007|Period 1|Physician Decision|0|||
131680192|NCT01968070|474116241|FG008|Period 1|Physician Decision|0|||
131680193|NCT01968070|474116242|FG009|Period 1|Physician Decision|0|||
131680194|NCT01968070|474116243|FG010|Period 1|Physician Decision|0|||
131680195|NCT01968070|474116244|FG011|Period 1|Physician Decision|1|||
131680196|NCT01968070|474116245|FG012|Period 1|Physician Decision|0|||
131680197|NCT01968070|474116246|FG013|Period 1|Physician Decision|0|||
131680198|NCT01968070|474116247|FG014|Period 1|Physician Decision|0|||
131680199|NCT01968070|474116248|FG015|Period 1|Physician Decision|0|||
131555709|NCT02632786|473660207|FG000|Overall Study|Withdrawal by Subject|1|||
131680200|NCT01968070|474116249|FG016|Period 1|Physician Decision|0|||
131680201|NCT01968070|474116250|FG017|Period 1|Physician Decision|0|||
131680202|NCT01968070|474116233|FG000|Period 2|Withdrawal by Subject|0|||
131680203|NCT01968070|474116234|FG001|Period 2|Withdrawal by Subject|0|||
131680204|NCT01968070|474116235|FG002|Period 2|Withdrawal by Subject|0|||
131680205|NCT01968070|474116236|FG003|Period 2|Withdrawal by Subject|0|||
131680206|NCT01968070|474116237|FG004|Period 2|Withdrawal by Subject|1|||
131680207|NCT01968070|474116238|FG005|Period 2|Withdrawal by Subject|0|||
131680208|NCT01968070|474116239|FG006|Period 2|Withdrawal by Subject|0|||
131680209|NCT01968070|474116240|FG007|Period 2|Withdrawal by Subject|0|||
131680210|NCT01968070|474116241|FG008|Period 2|Withdrawal by Subject|0|||
131680211|NCT01968070|474116242|FG009|Period 2|Withdrawal by Subject|0|||
131680212|NCT01968070|474116243|FG010|Period 2|Withdrawal by Subject|0|||
131680213|NCT01968070|474116244|FG011|Period 2|Withdrawal by Subject|0|||
131680214|NCT01968070|474116245|FG012|Period 2|Withdrawal by Subject|0|||
131680215|NCT01968070|474116246|FG013|Period 2|Withdrawal by Subject|0|||
131680216|NCT01968070|474116247|FG014|Period 2|Withdrawal by Subject|0|||
131680217|NCT01968070|474116248|FG015|Period 2|Withdrawal by Subject|0|||
131680218|NCT01968070|474116249|FG016|Period 2|Withdrawal by Subject|0|||
131680219|NCT01968070|474116250|FG017|Period 2|Withdrawal by Subject|0|||
131680220|NCT00108069|474116255|FG000|Overall Study|Never rec'd study drug|0|||
131555710|NCT02632786|473660208|FG001|Overall Study|Withdrawal by Subject|0|||
131555711|NCT01928225|473660209|FG000|Overall Study|Pregnancy|1|||
131555712|NCT01928225|473660210|FG001|Overall Study|Pregnancy|0|||
131555713|NCT01928225|473660209|FG000|Overall Study|basaloid cervical cancer|1|||
131555714|NCT01928225|473660210|FG001|Overall Study|basaloid cervical cancer|0|||
131555715|NCT01928225|473660209|FG000|Overall Study|Lost to Follow-up|1|||
131555716|NCT01928225|473660210|FG001|Overall Study|Lost to Follow-up|3|||
131555717|NCT00474175|473660212|FG000|Overall Study|Lack of Efficacy|0|||
131555718|NCT00474175|473660213|FG001|Overall Study|Lack of Efficacy|0|||
131555719|NCT00474175|473660214|FG002|Overall Study|Lack of Efficacy|1|||
131555720|NCT00474175|473660212|FG000|Overall Study|Withdrawal by Subject|0|||
131555721|NCT00474175|473660213|FG001|Overall Study|Withdrawal by Subject|1|||
131555722|NCT00474175|473660214|FG002|Overall Study|Withdrawal by Subject|1|||
131555723|NCT00474175|473660212|FG000|Overall Study|Ineligible|1|||
131555724|NCT00474175|473660213|FG001|Overall Study|Ineligible|3|||
131555725|NCT00474175|473660214|FG002|Overall Study|Ineligible|1|||
131555726|NCT00474175|473660212|FG000|Overall Study|Protocol Violation|0|||
131555727|NCT00474175|473660213|FG001|Overall Study|Protocol Violation|2|||
131555728|NCT00474175|473660214|FG002|Overall Study|Protocol Violation|1|||
131555729|NCT00474175|473660212|FG000|Overall Study|Administrative|0|||
131555730|NCT00474175|473660213|FG001|Overall Study|Administrative|1|||
131555731|NCT00474175|473660214|FG002|Overall Study|Administrative|0|||
131555732|NCT01460160|473660216|FG000|Treatment Phase|Lack of Efficacy|3|||
131555733|NCT01460160|473660216|FG000|Treatment Phase|Study Drug Toxicity|2|||
131555734|NCT01460160|473660216|FG000|Treatment Phase|Adverse Event|8|||
131555735|NCT01460160|473660216|FG000|Treatment Phase|Withdrawal by Subject|4|||
131555736|NCT01460160|473660216|FG000|Treatment Phase|Death|2|||
131555737|NCT01460160|473660216|FG000|Treatment Phase|Other reasons|9|||
131555738|NCT01460160|473660216|FG000|Follow-up Phase|Withdrawal by Subject|4|||
131555739|NCT01460160|473660216|FG000|Follow-up Phase|Death|14|||
131555740|NCT01460160|473660216|FG000|Follow-up Phase|Lost to Follow-up|7|||
131555741|NCT01460160|473660216|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
131555742|NCT01460160|473660216|FG000|Follow-up Phase|Other and not reported reasons|5|||
131555743|NCT02091739|473660218|FG000|MP: 16 Weeks|Adverse Event|1|||
131555744|NCT02091739|473660219|FG001|MP: 16 Weeks|Adverse Event|1|||
131555745|NCT02091739|473660220|FG002|MP: 16 Weeks|Adverse Event|1|||
131555746|NCT02091739|473660221|FG003|MP: 16 Weeks|Adverse Event|0|||
131555747|NCT02091739|473660222|FG004|MP: 16 Weeks|Adverse Event|0|||
131555748|NCT02091739|473660218|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
131555749|NCT02091739|473660219|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
131555750|NCT02091739|473660220|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
131555751|NCT02091739|473660221|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
131555752|NCT02091739|473660222|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
131555753|NCT02091739|473660218|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
131555754|NCT02091739|473660219|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
131555755|NCT02091739|473660220|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
131555756|NCT02091739|473660221|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
131555757|NCT02091739|473660222|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
131555758|NCT02091739|473660218|FG000|EP: 48 Weeks|Other|0|||
131555759|NCT02091739|473660219|FG001|EP: 48 Weeks|Other|0|||
131555760|NCT02091739|473660220|FG002|EP: 48 Weeks|Other|0|||
131555761|NCT02091739|473660221|FG003|EP: 48 Weeks|Other|1|||
131555762|NCT02091739|473660222|FG004|EP: 48 Weeks|Other|0|||
131555763|NCT02091739|473660218|FG000|EP: 48 Weeks|Death|0|||
131555764|NCT02091739|473660219|FG001|EP: 48 Weeks|Death|0|||
131555765|NCT02091739|473660220|FG002|EP: 48 Weeks|Death|0|||
131555766|NCT02091739|473660221|FG003|EP: 48 Weeks|Death|3|||
131555767|NCT02091739|473660222|FG004|EP: 48 Weeks|Death|2|||
131555768|NCT02091739|473660218|FG000|EP: 48 Weeks|Adverse Event|0|||
131555769|NCT02091739|473660219|FG001|EP: 48 Weeks|Adverse Event|0|||
131555770|NCT02091739|473660220|FG002|EP: 48 Weeks|Adverse Event|0|||
131555771|NCT02091739|473660221|FG003|EP: 48 Weeks|Adverse Event|2|||
131555772|NCT02091739|473660222|FG004|EP: 48 Weeks|Adverse Event|6|||
131555773|NCT02091739|473660218|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
131555774|NCT02091739|473660219|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
131555775|NCT02091739|473660220|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
131555776|NCT02091739|473660221|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
131680221|NCT00108069|474116256|FG001|Overall Study|Never rec'd study drug|1|||
131680222|NCT00108069|474116255|FG000|Overall Study|Adverse Event|1|||
131680223|NCT00108069|474116256|FG001|Overall Study|Adverse Event|1|||
131680224|NCT00108069|474116255|FG000|Overall Study|Withdrawal by Subject|1|||
131680225|NCT00108069|474116256|FG001|Overall Study|Withdrawal by Subject|0|||
131680226|NCT00108069|474116255|FG000|Overall Study|Death|1|||
131680227|NCT00108069|474116256|FG001|Overall Study|Death|0|||
131680228|NCT00108069|474116255|FG000|Overall Study|Progessive disease|27|||
131680229|NCT00108069|474116256|FG001|Overall Study|Progessive disease|11|||
131680230|NCT00995007|474116257|FG000|Overall Study|Withdrew consent|1|||
131680231|NCT00995007|474116258|FG001|Overall Study|Withdrew consent|0|||
131680232|NCT00995007|474116257|FG000|Overall Study|Refused further treatment|8|||
131680233|NCT00995007|474116258|FG001|Overall Study|Refused further treatment|2|||
131680234|NCT00995007|474116257|FG000|Overall Study|Toxicity|8|||
131680235|NCT00995007|474116258|FG001|Overall Study|Toxicity|0|||
131680236|NCT03933397|474116259|FG000|Overall Study|No emergency department visit|65|||
131680237|NCT03933397|474116260|FG001|Overall Study|No emergency department visit|71|||
131680238|NCT03933397|474116259|FG000|Overall Study|Missed emergency department visit|25|||
131680239|NCT03933397|474116260|FG001|Overall Study|Missed emergency department visit|30|||
131680240|NCT03933397|474116259|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
131680241|NCT03933397|474116260|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
131680242|NCT03933397|474116259|FG000|Overall Study|Withdrawal by Subject|1|||
131680243|NCT03933397|474116260|FG001|Overall Study|Withdrawal by Subject|0|||
131680244|NCT03933397|474116259|FG000|Overall Study|Physician Decision|1|||
131680245|NCT03933397|474116260|FG001|Overall Study|Physician Decision|1|||
131680246|NCT03933397|474116259|FG000|Overall Study|missing pain score|1|||
131680247|NCT03933397|474116260|FG001|Overall Study|missing pain score|1|||
131680248|NCT03933397|474116259|FG000|Overall Study|Confirmed COVID-19|1|||
131680249|NCT03933397|474116260|FG001|Overall Study|Confirmed COVID-19|2|||
131680250|NCT03606980|474116263|FG000|Overall Study|Lost to Follow-up|3|||
131680251|NCT03606980|474116264|FG001|Overall Study|Lost to Follow-up|2|||
131680252|NCT03606980|474116265|FG002|Overall Study|Lost to Follow-up|3|||
131680253|NCT03606980|474116263|FG000|Overall Study|Withdrawal by Subject|1|||
131680254|NCT03606980|474116264|FG001|Overall Study|Withdrawal by Subject|0|||
131680255|NCT03606980|474116265|FG002|Overall Study|Withdrawal by Subject|4|||
131680256|NCT02469896|474116268|FG000|Overall Study|Withdrawal by Subject|2|||
131680257|NCT02469896|474116269|FG001|Overall Study|Withdrawal by Subject|0|||
131680258|NCT01294150|474116270|FG000|Overall Study|Physician Decision|2|||
131680259|NCT01294150|474116271|FG001|Overall Study|Physician Decision|2|||
131680260|NCT03675776|474116272|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
131680261|NCT03675776|474116273|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
131680262|NCT03675776|474116274|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
131680263|NCT03675776|474116272|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
131680264|NCT03675776|474116273|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
131680265|NCT03675776|474116274|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
131680266|NCT02401412|474116275|FG000|Overall Study|Lost to Follow-up|1|||
131680267|NCT02401412|474116276|FG001|Overall Study|Lost to Follow-up|0|||
131680268|NCT02401412|474116275|FG000|Overall Study|Discontinued Intervention|15|||
131680269|NCT02401412|474116276|FG001|Overall Study|Discontinued Intervention|21|||
131680270|NCT02401412|474116275|FG000|Overall Study|Withdrawal by Subject|4|||
131680271|NCT02401412|474116276|FG001|Overall Study|Withdrawal by Subject|4|||
131680272|NCT02401412|474116275|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
131680273|NCT02401412|474116276|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
131680274|NCT02401412|474116275|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
131680275|NCT02401412|474116276|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
131680276|NCT00882310|474116277|FG000|Overall Study|Screen Failure|10|||
131680277|NCT00882310|474116277|FG000|Overall Study|Never received treatment|1|||
131680278|NCT00882310|474116277|FG000|Overall Study|Death|6|||
131680279|NCT00882310|474116277|FG000|Overall Study|Progression of disease|4|||
131680280|NCT00882310|474116277|FG000|Overall Study|Adverse Event|1|||
131680281|NCT04513665|474116280|FG000|Overall Study|Adverse Event|2|||
131680282|NCT04513665|474116281|FG001|Overall Study|Adverse Event|0|||
131680283|NCT04513665|474116280|FG000|Overall Study|Lack of Efficacy|14|||
131680284|NCT04513665|474116281|FG001|Overall Study|Lack of Efficacy|0|||
131680285|NCT02608879|474116283|FG000|Overall Study|Lost to Follow-up|1|||
131680286|NCT02608879|474116284|FG001|Overall Study|Lost to Follow-up|0|||
131680287|NCT02608879|474116285|FG002|Overall Study|Lost to Follow-up|0|||
131680288|NCT02608879|474116283|FG000|Overall Study|Did not meet continuation criteria|0|||
131680289|NCT02608879|474116284|FG001|Overall Study|Did not meet continuation criteria|0|||
131680290|NCT02608879|474116285|FG002|Overall Study|Did not meet continuation criteria|3|||
131680291|NCT04246801|474116286|FG000|Overall Study|Adverse Event|1|||
131680292|NCT04246801|474116287|FG001|Overall Study|Adverse Event|1|||
131680293|NCT04246801|474116286|FG000|Overall Study|Protocol Violation|1|||
131680294|NCT04246801|474116287|FG001|Overall Study|Protocol Violation|1|||
131680295|NCT04246801|474116286|FG000|Overall Study|Lack of Efficacy|0|||
131680296|NCT04246801|474116287|FG001|Overall Study|Lack of Efficacy|2|||
131680297|NCT04246801|474116286|FG000|Overall Study|Lost to Follow-up|1|||
131680298|NCT04246801|474116287|FG001|Overall Study|Lost to Follow-up|1|||
131680299|NCT04246801|474116286|FG000|Overall Study|Withdrawal by Subject|2|||
131680300|NCT04246801|474116287|FG001|Overall Study|Withdrawal by Subject|1|||
131680301|NCT03684642|474116288|FG000|Overall Study|Adverse Event|6|||
131680302|NCT03684642|474116289|FG001|Overall Study|Adverse Event|15|||
131680303|NCT03684642|474116290|FG002|Overall Study|Adverse Event|11|||
131680304|NCT03684642|474116288|FG000|Overall Study|Withdrawal by Subject|35|||
131680305|NCT03684642|474116289|FG001|Overall Study|Withdrawal by Subject|53|||
131680306|NCT03684642|474116290|FG002|Overall Study|Withdrawal by Subject|23|||
131680307|NCT03684642|474116288|FG000|Overall Study|Lack of Efficacy|0|||
131680308|NCT03684642|474116289|FG001|Overall Study|Lack of Efficacy|0|||
131680309|NCT03684642|474116290|FG002|Overall Study|Lack of Efficacy|1|||
131680310|NCT03684642|474116288|FG000|Overall Study|Poor compliance to protocol|0|||
131680311|NCT03684642|474116289|FG001|Overall Study|Poor compliance to protocol|4|||
131680312|NCT03684642|474116290|FG002|Overall Study|Poor compliance to protocol|1|||
131680313|NCT03684642|474116288|FG000|Overall Study|Other than specified|62|||
131680314|NCT03684642|474116289|FG001|Overall Study|Other than specified|60|||
131680315|NCT03684642|474116290|FG002|Overall Study|Other than specified|67|||
131680316|NCT03684642|474116288|FG000|Overall Study|Randomized and not treated|0|||
131680317|NCT03684642|474116289|FG001|Overall Study|Randomized and not treated|0|||
131680318|NCT03684642|474116290|FG002|Overall Study|Randomized and not treated|1|||
131680319|NCT03684642|474116288|FG000|Overall Study|Missing completion status but alive at last contact|0|||
131680320|NCT03684642|474116289|FG001|Overall Study|Missing completion status but alive at last contact|1|||
131680321|NCT03684642|474116290|FG002|Overall Study|Missing completion status but alive at last contact|2|||
131680322|NCT02966223|474116301|FG000|Overall Study|Physician Decision|3|||
131680323|NCT02966223|474116301|FG000|Overall Study|Withdrawal by Subject|11|||
131680324|NCT02966223|474116301|FG000|Overall Study|Lost to Follow-up|1|||
131680325|NCT00805025|474116305|FG000|Overall Study|Screened but not enrolled/treated|42|||
131680326|NCT00805025|474116305|FG000|Overall Study|Adverse Event|4|||
131680327|NCT00805025|474116305|FG000|Overall Study|Withdrawal by Subject|2|||
131680328|NCT00805025|474116305|FG000|Overall Study|Physician Decision|1|||
131680329|NCT00375219|474116306|FG000|Overall Study|Failure to achieve a response|16|||
131680330|NCT00375219|474116307|FG001|Overall Study|Failure to achieve a response|2|||
131555777|NCT02091739|473660222|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
131680331|NCT00375219|474116308|FG002|Overall Study|Failure to achieve a response|0|||
131680332|NCT00375219|474116306|FG000|Overall Study|Adverse Event|8|||
131680333|NCT00375219|474116307|FG001|Overall Study|Adverse Event|2|||
131680334|NCT00375219|474116308|FG002|Overall Study|Adverse Event|1|||
131555778|NCT00192023|473660223|FG000|Period III - Double-Blind|Adverse Event|3|||
131555779|NCT00192023|473660224|FG001|Period III - Double-Blind|Adverse Event|0|||
131555780|NCT00192023|473660223|FG000|Period III - Double-Blind|Physician Decision|2|||
131555781|NCT00192023|473660224|FG001|Period III - Double-Blind|Physician Decision|0|||
131555782|NCT00192023|473660223|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
131555783|NCT00192023|473660224|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
131555784|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
131555785|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
131555786|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
131555787|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
131555788|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
131555789|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
131555790|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
131555791|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
131555792|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
131555793|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
131555794|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
131555795|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
131555796|NCT00192023|473660223|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
131555797|NCT00192023|473660224|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
131555798|NCT01381874|473660225|FG000|Overall Study|Lost to Follow-up|1|||
131555799|NCT01381874|473660226|FG001|Overall Study|Lost to Follow-up|1|||
131555800|NCT01381874|473660227|FG002|Overall Study|Lost to Follow-up|0|||
131555801|NCT01381874|473660225|FG000|Overall Study|Withdrawal by Subject|9|||
131555802|NCT01381874|473660226|FG001|Overall Study|Withdrawal by Subject|10|||
131555803|NCT01381874|473660227|FG002|Overall Study|Withdrawal by Subject|9|||
131555804|NCT01381874|473660225|FG000|Overall Study|Other|67|||
131555805|NCT01381874|473660226|FG001|Overall Study|Other|52|||
131555806|NCT01381874|473660227|FG002|Overall Study|Other|67|||
131555807|NCT01737996|473660234|FG000|Overall Study|Adverse Event|0|||
131555808|NCT01737996|473660235|FG001|Overall Study|Adverse Event|1|||
131555809|NCT01737996|473660236|FG002|Overall Study|Adverse Event|1|||
131555810|NCT01737996|473660234|FG000|Overall Study|Withdrawal by Subject|0|||
131555811|NCT01737996|473660235|FG001|Overall Study|Withdrawal by Subject|0|||
131555812|NCT01737996|473660236|FG002|Overall Study|Withdrawal by Subject|1|||
131555813|NCT00452413|473660237|FG000|Overall Study|Progressive Disease|4|||
131555814|NCT00452413|473660238|FG001|Overall Study|Progressive Disease|11|||
131555815|NCT00452413|473660239|FG002|Overall Study|Progressive Disease|30|||
131555816|NCT00452413|473660237|FG000|Overall Study|Withdrawal by Subject|0|||
131555817|NCT00452413|473660238|FG001|Overall Study|Withdrawal by Subject|1|||
131555818|NCT00452413|473660239|FG002|Overall Study|Withdrawal by Subject|4|||
131555819|NCT00452413|473660237|FG000|Overall Study|Adverse Event|0|||
131555820|NCT00452413|473660238|FG001|Overall Study|Adverse Event|0|||
131555821|NCT00452413|473660239|FG002|Overall Study|Adverse Event|5|||
131555822|NCT00452413|473660237|FG000|Overall Study|Physician Decision|0|||
131555823|NCT00452413|473660238|FG001|Overall Study|Physician Decision|0|||
131555824|NCT00452413|473660239|FG002|Overall Study|Physician Decision|4|||
131555825|NCT00452413|473660237|FG000|Overall Study|Death due to study disease|0|||
131555826|NCT00452413|473660238|FG001|Overall Study|Death due to study disease|0|||
131555827|NCT00452413|473660239|FG002|Overall Study|Death due to study disease|2|||
131555828|NCT00452413|473660237|FG000|Overall Study|Death due to adverse event (AE)|0|||
131555829|NCT00452413|473660238|FG001|Overall Study|Death due to adverse event (AE)|0|||
131555830|NCT00452413|473660239|FG002|Overall Study|Death due to adverse event (AE)|1|||
131555831|NCT00452413|473660237|FG000|Overall Study|On treatment|0|||
131555832|NCT00452413|473660238|FG001|Overall Study|On treatment|0|||
131555833|NCT00452413|473660239|FG002|Overall Study|On treatment|3|||
131555834|NCT01248962|473660240|FG000|Overall Study|Withdrawal by Subject|1|||
131555835|NCT01248962|473660241|FG001|Overall Study|Withdrawal by Subject|1|||
131555836|NCT01248962|473660240|FG000|Overall Study|Adverse Event|2|||
131555837|NCT01248962|473660241|FG001|Overall Study|Adverse Event|1|||
131555838|NCT01248962|473660240|FG000|Overall Study|Complete Response after 4 Cycles|1|||
131555839|NCT01248962|473660241|FG001|Overall Study|Complete Response after 4 Cycles|0|||
131555840|NCT01248962|473660240|FG000|Overall Study|Complete Response after 3 Cycles|0|||
131555841|NCT01248962|473660241|FG001|Overall Study|Complete Response after 3 Cycles|1|||
131555842|NCT01248962|473660240|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
131555843|NCT01248962|473660241|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
131555844|NCT01027364|473660242|FG000|Overall Study|Adverse Event|1|||
131555845|NCT01027364|473660243|FG001|Overall Study|Adverse Event|0|||
131555846|NCT01027364|473660244|FG002|Overall Study|Adverse Event|1|||
131555847|NCT01027364|473660245|FG003|Overall Study|Adverse Event|0|||
131555848|NCT01027364|473660242|FG000|Overall Study|Lost to Follow-up|1|||
131555849|NCT01027364|473660243|FG001|Overall Study|Lost to Follow-up|0|||
131555850|NCT01027364|473660244|FG002|Overall Study|Lost to Follow-up|0|||
131555851|NCT01027364|473660245|FG003|Overall Study|Lost to Follow-up|0|||
131555852|NCT01027364|473660242|FG000|Overall Study|Protocol Violation|1|||
131680335|NCT00375219|474116306|FG000|Overall Study|Protocol Violation|1|||
131680336|NCT00375219|474116307|FG001|Overall Study|Protocol Violation|0|||
131680337|NCT00375219|474116308|FG002|Overall Study|Protocol Violation|1|||
131680338|NCT00375219|474116306|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
131680339|NCT00375219|474116307|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
131680340|NCT00375219|474116308|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
131680341|NCT00375219|474116306|FG000|Overall Study|Lost to Follow-up|1|||
131680342|NCT00375219|474116307|FG001|Overall Study|Lost to Follow-up|1|||
131680343|NCT00375219|474116308|FG002|Overall Study|Lost to Follow-up|0|||
131680344|NCT00375219|474116306|FG000|Overall Study|Disease progression|18|||
131680345|NCT00375219|474116307|FG001|Overall Study|Disease progression|9|||
131680346|NCT00375219|474116308|FG002|Overall Study|Disease progression|12|||
131680347|NCT00375219|474116306|FG000|Overall Study|Death|4|||
131680348|NCT00375219|474116307|FG001|Overall Study|Death|3|||
131680349|NCT00375219|474116308|FG002|Overall Study|Death|7|||
131680350|NCT00375219|474116306|FG000|Overall Study|Hematologic resistance|1|||
131680351|NCT00375219|474116307|FG001|Overall Study|Hematologic resistance|0|||
131680352|NCT00375219|474116308|FG002|Overall Study|Hematologic resistance|0|||
131680353|NCT00375219|474116306|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
131680354|NCT00375219|474116307|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
131680355|NCT00375219|474116308|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
131680356|NCT00375219|474116306|FG000|Overall Study|Allograft|2|||
131680357|NCT00375219|474116307|FG001|Overall Study|Allograft|0|||
131680358|NCT00375219|474116308|FG002|Overall Study|Allograft|0|||
131680359|NCT00375219|474116306|FG000|Overall Study|Cord blood transplantation|1|||
131680360|NCT00375219|474116307|FG001|Overall Study|Cord blood transplantation|0|||
131680361|NCT00375219|474116308|FG002|Overall Study|Cord blood transplantation|0|||
131680362|NCT00375219|474116306|FG000|Overall Study|Withdrawal by Subject|1|||
131680363|NCT00375219|474116307|FG001|Overall Study|Withdrawal by Subject|0|||
131680364|NCT00375219|474116308|FG002|Overall Study|Withdrawal by Subject|0|||
131680365|NCT01667107|474116309|FG000|Overall Study|Adverse Event|4|||
131680366|NCT01667107|474116310|FG001|Overall Study|Adverse Event|3|||
131680367|NCT01667107|474116309|FG000|Overall Study|Tolerability issues|0|||
131680368|NCT01667107|474116310|FG001|Overall Study|Tolerability issues|2|||
131680369|NCT01667107|474116309|FG000|Overall Study|Protocol Violation|0|||
131680370|NCT01667107|474116310|FG001|Overall Study|Protocol Violation|1|||
131680371|NCT01667107|474116309|FG000|Overall Study|Lack of Efficacy|0|||
131680372|NCT01667107|474116310|FG001|Overall Study|Lack of Efficacy|1|||
131680373|NCT02733185|474116313|FG000|Overall Study|Withdrawal by Subject|12|||
131680374|NCT02733185|474116314|FG001|Overall Study|Withdrawal by Subject|10|||
131680375|NCT02733185|474116315|FG002|Overall Study|Withdrawal by Subject|17|||
131680376|NCT02733185|474116316|FG003|Overall Study|Withdrawal by Subject|21|||
131680377|NCT02733185|474116313|FG000|Overall Study|Death|46|||
131680378|NCT02733185|474116314|FG001|Overall Study|Death|34|||
131680379|NCT02733185|474116315|FG002|Overall Study|Death|35|||
131680380|NCT02733185|474116316|FG003|Overall Study|Death|43|||
131680381|NCT02733185|474116313|FG000|Overall Study|Lost to Follow-up|17|||
131680382|NCT02733185|474116314|FG001|Overall Study|Lost to Follow-up|18|||
131680383|NCT02733185|474116315|FG002|Overall Study|Lost to Follow-up|16|||
131680384|NCT02733185|474116316|FG003|Overall Study|Lost to Follow-up|11|||
131680385|NCT01624259|474116317|FG000|Overall Study|Adverse Event|18|||
131680386|NCT01624259|474116318|FG001|Overall Study|Adverse Event|18|||
131680387|NCT01624259|474116317|FG000|Overall Study|Protocol Violation|1|||
131680388|NCT01624259|474116318|FG001|Overall Study|Protocol Violation|2|||
131680389|NCT01624259|474116317|FG000|Overall Study|Withdrawal by Subject|5|||
131680390|NCT01624259|474116318|FG001|Overall Study|Withdrawal by Subject|7|||
131680391|NCT01624259|474116317|FG000|Overall Study|Physician Decision|1|||
131680392|NCT01624259|474116318|FG001|Overall Study|Physician Decision|1|||
131680393|NCT01624259|474116317|FG000|Overall Study|Lost to Follow-up|2|||
131680394|NCT01624259|474116318|FG001|Overall Study|Lost to Follow-up|3|||
131680395|NCT01624259|474116317|FG000|Overall Study|Abnormal laboratory measure|3|||
131680396|NCT01624259|474116318|FG001|Overall Study|Abnormal laboratory measure|0|||
131680397|NCT03828292|474116319|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131680398|NCT03828292|474116320|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
131680399|NCT03828292|474116321|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131680400|NCT03828292|474116322|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131680401|NCT03828292|474116323|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131680402|NCT03828292|474116324|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131680403|NCT03828292|474116319|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131680404|NCT03828292|474116320|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131680405|NCT03828292|474116321|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
131680406|NCT03828292|474116322|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131680407|NCT03828292|474116323|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131680408|NCT03828292|474116324|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131680409|NCT03828292|474116319|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131680410|NCT03828292|474116320|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131680411|NCT03828292|474116321|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131680412|NCT03828292|474116322|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
131680413|NCT03828292|474116323|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131680414|NCT03828292|474116324|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131680415|NCT03828292|474116319|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131680416|NCT03828292|474116320|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131680417|NCT03828292|474116321|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131680418|NCT03828292|474116322|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
131680419|NCT03828292|474116323|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131680420|NCT03828292|474116324|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131680421|NCT03828292|474116319|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131680422|NCT03828292|474116320|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131680423|NCT03828292|474116321|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
131680424|NCT03828292|474116322|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
131680425|NCT03828292|474116323|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131680426|NCT03828292|474116324|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131680427|NCT01444456|474116325|FG000|Overall Study|Withdrawal by Subject|21|||
131680428|NCT01444456|474116325|FG000|Overall Study|Physician Decision|9|||
131680429|NCT01444456|474116325|FG000|Overall Study|Lost to Follow-up|37|||
131680430|NCT01444456|474116325|FG000|Overall Study|Death|73|||
131680431|NCT01444456|474116325|FG000|Overall Study|Ineligibility determined|23|||
131680432|NCT01444456|474116325|FG000|Overall Study|Other|18|||
131680433|NCT01444456|474116325|FG000|Overall Study|Not treated|104|||
131680434|NCT04313153|474117621|FG000|Overall Study|Adverse Event (includes Death)|14|||
131680435|NCT04313153|474117622|FG001|Overall Study|Adverse Event (includes Death)|19|||
131680436|NCT04313153|474117623|FG002|Overall Study|Adverse Event (includes Death)|10|||
131680437|NCT04313153|474117621|FG000|Overall Study|Physician Decision|4|||
131680438|NCT04313153|474117622|FG001|Overall Study|Physician Decision|2|||
131680439|NCT04313153|474117623|FG002|Overall Study|Physician Decision|1|||
131680440|NCT04313153|474117621|FG000|Overall Study|Withdrawal by Subject|7|||
131680441|NCT04313153|474117622|FG001|Overall Study|Withdrawal by Subject|6|||
131680442|NCT04313153|474117623|FG002|Overall Study|Withdrawal by Subject|2|||
131680443|NCT04313153|474117621|FG000|Overall Study|Lack of Efficacy|3|||
131680444|NCT04313153|474117622|FG001|Overall Study|Lack of Efficacy|3|||
131680445|NCT04313153|474117623|FG002|Overall Study|Lack of Efficacy|0|||
131680446|NCT04313153|474117621|FG000|Overall Study|Lost to Follow-up|1|||
131680447|NCT04313153|474117622|FG001|Overall Study|Lost to Follow-up|0|||
131680448|NCT04313153|474117623|FG002|Overall Study|Lost to Follow-up|2|||
131680449|NCT04313153|474117621|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
131680450|NCT04313153|474117622|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
131680451|NCT04313153|474117623|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
131680452|NCT04313153|474117621|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
131680453|NCT04313153|474117622|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
131680454|NCT04313153|474117623|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
131680455|NCT04313153|474117621|FG000|Overall Study|Change in Dialysis Modality|0|||
131680456|NCT04313153|474117622|FG001|Overall Study|Change in Dialysis Modality|1|||
131680457|NCT04313153|474117623|FG002|Overall Study|Change in Dialysis Modality|2|||
131680458|NCT04313153|474117621|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
131680459|NCT04313153|474117622|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
131680460|NCT04313153|474117623|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
131680461|NCT04313153|474117621|FG000|Overall Study|Other|5|||
131680462|NCT04313153|474117622|FG001|Overall Study|Other|3|||
131680463|NCT04313153|474117623|FG002|Overall Study|Other|2|||
131680464|NCT00332839|474117624|FG000|Core (Months 0 - 12)|Administrative problems|1|||
131680465|NCT00332839|474117625|FG001|Core (Months 0 - 12)|Administrative problems|1|||
131680466|NCT00332839|474117624|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
131680467|NCT00332839|474117625|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
131680468|NCT00332839|474117624|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
131680469|NCT00332839|474117625|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
131680470|NCT00332839|474117624|FG000|Core (Months 0 - 12)|Adverse Event|5|||
131680471|NCT00332839|474117625|FG001|Core (Months 0 - 12)|Adverse Event|15|||
131555853|NCT01027364|473660243|FG001|Overall Study|Protocol Violation|0|||
131555854|NCT01027364|473660244|FG002|Overall Study|Protocol Violation|0|||
131680472|NCT00332839|474117624|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
131680473|NCT00332839|474117625|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
131680474|NCT00332839|474117624|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
131680475|NCT00332839|474117625|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
131680476|NCT00332839|474117624|FG000|Follow-up (Months 12 - 60)|Death|1|||
131680477|NCT00332839|474117625|FG001|Follow-up (Months 12 - 60)|Death|1|||
131680478|NCT04641299|474117627|FG000|Overall Study|Adverse Event|0|||
131680479|NCT04641299|474117628|FG001|Overall Study|Adverse Event|0|||
131680480|NCT04641299|474117629|FG002|Overall Study|Adverse Event|2|||
131680481|NCT04641299|474117630|FG003|Overall Study|Adverse Event|0|||
131680482|NCT04641299|474117627|FG000|Overall Study|Lost to Follow-up|0|||
131680483|NCT04641299|474117628|FG001|Overall Study|Lost to Follow-up|1|||
131680484|NCT04641299|474117629|FG002|Overall Study|Lost to Follow-up|0|||
131680485|NCT04641299|474117630|FG003|Overall Study|Lost to Follow-up|0|||
131680486|NCT04641299|474117627|FG000|Overall Study|Withdrawal by Subject|1|||
131680487|NCT04641299|474117628|FG001|Overall Study|Withdrawal by Subject|0|||
131680488|NCT04641299|474117629|FG002|Overall Study|Withdrawal by Subject|0|||
131680489|NCT04641299|474117630|FG003|Overall Study|Withdrawal by Subject|0|||
131680490|NCT04641299|474117627|FG000|Overall Study|Reason not given|1|||
131680491|NCT04641299|474117628|FG001|Overall Study|Reason not given|0|||
131680492|NCT04641299|474117629|FG002|Overall Study|Reason not given|0|||
131680493|NCT04641299|474117630|FG003|Overall Study|Reason not given|0|||
131680494|NCT01920594|474117633|FG000|Overall Study|Adverse Event|4|||
131680495|NCT01920594|474117634|FG001|Overall Study|Adverse Event|2|||
131680496|NCT01920594|474117633|FG000|Overall Study|Lost to Follow-up|1|||
131680497|NCT01920594|474117634|FG001|Overall Study|Lost to Follow-up|0|||
131680498|NCT01920594|474117633|FG000|Overall Study|Recovery|2|||
131680499|NCT01920594|474117634|FG001|Overall Study|Recovery|0|||
131680500|NCT01920594|474117633|FG000|Overall Study|Investigator discretion|0|||
131680501|NCT01920594|474117634|FG001|Overall Study|Investigator discretion|1|||
131680502|NCT02460497|474117637|FG000|Overall Study|Participant Requested Withdrawal|4|||
131680503|NCT02460497|474117637|FG000|Overall Study|Non-Compliance|1|||
131680504|NCT02460497|474117637|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
131680505|NCT02460497|474117637|FG000|Overall Study|Lost to Follow-up|2|||
131680506|NCT02460497|474117637|FG000|Overall Study|Investigator Decision|1|||
131680507|NCT02012296|474117642|FG000|Overall Study|Lack of Efficacy|0|||
131680508|NCT02012296|474117643|FG001|Overall Study|Lack of Efficacy|0|||
131680509|NCT02012296|474117644|FG002|Overall Study|Lack of Efficacy|15|||
131680510|NCT02012296|474117642|FG000|Overall Study|Adverse Event|0|||
131680511|NCT02012296|474117643|FG001|Overall Study|Adverse Event|0|||
131680512|NCT02012296|474117644|FG002|Overall Study|Adverse Event|2|||
131680513|NCT02012296|474117642|FG000|Overall Study|Early study closure|0|||
131680514|NCT02012296|474117643|FG001|Overall Study|Early study closure|0|||
131680515|NCT02012296|474117644|FG002|Overall Study|Early study closure|5|||
131680516|NCT02012296|474117642|FG000|Overall Study|Protocol Violation|0|||
131680517|NCT02012296|474117643|FG001|Overall Study|Protocol Violation|1|||
131680518|NCT02012296|474117644|FG002|Overall Study|Protocol Violation|0|||
131680519|NCT01448213|474117645|FG000|Overall Study|Lost to Follow-up|12|||
131680520|NCT01448213|474117646|FG001|Overall Study|Lost to Follow-up|10|||
131680521|NCT01448213|474117645|FG000|Overall Study|Adverse Event|4|||
131680522|NCT01448213|474117646|FG001|Overall Study|Adverse Event|10|||
131680523|NCT01448213|474117645|FG000|Overall Study|Protocol Violation|1|||
131680524|NCT01448213|474117646|FG001|Overall Study|Protocol Violation|2|||
131680525|NCT01330914|474117647|FG000|Overall Study|Withdrawal by Subject|4|||
131680526|NCT01330914|474117647|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
131680527|NCT01830855|474117648|FG000|Overall Study|Other|7|||
131680528|NCT01830855|474117649|FG001|Overall Study|Other|1|||
131680529|NCT01830855|474117650|FG002|Overall Study|Other|4|||
131680530|NCT01830855|474117651|FG003|Overall Study|Other|4|||
131680531|NCT01830855|474117648|FG000|Overall Study|Medication error without associated AE|1|||
131680532|NCT01830855|474117649|FG001|Overall Study|Medication error without associated AE|0|||
131680533|NCT01830855|474117650|FG002|Overall Study|Medication error without associated AE|0|||
131680534|NCT01830855|474117651|FG003|Overall Study|Medication error without associated AE|1|||
131680535|NCT01830855|474117648|FG000|Overall Study|Pregnancy|3|||
131680536|NCT01830855|474117649|FG001|Overall Study|Pregnancy|1|||
131680537|NCT01830855|474117650|FG002|Overall Study|Pregnancy|2|||
131680538|NCT01830855|474117651|FG003|Overall Study|Pregnancy|1|||
131680539|NCT01830855|474117648|FG000|Overall Study|No longer meets eligibility criteria|11|||
131680540|NCT01830855|474117649|FG001|Overall Study|No longer meets eligibility criteria|2|||
131680541|NCT01830855|474117650|FG002|Overall Study|No longer meets eligibility criteria|3|||
131680542|NCT01830855|474117651|FG003|Overall Study|No longer meets eligibility criteria|5|||
131680543|NCT01830855|474117648|FG000|Overall Study|Adverse Event|11|||
131680544|NCT01830855|474117649|FG001|Overall Study|Adverse Event|5|||
131680545|NCT01830855|474117650|FG002|Overall Study|Adverse Event|6|||
131680546|NCT01830855|474117651|FG003|Overall Study|Adverse Event|3|||
131680547|NCT01830855|474117648|FG000|Overall Study|Protocol deviation|10|||
131680548|NCT01830855|474117649|FG001|Overall Study|Protocol deviation|5|||
131680549|NCT01830855|474117650|FG002|Overall Study|Protocol deviation|6|||
131680550|NCT01830855|474117651|FG003|Overall Study|Protocol deviation|6|||
131680551|NCT01830855|474117648|FG000|Overall Study|Withdrawal by Subject|33|||
131680552|NCT01830855|474117649|FG001|Overall Study|Withdrawal by Subject|14|||
131680553|NCT01830855|474117650|FG002|Overall Study|Withdrawal by Subject|10|||
131680554|NCT01830855|474117651|FG003|Overall Study|Withdrawal by Subject|12|||
131680555|NCT01830855|474117648|FG000|Overall Study|No longer willing to participate|32|||
131680556|NCT01830855|474117649|FG001|Overall Study|No longer willing to participate|13|||
131680557|NCT01830855|474117650|FG002|Overall Study|No longer willing to participate|12|||
131680558|NCT01830855|474117651|FG003|Overall Study|No longer willing to participate|17|||
131680559|NCT01830855|474117648|FG000|Overall Study|Lost to Follow-up|47|||
131680560|NCT01830855|474117649|FG001|Overall Study|Lost to Follow-up|20|||
131680561|NCT01830855|474117650|FG002|Overall Study|Lost to Follow-up|23|||
131680562|NCT01830855|474117651|FG003|Overall Study|Lost to Follow-up|33|||
131680563|NCT03631667|474117656|FG000|Overall Study|Withdrawal by Subject|3|||
131680564|NCT00884325|474117657|FG000|Overall Study|Lost to Follow-up|1|||
131680565|NCT00884325|474117658|FG001|Overall Study|Lost to Follow-up|2|||
131680566|NCT00884325|474117657|FG000|Overall Study|Lack of Efficacy|0|||
131680567|NCT00884325|474117658|FG001|Overall Study|Lack of Efficacy|1|||
131680568|NCT00884325|474117657|FG000|Overall Study|Withdrawal by Subject|1|||
131680569|NCT00884325|474117658|FG001|Overall Study|Withdrawal by Subject|1|||
131680570|NCT00884325|474117657|FG000|Overall Study|Not provided|1|||
131680571|NCT00884325|474117658|FG001|Overall Study|Not provided|0|||
131680572|NCT00892177|474117659|FG000|Phase II|Ineligible|0|||
131680573|NCT00892177|474117660|FG001|Phase II|Ineligible|0|||
131680574|NCT00892177|474117661|FG002|Phase II|Ineligible|0|||
131680575|NCT00892177|474117662|FG003|Phase II|Ineligible|0|||
131680576|NCT00892177|474117663|FG004|Phase II|Ineligible|1|||
131680577|NCT00892177|474117664|FG005|Phase II|Ineligible|1|||
131680578|NCT00892177|474117659|FG000|Phase II|Withdrawal by Subject|0|||
131680579|NCT00892177|474117660|FG001|Phase II|Withdrawal by Subject|0|||
131680580|NCT00892177|474117661|FG002|Phase II|Withdrawal by Subject|0|||
131680581|NCT00892177|474117662|FG003|Phase II|Withdrawal by Subject|0|||
131680582|NCT00892177|474117663|FG004|Phase II|Withdrawal by Subject|4|||
131680583|NCT00892177|474117664|FG005|Phase II|Withdrawal by Subject|1|||
131680584|NCT01087957|474117666|FG000|Overall Study|Death|2|||
131680585|NCT01087957|474117667|FG001|Overall Study|Death|2|||
131680586|NCT01087957|474117666|FG000|Overall Study|Lost to Follow-up|3|||
131680587|NCT01087957|474117667|FG001|Overall Study|Lost to Follow-up|4|||
131680588|NCT01087957|474117666|FG000|Overall Study|Protocol Violation|13|||
131680589|NCT01087957|474117667|FG001|Overall Study|Protocol Violation|25|||
131680590|NCT01087957|474117666|FG000|Overall Study|Withdrawal by Subject|18|||
131680591|NCT01087957|474117667|FG001|Overall Study|Withdrawal by Subject|15|||
131680592|NCT01087957|474117666|FG000|Overall Study|Physician Decision|5|||
131680593|NCT01087957|474117667|FG001|Overall Study|Physician Decision|9|||
131680594|NCT00616434|474117672|FG000|Overall Study|Adverse Event|5|||
131680595|NCT00616434|474117673|FG001|Overall Study|Adverse Event|2|||
131680596|NCT00616434|474117672|FG000|Overall Study|Physician Decision|0|||
131680597|NCT00616434|474117673|FG001|Overall Study|Physician Decision|4|||
131680598|NCT00616434|474117672|FG000|Overall Study|Withdrawal by Subject|1|||
131680599|NCT00616434|474117673|FG001|Overall Study|Withdrawal by Subject|1|||
131680600|NCT00616434|474117672|FG000|Overall Study|Protocol deviation|0|||
131680601|NCT00616434|474117673|FG001|Overall Study|Protocol deviation|1|||
131680602|NCT01118325|474117676|FG000|Overall Study|Adverse Event|1|||
131680603|NCT01118325|474117677|FG001|Overall Study|Adverse Event|0|||
131680604|NCT01118325|474117678|FG002|Overall Study|Adverse Event|1|||
131680605|NCT03334409|474117679|FG000|Overall Study|Did not meet inclusion criteria|1|||
131680606|NCT03334409|474117680|FG001|Overall Study|Did not meet inclusion criteria|0|||
131680607|NCT01674712|474117687|FG000|Overall Study|Adverse Event|5|||
131680608|NCT01674712|474117688|FG001|Overall Study|Adverse Event|6|||
131680609|NCT01674712|474117689|FG002|Overall Study|Adverse Event|3|||
131680610|NCT01674712|474117690|FG003|Overall Study|Adverse Event|4|||
131680611|NCT01674712|474117691|FG004|Overall Study|Adverse Event|6|||
131680612|NCT01674712|474117687|FG000|Overall Study|Lost to Follow-up|1|||
131680613|NCT01674712|474117688|FG001|Overall Study|Lost to Follow-up|0|||
131680614|NCT01674712|474117689|FG002|Overall Study|Lost to Follow-up|0|||
131680615|NCT01674712|474117690|FG003|Overall Study|Lost to Follow-up|0|||
131680616|NCT01674712|474117691|FG004|Overall Study|Lost to Follow-up|0|||
131680617|NCT01674712|474117687|FG000|Overall Study|Protocol Violation|2|||
131680618|NCT01674712|474117688|FG001|Overall Study|Protocol Violation|0|||
131680619|NCT01674712|474117689|FG002|Overall Study|Protocol Violation|0|||
131680620|NCT01674712|474117690|FG003|Overall Study|Protocol Violation|0|||
131680621|NCT01674712|474117691|FG004|Overall Study|Protocol Violation|0|||
131680622|NCT01674712|474117687|FG000|Overall Study|Withdrawal by Subject|2|||
131680623|NCT01674712|474117688|FG001|Overall Study|Withdrawal by Subject|2|||
131680624|NCT01674712|474117689|FG002|Overall Study|Withdrawal by Subject|5|||
131680625|NCT01674712|474117690|FG003|Overall Study|Withdrawal by Subject|4|||
131680626|NCT01674712|474117691|FG004|Overall Study|Withdrawal by Subject|3|||
131680627|NCT01674712|474117687|FG000|Overall Study|Administrative|0|||
131680628|NCT01674712|474117688|FG001|Overall Study|Administrative|1|||
131680629|NCT01674712|474117689|FG002|Overall Study|Administrative|0|||
131680630|NCT01674712|474117690|FG003|Overall Study|Administrative|0|||
131680631|NCT01674712|474117691|FG004|Overall Study|Administrative|1|||
131680632|NCT01674712|474117687|FG000|Overall Study|Lack of Efficacy|0|||
131680633|NCT01674712|474117688|FG001|Overall Study|Lack of Efficacy|0|||
131680634|NCT01674712|474117689|FG002|Overall Study|Lack of Efficacy|1|||
131680635|NCT01674712|474117690|FG003|Overall Study|Lack of Efficacy|0|||
131680636|NCT01674712|474117691|FG004|Overall Study|Lack of Efficacy|1|||
131680637|NCT05395104|474117696|FG000|Overall Study|Met Liver Stopping Criteria|1|||
131680638|NCT05395104|474117696|FG000|Overall Study|Withdrawal by Subject|1|||
131680639|NCT00381563|474117697|FG000|Overall Study|Withdrawal by Subject|5|||
131680640|NCT00381563|474117698|FG001|Overall Study|Withdrawal by Subject|5|||
131680641|NCT00381563|474117697|FG000|Overall Study|Lost to Follow-up|2|||
131680642|NCT00381563|474117698|FG001|Overall Study|Lost to Follow-up|0|||
131680643|NCT00381563|474117697|FG000|Overall Study|Protocol Violation|0|||
131680644|NCT00381563|474117698|FG001|Overall Study|Protocol Violation|1|||
131680645|NCT03974334|474117700|FG000|Overall Study|Lost to Follow-up|1|||
131680646|NCT01109173|474117701|FG000|Overall Study|Adverse Event|15|||
131680647|NCT01109173|474117702|FG001|Overall Study|Adverse Event|17|||
131680648|NCT01109173|474117703|FG002|Overall Study|Adverse Event|9|||
131680649|NCT01109173|474117704|FG003|Overall Study|Adverse Event|6|||
131680650|NCT01109173|474117701|FG000|Overall Study|Lost to Follow-up|0|||
131680651|NCT01109173|474117702|FG001|Overall Study|Lost to Follow-up|1|||
131680652|NCT01109173|474117703|FG002|Overall Study|Lost to Follow-up|0|||
131680653|NCT01109173|474117704|FG003|Overall Study|Lost to Follow-up|0|||
131680654|NCT01109173|474117701|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
131680655|NCT01109173|474117702|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
131680656|NCT01109173|474117703|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
131680657|NCT01109173|474117704|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
131680658|NCT01109173|474117701|FG000|Overall Study|Noncompliance|0|||
131680659|NCT01109173|474117702|FG001|Overall Study|Noncompliance|1|||
131680660|NCT01109173|474117703|FG002|Overall Study|Noncompliance|0|||
131680661|NCT01109173|474117704|FG003|Overall Study|Noncompliance|0|||
131680662|NCT01109173|474117701|FG000|Overall Study|Treatment Failure|25|||
131680663|NCT01109173|474117702|FG001|Overall Study|Treatment Failure|32|||
131680664|NCT01109173|474117703|FG002|Overall Study|Treatment Failure|69|||
131680665|NCT01109173|474117704|FG003|Overall Study|Treatment Failure|64|||
131680666|NCT01109173|474117701|FG000|Overall Study|Protocol Violation|4|||
131680667|NCT01109173|474117702|FG001|Overall Study|Protocol Violation|5|||
131680668|NCT01109173|474117703|FG002|Overall Study|Protocol Violation|1|||
131680669|NCT01109173|474117704|FG003|Overall Study|Protocol Violation|2|||
131680670|NCT01109173|474117701|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
131680671|NCT01109173|474117702|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
131680672|NCT01109173|474117703|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
131555855|NCT01027364|473660245|FG003|Overall Study|Protocol Violation|1|||
131680673|NCT01109173|474117704|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
131680674|NCT01109173|474117701|FG000|Overall Study|Not Specifiied|5|||
131680675|NCT01109173|474117702|FG001|Overall Study|Not Specifiied|4|||
131680676|NCT01109173|474117703|FG002|Overall Study|Not Specifiied|9|||
131680677|NCT01109173|474117704|FG003|Overall Study|Not Specifiied|14|||
131680678|NCT00006392|474117712|FG000|Overall Study|Ineligible|11|||
131680679|NCT00006392|474117713|FG001|Overall Study|Ineligible|3|||
131680680|NCT00006392|474117714|FG002|Overall Study|Ineligible|5|||
131680681|NCT00006392|474117715|FG003|Overall Study|Ineligible|5|||
131680682|NCT00006392|474117712|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
131680683|NCT00006392|474117713|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
131680684|NCT00006392|474117714|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
131680685|NCT00006392|474117715|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
131680686|NCT01186796|474117716|FG000|Overall Study|Adverse Event|3|||
131680687|NCT01186796|474117717|FG001|Overall Study|Adverse Event|0|||
131680688|NCT01186796|474117716|FG000|Overall Study|Withdrawal by Subject|1|||
131680689|NCT01186796|474117717|FG001|Overall Study|Withdrawal by Subject|1|||
131680690|NCT01186796|474117716|FG000|Overall Study|Protocol Violation|0|||
131680691|NCT01186796|474117717|FG001|Overall Study|Protocol Violation|1|||
131680692|NCT01910116|474117723|FG000|Overall Study|Adverse Event|0|||
131680693|NCT01910116|474117724|FG001|Overall Study|Adverse Event|3|||
131680694|NCT01910116|474117723|FG000|Overall Study|Lack of Efficacy|3|||
131680695|NCT01910116|474117724|FG001|Overall Study|Lack of Efficacy|4|||
131680696|NCT01910116|474117723|FG000|Overall Study|Lost to Follow-up|1|||
131680697|NCT01910116|474117724|FG001|Overall Study|Lost to Follow-up|0|||
131680698|NCT01910116|474117723|FG000|Overall Study|Protocol Violation|1|||
131680699|NCT01910116|474117724|FG001|Overall Study|Protocol Violation|2|||
131680700|NCT01910116|474117723|FG000|Overall Study|Withdrawal by Subject|8|||
131680701|NCT01910116|474117724|FG001|Overall Study|Withdrawal by Subject|3|||
131680702|NCT01910116|474117723|FG000|Overall Study|uncertain allocation|1|||
131680703|NCT01910116|474117724|FG001|Overall Study|uncertain allocation|3|||
131680704|NCT01910116|474117723|FG000|Overall Study|incomplete data|0|||
131680705|NCT01910116|474117724|FG001|Overall Study|incomplete data|1|||
131680706|NCT04029116|474117725|FG000|Overall Study|Adverse Event|0|||
131680707|NCT04029116|474117726|FG001|Overall Study|Adverse Event|2|||
131680708|NCT04029116|474117725|FG000|Overall Study|Lost to Follow-up|3|||
131680709|NCT04029116|474117726|FG001|Overall Study|Lost to Follow-up|5|||
131680710|NCT04029116|474117725|FG000|Overall Study|Physician Decision|2|||
131680711|NCT04029116|474117726|FG001|Overall Study|Physician Decision|0|||
131680712|NCT04029116|474117725|FG000|Overall Study|Pregnancy|1|||
131680713|NCT04029116|474117726|FG001|Overall Study|Pregnancy|2|||
131680714|NCT04029116|474117725|FG000|Overall Study|Withdrawal by Subject|4|||
131680715|NCT04029116|474117726|FG001|Overall Study|Withdrawal by Subject|6|||
131680716|NCT04029116|474117725|FG000|Overall Study|Other|2|||
131680717|NCT04029116|474117726|FG001|Overall Study|Other|1|||
131680718|NCT01326728|474117727|FG000|Overall Study|Death|13|||
131680719|NCT01326728|474117728|FG001|Overall Study|Death|0|||
131680720|NCT01326728|474117727|FG000|Overall Study|Early closure of study|34|||
131680721|NCT01326728|474117728|FG001|Overall Study|Early closure of study|9|||
131680722|NCT03785678|474117731|FG000|Overall Study|Death|44|||
131680723|NCT03785678|474117732|FG001|Overall Study|Death|42|||
131680724|NCT03785678|474117731|FG000|Overall Study|Lost to Follow-up|4|||
131680725|NCT03785678|474117732|FG001|Overall Study|Lost to Follow-up|2|||
131680726|NCT03785678|474117731|FG000|Overall Study|Physician Decision|0|||
131680727|NCT03785678|474117732|FG001|Overall Study|Physician Decision|2|||
131680728|NCT03785678|474117731|FG000|Overall Study|Withdrawal by Subject|5|||
131680729|NCT03785678|474117732|FG001|Overall Study|Withdrawal by Subject|3|||
131680730|NCT01162239|474117733|FG000|Treatment Phase|Withdrawal by Subject|1|||
131680731|NCT01162239|474117734|FG001|Treatment Phase|Withdrawal by Subject|3|||
131680732|NCT01162239|474117735|FG002|Treatment Phase|Withdrawal by Subject|2|||
131680733|NCT01162239|474117736|FG003|Treatment Phase|Withdrawal by Subject|3|||
131680734|NCT01162239|474117733|FG000|Treatment Phase|Death|0|||
131680735|NCT01162239|474117734|FG001|Treatment Phase|Death|0|||
131680736|NCT01162239|474117735|FG002|Treatment Phase|Death|0|||
131680737|NCT01162239|474117736|FG003|Treatment Phase|Death|1|||
131680738|NCT01162239|474117733|FG000|Treatment Phase|Lost to Follow-up|5|||
131680739|NCT01162239|474117734|FG001|Treatment Phase|Lost to Follow-up|4|||
131680740|NCT01162239|474117735|FG002|Treatment Phase|Lost to Follow-up|2|||
131680741|NCT01162239|474117736|FG003|Treatment Phase|Lost to Follow-up|1|||
131680742|NCT01162239|474117733|FG000|Extended Follow-up|Lost to Follow-up|8|||
131680743|NCT01162239|474117734|FG001|Extended Follow-up|Lost to Follow-up|13|||
131680744|NCT01162239|474117735|FG002|Extended Follow-up|Lost to Follow-up|8|||
131680745|NCT01162239|474117736|FG003|Extended Follow-up|Lost to Follow-up|6|||
131680746|NCT00228566|474117737|FG000|Overall Study|Adverse Event|31|||
131680747|NCT00228566|474117737|FG000|Overall Study|Lack of Efficacy|14|||
131680748|NCT00228566|474117737|FG000|Overall Study|Lost to Follow-up|16|||
131680749|NCT00228566|474117737|FG000|Overall Study|Physician Decision|5|||
131680750|NCT00228566|474117737|FG000|Overall Study|Withdrawal by Subject|4|||
131680751|NCT00228566|474117737|FG000|Overall Study|Miscellaneous|1|||
131680752|NCT04448756|474117738|FG000|Overall Study|Adverse Event|0|||
131680753|NCT04448756|474117739|FG001|Overall Study|Adverse Event|1|||
131680754|NCT04448756|474117740|FG002|Overall Study|Adverse Event|0|||
131680755|NCT04448756|474117738|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
131680756|NCT04448756|474117739|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
131680757|NCT04448756|474117740|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
131680758|NCT04448756|474117738|FG000|Overall Study|Withdrawal by Subject|0|||
131680759|NCT04448756|474117739|FG001|Overall Study|Withdrawal by Subject|3|||
131680760|NCT04448756|474117740|FG002|Overall Study|Withdrawal by Subject|1|||
131680761|NCT04448756|474117738|FG000|Overall Study|Death|2|||
131680762|NCT04448756|474117739|FG001|Overall Study|Death|1|||
131680763|NCT04448756|474117740|FG002|Overall Study|Death|0|||
131680764|NCT00232141|474117741|FG000|Overall Study|Adverse Event|9|||
131680765|NCT00232141|474117742|FG001|Overall Study|Adverse Event|4|||
131680766|NCT00232141|474117741|FG000|Overall Study|Lack of Efficacy|0|||
131680767|NCT00232141|474117742|FG001|Overall Study|Lack of Efficacy|3|||
131680768|NCT00232141|474117741|FG000|Overall Study|Lost to Follow-up|9|||
131680769|NCT00232141|474117742|FG001|Overall Study|Lost to Follow-up|6|||
131680770|NCT00232141|474117741|FG000|Overall Study|Other|8|||
131680771|NCT00232141|474117742|FG001|Overall Study|Other|10|||
131680772|NCT00232141|474117741|FG000|Overall Study|Withdrawal by Subject|5|||
131680773|NCT00232141|474117742|FG001|Overall Study|Withdrawal by Subject|3|||
131680774|NCT01479829|474117743|FG000|Overall Study|Withdrawal by Subject|8|||
131680775|NCT01479829|474117744|FG001|Overall Study|Withdrawal by Subject|10|||
131680776|NCT00601250|474117745|FG000|Overall Study|Adverse Event|3|||
131680777|NCT00601250|474117746|FG001|Overall Study|Adverse Event|9|||
131680778|NCT00601250|474117745|FG000|Overall Study|Protocol Violation|3|||
131680779|NCT00601250|474117746|FG001|Overall Study|Protocol Violation|2|||
131680780|NCT00601250|474117745|FG000|Overall Study|Lost to Follow-up|2|||
131680781|NCT00601250|474117746|FG001|Overall Study|Lost to Follow-up|6|||
131680782|NCT00601250|474117745|FG000|Overall Study|Withdrawal by Subject|4|||
131680783|NCT00601250|474117746|FG001|Overall Study|Withdrawal by Subject|13|||
131680784|NCT00601250|474117745|FG000|Overall Study|Other incl. lack of efficacy|2|||
131680785|NCT00601250|474117746|FG001|Overall Study|Other incl. lack of efficacy|9|||
131680786|NCT01791803|474117747|FG000|Overall Study|Withdrawal by Subject|0|||
131680787|NCT01791803|474117748|FG001|Overall Study|Withdrawal by Subject|0|||
131680788|NCT01791803|474117749|FG002|Overall Study|Withdrawal by Subject|0|||
131680789|NCT01791803|474117750|FG003|Overall Study|Withdrawal by Subject|2|||
131680790|NCT01791803|474117747|FG000|Overall Study|Physician Decision|0|||
131680791|NCT01791803|474117748|FG001|Overall Study|Physician Decision|2|||
131680792|NCT01791803|474117749|FG002|Overall Study|Physician Decision|0|||
131680793|NCT01791803|474117750|FG003|Overall Study|Physician Decision|1|||
131680794|NCT01791803|474117747|FG000|Overall Study|Death|0|||
131680795|NCT01791803|474117748|FG001|Overall Study|Death|0|||
131680796|NCT01791803|474117749|FG002|Overall Study|Death|2|||
131680797|NCT01791803|474117750|FG003|Overall Study|Death|2|||
131680798|NCT04572854|474117751|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
131680799|NCT04572854|474117752|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
131680800|NCT04572854|474117753|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
131680801|NCT04572854|474117754|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
131680802|NCT04572854|474117751|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
131680803|NCT04572854|474117752|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
131680804|NCT04572854|474117753|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
131680805|NCT04572854|474117754|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
131680806|NCT05586269|474119145|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
131680807|NCT05586269|474119146|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
131680808|NCT05586269|474119147|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
131680809|NCT05586269|474119148|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
131680810|NCT05586269|474119145|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
131680811|NCT05586269|474119146|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
131680812|NCT05586269|474119147|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
131680813|NCT05586269|474119148|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
131680814|NCT00523718|474119150|FG000|Overall Study|Withdrawal by Subject|1|||
131680815|NCT00523718|474119151|FG001|Overall Study|Withdrawal by Subject|0|||
131680816|NCT00523718|474119150|FG000|Overall Study|Protocol Violation|2|||
131680817|NCT00523718|474119151|FG001|Overall Study|Protocol Violation|0|||
131680818|NCT03441334|474119152|FG000|Overall Study|Withdrawal by Subject|1|||
131680819|NCT03441334|474119153|FG001|Overall Study|Withdrawal by Subject|0|||
131680820|NCT00088907|474119154|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
131680821|NCT00088907|474119155|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
131680822|NCT00088907|474119154|FG000|Randomized Study (Step 1)|Adverse Event|14|||
131680823|NCT00088907|474119155|FG001|Randomized Study (Step 1)|Adverse Event|19|||
131680824|NCT00088907|474119154|FG000|Randomized Study (Step 1)|Death|11|||
131680825|NCT00088907|474119155|FG001|Randomized Study (Step 1)|Death|12|||
131680826|NCT00088907|474119154|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
131680827|NCT00088907|474119155|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
131680828|NCT00088907|474119154|FG000|Randomized Study (Step 1)|complicating disease|3|||
131680829|NCT00088907|474119155|FG001|Randomized Study (Step 1)|complicating disease|1|||
131680830|NCT00088907|474119154|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
131680831|NCT00088907|474119155|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
131680832|NCT00088907|474119154|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
131680833|NCT00088907|474119155|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
131680834|NCT00088907|474119154|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
131680835|NCT00088907|474119155|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
131680836|NCT00088907|474119154|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
131680837|NCT00088907|474119155|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
131680838|NCT00088907|474119154|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
131680839|NCT00088907|474119155|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
131680840|NCT00088907|474119154|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
131680841|NCT00088907|474119155|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
131680842|NCT03426787|474119160|FG000|Overall Study|Withdrawal by Subject|6|||
131680843|NCT03426787|474119160|FG000|Overall Study|Lost to Follow-up|7|||
131680844|NCT03426787|474119160|FG000|Overall Study|Unrelated to intervention death|1|||
131680845|NCT02615470|474119164|FG000|Overall Study|Lost to Follow-up|21|||
131680846|NCT02615470|474119165|FG001|Overall Study|Lost to Follow-up|32|||
131680847|NCT01650285|474119168|FG000|Overall Study|Adverse Event|1|||
131680848|NCT00659529|474119169|FG000|Overall Study|Withdrawal by Subject|4|||
131680849|NCT00659529|474119169|FG000|Overall Study|Protocol Violation|3|||
131680850|NCT00659529|474119169|FG000|Overall Study|Screen failure|9|||
131680851|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
131680852|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131680853|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131680854|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131680855|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131680856|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
131680857|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131680858|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131680859|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131680860|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131680861|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
131680862|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131680863|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131680864|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131680865|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131680866|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
131680867|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131680868|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131680869|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131680870|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131680871|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
131680872|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131680873|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131680874|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131680875|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131680876|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
131680877|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131680878|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131680879|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131680880|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131898484|NCT00705341|474914081|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
131898485|NCT00705341|474914082|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
131680881|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
131680882|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131680883|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131680884|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131680885|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131680886|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
131680887|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131680888|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131680889|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131680890|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131680891|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
131680892|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131680893|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131680894|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131680895|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131680896|NCT03627767|474119176|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
131680897|NCT03627767|474119177|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131680898|NCT03627767|474119178|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131680899|NCT03627767|474119179|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131680900|NCT03627767|474119180|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131680901|NCT03627767|474119176|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
131680902|NCT03627767|474119177|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
131680903|NCT03627767|474119178|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
131680904|NCT03627767|474119179|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
131680905|NCT03627767|474119180|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
131680906|NCT03627767|474119176|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131680907|NCT03627767|474119177|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131680908|NCT03627767|474119178|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
131680909|NCT03627767|474119179|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
131680910|NCT03627767|474119180|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131680911|NCT03627767|474119176|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
131680912|NCT03627767|474119177|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
131680913|NCT03627767|474119178|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
131680914|NCT03627767|474119179|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
131680915|NCT03627767|474119180|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
131680916|NCT03627767|474119176|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131680917|NCT03627767|474119177|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
131680918|NCT03627767|474119178|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
131680919|NCT03627767|474119179|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
131680920|NCT03627767|474119180|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131680921|NCT03627767|474119176|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131680922|NCT03627767|474119177|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131680923|NCT03627767|474119178|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
131680924|NCT03627767|474119179|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131680925|NCT03627767|474119180|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131680926|NCT03627767|474119176|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
131680927|NCT03627767|474119177|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
131680928|NCT03627767|474119178|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
131680929|NCT03627767|474119179|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
131680930|NCT03627767|474119180|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
131680931|NCT03627767|474119176|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131680932|NCT03627767|474119177|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131680933|NCT03627767|474119178|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131680934|NCT03627767|474119179|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131680935|NCT03627767|474119180|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
131680936|NCT03627767|474119176|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131680937|NCT03627767|474119177|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131680938|NCT03627767|474119178|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131680939|NCT03627767|474119179|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131680940|NCT03627767|474119180|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
131680941|NCT03627767|474119176|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131680942|NCT03627767|474119177|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131680943|NCT03627767|474119178|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131680944|NCT03627767|474119179|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131680945|NCT03627767|474119180|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
131680946|NCT03627767|474119176|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
131680947|NCT03627767|474119177|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
131680948|NCT03627767|474119178|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
131680949|NCT03627767|474119179|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
131680950|NCT03627767|474119180|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
131680951|NCT04163900|474119181|FG000|Overall Study|Radiological disease progression|112|||
131680952|NCT04163900|474119182|FG001|Overall Study|Radiological disease progression|127|||
131680953|NCT04163900|474119181|FG000|Overall Study|Study closure|98|||
131680954|NCT04163900|474119182|FG001|Overall Study|Study closure|133|||
131680955|NCT04163900|474119181|FG000|Overall Study|Adverse Event|78|||
131680956|NCT04163900|474119182|FG001|Overall Study|Adverse Event|32|||
131680957|NCT04163900|474119181|FG000|Overall Study|Withdrawal by Subject|37|||
131680958|NCT04163900|474119182|FG001|Overall Study|Withdrawal by Subject|34|||
131680959|NCT04163900|474119181|FG000|Overall Study|Death|29|||
131680960|NCT04163900|474119182|FG001|Overall Study|Death|16|||
131680961|NCT04163900|474119181|FG000|Overall Study|Physician Decision|17|||
131680962|NCT04163900|474119182|FG001|Overall Study|Physician Decision|25|||
131680963|NCT04163900|474119181|FG000|Overall Study|Clinical disease progression|14|||
131680964|NCT04163900|474119182|FG001|Overall Study|Clinical disease progression|13|||
131680965|NCT04163900|474119181|FG000|Overall Study|Protocol Violation|3|||
131680966|NCT04163900|474119182|FG001|Overall Study|Protocol Violation|4|||
131680967|NCT04163900|474119181|FG000|Overall Study|Lost to Follow-up|0|||
131680968|NCT04163900|474119182|FG001|Overall Study|Lost to Follow-up|1|||
131680969|NCT01873417|474119183|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
131680970|NCT01873417|474119183|FG000|Overall Study|Adverse Event|24|||
131680971|NCT01873417|474119183|FG000|Overall Study|Lost to Follow-up|2|||
131680972|NCT01873417|474119183|FG000|Overall Study|Withdrawal by Subject|2|||
131680973|NCT01873417|474119183|FG000|Overall Study|Physician Decision|3|||
131680974|NCT00785044|474119184|FG000|Overall Study|Dosed at non-participating sites|152|||
131680975|NCT00785044|474119184|FG000|Overall Study|Death|77|||
131680976|NCT00785044|474119184|FG000|Overall Study|Lost to Follow-up|266|||
131680977|NCT00785044|474119184|FG000|Overall Study|Withdrawal by Subject|1|||
131680978|NCT01628107|474119185|FG000|Overall Study|Withdrawal by Subject|17|||
131680979|NCT01628107|474119185|FG000|Overall Study|Lost to Follow-up|4|||
131680980|NCT01628107|474119185|FG000|Overall Study|Adverse Event|33|||
131680981|NCT01628107|474119185|FG000|Overall Study|Physician Decision|2|||
131680982|NCT01628107|474119185|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
131680983|NCT01628107|474119185|FG000|Overall Study|Non-compliant with Study Procedures|10|||
131680984|NCT01628107|474119185|FG000|Overall Study|Not Treated|8|||
131680985|NCT01628107|474119185|FG000|Overall Study|Sponsor Decision|11|||
131680986|NCT01628107|474119185|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
131680987|NCT01628107|474119185|FG000|Overall Study|Relocated|8|||
131680988|NCT01628107|474119185|FG000|Overall Study|Kidney Transplant|9|||
131680989|NCT01628107|474119185|FG000|Overall Study|Use of Standard of Care|9|||
131680990|NCT02953639|474119186|FG000|Overall Study|Adverse Event|2|||
131680991|NCT02953639|474119187|FG001|Overall Study|Adverse Event|0|||
131680992|NCT02953639|474119188|FG002|Overall Study|Adverse Event|1|||
131680993|NCT02953639|474119186|FG000|Overall Study|Lost to Follow-up|8|||
131680994|NCT02953639|474119187|FG001|Overall Study|Lost to Follow-up|4|||
131680995|NCT02953639|474119188|FG002|Overall Study|Lost to Follow-up|3|||
131680996|NCT02953639|474119186|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131680997|NCT02953639|474119187|FG001|Overall Study|Non-Compliance With Study Drug|2|||
131680998|NCT02953639|474119188|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131680999|NCT02953639|474119186|FG000|Overall Study|Multiple Reasons|1|||
131681000|NCT02953639|474119187|FG001|Overall Study|Multiple Reasons|0|||
131681001|NCT02953639|474119188|FG002|Overall Study|Multiple Reasons|1|||
131681002|NCT02953639|474119186|FG000|Overall Study|Physician Decision|1|||
131681003|NCT02953639|474119187|FG001|Overall Study|Physician Decision|0|||
131681004|NCT02953639|474119188|FG002|Overall Study|Physician Decision|0|||
131681005|NCT02953639|474119186|FG000|Overall Study|Withdrawal by Subject|7|||
131681006|NCT02953639|474119187|FG001|Overall Study|Withdrawal by Subject|8|||
131681007|NCT02953639|474119188|FG002|Overall Study|Withdrawal by Subject|10|||
131681008|NCT02953639|474119186|FG000|Overall Study|Completed or Discontinued information is missing|1|||
131681009|NCT02953639|474119187|FG001|Overall Study|Completed or Discontinued information is missing|0|||
131681010|NCT02953639|474119188|FG002|Overall Study|Completed or Discontinued information is missing|0|||
131681011|NCT00930722|474119189|FG000|Overall Study|Lost to Follow-up|16|||
131681012|NCT00930722|474119189|FG000|Overall Study|No longer willing to participate|9|||
131681013|NCT00930722|474119189|FG000|Overall Study|Study terminated by sponsor|2|||
131681014|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Adverse Event|2|||
131681015|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Adverse Event|2|||
131681016|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Adverse Event|4|||
131681017|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Adverse Event|0|||
131681018|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Adverse Event|0|||
131681019|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Progressive disease|0|||
131681020|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Progressive disease|0|||
131681021|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Progressive disease|1|||
131681022|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Progressive disease|0|||
131681023|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Progressive disease|0|||
131681024|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
131681025|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
131681026|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
131681027|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
131681028|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
131681029|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
131681030|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131681031|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131681032|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131681033|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131681034|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
131681035|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
131681036|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
131681037|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
131681038|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
131681039|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
131681040|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
131681041|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
131681042|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
131681043|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
131681044|NCT03523728|474119190|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
131681045|NCT03523728|474119191|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
131681046|NCT03523728|474119192|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
131681047|NCT03523728|474119193|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
131681048|NCT03523728|474119194|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
131681049|NCT03523728|474119190|FG000|Stage 2 (24 Months)|Adverse Event|0|||
131681050|NCT03523728|474119191|FG001|Stage 2 (24 Months)|Adverse Event|0|||
131681051|NCT03523728|474119192|FG002|Stage 2 (24 Months)|Adverse Event|0|||
131681052|NCT03523728|474119193|FG003|Stage 2 (24 Months)|Adverse Event|1|||
131681053|NCT03523728|474119194|FG004|Stage 2 (24 Months)|Adverse Event|2|||
131681054|NCT03523728|474119190|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131681055|NCT03523728|474119191|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131681056|NCT03523728|474119192|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131681057|NCT03523728|474119193|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131681058|NCT03523728|474119194|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
131681059|NCT03523728|474119190|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
131681060|NCT03523728|474119191|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
131681061|NCT03523728|474119192|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
131681062|NCT03523728|474119193|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
131681063|NCT03523728|474119194|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
131681064|NCT03523728|474119190|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
131681065|NCT03523728|474119191|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
131681066|NCT03523728|474119192|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
131681067|NCT03523728|474119193|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
131681068|NCT03523728|474119194|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
131681069|NCT03523728|474119190|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
131681070|NCT03523728|474119191|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
131681071|NCT03523728|474119192|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
131681072|NCT03523728|474119193|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
131681073|NCT03523728|474119194|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
131681074|NCT00621751|474119195|FG000|Overall Study|Adverse Event|0|||
131681075|NCT00621751|474119196|FG001|Overall Study|Adverse Event|1|||
131681076|NCT00295633|474119197|FG000|Overall Study|Lack of Efficacy|19|||
131681077|NCT00295633|474119198|FG001|Overall Study|Lack of Efficacy|7|||
131681078|NCT00295633|474119199|FG002|Overall Study|Lack of Efficacy|16|||
131681079|NCT00295633|474119197|FG000|Overall Study|Withdrawal of consent by subject|16|||
131681080|NCT00295633|474119198|FG001|Overall Study|Withdrawal of consent by subject|16|||
131681081|NCT00295633|474119199|FG002|Overall Study|Withdrawal of consent by subject|26|||
131681082|NCT00295633|474119197|FG000|Overall Study|Adverse Event|9|||
131681083|NCT00295633|474119198|FG001|Overall Study|Adverse Event|17|||
131681084|NCT00295633|474119199|FG002|Overall Study|Adverse Event|9|||
131681085|NCT00295633|474119197|FG000|Overall Study|Lost to Follow-up|6|||
131681086|NCT00295633|474119198|FG001|Overall Study|Lost to Follow-up|11|||
131681087|NCT00295633|474119199|FG002|Overall Study|Lost to Follow-up|7|||
131681088|NCT00295633|474119197|FG000|Overall Study|Physician Decision|9|||
131681089|NCT00295633|474119198|FG001|Overall Study|Physician Decision|10|||
131681090|NCT00295633|474119199|FG002|Overall Study|Physician Decision|8|||
131681091|NCT00295633|474119197|FG000|Overall Study|Poor/Noncompliance|2|||
131681092|NCT00295633|474119198|FG001|Overall Study|Poor/Noncompliance|2|||
131681093|NCT00295633|474119199|FG002|Overall Study|Poor/Noncompliance|6|||
131681094|NCT00295633|474119197|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
131681095|NCT00295633|474119198|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
131681096|NCT00295633|474119199|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
131681097|NCT00295633|474119197|FG000|Overall Study|Death|1|||
131681098|NCT00295633|474119198|FG001|Overall Study|Death|1|||
131681099|NCT00295633|474119199|FG002|Overall Study|Death|0|||
131681100|NCT00295633|474119197|FG000|Overall Study|Administrative reason by sponsor|0|||
131681101|NCT00295633|474119198|FG001|Overall Study|Administrative reason by sponsor|0|||
131681102|NCT00295633|474119199|FG002|Overall Study|Administrative reason by sponsor|1|||
131681103|NCT00419120|474119201|FG000|Long Term Follow up Period|study ongoing|10|||
131681104|NCT01950247|474119202|FG000|Overall Study|Withdrawal by Subject|28|||
131681105|NCT01950247|474119203|FG001|Overall Study|Withdrawal by Subject|13|||
131681106|NCT01950247|474119202|FG000|Overall Study|Lost to Follow-up|18|||
131681107|NCT01950247|474119203|FG001|Overall Study|Lost to Follow-up|16|||
131681108|NCT01950247|474119202|FG000|Overall Study|Physician Decision|3|||
131681109|NCT01950247|474119203|FG001|Overall Study|Physician Decision|4|||
131681110|NCT01950247|474119202|FG000|Overall Study|Adverse Event|3|||
131681111|NCT01950247|474119203|FG001|Overall Study|Adverse Event|2|||
131681112|NCT01950247|474119202|FG000|Overall Study|Death|1|||
131681113|NCT01950247|474119203|FG001|Overall Study|Death|1|||
131681114|NCT01950247|474119202|FG000|Overall Study|Not Defined|4|||
131681115|NCT01950247|474119203|FG001|Overall Study|Not Defined|10|||
131681116|NCT01069120|474119204|FG000|Overall Study|Study prematurely terminated|27|||
131681117|NCT00763971|474119205|FG000|Overall Study|Adverse Event|5|||
131681118|NCT00763971|474119206|FG001|Overall Study|Adverse Event|2|||
131681119|NCT00763971|474119207|FG002|Overall Study|Adverse Event|4|||
131681120|NCT00763971|474119205|FG000|Overall Study|Protocol Violation|3|||
131681121|NCT00763971|474119206|FG001|Overall Study|Protocol Violation|3|||
131681122|NCT00763971|474119207|FG002|Overall Study|Protocol Violation|2|||
131681123|NCT00763971|474119205|FG000|Overall Study|Withdrawal by Subject|4|||
131681124|NCT00763971|474119206|FG001|Overall Study|Withdrawal by Subject|5|||
131681125|NCT00763971|474119207|FG002|Overall Study|Withdrawal by Subject|5|||
131681126|NCT00763971|474119205|FG000|Overall Study|Lost to Follow-up|0|||
131681127|NCT00763971|474119206|FG001|Overall Study|Lost to Follow-up|1|||
131681128|NCT00763971|474119207|FG002|Overall Study|Lost to Follow-up|0|||
131681129|NCT00763971|474119205|FG000|Overall Study|Lack of Efficacy|11|||
131681130|NCT00763971|474119206|FG001|Overall Study|Lack of Efficacy|22|||
131681131|NCT00763971|474119207|FG002|Overall Study|Lack of Efficacy|54|||
131681132|NCT00763971|474119205|FG000|Overall Study|Unable to swallow capsule|2|||
131681133|NCT00763971|474119206|FG001|Overall Study|Unable to swallow capsule|1|||
131681134|NCT00763971|474119207|FG002|Overall Study|Unable to swallow capsule|1|||
131681135|NCT00763971|474119205|FG000|Overall Study|Personal reason|3|||
131681136|NCT00763971|474119206|FG001|Overall Study|Personal reason|0|||
131681137|NCT00763971|474119207|FG002|Overall Study|Personal reason|0|||
131681138|NCT00763971|474119205|FG000|Overall Study|Exclusion criteria met|1|||
131681139|NCT00763971|474119206|FG001|Overall Study|Exclusion criteria met|0|||
131681140|NCT00763971|474119207|FG002|Overall Study|Exclusion criteria met|0|||
131681141|NCT00763971|474119205|FG000|Overall Study|Sponsor decision|1|||
131681142|NCT00763971|474119206|FG001|Overall Study|Sponsor decision|0|||
131681143|NCT00763971|474119207|FG002|Overall Study|Sponsor decision|0|||
131681144|NCT00763971|474119205|FG000|Overall Study|Due to holiday season|2|||
131681145|NCT00763971|474119206|FG001|Overall Study|Due to holiday season|0|||
131681146|NCT00763971|474119207|FG002|Overall Study|Due to holiday season|1|||
131681147|NCT00763971|474119205|FG000|Overall Study|Randomization error|0|||
131681148|NCT00763971|474119206|FG001|Overall Study|Randomization error|0|||
131681149|NCT00763971|474119207|FG002|Overall Study|Randomization error|1|||
131681150|NCT00763971|474119205|FG000|Overall Study|Medical monitor decision|0|||
131681151|NCT00763971|474119206|FG001|Overall Study|Medical monitor decision|0|||
131681152|NCT00763971|474119207|FG002|Overall Study|Medical monitor decision|1|||
131681153|NCT00763971|474119205|FG000|Overall Study|Moved to another country|0|||
131681154|NCT00763971|474119206|FG001|Overall Study|Moved to another country|1|||
131681155|NCT00763971|474119207|FG002|Overall Study|Moved to another country|0|||
131681156|NCT00763971|474119205|FG000|Overall Study|Subject wanted dose reduction|0|||
131681157|NCT00763971|474119206|FG001|Overall Study|Subject wanted dose reduction|1|||
131681158|NCT00763971|474119207|FG002|Overall Study|Subject wanted dose reduction|0|||
131681159|NCT00763971|474119205|FG000|Overall Study|Lack of availability|0|||
131681160|NCT00763971|474119206|FG001|Overall Study|Lack of availability|1|||
131681161|NCT00763971|474119207|FG002|Overall Study|Lack of availability|0|||
131681162|NCT00763971|474119205|FG000|Overall Study|Performed final visit on phone|0|||
131681163|NCT00763971|474119206|FG001|Overall Study|Performed final visit on phone|1|||
131681164|NCT00763971|474119207|FG002|Overall Study|Performed final visit on phone|0|||
131681165|NCT00763971|474119205|FG000|Overall Study|Participation in 489-326 required|1|||
131681166|NCT00763971|474119206|FG001|Overall Study|Participation in 489-326 required|0|||
131681167|NCT00763971|474119207|FG002|Overall Study|Participation in 489-326 required|0|||
131681168|NCT00710879|474119209|FG000|Overall Study|Lost to Follow-up|2|||
131681169|NCT00710879|474119210|FG001|Overall Study|Lost to Follow-up|1|||
131681170|NCT00710879|474119209|FG000|Overall Study|Protocol Violation|0|||
131681171|NCT00710879|474119210|FG001|Overall Study|Protocol Violation|3|||
131681172|NCT01809132|474119211|FG000|Overall Study|Withdrawal by Subject|0|||
131681173|NCT01809132|474119212|FG001|Overall Study|Withdrawal by Subject|0|||
131681174|NCT01809132|474119213|FG002|Overall Study|Withdrawal by Subject|1|||
131681175|NCT03349775|474119214|FG000|Overall Study|Side Effects|1|||
131681176|NCT03349775|474119215|FG001|Overall Study|Side Effects|2|||
131681177|NCT03349775|474119214|FG000|Overall Study|Withdrawal by Subject|1|||
131681178|NCT03349775|474119215|FG001|Overall Study|Withdrawal by Subject|1|||
131681179|NCT03349775|474119214|FG000|Overall Study|No primary outcome measurements|0|||
131681180|NCT03349775|474119215|FG001|Overall Study|No primary outcome measurements|1|||
131681181|NCT01516970|474119216|FG000|Overall Study|Lost to Follow-up|7|||
131681182|NCT01516970|474119217|FG001|Overall Study|Lost to Follow-up|8|||
131681183|NCT01516970|474119216|FG000|Overall Study|Adverse Event|1|||
131681184|NCT01516970|474119217|FG001|Overall Study|Adverse Event|5|||
131681185|NCT01516970|474119216|FG000|Overall Study|Withdrawal by Subject|1|||
131681186|NCT01516970|474119217|FG001|Overall Study|Withdrawal by Subject|1|||
131681187|NCT01516970|474119216|FG000|Overall Study|Other|9|||
131681188|NCT01516970|474119217|FG001|Overall Study|Other|7|||
131681189|NCT00434421|474119218|FG000|Overall Study|Withdrawal by Subject|1|||
131681190|NCT00434421|474119218|FG000|Overall Study|Non-compliance with study treatment|1|||
131681191|NCT01756040|474119219|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
131435991|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
131681192|NCT01756040|474119219|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
131681193|NCT01756040|474119219|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
131681194|NCT01205438|474119220|FG000|Overall Study|Adverse Event|19|||
131681195|NCT01205438|474119221|FG001|Overall Study|Adverse Event|17|||
131681196|NCT01205438|474119222|FG002|Overall Study|Adverse Event|24|||
131681197|NCT01205438|474119220|FG000|Overall Study|Death|1|||
131681198|NCT01205438|474119221|FG001|Overall Study|Death|1|||
131681199|NCT01205438|474119222|FG002|Overall Study|Death|3|||
131681200|NCT01205438|474119220|FG000|Overall Study|Entry Criteria Not Met|16|||
131681201|NCT01205438|474119221|FG001|Overall Study|Entry Criteria Not Met|15|||
131681202|NCT01205438|474119222|FG002|Overall Study|Entry Criteria Not Met|13|||
131681203|NCT01205438|474119220|FG000|Overall Study|Lack of Efficacy|14|||
131681204|NCT01205438|474119221|FG001|Overall Study|Lack of Efficacy|11|||
131681205|NCT01205438|474119222|FG002|Overall Study|Lack of Efficacy|14|||
131681206|NCT01205438|474119220|FG000|Overall Study|Lost to Follow-up|6|||
131681207|NCT01205438|474119221|FG001|Overall Study|Lost to Follow-up|7|||
131681208|NCT01205438|474119222|FG002|Overall Study|Lost to Follow-up|8|||
131681209|NCT01205438|474119220|FG000|Overall Study|Withdrawal by Subject|19|||
131681210|NCT01205438|474119221|FG001|Overall Study|Withdrawal by Subject|25|||
131681211|NCT01205438|474119222|FG002|Overall Study|Withdrawal by Subject|19|||
131681212|NCT01205438|474119220|FG000|Overall Study|Physician Decision|0|||
131681213|NCT01205438|474119221|FG001|Overall Study|Physician Decision|3|||
131681214|NCT01205438|474119222|FG002|Overall Study|Physician Decision|2|||
131681215|NCT01205438|474119220|FG000|Overall Study|Protocol Violation|2|||
131681216|NCT01205438|474119221|FG001|Overall Study|Protocol Violation|7|||
131681217|NCT01205438|474119222|FG002|Overall Study|Protocol Violation|4|||
131681218|NCT01205438|474119220|FG000|Overall Study|Sponsor Decision|0|||
131681219|NCT01205438|474119221|FG001|Overall Study|Sponsor Decision|1|||
131681220|NCT01205438|474119222|FG002|Overall Study|Sponsor Decision|1|||
131681221|NCT01446016|474119223|FG000|Overall Study|Lost to Follow-up|3|||
131681222|NCT01446016|474119223|FG000|Overall Study|Withdrawal by Subject|1|||
131681223|NCT01446016|474119223|FG000|Overall Study|Toxicity|3|||
131681224|NCT01186939|474119230|FG000|Overall Study|Death|7|||
131681225|NCT01186939|474119230|FG000|Overall Study|Withdrawal by Subject|2|||
131681226|NCT01186939|474119230|FG000|Overall Study|No longer receiving clinical benefit|17|||
131681227|NCT01186939|474119230|FG000|Overall Study|Program closed|5|||
131681228|NCT01186939|474119230|FG000|Overall Study|Sponsor decision|4|||
131681229|NCT01186939|474119230|FG000|Overall Study|Started additional treatment|1|||
131681230|NCT01186939|474119230|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
131681231|NCT01186939|474119230|FG000|Overall Study|Myocardial infarction|1|||
131681232|NCT01186939|474119230|FG000|Overall Study|Bone marrow transplant|1|||
131681233|NCT01186939|474119230|FG000|Overall Study|Transformation to AML|1|||
131681234|NCT05097716|474119231|FG000|Period 1|Adverse Event|1|||
131681235|NCT05097716|474119231|FG000|Period 1|Close contact with highly-transmissible infection|1|||
131681236|NCT01754857|474119232|FG000|Overall Study|Adverse Event|7|||
131681237|NCT01754857|474119232|FG000|Overall Study|Disease progression|3|||
131681238|NCT01754857|474119232|FG000|Overall Study|Physician Decision|2|||
131681239|NCT01754857|474119232|FG000|Overall Study|Withdrawal by Subject|3|||
131681240|NCT01754857|474119232|FG000|Overall Study|other complicating disease|1|||
131681241|NCT01754857|474119232|FG000|Overall Study|ineligible to continue onto maintenance|1|||
131681242|NCT01754857|474119232|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
131681243|NCT01754857|474119232|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
131681244|NCT01509079|474119233|FG000|Overall Study|Lack of Efficacy|0|||
131681245|NCT01509079|474119234|FG001|Overall Study|Lack of Efficacy|2|||
131681246|NCT01509079|474119233|FG000|Overall Study|started an excluded medication|0|||
131681247|NCT01509079|474119234|FG001|Overall Study|started an excluded medication|1|||
131681248|NCT01399190|474119237|FG000|Overall Study|Not Eligible for Final Analysis|5|||
131681249|NCT01399190|474119237|FG000|Overall Study|Adverse Event|8|||
131681250|NCT01399190|474119237|FG000|Overall Study|Participant's Request|5|||
131681251|NCT01399190|474119237|FG000|Overall Study|Physician Decision|2|||
131681252|NCT00436618|474119238|FG000|Overall Study|Withdrawal by Subject|5|||
131681253|NCT00436618|474119239|FG001|Overall Study|Withdrawal by Subject|8|||
131681254|NCT00436618|474119240|FG002|Overall Study|Withdrawal by Subject|11|||
131681255|NCT00436618|474119238|FG000|Overall Study|Adverse Event|8|||
131681256|NCT00436618|474119239|FG001|Overall Study|Adverse Event|8|||
131681257|NCT00436618|474119240|FG002|Overall Study|Adverse Event|9|||
131681258|NCT00436618|474119238|FG000|Overall Study|Alternate Treatment|3|||
131681259|NCT00436618|474119239|FG001|Overall Study|Alternate Treatment|4|||
131681260|NCT00436618|474119240|FG002|Overall Study|Alternate Treatment|12|||
131681261|NCT00436618|474119238|FG000|Overall Study|Other Medical Problems|3|||
131681262|NCT00436618|474119239|FG001|Overall Study|Other Medical Problems|1|||
131681263|NCT00436618|474119240|FG002|Overall Study|Other Medical Problems|7|||
131681264|NCT00436618|474119238|FG000|Overall Study|Death|4|||
131681265|NCT00436618|474119239|FG001|Overall Study|Death|2|||
131681266|NCT00436618|474119240|FG002|Overall Study|Death|3|||
131681267|NCT00436618|474119238|FG000|Overall Study|New Primary or Other Reasons|6|||
131681268|NCT00436618|474119239|FG001|Overall Study|New Primary or Other Reasons|2|||
131681269|NCT00436618|474119240|FG002|Overall Study|New Primary or Other Reasons|12|||
131681270|NCT00436618|474119238|FG000|Overall Study|Still on treatment|1|||
131681271|NCT00436618|474119239|FG001|Overall Study|Still on treatment|2|||
131681272|NCT00436618|474119240|FG002|Overall Study|Still on treatment|7|||
131681273|NCT00698204|474119241|FG000|Overall Study|Withdrawal by Subject|1|||
131681274|NCT00698204|474119242|FG001|Overall Study|Withdrawal by Subject|0|||
131681275|NCT00975715|474119243|FG000|Titration Period|Adverse Event|6|||
131681276|NCT00975715|474119244|FG001|Titration Period|Adverse Event|0|||
131681277|NCT00975715|474119243|FG000|Titration Period|Protocol Violation|1|||
131681278|NCT00975715|474119244|FG001|Titration Period|Protocol Violation|0|||
131681279|NCT00975715|474119243|FG000|Maintenance Period|Adverse Event|2|||
131681280|NCT00975715|474119244|FG001|Maintenance Period|Adverse Event|1|||
131681281|NCT00874770|474119245|FG000|Overall Study|Lack of Efficacy|2|||
131681282|NCT00874770|474119246|FG001|Overall Study|Lack of Efficacy|0|||
131681283|NCT00874770|474119247|FG002|Overall Study|Lack of Efficacy|0|||
131681284|NCT00874770|474119248|FG003|Overall Study|Lack of Efficacy|2|||
131681285|NCT00874770|474119245|FG000|Overall Study|Adverse Event|1|||
131681286|NCT00874770|474119246|FG001|Overall Study|Adverse Event|1|||
131681287|NCT00874770|474119247|FG002|Overall Study|Adverse Event|4|||
131681288|NCT00874770|474119248|FG003|Overall Study|Adverse Event|2|||
131681289|NCT00874770|474119245|FG000|Overall Study|Lost to Follow-up|1|||
131681290|NCT00874770|474119246|FG001|Overall Study|Lost to Follow-up|0|||
131681291|NCT00874770|474119247|FG002|Overall Study|Lost to Follow-up|0|||
131681292|NCT00874770|474119248|FG003|Overall Study|Lost to Follow-up|1|||
131681293|NCT00874770|474119245|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
131681294|NCT00874770|474119246|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
131681295|NCT00874770|474119247|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
131681296|NCT00874770|474119248|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
131681297|NCT00024167|474119249|FG000|Overall Study|Death|53|||
131681298|NCT00024167|474119250|FG001|Overall Study|Death|47|||
131681299|NCT00770770|474119260|FG000|Overall Study|Lost to Follow-up|1|||
131681300|NCT00770770|474119261|FG001|Overall Study|Lost to Follow-up|0|||
131681301|NCT00770770|474119260|FG000|Overall Study|Withdrawal by Subject|1|||
131681302|NCT00770770|474119261|FG001|Overall Study|Withdrawal by Subject|0|||
131681303|NCT00770770|474119260|FG000|Overall Study|Death|0|||
131681304|NCT00770770|474119261|FG001|Overall Study|Death|1|||
131681305|NCT00770770|474119260|FG000|Overall Study|Study Terminated|8|||
131681306|NCT00770770|474119261|FG001|Overall Study|Study Terminated|0|||
131681307|NCT01230554|474119272|FG000|Overall Study|Lost to Follow-up|2|||
131681308|NCT01230554|474119272|FG000|Overall Study|Inability to maintain visit schedule|1|||
131681309|NCT00685685|474119273|FG000|Washout Period of 7 Days|Adverse Event|2|||
131681310|NCT00685685|474119274|FG001|Washout Period of 7 Days|Adverse Event|0|||
131681311|NCT00685685|474119273|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131681312|NCT00685685|474119274|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131681313|NCT02374021|474119275|FG000|Overall Study|Adverse Event|1|||
131681314|NCT02374021|474119276|FG001|Overall Study|Adverse Event|0|||
131681315|NCT02374021|474119275|FG000|Overall Study|Lost to Follow-up|3|||
131681316|NCT02374021|474119276|FG001|Overall Study|Lost to Follow-up|2|||
131681317|NCT02374021|474119275|FG000|Overall Study|Physician Decision|0|||
131681318|NCT02374021|474119276|FG001|Overall Study|Physician Decision|3|||
131681319|NCT02374021|474119275|FG000|Overall Study|Withdrawal by Subject|6|||
131681320|NCT02374021|474119276|FG001|Overall Study|Withdrawal by Subject|5|||
131681321|NCT02374021|474119275|FG000|Overall Study|Poor Adherence|0|||
131681322|NCT02374021|474119276|FG001|Overall Study|Poor Adherence|1|||
131681323|NCT02374021|474119275|FG000|Overall Study|Scan protocol not followed|0|||
131681324|NCT02374021|474119276|FG001|Overall Study|Scan protocol not followed|1|||
131681325|NCT02374021|474119275|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
131681326|NCT02374021|474119276|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
131681327|NCT00504153|474119277|FG000|Overall Study|Withdrawal by Subject|1|||
131681328|NCT00504153|474119277|FG000|Overall Study|Adverse Event|4|||
131681329|NCT00504153|474119277|FG000|Overall Study|Death|1|||
131681330|NCT02281357|474119281|FG000|Overall Study|Adverse Event|2|||
131681331|NCT02281357|474119282|FG001|Overall Study|Adverse Event|1|||
131681332|NCT02281357|474119281|FG000|Overall Study|Lost to Follow-up|1|||
131681333|NCT02281357|474119282|FG001|Overall Study|Lost to Follow-up|0|||
131681334|NCT02281357|474119281|FG000|Overall Study|Withdrawal by Subject|4|||
131681335|NCT02281357|474119282|FG001|Overall Study|Withdrawal by Subject|3|||
131681336|NCT03007979|474119285|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
131681337|NCT00972777|474119293|FG000|Overall Study|Adverse Event|3|||
131681338|NCT00972777|474119294|FG001|Overall Study|Adverse Event|2|||
131681339|NCT00972777|474119293|FG000|Overall Study|Lost to Follow-up|0|||
131681340|NCT00972777|474119294|FG001|Overall Study|Lost to Follow-up|4|||
131681341|NCT00972777|474119293|FG000|Overall Study|Withdrawal by Subject|4|||
131681342|NCT00972777|474119294|FG001|Overall Study|Withdrawal by Subject|5|||
131681343|NCT00972777|474119293|FG000|Overall Study|Physician Decision|4|||
131681344|NCT00972777|474119294|FG001|Overall Study|Physician Decision|0|||
131681345|NCT00972777|474119293|FG000|Overall Study|Protocol Violation|0|||
131681346|NCT00972777|474119294|FG001|Overall Study|Protocol Violation|2|||
131681347|NCT00972777|474119293|FG000|Overall Study|Screening Failure|2|||
131681348|NCT00972777|474119294|FG001|Overall Study|Screening Failure|1|||
131681349|NCT00972777|474119293|FG000|Overall Study|Missed visit|1|||
131681350|NCT00972777|474119294|FG001|Overall Study|Missed visit|0|||
131681351|NCT01093326|474119295|FG000|Overall Study|Death|0|||
131681352|NCT01093326|474119296|FG001|Overall Study|Death|1|||
131681353|NCT01093326|474119297|FG002|Overall Study|Death|0|||
131681354|NCT01093326|474119295|FG000|Overall Study|Lack of Efficacy|7|||
131681355|NCT01093326|474119296|FG001|Overall Study|Lack of Efficacy|6|||
131681356|NCT01093326|474119297|FG002|Overall Study|Lack of Efficacy|3|||
131681357|NCT01093326|474119295|FG000|Overall Study|Lost to Follow-up|2|||
131681358|NCT01093326|474119296|FG001|Overall Study|Lost to Follow-up|5|||
131681359|NCT01093326|474119297|FG002|Overall Study|Lost to Follow-up|4|||
131681360|NCT01093326|474119295|FG000|Overall Study|Physician Decision|3|||
131681361|NCT01093326|474119296|FG001|Overall Study|Physician Decision|1|||
131681362|NCT01093326|474119297|FG002|Overall Study|Physician Decision|3|||
131681363|NCT01093326|474119295|FG000|Overall Study|Withdrawal by Subject|30|||
131681364|NCT01093326|474119296|FG001|Overall Study|Withdrawal by Subject|27|||
131681365|NCT01093326|474119297|FG002|Overall Study|Withdrawal by Subject|26|||
131681366|NCT01093326|474119295|FG000|Overall Study|Adverse Event|2|||
131681367|NCT01093326|474119296|FG001|Overall Study|Adverse Event|1|||
131681368|NCT01093326|474119297|FG002|Overall Study|Adverse Event|4|||
131681369|NCT01093326|474119295|FG000|Overall Study|Other|0|||
131681370|NCT01093326|474119296|FG001|Overall Study|Other|0|||
131681371|NCT01093326|474119297|FG002|Overall Study|Other|1|||
131681372|NCT04263896|474119298|FG000|Overall Study|Withdrawal by Subject|2|||
131681373|NCT04263896|474119299|FG001|Overall Study|Withdrawal by Subject|4|||
131681374|NCT04263896|474119298|FG000|Overall Study|converted to open procedure|0|||
131681375|NCT04263896|474119299|FG001|Overall Study|converted to open procedure|1|||
131681376|NCT04263896|474119298|FG000|Overall Study|Lost to Follow-up|9|||
131681377|NCT04263896|474119299|FG001|Overall Study|Lost to Follow-up|11|||
131681378|NCT04263896|474119298|FG000|Overall Study|surveys lost in mail|5|||
131681379|NCT04263896|474119299|FG001|Overall Study|surveys lost in mail|3|||
131681380|NCT04263896|474119298|FG000|Overall Study|excluded from analysis|1|||
131681381|NCT04263896|474119299|FG001|Overall Study|excluded from analysis|0|||
131681382|NCT00729378|474121012|FG000|Baseline|Did not complete study measurements|72|||
131681383|NCT00729378|474121013|FG001|Baseline|Did not complete study measurements|33|||
131681384|NCT00729378|474121012|FG000|Baseline|Withdrawal by Subject|66|||
131681385|NCT00729378|474121013|FG001|Baseline|Withdrawal by Subject|59|||
131681386|NCT00729378|474121012|FG000|12-months|Lost to Follow-up|100|||
131681387|NCT00729378|474121013|FG001|12-months|Lost to Follow-up|65|||
131681388|NCT00729378|474121012|FG000|24-months|Lost to Follow-up|72|||
131681389|NCT00729378|474121013|FG001|24-months|Lost to Follow-up|51|||
131681390|NCT00729378|474121012|FG000|36-months|Lost to Follow-up|15|||
131681391|NCT00729378|474121013|FG001|36-months|Lost to Follow-up|6|||
131681392|NCT02246582|474121016|FG000|Overall Study|Withdrawal by Subject|3|||
131681393|NCT02246582|474121017|FG001|Overall Study|Withdrawal by Subject|4|||
131681394|NCT02060383|474121018|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
131681395|NCT02060383|474121019|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
131681396|NCT02060383|474121020|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
131681397|NCT02060383|474121021|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
131681398|NCT02060383|474121022|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
131681399|NCT02060383|474121018|FG000|Core Phase|Adverse Event|2|||
131681400|NCT02060383|474121019|FG001|Core Phase|Adverse Event|0|||
131681401|NCT02060383|474121020|FG002|Core Phase|Adverse Event|0|||
131681402|NCT02060383|474121021|FG003|Core Phase|Adverse Event|2|||
131681403|NCT02060383|474121022|FG004|Core Phase|Adverse Event|6|||
131681404|NCT02060383|474121018|FG000|Core Phase|Administrative problems|0|||
131681405|NCT02060383|474121019|FG001|Core Phase|Administrative problems|1|||
131681406|NCT02060383|474121020|FG002|Core Phase|Administrative problems|0|||
131681407|NCT02060383|474121021|FG003|Core Phase|Administrative problems|0|||
131681408|NCT02060383|474121022|FG004|Core Phase|Administrative problems|0|||
131681409|NCT02060383|474121018|FG000|Core Phase|Protocol Violation|0|||
131681410|NCT02060383|474121019|FG001|Core Phase|Protocol Violation|0|||
131681411|NCT02060383|474121020|FG002|Core Phase|Protocol Violation|0|||
131681412|NCT02060383|474121021|FG003|Core Phase|Protocol Violation|1|||
131681413|NCT02060383|474121022|FG004|Core Phase|Protocol Violation|0|||
131681414|NCT02060383|474121018|FG000|Core Phase|Withdrawal by Subject|0|||
131681415|NCT02060383|474121019|FG001|Core Phase|Withdrawal by Subject|0|||
131681416|NCT02060383|474121020|FG002|Core Phase|Withdrawal by Subject|0|||
131681417|NCT02060383|474121021|FG003|Core Phase|Withdrawal by Subject|4|||
131681418|NCT02060383|474121022|FG004|Core Phase|Withdrawal by Subject|2|||
131681419|NCT02060383|474121018|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
131681420|NCT02060383|474121019|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
131681421|NCT02060383|474121020|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
131681422|NCT02060383|474121021|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
131681423|NCT02060383|474121022|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
131681424|NCT02060383|474121018|FG000|Extension Phase|Adverse Event|1|||
131681425|NCT02060383|474121019|FG001|Extension Phase|Adverse Event|1|||
131681426|NCT02060383|474121020|FG002|Extension Phase|Adverse Event|2|||
131681427|NCT02060383|474121021|FG003|Extension Phase|Adverse Event|0|||
131681428|NCT02060383|474121022|FG004|Extension Phase|Adverse Event|1|||
131681429|NCT02060383|474121018|FG000|Extension Phase|Withdrawal by Subject|0|||
131681430|NCT02060383|474121019|FG001|Extension Phase|Withdrawal by Subject|1|||
131681431|NCT02060383|474121020|FG002|Extension Phase|Withdrawal by Subject|0|||
131681432|NCT02060383|474121021|FG003|Extension Phase|Withdrawal by Subject|0|||
131681433|NCT02060383|474121022|FG004|Extension Phase|Withdrawal by Subject|2|||
131681434|NCT02060383|474121018|FG000|Extension Phase|Administrative problems|1|||
131681435|NCT02060383|474121019|FG001|Extension Phase|Administrative problems|0|||
131681436|NCT02060383|474121020|FG002|Extension Phase|Administrative problems|0|||
131681437|NCT02060383|474121021|FG003|Extension Phase|Administrative problems|0|||
131681438|NCT02060383|474121022|FG004|Extension Phase|Administrative problems|0|||
131681439|NCT02060383|474121018|FG000|Extension Phase|Death|0|||
131681440|NCT02060383|474121019|FG001|Extension Phase|Death|0|||
131681441|NCT02060383|474121020|FG002|Extension Phase|Death|1|||
131681442|NCT02060383|474121021|FG003|Extension Phase|Death|0|||
131681443|NCT02060383|474121022|FG004|Extension Phase|Death|1|||
131681444|NCT02060383|474121018|FG000|Extension Phase|Protocol Violation|0|||
131681445|NCT02060383|474121019|FG001|Extension Phase|Protocol Violation|0|||
131681446|NCT02060383|474121020|FG002|Extension Phase|Protocol Violation|0|||
131681447|NCT02060383|474121021|FG003|Extension Phase|Protocol Violation|0|||
131681448|NCT02060383|474121022|FG004|Extension Phase|Protocol Violation|1|||
131681449|NCT00395863|474121025|FG000|Overall Study|Patients did not complete both exams|2|||
131681450|NCT00395863|474121026|FG001|Overall Study|Patients did not complete both exams|3|||
131681451|NCT02592551|474121029|FG000|Overall Study|Not evaluable|1|||
131681452|NCT02592551|474121030|FG001|Overall Study|Not evaluable|3|||
131681453|NCT02592551|474121031|FG002|Overall Study|Not evaluable|0|||
131681454|NCT01876251|474121032|FG000|Overall Study|Clinical progression|1|||
131681455|NCT01876251|474121033|FG001|Overall Study|Clinical progression|0|||
131681456|NCT01876251|474121034|FG002|Overall Study|Clinical progression|0|||
131681457|NCT01876251|474121032|FG000|Overall Study|Death|2|||
131681458|NCT01876251|474121033|FG001|Overall Study|Death|0|||
131681459|NCT01876251|474121034|FG002|Overall Study|Death|1|||
131681460|NCT01876251|474121032|FG000|Overall Study|Participant started new treatment|1|||
131681461|NCT01876251|474121033|FG001|Overall Study|Participant started new treatment|0|||
131681462|NCT01876251|474121034|FG002|Overall Study|Participant started new treatment|1|||
131681463|NCT01876251|474121032|FG000|Overall Study|Participant refused further follow-up|0|||
131681464|NCT01876251|474121033|FG001|Overall Study|Participant refused further follow-up|0|||
131681465|NCT01876251|474121034|FG002|Overall Study|Participant refused further follow-up|1|||
131681466|NCT01876251|474121032|FG000|Overall Study|Study terminated|1|||
131681467|NCT01876251|474121033|FG001|Overall Study|Study terminated|0|||
131681468|NCT01876251|474121034|FG002|Overall Study|Study terminated|0|||
131681469|NCT01876251|474121032|FG000|Overall Study|Objective progression or relapse|10|||
131681470|NCT01876251|474121033|FG001|Overall Study|Objective progression or relapse|3|||
131681471|NCT01876251|474121034|FG002|Overall Study|Objective progression or relapse|8|||
131681472|NCT00268437|474121035|FG000|Overall Study|Ineligible|1|||
131681473|NCT03335163|474121038|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
131681474|NCT03335163|474121038|FG000|Overall Study|Withdrawal by Subject|18|||
131681475|NCT02020863|474121039|FG000|Overall Study|Discovery of Metastatic disease|4|||
131681476|NCT02020863|474121039|FG000|Overall Study|Team chose not to place an a line|1|||
131681477|NCT00907257|474121041|FG000|Overall Study|Adverse Event|0|||
131681478|NCT00907257|474121042|FG001|Overall Study|Adverse Event|4|||
131681479|NCT00907257|474121041|FG000|Overall Study|Protocol Violation|1|||
131681480|NCT00907257|474121042|FG001|Overall Study|Protocol Violation|2|||
131681481|NCT00907257|474121041|FG000|Overall Study|Lost to Follow-up|3|||
131681482|NCT00907257|474121042|FG001|Overall Study|Lost to Follow-up|3|||
131681483|NCT00907257|474121041|FG000|Overall Study|Withdrawal by Subject|1|||
131681484|NCT00907257|474121042|FG001|Overall Study|Withdrawal by Subject|2|||
131681485|NCT00907257|474121041|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
131681486|NCT00907257|474121042|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
131681487|NCT00907257|474121041|FG000|Overall Study|Moved|1|||
131681488|NCT00907257|474121042|FG001|Overall Study|Moved|0|||
131681489|NCT00907257|474121041|FG000|Overall Study|Personal Reasons|6|||
131681490|NCT00907257|474121042|FG001|Overall Study|Personal Reasons|1|||
131681491|NCT00283049|474121043|FG000|Overall Study|Adverse Event|6|||
131681492|NCT00283049|474121044|FG001|Overall Study|Adverse Event|1|||
131681493|NCT00283049|474121045|FG002|Overall Study|Adverse Event|4|||
131681494|NCT00283049|474121043|FG000|Overall Study|Protocol Violation|3|||
131681495|NCT00283049|474121044|FG001|Overall Study|Protocol Violation|0|||
131681496|NCT00283049|474121045|FG002|Overall Study|Protocol Violation|3|||
131681497|NCT00283049|474121043|FG000|Overall Study|Death|1|||
131681498|NCT00283049|474121044|FG001|Overall Study|Death|1|||
131681499|NCT00283049|474121045|FG002|Overall Study|Death|1|||
131681500|NCT00283049|474121043|FG000|Overall Study|Lack of Efficacy|0|||
131681501|NCT00283049|474121044|FG001|Overall Study|Lack of Efficacy|1|||
131681502|NCT00283049|474121045|FG002|Overall Study|Lack of Efficacy|1|||
131681503|NCT00283049|474121043|FG000|Overall Study|Lost to Follow-up|4|||
131681504|NCT00283049|474121044|FG001|Overall Study|Lost to Follow-up|2|||
131681505|NCT00283049|474121045|FG002|Overall Study|Lost to Follow-up|5|||
131681506|NCT00283049|474121043|FG000|Overall Study|Withdrawal by Subject|26|||
131681507|NCT00283049|474121044|FG001|Overall Study|Withdrawal by Subject|24|||
131681508|NCT00283049|474121045|FG002|Overall Study|Withdrawal by Subject|19|||
131681509|NCT00283049|474121043|FG000|Overall Study|Discontinuation of Study|18|||
131681510|NCT00283049|474121044|FG001|Overall Study|Discontinuation of Study|16|||
131681511|NCT00283049|474121045|FG002|Overall Study|Discontinuation of Study|20|||
131681512|NCT00283049|474121043|FG000|Overall Study|No longer requires study treatment|0|||
131681513|NCT00283049|474121044|FG001|Overall Study|No longer requires study treatment|0|||
131681514|NCT00283049|474121045|FG002|Overall Study|No longer requires study treatment|1|||
131681515|NCT01086410|474121046|FG000|Overall Study|Adverse Event|1|||
131681516|NCT01086410|474121047|FG001|Overall Study|Adverse Event|0|||
131681517|NCT01086410|474121048|FG002|Overall Study|Adverse Event|0|||
131681518|NCT01086410|474121049|FG003|Overall Study|Adverse Event|2|||
131681519|NCT01086410|474121046|FG000|Overall Study|Lack of Efficacy|1|||
131681520|NCT01086410|474121047|FG001|Overall Study|Lack of Efficacy|1|||
131681521|NCT01086410|474121048|FG002|Overall Study|Lack of Efficacy|0|||
131681522|NCT01086410|474121049|FG003|Overall Study|Lack of Efficacy|0|||
131681523|NCT01086410|474121046|FG000|Overall Study|Protocol Violation|1|||
131681524|NCT01086410|474121047|FG001|Overall Study|Protocol Violation|1|||
131681525|NCT01086410|474121048|FG002|Overall Study|Protocol Violation|0|||
131681526|NCT01086410|474121049|FG003|Overall Study|Protocol Violation|0|||
131681527|NCT01086410|474121046|FG000|Overall Study|Lost to Follow-up|0|||
131681528|NCT01086410|474121047|FG001|Overall Study|Lost to Follow-up|0|||
131681529|NCT01086410|474121048|FG002|Overall Study|Lost to Follow-up|1|||
131681530|NCT01086410|474121049|FG003|Overall Study|Lost to Follow-up|0|||
131681531|NCT04196803|474121050|FG000|Overall Study|Withdrawal by Subject|1|||
131681532|NCT04196803|474121051|FG001|Overall Study|Withdrawal by Subject|3|||
131681533|NCT04196803|474121050|FG000|Overall Study|Adverse Event|4|||
131681534|NCT04196803|474121051|FG001|Overall Study|Adverse Event|2|||
131681535|NCT04196803|474121050|FG000|Overall Study|Lost to Follow-up|0|||
131681536|NCT04196803|474121051|FG001|Overall Study|Lost to Follow-up|1|||
131681537|NCT01022996|474121052|FG000|Overall Study|Adverse Event|14|||
131681538|NCT01022996|474121052|FG000|Overall Study|Withdrawal by Subject|3|||
131681539|NCT01022996|474121052|FG000|Overall Study|Lost to Follow-up|1|||
131681540|NCT01022996|474121052|FG000|Overall Study|Administrative problems|6|||
131681541|NCT01022996|474121052|FG000|Overall Study|Disease Progression|32|||
131555856|NCT01027364|473660242|FG000|Overall Study|Withdrawal by Subject|1|||
131555857|NCT01027364|473660243|FG001|Overall Study|Withdrawal by Subject|2|||
131555858|NCT01027364|473660244|FG002|Overall Study|Withdrawal by Subject|0|||
131555859|NCT01027364|473660245|FG003|Overall Study|Withdrawal by Subject|0|||
131555860|NCT03119610|473660247|FG000|Overall Study|Adverse Event|1|||
131555861|NCT03119610|473660248|FG001|Overall Study|Adverse Event|0|||
131555862|NCT03119610|473660247|FG000|Overall Study|Lost to Follow-up|0|||
131555863|NCT03119610|473660248|FG001|Overall Study|Lost to Follow-up|1|||
131555864|NCT00114634|473660249|FG000|Overall Study|failure to return forms|3|||
131555865|NCT03283696|473660250|FG000|Overall Study|Physician Decision|5|||
131555866|NCT03283696|473660251|FG001|Overall Study|Physician Decision|6|||
131555867|NCT03283696|473660250|FG000|Overall Study|Withdrawal by Subject|2|||
131555868|NCT03283696|473660251|FG001|Overall Study|Withdrawal by Subject|0|||
131555869|NCT01539863|473660255|FG000|Overall Study|Lost to Follow-up|5|||
131555870|NCT01539863|473660256|FG001|Overall Study|Lost to Follow-up|4|||
131555871|NCT00557622|473660257|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
131555872|NCT00557622|473660258|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
131555873|NCT00557622|473660257|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
131555874|NCT00557622|473660258|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
131555875|NCT00557622|473660257|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
131555876|NCT00557622|473660258|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
131555877|NCT02765490|473660261|FG000|Overall Study|Lost to Follow-up|1|||
131555878|NCT02765490|473660262|FG001|Overall Study|Lost to Follow-up|1|||
131555879|NCT02765490|473660261|FG000|Overall Study|Other|0|||
131681542|NCT01022996|474121052|FG000|Overall Study|Protocol Violation|1|||
131681543|NCT03945591|474121055|FG000|Overall Study|Participant not transplanted|1|||
131681544|NCT03945591|474121055|FG000|Overall Study|Change in treatment plan|3|||
131681545|NCT03945591|474121055|FG000|Overall Study|Adverse Event|1|||
131681546|NCT03083847|474121059|FG000|Main|Physician Decision|0|||
131681547|NCT03083847|474121060|FG001|Main|Physician Decision|0|||
131681548|NCT03083847|474121061|FG002|Main|Physician Decision|0|||
131681549|NCT03083847|474121062|FG003|Main|Physician Decision|0|||
131681550|NCT03083847|474121063|FG004|Main|Physician Decision|0|||
131681551|NCT03083847|474121064|FG005|Main|Physician Decision|1|||
131681552|NCT03083847|474121065|FG006|Main|Physician Decision|0|||
131681553|NCT03083847|474121066|FG007|Main|Physician Decision|0|||
131681554|NCT03083847|474121067|FG008|Main|Physician Decision|0|||
131681555|NCT03083847|474121068|FG009|Main|Physician Decision|0|||
131681556|NCT03083847|474121059|FG000|Main|Pregnancy|0|||
131681557|NCT03083847|474121060|FG001|Main|Pregnancy|0|||
131681558|NCT03083847|474121061|FG002|Main|Pregnancy|0|||
131681559|NCT03083847|474121062|FG003|Main|Pregnancy|0|||
131681560|NCT03083847|474121063|FG004|Main|Pregnancy|0|||
131681561|NCT03083847|474121064|FG005|Main|Pregnancy|0|||
131681562|NCT03083847|474121065|FG006|Main|Pregnancy|0|||
131681563|NCT03083847|474121066|FG007|Main|Pregnancy|1|||
131681564|NCT03083847|474121067|FG008|Main|Pregnancy|0|||
131681565|NCT03083847|474121068|FG009|Main|Pregnancy|0|||
131681566|NCT03083847|474121059|FG000|Main|Adverse Event|0|||
131681567|NCT03083847|474121060|FG001|Main|Adverse Event|0|||
131681568|NCT03083847|474121061|FG002|Main|Adverse Event|0|||
131681569|NCT03083847|474121062|FG003|Main|Adverse Event|0|||
131681570|NCT03083847|474121063|FG004|Main|Adverse Event|0|||
131681571|NCT03083847|474121064|FG005|Main|Adverse Event|0|||
131681572|NCT03083847|474121065|FG006|Main|Adverse Event|0|||
131681573|NCT03083847|474121066|FG007|Main|Adverse Event|2|||
131681574|NCT03083847|474121067|FG008|Main|Adverse Event|0|||
131681575|NCT03083847|474121068|FG009|Main|Adverse Event|0|||
131681576|NCT03083847|474121059|FG000|Main|Withdrawal by Subject|0|||
131681577|NCT03083847|474121060|FG001|Main|Withdrawal by Subject|0|||
131681578|NCT03083847|474121061|FG002|Main|Withdrawal by Subject|0|||
131681579|NCT03083847|474121062|FG003|Main|Withdrawal by Subject|0|||
131681580|NCT03083847|474121063|FG004|Main|Withdrawal by Subject|0|||
131681581|NCT03083847|474121064|FG005|Main|Withdrawal by Subject|0|||
131681582|NCT03083847|474121065|FG006|Main|Withdrawal by Subject|1|||
131681583|NCT03083847|474121066|FG007|Main|Withdrawal by Subject|1|||
131681584|NCT03083847|474121067|FG008|Main|Withdrawal by Subject|0|||
131681585|NCT03083847|474121068|FG009|Main|Withdrawal by Subject|0|||
131681586|NCT01949155|474121070|FG000|Overall Study|Lost to Follow-up|1|||
131681587|NCT01949155|474121071|FG001|Overall Study|Lost to Follow-up|0|||
131681588|NCT01949155|474121070|FG000|Overall Study|Protocol Violation|1|||
131681589|NCT01949155|474121071|FG001|Overall Study|Protocol Violation|0|||
131681590|NCT00314249|474121072|FG000|Overall Study|Adverse Event|73|||
131681591|NCT00314249|474121073|FG001|Overall Study|Adverse Event|94|||
131681592|NCT00314249|474121072|FG000|Overall Study|Lack of Efficacy|33|||
131555880|NCT02765490|473660262|FG001|Overall Study|Other|1|||
131681593|NCT00314249|474121073|FG001|Overall Study|Lack of Efficacy|24|||
131681594|NCT00314249|474121072|FG000|Overall Study|Withdrawal by Subject|21|||
131681595|NCT00314249|474121073|FG001|Overall Study|Withdrawal by Subject|28|||
131681596|NCT00314249|474121072|FG000|Overall Study|Lost to Follow-up|15|||
131681597|NCT00314249|474121073|FG001|Overall Study|Lost to Follow-up|9|||
131681598|NCT00314249|474121072|FG000|Overall Study|Physician Decision|1|||
131681599|NCT00314249|474121073|FG001|Overall Study|Physician Decision|1|||
131681600|NCT00314249|474121072|FG000|Overall Study|Withdrawn for other reasons|4|||
131681601|NCT00314249|474121073|FG001|Overall Study|Withdrawn for other reasons|1|||
131681602|NCT00314249|474121072|FG000|Overall Study|Non-Compliant|5|||
131681603|NCT00314249|474121073|FG001|Overall Study|Non-Compliant|6|||
131681604|NCT00210184|474121074|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
131681605|NCT01353508|474121075|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
131681606|NCT01353508|474121076|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
131681607|NCT01353508|474121077|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
131681608|NCT01353508|474121078|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
131681609|NCT01353508|474121075|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
131681610|NCT01353508|474121076|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
131681611|NCT01353508|474121077|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
131681612|NCT01353508|474121078|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
131681613|NCT02606461|474121079|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131681614|NCT02606461|474121080|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131681615|NCT02606461|474121081|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
131681616|NCT02606461|474121082|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131681617|NCT02606461|474121083|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131681618|NCT02606461|474121084|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131681619|NCT02092350|474121085|FG000|Overall Study|Adverse Event|0|||
131681620|NCT02092350|474121086|FG001|Overall Study|Adverse Event|3|||
131681621|NCT02092350|474121085|FG000|Overall Study|Death|2|||
131681622|NCT02092350|474121086|FG001|Overall Study|Death|5|||
131681623|NCT02092350|474121085|FG000|Overall Study|Lost to Follow-up|3|||
131681624|NCT02092350|474121086|FG001|Overall Study|Lost to Follow-up|1|||
131681625|NCT02092350|474121085|FG000|Overall Study|Protocol Violation|1|||
131681626|NCT02092350|474121086|FG001|Overall Study|Protocol Violation|0|||
131681627|NCT02092350|474121085|FG000|Overall Study|Physician Decision|1|||
131681628|NCT02092350|474121086|FG001|Overall Study|Physician Decision|1|||
131681629|NCT02092350|474121085|FG000|Overall Study|Screen Failure|1|||
131681630|NCT02092350|474121086|FG001|Overall Study|Screen Failure|0|||
131681631|NCT02092350|474121085|FG000|Overall Study|Withdrawal by Subject|2|||
131681632|NCT02092350|474121086|FG001|Overall Study|Withdrawal by Subject|2|||
131681633|NCT00239226|474121087|FG000|Overall Study|permAF during stabilization period|0|||
131681634|NCT00239226|474121088|FG001|Overall Study|permAF during stabilization period|0|||
131681635|NCT00239226|474121089|FG002|Overall Study|permAF during stabilization period|0|||
131681636|NCT00239226|474121090|FG003|Overall Study|permAF during stabilization period|3|||
131681637|NCT00239226|474121087|FG000|Overall Study|Lost to Follow-up|1|||
131681638|NCT00239226|474121088|FG001|Overall Study|Lost to Follow-up|0|||
131681639|NCT00239226|474121089|FG002|Overall Study|Lost to Follow-up|1|||
131681640|NCT00239226|474121090|FG003|Overall Study|Lost to Follow-up|0|||
131681641|NCT00646906|474121091|FG000|Crossover Period 1|Withdrawal by Subject|1|||
131681642|NCT00646906|474121092|FG001|Crossover Period 1|Withdrawal by Subject|0|||
131681643|NCT00646906|474121093|FG002|Crossover Period 1|Withdrawal by Subject|0|||
131681644|NCT00646906|474121094|FG003|Crossover Period 1|Withdrawal by Subject|0|||
131681645|NCT00646906|474121095|FG004|Crossover Period 1|Withdrawal by Subject|0|||
131681646|NCT00646906|474121096|FG005|Crossover Period 1|Withdrawal by Subject|1|||
131681647|NCT00646906|474121097|FG006|Crossover Period 1|Withdrawal by Subject|0|||
131681648|NCT00646906|474121091|FG000|Crossover Period 2|Withdrawal by Subject|0|||
131681649|NCT00646906|474121092|FG001|Crossover Period 2|Withdrawal by Subject|1|||
131681650|NCT00646906|474121093|FG002|Crossover Period 2|Withdrawal by Subject|2|||
131681651|NCT00646906|474121094|FG003|Crossover Period 2|Withdrawal by Subject|1|||
131681652|NCT00646906|474121095|FG004|Crossover Period 2|Withdrawal by Subject|0|||
131681653|NCT00646906|474121096|FG005|Crossover Period 2|Withdrawal by Subject|0|||
131681654|NCT00646906|474121097|FG006|Crossover Period 2|Withdrawal by Subject|0|||
131681655|NCT00646906|474121091|FG000|Crossover Period 2|Physician Decision|0|||
131681656|NCT00646906|474121092|FG001|Crossover Period 2|Physician Decision|0|||
131681657|NCT00646906|474121093|FG002|Crossover Period 2|Physician Decision|0|||
131681658|NCT00646906|474121094|FG003|Crossover Period 2|Physician Decision|0|||
131681659|NCT00646906|474121095|FG004|Crossover Period 2|Physician Decision|0|||
131681660|NCT00646906|474121096|FG005|Crossover Period 2|Physician Decision|0|||
131681661|NCT00646906|474121097|FG006|Crossover Period 2|Physician Decision|1|||
131681662|NCT04060563|474121100|FG000|Overall Study|Lost to Follow-up|1|||
131681663|NCT04060563|474121101|FG001|Overall Study|Lost to Follow-up|1|||
131681664|NCT04060563|474121100|FG000|Overall Study|Physician Decision|0|||
131681665|NCT04060563|474121101|FG001|Overall Study|Physician Decision|1|||
131681666|NCT00851682|474121102|FG000|Overall Study|screen failure|5|||
131681667|NCT00851682|474121103|FG001|Overall Study|screen failure|0|||
131681668|NCT01379573|474121107|FG000|Overall Study|Lost to Follow-up|1|||
131681669|NCT01379573|474121107|FG000|Overall Study|Screen Failure|10|||
131681670|NCT00962390|474121108|FG000|Overall Study|Adverse Event|0|||
131681671|NCT00962390|474121109|FG001|Overall Study|Adverse Event|0|||
131681672|NCT00962390|474121110|FG002|Overall Study|Adverse Event|3|||
131681673|NCT00962390|474121111|FG003|Overall Study|Adverse Event|1|||
131681674|NCT00962390|474121108|FG000|Overall Study|Lost to Follow-up|2|||
131681675|NCT00962390|474121109|FG001|Overall Study|Lost to Follow-up|2|||
131681676|NCT00962390|474121110|FG002|Overall Study|Lost to Follow-up|0|||
131681677|NCT00962390|474121111|FG003|Overall Study|Lost to Follow-up|0|||
131681678|NCT00962390|474121108|FG000|Overall Study|Protocol Violation|1|||
131681679|NCT00962390|474121109|FG001|Overall Study|Protocol Violation|0|||
131681680|NCT00962390|474121110|FG002|Overall Study|Protocol Violation|0|||
131681681|NCT00962390|474121111|FG003|Overall Study|Protocol Violation|0|||
131681682|NCT00962390|474121108|FG000|Overall Study|Withdrawal by Subject|1|||
131681683|NCT00962390|474121109|FG001|Overall Study|Withdrawal by Subject|1|||
131681684|NCT00962390|474121110|FG002|Overall Study|Withdrawal by Subject|1|||
131681685|NCT00962390|474121111|FG003|Overall Study|Withdrawal by Subject|0|||
131681686|NCT02613884|474121112|FG000|Overall Study|Death|1|||
131681687|NCT02613884|474121112|FG000|Overall Study|Lost to Follow-up|1|||
131681688|NCT01514136|474121113|FG000|Test Period 1; Test A|Protocol Violation|1|||
131681689|NCT01514136|474121114|FG001|Test Period 1; Test A|Protocol Violation|0|||
131681690|NCT01514136|474121115|FG002|Test Period 1; Test A|Protocol Violation|0|||
131681691|NCT01514136|474121116|FG003|Test Period 1; Test A|Protocol Violation|0|||
131681692|NCT01514136|474121117|FG004|Test Period 1; Test A|Protocol Violation|0|||
131681693|NCT01514136|474121118|FG005|Test Period 1; Test A|Protocol Violation|0|||
131681694|NCT01514136|474121119|FG006|Test Period 1; Test A|Protocol Violation|0|||
131681695|NCT01514136|474121120|FG007|Test Period 1; Test A|Protocol Violation|0|||
131681696|NCT01514136|474121113|FG000|Test Period 1; Test A|Break from study holiday|2|||
131681697|NCT01514136|474121114|FG001|Test Period 1; Test A|Break from study holiday|0|||
131681698|NCT01514136|474121115|FG002|Test Period 1; Test A|Break from study holiday|0|||
131681699|NCT01514136|474121116|FG003|Test Period 1; Test A|Break from study holiday|0|||
131681700|NCT01514136|474121117|FG004|Test Period 1; Test A|Break from study holiday|0|||
131681701|NCT01514136|474121118|FG005|Test Period 1; Test A|Break from study holiday|0|||
131681702|NCT01514136|474121119|FG006|Test Period 1; Test A|Break from study holiday|0|||
131681703|NCT01514136|474121120|FG007|Test Period 1; Test A|Break from study holiday|0|||
131681704|NCT01514136|474121113|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
131681705|NCT01514136|474121114|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
131681706|NCT01514136|474121115|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
131681707|NCT01514136|474121116|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
131681708|NCT01514136|474121117|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
131681709|NCT01514136|474121118|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
131681710|NCT01514136|474121119|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
131681711|NCT01514136|474121120|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
131681712|NCT01514136|474121113|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681713|NCT01514136|474121114|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681714|NCT01514136|474121115|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681715|NCT01514136|474121116|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
131681716|NCT01514136|474121117|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681717|NCT01514136|474121118|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681718|NCT01514136|474121119|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681719|NCT01514136|474121120|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
131681720|NCT01514136|474121113|FG000|Test Period 2; Test A*|Adverse Event|0|||
131681721|NCT01514136|474121114|FG001|Test Period 2; Test A*|Adverse Event|0|||
131681722|NCT01514136|474121115|FG002|Test Period 2; Test A*|Adverse Event|0|||
131681723|NCT01514136|474121116|FG003|Test Period 2; Test A*|Adverse Event|0|||
131681724|NCT01514136|474121117|FG004|Test Period 2; Test A*|Adverse Event|1|||
131681725|NCT01514136|474121118|FG005|Test Period 2; Test A*|Adverse Event|0|||
131681726|NCT01514136|474121119|FG006|Test Period 2; Test A*|Adverse Event|0|||
131681727|NCT01514136|474121120|FG007|Test Period 2; Test A*|Adverse Event|0|||
131681728|NCT01514136|474121113|FG000|Test Period 2; Test A*|Holiday|0|||
131681729|NCT01514136|474121114|FG001|Test Period 2; Test A*|Holiday|0|||
131681730|NCT01514136|474121115|FG002|Test Period 2; Test A*|Holiday|0|||
131681731|NCT01514136|474121116|FG003|Test Period 2; Test A*|Holiday|0|||
131681732|NCT01514136|474121117|FG004|Test Period 2; Test A*|Holiday|1|||
131681733|NCT01514136|474121118|FG005|Test Period 2; Test A*|Holiday|0|||
131681734|NCT01514136|474121119|FG006|Test Period 2; Test A*|Holiday|0|||
131681735|NCT01514136|474121120|FG007|Test Period 2; Test A*|Holiday|0|||
131681736|NCT01514136|474121113|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681737|NCT01514136|474121114|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681738|NCT01514136|474121115|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681739|NCT01514136|474121116|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681740|NCT01514136|474121117|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681741|NCT01514136|474121118|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
131681742|NCT01514136|474121119|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681743|NCT01514136|474121120|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
131681744|NCT01514136|474121113|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
131681745|NCT01514136|474121114|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
131681746|NCT01514136|474121115|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
131555881|NCT02765490|473660261|FG000|Overall Study|Death|0|||
131555882|NCT02765490|473660262|FG001|Overall Study|Death|1|||
131681747|NCT01514136|474121116|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
131681748|NCT01514136|474121117|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
131681749|NCT01514136|474121118|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
131681750|NCT01514136|474121119|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
131681751|NCT01514136|474121120|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
131681752|NCT01514136|474121113|FG000|Test Period 2; Test C*|holiday|0|||
131681753|NCT01514136|474121114|FG001|Test Period 2; Test C*|holiday|0|||
131681754|NCT01514136|474121115|FG002|Test Period 2; Test C*|holiday|0|||
131681755|NCT01514136|474121116|FG003|Test Period 2; Test C*|holiday|0|||
131681756|NCT01514136|474121117|FG004|Test Period 2; Test C*|holiday|0|||
131681757|NCT01514136|474121118|FG005|Test Period 2; Test C*|holiday|0|||
131681758|NCT01514136|474121119|FG006|Test Period 2; Test C*|holiday|1|||
131681759|NCT01514136|474121120|FG007|Test Period 2; Test C*|holiday|0|||
131681760|NCT01514136|474121113|FG000|Test Period 2; Test C*|Protocol Violation|0|||
131681761|NCT01514136|474121114|FG001|Test Period 2; Test C*|Protocol Violation|0|||
131681762|NCT01514136|474121115|FG002|Test Period 2; Test C*|Protocol Violation|0|||
131681763|NCT01514136|474121116|FG003|Test Period 2; Test C*|Protocol Violation|0|||
131681764|NCT01514136|474121117|FG004|Test Period 2; Test C*|Protocol Violation|0|||
131681765|NCT01514136|474121118|FG005|Test Period 2; Test C*|Protocol Violation|0|||
131681766|NCT01514136|474121119|FG006|Test Period 2; Test C*|Protocol Violation|1|||
131681767|NCT01514136|474121120|FG007|Test Period 2; Test C*|Protocol Violation|0|||
131681768|NCT02729740|474121121|FG000|Overall Study|Early Termination|130|||
131681769|NCT02729740|474121121|FG000|Overall Study|Other|1|||
131681770|NCT00601705|474121125|FG000|Overall Study|Withdrawal by Subject|1|||
131681771|NCT02101021|474121128|FG000|Overall Study|Death|4|||
131681772|NCT02101021|474121129|FG001|Overall Study|Death|3|||
131681773|NCT02101021|474121130|FG002|Overall Study|Death|6|||
131681774|NCT02101021|474121131|FG003|Overall Study|Death|0|||
131681775|NCT02101021|474121132|FG004|Overall Study|Death|3|||
131681776|NCT02101021|474121128|FG000|Overall Study|Withdrew Consent from study|1|||
131681777|NCT02101021|474121129|FG001|Overall Study|Withdrew Consent from study|1|||
131681778|NCT02101021|474121130|FG002|Overall Study|Withdrew Consent from study|0|||
131681779|NCT02101021|474121131|FG003|Overall Study|Withdrew Consent from study|2|||
131681780|NCT02101021|474121132|FG004|Overall Study|Withdrew Consent from study|0|||
131681781|NCT02101021|474121128|FG000|Overall Study|Lost to Follow-up|1|||
131681782|NCT02101021|474121129|FG001|Overall Study|Lost to Follow-up|0|||
131681783|NCT02101021|474121130|FG002|Overall Study|Lost to Follow-up|0|||
131681784|NCT02101021|474121131|FG003|Overall Study|Lost to Follow-up|0|||
131681785|NCT02101021|474121132|FG004|Overall Study|Lost to Follow-up|0|||
131681786|NCT02101021|474121128|FG000|Overall Study|Study Terminated by Sponsor|1|||
131681787|NCT02101021|474121129|FG001|Overall Study|Study Terminated by Sponsor|0|||
131681788|NCT02101021|474121130|FG002|Overall Study|Study Terminated by Sponsor|1|||
131681789|NCT02101021|474121131|FG003|Overall Study|Study Terminated by Sponsor|1|||
131681790|NCT02101021|474121132|FG004|Overall Study|Study Terminated by Sponsor|1|||
131681791|NCT01368042|474121133|FG000|Overall Study|Death|14|||
131681792|NCT01368042|474121133|FG000|Overall Study|Protocol Violation|11|||
131681793|NCT01368042|474121133|FG000|Overall Study|Lost to Follow-up|4|||
131681794|NCT01368042|474121133|FG000|Overall Study|Transplanted|1|||
131681795|NCT01621542|474121134|FG000|Overall Study|Adverse Event|0|||
131681796|NCT01621542|474121135|FG001|Overall Study|Adverse Event|0|||
131681797|NCT01621542|474121136|FG002|Overall Study|Adverse Event|1|||
131681798|NCT01621542|474121137|FG003|Overall Study|Adverse Event|3|||
131681799|NCT01621542|474121138|FG004|Overall Study|Adverse Event|0|||
131681800|NCT01621542|474121139|FG005|Overall Study|Adverse Event|0|||
131681801|NCT01621542|474121134|FG000|Overall Study|Death|0|||
131681802|NCT01621542|474121135|FG001|Overall Study|Death|1|||
131681803|NCT01621542|474121136|FG002|Overall Study|Death|0|||
131681804|NCT01621542|474121137|FG003|Overall Study|Death|0|||
131681805|NCT01621542|474121138|FG004|Overall Study|Death|0|||
131681806|NCT01621542|474121139|FG005|Overall Study|Death|0|||
131681807|NCT01621542|474121134|FG000|Overall Study|Physician Decision|1|||
131681808|NCT01621542|474121135|FG001|Overall Study|Physician Decision|0|||
131681809|NCT01621542|474121136|FG002|Overall Study|Physician Decision|1|||
131681810|NCT01621542|474121137|FG003|Overall Study|Physician Decision|13|||
131681811|NCT01621542|474121138|FG004|Overall Study|Physician Decision|3|||
131681812|NCT01621542|474121139|FG005|Overall Study|Physician Decision|1|||
131681813|NCT01621542|474121134|FG000|Overall Study|Withdrawal by Subject|2|||
131681814|NCT01621542|474121135|FG001|Overall Study|Withdrawal by Subject|0|||
131681815|NCT01621542|474121136|FG002|Overall Study|Withdrawal by Subject|1|||
131681816|NCT01621542|474121137|FG003|Overall Study|Withdrawal by Subject|3|||
131681817|NCT01621542|474121138|FG004|Overall Study|Withdrawal by Subject|3|||
131681818|NCT01621542|474121139|FG005|Overall Study|Withdrawal by Subject|3|||
131681819|NCT01621542|474121134|FG000|Overall Study|progression/treatment failure|2|||
131681820|NCT01621542|474121135|FG001|Overall Study|progression/treatment failure|4|||
131555883|NCT01468922|473660263|FG000|Overall Study|Screening failure|0|||
131681821|NCT01621542|474121136|FG002|Overall Study|progression/treatment failure|3|||
131681822|NCT01621542|474121137|FG003|Overall Study|progression/treatment failure|7|||
131681823|NCT01621542|474121138|FG004|Overall Study|progression/treatment failure|3|||
131681824|NCT01621542|474121139|FG005|Overall Study|progression/treatment failure|5|||
131681825|NCT01621542|474121134|FG000|Overall Study|Protocol Violation|0|||
131681826|NCT01621542|474121135|FG001|Overall Study|Protocol Violation|0|||
131681827|NCT01621542|474121136|FG002|Overall Study|Protocol Violation|0|||
131681828|NCT01621542|474121137|FG003|Overall Study|Protocol Violation|1|||
131681829|NCT01621542|474121138|FG004|Overall Study|Protocol Violation|0|||
131681830|NCT01621542|474121139|FG005|Overall Study|Protocol Violation|0|||
131681831|NCT01621542|474121134|FG000|Overall Study|study stopped by sponsor|0|||
131681832|NCT01621542|474121135|FG001|Overall Study|study stopped by sponsor|0|||
131681833|NCT01621542|474121136|FG002|Overall Study|study stopped by sponsor|0|||
131681834|NCT01621542|474121137|FG003|Overall Study|study stopped by sponsor|1|||
131681835|NCT01621542|474121138|FG004|Overall Study|study stopped by sponsor|0|||
131681836|NCT01621542|474121139|FG005|Overall Study|study stopped by sponsor|0|||
131681837|NCT00760669|474121140|FG000|Overall Study|Not assessed for overall improvement|18|||
131681838|NCT00760669|474121140|FG000|Overall Study|Participants missing efficacy assessment|6|||
131681839|NCT00760669|474121140|FG000|Overall Study|Participants with overlapping cases|1|||
131681840|NCT00760669|474121140|FG000|Overall Study|Took drug before entering in contract|5|||
131681841|NCT02663271|474121141|FG000|Overall Study|Withdrawal by Subject|5|||
131681842|NCT02663271|474121141|FG000|Overall Study|Lack of Efficacy|1|||
131681843|NCT01572675|474121142|FG000|Overall Study|End of prescribed treatment|140|||
131681844|NCT01572675|474121143|FG001|Overall Study|End of prescribed treatment|118|||
131681845|NCT01572675|474121142|FG000|Overall Study|Recovery|16|||
131681846|NCT01572675|474121143|FG001|Overall Study|Recovery|23|||
131681847|NCT01572675|474121142|FG000|Overall Study|Lack of Efficacy|31|||
131681848|NCT01572675|474121143|FG001|Overall Study|Lack of Efficacy|31|||
131681849|NCT01572675|474121142|FG000|Overall Study|Intolerance|6|||
131681850|NCT01572675|474121143|FG001|Overall Study|Intolerance|5|||
131681851|NCT01572675|474121142|FG000|Overall Study|Improved symptoms|8|||
131681852|NCT01572675|474121143|FG001|Overall Study|Improved symptoms|2|||
131681853|NCT01572675|474121142|FG000|Overall Study|Surgical intervention|3|||
131681854|NCT01572675|474121143|FG001|Overall Study|Surgical intervention|6|||
131681855|NCT01572675|474121142|FG000|Overall Study|Withdrawal by Subject|5|||
131681856|NCT01572675|474121143|FG001|Overall Study|Withdrawal by Subject|1|||
131681857|NCT01572675|474121142|FG000|Overall Study|Physician Decision|2|||
131681858|NCT01572675|474121143|FG001|Overall Study|Physician Decision|2|||
131681859|NCT01572675|474121142|FG000|Overall Study|Death unrelated to coxibs|1|||
131681860|NCT01572675|474121143|FG001|Overall Study|Death unrelated to coxibs|1|||
131681861|NCT01572675|474121142|FG000|Overall Study|Other disease detected|1|||
131681862|NCT01572675|474121143|FG001|Overall Study|Other disease detected|1|||
131681863|NCT01572675|474121142|FG000|Overall Study|Unknown reason|1|||
131681864|NCT01572675|474121143|FG001|Overall Study|Unknown reason|1|||
131681865|NCT01572675|474121142|FG000|Overall Study|Rheumatologist new evaluation|0|||
131681866|NCT01572675|474121143|FG001|Overall Study|Rheumatologist new evaluation|1|||
131681867|NCT01572675|474121142|FG000|Overall Study|Missing data|1|||
131681868|NCT01572675|474121143|FG001|Overall Study|Missing data|4|||
131681869|NCT01572675|474121142|FG000|Overall Study|Lost to Follow-up|22|||
131681870|NCT01572675|474121143|FG001|Overall Study|Lost to Follow-up|27|||
131681871|NCT02921269|474121147|FG000|Overall Study|Did not complete DLT period|1|||
131681872|NCT02322229|474121157|FG000|Overall Study|Physician Decision|2|||
131681873|NCT00705432|474121158|FG000|Treatment Period|Adverse Event|45|||
131681874|NCT00705432|474121159|FG001|Treatment Period|Adverse Event|37|||
131681875|NCT00705432|474121160|FG002|Treatment Period|Adverse Event|51|||
131681876|NCT00705432|474121161|FG003|Treatment Period|Adverse Event|12|||
131681877|NCT00705432|474121162|FG004|Treatment Period|Adverse Event|8|||
131681878|NCT00705432|474121163|FG005|Treatment Period|Adverse Event|9|||
131681879|NCT00705432|474121158|FG000|Treatment Period|Treatment failure|92|||
131681880|NCT00705432|474121159|FG001|Treatment Period|Treatment failure|42|||
131681881|NCT00705432|474121160|FG002|Treatment Period|Treatment failure|33|||
131681882|NCT00705432|474121161|FG003|Treatment Period|Treatment failure|25|||
131681883|NCT00705432|474121162|FG004|Treatment Period|Treatment failure|13|||
131681884|NCT00705432|474121163|FG005|Treatment Period|Treatment failure|14|||
131681885|NCT00705432|474121158|FG000|Treatment Period|Non medical reason|26|||
131681886|NCT00705432|474121159|FG001|Treatment Period|Non medical reason|32|||
131681887|NCT00705432|474121160|FG002|Treatment Period|Non medical reason|37|||
131681888|NCT00705432|474121161|FG003|Treatment Period|Non medical reason|4|||
131681889|NCT00705432|474121162|FG004|Treatment Period|Non medical reason|7|||
131681890|NCT00705432|474121163|FG005|Treatment Period|Non medical reason|7|||
131681891|NCT00705432|474121158|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
131681892|NCT00705432|474121159|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
131681893|NCT00705432|474121160|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
131681894|NCT00705432|474121161|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
131681895|NCT00705432|474121162|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
131681896|NCT00705432|474121163|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
131681897|NCT00705432|474121158|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
131681898|NCT00705432|474121159|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
131681899|NCT00705432|474121160|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
131681900|NCT00705432|474121161|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
131681901|NCT00705432|474121162|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
131681902|NCT00705432|474121163|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
131681903|NCT00521053|474121164|FG000|Observation Phase|Disease Progression|55|||
131681904|NCT00521053|474121164|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
131681905|NCT00521053|474121164|FG000|Observation Phase|Death|2|||
131681906|NCT00521053|474121164|FG000|Observation Phase|Adverse Event|1|||
131681907|NCT00521053|474121164|FG000|Observation Phase|Other non-study melanoma treatment|1|||
131681908|NCT00521053|474121164|FG000|Observation Phase|Physician Decision|1|||
131681909|NCT00482703|474121165|FG000|Overall Study|Poor compliance|1|||
131898486|NCT01502033|474914085|FG000|Overall Study|1 participant had scalp discomfort|1|||
131681910|NCT00482703|474121166|FG001|Overall Study|Poor compliance|0|||
131681911|NCT04223791|474121168|FG000|Overall Study|Lost to Follow-up|0|||
131681912|NCT04223791|474121169|FG001|Overall Study|Lost to Follow-up|4|||
131681913|NCT04223791|474121168|FG000|Overall Study|Physician Decision|5|||
131681914|NCT04223791|474121169|FG001|Overall Study|Physician Decision|1|||
131681915|NCT04223791|474121168|FG000|Overall Study|Protocol Violation|1|||
131681916|NCT04223791|474121169|FG001|Overall Study|Protocol Violation|1|||
131681917|NCT04223791|474121168|FG000|Overall Study|Withdrawal by Subject|10|||
131681918|NCT04223791|474121169|FG001|Overall Study|Withdrawal by Subject|12|||
131681919|NCT04223791|474121168|FG000|Overall Study|Pregnancy|1|||
131681920|NCT04223791|474121169|FG001|Overall Study|Pregnancy|1|||
131681921|NCT04223791|474121168|FG000|Overall Study|Ongoing in Study|305|||
131681922|NCT04223791|474121169|FG001|Overall Study|Ongoing in Study|302|||
131681923|NCT00761306|474122333|FG000|Overall Study|Adverse Event|5|||
131681924|NCT00761306|474122333|FG000|Overall Study|Lack of Efficacy|4|||
131681925|NCT00761306|474122333|FG000|Overall Study|Protocol Violation|2|||
131681926|NCT00761306|474122333|FG000|Overall Study|Withdrawal of Consent|3|||
131681927|NCT00761306|474122333|FG000|Overall Study|Lost to Follow-up|1|||
131681928|NCT00761306|474122333|FG000|Overall Study|Administrative or Other Reasons|5|||
131681929|NCT05162027|474122334|FG000|Overall Study|Adverse Event|1|||
131681930|NCT05162027|474122335|FG001|Overall Study|Adverse Event|0|||
131681931|NCT03713034|474122336|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
131681932|NCT03713034|474122337|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
131681933|NCT02982239|474122340|FG000|Overall Study|Lost to Follow-up|3|||
131681934|NCT02982239|474122341|FG001|Overall Study|Lost to Follow-up|2|||
131681935|NCT02767323|474122348|FG000|Overall Study|Withdrawal by Subject|17|||
131681936|NCT02767323|474122349|FG001|Overall Study|Withdrawal by Subject|5|||
131681937|NCT02767323|474122350|FG002|Overall Study|Withdrawal by Subject|13|||
131681938|NCT02767323|474122351|FG003|Overall Study|Withdrawal by Subject|0|||
131681939|NCT02767323|474122348|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
131681940|NCT02767323|474122349|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
131681941|NCT02767323|474122350|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
131681942|NCT02767323|474122351|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
131681943|NCT01986920|474122359|FG000|A- 101 25%|Withdrawal by Subject|1|||
131681944|NCT01986920|474122360|FG001|A- 101 25%|Withdrawal by Subject|0|||
131681945|NCT01986920|474122361|FG002|A- 101 25%|Withdrawal by Subject|0|||
131681946|NCT01986920|474122362|FG003|A- 101 25%|Withdrawal by Subject|0|||
131681947|NCT01986920|474122359|FG000|A-101 32.5%|Withdrawal by Subject|0|||
131681948|NCT01986920|474122360|FG001|A-101 32.5%|Withdrawal by Subject|1|||
131681949|NCT01986920|474122361|FG002|A-101 32.5%|Withdrawal by Subject|0|||
131681950|NCT01986920|474122362|FG003|A-101 32.5%|Withdrawal by Subject|0|||
131681951|NCT01986920|474122359|FG000|A-101 40%|Withdrawal by Subject|0|||
131681952|NCT01986920|474122360|FG001|A-101 40%|Withdrawal by Subject|0|||
131681953|NCT01986920|474122361|FG002|A-101 40%|Withdrawal by Subject|1|||
131681954|NCT01986920|474122362|FG003|A-101 40%|Withdrawal by Subject|0|||
131898487|NCT01502033|474914085|FG000|Overall Study|1 participant had worsening depression|1|||
131681955|NCT01986920|474122359|FG000|Placebo|Withdrawal by Subject|0|||
131681956|NCT01986920|474122360|FG001|Placebo|Withdrawal by Subject|0|||
131681957|NCT01986920|474122361|FG002|Placebo|Withdrawal by Subject|0|||
131681958|NCT01986920|474122362|FG003|Placebo|Withdrawal by Subject|1|||
131681959|NCT01338415|474122363|FG000|Core + Extension|Adverse Event|8|||
131681960|NCT01338415|474122364|FG001|Core + Extension|Adverse Event|6|||
131681961|NCT01338415|474122365|FG002|Core + Extension|Adverse Event|0|||
131681962|NCT01338415|474122363|FG000|Core + Extension|Withdrawal by Subject|1|||
131681963|NCT01338415|474122364|FG001|Core + Extension|Withdrawal by Subject|1|||
131681964|NCT01338415|474122365|FG002|Core + Extension|Withdrawal by Subject|0|||
131681965|NCT01338415|474122363|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
131681966|NCT01338415|474122364|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
131681967|NCT01338415|474122365|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
131681968|NCT01338415|474122363|FG000|Core + Extension|Other (administrative reason)|1|||
131681969|NCT01338415|474122364|FG001|Core + Extension|Other (administrative reason)|0|||
131681970|NCT01338415|474122365|FG002|Core + Extension|Other (administrative reason)|0|||
131681971|NCT01338415|474122363|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
131681972|NCT01338415|474122364|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
131681973|NCT01338415|474122365|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
131681974|NCT01338415|474122363|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
131681975|NCT01338415|474122364|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
131681976|NCT01338415|474122365|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
131681977|NCT01338415|474122363|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
131681978|NCT01338415|474122364|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
131681979|NCT01338415|474122365|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
131681980|NCT01338415|474122363|FG000|Exceptional Use Treatment Period|Death|0|||
131681981|NCT01338415|474122364|FG001|Exceptional Use Treatment Period|Death|0|||
131681982|NCT01338415|474122365|FG002|Exceptional Use Treatment Period|Death|1|||
131681983|NCT05215262|474122368|FG000|Overall Study|Lost to Follow-up|12|||
131681984|NCT05215262|474122369|FG001|Overall Study|Lost to Follow-up|0|||
131681985|NCT04880447|474122371|FG000|Overall Study|No vaccination information|1|||
131681986|NCT04880447|474122371|FG000|Overall Study|No adverse event information (missing information)|1|||
131681987|NCT04880447|474122371|FG000|Overall Study|Disease not covered in this study|35|||
131681988|NCT00718549|474122372|FG000|Induction Phase|Disease Progression|1|||
131681989|NCT00718549|474122373|FG001|Induction Phase|Disease Progression|0|||
131681990|NCT00718549|474122374|FG002|Induction Phase|Disease Progression|0|||
131681991|NCT00718549|474122372|FG000|Induction Phase|Eligibility Criteria Violation|2|||
131681992|NCT00718549|474122373|FG001|Induction Phase|Eligibility Criteria Violation|0|||
131681993|NCT00718549|474122374|FG002|Induction Phase|Eligibility Criteria Violation|0|||
131681994|NCT00718549|474122372|FG000|Induction Phase|Early Termination - No Additional Info|59|||
131681995|NCT00718549|474122373|FG001|Induction Phase|Early Termination - No Additional Info|0|||
131681996|NCT00718549|474122374|FG002|Induction Phase|Early Termination - No Additional Info|0|||
131681997|NCT00718549|474122372|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
131681998|NCT00718549|474122373|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
131681999|NCT00718549|474122374|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
131682000|NCT00718549|474122372|FG000|Maintenance/ Observation Phase|Death|0|||
131682001|NCT00718549|474122373|FG001|Maintenance/ Observation Phase|Death|1|||
131682002|NCT00718549|474122374|FG002|Maintenance/ Observation Phase|Death|2|||
131682003|NCT00718549|474122372|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
131682004|NCT00718549|474122373|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
131682005|NCT00718549|474122374|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
131682006|NCT00718549|474122372|FG000|Maintenance/ Observation Phase|Progression|0|||
131682007|NCT00718549|474122373|FG001|Maintenance/ Observation Phase|Progression|5|||
131682008|NCT00718549|474122374|FG002|Maintenance/ Observation Phase|Progression|14|||
131682009|NCT00718549|474122372|FG000|Maintenance/ Observation Phase|Relapse|0|||
131682010|NCT00718549|474122373|FG001|Maintenance/ Observation Phase|Relapse|3|||
131555884|NCT01468922|473660264|FG001|Overall Study|Screening failure|0|||
131682011|NCT00718549|474122374|FG002|Maintenance/ Observation Phase|Relapse|2|||
131682012|NCT01970488|474122379|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
131682013|NCT01970488|474122380|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
131682014|NCT01970488|474122381|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
131682015|NCT01970488|474122382|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
131682016|NCT01970488|474122383|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
131682017|NCT01970488|474122379|FG000|Part 1: Through Week 16|Protocol Violation|1|||
131682018|NCT01970488|474122380|FG001|Part 1: Through Week 16|Protocol Violation|2|||
131682019|NCT01970488|474122381|FG002|Part 1: Through Week 16|Protocol Violation|0|||
131682020|NCT01970488|474122382|FG003|Part 1: Through Week 16|Protocol Violation|0|||
131682021|NCT01970488|474122383|FG004|Part 1: Through Week 16|Protocol Violation|0|||
131682022|NCT01970488|474122379|FG000|Part 1: Through Week 16|Adverse Event|6|||
131682023|NCT01970488|474122380|FG001|Part 1: Through Week 16|Adverse Event|5|||
131682024|NCT01970488|474122381|FG002|Part 1: Through Week 16|Adverse Event|0|||
131682025|NCT01970488|474122382|FG003|Part 1: Through Week 16|Adverse Event|0|||
131682026|NCT01970488|474122383|FG004|Part 1: Through Week 16|Adverse Event|0|||
131682027|NCT01970488|474122379|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
131682028|NCT01970488|474122380|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
131682029|NCT01970488|474122381|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
131682030|NCT01970488|474122382|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
131682031|NCT01970488|474122383|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
131682032|NCT01970488|474122379|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
131682033|NCT01970488|474122380|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
131682034|NCT01970488|474122381|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
131682035|NCT01970488|474122382|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
131682036|NCT01970488|474122383|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
131682037|NCT01970488|474122379|FG000|Part 2: Post Week 16|Physician Decision|0|||
131682038|NCT01970488|474122380|FG001|Part 2: Post Week 16|Physician Decision|0|||
131682039|NCT01970488|474122381|FG002|Part 2: Post Week 16|Physician Decision|0|||
131682040|NCT01970488|474122382|FG003|Part 2: Post Week 16|Physician Decision|0|||
131682041|NCT01970488|474122383|FG004|Part 2: Post Week 16|Physician Decision|1|||
131682042|NCT01970488|474122379|FG000|Part 2: Post Week 16|Non-compliance|0|||
131682043|NCT01970488|474122380|FG001|Part 2: Post Week 16|Non-compliance|0|||
131682044|NCT01970488|474122381|FG002|Part 2: Post Week 16|Non-compliance|1|||
131682045|NCT01970488|474122382|FG003|Part 2: Post Week 16|Non-compliance|0|||
131682046|NCT01970488|474122383|FG004|Part 2: Post Week 16|Non-compliance|0|||
131682047|NCT01970488|474122379|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
131682048|NCT01970488|474122380|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
131682049|NCT01970488|474122381|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
131682050|NCT01970488|474122382|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
131682051|NCT01970488|474122383|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
131682052|NCT01970488|474122379|FG000|Part 2: Post Week 16|Adverse Event|0|||
131682053|NCT01970488|474122380|FG001|Part 2: Post Week 16|Adverse Event|0|||
131682054|NCT01970488|474122381|FG002|Part 2: Post Week 16|Adverse Event|5|||
131555885|NCT01468922|473660265|FG002|Overall Study|Screening failure|0|||
131682055|NCT01970488|474122382|FG003|Part 2: Post Week 16|Adverse Event|1|||
131682056|NCT01970488|474122383|FG004|Part 2: Post Week 16|Adverse Event|1|||
131682057|NCT01970488|474122379|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
131682058|NCT01970488|474122380|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
131682059|NCT01970488|474122381|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
131682060|NCT01970488|474122382|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
131682061|NCT01970488|474122383|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
131682062|NCT01970488|474122379|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
131682063|NCT01970488|474122380|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
131682064|NCT01970488|474122381|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
131682065|NCT01970488|474122382|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
131682066|NCT01970488|474122383|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
131682067|NCT02448225|474122385|FG000|Overall Study|Withdrawal by Subject|1|||
131682068|NCT02448225|474122385|FG000|Overall Study|Did not get FSPG scan|18|||
131682069|NCT02448225|474122385|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
131682070|NCT02486653|474122388|FG000|Overall Study|Withdrawal by Subject|1|||
131682071|NCT02486653|474122389|FG001|Overall Study|Withdrawal by Subject|3|||
131682072|NCT02486653|474122388|FG000|Overall Study|Protocol Violation|1|||
131682073|NCT02486653|474122389|FG001|Overall Study|Protocol Violation|0|||
131682074|NCT02486653|474122388|FG000|Overall Study|surgery cancelled|4|||
131682075|NCT02486653|474122389|FG001|Overall Study|surgery cancelled|1|||
131682076|NCT01177384|474122391|FG000|Overall Study|Adverse Event|6|||
131682077|NCT01177384|474122392|FG001|Overall Study|Adverse Event|4|||
131682078|NCT01177384|474122391|FG000|Overall Study|Lack of Efficacy|0|||
131682079|NCT01177384|474122392|FG001|Overall Study|Lack of Efficacy|1|||
131682080|NCT01177384|474122391|FG000|Overall Study|Lost to Follow-up|3|||
131682081|NCT01177384|474122392|FG001|Overall Study|Lost to Follow-up|4|||
131682082|NCT01177384|474122391|FG000|Overall Study|Physician Decision|0|||
131682083|NCT01177384|474122392|FG001|Overall Study|Physician Decision|3|||
131682084|NCT01177384|474122391|FG000|Overall Study|Protocol Violation|0|||
131682085|NCT01177384|474122392|FG001|Overall Study|Protocol Violation|2|||
131682086|NCT01177384|474122391|FG000|Overall Study|Withdrawal by Subject|5|||
131682087|NCT01177384|474122392|FG001|Overall Study|Withdrawal by Subject|12|||
131682088|NCT01849497|474122393|FG000|Overall Study|Withdrawal by Subject|1|||
131682089|NCT01849497|474122394|FG001|Overall Study|Withdrawal by Subject|2|||
131682090|NCT01849497|474122393|FG000|Overall Study|Sponsor Decision|0|||
131682091|NCT01849497|474122394|FG001|Overall Study|Sponsor Decision|1|||
131682092|NCT01849497|474122393|FG000|Overall Study|Lost to Follow-up|0|||
131682093|NCT01849497|474122394|FG001|Overall Study|Lost to Follow-up|1|||
131682094|NCT02941926|474122395|FG000|Core Phase|Progressive disease|1109|||
131682095|NCT02941926|474122395|FG000|Core Phase|Adverse Event|504|||
131682096|NCT02941926|474122395|FG000|Core Phase|Subject/guardian decision|127|||
131682097|NCT02941926|474122395|FG000|Core Phase|Physician Decision|112|||
131682098|NCT02941926|474122395|FG000|Core Phase|Death|46|||
131682099|NCT02941926|474122395|FG000|Core Phase|Protocol deviation|34|||
131682100|NCT02941926|474122395|FG000|Core Phase|Lost to Follow-up|8|||
131682101|NCT02941926|474122395|FG000|Core Phase|Technical problems|5|||
131682102|NCT02941926|474122395|FG000|Extension Phase|Physician Decision|155|||
131682103|NCT02941926|474122395|FG000|Extension Phase|Progressive disease|115|||
131682104|NCT02941926|474122395|FG000|Extension Phase|Adverse Event|13|||
131682105|NCT02941926|474122395|FG000|Extension Phase|Subject/Guardian decision|12|||
131682106|NCT02941926|474122395|FG000|Extension Phase|Death|6|||
131682107|NCT00307333|474122396|FG000|Overall Study|Lost to Follow-up|11|||
131682108|NCT00307333|474122397|FG001|Overall Study|Lost to Follow-up|3|||
131682109|NCT00698932|474122398|FG000|Overall Study|Adverse Event|0|||
131682110|NCT00698932|474122399|FG001|Overall Study|Adverse Event|2|||
131682111|NCT00698932|474122398|FG000|Overall Study|Incorrect enrollment|0|||
131682112|NCT00698932|474122399|FG001|Overall Study|Incorrect enrollment|2|||
131682113|NCT00698932|474122398|FG000|Overall Study|Study specific discontinuation criteria|3|||
131682114|NCT00698932|474122399|FG001|Overall Study|Study specific discontinuation criteria|4|||
131682115|NCT00698932|474122398|FG000|Overall Study|Withdrawal by Subject|11|||
131682116|NCT00698932|474122399|FG001|Overall Study|Withdrawal by Subject|23|||
131682117|NCT00698932|474122398|FG000|Overall Study|Lost to Follow-up|6|||
131682118|NCT00698932|474122399|FG001|Overall Study|Lost to Follow-up|1|||
131682119|NCT00698932|474122398|FG000|Overall Study|Severe non-compliance to protocol|1|||
131682120|NCT00698932|474122399|FG001|Overall Study|Severe non-compliance to protocol|2|||
131682121|NCT00698932|474122398|FG000|Overall Study|Safety reasons|0|||
131682122|NCT00698932|474122399|FG001|Overall Study|Safety reasons|2|||
131682123|NCT00698932|474122398|FG000|Overall Study|Death|1|||
131682124|NCT00698932|474122399|FG001|Overall Study|Death|0|||
131898488|NCT01502033|474914085|FG000|Overall Study|1 participant went back to school|1|||
131682125|NCT03044249|474122404|FG000|Overall Study|Adverse Event|4|||
131682126|NCT03044249|474122405|FG001|Overall Study|Adverse Event|9|||
131682127|NCT03044249|474122404|FG000|Overall Study|Lost to Follow-up|1|||
131682128|NCT03044249|474122405|FG001|Overall Study|Lost to Follow-up|0|||
131682129|NCT03044249|474122404|FG000|Overall Study|Non-compliance with Study Drug|1|||
131682130|NCT03044249|474122405|FG001|Overall Study|Non-compliance with Study Drug|0|||
131682131|NCT03044249|474122404|FG000|Overall Study|Study Terminated by Sponsor|2|||
131682132|NCT03044249|474122405|FG001|Overall Study|Study Terminated by Sponsor|0|||
131682133|NCT03044249|474122404|FG000|Overall Study|Withdrawal by Subject|2|||
131682134|NCT03044249|474122405|FG001|Overall Study|Withdrawal by Subject|5|||
131682135|NCT00955279|474122406|FG000|Overall Study|Other|0|||
131682136|NCT00955279|474122407|FG001|Overall Study|Other|0|||
131682137|NCT00955279|474122408|FG002|Overall Study|Other|3|||
131682138|NCT00955279|474122406|FG000|Overall Study|Death|1|||
131682139|NCT00955279|474122407|FG001|Overall Study|Death|1|||
131682140|NCT00955279|474122408|FG002|Overall Study|Death|1|||
131682141|NCT00955279|474122406|FG000|Overall Study|Lost to Follow-up|0|||
131682142|NCT00955279|474122407|FG001|Overall Study|Lost to Follow-up|3|||
131682143|NCT00955279|474122408|FG002|Overall Study|Lost to Follow-up|1|||
131682144|NCT00955279|474122406|FG000|Overall Study|Withdrawal by Subject|2|||
131682145|NCT00955279|474122407|FG001|Overall Study|Withdrawal by Subject|0|||
131682146|NCT00955279|474122408|FG002|Overall Study|Withdrawal by Subject|3|||
131682147|NCT02632721|474122410|FG000|Overall Study|Adverse Event|0|||
131682148|NCT02632721|474122411|FG001|Overall Study|Adverse Event|0|||
131682149|NCT02632721|474122412|FG002|Overall Study|Adverse Event|2|||
131682150|NCT02632721|474122413|FG003|Overall Study|Adverse Event|5|||
131682151|NCT02632721|474122414|FG004|Overall Study|Adverse Event|3|||
131682152|NCT02632721|474122410|FG000|Overall Study|Dose limiting toxicity|0|||
131682153|NCT02632721|474122411|FG001|Overall Study|Dose limiting toxicity|0|||
131682154|NCT02632721|474122412|FG002|Overall Study|Dose limiting toxicity|0|||
131682155|NCT02632721|474122413|FG003|Overall Study|Dose limiting toxicity|1|||
131682156|NCT02632721|474122414|FG004|Overall Study|Dose limiting toxicity|0|||
131682157|NCT02632721|474122410|FG000|Overall Study|Progressive disease|3|||
131682158|NCT02632721|474122411|FG001|Overall Study|Progressive disease|0|||
131682159|NCT02632721|474122412|FG002|Overall Study|Progressive disease|4|||
131682160|NCT02632721|474122413|FG003|Overall Study|Progressive disease|6|||
131682161|NCT02632721|474122414|FG004|Overall Study|Progressive disease|5|||
131682162|NCT02632721|474122410|FG000|Overall Study|Refused to continue taking trial medication|0|||
131682163|NCT02632721|474122411|FG001|Overall Study|Refused to continue taking trial medication|1|||
131682164|NCT02632721|474122412|FG002|Overall Study|Refused to continue taking trial medication|1|||
131682165|NCT02632721|474122413|FG003|Overall Study|Refused to continue taking trial medication|1|||
131682166|NCT02632721|474122414|FG004|Overall Study|Refused to continue taking trial medication|2|||
131682167|NCT02632721|474122410|FG000|Overall Study|Inadequate clinical condition|0|||
131682168|NCT02632721|474122411|FG001|Overall Study|Inadequate clinical condition|0|||
131682169|NCT02632721|474122412|FG002|Overall Study|Inadequate clinical condition|0|||
131682170|NCT02632721|474122413|FG003|Overall Study|Inadequate clinical condition|0|||
131682171|NCT02632721|474122414|FG004|Overall Study|Inadequate clinical condition|1|||
131682172|NCT02632721|474122410|FG000|Overall Study|No meet eligibility|0|||
131682173|NCT02632721|474122411|FG001|Overall Study|No meet eligibility|0|||
131682174|NCT02632721|474122412|FG002|Overall Study|No meet eligibility|0|||
131682175|NCT02632721|474122413|FG003|Overall Study|No meet eligibility|0|||
131682176|NCT02632721|474122414|FG004|Overall Study|No meet eligibility|1|||
131682177|NCT02632721|474122410|FG000|Overall Study|Allergic reaction|0|||
131682178|NCT02632721|474122411|FG001|Overall Study|Allergic reaction|0|||
131682179|NCT02632721|474122412|FG002|Overall Study|Allergic reaction|0|||
131682180|NCT02632721|474122413|FG003|Overall Study|Allergic reaction|1|||
131682181|NCT02632721|474122414|FG004|Overall Study|Allergic reaction|0|||
131682182|NCT02632721|474122410|FG000|Overall Study|Receiving Decitabine locally|0|||
131682183|NCT02632721|474122411|FG001|Overall Study|Receiving Decitabine locally|0|||
131682184|NCT02632721|474122412|FG002|Overall Study|Receiving Decitabine locally|1|||
131682185|NCT02632721|474122413|FG003|Overall Study|Receiving Decitabine locally|0|||
131682186|NCT02632721|474122414|FG004|Overall Study|Receiving Decitabine locally|0|||
131682187|NCT02632721|474122410|FG000|Overall Study|No benefit from study treatment|1|||
131682188|NCT02632721|474122411|FG001|Overall Study|No benefit from study treatment|1|||
131682189|NCT02632721|474122412|FG002|Overall Study|No benefit from study treatment|0|||
131682190|NCT02632721|474122413|FG003|Overall Study|No benefit from study treatment|0|||
131555886|NCT01468922|473660266|FG003|Overall Study|Screening failure|0|||
131682191|NCT02632721|474122414|FG004|Overall Study|No benefit from study treatment|1|||
131682192|NCT02632721|474122410|FG000|Overall Study|Patient wish for other treatment|0|||
131682193|NCT02632721|474122411|FG001|Overall Study|Patient wish for other treatment|1|||
131682194|NCT02632721|474122412|FG002|Overall Study|Patient wish for other treatment|0|||
131682195|NCT02632721|474122413|FG003|Overall Study|Patient wish for other treatment|0|||
131682196|NCT02632721|474122414|FG004|Overall Study|Patient wish for other treatment|0|||
131682197|NCT02632721|474122410|FG000|Overall Study|Relapsed Pneumonia|0|||
131682198|NCT02632721|474122411|FG001|Overall Study|Relapsed Pneumonia|0|||
131682199|NCT02632721|474122412|FG002|Overall Study|Relapsed Pneumonia|0|||
131682200|NCT02632721|474122413|FG003|Overall Study|Relapsed Pneumonia|0|||
131682201|NCT02632721|474122414|FG004|Overall Study|Relapsed Pneumonia|1|||
131682202|NCT02632721|474122410|FG000|Overall Study|Therapy refractory AML|0|||
131682203|NCT02632721|474122411|FG001|Overall Study|Therapy refractory AML|0|||
131682204|NCT02632721|474122412|FG002|Overall Study|Therapy refractory AML|0|||
131682205|NCT02632721|474122413|FG003|Overall Study|Therapy refractory AML|0|||
131682206|NCT02632721|474122414|FG004|Overall Study|Therapy refractory AML|1|||
131682207|NCT02632721|474122410|FG000|Overall Study|Increase of white blood cell count|0|||
131682208|NCT02632721|474122411|FG001|Overall Study|Increase of white blood cell count|0|||
131682209|NCT02632721|474122412|FG002|Overall Study|Increase of white blood cell count|0|||
131682210|NCT02632721|474122413|FG003|Overall Study|Increase of white blood cell count|0|||
131682211|NCT02632721|474122414|FG004|Overall Study|Increase of white blood cell count|1|||
131682212|NCT02632721|474122410|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131682213|NCT02632721|474122411|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131682214|NCT02632721|474122412|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
131682215|NCT02632721|474122413|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131682216|NCT02632721|474122414|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131682217|NCT00544648|474122417|FG000|Overall Study|Withdrawal by Subject|1|||
131682218|NCT00544648|474122418|FG001|Overall Study|Withdrawal by Subject|0|||
131682219|NCT00544648|474122417|FG000|Overall Study|Adverse Event|1|||
131682220|NCT00544648|474122418|FG001|Overall Study|Adverse Event|1|||
131682221|NCT00544648|474122417|FG000|Overall Study|progression of disease|1|||
131682222|NCT00544648|474122418|FG001|Overall Study|progression of disease|0|||
131682223|NCT04166383|474122420|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
131682224|NCT04166383|474122420|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
131682225|NCT04166383|474122420|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
131682226|NCT03346057|474122421|FG000|Overall Study|Death|1|||
131682227|NCT03346057|474122422|FG001|Overall Study|Death|2|||
131682228|NCT03346057|474122423|FG002|Overall Study|Death|0|||
131682229|NCT03346057|474122424|FG003|Overall Study|Death|0|||
131682230|NCT03346057|474122421|FG000|Overall Study|Lost to Follow-up|0|||
131682231|NCT03346057|474122422|FG001|Overall Study|Lost to Follow-up|2|||
131682232|NCT03346057|474122423|FG002|Overall Study|Lost to Follow-up|1|||
131682233|NCT03346057|474122424|FG003|Overall Study|Lost to Follow-up|0|||
131682234|NCT03346057|474122421|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
131682235|NCT03346057|474122422|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
131682236|NCT03346057|474122423|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
131682237|NCT03346057|474122424|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
131682238|NCT03346057|474122421|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
131682239|NCT03346057|474122422|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
131682240|NCT03346057|474122423|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
131682241|NCT03346057|474122424|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
131682242|NCT03346057|474122421|FG000|Overall Study|Physician Decision|3|||
131682243|NCT03346057|474122422|FG001|Overall Study|Physician Decision|2|||
131682244|NCT03346057|474122423|FG002|Overall Study|Physician Decision|0|||
131682245|NCT03346057|474122424|FG003|Overall Study|Physician Decision|2|||
131682246|NCT03346057|474122421|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
131682247|NCT03346057|474122422|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
131682248|NCT03346057|474122423|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
131682249|NCT03346057|474122424|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
131682250|NCT03346057|474122421|FG000|Overall Study|Withdrawal by Subject|1|||
131682251|NCT03346057|474122422|FG001|Overall Study|Withdrawal by Subject|0|||
131682252|NCT03346057|474122423|FG002|Overall Study|Withdrawal by Subject|0|||
131682253|NCT03346057|474122424|FG003|Overall Study|Withdrawal by Subject|0|||
131682254|NCT03044886|474122425|FG000|Overall Study|Lost to Follow-up|15|||
131682255|NCT03044886|474122426|FG001|Overall Study|Lost to Follow-up|10|||
131682256|NCT03044886|474122427|FG002|Overall Study|Lost to Follow-up|12|||
131682257|NCT02003014|474122428|FG000|Overall Study|Case report forms uncollected|9|||
131682258|NCT02003014|474122428|FG000|Overall Study|Treatment started after contract period|1|||
131682259|NCT02003014|474122428|FG000|Overall Study|Patient did not visit the study site|5|||
131682260|NCT02003014|474122428|FG000|Overall Study|Investigator's transfer|4|||
131682261|NCT01660451|474122429|FG000|Overall Study|Protocol Violation|0|||
131682262|NCT01660451|474122430|FG001|Overall Study|Protocol Violation|1|||
131682263|NCT01660451|474122431|FG002|Overall Study|Protocol Violation|1|||
131682264|NCT01660451|474122429|FG000|Overall Study|AE not associated with clinical disease progression|13|||
131682265|NCT01660451|474122430|FG001|Overall Study|AE not associated with clinical disease progression|10|||
131682266|NCT01660451|474122431|FG002|Overall Study|AE not associated with clinical disease progression|40|||
131682267|NCT01660451|474122429|FG000|Overall Study|AE associated with clinical disease progression|1|||
131682268|NCT01660451|474122430|FG001|Overall Study|AE associated with clinical disease progression|3|||
131682269|NCT01660451|474122431|FG002|Overall Study|AE associated with clinical disease progression|11|||
131682270|NCT01660451|474122429|FG000|Overall Study|Sponsor Decision|0|||
131682271|NCT01660451|474122430|FG001|Overall Study|Sponsor Decision|0|||
131682272|NCT01660451|474122431|FG002|Overall Study|Sponsor Decision|1|||
131682273|NCT01660451|474122429|FG000|Overall Study|Protocol Deviation|0|||
131682274|NCT01660451|474122430|FG001|Overall Study|Protocol Deviation|0|||
131682275|NCT01660451|474122431|FG002|Overall Study|Protocol Deviation|1|||
131682276|NCT01660451|474122429|FG000|Overall Study|Physician Decision|1|||
131682277|NCT01660451|474122430|FG001|Overall Study|Physician Decision|2|||
131682278|NCT01660451|474122431|FG002|Overall Study|Physician Decision|5|||
131682279|NCT01660451|474122429|FG000|Overall Study|Withdrawal by Subject|1|||
131682280|NCT01660451|474122430|FG001|Overall Study|Withdrawal by Subject|1|||
131682281|NCT01660451|474122431|FG002|Overall Study|Withdrawal by Subject|20|||
131682282|NCT01660451|474122429|FG000|Overall Study|Trial closure.|0|||
131682283|NCT01660451|474122430|FG001|Overall Study|Trial closure.|0|||
131682284|NCT01660451|474122431|FG002|Overall Study|Trial closure.|1|||
131682285|NCT01660451|474122429|FG000|Overall Study|Switching to other therapy|0|||
131682286|NCT01660451|474122430|FG001|Overall Study|Switching to other therapy|1|||
131682287|NCT01660451|474122431|FG002|Overall Study|Switching to other therapy|1|||
131682288|NCT01660451|474122429|FG000|Overall Study|Progressive disease - clinical progression|4|||
131682289|NCT01660451|474122430|FG001|Overall Study|Progressive disease - clinical progression|10|||
131682290|NCT01660451|474122431|FG002|Overall Study|Progressive disease - clinical progression|9|||
131682291|NCT01660451|474122429|FG000|Overall Study|Progressive disease - radiological progression|12|||
131682292|NCT01660451|474122430|FG001|Overall Study|Progressive disease - radiological progression|23|||
131682293|NCT01660451|474122431|FG002|Overall Study|Progressive disease - radiological progression|50|||
131682294|NCT01660451|474122429|FG000|Overall Study|Death|1|||
131682295|NCT01660451|474122430|FG001|Overall Study|Death|0|||
131682296|NCT01660451|474122431|FG002|Overall Study|Death|1|||
131682297|NCT01660451|474122429|FG000|Overall Study|Other|0|||
131682298|NCT01660451|474122430|FG001|Overall Study|Other|0|||
131682299|NCT01660451|474122431|FG002|Overall Study|Other|1|||
131682300|NCT02456662|474122433|FG000|Overall Study|Lost to Follow-up|2|||
131682301|NCT02456662|474122434|FG001|Overall Study|Lost to Follow-up|1|||
131682302|NCT00074581|474122436|FG000|Overall Study|Death|15|||
131682303|NCT00074581|474122437|FG001|Overall Study|Death|16|||
131682304|NCT00074581|474122436|FG000|Overall Study|Withdrawal by Subject|50|||
131682305|NCT00074581|474122437|FG001|Overall Study|Withdrawal by Subject|49|||
131682306|NCT00074581|474122436|FG000|Overall Study|Unable to adhere to visit schedule|13|||
131682307|NCT00074581|474122437|FG001|Overall Study|Unable to adhere to visit schedule|14|||
131682308|NCT00074581|474122436|FG000|Overall Study|Relocated|14|||
131682309|NCT00074581|474122437|FG001|Overall Study|Relocated|9|||
131682310|NCT00074581|474122436|FG000|Overall Study|Were withdrawn by investigator|5|||
131682311|NCT00074581|474122437|FG001|Overall Study|Were withdrawn by investigator|2|||
131682312|NCT00074581|474122436|FG000|Overall Study|Lost to Follow-up|16|||
131682313|NCT00074581|474122437|FG001|Overall Study|Lost to Follow-up|11|||
131682314|NCT00074581|474122436|FG000|Overall Study|Ended relationship w. index participant|117|||
131682315|NCT00074581|474122437|FG001|Overall Study|Ended relationship w. index participant|106|||
131682316|NCT00074581|474122436|FG000|Overall Study|Other|14|||
131682317|NCT00074581|474122437|FG001|Overall Study|Other|19|||
131682318|NCT04411628|474122442|FG000|Overall Study|Withdrawal by Subject|1|||
131682319|NCT04411628|474122443|FG001|Overall Study|Withdrawal by Subject|1|||
131682320|NCT04411628|474122444|FG002|Overall Study|Withdrawal by Subject|2|||
131682321|NCT04411628|474122445|FG003|Overall Study|Withdrawal by Subject|0|||
131682322|NCT04411628|474122442|FG000|Overall Study|Lost to Follow-up|0|||
131682323|NCT04411628|474122443|FG001|Overall Study|Lost to Follow-up|1|||
131682324|NCT04411628|474122444|FG002|Overall Study|Lost to Follow-up|0|||
131682325|NCT04411628|474122445|FG003|Overall Study|Lost to Follow-up|0|||
131682326|NCT00732251|474122446|FG000|Overall Study|Lost to Follow-up|3|||
131682327|NCT00732251|474122446|FG000|Overall Study|Withdrawal by Subject|3|||
131682328|NCT00732251|474122446|FG000|Overall Study|Early Term due to Site Closure|1|||
131682329|NCT01034540|474122447|FG000|Overall Study|Adverse Event|0|||
131682330|NCT01034540|474122448|FG001|Overall Study|Adverse Event|1|||
131682331|NCT03519867|474122451|FG000|Overall Study|Adverse Event|1|||
131682332|NCT03519867|474122452|FG001|Overall Study|Adverse Event|1|||
131682333|NCT03519867|474122453|FG002|Overall Study|Adverse Event|0|||
131682334|NCT03519867|474122454|FG003|Overall Study|Adverse Event|0|||
131682335|NCT03519867|474122455|FG004|Overall Study|Adverse Event|0|||
131682336|NCT03519867|474122456|FG005|Overall Study|Adverse Event|0|||
131682337|NCT03519867|474122457|FG006|Overall Study|Adverse Event|0|||
131682338|NCT03519867|474122458|FG007|Overall Study|Adverse Event|0|||
131682339|NCT03519867|474122459|FG008|Overall Study|Adverse Event|0|||
131682340|NCT03519867|474122460|FG009|Overall Study|Adverse Event|0|||
131682341|NCT03519867|474122451|FG000|Overall Study|Protocol Violation|0|||
131682342|NCT03519867|474122452|FG001|Overall Study|Protocol Violation|0|||
131682343|NCT03519867|474122453|FG002|Overall Study|Protocol Violation|0|||
131682344|NCT03519867|474122454|FG003|Overall Study|Protocol Violation|0|||
131682345|NCT03519867|474122455|FG004|Overall Study|Protocol Violation|0|||
131682346|NCT03519867|474122456|FG005|Overall Study|Protocol Violation|1|||
131682347|NCT03519867|474122457|FG006|Overall Study|Protocol Violation|0|||
131682348|NCT03519867|474122458|FG007|Overall Study|Protocol Violation|0|||
131682349|NCT03519867|474122459|FG008|Overall Study|Protocol Violation|0|||
131682350|NCT03519867|474122460|FG009|Overall Study|Protocol Violation|0|||
131682351|NCT03519867|474122451|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682352|NCT03519867|474122452|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682353|NCT03519867|474122453|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682354|NCT03519867|474122454|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682355|NCT03519867|474122455|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682356|NCT03519867|474122456|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682357|NCT03519867|474122457|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
131682358|NCT03519867|474122458|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682359|NCT03519867|474122459|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682360|NCT03519867|474122460|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131682361|NCT03519867|474122451|FG000|Overall Study|Admin. of other reversal agent|1|||
131682362|NCT03519867|474122452|FG001|Overall Study|Admin. of other reversal agent|1|||
131682363|NCT03519867|474122453|FG002|Overall Study|Admin. of other reversal agent|0|||
131682364|NCT03519867|474122454|FG003|Overall Study|Admin. of other reversal agent|0|||
131682365|NCT03519867|474122455|FG004|Overall Study|Admin. of other reversal agent|0|||
131682366|NCT03519867|474122456|FG005|Overall Study|Admin. of other reversal agent|1|||
131682367|NCT03519867|474122457|FG006|Overall Study|Admin. of other reversal agent|0|||
131682368|NCT03519867|474122458|FG007|Overall Study|Admin. of other reversal agent|0|||
131682369|NCT03519867|474122459|FG008|Overall Study|Admin. of other reversal agent|0|||
131682370|NCT03519867|474122460|FG009|Overall Study|Admin. of other reversal agent|0|||
131682371|NCT03519867|474122451|FG000|Overall Study|Reason not provided|1|||
131682372|NCT03519867|474122452|FG001|Overall Study|Reason not provided|1|||
131682373|NCT03519867|474122453|FG002|Overall Study|Reason not provided|1|||
131682374|NCT03519867|474122454|FG003|Overall Study|Reason not provided|1|||
131682375|NCT03519867|474122455|FG004|Overall Study|Reason not provided|0|||
131682376|NCT03519867|474122456|FG005|Overall Study|Reason not provided|1|||
131682377|NCT03519867|474122457|FG006|Overall Study|Reason not provided|0|||
131682378|NCT03519867|474122458|FG007|Overall Study|Reason not provided|1|||
131682379|NCT03519867|474122459|FG008|Overall Study|Reason not provided|1|||
131682380|NCT03519867|474122460|FG009|Overall Study|Reason not provided|0|||
131682381|NCT01252810|474122461|FG000|Overall Study|Withdrawal by Subject|4|||
131682382|NCT01252810|474122462|FG001|Overall Study|Withdrawal by Subject|1|||
131682383|NCT01252810|474122461|FG000|Overall Study|Lost to Follow-up|0|||
131682384|NCT01252810|474122462|FG001|Overall Study|Lost to Follow-up|1|||
131682385|NCT01252810|474122461|FG000|Overall Study|Physician Decision|2|||
131682386|NCT01252810|474122462|FG001|Overall Study|Physician Decision|1|||
131682387|NCT01252810|474122461|FG000|Overall Study|Various reasons|8|||
131682388|NCT01252810|474122462|FG001|Overall Study|Various reasons|0|||
131682389|NCT04376827|474122467|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
131682390|NCT04376827|474122468|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
131682391|NCT04376827|474122467|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
131682392|NCT04376827|474122468|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
131682393|NCT04376827|474122467|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
131682394|NCT04376827|474122468|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
131682395|NCT04376827|474122467|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
131682396|NCT04376827|474122468|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
131682397|NCT04376827|474122467|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
131682398|NCT04376827|474122468|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
131682399|NCT02229539|474124272|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
131682400|NCT02229539|474124273|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
131682401|NCT02229539|474124274|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
131682402|NCT02229539|474124272|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
131682403|NCT02229539|474124273|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
131682404|NCT02229539|474124274|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
131682405|NCT02229539|474124272|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
131682406|NCT02229539|474124273|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
131682407|NCT02229539|474124274|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
131682408|NCT02229539|474124272|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
131682409|NCT02229539|474124273|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
131682410|NCT02229539|474124274|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
131682411|NCT02229539|474124272|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
131682412|NCT02229539|474124273|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
131682413|NCT02229539|474124274|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
131682414|NCT02229539|474124272|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
131682415|NCT02229539|474124273|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
131682416|NCT02229539|474124274|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
131682417|NCT04050670|474124277|FG000|Period 3|Physician Decision|0|||
131682418|NCT04050670|474124278|FG001|Period 3|Physician Decision|1|||
131682419|NCT04050670|474124279|FG002|Period 3|Physician Decision|0|||
131682420|NCT00880555|474124290|FG000|Overall Study|Physician Decision|0|||
131682421|NCT00880555|474124291|FG001|Overall Study|Physician Decision|8|||
131682422|NCT00880555|474124292|FG002|Overall Study|Physician Decision|0|||
131682423|NCT00880555|474124293|FG003|Overall Study|Physician Decision|2|||
131682424|NCT00880555|474124294|FG004|Overall Study|Physician Decision|1|||
131682425|NCT00880555|474124295|FG005|Overall Study|Physician Decision|0|||
131682426|NCT00880555|474124290|FG000|Overall Study|Withdrawal by Subject|1|||
131682427|NCT00880555|474124291|FG001|Overall Study|Withdrawal by Subject|1|||
131682428|NCT00880555|474124292|FG002|Overall Study|Withdrawal by Subject|0|||
131682429|NCT00880555|474124293|FG003|Overall Study|Withdrawal by Subject|0|||
131682430|NCT00880555|474124294|FG004|Overall Study|Withdrawal by Subject|0|||
131682431|NCT00880555|474124295|FG005|Overall Study|Withdrawal by Subject|0|||
131682432|NCT00880555|474124290|FG000|Overall Study|Lack of resources (hired rater)|9|||
131682433|NCT00880555|474124291|FG001|Overall Study|Lack of resources (hired rater)|7|||
131682434|NCT00880555|474124292|FG002|Overall Study|Lack of resources (hired rater)|5|||
131682435|NCT00880555|474124293|FG003|Overall Study|Lack of resources (hired rater)|0|||
131682436|NCT00880555|474124294|FG004|Overall Study|Lack of resources (hired rater)|0|||
131682437|NCT00880555|474124295|FG005|Overall Study|Lack of resources (hired rater)|0|||
131682438|NCT00880555|474124290|FG000|Overall Study|Death|0|||
131682439|NCT00880555|474124291|FG001|Overall Study|Death|0|||
131682440|NCT00880555|474124292|FG002|Overall Study|Death|0|||
131682441|NCT00880555|474124293|FG003|Overall Study|Death|0|||
131682442|NCT00880555|474124294|FG004|Overall Study|Death|0|||
131682443|NCT00880555|474124295|FG005|Overall Study|Death|1|||
131682444|NCT00880555|474124290|FG000|Overall Study|Lost to Follow-up|0|||
131682445|NCT00880555|474124291|FG001|Overall Study|Lost to Follow-up|1|||
131682446|NCT00880555|474124292|FG002|Overall Study|Lost to Follow-up|0|||
131682447|NCT00880555|474124293|FG003|Overall Study|Lost to Follow-up|0|||
131682448|NCT00880555|474124294|FG004|Overall Study|Lost to Follow-up|0|||
131682449|NCT00880555|474124295|FG005|Overall Study|Lost to Follow-up|0|||
131682450|NCT02982590|474124297|FG000|Overall Study|Lost to Follow-up|0|||
131682451|NCT02982590|474124298|FG001|Overall Study|Lost to Follow-up|1|||
131682452|NCT02982590|474124297|FG000|Overall Study|Death|4|||
131682453|NCT02982590|474124298|FG001|Overall Study|Death|0|||
131682454|NCT01168973|474124299|FG000|Overall Study|Progressive Disease|341|||
131682455|NCT01168973|474124300|FG001|Overall Study|Progressive Disease|429|||
131682456|NCT01168973|474124299|FG000|Overall Study|Adverse Event|94|||
131682457|NCT01168973|474124300|FG001|Overall Study|Adverse Event|55|||
131682458|NCT01168973|474124299|FG000|Overall Study|Withdrawal by Subject|90|||
131682459|NCT01168973|474124300|FG001|Overall Study|Withdrawal by Subject|53|||
131682460|NCT01168973|474124299|FG000|Overall Study|Death|42|||
131682461|NCT01168973|474124300|FG001|Overall Study|Death|45|||
131682462|NCT01168973|474124299|FG000|Overall Study|Physician Decision|37|||
131682463|NCT01168973|474124300|FG001|Overall Study|Physician Decision|19|||
131682464|NCT01168973|474124299|FG000|Overall Study|Sponsor Decision|2|||
131682465|NCT01168973|474124300|FG001|Overall Study|Sponsor Decision|1|||
131682466|NCT01168973|474124299|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
131682467|NCT01168973|474124300|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
131682468|NCT02230254|474124301|FG000|Overall Study|Lost to Follow-up|3|||
131682469|NCT02023242|474124302|FG000|Overall Study|Lost to Follow-up|3|||
131682470|NCT02023242|474124303|FG001|Overall Study|Lost to Follow-up|1|||
131682471|NCT02023242|474124302|FG000|Overall Study|Death|0|||
131682472|NCT02023242|474124303|FG001|Overall Study|Death|1|||
131682473|NCT00388505|474124308|FG000|Overall Study|Adverse Event or Death|43|||
131682474|NCT00388505|474124309|FG001|Overall Study|Adverse Event or Death|17|||
131682475|NCT00388505|474124308|FG000|Overall Study|Withdrawal by Subject|24|||
131682476|NCT00388505|474124309|FG001|Overall Study|Withdrawal by Subject|9|||
131682477|NCT00388505|474124308|FG000|Overall Study|Lost to Follow-up|5|||
131682478|NCT00388505|474124309|FG001|Overall Study|Lost to Follow-up|3|||
131682479|NCT00388505|474124308|FG000|Overall Study|Inappropriate Enrollment|0|||
131682480|NCT00388505|474124309|FG001|Overall Study|Inappropriate Enrollment|1|||
131682481|NCT00388505|474124308|FG000|Overall Study|Administrative Reason|1|||
131682482|NCT00388505|474124309|FG001|Overall Study|Administrative Reason|0|||
131682483|NCT00388505|474124308|FG000|Overall Study|Protocol Violation|6|||
131682484|NCT00388505|474124309|FG001|Overall Study|Protocol Violation|5|||
131682485|NCT00388505|474124308|FG000|Overall Study|Unable to classify|4|||
131682486|NCT00388505|474124309|FG001|Overall Study|Unable to classify|3|||
131682487|NCT04479436|474124312|FG000|Overall Study|Progressive disease|26|||
131682488|NCT04479436|474124313|FG001|Overall Study|Progressive disease|1|||
131682489|NCT04479436|474124312|FG000|Overall Study|Adverse Event|6|||
131682490|NCT04479436|474124313|FG001|Overall Study|Adverse Event|0|||
131682491|NCT04479436|474124312|FG000|Overall Study|Withdrawal by Subject|5|||
131682492|NCT04479436|474124313|FG001|Overall Study|Withdrawal by Subject|0|||
131682493|NCT04479436|474124312|FG000|Overall Study|Clinical progression|1|||
131682494|NCT04479436|474124313|FG001|Overall Study|Clinical progression|0|||
131682495|NCT04479436|474124312|FG000|Overall Study|Physician Decision|1|||
131682496|NCT04479436|474124313|FG001|Overall Study|Physician Decision|0|||
131682497|NCT00791258|474124320|FG000|Overall Study|Adverse Event|87|||
131682498|NCT00791258|474124320|FG000|Overall Study|Lost to Follow-up|18|||
131682499|NCT00791258|474124320|FG000|Overall Study|Protocol Violation|109|||
131682500|NCT00791258|474124320|FG000|Overall Study|Withdrawal by Subject|40|||
131682501|NCT00791258|474124320|FG000|Overall Study|Did not take medication for >3 days|1|||
131682502|NCT00791258|474124320|FG000|Overall Study|subject left area|2|||
131682503|NCT00791258|474124320|FG000|Overall Study|non-compliance|3|||
131682504|NCT00791258|474124320|FG000|Overall Study|Subject incarcerated|1|||
131682505|NCT00791258|474124320|FG000|Overall Study|Subject required restricted medication|1|||
131682506|NCT00791258|474124320|FG000|Overall Study|Lack of Efficacy|1|||
131682507|NCT00058552|474124321|FG000|Overall Study|Died prior to receiving treatment|4|||
131682508|NCT00058552|474124322|FG001|Overall Study|Died prior to receiving treatment|2|||
131682509|NCT00058552|474124321|FG000|Overall Study|Disease progression|52|||
131682510|NCT00058552|474124322|FG001|Overall Study|Disease progression|44|||
131682511|NCT00058552|474124321|FG000|Overall Study|Adverse Event|4|||
131682512|NCT00058552|474124322|FG001|Overall Study|Adverse Event|2|||
131682513|NCT00058552|474124321|FG000|Overall Study|Withdrawal by Subject|3|||
131682514|NCT00058552|474124322|FG001|Overall Study|Withdrawal by Subject|5|||
131682515|NCT00058552|474124321|FG000|Overall Study|Physician Decision|2|||
131682516|NCT00058552|474124322|FG001|Overall Study|Physician Decision|5|||
131682517|NCT00058552|474124321|FG000|Overall Study|Clinical disease progression|0|||
131682518|NCT00058552|474124322|FG001|Overall Study|Clinical disease progression|4|||
131682519|NCT02319668|474124323|FG000|Overall Study|Other (Not specified)|0|||
131682520|NCT02319668|474124324|FG001|Overall Study|Other (Not specified)|2|||
131682521|NCT01372150|474124325|FG000|Overall Study|Lack of Efficacy|3|||
131682522|NCT01372150|474124326|FG001|Overall Study|Lack of Efficacy|0|||
131682523|NCT01372150|474124327|FG002|Overall Study|Lack of Efficacy|1|||
131682524|NCT01372150|474124325|FG000|Overall Study|Lost to Follow-up|4|||
131682525|NCT01372150|474124326|FG001|Overall Study|Lost to Follow-up|5|||
131682526|NCT01372150|474124327|FG002|Overall Study|Lost to Follow-up|6|||
131682527|NCT01372150|474124325|FG000|Overall Study|Protocol Violation|1|||
131682528|NCT01372150|474124326|FG001|Overall Study|Protocol Violation|0|||
131682529|NCT01372150|474124327|FG002|Overall Study|Protocol Violation|3|||
131682530|NCT01372150|474124325|FG000|Overall Study|Withdrawal by Subject|2|||
131682531|NCT01372150|474124326|FG001|Overall Study|Withdrawal by Subject|7|||
131682532|NCT01372150|474124327|FG002|Overall Study|Withdrawal by Subject|2|||
131682533|NCT01372150|474124325|FG000|Overall Study|Other|1|||
131682534|NCT01372150|474124326|FG001|Overall Study|Other|0|||
131682535|NCT01372150|474124327|FG002|Overall Study|Other|2|||
131682536|NCT01372150|474124325|FG000|Overall Study|Adverse Event|2|||
131682537|NCT01372150|474124326|FG001|Overall Study|Adverse Event|1|||
131682538|NCT01372150|474124327|FG002|Overall Study|Adverse Event|2|||
131682539|NCT01372150|474124325|FG000|Overall Study|Randomized but not treated|0|||
131682540|NCT01372150|474124326|FG001|Overall Study|Randomized but not treated|1|||
131682541|NCT01372150|474124327|FG002|Overall Study|Randomized but not treated|0|||
131682542|NCT02316340|474124328|FG000|First Progression|Clinical progression|2|||
131682543|NCT02316340|474124329|FG001|First Progression|Clinical progression|1|||
131682544|NCT02316340|474124328|FG000|First Progression|Withdrawal by Subject|1|||
131682545|NCT02316340|474124329|FG001|First Progression|Withdrawal by Subject|0|||
131682546|NCT03781323|474124330|FG000|Overall Study|Withdrawal by Subject|1|||
131682547|NCT01526551|474124331|FG000|Overall Study|Lack of returned parental consent form|424|||
131682548|NCT04422990|474124336|FG000|Overall Study|Withdrawal by Subject|0|||
131682549|NCT04422990|474124337|FG001|Overall Study|Withdrawal by Subject|1|||
131682550|NCT04422990|474124336|FG000|Overall Study|Travel|3|||
131682551|NCT04422990|474124337|FG001|Overall Study|Travel|0|||
131682552|NCT00433914|474124341|FG000|Overall Study|Withdrawal by Subject|0|||
131682553|NCT00433914|474124342|FG001|Overall Study|Withdrawal by Subject|2|||
131682554|NCT00433914|474124341|FG000|Overall Study|Lost to Follow-up|0|||
131682555|NCT00433914|474124342|FG001|Overall Study|Lost to Follow-up|1|||
131682556|NCT02844920|474124345|FG000|Overall Study|Lost to Follow-up|2|||
131682557|NCT00766090|474124356|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682558|NCT00766090|474124357|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682559|NCT00766090|474124358|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682560|NCT00766090|474124359|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682561|NCT00766090|474124360|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682562|NCT00766090|474124361|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682563|NCT00766090|474124362|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682564|NCT00766090|474124363|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682565|NCT00766090|474124364|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
131682566|NCT00766090|474124365|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682567|NCT00766090|474124366|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682568|NCT00766090|474124367|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131682569|NCT00766090|474124356|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
131682570|NCT00766090|474124357|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682571|NCT00766090|474124358|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682572|NCT00766090|474124359|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682573|NCT00766090|474124360|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682574|NCT00766090|474124361|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682575|NCT00766090|474124362|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682576|NCT00766090|474124363|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682577|NCT00766090|474124364|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682578|NCT00766090|474124365|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682579|NCT00766090|474124366|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682580|NCT00766090|474124367|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131682581|NCT00766090|474124356|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131682582|NCT00766090|474124357|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682583|NCT00766090|474124358|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682584|NCT00766090|474124359|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131682585|NCT00766090|474124360|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682586|NCT00766090|474124361|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682587|NCT00766090|474124362|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682588|NCT00766090|474124363|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682589|NCT00766090|474124364|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682590|NCT00766090|474124365|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682591|NCT00766090|474124366|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682592|NCT00766090|474124367|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131682593|NCT00766090|474124356|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682594|NCT00766090|474124357|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682595|NCT00766090|474124358|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
131682596|NCT00766090|474124359|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682597|NCT00766090|474124360|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682598|NCT00766090|474124361|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682599|NCT00766090|474124362|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682600|NCT00766090|474124363|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682601|NCT00766090|474124364|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682602|NCT00766090|474124365|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682603|NCT00766090|474124366|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682604|NCT00766090|474124367|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
131682605|NCT00766090|474124356|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682606|NCT00766090|474124357|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682607|NCT00766090|474124358|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682608|NCT00766090|474124359|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682609|NCT00766090|474124360|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
131682610|NCT00766090|474124361|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682611|NCT00766090|474124362|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682612|NCT00766090|474124363|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682613|NCT00766090|474124364|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682614|NCT00766090|474124365|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682615|NCT00766090|474124366|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682616|NCT00766090|474124367|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131682617|NCT00766090|474124356|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682618|NCT00766090|474124357|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682619|NCT00766090|474124358|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
131682620|NCT00766090|474124359|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682621|NCT00766090|474124360|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682622|NCT00766090|474124361|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682623|NCT00766090|474124362|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682624|NCT00766090|474124363|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682625|NCT00766090|474124364|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682626|NCT00766090|474124365|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682627|NCT00766090|474124366|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682628|NCT00766090|474124367|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131682629|NCT00766090|474124356|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
131682630|NCT00766090|474124357|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
131682631|NCT00766090|474124358|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
131682632|NCT00766090|474124359|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
131682633|NCT00766090|474124360|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
131682634|NCT00766090|474124361|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
131682635|NCT00766090|474124362|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
131682636|NCT00766090|474124363|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
131682637|NCT00766090|474124364|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
131682638|NCT00766090|474124365|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
131682639|NCT00766090|474124366|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
131682640|NCT00766090|474124367|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
131682641|NCT00766090|474124356|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682642|NCT00766090|474124357|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682643|NCT00766090|474124358|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682644|NCT00766090|474124359|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682645|NCT00766090|474124360|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682646|NCT00766090|474124361|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
131682647|NCT00766090|474124362|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682648|NCT00766090|474124363|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682649|NCT00766090|474124364|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682650|NCT00766090|474124365|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682651|NCT00766090|474124366|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682652|NCT00766090|474124367|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131682653|NCT00766090|474124356|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682654|NCT00766090|474124357|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
131682655|NCT00766090|474124358|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682656|NCT00766090|474124359|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
131682657|NCT00766090|474124360|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682658|NCT00766090|474124361|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682659|NCT00766090|474124362|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682660|NCT00766090|474124363|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682661|NCT00766090|474124364|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682662|NCT00766090|474124365|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682663|NCT00766090|474124366|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131682664|NCT00766090|474124367|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
131682665|NCT00766090|474124356|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682666|NCT00766090|474124357|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682667|NCT00766090|474124358|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682668|NCT00766090|474124359|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682669|NCT00766090|474124360|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
131682670|NCT00766090|474124361|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682671|NCT00766090|474124362|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682672|NCT00766090|474124363|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682673|NCT00766090|474124364|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682674|NCT00766090|474124365|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682675|NCT00766090|474124366|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682676|NCT00766090|474124367|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131682677|NCT00800436|474124368|FG000|Overall Study|Withdrawal by Subject|0|||
131682678|NCT00800436|474124369|FG001|Overall Study|Withdrawal by Subject|0|||
131682679|NCT00800436|474124370|FG002|Overall Study|Withdrawal by Subject|1|||
131682680|NCT00800436|474124371|FG003|Overall Study|Withdrawal by Subject|1|||
131682681|NCT00800436|474124372|FG004|Overall Study|Withdrawal by Subject|0|||
131555887|NCT01468922|473660267|FG004|Overall Study|Screening failure|0|||
131682682|NCT00800436|474124373|FG005|Overall Study|Withdrawal by Subject|0|||
131682683|NCT00800436|474124374|FG006|Overall Study|Withdrawal by Subject|0|||
131682684|NCT01106027|474124381|FG000|Overall Study|Lost graft early, discontinued|1|||
131682685|NCT02871778|474124382|FG000|Part A: Treatment Period 1|Adverse Event|1|||
131682686|NCT02871778|474124383|FG001|Part A: Treatment Period 1|Adverse Event|1|||
131682687|NCT02871778|474124384|FG002|Part A: Treatment Period 1|Adverse Event|1|||
131682688|NCT02871778|474124385|FG003|Part A: Treatment Period 1|Adverse Event|0|||
131682689|NCT02871778|474124386|FG004|Part A: Treatment Period 1|Adverse Event|0|||
131682690|NCT02871778|474124387|FG005|Part A: Treatment Period 1|Adverse Event|0|||
131682691|NCT02871778|474124388|FG006|Part A: Treatment Period 1|Adverse Event|0|||
131682692|NCT02871778|474124389|FG007|Part A: Treatment Period 1|Adverse Event|0|||
131682693|NCT02871778|474124382|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
131682694|NCT02871778|474124383|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
131682695|NCT02871778|474124384|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131682696|NCT02871778|474124385|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
131682697|NCT02871778|474124386|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131682698|NCT02871778|474124387|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131682699|NCT02871778|474124388|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131682700|NCT02871778|474124389|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131682701|NCT02871778|474124382|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682702|NCT02871778|474124383|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682703|NCT02871778|474124384|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
131682704|NCT02871778|474124385|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682705|NCT02871778|474124386|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682706|NCT02871778|474124387|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682707|NCT02871778|474124388|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682708|NCT02871778|474124389|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131682709|NCT02871778|474124382|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682710|NCT02871778|474124383|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682711|NCT02871778|474124384|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
131682712|NCT02871778|474124385|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682713|NCT02871778|474124386|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682714|NCT02871778|474124387|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682715|NCT02871778|474124388|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682716|NCT02871778|474124389|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131682717|NCT02871778|474124382|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682718|NCT02871778|474124383|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
131682719|NCT02871778|474124384|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682720|NCT02871778|474124385|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682721|NCT02871778|474124386|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682722|NCT02871778|474124387|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682723|NCT02871778|474124388|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682724|NCT02871778|474124389|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
131682725|NCT02871778|474124382|FG000|Part A: Treatment Period 2|Adverse Event|2|||
131682726|NCT02871778|474124383|FG001|Part A: Treatment Period 2|Adverse Event|2|||
131682727|NCT02871778|474124384|FG002|Part A: Treatment Period 2|Adverse Event|0|||
131682728|NCT02871778|474124385|FG003|Part A: Treatment Period 2|Adverse Event|0|||
131682729|NCT02871778|474124386|FG004|Part A: Treatment Period 2|Adverse Event|0|||
131682730|NCT02871778|474124387|FG005|Part A: Treatment Period 2|Adverse Event|0|||
131682731|NCT02871778|474124388|FG006|Part A: Treatment Period 2|Adverse Event|0|||
131682732|NCT02871778|474124389|FG007|Part A: Treatment Period 2|Adverse Event|0|||
131682733|NCT02871778|474124382|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682734|NCT02871778|474124383|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682735|NCT02871778|474124384|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682736|NCT02871778|474124385|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
131682737|NCT02871778|474124386|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682738|NCT02871778|474124387|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682739|NCT02871778|474124388|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682740|NCT02871778|474124389|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
131682741|NCT02871778|474124382|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
131682742|NCT02871778|474124383|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131682743|NCT02871778|474124384|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
131682744|NCT02871778|474124385|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131682745|NCT02871778|474124386|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131682746|NCT02871778|474124387|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131682747|NCT02871778|474124388|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131435992|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
131435993|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
131682748|NCT02871778|474124389|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131682749|NCT02871778|474124382|FG000|Part B: Treatment Period 3|Adverse Event|0|||
131682750|NCT02871778|474124383|FG001|Part B: Treatment Period 3|Adverse Event|0|||
131682751|NCT02871778|474124384|FG002|Part B: Treatment Period 3|Adverse Event|0|||
131682752|NCT02871778|474124385|FG003|Part B: Treatment Period 3|Adverse Event|0|||
131682753|NCT02871778|474124386|FG004|Part B: Treatment Period 3|Adverse Event|1|||
131682754|NCT02871778|474124387|FG005|Part B: Treatment Period 3|Adverse Event|1|||
131682755|NCT02871778|474124388|FG006|Part B: Treatment Period 3|Adverse Event|1|||
131682756|NCT02871778|474124389|FG007|Part B: Treatment Period 3|Adverse Event|0|||
131682757|NCT02653300|474124391|FG000|Overall Study|Withdrawal by Subject|2|||
131682758|NCT00800683|474124411|FG000|Overall Study|Adverse Event|11|||
131682759|NCT00800683|474124412|FG001|Overall Study|Adverse Event|8|||
131682760|NCT00800683|474124411|FG000|Overall Study|Lost to Follow-up|3|||
131682761|NCT00800683|474124412|FG001|Overall Study|Lost to Follow-up|1|||
131682762|NCT00800683|474124411|FG000|Overall Study|Withdrawal by Subject|1|||
131682763|NCT00800683|474124412|FG001|Overall Study|Withdrawal by Subject|7|||
131682764|NCT00800683|474124411|FG000|Overall Study|Lack of Efficacy|1|||
131682765|NCT00800683|474124412|FG001|Overall Study|Lack of Efficacy|1|||
131682766|NCT00800683|474124411|FG000|Overall Study|Other|1|||
131682767|NCT00800683|474124412|FG001|Overall Study|Other|2|||
131682768|NCT01478360|474124413|FG000|Overall Study|Lost to Follow-up|1|||
131682769|NCT01478360|474124414|FG001|Overall Study|Lost to Follow-up|0|||
131682770|NCT01478360|474124413|FG000|Overall Study|Adverse Event|0|||
131682771|NCT01478360|474124414|FG001|Overall Study|Adverse Event|1|||
131682772|NCT01478360|474124413|FG000|Overall Study|Administrative problems|1|||
131682773|NCT01478360|474124414|FG001|Overall Study|Administrative problems|2|||
131682774|NCT02289352|474124415|FG000|Overall Study|Withdrawal by Subject|1|||
131682775|NCT02289352|474124416|FG001|Overall Study|Withdrawal by Subject|1|||
131682776|NCT02289352|474124417|FG002|Overall Study|Withdrawal by Subject|0|||
131682777|NCT00911625|474124418|FG000|Overall Study|Lost to Follow-up|7|||
131682778|NCT00911625|474124419|FG001|Overall Study|Lost to Follow-up|0|||
131682779|NCT01289821|474124420|FG000|Treatment Period|Withdrawal by Subject|1|||
131682780|NCT01289821|474124420|FG000|Treatment Period|Physician Decision|3|||
131682781|NCT01289821|474124420|FG000|Treatment Period|Adverse Event|4|||
131682782|NCT01289821|474124420|FG000|Treatment Period|Radiological Progression|43|||
131682783|NCT01289821|474124420|FG000|Treatment Period|Clinical Progression|2|||
131682784|NCT01289821|474124420|FG000|Treatment Period|Therapeutic procedure required|1|||
131682785|NCT01289821|474124420|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
131682786|NCT01289821|474124420|FG000|Safety Follow-up Period|Protocol Violation|3|||
131682787|NCT01289821|474124420|FG000|Safety Follow-up Period|Unspecified reason|1|||
131682788|NCT01289821|474124420|FG000|Survival Follow-up Period|Protocol Violation|1|||
131682789|NCT01289821|474124420|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
131682790|NCT01289821|474124420|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
131682791|NCT02463071|474124427|FG000|Overall Study|Adverse Event|3|||
131682792|NCT02463071|474124428|FG001|Overall Study|Adverse Event|5|||
131682793|NCT02463071|474124429|FG002|Overall Study|Adverse Event|1|||
131682794|NCT02463071|474124427|FG000|Overall Study|Death|1|||
131682795|NCT02463071|474124428|FG001|Overall Study|Death|0|||
131682796|NCT02463071|474124429|FG002|Overall Study|Death|0|||
131682797|NCT02463071|474124427|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
131555888|NCT01468922|473660268|FG005|Overall Study|Screening failure|0|||
131555889|NCT01468922|473660269|FG006|Overall Study|Screening failure|0|||
131555890|NCT01468922|473660270|FG007|Overall Study|Screening failure|0|||
131555891|NCT01468922|473660271|FG008|Overall Study|Screening failure|1|||
131555892|NCT01468922|473660263|FG000|Overall Study|Per patient choice|1|||
131555893|NCT01468922|473660264|FG001|Overall Study|Per patient choice|0|||
131555894|NCT01468922|473660265|FG002|Overall Study|Per patient choice|0|||
131555895|NCT01468922|473660266|FG003|Overall Study|Per patient choice|0|||
131555896|NCT01468922|473660267|FG004|Overall Study|Per patient choice|0|||
131555897|NCT01468922|473660268|FG005|Overall Study|Per patient choice|0|||
131555898|NCT01468922|473660269|FG006|Overall Study|Per patient choice|0|||
131555899|NCT01468922|473660270|FG007|Overall Study|Per patient choice|0|||
131555900|NCT01468922|473660271|FG008|Overall Study|Per patient choice|0|||
131555901|NCT01468922|473660263|FG000|Overall Study|Switched to alternative treatment|1|||
131555902|NCT01468922|473660264|FG001|Overall Study|Switched to alternative treatment|0|||
131555903|NCT01468922|473660265|FG002|Overall Study|Switched to alternative treatment|0|||
131555904|NCT01468922|473660266|FG003|Overall Study|Switched to alternative treatment|0|||
131555905|NCT01468922|473660267|FG004|Overall Study|Switched to alternative treatment|1|||
131555906|NCT01468922|473660268|FG005|Overall Study|Switched to alternative treatment|0|||
131555907|NCT01468922|473660269|FG006|Overall Study|Switched to alternative treatment|0|||
131555908|NCT01468922|473660270|FG007|Overall Study|Switched to alternative treatment|0|||
131555909|NCT01468922|473660271|FG008|Overall Study|Switched to alternative treatment|0|||
131682798|NCT02463071|474124428|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131682799|NCT02463071|474124429|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
131682800|NCT02463071|474124427|FG000|Overall Study|Reason not specified|7|||
131682801|NCT02463071|474124428|FG001|Overall Study|Reason not specified|9|||
131682802|NCT02463071|474124429|FG002|Overall Study|Reason not specified|4|||
131682803|NCT02463071|474124427|FG000|Overall Study|Protocol Violation|0|||
131682804|NCT02463071|474124428|FG001|Overall Study|Protocol Violation|2|||
131682805|NCT02463071|474124429|FG002|Overall Study|Protocol Violation|0|||
131682806|NCT02463071|474124427|FG000|Overall Study|Lost to Follow-up|0|||
131682807|NCT02463071|474124428|FG001|Overall Study|Lost to Follow-up|0|||
131682808|NCT02463071|474124429|FG002|Overall Study|Lost to Follow-up|1|||
131682809|NCT01245387|474124430|FG000|Overall Study|Lost to Follow-up|106|||
131682810|NCT01245387|474124430|FG000|Overall Study|Lack of Efficacy|195|||
131682811|NCT01245387|474124430|FG000|Overall Study|Adverse Event|9|||
131682812|NCT01245387|474124430|FG000|Overall Study|Death|3|||
131682813|NCT01245387|474124430|FG000|Overall Study|Other|131|||
131682814|NCT01245387|474124430|FG000|Overall Study|Missing discontinuation status|369|||
131682815|NCT00757003|474124431|FG000|Overall Study|Death|33|||
131682816|NCT00757003|474124431|FG000|Overall Study|Lost to Follow-up|9|||
131682817|NCT00757003|474124431|FG000|Overall Study|Withdrawal by Subject|4|||
131682818|NCT00757003|474124431|FG000|Overall Study|Surgically explanted|2|||
131682819|NCT00757003|474124431|FG000|Overall Study|Not implanted|1|||
131682820|NCT02146599|474124447|FG000|Overall Study|Failed to meet inclusion criteria|5|||
131682821|NCT03061175|474124451|FG000|Baseline|Participant was deemed ineligible|1|||
131682822|NCT03061175|474124452|FG001|Baseline|Participant was deemed ineligible|0|||
131682823|NCT03061175|474124451|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
131682824|NCT03061175|474124452|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
131682825|NCT03061175|474124451|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
131682826|NCT03061175|474124452|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
131682827|NCT03061175|474124451|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
131682828|NCT03061175|474124452|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
131682829|NCT02243865|474124453|FG000|Overall Study|Protocol Violation|1|||
131682830|NCT02243865|474124454|FG001|Overall Study|Protocol Violation|3|||
131682831|NCT02243865|474124453|FG000|Overall Study|Lost to Follow-up|1|||
131682832|NCT02243865|474124454|FG001|Overall Study|Lost to Follow-up|1|||
131682833|NCT02243865|474124453|FG000|Overall Study|Withdrawal by Subject|1|||
131682834|NCT02243865|474124454|FG001|Overall Study|Withdrawal by Subject|0|||
131682835|NCT02243865|474124453|FG000|Overall Study|Adverse Event|1|||
131682836|NCT02243865|474124454|FG001|Overall Study|Adverse Event|1|||
131682837|NCT01235793|474124458|FG000|Overall Study|Death|6|||
131682838|NCT01159912|474124462|FG000|Overall Study|Adverse Event|2|||
131682839|NCT01159912|474124463|FG001|Overall Study|Adverse Event|2|||
131682840|NCT01159912|474124464|FG002|Overall Study|Adverse Event|3|||
131682841|NCT01159912|474124462|FG000|Overall Study|Lack of Efficacy|23|||
131898489|NCT05285787|474914087|FG000|Overall Study|Withdrawal by Subject|1|||
131682842|NCT01159912|474124463|FG001|Overall Study|Lack of Efficacy|15|||
131682843|NCT01159912|474124464|FG002|Overall Study|Lack of Efficacy|14|||
131682844|NCT01159912|474124462|FG000|Overall Study|Protocol Violation|1|||
131682845|NCT01159912|474124463|FG001|Overall Study|Protocol Violation|2|||
131682846|NCT01159912|474124464|FG002|Overall Study|Protocol Violation|3|||
131682847|NCT01159912|474124462|FG000|Overall Study|Lost to Follow-up|4|||
131682848|NCT01159912|474124463|FG001|Overall Study|Lost to Follow-up|0|||
131682849|NCT01159912|474124464|FG002|Overall Study|Lost to Follow-up|0|||
131682850|NCT01159912|474124462|FG000|Overall Study|Physician Decision|0|||
131682851|NCT01159912|474124463|FG001|Overall Study|Physician Decision|0|||
131682852|NCT01159912|474124464|FG002|Overall Study|Physician Decision|3|||
131682853|NCT01159912|474124462|FG000|Overall Study|Withdrawal by Subject|10|||
131682854|NCT01159912|474124463|FG001|Overall Study|Withdrawal by Subject|3|||
131682855|NCT01159912|474124464|FG002|Overall Study|Withdrawal by Subject|3|||
131682856|NCT01428661|474124472|FG000|Double-Masked Phase|Protocol Violation|9|||
131682857|NCT01428661|474124473|FG001|Double-Masked Phase|Protocol Violation|4|||
131682858|NCT01428661|474124474|FG002|Double-Masked Phase|Protocol Violation|0|||
131682859|NCT01428661|474124472|FG000|Double-Masked Phase|Adverse Event|13|||
131682860|NCT01428661|474124473|FG001|Double-Masked Phase|Adverse Event|4|||
131682861|NCT01428661|474124474|FG002|Double-Masked Phase|Adverse Event|0|||
131682862|NCT01428661|474124472|FG000|Double-Masked Phase|Lost to Follow-up|14|||
131682863|NCT01428661|474124473|FG001|Double-Masked Phase|Lost to Follow-up|14|||
131682864|NCT01428661|474124474|FG002|Double-Masked Phase|Lost to Follow-up|0|||
131682865|NCT01428661|474124472|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
131682866|NCT01428661|474124473|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
131682867|NCT01428661|474124474|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
131682868|NCT01428661|474124472|FG000|Double-Masked Phase|Lack of Efficacy|2|||
131682869|NCT01428661|474124473|FG001|Double-Masked Phase|Lack of Efficacy|1|||
131682870|NCT01428661|474124474|FG002|Double-Masked Phase|Lack of Efficacy|0|||
131682871|NCT01428661|474124472|FG000|Double-Masked Phase|*Various|1|||
131682872|NCT01428661|474124473|FG001|Double-Masked Phase|*Various|6|||
131682873|NCT01428661|474124474|FG002|Double-Masked Phase|*Various|0|||
131682874|NCT01428661|474124472|FG000|Open Label Extension|Protocol Violation|0|||
131682875|NCT01428661|474124473|FG001|Open Label Extension|Protocol Violation|0|||
131682876|NCT01428661|474124474|FG002|Open Label Extension|Protocol Violation|9|||
131682877|NCT01428661|474124472|FG000|Open Label Extension|Adverse Event|0|||
131682878|NCT01428661|474124473|FG001|Open Label Extension|Adverse Event|0|||
131682879|NCT01428661|474124474|FG002|Open Label Extension|Adverse Event|15|||
131682880|NCT01428661|474124472|FG000|Open Label Extension|Lost to Follow-up|0|||
131682881|NCT01428661|474124473|FG001|Open Label Extension|Lost to Follow-up|0|||
131682882|NCT01428661|474124474|FG002|Open Label Extension|Lost to Follow-up|38|||
131682883|NCT01428661|474124472|FG000|Open Label Extension|Withdrawal by Subject|0|||
131682884|NCT01428661|474124473|FG001|Open Label Extension|Withdrawal by Subject|0|||
131682885|NCT01428661|474124474|FG002|Open Label Extension|Withdrawal by Subject|49|||
131682886|NCT01428661|474124472|FG000|Open Label Extension|Lack of Efficacy|0|||
131682887|NCT01428661|474124473|FG001|Open Label Extension|Lack of Efficacy|0|||
131682888|NCT01428661|474124474|FG002|Open Label Extension|Lack of Efficacy|24|||
131682889|NCT01428661|474124472|FG000|Open Label Extension|**Various|0|||
131682890|NCT01428661|474124473|FG001|Open Label Extension|**Various|0|||
131682891|NCT01428661|474124474|FG002|Open Label Extension|**Various|185|||
131682892|NCT02553265|474126948|FG000|Enrollment|Death|0|||
131682893|NCT02553265|474126949|FG001|Enrollment|Death|0|||
131682894|NCT02553265|474126950|FG002|Enrollment|Death|1|||
131682895|NCT02553265|474126948|FG000|First Intervention (28 Days)|Adverse Event|1|||
131682896|NCT02553265|474126949|FG001|First Intervention (28 Days)|Adverse Event|0|||
131682897|NCT02553265|474126950|FG002|First Intervention (28 Days)|Adverse Event|0|||
131682898|NCT02553265|474126948|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
131682899|NCT02553265|474126949|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
131682900|NCT02553265|474126950|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
131682901|NCT02553265|474126948|FG000|Second Intervention (28 Days)|Adverse Event|1|||
131682902|NCT02553265|474126949|FG001|Second Intervention (28 Days)|Adverse Event|0|||
131682903|NCT02553265|474126950|FG002|Second Intervention (28 Days)|Adverse Event|0|||
131682904|NCT02553265|474126948|FG000|Third Intervention (28 Days)|Adverse Event|1|||
131682905|NCT02553265|474126949|FG001|Third Intervention (28 Days)|Adverse Event|0|||
131682906|NCT02553265|474126950|FG002|Third Intervention (28 Days)|Adverse Event|0|||
131682907|NCT02553265|474126948|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
131682908|NCT02553265|474126949|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
131682909|NCT02553265|474126950|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
131682910|NCT04854434|474126954|FG000|Overall Study|Death|1|||
131682911|NCT04854434|474126955|FG001|Overall Study|Death|3|||
131682912|NCT04854434|474126956|FG002|Overall Study|Death|4|||
131682913|NCT04854434|474126954|FG000|Overall Study|Study Terminated by Sponsor|2|||
131682914|NCT04854434|474126955|FG001|Overall Study|Study Terminated by Sponsor|0|||
131682915|NCT04854434|474126956|FG002|Overall Study|Study Terminated by Sponsor|0|||
131682916|NCT04854434|474126954|FG000|Overall Study|Other|1|||
131682917|NCT04854434|474126955|FG001|Overall Study|Other|1|||
131682918|NCT04854434|474126956|FG002|Overall Study|Other|0|||
131682919|NCT02667275|474126957|FG000|Overall Study|Protocol Violation|11|||
131898490|NCT02360280|474914091|FG000|Overall Study|Withdrawal by Subject|2|||
131898491|NCT02360280|474914092|FG001|Overall Study|Withdrawal by Subject|0|||
131682920|NCT02667275|474126958|FG001|Overall Study|Protocol Violation|7|||
131682921|NCT02667275|474126957|FG000|Overall Study|Lost to Follow-up|0|||
131682922|NCT02667275|474126958|FG001|Overall Study|Lost to Follow-up|2|||
131682923|NCT02667275|474126957|FG000|Overall Study|Withdrawal by Subject|0|||
131682924|NCT02667275|474126958|FG001|Overall Study|Withdrawal by Subject|5|||
131682925|NCT02667275|474126957|FG000|Overall Study|Discontinued early without completing|0|||
131682926|NCT02667275|474126958|FG001|Overall Study|Discontinued early without completing|1|||
131682927|NCT01274715|474126959|FG000|Overall Study|Lost to Follow-up|1|||
131555910|NCT01468922|473660263|FG000|Overall Study|Enrolled on new protocol|0|||
131555911|NCT01468922|473660264|FG001|Overall Study|Enrolled on new protocol|0|||
131555912|NCT01468922|473660265|FG002|Overall Study|Enrolled on new protocol|0|||
131555913|NCT01468922|473660266|FG003|Overall Study|Enrolled on new protocol|0|||
131555914|NCT01468922|473660267|FG004|Overall Study|Enrolled on new protocol|1|||
131555915|NCT01468922|473660268|FG005|Overall Study|Enrolled on new protocol|0|||
131555916|NCT01468922|473660269|FG006|Overall Study|Enrolled on new protocol|0|||
131555917|NCT01468922|473660270|FG007|Overall Study|Enrolled on new protocol|0|||
131555918|NCT01468922|473660271|FG008|Overall Study|Enrolled on new protocol|0|||
131555919|NCT01468922|473660263|FG000|Overall Study|Adverse Event|0|||
131555920|NCT01468922|473660264|FG001|Overall Study|Adverse Event|0|||
131555921|NCT01468922|473660265|FG002|Overall Study|Adverse Event|0|||
131555922|NCT01468922|473660266|FG003|Overall Study|Adverse Event|0|||
131555923|NCT01468922|473660267|FG004|Overall Study|Adverse Event|0|||
131555924|NCT01468922|473660268|FG005|Overall Study|Adverse Event|0|||
131555925|NCT01468922|473660269|FG006|Overall Study|Adverse Event|0|||
131555926|NCT01468922|473660270|FG007|Overall Study|Adverse Event|1|||
131555927|NCT01468922|473660271|FG008|Overall Study|Adverse Event|0|||
131555928|NCT01468922|473660263|FG000|Overall Study|Infection of blood|0|||
131555929|NCT01468922|473660264|FG001|Overall Study|Infection of blood|0|||
131555930|NCT01468922|473660265|FG002|Overall Study|Infection of blood|0|||
131555931|NCT01468922|473660266|FG003|Overall Study|Infection of blood|0|||
131555932|NCT01468922|473660267|FG004|Overall Study|Infection of blood|0|||
131555933|NCT01468922|473660268|FG005|Overall Study|Infection of blood|0|||
131555934|NCT01468922|473660269|FG006|Overall Study|Infection of blood|0|||
131555935|NCT01468922|473660270|FG007|Overall Study|Infection of blood|1|||
131555936|NCT01468922|473660271|FG008|Overall Study|Infection of blood|0|||
131555937|NCT01468922|473660263|FG000|Overall Study|Patient choice - surgery|0|||
131555938|NCT01468922|473660264|FG001|Overall Study|Patient choice - surgery|0|||
131555939|NCT01468922|473660265|FG002|Overall Study|Patient choice - surgery|0|||
131555940|NCT01468922|473660266|FG003|Overall Study|Patient choice - surgery|0|||
131555941|NCT01468922|473660267|FG004|Overall Study|Patient choice - surgery|0|||
131555942|NCT01468922|473660268|FG005|Overall Study|Patient choice - surgery|0|||
131555943|NCT01468922|473660269|FG006|Overall Study|Patient choice - surgery|0|||
131555944|NCT01468922|473660270|FG007|Overall Study|Patient choice - surgery|1|||
131555945|NCT01468922|473660271|FG008|Overall Study|Patient choice - surgery|0|||
131555946|NCT01468922|473660263|FG000|Overall Study|Refused further treatment|0|||
131555947|NCT01468922|473660264|FG001|Overall Study|Refused further treatment|0|||
131555948|NCT01468922|473660265|FG002|Overall Study|Refused further treatment|0|||
131555949|NCT01468922|473660266|FG003|Overall Study|Refused further treatment|0|||
131555950|NCT01468922|473660267|FG004|Overall Study|Refused further treatment|0|||
131555951|NCT01468922|473660268|FG005|Overall Study|Refused further treatment|0|||
131555952|NCT01468922|473660269|FG006|Overall Study|Refused further treatment|0|||
131555953|NCT01468922|473660270|FG007|Overall Study|Refused further treatment|1|||
131555954|NCT01468922|473660271|FG008|Overall Study|Refused further treatment|0|||
131555955|NCT03662997|473660278|FG000|Overall Study|Adverse Event|0|||
131555956|NCT03662997|473660279|FG001|Overall Study|Adverse Event|2|||
131555957|NCT03662997|473660280|FG002|Overall Study|Adverse Event|0|||
131555958|NCT03662997|473660281|FG003|Overall Study|Adverse Event|0|||
131555959|NCT00007475|473660282|FG000|Overall Study|Withdrawal by Subject|1|||
131555960|NCT00007475|473660283|FG001|Overall Study|Withdrawal by Subject|0|||
131555961|NCT00007475|473660284|FG002|Overall Study|Withdrawal by Subject|0|||
131555962|NCT00007475|473660285|FG003|Overall Study|Withdrawal by Subject|0|||
131682928|NCT01274715|474126959|FG000|Overall Study|After consent, met exclusion criteria.|1|||
131682929|NCT01274715|474126959|FG000|Overall Study|After consent, met exclusion criteria.|1|||
131682930|NCT01274715|474126959|FG000|Overall Study|After consent, met exclusion criteria.|1|||
131682931|NCT02285920|474126961|FG000|Overall Study|Kidney transplantation|2|||
131682932|NCT02285920|474126962|FG001|Overall Study|Kidney transplantation|2|||
131682933|NCT02285920|474126963|FG002|Overall Study|Kidney transplantation|2|||
131682934|NCT02285920|474126964|FG003|Overall Study|Kidney transplantation|0|||
131682935|NCT02285920|474126961|FG000|Overall Study|Change to peritoneal dialysis|0|||
131682936|NCT02285920|474126962|FG001|Overall Study|Change to peritoneal dialysis|0|||
131682937|NCT02285920|474126963|FG002|Overall Study|Change to peritoneal dialysis|1|||
131682938|NCT02285920|474126964|FG003|Overall Study|Change to peritoneal dialysis|0|||
131682939|NCT02285920|474126961|FG000|Overall Study|Transfer to non-participating unit|0|||
131682940|NCT02285920|474126962|FG001|Overall Study|Transfer to non-participating unit|1|||
131682941|NCT02285920|474126963|FG002|Overall Study|Transfer to non-participating unit|0|||
131682942|NCT02285920|474126964|FG003|Overall Study|Transfer to non-participating unit|0|||
131682943|NCT02285920|474126961|FG000|Overall Study|Dialysis discontinuation|0|||
131682944|NCT02285920|474126962|FG001|Overall Study|Dialysis discontinuation|1|||
131682945|NCT02285920|474126963|FG002|Overall Study|Dialysis discontinuation|0|||
131682946|NCT02285920|474126964|FG003|Overall Study|Dialysis discontinuation|0|||
131682947|NCT02285920|474126961|FG000|Overall Study|Death|2|||
131682948|NCT02285920|474126962|FG001|Overall Study|Death|0|||
131682949|NCT02285920|474126963|FG002|Overall Study|Death|2|||
131682950|NCT02285920|474126964|FG003|Overall Study|Death|1|||
131682951|NCT01480284|474126965|FG000|Overall Study|Withdrawal by Subject|2|||
131682952|NCT01480284|474126966|FG001|Overall Study|Withdrawal by Subject|0|||
131682953|NCT01480284|474126965|FG000|Overall Study|Adverse Event|1|||
131682954|NCT01480284|474126966|FG001|Overall Study|Adverse Event|0|||
131682955|NCT01480284|474126965|FG000|Overall Study|Study closed/terminated|3|||
131682956|NCT01480284|474126966|FG001|Overall Study|Study closed/terminated|0|||
131682957|NCT01480284|474126965|FG000|Overall Study|Lost to Follow-up|1|||
131682958|NCT01480284|474126966|FG001|Overall Study|Lost to Follow-up|0|||
131682959|NCT01480284|474126965|FG000|Overall Study|Physician Decision|1|||
131682960|NCT01480284|474126966|FG001|Overall Study|Physician Decision|0|||
131682961|NCT02357134|474126967|FG000|Overall Study|Lost to Follow-up|1|||
131682962|NCT02357134|474126968|FG001|Overall Study|Lost to Follow-up|0|||
131682963|NCT02357134|474126969|FG002|Overall Study|Lost to Follow-up|0|||
131682964|NCT02357134|474126970|FG003|Overall Study|Lost to Follow-up|0|||
131682965|NCT01641237|474126982|FG000|Period II|Withdrawal by Subject|1|||
131682966|NCT01641237|474126983|FG001|Period II|Withdrawal by Subject|0|||
131682967|NCT01641237|474126984|FG002|Period II|Withdrawal by Subject|0|||
131682968|NCT01641237|474126985|FG003|Period II|Withdrawal by Subject|0|||
131682969|NCT01641237|474126982|FG000|Period III|Lost to Follow-up|1|||
131682970|NCT01641237|474126983|FG001|Period III|Lost to Follow-up|0|||
131682971|NCT01641237|474126984|FG002|Period III|Lost to Follow-up|0|||
131682972|NCT01641237|474126985|FG003|Period III|Lost to Follow-up|0|||
131682973|NCT02716675|474126987|FG000|Overall Study|Death|2|||
131682974|NCT02716675|474126988|FG001|Overall Study|Death|3|||
131682975|NCT02716675|474126989|FG002|Overall Study|Death|0|||
131555963|NCT00007475|473660282|FG000|Overall Study|Adverse Event|3|||
131555964|NCT00007475|473660283|FG001|Overall Study|Adverse Event|0|||
131682976|NCT02716675|474126987|FG000|Overall Study|Physician Decision|2|||
131682977|NCT02716675|474126988|FG001|Overall Study|Physician Decision|1|||
131682978|NCT02716675|474126989|FG002|Overall Study|Physician Decision|1|||
131682979|NCT02716675|474126987|FG000|Overall Study|Lost to Follow-up|100|||
131682980|NCT02716675|474126988|FG001|Overall Study|Lost to Follow-up|87|||
131682981|NCT02716675|474126989|FG002|Overall Study|Lost to Follow-up|99|||
131682982|NCT02716675|474126987|FG000|Overall Study|Withdrawal by Subject|22|||
131682983|NCT02716675|474126988|FG001|Overall Study|Withdrawal by Subject|25|||
131682984|NCT02716675|474126989|FG002|Overall Study|Withdrawal by Subject|20|||
131682985|NCT02716675|474126987|FG000|Overall Study|Protocol Violation|0|||
131682986|NCT02716675|474126988|FG001|Overall Study|Protocol Violation|3|||
131682987|NCT02716675|474126989|FG002|Overall Study|Protocol Violation|1|||
131682988|NCT02716675|474126987|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
131682989|NCT02716675|474126988|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
131682990|NCT02716675|474126989|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
131682991|NCT02716675|474126987|FG000|Overall Study|Other|38|||
131682992|NCT02716675|474126988|FG001|Overall Study|Other|47|||
131682993|NCT02716675|474126989|FG002|Overall Study|Other|48|||
131682994|NCT00709111|474126990|FG000|Overall Study|Withdrawal by Subject|1|||
131682995|NCT00709111|474126990|FG000|Overall Study|Unable to attend clinic visits|1|||
131682996|NCT01301456|474126991|FG000|Stage 1|Withdrawal by Subject|0|||
131682997|NCT01301456|474126992|FG001|Stage 1|Withdrawal by Subject|0|||
131682998|NCT01301456|474126993|FG002|Stage 1|Withdrawal by Subject|1|||
131682999|NCT01301456|474126994|FG003|Stage 1|Withdrawal by Subject|0|||
131683000|NCT01301456|474126995|FG004|Stage 1|Withdrawal by Subject|1|||
131683001|NCT01301456|474126996|FG005|Stage 1|Withdrawal by Subject|0|||
131683002|NCT01301456|474126997|FG006|Stage 1|Withdrawal by Subject|0|||
131683003|NCT01301456|474126998|FG007|Stage 1|Withdrawal by Subject|0|||
131683004|NCT01301456|474126999|FG008|Stage 1|Withdrawal by Subject|0|||
131683005|NCT01301456|474127000|FG009|Stage 1|Withdrawal by Subject|0|||
131683006|NCT01301456|474127001|FG010|Stage 1|Withdrawal by Subject|0|||
131683007|NCT01301456|474127002|FG011|Stage 1|Withdrawal by Subject|0|||
131683008|NCT01301456|474126991|FG000|Stage 1|Randomized but not treated|0|||
131683009|NCT01301456|474126992|FG001|Stage 1|Randomized but not treated|0|||
131683010|NCT01301456|474126993|FG002|Stage 1|Randomized but not treated|0|||
131683011|NCT01301456|474126994|FG003|Stage 1|Randomized but not treated|0|||
131683012|NCT01301456|474126995|FG004|Stage 1|Randomized but not treated|0|||
131683013|NCT01301456|474126996|FG005|Stage 1|Randomized but not treated|0|||
131683014|NCT01301456|474126997|FG006|Stage 1|Randomized but not treated|1|||
131683015|NCT01301456|474126998|FG007|Stage 1|Randomized but not treated|0|||
131683016|NCT01301456|474126999|FG008|Stage 1|Randomized but not treated|0|||
131683017|NCT01301456|474127000|FG009|Stage 1|Randomized but not treated|0|||
131683018|NCT01301456|474127001|FG010|Stage 1|Randomized but not treated|0|||
131683019|NCT01301456|474127002|FG011|Stage 1|Randomized but not treated|0|||
131683020|NCT01301456|474126991|FG000|Stage 2|Adverse Event|0|||
131683021|NCT01301456|474126992|FG001|Stage 2|Adverse Event|0|||
131683022|NCT01301456|474126993|FG002|Stage 2|Adverse Event|0|||
131683023|NCT01301456|474126994|FG003|Stage 2|Adverse Event|0|||
131683024|NCT01301456|474126995|FG004|Stage 2|Adverse Event|0|||
131683025|NCT01301456|474126996|FG005|Stage 2|Adverse Event|0|||
131683026|NCT01301456|474126997|FG006|Stage 2|Adverse Event|0|||
131683027|NCT01301456|474126998|FG007|Stage 2|Adverse Event|0|||
131683028|NCT01301456|474126999|FG008|Stage 2|Adverse Event|0|||
131683029|NCT01301456|474127000|FG009|Stage 2|Adverse Event|0|||
131683030|NCT01301456|474127001|FG010|Stage 2|Adverse Event|1|||
131683031|NCT01301456|474127002|FG011|Stage 2|Adverse Event|0|||
131683032|NCT00915772|474127007|FG000|Overall Study|Adverse Event|12|||
131683033|NCT00915772|474127008|FG001|Overall Study|Adverse Event|13|||
131683034|NCT00915772|474127009|FG002|Overall Study|Adverse Event|11|||
131683035|NCT00915772|474127007|FG000|Overall Study|Protocol Violation|4|||
131683036|NCT00915772|474127008|FG001|Overall Study|Protocol Violation|1|||
131683037|NCT00915772|474127009|FG002|Overall Study|Protocol Violation|2|||
131683038|NCT00915772|474127007|FG000|Overall Study|Lost to Follow-up|1|||
131683039|NCT00915772|474127008|FG001|Overall Study|Lost to Follow-up|2|||
131683040|NCT00915772|474127009|FG002|Overall Study|Lost to Follow-up|2|||
131683041|NCT00915772|474127007|FG000|Overall Study|Lack of Efficacy|9|||
131683042|NCT00915772|474127008|FG001|Overall Study|Lack of Efficacy|15|||
131683043|NCT00915772|474127009|FG002|Overall Study|Lack of Efficacy|3|||
131683044|NCT00915772|474127007|FG000|Overall Study|Refused to continue trial medication|6|||
131683045|NCT00915772|474127008|FG001|Overall Study|Refused to continue trial medication|8|||
131683046|NCT00915772|474127009|FG002|Overall Study|Refused to continue trial medication|4|||
131683047|NCT00915772|474127007|FG000|Overall Study|Any other reason|4|||
131683048|NCT00915772|474127008|FG001|Overall Study|Any other reason|7|||
131683049|NCT00915772|474127009|FG002|Overall Study|Any other reason|7|||
131683050|NCT03583450|474127010|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
131683051|NCT03583450|474127011|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
131683052|NCT03374995|474127012|FG000|Overall Study|Withdrawal by Subject|0|||
131683053|NCT03374995|474127013|FG001|Overall Study|Withdrawal by Subject|1|||
131683054|NCT01383096|474127016|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
131683055|NCT01383096|474127017|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
131683056|NCT01383096|474127018|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
131683057|NCT01383096|474127016|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
131683058|NCT01383096|474127017|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
131683059|NCT01383096|474127018|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
131683060|NCT01383096|474127016|FG000|Third Intervention (8 Days)|Elevated AST|0|||
131683061|NCT01383096|474127017|FG001|Third Intervention (8 Days)|Elevated AST|1|||
131683062|NCT01383096|474127018|FG002|Third Intervention (8 Days)|Elevated AST|0|||
131683063|NCT01383096|474127016|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
131683064|NCT01383096|474127017|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
131683065|NCT01383096|474127018|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
131683066|NCT01383096|474127016|FG000|Third Intervention (8 Days)|Adverse Event|1|||
131683067|NCT01383096|474127017|FG001|Third Intervention (8 Days)|Adverse Event|0|||
131683068|NCT01383096|474127018|FG002|Third Intervention (8 Days)|Adverse Event|0|||
131683069|NCT01383096|474127016|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
131683070|NCT01383096|474127017|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
131683071|NCT01383096|474127018|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
131683072|NCT01383096|474127016|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
131683073|NCT01383096|474127017|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131683074|NCT01383096|474127018|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131683075|NCT01383096|474127016|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
131555965|NCT00007475|473660284|FG002|Overall Study|Adverse Event|0|||
131683076|NCT01383096|474127017|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
131683077|NCT01383096|474127018|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
131683078|NCT01383096|474127016|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
131555966|NCT00007475|473660285|FG003|Overall Study|Adverse Event|0|||
131683079|NCT01383096|474127017|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131683080|NCT01383096|474127018|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131898492|NCT02360280|474914091|FG000|Overall Study|Adverse Event|0|||
131555967|NCT01719224|473660286|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
131683081|NCT01383096|474127016|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
131683082|NCT01383096|474127017|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
131683083|NCT01383096|474127018|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
131683084|NCT01383096|474127016|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
131683085|NCT01383096|474127017|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
131683086|NCT01383096|474127018|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
131683087|NCT01211535|474127019|FG000|Overall Study|Adverse Event|0|||
131683088|NCT01211535|474127020|FG001|Overall Study|Adverse Event|1|||
131683089|NCT03593850|474127025|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
131683090|NCT03593850|474127026|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
131683091|NCT01735279|474127027|FG000|Overall Study|Lost to Follow-up|11|||
131683092|NCT01735279|474127028|FG001|Overall Study|Lost to Follow-up|8|||
131683093|NCT00233363|474127033|FG000|Overall Study|Adverse Event|1|||
131683094|NCT00233363|474127034|FG001|Overall Study|Adverse Event|2|||
131683095|NCT00233363|474127033|FG000|Overall Study|Lack of Efficacy|0|||
131683096|NCT00233363|474127034|FG001|Overall Study|Lack of Efficacy|2|||
131683097|NCT00233363|474127033|FG000|Overall Study|Withdrawal by Subject|1|||
131683098|NCT00233363|474127034|FG001|Overall Study|Withdrawal by Subject|1|||
131683099|NCT00233363|474127033|FG000|Overall Study|Aggravation of complication|1|||
131683100|NCT00233363|474127034|FG001|Overall Study|Aggravation of complication|0|||
131683101|NCT02170779|474127035|FG000|Overall Study|Withdrawal by Subject|1|||
131683102|NCT02170779|474127036|FG001|Overall Study|Withdrawal by Subject|0|||
131683103|NCT02170779|474127035|FG000|Overall Study|Lost to Follow-up|0|||
131683104|NCT02170779|474127036|FG001|Overall Study|Lost to Follow-up|1|||
131683105|NCT00369785|474127037|FG000|Overall Study|Physician Decision|3|||
131683106|NCT00369785|474127038|FG001|Overall Study|Physician Decision|2|||
131683107|NCT00369785|474127037|FG000|Overall Study|Death|1|||
131683108|NCT00369785|474127038|FG001|Overall Study|Death|2|||
131683109|NCT00369785|474127037|FG000|Overall Study|Withdrawal by Subject|7|||
131683110|NCT00369785|474127038|FG001|Overall Study|Withdrawal by Subject|6|||
131683111|NCT00369785|474127037|FG000|Overall Study|Toxicity|6|||
131683112|NCT00369785|474127038|FG001|Overall Study|Toxicity|4|||
131683113|NCT00369785|474127037|FG000|Overall Study|Never started|0|||
131683114|NCT00369785|474127038|FG001|Overall Study|Never started|2|||
131683115|NCT00369785|474127037|FG000|Overall Study|Progression|4|||
131683116|NCT00369785|474127038|FG001|Overall Study|Progression|4|||
131683117|NCT00369785|474127037|FG000|Overall Study|Multiple reasons|6|||
131683118|NCT00369785|474127038|FG001|Overall Study|Multiple reasons|5|||
131683119|NCT04556136|474127046|FG000|Overall Study|Lost to Follow-up|6|||
131683120|NCT04556136|474127047|FG001|Overall Study|Lost to Follow-up|6|||
131683121|NCT04556136|474127046|FG000|Overall Study|Physician Decision|2|||
131683122|NCT04556136|474127047|FG001|Overall Study|Physician Decision|1|||
131683123|NCT04556136|474127046|FG000|Overall Study|Withdrawal by Subject|2|||
131683124|NCT04556136|474127047|FG001|Overall Study|Withdrawal by Subject|1|||
131683125|NCT02678416|474127048|FG000|Part 1|Withdrawal by Subject|1|||
131683126|NCT02678416|474127048|FG000|Part 2|Adverse Event|2|||
131683127|NCT02678416|474127048|FG000|Part 2|Withdrawal by Subject|1|||
131683128|NCT01848353|474127049|FG000|Phase 1|Withdrawal by Subject|3|||
131683129|NCT01848353|474127050|FG001|Phase 1|Withdrawal by Subject|1|||
131683130|NCT01848353|474127051|FG002|Phase 1|Withdrawal by Subject|0|||
131683131|NCT01848353|474127052|FG003|Phase 1|Withdrawal by Subject|0|||
131683132|NCT01848353|474127049|FG000|Phase 2|Withdrawal by Subject|3|||
131683133|NCT01848353|474127050|FG001|Phase 2|Withdrawal by Subject|2|||
131683134|NCT01848353|474127051|FG002|Phase 2|Withdrawal by Subject|0|||
131683135|NCT01848353|474127052|FG003|Phase 2|Withdrawal by Subject|0|||
131683136|NCT01848353|474127049|FG000|Phase 3|Withdrawal by Subject|1|||
131683137|NCT01848353|474127050|FG001|Phase 3|Withdrawal by Subject|1|||
131683138|NCT01848353|474127051|FG002|Phase 3|Withdrawal by Subject|0|||
131683139|NCT01848353|474127052|FG003|Phase 3|Withdrawal by Subject|0|||
131683140|NCT00935272|474127055|FG000|Overall Study|Lost to Follow-up|10|||
131683141|NCT00935272|474127056|FG001|Overall Study|Lost to Follow-up|3|||
131683142|NCT00935272|474127055|FG000|Overall Study|Withdrawal by Subject|8|||
131683143|NCT00935272|474127056|FG001|Overall Study|Withdrawal by Subject|2|||
131683144|NCT00935272|474127055|FG000|Overall Study|Physician Decision|1|||
131683145|NCT00935272|474127056|FG001|Overall Study|Physician Decision|0|||
131683146|NCT00935272|474127055|FG000|Overall Study|Protocol Violation|0|||
131683147|NCT00935272|474127056|FG001|Overall Study|Protocol Violation|1|||
131683148|NCT03492554|474127064|FG000|Overall Study|Protocol Violation|0|||
131683149|NCT03492554|474127065|FG001|Overall Study|Protocol Violation|14|||
131683150|NCT04340557|474127068|FG000|Overall Study|Transferred to ICU and/or death|1|||
131683151|NCT04340557|474127069|FG001|Overall Study|Transferred to ICU and/or death|2|||
131683152|NCT01221727|474127070|FG000|Overall Study|Physician Decision|2|||
131683153|NCT01221727|474127071|FG001|Overall Study|Physician Decision|0|||
131683154|NCT01221727|474127070|FG000|Overall Study|Withdrawal by Subject|1|||
131683155|NCT01221727|474127071|FG001|Overall Study|Withdrawal by Subject|1|||
131683156|NCT00529451|474127099|FG000|Overall Study|Subject withdrew consent|16|||
131683157|NCT00529451|474127100|FG001|Overall Study|Subject withdrew consent|21|||
131683158|NCT00529451|474127101|FG002|Overall Study|Subject withdrew consent|13|||
131683159|NCT00529451|474127102|FG003|Overall Study|Subject withdrew consent|12|||
131683160|NCT00529451|474127099|FG000|Overall Study|Adverse Event|9|||
131683161|NCT00529451|474127100|FG001|Overall Study|Adverse Event|16|||
131683162|NCT00529451|474127101|FG002|Overall Study|Adverse Event|14|||
131683163|NCT00529451|474127102|FG003|Overall Study|Adverse Event|8|||
131683164|NCT00529451|474127099|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
131683165|NCT00529451|474127100|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
131683166|NCT00529451|474127101|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
131683167|NCT00529451|474127102|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
131683168|NCT00529451|474127099|FG000|Overall Study|Lost to Follow-up|4|||
131683169|NCT00529451|474127100|FG001|Overall Study|Lost to Follow-up|7|||
131683170|NCT00529451|474127101|FG002|Overall Study|Lost to Follow-up|4|||
131683171|NCT00529451|474127102|FG003|Overall Study|Lost to Follow-up|4|||
131683172|NCT00529451|474127099|FG000|Overall Study|Protocol deviation|1|||
131683173|NCT00529451|474127100|FG001|Overall Study|Protocol deviation|1|||
131683174|NCT00529451|474127101|FG002|Overall Study|Protocol deviation|4|||
131683175|NCT00529451|474127102|FG003|Overall Study|Protocol deviation|1|||
131683176|NCT00529451|474127099|FG000|Overall Study|Administrative problems|1|||
131683177|NCT00529451|474127100|FG001|Overall Study|Administrative problems|1|||
131683178|NCT00529451|474127101|FG002|Overall Study|Administrative problems|0|||
131683179|NCT00529451|474127102|FG003|Overall Study|Administrative problems|2|||
131683180|NCT00590044|474127105|FG000|Overall Study|Withdrawal by Subject|2|||
131683181|NCT00590044|474127106|FG001|Overall Study|Withdrawal by Subject|2|||
131683182|NCT00590044|474127105|FG000|Overall Study|wrong insulin arm assigned|1|||
131683183|NCT00590044|474127106|FG001|Overall Study|wrong insulin arm assigned|0|||
131683184|NCT00590044|474127105|FG000|Overall Study|Protocol Violation|1|||
131683185|NCT00590044|474127106|FG001|Overall Study|Protocol Violation|0|||
131683186|NCT00773136|474127107|FG000|Overall Study|Physician Decision|2|||
131683187|NCT01010633|474127111|FG000|Overall Study|Adverse Event|1|||
131683188|NCT01010633|474127112|FG001|Overall Study|Adverse Event|1|||
131683189|NCT01010633|474127111|FG000|Overall Study|Protocol Violation|1|||
131683190|NCT01010633|474127112|FG001|Overall Study|Protocol Violation|2|||
131683191|NCT01010633|474127111|FG000|Overall Study|Withdrawal by Subject|2|||
131683192|NCT01010633|474127112|FG001|Overall Study|Withdrawal by Subject|1|||
131683193|NCT01010633|474127111|FG000|Overall Study|Investigator decision|0|||
131683194|NCT01010633|474127112|FG001|Overall Study|Investigator decision|1|||
131683195|NCT00888381|474127116|FG000|Overall Study|Lost to Follow-up|0|||
131683196|NCT00888381|474127117|FG001|Overall Study|Lost to Follow-up|1|||
131683197|NCT00097773|474127118|FG000|Overall Study|Lost to Follow-up|2|||
131683198|NCT00097773|474127119|FG001|Overall Study|Lost to Follow-up|2|||
131683199|NCT00097773|474127120|FG002|Overall Study|Lost to Follow-up|0|||
131683200|NCT00097773|474127121|FG003|Overall Study|Lost to Follow-up|1|||
131683201|NCT00097773|474127118|FG000|Overall Study|Physician Decision|2|||
131683202|NCT00097773|474127119|FG001|Overall Study|Physician Decision|2|||
131683203|NCT00097773|474127120|FG002|Overall Study|Physician Decision|3|||
131683204|NCT00097773|474127121|FG003|Overall Study|Physician Decision|1|||
131683205|NCT00097773|474127118|FG000|Overall Study|Withdrawal by Subject|3|||
131683206|NCT00097773|474127119|FG001|Overall Study|Withdrawal by Subject|3|||
131683207|NCT00097773|474127120|FG002|Overall Study|Withdrawal by Subject|3|||
131683208|NCT00097773|474127121|FG003|Overall Study|Withdrawal by Subject|1|||
131683209|NCT00097773|474127118|FG000|Overall Study|Adverse Event|0|||
131683210|NCT00097773|474127119|FG001|Overall Study|Adverse Event|1|||
131683211|NCT00097773|474127120|FG002|Overall Study|Adverse Event|0|||
131683212|NCT00097773|474127121|FG003|Overall Study|Adverse Event|0|||
131898493|NCT02360280|474914092|FG001|Overall Study|Adverse Event|1|||
131683213|NCT00097773|474127118|FG000|Overall Study|Other|1|||
131683214|NCT00097773|474127119|FG001|Overall Study|Other|0|||
131683215|NCT00097773|474127120|FG002|Overall Study|Other|2|||
131683216|NCT00097773|474127121|FG003|Overall Study|Other|0|||
131683217|NCT00003702|474127122|FG000|Overall Study|Ineligible cell types|2|||
131683218|NCT00003702|474127123|FG001|Overall Study|Ineligible cell types|2|||
131683219|NCT00003702|474127122|FG000|Overall Study|Did not meet criteria for persistence|8|||
131683220|NCT00003702|474127123|FG001|Overall Study|Did not meet criteria for persistence|5|||
131683221|NCT00003702|474127122|FG000|Overall Study|WHO score > 6|2|||
131683222|NCT00003702|474127123|FG001|Overall Study|WHO score > 6|1|||
131683223|NCT00003702|474127122|FG000|Overall Study|Inadequate documentation of disease|1|||
131683224|NCT00003702|474127123|FG001|Overall Study|Inadequate documentation of disease|3|||
131683225|NCT01009034|474127124|FG000|Overall Study|Lost to Follow-up|2|||
131683226|NCT01009034|474127124|FG000|Overall Study|Withdrawal by Subject|2|||
131683227|NCT01494350|474127125|FG000|Overall Study|Worsening of lesion|1|||
131683228|NCT03986866|474127126|FG000|Overall Study|Withdrawal by Subject|0|||
131683229|NCT03986866|474127127|FG001|Overall Study|Withdrawal by Subject|3|||
131683230|NCT03986866|474127126|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
131683231|NCT03986866|474127127|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
131683232|NCT02054325|474127129|FG000|Overall Study|Lost to Follow-up|8|||
131683233|NCT02054325|474127130|FG001|Overall Study|Lost to Follow-up|5|||
131683234|NCT05093322|474127131|FG000|Overall Study|Death|6|||
131683235|NCT05093322|474127132|FG001|Overall Study|Death|2|||
131683236|NCT05093322|474127131|FG000|Overall Study|Other|4|||
131683237|NCT05093322|474127132|FG001|Overall Study|Other|1|||
131683238|NCT00617604|474127133|FG000|Overall Study|Death|2|||
131683239|NCT00617604|474127134|FG001|Overall Study|Death|1|||
131683240|NCT00617604|474127133|FG000|Overall Study|Lost to Follow-up|1|||
131683241|NCT00617604|474127134|FG001|Overall Study|Lost to Follow-up|0|||
131683242|NCT00617604|474127133|FG000|Overall Study|Miscellaneous Reasons|8|||
131683243|NCT00617604|474127134|FG001|Overall Study|Miscellaneous Reasons|10|||
131683244|NCT00617604|474127133|FG000|Overall Study|Withdrawal by Subject|4|||
131683245|NCT00617604|474127134|FG001|Overall Study|Withdrawal by Subject|6|||
131683246|NCT00617604|474127133|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
131683247|NCT00617604|474127134|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
131683248|NCT03250832|474127135|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
131683249|NCT03250832|474127136|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
131683250|NCT03250832|474127137|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
131683251|NCT03250832|474127138|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
131683252|NCT03250832|474127139|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
131683253|NCT03250832|474127140|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
131683254|NCT03250832|474127141|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
131683255|NCT03250832|474127142|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
131683256|NCT03250832|474127143|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
131683257|NCT03250832|474127144|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
131683258|NCT03250832|474127145|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
131683259|NCT03250832|474127146|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
131683260|NCT03250832|474127135|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
131683261|NCT03250832|474127136|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
131683262|NCT03250832|474127137|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
131683263|NCT03250832|474127138|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
131683264|NCT03250832|474127139|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
131683265|NCT03250832|474127140|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
131683266|NCT03250832|474127141|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
131683267|NCT03250832|474127142|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131683268|NCT03250832|474127143|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131683269|NCT03250832|474127144|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131683270|NCT03250832|474127145|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131683271|NCT03250832|474127146|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131683272|NCT03250832|474127135|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683273|NCT03250832|474127136|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683274|NCT03250832|474127137|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
131683275|NCT03250832|474127138|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683276|NCT03250832|474127139|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683277|NCT03250832|474127140|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683278|NCT03250832|474127141|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683279|NCT03250832|474127142|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683280|NCT03250832|474127143|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683281|NCT03250832|474127144|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683282|NCT03250832|474127145|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683283|NCT03250832|474127146|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131683284|NCT03250832|474127135|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683285|NCT03250832|474127136|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
131898494|NCT02360280|474914091|FG000|Overall Study|Lost to Follow-up|1|||
131683286|NCT03250832|474127137|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
131898495|NCT02360280|474914092|FG001|Overall Study|Lost to Follow-up|0|||
131898496|NCT02472886|474914093|FG000|Overall Study|Lack of Efficacy|0|||
131683287|NCT03250832|474127138|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683288|NCT03250832|474127139|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683289|NCT03250832|474127140|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683290|NCT03250832|474127141|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683291|NCT03250832|474127142|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
131683292|NCT03250832|474127143|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683293|NCT03250832|474127144|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683294|NCT03250832|474127145|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683295|NCT03250832|474127146|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
131683296|NCT03250832|474127135|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683297|NCT03250832|474127136|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683298|NCT03250832|474127137|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683299|NCT03250832|474127138|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683300|NCT03250832|474127139|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683301|NCT03250832|474127140|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683302|NCT03250832|474127141|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683303|NCT03250832|474127142|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
131683304|NCT03250832|474127143|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683305|NCT03250832|474127144|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683306|NCT03250832|474127145|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131898497|NCT02472886|474914094|FG001|Overall Study|Lack of Efficacy|2|||
131683307|NCT03250832|474127146|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131683308|NCT03250832|474127135|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683309|NCT03250832|474127136|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131898498|NCT02472886|474914095|FG002|Overall Study|Lack of Efficacy|1|||
131555968|NCT01719224|473660287|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
131683310|NCT03250832|474127137|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683311|NCT03250832|474127138|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683312|NCT03250832|474127139|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683313|NCT03250832|474127140|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683314|NCT03250832|474127141|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683315|NCT03250832|474127142|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
131683316|NCT03250832|474127143|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683317|NCT03250832|474127144|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683318|NCT03250832|474127145|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683319|NCT03250832|474127146|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131683320|NCT03250832|474127135|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683321|NCT03250832|474127136|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683322|NCT03250832|474127137|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683323|NCT03250832|474127138|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683324|NCT03250832|474127139|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683325|NCT03250832|474127140|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683326|NCT03250832|474127141|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683327|NCT03250832|474127142|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
131683328|NCT03250832|474127143|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683329|NCT03250832|474127144|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683330|NCT03250832|474127145|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683331|NCT03250832|474127146|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131683332|NCT03250832|474127135|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683333|NCT03250832|474127136|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683334|NCT03250832|474127137|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683335|NCT03250832|474127138|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683336|NCT03250832|474127139|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683337|NCT03250832|474127140|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683338|NCT03250832|474127141|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683339|NCT03250832|474127142|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
131683340|NCT03250832|474127143|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683341|NCT03250832|474127144|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683342|NCT03250832|474127145|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683343|NCT03250832|474127146|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
131683344|NCT03250832|474127135|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683345|NCT03250832|474127136|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683346|NCT03250832|474127137|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683347|NCT03250832|474127138|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683348|NCT03250832|474127139|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683349|NCT03250832|474127140|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683350|NCT03250832|474127141|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683351|NCT03250832|474127142|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683352|NCT03250832|474127143|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
131898499|NCT00320788|474914096|FG000|Overall Study|Adverse Event|0|||
131683353|NCT03250832|474127144|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
131683354|NCT03250832|474127145|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683355|NCT03250832|474127146|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
131683356|NCT03250832|474127135|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683357|NCT03250832|474127136|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683358|NCT03250832|474127137|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683359|NCT03250832|474127138|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683360|NCT03250832|474127139|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683361|NCT03250832|474127140|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683362|NCT03250832|474127141|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683363|NCT03250832|474127142|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683364|NCT03250832|474127143|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
131683365|NCT03250832|474127144|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
131683366|NCT03250832|474127145|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683367|NCT03250832|474127146|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131683368|NCT03250832|474127135|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683369|NCT03250832|474127136|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683370|NCT03250832|474127137|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683371|NCT03250832|474127138|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683372|NCT03250832|474127139|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683373|NCT03250832|474127140|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683374|NCT03250832|474127141|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683375|NCT03250832|474127142|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683376|NCT03250832|474127143|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
131683377|NCT03250832|474127144|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
131683378|NCT03250832|474127145|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683379|NCT03250832|474127146|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131683380|NCT03250832|474127135|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683381|NCT03250832|474127136|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683382|NCT03250832|474127137|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683383|NCT03250832|474127138|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683384|NCT03250832|474127139|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683385|NCT03250832|474127140|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683386|NCT03250832|474127141|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683387|NCT03250832|474127142|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683388|NCT03250832|474127143|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683389|NCT03250832|474127144|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683390|NCT03250832|474127145|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131683391|NCT03250832|474127146|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
131683392|NCT02303704|474127147|FG000|Overall Study|Protocol Violation|5|||
131683393|NCT02303704|474127148|FG001|Overall Study|Protocol Violation|9|||
131683394|NCT00397033|474127155|FG000|Overall Study|Adverse Event|7|||
131683395|NCT00397033|474127156|FG001|Overall Study|Adverse Event|10|||
131683396|NCT00397033|474127157|FG002|Overall Study|Adverse Event|4|||
131683397|NCT00397033|474127155|FG000|Overall Study|Lack of Efficacy|22|||
131683398|NCT00397033|474127156|FG001|Overall Study|Lack of Efficacy|12|||
131683399|NCT00397033|474127157|FG002|Overall Study|Lack of Efficacy|9|||
131683400|NCT00397033|474127155|FG000|Overall Study|Lost to Follow-up|3|||
131683401|NCT00397033|474127156|FG001|Overall Study|Lost to Follow-up|3|||
131683402|NCT00397033|474127157|FG002|Overall Study|Lost to Follow-up|3|||
131683403|NCT00397033|474127155|FG000|Overall Study|Withdrawal by Subject|12|||
131683404|NCT00397033|474127156|FG001|Overall Study|Withdrawal by Subject|7|||
131683405|NCT00397033|474127157|FG002|Overall Study|Withdrawal by Subject|5|||
131683406|NCT00397033|474127155|FG000|Overall Study|Other|0|||
131683407|NCT00397033|474127156|FG001|Overall Study|Other|5|||
131683408|NCT00397033|474127157|FG002|Overall Study|Other|2|||
131683409|NCT01202279|474127158|FG000|Overall Study|Adverse Event|8|||
131683410|NCT01202279|474127159|FG001|Overall Study|Adverse Event|6|||
131683411|NCT01202279|474127158|FG000|Overall Study|Withdrawal by Subject|13|||
131683412|NCT01202279|474127159|FG001|Overall Study|Withdrawal by Subject|10|||
131683413|NCT01202279|474127158|FG000|Overall Study|Physician Decision|0|||
131683414|NCT01202279|474127159|FG001|Overall Study|Physician Decision|1|||
131683415|NCT01202279|474127158|FG000|Overall Study|Lost to Follow-up|10|||
131683416|NCT01202279|474127159|FG001|Overall Study|Lost to Follow-up|7|||
131683417|NCT01202279|474127158|FG000|Overall Study|Protocol Violation|1|||
131683418|NCT01202279|474127159|FG001|Overall Study|Protocol Violation|1|||
131683419|NCT01202279|474127158|FG000|Overall Study|study compliance|5|||
131683420|NCT01202279|474127159|FG001|Overall Study|study compliance|2|||
131683421|NCT01984164|474127160|FG000|Overall Study|Withdrawal by Subject|4|||
131683422|NCT01984164|474127161|FG001|Overall Study|Withdrawal by Subject|3|||
131683423|NCT01984164|474127160|FG000|Overall Study|Adverse Event|5|||
131683424|NCT01984164|474127161|FG001|Overall Study|Adverse Event|19|||
131683425|NCT01984164|474127160|FG000|Overall Study|Lost to Follow-up|1|||
131683426|NCT01984164|474127161|FG001|Overall Study|Lost to Follow-up|3|||
131683427|NCT05293743|474127162|FG000|Overall Study|Withdrawal by Subject|1|||
131683428|NCT05293743|474127163|FG001|Overall Study|Withdrawal by Subject|0|||
131683429|NCT02064920|474127164|FG000|Overall Study|Adverse Event|0|||
131683430|NCT02064920|474127165|FG001|Overall Study|Adverse Event|4|||
131683431|NCT02064920|474127164|FG000|Overall Study|Physician Decision|0|||
131683432|NCT02064920|474127165|FG001|Overall Study|Physician Decision|1|||
131683433|NCT02064920|474127164|FG000|Overall Study|Technical Problems|0|||
131683434|NCT02064920|474127165|FG001|Overall Study|Technical Problems|1|||
131683435|NCT02064920|474127164|FG000|Overall Study|Withdrawal by Subject|1|||
131683436|NCT02064920|474127165|FG001|Overall Study|Withdrawal by Subject|3|||
131683437|NCT02109562|474127166|FG000|Overall Study|Insufficient clinical response|2|||
131683438|NCT02109562|474127167|FG001|Overall Study|Insufficient clinical response|0|||
131683439|NCT02109562|474127168|FG002|Overall Study|Insufficient clinical response|4|||
131683440|NCT02109562|474127166|FG000|Overall Study|Adverse Event|0|||
131683441|NCT02109562|474127167|FG001|Overall Study|Adverse Event|2|||
131555969|NCT03000673|473660288|FG000|Overall Study|Withdrawal by Subject|1|||
131683442|NCT02109562|474127168|FG002|Overall Study|Adverse Event|3|||
131683443|NCT02109562|474127166|FG000|Overall Study|Lost to Follow-up|1|||
131683444|NCT02109562|474127167|FG001|Overall Study|Lost to Follow-up|0|||
131555970|NCT03000673|473660289|FG001|Overall Study|Withdrawal by Subject|0|||
131683445|NCT02109562|474127168|FG002|Overall Study|Lost to Follow-up|1|||
131683446|NCT02109562|474127166|FG000|Overall Study|Protocol Violation|0|||
131683447|NCT02109562|474127167|FG001|Overall Study|Protocol Violation|3|||
131683448|NCT02109562|474127168|FG002|Overall Study|Protocol Violation|1|||
131683449|NCT02109562|474127166|FG000|Overall Study|Withdrawal by Subject|20|||
131683450|NCT02109562|474127167|FG001|Overall Study|Withdrawal by Subject|25|||
131683451|NCT02109562|474127168|FG002|Overall Study|Withdrawal by Subject|21|||
131683452|NCT02109562|474127166|FG000|Overall Study|Physician Decision|3|||
131683453|NCT02109562|474127167|FG001|Overall Study|Physician Decision|4|||
131683454|NCT02109562|474127168|FG002|Overall Study|Physician Decision|5|||
131683455|NCT00667823|474127173|FG000|Overall Study|Lost to Follow-up|5|||
131683456|NCT00667823|474127173|FG000|Overall Study|Adverse Event|7|||
131683457|NCT00667823|474127173|FG000|Overall Study|Death|182|||
131683458|NCT00667823|474127173|FG000|Overall Study|Withdrawal by Subject|12|||
131683459|NCT00667823|474127173|FG000|Overall Study|Other|8|||
131898500|NCT00320788|474914097|FG001|Overall Study|Adverse Event|0|||
131683460|NCT00667823|474127173|FG000|Overall Study|Missing (completion page missing)|2|||
131683461|NCT00583024|474127174|FG000|Overall Study|Lost to Follow-up|4|||
131683462|NCT00682448|474129073|FG000|Overall Study|Adverse Event|1|||
131683463|NCT00682448|474129074|FG001|Overall Study|Adverse Event|2|||
131683464|NCT00682448|474129073|FG000|Overall Study|Lack of Efficacy|1|||
131683465|NCT00682448|474129074|FG001|Overall Study|Lack of Efficacy|0|||
131683466|NCT00682448|474129073|FG000|Overall Study|Lost to Follow-up|1|||
131683467|NCT00682448|474129074|FG001|Overall Study|Lost to Follow-up|3|||
131555971|NCT03000673|473660290|FG002|Overall Study|Withdrawal by Subject|0|||
131898501|NCT00320788|474914098|FG002|Overall Study|Adverse Event|0|||
131898502|NCT00320788|474914099|FG003|Overall Study|Adverse Event|1|||
131683468|NCT00682448|474129073|FG000|Overall Study|Pregnancy|0|||
131683469|NCT00682448|474129074|FG001|Overall Study|Pregnancy|1|||
131683470|NCT00682448|474129073|FG000|Overall Study|Withdrawal by Subject|2|||
131898503|NCT00320788|474914100|FG004|Overall Study|Adverse Event|0|||
131898504|NCT00320788|474914096|FG000|Overall Study|Death|0|||
131898505|NCT00320788|474914097|FG001|Overall Study|Death|0|||
131683471|NCT00682448|474129074|FG001|Overall Study|Withdrawal by Subject|0|||
131683472|NCT00257166|474129078|FG000|Overall Study|Adverse Event|18|||
131683473|NCT00257166|474129079|FG001|Overall Study|Adverse Event|13|||
131683474|NCT00257166|474129078|FG000|Overall Study|Laboratory abnormality|1|||
131683475|NCT00257166|474129079|FG001|Overall Study|Laboratory abnormality|0|||
131683476|NCT00257166|474129078|FG000|Overall Study|Lost to Follow-up|8|||
131683477|NCT00257166|474129079|FG001|Overall Study|Lost to Follow-up|1|||
131683478|NCT00257166|474129078|FG000|Overall Study|Withdrawal by Subject|9|||
131683479|NCT00257166|474129079|FG001|Overall Study|Withdrawal by Subject|2|||
131683480|NCT00257166|474129078|FG000|Overall Study|Other|16|||
131683481|NCT00257166|474129079|FG001|Overall Study|Other|21|||
131683482|NCT00257166|474129078|FG000|Overall Study|Randomized, but not treated|1|||
131683483|NCT00257166|474129079|FG001|Overall Study|Randomized, but not treated|0|||
131683484|NCT02737852|474129082|FG000|Overall Study|Withdrawal by Subject|2|||
131683485|NCT00525044|474129083|FG000|Overall Study|Lost to Follow-up|0|||
131683486|NCT00525044|474129084|FG001|Overall Study|Lost to Follow-up|1|||
131683487|NCT04042740|474129085|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
131683488|NCT04042740|474129085|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
131683489|NCT01380730|474129088|FG000|Overall Study|Death|0|||
131683490|NCT01380730|474129089|FG001|Overall Study|Death|0|||
131683491|NCT01380730|474129090|FG002|Overall Study|Death|0|||
131683492|NCT01380730|474129091|FG003|Overall Study|Death|0|||
131555972|NCT03000673|473660291|FG003|Overall Study|Withdrawal by Subject|0|||
131683493|NCT01380730|474129092|FG004|Overall Study|Death|1|||
131683494|NCT01380730|474129093|FG005|Overall Study|Death|0|||
131683495|NCT01380730|474129094|FG006|Overall Study|Death|0|||
131683496|NCT01380730|474129095|FG007|Overall Study|Death|0|||
131683497|NCT00467779|474129100|FG000|Stage 1|Adverse Event|1|||
131683498|NCT00467779|474129101|FG001|Stage 1|Adverse Event|0|||
131683499|NCT00467779|474129102|FG002|Stage 1|Adverse Event|0|||
131683500|NCT00467779|474129103|FG003|Stage 1|Adverse Event|0|||
131683501|NCT00467779|474129104|FG004|Stage 1|Adverse Event|0|||
131683502|NCT00467779|474129105|FG005|Stage 1|Adverse Event|1|||
131683503|NCT00467779|474129106|FG006|Stage 1|Adverse Event|2|||
131683504|NCT00467779|474129107|FG007|Stage 1|Adverse Event|1|||
131683505|NCT00467779|474129108|FG008|Stage 1|Adverse Event|0|||
131683506|NCT00467779|474129109|FG009|Stage 1|Adverse Event|0|||
131683507|NCT00467779|474129110|FG010|Stage 1|Adverse Event|0|||
131683508|NCT00467779|474129111|FG011|Stage 1|Adverse Event|0|||
131683509|NCT00467779|474129112|FG012|Stage 1|Adverse Event|0|||
131683510|NCT00467779|474129113|FG013|Stage 1|Adverse Event|0|||
131683511|NCT00467779|474129114|FG014|Stage 1|Adverse Event|0|||
131683512|NCT00467779|474129100|FG000|Stage 1|Disease Progression|2|||
131683513|NCT00467779|474129101|FG001|Stage 1|Disease Progression|2|||
131683514|NCT00467779|474129102|FG002|Stage 1|Disease Progression|2|||
131683515|NCT00467779|474129103|FG003|Stage 1|Disease Progression|3|||
131683516|NCT00467779|474129104|FG004|Stage 1|Disease Progression|2|||
131683517|NCT00467779|474129105|FG005|Stage 1|Disease Progression|2|||
131683518|NCT00467779|474129106|FG006|Stage 1|Disease Progression|4|||
131683519|NCT00467779|474129107|FG007|Stage 1|Disease Progression|5|||
131683520|NCT00467779|474129108|FG008|Stage 1|Disease Progression|0|||
131683521|NCT00467779|474129109|FG009|Stage 1|Disease Progression|0|||
131683522|NCT00467779|474129110|FG010|Stage 1|Disease Progression|0|||
131683523|NCT00467779|474129111|FG011|Stage 1|Disease Progression|0|||
131683524|NCT00467779|474129112|FG012|Stage 1|Disease Progression|0|||
131683525|NCT00467779|474129113|FG013|Stage 1|Disease Progression|0|||
131683526|NCT00467779|474129114|FG014|Stage 1|Disease Progression|0|||
131683527|NCT00467779|474129100|FG000|Stage 1|Unspecified Reason|1|||
131683528|NCT00467779|474129101|FG001|Stage 1|Unspecified Reason|0|||
131683529|NCT00467779|474129102|FG002|Stage 1|Unspecified Reason|1|||
131683530|NCT00467779|474129103|FG003|Stage 1|Unspecified Reason|0|||
131683531|NCT00467779|474129104|FG004|Stage 1|Unspecified Reason|1|||
131683532|NCT00467779|474129105|FG005|Stage 1|Unspecified Reason|2|||
131683533|NCT00467779|474129106|FG006|Stage 1|Unspecified Reason|0|||
131683534|NCT00467779|474129107|FG007|Stage 1|Unspecified Reason|0|||
131555973|NCT01121484|473660292|FG000|Overall Study|Adverse Event|12|||
131683535|NCT00467779|474129108|FG008|Stage 1|Unspecified Reason|0|||
131683536|NCT00467779|474129109|FG009|Stage 1|Unspecified Reason|0|||
131683537|NCT00467779|474129110|FG010|Stage 1|Unspecified Reason|0|||
131683538|NCT00467779|474129111|FG011|Stage 1|Unspecified Reason|0|||
131683539|NCT00467779|474129112|FG012|Stage 1|Unspecified Reason|0|||
131683540|NCT00467779|474129113|FG013|Stage 1|Unspecified Reason|0|||
131683541|NCT00467779|474129114|FG014|Stage 1|Unspecified Reason|0|||
131683542|NCT00467779|474129100|FG000|Stage 1|Physician Decision|0|||
131683543|NCT00467779|474129101|FG001|Stage 1|Physician Decision|1|||
131683544|NCT00467779|474129102|FG002|Stage 1|Physician Decision|0|||
131683545|NCT00467779|474129103|FG003|Stage 1|Physician Decision|0|||
131683546|NCT00467779|474129104|FG004|Stage 1|Physician Decision|0|||
131683547|NCT00467779|474129105|FG005|Stage 1|Physician Decision|0|||
131683548|NCT00467779|474129106|FG006|Stage 1|Physician Decision|0|||
131683549|NCT00467779|474129107|FG007|Stage 1|Physician Decision|0|||
131683550|NCT00467779|474129108|FG008|Stage 1|Physician Decision|0|||
131683551|NCT00467779|474129109|FG009|Stage 1|Physician Decision|0|||
131683552|NCT00467779|474129110|FG010|Stage 1|Physician Decision|0|||
131683553|NCT00467779|474129111|FG011|Stage 1|Physician Decision|0|||
131683554|NCT00467779|474129112|FG012|Stage 1|Physician Decision|0|||
131683555|NCT00467779|474129113|FG013|Stage 1|Physician Decision|0|||
131683556|NCT00467779|474129114|FG014|Stage 1|Physician Decision|0|||
131683557|NCT00467779|474129100|FG000|Stage 1|Withdrawal by Subject|0|||
131683558|NCT00467779|474129101|FG001|Stage 1|Withdrawal by Subject|0|||
131683559|NCT00467779|474129102|FG002|Stage 1|Withdrawal by Subject|0|||
131683560|NCT00467779|474129103|FG003|Stage 1|Withdrawal by Subject|0|||
131683561|NCT00467779|474129104|FG004|Stage 1|Withdrawal by Subject|0|||
131683562|NCT00467779|474129105|FG005|Stage 1|Withdrawal by Subject|0|||
131683563|NCT00467779|474129106|FG006|Stage 1|Withdrawal by Subject|1|||
131683564|NCT00467779|474129107|FG007|Stage 1|Withdrawal by Subject|1|||
131683565|NCT00467779|474129108|FG008|Stage 1|Withdrawal by Subject|0|||
131683566|NCT00467779|474129109|FG009|Stage 1|Withdrawal by Subject|0|||
131683567|NCT00467779|474129110|FG010|Stage 1|Withdrawal by Subject|0|||
131683568|NCT00467779|474129111|FG011|Stage 1|Withdrawal by Subject|0|||
131683569|NCT00467779|474129112|FG012|Stage 1|Withdrawal by Subject|0|||
131683570|NCT00467779|474129113|FG013|Stage 1|Withdrawal by Subject|0|||
131683571|NCT00467779|474129114|FG014|Stage 1|Withdrawal by Subject|0|||
131683572|NCT00467779|474129100|FG000|Stage 1A|Adverse Event|0|||
131683573|NCT00467779|474129101|FG001|Stage 1A|Adverse Event|0|||
131683574|NCT00467779|474129102|FG002|Stage 1A|Adverse Event|0|||
131683575|NCT00467779|474129103|FG003|Stage 1A|Adverse Event|0|||
131683576|NCT00467779|474129104|FG004|Stage 1A|Adverse Event|0|||
131683577|NCT00467779|474129105|FG005|Stage 1A|Adverse Event|0|||
131683578|NCT00467779|474129106|FG006|Stage 1A|Adverse Event|0|||
131683579|NCT00467779|474129107|FG007|Stage 1A|Adverse Event|0|||
131683580|NCT00467779|474129108|FG008|Stage 1A|Adverse Event|0|||
131683581|NCT00467779|474129109|FG009|Stage 1A|Adverse Event|0|||
131683582|NCT00467779|474129110|FG010|Stage 1A|Adverse Event|0|||
131683583|NCT00467779|474129111|FG011|Stage 1A|Adverse Event|0|||
131683584|NCT00467779|474129112|FG012|Stage 1A|Adverse Event|1|||
131683585|NCT00467779|474129113|FG013|Stage 1A|Adverse Event|0|||
131683586|NCT00467779|474129114|FG014|Stage 1A|Adverse Event|0|||
131683587|NCT00467779|474129100|FG000|Stage 1A|Death|0|||
131683588|NCT00467779|474129101|FG001|Stage 1A|Death|0|||
131683589|NCT00467779|474129102|FG002|Stage 1A|Death|0|||
131683590|NCT00467779|474129103|FG003|Stage 1A|Death|0|||
131683591|NCT00467779|474129104|FG004|Stage 1A|Death|0|||
131683592|NCT00467779|474129105|FG005|Stage 1A|Death|0|||
131683593|NCT00467779|474129106|FG006|Stage 1A|Death|0|||
131683594|NCT00467779|474129107|FG007|Stage 1A|Death|0|||
131683595|NCT00467779|474129108|FG008|Stage 1A|Death|0|||
131683596|NCT00467779|474129109|FG009|Stage 1A|Death|0|||
131683597|NCT00467779|474129110|FG010|Stage 1A|Death|0|||
131683598|NCT00467779|474129111|FG011|Stage 1A|Death|1|||
131683599|NCT00467779|474129112|FG012|Stage 1A|Death|1|||
131683600|NCT00467779|474129113|FG013|Stage 1A|Death|0|||
131683601|NCT00467779|474129114|FG014|Stage 1A|Death|0|||
131683602|NCT00467779|474129100|FG000|Stage 1A|Disease Progression|0|||
131683603|NCT00467779|474129101|FG001|Stage 1A|Disease Progression|0|||
131683604|NCT00467779|474129102|FG002|Stage 1A|Disease Progression|0|||
131683605|NCT00467779|474129103|FG003|Stage 1A|Disease Progression|0|||
131683606|NCT00467779|474129104|FG004|Stage 1A|Disease Progression|0|||
131683607|NCT00467779|474129105|FG005|Stage 1A|Disease Progression|0|||
131683608|NCT00467779|474129106|FG006|Stage 1A|Disease Progression|0|||
131683609|NCT00467779|474129107|FG007|Stage 1A|Disease Progression|0|||
131683610|NCT00467779|474129108|FG008|Stage 1A|Disease Progression|0|||
131683611|NCT00467779|474129109|FG009|Stage 1A|Disease Progression|2|||
131683612|NCT00467779|474129110|FG010|Stage 1A|Disease Progression|2|||
131683613|NCT00467779|474129111|FG011|Stage 1A|Disease Progression|5|||
131683614|NCT00467779|474129112|FG012|Stage 1A|Disease Progression|2|||
131683615|NCT00467779|474129113|FG013|Stage 1A|Disease Progression|0|||
131683616|NCT00467779|474129114|FG014|Stage 1A|Disease Progression|0|||
131683617|NCT00467779|474129100|FG000|Stage 1A|Physician Decision|0|||
131683618|NCT00467779|474129101|FG001|Stage 1A|Physician Decision|0|||
131683619|NCT00467779|474129102|FG002|Stage 1A|Physician Decision|0|||
131683620|NCT00467779|474129103|FG003|Stage 1A|Physician Decision|0|||
131683621|NCT00467779|474129104|FG004|Stage 1A|Physician Decision|0|||
131683622|NCT00467779|474129105|FG005|Stage 1A|Physician Decision|0|||
131683623|NCT00467779|474129106|FG006|Stage 1A|Physician Decision|0|||
131683624|NCT00467779|474129107|FG007|Stage 1A|Physician Decision|0|||
131683625|NCT00467779|474129108|FG008|Stage 1A|Physician Decision|0|||
131683626|NCT00467779|474129109|FG009|Stage 1A|Physician Decision|1|||
131683627|NCT00467779|474129110|FG010|Stage 1A|Physician Decision|0|||
131683628|NCT00467779|474129111|FG011|Stage 1A|Physician Decision|0|||
131683629|NCT00467779|474129112|FG012|Stage 1A|Physician Decision|0|||
131683630|NCT00467779|474129113|FG013|Stage 1A|Physician Decision|0|||
131683631|NCT00467779|474129114|FG014|Stage 1A|Physician Decision|0|||
131683632|NCT00467779|474129100|FG000|Stage 1A|Withdrawal by Subject|0|||
131683633|NCT00467779|474129101|FG001|Stage 1A|Withdrawal by Subject|0|||
131683634|NCT00467779|474129102|FG002|Stage 1A|Withdrawal by Subject|0|||
131683635|NCT00467779|474129103|FG003|Stage 1A|Withdrawal by Subject|0|||
131683636|NCT00467779|474129104|FG004|Stage 1A|Withdrawal by Subject|0|||
131683637|NCT00467779|474129105|FG005|Stage 1A|Withdrawal by Subject|0|||
131683638|NCT00467779|474129106|FG006|Stage 1A|Withdrawal by Subject|0|||
131683639|NCT00467779|474129107|FG007|Stage 1A|Withdrawal by Subject|0|||
131683640|NCT00467779|474129108|FG008|Stage 1A|Withdrawal by Subject|0|||
131683641|NCT00467779|474129109|FG009|Stage 1A|Withdrawal by Subject|0|||
131683642|NCT00467779|474129110|FG010|Stage 1A|Withdrawal by Subject|1|||
131683643|NCT00467779|474129111|FG011|Stage 1A|Withdrawal by Subject|1|||
131683644|NCT00467779|474129112|FG012|Stage 1A|Withdrawal by Subject|1|||
131683645|NCT00467779|474129113|FG013|Stage 1A|Withdrawal by Subject|0|||
131683646|NCT00467779|474129114|FG014|Stage 1A|Withdrawal by Subject|0|||
131683647|NCT00467779|474129100|FG000|Stage 1A|Unspecified Reason|0|||
131683648|NCT00467779|474129101|FG001|Stage 1A|Unspecified Reason|0|||
131683649|NCT00467779|474129102|FG002|Stage 1A|Unspecified Reason|0|||
131683650|NCT00467779|474129103|FG003|Stage 1A|Unspecified Reason|0|||
131683651|NCT00467779|474129104|FG004|Stage 1A|Unspecified Reason|0|||
131683652|NCT00467779|474129105|FG005|Stage 1A|Unspecified Reason|0|||
131683653|NCT00467779|474129106|FG006|Stage 1A|Unspecified Reason|0|||
131683654|NCT00467779|474129107|FG007|Stage 1A|Unspecified Reason|0|||
131683655|NCT00467779|474129108|FG008|Stage 1A|Unspecified Reason|0|||
131683656|NCT00467779|474129109|FG009|Stage 1A|Unspecified Reason|0|||
131683657|NCT00467779|474129110|FG010|Stage 1A|Unspecified Reason|0|||
131683658|NCT00467779|474129111|FG011|Stage 1A|Unspecified Reason|1|||
131683659|NCT00467779|474129112|FG012|Stage 1A|Unspecified Reason|1|||
131683660|NCT00467779|474129113|FG013|Stage 1A|Unspecified Reason|0|||
131683661|NCT00467779|474129114|FG014|Stage 1A|Unspecified Reason|0|||
131683662|NCT00467779|474129100|FG000|Stage 2|Adverse Event|0|||
131683663|NCT00467779|474129101|FG001|Stage 2|Adverse Event|0|||
131683664|NCT00467779|474129102|FG002|Stage 2|Adverse Event|0|||
131683665|NCT00467779|474129103|FG003|Stage 2|Adverse Event|0|||
131683666|NCT00467779|474129104|FG004|Stage 2|Adverse Event|0|||
131683667|NCT00467779|474129105|FG005|Stage 2|Adverse Event|0|||
131683668|NCT00467779|474129106|FG006|Stage 2|Adverse Event|0|||
131683669|NCT00467779|474129107|FG007|Stage 2|Adverse Event|0|||
131683670|NCT00467779|474129108|FG008|Stage 2|Adverse Event|1|||
131683671|NCT00467779|474129109|FG009|Stage 2|Adverse Event|0|||
131683672|NCT00467779|474129110|FG010|Stage 2|Adverse Event|0|||
131683673|NCT00467779|474129111|FG011|Stage 2|Adverse Event|0|||
131683674|NCT00467779|474129112|FG012|Stage 2|Adverse Event|0|||
131683675|NCT00467779|474129113|FG013|Stage 2|Adverse Event|0|||
131683676|NCT00467779|474129114|FG014|Stage 2|Adverse Event|0|||
131683677|NCT00467779|474129100|FG000|Stage 2|Death|0|||
131683678|NCT00467779|474129101|FG001|Stage 2|Death|0|||
131683679|NCT00467779|474129102|FG002|Stage 2|Death|0|||
131683680|NCT00467779|474129103|FG003|Stage 2|Death|0|||
131683681|NCT00467779|474129104|FG004|Stage 2|Death|0|||
131683682|NCT00467779|474129105|FG005|Stage 2|Death|0|||
131683683|NCT00467779|474129106|FG006|Stage 2|Death|0|||
131683684|NCT00467779|474129107|FG007|Stage 2|Death|0|||
131683685|NCT00467779|474129108|FG008|Stage 2|Death|1|||
131683686|NCT00467779|474129109|FG009|Stage 2|Death|0|||
131683687|NCT00467779|474129110|FG010|Stage 2|Death|0|||
131683688|NCT00467779|474129111|FG011|Stage 2|Death|0|||
131683689|NCT00467779|474129112|FG012|Stage 2|Death|0|||
131683690|NCT00467779|474129113|FG013|Stage 2|Death|0|||
131683691|NCT00467779|474129114|FG014|Stage 2|Death|0|||
131683692|NCT00467779|474129100|FG000|Stage 2|Disease Progression|0|||
131683693|NCT00467779|474129101|FG001|Stage 2|Disease Progression|0|||
131683694|NCT00467779|474129102|FG002|Stage 2|Disease Progression|0|||
131683695|NCT00467779|474129103|FG003|Stage 2|Disease Progression|0|||
131683696|NCT00467779|474129104|FG004|Stage 2|Disease Progression|0|||
131683697|NCT00467779|474129105|FG005|Stage 2|Disease Progression|0|||
131683698|NCT00467779|474129106|FG006|Stage 2|Disease Progression|0|||
131683699|NCT00467779|474129107|FG007|Stage 2|Disease Progression|0|||
131683700|NCT00467779|474129108|FG008|Stage 2|Disease Progression|16|||
131683701|NCT00467779|474129109|FG009|Stage 2|Disease Progression|0|||
131683702|NCT00467779|474129110|FG010|Stage 2|Disease Progression|0|||
131683703|NCT00467779|474129111|FG011|Stage 2|Disease Progression|0|||
131683704|NCT00467779|474129112|FG012|Stage 2|Disease Progression|0|||
131683705|NCT00467779|474129113|FG013|Stage 2|Disease Progression|0|||
131683706|NCT00467779|474129114|FG014|Stage 2|Disease Progression|0|||
131683707|NCT00467779|474129100|FG000|Stage 2|Unspecified Reason|0|||
131683708|NCT00467779|474129101|FG001|Stage 2|Unspecified Reason|0|||
131683709|NCT00467779|474129102|FG002|Stage 2|Unspecified Reason|0|||
131683710|NCT00467779|474129103|FG003|Stage 2|Unspecified Reason|0|||
131683711|NCT00467779|474129104|FG004|Stage 2|Unspecified Reason|0|||
131683712|NCT00467779|474129105|FG005|Stage 2|Unspecified Reason|0|||
131683713|NCT00467779|474129106|FG006|Stage 2|Unspecified Reason|0|||
131683714|NCT00467779|474129107|FG007|Stage 2|Unspecified Reason|0|||
131683715|NCT00467779|474129108|FG008|Stage 2|Unspecified Reason|3|||
131683716|NCT00467779|474129109|FG009|Stage 2|Unspecified Reason|0|||
131683717|NCT00467779|474129110|FG010|Stage 2|Unspecified Reason|0|||
131683718|NCT00467779|474129111|FG011|Stage 2|Unspecified Reason|0|||
131683719|NCT00467779|474129112|FG012|Stage 2|Unspecified Reason|0|||
131683720|NCT00467779|474129113|FG013|Stage 2|Unspecified Reason|0|||
131683721|NCT00467779|474129114|FG014|Stage 2|Unspecified Reason|0|||
131683722|NCT00467779|474129100|FG000|Stage 2A|Adverse Event|0|||
131683723|NCT00467779|474129101|FG001|Stage 2A|Adverse Event|0|||
131683724|NCT00467779|474129102|FG002|Stage 2A|Adverse Event|0|||
131683725|NCT00467779|474129103|FG003|Stage 2A|Adverse Event|0|||
131683726|NCT00467779|474129104|FG004|Stage 2A|Adverse Event|0|||
131683727|NCT00467779|474129105|FG005|Stage 2A|Adverse Event|0|||
131683728|NCT00467779|474129106|FG006|Stage 2A|Adverse Event|0|||
131683729|NCT00467779|474129107|FG007|Stage 2A|Adverse Event|0|||
131683730|NCT00467779|474129108|FG008|Stage 2A|Adverse Event|0|||
131683731|NCT00467779|474129109|FG009|Stage 2A|Adverse Event|0|||
131683732|NCT00467779|474129110|FG010|Stage 2A|Adverse Event|0|||
131683733|NCT00467779|474129111|FG011|Stage 2A|Adverse Event|0|||
131683734|NCT00467779|474129112|FG012|Stage 2A|Adverse Event|0|||
131683735|NCT00467779|474129113|FG013|Stage 2A|Adverse Event|2|||
131683736|NCT00467779|474129114|FG014|Stage 2A|Adverse Event|0|||
131683737|NCT00467779|474129100|FG000|Stage 2A|Death|0|||
131683738|NCT00467779|474129101|FG001|Stage 2A|Death|0|||
131683739|NCT00467779|474129102|FG002|Stage 2A|Death|0|||
131683740|NCT00467779|474129103|FG003|Stage 2A|Death|0|||
131683741|NCT00467779|474129104|FG004|Stage 2A|Death|0|||
131683742|NCT00467779|474129105|FG005|Stage 2A|Death|0|||
131683743|NCT00467779|474129106|FG006|Stage 2A|Death|0|||
131683744|NCT00467779|474129107|FG007|Stage 2A|Death|0|||
131683745|NCT00467779|474129108|FG008|Stage 2A|Death|0|||
131683746|NCT00467779|474129109|FG009|Stage 2A|Death|0|||
131683747|NCT00467779|474129110|FG010|Stage 2A|Death|0|||
131683748|NCT00467779|474129111|FG011|Stage 2A|Death|0|||
131683749|NCT00467779|474129112|FG012|Stage 2A|Death|0|||
131683750|NCT00467779|474129113|FG013|Stage 2A|Death|1|||
131683751|NCT00467779|474129114|FG014|Stage 2A|Death|0|||
131683752|NCT00467779|474129100|FG000|Stage 2A|Disease Progression|0|||
131683753|NCT00467779|474129101|FG001|Stage 2A|Disease Progression|0|||
131683754|NCT00467779|474129102|FG002|Stage 2A|Disease Progression|0|||
131683755|NCT00467779|474129103|FG003|Stage 2A|Disease Progression|0|||
131683756|NCT00467779|474129104|FG004|Stage 2A|Disease Progression|0|||
131683757|NCT00467779|474129105|FG005|Stage 2A|Disease Progression|0|||
131683758|NCT00467779|474129106|FG006|Stage 2A|Disease Progression|0|||
131683759|NCT00467779|474129107|FG007|Stage 2A|Disease Progression|0|||
131683760|NCT00467779|474129108|FG008|Stage 2A|Disease Progression|0|||
131683761|NCT00467779|474129109|FG009|Stage 2A|Disease Progression|0|||
131683762|NCT00467779|474129110|FG010|Stage 2A|Disease Progression|0|||
131683763|NCT00467779|474129111|FG011|Stage 2A|Disease Progression|0|||
131683764|NCT00467779|474129112|FG012|Stage 2A|Disease Progression|0|||
131683765|NCT00467779|474129113|FG013|Stage 2A|Disease Progression|10|||
131683766|NCT00467779|474129114|FG014|Stage 2A|Disease Progression|0|||
131683767|NCT00467779|474129100|FG000|Stage 2A|Unspecified Reason|0|||
131683768|NCT00467779|474129101|FG001|Stage 2A|Unspecified Reason|0|||
131683769|NCT00467779|474129102|FG002|Stage 2A|Unspecified Reason|0|||
131683770|NCT00467779|474129103|FG003|Stage 2A|Unspecified Reason|0|||
131683771|NCT00467779|474129104|FG004|Stage 2A|Unspecified Reason|0|||
131683772|NCT00467779|474129105|FG005|Stage 2A|Unspecified Reason|0|||
131683773|NCT00467779|474129106|FG006|Stage 2A|Unspecified Reason|0|||
131683774|NCT00467779|474129107|FG007|Stage 2A|Unspecified Reason|0|||
131683775|NCT00467779|474129108|FG008|Stage 2A|Unspecified Reason|0|||
131555974|NCT01121484|473660293|FG001|Overall Study|Adverse Event|5|||
131683776|NCT00467779|474129109|FG009|Stage 2A|Unspecified Reason|0|||
131683777|NCT00467779|474129110|FG010|Stage 2A|Unspecified Reason|0|||
131683778|NCT00467779|474129111|FG011|Stage 2A|Unspecified Reason|0|||
131683779|NCT00467779|474129112|FG012|Stage 2A|Unspecified Reason|0|||
131683780|NCT00467779|474129113|FG013|Stage 2A|Unspecified Reason|7|||
131683781|NCT00467779|474129114|FG014|Stage 2A|Unspecified Reason|0|||
131555975|NCT01121484|473660292|FG000|Overall Study|Lack of Efficacy|3|||
131683782|NCT00467779|474129100|FG000|Stage 2A|Withdrawal by Subject|0|||
131683783|NCT00467779|474129101|FG001|Stage 2A|Withdrawal by Subject|0|||
131683784|NCT00467779|474129102|FG002|Stage 2A|Withdrawal by Subject|0|||
131683785|NCT00467779|474129103|FG003|Stage 2A|Withdrawal by Subject|0|||
131683786|NCT00467779|474129104|FG004|Stage 2A|Withdrawal by Subject|0|||
131683787|NCT00467779|474129105|FG005|Stage 2A|Withdrawal by Subject|0|||
131683788|NCT00467779|474129106|FG006|Stage 2A|Withdrawal by Subject|0|||
131683789|NCT00467779|474129107|FG007|Stage 2A|Withdrawal by Subject|0|||
131683790|NCT00467779|474129108|FG008|Stage 2A|Withdrawal by Subject|0|||
131683791|NCT00467779|474129109|FG009|Stage 2A|Withdrawal by Subject|0|||
131683792|NCT00467779|474129110|FG010|Stage 2A|Withdrawal by Subject|0|||
131683793|NCT00467779|474129111|FG011|Stage 2A|Withdrawal by Subject|0|||
131683794|NCT00467779|474129112|FG012|Stage 2A|Withdrawal by Subject|0|||
131683795|NCT00467779|474129113|FG013|Stage 2A|Withdrawal by Subject|1|||
131683796|NCT00467779|474129114|FG014|Stage 2A|Withdrawal by Subject|0|||
131683797|NCT00467779|474129100|FG000|Stage 3|Adverse Event|0|||
131683798|NCT00467779|474129101|FG001|Stage 3|Adverse Event|0|||
131555976|NCT01121484|473660293|FG001|Overall Study|Lack of Efficacy|11|||
131683799|NCT00467779|474129102|FG002|Stage 3|Adverse Event|0|||
131683800|NCT00467779|474129103|FG003|Stage 3|Adverse Event|0|||
131683801|NCT00467779|474129104|FG004|Stage 3|Adverse Event|0|||
131683802|NCT00467779|474129105|FG005|Stage 3|Adverse Event|0|||
131683803|NCT00467779|474129106|FG006|Stage 3|Adverse Event|0|||
131683804|NCT00467779|474129107|FG007|Stage 3|Adverse Event|0|||
131683805|NCT00467779|474129108|FG008|Stage 3|Adverse Event|0|||
131683806|NCT00467779|474129109|FG009|Stage 3|Adverse Event|0|||
131683807|NCT00467779|474129110|FG010|Stage 3|Adverse Event|0|||
131683808|NCT00467779|474129111|FG011|Stage 3|Adverse Event|0|||
131683809|NCT00467779|474129112|FG012|Stage 3|Adverse Event|0|||
131683810|NCT00467779|474129113|FG013|Stage 3|Adverse Event|0|||
131683811|NCT00467779|474129114|FG014|Stage 3|Adverse Event|2|||
131683812|NCT00467779|474129100|FG000|Stage 3|Death|0|||
131683813|NCT00467779|474129101|FG001|Stage 3|Death|0|||
131683814|NCT00467779|474129102|FG002|Stage 3|Death|0|||
131683815|NCT00467779|474129103|FG003|Stage 3|Death|0|||
131683816|NCT00467779|474129104|FG004|Stage 3|Death|0|||
131683817|NCT00467779|474129105|FG005|Stage 3|Death|0|||
131683818|NCT00467779|474129106|FG006|Stage 3|Death|0|||
131683819|NCT00467779|474129107|FG007|Stage 3|Death|0|||
131683820|NCT00467779|474129108|FG008|Stage 3|Death|0|||
131683821|NCT00467779|474129109|FG009|Stage 3|Death|0|||
131683822|NCT00467779|474129110|FG010|Stage 3|Death|0|||
131683823|NCT00467779|474129111|FG011|Stage 3|Death|0|||
131683824|NCT00467779|474129112|FG012|Stage 3|Death|0|||
131683825|NCT00467779|474129113|FG013|Stage 3|Death|0|||
131898506|NCT00320788|474914098|FG002|Overall Study|Death|1|||
131683826|NCT00467779|474129114|FG014|Stage 3|Death|1|||
131683827|NCT00467779|474129100|FG000|Stage 3|Disease Progression|0|||
131683828|NCT00467779|474129101|FG001|Stage 3|Disease Progression|0|||
131683829|NCT00467779|474129102|FG002|Stage 3|Disease Progression|0|||
131683830|NCT00467779|474129103|FG003|Stage 3|Disease Progression|0|||
131683831|NCT00467779|474129104|FG004|Stage 3|Disease Progression|0|||
131555977|NCT01121484|473660292|FG000|Overall Study|Lost to Follow-up|5|||
131683832|NCT00467779|474129105|FG005|Stage 3|Disease Progression|0|||
131898507|NCT00320788|474914099|FG003|Overall Study|Death|0|||
131683833|NCT00467779|474129106|FG006|Stage 3|Disease Progression|0|||
131555978|NCT01121484|473660293|FG001|Overall Study|Lost to Follow-up|9|||
131683834|NCT00467779|474129107|FG007|Stage 3|Disease Progression|0|||
131683835|NCT00467779|474129108|FG008|Stage 3|Disease Progression|0|||
131683836|NCT00467779|474129109|FG009|Stage 3|Disease Progression|0|||
131683837|NCT00467779|474129110|FG010|Stage 3|Disease Progression|0|||
131683838|NCT00467779|474129111|FG011|Stage 3|Disease Progression|0|||
131683839|NCT00467779|474129112|FG012|Stage 3|Disease Progression|0|||
131683840|NCT00467779|474129113|FG013|Stage 3|Disease Progression|0|||
131683841|NCT00467779|474129114|FG014|Stage 3|Disease Progression|9|||
131683842|NCT00467779|474129100|FG000|Stage 3|Unspecified Reason|0|||
131683843|NCT00467779|474129101|FG001|Stage 3|Unspecified Reason|0|||
131683844|NCT00467779|474129102|FG002|Stage 3|Unspecified Reason|0|||
131683845|NCT00467779|474129103|FG003|Stage 3|Unspecified Reason|0|||
131683846|NCT00467779|474129104|FG004|Stage 3|Unspecified Reason|0|||
131683847|NCT00467779|474129105|FG005|Stage 3|Unspecified Reason|0|||
131683848|NCT00467779|474129106|FG006|Stage 3|Unspecified Reason|0|||
131683849|NCT00467779|474129107|FG007|Stage 3|Unspecified Reason|0|||
131683850|NCT00467779|474129108|FG008|Stage 3|Unspecified Reason|0|||
131683851|NCT00467779|474129109|FG009|Stage 3|Unspecified Reason|0|||
131683852|NCT00467779|474129110|FG010|Stage 3|Unspecified Reason|0|||
131683853|NCT00467779|474129111|FG011|Stage 3|Unspecified Reason|0|||
131683854|NCT00467779|474129112|FG012|Stage 3|Unspecified Reason|0|||
131683855|NCT00467779|474129113|FG013|Stage 3|Unspecified Reason|0|||
131683856|NCT00467779|474129114|FG014|Stage 3|Unspecified Reason|5|||
131683857|NCT01195090|474129115|FG000|Overall Study|Adverse Event|1|||
131683858|NCT01195090|474129116|FG001|Overall Study|Adverse Event|2|||
131683859|NCT01195090|474129115|FG000|Overall Study|Lost to Follow-up|2|||
131683860|NCT01195090|474129116|FG001|Overall Study|Lost to Follow-up|2|||
131683861|NCT01195090|474129115|FG000|Overall Study|Protocol Violation|3|||
131683862|NCT01195090|474129116|FG001|Overall Study|Protocol Violation|4|||
131683863|NCT05111041|474129119|FG000|Overall Study|Lost to Follow-up|6|||
131683864|NCT05111041|474129120|FG001|Overall Study|Lost to Follow-up|7|||
131683865|NCT05111041|474129119|FG000|Overall Study|Withdrawal by Subject|1|||
131683866|NCT05111041|474129120|FG001|Overall Study|Withdrawal by Subject|0|||
131683867|NCT01205230|474129121|FG000|Overall Study|Adverse Event|4|||
131683868|NCT01205230|474129122|FG001|Overall Study|Adverse Event|0|||
131683869|NCT01205230|474129121|FG000|Overall Study|Physician Decision|1|||
131683870|NCT01205230|474129122|FG001|Overall Study|Physician Decision|0|||
131683871|NCT00041080|474129123|FG000|Overall Study|Adverse Event|21|||
131683872|NCT00041080|474129124|FG001|Overall Study|Adverse Event|1|||
131683873|NCT00041080|474129123|FG000|Overall Study|Withdrawal by Subject|6|||
131683874|NCT00041080|474129124|FG001|Overall Study|Withdrawal by Subject|6|||
131683875|NCT00041080|474129123|FG000|Overall Study|Concommitant Illness/Other|1|||
131683876|NCT00041080|474129124|FG001|Overall Study|Concommitant Illness/Other|2|||
131683877|NCT00041080|474129123|FG000|Overall Study|Did not start therapy|1|||
131683878|NCT00041080|474129124|FG001|Overall Study|Did not start therapy|1|||
131683879|NCT00041080|474129123|FG000|Overall Study|Ineligible|1|||
131683880|NCT00041080|474129124|FG001|Overall Study|Ineligible|0|||
131683881|NCT00922480|474129125|FG000|Main Study|Protocol Violation|3|||
131683882|NCT00922480|474129126|FG001|Main Study|Protocol Violation|6|||
131683883|NCT00922480|474129125|FG000|Main Study|Adverse Event|6|||
131683884|NCT00922480|474129126|FG001|Main Study|Adverse Event|7|||
131683885|NCT00922480|474129125|FG000|Main Study|Lack of Efficacy|3|||
131683886|NCT00922480|474129126|FG001|Main Study|Lack of Efficacy|0|||
131683887|NCT00922480|474129125|FG000|Main Study|Withdrawal by Subject|20|||
131683888|NCT00922480|474129126|FG001|Main Study|Withdrawal by Subject|15|||
131683889|NCT00922480|474129125|FG000|Main Study|Lost to Follow-up|5|||
131683890|NCT00922480|474129126|FG001|Main Study|Lost to Follow-up|0|||
131683891|NCT00922480|474129125|FG000|Main Study|Physician Decision|0|||
131683892|NCT00922480|474129126|FG001|Main Study|Physician Decision|1|||
131683893|NCT00922480|474129125|FG000|Extension Study|Protocol Violation|3|||
131683894|NCT00922480|474129126|FG001|Extension Study|Protocol Violation|0|||
131683895|NCT00922480|474129125|FG000|Extension Study|Adverse Event|1|||
131683896|NCT00922480|474129126|FG001|Extension Study|Adverse Event|1|||
131683897|NCT00922480|474129125|FG000|Extension Study|Withdrawal by Subject|1|||
131683898|NCT00922480|474129126|FG001|Extension Study|Withdrawal by Subject|1|||
131683899|NCT00922480|474129125|FG000|Extension Study|Others|0|||
131683900|NCT00922480|474129126|FG001|Extension Study|Others|1|||
131683901|NCT04784897|474129127|FG000|Overall Study|Death|4|||
131683902|NCT04784897|474129128|FG001|Overall Study|Death|2|||
131683903|NCT04784897|474129129|FG002|Overall Study|Death|1|||
131683904|NCT04784897|474129127|FG000|Overall Study|Withdrawal by Subject|0|||
131683905|NCT04784897|474129128|FG001|Overall Study|Withdrawal by Subject|0|||
131683906|NCT04784897|474129129|FG002|Overall Study|Withdrawal by Subject|1|||
131683907|NCT01994382|474129130|FG000|Overall Study|Informed consent withdrawn|0|||
131683908|NCT01994382|474129131|FG001|Overall Study|Informed consent withdrawn|0|||
131683909|NCT01994382|474129132|FG002|Overall Study|Informed consent withdrawn|0|||
131683910|NCT01994382|474129133|FG003|Overall Study|Informed consent withdrawn|0|||
131683911|NCT01994382|474129134|FG004|Overall Study|Informed consent withdrawn|0|||
131683912|NCT01994382|474129135|FG005|Overall Study|Informed consent withdrawn|0|||
131683913|NCT01994382|474129136|FG006|Overall Study|Informed consent withdrawn|1|||
131683914|NCT01994382|474129137|FG007|Overall Study|Informed consent withdrawn|0|||
131683915|NCT01994382|474129138|FG008|Overall Study|Informed consent withdrawn|0|||
131683916|NCT01994382|474129139|FG009|Overall Study|Informed consent withdrawn|0|||
131683917|NCT01994382|474129140|FG010|Overall Study|Informed consent withdrawn|0|||
131683918|NCT01994382|474129141|FG011|Overall Study|Informed consent withdrawn|0|||
131683919|NCT01994382|474129142|FG012|Overall Study|Informed consent withdrawn|0|||
131683920|NCT01994382|474129143|FG013|Overall Study|Informed consent withdrawn|0|||
131683921|NCT01994382|474129144|FG014|Overall Study|Informed consent withdrawn|0|||
131683922|NCT01994382|474129145|FG015|Overall Study|Informed consent withdrawn|0|||
131683923|NCT01994382|474129146|FG016|Overall Study|Informed consent withdrawn|0|||
131683924|NCT01994382|474129130|FG000|Overall Study|Progressive disease|3|||
131683925|NCT01994382|474129131|FG001|Overall Study|Progressive disease|4|||
131683926|NCT01994382|474129132|FG002|Overall Study|Progressive disease|4|||
131683927|NCT01994382|474129133|FG003|Overall Study|Progressive disease|3|||
131683928|NCT01994382|474129134|FG004|Overall Study|Progressive disease|2|||
131683929|NCT01994382|474129135|FG005|Overall Study|Progressive disease|3|||
131683930|NCT01994382|474129136|FG006|Overall Study|Progressive disease|3|||
131683931|NCT01994382|474129137|FG007|Overall Study|Progressive disease|6|||
131683932|NCT01994382|474129138|FG008|Overall Study|Progressive disease|2|||
131683933|NCT01994382|474129139|FG009|Overall Study|Progressive disease|2|||
131683934|NCT01994382|474129140|FG010|Overall Study|Progressive disease|13|||
131683935|NCT01994382|474129141|FG011|Overall Study|Progressive disease|8|||
131683936|NCT01994382|474129142|FG012|Overall Study|Progressive disease|7|||
131683937|NCT01994382|474129143|FG013|Overall Study|Progressive disease|3|||
131683938|NCT01994382|474129144|FG014|Overall Study|Progressive disease|6|||
131683939|NCT01994382|474129145|FG015|Overall Study|Progressive disease|44|||
131683940|NCT01994382|474129146|FG016|Overall Study|Progressive disease|28|||
131683941|NCT01994382|474129130|FG000|Overall Study|Physician Decision|0|||
131683942|NCT01994382|474129131|FG001|Overall Study|Physician Decision|1|||
131683943|NCT01994382|474129132|FG002|Overall Study|Physician Decision|0|||
131683944|NCT01994382|474129133|FG003|Overall Study|Physician Decision|0|||
131683945|NCT01994382|474129134|FG004|Overall Study|Physician Decision|0|||
131683946|NCT01994382|474129135|FG005|Overall Study|Physician Decision|0|||
131683947|NCT01994382|474129136|FG006|Overall Study|Physician Decision|0|||
131683948|NCT01994382|474129137|FG007|Overall Study|Physician Decision|0|||
131683949|NCT01994382|474129138|FG008|Overall Study|Physician Decision|0|||
131683950|NCT01994382|474129139|FG009|Overall Study|Physician Decision|0|||
131683951|NCT01994382|474129140|FG010|Overall Study|Physician Decision|3|||
131683952|NCT01994382|474129141|FG011|Overall Study|Physician Decision|1|||
131683953|NCT01994382|474129142|FG012|Overall Study|Physician Decision|1|||
131683954|NCT01994382|474129143|FG013|Overall Study|Physician Decision|0|||
131683955|NCT01994382|474129144|FG014|Overall Study|Physician Decision|1|||
131683956|NCT01994382|474129145|FG015|Overall Study|Physician Decision|4|||
131683957|NCT01994382|474129146|FG016|Overall Study|Physician Decision|2|||
131683958|NCT01994382|474129130|FG000|Overall Study|Death|0|||
131683959|NCT01994382|474129131|FG001|Overall Study|Death|0|||
131683960|NCT01994382|474129132|FG002|Overall Study|Death|0|||
131683961|NCT01994382|474129133|FG003|Overall Study|Death|0|||
131683962|NCT01994382|474129134|FG004|Overall Study|Death|1|||
131683963|NCT01994382|474129135|FG005|Overall Study|Death|0|||
131683964|NCT01994382|474129136|FG006|Overall Study|Death|0|||
131683965|NCT01994382|474129137|FG007|Overall Study|Death|0|||
131683966|NCT01994382|474129138|FG008|Overall Study|Death|1|||
131683967|NCT01994382|474129139|FG009|Overall Study|Death|1|||
131683968|NCT01994382|474129140|FG010|Overall Study|Death|0|||
131683969|NCT01994382|474129141|FG011|Overall Study|Death|0|||
131683970|NCT01994382|474129142|FG012|Overall Study|Death|0|||
131683971|NCT01994382|474129143|FG013|Overall Study|Death|0|||
131683972|NCT01994382|474129144|FG014|Overall Study|Death|0|||
131683973|NCT01994382|474129145|FG015|Overall Study|Death|1|||
131683974|NCT01994382|474129146|FG016|Overall Study|Death|0|||
131683975|NCT01994382|474129130|FG000|Overall Study|Adverse Event|0|||
131683976|NCT01994382|474129131|FG001|Overall Study|Adverse Event|1|||
131683977|NCT01994382|474129132|FG002|Overall Study|Adverse Event|2|||
131683978|NCT01994382|474129133|FG003|Overall Study|Adverse Event|0|||
131683979|NCT01994382|474129134|FG004|Overall Study|Adverse Event|0|||
131683980|NCT01994382|474129135|FG005|Overall Study|Adverse Event|0|||
131683981|NCT01994382|474129136|FG006|Overall Study|Adverse Event|0|||
131683982|NCT01994382|474129137|FG007|Overall Study|Adverse Event|0|||
131683983|NCT01994382|474129138|FG008|Overall Study|Adverse Event|0|||
131683984|NCT01994382|474129139|FG009|Overall Study|Adverse Event|0|||
131683985|NCT01994382|474129140|FG010|Overall Study|Adverse Event|15|||
131683986|NCT01994382|474129141|FG011|Overall Study|Adverse Event|2|||
131683987|NCT01994382|474129142|FG012|Overall Study|Adverse Event|7|||
131683988|NCT01994382|474129143|FG013|Overall Study|Adverse Event|3|||
131683989|NCT01994382|474129144|FG014|Overall Study|Adverse Event|17|||
131683990|NCT01994382|474129145|FG015|Overall Study|Adverse Event|6|||
131683991|NCT01994382|474129146|FG016|Overall Study|Adverse Event|3|||
131683992|NCT01994382|474129130|FG000|Overall Study|Other than specified|0|||
131683993|NCT01994382|474129131|FG001|Overall Study|Other than specified|0|||
131683994|NCT01994382|474129132|FG002|Overall Study|Other than specified|0|||
131683995|NCT01994382|474129133|FG003|Overall Study|Other than specified|0|||
131683996|NCT01994382|474129134|FG004|Overall Study|Other than specified|0|||
131683997|NCT01994382|474129135|FG005|Overall Study|Other than specified|0|||
131683998|NCT01994382|474129136|FG006|Overall Study|Other than specified|0|||
131683999|NCT01994382|474129137|FG007|Overall Study|Other than specified|0|||
131684000|NCT01994382|474129138|FG008|Overall Study|Other than specified|0|||
131684001|NCT01994382|474129139|FG009|Overall Study|Other than specified|0|||
131684002|NCT01994382|474129140|FG010|Overall Study|Other than specified|2|||
131684003|NCT01994382|474129141|FG011|Overall Study|Other than specified|0|||
131684004|NCT01994382|474129142|FG012|Overall Study|Other than specified|2|||
131684005|NCT01994382|474129143|FG013|Overall Study|Other than specified|0|||
131684006|NCT01994382|474129144|FG014|Overall Study|Other than specified|0|||
131684007|NCT01994382|474129145|FG015|Overall Study|Other than specified|4|||
131684008|NCT01994382|474129146|FG016|Overall Study|Other than specified|4|||
131684009|NCT01994382|474129130|FG000|Overall Study|Withdrawal by Subject|0|||
131684010|NCT01994382|474129131|FG001|Overall Study|Withdrawal by Subject|0|||
131684011|NCT01994382|474129132|FG002|Overall Study|Withdrawal by Subject|0|||
131684012|NCT01994382|474129133|FG003|Overall Study|Withdrawal by Subject|0|||
131684013|NCT01994382|474129134|FG004|Overall Study|Withdrawal by Subject|0|||
131684014|NCT01994382|474129135|FG005|Overall Study|Withdrawal by Subject|0|||
131684015|NCT01994382|474129136|FG006|Overall Study|Withdrawal by Subject|0|||
131684016|NCT01994382|474129137|FG007|Overall Study|Withdrawal by Subject|0|||
131684017|NCT01994382|474129138|FG008|Overall Study|Withdrawal by Subject|0|||
131684018|NCT01994382|474129139|FG009|Overall Study|Withdrawal by Subject|0|||
131684019|NCT01994382|474129140|FG010|Overall Study|Withdrawal by Subject|6|||
131684020|NCT01994382|474129141|FG011|Overall Study|Withdrawal by Subject|0|||
131684021|NCT01994382|474129142|FG012|Overall Study|Withdrawal by Subject|2|||
131684022|NCT01994382|474129143|FG013|Overall Study|Withdrawal by Subject|0|||
131684023|NCT01994382|474129144|FG014|Overall Study|Withdrawal by Subject|4|||
131684024|NCT01994382|474129145|FG015|Overall Study|Withdrawal by Subject|3|||
131684025|NCT01994382|474129146|FG016|Overall Study|Withdrawal by Subject|0|||
131684026|NCT01994382|474129130|FG000|Overall Study|Lost to Follow-up|0|||
131684027|NCT01994382|474129131|FG001|Overall Study|Lost to Follow-up|0|||
131684028|NCT01994382|474129132|FG002|Overall Study|Lost to Follow-up|0|||
131684029|NCT01994382|474129133|FG003|Overall Study|Lost to Follow-up|0|||
131684030|NCT01994382|474129134|FG004|Overall Study|Lost to Follow-up|0|||
131684031|NCT01994382|474129135|FG005|Overall Study|Lost to Follow-up|0|||
131684032|NCT01994382|474129136|FG006|Overall Study|Lost to Follow-up|0|||
131684033|NCT01994382|474129137|FG007|Overall Study|Lost to Follow-up|0|||
131684034|NCT01994382|474129138|FG008|Overall Study|Lost to Follow-up|0|||
131684035|NCT01994382|474129139|FG009|Overall Study|Lost to Follow-up|0|||
131684036|NCT01994382|474129140|FG010|Overall Study|Lost to Follow-up|1|||
131684037|NCT01994382|474129141|FG011|Overall Study|Lost to Follow-up|0|||
131684038|NCT01994382|474129142|FG012|Overall Study|Lost to Follow-up|0|||
131684039|NCT01994382|474129143|FG013|Overall Study|Lost to Follow-up|0|||
131684040|NCT01994382|474129144|FG014|Overall Study|Lost to Follow-up|0|||
131684041|NCT01994382|474129145|FG015|Overall Study|Lost to Follow-up|0|||
131684042|NCT01994382|474129146|FG016|Overall Study|Lost to Follow-up|0|||
131684043|NCT01994382|474129130|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684044|NCT01994382|474129131|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684045|NCT01994382|474129132|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684046|NCT01994382|474129133|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684047|NCT01994382|474129134|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684048|NCT01994382|474129135|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684049|NCT01994382|474129136|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684050|NCT01994382|474129137|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684051|NCT01994382|474129138|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684052|NCT01994382|474129139|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684053|NCT01994382|474129140|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
131684054|NCT01994382|474129141|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684055|NCT01994382|474129142|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
131684056|NCT01994382|474129143|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684057|NCT01994382|474129144|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131684058|NCT01994382|474129145|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
131684059|NCT01994382|474129146|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
131684060|NCT01994382|474129130|FG000|Overall Study|Protocol violation/noncompliance|0|||
131684061|NCT01994382|474129131|FG001|Overall Study|Protocol violation/noncompliance|0|||
131684062|NCT01994382|474129132|FG002|Overall Study|Protocol violation/noncompliance|0|||
131684063|NCT01994382|474129133|FG003|Overall Study|Protocol violation/noncompliance|0|||
131684064|NCT01994382|474129134|FG004|Overall Study|Protocol violation/noncompliance|0|||
131684065|NCT01994382|474129135|FG005|Overall Study|Protocol violation/noncompliance|0|||
131684066|NCT01994382|474129136|FG006|Overall Study|Protocol violation/noncompliance|0|||
131684067|NCT01994382|474129137|FG007|Overall Study|Protocol violation/noncompliance|0|||
131684068|NCT01994382|474129138|FG008|Overall Study|Protocol violation/noncompliance|0|||
131684069|NCT01994382|474129139|FG009|Overall Study|Protocol violation/noncompliance|0|||
131684070|NCT01994382|474129140|FG010|Overall Study|Protocol violation/noncompliance|0|||
131684071|NCT01994382|474129141|FG011|Overall Study|Protocol violation/noncompliance|1|||
131684072|NCT01994382|474129142|FG012|Overall Study|Protocol violation/noncompliance|0|||
131684073|NCT01994382|474129143|FG013|Overall Study|Protocol violation/noncompliance|0|||
131684074|NCT01994382|474129144|FG014|Overall Study|Protocol violation/noncompliance|0|||
131684075|NCT01994382|474129145|FG015|Overall Study|Protocol violation/noncompliance|0|||
131684076|NCT01994382|474129146|FG016|Overall Study|Protocol violation/noncompliance|2|||
131684077|NCT01994382|474129130|FG000|Overall Study|Rolled over to Phase 2a|0|||
131684078|NCT01994382|474129131|FG001|Overall Study|Rolled over to Phase 2a|0|||
131684079|NCT01994382|474129132|FG002|Overall Study|Rolled over to Phase 2a|1|||
131684080|NCT01994382|474129133|FG003|Overall Study|Rolled over to Phase 2a|0|||
131684081|NCT01994382|474129134|FG004|Overall Study|Rolled over to Phase 2a|0|||
131684082|NCT01994382|474129135|FG005|Overall Study|Rolled over to Phase 2a|0|||
131684083|NCT01994382|474129136|FG006|Overall Study|Rolled over to Phase 2a|0|||
131684084|NCT01994382|474129137|FG007|Overall Study|Rolled over to Phase 2a|0|||
131684085|NCT01994382|474129138|FG008|Overall Study|Rolled over to Phase 2a|0|||
131684086|NCT01994382|474129139|FG009|Overall Study|Rolled over to Phase 2a|2|||
131684087|NCT01994382|474129140|FG010|Overall Study|Rolled over to Phase 2a|0|||
131684088|NCT01994382|474129141|FG011|Overall Study|Rolled over to Phase 2a|0|||
131684089|NCT01994382|474129142|FG012|Overall Study|Rolled over to Phase 2a|0|||
131684090|NCT01994382|474129143|FG013|Overall Study|Rolled over to Phase 2a|0|||
131684091|NCT01994382|474129144|FG014|Overall Study|Rolled over to Phase 2a|0|||
131684092|NCT01994382|474129145|FG015|Overall Study|Rolled over to Phase 2a|0|||
131684093|NCT01994382|474129146|FG016|Overall Study|Rolled over to Phase 2a|0|||
131684094|NCT04667377|474129147|FG000|Dose Escalation Period|Other not specified below|3|||
131684095|NCT04667377|474129148|FG001|Dose Escalation Period|Other not specified below|3|||
131684096|NCT04667377|474129149|FG002|Dose Escalation Period|Other not specified below|2|||
131684097|NCT04667377|474129150|FG003|Dose Escalation Period|Other not specified below|1|||
131684098|NCT04667377|474129151|FG004|Dose Escalation Period|Other not specified below|3|||
131684099|NCT04667377|474129147|FG000|Dose Escalation Period|Protocol Violation|2|||
131684100|NCT04667377|474129148|FG001|Dose Escalation Period|Protocol Violation|2|||
131684101|NCT04667377|474129149|FG002|Dose Escalation Period|Protocol Violation|0|||
131684102|NCT04667377|474129150|FG003|Dose Escalation Period|Protocol Violation|2|||
131684103|NCT04667377|474129151|FG004|Dose Escalation Period|Protocol Violation|1|||
131684104|NCT04667377|474129147|FG000|Dose Escalation Period|Burden of study procedures|2|||
131684105|NCT04667377|474129148|FG001|Dose Escalation Period|Burden of study procedures|1|||
131684106|NCT04667377|474129149|FG002|Dose Escalation Period|Burden of study procedures|1|||
131684107|NCT04667377|474129150|FG003|Dose Escalation Period|Burden of study procedures|1|||
131684108|NCT04667377|474129151|FG004|Dose Escalation Period|Burden of study procedures|5|||
131684109|NCT04667377|474129147|FG000|Dose Escalation Period|Change of residence|0|||
131684110|NCT04667377|474129148|FG001|Dose Escalation Period|Change of residence|0|||
131684111|NCT04667377|474129149|FG002|Dose Escalation Period|Change of residence|1|||
131684112|NCT04667377|474129150|FG003|Dose Escalation Period|Change of residence|0|||
131684113|NCT04667377|474129151|FG004|Dose Escalation Period|Change of residence|0|||
131684114|NCT04667377|474129147|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
131684115|NCT04667377|474129148|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
131684116|NCT04667377|474129149|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
131684117|NCT04667377|474129150|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
131684118|NCT04667377|474129151|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
131684119|NCT04667377|474129147|FG000|Dose Escalation Period|Adverse Event|9|||
131684120|NCT04667377|474129148|FG001|Dose Escalation Period|Adverse Event|10|||
131684121|NCT04667377|474129149|FG002|Dose Escalation Period|Adverse Event|12|||
131684122|NCT04667377|474129150|FG003|Dose Escalation Period|Adverse Event|17|||
131684123|NCT04667377|474129151|FG004|Dose Escalation Period|Adverse Event|3|||
131684124|NCT04667377|474129147|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
131684125|NCT04667377|474129148|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
131684126|NCT04667377|474129149|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
131684127|NCT04667377|474129150|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
131684128|NCT04667377|474129151|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
131684129|NCT04667377|474129147|FG000|Dose Escalation Period|Not treated|1|||
131684130|NCT04667377|474129148|FG001|Dose Escalation Period|Not treated|0|||
131684131|NCT04667377|474129149|FG002|Dose Escalation Period|Not treated|0|||
131684132|NCT04667377|474129150|FG003|Dose Escalation Period|Not treated|0|||
131684133|NCT04667377|474129151|FG004|Dose Escalation Period|Not treated|0|||
131684134|NCT04667377|474129147|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
131684135|NCT04667377|474129148|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
131684136|NCT04667377|474129149|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
131684137|NCT04667377|474129150|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
131684138|NCT04667377|474129151|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
131684139|NCT04667377|474129147|FG000|Dose Escalation Period|Lost to Follow-up|0|||
131684140|NCT04667377|474129148|FG001|Dose Escalation Period|Lost to Follow-up|1|||
131684141|NCT04667377|474129149|FG002|Dose Escalation Period|Lost to Follow-up|0|||
131684142|NCT04667377|474129150|FG003|Dose Escalation Period|Lost to Follow-up|0|||
131684143|NCT04667377|474129151|FG004|Dose Escalation Period|Lost to Follow-up|0|||
131684144|NCT04667377|474129147|FG000|Maintenance Period|Perceived lack of efficacy|0|||
131684145|NCT04667377|474129148|FG001|Maintenance Period|Perceived lack of efficacy|2|||
131684146|NCT04667377|474129149|FG002|Maintenance Period|Perceived lack of efficacy|1|||
131684147|NCT04667377|474129150|FG003|Maintenance Period|Perceived lack of efficacy|0|||
131684148|NCT04667377|474129151|FG004|Maintenance Period|Perceived lack of efficacy|1|||
131684149|NCT04667377|474129147|FG000|Maintenance Period|Adverse Event|2|||
131684150|NCT04667377|474129148|FG001|Maintenance Period|Adverse Event|8|||
131684151|NCT04667377|474129149|FG002|Maintenance Period|Adverse Event|5|||
131684152|NCT04667377|474129150|FG003|Maintenance Period|Adverse Event|4|||
131684153|NCT04667377|474129151|FG004|Maintenance Period|Adverse Event|1|||
131684154|NCT04667377|474129147|FG000|Maintenance Period|Adverse event: COVID infection|0|||
131684155|NCT04667377|474129148|FG001|Maintenance Period|Adverse event: COVID infection|1|||
131684156|NCT04667377|474129149|FG002|Maintenance Period|Adverse event: COVID infection|0|||
131684157|NCT04667377|474129150|FG003|Maintenance Period|Adverse event: COVID infection|0|||
131684158|NCT04667377|474129151|FG004|Maintenance Period|Adverse event: COVID infection|0|||
131684159|NCT04667377|474129147|FG000|Maintenance Period|COVID-related|0|||
131684160|NCT04667377|474129148|FG001|Maintenance Period|COVID-related|0|||
131684161|NCT04667377|474129149|FG002|Maintenance Period|COVID-related|1|||
131684162|NCT04667377|474129150|FG003|Maintenance Period|COVID-related|1|||
131684163|NCT04667377|474129151|FG004|Maintenance Period|COVID-related|0|||
131684164|NCT04667377|474129147|FG000|Maintenance Period|Protocol Violation|1|||
131684165|NCT04667377|474129148|FG001|Maintenance Period|Protocol Violation|0|||
131684166|NCT04667377|474129149|FG002|Maintenance Period|Protocol Violation|0|||
131684167|NCT04667377|474129150|FG003|Maintenance Period|Protocol Violation|0|||
131684168|NCT04667377|474129151|FG004|Maintenance Period|Protocol Violation|1|||
131684169|NCT04667377|474129147|FG000|Maintenance Period|Burden of study procedures|1|||
131898508|NCT00320788|474914100|FG004|Overall Study|Death|1|||
131684170|NCT04667377|474129148|FG001|Maintenance Period|Burden of study procedures|2|||
131684171|NCT04667377|474129149|FG002|Maintenance Period|Burden of study procedures|0|||
131684172|NCT04667377|474129150|FG003|Maintenance Period|Burden of study procedures|1|||
131684173|NCT04667377|474129151|FG004|Maintenance Period|Burden of study procedures|0|||
131684174|NCT04667377|474129147|FG000|Maintenance Period|Change of residence|0|||
131684175|NCT04667377|474129148|FG001|Maintenance Period|Change of residence|1|||
131684176|NCT04667377|474129149|FG002|Maintenance Period|Change of residence|0|||
131684177|NCT04667377|474129150|FG003|Maintenance Period|Change of residence|0|||
131684178|NCT04667377|474129151|FG004|Maintenance Period|Change of residence|1|||
131684179|NCT04667377|474129147|FG000|Maintenance Period|Missing|1|||
131684180|NCT04667377|474129148|FG001|Maintenance Period|Missing|0|||
131684181|NCT04667377|474129149|FG002|Maintenance Period|Missing|0|||
131684182|NCT04667377|474129150|FG003|Maintenance Period|Missing|0|||
131684183|NCT04667377|474129151|FG004|Maintenance Period|Missing|0|||
131684184|NCT04667377|474129147|FG000|Maintenance Period|Other than listed above|2|||
131684185|NCT04667377|474129148|FG001|Maintenance Period|Other than listed above|0|||
131684186|NCT04667377|474129149|FG002|Maintenance Period|Other than listed above|3|||
131684187|NCT04667377|474129150|FG003|Maintenance Period|Other than listed above|2|||
131684188|NCT04667377|474129151|FG004|Maintenance Period|Other than listed above|6|||
131684189|NCT04667377|474129147|FG000|Maintenance Period|Withdrawal by Subject|0|||
131684190|NCT04667377|474129148|FG001|Maintenance Period|Withdrawal by Subject|1|||
131684191|NCT04667377|474129149|FG002|Maintenance Period|Withdrawal by Subject|0|||
131684192|NCT04667377|474129150|FG003|Maintenance Period|Withdrawal by Subject|0|||
131684193|NCT04667377|474129151|FG004|Maintenance Period|Withdrawal by Subject|0|||
131684194|NCT04667377|474129147|FG000|Maintenance Period|Lost to Follow-up|1|||
131684195|NCT04667377|474129148|FG001|Maintenance Period|Lost to Follow-up|0|||
131684196|NCT04667377|474129149|FG002|Maintenance Period|Lost to Follow-up|1|||
131684197|NCT04667377|474129150|FG003|Maintenance Period|Lost to Follow-up|0|||
131684198|NCT04667377|474129151|FG004|Maintenance Period|Lost to Follow-up|1|||
131684199|NCT01011439|474129152|FG000|Overall Study|Death|37|||
131684200|NCT01011439|474129152|FG000|Overall Study|Lost to Follow-up|4|||
131684201|NCT01011439|474129152|FG000|Overall Study|Withdrawal by Subject|1|||
131684202|NCT01011439|474129152|FG000|Overall Study|Sponsor's decision|15|||
131684203|NCT02428855|474129153|FG000|Overall Study|Withdrawal by Subject|2|||
131684204|NCT02066311|474129154|FG000|Overall Study|Adverse Event|4|||
131684205|NCT02066311|474129154|FG000|Overall Study|Withdrawal by Subject|1|||
131684206|NCT03198520|474129161|FG000|Overall Study|Physician Decision|2|||
131684207|NCT03198520|474129161|FG000|Overall Study|Protocol Violation|2|||
131684208|NCT03198520|474129161|FG000|Overall Study|Withdrawal by Subject|1|||
131684209|NCT03198520|474129161|FG000|Overall Study|Study Ended|1|||
131684210|NCT01670539|474129162|FG000|Overall Study|Death|3|||
131684211|NCT01670539|474129163|FG001|Overall Study|Death|5|||
131684212|NCT01670539|474129162|FG000|Overall Study|Withdrawal by Subject|3|||
131684213|NCT01670539|474129163|FG001|Overall Study|Withdrawal by Subject|0|||
131684214|NCT04353596|474129164|FG000|Overall Study|Protocol Violation|4|||
131684215|NCT04353596|474129165|FG001|Overall Study|Protocol Violation|4|||
131684216|NCT04353596|474129164|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
131684217|NCT04353596|474129165|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
131684218|NCT05418673|474129166|FG000|Overall Study|Study Terminated by Sponsor|2|||
131684219|NCT05418673|474129167|FG001|Overall Study|Study Terminated by Sponsor|4|||
131684220|NCT05418673|474129166|FG000|Overall Study|Lost to Follow-up|1|||
131684221|NCT05418673|474129167|FG001|Overall Study|Lost to Follow-up|0|||
131684222|NCT02665052|474129170|FG000|Overall Study|Lost to Follow-up|1|||
131684223|NCT02665052|474129171|FG001|Overall Study|Lost to Follow-up|0|||
131684224|NCT02665052|474129172|FG002|Overall Study|Lost to Follow-up|0|||
131684225|NCT02665052|474129173|FG003|Overall Study|Lost to Follow-up|0|||
131684226|NCT02665052|474129170|FG000|Overall Study|Withdrawal by Subject|1|||
131684227|NCT02665052|474129171|FG001|Overall Study|Withdrawal by Subject|1|||
131684228|NCT02665052|474129172|FG002|Overall Study|Withdrawal by Subject|0|||
131684229|NCT02665052|474129173|FG003|Overall Study|Withdrawal by Subject|5|||
131684230|NCT02665052|474129170|FG000|Overall Study|Adverse Event|1|||
131684231|NCT02665052|474129171|FG001|Overall Study|Adverse Event|1|||
131684232|NCT02665052|474129172|FG002|Overall Study|Adverse Event|0|||
131684233|NCT02665052|474129173|FG003|Overall Study|Adverse Event|0|||
131684234|NCT00823823|474129174|FG000|Overall Study|Lost to Follow-up|3|||
131684235|NCT00823823|474129175|FG001|Overall Study|Lost to Follow-up|1|||
131684236|NCT00823823|474129174|FG000|Overall Study|Protocol Violation|5|||
131684237|NCT00823823|474129175|FG001|Overall Study|Protocol Violation|5|||
131684238|NCT02161575|474129176|FG000|Overall Study|Protocol Violation|8|||
131684239|NCT02161575|474129176|FG000|Overall Study|Lack of Efficacy|1|||
131684240|NCT02161575|474129176|FG000|Overall Study|Adverse Event|2|||
131684241|NCT02234284|474129177|FG000|Overall Study|Death|4|||
131684242|NCT02234284|474129178|FG001|Overall Study|Death|2|||
131684243|NCT02234284|474129177|FG000|Overall Study|Withdrawal by Subject|1|||
131684244|NCT02234284|474129178|FG001|Overall Study|Withdrawal by Subject|0|||
131684245|NCT02234284|474129177|FG000|Overall Study|Lost to Follow-up|20|||
131684246|NCT02234284|474129178|FG001|Overall Study|Lost to Follow-up|7|||
131684247|NCT01835015|474129179|FG000|Overall Study|Adverse Event|0|||
131684248|NCT01835015|474129180|FG001|Overall Study|Adverse Event|0|||
131684249|NCT01835015|474129181|FG002|Overall Study|Adverse Event|1|||
131684250|NCT01835015|474129182|FG003|Overall Study|Adverse Event|0|||
131684251|NCT01835015|474129183|FG004|Overall Study|Adverse Event|0|||
131684252|NCT00536809|474129186|FG000|Phase II|Adverse Event|1|||
131684253|NCT00536809|474129186|FG000|Phase II|Referred for surgical resection|1|||
131684254|NCT01576172|474129187|FG000|Overall Study|Ineligible|2|||
131684255|NCT01576172|474129188|FG001|Overall Study|Ineligible|1|||
131684256|NCT01576172|474129187|FG000|Overall Study|Withdrawal by Subject|2|||
131684257|NCT01576172|474129188|FG001|Overall Study|Withdrawal by Subject|0|||
131684258|NCT01576172|474129187|FG000|Overall Study|Insurance issue|1|||
131684259|NCT01576172|474129188|FG001|Overall Study|Insurance issue|0|||
131684260|NCT01303965|474129189|FG000|Overall Study|Adverse Event|1|||
131684261|NCT01303965|474129190|FG001|Overall Study|Adverse Event|1|||
131684262|NCT01303965|474129189|FG000|Overall Study|Death|0|||
131684263|NCT01303965|474129190|FG001|Overall Study|Death|3|||
131684264|NCT01303965|474129189|FG000|Overall Study|Withdrawal by Subject|1|||
131684265|NCT01303965|474129190|FG001|Overall Study|Withdrawal by Subject|0|||
131684266|NCT01303965|474129189|FG000|Overall Study|Disease Progression|1|||
131684267|NCT01303965|474129190|FG001|Overall Study|Disease Progression|6|||
131684268|NCT01490814|474129197|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
131684269|NCT01490814|474129198|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
131684270|NCT01490814|474129197|FG000|Overall Study|Physician Decision|1|||
131684271|NCT01490814|474129198|FG001|Overall Study|Physician Decision|0|||
131684272|NCT01490814|474129197|FG000|Overall Study|Withdrawal by Subject|0|||
131684273|NCT01490814|474129198|FG001|Overall Study|Withdrawal by Subject|5|||
131684274|NCT03024970|474129202|FG000|First Intervention|Adverse Event|1|||
131684275|NCT03024970|474129203|FG001|First Intervention|Adverse Event|0|||
131684276|NCT03024970|474129202|FG000|Second Intervention|Lost to Follow-up|1|||
131684277|NCT03024970|474129203|FG001|Second Intervention|Lost to Follow-up|0|||
131684278|NCT01390272|474129207|FG000|Overall Study|Death|3|||
131684279|NCT01390272|474129208|FG001|Overall Study|Death|2|||
131684280|NCT01390272|474129207|FG000|Overall Study|Withdrawal by Subject|9|||
131684281|NCT01390272|474129208|FG001|Overall Study|Withdrawal by Subject|5|||
131684282|NCT01390272|474129207|FG000|Overall Study|Patient moved, no longer eligible|5|||
131684283|NCT01390272|474129208|FG001|Overall Study|Patient moved, no longer eligible|8|||
131684284|NCT02790138|474129211|FG000|Overall Study|Adverse Event|5|||
131684285|NCT02790138|474129212|FG001|Overall Study|Adverse Event|2|||
131684286|NCT02790138|474129211|FG000|Overall Study|Significant Protocol Deviation|0|||
131684287|NCT02790138|474129212|FG001|Overall Study|Significant Protocol Deviation|1|||
131684288|NCT02790138|474129211|FG000|Overall Study|Lost to Follow-up|1|||
131684289|NCT02790138|474129212|FG001|Overall Study|Lost to Follow-up|0|||
131684290|NCT02790138|474129211|FG000|Overall Study|Voluntary Withdrawal|8|||
131684291|NCT02790138|474129212|FG001|Overall Study|Voluntary Withdrawal|9|||
131684292|NCT02790138|474129211|FG000|Overall Study|Lack of Efficacy|6|||
131684293|NCT02790138|474129212|FG001|Overall Study|Lack of Efficacy|7|||
131684294|NCT02790138|474129211|FG000|Overall Study|Reason not Specified|1|||
131684295|NCT02790138|474129212|FG001|Overall Study|Reason not Specified|0|||
131684296|NCT01786603|474129213|FG000|Overall Study|Death|5|||
131684297|NCT01786603|474129214|FG001|Overall Study|Death|1|||
131684298|NCT01786603|474129213|FG000|Overall Study|Adverse Event|6|||
131684299|NCT01786603|474129214|FG001|Overall Study|Adverse Event|2|||
131684300|NCT01786603|474129213|FG000|Overall Study|Physician decision to withdraw|6|||
131684301|NCT01786603|474129214|FG001|Overall Study|Physician decision to withdraw|7|||
131684302|NCT01786603|474129213|FG000|Overall Study|Lost to Follow-up|1|||
131684303|NCT01786603|474129214|FG001|Overall Study|Lost to Follow-up|2|||
131684304|NCT01226459|474129215|FG000|Overall Study|Adverse Event|2|||
131684305|NCT01226459|474129216|FG001|Overall Study|Adverse Event|8|||
131684306|NCT01226459|474129215|FG000|Overall Study|Protocol Violation|4|||
131684307|NCT01226459|474129216|FG001|Overall Study|Protocol Violation|3|||
131684308|NCT01226459|474129215|FG000|Overall Study|Withdrawal by Subject|10|||
131684309|NCT01226459|474129216|FG001|Overall Study|Withdrawal by Subject|13|||
131684310|NCT01226459|474129215|FG000|Overall Study|Lost to Follow-up|4|||
131684311|NCT01226459|474129216|FG001|Overall Study|Lost to Follow-up|8|||
131684312|NCT01226459|474129215|FG000|Overall Study|Pregnancy|1|||
131684313|NCT01226459|474129216|FG001|Overall Study|Pregnancy|0|||
131684314|NCT00474708|474129217|FG000|Overall Study|Lack of Efficacy|11|||
131684315|NCT00474708|474129218|FG001|Overall Study|Lack of Efficacy|5|||
131684316|NCT00474708|474129217|FG000|Overall Study|Suicide ideation/behavior|0|||
131684317|NCT00474708|474129218|FG001|Overall Study|Suicide ideation/behavior|1|||
131684318|NCT00474708|474129217|FG000|Overall Study|Withdrawal by Subject|7|||
131684319|NCT00474708|474129218|FG001|Overall Study|Withdrawal by Subject|0|||
131684320|NCT00474708|474129217|FG000|Overall Study|Lack of compliance|12|||
131684321|NCT00474708|474129218|FG001|Overall Study|Lack of compliance|4|||
131684322|NCT00474708|474129217|FG000|Overall Study|Lost to Follow-up|18|||
131684323|NCT00474708|474129218|FG001|Overall Study|Lost to Follow-up|9|||
131684324|NCT00474708|474129217|FG000|Overall Study|Physician Decision|9|||
131684325|NCT00474708|474129218|FG001|Overall Study|Physician Decision|6|||
131684326|NCT03700320|474129219|FG000|Overall Study|Adverse Event|5|||
131684327|NCT03700320|474129220|FG001|Overall Study|Adverse Event|31|||
131684328|NCT03700320|474129219|FG000|Overall Study|Lack of Efficacy|2|||
131684329|NCT03700320|474129220|FG001|Overall Study|Lack of Efficacy|5|||
131684330|NCT03700320|474129219|FG000|Overall Study|Withdrawal by Subject|29|||
131684331|NCT03700320|474129220|FG001|Overall Study|Withdrawal by Subject|75|||
131684332|NCT03700320|474129219|FG000|Overall Study|Lost to Follow-up|16|||
131684333|NCT03700320|474129220|FG001|Overall Study|Lost to Follow-up|23|||
131684334|NCT03700320|474129219|FG000|Overall Study|Pregnancy|2|||
131684335|NCT03700320|474129220|FG001|Overall Study|Pregnancy|4|||
131684336|NCT03700320|474129219|FG000|Overall Study|Protocol Deviation|7|||
131684337|NCT03700320|474129220|FG001|Overall Study|Protocol Deviation|31|||
131684338|NCT03700320|474129219|FG000|Overall Study|Non-compliance with Study Drug|1|||
131684339|NCT03700320|474129220|FG001|Overall Study|Non-compliance with Study Drug|3|||
131684340|NCT03700320|474129219|FG000|Overall Study|Reason not Specified|0|||
131684341|NCT03700320|474129220|FG001|Overall Study|Reason not Specified|1|||
131684342|NCT00175877|474129224|FG000|Overall Study|Adverse Event|136|||
131684343|NCT00175877|474129224|FG000|Overall Study|Withdrawal by Subject|141|||
131684344|NCT00175877|474129224|FG000|Overall Study|Lost to Follow-up|9|||
131684345|NCT00175877|474129224|FG000|Overall Study|Lack of Efficacy|26|||
131684346|NCT00175877|474129224|FG000|Overall Study|Protocol Violation|15|||
131684347|NCT00175877|474129224|FG000|Overall Study|Other Reason|20|||
131684348|NCT00175877|474129224|FG000|Overall Study|AE & Other|1|||
131684349|NCT00175877|474129224|FG000|Overall Study|Withdrawal by subject & Other|1|||
131684350|NCT01092143|474129227|FG000|Overall Study|Adverse Event|10|||
131684351|NCT01092143|474129228|FG001|Overall Study|Adverse Event|5|||
131684352|NCT01092143|474129229|FG002|Overall Study|Adverse Event|1|||
131684353|NCT01092143|474129230|FG003|Overall Study|Adverse Event|4|||
131684354|NCT01092143|474129231|FG004|Overall Study|Adverse Event|3|||
131684355|NCT01092143|474129227|FG000|Overall Study|Lost to Follow-up|1|||
131684356|NCT01092143|474129228|FG001|Overall Study|Lost to Follow-up|0|||
131684357|NCT01092143|474129229|FG002|Overall Study|Lost to Follow-up|1|||
131684358|NCT01092143|474129230|FG003|Overall Study|Lost to Follow-up|0|||
131684359|NCT01092143|474129231|FG004|Overall Study|Lost to Follow-up|0|||
131684360|NCT01092143|474129227|FG000|Overall Study|Consent withdrawn|2|||
131684361|NCT01092143|474129228|FG001|Overall Study|Consent withdrawn|1|||
131684362|NCT01092143|474129229|FG002|Overall Study|Consent withdrawn|0|||
131684363|NCT01092143|474129230|FG003|Overall Study|Consent withdrawn|1|||
131684364|NCT01092143|474129231|FG004|Overall Study|Consent withdrawn|3|||
131684365|NCT01092143|474129227|FG000|Overall Study|Not treated|0|||
131684366|NCT01092143|474129228|FG001|Overall Study|Not treated|0|||
131684367|NCT01092143|474129229|FG002|Overall Study|Not treated|1|||
131684368|NCT01092143|474129230|FG003|Overall Study|Not treated|0|||
131684369|NCT01092143|474129231|FG004|Overall Study|Not treated|0|||
131684370|NCT01092143|474129227|FG000|Overall Study|did not reversibility criteria|0|||
131684371|NCT01092143|474129228|FG001|Overall Study|did not reversibility criteria|0|||
131684372|NCT01092143|474129229|FG002|Overall Study|did not reversibility criteria|1|||
131684373|NCT01092143|474129230|FG003|Overall Study|did not reversibility criteria|0|||
131684374|NCT01092143|474129231|FG004|Overall Study|did not reversibility criteria|0|||
131684375|NCT01092143|474129227|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
131684376|NCT01092143|474129228|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
131684377|NCT01092143|474129229|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
131684378|NCT01092143|474129230|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
131684379|NCT01092143|474129231|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
131684380|NCT01092143|474129227|FG000|Overall Study|Ineligible patient|1|||
131684381|NCT01092143|474129228|FG001|Overall Study|Ineligible patient|0|||
131684382|NCT01092143|474129229|FG002|Overall Study|Ineligible patient|0|||
131684383|NCT01092143|474129230|FG003|Overall Study|Ineligible patient|0|||
131684384|NCT01092143|474129231|FG004|Overall Study|Ineligible patient|0|||
131684385|NCT01092143|474129227|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
131684386|NCT01092143|474129228|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
131684387|NCT01092143|474129229|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
131684388|NCT01092143|474129230|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
131684389|NCT01092143|474129231|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
131684390|NCT01092143|474129227|FG000|Overall Study|Patient travel|0|||
131684391|NCT01092143|474129228|FG001|Overall Study|Patient travel|0|||
131684392|NCT01092143|474129229|FG002|Overall Study|Patient travel|0|||
131684393|NCT01092143|474129230|FG003|Overall Study|Patient travel|0|||
131684394|NCT01092143|474129231|FG004|Overall Study|Patient travel|1|||
131684395|NCT01092143|474129227|FG000|Overall Study|Non compliance with study medication|0|||
131684396|NCT01092143|474129228|FG001|Overall Study|Non compliance with study medication|0|||
131684397|NCT01092143|474129229|FG002|Overall Study|Non compliance with study medication|0|||
131684398|NCT01092143|474129230|FG003|Overall Study|Non compliance with study medication|0|||
131684399|NCT01092143|474129231|FG004|Overall Study|Non compliance with study medication|1|||
131684400|NCT01092143|474129227|FG000|Overall Study|Randomized by mistake|0|||
131684401|NCT01092143|474129228|FG001|Overall Study|Randomized by mistake|0|||
131684402|NCT01092143|474129229|FG002|Overall Study|Randomized by mistake|0|||
131684403|NCT01092143|474129230|FG003|Overall Study|Randomized by mistake|1|||
131684404|NCT01092143|474129231|FG004|Overall Study|Randomized by mistake|0|||
131684405|NCT01092143|474129227|FG000|Overall Study|Pregnancy|0|||
131684406|NCT01092143|474129228|FG001|Overall Study|Pregnancy|0|||
131684407|NCT01092143|474129229|FG002|Overall Study|Pregnancy|0|||
131684408|NCT01092143|474129230|FG003|Overall Study|Pregnancy|1|||
131684409|NCT01092143|474129231|FG004|Overall Study|Pregnancy|0|||
131684410|NCT00555477|474129234|FG000|Overall Study|Adverse Event|0|||
131684411|NCT00555477|474129235|FG001|Overall Study|Adverse Event|9|||
131684412|NCT00555477|474129234|FG000|Overall Study|Withdrawal by Subject|1|||
131684413|NCT00555477|474129235|FG001|Overall Study|Withdrawal by Subject|2|||
131684414|NCT00555477|474129234|FG000|Overall Study|Physician Decision|1|||
131684415|NCT00555477|474129235|FG001|Overall Study|Physician Decision|2|||
131684416|NCT00545402|474129236|FG000|Overall Study|Discontinuation of treatment|17|||
131684417|NCT00545402|474129237|FG001|Overall Study|Discontinuation of treatment|9|||
131684418|NCT00545402|474129236|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
131684419|NCT00545402|474129237|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
131684420|NCT00545402|474129236|FG000|Overall Study|Death|5|||
131684421|NCT00545402|474129237|FG001|Overall Study|Death|7|||
131684422|NCT00545402|474129236|FG000|Overall Study|Graft loss|2|||
131684423|NCT00545402|474129237|FG001|Overall Study|Graft loss|4|||
131684424|NCT00545402|474129236|FG000|Overall Study|Withdrawal by Subject|0|||
131684425|NCT00545402|474129237|FG001|Overall Study|Withdrawal by Subject|1|||
131684426|NCT00545402|474129236|FG000|Overall Study|Protocol Violation|1|||
131684427|NCT00545402|474129237|FG001|Overall Study|Protocol Violation|0|||
131684428|NCT00545402|474129236|FG000|Overall Study|Reason not specified|1|||
131684429|NCT00545402|474129237|FG001|Overall Study|Reason not specified|1|||
131684430|NCT01721876|474129238|FG000|Overall Study|Not treated|1|||
131684431|NCT01721876|474129239|FG001|Overall Study|Not treated|4|||
131684432|NCT01721876|474129238|FG000|Overall Study|Disease progression / relapse|123|||
131684433|NCT01721876|474129239|FG001|Overall Study|Disease progression / relapse|156|||
131684434|NCT01721876|474129238|FG000|Overall Study|Death|6|||
131684435|NCT01721876|474129239|FG001|Overall Study|Death|13|||
131684436|NCT01721876|474129238|FG000|Overall Study|Adverse Event|41|||
131684437|NCT01721876|474129239|FG001|Overall Study|Adverse Event|165|||
131684438|NCT01721876|474129238|FG000|Overall Study|Protocol Violation|2|||
131684439|NCT01721876|474129239|FG001|Overall Study|Protocol Violation|1|||
131684440|NCT01721876|474129238|FG000|Overall Study|Withdrawal by Subject|15|||
131684441|NCT01721876|474129239|FG001|Overall Study|Withdrawal by Subject|38|||
131684442|NCT01721876|474129238|FG000|Overall Study|Reason not listed|34|||
131684443|NCT01721876|474129239|FG001|Overall Study|Reason not listed|63|||
131684444|NCT01721876|474129238|FG000|Overall Study|Sponsor terminated trial|0|||
131684445|NCT01721876|474129239|FG001|Overall Study|Sponsor terminated trial|4|||
131684446|NCT01721057|474129242|FG000|Treatment Period|Withdrawal by Subject|11|||
131684447|NCT01721057|474129243|FG001|Treatment Period|Withdrawal by Subject|5|||
131684448|NCT01721057|474129244|FG002|Treatment Period|Withdrawal by Subject|8|||
131684449|NCT01721057|474129245|FG003|Treatment Period|Withdrawal by Subject|0|||
131684450|NCT01721057|474129246|FG004|Treatment Period|Withdrawal by Subject|0|||
131684451|NCT01721057|474129247|FG005|Treatment Period|Withdrawal by Subject|0|||
131684452|NCT01721057|474129248|FG006|Treatment Period|Withdrawal by Subject|0|||
131684453|NCT01721057|474129242|FG000|Treatment Period|Adverse Event|7|||
131684454|NCT01721057|474129243|FG001|Treatment Period|Adverse Event|10|||
131684455|NCT01721057|474129244|FG002|Treatment Period|Adverse Event|12|||
131684456|NCT01721057|474129245|FG003|Treatment Period|Adverse Event|0|||
131684457|NCT01721057|474129246|FG004|Treatment Period|Adverse Event|0|||
131684458|NCT01721057|474129247|FG005|Treatment Period|Adverse Event|0|||
131684459|NCT01721057|474129248|FG006|Treatment Period|Adverse Event|0|||
131684460|NCT01721057|474129242|FG000|Treatment Period|Lack of Efficacy|7|||
131684461|NCT01721057|474129243|FG001|Treatment Period|Lack of Efficacy|3|||
131684462|NCT01721057|474129244|FG002|Treatment Period|Lack of Efficacy|0|||
131684463|NCT01721057|474129245|FG003|Treatment Period|Lack of Efficacy|0|||
131684464|NCT01721057|474129246|FG004|Treatment Period|Lack of Efficacy|0|||
131684465|NCT01721057|474129247|FG005|Treatment Period|Lack of Efficacy|0|||
131684466|NCT01721057|474129248|FG006|Treatment Period|Lack of Efficacy|0|||
131684467|NCT01721057|474129242|FG000|Treatment Period|Lost to Follow-up|1|||
131684468|NCT01721057|474129243|FG001|Treatment Period|Lost to Follow-up|0|||
131684469|NCT01721057|474129244|FG002|Treatment Period|Lost to Follow-up|0|||
131684470|NCT01721057|474129245|FG003|Treatment Period|Lost to Follow-up|0|||
131684471|NCT01721057|474129246|FG004|Treatment Period|Lost to Follow-up|0|||
131684472|NCT01721057|474129247|FG005|Treatment Period|Lost to Follow-up|0|||
131684473|NCT01721057|474129248|FG006|Treatment Period|Lost to Follow-up|0|||
131684474|NCT01721057|474129242|FG000|Treatment Period|Physician Decision|0|||
131684475|NCT01721057|474129243|FG001|Treatment Period|Physician Decision|1|||
131684476|NCT01721057|474129244|FG002|Treatment Period|Physician Decision|3|||
131684477|NCT01721057|474129245|FG003|Treatment Period|Physician Decision|0|||
131684478|NCT01721057|474129246|FG004|Treatment Period|Physician Decision|0|||
131684479|NCT01721057|474129247|FG005|Treatment Period|Physician Decision|0|||
131684480|NCT01721057|474129248|FG006|Treatment Period|Physician Decision|0|||
131684481|NCT01721057|474129242|FG000|Treatment Period|Death|2|||
131684482|NCT01721057|474129243|FG001|Treatment Period|Death|0|||
131684483|NCT01721057|474129244|FG002|Treatment Period|Death|0|||
131684484|NCT01721057|474129245|FG003|Treatment Period|Death|0|||
131684485|NCT01721057|474129246|FG004|Treatment Period|Death|0|||
131684486|NCT01721057|474129247|FG005|Treatment Period|Death|0|||
131684487|NCT01721057|474129248|FG006|Treatment Period|Death|0|||
131684488|NCT01721057|474129242|FG000|Rescue Period|Adverse Event|0|||
131684489|NCT01721057|474129243|FG001|Rescue Period|Adverse Event|0|||
131684490|NCT01721057|474129244|FG002|Rescue Period|Adverse Event|0|||
131684491|NCT01721057|474129245|FG003|Rescue Period|Adverse Event|1|||
131684492|NCT01721057|474129246|FG004|Rescue Period|Adverse Event|0|||
131684493|NCT01721057|474129247|FG005|Rescue Period|Adverse Event|0|||
131684494|NCT01721057|474129248|FG006|Rescue Period|Adverse Event|0|||
131684495|NCT01721057|474129242|FG000|Rescue Period|Lack of Efficacy|0|||
131684496|NCT01721057|474129243|FG001|Rescue Period|Lack of Efficacy|0|||
131684497|NCT01721057|474129244|FG002|Rescue Period|Lack of Efficacy|0|||
131684498|NCT01721057|474129245|FG003|Rescue Period|Lack of Efficacy|2|||
131684499|NCT01721057|474129246|FG004|Rescue Period|Lack of Efficacy|0|||
131684500|NCT01721057|474129247|FG005|Rescue Period|Lack of Efficacy|0|||
131684501|NCT01721057|474129248|FG006|Rescue Period|Lack of Efficacy|0|||
131684502|NCT01177683|474129249|FG000|Study Treatment|Disease Progressions during treatment|2|||
131684503|NCT01177683|474129250|FG001|Study Treatment|Disease Progressions during treatment|0|||
131684504|NCT01177683|474129251|FG002|Study Treatment|Disease Progressions during treatment|3|||
131684505|NCT01177683|474129249|FG000|Study Treatment|Adverse Event|0|||
131684506|NCT01177683|474129250|FG001|Study Treatment|Adverse Event|1|||
131684507|NCT01177683|474129251|FG002|Study Treatment|Adverse Event|12|||
131684508|NCT01177683|474129249|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
131684509|NCT01177683|474129250|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
131684510|NCT01177683|474129251|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
131684511|NCT01177683|474129249|FG000|Study Treatment|Alternative therapy|0|||
131684512|NCT01177683|474129250|FG001|Study Treatment|Alternative therapy|0|||
131684513|NCT01177683|474129251|FG002|Study Treatment|Alternative therapy|4|||
131684514|NCT01177683|474129249|FG000|Study Treatment|Physician Decision|1|||
131684515|NCT01177683|474129250|FG001|Study Treatment|Physician Decision|0|||
131684516|NCT01177683|474129251|FG002|Study Treatment|Physician Decision|1|||
131684517|NCT01177683|474129249|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
131684518|NCT01177683|474129250|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
131684519|NCT01177683|474129251|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
131684520|NCT01177683|474129249|FG000|Study Treatment|Symptomatic Deterioration|0|||
131684521|NCT01177683|474129250|FG001|Study Treatment|Symptomatic Deterioration|0|||
131684522|NCT01177683|474129251|FG002|Study Treatment|Symptomatic Deterioration|1|||
131684523|NCT01177683|474129249|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
131684524|NCT01177683|474129250|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
131684525|NCT01177683|474129251|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
131684526|NCT01177683|474129249|FG000|Follow up|Patient lost to follow up|0|||
131684527|NCT01177683|474129250|FG001|Follow up|Patient lost to follow up|0|||
131684528|NCT01177683|474129251|FG002|Follow up|Patient lost to follow up|2|||
131684529|NCT01177683|474129249|FG000|Follow up|Death|2|||
131684530|NCT01177683|474129250|FG001|Follow up|Death|1|||
131684531|NCT01177683|474129251|FG002|Follow up|Death|7|||
131684532|NCT01177683|474129249|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
131684533|NCT01177683|474129250|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
131684534|NCT01177683|474129251|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
131684535|NCT02713542|474130657|FG000|Overall Study|Use of prohibited medication|14|||
131684536|NCT02713542|474130658|FG001|Overall Study|Use of prohibited medication|5|||
131684537|NCT02713542|474130657|FG000|Overall Study|Withdrawal by Subject|4|||
131684538|NCT02713542|474130658|FG001|Overall Study|Withdrawal by Subject|1|||
131684539|NCT00066742|474130659|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
131684540|NCT00066742|474130659|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
131684541|NCT00066742|474130659|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
131684542|NCT00066742|474130659|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
131684543|NCT00066742|474130659|FG000|Induction Chemoradiotherapy|Ineligible|3|||
131684544|NCT00066742|474130659|FG000|Consolidation Chemotherapy|not protocol specified|1|||
131684545|NCT00066742|474130659|FG000|Consolidation Chemotherapy|Ineligible|2|||
131684546|NCT01134614|474130663|FG000|Overall Study|Still on treatment as of March 2013|21|||
131684547|NCT01134614|474130664|FG001|Overall Study|Still on treatment as of March 2013|13|||
131684548|NCT01134614|474130663|FG000|Overall Study|Progressive disease|60|||
131684549|NCT01134614|474130664|FG001|Overall Study|Progressive disease|54|||
131684550|NCT01134614|474130663|FG000|Overall Study|Adverse Event|26|||
131684551|NCT01134614|474130664|FG001|Overall Study|Adverse Event|39|||
131684552|NCT01134614|474130663|FG000|Overall Study|Death|5|||
131684553|NCT01134614|474130664|FG001|Overall Study|Death|8|||
131684554|NCT01134614|474130663|FG000|Overall Study|Withdrawal by Subject|3|||
131684555|NCT01134614|474130664|FG001|Overall Study|Withdrawal by Subject|2|||
131684556|NCT01134614|474130663|FG000|Overall Study|Alternative therapy|2|||
131684557|NCT01134614|474130664|FG001|Overall Study|Alternative therapy|0|||
131684558|NCT01134614|474130663|FG000|Overall Study|Complicating disease|2|||
131684559|NCT01134614|474130664|FG001|Overall Study|Complicating disease|1|||
131684560|NCT01134614|474130663|FG000|Overall Study|Physician's decision|0|||
131684561|NCT01134614|474130664|FG001|Overall Study|Physician's decision|1|||
131684562|NCT01134614|474130663|FG000|Overall Study|Never started treatment|4|||
131684563|NCT01134614|474130664|FG001|Overall Study|Never started treatment|1|||
131684564|NCT01134614|474130663|FG000|Overall Study|Pt received tx not allowed on study|0|||
131684565|NCT01134614|474130664|FG001|Overall Study|Pt received tx not allowed on study|1|||
131684566|NCT01134614|474130663|FG000|Overall Study|Symptomatic deterioration|0|||
131684567|NCT01134614|474130664|FG001|Overall Study|Symptomatic deterioration|1|||
131684568|NCT01134614|474130663|FG000|Overall Study|Patient in hospice care|0|||
131684569|NCT01134614|474130664|FG001|Overall Study|Patient in hospice care|1|||
131684570|NCT01519934|474130665|FG000|Overall Study|Lost to Follow-up|3|||
131684571|NCT03861936|474130666|FG000|Overall Study|Withdrawal by Subject|4|||
131684572|NCT03861936|474130667|FG001|Overall Study|Withdrawal by Subject|1|||
131684573|NCT03861936|474130668|FG002|Overall Study|Withdrawal by Subject|3|||
131684574|NCT03861936|474130666|FG000|Overall Study|Lost to Follow-up|5|||
131684575|NCT03861936|474130667|FG001|Overall Study|Lost to Follow-up|3|||
131684576|NCT03861936|474130668|FG002|Overall Study|Lost to Follow-up|3|||
131684577|NCT03861936|474130666|FG000|Overall Study|Physician Decision|0|||
131684578|NCT03861936|474130667|FG001|Overall Study|Physician Decision|1|||
131684579|NCT03861936|474130668|FG002|Overall Study|Physician Decision|0|||
131684580|NCT03861936|474130666|FG000|Overall Study|Protocol Deviation|0|||
131772596|NCT00495794|474445130|FG000|Overall Study|Pharmacist did not activate patient|522|||
131772597|NCT00495794|474445131|FG001|Overall Study|Pharmacist did not activate patient|0|||
131772598|NCT02441517|474445132|FG000|Overall Study|Lost to Follow-up|1|||
131772599|NCT02441517|474445132|FG000|Overall Study|Withdrawal by Subject|2|||
131772600|NCT02441517|474445132|FG000|Overall Study|Study Terminated by Sponsor|1|||
131772601|NCT01393444|474445133|FG000|Overall Study|Withdrawal by Subject|1|||
131772602|NCT01393444|474445133|FG000|Overall Study|Determined ineligible during screening.|2|||
131772603|NCT03039699|474445135|FG000|Overall Study|Incorrect inclusion|5|||
131772604|NCT03039699|474445136|FG001|Overall Study|Incorrect inclusion|4|||
131772605|NCT03039699|474445135|FG000|Overall Study|Lack of data to assess study endpoint|5|||
131772606|NCT03039699|474445136|FG001|Overall Study|Lack of data to assess study endpoint|3|||
131772607|NCT03039699|474445135|FG000|Overall Study|Bacterial infection|12|||
131772608|NCT03039699|474445136|FG001|Overall Study|Bacterial infection|28|||
131772609|NCT00129220|474445137|FG000|Study Period II|Adverse Event|9|||
131772610|NCT00129220|474445138|FG001|Study Period II|Adverse Event|5|||
131772611|NCT00129220|474445139|FG002|Study Period II|Adverse Event|7|||
131772612|NCT00129220|474445137|FG000|Study Period II|Lack of Efficacy|15|||
131772613|NCT00129220|474445138|FG001|Study Period II|Lack of Efficacy|1|||
131772614|NCT00129220|474445139|FG002|Study Period II|Lack of Efficacy|28|||
131772615|NCT00129220|474445137|FG000|Study Period II|Entry Criteria Not Met|2|||
131772616|NCT00129220|474445138|FG001|Study Period II|Entry Criteria Not Met|0|||
131772617|NCT00129220|474445139|FG002|Study Period II|Entry Criteria Not Met|2|||
131772618|NCT00129220|474445137|FG000|Study Period II|Protocol Violation|4|||
131772619|NCT00129220|474445138|FG001|Study Period II|Protocol Violation|2|||
131772620|NCT00129220|474445139|FG002|Study Period II|Protocol Violation|1|||
131772621|NCT00129220|474445137|FG000|Study Period II|Physician Decision|0|||
131684581|NCT03861936|474130667|FG001|Overall Study|Protocol Deviation|0|||
131684582|NCT03861936|474130668|FG002|Overall Study|Protocol Deviation|1|||
131684583|NCT03861936|474130666|FG000|Overall Study|Reason not Specified|5|||
131684584|NCT03861936|474130667|FG001|Overall Study|Reason not Specified|5|||
131684585|NCT03861936|474130668|FG002|Overall Study|Reason not Specified|3|||
131684586|NCT00359021|474130669|FG000|Overall Study|Adverse Event|26|||
131684587|NCT00359021|474130670|FG001|Overall Study|Adverse Event|8|||
131684588|NCT00359021|474130669|FG000|Overall Study|Subject Non-Compliant|1|||
131684589|NCT00359021|474130670|FG001|Overall Study|Subject Non-Compliant|2|||
131684590|NCT00359021|474130669|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
131684591|NCT00359021|474130670|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
131684592|NCT00359021|474130669|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
131684593|NCT00359021|474130670|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
131684594|NCT00359021|474130669|FG000|Overall Study|Withdrawal by Subject|2|||
131684595|NCT00359021|474130670|FG001|Overall Study|Withdrawal by Subject|9|||
131684596|NCT00359021|474130669|FG000|Overall Study|Lost to Follow-up|1|||
131684597|NCT00359021|474130670|FG001|Overall Study|Lost to Follow-up|0|||
131684598|NCT00359021|474130669|FG000|Overall Study|Other|4|||
131684599|NCT00359021|474130670|FG001|Overall Study|Other|1|||
131684600|NCT00359021|474130669|FG000|Overall Study|Pregnancy|1|||
131684601|NCT00359021|474130670|FG001|Overall Study|Pregnancy|0|||
131684602|NCT01236573|474130671|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684603|NCT01236573|474130672|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684604|NCT01236573|474130673|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131772622|NCT00129220|474445138|FG001|Study Period II|Physician Decision|1|||
131772623|NCT00129220|474445139|FG002|Study Period II|Physician Decision|0|||
131772624|NCT00129220|474445137|FG000|Study Period II|Withdrawal by Subject|1|||
131684605|NCT01236573|474130674|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684606|NCT01236573|474130675|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684607|NCT01236573|474130676|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684608|NCT01236573|474130677|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
131684609|NCT01236573|474130678|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684610|NCT01236573|474130679|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
131684611|NCT01236573|474130680|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
131684612|NCT01236573|474130681|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131684613|NCT01236573|474130671|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684614|NCT01236573|474130672|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684615|NCT01236573|474130673|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684616|NCT01236573|474130674|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684617|NCT01236573|474130675|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684618|NCT01236573|474130676|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684619|NCT01236573|474130677|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684620|NCT01236573|474130678|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684621|NCT01236573|474130679|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
131684622|NCT01236573|474130680|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684623|NCT01236573|474130681|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131684624|NCT01236573|474130671|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684625|NCT01236573|474130672|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684626|NCT01236573|474130673|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684627|NCT01236573|474130674|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684628|NCT01236573|474130675|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684629|NCT01236573|474130676|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684630|NCT01236573|474130677|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684631|NCT01236573|474130678|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684632|NCT01236573|474130679|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684633|NCT01236573|474130680|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131684634|NCT01236573|474130681|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
131684635|NCT04109222|474130692|FG000|Overall Study|Adverse Event|1|||
131684636|NCT04109222|474130693|FG001|Overall Study|Adverse Event|0|||
131684637|NCT04109222|474130694|FG002|Overall Study|Adverse Event|0|||
131684638|NCT03023059|474130695|FG000|Overall Study|Withdrawal by Subject|5|||
131684639|NCT04569032|474130698|FG000|Overall Study|Death|10|||
131684640|NCT04569032|474130699|FG001|Overall Study|Death|13|||
131684641|NCT04569032|474130698|FG000|Overall Study|Withdrawal by Subject|2|||
131684642|NCT04569032|474130699|FG001|Overall Study|Withdrawal by Subject|0|||
131684643|NCT04569032|474130698|FG000|Overall Study|Lost to Follow-up|0|||
131684644|NCT04569032|474130699|FG001|Overall Study|Lost to Follow-up|1|||
131684645|NCT04569032|474130698|FG000|Overall Study|In long term follow up|22|||
131684646|NCT04569032|474130699|FG001|Overall Study|In long term follow up|34|||
131684647|NCT00701090|474130701|FG000|Overall Study|Adverse Event|11|||
131684648|NCT00701090|474130702|FG001|Overall Study|Adverse Event|2|||
131684649|NCT00701090|474130701|FG000|Overall Study|Death|0|||
131684650|NCT00701090|474130702|FG001|Overall Study|Death|1|||
131684651|NCT00701090|474130701|FG000|Overall Study|Lack of Efficacy|5|||
131684652|NCT00701090|474130702|FG001|Overall Study|Lack of Efficacy|4|||
131684653|NCT00701090|474130701|FG000|Overall Study|Lost to Follow-up|9|||
131684654|NCT00701090|474130702|FG001|Overall Study|Lost to Follow-up|9|||
131684655|NCT00701090|474130701|FG000|Overall Study|Physician Decision|3|||
131684656|NCT00701090|474130702|FG001|Overall Study|Physician Decision|4|||
131684657|NCT00701090|474130701|FG000|Overall Study|Protocol Violation|2|||
131684658|NCT00701090|474130702|FG001|Overall Study|Protocol Violation|3|||
131684659|NCT00701090|474130701|FG000|Overall Study|Withdrawal by Subject|11|||
131684660|NCT00701090|474130702|FG001|Overall Study|Withdrawal by Subject|16|||
131684661|NCT00701090|474130701|FG000|Overall Study|Other|7|||
131684662|NCT00701090|474130702|FG001|Overall Study|Other|12|||
131772625|NCT00129220|474445138|FG001|Study Period II|Withdrawal by Subject|3|||
131772626|NCT00129220|474445139|FG002|Study Period II|Withdrawal by Subject|4|||
131772627|NCT00129220|474445137|FG000|Study Period II|Reason Not Specified|2|||
131772628|NCT00129220|474445138|FG001|Study Period II|Reason Not Specified|0|||
131772629|NCT00129220|474445139|FG002|Study Period II|Reason Not Specified|5|||
131772630|NCT00129220|474445137|FG000|Study Period III|Adverse Event|1|||
131772631|NCT00129220|474445138|FG001|Study Period III|Adverse Event|0|||
131772632|NCT00129220|474445139|FG002|Study Period III|Adverse Event|3|||
131772633|NCT00129220|474445137|FG000|Study Period III|Protocol Violation|1|||
131772634|NCT00129220|474445138|FG001|Study Period III|Protocol Violation|1|||
131772635|NCT00129220|474445139|FG002|Study Period III|Protocol Violation|2|||
131684663|NCT00873366|474130703|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
131684664|NCT00873366|474130703|FG000|Overall Study|Off tamoxifen due to side effects|2|||
131772636|NCT00129220|474445137|FG000|Study Period III|Withdrawal by Subject|1|||
131772637|NCT00129220|474445138|FG001|Study Period III|Withdrawal by Subject|0|||
131772638|NCT00129220|474445139|FG002|Study Period III|Withdrawal by Subject|3|||
131772639|NCT00129220|474445137|FG000|Study Period III|Sponsor Decision|1|||
131772640|NCT00129220|474445138|FG001|Study Period III|Sponsor Decision|0|||
131772641|NCT00129220|474445139|FG002|Study Period III|Sponsor Decision|0|||
131772642|NCT00129220|474445137|FG000|Study Period III|Reason Not Specified|9|||
131772643|NCT00129220|474445138|FG001|Study Period III|Reason Not Specified|0|||
131772644|NCT00129220|474445139|FG002|Study Period III|Reason Not Specified|2|||
131772645|NCT01883362|474445140|FG000|Treatment|Adverse Event|1|||
131772646|NCT01883362|474445141|FG001|Treatment|Adverse Event|8|||
131772647|NCT01883362|474445140|FG000|Treatment|Withdrawal by Subject|6|||
131772648|NCT01883362|474445141|FG001|Treatment|Withdrawal by Subject|2|||
131772649|NCT01883362|474445140|FG000|Treatment|Administrative problems|4|||
131772650|NCT01883362|474445141|FG001|Treatment|Administrative problems|1|||
131772651|NCT01883362|474445140|FG000|Treatment|Relapse|4|||
131772652|NCT01883362|474445141|FG001|Treatment|Relapse|2|||
131772653|NCT01883362|474445140|FG000|Treatment|Randomized, not treated|1|||
131772654|NCT01883362|474445141|FG001|Treatment|Randomized, not treated|1|||
131772655|NCT01883362|474445140|FG000|Post Treatment Follow-up|Protocol Violation|0|||
131772656|NCT01883362|474445141|FG001|Post Treatment Follow-up|Protocol Violation|1|||
131772657|NCT01883362|474445140|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
131684665|NCT00873366|474130703|FG000|Overall Study|Refused to continue DM-BT testing|3|||
131684666|NCT00702325|474130704|FG000|Overall Study|Adverse Event|1|||
131684667|NCT00702325|474130705|FG001|Overall Study|Adverse Event|0|||
131684668|NCT00702325|474130704|FG000|Overall Study|Withdrawal by Subject|7|||
131684669|NCT00702325|474130705|FG001|Overall Study|Withdrawal by Subject|7|||
131684670|NCT00702325|474130704|FG000|Overall Study|Lost to Follow-up|3|||
131684671|NCT00702325|474130705|FG001|Overall Study|Lost to Follow-up|4|||
131684672|NCT00702325|474130704|FG000|Overall Study|Incorrect enrollment|5|||
131684673|NCT00702325|474130705|FG001|Overall Study|Incorrect enrollment|7|||
131684674|NCT00702325|474130704|FG000|Overall Study|Developed study discontinuation criteria|18|||
131684675|NCT00702325|474130705|FG001|Overall Study|Developed study discontinuation criteria|28|||
131684676|NCT00702325|474130704|FG000|Overall Study|Severe noncompliance to protocol|3|||
131684677|NCT00702325|474130705|FG001|Overall Study|Severe noncompliance to protocol|3|||
131684678|NCT00702325|474130704|FG000|Overall Study|Termination due to lab results|1|||
131684679|NCT00702325|474130705|FG001|Overall Study|Termination due to lab results|0|||
131684680|NCT00702325|474130704|FG000|Overall Study|Didn't follow study medication dosage|0|||
131684681|NCT00702325|474130705|FG001|Overall Study|Didn't follow study medication dosage|2|||
131684682|NCT00702325|474130704|FG000|Overall Study|Withdrew consent|0|||
131684683|NCT00702325|474130705|FG001|Overall Study|Withdrew consent|1|||
131684684|NCT00702325|474130704|FG000|Overall Study|Incorrectly Discontinued|0|||
131684685|NCT00702325|474130705|FG001|Overall Study|Incorrectly Discontinued|1|||
131684686|NCT01022502|474130706|FG000|Overall Study|Adverse Event|1|||
131684687|NCT01022502|474130706|FG000|Overall Study|employment related reasons|1|||
131684688|NCT01022502|474130706|FG000|Overall Study|Withdrawal by Subject|1|||
131684689|NCT03716050|474130707|FG000|Overall Study|Lost to Follow-up|0|||
131684690|NCT03716050|474130708|FG001|Overall Study|Lost to Follow-up|0|||
131684691|NCT03716050|474130709|FG002|Overall Study|Lost to Follow-up|1|||
131684692|NCT03716050|474130710|FG003|Overall Study|Lost to Follow-up|0|||
131684693|NCT03716050|474130711|FG004|Overall Study|Lost to Follow-up|0|||
131684694|NCT03716050|474130712|FG005|Overall Study|Lost to Follow-up|0|||
131684695|NCT03716050|474130713|FG006|Overall Study|Lost to Follow-up|0|||
131684696|NCT03716050|474130714|FG007|Overall Study|Lost to Follow-up|0|||
131684697|NCT03716050|474130707|FG000|Overall Study|Physician Decision|0|||
131684698|NCT03716050|474130708|FG001|Overall Study|Physician Decision|0|||
131684699|NCT03716050|474130709|FG002|Overall Study|Physician Decision|0|||
131684700|NCT03716050|474130710|FG003|Overall Study|Physician Decision|1|||
131684701|NCT03716050|474130711|FG004|Overall Study|Physician Decision|0|||
131684702|NCT03716050|474130712|FG005|Overall Study|Physician Decision|0|||
131684703|NCT03716050|474130713|FG006|Overall Study|Physician Decision|0|||
131684704|NCT03716050|474130714|FG007|Overall Study|Physician Decision|0|||
131684705|NCT03716050|474130707|FG000|Overall Study|Protocol Violation|0|||
131684706|NCT03716050|474130708|FG001|Overall Study|Protocol Violation|0|||
131684707|NCT03716050|474130709|FG002|Overall Study|Protocol Violation|0|||
131684708|NCT03716050|474130710|FG003|Overall Study|Protocol Violation|1|||
131684709|NCT03716050|474130711|FG004|Overall Study|Protocol Violation|0|||
131684710|NCT03716050|474130712|FG005|Overall Study|Protocol Violation|0|||
131684711|NCT03716050|474130713|FG006|Overall Study|Protocol Violation|0|||
131684712|NCT03716050|474130714|FG007|Overall Study|Protocol Violation|2|||
131684713|NCT03123250|474130715|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
131684714|NCT02566577|474130716|FG000|Overall Study|Withdrawal by Subject|1|||
131684715|NCT02566577|474130717|FG001|Overall Study|Withdrawal by Subject|1|||
131684716|NCT02566577|474130716|FG000|Overall Study|Equipment failure|1|||
131684717|NCT02566577|474130717|FG001|Overall Study|Equipment failure|1|||
131684718|NCT02566577|474130716|FG000|Overall Study|Physical limitation|1|||
131684719|NCT02566577|474130717|FG001|Overall Study|Physical limitation|0|||
131772658|NCT01883362|474445141|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
131772659|NCT01883362|474445140|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
131684720|NCT03199040|474130718|FG000|Overall Study|Lack of Efficacy|2|||
131684721|NCT03199040|474130719|FG001|Overall Study|Lack of Efficacy|0|||
131684722|NCT03199040|474130718|FG000|Overall Study|Withdrawal by Subject|2|||
131684723|NCT03199040|474130719|FG001|Overall Study|Withdrawal by Subject|0|||
131684724|NCT03199040|474130718|FG000|Overall Study|Adverse Event|0|||
131684725|NCT03199040|474130719|FG001|Overall Study|Adverse Event|1|||
131684726|NCT03199040|474130718|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
131684727|NCT03199040|474130719|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
131684728|NCT00199836|474130721|FG000|Overall Study|Progressive Disease|5|||
131684729|NCT00199836|474130721|FG000|Overall Study|Death|1|||
131684730|NCT01708291|474130722|FG000|Overall Study|fighting|2|||
131684731|NCT01708291|474130723|FG001|Overall Study|fighting|1|||
131684732|NCT00932425|474130727|FG000|Overall Study|Lost to Follow-up|0|||
131684733|NCT00932425|474130728|FG001|Overall Study|Lost to Follow-up|1|||
131684734|NCT00932425|474130727|FG000|Overall Study|Withdrawal by Subject|0|||
131684735|NCT00932425|474130728|FG001|Overall Study|Withdrawal by Subject|1|||
131684736|NCT01854645|474130731|FG000|Overall Study|Protocol-Specified Criteria|13|||
131684737|NCT01854645|474130732|FG001|Overall Study|Protocol-Specified Criteria|10|||
131684738|NCT01854645|474130733|FG002|Overall Study|Protocol-Specified Criteria|8|||
131684739|NCT01854645|474130734|FG003|Overall Study|Protocol-Specified Criteria|5|||
131684740|NCT01854645|474130735|FG004|Overall Study|Protocol-Specified Criteria|7|||
131684741|NCT01854645|474130731|FG000|Overall Study|Administrative Reasons / Missing|0|||
131684742|NCT01854645|474130732|FG001|Overall Study|Administrative Reasons / Missing|0|||
131684743|NCT01854645|474130733|FG002|Overall Study|Administrative Reasons / Missing|0|||
131684744|NCT01854645|474130734|FG003|Overall Study|Administrative Reasons / Missing|1|||
131684745|NCT01854645|474130735|FG004|Overall Study|Administrative Reasons / Missing|1|||
131684746|NCT01854645|474130731|FG000|Overall Study|Protocol Violation|3|||
131684747|NCT01854645|474130732|FG001|Overall Study|Protocol Violation|0|||
131684748|NCT01854645|474130733|FG002|Overall Study|Protocol Violation|5|||
131684749|NCT01854645|474130734|FG003|Overall Study|Protocol Violation|4|||
131684750|NCT01854645|474130735|FG004|Overall Study|Protocol Violation|1|||
131684751|NCT01854645|474130731|FG000|Overall Study|Lost to Follow-up|10|||
131684752|NCT01854645|474130732|FG001|Overall Study|Lost to Follow-up|7|||
131684753|NCT01854645|474130733|FG002|Overall Study|Lost to Follow-up|8|||
131684754|NCT01854645|474130734|FG003|Overall Study|Lost to Follow-up|5|||
131684755|NCT01854645|474130735|FG004|Overall Study|Lost to Follow-up|0|||
131684756|NCT01854645|474130731|FG000|Overall Study|Physician Decision|1|||
131684757|NCT01854645|474130732|FG001|Overall Study|Physician Decision|5|||
131684758|NCT01854645|474130733|FG002|Overall Study|Physician Decision|3|||
131684759|NCT01854645|474130734|FG003|Overall Study|Physician Decision|3|||
131684760|NCT01854645|474130735|FG004|Overall Study|Physician Decision|7|||
131684761|NCT01854645|474130731|FG000|Overall Study|Withdrawal by Subject|31|||
131684762|NCT01854645|474130732|FG001|Overall Study|Withdrawal by Subject|41|||
131684763|NCT01854645|474130733|FG002|Overall Study|Withdrawal by Subject|30|||
131684764|NCT01854645|474130734|FG003|Overall Study|Withdrawal by Subject|21|||
131684765|NCT01854645|474130735|FG004|Overall Study|Withdrawal by Subject|24|||
131684766|NCT01854645|474130731|FG000|Overall Study|Lack of Efficacy|7|||
131684767|NCT01854645|474130732|FG001|Overall Study|Lack of Efficacy|12|||
131684768|NCT01854645|474130733|FG002|Overall Study|Lack of Efficacy|9|||
131684769|NCT01854645|474130734|FG003|Overall Study|Lack of Efficacy|3|||
131684770|NCT01854645|474130735|FG004|Overall Study|Lack of Efficacy|9|||
131684771|NCT01854645|474130731|FG000|Overall Study|Adverse Event|33|||
131684772|NCT01854645|474130732|FG001|Overall Study|Adverse Event|31|||
131684773|NCT01854645|474130733|FG002|Overall Study|Adverse Event|19|||
131684774|NCT01854645|474130734|FG003|Overall Study|Adverse Event|20|||
131684775|NCT01854645|474130735|FG004|Overall Study|Adverse Event|11|||
131684776|NCT00430482|474130736|FG000|Completed Treatment|Insufficient Treatment|7|||
131684777|NCT00430482|474130737|FG001|Completed Treatment|Insufficient Treatment|11|||
131684778|NCT00382018|474130738|FG000|Overall Study|Progression|0|||
131684779|NCT00382018|474130739|FG001|Overall Study|Progression|136|||
131684780|NCT00382018|474130740|FG002|Overall Study|Progression|51|||
131684781|NCT00382018|474130741|FG003|Overall Study|Progression|43|||
131684782|NCT00382018|474130738|FG000|Overall Study|Death|0|||
131684783|NCT00382018|474130739|FG001|Overall Study|Death|9|||
131684784|NCT00382018|474130740|FG002|Overall Study|Death|7|||
131684785|NCT00382018|474130741|FG003|Overall Study|Death|11|||
131684786|NCT00382018|474130738|FG000|Overall Study|Withdrawal by Subject|0|||
131772660|NCT01883362|474445141|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
131684787|NCT00382018|474130739|FG001|Overall Study|Withdrawal by Subject|4|||
131684788|NCT00382018|474130740|FG002|Overall Study|Withdrawal by Subject|3|||
131684789|NCT00382018|474130741|FG003|Overall Study|Withdrawal by Subject|4|||
131684790|NCT00382018|474130738|FG000|Overall Study|Other, not protocol specified|0|||
131684791|NCT00382018|474130739|FG001|Overall Study|Other, not protocol specified|16|||
131684792|NCT00382018|474130740|FG002|Overall Study|Other, not protocol specified|3|||
131684793|NCT00382018|474130741|FG003|Overall Study|Other, not protocol specified|1|||
131684794|NCT03805750|474130742|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
131684795|NCT03805750|474130743|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
131684796|NCT02811549|474130744|FG000|Overall Study|Lost to Follow-up|1|||
131684797|NCT02811549|474130744|FG000|Overall Study|Withdrawal by Subject|3|||
131684798|NCT02811549|474130744|FG000|Overall Study|Subject screen failed|4|||
131684799|NCT02811549|474130744|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
131684800|NCT02546765|474130748|FG000|Overall Study|Withdrawal by Subject|0|||
131684801|NCT02546765|474130749|FG001|Overall Study|Withdrawal by Subject|1|||
131684802|NCT02546765|474130750|FG002|Overall Study|Withdrawal by Subject|0|||
131684803|NCT02546765|474130751|FG003|Overall Study|Withdrawal by Subject|0|||
131772661|NCT01883362|474445140|FG000|Post Treatment Follow-up|Administrative problems|2|||
131772662|NCT01883362|474445141|FG001|Post Treatment Follow-up|Administrative problems|0|||
131772663|NCT01883362|474445140|FG000|Post Treatment Follow-up|Death|8|||
131772664|NCT01883362|474445141|FG001|Post Treatment Follow-up|Death|4|||
131684804|NCT00475722|474130752|FG000|Overall Study|Withdrawal by Subject|12|||
131684805|NCT00475722|474130753|FG001|Overall Study|Withdrawal by Subject|12|||
131684806|NCT00475722|474130752|FG000|Overall Study|Protocol Violation|3|||
131684807|NCT00475722|474130753|FG001|Overall Study|Protocol Violation|0|||
131684808|NCT00916279|474130754|FG000|Overall Study|Death|2|||
131684809|NCT00916279|474130754|FG000|Overall Study|Lost to Follow-up|2|||
131684810|NCT00310804|474130755|FG000|Overall Study|Lost to Follow-up|2|||
131684811|NCT00310804|474130756|FG001|Overall Study|Lost to Follow-up|0|||
131684812|NCT00310804|474130755|FG000|Overall Study|Withdrawal by Subject|3|||
131684813|NCT00310804|474130756|FG001|Overall Study|Withdrawal by Subject|0|||
131684814|NCT00688155|474130757|FG000|Overall Study|Withdrawal by Subject|2|||
131684815|NCT00688155|474130758|FG001|Overall Study|Withdrawal by Subject|2|||
131684816|NCT00688155|474130759|FG002|Overall Study|Withdrawal by Subject|1|||
131684817|NCT00688155|474130760|FG003|Overall Study|Withdrawal by Subject|1|||
131684818|NCT01889238|474130764|FG000|Overall Study|Death|1|||
131684819|NCT01889238|474130764|FG000|Overall Study|Withdrawal by Subject|1|||
131684820|NCT01889238|474130764|FG000|Overall Study|Adverse Event|6|||
131684821|NCT01889238|474130764|FG000|Overall Study|Disease Progression|104|||
131684822|NCT01889238|474130764|FG000|Overall Study|Other|6|||
131684823|NCT04136184|474130765|FG000|Overall Study|Lost to Follow-up|0|||
131684824|NCT04136184|474130766|FG001|Overall Study|Lost to Follow-up|3|||
131684825|NCT04136184|474130765|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
131684826|NCT04136184|474130766|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
131684827|NCT03318978|474130767|FG000|Overall Study|Withdrawal by Subject|1|||
131684828|NCT02844816|474130768|FG000|Overall Study|No protocol treatment received|5|||
131684829|NCT02844816|474130769|FG001|Overall Study|No protocol treatment received|1|||
131684830|NCT02844816|474130768|FG000|Overall Study|Ineligible|22|||
131684831|NCT02844816|474130769|FG001|Overall Study|Ineligible|15|||
131684832|NCT02844816|474130768|FG000|Overall Study|Participant refusal|5|||
131684833|NCT02844816|474130769|FG001|Overall Study|Participant refusal|5|||
131684834|NCT02844816|474130768|FG000|Overall Study|Adverse Event|5|||
131684835|NCT02844816|474130769|FG001|Overall Study|Adverse Event|4|||
131684836|NCT02844816|474130768|FG000|Overall Study|Death|0|||
131684837|NCT02844816|474130769|FG001|Overall Study|Death|1|||
131684838|NCT02844816|474130768|FG000|Overall Study|Disease progression/recurrence|50|||
131684839|NCT02844816|474130769|FG001|Overall Study|Disease progression/recurrence|24|||
131684840|NCT02844816|474130768|FG000|Overall Study|Physician Decision|1|||
131684841|NCT02844816|474130769|FG001|Overall Study|Physician Decision|1|||
131684842|NCT02717754|474130771|FG000|Overall Study|Incorrect Infusion Duration|0|||
131684843|NCT02717754|474130772|FG001|Overall Study|Incorrect Infusion Duration|0|||
131684844|NCT02717754|474130773|FG002|Overall Study|Incorrect Infusion Duration|0|||
131684845|NCT02717754|474130774|FG003|Overall Study|Incorrect Infusion Duration|10|||
131772665|NCT01883362|474445140|FG000|Post Treatment Follow-up|Relapse|1|||
131772666|NCT01883362|474445141|FG001|Post Treatment Follow-up|Relapse|2|||
131772667|NCT02911285|474445145|FG000|Overall Study|Lost to Follow-up|8|||
131772668|NCT02911285|474445146|FG001|Overall Study|Lost to Follow-up|5|||
131772669|NCT02911285|474445145|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
131772670|NCT02911285|474445146|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
131772671|NCT03996694|474446729|FG000|First Washout (7 Days)|positive urine drug screen|0|||
131772672|NCT03996694|474446730|FG001|First Washout (7 Days)|positive urine drug screen|0|||
131772673|NCT03996694|474446731|FG002|First Washout (7 Days)|positive urine drug screen|1|||
131772674|NCT03996694|474446732|FG003|First Washout (7 Days)|positive urine drug screen|0|||
131772675|NCT03996694|474446733|FG004|First Washout (7 Days)|positive urine drug screen|0|||
131684846|NCT02717754|474130775|FG004|Overall Study|Incorrect Infusion Duration|20|||
131684847|NCT02717754|474130776|FG005|Overall Study|Incorrect Infusion Duration|20|||
131684848|NCT01200238|474130777|FG000|Overall Study|Adverse Event|2|||
131684849|NCT01200238|474130778|FG001|Overall Study|Adverse Event|1|||
131684850|NCT01200238|474130777|FG000|Overall Study|Progressive Disease|5|||
131684851|NCT01200238|474130778|FG001|Overall Study|Progressive Disease|8|||
131684852|NCT01200238|474130777|FG000|Overall Study|Withdrawal by Subject|0|||
131684853|NCT01200238|474130778|FG001|Overall Study|Withdrawal by Subject|1|||
131684854|NCT03734016|474130782|FG000|Overall Study|Sponsor Ended Study|225|||
131684855|NCT03734016|474130783|FG001|Overall Study|Sponsor Ended Study|200|||
131684856|NCT03734016|474130782|FG000|Overall Study|Death|69|||
131772676|NCT03996694|474446734|FG005|First Washout (7 Days)|positive urine drug screen|0|||
131684857|NCT03734016|474130783|FG001|Overall Study|Death|83|||
131684858|NCT03734016|474130782|FG000|Overall Study|Withdrawal by Subject|21|||
131684859|NCT03734016|474130783|FG001|Overall Study|Withdrawal by Subject|27|||
131684860|NCT03734016|474130782|FG000|Overall Study|Physician Decision|1|||
131684861|NCT03734016|474130783|FG001|Overall Study|Physician Decision|12|||
131684862|NCT03734016|474130782|FG000|Overall Study|Lost to Follow-up|6|||
131684863|NCT03734016|474130783|FG001|Overall Study|Lost to Follow-up|2|||
131684864|NCT03734016|474130782|FG000|Overall Study|Miscellaneous|5|||
131684865|NCT03734016|474130783|FG001|Overall Study|Miscellaneous|1|||
131684866|NCT01979835|474130784|FG000|Primary Outcome SA Measurment|failed insertion|18|||
131684867|NCT01979835|474130784|FG000|Follow-up|Lost to Follow-up|32|||
131684868|NCT02592018|474130787|FG000|Overall Study|Adverse Event|1|||
131684869|NCT02592018|474130787|FG000|Overall Study|Lost to Follow-up|1|||
131684870|NCT02710136|474130790|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
131684871|NCT02710136|474130791|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
131684872|NCT00418665|474130792|FG000|Treatment Period|Ineligibility determined|1|||
131684873|NCT00418665|474130793|FG001|Treatment Period|Ineligibility determined|1|||
131684874|NCT00418665|474130794|FG002|Treatment Period|Ineligibility determined|0|||
131684875|NCT00418665|474130792|FG000|Treatment Period|Adverse Event|2|||
131684876|NCT00418665|474130793|FG001|Treatment Period|Adverse Event|2|||
131684877|NCT00418665|474130794|FG002|Treatment Period|Adverse Event|0|||
131555979|NCT01121484|473660292|FG000|Overall Study|Physician Decision|0|||
131684878|NCT00418665|474130792|FG000|Treatment Period|Withdrawal by Subject|0|||
131684879|NCT00418665|474130793|FG001|Treatment Period|Withdrawal by Subject|3|||
131684880|NCT00418665|474130794|FG002|Treatment Period|Withdrawal by Subject|1|||
131684881|NCT00418665|474130792|FG000|Treatment Period|Requirement for alternative therapy|1|||
131684882|NCT00418665|474130793|FG001|Treatment Period|Requirement for alternative therapy|0|||
131684883|NCT00418665|474130794|FG002|Treatment Period|Requirement for alternative therapy|0|||
131684884|NCT00418665|474130792|FG000|Treatment Period|Physician Decision|1|||
131684885|NCT00418665|474130793|FG001|Treatment Period|Physician Decision|0|||
131684886|NCT00418665|474130794|FG002|Treatment Period|Physician Decision|3|||
131684887|NCT00418665|474130792|FG000|Treatment Extension|Adverse Event|1|||
131684888|NCT00418665|474130793|FG001|Treatment Extension|Adverse Event|0|||
131684889|NCT00418665|474130794|FG002|Treatment Extension|Adverse Event|0|||
131684890|NCT00418665|474130792|FG000|Treatment Extension|Withdrawal by Subject|1|||
131684891|NCT00418665|474130793|FG001|Treatment Extension|Withdrawal by Subject|0|||
131684892|NCT00418665|474130794|FG002|Treatment Extension|Withdrawal by Subject|0|||
131684893|NCT00418665|474130792|FG000|Treatment Extension|Requirement for alternative therapy|2|||
131684894|NCT00418665|474130793|FG001|Treatment Extension|Requirement for alternative therapy|2|||
131684895|NCT00418665|474130794|FG002|Treatment Extension|Requirement for alternative therapy|0|||
131684896|NCT00418665|474130792|FG000|Treatment Extension|Physician Decision|2|||
131684897|NCT00418665|474130793|FG001|Treatment Extension|Physician Decision|2|||
131684898|NCT00418665|474130794|FG002|Treatment Extension|Physician Decision|1|||
131684899|NCT00418665|474130792|FG000|Treatment Extension|Death|0|||
131684900|NCT00418665|474130793|FG001|Treatment Extension|Death|0|||
131684901|NCT00418665|474130794|FG002|Treatment Extension|Death|1|||
131684902|NCT01133379|474130797|FG000|Overall Study|Withdrawal by Subject|0|||
131684903|NCT01133379|474130798|FG001|Overall Study|Withdrawal by Subject|1|||
131684904|NCT01133379|474130799|FG002|Overall Study|Withdrawal by Subject|1|||
131684905|NCT01133379|474130797|FG000|Overall Study|Lost to Follow-up|1|||
131684906|NCT01133379|474130798|FG001|Overall Study|Lost to Follow-up|1|||
131684907|NCT01133379|474130799|FG002|Overall Study|Lost to Follow-up|1|||
131684908|NCT01704287|474131832|FG000|Initial Treatment Period|Death|139|||
131684909|NCT01704287|474131833|FG001|Initial Treatment Period|Death|129|||
131684910|NCT01704287|474131834|FG002|Initial Treatment Period|Death|71|||
131684911|NCT01704287|474131835|FG003|Initial Treatment Period|Death|0|||
131684912|NCT01704287|474131836|FG004|Initial Treatment Period|Death|0|||
131684913|NCT01704287|474131832|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
131684914|NCT01704287|474131833|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
131684915|NCT01704287|474131834|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
131684916|NCT01704287|474131835|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
131684917|NCT01704287|474131836|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
131684918|NCT01704287|474131832|FG000|Initial Treatment Period|Lost to Follow-up|5|||
131684919|NCT01704287|474131833|FG001|Initial Treatment Period|Lost to Follow-up|3|||
131684920|NCT01704287|474131834|FG002|Initial Treatment Period|Lost to Follow-up|0|||
131684921|NCT01704287|474131835|FG003|Initial Treatment Period|Lost to Follow-up|0|||
131684922|NCT01704287|474131836|FG004|Initial Treatment Period|Lost to Follow-up|0|||
131684923|NCT01704287|474131832|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
131684924|NCT01704287|474131833|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
131684925|NCT01704287|474131834|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
131684926|NCT01704287|474131835|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
131684927|NCT01704287|474131836|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
131684928|NCT01704287|474131832|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
131684929|NCT01704287|474131833|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
131684930|NCT01704287|474131834|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
131684931|NCT01704287|474131835|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
131684932|NCT01704287|474131836|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
131684933|NCT01704287|474131832|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
131684934|NCT01704287|474131833|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
131684935|NCT01704287|474131834|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
131684936|NCT01704287|474131835|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
131684937|NCT01704287|474131836|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
131684938|NCT01704287|474131832|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131684939|NCT01704287|474131833|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131684940|NCT01704287|474131834|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131684941|NCT01704287|474131835|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
131684942|NCT01704287|474131836|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131684943|NCT04024228|474131837|FG000|Overall Study|Adverse Event|1|||
131684944|NCT04024228|474131838|FG001|Overall Study|Adverse Event|0|||
131684945|NCT04024228|474131837|FG000|Overall Study|Protocol Deviation|0|||
131684946|NCT04024228|474131838|FG001|Overall Study|Protocol Deviation|2|||
131684947|NCT04024228|474131837|FG000|Overall Study|Withdrawal by Subject|3|||
131684948|NCT04024228|474131838|FG001|Overall Study|Withdrawal by Subject|4|||
131684949|NCT04490395|474131839|FG000|Overall Study|Lost to Follow-up|0|||
131684950|NCT04490395|474131840|FG001|Overall Study|Lost to Follow-up|1|||
131684951|NCT00938717|474131841|FG000|Overall Study|Adverse Event|10|||
131684952|NCT00938717|474131842|FG001|Overall Study|Adverse Event|41|||
131684953|NCT00938717|474131841|FG000|Overall Study|Protocol Violation|11|||
131684954|NCT00938717|474131842|FG001|Overall Study|Protocol Violation|8|||
131684955|NCT00938717|474131841|FG000|Overall Study|Withdrawal by Subject|26|||
131684956|NCT00938717|474131842|FG001|Overall Study|Withdrawal by Subject|24|||
131684957|NCT00938717|474131841|FG000|Overall Study|Lost to Follow-up|13|||
131684958|NCT00938717|474131842|FG001|Overall Study|Lost to Follow-up|18|||
131684959|NCT00938717|474131841|FG000|Overall Study|Lack of Efficacy|33|||
131684960|NCT00938717|474131842|FG001|Overall Study|Lack of Efficacy|15|||
131684961|NCT00938717|474131841|FG000|Overall Study|Other reason|5|||
131684962|NCT00938717|474131842|FG001|Overall Study|Other reason|2|||
131684963|NCT01462435|474131843|FG000|Overall Study|Lack of Efficacy|1|||
131684964|NCT01462435|474131844|FG001|Overall Study|Lack of Efficacy|0|||
131684965|NCT01462435|474131845|FG002|Overall Study|Lack of Efficacy|0|||
131684966|NCT01462435|474131846|FG003|Overall Study|Lack of Efficacy|3|||
131684967|NCT01462435|474131843|FG000|Overall Study|Physician Decision|0|||
131684968|NCT01462435|474131844|FG001|Overall Study|Physician Decision|0|||
131684969|NCT01462435|474131845|FG002|Overall Study|Physician Decision|1|||
131684970|NCT01462435|474131846|FG003|Overall Study|Physician Decision|0|||
131684971|NCT01462435|474131843|FG000|Overall Study|Withdrawal by Subject|0|||
131684972|NCT01462435|474131844|FG001|Overall Study|Withdrawal by Subject|0|||
131684973|NCT01462435|474131845|FG002|Overall Study|Withdrawal by Subject|0|||
131684974|NCT01462435|474131846|FG003|Overall Study|Withdrawal by Subject|1|||
131684975|NCT01462435|474131843|FG000|Overall Study|Lost to Follow-up|0|||
131772677|NCT03996694|474446729|FG000|First Washout (7 Days)|Adverse Event|0|||
131772678|NCT03996694|474446730|FG001|First Washout (7 Days)|Adverse Event|1|||
131772679|NCT03996694|474446731|FG002|First Washout (7 Days)|Adverse Event|0|||
131772680|NCT03996694|474446732|FG003|First Washout (7 Days)|Adverse Event|0|||
131772681|NCT03996694|474446733|FG004|First Washout (7 Days)|Adverse Event|0|||
131772682|NCT03996694|474446734|FG005|First Washout (7 Days)|Adverse Event|0|||
131772683|NCT03996694|474446729|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
131772684|NCT03996694|474446730|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
131772685|NCT03996694|474446731|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
131772686|NCT03996694|474446732|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
131772687|NCT03996694|474446733|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
131772688|NCT03996694|474446734|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
131772689|NCT03996694|474446729|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
131772690|NCT03996694|474446730|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
131772691|NCT03996694|474446731|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
131772692|NCT03996694|474446732|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
131772693|NCT03996694|474446733|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
131772694|NCT03996694|474446734|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
131898509|NCT00320788|474914096|FG000|Overall Study|Lost to Follow-up|0|||
131684976|NCT01462435|474131844|FG001|Overall Study|Lost to Follow-up|0|||
131684977|NCT01462435|474131845|FG002|Overall Study|Lost to Follow-up|0|||
131684978|NCT01462435|474131846|FG003|Overall Study|Lost to Follow-up|1|||
131684979|NCT01007032|474131853|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
131684980|NCT01007032|474131854|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
131684981|NCT01007032|474131855|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
131684982|NCT01007032|474131856|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
131684983|NCT01007032|474131853|FG000|Overall Study|Withdrawal by Subject|0|||
131684984|NCT01007032|474131854|FG001|Overall Study|Withdrawal by Subject|0|||
131772695|NCT02777554|474446735|FG000|Overall Study|Adverse Event|4|||
131772696|NCT02777554|474446736|FG001|Overall Study|Adverse Event|4|||
131772697|NCT02777554|474446737|FG002|Overall Study|Adverse Event|0|||
131772698|NCT02777554|474446738|FG003|Overall Study|Adverse Event|1|||
131772699|NCT02777554|474446739|FG004|Overall Study|Adverse Event|0|||
131772700|NCT02777554|474446740|FG005|Overall Study|Adverse Event|0|||
131772701|NCT02777554|474446735|FG000|Overall Study|Withdrawal by Subject|3|||
131772702|NCT02777554|474446736|FG001|Overall Study|Withdrawal by Subject|1|||
131772703|NCT02777554|474446737|FG002|Overall Study|Withdrawal by Subject|1|||
131772704|NCT02777554|474446738|FG003|Overall Study|Withdrawal by Subject|0|||
131772705|NCT02777554|474446739|FG004|Overall Study|Withdrawal by Subject|0|||
131772706|NCT02777554|474446740|FG005|Overall Study|Withdrawal by Subject|0|||
131772707|NCT02777554|474446735|FG000|Overall Study|Discharged early due to hurricane|22|||
131772708|NCT02777554|474446736|FG001|Overall Study|Discharged early due to hurricane|20|||
131772709|NCT02777554|474446737|FG002|Overall Study|Discharged early due to hurricane|0|||
131772710|NCT02777554|474446738|FG003|Overall Study|Discharged early due to hurricane|0|||
131772711|NCT02777554|474446739|FG004|Overall Study|Discharged early due to hurricane|0|||
131772712|NCT02777554|474446740|FG005|Overall Study|Discharged early due to hurricane|0|||
131772713|NCT02777554|474446735|FG000|Overall Study|Other - Miscellaneous|1|||
131772714|NCT02777554|474446736|FG001|Overall Study|Other - Miscellaneous|0|||
131772715|NCT02777554|474446737|FG002|Overall Study|Other - Miscellaneous|0|||
131772716|NCT02777554|474446738|FG003|Overall Study|Other - Miscellaneous|0|||
131772717|NCT02777554|474446739|FG004|Overall Study|Other - Miscellaneous|0|||
131772718|NCT02777554|474446740|FG005|Overall Study|Other - Miscellaneous|0|||
131772719|NCT00066573|474446741|FG000|Overall Study|Did not received protocol treatment|28|||
131772720|NCT00066573|474446742|FG001|Overall Study|Did not received protocol treatment|28|||
131772721|NCT01458535|474446743|FG000|Overall Study|Other|0|||
131772722|NCT01458535|474446744|FG001|Overall Study|Other|0|||
131772723|NCT01458535|474446745|FG002|Overall Study|Other|0|||
131772724|NCT01458535|474446746|FG003|Overall Study|Other|0|||
131772725|NCT01458535|474446747|FG004|Overall Study|Other|1|||
131772726|NCT01458535|474446748|FG005|Overall Study|Other|1|||
131772727|NCT01458535|474446743|FG000|Overall Study|Withdrawal by Subject|0|||
131772728|NCT01458535|474446744|FG001|Overall Study|Withdrawal by Subject|0|||
131772729|NCT01458535|474446745|FG002|Overall Study|Withdrawal by Subject|2|||
131772730|NCT01458535|474446746|FG003|Overall Study|Withdrawal by Subject|0|||
131772731|NCT01458535|474446747|FG004|Overall Study|Withdrawal by Subject|1|||
131772732|NCT01458535|474446748|FG005|Overall Study|Withdrawal by Subject|1|||
131772733|NCT01458535|474446743|FG000|Overall Study|Lost to Follow-up|0|||
131772734|NCT01458535|474446744|FG001|Overall Study|Lost to Follow-up|2|||
131772735|NCT01458535|474446745|FG002|Overall Study|Lost to Follow-up|0|||
131772736|NCT01458535|474446746|FG003|Overall Study|Lost to Follow-up|3|||
131772737|NCT01458535|474446747|FG004|Overall Study|Lost to Follow-up|2|||
131772738|NCT01458535|474446748|FG005|Overall Study|Lost to Follow-up|2|||
131772739|NCT01458535|474446743|FG000|Overall Study|Adverse Event|0|||
131772740|NCT01458535|474446744|FG001|Overall Study|Adverse Event|0|||
131772741|NCT01458535|474446745|FG002|Overall Study|Adverse Event|0|||
131772742|NCT01458535|474446746|FG003|Overall Study|Adverse Event|1|||
131772743|NCT01458535|474446747|FG004|Overall Study|Adverse Event|0|||
131772744|NCT01458535|474446748|FG005|Overall Study|Adverse Event|0|||
131772745|NCT04001790|474446749|FG000|Overall Study|Withdrawal by Subject|1|||
131772746|NCT04001790|474446750|FG001|Overall Study|Withdrawal by Subject|2|||
131772747|NCT02706327|474446751|FG000|Overall Study|Lost to Follow-up|1|||
131772748|NCT02706327|474446752|FG001|Overall Study|Lost to Follow-up|1|||
131772749|NCT02706327|474446753|FG002|Overall Study|Lost to Follow-up|2|||
131772750|NCT03471507|474446759|FG000|Overall Study|Lost to Follow-up|1|||
131772751|NCT03471507|474446760|FG001|Overall Study|Lost to Follow-up|3|||
131772752|NCT03471507|474446759|FG000|Overall Study|Physician Decision|0|||
131772753|NCT03471507|474446760|FG001|Overall Study|Physician Decision|1|||
131772754|NCT03471507|474446759|FG000|Overall Study|Withdrawal by Subject|2|||
131772755|NCT03471507|474446760|FG001|Overall Study|Withdrawal by Subject|1|||
131772756|NCT02213666|474446761|FG000|Overall Study|Withdrawal by Subject|1|||
131772757|NCT00750061|474446765|FG000|Overall Study|Adverse Event|2|||
131772758|NCT00750061|474446766|FG001|Overall Study|Adverse Event|0|||
131772759|NCT00750061|474446765|FG000|Overall Study|Withdrawal by Subject|0|||
131772760|NCT00750061|474446766|FG001|Overall Study|Withdrawal by Subject|1|||
131772761|NCT00750061|474446765|FG000|Overall Study|Physician Decision|0|||
131772762|NCT00750061|474446766|FG001|Overall Study|Physician Decision|1|||
131772763|NCT00229931|474446773|FG000|Overall Study|Death|1|||
131772764|NCT00229931|474446774|FG001|Overall Study|Death|0|||
131772765|NCT00229931|474446773|FG000|Overall Study|Lost to Follow-up|3|||
131772766|NCT00229931|474446774|FG001|Overall Study|Lost to Follow-up|2|||
131772767|NCT02992743|474446775|FG000|Overall Study|Withdrawal by Subject|1|||
131772768|NCT02992743|474446776|FG001|Overall Study|Withdrawal by Subject|1|||
131772769|NCT02992743|474446775|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
131772770|NCT02992743|474446776|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
131898510|NCT00320788|474914097|FG001|Overall Study|Lost to Follow-up|2|||
131772771|NCT02992743|474446775|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
131684985|NCT01007032|474131855|FG002|Overall Study|Withdrawal by Subject|0|||
131772772|NCT02992743|474446776|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
131772773|NCT02992743|474446775|FG000|Overall Study|No measurable disease|1|||
131772774|NCT02992743|474446776|FG001|Overall Study|No measurable disease|0|||
131772775|NCT02992743|474446775|FG000|Overall Study|Lost to Follow-up|0|||
131772776|NCT02992743|474446776|FG001|Overall Study|Lost to Follow-up|1|||
131772777|NCT02067728|474446777|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
131772778|NCT02067728|474446778|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
131772779|NCT02067728|474446777|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
131772780|NCT02067728|474446778|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
131772781|NCT02067728|474446777|FG000|6 Month Measurements|Unable to attend|114|||
131772782|NCT02067728|474446778|FG001|6 Month Measurements|Unable to attend|97|||
131772783|NCT04629534|474446779|FG000|Overall Study|Physician Decision|1|||
131772784|NCT04629534|474446780|FG001|Overall Study|Physician Decision|0|||
131772785|NCT04629534|474446779|FG000|Overall Study|Protocol Violation|0|||
131772786|NCT04629534|474446780|FG001|Overall Study|Protocol Violation|2|||
131772787|NCT03732534|474446781|FG000|Overall Study|Study terminated by Sponsor|6|||
131772788|NCT02190604|474446782|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772789|NCT02190604|474446783|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772790|NCT02190604|474446784|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772791|NCT02190604|474446785|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772792|NCT02190604|474446786|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772793|NCT02190604|474446787|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772794|NCT02190604|474446788|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772795|NCT02190604|474446789|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772796|NCT02190604|474446790|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772797|NCT02190604|474446791|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772798|NCT02190604|474446792|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772799|NCT02190604|474446793|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772800|NCT02190604|474446794|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772801|NCT02190604|474446795|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772802|NCT02190604|474446796|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
131772803|NCT02190604|474446797|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772804|NCT02190604|474446798|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772805|NCT02190604|474446799|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772806|NCT02190604|474446800|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131772807|NCT02190604|474446782|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772808|NCT02190604|474446783|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772809|NCT02190604|474446784|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772810|NCT02190604|474446785|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772811|NCT02190604|474446786|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772812|NCT02190604|474446787|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772813|NCT02190604|474446788|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772814|NCT02190604|474446789|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772815|NCT02190604|474446790|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772816|NCT02190604|474446791|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772817|NCT02190604|474446792|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772818|NCT02190604|474446793|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772819|NCT02190604|474446794|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772820|NCT02190604|474446795|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
131772821|NCT02190604|474446796|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772822|NCT02190604|474446797|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772823|NCT02190604|474446798|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772824|NCT02190604|474446799|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772825|NCT02190604|474446800|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131772826|NCT02797951|474446801|FG000|Overall Study|Adverse Event|4|||
131772827|NCT02797951|474446801|FG000|Overall Study|Death|1|||
131772828|NCT02797951|474446801|FG000|Overall Study|Lack of Efficacy|19|||
131772829|NCT02797951|474446801|FG000|Overall Study|Lost to Follow-up|4|||
131772830|NCT02797951|474446801|FG000|Overall Study|Physician Decision|6|||
131772831|NCT02797951|474446801|FG000|Overall Study|Withdrawal by Subject|15|||
131772832|NCT00814502|474446802|FG000|Overall Study|Adverse Event|1|||
131684986|NCT01007032|474131856|FG003|Overall Study|Withdrawal by Subject|1|||
131684987|NCT01841749|474131857|FG000|Overall Study|Protocol Violation|1|||
131684988|NCT00677820|474131858|FG000|Overall Study|Lost to Follow-up|1|||
131684989|NCT00677820|474131859|FG001|Overall Study|Lost to Follow-up|0|||
131684990|NCT00290290|474131860|FG000|Overall Study|Death|3|||
131684991|NCT00290290|474131861|FG001|Overall Study|Death|4|||
131684992|NCT00290290|474131860|FG000|Overall Study|Withdrawal by Subject|2|||
131772833|NCT00814502|474446803|FG001|Overall Study|Adverse Event|0|||
131772834|NCT00814502|474446802|FG000|Overall Study|Withdrawal by Subject|0|||
131684993|NCT00290290|474131861|FG001|Overall Study|Withdrawal by Subject|2|||
131684994|NCT00290290|474131860|FG000|Overall Study|Underwent clean surgical procedure|13|||
131684995|NCT00290290|474131861|FG001|Overall Study|Underwent clean surgical procedure|12|||
131684996|NCT01537198|474131878|FG000|Overall Study|RSV infection|2|||
131684997|NCT01537198|474131878|FG000|Overall Study|Adverse Event|4|||
131684998|NCT01537198|474131878|FG000|Overall Study|No Further Visits to the Clinic|37|||
131684999|NCT01537198|474131878|FG000|Overall Study|Other|111|||
131685000|NCT01231659|474131879|FG000|Overall Study|Adverse Event|9|||
131685001|NCT01231659|474131879|FG000|Overall Study|Disease Progression|48|||
131685002|NCT01231659|474131879|FG000|Overall Study|Death|2|||
131685003|NCT01231659|474131879|FG000|Overall Study|Patient refused to complete study visit|1|||
131685004|NCT01231659|474131879|FG000|Overall Study|Other protocol defined criteria|12|||
131685005|NCT04534491|474131880|FG000|Overall Study|Not completed end-of-study interview|24|||
131685006|NCT04534491|474131880|FG000|Overall Study|Non-users|70|||
131685007|NCT04534491|474131880|FG000|Overall Study|Non-verifiable users|58|||
131685008|NCT00131469|474131882|FG000|Overall Study|Withdrawal by Subject|3|||
131685009|NCT00131469|474131883|FG001|Overall Study|Withdrawal by Subject|4|||
131685010|NCT00131469|474131882|FG000|Overall Study|Protocol Violation|3|||
131685011|NCT00131469|474131883|FG001|Overall Study|Protocol Violation|1|||
131685012|NCT00131469|474131882|FG000|Overall Study|Death|0|||
131685013|NCT00131469|474131883|FG001|Overall Study|Death|1|||
131685014|NCT00131469|474131882|FG000|Overall Study|Lost to Follow-up|0|||
131685015|NCT00131469|474131883|FG001|Overall Study|Lost to Follow-up|1|||
131685016|NCT00131469|474131882|FG000|Overall Study|scan not analyzable|3|||
131772835|NCT00814502|474446803|FG001|Overall Study|Withdrawal by Subject|2|||
131772836|NCT03735849|474446804|FG000|Overall Study|Lost to Follow-up|1|||
131772837|NCT03735849|474446805|FG001|Overall Study|Lost to Follow-up|0|||
131772838|NCT03735849|474446806|FG002|Overall Study|Lost to Follow-up|0|||
131555980|NCT01121484|473660293|FG001|Overall Study|Physician Decision|3|||
131685017|NCT00131469|474131883|FG001|Overall Study|scan not analyzable|6|||
131772839|NCT03735849|474446804|FG000|Overall Study|Participant unable to adhere to visit|1|||
131772840|NCT03735849|474446805|FG001|Overall Study|Participant unable to adhere to visit|0|||
131555981|NCT01121484|473660292|FG000|Overall Study|Protocol Violation|1|||
131685018|NCT00356889|474131885|FG000|Overall Study|Protocol Violation|2|||
131685019|NCT00356889|474131885|FG000|Overall Study|Adverse Event|1|||
131685020|NCT02247960|474131886|FG000|Patient Consent and Randomization|Physician Decision|2|||
131772841|NCT03735849|474446806|FG002|Overall Study|Participant unable to adhere to visit|0|||
131555982|NCT01121484|473660293|FG001|Overall Study|Protocol Violation|0|||
131685021|NCT02247960|474131887|FG001|Patient Consent and Randomization|Physician Decision|2|||
131685022|NCT02247960|474131886|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
131685023|NCT02247960|474131887|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
131685024|NCT02247960|474131886|FG000|Catheter Removed|Lost to Follow-up|7|||
131685025|NCT02247960|474131887|FG001|Catheter Removed|Lost to Follow-up|10|||
131685026|NCT00736034|474131888|FG000|Overall Study|Adverse Event|2|||
131685027|NCT00073528|474131895|FG000|Overall Study|Death|488|||
131685028|NCT00073528|474131896|FG001|Overall Study|Death|473|||
131685029|NCT00073528|474131895|FG000|Overall Study|Lost to Follow-up|52|||
131685030|NCT00073528|474131896|FG001|Overall Study|Lost to Follow-up|45|||
131898511|NCT00320788|474914098|FG002|Overall Study|Lost to Follow-up|1|||
131685031|NCT00073528|474131895|FG000|Overall Study|Withdrawal by Subject|50|||
131685032|NCT00073528|474131896|FG001|Overall Study|Withdrawal by Subject|45|||
131685033|NCT00073528|474131895|FG000|Overall Study|Study terminated by Sponsor|10|||
131685034|NCT00073528|474131896|FG001|Overall Study|Study terminated by Sponsor|29|||
131685035|NCT00073528|474131895|FG000|Overall Study|Other|18|||
131685036|NCT00073528|474131896|FG001|Overall Study|Other|19|||
131685037|NCT00073528|474131895|FG000|Overall Study|Other|9|||
131685038|NCT00073528|474131896|FG001|Overall Study|Other|12|||
131685039|NCT00073528|474131895|FG000|Overall Study|Protocol Violation|3|||
131685040|NCT00073528|474131896|FG001|Overall Study|Protocol Violation|5|||
131685041|NCT03086057|474131897|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
131685042|NCT03086057|474131898|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
131685043|NCT03086057|474131899|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
131685044|NCT03086057|474131900|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
131685045|NCT03086057|474131897|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
131685046|NCT03086057|474131898|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
131685047|NCT03086057|474131899|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
131685048|NCT03086057|474131900|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
131685049|NCT03086057|474131897|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
131772842|NCT03735849|474446804|FG000|Overall Study|Not Randomized|0|||
131772843|NCT03735849|474446805|FG001|Overall Study|Not Randomized|0|||
131772844|NCT03735849|474446806|FG002|Overall Study|Not Randomized|4|||
131772845|NCT04585906|474446809|FG000|Overall Study|Lost to Follow-up|8|||
131772846|NCT04585906|474446810|FG001|Overall Study|Lost to Follow-up|5|||
131772847|NCT01428882|474446818|FG000|Overall Study|Lack of Efficacy|2|||
131772848|NCT01428882|474446819|FG001|Overall Study|Lack of Efficacy|7|||
131772849|NCT01428882|474446818|FG000|Overall Study|Protocol Violation|4|||
131772850|NCT01428882|474446819|FG001|Overall Study|Protocol Violation|3|||
131772851|NCT00429026|474446822|FG000|Overall Study|Inevaluable for response.|40|||
131772852|NCT02219477|474446825|FG000|Overall Study|Adverse Event|0|||
131772853|NCT02219477|474446826|FG001|Overall Study|Adverse Event|1|||
131772854|NCT02219477|474446827|FG002|Overall Study|Adverse Event|1|||
131772855|NCT02219477|474446825|FG000|Overall Study|Withdrawal by Subject|0|||
131772856|NCT02219477|474446826|FG001|Overall Study|Withdrawal by Subject|1|||
131772857|NCT02219477|474446827|FG002|Overall Study|Withdrawal by Subject|0|||
131772858|NCT00976989|474446836|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131898512|NCT00320788|474914099|FG003|Overall Study|Lost to Follow-up|0|||
131772859|NCT00976989|474446837|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
131772860|NCT00976989|474446838|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
131772861|NCT00976989|474446836|FG000|Overall Study|Death|5|||
131772862|NCT00976989|474446837|FG001|Overall Study|Death|7|||
131685050|NCT03086057|474131898|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
131685051|NCT03086057|474131899|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
131685052|NCT03086057|474131900|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
131685053|NCT03086057|474131897|FG000|Stage 1: PrEP Uptake|Death|1|||
131685054|NCT03086057|474131898|FG001|Stage 1: PrEP Uptake|Death|0|||
131685055|NCT03086057|474131899|FG002|Stage 1: PrEP Uptake|Death|0|||
131685056|NCT03086057|474131900|FG003|Stage 1: PrEP Uptake|Death|0|||
131685057|NCT03086057|474131897|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
131685058|NCT03086057|474131898|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
131685059|NCT03086057|474131899|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
131685060|NCT03086057|474131900|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
131685061|NCT03086057|474131897|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
131685062|NCT03086057|474131898|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
131685063|NCT03086057|474131899|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
131685064|NCT03086057|474131900|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
131685065|NCT03086057|474131897|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
131685066|NCT03086057|474131898|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
131685067|NCT03086057|474131899|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
131685068|NCT03086057|474131900|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
131685069|NCT04305275|474131901|FG000|Overall Study|Adverse Event|4|||
131685070|NCT04305275|474131902|FG001|Overall Study|Adverse Event|0|||
131685071|NCT04305275|474131901|FG000|Overall Study|Lost to Follow-up|1|||
131685072|NCT04305275|474131902|FG001|Overall Study|Lost to Follow-up|1|||
131685073|NCT04305275|474131901|FG000|Overall Study|Withdrawal by Participant|8|||
131685074|NCT04305275|474131902|FG001|Overall Study|Withdrawal by Participant|1|||
131685075|NCT01536951|474131912|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685076|NCT01536951|474131913|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685077|NCT01536951|474131914|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
131685078|NCT01536951|474131915|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685079|NCT01536951|474131916|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685080|NCT01536951|474131917|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685081|NCT01536951|474131918|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685082|NCT01536951|474131919|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685083|NCT01536951|474131920|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131685084|NCT01536951|474131912|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
131685085|NCT01536951|474131913|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
131685086|NCT01536951|474131914|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
131685087|NCT01536951|474131915|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
131685088|NCT01536951|474131916|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
131685089|NCT01536951|474131917|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
131685090|NCT01536951|474131918|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
131685091|NCT01536951|474131919|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
131685092|NCT01536951|474131920|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
131685093|NCT01843972|474131921|FG000|Overall Study|Withdrawal by Subject|0|||
131685094|NCT01843972|474131922|FG001|Overall Study|Withdrawal by Subject|0|||
131685095|NCT01843972|474131923|FG002|Overall Study|Withdrawal by Subject|0|||
131685096|NCT01843972|474131924|FG003|Overall Study|Withdrawal by Subject|0|||
131685097|NCT01843972|474131925|FG004|Overall Study|Withdrawal by Subject|1|||
131685098|NCT01843972|474131926|FG005|Overall Study|Withdrawal by Subject|0|||
131685099|NCT01843972|474131927|FG006|Overall Study|Withdrawal by Subject|0|||
131685100|NCT01843972|474131928|FG007|Overall Study|Withdrawal by Subject|0|||
131685101|NCT01843972|474131929|FG008|Overall Study|Withdrawal by Subject|0|||
131685102|NCT01843972|474131930|FG009|Overall Study|Withdrawal by Subject|0|||
131685103|NCT00789880|474131931|FG000|Overall Study|Adverse Event|0|||
131685104|NCT00789880|474131932|FG001|Overall Study|Adverse Event|0|||
131685105|NCT00789880|474131933|FG002|Overall Study|Adverse Event|0|||
131685106|NCT00789880|474131934|FG003|Overall Study|Adverse Event|0|||
131685107|NCT00789880|474131935|FG004|Overall Study|Adverse Event|1|||
131685108|NCT00789880|474131936|FG005|Overall Study|Adverse Event|0|||
131685109|NCT00789880|474131931|FG000|Overall Study|Protocol Violation|0|||
131685110|NCT00789880|474131932|FG001|Overall Study|Protocol Violation|1|||
131685111|NCT00789880|474131933|FG002|Overall Study|Protocol Violation|0|||
131685112|NCT00789880|474131934|FG003|Overall Study|Protocol Violation|1|||
131685113|NCT00789880|474131935|FG004|Overall Study|Protocol Violation|0|||
131772863|NCT00976989|474446838|FG002|Overall Study|Death|10|||
131772864|NCT00976989|474446836|FG000|Overall Study|Refused Treatment|4|||
131772865|NCT00976989|474446837|FG001|Overall Study|Refused Treatment|3|||
131772866|NCT00976989|474446838|FG002|Overall Study|Refused Treatment|5|||
131772867|NCT00976989|474446836|FG000|Overall Study|Failure to Return|2|||
131772868|NCT00976989|474446837|FG001|Overall Study|Failure to Return|1|||
131898513|NCT00320788|474914100|FG004|Overall Study|Lost to Follow-up|0|||
131555983|NCT01121484|473660292|FG000|Overall Study|Withdrawal by Subject|8|||
131772869|NCT00976989|474446838|FG002|Overall Study|Failure to Return|0|||
131772870|NCT00976989|474446836|FG000|Overall Study|Recurrence of Disease|0|||
131898514|NCT00320788|474914096|FG000|Overall Study|Decision by the Sponsor|1|||
131685114|NCT00789880|474131936|FG005|Overall Study|Protocol Violation|0|||
131685115|NCT00789880|474131931|FG000|Overall Study|Withdrawal by Subject|1|||
131685116|NCT00789880|474131932|FG001|Overall Study|Withdrawal by Subject|0|||
131685117|NCT00789880|474131933|FG002|Overall Study|Withdrawal by Subject|0|||
131685118|NCT00789880|474131934|FG003|Overall Study|Withdrawal by Subject|0|||
131685119|NCT00789880|474131935|FG004|Overall Study|Withdrawal by Subject|2|||
131898515|NCT00320788|474914097|FG001|Overall Study|Decision by the Sponsor|1|||
131685120|NCT00789880|474131936|FG005|Overall Study|Withdrawal by Subject|0|||
131685121|NCT01977820|474131941|FG000|Overall Study|Sponsor terminated the study|1|||
131685122|NCT01977820|474131942|FG001|Overall Study|Sponsor terminated the study|1|||
131685123|NCT02568475|474131943|FG000|Overall Study|Lost to Follow-up|40|||
131685124|NCT02568475|474131944|FG001|Overall Study|Lost to Follow-up|39|||
131685125|NCT02568475|474131943|FG000|Overall Study|Withdrawal by Subject|2|||
131685126|NCT02568475|474131944|FG001|Overall Study|Withdrawal by Subject|0|||
131685127|NCT02568475|474131943|FG000|Overall Study|Discharged home|4|||
131685128|NCT02568475|474131944|FG001|Overall Study|Discharged home|4|||
131685129|NCT02568475|474131943|FG000|Overall Study|Short-term: Discharge location unknown|4|||
131685130|NCT02568475|474131944|FG001|Overall Study|Short-term: Discharge location unknown|0|||
131685131|NCT02568475|474131943|FG000|Overall Study|Transferred to another facility|1|||
131685132|NCT02568475|474131944|FG001|Overall Study|Transferred to another facility|0|||
131685133|NCT00493220|474131945|FG000|Third Intervention|Withdrawal by Subject|1|||
131685134|NCT00493220|474131946|FG001|Third Intervention|Withdrawal by Subject|0|||
131685135|NCT00493220|474131947|FG002|Third Intervention|Withdrawal by Subject|0|||
131685136|NCT00493220|474131948|FG003|Third Intervention|Withdrawal by Subject|0|||
131685137|NCT00493220|474131949|FG004|Third Intervention|Withdrawal by Subject|0|||
131685138|NCT00493220|474131950|FG005|Third Intervention|Withdrawal by Subject|0|||
131685139|NCT02625233|474131951|FG000|Overall Study|Adverse Event|2|||
131685140|NCT02625233|474131952|FG001|Overall Study|Adverse Event|0|||
131685141|NCT00445224|474131960|FG000|Specific Exercises|Withdrawal by Subject|3|||
131685142|NCT00445224|474131961|FG001|Specific Exercises|Withdrawal by Subject|3|||
131685143|NCT00445224|474131960|FG000|Specific Exercises|Withdrawal by Subject|1|||
131685144|NCT00445224|474131961|FG001|Specific Exercises|Withdrawal by Subject|0|||
131685145|NCT00591214|474131964|FG000|Overall Study|Physician Decision|7|||
131685146|NCT00591214|474131964|FG000|Overall Study|Withdrawal by Subject|1|||
131685147|NCT01129921|474131965|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
131685148|NCT01129921|474131966|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
131685149|NCT01129921|474131965|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
131685150|NCT01129921|474131966|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
131685151|NCT01129921|474131965|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
131685152|NCT01129921|474131966|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
131685153|NCT01129921|474131965|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
131685154|NCT01129921|474131966|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
131685155|NCT03697720|474133160|FG000|Overall Study|Lost to Follow-up|7|||
131685156|NCT05050318|474133165|FG000|Overall Study|Protocol Deviation|1|||
131685157|NCT05050318|474133166|FG001|Overall Study|Protocol Deviation|0|||
131685158|NCT05050318|474133167|FG002|Overall Study|Protocol Deviation|0|||
131685159|NCT00574145|474133175|FG000|Overall Study|Withdrawal by Subject|2|||
131685160|NCT00574145|474133176|FG001|Overall Study|Withdrawal by Subject|1|||
131685161|NCT03227471|474133180|FG000|Overall Study|Withdrawal by Subject|0|||
131685162|NCT03227471|474133181|FG001|Overall Study|Withdrawal by Subject|0|||
131685163|NCT03227471|474133182|FG002|Overall Study|Withdrawal by Subject|0|||
131685164|NCT03227471|474133183|FG003|Overall Study|Withdrawal by Subject|0|||
131685165|NCT03227471|474133184|FG004|Overall Study|Withdrawal by Subject|1|||
131685166|NCT03227471|474133185|FG005|Overall Study|Withdrawal by Subject|0|||
131685167|NCT03227471|474133186|FG006|Overall Study|Withdrawal by Subject|0|||
131685168|NCT03227471|474133187|FG007|Overall Study|Withdrawal by Subject|0|||
131685169|NCT03227471|474133188|FG008|Overall Study|Withdrawal by Subject|0|||
131685170|NCT03227471|474133189|FG009|Overall Study|Withdrawal by Subject|0|||
131685171|NCT03227471|474133190|FG010|Overall Study|Withdrawal by Subject|0|||
131685172|NCT03227471|474133191|FG011|Overall Study|Withdrawal by Subject|0|||
131772871|NCT00976989|474446837|FG001|Overall Study|Recurrence of Disease|1|||
131772872|NCT00976989|474446838|FG002|Overall Study|Recurrence of Disease|0|||
131772873|NCT00976989|474446836|FG000|Overall Study|Other|1|||
131772874|NCT00976989|474446837|FG001|Overall Study|Other|0|||
131772875|NCT00976989|474446838|FG002|Overall Study|Other|1|||
131772876|NCT01539512|474446839|FG000|Overall Study|Adverse Event|9|||
131772877|NCT01539512|474446840|FG001|Overall Study|Adverse Event|7|||
131772878|NCT01539512|474446839|FG000|Overall Study|Physician Decision|1|||
131772879|NCT01539512|474446840|FG001|Overall Study|Physician Decision|1|||
131772880|NCT01539512|474446839|FG000|Overall Study|Withdrawal by Subject|12|||
131772881|NCT01539512|474446840|FG001|Overall Study|Withdrawal by Subject|5|||
131772882|NCT01539512|474446839|FG000|Overall Study|Richter's Transformation|1|||
131772883|NCT01539512|474446840|FG001|Overall Study|Richter's Transformation|0|||
131772884|NCT04668157|474446841|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
131772885|NCT04668157|474446842|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
131772886|NCT04668157|474446841|FG000|Treatment Period (52 Weeks)|Other|0|||
131772887|NCT04668157|474446842|FG001|Treatment Period (52 Weeks)|Other|2|||
131772888|NCT04479358|474446849|FG000|Overall Study|Withdrawal by Subject|0|||
131772889|NCT04479358|474446850|FG001|Overall Study|Withdrawal by Subject|0|||
131772890|NCT04479358|474446851|FG002|Overall Study|Withdrawal by Subject|1|||
131772891|NCT04479358|474446852|FG003|Overall Study|Withdrawal by Subject|0|||
131772892|NCT04479358|474446853|FG004|Overall Study|Withdrawal by Subject|0|||
131685173|NCT03227471|474133192|FG012|Overall Study|Withdrawal by Subject|1|||
131685174|NCT03227471|474133193|FG013|Overall Study|Withdrawal by Subject|0|||
131685175|NCT03227471|474133194|FG014|Overall Study|Withdrawal by Subject|0|||
131685176|NCT03227471|474133180|FG000|Overall Study|Randomized, Never Dosed|0|||
131685177|NCT03227471|474133181|FG001|Overall Study|Randomized, Never Dosed|0|||
131685178|NCT03227471|474133182|FG002|Overall Study|Randomized, Never Dosed|0|||
131772893|NCT04479358|474446854|FG005|Overall Study|Withdrawal by Subject|1|||
131772894|NCT00764465|474446855|FG000|Overall Study|Adverse Event|2|||
131772895|NCT00764465|474446856|FG001|Overall Study|Adverse Event|0|||
131772896|NCT00764465|474446857|FG002|Overall Study|Adverse Event|0|||
131772897|NCT00764465|474446858|FG003|Overall Study|Adverse Event|1|||
131772898|NCT00764465|474446859|FG004|Overall Study|Adverse Event|1|||
131772899|NCT00764465|474446860|FG005|Overall Study|Adverse Event|1|||
131772900|NCT00764465|474446855|FG000|Overall Study|Withdrawal by Subject|0|||
131772901|NCT00764465|474446856|FG001|Overall Study|Withdrawal by Subject|1|||
131772902|NCT00764465|474446857|FG002|Overall Study|Withdrawal by Subject|1|||
131772903|NCT00764465|474446858|FG003|Overall Study|Withdrawal by Subject|0|||
131772904|NCT00764465|474446859|FG004|Overall Study|Withdrawal by Subject|0|||
131772905|NCT00764465|474446860|FG005|Overall Study|Withdrawal by Subject|0|||
131685179|NCT03227471|474133183|FG003|Overall Study|Randomized, Never Dosed|0|||
131685180|NCT03227471|474133184|FG004|Overall Study|Randomized, Never Dosed|0|||
131685181|NCT03227471|474133185|FG005|Overall Study|Randomized, Never Dosed|0|||
131685182|NCT03227471|474133186|FG006|Overall Study|Randomized, Never Dosed|0|||
131685183|NCT03227471|474133187|FG007|Overall Study|Randomized, Never Dosed|0|||
131685184|NCT03227471|474133188|FG008|Overall Study|Randomized, Never Dosed|0|||
131685185|NCT03227471|474133189|FG009|Overall Study|Randomized, Never Dosed|0|||
131685186|NCT03227471|474133190|FG010|Overall Study|Randomized, Never Dosed|0|||
131685187|NCT03227471|474133191|FG011|Overall Study|Randomized, Never Dosed|0|||
131685188|NCT03227471|474133192|FG012|Overall Study|Randomized, Never Dosed|0|||
131685189|NCT03227471|474133193|FG013|Overall Study|Randomized, Never Dosed|0|||
131685190|NCT03227471|474133194|FG014|Overall Study|Randomized, Never Dosed|1|||
131685191|NCT00382720|474133195|FG000|Overall Study|Adverse Event|21|||
131685192|NCT00382720|474133196|FG001|Overall Study|Adverse Event|23|||
131685193|NCT00382720|474133197|FG002|Overall Study|Adverse Event|15|||
131685194|NCT00382720|474133195|FG000|Overall Study|Protocol Violation|2|||
131685195|NCT00382720|474133196|FG001|Overall Study|Protocol Violation|5|||
131685196|NCT00382720|474133197|FG002|Overall Study|Protocol Violation|1|||
131685197|NCT00382720|474133195|FG000|Overall Study|Death|0|||
131685198|NCT00382720|474133196|FG001|Overall Study|Death|1|||
131685199|NCT00382720|474133197|FG002|Overall Study|Death|2|||
131685200|NCT00382720|474133195|FG000|Overall Study|Progressive disease|37|||
131685201|NCT00382720|474133196|FG001|Overall Study|Progressive disease|28|||
131685202|NCT00382720|474133197|FG002|Overall Study|Progressive disease|38|||
131685203|NCT00382720|474133195|FG000|Overall Study|Withdrew consent|1|||
131685204|NCT00382720|474133196|FG001|Overall Study|Withdrew consent|1|||
131685205|NCT00382720|474133197|FG002|Overall Study|Withdrew consent|2|||
131685206|NCT00382720|474133195|FG000|Overall Study|Withdrawal by Subject|11|||
131685207|NCT00382720|474133196|FG001|Overall Study|Withdrawal by Subject|20|||
131685208|NCT00382720|474133197|FG002|Overall Study|Withdrawal by Subject|12|||
131685209|NCT00382720|474133195|FG000|Overall Study|Surgery|1|||
131685210|NCT00382720|474133196|FG001|Overall Study|Surgery|1|||
131685211|NCT00382720|474133197|FG002|Overall Study|Surgery|4|||
131685212|NCT00382720|474133195|FG000|Overall Study|Patient did not receive study medication|1|||
131685213|NCT00382720|474133196|FG001|Overall Study|Patient did not receive study medication|1|||
131685214|NCT00382720|474133197|FG002|Overall Study|Patient did not receive study medication|4|||
131685215|NCT00382720|474133195|FG000|Overall Study|Clinically progressive disease|0|||
131685216|NCT00382720|474133196|FG001|Overall Study|Clinically progressive disease|1|||
131685217|NCT00382720|474133197|FG002|Overall Study|Clinically progressive disease|0|||
131685218|NCT00382720|474133195|FG000|Overall Study|Good prognosis|0|||
131685219|NCT00382720|474133196|FG001|Overall Study|Good prognosis|1|||
131685220|NCT00382720|474133197|FG002|Overall Study|Good prognosis|0|||
131685221|NCT00382720|474133195|FG000|Overall Study|Investigator/Clinical decision|5|||
131685222|NCT00382720|474133196|FG001|Overall Study|Investigator/Clinical decision|6|||
131685223|NCT00382720|474133197|FG002|Overall Study|Investigator/Clinical decision|6|||
131685224|NCT00382720|474133195|FG000|Overall Study|Discontinued at end of study|0|||
131685225|NCT00382720|474133196|FG001|Overall Study|Discontinued at end of study|1|||
131685226|NCT00382720|474133197|FG002|Overall Study|Discontinued at end of study|2|||
131685227|NCT02142738|474133200|FG000|Overall Study|Adverse Event|13|||
131685228|NCT02142738|474133201|FG001|Overall Study|Adverse Event|9|||
131685229|NCT02142738|474133200|FG000|Overall Study|Death|92|||
131685230|NCT02142738|474133201|FG001|Overall Study|Death|112|||
131685231|NCT02142738|474133200|FG000|Overall Study|Lost to Follow-up|0|||
131685232|NCT02142738|474133201|FG001|Overall Study|Lost to Follow-up|3|||
131685233|NCT02142738|474133200|FG000|Overall Study|Withdrawal by Subject|6|||
131685234|NCT02142738|474133201|FG001|Overall Study|Withdrawal by Subject|7|||
131685235|NCT02142738|474133200|FG000|Overall Study|Follow up ended by sponsor|43|||
131685236|NCT02142738|474133201|FG001|Overall Study|Follow up ended by sponsor|20|||
131685237|NCT03688880|474133202|FG000|Overall Study|Withdrawal by Subject|0|||
131685238|NCT03688880|474133203|FG001|Overall Study|Withdrawal by Subject|2|||
131685239|NCT03688880|474133202|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
131555984|NCT01121484|473660293|FG001|Overall Study|Withdrawal by Subject|7|||
131685240|NCT03688880|474133203|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
131685241|NCT03688880|474133202|FG000|Overall Study|Lost to Follow-up|4|||
131685242|NCT03688880|474133203|FG001|Overall Study|Lost to Follow-up|7|||
131685243|NCT03688880|474133202|FG000|Overall Study|Adverse Event|0|||
131685244|NCT03688880|474133203|FG001|Overall Study|Adverse Event|2|||
131685245|NCT03688880|474133202|FG000|Overall Study|Device deficiencies|0|||
131685246|NCT03688880|474133203|FG001|Overall Study|Device deficiencies|2|||
131685247|NCT03688880|474133202|FG000|Overall Study|Other|10|||
131685248|NCT03688880|474133203|FG001|Overall Study|Other|16|||
131685249|NCT05092919|474133206|FG000|Overall Study|Lost to Follow-up|7|||
131685250|NCT05092919|474133206|FG000|Overall Study|Withdrawal by Subject|2|||
131685251|NCT01942148|474133208|FG000|Overall Study|Adverse Event|4|||
131685252|NCT01942148|474133208|FG000|Overall Study|Lack of Efficacy|2|||
131685253|NCT01942148|474133208|FG000|Overall Study|Physician Decision|11|||
131685254|NCT01942148|474133208|FG000|Overall Study|Protocol Violation|1|||
131685255|NCT01942148|474133208|FG000|Overall Study|Withdrawal by Subject|8|||
131685256|NCT01942148|474133208|FG000|Overall Study|Use of the prohibition medicine|1|||
131685257|NCT02163187|474133209|FG000|Overall Study|Device removed|1|||
131685258|NCT02163187|474133210|FG001|Overall Study|Device removed|0|||
131685259|NCT02163187|474133209|FG000|Overall Study|Progressive disease|1|||
131685260|NCT02163187|474133210|FG001|Overall Study|Progressive disease|0|||
131685261|NCT02573870|474133212|FG000|Overall Study|Adverse Event|0|||
131685262|NCT02573870|474133213|FG001|Overall Study|Adverse Event|2|||
131685263|NCT02573870|474133212|FG000|Overall Study|Lack of Efficacy|0|||
131685264|NCT02573870|474133213|FG001|Overall Study|Lack of Efficacy|1|||
131685265|NCT02573870|474133212|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
131685266|NCT02573870|474133213|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
131685267|NCT02573870|474133212|FG000|Overall Study|Lost to Follow-up|0|||
131685268|NCT02573870|474133213|FG001|Overall Study|Lost to Follow-up|1|||
131685269|NCT02573870|474133212|FG000|Overall Study|Other: Fail to Meet Visit|0|||
131685270|NCT02573870|474133213|FG001|Overall Study|Other: Fail to Meet Visit|2|||
131685271|NCT00257725|474133214|FG000|Overall Study|Adverse Event|3|||
131685272|NCT01858532|474133215|FG000|Overall Study|Adverse Event|58|||
131685273|NCT01858532|474133216|FG001|Overall Study|Adverse Event|50|||
131685274|NCT01858532|474133217|FG002|Overall Study|Adverse Event|23|||
131685275|NCT01858532|474133218|FG003|Overall Study|Adverse Event|28|||
131685276|NCT01858532|474133215|FG000|Overall Study|Withdrew consent|71|||
131685277|NCT01858532|474133216|FG001|Overall Study|Withdrew consent|93|||
131685278|NCT01858532|474133217|FG002|Overall Study|Withdrew consent|46|||
131685279|NCT01858532|474133218|FG003|Overall Study|Withdrew consent|27|||
131685280|NCT01858532|474133215|FG000|Overall Study|Lost to Follow-up|17|||
131685281|NCT01858532|474133216|FG001|Overall Study|Lost to Follow-up|26|||
131685282|NCT01858532|474133217|FG002|Overall Study|Lost to Follow-up|11|||
131685283|NCT01858532|474133218|FG003|Overall Study|Lost to Follow-up|14|||
131685284|NCT01858532|474133215|FG000|Overall Study|Deterioration of medical status|3|||
131685285|NCT01858532|474133216|FG001|Overall Study|Deterioration of medical status|4|||
131685286|NCT01858532|474133217|FG002|Overall Study|Deterioration of medical status|3|||
131685287|NCT01858532|474133218|FG003|Overall Study|Deterioration of medical status|7|||
131685288|NCT01858532|474133215|FG000|Overall Study|Investigator request|3|||
131685289|NCT01858532|474133216|FG001|Overall Study|Investigator request|4|||
131685290|NCT01858532|474133217|FG002|Overall Study|Investigator request|2|||
131685291|NCT01858532|474133218|FG003|Overall Study|Investigator request|6|||
131685292|NCT01858532|474133215|FG000|Overall Study|Other, not specified|29|||
131685293|NCT01858532|474133216|FG001|Overall Study|Other, not specified|15|||
131685294|NCT01858532|474133217|FG002|Overall Study|Other, not specified|13|||
131685295|NCT01858532|474133218|FG003|Overall Study|Other, not specified|11|||
131685296|NCT00514514|474133219|FG000|Pre-phase|Death|10|||
131685297|NCT00514514|474133220|FG001|Pre-phase|Death|0|||
131685298|NCT00514514|474133221|FG002|Pre-phase|Death|0|||
131685299|NCT00514514|474133219|FG000|Pre-phase|administrative problems|2|||
131685300|NCT00514514|474133220|FG001|Pre-phase|administrative problems|0|||
131685301|NCT00514514|474133221|FG002|Pre-phase|administrative problems|0|||
131685302|NCT00514514|474133219|FG000|Pre-phase|Protocol Violation|6|||
131685303|NCT00514514|474133220|FG001|Pre-phase|Protocol Violation|0|||
131685304|NCT00514514|474133221|FG002|Pre-phase|Protocol Violation|0|||
131772906|NCT01333501|474446861|FG000|Overall Study|Adverse Event|3|||
131685305|NCT00514514|474133219|FG000|Pre-phase|condition no longer requires study drug|7|||
131685306|NCT00514514|474133220|FG001|Pre-phase|condition no longer requires study drug|0|||
131685307|NCT00514514|474133221|FG002|Pre-phase|condition no longer requires study drug|0|||
131685308|NCT00514514|474133219|FG000|Pre-phase|abnormal test procedure results|15|||
131685309|NCT00514514|474133220|FG001|Pre-phase|abnormal test procedure results|0|||
131685310|NCT00514514|474133221|FG002|Pre-phase|abnormal test procedure results|0|||
131685311|NCT00514514|474133219|FG000|Pre-phase|Lost to Follow-up|2|||
131685312|NCT00514514|474133220|FG001|Pre-phase|Lost to Follow-up|0|||
131685313|NCT00514514|474133221|FG002|Pre-phase|Lost to Follow-up|0|||
131685314|NCT00514514|474133219|FG000|Pre-phase|abnormal lab values|23|||
131685315|NCT00514514|474133220|FG001|Pre-phase|abnormal lab values|0|||
131685316|NCT00514514|474133221|FG002|Pre-phase|abnormal lab values|0|||
131685317|NCT00514514|474133219|FG000|Pre-phase|Lack of Efficacy|35|||
131685318|NCT00514514|474133220|FG001|Pre-phase|Lack of Efficacy|0|||
131685319|NCT00514514|474133221|FG002|Pre-phase|Lack of Efficacy|0|||
131685320|NCT00514514|474133219|FG000|Pre-phase|Adverse Event|137|||
131685321|NCT00514514|474133220|FG001|Pre-phase|Adverse Event|0|||
131685322|NCT00514514|474133221|FG002|Pre-phase|Adverse Event|0|||
131685323|NCT00514514|474133219|FG000|Pre-phase|Withdrawal by Subject|66|||
131685324|NCT00514514|474133220|FG001|Pre-phase|Withdrawal by Subject|0|||
131685325|NCT00514514|474133221|FG002|Pre-phase|Withdrawal by Subject|0|||
131685326|NCT00514514|474133219|FG000|Randomized - 9 Month|Death|3|||
131685327|NCT00514514|474133220|FG001|Randomized - 9 Month|Death|2|||
131685328|NCT00514514|474133221|FG002|Randomized - 9 Month|Death|2|||
131685329|NCT00514514|474133219|FG000|Randomized - 9 Month|Administrative problems|1|||
131685330|NCT00514514|474133220|FG001|Randomized - 9 Month|Administrative problems|1|||
131685331|NCT00514514|474133221|FG002|Randomized - 9 Month|Administrative problems|2|||
131685332|NCT00514514|474133219|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
131685333|NCT00514514|474133220|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
131685334|NCT00514514|474133221|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
131685335|NCT00514514|474133219|FG000|Randomized - 9 Month|Protocol Violation|1|||
131685336|NCT00514514|474133220|FG001|Randomized - 9 Month|Protocol Violation|1|||
131685337|NCT00514514|474133221|FG002|Randomized - 9 Month|Protocol Violation|0|||
131685338|NCT00514514|474133219|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
131685339|NCT00514514|474133220|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
131685340|NCT00514514|474133221|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
131685341|NCT00514514|474133219|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
131685342|NCT00514514|474133220|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
131685343|NCT00514514|474133221|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
131685344|NCT00514514|474133219|FG000|Randomized - 9 Month|Adverse Event|25|||
131685345|NCT00514514|474133220|FG001|Randomized - 9 Month|Adverse Event|44|||
131685346|NCT00514514|474133221|FG002|Randomized - 9 Month|Adverse Event|27|||
131685347|NCT00514514|474133219|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
131685348|NCT00514514|474133220|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
131685349|NCT00514514|474133221|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
131685350|NCT00514514|474133219|FG000|Extension - 4 Years|Lost to Follow-up|12|||
131685351|NCT00514514|474133220|FG001|Extension - 4 Years|Lost to Follow-up|10|||
131685352|NCT00514514|474133221|FG002|Extension - 4 Years|Lost to Follow-up|9|||
131685353|NCT00514514|474133219|FG000|Extension - 4 Years|Administrative problems|3|||
131685354|NCT00514514|474133220|FG001|Extension - 4 Years|Administrative problems|1|||
131685355|NCT00514514|474133221|FG002|Extension - 4 Years|Administrative problems|1|||
131685356|NCT00514514|474133219|FG000|Extension - 4 Years|Death|8|||
131685357|NCT00514514|474133220|FG001|Extension - 4 Years|Death|3|||
131685358|NCT00514514|474133221|FG002|Extension - 4 Years|Death|6|||
131685359|NCT00514514|474133219|FG000|Extension - 4 Years|Adverse Event|9|||
131685360|NCT00514514|474133220|FG001|Extension - 4 Years|Adverse Event|6|||
131685361|NCT00514514|474133221|FG002|Extension - 4 Years|Adverse Event|3|||
131685362|NCT03785925|474133226|FG000|Overall Study|Withdrawal by Subject|15|||
131685363|NCT03785925|474133226|FG000|Overall Study|Lost to Follow-up|1|||
131685364|NCT00762892|474133230|FG000|Overall Study|Lost to Follow-up|2|||
131685365|NCT00762892|474133231|FG001|Overall Study|Lost to Follow-up|5|||
131685366|NCT00762892|474133230|FG000|Overall Study|Withdrawal by Subject|0|||
131685367|NCT00762892|474133231|FG001|Overall Study|Withdrawal by Subject|1|||
131685368|NCT00762892|474133230|FG000|Overall Study|Death|1|||
131685369|NCT00762892|474133231|FG001|Overall Study|Death|0|||
131685370|NCT00762892|474133230|FG000|Overall Study|Pregnancy|1|||
131685371|NCT00762892|474133231|FG001|Overall Study|Pregnancy|0|||
131685372|NCT00762892|474133230|FG000|Overall Study|Incarceration|1|||
131685373|NCT00762892|474133231|FG001|Overall Study|Incarceration|0|||
131685374|NCT01848288|474133232|FG000|Overall Study|Death|1|||
131685375|NCT01848288|474133232|FG000|Overall Study|Protocol Violation|1|||
131685376|NCT01848288|474133232|FG000|Overall Study|Withdrawal by Subject|1|||
131685377|NCT01101438|474133236|FG000|Overall Study|Withdrawal by Subject|8|||
131685378|NCT01101438|474133237|FG001|Overall Study|Withdrawal by Subject|9|||
131685379|NCT03794583|474133252|FG000|Overall Study|Death|8|||
131685380|NCT03794583|474133252|FG000|Overall Study|Study Terminated by Sponsor|24|||
131685381|NCT03794583|474133252|FG000|Overall Study|Withdrawal by Subject|9|||
131685382|NCT00003895|474133253|FG000|Overall Study|Adverse Event|4|||
131685383|NCT00003895|474133254|FG001|Overall Study|Adverse Event|0|||
131685384|NCT00003895|474133253|FG000|Overall Study|Lack of Efficacy|1|||
131685385|NCT00003895|474133254|FG001|Overall Study|Lack of Efficacy|1|||
131685386|NCT00003895|474133253|FG000|Overall Study|Patient Vacation|2|||
131685387|NCT00003895|474133254|FG001|Overall Study|Patient Vacation|0|||
131685388|NCT00003895|474133253|FG000|Overall Study|Withdrawal by Subject|0|||
131685389|NCT00003895|474133254|FG001|Overall Study|Withdrawal by Subject|3|||
131685390|NCT00806195|474133257|FG000|Overall Study|Death|6|||
131685391|NCT00806195|474133258|FG001|Overall Study|Death|0|||
131685392|NCT00806195|474133259|FG002|Overall Study|Death|1|||
131685393|NCT00806195|474133260|FG003|Overall Study|Death|0|||
131685394|NCT00806195|474133257|FG000|Overall Study|Adverse Event|25|||
131685395|NCT00806195|474133258|FG001|Overall Study|Adverse Event|5|||
131685396|NCT00806195|474133259|FG002|Overall Study|Adverse Event|11|||
131685397|NCT00806195|474133260|FG003|Overall Study|Adverse Event|2|||
131685398|NCT00806195|474133257|FG000|Overall Study|Withdrawal by Subject|119|||
131685399|NCT00806195|474133258|FG001|Overall Study|Withdrawal by Subject|31|||
131685400|NCT00806195|474133259|FG002|Overall Study|Withdrawal by Subject|76|||
131685401|NCT00806195|474133260|FG003|Overall Study|Withdrawal by Subject|35|||
131685402|NCT00806195|474133257|FG000|Overall Study|Lost to Follow-up|217|||
131685403|NCT00806195|474133258|FG001|Overall Study|Lost to Follow-up|66|||
131685404|NCT00806195|474133259|FG002|Overall Study|Lost to Follow-up|90|||
131685405|NCT00806195|474133260|FG003|Overall Study|Lost to Follow-up|34|||
131685406|NCT00806195|474133257|FG000|Overall Study|Inappropriate Enrollment|0|||
131685407|NCT00806195|474133258|FG001|Overall Study|Inappropriate Enrollment|1|||
131685408|NCT00806195|474133259|FG002|Overall Study|Inappropriate Enrollment|0|||
131685409|NCT00806195|474133260|FG003|Overall Study|Inappropriate Enrollment|0|||
131685410|NCT00806195|474133257|FG000|Overall Study|Administrative Reason|113|||
131685411|NCT00806195|474133258|FG001|Overall Study|Administrative Reason|35|||
131685412|NCT00806195|474133259|FG002|Overall Study|Administrative Reason|66|||
131685413|NCT00806195|474133260|FG003|Overall Study|Administrative Reason|26|||
131685414|NCT00806195|474133257|FG000|Overall Study|Protocol Violation|34|||
131685415|NCT00806195|474133258|FG001|Overall Study|Protocol Violation|24|||
131685416|NCT00806195|474133259|FG002|Overall Study|Protocol Violation|26|||
131685417|NCT00806195|474133260|FG003|Overall Study|Protocol Violation|9|||
131685418|NCT02490475|474133261|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
131685419|NCT02490475|474133262|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
131685420|NCT02490475|474133263|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
131685421|NCT02490475|474133264|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
131685422|NCT02490475|474133261|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
131685423|NCT02490475|474133262|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
131685424|NCT02490475|474133263|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
131685425|NCT02490475|474133264|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
131685426|NCT02490475|474133261|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
131685427|NCT02490475|474133262|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
131685428|NCT02490475|474133263|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
131685429|NCT02490475|474133264|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
131685430|NCT02490475|474133261|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
131685431|NCT02490475|474133262|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
131685432|NCT02490475|474133263|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
131685433|NCT02490475|474133264|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
131685434|NCT02490475|474133261|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
131685435|NCT02490475|474133262|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
131685436|NCT02490475|474133263|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
131685437|NCT02490475|474133264|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
131685438|NCT02490475|474133261|FG000|Period 2: Extension Phase|Refused Treatment|0|||
131685439|NCT02490475|474133262|FG001|Period 2: Extension Phase|Refused Treatment|0|||
131685440|NCT02490475|474133263|FG002|Period 2: Extension Phase|Refused Treatment|0|||
131685441|NCT02490475|474133264|FG003|Period 2: Extension Phase|Refused Treatment|1|||
131685442|NCT02490475|474133261|FG000|Period 2: Extension Phase|Adverse Event|0|||
131685443|NCT02490475|474133262|FG001|Period 2: Extension Phase|Adverse Event|0|||
131685444|NCT02490475|474133263|FG002|Period 2: Extension Phase|Adverse Event|1|||
131685445|NCT02490475|474133264|FG003|Period 2: Extension Phase|Adverse Event|0|||
131685446|NCT00139776|474133265|FG000|Period I|Did not enter Period II|575|||
131685447|NCT00139776|474133266|FG001|Period I|Did not enter Period II|0|||
131685448|NCT00139776|474133267|FG002|Period I|Did not enter Period II|0|||
131685449|NCT00139776|474133268|FG003|Period I|Did not enter Period II|0|||
131685450|NCT00139776|474133265|FG000|Period II|Not Randomized into Period III|0|||
131685451|NCT00139776|474133266|FG001|Period II|Not Randomized into Period III|322|||
131685452|NCT00139776|474133267|FG002|Period II|Not Randomized into Period III|0|||
131685453|NCT00139776|474133268|FG003|Period II|Not Randomized into Period III|0|||
131685454|NCT00139776|474133265|FG000|Period III|Adverse Event|0|||
131685455|NCT00139776|474133266|FG001|Period III|Adverse Event|0|||
131685456|NCT00139776|474133267|FG002|Period III|Adverse Event|22|||
131685457|NCT00139776|474133268|FG003|Period III|Adverse Event|23|||
131685458|NCT00139776|474133265|FG000|Period III|Other|0|||
131685459|NCT00139776|474133266|FG001|Period III|Other|0|||
131685460|NCT00139776|474133267|FG002|Period III|Other|23|||
131685461|NCT00139776|474133268|FG003|Period III|Other|34|||
131685462|NCT00139776|474133265|FG000|Period III|Lack of Efficacy|0|||
131685463|NCT00139776|474133266|FG001|Period III|Lack of Efficacy|0|||
131685464|NCT00139776|474133267|FG002|Period III|Lack of Efficacy|10|||
131685465|NCT00139776|474133268|FG003|Period III|Lack of Efficacy|24|||
131685466|NCT00139776|474133265|FG000|Period III|Lost to Follow-up|0|||
131685467|NCT00139776|474133266|FG001|Period III|Lost to Follow-up|0|||
131685468|NCT00139776|474133267|FG002|Period III|Lost to Follow-up|5|||
131685469|NCT00139776|474133268|FG003|Period III|Lost to Follow-up|4|||
131685470|NCT00139776|474133265|FG000|Period III|Withdrawal by Subject|0|||
131685471|NCT00139776|474133266|FG001|Period III|Withdrawal by Subject|0|||
131685472|NCT00139776|474133267|FG002|Period III|Withdrawal by Subject|16|||
131685473|NCT00139776|474133268|FG003|Period III|Withdrawal by Subject|21|||
131685474|NCT04912245|474133271|FG000|Overall Study|Withdrawal by Subject|21|||
131685475|NCT04912245|474133272|FG001|Overall Study|Withdrawal by Subject|4|||
131685476|NCT04912245|474133271|FG000|Overall Study|Lost to Follow-up|5|||
131685477|NCT04912245|474133272|FG001|Overall Study|Lost to Follow-up|11|||
131685478|NCT02752035|474133273|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
131685479|NCT02752035|474133274|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
131685480|NCT02752035|474133275|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
131685481|NCT02752035|474133276|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
131685482|NCT02752035|474133273|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
131685483|NCT02752035|474133274|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
131685484|NCT02752035|474133275|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
131685485|NCT02752035|474133276|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
131685486|NCT02752035|474133273|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
131685487|NCT02752035|474133274|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
131685488|NCT02752035|474133275|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
131772907|NCT01333501|474446862|FG001|Overall Study|Adverse Event|1|||
131685489|NCT02752035|474133276|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
131685490|NCT02752035|474133273|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
131685491|NCT02752035|474133274|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
131685492|NCT02752035|474133275|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
131685493|NCT02752035|474133276|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
131685494|NCT02752035|474133273|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
131685495|NCT02752035|474133274|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
131685496|NCT02752035|474133275|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
131685497|NCT02752035|474133276|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
131685498|NCT02752035|474133273|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
131685499|NCT02752035|474133274|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
131685500|NCT02752035|474133275|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
131685501|NCT02752035|474133276|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
131685502|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
131685503|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
131685504|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
131685505|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
131685506|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
131685507|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
131685508|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
131685509|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
131685510|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
131685511|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
131685512|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
131685513|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
131685514|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
131685515|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
131685516|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
131685517|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
131685518|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
131685519|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
131685520|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
131685521|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
131685522|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Death|0|||
131685523|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Death|25|||
131555985|NCT01121484|473660292|FG000|Overall Study|Discontinuation of study by sponsor|0|||
131685524|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Death|13|||
131685525|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Death|4|||
131685526|NCT02752035|474133273|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
131685527|NCT02752035|474133274|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
131685528|NCT02752035|474133275|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
131685529|NCT02752035|474133276|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
131685530|NCT02752035|474133273|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
131685531|NCT02752035|474133274|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
131685532|NCT02752035|474133275|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
131685533|NCT02752035|474133276|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
131685534|NCT02752035|474133273|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
131685535|NCT02752035|474133274|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
131685536|NCT02752035|474133275|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
131685537|NCT02752035|474133276|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
131685538|NCT02752035|474133273|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
131685539|NCT02752035|474133274|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
131685540|NCT02752035|474133275|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
131685541|NCT02752035|474133276|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
131685542|NCT02752035|474133273|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
131685543|NCT02752035|474133274|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
131685544|NCT02752035|474133275|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
131685545|NCT02752035|474133276|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
131685546|NCT04754802|474133283|FG000|Overall Study|Lost to Follow-up|0|||
131685547|NCT04754802|474133284|FG001|Overall Study|Lost to Follow-up|2|||
131685548|NCT04754802|474133283|FG000|Overall Study|Withdrawal by Subject|2|||
131555986|NCT01121484|473660293|FG001|Overall Study|Discontinuation of study by sponsor|1|||
131685549|NCT04754802|474133284|FG001|Overall Study|Withdrawal by Subject|0|||
131685550|NCT04451161|474133285|FG000|Overall Study|Lost to Follow-up|28|||
131685551|NCT04451161|474133286|FG001|Overall Study|Lost to Follow-up|37|||
131772908|NCT01333501|474446861|FG000|Overall Study|Abnormal laboratory value|2|||
131685552|NCT04451161|474133287|FG002|Overall Study|Lost to Follow-up|22|||
131772909|NCT01333501|474446862|FG001|Overall Study|Abnormal laboratory value|1|||
131772910|NCT01333501|474446861|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131772911|NCT01333501|474446862|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
131772912|NCT01333501|474446861|FG000|Overall Study|Withdrawn consent|3|||
131772913|NCT01333501|474446862|FG001|Overall Study|Withdrawn consent|12|||
131772914|NCT00674440|474446863|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
131772915|NCT00674440|474446863|FG000|Overall Study|did not have surgery, so unevaluable|7|||
131772916|NCT00674440|474446863|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
131772917|NCT03329404|474446864|FG000|Overall Study|The study was suspended.|1|||
131772918|NCT03329404|474446865|FG001|Overall Study|The study was suspended.|4|||
131772919|NCT00914940|474446866|FG000|D0 to D100 Post-transplant|Death|2|||
131772920|NCT00914940|474446866|FG000|D101 to 2 Years Post-transplant|Death|8|||
131772921|NCT00914940|474446866|FG000|2 Years to 5 Years Post-transplant|Death|3|||
131772922|NCT00796367|474446867|FG000|Overall Study|Adverse Event|6|||
131772923|NCT00796367|474446868|FG001|Overall Study|Adverse Event|4|||
131772924|NCT00796367|474446869|FG002|Overall Study|Adverse Event|7|||
131772925|NCT00796367|474446867|FG000|Overall Study|Lost to Follow-up|5|||
131772926|NCT00796367|474446868|FG001|Overall Study|Lost to Follow-up|4|||
131772927|NCT00796367|474446869|FG002|Overall Study|Lost to Follow-up|21|||
131772928|NCT00796367|474446867|FG000|Overall Study|Withdrawal by Subject|9|||
131772929|NCT00796367|474446868|FG001|Overall Study|Withdrawal by Subject|11|||
131772930|NCT00796367|474446869|FG002|Overall Study|Withdrawal by Subject|12|||
131772931|NCT00796367|474446867|FG000|Overall Study|Lack of Efficacy|2|||
131772932|NCT00796367|474446868|FG001|Overall Study|Lack of Efficacy|1|||
131772933|NCT00796367|474446869|FG002|Overall Study|Lack of Efficacy|0|||
131772934|NCT00796367|474446867|FG000|Overall Study|non compliance|3|||
131772935|NCT00796367|474446868|FG001|Overall Study|non compliance|1|||
131772936|NCT00796367|474446869|FG002|Overall Study|non compliance|1|||
131772937|NCT00796367|474446867|FG000|Overall Study|Pregnancy|1|||
131772938|NCT00796367|474446868|FG001|Overall Study|Pregnancy|0|||
131685553|NCT04451161|474133288|FG003|Overall Study|Lost to Follow-up|13|||
131685554|NCT04451161|474133289|FG004|Overall Study|Lost to Follow-up|11|||
131685555|NCT04451161|474133290|FG005|Overall Study|Lost to Follow-up|14|||
131685556|NCT04451161|474133285|FG000|Overall Study|Withdrawal by Subject|3|||
131685557|NCT04451161|474133286|FG001|Overall Study|Withdrawal by Subject|0|||
131685558|NCT04451161|474133287|FG002|Overall Study|Withdrawal by Subject|0|||
131685559|NCT04451161|474133288|FG003|Overall Study|Withdrawal by Subject|0|||
131685560|NCT04451161|474133289|FG004|Overall Study|Withdrawal by Subject|2|||
131685561|NCT04451161|474133290|FG005|Overall Study|Withdrawal by Subject|4|||
131685562|NCT00117598|474133296|FG000|Prior to Treatment Cross Over|Death|40|||
131685563|NCT00117598|474133297|FG001|Prior to Treatment Cross Over|Death|41|||
131685564|NCT00117598|474133298|FG002|Prior to Treatment Cross Over|Death|37|||
131685565|NCT00117598|474133299|FG003|Prior to Treatment Cross Over|Death|0|||
131685566|NCT00117598|474133300|FG004|Prior to Treatment Cross Over|Death|0|||
131685567|NCT00117598|474133296|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
131685568|NCT00117598|474133297|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
131685569|NCT00117598|474133298|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
131685570|NCT00117598|474133299|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
131772939|NCT00796367|474446869|FG002|Overall Study|Pregnancy|1|||
131772940|NCT00796367|474446867|FG000|Overall Study|Requirement for restricted medication|2|||
131772941|NCT00796367|474446868|FG001|Overall Study|Requirement for restricted medication|0|||
131772942|NCT00796367|474446869|FG002|Overall Study|Requirement for restricted medication|2|||
131772943|NCT00796367|474446867|FG000|Overall Study|other|2|||
131772944|NCT00796367|474446868|FG001|Overall Study|other|4|||
131685571|NCT00117598|474133300|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
131685572|NCT00117598|474133296|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
131685573|NCT00117598|474133297|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
131898516|NCT00320788|474914098|FG002|Overall Study|Decision by the Sponsor|0|||
131898517|NCT00320788|474914099|FG003|Overall Study|Decision by the Sponsor|0|||
131685574|NCT00117598|474133298|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
131685575|NCT00117598|474133299|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
131685576|NCT00117598|474133300|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
131685577|NCT00117598|474133296|FG000|Prior to Treatment Cross Over|Other|15|||
131685578|NCT00117598|474133297|FG001|Prior to Treatment Cross Over|Other|9|||
131685579|NCT00117598|474133298|FG002|Prior to Treatment Cross Over|Other|9|||
131685580|NCT00117598|474133299|FG003|Prior to Treatment Cross Over|Other|0|||
131685581|NCT00117598|474133300|FG004|Prior to Treatment Cross Over|Other|0|||
131685582|NCT00117598|474133296|FG000|After Treament Cross Over|Death|0|||
131685583|NCT00117598|474133297|FG001|After Treament Cross Over|Death|0|||
131685584|NCT00117598|474133298|FG002|After Treament Cross Over|Death|0|||
131685585|NCT00117598|474133299|FG003|After Treament Cross Over|Death|1|||
131685586|NCT00117598|474133300|FG004|After Treament Cross Over|Death|2|||
131685587|NCT00117598|474133296|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
131685588|NCT00117598|474133297|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
131685589|NCT00117598|474133298|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
131685590|NCT00117598|474133299|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
131685591|NCT00117598|474133300|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
131685592|NCT00117598|474133296|FG000|After Treament Cross Over|Other|0|||
131685593|NCT00117598|474133297|FG001|After Treament Cross Over|Other|0|||
131685594|NCT00117598|474133298|FG002|After Treament Cross Over|Other|0|||
131685595|NCT00117598|474133299|FG003|After Treament Cross Over|Other|1|||
131685596|NCT00117598|474133300|FG004|After Treament Cross Over|Other|2|||
131685597|NCT04688775|474133303|FG000|Placebo-controlled Period|Randomized, not treated|1|||
131685598|NCT04688775|474133304|FG001|Placebo-controlled Period|Randomized, not treated|1|||
131685599|NCT04688775|474133305|FG002|Placebo-controlled Period|Randomized, not treated|0|||
131685600|NCT04688775|474133306|FG003|Placebo-controlled Period|Randomized, not treated|0|||
131685601|NCT04688775|474133303|FG000|Placebo-controlled Period|Adverse Event|2|||
131685602|NCT04688775|474133304|FG001|Placebo-controlled Period|Adverse Event|0|||
131685603|NCT04688775|474133305|FG002|Placebo-controlled Period|Adverse Event|0|||
131685604|NCT04688775|474133306|FG003|Placebo-controlled Period|Adverse Event|0|||
131685605|NCT04688775|474133303|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
131685606|NCT04688775|474133304|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
131685607|NCT04688775|474133305|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
131685608|NCT04688775|474133306|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
131685609|NCT04688775|474133303|FG000|Placebo-controlled Period|Protocol Violation|0|||
131685610|NCT04688775|474133304|FG001|Placebo-controlled Period|Protocol Violation|1|||
131685611|NCT04688775|474133305|FG002|Placebo-controlled Period|Protocol Violation|0|||
131685612|NCT04688775|474133306|FG003|Placebo-controlled Period|Protocol Violation|0|||
131685613|NCT04688775|474133303|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
131685614|NCT04688775|474133304|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
131685615|NCT04688775|474133305|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
131685616|NCT04688775|474133306|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
131685617|NCT04688775|474133303|FG000|Placebo-controlled Period|Other reasons|0|||
131685618|NCT04688775|474133304|FG001|Placebo-controlled Period|Other reasons|1|||
131685619|NCT04688775|474133305|FG002|Placebo-controlled Period|Other reasons|0|||
131685620|NCT04688775|474133306|FG003|Placebo-controlled Period|Other reasons|0|||
131685621|NCT04688775|474133303|FG000|Delayed Start Period|Adverse Event|0|||
131685622|NCT04688775|474133304|FG001|Delayed Start Period|Adverse Event|0|||
131685623|NCT04688775|474133305|FG002|Delayed Start Period|Adverse Event|1|||
131685624|NCT04688775|474133306|FG003|Delayed Start Period|Adverse Event|0|||
131685625|NCT04688775|474133303|FG000|Delayed Start Period|Lack of Efficacy|0|||
131685626|NCT04688775|474133304|FG001|Delayed Start Period|Lack of Efficacy|0|||
131685627|NCT04688775|474133305|FG002|Delayed Start Period|Lack of Efficacy|0|||
131685628|NCT04688775|474133306|FG003|Delayed Start Period|Lack of Efficacy|3|||
131685629|NCT04688775|474133303|FG000|Delayed Start Period|Withdrawal by Subject|0|||
131685630|NCT04688775|474133304|FG001|Delayed Start Period|Withdrawal by Subject|0|||
131685631|NCT04688775|474133305|FG002|Delayed Start Period|Withdrawal by Subject|2|||
131685632|NCT04688775|474133306|FG003|Delayed Start Period|Withdrawal by Subject|4|||
131685633|NCT04688775|474133303|FG000|Delayed Start Period|Lost to Follow-up|0|||
131685634|NCT04688775|474133304|FG001|Delayed Start Period|Lost to Follow-up|0|||
131772945|NCT00796367|474446869|FG002|Overall Study|other|3|||
131685635|NCT04688775|474133305|FG002|Delayed Start Period|Lost to Follow-up|2|||
131685636|NCT04688775|474133306|FG003|Delayed Start Period|Lost to Follow-up|1|||
131685637|NCT04688775|474133303|FG000|Delayed Start Period|other reasons|0|||
131685638|NCT04688775|474133304|FG001|Delayed Start Period|other reasons|0|||
131685639|NCT04688775|474133305|FG002|Delayed Start Period|other reasons|1|||
131685640|NCT04688775|474133306|FG003|Delayed Start Period|other reasons|0|||
131685641|NCT00898443|474133307|FG000|Overall Study|Withdrawal by Subject|1|||
131685642|NCT00898443|474133308|FG001|Overall Study|Withdrawal by Subject|0|||
131685643|NCT04695392|474133309|FG000|Overall Study|Withdrawn by parent/guardian|0|||
131685644|NCT04695392|474133310|FG001|Overall Study|Withdrawn by parent/guardian|1|||
131685645|NCT04695392|474133309|FG000|Overall Study|Withdrawn by physician|0|||
131772946|NCT04095039|474446873|FG000|Overall Study|Withdrawal by Subject|2|||
131685646|NCT04695392|474133310|FG001|Overall Study|Withdrawn by physician|1|||
131685647|NCT04085523|474133319|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131685648|NCT04085523|474133320|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131685649|NCT04085523|474133321|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131685650|NCT04085523|474133322|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131685651|NCT04085523|474133323|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131685652|NCT04085523|474133324|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
131685653|NCT00549939|474134719|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
131685654|NCT00549939|474134720|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
131685655|NCT00549939|474134721|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
131685656|NCT00549939|474134719|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
131685657|NCT00549939|474134720|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
131685658|NCT00549939|474134721|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
131685659|NCT00549939|474134719|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
131685660|NCT00549939|474134720|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
131685661|NCT00549939|474134721|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
131685662|NCT00549939|474134719|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
131685663|NCT00549939|474134720|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
131685664|NCT00549939|474134721|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
131685665|NCT00549939|474134719|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
131685666|NCT00549939|474134720|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
131685667|NCT00549939|474134721|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
131685668|NCT00549939|474134719|FG000|40-week Open Label Treatment Period|Other|0|||
131685669|NCT00549939|474134720|FG001|40-week Open Label Treatment Period|Other|1|||
131685670|NCT00549939|474134721|FG002|40-week Open Label Treatment Period|Other|4|||
131685671|NCT03677596|474134722|FG000|Overall Study|Adverse Event|0|||
131685672|NCT03677596|474134723|FG001|Overall Study|Adverse Event|1|||
131685673|NCT03677596|474134722|FG000|Overall Study|Death|10|||
131685674|NCT03677596|474134723|FG001|Overall Study|Death|6|||
131685675|NCT03677596|474134722|FG000|Overall Study|Lost to Follow-up|0|||
131685676|NCT03677596|474134723|FG001|Overall Study|Lost to Follow-up|1|||
131685677|NCT03677596|474134722|FG000|Overall Study|Progressive Disease|8|||
131685678|NCT03677596|474134723|FG001|Overall Study|Progressive Disease|8|||
131685679|NCT03677596|474134722|FG000|Overall Study|Withdrawal by Subject|3|||
131685680|NCT03677596|474134723|FG001|Overall Study|Withdrawal by Subject|0|||
131685681|NCT03677596|474134722|FG000|Overall Study|Disease Relapse|2|||
131685682|NCT03677596|474134723|FG001|Overall Study|Disease Relapse|2|||
131685683|NCT03677596|474134722|FG000|Overall Study|Other|0|||
131685684|NCT03677596|474134723|FG001|Overall Study|Other|1|||
131685685|NCT05197049|474134726|FG000|Overall Study|Death|0|||
131685686|NCT05197049|474134727|FG001|Overall Study|Death|1|||
131685687|NCT05197049|474134728|FG002|Overall Study|Death|0|||
131685688|NCT05197049|474134726|FG000|Overall Study|Lost to Follow-up|3|||
131685689|NCT05197049|474134727|FG001|Overall Study|Lost to Follow-up|1|||
131685690|NCT05197049|474134728|FG002|Overall Study|Lost to Follow-up|0|||
131685691|NCT05197049|474134726|FG000|Overall Study|Withdrawal by Subject|15|||
131685692|NCT05197049|474134727|FG001|Overall Study|Withdrawal by Subject|3|||
131685693|NCT05197049|474134728|FG002|Overall Study|Withdrawal by Subject|1|||
131772947|NCT04095039|474446874|FG001|Overall Study|Withdrawal by Subject|16|||
131772948|NCT04095039|474446873|FG000|Overall Study|Transplanted|21|||
131772949|NCT04095039|474446874|FG001|Overall Study|Transplanted|24|||
131772950|NCT04095039|474446873|FG000|Overall Study|Transferred to Non-study Facility|47|||
131772951|NCT04095039|474446874|FG001|Overall Study|Transferred to Non-study Facility|44|||
131772952|NCT04095039|474446873|FG000|Overall Study|Withdrawal from internvention target|0|||
131772953|NCT04095039|474446874|FG001|Overall Study|Withdrawal from internvention target|2|||
131772954|NCT04095039|474446873|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
131772955|NCT04095039|474446874|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
131772956|NCT04095039|474446873|FG000|Overall Study|Cacliphylaxis|0|||
131772957|NCT04095039|474446874|FG001|Overall Study|Cacliphylaxis|1|||
131772958|NCT04095039|474446873|FG000|Overall Study|Pregnancy|1|||
131772959|NCT04095039|474446874|FG001|Overall Study|Pregnancy|0|||
131772960|NCT01728194|474446876|FG000|Overall Study|Lost to Follow-up|4|||
131772961|NCT01728194|474446877|FG001|Overall Study|Lost to Follow-up|3|||
131772962|NCT01728194|474446876|FG000|Overall Study|Physician Decision|4|||
131685694|NCT05197049|474134726|FG000|Overall Study|GCP non-compliance|1|||
131685695|NCT05197049|474134727|FG001|Overall Study|GCP non-compliance|2|||
131685696|NCT05197049|474134728|FG002|Overall Study|GCP non-compliance|0|||
131685697|NCT01368536|474134729|FG000|Overall Study|Adverse Event|5|||
131685698|NCT01368536|474134730|FG001|Overall Study|Adverse Event|6|||
131685699|NCT01368536|474134731|FG002|Overall Study|Adverse Event|8|||
131685700|NCT01368536|474134729|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131685701|NCT01368536|474134730|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131685702|NCT01368536|474134731|FG002|Overall Study|Abnormal laboratory value(s)|2|||
131685703|NCT01368536|474134729|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131772963|NCT01728194|474446877|FG001|Overall Study|Physician Decision|0|||
131772964|NCT01728194|474446876|FG000|Overall Study|Withdrawal by Subject|7|||
131772965|NCT01728194|474446877|FG001|Overall Study|Withdrawal by Subject|3|||
131772966|NCT01728194|474446876|FG000|Overall Study|Perceived Medication Side Effects|4|||
131772967|NCT01728194|474446877|FG001|Overall Study|Perceived Medication Side Effects|0|||
131772968|NCT01728194|474446876|FG000|Overall Study|Family Member Request|1|||
131772969|NCT01728194|474446877|FG001|Overall Study|Family Member Request|0|||
131772970|NCT02309372|474446878|FG000|Overall Study|Lost to Follow-up|3|||
131772971|NCT02309372|474446879|FG001|Overall Study|Lost to Follow-up|2|||
131772972|NCT01590810|474446882|FG000|Overall Study|Physician Decision|0|||
131772973|NCT01590810|474446883|FG001|Overall Study|Physician Decision|1|||
131772974|NCT01590810|474446884|FG002|Overall Study|Physician Decision|1|||
131772975|NCT01590810|474446885|FG003|Overall Study|Physician Decision|0|||
131772976|NCT01590810|474446886|FG004|Overall Study|Physician Decision|0|||
131772977|NCT04604015|474446887|FG000|Overall Study|Incomplete Data Collection|33|||
131772978|NCT02576652|474446889|FG000|Overall Study|Withdrawal by Subject|2|||
131772979|NCT00553319|474446897|FG000|Overall Study|Lost to Follow-up|10|||
131772980|NCT00553319|474446898|FG001|Overall Study|Lost to Follow-up|9|||
131772981|NCT00553319|474446899|FG002|Overall Study|Lost to Follow-up|5|||
131772982|NCT00553319|474446897|FG000|Overall Study|wanted treatment elsewhere|2|||
131772983|NCT00553319|474446898|FG001|Overall Study|wanted treatment elsewhere|1|||
131772984|NCT00553319|474446899|FG002|Overall Study|wanted treatment elsewhere|1|||
131772985|NCT00553319|474446897|FG000|Overall Study|non-compliance|0|||
131772986|NCT00553319|474446898|FG001|Overall Study|non-compliance|0|||
131772987|NCT00553319|474446899|FG002|Overall Study|non-compliance|2|||
131772988|NCT00553319|474446897|FG000|Overall Study|incarceration|1|||
131772989|NCT00553319|474446898|FG001|Overall Study|incarceration|0|||
131772990|NCT00553319|474446899|FG002|Overall Study|incarceration|0|||
131772991|NCT00553319|474446897|FG000|Overall Study|moved|1|||
131772992|NCT00553319|474446898|FG001|Overall Study|moved|0|||
131772993|NCT00553319|474446899|FG002|Overall Study|moved|1|||
131772994|NCT01349816|474446901|FG000|Overall Study|Withdrawal by Subject|4|||
131772995|NCT01349816|474446901|FG000|Overall Study|Physician Decision|1|||
131772996|NCT01349816|474446901|FG000|Overall Study|Adverse Event|14|||
131772997|NCT01349816|474446901|FG000|Overall Study|Lost to Follow-up|2|||
131772998|NCT01349816|474446901|FG000|Overall Study|Protocol Violation|1|||
131772999|NCT01349816|474446901|FG000|Overall Study|Protocol-specified criteria|8|||
131773000|NCT01230489|474446902|FG000|Overall Study|Death|2|||
131773001|NCT01230489|474446902|FG000|Overall Study|Adverse Event|2|||
131773002|NCT01230489|474446902|FG000|Overall Study|Treatment modality changed|1|||
131773003|NCT01791543|474446903|FG000|Overall Study|Lost to Follow-up|1|||
131773004|NCT01791543|474446903|FG000|Overall Study|Adverse Event|1|||
131773005|NCT00198107|474448870|FG000|Double-Blind Period|Adverse Event|1|||
131773006|NCT00198107|474448871|FG001|Double-Blind Period|Adverse Event|1|||
131773007|NCT00198107|474448872|FG002|Double-Blind Period|Adverse Event|0|||
131773008|NCT00198107|474448870|FG000|Double-Blind Period|Lack of Efficacy|2|||
131773009|NCT00198107|474448871|FG001|Double-Blind Period|Lack of Efficacy|0|||
131773010|NCT00198107|474448872|FG002|Double-Blind Period|Lack of Efficacy|0|||
131773011|NCT00198107|474448870|FG000|Double-Blind Period|Lost to Follow-up|2|||
131773012|NCT00198107|474448871|FG001|Double-Blind Period|Lost to Follow-up|1|||
131773013|NCT00198107|474448872|FG002|Double-Blind Period|Lost to Follow-up|0|||
131773014|NCT00198107|474448870|FG000|Double-Blind Period|Physician Decision|1|||
131773015|NCT00198107|474448871|FG001|Double-Blind Period|Physician Decision|0|||
131773016|NCT00198107|474448872|FG002|Double-Blind Period|Physician Decision|0|||
131773017|NCT00198107|474448870|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131773018|NCT00198107|474448871|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131555987|NCT01121484|473660292|FG000|Overall Study|Other|3|||
131685704|NCT01368536|474134730|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131773019|NCT00198107|474448872|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131685705|NCT01368536|474134731|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131685706|NCT01368536|474134729|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
131685707|NCT01368536|474134730|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131685708|NCT01368536|474134731|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131685709|NCT01368536|474134729|FG000|Overall Study|No longer required study medication|0|||
131685710|NCT01368536|474134730|FG001|Overall Study|No longer required study medication|0|||
131685711|NCT01368536|474134731|FG002|Overall Study|No longer required study medication|1|||
131685712|NCT01368536|474134729|FG000|Overall Study|Withdrawal by Subject|2|||
131685713|NCT01368536|474134730|FG001|Overall Study|Withdrawal by Subject|5|||
131685714|NCT01368536|474134731|FG002|Overall Study|Withdrawal by Subject|4|||
131685715|NCT01368536|474134729|FG000|Overall Study|Lost to Follow-up|3|||
131685716|NCT01368536|474134730|FG001|Overall Study|Lost to Follow-up|3|||
131685717|NCT01368536|474134731|FG002|Overall Study|Lost to Follow-up|5|||
131685718|NCT01368536|474134729|FG000|Overall Study|Administrative problems|34|||
131685719|NCT01368536|474134730|FG001|Overall Study|Administrative problems|39|||
131685720|NCT01368536|474134731|FG002|Overall Study|Administrative problems|35|||
131685721|NCT01368536|474134729|FG000|Overall Study|Protocol deviation|0|||
131685722|NCT01368536|474134730|FG001|Overall Study|Protocol deviation|3|||
131685723|NCT01368536|474134731|FG002|Overall Study|Protocol deviation|1|||
131685724|NCT01161043|474134734|FG000|Overall Study|Withdrawal by Subject|3|||
131685725|NCT02164929|474134741|FG000|Overall Study|Converted to open procedure|1|||
131685726|NCT02164929|474134742|FG001|Overall Study|Converted to open procedure|0|||
131685727|NCT02164929|474134743|FG002|Overall Study|Converted to open procedure|0|||
131685728|NCT02164929|474134744|FG003|Overall Study|Converted to open procedure|2|||
131685729|NCT02164929|474134741|FG000|Overall Study|Failed regional block|0|||
131685730|NCT02164929|474134742|FG001|Overall Study|Failed regional block|0|||
131685731|NCT02164929|474134743|FG002|Overall Study|Failed regional block|1|||
131685732|NCT02164929|474134744|FG003|Overall Study|Failed regional block|0|||
131685733|NCT00971178|474134745|FG000|Overall Study|Lost to Follow-up|2|||
131685734|NCT00971178|474134746|FG001|Overall Study|Lost to Follow-up|2|||
131685735|NCT00971178|474134747|FG002|Overall Study|Lost to Follow-up|2|||
131685736|NCT00424749|474134749|FG000|Overall Study|Withdrawal by Subject|1|||
131685737|NCT02577406|474134750|FG000|Randomized Period|Death|1|||
131685738|NCT02577406|474134751|FG001|Randomized Period|Death|0|||
131685739|NCT02577406|474134750|FG000|Randomized Period|Other reasons|0|||
131685740|NCT02577406|474134751|FG001|Randomized Period|Other reasons|20|||
131685741|NCT02577406|474134750|FG000|Treatment Period|Death|38|||
131685742|NCT02577406|474134751|FG001|Treatment Period|Death|23|||
131685743|NCT02577406|474134750|FG000|Treatment Period|Adverse Event|17|||
131685744|NCT02577406|474134751|FG001|Treatment Period|Adverse Event|12|||
131685745|NCT02577406|474134750|FG000|Treatment Period|Progressive Disease|53|||
131685746|NCT02577406|474134751|FG001|Treatment Period|Progressive Disease|37|||
131773020|NCT00198107|474448870|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
131685747|NCT02577406|474134750|FG000|Treatment Period|Withdrawal by Subject|10|||
131685748|NCT02577406|474134751|FG001|Treatment Period|Withdrawal by Subject|24|||
131685749|NCT02577406|474134750|FG000|Treatment Period|Lost to Follow-up|0|||
131685750|NCT02577406|474134751|FG001|Treatment Period|Lost to Follow-up|1|||
131685751|NCT02577406|474134750|FG000|Treatment Period|Transition to commercially available treatment|1|||
131685752|NCT02577406|474134751|FG001|Treatment Period|Transition to commercially available treatment|1|||
131685753|NCT02577406|474134750|FG000|Treatment Period|Physician Decision|1|||
131685754|NCT02577406|474134751|FG001|Treatment Period|Physician Decision|0|||
131685755|NCT02577406|474134750|FG000|Treatment Period|Disease Relapse|28|||
131685756|NCT02577406|474134751|FG001|Treatment Period|Disease Relapse|1|||
131685757|NCT02577406|474134750|FG000|Treatment Period|Protocol Violation|0|||
131685758|NCT02577406|474134751|FG001|Treatment Period|Protocol Violation|1|||
131685759|NCT02577406|474134750|FG000|Treatment Period|Other Reasons|3|||
131685760|NCT02577406|474134751|FG001|Treatment Period|Other Reasons|39|||
131685761|NCT02577406|474134750|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
131685762|NCT02577406|474134751|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
131685763|NCT02138617|474134752|FG000|Overall Study|Death|1|||
131685764|NCT02138617|474134753|FG001|Overall Study|Death|2|||
131685765|NCT02138617|474134754|FG002|Overall Study|Death|2|||
131685766|NCT02138617|474134752|FG000|Overall Study|Adverse Event|8|||
131685767|NCT02138617|474134753|FG001|Overall Study|Adverse Event|5|||
131685768|NCT02138617|474134754|FG002|Overall Study|Adverse Event|2|||
131685769|NCT02138617|474134752|FG000|Overall Study|Disease Progression|20|||
131685770|NCT02138617|474134753|FG001|Overall Study|Disease Progression|13|||
131685771|NCT02138617|474134754|FG002|Overall Study|Disease Progression|4|||
131685772|NCT02138617|474134752|FG000|Overall Study|Withdrawal by Subject|7|||
131685773|NCT02138617|474134753|FG001|Overall Study|Withdrawal by Subject|10|||
131685774|NCT02138617|474134754|FG002|Overall Study|Withdrawal by Subject|2|||
131685775|NCT02138617|474134752|FG000|Overall Study|other complicating disease|0|||
131685776|NCT02138617|474134753|FG001|Overall Study|other complicating disease|2|||
131685777|NCT02138617|474134754|FG002|Overall Study|other complicating disease|0|||
131685778|NCT02138617|474134752|FG000|Overall Study|Protocol Violation|1|||
131685779|NCT02138617|474134753|FG001|Overall Study|Protocol Violation|0|||
131685780|NCT02138617|474134754|FG002|Overall Study|Protocol Violation|0|||
131685781|NCT02138617|474134752|FG000|Overall Study|Physician Decision|7|||
131685782|NCT02138617|474134753|FG001|Overall Study|Physician Decision|6|||
131685783|NCT02138617|474134754|FG002|Overall Study|Physician Decision|0|||
131685784|NCT02138617|474134752|FG000|Overall Study|financial reason|0|||
131685785|NCT02138617|474134753|FG001|Overall Study|financial reason|1|||
131685786|NCT02138617|474134754|FG002|Overall Study|financial reason|0|||
131685787|NCT02138617|474134752|FG000|Overall Study|other therapy|3|||
131685788|NCT02138617|474134753|FG001|Overall Study|other therapy|4|||
131685789|NCT02138617|474134754|FG002|Overall Study|other therapy|0|||
131685790|NCT05807464|474134760|FG000|Overall Study|Adverse Event|1|||
131685791|NCT05525689|474134762|FG000|Overall Study|Lost to Follow-up|1|||
131685792|NCT05525689|474134763|FG001|Overall Study|Lost to Follow-up|0|||
131685793|NCT01671111|474134766|FG000|Overall Study|Adverse Event|2|||
131685794|NCT01671111|474134766|FG000|Overall Study|Lack of Efficacy|1|||
131685795|NCT01671111|474134766|FG000|Overall Study|Withdrawal by Subject|2|||
131685796|NCT01671111|474134766|FG000|Overall Study|Physician Decision|1|||
131685797|NCT01671111|474134766|FG000|Overall Study|Other|24|||
131685798|NCT00596947|474134767|FG000|Overall Study|study halted due to low enrollment|5|||
131685799|NCT00596947|474134768|FG001|Overall Study|study halted due to low enrollment|3|||
131685800|NCT00596947|474134767|FG000|Overall Study|Lost to Follow-up|1|||
131685801|NCT00596947|474134768|FG001|Overall Study|Lost to Follow-up|0|||
131685802|NCT00496730|474134769|FG000|Overall Study|Lost to Follow-up|4|||
131685803|NCT00496730|474134770|FG001|Overall Study|Lost to Follow-up|3|||
131685804|NCT00496730|474134769|FG000|Overall Study|Withdrawal by Subject|2|||
131685805|NCT00496730|474134770|FG001|Overall Study|Withdrawal by Subject|2|||
131685806|NCT00113074|474134771|FG000|Overall Study|Lost to Follow-up|10|||
131685807|NCT00113074|474134772|FG001|Overall Study|Lost to Follow-up|10|||
131685808|NCT00113074|474134773|FG002|Overall Study|Lost to Follow-up|14|||
131685809|NCT03680911|474134774|FG000|At Home Treatment|Study Termination|3|||
131685810|NCT03680911|474134775|FG001|At Home Treatment|Study Termination|0|||
131685811|NCT03680911|474134774|FG000|At Home Treatment|Lost to Follow-up|0|||
131685812|NCT03680911|474134775|FG001|At Home Treatment|Lost to Follow-up|1|||
131685813|NCT03680911|474134774|FG000|At Home Treatment|Withdrawal by Subject|0|||
131685814|NCT03680911|474134775|FG001|At Home Treatment|Withdrawal by Subject|2|||
131685815|NCT03680911|474134774|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
131685816|NCT03680911|474134775|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
131685817|NCT02114268|474134776|FG000|Overall Study|Lost to Follow-up|4|||
131685818|NCT02114268|474134777|FG001|Overall Study|Lost to Follow-up|1|||
131685819|NCT02114268|474134778|FG002|Overall Study|Lost to Follow-up|1|||
131685820|NCT02114268|474134779|FG003|Overall Study|Lost to Follow-up|0|||
131685821|NCT02114268|474134780|FG004|Overall Study|Lost to Follow-up|0|||
131685822|NCT02114268|474134781|FG005|Overall Study|Lost to Follow-up|2|||
131685823|NCT02114268|474134776|FG000|Overall Study|Withdrawal by Subject|1|||
131685824|NCT02114268|474134777|FG001|Overall Study|Withdrawal by Subject|0|||
131685825|NCT02114268|474134778|FG002|Overall Study|Withdrawal by Subject|0|||
131773021|NCT00198107|474448871|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
131773022|NCT00198107|474448872|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
131773023|NCT02985541|474448878|FG000|Overall Study|Withdrawal by Subject|33|||
131773024|NCT02985541|474448878|FG000|Overall Study|Lost to Follow-up|26|||
131773025|NCT02985541|474448878|FG000|Overall Study|Adverse Event|27|||
131773026|NCT02985541|474448878|FG000|Overall Study|Physician Decision|2|||
131773027|NCT02985541|474448878|FG000|Overall Study|Pregnancy|2|||
131773028|NCT02985541|474448878|FG000|Overall Study|Wish for pregnancy|44|||
131773029|NCT02985541|474448878|FG000|Overall Study|Other reason|5|||
131773030|NCT02985541|474448878|FG000|Overall Study|Not valid for analysis|2|||
131773031|NCT02383966|474448879|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
131773032|NCT02383966|474448880|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
131773033|NCT02383966|474448879|FG000|Overall Study|Randomized, but not treated|1|||
131773034|NCT02383966|474448880|FG001|Overall Study|Randomized, but not treated|3|||
131773035|NCT02163759|474448881|FG000|Overall Study|Withdrawal by Subject|1|||
131773036|NCT02163759|474448882|FG001|Overall Study|Withdrawal by Subject|5|||
131773037|NCT02163759|474448883|FG002|Overall Study|Withdrawal by Subject|1|||
131773038|NCT02163759|474448881|FG000|Overall Study|Adverse Event|0|||
131685826|NCT02114268|474134779|FG003|Overall Study|Withdrawal by Subject|0|||
131685827|NCT02114268|474134780|FG004|Overall Study|Withdrawal by Subject|0|||
131685828|NCT02114268|474134781|FG005|Overall Study|Withdrawal by Subject|1|||
131685829|NCT02114268|474134776|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
131685830|NCT02114268|474134777|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
131685831|NCT02114268|474134778|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
131685832|NCT02114268|474134779|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
131685833|NCT02114268|474134780|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
131685834|NCT02114268|474134781|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
131685835|NCT03962738|474134784|FG000|Overall Study|Protocol Deviation|3|||
131685836|NCT03962738|474134785|FG001|Overall Study|Protocol Deviation|0|||
131685837|NCT03962738|474134786|FG002|Overall Study|Protocol Deviation|1|||
131685838|NCT03962738|474134787|FG003|Overall Study|Protocol Deviation|1|||
131685839|NCT03962738|474134784|FG000|Overall Study|Withdrawal by Subject|4|||
131685840|NCT03962738|474134785|FG001|Overall Study|Withdrawal by Subject|0|||
131685841|NCT03962738|474134786|FG002|Overall Study|Withdrawal by Subject|0|||
131685842|NCT03962738|474134787|FG003|Overall Study|Withdrawal by Subject|0|||
131685843|NCT03962738|474134784|FG000|Overall Study|Lost to Follow-up|0|||
131685844|NCT03962738|474134785|FG001|Overall Study|Lost to Follow-up|0|||
131685845|NCT03962738|474134786|FG002|Overall Study|Lost to Follow-up|1|||
131685846|NCT03962738|474134787|FG003|Overall Study|Lost to Follow-up|0|||
131685847|NCT00509067|474134788|FG000|Overall Study|Lost to Follow-up|1|||
131685848|NCT00509067|474134789|FG001|Overall Study|Lost to Follow-up|1|||
131685849|NCT00509067|474134788|FG000|Overall Study|Adverse Event|3|||
131685850|NCT00509067|474134789|FG001|Overall Study|Adverse Event|1|||
131685851|NCT00509067|474134788|FG000|Overall Study|Protocol Violation|0|||
131685852|NCT00509067|474134789|FG001|Overall Study|Protocol Violation|3|||
131685853|NCT00574288|474134790|FG000|Overall Study|Adverse Event|2|||
131685854|NCT00574288|474134791|FG001|Overall Study|Adverse Event|0|||
131685855|NCT00574288|474134792|FG002|Overall Study|Adverse Event|0|||
131685856|NCT00574288|474134793|FG003|Overall Study|Adverse Event|0|||
131685857|NCT00574288|474134794|FG004|Overall Study|Adverse Event|1|||
131685858|NCT00574288|474134795|FG005|Overall Study|Adverse Event|0|||
131685859|NCT00574288|474134796|FG006|Overall Study|Adverse Event|0|||
131685860|NCT00574288|474134790|FG000|Overall Study|Death|0|||
131685861|NCT00574288|474134791|FG001|Overall Study|Death|0|||
131685862|NCT00574288|474134792|FG002|Overall Study|Death|0|||
131685863|NCT00574288|474134793|FG003|Overall Study|Death|0|||
131685864|NCT00574288|474134794|FG004|Overall Study|Death|0|||
131685865|NCT00574288|474134795|FG005|Overall Study|Death|25|||
131685866|NCT00574288|474134796|FG006|Overall Study|Death|21|||
131685867|NCT00574288|474134790|FG000|Overall Study|Lost to Follow-up|0|||
131685868|NCT00574288|474134791|FG001|Overall Study|Lost to Follow-up|0|||
131773039|NCT02163759|474448882|FG001|Overall Study|Adverse Event|0|||
131773040|NCT02163759|474448883|FG002|Overall Study|Adverse Event|1|||
131685869|NCT00574288|474134792|FG002|Overall Study|Lost to Follow-up|0|||
131685870|NCT00574288|474134793|FG003|Overall Study|Lost to Follow-up|0|||
131685871|NCT00574288|474134794|FG004|Overall Study|Lost to Follow-up|0|||
131685872|NCT00574288|474134795|FG005|Overall Study|Lost to Follow-up|1|||
131685873|NCT00574288|474134796|FG006|Overall Study|Lost to Follow-up|2|||
131685874|NCT00574288|474134790|FG000|Overall Study|Study Terminated By Sponsor|0|||
131685875|NCT00574288|474134791|FG001|Overall Study|Study Terminated By Sponsor|0|||
131773041|NCT02163759|474448881|FG000|Overall Study|Death|0|||
131898518|NCT00320788|474914100|FG004|Overall Study|Decision by the Sponsor|1|||
131685876|NCT00574288|474134792|FG002|Overall Study|Study Terminated By Sponsor|0|||
131685877|NCT00574288|474134793|FG003|Overall Study|Study Terminated By Sponsor|0|||
131685878|NCT00574288|474134794|FG004|Overall Study|Study Terminated By Sponsor|0|||
131685879|NCT00574288|474134795|FG005|Overall Study|Study Terminated By Sponsor|0|||
131685880|NCT00574288|474134796|FG006|Overall Study|Study Terminated By Sponsor|5|||
131685881|NCT00574288|474134790|FG000|Overall Study|Progressive Disease|17|||
131685882|NCT00574288|474134791|FG001|Overall Study|Progressive Disease|2|||
131685883|NCT00574288|474134792|FG002|Overall Study|Progressive Disease|3|||
131685884|NCT00574288|474134793|FG003|Overall Study|Progressive Disease|2|||
131685885|NCT00574288|474134794|FG004|Overall Study|Progressive Disease|1|||
131685886|NCT00574288|474134795|FG005|Overall Study|Progressive Disease|0|||
131685887|NCT00574288|474134796|FG006|Overall Study|Progressive Disease|0|||
131685888|NCT00574288|474134790|FG000|Overall Study|Other|1|||
131685889|NCT00574288|474134791|FG001|Overall Study|Other|1|||
131685890|NCT00574288|474134792|FG002|Overall Study|Other|0|||
131685891|NCT00574288|474134793|FG003|Overall Study|Other|0|||
131685892|NCT00574288|474134794|FG004|Overall Study|Other|0|||
131685893|NCT00574288|474134795|FG005|Overall Study|Other|0|||
131685894|NCT00574288|474134796|FG006|Overall Study|Other|0|||
131685895|NCT02361944|474134799|FG000|Overall Study|surgery cancellation|0|||
131685896|NCT02361944|474134800|FG001|Overall Study|surgery cancellation|1|||
131685897|NCT03654976|474134803|FG000|Overall Study|Withdrawal by Subject|12|||
131685898|NCT03654976|474134804|FG001|Overall Study|Withdrawal by Subject|11|||
131685899|NCT03654976|474134803|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
131685900|NCT03654976|474134804|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
131685901|NCT03654976|474134803|FG000|Overall Study|Adverse Event|5|||
131685902|NCT03654976|474134804|FG001|Overall Study|Adverse Event|0|||
131685903|NCT03654976|474134803|FG000|Overall Study|Lost to Follow-up|2|||
131685904|NCT03654976|474134804|FG001|Overall Study|Lost to Follow-up|0|||
131685905|NCT03654976|474134803|FG000|Overall Study|Lack of Efficacy|0|||
131685906|NCT03654976|474134804|FG001|Overall Study|Lack of Efficacy|1|||
131685907|NCT03098836|474134805|FG000|Overall Study|Adverse Event|1|||
131685908|NCT03098836|474134806|FG001|Overall Study|Adverse Event|3|||
131685909|NCT03098836|474134805|FG000|Overall Study|Lack of Efficacy|30|||
131685910|NCT03098836|474134806|FG001|Overall Study|Lack of Efficacy|15|||
131685911|NCT03098836|474134805|FG000|Overall Study|Physician Decision|2|||
131685912|NCT03098836|474134806|FG001|Overall Study|Physician Decision|1|||
131685913|NCT03098836|474134805|FG000|Overall Study|Withdrawal by Subject|3|||
131685914|NCT03098836|474134806|FG001|Overall Study|Withdrawal by Subject|2|||
131685915|NCT01770912|474134807|FG000|Overall Study|Lost to Follow-up|2|||
131685916|NCT01770912|474134808|FG001|Overall Study|Lost to Follow-up|0|||
131685917|NCT01817751|474134811|FG000|Overall Study|Physician Decision|1|||
131685918|NCT01846624|474134814|FG000|Overall Study|Died during induction, no midostaurin|1|||
131685919|NCT03472924|474134818|FG000|Overall Study|Adverse Event|1|||
131685920|NCT03472924|474134819|FG001|Overall Study|Adverse Event|0|||
131685921|NCT00427349|474134820|FG000|Overall Study|Lack of Efficacy|23|||
131685922|NCT00427349|474134820|FG000|Overall Study|Adverse Event|14|||
131685923|NCT00427349|474134820|FG000|Overall Study|Death|1|||
131685924|NCT00427349|474134820|FG000|Overall Study|Withdrawal by Subject|3|||
131685925|NCT00427349|474134820|FG000|Overall Study|Alternative therapy|1|||
131685926|NCT00427349|474134820|FG000|Overall Study|Other|2|||
131685927|NCT00427349|474134820|FG000|Overall Study|Ineligible|1|||
131685928|NCT00427349|474134820|FG000|Overall Study|Never started therapy|1|||
131685929|NCT00698997|474134822|FG000|Overall Study|Lost to Follow-up|3|||
131685930|NCT00698997|474134823|FG001|Overall Study|Lost to Follow-up|0|||
131685931|NCT00698997|474134822|FG000|Overall Study|Withdrawal by Subject|7|||
131685932|NCT00698997|474134823|FG001|Overall Study|Withdrawal by Subject|27|||
131685933|NCT05082376|474134826|FG000|Overall Study|Lost to Follow-up|2|||
131685934|NCT04425720|474134827|FG000|Overall Study|Withdrawal by Subject|0|||
131685935|NCT04425720|474134828|FG001|Overall Study|Withdrawal by Subject|20|||
131685936|NCT00290186|474134829|FG000|Overall Study|Adverse Event|1|||
131685937|NCT00290186|474134830|FG001|Overall Study|Adverse Event|1|||
131685938|NCT00290186|474134829|FG000|Overall Study|Lost to Follow-up|3|||
131685939|NCT00290186|474134830|FG001|Overall Study|Lost to Follow-up|2|||
131685940|NCT00290186|474134829|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
131685941|NCT00290186|474134830|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
131685942|NCT00290186|474134829|FG000|Overall Study|Withdrawal by Subject|0|||
131685943|NCT00290186|474134830|FG001|Overall Study|Withdrawal by Subject|1|||
131685944|NCT00943579|474134833|FG000|Overall Study|Adverse Event|4|||
131685945|NCT00943579|474134834|FG001|Overall Study|Adverse Event|3|||
131685946|NCT00943579|474134833|FG000|Overall Study|Lack of Efficacy|2|||
131685947|NCT00943579|474134834|FG001|Overall Study|Lack of Efficacy|2|||
131685948|NCT01357577|474134837|FG000|Overall Study|Lost to Follow-up|20|||
131685949|NCT01357577|474134838|FG001|Overall Study|Lost to Follow-up|16|||
131685950|NCT01357577|474134837|FG000|Overall Study|Withdrawal by Subject|16|||
131685951|NCT01357577|474134838|FG001|Overall Study|Withdrawal by Subject|8|||
131685952|NCT01357577|474134837|FG000|Overall Study|look at data in database?|1|||
131685953|NCT01357577|474134838|FG001|Overall Study|look at data in database?|2|||
131685954|NCT06156215|474134841|FG000|Overall Study|Withdrawal by Subject|2|||
131685955|NCT06156215|474134842|FG001|Overall Study|Withdrawal by Subject|4|||
131685956|NCT06156215|474134843|FG002|Overall Study|Withdrawal by Subject|4|||
131685957|NCT06156215|474134844|FG003|Overall Study|Withdrawal by Subject|0|||
131685958|NCT06156215|474134845|FG004|Overall Study|Withdrawal by Subject|2|||
131685959|NCT06156215|474134846|FG005|Overall Study|Withdrawal by Subject|2|||
131685960|NCT06156215|474134841|FG000|Overall Study|Left ED without completing study|9|||
131685961|NCT06156215|474134842|FG001|Overall Study|Left ED without completing study|3|||
131685962|NCT06156215|474134843|FG002|Overall Study|Left ED without completing study|9|||
131685963|NCT06156215|474134844|FG003|Overall Study|Left ED without completing study|0|||
131685964|NCT06156215|474134845|FG004|Overall Study|Left ED without completing study|8|||
131685965|NCT06156215|474134846|FG005|Overall Study|Left ED without completing study|16|||
131685966|NCT06156215|474134841|FG000|Overall Study|Physician Decision|1|||
131685967|NCT06156215|474134842|FG001|Overall Study|Physician Decision|0|||
131685968|NCT06156215|474134843|FG002|Overall Study|Physician Decision|0|||
131685969|NCT06156215|474134844|FG003|Overall Study|Physician Decision|0|||
131685970|NCT06156215|474134845|FG004|Overall Study|Physician Decision|0|||
131685971|NCT06156215|474134846|FG005|Overall Study|Physician Decision|0|||
131685972|NCT06156215|474134841|FG000|Overall Study|Became or found ineligible|2|||
131685973|NCT06156215|474134842|FG001|Overall Study|Became or found ineligible|0|||
131685974|NCT06156215|474134843|FG002|Overall Study|Became or found ineligible|2|||
131685975|NCT06156215|474134844|FG003|Overall Study|Became or found ineligible|0|||
131685976|NCT06156215|474134845|FG004|Overall Study|Became or found ineligible|1|||
131685977|NCT06156215|474134846|FG005|Overall Study|Became or found ineligible|2|||
131685978|NCT03977974|474134851|FG000|Period 2|Adverse Event|0|||
131685979|NCT03977974|474134852|FG001|Period 2|Adverse Event|0|||
131685980|NCT03977974|474134853|FG002|Period 2|Adverse Event|0|||
131685981|NCT03977974|474134854|FG003|Period 2|Adverse Event|0|||
131685982|NCT03977974|474134855|FG004|Period 2|Adverse Event|1|||
131685983|NCT03977974|474134856|FG005|Period 2|Adverse Event|0|||
131685984|NCT03977974|474134857|FG006|Period 2|Adverse Event|0|||
131685985|NCT03977974|474134858|FG007|Period 2|Adverse Event|0|||
131685986|NCT03977974|474134859|FG008|Period 2|Adverse Event|0|||
131685987|NCT03977974|474134860|FG009|Period 2|Adverse Event|0|||
131685988|NCT03977974|474134861|FG010|Period 2|Adverse Event|0|||
131685989|NCT03977974|474134862|FG011|Period 2|Adverse Event|0|||
131685990|NCT03977974|474134863|FG012|Period 2|Adverse Event|0|||
131685991|NCT03496012|474136512|FG000|Overall Study|Withdrawal by Subject|2|||
131685992|NCT03496012|474136513|FG001|Overall Study|Withdrawal by Subject|0|||
131685993|NCT03496012|474136514|FG002|Overall Study|Withdrawal by Subject|2|||
131685994|NCT03496012|474136512|FG000|Overall Study|Adverse Event|0|||
131685995|NCT03496012|474136513|FG001|Overall Study|Adverse Event|0|||
131685996|NCT03496012|474136514|FG002|Overall Study|Adverse Event|1|||
131685997|NCT03496012|474136512|FG000|Overall Study|Reason Not Specified|2|||
131685998|NCT03496012|474136513|FG001|Overall Study|Reason Not Specified|0|||
131685999|NCT03496012|474136514|FG002|Overall Study|Reason Not Specified|1|||
131686000|NCT02322125|474136515|FG000|Overall Study|Withdrawal by Subject|2|||
131686001|NCT00449670|474136517|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
131686002|NCT00449670|474136518|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
131686003|NCT00449670|474136517|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
131686004|NCT00449670|474136518|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
131686005|NCT00449670|474136517|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
131686006|NCT00449670|474136518|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
131686007|NCT00449670|474136517|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
131686008|NCT00449670|474136518|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
131686009|NCT00449670|474136517|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
131686010|NCT00449670|474136518|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
131686011|NCT00449670|474136517|FG000|Booster Phase (Study no.109873)|Other|0|||
131686012|NCT00449670|474136518|FG001|Booster Phase (Study no.109873)|Other|2|||
131686013|NCT04183790|474136519|FG000|Overall Study|Participants did not rollover to Part B|12|||
131686014|NCT04183790|474136520|FG001|Overall Study|Participants did not rollover to Part B|0|||
131686015|NCT04183790|474136519|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
131686016|NCT04183790|474136520|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
131686017|NCT04183790|474136519|FG000|Overall Study|Commercial drug is available for participant|6|||
131686018|NCT04183790|474136520|FG001|Overall Study|Commercial drug is available for participant|0|||
131686019|NCT04183790|474136519|FG000|Overall Study|Adverse Event|1|||
131686020|NCT04183790|474136520|FG001|Overall Study|Adverse Event|0|||
131686021|NCT04183790|474136519|FG000|Overall Study|Not enrolled in 107 study|0|||
131686022|NCT04183790|474136520|FG001|Overall Study|Not enrolled in 107 study|2|||
131686023|NCT01524198|474136521|FG000|Overall Study|Protocol Violation|8|||
131773042|NCT02163759|474448882|FG001|Overall Study|Death|0|||
131773043|NCT02163759|474448883|FG002|Overall Study|Death|1|||
131773044|NCT00451191|474448895|FG000|Overall Study|withdrawal or received alternate tx|15|||
131773045|NCT00451191|474448896|FG001|Overall Study|withdrawal or received alternate tx|11|||
131773046|NCT03575806|474448908|FG000|Overall Study|Withdrawal by Subject|0|||
131686024|NCT01524198|474136522|FG001|Overall Study|Protocol Violation|6|||
131686025|NCT01524198|474136521|FG000|Overall Study|Withdrawal by Subject|15|||
131686026|NCT01524198|474136522|FG001|Overall Study|Withdrawal by Subject|10|||
131686027|NCT01439282|474136523|FG000|Overall Study|Adverse Event|5|||
131686028|NCT01439282|474136524|FG001|Overall Study|Adverse Event|0|||
131686029|NCT01439282|474136523|FG000|Overall Study|Withdrawal by Subject|2|||
131686030|NCT01439282|474136524|FG001|Overall Study|Withdrawal by Subject|0|||
131686031|NCT01439282|474136523|FG000|Overall Study|Other|1|||
131686032|NCT01439282|474136524|FG001|Overall Study|Other|1|||
131686033|NCT04419610|474136525|FG000|Overall Study|Withdrawal by Subject|3|||
131686034|NCT04419610|474136526|FG001|Overall Study|Withdrawal by Subject|1|||
131686035|NCT04419610|474136525|FG000|Overall Study|Adverse Event|1|||
131686036|NCT04419610|474136526|FG001|Overall Study|Adverse Event|0|||
131686037|NCT04419610|474136525|FG000|Overall Study|discharged early|1|||
131686038|NCT04419610|474136526|FG001|Overall Study|discharged early|1|||
131686039|NCT02232802|474136527|FG000|Period 1|Sponsor request|1|||
131686040|NCT02232802|474136528|FG001|Period 1|Sponsor request|0|||
131686041|NCT02232802|474136527|FG000|Period 1|Adverse Event|1|||
131686042|NCT02232802|474136528|FG001|Period 1|Adverse Event|1|||
131686043|NCT00885703|474136535|FG000|Overall Study|Death|9|||
131686044|NCT00885703|474136536|FG001|Overall Study|Death|7|||
131686045|NCT00885703|474136537|FG002|Overall Study|Death|8|||
131686046|NCT00885703|474136538|FG003|Overall Study|Death|7|||
131686047|NCT00885703|474136539|FG004|Overall Study|Death|7|||
131686048|NCT00885703|474136540|FG005|Overall Study|Death|8|||
131686049|NCT00885703|474136541|FG006|Overall Study|Death|4|||
131686050|NCT00885703|474136535|FG000|Overall Study|Lost to Follow-up|0|||
131686051|NCT00885703|474136536|FG001|Overall Study|Lost to Follow-up|0|||
131686052|NCT00885703|474136537|FG002|Overall Study|Lost to Follow-up|1|||
131686053|NCT00885703|474136538|FG003|Overall Study|Lost to Follow-up|0|||
131686054|NCT00885703|474136539|FG004|Overall Study|Lost to Follow-up|0|||
131686055|NCT00885703|474136540|FG005|Overall Study|Lost to Follow-up|1|||
131686056|NCT00885703|474136541|FG006|Overall Study|Lost to Follow-up|0|||
131686057|NCT00885703|474136535|FG000|Overall Study|Withdrawal by Subject|0|||
131686058|NCT00885703|474136536|FG001|Overall Study|Withdrawal by Subject|0|||
131686059|NCT00885703|474136537|FG002|Overall Study|Withdrawal by Subject|0|||
131686060|NCT00885703|474136538|FG003|Overall Study|Withdrawal by Subject|1|||
131686061|NCT00885703|474136539|FG004|Overall Study|Withdrawal by Subject|3|||
131686062|NCT00885703|474136540|FG005|Overall Study|Withdrawal by Subject|1|||
131686063|NCT00885703|474136541|FG006|Overall Study|Withdrawal by Subject|1|||
131686064|NCT00885703|474136535|FG000|Overall Study|Ineligible (no CM)|1|||
131686065|NCT00885703|474136536|FG001|Overall Study|Ineligible (no CM)|3|||
131686066|NCT00885703|474136537|FG002|Overall Study|Ineligible (no CM)|2|||
131686067|NCT00885703|474136538|FG003|Overall Study|Ineligible (no CM)|1|||
131686068|NCT00885703|474136539|FG004|Overall Study|Ineligible (no CM)|2|||
131686069|NCT00885703|474136540|FG005|Overall Study|Ineligible (no CM)|3|||
131686070|NCT00885703|474136541|FG006|Overall Study|Ineligible (no CM)|1|||
131686071|NCT01183143|474136544|FG000|Overall Study|Protocol Violation|115|||
131773047|NCT03575806|474448909|FG001|Overall Study|Withdrawal by Subject|2|||
131686072|NCT01183143|474136544|FG000|Overall Study|Withdrawal by Subject|19|||
131686073|NCT01183143|474136544|FG000|Overall Study|Subject Questionnaires not returned|5|||
131686074|NCT01183143|474136544|FG000|Overall Study|Subjects enrolled, but not treated|11|||
131686075|NCT01502709|474136545|FG000|Overall Study|Lost to Follow-up|4|||
131686076|NCT01502709|474136546|FG001|Overall Study|Lost to Follow-up|0|||
131686077|NCT04096274|474136547|FG000|Phase I|Lost to Follow-up|5|||
131686078|NCT04096274|474136548|FG001|Phase I|Lost to Follow-up|5|||
131686079|NCT04096274|474136547|FG000|Phase II|Lost to Follow-up|11|||
131686080|NCT04096274|474136548|FG001|Phase II|Lost to Follow-up|11|||
131686081|NCT00937937|474136549|FG000|Overall Study|Adverse Event|6|||
131686082|NCT00937937|474136549|FG000|Overall Study|Withdrawal by Subject|2|||
131686083|NCT00937937|474136549|FG000|Overall Study|Progression/relapse|61|||
131686084|NCT00937937|474136549|FG000|Overall Study|Death|1|||
131555988|NCT01121484|473660293|FG001|Overall Study|Other|3|||
131555989|NCT01121484|473660292|FG000|Overall Study|Randomized, not treated|1|||
131555990|NCT01121484|473660293|FG001|Overall Study|Randomized, not treated|4|||
131686085|NCT00937937|474136549|FG000|Overall Study|Other|2|||
131686086|NCT01490450|474136551|FG000|Period 1|Lack of Efficacy|2|||
131686087|NCT01490450|474136552|FG001|Period 1|Lack of Efficacy|0|||
131686088|NCT01490450|474136553|FG002|Period 1|Lack of Efficacy|3|||
131686089|NCT01490450|474136554|FG003|Period 1|Lack of Efficacy|0|||
131686090|NCT01490450|474136551|FG000|Period 1|Adverse Event|0|||
131686091|NCT01490450|474136552|FG001|Period 1|Adverse Event|0|||
131686092|NCT01490450|474136553|FG002|Period 1|Adverse Event|0|||
131686093|NCT01490450|474136554|FG003|Period 1|Adverse Event|5|||
131686094|NCT01490450|474136551|FG000|Period 1|Request to discontinue treatment|1|||
131686095|NCT01490450|474136552|FG001|Period 1|Request to discontinue treatment|0|||
131686096|NCT01490450|474136553|FG002|Period 1|Request to discontinue treatment|0|||
131686097|NCT01490450|474136554|FG003|Period 1|Request to discontinue treatment|0|||
131686098|NCT01490450|474136551|FG000|Period 1|Withdrawal by Subject|0|||
131686099|NCT01490450|474136552|FG001|Period 1|Withdrawal by Subject|0|||
131686100|NCT01490450|474136553|FG002|Period 1|Withdrawal by Subject|0|||
131686101|NCT01490450|474136554|FG003|Period 1|Withdrawal by Subject|3|||
131686102|NCT01490450|474136551|FG000|Period 1|No longer met study criteria|0|||
131686103|NCT01490450|474136552|FG001|Period 1|No longer met study criteria|1|||
131686104|NCT01490450|474136553|FG002|Period 1|No longer met study criteria|1|||
131686105|NCT01490450|474136554|FG003|Period 1|No longer met study criteria|0|||
131686106|NCT01490450|474136551|FG000|Period 2|Lack of Efficacy|0|||
131686107|NCT01490450|474136552|FG001|Period 2|Lack of Efficacy|0|||
131686108|NCT01490450|474136553|FG002|Period 2|Lack of Efficacy|0|||
131686109|NCT01490450|474136554|FG003|Period 2|Lack of Efficacy|1|||
131686110|NCT01490450|474136551|FG000|Period 2|Adverse Event|1|||
131686111|NCT01490450|474136552|FG001|Period 2|Adverse Event|1|||
131686112|NCT01490450|474136553|FG002|Period 2|Adverse Event|0|||
131686113|NCT01490450|474136554|FG003|Period 2|Adverse Event|1|||
131686114|NCT01490450|474136551|FG000|Period 2|Withdrawal by Subject|1|||
131686115|NCT01490450|474136552|FG001|Period 2|Withdrawal by Subject|0|||
131686116|NCT01490450|474136553|FG002|Period 2|Withdrawal by Subject|0|||
131686117|NCT01490450|474136554|FG003|Period 2|Withdrawal by Subject|0|||
131686118|NCT01490450|474136551|FG000|Period 2|Lost to Follow-up|0|||
131686119|NCT01490450|474136552|FG001|Period 2|Lost to Follow-up|0|||
131686120|NCT01490450|474136553|FG002|Period 2|Lost to Follow-up|0|||
131686121|NCT01490450|474136554|FG003|Period 2|Lost to Follow-up|2|||
131686122|NCT03197493|474136555|FG000|Overall Study|Withdrawal by Subject|5|||
131686123|NCT02248259|474136556|FG000|Treatment Period 1|Adverse Event|0|||
131686124|NCT02248259|474136557|FG001|Treatment Period 1|Adverse Event|0|||
131686125|NCT02248259|474136558|FG002|Treatment Period 1|Adverse Event|1|||
131686126|NCT02248259|474136559|FG003|Treatment Period 1|Adverse Event|0|||
131686127|NCT02807480|474136560|FG000|Overall Study|Withdrawal by Subject|14|||
131686128|NCT02807480|474136561|FG001|Overall Study|Withdrawal by Subject|10|||
131686129|NCT02369848|474136562|FG000|Overall Study|Death|1|||
131686130|NCT02369848|474136562|FG000|Overall Study|Withdrawal by Subject|2|||
131686131|NCT02369848|474136562|FG000|Overall Study|Lost to Follow-up|1|||
131686132|NCT03281668|474136564|FG000|Overall Study|Physician Decision|1|||
131686133|NCT03281668|474136564|FG000|Overall Study|scheduling conflict, family circumstance|2|||
131686134|NCT03281668|474136564|FG000|Overall Study|Withdrawal by Subject|4|||
131686135|NCT03281668|474136564|FG000|Overall Study|Lost to Follow-up|1|||
131686136|NCT01543152|474136565|FG000|Overall Study|Withdrawal by Subject|0|||
131686137|NCT01543152|474136566|FG001|Overall Study|Withdrawal by Subject|2|||
131686138|NCT01543152|474136567|FG002|Overall Study|Withdrawal by Subject|0|||
131686139|NCT01543152|474136568|FG003|Overall Study|Withdrawal by Subject|0|||
131686140|NCT01543152|474136569|FG004|Overall Study|Withdrawal by Subject|0|||
131686141|NCT00636675|474136570|FG000|Overall Study|Lost to Follow-up|121|||
131686142|NCT00636675|474136571|FG001|Overall Study|Lost to Follow-up|31|||
131686143|NCT00636675|474136570|FG000|Overall Study|Withdrawal by Subject|19|||
131686144|NCT00636675|474136571|FG001|Overall Study|Withdrawal by Subject|10|||
131686145|NCT00096785|474136574|FG000|Overall Study|Lost to Follow-up|1|||
131898519|NCT00320788|474914096|FG000|Overall Study|Other|1|||
131555991|NCT01512745|473660295|FG000|Overall Study|Adverse Event|22|||
131686146|NCT00096785|474136575|FG001|Overall Study|Lost to Follow-up|0|||
131686147|NCT00096785|474136574|FG000|Overall Study|Withdrawal by Subject|0|||
131686148|NCT00096785|474136575|FG001|Overall Study|Withdrawal by Subject|1|||
131686149|NCT00096785|474136574|FG000|Overall Study|Relocated|1|||
131686150|NCT00096785|474136575|FG001|Overall Study|Relocated|0|||
131686151|NCT02081534|474136581|FG000|Overall Study|Adverse Event|5|||
131686152|NCT02081534|474136582|FG001|Overall Study|Adverse Event|4|||
131686153|NCT02081534|474136583|FG002|Overall Study|Adverse Event|3|||
131686154|NCT02081534|474136584|FG003|Overall Study|Adverse Event|10|||
131686155|NCT02081534|474136585|FG004|Overall Study|Adverse Event|2|||
131686156|NCT02081534|474136586|FG005|Overall Study|Adverse Event|8|||
131686157|NCT02081534|474136587|FG006|Overall Study|Adverse Event|2|||
131686158|NCT02081534|474136581|FG000|Overall Study|Withdrawal by Subject|0|||
131686159|NCT02081534|474136582|FG001|Overall Study|Withdrawal by Subject|1|||
131773048|NCT03575806|474448908|FG000|Overall Study|Protocol Violation|0|||
131555992|NCT01512745|473660296|FG001|Overall Study|Adverse Event|3|||
131555993|NCT01512745|473660295|FG000|Overall Study|Death|9|||
131555994|NCT01512745|473660296|FG001|Overall Study|Death|13|||
131686160|NCT02081534|474136583|FG002|Overall Study|Withdrawal by Subject|1|||
131773049|NCT03575806|474448909|FG001|Overall Study|Protocol Violation|2|||
131773050|NCT00219349|474448910|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
131773051|NCT00219349|474448910|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
131773052|NCT00219349|474448910|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
131773053|NCT00219349|474448910|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
131773054|NCT00270205|474448912|FG000|Overall Study|Lost to Follow-up|1|||
131773055|NCT00270205|474448913|FG001|Overall Study|Lost to Follow-up|0|||
131773056|NCT00270205|474448914|FG002|Overall Study|Lost to Follow-up|0|||
131773057|NCT00270205|474448915|FG003|Overall Study|Lost to Follow-up|1|||
131773058|NCT00869362|474448916|FG000|Overall Study|Death|0|||
131773059|NCT00869362|474448917|FG001|Overall Study|Death|2|||
131773060|NCT00869362|474448916|FG000|Overall Study|Lost to Follow-up|1|||
131773061|NCT00869362|474448917|FG001|Overall Study|Lost to Follow-up|3|||
131773062|NCT01241591|474448918|FG000|Overall Study|Lack of Efficacy|5|||
131773063|NCT01241591|474448919|FG001|Overall Study|Lack of Efficacy|2|||
131773064|NCT01241591|474448920|FG002|Overall Study|Lack of Efficacy|2|||
131773065|NCT01241591|474448921|FG003|Overall Study|Lack of Efficacy|3|||
131773066|NCT01241591|474448918|FG000|Overall Study|Protocol Violation|5|||
131773067|NCT01241591|474448919|FG001|Overall Study|Protocol Violation|2|||
131773068|NCT01241591|474448920|FG002|Overall Study|Protocol Violation|3|||
131773069|NCT01241591|474448921|FG003|Overall Study|Protocol Violation|0|||
131773070|NCT01241591|474448918|FG000|Overall Study|Lost to Follow-up|1|||
131773071|NCT01241591|474448919|FG001|Overall Study|Lost to Follow-up|2|||
131773072|NCT01241591|474448920|FG002|Overall Study|Lost to Follow-up|2|||
131773073|NCT01241591|474448921|FG003|Overall Study|Lost to Follow-up|2|||
131773074|NCT01241591|474448918|FG000|Overall Study|Screen Failure|3|||
131773075|NCT01241591|474448919|FG001|Overall Study|Screen Failure|2|||
131773076|NCT01241591|474448920|FG002|Overall Study|Screen Failure|1|||
131773077|NCT01241591|474448921|FG003|Overall Study|Screen Failure|0|||
131773078|NCT01241591|474448918|FG000|Overall Study|Withdrawal by Subject|6|||
131773079|NCT01241591|474448919|FG001|Overall Study|Withdrawal by Subject|4|||
131773080|NCT01241591|474448920|FG002|Overall Study|Withdrawal by Subject|2|||
131773081|NCT01241591|474448921|FG003|Overall Study|Withdrawal by Subject|2|||
131773082|NCT01241591|474448918|FG000|Overall Study|Other|0|||
131773083|NCT01241591|474448919|FG001|Overall Study|Other|1|||
131773084|NCT01241591|474448920|FG002|Overall Study|Other|0|||
131773085|NCT01241591|474448921|FG003|Overall Study|Other|1|||
131773086|NCT01241591|474448918|FG000|Overall Study|Adverse Event|3|||
131773087|NCT01241591|474448919|FG001|Overall Study|Adverse Event|11|||
131773088|NCT01241591|474448920|FG002|Overall Study|Adverse Event|12|||
131773089|NCT01241591|474448921|FG003|Overall Study|Adverse Event|4|||
131773090|NCT01945034|474448922|FG000|Overall Study|Medication Error|0|||
131773091|NCT01945034|474448923|FG001|Overall Study|Medication Error|1|||
131773092|NCT01945034|474448924|FG002|Overall Study|Medication Error|0|||
131773093|NCT01945034|474448922|FG000|Overall Study|Withdrawal by Subject|0|||
131773094|NCT01945034|474448923|FG001|Overall Study|Withdrawal by Subject|3|||
131773095|NCT01945034|474448924|FG002|Overall Study|Withdrawal by Subject|1|||
131773096|NCT01945034|474448922|FG000|Overall Study|Other|0|||
131773097|NCT01945034|474448923|FG001|Overall Study|Other|1|||
131773098|NCT01945034|474448924|FG002|Overall Study|Other|3|||
131773099|NCT01945034|474448922|FG000|Overall Study|Lost to Follow-up|0|||
131686161|NCT02081534|474136584|FG003|Overall Study|Withdrawal by Subject|1|||
131686162|NCT02081534|474136585|FG004|Overall Study|Withdrawal by Subject|1|||
131686163|NCT02081534|474136586|FG005|Overall Study|Withdrawal by Subject|0|||
131686164|NCT02081534|474136587|FG006|Overall Study|Withdrawal by Subject|1|||
131686165|NCT02081534|474136581|FG000|Overall Study|Protocol Violation|0|||
131686166|NCT02081534|474136582|FG001|Overall Study|Protocol Violation|3|||
131686167|NCT02081534|474136583|FG002|Overall Study|Protocol Violation|0|||
131686168|NCT02081534|474136584|FG003|Overall Study|Protocol Violation|0|||
131686169|NCT02081534|474136585|FG004|Overall Study|Protocol Violation|0|||
131773100|NCT01945034|474448923|FG001|Overall Study|Lost to Follow-up|0|||
131773101|NCT01945034|474448924|FG002|Overall Study|Lost to Follow-up|2|||
131773102|NCT01945034|474448922|FG000|Overall Study|Protocol Violation|1|||
131773103|NCT01945034|474448923|FG001|Overall Study|Protocol Violation|0|||
131773104|NCT01945034|474448924|FG002|Overall Study|Protocol Violation|1|||
131773105|NCT02147132|474448925|FG000|Overall Study|Lost to Follow-up|1|||
131773106|NCT02147132|474448926|FG001|Overall Study|Lost to Follow-up|0|||
131773107|NCT02147132|474448927|FG002|Overall Study|Lost to Follow-up|0|||
131773108|NCT02147132|474448928|FG003|Overall Study|Lost to Follow-up|0|||
131555995|NCT01512745|473660295|FG000|Overall Study|Withdrawal by Subject|2|||
131686170|NCT02081534|474136586|FG005|Overall Study|Protocol Violation|0|||
131686171|NCT02081534|474136587|FG006|Overall Study|Protocol Violation|1|||
131773109|NCT02646566|474448930|FG000|Overall Study|Lost to Follow-up|5|||
131773110|NCT02646566|474448931|FG001|Overall Study|Lost to Follow-up|4|||
131773111|NCT02646566|474448932|FG002|Overall Study|Lost to Follow-up|5|||
131773112|NCT02646566|474448930|FG000|Overall Study|Treatment failure|1|||
131773113|NCT02646566|474448931|FG001|Overall Study|Treatment failure|0|||
131773114|NCT02646566|474448932|FG002|Overall Study|Treatment failure|0|||
131773115|NCT02660489|474448935|FG000|Overall Study|Lost to Follow-up|1|||
131773116|NCT02660489|474448936|FG001|Overall Study|Lost to Follow-up|1|||
131773117|NCT02660489|474448935|FG000|Overall Study|Adverse Event|1|||
131773118|NCT02660489|474448936|FG001|Overall Study|Adverse Event|3|||
131773119|NCT02660489|474448935|FG000|Overall Study|no rhinovirus infection|4|||
131773120|NCT02660489|474448936|FG001|Overall Study|no rhinovirus infection|4|||
131773121|NCT02064231|474448937|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
131773122|NCT02064231|474448938|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
131773123|NCT02064231|474448939|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
131773124|NCT02064231|474448940|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
131773125|NCT02064231|474448937|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
131773126|NCT02064231|474448938|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
131773127|NCT02064231|474448939|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
131773128|NCT02064231|474448940|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
131773129|NCT02064231|474448937|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
131773130|NCT02064231|474448938|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
131773131|NCT02064231|474448939|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
131773132|NCT02064231|474448940|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
131773133|NCT02064231|474448937|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
131773134|NCT02064231|474448938|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
131773135|NCT02064231|474448939|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
131773136|NCT02064231|474448940|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
131773137|NCT02392078|474448941|FG000|Overall Study|Did not have procedure|32|||
131773138|NCT02392078|474448942|FG001|Overall Study|Did not have procedure|43|||
131773139|NCT02392078|474448943|FG002|Overall Study|Did not have procedure|20|||
131773140|NCT02392078|474448944|FG003|Overall Study|Did not have procedure|1|||
131773141|NCT02652793|474448945|FG000|Overall Study|Adverse Event|1|||
131773142|NCT02652793|474448945|FG000|Overall Study|Lost to Follow-up|2|||
131773143|NCT02652793|474448945|FG000|Overall Study|Withdrawal by Subject|1|||
131773144|NCT05450198|474448946|FG000|Overall Study|Withdrawal by Subject|1|||
131773145|NCT05450198|474448947|FG001|Overall Study|Withdrawal by Subject|1|||
131773146|NCT05450198|474448948|FG002|Overall Study|Withdrawal by Subject|2|||
131773147|NCT05450198|474448949|FG003|Overall Study|Withdrawal by Subject|0|||
131773148|NCT05450198|474448946|FG000|Overall Study|Lost to Follow-up|1|||
131773149|NCT05450198|474448947|FG001|Overall Study|Lost to Follow-up|0|||
131773150|NCT05450198|474448948|FG002|Overall Study|Lost to Follow-up|2|||
131773151|NCT05450198|474448949|FG003|Overall Study|Lost to Follow-up|1|||
131773152|NCT01982942|474448950|FG000|Overall Study|Adverse Event|10|||
131773153|NCT01982942|474448951|FG001|Overall Study|Adverse Event|5|||
131773154|NCT01982942|474448950|FG000|Overall Study|Lost to Follow-up|4|||
131773155|NCT01982942|474448951|FG001|Overall Study|Lost to Follow-up|3|||
131773156|NCT01982942|474448950|FG000|Overall Study|Multiple sclerosis progression|3|||
131773157|NCT01982942|474448951|FG001|Overall Study|Multiple sclerosis progression|2|||
131773158|NCT01982942|474448950|FG000|Overall Study|Wanted to try therapy not permitted|1|||
131773159|NCT01982942|474448951|FG001|Overall Study|Wanted to try therapy not permitted|0|||
131773160|NCT01982942|474448950|FG000|Overall Study|Subject declined future visits|0|||
131773161|NCT01982942|474448951|FG001|Overall Study|Subject declined future visits|1|||
131773162|NCT01982942|474448950|FG000|Overall Study|Left geographical area|2|||
131773163|NCT01982942|474448951|FG001|Overall Study|Left geographical area|0|||
131773164|NCT01982942|474448950|FG000|Overall Study|Too many pills|1|||
131773165|NCT01982942|474448951|FG001|Overall Study|Too many pills|0|||
131773166|NCT01982942|474448950|FG000|Overall Study|MS Relapse|0|||
131773167|NCT01982942|474448951|FG001|Overall Study|MS Relapse|1|||
131773168|NCT01982942|474448950|FG000|Overall Study|Chose to join a stem cell trial|0|||
131773169|NCT01982942|474448951|FG001|Overall Study|Chose to join a stem cell trial|1|||
131773170|NCT01982942|474448950|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
131773171|NCT01982942|474448951|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
131773172|NCT02696382|474448952|FG000|Overall Study|Death|7|||
131773173|NCT02696382|474448953|FG001|Overall Study|Death|2|||
131773174|NCT02696382|474448952|FG000|Overall Study|Withdrawal by Subject|5|||
131773175|NCT02696382|474448953|FG001|Overall Study|Withdrawal by Subject|12|||
131773176|NCT02696382|474448952|FG000|Overall Study|Lost to Follow-up|4|||
131773177|NCT02696382|474448953|FG001|Overall Study|Lost to Follow-up|7|||
131773178|NCT03417245|474448954|FG000|Overall Study|Adverse Event|1|||
131773179|NCT03417245|474448955|FG001|Overall Study|Adverse Event|0|||
131773180|NCT03417245|474448954|FG000|Overall Study|Protocol Violation|1|||
131773181|NCT03417245|474448955|FG001|Overall Study|Protocol Violation|0|||
131773182|NCT03417245|474448954|FG000|Overall Study|Withdrawal by Subject|1|||
131773183|NCT03417245|474448955|FG001|Overall Study|Withdrawal by Subject|1|||
131773184|NCT02708524|474448959|FG000|Overall Study|Adverse Event|0|||
131773185|NCT02708524|474448960|FG001|Overall Study|Adverse Event|1|||
131773186|NCT02708524|474448961|FG002|Overall Study|Adverse Event|0|||
131773187|NCT02708524|474448962|FG003|Overall Study|Adverse Event|0|||
131773188|NCT02708524|474448959|FG000|Overall Study|Lens Discomfort|1|||
131773189|NCT02708524|474448960|FG001|Overall Study|Lens Discomfort|0|||
131773190|NCT02708524|474448961|FG002|Overall Study|Lens Discomfort|1|||
131773191|NCT02708524|474448962|FG003|Overall Study|Lens Discomfort|0|||
131773192|NCT02708524|474448959|FG000|Overall Study|Lost to Follow-up|1|||
131773193|NCT02708524|474448960|FG001|Overall Study|Lost to Follow-up|1|||
131773194|NCT02708524|474448961|FG002|Overall Study|Lost to Follow-up|1|||
131773195|NCT02708524|474448962|FG003|Overall Study|Lost to Follow-up|0|||
131773196|NCT02708524|474448959|FG000|Overall Study|Protocol Violation|0|||
131773197|NCT02708524|474448960|FG001|Overall Study|Protocol Violation|1|||
131773198|NCT02708524|474448961|FG002|Overall Study|Protocol Violation|0|||
131773199|NCT02708524|474448962|FG003|Overall Study|Protocol Violation|0|||
131773200|NCT02708524|474448959|FG000|Overall Study|Withdrawal by Subject|1|||
131773201|NCT02708524|474448960|FG001|Overall Study|Withdrawal by Subject|1|||
131773202|NCT02708524|474448961|FG002|Overall Study|Withdrawal by Subject|0|||
131773203|NCT02708524|474448962|FG003|Overall Study|Withdrawal by Subject|0|||
131773204|NCT02708524|474448959|FG000|Overall Study|Dispensed incorrect study lens|0|||
131773205|NCT02708524|474448960|FG001|Overall Study|Dispensed incorrect study lens|1|||
131773206|NCT02708524|474448961|FG002|Overall Study|Dispensed incorrect study lens|1|||
131773207|NCT02708524|474448962|FG003|Overall Study|Dispensed incorrect study lens|0|||
131773208|NCT02708524|474448959|FG000|Overall Study|Did not wear lens at final visit|0|||
131773209|NCT02708524|474448960|FG001|Overall Study|Did not wear lens at final visit|1|||
131773210|NCT02708524|474448961|FG002|Overall Study|Did not wear lens at final visit|0|||
131773211|NCT02708524|474448962|FG003|Overall Study|Did not wear lens at final visit|0|||
131773212|NCT02708524|474448959|FG000|Overall Study|Subject lost study lens|1|||
131773213|NCT02708524|474448960|FG001|Overall Study|Subject lost study lens|0|||
131773214|NCT02708524|474448961|FG002|Overall Study|Subject lost study lens|0|||
131773215|NCT02708524|474448962|FG003|Overall Study|Subject lost study lens|0|||
131773216|NCT03246152|474448963|FG000|Overall Study|Lost to Follow-up|2|||
131773217|NCT03246152|474448963|FG000|Overall Study|Protocol Violation|1|||
131773218|NCT02059265|474448964|FG000|Overall Study|Ineligible|4|||
131773219|NCT00761735|474448965|FG000|Overall Study|Lost to Follow-up|6|||
131773220|NCT00761735|474448965|FG000|Overall Study|Withdrawal by Subject|6|||
131773221|NCT00761735|474448965|FG000|Overall Study|Non-compliance with protocol|1|||
131773222|NCT00761735|474448965|FG000|Overall Study|Administrative|1|||
131773223|NCT03290131|474448966|FG000|Overall Study|Adverse Event|22|||
131773224|NCT03290131|474448967|FG001|Overall Study|Adverse Event|57|||
131773225|NCT03290131|474448968|FG002|Overall Study|Adverse Event|11|||
131773226|NCT03290131|474448966|FG000|Overall Study|Withdrawal by Subject|18|||
131773227|NCT03290131|474448967|FG001|Overall Study|Withdrawal by Subject|13|||
131773228|NCT03290131|474448968|FG002|Overall Study|Withdrawal by Subject|8|||
131773229|NCT03290131|474448966|FG000|Overall Study|MS Relapse|2|||
131773230|NCT03290131|474448967|FG001|Overall Study|MS Relapse|1|||
131773231|NCT03290131|474448968|FG002|Overall Study|MS Relapse|0|||
131773232|NCT03290131|474448966|FG000|Overall Study|Unknown reason|0|||
131773233|NCT03290131|474448967|FG001|Overall Study|Unknown reason|1|||
131773234|NCT03290131|474448968|FG002|Overall Study|Unknown reason|0|||
131773235|NCT00465101|474448969|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
131773236|NCT00465101|474448969|FG000|Overall Study|Change in health precluded follow up|4|||
131773237|NCT00465101|474448969|FG000|Overall Study|Did not meet study criteria|4|||
131773238|NCT00465101|474448969|FG000|Overall Study|Lost to Follow-up|5|||
131773239|NCT00465101|474448969|FG000|Overall Study|Other|6|||
131773240|NCT00465101|474448969|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
131773241|NCT00465101|474448969|FG000|Overall Study|Patient postponed procedure|1|||
131773242|NCT00465101|474448969|FG000|Overall Study|Site closed due to IRB expiration|1|||
131773243|NCT00465101|474448969|FG000|Overall Study|Unable to obtain IRB approval|1|||
131773244|NCT00465101|474448969|FG000|Overall Study|Death|3|||
131773245|NCT00465101|474448969|FG000|Overall Study|Withdrawal by Subject|25|||
131773246|NCT00465101|474448969|FG000|Overall Study|Physician Decision|1|||
131898520|NCT00320788|474914097|FG001|Overall Study|Other|2|||
131686172|NCT02081534|474136581|FG000|Overall Study|Lost to Follow-up|0|||
131686173|NCT02081534|474136582|FG001|Overall Study|Lost to Follow-up|0|||
131686174|NCT02081534|474136583|FG002|Overall Study|Lost to Follow-up|0|||
131686175|NCT02081534|474136584|FG003|Overall Study|Lost to Follow-up|2|||
131686176|NCT02081534|474136585|FG004|Overall Study|Lost to Follow-up|1|||
131686177|NCT02081534|474136586|FG005|Overall Study|Lost to Follow-up|1|||
131686178|NCT02081534|474136587|FG006|Overall Study|Lost to Follow-up|0|||
131686179|NCT00383084|474136596|FG000|Overall Study|Withdrawal by Subject|12|||
131686180|NCT00383084|474136597|FG001|Overall Study|Withdrawal by Subject|10|||
131686181|NCT00326209|474136598|FG000|Overall Study|Adverse Event|28|||
131686182|NCT00326209|474136598|FG000|Overall Study|Withdrawal by Subject|22|||
131686183|NCT00326209|474136598|FG000|Overall Study|Lack of Efficacy|31|||
131686184|NCT00326209|474136598|FG000|Overall Study|Lost to Follow-up|18|||
131686185|NCT00326209|474136598|FG000|Overall Study|Participant non-compliant|6|||
131686186|NCT00326209|474136598|FG000|Overall Study|Sponsor closed study|173|||
131686187|NCT00326209|474136598|FG000|Overall Study|Prohibited medication use|1|||
131686188|NCT00326209|474136598|FG000|Overall Study|Violation of entry criteria|1|||
131686189|NCT00326209|474136598|FG000|Overall Study|Withdrawn in error|1|||
131686190|NCT00326209|474136598|FG000|Overall Study|Pregnancy|1|||
131686191|NCT01299376|474136603|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
131686192|NCT01299376|474136604|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
131686193|NCT01299376|474136603|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
131686194|NCT01299376|474136604|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
131686195|NCT01299376|474136603|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
131686196|NCT01299376|474136604|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
131686197|NCT01299376|474136603|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
131686198|NCT01299376|474136604|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
131686199|NCT01299376|474136603|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
131686200|NCT01299376|474136604|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
131686201|NCT01299376|474136603|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
131686202|NCT01299376|474136604|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
131686203|NCT01299376|474136603|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
131686204|NCT01299376|474136604|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
131686205|NCT01299376|474136603|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
131686206|NCT01299376|474136604|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
131686207|NCT01299376|474136603|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
131686208|NCT01299376|474136604|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
131686209|NCT01299376|474136603|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
131686210|NCT01299376|474136604|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
131686211|NCT01299376|474136603|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
131686212|NCT01299376|474136604|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
131686213|NCT02343159|474136607|FG000|Overall Study|Early Study Termination|16|||
131686214|NCT02343159|474136608|FG001|Overall Study|Early Study Termination|19|||
131686215|NCT02343159|474136609|FG002|Overall Study|Early Study Termination|23|||
131686216|NCT02343159|474136607|FG000|Overall Study|Physician Decision|2|||
131686217|NCT02343159|474136608|FG001|Overall Study|Physician Decision|0|||
131686218|NCT02343159|474136609|FG002|Overall Study|Physician Decision|1|||
131686219|NCT02343159|474136607|FG000|Overall Study|Withdrawal by Subject|3|||
131686220|NCT02343159|474136608|FG001|Overall Study|Withdrawal by Subject|0|||
131686221|NCT02343159|474136609|FG002|Overall Study|Withdrawal by Subject|2|||
131686222|NCT02343159|474136607|FG000|Overall Study|Lost to Follow-up|0|||
131686223|NCT02343159|474136608|FG001|Overall Study|Lost to Follow-up|2|||
131686224|NCT02343159|474136609|FG002|Overall Study|Lost to Follow-up|2|||
131686225|NCT02343159|474136607|FG000|Overall Study|Adverse Event|4|||
131686226|NCT02343159|474136608|FG001|Overall Study|Adverse Event|4|||
131686227|NCT02343159|474136609|FG002|Overall Study|Adverse Event|2|||
131686228|NCT02343159|474136607|FG000|Overall Study|Sponsor Decision|0|||
131686229|NCT02343159|474136608|FG001|Overall Study|Sponsor Decision|1|||
131686230|NCT02343159|474136609|FG002|Overall Study|Sponsor Decision|0|||
131686231|NCT02343159|474136607|FG000|Overall Study|Enrollment Error|1|||
131686232|NCT02343159|474136608|FG001|Overall Study|Enrollment Error|0|||
131686233|NCT02343159|474136609|FG002|Overall Study|Enrollment Error|0|||
131686234|NCT04702737|474136610|FG000|Overall Study|Decision by Sponsor|1|||
131686235|NCT04702737|474136610|FG000|Overall Study|Withdrawal of Consent from Study|3|||
131773247|NCT00465101|474448969|FG000|Overall Study|Withdrew consent prior to procedure|3|||
131773248|NCT00483574|474448970|FG000|Overall Study|Adverse Event|6|||
131773249|NCT00483574|474448971|FG001|Overall Study|Adverse Event|0|||
131686236|NCT04702737|474136610|FG000|Overall Study|Lost to Follow-up|1|||
131686237|NCT04702737|474136610|FG000|Overall Study|Death|35|||
131686238|NCT03184077|474136611|FG000|Overall Study|Lost to Follow-up|21|||
131686239|NCT03184077|474136612|FG001|Overall Study|Lost to Follow-up|21|||
131686240|NCT03159091|474136615|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
131686241|NCT03159091|474136616|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
131686242|NCT03159091|474136615|FG000|Overall Study|Patient has taken no dose of study drug|0|||
131686243|NCT03159091|474136616|FG001|Overall Study|Patient has taken no dose of study drug|1|||
131686244|NCT00262522|474136617|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
131686245|NCT00262522|474136618|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
131686246|NCT00262522|474136619|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
131686247|NCT00262522|474136620|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
131686248|NCT00262522|474136617|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
131686249|NCT00262522|474136618|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
131686250|NCT00262522|474136619|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
131686251|NCT00262522|474136620|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
131686252|NCT00262522|474136617|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
131686253|NCT00262522|474136618|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
131686254|NCT00262522|474136619|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
131686255|NCT00262522|474136620|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
131686256|NCT00262522|474136617|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
131686257|NCT00262522|474136618|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
131686258|NCT00262522|474136619|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
131686259|NCT00262522|474136620|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
131686260|NCT00262522|474136617|FG000|Study Start Through 8 Weeks|Death|1|||
131686261|NCT00262522|474136618|FG001|Study Start Through 8 Weeks|Death|0|||
131686262|NCT00262522|474136619|FG002|Study Start Through 8 Weeks|Death|0|||
131686263|NCT00262522|474136620|FG003|Study Start Through 8 Weeks|Death|0|||
131686264|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
131686265|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
131686266|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
131686267|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
131686268|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
131686269|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
131686270|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
131686271|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
131686272|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
131686273|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
131686274|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
131686275|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
131686276|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
131686277|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
131686278|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
131686279|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
131686280|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Death|2|||
131686281|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Death|0|||
131686282|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Death|1|||
131686283|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Death|0|||
131686284|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
131686285|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
131686286|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
131686287|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
131686288|NCT00262522|474136617|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
131686289|NCT00262522|474136618|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
131686290|NCT00262522|474136619|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
131686291|NCT00262522|474136620|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
131686292|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
131686293|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
131686294|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
131686295|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
131686296|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
131686297|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
131686298|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
131686299|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
131686300|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
131686301|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
131686302|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
131686303|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
131686304|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
131686305|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
131686306|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
131686307|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
131686308|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Death|2|||
131686309|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Death|0|||
131686310|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Death|2|||
131686311|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Death|0|||
131686312|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
131686313|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
131686314|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
131686315|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
131686316|NCT00262522|474136617|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
131686317|NCT00262522|474136618|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
131686318|NCT00262522|474136619|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
131686319|NCT00262522|474136620|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
131686320|NCT04814823|474136621|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
131686333|NCT05318937|474136629|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131686334|NCT05318937|474136630|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131686335|NCT05318937|474136629|FG000|Overall Study|Lost to Follow-up|0|||
131686336|NCT05318937|474136630|FG001|Overall Study|Lost to Follow-up|1|||
131686337|NCT05318937|474136629|FG000|Overall Study|Withdrawal by Subject|0|||
131686338|NCT05318937|474136630|FG001|Overall Study|Withdrawal by Subject|2|||
131686339|NCT05318937|474136629|FG000|Overall Study|Protocol Violation|0|||
131686340|NCT05318937|474136630|FG001|Overall Study|Protocol Violation|1|||
131686341|NCT01877915|474136638|FG000|Overall Study|Lost to Follow-up|10|||
131686342|NCT01877915|474136639|FG001|Overall Study|Lost to Follow-up|9|||
131686343|NCT01877915|474136638|FG000|Overall Study|Withdrawal by Subject|42|||
131686344|NCT01877915|474136639|FG001|Overall Study|Withdrawal by Subject|55|||
131686345|NCT01877915|474136638|FG000|Overall Study|Other|2|||
131686346|NCT01877915|474136639|FG001|Overall Study|Other|4|||
131686347|NCT05678257|474136640|FG000|Overall Study|Withdrawal by Subject|2|||
131686348|NCT05678257|474136641|FG001|Overall Study|Withdrawal by Subject|0|||
131686349|NCT05678257|474136642|FG002|Overall Study|Withdrawal by Subject|5|||
131686350|NCT05678257|474136640|FG000|Overall Study|Physician Decision|1|||
131686351|NCT05678257|474136641|FG001|Overall Study|Physician Decision|0|||
131686352|NCT05678257|474136642|FG002|Overall Study|Physician Decision|1|||
131686353|NCT05678257|474136640|FG000|Overall Study|Adverse Event|1|||
131686354|NCT05678257|474136641|FG001|Overall Study|Adverse Event|3|||
131686355|NCT05678257|474136642|FG002|Overall Study|Adverse Event|1|||
131686356|NCT05678257|474136640|FG000|Overall Study|Progressive disease|11|||
131686357|NCT05678257|474136641|FG001|Overall Study|Progressive disease|18|||
131686358|NCT05678257|474136642|FG002|Overall Study|Progressive disease|7|||
131686359|NCT05678257|474136640|FG000|Overall Study|No longer clinically benefitting|2|||
131686360|NCT05678257|474136641|FG001|Overall Study|No longer clinically benefitting|1|||
131686361|NCT05678257|474136642|FG002|Overall Study|No longer clinically benefitting|0|||
131686362|NCT05678257|474136640|FG000|Overall Study|Sponsor decision|5|||
131686363|NCT05678257|474136641|FG001|Overall Study|Sponsor decision|9|||
131773250|NCT00483574|474448970|FG000|Overall Study|Protocol Violation|28|||
131773251|NCT00483574|474448971|FG001|Overall Study|Protocol Violation|9|||
131686364|NCT05678257|474136642|FG002|Overall Study|Sponsor decision|8|||
131686365|NCT05678257|474136640|FG000|Overall Study|Protocol Violation|0|||
131686366|NCT05678257|474136641|FG001|Overall Study|Protocol Violation|0|||
131686367|NCT05678257|474136642|FG002|Overall Study|Protocol Violation|1|||
131686368|NCT05678257|474136640|FG000|Overall Study|Patient non-compliance|0|||
131686369|NCT05678257|474136641|FG001|Overall Study|Patient non-compliance|0|||
131686370|NCT05678257|474136642|FG002|Overall Study|Patient non-compliance|3|||
131686371|NCT02046096|474136643|FG000|Overall Study|Death|28|||
131773252|NCT00483574|474448970|FG000|Overall Study|Lost to Follow-up|16|||
131773253|NCT00483574|474448971|FG001|Overall Study|Lost to Follow-up|4|||
131773254|NCT00483574|474448970|FG000|Overall Study|Withdrawal by Subject|52|||
131773255|NCT00483574|474448971|FG001|Overall Study|Withdrawal by Subject|0|||
131773256|NCT03099096|474448974|FG000|Overall Study|Adverse Event|1|||
131773257|NCT03099096|474448974|FG000|Overall Study|Physician Decision|1|||
131773258|NCT00361504|474448977|FG000|Overall Study|Withdrawal by Subject|94|||
131773259|NCT00361504|474448978|FG001|Overall Study|Withdrawal by Subject|31|||
131773260|NCT00361504|474448977|FG000|Overall Study|Lost to Follow-up|40|||
131773261|NCT00361504|474448978|FG001|Overall Study|Lost to Follow-up|7|||
131773262|NCT00361504|474448977|FG000|Overall Study|Adverse Event|203|||
131773263|NCT00361504|474448978|FG001|Overall Study|Adverse Event|82|||
131773264|NCT00361504|474448977|FG000|Overall Study|Lack of Efficacy|72|||
131773265|NCT00361504|474448978|FG001|Overall Study|Lack of Efficacy|7|||
131773266|NCT00361504|474448977|FG000|Overall Study|Resolution of Pain|2|||
131773267|NCT00361504|474448978|FG001|Overall Study|Resolution of Pain|0|||
131773268|NCT00361504|474448977|FG000|Overall Study|Study medication non compliant|42|||
131773269|NCT00361504|474448978|FG001|Overall Study|Study medication non compliant|15|||
131773270|NCT00361504|474448977|FG000|Overall Study|All other|28|||
131773271|NCT00361504|474448978|FG001|Overall Study|All other|3|||
131773272|NCT01374516|474448981|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
131773273|NCT01374516|474448982|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
131773274|NCT01374516|474448981|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
131773275|NCT01374516|474448982|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
131773276|NCT01374516|474448981|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
131773277|NCT01374516|474448982|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
131773278|NCT01374516|474448981|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
131773279|NCT01374516|474448982|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
131773280|NCT01374516|474448981|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
131773281|NCT01374516|474448982|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
131773282|NCT01374516|474448981|FG000|Surveillance Expansion Period|Protocol Violation|386|||
131773283|NCT01374516|474448982|FG001|Surveillance Expansion Period|Protocol Violation|217|||
131773284|NCT01374516|474448981|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
131773285|NCT01374516|474448982|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
131773286|NCT01374516|474448981|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
131773287|NCT01374516|474448982|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
131773288|NCT01374516|474448981|FG000|Surveillance Expansion Period|Serious adverse event|20|||
131773289|NCT01374516|474448982|FG001|Surveillance Expansion Period|Serious adverse event|5|||
131773290|NCT03219372|474448988|FG000|Overall Study|Withdrawal by Subject|1|||
131773291|NCT03219372|474448989|FG001|Overall Study|Withdrawal by Subject|0|||
131773292|NCT00450814|474448993|FG000|Overall Study|Failed to complete the initial therapy|0|||
131773293|NCT00450814|474448994|FG001|Overall Study|Failed to complete the initial therapy|0|||
131773294|NCT00450814|474448995|FG002|Overall Study|Failed to complete the initial therapy|0|||
131773295|NCT00450814|474448996|FG003|Overall Study|Failed to complete the initial therapy|1|||
131773296|NCT00450814|474448997|FG004|Overall Study|Failed to complete the initial therapy|1|||
131773297|NCT00450814|474448998|FG005|Overall Study|Failed to complete the initial therapy|1|||
131773298|NCT00450814|474448999|FG006|Overall Study|Failed to complete the initial therapy|0|||
131773299|NCT00450814|474449000|FG007|Overall Study|Failed to complete the initial therapy|0|||
131773300|NCT00450814|474449001|FG008|Overall Study|Failed to complete the initial therapy|0|||
131773301|NCT00450814|474449002|FG009|Overall Study|Failed to complete the initial therapy|0|||
131773302|NCT00450814|474449003|FG010|Overall Study|Failed to complete the initial therapy|0|||
131773303|NCT00450814|474448993|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
131773304|NCT00450814|474448994|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
131773305|NCT00450814|474448995|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
131773306|NCT00450814|474448996|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
131773307|NCT00450814|474448997|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
131773308|NCT00450814|474448998|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
131773309|NCT00450814|474448999|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
131773310|NCT00450814|474449000|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
131773311|NCT00450814|474449001|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
131773312|NCT00450814|474449002|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
131773313|NCT00450814|474449003|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
131773314|NCT04145531|474449004|FG000|Part A|Adverse Event|2|||
131773315|NCT04145531|474449005|FG001|Part A|Adverse Event|12|||
131773316|NCT04145531|474449006|FG002|Part A|Adverse Event|6|||
131773317|NCT04145531|474449007|FG003|Part A|Adverse Event|0|||
131773318|NCT04145531|474449004|FG000|Part A|Death|1|||
131773319|NCT04145531|474449005|FG001|Part A|Death|2|||
131773320|NCT04145531|474449006|FG002|Part A|Death|0|||
131773321|NCT04145531|474449007|FG003|Part A|Death|0|||
131686372|NCT02046096|474136644|FG001|Overall Study|Death|45|||
131686373|NCT02046096|474136643|FG000|Overall Study|Lost to Follow-up|9|||
131686374|NCT02046096|474136644|FG001|Overall Study|Lost to Follow-up|20|||
131686375|NCT02046096|474136643|FG000|Overall Study|Withdrawal by Subject|5|||
131686376|NCT02046096|474136644|FG001|Overall Study|Withdrawal by Subject|17|||
131686377|NCT02046096|474136643|FG000|Overall Study|Other endpoint|2|||
131686378|NCT02046096|474136644|FG001|Overall Study|Other endpoint|19|||
131686379|NCT03520959|474136645|FG000|Overall Study|Study terminated by Sponsor|0|||
131686380|NCT03520959|474136646|FG001|Overall Study|Study terminated by Sponsor|1|||
131686381|NCT01449461|474136647|FG000|Overall Study|Adverse Event|0|||
131686382|NCT01449461|474136648|FG001|Overall Study|Adverse Event|3|||
131686383|NCT01449461|474136649|FG002|Overall Study|Adverse Event|2|||
131686384|NCT01449461|474136650|FG003|Overall Study|Adverse Event|3|||
131686385|NCT01449461|474136651|FG004|Overall Study|Adverse Event|4|||
131686386|NCT01449461|474136652|FG005|Overall Study|Adverse Event|4|||
131686387|NCT01449461|474136647|FG000|Overall Study|Death|0|||
131686388|NCT01449461|474136648|FG001|Overall Study|Death|2|||
131686389|NCT01449461|474136649|FG002|Overall Study|Death|0|||
131686390|NCT01449461|474136650|FG003|Overall Study|Death|0|||
131686391|NCT01449461|474136651|FG004|Overall Study|Death|7|||
131686392|NCT01449461|474136652|FG005|Overall Study|Death|1|||
131686393|NCT01449461|474136647|FG000|Overall Study|Physician Decision|0|||
131686394|NCT01449461|474136648|FG001|Overall Study|Physician Decision|1|||
131686395|NCT01449461|474136649|FG002|Overall Study|Physician Decision|0|||
131686396|NCT01449461|474136650|FG003|Overall Study|Physician Decision|4|||
131686397|NCT01449461|474136651|FG004|Overall Study|Physician Decision|1|||
131686398|NCT01449461|474136652|FG005|Overall Study|Physician Decision|0|||
131686399|NCT01449461|474136647|FG000|Overall Study|Documented Progressive Disease|4|||
131686400|NCT01449461|474136648|FG001|Overall Study|Documented Progressive Disease|7|||
131686401|NCT01449461|474136649|FG002|Overall Study|Documented Progressive Disease|14|||
131686402|NCT01449461|474136650|FG003|Overall Study|Documented Progressive Disease|15|||
131686403|NCT01449461|474136651|FG004|Overall Study|Documented Progressive Disease|24|||
131686404|NCT01449461|474136652|FG005|Overall Study|Documented Progressive Disease|5|||
131686405|NCT01449461|474136647|FG000|Overall Study|Clinical Progressive Disease|2|||
131686406|NCT01449461|474136648|FG001|Overall Study|Clinical Progressive Disease|2|||
131686407|NCT01449461|474136649|FG002|Overall Study|Clinical Progressive Disease|0|||
131686408|NCT01449461|474136650|FG003|Overall Study|Clinical Progressive Disease|3|||
131686409|NCT01449461|474136651|FG004|Overall Study|Clinical Progressive Disease|4|||
131686410|NCT01449461|474136652|FG005|Overall Study|Clinical Progressive Disease|2|||
131686411|NCT01449461|474136647|FG000|Overall Study|Protocol Violation|0|||
131686412|NCT01449461|474136648|FG001|Overall Study|Protocol Violation|0|||
131686413|NCT01449461|474136649|FG002|Overall Study|Protocol Violation|0|||
131686414|NCT01449461|474136650|FG003|Overall Study|Protocol Violation|1|||
131686415|NCT01449461|474136651|FG004|Overall Study|Protocol Violation|0|||
131686416|NCT01449461|474136652|FG005|Overall Study|Protocol Violation|0|||
131686417|NCT01449461|474136647|FG000|Overall Study|Site Terminated by Sponsor|0|||
131686418|NCT01449461|474136648|FG001|Overall Study|Site Terminated by Sponsor|1|||
131686419|NCT01449461|474136649|FG002|Overall Study|Site Terminated by Sponsor|2|||
131686420|NCT01449461|474136650|FG003|Overall Study|Site Terminated by Sponsor|3|||
131686421|NCT01449461|474136651|FG004|Overall Study|Site Terminated by Sponsor|4|||
131686422|NCT01449461|474136652|FG005|Overall Study|Site Terminated by Sponsor|1|||
131686423|NCT01449461|474136647|FG000|Overall Study|Withdrawal by Subject|0|||
131686424|NCT01449461|474136648|FG001|Overall Study|Withdrawal by Subject|1|||
131686425|NCT01449461|474136649|FG002|Overall Study|Withdrawal by Subject|0|||
131686426|NCT01449461|474136650|FG003|Overall Study|Withdrawal by Subject|0|||
131686427|NCT01449461|474136651|FG004|Overall Study|Withdrawal by Subject|2|||
131686428|NCT01449461|474136652|FG005|Overall Study|Withdrawal by Subject|1|||
131686429|NCT01449461|474136647|FG000|Overall Study|Reason not Specified|0|||
131773322|NCT04145531|474449004|FG000|Part A|Physician Decision|2|||
131773323|NCT04145531|474449005|FG001|Part A|Physician Decision|5|||
131773324|NCT04145531|474449006|FG002|Part A|Physician Decision|2|||
131773325|NCT04145531|474449007|FG003|Part A|Physician Decision|0|||
131773326|NCT04145531|474449004|FG000|Part A|Progressive disease|0|||
131773327|NCT04145531|474449005|FG001|Part A|Progressive disease|2|||
131773328|NCT04145531|474449006|FG002|Part A|Progressive disease|1|||
131773329|NCT04145531|474449007|FG003|Part A|Progressive disease|0|||
131773330|NCT04145531|474449004|FG000|Part A|Protocol deviation|0|||
131773331|NCT04145531|474449005|FG001|Part A|Protocol deviation|0|||
131773332|NCT04145531|474449006|FG002|Part A|Protocol deviation|1|||
131773333|NCT04145531|474449007|FG003|Part A|Protocol deviation|0|||
131773334|NCT04145531|474449004|FG000|Part A|Withdrawal by parent or guardian|1|||
131773335|NCT04145531|474449005|FG001|Part A|Withdrawal by parent or guardian|0|||
131773336|NCT04145531|474449006|FG002|Part A|Withdrawal by parent or guardian|0|||
131773337|NCT04145531|474449007|FG003|Part A|Withdrawal by parent or guardian|0|||
131773338|NCT04145531|474449004|FG000|Part A|Withdrawal by participant|0|||
131773339|NCT04145531|474449005|FG001|Part A|Withdrawal by participant|0|||
131773340|NCT04145531|474449006|FG002|Part A|Withdrawal by participant|1|||
131773341|NCT04145531|474449007|FG003|Part A|Withdrawal by participant|0|||
131773342|NCT04145531|474449004|FG000|Part A|Other|0|||
131773343|NCT04145531|474449005|FG001|Part A|Other|0|||
131773344|NCT04145531|474449006|FG002|Part A|Other|1|||
131773345|NCT04145531|474449007|FG003|Part A|Other|0|||
131773346|NCT04145531|474449004|FG000|Part B|Adverse Event|0|||
131773347|NCT04145531|474449005|FG001|Part B|Adverse Event|0|||
131773348|NCT04145531|474449006|FG002|Part B|Adverse Event|0|||
131773349|NCT04145531|474449007|FG003|Part B|Adverse Event|21|||
131773350|NCT04145531|474449004|FG000|Part B|Physician Decision|0|||
131773351|NCT04145531|474449005|FG001|Part B|Physician Decision|0|||
131773352|NCT04145531|474449006|FG002|Part B|Physician Decision|0|||
131773353|NCT04145531|474449007|FG003|Part B|Physician Decision|7|||
131773354|NCT04145531|474449004|FG000|Part B|Progressive disease|0|||
131773355|NCT04145531|474449005|FG001|Part B|Progressive disease|0|||
131773356|NCT04145531|474449006|FG002|Part B|Progressive disease|0|||
131773357|NCT04145531|474449007|FG003|Part B|Progressive disease|1|||
131773358|NCT04145531|474449004|FG000|Part B|Recurrent disease|0|||
131773359|NCT04145531|474449005|FG001|Part B|Recurrent disease|0|||
131773360|NCT04145531|474449006|FG002|Part B|Recurrent disease|0|||
131773361|NCT04145531|474449007|FG003|Part B|Recurrent disease|1|||
131773362|NCT04145531|474449004|FG000|Part B|Withdrawal by parent or guardian|0|||
131773363|NCT04145531|474449005|FG001|Part B|Withdrawal by parent or guardian|0|||
131773364|NCT04145531|474449006|FG002|Part B|Withdrawal by parent or guardian|0|||
131773365|NCT04145531|474449007|FG003|Part B|Withdrawal by parent or guardian|3|||
131773366|NCT04145531|474449004|FG000|Part B|Withdrawal by participant|0|||
131773367|NCT04145531|474449005|FG001|Part B|Withdrawal by participant|0|||
131773368|NCT04145531|474449006|FG002|Part B|Withdrawal by participant|0|||
131686430|NCT01449461|474136648|FG001|Overall Study|Reason not Specified|1|||
131686431|NCT01449461|474136649|FG002|Overall Study|Reason not Specified|0|||
131686432|NCT01449461|474136650|FG003|Overall Study|Reason not Specified|3|||
131686433|NCT01449461|474136651|FG004|Overall Study|Reason not Specified|2|||
131686434|NCT01449461|474136652|FG005|Overall Study|Reason not Specified|1|||
131686435|NCT05314517|474136653|FG000|Double-blind Period|Adverse Event|4|||
131686436|NCT05314517|474136654|FG001|Double-blind Period|Adverse Event|0|||
131686437|NCT05314517|474136655|FG002|Double-blind Period|Adverse Event|0|||
131686438|NCT05314517|474136656|FG003|Double-blind Period|Adverse Event|0|||
131686439|NCT05314517|474136653|FG000|Double-blind Period|Noncompliance|0|||
131686440|NCT05314517|474136654|FG001|Double-blind Period|Noncompliance|1|||
131686441|NCT05314517|474136655|FG002|Double-blind Period|Noncompliance|0|||
131686442|NCT05314517|474136656|FG003|Double-blind Period|Noncompliance|0|||
131686443|NCT05314517|474136653|FG000|Double-blind Period|Randomized, not treated|1|||
131686444|NCT05314517|474136654|FG001|Double-blind Period|Randomized, not treated|0|||
131686445|NCT05314517|474136655|FG002|Double-blind Period|Randomized, not treated|0|||
131686446|NCT05314517|474136656|FG003|Double-blind Period|Randomized, not treated|0|||
131686447|NCT05314517|474136653|FG000|Open-label Extension|Adverse Event|0|||
131686448|NCT05314517|474136654|FG001|Open-label Extension|Adverse Event|0|||
131686449|NCT05314517|474136655|FG002|Open-label Extension|Adverse Event|1|||
131686450|NCT05314517|474136656|FG003|Open-label Extension|Adverse Event|2|||
131686451|NCT05314517|474136653|FG000|Open-label Extension|Investigator decision|0|||
131686452|NCT05314517|474136654|FG001|Open-label Extension|Investigator decision|0|||
131686453|NCT05314517|474136655|FG002|Open-label Extension|Investigator decision|1|||
131686454|NCT05314517|474136656|FG003|Open-label Extension|Investigator decision|0|||
131686455|NCT05314517|474136653|FG000|Open-label Extension|Lost to Follow-up|0|||
131686456|NCT05314517|474136654|FG001|Open-label Extension|Lost to Follow-up|0|||
131686457|NCT05314517|474136655|FG002|Open-label Extension|Lost to Follow-up|0|||
131686458|NCT05314517|474136656|FG003|Open-label Extension|Lost to Follow-up|1|||
131686459|NCT05314517|474136653|FG000|Open-label Extension|Withdrawal by Subject|0|||
131686460|NCT05314517|474136654|FG001|Open-label Extension|Withdrawal by Subject|0|||
131686461|NCT05314517|474136655|FG002|Open-label Extension|Withdrawal by Subject|1|||
131686462|NCT05314517|474136656|FG003|Open-label Extension|Withdrawal by Subject|2|||
131686463|NCT05314517|474136653|FG000|Open-label Extension|Use of prohibited medication|0|||
131686464|NCT05314517|474136654|FG001|Open-label Extension|Use of prohibited medication|0|||
131686465|NCT05314517|474136655|FG002|Open-label Extension|Use of prohibited medication|1|||
131686466|NCT05314517|474136656|FG003|Open-label Extension|Use of prohibited medication|0|||
131686467|NCT05314517|474136653|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
131686468|NCT05314517|474136654|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
131686469|NCT05314517|474136655|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
131686470|NCT05314517|474136656|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
131686471|NCT04969276|474136657|FG000|Overall Study|Protocol Deviation|0|||
131686472|NCT04969276|474136658|FG001|Overall Study|Protocol Deviation|1|||
131686473|NCT04969276|474136659|FG002|Overall Study|Protocol Deviation|0|||
131686474|NCT04969276|474136657|FG000|Overall Study|Withdrawal by Subject|1|||
131686475|NCT04969276|474136658|FG001|Overall Study|Withdrawal by Subject|10|||
131686476|NCT04969276|474136659|FG002|Overall Study|Withdrawal by Subject|0|||
131686477|NCT04969276|474136657|FG000|Overall Study|Lost to Follow-up|0|||
131686478|NCT04969276|474136658|FG001|Overall Study|Lost to Follow-up|1|||
131686479|NCT04969276|474136659|FG002|Overall Study|Lost to Follow-up|0|||
131686480|NCT04655144|474136663|FG000|Overall Study|Consumed THC|1|||
131686481|NCT04655144|474136664|FG001|Overall Study|Consumed THC|0|||
131686482|NCT04655144|474136663|FG000|Overall Study|Unilateral embolization|0|||
131686483|NCT04655144|474136664|FG001|Overall Study|Unilateral embolization|1|||
131686484|NCT04490018|474136668|FG000|Overall Study|Protocol Violation|0|||
131686485|NCT04490018|474136669|FG001|Overall Study|Protocol Violation|2|||
131686486|NCT04490018|474136670|FG002|Overall Study|Protocol Violation|1|||
131686487|NCT04490018|474136668|FG000|Overall Study|Lost to Follow-up|2|||
131686488|NCT04490018|474136669|FG001|Overall Study|Lost to Follow-up|2|||
131686489|NCT04490018|474136670|FG002|Overall Study|Lost to Follow-up|0|||
131686490|NCT04490018|474136668|FG000|Overall Study|Withdrawal by Subject|2|||
131773369|NCT04145531|474449007|FG003|Part B|Withdrawal by participant|1|||
131773370|NCT04145531|474449004|FG000|Part B|Other|0|||
131773371|NCT04145531|474449005|FG001|Part B|Other|0|||
131773372|NCT04145531|474449006|FG002|Part B|Other|0|||
131773373|NCT04145531|474449007|FG003|Part B|Other|1|||
131773374|NCT03602976|474449011|FG000|Overall Study|Withdrawal by Subject|1|||
131773375|NCT04837807|474449012|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
131773376|NCT04837807|474449013|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
131773377|NCT00234533|474449021|FG000|Overall Study|Withdrawal by Subject|6|||
131773378|NCT00234533|474449021|FG000|Overall Study|Adverse Event|2|||
131773379|NCT00234533|474449021|FG000|Overall Study|Enrolled but not treated|3|||
131773380|NCT01484691|474449022|FG000|Overall Study|Withdrawal by Subject|1|||
131773381|NCT01484691|474449023|FG001|Overall Study|Withdrawal by Subject|1|||
131773382|NCT01484691|474449024|FG002|Overall Study|Withdrawal by Subject|1|||
131773383|NCT01484691|474449022|FG000|Overall Study|Physician Decision|0|||
131773384|NCT01484691|474449023|FG001|Overall Study|Physician Decision|2|||
131773385|NCT01484691|474449024|FG002|Overall Study|Physician Decision|1|||
131773386|NCT00736840|474449028|FG000|Overall Study|Lost to Follow-up|13|||
131773387|NCT03655951|474449029|FG000|Overall Study|Lost to Follow-up|39|||
131773388|NCT03655951|474449030|FG001|Overall Study|Lost to Follow-up|20|||
131773389|NCT03655951|474449029|FG000|Overall Study|Withdrawal by Subject|0|||
131773390|NCT03655951|474449030|FG001|Overall Study|Withdrawal by Subject|1|||
131773391|NCT02811640|474449031|FG000|Overall Study|Technology malfunction|2|||
131773392|NCT02513732|474450918|FG000|Overall Study|Lost to Follow-up|11|||
131773393|NCT02513732|474450918|FG000|Overall Study|Death|9|||
131773394|NCT02513732|474450918|FG000|Overall Study|Changing hospital|2|||
131773395|NCT01151085|474450919|FG000|Overall Study|Lost to Follow-up|31|||
131773396|NCT01151085|474450919|FG000|Overall Study|Protocol Violation|25|||
131773397|NCT04196023|474450927|FG000|Overall Study|Withdrawal by Subject|0|||
131773398|NCT04196023|474450928|FG001|Overall Study|Withdrawal by Subject|1|||
131555996|NCT01512745|473660296|FG001|Overall Study|Withdrawal by Subject|2|||
131773399|NCT04196023|474450927|FG000|Overall Study|Adverse Event|3|||
131773400|NCT04196023|474450928|FG001|Overall Study|Adverse Event|1|||
131773401|NCT04196023|474450927|FG000|Overall Study|Lost to Follow-up|0|||
131773402|NCT04196023|474450928|FG001|Overall Study|Lost to Follow-up|1|||
131898521|NCT00320788|474914098|FG002|Overall Study|Other|1|||
131555997|NCT01512745|473660295|FG000|Overall Study|Lost to Follow-up|4|||
131773403|NCT02985996|474450929|FG000|Overall Study|Withdrawal by Subject|0|||
131773404|NCT02985996|474450930|FG001|Overall Study|Withdrawal by Subject|0|||
131773405|NCT02985996|474450931|FG002|Overall Study|Withdrawal by Subject|1|||
131773406|NCT02985996|474450932|FG003|Overall Study|Withdrawal by Subject|0|||
131773407|NCT02985996|474450933|FG004|Overall Study|Withdrawal by Subject|0|||
131773408|NCT02985996|474450929|FG000|Overall Study|Protocol Violation|0|||
131773409|NCT02985996|474450930|FG001|Overall Study|Protocol Violation|1|||
131773410|NCT02985996|474450931|FG002|Overall Study|Protocol Violation|0|||
131773411|NCT02985996|474450932|FG003|Overall Study|Protocol Violation|0|||
131773412|NCT02985996|474450933|FG004|Overall Study|Protocol Violation|0|||
131773413|NCT00401726|474450934|FG000|Overall Study|Adverse Event|34|||
131773414|NCT00401726|474450935|FG001|Overall Study|Adverse Event|45|||
131773415|NCT00401726|474450934|FG000|Overall Study|Death|0|||
131773416|NCT00401726|474450935|FG001|Overall Study|Death|3|||
131773417|NCT00401726|474450934|FG000|Overall Study|Sponsor Request|0|||
131773418|NCT00401726|474450935|FG001|Overall Study|Sponsor Request|1|||
131773419|NCT00401726|474450934|FG000|Overall Study|Physician Decision|3|||
131773420|NCT00401726|474450935|FG001|Overall Study|Physician Decision|6|||
131773421|NCT00401726|474450934|FG000|Overall Study|Lost to Follow-up|23|||
131773422|NCT00401726|474450935|FG001|Overall Study|Lost to Follow-up|20|||
131773423|NCT00401726|474450934|FG000|Overall Study|Protocol Violation|6|||
131773424|NCT00401726|474450935|FG001|Overall Study|Protocol Violation|3|||
131773425|NCT00401726|474450934|FG000|Overall Study|Withdrawal by Subject|18|||
131773426|NCT00401726|474450935|FG001|Overall Study|Withdrawal by Subject|24|||
131773427|NCT00401726|474450934|FG000|Overall Study|Lack of Efficacy|4|||
131773428|NCT00401726|474450935|FG001|Overall Study|Lack of Efficacy|6|||
131773429|NCT00401726|474450934|FG000|Overall Study|Protocol Deviation|9|||
131773430|NCT00401726|474450935|FG001|Overall Study|Protocol Deviation|4|||
131773431|NCT00442572|474450936|FG000|Overall Study|Relapse|8|||
131773432|NCT00442572|474450937|FG001|Overall Study|Relapse|1|||
131773433|NCT00442572|474450936|FG000|Overall Study|Lost to Follow-up|0|||
131773434|NCT00442572|474450937|FG001|Overall Study|Lost to Follow-up|1|||
131773435|NCT00442572|474450936|FG000|Overall Study|Withdrawal by Subject|0|||
131773436|NCT00442572|474450937|FG001|Overall Study|Withdrawal by Subject|1|||
131686491|NCT04490018|474136669|FG001|Overall Study|Withdrawal by Subject|1|||
131686492|NCT04490018|474136670|FG002|Overall Study|Withdrawal by Subject|0|||
131686493|NCT04490018|474136668|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131686494|NCT04490018|474136669|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131686495|NCT04490018|474136670|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131686496|NCT01401842|474136671|FG000|Overall Study|Withdrawal by Subject|3|||
131686497|NCT01401842|474136672|FG001|Overall Study|Withdrawal by Subject|2|||
131686498|NCT01401842|474136671|FG000|Overall Study|academic reason|4|||
131686499|NCT01401842|474136672|FG001|Overall Study|academic reason|1|||
131686500|NCT01401842|474136671|FG000|Overall Study|changed companies|20|||
131686501|NCT01401842|474136672|FG001|Overall Study|changed companies|34|||
131686502|NCT01401842|474136671|FG000|Overall Study|discharged from US Army|3|||
131686503|NCT01401842|474136672|FG001|Overall Study|discharged from US Army|4|||
131686504|NCT01401842|474136671|FG000|Overall Study|invalid follow-up strength data|1|||
131686505|NCT01401842|474136672|FG001|Overall Study|invalid follow-up strength data|4|||
131686506|NCT01401842|474136671|FG000|Overall Study|on profile|9|||
131686507|NCT01401842|474136672|FG001|Overall Study|on profile|5|||
131686508|NCT01401842|474136671|FG000|Overall Study|other/unknown|28|||
131686509|NCT01401842|474136672|FG001|Overall Study|other/unknown|17|||
131686510|NCT03337542|474136673|FG000|Overall Study|Withdrew Consent|17|||
131686511|NCT03337542|474136673|FG000|Overall Study|Allergic Adverse Event|1|||
131686512|NCT03337542|474136673|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
131686513|NCT03337542|474136673|FG000|Overall Study|Lost to Follow-up|1|||
131686514|NCT03337542|474136673|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
131686515|NCT00282295|474136674|FG000|Overall Study|Adverse Event|0|||
131686516|NCT00282295|474136675|FG001|Overall Study|Adverse Event|1|||
131773437|NCT01901393|474450938|FG000|Overall Study|Adverse Event|1|||
131773438|NCT01901393|474450939|FG001|Overall Study|Adverse Event|0|||
131773439|NCT01050998|474450941|FG000|Overall Study|Adverse Event|1|||
131773440|NCT01050998|474450942|FG001|Overall Study|Adverse Event|0|||
131773441|NCT01050998|474450943|FG002|Overall Study|Adverse Event|1|||
131773442|NCT01050998|474450944|FG003|Overall Study|Adverse Event|0|||
131686517|NCT00282295|474136676|FG002|Overall Study|Adverse Event|0|||
131686518|NCT00282295|474136674|FG000|Overall Study|Serious Adverse Events|0|||
131773443|NCT01050998|474450945|FG004|Overall Study|Adverse Event|2|||
131773444|NCT01050998|474450941|FG000|Overall Study|Withdrawal by Subject|0|||
131773445|NCT01050998|474450942|FG001|Overall Study|Withdrawal by Subject|0|||
131773446|NCT01050998|474450943|FG002|Overall Study|Withdrawal by Subject|0|||
131686519|NCT00282295|474136675|FG001|Overall Study|Serious Adverse Events|0|||
131686520|NCT00282295|474136676|FG002|Overall Study|Serious Adverse Events|1|||
131686521|NCT00282295|474136674|FG000|Overall Study|Protocol Violation|0|||
131686522|NCT00282295|474136675|FG001|Overall Study|Protocol Violation|2|||
131686523|NCT00282295|474136676|FG002|Overall Study|Protocol Violation|1|||
131686524|NCT00282295|474136674|FG000|Overall Study|Withdrawal by Subject|2|||
131686525|NCT00282295|474136675|FG001|Overall Study|Withdrawal by Subject|6|||
131686526|NCT00282295|474136676|FG002|Overall Study|Withdrawal by Subject|4|||
131686527|NCT00282295|474136674|FG000|Overall Study|Lost to Follow-up|1|||
131686528|NCT00282295|474136675|FG001|Overall Study|Lost to Follow-up|7|||
131686529|NCT00282295|474136676|FG002|Overall Study|Lost to Follow-up|2|||
131686530|NCT00282295|474136674|FG000|Overall Study|Other|0|||
131686531|NCT00282295|474136675|FG001|Overall Study|Other|1|||
131686532|NCT00282295|474136676|FG002|Overall Study|Other|0|||
131686533|NCT00121108|474136677|FG000|Overall Study|Lost to Follow-up|10|||
131686534|NCT00121108|474136678|FG001|Overall Study|Lost to Follow-up|22|||
131686535|NCT00121108|474136677|FG000|Overall Study|Withdrawal by Subject|106|||
131686536|NCT00121108|474136678|FG001|Overall Study|Withdrawal by Subject|195|||
131686537|NCT00121108|474136677|FG000|Overall Study|Death|5|||
131686538|NCT00121108|474136678|FG001|Overall Study|Death|8|||
131686539|NCT01380379|474136679|FG000|Overall Study|Pregnancy|1|||
131686540|NCT02187471|474137939|FG000|Overall Study|Protocol Violation|4|||
131686541|NCT02187471|474137940|FG001|Overall Study|Protocol Violation|5|||
131686542|NCT02187471|474137941|FG002|Overall Study|Protocol Violation|4|||
131686543|NCT02187471|474137942|FG003|Overall Study|Protocol Violation|4|||
131686544|NCT02187471|474137939|FG000|Overall Study|Missing|0|||
131686545|NCT02187471|474137940|FG001|Overall Study|Missing|0|||
131686546|NCT02187471|474137941|FG002|Overall Study|Missing|0|||
131686547|NCT02187471|474137942|FG003|Overall Study|Missing|1|||
131686548|NCT02187471|474137939|FG000|Overall Study|Lack of Efficacy|18|||
131686549|NCT02187471|474137940|FG001|Overall Study|Lack of Efficacy|9|||
131686550|NCT02187471|474137941|FG002|Overall Study|Lack of Efficacy|13|||
131686551|NCT02187471|474137942|FG003|Overall Study|Lack of Efficacy|11|||
131686552|NCT02187471|474137939|FG000|Overall Study|Adverse Event|24|||
131686553|NCT02187471|474137940|FG001|Overall Study|Adverse Event|34|||
131686554|NCT02187471|474137941|FG002|Overall Study|Adverse Event|44|||
131686555|NCT02187471|474137942|FG003|Overall Study|Adverse Event|36|||
131686556|NCT02187471|474137939|FG000|Overall Study|Withdrawal by Subject|23|||
131686557|NCT02187471|474137940|FG001|Overall Study|Withdrawal by Subject|29|||
131686558|NCT02187471|474137941|FG002|Overall Study|Withdrawal by Subject|22|||
131686559|NCT02187471|474137942|FG003|Overall Study|Withdrawal by Subject|24|||
131686560|NCT02187471|474137939|FG000|Overall Study|Other|7|||
131686561|NCT02187471|474137940|FG001|Overall Study|Other|5|||
131686562|NCT02187471|474137941|FG002|Overall Study|Other|3|||
131686563|NCT02187471|474137942|FG003|Overall Study|Other|4|||
131686564|NCT02236520|474137943|FG000|Overall Study|Physician Decision|0|||
131686565|NCT02236520|474137944|FG001|Overall Study|Physician Decision|5|||
131686566|NCT02236520|474137945|FG002|Overall Study|Physician Decision|0|||
131686567|NCT02236520|474137946|FG003|Overall Study|Physician Decision|0|||
131686568|NCT02236520|474137943|FG000|Overall Study|Withdrawal by Subject|1|||
131555998|NCT01512745|473660296|FG001|Overall Study|Lost to Follow-up|0|||
131686569|NCT02236520|474137944|FG001|Overall Study|Withdrawal by Subject|0|||
131686570|NCT02236520|474137945|FG002|Overall Study|Withdrawal by Subject|0|||
131686571|NCT02236520|474137946|FG003|Overall Study|Withdrawal by Subject|1|||
131686572|NCT02236520|474137943|FG000|Overall Study|Pregnancy|1|||
131773447|NCT01050998|474450944|FG003|Overall Study|Withdrawal by Subject|1|||
131773448|NCT01050998|474450945|FG004|Overall Study|Withdrawal by Subject|3|||
131773449|NCT01050998|474450941|FG000|Overall Study|Other|3|||
131773450|NCT01050998|474450942|FG001|Overall Study|Other|2|||
131773451|NCT01050998|474450943|FG002|Overall Study|Other|1|||
131773452|NCT01050998|474450944|FG003|Overall Study|Other|1|||
131773453|NCT01050998|474450945|FG004|Overall Study|Other|5|||
131773454|NCT01050998|474450941|FG000|Overall Study|Data integrity issues|0|||
131773455|NCT01050998|474450942|FG001|Overall Study|Data integrity issues|0|||
131773456|NCT01050998|474450943|FG002|Overall Study|Data integrity issues|1|||
131773457|NCT01050998|474450944|FG003|Overall Study|Data integrity issues|1|||
131773458|NCT01050998|474450945|FG004|Overall Study|Data integrity issues|4|||
131773459|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
131773460|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
131773461|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
131773462|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
131773463|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
131773464|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Death|1|||
131773465|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Death|0|||
131773466|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Death|0|||
131773467|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Death|0|||
131773468|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Death|0|||
131773469|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
131773470|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
131773471|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
131773472|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
131773473|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
131773474|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
131773475|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
131773476|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
131773477|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
131555999|NCT01512745|473660295|FG000|Overall Study|Lack of Efficacy|2|||
131556000|NCT01512745|473660296|FG001|Overall Study|Lack of Efficacy|2|||
131556001|NCT01512745|473660295|FG000|Overall Study|Protocol Violation|1|||
131556002|NCT01512745|473660296|FG001|Overall Study|Protocol Violation|0|||
131773478|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
131773479|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
131773480|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
131773481|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
131773482|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
131773483|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
131898522|NCT00320788|474914099|FG003|Overall Study|Other|1|||
131686573|NCT02236520|474137944|FG001|Overall Study|Pregnancy|0|||
131686574|NCT02236520|474137945|FG002|Overall Study|Pregnancy|0|||
131686575|NCT02236520|474137946|FG003|Overall Study|Pregnancy|0|||
131686576|NCT01785160|474137947|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
131686577|NCT01785160|474137947|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
131686578|NCT00957528|474137948|FG000|Overall Study|Protocol Violation|0|||
131686579|NCT00957528|474137949|FG001|Overall Study|Protocol Violation|1|||
131686580|NCT00957528|474137950|FG002|Overall Study|Protocol Violation|0|||
131686581|NCT00957528|474137948|FG000|Overall Study|Withdrawal by Subject|0|||
131686582|NCT00957528|474137949|FG001|Overall Study|Withdrawal by Subject|0|||
131686583|NCT00957528|474137950|FG002|Overall Study|Withdrawal by Subject|1|||
131686584|NCT02234479|474137951|FG000|Overall Study|Withdrawal by Subject|1|||
131686585|NCT02234479|474137952|FG001|Overall Study|Withdrawal by Subject|3|||
131686586|NCT02318667|474137953|FG000|Overall Study|Adverse Event|1|||
131686587|NCT02318667|474137953|FG000|Overall Study|Lack of Efficacy|6|||
131686588|NCT02318667|474137953|FG000|Overall Study|Protocol Violation|2|||
131686589|NCT01033734|474137954|FG000|Overall Study|Withdrawal by Subject|1|||
131686590|NCT00003535|474137955|FG000|Overall Study|Not evaluable|5|||
131686591|NCT02289742|474137957|FG000|First Wear Period|Adverse event prior to treatment|0|||
131686592|NCT02289742|474137958|FG001|First Wear Period|Adverse event prior to treatment|1|||
131686593|NCT02289742|474137959|FG002|First Wear Period|Adverse event prior to treatment|0|||
131686594|NCT02289742|474137960|FG003|First Wear Period|Adverse event prior to treatment|0|||
131686595|NCT02289742|474137957|FG000|First Wear Period|Adverse Event|0|||
131686596|NCT02289742|474137958|FG001|First Wear Period|Adverse Event|0|||
131686597|NCT02289742|474137959|FG002|First Wear Period|Adverse Event|1|||
131686598|NCT02289742|474137960|FG003|First Wear Period|Adverse Event|0|||
131686599|NCT02289742|474137957|FG000|First Wear Period|Other prior to treatment|0|||
131686600|NCT02289742|474137958|FG001|First Wear Period|Other prior to treatment|0|||
131686601|NCT02289742|474137959|FG002|First Wear Period|Other prior to treatment|0|||
131686602|NCT02289742|474137960|FG003|First Wear Period|Other prior to treatment|1|||
131686603|NCT02289742|474137957|FG000|Third Wear Period|Adverse Event|0|||
131686604|NCT02289742|474137958|FG001|Third Wear Period|Adverse Event|1|||
131686605|NCT02289742|474137959|FG002|Third Wear Period|Adverse Event|0|||
131686606|NCT02289742|474137960|FG003|Third Wear Period|Adverse Event|0|||
131686607|NCT02289742|474137957|FG000|Third Wear Period|Reason not given|0|||
131686608|NCT02289742|474137958|FG001|Third Wear Period|Reason not given|0|||
131686609|NCT02289742|474137959|FG002|Third Wear Period|Reason not given|0|||
131686610|NCT02289742|474137960|FG003|Third Wear Period|Reason not given|1|||
131686611|NCT00294060|474137961|FG000|Overall Study|Death|225|||
131686612|NCT00294060|474137961|FG000|Overall Study|Other|59|||
131686613|NCT00294060|474137961|FG000|Overall Study|Lost to Follow-up|55|||
131686614|NCT00294060|474137961|FG000|Overall Study|Withdrawal by Subject|11|||
131686615|NCT00294060|474137961|FG000|Overall Study|Physician Decision|797|||
131686616|NCT00294060|474137961|FG000|Overall Study|Medical condition|3|||
131686617|NCT00294060|474137961|FG000|Overall Study|Device explanted/not replaced|23|||
131686618|NCT02113436|474137965|FG000|Period 1: 8 Weeks|Adverse Event|1|||
131686619|NCT02113436|474137966|FG001|Period 1: 8 Weeks|Adverse Event|0|||
131686620|NCT02113436|474137967|FG002|Period 1: 8 Weeks|Adverse Event|0|||
131686621|NCT02113436|474137968|FG003|Period 1: 8 Weeks|Adverse Event|0|||
131686622|NCT02113436|474137965|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
131686623|NCT02113436|474137966|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
131686624|NCT02113436|474137967|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
131686625|NCT02113436|474137968|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
131686626|NCT02113436|474137965|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
131686627|NCT02113436|474137966|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
131686628|NCT02113436|474137967|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
131686629|NCT02113436|474137968|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
131686630|NCT02113436|474137965|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
131686631|NCT02113436|474137966|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
131686632|NCT02113436|474137967|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
131686633|NCT02113436|474137968|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
131686634|NCT02113436|474137965|FG000|Period 2: 16 Weeks|Adverse Event|0|||
131686635|NCT02113436|474137966|FG001|Period 2: 16 Weeks|Adverse Event|0|||
131686636|NCT02113436|474137967|FG002|Period 2: 16 Weeks|Adverse Event|4|||
131686637|NCT02113436|474137968|FG003|Period 2: 16 Weeks|Adverse Event|5|||
131686638|NCT02113436|474137965|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
131686639|NCT02113436|474137966|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
131686640|NCT02113436|474137967|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
131686641|NCT02113436|474137968|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
131686642|NCT02113436|474137965|FG000|Period 2: 16 Weeks|Physician Decision|0|||
131686643|NCT02113436|474137966|FG001|Period 2: 16 Weeks|Physician Decision|0|||
131686644|NCT02113436|474137967|FG002|Period 2: 16 Weeks|Physician Decision|2|||
131686645|NCT02113436|474137968|FG003|Period 2: 16 Weeks|Physician Decision|0|||
131686646|NCT02113436|474137965|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
131773484|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
131773485|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
131773486|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
131773487|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
131773488|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
131773489|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
131773490|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
131773491|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
131773492|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
131773493|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
131773494|NCT00634933|474450948|FG000|Part A: Baseline to Week 24|Other|1|||
131773495|NCT00634933|474450949|FG001|Part A: Baseline to Week 24|Other|8|||
131773496|NCT00634933|474450950|FG002|Part A: Baseline to Week 24|Other|5|||
131773497|NCT00634933|474450951|FG003|Part A: Baseline to Week 24|Other|0|||
131773498|NCT00634933|474450952|FG004|Part A: Baseline to Week 24|Other|0|||
131773499|NCT00634933|474450948|FG000|Between Part A and Part B|Physician Decision|0|||
131773500|NCT00634933|474450949|FG001|Between Part A and Part B|Physician Decision|1|||
131773501|NCT00634933|474450950|FG002|Between Part A and Part B|Physician Decision|0|||
131773502|NCT00634933|474450951|FG003|Between Part A and Part B|Physician Decision|0|||
131773503|NCT00634933|474450952|FG004|Between Part A and Part B|Physician Decision|0|||
131773504|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
131773505|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
131773506|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
131773507|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
131773508|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
131773509|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
131773510|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
131773511|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
131773512|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
131773513|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
131773514|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
131773515|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
131773516|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
131773517|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
131773518|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
131773519|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
131773520|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
131773521|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
131773522|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
131773523|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
131773524|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
131773525|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
131773526|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
131773527|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
131773528|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
131773529|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
131773530|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
131773531|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
131773532|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
131773533|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
131773534|NCT00634933|474450948|FG000|Part B: Week 24 to Week 52|Other|0|||
131773535|NCT00634933|474450949|FG001|Part B: Week 24 to Week 52|Other|0|||
131773536|NCT00634933|474450950|FG002|Part B: Week 24 to Week 52|Other|5|||
131773537|NCT00634933|474450951|FG003|Part B: Week 24 to Week 52|Other|0|||
131773538|NCT00634933|474450952|FG004|Part B: Week 24 to Week 52|Other|1|||
131773539|NCT02058849|474450953|FG000|Overall Study|Hospitalization|1|||
131773540|NCT02058849|474450954|FG001|Overall Study|Hospitalization|1|||
131773541|NCT02058849|474450953|FG000|Overall Study|Death|1|||
131773542|NCT02058849|474450954|FG001|Overall Study|Death|0|||
131773543|NCT02058849|474450953|FG000|Overall Study|Lost to Follow-up|1|||
131686647|NCT02113436|474137966|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
131686648|NCT02113436|474137967|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
131686649|NCT02113436|474137968|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
131686650|NCT01263483|474137969|FG000|Overall Study|Adverse Event|4|||
131686651|NCT01263483|474137970|FG001|Overall Study|Adverse Event|0|||
131686652|NCT01263483|474137971|FG002|Overall Study|Adverse Event|3|||
131686653|NCT01263483|474137969|FG000|Overall Study|Withdrawal by Subject|1|||
131686654|NCT01263483|474137970|FG001|Overall Study|Withdrawal by Subject|0|||
131686655|NCT01263483|474137971|FG002|Overall Study|Withdrawal by Subject|0|||
131686656|NCT01263483|474137969|FG000|Overall Study|Lack of Efficacy|2|||
131686657|NCT01263483|474137970|FG001|Overall Study|Lack of Efficacy|0|||
131686658|NCT01263483|474137971|FG002|Overall Study|Lack of Efficacy|0|||
131686659|NCT01263483|474137969|FG000|Overall Study|Protocol Violation|0|||
131686660|NCT01263483|474137970|FG001|Overall Study|Protocol Violation|1|||
131686661|NCT01263483|474137971|FG002|Overall Study|Protocol Violation|1|||
131686662|NCT01263483|474137969|FG000|Overall Study|Participant Unavailability|0|||
131686663|NCT01263483|474137970|FG001|Overall Study|Participant Unavailability|1|||
131686664|NCT01263483|474137971|FG002|Overall Study|Participant Unavailability|1|||
131686665|NCT00714285|474137972|FG000|Overall Study|Lost to Follow-up|0|||
131686666|NCT00714285|474137973|FG001|Overall Study|Lost to Follow-up|2|||
131686667|NCT00714285|474137974|FG002|Overall Study|Lost to Follow-up|0|||
131686668|NCT00714285|474137975|FG003|Overall Study|Lost to Follow-up|1|||
131686669|NCT00714285|474137972|FG000|Overall Study|Migrated/moved from study area|0|||
131686670|NCT00714285|474137973|FG001|Overall Study|Migrated/moved from study area|1|||
131686671|NCT00714285|474137974|FG002|Overall Study|Migrated/moved from study area|0|||
131686672|NCT00714285|474137975|FG003|Overall Study|Migrated/moved from study area|0|||
131686673|NCT01372384|474137976|FG000|Overall Study|Progression of disease|3|||
131686674|NCT02576444|474137977|FG000|Overall Study|Death|1|||
131686675|NCT02576444|474137978|FG001|Overall Study|Death|1|||
131686676|NCT02576444|474137979|FG002|Overall Study|Death|0|||
131686677|NCT02576444|474137980|FG003|Overall Study|Death|0|||
131686678|NCT02576444|474137977|FG000|Overall Study|Withdrawal by Subject|0|||
131686679|NCT02576444|474137978|FG001|Overall Study|Withdrawal by Subject|0|||
131686680|NCT02576444|474137979|FG002|Overall Study|Withdrawal by Subject|2|||
131686681|NCT02576444|474137980|FG003|Overall Study|Withdrawal by Subject|0|||
131686682|NCT02576444|474137977|FG000|Overall Study|Adverse Event|0|||
131686683|NCT02576444|474137978|FG001|Overall Study|Adverse Event|0|||
131686684|NCT02576444|474137979|FG002|Overall Study|Adverse Event|1|||
131686685|NCT02576444|474137980|FG003|Overall Study|Adverse Event|0|||
131686686|NCT02576444|474137977|FG000|Overall Study|Physician Decision|0|||
131686687|NCT02576444|474137978|FG001|Overall Study|Physician Decision|0|||
131686688|NCT02576444|474137979|FG002|Overall Study|Physician Decision|1|||
131686689|NCT02576444|474137980|FG003|Overall Study|Physician Decision|0|||
131686690|NCT00829179|474137984|FG000|Overall Study|Withdrawal by Subject|1|||
131686691|NCT03000179|474137985|FG000|Overall Study|Lost to Follow-up|2|||
131686692|NCT01075412|474137989|FG000|Overall Study|Withdrawal by Subject|0|||
131686693|NCT01075412|474137990|FG001|Overall Study|Withdrawal by Subject|1|||
131686694|NCT00865904|474137995|FG000|Overall Study|Randomized but not Treated|2|||
131686695|NCT00865904|474137996|FG001|Overall Study|Randomized but not Treated|0|||
131686696|NCT00865904|474137997|FG002|Overall Study|Randomized but not Treated|0|||
131686697|NCT00865904|474137998|FG003|Overall Study|Randomized but not Treated|1|||
131686698|NCT00865904|474137999|FG004|Overall Study|Randomized but not Treated|1|||
131686699|NCT03625687|474138000|FG000|Overall Study|Death|1|||
131686700|NCT00711425|474138005|FG000|Overall Study|Protocol Violation|1|||
131686701|NCT00711425|474138005|FG000|Overall Study|Death|2|||
131686702|NCT00711425|474138005|FG000|Overall Study|Lost to Follow-up|1|||
131686703|NCT05879107|474138008|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
131686704|NCT05879107|474138009|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
131686705|NCT05879107|474138008|FG000|Overall Study|Migrated / moved from the study area|1|||
131686706|NCT05879107|474138009|FG001|Overall Study|Migrated / moved from the study area|1|||
131686707|NCT05879107|474138008|FG000|Overall Study|Lost to Follow-up|8|||
131686708|NCT05879107|474138009|FG001|Overall Study|Lost to Follow-up|13|||
131686709|NCT05879107|474138008|FG000|Overall Study|Death|0|||
131686710|NCT05879107|474138009|FG001|Overall Study|Death|2|||
131686711|NCT05879107|474138008|FG000|Overall Study|Other|0|||
131686712|NCT05879107|474138009|FG001|Overall Study|Other|3|||
131686713|NCT04607148|474138012|FG000|Overall Study|Withdrawal by Subject|0|||
131686714|NCT04607148|474138013|FG001|Overall Study|Withdrawal by Subject|4|||
131686715|NCT04607148|474138014|FG002|Overall Study|Withdrawal by Subject|2|||
131773544|NCT02058849|474450954|FG001|Overall Study|Lost to Follow-up|0|||
131773545|NCT02058849|474450953|FG000|Overall Study|Withdrawal by Subject|4|||
131773546|NCT02058849|474450954|FG001|Overall Study|Withdrawal by Subject|0|||
131773547|NCT01049360|474450955|FG000|Period 1|Adverse Event|0|||
131773548|NCT01049360|474450956|FG001|Period 1|Adverse Event|1|||
131773549|NCT01049360|474450957|FG002|Period 1|Adverse Event|0|||
131773550|NCT01049360|474450958|FG003|Period 1|Adverse Event|1|||
131773551|NCT01049360|474450959|FG004|Period 1|Adverse Event|0|||
131773552|NCT01049360|474450960|FG005|Period 1|Adverse Event|0|||
131773553|NCT01049360|474450961|FG006|Period 1|Adverse Event|0|||
131773554|NCT01049360|474450962|FG007|Period 1|Adverse Event|1|||
131773555|NCT01049360|474450963|FG008|Period 1|Adverse Event|0|||
131773556|NCT01049360|474450964|FG009|Period 1|Adverse Event|0|||
131773557|NCT01049360|474450965|FG010|Period 1|Adverse Event|0|||
131773558|NCT01049360|474450966|FG011|Period 1|Adverse Event|0|||
131773559|NCT01049360|474450967|FG012|Period 1|Adverse Event|1|||
131773560|NCT01049360|474450968|FG013|Period 1|Adverse Event|1|||
131773561|NCT01049360|474450969|FG014|Period 1|Adverse Event|0|||
131773562|NCT01049360|474450970|FG015|Period 1|Adverse Event|0|||
131773563|NCT01049360|474450971|FG016|Period 1|Adverse Event|1|||
131773564|NCT01049360|474450972|FG017|Period 1|Adverse Event|0|||
131773565|NCT01049360|474450973|FG018|Period 1|Adverse Event|1|||
131773566|NCT01049360|474450974|FG019|Period 1|Adverse Event|0|||
131773567|NCT01049360|474450955|FG000|Period 1|Did not meet inc/exc criteria|0|||
131773568|NCT01049360|474450956|FG001|Period 1|Did not meet inc/exc criteria|0|||
131773569|NCT01049360|474450957|FG002|Period 1|Did not meet inc/exc criteria|0|||
131773570|NCT01049360|474450958|FG003|Period 1|Did not meet inc/exc criteria|0|||
131773571|NCT01049360|474450959|FG004|Period 1|Did not meet inc/exc criteria|0|||
131773572|NCT01049360|474450960|FG005|Period 1|Did not meet inc/exc criteria|0|||
131773573|NCT01049360|474450961|FG006|Period 1|Did not meet inc/exc criteria|0|||
131773574|NCT01049360|474450962|FG007|Period 1|Did not meet inc/exc criteria|1|||
131773575|NCT01049360|474450963|FG008|Period 1|Did not meet inc/exc criteria|1|||
131773576|NCT01049360|474450964|FG009|Period 1|Did not meet inc/exc criteria|0|||
131773577|NCT01049360|474450965|FG010|Period 1|Did not meet inc/exc criteria|0|||
131773578|NCT01049360|474450966|FG011|Period 1|Did not meet inc/exc criteria|0|||
131773579|NCT01049360|474450967|FG012|Period 1|Did not meet inc/exc criteria|0|||
131773580|NCT01049360|474450968|FG013|Period 1|Did not meet inc/exc criteria|0|||
131773581|NCT01049360|474450969|FG014|Period 1|Did not meet inc/exc criteria|0|||
131773582|NCT01049360|474450970|FG015|Period 1|Did not meet inc/exc criteria|0|||
131773583|NCT01049360|474450971|FG016|Period 1|Did not meet inc/exc criteria|0|||
131773584|NCT01049360|474450972|FG017|Period 1|Did not meet inc/exc criteria|0|||
131773585|NCT01049360|474450973|FG018|Period 1|Did not meet inc/exc criteria|0|||
131773586|NCT01049360|474450974|FG019|Period 1|Did not meet inc/exc criteria|0|||
131773587|NCT01049360|474450955|FG000|Period 1|Withdrawal by Subject|0|||
131773588|NCT01049360|474450956|FG001|Period 1|Withdrawal by Subject|0|||
131773589|NCT01049360|474450957|FG002|Period 1|Withdrawal by Subject|0|||
131773590|NCT01049360|474450958|FG003|Period 1|Withdrawal by Subject|0|||
131773591|NCT01049360|474450959|FG004|Period 1|Withdrawal by Subject|0|||
131773592|NCT01049360|474450960|FG005|Period 1|Withdrawal by Subject|0|||
131773593|NCT01049360|474450961|FG006|Period 1|Withdrawal by Subject|0|||
131773594|NCT01049360|474450962|FG007|Period 1|Withdrawal by Subject|0|||
131773595|NCT01049360|474450963|FG008|Period 1|Withdrawal by Subject|1|||
131773596|NCT01049360|474450964|FG009|Period 1|Withdrawal by Subject|0|||
131773597|NCT01049360|474450965|FG010|Period 1|Withdrawal by Subject|1|||
131773598|NCT01049360|474450966|FG011|Period 1|Withdrawal by Subject|0|||
131773599|NCT01049360|474450967|FG012|Period 1|Withdrawal by Subject|1|||
131773600|NCT01049360|474450968|FG013|Period 1|Withdrawal by Subject|0|||
131773601|NCT01049360|474450969|FG014|Period 1|Withdrawal by Subject|0|||
131773602|NCT01049360|474450970|FG015|Period 1|Withdrawal by Subject|0|||
131773603|NCT01049360|474450971|FG016|Period 1|Withdrawal by Subject|0|||
131773604|NCT01049360|474450972|FG017|Period 1|Withdrawal by Subject|0|||
131773605|NCT01049360|474450973|FG018|Period 1|Withdrawal by Subject|0|||
131773606|NCT01049360|474450974|FG019|Period 1|Withdrawal by Subject|0|||
131773607|NCT01049360|474450955|FG000|Period 2|Protocol Violation|0|||
131773608|NCT01049360|474450956|FG001|Period 2|Protocol Violation|0|||
131773609|NCT01049360|474450957|FG002|Period 2|Protocol Violation|0|||
131773610|NCT01049360|474450958|FG003|Period 2|Protocol Violation|1|||
131773611|NCT01049360|474450959|FG004|Period 2|Protocol Violation|0|||
131773612|NCT01049360|474450960|FG005|Period 2|Protocol Violation|0|||
131773613|NCT01049360|474450961|FG006|Period 2|Protocol Violation|0|||
131773614|NCT01049360|474450962|FG007|Period 2|Protocol Violation|0|||
131773615|NCT01049360|474450963|FG008|Period 2|Protocol Violation|0|||
131773616|NCT01049360|474450964|FG009|Period 2|Protocol Violation|0|||
131773617|NCT01049360|474450965|FG010|Period 2|Protocol Violation|0|||
131773618|NCT01049360|474450966|FG011|Period 2|Protocol Violation|0|||
131773619|NCT01049360|474450967|FG012|Period 2|Protocol Violation|0|||
131773620|NCT01049360|474450968|FG013|Period 2|Protocol Violation|0|||
131686716|NCT04607148|474138015|FG003|Overall Study|Withdrawal by Subject|8|||
131686717|NCT04607148|474138012|FG000|Overall Study|Study Terminated by Sponsor|14|||
131686718|NCT04607148|474138013|FG001|Overall Study|Study Terminated by Sponsor|59|||
131686719|NCT04607148|474138014|FG002|Overall Study|Study Terminated by Sponsor|9|||
131686720|NCT04607148|474138015|FG003|Overall Study|Study Terminated by Sponsor|39|||
131686721|NCT04607148|474138012|FG000|Overall Study|Sponsor Decision|0|||
131686722|NCT04607148|474138013|FG001|Overall Study|Sponsor Decision|0|||
131686723|NCT04607148|474138014|FG002|Overall Study|Sponsor Decision|1|||
131686724|NCT04607148|474138015|FG003|Overall Study|Sponsor Decision|0|||
131686725|NCT04607148|474138012|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131686726|NCT04607148|474138013|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131686727|NCT04607148|474138014|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131686728|NCT04607148|474138015|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131686729|NCT04607148|474138012|FG000|Overall Study|Lost to Follow-up|0|||
131686730|NCT04607148|474138013|FG001|Overall Study|Lost to Follow-up|2|||
131686731|NCT04607148|474138014|FG002|Overall Study|Lost to Follow-up|0|||
131686732|NCT04607148|474138015|FG003|Overall Study|Lost to Follow-up|0|||
131686733|NCT04607148|474138012|FG000|Overall Study|Death|0|||
131686734|NCT04607148|474138013|FG001|Overall Study|Death|3|||
131686735|NCT04607148|474138014|FG002|Overall Study|Death|0|||
131686736|NCT04607148|474138015|FG003|Overall Study|Death|1|||
131686737|NCT04607148|474138012|FG000|Overall Study|Adverse Event|0|||
131686738|NCT04607148|474138013|FG001|Overall Study|Adverse Event|1|||
131686739|NCT04607148|474138014|FG002|Overall Study|Adverse Event|0|||
131686740|NCT04607148|474138015|FG003|Overall Study|Adverse Event|0|||
131686741|NCT00916149|474138018|FG000|Overall Study|Lost to Follow-up|3|||
131686742|NCT00916149|474138019|FG001|Overall Study|Lost to Follow-up|2|||
131686743|NCT00916149|474138020|FG002|Overall Study|Lost to Follow-up|0|||
131686744|NCT00916149|474138018|FG000|Overall Study|Unable to place scalp EEG leads|1|||
131686745|NCT00916149|474138019|FG001|Overall Study|Unable to place scalp EEG leads|0|||
131686746|NCT00916149|474138020|FG002|Overall Study|Unable to place scalp EEG leads|0|||
131686747|NCT00589420|474138021|FG000|Overall Study|screen failure|1|||
131686748|NCT00912028|474138022|FG000|Overall Study|Lost to Follow-up|2|||
131686749|NCT00912028|474138023|FG001|Overall Study|Lost to Follow-up|3|||
131686750|NCT00912028|474138024|FG002|Overall Study|Lost to Follow-up|0|||
131686751|NCT00912028|474138025|FG003|Overall Study|Lost to Follow-up|1|||
131686752|NCT00912028|474138026|FG004|Overall Study|Lost to Follow-up|3|||
131686753|NCT00912028|474138022|FG000|Overall Study|Withdrawal by Subject|3|||
131686754|NCT00912028|474138023|FG001|Overall Study|Withdrawal by Subject|0|||
131686755|NCT00912028|474138024|FG002|Overall Study|Withdrawal by Subject|0|||
131686756|NCT00912028|474138025|FG003|Overall Study|Withdrawal by Subject|0|||
131686757|NCT00912028|474138026|FG004|Overall Study|Withdrawal by Subject|0|||
131686758|NCT00942175|474138027|FG000|Overall Study|Adverse Event|2|||
131686759|NCT00942175|474138028|FG001|Overall Study|Adverse Event|1|||
131686760|NCT00942175|474138029|FG002|Overall Study|Adverse Event|0|||
131686761|NCT00942175|474138030|FG003|Overall Study|Adverse Event|0|||
131686762|NCT00942175|474138027|FG000|Overall Study|Protocol Violation|0|||
131686763|NCT00942175|474138028|FG001|Overall Study|Protocol Violation|1|||
131686764|NCT00942175|474138029|FG002|Overall Study|Protocol Violation|2|||
131686765|NCT00942175|474138030|FG003|Overall Study|Protocol Violation|0|||
131686766|NCT00942175|474138027|FG000|Overall Study|Pregnancy|0|||
131686767|NCT00942175|474138028|FG001|Overall Study|Pregnancy|0|||
131686768|NCT00942175|474138029|FG002|Overall Study|Pregnancy|0|||
131686769|NCT00942175|474138030|FG003|Overall Study|Pregnancy|1|||
131686770|NCT00942175|474138027|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
131686771|NCT00942175|474138028|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
131686772|NCT00942175|474138029|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
131686773|NCT00942175|474138030|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
131686774|NCT00942175|474138027|FG000|Overall Study|Low Platelet Count|0|||
131686775|NCT00942175|474138028|FG001|Overall Study|Low Platelet Count|2|||
131686776|NCT00942175|474138029|FG002|Overall Study|Low Platelet Count|0|||
131686777|NCT00942175|474138030|FG003|Overall Study|Low Platelet Count|0|||
131686778|NCT02664272|474138031|FG000|Overall Study|Fluoroscopic images not made available|2|||
131686779|NCT03073980|474138032|FG000|Overall Study|Lost to Follow-up|10|||
131686780|NCT03073980|474138033|FG001|Overall Study|Lost to Follow-up|2|||
131686781|NCT03073980|474138034|FG002|Overall Study|Lost to Follow-up|9|||
131686782|NCT03073980|474138032|FG000|Overall Study|No post-procedure data|0|||
131686783|NCT03073980|474138033|FG001|Overall Study|No post-procedure data|0|||
131686784|NCT03073980|474138034|FG002|Overall Study|No post-procedure data|2|||
131686785|NCT00545064|474138035|FG000|Overall Study|Lost to Follow-up|3|||
131686786|NCT00545064|474138035|FG000|Overall Study|Withdrawal by Subject|2|||
131773621|NCT01049360|474450969|FG014|Period 2|Protocol Violation|1|||
131898523|NCT00320788|474914100|FG004|Overall Study|Other|1|||
131773622|NCT01049360|474450970|FG015|Period 2|Protocol Violation|1|||
131686787|NCT00545064|474138035|FG000|Overall Study|did not complete course of treatment|1|||
131686788|NCT00545064|474138035|FG000|Overall Study|cancel all appointments, no rebooking|1|||
131686789|NCT00545064|474138035|FG000|Overall Study|inclement weather|1|||
131686790|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
131686791|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
131686792|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
131686793|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
131686794|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
131686795|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
131686796|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131686797|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131686798|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
131686799|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
131686800|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
131686801|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
131686802|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
131686803|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
131686804|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
131686805|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
131686806|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
131686807|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
131686808|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
131686809|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
131686810|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
131686811|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
131686812|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
131686813|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
131686814|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Death|2|||
131686815|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Death|1|||
131686816|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Death|0|||
131686817|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Death|0|||
131686818|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
131686819|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
131686820|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
131686821|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
131686822|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
131719355|NCT00345605|474253269|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
131719356|NCT01389128|474253270|FG000|Overall Study|Fetal distress|1|||
131719357|NCT01389128|474253271|FG001|Overall Study|Fetal distress|0|||
131719358|NCT01389128|474253270|FG000|Overall Study|Cervix dilation stop|1|||
131719359|NCT01389128|474253271|FG001|Overall Study|Cervix dilation stop|2|||
131719360|NCT01389128|474253270|FG000|Overall Study|Rapid labor evolution|3|||
131719361|NCT01389128|474253271|FG001|Overall Study|Rapid labor evolution|2|||
131719362|NCT01389128|474253270|FG000|Overall Study|Intolerance to procedure|0|||
131719363|NCT01389128|474253271|FG001|Overall Study|Intolerance to procedure|2|||
131719364|NCT03180736|474253272|FG000|Overall Study|Adverse Event|3|||
131719365|NCT03180736|474253273|FG001|Overall Study|Adverse Event|4|||
131719366|NCT03180736|474253272|FG000|Overall Study|Death|10|||
131719367|NCT03180736|474253273|FG001|Overall Study|Death|7|||
131719368|NCT03180736|474253272|FG000|Overall Study|Withdrawal by Subject|5|||
131719369|NCT03180736|474253273|FG001|Overall Study|Withdrawal by Subject|12|||
131719370|NCT03180736|474253272|FG000|Overall Study|Lost to Follow-up|1|||
131719371|NCT03180736|474253273|FG001|Overall Study|Lost to Follow-up|0|||
131719372|NCT03180736|474253272|FG000|Overall Study|Lack of Efficacy|66|||
131719373|NCT03180736|474253273|FG001|Overall Study|Lack of Efficacy|87|||
131719374|NCT03180736|474253272|FG000|Overall Study|Physician Decision|4|||
131719375|NCT03180736|474253273|FG001|Overall Study|Physician Decision|7|||
131719376|NCT03180736|474253272|FG000|Overall Study|randomized but not treated|2|||
131719377|NCT03180736|474253273|FG001|Overall Study|randomized but not treated|3|||
131719378|NCT01059812|474253274|FG000|Overall Study|Adverse Event|9|||
131719379|NCT01059812|474253275|FG001|Overall Study|Adverse Event|5|||
131719380|NCT01059812|474253274|FG000|Overall Study|Lack of Efficacy|2|||
131719381|NCT01059812|474253275|FG001|Overall Study|Lack of Efficacy|2|||
131719382|NCT01059812|474253274|FG000|Overall Study|Protocol Violation|3|||
131719383|NCT01059812|474253275|FG001|Overall Study|Protocol Violation|1|||
131719384|NCT01059812|474253274|FG000|Overall Study|Withdrawal Criteria|9|||
131719385|NCT01059812|474253275|FG001|Overall Study|Withdrawal Criteria|4|||
131719386|NCT01059812|474253274|FG000|Overall Study|Unclassified|14|||
131773623|NCT01049360|474450971|FG016|Period 2|Protocol Violation|0|||
131773624|NCT01049360|474450972|FG017|Period 2|Protocol Violation|0|||
131773625|NCT01049360|474450973|FG018|Period 2|Protocol Violation|0|||
131773626|NCT01049360|474450974|FG019|Period 2|Protocol Violation|0|||
131773627|NCT01049360|474450955|FG000|Period 2|Adverse Event|0|||
131773628|NCT01049360|474450956|FG001|Period 2|Adverse Event|1|||
131773629|NCT01049360|474450957|FG002|Period 2|Adverse Event|0|||
131773630|NCT01049360|474450958|FG003|Period 2|Adverse Event|0|||
131773631|NCT01049360|474450959|FG004|Period 2|Adverse Event|0|||
131773632|NCT01049360|474450960|FG005|Period 2|Adverse Event|0|||
131773633|NCT01049360|474450961|FG006|Period 2|Adverse Event|0|||
131773634|NCT01049360|474450962|FG007|Period 2|Adverse Event|0|||
131773635|NCT01049360|474450963|FG008|Period 2|Adverse Event|1|||
131773636|NCT01049360|474450964|FG009|Period 2|Adverse Event|0|||
131773637|NCT01049360|474450965|FG010|Period 2|Adverse Event|0|||
131686823|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
131686824|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
131686825|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
131686826|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
131686827|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
131686828|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131686829|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131686830|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
131686831|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
131686832|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
131686833|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
131686834|NCT01940471|474138038|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
131686835|NCT01940471|474138039|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
131686836|NCT01940471|474138040|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
131686837|NCT01940471|474138041|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
131686838|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
131686839|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
131686840|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
131686841|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
131686842|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131686843|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131686844|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
131686845|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
131686846|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
131686847|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
131686848|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
131686849|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
131686850|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
131686851|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
131686852|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
131686853|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
131686854|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131686855|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131686856|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
131686857|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
131686858|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131686859|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131686860|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
131686861|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
131686862|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131773638|NCT01049360|474450966|FG011|Period 2|Adverse Event|0|||
131773639|NCT01049360|474450967|FG012|Period 2|Adverse Event|0|||
131773640|NCT01049360|474450968|FG013|Period 2|Adverse Event|0|||
131773641|NCT01049360|474450969|FG014|Period 2|Adverse Event|0|||
131773642|NCT01049360|474450970|FG015|Period 2|Adverse Event|0|||
131686863|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131686864|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
131686865|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131686866|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
131686867|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
131686868|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
131686869|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
131686870|NCT01940471|474138038|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131686871|NCT01940471|474138039|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131686872|NCT01940471|474138040|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
131686873|NCT01940471|474138041|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131686874|NCT00258674|474138042|FG000|Overall Study|Death|32|||
131686875|NCT00258674|474138043|FG001|Overall Study|Death|53|||
131686876|NCT00258674|474138044|FG002|Overall Study|Death|34|||
131686877|NCT03715153|474138045|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
131686878|NCT03715153|474138046|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
131686879|NCT03715153|474138045|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
131686880|NCT03715153|474138046|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
131686881|NCT03715153|474138045|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
131686882|NCT03715153|474138046|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
131719387|NCT01059812|474253275|FG001|Overall Study|Unclassified|4|||
131773643|NCT01049360|474450971|FG016|Period 2|Adverse Event|0|||
131773644|NCT01049360|474450972|FG017|Period 2|Adverse Event|0|||
131773645|NCT01049360|474450973|FG018|Period 2|Adverse Event|0|||
131773646|NCT01049360|474450974|FG019|Period 2|Adverse Event|1|||
131773647|NCT01049360|474450955|FG000|Period 2|Withdrawal by Subject|0|||
131773648|NCT01049360|474450956|FG001|Period 2|Withdrawal by Subject|0|||
131773649|NCT01049360|474450957|FG002|Period 2|Withdrawal by Subject|0|||
131773650|NCT01049360|474450958|FG003|Period 2|Withdrawal by Subject|1|||
131773651|NCT01049360|474450959|FG004|Period 2|Withdrawal by Subject|0|||
131773652|NCT01049360|474450960|FG005|Period 2|Withdrawal by Subject|0|||
131773653|NCT01049360|474450961|FG006|Period 2|Withdrawal by Subject|0|||
131773654|NCT01049360|474450962|FG007|Period 2|Withdrawal by Subject|0|||
131773655|NCT01049360|474450963|FG008|Period 2|Withdrawal by Subject|0|||
131773656|NCT01049360|474450964|FG009|Period 2|Withdrawal by Subject|0|||
131773657|NCT01049360|474450965|FG010|Period 2|Withdrawal by Subject|0|||
131773658|NCT01049360|474450966|FG011|Period 2|Withdrawal by Subject|0|||
131773659|NCT01049360|474450967|FG012|Period 2|Withdrawal by Subject|0|||
131773660|NCT01049360|474450968|FG013|Period 2|Withdrawal by Subject|0|||
131773661|NCT01049360|474450969|FG014|Period 2|Withdrawal by Subject|1|||
131773662|NCT01049360|474450970|FG015|Period 2|Withdrawal by Subject|0|||
131773663|NCT01049360|474450971|FG016|Period 2|Withdrawal by Subject|0|||
131773664|NCT01049360|474450972|FG017|Period 2|Withdrawal by Subject|0|||
131773665|NCT01049360|474450973|FG018|Period 2|Withdrawal by Subject|0|||
131773666|NCT01049360|474450974|FG019|Period 2|Withdrawal by Subject|1|||
131773667|NCT01049360|474450955|FG000|Period 2|Lack of Efficacy|0|||
131773668|NCT01049360|474450956|FG001|Period 2|Lack of Efficacy|0|||
131773669|NCT01049360|474450957|FG002|Period 2|Lack of Efficacy|0|||
131773670|NCT01049360|474450958|FG003|Period 2|Lack of Efficacy|0|||
131773671|NCT01049360|474450959|FG004|Period 2|Lack of Efficacy|0|||
131773672|NCT01049360|474450960|FG005|Period 2|Lack of Efficacy|1|||
131773673|NCT01049360|474450961|FG006|Period 2|Lack of Efficacy|0|||
131773674|NCT01049360|474450962|FG007|Period 2|Lack of Efficacy|0|||
131773675|NCT01049360|474450963|FG008|Period 2|Lack of Efficacy|0|||
131773676|NCT01049360|474450964|FG009|Period 2|Lack of Efficacy|0|||
131773677|NCT01049360|474450965|FG010|Period 2|Lack of Efficacy|0|||
131773678|NCT01049360|474450966|FG011|Period 2|Lack of Efficacy|0|||
131773679|NCT01049360|474450967|FG012|Period 2|Lack of Efficacy|0|||
131773680|NCT01049360|474450968|FG013|Period 2|Lack of Efficacy|0|||
131773681|NCT01049360|474450969|FG014|Period 2|Lack of Efficacy|0|||
131773682|NCT01049360|474450970|FG015|Period 2|Lack of Efficacy|0|||
131773683|NCT01049360|474450971|FG016|Period 2|Lack of Efficacy|0|||
131773684|NCT01049360|474450972|FG017|Period 2|Lack of Efficacy|0|||
131773685|NCT01049360|474450973|FG018|Period 2|Lack of Efficacy|0|||
131773686|NCT01049360|474450974|FG019|Period 2|Lack of Efficacy|0|||
131773687|NCT01049360|474450955|FG000|Period 4|Protocol Violation|0|||
131773688|NCT01049360|474450956|FG001|Period 4|Protocol Violation|0|||
131773689|NCT01049360|474450957|FG002|Period 4|Protocol Violation|0|||
131773690|NCT01049360|474450958|FG003|Period 4|Protocol Violation|0|||
131773691|NCT01049360|474450959|FG004|Period 4|Protocol Violation|0|||
131773692|NCT01049360|474450960|FG005|Period 4|Protocol Violation|0|||
131773693|NCT01049360|474450961|FG006|Period 4|Protocol Violation|0|||
131773694|NCT01049360|474450962|FG007|Period 4|Protocol Violation|0|||
131773695|NCT01049360|474450963|FG008|Period 4|Protocol Violation|0|||
131773696|NCT01049360|474450964|FG009|Period 4|Protocol Violation|0|||
131773697|NCT01049360|474450965|FG010|Period 4|Protocol Violation|0|||
131773698|NCT01049360|474450966|FG011|Period 4|Protocol Violation|0|||
131773699|NCT01049360|474450967|FG012|Period 4|Protocol Violation|0|||
131773700|NCT01049360|474450968|FG013|Period 4|Protocol Violation|0|||
131773701|NCT01049360|474450969|FG014|Period 4|Protocol Violation|0|||
131773702|NCT01049360|474450970|FG015|Period 4|Protocol Violation|0|||
131773703|NCT01049360|474450971|FG016|Period 4|Protocol Violation|0|||
131773704|NCT01049360|474450972|FG017|Period 4|Protocol Violation|1|||
131773705|NCT01049360|474450973|FG018|Period 4|Protocol Violation|0|||
131773706|NCT01049360|474450974|FG019|Period 4|Protocol Violation|0|||
131773707|NCT01049360|474450955|FG000|Period 4|Withdrawal by Subject|0|||
131773708|NCT01049360|474450956|FG001|Period 4|Withdrawal by Subject|0|||
131773709|NCT01049360|474450957|FG002|Period 4|Withdrawal by Subject|0|||
131773710|NCT01049360|474450958|FG003|Period 4|Withdrawal by Subject|1|||
131773711|NCT01049360|474450959|FG004|Period 4|Withdrawal by Subject|0|||
131773712|NCT01049360|474450960|FG005|Period 4|Withdrawal by Subject|0|||
131773713|NCT01049360|474450961|FG006|Period 4|Withdrawal by Subject|0|||
131773714|NCT01049360|474450962|FG007|Period 4|Withdrawal by Subject|0|||
131773715|NCT01049360|474450963|FG008|Period 4|Withdrawal by Subject|0|||
131773716|NCT01049360|474450964|FG009|Period 4|Withdrawal by Subject|0|||
131773717|NCT01049360|474450965|FG010|Period 4|Withdrawal by Subject|0|||
131773718|NCT01049360|474450966|FG011|Period 4|Withdrawal by Subject|0|||
131773719|NCT01049360|474450967|FG012|Period 4|Withdrawal by Subject|0|||
131773720|NCT01049360|474450968|FG013|Period 4|Withdrawal by Subject|0|||
131773721|NCT01049360|474450969|FG014|Period 4|Withdrawal by Subject|0|||
131773722|NCT01049360|474450970|FG015|Period 4|Withdrawal by Subject|0|||
131773723|NCT01049360|474450971|FG016|Period 4|Withdrawal by Subject|0|||
131773724|NCT01049360|474450972|FG017|Period 4|Withdrawal by Subject|0|||
131773725|NCT01049360|474450973|FG018|Period 4|Withdrawal by Subject|0|||
131773726|NCT01049360|474450974|FG019|Period 4|Withdrawal by Subject|0|||
131773727|NCT01694849|474450975|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
131773728|NCT01694849|474450976|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
131773729|NCT01694849|474450977|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
131773730|NCT01694849|474450975|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
131773731|NCT01694849|474450976|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
131773732|NCT01694849|474450977|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
131773733|NCT01694849|474450975|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
131773734|NCT01694849|474450976|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
131773735|NCT01694849|474450977|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
131773736|NCT01694849|474450975|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
131773737|NCT01694849|474450976|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
131773738|NCT01694849|474450977|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
131773739|NCT01694849|474450975|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
131773740|NCT01694849|474450976|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
131773741|NCT01694849|474450977|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
131773742|NCT01694849|474450975|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
131773743|NCT01694849|474450976|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
131773744|NCT01694849|474450977|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
131773745|NCT01694849|474450975|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
131773746|NCT01694849|474450976|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
131773747|NCT01694849|474450977|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
131773748|NCT01694849|474450975|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
131773749|NCT01694849|474450976|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
131773750|NCT01694849|474450977|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
131773751|NCT01326312|474450978|FG000|Overall Study|Adverse Event|11|||
131773752|NCT01326312|474450979|FG001|Overall Study|Adverse Event|11|||
131773753|NCT01326312|474450980|FG002|Overall Study|Adverse Event|1|||
131773754|NCT01326312|474450978|FG000|Overall Study|Withdrawal by Subject|1|||
131773755|NCT01326312|474450979|FG001|Overall Study|Withdrawal by Subject|2|||
131773756|NCT01326312|474450980|FG002|Overall Study|Withdrawal by Subject|1|||
131773757|NCT01326312|474450978|FG000|Overall Study|Protocol Violation|0|||
131773758|NCT01326312|474450979|FG001|Overall Study|Protocol Violation|1|||
131773759|NCT01326312|474450980|FG002|Overall Study|Protocol Violation|0|||
131773760|NCT01326312|474450978|FG000|Overall Study|Lack of Efficacy|13|||
131773761|NCT01326312|474450979|FG001|Overall Study|Lack of Efficacy|7|||
131773762|NCT01326312|474450980|FG002|Overall Study|Lack of Efficacy|1|||
131773763|NCT01326312|474450978|FG000|Overall Study|Death|1|||
131773764|NCT01326312|474450979|FG001|Overall Study|Death|0|||
131773765|NCT01326312|474450980|FG002|Overall Study|Death|1|||
131773766|NCT01326312|474450978|FG000|Overall Study|progressive disease|0|||
131773767|NCT01326312|474450979|FG001|Overall Study|progressive disease|1|||
131773768|NCT01326312|474450980|FG002|Overall Study|progressive disease|1|||
131773769|NCT01326312|474450978|FG000|Overall Study|Study terminated by Sponsor|8|||
131773770|NCT01326312|474450979|FG001|Overall Study|Study terminated by Sponsor|32|||
131773771|NCT01326312|474450980|FG002|Overall Study|Study terminated by Sponsor|46|||
131773772|NCT01326312|474450978|FG000|Overall Study|Treatment arm terminated|19|||
131773773|NCT01326312|474450979|FG001|Overall Study|Treatment arm terminated|0|||
131773774|NCT01326312|474450980|FG002|Overall Study|Treatment arm terminated|0|||
131773775|NCT01326312|474450978|FG000|Overall Study|QTc > 500|0|||
131773776|NCT01326312|474450979|FG001|Overall Study|QTc > 500|1|||
131773777|NCT01326312|474450980|FG002|Overall Study|QTc > 500|0|||
131773778|NCT00499694|474450983|FG000|Overall Study|Patient never received treatment.|1|||
131773779|NCT02304484|474450986|FG000|Overall Study|Death|9|||
131773780|NCT02304484|474450986|FG000|Overall Study|Withdrawal by Subject|14|||
131773781|NCT02304484|474450986|FG000|Overall Study|Lost to Follow-up|2|||
131773782|NCT04338685|474450987|FG000|Overall Study|Death|3|||
131773783|NCT04338685|474450988|FG001|Overall Study|Death|4|||
131773784|NCT04338685|474450989|FG002|Overall Study|Death|2|||
131773785|NCT04338685|474450990|FG003|Overall Study|Death|4|||
131773786|NCT04338685|474450991|FG004|Overall Study|Death|4|||
131773787|NCT04338685|474450992|FG005|Overall Study|Death|8|||
131773788|NCT04338685|474450993|FG006|Overall Study|Death|1|||
131773789|NCT04338685|474450994|FG007|Overall Study|Death|0|||
131773790|NCT04338685|474450995|FG008|Overall Study|Death|0|||
131773791|NCT04338685|474450987|FG000|Overall Study|Study terminated by Sponsor|0|||
131773792|NCT04338685|474450988|FG001|Overall Study|Study terminated by Sponsor|0|||
131773793|NCT04338685|474450989|FG002|Overall Study|Study terminated by Sponsor|1|||
131773794|NCT04338685|474450990|FG003|Overall Study|Study terminated by Sponsor|4|||
131773795|NCT04338685|474450991|FG004|Overall Study|Study terminated by Sponsor|0|||
131773796|NCT04338685|474450992|FG005|Overall Study|Study terminated by Sponsor|5|||
131773797|NCT04338685|474450993|FG006|Overall Study|Study terminated by Sponsor|2|||
131773798|NCT04338685|474450994|FG007|Overall Study|Study terminated by Sponsor|4|||
131773799|NCT04338685|474450995|FG008|Overall Study|Study terminated by Sponsor|1|||
131773800|NCT04338685|474450987|FG000|Overall Study|Withdrawal by Subject|1|||
131773801|NCT04338685|474450988|FG001|Overall Study|Withdrawal by Subject|2|||
131773802|NCT04338685|474450989|FG002|Overall Study|Withdrawal by Subject|0|||
131773803|NCT04338685|474450990|FG003|Overall Study|Withdrawal by Subject|2|||
131773804|NCT04338685|474450991|FG004|Overall Study|Withdrawal by Subject|0|||
131773805|NCT04338685|474450992|FG005|Overall Study|Withdrawal by Subject|5|||
131773806|NCT04338685|474450993|FG006|Overall Study|Withdrawal by Subject|1|||
131773807|NCT04338685|474450994|FG007|Overall Study|Withdrawal by Subject|1|||
131773808|NCT04338685|474450995|FG008|Overall Study|Withdrawal by Subject|0|||
131773809|NCT02967055|474450996|FG000|Overall Study|Excluded|40|||
131773810|NCT02967055|474450996|FG000|Overall Study|Screen fail|3|||
131773811|NCT02967055|474450996|FG000|Overall Study|Lost to Follow-up|2|||
131773812|NCT02967055|474450996|FG000|Overall Study|Stopped due to side effects|3|||
131773813|NCT02967055|474450996|FG000|Overall Study|Stopped due to drug cost|1|||
131773814|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
131773815|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
131686883|NCT03715153|474138045|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
131686884|NCT03715153|474138046|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
131686885|NCT03715153|474138045|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
131686886|NCT03715153|474138046|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
131686887|NCT03715153|474138045|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
131686888|NCT03715153|474138046|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
131686889|NCT01358760|474138051|FG000|Overall Study|Adverse Event|3|||
131686890|NCT01358760|474138052|FG001|Overall Study|Adverse Event|4|||
131686891|NCT01358760|474138053|FG002|Overall Study|Adverse Event|3|||
131686892|NCT01358760|474138051|FG000|Overall Study|Lost to Follow-up|1|||
131686893|NCT01358760|474138052|FG001|Overall Study|Lost to Follow-up|1|||
131686894|NCT01358760|474138053|FG002|Overall Study|Lost to Follow-up|3|||
131686895|NCT01358760|474138051|FG000|Overall Study|Withdrawal by Subject|5|||
131686896|NCT01358760|474138052|FG001|Overall Study|Withdrawal by Subject|3|||
131686897|NCT01358760|474138053|FG002|Overall Study|Withdrawal by Subject|2|||
131686898|NCT01358760|474138051|FG000|Overall Study|Physician Decision|1|||
131686899|NCT01358760|474138052|FG001|Overall Study|Physician Decision|0|||
131686900|NCT01358760|474138053|FG002|Overall Study|Physician Decision|1|||
131686901|NCT01358760|474138051|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
131686902|NCT01358760|474138052|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
131686903|NCT01358760|474138053|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
131686904|NCT01506960|474138056|FG000|Overall Study|Did not meet angiographic criteria|47|||
131686905|NCT00450723|474138058|FG000|Overall Study|Physician Decision|5|||
131686906|NCT03574753|474138061|FG000|Overall Study|Adverse Event|3|||
131686907|NCT03574753|474138061|FG000|Overall Study|Progression/relapse|19|||
131686908|NCT03574753|474138061|FG000|Overall Study|Death|1|||
131686909|NCT01436084|474138064|FG000|Overall Study|Disease Progression|2|||
131686910|NCT01436084|474138064|FG000|Overall Study|Withdrawal by Subject|1|||
131686911|NCT01436084|474138064|FG000|Overall Study|Early Closure of Study|1|||
131686912|NCT01744665|474138065|FG000|Monitoring Phase|Adverse Event|4|||
131686913|NCT01744665|474138065|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
131686914|NCT01744665|474138065|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
131686915|NCT01744665|474138065|FG000|Monitoring Phase|Withdrawal by Subject|5|||
131686916|NCT01744665|474138065|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
131686917|NCT01744665|474138065|FG000|Consolidation Phase|Adverse Event|2|||
131686918|NCT01744665|474138065|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
131686919|NCT01744665|474138065|FG000|Consolidation Phase|Withdrawal by Subject|4|||
131686920|NCT01744665|474138065|FG000|Consolidation Phase|Administrative problems|9|||
131686921|NCT01744665|474138065|FG000|Re-initiation Phase|Administrative problems|10|||
131686922|NCT01744665|474138065|FG000|Re-initiation Phase|Adverse Event|1|||
131686923|NCT01744665|474138065|FG000|Re-initiation Phase|No longer required treatment|1|||
131686924|NCT01744665|474138065|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
131686925|NCT02044133|474138069|FG000|Overall Study|Lost to Follow-up|1|||
131686926|NCT02044133|474138070|FG001|Overall Study|Lost to Follow-up|1|||
131686927|NCT02044133|474138069|FG000|Overall Study|Death|1|||
131686928|NCT02044133|474138070|FG001|Overall Study|Death|0|||
131686929|NCT02044133|474138069|FG000|Overall Study|Release|3|||
131686930|NCT02044133|474138070|FG001|Overall Study|Release|4|||
131686931|NCT02044133|474138069|FG000|Overall Study|Transfer|1|||
131686932|NCT02044133|474138070|FG001|Overall Study|Transfer|0|||
131686933|NCT02044133|474138069|FG000|Overall Study|refusal of blood sampling|0|||
131686934|NCT02044133|474138070|FG001|Overall Study|refusal of blood sampling|1|||
131719388|NCT03230097|474253284|FG000|Overall Study|Adverse Event|2|||
131719389|NCT03230097|474253285|FG001|Overall Study|Adverse Event|1|||
131719390|NCT03230097|474253284|FG000|Overall Study|non-compliance|0|||
131719391|NCT03230097|474253285|FG001|Overall Study|non-compliance|1|||
131719392|NCT03230097|474253284|FG000|Overall Study|Lost to Follow-up|2|||
131719393|NCT03230097|474253285|FG001|Overall Study|Lost to Follow-up|4|||
131719394|NCT03230097|474253284|FG000|Overall Study|Withdrawal by Subject|7|||
131719395|NCT03230097|474253285|FG001|Overall Study|Withdrawal by Subject|3|||
131719396|NCT03230097|474253284|FG000|Overall Study|Trial termination|4|||
131719397|NCT03230097|474253285|FG001|Overall Study|Trial termination|5|||
131719398|NCT03230097|474253284|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
131719399|NCT03230097|474253285|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
131719400|NCT03230097|474253284|FG000|Overall Study|outcome event|0|||
131773816|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
131773817|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
131686935|NCT00736255|474139626|FG000|Overall Study|Adverse Event|1|||
131686936|NCT00736255|474139627|FG001|Overall Study|Adverse Event|0|||
131686937|NCT00736255|474139626|FG000|Overall Study|Physician Decision|1|||
131686938|NCT00736255|474139627|FG001|Overall Study|Physician Decision|0|||
131686939|NCT00736255|474139626|FG000|Overall Study|Non-compliance|1|||
131686940|NCT00736255|474139627|FG001|Overall Study|Non-compliance|1|||
131686941|NCT00766038|474139632|FG000|Overall Study|Lost to Follow-up|15|||
131686942|NCT00766038|474139633|FG001|Overall Study|Lost to Follow-up|14|||
131686943|NCT01251653|474139638|FG000|Overall Study|Progressive Disease|1|||
131686944|NCT01251653|474139639|FG001|Overall Study|Progressive Disease|7|||
131686945|NCT01251653|474139640|FG002|Overall Study|Progressive Disease|16|||
131686946|NCT01251653|474139641|FG003|Overall Study|Progressive Disease|4|||
131686947|NCT01251653|474139642|FG004|Overall Study|Progressive Disease|0|||
131686948|NCT01251653|474139643|FG005|Overall Study|Progressive Disease|17|||
131686949|NCT01251653|474139644|FG006|Overall Study|Progressive Disease|14|||
131686950|NCT01251653|474139645|FG007|Overall Study|Progressive Disease|7|||
131686951|NCT01251653|474139646|FG008|Overall Study|Progressive Disease|5|||
131686952|NCT01251653|474139638|FG000|Overall Study|Dose-limiting toxicity|0|||
131686953|NCT01251653|474139639|FG001|Overall Study|Dose-limiting toxicity|1|||
131686954|NCT01251653|474139640|FG002|Overall Study|Dose-limiting toxicity|1|||
131686955|NCT01251653|474139641|FG003|Overall Study|Dose-limiting toxicity|1|||
131686956|NCT01251653|474139642|FG004|Overall Study|Dose-limiting toxicity|0|||
131686957|NCT01251653|474139643|FG005|Overall Study|Dose-limiting toxicity|0|||
131686958|NCT01251653|474139644|FG006|Overall Study|Dose-limiting toxicity|2|||
131686959|NCT01251653|474139645|FG007|Overall Study|Dose-limiting toxicity|0|||
131686960|NCT01251653|474139646|FG008|Overall Study|Dose-limiting toxicity|0|||
131686961|NCT01251653|474139638|FG000|Overall Study|Adverse Event|1|||
131686962|NCT01251653|474139639|FG001|Overall Study|Adverse Event|0|||
131686963|NCT01251653|474139640|FG002|Overall Study|Adverse Event|2|||
131686964|NCT01251653|474139641|FG003|Overall Study|Adverse Event|1|||
131686965|NCT01251653|474139642|FG004|Overall Study|Adverse Event|1|||
131686966|NCT01251653|474139643|FG005|Overall Study|Adverse Event|0|||
131686967|NCT01251653|474139644|FG006|Overall Study|Adverse Event|2|||
131686968|NCT01251653|474139645|FG007|Overall Study|Adverse Event|2|||
131686969|NCT01251653|474139646|FG008|Overall Study|Adverse Event|1|||
131686970|NCT01251653|474139638|FG000|Overall Study|Withdrawal by Subject|1|||
131686971|NCT01251653|474139639|FG001|Overall Study|Withdrawal by Subject|0|||
131686972|NCT01251653|474139640|FG002|Overall Study|Withdrawal by Subject|1|||
131686973|NCT01251653|474139641|FG003|Overall Study|Withdrawal by Subject|0|||
131686974|NCT01251653|474139642|FG004|Overall Study|Withdrawal by Subject|1|||
131686975|NCT01251653|474139643|FG005|Overall Study|Withdrawal by Subject|1|||
131686976|NCT01251653|474139644|FG006|Overall Study|Withdrawal by Subject|0|||
131686977|NCT01251653|474139645|FG007|Overall Study|Withdrawal by Subject|1|||
131686978|NCT01251653|474139646|FG008|Overall Study|Withdrawal by Subject|0|||
131686979|NCT01251653|474139638|FG000|Overall Study|Other reason not mentioned above|0|||
131686980|NCT01251653|474139639|FG001|Overall Study|Other reason not mentioned above|0|||
131686981|NCT01251653|474139640|FG002|Overall Study|Other reason not mentioned above|0|||
131686982|NCT01251653|474139641|FG003|Overall Study|Other reason not mentioned above|0|||
131686983|NCT01251653|474139642|FG004|Overall Study|Other reason not mentioned above|0|||
131686984|NCT01251653|474139643|FG005|Overall Study|Other reason not mentioned above|0|||
131686985|NCT01251653|474139644|FG006|Overall Study|Other reason not mentioned above|0|||
131686986|NCT01251653|474139645|FG007|Overall Study|Other reason not mentioned above|2|||
131686987|NCT01251653|474139646|FG008|Overall Study|Other reason not mentioned above|0|||
131686988|NCT00847145|474139647|FG000|Overall Study|AE or Death|0|||
131686989|NCT00847145|474139648|FG001|Overall Study|AE or Death|1|||
131686990|NCT00847145|474139649|FG002|Overall Study|AE or Death|1|||
131686991|NCT00847145|474139650|FG003|Overall Study|AE or Death|0|||
131686992|NCT00847145|474139651|FG004|Overall Study|AE or Death|0|||
131686993|NCT00847145|474139652|FG005|Overall Study|AE or Death|0|||
131773818|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
131773819|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
131773820|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
131773821|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
131773822|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
131773823|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
131773824|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
131773825|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
131773826|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
131773827|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
131773828|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
131773829|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
131773830|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
131773831|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
131773832|NCT00570492|474450997|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
131773833|NCT00570492|474450998|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
131773834|NCT00570492|474450999|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
131773835|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131773836|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
131773837|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
131773838|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
131773839|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
131773840|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
131773841|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
131773842|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
131773843|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
131773844|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
131773845|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
131773846|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
131773847|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
131773848|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
131773849|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
131773850|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
131773851|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
131773852|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
131773853|NCT00570492|474450997|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
131686994|NCT00847145|474139653|FG006|Overall Study|AE or Death|0|||
131686995|NCT00847145|474139654|FG007|Overall Study|AE or Death|0|||
131686996|NCT00847145|474139647|FG000|Overall Study|Withdrawal by Subject|3|||
131686997|NCT00847145|474139648|FG001|Overall Study|Withdrawal by Subject|4|||
131686998|NCT00847145|474139649|FG002|Overall Study|Withdrawal by Subject|6|||
131686999|NCT00847145|474139650|FG003|Overall Study|Withdrawal by Subject|1|||
131687000|NCT00847145|474139651|FG004|Overall Study|Withdrawal by Subject|0|||
131687001|NCT00847145|474139652|FG005|Overall Study|Withdrawal by Subject|0|||
131687002|NCT00847145|474139653|FG006|Overall Study|Withdrawal by Subject|1|||
131687003|NCT00847145|474139654|FG007|Overall Study|Withdrawal by Subject|1|||
131687004|NCT00847145|474139647|FG000|Overall Study|Lost to Follow-up|3|||
131687005|NCT00847145|474139648|FG001|Overall Study|Lost to Follow-up|1|||
131687006|NCT00847145|474139649|FG002|Overall Study|Lost to Follow-up|1|||
131687007|NCT00847145|474139650|FG003|Overall Study|Lost to Follow-up|0|||
131687008|NCT00847145|474139651|FG004|Overall Study|Lost to Follow-up|4|||
131687009|NCT00847145|474139652|FG005|Overall Study|Lost to Follow-up|4|||
131687010|NCT00847145|474139653|FG006|Overall Study|Lost to Follow-up|8|||
131687011|NCT00847145|474139654|FG007|Overall Study|Lost to Follow-up|2|||
131687012|NCT00847145|474139647|FG000|Overall Study|Inappropriate enrollment|0|||
131687013|NCT00847145|474139648|FG001|Overall Study|Inappropriate enrollment|0|||
131687014|NCT00847145|474139649|FG002|Overall Study|Inappropriate enrollment|0|||
131687015|NCT00847145|474139650|FG003|Overall Study|Inappropriate enrollment|0|||
131687016|NCT00847145|474139651|FG004|Overall Study|Inappropriate enrollment|1|||
131687017|NCT00847145|474139652|FG005|Overall Study|Inappropriate enrollment|0|||
131687018|NCT00847145|474139653|FG006|Overall Study|Inappropriate enrollment|0|||
131773854|NCT00570492|474450998|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
131773855|NCT00570492|474450999|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
131773856|NCT00908375|474451000|FG000|Overall Study|Withdrawal by Subject|2|||
131773857|NCT00908375|474451001|FG001|Overall Study|Withdrawal by Subject|4|||
131773858|NCT00908375|474451000|FG000|Overall Study|Lost to Follow-up|8|||
131773859|NCT00908375|474451001|FG001|Overall Study|Lost to Follow-up|6|||
131773860|NCT00752206|474451003|FG000|Overall Study|Disease progression|8|||
131773861|NCT00752206|474451004|FG001|Overall Study|Disease progression|11|||
131773862|NCT00752206|474451003|FG000|Overall Study|Pregnancy|1|||
131773863|NCT00752206|474451004|FG001|Overall Study|Pregnancy|0|||
131773864|NCT00678652|474451005|FG000|Overall Study|Protocol Violation|2|||
131773865|NCT00678652|474451006|FG001|Overall Study|Protocol Violation|0|||
131773866|NCT00678652|474451007|FG002|Overall Study|Protocol Violation|0|||
131773867|NCT00678652|474451008|FG003|Overall Study|Protocol Violation|0|||
131773868|NCT00678652|474451005|FG000|Overall Study|Pregnancy|0|||
131773869|NCT00678652|474451006|FG001|Overall Study|Pregnancy|0|||
131773870|NCT00678652|474451007|FG002|Overall Study|Pregnancy|1|||
131773871|NCT00678652|474451008|FG003|Overall Study|Pregnancy|0|||
131773872|NCT00678652|474451005|FG000|Overall Study|Relocation|1|||
131773873|NCT00678652|474451006|FG001|Overall Study|Relocation|0|||
131773874|NCT00678652|474451007|FG002|Overall Study|Relocation|0|||
131773875|NCT00678652|474451008|FG003|Overall Study|Relocation|0|||
131773876|NCT03958045|474451011|FG000|Overall Study|Withdrawal by Subject|1|||
131773877|NCT02283411|474451012|FG000|Overall Study|Withdrawal by Subject|3|||
131773878|NCT02283411|474451012|FG000|Overall Study|Screen Failed|28|||
131773879|NCT01298323|474451014|FG000|Overall Study|Adverse Event|2|||
131773880|NCT01298323|474451015|FG001|Overall Study|Adverse Event|4|||
131773881|NCT01298323|474451014|FG000|Overall Study|Death|11|||
131773882|NCT01298323|474451015|FG001|Overall Study|Death|16|||
131773883|NCT01298323|474451014|FG000|Overall Study|Lost to Follow-up|1|||
131773884|NCT01298323|474451015|FG001|Overall Study|Lost to Follow-up|0|||
131773885|NCT01298323|474451014|FG000|Overall Study|Withdrawal by Subject|6|||
131773886|NCT01298323|474451015|FG001|Overall Study|Withdrawal by Subject|3|||
131773887|NCT01298323|474451014|FG000|Overall Study|Protocol Violation|1|||
131773888|NCT01298323|474451015|FG001|Overall Study|Protocol Violation|0|||
131773889|NCT01298323|474451014|FG000|Overall Study|Other|10|||
131773890|NCT01298323|474451015|FG001|Overall Study|Other|9|||
131773891|NCT01298323|474451014|FG000|Overall Study|Ongoing|55|||
131773892|NCT01298323|474451015|FG001|Overall Study|Ongoing|55|||
131773893|NCT01298323|474451014|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131773894|NCT01298323|474451015|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131773895|NCT02500732|474451017|FG000|Overall Study|Physician Decision|0|||
131773896|NCT02500732|474451018|FG001|Overall Study|Physician Decision|1|||
131773897|NCT04409262|474451019|FG000|Overall Study|Adverse Event|0|||
131773898|NCT04409262|474451020|FG001|Overall Study|Adverse Event|2|||
131773899|NCT04409262|474451019|FG000|Overall Study|Death|55|||
131773900|NCT04409262|474451020|FG001|Overall Study|Death|97|||
131773901|NCT04409262|474451019|FG000|Overall Study|Lost to Follow-up|12|||
131773902|NCT04409262|474451020|FG001|Overall Study|Lost to Follow-up|23|||
131773903|NCT04409262|474451019|FG000|Overall Study|Lack of Staff|0|||
131773904|NCT04409262|474451020|FG001|Overall Study|Lack of Staff|1|||
131773905|NCT04409262|474451019|FG000|Overall Study|Protocol Violation|3|||
131773906|NCT04409262|474451020|FG001|Overall Study|Protocol Violation|1|||
131773907|NCT04409262|474451019|FG000|Overall Study|Withdrawal by Subject|5|||
131773908|NCT04409262|474451020|FG001|Overall Study|Withdrawal by Subject|10|||
131773909|NCT03205605|474451021|FG000|Overall Study|Withdrawal by Subject|1|||
131773910|NCT02396849|474451022|FG000|Overall Study|Lost to Follow-up|1|||
131773911|NCT02396849|474451023|FG001|Overall Study|Lost to Follow-up|1|||
131773912|NCT02396849|474451022|FG000|Overall Study|Did not tolerate intervention|1|||
131773913|NCT02396849|474451023|FG001|Overall Study|Did not tolerate intervention|1|||
131773914|NCT03328325|474451028|FG000|Overall Study|Lost to Follow-up|4|||
131773915|NCT03328325|474451028|FG000|Overall Study|Physician Decision|1|||
131773916|NCT03328325|474451028|FG000|Overall Study|Withdrawal by Subject|3|||
131773917|NCT03328325|474451028|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
131773918|NCT04794491|474451029|FG000|Overall Study|Adverse Event|1|||
131773919|NCT04794491|474451029|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
131773920|NCT04794491|474451029|FG000|Overall Study|Noncompliance With Study Intervention|1|||
131773921|NCT04794491|474451029|FG000|Overall Study|Withdrawal by Subject|2|||
131773922|NCT01965600|474451030|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
131773923|NCT01965600|474451031|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
131773924|NCT01965600|474451032|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
131773925|NCT01965600|474451033|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
131773926|NCT01965600|474451030|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
131773927|NCT01965600|474451031|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
131773928|NCT01965600|474451032|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
131773929|NCT01965600|474451033|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
131687019|NCT00847145|474139654|FG007|Overall Study|Inappropriate enrollment|0|||
131687020|NCT00847145|474139647|FG000|Overall Study|Protocol Violation|0|||
131687021|NCT00847145|474139648|FG001|Overall Study|Protocol Violation|0|||
131687022|NCT00847145|474139649|FG002|Overall Study|Protocol Violation|3|||
131687023|NCT00847145|474139650|FG003|Overall Study|Protocol Violation|0|||
131687024|NCT00847145|474139651|FG004|Overall Study|Protocol Violation|1|||
131687025|NCT00847145|474139652|FG005|Overall Study|Protocol Violation|0|||
131687026|NCT00847145|474139653|FG006|Overall Study|Protocol Violation|0|||
131687027|NCT00847145|474139654|FG007|Overall Study|Protocol Violation|1|||
131687028|NCT02833974|474139656|FG000|Overall Study|Lost to Follow-up|1|||
131687029|NCT02833974|474139657|FG001|Overall Study|Lost to Follow-up|0|||
131687030|NCT02833974|474139656|FG000|Overall Study|Adverse Event|0|||
131687031|NCT02833974|474139657|FG001|Overall Study|Adverse Event|3|||
131687032|NCT00307151|474139659|FG000|Overall Study|Death|4|||
131687033|NCT00307151|474139660|FG001|Overall Study|Death|3|||
131687034|NCT00307151|474139661|FG002|Overall Study|Death|10|||
131687035|NCT00307151|474139662|FG003|Overall Study|Death|3|||
131687036|NCT00307151|474139659|FG000|Overall Study|Severe debilitation, unable to continue|1|||
131687037|NCT00307151|474139660|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131687038|NCT00307151|474139661|FG002|Overall Study|Severe debilitation, unable to continue|0|||
131687039|NCT00307151|474139662|FG003|Overall Study|Severe debilitation, unable to continue|0|||
131687040|NCT00307151|474139659|FG000|Overall Study|Subject unable to get to clinic|1|||
131687041|NCT00307151|474139660|FG001|Overall Study|Subject unable to get to clinic|0|||
131687042|NCT00307151|474139661|FG002|Overall Study|Subject unable to get to clinic|6|||
131687043|NCT00307151|474139662|FG003|Overall Study|Subject unable to get to clinic|2|||
131687044|NCT00307151|474139659|FG000|Overall Study|Withdrew consent|0|||
131687045|NCT00307151|474139660|FG001|Overall Study|Withdrew consent|1|||
131687046|NCT00307151|474139661|FG002|Overall Study|Withdrew consent|1|||
131687047|NCT00307151|474139662|FG003|Overall Study|Withdrew consent|3|||
131687048|NCT00307151|474139659|FG000|Overall Study|Not willing to adhere to study reqs|2|||
131687049|NCT00307151|474139660|FG001|Overall Study|Not willing to adhere to study reqs|0|||
131687050|NCT00307151|474139661|FG002|Overall Study|Not willing to adhere to study reqs|2|||
131687051|NCT00307151|474139662|FG003|Overall Study|Not willing to adhere to study reqs|2|||
131687052|NCT00307151|474139659|FG000|Overall Study|Clinic unable to contact subject|3|||
131687053|NCT00307151|474139660|FG001|Overall Study|Clinic unable to contact subject|3|||
131687054|NCT00307151|474139661|FG002|Overall Study|Clinic unable to contact subject|1|||
131687055|NCT00307151|474139662|FG003|Overall Study|Clinic unable to contact subject|1|||
131687056|NCT02966509|474139666|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
131687057|NCT02966509|474139667|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
131687058|NCT02966509|474139666|FG000|Baseline Satisfaction Survey|Death|0|||
131687059|NCT02966509|474139667|FG001|Baseline Satisfaction Survey|Death|1|||
131687060|NCT02966509|474139666|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
131687061|NCT02966509|474139667|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
131687062|NCT02966509|474139666|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
131687063|NCT02966509|474139667|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
131687064|NCT02966509|474139666|FG000|6 Month Satisfaction Decision Survey|Death|22|||
131687065|NCT02966509|474139667|FG001|6 Month Satisfaction Decision Survey|Death|25|||
131687066|NCT02966509|474139666|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
131687067|NCT02966509|474139667|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
131687068|NCT02966509|474139666|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
131687069|NCT02966509|474139667|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
131687070|NCT02966509|474139666|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
131687071|NCT02966509|474139667|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
131687072|NCT02966509|474139666|FG000|6 Month Satisfaction Survey|Death|36|||
131687073|NCT02966509|474139667|FG001|6 Month Satisfaction Survey|Death|33|||
131687074|NCT02966509|474139666|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
131687075|NCT02966509|474139667|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
131687076|NCT02966509|474139666|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
131687077|NCT02966509|474139667|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
131687078|NCT02966509|474139666|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
131687079|NCT02966509|474139667|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
131687080|NCT02966509|474139666|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
131687081|NCT02966509|474139667|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
131687082|NCT02966509|474139666|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
131687083|NCT02966509|474139667|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
131687084|NCT01717287|474139670|FG000|Overall Study|Lost to Follow-up|0|||
131687085|NCT01717287|474139671|FG001|Overall Study|Lost to Follow-up|2|||
131687086|NCT01717287|474139670|FG000|Overall Study|Protocol Violation|0|||
131687087|NCT01717287|474139671|FG001|Overall Study|Protocol Violation|1|||
131687088|NCT00404820|474139672|FG000|Overall Study|Adverse Event|4|||
131687089|NCT00404820|474139673|FG001|Overall Study|Adverse Event|16|||
131687090|NCT00404820|474139672|FG000|Overall Study|Withdrawal by Subject|5|||
131687091|NCT00404820|474139673|FG001|Overall Study|Withdrawal by Subject|3|||
131687092|NCT00404820|474139672|FG000|Overall Study|Lost to Follow-up|7|||
131687093|NCT00404820|474139673|FG001|Overall Study|Lost to Follow-up|3|||
131687094|NCT00404820|474139672|FG000|Overall Study|Administrative problems|2|||
131687095|NCT00404820|474139673|FG001|Overall Study|Administrative problems|0|||
131687096|NCT00404820|474139672|FG000|Overall Study|Death|1|||
131687097|NCT00404820|474139673|FG001|Overall Study|Death|0|||
131687098|NCT00404820|474139672|FG000|Overall Study|Other|0|||
131687099|NCT00404820|474139673|FG001|Overall Study|Other|2|||
131687100|NCT00516048|474139678|FG000|Overall Study|Death|0|||
131687101|NCT00516048|474139679|FG001|Overall Study|Death|0|||
131687102|NCT00516048|474139680|FG002|Overall Study|Death|1|||
131687103|NCT00516048|474139678|FG000|Overall Study|Subject Decision|0|||
131687104|NCT00516048|474139679|FG001|Overall Study|Subject Decision|2|||
131687105|NCT00516048|474139680|FG002|Overall Study|Subject Decision|0|||
131687106|NCT00054704|474139681|FG000|Overall Study|Lack of Efficacy|2|||
131687107|NCT00054704|474139682|FG001|Overall Study|Lack of Efficacy|3|||
131687108|NCT00054704|474139681|FG000|Overall Study|Adverse Event|3|||
131687109|NCT00054704|474139682|FG001|Overall Study|Adverse Event|1|||
131687110|NCT00054704|474139681|FG000|Overall Study|Lost to Follow-up|0|||
131687111|NCT00054704|474139682|FG001|Overall Study|Lost to Follow-up|1|||
131687112|NCT00362414|474139683|FG000|Overall Study|Death|2|||
131687113|NCT00362414|474139683|FG000|Overall Study|Adverse Event|1|||
131687114|NCT01469182|474139686|FG000|Overall Study|Adverse Event|21|||
131687115|NCT01469182|474139687|FG001|Overall Study|Adverse Event|3|||
131687116|NCT01469182|474139686|FG000|Overall Study|Lost to Follow-up|3|||
131687117|NCT01469182|474139687|FG001|Overall Study|Lost to Follow-up|0|||
131687118|NCT01469182|474139686|FG000|Overall Study|Withdrawal by Subject|4|||
131687119|NCT01469182|474139687|FG001|Overall Study|Withdrawal by Subject|1|||
131687120|NCT01469182|474139686|FG000|Overall Study|Protocol Violation|4|||
131687121|NCT01469182|474139687|FG001|Overall Study|Protocol Violation|2|||
131687122|NCT01469182|474139686|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
131687123|NCT01469182|474139687|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
131687124|NCT02053168|474139688|FG000|Overall Study|Withdrawal by Subject|1|||
131687125|NCT02053168|474139688|FG000|Overall Study|Physician Decision|1|||
131687126|NCT02053168|474139688|FG000|Overall Study|Lost to Follow-up|1|||
131687127|NCT02687542|474139689|FG000|Overall Study|Medication error without associated AEs|0|||
131687128|NCT02687542|474139690|FG001|Overall Study|Medication error without associated AEs|0|||
131687129|NCT02687542|474139691|FG002|Overall Study|Medication error without associated AEs|0|||
131687130|NCT02687542|474139692|FG003|Overall Study|Medication error without associated AEs|0|||
131687131|NCT02687542|474139693|FG004|Overall Study|Medication error without associated AEs|1|||
131687132|NCT02687542|474139689|FG000|Overall Study|Lost to Follow-up|0|||
131687133|NCT02687542|474139690|FG001|Overall Study|Lost to Follow-up|0|||
131687134|NCT02687542|474139691|FG002|Overall Study|Lost to Follow-up|0|||
131687135|NCT02687542|474139692|FG003|Overall Study|Lost to Follow-up|0|||
131687136|NCT02687542|474139693|FG004|Overall Study|Lost to Follow-up|1|||
131687137|NCT02687542|474139689|FG000|Overall Study|Protocol Violation|0|||
131687138|NCT02687542|474139690|FG001|Overall Study|Protocol Violation|1|||
131687139|NCT02687542|474139691|FG002|Overall Study|Protocol Violation|0|||
131687140|NCT02687542|474139692|FG003|Overall Study|Protocol Violation|0|||
131687141|NCT02687542|474139693|FG004|Overall Study|Protocol Violation|0|||
131687142|NCT02687542|474139689|FG000|Overall Study|Other|5|||
131687143|NCT02687542|474139690|FG001|Overall Study|Other|9|||
131687144|NCT02687542|474139691|FG002|Overall Study|Other|10|||
131687145|NCT02687542|474139692|FG003|Overall Study|Other|6|||
131773930|NCT01965600|474451030|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
131773931|NCT01965600|474451031|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
131773932|NCT01965600|474451032|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
131773933|NCT01965600|474451033|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
131773934|NCT01965600|474451030|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
131773935|NCT01965600|474451031|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
131773936|NCT01965600|474451032|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
131773937|NCT01965600|474451033|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
131773938|NCT01965600|474451030|FG000|Second Intervention|Study terminated by Sponsor|0|||
131773939|NCT01965600|474451031|FG001|Second Intervention|Study terminated by Sponsor|0|||
131773940|NCT01965600|474451032|FG002|Second Intervention|Study terminated by Sponsor|2|||
131773941|NCT01965600|474451033|FG003|Second Intervention|Study terminated by Sponsor|2|||
131773942|NCT01990339|474451036|FG000|Overall Study|Data Not Available|49|||
131773943|NCT01990339|474451036|FG000|Overall Study|Voluntary Withdrawal|1402|||
131773944|NCT01990339|474451036|FG000|Overall Study|Lost to Follow-up|861|||
131773945|NCT01038609|474451037|FG000|Overall Study|Adverse Event|0|||
131773946|NCT01038609|474451038|FG001|Overall Study|Adverse Event|0|||
131773947|NCT01038609|474451039|FG002|Overall Study|Adverse Event|1|||
131773948|NCT01038609|474451040|FG003|Overall Study|Adverse Event|0|||
131773949|NCT01038609|474451041|FG004|Overall Study|Adverse Event|0|||
131773950|NCT01038609|474451037|FG000|Overall Study|Dosing Error|0|||
131773951|NCT01038609|474451038|FG001|Overall Study|Dosing Error|0|||
131773952|NCT01038609|474451039|FG002|Overall Study|Dosing Error|0|||
131773953|NCT01038609|474451040|FG003|Overall Study|Dosing Error|1|||
131773954|NCT01038609|474451041|FG004|Overall Study|Dosing Error|1|||
131773955|NCT01038609|474451037|FG000|Overall Study|Death in the Family|1|||
131773956|NCT01038609|474451038|FG001|Overall Study|Death in the Family|0|||
131773957|NCT01038609|474451039|FG002|Overall Study|Death in the Family|0|||
131773958|NCT01038609|474451040|FG003|Overall Study|Death in the Family|0|||
131773959|NCT01038609|474451041|FG004|Overall Study|Death in the Family|0|||
131773960|NCT01038609|474451037|FG000|Overall Study|Refusal of Blood Draws|0|||
131773961|NCT01038609|474451038|FG001|Overall Study|Refusal of Blood Draws|1|||
131773962|NCT01038609|474451039|FG002|Overall Study|Refusal of Blood Draws|0|||
131773963|NCT01038609|474451040|FG003|Overall Study|Refusal of Blood Draws|0|||
131773964|NCT01038609|474451041|FG004|Overall Study|Refusal of Blood Draws|0|||
131773965|NCT03289676|474451044|FG000|Overall Study|Withdrawal by Subject|2|||
131773966|NCT03289676|474451045|FG001|Overall Study|Withdrawal by Subject|0|||
131773967|NCT03289676|474451044|FG000|Overall Study|Protocol Violation|2|||
131773968|NCT03289676|474451045|FG001|Overall Study|Protocol Violation|0|||
131773969|NCT03289676|474451044|FG000|Overall Study|Lost to Follow-up|0|||
131773970|NCT03289676|474451045|FG001|Overall Study|Lost to Follow-up|1|||
131773971|NCT01314261|474451046|FG000|Overall Study|Adverse Event|1|||
131773972|NCT01314261|474451047|FG001|Overall Study|Adverse Event|0|||
131773973|NCT01314261|474451048|FG002|Overall Study|Adverse Event|0|||
131773974|NCT01314261|474451049|FG003|Overall Study|Adverse Event|0|||
131773975|NCT01314261|474451046|FG000|Overall Study|Withdrawal by Subject|0|||
131773976|NCT01314261|474451047|FG001|Overall Study|Withdrawal by Subject|3|||
131773977|NCT01314261|474451048|FG002|Overall Study|Withdrawal by Subject|1|||
131773978|NCT01314261|474451049|FG003|Overall Study|Withdrawal by Subject|0|||
131773979|NCT01314261|474451046|FG000|Overall Study|Lost to Follow-up|1|||
131773980|NCT01314261|474451047|FG001|Overall Study|Lost to Follow-up|0|||
131773981|NCT01314261|474451048|FG002|Overall Study|Lost to Follow-up|2|||
131773982|NCT01314261|474451049|FG003|Overall Study|Lost to Follow-up|2|||
131773983|NCT01314261|474451046|FG000|Overall Study|Virologic Failure|0|||
131773984|NCT01314261|474451047|FG001|Overall Study|Virologic Failure|1|||
131773985|NCT01314261|474451048|FG002|Overall Study|Virologic Failure|0|||
131773986|NCT01314261|474451049|FG003|Overall Study|Virologic Failure|1|||
131773987|NCT04524507|474451050|FG000|Overall Study|Lost to Follow-up|2|||
131773988|NCT04524507|474451051|FG001|Overall Study|Lost to Follow-up|4|||
131773989|NCT04524507|474451050|FG000|Overall Study|Withdrawal by Subject|2|||
131773990|NCT04524507|474451051|FG001|Overall Study|Withdrawal by Subject|9|||
131773991|NCT04524507|474451050|FG000|Overall Study|Death|2|||
131773992|NCT04524507|474451051|FG001|Overall Study|Death|10|||
131773993|NCT00412360|474451052|FG000|Overall Study|Lost to Follow-up|0|||
131773994|NCT00412360|474451053|FG001|Overall Study|Lost to Follow-up|1|||
131773995|NCT00412360|474451052|FG000|Overall Study|Not Transplanted|1|||
131773996|NCT00412360|474451053|FG001|Overall Study|Not Transplanted|2|||
131773997|NCT02711306|474451054|FG000|Overall Study|Withdrawal by Subject|2|||
131773998|NCT02711306|474451055|FG001|Overall Study|Withdrawal by Subject|2|||
131773999|NCT02569996|474451056|FG000|Overall Study|Adverse Event|6|||
131774000|NCT02569996|474451056|FG000|Overall Study|Physician Decision|3|||
131774001|NCT02569996|474451056|FG000|Overall Study|Progression of the disease|18|||
131774002|NCT02569996|474451056|FG000|Overall Study|New anti-lymphoma treatment|1|||
131774003|NCT02569996|474451056|FG000|Overall Study|Non-compliance|9|||
131774004|NCT02569996|474451056|FG000|Overall Study|Withdrawal by Subject|5|||
131774005|NCT02569996|474451056|FG000|Overall Study|Lost to Follow-up|5|||
131774006|NCT02569996|474451056|FG000|Overall Study|Complete remission|7|||
131774007|NCT02569996|474451056|FG000|Overall Study|Unknown reason|1|||
131774008|NCT01383317|474451057|FG000|Overall Study|Lost to Follow-up|2|||
131774009|NCT01383317|474451058|FG001|Overall Study|Lost to Follow-up|1|||
131774010|NCT01383317|474451057|FG000|Overall Study|Death|1|||
131774011|NCT01383317|474451058|FG001|Overall Study|Death|0|||
131774012|NCT01383317|474451057|FG000|Overall Study|Adverse Event|0|||
131774013|NCT01383317|474451058|FG001|Overall Study|Adverse Event|1|||
131774014|NCT01397409|474451060|FG000|Stage 2|Adverse Event|0|||
131774015|NCT01397409|474451061|FG001|Stage 2|Adverse Event|0|||
131774016|NCT01397409|474451062|FG002|Stage 2|Adverse Event|0|||
131774017|NCT01397409|474451063|FG003|Stage 2|Adverse Event|0|||
131774018|NCT01397409|474451064|FG004|Stage 2|Adverse Event|6|||
131774019|NCT01397409|474451065|FG005|Stage 2|Adverse Event|3|||
131774020|NCT01397409|474451066|FG006|Stage 2|Adverse Event|0|||
131774021|NCT01397409|474451067|FG007|Stage 2|Adverse Event|0|||
131774022|NCT01397409|474451068|FG008|Stage 2|Adverse Event|0|||
131774023|NCT01397409|474451069|FG009|Stage 2|Adverse Event|0|||
131774024|NCT01397409|474451060|FG000|Stage 2|Personal Reasons|0|||
131774025|NCT01397409|474451061|FG001|Stage 2|Personal Reasons|0|||
131774026|NCT01397409|474451062|FG002|Stage 2|Personal Reasons|0|||
131774027|NCT01397409|474451063|FG003|Stage 2|Personal Reasons|0|||
131774028|NCT01397409|474451064|FG004|Stage 2|Personal Reasons|1|||
131774029|NCT01397409|474451065|FG005|Stage 2|Personal Reasons|0|||
131774030|NCT01397409|474451066|FG006|Stage 2|Personal Reasons|0|||
131774031|NCT01397409|474451067|FG007|Stage 2|Personal Reasons|0|||
131774032|NCT01397409|474451068|FG008|Stage 2|Personal Reasons|0|||
131774033|NCT01397409|474451069|FG009|Stage 2|Personal Reasons|0|||
131774034|NCT01397409|474451060|FG000|Stage 2|Other Miscellaneous Reasons|0|||
131774035|NCT01397409|474451061|FG001|Stage 2|Other Miscellaneous Reasons|0|||
131774036|NCT01397409|474451062|FG002|Stage 2|Other Miscellaneous Reasons|0|||
131774037|NCT01397409|474451063|FG003|Stage 2|Other Miscellaneous Reasons|0|||
131774038|NCT01397409|474451064|FG004|Stage 2|Other Miscellaneous Reasons|1|||
131774039|NCT01397409|474451065|FG005|Stage 2|Other Miscellaneous Reasons|1|||
131774040|NCT01397409|474451066|FG006|Stage 2|Other Miscellaneous Reasons|0|||
131774041|NCT01397409|474451067|FG007|Stage 2|Other Miscellaneous Reasons|0|||
131774042|NCT01397409|474451068|FG008|Stage 2|Other Miscellaneous Reasons|0|||
131774043|NCT01397409|474451069|FG009|Stage 2|Other Miscellaneous Reasons|0|||
131774044|NCT01397409|474451060|FG000|Stage 3|Adverse Event|0|||
131774045|NCT01397409|474451061|FG001|Stage 3|Adverse Event|0|||
131774046|NCT01397409|474451062|FG002|Stage 3|Adverse Event|0|||
131774047|NCT01397409|474451063|FG003|Stage 3|Adverse Event|0|||
131774048|NCT01397409|474451064|FG004|Stage 3|Adverse Event|0|||
131774049|NCT01397409|474451065|FG005|Stage 3|Adverse Event|0|||
131774050|NCT01397409|474451066|FG006|Stage 3|Adverse Event|0|||
131774051|NCT01397409|474451067|FG007|Stage 3|Adverse Event|1|||
131774052|NCT01397409|474451068|FG008|Stage 3|Adverse Event|0|||
131774053|NCT01397409|474451069|FG009|Stage 3|Adverse Event|0|||
131774054|NCT01397409|474451060|FG000|Stage 3|Other Miscellaneous Reasons|0|||
131774055|NCT01397409|474451061|FG001|Stage 3|Other Miscellaneous Reasons|0|||
131774056|NCT01397409|474451062|FG002|Stage 3|Other Miscellaneous Reasons|0|||
131774057|NCT01397409|474451063|FG003|Stage 3|Other Miscellaneous Reasons|0|||
131774058|NCT01397409|474451064|FG004|Stage 3|Other Miscellaneous Reasons|0|||
131774059|NCT01397409|474451065|FG005|Stage 3|Other Miscellaneous Reasons|0|||
131774060|NCT01397409|474451066|FG006|Stage 3|Other Miscellaneous Reasons|0|||
131774061|NCT01397409|474451067|FG007|Stage 3|Other Miscellaneous Reasons|1|||
131774062|NCT01397409|474451068|FG008|Stage 3|Other Miscellaneous Reasons|0|||
131774063|NCT01397409|474451069|FG009|Stage 3|Other Miscellaneous Reasons|0|||
131774064|NCT01207427|474451070|FG000|Double-blind Treatment Period|Adverse Event|0|||
131774065|NCT01207427|474451071|FG001|Double-blind Treatment Period|Adverse Event|1|||
131774066|NCT01207427|474451072|FG002|Double-blind Treatment Period|Adverse Event|0|||
131774067|NCT01207427|474451070|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131898524|NCT00320788|474914096|FG000|Overall Study|Physician Decision|1|||
131774068|NCT01207427|474451071|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131774069|NCT01207427|474451072|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
131774070|NCT01207427|474451070|FG000|Double-blind Treatment Period|Protocol Violation|2|||
131774071|NCT01207427|474451071|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131774072|NCT01207427|474451072|FG002|Double-blind Treatment Period|Protocol Violation|1|||
131774073|NCT01207427|474451070|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131774074|NCT01207427|474451071|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131774075|NCT01207427|474451072|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131774076|NCT00422227|474451073|FG000|Overall Study|Adverse Event|3|||
131774077|NCT00422227|474451074|FG001|Overall Study|Adverse Event|8|||
131774078|NCT00422227|474451073|FG000|Overall Study|Lost to Follow-up|1|||
131774079|NCT00422227|474451074|FG001|Overall Study|Lost to Follow-up|3|||
131774080|NCT00422227|474451073|FG000|Overall Study|Withdrawal by Subject|0|||
131774081|NCT00422227|474451074|FG001|Overall Study|Withdrawal by Subject|4|||
131774082|NCT01740297|474452534|FG000|Overall Study|Withdrawal by Subject|4|||
131774083|NCT01740297|474452535|FG001|Overall Study|Withdrawal by Subject|16|||
131774084|NCT01740297|474452536|FG002|Overall Study|Withdrawal by Subject|17|||
131774085|NCT01740297|474452534|FG000|Overall Study|Death|8|||
131774086|NCT01740297|474452535|FG001|Overall Study|Death|46|||
131774087|NCT01740297|474452536|FG002|Overall Study|Death|40|||
131774088|NCT01740297|474452534|FG000|Overall Study|Lost to Follow-up|1|||
131774089|NCT01740297|474452535|FG001|Overall Study|Lost to Follow-up|2|||
131774090|NCT01740297|474452536|FG002|Overall Study|Lost to Follow-up|4|||
131774091|NCT01798056|474452538|FG000|Overall Study|Serious Adverse Event|13|||
131774092|NCT01798056|474452539|FG001|Overall Study|Serious Adverse Event|12|||
131774093|NCT01798056|474452538|FG000|Overall Study|Withdrawal by Subject|12|||
131774094|NCT01798056|474452539|FG001|Overall Study|Withdrawal by Subject|9|||
131774095|NCT01798056|474452538|FG000|Overall Study|Migrated/moved from study area|1|||
131774096|NCT01798056|474452539|FG001|Overall Study|Migrated/moved from study area|1|||
131774097|NCT01798056|474452538|FG000|Overall Study|Lost to Follow-up|1|||
131774098|NCT01798056|474452539|FG001|Overall Study|Lost to Follow-up|1|||
131774099|NCT01798056|474452538|FG000|Overall Study|Other|0|||
131774100|NCT01798056|474452539|FG001|Overall Study|Other|2|||
131774101|NCT02842736|474452544|FG000|Overall Study|Lost to Follow-up|13|||
131774102|NCT02842736|474452544|FG000|Overall Study|Intervention for menstrual bleeding|17|||
131774103|NCT02842736|474452544|FG000|Overall Study|Withdrawal by Subject|4|||
131774104|NCT02842736|474452544|FG000|Overall Study|Pregnancy|3|||
131774105|NCT02842736|474452544|FG000|Overall Study|Hysterectomy for fibroids|2|||
131774106|NCT02842736|474452544|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
131774107|NCT02842736|474452544|FG000|Overall Study|IUD: Mirena|1|||
131774108|NCT03323034|474452547|FG000|Overall Study|Lack of Efficacy|5|||
131774109|NCT03323034|474452548|FG001|Overall Study|Lack of Efficacy|5|||
131774110|NCT03323034|474452549|FG002|Overall Study|Lack of Efficacy|6|||
131774111|NCT03323034|474452550|FG003|Overall Study|Lack of Efficacy|5|||
131774112|NCT03323034|474452551|FG004|Overall Study|Lack of Efficacy|5|||
131774113|NCT03323034|474452547|FG000|Overall Study|Physician Decision|0|||
131774114|NCT03323034|474452548|FG001|Overall Study|Physician Decision|0|||
131774115|NCT03323034|474452549|FG002|Overall Study|Physician Decision|0|||
131774116|NCT03323034|474452550|FG003|Overall Study|Physician Decision|0|||
131774117|NCT03323034|474452551|FG004|Overall Study|Physician Decision|1|||
131774118|NCT03323034|474452547|FG000|Overall Study|Withdrawal by Subject|1|||
131774119|NCT03323034|474452548|FG001|Overall Study|Withdrawal by Subject|1|||
131774120|NCT03323034|474452549|FG002|Overall Study|Withdrawal by Subject|0|||
131774121|NCT03323034|474452550|FG003|Overall Study|Withdrawal by Subject|1|||
131774122|NCT03323034|474452551|FG004|Overall Study|Withdrawal by Subject|0|||
131774123|NCT02815540|474452554|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
131774124|NCT02222246|474452555|FG000|Overall Study|No Emergency Department Visits|27|||
131774125|NCT02222246|474452556|FG001|Overall Study|No Emergency Department Visits|26|||
131774126|NCT02222246|474452555|FG000|Overall Study|Physician Decision|0|||
131774127|NCT02222246|474452556|FG001|Overall Study|Physician Decision|1|||
131774128|NCT04887922|474452558|FG000|1st Randomization|Decided not to have surgery|0|||
131774129|NCT04887922|474452559|FG001|1st Randomization|Decided not to have surgery|1|||
131774130|NCT04887922|474452560|FG002|1st Randomization|Decided not to have surgery|0|||
131435994|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
131687146|NCT02687542|474139693|FG004|Overall Study|Other|5|||
131687147|NCT02687542|474139689|FG000|Overall Study|Adverse Event|3|||
131687148|NCT02687542|474139690|FG001|Overall Study|Adverse Event|1|||
131687149|NCT02687542|474139691|FG002|Overall Study|Adverse Event|3|||
131687150|NCT02687542|474139692|FG003|Overall Study|Adverse Event|2|||
131687151|NCT02687542|474139693|FG004|Overall Study|Adverse Event|9|||
131687152|NCT02687542|474139689|FG000|Overall Study|Withdrawal by Subject|0|||
131774131|NCT04887922|474452561|FG003|1st Randomization|Decided not to have surgery|0|||
131774132|NCT04887922|474452562|FG004|1st Randomization|Decided not to have surgery|0|||
131774133|NCT00718809|474452564|FG000|Overall Study|Disease progression|9|||
131774134|NCT00718809|474452565|FG001|Overall Study|Disease progression|7|||
131774135|NCT00718809|474452564|FG000|Overall Study|Adverse Event|1|||
131774136|NCT00718809|474452565|FG001|Overall Study|Adverse Event|1|||
131774137|NCT00718809|474452564|FG000|Overall Study|Withdrawal by Subject|0|||
131774138|NCT00718809|474452565|FG001|Overall Study|Withdrawal by Subject|1|||
131774139|NCT00718809|474452564|FG000|Overall Study|Lost to Follow-up|1|||
131774140|NCT00718809|474452565|FG001|Overall Study|Lost to Follow-up|0|||
131774141|NCT00718809|474452564|FG000|Overall Study|Noncompliance|1|||
131774142|NCT00718809|474452565|FG001|Overall Study|Noncompliance|0|||
131774143|NCT00463385|474452566|FG000|Overall Study|Other|4|||
131774144|NCT00463385|474452567|FG001|Overall Study|Other|3|||
131774145|NCT00463385|474452568|FG002|Overall Study|Other|6|||
131774146|NCT00463385|474452569|FG003|Overall Study|Other|4|||
131774147|NCT00463385|474452566|FG000|Overall Study|Adverse Event|5|||
131774148|NCT00463385|474452567|FG001|Overall Study|Adverse Event|8|||
131774149|NCT00463385|474452568|FG002|Overall Study|Adverse Event|4|||
131774150|NCT00463385|474452569|FG003|Overall Study|Adverse Event|2|||
131774151|NCT00463385|474452566|FG000|Overall Study|Lack of Efficacy|6|||
131774152|NCT00463385|474452567|FG001|Overall Study|Lack of Efficacy|6|||
131774153|NCT00463385|474452568|FG002|Overall Study|Lack of Efficacy|7|||
131774154|NCT00463385|474452569|FG003|Overall Study|Lack of Efficacy|9|||
131774155|NCT00463385|474452566|FG000|Overall Study|Withdrawal by Subject|3|||
131774156|NCT00463385|474452567|FG001|Overall Study|Withdrawal by Subject|3|||
131774157|NCT00463385|474452568|FG002|Overall Study|Withdrawal by Subject|3|||
131774158|NCT00463385|474452569|FG003|Overall Study|Withdrawal by Subject|4|||
131774159|NCT00463385|474452566|FG000|Overall Study|Lost to Follow-up|0|||
131774160|NCT00463385|474452567|FG001|Overall Study|Lost to Follow-up|0|||
131774161|NCT00463385|474452568|FG002|Overall Study|Lost to Follow-up|0|||
131774162|NCT00463385|474452569|FG003|Overall Study|Lost to Follow-up|1|||
131774163|NCT00463385|474452566|FG000|Overall Study|Death|2|||
131774164|NCT00463385|474452567|FG001|Overall Study|Death|1|||
131774165|NCT00463385|474452568|FG002|Overall Study|Death|2|||
131774166|NCT00463385|474452569|FG003|Overall Study|Death|0|||
131774167|NCT00463385|474452566|FG000|Overall Study|Missing|2|||
131774168|NCT00463385|474452567|FG001|Overall Study|Missing|0|||
131774169|NCT00463385|474452568|FG002|Overall Study|Missing|0|||
131774170|NCT00463385|474452569|FG003|Overall Study|Missing|2|||
131774171|NCT00463385|474452566|FG000|Overall Study|1 participant received commercial drug|0|||
131774172|NCT00463385|474452567|FG001|Overall Study|1 participant received commercial drug|1|||
131774173|NCT00463385|474452568|FG002|Overall Study|1 participant received commercial drug|0|||
131774174|NCT00463385|474452569|FG003|Overall Study|1 participant received commercial drug|0|||
131774175|NCT00449761|474452570|FG000|Overall Study|Disease progression|12|||
131774176|NCT00449761|474452570|FG000|Overall Study|Death|5|||
131774177|NCT00449761|474452570|FG000|Overall Study|New cancer therapy|1|||
131774178|NCT00344968|474452573|FG000|Overall Study|Adverse Event|5|||
131774179|NCT00344968|474452574|FG001|Overall Study|Adverse Event|4|||
131774180|NCT00344968|474452575|FG002|Overall Study|Adverse Event|15|||
131774181|NCT00344968|474452573|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131774182|NCT00344968|474452574|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131774183|NCT00344968|474452575|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131774184|NCT00344968|474452573|FG000|Overall Study|Protocol Violation|2|||
131774185|NCT00344968|474452574|FG001|Overall Study|Protocol Violation|2|||
131774186|NCT00344968|474452575|FG002|Overall Study|Protocol Violation|5|||
131774187|NCT00344968|474452573|FG000|Overall Study|Withdrawal by Subject|14|||
131774188|NCT00344968|474452574|FG001|Overall Study|Withdrawal by Subject|31|||
131774189|NCT00344968|474452575|FG002|Overall Study|Withdrawal by Subject|27|||
131774190|NCT00344968|474452573|FG000|Overall Study|Lost to Follow-up|24|||
131774191|NCT00344968|474452574|FG001|Overall Study|Lost to Follow-up|37|||
131774192|NCT00344968|474452575|FG002|Overall Study|Lost to Follow-up|37|||
131774193|NCT00344968|474452573|FG000|Overall Study|Death|11|||
131774194|NCT00344968|474452574|FG001|Overall Study|Death|27|||
131774195|NCT00344968|474452575|FG002|Overall Study|Death|31|||
131774196|NCT00344968|474452573|FG000|Overall Study|Other|0|||
131774197|NCT00344968|474452574|FG001|Overall Study|Other|1|||
131774198|NCT00344968|474452575|FG002|Overall Study|Other|0|||
131774199|NCT03735680|474452576|FG000|Overall Study|Withdrawal by Subject|0|||
131774200|NCT03735680|474452577|FG001|Overall Study|Withdrawal by Subject|1|||
131774201|NCT03735680|474452578|FG002|Overall Study|Withdrawal by Subject|0|||
131774202|NCT03735680|474452579|FG003|Overall Study|Withdrawal by Subject|0|||
131774203|NCT03735680|474452580|FG004|Overall Study|Withdrawal by Subject|0|||
131774204|NCT03735680|474452581|FG005|Overall Study|Withdrawal by Subject|1|||
131774205|NCT03735680|474452576|FG000|Overall Study|Patient unable or unwilling to continue|0|||
131774206|NCT03735680|474452577|FG001|Overall Study|Patient unable or unwilling to continue|0|||
131774207|NCT03735680|474452578|FG002|Overall Study|Patient unable or unwilling to continue|1|||
131774208|NCT03735680|474452579|FG003|Overall Study|Patient unable or unwilling to continue|0|||
131774209|NCT03735680|474452580|FG004|Overall Study|Patient unable or unwilling to continue|0|||
131774210|NCT03735680|474452581|FG005|Overall Study|Patient unable or unwilling to continue|0|||
131774211|NCT01422876|474452582|FG000|Week 24|Lost to Follow-up|1|||
131774212|NCT01422876|474452583|FG001|Week 24|Lost to Follow-up|1|||
131774213|NCT01422876|474452584|FG002|Week 24|Lost to Follow-up|2|||
131774214|NCT01422876|474452585|FG003|Week 24|Lost to Follow-up|4|||
131774215|NCT01422876|474452586|FG004|Week 24|Lost to Follow-up|2|||
131774216|NCT01422876|474452587|FG005|Week 24|Lost to Follow-up|0|||
131774217|NCT01422876|474452588|FG006|Week 24|Lost to Follow-up|1|||
131774218|NCT01422876|474452589|FG007|Week 24|Lost to Follow-up|3|||
131774219|NCT01422876|474452590|FG008|Week 24|Lost to Follow-up|3|||
131774220|NCT01422876|474452591|FG009|Week 24|Lost to Follow-up|4|||
131774221|NCT01422876|474452582|FG000|Week 24|Consent withdrawn|5|||
131774222|NCT01422876|474452583|FG001|Week 24|Consent withdrawn|1|||
131774223|NCT01422876|474452584|FG002|Week 24|Consent withdrawn|3|||
131774224|NCT01422876|474452585|FG003|Week 24|Consent withdrawn|4|||
131687153|NCT02687542|474139690|FG001|Overall Study|Withdrawal by Subject|1|||
131687154|NCT02687542|474139691|FG002|Overall Study|Withdrawal by Subject|1|||
131687155|NCT02687542|474139692|FG003|Overall Study|Withdrawal by Subject|2|||
131687156|NCT02687542|474139693|FG004|Overall Study|Withdrawal by Subject|4|||
131687157|NCT01838616|474139694|FG000|Titration Period|Adverse Event|18|||
131687158|NCT01838616|474139695|FG001|Titration Period|Adverse Event|48|||
131687159|NCT01838616|474139694|FG000|Titration Period|Lack of Efficacy|5|||
131687160|NCT01838616|474139695|FG001|Titration Period|Lack of Efficacy|12|||
131687161|NCT01838616|474139694|FG000|Titration Period|Withdrawal by Subject|5|||
131687162|NCT01838616|474139695|FG001|Titration Period|Withdrawal by Subject|5|||
131687163|NCT01838616|474139694|FG000|Titration Period|Technical problems|1|||
131687164|NCT01838616|474139695|FG001|Titration Period|Technical problems|0|||
131687165|NCT01838616|474139694|FG000|Titration Period|Other|1|||
131687166|NCT01838616|474139695|FG001|Titration Period|Other|0|||
131687167|NCT01838616|474139694|FG000|Titration Period|Protocol Violation|0|||
131687168|NCT01838616|474139695|FG001|Titration Period|Protocol Violation|1|||
131687169|NCT01838616|474139694|FG000|Continuation Period|Lack of Efficacy|3|||
131687170|NCT01838616|474139695|FG001|Continuation Period|Lack of Efficacy|5|||
131687171|NCT01838616|474139694|FG000|Continuation Period|Adverse Event|8|||
131687172|NCT01838616|474139695|FG001|Continuation Period|Adverse Event|4|||
131687173|NCT01838616|474139694|FG000|Continuation Period|Protocol Violation|2|||
131687174|NCT01838616|474139695|FG001|Continuation Period|Protocol Violation|0|||
131687175|NCT01838616|474139694|FG000|Continuation Period|Lost to Follow-up|1|||
131687176|NCT01838616|474139695|FG001|Continuation Period|Lost to Follow-up|0|||
131687177|NCT01838616|474139694|FG000|Continuation Period|Withdrawal by Subject|0|||
131687178|NCT01838616|474139695|FG001|Continuation Period|Withdrawal by Subject|4|||
131687179|NCT01838616|474139694|FG000|Continuation Period|Technical problems|0|||
131687180|NCT01838616|474139695|FG001|Continuation Period|Technical problems|1|||
131687181|NCT01838616|474139694|FG000|Pick-up Arm|Lack of Efficacy|4|||
131687182|NCT01838616|474139695|FG001|Pick-up Arm|Lack of Efficacy|0|||
131687183|NCT01838616|474139694|FG000|Pick-up Arm|Adverse Event|9|||
131687184|NCT01838616|474139695|FG001|Pick-up Arm|Adverse Event|0|||
131687185|NCT01838616|474139694|FG000|Pick-up Arm|Withdrawal by Subject|1|||
131687186|NCT01838616|474139695|FG001|Pick-up Arm|Withdrawal by Subject|0|||
131687187|NCT01838616|474139694|FG000|Pick-up Arm|Technical problems|1|||
131687188|NCT01838616|474139695|FG001|Pick-up Arm|Technical problems|0|||
131687189|NCT01566773|474139698|FG000|Overall Study|Protocol specified criteria|4|||
131687190|NCT01566773|474139698|FG000|Overall Study|Protocol Violation|4|||
131687191|NCT01566773|474139698|FG000|Overall Study|Withdrawal by Subject|9|||
131687192|NCT01566773|474139698|FG000|Overall Study|Administrative reason|1|||
131687193|NCT01566773|474139698|FG000|Overall Study|Adverse Event|10|||
131687194|NCT01566773|474139698|FG000|Overall Study|Physician Decision|2|||
131687195|NCT00833053|474139699|FG000|Overall Study|Adverse Event|4|||
131687196|NCT00833053|474139700|FG001|Overall Study|Adverse Event|0|||
131687197|NCT00833053|474139699|FG000|Overall Study|Treatment Failure|3|||
131687198|NCT00833053|474139700|FG001|Overall Study|Treatment Failure|1|||
131687199|NCT00833053|474139699|FG000|Overall Study|Withdrawal by Subject|0|||
131687200|NCT00833053|474139700|FG001|Overall Study|Withdrawal by Subject|1|||
131774225|NCT01422876|474452586|FG004|Week 24|Consent withdrawn|5|||
131774226|NCT01422876|474452587|FG005|Week 24|Consent withdrawn|6|||
131774227|NCT01422876|474452588|FG006|Week 24|Consent withdrawn|5|||
131687201|NCT00833053|474139699|FG000|Overall Study|Protocol Violation|2|||
131687202|NCT00833053|474139700|FG001|Overall Study|Protocol Violation|1|||
131687203|NCT02865018|474139702|FG000|Overall Study|Withdrawal by Subject|1|||
131687204|NCT02181816|474139703|FG000|Overall Study|Case Report Forms Uncollected|38|||
131687205|NCT02181816|474139703|FG000|Overall Study|Protocol Deviation|21|||
131687206|NCT01365039|474139704|FG000|Overall Study|Study related symptoms and complaints|1|||
131687207|NCT01365039|474139705|FG001|Overall Study|Study related symptoms and complaints|0|||
131687208|NCT03807349|474139708|FG000|Overall Study|Early Study Termination|9|||
131687209|NCT01360554|474139709|FG000|Overall Study|Death|359|||
131687210|NCT01360554|474139710|FG001|Overall Study|Death|371|||
131774228|NCT01422876|474452589|FG007|Week 24|Consent withdrawn|4|||
131774229|NCT01422876|474452590|FG008|Week 24|Consent withdrawn|3|||
131687211|NCT01360554|474139709|FG000|Overall Study|Lost to Follow-up|4|||
131687212|NCT01360554|474139710|FG001|Overall Study|Lost to Follow-up|4|||
131687213|NCT01360554|474139709|FG000|Overall Study|Withdrawal by Subject|23|||
131687214|NCT01360554|474139710|FG001|Overall Study|Withdrawal by Subject|24|||
131687215|NCT01360554|474139709|FG000|Overall Study|Study terminated by sponsor|49|||
131687216|NCT01360554|474139710|FG001|Overall Study|Study terminated by sponsor|37|||
131687217|NCT01360554|474139709|FG000|Overall Study|Other, not specified|1|||
131687218|NCT01360554|474139710|FG001|Overall Study|Other, not specified|0|||
131687219|NCT01360554|474139709|FG000|Overall Study|Randomized but not treated.|3|||
131687220|NCT01360554|474139710|FG001|Overall Study|Randomized but not treated.|3|||
131687221|NCT00187096|474139712|FG000|Overall Study|unacceptable toxicity|0|||
131687222|NCT00187096|474139713|FG001|Overall Study|unacceptable toxicity|0|||
131687223|NCT00187096|474139714|FG002|Overall Study|unacceptable toxicity|1|||
131687224|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
131687225|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
131687226|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
131687227|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
131687228|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
131687229|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
131687230|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
131687231|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
131687232|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
131687233|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
131687234|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
131687235|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
131687236|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
131687237|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
131687238|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
131687239|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
131687240|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
131687241|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
131687242|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
131687243|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
131687244|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
131687245|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
131687246|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
131687247|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
131687248|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
131687249|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131687250|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131687251|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
131687252|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131687253|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131687254|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687255|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131687256|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131687257|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131687258|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687259|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131687260|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
131687261|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
131687262|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
131687263|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
131687264|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
131687265|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
131687266|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
131687267|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
131687268|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131687269|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131687270|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131687271|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131687272|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
131687273|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131687274|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131898525|NCT00320788|474914097|FG001|Overall Study|Physician Decision|1|||
131687275|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131687276|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131774230|NCT01422876|474452591|FG009|Week 24|Consent withdrawn|6|||
131774231|NCT01422876|474452582|FG000|Week 24|Death|0|||
131774232|NCT01422876|474452583|FG001|Week 24|Death|1|||
131774233|NCT01422876|474452584|FG002|Week 24|Death|0|||
131774234|NCT01422876|474452585|FG003|Week 24|Death|0|||
131774235|NCT01422876|474452586|FG004|Week 24|Death|0|||
131774236|NCT01422876|474452587|FG005|Week 24|Death|0|||
131774237|NCT01422876|474452588|FG006|Week 24|Death|0|||
131774238|NCT01422876|474452589|FG007|Week 24|Death|0|||
131774239|NCT01422876|474452590|FG008|Week 24|Death|0|||
131774240|NCT01422876|474452591|FG009|Week 24|Death|0|||
131774241|NCT01422876|474452582|FG000|Week 52|Lost to Follow-up|3|||
131774242|NCT01422876|474452583|FG001|Week 52|Lost to Follow-up|5|||
131774243|NCT01422876|474452584|FG002|Week 52|Lost to Follow-up|7|||
131774244|NCT01422876|474452585|FG003|Week 52|Lost to Follow-up|5|||
131774245|NCT01422876|474452586|FG004|Week 52|Lost to Follow-up|8|||
131774246|NCT01422876|474452587|FG005|Week 52|Lost to Follow-up|5|||
131774247|NCT01422876|474452588|FG006|Week 52|Lost to Follow-up|5|||
131774248|NCT01422876|474452589|FG007|Week 52|Lost to Follow-up|8|||
131774249|NCT01422876|474452590|FG008|Week 52|Lost to Follow-up|7|||
131774250|NCT01422876|474452591|FG009|Week 52|Lost to Follow-up|8|||
131774251|NCT01422876|474452582|FG000|Week 52|Consent withdrawn|9|||
131774252|NCT01422876|474452583|FG001|Week 52|Consent withdrawn|4|||
131774253|NCT01422876|474452584|FG002|Week 52|Consent withdrawn|6|||
131774254|NCT01422876|474452585|FG003|Week 52|Consent withdrawn|12|||
131774255|NCT01422876|474452586|FG004|Week 52|Consent withdrawn|7|||
131774256|NCT01422876|474452587|FG005|Week 52|Consent withdrawn|12|||
131774257|NCT01422876|474452588|FG006|Week 52|Consent withdrawn|10|||
131774258|NCT01422876|474452589|FG007|Week 52|Consent withdrawn|12|||
131774259|NCT01422876|474452590|FG008|Week 52|Consent withdrawn|13|||
131774260|NCT01422876|474452591|FG009|Week 52|Consent withdrawn|9|||
131774261|NCT01422876|474452582|FG000|Week 52|Death|0|||
131774262|NCT01422876|474452583|FG001|Week 52|Death|1|||
131774263|NCT01422876|474452584|FG002|Week 52|Death|0|||
131774264|NCT01422876|474452585|FG003|Week 52|Death|1|||
131774265|NCT01422876|474452586|FG004|Week 52|Death|0|||
131774266|NCT01422876|474452587|FG005|Week 52|Death|0|||
131774267|NCT01422876|474452588|FG006|Week 52|Death|1|||
131774268|NCT01422876|474452589|FG007|Week 52|Death|3|||
131774269|NCT01422876|474452590|FG008|Week 52|Death|1|||
131774270|NCT01422876|474452591|FG009|Week 52|Death|0|||
131774271|NCT00447265|474452594|FG000|Overall Study|Physician Decision|1|||
131774272|NCT00447265|474452595|FG001|Overall Study|Physician Decision|0|||
131774273|NCT02204449|474452598|FG000|Overall Study|Lost to Follow-up|7|||
131774274|NCT02204449|474452599|FG001|Overall Study|Lost to Follow-up|9|||
131774275|NCT02204449|474452598|FG000|Overall Study|Death|0|||
131774276|NCT02204449|474452599|FG001|Overall Study|Death|1|||
131774277|NCT02204449|474452598|FG000|Overall Study|Withdrawal by Subject|0|||
131774278|NCT02204449|474452599|FG001|Overall Study|Withdrawal by Subject|1|||
131774279|NCT00503035|474452600|FG000|Overall Study|Lost to Follow-up|2|||
131774280|NCT00503035|474452600|FG000|Overall Study|Physician Decision|3|||
131774281|NCT00503035|474452600|FG000|Overall Study|Ineligible|15|||
131774282|NCT05028816|474452603|FG000|Overall Study|Lost to Follow-up|5|||
131774283|NCT05028816|474452604|FG001|Overall Study|Lost to Follow-up|3|||
131774284|NCT05028816|474452603|FG000|Overall Study|Withdrawal by Subject|4|||
131774285|NCT05028816|474452604|FG001|Overall Study|Withdrawal by Subject|1|||
131774286|NCT05028816|474452603|FG000|Overall Study|Physician Decision|1|||
131774287|NCT05028816|474452604|FG001|Overall Study|Physician Decision|0|||
131774288|NCT05064436|474452605|FG000|Overall Study|Other Reasons|1|||
131774289|NCT05064436|474452606|FG001|Overall Study|Other Reasons|0|||
131774290|NCT01711736|474452608|FG000|Overall Study|Lost to Follow-up|4|||
131774291|NCT01711736|474452609|FG001|Overall Study|Lost to Follow-up|1|||
131774292|NCT01711736|474452608|FG000|Overall Study|Withdrawal by Subject|6|||
131774293|NCT01711736|474452609|FG001|Overall Study|Withdrawal by Subject|6|||
131774294|NCT01711736|474452608|FG000|Overall Study|Migrated/moved from study area|2|||
131774295|NCT01711736|474452609|FG001|Overall Study|Migrated/moved from study area|1|||
131774296|NCT01342445|474452610|FG000|Overall Study|Experienced side effects|0|||
131774297|NCT01342445|474452611|FG001|Overall Study|Experienced side effects|2|||
131774298|NCT05299359|474452612|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
131774299|NCT05299359|474452613|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
131774300|NCT05299359|474452612|FG000|Main Part: Day 1 up to Day 366|Other|2|||
131774301|NCT05299359|474452613|FG001|Main Part: Day 1 up to Day 366|Other|0|||
131774302|NCT05299359|474452612|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
131774303|NCT05299359|474452613|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
131774304|NCT05299359|474452612|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
131774305|NCT05299359|474452613|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
131774306|NCT05299359|474452612|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
131774307|NCT05299359|474452613|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
131774308|NCT05299359|474452612|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
131774309|NCT05299359|474452613|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
131774310|NCT05299359|474452612|FG000|Extension Part: Day 1 to Day 366|Other|0|||
131774311|NCT05299359|474452613|FG001|Extension Part: Day 1 to Day 366|Other|1|||
131774312|NCT03868410|474452616|FG000|Overall Study|Physician Decision|0|||
131774313|NCT03868410|474452617|FG001|Overall Study|Physician Decision|1|||
131774314|NCT01059175|474452618|FG000|Overall Study|Death|17|||
131774315|NCT01059175|474452619|FG001|Overall Study|Death|17|||
131774316|NCT01059175|474452618|FG000|Overall Study|Adverse Event|4|||
131774317|NCT01059175|474452619|FG001|Overall Study|Adverse Event|2|||
131774318|NCT01059175|474452618|FG000|Overall Study|Lost to Follow-up|0|||
131774319|NCT01059175|474452619|FG001|Overall Study|Lost to Follow-up|1|||
131774320|NCT04113746|474452620|FG000|Overall Study|Lost to Follow-up|4|||
131774321|NCT04113746|474452621|FG001|Overall Study|Lost to Follow-up|4|||
131774322|NCT02594384|474452622|FG000|Overall Study|Disease Progression|3|||
131774323|NCT02594384|474452623|FG001|Overall Study|Disease Progression|7|||
131774324|NCT02594384|474452624|FG002|Overall Study|Disease Progression|0|||
131774325|NCT02594384|474452625|FG003|Overall Study|Disease Progression|2|||
131774326|NCT02594384|474452626|FG004|Overall Study|Disease Progression|2|||
131774327|NCT02594384|474452627|FG005|Overall Study|Disease Progression|12|||
131774328|NCT02594384|474452628|FG006|Overall Study|Disease Progression|5|||
131774329|NCT02594384|474452629|FG007|Overall Study|Disease Progression|5|||
131774330|NCT02594384|474452622|FG000|Overall Study|Adverse Event|0|||
131774331|NCT02594384|474452623|FG001|Overall Study|Adverse Event|1|||
131774332|NCT02594384|474452624|FG002|Overall Study|Adverse Event|4|||
131774333|NCT02594384|474452625|FG003|Overall Study|Adverse Event|1|||
131774334|NCT02594384|474452626|FG004|Overall Study|Adverse Event|0|||
131774335|NCT02594384|474452627|FG005|Overall Study|Adverse Event|6|||
131774336|NCT02594384|474452628|FG006|Overall Study|Adverse Event|1|||
131774337|NCT02594384|474452629|FG007|Overall Study|Adverse Event|1|||
131774338|NCT02594384|474452622|FG000|Overall Study|Withdrawal by Subject|0|||
131774339|NCT02594384|474452623|FG001|Overall Study|Withdrawal by Subject|0|||
131774340|NCT02594384|474452624|FG002|Overall Study|Withdrawal by Subject|0|||
131774341|NCT02594384|474452625|FG003|Overall Study|Withdrawal by Subject|1|||
131774342|NCT02594384|474452626|FG004|Overall Study|Withdrawal by Subject|0|||
131774343|NCT02594384|474452627|FG005|Overall Study|Withdrawal by Subject|0|||
131774344|NCT02594384|474452628|FG006|Overall Study|Withdrawal by Subject|0|||
131774345|NCT02594384|474452629|FG007|Overall Study|Withdrawal by Subject|1|||
131774346|NCT02594384|474452622|FG000|Overall Study|Physician Decision|0|||
131774347|NCT02594384|474452623|FG001|Overall Study|Physician Decision|0|||
131774348|NCT02594384|474452624|FG002|Overall Study|Physician Decision|0|||
131774349|NCT02594384|474452625|FG003|Overall Study|Physician Decision|0|||
131774350|NCT02594384|474452626|FG004|Overall Study|Physician Decision|0|||
131774351|NCT02594384|474452627|FG005|Overall Study|Physician Decision|1|||
131774352|NCT02594384|474452628|FG006|Overall Study|Physician Decision|2|||
131774353|NCT02594384|474452629|FG007|Overall Study|Physician Decision|0|||
131774354|NCT02594384|474452622|FG000|Overall Study|Progressive Leukocytosis|0|||
131774355|NCT02594384|474452623|FG001|Overall Study|Progressive Leukocytosis|0|||
131774356|NCT02594384|474452624|FG002|Overall Study|Progressive Leukocytosis|1|||
131774357|NCT02594384|474452625|FG003|Overall Study|Progressive Leukocytosis|0|||
131774358|NCT02594384|474452626|FG004|Overall Study|Progressive Leukocytosis|0|||
131774359|NCT02594384|474452627|FG005|Overall Study|Progressive Leukocytosis|0|||
131774360|NCT02594384|474452628|FG006|Overall Study|Progressive Leukocytosis|0|||
131774361|NCT02594384|474452629|FG007|Overall Study|Progressive Leukocytosis|0|||
131774362|NCT02594384|474452622|FG000|Overall Study|Lack of Efficacy|0|||
131774363|NCT02594384|474452623|FG001|Overall Study|Lack of Efficacy|0|||
131774364|NCT02594384|474452624|FG002|Overall Study|Lack of Efficacy|0|||
131774365|NCT02594384|474452625|FG003|Overall Study|Lack of Efficacy|0|||
131774366|NCT02594384|474452626|FG004|Overall Study|Lack of Efficacy|1|||
131774367|NCT02594384|474452627|FG005|Overall Study|Lack of Efficacy|0|||
131774368|NCT02594384|474452628|FG006|Overall Study|Lack of Efficacy|0|||
131774369|NCT02594384|474452629|FG007|Overall Study|Lack of Efficacy|0|||
131774370|NCT02594384|474452622|FG000|Overall Study|Substantial noncompliance|0|||
131774371|NCT02594384|474452623|FG001|Overall Study|Substantial noncompliance|0|||
131774372|NCT02594384|474452624|FG002|Overall Study|Substantial noncompliance|0|||
131774373|NCT02594384|474452625|FG003|Overall Study|Substantial noncompliance|0|||
131774374|NCT02594384|474452626|FG004|Overall Study|Substantial noncompliance|0|||
131774375|NCT02594384|474452627|FG005|Overall Study|Substantial noncompliance|0|||
131774376|NCT02594384|474452628|FG006|Overall Study|Substantial noncompliance|1|||
131774377|NCT02594384|474452629|FG007|Overall Study|Substantial noncompliance|0|||
131774378|NCT04964960|474452632|FG000|Overall Study|Withdrawal by Subject|1|||
131774379|NCT04246593|474452633|FG000|Overall Study|Withdrawal by Subject|14|||
131774380|NCT04246593|474452634|FG001|Overall Study|Withdrawal by Subject|13|||
131774381|NCT04246593|474452633|FG000|Overall Study|Lost to Follow-up|124|||
131774382|NCT04246593|474452634|FG001|Overall Study|Lost to Follow-up|71|||
131774383|NCT04246593|474452633|FG000|Overall Study|Moved out of area/became ineligible|3|||
131774384|NCT04246593|474452634|FG001|Overall Study|Moved out of area/became ineligible|1|||
131774385|NCT04246593|474452633|FG000|Overall Study|Reason unknown|4|||
131774386|NCT04246593|474452634|FG001|Overall Study|Reason unknown|2|||
131774387|NCT02369874|474452640|FG000|Overall Study|Lost to Follow-up|2|||
131774388|NCT02369874|474452641|FG001|Overall Study|Lost to Follow-up|2|||
131774389|NCT02369874|474452642|FG002|Overall Study|Lost to Follow-up|2|||
131774390|NCT02369874|474452640|FG000|Overall Study|Withdrawal by Subject|7|||
131774391|NCT02369874|474452641|FG001|Overall Study|Withdrawal by Subject|9|||
131774392|NCT02369874|474452642|FG002|Overall Study|Withdrawal by Subject|27|||
131774393|NCT02369874|474452640|FG000|Overall Study|Miscellaneous|1|||
131774394|NCT02369874|474452641|FG001|Overall Study|Miscellaneous|1|||
131774395|NCT02369874|474452642|FG002|Overall Study|Miscellaneous|0|||
131774396|NCT02369874|474452640|FG000|Overall Study|On Treatment/Off Study|34|||
131774397|NCT02369874|474452641|FG001|Overall Study|On Treatment/Off Study|45|||
131774398|NCT02369874|474452642|FG002|Overall Study|On Treatment/Off Study|32|||
131774399|NCT01012765|474452647|FG000|Treatment Period 1|Adverse Event|1|||
131774400|NCT01012765|474452648|FG001|Treatment Period 1|Adverse Event|0|||
131774401|NCT01012765|474452649|FG002|Treatment Period 1|Adverse Event|1|||
131774402|NCT01012765|474452650|FG003|Treatment Period 1|Adverse Event|0|||
131774403|NCT01012765|474452651|FG004|Treatment Period 1|Adverse Event|0|||
131774404|NCT01012765|474452652|FG005|Treatment Period 1|Adverse Event|0|||
131774405|NCT01012765|474452647|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131774406|NCT01012765|474452648|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131774407|NCT01012765|474452649|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131774408|NCT01012765|474452650|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131774409|NCT01012765|474452651|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131774410|NCT01012765|474452652|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131774411|NCT01012765|474452647|FG000|Treatment Period 1|Administrative problems|0|||
131774412|NCT01012765|474452648|FG001|Treatment Period 1|Administrative problems|0|||
131774413|NCT01012765|474452649|FG002|Treatment Period 1|Administrative problems|1|||
131774414|NCT01012765|474452650|FG003|Treatment Period 1|Administrative problems|1|||
131774415|NCT01012765|474452651|FG004|Treatment Period 1|Administrative problems|1|||
131774416|NCT01012765|474452652|FG005|Treatment Period 1|Administrative problems|0|||
131774417|NCT01012765|474452647|FG000|Treatment Period 1|Protocol Violation|0|||
131774418|NCT01012765|474452648|FG001|Treatment Period 1|Protocol Violation|0|||
131774419|NCT01012765|474452649|FG002|Treatment Period 1|Protocol Violation|0|||
131774420|NCT01012765|474452650|FG003|Treatment Period 1|Protocol Violation|2|||
131774421|NCT01012765|474452651|FG004|Treatment Period 1|Protocol Violation|1|||
131774422|NCT01012765|474452652|FG005|Treatment Period 1|Protocol Violation|0|||
131774423|NCT01012765|474452647|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131774424|NCT01012765|474452648|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131774425|NCT01012765|474452649|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131774426|NCT01012765|474452650|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131774427|NCT01012765|474452651|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
131774428|NCT01012765|474452652|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131774429|NCT01012765|474452647|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131774430|NCT01012765|474452648|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131774431|NCT01012765|474452649|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131774432|NCT01012765|474452650|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131774433|NCT01012765|474452651|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131774434|NCT01012765|474452652|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131774435|NCT01012765|474452647|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
131774436|NCT01012765|474452648|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
131774437|NCT01012765|474452649|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
131774438|NCT01012765|474452650|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
131774439|NCT01012765|474452651|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
131774440|NCT01012765|474452652|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
131774441|NCT01012765|474452647|FG000|Treatment Period 2|Adverse Event|0|||
131774442|NCT01012765|474452648|FG001|Treatment Period 2|Adverse Event|1|||
131774443|NCT01012765|474452649|FG002|Treatment Period 2|Adverse Event|1|||
131774444|NCT01012765|474452650|FG003|Treatment Period 2|Adverse Event|0|||
131774445|NCT01012765|474452651|FG004|Treatment Period 2|Adverse Event|0|||
131774446|NCT01012765|474452652|FG005|Treatment Period 2|Adverse Event|0|||
131774447|NCT01012765|474452647|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131774448|NCT01012765|474452648|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
131774449|NCT01012765|474452649|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
131774450|NCT01012765|474452650|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131774451|NCT01012765|474452651|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131774452|NCT01012765|474452652|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131774453|NCT00596466|474452654|FG000|Overall Study|Lack of Efficacy|5|||
131774454|NCT00596466|474452654|FG000|Overall Study|Adverse Event|4|||
131774455|NCT00596466|474452654|FG000|Overall Study|Withdrawal by Subject|2|||
131687277|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131687278|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131687279|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
131687280|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131687281|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131687282|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131687283|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131687284|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131687285|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
131687286|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131687287|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131687288|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131687289|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131687290|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131687291|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
131687292|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131687293|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131687294|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131687295|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131687296|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131687297|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
131687298|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131687299|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131687300|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131687301|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131687302|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131687303|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131687304|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131687305|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
131687306|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131687307|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131687308|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131687309|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131687310|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131687311|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
131687312|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131687313|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131687314|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131687315|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131687316|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131687317|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131687318|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
131687319|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131687320|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131687321|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131687322|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131687323|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131687324|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
131687325|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131719401|NCT03230097|474253285|FG001|Overall Study|outcome event|1|||
131774456|NCT00596466|474452654|FG000|Overall Study|Protocol Violation|2|||
131774457|NCT00596466|474452654|FG000|Overall Study|Unpecified|2|||
131774458|NCT00596466|474452654|FG000|Overall Study|Enrolled, not treated|2|||
131774459|NCT00145795|474452655|FG000|Overall Study|Adverse Event|1|||
131774460|NCT00145795|474452656|FG001|Overall Study|Adverse Event|0|||
131774461|NCT01683565|474452657|FG000|Overall Study|Lost to Follow-up|2|||
131774462|NCT01683565|474452658|FG001|Overall Study|Lost to Follow-up|0|||
131774463|NCT01683565|474452657|FG000|Overall Study|Discontinued Intervention|1|||
131774464|NCT01683565|474452658|FG001|Overall Study|Discontinued Intervention|1|||
131774465|NCT00931515|474452667|FG000|Overall Study|Lost to Follow-up|2|||
131774466|NCT00931515|474452668|FG001|Overall Study|Lost to Follow-up|5|||
131774467|NCT03759340|474452669|FG000|Overall Study|Adverse Event|2|||
131774468|NCT03759340|474452669|FG000|Overall Study|Lost to Follow-up|1|||
131774469|NCT03759340|474452669|FG000|Overall Study|Withdrawal by Subject|15|||
131687326|NCT00111800|474139719|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131687327|NCT00111800|474139720|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131687328|NCT00111800|474139721|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131687329|NCT00111800|474139722|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131687330|NCT00111800|474139723|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131687331|NCT00111800|474139724|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
131687332|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
131687333|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
131687334|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
131687335|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
131687336|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
131687337|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
131687338|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131687339|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
131687340|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
131687341|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131687342|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131687343|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131687344|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
131687345|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
131687346|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
131687347|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
131687348|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
131687349|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
131687350|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131687351|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
131687352|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131687353|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131687354|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
131687355|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131687356|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687357|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687358|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131687359|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687360|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687361|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131687362|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131687363|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
131687364|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131687365|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131687366|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131687367|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131687368|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131687369|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131687370|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
131687371|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131687372|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131774470|NCT03759340|474452669|FG000|Overall Study|Study Terminated by Sponsor|38|||
131774471|NCT02950831|474452670|FG000|Overall Study|Lost to Follow-up|1|||
131774472|NCT02950831|474452670|FG000|Overall Study|Withdrawal by Subject|3|||
131774473|NCT02950831|474452670|FG000|Overall Study|stimulation trail failure|5|||
131774474|NCT00945815|474452671|FG000|Overall Study|Death|3|||
131774475|NCT00945815|474452671|FG000|Overall Study|Not protocol specified|1|||
131774476|NCT00945815|474452671|FG000|Overall Study|Ineligible|3|||
131774477|NCT00945815|474452671|FG000|Overall Study|Did not begin protocol therapy|1|||
131774478|NCT03418727|474452677|FG000|Overall Study|Adverse Event|1|||
131774479|NCT03418727|474452678|FG001|Overall Study|Adverse Event|2|||
131774480|NCT03418727|474452679|FG002|Overall Study|Adverse Event|0|||
131774481|NCT03418727|474452677|FG000|Overall Study|Withdrawal by Subject|0|||
131774482|NCT03418727|474452678|FG001|Overall Study|Withdrawal by Subject|0|||
131774483|NCT03418727|474452679|FG002|Overall Study|Withdrawal by Subject|2|||
131774484|NCT00686894|474452681|FG000|Overall Study|Relapse|2|||
131774485|NCT00686894|474452681|FG000|Overall Study|Protocol Violation|4|||
131774486|NCT01790633|474452682|FG000|Overall Study|Protocol Violation|1|||
131774487|NCT01790633|474452683|FG001|Overall Study|Protocol Violation|2|||
131774488|NCT01790633|474452682|FG000|Overall Study|Did not have serology performed|47|||
131774489|NCT01790633|474452683|FG001|Overall Study|Did not have serology performed|0|||
131774490|NCT01790633|474452682|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
131774491|NCT01790633|474452683|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
131774492|NCT00157157|474452684|FG000|Overall Study|Withdrawal by Subject|6|||
131774493|NCT00157157|474452684|FG000|Overall Study|Physician Decision|1|||
131774494|NCT00157157|474452684|FG000|Overall Study|Lost to Follow-up|1|||
131774495|NCT00157157|474452684|FG000|Overall Study|Enrolled in another study|1|||
131774496|NCT00157157|474452684|FG000|Overall Study|Met exclusion criteria|1|||
131774497|NCT00157157|474452684|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
131774498|NCT02260804|474452691|FG000|Induction Study Period|Protocol Violation|2|||
131774499|NCT02260804|474452692|FG001|Induction Study Period|Protocol Violation|0|||
131774500|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
131774501|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
131774502|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
131774503|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
131774504|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
131774505|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
131774506|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
131774507|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
131774508|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
131774509|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
131774510|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
131774511|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
131774512|NCT02260804|474452691|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
131774513|NCT02260804|474452692|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
131774514|NCT02260804|474452691|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
131774515|NCT02260804|474452692|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
131774516|NCT02260804|474452691|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
131774517|NCT02260804|474452692|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
131774518|NCT02260804|474452691|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
131774519|NCT02260804|474452692|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
131774520|NCT01302366|474454457|FG000|Overall Study|patient choice or noncompliance|5|||
131774521|NCT00934661|474454458|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
131774522|NCT00934661|474454459|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
131774523|NCT00467051|474454460|FG000|Overall Study|Adverse Event|2|||
131774524|NCT00761462|474454464|FG000|Treatment|Subjects never received study medication|23|||
131774525|NCT00761462|474454465|FG001|Treatment|Subjects never received study medication|12|||
131774526|NCT00761462|474454464|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
131774527|NCT00761462|474454465|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
131774528|NCT00761462|474454464|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
131774529|NCT00761462|474454465|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
131774530|NCT00761462|474454464|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
131774531|NCT00761462|474454465|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
131774532|NCT01479777|474454466|FG000|Overall Study|Physician Decision|2|||
131774533|NCT01013207|474454470|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
131774534|NCT01541644|474454475|FG000|Overall Study|Withdrawal by Subject|3|||
131774535|NCT02389621|474454476|FG000|Treatment Period|Withdrawal by Subject|1|||
131774536|NCT02389621|474454477|FG001|Treatment Period|Withdrawal by Subject|1|||
131774537|NCT02389621|474454476|FG000|Posttreatment Period|Adverse Event|3|||
131774538|NCT02389621|474454477|FG001|Posttreatment Period|Adverse Event|1|||
131774539|NCT02389621|474454476|FG000|Posttreatment Period|Withdrawal by Subject|3|||
131898526|NCT00320788|474914098|FG002|Overall Study|Physician Decision|0|||
131687373|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131687374|NCT00111800|474139719|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131687375|NCT00111800|474139720|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131687376|NCT00111800|474139721|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
131687377|NCT00111800|474139722|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131687378|NCT00111800|474139723|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131687379|NCT00111800|474139724|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131687380|NCT00253643|474139726|FG000|Overall Study|Withdrawal by Subject|0|||
131687381|NCT00253643|474139727|FG001|Overall Study|Withdrawal by Subject|0|||
131687382|NCT00253643|474139728|FG002|Overall Study|Withdrawal by Subject|1|||
131687383|NCT00253643|474139729|FG003|Overall Study|Withdrawal by Subject|1|||
131687384|NCT00253643|474139726|FG000|Overall Study|Non-Compliance|0|||
131687385|NCT00253643|474139727|FG001|Overall Study|Non-Compliance|0|||
131687386|NCT00253643|474139728|FG002|Overall Study|Non-Compliance|0|||
131687387|NCT00253643|474139729|FG003|Overall Study|Non-Compliance|2|||
131687388|NCT01549275|474139730|FG000|Overall Study|Lost to Follow-up|1|||
131687389|NCT01549275|474139731|FG001|Overall Study|Lost to Follow-up|0|||
131687390|NCT00365456|474139734|FG000|Trial Period I (12 Months)|Adverse Event|84|||
131687391|NCT00365456|474139735|FG001|Trial Period I (12 Months)|Adverse Event|0|||
131687392|NCT00365456|474139734|FG000|Trial Period I (12 Months)|Non-compliance|3|||
131687393|NCT00365456|474139735|FG001|Trial Period I (12 Months)|Non-compliance|0|||
131687394|NCT00365456|474139734|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
131687395|NCT00365456|474139735|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
131687396|NCT00365456|474139734|FG000|Trial Period I (12 Months)|Other|11|||
131687397|NCT00365456|474139735|FG001|Trial Period I (12 Months)|Other|0|||
131687398|NCT00365456|474139734|FG000|Trial Period II (12 Months)|Adverse Event|0|||
131687399|NCT00365456|474139735|FG001|Trial Period II (12 Months)|Adverse Event|6|||
131687400|NCT00365456|474139734|FG000|Trial Period II (12 Months)|Non-compliance|0|||
131687401|NCT00365456|474139735|FG001|Trial Period II (12 Months)|Non-compliance|2|||
131687402|NCT00365456|474139734|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
131687403|NCT00365456|474139735|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
131687404|NCT00365456|474139734|FG000|Trial Period II (12 Months)|Other|0|||
131687405|NCT00365456|474139735|FG001|Trial Period II (12 Months)|Other|1|||
131687406|NCT00365456|474139734|FG000|Trial Period III (12 Months)|Adverse Event|13|||
131687407|NCT00365456|474139735|FG001|Trial Period III (12 Months)|Adverse Event|3|||
131687408|NCT00365456|474139734|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
131687409|NCT00365456|474139735|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
131687410|NCT00365456|474139734|FG000|Trial Period III (12 Months)|Other|1|||
131687411|NCT00365456|474139735|FG001|Trial Period III (12 Months)|Other|1|||
131687412|NCT03668600|474139736|FG000|Overall Study|Study Terminated by the Sponsor|157|||
131687413|NCT03668600|474139736|FG000|Overall Study|Protocol Violation|1|||
131687414|NCT03668600|474139736|FG000|Overall Study|Pregnancy|1|||
131687415|NCT03668600|474139736|FG000|Overall Study|Lost to Follow-up|7|||
131687416|NCT03668600|474139736|FG000|Overall Study|Withdrawal by Subject|56|||
131687417|NCT03668600|474139736|FG000|Overall Study|Lack of Efficacy|7|||
131687418|NCT03668600|474139736|FG000|Overall Study|Adverse Event|1|||
131687419|NCT02159729|474139737|FG000|Overall Study|Adverse Event|0|||
131687420|NCT02159729|474139738|FG001|Overall Study|Adverse Event|1|||
131687421|NCT02159729|474139737|FG000|Overall Study|Subject's Request|13|||
131687422|NCT02159729|474139738|FG001|Overall Study|Subject's Request|10|||
131687423|NCT02159729|474139737|FG000|Overall Study|Lost to Follow-up|24|||
131687424|NCT02159729|474139738|FG001|Overall Study|Lost to Follow-up|9|||
131687425|NCT02159729|474139737|FG000|Overall Study|Non compliance|2|||
131687426|NCT02159729|474139738|FG001|Overall Study|Non compliance|0|||
131687427|NCT02159729|474139737|FG000|Overall Study|Other Unspecified|3|||
131687428|NCT02159729|474139738|FG001|Overall Study|Other Unspecified|1|||
131687429|NCT02636582|474139739|FG000|Overall Study|Surgical Pathology|1|||
131687430|NCT02636582|474139740|FG001|Overall Study|Surgical Pathology|0|||
131687431|NCT01131676|474139741|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
131687432|NCT01131676|474139742|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
131687433|NCT01131676|474139743|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
131687434|NCT01131676|474139741|FG000|Discontinuation From Treatment|Not treated|4|||
131687435|NCT01131676|474139742|FG001|Discontinuation From Treatment|Not treated|2|||
131687436|NCT01131676|474139743|FG002|Discontinuation From Treatment|Not treated|2|||
131687437|NCT01131676|474139741|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
131687438|NCT01131676|474139742|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
131687439|NCT01131676|474139743|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
131687440|NCT01131676|474139741|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
131687441|NCT01131676|474139742|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
131687442|NCT01131676|474139743|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
131687443|NCT01131676|474139741|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
131687444|NCT01131676|474139742|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
131687445|NCT01131676|474139743|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
131687446|NCT01131676|474139741|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
131687447|NCT01131676|474139742|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
131687448|NCT01131676|474139743|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
131687449|NCT01131676|474139741|FG000|Discontinuation From Treatment|Other than those specified|162|||
131687450|NCT01131676|474139742|FG001|Discontinuation From Treatment|Other than those specified|142|||
131687451|NCT01131676|474139743|FG002|Discontinuation From Treatment|Other than those specified|125|||
131687452|NCT01131676|474139741|FG000|Discontinuation From Treatment|Adverse Event|303|||
131687453|NCT01131676|474139742|FG001|Discontinuation From Treatment|Adverse Event|267|||
131687454|NCT01131676|474139743|FG002|Discontinuation From Treatment|Adverse Event|273|||
131687455|NCT01131676|474139741|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
131687456|NCT01131676|474139742|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
131687457|NCT01131676|474139743|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
131687458|NCT01131676|474139741|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
131687459|NCT01131676|474139742|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
131687460|NCT01131676|474139743|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
131687461|NCT01131676|474139741|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
131687462|NCT01131676|474139742|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
131687463|NCT01131676|474139743|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
131687464|NCT01131676|474139741|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
131687465|NCT01131676|474139742|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
131687466|NCT01131676|474139743|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
131687467|NCT01131676|474139741|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
131774540|NCT02389621|474454477|FG001|Posttreatment Period|Withdrawal by Subject|2|||
131774541|NCT02389621|474454476|FG000|Posttreatment Period|Lost to Follow-up|1|||
131774542|NCT02389621|474454477|FG001|Posttreatment Period|Lost to Follow-up|1|||
131774543|NCT02389621|474454476|FG000|Posttreatment Period|Other - Miscellaneous|2|||
131774544|NCT02389621|474454477|FG001|Posttreatment Period|Other - Miscellaneous|0|||
131774545|NCT00953017|474454490|FG000|Overall Study|DId not show up for colonoscopy|4|||
131774546|NCT00953017|474454491|FG001|Overall Study|DId not show up for colonoscopy|4|||
131774547|NCT00953017|474454492|FG002|Overall Study|DId not show up for colonoscopy|5|||
131774548|NCT00953017|474454493|FG003|Overall Study|DId not show up for colonoscopy|4|||
131774549|NCT00953017|474454490|FG000|Overall Study|Incomplete data|1|||
131774550|NCT00953017|474454491|FG001|Overall Study|Incomplete data|1|||
131774551|NCT00953017|474454492|FG002|Overall Study|Incomplete data|0|||
131774552|NCT00953017|474454493|FG003|Overall Study|Incomplete data|0|||
131774553|NCT00953017|474454490|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
131774554|NCT00953017|474454491|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
131774555|NCT00953017|474454492|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
131774556|NCT00953017|474454493|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
131774557|NCT00953017|474454490|FG000|Overall Study|Brown stool prior to procedure|0|||
131774558|NCT00953017|474454491|FG001|Overall Study|Brown stool prior to procedure|0|||
131774559|NCT00953017|474454492|FG002|Overall Study|Brown stool prior to procedure|1|||
131774560|NCT00953017|474454493|FG003|Overall Study|Brown stool prior to procedure|0|||
131774561|NCT00536991|474454505|FG000|Overall Study|Withdrawal by Subject|10|||
131774562|NCT00536991|474454505|FG000|Overall Study|Physician Decision|1|||
131774563|NCT00536991|474454505|FG000|Overall Study|patient ineligible|2|||
131774564|NCT00054639|474454506|FG000|Overall Study|Lack of Efficacy|1|||
131774565|NCT00054639|474454506|FG000|Overall Study|Physician Decision|1|||
131774566|NCT01600755|474454507|FG000|Overall Study|Withdrawal by Subject|6|||
131774567|NCT04621227|474454516|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
131774568|NCT04621227|474454516|FG000|Period 3 (29 Days)|Adverse Event|1|||
131774569|NCT04621227|474454516|FG000|Period 8 (2 Days)|Adverse Event|1|||
131774570|NCT01548573|474454517|FG000|Overall Study|Death|3|||
131774571|NCT01548573|474454517|FG000|Overall Study|Withdrawal by Subject|2|||
131774572|NCT01366846|474454520|FG000|Overall Study|Withdrawal by Subject|2|||
131774573|NCT01366846|474454521|FG001|Overall Study|Withdrawal by Subject|0|||
131774574|NCT01366846|474454522|FG002|Overall Study|Withdrawal by Subject|0|||
131774575|NCT01366846|474454523|FG003|Overall Study|Withdrawal by Subject|0|||
131774576|NCT01366846|474454520|FG000|Overall Study|Communication Difficulties|1|||
131774577|NCT01366846|474454521|FG001|Overall Study|Communication Difficulties|4|||
131774578|NCT01366846|474454522|FG002|Overall Study|Communication Difficulties|0|||
131774579|NCT01366846|474454523|FG003|Overall Study|Communication Difficulties|1|||
131774580|NCT01366846|474454520|FG000|Overall Study|Scheduling Conflicts|0|||
131687468|NCT01131676|474139742|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
131687469|NCT01131676|474139743|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
131687470|NCT01131676|474139741|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
131687471|NCT01131676|474139742|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
131687472|NCT01131676|474139743|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
131687473|NCT01111851|474139746|FG000|Overall Study|All planned PET scans were not obtained.|2|||
131687474|NCT01111851|474139747|FG001|Overall Study|All planned PET scans were not obtained.|0|||
131898527|NCT00320788|474914099|FG003|Overall Study|Physician Decision|0|||
131898528|NCT00320788|474914100|FG004|Overall Study|Physician Decision|0|||
131687475|NCT05500274|474139748|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
131687476|NCT05500274|474139749|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
131687477|NCT05500274|474139748|FG000|Overall Study|Lost to Follow-up|76|||
131687478|NCT05500274|474139749|FG001|Overall Study|Lost to Follow-up|51|||
131687479|NCT01555151|474139750|FG000|Overall Study|Withdrawal by Subject|6|||
131687480|NCT01555151|474139751|FG001|Overall Study|Withdrawal by Subject|2|||
131687481|NCT01555151|474139752|FG002|Overall Study|Withdrawal by Subject|0|||
131687482|NCT01555151|474139753|FG003|Overall Study|Withdrawal by Subject|2|||
131687483|NCT01555151|474139750|FG000|Overall Study|Administrative|3|||
131687484|NCT01555151|474139751|FG001|Overall Study|Administrative|1|||
131687485|NCT01555151|474139752|FG002|Overall Study|Administrative|2|||
131687486|NCT01555151|474139753|FG003|Overall Study|Administrative|0|||
131687487|NCT01555151|474139750|FG000|Overall Study|Protocol Violation|3|||
131687488|NCT01555151|474139751|FG001|Overall Study|Protocol Violation|3|||
131687489|NCT01555151|474139752|FG002|Overall Study|Protocol Violation|3|||
131687490|NCT01555151|474139753|FG003|Overall Study|Protocol Violation|5|||
131687491|NCT01555151|474139750|FG000|Overall Study|Adverse Event|1|||
131687492|NCT01555151|474139751|FG001|Overall Study|Adverse Event|2|||
131687493|NCT01555151|474139752|FG002|Overall Study|Adverse Event|1|||
131687494|NCT01555151|474139753|FG003|Overall Study|Adverse Event|2|||
131687495|NCT01555151|474139750|FG000|Overall Study|Lost to Follow-up|0|||
131687496|NCT01555151|474139751|FG001|Overall Study|Lost to Follow-up|0|||
131687497|NCT01555151|474139752|FG002|Overall Study|Lost to Follow-up|0|||
131687498|NCT01555151|474139753|FG003|Overall Study|Lost to Follow-up|1|||
131687499|NCT03596866|474139754|FG000|Overall Study|Site terminated by Sponsor|64|||
131687500|NCT03596866|474139755|FG001|Overall Study|Site terminated by Sponsor|65|||
131687501|NCT03596866|474139754|FG000|Overall Study|Death|37|||
131687502|NCT03596866|474139755|FG001|Overall Study|Death|24|||
131687503|NCT03596866|474139754|FG000|Overall Study|Withdrawal by Subject|4|||
131687504|NCT03596866|474139755|FG001|Overall Study|Withdrawal by Subject|6|||
131687505|NCT03596866|474139754|FG000|Overall Study|Missing|0|||
131687506|NCT03596866|474139755|FG001|Overall Study|Missing|6|||
131687507|NCT03596866|474139754|FG000|Overall Study|Lost to Follow-up|2|||
131687508|NCT03596866|474139755|FG001|Overall Study|Lost to Follow-up|3|||
131687509|NCT03596866|474139754|FG000|Overall Study|Protocol Violation|1|||
131687510|NCT03596866|474139755|FG001|Overall Study|Protocol Violation|0|||
131687511|NCT03596866|474139754|FG000|Overall Study|Reason Not Specified|14|||
131687512|NCT03596866|474139755|FG001|Overall Study|Reason Not Specified|13|||
131687513|NCT01816061|474139756|FG000|Overall Study|Lost to Follow-up|13|||
131687514|NCT01816061|474139757|FG001|Overall Study|Lost to Follow-up|24|||
131687515|NCT01961349|474139758|FG000|Overall Study|Withdrawal by Subject|1|||
131687516|NCT01961349|474139759|FG001|Overall Study|Withdrawal by Subject|4|||
131687517|NCT01961349|474139760|FG002|Overall Study|Withdrawal by Subject|0|||
131687518|NCT01961349|474139758|FG000|Overall Study|Adverse Event|0|||
131687519|NCT01961349|474139759|FG001|Overall Study|Adverse Event|0|||
131687520|NCT01961349|474139760|FG002|Overall Study|Adverse Event|1|||
131687521|NCT01961349|474139758|FG000|Overall Study|registration error, personal reason etc|2|||
131687522|NCT01961349|474139759|FG001|Overall Study|registration error, personal reason etc|2|||
131687523|NCT01961349|474139760|FG002|Overall Study|registration error, personal reason etc|1|||
131687524|NCT04360551|474141232|FG000|Overall Study|Withdrawal by Subject|1|||
131687525|NCT04360551|474141233|FG001|Overall Study|Withdrawal by Subject|0|||
131687526|NCT00388973|474141238|FG000|Overall Study|Adverse Event|16|||
131556003|NCT02357810|473660297|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
131687527|NCT00388973|474141239|FG001|Overall Study|Adverse Event|6|||
131687528|NCT00388973|474141238|FG000|Overall Study|Lack of Efficacy|1|||
131687529|NCT00388973|474141239|FG001|Overall Study|Lack of Efficacy|12|||
131687530|NCT00388973|474141238|FG000|Overall Study|Protocol Violation|3|||
131687531|NCT00388973|474141239|FG001|Overall Study|Protocol Violation|0|||
131687532|NCT00388973|474141238|FG000|Overall Study|Withdrawal by Subject|14|||
131687533|NCT00388973|474141239|FG001|Overall Study|Withdrawal by Subject|17|||
131774581|NCT01366846|474454521|FG001|Overall Study|Scheduling Conflicts|0|||
131774582|NCT01366846|474454522|FG002|Overall Study|Scheduling Conflicts|1|||
131774583|NCT01366846|474454523|FG003|Overall Study|Scheduling Conflicts|0|||
131774584|NCT00558831|474454529|FG000|Overall Study|Lost to Follow-up|1|||
131774585|NCT04780776|474454532|FG000|Titration Week 1-5|Lost to Follow-up|2|||
131774586|NCT04780776|474454533|FG001|Titration Week 1-5|Lost to Follow-up|8|||
131774587|NCT04780776|474454532|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
131774588|NCT04780776|474454533|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
131774589|NCT04780776|474454532|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
131774590|NCT04780776|474454533|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
131774591|NCT03113760|474454534|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
131774592|NCT03113760|474454535|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
131774593|NCT03113760|474454536|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
131774594|NCT03113760|474454537|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
131774595|NCT03113760|474454534|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
131774596|NCT03113760|474454535|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
131774597|NCT03113760|474454536|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
131774598|NCT03113760|474454537|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
131774599|NCT03113760|474454534|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
131774600|NCT03113760|474454535|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
131774601|NCT03113760|474454536|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
131774602|NCT03113760|474454537|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
131774603|NCT02957149|474454538|FG000|Overall Study|Withdrawal by Subject|5|||
131774604|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Adverse Event|4|||
131774605|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Adverse Event|3|||
131774606|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Adverse Event|0|||
131774607|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Adverse Event|0|||
131774608|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Death|24|||
131774609|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Death|9|||
131774610|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Death|0|||
131774611|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Death|0|||
131774612|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
131774613|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
131774614|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
131774615|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
131774616|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Physician Decision|4|||
131774617|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Physician Decision|1|||
131774618|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Physician Decision|0|||
131774619|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Physician Decision|0|||
131774620|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Progressive disease|1|||
131774621|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Progressive disease|0|||
131774622|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Progressive disease|0|||
131774623|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Progressive disease|0|||
131774624|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
131774625|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
131774626|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
131774627|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
131774628|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
131774629|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
131774630|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
131774631|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
131774632|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
131774633|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
131774634|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
131774635|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
131774636|NCT04579666|474454539|FG000|RTP (Up to Week 52)|Other|2|||
131774637|NCT04579666|474454540|FG001|RTP (Up to Week 52)|Other|0|||
131774638|NCT04579666|474454541|FG002|RTP (Up to Week 52)|Other|0|||
131774639|NCT04579666|474454542|FG003|RTP (Up to Week 52)|Other|0|||
131774640|NCT04579666|474454539|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
131774641|NCT04579666|474454540|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
131774642|NCT04579666|474454541|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
131774643|NCT04579666|474454542|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
131774644|NCT04579666|474454539|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
131774645|NCT04579666|474454540|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
131774646|NCT04579666|474454541|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
131774647|NCT04579666|474454542|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
131774648|NCT04579666|474454539|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
131774649|NCT04579666|474454540|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
131774650|NCT04579666|474454541|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
131774651|NCT04579666|474454542|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
131774652|NCT04579666|474454539|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
131774653|NCT04579666|474454540|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
131774654|NCT04579666|474454541|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
131774655|NCT04579666|474454542|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
131774656|NCT04579666|474454539|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
131774657|NCT04579666|474454540|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
131774658|NCT04579666|474454541|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
131774659|NCT04579666|474454542|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
131774660|NCT00643006|474454546|FG000|Overall Study|Lost to Follow-up|5|||
131774661|NCT00643006|474454547|FG001|Overall Study|Lost to Follow-up|4|||
131774662|NCT02506101|474454548|FG000|Overall Study|Transportation issues|1|||
131774663|NCT02506101|474454549|FG001|Overall Study|Transportation issues|0|||
131774664|NCT02506101|474454548|FG000|Overall Study|No enrollment and staff unavailability|1|||
131774665|NCT02506101|474454549|FG001|Overall Study|No enrollment and staff unavailability|0|||
131774666|NCT01308476|474454551|FG000|Overall Study|Lost to Follow-up|2|||
131774667|NCT01308476|474454552|FG001|Overall Study|Lost to Follow-up|2|||
131774668|NCT01308476|474454551|FG000|Overall Study|Other|1|||
131774669|NCT01308476|474454552|FG001|Overall Study|Other|0|||
131774670|NCT00812968|474454553|FG000|Overall Study|Relapse after erythroid response|6|||
131774671|NCT00812968|474454553|FG000|Overall Study|Disease progression|1|||
131774672|NCT00812968|474454553|FG000|Overall Study|No further treatment required|1|||
131774673|NCT00812968|474454553|FG000|Overall Study|Study closed due to marketing approval|3|||
131774674|NCT01243762|474454554|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131774675|NCT01243762|474454555|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
131774676|NCT01243762|474454556|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131774677|NCT01243762|474454557|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131774678|NCT01243762|474454558|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
131774679|NCT01243762|474454559|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
131774680|NCT01243762|474454560|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131774681|NCT01243762|474454554|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131774682|NCT01243762|474454555|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
131774683|NCT01243762|474454556|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131774684|NCT01243762|474454557|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
131774685|NCT01243762|474454558|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131774686|NCT01243762|474454559|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131774687|NCT01243762|474454560|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131774688|NCT01243762|474454554|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
131774689|NCT01243762|474454555|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
131774690|NCT01243762|474454556|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
131774691|NCT01243762|474454557|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
131774692|NCT01243762|474454558|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
131774693|NCT01243762|474454559|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
131774694|NCT01243762|474454560|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
131774695|NCT01243762|474454554|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131774696|NCT01243762|474454555|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
131774697|NCT01243762|474454556|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131774698|NCT01243762|474454557|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131774699|NCT01243762|474454558|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131774700|NCT01243762|474454559|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131774701|NCT01243762|474454560|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131774702|NCT01243762|474454554|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131774703|NCT01243762|474454555|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
131774704|NCT01243762|474454556|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131774705|NCT01243762|474454557|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131774706|NCT01243762|474454558|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131774707|NCT01243762|474454559|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131774708|NCT01243762|474454560|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
131774709|NCT01243762|474454554|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
131774710|NCT01243762|474454555|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
131774711|NCT01243762|474454556|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
131687534|NCT00388973|474141238|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
131687535|NCT00388973|474141239|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
131687536|NCT00388973|474141238|FG000|Overall Study|Did not complete 61 days of treatment|5|||
131687537|NCT00388973|474141239|FG001|Overall Study|Did not complete 61 days of treatment|4|||
131687538|NCT00388973|474141238|FG000|Overall Study|Left region|0|||
131687539|NCT00388973|474141239|FG001|Overall Study|Left region|1|||
131687540|NCT00388973|474141238|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
131687541|NCT00388973|474141239|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
131687542|NCT00346073|474141254|FG000|Overall Study|Serious Adverse Event|2|||
131687543|NCT00346073|474141255|FG001|Overall Study|Serious Adverse Event|0|||
131687544|NCT00346073|474141254|FG000|Overall Study|Lost to Follow-up|39|||
131687545|NCT00346073|474141255|FG001|Overall Study|Lost to Follow-up|24|||
131687546|NCT00914927|474141257|FG000|Overall Study|Adverse Event|0|||
131687547|NCT00914927|474141258|FG001|Overall Study|Adverse Event|0|||
131687548|NCT00914927|474141259|FG002|Overall Study|Adverse Event|0|||
131687549|NCT00914927|474141260|FG003|Overall Study|Adverse Event|0|||
131687550|NCT00914927|474141261|FG004|Overall Study|Adverse Event|1|||
131687551|NCT00914927|474141262|FG005|Overall Study|Adverse Event|0|||
131687552|NCT00914927|474141263|FG006|Overall Study|Adverse Event|0|||
131687553|NCT00914927|474141257|FG000|Overall Study|Withdrawal by Subject|0|||
131687554|NCT00914927|474141258|FG001|Overall Study|Withdrawal by Subject|1|||
131687555|NCT00914927|474141259|FG002|Overall Study|Withdrawal by Subject|0|||
131687556|NCT00914927|474141260|FG003|Overall Study|Withdrawal by Subject|1|||
131687557|NCT00914927|474141261|FG004|Overall Study|Withdrawal by Subject|0|||
131687558|NCT00914927|474141262|FG005|Overall Study|Withdrawal by Subject|0|||
131687559|NCT00914927|474141263|FG006|Overall Study|Withdrawal by Subject|0|||
131687560|NCT00914927|474141257|FG000|Overall Study|Lost to Follow-up|0|||
131687561|NCT00914927|474141258|FG001|Overall Study|Lost to Follow-up|0|||
131687562|NCT00914927|474141259|FG002|Overall Study|Lost to Follow-up|0|||
131687563|NCT00914927|474141260|FG003|Overall Study|Lost to Follow-up|1|||
131687564|NCT00914927|474141261|FG004|Overall Study|Lost to Follow-up|0|||
131687565|NCT00914927|474141262|FG005|Overall Study|Lost to Follow-up|0|||
131687566|NCT00914927|474141263|FG006|Overall Study|Lost to Follow-up|0|||
131687567|NCT00914927|474141257|FG000|Overall Study|Administrative/Other|2|||
131687568|NCT00914927|474141258|FG001|Overall Study|Administrative/Other|1|||
131687569|NCT00914927|474141259|FG002|Overall Study|Administrative/Other|0|||
131687570|NCT00914927|474141260|FG003|Overall Study|Administrative/Other|0|||
131687571|NCT00914927|474141261|FG004|Overall Study|Administrative/Other|1|||
131687572|NCT00914927|474141262|FG005|Overall Study|Administrative/Other|0|||
131774712|NCT01243762|474454557|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
131774713|NCT01243762|474454558|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
131774714|NCT01243762|474454559|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
131774715|NCT01243762|474454560|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
131774716|NCT01243762|474454554|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131774717|NCT01243762|474454555|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
131774718|NCT01243762|474454556|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131774719|NCT01243762|474454557|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131774720|NCT01243762|474454558|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
131774721|NCT01243762|474454559|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131687573|NCT00914927|474141263|FG006|Overall Study|Administrative/Other|0|||
131687574|NCT01648790|474141266|FG000|Treatment 3|Withdrawal by Subject|0|||
131687575|NCT01648790|474141267|FG001|Treatment 3|Withdrawal by Subject|0|||
131687576|NCT01648790|474141268|FG002|Treatment 3|Withdrawal by Subject|0|||
131687577|NCT01648790|474141269|FG003|Treatment 3|Withdrawal by Subject|1|||
131687578|NCT01648790|474141270|FG004|Treatment 3|Withdrawal by Subject|0|||
131687579|NCT02969187|474141271|FG000|Overall Study|Physician Decision|12|||
131687580|NCT02969187|474141272|FG001|Overall Study|Physician Decision|13|||
131687581|NCT01471015|474141273|FG000|Overall Study|Death|0|||
131687582|NCT01471015|474141274|FG001|Overall Study|Death|1|||
131687583|NCT01471015|474141275|FG002|Overall Study|Death|1|||
131687584|NCT02953340|474141276|FG000|Overall Study|Death|0|||
131687585|NCT02953340|474141277|FG001|Overall Study|Death|1|||
131687586|NCT02953340|474141276|FG000|Overall Study|Investigator Decision|3|||
131687587|NCT02953340|474141277|FG001|Overall Study|Investigator Decision|3|||
131687588|NCT02953340|474141276|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
131687589|NCT02953340|474141277|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
131687590|NCT02953340|474141276|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
131687591|NCT02953340|474141277|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
131687592|NCT02953340|474141276|FG000|Overall Study|Withdrawal by Subject|9|||
131687593|NCT02953340|474141277|FG001|Overall Study|Withdrawal by Subject|9|||
131687594|NCT02953340|474141276|FG000|Overall Study|Sponsor decision|0|||
131687595|NCT02953340|474141277|FG001|Overall Study|Sponsor decision|2|||
131774722|NCT01243762|474454560|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131774723|NCT01243762|474454554|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131774724|NCT01243762|474454555|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131774725|NCT01243762|474454556|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131774726|NCT01243762|474454557|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
131774727|NCT01243762|474454558|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
131774728|NCT01243762|474454559|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131774729|NCT01243762|474454560|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131774730|NCT04359758|474454561|FG000|Overall Study|Protocol Violation|3|||
131774731|NCT04359758|474454562|FG001|Overall Study|Protocol Violation|2|||
131774732|NCT03358407|474454563|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774733|NCT03358407|474454564|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774734|NCT03358407|474454565|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
131774735|NCT03358407|474454566|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774736|NCT03358407|474454567|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774737|NCT03358407|474454568|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774738|NCT03358407|474454569|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774739|NCT03358407|474454570|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774740|NCT03358407|474454571|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774741|NCT03358407|474454572|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131774742|NCT03358407|474454563|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774743|NCT03358407|474454564|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774744|NCT03358407|474454565|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774745|NCT03358407|474454566|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774746|NCT03358407|474454567|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
131774747|NCT03358407|474454568|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774748|NCT03358407|474454569|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774749|NCT03358407|474454570|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774750|NCT03358407|474454571|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774751|NCT03358407|474454572|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774752|NCT03358407|474454563|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774753|NCT03358407|474454564|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774754|NCT03358407|474454565|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774755|NCT03358407|474454566|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774756|NCT03358407|474454567|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774757|NCT03358407|474454568|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
131774758|NCT03358407|474454569|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774759|NCT03358407|474454570|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
131774760|NCT03358407|474454571|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774761|NCT03358407|474454572|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131774762|NCT03358407|474454563|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774763|NCT03358407|474454564|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774764|NCT03358407|474454565|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774765|NCT03358407|474454566|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774766|NCT03358407|474454567|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774767|NCT03358407|474454568|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
131774768|NCT03358407|474454569|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774769|NCT03358407|474454570|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
131774770|NCT03358407|474454571|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774771|NCT03358407|474454572|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131774772|NCT03358407|474454563|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774773|NCT03358407|474454564|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774774|NCT03358407|474454565|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774775|NCT03358407|474454566|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774776|NCT03358407|474454567|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774777|NCT03358407|474454568|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
131774778|NCT03358407|474454569|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
131774779|NCT03358407|474454570|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774780|NCT03358407|474454571|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774781|NCT03358407|474454572|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131774782|NCT03358407|474454563|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131774783|NCT03358407|474454564|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131774784|NCT03358407|474454565|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131774785|NCT03358407|474454566|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131687596|NCT02953340|474141276|FG000|Overall Study|Lost to Follow-up|3|||
131687597|NCT02953340|474141277|FG001|Overall Study|Lost to Follow-up|2|||
131687598|NCT02953340|474141276|FG000|Overall Study|Reason not specified|2|||
131687599|NCT02953340|474141277|FG001|Overall Study|Reason not specified|2|||
131687600|NCT01376778|474141278|FG000|Overall Study|Lost to Follow-up|3|||
131687601|NCT01376778|474141279|FG001|Overall Study|Lost to Follow-up|2|||
131687602|NCT02700412|474141280|FG000|Overall Study|Adverse Event|6|||
131687603|NCT02700412|474141280|FG000|Overall Study|Death|1|||
131687604|NCT02700412|474141280|FG000|Overall Study|Lack of Efficacy|19|||
131687605|NCT02700412|474141280|FG000|Overall Study|Protocol Violation|5|||
131687606|NCT02700412|474141280|FG000|Overall Study|Withdrawal by Subject|2|||
131687607|NCT00928889|474141281|FG000|Overall Study|Lost to Follow-up|3|||
131687608|NCT00928889|474141282|FG001|Overall Study|Lost to Follow-up|1|||
131687609|NCT00928889|474141281|FG000|Overall Study|Protocol Violation|0|||
131687610|NCT00928889|474141282|FG001|Overall Study|Protocol Violation|1|||
131687611|NCT00928889|474141281|FG000|Overall Study|Adverse Event|1|||
131687612|NCT00928889|474141282|FG001|Overall Study|Adverse Event|0|||
131687613|NCT00928889|474141281|FG000|Overall Study|Other|1|||
131687614|NCT00928889|474141282|FG001|Overall Study|Other|0|||
131687615|NCT04712110|474141283|FG000|Overall Study|Lost to Follow-up|0|||
131687616|NCT04712110|474141284|FG001|Overall Study|Lost to Follow-up|1|||
131687617|NCT04712110|474141283|FG000|Overall Study|Withdrawal by Subject|0|||
131687618|NCT04712110|474141284|FG001|Overall Study|Withdrawal by Subject|4|||
131687619|NCT04712110|474141283|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
131687620|NCT04712110|474141284|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
131687621|NCT01197521|474141287|FG000|Overall Study|Not reported|24|||
131687622|NCT01197521|474141288|FG001|Overall Study|Not reported|25|||
131687623|NCT01197521|474141289|FG002|Overall Study|Not reported|21|||
131687624|NCT01197521|474141287|FG000|Overall Study|Enrolment in long term extension|42|||
131687625|NCT01197521|474141288|FG001|Overall Study|Enrolment in long term extension|36|||
131687626|NCT01197521|474141289|FG002|Overall Study|Enrolment in long term extension|87|||
131687627|NCT01197521|474141287|FG000|Overall Study|Severe non-compliance to protocol|1|||
131687628|NCT01197521|474141288|FG001|Overall Study|Severe non-compliance to protocol|3|||
131687629|NCT01197521|474141289|FG002|Overall Study|Severe non-compliance to protocol|3|||
131687630|NCT01197521|474141287|FG000|Overall Study|Lack of therapeutic response|2|||
131687631|NCT01197521|474141288|FG001|Overall Study|Lack of therapeutic response|3|||
131687632|NCT01197521|474141289|FG002|Overall Study|Lack of therapeutic response|4|||
131687633|NCT01197521|474141287|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
131687634|NCT01197521|474141288|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
131687635|NCT01197521|474141289|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
131687636|NCT01197521|474141287|FG000|Overall Study|Lost to Follow-up|3|||
131687637|NCT01197521|474141288|FG001|Overall Study|Lost to Follow-up|2|||
131687638|NCT01197521|474141289|FG002|Overall Study|Lost to Follow-up|2|||
131687639|NCT01197521|474141287|FG000|Overall Study|Adverse Event|25|||
131687640|NCT01197521|474141288|FG001|Overall Study|Adverse Event|28|||
131687641|NCT01197521|474141289|FG002|Overall Study|Adverse Event|24|||
131687642|NCT01517893|474141290|FG000|Overall Study|Withdrawal by Subject|3|||
131687643|NCT01517893|474141291|FG001|Overall Study|Withdrawal by Subject|0|||
131687644|NCT02285777|474141295|FG000|Overall Study|Withdrawal by Subject|1|||
131687645|NCT02285777|474141296|FG001|Overall Study|Withdrawal by Subject|1|||
131687646|NCT02285777|474141295|FG000|Overall Study|Lost to Follow-up|4|||
131687647|NCT02285777|474141296|FG001|Overall Study|Lost to Follow-up|2|||
131687648|NCT01431274|474141304|FG000|Overall Study|Adverse Event|51|||
131687649|NCT01431274|474141305|FG001|Overall Study|Adverse Event|37|||
131687650|NCT01431274|474141306|FG002|Overall Study|Adverse Event|43|||
131687651|NCT01431274|474141307|FG003|Overall Study|Adverse Event|30|||
131687652|NCT01431274|474141308|FG004|Overall Study|Adverse Event|37|||
131687653|NCT01431274|474141304|FG000|Overall Study|Consent withdrawn not due to AE|29|||
131687654|NCT01431274|474141305|FG001|Overall Study|Consent withdrawn not due to AE|20|||
131687655|NCT01431274|474141306|FG002|Overall Study|Consent withdrawn not due to AE|17|||
131687656|NCT01431274|474141307|FG003|Overall Study|Consent withdrawn not due to AE|20|||
131687657|NCT01431274|474141308|FG004|Overall Study|Consent withdrawn not due to AE|11|||
131687658|NCT01431274|474141304|FG000|Overall Study|Non compliant with protocol|5|||
131687659|NCT01431274|474141305|FG001|Overall Study|Non compliant with protocol|8|||
131687660|NCT01431274|474141306|FG002|Overall Study|Non compliant with protocol|4|||
131687661|NCT01431274|474141307|FG003|Overall Study|Non compliant with protocol|4|||
131687662|NCT01431274|474141308|FG004|Overall Study|Non compliant with protocol|4|||
131687663|NCT01431274|474141304|FG000|Overall Study|Lost to Follow-up|6|||
131687664|NCT01431274|474141305|FG001|Overall Study|Lost to Follow-up|7|||
131687665|NCT01431274|474141306|FG002|Overall Study|Lost to Follow-up|1|||
131687666|NCT01431274|474141307|FG003|Overall Study|Lost to Follow-up|4|||
131687667|NCT01431274|474141308|FG004|Overall Study|Lost to Follow-up|0|||
131687668|NCT01431274|474141304|FG000|Overall Study|Other reason not stated above|6|||
131687669|NCT01431274|474141305|FG001|Overall Study|Other reason not stated above|5|||
131687670|NCT01431274|474141306|FG002|Overall Study|Other reason not stated above|7|||
131687671|NCT01431274|474141307|FG003|Overall Study|Other reason not stated above|2|||
131687672|NCT01431274|474141308|FG004|Overall Study|Other reason not stated above|4|||
131687673|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
131687674|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
131687675|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Death|0|||
131687676|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Death|1|||
131687677|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
131687678|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
131687679|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
131687680|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
131687681|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
131687682|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
131687683|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
131687684|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
131687685|NCT00843518|474141309|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
131687686|NCT00843518|474141310|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
131687687|NCT00827606|474141311|FG000|Overall Study|Protocol Violation|4|||
131687688|NCT00827606|474141312|FG001|Overall Study|Protocol Violation|3|||
131687689|NCT00827606|474141311|FG000|Overall Study|Lost to Follow-up|3|||
131687690|NCT00827606|474141312|FG001|Overall Study|Lost to Follow-up|1|||
131687691|NCT00827606|474141311|FG000|Overall Study|Withdrawal by Subject|7|||
131687692|NCT00827606|474141312|FG001|Overall Study|Withdrawal by Subject|6|||
131687693|NCT00827606|474141311|FG000|Overall Study|Pregnancy|0|||
131687694|NCT00827606|474141312|FG001|Overall Study|Pregnancy|1|||
131687695|NCT00827606|474141311|FG000|Overall Study|Other|5|||
131687696|NCT00827606|474141312|FG001|Overall Study|Other|13|||
131687697|NCT00827606|474141311|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
131687698|NCT00827606|474141312|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
131687699|NCT00827606|474141311|FG000|Overall Study|Adverse Event|4|||
131687700|NCT00827606|474141312|FG001|Overall Study|Adverse Event|2|||
131687701|NCT04037748|474141315|FG000|Treatment Period 1|Withdrawal by Subject|3|||
131687702|NCT04037748|474141316|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131687703|NCT04037748|474141315|FG000|Treatment Period 1|Adverse Event|1|||
131687704|NCT04037748|474141316|FG001|Treatment Period 1|Adverse Event|1|||
131687705|NCT04037748|474141315|FG000|Treatment Period 1|Protocol Violation|4|||
131687706|NCT04037748|474141316|FG001|Treatment Period 1|Protocol Violation|5|||
131687707|NCT04037748|474141315|FG000|Treatment Period 2|Adverse Event|0|||
131687708|NCT04037748|474141316|FG001|Treatment Period 2|Adverse Event|1|||
131687709|NCT04037748|474141315|FG000|Treatment Period 2|Protocol Violation|2|||
131687710|NCT04037748|474141316|FG001|Treatment Period 2|Protocol Violation|0|||
131687711|NCT04544475|474141321|FG000|Overall Study|Withdrawal by Subject|1|||
131687712|NCT04544475|474141322|FG001|Overall Study|Withdrawal by Subject|3|||
131687713|NCT01378858|474141323|FG000|Overall Study|Withdrawal by Subject|4|||
131687714|NCT01378858|474141324|FG001|Overall Study|Withdrawal by Subject|4|||
131687715|NCT00501007|474141325|FG000|Overall Study|Inclusion criteria not met.|29|||
131687716|NCT00501007|474141326|FG001|Overall Study|Inclusion criteria not met.|25|||
131687717|NCT02973087|474141329|FG000|Overall Study|Withdrawal by Subject|2|||
131687718|NCT02973087|474141330|FG001|Overall Study|Withdrawal by Subject|1|||
131687719|NCT02973087|474141329|FG000|Overall Study|Adverse Event|1|||
131687720|NCT02973087|474141330|FG001|Overall Study|Adverse Event|0|||
131687721|NCT02973087|474141329|FG000|Overall Study|other|1|||
131687722|NCT02973087|474141330|FG001|Overall Study|other|1|||
131687723|NCT00932360|474141331|FG000|Washout (One Week)|Withdrawal by Subject|0|||
131687724|NCT00932360|474141332|FG001|Washout (One Week)|Withdrawal by Subject|0|||
131687725|NCT00932360|474141333|FG002|Washout (One Week)|Withdrawal by Subject|0|||
131687726|NCT00932360|474141334|FG003|Washout (One Week)|Withdrawal by Subject|0|||
131687727|NCT00932360|474141335|FG004|Washout (One Week)|Withdrawal by Subject|2|||
131687728|NCT00932360|474141336|FG005|Washout (One Week)|Withdrawal by Subject|0|||
131687729|NCT04143009|474141337|FG000|Pilot Trial|Lost to Follow-up|0|||
131687730|NCT04143009|474141338|FG001|Pilot Trial|Lost to Follow-up|1|||
131687731|NCT04143009|474141339|FG002|Pilot Trial|Lost to Follow-up|1|||
131687732|NCT05003622|474141340|FG000|Overall Study|Progressive disease|2|||
131687733|NCT05003622|474141340|FG000|Overall Study|Withdrawal by Subject|1|||
131687734|NCT01045798|474141346|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
131687735|NCT01045798|474141347|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
131687736|NCT01045798|474141346|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
131687737|NCT01045798|474141347|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
131687738|NCT01045798|474141346|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
131687739|NCT01045798|474141347|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
131687740|NCT01045798|474141346|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
131687741|NCT01045798|474141347|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
131687742|NCT01484977|474141351|FG000|Overall Study|Adverse Event|8|||
131687743|NCT01484977|474141351|FG000|Overall Study|Lack of Efficacy|4|||
131687744|NCT01484977|474141351|FG000|Overall Study|Protocol Violation|6|||
131687745|NCT01484977|474141351|FG000|Overall Study|Lost to Follow-up|1|||
131687746|NCT01484977|474141351|FG000|Overall Study|Withdrawal by Subject|4|||
131687747|NCT01484977|474141351|FG000|Overall Study|Subject Protocol Non-compliant|1|||
131687748|NCT01484977|474141351|FG000|Overall Study|Moving Overseas|1|||
131687749|NCT01484977|474141351|FG000|Overall Study|Low White Blood Cell Count|1|||
131687750|NCT01484977|474141351|FG000|Overall Study|Lack of Compliance|1|||
131687751|NCT04857996|474141352|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
131687752|NCT04857996|474141353|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
131687753|NCT04857996|474141352|FG000|Overall Study|Lost to Follow-up|1|||
131687754|NCT04857996|474141353|FG001|Overall Study|Lost to Follow-up|3|||
131687755|NCT04857996|474141352|FG000|Overall Study|Site Closure|1|||
131687756|NCT04857996|474141353|FG001|Overall Study|Site Closure|0|||
131687757|NCT04857996|474141352|FG000|Overall Study|Withdrawal by Subject|1|||
131687758|NCT04857996|474141353|FG001|Overall Study|Withdrawal by Subject|0|||
131687759|NCT05264740|474141356|FG000|Baseline|Withdrawal by Subject|0|||
131687760|NCT05264740|474141357|FG001|Baseline|Withdrawal by Subject|1|||
131687761|NCT05264740|474141356|FG000|Follow Up 1|Lost to Follow-up|1|||
131687762|NCT05264740|474141357|FG001|Follow Up 1|Lost to Follow-up|1|||
131687763|NCT05264740|474141356|FG000|Follow Up 1|Withdrawal by Subject|0|||
131687764|NCT05264740|474141357|FG001|Follow Up 1|Withdrawal by Subject|1|||
131687765|NCT05264740|474141356|FG000|Follow Up 2|Lost to Follow-up|1|||
131687766|NCT05264740|474141357|FG001|Follow Up 2|Lost to Follow-up|4|||
131687767|NCT05264740|474141356|FG000|Follow Up 3|Lost to Follow-up|7|||
131687768|NCT05264740|474141357|FG001|Follow Up 3|Lost to Follow-up|4|||
131687769|NCT01538628|474141358|FG000|Overall Study|Withdrawal by Subject|1|||
131687770|NCT01538628|474141359|FG001|Overall Study|Withdrawal by Subject|1|||
131687771|NCT01538628|474141358|FG000|Overall Study|Lost to Follow-up|0|||
131687772|NCT01538628|474141359|FG001|Overall Study|Lost to Follow-up|1|||
131687773|NCT00597753|474141360|FG000|Overall Study|Adverse Event|6|||
131687774|NCT00597753|474141361|FG001|Overall Study|Adverse Event|2|||
131687775|NCT00597753|474141360|FG000|Overall Study|Death|55|||
131687776|NCT00597753|474141361|FG001|Overall Study|Death|29|||
131687777|NCT00597753|474141360|FG000|Overall Study|Lack of Efficacy|2|||
131687778|NCT00597753|474141361|FG001|Overall Study|Lack of Efficacy|0|||
131687779|NCT00597753|474141360|FG000|Overall Study|Lost to Follow-up|10|||
131687780|NCT00597753|474141361|FG001|Overall Study|Lost to Follow-up|3|||
131687781|NCT00597753|474141360|FG000|Overall Study|Physician Decision|5|||
131687782|NCT00597753|474141361|FG001|Overall Study|Physician Decision|1|||
131687783|NCT00597753|474141360|FG000|Overall Study|Pregnancy|1|||
131687784|NCT00597753|474141361|FG001|Overall Study|Pregnancy|0|||
131687785|NCT00597753|474141360|FG000|Overall Study|Withdrawal by Subject|35|||
131687786|NCT00597753|474141361|FG001|Overall Study|Withdrawal by Subject|12|||
131687787|NCT00597753|474141360|FG000|Overall Study|Discontinued Dialysis|0|||
131687788|NCT00597753|474141361|FG001|Overall Study|Discontinued Dialysis|1|||
131687789|NCT00597753|474141360|FG000|Overall Study|Never dosed|2|||
131687790|NCT00597753|474141361|FG001|Overall Study|Never dosed|0|||
131687791|NCT00597753|474141360|FG000|Overall Study|Noncompliance|2|||
131687792|NCT00597753|474141361|FG001|Overall Study|Noncompliance|1|||
131687793|NCT00597753|474141360|FG000|Overall Study|Relocation|17|||
131687794|NCT00597753|474141361|FG001|Overall Study|Relocation|6|||
131687795|NCT00597753|474141360|FG000|Overall Study|Renal transplant|10|||
131687796|NCT00597753|474141361|FG001|Overall Study|Renal transplant|3|||
131687797|NCT00597753|474141360|FG000|Overall Study|Site closed by sponsor|19|||
131687798|NCT00597753|474141361|FG001|Overall Study|Site closed by sponsor|7|||
131687799|NCT00597753|474141360|FG000|Overall Study|Site elected to close|2|||
131687800|NCT00597753|474141361|FG001|Overall Study|Site elected to close|4|||
131687801|NCT03080883|474141362|FG000|Overall Study|Withdrawal by Subject|11|||
131687802|NCT03080883|474141363|FG001|Overall Study|Withdrawal by Subject|15|||
131687803|NCT03080883|474141362|FG000|Overall Study|Adverse Event|22|||
131687804|NCT03080883|474141363|FG001|Overall Study|Adverse Event|22|||
131687805|NCT03080883|474141362|FG000|Overall Study|Alternative Therapy|0|||
131687806|NCT03080883|474141363|FG001|Overall Study|Alternative Therapy|3|||
131687807|NCT03080883|474141362|FG000|Overall Study|Other Complicating Disease|9|||
131687808|NCT03080883|474141363|FG001|Overall Study|Other Complicating Disease|5|||
131687809|NCT03080883|474141362|FG000|Overall Study|Death|21|||
131687810|NCT03080883|474141363|FG001|Overall Study|Death|16|||
131687811|NCT03080883|474141362|FG000|Overall Study|Physician Decision|2|||
131687812|NCT03080883|474141363|FG001|Overall Study|Physician Decision|2|||
131687813|NCT03080883|474141362|FG000|Overall Study|Disease Progression|2|||
131687814|NCT03080883|474141363|FG001|Overall Study|Disease Progression|8|||
131687815|NCT03080883|474141362|FG000|Overall Study|Lost to Follow-up|1|||
131687816|NCT03080883|474141363|FG001|Overall Study|Lost to Follow-up|1|||
131687817|NCT00075023|474142369|FG000|Pilot Study|Physician Decision|1|||
131687818|NCT00075023|474142370|FG001|Pilot Study|Physician Decision|2|||
131687819|NCT00075023|474142369|FG000|Pilot Study|Withdrawal by Subject|1|||
131687820|NCT00075023|474142370|FG001|Pilot Study|Withdrawal by Subject|0|||
131687821|NCT00909181|474142373|FG000|Overall Study|Lost to Follow-up|39|||
131687822|NCT00909181|474142374|FG001|Overall Study|Lost to Follow-up|18|||
131774786|NCT03358407|474454567|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131774787|NCT03358407|474454568|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
131687823|NCT00909181|474142375|FG002|Overall Study|Lost to Follow-up|33|||
131687824|NCT00122681|474142376|FG000|Overall Study|Adverse Event|20|||
131687825|NCT00122681|474142377|FG001|Overall Study|Adverse Event|16|||
131687826|NCT00122681|474142376|FG000|Overall Study|Lost to Follow-up|1080|||
131687827|NCT00122681|474142377|FG001|Overall Study|Lost to Follow-up|1097|||
131687828|NCT00122681|474142376|FG000|Overall Study|Protocol Violation|7|||
131687829|NCT00122681|474142377|FG001|Overall Study|Protocol Violation|10|||
131687830|NCT00122681|474142376|FG000|Overall Study|Withdrawal by Subject|257|||
131687831|NCT00122681|474142377|FG001|Overall Study|Withdrawal by Subject|251|||
131687832|NCT00122681|474142376|FG000|Overall Study|Personal reasons|150|||
131687833|NCT00122681|474142377|FG001|Overall Study|Personal reasons|147|||
131687834|NCT01349465|474142378|FG000|Overall Study|Adverse Event|1|||
131687835|NCT01349465|474142379|FG001|Overall Study|Adverse Event|0|||
131687836|NCT01349465|474142378|FG000|Overall Study|Death|3|||
131687837|NCT01349465|474142379|FG001|Overall Study|Death|0|||
131687838|NCT01349465|474142378|FG000|Overall Study|Lost to Follow-up|10|||
131687839|NCT01349465|474142379|FG001|Overall Study|Lost to Follow-up|1|||
131687840|NCT01349465|474142378|FG000|Overall Study|Withdrawal by Subject|4|||
131687841|NCT01349465|474142379|FG001|Overall Study|Withdrawal by Subject|2|||
131687842|NCT01349465|474142378|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
131687843|NCT01349465|474142379|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
131687844|NCT01486927|474142380|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
131687845|NCT01486927|474142380|FG000|Overall Study|Physician Decision|1|||
131687846|NCT01486927|474142380|FG000|Overall Study|50 Exposure days not reached|2|||
131687847|NCT01486927|474142380|FG000|Overall Study|Withdrawal by Subject|8|||
131687848|NCT01486927|474142380|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
131687849|NCT01476475|474142382|FG000|Overall Study|Adverse Event|6|||
131687850|NCT01476475|474142383|FG001|Overall Study|Adverse Event|0|||
131687851|NCT01476475|474142382|FG000|Overall Study|Poor compliance to protocol|1|||
131687852|NCT01476475|474142383|FG001|Overall Study|Poor compliance to protocol|1|||
131687853|NCT01476475|474142382|FG000|Overall Study|Other reasons|4|||
131687854|NCT01476475|474142383|FG001|Overall Study|Other reasons|2|||
131687855|NCT01278745|474142384|FG000|Overall Study|Death|2|||
131687856|NCT01278745|474142385|FG001|Overall Study|Death|5|||
131687857|NCT01278745|474142386|FG002|Overall Study|Death|7|||
131687858|NCT01278745|474142387|FG003|Overall Study|Death|0|||
131687859|NCT01278745|474142384|FG000|Overall Study|Physician Decision|1|||
131687860|NCT01278745|474142385|FG001|Overall Study|Physician Decision|0|||
131687861|NCT01278745|474142386|FG002|Overall Study|Physician Decision|0|||
131687862|NCT01278745|474142387|FG003|Overall Study|Physician Decision|9|||
131687863|NCT01278745|474142384|FG000|Overall Study|Withdrawal by Subject|1|||
131687864|NCT01278745|474142385|FG001|Overall Study|Withdrawal by Subject|1|||
131687865|NCT01278745|474142386|FG002|Overall Study|Withdrawal by Subject|5|||
131687866|NCT01278745|474142387|FG003|Overall Study|Withdrawal by Subject|1|||
131687867|NCT01278745|474142384|FG000|Overall Study|Sponsor Decision|1|||
131687868|NCT01278745|474142385|FG001|Overall Study|Sponsor Decision|0|||
131687869|NCT01278745|474142386|FG002|Overall Study|Sponsor Decision|62|||
131687870|NCT01278745|474142387|FG003|Overall Study|Sponsor Decision|6|||
131687871|NCT01278745|474142384|FG000|Overall Study|Ineligible|0|||
131687872|NCT01278745|474142385|FG001|Overall Study|Ineligible|0|||
131687873|NCT01278745|474142386|FG002|Overall Study|Ineligible|42|||
131687874|NCT01278745|474142387|FG003|Overall Study|Ineligible|61|||
131774788|NCT03358407|474454569|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
131774789|NCT03358407|474454570|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
131774790|NCT03358407|474454571|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131774791|NCT03358407|474454572|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131774792|NCT03605758|474454573|FG000|Overall Study|Lost to Follow-up|2|||
131774793|NCT03605758|474454574|FG001|Overall Study|Lost to Follow-up|1|||
131774794|NCT03605758|474454573|FG000|Overall Study|Illness|0|||
131774795|NCT03605758|474454574|FG001|Overall Study|Illness|1|||
131774796|NCT03605758|474454573|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
131774797|NCT03605758|474454574|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
131774798|NCT00489411|474454575|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
131774799|NCT00489411|474454576|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
131774800|NCT00489411|474454575|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
131774801|NCT00489411|474454576|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
131774802|NCT00489411|474454575|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
131774803|NCT00489411|474454576|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
131774804|NCT00489411|474454575|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
131774805|NCT00489411|474454576|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
131774806|NCT00489411|474454575|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
131774807|NCT00489411|474454576|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
131774808|NCT00505765|474454577|FG000|Overall Study|Withdrawal by Subject|1|||
131774809|NCT00505765|474454578|FG001|Overall Study|Withdrawal by Subject|0|||
131774810|NCT00505765|474454579|FG002|Overall Study|Withdrawal by Subject|0|||
131774811|NCT00505765|474454577|FG000|Overall Study|Adverse Event|1|||
131774812|NCT00505765|474454578|FG001|Overall Study|Adverse Event|2|||
131774813|NCT00505765|474454579|FG002|Overall Study|Adverse Event|0|||
131774814|NCT00505765|474454577|FG000|Overall Study|Noncompliance|0|||
131774815|NCT00505765|474454578|FG001|Overall Study|Noncompliance|1|||
131774816|NCT00505765|474454579|FG002|Overall Study|Noncompliance|3|||
131774817|NCT03841331|474454580|FG000|Overall Study|Withdrawal by Subject|4|||
131687875|NCT01278745|474142384|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
131687876|NCT01278745|474142385|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
131687877|NCT01278745|474142386|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
131687878|NCT01278745|474142387|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
131687879|NCT01843842|474142388|FG000|Overall Study|Do not meet inclusion criteria|1|||
131687880|NCT01843842|474142389|FG001|Overall Study|Do not meet inclusion criteria|1|||
131687881|NCT00632099|474142393|FG000|Overall Study|Lost to Follow-up|3|||
131687882|NCT00632099|474142394|FG001|Overall Study|Lost to Follow-up|3|||
131687883|NCT03374189|474142395|FG000|Overall Study|Lost to Follow-up|1|||
131687884|NCT03374189|474142396|FG001|Overall Study|Lost to Follow-up|0|||
131687885|NCT02375724|474142397|FG000|Overall Study|Lack of Efficacy|1|||
131774818|NCT03841331|474454581|FG001|Overall Study|Withdrawal by Subject|9|||
131774819|NCT03841331|474454580|FG000|Overall Study|Lost to Follow-up|5|||
131774820|NCT03841331|474454581|FG001|Overall Study|Lost to Follow-up|1|||
131687886|NCT02375724|474142398|FG001|Overall Study|Lack of Efficacy|1|||
131687887|NCT02375724|474142397|FG000|Overall Study|Withdrawal by Subject|1|||
131687888|NCT02375724|474142398|FG001|Overall Study|Withdrawal by Subject|1|||
131687889|NCT02375724|474142397|FG000|Overall Study|Lost to Follow-up|1|||
131687890|NCT02375724|474142398|FG001|Overall Study|Lost to Follow-up|0|||
131687891|NCT02375724|474142397|FG000|Overall Study|Protocol Violation|1|||
131687892|NCT02375724|474142398|FG001|Overall Study|Protocol Violation|0|||
131687893|NCT02375724|474142397|FG000|Overall Study|Adverse Event|2|||
131687894|NCT02375724|474142398|FG001|Overall Study|Adverse Event|4|||
131687895|NCT01309659|474142399|FG000|Overall Study|Protocol Violation|0|||
131687896|NCT01309659|474142400|FG001|Overall Study|Protocol Violation|1|||
131687897|NCT03462576|474142401|FG000|Overall Study|Protocol Violation|5|||
131687898|NCT03462576|474142402|FG001|Overall Study|Protocol Violation|11|||
131687899|NCT03462576|474142403|FG002|Overall Study|Protocol Violation|7|||
131687900|NCT03462576|474142401|FG000|Overall Study|Device Malfunction|0|||
131687901|NCT03462576|474142402|FG001|Overall Study|Device Malfunction|0|||
131687902|NCT03462576|474142403|FG002|Overall Study|Device Malfunction|1|||
131687903|NCT03962101|474142405|FG000|Overall Study|Adverse Event|1|||
131687904|NCT03962101|474142405|FG000|Overall Study|Physician Decision|2|||
131687905|NCT03962101|474142405|FG000|Overall Study|Not related to medical events|1|||
131687906|NCT00271596|474142408|FG000|Overall Study|Protocol Violation|1|||
131687907|NCT00271596|474142409|FG001|Overall Study|Protocol Violation|0|||
131687908|NCT00271596|474142408|FG000|Overall Study|Withdrawal by Subject|0|||
131687909|NCT00271596|474142409|FG001|Overall Study|Withdrawal by Subject|1|||
131687910|NCT04707157|474142410|FG000|Overall Study|Adverse Event|12|||
131687911|NCT04707157|474142411|FG001|Overall Study|Adverse Event|3|||
131687912|NCT04707157|474142410|FG000|Overall Study|Lost to Follow-up|2|||
131687913|NCT04707157|474142411|FG001|Overall Study|Lost to Follow-up|0|||
131687914|NCT04707157|474142410|FG000|Overall Study|Sponsor's decision|1|||
131687915|NCT04707157|474142411|FG001|Overall Study|Sponsor's decision|0|||
131687916|NCT04707157|474142410|FG000|Overall Study|Physician Decision|8|||
131687917|NCT04707157|474142411|FG001|Overall Study|Physician Decision|5|||
131687918|NCT04707157|474142410|FG000|Overall Study|Protocol Deviation|1|||
131687919|NCT04707157|474142411|FG001|Overall Study|Protocol Deviation|0|||
131687920|NCT04707157|474142410|FG000|Overall Study|Withdrawal by Subject|1|||
131687921|NCT04707157|474142411|FG001|Overall Study|Withdrawal by Subject|1|||
131687922|NCT01069172|474142413|FG000|Overall Study|Withdrawal by Subject|1|||
131687923|NCT01069172|474142414|FG001|Overall Study|Withdrawal by Subject|0|||
131687924|NCT04206605|474142415|FG000|Overall Study|Adverse Event|0|||
131687925|NCT04206605|474142416|FG001|Overall Study|Adverse Event|1|||
131687926|NCT04206605|474142415|FG000|Overall Study|Withdrawal by Subject|1|||
131687927|NCT04206605|474142416|FG001|Overall Study|Withdrawal by Subject|0|||
131687928|NCT03901079|474142419|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
131687929|NCT04995055|474142422|FG000|Period 1|COVID-19 Related|1|||
131687930|NCT04995055|474142423|FG001|Period 1|COVID-19 Related|0|||
131687931|NCT04995055|474142422|FG000|Period 1|Withdrawal by Subject|0|||
131687932|NCT04995055|474142423|FG001|Period 1|Withdrawal by Subject|1|||
131687933|NCT04995055|474142422|FG000|Period 1|Subject discontinued due to timing|4|||
131687934|NCT04995055|474142423|FG001|Period 1|Subject discontinued due to timing|4|||
131687935|NCT01066585|474142424|FG000|Overall Study|Protocol Violation|1|||
131687936|NCT01066585|474142425|FG001|Overall Study|Protocol Violation|0|||
131687937|NCT01066585|474142424|FG000|Overall Study|Withdrawal by Subject|0|||
131687938|NCT01066585|474142425|FG001|Overall Study|Withdrawal by Subject|3|||
131687939|NCT00884273|474142426|FG000|Overall Study|Adverse Event|0|||
131687940|NCT00884273|474142427|FG001|Overall Study|Adverse Event|2|||
131687941|NCT00884273|474142426|FG000|Overall Study|Protocol Violation|1|||
131687942|NCT00884273|474142427|FG001|Overall Study|Protocol Violation|3|||
131687943|NCT00884273|474142426|FG000|Overall Study|Practical reasons|1|||
131687944|NCT00884273|474142427|FG001|Overall Study|Practical reasons|0|||
131687945|NCT00578136|474142430|FG000|Overall Study|Not given intervention|1|||
131687946|NCT00578136|474142431|FG001|Overall Study|Not given intervention|1|||
131687947|NCT02047253|474142432|FG000|Overall Study|Lost to Follow-up|8|||
131687948|NCT01987960|474142434|FG000|Period 1|Adverse Event|24|||
131687949|NCT01987960|474142435|FG001|Period 1|Adverse Event|0|||
131687950|NCT01987960|474142436|FG002|Period 1|Adverse Event|0|||
131687951|NCT01987960|474142437|FG003|Period 1|Adverse Event|0|||
131687952|NCT01987960|474142434|FG000|Period 1|Lack of Efficacy|4|||
131687953|NCT01987960|474142435|FG001|Period 1|Lack of Efficacy|0|||
131687954|NCT01987960|474142436|FG002|Period 1|Lack of Efficacy|0|||
131687955|NCT01987960|474142437|FG003|Period 1|Lack of Efficacy|0|||
131687956|NCT01987960|474142434|FG000|Period 1|Non-compliance with IMP|6|||
131687957|NCT01987960|474142435|FG001|Period 1|Non-compliance with IMP|0|||
131687958|NCT01987960|474142436|FG002|Period 1|Non-compliance with IMP|0|||
131687959|NCT01987960|474142437|FG003|Period 1|Non-compliance with IMP|0|||
131687960|NCT01987960|474142434|FG000|Period 1|Protocol Violation|12|||
131687961|NCT01987960|474142435|FG001|Period 1|Protocol Violation|0|||
131687962|NCT01987960|474142436|FG002|Period 1|Protocol Violation|0|||
131687963|NCT01987960|474142437|FG003|Period 1|Protocol Violation|0|||
131687964|NCT01987960|474142434|FG000|Period 1|Withdrawal by Subject|21|||
131687965|NCT01987960|474142435|FG001|Period 1|Withdrawal by Subject|0|||
131774821|NCT03532048|474454583|FG000|Overall Study|Lost to Follow-up|12|||
131774822|NCT03532048|474454584|FG001|Overall Study|Lost to Follow-up|17|||
131774823|NCT03532048|474454583|FG000|Overall Study|Withdrawal by Subject|7|||
131774824|NCT03532048|474454584|FG001|Overall Study|Withdrawal by Subject|0|||
131774825|NCT04366258|474454585|FG000|Baseline Assessments|Screen Failure|21|||
131774826|NCT04366258|474454585|FG000|Baseline Assessments|Early Termination|3|||
131774827|NCT00308555|474454592|FG000|Overall Study|Withdrawal by Subject|1|||
131774828|NCT00308555|474454593|FG001|Overall Study|Withdrawal by Subject|0|||
131774829|NCT00308555|474454592|FG000|Overall Study|Physician Decision|2|||
131774830|NCT00308555|474454593|FG001|Overall Study|Physician Decision|0|||
131774831|NCT00276458|474454594|FG000|Overall Study|Adverse Event|0|||
131774832|NCT00276458|474454595|FG001|Overall Study|Adverse Event|2|||
131774833|NCT00276458|474454594|FG000|Overall Study|Lost to Follow-up|2|||
131774834|NCT00276458|474454595|FG001|Overall Study|Lost to Follow-up|2|||
131774835|NCT00276458|474454594|FG000|Overall Study|Protocol Violation|4|||
131774836|NCT00276458|474454595|FG001|Overall Study|Protocol Violation|3|||
131774837|NCT02940392|474454600|FG000|Overall Study|Lost to Follow-up|3|||
131774838|NCT02940392|474454600|FG000|Overall Study|Retreatment|3|||
131774839|NCT02940392|474454600|FG000|Overall Study|Death|2|||
131774840|NCT03205046|474454602|FG000|Overall Study|Death|10|||
131774841|NCT03205046|474454603|FG001|Overall Study|Death|6|||
131774842|NCT03205046|474454602|FG000|Overall Study|Withdrawal by Subject|1|||
131774843|NCT03205046|474454603|FG001|Overall Study|Withdrawal by Subject|2|||
131774844|NCT03205046|474454602|FG000|Overall Study|Lost to Follow-up|0|||
131774845|NCT03205046|474454603|FG001|Overall Study|Lost to Follow-up|1|||
131774846|NCT03205046|474454602|FG000|Overall Study|Study terminated by sponsor|2|||
131774847|NCT03205046|474454603|FG001|Overall Study|Study terminated by sponsor|1|||
131774848|NCT01023815|474454604|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
131774849|NCT01023815|474454605|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
131774850|NCT01023815|474454606|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
131774851|NCT01023815|474454607|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
131774852|NCT01023815|474454604|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
131774853|NCT01023815|474454605|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
131774854|NCT01023815|474454606|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
131774855|NCT01023815|474454607|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
131774856|NCT01023815|474454604|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
131774857|NCT01023815|474454605|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
131774858|NCT01023815|474454606|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
131774859|NCT01023815|474454607|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
131774860|NCT01023815|474454604|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
131774861|NCT01023815|474454605|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
131774862|NCT01023815|474454606|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
131774863|NCT01023815|474454607|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
131774864|NCT01023815|474454604|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
131774865|NCT01023815|474454605|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
131774866|NCT01023815|474454606|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
131774867|NCT01023815|474454607|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
131774868|NCT03253809|474454610|FG000|Overall Study|Unable to obtain study related data|14|||
131774869|NCT03992456|474454611|FG000|Overall Study|Withdrawal by Subject|1|||
131774870|NCT03992456|474454612|FG001|Overall Study|Withdrawal by Subject|0|||
131774871|NCT03992456|474454611|FG000|Overall Study|Disease progression|4|||
131774872|NCT03992456|474454612|FG001|Overall Study|Disease progression|5|||
131774873|NCT03992456|474454611|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
131774874|NCT03992456|474454612|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
131774875|NCT00910000|474454613|FG000|Overall Study|Adverse Event|0|||
131774876|NCT00910000|474454614|FG001|Overall Study|Adverse Event|3|||
131774877|NCT00910000|474454615|FG002|Overall Study|Adverse Event|2|||
131774878|NCT00910000|474454616|FG003|Overall Study|Adverse Event|2|||
131774879|NCT00910000|474454617|FG004|Overall Study|Adverse Event|0|||
131774880|NCT00910000|474454618|FG005|Overall Study|Adverse Event|1|||
131774881|NCT00910000|474454613|FG000|Overall Study|Withdrawal by Subject|0|||
131774882|NCT00910000|474454614|FG001|Overall Study|Withdrawal by Subject|0|||
131774883|NCT00910000|474454615|FG002|Overall Study|Withdrawal by Subject|1|||
131774884|NCT00910000|474454616|FG003|Overall Study|Withdrawal by Subject|0|||
131774885|NCT00910000|474454617|FG004|Overall Study|Withdrawal by Subject|1|||
131774886|NCT00910000|474454618|FG005|Overall Study|Withdrawal by Subject|0|||
131774887|NCT01977625|474454619|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
131774888|NCT01977625|474454620|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131774889|NCT01977625|474454619|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131774890|NCT01977625|474454620|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
131774891|NCT03125382|474454622|FG000|Randomization|screening failure|1|||
131774892|NCT03125382|474454623|FG001|Randomization|screening failure|4|||
131774893|NCT03125382|474454624|FG002|Randomization|screening failure|2|||
131774894|NCT03125382|474454625|FG003|Randomization|screening failure|0|||
131774895|NCT03125382|474454622|FG000|Follow-up|Death|1|||
131774896|NCT03125382|474454623|FG001|Follow-up|Death|2|||
131774897|NCT03125382|474454624|FG002|Follow-up|Death|1|||
131774898|NCT03125382|474454625|FG003|Follow-up|Death|2|||
131774899|NCT03125382|474454622|FG000|Follow-up|Lost to Follow-up|1|||
131774900|NCT03125382|474454623|FG001|Follow-up|Lost to Follow-up|4|||
131774901|NCT03125382|474454624|FG002|Follow-up|Lost to Follow-up|3|||
131774902|NCT03125382|474454625|FG003|Follow-up|Lost to Follow-up|1|||
131774903|NCT02686749|474454626|FG000|Overall Study|terminated for poor enrollment|2|||
131774904|NCT02686749|474454627|FG001|Overall Study|terminated for poor enrollment|2|||
131774905|NCT04668066|474454628|FG000|Part 1: Treatment Phase|Adverse Event|0|||
131774906|NCT04668066|474454629|FG001|Part 1: Treatment Phase|Adverse Event|0|||
131774907|NCT04668066|474454630|FG002|Part 1: Treatment Phase|Adverse Event|0|||
131774908|NCT04668066|474454631|FG003|Part 1: Treatment Phase|Adverse Event|0|||
131774909|NCT04668066|474454632|FG004|Part 1: Treatment Phase|Adverse Event|0|||
131774910|NCT04668066|474454633|FG005|Part 1: Treatment Phase|Adverse Event|0|||
131774911|NCT04668066|474454634|FG006|Part 1: Treatment Phase|Adverse Event|0|||
131774912|NCT04668066|474454635|FG007|Part 1: Treatment Phase|Adverse Event|0|||
131774913|NCT04668066|474454636|FG008|Part 1: Treatment Phase|Adverse Event|0|||
131774914|NCT04668066|474454637|FG009|Part 1: Treatment Phase|Adverse Event|0|||
131774915|NCT04668066|474454638|FG010|Part 1: Treatment Phase|Adverse Event|0|||
131774916|NCT04668066|474454639|FG011|Part 1: Treatment Phase|Adverse Event|1|||
131774917|NCT04668066|474454640|FG012|Part 1: Treatment Phase|Adverse Event|1|||
131774918|NCT04668066|474454641|FG013|Part 1: Treatment Phase|Adverse Event|0|||
131774919|NCT04668066|474454642|FG014|Part 1: Treatment Phase|Adverse Event|0|||
131774920|NCT04668066|474454643|FG015|Part 1: Treatment Phase|Adverse Event|0|||
131774921|NCT04668066|474454644|FG016|Part 1: Treatment Phase|Adverse Event|0|||
131774922|NCT04668066|474454645|FG017|Part 1: Treatment Phase|Adverse Event|0|||
131774923|NCT04668066|474454646|FG018|Part 1: Treatment Phase|Adverse Event|0|||
131774924|NCT04668066|474454628|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774925|NCT04668066|474454629|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774926|NCT04668066|474454630|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
131774927|NCT04668066|474454631|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774928|NCT04668066|474454632|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774929|NCT04668066|474454633|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774930|NCT04668066|474454634|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774931|NCT04668066|474454635|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774932|NCT04668066|474454636|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774933|NCT04668066|474454637|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774934|NCT04668066|474454638|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774935|NCT04668066|474454639|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774936|NCT04668066|474454640|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774937|NCT04668066|474454641|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774938|NCT04668066|474454642|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774939|NCT04668066|474454643|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774940|NCT04668066|474454644|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774941|NCT04668066|474454645|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774942|NCT04668066|474454646|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
131774943|NCT04668066|474454628|FG000|Part 1: Treatment Phase|Other|0|||
131774944|NCT04668066|474454629|FG001|Part 1: Treatment Phase|Other|0|||
131774945|NCT04668066|474454630|FG002|Part 1: Treatment Phase|Other|0|||
131774946|NCT04668066|474454631|FG003|Part 1: Treatment Phase|Other|0|||
131774947|NCT04668066|474454632|FG004|Part 1: Treatment Phase|Other|0|||
131774948|NCT04668066|474454633|FG005|Part 1: Treatment Phase|Other|0|||
131774949|NCT04668066|474454634|FG006|Part 1: Treatment Phase|Other|0|||
131774950|NCT04668066|474454635|FG007|Part 1: Treatment Phase|Other|0|||
131774951|NCT04668066|474454636|FG008|Part 1: Treatment Phase|Other|0|||
131774952|NCT04668066|474454637|FG009|Part 1: Treatment Phase|Other|0|||
131774953|NCT04668066|474454638|FG010|Part 1: Treatment Phase|Other|0|||
131774954|NCT04668066|474454639|FG011|Part 1: Treatment Phase|Other|1|||
131774955|NCT04668066|474454640|FG012|Part 1: Treatment Phase|Other|0|||
131774956|NCT04668066|474454641|FG013|Part 1: Treatment Phase|Other|0|||
131774957|NCT04668066|474454642|FG014|Part 1: Treatment Phase|Other|0|||
131774958|NCT04668066|474454643|FG015|Part 1: Treatment Phase|Other|0|||
131774959|NCT04668066|474454644|FG016|Part 1: Treatment Phase|Other|0|||
131774960|NCT04668066|474454645|FG017|Part 1: Treatment Phase|Other|0|||
131774961|NCT04668066|474454646|FG018|Part 1: Treatment Phase|Other|0|||
131774962|NCT04668066|474454628|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774963|NCT04668066|474454629|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774964|NCT04668066|474454630|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774965|NCT04668066|474454631|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774966|NCT04668066|474454632|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774967|NCT04668066|474454633|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774968|NCT04668066|474454634|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774969|NCT04668066|474454635|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774970|NCT04668066|474454636|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774971|NCT04668066|474454637|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131687966|NCT01987960|474142436|FG002|Period 1|Withdrawal by Subject|0|||
131687967|NCT01987960|474142437|FG003|Period 1|Withdrawal by Subject|0|||
131687968|NCT01987960|474142434|FG000|Period 1|Lost to Follow-up|40|||
131687969|NCT01987960|474142435|FG001|Period 1|Lost to Follow-up|0|||
131687970|NCT01987960|474142436|FG002|Period 1|Lost to Follow-up|0|||
131687971|NCT01987960|474142437|FG003|Period 1|Lost to Follow-up|0|||
131687972|NCT01987960|474142434|FG000|Period 1|administrative or other reason|75|||
131687973|NCT01987960|474142435|FG001|Period 1|administrative or other reason|0|||
131687974|NCT01987960|474142436|FG002|Period 1|administrative or other reason|0|||
131687975|NCT01987960|474142437|FG003|Period 1|administrative or other reason|0|||
131687976|NCT01987960|474142434|FG000|Period 1|Withdrawal of consent before treatment|4|||
131687977|NCT01987960|474142435|FG001|Period 1|Withdrawal of consent before treatment|0|||
131687978|NCT01987960|474142436|FG002|Period 1|Withdrawal of consent before treatment|0|||
131687979|NCT01987960|474142437|FG003|Period 1|Withdrawal of consent before treatment|0|||
131687980|NCT01987960|474142434|FG000|Period 2|Adverse Event|0|||
131687981|NCT01987960|474142435|FG001|Period 2|Adverse Event|0|||
131687982|NCT01987960|474142436|FG002|Period 2|Adverse Event|1|||
131687983|NCT01987960|474142437|FG003|Period 2|Adverse Event|0|||
131687984|NCT01987960|474142434|FG000|Period 2|Withdrawal by Subject|0|||
131687985|NCT01987960|474142435|FG001|Period 2|Withdrawal by Subject|0|||
131687986|NCT01987960|474142436|FG002|Period 2|Withdrawal by Subject|1|||
131687987|NCT01987960|474142437|FG003|Period 2|Withdrawal by Subject|0|||
131687988|NCT01987960|474142434|FG000|Period 2|Administrative or other reason|0|||
131687989|NCT01987960|474142435|FG001|Period 2|Administrative or other reason|5|||
131687990|NCT01987960|474142436|FG002|Period 2|Administrative or other reason|7|||
131687991|NCT01987960|474142437|FG003|Period 2|Administrative or other reason|0|||
131687992|NCT01987960|474142434|FG000|Period 3|Adverse Event|0|||
131687993|NCT01987960|474142435|FG001|Period 3|Adverse Event|0|||
131687994|NCT01987960|474142436|FG002|Period 3|Adverse Event|0|||
131687995|NCT01987960|474142437|FG003|Period 3|Adverse Event|7|||
131687996|NCT01987960|474142434|FG000|Period 3|Non-compliance with IMP|0|||
131687997|NCT01987960|474142435|FG001|Period 3|Non-compliance with IMP|0|||
131687998|NCT01987960|474142436|FG002|Period 3|Non-compliance with IMP|0|||
131687999|NCT01987960|474142437|FG003|Period 3|Non-compliance with IMP|1|||
131688000|NCT01987960|474142434|FG000|Period 3|Protocol Violation|0|||
131688001|NCT01987960|474142435|FG001|Period 3|Protocol Violation|0|||
131688002|NCT01987960|474142436|FG002|Period 3|Protocol Violation|0|||
131688003|NCT01987960|474142437|FG003|Period 3|Protocol Violation|6|||
131688004|NCT01987960|474142434|FG000|Period 3|Withdrawal by Subject|0|||
131688005|NCT01987960|474142435|FG001|Period 3|Withdrawal by Subject|0|||
131688006|NCT01987960|474142436|FG002|Period 3|Withdrawal by Subject|0|||
131688007|NCT01987960|474142437|FG003|Period 3|Withdrawal by Subject|9|||
131688008|NCT01987960|474142434|FG000|Period 3|Lost to Follow-up|0|||
131688009|NCT01987960|474142435|FG001|Period 3|Lost to Follow-up|0|||
131688010|NCT01987960|474142436|FG002|Period 3|Lost to Follow-up|0|||
131688011|NCT01987960|474142437|FG003|Period 3|Lost to Follow-up|5|||
131688012|NCT01987960|474142434|FG000|Period 3|Administrative or other reason|0|||
131688013|NCT01987960|474142435|FG001|Period 3|Administrative or other reason|0|||
131688014|NCT01987960|474142436|FG002|Period 3|Administrative or other reason|0|||
131688015|NCT01987960|474142437|FG003|Period 3|Administrative or other reason|43|||
131688016|NCT02536313|474142440|FG000|Overall Study|Lack of Efficacy|0|||
131688017|NCT02536313|474142441|FG001|Overall Study|Lack of Efficacy|1|||
131688018|NCT00993265|474142452|FG000|Overall Study|Adverse Event|1|||
131688019|NCT00993265|474142453|FG001|Overall Study|Adverse Event|0|||
131688020|NCT00993265|474142452|FG000|Overall Study|Changed dose of concomitant drug|2|||
131688021|NCT00993265|474142453|FG001|Overall Study|Changed dose of concomitant drug|0|||
131688022|NCT00993265|474142452|FG000|Overall Study|Non-compliant with study medication|1|||
131774972|NCT04668066|474454638|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774973|NCT04668066|474454639|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131688023|NCT00993265|474142453|FG001|Overall Study|Non-compliant with study medication|0|||
131688024|NCT02090413|474142455|FG000|Overall Study|Adverse Event|11|||
131688025|NCT02090413|474142456|FG001|Overall Study|Adverse Event|15|||
131688026|NCT02090413|474142457|FG002|Overall Study|Adverse Event|20|||
131688027|NCT02090413|474142455|FG000|Overall Study|Flushing event|2|||
131688028|NCT02090413|474142456|FG001|Overall Study|Flushing event|0|||
131688029|NCT02090413|474142457|FG002|Overall Study|Flushing event|1|||
131688030|NCT02090413|474142455|FG000|Overall Study|Withdrawal by Subject|2|||
131688031|NCT02090413|474142456|FG001|Overall Study|Withdrawal by Subject|2|||
131688032|NCT02090413|474142457|FG002|Overall Study|Withdrawal by Subject|2|||
131688033|NCT02090413|474142455|FG000|Overall Study|Investigator Decision|1|||
131688034|NCT02090413|474142456|FG001|Overall Study|Investigator Decision|1|||
131688035|NCT02090413|474142457|FG002|Overall Study|Investigator Decision|0|||
131688036|NCT02090413|474142455|FG000|Overall Study|Other|2|||
131774974|NCT04668066|474454640|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
131688037|NCT02090413|474142456|FG001|Overall Study|Other|1|||
131688038|NCT02090413|474142457|FG002|Overall Study|Other|0|||
131774975|NCT04668066|474454641|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131688039|NCT02090413|474142455|FG000|Overall Study|Lost to Follow-up|1|||
131898529|NCT00320788|474914096|FG000|Overall Study|Protocol Violation|0|||
131688040|NCT02090413|474142456|FG001|Overall Study|Lost to Follow-up|1|||
131688041|NCT02090413|474142457|FG002|Overall Study|Lost to Follow-up|0|||
131688042|NCT02321930|474142462|FG000|Overall Study|Lost to Follow-up|1|||
131688043|NCT00853749|474142463|FG000|Overall Study|Lost to Follow-up|0|||
131688044|NCT00853749|474142464|FG001|Overall Study|Lost to Follow-up|1|||
131688045|NCT02269787|474142467|FG000|Overall Study|Lost to Follow-up|20|||
131688046|NCT02269787|474142468|FG001|Overall Study|Lost to Follow-up|6|||
131688047|NCT02269787|474142467|FG000|Overall Study|Death|2|||
131688048|NCT02269787|474142468|FG001|Overall Study|Death|3|||
131688049|NCT02269787|474142467|FG000|Overall Study|Incapacitated|0|||
131688050|NCT02269787|474142468|FG001|Overall Study|Incapacitated|1|||
131688051|NCT00798135|474142469|FG000|Overall Study|Disease progression, relapse|11|||
131688052|NCT00798135|474142469|FG000|Overall Study|Disease progression, refractory|1|||
131688053|NCT00798135|474142469|FG000|Overall Study|Physician Decision|1|||
131688054|NCT00687440|474142470|FG000|Overall Study|Adverse Event|3|||
131688055|NCT00687440|474142470|FG000|Overall Study|Lost to Follow-up|3|||
131688056|NCT00687440|474142470|FG000|Overall Study|Lack of Efficacy|2|||
131688057|NCT00687440|474142470|FG000|Overall Study|Death|2|||
131688058|NCT00687440|474142470|FG000|Overall Study|Other|1|||
131688059|NCT00687440|474142470|FG000|Overall Study|Missing|1|||
131688060|NCT02228720|474142471|FG000|Open Label - Day 30|Lost to Follow-up|1|||
131688061|NCT01392677|474142474|FG000|Overall Study|Adverse Event|3|||
131688062|NCT01392677|474142475|FG001|Overall Study|Adverse Event|1|||
131688063|NCT01392677|474142474|FG000|Overall Study|Withdrawal by Subject|0|||
131688064|NCT01392677|474142475|FG001|Overall Study|Withdrawal by Subject|2|||
131688065|NCT01392677|474142474|FG000|Overall Study|Incorrect enrollment|2|||
131688066|NCT01392677|474142475|FG001|Overall Study|Incorrect enrollment|3|||
131688067|NCT01392677|474142474|FG000|Overall Study|Other reason|3|||
131688068|NCT01392677|474142475|FG001|Overall Study|Other reason|2|||
131688069|NCT03996876|474142476|FG000|Overall Study|Incomplete Data|2|||
131688070|NCT03996876|474142477|FG001|Overall Study|Incomplete Data|4|||
131688071|NCT05885737|474142482|FG000|DB Period|Adverse Event|4|||
131688072|NCT05885737|474142483|FG001|DB Period|Adverse Event|4|||
131688073|NCT05885737|474142482|FG000|DB Period|Lost to Follow-up|0|||
131688074|NCT05885737|474142483|FG001|DB Period|Lost to Follow-up|1|||
131688075|NCT05885737|474142482|FG000|DB Period|Physician Decision|2|||
131688076|NCT05885737|474142483|FG001|DB Period|Physician Decision|0|||
131688077|NCT05885737|474142482|FG000|DB Period|Withdrawal by Subject|12|||
131688078|NCT05885737|474142483|FG001|DB Period|Withdrawal by Subject|6|||
131688079|NCT05885737|474142482|FG000|DB Period|Other: Unspecified|2|||
131688080|NCT05885737|474142483|FG001|DB Period|Other: Unspecified|2|||
131688081|NCT05885737|474142482|FG000|OLE Period|Adverse Event|3|||
131688082|NCT05885737|474142483|FG001|OLE Period|Adverse Event|2|||
131688083|NCT05885737|474142482|FG000|OLE Period|Physician Decision|1|||
131688084|NCT05885737|474142483|FG001|OLE Period|Physician Decision|0|||
131688085|NCT05885737|474142482|FG000|OLE Period|Withdrawal by Subject|5|||
131688086|NCT05885737|474142483|FG001|OLE Period|Withdrawal by Subject|5|||
131688087|NCT05885737|474142482|FG000|OLE Period|Other: Unspecified|2|||
131688088|NCT05885737|474142483|FG001|OLE Period|Other: Unspecified|1|||
131688089|NCT01617460|474143670|FG000|Overall Study|Adverse Event|10|||
131688090|NCT01617460|474143670|FG000|Overall Study|Physician Decision|16|||
131688091|NCT01617460|474143670|FG000|Overall Study|Protocol Violation|5|||
131688092|NCT01617460|474143670|FG000|Overall Study|Withdrawal by Subject|9|||
131688093|NCT03703882|474143671|FG000|Overall Study|Adverse Event|1|||
131688094|NCT03703882|474143672|FG001|Overall Study|Adverse Event|0|||
131688095|NCT03703882|474143671|FG000|Overall Study|Lost to Follow-up|0|||
131688096|NCT03703882|474143672|FG001|Overall Study|Lost to Follow-up|2|||
131688097|NCT03703882|474143671|FG000|Overall Study|Non-compliance with study drug|0|||
131688098|NCT03703882|474143672|FG001|Overall Study|Non-compliance with study drug|1|||
131688099|NCT03703882|474143671|FG000|Overall Study|Physician Decision|0|||
131688100|NCT03703882|474143672|FG001|Overall Study|Physician Decision|1|||
131688101|NCT03703882|474143671|FG000|Overall Study|Progressive disease|1|||
131688102|NCT03703882|474143672|FG001|Overall Study|Progressive disease|0|||
131688103|NCT03703882|474143671|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131688104|NCT03703882|474143672|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131688105|NCT03703882|474143671|FG000|Overall Study|Starting another treatment|0|||
131688106|NCT03703882|474143672|FG001|Overall Study|Starting another treatment|1|||
131688107|NCT03703882|474143671|FG000|Overall Study|noncompliance with study procedures|0|||
131688108|NCT03703882|474143672|FG001|Overall Study|noncompliance with study procedures|1|||
131688109|NCT04342871|474143679|FG000|Overall Study|Death|4|||
131688110|NCT04342871|474143679|FG000|Overall Study|Clinical deterioration/illness progression|2|||
131688111|NCT04342871|474143679|FG000|Overall Study|Did not complete baseline assessments|5|||
131688112|NCT04342871|474143679|FG000|Overall Study|Lost to Follow-up|13|||
131688113|NCT03670953|474143680|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
131688114|NCT03670953|474143681|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
131688115|NCT03670953|474143682|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
131688116|NCT03670953|474143683|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
131688117|NCT03670953|474143680|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
131688118|NCT03670953|474143681|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
131688119|NCT03670953|474143682|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
131688120|NCT03670953|474143683|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
131688121|NCT03670953|474143680|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
131688122|NCT03670953|474143681|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
131688123|NCT03670953|474143682|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
131688124|NCT03670953|474143683|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
131688125|NCT03670953|474143680|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
131688126|NCT03670953|474143681|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
131688127|NCT03670953|474143682|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
131688128|NCT03670953|474143683|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
131688129|NCT03670953|474143680|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
131688130|NCT03670953|474143681|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
131688131|NCT03670953|474143682|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
131688132|NCT03670953|474143683|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
131688133|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
131688134|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
131688135|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
131688136|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
131688137|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
131688138|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
131688139|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
131688140|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
131688141|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
131688142|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
131688143|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
131688144|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
131688145|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
131688146|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
131688147|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
131688148|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
131688149|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
131688150|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
131688151|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
131688152|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
131688153|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
131688154|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
131688155|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
131688156|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
131688157|NCT03670953|474143680|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
131688158|NCT03670953|474143681|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
131688159|NCT03670953|474143682|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
131688160|NCT03670953|474143683|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
131688161|NCT03670953|474143680|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
131688162|NCT03670953|474143681|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
131688163|NCT03670953|474143682|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
131688164|NCT03670953|474143683|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
131688165|NCT03670953|474143680|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
131688166|NCT03670953|474143681|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
131688167|NCT03670953|474143682|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
131688168|NCT03670953|474143683|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
131688169|NCT03670953|474143680|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
131688170|NCT03670953|474143681|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
131688171|NCT03670953|474143682|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
131688172|NCT03670953|474143683|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
131688173|NCT03670953|474143680|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
131688174|NCT03670953|474143681|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
131688175|NCT03670953|474143682|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
131688176|NCT03670953|474143683|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
131688177|NCT03670953|474143680|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
131688178|NCT03670953|474143681|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
131688179|NCT03670953|474143682|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
131898530|NCT00320788|474914097|FG001|Overall Study|Protocol Violation|0|||
131774976|NCT04668066|474454642|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774977|NCT04668066|474454643|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
131774978|NCT04668066|474454644|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774979|NCT04668066|474454645|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774980|NCT04668066|474454646|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131774981|NCT04668066|474454628|FG000|Part 1: Follow-Up|Adverse Event|0|||
131774982|NCT04668066|474454629|FG001|Part 1: Follow-Up|Adverse Event|0|||
131774983|NCT04668066|474454630|FG002|Part 1: Follow-Up|Adverse Event|0|||
131774984|NCT04668066|474454631|FG003|Part 1: Follow-Up|Adverse Event|0|||
131774985|NCT04668066|474454632|FG004|Part 1: Follow-Up|Adverse Event|0|||
131774986|NCT04668066|474454633|FG005|Part 1: Follow-Up|Adverse Event|0|||
131774987|NCT04668066|474454634|FG006|Part 1: Follow-Up|Adverse Event|0|||
131774988|NCT04668066|474454635|FG007|Part 1: Follow-Up|Adverse Event|0|||
131774989|NCT04668066|474454636|FG008|Part 1: Follow-Up|Adverse Event|0|||
131688180|NCT03670953|474143683|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
131688181|NCT03670953|474143680|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
131688182|NCT03670953|474143681|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
131688183|NCT03670953|474143682|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
131688184|NCT03670953|474143683|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
131688185|NCT04179734|474143684|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
131688186|NCT04179734|474143685|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
131688187|NCT04179734|474143684|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
131688188|NCT04179734|474143685|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
131688189|NCT00666458|474143687|FG000|Overall Study|Adverse Event|8|||
131688190|NCT00666458|474143688|FG001|Overall Study|Adverse Event|7|||
131688191|NCT00666458|474143687|FG000|Overall Study|Withdrawal by Subject|5|||
131688192|NCT00666458|474143688|FG001|Overall Study|Withdrawal by Subject|4|||
131688193|NCT00666458|474143687|FG000|Overall Study|Lost to Follow-up|0|||
131688194|NCT00666458|474143688|FG001|Overall Study|Lost to Follow-up|3|||
131688195|NCT00666458|474143687|FG000|Overall Study|Administrative reason by sponsor|1|||
131688196|NCT00666458|474143688|FG001|Overall Study|Administrative reason by sponsor|1|||
131688197|NCT00666458|474143687|FG000|Overall Study|Incorrect enrollment|7|||
131688198|NCT00666458|474143688|FG001|Overall Study|Incorrect enrollment|1|||
131688199|NCT00666458|474143687|FG000|Overall Study|Study specific discontinuation criteria|14|||
131688200|NCT00666458|474143688|FG001|Overall Study|Study specific discontinuation criteria|7|||
131688201|NCT00666458|474143687|FG000|Overall Study|Severe non-compliance to the protocol|1|||
131688202|NCT00666458|474143688|FG001|Overall Study|Severe non-compliance to the protocol|1|||
131688203|NCT00666458|474143687|FG000|Overall Study|Safety reasons|1|||
131688204|NCT00666458|474143688|FG001|Overall Study|Safety reasons|0|||
131688205|NCT00666458|474143687|FG000|Overall Study|Medical history of anemia|1|||
131688206|NCT00666458|474143688|FG001|Overall Study|Medical history of anemia|0|||
131688207|NCT02222207|474143690|FG000|Overall Study|Death|1|||
131688208|NCT02222207|474143690|FG000|Overall Study|Other reasons|2|||
131688209|NCT02222207|474143690|FG000|Overall Study|Adverse Event|1|||
131688210|NCT02982954|474143691|FG000|Overall Study|Death|55|||
131688211|NCT02982954|474143692|FG001|Overall Study|Death|29|||
131688212|NCT02982954|474143693|FG002|Overall Study|Death|15|||
131688213|NCT02982954|474143694|FG003|Overall Study|Death|20|||
131688214|NCT02982954|474143691|FG000|Overall Study|Lost to Follow-up|2|||
131688215|NCT02982954|474143692|FG001|Overall Study|Lost to Follow-up|1|||
131688216|NCT02982954|474143693|FG002|Overall Study|Lost to Follow-up|0|||
131688217|NCT02982954|474143694|FG003|Overall Study|Lost to Follow-up|0|||
131688218|NCT02982954|474143691|FG000|Overall Study|Participant withdrew consent|7|||
131688219|NCT02982954|474143692|FG001|Overall Study|Participant withdrew consent|5|||
131688220|NCT02982954|474143693|FG002|Overall Study|Participant withdrew consent|1|||
131688221|NCT02982954|474143694|FG003|Overall Study|Participant withdrew consent|1|||
131688222|NCT02982954|474143691|FG000|Overall Study|Other reasons|42|||
131688223|NCT02982954|474143692|FG001|Overall Study|Other reasons|17|||
131688224|NCT02982954|474143693|FG002|Overall Study|Other reasons|12|||
131688225|NCT02982954|474143694|FG003|Overall Study|Other reasons|3|||
131688226|NCT02982954|474143691|FG000|Overall Study|Premature site closure|0|||
131688227|NCT02982954|474143692|FG001|Overall Study|Premature site closure|0|||
131688228|NCT02982954|474143693|FG002|Overall Study|Premature site closure|0|||
131688229|NCT02982954|474143694|FG003|Overall Study|Premature site closure|1|||
131688230|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
131688231|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
131688232|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
131688233|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
131688234|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
131688235|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
131688236|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Death|2|||
131688237|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Death|0|||
131688238|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
131688239|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
131688240|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
131688241|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
131688242|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
131688243|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
131688244|NCT02603120|474143695|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
131688245|NCT02603120|474143696|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
131688246|NCT02603120|474143695|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
131688247|NCT02603120|474143696|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
131688248|NCT02603120|474143695|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
131688249|NCT02603120|474143696|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
131688250|NCT02603120|474143695|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
131688251|NCT02603120|474143696|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
131688252|NCT02603120|474143695|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
131688253|NCT02603120|474143696|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
131688254|NCT02603120|474143695|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
131688255|NCT02603120|474143696|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
131688256|NCT02603120|474143695|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
131688257|NCT02603120|474143696|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
131688258|NCT00176605|474143697|FG000|Overall Study|Withdrawal by Subject|2|||
131688259|NCT01321710|474143698|FG000|Overall Study|Lost to Follow-up|4|||
131688260|NCT01321710|474143699|FG001|Overall Study|Lost to Follow-up|5|||
131688261|NCT01321710|474143700|FG002|Overall Study|Lost to Follow-up|0|||
131688262|NCT01227187|474143701|FG000|Overall Study|Physician Decision|0|||
131688263|NCT01227187|474143702|FG001|Overall Study|Physician Decision|0|||
131688264|NCT01227187|474143703|FG002|Overall Study|Physician Decision|0|||
131688265|NCT01227187|474143704|FG003|Overall Study|Physician Decision|1|||
131688266|NCT01761292|474143705|FG000|Part 1|Adverse Event|1|||
131688267|NCT01761292|474143705|FG000|Part 1|not receiving treatment in Part 1|1|||
131688268|NCT01761292|474143705|FG000|Extension 1|Withdrawal by Subject|1|||
131688269|NCT00840086|474143706|FG000|Overall Study|Adverse Event|1|||
131688270|NCT00840086|474143706|FG000|Overall Study|Protocol Violation|2|||
131688271|NCT00840086|474143706|FG000|Overall Study|Lost to Follow-up|1|||
131688272|NCT03332498|474143707|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
131688273|NCT03332498|474143708|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
131688274|NCT03332498|474143709|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
131688275|NCT04036708|474143710|FG000|Overall Study|Lost to Follow-up|14|||
131688276|NCT04036708|474143711|FG001|Overall Study|Lost to Follow-up|4|||
131688277|NCT04036708|474143712|FG002|Overall Study|Lost to Follow-up|14|||
131688278|NCT04036708|474143713|FG003|Overall Study|Lost to Follow-up|4|||
131688279|NCT03577730|474143715|FG000|Overall Study|Physician Decision|3|||
131688280|NCT03577730|474143716|FG001|Overall Study|Physician Decision|1|||
131688281|NCT03577730|474143715|FG000|Overall Study|Did not receive allocated intervention|1|||
131688282|NCT03577730|474143716|FG001|Overall Study|Did not receive allocated intervention|0|||
131688283|NCT01444742|474143719|FG000|Overall Study|Death|1|||
131688284|NCT02535715|474143720|FG000|Overall Study|Withdrawal by Subject|0|||
131688285|NCT02535715|474143721|FG001|Overall Study|Withdrawal by Subject|0|||
131688286|NCT02535715|474143722|FG002|Overall Study|Withdrawal by Subject|1|||
131688287|NCT02349048|474143724|FG000|Overall Study|Withdrawal by Subject|4|||
131688288|NCT02349048|474143725|FG001|Overall Study|Withdrawal by Subject|0|||
131688289|NCT02349048|474143724|FG000|Overall Study|Lost to Follow-up|1|||
131688290|NCT02349048|474143725|FG001|Overall Study|Lost to Follow-up|0|||
131688291|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
131688292|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
131688293|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
131688294|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
131688295|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
131688296|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
131688297|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
131688298|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
131688299|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
131688300|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
131688301|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
131688302|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
131688303|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
131688304|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
131688305|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
131688306|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
131688307|NCT00094770|474143728|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
131688308|NCT00094770|474143729|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
131688309|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
131688310|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
131688311|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
131688312|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
131688313|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
131688314|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
131688315|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
131688316|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
131688317|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
131688318|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
131688319|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
131688320|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
131688321|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
131688322|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
131688323|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
131688324|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
131688325|NCT00094770|474143728|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
131688326|NCT00094770|474143729|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
131688327|NCT01911442|474143730|FG000|Overall Study|Adverse Event|2|||
131688328|NCT01911442|474143731|FG001|Overall Study|Adverse Event|2|||
131688329|NCT01911442|474143732|FG002|Overall Study|Adverse Event|4|||
131688330|NCT01911442|474143730|FG000|Overall Study|Lack of Efficacy|1|||
131688331|NCT01911442|474143731|FG001|Overall Study|Lack of Efficacy|1|||
131688332|NCT01911442|474143732|FG002|Overall Study|Lack of Efficacy|1|||
131688333|NCT01911442|474143730|FG000|Overall Study|Lost to Follow-up|2|||
131688334|NCT01911442|474143731|FG001|Overall Study|Lost to Follow-up|0|||
131688335|NCT01911442|474143732|FG002|Overall Study|Lost to Follow-up|1|||
131688336|NCT01911442|474143730|FG000|Overall Study|Withdrawal by Subject|1|||
131688337|NCT01911442|474143731|FG001|Overall Study|Withdrawal by Subject|0|||
131688338|NCT01911442|474143732|FG002|Overall Study|Withdrawal by Subject|6|||
131688339|NCT01911442|474143730|FG000|Overall Study|Mother's Work Schedule|0|||
131688340|NCT01911442|474143731|FG001|Overall Study|Mother's Work Schedule|1|||
131688341|NCT01911442|474143732|FG002|Overall Study|Mother's Work Schedule|0|||
131688342|NCT04773106|474143736|FG000|Overall Study|Withdrawal by Subject|3|||
131688343|NCT04773106|474143736|FG000|Overall Study|Death|1|||
131688344|NCT01265615|474143739|FG000|Overall Study|Protocol Violation|2|||
131688345|NCT01265615|474143740|FG001|Overall Study|Protocol Violation|2|||
131688346|NCT01265615|474143741|FG002|Overall Study|Protocol Violation|4|||
131688347|NCT01265615|474143742|FG003|Overall Study|Protocol Violation|3|||
131688348|NCT04416555|474143747|FG000|Overall Study|Withdrawal by Subject|0|||
131688349|NCT04416555|474143748|FG001|Overall Study|Withdrawal by Subject|3|||
131688350|NCT02004262|474143756|FG000|Overall Study|Death|67|||
131688351|NCT02004262|474143757|FG001|Overall Study|Death|64|||
131688352|NCT02004262|474143758|FG002|Overall Study|Death|66|||
131688353|NCT02004262|474143759|FG003|Overall Study|Death|28|||
131688354|NCT02004262|474143760|FG004|Overall Study|Death|29|||
131688355|NCT02004262|474143761|FG005|Overall Study|Death|22|||
131688356|NCT02004262|474143756|FG000|Overall Study|Withdrawal by Subject|1|||
131688357|NCT02004262|474143757|FG001|Overall Study|Withdrawal by Subject|0|||
131688358|NCT02004262|474143758|FG002|Overall Study|Withdrawal by Subject|4|||
131688359|NCT02004262|474143759|FG003|Overall Study|Withdrawal by Subject|0|||
131688360|NCT02004262|474143760|FG004|Overall Study|Withdrawal by Subject|1|||
131688361|NCT02004262|474143761|FG005|Overall Study|Withdrawal by Subject|3|||
131688362|NCT02004262|474143756|FG000|Overall Study|Lost to Follow-up|1|||
131688363|NCT02004262|474143757|FG001|Overall Study|Lost to Follow-up|1|||
131688364|NCT02004262|474143758|FG002|Overall Study|Lost to Follow-up|0|||
131688365|NCT02004262|474143759|FG003|Overall Study|Lost to Follow-up|0|||
131688366|NCT02004262|474143760|FG004|Overall Study|Lost to Follow-up|0|||
131688367|NCT02004262|474143761|FG005|Overall Study|Lost to Follow-up|0|||
131688368|NCT02004262|474143756|FG000|Overall Study|Study Terminated by Sponsor|4|||
131688369|NCT02004262|474143757|FG001|Overall Study|Study Terminated by Sponsor|3|||
131688370|NCT02004262|474143758|FG002|Overall Study|Study Terminated by Sponsor|2|||
131688371|NCT02004262|474143759|FG003|Overall Study|Study Terminated by Sponsor|1|||
131688372|NCT02004262|474143760|FG004|Overall Study|Study Terminated by Sponsor|1|||
131688373|NCT02004262|474143761|FG005|Overall Study|Study Terminated by Sponsor|5|||
131688374|NCT01923285|474143762|FG000|Overall Study|Withdrawal by Subject|7|||
131688375|NCT01923285|474143763|FG001|Overall Study|Withdrawal by Subject|6|||
131688376|NCT01543828|474143767|FG000|Treatment 2|Lost to Follow-up|1|||
131688377|NCT01543828|474143768|FG001|Treatment 2|Lost to Follow-up|0|||
131688378|NCT00243386|474143770|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
131688379|NCT00243386|474143771|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
131688380|NCT00243386|474143772|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
131688381|NCT00243386|474143770|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
131688382|NCT00243386|474143771|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
131688383|NCT00243386|474143772|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
131688384|NCT00243386|474143770|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
131688385|NCT00243386|474143771|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
131688386|NCT00243386|474143772|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
131688387|NCT00243386|474143770|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
131688388|NCT00243386|474143771|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
131688389|NCT00243386|474143772|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
131688390|NCT00243386|474143770|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
131688391|NCT00243386|474143771|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
131688392|NCT00243386|474143772|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
131688393|NCT00243386|474143770|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
131688394|NCT00243386|474143771|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
131688395|NCT00243386|474143772|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
131688396|NCT00243386|474143770|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
131688397|NCT00243386|474143771|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
131688398|NCT00243386|474143772|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
131688399|NCT00243386|474143770|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
131688400|NCT00243386|474143771|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
131688401|NCT00243386|474143772|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
131688402|NCT00133991|474143773|FG000|Overall Study|Death|4|||
131688403|NCT03002155|474143774|FG000|Overall Study|Lost to Follow-up|1|||
131688404|NCT03002155|474143775|FG001|Overall Study|Lost to Follow-up|2|||
131688405|NCT03002155|474143774|FG000|Overall Study|Withdrawal by Subject|1|||
131688406|NCT03002155|474143775|FG001|Overall Study|Withdrawal by Subject|0|||
131774990|NCT04668066|474454637|FG009|Part 1: Follow-Up|Adverse Event|0|||
131774991|NCT04668066|474454638|FG010|Part 1: Follow-Up|Adverse Event|0|||
131774992|NCT04668066|474454639|FG011|Part 1: Follow-Up|Adverse Event|1|||
131774993|NCT04668066|474454640|FG012|Part 1: Follow-Up|Adverse Event|0|||
131774994|NCT04668066|474454641|FG013|Part 1: Follow-Up|Adverse Event|0|||
131774995|NCT04668066|474454642|FG014|Part 1: Follow-Up|Adverse Event|0|||
131774996|NCT04668066|474454643|FG015|Part 1: Follow-Up|Adverse Event|0|||
131774997|NCT04668066|474454644|FG016|Part 1: Follow-Up|Adverse Event|0|||
131774998|NCT04668066|474454645|FG017|Part 1: Follow-Up|Adverse Event|0|||
131774999|NCT04668066|474454646|FG018|Part 1: Follow-Up|Adverse Event|0|||
131775000|NCT04668066|474454628|FG000|Part 1: Follow-Up|Other|0|||
131775001|NCT04668066|474454629|FG001|Part 1: Follow-Up|Other|0|||
131775002|NCT04668066|474454630|FG002|Part 1: Follow-Up|Other|0|||
131775003|NCT04668066|474454631|FG003|Part 1: Follow-Up|Other|0|||
131775004|NCT04668066|474454632|FG004|Part 1: Follow-Up|Other|0|||
131775005|NCT04668066|474454633|FG005|Part 1: Follow-Up|Other|0|||
131775006|NCT04668066|474454634|FG006|Part 1: Follow-Up|Other|0|||
131775007|NCT04668066|474454635|FG007|Part 1: Follow-Up|Other|0|||
131775008|NCT04668066|474454636|FG008|Part 1: Follow-Up|Other|0|||
131775009|NCT04668066|474454637|FG009|Part 1: Follow-Up|Other|0|||
131775010|NCT04668066|474454638|FG010|Part 1: Follow-Up|Other|0|||
131775011|NCT04668066|474454639|FG011|Part 1: Follow-Up|Other|1|||
131775012|NCT04668066|474454640|FG012|Part 1: Follow-Up|Other|1|||
131775013|NCT04668066|474454641|FG013|Part 1: Follow-Up|Other|0|||
131775014|NCT04668066|474454642|FG014|Part 1: Follow-Up|Other|0|||
131775015|NCT04668066|474454643|FG015|Part 1: Follow-Up|Other|0|||
131775016|NCT04668066|474454644|FG016|Part 1: Follow-Up|Other|0|||
131775017|NCT04668066|474454645|FG017|Part 1: Follow-Up|Other|0|||
131775018|NCT04668066|474454646|FG018|Part 1: Follow-Up|Other|0|||
131775019|NCT04668066|474454628|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775020|NCT04668066|474454629|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775021|NCT04668066|474454630|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775022|NCT04668066|474454631|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775023|NCT04668066|474454632|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775024|NCT04668066|474454633|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775025|NCT04668066|474454634|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775026|NCT04668066|474454635|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775027|NCT04668066|474454636|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775028|NCT04668066|474454637|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775029|NCT04668066|474454638|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775030|NCT04668066|474454639|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
131435995|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
131775031|NCT04668066|474454640|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
131775032|NCT04668066|474454641|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775033|NCT04668066|474454642|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775034|NCT04668066|474454643|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
131775035|NCT04668066|474454644|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775036|NCT04668066|474454645|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775037|NCT04668066|474454646|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
131775038|NCT04668066|474454628|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775039|NCT04668066|474454629|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775040|NCT04668066|474454630|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775041|NCT04668066|474454631|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775042|NCT04668066|474454632|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131688407|NCT03002155|474143774|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
131688408|NCT03002155|474143775|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
131688409|NCT03418129|474143779|FG000|Overall Study|Lost to Follow-up|11|||
131688410|NCT03418129|474143780|FG001|Overall Study|Lost to Follow-up|20|||
131688411|NCT03418129|474143781|FG002|Overall Study|Lost to Follow-up|15|||
131688412|NCT03418129|474143779|FG000|Overall Study|Withdrawal by Subject|3|||
131688413|NCT03418129|474143780|FG001|Overall Study|Withdrawal by Subject|6|||
131688414|NCT03418129|474143781|FG002|Overall Study|Withdrawal by Subject|4|||
131688415|NCT02437864|474143790|FG000|Overall Study|Protocol Violation|4|||
131688416|NCT02437864|474143791|FG001|Overall Study|Protocol Violation|0|||
131688417|NCT01892163|474143792|FG000|Overall Study|Death|1|||
131688418|NCT01892163|474143793|FG001|Overall Study|Death|1|||
131688419|NCT01892163|474143792|FG000|Overall Study|Lost to Follow-up|1|||
131688420|NCT01892163|474143793|FG001|Overall Study|Lost to Follow-up|0|||
131688421|NCT03302975|474143794|FG000|Overall Study|Lost to Follow-up|4|||
131688422|NCT00807742|474143797|FG000|Overall Study|Death|9|||
131688423|NCT00807742|474143798|FG001|Overall Study|Death|2|||
131688424|NCT00807742|474143797|FG000|Overall Study|Withdrawal by Subject|2|||
131688425|NCT00807742|474143798|FG001|Overall Study|Withdrawal by Subject|1|||
131688426|NCT00807742|474143797|FG000|Overall Study|Lost to Follow-up|35|||
131688427|NCT00807742|474143798|FG001|Overall Study|Lost to Follow-up|51|||
131688428|NCT00492752|474143799|FG000|Double Blind Treatment|Death|13|||
131688429|NCT00492752|474143800|FG001|Double Blind Treatment|Death|0|||
131688430|NCT00492752|474143801|FG002|Double Blind Treatment|Death|2|||
131688431|NCT00492752|474143802|FG003|Double Blind Treatment|Death|0|||
131688432|NCT00492752|474143799|FG000|Double Blind Treatment|Adverse Event|1|||
131688433|NCT00492752|474143800|FG001|Double Blind Treatment|Adverse Event|0|||
131688434|NCT00492752|474143801|FG002|Double Blind Treatment|Adverse Event|0|||
131688435|NCT00492752|474143802|FG003|Double Blind Treatment|Adverse Event|0|||
131688436|NCT00492752|474143799|FG000|Double Blind Treatment|Protocol Violation|0|||
131688437|NCT00492752|474143800|FG001|Double Blind Treatment|Protocol Violation|0|||
131688438|NCT00492752|474143801|FG002|Double Blind Treatment|Protocol Violation|1|||
131688439|NCT00492752|474143802|FG003|Double Blind Treatment|Protocol Violation|0|||
131688440|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
131688441|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
131688442|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
131688443|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
131688444|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
131688445|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
131688446|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
131688447|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
131688448|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
131688449|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
131688450|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
131688451|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
131688452|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
131688453|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
131688454|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
131435996|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
131898531|NCT00320788|474914098|FG002|Overall Study|Protocol Violation|0|||
131688455|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
131688456|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
131688457|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
131688458|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
131688459|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
131688460|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
131688461|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
131688462|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
131688463|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
131688464|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
131688465|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
131688466|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
131688467|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
131688468|NCT00492752|474143799|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
131688469|NCT00492752|474143800|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
131688470|NCT00492752|474143801|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
131688471|NCT00492752|474143802|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
131688472|NCT01357655|474143803|FG000|Overall Study|Administrative Reason by Sponsor|45|||
131688473|NCT01357655|474143804|FG001|Overall Study|Administrative Reason by Sponsor|0|||
131688474|NCT01357655|474143803|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
131688475|NCT01357655|474143804|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131688476|NCT01357655|474143803|FG000|Overall Study|Disease Progression|1|||
131688477|NCT01357655|474143804|FG001|Overall Study|Disease Progression|0|||
131688478|NCT01357655|474143803|FG000|Overall Study|Lost to Follow-up|2|||
131688479|NCT01357655|474143804|FG001|Overall Study|Lost to Follow-up|0|||
131688480|NCT01357655|474143803|FG000|Overall Study|Maximum Clinical Benefit|2|||
131688481|NCT01357655|474143804|FG001|Overall Study|Maximum Clinical Benefit|0|||
131688482|NCT01357655|474143803|FG000|Overall Study|Reason Unspecified|1|||
131688483|NCT01357655|474143804|FG001|Overall Study|Reason Unspecified|0|||
131688484|NCT01357655|474143803|FG000|Overall Study|Study Drug Toxicity|11|||
131688485|NCT01357655|474143804|FG001|Overall Study|Study Drug Toxicity|0|||
131688486|NCT01357655|474143803|FG000|Overall Study|Subject Withdrew Consent|1|||
131688487|NCT01357655|474143804|FG001|Overall Study|Subject Withdrew Consent|0|||
131688488|NCT00219284|474143805|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
131688489|NCT00219284|474143806|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
131688490|NCT00219284|474143805|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
131688491|NCT00219284|474143806|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
131688492|NCT00219284|474143805|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
131688493|NCT00219284|474143806|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
131688494|NCT00219284|474143805|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
131688495|NCT00219284|474143806|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
131688496|NCT00219284|474143805|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
131688497|NCT00219284|474143806|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
131688498|NCT00219284|474143805|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
131688499|NCT00219284|474143806|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
131688500|NCT00219284|474143805|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
131688501|NCT00219284|474143806|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
131688502|NCT00219284|474143805|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
131688503|NCT00219284|474143806|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
131688504|NCT00219284|474143805|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
131688505|NCT00219284|474143806|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
131688506|NCT00609986|474143807|FG000|Overall Study|Did not receive transplant or treatment|8|||
131688507|NCT00609986|474143808|FG001|Overall Study|Did not receive transplant or treatment|3|||
131688508|NCT04722042|474143809|FG000|Overall Study|Withdrawal by Subject|2|||
131688509|NCT04722042|474143810|FG001|Overall Study|Withdrawal by Subject|1|||
131688510|NCT04722042|474143811|FG002|Overall Study|Withdrawal by Subject|0|||
131688511|NCT01293968|474143814|FG000|Overall Study|non-cooperation|3|||
131688512|NCT01293968|474143815|FG001|Overall Study|non-cooperation|3|||
131688513|NCT00980200|474145762|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
131688514|NCT00980200|474145763|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
131688515|NCT00980200|474145764|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
131688516|NCT00980200|474145765|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
131688517|NCT00980200|474145766|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
131688518|NCT00980200|474145762|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
131688519|NCT00980200|474145763|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
131775043|NCT04668066|474454633|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775044|NCT04668066|474454634|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775045|NCT04668066|474454635|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775046|NCT04668066|474454636|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775047|NCT04668066|474454637|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775048|NCT04668066|474454638|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775049|NCT04668066|474454639|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775050|NCT04668066|474454640|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775051|NCT04668066|474454641|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775052|NCT04668066|474454642|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775053|NCT04668066|474454643|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775054|NCT04668066|474454644|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775055|NCT04668066|474454645|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131775056|NCT04668066|474454646|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
131775057|NCT04668066|474454628|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775058|NCT04668066|474454629|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775059|NCT04668066|474454630|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775060|NCT04668066|474454631|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775061|NCT04668066|474454632|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775062|NCT04668066|474454633|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775063|NCT04668066|474454634|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775064|NCT04668066|474454635|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775065|NCT04668066|474454636|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775066|NCT04668066|474454637|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775067|NCT04668066|474454638|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775068|NCT04668066|474454639|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775069|NCT04668066|474454640|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775070|NCT04668066|474454641|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775071|NCT04668066|474454642|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775072|NCT04668066|474454643|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775073|NCT04668066|474454644|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775074|NCT04668066|474454645|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
131775075|NCT04668066|474454646|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
131775076|NCT04668066|474454628|FG000|Part 2: Treatment Phase|Other|0|||
131775077|NCT04668066|474454629|FG001|Part 2: Treatment Phase|Other|0|||
131775078|NCT04668066|474454630|FG002|Part 2: Treatment Phase|Other|0|||
131775079|NCT04668066|474454631|FG003|Part 2: Treatment Phase|Other|0|||
131775080|NCT04668066|474454632|FG004|Part 2: Treatment Phase|Other|0|||
131775081|NCT04668066|474454633|FG005|Part 2: Treatment Phase|Other|0|||
131775082|NCT04668066|474454634|FG006|Part 2: Treatment Phase|Other|0|||
131775083|NCT04668066|474454635|FG007|Part 2: Treatment Phase|Other|0|||
131775084|NCT04668066|474454636|FG008|Part 2: Treatment Phase|Other|0|||
131775085|NCT04668066|474454637|FG009|Part 2: Treatment Phase|Other|0|||
131775086|NCT04668066|474454638|FG010|Part 2: Treatment Phase|Other|0|||
131775087|NCT04668066|474454639|FG011|Part 2: Treatment Phase|Other|0|||
131775088|NCT04668066|474454640|FG012|Part 2: Treatment Phase|Other|0|||
131775089|NCT04668066|474454641|FG013|Part 2: Treatment Phase|Other|0|||
131775090|NCT04668066|474454642|FG014|Part 2: Treatment Phase|Other|0|||
131775091|NCT04668066|474454643|FG015|Part 2: Treatment Phase|Other|0|||
131775092|NCT04668066|474454644|FG016|Part 2: Treatment Phase|Other|0|||
131775093|NCT04668066|474454645|FG017|Part 2: Treatment Phase|Other|0|||
131775094|NCT04668066|474454646|FG018|Part 2: Treatment Phase|Other|1|||
131775095|NCT04668066|474454628|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775096|NCT04668066|474454629|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775097|NCT04668066|474454630|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775098|NCT04668066|474454631|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775099|NCT04668066|474454632|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775100|NCT04668066|474454633|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775101|NCT04668066|474454634|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775102|NCT04668066|474454635|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775103|NCT04668066|474454636|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775104|NCT04668066|474454637|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775105|NCT04668066|474454638|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775106|NCT04668066|474454639|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775107|NCT04668066|474454640|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775108|NCT04668066|474454641|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775109|NCT04668066|474454642|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775110|NCT04668066|474454643|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775111|NCT04668066|474454644|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775112|NCT04668066|474454645|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
131775113|NCT04668066|474454646|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
131775114|NCT05147311|474454647|FG000|Overall Study|Did not complete survey|2|||
131775115|NCT05147311|474454648|FG001|Overall Study|Did not complete survey|1|||
131688520|NCT00980200|474145764|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
131688521|NCT00980200|474145765|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
131688522|NCT00980200|474145766|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
131688523|NCT00457015|474145767|FG000|Overall Study|Left study site against medical advice|0|||
131688524|NCT00457015|474145768|FG001|Overall Study|Left study site against medical advice|1|||
131688525|NCT01429584|474145769|FG000|Overall Study|Withdrawal by Subject|1|||
131688526|NCT01429584|474145770|FG001|Overall Study|Withdrawal by Subject|0|||
131688527|NCT01429584|474145769|FG000|Overall Study|Protocol Violation|0|||
131688528|NCT01429584|474145770|FG001|Overall Study|Protocol Violation|1|||
131688529|NCT00747643|474145774|FG000|Overall Study|Withdrawal by Subject|36|||
131688530|NCT00747643|474145775|FG001|Overall Study|Withdrawal by Subject|27|||
131688531|NCT00750698|474145776|FG000|Overall Study|Withdrawal by Subject|1|||
131688532|NCT00750698|474145777|FG001|Overall Study|Withdrawal by Subject|0|||
131688533|NCT00750698|474145776|FG000|Overall Study|Progressive disease|5|||
131688534|NCT00750698|474145777|FG001|Overall Study|Progressive disease|2|||
131688535|NCT02263079|474145778|FG000|Overall Study|Physician Decision|1|||
131688536|NCT02263079|474145779|FG001|Overall Study|Physician Decision|0|||
131688537|NCT02263079|474145780|FG002|Overall Study|Physician Decision|0|||
131688538|NCT02263079|474145778|FG000|Overall Study|Withdrawal by Subject|2|||
131688539|NCT02263079|474145779|FG001|Overall Study|Withdrawal by Subject|8|||
131688540|NCT02263079|474145780|FG002|Overall Study|Withdrawal by Subject|0|||
131688541|NCT03557281|474145781|FG000|Overall Study|Investigator discretion|0|||
131688542|NCT03557281|474145782|FG001|Overall Study|Investigator discretion|0|||
131688543|NCT03557281|474145783|FG002|Overall Study|Investigator discretion|1|||
131688544|NCT03557281|474145784|FG003|Overall Study|Investigator discretion|0|||
131688545|NCT03557281|474145785|FG004|Overall Study|Investigator discretion|0|||
131688546|NCT03557281|474145781|FG000|Overall Study|Withdrawal by Subject|0|||
131688547|NCT03557281|474145782|FG001|Overall Study|Withdrawal by Subject|1|||
131688548|NCT03557281|474145783|FG002|Overall Study|Withdrawal by Subject|1|||
131688549|NCT03557281|474145784|FG003|Overall Study|Withdrawal by Subject|1|||
131688550|NCT03557281|474145785|FG004|Overall Study|Withdrawal by Subject|2|||
131688551|NCT03557281|474145781|FG000|Overall Study|Randomized, but did not receive treatment|0|||
131688552|NCT03557281|474145782|FG001|Overall Study|Randomized, but did not receive treatment|0|||
131688553|NCT03557281|474145783|FG002|Overall Study|Randomized, but did not receive treatment|0|||
131688554|NCT03557281|474145784|FG003|Overall Study|Randomized, but did not receive treatment|0|||
131688555|NCT03557281|474145785|FG004|Overall Study|Randomized, but did not receive treatment|1|||
131688556|NCT00402649|474145786|FG000|Overall Study|Lost to Follow-up|1|||
131688557|NCT00402649|474145786|FG000|Overall Study|Withdrawal by Subject|1|||
131688558|NCT01199042|474145789|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
131688559|NCT01199042|474145789|FG000|At Home (3 Months)|Lost to Follow-up|1|||
131688560|NCT01999465|474145790|FG000|Overall Study|Lost to Follow-up|0|||
131688561|NCT01999465|474145791|FG001|Overall Study|Lost to Follow-up|2|||
131688562|NCT01999465|474145790|FG000|Overall Study|Protocol Violation|0|||
131688563|NCT01999465|474145791|FG001|Overall Study|Protocol Violation|1|||
131688564|NCT02554019|474145802|FG000|Overall Study|Withdrawal by Subject|1|||
131688565|NCT02554019|474145803|FG001|Overall Study|Withdrawal by Subject|0|||
131688566|NCT02554019|474145804|FG002|Overall Study|Withdrawal by Subject|2|||
131688567|NCT02554019|474145802|FG000|Overall Study|Adverse Event|1|||
131688568|NCT02554019|474145803|FG001|Overall Study|Adverse Event|0|||
131688569|NCT02554019|474145804|FG002|Overall Study|Adverse Event|0|||
131688570|NCT03370120|474145805|FG000|Overall Study|Adverse event, non-fatal|24|||
131688571|NCT03370120|474145805|FG000|Overall Study|Withdrawal by Subject|6|||
131688572|NCT03370120|474145805|FG000|Overall Study|Lost to Follow-up|1|||
131688573|NCT03370120|474145805|FG000|Overall Study|Lack of Efficacy|37|||
131688574|NCT03370120|474145805|FG000|Overall Study|Per sponsor's instructions|1|||
131688575|NCT03370120|474145805|FG000|Overall Study|Study was terminated by parent company UCB|2|||
131688576|NCT03370120|474145805|FG000|Overall Study|The study was ended by the promoter|3|||
131688577|NCT03370120|474145805|FG000|Overall Study|Discontinuation of drug development|3|||
131688578|NCT03370120|474145805|FG000|Overall Study|End of project|2|||
131688579|NCT03370120|474145805|FG000|Overall Study|Premature study closure|2|||
131688580|NCT03370120|474145805|FG000|Overall Study|Premature program termination|1|||
131688581|NCT03370120|474145805|FG000|Overall Study|Premature study termination|7|||
131688582|NCT03370120|474145805|FG000|Overall Study|Trial terminated by sponsor|2|||
131688583|NCT03370120|474145805|FG000|Overall Study|Trial discontinued by sponsor|2|||
131688584|NCT03370120|474145805|FG000|Overall Study|Study ended|15|||
131688585|NCT03370120|474145805|FG000|Overall Study|Clinical trial has been cancelled|1|||
131688586|NCT03370120|474145805|FG000|Overall Study|End of study per sponsor decision|2|||
131688587|NCT03370120|474145805|FG000|Overall Study|Promoter's decision|2|||
131688588|NCT03370120|474145805|FG000|Overall Study|The trial has been suspended|3|||
131688589|NCT03370120|474145805|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
131688590|NCT03370120|474145805|FG000|Overall Study|Early termination by order of sponsor|2|||
131688591|NCT03370120|474145805|FG000|Overall Study|Discontinuation of the study|5|||
131688592|NCT03370120|474145805|FG000|Overall Study|End of clinical trial discontinuation|1|||
131688593|NCT03370120|474145805|FG000|Overall Study|Because the clinical trial ended halfway|4|||
131688594|NCT03370120|474145805|FG000|Overall Study|Development discontinued|5|||
131688595|NCT03370120|474145805|FG000|Overall Study|Padsenovil program closed|3|||
131688596|NCT03370120|474145805|FG000|Overall Study|End of project|2|||
131688597|NCT03370120|474145805|FG000|Overall Study|Termination of project|1|||
131688598|NCT03370120|474145805|FG000|Overall Study|The study was interrupted by sponsor|4|||
131688599|NCT03370120|474145805|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
131688600|NCT03370120|474145805|FG000|Overall Study|End of sponsor decision|1|||
131688601|NCT03370120|474145805|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
131688602|NCT03370120|474145805|FG000|Overall Study|Early termination of studies|5|||
131688603|NCT03370120|474145805|FG000|Overall Study|This study is ended early|1|||
131688604|NCT03370120|474145805|FG000|Overall Study|End of padsevonil program|2|||
131688605|NCT03370120|474145805|FG000|Overall Study|Decision of sponsor|6|||
131688606|NCT03370120|474145805|FG000|Overall Study|Asked by the sponsor|3|||
131688607|NCT03370120|474145805|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
131688608|NCT03370120|474145805|FG000|Overall Study|PI decision poor compliance from participant|1|||
131688609|NCT03370120|474145805|FG000|Overall Study|Promoter ended the study|3|||
131688610|NCT03370120|474145805|FG000|Overall Study|Premature study close by sponsor's decision|4|||
131688611|NCT03370120|474145805|FG000|Overall Study|Study terminated by sponsor|33|||
131688612|NCT03370120|474145805|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
131688613|NCT03370120|474145805|FG000|Overall Study|Sponsor decision to terminate study|63|||
131688614|NCT03370120|474145805|FG000|Overall Study|Program closure|3|||
131688615|NCT03370120|474145805|FG000|Overall Study|Study ended prematurely|1|||
131688616|NCT03370120|474145805|FG000|Overall Study|Study stopped by sponsor|2|||
131688617|NCT03370120|474145805|FG000|Overall Study|Program termination|55|||
131688618|NCT03370120|474145805|FG000|Overall Study|Sponsor decision|62|||
131688619|NCT03370120|474145805|FG000|Overall Study|Sponsor study closure|10|||
131688620|NCT00454857|474145806|FG000|Overall Study|Withdrawal by Subject|15|||
131688621|NCT00454857|474145806|FG000|Overall Study|Lost to Follow-up|16|||
131688622|NCT00454857|474145806|FG000|Overall Study|Noncompliance|6|||
131688623|NCT00454857|474145806|FG000|Overall Study|Death|5|||
131688624|NCT00454857|474145806|FG000|Overall Study|Other|11|||
131688625|NCT00454857|474145806|FG000|Overall Study|Reason unknown|1|||
131688626|NCT04206020|474145807|FG000|Overall Study|Adverse Event|1|||
131688627|NCT04206020|474145808|FG001|Overall Study|Adverse Event|4|||
131688628|NCT04206020|474145807|FG000|Overall Study|Protocol Violation|2|||
131688629|NCT04206020|474145808|FG001|Overall Study|Protocol Violation|0|||
131688630|NCT04206020|474145807|FG000|Overall Study|Withdrawal by Subject|2|||
131688631|NCT04206020|474145808|FG001|Overall Study|Withdrawal by Subject|0|||
131688632|NCT04206020|474145807|FG000|Overall Study|Lost to Follow-up|2|||
131688633|NCT04206020|474145808|FG001|Overall Study|Lost to Follow-up|0|||
131688634|NCT04206020|474145807|FG000|Overall Study|Pregnancy|0|||
131688635|NCT04206020|474145808|FG001|Overall Study|Pregnancy|1|||
131688636|NCT04206020|474145807|FG000|Overall Study|Unable to attend visits|1|||
131688637|NCT04206020|474145808|FG001|Overall Study|Unable to attend visits|2|||
131688638|NCT03200366|474145819|FG000|Patient Navigation Intervention Given|Death|0|||
131688639|NCT03200366|474145820|FG001|Patient Navigation Intervention Given|Death|2|||
131688640|NCT03200366|474145821|FG002|Patient Navigation Intervention Given|Death|0|||
131688641|NCT03200366|474145819|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
131688642|NCT03200366|474145820|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
131688643|NCT03200366|474145821|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
131688644|NCT03200366|474145819|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
131688645|NCT03200366|474145820|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
131688646|NCT03200366|474145821|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
131688647|NCT03200366|474145819|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
131688648|NCT03200366|474145820|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
131719402|NCT03056287|474253286|FG000|Overall Study|Withdrawal by Subject|0|||
131719403|NCT03056287|474253287|FG001|Overall Study|Withdrawal by Subject|1|||
131719404|NCT03056287|474253288|FG002|Overall Study|Withdrawal by Subject|0|||
131719405|NCT03056287|474253289|FG003|Overall Study|Withdrawal by Subject|0|||
131719406|NCT03056287|474253286|FG000|Overall Study|move out of area|0|||
131719407|NCT03056287|474253287|FG001|Overall Study|move out of area|0|||
131719408|NCT03056287|474253288|FG002|Overall Study|move out of area|1|||
131719409|NCT03056287|474253289|FG003|Overall Study|move out of area|1|||
131719410|NCT00440401|474253301|FG000|Overall Study|Adverse Event|2|||
131719411|NCT00440401|474253302|FG001|Overall Study|Adverse Event|1|||
131719412|NCT00440401|474253301|FG000|Overall Study|Other|2|||
131719413|NCT00440401|474253302|FG001|Overall Study|Other|5|||
131719414|NCT02286960|474253303|FG000|Overall Study|Lost to Follow-up|3|||
131719415|NCT02286960|474253304|FG001|Overall Study|Lost to Follow-up|3|||
131719416|NCT00091793|474253305|FG000|Overall Study|Adverse Event|1|||
131719417|NCT00091793|474253306|FG001|Overall Study|Adverse Event|2|||
131719418|NCT00091793|474253305|FG000|Overall Study|Withdrawal by Subject|10|||
131719419|NCT00091793|474253306|FG001|Overall Study|Withdrawal by Subject|15|||
131719420|NCT00091793|474253305|FG000|Overall Study|Ineligibility determined|2|||
131719421|NCT00091793|474253306|FG001|Overall Study|Ineligibility determined|0|||
131719422|NCT00091793|474253305|FG000|Overall Study|Lost to Follow-up|7|||
131719423|NCT00091793|474253306|FG001|Overall Study|Lost to Follow-up|5|||
131719424|NCT00091793|474253305|FG000|Overall Study|Noncompliance|2|||
131719425|NCT00091793|474253306|FG001|Overall Study|Noncompliance|0|||
131719426|NCT00091793|474253305|FG000|Overall Study|Other|2|||
131719427|NCT00091793|474253306|FG001|Overall Study|Other|0|||
131719428|NCT00550238|474253307|FG000|Overall Study|Adverse Event|88|||
131719429|NCT00550238|474253307|FG000|Overall Study|Death|34|||
131719430|NCT00550238|474253307|FG000|Overall Study|Disease progression|46|||
131719431|NCT00550238|474253307|FG000|Overall Study|Withdrawal by Subject|167|||
131719432|NCT00550238|474253307|FG000|Overall Study|Physician Decision|31|||
131719433|NCT00550238|474253307|FG000|Overall Study|Patient noncompliance|25|||
131719434|NCT00550238|474253307|FG000|Overall Study|Lost to Follow-up|13|||
131719435|NCT00550238|474253307|FG000|Overall Study|Sponsor decision|55|||
131688649|NCT03200366|474145821|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
131688650|NCT03200366|474145819|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
131688651|NCT03200366|474145820|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
131688652|NCT03200366|474145821|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
131688653|NCT03200366|474145819|FG000|6 Month Post-Baseline Interview|Death|1|||
131688654|NCT03200366|474145820|FG001|6 Month Post-Baseline Interview|Death|1|||
131688655|NCT03200366|474145821|FG002|6 Month Post-Baseline Interview|Death|1|||
131688656|NCT03200366|474145819|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
131688657|NCT03200366|474145820|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
131688658|NCT03200366|474145821|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
131688659|NCT03200366|474145819|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
131688660|NCT03200366|474145820|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
131688661|NCT03200366|474145821|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
131688662|NCT03200366|474145819|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
131688663|NCT03200366|474145820|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
131688664|NCT03200366|474145821|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
131688665|NCT03200366|474145819|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
131688666|NCT03200366|474145820|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
131688667|NCT03200366|474145821|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
131688668|NCT03200366|474145819|FG000|9 Month Post-Baseline Interview|Death|1|||
131688669|NCT03200366|474145820|FG001|9 Month Post-Baseline Interview|Death|1|||
131688670|NCT03200366|474145821|FG002|9 Month Post-Baseline Interview|Death|1|||
131688671|NCT03200366|474145819|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
131688672|NCT03200366|474145820|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
131688673|NCT03200366|474145821|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
131688674|NCT03200366|474145819|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
131688675|NCT03200366|474145820|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
131688676|NCT03200366|474145821|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
131719436|NCT00637728|474253308|FG000|Double-blind Phase|Adverse Event|1|||
131719437|NCT00637728|474253309|FG001|Double-blind Phase|Adverse Event|0|||
131719438|NCT00637728|474253310|FG002|Double-blind Phase|Adverse Event|0|||
131719439|NCT00637728|474253308|FG000|Double-blind Phase|Non-compliance|2|||
131719440|NCT00637728|474253309|FG001|Double-blind Phase|Non-compliance|0|||
131719441|NCT00637728|474253310|FG002|Double-blind Phase|Non-compliance|0|||
131719442|NCT00637728|474253308|FG000|Double-blind Phase|Study Discontinued|1|||
131719443|NCT00637728|474253309|FG001|Double-blind Phase|Study Discontinued|1|||
131719444|NCT00637728|474253310|FG002|Double-blind Phase|Study Discontinued|0|||
131719445|NCT02723630|474253311|FG000|Intervention Period 1|Adverse Event|1|||
131719446|NCT02723630|474253312|FG001|Intervention Period 1|Adverse Event|0|||
131719447|NCT02723630|474253313|FG002|Intervention Period 1|Adverse Event|0|||
131719448|NCT02723630|474253314|FG003|Intervention Period 1|Adverse Event|0|||
131719449|NCT02723630|474253315|FG004|Intervention Period 1|Adverse Event|0|||
131719450|NCT02723630|474253316|FG005|Intervention Period 1|Adverse Event|0|||
131719451|NCT02723630|474253311|FG000|Intervention Period 3|consumption of restricted item|0|||
131719452|NCT02723630|474253312|FG001|Intervention Period 3|consumption of restricted item|1|||
131719453|NCT02723630|474253313|FG002|Intervention Period 3|consumption of restricted item|0|||
131719454|NCT02723630|474253314|FG003|Intervention Period 3|consumption of restricted item|0|||
131719455|NCT02723630|474253315|FG004|Intervention Period 3|consumption of restricted item|0|||
131719456|NCT02723630|474253316|FG005|Intervention Period 3|consumption of restricted item|0|||
131719457|NCT00537745|474253317|FG000|Overall Study|Did not meet eligibility criteria|2|||
131719458|NCT00537745|474253317|FG000|Overall Study|Withdrawal by Subject|2|||
131719459|NCT00537745|474253317|FG000|Overall Study|Subject unable to provide Interlock info|1|||
131719460|NCT03047213|474253318|FG000|Overall Study|Withdrawal by Subject|2|||
131719461|NCT03047213|474253319|FG001|Overall Study|Withdrawal by Subject|0|||
131719462|NCT03047213|474253318|FG000|Overall Study|Adverse Event|2|||
131719463|NCT03047213|474253319|FG001|Overall Study|Adverse Event|0|||
131719464|NCT00482001|474253320|FG000|Overall Study|Protocol Violation|1|||
131719465|NCT00482001|474253321|FG001|Overall Study|Protocol Violation|1|||
131719466|NCT03700892|474253322|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
131719467|NCT03700892|474253323|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
131719468|NCT03700892|474253324|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
131719469|NCT00258154|474253327|FG000|Overall Study|Adverse Event|1|||
131719470|NCT00258154|474253328|FG001|Overall Study|Adverse Event|0|||
131688677|NCT03200366|474145819|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
131688678|NCT03200366|474145820|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
131688679|NCT03200366|474145821|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
131688680|NCT02018822|474145822|FG000|Overall Study|filling replaced by crown|0|||
131688681|NCT02018822|474145823|FG001|Overall Study|filling replaced by crown|1|||
131688682|NCT02018822|474145824|FG002|Overall Study|filling replaced by crown|0|||
131688683|NCT02018822|474145822|FG000|Overall Study|Physician Decision|0|||
131688684|NCT02018822|474145823|FG001|Overall Study|Physician Decision|1|||
131688685|NCT02018822|474145824|FG002|Overall Study|Physician Decision|1|||
131688686|NCT02018822|474145822|FG000|Overall Study|Lost to Follow-up|6|||
131688687|NCT02018822|474145823|FG001|Overall Study|Lost to Follow-up|6|||
131688688|NCT02018822|474145824|FG002|Overall Study|Lost to Follow-up|5|||
131688689|NCT00715026|474145827|FG000|Overall Study|Withdrawal by Subject|5|||
131688690|NCT00715026|474145827|FG000|Overall Study|Lost to Follow-up|3|||
131688691|NCT00715026|474145827|FG000|Overall Study|Protocol Violation|1|||
131688692|NCT00715026|474145827|FG000|Overall Study|Surgery done on non-study consented hip|1|||
131688693|NCT00552175|474145828|FG000|Overall Study|Lack of Efficacy|2|||
131688694|NCT00552175|474145829|FG001|Overall Study|Lack of Efficacy|0|||
131688695|NCT00552175|474145830|FG002|Overall Study|Lack of Efficacy|1|||
131688696|NCT00552175|474145828|FG000|Overall Study|Adverse Event|9|||
131688697|NCT00552175|474145829|FG001|Overall Study|Adverse Event|9|||
131688698|NCT00552175|474145830|FG002|Overall Study|Adverse Event|10|||
131688699|NCT00552175|474145828|FG000|Overall Study|Withdrawal by Subject|2|||
131688700|NCT00552175|474145829|FG001|Overall Study|Withdrawal by Subject|2|||
131688701|NCT00552175|474145830|FG002|Overall Study|Withdrawal by Subject|1|||
131688702|NCT00552175|474145828|FG000|Overall Study|Lost to Follow-up|0|||
131688703|NCT00552175|474145829|FG001|Overall Study|Lost to Follow-up|0|||
131556004|NCT02357810|473660297|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
131688704|NCT00552175|474145830|FG002|Overall Study|Lost to Follow-up|1|||
131688705|NCT00552175|474145828|FG000|Overall Study|Entry Criteria Not Met|1|||
131688706|NCT00552175|474145829|FG001|Overall Study|Entry Criteria Not Met|1|||
131688707|NCT00552175|474145830|FG002|Overall Study|Entry Criteria Not Met|0|||
131688708|NCT00552175|474145828|FG000|Overall Study|Reason Not Specified|3|||
131688709|NCT00552175|474145829|FG001|Overall Study|Reason Not Specified|1|||
131688710|NCT00552175|474145830|FG002|Overall Study|Reason Not Specified|1|||
131688711|NCT02614859|474145831|FG000|Overall Study|Physician Decision|0|||
131688712|NCT02614859|474145832|FG001|Overall Study|Physician Decision|1|||
131688713|NCT00804570|474145837|FG000|Overall Study|Adverse Event|14|||
131688714|NCT00804570|474145838|FG001|Overall Study|Adverse Event|7|||
131688715|NCT00804570|474145837|FG000|Overall Study|Lack of Efficacy|0|||
131688716|NCT00804570|474145838|FG001|Overall Study|Lack of Efficacy|1|||
131688717|NCT00804570|474145837|FG000|Overall Study|Lost to Follow-up|18|||
131688718|NCT00804570|474145838|FG001|Overall Study|Lost to Follow-up|21|||
131688719|NCT00804570|474145837|FG000|Overall Study|Entry criteria not met|5|||
131688720|NCT00804570|474145838|FG001|Overall Study|Entry criteria not met|5|||
131688721|NCT00804570|474145837|FG000|Overall Study|Protocol Violation|12|||
131688722|NCT00804570|474145838|FG001|Overall Study|Protocol Violation|16|||
131688723|NCT00804570|474145837|FG000|Overall Study|Physician Decision|1|||
131688724|NCT00804570|474145838|FG001|Overall Study|Physician Decision|2|||
131688725|NCT00804570|474145837|FG000|Overall Study|Sponsor decision|1|||
131688726|NCT00804570|474145838|FG001|Overall Study|Sponsor decision|4|||
131688727|NCT00804570|474145837|FG000|Overall Study|Withdrawal by Subject|21|||
131688728|NCT00804570|474145838|FG001|Overall Study|Withdrawal by Subject|38|||
131688729|NCT00290342|474145839|FG000|Overall Study|Other|0|||
131688730|NCT00290342|474145840|FG001|Overall Study|Other|1|||
131688731|NCT00290342|474145839|FG000|Overall Study|Withdrawal by Subject|6|||
131688732|NCT00290342|474145840|FG001|Overall Study|Withdrawal by Subject|4|||
131688733|NCT00290342|474145839|FG000|Overall Study|Lost to Follow-up|1|||
131688734|NCT00290342|474145840|FG001|Overall Study|Lost to Follow-up|0|||
131688735|NCT01056510|474145843|FG000|Overall Study|Dropout Before Start of Treatment|1|||
131688736|NCT01056510|474145844|FG001|Overall Study|Dropout Before Start of Treatment|1|||
131688737|NCT01056510|474145843|FG000|Overall Study|Withdrawal by Subject|4|||
131688738|NCT01056510|474145844|FG001|Overall Study|Withdrawal by Subject|2|||
131688739|NCT01056510|474145843|FG000|Overall Study|Death|29|||
131688740|NCT01056510|474145844|FG001|Overall Study|Death|34|||
131688741|NCT01056510|474145843|FG000|Overall Study|Noncompliance|1|||
131688742|NCT01056510|474145844|FG001|Overall Study|Noncompliance|3|||
131688743|NCT01056510|474145843|FG000|Overall Study|Physician Decision|4|||
131688744|NCT01056510|474145844|FG001|Overall Study|Physician Decision|5|||
131688745|NCT01056510|474145843|FG000|Overall Study|Lost to Follow-up|5|||
131688746|NCT01056510|474145844|FG001|Overall Study|Lost to Follow-up|6|||
131688747|NCT01056510|474145843|FG000|Overall Study|Other|10|||
131688748|NCT01056510|474145844|FG001|Overall Study|Other|12|||
131688749|NCT01056510|474145843|FG000|Overall Study|Missing|0|||
131688750|NCT01056510|474145844|FG001|Overall Study|Missing|1|||
131688751|NCT02285998|474145845|FG000|Overall Study|Adverse Event|9|||
131688752|NCT02285998|474145846|FG001|Overall Study|Adverse Event|8|||
131688753|NCT02285998|474145845|FG000|Overall Study|Physician Decision|1|||
131688754|NCT02285998|474145846|FG001|Overall Study|Physician Decision|2|||
131688755|NCT02285998|474145845|FG000|Overall Study|Lost to Follow-up|176|||
131688756|NCT02285998|474145846|FG001|Overall Study|Lost to Follow-up|172|||
131688757|NCT02285998|474145845|FG000|Overall Study|Withdrawal by Subject|53|||
131688758|NCT02285998|474145846|FG001|Overall Study|Withdrawal by Subject|61|||
131688759|NCT02285998|474145845|FG000|Overall Study|Other Reasons|7|||
131688760|NCT02285998|474145846|FG001|Overall Study|Other Reasons|10|||
131688761|NCT00978029|474145847|FG000|Overall Study|Adverse Event|1|||
131688762|NCT00978029|474145848|FG001|Overall Study|Adverse Event|2|||
131688763|NCT00978029|474145849|FG002|Overall Study|Adverse Event|5|||
131688764|NCT00978029|474145847|FG000|Overall Study|Withdrawal by Subject|0|||
131688765|NCT00978029|474145848|FG001|Overall Study|Withdrawal by Subject|0|||
131688766|NCT00978029|474145849|FG002|Overall Study|Withdrawal by Subject|1|||
131688767|NCT00978029|474145847|FG000|Overall Study|Protocol Violation|0|||
131688768|NCT00978029|474145848|FG001|Overall Study|Protocol Violation|1|||
131688769|NCT00978029|474145849|FG002|Overall Study|Protocol Violation|0|||
131688770|NCT00545298|474145850|FG000|Overall Study|Issues with Standard of Care|2|||
131688771|NCT00545298|474145851|FG001|Overall Study|Issues with Standard of Care|0|||
131688772|NCT00545298|474145852|FG002|Overall Study|Issues with Standard of Care|1|||
131688773|NCT01820364|474145853|FG000|Part I: LGX818|Death|1|||
131688774|NCT01820364|474145854|FG001|Part I: LGX818|Death|0|||
131688775|NCT01820364|474145853|FG000|Part I: LGX818|Administrative Problems|3|||
131688776|NCT01820364|474145854|FG001|Part I: LGX818|Administrative Problems|0|||
131688777|NCT01820364|474145853|FG000|Part I: LGX818|Adverse Event|6|||
131688778|NCT01820364|474145854|FG001|Part I: LGX818|Adverse Event|0|||
131688779|NCT01820364|474145853|FG000|Part I: LGX818|Disease Progression|4|||
131688780|NCT01820364|474145854|FG001|Part I: LGX818|Disease Progression|0|||
131688781|NCT01820364|474145853|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
131688782|NCT01820364|474145854|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
131688783|NCT01793142|474145859|FG000|Overall Study|Randomized not treated|7|||
131688784|NCT03451084|474145863|FG000|Overall Study|Withdrawal by Subject|2|||
131688785|NCT03451084|474145864|FG001|Overall Study|Withdrawal by Subject|1|||
131688786|NCT03451084|474145865|FG002|Overall Study|Withdrawal by Subject|2|||
131688787|NCT03451084|474145866|FG003|Overall Study|Withdrawal by Subject|1|||
131688788|NCT03451084|474145863|FG000|Overall Study|Disease recurrence|0|||
131688789|NCT03451084|474145864|FG001|Overall Study|Disease recurrence|2|||
131688790|NCT03451084|474145865|FG002|Overall Study|Disease recurrence|0|||
131688791|NCT03451084|474145866|FG003|Overall Study|Disease recurrence|0|||
131688792|NCT03451084|474145863|FG000|Overall Study|Lack of Efficacy|0|||
131688793|NCT03451084|474145864|FG001|Overall Study|Lack of Efficacy|3|||
131688794|NCT03451084|474145865|FG002|Overall Study|Lack of Efficacy|0|||
131688795|NCT03451084|474145866|FG003|Overall Study|Lack of Efficacy|1|||
131688796|NCT03451084|474145863|FG000|Overall Study|Death|1|||
131688797|NCT03451084|474145864|FG001|Overall Study|Death|0|||
131688798|NCT03451084|474145865|FG002|Overall Study|Death|2|||
131688799|NCT03451084|474145866|FG003|Overall Study|Death|0|||
131688800|NCT03451084|474145863|FG000|Overall Study|Physician Decision|0|||
131688801|NCT03451084|474145864|FG001|Overall Study|Physician Decision|0|||
131688802|NCT03451084|474145865|FG002|Overall Study|Physician Decision|2|||
131688803|NCT03451084|474145866|FG003|Overall Study|Physician Decision|2|||
131688804|NCT03451084|474145863|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
131688805|NCT03451084|474145864|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
131688806|NCT03451084|474145865|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
131688807|NCT03451084|474145866|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
131688808|NCT01553188|474145869|FG000|Overall Study|Patient choice|1|||
131688809|NCT01553188|474145870|FG001|Overall Study|Patient choice|0|||
131688810|NCT01553188|474145871|FG002|Overall Study|Patient choice|0|||
131688811|NCT01553188|474145872|FG003|Overall Study|Patient choice|0|||
131688812|NCT01553188|474145869|FG000|Overall Study|Intercurrent illness and adverse event|0|||
131688813|NCT01553188|474145870|FG001|Overall Study|Intercurrent illness and adverse event|1|||
131688814|NCT01553188|474145871|FG002|Overall Study|Intercurrent illness and adverse event|2|||
131688815|NCT01553188|474145872|FG003|Overall Study|Intercurrent illness and adverse event|0|||
131688816|NCT04744207|474145876|FG000|Treatment|Withdrawal by Subject|2|||
131688817|NCT04744207|474145877|FG001|Treatment|Withdrawal by Subject|0|||
131688818|NCT04744207|474145876|FG000|Treatment|Adverse Event|1|||
131688819|NCT04744207|474145877|FG001|Treatment|Adverse Event|2|||
131688820|NCT01617070|474145883|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
131688821|NCT00777101|474145885|FG000|Overall Study|Death|48|||
131688822|NCT00777101|474145886|FG001|Overall Study|Death|43|||
131688823|NCT00777101|474145885|FG000|Overall Study|Withdrawal by Subject|11|||
131688824|NCT00777101|474145886|FG001|Overall Study|Withdrawal by Subject|6|||
131688825|NCT00777101|474145885|FG000|Overall Study|Lost to Follow-up|2|||
131688826|NCT00777101|474145886|FG001|Overall Study|Lost to Follow-up|1|||
131556005|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Adverse Event|5|||
131556006|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
131688827|NCT00777101|474145885|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
131688828|NCT00777101|474145886|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131688829|NCT00777101|474145885|FG000|Overall Study|Failed to Return|0|||
131688830|NCT00777101|474145886|FG001|Overall Study|Failed to Return|1|||
131688831|NCT05376215|474145887|FG000|Overall Study|Withdrawal by Subject|2|||
131688832|NCT05376215|474145888|FG001|Overall Study|Withdrawal by Subject|1|||
131688833|NCT05376215|474145887|FG000|Overall Study|Lost to Follow-up|0|||
131688834|NCT05376215|474145888|FG001|Overall Study|Lost to Follow-up|1|||
131688835|NCT01301950|474145890|FG000|Overall Study|Surgery was cancelled by patient|0|||
131688836|NCT01301950|474145891|FG001|Overall Study|Surgery was cancelled by patient|1|||
131688837|NCT00078325|474145895|FG000|Overall Study|Adverse Event|15|||
131688838|NCT00078325|474145896|FG001|Overall Study|Adverse Event|10|||
131688839|NCT00078325|474145897|FG002|Overall Study|Adverse Event|5|||
131688840|NCT00078325|474145895|FG000|Overall Study|Protocol Violation|2|||
131688841|NCT00078325|474145896|FG001|Overall Study|Protocol Violation|2|||
131688842|NCT00078325|474145897|FG002|Overall Study|Protocol Violation|0|||
131688843|NCT00078325|474145895|FG000|Overall Study|Withdrawal by Subject|1|||
131688844|NCT00078325|474145896|FG001|Overall Study|Withdrawal by Subject|5|||
131688845|NCT00078325|474145897|FG002|Overall Study|Withdrawal by Subject|3|||
131688846|NCT00078325|474145895|FG000|Overall Study|Lost to Follow-up|0|||
131688847|NCT00078325|474145896|FG001|Overall Study|Lost to Follow-up|1|||
131688848|NCT00078325|474145897|FG002|Overall Study|Lost to Follow-up|1|||
131688849|NCT00078325|474145895|FG000|Overall Study|Physician Decision|2|||
131688850|NCT00078325|474145896|FG001|Overall Study|Physician Decision|0|||
131688851|NCT00078325|474145897|FG002|Overall Study|Physician Decision|1|||
131688852|NCT00078325|474145895|FG000|Overall Study|Miscellaneous|1|||
131688853|NCT00078325|474145896|FG001|Overall Study|Miscellaneous|1|||
131688854|NCT00078325|474145897|FG002|Overall Study|Miscellaneous|1|||
131688855|NCT04126083|474145898|FG000|Overall Study|Withdrawal by Subject|1|||
131688856|NCT03710486|474145902|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
131688857|NCT03710486|474145903|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
131688858|NCT03710486|474145902|FG000|Overall Study|Missing|0|||
131688859|NCT03710486|474145903|FG001|Overall Study|Missing|2|||
131688860|NCT01279850|474145908|FG000|Overall Study|Protocol Violation|50|||
131688861|NCT01279850|474145908|FG000|Overall Study|No Drug Administration Information|7|||
131688862|NCT01279850|474145908|FG000|Overall Study|No Visit After Treatment|34|||
131688863|NCT01131520|474145909|FG000|Overall Study|Computer problem|1|||
131688864|NCT01131520|474145910|FG001|Overall Study|Computer problem|0|||
131688865|NCT01131520|474145909|FG000|Overall Study|Counselor not available|0|||
131688866|NCT01131520|474145910|FG001|Overall Study|Counselor not available|3|||
131688867|NCT01131520|474145909|FG000|Overall Study|Subject changed history after enrollment|0|||
131688868|NCT01131520|474145910|FG001|Overall Study|Subject changed history after enrollment|1|||
131688869|NCT01147744|474145911|FG000|Overall Study|Protocol Violation|1|||
131688870|NCT01147744|474145912|FG001|Overall Study|Protocol Violation|0|||
131688871|NCT01147744|474145913|FG002|Overall Study|Protocol Violation|1|||
131688872|NCT01147744|474145914|FG003|Overall Study|Protocol Violation|0|||
131688873|NCT01147744|474145915|FG004|Overall Study|Protocol Violation|1|||
131688874|NCT01147744|474145916|FG005|Overall Study|Protocol Violation|3|||
131688875|NCT01147744|474145917|FG006|Overall Study|Protocol Violation|1|||
131688876|NCT01147744|474145911|FG000|Overall Study|Physician Decision|0|||
131688877|NCT01147744|474145912|FG001|Overall Study|Physician Decision|1|||
131688878|NCT01147744|474145913|FG002|Overall Study|Physician Decision|1|||
131688879|NCT01147744|474145914|FG003|Overall Study|Physician Decision|0|||
131688880|NCT01147744|474145915|FG004|Overall Study|Physician Decision|0|||
131688881|NCT01147744|474145916|FG005|Overall Study|Physician Decision|0|||
131688882|NCT01147744|474145917|FG006|Overall Study|Physician Decision|1|||
131688883|NCT01147744|474145911|FG000|Overall Study|Lack of Efficacy|11|||
131688884|NCT01147744|474145912|FG001|Overall Study|Lack of Efficacy|11|||
131688885|NCT01147744|474145913|FG002|Overall Study|Lack of Efficacy|9|||
131688886|NCT01147744|474145914|FG003|Overall Study|Lack of Efficacy|11|||
131688887|NCT01147744|474145915|FG004|Overall Study|Lack of Efficacy|13|||
131688888|NCT01147744|474145916|FG005|Overall Study|Lack of Efficacy|8|||
131688889|NCT01147744|474145917|FG006|Overall Study|Lack of Efficacy|7|||
131688890|NCT01147744|474145911|FG000|Overall Study|Adverse Event|1|||
131688891|NCT01147744|474145912|FG001|Overall Study|Adverse Event|2|||
131775116|NCT05147311|474454647|FG000|Overall Study|Patient too sick|1|||
131688892|NCT01147744|474145913|FG002|Overall Study|Adverse Event|3|||
131688893|NCT01147744|474145914|FG003|Overall Study|Adverse Event|0|||
131688894|NCT01147744|474145915|FG004|Overall Study|Adverse Event|2|||
131688895|NCT01147744|474145916|FG005|Overall Study|Adverse Event|1|||
131688896|NCT01147744|474145917|FG006|Overall Study|Adverse Event|2|||
131688897|NCT01147744|474145911|FG000|Overall Study|Withdrawal by Subject|8|||
131688898|NCT01147744|474145912|FG001|Overall Study|Withdrawal by Subject|4|||
131556007|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
131556008|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
131556009|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Death|1|||
131556010|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Physician Decision|1|||
131556011|NCT02357810|473660297|FG000|Reached 12 Weeks Response|Other|1|||
131556012|NCT02357810|473660297|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
131556013|NCT02357810|473660297|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
131556014|NCT02357810|473660297|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
131556015|NCT02357810|473660297|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
131556016|NCT02357810|473660297|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
131556017|NCT02357810|473660297|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
131556018|NCT00675506|473660301|FG000|Overall Study|Lost to Follow-up|1|||
131556019|NCT00675506|473660302|FG001|Overall Study|Lost to Follow-up|5|||
131556020|NCT00675506|473660301|FG000|Overall Study|Lost interest|3|||
131556021|NCT00675506|473660302|FG001|Overall Study|Lost interest|5|||
131556022|NCT00675506|473660301|FG000|Overall Study|Elevated fasting glucose|2|||
131556023|NCT00675506|473660302|FG001|Overall Study|Elevated fasting glucose|1|||
131556024|NCT00675506|473660301|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
131556025|NCT00675506|473660302|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
131556026|NCT00675506|473660301|FG000|Overall Study|Elevated IGF-1|2|||
131556027|NCT00675506|473660302|FG001|Overall Study|Elevated IGF-1|0|||
131556028|NCT00675506|473660301|FG000|Overall Study|Hypersensitivity Reaction|1|||
131556029|NCT00675506|473660302|FG001|Overall Study|Hypersensitivity Reaction|0|||
131556030|NCT00675506|473660301|FG000|Overall Study|Disclosed history of cancer|1|||
131556031|NCT00675506|473660302|FG001|Overall Study|Disclosed history of cancer|0|||
131556032|NCT00675506|473660301|FG000|Overall Study|Declined participation|1|||
131556033|NCT00675506|473660302|FG001|Overall Study|Declined participation|0|||
131556034|NCT00675506|473660301|FG000|Overall Study|Schedule conflict|0|||
131775117|NCT05147311|474454648|FG001|Overall Study|Patient too sick|2|||
131775118|NCT05147311|474454647|FG000|Overall Study|Death|0|||
131775119|NCT05147311|474454648|FG001|Overall Study|Death|1|||
131775120|NCT05147311|474454647|FG000|Overall Study|Declined survey|1|||
131775121|NCT05147311|474454648|FG001|Overall Study|Declined survey|0|||
131775122|NCT04505592|474454649|FG000|Overall Study|Death|2|||
131775123|NCT04505592|474454650|FG001|Overall Study|Death|1|||
131775124|NCT03145207|474454659|FG000|Overall Study|volunteer started taking allergy shots|1|||
131775125|NCT03145207|474454659|FG000|Overall Study|baseline blood pressure high|1|||
131775126|NCT01396434|474454660|FG000|Overall Study|Lost to Follow-up|1|||
131775127|NCT01396434|474454661|FG001|Overall Study|Lost to Follow-up|0|||
131775128|NCT01396434|474454662|FG002|Overall Study|Lost to Follow-up|0|||
131775129|NCT01396434|474454660|FG000|Overall Study|Other|10|||
131775130|NCT01396434|474454661|FG001|Overall Study|Other|0|||
131775131|NCT01396434|474454662|FG002|Overall Study|Other|0|||
131775132|NCT04678557|474454663|FG000|Overall Study|Withdrawal by Subject|1|||
131775133|NCT04678557|474454664|FG001|Overall Study|Withdrawal by Subject|0|||
131775134|NCT04678557|474454663|FG000|Overall Study|Lack of Efficacy|0|||
131775135|NCT04678557|474454664|FG001|Overall Study|Lack of Efficacy|13|||
131775136|NCT04678557|474454663|FG000|Overall Study|Safety Evaluation|0|||
131775137|NCT04678557|474454664|FG001|Overall Study|Safety Evaluation|1|||
131775138|NCT02207413|474454665|FG000|Overall Study|Withdrawal by Subject|1|||
131775139|NCT02207413|474454666|FG001|Overall Study|Withdrawal by Subject|0|||
131775140|NCT02207413|474454667|FG002|Overall Study|Withdrawal by Subject|0|||
131775141|NCT02207413|474454668|FG003|Overall Study|Withdrawal by Subject|0|||
131775142|NCT02207413|474454669|FG004|Overall Study|Withdrawal by Subject|3|||
131775143|NCT02207413|474454670|FG005|Overall Study|Withdrawal by Subject|7|||
131775144|NCT02207413|474454665|FG000|Overall Study|Lost to Follow-up|0|||
131775145|NCT02207413|474454666|FG001|Overall Study|Lost to Follow-up|0|||
131775146|NCT02207413|474454667|FG002|Overall Study|Lost to Follow-up|0|||
131775147|NCT02207413|474454668|FG003|Overall Study|Lost to Follow-up|1|||
131775148|NCT02207413|474454669|FG004|Overall Study|Lost to Follow-up|1|||
131775149|NCT02207413|474454670|FG005|Overall Study|Lost to Follow-up|5|||
131775150|NCT02207413|474454665|FG000|Overall Study|Adverse Event|0|||
131775151|NCT02207413|474454666|FG001|Overall Study|Adverse Event|0|||
131775152|NCT02207413|474454667|FG002|Overall Study|Adverse Event|0|||
131775153|NCT02207413|474454668|FG003|Overall Study|Adverse Event|0|||
131775154|NCT02207413|474454669|FG004|Overall Study|Adverse Event|2|||
131775155|NCT02207413|474454670|FG005|Overall Study|Adverse Event|1|||
131775156|NCT02207413|474454665|FG000|Overall Study|Migrated/moved from study area|0|||
131775157|NCT02207413|474454666|FG001|Overall Study|Migrated/moved from study area|0|||
131775158|NCT02207413|474454667|FG002|Overall Study|Migrated/moved from study area|0|||
131775159|NCT02207413|474454668|FG003|Overall Study|Migrated/moved from study area|0|||
131775160|NCT02207413|474454669|FG004|Overall Study|Migrated/moved from study area|1|||
131775161|NCT02207413|474454670|FG005|Overall Study|Migrated/moved from study area|0|||
131775162|NCT00560573|474456514|FG000|Overall Study|Death|4|||
131775163|NCT00560573|474456515|FG001|Overall Study|Death|1|||
131775164|NCT00560573|474456516|FG002|Overall Study|Death|4|||
131775165|NCT00560573|474456517|FG003|Overall Study|Death|5|||
131775166|NCT00560573|474456518|FG004|Overall Study|Death|1|||
131775167|NCT00560573|474456519|FG005|Overall Study|Death|10|||
131775168|NCT00560573|474456514|FG000|Overall Study|Lost to Follow-up|0|||
131775169|NCT00560573|474456515|FG001|Overall Study|Lost to Follow-up|0|||
131775170|NCT00560573|474456516|FG002|Overall Study|Lost to Follow-up|0|||
131775171|NCT00560573|474456517|FG003|Overall Study|Lost to Follow-up|1|||
131775172|NCT00560573|474456518|FG004|Overall Study|Lost to Follow-up|1|||
131775173|NCT00560573|474456519|FG005|Overall Study|Lost to Follow-up|0|||
131775174|NCT00560573|474456514|FG000|Overall Study|Withdrawal by Subject|0|||
131775175|NCT00560573|474456515|FG001|Overall Study|Withdrawal by Subject|0|||
131775176|NCT00560573|474456516|FG002|Overall Study|Withdrawal by Subject|0|||
131775177|NCT00560573|474456517|FG003|Overall Study|Withdrawal by Subject|1|||
131775178|NCT00560573|474456518|FG004|Overall Study|Withdrawal by Subject|1|||
131775179|NCT00560573|474456519|FG005|Overall Study|Withdrawal by Subject|0|||
131775180|NCT00560573|474456514|FG000|Overall Study|Other|2|||
131556035|NCT00675506|473660302|FG001|Overall Study|Schedule conflict|1|||
131556036|NCT00936221|473660303|FG000|Overall Study|Withdrawal by Subject|1|||
131775181|NCT00560573|474456515|FG001|Overall Study|Other|2|||
131775182|NCT00560573|474456516|FG002|Overall Study|Other|2|||
131775183|NCT00560573|474456517|FG003|Overall Study|Other|3|||
131775184|NCT00560573|474456518|FG004|Overall Study|Other|3|||
131775185|NCT00560573|474456519|FG005|Overall Study|Other|3|||
131775186|NCT00560573|474456514|FG000|Overall Study|Enrolled, not treated|0|||
131775187|NCT00560573|474456515|FG001|Overall Study|Enrolled, not treated|0|||
131775188|NCT00560573|474456516|FG002|Overall Study|Enrolled, not treated|0|||
131775189|NCT00560573|474456517|FG003|Overall Study|Enrolled, not treated|0|||
131775190|NCT00560573|474456518|FG004|Overall Study|Enrolled, not treated|1|||
131775191|NCT00560573|474456519|FG005|Overall Study|Enrolled, not treated|0|||
131775192|NCT00003526|474456524|FG000|Overall Study|Not evaluable|6|||
131688899|NCT01147744|474145913|FG002|Overall Study|Withdrawal by Subject|2|||
131688900|NCT01147744|474145914|FG003|Overall Study|Withdrawal by Subject|2|||
131688901|NCT01147744|474145915|FG004|Overall Study|Withdrawal by Subject|2|||
131688902|NCT01147744|474145916|FG005|Overall Study|Withdrawal by Subject|5|||
131688903|NCT01147744|474145917|FG006|Overall Study|Withdrawal by Subject|2|||
131688904|NCT01147744|474145911|FG000|Overall Study|Lost to Follow-up|0|||
131688905|NCT01147744|474145912|FG001|Overall Study|Lost to Follow-up|1|||
131688906|NCT01147744|474145913|FG002|Overall Study|Lost to Follow-up|0|||
131688907|NCT01147744|474145914|FG003|Overall Study|Lost to Follow-up|0|||
131688908|NCT01147744|474145915|FG004|Overall Study|Lost to Follow-up|0|||
131688909|NCT01147744|474145916|FG005|Overall Study|Lost to Follow-up|0|||
131688910|NCT01147744|474145917|FG006|Overall Study|Lost to Follow-up|0|||
131688911|NCT01147744|474145911|FG000|Overall Study|Sponsor decision to amend protocol|7|||
131688912|NCT01147744|474145912|FG001|Overall Study|Sponsor decision to amend protocol|4|||
131688913|NCT01147744|474145913|FG002|Overall Study|Sponsor decision to amend protocol|2|||
131688914|NCT01147744|474145914|FG003|Overall Study|Sponsor decision to amend protocol|5|||
131688915|NCT01147744|474145915|FG004|Overall Study|Sponsor decision to amend protocol|7|||
131688916|NCT01147744|474145916|FG005|Overall Study|Sponsor decision to amend protocol|2|||
131688917|NCT01147744|474145917|FG006|Overall Study|Sponsor decision to amend protocol|6|||
131688918|NCT01147744|474145911|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131688919|NCT01147744|474145912|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131688920|NCT01147744|474145913|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131688921|NCT01147744|474145914|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131688922|NCT01147744|474145915|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131688923|NCT01147744|474145916|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131688924|NCT01147744|474145917|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131688925|NCT01342484|474145920|FG000|Overall Study|Other Reasons|1|||
131688926|NCT01342484|474145921|FG001|Overall Study|Other Reasons|0|||
131688927|NCT01342484|474145922|FG002|Overall Study|Other Reasons|0|||
131688928|NCT01342484|474145920|FG000|Overall Study|Protocol Violation|0|||
131688929|NCT01342484|474145921|FG001|Overall Study|Protocol Violation|0|||
131688930|NCT01342484|474145922|FG002|Overall Study|Protocol Violation|1|||
131688931|NCT01342484|474145920|FG000|Overall Study|Withdrawal by Subject|1|||
131688932|NCT01342484|474145921|FG001|Overall Study|Withdrawal by Subject|0|||
131688933|NCT01342484|474145922|FG002|Overall Study|Withdrawal by Subject|0|||
131688934|NCT01840579|474145923|FG000|Overall Study|Status not recorded|0|||
131688935|NCT01840579|474145924|FG001|Overall Study|Status not recorded|0|||
131688936|NCT01840579|474145925|FG002|Overall Study|Status not recorded|2|||
131688937|NCT01840579|474145926|FG003|Overall Study|Status not recorded|3|||
131688938|NCT01840579|474145927|FG004|Overall Study|Status not recorded|4|||
131688939|NCT01840579|474145928|FG005|Overall Study|Status not recorded|3|||
131688940|NCT01840579|474145929|FG006|Overall Study|Status not recorded|0|||
131688941|NCT01840579|474145930|FG007|Overall Study|Status not recorded|3|||
131688942|NCT01840579|474145931|FG008|Overall Study|Status not recorded|3|||
131688943|NCT01840579|474145932|FG009|Overall Study|Status not recorded|3|||
131688944|NCT01840579|474145923|FG000|Overall Study|Progressive disease|3|||
131688945|NCT01840579|474145924|FG001|Overall Study|Progressive disease|5|||
131688946|NCT01840579|474145925|FG002|Overall Study|Progressive disease|0|||
131688947|NCT01840579|474145926|FG003|Overall Study|Progressive disease|0|||
131688948|NCT01840579|474145927|FG004|Overall Study|Progressive disease|0|||
131688949|NCT01840579|474145928|FG005|Overall Study|Progressive disease|0|||
131556037|NCT00936221|473660304|FG001|Overall Study|Withdrawal by Subject|1|||
131688950|NCT01840579|474145929|FG006|Overall Study|Progressive disease|0|||
131688951|NCT01840579|474145930|FG007|Overall Study|Progressive disease|0|||
131688952|NCT01840579|474145931|FG008|Overall Study|Progressive disease|0|||
131688953|NCT01840579|474145932|FG009|Overall Study|Progressive disease|0|||
131688954|NCT01840579|474145923|FG000|Overall Study|Ongoing in study|0|||
131688955|NCT01840579|474145924|FG001|Overall Study|Ongoing in study|1|||
131688956|NCT01840579|474145925|FG002|Overall Study|Ongoing in study|0|||
131775193|NCT04753606|474456531|FG000|Overall Study|Adverse Event|1|||
131775194|NCT04753606|474456532|FG001|Overall Study|Adverse Event|0|||
131775195|NCT04753606|474456533|FG002|Overall Study|Adverse Event|0|||
131775196|NCT01283009|474456534|FG000|Overall Study|Death|83|||
131775197|NCT01283009|474456535|FG001|Overall Study|Death|78|||
131775198|NCT01283009|474456534|FG000|Overall Study|Study ended early|23|||
131775199|NCT01283009|474456535|FG001|Overall Study|Study ended early|26|||
131775200|NCT01283009|474456534|FG000|Overall Study|Withdrawal by Subject|10|||
131775201|NCT01283009|474456535|FG001|Overall Study|Withdrawal by Subject|8|||
131775202|NCT01283009|474456534|FG000|Overall Study|Physician Decision|1|||
131775203|NCT01283009|474456535|FG001|Overall Study|Physician Decision|1|||
131775204|NCT01283009|474456534|FG000|Overall Study|Lost to Follow-up|1|||
131775205|NCT01283009|474456535|FG001|Overall Study|Lost to Follow-up|0|||
131775206|NCT01283009|474456534|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
131775207|NCT01283009|474456535|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
131775208|NCT01748162|474456538|FG000|Overall Study|no additional croup episodes to evaluate|2|||
131775209|NCT01748162|474456539|FG001|Overall Study|no additional croup episodes to evaluate|2|||
131775210|NCT01748162|474456538|FG000|Overall Study|participant consented but did not begin|0|||
131775211|NCT01748162|474456539|FG001|Overall Study|participant consented but did not begin|1|||
131775212|NCT01748162|474456538|FG000|Overall Study|reasons not available|3|||
131775213|NCT01748162|474456539|FG001|Overall Study|reasons not available|2|||
131775214|NCT02743117|474456540|FG000|Overall Study|Lost to Follow-up|0|||
131775215|NCT02743117|474456541|FG001|Overall Study|Lost to Follow-up|1|||
131688957|NCT01840579|474145926|FG003|Overall Study|Ongoing in study|0|||
131688958|NCT01840579|474145927|FG004|Overall Study|Ongoing in study|0|||
131688959|NCT01840579|474145928|FG005|Overall Study|Ongoing in study|0|||
131688960|NCT01840579|474145929|FG006|Overall Study|Ongoing in study|0|||
131775216|NCT02743117|474456540|FG000|Overall Study|Other|1|||
131775217|NCT02743117|474456541|FG001|Overall Study|Other|0|||
131775218|NCT01207219|474456542|FG000|Overall Study|changed diagnosis during study period|5|||
131775219|NCT01207219|474456543|FG001|Overall Study|changed diagnosis during study period|3|||
131775220|NCT01207219|474456544|FG002|Overall Study|changed diagnosis during study period|1|||
131775221|NCT01207219|474456542|FG000|Overall Study|Lost to Follow-up|6|||
131775222|NCT01207219|474456543|FG001|Overall Study|Lost to Follow-up|8|||
131775223|NCT01207219|474456544|FG002|Overall Study|Lost to Follow-up|6|||
131775224|NCT00779857|474456545|FG000|Overall Study|Death|1|||
131775225|NCT00779857|474456545|FG000|Overall Study|Withdrawal by Subject|3|||
131775226|NCT00779857|474456545|FG000|Overall Study|Missed Visit|2|||
131775227|NCT04640168|474456546|FG000|Overall Study|Withdrawal by Subject|8|||
131775228|NCT04640168|474456547|FG001|Overall Study|Withdrawal by Subject|7|||
131775229|NCT04640168|474456546|FG000|Overall Study|Lost to Follow-up|1|||
131775230|NCT04640168|474456547|FG001|Overall Study|Lost to Follow-up|0|||
131556038|NCT03820323|473660305|FG000|Overall Study|Lost to Follow-up|2|||
131556039|NCT03820323|473660306|FG001|Overall Study|Lost to Follow-up|1|||
131556040|NCT03820323|473660305|FG000|Overall Study|Missed 12-month visit|22|||
131556041|NCT03820323|473660306|FG001|Overall Study|Missed 12-month visit|14|||
131556042|NCT03820323|473660305|FG000|Overall Study|Death|2|||
131556043|NCT03820323|473660306|FG001|Overall Study|Death|1|||
131556044|NCT03820323|473660305|FG000|Overall Study|Transferred out|13|||
131556045|NCT03820323|473660306|FG001|Overall Study|Transferred out|11|||
131556046|NCT03820323|473660305|FG000|Overall Study|Terminated|0|||
131556047|NCT03820323|473660306|FG001|Overall Study|Terminated|3|||
131556048|NCT03820323|473660305|FG000|Overall Study|Withdrawal by Subject|1|||
131775231|NCT04640168|474456546|FG000|Overall Study|Enrolled but not treated|12|||
131775232|NCT04640168|474456547|FG001|Overall Study|Enrolled but not treated|12|||
131775233|NCT01453296|474456552|FG000|Treatment Period 1|Adverse Event|0|||
131775234|NCT01453296|474456553|FG001|Treatment Period 1|Adverse Event|1|||
131556049|NCT03820323|473660306|FG001|Overall Study|Withdrawal by Subject|6|||
131556050|NCT03151395|473660307|FG000|Overall Study|Adverse Event|2|||
131556051|NCT03151395|473660307|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
131556052|NCT03151395|473660307|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
131556053|NCT03151395|473660307|FG000|Overall Study|Unspecified reason|4|||
131556054|NCT05644353|473660310|FG000|Overall Study|Physician Decision|1|||
131556055|NCT05644353|473660311|FG001|Overall Study|Physician Decision|0|||
131556056|NCT05644353|473660312|FG002|Overall Study|Physician Decision|0|||
131556057|NCT05644353|473660313|FG003|Overall Study|Physician Decision|0|||
131556058|NCT05644353|473660314|FG004|Overall Study|Physician Decision|0|||
131556059|NCT05644353|473660315|FG005|Overall Study|Physician Decision|0|||
131556060|NCT05644353|473660310|FG000|Overall Study|Protocol Violation|1|||
131556061|NCT05644353|473660311|FG001|Overall Study|Protocol Violation|0|||
131556062|NCT05644353|473660312|FG002|Overall Study|Protocol Violation|0|||
131556063|NCT05644353|473660313|FG003|Overall Study|Protocol Violation|0|||
131556064|NCT05644353|473660314|FG004|Overall Study|Protocol Violation|0|||
131556065|NCT05644353|473660315|FG005|Overall Study|Protocol Violation|0|||
131556066|NCT05644353|473660310|FG000|Overall Study|Withdrawal by Subject|0|||
131556067|NCT05644353|473660311|FG001|Overall Study|Withdrawal by Subject|2|||
131556068|NCT05644353|473660312|FG002|Overall Study|Withdrawal by Subject|0|||
131556069|NCT05644353|473660313|FG003|Overall Study|Withdrawal by Subject|0|||
131556070|NCT05644353|473660314|FG004|Overall Study|Withdrawal by Subject|1|||
131556071|NCT05644353|473660315|FG005|Overall Study|Withdrawal by Subject|0|||
131556072|NCT05644353|473660310|FG000|Overall Study|Lost to Follow-up|0|||
131556073|NCT05644353|473660311|FG001|Overall Study|Lost to Follow-up|0|||
131556074|NCT05644353|473660312|FG002|Overall Study|Lost to Follow-up|1|||
131556075|NCT05644353|473660313|FG003|Overall Study|Lost to Follow-up|0|||
131556076|NCT05644353|473660314|FG004|Overall Study|Lost to Follow-up|0|||
131556077|NCT05644353|473660315|FG005|Overall Study|Lost to Follow-up|0|||
131556078|NCT01535274|473660316|FG000|Overall Study|Determined to be ineligible|0|||
131556079|NCT01535274|473660317|FG001|Overall Study|Determined to be ineligible|1|||
131556080|NCT01535274|473660316|FG000|Overall Study|Misallocated to propofol intervention|0|||
131556081|NCT01535274|473660317|FG001|Overall Study|Misallocated to propofol intervention|1|||
131556082|NCT03679767|473660318|FG000|Overall Study|Death|16|||
131556083|NCT03679767|473660319|FG001|Overall Study|Death|11|||
131556084|NCT03679767|473660320|FG002|Overall Study|Death|17|||
131556085|NCT03679767|473660321|FG003|Overall Study|Death|10|||
131556086|NCT03679767|473660318|FG000|Overall Study|Lost to Follow-up|1|||
131556087|NCT03679767|473660319|FG001|Overall Study|Lost to Follow-up|1|||
131556088|NCT03679767|473660320|FG002|Overall Study|Lost to Follow-up|1|||
131556089|NCT03679767|473660321|FG003|Overall Study|Lost to Follow-up|1|||
131556090|NCT03679767|473660318|FG000|Overall Study|Withdrawal by Subject|0|||
131556091|NCT03679767|473660319|FG001|Overall Study|Withdrawal by Subject|0|||
131556092|NCT03679767|473660320|FG002|Overall Study|Withdrawal by Subject|0|||
131556093|NCT03679767|473660321|FG003|Overall Study|Withdrawal by Subject|1|||
131556094|NCT03679767|473660318|FG000|Overall Study|Follow-up Completed|18|||
131556095|NCT03679767|473660319|FG001|Overall Study|Follow-up Completed|11|||
131556096|NCT03679767|473660320|FG002|Overall Study|Follow-up Completed|11|||
131556097|NCT03679767|473660321|FG003|Overall Study|Follow-up Completed|20|||
131556098|NCT03679767|473660318|FG000|Overall Study|Entered Hospice Care|0|||
131556099|NCT03679767|473660319|FG001|Overall Study|Entered Hospice Care|0|||
131556100|NCT03679767|473660320|FG002|Overall Study|Entered Hospice Care|0|||
131688961|NCT01840579|474145930|FG007|Overall Study|Ongoing in study|0|||
131556101|NCT03679767|473660321|FG003|Overall Study|Entered Hospice Care|1|||
131556102|NCT03679767|473660318|FG000|Overall Study|Progressive Disease|0|||
131556103|NCT03679767|473660319|FG001|Overall Study|Progressive Disease|0|||
131556104|NCT03679767|473660320|FG002|Overall Study|Progressive Disease|0|||
131556105|NCT03679767|473660321|FG003|Overall Study|Progressive Disease|1|||
131556106|NCT01407354|473660323|FG000|First Intervention|Withdrawal by Subject|0|||
131556107|NCT01407354|473660324|FG001|First Intervention|Withdrawal by Subject|2|||
131556108|NCT01407354|473660323|FG000|First Intervention|Adverse Event|1|||
131556109|NCT01407354|473660324|FG001|First Intervention|Adverse Event|0|||
131556110|NCT01407354|473660323|FG000|First Intervention|Physician Decision|1|||
131556111|NCT01407354|473660324|FG001|First Intervention|Physician Decision|0|||
131556112|NCT02204579|473660325|FG000|Overall Study|Screen failures|2|||
131556113|NCT02778399|473660326|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
131556114|NCT02778399|473660327|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
131556115|NCT02778399|473660328|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
131556116|NCT02778399|473660329|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
131556117|NCT02778399|473660330|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
131556118|NCT02778399|473660331|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
131556119|NCT02778399|473660326|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
131556120|NCT02778399|473660327|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
131556121|NCT02778399|473660328|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
131556122|NCT02778399|473660329|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
131556123|NCT02778399|473660330|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
131556124|NCT02778399|473660331|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
131556125|NCT02778399|473660326|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
131556126|NCT02778399|473660327|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
131556127|NCT02778399|473660328|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
131556128|NCT02778399|473660329|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
131556129|NCT02778399|473660330|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
131556130|NCT02778399|473660331|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
131556131|NCT02778399|473660326|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
131556132|NCT02778399|473660327|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
131556133|NCT02778399|473660328|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
131556134|NCT02778399|473660329|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
131556135|NCT02778399|473660330|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
131556136|NCT02778399|473660331|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
131556137|NCT02778399|473660326|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
131556138|NCT02778399|473660327|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
131556139|NCT02778399|473660328|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
131556140|NCT02778399|473660329|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
131556141|NCT02778399|473660330|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
131556142|NCT02778399|473660331|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
131556143|NCT02778399|473660326|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
131556144|NCT02778399|473660327|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
131556145|NCT02778399|473660328|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
131556146|NCT02778399|473660329|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
131556147|NCT02778399|473660330|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
131556148|NCT02778399|473660331|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
131556149|NCT02778399|473660326|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
131556150|NCT02778399|473660327|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
131556151|NCT02778399|473660328|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
131556152|NCT02778399|473660329|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
131556153|NCT02778399|473660330|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
131556154|NCT02778399|473660331|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
131556155|NCT02778399|473660326|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
131556156|NCT02778399|473660327|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
131556157|NCT02778399|473660328|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
131556158|NCT02778399|473660329|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
131556159|NCT02778399|473660330|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
131556160|NCT02778399|473660331|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
131556161|NCT02778399|473660326|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
131556162|NCT02778399|473660327|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
131556163|NCT02778399|473660328|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
131556164|NCT02778399|473660329|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
131688962|NCT01840579|474145931|FG008|Overall Study|Ongoing in study|0|||
131688963|NCT01840579|474145932|FG009|Overall Study|Ongoing in study|0|||
131688964|NCT01840579|474145923|FG000|Overall Study|Death|0|||
131688965|NCT01840579|474145924|FG001|Overall Study|Death|0|||
131688966|NCT01840579|474145925|FG002|Overall Study|Death|0|||
131688967|NCT01840579|474145926|FG003|Overall Study|Death|0|||
131688968|NCT01840579|474145927|FG004|Overall Study|Death|0|||
131688969|NCT01840579|474145928|FG005|Overall Study|Death|1|||
131688970|NCT01840579|474145929|FG006|Overall Study|Death|0|||
131688971|NCT01840579|474145930|FG007|Overall Study|Death|0|||
131688972|NCT01840579|474145931|FG008|Overall Study|Death|0|||
131688973|NCT01840579|474145932|FG009|Overall Study|Death|0|||
131556165|NCT02778399|473660330|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
131556166|NCT02778399|473660331|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
131556167|NCT02778399|473660326|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
131556168|NCT02778399|473660327|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
131556169|NCT02778399|473660328|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
131556170|NCT02778399|473660329|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
131556171|NCT02778399|473660330|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
131556172|NCT02778399|473660331|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
131556173|NCT02778399|473660326|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
131688974|NCT01840579|474145923|FG000|Overall Study|Adverse Event|0|||
131688975|NCT01840579|474145924|FG001|Overall Study|Adverse Event|1|||
131688976|NCT01840579|474145925|FG002|Overall Study|Adverse Event|0|||
131688977|NCT01840579|474145926|FG003|Overall Study|Adverse Event|0|||
131688978|NCT01840579|474145927|FG004|Overall Study|Adverse Event|0|||
131688979|NCT01840579|474145928|FG005|Overall Study|Adverse Event|0|||
131688980|NCT01840579|474145929|FG006|Overall Study|Adverse Event|0|||
131688981|NCT01840579|474145930|FG007|Overall Study|Adverse Event|0|||
131688982|NCT01840579|474145931|FG008|Overall Study|Adverse Event|0|||
131688983|NCT01840579|474145932|FG009|Overall Study|Adverse Event|0|||
131688984|NCT01840579|474145923|FG000|Overall Study|Follow-up ended by Sponsor|0|||
131688985|NCT01840579|474145924|FG001|Overall Study|Follow-up ended by Sponsor|0|||
131688986|NCT01840579|474145925|FG002|Overall Study|Follow-up ended by Sponsor|0|||
131688987|NCT01840579|474145926|FG003|Overall Study|Follow-up ended by Sponsor|0|||
131688988|NCT01840579|474145927|FG004|Overall Study|Follow-up ended by Sponsor|0|||
131688989|NCT01840579|474145928|FG005|Overall Study|Follow-up ended by Sponsor|0|||
131688990|NCT01840579|474145929|FG006|Overall Study|Follow-up ended by Sponsor|2|||
131688991|NCT01840579|474145930|FG007|Overall Study|Follow-up ended by Sponsor|0|||
131688992|NCT01840579|474145931|FG008|Overall Study|Follow-up ended by Sponsor|0|||
131688993|NCT01840579|474145932|FG009|Overall Study|Follow-up ended by Sponsor|0|||
131435997|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
131435998|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
131435999|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
131436000|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
131688994|NCT01924182|474145933|FG000|Overall Study|Withdrawal by Subject|1|||
131688995|NCT01924182|474145934|FG001|Overall Study|Withdrawal by Subject|0|||
131688996|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
131688997|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
131688998|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
131688999|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
131689000|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
131689001|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
131689002|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
131436001|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
131436002|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
131436003|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
131436004|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
131436005|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
131436006|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
131689003|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
131689004|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to death|4|||
131689005|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to death|3|||
131689006|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
131689007|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
131689008|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
131689009|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
131689010|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
131436007|NCT02586623|473221905|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
131436008|NCT02586623|473221906|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
131436009|NCT02586623|473221907|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
131436010|NCT02910466|473221910|FG000|Overall Study|Adverse Event|1|||
131436011|NCT02910466|473221910|FG000|Overall Study|Withdrawal by Subject|3|||
131436012|NCT02910466|473221910|FG000|Overall Study|Lost to Follow-up|5|||
131436013|NCT02910466|473221910|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
131436014|NCT02910466|473221910|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
131436015|NCT04332107|473221919|FG000|Day 3|Lost to Follow-up|23|||
131436016|NCT04332107|473221920|FG001|Day 3|Lost to Follow-up|14|||
131436017|NCT04332107|473221919|FG000|Day 3|Missing outcome data|3|||
131436018|NCT04332107|473221920|FG001|Day 3|Missing outcome data|6|||
131436019|NCT04332107|473221919|FG000|Day 14|Lost to Follow-up|13|||
131436020|NCT04332107|473221920|FG001|Day 14|Lost to Follow-up|4|||
131436021|NCT04332107|473221919|FG000|Day 14|Missing outcome data|4|||
131436022|NCT04332107|473221920|FG001|Day 14|Missing outcome data|4|||
131436023|NCT04332107|473221919|FG000|Day 21|Lost to Follow-up|10|||
131436024|NCT04332107|473221920|FG001|Day 21|Lost to Follow-up|2|||
131436025|NCT03064490|473221926|FG000|Overall Study|Physician Decision|5|||
131436026|NCT04158583|473221931|FG000|Overall Study|Withdrawal by Subject|1|||
131436027|NCT04158583|473221932|FG001|Overall Study|Withdrawal by Subject|1|||
131436028|NCT04158583|473221933|FG002|Overall Study|Withdrawal by Subject|0|||
131436029|NCT04158583|473221934|FG003|Overall Study|Withdrawal by Subject|0|||
131436030|NCT04158583|473221935|FG004|Overall Study|Withdrawal by Subject|1|||
131689011|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
131689012|NCT02258451|474145935|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
131436031|NCT04158583|473221936|FG005|Overall Study|Withdrawal by Subject|0|||
131436032|NCT04158583|473221937|FG006|Overall Study|Withdrawal by Subject|0|||
131436033|NCT04158583|473221938|FG007|Overall Study|Withdrawal by Subject|0|||
131436034|NCT04158583|473221939|FG008|Overall Study|Withdrawal by Subject|2|||
131436035|NCT04158583|473221940|FG009|Overall Study|Withdrawal by Subject|0|||
131436036|NCT04158583|473221931|FG000|Overall Study|Study Terminated by Sponsor|0|||
131436037|NCT04158583|473221932|FG001|Overall Study|Study Terminated by Sponsor|0|||
131436038|NCT04158583|473221933|FG002|Overall Study|Study Terminated by Sponsor|0|||
131689013|NCT02258451|474145936|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
131689014|NCT02258451|474145935|FG000|Overall Study|Other reason|1|||
131689015|NCT02258451|474145936|FG001|Overall Study|Other reason|1|||
131689016|NCT02258451|474145935|FG000|Overall Study|Never treated|2|||
131436039|NCT04158583|473221934|FG003|Overall Study|Study Terminated by Sponsor|1|||
131436040|NCT04158583|473221935|FG004|Overall Study|Study Terminated by Sponsor|0|||
131436041|NCT04158583|473221936|FG005|Overall Study|Study Terminated by Sponsor|0|||
131436042|NCT04158583|473221937|FG006|Overall Study|Study Terminated by Sponsor|0|||
131436043|NCT04158583|473221938|FG007|Overall Study|Study Terminated by Sponsor|0|||
131436044|NCT04158583|473221939|FG008|Overall Study|Study Terminated by Sponsor|0|||
131436045|NCT04158583|473221940|FG009|Overall Study|Study Terminated by Sponsor|0|||
131436046|NCT04158583|473221931|FG000|Overall Study|Progressive Disease|1|||
131436047|NCT04158583|473221932|FG001|Overall Study|Progressive Disease|0|||
131436048|NCT04158583|473221933|FG002|Overall Study|Progressive Disease|3|||
131436049|NCT04158583|473221934|FG003|Overall Study|Progressive Disease|5|||
131436050|NCT04158583|473221935|FG004|Overall Study|Progressive Disease|0|||
131436051|NCT04158583|473221936|FG005|Overall Study|Progressive Disease|1|||
131436052|NCT04158583|473221937|FG006|Overall Study|Progressive Disease|6|||
131436053|NCT04158583|473221938|FG007|Overall Study|Progressive Disease|2|||
131689017|NCT02258451|474145936|FG001|Overall Study|Never treated|3|||
131689018|NCT05419128|474145941|FG000|Overall Study|Withdrawal by Subject|1|||
131689019|NCT05419128|474145942|FG001|Overall Study|Withdrawal by Subject|1|||
131689020|NCT05419128|474145943|FG002|Overall Study|Withdrawal by Subject|0|||
131689021|NCT05419128|474145944|FG003|Overall Study|Withdrawal by Subject|1|||
131689022|NCT05419128|474145945|FG004|Overall Study|Withdrawal by Subject|1|||
131689023|NCT05419128|474145946|FG005|Overall Study|Withdrawal by Subject|0|||
131436054|NCT04158583|473221939|FG008|Overall Study|Progressive Disease|1|||
131898532|NCT00320788|474914099|FG003|Overall Study|Protocol Violation|0|||
131436055|NCT04158583|473221940|FG009|Overall Study|Progressive Disease|2|||
131436056|NCT04158583|473221931|FG000|Overall Study|Lost to Follow-up|0|||
131775235|NCT01453296|474456552|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
131775236|NCT01453296|474456553|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
131775237|NCT01453296|474456552|FG000|Treatment Period 2|Adverse Event|1|||
131775238|NCT01453296|474456553|FG001|Treatment Period 2|Adverse Event|0|||
131556174|NCT02778399|473660327|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
131556175|NCT02778399|473660328|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
131556176|NCT02778399|473660329|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
131556177|NCT02778399|473660330|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
131556178|NCT02778399|473660331|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
131556179|NCT00447954|473660336|FG000|Overall Study|Adverse Event|0|||
131556180|NCT00447954|473660337|FG001|Overall Study|Adverse Event|2|||
131556181|NCT00447954|473660338|FG002|Overall Study|Adverse Event|0|||
131556182|NCT00447954|473660336|FG000|Overall Study|Withdrawal by Subject|0|||
131556183|NCT00447954|473660337|FG001|Overall Study|Withdrawal by Subject|1|||
131556184|NCT00447954|473660338|FG002|Overall Study|Withdrawal by Subject|1|||
131556185|NCT00447954|473660336|FG000|Overall Study|Lost to Follow-up|0|||
131556186|NCT00447954|473660337|FG001|Overall Study|Lost to Follow-up|1|||
131556187|NCT00447954|473660338|FG002|Overall Study|Lost to Follow-up|0|||
131775239|NCT01453296|474456552|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131556188|NCT00447954|473660336|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
131556189|NCT00447954|473660337|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
131556190|NCT00447954|473660338|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
131556191|NCT03556358|473660341|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
131556192|NCT03556358|473660342|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
131556193|NCT03556358|473660341|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
131556194|NCT03556358|473660342|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
131556195|NCT03556358|473660341|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
131556196|NCT03556358|473660342|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
131556197|NCT03556358|473660341|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
131556198|NCT03556358|473660342|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
131556199|NCT03556358|473660341|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
131556200|NCT03556358|473660342|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
131556201|NCT03556358|473660341|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
131775240|NCT01453296|474456553|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131775241|NCT00620776|474456554|FG000|Overall Study|Did not receive treatment|3|||
131556202|NCT03556358|473660342|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
131556203|NCT03556358|473660341|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
131556204|NCT03556358|473660342|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
131556205|NCT01351025|473660343|FG000|Week 0 - 20|Lost to Follow-up|2|||
131556206|NCT01351025|473660344|FG001|Week 0 - 20|Lost to Follow-up|1|||
131556207|NCT01351025|473660343|FG000|Week 0 - 20|Withdrawal by Subject|1|||
131556208|NCT01351025|473660344|FG001|Week 0 - 20|Withdrawal by Subject|0|||
131556209|NCT01351025|473660343|FG000|Week 24 - 44|Lost to Follow-up|0|||
131556210|NCT01351025|473660344|FG001|Week 24 - 44|Lost to Follow-up|2|||
131556211|NCT01351025|473660343|FG000|Week 24 - 44|Site closed|0|||
131556212|NCT01351025|473660344|FG001|Week 24 - 44|Site closed|1|||
131556213|NCT01351025|473660343|FG000|Week 24 - 44|unable to get to clinic|1|||
131556214|NCT01351025|473660344|FG001|Week 24 - 44|unable to get to clinic|1|||
131556215|NCT01861522|473660349|FG000|Overall Study|Adverse Event|1|||
131556216|NCT01861522|473660350|FG001|Overall Study|Adverse Event|0|||
131556217|NCT01861522|473660349|FG000|Overall Study|Withdrawal by Subject|2|||
131556218|NCT01861522|473660350|FG001|Overall Study|Withdrawal by Subject|0|||
131556219|NCT00550550|473660351|FG000|Overall Study|Adverse Event|13|||
131556220|NCT00550550|473660352|FG001|Overall Study|Adverse Event|5|||
131556221|NCT00550550|473660351|FG000|Overall Study|Treatment Failure|0|||
131556222|NCT00550550|473660352|FG001|Overall Study|Treatment Failure|1|||
131556223|NCT00550550|473660351|FG000|Overall Study|Lost to Follow-up|4|||
131556224|NCT00550550|473660352|FG001|Overall Study|Lost to Follow-up|0|||
131556225|NCT00550550|473660351|FG000|Overall Study|Withdrawal by Subject|10|||
131556226|NCT00550550|473660352|FG001|Overall Study|Withdrawal by Subject|8|||
131556227|NCT00550550|473660351|FG000|Overall Study|Protocol Violation|5|||
131556228|NCT00550550|473660352|FG001|Overall Study|Protocol Violation|14|||
131556229|NCT00550550|473660351|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
131556230|NCT00550550|473660352|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
131556231|NCT00550550|473660351|FG000|Overall Study|Randomized But Not Treated|1|||
131556232|NCT00550550|473660352|FG001|Overall Study|Randomized But Not Treated|0|||
131556233|NCT00381641|473660355|FG000|Overall Study|Withdrawal by Subject|0|||
131556234|NCT00381641|473660356|FG001|Overall Study|Withdrawal by Subject|2|||
131556235|NCT01598298|473660357|FG000|Overall Study|Not eligible|5|||
131556236|NCT01598298|473660358|FG001|Overall Study|Not eligible|5|||
131556237|NCT01598298|473660357|FG000|Overall Study|Adverse Event|21|||
131556238|NCT01598298|473660358|FG001|Overall Study|Adverse Event|19|||
131556239|NCT01598298|473660357|FG000|Overall Study|Progression/relapse|0|||
131556240|NCT01598298|473660358|FG001|Overall Study|Progression/relapse|2|||
131556241|NCT01598298|473660357|FG000|Overall Study|Withdrawal by Subject|10|||
131556242|NCT01598298|473660358|FG001|Overall Study|Withdrawal by Subject|15|||
131556243|NCT01598298|473660357|FG000|Overall Study|Other reason (not protocol specified)|4|||
131556244|NCT01598298|473660358|FG001|Overall Study|Other reason (not protocol specified)|0|||
131556245|NCT03813147|473660359|FG000|Overall Study|Lack of Efficacy|4|||
131556246|NCT03813147|473660360|FG001|Overall Study|Lack of Efficacy|4|||
131556247|NCT03813147|473660359|FG000|Overall Study|Physician Decision|2|||
131556248|NCT03813147|473660360|FG001|Overall Study|Physician Decision|1|||
131556249|NCT04666922|473662374|FG000|Overall Study|Withdrawal by Subject|1|||
131556250|NCT04666922|473662375|FG001|Overall Study|Withdrawal by Subject|0|||
131556251|NCT04666922|473662376|FG002|Overall Study|Withdrawal by Subject|0|||
131556252|NCT04666922|473662377|FG003|Overall Study|Withdrawal by Subject|0|||
131556253|NCT04666922|473662378|FG004|Overall Study|Withdrawal by Subject|0|||
131556254|NCT04666922|473662379|FG005|Overall Study|Withdrawal by Subject|0|||
131556255|NCT04666922|473662380|FG006|Overall Study|Withdrawal by Subject|0|||
131556256|NCT00244374|473662381|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
131556257|NCT00244374|473662382|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
131556258|NCT00244374|473662383|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
131556259|NCT00244374|473662384|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
131556260|NCT00244374|473662385|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
131556261|NCT00244374|473662381|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
131556262|NCT00244374|473662382|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
131556263|NCT00244374|473662383|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
131556264|NCT00244374|473662384|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
131556265|NCT00244374|473662385|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
131556266|NCT00244374|473662381|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
131556267|NCT00244374|473662382|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
131556268|NCT00244374|473662383|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
131556269|NCT00244374|473662384|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
131556270|NCT00244374|473662385|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
131556271|NCT00244374|473662381|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
131556272|NCT00244374|473662382|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
131556273|NCT00244374|473662383|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
131556274|NCT00244374|473662384|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
131556275|NCT00244374|473662385|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
131556276|NCT00244374|473662381|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
131689024|NCT05419128|474145941|FG000|Overall Study|Lost to Follow-up|0|||
131689025|NCT05419128|474145942|FG001|Overall Study|Lost to Follow-up|0|||
131689026|NCT05419128|474145943|FG002|Overall Study|Lost to Follow-up|1|||
131689027|NCT05419128|474145944|FG003|Overall Study|Lost to Follow-up|0|||
131689028|NCT05419128|474145945|FG004|Overall Study|Lost to Follow-up|0|||
131689029|NCT05419128|474145946|FG005|Overall Study|Lost to Follow-up|1|||
131689030|NCT03834519|474145947|FG000|Overall Study|Lost to Follow-up|2|||
131689031|NCT03834519|474145948|FG001|Overall Study|Lost to Follow-up|1|||
131556277|NCT00244374|473662382|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
131556278|NCT00244374|473662383|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
131556279|NCT00244374|473662384|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
131556280|NCT00244374|473662385|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
131556281|NCT00244374|473662381|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
131556282|NCT00244374|473662382|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
131556283|NCT00244374|473662383|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
131556284|NCT00244374|473662384|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
131556285|NCT00244374|473662385|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
131556286|NCT00244374|473662381|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
131556287|NCT00244374|473662382|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
131556288|NCT00244374|473662383|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
131556289|NCT00244374|473662384|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
131556290|NCT00244374|473662385|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
131556291|NCT00244374|473662381|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
131556292|NCT00244374|473662382|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
131556293|NCT00244374|473662383|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
131556294|NCT00244374|473662384|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
131556295|NCT00244374|473662385|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
131556296|NCT00244374|473662381|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
131556297|NCT00244374|473662382|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
131556298|NCT00244374|473662383|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
131556299|NCT00244374|473662384|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
131556300|NCT00244374|473662385|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
131556301|NCT04651114|473662388|FG000|Overall Study|Withdrawal by Subject|8|||
131556302|NCT01923896|473662393|FG000|Overall Study|Adverse Event|1|||
131556303|NCT01923896|473662394|FG001|Overall Study|Adverse Event|0|||
131556304|NCT00474929|473662397|FG000|Overall Study|Withdrawal by Subject|0|||
131556305|NCT00474929|473662398|FG001|Overall Study|Withdrawal by Subject|1|||
131556306|NCT00474929|473662399|FG002|Overall Study|Withdrawal by Subject|0|||
131556307|NCT00474929|473662400|FG003|Overall Study|Withdrawal by Subject|0|||
131556308|NCT00474929|473662401|FG004|Overall Study|Withdrawal by Subject|0|||
131556309|NCT00474929|473662397|FG000|Overall Study|Unrelated medical condition|0|||
131556310|NCT00474929|473662398|FG001|Overall Study|Unrelated medical condition|0|||
131556311|NCT00474929|473662399|FG002|Overall Study|Unrelated medical condition|1|||
131556312|NCT00474929|473662400|FG003|Overall Study|Unrelated medical condition|0|||
131556313|NCT00474929|473662401|FG004|Overall Study|Unrelated medical condition|0|||
131556314|NCT00474929|473662397|FG000|Overall Study|Physician Decision|0|||
131556315|NCT00474929|473662398|FG001|Overall Study|Physician Decision|0|||
131556316|NCT00474929|473662399|FG002|Overall Study|Physician Decision|1|||
131556317|NCT00474929|473662400|FG003|Overall Study|Physician Decision|2|||
131556318|NCT00474929|473662401|FG004|Overall Study|Physician Decision|0|||
131556319|NCT03661996|473662404|FG000|Overall Study|Adverse Event|0|||
131556320|NCT03661996|473662405|FG001|Overall Study|Adverse Event|0|||
131556321|NCT03661996|473662406|FG002|Overall Study|Adverse Event|1|||
131556322|NCT03661996|473662407|FG003|Overall Study|Adverse Event|1|||
131556323|NCT03661996|473662408|FG004|Overall Study|Adverse Event|0|||
131556324|NCT03661996|473662404|FG000|Overall Study|Lost to Follow-up|5|||
131556325|NCT03661996|473662405|FG001|Overall Study|Lost to Follow-up|1|||
131556326|NCT03661996|473662406|FG002|Overall Study|Lost to Follow-up|2|||
131556327|NCT03661996|473662407|FG003|Overall Study|Lost to Follow-up|2|||
131556328|NCT03661996|473662408|FG004|Overall Study|Lost to Follow-up|6|||
131556329|NCT03661996|473662404|FG000|Overall Study|Physician Decision|1|||
131556330|NCT03661996|473662405|FG001|Overall Study|Physician Decision|1|||
131556331|NCT03661996|473662406|FG002|Overall Study|Physician Decision|1|||
131556332|NCT03661996|473662407|FG003|Overall Study|Physician Decision|2|||
131556333|NCT03661996|473662408|FG004|Overall Study|Physician Decision|0|||
131556334|NCT03661996|473662404|FG000|Overall Study|Protocol Violation|0|||
131556335|NCT03661996|473662405|FG001|Overall Study|Protocol Violation|0|||
131556336|NCT03661996|473662406|FG002|Overall Study|Protocol Violation|0|||
131556337|NCT03661996|473662407|FG003|Overall Study|Protocol Violation|0|||
131556338|NCT03661996|473662408|FG004|Overall Study|Protocol Violation|1|||
131556339|NCT03661996|473662404|FG000|Overall Study|Withdrawal by Subject|3|||
131556340|NCT03661996|473662405|FG001|Overall Study|Withdrawal by Subject|5|||
131556341|NCT03661996|473662406|FG002|Overall Study|Withdrawal by Subject|1|||
131556342|NCT03661996|473662407|FG003|Overall Study|Withdrawal by Subject|7|||
131719471|NCT00258154|474253327|FG000|Overall Study|Lost to Follow-up|0|||
131689032|NCT03834519|474145947|FG000|Overall Study|Withdrawal by Subject|5|||
131689033|NCT03834519|474145948|FG001|Overall Study|Withdrawal by Subject|8|||
131689034|NCT03834519|474145947|FG000|Overall Study|Death|368|||
131689035|NCT03834519|474145948|FG001|Overall Study|Death|174|||
131689036|NCT03834519|474145947|FG000|Overall Study|Physician Decision|5|||
131689037|NCT03834519|474145948|FG001|Overall Study|Physician Decision|1|||
131689038|NCT03834519|474145947|FG000|Overall Study|Sponsor decision|149|||
131689039|NCT03834519|474145948|FG001|Overall Study|Sponsor decision|80|||
131689040|NCT04506086|474145949|FG000|Overall Study|Withdrawal by Subject|2|||
131689041|NCT00517751|474145950|FG000|Overall Study|Death|3|||
131556343|NCT03661996|473662408|FG004|Overall Study|Withdrawal by Subject|7|||
131556344|NCT03661996|473662404|FG000|Overall Study|Sponsors Decision|2|||
131556345|NCT03661996|473662405|FG001|Overall Study|Sponsors Decision|0|||
131556346|NCT03661996|473662406|FG002|Overall Study|Sponsors Decision|0|||
131556347|NCT03661996|473662407|FG003|Overall Study|Sponsors Decision|0|||
131556348|NCT03661996|473662408|FG004|Overall Study|Sponsors Decision|0|||
131556349|NCT03661996|473662404|FG000|Overall Study|Other|1|||
131556350|NCT03661996|473662405|FG001|Overall Study|Other|1|||
131556351|NCT03661996|473662406|FG002|Overall Study|Other|1|||
131556352|NCT03661996|473662407|FG003|Overall Study|Other|1|||
131556353|NCT03661996|473662408|FG004|Overall Study|Other|0|||
131436057|NCT04158583|473221932|FG001|Overall Study|Lost to Follow-up|0|||
131436058|NCT04158583|473221933|FG002|Overall Study|Lost to Follow-up|1|||
131436059|NCT04158583|473221934|FG003|Overall Study|Lost to Follow-up|1|||
131436060|NCT04158583|473221935|FG004|Overall Study|Lost to Follow-up|1|||
131436061|NCT04158583|473221936|FG005|Overall Study|Lost to Follow-up|0|||
131436062|NCT04158583|473221937|FG006|Overall Study|Lost to Follow-up|0|||
131436063|NCT04158583|473221938|FG007|Overall Study|Lost to Follow-up|0|||
131436064|NCT04158583|473221939|FG008|Overall Study|Lost to Follow-up|0|||
131436065|NCT04158583|473221940|FG009|Overall Study|Lost to Follow-up|0|||
131436066|NCT04158583|473221931|FG000|Overall Study|Due To Patient Status|0|||
131436067|NCT04158583|473221932|FG001|Overall Study|Due To Patient Status|0|||
131436068|NCT04158583|473221933|FG002|Overall Study|Due To Patient Status|0|||
131436069|NCT04158583|473221934|FG003|Overall Study|Due To Patient Status|0|||
131436070|NCT04158583|473221935|FG004|Overall Study|Due To Patient Status|0|||
131436071|NCT04158583|473221936|FG005|Overall Study|Due To Patient Status|0|||
131436072|NCT04158583|473221937|FG006|Overall Study|Due To Patient Status|0|||
131436073|NCT04158583|473221938|FG007|Overall Study|Due To Patient Status|0|||
131436074|NCT04158583|473221939|FG008|Overall Study|Due To Patient Status|1|||
131556354|NCT00068380|473662409|FG000|Overall Study|Withdrawal by Subject|3|||
131436075|NCT04158583|473221940|FG009|Overall Study|Due To Patient Status|0|||
131436076|NCT04158583|473221931|FG000|Overall Study|Death|3|||
131436077|NCT04158583|473221932|FG001|Overall Study|Death|4|||
131436078|NCT04158583|473221933|FG002|Overall Study|Death|2|||
131436079|NCT04158583|473221934|FG003|Overall Study|Death|2|||
131436080|NCT04158583|473221935|FG004|Overall Study|Death|4|||
131436081|NCT04158583|473221936|FG005|Overall Study|Death|3|||
131436082|NCT04158583|473221937|FG006|Overall Study|Death|5|||
131436083|NCT04158583|473221938|FG007|Overall Study|Death|2|||
131436084|NCT04158583|473221939|FG008|Overall Study|Death|0|||
131436085|NCT04158583|473221940|FG009|Overall Study|Death|1|||
131436086|NCT04158583|473221931|FG000|Overall Study|Clinical Progression Disease|0|||
131436087|NCT04158583|473221932|FG001|Overall Study|Clinical Progression Disease|0|||
131436088|NCT04158583|473221933|FG002|Overall Study|Clinical Progression Disease|0|||
131436089|NCT04158583|473221934|FG003|Overall Study|Clinical Progression Disease|1|||
131436090|NCT04158583|473221935|FG004|Overall Study|Clinical Progression Disease|0|||
131436091|NCT04158583|473221936|FG005|Overall Study|Clinical Progression Disease|0|||
131436092|NCT04158583|473221937|FG006|Overall Study|Clinical Progression Disease|0|||
131436093|NCT04158583|473221938|FG007|Overall Study|Clinical Progression Disease|0|||
131436094|NCT04158583|473221939|FG008|Overall Study|Clinical Progression Disease|0|||
131436095|NCT04158583|473221940|FG009|Overall Study|Clinical Progression Disease|0|||
131436096|NCT04158583|473221931|FG000|Overall Study|Clinical Progression|0|||
131436097|NCT04158583|473221932|FG001|Overall Study|Clinical Progression|0|||
131436098|NCT04158583|473221933|FG002|Overall Study|Clinical Progression|0|||
131436099|NCT04158583|473221934|FG003|Overall Study|Clinical Progression|0|||
131436100|NCT04158583|473221935|FG004|Overall Study|Clinical Progression|1|||
131436101|NCT04158583|473221936|FG005|Overall Study|Clinical Progression|0|||
131436102|NCT04158583|473221937|FG006|Overall Study|Clinical Progression|2|||
131436103|NCT04158583|473221938|FG007|Overall Study|Clinical Progression|0|||
131436104|NCT04158583|473221939|FG008|Overall Study|Clinical Progression|0|||
131436105|NCT04158583|473221940|FG009|Overall Study|Clinical Progression|0|||
131436106|NCT04158583|473221931|FG000|Overall Study|Clinical Deterioration|0|||
131436107|NCT04158583|473221932|FG001|Overall Study|Clinical Deterioration|0|||
131436108|NCT04158583|473221933|FG002|Overall Study|Clinical Deterioration|0|||
131436109|NCT04158583|473221934|FG003|Overall Study|Clinical Deterioration|1|||
131436110|NCT04158583|473221935|FG004|Overall Study|Clinical Deterioration|0|||
131436111|NCT04158583|473221936|FG005|Overall Study|Clinical Deterioration|0|||
131436112|NCT04158583|473221937|FG006|Overall Study|Clinical Deterioration|0|||
131436113|NCT04158583|473221938|FG007|Overall Study|Clinical Deterioration|0|||
131436114|NCT04158583|473221939|FG008|Overall Study|Clinical Deterioration|0|||
131436115|NCT04158583|473221940|FG009|Overall Study|Clinical Deterioration|1|||
131436116|NCT01871519|473221941|FG000|Overall Study|Death|26|||
131436117|NCT01871519|473221941|FG000|Overall Study|Lost to Follow-up|15|||
131436118|NCT01871519|473221941|FG000|Overall Study|Withdrawal by Subject|49|||
131436119|NCT01063153|473221942|FG000|Overall Study|Found Ineligible During Screening|2|||
131436120|NCT01063153|473221943|FG001|Overall Study|Found Ineligible During Screening|0|||
131436121|NCT01063153|473221942|FG000|Overall Study|Lost to Follow-up|0|||
131436122|NCT01063153|473221943|FG001|Overall Study|Lost to Follow-up|7|||
131436123|NCT01063153|473221942|FG000|Overall Study|Withdrawal by Subject|0|||
131436124|NCT01063153|473221943|FG001|Overall Study|Withdrawal by Subject|1|||
131436125|NCT01063153|473221942|FG000|Overall Study|Physician Decision|0|||
131436126|NCT01063153|473221943|FG001|Overall Study|Physician Decision|4|||
131436127|NCT02485704|473221944|FG000|Overall Study|Lost to Follow-up|4|||
131436128|NCT02485704|473221945|FG001|Overall Study|Lost to Follow-up|5|||
131436129|NCT02485704|473221944|FG000|Overall Study|Withdrawal by Subject|0|||
131436130|NCT02485704|473221945|FG001|Overall Study|Withdrawal by Subject|3|||
131436131|NCT02485704|473221944|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
131556355|NCT00068380|473662409|FG000|Overall Study|Adverse Event|2|||
131556356|NCT00067990|473662426|FG000|Overall Study|Death|5|||
131556357|NCT00067990|473662427|FG001|Overall Study|Death|7|||
131556358|NCT00067990|473662426|FG000|Overall Study|ESRD, Non IF/TA|1|||
131556359|NCT00067990|473662427|FG001|Overall Study|ESRD, Non IF/TA|3|||
131556360|NCT00067990|473662426|FG000|Overall Study|Withdrawal by Subject|4|||
131775242|NCT00620776|474456555|FG001|Overall Study|Did not receive treatment|5|||
131775243|NCT00620776|474456554|FG000|Overall Study|Adverse Event|2|||
131775244|NCT00620776|474456555|FG001|Overall Study|Adverse Event|3|||
131775245|NCT00620776|474456554|FG000|Overall Study|Lack of Efficacy|2|||
131556361|NCT00067990|473662427|FG001|Overall Study|Withdrawal by Subject|12|||
131556362|NCT01112514|473662428|FG000|Overall Study|Lost to Follow-up|1|||
131556363|NCT01118455|473662429|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
131556364|NCT01118455|473662430|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
131556365|NCT01973491|473662431|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
131556366|NCT01973491|473662431|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
131556367|NCT01973491|473662431|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
131556368|NCT01454830|473662441|FG000|Overall Study|Withdrawal by Subject|4|||
131556369|NCT01454830|473662442|FG001|Overall Study|Withdrawal by Subject|4|||
131556370|NCT01454830|473662441|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
131556371|NCT01454830|473662442|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
131556372|NCT01454830|473662441|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
131556373|NCT01454830|473662442|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
131556374|NCT01454830|473662441|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
131556375|NCT01454830|473662442|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
131556376|NCT01454830|473662441|FG000|Overall Study|Withdrawal - no polysomnography|3|||
131556377|NCT01454830|473662442|FG001|Overall Study|Withdrawal - no polysomnography|2|||
131556378|NCT00152763|473662443|FG000|Overall Study|Death|4|||
131556379|NCT00152763|473662444|FG001|Overall Study|Death|1|||
131556380|NCT00152763|473662445|FG002|Overall Study|Death|2|||
131556381|NCT00152763|473662446|FG003|Overall Study|Death|1|||
131556382|NCT00152763|473662443|FG000|Overall Study|Lost to Follow-up|6|||
131556383|NCT00152763|473662444|FG001|Overall Study|Lost to Follow-up|4|||
131556384|NCT00152763|473662445|FG002|Overall Study|Lost to Follow-up|2|||
131556385|NCT00152763|473662446|FG003|Overall Study|Lost to Follow-up|13|||
131556386|NCT00569803|473662449|FG000|Overall Study|Lost to Follow-up|1|||
131556387|NCT00569803|473662450|FG001|Overall Study|Lost to Follow-up|0|||
131556388|NCT00569803|473662451|FG002|Overall Study|Lost to Follow-up|0|||
131556389|NCT00569803|473662452|FG003|Overall Study|Lost to Follow-up|0|||
131556390|NCT00569803|473662453|FG004|Overall Study|Lost to Follow-up|0|||
131556391|NCT00569803|473662454|FG005|Overall Study|Lost to Follow-up|0|||
131556392|NCT00569803|473662455|FG006|Overall Study|Lost to Follow-up|0|||
131556393|NCT00569803|473662456|FG007|Overall Study|Lost to Follow-up|0|||
131556394|NCT00569803|473662449|FG000|Overall Study|injection syringe leaked during dosing|0|||
131556395|NCT00569803|473662450|FG001|Overall Study|injection syringe leaked during dosing|0|||
131556396|NCT00569803|473662451|FG002|Overall Study|injection syringe leaked during dosing|0|||
131556397|NCT00569803|473662452|FG003|Overall Study|injection syringe leaked during dosing|1|||
131556398|NCT00569803|473662453|FG004|Overall Study|injection syringe leaked during dosing|0|||
131556399|NCT00569803|473662454|FG005|Overall Study|injection syringe leaked during dosing|0|||
131556400|NCT00569803|473662455|FG006|Overall Study|injection syringe leaked during dosing|0|||
131556401|NCT00569803|473662456|FG007|Overall Study|injection syringe leaked during dosing|0|||
131556402|NCT00569803|473662449|FG000|Overall Study|Withdrawal by Subject|0|||
131556403|NCT00569803|473662450|FG001|Overall Study|Withdrawal by Subject|0|||
131556404|NCT00569803|473662451|FG002|Overall Study|Withdrawal by Subject|0|||
131556405|NCT00569803|473662452|FG003|Overall Study|Withdrawal by Subject|0|||
131556406|NCT00569803|473662453|FG004|Overall Study|Withdrawal by Subject|0|||
131556407|NCT00569803|473662454|FG005|Overall Study|Withdrawal by Subject|0|||
131556408|NCT00569803|473662455|FG006|Overall Study|Withdrawal by Subject|0|||
131556409|NCT00569803|473662456|FG007|Overall Study|Withdrawal by Subject|1|||
131556410|NCT01993823|473662457|FG000|Overall Study|Requested by the patient|6|||
131556411|NCT01993823|473662458|FG001|Overall Study|Requested by the patient|11|||
131556412|NCT01993823|473662457|FG000|Overall Study|Protocol Violation|0|||
131556413|NCT01993823|473662458|FG001|Overall Study|Protocol Violation|1|||
131556414|NCT01993823|473662457|FG000|Overall Study|Lost to Follow-up|1|||
131556415|NCT01993823|473662458|FG001|Overall Study|Lost to Follow-up|4|||
131556416|NCT01235975|473662459|FG000|Overall Study|Serious Adverse Event|0|||
131556417|NCT01235975|473662460|FG001|Overall Study|Serious Adverse Event|1|||
131556418|NCT01235975|473662459|FG000|Overall Study|Withdrawal by Subject|8|||
131775246|NCT00620776|474456555|FG001|Overall Study|Lack of Efficacy|1|||
131556419|NCT01235975|473662460|FG001|Overall Study|Withdrawal by Subject|2|||
131556420|NCT01235975|473662459|FG000|Overall Study|Migrated/moved from study area|2|||
131556421|NCT01235975|473662460|FG001|Overall Study|Migrated/moved from study area|1|||
131556422|NCT01235975|473662459|FG000|Overall Study|Lost to Follow-up|7|||
131556423|NCT01235975|473662460|FG001|Overall Study|Lost to Follow-up|3|||
131556424|NCT00791921|473662463|FG000|Overall Study|Protocol planed|24|||
131556425|NCT00791921|473662464|FG001|Overall Study|Protocol planed|88|||
131556426|NCT00791921|473662463|FG000|Overall Study|Withdrawal by Subject|1|||
131556427|NCT00791921|473662464|FG001|Overall Study|Withdrawal by Subject|2|||
131556428|NCT00791921|473662463|FG000|Overall Study|Adverse Event|8|||
131556429|NCT00791921|473662464|FG001|Overall Study|Adverse Event|2|||
131556430|NCT00791921|473662463|FG000|Overall Study|Lack of Efficacy|0|||
131556431|NCT00791921|473662464|FG001|Overall Study|Lack of Efficacy|2|||
131556432|NCT00791921|473662463|FG000|Overall Study|Lack of study drug administration|1|||
131556433|NCT00791921|473662464|FG001|Overall Study|Lack of study drug administration|1|||
131556434|NCT00791921|473662463|FG000|Overall Study|Reason other than those above|0|||
131556435|NCT00791921|473662464|FG001|Overall Study|Reason other than those above|1|||
131556436|NCT00422799|473662466|FG000|Overall Study|Withdrawal by Subject|6|||
131556437|NCT00422799|473662466|FG000|Overall Study|Adverse Event|7|||
131556438|NCT01965158|473662467|FG000|Overall Study|Adverse Event|14|||
131556439|NCT01965158|473662468|FG001|Overall Study|Adverse Event|5|||
131556440|NCT01965158|473662467|FG000|Overall Study|Withdrawal by Subject|16|||
131556441|NCT01965158|473662468|FG001|Overall Study|Withdrawal by Subject|24|||
131775247|NCT00620776|474456554|FG000|Overall Study|Lost to Follow-up|2|||
131775248|NCT00620776|474456555|FG001|Overall Study|Lost to Follow-up|5|||
131775249|NCT00620776|474456554|FG000|Overall Study|Withdrawal by Subject|3|||
131775250|NCT00620776|474456555|FG001|Overall Study|Withdrawal by Subject|2|||
131775251|NCT01725217|474456560|FG000|Overall Study|Withdrawal by Subject|1|||
131775252|NCT01725217|474456561|FG001|Overall Study|Withdrawal by Subject|0|||
131775253|NCT01725217|474456562|FG002|Overall Study|Withdrawal by Subject|0|||
131775254|NCT03919669|474456566|FG000|Overall Study|Withdrawal by Subject|1|||
131775255|NCT03919669|474456567|FG001|Overall Study|Withdrawal by Subject|0|||
131775256|NCT03919669|474456568|FG002|Overall Study|Withdrawal by Subject|0|||
131775257|NCT02319642|474456569|FG000|Overall Study|Adverse Event|2|||
131775258|NCT02319642|474456570|FG001|Overall Study|Adverse Event|4|||
131775259|NCT02319642|474456569|FG000|Overall Study|Lack of Efficacy|1|||
131556442|NCT01965158|473662467|FG000|Overall Study|Lost to Follow-up|7|||
131556443|NCT01965158|473662468|FG001|Overall Study|Lost to Follow-up|5|||
131556444|NCT01965158|473662467|FG000|Overall Study|Protocol Violation|1|||
131556445|NCT01965158|473662468|FG001|Overall Study|Protocol Violation|1|||
131556446|NCT01965158|473662467|FG000|Overall Study|Other - Miscellaneous|3|||
131556447|NCT01965158|473662468|FG001|Overall Study|Other - Miscellaneous|0|||
131556448|NCT01619787|473662469|FG000|Overall Study|Lost to Follow-up|5|||
131556449|NCT00669903|473662470|FG000|Overall Study|Adverse Event|0|||
131556450|NCT00669903|473662471|FG001|Overall Study|Adverse Event|1|||
131556451|NCT00669903|473662472|FG002|Overall Study|Adverse Event|3|||
131556452|NCT00669903|473662473|FG003|Overall Study|Adverse Event|1|||
131556453|NCT00669903|473662470|FG000|Overall Study|Withdrawal by Subject|0|||
131556454|NCT00669903|473662471|FG001|Overall Study|Withdrawal by Subject|2|||
131556455|NCT00669903|473662472|FG002|Overall Study|Withdrawal by Subject|2|||
131556456|NCT00669903|473662473|FG003|Overall Study|Withdrawal by Subject|2|||
131556457|NCT00669903|473662470|FG000|Overall Study|Lost to Follow-up|1|||
131556458|NCT00669903|473662471|FG001|Overall Study|Lost to Follow-up|1|||
131556459|NCT00669903|473662472|FG002|Overall Study|Lost to Follow-up|0|||
131556460|NCT00669903|473662473|FG003|Overall Study|Lost to Follow-up|1|||
131556461|NCT00669903|473662470|FG000|Overall Study|Protocol Violation|0|||
131556462|NCT00669903|473662471|FG001|Overall Study|Protocol Violation|1|||
131556463|NCT00669903|473662472|FG002|Overall Study|Protocol Violation|0|||
131556464|NCT00669903|473662473|FG003|Overall Study|Protocol Violation|0|||
131775260|NCT02319642|474456570|FG001|Overall Study|Lack of Efficacy|1|||
131775261|NCT02319642|474456569|FG000|Overall Study|Withdrawal by Subject|1|||
131556465|NCT02086162|473662474|FG000|Overall Study|Withdrawal by Subject|4|||
131556466|NCT02086162|473662475|FG001|Overall Study|Withdrawal by Subject|4|||
131556467|NCT02086162|473662474|FG000|Overall Study|moved|1|||
131556468|NCT02086162|473662475|FG001|Overall Study|moved|1|||
131775262|NCT02319642|474456570|FG001|Overall Study|Withdrawal by Subject|1|||
131556469|NCT02086162|473662474|FG000|Overall Study|Lost to Follow-up|4|||
131556470|NCT02086162|473662475|FG001|Overall Study|Lost to Follow-up|2|||
131556471|NCT02086162|473662474|FG000|Overall Study|Death|1|||
131556472|NCT02086162|473662475|FG001|Overall Study|Death|0|||
131556473|NCT04789577|473662479|FG000|Overall Study|Withdrawal by Subject|1|||
131556474|NCT04789577|473662480|FG001|Overall Study|Withdrawal by Subject|1|||
131556475|NCT04789577|473662481|FG002|Overall Study|Withdrawal by Subject|1|||
131556476|NCT04789577|473662482|FG003|Overall Study|Withdrawal by Subject|3|||
131556477|NCT04789577|473662483|FG004|Overall Study|Withdrawal by Subject|1|||
131556478|NCT04789577|473662484|FG005|Overall Study|Withdrawal by Subject|7|||
131556479|NCT04789577|473662485|FG006|Overall Study|Withdrawal by Subject|1|||
131556480|NCT04789577|473662479|FG000|Overall Study|Lost to Follow-up|7|||
131556481|NCT04789577|473662480|FG001|Overall Study|Lost to Follow-up|12|||
131556482|NCT04789577|473662481|FG002|Overall Study|Lost to Follow-up|7|||
131556483|NCT04789577|473662482|FG003|Overall Study|Lost to Follow-up|10|||
131556484|NCT04789577|473662483|FG004|Overall Study|Lost to Follow-up|8|||
131556485|NCT04789577|473662484|FG005|Overall Study|Lost to Follow-up|6|||
131556486|NCT04789577|473662485|FG006|Overall Study|Lost to Follow-up|10|||
131556487|NCT04789577|473662479|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
131556488|NCT04789577|473662480|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
131556489|NCT04789577|473662481|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
131556490|NCT04789577|473662482|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
131556491|NCT04789577|473662483|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
131556492|NCT04789577|473662484|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
131556493|NCT04789577|473662485|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
131556494|NCT04789577|473662479|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
131556495|NCT04789577|473662480|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
131556496|NCT04789577|473662481|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
131556497|NCT04789577|473662482|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
131556498|NCT04789577|473662483|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
131556499|NCT04789577|473662484|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
131556500|NCT04789577|473662485|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
131556501|NCT01827254|473662486|FG000|Overall Study|Death|10|||
131556502|NCT01827254|473662486|FG000|Overall Study|Case report form not completed|4|||
131556503|NCT01827254|473662486|FG000|Overall Study|Invalidated centre|3|||
131556504|NCT01827254|473662486|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
131556505|NCT01827254|473662486|FG000|Overall Study|Did not complete re-challenge|1|||
131556506|NCT01827254|473662486|FG000|Overall Study|Disease progression|36|||
131556507|NCT01827254|473662486|FG000|Overall Study|Intolerance to treatment|4|||
131556508|NCT01107743|473662493|FG000|Overall Study|Protocol Violation|46|||
131556509|NCT00308737|473662494|FG000|Overall Study|Adverse Event|104|||
131556510|NCT00308737|473662495|FG001|Overall Study|Adverse Event|9|||
131556511|NCT00308737|473662496|FG002|Overall Study|Adverse Event|0|||
131556512|NCT00308737|473662494|FG000|Overall Study|Death|4|||
131556513|NCT00308737|473662495|FG001|Overall Study|Death|3|||
131556514|NCT00308737|473662496|FG002|Overall Study|Death|0|||
131556515|NCT00308737|473662494|FG000|Overall Study|Lost to Follow-up|56|||
131556516|NCT00308737|473662495|FG001|Overall Study|Lost to Follow-up|80|||
131556517|NCT00308737|473662496|FG002|Overall Study|Lost to Follow-up|5|||
131556518|NCT00308737|473662494|FG000|Overall Study|Physician Decision|15|||
131556519|NCT00308737|473662495|FG001|Overall Study|Physician Decision|2|||
131556520|NCT00308737|473662496|FG002|Overall Study|Physician Decision|1|||
131556521|NCT00308737|473662494|FG000|Overall Study|Protocol Violation|34|||
131556522|NCT00308737|473662495|FG001|Overall Study|Protocol Violation|9|||
131556523|NCT00308737|473662496|FG002|Overall Study|Protocol Violation|5|||
131556524|NCT00308737|473662494|FG000|Overall Study|Withdrawal by Subject|218|||
131556525|NCT00308737|473662495|FG001|Overall Study|Withdrawal by Subject|166|||
131556526|NCT00308737|473662496|FG002|Overall Study|Withdrawal by Subject|18|||
131556527|NCT00308737|473662494|FG000|Overall Study|Various|32|||
131556528|NCT00308737|473662495|FG001|Overall Study|Various|20|||
131556529|NCT00308737|473662496|FG002|Overall Study|Various|8|||
131556530|NCT00089895|473662497|FG000|Overall Study|Consent Withdrawn|11|||
131556531|NCT00089895|473662498|FG001|Overall Study|Consent Withdrawn|14|||
131556532|NCT00089895|473662497|FG000|Overall Study|Technical reason|7|||
131556533|NCT00089895|473662498|FG001|Overall Study|Technical reason|2|||
131556534|NCT00089895|473662497|FG000|Overall Study|Surgery|0|||
131556535|NCT00089895|473662498|FG001|Overall Study|Surgery|1|||
131556536|NCT00089895|473662497|FG000|Overall Study|Bleeding|0|||
131556537|NCT00089895|473662498|FG001|Overall Study|Bleeding|2|||
131556538|NCT00089895|473662497|FG000|Overall Study|Physician Decision|3|||
131556539|NCT00089895|473662498|FG001|Overall Study|Physician Decision|7|||
131556540|NCT00089895|473662497|FG000|Overall Study|Exclusion criteria met|6|||
131556541|NCT00089895|473662498|FG001|Overall Study|Exclusion criteria met|6|||
131556542|NCT00089895|473662497|FG000|Overall Study|Not otherwise specified|4|||
131556543|NCT00089895|473662498|FG001|Overall Study|Not otherwise specified|8|||
131556544|NCT00089895|473662497|FG000|Overall Study|Missing|4|||
131556545|NCT00089895|473662498|FG001|Overall Study|Missing|2|||
131556546|NCT02494206|473662512|FG000|Overall Study|Adverse Event|1|||
131556547|NCT02494206|473662512|FG000|Overall Study|Disease Progression|1|||
131556548|NCT04986982|473662514|FG000|Overall Study|Withdrawal by Subject|3|||
131556549|NCT04986982|473662515|FG001|Overall Study|Withdrawal by Subject|1|||
131556550|NCT04986982|473662514|FG000|Overall Study|Lack of Efficacy|0|||
131556551|NCT04986982|473662515|FG001|Overall Study|Lack of Efficacy|2|||
131556552|NCT04986982|473662514|FG000|Overall Study|Ineligibility|3|||
131556553|NCT04986982|473662515|FG001|Overall Study|Ineligibility|0|||
131556554|NCT04986982|473662514|FG000|Overall Study|Adverse Event|4|||
131556555|NCT04986982|473662515|FG001|Overall Study|Adverse Event|4|||
131556556|NCT04986982|473662514|FG000|Overall Study|Lost to Follow-up|0|||
131556557|NCT04986982|473662515|FG001|Overall Study|Lost to Follow-up|1|||
131556558|NCT04986982|473662514|FG000|Overall Study|Sponsor's discretion|1|||
131556559|NCT04986982|473662515|FG001|Overall Study|Sponsor's discretion|0|||
131556560|NCT01155661|473662516|FG000|Overall Study|Adverse Event|101|||
131556561|NCT01155661|473662516|FG000|Overall Study|Death|1|||
131556562|NCT01155661|473662516|FG000|Overall Study|Lack of Efficacy|32|||
131556563|NCT01155661|473662516|FG000|Overall Study|Lost to Follow-up|22|||
131556564|NCT01155661|473662516|FG000|Overall Study|Physician Decision|3|||
131556565|NCT01155661|473662516|FG000|Overall Study|Protocol Violation|35|||
131556566|NCT01155661|473662516|FG000|Overall Study|Withdrawal by Subject|73|||
131556567|NCT01155661|473662516|FG000|Overall Study|Sponsor Decision|13|||
131556568|NCT01396395|473662520|FG000|Overall Study|Withdrawal by Subject|10|||
131556569|NCT01396395|473662521|FG001|Overall Study|Withdrawal by Subject|12|||
131556570|NCT01396395|473662520|FG000|Overall Study|Protocol Violation|3|||
131556571|NCT01396395|473662521|FG001|Overall Study|Protocol Violation|1|||
131556572|NCT01396395|473662520|FG000|Overall Study|Adverse Event|10|||
131556573|NCT01396395|473662521|FG001|Overall Study|Adverse Event|2|||
131556574|NCT01396395|473662520|FG000|Overall Study|Lost to Follow-up|17|||
131556575|NCT01396395|473662521|FG001|Overall Study|Lost to Follow-up|11|||
131556576|NCT01396395|473662520|FG000|Overall Study|Other|0|||
131556577|NCT01396395|473662521|FG001|Overall Study|Other|1|||
131556578|NCT00882921|473662526|FG000|Overall Study|Death|2|||
131556579|NCT00882921|473662526|FG000|Overall Study|Other|3|||
131556580|NCT00882921|473662526|FG000|Overall Study|Lost to Follow-up|2|||
131556581|NCT00882921|473662526|FG000|Overall Study|Termination By Investigator|3|||
131556582|NCT00882921|473662526|FG000|Overall Study|Withdrawal Of Consent|1|||
131556583|NCT01370005|473662527|FG000|Overall Study|Not treated|1|||
131556584|NCT01370005|473662528|FG001|Overall Study|Not treated|0|||
131556585|NCT01370005|473662529|FG002|Overall Study|Not treated|0|||
131556586|NCT01370005|473662527|FG000|Overall Study|Adverse Event|5|||
131556587|NCT01370005|473662528|FG001|Overall Study|Adverse Event|5|||
131556588|NCT01370005|473662529|FG002|Overall Study|Adverse Event|6|||
131556589|NCT01370005|473662527|FG000|Overall Study|Lack of Efficacy|1|||
131556590|NCT01370005|473662528|FG001|Overall Study|Lack of Efficacy|0|||
131556591|NCT01370005|473662529|FG002|Overall Study|Lack of Efficacy|0|||
131556592|NCT01370005|473662527|FG000|Overall Study|Non compliant with protocol|0|||
131556593|NCT01370005|473662528|FG001|Overall Study|Non compliant with protocol|1|||
131556594|NCT01370005|473662529|FG002|Overall Study|Non compliant with protocol|2|||
131556595|NCT01370005|473662527|FG000|Overall Study|Lost to Follow-up|1|||
131556596|NCT01370005|473662528|FG001|Overall Study|Lost to Follow-up|1|||
131556597|NCT01370005|473662529|FG002|Overall Study|Lost to Follow-up|1|||
131556598|NCT01370005|473662527|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
131556599|NCT01370005|473662528|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
131556600|NCT01370005|473662529|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
131556601|NCT01370005|473662527|FG000|Overall Study|Other reason not defined above|3|||
131556602|NCT01370005|473662528|FG001|Overall Study|Other reason not defined above|0|||
131556603|NCT01370005|473662529|FG002|Overall Study|Other reason not defined above|2|||
131556604|NCT02009696|473662530|FG000|Overall Study|Withdrawal by Subject|2|||
131556605|NCT00856661|473662531|FG000|Overall Study|Death|15|||
131556606|NCT00856661|473662532|FG001|Overall Study|Death|18|||
131556607|NCT00856661|473662531|FG000|Overall Study|Protocol Violation|2|||
131556608|NCT00856661|473662532|FG001|Overall Study|Protocol Violation|1|||
131556609|NCT00856661|473662531|FG000|Overall Study|Withdrawal by Subject|1|||
131556610|NCT00856661|473662532|FG001|Overall Study|Withdrawal by Subject|2|||
131556611|NCT00856661|473662531|FG000|Overall Study|Lost to Follow-up|1|||
131556612|NCT00856661|473662532|FG001|Overall Study|Lost to Follow-up|3|||
131556613|NCT00856661|473662531|FG000|Overall Study|Physician Judgement|8|||
131556614|NCT00856661|473662532|FG001|Overall Study|Physician Judgement|5|||
131556615|NCT02120664|473662533|FG000|Overall Study|Withdrawal by Subject|0|||
131556616|NCT02120664|473662534|FG001|Overall Study|Withdrawal by Subject|0|||
131556617|NCT02120664|473662535|FG002|Overall Study|Withdrawal by Subject|0|||
131556618|NCT02120664|473662536|FG003|Overall Study|Withdrawal by Subject|1|||
131556619|NCT02120664|473662537|FG004|Overall Study|Withdrawal by Subject|0|||
131556620|NCT02460263|473662538|FG000|Transition Period|Withdrawal by Subject|1|||
131556621|NCT02460263|473662538|FG000|Transition Period|Death|1|||
131556622|NCT03916744|473662539|FG000|Overall Study|Withdrawal by Subject|0|||
131556623|NCT03916744|473662540|FG001|Overall Study|Withdrawal by Subject|1|||
131556624|NCT03916744|473662541|FG002|Overall Study|Withdrawal by Subject|2|||
131556625|NCT03176238|473662542|FG000|Overall Study|Unacceptable AEs|15|||
131556626|NCT03176238|473662543|FG001|Overall Study|Unacceptable AEs|8|||
131556627|NCT03176238|473662542|FG000|Overall Study|Abnormal lab value(s)|2|||
131556628|NCT03176238|473662543|FG001|Overall Study|Abnormal lab value(s)|0|||
131556629|NCT03176238|473662542|FG000|Overall Study|Inter-current illness|0|||
131556630|NCT03176238|473662543|FG001|Overall Study|Inter-current illness|1|||
131556631|NCT03176238|473662542|FG000|Overall Study|Consent withdrawal|14|||
131556632|NCT03176238|473662543|FG001|Overall Study|Consent withdrawal|2|||
131556633|NCT03176238|473662542|FG000|Overall Study|Lost to Follow-up|3|||
131556634|NCT03176238|473662543|FG001|Overall Study|Lost to Follow-up|0|||
131556635|NCT03176238|473662542|FG000|Overall Study|Administrative problems|1|||
131556636|NCT03176238|473662543|FG001|Overall Study|Administrative problems|0|||
131556637|NCT03176238|473662542|FG000|Overall Study|Death|3|||
131556638|NCT03176238|473662543|FG001|Overall Study|Death|0|||
131556639|NCT03176238|473662542|FG000|Overall Study|Disease Progression|133|||
131556640|NCT03176238|473662543|FG001|Overall Study|Disease Progression|22|||
131556641|NCT03176238|473662542|FG000|Overall Study|Tx duration completed per EAP|0|||
131556642|NCT03176238|473662543|FG001|Overall Study|Tx duration completed per EAP|1|||
131556643|NCT03176238|473662542|FG000|Overall Study|Patient is switched to commercial drug|16|||
131556644|NCT03176238|473662543|FG001|Overall Study|Patient is switched to commercial drug|1|||
131556645|NCT03176238|473662542|FG000|Overall Study|Protocol Violation|1|||
131556646|NCT03176238|473662543|FG001|Overall Study|Protocol Violation|0|||
131556647|NCT03176238|473662542|FG000|Overall Study|Changes in the patient's condition|2|||
131556648|NCT03176238|473662543|FG001|Overall Study|Changes in the patient's condition|1|||
131556649|NCT03176238|473662542|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
131556650|NCT03176238|473662543|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
131556651|NCT04524598|473662544|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
131556652|NCT04524598|473662545|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
131556653|NCT04524598|473662546|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
131556654|NCT04524598|473662547|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
131556655|NCT04524598|473662548|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
131556656|NCT04524598|473662544|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
131556657|NCT04524598|473662545|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
131556658|NCT04524598|473662546|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556659|NCT04524598|473662547|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556660|NCT04524598|473662548|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556661|NCT04524598|473662544|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
131556662|NCT04524598|473662545|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
131556663|NCT04524598|473662546|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
131556664|NCT04524598|473662547|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
131556665|NCT04524598|473662548|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
131556666|NCT04524598|473662544|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
131556667|NCT04524598|473662545|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
131556668|NCT04524598|473662546|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
131556669|NCT04524598|473662547|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
131556670|NCT04524598|473662548|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
131556671|NCT04524598|473662544|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556672|NCT04524598|473662545|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556673|NCT04524598|473662546|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
131556674|NCT04524598|473662547|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
131556675|NCT04524598|473662548|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
131775263|NCT01015118|474456572|FG000|Overall Study|Protocol Violation|5|||
131775264|NCT01015118|474456573|FG001|Overall Study|Protocol Violation|6|||
131775265|NCT01015118|474456572|FG000|Overall Study|Withdrawal by Subject|103|||
131775266|NCT01015118|474456573|FG001|Overall Study|Withdrawal by Subject|27|||
131556676|NCT04524598|473662544|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
131556677|NCT04524598|473662545|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
131775267|NCT01015118|474456572|FG000|Overall Study|Other Adverse Event (AE)|141|||
131556678|NCT04524598|473662546|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
131556679|NCT04524598|473662547|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
131556680|NCT04524598|473662548|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
131556681|NCT04524598|473662544|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556682|NCT04524598|473662545|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556683|NCT04524598|473662546|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556684|NCT04524598|473662547|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
131556685|NCT04524598|473662548|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
131556686|NCT02301156|473662549|FG000|Overall Study|Adverse Event|13|||
131556687|NCT02301156|473662550|FG001|Overall Study|Adverse Event|14|||
131556688|NCT02301156|473662549|FG000|Overall Study|Death|1|||
131556689|NCT02301156|473662550|FG001|Overall Study|Death|5|||
131556690|NCT02301156|473662549|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
131556691|NCT02301156|473662550|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
131556692|NCT02301156|473662549|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
131556693|NCT02301156|473662550|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
131556694|NCT02301156|473662549|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
131556695|NCT02301156|473662550|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
131556696|NCT02301156|473662549|FG000|Overall Study|Reason not Specified|6|||
131556697|NCT02301156|473662550|FG001|Overall Study|Reason not Specified|3|||
131556698|NCT00886639|473662551|FG000|Overall Study|acute exacerbation|14|||
131556699|NCT00886639|473662551|FG000|Overall Study|non-compliance|2|||
131556700|NCT01871558|473662552|FG000|Overall Study|Other reason|0|||
131556701|NCT01871558|473662553|FG001|Overall Study|Other reason|1|||
131556702|NCT01871558|473662552|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
131556703|NCT01871558|473662553|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
131556704|NCT01871558|473662552|FG000|Overall Study|Withdrawal by Subject|2|||
131556705|NCT01871558|473662553|FG001|Overall Study|Withdrawal by Subject|0|||
131556706|NCT03203694|473662554|FG000|Overall Study|Withdrawal by Subject|2|||
131556707|NCT03203694|473662555|FG001|Overall Study|Withdrawal by Subject|0|||
131556708|NCT03203694|473662556|FG002|Overall Study|Withdrawal by Subject|0|||
131556709|NCT03203694|473662557|FG003|Overall Study|Withdrawal by Subject|0|||
131556710|NCT03203694|473662558|FG004|Overall Study|Withdrawal by Subject|0|||
131556711|NCT03203694|473662559|FG005|Overall Study|Withdrawal by Subject|0|||
131556712|NCT01103960|473662565|FG000|Overall Study|Adverse Event|2|||
131556713|NCT01103960|473662566|FG001|Overall Study|Adverse Event|1|||
131556714|NCT01103960|473662565|FG000|Overall Study|Withdrawal by Subject|2|||
131556715|NCT01103960|473662566|FG001|Overall Study|Withdrawal by Subject|1|||
131556716|NCT01103960|473662565|FG000|Overall Study|Other|1|||
131556717|NCT01103960|473662566|FG001|Overall Study|Other|0|||
131556718|NCT04287868|473662573|FG000|Overall Study|Screening fail|1|||
131556719|NCT04287868|473662574|FG001|Overall Study|Screening fail|0|||
131556720|NCT01167179|473664322|FG000|Overall Study|disease recurrence|4|||
131556721|NCT01167179|473664323|FG001|Overall Study|disease recurrence|4|||
131556722|NCT01167179|473664322|FG000|Overall Study|Death|4|||
131556723|NCT01167179|473664323|FG001|Overall Study|Death|10|||
131556724|NCT01167179|473664322|FG000|Overall Study|Withdrawal by Subject|1|||
131556725|NCT01167179|473664323|FG001|Overall Study|Withdrawal by Subject|2|||
131556726|NCT01167179|473664322|FG000|Overall Study|diverse|6|||
131556727|NCT01167179|473664323|FG001|Overall Study|diverse|5|||
131556728|NCT02781506|473664324|FG000|Overall Study|Adverse Event|5|||
131556729|NCT01158378|473664325|FG000|Overall Study|Death|4|||
131556730|NCT01158378|473664326|FG001|Overall Study|Death|5|||
131556731|NCT01158378|473664325|FG000|Overall Study|Lost to Follow-up|2|||
131556732|NCT01158378|473664326|FG001|Overall Study|Lost to Follow-up|4|||
131556733|NCT01158378|473664325|FG000|Overall Study|Withdrawal by Subject|4|||
131556734|NCT01158378|473664326|FG001|Overall Study|Withdrawal by Subject|0|||
131556735|NCT03017235|473664327|FG000|Overall Study|Withdrawal by Subject|4|||
131556736|NCT03017235|473664328|FG001|Overall Study|Withdrawal by Subject|3|||
131556737|NCT03017235|473664327|FG000|Overall Study|Lost to Follow-up|2|||
131898533|NCT00320788|474914100|FG004|Overall Study|Protocol Violation|1|||
131556738|NCT03017235|473664328|FG001|Overall Study|Lost to Follow-up|7|||
131556739|NCT03017235|473664327|FG000|Overall Study|Adverse Event|0|||
131556740|NCT03017235|473664328|FG001|Overall Study|Adverse Event|1|||
131556741|NCT03017235|473664327|FG000|Overall Study|Protocol Violation|2|||
131556742|NCT03017235|473664328|FG001|Overall Study|Protocol Violation|1|||
131556743|NCT03017235|473664327|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
131556744|NCT03017235|473664328|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
131556745|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
131556746|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
131556747|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
131556748|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
131556749|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
131556750|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
131436132|NCT02485704|473221945|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
131436133|NCT01777776|473221946|FG000|Overall Study|Adverse Event|2|||
131436134|NCT01777776|473221947|FG001|Overall Study|Adverse Event|4|||
131436135|NCT01777776|473221948|FG002|Overall Study|Adverse Event|0|||
131436136|NCT01777776|473221949|FG003|Overall Study|Adverse Event|0|||
131436137|NCT01777776|473221946|FG000|Overall Study|Disease Progression|4|||
131436138|NCT01777776|473221947|FG001|Overall Study|Disease Progression|8|||
131436139|NCT01777776|473221948|FG002|Overall Study|Disease Progression|6|||
131436140|NCT01777776|473221949|FG003|Overall Study|Disease Progression|3|||
131436141|NCT01777776|473221946|FG000|Overall Study|Withdrawal by Subject|0|||
131436142|NCT01777776|473221947|FG001|Overall Study|Withdrawal by Subject|0|||
131436143|NCT01777776|473221948|FG002|Overall Study|Withdrawal by Subject|0|||
131436144|NCT01777776|473221949|FG003|Overall Study|Withdrawal by Subject|1|||
131436145|NCT00350844|473221950|FG000|Overall Study|Lost to Follow-up|1|||
131436146|NCT02775916|473221953|FG000|Overall Study|Adverse Event|1|||
131436147|NCT02775916|473221954|FG001|Overall Study|Adverse Event|0|||
131436148|NCT02775916|473221953|FG000|Overall Study|Subject/Guardian Decision|2|||
131436149|NCT02775916|473221954|FG001|Overall Study|Subject/Guardian Decision|0|||
131436150|NCT03737123|473223913|FG000|Study Treatment|Adverse Event|2|||
131436151|NCT03737123|473223914|FG001|Study Treatment|Adverse Event|0|||
131436152|NCT03737123|473223913|FG000|Study Treatment|Disease Progression|2|||
131436153|NCT03737123|473223914|FG001|Study Treatment|Disease Progression|0|||
131436154|NCT03737123|473223913|FG000|Study Treatment|Withdrawal by Subject|2|||
131436155|NCT03737123|473223914|FG001|Study Treatment|Withdrawal by Subject|0|||
131436156|NCT03737123|473223913|FG000|Follow up|Death|1|||
131436157|NCT03737123|473223914|FG001|Follow up|Death|0|||
131436158|NCT03737123|473223913|FG000|Follow up|Withdrawal by Subject|1|||
131436159|NCT03737123|473223914|FG001|Follow up|Withdrawal by Subject|0|||
131436160|NCT03737123|473223913|FG000|Follow up|Termination of study|4|||
131436161|NCT03737123|473223914|FG001|Follow up|Termination of study|0|||
131436162|NCT02173769|473223915|FG000|Overall Study|Protocol Violation|4|||
131436163|NCT01342913|473223916|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
131689042|NCT00517751|474145950|FG000|Overall Study|Withdrawal by Subject|37|||
131689043|NCT00517751|474145950|FG000|Overall Study|Lost to Follow-up|4|||
131689044|NCT00517751|474145950|FG000|Overall Study|patient not over due|6|||
131689045|NCT00517751|474145950|FG000|Overall Study|Patient not due for visit|76|||
131689046|NCT00517751|474145950|FG000|Overall Study|Missing|3|||
131689047|NCT02463409|474148177|FG000|Overall Study|Withdrawal by Subject|1|||
131689048|NCT02463409|474148177|FG000|Overall Study|Screen failure|1|||
131689049|NCT00916357|474148178|FG000|Period 1|Withdrawal by Subject|1|||
131689050|NCT00916357|474148179|FG001|Period 1|Withdrawal by Subject|0|||
131689051|NCT00916357|474148180|FG002|Period 1|Withdrawal by Subject|0|||
131689052|NCT00916357|474148181|FG003|Period 1|Withdrawal by Subject|0|||
131689053|NCT00916357|474148182|FG004|Period 1|Withdrawal by Subject|0|||
131689054|NCT00916357|474148183|FG005|Period 1|Withdrawal by Subject|0|||
131689055|NCT00916357|474148178|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
131689056|NCT00916357|474148179|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
131436164|NCT01342913|473223917|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131436165|NCT01342913|473223918|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131436166|NCT01342913|473223916|FG000|2-week Run-in Period|Physician Decision|6|||
131436167|NCT01342913|473223917|FG001|2-week Run-in Period|Physician Decision|0|||
131436168|NCT01342913|473223918|FG002|2-week Run-in Period|Physician Decision|0|||
131436169|NCT01342913|473223916|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
131436170|NCT01342913|473223917|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131436171|NCT01342913|473223918|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131436172|NCT01342913|473223916|FG000|2-week Run-in Period|Adverse Event|2|||
131436173|NCT01342913|473223917|FG001|2-week Run-in Period|Adverse Event|0|||
131436174|NCT01342913|473223918|FG002|2-week Run-in Period|Adverse Event|0|||
131436175|NCT01342913|473223916|FG000|2-week Run-in Period|Protocol Violation|5|||
131436176|NCT01342913|473223917|FG001|2-week Run-in Period|Protocol Violation|0|||
131436177|NCT01342913|473223918|FG002|2-week Run-in Period|Protocol Violation|0|||
131436178|NCT01342913|473223916|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
131436179|NCT01342913|473223917|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
131436180|NCT01342913|473223918|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
131436181|NCT01342913|473223916|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131436182|NCT01342913|473223917|FG001|Double-Blind Treatment Period|Adverse Event|3|||
131436183|NCT01342913|473223918|FG002|Double-Blind Treatment Period|Adverse Event|6|||
131436184|NCT01342913|473223916|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
131436185|NCT01342913|473223917|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
131436186|NCT01342913|473223918|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
131436187|NCT01342913|473223916|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131436188|NCT01342913|473223917|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
131436189|NCT01342913|473223918|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
131436190|NCT01342913|473223916|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131689057|NCT00916357|474148180|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
131556751|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Death|0|||
131556752|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Death|1|||
131556753|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Adverse Event|11|||
131556754|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Adverse Event|11|||
131556755|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
131556756|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
131556757|NCT02936037|473664332|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131556758|NCT02936037|473664333|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131556759|NCT02936037|473664332|FG000|Open Label Extension|Adverse Event|0|||
131556760|NCT02936037|473664333|FG001|Open Label Extension|Adverse Event|3|||
131556761|NCT02936037|473664332|FG000|Open Label Extension|Other|0|||
131556762|NCT02936037|473664333|FG001|Open Label Extension|Other|3|||
131556763|NCT02936037|473664332|FG000|Open Label Extension|Withdrawal by Subject|0|||
131556764|NCT02936037|473664333|FG001|Open Label Extension|Withdrawal by Subject|4|||
131556765|NCT02105636|473664338|FG000|Pre-Treatment|Disease Progression|1|||
131556766|NCT02105636|473664339|FG001|Pre-Treatment|Disease Progression|0|||
131556767|NCT02105636|473664338|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
131556768|NCT02105636|473664339|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
131556769|NCT02105636|473664338|FG000|Pre-Treatment|Participant withdrew consent|0|||
131556770|NCT02105636|473664339|FG001|Pre-Treatment|Participant withdrew consent|6|||
131556771|NCT02105636|473664338|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
131556772|NCT02105636|473664339|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
131556773|NCT02105636|473664338|FG000|Treatment|Study Drug Toxicity|14|||
131556774|NCT02105636|473664339|FG001|Treatment|Study Drug Toxicity|10|||
131556775|NCT02105636|473664338|FG000|Treatment|Adverse event unrelated to study drug|19|||
131556776|NCT02105636|473664339|FG001|Treatment|Adverse event unrelated to study drug|3|||
131556777|NCT02105636|473664338|FG000|Treatment|Participant request to discontinue study treatment|8|||
131556778|NCT02105636|473664339|FG001|Treatment|Participant request to discontinue study treatment|6|||
131556779|NCT02105636|473664338|FG000|Treatment|Participant withdrew consent|5|||
131556780|NCT02105636|473664339|FG001|Treatment|Participant withdrew consent|1|||
131556781|NCT02105636|473664338|FG000|Treatment|Lost to Follow-up|1|||
131556782|NCT02105636|473664339|FG001|Treatment|Lost to Follow-up|0|||
131556783|NCT02105636|473664338|FG000|Treatment|Maximum Clinical Benefit|1|||
131556784|NCT02105636|473664339|FG001|Treatment|Maximum Clinical Benefit|3|||
131556785|NCT02105636|473664338|FG000|Treatment|Poor/Non-compliance|0|||
131556786|NCT02105636|473664339|FG001|Treatment|Poor/Non-compliance|1|||
131556787|NCT02105636|473664338|FG000|Treatment|Participant no longer meets study criteria|1|||
131556788|NCT02105636|473664339|FG001|Treatment|Participant no longer meets study criteria|0|||
131556789|NCT02105636|473664338|FG000|Treatment|Other reasons|1|||
131898534|NCT00320788|474914096|FG000|Overall Study|Withdrawal by Subject|3|||
131898535|NCT00320788|474914097|FG001|Overall Study|Withdrawal by Subject|0|||
131898536|NCT00320788|474914098|FG002|Overall Study|Withdrawal by Subject|0|||
131898537|NCT00320788|474914099|FG003|Overall Study|Withdrawal by Subject|3|||
131436191|NCT01342913|473223917|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131436192|NCT01342913|473223918|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
131436193|NCT01342913|473223916|FG000|Double-Blind Treatment Period|Physician Decision|0|||
131436194|NCT01342913|473223917|FG001|Double-Blind Treatment Period|Physician Decision|2|||
131436195|NCT01342913|473223918|FG002|Double-Blind Treatment Period|Physician Decision|0|||
131898538|NCT00320788|474914100|FG004|Overall Study|Withdrawal by Subject|1|||
131436196|NCT01342913|473223916|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131556790|NCT02105636|473664339|FG001|Treatment|Other reasons|0|||
131556791|NCT02105636|473664338|FG000|Treatment|Disease Progression|185|||
131556792|NCT02105636|473664339|FG001|Treatment|Disease Progression|87|||
131556793|NCT00235443|473664341|FG000|Overall Study|Adverse Event|4|||
131436197|NCT01342913|473223917|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131436198|NCT01342913|473223918|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131556794|NCT00235443|473664342|FG001|Overall Study|Adverse Event|12|||
131556795|NCT00235443|473664343|FG002|Overall Study|Adverse Event|17|||
131556796|NCT00235443|473664344|FG003|Overall Study|Adverse Event|44|||
131556797|NCT00235443|473664345|FG004|Overall Study|Adverse Event|10|||
131556798|NCT00235443|473664346|FG005|Overall Study|Adverse Event|15|||
131556799|NCT00235443|473664341|FG000|Overall Study|Lack of Efficacy|0|||
131556800|NCT00235443|473664342|FG001|Overall Study|Lack of Efficacy|1|||
131556801|NCT00235443|473664343|FG002|Overall Study|Lack of Efficacy|5|||
131556802|NCT00235443|473664344|FG003|Overall Study|Lack of Efficacy|12|||
131556803|NCT00235443|473664345|FG004|Overall Study|Lack of Efficacy|2|||
131556804|NCT00235443|473664346|FG005|Overall Study|Lack of Efficacy|9|||
131556805|NCT00235443|473664341|FG000|Overall Study|Withdrawal by Subject|3|||
131556806|NCT00235443|473664342|FG001|Overall Study|Withdrawal by Subject|9|||
131556807|NCT00235443|473664343|FG002|Overall Study|Withdrawal by Subject|25|||
131556808|NCT00235443|473664344|FG003|Overall Study|Withdrawal by Subject|24|||
131556809|NCT00235443|473664345|FG004|Overall Study|Withdrawal by Subject|10|||
131556810|NCT00235443|473664346|FG005|Overall Study|Withdrawal by Subject|12|||
131556811|NCT00235443|473664341|FG000|Overall Study|Lost to Follow-up|0|||
131556812|NCT00235443|473664342|FG001|Overall Study|Lost to Follow-up|8|||
131556813|NCT00235443|473664343|FG002|Overall Study|Lost to Follow-up|6|||
131556814|NCT00235443|473664344|FG003|Overall Study|Lost to Follow-up|6|||
131556815|NCT00235443|473664345|FG004|Overall Study|Lost to Follow-up|4|||
131556816|NCT00235443|473664346|FG005|Overall Study|Lost to Follow-up|3|||
131556817|NCT00235443|473664341|FG000|Overall Study|Unsatisfactory compliance|0|||
131689058|NCT00916357|474148181|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
131556818|NCT00235443|473664342|FG001|Overall Study|Unsatisfactory compliance|2|||
131556819|NCT00235443|473664343|FG002|Overall Study|Unsatisfactory compliance|3|||
131556820|NCT00235443|473664344|FG003|Overall Study|Unsatisfactory compliance|4|||
131556821|NCT00235443|473664345|FG004|Overall Study|Unsatisfactory compliance|1|||
131556822|NCT00235443|473664346|FG005|Overall Study|Unsatisfactory compliance|0|||
131556823|NCT00235443|473664341|FG000|Overall Study|Other reasons for premature termination|1|||
131556824|NCT00235443|473664342|FG001|Overall Study|Other reasons for premature termination|6|||
131556825|NCT00235443|473664343|FG002|Overall Study|Other reasons for premature termination|6|||
131556826|NCT00235443|473664344|FG003|Overall Study|Other reasons for premature termination|7|||
131556827|NCT00235443|473664345|FG004|Overall Study|Other reasons for premature termination|3|||
131556828|NCT00235443|473664346|FG005|Overall Study|Other reasons for premature termination|6|||
131556829|NCT03029247|473664347|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
131556830|NCT03029247|473664348|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
131556831|NCT03029247|473664347|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
131556832|NCT03029247|473664348|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
131556833|NCT03029247|473664347|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
131556834|NCT03029247|473664348|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
131556835|NCT03029247|473664347|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
131556836|NCT03029247|473664348|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
131556837|NCT01976364|473664351|FG000|Main Study (36 Months)|Adverse Event|63|||
131556838|NCT01976364|473664352|FG001|Main Study (36 Months)|Adverse Event|0|||
131556839|NCT01976364|473664353|FG002|Main Study (36 Months)|Adverse Event|0|||
131556840|NCT01976364|473664351|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
131556841|NCT01976364|473664352|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
131556842|NCT01976364|473664353|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
131556843|NCT01976364|473664351|FG000|Main Study (36 Months)|Other|13|||
131556844|NCT01976364|473664352|FG001|Main Study (36 Months)|Other|0|||
131556845|NCT01976364|473664353|FG002|Main Study (36 Months)|Other|0|||
131556846|NCT01976364|473664351|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
131556847|NCT01976364|473664352|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
131556848|NCT01976364|473664353|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
131556849|NCT01976364|473664351|FG000|Main Study (36 Months)|Medication error|1|||
131556850|NCT01976364|473664352|FG001|Main Study (36 Months)|Medication error|0|||
131556851|NCT01976364|473664353|FG002|Main Study (36 Months)|Medication error|0|||
131556852|NCT01976364|473664351|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
131556853|NCT01976364|473664352|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
131556854|NCT01976364|473664353|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
131556855|NCT01976364|473664351|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
131556856|NCT01976364|473664352|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
131556857|NCT01976364|473664353|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
131556858|NCT01976364|473664351|FG000|Main Study (36 Months)|Protocol Violation|13|||
131556859|NCT01976364|473664352|FG001|Main Study (36 Months)|Protocol Violation|0|||
131556860|NCT01976364|473664353|FG002|Main Study (36 Months)|Protocol Violation|0|||
131556861|NCT01976364|473664351|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
131556862|NCT01976364|473664352|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
131556863|NCT01976364|473664353|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
131556864|NCT01976364|473664351|FG000|Main Study (36 Months)|Death|5|||
131556865|NCT01976364|473664352|FG001|Main Study (36 Months)|Death|0|||
131556866|NCT01976364|473664353|FG002|Main Study (36 Months)|Death|0|||
131556867|NCT01976364|473664351|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
131556868|NCT01976364|473664352|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
131556869|NCT01976364|473664353|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
131556870|NCT01976364|473664351|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
131436199|NCT04024891|473223925|FG000|Overall Study|Pregnancy|0|||
131556871|NCT01976364|473664352|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
131556872|NCT01976364|473664353|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
131556873|NCT01976364|473664351|FG000|Sub-study (12 Months)|Protocol Violation|0|||
131556874|NCT01976364|473664352|FG001|Sub-study (12 Months)|Protocol Violation|1|||
131556875|NCT01976364|473664353|FG002|Sub-study (12 Months)|Protocol Violation|1|||
131556876|NCT01976364|473664351|FG000|Sub-study (12 Months)|Adverse Event|0|||
131556877|NCT01976364|473664352|FG001|Sub-study (12 Months)|Adverse Event|4|||
131556878|NCT01976364|473664353|FG002|Sub-study (12 Months)|Adverse Event|3|||
131556879|NCT02960763|473664354|FG000|Step 1|Withdrawal by Subject|10|||
131556880|NCT02960763|473664355|FG001|Step 1|Withdrawal by Subject|8|||
131556881|NCT02960763|473664356|FG002|Step 1|Withdrawal by Subject|13|||
131556882|NCT02960763|473664357|FG003|Step 1|Withdrawal by Subject|0|||
131556883|NCT02960763|473664358|FG004|Step 1|Withdrawal by Subject|0|||
131556884|NCT02960763|473664354|FG000|Step 1|Lost to Follow-up|7|||
131556885|NCT02960763|473664355|FG001|Step 1|Lost to Follow-up|9|||
131556886|NCT02960763|473664356|FG002|Step 1|Lost to Follow-up|12|||
131556887|NCT02960763|473664357|FG003|Step 1|Lost to Follow-up|0|||
131556888|NCT02960763|473664358|FG004|Step 1|Lost to Follow-up|0|||
131556889|NCT02960763|473664354|FG000|Step 1|Death|1|||
131556890|NCT02960763|473664355|FG001|Step 1|Death|1|||
131556891|NCT02960763|473664356|FG002|Step 1|Death|1|||
131556892|NCT02960763|473664357|FG003|Step 1|Death|0|||
131556893|NCT02960763|473664358|FG004|Step 1|Death|0|||
131556894|NCT02960763|473664354|FG000|Step 1|Investigator discretion|1|||
131556895|NCT02960763|473664355|FG001|Step 1|Investigator discretion|0|||
131556896|NCT02960763|473664356|FG002|Step 1|Investigator discretion|1|||
131556897|NCT02960763|473664357|FG003|Step 1|Investigator discretion|0|||
131556898|NCT02960763|473664358|FG004|Step 1|Investigator discretion|0|||
131556899|NCT02960763|473664354|FG000|Step 1|Other|0|||
131556900|NCT02960763|473664355|FG001|Step 1|Other|0|||
131556901|NCT02960763|473664356|FG002|Step 1|Other|1|||
131556902|NCT02960763|473664357|FG003|Step 1|Other|0|||
131556903|NCT02960763|473664358|FG004|Step 1|Other|0|||
131556904|NCT02960763|473664354|FG000|Step 2|Withdrawal by Subject|0|||
131556905|NCT02960763|473664355|FG001|Step 2|Withdrawal by Subject|0|||
131556906|NCT02960763|473664356|FG002|Step 2|Withdrawal by Subject|0|||
131556907|NCT02960763|473664357|FG003|Step 2|Withdrawal by Subject|7|||
131556908|NCT02960763|473664358|FG004|Step 2|Withdrawal by Subject|3|||
131556909|NCT02960763|473664354|FG000|Step 2|Lost to Follow-up|0|||
131556910|NCT02960763|473664355|FG001|Step 2|Lost to Follow-up|0|||
131556911|NCT02960763|473664356|FG002|Step 2|Lost to Follow-up|0|||
131556912|NCT02960763|473664357|FG003|Step 2|Lost to Follow-up|4|||
131556913|NCT02960763|473664358|FG004|Step 2|Lost to Follow-up|1|||
131556914|NCT02960763|473664354|FG000|Step 2|Investigator discretion|0|||
131556915|NCT02960763|473664355|FG001|Step 2|Investigator discretion|0|||
131556916|NCT02960763|473664356|FG002|Step 2|Investigator discretion|0|||
131556917|NCT02960763|473664357|FG003|Step 2|Investigator discretion|0|||
131556918|NCT02960763|473664358|FG004|Step 2|Investigator discretion|1|||
131556919|NCT00312858|473664360|FG000|Overall Study|Adverse Event|0|||
131689059|NCT00916357|474148182|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
131689060|NCT00916357|474148183|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
131689061|NCT01308008|474148184|FG000|4 Weeks|Illness, disinterest, time|9|||
131689062|NCT01308008|474148185|FG001|4 Weeks|Illness, disinterest, time|2|||
131436200|NCT04024891|473223926|FG001|Overall Study|Pregnancy|1|||
131436201|NCT00453154|473223942|FG000|Double BIind Maintenance|Adverse Event|0|||
131436202|NCT00453154|473223943|FG001|Double BIind Maintenance|Adverse Event|0|||
131436203|NCT00453154|473223944|FG002|Double BIind Maintenance|Adverse Event|3|||
131436204|NCT00453154|473223945|FG003|Double BIind Maintenance|Adverse Event|12|||
131436205|NCT00453154|473223942|FG000|Double BIind Maintenance|Death|0|||
131436206|NCT00453154|473223943|FG001|Double BIind Maintenance|Death|0|||
131436207|NCT00453154|473223944|FG002|Double BIind Maintenance|Death|2|||
131436208|NCT00453154|473223945|FG003|Double BIind Maintenance|Death|1|||
131436209|NCT00453154|473223942|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
131436210|NCT00453154|473223943|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
131436211|NCT00453154|473223944|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
131436212|NCT00453154|473223945|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
131436213|NCT00453154|473223942|FG000|Double BIind Maintenance|Progression|0|||
131436214|NCT00453154|473223943|FG001|Double BIind Maintenance|Progression|0|||
131436215|NCT00453154|473223944|FG002|Double BIind Maintenance|Progression|29|||
131436216|NCT00453154|473223945|FG003|Double BIind Maintenance|Progression|26|||
131556920|NCT00312858|473664361|FG001|Overall Study|Adverse Event|1|||
131556921|NCT00312858|473664360|FG000|Overall Study|Lost to Follow-up|25|||
131556922|NCT00312858|473664361|FG001|Overall Study|Lost to Follow-up|42|||
131556923|NCT00312858|473664360|FG000|Overall Study|Protocol Violation|3|||
131556924|NCT00312858|473664361|FG001|Overall Study|Protocol Violation|8|||
131556925|NCT00312858|473664360|FG000|Overall Study|Withdraw by Participant|20|||
131556926|NCT00312858|473664361|FG001|Overall Study|Withdraw by Participant|20|||
131556927|NCT00312858|473664360|FG000|Overall Study|Participant Moved|11|||
131556928|NCT00312858|473664361|FG001|Overall Study|Participant Moved|10|||
131556929|NCT00312858|473664360|FG000|Overall Study|Other|9|||
131556930|NCT00312858|473664361|FG001|Overall Study|Other|12|||
131556931|NCT03638635|473664363|FG000|Initial Hospitalization|Study terminated prematurely|0|||
131556932|NCT03638635|473664364|FG001|Initial Hospitalization|Study terminated prematurely|1|||
131556933|NCT03638635|473664363|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
131556934|NCT03638635|473664364|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
131556935|NCT03638635|473664363|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
131556936|NCT03638635|473664364|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
131556937|NCT01868035|473664367|FG000|Overall Study|Lost to Follow-up|3|||
131556938|NCT01868035|473664367|FG000|Overall Study|Withdrawal by Subject|1|||
131556939|NCT01868035|473664367|FG000|Overall Study|Progressive Disease|2|||
131556940|NCT01868035|473664367|FG000|Overall Study|Non-compliance|1|||
131556941|NCT02318719|473664368|FG000|Double-blind Phase|Adverse Event|7|||
131556942|NCT02318719|473664369|FG001|Double-blind Phase|Adverse Event|6|||
131556943|NCT02318719|473664370|FG002|Double-blind Phase|Adverse Event|12|||
131556944|NCT02318719|473664371|FG003|Double-blind Phase|Adverse Event|4|||
131556945|NCT02318719|473664372|FG004|Double-blind Phase|Adverse Event|0|||
131556946|NCT02318719|473664368|FG000|Double-blind Phase|Lack of Efficacy|5|||
131556947|NCT02318719|473664369|FG001|Double-blind Phase|Lack of Efficacy|0|||
131556948|NCT02318719|473664370|FG002|Double-blind Phase|Lack of Efficacy|1|||
131689063|NCT01417195|474148186|FG000|Overall Study|Stimulation failure|1|||
131689064|NCT01417195|474148187|FG001|Overall Study|Stimulation failure|0|||
131436217|NCT00453154|473223942|FG000|Double BIind Maintenance|Medical Issues|0|||
131436218|NCT00453154|473223943|FG001|Double BIind Maintenance|Medical Issues|0|||
131436219|NCT00453154|473223944|FG002|Double BIind Maintenance|Medical Issues|3|||
131436220|NCT00453154|473223945|FG003|Double BIind Maintenance|Medical Issues|1|||
131436221|NCT00453154|473223942|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
131556949|NCT02318719|473664371|FG003|Double-blind Phase|Lack of Efficacy|1|||
131556950|NCT02318719|473664372|FG004|Double-blind Phase|Lack of Efficacy|0|||
131689065|NCT01417195|474148186|FG000|Overall Study|No embryos for transfer|0|||
131689066|NCT01417195|474148187|FG001|Overall Study|No embryos for transfer|1|||
131689067|NCT01417195|474148186|FG000|Overall Study|No transfer due to risk of OHSS|1|||
131689068|NCT01417195|474148187|FG001|Overall Study|No transfer due to risk of OHSS|0|||
131689069|NCT01417195|474148186|FG000|Overall Study|No transfer due to elevated progesterone|1|||
131689070|NCT01417195|474148187|FG001|Overall Study|No transfer due to elevated progesterone|0|||
131689071|NCT03357731|474148188|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
131689072|NCT03357731|474148189|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
131689073|NCT03357731|474148190|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
131689074|NCT03357731|474148191|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
131689075|NCT03357731|474148192|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
131689076|NCT03357731|474148193|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
131689077|NCT03357731|474148188|FG000|Overall Study|Acute bradycardia and hypotension|0|||
131689078|NCT03357731|474148189|FG001|Overall Study|Acute bradycardia and hypotension|0|||
131689079|NCT03357731|474148190|FG002|Overall Study|Acute bradycardia and hypotension|0|||
131556951|NCT02318719|473664368|FG000|Double-blind Phase|Protocol Violation|0|||
131556952|NCT02318719|473664369|FG001|Double-blind Phase|Protocol Violation|1|||
131556953|NCT02318719|473664370|FG002|Double-blind Phase|Protocol Violation|3|||
131556954|NCT02318719|473664371|FG003|Double-blind Phase|Protocol Violation|0|||
131556955|NCT02318719|473664372|FG004|Double-blind Phase|Protocol Violation|0|||
131556956|NCT02318719|473664368|FG000|Double-blind Phase|Withdrawal by Subject|25|||
131556957|NCT02318719|473664369|FG001|Double-blind Phase|Withdrawal by Subject|7|||
131556958|NCT02318719|473664370|FG002|Double-blind Phase|Withdrawal by Subject|9|||
131556959|NCT02318719|473664371|FG003|Double-blind Phase|Withdrawal by Subject|10|||
131556960|NCT02318719|473664372|FG004|Double-blind Phase|Withdrawal by Subject|0|||
131556961|NCT02318719|473664368|FG000|Double-blind Phase|Other|1|||
131556962|NCT02318719|473664369|FG001|Double-blind Phase|Other|2|||
131556963|NCT02318719|473664370|FG002|Double-blind Phase|Other|0|||
131556964|NCT02318719|473664371|FG003|Double-blind Phase|Other|0|||
131556965|NCT02318719|473664372|FG004|Double-blind Phase|Other|0|||
131556966|NCT02318719|473664368|FG000|Open-label Extension Phase|Adverse Event|0|||
131556967|NCT02318719|473664369|FG001|Open-label Extension Phase|Adverse Event|0|||
131556968|NCT02318719|473664370|FG002|Open-label Extension Phase|Adverse Event|0|||
131556969|NCT02318719|473664371|FG003|Open-label Extension Phase|Adverse Event|0|||
131556970|NCT02318719|473664372|FG004|Open-label Extension Phase|Adverse Event|15|||
131556971|NCT02318719|473664368|FG000|Open-label Extension Phase|Death|0|||
131556972|NCT02318719|473664369|FG001|Open-label Extension Phase|Death|0|||
131556973|NCT02318719|473664370|FG002|Open-label Extension Phase|Death|0|||
131556974|NCT02318719|473664371|FG003|Open-label Extension Phase|Death|0|||
131556975|NCT02318719|473664372|FG004|Open-label Extension Phase|Death|1|||
131556976|NCT02318719|473664368|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
131556977|NCT02318719|473664369|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
131556978|NCT02318719|473664370|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
131556979|NCT02318719|473664371|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
131556980|NCT02318719|473664372|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
131556981|NCT02318719|473664368|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
131556982|NCT02318719|473664369|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
131556983|NCT02318719|473664370|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
131556984|NCT02318719|473664371|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
131556985|NCT02318719|473664372|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
131556986|NCT02318719|473664368|FG000|Open-label Extension Phase|Other|0|||
131556987|NCT02318719|473664369|FG001|Open-label Extension Phase|Other|0|||
131556988|NCT02318719|473664370|FG002|Open-label Extension Phase|Other|0|||
131556989|NCT02318719|473664371|FG003|Open-label Extension Phase|Other|0|||
131556990|NCT02318719|473664372|FG004|Open-label Extension Phase|Other|7|||
131556991|NCT00432835|473664376|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
131775268|NCT01015118|474456573|FG001|Overall Study|Other Adverse Event (AE)|33|||
131775269|NCT01015118|474456572|FG000|Overall Study|Worsening or AE of underlying disease|5|||
131775270|NCT01015118|474456573|FG001|Overall Study|Worsening or AE of underlying disease|4|||
131775271|NCT01015118|474456572|FG000|Overall Study|Progressive disease|364|||
131556992|NCT00432835|473664377|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
131556993|NCT00802659|473664378|FG000|Overall Study|Physician Decision|0|||
131556994|NCT00802659|473664379|FG001|Overall Study|Physician Decision|1|||
131556995|NCT00802659|473664380|FG002|Overall Study|Physician Decision|0|||
131556996|NCT00802659|473664381|FG003|Overall Study|Physician Decision|0|||
131556997|NCT00423293|473664382|FG000|Overall Study|Ineligible / No protocol treatment|11|||
131556998|NCT01912222|473664383|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
131775272|NCT01015118|474456573|FG001|Overall Study|Progressive disease|229|||
131775273|NCT01015118|474456572|FG000|Overall Study|Not treated|9|||
131775274|NCT01015118|474456573|FG001|Overall Study|Not treated|5|||
131775275|NCT01015118|474456572|FG000|Overall Study|Other than stated above|42|||
131775276|NCT01015118|474456573|FG001|Overall Study|Other than stated above|23|||
131556999|NCT01912222|473664384|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
131557000|NCT01912222|473664385|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
131557001|NCT01912222|473664383|FG000|Part B: Treatment Period|Progressive disease|10|||
131557002|NCT01912222|473664384|FG001|Part B: Treatment Period|Progressive disease|12|||
131557003|NCT01912222|473664385|FG002|Part B: Treatment Period|Progressive disease|15|||
131775277|NCT03522506|474456574|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131775278|NCT03522506|474456575|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131775279|NCT03522506|474456576|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131775280|NCT03522506|474456577|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131775281|NCT03522506|474456574|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131775282|NCT03522506|474456575|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131775283|NCT03522506|474456576|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131775284|NCT03522506|474456577|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
131775285|NCT03480243|474456578|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
131775286|NCT03480243|474456578|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
131775287|NCT02388906|474456587|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
131775288|NCT02388906|474456588|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131775289|NCT02388906|474456587|FG000|Treatment Period|Disease progression|121|||
131775290|NCT02388906|474456588|FG001|Treatment Period|Disease progression|100|||
131775291|NCT02388906|474456587|FG000|Treatment Period|Study drug toxicity|41|||
131775292|NCT02388906|474456588|FG001|Treatment Period|Study drug toxicity|208|||
131775293|NCT02388906|474456587|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
131557004|NCT01912222|473664383|FG000|Part B: Treatment Period|Adverse Event|1|||
131557005|NCT01912222|473664384|FG001|Part B: Treatment Period|Adverse Event|2|||
131557006|NCT01912222|473664385|FG002|Part B: Treatment Period|Adverse Event|3|||
131557007|NCT01912222|473664383|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
131557008|NCT01912222|473664384|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
131557009|NCT01912222|473664385|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
131557010|NCT03154359|473664386|FG000|Overall Study|Adverse Event|1|||
131557011|NCT03154359|473664386|FG000|Overall Study|Lack of Efficacy|2|||
131557012|NCT03154359|473664386|FG000|Overall Study|Lost to Follow-up|3|||
131557013|NCT03154359|473664386|FG000|Overall Study|Physician Decision|3|||
131557014|NCT03154359|473664386|FG000|Overall Study|Protocol Violation|4|||
131557015|NCT03154359|473664386|FG000|Overall Study|Withdrawal by Subject|5|||
131557016|NCT03154359|473664386|FG000|Overall Study|Disruption of study due to COVID-19|4|||
131557017|NCT03321006|473664389|FG000|Overall Study|Death|1|||
131557018|NCT03321006|473664390|FG001|Overall Study|Death|0|||
131557019|NCT03321006|473664389|FG000|Overall Study|Lack of Efficacy|1|||
131557020|NCT03321006|473664390|FG001|Overall Study|Lack of Efficacy|0|||
131557021|NCT00885352|473664391|FG000|Overall Study|Adverse Event|2|||
131557022|NCT00885352|473664392|FG001|Overall Study|Adverse Event|3|||
131557023|NCT00885352|473664391|FG000|Overall Study|Lost to Follow-up|2|||
131557024|NCT00885352|473664392|FG001|Overall Study|Lost to Follow-up|2|||
131557025|NCT00885352|473664391|FG000|Overall Study|Physician Decision|0|||
131557026|NCT00885352|473664392|FG001|Overall Study|Physician Decision|3|||
131557027|NCT00885352|473664391|FG000|Overall Study|Protocol Violation|0|||
131557028|NCT00885352|473664392|FG001|Overall Study|Protocol Violation|2|||
131557029|NCT00885352|473664391|FG000|Overall Study|Withdrawal by Subject|1|||
131557030|NCT00885352|473664392|FG001|Overall Study|Withdrawal by Subject|5|||
131557031|NCT00885352|473664391|FG000|Overall Study|Contradiction to study medication|0|||
131557032|NCT00885352|473664392|FG001|Overall Study|Contradiction to study medication|2|||
131557033|NCT00885352|473664391|FG000|Overall Study|Excluded medication|2|||
131557034|NCT00885352|473664392|FG001|Overall Study|Excluded medication|2|||
131557035|NCT00885352|473664391|FG000|Overall Study|Lab abnormalities|1|||
131557036|NCT00885352|473664392|FG001|Overall Study|Lab abnormalities|1|||
131557037|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
131557038|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
131557039|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131557040|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
131557041|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
131775294|NCT02388906|474456588|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
131775295|NCT02388906|474456587|FG000|Treatment Period|Participant request to stop treatment|5|||
131775296|NCT02388906|474456588|FG001|Treatment Period|Participant request to stop treatment|9|||
131775297|NCT02388906|474456587|FG000|Treatment Period|Participant withdrew consent|2|||
131775298|NCT02388906|474456588|FG001|Treatment Period|Participant withdrew consent|3|||
131775299|NCT02388906|474456587|FG000|Treatment Period|Poor/non-compliance|0|||
131775300|NCT02388906|474456588|FG001|Treatment Period|Poor/non-compliance|1|||
131775301|NCT02388906|474456587|FG000|Treatment Period|Participant no longer meets study criteria|0|||
131775302|NCT02388906|474456588|FG001|Treatment Period|Participant no longer meets study criteria|1|||
131557042|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
131557043|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
131557044|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
131557045|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
131557046|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
131557047|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
131557048|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
131557049|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
131557050|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
131557051|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
131775303|NCT02388906|474456587|FG000|Treatment Period|Other reasons|3|||
131775304|NCT02388906|474456588|FG001|Treatment Period|Other reasons|3|||
131775305|NCT04365387|474456589|FG000|Overall Study|Adverse Event|4|||
131775306|NCT04365387|474456590|FG001|Overall Study|Adverse Event|2|||
131775307|NCT04365387|474456589|FG000|Overall Study|Participants request|14|||
131775308|NCT04365387|474456590|FG001|Overall Study|Participants request|14|||
131775309|NCT04365387|474456589|FG000|Overall Study|Lost to Follow-up|8|||
131775310|NCT04365387|474456590|FG001|Overall Study|Lost to Follow-up|5|||
131775311|NCT04365387|474456589|FG000|Overall Study|Protocol deviation|3|||
131775312|NCT04365387|474456590|FG001|Overall Study|Protocol deviation|4|||
131719472|NCT00258154|474253328|FG001|Overall Study|Lost to Follow-up|1|||
131719473|NCT00258154|474253327|FG000|Overall Study|Protocol Violation|2|||
131719474|NCT00258154|474253328|FG001|Overall Study|Protocol Violation|1|||
131719475|NCT00258154|474253327|FG000|Overall Study|Withdrawal by Subject|3|||
131719476|NCT00258154|474253328|FG001|Overall Study|Withdrawal by Subject|4|||
131719477|NCT00258154|474253327|FG000|Overall Study|Patient Moved|3|||
131719478|NCT00258154|474253328|FG001|Overall Study|Patient Moved|1|||
131719479|NCT01856673|474253333|FG000|Overall Study|Withdrawal by Subject|44|||
131719480|NCT01856673|474253334|FG001|Overall Study|Withdrawal by Subject|50|||
131719481|NCT01856673|474253335|FG002|Overall Study|Withdrawal by Subject|33|||
131719482|NCT01856673|474253333|FG000|Overall Study|Lost to Follow-up|31|||
131719483|NCT01856673|474253334|FG001|Overall Study|Lost to Follow-up|34|||
131557052|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
131557053|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
131557054|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
131557055|NCT00365378|473664393|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
131557056|NCT00365378|473664394|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
131557057|NCT00365378|473664395|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
131557058|NCT00365378|473664393|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
131557059|NCT00365378|473664394|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
131557060|NCT00365378|473664395|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
131557061|NCT00365378|473664393|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
131557062|NCT00365378|473664394|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
131557063|NCT00365378|473664395|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
131557064|NCT00365378|473664393|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
131775313|NCT04365387|474456589|FG000|Overall Study|Participant compliance with visit schedule|1|||
131775314|NCT04365387|474456590|FG001|Overall Study|Participant compliance with visit schedule|0|||
131775315|NCT04365387|474456589|FG000|Overall Study|Participant incarcerated|1|||
131775316|NCT04365387|474456590|FG001|Overall Study|Participant incarcerated|0|||
131775317|NCT04365387|474456589|FG000|Overall Study|Participant moved out of town (relocated)|0|||
131775318|NCT04365387|474456590|FG001|Overall Study|Participant moved out of town (relocated)|1|||
131775319|NCT04365387|474456589|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
131775320|NCT04365387|474456590|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
131775321|NCT04365387|474456589|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
131775322|NCT04365387|474456590|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
131775323|NCT05770401|474456599|FG000|Overall Study|Lost to Follow-up|5|||
131775324|NCT05770401|474456600|FG001|Overall Study|Lost to Follow-up|4|||
131775325|NCT00402298|474456601|FG000|Overall Study|Withdrawal by Subject|1|||
131775326|NCT00402298|474456602|FG001|Overall Study|Withdrawal by Subject|0|||
131775327|NCT00480077|474456603|FG000|Overall Study|Death|19|||
131775328|NCT00480077|474456604|FG001|Overall Study|Death|15|||
131775329|NCT00480077|474456603|FG000|Overall Study|early exit|12|||
131775330|NCT00480077|474456604|FG001|Overall Study|early exit|11|||
131775331|NCT04784455|474456605|FG000|Overall Study|Death|4|||
131775332|NCT04298229|474456610|FG000|Overall Study|Physician Decision|1|||
131775333|NCT04298229|474456611|FG001|Overall Study|Physician Decision|1|||
131775334|NCT04298229|474456610|FG000|Overall Study|Withdrawal by Subject|1|||
131775335|NCT04298229|474456611|FG001|Overall Study|Withdrawal by Subject|1|||
131775336|NCT04298229|474456610|FG000|Overall Study|Did not receive IV loop diuretics|2|||
131775337|NCT04298229|474456611|FG001|Overall Study|Did not receive IV loop diuretics|0|||
131557065|NCT00365378|473664394|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
131557066|NCT00365378|473664395|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
131557067|NCT00365378|473664393|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
131557068|NCT00365378|473664394|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
131557069|NCT00365378|473664395|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
131557070|NCT00365378|473664393|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
131557071|NCT00365378|473664394|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
131557072|NCT00365378|473664395|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
131557073|NCT00365378|473664393|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
131557074|NCT00365378|473664394|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
131557075|NCT00365378|473664395|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
131557076|NCT00365378|473664393|FG000|Extension|Adverse Event|0|||
131557077|NCT00365378|473664394|FG001|Extension|Adverse Event|0|||
131557078|NCT00365378|473664395|FG002|Extension|Adverse Event|1|||
131557079|NCT00365378|473664393|FG000|Extension|Moved|0|||
131557080|NCT00365378|473664394|FG001|Extension|Moved|0|||
131557081|NCT00365378|473664395|FG002|Extension|Moved|8|||
131557082|NCT00365378|473664393|FG000|Extension|Lost to Follow-up|0|||
131557083|NCT00365378|473664394|FG001|Extension|Lost to Follow-up|0|||
131557084|NCT00365378|473664395|FG002|Extension|Lost to Follow-up|57|||
131557085|NCT00365378|473664393|FG000|Extension|Protocol Violation|0|||
131557086|NCT00365378|473664394|FG001|Extension|Protocol Violation|0|||
131557087|NCT00365378|473664395|FG002|Extension|Protocol Violation|2|||
131557088|NCT00365378|473664393|FG000|Extension|Withdrawal by Subject|0|||
131557089|NCT00365378|473664394|FG001|Extension|Withdrawal by Subject|0|||
131557090|NCT00365378|473664395|FG002|Extension|Withdrawal by Subject|98|||
131557091|NCT00365378|473664393|FG000|Extension|Other|0|||
131557092|NCT00365378|473664394|FG001|Extension|Other|0|||
131557093|NCT00365378|473664395|FG002|Extension|Other|31|||
131557094|NCT03560258|473664398|FG000|Overall Study|Lost to Follow-up|3|||
131557095|NCT03560258|473664399|FG001|Overall Study|Lost to Follow-up|0|||
131557096|NCT03560258|473664400|FG002|Overall Study|Lost to Follow-up|0|||
131557097|NCT03560258|473664398|FG000|Overall Study|Protocol Violation|0|||
131557098|NCT03560258|473664399|FG001|Overall Study|Protocol Violation|1|||
131557099|NCT03560258|473664400|FG002|Overall Study|Protocol Violation|0|||
131557100|NCT03560258|473664398|FG000|Overall Study|Withdrawal by Subject|0|||
131557101|NCT03560258|473664399|FG001|Overall Study|Withdrawal by Subject|0|||
131436222|NCT00453154|473223943|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
131436223|NCT00453154|473223944|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
131436224|NCT00453154|473223945|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
131436225|NCT01693029|473223954|FG000|Overall Study|Withdrawal by Subject|15|||
131436226|NCT01693029|473223955|FG001|Overall Study|Withdrawal by Subject|22|||
131436227|NCT01693029|473223954|FG000|Overall Study|Kidney transplantation|7|||
131436228|NCT01693029|473223955|FG001|Overall Study|Kidney transplantation|7|||
131436229|NCT01693029|473223954|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
131436230|NCT01693029|473223955|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
131436231|NCT01693029|473223954|FG000|Overall Study|Protocol Violation|6|||
131436232|NCT01693029|473223955|FG001|Overall Study|Protocol Violation|7|||
131436233|NCT01693029|473223954|FG000|Overall Study|Change in dialysis modality|2|||
131436234|NCT01693029|473223955|FG001|Overall Study|Change in dialysis modality|1|||
131436235|NCT01693029|473223954|FG000|Overall Study|Physician Decision|0|||
131436236|NCT01693029|473223955|FG001|Overall Study|Physician Decision|2|||
131436237|NCT01693029|473223954|FG000|Overall Study|Lost to Follow-up|0|||
131436238|NCT01693029|473223955|FG001|Overall Study|Lost to Follow-up|1|||
131436239|NCT01693029|473223954|FG000|Overall Study|Adverse Event|1|||
131436240|NCT01693029|473223955|FG001|Overall Study|Adverse Event|6|||
131689080|NCT03357731|474148191|FG003|Overall Study|Acute bradycardia and hypotension|1|||
131689081|NCT03357731|474148192|FG004|Overall Study|Acute bradycardia and hypotension|0|||
131436241|NCT01693029|473223954|FG000|Overall Study|Death|5|||
131436242|NCT01693029|473223955|FG001|Overall Study|Death|8|||
131436243|NCT01693029|473223954|FG000|Overall Study|Non-compliance|2|||
131436244|NCT01693029|473223955|FG001|Overall Study|Non-compliance|1|||
131689082|NCT03357731|474148193|FG005|Overall Study|Acute bradycardia and hypotension|0|||
131689083|NCT03357731|474148188|FG000|Overall Study|Adverse Event|0|||
131689084|NCT03357731|474148189|FG001|Overall Study|Adverse Event|0|||
131689085|NCT03357731|474148190|FG002|Overall Study|Adverse Event|0|||
131689086|NCT03357731|474148191|FG003|Overall Study|Adverse Event|0|||
131689087|NCT03357731|474148192|FG004|Overall Study|Adverse Event|0|||
131689088|NCT03357731|474148193|FG005|Overall Study|Adverse Event|1|||
131689089|NCT03357731|474148188|FG000|Overall Study|Hypotension|0|||
131689090|NCT03357731|474148189|FG001|Overall Study|Hypotension|0|||
131689091|NCT03357731|474148190|FG002|Overall Study|Hypotension|1|||
131689092|NCT03357731|474148191|FG003|Overall Study|Hypotension|1|||
131689093|NCT03357731|474148192|FG004|Overall Study|Hypotension|0|||
131689094|NCT03357731|474148193|FG005|Overall Study|Hypotension|0|||
131689095|NCT03357731|474148188|FG000|Overall Study|Lost to Follow-up|0|||
131689096|NCT03357731|474148189|FG001|Overall Study|Lost to Follow-up|0|||
131689097|NCT03357731|474148190|FG002|Overall Study|Lost to Follow-up|0|||
131689098|NCT03357731|474148191|FG003|Overall Study|Lost to Follow-up|1|||
131689099|NCT03357731|474148192|FG004|Overall Study|Lost to Follow-up|0|||
131689100|NCT03357731|474148193|FG005|Overall Study|Lost to Follow-up|0|||
131689101|NCT00772954|474148194|FG000|Overall Study|Adverse Event|0|||
131689102|NCT00772954|474148195|FG001|Overall Study|Adverse Event|0|||
131689103|NCT00772954|474148196|FG002|Overall Study|Adverse Event|1|||
131689104|NCT01773109|474148197|FG000|Overall Study|Symptomatic Progression|2|||
131689105|NCT01773109|474148197|FG000|Overall Study|Death|1|||
131689106|NCT01239342|474148198|FG000|Overall Study|Adverse Event|1|||
131689107|NCT01239342|474148199|FG001|Overall Study|Adverse Event|0|||
131689108|NCT01239342|474148198|FG000|Overall Study|Withdrawal by Subject|1|||
131689109|NCT01239342|474148199|FG001|Overall Study|Withdrawal by Subject|5|||
131689110|NCT01239342|474148198|FG000|Overall Study|Reason Unknown|1|||
131689111|NCT01239342|474148199|FG001|Overall Study|Reason Unknown|1|||
131689112|NCT02495844|474148200|FG000|Overall Study|Lack of Efficacy|1|||
131689113|NCT02495844|474148201|FG001|Overall Study|Lack of Efficacy|2|||
131689114|NCT02495844|474148200|FG000|Overall Study|AE, non-fatal|0|||
131689115|NCT02495844|474148201|FG001|Overall Study|AE, non-fatal|1|||
131689116|NCT02495844|474148200|FG000|Overall Study|Hepatitis Positivity|0|||
131689117|NCT02495844|474148201|FG001|Overall Study|Hepatitis Positivity|1|||
131689118|NCT02325219|474148204|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
131689119|NCT02325219|474148205|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
131689120|NCT02325219|474148206|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
131689121|NCT02325219|474148207|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
131689122|NCT02325219|474148208|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
131689123|NCT02325219|474148204|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
131689124|NCT02325219|474148205|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
131689125|NCT02325219|474148206|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131689126|NCT02325219|474148207|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131689127|NCT02325219|474148208|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131689128|NCT02325219|474148204|FG000|Controlled Period (Week 0 - 16)|Other|0|||
131689129|NCT02325219|474148205|FG001|Controlled Period (Week 0 - 16)|Other|0|||
131775338|NCT00262119|474456613|FG000|Overall Study|Lost to Follow-up|38|||
131436245|NCT03683173|473223956|FG000|Completed Follow-up|Unavailable|235|||
131436246|NCT03683173|473223957|FG001|Completed Follow-up|Unavailable|217|||
131436247|NCT03683173|473223956|FG000|Completed Follow-up|Refused|69|||
131557102|NCT03560258|473664400|FG002|Overall Study|Withdrawal by Subject|1|||
131557103|NCT04161807|473664404|FG000|Overall Study|Withdrawal by Subject|2|||
131557104|NCT04161807|473664404|FG000|Overall Study|Performed only 1 treatment|2|||
131557105|NCT02006121|473664405|FG000|Double Blind Phase|Adverse Event|6|||
131557106|NCT02006121|473664406|FG001|Double Blind Phase|Adverse Event|0|||
131557107|NCT02006121|473664405|FG000|Double Blind Phase|Lack of Efficacy|1|||
131557108|NCT02006121|473664406|FG001|Double Blind Phase|Lack of Efficacy|16|||
131557109|NCT02006121|473664405|FG000|Double Blind Phase|Withdrawal by Subject|3|||
131557110|NCT02006121|473664406|FG001|Double Blind Phase|Withdrawal by Subject|4|||
131557111|NCT02006121|473664405|FG000|Double Blind Phase|Non-compliance with study drug|1|||
131557112|NCT02006121|473664406|FG001|Double Blind Phase|Non-compliance with study drug|3|||
131557113|NCT02006121|473664405|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
131557114|NCT02006121|473664406|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
131557115|NCT02006121|473664405|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
131557116|NCT02006121|473664406|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
131557117|NCT02006121|473664405|FG000|Open Label Phase|Adverse Event|15|||
131557118|NCT02006121|473664406|FG001|Open Label Phase|Adverse Event|0|||
131557119|NCT02006121|473664405|FG000|Open Label Phase|Lack of Efficacy|2|||
131557120|NCT02006121|473664406|FG001|Open Label Phase|Lack of Efficacy|0|||
131557121|NCT02006121|473664405|FG000|Open Label Phase|Protocol Violation|2|||
131775339|NCT00262119|474456614|FG001|Overall Study|Lost to Follow-up|51|||
131436248|NCT03683173|473223957|FG001|Completed Follow-up|Refused|59|||
131557122|NCT02006121|473664406|FG001|Open Label Phase|Protocol Violation|0|||
131557123|NCT02006121|473664405|FG000|Open Label Phase|Withdrawal by Subject|3|||
131557124|NCT02006121|473664406|FG001|Open Label Phase|Withdrawal by Subject|0|||
131557125|NCT02006121|473664405|FG000|Open Label Phase|Non-compliance with study drug|3|||
131557126|NCT02006121|473664406|FG001|Open Label Phase|Non-compliance with study drug|0|||
131557127|NCT00245856|473664424|FG000|Period Two|Withdrawal by Subject|0|||
131557128|NCT00245856|473664425|FG001|Period Two|Withdrawal by Subject|1|||
131557129|NCT01003184|473664427|FG000|Overall Study|Adverse Event|12|||
131557130|NCT01003184|473664428|FG001|Overall Study|Adverse Event|5|||
131557131|NCT01003184|473664427|FG000|Overall Study|Lost to Follow-up|1|||
131557132|NCT01003184|473664428|FG001|Overall Study|Lost to Follow-up|0|||
131557133|NCT01003184|473664427|FG000|Overall Study|Loss of glucose control|1|||
131436249|NCT03683173|473223956|FG000|Completed Follow-up|Disconnected phone|65|||
131557134|NCT01003184|473664428|FG001|Overall Study|Loss of glucose control|1|||
131557135|NCT01003184|473664427|FG000|Overall Study|Protocol Violation|3|||
131557136|NCT01003184|473664428|FG001|Overall Study|Protocol Violation|0|||
131557137|NCT01003184|473664427|FG000|Overall Study|Withdrawal by Subject|1|||
131557138|NCT01003184|473664428|FG001|Overall Study|Withdrawal by Subject|6|||
131436250|NCT03683173|473223957|FG001|Completed Follow-up|Disconnected phone|95|||
131436251|NCT03683173|473223956|FG000|Completed Follow-up|Health issue/deceased|10|||
131436252|NCT03683173|473223957|FG001|Completed Follow-up|Health issue/deceased|4|||
131557139|NCT01003184|473664427|FG000|Overall Study|Physician Decision|1|||
131557140|NCT01003184|473664428|FG001|Overall Study|Physician Decision|0|||
131557141|NCT02693834|473664429|FG000|Baseline Measurement|Withdrawal by Subject|1|||
131557142|NCT02693834|473664430|FG001|Baseline Measurement|Withdrawal by Subject|0|||
131557143|NCT02693834|473664429|FG000|Baseline Measurement|Adverse Event|1|||
131557144|NCT02693834|473664430|FG001|Baseline Measurement|Adverse Event|0|||
131557145|NCT02693834|473664429|FG000|Week 2 Practice|Adverse Event|0|||
131557146|NCT02693834|473664430|FG001|Week 2 Practice|Adverse Event|1|||
131557147|NCT04848662|473664431|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
131557148|NCT04848662|473664432|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
131557149|NCT00562978|473664433|FG000|Overall Study|Patient had imaging dose only|1|||
131557150|NCT00562978|473664434|FG001|Overall Study|Patient had imaging dose only|11|||
131557151|NCT00152971|473664436|FG000|Overall Study|Adverse Event|12|||
131557152|NCT00152971|473664437|FG001|Overall Study|Adverse Event|10|||
131689130|NCT02325219|474148206|FG002|Controlled Period (Week 0 - 16)|Other|1|||
131689131|NCT02325219|474148207|FG003|Controlled Period (Week 0 - 16)|Other|0|||
131436253|NCT03683173|473223956|FG000|Completed Follow-up|Moved away|8|||
131436254|NCT03683173|473223957|FG001|Completed Follow-up|Moved away|1|||
131689132|NCT02325219|474148208|FG004|Controlled Period (Week 0 - 16)|Other|0|||
131689133|NCT02325219|474148204|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131689134|NCT02325219|474148205|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131689135|NCT02325219|474148206|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131689136|NCT02325219|474148207|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131689137|NCT02325219|474148208|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
131436255|NCT05801991|473223958|FG000|Overall Study|Lost to Follow-up|1|||
131436256|NCT05801991|473223959|FG001|Overall Study|Lost to Follow-up|0|||
131557153|NCT00152971|473664438|FG002|Overall Study|Adverse Event|9|||
131557154|NCT00152971|473664436|FG000|Overall Study|Protocol Violation|10|||
131557155|NCT00152971|473664437|FG001|Overall Study|Protocol Violation|11|||
131775340|NCT00262119|474456615|FG002|Overall Study|Lost to Follow-up|42|||
131775341|NCT00262119|474456613|FG000|Overall Study|Death|20|||
131775342|NCT00262119|474456614|FG001|Overall Study|Death|19|||
131775343|NCT00262119|474456615|FG002|Overall Study|Death|16|||
131775344|NCT00859313|474456616|FG000|Overall Study|Lack of Efficacy|2|||
131775345|NCT00859313|474456616|FG000|Overall Study|Adverse Event|1|||
131775346|NCT00859313|474456616|FG000|Overall Study|staff error|1|||
131775347|NCT05261126|474456617|FG000|Overall Study|Death|0|||
131775348|NCT05261126|474456618|FG001|Overall Study|Death|0|||
131775349|NCT05261126|474456619|FG002|Overall Study|Death|1|||
131775350|NCT05261126|474456620|FG003|Overall Study|Death|0|||
131775351|NCT05261126|474456621|FG004|Overall Study|Death|0|||
131775352|NCT05261126|474456617|FG000|Overall Study|Lost to Follow-up|0|||
131775353|NCT05261126|474456618|FG001|Overall Study|Lost to Follow-up|0|||
131775354|NCT05261126|474456619|FG002|Overall Study|Lost to Follow-up|0|||
131775355|NCT05261126|474456620|FG003|Overall Study|Lost to Follow-up|0|||
131775356|NCT05261126|474456621|FG004|Overall Study|Lost to Follow-up|1|||
131775357|NCT05261126|474456617|FG000|Overall Study|Physician Decision|1|||
131775358|NCT05261126|474456618|FG001|Overall Study|Physician Decision|0|||
131775359|NCT05261126|474456619|FG002|Overall Study|Physician Decision|0|||
131775360|NCT05261126|474456620|FG003|Overall Study|Physician Decision|0|||
131775361|NCT05261126|474456621|FG004|Overall Study|Physician Decision|0|||
131775362|NCT05261126|474456617|FG000|Overall Study|Screen Failure|0|||
131775363|NCT05261126|474456618|FG001|Overall Study|Screen Failure|0|||
131775364|NCT05261126|474456619|FG002|Overall Study|Screen Failure|0|||
131775365|NCT05261126|474456620|FG003|Overall Study|Screen Failure|0|||
131775366|NCT05261126|474456621|FG004|Overall Study|Screen Failure|1|||
131775367|NCT05261126|474456617|FG000|Overall Study|Withdrawal by Subject|1|||
131775368|NCT05261126|474456618|FG001|Overall Study|Withdrawal by Subject|0|||
131775369|NCT05261126|474456619|FG002|Overall Study|Withdrawal by Subject|1|||
131775370|NCT05261126|474456620|FG003|Overall Study|Withdrawal by Subject|1|||
131775371|NCT05261126|474456621|FG004|Overall Study|Withdrawal by Subject|0|||
131775372|NCT05261126|474456617|FG000|Overall Study|Not Recorded|0|||
131775373|NCT05261126|474456618|FG001|Overall Study|Not Recorded|0|||
131775374|NCT05261126|474456619|FG002|Overall Study|Not Recorded|0|||
131775375|NCT05261126|474456620|FG003|Overall Study|Not Recorded|1|||
131775376|NCT05261126|474456621|FG004|Overall Study|Not Recorded|0|||
131775377|NCT05570604|474456622|FG000|Overall Study|Lost to Follow-up|1|||
131775378|NCT05570604|474456623|FG001|Overall Study|Lost to Follow-up|5|||
131775379|NCT05570604|474456622|FG000|Overall Study|Illness|2|||
131775380|NCT05570604|474456623|FG001|Overall Study|Illness|2|||
131775381|NCT04527380|474456624|FG000|Overall Study|Lack of Efficacy|0|||
131775382|NCT04527380|474456625|FG001|Overall Study|Lack of Efficacy|1|||
131775383|NCT04527380|474456624|FG000|Overall Study|Withdrawal by Subject|1|||
131775384|NCT04527380|474456625|FG001|Overall Study|Withdrawal by Subject|0|||
131775385|NCT05437211|474456630|FG000|Overall Study|Patient's decision|1|||
131775386|NCT05437211|474456631|FG001|Overall Study|Patient's decision|1|||
131775387|NCT04410991|474456636|FG000|Overall Study|Poor compliance to protocol|5|||
131775388|NCT04410991|474456637|FG001|Overall Study|Poor compliance to protocol|4|||
131775389|NCT04410991|474456636|FG000|Overall Study|Withdrawal by Subject|59|||
131775390|NCT04410991|474456637|FG001|Overall Study|Withdrawal by Subject|55|||
131775391|NCT04410991|474456636|FG000|Overall Study|Other|10|||
131775392|NCT04410991|474456637|FG001|Overall Study|Other|4|||
131775393|NCT03282123|474456638|FG000|Overall Study|Withdrawal by Subject|5|||
131775394|NCT01195662|474456639|FG000|Double Blind Treatment Period|Adverse Event|4|||
131775395|NCT01195662|474456640|FG001|Double Blind Treatment Period|Adverse Event|1|||
131775396|NCT01195662|474456641|FG002|Double Blind Treatment Period|Adverse Event|2|||
131775397|NCT01195662|474456639|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
131557156|NCT00152971|473664438|FG002|Overall Study|Protocol Violation|8|||
131775398|NCT01195662|474456640|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
131775399|NCT01195662|474456641|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
131775400|NCT01195662|474456639|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
131775401|NCT01195662|474456640|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
131775402|NCT01195662|474456641|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
131775403|NCT01195662|474456639|FG000|Double Blind Treatment Period|Administrative reason|2|||
131436257|NCT03016312|473223960|FG000|Overall Study|discontinued before the treatment started|0|||
131436258|NCT03016312|473223961|FG001|Overall Study|discontinued before the treatment started|1|||
131436259|NCT03016312|473223960|FG000|Overall Study|Withdrawal by Subject|37|||
131436260|NCT03016312|473223961|FG001|Overall Study|Withdrawal by Subject|44|||
131436261|NCT03016312|473223960|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
131436262|NCT03016312|473223961|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
131436263|NCT03016312|473223960|FG000|Overall Study|Physician Decision|1|||
131436264|NCT03016312|473223961|FG001|Overall Study|Physician Decision|3|||
131436265|NCT03016312|473223960|FG000|Overall Study|Lost to Follow-up|12|||
131436266|NCT03016312|473223961|FG001|Overall Study|Lost to Follow-up|12|||
131436267|NCT03016312|473223960|FG000|Overall Study|Death|210|||
131436268|NCT03016312|473223961|FG001|Overall Study|Death|184|||
131436269|NCT03016312|473223960|FG000|Overall Study|loss to contact|1|||
131436270|NCT03016312|473223961|FG001|Overall Study|loss to contact|0|||
131436271|NCT03016312|473223960|FG000|Overall Study|started a new cancer therapy|1|||
131436272|NCT03016312|473223961|FG001|Overall Study|started a new cancer therapy|0|||
131436273|NCT02210000|473223962|FG000|Overall Study|Study Terminated|11|||
131436274|NCT02210000|473223963|FG001|Overall Study|Study Terminated|12|||
131436275|NCT02210000|473223962|FG000|Overall Study|Withdrawal by Subject|7|||
131436276|NCT02210000|473223963|FG001|Overall Study|Withdrawal by Subject|1|||
131436277|NCT02210000|473223962|FG000|Overall Study|Adverse Event|1|||
131436278|NCT02210000|473223963|FG001|Overall Study|Adverse Event|5|||
131436279|NCT02210000|473223962|FG000|Overall Study|Lost to Follow-up|0|||
131436280|NCT02210000|473223963|FG001|Overall Study|Lost to Follow-up|2|||
131436281|NCT02210000|473223962|FG000|Overall Study|Physician Decision|0|||
131436282|NCT02210000|473223963|FG001|Overall Study|Physician Decision|1|||
131436283|NCT00308139|473223964|FG000|Overall Study|Adverse Event|20|||
131436284|NCT00308139|473223965|FG001|Overall Study|Adverse Event|14|||
131436285|NCT00308139|473223964|FG000|Overall Study|Lost to Follow-up|13|||
131436286|NCT00308139|473223965|FG001|Overall Study|Lost to Follow-up|8|||
131436287|NCT00308139|473223964|FG000|Overall Study|Protocol Violation|3|||
131775404|NCT01195662|474456640|FG001|Double Blind Treatment Period|Administrative reason|1|||
131775405|NCT01195662|474456641|FG002|Double Blind Treatment Period|Administrative reason|1|||
131775406|NCT01195662|474456639|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
131775407|NCT01195662|474456640|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
131775408|NCT01195662|474456641|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
131775409|NCT01195662|474456639|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
131775410|NCT01195662|474456640|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
131557157|NCT00152971|473664436|FG000|Overall Study|Lost to Follow-up|17|||
131557158|NCT00152971|473664437|FG001|Overall Study|Lost to Follow-up|14|||
131436288|NCT00308139|473223965|FG001|Overall Study|Protocol Violation|2|||
131436289|NCT00308139|473223964|FG000|Overall Study|Withdrawal of Consent|40|||
131436290|NCT00308139|473223965|FG001|Overall Study|Withdrawal of Consent|42|||
131436291|NCT00308139|473223964|FG000|Overall Study|Investigator Decision|11|||
131436292|NCT00308139|473223965|FG001|Overall Study|Investigator Decision|10|||
131436293|NCT00308139|473223964|FG000|Overall Study|Loss of Glucose Control|5|||
131436294|NCT00308139|473223965|FG001|Overall Study|Loss of Glucose Control|7|||
131436295|NCT00308139|473223964|FG000|Overall Study|Administrative|1|||
131436296|NCT00308139|473223965|FG001|Overall Study|Administrative|4|||
131436297|NCT00308139|473223964|FG000|Overall Study|Other|1|||
131436298|NCT00308139|473223965|FG001|Overall Study|Other|0|||
131436299|NCT00833040|473223966|FG000|Overall Study|Adverse Event|0|||
131436300|NCT00833040|473223967|FG001|Overall Study|Adverse Event|0|||
131436301|NCT00833040|473223968|FG002|Overall Study|Adverse Event|0|||
131436302|NCT00833040|473223969|FG003|Overall Study|Adverse Event|0|||
131436303|NCT00833040|473223970|FG004|Overall Study|Adverse Event|0|||
131436304|NCT00833040|473223971|FG005|Overall Study|Adverse Event|1|||
131436305|NCT02995980|473223973|FG000|Overall Study|Lost to Follow-up|14|||
131436306|NCT00657540|473223975|FG000|Overall Study|Lost to Follow-up|1|||
131436307|NCT00657540|473223976|FG001|Overall Study|Lost to Follow-up|4|||
131436308|NCT01458639|473223978|FG000|Overall Study|Physician Decision|4|||
131436309|NCT01458639|473223978|FG000|Overall Study|Equipment issue|1|||
131436310|NCT01458639|473223978|FG000|Overall Study|Inability to obtain subject blood sample|1|||
131436311|NCT02656017|473223979|FG000|Overall Study|Study burden|3|||
131436312|NCT02656017|473223980|FG001|Overall Study|Study burden|3|||
131436313|NCT02656017|473223979|FG000|Overall Study|Adverse Event|2|||
131436314|NCT02656017|473223980|FG001|Overall Study|Adverse Event|1|||
131436315|NCT02656017|473223979|FG000|Overall Study|Unable/unwilling to take study medication|2|||
131436316|NCT02656017|473223980|FG001|Overall Study|Unable/unwilling to take study medication|1|||
131436317|NCT02656017|473223979|FG000|Overall Study|Began Tolvaptan|1|||
131436318|NCT02656017|473223980|FG001|Overall Study|Began Tolvaptan|1|||
131436319|NCT02656017|473223979|FG000|Overall Study|Withdrawal by Subject|1|||
131436320|NCT02656017|473223980|FG001|Overall Study|Withdrawal by Subject|0|||
131436321|NCT02792231|473223986|FG000|Overall Study|Patient/guardian decision|32|||
131436322|NCT02792231|473223987|FG001|Overall Study|Patient/guardian decision|42|||
131436323|NCT02792231|473223986|FG000|Overall Study|Adverse Event|15|||
131436324|NCT02792231|473223987|FG001|Overall Study|Adverse Event|11|||
131436325|NCT02792231|473223986|FG000|Overall Study|Physician Decision|14|||
131436326|NCT02792231|473223987|FG001|Overall Study|Physician Decision|12|||
131436327|NCT02792231|473223986|FG000|Overall Study|Lack of Efficacy|7|||
131436328|NCT02792231|473223987|FG001|Overall Study|Lack of Efficacy|9|||
131898539|NCT02797678|474914124|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
131898540|NCT02797678|474914125|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
131689138|NCT02325219|474148204|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131689139|NCT02325219|474148205|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
131689140|NCT02325219|474148206|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131689141|NCT02325219|474148207|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131689142|NCT02325219|474148208|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131689143|NCT02325219|474148204|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131689144|NCT02325219|474148205|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
131689145|NCT02325219|474148206|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131689146|NCT02325219|474148207|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131689147|NCT02325219|474148208|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131689148|NCT02918864|474148209|FG000|Overall Study|Withdrawal by Subject|1|||
131689149|NCT02918864|474148210|FG001|Overall Study|Withdrawal by Subject|1|||
131689150|NCT02918864|474148209|FG000|Overall Study|Lost to Follow-up|3|||
131689151|NCT02918864|474148210|FG001|Overall Study|Lost to Follow-up|2|||
131689152|NCT04766021|474148211|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
131689153|NCT04766021|474148211|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
131689154|NCT02257372|474148217|FG000|Overall Study|Adverse Event|3|||
131689155|NCT02257372|474148218|FG001|Overall Study|Adverse Event|7|||
131689156|NCT02257372|474148217|FG000|Overall Study|Lack of Efficacy|2|||
131689157|NCT02257372|474148218|FG001|Overall Study|Lack of Efficacy|1|||
131689158|NCT02257372|474148217|FG000|Overall Study|Protocol Violation|1|||
131689159|NCT02257372|474148218|FG001|Overall Study|Protocol Violation|1|||
131689160|NCT02257372|474148217|FG000|Overall Study|Lost to Follow-up|0|||
131689161|NCT02257372|474148218|FG001|Overall Study|Lost to Follow-up|1|||
131689162|NCT02257372|474148217|FG000|Overall Study|Withdrew consent|1|||
131689163|NCT02257372|474148218|FG001|Overall Study|Withdrew consent|0|||
131689164|NCT00789529|474148219|FG000|Overall Study|Withdrawal by Subject|0|||
131689165|NCT00789529|474148220|FG001|Overall Study|Withdrawal by Subject|1|||
131689166|NCT00789529|474148219|FG000|Overall Study|Other Reason|1|||
131689167|NCT00789529|474148220|FG001|Overall Study|Other Reason|0|||
131689168|NCT02634151|474148221|FG000|Overall Study|Withdrawal by Subject|1|||
131689169|NCT02634151|474148222|FG001|Overall Study|Withdrawal by Subject|0|||
131689170|NCT02634151|474148221|FG000|Overall Study|Non-Compliance|0|||
131689171|NCT02634151|474148222|FG001|Overall Study|Non-Compliance|1|||
131689172|NCT02634151|474148221|FG000|Overall Study|Other|0|||
131689173|NCT02634151|474148222|FG001|Overall Study|Other|1|||
131689174|NCT02347098|474148223|FG000|Overall Study|Death|1|||
131689175|NCT02347098|474148224|FG001|Overall Study|Death|0|||
131689176|NCT02347098|474148223|FG000|Overall Study|Withdrawal by Subject|1|||
131689177|NCT02347098|474148224|FG001|Overall Study|Withdrawal by Subject|0|||
131689178|NCT02347098|474148223|FG000|Overall Study|Lost to Follow-up|2|||
131689179|NCT02347098|474148224|FG001|Overall Study|Lost to Follow-up|2|||
131689180|NCT02347098|474148223|FG000|Overall Study|Refuse Follow-up Visit|1|||
131689181|NCT02347098|474148224|FG001|Overall Study|Refuse Follow-up Visit|5|||
131689182|NCT02347098|474148223|FG000|Overall Study|no visit due to illness|2|||
131689183|NCT02347098|474148224|FG001|Overall Study|no visit due to illness|1|||
131689184|NCT02187172|474148225|FG000|Overall Study|Lost to Follow-up|1|||
131689185|NCT02187172|474148226|FG001|Overall Study|Lost to Follow-up|2|||
131689186|NCT02187172|474148225|FG000|Overall Study|Lack of Efficacy|1|||
131689187|NCT02187172|474148226|FG001|Overall Study|Lack of Efficacy|2|||
131689188|NCT02187172|474148225|FG000|Overall Study|Adverse Event|0|||
131689189|NCT02187172|474148226|FG001|Overall Study|Adverse Event|1|||
131689190|NCT02187172|474148225|FG000|Overall Study|Physician Decision|1|||
131689191|NCT02187172|474148226|FG001|Overall Study|Physician Decision|1|||
131689192|NCT04640272|474148227|FG000|Overall Study|Subject moved out of area|1|||
131689193|NCT00880399|474148228|FG000|Overall Study|Adverse Event|4|||
131689194|NCT00880399|474148229|FG001|Overall Study|Adverse Event|6|||
131689195|NCT00880399|474148230|FG002|Overall Study|Adverse Event|5|||
131689196|NCT00880399|474148228|FG000|Overall Study|Lack of Efficacy|1|||
131689197|NCT00880399|474148229|FG001|Overall Study|Lack of Efficacy|4|||
131689198|NCT00880399|474148230|FG002|Overall Study|Lack of Efficacy|2|||
131689199|NCT00880399|474148228|FG000|Overall Study|Protocol Violation|4|||
131689200|NCT00880399|474148229|FG001|Overall Study|Protocol Violation|4|||
131775411|NCT01195662|474456641|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
131775412|NCT01195662|474456639|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
131775413|NCT01195662|474456640|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
131775414|NCT01195662|474456641|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
131775415|NCT01195662|474456639|FG000|Double Blind Treatment Period|Non-specified|3|||
131775416|NCT01195662|474456640|FG001|Double Blind Treatment Period|Non-specified|0|||
131775417|NCT01195662|474456641|FG002|Double Blind Treatment Period|Non-specified|0|||
131775418|NCT01195662|474456639|FG000|Double Blind Treatment Period|Missing disposition information|0|||
131775419|NCT01195662|474456640|FG001|Double Blind Treatment Period|Missing disposition information|1|||
131775420|NCT01195662|474456641|FG002|Double Blind Treatment Period|Missing disposition information|1|||
131775421|NCT01195662|474456639|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
131775422|NCT01195662|474456640|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
131775423|NCT01195662|474456641|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
131775424|NCT01195662|474456639|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
131775425|NCT01195662|474456640|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
131775426|NCT01195662|474456641|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
131775427|NCT01215968|474456645|FG000|Overall Study|Adverse Event|0|||
131775428|NCT01215968|474456646|FG001|Overall Study|Adverse Event|2|||
131775429|NCT01215968|474456645|FG000|Overall Study|Protocol Violation|2|||
131775430|NCT01215968|474456646|FG001|Overall Study|Protocol Violation|4|||
131775431|NCT01215968|474456645|FG000|Overall Study|Not received study drug|0|||
131775432|NCT01215968|474456646|FG001|Overall Study|Not received study drug|1|||
131775433|NCT01463631|474456648|FG000|Overall Study|Withdrawal by Subject|0|||
131775434|NCT01463631|474456649|FG001|Overall Study|Withdrawal by Subject|0|||
131775435|NCT01463631|474456650|FG002|Overall Study|Withdrawal by Subject|0|||
131775436|NCT01463631|474456651|FG003|Overall Study|Withdrawal by Subject|1|||
131775437|NCT01463631|474456648|FG000|Overall Study|Death|0|||
131775438|NCT01463631|474456649|FG001|Overall Study|Death|0|||
131775439|NCT01463631|474456650|FG002|Overall Study|Death|1|||
131775440|NCT01463631|474456651|FG003|Overall Study|Death|0|||
131775441|NCT01463631|474456648|FG000|Overall Study|Progressive Disease|0|||
131775442|NCT01463631|474456649|FG001|Overall Study|Progressive Disease|0|||
131775443|NCT01463631|474456650|FG002|Overall Study|Progressive Disease|0|||
131775444|NCT01463631|474456651|FG003|Overall Study|Progressive Disease|5|||
131775445|NCT05966129|474456654|FG000|Overall Study|Death|1|||
131775446|NCT05966129|474456655|FG001|Overall Study|Death|2|||
131775447|NCT05966129|474456654|FG000|Overall Study|Lost to Follow-up|63|||
131775448|NCT05966129|474456655|FG001|Overall Study|Lost to Follow-up|66|||
131775449|NCT05966129|474456654|FG000|Overall Study|Protocol Violation|1|||
131775450|NCT05966129|474456655|FG001|Overall Study|Protocol Violation|0|||
131775451|NCT05966129|474456654|FG000|Overall Study|Withdrawal by Subject|26|||
131775452|NCT05966129|474456655|FG001|Overall Study|Withdrawal by Subject|25|||
131775453|NCT05966129|474456654|FG000|Overall Study|Surgery not completed|63|||
131775454|NCT05966129|474456655|FG001|Overall Study|Surgery not completed|69|||
131775455|NCT05966129|474456654|FG000|Overall Study|Surgery logistics issue|2|||
131775456|NCT05966129|474456655|FG001|Overall Study|Surgery logistics issue|1|||
131775457|NCT05182840|474456656|FG000|Run-in Period|Not treated|0|||
131775458|NCT05182840|474456657|FG001|Run-in Period|Not treated|1|||
131775459|NCT05182840|474456658|FG002|Run-in Period|Not treated|0|||
131775460|NCT05182840|474456659|FG003|Run-in Period|Not treated|0|||
131775461|NCT05182840|474456660|FG004|Run-in Period|Not treated|0|||
131775462|NCT05182840|474456661|FG005|Run-in Period|Not treated|0|||
131775463|NCT05182840|474456662|FG006|Run-in Period|Not treated|0|||
131775464|NCT05182840|474456663|FG007|Run-in Period|Not treated|0|||
131775465|NCT05182840|474456664|FG008|Run-in Period|Not treated|0|||
131775466|NCT05182840|474456665|FG009|Run-in Period|Not treated|0|||
131775467|NCT05182840|474456656|FG000|Run-in Period|Other reason but not sponsor termination|14|||
131775468|NCT05182840|474456657|FG001|Run-in Period|Other reason but not sponsor termination|18|||
131775469|NCT05182840|474456658|FG002|Run-in Period|Other reason but not sponsor termination|0|||
131775470|NCT05182840|474456659|FG003|Run-in Period|Other reason but not sponsor termination|0|||
131775471|NCT05182840|474456660|FG004|Run-in Period|Other reason but not sponsor termination|0|||
131775472|NCT05182840|474456661|FG005|Run-in Period|Other reason but not sponsor termination|0|||
131775473|NCT05182840|474456662|FG006|Run-in Period|Other reason but not sponsor termination|0|||
131775474|NCT05182840|474456663|FG007|Run-in Period|Other reason but not sponsor termination|0|||
131775475|NCT05182840|474456664|FG008|Run-in Period|Other reason but not sponsor termination|0|||
131775476|NCT05182840|474456665|FG009|Run-in Period|Other reason but not sponsor termination|0|||
131775477|NCT05182840|474456656|FG000|Run-in Period|No reason available|2|||
131775478|NCT05182840|474456657|FG001|Run-in Period|No reason available|2|||
131775479|NCT05182840|474456658|FG002|Run-in Period|No reason available|0|||
131775480|NCT05182840|474456659|FG003|Run-in Period|No reason available|0|||
131775481|NCT05182840|474456660|FG004|Run-in Period|No reason available|0|||
131775482|NCT05182840|474456661|FG005|Run-in Period|No reason available|0|||
131775483|NCT05182840|474456662|FG006|Run-in Period|No reason available|0|||
131775484|NCT05182840|474456663|FG007|Run-in Period|No reason available|0|||
131775485|NCT05182840|474456664|FG008|Run-in Period|No reason available|0|||
131775486|NCT05182840|474456665|FG009|Run-in Period|No reason available|0|||
131775487|NCT05182840|474456656|FG000|Run-in Period|Burden of study procedures|2|||
131775488|NCT05182840|474456657|FG001|Run-in Period|Burden of study procedures|2|||
131775489|NCT05182840|474456658|FG002|Run-in Period|Burden of study procedures|0|||
131775490|NCT05182840|474456659|FG003|Run-in Period|Burden of study procedures|0|||
131775491|NCT05182840|474456660|FG004|Run-in Period|Burden of study procedures|0|||
131775492|NCT05182840|474456661|FG005|Run-in Period|Burden of study procedures|0|||
131775493|NCT05182840|474456662|FG006|Run-in Period|Burden of study procedures|0|||
131775494|NCT05182840|474456663|FG007|Run-in Period|Burden of study procedures|0|||
131775495|NCT05182840|474456664|FG008|Run-in Period|Burden of study procedures|0|||
131775496|NCT05182840|474456665|FG009|Run-in Period|Burden of study procedures|0|||
131775497|NCT05182840|474456656|FG000|Run-in Period|Change of residence|1|||
131775498|NCT05182840|474456657|FG001|Run-in Period|Change of residence|0|||
131775499|NCT05182840|474456658|FG002|Run-in Period|Change of residence|0|||
131775500|NCT05182840|474456659|FG003|Run-in Period|Change of residence|0|||
131775501|NCT05182840|474456660|FG004|Run-in Period|Change of residence|0|||
131775502|NCT05182840|474456661|FG005|Run-in Period|Change of residence|0|||
131775503|NCT05182840|474456662|FG006|Run-in Period|Change of residence|0|||
131775504|NCT05182840|474456663|FG007|Run-in Period|Change of residence|0|||
131775505|NCT05182840|474456664|FG008|Run-in Period|Change of residence|0|||
131775506|NCT05182840|474456665|FG009|Run-in Period|Change of residence|0|||
131775507|NCT05182840|474456656|FG000|Run-in Period|Adverse Event|5|||
131775508|NCT05182840|474456657|FG001|Run-in Period|Adverse Event|5|||
131775509|NCT05182840|474456658|FG002|Run-in Period|Adverse Event|0|||
131775510|NCT05182840|474456659|FG003|Run-in Period|Adverse Event|0|||
131775511|NCT05182840|474456660|FG004|Run-in Period|Adverse Event|0|||
131775512|NCT05182840|474456661|FG005|Run-in Period|Adverse Event|0|||
131775513|NCT05182840|474456662|FG006|Run-in Period|Adverse Event|0|||
131775514|NCT05182840|474456663|FG007|Run-in Period|Adverse Event|0|||
131775515|NCT05182840|474456664|FG008|Run-in Period|Adverse Event|0|||
131775516|NCT05182840|474456665|FG009|Run-in Period|Adverse Event|0|||
131775517|NCT05182840|474456656|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
131775518|NCT05182840|474456657|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
131775519|NCT05182840|474456658|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775520|NCT05182840|474456659|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775521|NCT05182840|474456660|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775522|NCT05182840|474456661|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775523|NCT05182840|474456662|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775524|NCT05182840|474456663|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775525|NCT05182840|474456664|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775526|NCT05182840|474456665|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131775527|NCT05182840|474456656|FG000|Treatment Period|Reason missing|0|||
131775528|NCT05182840|474456657|FG001|Treatment Period|Reason missing|0|||
131775529|NCT05182840|474456658|FG002|Treatment Period|Reason missing|1|||
131775530|NCT05182840|474456659|FG003|Treatment Period|Reason missing|0|||
131775531|NCT05182840|474456660|FG004|Treatment Period|Reason missing|0|||
131775532|NCT05182840|474456661|FG005|Treatment Period|Reason missing|0|||
131775533|NCT05182840|474456662|FG006|Treatment Period|Reason missing|0|||
131775534|NCT05182840|474456663|FG007|Treatment Period|Reason missing|0|||
131775535|NCT05182840|474456664|FG008|Treatment Period|Reason missing|0|||
131775536|NCT05182840|474456665|FG009|Treatment Period|Reason missing|0|||
131775537|NCT05182840|474456656|FG000|Treatment Period|Other but not sponsor termination|0|||
131775538|NCT05182840|474456657|FG001|Treatment Period|Other but not sponsor termination|0|||
131775539|NCT05182840|474456658|FG002|Treatment Period|Other but not sponsor termination|8|||
131775540|NCT05182840|474456659|FG003|Treatment Period|Other but not sponsor termination|6|||
131775541|NCT05182840|474456660|FG004|Treatment Period|Other but not sponsor termination|6|||
131775542|NCT05182840|474456661|FG005|Treatment Period|Other but not sponsor termination|7|||
131775543|NCT05182840|474456662|FG006|Treatment Period|Other but not sponsor termination|5|||
131775544|NCT05182840|474456663|FG007|Treatment Period|Other but not sponsor termination|8|||
131775545|NCT05182840|474456664|FG008|Treatment Period|Other but not sponsor termination|7|||
131775546|NCT05182840|474456665|FG009|Treatment Period|Other but not sponsor termination|2|||
131775547|NCT05182840|474456656|FG000|Treatment Period|Protocol deviation|0|||
131775548|NCT05182840|474456657|FG001|Treatment Period|Protocol deviation|0|||
131775549|NCT05182840|474456658|FG002|Treatment Period|Protocol deviation|0|||
131775550|NCT05182840|474456659|FG003|Treatment Period|Protocol deviation|0|||
131775551|NCT05182840|474456660|FG004|Treatment Period|Protocol deviation|0|||
131775552|NCT05182840|474456661|FG005|Treatment Period|Protocol deviation|0|||
131775553|NCT05182840|474456662|FG006|Treatment Period|Protocol deviation|0|||
131775554|NCT05182840|474456663|FG007|Treatment Period|Protocol deviation|0|||
131775555|NCT05182840|474456664|FG008|Treatment Period|Protocol deviation|1|||
131775556|NCT05182840|474456665|FG009|Treatment Period|Protocol deviation|0|||
131775557|NCT05182840|474456656|FG000|Treatment Period|No reason available|0|||
131775558|NCT05182840|474456657|FG001|Treatment Period|No reason available|0|||
131775559|NCT05182840|474456658|FG002|Treatment Period|No reason available|0|||
131775560|NCT05182840|474456659|FG003|Treatment Period|No reason available|1|||
131775561|NCT05182840|474456660|FG004|Treatment Period|No reason available|0|||
131775562|NCT05182840|474456661|FG005|Treatment Period|No reason available|2|||
131775563|NCT05182840|474456662|FG006|Treatment Period|No reason available|0|||
131775564|NCT05182840|474456663|FG007|Treatment Period|No reason available|1|||
131775565|NCT05182840|474456664|FG008|Treatment Period|No reason available|0|||
131775566|NCT05182840|474456665|FG009|Treatment Period|No reason available|0|||
131775567|NCT05182840|474456656|FG000|Treatment Period|Burden of study procedures|0|||
131775568|NCT05182840|474456657|FG001|Treatment Period|Burden of study procedures|0|||
131775569|NCT05182840|474456658|FG002|Treatment Period|Burden of study procedures|0|||
131775570|NCT05182840|474456659|FG003|Treatment Period|Burden of study procedures|0|||
131775571|NCT05182840|474456660|FG004|Treatment Period|Burden of study procedures|1|||
131775572|NCT05182840|474456661|FG005|Treatment Period|Burden of study procedures|0|||
131775573|NCT05182840|474456662|FG006|Treatment Period|Burden of study procedures|0|||
131775574|NCT05182840|474456663|FG007|Treatment Period|Burden of study procedures|0|||
131775575|NCT05182840|474456664|FG008|Treatment Period|Burden of study procedures|0|||
131775576|NCT05182840|474456665|FG009|Treatment Period|Burden of study procedures|0|||
131775577|NCT05182840|474456656|FG000|Treatment Period|Change of residence|0|||
131775578|NCT05182840|474456657|FG001|Treatment Period|Change of residence|0|||
131775579|NCT05182840|474456658|FG002|Treatment Period|Change of residence|0|||
131775580|NCT05182840|474456659|FG003|Treatment Period|Change of residence|0|||
131775581|NCT05182840|474456660|FG004|Treatment Period|Change of residence|0|||
131775582|NCT05182840|474456661|FG005|Treatment Period|Change of residence|1|||
131775583|NCT05182840|474456662|FG006|Treatment Period|Change of residence|0|||
131775584|NCT05182840|474456663|FG007|Treatment Period|Change of residence|0|||
131775585|NCT05182840|474456664|FG008|Treatment Period|Change of residence|0|||
131775586|NCT05182840|474456665|FG009|Treatment Period|Change of residence|0|||
131775587|NCT05182840|474456656|FG000|Treatment Period|Adverse Event|0|||
131775588|NCT05182840|474456657|FG001|Treatment Period|Adverse Event|0|||
131775589|NCT05182840|474456658|FG002|Treatment Period|Adverse Event|4|||
131775590|NCT05182840|474456659|FG003|Treatment Period|Adverse Event|16|||
131775591|NCT05182840|474456660|FG004|Treatment Period|Adverse Event|12|||
131775592|NCT05182840|474456661|FG005|Treatment Period|Adverse Event|6|||
131775593|NCT05182840|474456662|FG006|Treatment Period|Adverse Event|4|||
131775594|NCT05182840|474456663|FG007|Treatment Period|Adverse Event|8|||
131775595|NCT05182840|474456664|FG008|Treatment Period|Adverse Event|16|||
131775596|NCT05182840|474456665|FG009|Treatment Period|Adverse Event|5|||
131775597|NCT05182840|474456656|FG000|Treatment Period|Not treated with study drug|0|||
131436329|NCT02792231|473223986|FG000|Overall Study|Lost to Follow-up|9|||
131436330|NCT02792231|473223987|FG001|Overall Study|Lost to Follow-up|5|||
131436331|NCT02792231|473223986|FG000|Overall Study|Pregnancy|1|||
131436332|NCT02792231|473223987|FG001|Overall Study|Pregnancy|3|||
131436333|NCT02792231|473223986|FG000|Overall Study|Non-compliance with study treatment|2|||
131436334|NCT02792231|473223987|FG001|Overall Study|Non-compliance with study treatment|1|||
131436335|NCT02792231|473223986|FG000|Overall Study|Protocol deviation|2|||
131436336|NCT02792231|473223987|FG001|Overall Study|Protocol deviation|0|||
131436337|NCT02792231|473223986|FG000|Overall Study|Technical problems|0|||
131436338|NCT02792231|473223987|FG001|Overall Study|Technical problems|1|||
131436339|NCT05196828|473223988|FG000|Overall Study|Withdrawal by Subject|2|||
131436340|NCT05196828|473223989|FG001|Overall Study|Withdrawal by Subject|0|||
131436341|NCT05196828|473223988|FG000|Overall Study|Lost to Follow-up|0|||
131436342|NCT05196828|473223989|FG001|Overall Study|Lost to Follow-up|4|||
131436343|NCT05196828|473223988|FG000|Overall Study|Adverse Event|1|||
131436344|NCT05196828|473223989|FG001|Overall Study|Adverse Event|0|||
131436345|NCT03309878|473223990|FG000|Overall Study|Adverse Event|1|||
131436346|NCT03309878|473223991|FG001|Overall Study|Adverse Event|0|||
131436347|NCT03309878|473223992|FG002|Overall Study|Adverse Event|0|||
131436348|NCT03309878|473223993|FG003|Overall Study|Adverse Event|0|||
131436349|NCT03309878|473223990|FG000|Overall Study|Did not maintain eligibility|2|||
131436350|NCT03309878|473223991|FG001|Overall Study|Did not maintain eligibility|1|||
131436351|NCT03309878|473223992|FG002|Overall Study|Did not maintain eligibility|0|||
131436352|NCT03309878|473223993|FG003|Overall Study|Did not maintain eligibility|0|||
131436353|NCT03309878|473223990|FG000|Overall Study|Withdrawal by Subject|0|||
131436354|NCT03309878|473223991|FG001|Overall Study|Withdrawal by Subject|1|||
131436355|NCT03309878|473223992|FG002|Overall Study|Withdrawal by Subject|0|||
131436356|NCT03309878|473223993|FG003|Overall Study|Withdrawal by Subject|0|||
131436357|NCT01096316|473223994|FG000|Overall Study|Lost to Follow-up|15|||
131436358|NCT01096316|473223995|FG001|Overall Study|Lost to Follow-up|9|||
131436359|NCT01884077|473223996|FG000|Overall Study|screen fail|0|||
131436360|NCT01884077|473223997|FG001|Overall Study|screen fail|2|||
131436361|NCT01884077|473223996|FG000|Overall Study|canceled surgery|2|||
131436362|NCT01884077|473223997|FG001|Overall Study|canceled surgery|0|||
131436363|NCT01884077|473223996|FG000|Overall Study|Lost to Follow-up|0|||
131436364|NCT01884077|473223997|FG001|Overall Study|Lost to Follow-up|4|||
131436365|NCT01884077|473223996|FG000|Overall Study|study closed|6|||
131436366|NCT01884077|473223997|FG001|Overall Study|study closed|4|||
131436367|NCT02836652|473223998|FG000|Overall Study|Death|3|||
131436368|NCT02836652|473223999|FG001|Overall Study|Death|3|||
131436369|NCT02836652|473223998|FG000|Overall Study|Transplant/Explant|3|||
131436370|NCT02836652|473223999|FG001|Overall Study|Transplant/Explant|4|||
131436371|NCT02836652|473223998|FG000|Overall Study|Withdrawn|9|||
131436372|NCT02836652|473223999|FG001|Overall Study|Withdrawn|9|||
131436373|NCT02836652|473223998|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
131436374|NCT02836652|473223999|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
131436375|NCT02349633|473224000|FG000|Overall Study|Death|0|||
131436376|NCT02349633|473224001|FG001|Overall Study|Death|1|||
131436377|NCT02349633|473224002|FG002|Overall Study|Death|0|||
131436378|NCT02349633|473224003|FG003|Overall Study|Death|0|||
131436379|NCT02349633|473224004|FG004|Overall Study|Death|0|||
131436380|NCT02349633|473224005|FG005|Overall Study|Death|1|||
131436381|NCT02349633|473224006|FG006|Overall Study|Death|1|||
131436382|NCT02349633|473224007|FG007|Overall Study|Death|1|||
131436383|NCT02349633|473224008|FG008|Overall Study|Death|0|||
131436384|NCT02349633|473224009|FG009|Overall Study|Death|1|||
131436385|NCT02349633|473224010|FG010|Overall Study|Death|0|||
131436386|NCT02349633|473224011|FG011|Overall Study|Death|0|||
131436387|NCT02349633|473224012|FG012|Overall Study|Death|0|||
131436388|NCT02349633|473224013|FG013|Overall Study|Death|0|||
131436389|NCT02349633|473224000|FG000|Overall Study|Withdrawal by Subject|0|||
131436390|NCT02349633|473224001|FG001|Overall Study|Withdrawal by Subject|0|||
131436391|NCT02349633|473224002|FG002|Overall Study|Withdrawal by Subject|0|||
131436392|NCT02349633|473224003|FG003|Overall Study|Withdrawal by Subject|1|||
131436393|NCT02349633|473224004|FG004|Overall Study|Withdrawal by Subject|0|||
131436394|NCT02349633|473224005|FG005|Overall Study|Withdrawal by Subject|0|||
131436395|NCT02349633|473224006|FG006|Overall Study|Withdrawal by Subject|0|||
131436396|NCT02349633|473224007|FG007|Overall Study|Withdrawal by Subject|2|||
131436397|NCT02349633|473224008|FG008|Overall Study|Withdrawal by Subject|2|||
131436398|NCT02349633|473224009|FG009|Overall Study|Withdrawal by Subject|1|||
131436399|NCT02349633|473224010|FG010|Overall Study|Withdrawal by Subject|0|||
131436400|NCT02349633|473224011|FG011|Overall Study|Withdrawal by Subject|0|||
131436401|NCT02349633|473224012|FG012|Overall Study|Withdrawal by Subject|0|||
131436402|NCT02349633|473224013|FG013|Overall Study|Withdrawal by Subject|0|||
131436403|NCT02349633|473224000|FG000|Overall Study|Withdrawal of informed consent|0|||
131436404|NCT02349633|473224001|FG001|Overall Study|Withdrawal of informed consent|0|||
131436405|NCT02349633|473224002|FG002|Overall Study|Withdrawal of informed consent|0|||
131436406|NCT02349633|473224003|FG003|Overall Study|Withdrawal of informed consent|1|||
131436407|NCT02349633|473224004|FG004|Overall Study|Withdrawal of informed consent|1|||
131775598|NCT05182840|474456657|FG001|Treatment Period|Not treated with study drug|0|||
131775599|NCT05182840|474456658|FG002|Treatment Period|Not treated with study drug|0|||
131775600|NCT05182840|474456659|FG003|Treatment Period|Not treated with study drug|1|||
131775601|NCT05182840|474456660|FG004|Treatment Period|Not treated with study drug|0|||
131775602|NCT05182840|474456661|FG005|Treatment Period|Not treated with study drug|0|||
131775603|NCT05182840|474456662|FG006|Treatment Period|Not treated with study drug|1|||
131775604|NCT05182840|474456663|FG007|Treatment Period|Not treated with study drug|1|||
131775605|NCT05182840|474456664|FG008|Treatment Period|Not treated with study drug|0|||
131775606|NCT05182840|474456665|FG009|Treatment Period|Not treated with study drug|0|||
131775607|NCT02161380|474456666|FG000|Overall Study|Lost to Follow-up|0|||
131775608|NCT02161380|474456667|FG001|Overall Study|Lost to Follow-up|1|||
131775609|NCT02161380|474456668|FG002|Overall Study|Lost to Follow-up|0|||
131775610|NCT02161380|474456669|FG003|Overall Study|Lost to Follow-up|0|||
131775611|NCT04768881|474456678|FG000|Overall Study|Completed Study Follow-up|0|||
131775612|NCT04768881|474456679|FG001|Overall Study|Completed Study Follow-up|2|||
131775613|NCT04768881|474456678|FG000|Overall Study|Death|3|||
131775614|NCT04768881|474456679|FG001|Overall Study|Death|2|||
131775615|NCT04768881|474456678|FG000|Overall Study|Study Terminated by Sponsor|2|||
131775616|NCT04768881|474456679|FG001|Overall Study|Study Terminated by Sponsor|2|||
131775617|NCT04768881|474456678|FG000|Overall Study|Withdrawal by Subject|2|||
131775618|NCT04768881|474456679|FG001|Overall Study|Withdrawal by Subject|0|||
131775619|NCT04768881|474456678|FG000|Overall Study|Other|2|||
131775620|NCT04768881|474456679|FG001|Overall Study|Other|0|||
131775621|NCT01958619|474456680|FG000|Overall Study|Protocol Violation|2|||
131775622|NCT01958619|474456681|FG001|Overall Study|Protocol Violation|0|||
131775623|NCT01958619|474456682|FG002|Overall Study|Protocol Violation|1|||
131775624|NCT01958619|474456683|FG003|Overall Study|Protocol Violation|0|||
131775625|NCT00509223|474458330|FG000|Overall Study|Lost to Follow-up|1|||
131775626|NCT00509223|474458331|FG001|Overall Study|Lost to Follow-up|1|||
131775627|NCT00509223|474458330|FG000|Overall Study|Adverse Event|1|||
131775628|NCT00509223|474458331|FG001|Overall Study|Adverse Event|1|||
131775629|NCT00509223|474458330|FG000|Overall Study|Withdrawal by Subject|25|||
131775630|NCT00509223|474458331|FG001|Overall Study|Withdrawal by Subject|6|||
131775631|NCT00509223|474458330|FG000|Overall Study|Including: subject change of address|5|||
131775632|NCT00509223|474458331|FG001|Overall Study|Including: subject change of address|2|||
131775633|NCT00509223|474458330|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
131775634|NCT00509223|474458331|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
131775635|NCT00437294|474458335|FG000|Overall Study|Adverse Event|5|||
131775636|NCT00437294|474458336|FG001|Overall Study|Adverse Event|4|||
131775637|NCT00437294|474458335|FG000|Overall Study|Death|5|||
131775638|NCT00437294|474458336|FG001|Overall Study|Death|2|||
131775639|NCT00437294|474458335|FG000|Overall Study|Physician Decision|0|||
131775640|NCT00437294|474458336|FG001|Overall Study|Physician Decision|3|||
131775641|NCT00437294|474458335|FG000|Overall Study|Withdrawal by Subject|5|||
131775642|NCT00437294|474458336|FG001|Overall Study|Withdrawal by Subject|0|||
131775643|NCT00437294|474458335|FG000|Overall Study|Progressive Disease|19|||
131775644|NCT00437294|474458336|FG001|Overall Study|Progressive Disease|23|||
131775645|NCT00437294|474458335|FG000|Overall Study|Sponsor Decision|8|||
131775646|NCT00437294|474458336|FG001|Overall Study|Sponsor Decision|9|||
131775647|NCT00437294|474458335|FG000|Overall Study|Protocol Violation|0|||
131775648|NCT00437294|474458336|FG001|Overall Study|Protocol Violation|1|||
131775649|NCT00437294|474458335|FG000|Overall Study|Entry criteria not met|1|||
131775650|NCT00437294|474458336|FG001|Overall Study|Entry criteria not met|1|||
131775651|NCT01300741|474458343|FG000|Overall Study|Lens deposits|1|||
131775652|NCT01300741|474458343|FG000|Overall Study|Lost to Follow-up|1|||
131775653|NCT01300741|474458343|FG000|Overall Study|Discomfort|1|||
131775654|NCT01473602|474458344|FG000|Overall Study|Adverse Event|1|||
131775655|NCT01473602|474458345|FG001|Overall Study|Adverse Event|2|||
131775656|NCT01473602|474458344|FG000|Overall Study|Death|0|||
131775657|NCT01473602|474458345|FG001|Overall Study|Death|1|||
131775658|NCT01473602|474458344|FG000|Overall Study|Lost to Follow-up|1|||
131775659|NCT01473602|474458345|FG001|Overall Study|Lost to Follow-up|1|||
131775660|NCT01473602|474458344|FG000|Overall Study|Withdrawal by Subject|5|||
131775661|NCT01473602|474458345|FG001|Overall Study|Withdrawal by Subject|4|||
131775662|NCT01473602|474458344|FG000|Overall Study|Physician Decision|1|||
131775663|NCT01473602|474458345|FG001|Overall Study|Physician Decision|0|||
131775664|NCT00726882|474458347|FG000|Overall Study|Withdrawal by Subject|5|||
131775665|NCT00726882|474458347|FG000|Overall Study|Lost to Follow-up|7|||
131436408|NCT02349633|473224005|FG005|Overall Study|Withdrawal of informed consent|0|||
131436409|NCT02349633|473224006|FG006|Overall Study|Withdrawal of informed consent|0|||
131436410|NCT02349633|473224007|FG007|Overall Study|Withdrawal of informed consent|3|||
131436411|NCT02349633|473224008|FG008|Overall Study|Withdrawal of informed consent|0|||
131436412|NCT02349633|473224009|FG009|Overall Study|Withdrawal of informed consent|0|||
131436413|NCT02349633|473224010|FG010|Overall Study|Withdrawal of informed consent|0|||
131436414|NCT02349633|473224011|FG011|Overall Study|Withdrawal of informed consent|0|||
131436415|NCT02349633|473224012|FG012|Overall Study|Withdrawal of informed consent|0|||
131436416|NCT02349633|473224013|FG013|Overall Study|Withdrawal of informed consent|0|||
131436417|NCT02349633|473224000|FG000|Overall Study|Transition to compassionate use|0|||
131436418|NCT02349633|473224001|FG001|Overall Study|Transition to compassionate use|0|||
131436419|NCT02349633|473224002|FG002|Overall Study|Transition to compassionate use|0|||
131436420|NCT02349633|473224003|FG003|Overall Study|Transition to compassionate use|0|||
131436421|NCT02349633|473224004|FG004|Overall Study|Transition to compassionate use|1|||
131436422|NCT02349633|473224005|FG005|Overall Study|Transition to compassionate use|0|||
131436423|NCT02349633|473224006|FG006|Overall Study|Transition to compassionate use|0|||
131436424|NCT02349633|473224007|FG007|Overall Study|Transition to compassionate use|3|||
131436425|NCT02349633|473224008|FG008|Overall Study|Transition to compassionate use|0|||
131436426|NCT02349633|473224009|FG009|Overall Study|Transition to compassionate use|1|||
131436427|NCT02349633|473224010|FG010|Overall Study|Transition to compassionate use|0|||
131436428|NCT02349633|473224011|FG011|Overall Study|Transition to compassionate use|0|||
131436429|NCT02349633|473224012|FG012|Overall Study|Transition to compassionate use|0|||
131436430|NCT02349633|473224013|FG013|Overall Study|Transition to compassionate use|0|||
131436431|NCT02349633|473224000|FG000|Overall Study|Early termination of survival follow-up|0|||
131436432|NCT02349633|473224001|FG001|Overall Study|Early termination of survival follow-up|0|||
131436433|NCT02349633|473224002|FG002|Overall Study|Early termination of survival follow-up|0|||
131436434|NCT02349633|473224003|FG003|Overall Study|Early termination of survival follow-up|0|||
131689201|NCT00880399|474148230|FG002|Overall Study|Protocol Violation|6|||
131689202|NCT00880399|474148228|FG000|Overall Study|Study closed/terminated|3|||
131689203|NCT00880399|474148229|FG001|Overall Study|Study closed/terminated|7|||
131436435|NCT02349633|473224004|FG004|Overall Study|Early termination of survival follow-up|0|||
131436436|NCT02349633|473224005|FG005|Overall Study|Early termination of survival follow-up|0|||
131436437|NCT02349633|473224006|FG006|Overall Study|Early termination of survival follow-up|0|||
131436438|NCT02349633|473224007|FG007|Overall Study|Early termination of survival follow-up|4|||
131436439|NCT02349633|473224008|FG008|Overall Study|Early termination of survival follow-up|0|||
131436440|NCT02349633|473224009|FG009|Overall Study|Early termination of survival follow-up|0|||
131436441|NCT02349633|473224010|FG010|Overall Study|Early termination of survival follow-up|0|||
131436442|NCT02349633|473224011|FG011|Overall Study|Early termination of survival follow-up|0|||
131436443|NCT02349633|473224012|FG012|Overall Study|Early termination of survival follow-up|0|||
131436444|NCT02349633|473224013|FG013|Overall Study|Early termination of survival follow-up|0|||
131436445|NCT02349633|473224000|FG000|Overall Study|Termination by sponsor|0|||
131436446|NCT02349633|473224001|FG001|Overall Study|Termination by sponsor|0|||
131436447|NCT02349633|473224002|FG002|Overall Study|Termination by sponsor|0|||
131436448|NCT02349633|473224003|FG003|Overall Study|Termination by sponsor|0|||
131436449|NCT02349633|473224004|FG004|Overall Study|Termination by sponsor|0|||
131436450|NCT02349633|473224005|FG005|Overall Study|Termination by sponsor|0|||
131436451|NCT02349633|473224006|FG006|Overall Study|Termination by sponsor|0|||
131436452|NCT02349633|473224007|FG007|Overall Study|Termination by sponsor|1|||
131436453|NCT02349633|473224008|FG008|Overall Study|Termination by sponsor|0|||
131436454|NCT02349633|473224009|FG009|Overall Study|Termination by sponsor|2|||
131436455|NCT02349633|473224010|FG010|Overall Study|Termination by sponsor|0|||
131436456|NCT02349633|473224011|FG011|Overall Study|Termination by sponsor|0|||
131557159|NCT00152971|473664438|FG002|Overall Study|Lost to Follow-up|13|||
131436457|NCT02349633|473224012|FG012|Overall Study|Termination by sponsor|0|||
131436458|NCT02349633|473224013|FG013|Overall Study|Termination by sponsor|0|||
131436459|NCT02349633|473224000|FG000|Overall Study|Other|0|||
131436460|NCT02349633|473224001|FG001|Overall Study|Other|0|||
131436461|NCT02349633|473224002|FG002|Overall Study|Other|0|||
131436462|NCT02349633|473224003|FG003|Overall Study|Other|0|||
131775666|NCT00726882|474458347|FG000|Overall Study|Other|10|||
131775667|NCT01339273|474458348|FG000|Overall Study|Lost to Follow-up|8|||
131775668|NCT01339273|474458349|FG001|Overall Study|Lost to Follow-up|8|||
131775669|NCT02526017|474458350|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775670|NCT02526017|474458351|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775671|NCT02526017|474458352|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775672|NCT02526017|474458353|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775673|NCT02526017|474458354|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
131775674|NCT02526017|474458355|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775675|NCT02526017|474458356|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775676|NCT02526017|474458357|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775677|NCT02526017|474458358|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131775678|NCT00968539|474458362|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
131775679|NCT00968539|474458363|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131775680|NCT00326118|474458364|FG000|Active Phase|Withdrawal by Subject|4|||
131775681|NCT00326118|474458365|FG001|Active Phase|Withdrawal by Subject|1|||
131775682|NCT00938392|474458366|FG000|Overall Study|Adverse Event|0|||
131775683|NCT00938392|474458367|FG001|Overall Study|Adverse Event|1|||
131775684|NCT00938392|474458366|FG000|Overall Study|Withdrawal by Subject|0|||
131775685|NCT00938392|474458367|FG001|Overall Study|Withdrawal by Subject|1|||
131775686|NCT00938392|474458366|FG000|Overall Study|Lost to Follow-up|2|||
131775687|NCT00938392|474458367|FG001|Overall Study|Lost to Follow-up|2|||
131775688|NCT00290511|474458368|FG000|Overall Study|Adverse Event|1|||
131775689|NCT00290511|474458368|FG000|Overall Study|Death|1|||
131775690|NCT00290511|474458368|FG000|Overall Study|Physician Decision|1|||
131775691|NCT00290511|474458368|FG000|Overall Study|Withdrawal by Subject|1|||
131775692|NCT01491737|474458371|FG000|Overall Study|Withdrawal by Subject|20|||
131775693|NCT01491737|474458372|FG001|Overall Study|Withdrawal by Subject|17|||
131775694|NCT01491737|474458371|FG000|Overall Study|Lost to Follow-up|2|||
131775695|NCT01491737|474458372|FG001|Overall Study|Lost to Follow-up|10|||
131775696|NCT01491737|474458371|FG000|Overall Study|Death|63|||
131775697|NCT01491737|474458372|FG001|Overall Study|Death|57|||
131775698|NCT01491737|474458371|FG000|Overall Study|Study Termination by Sponsor|36|||
131775699|NCT01491737|474458372|FG001|Overall Study|Study Termination by Sponsor|36|||
131775700|NCT01491737|474458371|FG000|Overall Study|Reason Not Specified|8|||
131775701|NCT01491737|474458372|FG001|Overall Study|Reason Not Specified|9|||
131775702|NCT01976663|474458373|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
131775703|NCT01976663|474458373|FG000|Overall Study|Personal Reasons|6|||
131775704|NCT01976663|474458373|FG000|Overall Study|Withdrawal by Subject|4|||
131775705|NCT01976663|474458373|FG000|Overall Study|Screen Failure|3|||
131775706|NCT01976663|474458373|FG000|Overall Study|Adverse Event|2|||
131775707|NCT01976663|474458373|FG000|Overall Study|Lost to Follow-up|3|||
131775708|NCT01817764|474458374|FG000|Overall Study|Adverse Event|7|||
131775709|NCT01817764|474458375|FG001|Overall Study|Adverse Event|10|||
131775710|NCT01817764|474458374|FG000|Overall Study|Lack of Efficacy|9|||
131775711|NCT01817764|474458375|FG001|Overall Study|Lack of Efficacy|7|||
131775712|NCT01817764|474458374|FG000|Overall Study|Protocol Violation|7|||
131775713|NCT01817764|474458375|FG001|Overall Study|Protocol Violation|5|||
131775714|NCT01817764|474458374|FG000|Overall Study|Lost to Follow-up|1|||
131775715|NCT01817764|474458375|FG001|Overall Study|Lost to Follow-up|4|||
131775716|NCT01817764|474458374|FG000|Overall Study|Withdrawal by Subject|10|||
131775717|NCT01817764|474458375|FG001|Overall Study|Withdrawal by Subject|12|||
131775718|NCT03526549|474458376|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
131775719|NCT03526549|474458377|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
131775720|NCT03526549|474458376|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
131775721|NCT03526549|474458377|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
131775722|NCT03526549|474458376|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
131775723|NCT03526549|474458377|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
131775724|NCT03526549|474458376|FG000|Open-label Phase|Adverse Event|4|||
131775725|NCT03526549|474458377|FG001|Open-label Phase|Adverse Event|0|||
131775726|NCT03526549|474458376|FG000|Open-label Phase|Withdrawal by Subject|54|||
131775727|NCT03526549|474458377|FG001|Open-label Phase|Withdrawal by Subject|0|||
131775728|NCT03526549|474458376|FG000|Open-label Phase|Lost to Follow-up|35|||
131775729|NCT03526549|474458377|FG001|Open-label Phase|Lost to Follow-up|0|||
131775730|NCT03526549|474458376|FG000|Open-label Phase|Other than Specified|5|||
131775731|NCT03526549|474458377|FG001|Open-label Phase|Other than Specified|0|||
131775732|NCT05981365|474458378|FG000|Period 1|Adverse Event|1|||
131775733|NCT05981365|474458379|FG001|Period 1|Adverse Event|0|||
131775734|NCT03927989|474458380|FG000|Overall Study|Withdrawal by Subject|0|||
131775735|NCT03927989|474458381|FG001|Overall Study|Withdrawal by Subject|1|||
131775736|NCT00071006|474458384|FG000|Overall Study|Lack of Efficacy|7|||
131775737|NCT00071006|474458384|FG000|Overall Study|Adverse Event|1|||
131775738|NCT00071006|474458384|FG000|Overall Study|Withdrawal by Subject|1|||
131775739|NCT00071006|474458384|FG000|Overall Study|Other|3|||
131775740|NCT03901274|474458385|FG000|Overall Study|Lost to Follow-up|120|||
131775741|NCT03901274|474458386|FG001|Overall Study|Lost to Follow-up|124|||
131775742|NCT03901274|474458385|FG000|Overall Study|Withdrawal by Subject|0|||
131775743|NCT03901274|474458386|FG001|Overall Study|Withdrawal by Subject|6|||
131775744|NCT00145119|474458389|FG000|Overall Study|Death|45|||
131775745|NCT05048875|474458390|FG000|Overall Study|Withdrawal by Subject|1|||
131775746|NCT05048875|474458391|FG001|Overall Study|Withdrawal by Subject|0|||
131775747|NCT05048875|474458392|FG002|Overall Study|Withdrawal by Subject|0|||
131775748|NCT05048875|474458393|FG003|Overall Study|Withdrawal by Subject|0|||
131775749|NCT05048875|474458394|FG004|Overall Study|Withdrawal by Subject|0|||
131775750|NCT05048875|474458395|FG005|Overall Study|Withdrawal by Subject|0|||
131775751|NCT05048875|474458396|FG006|Overall Study|Withdrawal by Subject|0|||
131775752|NCT05048875|474458397|FG007|Overall Study|Withdrawal by Subject|0|||
131775753|NCT05048875|474458390|FG000|Overall Study|Adverse Event|0|||
131775754|NCT05048875|474458391|FG001|Overall Study|Adverse Event|0|||
131775755|NCT05048875|474458392|FG002|Overall Study|Adverse Event|0|||
131775756|NCT05048875|474458393|FG003|Overall Study|Adverse Event|1|||
131775757|NCT05048875|474458394|FG004|Overall Study|Adverse Event|0|||
131436463|NCT02349633|473224004|FG004|Overall Study|Other|0|||
131436464|NCT02349633|473224005|FG005|Overall Study|Other|0|||
131436465|NCT02349633|473224006|FG006|Overall Study|Other|0|||
131436466|NCT02349633|473224007|FG007|Overall Study|Other|2|||
131436467|NCT02349633|473224008|FG008|Overall Study|Other|0|||
131436468|NCT02349633|473224009|FG009|Overall Study|Other|0|||
131436469|NCT02349633|473224010|FG010|Overall Study|Other|0|||
131436470|NCT02349633|473224011|FG011|Overall Study|Other|0|||
131436471|NCT02349633|473224012|FG012|Overall Study|Other|0|||
131436472|NCT02349633|473224013|FG013|Overall Study|Other|0|||
131436473|NCT01220167|473224017|FG000|Period 3|Urine positive for substance abuse|0|||
131436474|NCT01220167|473224018|FG001|Period 3|Urine positive for substance abuse|1|||
131436475|NCT01220167|473224019|FG002|Period 3|Urine positive for substance abuse|0|||
131436476|NCT01008943|473224020|FG000|Overall Study|Withdrawal by Subject|1|||
131436477|NCT05789745|473224021|FG000|Overall Study|Withdrawal by Subject|0|||
131436478|NCT05789745|473224022|FG001|Overall Study|Withdrawal by Subject|0|||
131436479|NCT05789745|473224023|FG002|Overall Study|Withdrawal by Subject|0|||
131436480|NCT05789745|473224024|FG003|Overall Study|Withdrawal by Subject|0|||
131436481|NCT05789745|473224025|FG004|Overall Study|Withdrawal by Subject|1|||
131436482|NCT04244253|473224026|FG000|Overall Study|Adverse Event|2|||
131436483|NCT04244253|473224027|FG001|Overall Study|Adverse Event|2|||
131436484|NCT04244253|473224028|FG002|Overall Study|Adverse Event|4|||
131436485|NCT04244253|473224026|FG000|Overall Study|Protocol Violation|1|||
131436486|NCT04244253|473224027|FG001|Overall Study|Protocol Violation|2|||
131436487|NCT04244253|473224028|FG002|Overall Study|Protocol Violation|1|||
131436488|NCT04244253|473224026|FG000|Overall Study|Withdrawal by Subject|0|||
131436489|NCT04244253|473224027|FG001|Overall Study|Withdrawal by Subject|1|||
131436490|NCT04244253|473224028|FG002|Overall Study|Withdrawal by Subject|6|||
131436491|NCT04244253|473224026|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131436492|NCT04244253|473224027|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131436493|NCT04244253|473224028|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131436494|NCT04663321|473224029|FG000|Overall Study|Study terminated by Sponsor|2|||
131436495|NCT04663321|473224030|FG001|Overall Study|Study terminated by Sponsor|1|||
131436496|NCT04663321|473224031|FG002|Overall Study|Study terminated by Sponsor|2|||
131436497|NCT04663321|473224029|FG000|Overall Study|Withdrawal by Subject|10|||
131689204|NCT00880399|474148230|FG002|Overall Study|Study closed/terminated|4|||
131689205|NCT00880399|474148228|FG000|Overall Study|Lost to Follow-up|8|||
131689206|NCT00880399|474148229|FG001|Overall Study|Lost to Follow-up|5|||
131689207|NCT00880399|474148230|FG002|Overall Study|Lost to Follow-up|3|||
131689208|NCT00880399|474148228|FG000|Overall Study|Physician Decision|5|||
131689209|NCT00880399|474148229|FG001|Overall Study|Physician Decision|0|||
131689210|NCT00880399|474148230|FG002|Overall Study|Physician Decision|3|||
131689211|NCT00880399|474148228|FG000|Overall Study|Withdrawal by Subject|6|||
131689212|NCT00880399|474148229|FG001|Overall Study|Withdrawal by Subject|3|||
131689213|NCT00880399|474148230|FG002|Overall Study|Withdrawal by Subject|3|||
131689214|NCT04353284|474148235|FG000|Overall Study|Adverse Event|1|||
131689215|NCT04353284|474148236|FG001|Overall Study|Adverse Event|1|||
131689216|NCT04353284|474148235|FG000|Overall Study|Lost to Follow-up|1|||
131775758|NCT05048875|474458395|FG005|Overall Study|Adverse Event|0|||
131689217|NCT04353284|474148236|FG001|Overall Study|Lost to Follow-up|0|||
131689218|NCT02819635|474148249|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
131689219|NCT02819635|474148250|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
131689220|NCT02819635|474148251|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
131689221|NCT02819635|474148252|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
131436498|NCT04663321|473224030|FG001|Overall Study|Withdrawal by Subject|3|||
131436499|NCT04663321|473224031|FG002|Overall Study|Withdrawal by Subject|2|||
131775759|NCT05048875|474458396|FG006|Overall Study|Adverse Event|0|||
131775760|NCT05048875|474458397|FG007|Overall Study|Adverse Event|0|||
131775761|NCT04411641|474458398|FG000|DB Period|Other|7|||
131775762|NCT04411641|474458399|FG001|DB Period|Other|27|||
131775763|NCT04411641|474458400|FG002|DB Period|Other|0|||
131775764|NCT04411641|474458401|FG003|DB Period|Other|0|||
131775765|NCT04411641|474458398|FG000|DB Period|Withdrawal by Subject|67|||
131775766|NCT04411641|474458399|FG001|DB Period|Withdrawal by Subject|122|||
131775767|NCT04411641|474458400|FG002|DB Period|Withdrawal by Subject|0|||
131775768|NCT04411641|474458401|FG003|DB Period|Withdrawal by Subject|0|||
131775769|NCT04411641|474458398|FG000|DB Period|Progressive disease|76|||
131775770|NCT04411641|474458399|FG001|DB Period|Progressive disease|116|||
131775771|NCT04411641|474458400|FG002|DB Period|Progressive disease|0|||
131775772|NCT04411641|474458401|FG003|DB Period|Progressive disease|0|||
131775773|NCT04411641|474458398|FG000|DB Period|Poor compliance to protocol|1|||
131775774|NCT04411641|474458399|FG001|DB Period|Poor compliance to protocol|5|||
131775775|NCT04411641|474458400|FG002|DB Period|Poor compliance to protocol|0|||
131775776|NCT04411641|474458401|FG003|DB Period|Poor compliance to protocol|0|||
131775777|NCT04411641|474458398|FG000|DB Period|Lack of Efficacy|19|||
131775778|NCT04411641|474458399|FG001|DB Period|Lack of Efficacy|19|||
131775779|NCT04411641|474458400|FG002|DB Period|Lack of Efficacy|0|||
131775780|NCT04411641|474458401|FG003|DB Period|Lack of Efficacy|0|||
131775781|NCT04411641|474458398|FG000|DB Period|Adverse Event|13|||
131775782|NCT04411641|474458399|FG001|DB Period|Adverse Event|29|||
131775783|NCT04411641|474458400|FG002|DB Period|Adverse Event|0|||
131775784|NCT04411641|474458401|FG003|DB Period|Adverse Event|0|||
131775785|NCT04411641|474458398|FG000|DB Period|Randomized and not treated|2|||
131775786|NCT04411641|474458399|FG001|DB Period|Randomized and not treated|2|||
131775787|NCT04411641|474458400|FG002|DB Period|Randomized and not treated|0|||
131775788|NCT04411641|474458401|FG003|DB Period|Randomized and not treated|0|||
131775789|NCT04411641|474458398|FG000|OL|Withdrawal by Subject|0|||
131775790|NCT04411641|474458399|FG001|OL|Withdrawal by Subject|0|||
131775791|NCT04411641|474458400|FG002|OL|Withdrawal by Subject|6|||
131689222|NCT02819635|474148253|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
131689223|NCT02819635|474148254|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
131689224|NCT02819635|474148255|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
131689225|NCT02819635|474148256|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131689226|NCT02819635|474148257|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131689227|NCT02819635|474148258|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131689228|NCT02819635|474148259|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131689229|NCT02819635|474148260|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131689230|NCT02819635|474148249|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689231|NCT02819635|474148250|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689232|NCT02819635|474148251|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689233|NCT02819635|474148252|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689234|NCT02819635|474148253|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
131689235|NCT02819635|474148254|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
131436500|NCT04663321|473224029|FG000|Overall Study|Not provided|0|||
131436501|NCT04663321|473224030|FG001|Overall Study|Not provided|0|||
131436502|NCT04663321|473224031|FG002|Overall Study|Not provided|1|||
131436503|NCT01453140|473224034|FG000|Overall Study|Adverse Event|3|||
131436504|NCT02611479|473224035|FG000|Baseline Enrollment|Exited study|13|||
131436505|NCT02611479|473224035|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
131436506|NCT02611479|473224035|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
131436507|NCT02611479|473224035|FG000|Data Cleaning|No baseline function or pain metrics|2|||
131436508|NCT00423657|473224039|FG000|Overall Study|Withdrew consent|10|||
131436509|NCT00423657|473224040|FG001|Overall Study|Withdrew consent|8|||
131436510|NCT00423657|473224039|FG000|Overall Study|Non-compliance|0|||
131436511|NCT00423657|473224040|FG001|Overall Study|Non-compliance|1|||
131436512|NCT00423657|473224039|FG000|Overall Study|Other|15|||
131436513|NCT00423657|473224040|FG001|Overall Study|Other|16|||
131436514|NCT00423657|473224039|FG000|Overall Study|Request of sponsor/investigator|1|||
131436515|NCT00423657|473224040|FG001|Overall Study|Request of sponsor/investigator|0|||
131436516|NCT02748863|473224041|FG000|Treatment Period 1|Adverse Event|0|||
131436517|NCT02748863|473224042|FG001|Treatment Period 1|Adverse Event|1|||
131436518|NCT02748863|473224043|FG002|Treatment Period 1|Adverse Event|0|||
131436519|NCT02748863|473224044|FG003|Treatment Period 1|Adverse Event|0|||
131436520|NCT02748863|473224045|FG004|Treatment Period 1|Adverse Event|0|||
131436521|NCT02748863|473224041|FG000|Treatment Period 1|Lack of Efficacy|0|||
131436522|NCT02748863|473224042|FG001|Treatment Period 1|Lack of Efficacy|0|||
131436523|NCT02748863|473224043|FG002|Treatment Period 1|Lack of Efficacy|1|||
131436524|NCT02748863|473224044|FG003|Treatment Period 1|Lack of Efficacy|0|||
131436525|NCT02748863|473224045|FG004|Treatment Period 1|Lack of Efficacy|0|||
131436526|NCT02748863|473224041|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131436527|NCT02748863|473224042|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131436528|NCT02748863|473224043|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131436529|NCT02748863|473224044|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131436530|NCT02748863|473224045|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131436531|NCT02748863|473224041|FG000|Treatment Period 2|Lost to Follow-up|2|||
131436532|NCT02748863|473224042|FG001|Treatment Period 2|Lost to Follow-up|0|||
131436533|NCT02748863|473224043|FG002|Treatment Period 2|Lost to Follow-up|0|||
131436534|NCT02748863|473224044|FG003|Treatment Period 2|Lost to Follow-up|0|||
131436535|NCT02748863|473224045|FG004|Treatment Period 2|Lost to Follow-up|0|||
131436536|NCT02748863|473224041|FG000|Treatment Period 2|Adverse Event|3|||
131436537|NCT02748863|473224042|FG001|Treatment Period 2|Adverse Event|2|||
131436538|NCT02748863|473224043|FG002|Treatment Period 2|Adverse Event|0|||
131436539|NCT02748863|473224044|FG003|Treatment Period 2|Adverse Event|2|||
131775792|NCT04411641|474458401|FG003|OL|Withdrawal by Subject|17|||
131775793|NCT04411641|474458398|FG000|OL|Progressive disease|0|||
131775794|NCT04411641|474458399|FG001|OL|Progressive disease|0|||
131775795|NCT04411641|474458400|FG002|OL|Progressive disease|1|||
131775796|NCT04411641|474458401|FG003|OL|Progressive disease|2|||
131775797|NCT04411641|474458398|FG000|OL|Poor compliance to protocol|0|||
131775798|NCT04411641|474458399|FG001|OL|Poor compliance to protocol|0|||
131775799|NCT04411641|474458400|FG002|OL|Poor compliance to protocol|1|||
131775800|NCT04411641|474458401|FG003|OL|Poor compliance to protocol|0|||
131775801|NCT04411641|474458398|FG000|OL|Adverse Event|0|||
131775802|NCT04411641|474458399|FG001|OL|Adverse Event|0|||
131775803|NCT04411641|474458400|FG002|OL|Adverse Event|1|||
131775804|NCT04411641|474458401|FG003|OL|Adverse Event|0|||
131775805|NCT04411641|474458398|FG000|OL|Other|0|||
131775806|NCT04411641|474458399|FG001|OL|Other|0|||
131775807|NCT04411641|474458400|FG002|OL|Other|0|||
131775808|NCT04411641|474458401|FG003|OL|Other|6|||
131775809|NCT00938366|474458402|FG000|Overall Study|Withdrawal by Subject|1|||
131775810|NCT00938366|474458403|FG001|Overall Study|Withdrawal by Subject|0|||
131775811|NCT01250418|474458409|FG000|Overall Study|monitor data failure|1|||
131775812|NCT01250418|474458410|FG001|Overall Study|monitor data failure|1|||
131775813|NCT01761565|474458411|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
131775814|NCT05643573|474458413|FG000|Overall Study|Adverse Event|117|||
131775815|NCT05643573|474458414|FG001|Overall Study|Adverse Event|90|||
131775816|NCT05643573|474458413|FG000|Overall Study|Death|53|||
131775817|NCT05643573|474458414|FG001|Overall Study|Death|57|||
131775818|NCT05643573|474458413|FG000|Overall Study|Lost to Follow-up|6|||
131775819|NCT05643573|474458414|FG001|Overall Study|Lost to Follow-up|3|||
131775820|NCT05643573|474458413|FG000|Overall Study|Other|18|||
131775821|NCT05643573|474458414|FG001|Overall Study|Other|15|||
131775822|NCT05643573|474458413|FG000|Overall Study|Outcome event|64|||
131775823|NCT05643573|474458414|FG001|Overall Study|Outcome event|36|||
131775824|NCT05643573|474458413|FG000|Overall Study|Physician Decision|33|||
131775825|NCT05643573|474458414|FG001|Overall Study|Physician Decision|19|||
131775826|NCT05643573|474458413|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
131775827|NCT05643573|474458414|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
131775828|NCT05643573|474458413|FG000|Overall Study|Site terminated by sponsor|10|||
131775829|NCT05643573|474458414|FG001|Overall Study|Site terminated by sponsor|10|||
131775830|NCT05643573|474458413|FG000|Overall Study|Study terminated by sponsor|1|||
131775831|NCT05643573|474458414|FG001|Overall Study|Study terminated by sponsor|0|||
131775832|NCT05643573|474458413|FG000|Overall Study|Withdrawal by Subject|178|||
131775833|NCT05643573|474458414|FG001|Overall Study|Withdrawal by Subject|130|||
131775834|NCT00948896|474458419|FG000|Randomization to 24 Months of Age|Death|1|||
131775835|NCT00948896|474458420|FG001|Randomization to 24 Months of Age|Death|0|||
131775836|NCT00948896|474458421|FG002|Randomization to 24 Months of Age|Death|0|||
131775837|NCT00948896|474458422|FG003|Randomization to 24 Months of Age|Death|0|||
131775838|NCT00948896|474458423|FG004|Randomization to 24 Months of Age|Death|2|||
131775839|NCT00948896|474458424|FG005|Randomization to 24 Months of Age|Death|1|||
131775840|NCT00948896|474458425|FG006|Randomization to 24 Months of Age|Death|2|||
131775841|NCT00948896|474458426|FG007|Randomization to 24 Months of Age|Death|1|||
131775842|NCT00948896|474458419|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
131775843|NCT00948896|474458420|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
131775844|NCT00948896|474458421|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
131775845|NCT00948896|474458422|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
131775846|NCT00948896|474458423|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
131775847|NCT00948896|474458424|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
131775848|NCT00948896|474458425|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
131775849|NCT00948896|474458426|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
131775850|NCT00948896|474458419|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
131775851|NCT00948896|474458420|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
131775852|NCT00948896|474458421|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
131775853|NCT00948896|474458422|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
131775854|NCT00948896|474458423|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
131775855|NCT00948896|474458424|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
131775856|NCT00948896|474458425|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
131775857|NCT00948896|474458426|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
131689236|NCT02819635|474148255|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
131689237|NCT02819635|474148256|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689238|NCT02819635|474148257|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689239|NCT02819635|474148258|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689240|NCT02819635|474148259|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689241|NCT02819635|474148260|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131689242|NCT02819635|474148249|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689243|NCT02819635|474148250|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689244|NCT02819635|474148251|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689245|NCT02819635|474148252|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689246|NCT02819635|474148253|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689247|NCT02819635|474148254|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
131689248|NCT02819635|474148255|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
131689249|NCT02819635|474148256|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689250|NCT02819635|474148257|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689251|NCT02819635|474148258|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689252|NCT02819635|474148259|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131689253|NCT02819635|474148260|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131775858|NCT00948896|474458419|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
131775859|NCT00948896|474458420|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
131775860|NCT00948896|474458421|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
131775861|NCT00948896|474458422|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
131775862|NCT00948896|474458423|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
131775863|NCT00948896|474458424|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
131775864|NCT00948896|474458425|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
131775865|NCT00948896|474458426|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
131775866|NCT00948896|474458419|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131775867|NCT00948896|474458420|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
131775868|NCT00948896|474458421|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
131775869|NCT00948896|474458422|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
131775870|NCT00948896|474458423|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131775871|NCT00948896|474458424|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
131775872|NCT00948896|474458425|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131775873|NCT00948896|474458426|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131775874|NCT00948896|474458419|FG000|24 Months of Age to 36 Months of Age|Death|0|||
131775875|NCT00948896|474458420|FG001|24 Months of Age to 36 Months of Age|Death|2|||
131775876|NCT00948896|474458421|FG002|24 Months of Age to 36 Months of Age|Death|2|||
131775877|NCT00948896|474458422|FG003|24 Months of Age to 36 Months of Age|Death|0|||
131775878|NCT00948896|474458423|FG004|24 Months of Age to 36 Months of Age|Death|0|||
131775879|NCT00948896|474458424|FG005|24 Months of Age to 36 Months of Age|Death|1|||
131775880|NCT00948896|474458425|FG006|24 Months of Age to 36 Months of Age|Death|0|||
131775881|NCT00948896|474458426|FG007|24 Months of Age to 36 Months of Age|Death|0|||
131775882|NCT00948896|474458419|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
131775883|NCT00948896|474458420|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131775884|NCT00948896|474458421|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
131775885|NCT00948896|474458422|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
131775886|NCT00948896|474458423|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131775887|NCT00948896|474458424|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131775888|NCT00948896|474458425|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131775889|NCT00948896|474458426|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131775890|NCT00948896|474458419|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
131775891|NCT00948896|474458420|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131775892|NCT00948896|474458421|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
131775893|NCT00948896|474458422|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131775894|NCT00948896|474458423|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
131775895|NCT00948896|474458424|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131775896|NCT00948896|474458425|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131775897|NCT00948896|474458426|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131775898|NCT00948896|474458419|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131775899|NCT00948896|474458420|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131775900|NCT00948896|474458421|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
131775901|NCT00948896|474458422|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131775902|NCT00948896|474458423|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131775903|NCT00948896|474458424|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
131775904|NCT00948896|474458425|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131775905|NCT00948896|474458426|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131775906|NCT00948896|474458419|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775907|NCT00948896|474458420|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775908|NCT00948896|474458421|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775909|NCT00948896|474458422|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
131775910|NCT00948896|474458423|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775911|NCT00948896|474458424|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775912|NCT00948896|474458425|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775913|NCT00948896|474458426|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131775914|NCT03795233|474458427|FG000|Overall Study|Withdrawal by Subject|2|||
131775915|NCT03795233|474458428|FG001|Overall Study|Withdrawal by Subject|1|||
131775916|NCT03795233|474458427|FG000|Overall Study|Lost to Follow-up|1|||
131775917|NCT03795233|474458428|FG001|Overall Study|Lost to Follow-up|0|||
131775918|NCT03795233|474458427|FG000|Overall Study|Death|1|||
131775919|NCT03795233|474458428|FG001|Overall Study|Death|0|||
131775920|NCT05403502|474458429|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
131775921|NCT05403502|474458429|FG000|Humalog Lead-In Period|Physician Decision|2|||
131775922|NCT05403502|474458429|FG000|Humalog Lead-In Period|Protocol Violation|1|||
131775923|NCT05403502|474458429|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
131775924|NCT05403502|474458429|FG000|Lyumjev Treatment Period|Physician Decision|2|||
131775925|NCT01054443|474458430|FG000|Overall Study|Withdrawal by Subject|0|||
131775926|NCT01054443|474458431|FG001|Overall Study|Withdrawal by Subject|0|||
131775927|NCT01054443|474458432|FG002|Overall Study|Withdrawal by Subject|0|||
131775928|NCT01054443|474458433|FG003|Overall Study|Withdrawal by Subject|1|||
131775929|NCT00985114|474458435|FG000|Overall Study|Adverse Event|1|||
131775930|NCT00985114|474458436|FG001|Overall Study|Adverse Event|0|||
131775931|NCT00985114|474458435|FG000|Overall Study|Withdrawal by Subject|0|||
131775932|NCT00985114|474458436|FG001|Overall Study|Withdrawal by Subject|2|||
131775933|NCT01119118|474458437|FG000|Overall Study|Adverse Event|1|||
131775934|NCT01003691|474458440|FG000|Overall Study|Adverse Event|0|||
131775935|NCT01003691|474458441|FG001|Overall Study|Adverse Event|0|||
131775936|NCT01003691|474458442|FG002|Overall Study|Adverse Event|0|||
131775937|NCT01003691|474458443|FG003|Overall Study|Adverse Event|1|||
131775938|NCT00167414|474458445|FG000|Overall Study|Death|10|||
131775939|NCT01869959|474458452|FG000|Randomization Period|Physician Decision|0|||
131775940|NCT01869959|474458453|FG001|Randomization Period|Physician Decision|0|||
131775941|NCT01869959|474458454|FG002|Randomization Period|Physician Decision|0|||
131775942|NCT01869959|474458455|FG003|Randomization Period|Physician Decision|0|||
131775943|NCT01869959|474458456|FG004|Randomization Period|Physician Decision|1|||
131775944|NCT01869959|474458452|FG000|Treatment Period|Adverse Event|1|||
131775945|NCT01869959|474458453|FG001|Treatment Period|Adverse Event|0|||
131775946|NCT01869959|474458454|FG002|Treatment Period|Adverse Event|3|||
131775947|NCT01869959|474458455|FG003|Treatment Period|Adverse Event|1|||
131775948|NCT01869959|474458456|FG004|Treatment Period|Adverse Event|0|||
131775949|NCT01869959|474458452|FG000|Treatment Period|Sponsor decision|0|||
131775950|NCT01869959|474458453|FG001|Treatment Period|Sponsor decision|1|||
131775951|NCT01869959|474458454|FG002|Treatment Period|Sponsor decision|0|||
131775952|NCT01869959|474458455|FG003|Treatment Period|Sponsor decision|1|||
131775953|NCT01869959|474458456|FG004|Treatment Period|Sponsor decision|0|||
131775954|NCT01869959|474458452|FG000|Treatment Period|Withdrawal by Subject|0|||
131775955|NCT01869959|474458453|FG001|Treatment Period|Withdrawal by Subject|1|||
131775956|NCT01869959|474458454|FG002|Treatment Period|Withdrawal by Subject|0|||
131775957|NCT01869959|474458455|FG003|Treatment Period|Withdrawal by Subject|0|||
131775958|NCT01869959|474458456|FG004|Treatment Period|Withdrawal by Subject|0|||
131775959|NCT01875731|474458457|FG000|Overall Study|Fail to obtain lab sample|1|||
131775960|NCT01875731|474458458|FG001|Overall Study|Fail to obtain lab sample|0|||
131775961|NCT00157820|474458461|FG000|Randomized|Physician Decision|4|||
131775962|NCT00157820|474458462|FG001|Randomized|Physician Decision|2|||
131775963|NCT00157820|474458463|FG002|Randomized|Physician Decision|3|||
131775964|NCT00157820|474458461|FG000|Randomized|Withdrawal by Subject|1|||
131775965|NCT00157820|474458462|FG001|Randomized|Withdrawal by Subject|2|||
131775966|NCT00157820|474458463|FG002|Randomized|Withdrawal by Subject|3|||
131775967|NCT00157820|474458461|FG000|Randomized|Protocol Violation|2|||
131775968|NCT00157820|474458462|FG001|Randomized|Protocol Violation|1|||
131775969|NCT00157820|474458463|FG002|Randomized|Protocol Violation|2|||
131775970|NCT00157820|474458461|FG000|1st 8 Month|Death|7|||
131775971|NCT00157820|474458462|FG001|1st 8 Month|Death|8|||
131775972|NCT00157820|474458463|FG002|1st 8 Month|Death|3|||
131775973|NCT00157820|474458461|FG000|1st 8 Month|Lost to Follow-up|1|||
131775974|NCT00157820|474458462|FG001|1st 8 Month|Lost to Follow-up|2|||
131775975|NCT00157820|474458463|FG002|1st 8 Month|Lost to Follow-up|1|||
131775976|NCT00157820|474458461|FG000|1st 8 Month|Premature cross-over|0|||
131775977|NCT00157820|474458462|FG001|1st 8 Month|Premature cross-over|2|||
131775978|NCT00157820|474458463|FG002|1st 8 Month|Premature cross-over|2|||
131775979|NCT00157820|474458461|FG000|2nd 8 Months|Death|3|||
131775980|NCT00157820|474458462|FG001|2nd 8 Months|Death|1|||
131775981|NCT00157820|474458463|FG002|2nd 8 Months|Death|3|||
131775982|NCT00157820|474458461|FG000|2nd 8 Months|Lost to Follow-up|1|||
131775983|NCT00157820|474458462|FG001|2nd 8 Months|Lost to Follow-up|5|||
131775984|NCT00157820|474458463|FG002|2nd 8 Months|Lost to Follow-up|2|||
131775985|NCT00157820|474458461|FG000|2nd 8 Months|Premature cross-over|1|||
131775986|NCT00157820|474458462|FG001|2nd 8 Months|Premature cross-over|7|||
131775987|NCT00157820|474458463|FG002|2nd 8 Months|Premature cross-over|9|||
131775988|NCT00223990|474458464|FG000|Overall Study|Moved from area|2|||
131775989|NCT00223990|474458465|FG001|Overall Study|Moved from area|1|||
131775990|NCT00223990|474458464|FG000|Overall Study|Withdrawal by Subject|4|||
131775991|NCT00223990|474458465|FG001|Overall Study|Withdrawal by Subject|8|||
131775992|NCT00223990|474458464|FG000|Overall Study|Lost to Follow-up|1|||
131775993|NCT00223990|474458465|FG001|Overall Study|Lost to Follow-up|0|||
131775994|NCT02674568|474460523|FG000|Overall Study|Withdrawal by Subject|5|||
131775995|NCT02674568|474460523|FG000|Overall Study|Death|303|||
131689254|NCT02819635|474148249|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689255|NCT02819635|474148250|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689256|NCT02819635|474148251|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689257|NCT02819635|474148252|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131436540|NCT02748863|473224045|FG004|Treatment Period 2|Adverse Event|0|||
131436541|NCT02748863|473224041|FG000|Treatment Period 2|Lack of Efficacy|0|||
131436542|NCT02748863|473224042|FG001|Treatment Period 2|Lack of Efficacy|1|||
131436543|NCT02748863|473224043|FG002|Treatment Period 2|Lack of Efficacy|0|||
131436544|NCT02748863|473224044|FG003|Treatment Period 2|Lack of Efficacy|0|||
131436545|NCT02748863|473224045|FG004|Treatment Period 2|Lack of Efficacy|0|||
131436546|NCT02748863|473224041|FG000|Treatment Period 2|Pregnancy|0|||
131436547|NCT02748863|473224042|FG001|Treatment Period 2|Pregnancy|0|||
131436548|NCT02748863|473224043|FG002|Treatment Period 2|Pregnancy|0|||
131436549|NCT02748863|473224044|FG003|Treatment Period 2|Pregnancy|0|||
131436550|NCT02748863|473224045|FG004|Treatment Period 2|Pregnancy|1|||
131436551|NCT02422498|473224049|FG000|Overall Study|Inevaluable|4|||
131436552|NCT03206216|473224050|FG000|Overall Study|Withdrawal by Subject|0|||
131436553|NCT03206216|473224051|FG001|Overall Study|Withdrawal by Subject|1|||
131436554|NCT01960140|473224052|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
131436555|NCT00657046|473224055|FG000|Overall Study|Adverse Event|1|||
131436556|NCT00657046|473224056|FG001|Overall Study|Adverse Event|1|||
131436557|NCT00657046|473224057|FG002|Overall Study|Adverse Event|0|||
131436558|NCT00657046|473224055|FG000|Overall Study|Protocol Violation|2|||
131436559|NCT00657046|473224056|FG001|Overall Study|Protocol Violation|2|||
131436560|NCT00657046|473224057|FG002|Overall Study|Protocol Violation|0|||
131436561|NCT00657046|473224055|FG000|Overall Study|Withdrawal by Subject|1|||
131436562|NCT00657046|473224056|FG001|Overall Study|Withdrawal by Subject|0|||
131436563|NCT00657046|473224057|FG002|Overall Study|Withdrawal by Subject|0|||
131436564|NCT00657046|473224055|FG000|Overall Study|Death|0|||
131436565|NCT00657046|473224056|FG001|Overall Study|Death|0|||
131436566|NCT00657046|473224057|FG002|Overall Study|Death|1|||
131436567|NCT00657046|473224055|FG000|Overall Study|Surgery|0|||
131436568|NCT00657046|473224056|FG001|Overall Study|Surgery|0|||
131436569|NCT00657046|473224057|FG002|Overall Study|Surgery|1|||
131436570|NCT04154943|473224060|FG000|Overall Study|Study Ongoing|68|||
131436571|NCT04154943|473224060|FG000|Overall Study|Lost to Follow-up|1|||
131436572|NCT04154943|473224060|FG000|Overall Study|Decision by the Investigator|1|||
131436573|NCT04154943|473224060|FG000|Overall Study|Death|5|||
131436574|NCT04154943|473224060|FG000|Overall Study|Withdrawal by Subject|4|||
131436575|NCT06237049|473224061|FG000|Overall Study|Death|0|||
131436576|NCT06237049|473224062|FG001|Overall Study|Death|0|||
131436577|NCT06237049|473224063|FG002|Overall Study|Death|0|||
131436578|NCT06237049|473224064|FG003|Overall Study|Death|1|||
131436579|NCT06237049|473224061|FG000|Overall Study|Lost to Follow-up|11|||
131436580|NCT06237049|473224062|FG001|Overall Study|Lost to Follow-up|5|||
131436581|NCT06237049|473224063|FG002|Overall Study|Lost to Follow-up|8|||
131436582|NCT06237049|473224064|FG003|Overall Study|Lost to Follow-up|8|||
131436583|NCT06237049|473224061|FG000|Overall Study|Protocol Violation|0|||
131436584|NCT06237049|473224062|FG001|Overall Study|Protocol Violation|1|||
131436585|NCT06237049|473224063|FG002|Overall Study|Protocol Violation|0|||
131436586|NCT06237049|473224064|FG003|Overall Study|Protocol Violation|1|||
131557160|NCT00152971|473664436|FG000|Overall Study|Withdrawal by Subject|9|||
131436587|NCT06237049|473224061|FG000|Overall Study|Withdrawal by Subject|4|||
131436588|NCT06237049|473224062|FG001|Overall Study|Withdrawal by Subject|2|||
131436589|NCT06237049|473224063|FG002|Overall Study|Withdrawal by Subject|1|||
131436590|NCT06237049|473224064|FG003|Overall Study|Withdrawal by Subject|0|||
131436591|NCT02525471|473224065|FG000|Overall Study|Screen Failure|6|||
131436592|NCT02525471|473224065|FG000|Overall Study|Withdrawal by Subject|4|||
131436593|NCT02525471|473224065|FG000|Overall Study|Death|1|||
131436594|NCT00867165|473224066|FG000|Overall Study|Adverse Event|3|||
131436595|NCT00867165|473224067|FG001|Overall Study|Adverse Event|0|||
131436596|NCT00867165|473224066|FG000|Overall Study|Withdrawal by Subject|1|||
131436597|NCT00867165|473224067|FG001|Overall Study|Withdrawal by Subject|0|||
131436598|NCT00890825|473224068|FG000|Overall Study|Withdrawal by Subject|1|||
131436599|NCT00890825|473224069|FG001|Overall Study|Withdrawal by Subject|0|||
131719484|NCT01856673|474253335|FG002|Overall Study|Lost to Follow-up|0|||
131775996|NCT02674568|474460523|FG000|Overall Study|Physician Decision|2|||
131775997|NCT02674568|474460523|FG000|Overall Study|Lost to Follow-up|9|||
131775998|NCT02674568|474460523|FG000|Overall Study|Other, Not Specified|20|||
131775999|NCT00457249|474460524|FG000|Overall Study|Lost to Follow-up|3|||
131776000|NCT00457249|474460525|FG001|Overall Study|Lost to Follow-up|0|||
131776001|NCT00457249|474460524|FG000|Overall Study|Protocol Violation|4|||
131776002|NCT00457249|474460525|FG001|Overall Study|Protocol Violation|1|||
131776003|NCT00457249|474460524|FG000|Overall Study|Withdrawal by Subject|3|||
131776004|NCT00457249|474460525|FG001|Overall Study|Withdrawal by Subject|1|||
131776005|NCT00457249|474460524|FG000|Overall Study|Serious Adverse Events|2|||
131776006|NCT00457249|474460525|FG001|Overall Study|Serious Adverse Events|0|||
131776007|NCT00396318|474460526|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
131776008|NCT02916056|474460527|FG000|Overall Study|Adverse Event|6|||
131776009|NCT02916056|474460527|FG000|Overall Study|Lost to Follow-up|1|||
131776010|NCT02916056|474460527|FG000|Overall Study|Other|12|||
131776011|NCT02916056|474460527|FG000|Overall Study|Protocol Violation|1|||
131776012|NCT02916056|474460527|FG000|Overall Study|Withdrawal by Subject|8|||
131776013|NCT02916056|474460527|FG000|Overall Study|Study Terminated by Sponsor|269|||
131776014|NCT00124709|474460528|FG000|Overall Study|Randomized but did not take medication|3|||
131776015|NCT00124709|474460529|FG001|Overall Study|Randomized but did not take medication|1|||
131776016|NCT00124709|474460528|FG000|Overall Study|Adverse Event|3|||
131776017|NCT00124709|474460529|FG001|Overall Study|Adverse Event|0|||
131776018|NCT00124709|474460528|FG000|Overall Study|Lack of Efficacy|5|||
131776019|NCT00124709|474460529|FG001|Overall Study|Lack of Efficacy|10|||
131776020|NCT00124709|474460528|FG000|Overall Study|Protocol Violation|3|||
131776021|NCT00124709|474460529|FG001|Overall Study|Protocol Violation|5|||
131776022|NCT00124709|474460528|FG000|Overall Study|Withdrawal by Subject|127|||
131776023|NCT00124709|474460529|FG001|Overall Study|Withdrawal by Subject|136|||
131776024|NCT00124709|474460528|FG000|Overall Study|Lost to Follow-up|114|||
131776025|NCT00124709|474460529|FG001|Overall Study|Lost to Follow-up|120|||
131776026|NCT00122954|474460530|FG000|Overall Study|Withdrawal by Subject|2|||
131776027|NCT00122954|474460531|FG001|Overall Study|Withdrawal by Subject|2|||
131776028|NCT00122954|474460530|FG000|Overall Study|Protocol Violation|0|||
131776029|NCT00122954|474460531|FG001|Overall Study|Protocol Violation|1|||
131776030|NCT01728376|474460532|FG000|Overall Study|Adverse Event|1|||
131776031|NCT01728376|474460533|FG001|Overall Study|Adverse Event|1|||
131776032|NCT01728376|474460534|FG002|Overall Study|Adverse Event|1|||
131776033|NCT01728376|474460535|FG003|Overall Study|Adverse Event|1|||
131776034|NCT01728376|474460536|FG004|Overall Study|Adverse Event|1|||
131776035|NCT01728376|474460537|FG005|Overall Study|Adverse Event|0|||
131776036|NCT01728376|474460532|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
131776037|NCT01728376|474460533|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
131776038|NCT01728376|474460534|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
131776039|NCT01728376|474460535|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
131776040|NCT01728376|474460536|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
131776041|NCT01728376|474460537|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
131776042|NCT01728376|474460532|FG000|Overall Study|No relevant bacteria|2|||
131776043|NCT01728376|474460533|FG001|Overall Study|No relevant bacteria|0|||
131776044|NCT01728376|474460534|FG002|Overall Study|No relevant bacteria|0|||
131776045|NCT01728376|474460535|FG003|Overall Study|No relevant bacteria|0|||
131776046|NCT01728376|474460536|FG004|Overall Study|No relevant bacteria|1|||
131776047|NCT01728376|474460537|FG005|Overall Study|No relevant bacteria|1|||
131776048|NCT01728376|474460532|FG000|Overall Study|Did not receive treatment|0|||
131776049|NCT01728376|474460533|FG001|Overall Study|Did not receive treatment|1|||
131776050|NCT01728376|474460534|FG002|Overall Study|Did not receive treatment|0|||
131776051|NCT01728376|474460535|FG003|Overall Study|Did not receive treatment|0|||
131776052|NCT01728376|474460536|FG004|Overall Study|Did not receive treatment|0|||
131776053|NCT01728376|474460537|FG005|Overall Study|Did not receive treatment|0|||
131776054|NCT01728376|474460532|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131776055|NCT01728376|474460533|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131776056|NCT01728376|474460534|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131776057|NCT01728376|474460535|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
131776058|NCT01728376|474460536|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131436600|NCT00890825|473224068|FG000|Overall Study|Alive at data cut off (DCO)|13|||
131436601|NCT00890825|473224069|FG001|Overall Study|Alive at data cut off (DCO)|14|||
131436602|NCT01054456|473224070|FG000|Overall Study|Other|1|||
131436603|NCT03935126|473224071|FG000|Overall Study|Study termination by sponsor|3|||
131436604|NCT00377520|473224076|FG000|Overall Study|Ineligible (Prior radiation)|1|||
131436605|NCT02021565|473224081|FG000|Baseline Through Intervention|Death|0|||
131436606|NCT02021565|473224082|FG001|Baseline Through Intervention|Death|1|||
131436607|NCT02021565|473224081|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
131436608|NCT02021565|473224082|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
131436609|NCT02021565|473224081|FG000|Baseline Through Intervention|Protocol Violation|0|||
131436610|NCT02021565|473224082|FG001|Baseline Through Intervention|Protocol Violation|7|||
131436611|NCT02021565|473224081|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
131436612|NCT02021565|473224082|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
131436613|NCT02021565|473224081|FG000|3-month Follow-up|Death|3|||
131436614|NCT02021565|473224082|FG001|3-month Follow-up|Death|0|||
131436615|NCT02021565|473224081|FG000|3-month Follow-up|Withdrawal by Subject|4|||
131436616|NCT02021565|473224082|FG001|3-month Follow-up|Withdrawal by Subject|0|||
131436617|NCT02021565|473224081|FG000|3-month Follow-up|Protocol Violation|3|||
131436618|NCT02021565|473224082|FG001|3-month Follow-up|Protocol Violation|2|||
131436619|NCT03318549|473224083|FG000|Overall Study|Withdrawal by Subject|5|||
131436620|NCT03318549|473224084|FG001|Overall Study|Withdrawal by Subject|19|||
131436621|NCT03318549|473224085|FG002|Overall Study|Withdrawal by Subject|2|||
131436622|NCT03318549|473224086|FG003|Overall Study|Withdrawal by Subject|0|||
131436623|NCT03318549|473224087|FG004|Overall Study|Withdrawal by Subject|0|||
131436624|NCT03318549|473224088|FG005|Overall Study|Withdrawal by Subject|0|||
131557161|NCT00152971|473664437|FG001|Overall Study|Withdrawal by Subject|8|||
131776059|NCT01728376|474460537|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
131776060|NCT04341727|474460550|FG000|Overall Study|Withdrawal by Subject|0|||
131776061|NCT04341727|474460551|FG001|Overall Study|Withdrawal by Subject|0|||
131776062|NCT04341727|474460552|FG002|Overall Study|Withdrawal by Subject|1|||
131776063|NCT04341727|474460553|FG003|Overall Study|Withdrawal by Subject|0|||
131776064|NCT04341727|474460550|FG000|Overall Study|Lost to Follow-up|0|||
131776065|NCT04341727|474460551|FG001|Overall Study|Lost to Follow-up|0|||
131776066|NCT04341727|474460552|FG002|Overall Study|Lost to Follow-up|0|||
131776067|NCT04341727|474460553|FG003|Overall Study|Lost to Follow-up|1|||
131776068|NCT05604521|474460554|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
131776069|NCT05604521|474460555|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
131776070|NCT05604521|474460554|FG000|Overall Study|Adverse Event|1|||
131776071|NCT05604521|474460555|FG001|Overall Study|Adverse Event|0|||
131776072|NCT04311411|474460561|FG000|Overall Study|Adverse Event|2|||
131776073|NCT04311411|474460562|FG001|Overall Study|Adverse Event|3|||
131776074|NCT04311411|474460563|FG002|Overall Study|Adverse Event|2|||
131776075|NCT04311411|474460561|FG000|Overall Study|Withdrawal by Subject|3|||
131776076|NCT04311411|474460562|FG001|Overall Study|Withdrawal by Subject|3|||
131776077|NCT04311411|474460563|FG002|Overall Study|Withdrawal by Subject|0|||
131776078|NCT04888377|474460567|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
131776079|NCT04888377|474460568|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
131776080|NCT04888377|474460567|FG000|Overall Study|Physician Decision|6|||
131776081|NCT04888377|474460568|FG001|Overall Study|Physician Decision|6|||
131776082|NCT04888377|474460567|FG000|Overall Study|Withdrawal by Subject|7|||
131776083|NCT04888377|474460568|FG001|Overall Study|Withdrawal by Subject|3|||
131776084|NCT00526162|474460569|FG000|Overall Study|Device not implanted|3|||
131776085|NCT05279807|474460570|FG000|Overall Study|Withdrawal by Subject|1|||
131776086|NCT05279807|474460571|FG001|Overall Study|Withdrawal by Subject|0|||
131776087|NCT05279807|474460570|FG000|Overall Study|Adverse Event|0|||
131776088|NCT05279807|474460571|FG001|Overall Study|Adverse Event|1|||
131776089|NCT05279807|474460570|FG000|Overall Study|Laboratory Abnormal Results|1|||
131776090|NCT05279807|474460571|FG001|Overall Study|Laboratory Abnormal Results|0|||
131776091|NCT03110107|474460572|FG000|Treatment Period|Disease Progression|3|||
131776092|NCT03110107|474460573|FG001|Treatment Period|Disease Progression|9|||
131776093|NCT03110107|474460574|FG002|Treatment Period|Disease Progression|8|||
131776094|NCT03110107|474460575|FG003|Treatment Period|Disease Progression|11|||
131776095|NCT03110107|474460576|FG004|Treatment Period|Disease Progression|8|||
131776096|NCT03110107|474460577|FG005|Treatment Period|Disease Progression|4|||
131776097|NCT03110107|474460578|FG006|Treatment Period|Disease Progression|6|||
131776098|NCT03110107|474460579|FG007|Treatment Period|Disease Progression|7|||
131776099|NCT03110107|474460580|FG008|Treatment Period|Disease Progression|2|||
131776100|NCT03110107|474460581|FG009|Treatment Period|Disease Progression|10|||
131776101|NCT03110107|474460582|FG010|Treatment Period|Disease Progression|5|||
131776102|NCT03110107|474460583|FG011|Treatment Period|Disease Progression|2|||
131776103|NCT03110107|474460584|FG012|Treatment Period|Disease Progression|0|||
131776104|NCT03110107|474460585|FG013|Treatment Period|Disease Progression|5|||
131776105|NCT03110107|474460586|FG014|Treatment Period|Disease Progression|14|||
131776106|NCT03110107|474460587|FG015|Treatment Period|Disease Progression|14|||
131776107|NCT03110107|474460588|FG016|Treatment Period|Disease Progression|4|||
131776108|NCT03110107|474460589|FG017|Treatment Period|Disease Progression|3|||
131776109|NCT03110107|474460590|FG018|Treatment Period|Disease Progression|16|||
131776110|NCT03110107|474460591|FG019|Treatment Period|Disease Progression|14|||
131776111|NCT03110107|474460592|FG020|Treatment Period|Disease Progression|12|||
131776112|NCT03110107|474460593|FG021|Treatment Period|Disease Progression|16|||
131776113|NCT03110107|474460594|FG022|Treatment Period|Disease Progression|18|||
131776114|NCT03110107|474460595|FG023|Treatment Period|Disease Progression|13|||
131776115|NCT03110107|474460596|FG024|Treatment Period|Disease Progression|16|||
131776116|NCT03110107|474460597|FG025|Treatment Period|Disease Progression|31|||
131436625|NCT03318549|473224089|FG006|Overall Study|Withdrawal by Subject|0|||
131436626|NCT03318549|473224083|FG000|Overall Study|Physician Decision|0|||
131436627|NCT03318549|473224084|FG001|Overall Study|Physician Decision|4|||
131436628|NCT03318549|473224085|FG002|Overall Study|Physician Decision|1|||
131436629|NCT03318549|473224086|FG003|Overall Study|Physician Decision|0|||
131436630|NCT03318549|473224087|FG004|Overall Study|Physician Decision|0|||
131436631|NCT03318549|473224088|FG005|Overall Study|Physician Decision|0|||
131436632|NCT03318549|473224089|FG006|Overall Study|Physician Decision|0|||
131436633|NCT03318549|473224083|FG000|Overall Study|Lost to Follow-up|0|||
131436634|NCT03318549|473224084|FG001|Overall Study|Lost to Follow-up|3|||
131436635|NCT03318549|473224085|FG002|Overall Study|Lost to Follow-up|3|||
131436636|NCT03318549|473224086|FG003|Overall Study|Lost to Follow-up|0|||
131436637|NCT03318549|473224087|FG004|Overall Study|Lost to Follow-up|0|||
131436638|NCT03318549|473224088|FG005|Overall Study|Lost to Follow-up|0|||
131436639|NCT03318549|473224089|FG006|Overall Study|Lost to Follow-up|0|||
131436640|NCT01391663|473224090|FG000|Overall Study|Withdrawal by Subject|0|||
131436641|NCT01391663|473224091|FG001|Overall Study|Withdrawal by Subject|0|||
131436642|NCT01391663|473224092|FG002|Overall Study|Withdrawal by Subject|1|||
131436643|NCT01391663|473224093|FG003|Overall Study|Withdrawal by Subject|0|||
131436644|NCT03515824|473224094|FG000|Overall Study|Death|3|||
131436645|NCT03515824|473224095|FG001|Overall Study|Death|2|||
131436646|NCT03515824|473224096|FG002|Overall Study|Death|6|||
131436647|NCT03515824|473224097|FG003|Overall Study|Death|0|||
131436648|NCT03515824|473224094|FG000|Overall Study|Lost to Follow-up|0|||
131436649|NCT03515824|473224095|FG001|Overall Study|Lost to Follow-up|1|||
131436650|NCT03515824|473224096|FG002|Overall Study|Lost to Follow-up|1|||
131436651|NCT03515824|473224097|FG003|Overall Study|Lost to Follow-up|0|||
131436652|NCT03515824|473224094|FG000|Overall Study|Study terminated by sponsor|0|||
131436653|NCT03515824|473224095|FG001|Overall Study|Study terminated by sponsor|1|||
131436654|NCT03515824|473224096|FG002|Overall Study|Study terminated by sponsor|6|||
131436655|NCT03515824|473224097|FG003|Overall Study|Study terminated by sponsor|0|||
131436656|NCT03515824|473224094|FG000|Overall Study|Status not recorded|0|||
131436657|NCT03515824|473224095|FG001|Overall Study|Status not recorded|0|||
131436658|NCT03515824|473224096|FG002|Overall Study|Status not recorded|2|||
131436659|NCT03515824|473224097|FG003|Overall Study|Status not recorded|0|||
131436660|NCT00539994|473224099|FG000|Overall Study|Lost to Follow-up|2|||
131436661|NCT00539994|473224100|FG001|Overall Study|Lost to Follow-up|1|||
131436662|NCT00539994|473224101|FG002|Overall Study|Lost to Follow-up|0|||
131436663|NCT00539994|473224099|FG000|Overall Study|Withdrawal by Subject|1|||
131436664|NCT00539994|473224100|FG001|Overall Study|Withdrawal by Subject|0|||
131436665|NCT00539994|473224101|FG002|Overall Study|Withdrawal by Subject|1|||
131436666|NCT00539994|473224099|FG000|Overall Study|Physician Decision|0|||
131436667|NCT00539994|473224100|FG001|Overall Study|Physician Decision|0|||
131436668|NCT00539994|473224101|FG002|Overall Study|Physician Decision|1|||
131436669|NCT05470985|473224103|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
131436670|NCT05470985|473224104|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
131436671|NCT05470985|473224103|FG000|Double Blind Treatment Period|Physician Decision|0|||
131436672|NCT05470985|473224104|FG001|Double Blind Treatment Period|Physician Decision|1|||
131436673|NCT05470985|473224103|FG000|Long Term Extension|Adverse Event|0|||
131436674|NCT05470985|473224104|FG001|Long Term Extension|Adverse Event|1|||
131436675|NCT05470985|473224103|FG000|Long Term Extension|Study terminated by sponsor|2|||
131436676|NCT05470985|473224104|FG001|Long Term Extension|Study terminated by sponsor|0|||
131436677|NCT02741245|473224108|FG000|Overall Study|Adverse Event|0|||
131436678|NCT02741245|473224109|FG001|Overall Study|Adverse Event|0|||
131436679|NCT02741245|473224110|FG002|Overall Study|Adverse Event|0|||
131436680|NCT02741245|473224111|FG003|Overall Study|Adverse Event|2|||
131436681|NCT02741245|473224112|FG004|Overall Study|Adverse Event|2|||
131436682|NCT02741245|473224108|FG000|Overall Study|Protocol Violation|0|||
131436683|NCT02741245|473224109|FG001|Overall Study|Protocol Violation|1|||
131436684|NCT02741245|473224110|FG002|Overall Study|Protocol Violation|0|||
131436685|NCT02741245|473224111|FG003|Overall Study|Protocol Violation|1|||
131436686|NCT02741245|473224112|FG004|Overall Study|Protocol Violation|0|||
131436687|NCT02741245|473224108|FG000|Overall Study|Withdrawal by Subject|0|||
131436688|NCT02741245|473224109|FG001|Overall Study|Withdrawal by Subject|0|||
131436689|NCT02741245|473224110|FG002|Overall Study|Withdrawal by Subject|0|||
131436690|NCT02741245|473224111|FG003|Overall Study|Withdrawal by Subject|1|||
131436691|NCT02741245|473224112|FG004|Overall Study|Withdrawal by Subject|0|||
131436692|NCT00607087|473224113|FG000|Overall Study|Withdrawal by Subject|9|||
131436693|NCT00607087|473224114|FG001|Overall Study|Withdrawal by Subject|4|||
131436694|NCT00607087|473224115|FG002|Overall Study|Withdrawal by Subject|4|||
131436695|NCT00607087|473224113|FG000|Overall Study|Adverse Event|3|||
131436696|NCT00607087|473224114|FG001|Overall Study|Adverse Event|2|||
131436697|NCT00607087|473224115|FG002|Overall Study|Adverse Event|3|||
131436698|NCT00607087|473224113|FG000|Overall Study|Other reason|1|||
131436699|NCT00607087|473224114|FG001|Overall Study|Other reason|5|||
131436700|NCT00607087|473224115|FG002|Overall Study|Other reason|2|||
131436701|NCT00607087|473224113|FG000|Overall Study|Poor compliance to protocol|1|||
131436702|NCT00607087|473224114|FG001|Overall Study|Poor compliance to protocol|0|||
131436703|NCT00607087|473224115|FG002|Overall Study|Poor compliance to protocol|1|||
131436704|NCT00607087|473224113|FG000|Overall Study|Lost to Follow-up|1|||
131436705|NCT00607087|473224114|FG001|Overall Study|Lost to Follow-up|0|||
131436706|NCT00607087|473224115|FG002|Overall Study|Lost to Follow-up|0|||
131436707|NCT00607087|473224113|FG000|Period 1|Withdrawal by Subject|7|||
131436708|NCT00607087|473224114|FG001|Period 1|Withdrawal by Subject|2|||
131436709|NCT00607087|473224115|FG002|Period 1|Withdrawal by Subject|3|||
131776117|NCT03110107|474460572|FG000|Treatment Period|Study drug toxicity|1|||
131776118|NCT03110107|474460573|FG001|Treatment Period|Study drug toxicity|0|||
131776119|NCT03110107|474460574|FG002|Treatment Period|Study drug toxicity|1|||
131776120|NCT03110107|474460575|FG003|Treatment Period|Study drug toxicity|2|||
131776121|NCT03110107|474460576|FG004|Treatment Period|Study drug toxicity|0|||
131776122|NCT03110107|474460577|FG005|Treatment Period|Study drug toxicity|3|||
131776123|NCT03110107|474460578|FG006|Treatment Period|Study drug toxicity|1|||
131776124|NCT03110107|474460579|FG007|Treatment Period|Study drug toxicity|1|||
131776125|NCT03110107|474460580|FG008|Treatment Period|Study drug toxicity|3|||
131776126|NCT03110107|474460581|FG009|Treatment Period|Study drug toxicity|2|||
131776127|NCT03110107|474460582|FG010|Treatment Period|Study drug toxicity|0|||
131436710|NCT00607087|473224113|FG000|Period 1|Adverse Event|3|||
131436711|NCT00607087|473224114|FG001|Period 1|Adverse Event|0|||
131436712|NCT00607087|473224115|FG002|Period 1|Adverse Event|0|||
131436713|NCT00607087|473224113|FG000|Period 1|Poor compliance to protocol|1|||
131436714|NCT00607087|473224114|FG001|Period 1|Poor compliance to protocol|0|||
131436715|NCT00607087|473224115|FG002|Period 1|Poor compliance to protocol|0|||
131436716|NCT00607087|473224113|FG000|Period 1|Lost to Follow-up|1|||
131436717|NCT00607087|473224114|FG001|Period 1|Lost to Follow-up|0|||
131689258|NCT02819635|474148253|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689259|NCT02819635|474148254|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689260|NCT02819635|474148255|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
131689261|NCT02819635|474148256|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689262|NCT02819635|474148257|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689263|NCT02819635|474148258|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689264|NCT02819635|474148259|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689265|NCT02819635|474148260|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131689266|NCT02819635|474148249|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
131689267|NCT02819635|474148250|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
131689268|NCT02819635|474148251|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
131689269|NCT02819635|474148252|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
131689270|NCT02819635|474148253|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
131689271|NCT02819635|474148254|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
131689272|NCT02819635|474148255|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
131689273|NCT02819635|474148256|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131689274|NCT02819635|474148257|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131689275|NCT02819635|474148258|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131689276|NCT02819635|474148259|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131689277|NCT02819635|474148260|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131689278|NCT02819635|474148249|FG000|Substudy 2, Part 2|Adverse Event|0|||
131689279|NCT02819635|474148250|FG001|Substudy 2, Part 2|Adverse Event|0|||
131689280|NCT02819635|474148251|FG002|Substudy 2, Part 2|Adverse Event|0|||
131689281|NCT02819635|474148252|FG003|Substudy 2, Part 2|Adverse Event|0|||
131689282|NCT02819635|474148253|FG004|Substudy 2, Part 2|Adverse Event|0|||
131689283|NCT02819635|474148254|FG005|Substudy 2, Part 2|Adverse Event|4|||
131689284|NCT02819635|474148255|FG006|Substudy 2, Part 2|Adverse Event|0|||
131689285|NCT02819635|474148256|FG007|Substudy 2, Part 2|Adverse Event|0|||
131436718|NCT00607087|473224115|FG002|Period 1|Lost to Follow-up|0|||
131436719|NCT00607087|473224113|FG000|Period 1|Other reason|0|||
131436720|NCT00607087|473224114|FG001|Period 1|Other reason|4|||
131436721|NCT00607087|473224115|FG002|Period 1|Other reason|2|||
131436722|NCT00607087|473224113|FG000|Period 2|Withdrawal by Subject|0|||
131689286|NCT02819635|474148257|FG008|Substudy 2, Part 2|Adverse Event|0|||
131689287|NCT02819635|474148258|FG009|Substudy 2, Part 2|Adverse Event|0|||
131689288|NCT02819635|474148259|FG010|Substudy 2, Part 2|Adverse Event|0|||
131689289|NCT02819635|474148260|FG011|Substudy 2, Part 2|Adverse Event|0|||
131689290|NCT02819635|474148249|FG000|Substudy 2, Part 2|Withdrew consent|0|||
131689291|NCT02819635|474148250|FG001|Substudy 2, Part 2|Withdrew consent|0|||
131689292|NCT02819635|474148251|FG002|Substudy 2, Part 2|Withdrew consent|0|||
131689293|NCT02819635|474148252|FG003|Substudy 2, Part 2|Withdrew consent|0|||
131776128|NCT03110107|474460583|FG011|Treatment Period|Study drug toxicity|2|||
131776129|NCT03110107|474460584|FG012|Treatment Period|Study drug toxicity|0|||
131776130|NCT03110107|474460585|FG013|Treatment Period|Study drug toxicity|0|||
131689294|NCT02819635|474148253|FG004|Substudy 2, Part 2|Withdrew consent|0|||
131689295|NCT02819635|474148254|FG005|Substudy 2, Part 2|Withdrew consent|3|||
131689296|NCT02819635|474148255|FG006|Substudy 2, Part 2|Withdrew consent|1|||
131689297|NCT02819635|474148256|FG007|Substudy 2, Part 2|Withdrew consent|0|||
131689298|NCT02819635|474148257|FG008|Substudy 2, Part 2|Withdrew consent|0|||
131689299|NCT02819635|474148258|FG009|Substudy 2, Part 2|Withdrew consent|0|||
131689300|NCT02819635|474148259|FG010|Substudy 2, Part 2|Withdrew consent|0|||
131689301|NCT02819635|474148260|FG011|Substudy 2, Part 2|Withdrew consent|0|||
131689302|NCT02819635|474148249|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
131689303|NCT02819635|474148250|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
131689304|NCT02819635|474148251|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
131689305|NCT02819635|474148252|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
131689306|NCT02819635|474148253|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
131689307|NCT02819635|474148254|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
131689308|NCT02819635|474148255|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
131689309|NCT02819635|474148256|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
131689310|NCT02819635|474148257|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
131689311|NCT02819635|474148258|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
131689312|NCT02819635|474148259|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
131689313|NCT02819635|474148260|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
131689314|NCT02819635|474148249|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689315|NCT02819635|474148250|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689316|NCT02819635|474148251|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689317|NCT02819635|474148252|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689318|NCT02819635|474148253|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689319|NCT02819635|474148254|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689320|NCT02819635|474148255|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
131689321|NCT02819635|474148256|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689322|NCT02819635|474148257|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689323|NCT02819635|474148258|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689324|NCT02819635|474148259|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689325|NCT02819635|474148260|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131689326|NCT02819635|474148249|FG000|Substudy 2, Part 2|Other, not specified|0|||
131689327|NCT02819635|474148250|FG001|Substudy 2, Part 2|Other, not specified|0|||
131689328|NCT02819635|474148251|FG002|Substudy 2, Part 2|Other, not specified|0|||
131689329|NCT02819635|474148252|FG003|Substudy 2, Part 2|Other, not specified|0|||
131689330|NCT02819635|474148253|FG004|Substudy 2, Part 2|Other, not specified|0|||
131689331|NCT02819635|474148254|FG005|Substudy 2, Part 2|Other, not specified|4|||
131689332|NCT02819635|474148255|FG006|Substudy 2, Part 2|Other, not specified|8|||
131689333|NCT02819635|474148256|FG007|Substudy 2, Part 2|Other, not specified|0|||
131689334|NCT02819635|474148257|FG008|Substudy 2, Part 2|Other, not specified|0|||
131689335|NCT02819635|474148258|FG009|Substudy 2, Part 2|Other, not specified|0|||
131689336|NCT02819635|474148259|FG010|Substudy 2, Part 2|Other, not specified|0|||
131689337|NCT02819635|474148260|FG011|Substudy 2, Part 2|Other, not specified|0|||
131689338|NCT02819635|474148249|FG000|Substudy 3|Adverse Event|0|||
131689339|NCT02819635|474148250|FG001|Substudy 3|Adverse Event|0|||
131689340|NCT02819635|474148251|FG002|Substudy 3|Adverse Event|0|||
131689341|NCT02819635|474148252|FG003|Substudy 3|Adverse Event|0|||
131689342|NCT02819635|474148253|FG004|Substudy 3|Adverse Event|0|||
131689343|NCT02819635|474148254|FG005|Substudy 3|Adverse Event|0|||
131689344|NCT02819635|474148255|FG006|Substudy 3|Adverse Event|0|||
131689345|NCT02819635|474148256|FG007|Substudy 3|Adverse Event|0|||
131689346|NCT02819635|474148257|FG008|Substudy 3|Adverse Event|32|||
131689347|NCT02819635|474148258|FG009|Substudy 3|Adverse Event|3|||
131689348|NCT02819635|474148259|FG010|Substudy 3|Adverse Event|12|||
131689349|NCT02819635|474148260|FG011|Substudy 3|Adverse Event|18|||
131689350|NCT02819635|474148249|FG000|Substudy 3|Withdrew consent|0|||
131689351|NCT02819635|474148250|FG001|Substudy 3|Withdrew consent|0|||
131689352|NCT02819635|474148251|FG002|Substudy 3|Withdrew consent|0|||
131689353|NCT02819635|474148252|FG003|Substudy 3|Withdrew consent|0|||
131689354|NCT02819635|474148253|FG004|Substudy 3|Withdrew consent|0|||
131689355|NCT02819635|474148254|FG005|Substudy 3|Withdrew consent|0|||
131689356|NCT02819635|474148255|FG006|Substudy 3|Withdrew consent|0|||
131689357|NCT02819635|474148256|FG007|Substudy 3|Withdrew consent|0|||
131689358|NCT02819635|474148257|FG008|Substudy 3|Withdrew consent|11|||
131689359|NCT02819635|474148258|FG009|Substudy 3|Withdrew consent|1|||
131689360|NCT02819635|474148259|FG010|Substudy 3|Withdrew consent|4|||
131689361|NCT02819635|474148260|FG011|Substudy 3|Withdrew consent|9|||
131689362|NCT02819635|474148249|FG000|Substudy 3|Lost to Follow-up|0|||
131689363|NCT02819635|474148250|FG001|Substudy 3|Lost to Follow-up|0|||
131689364|NCT02819635|474148251|FG002|Substudy 3|Lost to Follow-up|0|||
131689365|NCT02819635|474148252|FG003|Substudy 3|Lost to Follow-up|0|||
131689366|NCT02819635|474148253|FG004|Substudy 3|Lost to Follow-up|0|||
131689367|NCT02819635|474148254|FG005|Substudy 3|Lost to Follow-up|0|||
131689368|NCT02819635|474148255|FG006|Substudy 3|Lost to Follow-up|0|||
131689369|NCT02819635|474148256|FG007|Substudy 3|Lost to Follow-up|0|||
131689370|NCT02819635|474148257|FG008|Substudy 3|Lost to Follow-up|1|||
131689371|NCT02819635|474148258|FG009|Substudy 3|Lost to Follow-up|0|||
131689372|NCT02819635|474148259|FG010|Substudy 3|Lost to Follow-up|1|||
131689373|NCT02819635|474148260|FG011|Substudy 3|Lost to Follow-up|1|||
131689374|NCT02819635|474148249|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689375|NCT02819635|474148250|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689376|NCT02819635|474148251|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689377|NCT02819635|474148252|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689378|NCT02819635|474148253|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689379|NCT02819635|474148254|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689380|NCT02819635|474148255|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689381|NCT02819635|474148256|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689382|NCT02819635|474148257|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689383|NCT02819635|474148258|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689384|NCT02819635|474148259|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
131689385|NCT02819635|474148260|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
131689386|NCT02819635|474148249|FG000|Substudy 3|Other, not specified|0|||
131689387|NCT02819635|474148250|FG001|Substudy 3|Other, not specified|0|||
131689388|NCT02819635|474148251|FG002|Substudy 3|Other, not specified|0|||
131689389|NCT02819635|474148252|FG003|Substudy 3|Other, not specified|0|||
131689390|NCT02819635|474148253|FG004|Substudy 3|Other, not specified|0|||
131689391|NCT02819635|474148254|FG005|Substudy 3|Other, not specified|0|||
131689392|NCT02819635|474148255|FG006|Substudy 3|Other, not specified|0|||
131689393|NCT02819635|474148256|FG007|Substudy 3|Other, not specified|0|||
131689394|NCT02819635|474148257|FG008|Substudy 3|Other, not specified|202|||
131689395|NCT02819635|474148258|FG009|Substudy 3|Other, not specified|5|||
131689396|NCT02819635|474148259|FG010|Substudy 3|Other, not specified|89|||
131689397|NCT02819635|474148260|FG011|Substudy 3|Other, not specified|39|||
131689398|NCT03179891|474148264|FG000|First Intervention|Withdrawal by Subject|1|||
131689399|NCT03179891|474148265|FG001|First Intervention|Withdrawal by Subject|1|||
131689400|NCT03179891|474148264|FG000|First Intervention|Unspecified reason|1|||
131689401|NCT03179891|474148265|FG001|First Intervention|Unspecified reason|0|||
131689402|NCT03179891|474148264|FG000|First Intervention|Protocol Violation|0|||
131689403|NCT03179891|474148265|FG001|First Intervention|Protocol Violation|1|||
131689404|NCT01438489|474148270|FG000|Overall Study|Lost to Follow-up|4|||
131689405|NCT01438489|474148271|FG001|Overall Study|Lost to Follow-up|2|||
131689406|NCT01438489|474148272|FG002|Overall Study|Lost to Follow-up|2|||
131689407|NCT01438489|474148270|FG000|Overall Study|Withdrawal by Subject|11|||
131689408|NCT01438489|474148271|FG001|Overall Study|Withdrawal by Subject|3|||
131689409|NCT01438489|474148272|FG002|Overall Study|Withdrawal by Subject|8|||
131689410|NCT01438489|474148270|FG000|Overall Study|Death|0|||
131689411|NCT01438489|474148271|FG001|Overall Study|Death|0|||
131689412|NCT01438489|474148272|FG002|Overall Study|Death|1|||
131689413|NCT01438489|474148270|FG000|Overall Study|Sponsor decision|4|||
131689414|NCT01438489|474148271|FG001|Overall Study|Sponsor decision|1|||
131689415|NCT01438489|474148272|FG002|Overall Study|Sponsor decision|4|||
131689416|NCT01438489|474148270|FG000|Overall Study|Subject choice/Subject moved|2|||
131689417|NCT01438489|474148271|FG001|Overall Study|Subject choice/Subject moved|1|||
131689418|NCT01438489|474148272|FG002|Overall Study|Subject choice/Subject moved|1|||
131689419|NCT01438489|474148270|FG000|Overall Study|Investigator decision|0|||
131689420|NCT01438489|474148271|FG001|Overall Study|Investigator decision|1|||
131689421|NCT01438489|474148272|FG002|Overall Study|Investigator decision|0|||
131689422|NCT01438489|474148270|FG000|Overall Study|AE/SAEs|2|||
131689423|NCT01438489|474148271|FG001|Overall Study|AE/SAEs|1|||
131689424|NCT01438489|474148272|FG002|Overall Study|AE/SAEs|1|||
131689425|NCT01438489|474148270|FG000|Overall Study|Received prohibited medication|1|||
131689426|NCT01438489|474148271|FG001|Overall Study|Received prohibited medication|0|||
131689427|NCT01438489|474148272|FG002|Overall Study|Received prohibited medication|0|||
131689428|NCT01438489|474148270|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
131689429|NCT01438489|474148271|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
131689430|NCT01438489|474148272|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
131689431|NCT01438489|474148270|FG000|Overall Study|Inadequate venous access|0|||
131689432|NCT01438489|474148271|FG001|Overall Study|Inadequate venous access|2|||
131689433|NCT01438489|474148272|FG002|Overall Study|Inadequate venous access|0|||
131689434|NCT00766532|474148273|FG000|Overall Study|Protocol Violation|2|||
131689435|NCT00573430|474148274|FG000|Overall Study|Incorrect enrollment of randomization|0|||
131689436|NCT00573430|474148275|FG001|Overall Study|Incorrect enrollment of randomization|4|||
131689437|NCT00573430|474148276|FG002|Overall Study|Incorrect enrollment of randomization|3|||
131689438|NCT00573430|474148274|FG000|Overall Study|Adverse Event|0|||
131689439|NCT00573430|474148275|FG001|Overall Study|Adverse Event|0|||
131776131|NCT03110107|474460586|FG014|Treatment Period|Study drug toxicity|2|||
131776132|NCT03110107|474460587|FG015|Treatment Period|Study drug toxicity|3|||
131776133|NCT03110107|474460588|FG016|Treatment Period|Study drug toxicity|3|||
131776134|NCT03110107|474460589|FG017|Treatment Period|Study drug toxicity|3|||
131776135|NCT03110107|474460590|FG018|Treatment Period|Study drug toxicity|1|||
131776136|NCT03110107|474460591|FG019|Treatment Period|Study drug toxicity|2|||
131776137|NCT03110107|474460592|FG020|Treatment Period|Study drug toxicity|2|||
131776138|NCT03110107|474460593|FG021|Treatment Period|Study drug toxicity|0|||
131776139|NCT03110107|474460594|FG022|Treatment Period|Study drug toxicity|2|||
131776140|NCT03110107|474460595|FG023|Treatment Period|Study drug toxicity|6|||
131776141|NCT03110107|474460596|FG024|Treatment Period|Study drug toxicity|7|||
131776142|NCT03110107|474460597|FG025|Treatment Period|Study drug toxicity|6|||
131776143|NCT03110107|474460572|FG000|Treatment Period|Death|0|||
131776144|NCT03110107|474460573|FG001|Treatment Period|Death|0|||
131776145|NCT03110107|474460574|FG002|Treatment Period|Death|0|||
131776146|NCT03110107|474460575|FG003|Treatment Period|Death|0|||
131776147|NCT03110107|474460576|FG004|Treatment Period|Death|0|||
131776148|NCT03110107|474460577|FG005|Treatment Period|Death|0|||
131776149|NCT03110107|474460578|FG006|Treatment Period|Death|0|||
131776150|NCT03110107|474460579|FG007|Treatment Period|Death|0|||
131776151|NCT03110107|474460580|FG008|Treatment Period|Death|0|||
131776152|NCT03110107|474460581|FG009|Treatment Period|Death|0|||
131776153|NCT03110107|474460582|FG010|Treatment Period|Death|0|||
131776154|NCT03110107|474460583|FG011|Treatment Period|Death|0|||
131776155|NCT03110107|474460584|FG012|Treatment Period|Death|1|||
131776156|NCT03110107|474460585|FG013|Treatment Period|Death|0|||
131776157|NCT03110107|474460586|FG014|Treatment Period|Death|0|||
131776158|NCT03110107|474460587|FG015|Treatment Period|Death|0|||
131776159|NCT03110107|474460588|FG016|Treatment Period|Death|0|||
131776160|NCT03110107|474460589|FG017|Treatment Period|Death|0|||
131776161|NCT03110107|474460590|FG018|Treatment Period|Death|0|||
131776162|NCT03110107|474460591|FG019|Treatment Period|Death|0|||
131776163|NCT03110107|474460592|FG020|Treatment Period|Death|0|||
131776164|NCT03110107|474460593|FG021|Treatment Period|Death|0|||
131776165|NCT03110107|474460594|FG022|Treatment Period|Death|0|||
131776166|NCT03110107|474460595|FG023|Treatment Period|Death|0|||
131776167|NCT03110107|474460596|FG024|Treatment Period|Death|0|||
131776168|NCT03110107|474460597|FG025|Treatment Period|Death|0|||
131776169|NCT03110107|474460572|FG000|Treatment Period|Adverse Event|0|||
131776170|NCT03110107|474460573|FG001|Treatment Period|Adverse Event|0|||
131776171|NCT03110107|474460574|FG002|Treatment Period|Adverse Event|1|||
131776172|NCT03110107|474460575|FG003|Treatment Period|Adverse Event|0|||
131776173|NCT03110107|474460576|FG004|Treatment Period|Adverse Event|0|||
131776174|NCT03110107|474460577|FG005|Treatment Period|Adverse Event|2|||
131776175|NCT03110107|474460578|FG006|Treatment Period|Adverse Event|0|||
131776176|NCT03110107|474460579|FG007|Treatment Period|Adverse Event|2|||
131776177|NCT03110107|474460580|FG008|Treatment Period|Adverse Event|0|||
131776178|NCT03110107|474460581|FG009|Treatment Period|Adverse Event|1|||
131776179|NCT03110107|474460582|FG010|Treatment Period|Adverse Event|0|||
131776180|NCT03110107|474460583|FG011|Treatment Period|Adverse Event|0|||
131776181|NCT03110107|474460584|FG012|Treatment Period|Adverse Event|0|||
131776182|NCT03110107|474460585|FG013|Treatment Period|Adverse Event|0|||
131776183|NCT03110107|474460586|FG014|Treatment Period|Adverse Event|0|||
131776184|NCT03110107|474460587|FG015|Treatment Period|Adverse Event|2|||
131776185|NCT03110107|474460588|FG016|Treatment Period|Adverse Event|0|||
131776186|NCT03110107|474460589|FG017|Treatment Period|Adverse Event|1|||
131776187|NCT03110107|474460590|FG018|Treatment Period|Adverse Event|2|||
131776188|NCT03110107|474460591|FG019|Treatment Period|Adverse Event|1|||
131776189|NCT03110107|474460592|FG020|Treatment Period|Adverse Event|4|||
131776190|NCT03110107|474460593|FG021|Treatment Period|Adverse Event|2|||
131776191|NCT03110107|474460594|FG022|Treatment Period|Adverse Event|2|||
131776192|NCT03110107|474460595|FG023|Treatment Period|Adverse Event|2|||
131776193|NCT03110107|474460596|FG024|Treatment Period|Adverse Event|2|||
131776194|NCT03110107|474460597|FG025|Treatment Period|Adverse Event|4|||
131776195|NCT03110107|474460572|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
131776196|NCT03110107|474460573|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
131776197|NCT03110107|474460574|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
131776198|NCT03110107|474460575|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
131776199|NCT03110107|474460576|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
131776200|NCT03110107|474460577|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
131776201|NCT03110107|474460578|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
131776202|NCT03110107|474460579|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
131776203|NCT03110107|474460580|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
131776204|NCT03110107|474460581|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
131898541|NCT02797678|474914126|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
131776205|NCT03110107|474460582|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
131776206|NCT03110107|474460583|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
131776207|NCT03110107|474460584|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
131776208|NCT03110107|474460585|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
131776209|NCT03110107|474460586|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
131776210|NCT03110107|474460587|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
131776211|NCT03110107|474460588|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
131776212|NCT03110107|474460589|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
131776213|NCT03110107|474460590|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
131776214|NCT03110107|474460591|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
131776215|NCT03110107|474460592|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
131776216|NCT03110107|474460593|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
131776217|NCT03110107|474460594|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
131776218|NCT03110107|474460595|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
131776219|NCT03110107|474460596|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
131776220|NCT03110107|474460597|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
131776221|NCT03110107|474460572|FG000|Treatment Period|Participant withdrew consent|0|||
131776222|NCT03110107|474460573|FG001|Treatment Period|Participant withdrew consent|0|||
131776223|NCT03110107|474460574|FG002|Treatment Period|Participant withdrew consent|1|||
131776224|NCT03110107|474460575|FG003|Treatment Period|Participant withdrew consent|0|||
131776225|NCT03110107|474460576|FG004|Treatment Period|Participant withdrew consent|4|||
131776226|NCT03110107|474460577|FG005|Treatment Period|Participant withdrew consent|3|||
131776227|NCT03110107|474460578|FG006|Treatment Period|Participant withdrew consent|0|||
131776228|NCT03110107|474460579|FG007|Treatment Period|Participant withdrew consent|0|||
131776229|NCT03110107|474460580|FG008|Treatment Period|Participant withdrew consent|0|||
131776230|NCT03110107|474460581|FG009|Treatment Period|Participant withdrew consent|1|||
131776231|NCT03110107|474460582|FG010|Treatment Period|Participant withdrew consent|0|||
131776232|NCT03110107|474460583|FG011|Treatment Period|Participant withdrew consent|0|||
131776233|NCT03110107|474460584|FG012|Treatment Period|Participant withdrew consent|0|||
131776234|NCT03110107|474460585|FG013|Treatment Period|Participant withdrew consent|0|||
131776235|NCT03110107|474460586|FG014|Treatment Period|Participant withdrew consent|0|||
131776236|NCT03110107|474460587|FG015|Treatment Period|Participant withdrew consent|0|||
131776237|NCT03110107|474460588|FG016|Treatment Period|Participant withdrew consent|0|||
131776238|NCT03110107|474460589|FG017|Treatment Period|Participant withdrew consent|0|||
131776239|NCT03110107|474460590|FG018|Treatment Period|Participant withdrew consent|0|||
131776240|NCT03110107|474460591|FG019|Treatment Period|Participant withdrew consent|1|||
131776241|NCT03110107|474460592|FG020|Treatment Period|Participant withdrew consent|0|||
131776242|NCT03110107|474460593|FG021|Treatment Period|Participant withdrew consent|2|||
131776243|NCT03110107|474460594|FG022|Treatment Period|Participant withdrew consent|0|||
131776244|NCT03110107|474460595|FG023|Treatment Period|Participant withdrew consent|0|||
131776245|NCT03110107|474460596|FG024|Treatment Period|Participant withdrew consent|0|||
131776246|NCT03110107|474460597|FG025|Treatment Period|Participant withdrew consent|2|||
131776247|NCT03110107|474460572|FG000|Treatment Period|Participants no longer meets study criteria|0|||
131776248|NCT03110107|474460573|FG001|Treatment Period|Participants no longer meets study criteria|0|||
131776249|NCT03110107|474460574|FG002|Treatment Period|Participants no longer meets study criteria|0|||
131776250|NCT03110107|474460575|FG003|Treatment Period|Participants no longer meets study criteria|0|||
131776251|NCT03110107|474460576|FG004|Treatment Period|Participants no longer meets study criteria|0|||
131776252|NCT03110107|474460577|FG005|Treatment Period|Participants no longer meets study criteria|0|||
131776253|NCT03110107|474460578|FG006|Treatment Period|Participants no longer meets study criteria|0|||
131776254|NCT03110107|474460579|FG007|Treatment Period|Participants no longer meets study criteria|0|||
131776255|NCT03110107|474460580|FG008|Treatment Period|Participants no longer meets study criteria|0|||
131776256|NCT03110107|474460581|FG009|Treatment Period|Participants no longer meets study criteria|0|||
131776257|NCT03110107|474460582|FG010|Treatment Period|Participants no longer meets study criteria|0|||
131776258|NCT03110107|474460583|FG011|Treatment Period|Participants no longer meets study criteria|0|||
131776259|NCT03110107|474460584|FG012|Treatment Period|Participants no longer meets study criteria|0|||
131776260|NCT03110107|474460585|FG013|Treatment Period|Participants no longer meets study criteria|0|||
131776261|NCT03110107|474460586|FG014|Treatment Period|Participants no longer meets study criteria|0|||
131898542|NCT02797678|474914127|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
131689440|NCT00573430|474148276|FG002|Overall Study|Adverse Event|2|||
131689441|NCT00573430|474148274|FG000|Overall Study|Withdrawal by Subject|1|||
131689442|NCT00573430|474148275|FG001|Overall Study|Withdrawal by Subject|0|||
131689443|NCT00573430|474148276|FG002|Overall Study|Withdrawal by Subject|1|||
131689444|NCT00573430|474148274|FG000|Overall Study|Protocol Violation|0|||
131689445|NCT00573430|474148275|FG001|Overall Study|Protocol Violation|1|||
131689446|NCT00573430|474148276|FG002|Overall Study|Protocol Violation|1|||
131689447|NCT00573430|474148274|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131689448|NCT00573430|474148275|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131689449|NCT00573430|474148276|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
131689450|NCT00751400|474148277|FG000|Overall Study|Lost to Follow-up|10|||
131689451|NCT01148537|474148283|FG000|Overall Study|Withdrawal by Subject|1|||
131689452|NCT01148537|474148284|FG001|Overall Study|Withdrawal by Subject|0|||
131689453|NCT01148537|474148285|FG002|Overall Study|Withdrawal by Subject|2|||
131689454|NCT01148537|474148283|FG000|Overall Study|Adverse Event|2|||
131689455|NCT01148537|474148284|FG001|Overall Study|Adverse Event|0|||
131689456|NCT01148537|474148285|FG002|Overall Study|Adverse Event|1|||
131689457|NCT01324232|474148286|FG000|Overall Study|Protocol Violation|0|||
131689458|NCT01324232|474148287|FG001|Overall Study|Protocol Violation|0|||
131689459|NCT01324232|474148288|FG002|Overall Study|Protocol Violation|0|||
131689460|NCT01324232|474148289|FG003|Overall Study|Protocol Violation|2|||
131689461|NCT01324232|474148286|FG000|Overall Study|Missing|0|||
131689462|NCT01324232|474148287|FG001|Overall Study|Missing|0|||
131689463|NCT01324232|474148288|FG002|Overall Study|Missing|1|||
131689464|NCT01324232|474148289|FG003|Overall Study|Missing|0|||
131689465|NCT01324232|474148286|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
131689466|NCT01324232|474148287|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
131689467|NCT01324232|474148288|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
131689468|NCT01324232|474148289|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
131689469|NCT01324232|474148286|FG000|Overall Study|Lack of Efficacy|2|||
131689470|NCT01324232|474148287|FG001|Overall Study|Lack of Efficacy|1|||
131689471|NCT01324232|474148288|FG002|Overall Study|Lack of Efficacy|2|||
131689472|NCT01324232|474148289|FG003|Overall Study|Lack of Efficacy|2|||
131689473|NCT01324232|474148286|FG000|Overall Study|Participant Refused Medication|0|||
131689474|NCT01324232|474148287|FG001|Overall Study|Participant Refused Medication|1|||
131689475|NCT01324232|474148288|FG002|Overall Study|Participant Refused Medication|0|||
131689476|NCT01324232|474148289|FG003|Overall Study|Participant Refused Medication|0|||
131689477|NCT01324232|474148286|FG000|Overall Study|Intercurrent illness|0|||
131689478|NCT01324232|474148287|FG001|Overall Study|Intercurrent illness|0|||
131689479|NCT01324232|474148288|FG002|Overall Study|Intercurrent illness|0|||
131689480|NCT01324232|474148289|FG003|Overall Study|Intercurrent illness|1|||
131689481|NCT01324232|474148286|FG000|Overall Study|Adverse Event|2|||
131689482|NCT01324232|474148287|FG001|Overall Study|Adverse Event|5|||
131689483|NCT01324232|474148288|FG002|Overall Study|Adverse Event|6|||
131689484|NCT01324232|474148289|FG003|Overall Study|Adverse Event|6|||
131689485|NCT01324232|474148286|FG000|Overall Study|Withdrawal by Subject|0|||
131689486|NCT01324232|474148287|FG001|Overall Study|Withdrawal by Subject|3|||
131689487|NCT01324232|474148288|FG002|Overall Study|Withdrawal by Subject|4|||
131689488|NCT01324232|474148289|FG003|Overall Study|Withdrawal by Subject|0|||
131689489|NCT01324232|474148286|FG000|Overall Study|Lost to Follow-up|1|||
131689490|NCT01324232|474148287|FG001|Overall Study|Lost to Follow-up|0|||
131689491|NCT01324232|474148288|FG002|Overall Study|Lost to Follow-up|0|||
131689492|NCT01324232|474148289|FG003|Overall Study|Lost to Follow-up|0|||
131689493|NCT00661531|474148290|FG000|Overall Study|Withdrawal by Subject|3|||
131689494|NCT03134599|474148292|FG000|Week 1|Lost to Follow-up|0|||
131689495|NCT03134599|474148293|FG001|Week 1|Lost to Follow-up|0|||
131689496|NCT03134599|474148294|FG002|Week 1|Lost to Follow-up|0|||
131689497|NCT03134599|474148295|FG003|Week 1|Lost to Follow-up|0|||
131689498|NCT03134599|474148296|FG004|Week 1|Lost to Follow-up|1|||
131689499|NCT03134599|474148297|FG005|Week 1|Lost to Follow-up|0|||
131689500|NCT03134599|474148292|FG000|Week 2|Lost to Follow-up|1|||
131689501|NCT03134599|474148293|FG001|Week 2|Lost to Follow-up|0|||
131689502|NCT03134599|474148294|FG002|Week 2|Lost to Follow-up|0|||
131689503|NCT03134599|474148295|FG003|Week 2|Lost to Follow-up|1|||
131689504|NCT03134599|474148296|FG004|Week 2|Lost to Follow-up|1|||
131689505|NCT03134599|474148297|FG005|Week 2|Lost to Follow-up|0|||
131689506|NCT03134599|474148292|FG000|Week 3|Lost to Follow-up|0|||
131689507|NCT03134599|474148293|FG001|Week 3|Lost to Follow-up|0|||
131776262|NCT03110107|474460587|FG015|Treatment Period|Participants no longer meets study criteria|0|||
131776263|NCT03110107|474460588|FG016|Treatment Period|Participants no longer meets study criteria|0|||
131776264|NCT03110107|474460589|FG017|Treatment Period|Participants no longer meets study criteria|0|||
131776265|NCT03110107|474460590|FG018|Treatment Period|Participants no longer meets study criteria|0|||
131776266|NCT03110107|474460591|FG019|Treatment Period|Participants no longer meets study criteria|0|||
131776267|NCT03110107|474460592|FG020|Treatment Period|Participants no longer meets study criteria|0|||
131776268|NCT03110107|474460593|FG021|Treatment Period|Participants no longer meets study criteria|0|||
131776269|NCT03110107|474460594|FG022|Treatment Period|Participants no longer meets study criteria|0|||
131776270|NCT03110107|474460595|FG023|Treatment Period|Participants no longer meets study criteria|1|||
131776271|NCT03110107|474460596|FG024|Treatment Period|Participants no longer meets study criteria|0|||
131776272|NCT03110107|474460597|FG025|Treatment Period|Participants no longer meets study criteria|0|||
131776273|NCT03110107|474460572|FG000|Treatment Period|Other Reasons|0|||
131776274|NCT03110107|474460573|FG001|Treatment Period|Other Reasons|0|||
131776275|NCT03110107|474460574|FG002|Treatment Period|Other Reasons|1|||
131776276|NCT03110107|474460575|FG003|Treatment Period|Other Reasons|1|||
131776277|NCT03110107|474460576|FG004|Treatment Period|Other Reasons|0|||
131776278|NCT03110107|474460577|FG005|Treatment Period|Other Reasons|1|||
131776279|NCT03110107|474460578|FG006|Treatment Period|Other Reasons|0|||
131776280|NCT03110107|474460579|FG007|Treatment Period|Other Reasons|0|||
131776281|NCT03110107|474460580|FG008|Treatment Period|Other Reasons|0|||
131776282|NCT03110107|474460581|FG009|Treatment Period|Other Reasons|0|||
131776283|NCT03110107|474460582|FG010|Treatment Period|Other Reasons|0|||
131776284|NCT03110107|474460583|FG011|Treatment Period|Other Reasons|0|||
131776285|NCT03110107|474460584|FG012|Treatment Period|Other Reasons|0|||
131776286|NCT03110107|474460585|FG013|Treatment Period|Other Reasons|0|||
131776287|NCT03110107|474460586|FG014|Treatment Period|Other Reasons|0|||
131776288|NCT03110107|474460587|FG015|Treatment Period|Other Reasons|0|||
131776289|NCT03110107|474460588|FG016|Treatment Period|Other Reasons|0|||
131776290|NCT03110107|474460589|FG017|Treatment Period|Other Reasons|0|||
131776291|NCT03110107|474460590|FG018|Treatment Period|Other Reasons|0|||
131776292|NCT03110107|474460591|FG019|Treatment Period|Other Reasons|0|||
131776293|NCT03110107|474460592|FG020|Treatment Period|Other Reasons|0|||
131776294|NCT03110107|474460593|FG021|Treatment Period|Other Reasons|0|||
131776295|NCT03110107|474460594|FG022|Treatment Period|Other Reasons|0|||
131776296|NCT03110107|474460595|FG023|Treatment Period|Other Reasons|0|||
131776297|NCT03110107|474460596|FG024|Treatment Period|Other Reasons|1|||
131776298|NCT03110107|474460597|FG025|Treatment Period|Other Reasons|0|||
131776299|NCT03586427|474460606|FG000|Overall Study|Lost to Follow-up|0|||
131776300|NCT03586427|474460607|FG001|Overall Study|Lost to Follow-up|3|||
131776301|NCT03586427|474460608|FG002|Overall Study|Lost to Follow-up|1|||
131776302|NCT03586427|474460609|FG003|Overall Study|Lost to Follow-up|3|||
131776303|NCT03586427|474460610|FG004|Overall Study|Lost to Follow-up|3|||
131776304|NCT03586427|474460606|FG000|Overall Study|Withdrawal by Subject|0|||
131776305|NCT03586427|474460607|FG001|Overall Study|Withdrawal by Subject|1|||
131776306|NCT03586427|474460608|FG002|Overall Study|Withdrawal by Subject|2|||
131776307|NCT03586427|474460609|FG003|Overall Study|Withdrawal by Subject|1|||
131776308|NCT03586427|474460610|FG004|Overall Study|Withdrawal by Subject|1|||
131776309|NCT03586427|474460606|FG000|Overall Study|Adverse Event|0|||
131776310|NCT03586427|474460607|FG001|Overall Study|Adverse Event|0|||
131776311|NCT03586427|474460608|FG002|Overall Study|Adverse Event|1|||
131776312|NCT03586427|474460609|FG003|Overall Study|Adverse Event|0|||
131776313|NCT03586427|474460610|FG004|Overall Study|Adverse Event|0|||
131776314|NCT03586427|474460606|FG000|Overall Study|Protocol Violation|0|||
131776315|NCT03586427|474460607|FG001|Overall Study|Protocol Violation|0|||
131776316|NCT03586427|474460608|FG002|Overall Study|Protocol Violation|1|||
131776317|NCT03586427|474460609|FG003|Overall Study|Protocol Violation|0|||
131776318|NCT03586427|474460610|FG004|Overall Study|Protocol Violation|1|||
131776319|NCT03586427|474460606|FG000|Overall Study|Noncompliance with study drug|0|||
131776320|NCT03586427|474460607|FG001|Overall Study|Noncompliance with study drug|0|||
131776321|NCT03586427|474460608|FG002|Overall Study|Noncompliance with study drug|1|||
131776322|NCT03586427|474460609|FG003|Overall Study|Noncompliance with study drug|0|||
131557162|NCT00152971|473664438|FG002|Overall Study|Withdrawal by Subject|14|||
131776323|NCT03586427|474460610|FG004|Overall Study|Noncompliance with study drug|0|||
131776324|NCT03193996|474460611|FG000|Overall Study|Withdrawal by Subject|4|||
131776325|NCT03193996|474460611|FG000|Overall Study|Lost to Follow-up|4|||
131776326|NCT03193996|474460611|FG000|Overall Study|Physician Decision|2|||
131776327|NCT03193996|474460611|FG000|Overall Study|Pregnancy|1|||
131776328|NCT03193996|474460611|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
131776329|NCT03193996|474460611|FG000|Overall Study|Complicating disease|1|||
131776330|NCT00494234|474460612|FG000|Overall Study|Withdrawal by Subject|1|||
131776331|NCT00494234|474460613|FG001|Overall Study|Withdrawal by Subject|0|||
131776332|NCT00494234|474460612|FG000|Overall Study|Disease progression|11|||
131776333|NCT00494234|474460613|FG001|Overall Study|Disease progression|8|||
131776334|NCT00494234|474460612|FG000|Overall Study|Death|2|||
131776335|NCT00494234|474460613|FG001|Overall Study|Death|1|||
131776336|NCT00423137|474460614|FG000|Overall Study|Lost to Follow-up|0|||
131689508|NCT03134599|474148294|FG002|Week 3|Lost to Follow-up|0|||
131689509|NCT03134599|474148295|FG003|Week 3|Lost to Follow-up|1|||
131689510|NCT03134599|474148296|FG004|Week 3|Lost to Follow-up|0|||
131689511|NCT03134599|474148297|FG005|Week 3|Lost to Follow-up|1|||
131689512|NCT01356407|474148300|FG000|Overall Study|Lost to Follow-up|2|||
131689513|NCT01356407|474148301|FG001|Overall Study|Lost to Follow-up|0|||
131689514|NCT01356407|474148300|FG000|Overall Study|Patient Withdrew Consent|2|||
131689515|NCT01356407|474148301|FG001|Overall Study|Patient Withdrew Consent|1|||
131689516|NCT01356407|474148300|FG000|Overall Study|Could not afford IMP administration|0|||
131689517|NCT01356407|474148301|FG001|Overall Study|Could not afford IMP administration|1|||
131689518|NCT01356407|474148300|FG000|Overall Study|Not complete Endoscopy|2|||
131689519|NCT01356407|474148301|FG001|Overall Study|Not complete Endoscopy|2|||
131689520|NCT03201458|474148302|FG000|Overall Study|No longer eligible|2|||
131689521|NCT03201458|474148303|FG001|Overall Study|No longer eligible|5|||
131689522|NCT03201458|474148302|FG000|Overall Study|Health event before starting|1|||
131689523|NCT03201458|474148303|FG001|Overall Study|Health event before starting|0|||
131689524|NCT03201458|474148302|FG000|Overall Study|Physician Decision|1|||
131689525|NCT03201458|474148303|FG001|Overall Study|Physician Decision|0|||
131689526|NCT00750737|474148304|FG000|Overall Study|Withdrawal by Subject|3|||
131689527|NCT00750737|474148305|FG001|Overall Study|Withdrawal by Subject|3|||
131689528|NCT01389752|474148307|FG000|Study Period 1|Sponsor decision|0|||
131689529|NCT01389752|474148308|FG001|Study Period 1|Sponsor decision|2|||
131689530|NCT01389752|474148307|FG000|Study Period 2|Sponsor decision|1|||
131689531|NCT01389752|474148308|FG001|Study Period 2|Sponsor decision|0|||
131689532|NCT03975920|474148319|FG000|Overall Study|Lost to Follow-up|1|||
131689533|NCT03975920|474148320|FG001|Overall Study|Lost to Follow-up|2|||
131689534|NCT03975920|474148319|FG000|Overall Study|Protocol Violation|1|||
131689535|NCT03975920|474148320|FG001|Overall Study|Protocol Violation|1|||
131689536|NCT03975920|474148319|FG000|Overall Study|Did not complete survey|2|||
131689537|NCT03975920|474148320|FG001|Overall Study|Did not complete survey|1|||
131689538|NCT04251910|474148324|FG000|Overall Study|Covid 19 lockdown|0|||
131689539|NCT04251910|474148325|FG001|Overall Study|Covid 19 lockdown|5|||
131689540|NCT04251910|474148326|FG002|Overall Study|Covid 19 lockdown|0|||
131689541|NCT04251910|474148327|FG003|Overall Study|Covid 19 lockdown|4|||
131689542|NCT04251910|474148328|FG004|Overall Study|Covid 19 lockdown|0|||
131689543|NCT04251910|474148329|FG005|Overall Study|Covid 19 lockdown|0|||
131689544|NCT04251910|474148324|FG000|Overall Study|Assisted living facility was closed|0|||
131689545|NCT04251910|474148325|FG001|Overall Study|Assisted living facility was closed|0|||
131689546|NCT04251910|474148326|FG002|Overall Study|Assisted living facility was closed|0|||
131689547|NCT04251910|474148327|FG003|Overall Study|Assisted living facility was closed|0|||
131689548|NCT04251910|474148328|FG004|Overall Study|Assisted living facility was closed|1|||
131689549|NCT04251910|474148329|FG005|Overall Study|Assisted living facility was closed|0|||
131689550|NCT02230384|474148332|FG000|Phase 1|Lost to Follow-up|1|||
131689551|NCT02230384|474148333|FG001|Phase 1|Lost to Follow-up|0|||
131689552|NCT02230384|474148332|FG000|Phase 1|Physician Decision|0|||
131689553|NCT02230384|474148333|FG001|Phase 1|Physician Decision|1|||
131689554|NCT02230384|474148332|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
131689555|NCT02230384|474148333|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
131689556|NCT02230384|474148332|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
131689557|NCT02230384|474148333|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
131689558|NCT02230384|474148332|FG000|Phase 2 - Switch|Adverse Event|2|||
131689559|NCT02230384|474148333|FG001|Phase 2 - Switch|Adverse Event|0|||
131689560|NCT00808236|474148334|FG000|Overall Study|Was not resuscitated|50|||
131689561|NCT00808236|474148335|FG001|Overall Study|Was not resuscitated|56|||
131689562|NCT00808236|474148334|FG000|Overall Study|Pre-defined exclusion|13|||
131689563|NCT00808236|474148335|FG001|Overall Study|Pre-defined exclusion|3|||
131689564|NCT00808236|474148334|FG000|Overall Study|Lost to Follow-up|1|||
131689565|NCT00808236|474148335|FG001|Overall Study|Lost to Follow-up|1|||
131689566|NCT00808236|474148334|FG000|Overall Study|Physician Decision|0|||
131689567|NCT00808236|474148335|FG001|Overall Study|Physician Decision|1|||
131689568|NCT00808236|474148334|FG000|Overall Study|Death|18|||
131689569|NCT00808236|474148335|FG001|Overall Study|Death|30|||
131689570|NCT00961220|474148336|FG000|Overall Study|Adverse Event|3|||
131689571|NCT00961220|474148336|FG000|Overall Study|Lack of Efficacy|1|||
131689572|NCT00961220|474148336|FG000|Overall Study|No IV access for O6BG|1|||
131689573|NCT00961220|474148336|FG000|Overall Study|O6BG no longer supplied|1|||
131689574|NCT00961220|474148336|FG000|Overall Study|Complete Response prior to 12 courses|1|||
131689575|NCT00825162|474148343|FG000|Overall Study|Withdrawal by Subject|11|||
131689576|NCT00825162|474148344|FG001|Overall Study|Withdrawal by Subject|13|||
131689577|NCT00825162|474148345|FG002|Overall Study|Withdrawal by Subject|3|||
131689578|NCT00825162|474148343|FG000|Overall Study|Lost to Follow-up|9|||
131689579|NCT00825162|474148344|FG001|Overall Study|Lost to Follow-up|6|||
131689580|NCT00825162|474148345|FG002|Overall Study|Lost to Follow-up|3|||
131689581|NCT00825162|474148343|FG000|Overall Study|Physician Decision|2|||
131689582|NCT00825162|474148344|FG001|Overall Study|Physician Decision|0|||
131689583|NCT00825162|474148345|FG002|Overall Study|Physician Decision|0|||
131689584|NCT00825162|474148343|FG000|Overall Study|Move away from the study area|1|||
131689585|NCT00825162|474148344|FG001|Overall Study|Move away from the study area|0|||
131689586|NCT00825162|474148345|FG002|Overall Study|Move away from the study area|0|||
131689587|NCT00825162|474148343|FG000|Overall Study|Unable to attend the study visit|5|||
131776337|NCT00423137|474460615|FG001|Overall Study|Lost to Follow-up|0|||
131776338|NCT00423137|474460616|FG002|Overall Study|Lost to Follow-up|1|||
131776339|NCT00423137|474460617|FG003|Overall Study|Lost to Follow-up|0|||
131776340|NCT00423137|474460614|FG000|Overall Study|Protocol Violation|0|||
131776341|NCT00423137|474460615|FG001|Overall Study|Protocol Violation|0|||
131776342|NCT00423137|474460616|FG002|Overall Study|Protocol Violation|0|||
131776343|NCT00423137|474460617|FG003|Overall Study|Protocol Violation|1|||
131776344|NCT00423137|474460614|FG000|Overall Study|Adverse Event Study disease worse|1|||
131776345|NCT00423137|474460615|FG001|Overall Study|Adverse Event Study disease worse|0|||
131776346|NCT00423137|474460616|FG002|Overall Study|Adverse Event Study disease worse|3|||
131776347|NCT00423137|474460617|FG003|Overall Study|Adverse Event Study disease worse|1|||
131689588|NCT00825162|474148344|FG001|Overall Study|Unable to attend the study visit|2|||
131689589|NCT00825162|474148345|FG002|Overall Study|Unable to attend the study visit|0|||
131689590|NCT00964743|474148349|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
131689591|NCT00781911|474148350|FG000|Overall Study|Adverse Event|4|||
131689592|NCT00781911|474148351|FG001|Overall Study|Adverse Event|4|||
131689593|NCT00781911|474148350|FG000|Overall Study|Withdrawal by Subject|1|||
131689594|NCT00781911|474148351|FG001|Overall Study|Withdrawal by Subject|2|||
131689595|NCT00781911|474148350|FG000|Overall Study|Physician Decision|0|||
131689596|NCT00781911|474148351|FG001|Overall Study|Physician Decision|2|||
131689597|NCT00781911|474148350|FG000|Overall Study|Sponsor Decision|1|||
131689598|NCT00781911|474148351|FG001|Overall Study|Sponsor Decision|0|||
131689599|NCT03317795|474148354|FG000|Overall Study|IUD Expulsion|1|||
131689600|NCT03317795|474148355|FG001|Overall Study|IUD Expulsion|0|||
131689601|NCT03317795|474148354|FG000|Overall Study|Lost to Follow-up|1|||
131689602|NCT03317795|474148355|FG001|Overall Study|Lost to Follow-up|3|||
131689603|NCT03317795|474148354|FG000|Overall Study|Treatment change|0|||
131689604|NCT03317795|474148355|FG001|Overall Study|Treatment change|3|||
131689605|NCT03317795|474148354|FG000|Overall Study|Intolerance of medication|0|||
131689606|NCT03317795|474148355|FG001|Overall Study|Intolerance of medication|1|||
131689607|NCT01549002|474148356|FG000|Overall Study|Excessive pain|0|||
131689608|NCT01549002|474148357|FG001|Overall Study|Excessive pain|2|||
131689609|NCT01549002|474148356|FG000|Overall Study|Moderate sedation required|0|||
131689610|NCT01549002|474148357|FG001|Overall Study|Moderate sedation required|2|||
131689611|NCT04066491|474148358|FG000|Overall Study|Randomized, not treated|0|||
131689612|NCT04066491|474148359|FG001|Overall Study|Randomized, not treated|0|||
131689613|NCT04066491|474148360|FG002|Overall Study|Randomized, not treated|2|||
131689614|NCT00495820|474148361|FG000|Overall Study|Adverse Event|1|||
131689615|NCT00495820|474148362|FG001|Overall Study|Adverse Event|1|||
131689616|NCT00820950|474148363|FG000|Overall Study|Scheduling Conflict|0|||
131689617|NCT00820950|474148364|FG001|Overall Study|Scheduling Conflict|0|||
131689618|NCT00820950|474148365|FG002|Overall Study|Scheduling Conflict|0|||
131689619|NCT00820950|474148366|FG003|Overall Study|Scheduling Conflict|0|||
131689620|NCT00820950|474148367|FG004|Overall Study|Scheduling Conflict|0|||
131689621|NCT00820950|474148368|FG005|Overall Study|Scheduling Conflict|0|||
131689622|NCT00820950|474148369|FG006|Overall Study|Scheduling Conflict|1|||
131689623|NCT00820950|474148370|FG007|Overall Study|Scheduling Conflict|1|||
131689624|NCT00820950|474148371|FG008|Overall Study|Scheduling Conflict|0|||
131689625|NCT00820950|474148372|FG009|Overall Study|Scheduling Conflict|0|||
131689626|NCT00820950|474148363|FG000|Overall Study|Protocol Violation|1|||
131689627|NCT00820950|474148364|FG001|Overall Study|Protocol Violation|1|||
131689628|NCT00820950|474148365|FG002|Overall Study|Protocol Violation|0|||
131689629|NCT00820950|474148366|FG003|Overall Study|Protocol Violation|0|||
131689630|NCT00820950|474148367|FG004|Overall Study|Protocol Violation|0|||
131689631|NCT00820950|474148368|FG005|Overall Study|Protocol Violation|0|||
131689632|NCT00820950|474148369|FG006|Overall Study|Protocol Violation|0|||
131689633|NCT00820950|474148370|FG007|Overall Study|Protocol Violation|0|||
131689634|NCT00820950|474148371|FG008|Overall Study|Protocol Violation|0|||
131776348|NCT00423137|474460614|FG000|Overall Study|Adverse Event Other|0|||
131776349|NCT00423137|474460615|FG001|Overall Study|Adverse Event Other|0|||
131689635|NCT00820950|474148372|FG009|Overall Study|Protocol Violation|0|||
131689636|NCT01423851|474148374|FG000|Whole Study|Disease progression|2|||
131689637|NCT01423851|474148375|FG001|Whole Study|Disease progression|1|||
131689638|NCT01423851|474148376|FG002|Whole Study|Disease progression|1|||
131689639|NCT01423851|474148377|FG003|Whole Study|Disease progression|4|||
131689640|NCT01423851|474148378|FG004|Whole Study|Disease progression|1|||
131689641|NCT01423851|474148379|FG005|Whole Study|Disease progression|3|||
131776350|NCT00423137|474460616|FG002|Overall Study|Adverse Event Other|2|||
131776351|NCT00423137|474460617|FG003|Overall Study|Adverse Event Other|0|||
131689642|NCT01423851|474148380|FG006|Whole Study|Disease progression|1|||
131689643|NCT01423851|474148381|FG007|Whole Study|Disease progression|4|||
131776352|NCT00593385|474460623|FG000|Overall Study|Death|14|||
131689644|NCT01423851|474148382|FG008|Whole Study|Disease progression|0|||
131689645|NCT01423851|474148383|FG009|Whole Study|Disease progression|2|||
131689646|NCT01423851|474148384|FG010|Whole Study|Disease progression|10|||
131689647|NCT01423851|474148374|FG000|Whole Study|Physician Decision|0|||
131689648|NCT01423851|474148375|FG001|Whole Study|Physician Decision|1|||
131689649|NCT01423851|474148376|FG002|Whole Study|Physician Decision|2|||
131689650|NCT01423851|474148377|FG003|Whole Study|Physician Decision|0|||
131689651|NCT01423851|474148378|FG004|Whole Study|Physician Decision|2|||
131689652|NCT01423851|474148379|FG005|Whole Study|Physician Decision|0|||
131689653|NCT01423851|474148380|FG006|Whole Study|Physician Decision|2|||
131689654|NCT01423851|474148381|FG007|Whole Study|Physician Decision|1|||
131689655|NCT01423851|474148382|FG008|Whole Study|Physician Decision|3|||
131689656|NCT01423851|474148383|FG009|Whole Study|Physician Decision|4|||
131689657|NCT01423851|474148384|FG010|Whole Study|Physician Decision|12|||
131689658|NCT01423851|474148374|FG000|Whole Study|Withdrawal by Subject|1|||
131689659|NCT01423851|474148375|FG001|Whole Study|Withdrawal by Subject|1|||
131689660|NCT01423851|474148376|FG002|Whole Study|Withdrawal by Subject|0|||
131689661|NCT01423851|474148377|FG003|Whole Study|Withdrawal by Subject|0|||
131689662|NCT01423851|474148378|FG004|Whole Study|Withdrawal by Subject|0|||
131689663|NCT01423851|474148379|FG005|Whole Study|Withdrawal by Subject|0|||
131689664|NCT01423851|474148380|FG006|Whole Study|Withdrawal by Subject|0|||
131689665|NCT01423851|474148381|FG007|Whole Study|Withdrawal by Subject|0|||
131689666|NCT01423851|474148382|FG008|Whole Study|Withdrawal by Subject|2|||
131689667|NCT01423851|474148383|FG009|Whole Study|Withdrawal by Subject|0|||
131689668|NCT01423851|474148384|FG010|Whole Study|Withdrawal by Subject|4|||
131689669|NCT01423851|474148374|FG000|Whole Study|Adverse Event|0|||
131689670|NCT01423851|474148375|FG001|Whole Study|Adverse Event|0|||
131689671|NCT01423851|474148376|FG002|Whole Study|Adverse Event|0|||
131689672|NCT01423851|474148377|FG003|Whole Study|Adverse Event|2|||
131689673|NCT01423851|474148378|FG004|Whole Study|Adverse Event|0|||
131689674|NCT01423851|474148379|FG005|Whole Study|Adverse Event|0|||
131689675|NCT01423851|474148380|FG006|Whole Study|Adverse Event|0|||
131689676|NCT01423851|474148381|FG007|Whole Study|Adverse Event|3|||
131689677|NCT01423851|474148382|FG008|Whole Study|Adverse Event|3|||
131689678|NCT01423851|474148383|FG009|Whole Study|Adverse Event|2|||
131689679|NCT01423851|474148384|FG010|Whole Study|Adverse Event|3|||
131689680|NCT03416153|474148385|FG000|Overall Study|Physician Decision|1|||
131689681|NCT03416153|474148386|FG001|Overall Study|Physician Decision|1|||
131689682|NCT03416153|474148385|FG000|Overall Study|Withdrawal by Subject|1|||
131689683|NCT03416153|474148386|FG001|Overall Study|Withdrawal by Subject|0|||
131689684|NCT02830880|474149937|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
131689685|NCT02830880|474149937|FG000|Overall Study|Death|1|||
131689686|NCT02830880|474149937|FG000|Overall Study|Physician Decision|1|||
131689687|NCT01040351|474149938|FG000|Overall Study|poor ovarian response|1|||
131689688|NCT01040351|474149939|FG001|Overall Study|poor ovarian response|2|||
131689689|NCT01230307|474149940|FG000|Overall Study|LVAD Placement|0|||
131689690|NCT01230307|474149941|FG001|Overall Study|LVAD Placement|2|||
131689691|NCT00530894|474149945|FG000|Overall Study|Death|84|||
131689692|NCT00530894|474149946|FG001|Overall Study|Death|89|||
131689693|NCT00530894|474149947|FG002|Overall Study|Death|55|||
131689694|NCT00530894|474149948|FG003|Overall Study|Death|89|||
131689695|NCT00530894|474149945|FG000|Overall Study|Lost to Follow-up|1|||
131689696|NCT00530894|474149946|FG001|Overall Study|Lost to Follow-up|3|||
131689697|NCT00530894|474149947|FG002|Overall Study|Lost to Follow-up|0|||
131689698|NCT00530894|474149948|FG003|Overall Study|Lost to Follow-up|0|||
131689699|NCT00530894|474149945|FG000|Overall Study|Withdrawal by Subject|1|||
131689700|NCT00530894|474149946|FG001|Overall Study|Withdrawal by Subject|23|||
131689701|NCT00530894|474149947|FG002|Overall Study|Withdrawal by Subject|0|||
131689702|NCT00530894|474149948|FG003|Overall Study|Withdrawal by Subject|5|||
131689703|NCT00530894|474149945|FG000|Overall Study|Alive and censored prior to 1 year|2|||
131689704|NCT00530894|474149946|FG001|Overall Study|Alive and censored prior to 1 year|0|||
131689705|NCT00530894|474149947|FG002|Overall Study|Alive and censored prior to 1 year|0|||
131689706|NCT00530894|474149948|FG003|Overall Study|Alive and censored prior to 1 year|0|||
131689707|NCT01230242|474149949|FG000|Overall Study|Physician Decision|2|||
131689708|NCT01230242|474149949|FG000|Overall Study|Withdrawal by Subject|1|||
131689709|NCT02256540|474149950|FG000|Overall Study|Withdrawal by Subject|0|||
131689710|NCT02256540|474149951|FG001|Overall Study|Withdrawal by Subject|1|||
131689711|NCT02256540|474149952|FG002|Overall Study|Withdrawal by Subject|1|||
131689712|NCT02256540|474149950|FG000|Overall Study|Back pain preventing exercise|0|||
131689713|NCT02256540|474149951|FG001|Overall Study|Back pain preventing exercise|0|||
131689714|NCT02256540|474149952|FG002|Overall Study|Back pain preventing exercise|1|||
131689715|NCT04329702|474149959|FG000|Overall Study|illness|3|||
131689716|NCT04329702|474149960|FG001|Overall Study|illness|4|||
131689717|NCT04329702|474149961|FG002|Overall Study|illness|0|||
131689718|NCT04329702|474149959|FG000|Overall Study|Lost to Follow-up|0|||
131689719|NCT04329702|474149960|FG001|Overall Study|Lost to Follow-up|0|||
131689720|NCT04329702|474149961|FG002|Overall Study|Lost to Follow-up|2|||
131689721|NCT04329702|474149959|FG000|Overall Study|Death|0|||
131689722|NCT04329702|474149960|FG001|Overall Study|Death|2|||
131689723|NCT04329702|474149961|FG002|Overall Study|Death|0|||
131689724|NCT03719690|474149968|FG000|Overall Study|Withdrawal by Subject|5|||
131689725|NCT03719690|474149969|FG001|Overall Study|Withdrawal by Subject|10|||
131689726|NCT03719690|474149968|FG000|Overall Study|Death|40|||
131689727|NCT03719690|474149969|FG001|Overall Study|Death|149|||
131689728|NCT03719690|474149968|FG000|Overall Study|Miscellaneous|12|||
131689729|NCT03719690|474149969|FG001|Overall Study|Miscellaneous|56|||
131689730|NCT03719690|474149968|FG000|Overall Study|Lost to Follow-up|2|||
131689731|NCT03719690|474149969|FG001|Overall Study|Lost to Follow-up|18|||
131689732|NCT03719690|474149968|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
131689733|NCT03719690|474149969|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
131776353|NCT00593385|474460623|FG000|Overall Study|Lost to Follow-up|17|||
131689734|NCT00841568|474149971|FG000|Overall Study|Adverse Event|1|||
131689735|NCT00841568|474149971|FG000|Overall Study|Death|1|||
131689736|NCT00841568|474149971|FG000|Overall Study|Withdrawal by Subject|2|||
131689737|NCT00841568|474149971|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
131689738|NCT01087775|474149972|FG000|Overall Study|failed inclusion criteria|2|||
131689739|NCT05289570|474149976|FG000|Overall Study|Physician Decision|1|||
131689740|NCT02424253|474149981|FG000|Overall Study|Other, unspecified|1|||
131689741|NCT02424253|474149982|FG001|Overall Study|Other, unspecified|0|||
131689742|NCT02424253|474149981|FG000|Overall Study|Compliance problems|1|||
131689743|NCT02424253|474149982|FG001|Overall Study|Compliance problems|0|||
131689744|NCT02424253|474149981|FG000|Overall Study|Physician Decision|2|||
131689745|NCT02424253|474149982|FG001|Overall Study|Physician Decision|0|||
131689746|NCT02424253|474149981|FG000|Overall Study|Lack of Efficacy|0|||
131689747|NCT02424253|474149982|FG001|Overall Study|Lack of Efficacy|7|||
131689748|NCT02424253|474149981|FG000|Overall Study|Adverse Event|2|||
131689749|NCT02424253|474149982|FG001|Overall Study|Adverse Event|0|||
131689750|NCT02424253|474149981|FG000|Overall Study|Consent withdrawn by subject|4|||
131689751|NCT02424253|474149982|FG001|Overall Study|Consent withdrawn by subject|1|||
131689752|NCT02424253|474149981|FG000|Overall Study|Lost to Follow-up|1|||
131689753|NCT02424253|474149982|FG001|Overall Study|Lost to Follow-up|1|||
131689754|NCT02290873|474149985|FG000|Overall Study|Withdrawal by Subject|0|||
131689755|NCT02290873|474149986|FG001|Overall Study|Withdrawal by Subject|1|||
131689756|NCT02290873|474149987|FG002|Overall Study|Withdrawal by Subject|1|||
131689757|NCT02290873|474149985|FG000|Overall Study|Nellcor device error|1|||
131689758|NCT02290873|474149986|FG001|Overall Study|Nellcor device error|0|||
131689759|NCT02290873|474149987|FG002|Overall Study|Nellcor device error|0|||
131689760|NCT02290873|474149985|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
131689761|NCT02290873|474149986|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
131689762|NCT02290873|474149987|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
131689763|NCT02290873|474149985|FG000|Overall Study|Protocol Violation|0|||
131689764|NCT02290873|474149986|FG001|Overall Study|Protocol Violation|0|||
131689765|NCT02290873|474149987|FG002|Overall Study|Protocol Violation|1|||
131689766|NCT02370615|474149988|FG000|Overall Study|Adverse Event|1|||
131689767|NCT02370615|474149989|FG001|Overall Study|Adverse Event|0|||
131689768|NCT01378104|474149990|FG000|Overall Study|Adverse Event|8|||
131689769|NCT01378104|474149991|FG001|Overall Study|Adverse Event|8|||
131689770|NCT01378104|474149990|FG000|Overall Study|Lack of Efficacy|7|||
131689771|NCT01378104|474149991|FG001|Overall Study|Lack of Efficacy|5|||
131689772|NCT01378104|474149990|FG000|Overall Study|Withdrawal by Subject|12|||
131689773|NCT01378104|474149991|FG001|Overall Study|Withdrawal by Subject|13|||
131689774|NCT02700997|474149992|FG000|Overall Study|Did not undergo CT imaging|1|||
131689775|NCT02700997|474149992|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
131689776|NCT01519765|474149993|FG000|Overall Study|Adverse Event|0|||
131689777|NCT01519765|474149994|FG001|Overall Study|Adverse Event|1|||
131689778|NCT01519765|474149993|FG000|Overall Study|Lack of Efficacy|2|||
131689779|NCT01519765|474149994|FG001|Overall Study|Lack of Efficacy|0|||
131689780|NCT01519765|474149993|FG000|Overall Study|Protocol Violation|1|||
131689781|NCT01519765|474149994|FG001|Overall Study|Protocol Violation|0|||
131689782|NCT01519765|474149993|FG000|Overall Study|Withdrawal by Subject|0|||
131689783|NCT01519765|474149994|FG001|Overall Study|Withdrawal by Subject|1|||
131689784|NCT03610724|474149995|FG000|Overall Study|Death|17|||
131689785|NCT03610724|474149995|FG000|Overall Study|Lost to Follow-up|1|||
131689786|NCT03610724|474149995|FG000|Overall Study|Physician Decision|1|||
131689787|NCT03610724|474149995|FG000|Overall Study|Died prior to infusion|1|||
131689788|NCT01473563|474149996|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
131689789|NCT02354222|474149997|FG000|Overall Study|Adverse Event|0|||
131776354|NCT00593385|474460623|FG000|Overall Study|Withdrawal by Subject|9|||
131776355|NCT01471197|474460624|FG000|Overall Study|Disease Progression|4|||
131776356|NCT01471197|474460625|FG001|Overall Study|Disease Progression|2|||
131776357|NCT01471197|474460624|FG000|Overall Study|Death|1|||
131776358|NCT01471197|474460625|FG001|Overall Study|Death|0|||
131776359|NCT01471197|474460624|FG000|Overall Study|Study Drug Toxicity|1|||
131776360|NCT01471197|474460625|FG001|Overall Study|Study Drug Toxicity|0|||
131776361|NCT00924313|474460631|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
131776362|NCT03557775|474460632|FG000|Overall Study|Withdrawal by Subject|1|||
131776363|NCT03557775|474460633|FG001|Overall Study|Withdrawal by Subject|2|||
131776364|NCT03557775|474460634|FG002|Overall Study|Withdrawal by Subject|4|||
131689790|NCT02354222|474149998|FG001|Overall Study|Adverse Event|3|||
131689791|NCT02354222|474149997|FG000|Overall Study|Physician Decision|1|||
131689792|NCT02354222|474149998|FG001|Overall Study|Physician Decision|1|||
131689793|NCT02354222|474149997|FG000|Overall Study|Pregnancy|1|||
131689794|NCT02354222|474149998|FG001|Overall Study|Pregnancy|0|||
131776365|NCT03557775|474460632|FG000|Overall Study|Physician Decision|0|||
131776366|NCT03557775|474460633|FG001|Overall Study|Physician Decision|1|||
131776367|NCT03557775|474460634|FG002|Overall Study|Physician Decision|0|||
131776368|NCT02255422|474460635|FG000|Overall Study|Withdrawal by Subject|0|||
131776369|NCT02255422|474460636|FG001|Overall Study|Withdrawal by Subject|0|||
131776370|NCT02255422|474460637|FG002|Overall Study|Withdrawal by Subject|0|||
131776371|NCT02255422|474460638|FG003|Overall Study|Withdrawal by Subject|0|||
131776372|NCT02255422|474460639|FG004|Overall Study|Withdrawal by Subject|0|||
131776373|NCT02255422|474460640|FG005|Overall Study|Withdrawal by Subject|0|||
131776374|NCT02255422|474460641|FG006|Overall Study|Withdrawal by Subject|2|||
131776375|NCT02255422|474460635|FG000|Overall Study|Lost to Follow-up|0|||
131776376|NCT02255422|474460636|FG001|Overall Study|Lost to Follow-up|0|||
131776377|NCT02255422|474460637|FG002|Overall Study|Lost to Follow-up|1|||
131776378|NCT02255422|474460638|FG003|Overall Study|Lost to Follow-up|0|||
131776379|NCT02255422|474460639|FG004|Overall Study|Lost to Follow-up|0|||
131776380|NCT02255422|474460640|FG005|Overall Study|Lost to Follow-up|0|||
131776381|NCT02255422|474460641|FG006|Overall Study|Lost to Follow-up|0|||
131776382|NCT02268214|474460644|FG000|Overall Study|Subject no longer meets study criteria|0|||
131776383|NCT02268214|474460645|FG001|Overall Study|Subject no longer meets study criteria|2|||
131776384|NCT02268214|474460646|FG002|Overall Study|Subject no longer meets study criteria|0|||
131776385|NCT02268214|474460644|FG000|Overall Study|Pregnancy|2|||
131776386|NCT02268214|474460645|FG001|Overall Study|Pregnancy|2|||
131776387|NCT02268214|474460646|FG002|Overall Study|Pregnancy|1|||
131776388|NCT02268214|474460644|FG000|Overall Study|Lost to Follow-up|3|||
131776389|NCT02268214|474460645|FG001|Overall Study|Lost to Follow-up|3|||
131776390|NCT02268214|474460646|FG002|Overall Study|Lost to Follow-up|4|||
131557163|NCT00152971|473664436|FG000|Overall Study|Other|3|||
131689795|NCT02354222|474149997|FG000|Overall Study|Withdrawal by Subject|2|||
131689796|NCT02354222|474149998|FG001|Overall Study|Withdrawal by Subject|3|||
131689797|NCT02354222|474149997|FG000|Overall Study|Conflict with the stopping criteria|0|||
131689798|NCT02354222|474149998|FG001|Overall Study|Conflict with the stopping criteria|4|||
131689799|NCT00786565|474149999|FG000|Enrollment Prior to Surgery|Site Closed|3|||
131689800|NCT00786565|474149999|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
131689801|NCT00786565|474149999|FG000|Post Surgery|Abnormal macular pucker|1|||
131689802|NCT00786565|474149999|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
131689803|NCT00432042|474150009|FG000|Overall Study|Protocol Violation|2|||
131689804|NCT00432042|474150010|FG001|Overall Study|Protocol Violation|0|||
131689805|NCT00432042|474150011|FG002|Overall Study|Protocol Violation|0|||
131689806|NCT00432042|474150009|FG000|Overall Study|Withdrawal by Subject|0|||
131689807|NCT00432042|474150010|FG001|Overall Study|Withdrawal by Subject|0|||
131689808|NCT00432042|474150011|FG002|Overall Study|Withdrawal by Subject|2|||
131689809|NCT00432042|474150009|FG000|Overall Study|Lost to Follow-up|5|||
131689810|NCT00432042|474150010|FG001|Overall Study|Lost to Follow-up|1|||
131689811|NCT00432042|474150011|FG002|Overall Study|Lost to Follow-up|0|||
131689812|NCT01585272|474150013|FG000|Overall Study|Adverse Event|22|||
131776391|NCT02268214|474460644|FG000|Overall Study|Lack of Efficacy|1|||
131776392|NCT02268214|474460645|FG001|Overall Study|Lack of Efficacy|0|||
131776393|NCT02268214|474460646|FG002|Overall Study|Lack of Efficacy|2|||
131776394|NCT02268214|474460644|FG000|Overall Study|Adverse Event|11|||
131776395|NCT02268214|474460645|FG001|Overall Study|Adverse Event|14|||
131557164|NCT00152971|473664437|FG001|Overall Study|Other|5|||
131776396|NCT02268214|474460646|FG002|Overall Study|Adverse Event|9|||
131776397|NCT02268214|474460644|FG000|Overall Study|Withdrawal by Subject|4|||
131776398|NCT02268214|474460645|FG001|Overall Study|Withdrawal by Subject|5|||
131776399|NCT02268214|474460646|FG002|Overall Study|Withdrawal by Subject|10|||
131776400|NCT02268214|474460644|FG000|Overall Study|Subject request to discontinue treatment|10|||
131776401|NCT02268214|474460645|FG001|Overall Study|Subject request to discontinue treatment|8|||
131689813|NCT01585272|474150013|FG000|Overall Study|Protocol Violation|7|||
131689814|NCT01585272|474150013|FG000|Overall Study|Withdrawal by Subject|10|||
131689815|NCT03765138|474150018|FG000|Overall Study|Lost to Follow-up|1|||
131689816|NCT03803059|474150020|FG000|Overall Study|Protocol Violation|2|||
131689817|NCT03803059|474150020|FG000|Overall Study|Lost to Follow-up|1|||
131689818|NCT04013529|474150023|FG000|Overall Study|Withdrawal by Subject|1|||
131689819|NCT04013529|474150024|FG001|Overall Study|Withdrawal by Subject|1|||
131689820|NCT03116698|474150025|FG000|Overall Study|Adverse Event|1|||
131689821|NCT03116698|474150026|FG001|Overall Study|Adverse Event|1|||
131689822|NCT03116698|474150027|FG002|Overall Study|Adverse Event|1|||
131689823|NCT03116698|474150028|FG003|Overall Study|Adverse Event|0|||
131689824|NCT03116698|474150025|FG000|Overall Study|Withdrawal by Subject|1|||
131689825|NCT03116698|474150026|FG001|Overall Study|Withdrawal by Subject|4|||
131689826|NCT03116698|474150027|FG002|Overall Study|Withdrawal by Subject|5|||
131689827|NCT03116698|474150028|FG003|Overall Study|Withdrawal by Subject|2|||
131689828|NCT03116698|474150025|FG000|Overall Study|Lost to Follow-up|2|||
131689829|NCT03116698|474150026|FG001|Overall Study|Lost to Follow-up|0|||
131689830|NCT03116698|474150027|FG002|Overall Study|Lost to Follow-up|0|||
131689831|NCT03116698|474150028|FG003|Overall Study|Lost to Follow-up|0|||
131689832|NCT03116698|474150025|FG000|Overall Study|Physician Decision|1|||
131689833|NCT03116698|474150026|FG001|Overall Study|Physician Decision|1|||
131689834|NCT03116698|474150027|FG002|Overall Study|Physician Decision|0|||
131689835|NCT03116698|474150028|FG003|Overall Study|Physician Decision|0|||
131689836|NCT03116698|474150025|FG000|Overall Study|Protocol Violation|1|||
131689837|NCT03116698|474150026|FG001|Overall Study|Protocol Violation|0|||
131689838|NCT03116698|474150027|FG002|Overall Study|Protocol Violation|0|||
131689839|NCT03116698|474150028|FG003|Overall Study|Protocol Violation|0|||
131689840|NCT03116698|474150025|FG000|Overall Study|Death|0|||
131689841|NCT03116698|474150026|FG001|Overall Study|Death|0|||
131689842|NCT03116698|474150027|FG002|Overall Study|Death|2|||
131689843|NCT03116698|474150028|FG003|Overall Study|Death|0|||
131689844|NCT00788372|474150029|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
131689845|NCT00788372|474150029|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
131689846|NCT00788372|474150029|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
131689847|NCT00788372|474150029|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
131689848|NCT00788372|474150029|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
131689849|NCT00788372|474150029|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
131689850|NCT00788372|474150029|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
131689851|NCT03099187|474150036|FG000|Double-blind Treatment|Adverse Event|19|||
131689852|NCT03099187|474150037|FG001|Double-blind Treatment|Adverse Event|1|||
131689853|NCT03099187|474150038|FG002|Double-blind Treatment|Adverse Event|0|||
131689854|NCT03099187|474150039|FG003|Double-blind Treatment|Adverse Event|0|||
131689855|NCT03099187|474150036|FG000|Double-blind Treatment|Death|1|||
131689856|NCT03099187|474150037|FG001|Double-blind Treatment|Death|3|||
131689857|NCT03099187|474150038|FG002|Double-blind Treatment|Death|0|||
131689858|NCT03099187|474150039|FG003|Double-blind Treatment|Death|0|||
131689859|NCT03099187|474150036|FG000|Double-blind Treatment|Lack of Efficacy|1|||
131689860|NCT03099187|474150037|FG001|Double-blind Treatment|Lack of Efficacy|0|||
131689861|NCT03099187|474150038|FG002|Double-blind Treatment|Lack of Efficacy|0|||
131689862|NCT03099187|474150039|FG003|Double-blind Treatment|Lack of Efficacy|0|||
131689863|NCT03099187|474150036|FG000|Double-blind Treatment|Physician Decision|2|||
131689864|NCT03099187|474150037|FG001|Double-blind Treatment|Physician Decision|1|||
131689865|NCT03099187|474150038|FG002|Double-blind Treatment|Physician Decision|0|||
131689866|NCT03099187|474150039|FG003|Double-blind Treatment|Physician Decision|0|||
131689867|NCT03099187|474150036|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
131689868|NCT03099187|474150037|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
131689869|NCT03099187|474150038|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
131689870|NCT03099187|474150039|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
131689871|NCT03099187|474150036|FG000|Double-blind Treatment|Lung transplantation|0|||
131689872|NCT03099187|474150037|FG001|Double-blind Treatment|Lung transplantation|1|||
131689873|NCT03099187|474150038|FG002|Double-blind Treatment|Lung transplantation|0|||
131689874|NCT03099187|474150039|FG003|Double-blind Treatment|Lung transplantation|0|||
131689875|NCT03099187|474150036|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
131689876|NCT03099187|474150037|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
131689877|NCT03099187|474150038|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
131689878|NCT03099187|474150039|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
131689879|NCT03099187|474150036|FG000|Double-blind Treatment|Disease progression|0|||
131689880|NCT03099187|474150037|FG001|Double-blind Treatment|Disease progression|1|||
131689881|NCT03099187|474150038|FG002|Double-blind Treatment|Disease progression|0|||
131689882|NCT03099187|474150039|FG003|Double-blind Treatment|Disease progression|0|||
131689883|NCT03099187|474150036|FG000|Double-blind Treatment|Randomization error|0|||
131689884|NCT03099187|474150037|FG001|Double-blind Treatment|Randomization error|2|||
131689885|NCT03099187|474150038|FG002|Double-blind Treatment|Randomization error|0|||
131689886|NCT03099187|474150039|FG003|Double-blind Treatment|Randomization error|0|||
131689887|NCT03099187|474150036|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
131689888|NCT03099187|474150037|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
131689889|NCT03099187|474150038|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
131689890|NCT03099187|474150039|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
131689891|NCT03099187|474150036|FG000|12-month Safety Follow-up|Adverse Event|0|||
131689892|NCT03099187|474150037|FG001|12-month Safety Follow-up|Adverse Event|0|||
131689893|NCT03099187|474150038|FG002|12-month Safety Follow-up|Adverse Event|5|||
131689894|NCT03099187|474150039|FG003|12-month Safety Follow-up|Adverse Event|12|||
131689895|NCT03099187|474150036|FG000|12-month Safety Follow-up|Death|0|||
131689896|NCT03099187|474150037|FG001|12-month Safety Follow-up|Death|0|||
131689897|NCT03099187|474150038|FG002|12-month Safety Follow-up|Death|7|||
131689898|NCT03099187|474150039|FG003|12-month Safety Follow-up|Death|9|||
131689899|NCT03099187|474150036|FG000|12-month Safety Follow-up|Lung transplantation|0|||
131689900|NCT03099187|474150037|FG001|12-month Safety Follow-up|Lung transplantation|0|||
131689901|NCT03099187|474150038|FG002|12-month Safety Follow-up|Lung transplantation|2|||
131689902|NCT03099187|474150039|FG003|12-month Safety Follow-up|Lung transplantation|1|||
131689903|NCT03099187|474150036|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
131689904|NCT03099187|474150037|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
131689905|NCT03099187|474150038|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
131689906|NCT03099187|474150039|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
131689907|NCT03099187|474150036|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
131689908|NCT03099187|474150037|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
131689909|NCT03099187|474150038|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
131689910|NCT03099187|474150039|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
131689911|NCT03099187|474150036|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
131689912|NCT03099187|474150037|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
131689913|NCT03099187|474150038|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
131689914|NCT03099187|474150039|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
131689915|NCT03099187|474150036|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
131689916|NCT03099187|474150037|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
131689917|NCT03099187|474150038|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
131689918|NCT03099187|474150039|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
131689919|NCT05248295|474150040|FG000|Overall Study|found ineligible|4|||
131689920|NCT05248295|474150041|FG001|Overall Study|found ineligible|1|||
131689921|NCT05248295|474150040|FG000|Overall Study|Withdrawal by Subject|0|||
131689922|NCT05248295|474150041|FG001|Overall Study|Withdrawal by Subject|1|||
131689923|NCT05248295|474150040|FG000|Overall Study|Data loss: audio recording error|1|||
131689924|NCT05248295|474150041|FG001|Overall Study|Data loss: audio recording error|1|||
131689925|NCT03021499|474150044|FG000|Overall Study|Adverse Event|1|||
131689926|NCT03021499|474150045|FG001|Overall Study|Adverse Event|0|||
131689927|NCT03021499|474150044|FG000|Overall Study|Death|1|||
131689928|NCT03021499|474150045|FG001|Overall Study|Death|5|||
131689929|NCT03021499|474150044|FG000|Overall Study|Lack of Efficacy|0|||
131689930|NCT03021499|474150045|FG001|Overall Study|Lack of Efficacy|1|||
131689931|NCT03021499|474150044|FG000|Overall Study|Lost to Follow-up|1|||
131689932|NCT03021499|474150045|FG001|Overall Study|Lost to Follow-up|3|||
131689933|NCT03021499|474150044|FG000|Overall Study|Physician Decision|2|||
131689934|NCT03021499|474150045|FG001|Overall Study|Physician Decision|3|||
131689935|NCT03021499|474150044|FG000|Overall Study|Pregnancy|1|||
131689936|NCT03021499|474150045|FG001|Overall Study|Pregnancy|0|||
131689937|NCT03021499|474150044|FG000|Overall Study|Withdrawal by Subject|7|||
131689938|NCT03021499|474150045|FG001|Overall Study|Withdrawal by Subject|14|||
131689939|NCT03021499|474150044|FG000|Overall Study|Prohibited medication required|1|||
131689940|NCT03021499|474150045|FG001|Overall Study|Prohibited medication required|0|||
131689941|NCT03021499|474150044|FG000|Overall Study|Protocol non-compliance|1|||
131689942|NCT03021499|474150045|FG001|Overall Study|Protocol non-compliance|1|||
131689943|NCT03021499|474150044|FG000|Overall Study|None of the above|0|||
131689944|NCT03021499|474150045|FG001|Overall Study|None of the above|4|||
131689945|NCT03021499|474150044|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
131689946|NCT03021499|474150045|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
131689947|NCT01210690|474150046|FG000|Overall Study|Adverse Event|7|||
131689948|NCT01210690|474150046|FG000|Overall Study|Lack of Efficacy|12|||
131689949|NCT01210690|474150046|FG000|Overall Study|Lost to Follow-up|3|||
131689950|NCT01210690|474150046|FG000|Overall Study|Disease Remission|1|||
131689951|NCT01210690|474150046|FG000|Overall Study|Withdrawal by Subject|1|||
131689952|NCT01210690|474150046|FG000|Overall Study|Patient refused to swallow|1|||
131689953|NCT01210690|474150046|FG000|Overall Study|Patient could not take glucose|1|||
131689954|NCT00470054|474150047|FG000|Overall Study|Ineligible|1|||
131689955|NCT04869345|474150054|FG000|Overall Study|Lost to Follow-up|8|||
131689956|NCT04869345|474150055|FG001|Overall Study|Lost to Follow-up|3|||
131689957|NCT00528021|474150059|FG000|Overall Study|Lack of Efficacy|17|||
131689958|NCT00528021|474150060|FG001|Overall Study|Lack of Efficacy|13|||
131689959|NCT00528021|474150061|FG002|Overall Study|Lack of Efficacy|7|||
131689960|NCT00528021|474150062|FG003|Overall Study|Lack of Efficacy|9|||
131689961|NCT04050982|474150063|FG000|Overall Study|Did not meet eligibility criteria|0|||
131689962|NCT04050982|474150064|FG001|Overall Study|Did not meet eligibility criteria|1|||
131689963|NCT04050982|474150065|FG002|Overall Study|Did not meet eligibility criteria|0|||
131689964|NCT04050982|474150063|FG000|Overall Study|Withdrawal by Subject|1|||
131689965|NCT04050982|474150064|FG001|Overall Study|Withdrawal by Subject|0|||
131689966|NCT04050982|474150065|FG002|Overall Study|Withdrawal by Subject|0|||
131689967|NCT04050982|474150063|FG000|Overall Study|Unable to enroll on platform|1|||
131689968|NCT04050982|474150064|FG001|Overall Study|Unable to enroll on platform|0|||
131689969|NCT04050982|474150065|FG002|Overall Study|Unable to enroll on platform|0|||
131689970|NCT01246583|474150066|FG000|Overall Study|Lost to Follow-up|0|||
131689971|NCT01246583|474150067|FG001|Overall Study|Lost to Follow-up|0|||
131689972|NCT01246583|474150068|FG002|Overall Study|Lost to Follow-up|0|||
131689973|NCT01246583|474150069|FG003|Overall Study|Lost to Follow-up|1|||
131689974|NCT01246583|474150066|FG000|Overall Study|Protocol Violation|0|||
131689975|NCT01246583|474150067|FG001|Overall Study|Protocol Violation|0|||
131689976|NCT01246583|474150068|FG002|Overall Study|Protocol Violation|1|||
131689977|NCT01246583|474150069|FG003|Overall Study|Protocol Violation|0|||
131719485|NCT01856673|474253333|FG000|Overall Study|Unknown reasons|9|||
131776402|NCT02268214|474460646|FG002|Overall Study|Subject request to discontinue treatment|6|||
131557165|NCT00152971|473664438|FG002|Overall Study|Other|5|||
131689978|NCT01246583|474150066|FG000|Overall Study|Withdrawal by Subject|1|||
131689979|NCT01246583|474150067|FG001|Overall Study|Withdrawal by Subject|0|||
131689980|NCT01246583|474150068|FG002|Overall Study|Withdrawal by Subject|0|||
131689981|NCT01246583|474150069|FG003|Overall Study|Withdrawal by Subject|0|||
131689982|NCT05054114|474150070|FG000|Overall Study|Protocol Violation|13|||
131689983|NCT05054114|474150071|FG001|Overall Study|Protocol Violation|1|||
131689984|NCT05054114|474150070|FG000|Overall Study|Pregnancy|0|||
131776403|NCT02268214|474460644|FG000|Overall Study|Poor/non-compliance|2|||
131776404|NCT02268214|474460645|FG001|Overall Study|Poor/non-compliance|1|||
131776405|NCT02268214|474460646|FG002|Overall Study|Poor/non-compliance|2|||
131776406|NCT02268214|474460644|FG000|Overall Study|Other reasons|7|||
131776407|NCT02268214|474460645|FG001|Overall Study|Other reasons|3|||
131689985|NCT05054114|474150071|FG001|Overall Study|Pregnancy|1|||
131689986|NCT02116777|474150074|FG000|Overall Study|Adverse Event|0|||
131689987|NCT02116777|474150075|FG001|Overall Study|Adverse Event|0|||
131689988|NCT02116777|474150076|FG002|Overall Study|Adverse Event|0|||
131689989|NCT02116777|474150077|FG003|Overall Study|Adverse Event|0|||
131689990|NCT02116777|474150078|FG004|Overall Study|Adverse Event|2|||
131689991|NCT02116777|474150079|FG005|Overall Study|Adverse Event|2|||
131689992|NCT02116777|474150080|FG006|Overall Study|Adverse Event|0|||
131689993|NCT02116777|474150074|FG000|Overall Study|Death|0|||
131689994|NCT02116777|474150075|FG001|Overall Study|Death|0|||
131689995|NCT02116777|474150076|FG002|Overall Study|Death|0|||
131689996|NCT02116777|474150077|FG003|Overall Study|Death|1|||
131689997|NCT02116777|474150078|FG004|Overall Study|Death|0|||
131689998|NCT02116777|474150079|FG005|Overall Study|Death|0|||
131689999|NCT02116777|474150080|FG006|Overall Study|Death|0|||
131690000|NCT02116777|474150074|FG000|Overall Study|Lack of Efficacy|3|||
131690001|NCT02116777|474150075|FG001|Overall Study|Lack of Efficacy|3|||
131690002|NCT02116777|474150076|FG002|Overall Study|Lack of Efficacy|3|||
131690003|NCT02116777|474150077|FG003|Overall Study|Lack of Efficacy|8|||
131690004|NCT02116777|474150078|FG004|Overall Study|Lack of Efficacy|4|||
131690005|NCT02116777|474150079|FG005|Overall Study|Lack of Efficacy|1|||
131690006|NCT02116777|474150080|FG006|Overall Study|Lack of Efficacy|9|||
131690007|NCT02116777|474150074|FG000|Overall Study|Physician Decision|0|||
131690008|NCT02116777|474150075|FG001|Overall Study|Physician Decision|0|||
131690009|NCT02116777|474150076|FG002|Overall Study|Physician Decision|0|||
131690010|NCT02116777|474150077|FG003|Overall Study|Physician Decision|2|||
131690011|NCT02116777|474150078|FG004|Overall Study|Physician Decision|0|||
131690012|NCT02116777|474150079|FG005|Overall Study|Physician Decision|0|||
131690013|NCT02116777|474150080|FG006|Overall Study|Physician Decision|0|||
131690014|NCT02116777|474150074|FG000|Overall Study|Protocol Violation|0|||
131690015|NCT02116777|474150075|FG001|Overall Study|Protocol Violation|0|||
131690016|NCT02116777|474150076|FG002|Overall Study|Protocol Violation|0|||
131690017|NCT02116777|474150077|FG003|Overall Study|Protocol Violation|1|||
131690018|NCT02116777|474150078|FG004|Overall Study|Protocol Violation|0|||
131690019|NCT02116777|474150079|FG005|Overall Study|Protocol Violation|0|||
131557166|NCT00152971|473664436|FG000|Treatment|Adverse Event|49|||
131690020|NCT02116777|474150080|FG006|Overall Study|Protocol Violation|0|||
131690021|NCT02116777|474150074|FG000|Overall Study|Withdrawal by Subject|0|||
131557167|NCT00152971|473664437|FG001|Treatment|Adverse Event|40|||
131690022|NCT02116777|474150075|FG001|Overall Study|Withdrawal by Subject|0|||
131690023|NCT02116777|474150076|FG002|Overall Study|Withdrawal by Subject|0|||
131690024|NCT02116777|474150077|FG003|Overall Study|Withdrawal by Subject|1|||
131690025|NCT02116777|474150078|FG004|Overall Study|Withdrawal by Subject|0|||
131690026|NCT02116777|474150079|FG005|Overall Study|Withdrawal by Subject|0|||
131690027|NCT02116777|474150080|FG006|Overall Study|Withdrawal by Subject|0|||
131690028|NCT00733954|474150081|FG000|Overall Study|Lost to Follow-up|5|||
131690029|NCT00733954|474150082|FG001|Overall Study|Lost to Follow-up|2|||
131776408|NCT02268214|474460646|FG002|Overall Study|Other reasons|3|||
131776409|NCT02268214|474460644|FG000|Overall Study|Not entering long-term period|2|||
131690030|NCT00733954|474150081|FG000|Overall Study|Protocol Violation|1|||
131690031|NCT00733954|474150082|FG001|Overall Study|Protocol Violation|0|||
131776410|NCT02268214|474460645|FG001|Overall Study|Not entering long-term period|3|||
131776411|NCT02268214|474460646|FG002|Overall Study|Not entering long-term period|5|||
131776412|NCT04342390|474460647|FG000|Overall Study|Lost to Follow-up|3|||
131776413|NCT04342390|474460648|FG001|Overall Study|Lost to Follow-up|0|||
131776414|NCT04089566|474460661|FG000|Overall Study|Death|0|||
131776415|NCT04089566|474460662|FG001|Overall Study|Death|6|||
131776416|NCT04089566|474460663|FG002|Overall Study|Death|10|||
131776417|NCT04089566|474460664|FG003|Overall Study|Death|0|||
131776418|NCT04089566|474460665|FG004|Overall Study|Death|0|||
131776419|NCT04089566|474460666|FG005|Overall Study|Death|0|||
131776420|NCT04089566|474460661|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
131776421|NCT04089566|474460662|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
131776422|NCT04089566|474460663|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
131776423|NCT04089566|474460664|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
131776424|NCT04089566|474460665|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
131776425|NCT04089566|474460666|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
131776426|NCT04089566|474460661|FG000|Overall Study|Reason not Specified|0|||
131776427|NCT04089566|474460662|FG001|Overall Study|Reason not Specified|4|||
131776428|NCT04089566|474460663|FG002|Overall Study|Reason not Specified|4|||
131776429|NCT04089566|474460664|FG003|Overall Study|Reason not Specified|1|||
131776430|NCT04089566|474460665|FG004|Overall Study|Reason not Specified|0|||
131690032|NCT00733954|474150081|FG000|Overall Study|Withdrawal by Subject|2|||
131690033|NCT00733954|474150082|FG001|Overall Study|Withdrawal by Subject|0|||
131690034|NCT02663453|474150083|FG000|Overall Study|Death|4|||
131690035|NCT02663453|474150084|FG001|Overall Study|Death|4|||
131690036|NCT02663453|474150083|FG000|Overall Study|Withdrawal by Subject|1|||
131690037|NCT02663453|474150084|FG001|Overall Study|Withdrawal by Subject|0|||
131690038|NCT01849874|474151274|FG000|Overall Study|Death|89|||
131690039|NCT01849874|474151275|FG001|Overall Study|Death|42|||
131690040|NCT01849874|474151274|FG000|Overall Study|Withdrawal by Subject|17|||
131690041|NCT01849874|474151275|FG001|Overall Study|Withdrawal by Subject|16|||
131690042|NCT01849874|474151274|FG000|Overall Study|Lost to Follow-up|3|||
131690043|NCT01849874|474151275|FG001|Overall Study|Lost to Follow-up|2|||
131690044|NCT01849874|474151274|FG000|Overall Study|Study Termination By Sponsor|93|||
131690045|NCT01849874|474151275|FG001|Overall Study|Study Termination By Sponsor|48|||
131690046|NCT01849874|474151274|FG000|Overall Study|Completed as per protocol amendment 6|3|||
131690047|NCT01849874|474151275|FG001|Overall Study|Completed as per protocol amendment 6|0|||
131690048|NCT01849874|474151274|FG000|Overall Study|Physician Decision|7|||
131690049|NCT01849874|474151275|FG001|Overall Study|Physician Decision|1|||
131690050|NCT01849874|474151274|FG000|Overall Study|Other|16|||
131690051|NCT01849874|474151275|FG001|Overall Study|Other|4|||
131690052|NCT03551509|474151280|FG000|Overall Study|Lost to Follow-up|0|||
131690053|NCT03551509|474151281|FG001|Overall Study|Lost to Follow-up|1|||
131690054|NCT03551509|474151282|FG002|Overall Study|Lost to Follow-up|0|||
131690055|NCT01918007|474151283|FG000|Overall Study|Baseline oximetry not acceptable|11|||
131690056|NCT01918007|474151284|FG001|Overall Study|Baseline oximetry not acceptable|7|||
131690057|NCT01918007|474151283|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
131690058|NCT01918007|474151284|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
131690059|NCT01918007|474151283|FG000|Overall Study|Lost to Follow-up|4|||
131690060|NCT01918007|474151284|FG001|Overall Study|Lost to Follow-up|7|||
131690061|NCT02037295|474151286|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
131690062|NCT02037295|474151287|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
131690063|NCT02037295|474151288|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
131690064|NCT02037295|474151289|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
131690065|NCT01140451|474151290|FG000|Overall Study|Withdrawal by Subject|26|||
131690066|NCT01140451|474151291|FG001|Overall Study|Withdrawal by Subject|33|||
131690067|NCT01140451|474151290|FG000|Overall Study|Adverse Event|2|||
131690068|NCT01140451|474151291|FG001|Overall Study|Adverse Event|6|||
131690069|NCT01140451|474151290|FG000|Overall Study|Physician Decision|5|||
131690070|NCT01140451|474151291|FG001|Overall Study|Physician Decision|3|||
131690071|NCT01140451|474151290|FG000|Overall Study|Lost to Follow-up|2|||
131690072|NCT01140451|474151291|FG001|Overall Study|Lost to Follow-up|0|||
131690073|NCT01140451|474151290|FG000|Overall Study|Participants Planning Pregnancy|3|||
131690074|NCT01140451|474151291|FG001|Overall Study|Participants Planning Pregnancy|0|||
131690075|NCT00441974|474151292|FG000|Overall Study|Adverse Event|6|||
131690076|NCT00441974|474151292|FG000|Overall Study|Consent Withdrawn|35|||
131690077|NCT00441974|474151292|FG000|Overall Study|Lost to Follow-up|80|||
131690078|NCT00441974|474151292|FG000|Overall Study|Protocol Violation|7|||
131776431|NCT04089566|474460666|FG005|Overall Study|Reason not Specified|0|||
131776432|NCT01083121|474460670|FG000|Overall Study|Use of Humira outside the approved label|81|||
131776433|NCT02576951|474460676|FG000|Overall Study|Lost to Follow-up|0|||
131776434|NCT02576951|474460677|FG001|Overall Study|Lost to Follow-up|0|||
131690079|NCT02770547|474151293|FG000|Overall Study|Patient non-compliant|1|||
131690080|NCT02770547|474151294|FG001|Overall Study|Patient non-compliant|0|||
131690081|NCT02770547|474151293|FG000|Overall Study|Adverse Event|0|||
131690082|NCT02770547|474151294|FG001|Overall Study|Adverse Event|1|||
131690083|NCT00393887|474151295|FG000|Overall Study|Physician Decision|5|||
131776435|NCT02576951|474460678|FG002|Overall Study|Lost to Follow-up|2|||
131776436|NCT02576951|474460679|FG003|Overall Study|Lost to Follow-up|2|||
131776437|NCT02576951|474460676|FG000|Overall Study|Withdrawal by Subject|1|||
131776438|NCT02576951|474460677|FG001|Overall Study|Withdrawal by Subject|0|||
131776439|NCT02576951|474460678|FG002|Overall Study|Withdrawal by Subject|0|||
131776440|NCT02576951|474460679|FG003|Overall Study|Withdrawal by Subject|2|||
131776441|NCT02576951|474460676|FG000|Overall Study|Protocol Violation|0|||
131776442|NCT02576951|474460677|FG001|Overall Study|Protocol Violation|0|||
131776443|NCT02576951|474460678|FG002|Overall Study|Protocol Violation|0|||
131776444|NCT02576951|474460679|FG003|Overall Study|Protocol Violation|1|||
131776445|NCT00700115|474462467|FG000|Overall Study|Withdrawal by Subject|1|||
131776446|NCT00700115|474462468|FG001|Overall Study|Withdrawal by Subject|0|||
131776447|NCT00700115|474462467|FG000|Overall Study|Lost to Follow-up|0|||
131776448|NCT00700115|474462468|FG001|Overall Study|Lost to Follow-up|1|||
131776449|NCT02503215|474462469|FG000|Overall Study|Unable to wear compression stockings|1|||
131776450|NCT02503215|474462469|FG000|Overall Study|Unable to use positive airway pressure|2|||
131776451|NCT02983305|474462474|FG000|Overall Study|incomplete data|2|||
131776452|NCT02983305|474462475|FG001|Overall Study|incomplete data|0|||
131776453|NCT00822237|474462476|FG000|Dose 1 Vaccination|Not vaccinated|3|||
131776454|NCT00822237|474462477|FG001|Dose 1 Vaccination|Not vaccinated|0|||
131776455|NCT00822237|474462476|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
131776456|NCT00822237|474462477|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
131776457|NCT00822237|474462476|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
131776458|NCT00822237|474462477|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
131776459|NCT00822237|474462476|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
131776460|NCT00822237|474462477|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
131776461|NCT00822237|474462476|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
131776462|NCT00822237|474462477|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
131776463|NCT03433482|474462478|FG000|Overall Study|Lost to Follow-up|1|||
131776464|NCT03433482|474462479|FG001|Overall Study|Lost to Follow-up|0|||
131690084|NCT00393887|474151296|FG001|Overall Study|Physician Decision|0|||
131690085|NCT00393887|474151295|FG000|Overall Study|Lost to Follow-up|11|||
131690086|NCT00393887|474151296|FG001|Overall Study|Lost to Follow-up|9|||
131690087|NCT04962022|474151299|FG000|Period 1|Withdrawal by Subject|1|||
131690088|NCT04962022|474151300|FG001|Period 1|Withdrawal by Subject|0|||
131690089|NCT01146873|474151304|FG000|Overall Study|Transfer out|0|||
131690090|NCT01146873|474151305|FG001|Overall Study|Transfer out|6|||
131690091|NCT01967628|474151306|FG000|Overall Study|Withdrawal by Subject|2|||
131690092|NCT01967628|474151307|FG001|Overall Study|Withdrawal by Subject|0|||
131690093|NCT01967628|474151306|FG000|Overall Study|Unable to complete bronchoscopy|4|||
131690094|NCT01967628|474151307|FG001|Overall Study|Unable to complete bronchoscopy|6|||
131776465|NCT03433482|474462480|FG002|Overall Study|Lost to Follow-up|1|||
131690095|NCT01967628|474151306|FG000|Overall Study|Lost to Follow-up|1|||
131776466|NCT03433482|474462481|FG003|Overall Study|Lost to Follow-up|1|||
131776467|NCT03433482|474462478|FG000|Overall Study|Withdrawal by Subject|0|||
131776468|NCT03433482|474462479|FG001|Overall Study|Withdrawal by Subject|0|||
131776469|NCT03433482|474462480|FG002|Overall Study|Withdrawal by Subject|1|||
131690096|NCT01967628|474151307|FG001|Overall Study|Lost to Follow-up|0|||
131690097|NCT01967628|474151306|FG000|Overall Study|Low protein concentration in sample|20|||
131690098|NCT01967628|474151307|FG001|Overall Study|Low protein concentration in sample|25|||
131690099|NCT02055820|474151310|FG000|Phase I: Dose-Finding|Death|1|||
131690100|NCT02055820|474151311|FG001|Phase I: Dose-Finding|Death|0|||
131690101|NCT02055820|474151312|FG002|Phase I: Dose-Finding|Death|1|||
131690102|NCT02055820|474151313|FG003|Phase I: Dose-Finding|Death|2|||
131690103|NCT02055820|474151314|FG004|Phase I: Dose-Finding|Death|0|||
131690104|NCT02055820|474151315|FG005|Phase I: Dose-Finding|Death|1|||
131690105|NCT02055820|474151316|FG006|Phase I: Dose-Finding|Death|1|||
131690106|NCT02055820|474151317|FG007|Phase I: Dose-Finding|Death|0|||
131690107|NCT02055820|474151318|FG008|Phase I: Dose-Finding|Death|0|||
131690108|NCT02055820|474151319|FG009|Phase I: Dose-Finding|Death|0|||
131690109|NCT02055820|474151310|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690110|NCT02055820|474151311|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690111|NCT02055820|474151312|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690112|NCT02055820|474151313|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690113|NCT02055820|474151314|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690114|NCT02055820|474151315|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
131690115|NCT02055820|474151316|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690116|NCT02055820|474151317|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690117|NCT02055820|474151318|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690118|NCT02055820|474151319|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131690119|NCT02055820|474151310|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690120|NCT02055820|474151311|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690121|NCT02055820|474151312|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690122|NCT02055820|474151313|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
131690123|NCT02055820|474151314|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690124|NCT02055820|474151315|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690125|NCT02055820|474151316|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
131690126|NCT02055820|474151317|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690127|NCT02055820|474151318|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690128|NCT02055820|474151319|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
131690129|NCT02055820|474151310|FG000|Phase II: Expansion|Death|0|||
131690130|NCT02055820|474151311|FG001|Phase II: Expansion|Death|0|||
131690131|NCT02055820|474151312|FG002|Phase II: Expansion|Death|0|||
131690132|NCT02055820|474151313|FG003|Phase II: Expansion|Death|0|||
131690133|NCT02055820|474151314|FG004|Phase II: Expansion|Death|33|||
131690134|NCT02055820|474151315|FG005|Phase II: Expansion|Death|0|||
131690135|NCT02055820|474151316|FG006|Phase II: Expansion|Death|0|||
131690136|NCT02055820|474151317|FG007|Phase II: Expansion|Death|0|||
131690137|NCT02055820|474151318|FG008|Phase II: Expansion|Death|0|||
131690138|NCT02055820|474151319|FG009|Phase II: Expansion|Death|0|||
131690139|NCT02055820|474151310|FG000|Phase II: Expansion|Lost to Follow-up|0|||
131690140|NCT02055820|474151311|FG001|Phase II: Expansion|Lost to Follow-up|0|||
131690141|NCT02055820|474151312|FG002|Phase II: Expansion|Lost to Follow-up|0|||
131690142|NCT02055820|474151313|FG003|Phase II: Expansion|Lost to Follow-up|0|||
131690143|NCT02055820|474151314|FG004|Phase II: Expansion|Lost to Follow-up|4|||
131690144|NCT02055820|474151315|FG005|Phase II: Expansion|Lost to Follow-up|0|||
131690145|NCT02055820|474151316|FG006|Phase II: Expansion|Lost to Follow-up|0|||
131690146|NCT02055820|474151317|FG007|Phase II: Expansion|Lost to Follow-up|0|||
131690147|NCT02055820|474151318|FG008|Phase II: Expansion|Lost to Follow-up|0|||
131690148|NCT02055820|474151319|FG009|Phase II: Expansion|Lost to Follow-up|0|||
131690149|NCT02055820|474151310|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
131690150|NCT02055820|474151311|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
131690151|NCT02055820|474151312|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
131690152|NCT02055820|474151313|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
131776470|NCT03433482|474462481|FG003|Overall Study|Withdrawal by Subject|0|||
131776471|NCT03433482|474462478|FG000|Overall Study|Unknown reason|0|||
131776472|NCT03433482|474462479|FG001|Overall Study|Unknown reason|0|||
131776473|NCT03433482|474462480|FG002|Overall Study|Unknown reason|2|||
131776474|NCT03433482|474462481|FG003|Overall Study|Unknown reason|0|||
131776475|NCT01646268|474462482|FG000|Overall Study|Adverse Event|6|||
131776476|NCT01646268|474462483|FG001|Overall Study|Adverse Event|7|||
131776477|NCT01646268|474462482|FG000|Overall Study|Lack of Efficacy|1|||
131776478|NCT01646268|474462483|FG001|Overall Study|Lack of Efficacy|3|||
131690153|NCT02055820|474151314|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
131690154|NCT02055820|474151315|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
131690155|NCT02055820|474151316|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
131690156|NCT02055820|474151317|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
131690157|NCT02055820|474151318|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
131690158|NCT02055820|474151319|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
131690159|NCT01399788|474151321|FG000|First Intervention Period|Adverse Event|1|||
131690160|NCT01399788|474151322|FG001|First Intervention Period|Adverse Event|0|||
131690161|NCT02919436|474151323|FG000|Overall Study|Did not undergo surgery|16|||
131690162|NCT02919436|474151324|FG001|Overall Study|Did not undergo surgery|20|||
131690163|NCT02919436|474151323|FG000|Overall Study|Enrolled before trial registration|44|||
131690164|NCT02919436|474151324|FG001|Overall Study|Enrolled before trial registration|33|||
131690165|NCT03699007|474151325|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
131690166|NCT03699007|474151326|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
131690167|NCT03699007|474151325|FG000|6-month Follow Up|Lost to Follow-up|2|||
131690168|NCT03699007|474151326|FG001|6-month Follow Up|Lost to Follow-up|3|||
131776479|NCT01646268|474462482|FG000|Overall Study|Protocol Violation|0|||
131776480|NCT01646268|474462483|FG001|Overall Study|Protocol Violation|1|||
131776481|NCT01646268|474462482|FG000|Overall Study|Withdrawal by Subject|2|||
131776482|NCT01646268|474462483|FG001|Overall Study|Withdrawal by Subject|5|||
131776483|NCT01646268|474462482|FG000|Overall Study|Other|2|||
131776484|NCT01646268|474462483|FG001|Overall Study|Other|0|||
131776485|NCT01519635|474462488|FG000|Overall Study|Withdrawal by Subject|0|||
131776486|NCT01519635|474462489|FG001|Overall Study|Withdrawal by Subject|1|||
131776487|NCT01519635|474462488|FG000|Overall Study|No possibility to put a catheter|1|||
131776488|NCT01519635|474462489|FG001|Overall Study|No possibility to put a catheter|2|||
131776489|NCT02325414|474462490|FG000|Overall Study|Withdrawal by Subject|3|||
131776490|NCT02325414|474462491|FG001|Overall Study|Withdrawal by Subject|1|||
131776491|NCT02325414|474462490|FG000|Overall Study|Lost to Follow-up|5|||
131776492|NCT02325414|474462491|FG001|Overall Study|Lost to Follow-up|5|||
131776493|NCT00347776|474462492|FG000|1.5 Month Follow-up|Death|2|||
131776494|NCT00347776|474462493|FG001|1.5 Month Follow-up|Death|0|||
131776495|NCT00347776|474462494|FG002|1.5 Month Follow-up|Death|0|||
131776496|NCT00347776|474462492|FG000|1.5 Month Follow-up|reached the endpoint|12|||
131776497|NCT00347776|474462493|FG001|1.5 Month Follow-up|reached the endpoint|8|||
131776498|NCT00347776|474462494|FG002|1.5 Month Follow-up|reached the endpoint|12|||
131776499|NCT00347776|474462492|FG000|6 Month Follow-up|Death|2|||
131776500|NCT00347776|474462493|FG001|6 Month Follow-up|Death|1|||
131776501|NCT00347776|474462494|FG002|6 Month Follow-up|Death|3|||
131776502|NCT00347776|474462492|FG000|6 Month Follow-up|reached endpont|20|||
131776503|NCT00347776|474462493|FG001|6 Month Follow-up|reached endpont|12|||
131776504|NCT00347776|474462494|FG002|6 Month Follow-up|reached endpont|15|||
131776505|NCT00347776|474462492|FG000|12 Month Follow-up|Lost to Follow-up|7|||
131776506|NCT00347776|474462493|FG001|12 Month Follow-up|Lost to Follow-up|6|||
131776507|NCT00347776|474462494|FG002|12 Month Follow-up|Lost to Follow-up|6|||
131776508|NCT00347776|474462492|FG000|12 Month Follow-up|Death|3|||
131776509|NCT00347776|474462493|FG001|12 Month Follow-up|Death|4|||
131776510|NCT00347776|474462494|FG002|12 Month Follow-up|Death|4|||
131776511|NCT00347776|474462492|FG000|12 Month Follow-up|Reached endpoint|13|||
131776512|NCT00347776|474462493|FG001|12 Month Follow-up|Reached endpoint|6|||
131776513|NCT00347776|474462494|FG002|12 Month Follow-up|Reached endpoint|9|||
131776514|NCT00594568|474462495|FG000|Initial Treatment|Adverse Event|51|||
131776515|NCT00594568|474462496|FG001|Initial Treatment|Adverse Event|121|||
131776516|NCT00594568|474462497|FG002|Initial Treatment|Adverse Event|144|||
131776517|NCT00594568|474462495|FG000|Initial Treatment|Death|6|||
131776518|NCT00594568|474462496|FG001|Initial Treatment|Death|11|||
131776519|NCT00594568|474462497|FG002|Initial Treatment|Death|15|||
131776520|NCT00594568|474462495|FG000|Initial Treatment|Lost to Follow-up|4|||
131776521|NCT00594568|474462496|FG001|Initial Treatment|Lost to Follow-up|1|||
131776522|NCT00594568|474462497|FG002|Initial Treatment|Lost to Follow-up|4|||
131776523|NCT00594568|474462495|FG000|Initial Treatment|Physician Decision|3|||
131776524|NCT00594568|474462496|FG001|Initial Treatment|Physician Decision|2|||
131776525|NCT00594568|474462497|FG002|Initial Treatment|Physician Decision|4|||
131776526|NCT00594568|474462495|FG000|Initial Treatment|Protocol Violation|2|||
131776527|NCT00594568|474462496|FG001|Initial Treatment|Protocol Violation|2|||
131776528|NCT00594568|474462497|FG002|Initial Treatment|Protocol Violation|5|||
131690169|NCT04718974|474151327|FG000|Overall Study|Death|0|||
131690170|NCT04718974|474151328|FG001|Overall Study|Death|2|||
131690171|NCT04718974|474151327|FG000|Overall Study|Lost to Follow-up|10|||
131690172|NCT04718974|474151328|FG001|Overall Study|Lost to Follow-up|20|||
131690173|NCT04718974|474151327|FG000|Overall Study|Transferred out|2|||
131690174|NCT04718974|474151328|FG001|Overall Study|Transferred out|4|||
131690175|NCT01157364|474151329|FG000|Overall Study|Other Reasons|1|||
131690176|NCT01157364|474151330|FG001|Overall Study|Other Reasons|1|||
131690177|NCT01157364|474151331|FG002|Overall Study|Other Reasons|2|||
131776529|NCT00594568|474462495|FG000|Initial Treatment|Withdrawal by Subject|25|||
131690178|NCT01157364|474151332|FG003|Overall Study|Other Reasons|1|||
131690179|NCT01157364|474151333|FG004|Overall Study|Other Reasons|0|||
131776530|NCT00594568|474462496|FG001|Initial Treatment|Withdrawal by Subject|31|||
131776531|NCT00594568|474462497|FG002|Initial Treatment|Withdrawal by Subject|46|||
131776532|NCT00594568|474462495|FG000|Initial Treatment|Sponsor decision|193|||
131776533|NCT00594568|474462496|FG001|Initial Treatment|Sponsor decision|142|||
131776534|NCT00594568|474462497|FG002|Initial Treatment|Sponsor decision|147|||
131776535|NCT00594568|474462495|FG000|Initial Treatment|Caregiver decision|21|||
131436723|NCT00607087|473224114|FG001|Period 2|Withdrawal by Subject|1|||
131690180|NCT01157364|474151334|FG005|Overall Study|Other Reasons|0|||
131690181|NCT01157364|474151329|FG000|Overall Study|Personal Reasons|0|||
131690182|NCT01157364|474151330|FG001|Overall Study|Personal Reasons|2|||
131690183|NCT01157364|474151331|FG002|Overall Study|Personal Reasons|0|||
131690184|NCT01157364|474151332|FG003|Overall Study|Personal Reasons|0|||
131690185|NCT01157364|474151333|FG004|Overall Study|Personal Reasons|1|||
131690186|NCT01157364|474151334|FG005|Overall Study|Personal Reasons|1|||
131690187|NCT01157364|474151329|FG000|Overall Study|Lost to Follow-up|1|||
131690188|NCT01157364|474151330|FG001|Overall Study|Lost to Follow-up|0|||
131436724|NCT00607087|473224115|FG002|Period 2|Withdrawal by Subject|1|||
131690189|NCT01157364|474151331|FG002|Overall Study|Lost to Follow-up|1|||
131690190|NCT01157364|474151332|FG003|Overall Study|Lost to Follow-up|0|||
131690191|NCT01157364|474151333|FG004|Overall Study|Lost to Follow-up|0|||
131690192|NCT01157364|474151334|FG005|Overall Study|Lost to Follow-up|0|||
131776536|NCT00594568|474462496|FG001|Initial Treatment|Caregiver decision|36|||
131776537|NCT00594568|474462497|FG002|Initial Treatment|Caregiver decision|36|||
131690193|NCT01157364|474151329|FG000|Overall Study|Lack of Efficacy|0|||
131690194|NCT01157364|474151330|FG001|Overall Study|Lack of Efficacy|0|||
131690195|NCT01157364|474151331|FG002|Overall Study|Lack of Efficacy|0|||
131690196|NCT01157364|474151332|FG003|Overall Study|Lack of Efficacy|1|||
131690197|NCT01157364|474151333|FG004|Overall Study|Lack of Efficacy|0|||
131690198|NCT01157364|474151334|FG005|Overall Study|Lack of Efficacy|0|||
131690199|NCT01157364|474151329|FG000|Overall Study|Adverse Event|0|||
131690200|NCT01157364|474151330|FG001|Overall Study|Adverse Event|1|||
131690201|NCT01157364|474151331|FG002|Overall Study|Adverse Event|1|||
131690202|NCT01157364|474151332|FG003|Overall Study|Adverse Event|0|||
131690203|NCT01157364|474151333|FG004|Overall Study|Adverse Event|1|||
131690204|NCT01157364|474151334|FG005|Overall Study|Adverse Event|0|||
131690205|NCT03259074|474151335|FG000|Overall Study|Adverse Event|9|||
131690206|NCT03259074|474151336|FG001|Overall Study|Adverse Event|12|||
131690207|NCT03259074|474151337|FG002|Overall Study|Adverse Event|8|||
131690208|NCT03259074|474151335|FG000|Overall Study|Death|1|||
131690209|NCT03259074|474151336|FG001|Overall Study|Death|1|||
131690210|NCT03259074|474151337|FG002|Overall Study|Death|3|||
131690211|NCT03259074|474151335|FG000|Overall Study|Lost to Follow-up|2|||
131690212|NCT03259074|474151336|FG001|Overall Study|Lost to Follow-up|4|||
131690213|NCT03259074|474151337|FG002|Overall Study|Lost to Follow-up|3|||
131690214|NCT03259074|474151335|FG000|Overall Study|New Therapy For Study Indication|1|||
131690215|NCT03259074|474151336|FG001|Overall Study|New Therapy For Study Indication|2|||
131690216|NCT03259074|474151337|FG002|Overall Study|New Therapy For Study Indication|2|||
131690217|NCT03259074|474151335|FG000|Overall Study|Physician Decision|4|||
131690218|NCT03259074|474151336|FG001|Overall Study|Physician Decision|12|||
131690219|NCT03259074|474151337|FG002|Overall Study|Physician Decision|10|||
131690220|NCT03259074|474151335|FG000|Overall Study|Pregnancy|1|||
131690221|NCT03259074|474151336|FG001|Overall Study|Pregnancy|1|||
131690222|NCT03259074|474151337|FG002|Overall Study|Pregnancy|0|||
131690223|NCT03259074|474151335|FG000|Overall Study|Progressive Disease|1|||
131690224|NCT03259074|474151336|FG001|Overall Study|Progressive Disease|0|||
131690225|NCT03259074|474151337|FG002|Overall Study|Progressive Disease|0|||
131690226|NCT03259074|474151335|FG000|Overall Study|Protocol Deviation|1|||
131690227|NCT03259074|474151336|FG001|Overall Study|Protocol Deviation|1|||
131690228|NCT03259074|474151337|FG002|Overall Study|Protocol Deviation|3|||
131690229|NCT03259074|474151335|FG000|Overall Study|Subject/Guardian Decision|13|||
131690230|NCT03259074|474151336|FG001|Overall Study|Subject/Guardian Decision|16|||
131690231|NCT03259074|474151337|FG002|Overall Study|Subject/Guardian Decision|14|||
131690232|NCT01780662|474151338|FG000|Overall Study|Adverse Event|1|||
131690233|NCT01780662|474151339|FG001|Overall Study|Adverse Event|0|||
131690234|NCT01780662|474151340|FG002|Overall Study|Adverse Event|2|||
131690235|NCT01780662|474151338|FG000|Overall Study|Physician Decision|0|||
131690236|NCT01780662|474151339|FG001|Overall Study|Physician Decision|5|||
131690237|NCT01780662|474151340|FG002|Overall Study|Physician Decision|7|||
131690238|NCT01780662|474151338|FG000|Overall Study|Protocol Violation|0|||
131690239|NCT01780662|474151339|FG001|Overall Study|Protocol Violation|1|||
131690240|NCT01780662|474151340|FG002|Overall Study|Protocol Violation|0|||
131690241|NCT01780662|474151338|FG000|Overall Study|Ineligible|0|||
131690242|NCT01780662|474151339|FG001|Overall Study|Ineligible|0|||
131690243|NCT01780662|474151340|FG002|Overall Study|Ineligible|1|||
131690244|NCT00053417|474151341|FG000|Overall Study|Adverse Event|1|||
131690245|NCT00053417|474151342|FG001|Overall Study|Adverse Event|0|||
131690246|NCT00053417|474151343|FG002|Overall Study|Adverse Event|1|||
131690247|NCT00053417|474151344|FG003|Overall Study|Adverse Event|5|||
131690248|NCT00053417|474151341|FG000|Overall Study|Non-Compliance|0|||
131690249|NCT00053417|474151342|FG001|Overall Study|Non-Compliance|0|||
131690250|NCT00053417|474151343|FG002|Overall Study|Non-Compliance|0|||
131690251|NCT00053417|474151344|FG003|Overall Study|Non-Compliance|1|||
131690252|NCT00053417|474151341|FG000|Overall Study|Withdrawal by Subject|0|||
131690253|NCT00053417|474151342|FG001|Overall Study|Withdrawal by Subject|1|||
131690254|NCT00053417|474151343|FG002|Overall Study|Withdrawal by Subject|0|||
131690255|NCT00053417|474151344|FG003|Overall Study|Withdrawal by Subject|0|||
131690256|NCT00053417|474151341|FG000|Overall Study|Lost to Follow-up|1|||
131690257|NCT00053417|474151342|FG001|Overall Study|Lost to Follow-up|1|||
131690258|NCT00053417|474151343|FG002|Overall Study|Lost to Follow-up|0|||
131690259|NCT00053417|474151344|FG003|Overall Study|Lost to Follow-up|0|||
131690260|NCT04081363|474151347|FG000|Overall Study|Withdrawal by Subject|1|||
131690261|NCT04081363|474151348|FG001|Overall Study|Withdrawal by Subject|0|||
131690262|NCT02182687|474151349|FG000|Overall Study|Withdrawal by Subject|4|||
131690263|NCT02182687|474151350|FG001|Overall Study|Withdrawal by Subject|0|||
131690264|NCT02182687|474151349|FG000|Overall Study|Adverse Event|1|||
131690265|NCT02182687|474151350|FG001|Overall Study|Adverse Event|0|||
131690266|NCT02182687|474151349|FG000|Overall Study|Lost to Follow-up|0|||
131690267|NCT02182687|474151350|FG001|Overall Study|Lost to Follow-up|1|||
131690268|NCT02184195|474151353|FG000|Overall Study|Patient decision|5|||
131690269|NCT02184195|474151354|FG001|Overall Study|Patient decision|2|||
131690270|NCT02184195|474151353|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131690271|NCT02184195|474151354|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131690272|NCT02184195|474151353|FG000|Overall Study|Death|67|||
131776538|NCT00594568|474462495|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
131776539|NCT00594568|474462496|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
131776540|NCT00594568|474462497|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
131776541|NCT00594568|474462495|FG000|Initial Treatment|Entry criteria exclusion|0|||
131776542|NCT00594568|474462496|FG001|Initial Treatment|Entry criteria exclusion|1|||
131776543|NCT00594568|474462497|FG002|Initial Treatment|Entry criteria exclusion|1|||
131776544|NCT00594568|474462495|FG000|Delayed Start|Death|0|||
131776545|NCT00594568|474462496|FG001|Delayed Start|Death|0|||
131776546|NCT00594568|474462497|FG002|Delayed Start|Death|1|||
131776547|NCT00594568|474462495|FG000|Delayed Start|Adverse Event|12|||
131776548|NCT00594568|474462496|FG001|Delayed Start|Adverse Event|2|||
131776549|NCT00594568|474462497|FG002|Delayed Start|Adverse Event|2|||
131776550|NCT00594568|474462495|FG000|Delayed Start|Withdrawal by Subject|4|||
131776551|NCT00594568|474462496|FG001|Delayed Start|Withdrawal by Subject|3|||
131776552|NCT00594568|474462497|FG002|Delayed Start|Withdrawal by Subject|0|||
131776553|NCT00594568|474462495|FG000|Delayed Start|Physician Decision|0|||
131776554|NCT00594568|474462496|FG001|Delayed Start|Physician Decision|0|||
131776555|NCT00594568|474462497|FG002|Delayed Start|Physician Decision|1|||
131776556|NCT00594568|474462495|FG000|Delayed Start|Lost to Follow-up|0|||
131776557|NCT00594568|474462496|FG001|Delayed Start|Lost to Follow-up|0|||
131776558|NCT00594568|474462497|FG002|Delayed Start|Lost to Follow-up|1|||
131776559|NCT00594568|474462495|FG000|Delayed Start|Caregiver Decision|5|||
131776560|NCT00594568|474462496|FG001|Delayed Start|Caregiver Decision|6|||
131776561|NCT00594568|474462497|FG002|Delayed Start|Caregiver Decision|2|||
131776562|NCT00594568|474462495|FG000|Delayed Start|Sponsor Decision|77|||
131776563|NCT00594568|474462496|FG001|Delayed Start|Sponsor Decision|66|||
131776564|NCT00594568|474462497|FG002|Delayed Start|Sponsor Decision|59|||
131776565|NCT00594568|474462495|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
131776566|NCT00594568|474462496|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
131776567|NCT00594568|474462497|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
131776568|NCT00594568|474462495|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
131776569|NCT00594568|474462496|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
131776570|NCT00594568|474462497|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
131776571|NCT00594568|474462495|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
131776572|NCT00594568|474462496|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
131776573|NCT00594568|474462497|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
131776574|NCT00594568|474462495|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
131776575|NCT00594568|474462496|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
131776576|NCT00594568|474462497|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
131776577|NCT00594568|474462495|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
131776578|NCT00594568|474462496|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
131776579|NCT00594568|474462497|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
131776580|NCT00594568|474462495|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
131776581|NCT00594568|474462496|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
131776582|NCT00594568|474462497|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
131776583|NCT00299546|474462498|FG000|Overall Study|Death|3|||
131776584|NCT00299546|474462499|FG001|Overall Study|Death|2|||
131776585|NCT00299546|474462500|FG002|Overall Study|Death|0|||
131776586|NCT00299546|474462498|FG000|Overall Study|Lost to Follow-up|2|||
131776587|NCT00299546|474462499|FG001|Overall Study|Lost to Follow-up|2|||
131776588|NCT00299546|474462500|FG002|Overall Study|Lost to Follow-up|5|||
131776589|NCT00299546|474462498|FG000|Overall Study|Adverse Event|37|||
131776590|NCT00299546|474462499|FG001|Overall Study|Adverse Event|22|||
131776591|NCT00299546|474462500|FG002|Overall Study|Adverse Event|27|||
131776592|NCT00299546|474462498|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
131776593|NCT00299546|474462499|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
131776594|NCT00299546|474462500|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
131776595|NCT00299546|474462498|FG000|Overall Study|Other|24|||
131776596|NCT00299546|474462499|FG001|Overall Study|Other|26|||
131776597|NCT00299546|474462500|FG002|Overall Study|Other|19|||
131776598|NCT00299546|474462498|FG000|Overall Study|Not treated|0|||
131776599|NCT00299546|474462499|FG001|Overall Study|Not treated|1|||
131776600|NCT00299546|474462500|FG002|Overall Study|Not treated|1|||
131776601|NCT00518531|474462501|FG000|Treatment Period 1|Adverse Event|5|||
131776602|NCT00518531|474462502|FG001|Treatment Period 1|Adverse Event|0|||
131776603|NCT00518531|474462501|FG000|Treatment Period 1|Lost to Follow-up|5|||
131776604|NCT00518531|474462502|FG001|Treatment Period 1|Lost to Follow-up|3|||
131776605|NCT00518531|474462501|FG000|Treatment Period 1|Physician Decision|1|||
131776606|NCT00518531|474462502|FG001|Treatment Period 1|Physician Decision|0|||
131776607|NCT00518531|474462501|FG000|Treatment Period 1|Protocol Violation|2|||
131776608|NCT00518531|474462502|FG001|Treatment Period 1|Protocol Violation|0|||
131776609|NCT00518531|474462501|FG000|Treatment Period 1|Withdrawal by Subject|4|||
131776610|NCT00518531|474462502|FG001|Treatment Period 1|Withdrawal by Subject|6|||
131776611|NCT00518531|474462501|FG000|Treatment Period 1|Early crossover|1|||
131690273|NCT02184195|474151354|FG001|Overall Study|Death|44|||
131690274|NCT02184195|474151353|FG000|Overall Study|Lost to Follow-up|1|||
131690275|NCT02184195|474151354|FG001|Overall Study|Lost to Follow-up|5|||
131690276|NCT02184195|474151353|FG000|Overall Study|Other|0|||
131690277|NCT02184195|474151354|FG001|Overall Study|Other|3|||
131690278|NCT00282334|474151357|FG000|Overall Study|Withdrawal by Subject|8|||
131690279|NCT00282334|474151358|FG001|Overall Study|Withdrawal by Subject|5|||
131690280|NCT04041284|474151359|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
131690281|NCT04041284|474151360|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
131690282|NCT04041284|474151359|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
131690283|NCT04041284|474151360|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
131690284|NCT04041284|474151359|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
131690285|NCT04041284|474151360|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
131690286|NCT04041284|474151359|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
131690287|NCT04041284|474151360|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
131690288|NCT04041284|474151359|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
131690289|NCT04041284|474151360|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
131690290|NCT04041284|474151359|FG000|DB Phase (12 Weeks)|Other than specified|1|||
131690291|NCT04041284|474151360|FG001|DB Phase (12 Weeks)|Other than specified|0|||
131690292|NCT04041284|474151359|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
131690293|NCT04041284|474151360|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
131690294|NCT04041284|474151359|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
131690295|NCT04041284|474151360|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
131690296|NCT04041284|474151359|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
131690297|NCT04041284|474151360|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
131690298|NCT04041284|474151359|FG000|OL Phase (12 Weeks)|Other than specified|6|||
131690299|NCT04041284|474151360|FG001|OL Phase (12 Weeks)|Other than specified|2|||
131690300|NCT00939783|474151363|FG000|Overall Study|Death|6|||
131690301|NCT00939783|474151363|FG000|Overall Study|Adverse Event|39|||
131690302|NCT00939783|474151363|FG000|Overall Study|Study Terminated by Sponsor|498|||
131690303|NCT00939783|474151363|FG000|Overall Study|Withdrawal by Subject|78|||
131690304|NCT00939783|474151363|FG000|Overall Study|Other|16|||
131690305|NCT00939783|474151363|FG000|Overall Study|Lost to Follow-up|8|||
131690306|NCT00939783|474151363|FG000|Overall Study|Protocol Violation|3|||
131690307|NCT00939783|474151363|FG000|Overall Study|Enrolled but not treated|1|||
131690308|NCT02255409|474151375|FG000|Overall Study|Administrative Reason|3|||
131690309|NCT02255409|474151376|FG001|Overall Study|Administrative Reason|7|||
131690310|NCT02255409|474151375|FG000|Overall Study|Withdrawal by Subject|1|||
131690311|NCT02255409|474151376|FG001|Overall Study|Withdrawal by Subject|5|||
131690312|NCT02255409|474151375|FG000|Overall Study|Lost to Follow-up|10|||
131690313|NCT02255409|474151376|FG001|Overall Study|Lost to Follow-up|19|||
131690314|NCT01251367|474151377|FG000|Overall Study|Protocol Violation|1|||
131690315|NCT01251367|474151377|FG000|Overall Study|Lack of Efficacy|2|||
131690316|NCT01251367|474151377|FG000|Overall Study|Adverse Event|19|||
131690317|NCT01251367|474151377|FG000|Overall Study|Withdrawal by Subject|36|||
131690318|NCT01251367|474151377|FG000|Overall Study|Lost to Follow-up|5|||
131690319|NCT01251367|474151377|FG000|Overall Study|Subject Required Alternative Treatment|7|||
131690320|NCT01251367|474151377|FG000|Overall Study|No Study Drug Available|1|||
131690321|NCT01251367|474151377|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
131690322|NCT01251367|474151377|FG000|Overall Study|End of Study Visit Performed in Error|1|||
131690323|NCT00645593|474151381|FG000|Overall Study|Later found to be ineligible|1|||
131690324|NCT00645593|474151382|FG001|Overall Study|Later found to be ineligible|0|||
131690325|NCT04218201|474152902|FG000|Overall Study|Death|0|||
131690326|NCT04218201|474152903|FG001|Overall Study|Death|0|||
131690327|NCT04218201|474152904|FG002|Overall Study|Death|2|||
131690328|NCT04218201|474152905|FG003|Overall Study|Death|0|||
131690329|NCT04218201|474152902|FG000|Overall Study|Unable to contact participant|4|||
131690330|NCT04218201|474152903|FG001|Overall Study|Unable to contact participant|0|||
131690331|NCT04218201|474152904|FG002|Overall Study|Unable to contact participant|3|||
131690332|NCT04218201|474152905|FG003|Overall Study|Unable to contact participant|0|||
131690333|NCT04218201|474152902|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
131690334|NCT04218201|474152903|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
131776612|NCT00518531|474462502|FG001|Treatment Period 1|Early crossover|3|||
131776613|NCT00518531|474462501|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131776614|NCT00518531|474462502|FG001|Treatment Period 2|Withdrawal by Subject|8|||
131776615|NCT00518531|474462501|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
131776616|NCT00518531|474462502|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
131776617|NCT00518531|474462501|FG000|Treatment Period 2|Adverse Event|1|||
131776618|NCT00518531|474462502|FG001|Treatment Period 2|Adverse Event|7|||
131776619|NCT00518531|474462501|FG000|Treatment Period 2|Protocol-specified criteria|0|||
131776620|NCT00518531|474462502|FG001|Treatment Period 2|Protocol-specified criteria|1|||
131776621|NCT00518531|474462501|FG000|Treatment Period 2|Non-compliance|1|||
131776622|NCT00518531|474462502|FG001|Treatment Period 2|Non-compliance|2|||
131776623|NCT02856282|474462506|FG000|Overall Study|Withdrawal by Subject|1|||
131776624|NCT00057330|474462507|FG000|Overall Study|Adverse Event|9|||
131776625|NCT00057330|474462508|FG001|Overall Study|Adverse Event|12|||
131776626|NCT00057330|474462507|FG000|Overall Study|Death|1|||
131776627|NCT00057330|474462508|FG001|Overall Study|Death|0|||
131776628|NCT00057330|474462507|FG000|Overall Study|Protocol Violation|1|||
131776629|NCT00057330|474462508|FG001|Overall Study|Protocol Violation|1|||
131776630|NCT00057330|474462507|FG000|Overall Study|Withdrawal by Subject|115|||
131776631|NCT00057330|474462508|FG001|Overall Study|Withdrawal by Subject|84|||
131776632|NCT00057330|474462507|FG000|Overall Study|Lost to Follow-up|745|||
131776633|NCT00057330|474462508|FG001|Overall Study|Lost to Follow-up|617|||
131776634|NCT00057330|474462507|FG000|Overall Study|Physician Decision|1|||
131776635|NCT00057330|474462508|FG001|Overall Study|Physician Decision|0|||
131776636|NCT00057330|474462507|FG000|Overall Study|Other|260|||
131776637|NCT00057330|474462508|FG001|Overall Study|Other|206|||
131776638|NCT05993299|474462509|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
131776639|NCT05993299|474462509|FG000|Overall Study|Ongoing|4|||
131776640|NCT05644756|474462510|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
131776641|NCT05644756|474462510|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
131776642|NCT01298362|474462514|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
131776643|NCT01298362|474462515|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
131776644|NCT01012609|474462526|FG000|Overall Study|Withdrawal by Subject|1|||
131776645|NCT01012609|474462527|FG001|Overall Study|Withdrawal by Subject|1|||
131776646|NCT00183170|474462531|FG000|First Intervention|Did not complete study|1|||
131776647|NCT00183170|474462532|FG001|First Intervention|Did not complete study|0|||
131776648|NCT00183170|474462531|FG000|First Intervention|Did not meet targeted BrAC|1|||
131776649|NCT00183170|474462532|FG001|First Intervention|Did not meet targeted BrAC|0|||
131776650|NCT00183170|474462531|FG000|Washout 1 Week|Did not complete study|6|||
131776651|NCT00183170|474462532|FG001|Washout 1 Week|Did not complete study|8|||
131776652|NCT00183170|474462531|FG000|Second Intervention|Did not complete study|1|||
131776653|NCT00183170|474462532|FG001|Second Intervention|Did not complete study|0|||
131776654|NCT00183170|474462531|FG000|Second Intervention|Did not meet targeted BrAC|0|||
131776655|NCT00183170|474462532|FG001|Second Intervention|Did not meet targeted BrAC|2|||
131776656|NCT00924820|474462533|FG000|Overall Study|Death|2|||
131776657|NCT00924820|474462533|FG000|Overall Study|Ineligible, Screen Failure|5|||
131776658|NCT04983589|474462534|FG000|Overall Study|Withdrawal by Subject|0|||
131776659|NCT04983589|474462535|FG001|Overall Study|Withdrawal by Subject|3|||
131776660|NCT04983589|474462534|FG000|Overall Study|COVID-19 Infection|1|||
131776661|NCT04983589|474462535|FG001|Overall Study|COVID-19 Infection|0|||
131776662|NCT04983589|474462534|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
131776663|NCT04983589|474462535|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
131776664|NCT00761969|474462536|FG000|Overall Study|Death|112|||
131776665|NCT00761969|474462537|FG001|Overall Study|Death|47|||
131776666|NCT00761969|474462536|FG000|Overall Study|Lost to Follow-up|88|||
131776667|NCT00761969|474462537|FG001|Overall Study|Lost to Follow-up|93|||
131776668|NCT01353586|474462538|FG000|Overall Study|Procedure terminated prior to ablation|3|||
131776669|NCT01353586|474462539|FG001|Overall Study|Procedure terminated prior to ablation|0|||
131776670|NCT01353586|474462538|FG000|Overall Study|Never had insertion of study catheter|4|||
131776671|NCT01353586|474462539|FG001|Overall Study|Never had insertion of study catheter|1|||
131776672|NCT01353586|474462538|FG000|Overall Study|Neurological exam not done|0|||
131776673|NCT01353586|474462539|FG001|Overall Study|Neurological exam not done|1|||
131776674|NCT00585468|474462540|FG000|First Intervention|Withdrawal by Subject|1|||
131776675|NCT00585468|474462541|FG001|First Intervention|Withdrawal by Subject|1|||
131776676|NCT00978120|474462546|FG000|Overall Study|Death|0|||
131776677|NCT00978120|474462547|FG001|Overall Study|Death|0|||
131776678|NCT00978120|474462548|FG002|Overall Study|Death|0|||
131776679|NCT00978120|474462549|FG003|Overall Study|Death|1|||
131776680|NCT00978120|474462546|FG000|Overall Study|Lost to Follow-up|0|||
131776681|NCT00978120|474462547|FG001|Overall Study|Lost to Follow-up|0|||
131776682|NCT00978120|474462548|FG002|Overall Study|Lost to Follow-up|3|||
131776683|NCT00978120|474462549|FG003|Overall Study|Lost to Follow-up|0|||
131776684|NCT00978120|474462546|FG000|Overall Study|Withdrawal by Subject|2|||
131776685|NCT00978120|474462547|FG001|Overall Study|Withdrawal by Subject|0|||
131776686|NCT00978120|474462548|FG002|Overall Study|Withdrawal by Subject|0|||
131898543|NCT02797678|474914124|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
131690335|NCT04218201|474152904|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
131690336|NCT04218201|474152905|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
131690337|NCT04218201|474152902|FG000|Overall Study|Withdrawal by Subject|2|||
131690338|NCT04218201|474152903|FG001|Overall Study|Withdrawal by Subject|0|||
131690339|NCT04218201|474152904|FG002|Overall Study|Withdrawal by Subject|0|||
131690340|NCT04218201|474152905|FG003|Overall Study|Withdrawal by Subject|0|||
131690341|NCT04218201|474152902|FG000|Overall Study|PCP plans to leave practice|0|||
131690342|NCT04218201|474152903|FG001|Overall Study|PCP plans to leave practice|8|||
131690343|NCT04218201|474152904|FG002|Overall Study|PCP plans to leave practice|0|||
131690344|NCT04218201|474152905|FG003|Overall Study|PCP plans to leave practice|5|||
131690345|NCT04218201|474152902|FG000|Overall Study|Reduced panel|0|||
131690346|NCT04218201|474152903|FG001|Overall Study|Reduced panel|0|||
131690347|NCT04218201|474152904|FG002|Overall Study|Reduced panel|0|||
131690348|NCT04218201|474152905|FG003|Overall Study|Reduced panel|1|||
131690349|NCT04218201|474152902|FG000|Overall Study|No longer interested in participating|0|||
131690350|NCT04218201|474152903|FG001|Overall Study|No longer interested in participating|1|||
131690351|NCT04218201|474152904|FG002|Overall Study|No longer interested in participating|0|||
131690352|NCT04218201|474152905|FG003|Overall Study|No longer interested in participating|0|||
131690353|NCT03723707|474152909|FG000|Overall Study|Death|32|||
131776687|NCT00978120|474462549|FG003|Overall Study|Withdrawal by Subject|0|||
131776688|NCT00978120|474462546|FG000|Overall Study|Moved out of state|0|||
131690354|NCT03723707|474152910|FG001|Overall Study|Death|32|||
131690355|NCT03723707|474152909|FG000|Overall Study|Admitted to long term care|12|||
131690356|NCT03723707|474152910|FG001|Overall Study|Admitted to long term care|12|||
131690357|NCT03723707|474152909|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
131690358|NCT03723707|474152910|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
131690359|NCT03723707|474152909|FG000|Overall Study|Lost to Follow-up|40|||
131690360|NCT03723707|474152910|FG001|Overall Study|Lost to Follow-up|22|||
131690361|NCT03723707|474152909|FG000|Overall Study|Discontinued after study closure|24|||
131690362|NCT03723707|474152910|FG001|Overall Study|Discontinued after study closure|12|||
131690363|NCT05121480|474152911|FG000|Overall Study|Lack of Efficacy|2|||
131690364|NCT05121480|474152912|FG001|Overall Study|Lack of Efficacy|2|||
131690365|NCT05121480|474152913|FG002|Overall Study|Lack of Efficacy|1|||
131690366|NCT05121480|474152914|FG003|Overall Study|Lack of Efficacy|4|||
131690367|NCT05121480|474152915|FG004|Overall Study|Lack of Efficacy|0|||
131690368|NCT05121480|474152916|FG005|Overall Study|Lack of Efficacy|1|||
131690369|NCT05121480|474152917|FG006|Overall Study|Lack of Efficacy|0|||
131690370|NCT05121480|474152918|FG007|Overall Study|Lack of Efficacy|2|||
131690371|NCT05121480|474152911|FG000|Overall Study|Treatment Failure|0|||
131690372|NCT05121480|474152912|FG001|Overall Study|Treatment Failure|2|||
131690373|NCT05121480|474152913|FG002|Overall Study|Treatment Failure|0|||
131690374|NCT05121480|474152914|FG003|Overall Study|Treatment Failure|1|||
131690375|NCT05121480|474152915|FG004|Overall Study|Treatment Failure|0|||
131690376|NCT05121480|474152916|FG005|Overall Study|Treatment Failure|0|||
131690377|NCT05121480|474152917|FG006|Overall Study|Treatment Failure|0|||
131690378|NCT05121480|474152918|FG007|Overall Study|Treatment Failure|0|||
131690379|NCT05121480|474152911|FG000|Overall Study|Adverse Event|0|||
131690380|NCT05121480|474152912|FG001|Overall Study|Adverse Event|1|||
131690381|NCT05121480|474152913|FG002|Overall Study|Adverse Event|0|||
131690382|NCT05121480|474152914|FG003|Overall Study|Adverse Event|5|||
131690383|NCT05121480|474152915|FG004|Overall Study|Adverse Event|3|||
131690384|NCT05121480|474152916|FG005|Overall Study|Adverse Event|2|||
131690385|NCT05121480|474152917|FG006|Overall Study|Adverse Event|0|||
131690386|NCT05121480|474152918|FG007|Overall Study|Adverse Event|4|||
131690387|NCT05121480|474152911|FG000|Overall Study|Withdrawal by Subject|4|||
131690388|NCT05121480|474152912|FG001|Overall Study|Withdrawal by Subject|9|||
131690389|NCT05121480|474152913|FG002|Overall Study|Withdrawal by Subject|1|||
131690390|NCT05121480|474152914|FG003|Overall Study|Withdrawal by Subject|8|||
131690391|NCT05121480|474152915|FG004|Overall Study|Withdrawal by Subject|0|||
131690392|NCT05121480|474152916|FG005|Overall Study|Withdrawal by Subject|9|||
131690393|NCT05121480|474152917|FG006|Overall Study|Withdrawal by Subject|0|||
131690394|NCT05121480|474152918|FG007|Overall Study|Withdrawal by Subject|4|||
131690395|NCT05121480|474152911|FG000|Overall Study|Non-compliance with the protocol|0|||
131690396|NCT05121480|474152912|FG001|Overall Study|Non-compliance with the protocol|0|||
131690397|NCT05121480|474152913|FG002|Overall Study|Non-compliance with the protocol|0|||
131690398|NCT05121480|474152914|FG003|Overall Study|Non-compliance with the protocol|0|||
131690399|NCT05121480|474152915|FG004|Overall Study|Non-compliance with the protocol|1|||
131690400|NCT05121480|474152916|FG005|Overall Study|Non-compliance with the protocol|6|||
131690401|NCT05121480|474152917|FG006|Overall Study|Non-compliance with the protocol|0|||
131690402|NCT05121480|474152918|FG007|Overall Study|Non-compliance with the protocol|1|||
131690403|NCT05121480|474152911|FG000|Overall Study|Lost to Follow-up|0|||
131690404|NCT05121480|474152912|FG001|Overall Study|Lost to Follow-up|4|||
131776689|NCT00978120|474462547|FG001|Overall Study|Moved out of state|0|||
131690405|NCT05121480|474152913|FG002|Overall Study|Lost to Follow-up|1|||
131690406|NCT05121480|474152914|FG003|Overall Study|Lost to Follow-up|3|||
131776690|NCT00978120|474462548|FG002|Overall Study|Moved out of state|0|||
131690407|NCT05121480|474152915|FG004|Overall Study|Lost to Follow-up|1|||
131690408|NCT05121480|474152916|FG005|Overall Study|Lost to Follow-up|1|||
131690409|NCT05121480|474152917|FG006|Overall Study|Lost to Follow-up|1|||
131690410|NCT05121480|474152918|FG007|Overall Study|Lost to Follow-up|4|||
131690411|NCT05121480|474152911|FG000|Overall Study|Physician Decision|0|||
131690412|NCT05121480|474152912|FG001|Overall Study|Physician Decision|0|||
131690413|NCT05121480|474152913|FG002|Overall Study|Physician Decision|0|||
131690414|NCT05121480|474152914|FG003|Overall Study|Physician Decision|0|||
131690415|NCT05121480|474152915|FG004|Overall Study|Physician Decision|0|||
131690416|NCT05121480|474152916|FG005|Overall Study|Physician Decision|1|||
131690417|NCT05121480|474152917|FG006|Overall Study|Physician Decision|0|||
131690418|NCT05121480|474152918|FG007|Overall Study|Physician Decision|1|||
131690419|NCT05121480|474152911|FG000|Overall Study|Other Reason|0|||
131690420|NCT05121480|474152912|FG001|Overall Study|Other Reason|0|||
131690421|NCT05121480|474152913|FG002|Overall Study|Other Reason|0|||
131690422|NCT05121480|474152914|FG003|Overall Study|Other Reason|0|||
131690423|NCT05121480|474152915|FG004|Overall Study|Other Reason|0|||
131690424|NCT05121480|474152916|FG005|Overall Study|Other Reason|1|||
131690425|NCT05121480|474152917|FG006|Overall Study|Other Reason|1|||
131690426|NCT05121480|474152918|FG007|Overall Study|Other Reason|1|||
131690427|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
131690428|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
131690429|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
131690430|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
131690431|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
131690432|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
131690433|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
131690434|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
131690435|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
131690436|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
131690437|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
131690438|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
131690439|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
131690440|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
131719486|NCT01856673|474253334|FG001|Overall Study|Unknown reasons|0|||
131719487|NCT01856673|474253335|FG002|Overall Study|Unknown reasons|0|||
131719488|NCT01856673|474253333|FG000|Overall Study|Psychologist decision|1|||
131719489|NCT01856673|474253334|FG001|Overall Study|Psychologist decision|0|||
131719490|NCT01856673|474253335|FG002|Overall Study|Psychologist decision|0|||
131719491|NCT01856673|474253333|FG000|Overall Study|Paperwork errors|8|||
131719492|NCT01856673|474253334|FG001|Overall Study|Paperwork errors|0|||
131719493|NCT01856673|474253335|FG002|Overall Study|Paperwork errors|0|||
131719494|NCT01856673|474253333|FG000|Overall Study|Death|1|||
131719495|NCT01856673|474253334|FG001|Overall Study|Death|1|||
131719496|NCT01856673|474253335|FG002|Overall Study|Death|0|||
131719497|NCT01856673|474253333|FG000|Overall Study|Protocol Violation|1|||
131719498|NCT01856673|474253334|FG001|Overall Study|Protocol Violation|0|||
131719499|NCT01856673|474253335|FG002|Overall Study|Protocol Violation|1|||
131719500|NCT03240081|474253336|FG000|Overall Study|Withdrawal by Subject|0|||
131719501|NCT03240081|474253337|FG001|Overall Study|Withdrawal by Subject|2|||
131719502|NCT03240081|474253336|FG000|Overall Study|Lost to Follow-up|0|||
131719503|NCT03240081|474253337|FG001|Overall Study|Lost to Follow-up|1|||
131719504|NCT00883753|474253338|FG000|Overall Study|Adverse Event|37|||
131719505|NCT00883753|474253338|FG000|Overall Study|Death|2|||
131719506|NCT00883753|474253338|FG000|Overall Study|Insufficient therapeutic response|16|||
131719507|NCT00883753|474253338|FG000|Overall Study|Lost to Follow-up|4|||
131776691|NCT00978120|474462549|FG003|Overall Study|Moved out of state|1|||
131776692|NCT00762073|474462550|FG000|Overall Study|Lack of Efficacy|1|||
131776693|NCT00762073|474462551|FG001|Overall Study|Lack of Efficacy|1|||
131776694|NCT00762073|474462552|FG002|Overall Study|Lack of Efficacy|0|||
131776695|NCT00762073|474462553|FG003|Overall Study|Lack of Efficacy|0|||
131776696|NCT00762073|474462550|FG000|Overall Study|Adverse Event|1|||
131776697|NCT00762073|474462551|FG001|Overall Study|Adverse Event|0|||
131776698|NCT00762073|474462552|FG002|Overall Study|Adverse Event|1|||
131776699|NCT00762073|474462553|FG003|Overall Study|Adverse Event|1|||
131776700|NCT00762073|474462550|FG000|Overall Study|Significant Subject Noncompliance|0|||
131776701|NCT00762073|474462551|FG001|Overall Study|Significant Subject Noncompliance|1|||
131776702|NCT00762073|474462552|FG002|Overall Study|Significant Subject Noncompliance|0|||
131776703|NCT00762073|474462553|FG003|Overall Study|Significant Subject Noncompliance|1|||
131776704|NCT00762073|474462550|FG000|Overall Study|Withdrawal by Subject|1|||
131776705|NCT00762073|474462551|FG001|Overall Study|Withdrawal by Subject|2|||
131776706|NCT00762073|474462552|FG002|Overall Study|Withdrawal by Subject|1|||
131776707|NCT00762073|474462553|FG003|Overall Study|Withdrawal by Subject|1|||
131776708|NCT00762073|474462550|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
131776709|NCT00762073|474462551|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
131776710|NCT00762073|474462552|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
131776711|NCT00762073|474462553|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
131776712|NCT01068418|474462556|FG000|Overall Study|Physician Decision|12|||
131776713|NCT03155269|474462563|FG000|Overall Study|Withdrawal by Subject|4|||
131776714|NCT03155269|474462564|FG001|Overall Study|Withdrawal by Subject|5|||
131776715|NCT03155269|474462563|FG000|Overall Study|Lost to Follow-up|1|||
131776716|NCT03155269|474462564|FG001|Overall Study|Lost to Follow-up|2|||
131776717|NCT00491322|474462566|FG000|Overall Study|Protocol Violation|1|||
131776718|NCT00491322|474462567|FG001|Overall Study|Protocol Violation|0|||
131776719|NCT00491322|474462566|FG000|Overall Study|Pregnancy|0|||
131776720|NCT00491322|474462567|FG001|Overall Study|Pregnancy|1|||
131776721|NCT00455923|474462568|FG000|Overall Study|Pregnancy|0|||
131776722|NCT00455923|474462569|FG001|Overall Study|Pregnancy|2|||
131776723|NCT00455923|474462568|FG000|Overall Study|Other|3|||
131776724|NCT00455923|474462569|FG001|Overall Study|Other|1|||
131776725|NCT00483119|474462570|FG000|Overall Study|Adverse Event|0|||
131776726|NCT00483119|474462571|FG001|Overall Study|Adverse Event|1|||
131776727|NCT00483119|474462570|FG000|Overall Study|Physician Decision|1|||
131776728|NCT00483119|474462571|FG001|Overall Study|Physician Decision|0|||
131776729|NCT03426995|474462572|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776730|NCT03426995|474462573|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776731|NCT03426995|474462574|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
131776732|NCT03426995|474462575|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776733|NCT03426995|474462576|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131690441|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
131776734|NCT03426995|474462577|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776735|NCT03426995|474462578|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776736|NCT03426995|474462579|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776737|NCT03426995|474462580|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776738|NCT03426995|474462581|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776739|NCT03426995|474462582|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131690442|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
131690443|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
131690444|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
131690445|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
131690446|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
131690447|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
131690448|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
131690449|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
131690450|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
131690451|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
131690452|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
131690453|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
131690454|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
131690455|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
131690456|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
131690457|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
131690458|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
131690459|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
131690460|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
131690461|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
131690462|NCT02831673|474152919|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
131690463|NCT02831673|474152920|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
131690464|NCT02831673|474152921|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
131690465|NCT02831673|474152922|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
131690466|NCT02831673|474152923|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
131690467|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131690468|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131690469|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
131690470|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
131690471|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131690472|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131690473|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131690474|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
131690475|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
131690476|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131690477|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131690478|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131690479|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131690480|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
131690481|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131690482|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
131690483|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
131690484|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
131690485|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
131690486|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
131690487|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131690488|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131690489|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
131690490|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
131690491|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131690492|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131690493|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131690494|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
131690495|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
131690496|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131690497|NCT02831673|474152919|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131690498|NCT02831673|474152920|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131690499|NCT02831673|474152921|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
131690500|NCT02831673|474152922|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
131690501|NCT02831673|474152923|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131690502|NCT02831673|474152919|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131690503|NCT02831673|474152920|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131690504|NCT02831673|474152921|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131690505|NCT02831673|474152922|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131690506|NCT02831673|474152923|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
131690507|NCT02831673|474152919|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131690508|NCT02831673|474152920|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131690509|NCT02831673|474152921|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131690510|NCT02831673|474152922|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131690511|NCT02831673|474152923|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
131690512|NCT02831673|474152919|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131690513|NCT02831673|474152920|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131690514|NCT02831673|474152921|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131690515|NCT02831673|474152922|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131690516|NCT02831673|474152923|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
131690517|NCT02831673|474152919|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131690518|NCT02831673|474152920|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131690519|NCT02831673|474152921|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131690520|NCT02831673|474152922|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131690521|NCT02831673|474152923|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
131690522|NCT02831673|474152919|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131690523|NCT02831673|474152920|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131690524|NCT02831673|474152921|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131690525|NCT02831673|474152922|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131690526|NCT02831673|474152923|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
131690527|NCT02356562|474152924|FG000|Overall Study|Withdrawal by Subject|0|||
131690528|NCT02356562|474152925|FG001|Overall Study|Withdrawal by Subject|1|||
131690529|NCT02356562|474152924|FG000|Overall Study|Re-entered treatment in a previous study|1|||
131690530|NCT02356562|474152925|FG001|Overall Study|Re-entered treatment in a previous study|0|||
131690531|NCT02356562|474152924|FG000|Overall Study|site closure|1|||
131690532|NCT02356562|474152925|FG001|Overall Study|site closure|0|||
131690533|NCT00412750|474152927|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131690534|NCT00412750|474152928|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131690535|NCT00412750|474152929|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131690536|NCT00412750|474152927|FG000|Overall Study|Administrative problems|21|||
131690537|NCT00412750|474152928|FG001|Overall Study|Administrative problems|17|||
131690538|NCT00412750|474152929|FG002|Overall Study|Administrative problems|14|||
131690539|NCT00412750|474152927|FG000|Overall Study|Adverse Event|8|||
131804437|NCT01196052|474568528|FG000|Overall Study|Reason not Specified|5|||
131690540|NCT00412750|474152928|FG001|Overall Study|Adverse Event|3|||
131690541|NCT00412750|474152929|FG002|Overall Study|Adverse Event|3|||
131690542|NCT00412750|474152927|FG000|Overall Study|Lost to Follow-up|1|||
131690543|NCT00412750|474152928|FG001|Overall Study|Lost to Follow-up|0|||
131690544|NCT00412750|474152929|FG002|Overall Study|Lost to Follow-up|1|||
131690545|NCT00412750|474152927|FG000|Overall Study|Withdrawal by Subject|0|||
131690546|NCT00412750|474152928|FG001|Overall Study|Withdrawal by Subject|1|||
131690547|NCT00412750|474152929|FG002|Overall Study|Withdrawal by Subject|2|||
131690548|NCT00412750|474152927|FG000|Overall Study|Lack of Efficacy|0|||
131690549|NCT00412750|474152928|FG001|Overall Study|Lack of Efficacy|0|||
131690550|NCT00412750|474152929|FG002|Overall Study|Lack of Efficacy|3|||
131690551|NCT01611974|474152935|FG000|Overall Study|Death|10|||
131690552|NCT01611974|474152936|FG001|Overall Study|Death|12|||
131690553|NCT01611974|474152937|FG002|Overall Study|Death|10|||
131690554|NCT01611974|474152935|FG000|Overall Study|Lost to Follow-up|0|||
131690555|NCT01611974|474152936|FG001|Overall Study|Lost to Follow-up|1|||
131690556|NCT01611974|474152937|FG002|Overall Study|Lost to Follow-up|0|||
131690557|NCT01611974|474152935|FG000|Overall Study|Physician Decision|5|||
131690558|NCT01611974|474152936|FG001|Overall Study|Physician Decision|1|||
131690559|NCT01611974|474152937|FG002|Overall Study|Physician Decision|2|||
131690560|NCT01611974|474152935|FG000|Overall Study|Withdrawal by Subject|0|||
131690561|NCT01611974|474152936|FG001|Overall Study|Withdrawal by Subject|1|||
131690562|NCT01611974|474152937|FG002|Overall Study|Withdrawal by Subject|4|||
131690563|NCT02104583|474152941|FG000|Overall Study|New ICD or CRT-D implanted|2|||
131690564|NCT02104583|474152942|FG001|Overall Study|New ICD or CRT-D implanted|0|||
131690565|NCT02104583|474152943|FG002|Overall Study|New ICD or CRT-D implanted|1|||
131690566|NCT02104583|474152944|FG003|Overall Study|New ICD or CRT-D implanted|0|||
131690567|NCT02104583|474152945|FG004|Overall Study|New ICD or CRT-D implanted|0|||
131690568|NCT02104583|474152941|FG000|Overall Study|Death|2|||
131690569|NCT02104583|474152942|FG001|Overall Study|Death|1|||
131690570|NCT02104583|474152943|FG002|Overall Study|Death|3|||
131690571|NCT02104583|474152944|FG003|Overall Study|Death|3|||
131690572|NCT02104583|474152945|FG004|Overall Study|Death|5|||
131690573|NCT02104583|474152941|FG000|Overall Study|Subject required cardiac ablation|6|||
131690574|NCT02104583|474152942|FG001|Overall Study|Subject required cardiac ablation|4|||
131690575|NCT02104583|474152943|FG002|Overall Study|Subject required cardiac ablation|4|||
131690576|NCT02104583|474152944|FG003|Overall Study|Subject required cardiac ablation|5|||
131690577|NCT02104583|474152945|FG004|Overall Study|Subject required cardiac ablation|4|||
131690578|NCT02104583|474152941|FG000|Overall Study|Subject required prohibited medication|0|||
131690579|NCT02104583|474152942|FG001|Overall Study|Subject required prohibited medication|1|||
131690580|NCT02104583|474152943|FG002|Overall Study|Subject required prohibited medication|1|||
131690581|NCT02104583|474152944|FG003|Overall Study|Subject required prohibited medication|0|||
131690582|NCT02104583|474152945|FG004|Overall Study|Subject required prohibited medication|1|||
131690583|NCT02104583|474152941|FG000|Overall Study|Withdrew Consent|3|||
131690584|NCT02104583|474152942|FG001|Overall Study|Withdrew Consent|2|||
131690585|NCT02104583|474152943|FG002|Overall Study|Withdrew Consent|0|||
131690586|NCT02104583|474152944|FG003|Overall Study|Withdrew Consent|2|||
131690587|NCT02104583|474152945|FG004|Overall Study|Withdrew Consent|1|||
131690588|NCT02104583|474152941|FG000|Overall Study|Investigator's Discretion|1|||
131690589|NCT02104583|474152942|FG001|Overall Study|Investigator's Discretion|0|||
131690590|NCT02104583|474152943|FG002|Overall Study|Investigator's Discretion|0|||
131690591|NCT02104583|474152944|FG003|Overall Study|Investigator's Discretion|0|||
131690592|NCT02104583|474152945|FG004|Overall Study|Investigator's Discretion|0|||
131690593|NCT02104583|474152941|FG000|Overall Study|Protocol Violation|0|||
131690594|NCT02104583|474152942|FG001|Overall Study|Protocol Violation|0|||
131690595|NCT02104583|474152943|FG002|Overall Study|Protocol Violation|1|||
131690596|NCT02104583|474152944|FG003|Overall Study|Protocol Violation|0|||
131690597|NCT02104583|474152945|FG004|Overall Study|Protocol Violation|0|||
131690598|NCT02104583|474152941|FG000|Overall Study|Adverse Event|3|||
131690599|NCT02104583|474152942|FG001|Overall Study|Adverse Event|3|||
131690600|NCT02104583|474152943|FG002|Overall Study|Adverse Event|6|||
131690601|NCT02104583|474152944|FG003|Overall Study|Adverse Event|6|||
131690602|NCT02104583|474152945|FG004|Overall Study|Adverse Event|1|||
131690603|NCT02104583|474152941|FG000|Overall Study|Lost to Follow-up|1|||
131690604|NCT02104583|474152942|FG001|Overall Study|Lost to Follow-up|0|||
131690605|NCT02104583|474152943|FG002|Overall Study|Lost to Follow-up|0|||
131690606|NCT02104583|474152944|FG003|Overall Study|Lost to Follow-up|0|||
131690607|NCT02104583|474152945|FG004|Overall Study|Lost to Follow-up|0|||
131690608|NCT02104583|474152941|FG000|Overall Study|Randomized but Never Treated|0|||
131690609|NCT02104583|474152942|FG001|Overall Study|Randomized but Never Treated|0|||
131690610|NCT02104583|474152943|FG002|Overall Study|Randomized but Never Treated|0|||
131690611|NCT02104583|474152944|FG003|Overall Study|Randomized but Never Treated|1|||
131690612|NCT02104583|474152945|FG004|Overall Study|Randomized but Never Treated|0|||
131690613|NCT01351389|474152946|FG000|Overall Study|Withdrawal by Subject|7|||
131690614|NCT01351389|474152947|FG001|Overall Study|Withdrawal by Subject|0|||
131690615|NCT01351389|474152946|FG000|Overall Study|did not complete intervention|23|||
131690616|NCT01351389|474152947|FG001|Overall Study|did not complete intervention|15|||
131690617|NCT00530270|474152952|FG000|Overall Study|Protocol Violation|1|||
131690618|NCT00530270|474152953|FG001|Overall Study|Protocol Violation|0|||
131690619|NCT00838331|474152957|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
131690620|NCT03972969|474152959|FG000|3-month Follow-up|Death|1|||
131690621|NCT03972969|474152960|FG001|3-month Follow-up|Death|1|||
131690622|NCT03972969|474152961|FG002|3-month Follow-up|Death|0|||
131690623|NCT03972969|474152959|FG000|6-month Follow-up|Death|1|||
131690624|NCT03972969|474152960|FG001|6-month Follow-up|Death|1|||
131690625|NCT03972969|474152961|FG002|6-month Follow-up|Death|1|||
131690626|NCT03972969|474152959|FG000|6-month Follow-up|Lost to Follow-up|2|||
131690627|NCT03972969|474152960|FG001|6-month Follow-up|Lost to Follow-up|2|||
131690628|NCT03972969|474152961|FG002|6-month Follow-up|Lost to Follow-up|2|||
131690629|NCT00264875|474152962|FG000|Overall Study|Adverse Event|6|||
131690630|NCT00264875|474152962|FG000|Overall Study|Lost to Follow-up|6|||
131690631|NCT00264875|474152962|FG000|Overall Study|Protocol Violation|11|||
131690632|NCT00264875|474152962|FG000|Overall Study|Withdrawal by Subject|7|||
131690633|NCT00732303|474152963|FG000|Overall Study|Study Terminated|2|||
131690634|NCT01074190|474152964|FG000|Overall Study|Emergency Cesarean Delivery|1|||
131690635|NCT01074190|474152965|FG001|Overall Study|Emergency Cesarean Delivery|2|||
131690636|NCT01074190|474152966|FG002|Overall Study|Emergency Cesarean Delivery|1|||
131690637|NCT01074190|474152964|FG000|Overall Study|Protocol Violation|2|||
131690638|NCT01074190|474152965|FG001|Overall Study|Protocol Violation|1|||
131690639|NCT01074190|474152966|FG002|Overall Study|Protocol Violation|0|||
131690640|NCT01074190|474152964|FG000|Overall Study|Delivered in under 90 minutes|0|||
131690641|NCT01074190|474152965|FG001|Overall Study|Delivered in under 90 minutes|2|||
131690642|NCT01074190|474152966|FG002|Overall Study|Delivered in under 90 minutes|1|||
131690643|NCT01074190|474152964|FG000|Overall Study|Subject withdrew consent|1|||
131690644|NCT01074190|474152965|FG001|Overall Study|Subject withdrew consent|1|||
131690645|NCT01074190|474152966|FG002|Overall Study|Subject withdrew consent|1|||
131690646|NCT02409290|474152970|FG000|Overall Study|Protocol Violation|3|||
131690647|NCT02409290|474152971|FG001|Overall Study|Protocol Violation|6|||
131690648|NCT02409290|474152972|FG002|Overall Study|Protocol Violation|9|||
131690649|NCT02409290|474152973|FG003|Overall Study|Protocol Violation|4|||
131690650|NCT02409290|474152970|FG000|Overall Study|No positive culture/no baseline sample|3|||
131690651|NCT02409290|474152971|FG001|Overall Study|No positive culture/no baseline sample|9|||
131690652|NCT02409290|474152972|FG002|Overall Study|No positive culture/no baseline sample|6|||
131690653|NCT02409290|474152973|FG003|Overall Study|No positive culture/no baseline sample|5|||
131690654|NCT02409290|474152970|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
131690655|NCT02409290|474152971|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
131690656|NCT02409290|474152972|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
131690657|NCT02409290|474152973|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
131690658|NCT00708500|474152974|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
131690659|NCT00708500|474152975|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
131690660|NCT00708500|474152976|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
131690661|NCT00708500|474152974|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
131690662|NCT00708500|474152975|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
131690663|NCT00708500|474152976|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
131690664|NCT00708500|474152974|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
131690665|NCT00708500|474152975|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
131690666|NCT00708500|474152976|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
131690667|NCT00708500|474152974|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
131690668|NCT00708500|474152975|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
131690669|NCT00708500|474152976|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
131690670|NCT00708500|474152974|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
131690671|NCT00708500|474152975|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
131690672|NCT00708500|474152976|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
131690673|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
131690674|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
131690675|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
131690676|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
131690677|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
131690678|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
131690679|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
131690680|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
131690681|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
131690682|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
131557168|NCT00152971|473664438|FG002|Treatment|Adverse Event|54|||
131690683|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
131690684|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
131690685|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
131690686|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
131690687|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
131690688|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
131690689|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
131690690|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
131690691|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
131690692|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
131690693|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
131690694|NCT00708500|474152974|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
131690695|NCT00708500|474152975|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
131690696|NCT00708500|474152976|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
131690697|NCT00708500|474152974|FG000|FOLLOWUP|Adverse Event|0|||
131690698|NCT00708500|474152975|FG001|FOLLOWUP|Adverse Event|1|||
131690699|NCT00708500|474152976|FG002|FOLLOWUP|Adverse Event|0|||
131690700|NCT00708500|474152974|FG000|FOLLOWUP|Lost to Follow-up|1|||
131690701|NCT00708500|474152975|FG001|FOLLOWUP|Lost to Follow-up|6|||
131690702|NCT00708500|474152976|FG002|FOLLOWUP|Lost to Follow-up|4|||
131690703|NCT00708500|474152974|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
131776740|NCT03426995|474462583|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131804438|NCT01196052|474568528|FG000|Overall Study|Withdrawal by Subject|6|||
131557169|NCT00152971|473664436|FG000|Treatment|Protocol Violation|8|||
131776741|NCT03426995|474462584|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776742|NCT03426995|474462585|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776743|NCT03426995|474462586|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776744|NCT03426995|474462587|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776745|NCT03426995|474462588|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776746|NCT03426995|474462589|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776747|NCT03426995|474462590|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131776748|NCT03426995|474462572|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776749|NCT03426995|474462573|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776750|NCT03426995|474462574|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776751|NCT03426995|474462575|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776752|NCT03426995|474462576|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776753|NCT03426995|474462577|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
131776754|NCT03426995|474462578|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776755|NCT03426995|474462579|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776756|NCT03426995|474462580|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776757|NCT03426995|474462581|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776758|NCT03426995|474462582|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776759|NCT03426995|474462583|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776760|NCT03426995|474462584|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776761|NCT03426995|474462585|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776762|NCT03426995|474462586|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776763|NCT03426995|474462587|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776764|NCT03426995|474462588|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776765|NCT03426995|474462589|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776766|NCT03426995|474462590|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131776767|NCT03426995|474462572|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776768|NCT03426995|474462573|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776769|NCT03426995|474462574|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776770|NCT03426995|474462575|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776771|NCT03426995|474462576|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
131690704|NCT00708500|474152975|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
131690705|NCT00708500|474152976|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
131690706|NCT00708500|474152974|FG000|FOLLOWUP|Subject withdrew consent|31|||
131690707|NCT00708500|474152975|FG001|FOLLOWUP|Subject withdrew consent|4|||
131690708|NCT00708500|474152976|FG002|FOLLOWUP|Subject withdrew consent|5|||
131690709|NCT00708500|474152974|FG000|FOLLOWUP|Non-compliance with protocol|5|||
131690710|NCT00708500|474152975|FG001|FOLLOWUP|Non-compliance with protocol|0|||
131690711|NCT00708500|474152976|FG002|FOLLOWUP|Non-compliance with protocol|1|||
131690712|NCT00705783|474152983|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
131690713|NCT00705783|474152984|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
131690714|NCT00705783|474152985|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
131690715|NCT00705783|474152983|FG000|Conversion Phase|Lost to Follow-up|13|||
131690716|NCT00705783|474152984|FG001|Conversion Phase|Lost to Follow-up|0|||
131690717|NCT00705783|474152985|FG002|Conversion Phase|Lost to Follow-up|0|||
131690718|NCT00705783|474152983|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
131690719|NCT00705783|474152984|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
131690720|NCT00705783|474152985|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
131690721|NCT00705783|474152983|FG000|Conversion Phase|Withdrawn by Investigator|4|||
131690722|NCT00705783|474152984|FG001|Conversion Phase|Withdrawn by Investigator|0|||
131690723|NCT00705783|474152985|FG002|Conversion Phase|Withdrawn by Investigator|0|||
131690724|NCT00705783|474152983|FG000|Conversion Phase|Withdrew Consent|24|||
131690725|NCT00705783|474152984|FG001|Conversion Phase|Withdrew Consent|0|||
131690726|NCT00705783|474152985|FG002|Conversion Phase|Withdrew Consent|0|||
131690727|NCT00705783|474152983|FG000|Conversion Phase|Protocol Deviation|2|||
131690728|NCT00705783|474152984|FG001|Conversion Phase|Protocol Deviation|0|||
131690729|NCT00705783|474152985|FG002|Conversion Phase|Protocol Deviation|0|||
131690730|NCT00705783|474152983|FG000|Conversion Phase|Adverse Event|11|||
131690731|NCT00705783|474152984|FG001|Conversion Phase|Adverse Event|0|||
131690732|NCT00705783|474152985|FG002|Conversion Phase|Adverse Event|0|||
131690733|NCT00705783|474152983|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
131690734|NCT00705783|474152984|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131690735|NCT00705783|474152985|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131690736|NCT00705783|474152983|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
131690737|NCT00705783|474152984|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131690738|NCT00705783|474152985|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131690739|NCT00705783|474152983|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
131690740|NCT00705783|474152984|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
131690741|NCT00705783|474152985|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
131690742|NCT00705783|474152983|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
131690743|NCT00705783|474152984|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
131690744|NCT00705783|474152985|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
131690745|NCT00705783|474152983|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
131690746|NCT00705783|474152984|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131690747|NCT00705783|474152985|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131690748|NCT00705783|474152983|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
131690749|NCT00705783|474152984|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131690750|NCT00705783|474152985|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131690751|NCT00705783|474152983|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
131690752|NCT00705783|474152984|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
131776772|NCT03426995|474462577|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
131690753|NCT00705783|474152985|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
131690754|NCT00705783|474152983|FG000|Oral Stabilization Phase|Adverse Event|14|||
131690755|NCT00705783|474152984|FG001|Oral Stabilization Phase|Adverse Event|0|||
131690756|NCT00705783|474152985|FG002|Oral Stabilization Phase|Adverse Event|0|||
131690757|NCT00705783|474152983|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
131690758|NCT00705783|474152984|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131690759|NCT00705783|474152985|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131690760|NCT00705783|474152983|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
131690761|NCT00705783|474152984|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131690762|NCT00705783|474152985|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131690763|NCT00705783|474152983|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
131690764|NCT00705783|474152984|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
131690765|NCT00705783|474152985|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
131690766|NCT00705783|474152983|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
131690767|NCT00705783|474152984|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
131690768|NCT00705783|474152985|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
131690769|NCT00705783|474152983|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
131690770|NCT00705783|474152984|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
131690771|NCT00705783|474152985|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
131690772|NCT00705783|474152983|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
131690773|NCT00705783|474152984|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
131690774|NCT00705783|474152985|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
131690775|NCT00705783|474152983|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
131690776|NCT00705783|474152984|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
131690777|NCT00705783|474152985|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
131690778|NCT00705783|474152983|FG000|Depot Stabilization Phase|Adverse Event|17|||
131690779|NCT00705783|474152984|FG001|Depot Stabilization Phase|Adverse Event|0|||
131690780|NCT00705783|474152985|FG002|Depot Stabilization Phase|Adverse Event|0|||
131690781|NCT00705783|474152983|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
131690782|NCT00705783|474152984|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131690783|NCT00705783|474152985|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131690784|NCT00705783|474152983|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
131690785|NCT00705783|474152984|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131690786|NCT00705783|474152985|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131690787|NCT00705783|474152983|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
131690788|NCT00705783|474152984|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
131690789|NCT00705783|474152985|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
131690790|NCT00705783|474152983|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
131690791|NCT00705783|474152984|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
131690792|NCT00705783|474152985|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
131690793|NCT00705783|474152983|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
131690794|NCT00705783|474152984|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
131690795|NCT00705783|474152985|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
131690796|NCT00705783|474152983|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
131690797|NCT00705783|474152984|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
131690798|NCT00705783|474152985|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
131690799|NCT00705783|474152983|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
131690800|NCT00705783|474152984|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
131690801|NCT00705783|474152985|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
131690802|NCT00705783|474152983|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
131690803|NCT00705783|474152984|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
131690804|NCT00705783|474152985|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
131690805|NCT00705783|474152983|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
131690806|NCT00705783|474152984|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
131690807|NCT00705783|474152985|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
131690808|NCT00705783|474152983|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
131690809|NCT00705783|474152984|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
131690810|NCT00705783|474152985|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
131690811|NCT00705783|474152983|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
131690812|NCT00705783|474152984|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
131690813|NCT00705783|474152985|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
131690814|NCT02830776|474152986|FG000|Overall Study|Lost to Follow-up|1|||
131690815|NCT03029143|474152987|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
131690816|NCT03029143|474152988|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
131690817|NCT03029143|474152989|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
131690818|NCT03029143|474152987|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
131690819|NCT03029143|474152988|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
131690820|NCT03029143|474152989|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
131690821|NCT03029143|474152987|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
131690822|NCT03029143|474152988|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
131690823|NCT03029143|474152989|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
131690824|NCT03029143|474152987|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
131690825|NCT03029143|474152988|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
131690826|NCT03029143|474152989|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
131690827|NCT03029143|474152987|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
131690828|NCT03029143|474152988|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
131690829|NCT03029143|474152989|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
131690830|NCT03029143|474152987|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
131690831|NCT03029143|474152988|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
131690832|NCT03029143|474152989|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
131690833|NCT03029143|474152987|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
131690834|NCT03029143|474152988|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
131690835|NCT03029143|474152989|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
131690836|NCT03029143|474152987|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131690837|NCT03029143|474152988|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131690838|NCT03029143|474152989|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
131690839|NCT03029143|474152987|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
131690840|NCT03029143|474152988|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
131690841|NCT03029143|474152989|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
131690842|NCT03029143|474152987|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131690843|NCT03029143|474152988|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
131690844|NCT03029143|474152989|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
131690845|NCT03029143|474152987|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
131690846|NCT03029143|474152988|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
131690847|NCT03029143|474152989|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
131690848|NCT00974675|474152990|FG000|Overall Study|Adverse Event|2|||
131690849|NCT00974675|474152991|FG001|Overall Study|Adverse Event|1|||
131690850|NCT00974675|474152992|FG002|Overall Study|Adverse Event|1|||
131690851|NCT00974675|474152993|FG003|Overall Study|Adverse Event|1|||
131690852|NCT00974675|474152990|FG000|Overall Study|Physician Decision|0|||
131690853|NCT00974675|474152991|FG001|Overall Study|Physician Decision|0|||
131690854|NCT00974675|474152992|FG002|Overall Study|Physician Decision|1|||
131690855|NCT00974675|474152993|FG003|Overall Study|Physician Decision|0|||
131690856|NCT00974675|474152990|FG000|Overall Study|Participant on holiday; unable to attend|0|||
131690857|NCT00974675|474152991|FG001|Overall Study|Participant on holiday; unable to attend|0|||
131690858|NCT00974675|474152992|FG002|Overall Study|Participant on holiday; unable to attend|0|||
131690859|NCT00974675|474152993|FG003|Overall Study|Participant on holiday; unable to attend|1|||
131690860|NCT01765920|474152997|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
131690861|NCT01765920|474152998|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
131690862|NCT01765920|474152997|FG000|Overall Study|Patient code disclosure|0|||
131690863|NCT01765920|474152998|FG001|Overall Study|Patient code disclosure|1|||
131690864|NCT01081249|474152999|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
131690865|NCT01081249|474153000|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
131690866|NCT00886600|474153001|FG000|Double-blind Monotherapy|Adverse Event|1|||
131690867|NCT00886600|474153002|FG001|Double-blind Monotherapy|Adverse Event|1|||
131690868|NCT00886600|474153003|FG002|Double-blind Monotherapy|Adverse Event|1|||
131690869|NCT00886600|474153004|FG003|Double-blind Monotherapy|Adverse Event|1|||
131690870|NCT00886600|474153001|FG000|Double-blind Monotherapy|Protocol Violation|0|||
131690871|NCT00886600|474153002|FG001|Double-blind Monotherapy|Protocol Violation|0|||
131690872|NCT00886600|474153003|FG002|Double-blind Monotherapy|Protocol Violation|0|||
131690873|NCT00886600|474153004|FG003|Double-blind Monotherapy|Protocol Violation|1|||
131690874|NCT00886600|474153001|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
131690875|NCT00886600|474153002|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
131690876|NCT00886600|474153003|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
131690877|NCT00886600|474153004|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
131690878|NCT00886600|474153001|FG000|Combination Therapy Period|Adverse Event|0|||
131690879|NCT00886600|474153002|FG001|Combination Therapy Period|Adverse Event|0|||
131690880|NCT00886600|474153003|FG002|Combination Therapy Period|Adverse Event|1|||
131690881|NCT00886600|474153004|FG003|Combination Therapy Period|Adverse Event|0|||
131690882|NCT00886600|474153001|FG000|Combination Therapy Period|Protocol Violation|0|||
131690883|NCT00886600|474153002|FG001|Combination Therapy Period|Protocol Violation|0|||
131690884|NCT00886600|474153003|FG002|Combination Therapy Period|Protocol Violation|1|||
131690885|NCT00886600|474153004|FG003|Combination Therapy Period|Protocol Violation|0|||
131690886|NCT01439204|474153005|FG000|Overall Study|Withdrawal by Subject|0|||
131690887|NCT01439204|474153006|FG001|Overall Study|Withdrawal by Subject|1|||
131690888|NCT01439204|474153005|FG000|Overall Study|Lost to Follow-up|0|||
131690889|NCT01439204|474153006|FG001|Overall Study|Lost to Follow-up|2|||
131690890|NCT01439204|474153005|FG000|Overall Study|No longer meets study criteria|1|||
131690891|NCT01439204|474153006|FG001|Overall Study|No longer meets study criteria|0|||
131690892|NCT01439204|474153005|FG000|Overall Study|poor/non-compliance|3|||
131690893|NCT01439204|474153006|FG001|Overall Study|poor/non-compliance|0|||
131690894|NCT03917823|474153008|FG000|Overall Study|Lost to Follow-up|1|||
131690895|NCT03917823|474153009|FG001|Overall Study|Lost to Follow-up|1|||
131690896|NCT03917823|474153008|FG000|Overall Study|Withdrawal by Subject|0|||
131690897|NCT03917823|474153009|FG001|Overall Study|Withdrawal by Subject|1|||
131690898|NCT03775421|474153010|FG000|Overall Study|Lost to Follow-up|2|||
131690899|NCT03775421|474153010|FG000|Overall Study|Withdrawal by Subject|10|||
131690900|NCT03775421|474153010|FG000|Overall Study|Physician Decision|3|||
131690901|NCT03775421|474153010|FG000|Overall Study|Death|1|||
131690902|NCT03775421|474153010|FG000|Overall Study|Study Terminated by Sponsor|94|||
131690903|NCT00135668|474153011|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
131690904|NCT00135668|474153012|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
131690905|NCT00135668|474153013|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
131690906|NCT00135668|474153014|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
131690907|NCT02016820|474153015|FG000|Overall Study|Lost to Follow-up|2|||
131690908|NCT02016820|474153016|FG001|Overall Study|Lost to Follow-up|4|||
131690909|NCT01227044|474153019|FG000|Overall Study|Lost to Follow-up|5|||
131690910|NCT01227044|474153020|FG001|Overall Study|Lost to Follow-up|7|||
131690911|NCT01227044|474153019|FG000|Overall Study|Discontinued Intervention|1|||
131690912|NCT01227044|474153020|FG001|Overall Study|Discontinued Intervention|2|||
131690913|NCT00583362|474153021|FG000|Overall Study|Adverse Event|44|||
131690914|NCT00583362|474153021|FG000|Overall Study|Lack of Efficacy|22|||
131690915|NCT00583362|474153021|FG000|Overall Study|Lost to Follow-up|4|||
131690916|NCT00583362|474153021|FG000|Overall Study|Non-compliance with study drug|28|||
131690917|NCT00583362|474153021|FG000|Overall Study|Pregnancy|7|||
131690918|NCT00583362|474153021|FG000|Overall Study|Miscommunication of visit window|5|||
131690919|NCT00583362|474153021|FG000|Overall Study|Current site closed|7|||
131690920|NCT00583362|474153021|FG000|Overall Study|Subject not dosed in LBSL99|1|||
131690921|NCT00583362|474153021|FG000|Overall Study|Subject moved out of the country/state|2|||
131690922|NCT00583362|474153021|FG000|Overall Study|Missed visits due to staff changes|1|||
131690923|NCT00583362|474153021|FG000|Overall Study|Misunderstanding of protocol|1|||
131690924|NCT00583362|474153021|FG000|Overall Study|Behavioral problems and non-compliance|1|||
131690925|NCT00583362|474153021|FG000|Overall Study|Sponsor request due to missed doses|1|||
131690926|NCT00583362|474153021|FG000|Overall Study|Physician Decision|19|||
131690927|NCT00583362|474153021|FG000|Overall Study|Protocol Violation|2|||
131690928|NCT00583362|474153021|FG000|Overall Study|Withdrawal by Subject|57|||
131690929|NCT00473343|474153022|FG000|Overall Study|Adverse Event|9|||
131690930|NCT00473343|474153022|FG000|Overall Study|Lost to Follow-up|8|||
131690931|NCT00473343|474153022|FG000|Overall Study|Treatment failure|27|||
131690932|NCT00473343|474153022|FG000|Overall Study|Withdrew consent|3|||
131690933|NCT00473343|474153022|FG000|Overall Study|Other un-specified reason|3|||
131690934|NCT04247061|474153025|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
131690935|NCT04247061|474153025|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
131690936|NCT04247061|474153025|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
131690937|NCT01136655|474153030|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
131690938|NCT01136655|474153030|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
131690939|NCT01136655|474153030|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
131690940|NCT01136655|474153030|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
131690941|NCT02287623|474153036|FG000|Overall Study|Protocol Violation|0|||
131690942|NCT02287623|474153037|FG001|Overall Study|Protocol Violation|1|||
131690943|NCT00455013|474153039|FG000|Short Term Period|Adverse Event|2|||
131690944|NCT00455013|474153040|FG001|Short Term Period|Adverse Event|5|||
131690945|NCT00455013|474153041|FG002|Short Term Period|Adverse Event|0|||
131690946|NCT00455013|474153039|FG000|Short Term Period|Withdrawal by Subject|0|||
131690947|NCT00455013|474153040|FG001|Short Term Period|Withdrawal by Subject|0|||
131690948|NCT00455013|474153041|FG002|Short Term Period|Withdrawal by Subject|1|||
131690949|NCT00455013|474153039|FG000|Short Term Period|Lack of Efficacy|4|||
131690950|NCT00455013|474153040|FG001|Short Term Period|Lack of Efficacy|0|||
131690951|NCT00455013|474153041|FG002|Short Term Period|Lack of Efficacy|0|||
131690952|NCT00455013|474153039|FG000|Short Term Period|Other|0|||
131690953|NCT00455013|474153040|FG001|Short Term Period|Other|0|||
131690954|NCT00455013|474153041|FG002|Short Term Period|Other|1|||
131690955|NCT00455013|474153039|FG000|Long Term Extension (LTE)|Adverse Event|0|||
131690956|NCT00455013|474153040|FG001|Long Term Extension (LTE)|Adverse Event|1|||
131690957|NCT00455013|474153041|FG002|Long Term Extension (LTE)|Adverse Event|1|||
131690958|NCT00455013|474153039|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
131690959|NCT00455013|474153040|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
131690960|NCT00455013|474153041|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
131690961|NCT00455013|474153039|FG000|Long Term Extension (LTE)|Death|1|||
131690962|NCT00455013|474153040|FG001|Long Term Extension (LTE)|Death|1|||
131690963|NCT00455013|474153041|FG002|Long Term Extension (LTE)|Death|0|||
131690964|NCT00455013|474153039|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
131690965|NCT00455013|474153040|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
131690966|NCT00455013|474153041|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
131690967|NCT00455013|474153039|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
131690968|NCT00455013|474153040|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
131690969|NCT00455013|474153041|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
131690970|NCT00455013|474153039|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
131690971|NCT00455013|474153040|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
131690972|NCT00455013|474153041|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
131690973|NCT00455013|474153039|FG000|Long Term Extension (LTE)|non-specified|0|||
131690974|NCT00455013|474153040|FG001|Long Term Extension (LTE)|non-specified|0|||
131690975|NCT00455013|474153041|FG002|Long Term Extension (LTE)|non-specified|1|||
131690976|NCT02739620|474153044|FG000|Overall Study|Lost to Follow-up|3|||
131690977|NCT02739620|474153045|FG001|Overall Study|Lost to Follow-up|1|||
131690978|NCT02739620|474153044|FG000|Overall Study|Adverse Event|0|||
131690979|NCT02739620|474153045|FG001|Overall Study|Adverse Event|1|||
131690980|NCT00754793|474153047|FG000|Overall Study|voluntary withdrawn from study|0|||
131690981|NCT00754793|474153048|FG001|Overall Study|voluntary withdrawn from study|1|||
131690982|NCT02577146|474153049|FG000|Overall Study|Lost to Follow-up|8|||
131690983|NCT02577146|474153049|FG000|Overall Study|Physician Decision|3|||
131690984|NCT02577146|474153049|FG000|Overall Study|Screen Failure|17|||
131690985|NCT01970501|474153050|FG000|Overall Study|Discontinuation of study by sponsor|16|||
131690986|NCT01970501|474153051|FG001|Overall Study|Discontinuation of study by sponsor|14|||
131690987|NCT01970501|474153050|FG000|Overall Study|Withdrawal by Subject|6|||
131690988|NCT01970501|474153051|FG001|Overall Study|Withdrawal by Subject|7|||
131690989|NCT01970501|474153050|FG000|Overall Study|Adverse Event|2|||
131690990|NCT01970501|474153051|FG001|Overall Study|Adverse Event|4|||
131690991|NCT01970501|474153050|FG000|Overall Study|Death|1|||
131690992|NCT01970501|474153051|FG001|Overall Study|Death|3|||
131690993|NCT01970501|474153050|FG000|Overall Study|Physician Decision|2|||
131690994|NCT01970501|474153051|FG001|Overall Study|Physician Decision|0|||
131690995|NCT01439555|474153055|FG000|Overall Study|Protocol Violation|1|||
131690996|NCT00102960|474153057|FG000|Overall Study|Death|23|||
131690997|NCT00102960|474153058|FG001|Overall Study|Death|11|||
131690998|NCT00102960|474153059|FG002|Overall Study|Death|11|||
131776773|NCT03426995|474462578|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776774|NCT03426995|474462579|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776775|NCT03426995|474462580|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776776|NCT03426995|474462581|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776777|NCT03426995|474462582|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776778|NCT03426995|474462583|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776779|NCT03426995|474462584|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776780|NCT03426995|474462585|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776781|NCT03426995|474462586|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776782|NCT03426995|474462587|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776783|NCT03426995|474462588|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776784|NCT03426995|474462589|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776785|NCT03426995|474462590|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131776786|NCT03426995|474462572|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776787|NCT03426995|474462573|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776788|NCT03426995|474462574|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776789|NCT03426995|474462575|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776790|NCT03426995|474462576|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776791|NCT03426995|474462577|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776792|NCT03426995|474462578|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776793|NCT03426995|474462579|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776794|NCT03426995|474462580|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131690999|NCT00102960|474153057|FG000|Overall Study|Lost to Follow-up|6|||
131691000|NCT00102960|474153058|FG001|Overall Study|Lost to Follow-up|12|||
131691001|NCT00102960|474153059|FG002|Overall Study|Lost to Follow-up|16|||
131691002|NCT00102960|474153057|FG000|Overall Study|Withdrawal by Subject|1|||
131691003|NCT00102960|474153058|FG001|Overall Study|Withdrawal by Subject|0|||
131776795|NCT03426995|474462581|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776796|NCT03426995|474462582|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
131776797|NCT03426995|474462583|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776798|NCT03426995|474462584|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776799|NCT03426995|474462585|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776800|NCT03426995|474462586|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776801|NCT03426995|474462587|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776802|NCT03426995|474462588|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776803|NCT03426995|474462589|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776804|NCT03426995|474462590|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131776805|NCT03426995|474462572|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776806|NCT03426995|474462573|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776807|NCT03426995|474462574|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776808|NCT03426995|474462575|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776809|NCT03426995|474462576|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776810|NCT03426995|474462577|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776811|NCT03426995|474462578|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776812|NCT03426995|474462579|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
131776813|NCT03426995|474462580|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776814|NCT03426995|474462581|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776815|NCT03426995|474462582|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776816|NCT03426995|474462583|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776817|NCT03426995|474462584|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776818|NCT03426995|474462585|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776819|NCT03426995|474462586|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776820|NCT03426995|474462587|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776821|NCT03426995|474462588|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776822|NCT03426995|474462589|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776823|NCT03426995|474462590|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131776824|NCT03426995|474462572|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776825|NCT03426995|474462573|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776826|NCT03426995|474462574|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776827|NCT03426995|474462575|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776828|NCT03426995|474462576|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776829|NCT03426995|474462577|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776830|NCT03426995|474462578|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776831|NCT03426995|474462579|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776832|NCT03426995|474462580|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776833|NCT03426995|474462581|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776834|NCT03426995|474462582|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776835|NCT03426995|474462583|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776836|NCT03426995|474462584|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776837|NCT03426995|474462585|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776838|NCT03426995|474462586|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
131776839|NCT03426995|474462587|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
131776840|NCT03426995|474462588|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776841|NCT03426995|474462589|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776842|NCT03426995|474462590|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131776843|NCT03426995|474462572|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776844|NCT03426995|474462573|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776845|NCT03426995|474462574|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776846|NCT03426995|474462575|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776847|NCT03426995|474462576|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776848|NCT03426995|474462577|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776849|NCT03426995|474462578|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776850|NCT03426995|474462579|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776851|NCT03426995|474462580|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776852|NCT03426995|474462581|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776853|NCT03426995|474462582|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776854|NCT03426995|474462583|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776855|NCT03426995|474462584|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776856|NCT03426995|474462585|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776857|NCT03426995|474462586|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
131776858|NCT03426995|474462587|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
131776859|NCT03426995|474462588|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776860|NCT03426995|474462589|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776861|NCT03426995|474462590|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131776862|NCT04410978|474462596|FG000|Overall Study|Poor compliance to protocol|2|||
131776863|NCT04410978|474462597|FG001|Overall Study|Poor compliance to protocol|4|||
131776864|NCT04410978|474462596|FG000|Overall Study|Withdrawal by Subject|64|||
131776865|NCT04410978|474462597|FG001|Overall Study|Withdrawal by Subject|66|||
131776866|NCT04410978|474462596|FG000|Overall Study|Other|6|||
131776867|NCT04410978|474462597|FG001|Overall Study|Other|7|||
131776868|NCT04410978|474462596|FG000|Overall Study|Missing study status|1|||
131776869|NCT04410978|474462597|FG001|Overall Study|Missing study status|0|||
131776870|NCT05153629|474462599|FG000|Overall Study|Withdrawal by Subject|0|||
131776871|NCT05153629|474462600|FG001|Overall Study|Withdrawal by Subject|2|||
131776872|NCT03743571|474462606|FG000|Overall Study|Withdrawal by Subject|1|||
131776873|NCT03743571|474462607|FG001|Overall Study|Withdrawal by Subject|1|||
131776874|NCT03743571|474462606|FG000|Overall Study|Lost to Follow-up|1|||
131776875|NCT03743571|474462607|FG001|Overall Study|Lost to Follow-up|2|||
131776876|NCT04115488|474462608|FG000|Overall Study|Adverse Event|8|||
131776877|NCT04115488|474462609|FG001|Overall Study|Adverse Event|4|||
131776878|NCT04115488|474462608|FG000|Overall Study|Withdrawal by Subject|3|||
131776879|NCT04115488|474462609|FG001|Overall Study|Withdrawal by Subject|6|||
131691004|NCT00102960|474153059|FG002|Overall Study|Withdrawal by Subject|1|||
131691005|NCT01135498|474154420|FG000|Overall Study|Adverse Event|20|||
131691006|NCT01135498|474154420|FG000|Overall Study|Progressive disease|38|||
131691007|NCT01135498|474154420|FG000|Overall Study|Investigator judgement|25|||
131691008|NCT01135498|474154420|FG000|Overall Study|Withdrawal by Subject|4|||
131691009|NCT01135498|474154420|FG000|Overall Study|Death|1|||
131691010|NCT01135498|474154420|FG000|Overall Study|Ongoing at time of analysis|2|||
131691011|NCT02646982|474154421|FG000|Overall Study|Adverse Event|1|||
131691012|NCT02646982|474154422|FG001|Overall Study|Adverse Event|1|||
131691013|NCT02646982|474154421|FG000|Overall Study|Withdrawal by Subject|2|||
131691014|NCT02646982|474154422|FG001|Overall Study|Withdrawal by Subject|1|||
131691015|NCT00713700|474154423|FG000|Overall Study|Lost to Follow-up|3|||
131691016|NCT00713700|474154423|FG000|Overall Study|Withdrawal by Subject|1|||
131691017|NCT01594853|474154424|FG000|Overall Study|Withdrawal by Subject|1|||
131691018|NCT01594853|474154425|FG001|Overall Study|Withdrawal by Subject|1|||
131691019|NCT01594853|474154424|FG000|Overall Study|Lost to Follow-up|1|||
131691020|NCT01594853|474154425|FG001|Overall Study|Lost to Follow-up|1|||
131691021|NCT01594853|474154424|FG000|Overall Study|noncompliance with exercise|0|||
131691022|NCT01594853|474154425|FG001|Overall Study|noncompliance with exercise|1|||
131691023|NCT03923426|474154427|FG000|Overall Study|Other|19|||
131691024|NCT03923426|474154427|FG000|Overall Study|Lost to Follow-up|16|||
131691025|NCT03923426|474154427|FG000|Overall Study|Death|107|||
131776880|NCT04115488|474462608|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
131776881|NCT04115488|474462609|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
131776882|NCT04115488|474462608|FG000|Overall Study|Patient 's location change|1|||
131776883|NCT04115488|474462609|FG001|Overall Study|Patient 's location change|0|||
131776884|NCT04115488|474462608|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
131776885|NCT04115488|474462609|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
131776886|NCT00885677|474462610|FG000|Overall Study|Death|40|||
131776887|NCT00885677|474462611|FG001|Overall Study|Death|34|||
131776888|NCT00885677|474462610|FG000|Overall Study|Lost to Follow-up|15|||
131776889|NCT00885677|474462611|FG001|Overall Study|Lost to Follow-up|13|||
131776890|NCT00885677|474462610|FG000|Overall Study|Protocol Violation|54|||
131776891|NCT00885677|474462611|FG001|Overall Study|Protocol Violation|54|||
131776892|NCT00885677|474462610|FG000|Overall Study|premature study closure|41|||
131776893|NCT00885677|474462611|FG001|Overall Study|premature study closure|44|||
131776894|NCT00885677|474462610|FG000|Overall Study|device/lead revision or replacement|7|||
131776895|NCT00885677|474462611|FG001|Overall Study|device/lead revision or replacement|6|||
131776896|NCT00885677|474462610|FG000|Overall Study|Heart transplantation|1|||
131776897|NCT00885677|474462611|FG001|Overall Study|Heart transplantation|0|||
131776898|NCT00885677|474462610|FG000|Overall Study|Inclusion/exclusion not met|25|||
131776899|NCT00885677|474462611|FG001|Overall Study|Inclusion/exclusion not met|27|||
131776900|NCT00972309|474462612|FG000|Overall Study|Switched to alternative treatment|0|||
131776901|NCT00972309|474462613|FG001|Overall Study|Switched to alternative treatment|2|||
131776902|NCT00972309|474462612|FG000|Overall Study|Refused further treatment|0|||
131691026|NCT03923426|474154427|FG000|Overall Study|Incomplete response to question|13|||
131776903|NCT00972309|474462613|FG001|Overall Study|Refused further treatment|1|||
131776904|NCT00972309|474462612|FG000|Overall Study|Late determination of ineligibility|0|||
131776905|NCT00972309|474462613|FG001|Overall Study|Late determination of ineligibility|1|||
131776906|NCT00972309|474462612|FG000|Overall Study|Second malignancy|1|||
131776907|NCT00972309|474462613|FG001|Overall Study|Second malignancy|1|||
131776908|NCT00972309|474462612|FG000|Overall Study|Visa issues|0|||
131776909|NCT00972309|474462613|FG001|Overall Study|Visa issues|1|||
131776910|NCT00972309|474462612|FG000|Overall Study|Secondary cancer (SCC)|0|||
131776911|NCT00972309|474462613|FG001|Overall Study|Secondary cancer (SCC)|1|||
131776912|NCT00972309|474462612|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
131776913|NCT00972309|474462613|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
131776914|NCT00972309|474462612|FG000|Overall Study|Lost to Follow-up|1|||
131776915|NCT00972309|474462613|FG001|Overall Study|Lost to Follow-up|1|||
131776916|NCT00972309|474462612|FG000|Overall Study|Disease progression on study|10|||
131776917|NCT00972309|474462613|FG001|Overall Study|Disease progression on study|4|||
131776918|NCT01593761|474462619|FG000|Overall Study|Lost to Follow-up|1|||
131776919|NCT01593761|474462619|FG000|Overall Study|culture negative for MRSA at baseline|5|||
131776920|NCT01593761|474462619|FG000|Overall Study|positive for hepatitis C virus|1|||
131776921|NCT01593761|474462619|FG000|Overall Study|secondary cellulitis|1|||
131691027|NCT00769002|474154428|FG000|Overall Study|Study was not completed, no data|9|||
131691028|NCT00769002|474154429|FG001|Overall Study|Study was not completed, no data|9|||
131691029|NCT00960661|474154435|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
131691030|NCT00960661|474154436|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
131691031|NCT00960661|474154437|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
131691032|NCT00960661|474154435|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
131691033|NCT00960661|474154436|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
131691034|NCT00960661|474154437|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
131691035|NCT00960661|474154435|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
131691036|NCT00960661|474154436|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
131691037|NCT00960661|474154437|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
131691038|NCT00960661|474154435|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
131691039|NCT00960661|474154436|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
131691040|NCT00960661|474154437|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
131691041|NCT00960661|474154435|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
131691042|NCT00960661|474154436|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
131691043|NCT00960661|474154437|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
131691044|NCT00960661|474154435|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
131776922|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
131691045|NCT00960661|474154436|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
131691046|NCT00960661|474154437|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
131691047|NCT00960661|474154435|FG000|Interventional Phase|Adverse Event|0|||
131691048|NCT00960661|474154436|FG001|Interventional Phase|Adverse Event|17|||
131691049|NCT00960661|474154437|FG002|Interventional Phase|Adverse Event|8|||
131691050|NCT00960661|474154435|FG000|Interventional Phase|Death|0|||
131691051|NCT00960661|474154436|FG001|Interventional Phase|Death|1|||
131691052|NCT00960661|474154437|FG002|Interventional Phase|Death|0|||
131691053|NCT00960661|474154435|FG000|Interventional Phase|Lost to Follow-up|0|||
131691054|NCT00960661|474154436|FG001|Interventional Phase|Lost to Follow-up|0|||
131691055|NCT00960661|474154437|FG002|Interventional Phase|Lost to Follow-up|2|||
131691056|NCT00960661|474154435|FG000|Interventional Phase|entry criteria not met|0|||
131691057|NCT00960661|474154436|FG001|Interventional Phase|entry criteria not met|3|||
131691058|NCT00960661|474154437|FG002|Interventional Phase|entry criteria not met|0|||
131691059|NCT00960661|474154435|FG000|Interventional Phase|Protocol Violation|0|||
131691060|NCT00960661|474154436|FG001|Interventional Phase|Protocol Violation|7|||
131691061|NCT00960661|474154437|FG002|Interventional Phase|Protocol Violation|2|||
131691062|NCT00960661|474154435|FG000|Interventional Phase|Withdrawal by Subject|0|||
131691063|NCT00960661|474154436|FG001|Interventional Phase|Withdrawal by Subject|18|||
131691064|NCT00960661|474154437|FG002|Interventional Phase|Withdrawal by Subject|29|||
131691065|NCT00960661|474154435|FG000|Interventional Phase|Physician Decision|0|||
131691066|NCT00960661|474154436|FG001|Interventional Phase|Physician Decision|3|||
131691067|NCT00960661|474154437|FG002|Interventional Phase|Physician Decision|5|||
131691068|NCT00960661|474154435|FG000|Interventional Phase|sponsor decision|0|||
131691069|NCT00960661|474154436|FG001|Interventional Phase|sponsor decision|1|||
131691070|NCT00960661|474154437|FG002|Interventional Phase|sponsor decision|0|||
131691071|NCT00960661|474154435|FG000|Interventional Phase|Lack of Efficacy|0|||
131691072|NCT00960661|474154436|FG001|Interventional Phase|Lack of Efficacy|2|||
131691073|NCT00960661|474154437|FG002|Interventional Phase|Lack of Efficacy|0|||
131691074|NCT02699892|474154438|FG000|Overall Study|Other|36|||
131691075|NCT00847912|474154448|FG000|Overall Study|Protocol Violation|6|||
131691076|NCT00847912|474154449|FG001|Overall Study|Protocol Violation|7|||
131691077|NCT00847912|474154448|FG000|Overall Study|Withdrawal by Subject|3|||
131691078|NCT00847912|474154449|FG001|Overall Study|Withdrawal by Subject|6|||
131691079|NCT01732796|474154456|FG000|Overall Study|Adverse Event|16|||
131691080|NCT01732796|474154457|FG001|Overall Study|Adverse Event|16|||
131691081|NCT01732796|474154458|FG002|Overall Study|Adverse Event|4|||
131691082|NCT01732796|474154456|FG000|Overall Study|Lack of Efficacy|21|||
131776923|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
131691083|NCT01732796|474154457|FG001|Overall Study|Lack of Efficacy|18|||
131691084|NCT01732796|474154458|FG002|Overall Study|Lack of Efficacy|5|||
131691085|NCT01732796|474154456|FG000|Overall Study|Lost to Follow-up|2|||
131691086|NCT01732796|474154457|FG001|Overall Study|Lost to Follow-up|0|||
131691087|NCT01732796|474154458|FG002|Overall Study|Lost to Follow-up|0|||
131691088|NCT01732796|474154456|FG000|Overall Study|Withdrawal by Subject|6|||
131691089|NCT01732796|474154457|FG001|Overall Study|Withdrawal by Subject|8|||
131691090|NCT01732796|474154458|FG002|Overall Study|Withdrawal by Subject|2|||
131691091|NCT01732796|474154456|FG000|Overall Study|Other reason not defined above|1|||
131691092|NCT01732796|474154457|FG001|Overall Study|Other reason not defined above|0|||
131691093|NCT01732796|474154458|FG002|Overall Study|Other reason not defined above|2|||
131691094|NCT00930761|474154461|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
131691095|NCT00930761|474154462|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
131691096|NCT00930761|474154461|FG000|Overall Study|less than 3 music therapy sessions|0|||
131691097|NCT00930761|474154462|FG001|Overall Study|less than 3 music therapy sessions|3|||
131691098|NCT01500278|474154469|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
131691099|NCT01500278|474154470|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
131691100|NCT01500278|474154469|FG000|Week 0 - Week 12|Protocol Violation|10|||
131691101|NCT01500278|474154470|FG001|Week 0 - Week 12|Protocol Violation|16|||
131691102|NCT01500278|474154469|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
131776924|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
131776925|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
131776926|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
131776927|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
131776928|NCT00828009|474462621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
131776929|NCT00828009|474462621|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
131776930|NCT00828009|474462621|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
131776931|NCT00828009|474462621|FG000|Step 2 - Maintenance Therapy|Death|1|||
131776932|NCT00828009|474462621|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
131776933|NCT00828009|474462621|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
131776934|NCT00828009|474462621|FG000|Step 2 - Maintenance Therapy|Other|1|||
131776935|NCT00563706|474464006|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
131776936|NCT00563706|474464007|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131776937|NCT00563706|474464008|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131776938|NCT00563706|474464009|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131776939|NCT00563706|474464010|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
131776940|NCT00563706|474464011|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
131776941|NCT00563706|474464012|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
131776942|NCT00563706|474464013|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131776943|NCT00563706|474464014|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
131776944|NCT00563706|474464006|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131776945|NCT00563706|474464007|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
131776946|NCT00563706|474464008|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131776947|NCT00563706|474464009|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
131776948|NCT00563706|474464010|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
131776949|NCT00563706|474464011|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131776950|NCT00563706|474464012|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131776951|NCT00563706|474464013|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
131776952|NCT00563706|474464014|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
131776953|NCT00563706|474464006|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
131776954|NCT00563706|474464007|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
131776955|NCT00563706|474464008|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
131776956|NCT00563706|474464009|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
131776957|NCT00563706|474464010|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
131776958|NCT00563706|474464011|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
131776959|NCT00563706|474464012|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
131776960|NCT00563706|474464013|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
131776961|NCT00563706|474464014|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
131776962|NCT00563706|474464006|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
131776963|NCT00563706|474464007|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776964|NCT00563706|474464008|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776965|NCT00563706|474464009|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776966|NCT00563706|474464010|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776967|NCT00563706|474464011|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776968|NCT00563706|474464012|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776969|NCT00563706|474464013|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
131776970|NCT00563706|474464014|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131776971|NCT00563706|474464006|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776972|NCT00563706|474464007|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776973|NCT00563706|474464008|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776974|NCT00563706|474464009|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776975|NCT00563706|474464010|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776976|NCT00563706|474464011|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776977|NCT00563706|474464012|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131776978|NCT00563706|474464013|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
131776979|NCT00563706|474464014|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
131776980|NCT03280628|474464015|FG000|Overall Study|Lost to Follow-up|8|||
131776981|NCT03280628|474464016|FG001|Overall Study|Lost to Follow-up|6|||
131776982|NCT03280628|474464017|FG002|Overall Study|Lost to Follow-up|11|||
131776983|NCT01361308|474464020|FG000|Overall Study|Withdrawal by Subject|9|||
131776984|NCT01361308|474464021|FG001|Overall Study|Withdrawal by Subject|13|||
131691103|NCT01500278|474154470|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
131691104|NCT01500278|474154469|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
131691105|NCT01500278|474154470|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
131691106|NCT01500278|474154469|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
131691107|NCT01500278|474154470|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
131691108|NCT01500278|474154469|FG000|Week 0 - Week 12|Patient decision|1|||
131691109|NCT01500278|474154470|FG001|Week 0 - Week 12|Patient decision|0|||
131691110|NCT01500278|474154469|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
131691111|NCT01500278|474154470|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
131691112|NCT01500278|474154469|FG000|Week 0 - Week 12|Investigator decision|1|||
131691113|NCT01500278|474154470|FG001|Week 0 - Week 12|Investigator decision|0|||
131691114|NCT01500278|474154469|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
131691115|NCT01500278|474154470|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
131691116|NCT01500278|474154469|FG000|Week 0 - Week 12|Sponsor decision|1|||
131691117|NCT01500278|474154470|FG001|Week 0 - Week 12|Sponsor decision|0|||
131691118|NCT01500278|474154469|FG000|Week 0 - Week 12|Personal reason|0|||
131691119|NCT01500278|474154470|FG001|Week 0 - Week 12|Personal reason|1|||
131691120|NCT01500278|474154469|FG000|Week 0 - Week 12|Other serious disease|0|||
131691121|NCT01500278|474154470|FG001|Week 0 - Week 12|Other serious disease|1|||
131691122|NCT01500278|474154469|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
131691123|NCT01500278|474154470|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
131691124|NCT01500278|474154469|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
131691125|NCT01500278|474154470|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
131691126|NCT01500278|474154469|FG000|Week 13 - Week 104|Protocol Violation|6|||
131691127|NCT01500278|474154470|FG001|Week 13 - Week 104|Protocol Violation|6|||
131691128|NCT01500278|474154469|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
131691129|NCT01500278|474154470|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
131691130|NCT01500278|474154469|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
131691131|NCT01500278|474154470|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
131691132|NCT01500278|474154469|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
131691133|NCT01500278|474154470|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
131691134|NCT01500278|474154469|FG000|Week 13 - Week 104|Non/bad compliance|7|||
131691135|NCT01500278|474154470|FG001|Week 13 - Week 104|Non/bad compliance|5|||
131691136|NCT01500278|474154469|FG000|Week 13 - Week 104|Recurrent infections|1|||
131691137|NCT01500278|474154470|FG001|Week 13 - Week 104|Recurrent infections|0|||
131691138|NCT01500278|474154469|FG000|Week 13 - Week 104|False positive test|1|||
131691139|NCT01500278|474154470|FG001|Week 13 - Week 104|False positive test|2|||
131691140|NCT01500278|474154469|FG000|Week 13 - Week 104|Sponsor request|4|||
131691141|NCT01500278|474154470|FG001|Week 13 - Week 104|Sponsor request|0|||
131691142|NCT01500278|474154469|FG000|Week 13 - Week 104|Withdrawn in error|1|||
131691143|NCT01500278|474154470|FG001|Week 13 - Week 104|Withdrawn in error|0|||
131691144|NCT01500278|474154469|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
131691145|NCT01500278|474154470|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
131691146|NCT01500278|474154469|FG000|Week 13 - Week 104|Protocol deviation|1|||
131691147|NCT01500278|474154470|FG001|Week 13 - Week 104|Protocol deviation|0|||
131691148|NCT01500278|474154469|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
131691149|NCT01500278|474154470|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
131691150|NCT01500278|474154469|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
131691151|NCT01500278|474154470|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
131691152|NCT01500278|474154469|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
131691153|NCT01500278|474154470|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
131691154|NCT01500278|474154469|FG000|Week 13 - Week 104|Relocation|0|||
131691155|NCT01500278|474154470|FG001|Week 13 - Week 104|Relocation|1|||
131691156|NCT01500278|474154469|FG000|Week 13 - Week 104|Sponsor decision|0|||
131691157|NCT01500278|474154470|FG001|Week 13 - Week 104|Sponsor decision|2|||
131691158|NCT01500278|474154469|FG000|Week 13 - Week 104|Medical monitor decision|0|||
131691159|NCT01500278|474154470|FG001|Week 13 - Week 104|Medical monitor decision|2|||
131691160|NCT01500278|474154469|FG000|Week 13 - Week 104|Personal reason|0|||
131691161|NCT01500278|474154470|FG001|Week 13 - Week 104|Personal reason|1|||
131691162|NCT01500278|474154469|FG000|Week 13 - Week 104|Not completed|0|||
131691163|NCT01500278|474154470|FG001|Week 13 - Week 104|Not completed|1|||
131776985|NCT01361308|474464020|FG000|Overall Study|Physician Decision|3|||
131691164|NCT01500278|474154469|FG000|Week 13 - Week 104|Death|2|||
131691165|NCT01500278|474154470|FG001|Week 13 - Week 104|Death|4|||
131691166|NCT01500278|474154469|FG000|Week 13 - Week 104|Adverse Event|54|||
131691167|NCT01500278|474154470|FG001|Week 13 - Week 104|Adverse Event|54|||
131691168|NCT00283595|474154471|FG000|Overall Study|Withdrawal by Subject|1|||
131691169|NCT00283595|474154472|FG001|Overall Study|Withdrawal by Subject|2|||
131691170|NCT01709435|474154476|FG000|Overall Study|Adverse Event|1|||
131691171|NCT01709435|474154477|FG001|Overall Study|Adverse Event|1|||
131691172|NCT01709435|474154478|FG002|Overall Study|Adverse Event|1|||
131691173|NCT01709435|474154479|FG003|Overall Study|Adverse Event|0|||
131691174|NCT01709435|474154480|FG004|Overall Study|Adverse Event|0|||
131691175|NCT01709435|474154481|FG005|Overall Study|Adverse Event|1|||
131776986|NCT01361308|474464021|FG001|Overall Study|Physician Decision|3|||
131776987|NCT01361308|474464020|FG000|Overall Study|Lack of Efficacy|2|||
131776988|NCT01361308|474464021|FG001|Overall Study|Lack of Efficacy|0|||
131776989|NCT01361308|474464020|FG000|Overall Study|Protocol Violation|1|||
131776990|NCT01361308|474464021|FG001|Overall Study|Protocol Violation|0|||
131776991|NCT01361308|474464020|FG000|Overall Study|Lost to Follow-up|5|||
131776992|NCT01361308|474464021|FG001|Overall Study|Lost to Follow-up|4|||
131776993|NCT01361308|474464020|FG000|Overall Study|Adverse Event|8|||
131776994|NCT01361308|474464021|FG001|Overall Study|Adverse Event|4|||
131776995|NCT01361308|474464020|FG000|Overall Study|Eligibility Criteria Not Met|2|||
131776996|NCT01361308|474464021|FG001|Overall Study|Eligibility Criteria Not Met|3|||
131776997|NCT01361308|474464020|FG000|Overall Study|Failed C-SSRS|5|||
131776998|NCT01361308|474464021|FG001|Overall Study|Failed C-SSRS|2|||
131776999|NCT01361308|474464020|FG000|Overall Study|Other|0|||
131777000|NCT01361308|474464021|FG001|Overall Study|Other|1|||
131777001|NCT03839693|474464026|FG000|Overall Study|Lost to Follow-up|0|||
131777002|NCT03839693|474464027|FG001|Overall Study|Lost to Follow-up|2|||
131777003|NCT03839693|474464028|FG002|Overall Study|Lost to Follow-up|2|||
131777004|NCT03839693|474464026|FG000|Overall Study|Withdrawal by Subject|1|||
131777005|NCT03839693|474464027|FG001|Overall Study|Withdrawal by Subject|0|||
131777006|NCT03839693|474464028|FG002|Overall Study|Withdrawal by Subject|2|||
131777007|NCT03839693|474464026|FG000|Overall Study|subject moved out of the area|1|||
131777008|NCT03839693|474464027|FG001|Overall Study|subject moved out of the area|0|||
131777009|NCT03839693|474464028|FG002|Overall Study|subject moved out of the area|0|||
131777010|NCT03099265|474464029|FG000|Overall Study|Adverse Event|1|||
131777011|NCT00602927|474464035|FG000|Period 1: 13 Days|Protocol Violation|2|||
131777012|NCT00602927|474464036|FG001|Period 1: 13 Days|Protocol Violation|4|||
131777013|NCT00602927|474464035|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
131777014|NCT00602927|474464036|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
131777015|NCT00602927|474464035|FG000|Period 1: 13 Days|Time|1|||
131777016|NCT00602927|474464036|FG001|Period 1: 13 Days|Time|0|||
131777017|NCT00602927|474464035|FG000|Period 1: 13 Days|Claustrophobia|0|||
131777018|NCT00602927|474464036|FG001|Period 1: 13 Days|Claustrophobia|1|||
131777019|NCT00602927|474464035|FG000|Period 2: 14 Days|Protocol Violation|0|||
131777020|NCT00602927|474464036|FG001|Period 2: 14 Days|Protocol Violation|2|||
131777021|NCT00602927|474464035|FG000|Period 3: 13 Days|Protocol Violation|0|||
131777022|NCT00602927|474464036|FG001|Period 3: 13 Days|Protocol Violation|1|||
131777023|NCT00602927|474464035|FG000|Period 3: 13 Days|MRI data quality|2|||
131777024|NCT00602927|474464036|FG001|Period 3: 13 Days|MRI data quality|2|||
131777025|NCT02074982|474464039|FG000|Overall Study|Adverse Event|15|||
131777026|NCT02074982|474464040|FG001|Overall Study|Adverse Event|7|||
131777027|NCT02074982|474464039|FG000|Overall Study|Lack of Efficacy|6|||
131777028|NCT02074982|474464040|FG001|Overall Study|Lack of Efficacy|1|||
131777029|NCT02074982|474464039|FG000|Overall Study|Lost to Follow-up|9|||
131777030|NCT02074982|474464040|FG001|Overall Study|Lost to Follow-up|10|||
131777031|NCT02074982|474464039|FG000|Overall Study|Non-compliance with study treatment|0|||
131777032|NCT02074982|474464040|FG001|Overall Study|Non-compliance with study treatment|2|||
131777033|NCT02074982|474464039|FG000|Overall Study|Physician Decision|1|||
131777034|NCT02074982|474464040|FG001|Overall Study|Physician Decision|1|||
131777035|NCT02074982|474464039|FG000|Overall Study|Pregnancy|1|||
131777036|NCT02074982|474464040|FG001|Overall Study|Pregnancy|2|||
131777037|NCT02074982|474464039|FG000|Overall Study|Protocol deviation|4|||
131777038|NCT02074982|474464040|FG001|Overall Study|Protocol deviation|3|||
131777039|NCT02074982|474464039|FG000|Overall Study|Technical problems|0|||
131777040|NCT02074982|474464040|FG001|Overall Study|Technical problems|2|||
131777041|NCT02074982|474464039|FG000|Overall Study|Subject/guardian decision|15|||
131777042|NCT02074982|474464040|FG001|Overall Study|Subject/guardian decision|24|||
131777043|NCT02074982|474464039|FG000|Overall Study|Death|0|||
131777044|NCT02074982|474464040|FG001|Overall Study|Death|2|||
131777045|NCT03722849|474464043|FG000|Overall Study|Withdrawal by Subject|1|||
131777046|NCT03722849|474464044|FG001|Overall Study|Withdrawal by Subject|1|||
131777047|NCT03985982|474464045|FG000|Double-Blind Phase|Lost to Follow-up|4|||
131777048|NCT03985982|474464046|FG001|Double-Blind Phase|Lost to Follow-up|3|||
131777049|NCT03985982|474464047|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131777050|NCT03985982|474464045|FG000|Double-Blind Phase|Physician Decision|1|||
131777051|NCT03985982|474464046|FG001|Double-Blind Phase|Physician Decision|0|||
131777052|NCT03985982|474464047|FG002|Double-Blind Phase|Physician Decision|0|||
131777053|NCT03985982|474464045|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
131777054|NCT03985982|474464046|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
131777055|NCT03985982|474464047|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131777056|NCT03985982|474464045|FG000|Double-Blind Phase|COVID-19|1|||
131777057|NCT03985982|474464046|FG001|Double-Blind Phase|COVID-19|0|||
131777058|NCT03985982|474464047|FG002|Double-Blind Phase|COVID-19|0|||
131691176|NCT01709435|474154476|FG000|Overall Study|Lack of Efficacy|5|||
131691177|NCT01709435|474154477|FG001|Overall Study|Lack of Efficacy|7|||
131691178|NCT01709435|474154478|FG002|Overall Study|Lack of Efficacy|2|||
131691179|NCT01709435|474154479|FG003|Overall Study|Lack of Efficacy|2|||
131691180|NCT01709435|474154480|FG004|Overall Study|Lack of Efficacy|6|||
131691181|NCT01709435|474154481|FG005|Overall Study|Lack of Efficacy|3|||
131691182|NCT01709435|474154476|FG000|Overall Study|Physician Decision|0|||
131691183|NCT01709435|474154477|FG001|Overall Study|Physician Decision|1|||
131691184|NCT01709435|474154478|FG002|Overall Study|Physician Decision|0|||
131691185|NCT01709435|474154479|FG003|Overall Study|Physician Decision|1|||
131691186|NCT01709435|474154480|FG004|Overall Study|Physician Decision|2|||
131691187|NCT01709435|474154481|FG005|Overall Study|Physician Decision|0|||
131691188|NCT01709435|474154476|FG000|Overall Study|Withdrawal by Subject|0|||
131691189|NCT01709435|474154477|FG001|Overall Study|Withdrawal by Subject|0|||
131691190|NCT01709435|474154478|FG002|Overall Study|Withdrawal by Subject|3|||
131691191|NCT01709435|474154479|FG003|Overall Study|Withdrawal by Subject|0|||
131691192|NCT01709435|474154480|FG004|Overall Study|Withdrawal by Subject|2|||
131691193|NCT01709435|474154481|FG005|Overall Study|Withdrawal by Subject|2|||
131691194|NCT00183274|474154482|FG000|Phase 1: Open-Label|Adverse Event|31|||
131691195|NCT00183274|474154483|FG001|Phase 1: Open-Label|Adverse Event|0|||
131691196|NCT00183274|474154484|FG002|Phase 1: Open-Label|Adverse Event|0|||
131691197|NCT00183274|474154485|FG003|Phase 1: Open-Label|Adverse Event|0|||
131691198|NCT00183274|474154486|FG004|Phase 1: Open-Label|Adverse Event|0|||
131691199|NCT00183274|474154487|FG005|Phase 1: Open-Label|Adverse Event|0|||
131691200|NCT00183274|474154482|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
131691201|NCT00183274|474154483|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
131691202|NCT00183274|474154484|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
131691203|NCT00183274|474154485|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
131691204|NCT00183274|474154486|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
131691205|NCT00183274|474154487|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
131691206|NCT00183274|474154482|FG000|Phase 1: Open-Label|Protocol Violation|11|||
131691207|NCT00183274|474154483|FG001|Phase 1: Open-Label|Protocol Violation|0|||
131691208|NCT00183274|474154484|FG002|Phase 1: Open-Label|Protocol Violation|0|||
131691209|NCT00183274|474154485|FG003|Phase 1: Open-Label|Protocol Violation|0|||
131691210|NCT00183274|474154486|FG004|Phase 1: Open-Label|Protocol Violation|0|||
131691211|NCT00183274|474154487|FG005|Phase 1: Open-Label|Protocol Violation|0|||
131691212|NCT00183274|474154482|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
131691213|NCT00183274|474154483|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
131691214|NCT00183274|474154484|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
131691215|NCT00183274|474154485|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
131691216|NCT00183274|474154486|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
131691217|NCT00183274|474154487|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
131691218|NCT00183274|474154482|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
131691219|NCT00183274|474154483|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
131691220|NCT00183274|474154484|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
131691221|NCT00183274|474154485|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
131691222|NCT00183274|474154486|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
131691223|NCT00183274|474154487|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
131691224|NCT00183274|474154482|FG000|Phase 1: Open-Label|Other|9|||
131691225|NCT00183274|474154483|FG001|Phase 1: Open-Label|Other|0|||
131691226|NCT00183274|474154484|FG002|Phase 1: Open-Label|Other|0|||
131691227|NCT00183274|474154485|FG003|Phase 1: Open-Label|Other|0|||
131691228|NCT00183274|474154486|FG004|Phase 1: Open-Label|Other|0|||
131691229|NCT00183274|474154487|FG005|Phase 1: Open-Label|Other|0|||
131691230|NCT00183274|474154482|FG000|Phase 2: Double-Blind|Relapsed|0|||
131691231|NCT00183274|474154483|FG001|Phase 2: Double-Blind|Relapsed|8|||
131691232|NCT00183274|474154484|FG002|Phase 2: Double-Blind|Relapsed|29|||
131691233|NCT00183274|474154485|FG003|Phase 2: Double-Blind|Relapsed|0|||
131691234|NCT00183274|474154486|FG004|Phase 2: Double-Blind|Relapsed|0|||
131691235|NCT00183274|474154487|FG005|Phase 2: Double-Blind|Relapsed|0|||
131691236|NCT00183274|474154482|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131691237|NCT00183274|474154483|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
131691238|NCT00183274|474154484|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
131691239|NCT00183274|474154485|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131691240|NCT00183274|474154486|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131691241|NCT00183274|474154487|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131691242|NCT00183274|474154482|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
131691243|NCT00183274|474154483|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
131691244|NCT00183274|474154484|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
131691245|NCT00183274|474154485|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
131691246|NCT00183274|474154486|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
131691247|NCT00183274|474154487|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
131691248|NCT00183274|474154482|FG000|Phase 3: Double-Blind|Relapsed|0|||
131691249|NCT00183274|474154483|FG001|Phase 3: Double-Blind|Relapsed|0|||
131691250|NCT00183274|474154484|FG002|Phase 3: Double-Blind|Relapsed|0|||
131691251|NCT00183274|474154485|FG003|Phase 3: Double-Blind|Relapsed|1|||
131691252|NCT00183274|474154486|FG004|Phase 3: Double-Blind|Relapsed|11|||
131691253|NCT00183274|474154487|FG005|Phase 3: Double-Blind|Relapsed|2|||
131691254|NCT00618410|474154490|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
131691255|NCT00618410|474154491|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
131691256|NCT01297270|474154498|FG000|Overall Study|Adverse Event|19|||
131691257|NCT01297270|474154499|FG001|Overall Study|Adverse Event|32|||
131691258|NCT01297270|474154500|FG002|Overall Study|Adverse Event|5|||
131691259|NCT01297270|474154498|FG000|Overall Study|Lack of Efficacy|15|||
131691260|NCT01297270|474154499|FG001|Overall Study|Lack of Efficacy|17|||
131691261|NCT01297270|474154500|FG002|Overall Study|Lack of Efficacy|15|||
131691262|NCT01297270|474154498|FG000|Overall Study|Lost to Follow-up|1|||
131691263|NCT01297270|474154499|FG001|Overall Study|Lost to Follow-up|2|||
131691264|NCT01297270|474154500|FG002|Overall Study|Lost to Follow-up|1|||
131691265|NCT01297270|474154498|FG000|Overall Study|Protocol Violation|0|||
131691266|NCT01297270|474154499|FG001|Overall Study|Protocol Violation|2|||
131691267|NCT01297270|474154500|FG002|Overall Study|Protocol Violation|0|||
131691268|NCT01297270|474154498|FG000|Overall Study|Withdrawal by Subject|7|||
131691269|NCT01297270|474154499|FG001|Overall Study|Withdrawal by Subject|15|||
131691270|NCT01297270|474154500|FG002|Overall Study|Withdrawal by Subject|7|||
131691271|NCT01297270|474154498|FG000|Overall Study|Other reason not defined above|3|||
131691272|NCT01297270|474154499|FG001|Overall Study|Other reason not defined above|3|||
131691273|NCT01297270|474154500|FG002|Overall Study|Other reason not defined above|1|||
131777059|NCT03985982|474464045|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
131691274|NCT01297270|474154498|FG000|Overall Study|Not treated|0|||
131691275|NCT01297270|474154499|FG001|Overall Study|Not treated|1|||
131691276|NCT01297270|474154500|FG002|Overall Study|Not treated|0|||
131691277|NCT03882970|474154503|FG000|Overall Study|Adverse Event|5|||
131691278|NCT03882970|474154504|FG001|Overall Study|Adverse Event|7|||
131777060|NCT03985982|474464046|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
131777061|NCT03985982|474464047|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
131777062|NCT03985982|474464045|FG000|Open-Label Phase|Lost to Follow-up|0|||
131777063|NCT03985982|474464046|FG001|Open-Label Phase|Lost to Follow-up|0|||
131777064|NCT03985982|474464047|FG002|Open-Label Phase|Lost to Follow-up|13|||
131777065|NCT03985982|474464045|FG000|Open-Label Phase|Physician Decision|0|||
131777066|NCT03985982|474464046|FG001|Open-Label Phase|Physician Decision|0|||
131777067|NCT03985982|474464047|FG002|Open-Label Phase|Physician Decision|2|||
131777068|NCT03985982|474464045|FG000|Open-Label Phase|Withdrawal by Subject|0|||
131777069|NCT03985982|474464046|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131777070|NCT03985982|474464047|FG002|Open-Label Phase|Withdrawal by Subject|11|||
131777071|NCT00478933|474464048|FG000|Overall Study|Protocol Violation|22|||
131777072|NCT00478933|474464048|FG000|Overall Study|Informed consent not verified|3|||
131777073|NCT00478933|474464048|FG000|Overall Study|Inadequate data available|53|||
131777074|NCT03772574|474464049|FG000|Overall Study|Protocol Violation|2|||
131777075|NCT03772574|474464050|FG001|Overall Study|Protocol Violation|0|||
131777076|NCT03772574|474464051|FG002|Overall Study|Protocol Violation|0|||
131777077|NCT03772574|474464049|FG000|Overall Study|Discomfort|0|||
131777078|NCT03772574|474464050|FG001|Overall Study|Discomfort|5|||
131777079|NCT03772574|474464051|FG002|Overall Study|Discomfort|4|||
131777080|NCT00348348|474464054|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
131777081|NCT00348348|474464055|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
131777082|NCT00348348|474464054|FG000|Overall Study|Lack of Efficacy|1|||
131777083|NCT00348348|474464055|FG001|Overall Study|Lack of Efficacy|1|||
131777084|NCT00348348|474464054|FG000|Overall Study|Lost to Follow-up|8|||
131777085|NCT00348348|474464055|FG001|Overall Study|Lost to Follow-up|10|||
131777086|NCT00348348|474464054|FG000|Overall Study|Withdrawal by Subject|4|||
131777087|NCT00348348|474464055|FG001|Overall Study|Withdrawal by Subject|1|||
131777088|NCT00348348|474464054|FG000|Overall Study|Other|7|||
131777089|NCT00348348|474464055|FG001|Overall Study|Other|4|||
131777090|NCT00348348|474464054|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
131777091|NCT00348348|474464055|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
131777092|NCT00348348|474464054|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
131777093|NCT00348348|474464055|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
131777094|NCT00348348|474464054|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
131777095|NCT00348348|474464055|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
131777096|NCT00348348|474464054|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
131777097|NCT00348348|474464055|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
131777098|NCT00348348|474464054|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
131777099|NCT00348348|474464055|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
131777100|NCT00348348|474464054|FG000|Overall Study|Adverse event probably related to study|1|||
131777101|NCT00348348|474464055|FG001|Overall Study|Adverse event probably related to study|0|||
131777102|NCT01870921|474464056|FG000|Overall Study|Subject decision|80|||
131777103|NCT01870921|474464056|FG000|Overall Study|Severe non-compliance to protocol|7|||
131777104|NCT01870921|474464056|FG000|Overall Study|Subject Lost to Follow up|2|||
131777105|NCT01870921|474464056|FG000|Overall Study|Other|1|||
131777106|NCT01265875|474464059|FG000|Overall Study|Uncooperative/unreliable|1|||
131777107|NCT05275673|474464060|FG000|Overall Study|Study Termination by Sponsor|2|||
131777108|NCT05275673|474464061|FG001|Overall Study|Study Termination by Sponsor|3|||
131777109|NCT05275673|474464060|FG000|Overall Study|Death|1|||
131777110|NCT05275673|474464061|FG001|Overall Study|Death|0|||
131777111|NCT05275673|474464060|FG000|Overall Study|Withdrawal by Subject|1|||
131777112|NCT05275673|474464061|FG001|Overall Study|Withdrawal by Subject|0|||
131777113|NCT04409509|474464062|FG000|Overall Study|Failure to meet randomization requirement|1|||
131777114|NCT04409509|474464063|FG001|Overall Study|Failure to meet randomization requirement|0|||
131777115|NCT04409509|474464062|FG000|Overall Study|Adverse Event|0|||
131777116|NCT04409509|474464063|FG001|Overall Study|Adverse Event|1|||
131777117|NCT04409509|474464062|FG000|Overall Study|Death|11|||
131777118|NCT04409509|474464063|FG001|Overall Study|Death|10|||
131777119|NCT04409509|474464062|FG000|Overall Study|Non-compliance with study drug|0|||
131777120|NCT04409509|474464063|FG001|Overall Study|Non-compliance with study drug|1|||
131777121|NCT04409509|474464062|FG000|Overall Study|Lost to Follow-up|0|||
131777122|NCT04409509|474464063|FG001|Overall Study|Lost to Follow-up|3|||
131777123|NCT04409509|474464062|FG000|Overall Study|Withdrawal by Subject|0|||
131777124|NCT04409509|474464063|FG001|Overall Study|Withdrawal by Subject|3|||
131777125|NCT04409509|474464062|FG000|Overall Study|Randomized by mistake|0|||
131777126|NCT04409509|474464063|FG001|Overall Study|Randomized by mistake|1|||
131777127|NCT04409509|474464062|FG000|Overall Study|Other|1|||
131777128|NCT04409509|474464063|FG001|Overall Study|Other|1|||
131436725|NCT00607087|473224113|FG000|Period 2|Other reason|1|||
131777129|NCT02331680|474464066|FG000|Overall Study|Adverse Event|3|||
131777130|NCT02331680|474464067|FG001|Overall Study|Adverse Event|0|||
131777131|NCT02331680|474464068|FG002|Overall Study|Adverse Event|2|||
131777132|NCT02331680|474464066|FG000|Overall Study|Physician Decision|1|||
131777133|NCT02331680|474464067|FG001|Overall Study|Physician Decision|1|||
131777134|NCT02331680|474464068|FG002|Overall Study|Physician Decision|2|||
131777135|NCT02331680|474464066|FG000|Overall Study|Withdrawal by Subject|0|||
131777136|NCT02331680|474464067|FG001|Overall Study|Withdrawal by Subject|1|||
131777137|NCT02331680|474464068|FG002|Overall Study|Withdrawal by Subject|2|||
131777138|NCT02331680|474464066|FG000|Overall Study|Met withdrawal criteria|2|||
131777139|NCT02331680|474464067|FG001|Overall Study|Met withdrawal criteria|2|||
131777140|NCT02331680|474464068|FG002|Overall Study|Met withdrawal criteria|5|||
131777141|NCT02331680|474464066|FG000|Overall Study|Non-compliance with study drug|0|||
131777142|NCT02331680|474464067|FG001|Overall Study|Non-compliance with study drug|0|||
131777143|NCT02331680|474464068|FG002|Overall Study|Non-compliance with study drug|1|||
131777144|NCT02331680|474464066|FG000|Overall Study|Protocol Violation|0|||
131777145|NCT02331680|474464067|FG001|Overall Study|Protocol Violation|0|||
131777146|NCT02331680|474464068|FG002|Overall Study|Protocol Violation|3|||
131777147|NCT02279888|474464069|FG000|Overall Study|Death|326|||
131777148|NCT02279888|474464069|FG000|Overall Study|Withdrawal by Subject|38|||
131777149|NCT02279888|474464069|FG000|Overall Study|Lost to Follow-up|21|||
131777150|NCT02279888|474464069|FG000|Overall Study|Physician Decision|62|||
131777151|NCT02279888|474464069|FG000|Overall Study|Subject Non-compliance|43|||
131777152|NCT02279888|474464069|FG000|Overall Study|Not implanted|14|||
131777153|NCT02279888|474464069|FG000|Overall Study|Visit not performed|26|||
131777154|NCT02335411|474464070|FG000|Overall Study|Death|223|||
131777155|NCT02335411|474464071|FG001|Overall Study|Death|22|||
131777156|NCT02335411|474464072|FG002|Overall Study|Death|26|||
131691279|NCT03882970|474154505|FG002|Overall Study|Adverse Event|3|||
131691280|NCT03882970|474154506|FG003|Overall Study|Adverse Event|1|||
131691281|NCT03882970|474154503|FG000|Overall Study|Death|1|||
131691282|NCT03882970|474154504|FG001|Overall Study|Death|2|||
131691283|NCT03882970|474154505|FG002|Overall Study|Death|1|||
131691284|NCT03882970|474154506|FG003|Overall Study|Death|1|||
131691285|NCT03882970|474154503|FG000|Overall Study|Lost to Follow-up|8|||
131691286|NCT03882970|474154504|FG001|Overall Study|Lost to Follow-up|9|||
131691287|NCT03882970|474154505|FG002|Overall Study|Lost to Follow-up|5|||
131691288|NCT03882970|474154506|FG003|Overall Study|Lost to Follow-up|5|||
131691289|NCT03882970|474154503|FG000|Overall Study|Physician Decision|0|||
131691290|NCT03882970|474154504|FG001|Overall Study|Physician Decision|2|||
131691291|NCT03882970|474154505|FG002|Overall Study|Physician Decision|2|||
131691292|NCT03882970|474154506|FG003|Overall Study|Physician Decision|2|||
131691293|NCT03882970|474154503|FG000|Overall Study|Protocol Violation|2|||
131691294|NCT03882970|474154504|FG001|Overall Study|Protocol Violation|0|||
131691295|NCT03882970|474154505|FG002|Overall Study|Protocol Violation|0|||
131691296|NCT03882970|474154506|FG003|Overall Study|Protocol Violation|0|||
131691297|NCT03882970|474154503|FG000|Overall Study|Withdrawal by Subject|8|||
131691298|NCT03882970|474154504|FG001|Overall Study|Withdrawal by Subject|17|||
131691299|NCT03882970|474154505|FG002|Overall Study|Withdrawal by Subject|7|||
131691300|NCT03882970|474154506|FG003|Overall Study|Withdrawal by Subject|22|||
131691301|NCT03882970|474154503|FG000|Overall Study|Personal Reason|2|||
131777157|NCT02335411|474464070|FG000|Overall Study|Physician Decision|3|||
131777158|NCT02335411|474464071|FG001|Overall Study|Physician Decision|0|||
131691302|NCT03882970|474154504|FG001|Overall Study|Personal Reason|3|||
131691303|NCT03882970|474154505|FG002|Overall Study|Personal Reason|1|||
131691304|NCT03882970|474154506|FG003|Overall Study|Personal Reason|3|||
131691305|NCT02863809|474154508|FG000|Overall Study|Adverse Event|8|||
131691306|NCT02863809|474154509|FG001|Overall Study|Adverse Event|8|||
131691307|NCT02863809|474154508|FG000|Overall Study|Withdrawal by Subject|0|||
131691308|NCT02863809|474154509|FG001|Overall Study|Withdrawal by Subject|1|||
131691309|NCT02863809|474154508|FG000|Overall Study|Lost to Follow-up|1|||
131777159|NCT02335411|474464072|FG002|Overall Study|Physician Decision|0|||
131777160|NCT02335411|474464070|FG000|Overall Study|Protocol Violation|1|||
131777161|NCT02335411|474464071|FG001|Overall Study|Protocol Violation|0|||
131777162|NCT02335411|474464072|FG002|Overall Study|Protocol Violation|0|||
131777163|NCT02335411|474464070|FG000|Overall Study|Withdrawal by Subject|11|||
131777164|NCT02335411|474464071|FG001|Overall Study|Withdrawal by Subject|0|||
131777165|NCT02335411|474464072|FG002|Overall Study|Withdrawal by Subject|3|||
131777166|NCT02335411|474464070|FG000|Overall Study|Sponsor Decision|12|||
131777167|NCT02335411|474464071|FG001|Overall Study|Sponsor Decision|3|||
131777168|NCT02335411|474464072|FG002|Overall Study|Sponsor Decision|2|||
131777169|NCT02335411|474464070|FG000|Overall Study|Adverse Event|9|||
131777170|NCT02335411|474464071|FG001|Overall Study|Adverse Event|0|||
131777171|NCT02335411|474464072|FG002|Overall Study|Adverse Event|0|||
131777172|NCT01891669|474464073|FG000|Overall Study|Death|0|||
131777173|NCT01891669|474464074|FG001|Overall Study|Death|0|||
131777174|NCT01891669|474464075|FG002|Overall Study|Death|0|||
131777175|NCT01891669|474464076|FG003|Overall Study|Death|0|||
131777176|NCT01891669|474464077|FG004|Overall Study|Death|0|||
131777177|NCT01891669|474464078|FG005|Overall Study|Death|0|||
131691310|NCT02863809|474154509|FG001|Overall Study|Lost to Follow-up|1|||
131691311|NCT02863809|474154508|FG000|Overall Study|Death|1|||
131777178|NCT01891669|474464079|FG006|Overall Study|Death|0|||
131777179|NCT01891669|474464080|FG007|Overall Study|Death|1|||
131777180|NCT01891669|474464081|FG008|Overall Study|Death|0|||
131777181|NCT01891669|474464082|FG009|Overall Study|Death|1|||
131777182|NCT01891669|474464073|FG000|Overall Study|Withdrawal by Subject|1|||
131777183|NCT01891669|474464074|FG001|Overall Study|Withdrawal by Subject|1|||
131777184|NCT01891669|474464075|FG002|Overall Study|Withdrawal by Subject|0|||
131777185|NCT01891669|474464076|FG003|Overall Study|Withdrawal by Subject|0|||
131777186|NCT01891669|474464077|FG004|Overall Study|Withdrawal by Subject|0|||
131777187|NCT01891669|474464078|FG005|Overall Study|Withdrawal by Subject|0|||
131777188|NCT01891669|474464079|FG006|Overall Study|Withdrawal by Subject|1|||
131777189|NCT01891669|474464080|FG007|Overall Study|Withdrawal by Subject|2|||
131777190|NCT01891669|474464081|FG008|Overall Study|Withdrawal by Subject|1|||
131777191|NCT01891669|474464082|FG009|Overall Study|Withdrawal by Subject|1|||
131777192|NCT01891669|474464073|FG000|Overall Study|Other|1|||
131777193|NCT01891669|474464074|FG001|Overall Study|Other|0|||
131777194|NCT01891669|474464075|FG002|Overall Study|Other|0|||
131777195|NCT01891669|474464076|FG003|Overall Study|Other|0|||
131777196|NCT01891669|474464077|FG004|Overall Study|Other|0|||
131777197|NCT01891669|474464078|FG005|Overall Study|Other|0|||
131777198|NCT01891669|474464079|FG006|Overall Study|Other|0|||
131777199|NCT01891669|474464080|FG007|Overall Study|Other|1|||
131777200|NCT01891669|474464081|FG008|Overall Study|Other|0|||
131777201|NCT01891669|474464082|FG009|Overall Study|Other|0|||
131777202|NCT03075826|474464084|FG000|Overall Study|Withdrawal by Subject|1|||
131777203|NCT03075826|474464084|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
131777204|NCT00650806|474464085|FG000|Overall Study|Adverse Event|0|||
131777205|NCT00650806|474464086|FG001|Overall Study|Adverse Event|5|||
131777206|NCT00650806|474464087|FG002|Overall Study|Adverse Event|3|||
131777207|NCT00650806|474464088|FG003|Overall Study|Adverse Event|4|||
131777208|NCT00650806|474464085|FG000|Overall Study|Lost to Follow-up|7|||
131777209|NCT00650806|474464086|FG001|Overall Study|Lost to Follow-up|6|||
131691312|NCT02863809|474154509|FG001|Overall Study|Death|0|||
131691313|NCT00607386|474154510|FG000|Overall Study|Physician Decision|1|||
131691314|NCT02121262|474154513|FG000|Overall Study|Adverse Event|6|||
131691315|NCT02121262|474154514|FG001|Overall Study|Adverse Event|3|||
131691316|NCT02121262|474154513|FG000|Overall Study|Lack of Efficacy|3|||
131691317|NCT02121262|474154514|FG001|Overall Study|Lack of Efficacy|0|||
131777210|NCT00650806|474464087|FG002|Overall Study|Lost to Follow-up|11|||
131777211|NCT00650806|474464088|FG003|Overall Study|Lost to Follow-up|10|||
131777212|NCT00650806|474464085|FG000|Overall Study|Protocol Violation|0|||
131777213|NCT00650806|474464086|FG001|Overall Study|Protocol Violation|0|||
131898544|NCT02797678|474914125|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
131691318|NCT02121262|474154513|FG000|Overall Study|Personal Reasons|19|||
131691319|NCT02121262|474154514|FG001|Overall Study|Personal Reasons|5|||
131777214|NCT00650806|474464087|FG002|Overall Study|Protocol Violation|0|||
131777215|NCT00650806|474464088|FG003|Overall Study|Protocol Violation|1|||
131777216|NCT00650806|474464085|FG000|Overall Study|Pregnancy|0|||
131777217|NCT00650806|474464086|FG001|Overall Study|Pregnancy|0|||
131777218|NCT00650806|474464087|FG002|Overall Study|Pregnancy|0|||
131777219|NCT00650806|474464088|FG003|Overall Study|Pregnancy|1|||
131691320|NCT02121262|474154513|FG000|Overall Study|Protocol Violation|1|||
131691321|NCT02121262|474154514|FG001|Overall Study|Protocol Violation|1|||
131691322|NCT02121262|474154513|FG000|Overall Study|Participant Dropped-out|0|||
131691323|NCT02121262|474154514|FG001|Overall Study|Participant Dropped-out|1|||
131691324|NCT02121262|474154513|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
131691325|NCT02121262|474154514|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
131691326|NCT02121262|474154513|FG000|Overall Study|Consent Withdrawn|1|||
131691327|NCT02121262|474154514|FG001|Overall Study|Consent Withdrawn|0|||
131691328|NCT02411539|474154515|FG000|Overall Study|Lost to Follow-up|2|||
131691329|NCT02411539|474154516|FG001|Overall Study|Lost to Follow-up|0|||
131691330|NCT02411539|474154515|FG000|Overall Study|Confounding medical condition|0|||
131691331|NCT02411539|474154516|FG001|Overall Study|Confounding medical condition|1|||
131691332|NCT02980224|474154517|FG000|Overall Study|Adverse Event|4|||
131691333|NCT02980224|474154518|FG001|Overall Study|Adverse Event|1|||
131691334|NCT02980224|474154517|FG000|Overall Study|Withdrawal by Subject|0|||
131691335|NCT02980224|474154518|FG001|Overall Study|Withdrawal by Subject|2|||
131691336|NCT03631732|474154519|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
131691337|NCT03631732|474154520|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
131691338|NCT03631732|474154519|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
131691339|NCT03631732|474154520|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
131691340|NCT03631732|474154519|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
131691341|NCT03631732|474154520|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
131691342|NCT03631732|474154519|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
131691343|NCT03631732|474154520|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
131691344|NCT03631732|474154519|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
131691345|NCT03631732|474154520|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
131691346|NCT03631732|474154519|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
131691347|NCT03631732|474154520|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
131691348|NCT03631732|474154519|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
131691349|NCT03631732|474154520|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
131691350|NCT03631732|474154519|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
131691351|NCT03631732|474154520|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
131691352|NCT03631732|474154519|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
131691353|NCT03631732|474154520|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
131691354|NCT03631732|474154519|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
131691355|NCT03631732|474154520|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
131691356|NCT02873936|474154521|FG000|Overall Study|Withdrew Consent|4|||
131691357|NCT02873936|474154522|FG001|Overall Study|Withdrew Consent|11|||
131691358|NCT02873936|474154523|FG002|Overall Study|Withdrew Consent|20|||
131691359|NCT02873936|474154521|FG000|Overall Study|Investigator's Discretion|3|||
131691360|NCT02873936|474154522|FG001|Overall Study|Investigator's Discretion|5|||
131691361|NCT02873936|474154523|FG002|Overall Study|Investigator's Discretion|4|||
131691362|NCT02873936|474154521|FG000|Overall Study|Adverse Event|3|||
131691363|NCT02873936|474154522|FG001|Overall Study|Adverse Event|5|||
131691364|NCT02873936|474154523|FG002|Overall Study|Adverse Event|3|||
131691365|NCT02873936|474154521|FG000|Overall Study|Protocol Violation|0|||
131691366|NCT02873936|474154522|FG001|Overall Study|Protocol Violation|1|||
131691367|NCT02873936|474154523|FG002|Overall Study|Protocol Violation|3|||
131691368|NCT02873936|474154521|FG000|Overall Study|Lost to Follow-up|1|||
131691369|NCT02873936|474154522|FG001|Overall Study|Lost to Follow-up|1|||
131691370|NCT02873936|474154523|FG002|Overall Study|Lost to Follow-up|1|||
131691371|NCT02873936|474154521|FG000|Overall Study|Non-compliance With Study Drug|1|||
131691372|NCT02873936|474154522|FG001|Overall Study|Non-compliance With Study Drug|0|||
131691373|NCT02873936|474154523|FG002|Overall Study|Non-compliance With Study Drug|1|||
131691374|NCT02873936|474154521|FG000|Overall Study|Randomized but not Dosed|1|||
131691375|NCT02873936|474154522|FG001|Overall Study|Randomized but not Dosed|0|||
131691376|NCT02873936|474154523|FG002|Overall Study|Randomized but not Dosed|0|||
131691377|NCT01225731|474154524|FG000|Part 1|Did not meet eligibility criteria|1|||
131691378|NCT01225731|474154525|FG001|Part 1|Did not meet eligibility criteria|0|||
131691379|NCT01225731|474154526|FG002|Part 1|Did not meet eligibility criteria|0|||
131691380|NCT01225731|474154527|FG003|Part 1|Did not meet eligibility criteria|0|||
131691381|NCT01225731|474154528|FG004|Part 1|Did not meet eligibility criteria|1|||
131777220|NCT00650806|474464085|FG000|Overall Study|Withdrawal by Subject|7|||
131777221|NCT00650806|474464086|FG001|Overall Study|Withdrawal by Subject|5|||
131777222|NCT00650806|474464087|FG002|Overall Study|Withdrawal by Subject|8|||
131691382|NCT01225731|474154529|FG005|Part 1|Did not meet eligibility criteria|0|||
131691383|NCT01225731|474154530|FG006|Part 1|Did not meet eligibility criteria|0|||
131691384|NCT01225731|474154531|FG007|Part 1|Did not meet eligibility criteria|0|||
131691385|NCT01225731|474154532|FG008|Part 1|Did not meet eligibility criteria|0|||
131691386|NCT01225731|474154533|FG009|Part 1|Did not meet eligibility criteria|0|||
131691387|NCT01225731|474154534|FG010|Part 1|Did not meet eligibility criteria|0|||
131691388|NCT01225731|474154535|FG011|Part 1|Did not meet eligibility criteria|0|||
131691389|NCT01225731|474154536|FG012|Part 1|Did not meet eligibility criteria|0|||
131691390|NCT01225731|474154524|FG000|Part 1|Adverse Event|1|||
131691391|NCT01225731|474154525|FG001|Part 1|Adverse Event|2|||
131691392|NCT01225731|474154526|FG002|Part 1|Adverse Event|1|||
131691393|NCT01225731|474154527|FG003|Part 1|Adverse Event|1|||
131691394|NCT01225731|474154528|FG004|Part 1|Adverse Event|1|||
131691395|NCT01225731|474154529|FG005|Part 1|Adverse Event|0|||
131691396|NCT01225731|474154530|FG006|Part 1|Adverse Event|0|||
131691397|NCT01225731|474154531|FG007|Part 1|Adverse Event|0|||
131691398|NCT01225731|474154532|FG008|Part 1|Adverse Event|0|||
131691399|NCT01225731|474154533|FG009|Part 1|Adverse Event|0|||
131691400|NCT01225731|474154534|FG010|Part 1|Adverse Event|0|||
131691401|NCT01225731|474154535|FG011|Part 1|Adverse Event|0|||
131691402|NCT01225731|474154536|FG012|Part 1|Adverse Event|0|||
131691403|NCT01225731|474154524|FG000|Part 1|Withdrawal by Subject|0|||
131691404|NCT01225731|474154525|FG001|Part 1|Withdrawal by Subject|3|||
131691405|NCT01225731|474154526|FG002|Part 1|Withdrawal by Subject|0|||
131691406|NCT01225731|474154527|FG003|Part 1|Withdrawal by Subject|0|||
131691407|NCT01225731|474154528|FG004|Part 1|Withdrawal by Subject|4|||
131691408|NCT01225731|474154529|FG005|Part 1|Withdrawal by Subject|0|||
131691409|NCT01225731|474154530|FG006|Part 1|Withdrawal by Subject|0|||
131691410|NCT01225731|474154531|FG007|Part 1|Withdrawal by Subject|0|||
131691411|NCT01225731|474154532|FG008|Part 1|Withdrawal by Subject|0|||
131691412|NCT01225731|474154533|FG009|Part 1|Withdrawal by Subject|0|||
131691413|NCT01225731|474154534|FG010|Part 1|Withdrawal by Subject|0|||
131691414|NCT01225731|474154535|FG011|Part 1|Withdrawal by Subject|0|||
131691415|NCT01225731|474154536|FG012|Part 1|Withdrawal by Subject|0|||
131691416|NCT01225731|474154524|FG000|Part 1|Protocol Violation|0|||
131691417|NCT01225731|474154525|FG001|Part 1|Protocol Violation|0|||
131691418|NCT01225731|474154526|FG002|Part 1|Protocol Violation|0|||
131691419|NCT01225731|474154527|FG003|Part 1|Protocol Violation|1|||
131691420|NCT01225731|474154528|FG004|Part 1|Protocol Violation|0|||
131691421|NCT01225731|474154529|FG005|Part 1|Protocol Violation|0|||
131691422|NCT01225731|474154530|FG006|Part 1|Protocol Violation|0|||
131691423|NCT01225731|474154531|FG007|Part 1|Protocol Violation|0|||
131691424|NCT01225731|474154532|FG008|Part 1|Protocol Violation|0|||
131691425|NCT01225731|474154533|FG009|Part 1|Protocol Violation|0|||
131691426|NCT01225731|474154534|FG010|Part 1|Protocol Violation|0|||
131691427|NCT01225731|474154535|FG011|Part 1|Protocol Violation|0|||
131691428|NCT01225731|474154536|FG012|Part 1|Protocol Violation|0|||
131691429|NCT01225731|474154524|FG000|Part 2|Protocol Violation|0|||
131691430|NCT01225731|474154525|FG001|Part 2|Protocol Violation|0|||
131691431|NCT01225731|474154526|FG002|Part 2|Protocol Violation|0|||
131691432|NCT01225731|474154527|FG003|Part 2|Protocol Violation|0|||
131691433|NCT01225731|474154528|FG004|Part 2|Protocol Violation|0|||
131691434|NCT01225731|474154529|FG005|Part 2|Protocol Violation|1|||
131691435|NCT01225731|474154530|FG006|Part 2|Protocol Violation|0|||
131691436|NCT01225731|474154531|FG007|Part 2|Protocol Violation|0|||
131691437|NCT01225731|474154532|FG008|Part 2|Protocol Violation|1|||
131691438|NCT01225731|474154533|FG009|Part 2|Protocol Violation|0|||
131691439|NCT01225731|474154534|FG010|Part 2|Protocol Violation|0|||
131691440|NCT01225731|474154535|FG011|Part 2|Protocol Violation|0|||
131691441|NCT01225731|474154536|FG012|Part 2|Protocol Violation|0|||
131777223|NCT00650806|474464088|FG003|Overall Study|Withdrawal by Subject|6|||
131777224|NCT00650806|474464085|FG000|Overall Study|Noncompliance with study drug regimen|1|||
131777225|NCT00650806|474464086|FG001|Overall Study|Noncompliance with study drug regimen|1|||
131777226|NCT00650806|474464087|FG002|Overall Study|Noncompliance with study drug regimen|0|||
131691442|NCT01225731|474154524|FG000|Part 2|Adverse Event|0|||
131691443|NCT01225731|474154525|FG001|Part 2|Adverse Event|0|||
131777227|NCT00650806|474464088|FG003|Overall Study|Noncompliance with study drug regimen|0|||
131691444|NCT01225731|474154526|FG002|Part 2|Adverse Event|0|||
131691445|NCT01225731|474154527|FG003|Part 2|Adverse Event|0|||
131691446|NCT01225731|474154528|FG004|Part 2|Adverse Event|0|||
131691447|NCT01225731|474154529|FG005|Part 2|Adverse Event|0|||
131691448|NCT01225731|474154530|FG006|Part 2|Adverse Event|4|||
131691449|NCT01225731|474154531|FG007|Part 2|Adverse Event|4|||
131691450|NCT01225731|474154532|FG008|Part 2|Adverse Event|2|||
131691451|NCT01225731|474154533|FG009|Part 2|Adverse Event|0|||
131691452|NCT01225731|474154534|FG010|Part 2|Adverse Event|0|||
131691453|NCT01225731|474154535|FG011|Part 2|Adverse Event|0|||
131691454|NCT01225731|474154536|FG012|Part 2|Adverse Event|0|||
131691455|NCT01225731|474154524|FG000|Part 2|Lack of Efficacy|0|||
131691456|NCT01225731|474154525|FG001|Part 2|Lack of Efficacy|0|||
131777228|NCT00650806|474464085|FG000|Overall Study|Study terminated by sponsor|2|||
131777229|NCT00650806|474464086|FG001|Overall Study|Study terminated by sponsor|3|||
131777230|NCT00650806|474464087|FG002|Overall Study|Study terminated by sponsor|5|||
131777231|NCT00650806|474464088|FG003|Overall Study|Study terminated by sponsor|4|||
131777232|NCT00650806|474464085|FG000|Overall Study|Other|1|||
131777233|NCT00650806|474464086|FG001|Overall Study|Other|1|||
131777234|NCT00650806|474464087|FG002|Overall Study|Other|2|||
131777235|NCT00650806|474464088|FG003|Overall Study|Other|0|||
131777236|NCT04456998|474464089|FG000|Overall Study|Adverse Event|0|||
131777237|NCT04456998|474464090|FG001|Overall Study|Adverse Event|4|||
131777238|NCT04456998|474464089|FG000|Overall Study|Protocol Deviation|0|||
131777239|NCT04456998|474464090|FG001|Overall Study|Protocol Deviation|1|||
131777240|NCT04456998|474464089|FG000|Overall Study|Withdrawal by Subject|0|||
131777241|NCT04456998|474464090|FG001|Overall Study|Withdrawal by Subject|1|||
131777242|NCT03707145|474464094|FG000|Overall Study|Lost to Follow-up|0|||
131777243|NCT03707145|474464095|FG001|Overall Study|Lost to Follow-up|1|||
131777244|NCT03707145|474464096|FG002|Overall Study|Lost to Follow-up|1|||
131777245|NCT03707145|474464097|FG003|Overall Study|Lost to Follow-up|0|||
131777246|NCT04882085|474464098|FG000|Overall Study|Death|6|||
131777247|NCT04882085|474464099|FG001|Overall Study|Death|9|||
131777248|NCT04882085|474464098|FG000|Overall Study|Withdrawal by Subject|0|||
131777249|NCT04882085|474464099|FG001|Overall Study|Withdrawal by Subject|3|||
131777250|NCT04882085|474464098|FG000|Overall Study|Randomized not treated|1|||
131777251|NCT04882085|474464099|FG001|Overall Study|Randomized not treated|0|||
131777252|NCT05939388|474464100|FG000|Overall Study|Lost to Follow-up|1|||
131777253|NCT00602667|474464101|FG000|Overall Study|Still on Therapy|0|||
131777254|NCT00602667|474464102|FG001|Overall Study|Still on Therapy|2|||
131777255|NCT00602667|474464103|FG002|Overall Study|Still on Therapy|2|||
131777256|NCT00602667|474464101|FG000|Overall Study|Death|0|||
131777257|NCT00602667|474464102|FG001|Overall Study|Death|1|||
131777258|NCT00602667|474464103|FG002|Overall Study|Death|1|||
131777259|NCT00602667|474464101|FG000|Overall Study|Family request|3|||
131777260|NCT00602667|474464102|FG001|Overall Study|Family request|25|||
131777261|NCT00602667|474464103|FG002|Overall Study|Family request|6|||
131777262|NCT00602667|474464101|FG000|Overall Study|Excessive toxicity|1|||
131777263|NCT00602667|474464102|FG001|Overall Study|Excessive toxicity|1|||
131777264|NCT00602667|474464103|FG002|Overall Study|Excessive toxicity|0|||
131777265|NCT00602667|474464101|FG000|Overall Study|Second malignancy|0|||
131777266|NCT00602667|474464102|FG001|Overall Study|Second malignancy|1|||
131777267|NCT00602667|474464103|FG002|Overall Study|Second malignancy|0|||
131777268|NCT00602667|474464101|FG000|Overall Study|Physician Decision|2|||
131777269|NCT00602667|474464102|FG001|Overall Study|Physician Decision|3|||
131777270|NCT00602667|474464103|FG002|Overall Study|Physician Decision|8|||
131777271|NCT00602667|474464101|FG000|Overall Study|Progressive disease|13|||
131777272|NCT00602667|474464102|FG001|Overall Study|Progressive disease|48|||
131777273|NCT00602667|474464103|FG002|Overall Study|Progressive disease|45|||
131777274|NCT00602667|474464101|FG000|Overall Study|Progressive disease prior to therapy|0|||
131777275|NCT00602667|474464102|FG001|Overall Study|Progressive disease prior to therapy|0|||
131777276|NCT00602667|474464103|FG002|Overall Study|Progressive disease prior to therapy|1|||
131777277|NCT00526227|474464116|FG000|Overall Study|Device not implanted|1|||
131777278|NCT00526227|474464116|FG000|Overall Study|Death|1|||
131777279|NCT03222856|474464119|FG000|Overall Study|Adverse Event|6|||
131691457|NCT01225731|474154526|FG002|Part 2|Lack of Efficacy|0|||
131691458|NCT01225731|474154527|FG003|Part 2|Lack of Efficacy|0|||
131691459|NCT01225731|474154528|FG004|Part 2|Lack of Efficacy|0|||
131691460|NCT01225731|474154529|FG005|Part 2|Lack of Efficacy|1|||
131691461|NCT01225731|474154530|FG006|Part 2|Lack of Efficacy|0|||
131691462|NCT01225731|474154531|FG007|Part 2|Lack of Efficacy|12|||
131691463|NCT01225731|474154532|FG008|Part 2|Lack of Efficacy|3|||
131691464|NCT01225731|474154533|FG009|Part 2|Lack of Efficacy|0|||
131691465|NCT01225731|474154534|FG010|Part 2|Lack of Efficacy|0|||
131691466|NCT01225731|474154535|FG011|Part 2|Lack of Efficacy|0|||
131691467|NCT01225731|474154536|FG012|Part 2|Lack of Efficacy|0|||
131691468|NCT01225731|474154524|FG000|Part 2|Pregnancy|0|||
131777280|NCT03222856|474464119|FG000|Overall Study|Death|1|||
131777281|NCT01721369|474464120|FG000|Overall Study|Not initial etiological diagnosis|12|||
131777282|NCT04478994|474465389|FG000|Overall Study|Withdrawal by Subject|1|||
131777283|NCT04478994|474465390|FG001|Overall Study|Withdrawal by Subject|1|||
131777284|NCT01100073|474465391|FG000|Overall Study|Lack of Efficacy|4|||
131777285|NCT01100073|474465391|FG000|Overall Study|Insufficient Tolerability|21|||
131691469|NCT01225731|474154525|FG001|Part 2|Pregnancy|0|||
131691470|NCT01225731|474154526|FG002|Part 2|Pregnancy|0|||
131691471|NCT01225731|474154527|FG003|Part 2|Pregnancy|0|||
131691472|NCT01225731|474154528|FG004|Part 2|Pregnancy|0|||
131777286|NCT01100073|474465391|FG000|Overall Study|Withdrawal by Subject|13|||
131777287|NCT01100073|474465391|FG000|Overall Study|Lost to Follow-up|39|||
131777288|NCT01100073|474465391|FG000|Overall Study|Lack of effect + patient's wish|2|||
131777289|NCT01100073|474465391|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
131777290|NCT01100073|474465391|FG000|Overall Study|Other|8|||
131777291|NCT01100073|474465391|FG000|Overall Study|Missing|5|||
131691473|NCT01225731|474154529|FG005|Part 2|Pregnancy|0|||
131691474|NCT01225731|474154530|FG006|Part 2|Pregnancy|1|||
131691475|NCT01225731|474154531|FG007|Part 2|Pregnancy|0|||
131691476|NCT01225731|474154532|FG008|Part 2|Pregnancy|1|||
131691477|NCT01225731|474154533|FG009|Part 2|Pregnancy|0|||
131691478|NCT01225731|474154534|FG010|Part 2|Pregnancy|0|||
131691479|NCT01225731|474154535|FG011|Part 2|Pregnancy|0|||
131691480|NCT01225731|474154536|FG012|Part 2|Pregnancy|0|||
131691481|NCT01225731|474154524|FG000|Part 2|Lost to Follow-up|0|||
131691482|NCT01225731|474154525|FG001|Part 2|Lost to Follow-up|0|||
131691483|NCT01225731|474154526|FG002|Part 2|Lost to Follow-up|0|||
131691484|NCT01225731|474154527|FG003|Part 2|Lost to Follow-up|0|||
131691485|NCT01225731|474154528|FG004|Part 2|Lost to Follow-up|0|||
131691486|NCT01225731|474154529|FG005|Part 2|Lost to Follow-up|0|||
131691487|NCT01225731|474154530|FG006|Part 2|Lost to Follow-up|0|||
131691488|NCT01225731|474154531|FG007|Part 2|Lost to Follow-up|3|||
131691489|NCT01225731|474154532|FG008|Part 2|Lost to Follow-up|1|||
131691490|NCT01225731|474154533|FG009|Part 2|Lost to Follow-up|0|||
131691491|NCT01225731|474154534|FG010|Part 2|Lost to Follow-up|0|||
131691492|NCT01225731|474154535|FG011|Part 2|Lost to Follow-up|0|||
131691493|NCT01225731|474154536|FG012|Part 2|Lost to Follow-up|0|||
131691494|NCT01225731|474154524|FG000|Part 2|Physician Decision|0|||
131691495|NCT01225731|474154525|FG001|Part 2|Physician Decision|0|||
131691496|NCT01225731|474154526|FG002|Part 2|Physician Decision|0|||
131691497|NCT01225731|474154527|FG003|Part 2|Physician Decision|0|||
131691498|NCT01225731|474154528|FG004|Part 2|Physician Decision|0|||
131691499|NCT01225731|474154529|FG005|Part 2|Physician Decision|0|||
131691500|NCT01225731|474154530|FG006|Part 2|Physician Decision|0|||
131691501|NCT01225731|474154531|FG007|Part 2|Physician Decision|2|||
131691502|NCT01225731|474154532|FG008|Part 2|Physician Decision|2|||
131691503|NCT01225731|474154533|FG009|Part 2|Physician Decision|0|||
131691504|NCT01225731|474154534|FG010|Part 2|Physician Decision|0|||
131691505|NCT01225731|474154535|FG011|Part 2|Physician Decision|0|||
131691506|NCT01225731|474154536|FG012|Part 2|Physician Decision|0|||
131691507|NCT01225731|474154524|FG000|Part 2|Withdrawal by Subject|0|||
131691508|NCT01225731|474154525|FG001|Part 2|Withdrawal by Subject|0|||
131691509|NCT01225731|474154526|FG002|Part 2|Withdrawal by Subject|0|||
131691510|NCT01225731|474154527|FG003|Part 2|Withdrawal by Subject|0|||
131691511|NCT01225731|474154528|FG004|Part 2|Withdrawal by Subject|0|||
131691512|NCT01225731|474154529|FG005|Part 2|Withdrawal by Subject|1|||
131691513|NCT01225731|474154530|FG006|Part 2|Withdrawal by Subject|3|||
131691514|NCT01225731|474154531|FG007|Part 2|Withdrawal by Subject|4|||
131691515|NCT01225731|474154532|FG008|Part 2|Withdrawal by Subject|1|||
131691516|NCT01225731|474154533|FG009|Part 2|Withdrawal by Subject|0|||
131691517|NCT01225731|474154534|FG010|Part 2|Withdrawal by Subject|0|||
131691518|NCT01225731|474154535|FG011|Part 2|Withdrawal by Subject|0|||
131691519|NCT01225731|474154536|FG012|Part 2|Withdrawal by Subject|0|||
131777292|NCT01656850|474465392|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
131777293|NCT01656850|474465393|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
131777294|NCT03255226|474465397|FG000|Overall Study|Adverse Event|2|||
131777295|NCT03255226|474465397|FG000|Overall Study|Physician Decision|3|||
131777296|NCT03255226|474465397|FG000|Overall Study|Withdrawal by Subject|1|||
131436726|NCT00607087|473224114|FG001|Period 2|Other reason|1|||
131436727|NCT00607087|473224115|FG002|Period 2|Other reason|0|||
131436728|NCT00607087|473224113|FG000|Period 2|Adverse Event|0|||
131436729|NCT00607087|473224114|FG001|Period 2|Adverse Event|1|||
131436730|NCT00607087|473224115|FG002|Period 2|Adverse Event|3|||
131436731|NCT00607087|473224113|FG000|Period 2|Poor compliance to protocol|0|||
131436732|NCT00607087|473224114|FG001|Period 2|Poor compliance to protocol|0|||
131436733|NCT00607087|473224115|FG002|Period 2|Poor compliance to protocol|1|||
131436734|NCT00607087|473224113|FG000|Period 3|Withdrawal by Subject|2|||
131436735|NCT00607087|473224114|FG001|Period 3|Withdrawal by Subject|1|||
131436736|NCT00607087|473224115|FG002|Period 3|Withdrawal by Subject|0|||
131436737|NCT00607087|473224113|FG000|Period 3|Adverse Event|0|||
131436738|NCT00607087|473224114|FG001|Period 3|Adverse Event|1|||
131436739|NCT00607087|473224115|FG002|Period 3|Adverse Event|0|||
131436740|NCT00154297|473224117|FG000|Overall Study|Death|5|||
131436741|NCT00154297|473224118|FG001|Overall Study|Death|2|||
131436742|NCT00154297|473224117|FG000|Overall Study|Withdrawal by Subject|0|||
131436743|NCT00154297|473224118|FG001|Overall Study|Withdrawal by Subject|5|||
131436744|NCT00154297|473224117|FG000|Overall Study|Lost to Follow-up|3|||
131436745|NCT00154297|473224118|FG001|Overall Study|Lost to Follow-up|0|||
131436746|NCT00320515|473224119|FG000|Overall Study|Death|33|||
131436747|NCT00320515|473224119|FG000|Overall Study|Lost to Follow-up|6|||
131436748|NCT00320515|473224119|FG000|Overall Study|Physician Decision|2|||
131436749|NCT00320515|473224119|FG000|Overall Study|Withdrawal by Subject|8|||
131436750|NCT00794950|473224120|FG000|BCG Induction|Withdrawal by Subject|2|||
131691520|NCT01225731|474154524|FG000|Part 3|Adverse Event|0|||
131691521|NCT01225731|474154525|FG001|Part 3|Adverse Event|0|||
131691522|NCT01225731|474154526|FG002|Part 3|Adverse Event|0|||
131691523|NCT01225731|474154527|FG003|Part 3|Adverse Event|0|||
131691524|NCT01225731|474154528|FG004|Part 3|Adverse Event|0|||
131691525|NCT01225731|474154529|FG005|Part 3|Adverse Event|0|||
131691526|NCT01225731|474154530|FG006|Part 3|Adverse Event|0|||
131691527|NCT01225731|474154531|FG007|Part 3|Adverse Event|0|||
131691528|NCT01225731|474154532|FG008|Part 3|Adverse Event|0|||
131691529|NCT01225731|474154533|FG009|Part 3|Adverse Event|0|||
131691530|NCT01225731|474154534|FG010|Part 3|Adverse Event|1|||
131691531|NCT01225731|474154535|FG011|Part 3|Adverse Event|1|||
131691532|NCT01225731|474154536|FG012|Part 3|Adverse Event|0|||
131691533|NCT01225731|474154524|FG000|Part 3|Lost to Follow-up|0|||
131691534|NCT01225731|474154525|FG001|Part 3|Lost to Follow-up|0|||
131691535|NCT01225731|474154526|FG002|Part 3|Lost to Follow-up|0|||
131691536|NCT01225731|474154527|FG003|Part 3|Lost to Follow-up|0|||
131691537|NCT01225731|474154528|FG004|Part 3|Lost to Follow-up|0|||
131691538|NCT01225731|474154529|FG005|Part 3|Lost to Follow-up|0|||
131691539|NCT01225731|474154530|FG006|Part 3|Lost to Follow-up|0|||
131691540|NCT01225731|474154531|FG007|Part 3|Lost to Follow-up|0|||
131691541|NCT01225731|474154532|FG008|Part 3|Lost to Follow-up|0|||
131691542|NCT01225731|474154533|FG009|Part 3|Lost to Follow-up|0|||
131691543|NCT01225731|474154534|FG010|Part 3|Lost to Follow-up|1|||
131691544|NCT01225731|474154535|FG011|Part 3|Lost to Follow-up|2|||
131691545|NCT01225731|474154536|FG012|Part 3|Lost to Follow-up|1|||
131691546|NCT01225731|474154524|FG000|Part 3|Physician Decision|0|||
131691547|NCT01225731|474154525|FG001|Part 3|Physician Decision|0|||
131691548|NCT01225731|474154526|FG002|Part 3|Physician Decision|0|||
131691549|NCT01225731|474154527|FG003|Part 3|Physician Decision|0|||
131691550|NCT01225731|474154528|FG004|Part 3|Physician Decision|0|||
131691551|NCT01225731|474154529|FG005|Part 3|Physician Decision|0|||
131691552|NCT01225731|474154530|FG006|Part 3|Physician Decision|0|||
131691553|NCT01225731|474154531|FG007|Part 3|Physician Decision|0|||
131691554|NCT01225731|474154532|FG008|Part 3|Physician Decision|0|||
131691555|NCT01225731|474154533|FG009|Part 3|Physician Decision|0|||
131691556|NCT01225731|474154534|FG010|Part 3|Physician Decision|0|||
131691557|NCT01225731|474154535|FG011|Part 3|Physician Decision|1|||
131691558|NCT01225731|474154536|FG012|Part 3|Physician Decision|2|||
131691559|NCT01225731|474154524|FG000|Part 3|Withdrawal by Subject|0|||
131691560|NCT01225731|474154525|FG001|Part 3|Withdrawal by Subject|0|||
131691561|NCT01225731|474154526|FG002|Part 3|Withdrawal by Subject|0|||
131691562|NCT01225731|474154527|FG003|Part 3|Withdrawal by Subject|0|||
131691563|NCT01225731|474154528|FG004|Part 3|Withdrawal by Subject|0|||
131691564|NCT01225731|474154529|FG005|Part 3|Withdrawal by Subject|0|||
131691565|NCT01225731|474154530|FG006|Part 3|Withdrawal by Subject|0|||
131691566|NCT01225731|474154531|FG007|Part 3|Withdrawal by Subject|0|||
131691567|NCT01225731|474154532|FG008|Part 3|Withdrawal by Subject|0|||
131691568|NCT01225731|474154533|FG009|Part 3|Withdrawal by Subject|0|||
131691569|NCT01225731|474154534|FG010|Part 3|Withdrawal by Subject|4|||
131691570|NCT01225731|474154535|FG011|Part 3|Withdrawal by Subject|6|||
131691571|NCT01225731|474154536|FG012|Part 3|Withdrawal by Subject|4|||
131691572|NCT01100437|474154537|FG000|Titration/Stabilization|Adverse Event|0|||
131691573|NCT01100437|474154538|FG001|Titration/Stabilization|Adverse Event|0|||
131691574|NCT01100437|474154539|FG002|Titration/Stabilization|Adverse Event|4|||
131691575|NCT01100437|474154537|FG000|Titration/Stabilization|Non-compliance|0|||
131691576|NCT01100437|474154538|FG001|Titration/Stabilization|Non-compliance|0|||
131691577|NCT01100437|474154539|FG002|Titration/Stabilization|Non-compliance|1|||
131691578|NCT01100437|474154537|FG000|Titration/Stabilization|Sponsor canceled study|0|||
131691579|NCT01100437|474154538|FG001|Titration/Stabilization|Sponsor canceled study|0|||
131691580|NCT01100437|474154539|FG002|Titration/Stabilization|Sponsor canceled study|1|||
131691581|NCT01100437|474154537|FG000|Maintenance|Withdrawal by Subject|0|||
131691582|NCT01100437|474154538|FG001|Maintenance|Withdrawal by Subject|0|||
131691583|NCT01100437|474154539|FG002|Maintenance|Withdrawal by Subject|1|||
131691584|NCT01100437|474154537|FG000|Maintenance|Sponsor termination of study|0|||
131436751|NCT00794950|473224120|FG000|BCG Induction|ineligible|3|||
131691585|NCT01100437|474154538|FG001|Maintenance|Sponsor termination of study|0|||
131691586|NCT01100437|474154539|FG002|Maintenance|Sponsor termination of study|1|||
131691587|NCT02581202|474154548|FG000|Overall Study|Lack of Efficacy|2|||
131691588|NCT02581202|474154548|FG000|Overall Study|Withdrawal by Subject|4|||
131691589|NCT02581202|474154548|FG000|Overall Study|Lost to Follow-up|5|||
131691590|NCT02581202|474154548|FG000|Overall Study|Pregnancy|3|||
131691591|NCT04294901|474154551|FG000|Overall Study|Death|86|||
131691592|NCT04294901|474154552|FG001|Overall Study|Death|110|||
131691593|NCT04294901|474154551|FG000|Overall Study|Provider did not have historical control patients|581|||
131691594|NCT04294901|474154552|FG001|Overall Study|Provider did not have historical control patients|0|||
131691595|NCT04294901|474154551|FG000|Overall Study|Provider did not have intervention patients|0|||
131691596|NCT04294901|474154552|FG001|Overall Study|Provider did not have intervention patients|98|||
131691597|NCT01934556|474154553|FG000|Overall Study|Withdrawal by Subject|0|||
131691598|NCT01934556|474154554|FG001|Overall Study|Withdrawal by Subject|1|||
131691599|NCT01934556|474154555|FG002|Overall Study|Withdrawal by Subject|1|||
131691600|NCT01934556|474154553|FG000|Overall Study|Lost to Follow-up|4|||
131691601|NCT01934556|474154554|FG001|Overall Study|Lost to Follow-up|10|||
131691602|NCT01934556|474154555|FG002|Overall Study|Lost to Follow-up|7|||
131691603|NCT01934556|474154553|FG000|Overall Study|Death|1|||
131691604|NCT01934556|474154554|FG001|Overall Study|Death|5|||
131691605|NCT01934556|474154555|FG002|Overall Study|Death|2|||
131691606|NCT05038020|474154561|FG000|Overall Study|Early Termination|3|||
131691607|NCT05038020|474154562|FG001|Overall Study|Early Termination|0|||
131691608|NCT03770260|474156133|FG000|Overall Study|Disease progression|0|||
131691609|NCT03770260|474156134|FG001|Overall Study|Disease progression|1|||
131691610|NCT03770260|474156135|FG002|Overall Study|Disease progression|0|||
131691611|NCT03770260|474156136|FG003|Overall Study|Disease progression|0|||
131691612|NCT02484911|474156138|FG000|Overall Study|Withdrawal by Subject|2|||
131691613|NCT02484911|474156139|FG001|Overall Study|Withdrawal by Subject|1|||
131691614|NCT02484911|474156138|FG000|Overall Study|Protocol Violation|2|||
131691615|NCT02484911|474156139|FG001|Overall Study|Protocol Violation|1|||
131691616|NCT01652885|474156145|FG000|Overall Study|Adverse Event|1|||
131691617|NCT00075400|474156146|FG000|Overall Study|Ineligible: wrong primary|1|||
131691618|NCT00075400|474156146|FG000|Overall Study|Never treated|2|||
131691619|NCT00490568|474156147|FG000|Overall Study|Adverse Event|116|||
131691620|NCT00490568|474156147|FG000|Overall Study|Lost to Follow-up|13|||
131691621|NCT00490568|474156147|FG000|Overall Study|Protocol Violation|45|||
131691622|NCT00490568|474156147|FG000|Overall Study|Withdrawal by Subject|135|||
131691623|NCT00490568|474156147|FG000|Overall Study|Still in the study at termination|974|||
131691624|NCT00490568|474156147|FG000|Overall Study|Other|1|||
131691625|NCT00490568|474156147|FG000|Overall Study|Exclusion criteria met|1|||
131691626|NCT00490568|474156147|FG000|Overall Study|Caregiver related|20|||
131691627|NCT00490568|474156147|FG000|Overall Study|Abnormal ECG|25|||
131691628|NCT00490568|474156147|FG000|Overall Study|Participant refused follow-up|9|||
131691629|NCT00490568|474156147|FG000|Overall Study|Legal representative withdrew consent|1|||
131691630|NCT00490568|474156147|FG000|Overall Study|Disease progression|4|||
131691631|NCT00490568|474156147|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
131691632|NCT00490568|474156147|FG000|Overall Study|Investigator decision|3|||
131691633|NCT00490568|474156147|FG000|Overall Study|Non-Compliance|7|||
131691634|NCT00490568|474156147|FG000|Overall Study|Efficacy related|3|||
131691635|NCT00490568|474156147|FG000|Overall Study|Participant died|1|||
131691636|NCT00490568|474156147|FG000|Overall Study|Participant withdrawal due to surgery|1|||
131691637|NCT01395394|474156148|FG000|Baseline Study Visit|Protocol Violation|1|||
131691638|NCT01395394|474156149|FG001|Baseline Study Visit|Protocol Violation|0|||
131691639|NCT01395394|474156150|FG002|Baseline Study Visit|Protocol Violation|0|||
131691640|NCT03451773|474156153|FG000|Overall Study|Death on study|1|||
131691641|NCT03451773|474156154|FG001|Overall Study|Death on study|5|||
131691642|NCT03451773|474156153|FG000|Overall Study|Death during follow-up period|0|||
131691643|NCT03451773|474156154|FG001|Overall Study|Death during follow-up period|1|||
131691644|NCT03468855|474156155|FG000|Overall Study|Adverse Event|2|||
131691645|NCT03468855|474156155|FG000|Overall Study|Lost to Follow-up|5|||
131691646|NCT03468855|474156155|FG000|Overall Study|Withdrawal by Subject|3|||
131691647|NCT03468855|474156155|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
131691648|NCT00390546|474156156|FG000|Overall Study|Renal impairment|1|||
131691649|NCT00390546|474156157|FG001|Overall Study|Renal impairment|0|||
131691650|NCT00390546|474156156|FG000|Overall Study|Physician Decision|5|||
131691651|NCT00390546|474156157|FG001|Overall Study|Physician Decision|5|||
131691652|NCT05440539|474156158|FG000|Overall Study|Lost to Follow-up|4|||
131777297|NCT03255226|474465397|FG000|Overall Study|Serum or blood sodium increased|4|||
131777298|NCT03255226|474465397|FG000|Overall Study|Serum or blood potassium increased|4|||
131777299|NCT00685763|474465404|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
131777300|NCT00685763|474465404|FG000|Overall Study|Protocol Violation|1|||
131777301|NCT01741259|474465405|FG000|Overall Study|Protocol Violation|6|||
131777302|NCT01741259|474465406|FG001|Overall Study|Protocol Violation|4|||
131777303|NCT01741259|474465405|FG000|Overall Study|Withdrawal by Subject|0|||
131777304|NCT01741259|474465406|FG001|Overall Study|Withdrawal by Subject|2|||
131777305|NCT00698009|474465407|FG000|Overall Study|Withdrawal by Subject|1|||
131777306|NCT02094573|474465408|FG000|Overall Study|Adverse Event|4|||
131777307|NCT02094573|474465409|FG001|Overall Study|Adverse Event|14|||
131777308|NCT02094573|474465408|FG000|Overall Study|Clinical Progressive Disease|9|||
131777309|NCT02094573|474465409|FG001|Overall Study|Clinical Progressive Disease|13|||
131777310|NCT02094573|474465408|FG000|Overall Study|Death|11|||
131777311|NCT02094573|474465409|FG001|Overall Study|Death|3|||
131777312|NCT02094573|474465408|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
131777313|NCT02094573|474465409|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
131777314|NCT02094573|474465408|FG000|Overall Study|Non-compliance with Study Drug|1|||
131777315|NCT02094573|474465409|FG001|Overall Study|Non-compliance with Study Drug|1|||
131777316|NCT02094573|474465408|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
131777317|NCT02094573|474465409|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
131777318|NCT02094573|474465408|FG000|Overall Study|Physician Decision|4|||
131777319|NCT02094573|474465409|FG001|Overall Study|Physician Decision|4|||
131777320|NCT02094573|474465408|FG000|Overall Study|Site Terminated by Sponsor|10|||
131777321|NCT02094573|474465409|FG001|Overall Study|Site Terminated by Sponsor|17|||
131777322|NCT02094573|474465408|FG000|Overall Study|Withdrawal by Subject|6|||
131777323|NCT02094573|474465409|FG001|Overall Study|Withdrawal by Subject|8|||
131777324|NCT02094573|474465408|FG000|Overall Study|Randomized but not Treated|3|||
131777325|NCT02094573|474465409|FG001|Overall Study|Randomized but not Treated|0|||
131777326|NCT00929201|474465410|FG000|Period 1|Withdrawal by Subject|0|||
131777327|NCT00929201|474465411|FG001|Period 1|Withdrawal by Subject|1|||
131777328|NCT04633434|474465418|FG000|Overall Study|Lost to Follow-up|32|||
131777329|NCT04633434|474465419|FG001|Overall Study|Lost to Follow-up|32|||
131777330|NCT04242264|474465423|FG000|Overall Study|Lost to Follow-up|2|||
131777331|NCT04242264|474465424|FG001|Overall Study|Lost to Follow-up|2|||
131777332|NCT04242264|474465425|FG002|Overall Study|Lost to Follow-up|1|||
131777333|NCT04242264|474465426|FG003|Overall Study|Lost to Follow-up|1|||
131777334|NCT04242264|474465423|FG000|Overall Study|Withdrawal by Subject|1|||
131777335|NCT04242264|474465424|FG001|Overall Study|Withdrawal by Subject|0|||
131777336|NCT04242264|474465425|FG002|Overall Study|Withdrawal by Subject|0|||
131436752|NCT00794950|473224120|FG000|BCG Induction|noncompliant w. BCG|1|||
131436753|NCT00794950|473224120|FG000|BCG Induction|Adverse Event|1|||
131777337|NCT04242264|474465426|FG003|Overall Study|Withdrawal by Subject|0|||
131777338|NCT00471237|474465430|FG000|Overall Study|Adverse Event|6|||
131777339|NCT00471237|474465431|FG001|Overall Study|Adverse Event|5|||
131777340|NCT00471237|474465432|FG002|Overall Study|Adverse Event|4|||
131777341|NCT00471237|474465433|FG003|Overall Study|Adverse Event|8|||
131777342|NCT00471237|474465434|FG004|Overall Study|Adverse Event|7|||
131777343|NCT00471237|474465435|FG005|Overall Study|Adverse Event|5|||
131777344|NCT00471237|474465436|FG006|Overall Study|Adverse Event|0|||
131777345|NCT00471237|474465430|FG000|Overall Study|Lost to Follow-up|1|||
131777346|NCT00471237|474465431|FG001|Overall Study|Lost to Follow-up|1|||
131777347|NCT00471237|474465432|FG002|Overall Study|Lost to Follow-up|0|||
131777348|NCT00471237|474465433|FG003|Overall Study|Lost to Follow-up|2|||
131777349|NCT00471237|474465434|FG004|Overall Study|Lost to Follow-up|3|||
131777350|NCT00471237|474465435|FG005|Overall Study|Lost to Follow-up|0|||
131777351|NCT00471237|474465436|FG006|Overall Study|Lost to Follow-up|0|||
131777352|NCT00471237|474465430|FG000|Overall Study|Protocol Violation|3|||
131777353|NCT00471237|474465431|FG001|Overall Study|Protocol Violation|6|||
131777354|NCT00471237|474465432|FG002|Overall Study|Protocol Violation|3|||
131777355|NCT00471237|474465433|FG003|Overall Study|Protocol Violation|2|||
131777356|NCT00471237|474465434|FG004|Overall Study|Protocol Violation|2|||
131777357|NCT00471237|474465435|FG005|Overall Study|Protocol Violation|4|||
131777358|NCT00471237|474465436|FG006|Overall Study|Protocol Violation|1|||
131777359|NCT00471237|474465430|FG000|Overall Study|Withdrawal by Subject|8|||
131777360|NCT00471237|474465431|FG001|Overall Study|Withdrawal by Subject|6|||
131777361|NCT00471237|474465432|FG002|Overall Study|Withdrawal by Subject|5|||
131777362|NCT00471237|474465433|FG003|Overall Study|Withdrawal by Subject|8|||
131777363|NCT00471237|474465434|FG004|Overall Study|Withdrawal by Subject|7|||
131777364|NCT00471237|474465435|FG005|Overall Study|Withdrawal by Subject|4|||
131777365|NCT00471237|474465436|FG006|Overall Study|Withdrawal by Subject|2|||
131777366|NCT00471237|474465430|FG000|Overall Study|Sponsor terminated study|20|||
131777367|NCT00471237|474465431|FG001|Overall Study|Sponsor terminated study|23|||
131777368|NCT00471237|474465432|FG002|Overall Study|Sponsor terminated study|19|||
131777369|NCT00471237|474465433|FG003|Overall Study|Sponsor terminated study|22|||
131777370|NCT00471237|474465434|FG004|Overall Study|Sponsor terminated study|18|||
131777371|NCT00471237|474465435|FG005|Overall Study|Sponsor terminated study|24|||
131777372|NCT00471237|474465436|FG006|Overall Study|Sponsor terminated study|0|||
131777373|NCT00471237|474465430|FG000|Overall Study|Non-compliance|0|||
131777374|NCT00471237|474465431|FG001|Overall Study|Non-compliance|1|||
131777375|NCT00471237|474465432|FG002|Overall Study|Non-compliance|0|||
131777376|NCT00471237|474465433|FG003|Overall Study|Non-compliance|1|||
131777377|NCT00471237|474465434|FG004|Overall Study|Non-compliance|0|||
131777378|NCT00471237|474465435|FG005|Overall Study|Non-compliance|0|||
131777379|NCT00471237|474465436|FG006|Overall Study|Non-compliance|0|||
131777380|NCT00471237|474465430|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
131777381|NCT00471237|474465431|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
131777382|NCT00471237|474465432|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
131777383|NCT00471237|474465433|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
131777384|NCT00471237|474465434|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
131777385|NCT00471237|474465435|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
131777386|NCT00471237|474465436|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
131777387|NCT00471237|474465430|FG000|Overall Study|Early stopping due to non-efficacy|1|||
131777388|NCT00471237|474465431|FG001|Overall Study|Early stopping due to non-efficacy|0|||
131777389|NCT00471237|474465432|FG002|Overall Study|Early stopping due to non-efficacy|0|||
131777390|NCT00471237|474465433|FG003|Overall Study|Early stopping due to non-efficacy|0|||
131777391|NCT00471237|474465434|FG004|Overall Study|Early stopping due to non-efficacy|1|||
131777392|NCT00471237|474465435|FG005|Overall Study|Early stopping due to non-efficacy|0|||
131777393|NCT00471237|474465436|FG006|Overall Study|Early stopping due to non-efficacy|0|||
131777394|NCT00471237|474465430|FG000|Overall Study|Participant planned to travel to abraod|1|||
131777395|NCT00471237|474465431|FG001|Overall Study|Participant planned to travel to abraod|0|||
131777396|NCT00471237|474465432|FG002|Overall Study|Participant planned to travel to abraod|0|||
131777397|NCT00471237|474465433|FG003|Overall Study|Participant planned to travel to abraod|0|||
131777398|NCT00471237|474465434|FG004|Overall Study|Participant planned to travel to abraod|0|||
131777399|NCT00471237|474465435|FG005|Overall Study|Participant planned to travel to abraod|1|||
131777400|NCT00471237|474465436|FG006|Overall Study|Participant planned to travel to abraod|0|||
131777401|NCT00471237|474465430|FG000|Overall Study|High parathyroid hormone|0|||
131777402|NCT00471237|474465431|FG001|Overall Study|High parathyroid hormone|0|||
131777403|NCT00471237|474465432|FG002|Overall Study|High parathyroid hormone|1|||
131777404|NCT00471237|474465433|FG003|Overall Study|High parathyroid hormone|0|||
131777405|NCT00471237|474465434|FG004|Overall Study|High parathyroid hormone|0|||
131777406|NCT00471237|474465435|FG005|Overall Study|High parathyroid hormone|0|||
131777407|NCT00471237|474465436|FG006|Overall Study|High parathyroid hormone|0|||
131777408|NCT00471237|474465430|FG000|Overall Study|Participant lost medication|0|||
131777409|NCT00471237|474465431|FG001|Overall Study|Participant lost medication|0|||
131777410|NCT00471237|474465432|FG002|Overall Study|Participant lost medication|0|||
131777411|NCT00471237|474465433|FG003|Overall Study|Participant lost medication|0|||
131777412|NCT00471237|474465434|FG004|Overall Study|Participant lost medication|1|||
131777413|NCT00471237|474465435|FG005|Overall Study|Participant lost medication|0|||
131777414|NCT00471237|474465436|FG006|Overall Study|Participant lost medication|0|||
131777415|NCT00471237|474465430|FG000|Overall Study|Administration of prohibited medicine|0|||
131777416|NCT00471237|474465431|FG001|Overall Study|Administration of prohibited medicine|0|||
131777417|NCT00471237|474465432|FG002|Overall Study|Administration of prohibited medicine|0|||
131777418|NCT00471237|474465433|FG003|Overall Study|Administration of prohibited medicine|0|||
131777419|NCT00471237|474465434|FG004|Overall Study|Administration of prohibited medicine|1|||
131777420|NCT00471237|474465435|FG005|Overall Study|Administration of prohibited medicine|0|||
131777421|NCT00471237|474465436|FG006|Overall Study|Administration of prohibited medicine|0|||
131777422|NCT00471237|474465430|FG000|Overall Study|Participant shifted residence|0|||
131777423|NCT00471237|474465431|FG001|Overall Study|Participant shifted residence|0|||
131777424|NCT00471237|474465432|FG002|Overall Study|Participant shifted residence|0|||
131777425|NCT00471237|474465433|FG003|Overall Study|Participant shifted residence|0|||
131777426|NCT00471237|474465434|FG004|Overall Study|Participant shifted residence|1|||
131777427|NCT00471237|474465435|FG005|Overall Study|Participant shifted residence|0|||
131777428|NCT00471237|474465436|FG006|Overall Study|Participant shifted residence|0|||
131777429|NCT00471237|474465430|FG000|Overall Study|Participant's decision|0|||
131777430|NCT00471237|474465431|FG001|Overall Study|Participant's decision|0|||
131777431|NCT00471237|474465432|FG002|Overall Study|Participant's decision|0|||
131777432|NCT00471237|474465433|FG003|Overall Study|Participant's decision|0|||
131691653|NCT05440539|474156159|FG001|Overall Study|Lost to Follow-up|4|||
131691654|NCT05440539|474156158|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
131691655|NCT05440539|474156159|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
131691656|NCT03808077|474156160|FG000|Overall Study|Physician Decision|2|||
131691657|NCT03808077|474156161|FG001|Overall Study|Physician Decision|3|||
131691658|NCT03808077|474156160|FG000|Overall Study|Withdrawal by Subject|1|||
131691659|NCT03808077|474156161|FG001|Overall Study|Withdrawal by Subject|0|||
131691660|NCT03808077|474156160|FG000|Overall Study|Equipment Issues|2|||
131691661|NCT03808077|474156161|FG001|Overall Study|Equipment Issues|1|||
131691662|NCT00631020|474156162|FG000|Overall Study|Lost to Follow-up|7|||
131691663|NCT00631020|474156162|FG000|Overall Study|Incarcerated|1|||
131691664|NCT03571646|474156163|FG000|Overall Study|Adverse Event|1|||
131691665|NCT03571646|474156164|FG001|Overall Study|Adverse Event|0|||
131691666|NCT03571646|474156163|FG000|Overall Study|Withdrawal by Subject|1|||
131691667|NCT03571646|474156164|FG001|Overall Study|Withdrawal by Subject|1|||
131691668|NCT03548935|474156165|FG000|Overall Study|Withdrawal by Subject|26|||
131691669|NCT03548935|474156166|FG001|Overall Study|Withdrawal by Subject|17|||
131691670|NCT03548935|474156165|FG000|Overall Study|Lost to Follow-up|39|||
131691671|NCT03548935|474156166|FG001|Overall Study|Lost to Follow-up|28|||
131691672|NCT03548935|474156165|FG000|Overall Study|Death|1|||
131691673|NCT03548935|474156166|FG001|Overall Study|Death|1|||
131691674|NCT04677959|474156167|FG000|Overall Study|Adverse Event|1|||
131691675|NCT04677959|474156168|FG001|Overall Study|Adverse Event|9|||
131691676|NCT04677959|474156167|FG000|Overall Study|Withdrawal by Subject|2|||
131691677|NCT04677959|474156168|FG001|Overall Study|Withdrawal by Subject|15|||
131691678|NCT04677959|474156167|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131691679|NCT04677959|474156168|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131691680|NCT04677959|474156167|FG000|Overall Study|Non-compliance with study drug|0|||
131691681|NCT04677959|474156168|FG001|Overall Study|Non-compliance with study drug|2|||
131691682|NCT04677959|474156167|FG000|Overall Study|Protocol deviation|0|||
131691683|NCT04677959|474156168|FG001|Overall Study|Protocol deviation|11|||
131691684|NCT04677959|474156167|FG000|Overall Study|Lost to Follow-up|9|||
131691685|NCT04677959|474156168|FG001|Overall Study|Lost to Follow-up|13|||
131691686|NCT04677959|474156167|FG000|Overall Study|Other than specified|0|||
131691687|NCT04677959|474156168|FG001|Overall Study|Other than specified|8|||
131691688|NCT00763815|474156169|FG000|Overall Study|Adverse Event|14|||
131691689|NCT00763815|474156170|FG001|Overall Study|Adverse Event|29|||
131691690|NCT00763815|474156169|FG000|Overall Study|Lack of Efficacy|10|||
131691691|NCT00763815|474156170|FG001|Overall Study|Lack of Efficacy|11|||
131691692|NCT00763815|474156169|FG000|Overall Study|Poor Compliance to Protocol|6|||
131691693|NCT00763815|474156170|FG001|Overall Study|Poor Compliance to Protocol|6|||
131691694|NCT00763815|474156169|FG000|Overall Study|Lost to Follow-up|2|||
131691695|NCT00763815|474156170|FG001|Overall Study|Lost to Follow-up|4|||
131691696|NCT00763815|474156169|FG000|Overall Study|Early Termination|1|||
131691697|NCT00763815|474156170|FG001|Overall Study|Early Termination|0|||
131691698|NCT00763815|474156169|FG000|Overall Study|Familial and Personal Reasons|9|||
131691699|NCT00763815|474156170|FG001|Overall Study|Familial and Personal Reasons|16|||
131691700|NCT00763815|474156169|FG000|Overall Study|Physician Decision|1|||
131691701|NCT00763815|474156170|FG001|Overall Study|Physician Decision|0|||
131691702|NCT00763815|474156169|FG000|Overall Study|Withdrawal by Subject|7|||
131691703|NCT00763815|474156170|FG001|Overall Study|Withdrawal by Subject|12|||
131691704|NCT00763815|474156169|FG000|Overall Study|Protocol Violation|2|||
131691705|NCT00763815|474156170|FG001|Overall Study|Protocol Violation|5|||
131691706|NCT00763815|474156169|FG000|Overall Study|Sponsor's Decision|0|||
131691707|NCT00763815|474156170|FG001|Overall Study|Sponsor's Decision|1|||
131691708|NCT01970995|474156171|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131691709|NCT01970995|474156172|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131691710|NCT01970995|474156173|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131691711|NCT01970995|474156171|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
131691712|NCT01970995|474156172|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
131691713|NCT01970995|474156173|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
131691714|NCT01263639|474156174|FG000|Overall Study|Lost to Follow-up|66|||
131691715|NCT01263639|474156175|FG001|Overall Study|Lost to Follow-up|70|||
131691716|NCT01263639|474156174|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
131691717|NCT01263639|474156175|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
131691718|NCT01576549|474156176|FG000|Overall Study|Sponsor Decision|2|||
131691719|NCT00586495|474156177|FG000|Treatment Period|Adverse Event|11|||
131691720|NCT00586495|474156177|FG000|Treatment Period|Death|1|||
131691721|NCT00586495|474156177|FG000|Treatment Period|Protocol Violation|1|||
131436754|NCT00794950|473224120|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
131436755|NCT00794950|473224120|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
131436756|NCT00794950|473224120|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
131436757|NCT00794950|473224120|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
131436758|NCT00851786|473224121|FG000|Overall Study|Withdrawal by Subject|0|||
131436759|NCT00851786|473224122|FG001|Overall Study|Withdrawal by Subject|1|||
131436760|NCT00851786|473224121|FG000|Overall Study|Protocol Violation|0|||
131436761|NCT00851786|473224122|FG001|Overall Study|Protocol Violation|1|||
131436762|NCT00851786|473224121|FG000|Overall Study|Lost to Follow-up|1|||
131436763|NCT00851786|473224122|FG001|Overall Study|Lost to Follow-up|0|||
131436764|NCT00851786|473224121|FG000|Overall Study|Incarceration|1|||
131436765|NCT00851786|473224122|FG001|Overall Study|Incarceration|0|||
131436766|NCT00851786|473224121|FG000|Overall Study|Site Closure|1|||
131436767|NCT00851786|473224122|FG001|Overall Study|Site Closure|0|||
131436768|NCT00851786|473224121|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
131436769|NCT00851786|473224122|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
131436770|NCT00445549|473225592|FG000|Overall Study|progressive disease|12|||
131436771|NCT03858049|473225603|FG000|Overall Study|Adverse Event|16|||
131436772|NCT03858049|473225604|FG001|Overall Study|Adverse Event|9|||
131436773|NCT03858049|473225603|FG000|Overall Study|Other|1|||
131436774|NCT03858049|473225604|FG001|Overall Study|Other|1|||
131436775|NCT02079740|473225605|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
131436776|NCT02079740|473225606|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
131436777|NCT02079740|473225607|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
131436778|NCT02079740|473225608|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
131436779|NCT02079740|473225609|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
131436780|NCT02079740|473225610|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
131436781|NCT02079740|473225611|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
131691722|NCT00586495|474156177|FG000|Treatment Period|Withdrawal by Subject|1|||
131691723|NCT00586495|474156177|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
131691724|NCT00586495|474156177|FG000|Treatment Period|Switch to commercial drug|10|||
131691725|NCT00586495|474156177|FG000|Follow-up|Death|40|||
131691726|NCT00586495|474156177|FG000|Follow-up|Lost to Follow-up|1|||
131691727|NCT00586495|474156177|FG000|Follow-up|Withdrawal by Subject|4|||
131691728|NCT00586495|474156177|FG000|Follow-up|Protocol driven decision point|37|||
131691729|NCT00586495|474156177|FG000|Follow-up|Switch to commercial drug|10|||
131691730|NCT02716987|474156190|FG000|Overall Study|Ligand synthesis failure|0|||
131691731|NCT02716987|474156191|FG001|Overall Study|Ligand synthesis failure|0|||
131691732|NCT02716987|474156192|FG002|Overall Study|Ligand synthesis failure|1|||
131691733|NCT02716987|474156193|FG003|Overall Study|Ligand synthesis failure|0|||
131691734|NCT02716987|474156194|FG004|Overall Study|Ligand synthesis failure|0|||
131691735|NCT02716987|474156195|FG005|Overall Study|Ligand synthesis failure|0|||
131691736|NCT02716987|474156190|FG000|Overall Study|Withdrawal by Subject|0|||
131691737|NCT02716987|474156191|FG001|Overall Study|Withdrawal by Subject|0|||
131691738|NCT02716987|474156192|FG002|Overall Study|Withdrawal by Subject|0|||
131691739|NCT02716987|474156193|FG003|Overall Study|Withdrawal by Subject|0|||
131691740|NCT02716987|474156194|FG004|Overall Study|Withdrawal by Subject|1|||
131691741|NCT02716987|474156195|FG005|Overall Study|Withdrawal by Subject|1|||
131691742|NCT02829138|474156196|FG000|Overall Study|Withdrawal by Subject|1|||
131691743|NCT02829138|474156197|FG001|Overall Study|Withdrawal by Subject|0|||
131691744|NCT01394627|474156198|FG000|First Intervention (1 Day)|poor intravenous access|0|||
131436782|NCT02079740|473225612|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
131436783|NCT02079740|473225613|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
131436784|NCT02079740|473225614|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
131691745|NCT01394627|474156199|FG001|First Intervention (1 Day)|poor intravenous access|1|||
131777433|NCT00471237|474465434|FG004|Overall Study|Participant's decision|0|||
131777434|NCT00471237|474465435|FG005|Overall Study|Participant's decision|1|||
131691746|NCT01394627|474156198|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
131691747|NCT01394627|474156199|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
131691748|NCT03223428|474156202|FG000|Overall Study|No longer taking Xermelo|27|||
131691749|NCT03223428|474156202|FG000|Overall Study|Declined Consent|1|||
131691750|NCT03223428|474156202|FG000|Overall Study|Non-responders|56|||
131691751|NCT03223428|474156202|FG000|Overall Study|Withdrawal by Subject|14|||
131691752|NCT02025907|474156203|FG000|Overall Study|Lack of Efficacy|1|||
131691753|NCT02025907|474156204|FG001|Overall Study|Lack of Efficacy|0|||
131691754|NCT02025907|474156203|FG000|Overall Study|Withdrawal by Subject|15|||
131691755|NCT02025907|474156204|FG001|Overall Study|Withdrawal by Subject|8|||
131691756|NCT02025907|474156203|FG000|Overall Study|Protocol Violation|2|||
131691757|NCT02025907|474156204|FG001|Overall Study|Protocol Violation|0|||
131691758|NCT02025907|474156203|FG000|Overall Study|Physician Decision|2|||
131691759|NCT02025907|474156204|FG001|Overall Study|Physician Decision|0|||
131691760|NCT02025907|474156203|FG000|Overall Study|Lost to Follow-up|2|||
131691761|NCT02025907|474156204|FG001|Overall Study|Lost to Follow-up|2|||
131691762|NCT02025907|474156203|FG000|Overall Study|Adverse Event|3|||
131691763|NCT02025907|474156204|FG001|Overall Study|Adverse Event|1|||
131691764|NCT02025907|474156203|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
131691765|NCT02025907|474156204|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
131691766|NCT03681119|474156209|FG000|Overall Study|No specific reason|4|||
131691767|NCT03681119|474156210|FG001|Overall Study|No specific reason|0|||
131691768|NCT03681119|474156209|FG000|Overall Study|Sickness|2|||
131691769|NCT03681119|474156210|FG001|Overall Study|Sickness|0|||
131691770|NCT01422915|474156211|FG000|Overall Study|Adverse Event|1|||
131691771|NCT00606320|474156216|FG000|Overall Study|Adverse Event|3|||
131691772|NCT00606320|474156216|FG000|Overall Study|Lack of Efficacy|5|||
131691773|NCT00606320|474156216|FG000|Overall Study|Physician Decision|7|||
131691774|NCT00606320|474156216|FG000|Overall Study|Protocol Violation|8|||
131691775|NCT00606320|474156216|FG000|Overall Study|Withdrawal by Subject|10|||
131691776|NCT00606320|474156216|FG000|Overall Study|Progression to depressive phase|4|||
131691777|NCT00563186|474156217|FG000|Overall Study|LOS<48 hours|97|||
131691778|NCT00563186|474156218|FG001|Overall Study|LOS<48 hours|74|||
131691779|NCT00563186|474156217|FG000|Overall Study|Incomplete data|1|||
131691780|NCT00563186|474156218|FG001|Overall Study|Incomplete data|1|||
131691781|NCT02595723|474156219|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
131691782|NCT02595723|474156220|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
131691783|NCT02595723|474156221|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
131691784|NCT02595723|474156219|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
131691785|NCT02595723|474156220|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
131691786|NCT02595723|474156221|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
131691787|NCT04839380|474156222|FG000|Overall Study|Withdrawal by Subject|2|||
131691788|NCT04839380|474156222|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
131691789|NCT01087905|474156223|FG000|Overall Study|Lost to Follow-up|24|||
131691790|NCT01087905|474156224|FG001|Overall Study|Lost to Follow-up|28|||
131691791|NCT01087905|474156225|FG002|Overall Study|Lost to Follow-up|18|||
131691792|NCT01087905|474156226|FG003|Overall Study|Lost to Follow-up|31|||
131691793|NCT01087905|474156227|FG004|Overall Study|Lost to Follow-up|27|||
131691794|NCT01087905|474156228|FG005|Overall Study|Lost to Follow-up|25|||
131691795|NCT01087905|474156229|FG006|Overall Study|Lost to Follow-up|20|||
131691796|NCT01087905|474156230|FG007|Overall Study|Lost to Follow-up|24|||
131691797|NCT01087905|474156223|FG000|Overall Study|Withdrawal by Subject|5|||
131691798|NCT01087905|474156224|FG001|Overall Study|Withdrawal by Subject|4|||
131691799|NCT01087905|474156225|FG002|Overall Study|Withdrawal by Subject|4|||
131691800|NCT01087905|474156226|FG003|Overall Study|Withdrawal by Subject|5|||
131691801|NCT01087905|474156227|FG004|Overall Study|Withdrawal by Subject|4|||
131691802|NCT01087905|474156228|FG005|Overall Study|Withdrawal by Subject|3|||
131691803|NCT01087905|474156229|FG006|Overall Study|Withdrawal by Subject|3|||
131691804|NCT01087905|474156230|FG007|Overall Study|Withdrawal by Subject|5|||
131691805|NCT00879645|474156231|FG000|Overall Study|Adverse Event|1|||
131691806|NCT00879645|474156232|FG001|Overall Study|Adverse Event|0|||
131691807|NCT00879645|474156233|FG002|Overall Study|Adverse Event|0|||
131691808|NCT00879645|474156234|FG003|Overall Study|Adverse Event|0|||
131691809|NCT01347554|474156235|FG000|Overall Study|Lack of Efficacy|7|||
131691810|NCT01347554|474156236|FG001|Overall Study|Lack of Efficacy|11|||
131691811|NCT04288154|474156237|FG000|Overall Study|Withdrawal by Subject|9|||
131691812|NCT04288154|474156238|FG001|Overall Study|Withdrawal by Subject|9|||
131691813|NCT00506883|474156241|FG000|Overall Study|Lost to Follow-up|1|||
131691814|NCT00506883|474156242|FG001|Overall Study|Lost to Follow-up|1|||
131691815|NCT00506883|474156243|FG002|Overall Study|Lost to Follow-up|1|||
131691816|NCT00506883|474156241|FG000|Overall Study|Withdrawal by Subject|1|||
131691817|NCT00506883|474156242|FG001|Overall Study|Withdrawal by Subject|0|||
131777435|NCT00471237|474465436|FG006|Overall Study|Participant's decision|0|||
131777436|NCT01301625|474465447|FG000|Overall Study|Death|5|||
131777437|NCT01301625|474465447|FG000|Overall Study|Not Due|21|||
131777438|NCT01301625|474465447|FG000|Overall Study|Expected|8|||
131777439|NCT01301625|474465447|FG000|Overall Study|Lost to Follow-up|1|||
131777440|NCT00627094|474465454|FG000|Overall Study|Adverse Event|8|||
131777441|NCT00627094|474465455|FG001|Overall Study|Adverse Event|7|||
131777442|NCT00627094|474465454|FG000|Overall Study|Lost to Follow-up|1|||
131777443|NCT00627094|474465455|FG001|Overall Study|Lost to Follow-up|0|||
131777444|NCT00627094|474465454|FG000|Overall Study|Withdrawal by Subject|1|||
131777445|NCT00627094|474465455|FG001|Overall Study|Withdrawal by Subject|1|||
131777446|NCT00627094|474465454|FG000|Overall Study|ulcer healed|1|||
131777447|NCT00627094|474465455|FG001|Overall Study|ulcer healed|7|||
131777448|NCT00627094|474465454|FG000|Overall Study|Other reason|1|||
131777449|NCT00627094|474465455|FG001|Overall Study|Other reason|0|||
131777450|NCT04637815|474465465|FG000|Overall Study|Death|1|||
131777451|NCT04637815|474465466|FG001|Overall Study|Death|0|||
131777452|NCT04637815|474465465|FG000|Overall Study|Lost to Follow-up|5|||
131777453|NCT04637815|474465466|FG001|Overall Study|Lost to Follow-up|2|||
131777454|NCT00943826|474465467|FG000|Concurrent Phase|Adverse Event|50|||
131777455|NCT00943826|474465468|FG001|Concurrent Phase|Adverse Event|27|||
131777456|NCT00943826|474465467|FG000|Concurrent Phase|Withdrew consent|3|||
131777457|NCT00943826|474465468|FG001|Concurrent Phase|Withdrew consent|7|||
131777458|NCT00943826|474465467|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
131777459|NCT00943826|474465468|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
131777460|NCT00943826|474465467|FG000|Concurrent Phase|Administrative reasons|2|||
131777461|NCT00943826|474465468|FG001|Concurrent Phase|Administrative reasons|1|||
131777462|NCT00943826|474465467|FG000|Concurrent Phase|Protocol Violation|1|||
131777463|NCT00943826|474465468|FG001|Concurrent Phase|Protocol Violation|0|||
131777464|NCT00943826|474465467|FG000|Maintenance Phase|Adverse Event|31|||
131777465|NCT00943826|474465468|FG001|Maintenance Phase|Adverse Event|30|||
131777466|NCT00943826|474465467|FG000|Maintenance Phase|Withdrew consent|2|||
131777467|NCT00943826|474465468|FG001|Maintenance Phase|Withdrew consent|4|||
131777468|NCT00943826|474465467|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
131777469|NCT00943826|474465468|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
131777470|NCT00943826|474465467|FG000|Maintenance Phase|Administrative reasons|4|||
131777471|NCT00943826|474465468|FG001|Maintenance Phase|Administrative reasons|1|||
131777472|NCT00943826|474465467|FG000|Maintenance Phase|Failure to return|0|||
131777473|NCT00943826|474465468|FG001|Maintenance Phase|Failure to return|1|||
131777474|NCT00943826|474465467|FG000|Monotherapy Phase|Adverse Event|42|||
131777475|NCT00943826|474465468|FG001|Monotherapy Phase|Adverse Event|5|||
131777476|NCT00943826|474465467|FG000|Monotherapy Phase|Administrative reasons|11|||
131777477|NCT00943826|474465468|FG001|Monotherapy Phase|Administrative reasons|5|||
131691818|NCT00506883|474156243|FG002|Overall Study|Withdrawal by Subject|1|||
131691819|NCT00506883|474156241|FG000|Overall Study|Lack of Efficacy|0|||
131691820|NCT00506883|474156242|FG001|Overall Study|Lack of Efficacy|1|||
131691821|NCT00506883|474156243|FG002|Overall Study|Lack of Efficacy|1|||
131691822|NCT00506883|474156241|FG000|Overall Study|Other|5|||
131691823|NCT00506883|474156242|FG001|Overall Study|Other|1|||
131691824|NCT00506883|474156243|FG002|Overall Study|Other|1|||
131691825|NCT02943564|474156244|FG000|Overall Study|Miscellaneous Reasons|0|||
131691826|NCT02943564|474156245|FG001|Overall Study|Miscellaneous Reasons|0|||
131691827|NCT02943564|474156246|FG002|Overall Study|Miscellaneous Reasons|3|||
131691828|NCT02943564|474156244|FG000|Overall Study|Site terminated by sponsor|0|||
131691829|NCT02943564|474156245|FG001|Overall Study|Site terminated by sponsor|1|||
131691830|NCT02943564|474156246|FG002|Overall Study|Site terminated by sponsor|0|||
131691831|NCT02943564|474156244|FG000|Overall Study|Non-compliance with study drug|0|||
131691832|NCT02943564|474156245|FG001|Overall Study|Non-compliance with study drug|1|||
131691833|NCT02943564|474156246|FG002|Overall Study|Non-compliance with study drug|0|||
131691834|NCT02943564|474156244|FG000|Overall Study|Pregnancy|0|||
131691835|NCT02943564|474156245|FG001|Overall Study|Pregnancy|1|||
131691836|NCT02943564|474156246|FG002|Overall Study|Pregnancy|1|||
131691837|NCT02943564|474156244|FG000|Overall Study|Protocol Violation|2|||
131691838|NCT02943564|474156245|FG001|Overall Study|Protocol Violation|2|||
131691839|NCT02943564|474156246|FG002|Overall Study|Protocol Violation|2|||
131691840|NCT02943564|474156244|FG000|Overall Study|Lost to Follow-up|1|||
131691841|NCT02943564|474156245|FG001|Overall Study|Lost to Follow-up|0|||
131691842|NCT02943564|474156246|FG002|Overall Study|Lost to Follow-up|0|||
131691843|NCT02943564|474156244|FG000|Overall Study|Withdrawal by Subject|6|||
131691844|NCT02943564|474156245|FG001|Overall Study|Withdrawal by Subject|5|||
131691845|NCT02943564|474156246|FG002|Overall Study|Withdrawal by Subject|2|||
131691846|NCT02943564|474156244|FG000|Overall Study|Adverse Event|1|||
131691847|NCT02943564|474156245|FG001|Overall Study|Adverse Event|2|||
131691848|NCT02943564|474156246|FG002|Overall Study|Adverse Event|1|||
131691849|NCT02943564|474156244|FG000|Overall Study|Lack of Efficacy|0|||
131691850|NCT02943564|474156245|FG001|Overall Study|Lack of Efficacy|1|||
131691851|NCT02943564|474156246|FG002|Overall Study|Lack of Efficacy|0|||
131691852|NCT01073267|474156250|FG000|Overall Study|Disease Progression|3|||
131691853|NCT00577642|474156251|FG000|Overall Study|Clinical Disease Progression|1|||
131777478|NCT00943826|474465467|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
131777479|NCT00943826|474465468|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
131777480|NCT00943826|474465467|FG000|Monotherapy Phase|Withdrew Consent|2|||
131777481|NCT00943826|474465468|FG001|Monotherapy Phase|Withdrew Consent|3|||
131777482|NCT00943826|474465467|FG000|Monotherapy Phase|Failure to return|2|||
131691854|NCT00917150|474156256|FG000|Overall Study|Adverse Event|12|||
131691855|NCT00917150|474156257|FG001|Overall Study|Adverse Event|7|||
131691856|NCT00917150|474156258|FG002|Overall Study|Adverse Event|12|||
131691857|NCT00917150|474156259|FG003|Overall Study|Adverse Event|11|||
131691858|NCT00917150|474156256|FG000|Overall Study|Death|1|||
131691859|NCT00917150|474156257|FG001|Overall Study|Death|4|||
131691860|NCT00917150|474156258|FG002|Overall Study|Death|3|||
131691861|NCT00917150|474156259|FG003|Overall Study|Death|2|||
131691862|NCT00917150|474156256|FG000|Overall Study|Lost to Follow-up|1|||
131691863|NCT00917150|474156257|FG001|Overall Study|Lost to Follow-up|0|||
131691864|NCT00917150|474156258|FG002|Overall Study|Lost to Follow-up|4|||
131691865|NCT00917150|474156259|FG003|Overall Study|Lost to Follow-up|2|||
131691866|NCT00917150|474156256|FG000|Overall Study|Physician Decision|0|||
131691867|NCT00917150|474156257|FG001|Overall Study|Physician Decision|2|||
131691868|NCT00917150|474156258|FG002|Overall Study|Physician Decision|0|||
131691869|NCT00917150|474156259|FG003|Overall Study|Physician Decision|1|||
131691870|NCT00917150|474156256|FG000|Overall Study|Protocol Violation|5|||
131691871|NCT00917150|474156257|FG001|Overall Study|Protocol Violation|5|||
131691872|NCT00917150|474156258|FG002|Overall Study|Protocol Violation|3|||
131691873|NCT00917150|474156259|FG003|Overall Study|Protocol Violation|5|||
131691874|NCT00917150|474156256|FG000|Overall Study|Withdrawal by Subject|15|||
131691875|NCT00917150|474156257|FG001|Overall Study|Withdrawal by Subject|16|||
131691876|NCT00917150|474156258|FG002|Overall Study|Withdrawal by Subject|18|||
131691877|NCT00917150|474156259|FG003|Overall Study|Withdrawal by Subject|11|||
131691878|NCT00917150|474156256|FG000|Overall Study|Other than specified|3|||
131691879|NCT00917150|474156257|FG001|Overall Study|Other than specified|3|||
131691880|NCT00917150|474156258|FG002|Overall Study|Other than specified|2|||
131691881|NCT00917150|474156259|FG003|Overall Study|Other than specified|2|||
131691882|NCT03891264|474156260|FG000|Overall Study|Adverse Event|1|||
131691883|NCT03891264|474156260|FG000|Overall Study|Withdrawal by Subject|2|||
131691884|NCT03891264|474156260|FG000|Overall Study|Physician Decision|2|||
131691885|NCT01505634|474156265|FG000|Overall Study|Withdrawal by Subject|2|||
131691886|NCT01505634|474156266|FG001|Overall Study|Withdrawal by Subject|5|||
131691887|NCT01505634|474156267|FG002|Overall Study|Withdrawal by Subject|1|||
131691888|NCT01505634|474156265|FG000|Overall Study|Physician Decision|1|||
131691889|NCT01505634|474156266|FG001|Overall Study|Physician Decision|1|||
131691890|NCT01505634|474156267|FG002|Overall Study|Physician Decision|0|||
131691891|NCT01505634|474156265|FG000|Overall Study|Adverse Event|1|||
131691892|NCT01505634|474156266|FG001|Overall Study|Adverse Event|0|||
131691893|NCT01505634|474156267|FG002|Overall Study|Adverse Event|0|||
131691894|NCT01505634|474156265|FG000|Overall Study|Insufficient supply of drug at site|1|||
131691895|NCT01505634|474156266|FG001|Overall Study|Insufficient supply of drug at site|0|||
131691896|NCT01505634|474156267|FG002|Overall Study|Insufficient supply of drug at site|0|||
131691897|NCT01505634|474156265|FG000|Overall Study|Protocol Violation|2|||
131691898|NCT01505634|474156266|FG001|Overall Study|Protocol Violation|0|||
131691899|NCT01505634|474156267|FG002|Overall Study|Protocol Violation|0|||
131691900|NCT01505634|474156265|FG000|Overall Study|Lost to Follow-up|1|||
131691901|NCT01505634|474156266|FG001|Overall Study|Lost to Follow-up|4|||
131691902|NCT01505634|474156267|FG002|Overall Study|Lost to Follow-up|4|||
131691903|NCT01505634|474156265|FG000|Overall Study|Death|1|||
131691904|NCT01505634|474156266|FG001|Overall Study|Death|0|||
131691905|NCT01505634|474156267|FG002|Overall Study|Death|0|||
131691906|NCT01505634|474156265|FG000|Overall Study|In a conflict zone|0|||
131691907|NCT01505634|474156266|FG001|Overall Study|In a conflict zone|0|||
131691908|NCT01505634|474156267|FG002|Overall Study|In a conflict zone|1|||
131691909|NCT02054897|474156268|FG000|Overall Study|Withdrawal by Subject|2|||
131691910|NCT02054897|474156269|FG001|Overall Study|Withdrawal by Subject|0|||
131691911|NCT02054897|474156270|FG002|Overall Study|Withdrawal by Subject|2|||
131691912|NCT02054897|474156268|FG000|Overall Study|Missing follow-up information|3|||
131691913|NCT02054897|474156269|FG001|Overall Study|Missing follow-up information|5|||
131691914|NCT02054897|474156270|FG002|Overall Study|Missing follow-up information|3|||
131691915|NCT02054897|474156268|FG000|Overall Study|Lost to Follow-up|4|||
131691916|NCT02054897|474156269|FG001|Overall Study|Lost to Follow-up|2|||
131691917|NCT02054897|474156270|FG002|Overall Study|Lost to Follow-up|7|||
131691918|NCT02054897|474156268|FG000|Overall Study|Randomized but not exposed|1|||
131691919|NCT02054897|474156269|FG001|Overall Study|Randomized but not exposed|0|||
131691920|NCT02054897|474156270|FG002|Overall Study|Randomized but not exposed|0|||
131691921|NCT00794157|474156271|FG000|Overall Study|Adverse Event|4|||
131691922|NCT00794157|474156272|FG001|Overall Study|Adverse Event|1|||
131691923|NCT00794157|474156273|FG002|Overall Study|Adverse Event|8|||
131691924|NCT00794157|474156271|FG000|Overall Study|Subject withdrew consent|2|||
131691925|NCT00794157|474156272|FG001|Overall Study|Subject withdrew consent|0|||
131691926|NCT00794157|474156273|FG002|Overall Study|Subject withdrew consent|3|||
131691927|NCT00794157|474156271|FG000|Overall Study|Lost to Follow-up|2|||
131691928|NCT00794157|474156272|FG001|Overall Study|Lost to Follow-up|0|||
131691929|NCT00794157|474156273|FG002|Overall Study|Lost to Follow-up|1|||
131691930|NCT00794157|474156271|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131691931|NCT00794157|474156272|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131691932|NCT00794157|474156273|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131691933|NCT00794157|474156271|FG000|Overall Study|Administrative problems|1|||
131691934|NCT00794157|474156272|FG001|Overall Study|Administrative problems|7|||
131777483|NCT00943826|474465468|FG001|Monotherapy Phase|Failure to return|1|||
131777484|NCT00943826|474465467|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
131777485|NCT00943826|474465468|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
131777486|NCT00943826|474465467|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
131557170|NCT00152971|473664437|FG001|Treatment|Protocol Violation|6|||
131557171|NCT00152971|473664438|FG002|Treatment|Protocol Violation|10|||
131557172|NCT00152971|473664436|FG000|Treatment|Lost to Follow-up|1|||
131557173|NCT00152971|473664437|FG001|Treatment|Lost to Follow-up|2|||
131557174|NCT00152971|473664438|FG002|Treatment|Lost to Follow-up|1|||
131777487|NCT00943826|474465468|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
131777488|NCT00943826|474465467|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
131777489|NCT00943826|474465468|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
131777490|NCT00943826|474465467|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
131777491|NCT00943826|474465468|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
131777492|NCT00326625|474465469|FG000|Overall Study|Adverse Event|20|||
131777493|NCT00326625|474465470|FG001|Overall Study|Adverse Event|9|||
131777494|NCT00326625|474465469|FG000|Overall Study|Withdrawal by Subject|15|||
131777495|NCT00326625|474465470|FG001|Overall Study|Withdrawal by Subject|12|||
131777496|NCT00326625|474465469|FG000|Overall Study|Death|18|||
131777497|NCT00326625|474465470|FG001|Overall Study|Death|16|||
131777498|NCT00326625|474465469|FG000|Overall Study|Lost to Follow-up|1|||
131777499|NCT00326625|474465470|FG001|Overall Study|Lost to Follow-up|0|||
131777500|NCT00326625|474465469|FG000|Overall Study|prescheduled medical intervention|0|||
131777501|NCT00326625|474465470|FG001|Overall Study|prescheduled medical intervention|1|||
131777502|NCT04054011|474465475|FG000|Overall Study|COVID|3|||
131777503|NCT00669110|474465477|FG000|Overall Study|Adverse Event|4|||
131777504|NCT00669110|474465478|FG001|Overall Study|Adverse Event|3|||
131777505|NCT00669110|474465477|FG000|Overall Study|Caregiver request|3|||
131777506|NCT00669110|474465478|FG001|Overall Study|Caregiver request|2|||
131777507|NCT00669110|474465477|FG000|Overall Study|Physician Decision|0|||
131777508|NCT00669110|474465478|FG001|Overall Study|Physician Decision|1|||
131777509|NCT00669110|474465477|FG000|Overall Study|Lost to Follow-up|1|||
131777510|NCT00669110|474465478|FG001|Overall Study|Lost to Follow-up|0|||
131777511|NCT00669110|474465477|FG000|Overall Study|Protocol Violation|0|||
131777512|NCT00669110|474465478|FG001|Overall Study|Protocol Violation|5|||
131777513|NCT00669110|474465477|FG000|Overall Study|Withdrawal by Subject|0|||
131777514|NCT00669110|474465478|FG001|Overall Study|Withdrawal by Subject|2|||
131777515|NCT04455620|474465482|FG000|Overall Study|Withdrawal by Subject|0|||
131777516|NCT04455620|474465483|FG001|Overall Study|Withdrawal by Subject|0|||
131777517|NCT04455620|474465484|FG002|Overall Study|Withdrawal by Subject|2|||
131777518|NCT04455620|474465485|FG003|Overall Study|Withdrawal by Subject|0|||
131777519|NCT04455620|474465486|FG004|Overall Study|Withdrawal by Subject|1|||
131777520|NCT04455620|474465482|FG000|Overall Study|Lost to Follow-up|0|||
131777521|NCT04455620|474465483|FG001|Overall Study|Lost to Follow-up|0|||
131777522|NCT04455620|474465484|FG002|Overall Study|Lost to Follow-up|1|||
131777523|NCT04455620|474465485|FG003|Overall Study|Lost to Follow-up|1|||
131777524|NCT04455620|474465486|FG004|Overall Study|Lost to Follow-up|0|||
131777525|NCT04455620|474465482|FG000|Overall Study|Death|1|||
131777526|NCT04455620|474465483|FG001|Overall Study|Death|6|||
131777527|NCT04455620|474465484|FG002|Overall Study|Death|20|||
131777528|NCT04455620|474465485|FG003|Overall Study|Death|1|||
131777529|NCT04455620|474465486|FG004|Overall Study|Death|7|||
131777530|NCT04455620|474465482|FG000|Overall Study|Study Termination|0|||
131777531|NCT04455620|474465483|FG001|Overall Study|Study Termination|2|||
131777532|NCT04455620|474465484|FG002|Overall Study|Study Termination|1|||
131777533|NCT04455620|474465485|FG003|Overall Study|Study Termination|0|||
131777534|NCT04455620|474465486|FG004|Overall Study|Study Termination|6|||
131777535|NCT00400985|474465487|FG000|Overall Study|Withdrawal by Subject|5|||
131777536|NCT00400985|474465487|FG000|Overall Study|system modification|8|||
131777537|NCT00400985|474465487|FG000|Overall Study|Death|30|||
131777538|NCT00400985|474465487|FG000|Overall Study|Lost to Follow-up|9|||
131777539|NCT00965562|474465488|FG000|Overall Study|Lost to Follow-up|1|||
131777540|NCT00965562|474465489|FG001|Overall Study|Lost to Follow-up|2|||
131777541|NCT00965562|474465490|FG002|Overall Study|Lost to Follow-up|3|||
131777542|NCT00965562|474465488|FG000|Overall Study|Withdrawal by Subject|2|||
131777543|NCT00965562|474465489|FG001|Overall Study|Withdrawal by Subject|2|||
131777544|NCT00965562|474465490|FG002|Overall Study|Withdrawal by Subject|0|||
131777545|NCT03792633|474465495|FG000|Overall Study|Alternative Treatment|17|||
131777546|NCT03792633|474465496|FG001|Overall Study|Alternative Treatment|19|||
131777547|NCT03792633|474465495|FG000|Overall Study|Death|2|||
131777548|NCT03792633|474465496|FG001|Overall Study|Death|0|||
131777549|NCT03792633|474465495|FG000|Overall Study|Disease progression|8|||
131777550|NCT03792633|474465496|FG001|Overall Study|Disease progression|9|||
131777551|NCT03792633|474465495|FG000|Overall Study|Lost to Follow-up|1|||
131777552|NCT03792633|474465496|FG001|Overall Study|Lost to Follow-up|1|||
131777553|NCT03792633|474465495|FG000|Overall Study|Screen fail|1|||
131777554|NCT03792633|474465496|FG001|Overall Study|Screen fail|0|||
131777555|NCT03792633|474465495|FG000|Overall Study|Second malignancy|0|||
131777556|NCT03792633|474465496|FG001|Overall Study|Second malignancy|1|||
131777557|NCT03179462|474465498|FG000|Overall Study|screening failure|1|||
131777558|NCT03179462|474465499|FG001|Overall Study|screening failure|2|||
131777559|NCT03179462|474465500|FG002|Overall Study|screening failure|0|||
131777560|NCT00816166|474465501|FG000|Overall Study|Lost to Follow-up|6|||
131777561|NCT00816166|474465502|FG001|Overall Study|Lost to Follow-up|10|||
131777562|NCT00816166|474465501|FG000|Overall Study|Death|4|||
131777563|NCT00816166|474465502|FG001|Overall Study|Death|2|||
131777564|NCT01843660|474465508|FG000|Overall Study|Other|30|||
131777565|NCT00209560|474465509|FG000|Overall Study|Lack of Efficacy|1|||
131777566|NCT00209560|474465510|FG001|Overall Study|Lack of Efficacy|0|||
131777567|NCT00795886|474465511|FG000|Overall Study|Death|10|||
131777568|NCT00706901|474467438|FG000|Overall Study|Lost to Follow-up|2|||
131777569|NCT00706901|474467439|FG001|Overall Study|Lost to Follow-up|3|||
131777570|NCT00706901|474467440|FG002|Overall Study|Lost to Follow-up|2|||
131777571|NCT00706901|474467438|FG000|Overall Study|Withdrawal by Subject|4|||
131777572|NCT00706901|474467439|FG001|Overall Study|Withdrawal by Subject|2|||
131777573|NCT00706901|474467440|FG002|Overall Study|Withdrawal by Subject|5|||
131777574|NCT00706901|474467438|FG000|Overall Study|In Jail|1|||
131777575|NCT00706901|474467439|FG001|Overall Study|In Jail|0|||
131777576|NCT00706901|474467440|FG002|Overall Study|In Jail|1|||
131777577|NCT00706901|474467438|FG000|Overall Study|Death|1|||
131777578|NCT00706901|474467439|FG001|Overall Study|Death|0|||
131777579|NCT00706901|474467440|FG002|Overall Study|Death|0|||
131777580|NCT01118949|474467443|FG000|Overall Study|Adverse Event|5|||
131777581|NCT01118949|474467443|FG000|Overall Study|Withdrawal by Subject|4|||
131777582|NCT00798707|474467444|FG000|Overall Study|Adverse Event|6|||
131777583|NCT00798707|474467445|FG001|Overall Study|Adverse Event|8|||
131777584|NCT00798707|474467446|FG002|Overall Study|Adverse Event|8|||
131777585|NCT00798707|474467444|FG000|Overall Study|Failed to return|2|||
131777586|NCT00798707|474467445|FG001|Overall Study|Failed to return|2|||
131777587|NCT00798707|474467446|FG002|Overall Study|Failed to return|0|||
131777588|NCT00798707|474467444|FG000|Overall Study|Investigator|0|||
131777589|NCT00798707|474467445|FG001|Overall Study|Investigator|1|||
131777590|NCT00798707|474467446|FG002|Overall Study|Investigator|2|||
131777591|NCT00798707|474467444|FG000|Overall Study|Lack of Efficacy|2|||
131777592|NCT00798707|474467445|FG001|Overall Study|Lack of Efficacy|2|||
131777593|NCT00798707|474467446|FG002|Overall Study|Lack of Efficacy|1|||
131777594|NCT00798707|474467444|FG000|Overall Study|Lost to Follow-up|5|||
131777595|NCT00798707|474467445|FG001|Overall Study|Lost to Follow-up|6|||
131777596|NCT00798707|474467446|FG002|Overall Study|Lost to Follow-up|6|||
131777597|NCT00798707|474467444|FG000|Overall Study|Other|0|||
131777598|NCT00798707|474467445|FG001|Overall Study|Other|1|||
131777599|NCT00798707|474467446|FG002|Overall Study|Other|0|||
131777600|NCT00798707|474467444|FG000|Overall Study|Protocol Violation|4|||
131777601|NCT00798707|474467445|FG001|Overall Study|Protocol Violation|0|||
131557175|NCT00152971|473664436|FG000|Treatment|Withdrawal by Subject|4|||
131777602|NCT00798707|474467446|FG002|Overall Study|Protocol Violation|2|||
131777603|NCT00798707|474467444|FG000|Overall Study|Withdrawal by Subject|3|||
131777604|NCT00798707|474467445|FG001|Overall Study|Withdrawal by Subject|8|||
131777605|NCT00798707|474467446|FG002|Overall Study|Withdrawal by Subject|2|||
131777606|NCT00798707|474467444|FG000|Overall Study|Randomized not treated|4|||
131777607|NCT00798707|474467445|FG001|Overall Study|Randomized not treated|5|||
131777608|NCT00798707|474467446|FG002|Overall Study|Randomized not treated|1|||
131777609|NCT02875340|474467447|FG000|Overall Study|Death|2|||
131777610|NCT02875340|474467447|FG000|Overall Study|Withdrawal by Subject|2|||
131777611|NCT02875340|474467447|FG000|Overall Study|Physician Decision|3|||
131777612|NCT02875340|474467447|FG000|Overall Study|Adverse Event|1|||
131777613|NCT01160770|474467448|FG000|Overall Study|Adverse Event|10|||
131691935|NCT00794157|474156273|FG002|Overall Study|Administrative problems|4|||
131691936|NCT00794157|474156271|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131691937|NCT00794157|474156272|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131691938|NCT00794157|474156273|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131691939|NCT00794157|474156271|FG000|Overall Study|Protocol deviation|0|||
131691940|NCT00794157|474156272|FG001|Overall Study|Protocol deviation|1|||
131691941|NCT00794157|474156273|FG002|Overall Study|Protocol deviation|1|||
131691942|NCT01692275|474156274|FG000|Overall Study|Lost to Follow-up|57|||
131691943|NCT01692275|474156275|FG001|Overall Study|Lost to Follow-up|48|||
131691944|NCT01692275|474156274|FG000|Overall Study|Withdrawal by Subject|9|||
131691945|NCT01692275|474156275|FG001|Overall Study|Withdrawal by Subject|11|||
131691946|NCT01624662|474156278|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
131691947|NCT01624662|474156279|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
131691948|NCT01624662|474156280|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
131691949|NCT01624662|474156281|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
131691950|NCT01624662|474156278|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
131691951|NCT01624662|474156279|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
131691952|NCT01624662|474156280|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
131691953|NCT01624662|474156281|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
131691954|NCT01624662|474156278|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131691955|NCT01624662|474156279|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
131691956|NCT01624662|474156280|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131691957|NCT01624662|474156281|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131691958|NCT01624662|474156278|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
131691959|NCT01624662|474156279|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
131691960|NCT01624662|474156280|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
131691961|NCT01624662|474156281|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
131691962|NCT01624662|474156278|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131691963|NCT01624662|474156279|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131691964|NCT01624662|474156280|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
131691965|NCT01624662|474156281|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131691966|NCT01624662|474156278|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131691967|NCT01624662|474156279|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
131691968|NCT01624662|474156280|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131691969|NCT01624662|474156281|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131691970|NCT01624662|474156278|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131691971|NCT01624662|474156279|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131691972|NCT01624662|474156280|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
131691973|NCT01624662|474156281|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131691974|NCT00361270|474156282|FG000|Overall Study|Death|0|||
131691975|NCT00361270|474156283|FG001|Overall Study|Death|0|||
131691976|NCT00361270|474156284|FG002|Overall Study|Death|0|||
131691977|NCT00361270|474156285|FG003|Overall Study|Death|2|||
131691978|NCT00361270|474156282|FG000|Overall Study|Lost to Follow-up|4|||
131691979|NCT00361270|474156283|FG001|Overall Study|Lost to Follow-up|1|||
131691980|NCT00361270|474156284|FG002|Overall Study|Lost to Follow-up|0|||
131691981|NCT00361270|474156285|FG003|Overall Study|Lost to Follow-up|0|||
131691982|NCT00361270|474156282|FG000|Overall Study|Physician Decision|0|||
131691983|NCT00361270|474156283|FG001|Overall Study|Physician Decision|0|||
131691984|NCT00361270|474156284|FG002|Overall Study|Physician Decision|1|||
131691985|NCT00361270|474156285|FG003|Overall Study|Physician Decision|0|||
131691986|NCT00361270|474156282|FG000|Overall Study|Protocol Violation|9|||
131691987|NCT00361270|474156283|FG001|Overall Study|Protocol Violation|4|||
131691988|NCT00361270|474156284|FG002|Overall Study|Protocol Violation|5|||
131691989|NCT00361270|474156285|FG003|Overall Study|Protocol Violation|4|||
131691990|NCT00361270|474156282|FG000|Overall Study|Withdrawal by Subject|6|||
131691991|NCT00361270|474156283|FG001|Overall Study|Withdrawal by Subject|6|||
131691992|NCT00361270|474156284|FG002|Overall Study|Withdrawal by Subject|3|||
131691993|NCT00361270|474156285|FG003|Overall Study|Withdrawal by Subject|7|||
131691994|NCT00361270|474156282|FG000|Overall Study|Afraid of Hypnosis|1|||
131691995|NCT00361270|474156283|FG001|Overall Study|Afraid of Hypnosis|2|||
131691996|NCT00361270|474156284|FG002|Overall Study|Afraid of Hypnosis|0|||
131691997|NCT00361270|474156285|FG003|Overall Study|Afraid of Hypnosis|0|||
131691998|NCT00361270|474156282|FG000|Overall Study|Problems with Transportation|4|||
131691999|NCT00361270|474156283|FG001|Overall Study|Problems with Transportation|0|||
131692000|NCT00361270|474156284|FG002|Overall Study|Problems with Transportation|0|||
131692001|NCT00361270|474156285|FG003|Overall Study|Problems with Transportation|0|||
131692002|NCT00361270|474156282|FG000|Overall Study|Adverse Event|0|||
131692003|NCT00361270|474156283|FG001|Overall Study|Adverse Event|1|||
131692004|NCT00361270|474156284|FG002|Overall Study|Adverse Event|1|||
131692005|NCT00361270|474156285|FG003|Overall Study|Adverse Event|0|||
131692006|NCT01033825|474156287|FG000|Overall Study|Withdrawal by Subject|2|||
131692007|NCT01033825|474156288|FG001|Overall Study|Withdrawal by Subject|3|||
131692008|NCT01033825|474156289|FG002|Overall Study|Withdrawal by Subject|2|||
131692009|NCT01033825|474156290|FG003|Overall Study|Withdrawal by Subject|1|||
131692010|NCT01033825|474156291|FG004|Overall Study|Withdrawal by Subject|1|||
131692011|NCT01033825|474156292|FG005|Overall Study|Withdrawal by Subject|0|||
131692012|NCT01033825|474156293|FG006|Overall Study|Withdrawal by Subject|0|||
131692013|NCT01033825|474156287|FG000|Overall Study|Adverse Event|0|||
131692014|NCT01033825|474156288|FG001|Overall Study|Adverse Event|0|||
131692015|NCT01033825|474156289|FG002|Overall Study|Adverse Event|0|||
131692016|NCT01033825|474156290|FG003|Overall Study|Adverse Event|1|||
131692017|NCT01033825|474156291|FG004|Overall Study|Adverse Event|0|||
131436785|NCT02079740|473225615|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
131557176|NCT00152971|473664437|FG001|Treatment|Withdrawal by Subject|4|||
131557177|NCT00152971|473664438|FG002|Treatment|Withdrawal by Subject|5|||
131692018|NCT01033825|474156292|FG005|Overall Study|Adverse Event|0|||
131692019|NCT01033825|474156293|FG006|Overall Study|Adverse Event|0|||
131692020|NCT01033825|474156287|FG000|Overall Study|Protocol Violation|1|||
131692021|NCT01033825|474156288|FG001|Overall Study|Protocol Violation|0|||
131692022|NCT01033825|474156289|FG002|Overall Study|Protocol Violation|0|||
131692023|NCT01033825|474156290|FG003|Overall Study|Protocol Violation|0|||
131692024|NCT01033825|474156291|FG004|Overall Study|Protocol Violation|0|||
131692025|NCT01033825|474156292|FG005|Overall Study|Protocol Violation|0|||
131692026|NCT01033825|474156293|FG006|Overall Study|Protocol Violation|0|||
131692027|NCT01033825|474156287|FG000|Overall Study|Other|0|||
131692028|NCT01033825|474156288|FG001|Overall Study|Other|0|||
131692029|NCT01033825|474156289|FG002|Overall Study|Other|0|||
131692030|NCT01033825|474156290|FG003|Overall Study|Other|0|||
131692031|NCT01033825|474156291|FG004|Overall Study|Other|1|||
131692032|NCT01033825|474156292|FG005|Overall Study|Other|0|||
131692033|NCT01033825|474156293|FG006|Overall Study|Other|0|||
131692034|NCT01806779|474156304|FG000|Overall Study|Physician Decision|2|||
131692035|NCT01806779|474156305|FG001|Overall Study|Physician Decision|0|||
131692036|NCT01806779|474156306|FG002|Overall Study|Physician Decision|1|||
131692037|NCT01806779|474156304|FG000|Overall Study|Lack of Efficacy|1|||
131692038|NCT01806779|474156305|FG001|Overall Study|Lack of Efficacy|1|||
131692039|NCT01806779|474156306|FG002|Overall Study|Lack of Efficacy|0|||
131692040|NCT01806779|474156304|FG000|Overall Study|Lost to Follow-up|19|||
131692041|NCT01806779|474156305|FG001|Overall Study|Lost to Follow-up|20|||
131692042|NCT01806779|474156306|FG002|Overall Study|Lost to Follow-up|0|||
131692043|NCT01806779|474156304|FG000|Overall Study|Withdrawal by Subject|20|||
131692044|NCT01806779|474156305|FG001|Overall Study|Withdrawal by Subject|23|||
131692045|NCT01806779|474156306|FG002|Overall Study|Withdrawal by Subject|22|||
131692046|NCT02595450|474156309|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
131692047|NCT02595450|474156309|FG000|Overall Study|Enrolled, but not treated|8|||
131692048|NCT04649255|474158206|FG000|Overall Study|Death|9|||
131692049|NCT04649255|474158206|FG000|Overall Study|Withdrawal by Subject|1|||
131692050|NCT04129528|474158207|FG000|Overall Study|Adverse Event|1|||
131692051|NCT04129528|474158208|FG001|Overall Study|Adverse Event|0|||
131692052|NCT04129528|474158207|FG000|Overall Study|Physician Decision|1|||
131692053|NCT04129528|474158208|FG001|Overall Study|Physician Decision|1|||
131692054|NCT04129528|474158207|FG000|Overall Study|Withdrawal by Subject|1|||
131692055|NCT04129528|474158208|FG001|Overall Study|Withdrawal by Subject|1|||
131692056|NCT01964352|474158209|FG000|Overall Study|Adverse Event|13|||
131692057|NCT01964352|474158210|FG001|Overall Study|Adverse Event|3|||
131692058|NCT01964352|474158211|FG002|Overall Study|Adverse Event|4|||
131692059|NCT01964352|474158212|FG003|Overall Study|Adverse Event|3|||
131692060|NCT01964352|474158209|FG000|Overall Study|Lack of Efficacy|6|||
131692061|NCT01964352|474158210|FG001|Overall Study|Lack of Efficacy|0|||
131692062|NCT01964352|474158211|FG002|Overall Study|Lack of Efficacy|0|||
131692063|NCT01964352|474158212|FG003|Overall Study|Lack of Efficacy|0|||
131692064|NCT01964352|474158209|FG000|Overall Study|Protocol Violation|2|||
131692065|NCT01964352|474158210|FG001|Overall Study|Protocol Violation|4|||
131692066|NCT01964352|474158211|FG002|Overall Study|Protocol Violation|0|||
131692067|NCT01964352|474158212|FG003|Overall Study|Protocol Violation|2|||
131692068|NCT01964352|474158209|FG000|Overall Study|Lost to Follow-up|1|||
131692069|NCT01964352|474158210|FG001|Overall Study|Lost to Follow-up|0|||
131692070|NCT01964352|474158211|FG002|Overall Study|Lost to Follow-up|0|||
131692071|NCT01964352|474158212|FG003|Overall Study|Lost to Follow-up|1|||
131692072|NCT01964352|474158209|FG000|Overall Study|Withdrawal by Subject|4|||
131692073|NCT01964352|474158210|FG001|Overall Study|Withdrawal by Subject|2|||
131692074|NCT01964352|474158211|FG002|Overall Study|Withdrawal by Subject|1|||
131692075|NCT01964352|474158212|FG003|Overall Study|Withdrawal by Subject|0|||
131692076|NCT01964352|474158209|FG000|Overall Study|Other than stated above|0|||
131692077|NCT01964352|474158210|FG001|Overall Study|Other than stated above|2|||
131692078|NCT01964352|474158211|FG002|Overall Study|Other than stated above|1|||
131692079|NCT01964352|474158212|FG003|Overall Study|Other than stated above|2|||
131692080|NCT01908101|474158213|FG000|Overall Study|Physician Decision|1|||
131692081|NCT01908101|474158213|FG000|Overall Study|Withdrawal by Subject|1|||
131692082|NCT01908101|474158213|FG000|Overall Study|Incorrect Diagnosis|2|||
131692083|NCT01908101|474158213|FG000|Overall Study|Incorrect Starting Dose|1|||
131692084|NCT01908101|474158213|FG000|Overall Study|Did not complete the first cycle|4|||
131692085|NCT00812214|474158219|FG000|Overall Study|Lost to Follow-up|3|||
131692086|NCT00812214|474158220|FG001|Overall Study|Lost to Follow-up|1|||
131692087|NCT02145741|474158221|FG000|Overall Study|Progressive disease|3|||
131692088|NCT02145741|474158222|FG001|Overall Study|Progressive disease|6|||
131692089|NCT02145741|474158223|FG002|Overall Study|Progressive disease|6|||
131557178|NCT00152971|473664436|FG000|Treatment|Other|9|||
131692090|NCT02145741|474158221|FG000|Overall Study|quality issue with the administered drug|3|||
131692091|NCT02145741|474158222|FG001|Overall Study|quality issue with the administered drug|0|||
131692092|NCT02145741|474158223|FG002|Overall Study|quality issue with the administered drug|0|||
131692093|NCT01192022|474158224|FG000|Overall Study|Withdrawal of Consent|3|||
131777614|NCT01160770|474467448|FG000|Overall Study|Protocol Violation|2|||
131777615|NCT01160770|474467448|FG000|Overall Study|Subject/parent/caregiver request|33|||
131777616|NCT01160770|474467448|FG000|Overall Study|Physician Decision|1|||
131777617|NCT01160770|474467448|FG000|Overall Study|Lost to Follow-up|7|||
131777618|NCT01160770|474467448|FG000|Overall Study|Study termination or sponsor request|1|||
131777619|NCT01160770|474467448|FG000|Overall Study|Death|9|||
131777620|NCT01160770|474467448|FG000|Overall Study|Lack of Efficacy|15|||
131777621|NCT01160770|474467448|FG000|Overall Study|Other Reasons|1|||
131777622|NCT03457727|474467449|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
131777623|NCT03457727|474467450|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
131777624|NCT03457727|474467451|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
131777625|NCT03457727|474467452|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
131777626|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
131777627|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
131777628|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
131777629|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
131777630|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
131777631|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
131777632|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
131777633|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
131777634|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
131777635|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
131777636|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
131777637|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
131777638|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
131777639|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
131777640|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
131777641|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
131777642|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
131777643|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
131777644|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
131777645|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
131777646|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
131777647|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
131777648|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
131777649|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
131777650|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
131777651|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
131777652|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
131777653|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
131777654|NCT01299272|474467458|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
131777655|NCT01299272|474467459|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
131777656|NCT01299272|474467460|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
131777657|NCT01299272|474467461|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
131777658|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
131777659|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
131777660|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
131777661|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
131777662|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
131777663|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
131777664|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
131777665|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
131777666|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
131777667|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
131777668|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
131777669|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
131777670|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
131777671|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
131777672|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
131777673|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
131777674|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
131777675|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
131777676|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
131777677|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
131777678|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
131777679|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
131777680|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
131777681|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
131777682|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
131777683|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
131777684|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
131777685|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
131777686|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
131777687|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
131777688|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
131777689|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
131777690|NCT01299272|474467458|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
131777691|NCT01299272|474467459|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
131777692|NCT01299272|474467460|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
131777693|NCT01299272|474467461|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
131777694|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
131777695|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
131777696|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
131777697|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
131777698|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
131777699|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
131777700|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
131777701|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
131777702|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
131777703|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
131777704|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
131777705|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
131777706|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
131777707|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
131777708|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
131777709|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
131777710|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
131777711|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
131692094|NCT01192022|474158225|FG001|Overall Study|Withdrawal of Consent|1|||
131692095|NCT01192022|474158226|FG002|Overall Study|Withdrawal of Consent|0|||
131692096|NCT01192022|474158227|FG003|Overall Study|Withdrawal of Consent|0|||
131692097|NCT01192022|474158228|FG004|Overall Study|Withdrawal of Consent|0|||
131692098|NCT01192022|474158224|FG000|Overall Study|Lost to Follow-up|4|||
131692099|NCT01192022|474158225|FG001|Overall Study|Lost to Follow-up|2|||
131692100|NCT01192022|474158226|FG002|Overall Study|Lost to Follow-up|1|||
131692101|NCT01192022|474158227|FG003|Overall Study|Lost to Follow-up|1|||
131692102|NCT01192022|474158228|FG004|Overall Study|Lost to Follow-up|0|||
131692103|NCT01192022|474158224|FG000|Overall Study|Adverse Event|1|||
131692104|NCT01192022|474158225|FG001|Overall Study|Adverse Event|0|||
131692105|NCT01192022|474158226|FG002|Overall Study|Adverse Event|0|||
131692106|NCT01192022|474158227|FG003|Overall Study|Adverse Event|0|||
131692107|NCT01192022|474158228|FG004|Overall Study|Adverse Event|0|||
131692108|NCT01192022|474158224|FG000|Overall Study|Fatal Adverse Event|4|||
131692109|NCT01192022|474158225|FG001|Overall Study|Fatal Adverse Event|6|||
131692110|NCT01192022|474158226|FG002|Overall Study|Fatal Adverse Event|0|||
131692111|NCT01192022|474158227|FG003|Overall Study|Fatal Adverse Event|0|||
131692112|NCT01192022|474158228|FG004|Overall Study|Fatal Adverse Event|1|||
131692113|NCT01192022|474158224|FG000|Overall Study|Physician withdrew-patient hardship|1|||
131692114|NCT01192022|474158225|FG001|Overall Study|Physician withdrew-patient hardship|0|||
131692115|NCT01192022|474158226|FG002|Overall Study|Physician withdrew-patient hardship|0|||
131692116|NCT01192022|474158227|FG003|Overall Study|Physician withdrew-patient hardship|0|||
131692117|NCT01192022|474158228|FG004|Overall Study|Physician withdrew-patient hardship|0|||
131692118|NCT01192022|474158224|FG000|Overall Study|Patient too sick from chemotherapy|0|||
131692119|NCT01192022|474158225|FG001|Overall Study|Patient too sick from chemotherapy|1|||
131692120|NCT01192022|474158226|FG002|Overall Study|Patient too sick from chemotherapy|0|||
131692121|NCT01192022|474158227|FG003|Overall Study|Patient too sick from chemotherapy|0|||
131692122|NCT01192022|474158228|FG004|Overall Study|Patient too sick from chemotherapy|0|||
131692123|NCT01192022|474158224|FG000|Overall Study|Patient needed surgery|0|||
131692124|NCT01192022|474158225|FG001|Overall Study|Patient needed surgery|1|||
131692125|NCT01192022|474158226|FG002|Overall Study|Patient needed surgery|0|||
131692126|NCT01192022|474158227|FG003|Overall Study|Patient needed surgery|0|||
131692127|NCT01192022|474158228|FG004|Overall Study|Patient needed surgery|0|||
131692128|NCT01192022|474158224|FG000|Overall Study|Parents did not allow all follow up|0|||
131692129|NCT01192022|474158225|FG001|Overall Study|Parents did not allow all follow up|0|||
131692130|NCT01192022|474158226|FG002|Overall Study|Parents did not allow all follow up|0|||
131692131|NCT01192022|474158227|FG003|Overall Study|Parents did not allow all follow up|1|||
131692132|NCT01192022|474158228|FG004|Overall Study|Parents did not allow all follow up|0|||
131692133|NCT00129766|474158230|FG000|Overall Study|Death|3|||
131692134|NCT00129766|474158231|FG001|Overall Study|Death|8|||
131692135|NCT00129766|474158230|FG000|Overall Study|Withdrawal of consent|31|||
131692136|NCT00129766|474158231|FG001|Overall Study|Withdrawal of consent|30|||
131692137|NCT00129766|474158230|FG000|Overall Study|Lost to Follow-up|26|||
131692138|NCT00129766|474158231|FG001|Overall Study|Lost to Follow-up|21|||
131692139|NCT02095535|474158233|FG000|Recruitment|Protocol Violation|2|||
131692140|NCT00623480|474158234|FG000|Overall Study|Lost to Follow-up|0|||
131692141|NCT00623480|474158235|FG001|Overall Study|Lost to Follow-up|1|||
131692142|NCT00623480|474158234|FG000|Overall Study|Withdrawal by Subject|2|||
131692143|NCT00623480|474158235|FG001|Overall Study|Withdrawal by Subject|4|||
131692144|NCT00623480|474158234|FG000|Overall Study|Lack of Efficacy|1|||
131692145|NCT00623480|474158235|FG001|Overall Study|Lack of Efficacy|0|||
131692146|NCT00623480|474158234|FG000|Overall Study|Non-compliant with study medication|4|||
131692147|NCT00623480|474158235|FG001|Overall Study|Non-compliant with study medication|0|||
131692148|NCT00623480|474158234|FG000|Overall Study|Protocol Violation|0|||
131692149|NCT00623480|474158235|FG001|Overall Study|Protocol Violation|1|||
131692150|NCT00623480|474158234|FG000|Overall Study|Site closed by sponsor|0|||
131692151|NCT00623480|474158235|FG001|Overall Study|Site closed by sponsor|1|||
131692152|NCT00781456|474158236|FG000|Overall Study|Adverse Event|3|||
131692153|NCT00781456|474158237|FG001|Overall Study|Adverse Event|3|||
131692154|NCT00781456|474158236|FG000|Overall Study|Withdrawal by Subject|3|||
131692155|NCT00781456|474158237|FG001|Overall Study|Withdrawal by Subject|5|||
131692156|NCT00781456|474158236|FG000|Overall Study|Protocol Violation|4|||
131692157|NCT00781456|474158237|FG001|Overall Study|Protocol Violation|1|||
131692158|NCT00781456|474158236|FG000|Overall Study|Noncompliance With Protocol|1|||
131692159|NCT00781456|474158237|FG001|Overall Study|Noncompliance With Protocol|1|||
131692160|NCT00781456|474158236|FG000|Overall Study|Lost to Follow-up|10|||
131692161|NCT00781456|474158237|FG001|Overall Study|Lost to Follow-up|5|||
131777712|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
131777713|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
131777714|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
131777715|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
131777716|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
131777717|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
131777718|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
131777719|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
131777720|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
131777721|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
131777722|NCT01299272|474467458|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
131777723|NCT01299272|474467459|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
131777724|NCT01299272|474467460|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
131777725|NCT01299272|474467461|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
131777726|NCT00464308|474467462|FG000|Overall Study|Adverse Event|22|||
131777727|NCT00464308|474467463|FG001|Overall Study|Adverse Event|27|||
131777728|NCT00464308|474467464|FG002|Overall Study|Adverse Event|16|||
131777729|NCT00464308|474467462|FG000|Overall Study|Lost to Follow-up|29|||
131777730|NCT00464308|474467463|FG001|Overall Study|Lost to Follow-up|19|||
131777731|NCT00464308|474467464|FG002|Overall Study|Lost to Follow-up|20|||
131777732|NCT00464308|474467462|FG000|Overall Study|Patient discontinued and other reasons|17|||
131777733|NCT00464308|474467463|FG001|Overall Study|Patient discontinued and other reasons|17|||
131777734|NCT00464308|474467464|FG002|Overall Study|Patient discontinued and other reasons|23|||
131777735|NCT00464308|474467462|FG000|Overall Study|Physician Decision|1|||
131777736|NCT00464308|474467463|FG001|Overall Study|Physician Decision|0|||
131777737|NCT00464308|474467464|FG002|Overall Study|Physician Decision|0|||
131777738|NCT01513759|474467465|FG000|Overall Study|Protocol Violation|4|||
131777739|NCT01513759|474467465|FG000|Overall Study|Death during catheter placement|1|||
131777740|NCT03606109|474467466|FG000|Overall Study|Lost to Follow-up|2|||
131777741|NCT03606109|474467467|FG001|Overall Study|Lost to Follow-up|1|||
131777742|NCT00630994|474467468|FG000|Overall Study|Adverse Event|1|||
131777743|NCT00630994|474467468|FG000|Overall Study|Disease Progression|1|||
131777744|NCT00630994|474467468|FG000|Overall Study|Lack of Efficacy|1|||
131777745|NCT00630994|474467468|FG000|Overall Study|Other|1|||
131692162|NCT00781456|474158236|FG000|Overall Study|Other Reason, Unknown|0|||
131692163|NCT00781456|474158237|FG001|Overall Study|Other Reason, Unknown|1|||
131692164|NCT03709654|474158238|FG000|Overall Study|Lost to Follow-up|1|||
131692165|NCT03709654|474158239|FG001|Overall Study|Lost to Follow-up|1|||
131692166|NCT03709654|474158238|FG000|Overall Study|Withdrawal by Subject|1|||
131692167|NCT03709654|474158239|FG001|Overall Study|Withdrawal by Subject|1|||
131692168|NCT03709654|474158238|FG000|Overall Study|Adverse Event|1|||
131692169|NCT03709654|474158239|FG001|Overall Study|Adverse Event|0|||
131692170|NCT01902966|474158240|FG000|Overall Study|Death|1|||
131692171|NCT01902966|474158240|FG000|Overall Study|Physician Decision|1|||
131692172|NCT01902966|474158240|FG000|Overall Study|Withdrawal by Subject|1|||
131692173|NCT02631200|474158241|FG000|First Period|Death|1|||
131692174|NCT02631200|474158242|FG001|First Period|Death|2|||
131692175|NCT02631200|474158241|FG000|First Period|Patient ill-health|2|||
131692176|NCT02631200|474158242|FG001|First Period|Patient ill-health|4|||
131692177|NCT02631200|474158241|FG000|First Period|Withdrawal by Subject|4|||
131692178|NCT02631200|474158242|FG001|First Period|Withdrawal by Subject|1|||
131692179|NCT02631200|474158241|FG000|Deferred Period|Death|0|||
131692180|NCT02631200|474158242|FG001|Deferred Period|Death|1|||
131692181|NCT02631200|474158241|FG000|Deferred Period|Received kidney transplant|0|||
131692182|NCT02631200|474158242|FG001|Deferred Period|Received kidney transplant|1|||
131692183|NCT02631200|474158241|FG000|Deferred Period|Withdrawal by Subject|0|||
131692184|NCT02631200|474158242|FG001|Deferred Period|Withdrawal by Subject|2|||
131692185|NCT02631200|474158241|FG000|Deferred Period|Lost to Follow-up|0|||
131692186|NCT02631200|474158242|FG001|Deferred Period|Lost to Follow-up|1|||
131692187|NCT04091087|474158244|FG000|Overall Study|Not treated|1|||
131692188|NCT04091087|474158245|FG001|Overall Study|Not treated|0|||
131692189|NCT04091087|474158244|FG000|Overall Study|Adverse Event|4|||
131692190|NCT04091087|474158245|FG001|Overall Study|Adverse Event|4|||
131692191|NCT04091087|474158244|FG000|Overall Study|Protocol Violation|0|||
131692192|NCT04091087|474158245|FG001|Overall Study|Protocol Violation|1|||
131692193|NCT04091087|474158244|FG000|Overall Study|Withdrawal by Subject|5|||
131692194|NCT04091087|474158245|FG001|Overall Study|Withdrawal by Subject|2|||
131692195|NCT04152161|474158246|FG000|Overall Study|Death|0|||
131692196|NCT04152161|474158247|FG001|Overall Study|Death|1|||
131692197|NCT04152161|474158246|FG000|Overall Study|Physician Decision|0|||
131692198|NCT04152161|474158247|FG001|Overall Study|Physician Decision|1|||
131692199|NCT04152161|474158246|FG000|Overall Study|Lost to Follow-up|9|||
131692200|NCT04152161|474158247|FG001|Overall Study|Lost to Follow-up|3|||
131692201|NCT04152161|474158246|FG000|Overall Study|Protocol Violation|1|||
131692202|NCT04152161|474158247|FG001|Overall Study|Protocol Violation|0|||
131436786|NCT02079740|473225616|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
131436787|NCT02079740|473225617|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
131436788|NCT02079740|473225605|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
131692203|NCT04152161|474158246|FG000|Overall Study|Withdrawal by Subject|29|||
131692204|NCT04152161|474158247|FG001|Overall Study|Withdrawal by Subject|28|||
131692205|NCT04152161|474158246|FG000|Overall Study|Sponsor termination of study|750|||
131692206|NCT04152161|474158247|FG001|Overall Study|Sponsor termination of study|755|||
131692207|NCT04152161|474158246|FG000|Overall Study|Other|20|||
131692208|NCT04152161|474158247|FG001|Overall Study|Other|18|||
131692209|NCT03246958|474158248|FG000|Overall Study|Withdrawal by Subject|0|||
131692210|NCT03246958|474158249|FG001|Overall Study|Withdrawal by Subject|1|||
131692211|NCT03246958|474158250|FG002|Overall Study|Withdrawal by Subject|0|||
131692212|NCT03246958|474158251|FG003|Overall Study|Withdrawal by Subject|0|||
131692213|NCT03246958|474158252|FG004|Overall Study|Withdrawal by Subject|0|||
131692214|NCT03246958|474158253|FG005|Overall Study|Withdrawal by Subject|1|||
131692215|NCT03246958|474158254|FG006|Overall Study|Withdrawal by Subject|0|||
131692216|NCT03246958|474158248|FG000|Overall Study|Progression|13|||
131692217|NCT03246958|474158249|FG001|Overall Study|Progression|9|||
131692218|NCT03246958|474158250|FG002|Overall Study|Progression|3|||
131692219|NCT03246958|474158251|FG003|Overall Study|Progression|2|||
131692220|NCT03246958|474158252|FG004|Overall Study|Progression|1|||
131692221|NCT03246958|474158253|FG005|Overall Study|Progression|2|||
131692222|NCT03246958|474158254|FG006|Overall Study|Progression|1|||
131692223|NCT03246958|474158248|FG000|Overall Study|Adverse Event|2|||
131692224|NCT03246958|474158249|FG001|Overall Study|Adverse Event|2|||
131692225|NCT03246958|474158250|FG002|Overall Study|Adverse Event|0|||
131692226|NCT03246958|474158251|FG003|Overall Study|Adverse Event|1|||
131692227|NCT03246958|474158252|FG004|Overall Study|Adverse Event|1|||
131692228|NCT03246958|474158253|FG005|Overall Study|Adverse Event|0|||
131692229|NCT03246958|474158254|FG006|Overall Study|Adverse Event|2|||
131692230|NCT03246958|474158248|FG000|Overall Study|Death|0|||
131692231|NCT03246958|474158249|FG001|Overall Study|Death|1|||
131692232|NCT03246958|474158250|FG002|Overall Study|Death|0|||
131692233|NCT03246958|474158251|FG003|Overall Study|Death|0|||
131692234|NCT03246958|474158252|FG004|Overall Study|Death|0|||
131692235|NCT03246958|474158253|FG005|Overall Study|Death|0|||
131692236|NCT03246958|474158254|FG006|Overall Study|Death|0|||
131692237|NCT03246958|474158248|FG000|Overall Study|Physician Decision|0|||
131692238|NCT03246958|474158249|FG001|Overall Study|Physician Decision|0|||
131692239|NCT03246958|474158250|FG002|Overall Study|Physician Decision|0|||
131692240|NCT03246958|474158251|FG003|Overall Study|Physician Decision|1|||
131692241|NCT03246958|474158252|FG004|Overall Study|Physician Decision|0|||
131692242|NCT03246958|474158253|FG005|Overall Study|Physician Decision|0|||
131692243|NCT03246958|474158254|FG006|Overall Study|Physician Decision|0|||
131692244|NCT03246958|474158248|FG000|Overall Study|Never start treatment|1|||
131692245|NCT03246958|474158249|FG001|Overall Study|Never start treatment|0|||
131692246|NCT03246958|474158250|FG002|Overall Study|Never start treatment|0|||
131692247|NCT03246958|474158251|FG003|Overall Study|Never start treatment|0|||
131692248|NCT03246958|474158252|FG004|Overall Study|Never start treatment|0|||
131692249|NCT03246958|474158253|FG005|Overall Study|Never start treatment|0|||
131692250|NCT03246958|474158254|FG006|Overall Study|Never start treatment|0|||
131692251|NCT03246958|474158248|FG000|Overall Study|Over enrollment|0|||
131692252|NCT03246958|474158249|FG001|Overall Study|Over enrollment|2|||
131692253|NCT03246958|474158250|FG002|Overall Study|Over enrollment|0|||
131692254|NCT03246958|474158251|FG003|Overall Study|Over enrollment|0|||
131692255|NCT03246958|474158252|FG004|Overall Study|Over enrollment|0|||
131777746|NCT03669640|474467469|FG000|Overall Study|Study Terminated by Sponsor|0|||
131777747|NCT03669640|474467470|FG001|Overall Study|Study Terminated by Sponsor|0|||
131777748|NCT03669640|474467471|FG002|Overall Study|Study Terminated by Sponsor|0|||
131692256|NCT03246958|474158253|FG005|Overall Study|Over enrollment|0|||
131692257|NCT03246958|474158254|FG006|Overall Study|Over enrollment|0|||
131692258|NCT03703102|474158257|FG000|Overall Study|Adverse Event|4|||
131692259|NCT03703102|474158258|FG001|Overall Study|Adverse Event|3|||
131557179|NCT00152971|473664437|FG001|Treatment|Other|11|||
131557180|NCT00152971|473664438|FG002|Treatment|Other|10|||
131557181|NCT03125941|473664445|FG000|Overall Study|did not receive intervention|1|||
131557182|NCT03125941|473664446|FG001|Overall Study|did not receive intervention|2|||
131557183|NCT03853317|473664447|FG000|Overall Study|Progressive Disease|5|||
131557184|NCT03853317|473664447|FG000|Overall Study|Adverse Event|1|||
131557185|NCT03853317|473664447|FG000|Overall Study|Death|1|||
131557186|NCT03853317|473664447|FG000|Overall Study|other event|2|||
131557187|NCT00779584|473664448|FG000|Overall Study|Protocol Violation|0|||
131557188|NCT00779584|473664449|FG001|Overall Study|Protocol Violation|0|||
131557189|NCT00779584|473664450|FG002|Overall Study|Protocol Violation|0|||
131557190|NCT00779584|473664451|FG003|Overall Study|Protocol Violation|0|||
131557191|NCT00779584|473664452|FG004|Overall Study|Protocol Violation|0|||
131557192|NCT00779584|473664453|FG005|Overall Study|Protocol Violation|1|||
131557193|NCT00779584|473664454|FG006|Overall Study|Protocol Violation|0|||
131557194|NCT00779584|473664455|FG007|Overall Study|Protocol Violation|0|||
131557195|NCT00779584|473664456|FG008|Overall Study|Protocol Violation|0|||
131557196|NCT00779584|473664448|FG000|Overall Study|Withdrawal by Subject|1|||
131557197|NCT00779584|473664449|FG001|Overall Study|Withdrawal by Subject|1|||
131777749|NCT03669640|474467472|FG003|Overall Study|Study Terminated by Sponsor|0|||
131777750|NCT03669640|474467473|FG004|Overall Study|Study Terminated by Sponsor|1|||
131777751|NCT03669640|474467474|FG005|Overall Study|Study Terminated by Sponsor|0|||
131777752|NCT03669640|474467469|FG000|Overall Study|Lost to Follow-up|0|||
131777753|NCT03669640|474467470|FG001|Overall Study|Lost to Follow-up|0|||
131777754|NCT03669640|474467471|FG002|Overall Study|Lost to Follow-up|2|||
131777755|NCT03669640|474467472|FG003|Overall Study|Lost to Follow-up|0|||
131777756|NCT03669640|474467473|FG004|Overall Study|Lost to Follow-up|0|||
131777757|NCT03669640|474467474|FG005|Overall Study|Lost to Follow-up|0|||
131777758|NCT03669640|474467469|FG000|Overall Study|Death|0|||
131777759|NCT03669640|474467470|FG001|Overall Study|Death|0|||
131777760|NCT03669640|474467471|FG002|Overall Study|Death|1|||
131777761|NCT03669640|474467472|FG003|Overall Study|Death|0|||
131777762|NCT03669640|474467473|FG004|Overall Study|Death|0|||
131777763|NCT03669640|474467474|FG005|Overall Study|Death|0|||
131777764|NCT03669640|474467469|FG000|Overall Study|Withdrawal by Subject|1|||
131777765|NCT03669640|474467470|FG001|Overall Study|Withdrawal by Subject|2|||
131777766|NCT03669640|474467471|FG002|Overall Study|Withdrawal by Subject|1|||
131777767|NCT03669640|474467472|FG003|Overall Study|Withdrawal by Subject|0|||
131777768|NCT03669640|474467473|FG004|Overall Study|Withdrawal by Subject|1|||
131777769|NCT03669640|474467474|FG005|Overall Study|Withdrawal by Subject|3|||
131777770|NCT03669640|474467469|FG000|Overall Study|Protocol Violation|1|||
131777771|NCT03669640|474467470|FG001|Overall Study|Protocol Violation|0|||
131777772|NCT03669640|474467471|FG002|Overall Study|Protocol Violation|0|||
131777773|NCT03669640|474467472|FG003|Overall Study|Protocol Violation|0|||
131777774|NCT03669640|474467473|FG004|Overall Study|Protocol Violation|0|||
131777775|NCT03669640|474467474|FG005|Overall Study|Protocol Violation|0|||
131777776|NCT03669640|474467469|FG000|Overall Study|Physician Decision|0|||
131777777|NCT03669640|474467470|FG001|Overall Study|Physician Decision|2|||
131777778|NCT03669640|474467471|FG002|Overall Study|Physician Decision|0|||
131777779|NCT03669640|474467472|FG003|Overall Study|Physician Decision|0|||
131777780|NCT03669640|474467473|FG004|Overall Study|Physician Decision|0|||
131777781|NCT03669640|474467474|FG005|Overall Study|Physician Decision|0|||
131777782|NCT03669640|474467469|FG000|Overall Study|Disease Relapse|1|||
131777783|NCT03669640|474467470|FG001|Overall Study|Disease Relapse|0|||
131777784|NCT03669640|474467471|FG002|Overall Study|Disease Relapse|0|||
131777785|NCT03669640|474467472|FG003|Overall Study|Disease Relapse|0|||
131777786|NCT03669640|474467473|FG004|Overall Study|Disease Relapse|0|||
131777787|NCT03669640|474467474|FG005|Overall Study|Disease Relapse|0|||
131777788|NCT03669640|474467469|FG000|Overall Study|Adverse Event|2|||
131777789|NCT03669640|474467470|FG001|Overall Study|Adverse Event|1|||
131777790|NCT03669640|474467471|FG002|Overall Study|Adverse Event|0|||
131777791|NCT03669640|474467472|FG003|Overall Study|Adverse Event|0|||
131777792|NCT03669640|474467473|FG004|Overall Study|Adverse Event|1|||
131777793|NCT03669640|474467474|FG005|Overall Study|Adverse Event|0|||
131777794|NCT03533608|474467475|FG000|Overall Study|Withdrawal by Subject|3|||
131557198|NCT00779584|473664450|FG002|Overall Study|Withdrawal by Subject|2|||
131777795|NCT03533608|474467475|FG000|Overall Study|Physician Decision|2|||
131777796|NCT03286426|474467476|FG000|Overall Study|Physician Decision|3|||
131777797|NCT03514121|474467477|FG000|Overall Study|Withdrawal by Subject|0|||
131777798|NCT03514121|474467478|FG001|Overall Study|Withdrawal by Subject|0|||
131777799|NCT03514121|474467479|FG002|Overall Study|Withdrawal by Subject|0|||
131777800|NCT03514121|474467480|FG003|Overall Study|Withdrawal by Subject|0|||
131777801|NCT03514121|474467481|FG004|Overall Study|Withdrawal by Subject|1|||
131777802|NCT03514121|474467482|FG005|Overall Study|Withdrawal by Subject|2|||
131777803|NCT03514121|474467483|FG006|Overall Study|Withdrawal by Subject|1|||
131557199|NCT00779584|473664451|FG003|Overall Study|Withdrawal by Subject|0|||
131557200|NCT00779584|473664452|FG004|Overall Study|Withdrawal by Subject|0|||
131557201|NCT00779584|473664453|FG005|Overall Study|Withdrawal by Subject|2|||
131557202|NCT00779584|473664454|FG006|Overall Study|Withdrawal by Subject|1|||
131777804|NCT03514121|474467484|FG007|Overall Study|Withdrawal by Subject|1|||
131557203|NCT00779584|473664455|FG007|Overall Study|Withdrawal by Subject|0|||
131557204|NCT00779584|473664456|FG008|Overall Study|Withdrawal by Subject|0|||
131557205|NCT00779584|473664448|FG000|Overall Study|Lost to Follow-up|0|||
131692260|NCT03703102|474158259|FG002|Overall Study|Adverse Event|7|||
131692261|NCT03703102|474158260|FG003|Overall Study|Adverse Event|3|||
131692262|NCT03703102|474158261|FG004|Overall Study|Adverse Event|13|||
131692263|NCT03703102|474158257|FG000|Overall Study|Lack of Efficacy|4|||
131692264|NCT03703102|474158258|FG001|Overall Study|Lack of Efficacy|0|||
131692265|NCT03703102|474158259|FG002|Overall Study|Lack of Efficacy|1|||
131692266|NCT03703102|474158260|FG003|Overall Study|Lack of Efficacy|4|||
131692267|NCT03703102|474158261|FG004|Overall Study|Lack of Efficacy|1|||
131692268|NCT03703102|474158257|FG000|Overall Study|Lost to Follow-up|0|||
131692269|NCT03703102|474158258|FG001|Overall Study|Lost to Follow-up|0|||
131692270|NCT03703102|474158259|FG002|Overall Study|Lost to Follow-up|1|||
131692271|NCT03703102|474158260|FG003|Overall Study|Lost to Follow-up|2|||
131692272|NCT03703102|474158261|FG004|Overall Study|Lost to Follow-up|2|||
131692273|NCT03703102|474158257|FG000|Overall Study|Physician Decision|2|||
131692274|NCT03703102|474158258|FG001|Overall Study|Physician Decision|2|||
131692275|NCT03703102|474158259|FG002|Overall Study|Physician Decision|2|||
131692276|NCT03703102|474158260|FG003|Overall Study|Physician Decision|2|||
131692277|NCT03703102|474158261|FG004|Overall Study|Physician Decision|4|||
131692278|NCT03703102|474158257|FG000|Overall Study|Withdrawal by Subject|7|||
131692279|NCT03703102|474158258|FG001|Overall Study|Withdrawal by Subject|5|||
131692280|NCT03703102|474158259|FG002|Overall Study|Withdrawal by Subject|5|||
131692281|NCT03703102|474158260|FG003|Overall Study|Withdrawal by Subject|5|||
131692282|NCT03703102|474158261|FG004|Overall Study|Withdrawal by Subject|9|||
131692283|NCT03703102|474158257|FG000|Overall Study|Ineligibility|0|||
131692284|NCT03703102|474158258|FG001|Overall Study|Ineligibility|0|||
131692285|NCT03703102|474158259|FG002|Overall Study|Ineligibility|1|||
131692286|NCT03703102|474158260|FG003|Overall Study|Ineligibility|0|||
131692287|NCT03703102|474158261|FG004|Overall Study|Ineligibility|0|||
131692288|NCT03703102|474158257|FG000|Overall Study|Protocol Deviation|4|||
131692289|NCT03703102|474158258|FG001|Overall Study|Protocol Deviation|4|||
131692290|NCT03703102|474158259|FG002|Overall Study|Protocol Deviation|3|||
131692291|NCT03703102|474158260|FG003|Overall Study|Protocol Deviation|0|||
131692292|NCT03703102|474158261|FG004|Overall Study|Protocol Deviation|0|||
131692293|NCT03703102|474158257|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131692294|NCT03703102|474158258|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131692295|NCT03703102|474158259|FG002|Overall Study|Non-Compliance with Study Drug|2|||
131692296|NCT03703102|474158260|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131692297|NCT03703102|474158261|FG004|Overall Study|Non-Compliance with Study Drug|4|||
131692298|NCT00876187|474158262|FG000|Overall Study|Adverse Event|14|||
131692299|NCT00876187|474158263|FG001|Overall Study|Adverse Event|12|||
131692300|NCT00876187|474158264|FG002|Overall Study|Adverse Event|19|||
131692301|NCT00876187|474158265|FG003|Overall Study|Adverse Event|29|||
131692302|NCT00876187|474158266|FG004|Overall Study|Adverse Event|10|||
131692303|NCT00876187|474158262|FG000|Overall Study|Lack of Efficacy|59|||
131692304|NCT00876187|474158263|FG001|Overall Study|Lack of Efficacy|34|||
131692305|NCT00876187|474158264|FG002|Overall Study|Lack of Efficacy|45|||
131692306|NCT00876187|474158265|FG003|Overall Study|Lack of Efficacy|34|||
131692307|NCT00876187|474158266|FG004|Overall Study|Lack of Efficacy|59|||
131692308|NCT00876187|474158262|FG000|Overall Study|Lost to Follow-up|9|||
131692309|NCT00876187|474158263|FG001|Overall Study|Lost to Follow-up|10|||
131692310|NCT00876187|474158264|FG002|Overall Study|Lost to Follow-up|8|||
131692311|NCT00876187|474158265|FG003|Overall Study|Lost to Follow-up|8|||
131692312|NCT00876187|474158266|FG004|Overall Study|Lost to Follow-up|11|||
131692313|NCT00876187|474158262|FG000|Overall Study|Protocol Violation|6|||
131692314|NCT00876187|474158263|FG001|Overall Study|Protocol Violation|7|||
131692315|NCT00876187|474158264|FG002|Overall Study|Protocol Violation|7|||
131692316|NCT00876187|474158265|FG003|Overall Study|Protocol Violation|6|||
131692317|NCT00876187|474158266|FG004|Overall Study|Protocol Violation|3|||
131692318|NCT00876187|474158262|FG000|Overall Study|Withdrawal by Subject|16|||
131692319|NCT00876187|474158263|FG001|Overall Study|Withdrawal by Subject|26|||
131692320|NCT00876187|474158264|FG002|Overall Study|Withdrawal by Subject|32|||
131692321|NCT00876187|474158265|FG003|Overall Study|Withdrawal by Subject|38|||
131692322|NCT00876187|474158266|FG004|Overall Study|Withdrawal by Subject|37|||
131692323|NCT00876187|474158262|FG000|Overall Study|Entered extension study|101|||
131692324|NCT00876187|474158263|FG001|Overall Study|Entered extension study|120|||
131692325|NCT00876187|474158264|FG002|Overall Study|Entered extension study|156|||
131692326|NCT00876187|474158265|FG003|Overall Study|Entered extension study|151|||
131692327|NCT00876187|474158266|FG004|Overall Study|Entered extension study|144|||
131692328|NCT00876187|474158262|FG000|Overall Study|Randomized but not treated|3|||
131692329|NCT00876187|474158263|FG001|Overall Study|Randomized but not treated|1|||
131692330|NCT00876187|474158264|FG002|Overall Study|Randomized but not treated|3|||
131692331|NCT00876187|474158265|FG003|Overall Study|Randomized but not treated|2|||
131692332|NCT00876187|474158266|FG004|Overall Study|Randomized but not treated|3|||
131692333|NCT00876187|474158262|FG000|Overall Study|Other|2|||
131692334|NCT00876187|474158263|FG001|Overall Study|Other|5|||
131692335|NCT00876187|474158264|FG002|Overall Study|Other|9|||
131692336|NCT00876187|474158265|FG003|Overall Study|Other|7|||
131692337|NCT00876187|474158266|FG004|Overall Study|Other|4|||
131692338|NCT01379274|474158267|FG000|Overall Study|funding withdrawn|1|||
131692339|NCT00405067|474158268|FG000|Overall Study|Adverse Event|4|||
131692340|NCT00405067|474158269|FG001|Overall Study|Adverse Event|9|||
131692341|NCT00405067|474158270|FG002|Overall Study|Adverse Event|4|||
131692342|NCT00405067|474158268|FG000|Overall Study|Lost to Follow-up|0|||
131692343|NCT00405067|474158269|FG001|Overall Study|Lost to Follow-up|0|||
131692344|NCT00405067|474158270|FG002|Overall Study|Lost to Follow-up|1|||
131692345|NCT01650636|474158271|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
131692346|NCT01650636|474158272|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
131692347|NCT01650636|474158271|FG000|Washout up to 5 Months|Physician Decision|2|||
131692348|NCT01650636|474158272|FG001|Washout up to 5 Months|Physician Decision|2|||
131692349|NCT01650636|474158271|FG000|Washout up to 5 Months|Death|1|||
131692350|NCT01650636|474158272|FG001|Washout up to 5 Months|Death|0|||
131692351|NCT01650636|474158271|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
131692352|NCT01650636|474158272|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
131692353|NCT01650636|474158271|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
131692354|NCT01650636|474158272|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
131692355|NCT01650636|474158271|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
131692356|NCT01650636|474158272|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
131692357|NCT03287219|474158274|FG000|Overall Study|Protocol Violation|0|||
131692358|NCT03287219|474158275|FG001|Overall Study|Protocol Violation|2|||
131692359|NCT03221751|474158276|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
131692360|NCT03221751|474158277|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
131898545|NCT02797678|474914126|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
131692361|NCT00440947|474158278|FG000|36-Week Induction Phase|Adverse Event|16|||
131692362|NCT00440947|474158279|FG001|36-Week Induction Phase|Adverse Event|0|||
131692363|NCT00440947|474158280|FG002|36-Week Induction Phase|Adverse Event|0|||
131777805|NCT03514121|474467485|FG008|Overall Study|Withdrawal by Subject|7|||
131777806|NCT03514121|474467486|FG009|Overall Study|Withdrawal by Subject|2|||
131777807|NCT03514121|474467477|FG000|Overall Study|Death|0|||
131777808|NCT03514121|474467478|FG001|Overall Study|Death|0|||
131777809|NCT03514121|474467479|FG002|Overall Study|Death|0|||
131777810|NCT03514121|474467480|FG003|Overall Study|Death|0|||
131777811|NCT03514121|474467481|FG004|Overall Study|Death|0|||
131777812|NCT03514121|474467482|FG005|Overall Study|Death|3|||
131777813|NCT03514121|474467483|FG006|Overall Study|Death|2|||
131777814|NCT03514121|474467484|FG007|Overall Study|Death|1|||
131777815|NCT03514121|474467485|FG008|Overall Study|Death|26|||
131777816|NCT03514121|474467486|FG009|Overall Study|Death|3|||
131777817|NCT03514121|474467477|FG000|Overall Study|Lost to Follow-up|0|||
131777818|NCT03514121|474467478|FG001|Overall Study|Lost to Follow-up|0|||
131777819|NCT03514121|474467479|FG002|Overall Study|Lost to Follow-up|1|||
131777820|NCT03514121|474467480|FG003|Overall Study|Lost to Follow-up|0|||
131777821|NCT03514121|474467481|FG004|Overall Study|Lost to Follow-up|0|||
131777822|NCT03514121|474467482|FG005|Overall Study|Lost to Follow-up|0|||
131777823|NCT03514121|474467483|FG006|Overall Study|Lost to Follow-up|0|||
131777824|NCT03514121|474467484|FG007|Overall Study|Lost to Follow-up|0|||
131777825|NCT03514121|474467485|FG008|Overall Study|Lost to Follow-up|1|||
131777826|NCT03514121|474467486|FG009|Overall Study|Lost to Follow-up|0|||
131777827|NCT03514121|474467477|FG000|Overall Study|Adverse Event|0|||
131777828|NCT03514121|474467478|FG001|Overall Study|Adverse Event|0|||
131777829|NCT03514121|474467479|FG002|Overall Study|Adverse Event|0|||
131777830|NCT03514121|474467480|FG003|Overall Study|Adverse Event|0|||
131777831|NCT03514121|474467481|FG004|Overall Study|Adverse Event|0|||
131777832|NCT03514121|474467482|FG005|Overall Study|Adverse Event|0|||
131777833|NCT03514121|474467483|FG006|Overall Study|Adverse Event|1|||
131777834|NCT03514121|474467484|FG007|Overall Study|Adverse Event|0|||
131777835|NCT03514121|474467485|FG008|Overall Study|Adverse Event|0|||
131777836|NCT03514121|474467486|FG009|Overall Study|Adverse Event|0|||
131777837|NCT03514121|474467477|FG000|Overall Study|Other|0|||
131777838|NCT03514121|474467478|FG001|Overall Study|Other|1|||
131777839|NCT03514121|474467479|FG002|Overall Study|Other|1|||
131777840|NCT03514121|474467480|FG003|Overall Study|Other|0|||
131777841|NCT03514121|474467481|FG004|Overall Study|Other|1|||
131777842|NCT03514121|474467482|FG005|Overall Study|Other|2|||
131777843|NCT03514121|474467483|FG006|Overall Study|Other|3|||
131777844|NCT03514121|474467484|FG007|Overall Study|Other|2|||
131777845|NCT03514121|474467485|FG008|Overall Study|Other|7|||
131777846|NCT03514121|474467486|FG009|Overall Study|Other|3|||
131777847|NCT03514121|474467477|FG000|Overall Study|Study termination by Sponsor|0|||
131777848|NCT03514121|474467478|FG001|Overall Study|Study termination by Sponsor|0|||
131777849|NCT03514121|474467479|FG002|Overall Study|Study termination by Sponsor|0|||
131777850|NCT03514121|474467480|FG003|Overall Study|Study termination by Sponsor|0|||
131777851|NCT03514121|474467481|FG004|Overall Study|Study termination by Sponsor|0|||
131777852|NCT03514121|474467482|FG005|Overall Study|Study termination by Sponsor|0|||
131777853|NCT03514121|474467483|FG006|Overall Study|Study termination by Sponsor|0|||
131557206|NCT00779584|473664449|FG001|Overall Study|Lost to Follow-up|0|||
131777854|NCT03514121|474467484|FG007|Overall Study|Study termination by Sponsor|0|||
131777855|NCT03514121|474467485|FG008|Overall Study|Study termination by Sponsor|11|||
131777856|NCT03514121|474467486|FG009|Overall Study|Study termination by Sponsor|3|||
131557207|NCT00779584|473664450|FG002|Overall Study|Lost to Follow-up|0|||
131557208|NCT00779584|473664451|FG003|Overall Study|Lost to Follow-up|0|||
131557209|NCT00779584|473664452|FG004|Overall Study|Lost to Follow-up|1|||
131557210|NCT00779584|473664453|FG005|Overall Study|Lost to Follow-up|0|||
131557211|NCT00779584|473664454|FG006|Overall Study|Lost to Follow-up|0|||
131557212|NCT00779584|473664455|FG007|Overall Study|Lost to Follow-up|0|||
131557213|NCT00779584|473664456|FG008|Overall Study|Lost to Follow-up|0|||
131557214|NCT00779584|473664448|FG000|Overall Study|Progression of Disease|0|||
131557215|NCT00779584|473664449|FG001|Overall Study|Progression of Disease|1|||
131557216|NCT00779584|473664450|FG002|Overall Study|Progression of Disease|2|||
131557217|NCT00779584|473664451|FG003|Overall Study|Progression of Disease|6|||
131557218|NCT00779584|473664452|FG004|Overall Study|Progression of Disease|5|||
131557219|NCT00779584|473664453|FG005|Overall Study|Progression of Disease|1|||
131557220|NCT00779584|473664454|FG006|Overall Study|Progression of Disease|4|||
131557221|NCT00779584|473664455|FG007|Overall Study|Progression of Disease|2|||
131557222|NCT00779584|473664456|FG008|Overall Study|Progression of Disease|1|||
131557223|NCT00779584|473664448|FG000|Overall Study|Adverse Event|1|||
131557224|NCT00779584|473664449|FG001|Overall Study|Adverse Event|0|||
131557225|NCT00779584|473664450|FG002|Overall Study|Adverse Event|2|||
131557226|NCT00779584|473664451|FG003|Overall Study|Adverse Event|0|||
131557227|NCT00779584|473664452|FG004|Overall Study|Adverse Event|0|||
131557228|NCT00779584|473664453|FG005|Overall Study|Adverse Event|0|||
131557229|NCT00779584|473664454|FG006|Overall Study|Adverse Event|2|||
131557230|NCT00779584|473664455|FG007|Overall Study|Adverse Event|1|||
131557231|NCT00779584|473664456|FG008|Overall Study|Adverse Event|1|||
131557232|NCT00779584|473664448|FG000|Overall Study|Symptomatic Deterioration|1|||
131557233|NCT00779584|473664449|FG001|Overall Study|Symptomatic Deterioration|1|||
131557234|NCT00779584|473664450|FG002|Overall Study|Symptomatic Deterioration|1|||
131557235|NCT00779584|473664451|FG003|Overall Study|Symptomatic Deterioration|0|||
131557236|NCT00779584|473664452|FG004|Overall Study|Symptomatic Deterioration|0|||
131557237|NCT00779584|473664453|FG005|Overall Study|Symptomatic Deterioration|1|||
131557238|NCT00779584|473664454|FG006|Overall Study|Symptomatic Deterioration|1|||
131557239|NCT00779584|473664455|FG007|Overall Study|Symptomatic Deterioration|0|||
131557240|NCT00779584|473664456|FG008|Overall Study|Symptomatic Deterioration|0|||
131557241|NCT00779584|473664448|FG000|Overall Study|Ongoing in Study|0|||
131557242|NCT00779584|473664449|FG001|Overall Study|Ongoing in Study|0|||
131557243|NCT00779584|473664450|FG002|Overall Study|Ongoing in Study|0|||
131557244|NCT00779584|473664451|FG003|Overall Study|Ongoing in Study|0|||
131557245|NCT00779584|473664452|FG004|Overall Study|Ongoing in Study|1|||
131557246|NCT00779584|473664453|FG005|Overall Study|Ongoing in Study|1|||
131557247|NCT00779584|473664454|FG006|Overall Study|Ongoing in Study|0|||
131557248|NCT00779584|473664455|FG007|Overall Study|Ongoing in Study|0|||
131557249|NCT00779584|473664456|FG008|Overall Study|Ongoing in Study|0|||
131557250|NCT00406419|473664459|FG000|Overall Study|Death|3|||
131692364|NCT00440947|474158281|FG003|36-Week Induction Phase|Adverse Event|0|||
131692365|NCT00440947|474158282|FG004|36-Week Induction Phase|Adverse Event|0|||
131436789|NCT02079740|473225606|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
131557251|NCT00406419|473664460|FG001|Overall Study|Death|1|||
131557252|NCT00406419|473664461|FG002|Overall Study|Death|4|||
131557253|NCT00406419|473664459|FG000|Overall Study|Protocol Violation|6|||
131557254|NCT00406419|473664460|FG001|Overall Study|Protocol Violation|2|||
131557255|NCT00406419|473664461|FG002|Overall Study|Protocol Violation|5|||
131557256|NCT00406419|473664459|FG000|Overall Study|Study Terminated by Sponsor|260|||
131557257|NCT00406419|473664460|FG001|Overall Study|Study Terminated by Sponsor|288|||
131557258|NCT00406419|473664461|FG002|Overall Study|Study Terminated by Sponsor|282|||
131692366|NCT00440947|474158278|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
131557259|NCT00406419|473664459|FG000|Overall Study|Withdrawal by Subject|17|||
131557260|NCT00406419|473664460|FG001|Overall Study|Withdrawal by Subject|24|||
131557261|NCT00406419|473664461|FG002|Overall Study|Withdrawal by Subject|26|||
131557262|NCT00406419|473664459|FG000|Overall Study|Lack of Efficacy|12|||
131557263|NCT00406419|473664460|FG001|Overall Study|Lack of Efficacy|1|||
131557264|NCT00406419|473664461|FG002|Overall Study|Lack of Efficacy|6|||
131557265|NCT00406419|473664459|FG000|Overall Study|Non-Compliance with Study Drug|5|||
131557266|NCT00406419|473664460|FG001|Overall Study|Non-Compliance with Study Drug|6|||
131557267|NCT00406419|473664461|FG002|Overall Study|Non-Compliance with Study Drug|3|||
131557268|NCT00406419|473664459|FG000|Overall Study|Adverse Event|10|||
131557269|NCT00406419|473664460|FG001|Overall Study|Adverse Event|12|||
131557270|NCT00406419|473664461|FG002|Overall Study|Adverse Event|16|||
131557271|NCT00406419|473664459|FG000|Overall Study|Lost to Follow-up|11|||
131557272|NCT00406419|473664460|FG001|Overall Study|Lost to Follow-up|10|||
131557273|NCT00406419|473664461|FG002|Overall Study|Lost to Follow-up|5|||
131557274|NCT02878213|473664462|FG000|Overall Study|Withdrawal by Subject|2|||
131557275|NCT02878213|473664462|FG000|Overall Study|Adverse Event|1|||
131557276|NCT05490329|473664465|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
131557277|NCT05490329|473664466|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
131557278|NCT05490329|473664465|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
131557279|NCT05490329|473664466|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
131557280|NCT05490329|473664465|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
131557281|NCT05490329|473664466|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
131557282|NCT02638623|473664468|FG000|Overall Study|Surgery timing|5|||
131557283|NCT02638623|473664469|FG001|Overall Study|Surgery timing|6|||
131557284|NCT02638623|473664468|FG000|Overall Study|Not given intervention|2|||
131557285|NCT02638623|473664469|FG001|Overall Study|Not given intervention|0|||
131557286|NCT04152343|473664470|FG000|Overall Study|Transplanted|5|||
131557287|NCT04152343|473664470|FG000|Overall Study|Death|20|||
131557288|NCT04152343|473664470|FG000|Overall Study|Lost to Follow-up|3|||
131557289|NCT02090634|473664475|FG000|Overall Study|Lost to Follow-up|0|||
131557290|NCT02090634|473664476|FG001|Overall Study|Lost to Follow-up|1|||
131557291|NCT02090634|473664475|FG000|Overall Study|Death|0|||
131557292|NCT02090634|473664476|FG001|Overall Study|Death|1|||
131557293|NCT02090634|473664475|FG000|Overall Study|Protocol Violation|3|||
131557294|NCT02090634|473664476|FG001|Overall Study|Protocol Violation|1|||
131557295|NCT02090634|473664475|FG000|Overall Study|Adverse Event|2|||
131557296|NCT02090634|473664476|FG001|Overall Study|Adverse Event|0|||
131557297|NCT01164228|473664477|FG000|Overall Study|Progression|24|||
131557298|NCT01164228|473664478|FG001|Overall Study|Progression|25|||
131557299|NCT01164228|473664477|FG000|Overall Study|Adverse Event|13|||
131557300|NCT01164228|473664478|FG001|Overall Study|Adverse Event|7|||
131557301|NCT01164228|473664477|FG000|Overall Study|Death|1|||
131557302|NCT01164228|473664478|FG001|Overall Study|Death|1|||
131557303|NCT01164228|473664477|FG000|Overall Study|Withdrawal by Subject|2|||
131557304|NCT01164228|473664478|FG001|Overall Study|Withdrawal by Subject|0|||
131557305|NCT01164228|473664477|FG000|Overall Study|Physician Decision|1|||
131557306|NCT01164228|473664478|FG001|Overall Study|Physician Decision|2|||
131557307|NCT01164228|473664477|FG000|Overall Study|Symptomatic deterioration|1|||
131557308|NCT01164228|473664478|FG001|Overall Study|Symptomatic deterioration|0|||
131557309|NCT01164228|473664477|FG000|Overall Study|Never started treatment|1|||
131557310|NCT01164228|473664478|FG001|Overall Study|Never started treatment|3|||
131692367|NCT00440947|474158279|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131692368|NCT00440947|474158280|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131692369|NCT00440947|474158281|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131692370|NCT00440947|474158282|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131692371|NCT00440947|474158278|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
131692372|NCT00440947|474158279|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131692373|NCT00440947|474158280|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131692374|NCT00440947|474158281|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131692375|NCT00440947|474158282|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131692376|NCT00440947|474158278|FG000|36-Week Induction Phase|Non-compliance|10|||
131692377|NCT00440947|474158279|FG001|36-Week Induction Phase|Non-compliance|0|||
131692378|NCT00440947|474158280|FG002|36-Week Induction Phase|Non-compliance|0|||
131692379|NCT00440947|474158281|FG003|36-Week Induction Phase|Non-compliance|0|||
131692380|NCT00440947|474158282|FG004|36-Week Induction Phase|Non-compliance|0|||
131692381|NCT00440947|474158278|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
131692382|NCT00440947|474158279|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
131692383|NCT00440947|474158280|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
131692384|NCT00440947|474158281|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
131692385|NCT00440947|474158282|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
131692386|NCT00440947|474158278|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
131692387|NCT00440947|474158279|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
131692388|NCT00440947|474158280|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
131692389|NCT00440947|474158281|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
131692390|NCT00440947|474158282|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
131436790|NCT02079740|473225607|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
131692391|NCT00440947|474158278|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
131692392|NCT00440947|474158279|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131557311|NCT01164228|473664477|FG000|Overall Study|Ineligible|1|||
131557312|NCT01164228|473664478|FG001|Overall Study|Ineligible|0|||
131557313|NCT01965938|473664479|FG000|Overall Study|Withdrawal by Subject|1|||
131557314|NCT01965938|473664480|FG001|Overall Study|Withdrawal by Subject|0|||
131557315|NCT03757234|473664481|FG000|Overall Study|Adverse Event|0|||
131557316|NCT03757234|473664482|FG001|Overall Study|Adverse Event|0|||
131557317|NCT03757234|473664483|FG002|Overall Study|Adverse Event|0|||
131557318|NCT03757234|473664484|FG003|Overall Study|Adverse Event|0|||
131692393|NCT00440947|474158280|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131692394|NCT00440947|474158281|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131692395|NCT00440947|474158282|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131692396|NCT00440947|474158278|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
131692397|NCT00440947|474158279|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
131692398|NCT00440947|474158280|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
131692399|NCT00440947|474158281|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
131692400|NCT00440947|474158282|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
131692401|NCT00440947|474158278|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
131692402|NCT00440947|474158279|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131692403|NCT00440947|474158280|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131692404|NCT00440947|474158281|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131692405|NCT00440947|474158282|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131692406|NCT00440947|474158278|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
131692407|NCT00440947|474158279|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131692408|NCT00440947|474158280|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131692409|NCT00440947|474158281|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131692410|NCT00440947|474158282|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131692411|NCT00440947|474158278|FG000|36-Week Induction Phase|Incarceration|3|||
131692412|NCT00440947|474158279|FG001|36-Week Induction Phase|Incarceration|0|||
131692413|NCT00440947|474158280|FG002|36-Week Induction Phase|Incarceration|0|||
131692414|NCT00440947|474158281|FG003|36-Week Induction Phase|Incarceration|0|||
131692415|NCT00440947|474158282|FG004|36-Week Induction Phase|Incarceration|0|||
131692416|NCT00440947|474158278|FG000|36-Week Induction Phase|Pregnancy|1|||
131692417|NCT00440947|474158279|FG001|36-Week Induction Phase|Pregnancy|0|||
131692418|NCT00440947|474158280|FG002|36-Week Induction Phase|Pregnancy|0|||
131692419|NCT00440947|474158281|FG003|36-Week Induction Phase|Pregnancy|0|||
131692420|NCT00440947|474158282|FG004|36-Week Induction Phase|Pregnancy|0|||
131692421|NCT00440947|474158278|FG000|48-Week Randomization Phase|Adverse Event|0|||
131692422|NCT00440947|474158279|FG001|48-Week Randomization Phase|Adverse Event|2|||
131692423|NCT00440947|474158280|FG002|48-Week Randomization Phase|Adverse Event|5|||
131692424|NCT00440947|474158281|FG003|48-Week Randomization Phase|Adverse Event|0|||
131692425|NCT00440947|474158282|FG004|48-Week Randomization Phase|Adverse Event|0|||
131692426|NCT00440947|474158278|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
131692427|NCT00440947|474158279|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
131692428|NCT00440947|474158280|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
131692429|NCT00440947|474158281|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
131692430|NCT00440947|474158282|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
131692431|NCT00440947|474158278|FG000|48-Week Randomization Phase|Non-compliance|0|||
131692432|NCT00440947|474158279|FG001|48-Week Randomization Phase|Non-compliance|3|||
131692433|NCT00440947|474158280|FG002|48-Week Randomization Phase|Non-compliance|4|||
131692434|NCT00440947|474158281|FG003|48-Week Randomization Phase|Non-compliance|0|||
131692435|NCT00440947|474158282|FG004|48-Week Randomization Phase|Non-compliance|0|||
131692436|NCT00440947|474158278|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
131692437|NCT00440947|474158279|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
131692438|NCT00440947|474158280|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
131692439|NCT00440947|474158281|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
131692440|NCT00440947|474158282|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
131692441|NCT00440947|474158278|FG000|48-Week Randomization Phase|Protocol Violation|0|||
131692442|NCT00440947|474158279|FG001|48-Week Randomization Phase|Protocol Violation|0|||
131557319|NCT03757234|473664485|FG004|Overall Study|Adverse Event|1|||
131557320|NCT03757234|473664481|FG000|Overall Study|Lost to Follow-up|1|||
131557321|NCT03757234|473664482|FG001|Overall Study|Lost to Follow-up|0|||
131557322|NCT03757234|473664483|FG002|Overall Study|Lost to Follow-up|0|||
131557323|NCT03757234|473664484|FG003|Overall Study|Lost to Follow-up|0|||
131557324|NCT03757234|473664485|FG004|Overall Study|Lost to Follow-up|1|||
131557325|NCT03757234|473664481|FG000|Overall Study|Withdrawal by Subject|1|||
131692443|NCT00440947|474158280|FG002|48-Week Randomization Phase|Protocol Violation|1|||
131692444|NCT00440947|474158281|FG003|48-Week Randomization Phase|Protocol Violation|0|||
131692445|NCT00440947|474158282|FG004|48-Week Randomization Phase|Protocol Violation|0|||
131692446|NCT00440947|474158278|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
131692447|NCT00440947|474158279|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
131692448|NCT00440947|474158280|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
131692449|NCT00440947|474158281|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
131692450|NCT00440947|474158282|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
131692451|NCT00440947|474158278|FG000|48-Week Randomization Phase|Pregnancy|0|||
131692452|NCT00440947|474158279|FG001|48-Week Randomization Phase|Pregnancy|0|||
131692453|NCT00440947|474158280|FG002|48-Week Randomization Phase|Pregnancy|1|||
131692454|NCT00440947|474158281|FG003|48-Week Randomization Phase|Pregnancy|0|||
131692455|NCT00440947|474158282|FG004|48-Week Randomization Phase|Pregnancy|0|||
131692456|NCT00440947|474158278|FG000|48-Week Randomization Phase|Incarceration|0|||
131692457|NCT00440947|474158279|FG001|48-Week Randomization Phase|Incarceration|3|||
131692458|NCT00440947|474158280|FG002|48-Week Randomization Phase|Incarceration|0|||
131692459|NCT00440947|474158281|FG003|48-Week Randomization Phase|Incarceration|0|||
131692460|NCT00440947|474158282|FG004|48-Week Randomization Phase|Incarceration|0|||
131692461|NCT00440947|474158278|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131692462|NCT00440947|474158279|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
131692463|NCT00440947|474158280|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131692464|NCT00440947|474158281|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131692465|NCT00440947|474158282|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131692466|NCT00440947|474158278|FG000|48-Week Randomization Phase|Physician Decision|0|||
131692467|NCT00440947|474158279|FG001|48-Week Randomization Phase|Physician Decision|2|||
131692468|NCT00440947|474158280|FG002|48-Week Randomization Phase|Physician Decision|0|||
131692469|NCT00440947|474158281|FG003|48-Week Randomization Phase|Physician Decision|0|||
131692470|NCT00440947|474158282|FG004|48-Week Randomization Phase|Physician Decision|0|||
131692471|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
131692472|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
131692473|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
131692474|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
131692475|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
131692476|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
131692477|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
131692478|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
131692479|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
131692480|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
131692481|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
131692482|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
131692483|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
131692484|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
131692485|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
131692486|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
131692487|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
131692488|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
131692489|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
131692490|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
131692491|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
131692492|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
131692493|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
131692494|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
131692495|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
131692496|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
131692497|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
131692498|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
131692499|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
131692500|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
131692501|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
131692502|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
131692503|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
131692504|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
131557326|NCT03757234|473664482|FG001|Overall Study|Withdrawal by Subject|1|||
131557327|NCT03757234|473664483|FG002|Overall Study|Withdrawal by Subject|0|||
131557328|NCT03757234|473664484|FG003|Overall Study|Withdrawal by Subject|1|||
131557329|NCT03757234|473664485|FG004|Overall Study|Withdrawal by Subject|2|||
131557330|NCT03757234|473664481|FG000|Overall Study|Other|1|||
131557331|NCT03757234|473664482|FG001|Overall Study|Other|1|||
131557332|NCT03757234|473664483|FG002|Overall Study|Other|0|||
131557333|NCT03757234|473664484|FG003|Overall Study|Other|0|||
131557334|NCT03757234|473664485|FG004|Overall Study|Other|0|||
131557335|NCT00917267|473666011|FG000|Overall Study|Adverse Event|15|||
131557336|NCT00917267|473666012|FG001|Overall Study|Adverse Event|36|||
131557337|NCT00917267|473666011|FG000|Overall Study|Physician Decision|2|||
131557338|NCT00917267|473666012|FG001|Overall Study|Physician Decision|4|||
131557339|NCT00917267|473666011|FG000|Overall Study|Protocol Violation|9|||
131557340|NCT00917267|473666012|FG001|Overall Study|Protocol Violation|18|||
131557341|NCT00917267|473666011|FG000|Overall Study|Withdrawal by Subject|5|||
131557342|NCT00917267|473666012|FG001|Overall Study|Withdrawal by Subject|12|||
131557343|NCT00917267|473666011|FG000|Overall Study|Lost to follow up|0|||
131557344|NCT00917267|473666012|FG001|Overall Study|Lost to follow up|2|||
131557345|NCT00917267|473666011|FG000|Overall Study|Entry Criteria Not Met|1|||
131557346|NCT00917267|473666012|FG001|Overall Study|Entry Criteria Not Met|0|||
131557347|NCT00917267|473666011|FG000|Overall Study|Sponsor Decision|5|||
131557348|NCT00917267|473666012|FG001|Overall Study|Sponsor Decision|5|||
131557349|NCT00917267|473666011|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
131557350|NCT00917267|473666012|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
131557351|NCT00289770|473666016|FG000|Year 15|Withdrawal by Subject|1|||
131557352|NCT05340751|473666022|FG000|Overall Study|Physician Decision|3|||
131557353|NCT04399551|473666023|FG000|Overall Study|Adverse Event|15|||
131557354|NCT04399551|473666023|FG000|Overall Study|Withdrawal by Subject|6|||
131557355|NCT04399551|473666023|FG000|Overall Study|Physician Decision|3|||
131557356|NCT04399551|473666023|FG000|Overall Study|Lost to Follow-up|2|||
131557357|NCT04399551|473666023|FG000|Overall Study|Protocol Deviation|2|||
131557358|NCT01014975|473666024|FG000|Overall Study|Withdrawal by Subject|1|||
131557359|NCT01014975|473666025|FG001|Overall Study|Withdrawal by Subject|0|||
131557360|NCT01014975|473666026|FG002|Overall Study|Withdrawal by Subject|1|||
131557361|NCT01014975|473666024|FG000|Overall Study|Death|3|||
131557362|NCT01014975|473666025|FG001|Overall Study|Death|3|||
131557363|NCT01014975|473666026|FG002|Overall Study|Death|4|||
131557364|NCT01014975|473666024|FG000|Overall Study|Lost to Follow-up|0|||
131692505|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
131692506|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
131692507|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
131692508|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
131692509|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
131692510|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
131692511|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
131557365|NCT01014975|473666025|FG001|Overall Study|Lost to Follow-up|0|||
131557366|NCT01014975|473666026|FG002|Overall Study|Lost to Follow-up|1|||
131557367|NCT01336634|473666029|FG000|Overall Study|Study closed/terminated|5|||
131557368|NCT01336634|473666030|FG001|Overall Study|Study closed/terminated|6|||
131557369|NCT01336634|473666031|FG002|Overall Study|Study closed/terminated|6|||
131557370|NCT01336634|473666029|FG000|Overall Study|Lost to Follow-up|2|||
131557371|NCT01336634|473666030|FG001|Overall Study|Lost to Follow-up|1|||
131777857|NCT03514121|474467477|FG000|Overall Study|Investigator decision|0|||
131777858|NCT03514121|474467478|FG001|Overall Study|Investigator decision|0|||
131777859|NCT03514121|474467479|FG002|Overall Study|Investigator decision|0|||
131777860|NCT03514121|474467480|FG003|Overall Study|Investigator decision|0|||
131777861|NCT03514121|474467481|FG004|Overall Study|Investigator decision|0|||
131777862|NCT03514121|474467482|FG005|Overall Study|Investigator decision|0|||
131777863|NCT03514121|474467483|FG006|Overall Study|Investigator decision|0|||
131777864|NCT03514121|474467484|FG007|Overall Study|Investigator decision|0|||
131777865|NCT03514121|474467485|FG008|Overall Study|Investigator decision|1|||
131777866|NCT03514121|474467486|FG009|Overall Study|Investigator decision|0|||
131777867|NCT05553600|474467487|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
131777868|NCT05553600|474467488|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
131777869|NCT05553600|474467489|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
131777870|NCT05553600|474467490|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
131777871|NCT05553600|474467487|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
131777872|NCT05553600|474467488|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
131777873|NCT05553600|474467489|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
131777874|NCT05553600|474467490|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
131777875|NCT05553600|474467487|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
131777876|NCT05553600|474467488|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
131777877|NCT05553600|474467489|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
131777878|NCT05553600|474467490|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
131557372|NCT01336634|473666031|FG002|Overall Study|Lost to Follow-up|1|||
131557373|NCT01336634|473666029|FG000|Overall Study|Physician Decision|1|||
131557374|NCT01336634|473666030|FG001|Overall Study|Physician Decision|1|||
131557375|NCT01336634|473666031|FG002|Overall Study|Physician Decision|0|||
131557376|NCT01336634|473666029|FG000|Overall Study|Withdrawal by Subject|6|||
131557377|NCT01336634|473666030|FG001|Overall Study|Withdrawal by Subject|0|||
131557378|NCT01336634|473666031|FG002|Overall Study|Withdrawal by Subject|2|||
131557379|NCT02961881|473666032|FG000|Overall Study|Adverse Event|1|||
131557380|NCT02961881|473666033|FG001|Overall Study|Adverse Event|2|||
131557381|NCT02961881|473666034|FG002|Overall Study|Adverse Event|2|||
131557382|NCT02961881|473666035|FG003|Overall Study|Adverse Event|0|||
131557383|NCT02961881|473666036|FG004|Overall Study|Adverse Event|1|||
131557384|NCT02961881|473666032|FG000|Overall Study|Participant request|0|||
131557385|NCT02961881|473666033|FG001|Overall Study|Participant request|2|||
131557386|NCT02961881|473666034|FG002|Overall Study|Participant request|0|||
131557387|NCT02961881|473666035|FG003|Overall Study|Participant request|0|||
131557388|NCT02961881|473666036|FG004|Overall Study|Participant request|0|||
131557389|NCT02961881|473666032|FG000|Overall Study|Disease progression|1|||
131557390|NCT02961881|473666033|FG001|Overall Study|Disease progression|0|||
131557391|NCT02961881|473666034|FG002|Overall Study|Disease progression|1|||
131557392|NCT02961881|473666035|FG003|Overall Study|Disease progression|0|||
131557393|NCT02961881|473666036|FG004|Overall Study|Disease progression|0|||
131557394|NCT01863043|473666038|FG000|Overall Study|Death|6|||
131557395|NCT01863043|473666039|FG001|Overall Study|Death|1|||
131557396|NCT01863043|473666038|FG000|Overall Study|Withdrawal by Subject|0|||
131557397|NCT01863043|473666039|FG001|Overall Study|Withdrawal by Subject|2|||
131557398|NCT01863043|473666038|FG000|Overall Study|Adverse Event|7|||
131557399|NCT01863043|473666039|FG001|Overall Study|Adverse Event|8|||
131557400|NCT01863043|473666038|FG000|Overall Study|exclusion criteria found after enrollment|0|||
131557401|NCT01863043|473666039|FG001|Overall Study|exclusion criteria found after enrollment|1|||
131557402|NCT00313911|473666040|FG000|Overall Study|Serious adverse event|6|||
131557403|NCT00313911|473666041|FG001|Overall Study|Serious adverse event|1|||
131557404|NCT00313911|473666040|FG000|Overall Study|Adverse Event|2|||
131557405|NCT00313911|473666041|FG001|Overall Study|Adverse Event|3|||
131557406|NCT00313911|473666040|FG000|Overall Study|Protocol Violation|19|||
131557407|NCT00313911|473666041|FG001|Overall Study|Protocol Violation|10|||
131557408|NCT00313911|473666040|FG000|Overall Study|Lost to Follow-up|27|||
131557409|NCT00313911|473666041|FG001|Overall Study|Lost to Follow-up|14|||
131557410|NCT00313911|473666040|FG000|Overall Study|Withdrawal by Subject|39|||
131557411|NCT00313911|473666041|FG001|Overall Study|Withdrawal by Subject|12|||
131557412|NCT00313911|473666040|FG000|Overall Study|Did not meet age criteria|1|||
131557413|NCT00313911|473666041|FG001|Overall Study|Did not meet age criteria|1|||
131557414|NCT01912781|473666044|FG000|Overall Study|Withdrawal by Subject|2|||
131557415|NCT01912781|473666045|FG001|Overall Study|Withdrawal by Subject|0|||
131557416|NCT00854295|473666048|FG000|Overall Study|Death|7|||
131557417|NCT00854295|473666049|FG001|Overall Study|Death|0|||
131557418|NCT00854295|473666050|FG002|Overall Study|Death|1|||
131557419|NCT00854295|473666051|FG003|Overall Study|Death|1|||
131557420|NCT00854295|473666048|FG000|Overall Study|Adverse Event|6|||
131557421|NCT00854295|473666049|FG001|Overall Study|Adverse Event|1|||
131557422|NCT00854295|473666050|FG002|Overall Study|Adverse Event|1|||
131557423|NCT00854295|473666051|FG003|Overall Study|Adverse Event|3|||
131557424|NCT00854295|473666048|FG000|Overall Study|Lost to Follow-up|18|||
131557425|NCT00854295|473666049|FG001|Overall Study|Lost to Follow-up|5|||
131557426|NCT00854295|473666050|FG002|Overall Study|Lost to Follow-up|21|||
131557427|NCT00854295|473666051|FG003|Overall Study|Lost to Follow-up|21|||
131557428|NCT00854295|473666048|FG000|Overall Study|Physician Decision|10|||
131777879|NCT05553600|474467487|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
131777880|NCT05553600|474467488|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
131557429|NCT00854295|473666049|FG001|Overall Study|Physician Decision|0|||
131557430|NCT00854295|473666050|FG002|Overall Study|Physician Decision|0|||
131557431|NCT00854295|473666051|FG003|Overall Study|Physician Decision|0|||
131777881|NCT05553600|474467489|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
131557432|NCT04250337|473666052|FG000|Overall Study|Adverse Event|0|||
131557433|NCT04250337|473666053|FG001|Overall Study|Adverse Event|3|||
131557434|NCT04250337|473666052|FG000|Overall Study|Lack of Efficacy|1|||
131557435|NCT04250337|473666053|FG001|Overall Study|Lack of Efficacy|3|||
131557436|NCT04250337|473666052|FG000|Overall Study|Physician Decision|1|||
131557437|NCT04250337|473666053|FG001|Overall Study|Physician Decision|0|||
131557438|NCT04250337|473666052|FG000|Overall Study|Protocol Deviation|2|||
131557439|NCT04250337|473666053|FG001|Overall Study|Protocol Deviation|2|||
131557440|NCT04250337|473666052|FG000|Overall Study|Withdrawal by Subject|4|||
131777882|NCT05553600|474467490|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
131777883|NCT05553600|474467487|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
131557441|NCT04250337|473666053|FG001|Overall Study|Withdrawal by Subject|3|||
131557442|NCT05033743|473666059|FG000|Overall Study|Lost to Follow-up|1|||
131557443|NCT05033743|473666059|FG000|Overall Study|Protocol Violation|2|||
131557444|NCT05033743|473666059|FG000|Overall Study|Withdrawal by Subject|1|||
131557445|NCT04537897|473666060|FG000|Overall Study|Other than listed|0|||
131557446|NCT04537897|473666061|FG001|Overall Study|Other than listed|0|||
131557447|NCT04537897|473666062|FG002|Overall Study|Other than listed|0|||
131557448|NCT04537897|473666063|FG003|Overall Study|Other than listed|0|||
131557449|NCT04537897|473666064|FG004|Overall Study|Other than listed|0|||
131557450|NCT04537897|473666065|FG005|Overall Study|Other than listed|0|||
131557451|NCT04537897|473666066|FG006|Overall Study|Other than listed|1|||
131557452|NCT04537897|473666067|FG007|Overall Study|Other than listed|0|||
131557453|NCT04537897|473666068|FG008|Overall Study|Other than listed|0|||
131557454|NCT04537897|473666060|FG000|Overall Study|Adverse Event|0|||
131557455|NCT04537897|473666061|FG001|Overall Study|Adverse Event|0|||
131557456|NCT04537897|473666062|FG002|Overall Study|Adverse Event|0|||
131557457|NCT04537897|473666063|FG003|Overall Study|Adverse Event|1|||
131557458|NCT04537897|473666064|FG004|Overall Study|Adverse Event|0|||
131557459|NCT04537897|473666065|FG005|Overall Study|Adverse Event|0|||
131557460|NCT04537897|473666066|FG006|Overall Study|Adverse Event|0|||
131557461|NCT04537897|473666067|FG007|Overall Study|Adverse Event|0|||
131557462|NCT04537897|473666068|FG008|Overall Study|Adverse Event|0|||
131557463|NCT04537897|473666060|FG000|Overall Study|Withdrawal by Subject|0|||
131557464|NCT04537897|473666061|FG001|Overall Study|Withdrawal by Subject|1|||
131557465|NCT04537897|473666062|FG002|Overall Study|Withdrawal by Subject|0|||
131557466|NCT04537897|473666063|FG003|Overall Study|Withdrawal by Subject|0|||
131557467|NCT04537897|473666064|FG004|Overall Study|Withdrawal by Subject|0|||
131557468|NCT04537897|473666065|FG005|Overall Study|Withdrawal by Subject|0|||
131557469|NCT04537897|473666066|FG006|Overall Study|Withdrawal by Subject|0|||
131557470|NCT04537897|473666067|FG007|Overall Study|Withdrawal by Subject|0|||
131557471|NCT04537897|473666068|FG008|Overall Study|Withdrawal by Subject|0|||
131557472|NCT00197028|473666072|FG000|Overall Study|Adverse Event|2|||
131557473|NCT00197028|473666073|FG001|Overall Study|Adverse Event|2|||
131557474|NCT00197028|473666072|FG000|Overall Study|Protocol Violation|2|||
131557475|NCT00197028|473666073|FG001|Overall Study|Protocol Violation|1|||
131557476|NCT00197028|473666072|FG000|Overall Study|Withdrawal by Subject|8|||
131557477|NCT00197028|473666073|FG001|Overall Study|Withdrawal by Subject|12|||
131557478|NCT00197028|473666072|FG000|Overall Study|Lost to Follow-up|1|||
131557479|NCT00197028|473666073|FG001|Overall Study|Lost to Follow-up|0|||
131557480|NCT00197028|473666072|FG000|Overall Study|Other|3|||
131557481|NCT00197028|473666073|FG001|Overall Study|Other|6|||
131557482|NCT01923389|473666085|FG000|Overall Study|Protocol Violation|1|||
131557483|NCT01923389|473666086|FG001|Overall Study|Protocol Violation|0|||
131557484|NCT03292146|473666092|FG000|Baseline to 12 Months|Relocation|1|||
131557485|NCT03292146|473666093|FG001|Baseline to 12 Months|Relocation|0|||
131557486|NCT03292146|473666092|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
131557487|NCT03292146|473666093|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
131557488|NCT03292146|473666092|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
131557489|NCT03292146|473666093|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
131557490|NCT03292146|473666092|FG000|12 Months to 24 Months|Planning pregnancy|2|||
131557491|NCT03292146|473666093|FG001|12 Months to 24 Months|Planning pregnancy|2|||
131557492|NCT03292146|473666092|FG000|12 Months to 24 Months|Personal reasons|1|||
131557493|NCT03292146|473666093|FG001|12 Months to 24 Months|Personal reasons|0|||
131557494|NCT03292146|473666092|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
131557495|NCT03292146|473666093|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
131557496|NCT00545363|473666096|FG000|Overall Study|Adverse Event|6|||
131557497|NCT00545363|473666097|FG001|Overall Study|Adverse Event|7|||
131557498|NCT00545363|473666096|FG000|Overall Study|Withdrawal by Subject|6|||
131557499|NCT00545363|473666097|FG001|Overall Study|Withdrawal by Subject|5|||
131557500|NCT00545363|473666096|FG000|Overall Study|Non-compliance|3|||
131777884|NCT05553600|474467488|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
131777885|NCT05553600|474467489|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
131777886|NCT05553600|474467490|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
131777887|NCT05553600|474467487|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
131777888|NCT05553600|474467488|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
131557501|NCT00545363|473666097|FG001|Overall Study|Non-compliance|1|||
131557502|NCT00545363|473666096|FG000|Overall Study|Did not meet entry criteria|1|||
131557503|NCT00545363|473666097|FG001|Overall Study|Did not meet entry criteria|1|||
131557504|NCT00545363|473666096|FG000|Overall Study|Lost to Follow-up|2|||
131557505|NCT00545363|473666097|FG001|Overall Study|Lost to Follow-up|0|||
131557506|NCT00545363|473666096|FG000|Overall Study|Other|1|||
131557507|NCT00545363|473666097|FG001|Overall Study|Other|1|||
131557508|NCT00366301|473666098|FG000|Overall Study|Lost to Follow-up|4|||
131557509|NCT00366301|473666099|FG001|Overall Study|Lost to Follow-up|4|||
131557510|NCT00366301|473666100|FG002|Overall Study|Lost to Follow-up|3|||
131557511|NCT00366301|473666101|FG003|Overall Study|Lost to Follow-up|7|||
131557512|NCT00366301|473666098|FG000|Overall Study|Withdrawal by Subject|4|||
131557513|NCT00366301|473666099|FG001|Overall Study|Withdrawal by Subject|2|||
131557514|NCT00366301|473666100|FG002|Overall Study|Withdrawal by Subject|1|||
131557515|NCT00366301|473666101|FG003|Overall Study|Withdrawal by Subject|1|||
131557516|NCT01348776|473666106|FG000|Overall Study|Lost to Follow-up|3|||
131557517|NCT01372605|473666107|FG000|Overall Study|Death|1|||
131557518|NCT01372605|473666108|FG001|Overall Study|Death|2|||
131557519|NCT01372605|473666107|FG000|Overall Study|Lost to Follow-up|2|||
131557520|NCT01372605|473666108|FG001|Overall Study|Lost to Follow-up|1|||
131557521|NCT01372605|473666107|FG000|Overall Study|Withdrawal by Subject|4|||
131557522|NCT01372605|473666108|FG001|Overall Study|Withdrawal by Subject|7|||
131557523|NCT01372605|473666107|FG000|Overall Study|Moved|3|||
131557524|NCT01372605|473666108|FG001|Overall Study|Moved|0|||
131557525|NCT01372605|473666107|FG000|Overall Study|Changed medical home|2|||
131557526|NCT01372605|473666108|FG001|Overall Study|Changed medical home|0|||
131557527|NCT01463293|473666109|FG000|Overall Study|Lost to Follow-up|1|||
131557528|NCT01463293|473666110|FG001|Overall Study|Lost to Follow-up|4|||
131557529|NCT01463293|473666111|FG002|Overall Study|Lost to Follow-up|5|||
131557530|NCT01463293|473666109|FG000|Overall Study|Adverse Event|1|||
131557531|NCT01463293|473666110|FG001|Overall Study|Adverse Event|2|||
131557532|NCT01463293|473666111|FG002|Overall Study|Adverse Event|0|||
131557533|NCT01463293|473666109|FG000|Overall Study|Withdrawal by Subject|4|||
131557534|NCT01463293|473666110|FG001|Overall Study|Withdrawal by Subject|10|||
131557535|NCT01463293|473666111|FG002|Overall Study|Withdrawal by Subject|5|||
131557536|NCT01463293|473666109|FG000|Overall Study|Other|0|||
131557537|NCT01463293|473666110|FG001|Overall Study|Other|0|||
131557538|NCT01463293|473666111|FG002|Overall Study|Other|2|||
131557539|NCT00951509|473666112|FG000|Overall Study|Withdrawal by Subject|2|||
131557540|NCT00582491|473666113|FG000|Overall Study|Withdrawal by Subject|1|||
131557541|NCT00582491|473666114|FG001|Overall Study|Withdrawal by Subject|0|||
131557542|NCT01775930|473666115|FG000|Overall Study|Futility stopping boundary met|1|||
131557543|NCT02302066|473666116|FG000|Overall Study|Adverse Event|1|||
131557544|NCT02302066|473666117|FG001|Overall Study|Adverse Event|1|||
131557545|NCT02302066|473666118|FG002|Overall Study|Adverse Event|3|||
131557546|NCT02302066|473666119|FG003|Overall Study|Adverse Event|0|||
131557547|NCT02302066|473666116|FG000|Overall Study|Lost to Follow-up|4|||
131557548|NCT02302066|473666117|FG001|Overall Study|Lost to Follow-up|5|||
131557549|NCT02302066|473666118|FG002|Overall Study|Lost to Follow-up|24|||
131557550|NCT02302066|473666119|FG003|Overall Study|Lost to Follow-up|7|||
131557551|NCT02302066|473666116|FG000|Overall Study|Withdrawal by Subject|25|||
131557552|NCT02302066|473666117|FG001|Overall Study|Withdrawal by Subject|58|||
131557553|NCT02302066|473666118|FG002|Overall Study|Withdrawal by Subject|124|||
131557554|NCT02302066|473666119|FG003|Overall Study|Withdrawal by Subject|33|||
131557555|NCT02302066|473666116|FG000|Overall Study|Pregnancy|2|||
131557556|NCT02302066|473666117|FG001|Overall Study|Pregnancy|10|||
131557557|NCT02302066|473666118|FG002|Overall Study|Pregnancy|12|||
131557558|NCT02302066|473666119|FG003|Overall Study|Pregnancy|0|||
131557559|NCT02302066|473666116|FG000|Overall Study|Reason Not Specified|1|||
131557560|NCT02302066|473666117|FG001|Overall Study|Reason Not Specified|1|||
131557561|NCT02302066|473666118|FG002|Overall Study|Reason Not Specified|9|||
131557562|NCT02302066|473666119|FG003|Overall Study|Reason Not Specified|1|||
131557563|NCT01032044|473666120|FG000|Overall Study|Protocol Violation|14|||
131557564|NCT01032044|473666121|FG001|Overall Study|Protocol Violation|8|||
131557565|NCT01032044|473666120|FG000|Overall Study|Adverse Event|0|||
131557566|NCT01032044|473666121|FG001|Overall Study|Adverse Event|1|||
131557567|NCT01032044|473666120|FG000|Overall Study|Lost to Follow-up|11|||
131557568|NCT01032044|473666121|FG001|Overall Study|Lost to Follow-up|11|||
131557569|NCT02875834|473666122|FG000|Open-label Phase|Withdrawal by Subject|3|||
131557570|NCT02875834|473666123|FG001|Open-label Phase|Withdrawal by Subject|0|||
131557571|NCT02875834|473666124|FG002|Open-label Phase|Withdrawal by Subject|0|||
131557572|NCT02875834|473666125|FG003|Open-label Phase|Withdrawal by Subject|0|||
131557573|NCT02875834|473666122|FG000|Open-label Phase|(Not collected)|4|||
131557574|NCT02875834|473666123|FG001|Open-label Phase|(Not collected)|0|||
131557575|NCT02875834|473666124|FG002|Open-label Phase|(Not collected)|0|||
131557576|NCT02875834|473666125|FG003|Open-label Phase|(Not collected)|0|||
131557577|NCT02875834|473666122|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
131557578|NCT02875834|473666123|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
131557579|NCT02875834|473666124|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
131557580|NCT02875834|473666125|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
131557581|NCT02875834|473666122|FG000|Randomized Treatment Phase|Protocol Violation|0|||
131557582|NCT02875834|473666123|FG001|Randomized Treatment Phase|Protocol Violation|2|||
131692512|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
131692513|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
131692514|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
131692515|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
131692516|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
131692517|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
131692518|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
131692519|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
131557583|NCT02875834|473666124|FG002|Randomized Treatment Phase|Protocol Violation|0|||
131557584|NCT02875834|473666125|FG003|Randomized Treatment Phase|Protocol Violation|0|||
131557585|NCT02875834|473666122|FG000|Randomized Treatment Phase|(Not collected)|0|||
131557586|NCT02875834|473666123|FG001|Randomized Treatment Phase|(Not collected)|9|||
131557587|NCT02875834|473666124|FG002|Randomized Treatment Phase|(Not collected)|10|||
131557588|NCT02875834|473666125|FG003|Randomized Treatment Phase|(Not collected)|9|||
131557589|NCT03311230|473666126|FG000|Overall Study|Withdrawal by Subject|1|||
131557590|NCT03311230|473666127|FG001|Overall Study|Withdrawal by Subject|4|||
131557591|NCT03311230|473666128|FG002|Overall Study|Withdrawal by Subject|2|||
131557592|NCT03311230|473666129|FG003|Overall Study|Withdrawal by Subject|7|||
131557593|NCT03311230|473666126|FG000|Overall Study|Unrelated injury|0|||
131557594|NCT03311230|473666127|FG001|Overall Study|Unrelated injury|1|||
131557595|NCT03311230|473666128|FG002|Overall Study|Unrelated injury|0|||
131557596|NCT03311230|473666129|FG003|Overall Study|Unrelated injury|0|||
131557597|NCT03342053|473666130|FG000|Overall Study|Adverse Event|2|||
131557598|NCT03342053|473666131|FG001|Overall Study|Adverse Event|0|||
131557599|NCT03342053|473666130|FG000|Overall Study|Withdrawal by Subject|0|||
131557600|NCT03342053|473666131|FG001|Overall Study|Withdrawal by Subject|1|||
131557601|NCT01302938|473666132|FG000|Overall Study|Withdrawal by Subject|1|||
131557602|NCT01302938|473666133|FG001|Overall Study|Withdrawal by Subject|0|||
131557603|NCT01302938|473666132|FG000|Overall Study|Adverse Event|1|||
131557604|NCT01302938|473666133|FG001|Overall Study|Adverse Event|0|||
131557605|NCT01233609|473666134|FG000|Overall Study|Death|1|||
131557606|NCT01233609|473666135|FG001|Overall Study|Death|0|||
131557607|NCT01233609|473666134|FG000|Overall Study|Lost to Follow-up|3|||
131557608|NCT01233609|473666135|FG001|Overall Study|Lost to Follow-up|1|||
131557609|NCT01233609|473666134|FG000|Overall Study|Adverse Event|2|||
131557610|NCT01233609|473666135|FG001|Overall Study|Adverse Event|1|||
131557611|NCT01233609|473666134|FG000|Overall Study|Withdrawal by Subject|3|||
131557612|NCT01233609|473666135|FG001|Overall Study|Withdrawal by Subject|0|||
131557613|NCT02961374|473666136|FG000|Overall Study|Adverse Event|4|||
131557614|NCT00735644|473666137|FG000|Overall Study|Did not receive study vaccine|0|||
131557615|NCT00735644|473666138|FG001|Overall Study|Did not receive study vaccine|1|||
131557616|NCT00735644|473666139|FG002|Overall Study|Did not receive study vaccine|0|||
131557617|NCT00735644|473666140|FG003|Overall Study|Did not receive study vaccine|0|||
131557618|NCT00735644|473666141|FG004|Overall Study|Did not receive study vaccine|0|||
131557619|NCT00735644|473666137|FG000|Overall Study|Withdrawal by Subject|0|||
131557620|NCT00735644|473666138|FG001|Overall Study|Withdrawal by Subject|1|||
131557621|NCT00735644|473666139|FG002|Overall Study|Withdrawal by Subject|1|||
131557622|NCT00735644|473666140|FG003|Overall Study|Withdrawal by Subject|1|||
131557623|NCT00735644|473666141|FG004|Overall Study|Withdrawal by Subject|0|||
131557624|NCT02041923|473666144|FG000|Overall Study|Lost to Follow-up|26|||
131557625|NCT02041923|473666145|FG001|Overall Study|Lost to Follow-up|30|||
131557626|NCT00309608|473666158|FG000|Overall Study|Adverse Event|1|||
131557627|NCT00309608|473666159|FG001|Overall Study|Adverse Event|5|||
131557628|NCT00309608|473666160|FG002|Overall Study|Adverse Event|3|||
131557629|NCT00309608|473666161|FG003|Overall Study|Adverse Event|2|||
131557630|NCT00309608|473666162|FG004|Overall Study|Adverse Event|3|||
131557631|NCT00309608|473666158|FG000|Overall Study|Protocol Violation|2|||
131557632|NCT00309608|473666159|FG001|Overall Study|Protocol Violation|0|||
131557633|NCT00309608|473666160|FG002|Overall Study|Protocol Violation|0|||
131692520|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
131692521|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
131692522|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
131692523|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
131692524|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
131692525|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
131557634|NCT00309608|473666161|FG003|Overall Study|Protocol Violation|0|||
131557635|NCT00309608|473666162|FG004|Overall Study|Protocol Violation|0|||
131557636|NCT00309608|473666158|FG000|Overall Study|Lost to Follow-up|0|||
131557637|NCT00309608|473666159|FG001|Overall Study|Lost to Follow-up|0|||
131557638|NCT00309608|473666160|FG002|Overall Study|Lost to Follow-up|2|||
131557639|NCT00309608|473666161|FG003|Overall Study|Lost to Follow-up|0|||
131557640|NCT00309608|473666162|FG004|Overall Study|Lost to Follow-up|1|||
131557641|NCT00309608|473666158|FG000|Overall Study|Withdrawal by Subject|1|||
131557642|NCT00309608|473666159|FG001|Overall Study|Withdrawal by Subject|4|||
131557643|NCT00309608|473666160|FG002|Overall Study|Withdrawal by Subject|2|||
131557644|NCT00309608|473666161|FG003|Overall Study|Withdrawal by Subject|0|||
131557645|NCT00309608|473666162|FG004|Overall Study|Withdrawal by Subject|0|||
131692526|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Other|0|||
131692527|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Other|0|||
131557646|NCT00309608|473666158|FG000|Overall Study|Other incl. Lack of efficacy|10|||
131557647|NCT00309608|473666159|FG001|Overall Study|Other incl. Lack of efficacy|4|||
131557648|NCT00309608|473666160|FG002|Overall Study|Other incl. Lack of efficacy|3|||
131557649|NCT00309608|473666161|FG003|Overall Study|Other incl. Lack of efficacy|4|||
131557650|NCT00309608|473666162|FG004|Overall Study|Other incl. Lack of efficacy|0|||
131557651|NCT00621296|473666163|FG000|Overall Study|Adverse Event|2|||
131557652|NCT00621296|473666163|FG000|Overall Study|Lack of Efficacy|1|||
131557653|NCT00621296|473666163|FG000|Overall Study|Physician Decision|7|||
131557654|NCT00621296|473666163|FG000|Overall Study|Unmatch Criteria|1|||
131557655|NCT00621296|473666163|FG000|Overall Study|Stopping Criteria|3|||
131557656|NCT02049710|473666164|FG000|Overall Study|Lost to Follow-up|319|||
131557657|NCT02049710|473666165|FG001|Overall Study|Lost to Follow-up|324|||
131557658|NCT00874432|473666167|FG000|Overall Study|Withdrawal by Subject|1|||
131557659|NCT00874432|473666168|FG001|Overall Study|Withdrawal by Subject|0|||
131557660|NCT00874432|473666169|FG002|Overall Study|Withdrawal by Subject|0|||
131557661|NCT00874432|473666170|FG003|Overall Study|Withdrawal by Subject|0|||
131557662|NCT00874432|473666167|FG000|Overall Study|Physician Decision|1|||
131557663|NCT00874432|473666168|FG001|Overall Study|Physician Decision|0|||
131557664|NCT00874432|473666169|FG002|Overall Study|Physician Decision|0|||
131557665|NCT00874432|473666170|FG003|Overall Study|Physician Decision|0|||
131557666|NCT00874432|473666167|FG000|Overall Study|Other|1|||
131557667|NCT00874432|473666168|FG001|Overall Study|Other|2|||
131557668|NCT00874432|473666169|FG002|Overall Study|Other|8|||
131557669|NCT00874432|473666170|FG003|Overall Study|Other|3|||
131557670|NCT01518946|473666171|FG000|Open-label Phase|Other|4|||
131557671|NCT01518946|473666172|FG001|Open-label Phase|Other|0|||
131557672|NCT01518946|473666173|FG002|Open-label Phase|Other|0|||
131557673|NCT01518946|473666171|FG000|Randomized Phase (First Intervention)|Other|0|||
131557674|NCT01518946|473666172|FG001|Randomized Phase (First Intervention)|Other|1|||
131557675|NCT01518946|473666173|FG002|Randomized Phase (First Intervention)|Other|0|||
131557676|NCT00384059|473666174|FG000|Infant Series|Not consented|2|||
131557677|NCT00384059|473666175|FG001|Infant Series|Not consented|6|||
131557678|NCT00384059|473666174|FG000|Infant Series|Withdrawal by Subject|2|||
131557679|NCT00384059|473666175|FG001|Infant Series|Withdrawal by Subject|2|||
131557680|NCT00384059|473666174|FG000|Infant Series|Adverse Event|1|||
131557681|NCT00384059|473666175|FG001|Infant Series|Adverse Event|2|||
131557682|NCT00384059|473666174|FG000|Infant Series|Protocol Violation|1|||
131557683|NCT00384059|473666175|FG001|Infant Series|Protocol Violation|2|||
131557684|NCT00384059|473666174|FG000|Infant Series|Lost to Follow-up|0|||
131557685|NCT00384059|473666175|FG001|Infant Series|Lost to Follow-up|1|||
131557686|NCT00384059|473666174|FG000|After Infant Series|Protocol Violation|2|||
131557687|NCT00384059|473666175|FG001|After Infant Series|Protocol Violation|3|||
131557688|NCT00384059|473666174|FG000|After Infant Series|Withdrawal by Subject|2|||
131557689|NCT00384059|473666175|FG001|After Infant Series|Withdrawal by Subject|2|||
131557690|NCT00384059|473666174|FG000|After Infant Series|Failed to Return|0|||
131557691|NCT00384059|473666175|FG001|After Infant Series|Failed to Return|2|||
131557692|NCT00384059|473666174|FG000|After Infant Series|Adverse Event|0|||
131557693|NCT00384059|473666175|FG001|After Infant Series|Adverse Event|1|||
131557694|NCT00384059|473666174|FG000|After Infant Series|Physician Decision|0|||
131557695|NCT00384059|473666175|FG001|After Infant Series|Physician Decision|1|||
131557696|NCT00384059|473666174|FG000|After Infant Series|Lost to Follow-up|0|||
131557697|NCT00384059|473666175|FG001|After Infant Series|Lost to Follow-up|1|||
131557698|NCT00384059|473666174|FG000|Toddler Dose|Lost to Follow-up|1|||
131557699|NCT00384059|473666175|FG001|Toddler Dose|Lost to Follow-up|1|||
131557700|NCT00384059|473666174|FG000|Toddler Dose|Failed to return|0|||
131692528|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Other|0|||
131692529|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Other|1|||
131692530|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Other|0|||
131692531|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
131692532|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
131692533|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
131557701|NCT00384059|473666175|FG001|Toddler Dose|Failed to return|1|||
131557702|NCT00386308|473667332|FG000|Overall Study|Adverse Event|3|||
131557703|NCT00386308|473667333|FG001|Overall Study|Adverse Event|3|||
131557704|NCT00386308|473667332|FG000|Overall Study|Protocol Violation|2|||
131557705|NCT00386308|473667333|FG001|Overall Study|Protocol Violation|5|||
131692534|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
131557706|NCT00386308|473667332|FG000|Overall Study|Lack of Efficacy|0|||
131557707|NCT00386308|473667333|FG001|Overall Study|Lack of Efficacy|2|||
131557708|NCT00386308|473667332|FG000|Overall Study|Lost to Follow-up|10|||
131557709|NCT00386308|473667333|FG001|Overall Study|Lost to Follow-up|6|||
131557710|NCT00386308|473667332|FG000|Overall Study|Withdrawal by Subject|6|||
131557711|NCT00386308|473667333|FG001|Overall Study|Withdrawal by Subject|2|||
131557712|NCT00386308|473667332|FG000|Overall Study|Other Event|8|||
131557713|NCT00386308|473667333|FG001|Overall Study|Other Event|1|||
131557714|NCT02906683|473667334|FG000|Overall Study|Adverse Event|0|||
131557715|NCT02906683|473667335|FG001|Overall Study|Adverse Event|1|||
131692535|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
131557716|NCT02906683|473667336|FG002|Overall Study|Adverse Event|0|||
131557717|NCT02906683|473667334|FG000|Overall Study|Physician Decision|0|||
131557718|NCT02906683|473667335|FG001|Overall Study|Physician Decision|1|||
131557719|NCT02906683|473667336|FG002|Overall Study|Physician Decision|1|||
131557720|NCT02906683|473667334|FG000|Overall Study|Withdrawal by Subject|0|||
131557721|NCT02906683|473667335|FG001|Overall Study|Withdrawal by Subject|2|||
131557722|NCT02906683|473667336|FG002|Overall Study|Withdrawal by Subject|1|||
131557723|NCT02906683|473667334|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
131557724|NCT02906683|473667335|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
131557725|NCT02906683|473667336|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
131557726|NCT02906683|473667334|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
131557727|NCT02906683|473667335|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
131557728|NCT02906683|473667336|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
131557729|NCT01340482|473667337|FG000|Overall Study|Adverse Event|2|||
131557730|NCT01340482|473667338|FG001|Overall Study|Adverse Event|0|||
131557731|NCT01340482|473667339|FG002|Overall Study|Adverse Event|0|||
131557732|NCT02593539|473667340|FG000|Overall Study|Adverse Event|1|||
131557733|NCT01282476|473667341|FG000|Overall Study|Death|11|||
131557734|NCT00437125|473667344|FG000|Overall Study|Adverse Event|12|||
131557735|NCT00437125|473667344|FG000|Overall Study|Death|1|||
131557736|NCT00437125|473667344|FG000|Overall Study|Clinical Relapse|1|||
131557737|NCT00437125|473667344|FG000|Overall Study|Lack of Efficacy|1|||
131557738|NCT00437125|473667344|FG000|Overall Study|Lost to Follow-up|1|||
131557739|NCT00437125|473667344|FG000|Overall Study|Withdrawal by Subject|13|||
131557740|NCT00437125|473667344|FG000|Overall Study|Withdrawal by Caregiver|2|||
131557741|NCT00437125|473667344|FG000|Overall Study|Physician Decision|1|||
131557742|NCT02248961|473667345|FG000|Overall Study|Adverse Event|1|||
131557743|NCT02248961|473667346|FG001|Overall Study|Adverse Event|0|||
131557744|NCT02248961|473667345|FG000|Overall Study|Withdrawal by Subject|1|||
131557745|NCT02248961|473667346|FG001|Overall Study|Withdrawal by Subject|2|||
131557746|NCT02248961|473667345|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
131557747|NCT02248961|473667346|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
131557748|NCT00649389|473667347|FG000|Overall Study|Adverse Event|22|||
131557749|NCT00649389|473667348|FG001|Overall Study|Adverse Event|46|||
131557750|NCT00649389|473667349|FG002|Overall Study|Adverse Event|38|||
131557751|NCT00649389|473667350|FG003|Overall Study|Adverse Event|48|||
131557752|NCT00649389|473667347|FG000|Overall Study|Lost to Follow-up|15|||
131557753|NCT00649389|473667348|FG001|Overall Study|Lost to Follow-up|17|||
131557754|NCT00649389|473667349|FG002|Overall Study|Lost to Follow-up|21|||
131557755|NCT00649389|473667350|FG003|Overall Study|Lost to Follow-up|26|||
131557756|NCT00649389|473667347|FG000|Overall Study|Protocol Violation|11|||
131557757|NCT00649389|473667348|FG001|Overall Study|Protocol Violation|13|||
131557758|NCT00649389|473667349|FG002|Overall Study|Protocol Violation|9|||
131557759|NCT00649389|473667350|FG003|Overall Study|Protocol Violation|8|||
131557760|NCT00649389|473667347|FG000|Overall Study|Withdrawal by Subject|20|||
131557761|NCT00649389|473667348|FG001|Overall Study|Withdrawal by Subject|21|||
131557762|NCT00649389|473667349|FG002|Overall Study|Withdrawal by Subject|19|||
131557763|NCT00649389|473667350|FG003|Overall Study|Withdrawal by Subject|23|||
131557764|NCT00649389|473667347|FG000|Overall Study|Other|3|||
131557765|NCT00649389|473667348|FG001|Overall Study|Other|9|||
131557766|NCT00649389|473667349|FG002|Overall Study|Other|1|||
131557767|NCT00649389|473667350|FG003|Overall Study|Other|6|||
131557768|NCT00453310|473667355|FG000|Overall Study|Progression of Disease|10|||
131557769|NCT01267825|473667356|FG000|Overall Study|study terminated. no data collected.|1|||
131557770|NCT01267825|473667357|FG001|Overall Study|study terminated. no data collected.|0|||
131557771|NCT01806740|473667358|FG000|Overall Study|Withdrawal by Subject|4|||
131557772|NCT01806740|473667358|FG000|Overall Study|Physician Decision|1|||
131557773|NCT01806740|473667358|FG000|Overall Study|Patient's refusal of treatment|1|||
131557774|NCT00871351|473667363|FG000|Overall Study|Withdrawal by Subject|1|||
131557775|NCT00871351|473667364|FG001|Overall Study|Withdrawal by Subject|0|||
131557776|NCT00871351|473667365|FG002|Overall Study|Withdrawal by Subject|0|||
131557777|NCT00871351|473667363|FG000|Overall Study|Adverse Event|3|||
131557778|NCT00871351|473667364|FG001|Overall Study|Adverse Event|1|||
131557779|NCT00871351|473667365|FG002|Overall Study|Adverse Event|0|||
131557780|NCT00744237|473667366|FG000|Overall Study|Lack of Efficacy|1|||
131557781|NCT00744237|473667367|FG001|Overall Study|Lack of Efficacy|1|||
131557782|NCT00744237|473667368|FG002|Overall Study|Lack of Efficacy|0|||
131557783|NCT00744237|473667366|FG000|Overall Study|Withdrawal by Subject|9|||
131557784|NCT00744237|473667367|FG001|Overall Study|Withdrawal by Subject|5|||
131557785|NCT00744237|473667368|FG002|Overall Study|Withdrawal by Subject|3|||
131557786|NCT00744237|473667366|FG000|Overall Study|Lost to Follow-up|1|||
131557787|NCT00744237|473667367|FG001|Overall Study|Lost to Follow-up|1|||
131557788|NCT00744237|473667368|FG002|Overall Study|Lost to Follow-up|1|||
131557789|NCT00744237|473667366|FG000|Overall Study|Protocol Violation|3|||
131692536|NCT00440947|474158278|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131692537|NCT00440947|474158279|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131557790|NCT00744237|473667367|FG001|Overall Study|Protocol Violation|4|||
131557791|NCT00744237|473667368|FG002|Overall Study|Protocol Violation|3|||
131557792|NCT00744237|473667366|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
131557793|NCT00744237|473667367|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
131557794|NCT00744237|473667368|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
131557795|NCT00744237|473667366|FG000|Overall Study|Dosing Error|1|||
131557796|NCT00744237|473667367|FG001|Overall Study|Dosing Error|0|||
131557797|NCT00744237|473667368|FG002|Overall Study|Dosing Error|1|||
131557798|NCT00744237|473667366|FG000|Overall Study|Study Drug Error|1|||
131557799|NCT00744237|473667367|FG001|Overall Study|Study Drug Error|0|||
131557800|NCT00744237|473667368|FG002|Overall Study|Study Drug Error|0|||
131557801|NCT00744237|473667366|FG000|Overall Study|Prohibited Concomitant Medication|0|||
131557802|NCT00744237|473667367|FG001|Overall Study|Prohibited Concomitant Medication|0|||
131557803|NCT00744237|473667368|FG002|Overall Study|Prohibited Concomitant Medication|1|||
131557804|NCT00744237|473667366|FG000|Overall Study|Poor Compliance|0|||
131557805|NCT00744237|473667367|FG001|Overall Study|Poor Compliance|2|||
131557806|NCT00744237|473667368|FG002|Overall Study|Poor Compliance|0|||
131557807|NCT00744237|473667366|FG000|Overall Study|Administrative. Site Closed|1|||
131557808|NCT00744237|473667367|FG001|Overall Study|Administrative. Site Closed|1|||
131557809|NCT00744237|473667368|FG002|Overall Study|Administrative. Site Closed|1|||
131557810|NCT00744237|473667366|FG000|Overall Study|Adverse Event|9|||
131557811|NCT00744237|473667367|FG001|Overall Study|Adverse Event|13|||
131557812|NCT00744237|473667368|FG002|Overall Study|Adverse Event|5|||
131557813|NCT02791490|473667370|FG000|Overall Study|Lost to Follow-up|1|||
131557814|NCT02791490|473667371|FG001|Overall Study|Lost to Follow-up|2|||
131557815|NCT02791490|473667370|FG000|Overall Study|Withdrawal by Subject|2|||
131557816|NCT02791490|473667371|FG001|Overall Study|Withdrawal by Subject|6|||
131557817|NCT01984424|473667372|FG000|Overall Study|Withdrawal by Subject|3|||
131557818|NCT01984424|473667373|FG001|Overall Study|Withdrawal by Subject|5|||
131557819|NCT01984424|473667372|FG000|Overall Study|Sponsor Decision|0|||
131557820|NCT01984424|473667373|FG001|Overall Study|Sponsor Decision|1|||
131557821|NCT01984424|473667372|FG000|Overall Study|Lost to Follow-up|0|||
131557822|NCT01984424|473667373|FG001|Overall Study|Lost to Follow-up|1|||
131557823|NCT02802319|473667374|FG000|Overall Study|Physician Decision|2|||
131557824|NCT02802319|473667375|FG001|Overall Study|Physician Decision|1|||
131557825|NCT02802319|473667374|FG000|Overall Study|Lost to Follow-up|0|||
131557826|NCT02802319|473667375|FG001|Overall Study|Lost to Follow-up|4|||
131557827|NCT00077636|473667376|FG000|Overall Study|Refused Treatment|9|||
131557828|NCT00077636|473667377|FG001|Overall Study|Refused Treatment|31|||
131557829|NCT00077636|473667376|FG000|Overall Study|Admin|3|||
131557830|NCT00077636|473667377|FG001|Overall Study|Admin|3|||
131557831|NCT00077636|473667376|FG000|Overall Study|Withdrawal by Subject|2|||
131557832|NCT00077636|473667377|FG001|Overall Study|Withdrawal by Subject|2|||
131557833|NCT00077636|473667376|FG000|Overall Study|Adverse Event|17|||
131557834|NCT00077636|473667377|FG001|Overall Study|Adverse Event|34|||
131557835|NCT00077636|473667376|FG000|Overall Study|Protocol Violation|0|||
131557836|NCT00077636|473667377|FG001|Overall Study|Protocol Violation|2|||
131557837|NCT00077636|473667376|FG000|Overall Study|Lost to Follow-up|10|||
131557838|NCT00077636|473667377|FG001|Overall Study|Lost to Follow-up|18|||
131557839|NCT00077636|473667376|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
131557840|NCT00077636|473667377|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
131557841|NCT00592319|473667378|FG000|Overall Study|Lost to Follow-up|0|||
131692538|NCT00440947|474158280|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131692539|NCT00440947|474158281|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131692540|NCT00440947|474158282|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
131692541|NCT01834274|474158286|FG000|Overall Study|Study Termination|41|||
131692542|NCT01834274|474158287|FG001|Overall Study|Study Termination|38|||
131692543|NCT01834274|474158286|FG000|Overall Study|Withdrawal by Subject|1|||
131692544|NCT01834274|474158287|FG001|Overall Study|Withdrawal by Subject|1|||
131692545|NCT01834274|474158286|FG000|Overall Study|Lost to Follow-up|3|||
131692546|NCT01834274|474158287|FG001|Overall Study|Lost to Follow-up|1|||
131692547|NCT01834274|474158286|FG000|Overall Study|Other|2|||
131898546|NCT02797678|474914127|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
131557842|NCT00592319|473667379|FG001|Overall Study|Lost to Follow-up|3|||
131557843|NCT02032173|473667380|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
131557844|NCT03321513|473667386|FG000|Overall Study|Death|11|||
131557845|NCT03321513|473667387|FG001|Overall Study|Death|5|||
131557846|NCT03321513|473667386|FG000|Overall Study|Withdrawal by Subject|5|||
131557847|NCT03321513|473667387|FG001|Overall Study|Withdrawal by Subject|10|||
131557848|NCT03321513|473667386|FG000|Overall Study|Lost to Follow-up|10|||
131557849|NCT03321513|473667387|FG001|Overall Study|Lost to Follow-up|11|||
131557850|NCT01993017|473667388|FG000|Overall Study|Death|23|||
131557851|NCT01993017|473667389|FG001|Overall Study|Death|26|||
131557852|NCT01993017|473667390|FG002|Overall Study|Death|18|||
131557853|NCT01993017|473667388|FG000|Overall Study|Could not be contacted|43|||
131557854|NCT01993017|473667389|FG001|Overall Study|Could not be contacted|42|||
131557855|NCT01993017|473667390|FG002|Overall Study|Could not be contacted|38|||
131557856|NCT01993017|473667388|FG000|Overall Study|Dropped out|19|||
131557857|NCT01993017|473667389|FG001|Overall Study|Dropped out|6|||
131557858|NCT01993017|473667390|FG002|Overall Study|Dropped out|11|||
131557859|NCT01993017|473667388|FG000|Overall Study|Other reasons|17|||
131557860|NCT01993017|473667389|FG001|Overall Study|Other reasons|11|||
131557861|NCT01993017|473667390|FG002|Overall Study|Other reasons|7|||
131557862|NCT01993017|473667388|FG000|Overall Study|Ineligible after randomization|4|||
131557863|NCT01993017|473667389|FG001|Overall Study|Ineligible after randomization|5|||
131557864|NCT01993017|473667390|FG002|Overall Study|Ineligible after randomization|5|||
131557865|NCT02757521|473667391|FG000|Overall Study|Adverse Event|1|||
131557866|NCT02757521|473667392|FG001|Overall Study|Adverse Event|0|||
131557867|NCT00003511|473667393|FG000|Overall Study|Not evaluable|4|||
131557868|NCT01683994|473667400|FG000|Overall Study|Withdrawal by Subject|1|||
131557869|NCT01683994|473667401|FG001|Overall Study|Withdrawal by Subject|0|||
131557870|NCT01683994|473667402|FG002|Overall Study|Withdrawal by Subject|0|||
131557871|NCT01683994|473667403|FG003|Overall Study|Withdrawal by Subject|1|||
131557872|NCT01683994|473667404|FG004|Overall Study|Withdrawal by Subject|0|||
131557873|NCT01683994|473667400|FG000|Overall Study|Intercurrent illness|0|||
131557874|NCT01683994|473667401|FG001|Overall Study|Intercurrent illness|0|||
131557875|NCT01683994|473667402|FG002|Overall Study|Intercurrent illness|0|||
131557876|NCT01683994|473667403|FG003|Overall Study|Intercurrent illness|2|||
131557877|NCT01683994|473667404|FG004|Overall Study|Intercurrent illness|1|||
131557878|NCT00999661|473667409|FG000|Overall Study|Lost to Follow-up|59|||
131557879|NCT00999661|473667409|FG000|Overall Study|Adverse Event|1|||
131557880|NCT00999661|473667409|FG000|Overall Study|Withdrawal by Subject|1|||
131557881|NCT00999661|473667409|FG000|Overall Study|Not meeting eligibility criteria|9|||
131557882|NCT01794117|473667417|FG000|Overall Study|Adverse Event|1|||
131557883|NCT01794117|473667418|FG001|Overall Study|Adverse Event|0|||
131557884|NCT01794117|473667419|FG002|Overall Study|Adverse Event|0|||
131557885|NCT01794117|473667420|FG003|Overall Study|Adverse Event|0|||
131557886|NCT01794117|473667417|FG000|Overall Study|Participant noncompliance|0|||
131557887|NCT01794117|473667418|FG001|Overall Study|Participant noncompliance|1|||
131557888|NCT01794117|473667419|FG002|Overall Study|Participant noncompliance|0|||
131557889|NCT01794117|473667420|FG003|Overall Study|Participant noncompliance|0|||
131557890|NCT01794117|473667417|FG000|Overall Study|Refused further treatment|0|||
131557891|NCT01794117|473667418|FG001|Overall Study|Refused further treatment|2|||
131557892|NCT01794117|473667419|FG002|Overall Study|Refused further treatment|0|||
131557893|NCT01794117|473667420|FG003|Overall Study|Refused further treatment|0|||
131557894|NCT03734991|473667421|FG000|Overall Study|Adverse Event|4|||
131557895|NCT03734991|473667422|FG001|Overall Study|Adverse Event|0|||
131557896|NCT03734991|473667421|FG000|Overall Study|Lost to Follow-up|4|||
131557897|NCT03734991|473667422|FG001|Overall Study|Lost to Follow-up|0|||
131557898|NCT03734991|473667421|FG000|Overall Study|Physician Decision|0|||
131557899|NCT03734991|473667422|FG001|Overall Study|Physician Decision|1|||
131557900|NCT03734991|473667421|FG000|Overall Study|Pregnancy|1|||
131557901|NCT03734991|473667422|FG001|Overall Study|Pregnancy|0|||
131557902|NCT03734991|473667421|FG000|Overall Study|Withdrawal by Subject|6|||
131557903|NCT03734991|473667422|FG001|Overall Study|Withdrawal by Subject|3|||
131557904|NCT03734991|473667421|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
131692548|NCT01834274|474158287|FG001|Overall Study|Other|1|||
131692549|NCT02813694|474158293|FG000|Overall Study|Physician Decision|0|||
131692550|NCT02813694|474158294|FG001|Overall Study|Physician Decision|1|||
131692551|NCT02813694|474158293|FG000|Overall Study|Withdrawal by Subject|10|||
131692552|NCT02813694|474158294|FG001|Overall Study|Withdrawal by Subject|9|||
131692553|NCT02813694|474158293|FG000|Overall Study|Lost to Follow-up|1|||
131692554|NCT02813694|474158294|FG001|Overall Study|Lost to Follow-up|1|||
131692555|NCT02813694|474158293|FG000|Overall Study|Death|3|||
131692556|NCT02813694|474158294|FG001|Overall Study|Death|3|||
131692557|NCT02813694|474158293|FG000|Overall Study|Randomized- did not receive study drug|2|||
131692558|NCT02813694|474158294|FG001|Overall Study|Randomized- did not receive study drug|0|||
131692559|NCT02813694|474158293|FG000|Overall Study|Patient hospitalized|1|||
131692560|NCT02813694|474158294|FG001|Overall Study|Patient hospitalized|0|||
131692561|NCT01265797|474158295|FG000|Run-in Month|Withdrawal by Subject|0|||
131557905|NCT03734991|473667422|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
131557906|NCT03734991|473667421|FG000|Overall Study|Other|2|||
131692562|NCT01265797|474158296|FG001|Run-in Month|Withdrawal by Subject|4|||
131692563|NCT01265797|474158295|FG000|Run-in Month|1st seizure during run-in month|0|||
131557907|NCT03734991|473667422|FG001|Overall Study|Other|2|||
131557908|NCT02322814|473667425|FG000|Overall Study|Death|7|||
131557909|NCT02322814|473667426|FG001|Overall Study|Death|29|||
131557910|NCT02322814|473667427|FG002|Overall Study|Death|32|||
131557911|NCT02322814|473667428|FG003|Overall Study|Death|23|||
131557912|NCT02322814|473667429|FG004|Overall Study|Death|14|||
131557913|NCT02322814|473667425|FG000|Overall Study|Lost to Follow-up|1|||
131692564|NCT01265797|474158296|FG001|Run-in Month|1st seizure during run-in month|1|||
131692565|NCT01265797|474158295|FG000|Blinded Month|Lack of Efficacy|5|||
131557914|NCT02322814|473667426|FG001|Overall Study|Lost to Follow-up|3|||
131557915|NCT02322814|473667427|FG002|Overall Study|Lost to Follow-up|3|||
131557916|NCT02322814|473667428|FG003|Overall Study|Lost to Follow-up|1|||
131557917|NCT02322814|473667429|FG004|Overall Study|Lost to Follow-up|0|||
131557918|NCT02322814|473667425|FG000|Overall Study|Various Reasons|2|||
131557919|NCT02322814|473667426|FG001|Overall Study|Various Reasons|0|||
131557920|NCT02322814|473667427|FG002|Overall Study|Various Reasons|1|||
131557921|NCT02322814|473667428|FG003|Overall Study|Various Reasons|1|||
131557922|NCT02322814|473667429|FG004|Overall Study|Various Reasons|0|||
131557923|NCT02322814|473667425|FG000|Overall Study|Progressive Disease|0|||
131557924|NCT02322814|473667426|FG001|Overall Study|Progressive Disease|0|||
131557925|NCT02322814|473667427|FG002|Overall Study|Progressive Disease|0|||
131557926|NCT02322814|473667428|FG003|Overall Study|Progressive Disease|1|||
131557927|NCT02322814|473667429|FG004|Overall Study|Progressive Disease|1|||
131557928|NCT02322814|473667425|FG000|Overall Study|Protocol Violation|1|||
131557929|NCT02322814|473667426|FG001|Overall Study|Protocol Violation|0|||
131557930|NCT02322814|473667427|FG002|Overall Study|Protocol Violation|0|||
131557931|NCT02322814|473667428|FG003|Overall Study|Protocol Violation|0|||
131557932|NCT02322814|473667429|FG004|Overall Study|Protocol Violation|0|||
131557933|NCT02322814|473667425|FG000|Overall Study|Study Terminated by Sponsor|0|||
131557934|NCT02322814|473667426|FG001|Overall Study|Study Terminated by Sponsor|7|||
131557935|NCT02322814|473667427|FG002|Overall Study|Study Terminated by Sponsor|9|||
131557936|NCT02322814|473667428|FG003|Overall Study|Study Terminated by Sponsor|5|||
131557937|NCT02322814|473667429|FG004|Overall Study|Study Terminated by Sponsor|13|||
131557938|NCT02322814|473667425|FG000|Overall Study|Withdrawal by Subject|5|||
131557939|NCT02322814|473667426|FG001|Overall Study|Withdrawal by Subject|4|||
131557940|NCT02322814|473667427|FG002|Overall Study|Withdrawal by Subject|2|||
131557941|NCT02322814|473667428|FG003|Overall Study|Withdrawal by Subject|1|||
131557942|NCT02322814|473667429|FG004|Overall Study|Withdrawal by Subject|3|||
131557943|NCT00591864|473667430|FG000|Overall Study|Incomplete Imaging|5|||
131557944|NCT02459093|473667431|FG000|Overall Study|Protocol Violation|6|||
131557945|NCT02459093|473667432|FG001|Overall Study|Protocol Violation|11|||
131557946|NCT02459093|473667431|FG000|Overall Study|Lost to Follow-up|6|||
131557947|NCT02459093|473667432|FG001|Overall Study|Lost to Follow-up|7|||
131557948|NCT00118092|473667433|FG000|Overall Study|Withdrawal by Subject|1|||
131557949|NCT00118092|473667433|FG000|Overall Study|Protocol Violation|1|||
131557950|NCT02401308|473667445|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
131557951|NCT02401308|473667446|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
131557952|NCT02736968|473667447|FG000|Overall Study|Lost to Follow-up|0|||
131557953|NCT02736968|473667448|FG001|Overall Study|Lost to Follow-up|0|||
131557954|NCT02736968|473667449|FG002|Overall Study|Lost to Follow-up|0|||
131557955|NCT02736968|473667450|FG003|Overall Study|Lost to Follow-up|0|||
131557956|NCT02736968|473667451|FG004|Overall Study|Lost to Follow-up|0|||
131557957|NCT02736968|473667452|FG005|Overall Study|Lost to Follow-up|0|||
131557958|NCT02736968|473667453|FG006|Overall Study|Lost to Follow-up|5|||
131557959|NCT02736968|473667454|FG007|Overall Study|Lost to Follow-up|2|||
131557960|NCT02736968|473667447|FG000|Overall Study|COVID-19 Pandemic|0|||
131557961|NCT02736968|473667448|FG001|Overall Study|COVID-19 Pandemic|0|||
131557962|NCT02736968|473667449|FG002|Overall Study|COVID-19 Pandemic|0|||
131557963|NCT02736968|473667450|FG003|Overall Study|COVID-19 Pandemic|0|||
131557964|NCT02736968|473667451|FG004|Overall Study|COVID-19 Pandemic|0|||
131557965|NCT02736968|473667452|FG005|Overall Study|COVID-19 Pandemic|0|||
131557966|NCT02736968|473667453|FG006|Overall Study|COVID-19 Pandemic|2|||
131557967|NCT02736968|473667454|FG007|Overall Study|COVID-19 Pandemic|0|||
131557968|NCT02736968|473667447|FG000|Overall Study|Withdrawal by Subject|0|||
131557969|NCT02736968|473667448|FG001|Overall Study|Withdrawal by Subject|0|||
131557970|NCT02736968|473667449|FG002|Overall Study|Withdrawal by Subject|0|||
131557971|NCT02736968|473667450|FG003|Overall Study|Withdrawal by Subject|0|||
131557972|NCT02736968|473667451|FG004|Overall Study|Withdrawal by Subject|0|||
131557973|NCT02736968|473667452|FG005|Overall Study|Withdrawal by Subject|0|||
131557974|NCT02736968|473667453|FG006|Overall Study|Withdrawal by Subject|1|||
131557975|NCT02736968|473667454|FG007|Overall Study|Withdrawal by Subject|0|||
131557976|NCT00147225|473667455|FG000|Overall Study|Withdrawal by Subject|1|||
131557977|NCT00147225|473667456|FG001|Overall Study|Withdrawal by Subject|0|||
131557978|NCT00147225|473667457|FG002|Overall Study|Withdrawal by Subject|1|||
131557979|NCT00147225|473667458|FG003|Overall Study|Withdrawal by Subject|0|||
131557980|NCT00147225|473667459|FG004|Overall Study|Withdrawal by Subject|0|||
131557981|NCT00147225|473667460|FG005|Overall Study|Withdrawal by Subject|1|||
131557982|NCT00147225|473667455|FG000|Overall Study|Adverse Event|0|||
131557983|NCT00147225|473667456|FG001|Overall Study|Adverse Event|0|||
131557984|NCT00147225|473667457|FG002|Overall Study|Adverse Event|1|||
131557985|NCT00147225|473667458|FG003|Overall Study|Adverse Event|1|||
131557986|NCT00147225|473667459|FG004|Overall Study|Adverse Event|0|||
131557987|NCT00147225|473667460|FG005|Overall Study|Adverse Event|0|||
131557988|NCT00147225|473667455|FG000|Overall Study|Screen Failure|0|||
131557989|NCT00147225|473667456|FG001|Overall Study|Screen Failure|0|||
131557990|NCT00147225|473667457|FG002|Overall Study|Screen Failure|0|||
131557991|NCT00147225|473667458|FG003|Overall Study|Screen Failure|0|||
131557992|NCT00147225|473667459|FG004|Overall Study|Screen Failure|1|||
131557993|NCT00147225|473667460|FG005|Overall Study|Screen Failure|0|||
131557994|NCT00147225|473667455|FG000|Overall Study|Chemotherapy Changed|0|||
131557995|NCT00147225|473667456|FG001|Overall Study|Chemotherapy Changed|0|||
131557996|NCT00147225|473667457|FG002|Overall Study|Chemotherapy Changed|0|||
131557997|NCT00147225|473667458|FG003|Overall Study|Chemotherapy Changed|0|||
131557998|NCT00147225|473667459|FG004|Overall Study|Chemotherapy Changed|0|||
131557999|NCT00147225|473667460|FG005|Overall Study|Chemotherapy Changed|1|||
131692566|NCT01265797|474158296|FG001|Blinded Month|Lack of Efficacy|0|||
131692567|NCT01265797|474158295|FG000|Blinded Month|Lost to Follow-up|1|||
131692568|NCT01265797|474158296|FG001|Blinded Month|Lost to Follow-up|0|||
131692569|NCT01265797|474158295|FG000|Blinded Month|Protocol Violation|2|||
131692570|NCT01265797|474158296|FG001|Blinded Month|Protocol Violation|1|||
131692571|NCT01265797|474158295|FG000|Blinded Month|Adverse Event|2|||
131692572|NCT01265797|474158296|FG001|Blinded Month|Adverse Event|0|||
131692573|NCT01265797|474158295|FG000|Blinded Month|Diary data incomplete|0|||
131692574|NCT01265797|474158296|FG001|Blinded Month|Diary data incomplete|1|||
131692575|NCT01265797|474158295|FG000|Open Label Month|Lost to Follow-up|0|||
131692576|NCT01265797|474158296|FG001|Open Label Month|Lost to Follow-up|1|||
131692577|NCT01152021|474158297|FG000|Overall Study|Adverse Event|4|||
131692578|NCT01152021|474158298|FG001|Overall Study|Adverse Event|4|||
131692579|NCT01152021|474158297|FG000|Overall Study|Study drug had expired|1|||
131692580|NCT01152021|474158298|FG001|Overall Study|Study drug had expired|0|||
131692581|NCT01152021|474158297|FG000|Overall Study|Physician Decision|1|||
131692582|NCT01152021|474158298|FG001|Overall Study|Physician Decision|1|||
131692583|NCT01152021|474158297|FG000|Overall Study|No access to study drug in Pharmacy|0|||
131692584|NCT01152021|474158298|FG001|Overall Study|No access to study drug in Pharmacy|1|||
131692585|NCT00004259|474158300|FG000|Overall Study|Protocol Violation|1|||
131692586|NCT00004259|474158301|FG001|Overall Study|Protocol Violation|2|||
131692587|NCT00004259|474158302|FG002|Overall Study|Protocol Violation|0|||
131692588|NCT00004259|474158303|FG003|Overall Study|Protocol Violation|0|||
131692589|NCT00004259|474158300|FG000|Overall Study|Withdrawal by Subject|0|||
131692590|NCT00004259|474158301|FG001|Overall Study|Withdrawal by Subject|2|||
131692591|NCT00004259|474158302|FG002|Overall Study|Withdrawal by Subject|0|||
131692592|NCT00004259|474158303|FG003|Overall Study|Withdrawal by Subject|0|||
131692593|NCT00996944|474158304|FG000|Double-blind Treatment Period|Adverse Event|2|||
131692594|NCT00996944|474158305|FG001|Double-blind Treatment Period|Adverse Event|1|||
131692595|NCT00996944|474158304|FG000|Double-blind Treatment Period|Protocol Violation|1|||
131692596|NCT00996944|474158305|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131692597|NCT00996944|474158304|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
131692598|NCT00996944|474158305|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
131692599|NCT00996944|474158304|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131692600|NCT00996944|474158305|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131692601|NCT00996944|474158304|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
131692602|NCT00996944|474158305|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
131692603|NCT00769184|474158306|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
131692604|NCT00769184|474158307|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
131692605|NCT00769184|474158306|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
131692606|NCT00769184|474158307|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
131692607|NCT00769184|474158306|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
131692608|NCT00769184|474158307|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
131692609|NCT00385255|474158308|FG000|Overall Study|Serious Adverse Event|1|||
131692610|NCT00385255|474158309|FG001|Overall Study|Serious Adverse Event|2|||
131692611|NCT00385255|474158308|FG000|Overall Study|Protocol Violation|0|||
131692612|NCT00385255|474158309|FG001|Overall Study|Protocol Violation|4|||
131692613|NCT00385255|474158308|FG000|Overall Study|Withdrawal by Subject|0|||
131692614|NCT00385255|474158309|FG001|Overall Study|Withdrawal by Subject|8|||
131692615|NCT00385255|474158308|FG000|Overall Study|Migrated/moved from study area|0|||
131692616|NCT00385255|474158309|FG001|Overall Study|Migrated/moved from study area|1|||
131692617|NCT00385255|474158308|FG000|Overall Study|Lost to Follow-up|20|||
131558000|NCT02998021|473667461|FG000|Overall Study|Withdrawal by Subject|3|||
131692618|NCT00385255|474158309|FG001|Overall Study|Lost to Follow-up|58|||
131692619|NCT02443883|474158310|FG000|Overall Study|Adverse Event|0|||
131692620|NCT02443883|474158311|FG001|Overall Study|Adverse Event|1|||
131692621|NCT02443883|474158312|FG002|Overall Study|Adverse Event|0|||
131692622|NCT02443883|474158313|FG003|Overall Study|Adverse Event|0|||
131692623|NCT02443883|474158310|FG000|Overall Study|Lost to Follow-up|3|||
131692624|NCT02443883|474158311|FG001|Overall Study|Lost to Follow-up|2|||
131692625|NCT02443883|474158312|FG002|Overall Study|Lost to Follow-up|1|||
131692626|NCT02443883|474158313|FG003|Overall Study|Lost to Follow-up|0|||
131692627|NCT02443883|474158310|FG000|Overall Study|Physician Decision|1|||
131692628|NCT02443883|474158311|FG001|Overall Study|Physician Decision|1|||
131692629|NCT02443883|474158312|FG002|Overall Study|Physician Decision|0|||
131558001|NCT02998021|473667462|FG001|Overall Study|Withdrawal by Subject|1|||
131777889|NCT05553600|474467489|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
131777890|NCT05553600|474467490|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
131777891|NCT05553600|474467487|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
131777892|NCT05553600|474467488|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
131777893|NCT05553600|474467489|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
131777894|NCT05553600|474467490|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
131777895|NCT05553600|474467487|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
131777896|NCT05553600|474467488|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
131777897|NCT05553600|474467489|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
131777898|NCT05553600|474467490|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
131777899|NCT05553600|474467487|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
131777900|NCT05553600|474467488|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
131777901|NCT05553600|474467489|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
131777902|NCT05553600|474467490|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
131777903|NCT05553600|474467487|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
131777904|NCT05553600|474467488|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
131777905|NCT05553600|474467489|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
131777906|NCT05553600|474467490|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
131777907|NCT05553600|474467487|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
131777908|NCT05553600|474467488|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
131777909|NCT05553600|474467489|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
131777910|NCT05553600|474467490|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
131777911|NCT05553600|474467487|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
131777912|NCT05553600|474467488|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
131777913|NCT05553600|474467489|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
131777914|NCT05553600|474467490|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
131777915|NCT04930536|474467491|FG000|Overall Study|Adverse Event|1|||
131777916|NCT04930536|474467492|FG001|Overall Study|Adverse Event|0|||
131777917|NCT04930536|474467491|FG000|Overall Study|Disease Progression|2|||
131777918|NCT04930536|474467492|FG001|Overall Study|Disease Progression|0|||
131777919|NCT04930536|474467491|FG000|Overall Study|Patient Decision|4|||
131777920|NCT04930536|474467492|FG001|Overall Study|Patient Decision|2|||
131777921|NCT04930536|474467491|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
131777922|NCT04930536|474467492|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
131777923|NCT01432600|474467493|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
131777924|NCT01432600|474467494|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
131777925|NCT01432600|474467495|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
131692630|NCT02443883|474158313|FG003|Overall Study|Physician Decision|3|||
131692631|NCT02443883|474158310|FG000|Overall Study|Withdrawal by Subject|1|||
131692632|NCT02443883|474158311|FG001|Overall Study|Withdrawal by Subject|0|||
131692633|NCT02443883|474158312|FG002|Overall Study|Withdrawal by Subject|0|||
131692634|NCT02443883|474158313|FG003|Overall Study|Withdrawal by Subject|2|||
131692635|NCT02443883|474158310|FG000|Overall Study|Randomized, but never treated|1|||
131692636|NCT02443883|474158311|FG001|Overall Study|Randomized, but never treated|0|||
131692637|NCT02443883|474158312|FG002|Overall Study|Randomized, but never treated|0|||
131692638|NCT02443883|474158313|FG003|Overall Study|Randomized, but never treated|0|||
131692639|NCT02937818|474158314|FG000|Overall Study|Participants decision|2|||
131692640|NCT02937818|474158315|FG001|Overall Study|Participants decision|1|||
131692641|NCT02937818|474158316|FG002|Overall Study|Participants decision|1|||
131692642|NCT02937818|474158317|FG003|Overall Study|Participants decision|1|||
131692643|NCT02937818|474158314|FG000|Overall Study|Adverse Event|2|||
131692644|NCT02937818|474158315|FG001|Overall Study|Adverse Event|4|||
131692645|NCT02937818|474158316|FG002|Overall Study|Adverse Event|1|||
131692646|NCT02937818|474158317|FG003|Overall Study|Adverse Event|1|||
131692647|NCT02937818|474158314|FG000|Overall Study|Disease progression|17|||
131692648|NCT02937818|474158315|FG001|Overall Study|Disease progression|15|||
131777926|NCT00877799|474467502|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
131777927|NCT00877799|474467503|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
131692649|NCT02937818|474158316|FG002|Overall Study|Disease progression|7|||
131692650|NCT02937818|474158317|FG003|Overall Study|Disease progression|19|||
131558002|NCT02998021|473667461|FG000|Overall Study|unsafe home|0|||
131558003|NCT02998021|473667462|FG001|Overall Study|unsafe home|1|||
131558004|NCT00655551|473667463|FG000|All Periods Combined|Adverse Event|0|||
131558005|NCT00655551|473667464|FG001|All Periods Combined|Adverse Event|3|||
131558006|NCT00655551|473667465|FG002|All Periods Combined|Adverse Event|4|||
131558007|NCT00655551|473667463|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
131558008|NCT00655551|473667464|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
131558009|NCT00655551|473667465|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
131558010|NCT00655551|473667463|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
131558011|NCT00655551|473667464|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
131558012|NCT00655551|473667465|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
131692651|NCT02937818|474158314|FG000|Overall Study|Condition under investigation worsened|0|||
131692652|NCT02937818|474158315|FG001|Overall Study|Condition under investigation worsened|0|||
131692653|NCT02937818|474158316|FG002|Overall Study|Condition under investigation worsened|1|||
131692654|NCT02937818|474158317|FG003|Overall Study|Condition under investigation worsened|0|||
131692655|NCT00205855|474158328|FG000|Overall Study|Only received temporary implants|16|||
131692656|NCT00205855|474158328|FG000|Overall Study|Withdrawal by Subject|5|||
131692657|NCT01445951|474158329|FG000|Overall Study|Adverse Event|16|||
131692658|NCT01445951|474158330|FG001|Overall Study|Adverse Event|9|||
131692659|NCT01445951|474158331|FG002|Overall Study|Adverse Event|0|||
131692660|NCT01445951|474158329|FG000|Overall Study|Protocol Violation|2|||
131692661|NCT01445951|474158330|FG001|Overall Study|Protocol Violation|2|||
131692662|NCT01445951|474158331|FG002|Overall Study|Protocol Violation|2|||
131692663|NCT01445951|474158329|FG000|Overall Study|Withdrawal by Subject|21|||
131692664|NCT01445951|474158330|FG001|Overall Study|Withdrawal by Subject|16|||
131692665|NCT01445951|474158331|FG002|Overall Study|Withdrawal by Subject|8|||
131692666|NCT01445951|474158329|FG000|Overall Study|Physician Decision|3|||
131692667|NCT01445951|474158330|FG001|Overall Study|Physician Decision|1|||
131692668|NCT01445951|474158331|FG002|Overall Study|Physician Decision|0|||
131692669|NCT01445951|474158329|FG000|Overall Study|Lost to Follow-up|1|||
131692670|NCT01445951|474158330|FG001|Overall Study|Lost to Follow-up|2|||
131692671|NCT01445951|474158331|FG002|Overall Study|Lost to Follow-up|4|||
131692672|NCT01445951|474158329|FG000|Overall Study|Pregnancy|0|||
131692673|NCT01445951|474158330|FG001|Overall Study|Pregnancy|1|||
131692674|NCT01445951|474158331|FG002|Overall Study|Pregnancy|4|||
131692675|NCT01445951|474158329|FG000|Overall Study|Death|0|||
131692676|NCT01445951|474158330|FG001|Overall Study|Death|0|||
131692677|NCT01445951|474158331|FG002|Overall Study|Death|1|||
131558013|NCT00655551|473667463|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
131558014|NCT00655551|473667464|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
131558015|NCT00655551|473667465|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
131558016|NCT01734434|473667468|FG000|Overall Study|Death Infant|3|||
131558017|NCT01734434|473667469|FG001|Overall Study|Death Infant|1|||
131558018|NCT01734434|473667470|FG002|Overall Study|Death Infant|17|||
131558019|NCT01734434|473667471|FG003|Overall Study|Death Infant|5|||
131558020|NCT01734434|473667468|FG000|Overall Study|Lost to Follow-up|2|||
131558021|NCT01734434|473667469|FG001|Overall Study|Lost to Follow-up|9|||
131558022|NCT01734434|473667470|FG002|Overall Study|Lost to Follow-up|67|||
131558023|NCT01734434|473667471|FG003|Overall Study|Lost to Follow-up|11|||
131558024|NCT01734434|473667468|FG000|Overall Study|No Live Birth|1|||
131777928|NCT00877799|474467504|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
131777929|NCT00877799|474467505|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
131777930|NCT00877799|474467506|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
131777931|NCT00877799|474467502|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
131777932|NCT00877799|474467503|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
131777933|NCT00877799|474467504|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
131777934|NCT00877799|474467505|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
131777935|NCT00877799|474467506|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
131777936|NCT00877799|474467502|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131777937|NCT00877799|474467503|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
131558025|NCT01734434|473667469|FG001|Overall Study|No Live Birth|2|||
131692678|NCT01445951|474158329|FG000|Overall Study|Non-compliance with study drug|1|||
131692679|NCT01445951|474158330|FG001|Overall Study|Non-compliance with study drug|2|||
131692680|NCT01445951|474158331|FG002|Overall Study|Non-compliance with study drug|0|||
131692681|NCT01445951|474158329|FG000|Overall Study|Non-compliance with protocol|0|||
131692682|NCT01445951|474158330|FG001|Overall Study|Non-compliance with protocol|1|||
131692683|NCT01445951|474158331|FG002|Overall Study|Non-compliance with protocol|0|||
131692684|NCT01445951|474158329|FG000|Overall Study|Sponsor decision - subject travel|0|||
131692685|NCT01445951|474158330|FG001|Overall Study|Sponsor decision - subject travel|1|||
131692686|NCT01445951|474158331|FG002|Overall Study|Sponsor decision - subject travel|0|||
131692687|NCT01445951|474158329|FG000|Overall Study|Cough|0|||
131692688|NCT01445951|474158330|FG001|Overall Study|Cough|1|||
131692689|NCT01445951|474158331|FG002|Overall Study|Cough|0|||
131692690|NCT05513625|474158332|FG000|Overall Study|Withdrawal by Subject|1|||
131692691|NCT01015768|474158333|FG000|Overall Study|Some subject data unuseable|4|||
131692692|NCT01015768|474158334|FG001|Overall Study|Some subject data unuseable|4|||
131692693|NCT01627860|474158335|FG000|Overall Study|Adverse Event|9|||
131692694|NCT01627860|474158336|FG001|Overall Study|Adverse Event|4|||
131692695|NCT01627860|474158335|FG000|Overall Study|Withdrawal by Subject|2|||
131692696|NCT01627860|474158336|FG001|Overall Study|Withdrawal by Subject|1|||
131692697|NCT01627860|474158335|FG000|Overall Study|Seizure frequency doubled|0|||
131692698|NCT01627860|474158336|FG001|Overall Study|Seizure frequency doubled|1|||
131692699|NCT01627860|474158335|FG000|Overall Study|Protocol Violation|1|||
131692700|NCT01627860|474158336|FG001|Overall Study|Protocol Violation|0|||
131692701|NCT00845650|474158349|FG000|Overall Study|Withdrawal by Subject|0|||
131692702|NCT00845650|474158350|FG001|Overall Study|Withdrawal by Subject|0|||
131692703|NCT00845650|474158351|FG002|Overall Study|Withdrawal by Subject|0|||
131692704|NCT00845650|474158352|FG003|Overall Study|Withdrawal by Subject|0|||
131692705|NCT00845650|474158353|FG004|Overall Study|Withdrawal by Subject|2|||
131692706|NCT00845650|474158354|FG005|Overall Study|Withdrawal by Subject|0|||
131692707|NCT00845650|474158349|FG000|Overall Study|Lost to Follow-up|0|||
131692708|NCT00845650|474158350|FG001|Overall Study|Lost to Follow-up|0|||
131692709|NCT00845650|474158351|FG002|Overall Study|Lost to Follow-up|3|||
131692710|NCT00845650|474158352|FG003|Overall Study|Lost to Follow-up|1|||
131692711|NCT00845650|474158353|FG004|Overall Study|Lost to Follow-up|0|||
131692712|NCT00845650|474158354|FG005|Overall Study|Lost to Follow-up|1|||
131692713|NCT00845650|474158349|FG000|Overall Study|Sponsor hold on dosing|0|||
131692714|NCT00845650|474158350|FG001|Overall Study|Sponsor hold on dosing|0|||
131692715|NCT00845650|474158351|FG002|Overall Study|Sponsor hold on dosing|0|||
131692716|NCT00845650|474158352|FG003|Overall Study|Sponsor hold on dosing|0|||
131692717|NCT00845650|474158353|FG004|Overall Study|Sponsor hold on dosing|1|||
131692718|NCT00845650|474158354|FG005|Overall Study|Sponsor hold on dosing|1|||
131692719|NCT00845650|474158349|FG000|Overall Study|Unable to access IV line|1|||
131692720|NCT00845650|474158350|FG001|Overall Study|Unable to access IV line|0|||
131692721|NCT00845650|474158351|FG002|Overall Study|Unable to access IV line|0|||
131692722|NCT00845650|474158352|FG003|Overall Study|Unable to access IV line|0|||
131692723|NCT00845650|474158353|FG004|Overall Study|Unable to access IV line|0|||
131558026|NCT01734434|473667470|FG002|Overall Study|No Live Birth|32|||
131558027|NCT01734434|473667471|FG003|Overall Study|No Live Birth|6|||
131692724|NCT00845650|474158354|FG005|Overall Study|Unable to access IV line|0|||
131558028|NCT01734434|473667468|FG000|Overall Study|Withdrawal by Subject|4|||
131558029|NCT01734434|473667469|FG001|Overall Study|Withdrawal by Subject|0|||
131558030|NCT01734434|473667470|FG002|Overall Study|Withdrawal by Subject|8|||
131558031|NCT01734434|473667471|FG003|Overall Study|Withdrawal by Subject|1|||
131558032|NCT01734434|473667468|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
131558033|NCT01734434|473667469|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
131558034|NCT01734434|473667470|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
131558035|NCT01734434|473667471|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
131558036|NCT01734434|473667468|FG000|Overall Study|Subject Not Reachable|0|||
131558037|NCT01734434|473667469|FG001|Overall Study|Subject Not Reachable|0|||
131558038|NCT01734434|473667470|FG002|Overall Study|Subject Not Reachable|1|||
131558039|NCT01734434|473667471|FG003|Overall Study|Subject Not Reachable|0|||
131558040|NCT01734434|473667468|FG000|Overall Study|Treatment Defaulter|0|||
131558041|NCT01734434|473667469|FG001|Overall Study|Treatment Defaulter|0|||
131558042|NCT01734434|473667470|FG002|Overall Study|Treatment Defaulter|1|||
131558043|NCT01734434|473667471|FG003|Overall Study|Treatment Defaulter|0|||
131558044|NCT01734434|473667468|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
131558045|NCT01734434|473667469|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
131558046|NCT01734434|473667470|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
131558047|NCT01734434|473667471|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
131558048|NCT01734434|473667468|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
131558049|NCT01734434|473667469|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
131558050|NCT01734434|473667470|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
131558051|NCT01734434|473667471|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
131558052|NCT03713021|473667476|FG000|Overall Study|Did not have CT sim scan available|6|||
131558053|NCT03713021|473667476|FG000|Overall Study|Not eligible|4|||
131558054|NCT03713021|473667476|FG000|Overall Study|Issues with TraceIT markers|5|||
131558055|NCT03391960|473667479|FG000|Overall Study|Protocol Violation|0|||
131558056|NCT03391960|473667480|FG001|Overall Study|Protocol Violation|0|||
131558057|NCT03518658|473669434|FG000|Overall Study|Other|51|||
131558058|NCT03518658|473669435|FG001|Overall Study|Other|0|||
131558059|NCT02531295|473669436|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
131558060|NCT02531295|473669437|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
131692725|NCT00814892|474158355|FG000|Overall Study|Disease Progression|1|||
131692726|NCT00814892|474158355|FG000|Overall Study|Study Termination|1|||
131692727|NCT00401375|474158356|FG000|Overall Study|Protocol Violation|2|||
131692728|NCT00401375|474158357|FG001|Overall Study|Protocol Violation|2|||
131692729|NCT00401375|474158358|FG002|Overall Study|Protocol Violation|1|||
131692730|NCT00401375|474158356|FG000|Overall Study|Adverse Event|6|||
131692731|NCT00401375|474158357|FG001|Overall Study|Adverse Event|11|||
131692732|NCT00401375|474158358|FG002|Overall Study|Adverse Event|10|||
131692733|NCT00401375|474158356|FG000|Overall Study|Withdrawal by Subject|9|||
131692734|NCT00401375|474158357|FG001|Overall Study|Withdrawal by Subject|7|||
131692735|NCT00401375|474158358|FG002|Overall Study|Withdrawal by Subject|7|||
131692736|NCT00401375|474158356|FG000|Overall Study|Lost to Follow-up|0|||
131692737|NCT00401375|474158357|FG001|Overall Study|Lost to Follow-up|1|||
131692738|NCT00401375|474158358|FG002|Overall Study|Lost to Follow-up|1|||
131692739|NCT00401375|474158356|FG000|Overall Study|Other than specified|2|||
131692740|NCT00401375|474158357|FG001|Overall Study|Other than specified|1|||
131692741|NCT00401375|474158358|FG002|Overall Study|Other than specified|3|||
131692742|NCT00401375|474158356|FG000|Overall Study|Randomized but not treated|3|||
131692743|NCT00401375|474158357|FG001|Overall Study|Randomized but not treated|3|||
131692744|NCT00401375|474158358|FG002|Overall Study|Randomized but not treated|3|||
131692745|NCT00677014|474158359|FG000|Overall Study|Lost to Follow-up|20|||
131692746|NCT00677014|474158360|FG001|Overall Study|Lost to Follow-up|12|||
131692747|NCT00677014|474158361|FG002|Overall Study|Lost to Follow-up|24|||
131692748|NCT00677014|474158359|FG000|Overall Study|Death|6|||
131692749|NCT00677014|474158360|FG001|Overall Study|Death|15|||
131692750|NCT00677014|474158361|FG002|Overall Study|Death|7|||
131692751|NCT00677014|474158359|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
131692752|NCT00677014|474158360|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
131777938|NCT00877799|474467504|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131777939|NCT00877799|474467505|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131558061|NCT02531295|473669438|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
131692753|NCT00677014|474158361|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
131692754|NCT02821715|474158362|FG000|Overall Study|Protocol Violation|1|||
131558062|NCT02531295|473669439|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
131692755|NCT02821715|474158363|FG001|Overall Study|Protocol Violation|0|||
131692756|NCT02821715|474158364|FG002|Overall Study|Protocol Violation|0|||
131777940|NCT00877799|474467506|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131558063|NCT02531295|473669440|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
131692757|NCT02821715|474158365|FG003|Overall Study|Protocol Violation|0|||
131692758|NCT02821715|474158366|FG004|Overall Study|Protocol Violation|0|||
131692759|NCT02821715|474158367|FG005|Overall Study|Protocol Violation|0|||
131558064|NCT02531295|473669441|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
131558065|NCT03545113|473669442|FG000|Overall Study|Surgery Cancelled|1|||
131558066|NCT03545113|473669443|FG001|Overall Study|Surgery Cancelled|0|||
131558067|NCT03545113|473669442|FG000|Overall Study|Death|1|||
131558068|NCT03545113|473669443|FG001|Overall Study|Death|0|||
131558069|NCT03545113|473669442|FG000|Overall Study|Adverse Event|2|||
131558070|NCT03545113|473669443|FG001|Overall Study|Adverse Event|0|||
131558071|NCT03545113|473669442|FG000|Overall Study|Received different surgery|1|||
131558072|NCT03545113|473669443|FG001|Overall Study|Received different surgery|0|||
131558073|NCT01804673|473669444|FG000|Overall Study|Adverse Event|4|||
131558074|NCT01804673|473669444|FG000|Overall Study|Withdrawal by Subject|1|||
131558075|NCT01804673|473669444|FG000|Overall Study|Lack of Efficacy|9|||
131558076|NCT01804673|473669444|FG000|Overall Study|Change to Oral Therapy|37|||
131558077|NCT01804673|473669444|FG000|Overall Study|No Further Therapy Required|84|||
131558078|NCT01804673|473669444|FG000|Overall Study|Use of Prohibited Medication|1|||
131558079|NCT01804673|473669444|FG000|Overall Study|Other|4|||
131558080|NCT01533714|473669445|FG000|Overall Study|Adverse Event|0|||
131558081|NCT01533714|473669446|FG001|Overall Study|Adverse Event|1|||
131558082|NCT01533714|473669447|FG002|Overall Study|Adverse Event|2|||
131558083|NCT01533714|473669448|FG003|Overall Study|Adverse Event|2|||
131558084|NCT01533714|473669449|FG004|Overall Study|Adverse Event|2|||
131558085|NCT01533714|473669450|FG005|Overall Study|Adverse Event|1|||
131558086|NCT01533714|473669445|FG000|Overall Study|Lack of Efficacy|0|||
131558087|NCT01533714|473669446|FG001|Overall Study|Lack of Efficacy|0|||
131558088|NCT01533714|473669447|FG002|Overall Study|Lack of Efficacy|0|||
131558089|NCT01533714|473669448|FG003|Overall Study|Lack of Efficacy|0|||
131558090|NCT01533714|473669449|FG004|Overall Study|Lack of Efficacy|0|||
131558091|NCT01533714|473669450|FG005|Overall Study|Lack of Efficacy|1|||
131558092|NCT01533714|473669445|FG000|Overall Study|Withdrawal by Subject|0|||
131558093|NCT01533714|473669446|FG001|Overall Study|Withdrawal by Subject|1|||
131558094|NCT01533714|473669447|FG002|Overall Study|Withdrawal by Subject|0|||
131558095|NCT01533714|473669448|FG003|Overall Study|Withdrawal by Subject|1|||
131558096|NCT01533714|473669449|FG004|Overall Study|Withdrawal by Subject|1|||
131558097|NCT01533714|473669450|FG005|Overall Study|Withdrawal by Subject|0|||
131558098|NCT01533714|473669445|FG000|Overall Study|Exclusion criteria|0|||
131558099|NCT01533714|473669446|FG001|Overall Study|Exclusion criteria|1|||
131558100|NCT01533714|473669447|FG002|Overall Study|Exclusion criteria|0|||
131558101|NCT01533714|473669448|FG003|Overall Study|Exclusion criteria|0|||
131558102|NCT01533714|473669449|FG004|Overall Study|Exclusion criteria|0|||
131558103|NCT01533714|473669450|FG005|Overall Study|Exclusion criteria|0|||
131558104|NCT01533714|473669445|FG000|Overall Study|Positive for purified protein derivative|0|||
131558105|NCT01533714|473669446|FG001|Overall Study|Positive for purified protein derivative|0|||
131558106|NCT01533714|473669447|FG002|Overall Study|Positive for purified protein derivative|1|||
131558107|NCT01533714|473669448|FG003|Overall Study|Positive for purified protein derivative|0|||
131558108|NCT01533714|473669449|FG004|Overall Study|Positive for purified protein derivative|1|||
131558109|NCT01533714|473669450|FG005|Overall Study|Positive for purified protein derivative|0|||
131558110|NCT01533714|473669445|FG000|Overall Study|Withdrawal criteria|0|||
131558111|NCT01533714|473669446|FG001|Overall Study|Withdrawal criteria|0|||
131558112|NCT01533714|473669447|FG002|Overall Study|Withdrawal criteria|1|||
131558113|NCT01533714|473669448|FG003|Overall Study|Withdrawal criteria|0|||
131558114|NCT01533714|473669449|FG004|Overall Study|Withdrawal criteria|3|||
131558115|NCT01533714|473669450|FG005|Overall Study|Withdrawal criteria|1|||
131558116|NCT01533714|473669445|FG000|Overall Study|Ineligibility reason|0|||
131558117|NCT01533714|473669446|FG001|Overall Study|Ineligibility reason|0|||
131558118|NCT01533714|473669447|FG002|Overall Study|Ineligibility reason|0|||
131558119|NCT01533714|473669448|FG003|Overall Study|Ineligibility reason|1|||
131558120|NCT01533714|473669449|FG004|Overall Study|Ineligibility reason|0|||
131692760|NCT00640328|474158368|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131692761|NCT00640328|474158369|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
131692762|NCT00640328|474158370|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131692763|NCT00640328|474158371|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131692764|NCT00640328|474158372|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131692765|NCT00640328|474158373|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131692766|NCT00640328|474158368|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131558121|NCT01533714|473669450|FG005|Overall Study|Ineligibility reason|0|||
131558122|NCT01844115|473669454|FG000|Overall Study|Adverse Event|4|||
131558123|NCT01844115|473669455|FG001|Overall Study|Adverse Event|22|||
131558124|NCT01844115|473669454|FG000|Overall Study|Lack of Efficacy|1|||
131558125|NCT01844115|473669455|FG001|Overall Study|Lack of Efficacy|4|||
131558126|NCT01844115|473669454|FG000|Overall Study|Protocol Violation|12|||
131558127|NCT01844115|473669455|FG001|Overall Study|Protocol Violation|10|||
131558128|NCT01844115|473669454|FG000|Overall Study|Withdrawal by Subject|11|||
131558129|NCT01844115|473669455|FG001|Overall Study|Withdrawal by Subject|11|||
131558130|NCT01844115|473669454|FG000|Overall Study|Lost to Follow-up|11|||
131558131|NCT01844115|473669455|FG001|Overall Study|Lost to Follow-up|10|||
131558132|NCT01844115|473669454|FG000|Overall Study|Pregnancy|0|||
131558133|NCT01844115|473669455|FG001|Overall Study|Pregnancy|1|||
131558134|NCT00758160|473669456|FG000|Overall Study|No Longer Requires Study Medication|4|||
131558135|NCT00758160|473669456|FG000|Overall Study|Administration Problems|3|||
131558136|NCT00758160|473669456|FG000|Overall Study|Adverse Event|15|||
131558137|NCT00758160|473669456|FG000|Overall Study|Lack of Efficacy|10|||
131558138|NCT00758160|473669456|FG000|Overall Study|Lost to Follow-up|14|||
131558139|NCT00758160|473669456|FG000|Overall Study|Protocol Violation|12|||
131558140|NCT00758160|473669456|FG000|Overall Study|Withdrawal by Subject|8|||
131558141|NCT01613027|473669457|FG000|Overall Study|Lost to Follow-up|5|||
131558142|NCT01613027|473669457|FG000|Overall Study|Switched Physician|1|||
131558143|NCT01613027|473669457|FG000|Overall Study|Lack of Efficacy|1|||
131558144|NCT01613027|473669457|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
131558145|NCT00993317|473669458|FG000|Overall Study|Adverse Event|2|||
131558146|NCT00993317|473669459|FG001|Overall Study|Adverse Event|4|||
131558147|NCT00993317|473669458|FG000|Overall Study|Lack of Efficacy|18|||
131558148|NCT00993317|473669459|FG001|Overall Study|Lack of Efficacy|18|||
131558149|NCT00993317|473669458|FG000|Overall Study|Withdrawal by Subject|0|||
131558150|NCT00993317|473669459|FG001|Overall Study|Withdrawal by Subject|2|||
131558151|NCT00993317|473669458|FG000|Overall Study|Investigator's opinion|0|||
131558152|NCT00993317|473669459|FG001|Overall Study|Investigator's opinion|1|||
131558153|NCT00993317|473669458|FG000|Overall Study|Early study termination at the site|1|||
131558154|NCT00993317|473669459|FG001|Overall Study|Early study termination at the site|0|||
131558155|NCT02153359|473669460|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
131558156|NCT02153359|473669461|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
131558157|NCT04422639|473669462|FG000|Overall Study|Death|1|||
131558158|NCT04422639|473669463|FG001|Overall Study|Death|0|||
131558159|NCT04422639|473669462|FG000|Overall Study|study closed prior to completion of FU visits|0|||
131558160|NCT04422639|473669463|FG001|Overall Study|study closed prior to completion of FU visits|2|||
131558161|NCT01964521|473669464|FG000|Overall Study|Lost to Follow-up|4|||
131558162|NCT01108510|473669465|FG000|Overall Study|Randomized but Not Treated|5|||
131558163|NCT01108510|473669466|FG001|Overall Study|Randomized but Not Treated|1|||
131558164|NCT01108510|473669465|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
131558165|NCT01108510|473669466|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
131558166|NCT01108510|473669465|FG000|Overall Study|Adverse Event|26|||
131558167|NCT01108510|473669466|FG001|Overall Study|Adverse Event|19|||
131558168|NCT01108510|473669465|FG000|Overall Study|Lost to Follow-up|20|||
131558169|NCT01108510|473669466|FG001|Overall Study|Lost to Follow-up|17|||
131558170|NCT01108510|473669465|FG000|Overall Study|Withdrew Consent|21|||
131558171|NCT01108510|473669466|FG001|Overall Study|Withdrew Consent|15|||
131558172|NCT01108510|473669465|FG000|Overall Study|Investigator's Discretion|12|||
131558173|NCT01108510|473669466|FG001|Overall Study|Investigator's Discretion|10|||
131558174|NCT01108510|473669465|FG000|Overall Study|Participant Noncompliance|5|||
131558175|NCT01108510|473669466|FG001|Overall Study|Participant Noncompliance|7|||
131558176|NCT01108510|473669465|FG000|Overall Study|Lack of Efficacy|3|||
131558177|NCT01108510|473669466|FG001|Overall Study|Lack of Efficacy|0|||
131558178|NCT01108510|473669465|FG000|Overall Study|Pregnancy|0|||
131558179|NCT01108510|473669466|FG001|Overall Study|Pregnancy|3|||
131558180|NCT01108510|473669465|FG000|Overall Study|Death|1|||
131558181|NCT01108510|473669466|FG001|Overall Study|Death|1|||
131558182|NCT02796963|473669467|FG000|Overall Study|Lost to Follow-up|89|||
131558183|NCT02796963|473669468|FG001|Overall Study|Lost to Follow-up|76|||
131558184|NCT02796963|473669469|FG002|Overall Study|Lost to Follow-up|69|||
131558185|NCT02796963|473669470|FG003|Overall Study|Lost to Follow-up|72|||
131558186|NCT01258660|473669472|FG000|Overall Study|Adverse Event|2|||
131558187|NCT01258660|473669473|FG001|Overall Study|Adverse Event|4|||
131558188|NCT01258660|473669472|FG000|Overall Study|Withdrawal by Subject|3|||
131558189|NCT01258660|473669473|FG001|Overall Study|Withdrawal by Subject|0|||
131558190|NCT01258660|473669472|FG000|Overall Study|due to relocation|2|||
131558191|NCT01258660|473669473|FG001|Overall Study|due to relocation|0|||
131558192|NCT01258660|473669472|FG000|Overall Study|Protocol Violation|0|||
131558193|NCT01258660|473669473|FG001|Overall Study|Protocol Violation|1|||
131558194|NCT01258660|473669472|FG000|Overall Study|Invalid for primary analysis data set|4|||
131558195|NCT01258660|473669473|FG001|Overall Study|Invalid for primary analysis data set|6|||
131558196|NCT04192630|473669474|FG000|Overall Study|Discontinued before surgery|2|||
131558197|NCT04192630|473669475|FG001|Overall Study|Discontinued before surgery|0|||
131558198|NCT04192630|473669474|FG000|Overall Study|Discontinued after surgery|5|||
131558199|NCT04192630|473669475|FG001|Overall Study|Discontinued after surgery|3|||
131558200|NCT01193582|473669476|FG000|Vaccination Series|Withdrawal by Subject|11|||
131558201|NCT01193582|473669477|FG001|Vaccination Series|Withdrawal by Subject|13|||
131558202|NCT01193582|473669478|FG002|Vaccination Series|Withdrawal by Subject|8|||
131558203|NCT01193582|473669479|FG003|Vaccination Series|Withdrawal by Subject|3|||
131558204|NCT01193582|473669476|FG000|12 Month Follow-up|Death|0|||
131558205|NCT01193582|473669477|FG001|12 Month Follow-up|Death|0|||
131558206|NCT01193582|473669478|FG002|12 Month Follow-up|Death|1|||
131558207|NCT01193582|473669479|FG003|12 Month Follow-up|Death|0|||
131558208|NCT01193582|473669476|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
131558209|NCT01193582|473669477|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
131558210|NCT01193582|473669478|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
131558211|NCT01193582|473669479|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
131558212|NCT01425632|473669480|FG000|Overall Study|Adverse Event|0|||
131558213|NCT01425632|473669481|FG001|Overall Study|Adverse Event|1|||
131558214|NCT01425632|473669482|FG002|Overall Study|Adverse Event|1|||
131558215|NCT01425632|473669480|FG000|Overall Study|Physician Decision|1|||
131558216|NCT01425632|473669481|FG001|Overall Study|Physician Decision|0|||
131558217|NCT01425632|473669482|FG002|Overall Study|Physician Decision|0|||
131558218|NCT01425632|473669480|FG000|Overall Study|Protocol Violation|0|||
131558219|NCT01425632|473669481|FG001|Overall Study|Protocol Violation|0|||
131558220|NCT01425632|473669482|FG002|Overall Study|Protocol Violation|2|||
131558221|NCT01425632|473669480|FG000|Overall Study|Withdrawal by Subject|0|||
131558222|NCT01425632|473669481|FG001|Overall Study|Withdrawal by Subject|0|||
131558223|NCT01425632|473669482|FG002|Overall Study|Withdrawal by Subject|1|||
131558224|NCT01208415|473669485|FG000|Overall Study|Death|1|||
131558225|NCT01208415|473669485|FG000|Overall Study|Lost to Follow-up|2|||
131558226|NCT01208415|473669485|FG000|Overall Study|Withdrawal by Subject|3|||
131558227|NCT01208415|473669485|FG000|Overall Study|Device not placed|1|||
131558228|NCT01208415|473669485|FG000|Overall Study|Still be eligible for follow-up|33|||
131558229|NCT01115491|473669486|FG000|Overall Study|Death|22|||
131558230|NCT01115491|473669486|FG000|Overall Study|Adverse Event|3|||
131558231|NCT01115491|473669486|FG000|Overall Study|Lost to Follow-up|3|||
131558232|NCT01115491|473669486|FG000|Overall Study|Withdrawal by Subject|1|||
131558233|NCT01115491|473669486|FG000|Overall Study|Physician Decision|1|||
131558234|NCT04297241|473669487|FG000|Overall Study|Withdrawal by Subject|1|||
131558235|NCT04297241|473669487|FG000|Overall Study|Adverse Event|1|||
131558236|NCT04297241|473669487|FG000|Overall Study|Physician Decision|3|||
131558237|NCT03856996|473669491|FG000|Overall Study|Withdrawal by Subject|1|||
131692767|NCT00640328|474158369|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131692768|NCT00640328|474158370|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131692769|NCT00640328|474158371|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131692770|NCT00640328|474158372|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
131692771|NCT00640328|474158373|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131692772|NCT00640328|474158368|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131692773|NCT00640328|474158369|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131692774|NCT00640328|474158370|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
131692775|NCT00640328|474158371|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131692776|NCT00640328|474158372|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131692777|NCT00640328|474158373|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131692778|NCT00640328|474158368|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131692779|NCT00640328|474158369|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
131692780|NCT00640328|474158370|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131692781|NCT00640328|474158371|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
131692782|NCT00640328|474158372|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131692783|NCT00640328|474158373|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131692784|NCT02374099|474158374|FG000|Overall Study|Adverse Event|1|||
131692785|NCT02374099|474158375|FG001|Overall Study|Adverse Event|0|||
131692786|NCT02374099|474158374|FG000|Overall Study|Progressive Disease|35|||
131692787|NCT02374099|474158375|FG001|Overall Study|Progressive Disease|40|||
131692788|NCT02374099|474158374|FG000|Overall Study|Withdrawal by Subject|5|||
131692789|NCT02374099|474158375|FG001|Overall Study|Withdrawal by Subject|1|||
131692790|NCT02374099|474158374|FG000|Overall Study|Miscellaneous|2|||
131692791|NCT02374099|474158375|FG001|Overall Study|Miscellaneous|3|||
131692792|NCT02374099|474158374|FG000|Overall Study|Randomized, but not treated|2|||
131692793|NCT02374099|474158375|FG001|Overall Study|Randomized, but not treated|1|||
131692794|NCT02374099|474158374|FG000|Overall Study|Study Terminated by Sponsor|3|||
131558238|NCT03856996|473669492|FG001|Overall Study|Withdrawal by Subject|0|||
131558239|NCT03856996|473669491|FG000|Overall Study|Lost to Follow-up|0|||
131558240|NCT03856996|473669492|FG001|Overall Study|Lost to Follow-up|1|||
131692795|NCT02374099|474158375|FG001|Overall Study|Study Terminated by Sponsor|4|||
131692796|NCT01326546|474158376|FG000|Overall Study|Lost to Follow-up|8|||
131692797|NCT01326546|474158377|FG001|Overall Study|Lost to Follow-up|7|||
131692798|NCT01326546|474158376|FG000|Overall Study|Protocol Violation|3|||
131692799|NCT01326546|474158377|FG001|Overall Study|Protocol Violation|4|||
131692800|NCT01326546|474158376|FG000|Overall Study|Pregnancy|0|||
131777941|NCT00877799|474467502|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131558241|NCT03856996|473669491|FG000|Overall Study|Adverse Event|1|||
131558242|NCT03856996|473669492|FG001|Overall Study|Adverse Event|1|||
131558243|NCT03856996|473669491|FG000|Overall Study|Other|1|||
131558244|NCT03856996|473669492|FG001|Overall Study|Other|0|||
131558245|NCT02340520|473669495|FG000|Overall Study|Lost to Follow-up|1|||
131558246|NCT02340520|473669495|FG000|Overall Study|Patient did not take drug as specified|1|||
131558247|NCT02340520|473669495|FG000|Overall Study|Withdrawal by Subject|1|||
131558248|NCT01464255|473669496|FG000|Overall Study|unresolve corneal staining|0|||
131558249|NCT01464255|473669497|FG001|Overall Study|unresolve corneal staining|1|||
131558250|NCT01003639|473669498|FG000|Overall Study|Lost to Follow-up|6|||
131558251|NCT01003639|473669499|FG001|Overall Study|Lost to Follow-up|9|||
131558252|NCT01003639|473669498|FG000|Overall Study|Withdrawal by Subject|9|||
131558253|NCT01003639|473669499|FG001|Overall Study|Withdrawal by Subject|5|||
131558254|NCT01003639|473669498|FG000|Overall Study|Lack of Efficacy|1|||
131558255|NCT01003639|473669499|FG001|Overall Study|Lack of Efficacy|6|||
131558256|NCT01003639|473669498|FG000|Overall Study|Adverse Event|0|||
131558257|NCT01003639|473669499|FG001|Overall Study|Adverse Event|1|||
131558258|NCT01003639|473669498|FG000|Overall Study|Protocol Violation|0|||
131558259|NCT01003639|473669499|FG001|Overall Study|Protocol Violation|1|||
131558260|NCT01003639|473669498|FG000|Overall Study|Physician Decision|1|||
131558261|NCT01003639|473669499|FG001|Overall Study|Physician Decision|0|||
131558262|NCT01231503|473669500|FG000|Overall Study|Adverse Event|0|||
131558263|NCT01231503|473669501|FG001|Overall Study|Adverse Event|0|||
131558264|NCT01231503|473669502|FG002|Overall Study|Adverse Event|0|||
131558265|NCT01231503|473669503|FG003|Overall Study|Adverse Event|0|||
131558266|NCT01231503|473669504|FG004|Overall Study|Adverse Event|0|||
131558267|NCT01231503|473669505|FG005|Overall Study|Adverse Event|1|||
131558268|NCT01231503|473669506|FG006|Overall Study|Adverse Event|0|||
131558269|NCT01231503|473669507|FG007|Overall Study|Adverse Event|0|||
131558270|NCT01231503|473669500|FG000|Overall Study|Adverse event, serious fatal|0|||
131558271|NCT01231503|473669501|FG001|Overall Study|Adverse event, serious fatal|0|||
131558272|NCT01231503|473669502|FG002|Overall Study|Adverse event, serious fatal|1|||
131558273|NCT01231503|473669503|FG003|Overall Study|Adverse event, serious fatal|1|||
131558274|NCT01231503|473669504|FG004|Overall Study|Adverse event, serious fatal|0|||
131558275|NCT01231503|473669505|FG005|Overall Study|Adverse event, serious fatal|1|||
131558276|NCT01231503|473669506|FG006|Overall Study|Adverse event, serious fatal|0|||
131558277|NCT01231503|473669507|FG007|Overall Study|Adverse event, serious fatal|0|||
131558278|NCT01231503|473669500|FG000|Overall Study|Withdrawal by Subject|6|||
131558279|NCT01231503|473669501|FG001|Overall Study|Withdrawal by Subject|3|||
131558280|NCT01231503|473669502|FG002|Overall Study|Withdrawal by Subject|3|||
131558281|NCT01231503|473669503|FG003|Overall Study|Withdrawal by Subject|1|||
131558282|NCT01231503|473669504|FG004|Overall Study|Withdrawal by Subject|3|||
131558283|NCT01231503|473669505|FG005|Overall Study|Withdrawal by Subject|5|||
131558284|NCT01231503|473669506|FG006|Overall Study|Withdrawal by Subject|1|||
131558285|NCT01231503|473669507|FG007|Overall Study|Withdrawal by Subject|2|||
131558286|NCT01231503|473669500|FG000|Overall Study|Lost to Follow-up|8|||
131558287|NCT01231503|473669501|FG001|Overall Study|Lost to Follow-up|10|||
131558288|NCT01231503|473669502|FG002|Overall Study|Lost to Follow-up|8|||
131558289|NCT01231503|473669503|FG003|Overall Study|Lost to Follow-up|5|||
131558290|NCT01231503|473669504|FG004|Overall Study|Lost to Follow-up|7|||
131558291|NCT01231503|473669505|FG005|Overall Study|Lost to Follow-up|9|||
131558292|NCT01231503|473669506|FG006|Overall Study|Lost to Follow-up|6|||
131558293|NCT01231503|473669507|FG007|Overall Study|Lost to Follow-up|6|||
131558294|NCT01231503|473669500|FG000|Overall Study|Protocol Violation|0|||
131558295|NCT01231503|473669501|FG001|Overall Study|Protocol Violation|0|||
131558296|NCT01231503|473669502|FG002|Overall Study|Protocol Violation|0|||
131558297|NCT01231503|473669503|FG003|Overall Study|Protocol Violation|1|||
131558298|NCT01231503|473669504|FG004|Overall Study|Protocol Violation|0|||
131558299|NCT01231503|473669505|FG005|Overall Study|Protocol Violation|0|||
131558300|NCT01231503|473669506|FG006|Overall Study|Protocol Violation|0|||
131558301|NCT01231503|473669507|FG007|Overall Study|Protocol Violation|0|||
131692801|NCT01326546|474158377|FG001|Overall Study|Pregnancy|1|||
131692802|NCT01326546|474158376|FG000|Overall Study|Adverse Event|1|||
131692803|NCT01326546|474158377|FG001|Overall Study|Adverse Event|0|||
131692804|NCT01326546|474158376|FG000|Overall Study|Withdrawal by Subject|5|||
131692805|NCT01326546|474158377|FG001|Overall Study|Withdrawal by Subject|1|||
131692806|NCT03152019|474158378|FG000|Overall Study|Adverse Event|0|||
131692807|NCT03152019|474158379|FG001|Overall Study|Adverse Event|1|||
131692808|NCT04294719|474158380|FG000|Overall Study|Withdrawal by Subject|1|||
131692809|NCT00081159|474158381|FG000|Overall Study|Withdrawal by Subject|0|||
131692810|NCT00081159|474158382|FG001|Overall Study|Withdrawal by Subject|3|||
131558302|NCT01586338|473669509|FG000|Overall Study|Adverse Event|3|||
131558303|NCT01586338|473669509|FG000|Overall Study|Lost to Follow-up|1|||
131558304|NCT01586338|473669509|FG000|Overall Study|Withdrawal by participant|3|||
131558305|NCT01586338|473669509|FG000|Overall Study|Other|1|||
131558306|NCT00284089|473669512|FG000|Multiple Dose Phase|Adverse Event|1|||
131558307|NCT00284089|473669513|FG001|Multiple Dose Phase|Adverse Event|0|||
131558308|NCT00284089|473669514|FG002|Multiple Dose Phase|Adverse Event|1|||
131558309|NCT00284089|473669515|FG003|Multiple Dose Phase|Adverse Event|1|||
131558310|NCT00284089|473669512|FG000|Multiple Dose Phase|Protocol Violation|0|||
131558311|NCT00284089|473669513|FG001|Multiple Dose Phase|Protocol Violation|0|||
131558312|NCT00284089|473669514|FG002|Multiple Dose Phase|Protocol Violation|1|||
131692811|NCT00081159|474158381|FG000|Overall Study|Myelosuppression prior to treatment|0|||
131558313|NCT00284089|473669515|FG003|Multiple Dose Phase|Protocol Violation|0|||
131558314|NCT00284089|473669512|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
131558315|NCT00284089|473669513|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
131558316|NCT00284089|473669514|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
131558317|NCT00284089|473669515|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
131558318|NCT00284089|473669512|FG000|Multiple Dose Phase|Death|0|||
131558319|NCT00284089|473669513|FG001|Multiple Dose Phase|Death|0|||
131558320|NCT00284089|473669514|FG002|Multiple Dose Phase|Death|1|||
131558321|NCT00284089|473669515|FG003|Multiple Dose Phase|Death|1|||
131558322|NCT00284089|473669512|FG000|Extension Phase|Adverse Event|0|||
131558323|NCT00284089|473669513|FG001|Extension Phase|Adverse Event|0|||
131558324|NCT00284089|473669514|FG002|Extension Phase|Adverse Event|2|||
131558325|NCT00284089|473669515|FG003|Extension Phase|Adverse Event|2|||
131558326|NCT00284089|473669512|FG000|Extension Phase|condition no longer requires study drug|2|||
131558327|NCT00284089|473669513|FG001|Extension Phase|condition no longer requires study drug|0|||
131558328|NCT00284089|473669514|FG002|Extension Phase|condition no longer requires study drug|2|||
131558329|NCT00284089|473669515|FG003|Extension Phase|condition no longer requires study drug|7|||
131558330|NCT00284089|473669512|FG000|Extension Phase|Protocol Violation|0|||
131558331|NCT00284089|473669513|FG001|Extension Phase|Protocol Violation|0|||
131558332|NCT00284089|473669514|FG002|Extension Phase|Protocol Violation|1|||
131558333|NCT00284089|473669515|FG003|Extension Phase|Protocol Violation|0|||
131558334|NCT00284089|473669512|FG000|Extension Phase|Withdrawal by Subject|0|||
131558335|NCT00284089|473669513|FG001|Extension Phase|Withdrawal by Subject|0|||
131558336|NCT00284089|473669514|FG002|Extension Phase|Withdrawal by Subject|1|||
131558337|NCT00284089|473669515|FG003|Extension Phase|Withdrawal by Subject|3|||
131558338|NCT04362137|473669518|FG000|Overall Study|Death|9|||
131558339|NCT04362137|473669519|FG001|Overall Study|Death|3|||
131558340|NCT04362137|473669518|FG000|Overall Study|Patient decision|6|||
131558341|NCT04362137|473669519|FG001|Overall Study|Patient decision|3|||
131558342|NCT04362137|473669518|FG000|Overall Study|Adverse Event|1|||
131558343|NCT04362137|473669519|FG001|Overall Study|Adverse Event|0|||
131558344|NCT04362137|473669518|FG000|Overall Study|Lost to Follow-up|1|||
131558345|NCT04362137|473669519|FG001|Overall Study|Lost to Follow-up|0|||
131558346|NCT04362137|473669518|FG000|Overall Study|Protocol deviation|1|||
131558347|NCT04362137|473669519|FG001|Overall Study|Protocol deviation|0|||
131558348|NCT01868074|473669520|FG000|Overall Study|Lost to Follow-up|3|||
131558349|NCT01868074|473669521|FG001|Overall Study|Lost to Follow-up|2|||
131558350|NCT01868074|473669520|FG000|Overall Study|Withdrawal by Subject|4|||
131692812|NCT00081159|474158382|FG001|Overall Study|Myelosuppression prior to treatment|1|||
131558351|NCT01868074|473669521|FG001|Overall Study|Withdrawal by Subject|2|||
131692813|NCT00081159|474158381|FG000|Overall Study|Lost to Follow-up|2|||
131692814|NCT00081159|474158382|FG001|Overall Study|Lost to Follow-up|1|||
131692815|NCT01714687|474158385|FG000|Overall Study|Withdrawal by Subject|1|||
131692816|NCT01714687|474158386|FG001|Overall Study|Withdrawal by Subject|0|||
131692817|NCT01714687|474158385|FG000|Overall Study|Lost to Follow-up|2|||
131692818|NCT01714687|474158386|FG001|Overall Study|Lost to Follow-up|4|||
131692819|NCT01553136|474158387|FG000|Overall Study|Adverse Event|3|||
131692820|NCT01553136|474158388|FG001|Overall Study|Adverse Event|2|||
131692821|NCT01553136|474158387|FG000|Overall Study|Withdrawal by Subject|2|||
131692822|NCT01553136|474158388|FG001|Overall Study|Withdrawal by Subject|3|||
131692823|NCT01553136|474158387|FG000|Overall Study|Lost to Follow-up|4|||
131692824|NCT01553136|474158388|FG001|Overall Study|Lost to Follow-up|10|||
131692825|NCT01553136|474158387|FG000|Overall Study|Physician Decision|2|||
131692826|NCT01553136|474158388|FG001|Overall Study|Physician Decision|3|||
131692827|NCT01553136|474158387|FG000|Overall Study|Scheduling Difficulties|5|||
131692828|NCT01553136|474158388|FG001|Overall Study|Scheduling Difficulties|4|||
131692829|NCT00894556|474158391|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
131692830|NCT00894556|474158392|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
131692831|NCT00894556|474158393|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
131692832|NCT00894556|474158394|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
131692833|NCT00894556|474158391|FG000|Treatment Phase|Lost to Follow-up|2|||
131558352|NCT03306043|473669525|FG000|Overall Study|Adverse Event|1|||
131558353|NCT03306043|473669525|FG000|Overall Study|Lost to Follow-up|1|||
131558354|NCT03306043|473669525|FG000|Overall Study|Withdrawal by Subject|2|||
131558355|NCT00785538|473669526|FG000|Treatment Period|Adverse Event|1|||
131692834|NCT00894556|474158392|FG001|Treatment Phase|Lost to Follow-up|3|||
131692835|NCT00894556|474158393|FG002|Treatment Phase|Lost to Follow-up|1|||
131692836|NCT00894556|474158394|FG003|Treatment Phase|Lost to Follow-up|0|||
131558356|NCT00785538|473669527|FG001|Treatment Period|Adverse Event|2|||
131692837|NCT00894556|474158391|FG000|Treatment Phase|Lack of Qualifying Event|2|||
131692838|NCT00894556|474158392|FG001|Treatment Phase|Lack of Qualifying Event|1|||
131692839|NCT00894556|474158393|FG002|Treatment Phase|Lack of Qualifying Event|0|||
131692840|NCT00894556|474158394|FG003|Treatment Phase|Lack of Qualifying Event|0|||
131558357|NCT00785538|473669528|FG002|Treatment Period|Adverse Event|2|||
131558358|NCT00785538|473669529|FG003|Treatment Period|Adverse Event|0|||
131558359|NCT00785538|473669526|FG000|Treatment Period|Withdrawal by Subject|0|||
131777942|NCT00877799|474467503|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131777943|NCT00877799|474467504|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131777944|NCT00877799|474467505|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
131777945|NCT00877799|474467506|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131777946|NCT00877799|474467502|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
131777947|NCT00877799|474467503|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
131777948|NCT00877799|474467504|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
131777949|NCT00877799|474467505|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
131777950|NCT00877799|474467506|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
131777951|NCT03664024|474467511|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
131777952|NCT03664024|474467511|FG000|Overall Study|Lost to Follow-up|2|||
131777953|NCT03664024|474467511|FG000|Overall Study|Withdrawal by Subject|2|||
131777954|NCT03664024|474467511|FG000|Overall Study|Death|80|||
131777955|NCT00077766|474467512|FG000|Overall Study|Adverse Event|1|||
131777956|NCT00077766|474467513|FG001|Overall Study|Adverse Event|1|||
131777957|NCT00077766|474467512|FG000|Overall Study|Withdrawal by Subject|4|||
131777958|NCT00077766|474467513|FG001|Overall Study|Withdrawal by Subject|3|||
131777959|NCT00077766|474467512|FG000|Overall Study|Death|12|||
131777960|NCT00077766|474467513|FG001|Overall Study|Death|10|||
131777961|NCT00077766|474467512|FG000|Overall Study|Lost to Follow-up|2|||
131777962|NCT00077766|474467513|FG001|Overall Study|Lost to Follow-up|0|||
131777963|NCT00077766|474467512|FG000|Overall Study|Protocol Violation|1|||
131777964|NCT00077766|474467513|FG001|Overall Study|Protocol Violation|0|||
131777965|NCT00077766|474467512|FG000|Overall Study|Kidney Transplantation|9|||
131777966|NCT00077766|474467513|FG001|Overall Study|Kidney Transplantation|5|||
131777967|NCT00077766|474467512|FG000|Overall Study|Transplantation|5|||
131777968|NCT00077766|474467513|FG001|Overall Study|Transplantation|1|||
131777969|NCT00077766|474467512|FG000|Overall Study|Investigators Discretion|1|||
131777970|NCT00077766|474467513|FG001|Overall Study|Investigators Discretion|0|||
131777971|NCT00077766|474467512|FG000|Overall Study|Participant's decision|1|||
131777972|NCT00077766|474467513|FG001|Overall Study|Participant's decision|0|||
131777973|NCT00077766|474467512|FG000|Overall Study|Dialysis Discontinued|1|||
131777974|NCT00077766|474467513|FG001|Overall Study|Dialysis Discontinued|0|||
131777975|NCT00077766|474467512|FG000|Overall Study|Dialysis|0|||
131777976|NCT00077766|474467513|FG001|Overall Study|Dialysis|1|||
131777977|NCT00077766|474467512|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
131777978|NCT00077766|474467513|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
131777979|NCT00077766|474467512|FG000|Overall Study|Started Nocturnal Dialysis|0|||
131777980|NCT00077766|474467513|FG001|Overall Study|Started Nocturnal Dialysis|1|||
131777981|NCT00077766|474467512|FG000|Overall Study|Stop Dialysis|0|||
131777982|NCT00077766|474467513|FG001|Overall Study|Stop Dialysis|1|||
131777983|NCT00077766|474467512|FG000|Overall Study|Participants Vacation|2|||
131558360|NCT00785538|473669527|FG001|Treatment Period|Withdrawal by Subject|0|||
131777984|NCT00077766|474467513|FG001|Overall Study|Participants Vacation|1|||
131777985|NCT01886105|474467514|FG000|Overall Study|Lack of Efficacy|3|||
131777986|NCT03843775|474467515|FG000|Overall Study|Adverse Event|1|||
131777987|NCT03843775|474467516|FG001|Overall Study|Adverse Event|1|||
131777988|NCT03843775|474467515|FG000|Overall Study|Lack of Efficacy|2|||
131777989|NCT03843775|474467516|FG001|Overall Study|Lack of Efficacy|6|||
131777990|NCT03843775|474467515|FG000|Overall Study|Withdrawal by Subject|0|||
131777991|NCT03843775|474467516|FG001|Overall Study|Withdrawal by Subject|1|||
131777992|NCT04150107|474467519|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
131777993|NCT04150107|474467520|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
131777994|NCT04150107|474467519|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
131777995|NCT04150107|474467520|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
131777996|NCT04636437|474467527|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
131777997|NCT04636437|474467528|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
131777998|NCT04636437|474467529|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
131898547|NCT02797678|474914124|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
131777999|NCT04636437|474467527|FG000|Overall Study|Started weight loss drug/program|2|||
131778000|NCT04636437|474467528|FG001|Overall Study|Started weight loss drug/program|1|||
131778001|NCT04636437|474467529|FG002|Overall Study|Started weight loss drug/program|1|||
131778002|NCT04636437|474467527|FG000|Overall Study|Lost to Follow-up|3|||
131778003|NCT04636437|474467528|FG001|Overall Study|Lost to Follow-up|1|||
131778004|NCT04636437|474467529|FG002|Overall Study|Lost to Follow-up|4|||
131778005|NCT04636437|474467527|FG000|Overall Study|Participant or physician decision|3|||
131558361|NCT00785538|473669528|FG002|Treatment Period|Withdrawal by Subject|0|||
131558362|NCT00785538|473669529|FG003|Treatment Period|Withdrawal by Subject|1|||
131558363|NCT01799720|473669530|FG000|Overall Study|Withdrawal by Subject|3|||
131558364|NCT01799720|473669531|FG001|Overall Study|Withdrawal by Subject|0|||
131558365|NCT01799720|473669532|FG002|Overall Study|Withdrawal by Subject|0|||
131558366|NCT01799720|473669530|FG000|Overall Study|Protocol Violation|0|||
131558367|NCT01799720|473669531|FG001|Overall Study|Protocol Violation|1|||
131558368|NCT01799720|473669532|FG002|Overall Study|Protocol Violation|0|||
131558369|NCT01799720|473669530|FG000|Overall Study|Pregnancy|0|||
131558370|NCT01799720|473669531|FG001|Overall Study|Pregnancy|0|||
131558371|NCT01799720|473669532|FG002|Overall Study|Pregnancy|1|||
131558372|NCT04276090|473669533|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
131558373|NCT04276090|473669534|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
131558374|NCT01234649|473669535|FG000|Overall Study|Withdrawal by Subject|32|||
131558375|NCT01234649|473669536|FG001|Overall Study|Withdrawal by Subject|26|||
131558376|NCT01234649|473669535|FG000|Overall Study|Pregnancy|6|||
131558377|NCT01234649|473669536|FG001|Overall Study|Pregnancy|6|||
131558378|NCT01234649|473669535|FG000|Overall Study|intolerant to side effects|4|||
131558379|NCT01234649|473669536|FG001|Overall Study|intolerant to side effects|3|||
131558380|NCT01234649|473669535|FG000|Overall Study|Allergic reaction|1|||
131558381|NCT01234649|473669536|FG001|Overall Study|Allergic reaction|0|||
131558382|NCT01234649|473669535|FG000|Overall Study|Lack of Efficacy|0|||
131558383|NCT01234649|473669536|FG001|Overall Study|Lack of Efficacy|3|||
131558384|NCT00318149|473669540|FG000|Overall Study|Adverse Event|0|||
131558385|NCT00318149|473669541|FG001|Overall Study|Adverse Event|0|||
131558386|NCT00318149|473669542|FG002|Overall Study|Adverse Event|0|||
131558387|NCT00318149|473669543|FG003|Overall Study|Adverse Event|0|||
131558388|NCT00318149|473669544|FG004|Overall Study|Adverse Event|0|||
131558389|NCT00318149|473669545|FG005|Overall Study|Adverse Event|2|||
131558390|NCT04642469|473669546|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
131558391|NCT04642469|473669547|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
131558392|NCT04642469|473669546|FG000|Overall Study|Death|1|||
131558393|NCT04642469|473669547|FG001|Overall Study|Death|2|||
131558394|NCT04642469|473669546|FG000|Overall Study|Study/site closed following amendment 1|11|||
131558395|NCT04642469|473669547|FG001|Overall Study|Study/site closed following amendment 1|11|||
131558396|NCT04642469|473669546|FG000|Overall Study|Other|1|||
131558397|NCT04642469|473669547|FG001|Overall Study|Other|1|||
131558398|NCT04642469|473669546|FG000|Overall Study|Withdrawal by Subject|1|||
131558399|NCT04642469|473669547|FG001|Overall Study|Withdrawal by Subject|0|||
131558400|NCT01461993|473669548|FG000|Overall Study|Withdrawal by Subject|60|||
131558401|NCT01461993|473669549|FG001|Overall Study|Withdrawal by Subject|53|||
131558402|NCT01461993|473669550|FG002|Overall Study|Withdrawal by Subject|16|||
131558403|NCT01461993|473669548|FG000|Overall Study|Lost to Follow-up|44|||
131558404|NCT01461993|473669549|FG001|Overall Study|Lost to Follow-up|48|||
131558405|NCT01461993|473669550|FG002|Overall Study|Lost to Follow-up|22|||
131558406|NCT01461993|473669548|FG000|Overall Study|Protocol Violation|10|||
131558407|NCT01461993|473669549|FG001|Overall Study|Protocol Violation|9|||
131558408|NCT01461993|473669550|FG002|Overall Study|Protocol Violation|7|||
131558409|NCT01461993|473669548|FG000|Overall Study|Adverse Event|9|||
131558410|NCT01461993|473669549|FG001|Overall Study|Adverse Event|11|||
131558411|NCT01461993|473669550|FG002|Overall Study|Adverse Event|3|||
131558412|NCT01461993|473669548|FG000|Overall Study|No longer met eligibility criteria|13|||
131558413|NCT01461993|473669549|FG001|Overall Study|No longer met eligibility criteria|18|||
131558414|NCT01461993|473669550|FG002|Overall Study|No longer met eligibility criteria|10|||
131558415|NCT01461993|473669548|FG000|Overall Study|Did not meet entrance criteria|2|||
131558416|NCT01461993|473669549|FG001|Overall Study|Did not meet entrance criteria|3|||
131558417|NCT01461993|473669550|FG002|Overall Study|Did not meet entrance criteria|0|||
131558418|NCT01461993|473669548|FG000|Overall Study|Other|13|||
131558419|NCT01461993|473669549|FG001|Overall Study|Other|15|||
131558420|NCT01461993|473669550|FG002|Overall Study|Other|6|||
131558421|NCT00680056|473669552|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
131558422|NCT00680056|473669553|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
131558423|NCT00680056|473669552|FG000|Second Intervention|Protocol Violation|3|||
131558424|NCT00680056|473669553|FG001|Second Intervention|Protocol Violation|1|||
131558425|NCT00219141|473669559|FG000|Overall Study|Adverse Event|4|||
131558426|NCT00219141|473669560|FG001|Overall Study|Adverse Event|10|||
131558427|NCT00219141|473669561|FG002|Overall Study|Adverse Event|5|||
131558428|NCT00219141|473669559|FG000|Overall Study|Lack of Efficacy|3|||
131692841|NCT01979536|474158397|FG000|Overall Study|Physician Decision|2|||
131692842|NCT01979536|474158398|FG001|Overall Study|Physician Decision|3|||
131692843|NCT01979536|474158397|FG000|Overall Study|Withdrawal by Subject|0|||
131558429|NCT00219141|473669560|FG001|Overall Study|Lack of Efficacy|2|||
131558430|NCT00219141|473669561|FG002|Overall Study|Lack of Efficacy|0|||
131558431|NCT00219141|473669559|FG000|Overall Study|Administrative problems|0|||
131558432|NCT00219141|473669560|FG001|Overall Study|Administrative problems|1|||
131558433|NCT00219141|473669561|FG002|Overall Study|Administrative problems|0|||
131558434|NCT00219141|473669559|FG000|Overall Study|Lost to Follow-up|2|||
131558435|NCT00219141|473669560|FG001|Overall Study|Lost to Follow-up|4|||
131558436|NCT00219141|473669561|FG002|Overall Study|Lost to Follow-up|1|||
131558437|NCT00219141|473669559|FG000|Overall Study|Protocol Violation|3|||
131558438|NCT00219141|473669560|FG001|Overall Study|Protocol Violation|1|||
131558439|NCT00219141|473669561|FG002|Overall Study|Protocol Violation|1|||
131558440|NCT00219141|473669559|FG000|Overall Study|Withdrawal by Subject|1|||
131558441|NCT00219141|473669560|FG001|Overall Study|Withdrawal by Subject|3|||
131558442|NCT00219141|473669561|FG002|Overall Study|Withdrawal by Subject|5|||
131558443|NCT00219141|473669559|FG000|Overall Study|Condition no longer requires study drug|1|||
131558444|NCT00219141|473669560|FG001|Overall Study|Condition no longer requires study drug|0|||
131558445|NCT00219141|473669561|FG002|Overall Study|Condition no longer requires study drug|0|||
131558446|NCT02838628|473669562|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
131558447|NCT02838628|473669563|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
131558448|NCT02838628|473669562|FG000|Recurrence Follow-up Period|Adverse Event|1|||
131558449|NCT02838628|473669563|FG001|Recurrence Follow-up Period|Adverse Event|0|||
131558450|NCT02838628|473669562|FG000|Recurrence Follow-up Period|Non-compliance|0|||
131558451|NCT02838628|473669563|FG001|Recurrence Follow-up Period|Non-compliance|1|||
131558452|NCT02838628|473669562|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
131558453|NCT02838628|473669563|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
131558454|NCT02838628|473669562|FG000|Recurrence Follow-up Period|Other un-specified|1|||
131558455|NCT02838628|473669563|FG001|Recurrence Follow-up Period|Other un-specified|1|||
131558456|NCT02066532|473669564|FG000|Phase II|Withdrawal by Subject|1|||
131558457|NCT02066532|473669565|FG001|Phase II|Withdrawal by Subject|0|||
131558458|NCT02066532|473669566|FG002|Phase II|Withdrawal by Subject|0|||
131558459|NCT02066532|473669567|FG003|Phase II|Withdrawal by Subject|0|||
131558460|NCT01265823|473669568|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
131558461|NCT01265823|473669568|FG000|Overall Study|Failure to Return|4|||
131558462|NCT01265823|473669568|FG000|Overall Study|Protocol Violation|1|||
131558463|NCT01265823|473669568|FG000|Overall Study|Participant Request|1|||
131558464|NCT01018563|473669575|FG000|Overall Study|Termination of the study by Sponsor|2|||
131558465|NCT01018563|473669576|FG001|Overall Study|Termination of the study by Sponsor|1|||
131558466|NCT02344537|473669577|FG000|Overall Study|Protocol Violation|1|||
131558467|NCT02344537|473669578|FG001|Overall Study|Protocol Violation|1|||
131558468|NCT02344537|473669577|FG000|Overall Study|Subject started another treatment after wk 6|1|||
131558469|NCT02344537|473669578|FG001|Overall Study|Subject started another treatment after wk 6|0|||
131558470|NCT02344537|473669577|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
131558471|NCT02344537|473669578|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
131558472|NCT00960752|473669580|FG000|Overall Study|Adverse Event|0|||
131558473|NCT00960752|473669581|FG001|Overall Study|Adverse Event|0|||
131558474|NCT00960752|473669582|FG002|Overall Study|Adverse Event|1|||
131558475|NCT00960752|473669580|FG000|Overall Study|Progression|0|||
131558476|NCT00960752|473669581|FG001|Overall Study|Progression|0|||
131558477|NCT00960752|473669582|FG002|Overall Study|Progression|1|||
131558478|NCT02180438|473669588|FG000|Overall Study|Lost to Follow-up|1|||
131558479|NCT00785707|473669590|FG000|Overall Study|Lost to Follow-up|7|||
131558480|NCT00105586|473669591|FG000|Overall Study|Adverse Event|4|||
131692844|NCT01979536|474158398|FG001|Overall Study|Withdrawal by Subject|1|||
131692845|NCT01979536|474158397|FG000|Overall Study|Refusal|0|||
131692846|NCT01979536|474158398|FG001|Overall Study|Refusal|1|||
131692847|NCT01979536|474158397|FG000|Overall Study|Relapse|0|||
131692848|NCT01979536|474158398|FG001|Overall Study|Relapse|1|||
131692849|NCT01979536|474158397|FG000|Overall Study|Study terminated by Sponsor|0|||
131692850|NCT01979536|474158398|FG001|Overall Study|Study terminated by Sponsor|1|||
131692851|NCT01979536|474158397|FG000|Overall Study|Did not start treatment|0|||
131692852|NCT01979536|474158398|FG001|Overall Study|Did not start treatment|1|||
131692853|NCT03077685|474158399|FG000|Overall Study|Lost to Follow-up|0|||
131692854|NCT03077685|474158400|FG001|Overall Study|Lost to Follow-up|0|||
131692855|NCT03077685|474158401|FG002|Overall Study|Lost to Follow-up|0|||
131692856|NCT03077685|474158402|FG003|Overall Study|Lost to Follow-up|0|||
131692857|NCT03077685|474158403|FG004|Overall Study|Lost to Follow-up|1|||
131692858|NCT03077685|474158399|FG000|Overall Study|Death|0|||
131692859|NCT03077685|474158400|FG001|Overall Study|Death|0|||
131692860|NCT03077685|474158401|FG002|Overall Study|Death|1|||
131692861|NCT03077685|474158402|FG003|Overall Study|Death|1|||
131692862|NCT03077685|474158403|FG004|Overall Study|Death|3|||
131692863|NCT03077685|474158399|FG000|Overall Study|Withdrawal by Subject|0|||
131692864|NCT03077685|474158400|FG001|Overall Study|Withdrawal by Subject|0|||
131692865|NCT03077685|474158401|FG002|Overall Study|Withdrawal by Subject|0|||
131692866|NCT03077685|474158402|FG003|Overall Study|Withdrawal by Subject|2|||
131692867|NCT03077685|474158403|FG004|Overall Study|Withdrawal by Subject|1|||
131558481|NCT00105586|473669592|FG001|Overall Study|Adverse Event|3|||
131558482|NCT00105586|473669591|FG000|Overall Study|Physician Decision|13|||
131558483|NCT00105586|473669592|FG001|Overall Study|Physician Decision|13|||
131558484|NCT02306122|473669593|FG000|Initial Physician Randomization|Physician Decision|0|||
131692868|NCT03077685|474158399|FG000|Overall Study|Physician Decision|0|||
131692869|NCT03077685|474158400|FG001|Overall Study|Physician Decision|0|||
131692870|NCT03077685|474158401|FG002|Overall Study|Physician Decision|1|||
131692871|NCT03077685|474158402|FG003|Overall Study|Physician Decision|0|||
131692872|NCT03077685|474158403|FG004|Overall Study|Physician Decision|3|||
131692873|NCT03077685|474158399|FG000|Overall Study|Disease Progression|1|||
131692874|NCT03077685|474158400|FG001|Overall Study|Disease Progression|0|||
131692875|NCT03077685|474158401|FG002|Overall Study|Disease Progression|0|||
131692876|NCT03077685|474158402|FG003|Overall Study|Disease Progression|2|||
131692877|NCT03077685|474158403|FG004|Overall Study|Disease Progression|1|||
131692878|NCT03077685|474158399|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
131692879|NCT03077685|474158400|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
131692880|NCT03077685|474158401|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
131692881|NCT03077685|474158402|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
131692882|NCT03077685|474158403|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
131692883|NCT03077685|474158399|FG000|Overall Study|Subject entered hospice care|0|||
131692884|NCT03077685|474158400|FG001|Overall Study|Subject entered hospice care|0|||
131692885|NCT03077685|474158401|FG002|Overall Study|Subject entered hospice care|0|||
131692886|NCT03077685|474158402|FG003|Overall Study|Subject entered hospice care|0|||
131692887|NCT03077685|474158403|FG004|Overall Study|Subject entered hospice care|1|||
131692888|NCT00609791|474160006|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
131692889|NCT01394939|474160011|FG000|Overall Study|Adverse Event|1|||
131692890|NCT01394939|474160012|FG001|Overall Study|Adverse Event|3|||
131692891|NCT01394939|474160013|FG002|Overall Study|Adverse Event|0|||
131692892|NCT01394939|474160014|FG003|Overall Study|Adverse Event|2|||
131692893|NCT01394939|474160011|FG000|Overall Study|Death|0|||
131692894|NCT01394939|474160012|FG001|Overall Study|Death|2|||
131692895|NCT01394939|474160013|FG002|Overall Study|Death|0|||
131692896|NCT01394939|474160014|FG003|Overall Study|Death|0|||
131692897|NCT01394939|474160011|FG000|Overall Study|Physician Decision|0|||
131692898|NCT01394939|474160012|FG001|Overall Study|Physician Decision|1|||
131692899|NCT01394939|474160013|FG002|Overall Study|Physician Decision|0|||
131692900|NCT01394939|474160014|FG003|Overall Study|Physician Decision|0|||
131692901|NCT01394939|474160011|FG000|Overall Study|Withdrawal by Subject|0|||
131692902|NCT01394939|474160012|FG001|Overall Study|Withdrawal by Subject|2|||
131692903|NCT01394939|474160013|FG002|Overall Study|Withdrawal by Subject|0|||
131692904|NCT01394939|474160014|FG003|Overall Study|Withdrawal by Subject|2|||
131692905|NCT01394939|474160011|FG000|Overall Study|Others|0|||
131692906|NCT01394939|474160012|FG001|Overall Study|Others|2|||
131692907|NCT01394939|474160013|FG002|Overall Study|Others|0|||
131692908|NCT01394939|474160014|FG003|Overall Study|Others|3|||
131692909|NCT00150592|474160018|FG000|Overall Study|Adverse Event|4|||
131692910|NCT00150592|474160019|FG001|Overall Study|Adverse Event|1|||
131692911|NCT00150592|474160018|FG000|Overall Study|Protocol Violation|1|||
131692912|NCT00150592|474160019|FG001|Overall Study|Protocol Violation|0|||
131692913|NCT00150592|474160018|FG000|Overall Study|Withdrawal by Subject|1|||
131692914|NCT00150592|474160019|FG001|Overall Study|Withdrawal by Subject|2|||
131692915|NCT00150592|474160018|FG000|Overall Study|Non-compliance|1|||
131692916|NCT00150592|474160019|FG001|Overall Study|Non-compliance|0|||
131692917|NCT00874120|474160026|FG000|First Intervention|Adverse Event|0|||
131692918|NCT00874120|474160027|FG001|First Intervention|Adverse Event|1|||
131692919|NCT00874120|474160026|FG000|First Intervention|Withdrawal by Subject|2|||
131692920|NCT00874120|474160027|FG001|First Intervention|Withdrawal by Subject|0|||
131692921|NCT00874120|474160026|FG000|First Intervention|Lost to Follow-up|0|||
131692922|NCT00874120|474160027|FG001|First Intervention|Lost to Follow-up|1|||
131692923|NCT00874120|474160026|FG000|First Intervention|Protocol Violation|3|||
131692924|NCT00874120|474160027|FG001|First Intervention|Protocol Violation|0|||
131692925|NCT00874120|474160026|FG000|First Intervention|positive drug test|1|||
131692926|NCT00874120|474160027|FG001|First Intervention|positive drug test|0|||
131692927|NCT00874120|474160026|FG000|Second Intervention|Withdrawal by Subject|1|||
131692928|NCT00874120|474160027|FG001|Second Intervention|Withdrawal by Subject|0|||
131692929|NCT00874120|474160026|FG000|Second Intervention|Protocol Violation|1|||
131692930|NCT00874120|474160027|FG001|Second Intervention|Protocol Violation|0|||
131692931|NCT00477165|474160028|FG000|Overall Study|Adverse Event|7|||
131692932|NCT00477165|474160029|FG001|Overall Study|Adverse Event|2|||
131692933|NCT01823679|474160030|FG000|Overall Study|Death|1|||
131692934|NCT00105443|474160032|FG000|Double-Blind Treatment|Adverse Event|1|||
131692935|NCT00105443|474160033|FG001|Double-Blind Treatment|Adverse Event|0|||
131692936|NCT00105443|474160034|FG002|Double-Blind Treatment|Adverse Event|0|||
131692937|NCT00105443|474160035|FG003|Double-Blind Treatment|Adverse Event|0|||
131692938|NCT00105443|474160032|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
131692939|NCT00105443|474160033|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
131692940|NCT00105443|474160034|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
131692941|NCT00105443|474160035|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
131692942|NCT00105443|474160032|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
131692943|NCT00105443|474160033|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
131692944|NCT00105443|474160034|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
131692945|NCT00105443|474160035|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
131558485|NCT02306122|473669594|FG001|Initial Physician Randomization|Physician Decision|0|||
131558486|NCT02306122|473669595|FG002|Initial Physician Randomization|Physician Decision|0|||
131558487|NCT02306122|473669596|FG003|Initial Physician Randomization|Physician Decision|0|||
131558488|NCT02306122|473669597|FG004|Initial Physician Randomization|Physician Decision|0|||
131558489|NCT02306122|473669598|FG005|Initial Physician Randomization|Physician Decision|0|||
131558490|NCT02306122|473669599|FG006|Initial Physician Randomization|Physician Decision|0|||
131558491|NCT02306122|473669600|FG007|Initial Physician Randomization|Physician Decision|0|||
131558492|NCT02306122|473669601|FG008|Initial Physician Randomization|Physician Decision|1|||
131692946|NCT00105443|474160032|FG000|Double-Blind Treatment|Physician Decision|1|||
131692947|NCT00105443|474160033|FG001|Double-Blind Treatment|Physician Decision|0|||
131692948|NCT00105443|474160034|FG002|Double-Blind Treatment|Physician Decision|2|||
131692949|NCT00105443|474160035|FG003|Double-Blind Treatment|Physician Decision|0|||
131692950|NCT00105443|474160032|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
131692951|NCT00105443|474160033|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
131692952|NCT00105443|474160034|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
131692953|NCT00105443|474160035|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
131692954|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
131692955|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
131692956|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
131692957|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
131692958|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
131692959|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
131692960|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
131692961|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
131692962|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
131692963|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
131692964|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
131692965|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
131692966|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
131692967|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
131692968|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
131692969|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
131692970|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
131692971|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
131692972|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
131692973|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
131692974|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
131692975|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
131692976|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
131692977|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
131692978|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
131692979|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
131692980|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
131692981|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
131692982|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
131692983|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
131692984|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
131692985|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
131692986|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
131692987|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
131692988|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
131692989|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
131692990|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
131692991|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
131692992|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
131692993|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
131692994|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
131692995|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
131692996|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
131692997|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
131692998|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
131692999|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
131693000|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
131558493|NCT02306122|473669602|FG009|Initial Physician Randomization|Physician Decision|0|||
131558494|NCT02306122|473669603|FG010|Initial Physician Randomization|Physician Decision|0|||
131558495|NCT02262260|473669604|FG000|Overall Study|Adverse Event|4|||
131558496|NCT02262260|473669605|FG001|Overall Study|Adverse Event|1|||
131558497|NCT02262260|473669604|FG000|Overall Study|Withdrawal of consent|4|||
131558498|NCT02262260|473669605|FG001|Overall Study|Withdrawal of consent|2|||
131558499|NCT02262260|473669604|FG000|Overall Study|Lost to Follow-up|1|||
131558500|NCT02262260|473669605|FG001|Overall Study|Lost to Follow-up|2|||
131558501|NCT02262260|473669604|FG000|Overall Study|Protocol deviation|2|||
131558502|NCT02262260|473669605|FG001|Overall Study|Protocol deviation|5|||
131558503|NCT00180713|473669611|FG000|Overall Study|Withdrawal by Subject|2|||
131558504|NCT00180713|473669612|FG001|Overall Study|Withdrawal by Subject|0|||
131558505|NCT00180713|473669611|FG000|Overall Study|Adverse Event|3|||
131558506|NCT00180713|473669612|FG001|Overall Study|Adverse Event|3|||
131558507|NCT01567865|473669616|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
131558508|NCT01567865|473669617|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
131558509|NCT01567865|473669618|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
131558510|NCT01567865|473669619|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
131558511|NCT01567865|473669616|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
131558512|NCT01567865|473669617|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
131558513|NCT01567865|473669618|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
131558514|NCT01567865|473669619|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
131558515|NCT01051063|473669622|FG000|Overall Study|Death|2|||
131558516|NCT01051063|473669623|FG001|Overall Study|Death|2|||
131558517|NCT01051063|473669622|FG000|Overall Study|Withdrawal by Subject|1|||
131558518|NCT01051063|473669623|FG001|Overall Study|Withdrawal by Subject|1|||
131558519|NCT01051063|473669622|FG000|Overall Study|Termination of the study|5|||
131558520|NCT01051063|473669623|FG001|Overall Study|Termination of the study|0|||
131558521|NCT01051063|473669622|FG000|Overall Study|Moved from the study site area|1|||
131558522|NCT01051063|473669623|FG001|Overall Study|Moved from the study site area|0|||
131558523|NCT01051063|473669622|FG000|Overall Study|Other|1|||
131558524|NCT01051063|473669623|FG001|Overall Study|Other|0|||
131558525|NCT01051063|473669622|FG000|Overall Study|Lost to Follow-up|0|||
131558526|NCT01051063|473669623|FG001|Overall Study|Lost to Follow-up|1|||
131558527|NCT03857841|473669625|FG000|Overall Study|Death|1|||
131558528|NCT03857841|473669626|FG001|Overall Study|Death|0|||
131558529|NCT03857841|473669627|FG002|Overall Study|Death|0|||
131558530|NCT03857841|473669628|FG003|Overall Study|Death|0|||
131558531|NCT03857841|473669625|FG000|Overall Study|Study Terminated by Sponsor|1|||
131558532|NCT03857841|473669626|FG001|Overall Study|Study Terminated by Sponsor|0|||
131558533|NCT03857841|473669627|FG002|Overall Study|Study Terminated by Sponsor|0|||
131558534|NCT03857841|473669628|FG003|Overall Study|Study Terminated by Sponsor|0|||
131558535|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
131558536|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
131558537|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
131558538|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
131558539|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
131558540|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
131558541|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
131558542|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
131558543|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131558544|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131558545|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131558546|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131558547|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131558548|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131558549|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
131558550|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
131693001|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
131558551|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
131558552|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131558553|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131558554|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131558555|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131558556|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
131558557|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
131558558|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
131558559|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
131558560|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
131558561|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
131558562|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
131558563|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
131558564|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
131558565|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
131558566|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
131558567|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
131558568|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
131558569|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
131558570|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
131558571|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
131558572|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
131558573|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131558574|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131558575|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131558576|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131558577|NCT04921969|473669629|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
131558578|NCT04921969|473669630|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
131558579|NCT04921969|473669631|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
131558580|NCT04921969|473669632|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
131558581|NCT04921969|473669633|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
131558582|NCT04921969|473669634|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
131558583|NCT04921969|473669635|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
131558584|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
131558585|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
131558586|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
131558587|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
131558588|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
131693002|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
131693003|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
131693004|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
131778006|NCT04636437|474467528|FG001|Overall Study|Participant or physician decision|1|||
131778007|NCT04636437|474467529|FG002|Overall Study|Participant or physician decision|1|||
131778008|NCT02851069|474467530|FG000|Overall Study|Failure to Return|3|||
131778009|NCT02851069|474467530|FG000|Overall Study|Other|3|||
131778010|NCT00352664|474467537|FG000|Overall Study|Withdrawal by Subject|7|||
131778011|NCT00352664|474467538|FG001|Overall Study|Withdrawal by Subject|0|||
131778012|NCT03539952|474467541|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
131778013|NCT03539952|474467542|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
131778014|NCT03539952|474467541|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
131778015|NCT03539952|474467542|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
131778016|NCT03539952|474467541|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
131693005|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
131693006|NCT00105443|474160032|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
131693007|NCT00105443|474160033|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
131693008|NCT00105443|474160034|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
131693009|NCT00105443|474160035|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
131693010|NCT02135692|474160036|FG000|Overall Study|Adverse Event|3|||
131693011|NCT02135692|474160036|FG000|Overall Study|Lack of Efficacy|2|||
131693012|NCT02135692|474160036|FG000|Overall Study|Protocol Violation|2|||
131693013|NCT02135692|474160036|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
131693014|NCT02135692|474160036|FG000|Overall Study|Product commercially available|159|||
131693015|NCT02135692|474160036|FG000|Overall Study|Study closed/terminated|153|||
131693016|NCT02135692|474160036|FG000|Overall Study|Lost to Follow-up|4|||
131693017|NCT02135692|474160036|FG000|Overall Study|Withdrawal by Subject|15|||
131693018|NCT01157078|474160037|FG000|Overall Study|Withdrawal by Subject|12|||
131693019|NCT01157078|474160038|FG001|Overall Study|Withdrawal by Subject|14|||
131693020|NCT01157078|474160037|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131693021|NCT01157078|474160038|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131693022|NCT01157078|474160037|FG000|Overall Study|Adverse Event|6|||
131693023|NCT01157078|474160038|FG001|Overall Study|Adverse Event|6|||
131693024|NCT01157078|474160037|FG000|Overall Study|Severe non-compliance to protocol|2|||
131693025|NCT01157078|474160038|FG001|Overall Study|Severe non-compliance to protocol|4|||
131693026|NCT01157078|474160037|FG000|Overall Study|Condition under investigation worsened|0|||
131693027|NCT01157078|474160038|FG001|Overall Study|Condition under investigation worsened|1|||
131693028|NCT01157078|474160037|FG000|Overall Study|Lack of Efficacy|2|||
131693029|NCT01157078|474160038|FG001|Overall Study|Lack of Efficacy|0|||
131778017|NCT03539952|474467542|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
131558589|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
131558590|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
131558591|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131558592|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131778018|NCT03539952|474467541|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
131558593|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131558594|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
131558595|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131558596|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
131558597|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
131558598|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131558599|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131558600|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131558601|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
131558602|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
131558603|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
131558604|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
131558605|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
131558606|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
131558607|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
131558608|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
131558609|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
131558610|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
131558611|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
131558612|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131558613|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131558614|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131558615|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
131558616|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
131558617|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
131558618|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
131558619|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
131558620|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
131558621|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
131558622|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
131558623|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
131558624|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
131558625|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
131558626|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
131558627|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
131558628|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
131558629|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
131558630|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
131558631|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
131558632|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
131558633|NCT04921969|473669629|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
131558634|NCT04921969|473669630|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
131558635|NCT04921969|473669631|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
131558636|NCT04921969|473669632|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
131558637|NCT04921969|473669633|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
131558638|NCT04921969|473669634|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
131558639|NCT04921969|473669635|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
131558640|NCT03884231|473671269|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
131558641|NCT03884231|473671269|FG000|Overall Study|Subject Withdrew Consent|1|||
131558642|NCT03884231|473671269|FG000|Overall Study|MRI Scan Not Performed|1|||
131558643|NCT01853254|473671270|FG000|Overall Study|Abnormal Laboratory Test|1|||
131558644|NCT01853254|473671270|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
131558645|NCT01853254|473671270|FG000|Overall Study|Death|1|||
131558646|NCT01853254|473671270|FG000|Overall Study|Failure to Return|43|||
131558647|NCT01853254|473671270|FG000|Overall Study|Insufficient Therapeutic Response|22|||
131693030|NCT01157078|474160037|FG000|Overall Study|Study-specific withdrawal criteria|2|||
131693031|NCT01157078|474160038|FG001|Overall Study|Study-specific withdrawal criteria|2|||
131693032|NCT01157078|474160037|FG000|Overall Study|Lost to Follow-up|7|||
131693033|NCT01157078|474160038|FG001|Overall Study|Lost to Follow-up|5|||
131558648|NCT01853254|473671270|FG000|Overall Study|Refusal of Treatment|1|||
131558649|NCT01853254|473671270|FG000|Overall Study|Other Protocol Violation|1|||
131558650|NCT01853254|473671270|FG000|Overall Study|Withdrawal of Consent|16|||
131558651|NCT01853254|473671270|FG000|Overall Study|Administrative/Other|16|||
131693034|NCT01157078|474160037|FG000|Overall Study|Other|2|||
131558652|NCT01017120|473671276|FG000|Overall Study|Adverse Event|9|||
131558653|NCT01017120|473671277|FG001|Overall Study|Adverse Event|0|||
131558654|NCT01017120|473671276|FG000|Overall Study|Lost to Follow-up|13|||
131558655|NCT01017120|473671277|FG001|Overall Study|Lost to Follow-up|11|||
131558656|NCT01017120|473671276|FG000|Overall Study|Lack of Efficacy|1|||
131558657|NCT01017120|473671277|FG001|Overall Study|Lack of Efficacy|0|||
131558658|NCT01017120|473671276|FG000|Overall Study|Withdrawal by Subject|39|||
131558659|NCT01017120|473671277|FG001|Overall Study|Withdrawal by Subject|21|||
131558660|NCT01017120|473671276|FG000|Overall Study|Pregnancy|1|||
131558661|NCT01017120|473671277|FG001|Overall Study|Pregnancy|1|||
131558662|NCT01017120|473671276|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
131558663|NCT01017120|473671277|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
131558664|NCT01017120|473671276|FG000|Overall Study|Relocated Out of Town|0|||
131558665|NCT01017120|473671277|FG001|Overall Study|Relocated Out of Town|2|||
131558666|NCT01017120|473671276|FG000|Overall Study|Protocol Violation|1|||
131558667|NCT01017120|473671277|FG001|Overall Study|Protocol Violation|0|||
131558668|NCT01017120|473671276|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
131558669|NCT01017120|473671277|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
131558670|NCT01087723|473671278|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
131558671|NCT01087723|473671279|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
131558672|NCT01087723|473671278|FG000|Overall Study|Withdrawal by Subject|10|||
131558673|NCT01087723|473671279|FG001|Overall Study|Withdrawal by Subject|13|||
131558674|NCT01087723|473671278|FG000|Overall Study|Physician Decision|2|||
131558675|NCT01087723|473671279|FG001|Overall Study|Physician Decision|0|||
131558676|NCT01087723|473671278|FG000|Overall Study|Lost to Follow-up|1|||
131558677|NCT01087723|473671279|FG001|Overall Study|Lost to Follow-up|4|||
131558678|NCT01087723|473671278|FG000|Overall Study|Reason Not Specified|1|||
131558679|NCT01087723|473671279|FG001|Overall Study|Reason Not Specified|2|||
131558680|NCT00806624|473671280|FG000|Overall Study|Adverse Event|2|||
131558681|NCT00806624|473671281|FG001|Overall Study|Adverse Event|8|||
131558682|NCT00806624|473671282|FG002|Overall Study|Adverse Event|0|||
131558683|NCT00806624|473671280|FG000|Overall Study|Death|0|||
131558684|NCT00806624|473671281|FG001|Overall Study|Death|1|||
131558685|NCT00806624|473671282|FG002|Overall Study|Death|1|||
131558686|NCT00806624|473671280|FG000|Overall Study|Lost to Follow-up|1|||
131558687|NCT00806624|473671281|FG001|Overall Study|Lost to Follow-up|0|||
131558688|NCT00806624|473671282|FG002|Overall Study|Lost to Follow-up|1|||
131558689|NCT00806624|473671280|FG000|Overall Study|Withdrawal by Subject|6|||
131558690|NCT00806624|473671281|FG001|Overall Study|Withdrawal by Subject|3|||
131558691|NCT00806624|473671282|FG002|Overall Study|Withdrawal by Subject|3|||
131558692|NCT00806624|473671280|FG000|Overall Study|discontinued before start of treatment|0|||
131558693|NCT00806624|473671281|FG001|Overall Study|discontinued before start of treatment|0|||
131558694|NCT00806624|473671282|FG002|Overall Study|discontinued before start of treatment|1|||
131558695|NCT01702428|473671284|FG000|Overall Study|Adverse Event|2|||
131558696|NCT01702428|473671285|FG001|Overall Study|Adverse Event|0|||
131558697|NCT01702428|473671286|FG002|Overall Study|Adverse Event|0|||
131558698|NCT01702428|473671287|FG003|Overall Study|Adverse Event|0|||
131558699|NCT01702428|473671284|FG000|Overall Study|Lost to Follow-up|33|||
131558700|NCT01702428|473671285|FG001|Overall Study|Lost to Follow-up|41|||
131558701|NCT01702428|473671286|FG002|Overall Study|Lost to Follow-up|37|||
131558702|NCT01702428|473671287|FG003|Overall Study|Lost to Follow-up|44|||
131558703|NCT01702428|473671284|FG000|Overall Study|Parents cannot assist to site|1|||
131558704|NCT01702428|473671285|FG001|Overall Study|Parents cannot assist to site|0|||
131558705|NCT01702428|473671286|FG002|Overall Study|Parents cannot assist to site|1|||
131558706|NCT01702428|473671287|FG003|Overall Study|Parents cannot assist to site|0|||
131558707|NCT01702428|473671284|FG000|Overall Study|Lost Coverage|0|||
131558708|NCT01702428|473671285|FG001|Overall Study|Lost Coverage|0|||
131558709|NCT01702428|473671286|FG002|Overall Study|Lost Coverage|0|||
131558710|NCT01702428|473671287|FG003|Overall Study|Lost Coverage|1|||
131558711|NCT01702428|473671284|FG000|Overall Study|Lost Health Plan|3|||
131693035|NCT01157078|474160038|FG001|Overall Study|Other|4|||
131693036|NCT04682405|474160041|FG000|Overall Study|Adverse Event|0|||
131693037|NCT04682405|474160042|FG001|Overall Study|Adverse Event|1|||
131558712|NCT01702428|473671285|FG001|Overall Study|Lost Health Plan|5|||
131558713|NCT01702428|473671286|FG002|Overall Study|Lost Health Plan|0|||
131558714|NCT01702428|473671287|FG003|Overall Study|Lost Health Plan|2|||
131558715|NCT01702428|473671284|FG000|Overall Study|Mother transferred care|0|||
131558716|NCT01702428|473671285|FG001|Overall Study|Mother transferred care|1|||
131558717|NCT01702428|473671286|FG002|Overall Study|Mother transferred care|0|||
131558718|NCT01702428|473671287|FG003|Overall Study|Mother transferred care|0|||
131558719|NCT01702428|473671284|FG000|Overall Study|Parents too busy|1|||
131558720|NCT01702428|473671285|FG001|Overall Study|Parents too busy|0|||
131558721|NCT01702428|473671286|FG002|Overall Study|Parents too busy|0|||
131558722|NCT01702428|473671287|FG003|Overall Study|Parents too busy|0|||
131558723|NCT01702428|473671284|FG000|Overall Study|Protocol Violation|3|||
131558724|NCT01702428|473671285|FG001|Overall Study|Protocol Violation|0|||
131693038|NCT04429061|474160043|FG000|Overall Study|Lost to Follow-up|62|||
131693039|NCT04429061|474160044|FG001|Overall Study|Lost to Follow-up|87|||
131558725|NCT01702428|473671286|FG002|Overall Study|Protocol Violation|1|||
131558726|NCT01702428|473671287|FG003|Overall Study|Protocol Violation|0|||
131558727|NCT01702428|473671284|FG000|Overall Study|Withdrawal by Subject|21|||
131558728|NCT01702428|473671285|FG001|Overall Study|Withdrawal by Subject|23|||
131558729|NCT01702428|473671286|FG002|Overall Study|Withdrawal by Subject|14|||
131558730|NCT01702428|473671287|FG003|Overall Study|Withdrawal by Subject|10|||
131558731|NCT00154063|473671290|FG000|Overall Study|Adverse Event|4|||
131558732|NCT00154063|473671291|FG001|Overall Study|Adverse Event|8|||
131558733|NCT00154063|473671290|FG000|Overall Study|Protocol Violation|1|||
131558734|NCT00154063|473671291|FG001|Overall Study|Protocol Violation|1|||
131558735|NCT00154063|473671290|FG000|Overall Study|Investigator or Sponsor Request|0|||
131558736|NCT00154063|473671291|FG001|Overall Study|Investigator or Sponsor Request|1|||
131558737|NCT00154063|473671290|FG000|Overall Study|Withdrawal by Subject|4|||
131558738|NCT00154063|473671291|FG001|Overall Study|Withdrawal by Subject|9|||
131558739|NCT00154063|473671290|FG000|Overall Study|Other|3|||
131558740|NCT00154063|473671291|FG001|Overall Study|Other|3|||
131558741|NCT02091869|473671292|FG000|Overall Study|Withdrawal by Subject|0|||
131558742|NCT02091869|473671293|FG001|Overall Study|Withdrawal by Subject|3|||
131558743|NCT00451217|473671302|FG000|Overall Study|Lost to Follow-up|0|||
131558744|NCT00451217|473671303|FG001|Overall Study|Lost to Follow-up|1|||
131558745|NCT00451217|473671304|FG002|Overall Study|Lost to Follow-up|1|||
131558746|NCT00451217|473671305|FG003|Overall Study|Lost to Follow-up|1|||
131558747|NCT00451217|473671302|FG000|Overall Study|Withdrawal by Subject|1|||
131558748|NCT00451217|473671303|FG001|Overall Study|Withdrawal by Subject|0|||
131558749|NCT00451217|473671304|FG002|Overall Study|Withdrawal by Subject|0|||
131558750|NCT00451217|473671305|FG003|Overall Study|Withdrawal by Subject|0|||
131558751|NCT00451217|473671302|FG000|Overall Study|Not Treated|1|||
131558752|NCT00451217|473671303|FG001|Overall Study|Not Treated|1|||
131558753|NCT00451217|473671304|FG002|Overall Study|Not Treated|3|||
131558754|NCT00451217|473671305|FG003|Overall Study|Not Treated|4|||
131558755|NCT04668989|473671306|FG000|First Intervention|Covid-19 related self-isolation|0|||
131558756|NCT04668989|473671307|FG001|First Intervention|Covid-19 related self-isolation|1|||
131558757|NCT04668989|473671306|FG000|Second Intervention|Adverse Event|0|||
131558758|NCT04668989|473671307|FG001|Second Intervention|Adverse Event|1|||
131558759|NCT01622348|473671312|FG000|Overall Study|Withdrawal by Subject|1|||
131558760|NCT01622348|473671313|FG001|Overall Study|Withdrawal by Subject|0|||
131558761|NCT01622348|473671314|FG002|Overall Study|Withdrawal by Subject|1|||
131558762|NCT01592695|473671321|FG000|Overall Study|Lost to Follow-up|8|||
131558763|NCT01592695|473671322|FG001|Overall Study|Lost to Follow-up|4|||
131558764|NCT00467142|473671323|FG000|Overall Study|Withdrawal by Subject|1|||
131558765|NCT00467142|473671323|FG000|Overall Study|Adverse Event|1|||
131558766|NCT00467142|473671323|FG000|Overall Study|Protocol Violation|1|||
131558767|NCT00919893|473671324|FG000|Overall Study|Protocol Violation|19|||
131558768|NCT00919893|473671325|FG001|Overall Study|Protocol Violation|9|||
131558769|NCT03893825|473671330|FG000|Overall Study|Death|2|||
131558770|NCT03893825|473671331|FG001|Overall Study|Death|1|||
131558771|NCT03893825|473671330|FG000|Overall Study|Adverse Event|0|||
131558772|NCT03893825|473671331|FG001|Overall Study|Adverse Event|2|||
131558773|NCT03893825|473671330|FG000|Overall Study|Withdrawal by Subject|19|||
131558774|NCT03893825|473671331|FG001|Overall Study|Withdrawal by Subject|21|||
131558775|NCT03893825|473671330|FG000|Overall Study|Protocol deviation|1|||
131558776|NCT03893825|473671331|FG001|Overall Study|Protocol deviation|0|||
131558777|NCT03893825|473671330|FG000|Overall Study|Lost to Follow-up|10|||
131558778|NCT03893825|473671331|FG001|Overall Study|Lost to Follow-up|10|||
131558779|NCT03893825|473671330|FG000|Overall Study|Other than specified|7|||
131558780|NCT03893825|473671331|FG001|Overall Study|Other than specified|6|||
131558781|NCT00251927|473671333|FG000|Overall Study|Adverse Event|3|||
131558782|NCT00251927|473671334|FG001|Overall Study|Adverse Event|15|||
131558783|NCT00251927|473671333|FG000|Overall Study|Lack of Efficacy|22|||
131693040|NCT04429061|474160043|FG000|Overall Study|Withdrawal by Subject|3|||
131693041|NCT04429061|474160044|FG001|Overall Study|Withdrawal by Subject|4|||
131693042|NCT00879229|474160051|FG000|Overall Study|Study terminated by Sponsor|13|||
131693043|NCT00879229|474160052|FG001|Overall Study|Study terminated by Sponsor|12|||
131693044|NCT00879229|474160051|FG000|Overall Study|Death|4|||
131558784|NCT00251927|473671334|FG001|Overall Study|Lack of Efficacy|16|||
131558785|NCT00251927|473671333|FG000|Overall Study|Lost to Follow-up|22|||
131558786|NCT00251927|473671334|FG001|Overall Study|Lost to Follow-up|8|||
131558787|NCT00251927|473671333|FG000|Overall Study|Protocol Violation|1|||
131558788|NCT00251927|473671334|FG001|Overall Study|Protocol Violation|2|||
131558789|NCT00251927|473671333|FG000|Overall Study|Pregnancy|2|||
131558790|NCT00251927|473671334|FG001|Overall Study|Pregnancy|0|||
131558791|NCT00251927|473671333|FG000|Overall Study|Withdrawal by Subject|40|||
131558792|NCT00251927|473671334|FG001|Overall Study|Withdrawal by Subject|25|||
131558793|NCT00251927|473671333|FG000|Overall Study|Study-specific discont. achieved|13|||
131693045|NCT00879229|474160052|FG001|Overall Study|Death|2|||
131558794|NCT00251927|473671334|FG001|Overall Study|Study-specific discont. achieved|2|||
131558795|NCT00251927|473671333|FG000|Overall Study|Study procedure non-compliance|5|||
131558796|NCT00251927|473671334|FG001|Overall Study|Study procedure non-compliance|6|||
131558797|NCT04012814|473671342|FG000|Overall Study|Lost to Follow-up|4|||
131558798|NCT04012814|473671342|FG000|Overall Study|Withdrawal by Subject|2|||
131558799|NCT04012814|473671342|FG000|Overall Study|Protocol Violation|1|||
131558800|NCT04012814|473671342|FG000|Overall Study|Adverse Event|1|||
131558801|NCT01275196|473671348|FG000|Overall Study|Adverse Event|3|||
131558802|NCT01275196|473671349|FG001|Overall Study|Adverse Event|5|||
131558803|NCT01275196|473671348|FG000|Overall Study|Withdrawal by Subject|4|||
131558804|NCT01275196|473671349|FG001|Overall Study|Withdrawal by Subject|5|||
131558805|NCT01275196|473671348|FG000|Overall Study|Lost to Follow-up|1|||
131558806|NCT01275196|473671349|FG001|Overall Study|Lost to Follow-up|0|||
131558807|NCT01275196|473671348|FG000|Overall Study|Disease Progression|6|||
131558808|NCT01275196|473671349|FG001|Overall Study|Disease Progression|5|||
131558809|NCT01275196|473671348|FG000|Overall Study|Protocol Violation|1|||
131558810|NCT01275196|473671349|FG001|Overall Study|Protocol Violation|0|||
131558811|NCT01275196|473671348|FG000|Overall Study|Suboptimal response/treatment failure|5|||
131558812|NCT01275196|473671349|FG001|Overall Study|Suboptimal response/treatment failure|6|||
131558813|NCT02406261|473671350|FG000|Period 1|Lost to Follow-up|2|||
131558814|NCT02406261|473671351|FG001|Period 1|Lost to Follow-up|0|||
131558815|NCT02406261|473671350|FG000|Period 1|Adverse Event|1|||
131558816|NCT02406261|473671351|FG001|Period 1|Adverse Event|0|||
131558817|NCT02406261|473671350|FG000|Period 2|Physician Decision|0|||
131558818|NCT02406261|473671351|FG001|Period 2|Physician Decision|1|||
131558819|NCT02406261|473671350|FG000|Period 2|Protocol Violation|0|||
131558820|NCT02406261|473671351|FG001|Period 2|Protocol Violation|1|||
131558821|NCT02406261|473671350|FG000|Period 2|Withdrawal by Subject|0|||
131558822|NCT02406261|473671351|FG001|Period 2|Withdrawal by Subject|1|||
131558823|NCT02572817|473671352|FG000|Overall Study|Death|6|||
131558824|NCT02572817|473671353|FG001|Overall Study|Death|3|||
131558825|NCT02572817|473671352|FG000|Overall Study|Lost to Follow-up|3|||
131558826|NCT02572817|473671353|FG001|Overall Study|Lost to Follow-up|3|||
131558827|NCT02222896|473671356|FG000|Abdomen|Did not qualify|34|||
131558828|NCT02222896|473671357|FG001|Abdomen|Did not qualify|10|||
131558829|NCT02222896|473671358|FG002|Abdomen|Did not qualify|32|||
131558830|NCT02222896|473671356|FG000|Groin|Did not qualify|43|||
131558831|NCT02222896|473671357|FG001|Groin|Did not qualify|9|||
131558832|NCT02222896|473671358|FG002|Groin|Did not qualify|40|||
131558833|NCT01865617|473671363|FG000|Overall Study|Death|27|||
131558834|NCT01865617|473671364|FG001|Overall Study|Death|3|||
131558835|NCT01865617|473671365|FG002|Overall Study|Death|1|||
131558836|NCT01865617|473671366|FG003|Overall Study|Death|1|||
131558837|NCT01865617|473671367|FG004|Overall Study|Death|5|||
131558838|NCT01865617|473671368|FG005|Overall Study|Death|1|||
131558839|NCT01865617|473671369|FG006|Overall Study|Death|11|||
131558840|NCT01865617|473671370|FG007|Overall Study|Death|1|||
131558841|NCT01865617|473671371|FG008|Overall Study|Death|11|||
131558842|NCT01865617|473671372|FG009|Overall Study|Death|3|||
131558843|NCT01865617|473671373|FG010|Overall Study|Death|32|||
131558844|NCT01865617|473671374|FG011|Overall Study|Death|6|||
131558845|NCT01865617|473671375|FG012|Overall Study|Death|13|||
131558846|NCT01865617|473671363|FG000|Overall Study|Lost to Follow-up|2|||
131558847|NCT01865617|473671364|FG001|Overall Study|Lost to Follow-up|0|||
131558848|NCT01865617|473671365|FG002|Overall Study|Lost to Follow-up|0|||
131693046|NCT00879229|474160051|FG000|Overall Study|Adverse Event|2|||
131693047|NCT00879229|474160052|FG001|Overall Study|Adverse Event|0|||
131693048|NCT00879229|474160051|FG000|Overall Study|Withdrawal by Subject|1|||
131693049|NCT00879229|474160052|FG001|Overall Study|Withdrawal by Subject|0|||
131693050|NCT00879229|474160051|FG000|Overall Study|Clinical status did not improve|1|||
131693051|NCT00879229|474160052|FG001|Overall Study|Clinical status did not improve|0|||
131693052|NCT00879229|474160051|FG000|Overall Study|Other|1|||
131693053|NCT00879229|474160052|FG001|Overall Study|Other|0|||
131693054|NCT01097746|474160053|FG000|Overall Study|Adverse Event|4|||
131693055|NCT01097746|474160053|FG000|Overall Study|taken off study before any treatment given|1|||
131693056|NCT00631371|474160060|FG000|Overall Study|Lost to Follow-up|24|||
131693057|NCT00631371|474160061|FG001|Overall Study|Lost to Follow-up|19|||
131558849|NCT01865617|473671366|FG003|Overall Study|Lost to Follow-up|0|||
131558850|NCT01865617|473671367|FG004|Overall Study|Lost to Follow-up|0|||
131558851|NCT01865617|473671368|FG005|Overall Study|Lost to Follow-up|0|||
131558852|NCT01865617|473671369|FG006|Overall Study|Lost to Follow-up|0|||
131558853|NCT01865617|473671370|FG007|Overall Study|Lost to Follow-up|0|||
131558854|NCT01865617|473671371|FG008|Overall Study|Lost to Follow-up|0|||
131558855|NCT01865617|473671372|FG009|Overall Study|Lost to Follow-up|0|||
131558856|NCT01865617|473671373|FG010|Overall Study|Lost to Follow-up|0|||
131558857|NCT01865617|473671374|FG011|Overall Study|Lost to Follow-up|0|||
131558858|NCT01865617|473671375|FG012|Overall Study|Lost to Follow-up|0|||
131558859|NCT01865617|473671363|FG000|Overall Study|Withdrawal by Subject|1|||
131558860|NCT01865617|473671364|FG001|Overall Study|Withdrawal by Subject|0|||
131693058|NCT00631371|474160060|FG000|Overall Study|Other reason|5|||
131693059|NCT00631371|474160061|FG001|Overall Study|Other reason|12|||
131558861|NCT01865617|473671365|FG002|Overall Study|Withdrawal by Subject|0|||
131558862|NCT01865617|473671366|FG003|Overall Study|Withdrawal by Subject|0|||
131558863|NCT01865617|473671367|FG004|Overall Study|Withdrawal by Subject|0|||
131558864|NCT01865617|473671368|FG005|Overall Study|Withdrawal by Subject|0|||
131558865|NCT01865617|473671369|FG006|Overall Study|Withdrawal by Subject|0|||
131558866|NCT01865617|473671370|FG007|Overall Study|Withdrawal by Subject|0|||
131558867|NCT01865617|473671371|FG008|Overall Study|Withdrawal by Subject|0|||
131558868|NCT01865617|473671372|FG009|Overall Study|Withdrawal by Subject|0|||
131558869|NCT01865617|473671373|FG010|Overall Study|Withdrawal by Subject|0|||
131558870|NCT01865617|473671374|FG011|Overall Study|Withdrawal by Subject|0|||
131558871|NCT01865617|473671375|FG012|Overall Study|Withdrawal by Subject|0|||
131558872|NCT01865617|473671363|FG000|Overall Study|Patient proceeded to new therapy|0|||
131558873|NCT01865617|473671364|FG001|Overall Study|Patient proceeded to new therapy|0|||
131558874|NCT01865617|473671365|FG002|Overall Study|Patient proceeded to new therapy|0|||
131558875|NCT01865617|473671366|FG003|Overall Study|Patient proceeded to new therapy|0|||
131558876|NCT01865617|473671367|FG004|Overall Study|Patient proceeded to new therapy|2|||
131558877|NCT01865617|473671368|FG005|Overall Study|Patient proceeded to new therapy|0|||
131558878|NCT01865617|473671369|FG006|Overall Study|Patient proceeded to new therapy|0|||
131558879|NCT01865617|473671370|FG007|Overall Study|Patient proceeded to new therapy|0|||
131558880|NCT01865617|473671371|FG008|Overall Study|Patient proceeded to new therapy|0|||
131558881|NCT01865617|473671372|FG009|Overall Study|Patient proceeded to new therapy|0|||
131558882|NCT01865617|473671373|FG010|Overall Study|Patient proceeded to new therapy|0|||
131558883|NCT01865617|473671374|FG011|Overall Study|Patient proceeded to new therapy|0|||
131558884|NCT01865617|473671375|FG012|Overall Study|Patient proceeded to new therapy|0|||
131558885|NCT01865617|473671363|FG000|Overall Study|Other|0|||
131558886|NCT01865617|473671364|FG001|Overall Study|Other|0|||
131558887|NCT01865617|473671365|FG002|Overall Study|Other|0|||
131558888|NCT01865617|473671366|FG003|Overall Study|Other|0|||
131558889|NCT01865617|473671367|FG004|Overall Study|Other|0|||
131558890|NCT01865617|473671368|FG005|Overall Study|Other|0|||
131558891|NCT01865617|473671369|FG006|Overall Study|Other|1|||
131558892|NCT01865617|473671370|FG007|Overall Study|Other|0|||
131558893|NCT01865617|473671371|FG008|Overall Study|Other|0|||
131558894|NCT01865617|473671372|FG009|Overall Study|Other|0|||
131558895|NCT01865617|473671373|FG010|Overall Study|Other|0|||
131558896|NCT01865617|473671374|FG011|Overall Study|Other|0|||
131558897|NCT01865617|473671375|FG012|Overall Study|Other|0|||
131558898|NCT02226172|473671376|FG000|Overall Study|Participant refused further follow-up|4|||
131558899|NCT02226172|473671376|FG000|Overall Study|Other|5|||
131558900|NCT02226172|473671376|FG000|Overall Study|Death|1|||
131558901|NCT02226172|473671376|FG000|Overall Study|Study terminated by sponsor|1|||
131558902|NCT02226172|473671376|FG000|Overall Study|Adverse Event|6|||
131558903|NCT03237013|473671378|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
131558904|NCT03237013|473671379|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
131558905|NCT03237013|473671380|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
131558906|NCT00258440|473671385|FG000|Overall Study|Withdrawal by Subject|0|||
131558907|NCT00258440|473671386|FG001|Overall Study|Withdrawal by Subject|0|||
131558908|NCT00258440|473671387|FG002|Overall Study|Withdrawal by Subject|1|||
131558909|NCT00737061|473671388|FG000|Waiting Period|Lost to Follow-up|6|||
131558910|NCT00737061|473671388|FG000|Waiting Period|Withdrawal by Subject|1|||
131558911|NCT00737061|473671388|FG000|Waiting Period|Bilateral placement failure|34|||
131558912|NCT00737061|473671388|FG000|Waiting Period|Deemed patent following HSG|26|||
131558913|NCT00737061|473671388|FG000|Waiting Period|Alternative contraception failure|3|||
131558914|NCT00737061|473671388|FG000|Waiting Period|Elected surgical tubal ligation|5|||
131558915|NCT00737061|473671388|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
131558916|NCT00737061|473671388|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
131558917|NCT00737061|473671388|FG000|1 Year Wearing Period|Discontinued reilance|3|||
131558918|NCT00737061|473671388|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
131558919|NCT00439179|473671390|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
131558920|NCT00439179|473671391|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
131558921|NCT00439179|473671392|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
131558922|NCT00439179|473671393|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
131558923|NCT03632434|473671396|FG000|Overall Study|Withdrawal by Subject|2|||
131558924|NCT01821898|473671401|FG000|Overall Study|Withdrawal by Subject|2|||
131558925|NCT01821898|473671402|FG001|Overall Study|Withdrawal by Subject|1|||
131558926|NCT00337662|473671407|FG000|Study Period II|Lost to Follow-up|0|||
131558927|NCT00337662|473671408|FG001|Study Period II|Lost to Follow-up|0|||
131558928|NCT00337662|473671409|FG002|Study Period II|Lost to Follow-up|0|||
131558929|NCT00337662|473671410|FG003|Study Period II|Lost to Follow-up|35|||
131558930|NCT00337662|473671407|FG000|Study Period II|Withdrawal by Subject|0|||
131558931|NCT00337662|473671408|FG001|Study Period II|Withdrawal by Subject|0|||
131558932|NCT00337662|473671409|FG002|Study Period II|Withdrawal by Subject|0|||
131558933|NCT00337662|473671410|FG003|Study Period II|Withdrawal by Subject|20|||
131558934|NCT00337662|473671407|FG000|Study Period II|Adverse Event|0|||
131558935|NCT00337662|473671408|FG001|Study Period II|Adverse Event|0|||
131778019|NCT03539952|474467542|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
131693060|NCT00631371|474160060|FG000|Overall Study|subject request|38|||
131693061|NCT00631371|474160061|FG001|Overall Study|subject request|45|||
131778020|NCT03539952|474467541|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
131778021|NCT03539952|474467542|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
131778022|NCT03539952|474467541|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
131778023|NCT03539952|474467542|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
131778024|NCT03539952|474467541|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
131778025|NCT03539952|474467542|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
131778026|NCT02184988|474467543|FG000|Overall Study|Pregnancy|2|||
131778027|NCT02184988|474467543|FG000|Overall Study|Adverse Event|2|||
131778028|NCT02184988|474467543|FG000|Overall Study|moving away/travelling/unable to complet|6|||
131778029|NCT02184988|474467543|FG000|Overall Study|work scheduling issues|4|||
131778030|NCT02184988|474467543|FG000|Overall Study|various other reasons|9|||
131778031|NCT02184988|474467543|FG000|Overall Study|Lost to Follow-up|32|||
131778032|NCT03075215|474467544|FG000|12-Month Primary Endpoint|Death|152|||
131778033|NCT03075215|474467544|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
131778034|NCT03075215|474467544|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
131778035|NCT03075215|474467544|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
131778036|NCT01233284|474467545|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
131778037|NCT01233284|474467546|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131778038|NCT01233284|474467547|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131778039|NCT01233284|474467548|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131778040|NCT01233284|474467549|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131778041|NCT01233284|474467545|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131778042|NCT01233284|474467546|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
131778043|NCT01233284|474467547|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131778044|NCT01233284|474467548|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131778045|NCT01233284|474467549|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131778046|NCT01233284|474467545|FG000|Period 1 (4 Weeks)|Other|0|||
131778047|NCT01233284|474467546|FG001|Period 1 (4 Weeks)|Other|0|||
131778048|NCT01233284|474467547|FG002|Period 1 (4 Weeks)|Other|1|||
131778049|NCT01233284|474467548|FG003|Period 1 (4 Weeks)|Other|0|||
131778050|NCT01233284|474467549|FG004|Period 1 (4 Weeks)|Other|0|||
131778051|NCT01233284|474467545|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131778052|NCT01233284|474467546|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131778053|NCT01233284|474467547|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
131778054|NCT01233284|474467548|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131778055|NCT01233284|474467549|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131778056|NCT01233284|474467545|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131693062|NCT00631371|474160060|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
131693063|NCT00631371|474160061|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
131693064|NCT00631371|474160060|FG000|Overall Study|Death|263|||
131693065|NCT00631371|474160061|FG001|Overall Study|Death|239|||
131693066|NCT01081912|474160062|FG000|Conversion/Titration|Adverse Event|47|||
131693067|NCT01081912|474160063|FG001|Conversion/Titration|Adverse Event|0|||
131693068|NCT01081912|474160064|FG002|Conversion/Titration|Adverse Event|0|||
131693069|NCT01081912|474160062|FG000|Conversion/Titration|Lack of Efficacy|17|||
131693070|NCT01081912|474160063|FG001|Conversion/Titration|Lack of Efficacy|0|||
131693071|NCT01081912|474160064|FG002|Conversion/Titration|Lack of Efficacy|0|||
131693072|NCT01081912|474160062|FG000|Conversion/Titration|Lost to Follow-up|5|||
131693073|NCT01081912|474160063|FG001|Conversion/Titration|Lost to Follow-up|0|||
131693074|NCT01081912|474160064|FG002|Conversion/Titration|Lost to Follow-up|0|||
131693075|NCT01081912|474160062|FG000|Conversion/Titration|Physician Decision|2|||
131693076|NCT01081912|474160063|FG001|Conversion/Titration|Physician Decision|0|||
131693077|NCT01081912|474160064|FG002|Conversion/Titration|Physician Decision|0|||
131693078|NCT01081912|474160062|FG000|Conversion/Titration|Protocol Violation|67|||
131693079|NCT01081912|474160063|FG001|Conversion/Titration|Protocol Violation|0|||
131693080|NCT01081912|474160064|FG002|Conversion/Titration|Protocol Violation|0|||
131693081|NCT01081912|474160062|FG000|Conversion/Titration|Withdrawal by Subject|23|||
131693082|NCT01081912|474160063|FG001|Conversion/Titration|Withdrawal by Subject|0|||
131693083|NCT01081912|474160064|FG002|Conversion/Titration|Withdrawal by Subject|0|||
131693084|NCT01081912|474160062|FG000|Conversion/Titration|Non-Compliance|47|||
131693085|NCT01081912|474160063|FG001|Conversion/Titration|Non-Compliance|0|||
131693086|NCT01081912|474160064|FG002|Conversion/Titration|Non-Compliance|0|||
131693087|NCT01081912|474160062|FG000|Maintenance Treatment|Adverse Event|0|||
131693088|NCT01081912|474160063|FG001|Maintenance Treatment|Adverse Event|2|||
131693089|NCT01081912|474160064|FG002|Maintenance Treatment|Adverse Event|12|||
131693090|NCT01081912|474160062|FG000|Maintenance Treatment|Lack of Efficacy|0|||
131693091|NCT01081912|474160063|FG001|Maintenance Treatment|Lack of Efficacy|14|||
131693092|NCT01081912|474160064|FG002|Maintenance Treatment|Lack of Efficacy|64|||
131693093|NCT01081912|474160062|FG000|Maintenance Treatment|Lost to Follow-up|0|||
131693094|NCT01081912|474160063|FG001|Maintenance Treatment|Lost to Follow-up|1|||
131693095|NCT01081912|474160064|FG002|Maintenance Treatment|Lost to Follow-up|0|||
131693096|NCT01081912|474160062|FG000|Maintenance Treatment|Physician Decision|0|||
131693097|NCT01081912|474160063|FG001|Maintenance Treatment|Physician Decision|0|||
131693098|NCT01081912|474160064|FG002|Maintenance Treatment|Physician Decision|1|||
131693099|NCT01081912|474160062|FG000|Maintenance Treatment|Protocol Violation|0|||
131693100|NCT01081912|474160063|FG001|Maintenance Treatment|Protocol Violation|1|||
131693101|NCT01081912|474160064|FG002|Maintenance Treatment|Protocol Violation|2|||
131693102|NCT01081912|474160062|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
131693103|NCT01081912|474160063|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
131693104|NCT01081912|474160064|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
131693105|NCT01081912|474160062|FG000|Maintenance Treatment|Non-Compliance|0|||
131693106|NCT01081912|474160063|FG001|Maintenance Treatment|Non-Compliance|4|||
131693107|NCT01081912|474160064|FG002|Maintenance Treatment|Non-Compliance|7|||
131693108|NCT01081912|474160062|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
131693109|NCT01081912|474160063|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
131693110|NCT01081912|474160064|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
131693111|NCT04677712|474160065|FG000|Overall Study|Lost to Follow-up|0|||
131693112|NCT04677712|474160066|FG001|Overall Study|Lost to Follow-up|1|||
131693113|NCT04677712|474160067|FG002|Overall Study|Lost to Follow-up|0|||
131693114|NCT04677712|474160068|FG003|Overall Study|Lost to Follow-up|0|||
131693115|NCT04677712|474160069|FG004|Overall Study|Lost to Follow-up|0|||
131693116|NCT04677712|474160070|FG005|Overall Study|Lost to Follow-up|0|||
131693117|NCT00711100|474160071|FG000|Overall Study|Lack of Efficacy|5|||
131693118|NCT00711100|474160071|FG000|Overall Study|Withdrawal by Subject|8|||
131693119|NCT00783094|474160072|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
131693120|NCT00783094|474160073|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
131693121|NCT00783094|474160074|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
131693122|NCT00783094|474160072|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
131693123|NCT00783094|474160073|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
131693124|NCT00783094|474160074|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
131693125|NCT00783094|474160072|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
131693126|NCT00783094|474160073|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
131693127|NCT00783094|474160074|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
131693128|NCT00783094|474160072|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
131693129|NCT00783094|474160073|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
131693130|NCT00783094|474160074|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
131693131|NCT00783094|474160072|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
131693132|NCT00783094|474160073|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
131693133|NCT00783094|474160074|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
131693134|NCT00783094|474160072|FG000|Open-Label Extension Period|Adverse Event|12|||
131693135|NCT00783094|474160073|FG001|Open-Label Extension Period|Adverse Event|7|||
131693136|NCT00783094|474160074|FG002|Open-Label Extension Period|Adverse Event|16|||
131693137|NCT00783094|474160072|FG000|Open-Label Extension Period|Death|0|||
131693138|NCT00783094|474160073|FG001|Open-Label Extension Period|Death|0|||
131693139|NCT00783094|474160074|FG002|Open-Label Extension Period|Death|1|||
131693140|NCT00783094|474160072|FG000|Open-Label Extension Period|Protocol Violation|4|||
131693141|NCT00783094|474160073|FG001|Open-Label Extension Period|Protocol Violation|5|||
131693142|NCT00783094|474160074|FG002|Open-Label Extension Period|Protocol Violation|7|||
131693143|NCT00783094|474160072|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
131693144|NCT00783094|474160073|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
131693145|NCT00783094|474160074|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
131693146|NCT00783094|474160072|FG000|Open-Label Extension Period|Physician Decision|4|||
131693147|NCT00783094|474160073|FG001|Open-Label Extension Period|Physician Decision|2|||
131693148|NCT00783094|474160074|FG002|Open-Label Extension Period|Physician Decision|3|||
131693149|NCT00783094|474160072|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
131693150|NCT00783094|474160073|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
131693151|NCT00783094|474160074|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
131693152|NCT02513329|474160075|FG000|Overall Study|Lost to Follow-up|5|||
131558936|NCT00337662|473671409|FG002|Study Period II|Adverse Event|0|||
131558937|NCT00337662|473671410|FG003|Study Period II|Adverse Event|16|||
131558938|NCT00337662|473671407|FG000|Study Period II|Physician Decision|0|||
131558939|NCT00337662|473671408|FG001|Study Period II|Physician Decision|0|||
131558940|NCT00337662|473671409|FG002|Study Period II|Physician Decision|0|||
131558941|NCT00337662|473671410|FG003|Study Period II|Physician Decision|13|||
131558942|NCT00337662|473671407|FG000|Study Period II|Entry Criteria Not Met|0|||
131558943|NCT00337662|473671408|FG001|Study Period II|Entry Criteria Not Met|0|||
131558944|NCT00337662|473671409|FG002|Study Period II|Entry Criteria Not Met|0|||
131558945|NCT00337662|473671410|FG003|Study Period II|Entry Criteria Not Met|6|||
131558946|NCT00337662|473671407|FG000|Study Period II|Protocol Violation|0|||
131558947|NCT00337662|473671408|FG001|Study Period II|Protocol Violation|0|||
131558948|NCT00337662|473671409|FG002|Study Period II|Protocol Violation|0|||
131558949|NCT00337662|473671410|FG003|Study Period II|Protocol Violation|6|||
131558950|NCT00337662|473671407|FG000|Study Period II|Lack of Efficacy|0|||
131558951|NCT00337662|473671408|FG001|Study Period II|Lack of Efficacy|0|||
131558952|NCT00337662|473671409|FG002|Study Period II|Lack of Efficacy|0|||
131558953|NCT00337662|473671410|FG003|Study Period II|Lack of Efficacy|7|||
131558954|NCT00337662|473671407|FG000|Study Period II|Sponsor Decision|0|||
131558955|NCT00337662|473671408|FG001|Study Period II|Sponsor Decision|0|||
131558956|NCT00337662|473671409|FG002|Study Period II|Sponsor Decision|0|||
131558957|NCT00337662|473671410|FG003|Study Period II|Sponsor Decision|2|||
131558958|NCT00337662|473671407|FG000|Study Period II|Parent/Caregiver Decision|0|||
131558959|NCT00337662|473671408|FG001|Study Period II|Parent/Caregiver Decision|0|||
131558960|NCT00337662|473671409|FG002|Study Period II|Parent/Caregiver Decision|0|||
131558961|NCT00337662|473671410|FG003|Study Period II|Parent/Caregiver Decision|1|||
131558962|NCT00337662|473671407|FG000|Study Period III|Lost to Follow-up|14|||
131558963|NCT00337662|473671408|FG001|Study Period III|Lost to Follow-up|16|||
131558964|NCT00337662|473671409|FG002|Study Period III|Lost to Follow-up|14|||
131558965|NCT00337662|473671410|FG003|Study Period III|Lost to Follow-up|0|||
131558966|NCT00337662|473671407|FG000|Study Period III|Withdrawal by Subject|18|||
131558967|NCT00337662|473671408|FG001|Study Period III|Withdrawal by Subject|14|||
131558968|NCT00337662|473671409|FG002|Study Period III|Withdrawal by Subject|12|||
131558969|NCT00337662|473671410|FG003|Study Period III|Withdrawal by Subject|0|||
131558970|NCT00337662|473671407|FG000|Study Period III|Adverse Event|9|||
131558971|NCT00337662|473671408|FG001|Study Period III|Adverse Event|10|||
131558972|NCT00337662|473671409|FG002|Study Period III|Adverse Event|8|||
131558973|NCT00337662|473671410|FG003|Study Period III|Adverse Event|0|||
131558974|NCT00337662|473671407|FG000|Study Period III|Protocol Violation|3|||
131558975|NCT00337662|473671408|FG001|Study Period III|Protocol Violation|8|||
131558976|NCT00337662|473671409|FG002|Study Period III|Protocol Violation|2|||
131558977|NCT00337662|473671410|FG003|Study Period III|Protocol Violation|0|||
131558978|NCT00337662|473671407|FG000|Study Period III|Physician Decision|6|||
131558979|NCT00337662|473671408|FG001|Study Period III|Physician Decision|5|||
131558980|NCT00337662|473671409|FG002|Study Period III|Physician Decision|0|||
131558981|NCT00337662|473671410|FG003|Study Period III|Physician Decision|0|||
131558982|NCT00337662|473671407|FG000|Study Period III|Entry Criteria Not Met|4|||
131558983|NCT00337662|473671408|FG001|Study Period III|Entry Criteria Not Met|1|||
131558984|NCT00337662|473671409|FG002|Study Period III|Entry Criteria Not Met|3|||
131558985|NCT00337662|473671410|FG003|Study Period III|Entry Criteria Not Met|0|||
131558986|NCT00337662|473671407|FG000|Study Period III|Lack of Efficacy|4|||
131558987|NCT00337662|473671408|FG001|Study Period III|Lack of Efficacy|4|||
131558988|NCT00337662|473671409|FG002|Study Period III|Lack of Efficacy|2|||
131558989|NCT00337662|473671410|FG003|Study Period III|Lack of Efficacy|0|||
131558990|NCT00337662|473671407|FG000|Study Period III|Parent/Caregiver Decision|0|||
131558991|NCT00337662|473671408|FG001|Study Period III|Parent/Caregiver Decision|0|||
131558992|NCT00337662|473671409|FG002|Study Period III|Parent/Caregiver Decision|2|||
131558993|NCT00337662|473671410|FG003|Study Period III|Parent/Caregiver Decision|0|||
131558994|NCT00337662|473671407|FG000|Study Period III|Sponsor Decision|1|||
131558995|NCT00337662|473671408|FG001|Study Period III|Sponsor Decision|0|||
131558996|NCT00337662|473671409|FG002|Study Period III|Sponsor Decision|1|||
131693153|NCT02513329|474160076|FG001|Overall Study|Lost to Follow-up|2|||
131693154|NCT01294670|474160077|FG000|Overall Study|Not treated|1|||
131693155|NCT01294670|474160078|FG001|Overall Study|Not treated|0|||
131693156|NCT01294670|474160079|FG002|Overall Study|Not treated|0|||
131558997|NCT00337662|473671410|FG003|Study Period III|Sponsor Decision|0|||
131558998|NCT00337662|473671407|FG000|Study Period III|Clinical Relapse|1|||
131693157|NCT01294670|474160080|FG003|Overall Study|Not treated|0|||
131436791|NCT02079740|473225608|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
131558999|NCT00337662|473671408|FG001|Study Period III|Clinical Relapse|0|||
131559000|NCT00337662|473671409|FG002|Study Period III|Clinical Relapse|0|||
131559001|NCT00337662|473671410|FG003|Study Period III|Clinical Relapse|0|||
131559002|NCT03691948|473671412|FG000|Overall Study|Lost to Follow-up|1|||
131559003|NCT03691948|473671413|FG001|Overall Study|Lost to Follow-up|3|||
131559004|NCT03012061|473671422|FG000|Overall Study|Withdrawal by Subject|1|||
131559005|NCT03012061|473671423|FG001|Overall Study|Withdrawal by Subject|5|||
131559006|NCT03012061|473671424|FG002|Overall Study|Withdrawal by Subject|4|||
131693158|NCT01294670|474160081|FG004|Overall Study|Not treated|0|||
131559007|NCT03012061|473671422|FG000|Overall Study|Investigator Site Closed|1|||
131559008|NCT03012061|473671423|FG001|Overall Study|Investigator Site Closed|2|||
131559009|NCT03012061|473671424|FG002|Overall Study|Investigator Site Closed|0|||
131559010|NCT03012061|473671422|FG000|Overall Study|Lost to Follow-up|2|||
131559011|NCT03012061|473671423|FG001|Overall Study|Lost to Follow-up|1|||
131559012|NCT03012061|473671424|FG002|Overall Study|Lost to Follow-up|0|||
131559013|NCT03012061|473671422|FG000|Overall Study|Study closed/ Terminated|0|||
131559014|NCT03012061|473671423|FG001|Overall Study|Study closed/ Terminated|0|||
131559015|NCT03012061|473671424|FG002|Overall Study|Study closed/ Terminated|1|||
131559016|NCT03012061|473671422|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
131559017|NCT03012061|473671423|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
131559018|NCT03012061|473671424|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
131559019|NCT03012061|473671422|FG000|Overall Study|Protocol Violation|0|||
131559020|NCT03012061|473671423|FG001|Overall Study|Protocol Violation|0|||
131559021|NCT03012061|473671424|FG002|Overall Study|Protocol Violation|2|||
131559022|NCT03012061|473671422|FG000|Overall Study|Lack of Efficacy|0|||
131559023|NCT03012061|473671423|FG001|Overall Study|Lack of Efficacy|1|||
131559024|NCT03012061|473671424|FG002|Overall Study|Lack of Efficacy|0|||
131559025|NCT03012061|473671422|FG000|Overall Study|Adverse Event|2|||
131559026|NCT03012061|473671423|FG001|Overall Study|Adverse Event|0|||
131559027|NCT03012061|473671424|FG002|Overall Study|Adverse Event|0|||
131559028|NCT02696902|473671425|FG000|Overall Study|Lost to Follow-up|0|||
131559029|NCT02696902|473671426|FG001|Overall Study|Lost to Follow-up|1|||
131559030|NCT02696902|473671427|FG002|Overall Study|Lost to Follow-up|1|||
131559031|NCT02696902|473671425|FG000|Overall Study|Withdrawal by Subject|0|||
131559032|NCT02696902|473671426|FG001|Overall Study|Withdrawal by Subject|0|||
131559033|NCT02696902|473671427|FG002|Overall Study|Withdrawal by Subject|1|||
131559034|NCT02696902|473671425|FG000|Overall Study|Death|19|||
131559035|NCT02696902|473671426|FG001|Overall Study|Death|3|||
131559036|NCT02696902|473671427|FG002|Overall Study|Death|24|||
131559037|NCT02696902|473671425|FG000|Overall Study|Participant not fit post-randomization|0|||
131559038|NCT02696902|473671426|FG001|Overall Study|Participant not fit post-randomization|0|||
131559039|NCT02696902|473671427|FG002|Overall Study|Participant not fit post-randomization|1|||
131559040|NCT02696902|473671425|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
131559041|NCT02696902|473671426|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
131559042|NCT02696902|473671427|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
131693159|NCT02083380|474160085|FG000|Overall Study|Lack of Efficacy|68|||
131693160|NCT02083380|474160086|FG001|Overall Study|Lack of Efficacy|79|||
131693161|NCT02083380|474160087|FG002|Overall Study|Lack of Efficacy|64|||
131693162|NCT02083380|474160085|FG000|Overall Study|Withdrawal by Subject|9|||
131693163|NCT02083380|474160086|FG001|Overall Study|Withdrawal by Subject|3|||
131693164|NCT02083380|474160087|FG002|Overall Study|Withdrawal by Subject|7|||
131693165|NCT02083380|474160085|FG000|Overall Study|Physician Decision|1|||
131693166|NCT02083380|474160086|FG001|Overall Study|Physician Decision|6|||
131693167|NCT02083380|474160087|FG002|Overall Study|Physician Decision|3|||
131693168|NCT02083380|474160085|FG000|Overall Study|Adverse Event|0|||
131693169|NCT02083380|474160086|FG001|Overall Study|Adverse Event|0|||
131693170|NCT02083380|474160087|FG002|Overall Study|Adverse Event|1|||
131693171|NCT02083380|474160085|FG000|Overall Study|Lost to Follow-up|5|||
131693172|NCT02083380|474160086|FG001|Overall Study|Lost to Follow-up|3|||
131693173|NCT02083380|474160087|FG002|Overall Study|Lost to Follow-up|3|||
131693174|NCT02083380|474160085|FG000|Overall Study|Other|8|||
131693175|NCT02083380|474160086|FG001|Overall Study|Other|4|||
131693176|NCT02083380|474160087|FG002|Overall Study|Other|6|||
131693177|NCT00001379|474160088|FG000|Initial Treatment|Disease progression|21|||
131693178|NCT00001379|474160089|FG001|Initial Treatment|Disease progression|3|||
131693179|NCT00001379|474160090|FG002|Initial Treatment|Disease progression|0|||
131693180|NCT00001379|474160091|FG003|Initial Treatment|Disease progression|0|||
131693181|NCT00001379|474160088|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
131693182|NCT00001379|474160089|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
131559043|NCT02696902|473671425|FG000|Overall Study|Principal investigator's decision|1|||
131559044|NCT02696902|473671426|FG001|Overall Study|Principal investigator's decision|0|||
131559045|NCT02696902|473671427|FG002|Overall Study|Principal investigator's decision|0|||
131559046|NCT02696902|473671425|FG000|Overall Study|Sponsor's decision|1|||
131559047|NCT02696902|473671426|FG001|Overall Study|Sponsor's decision|0|||
131559048|NCT02696902|473671427|FG002|Overall Study|Sponsor's decision|0|||
131559049|NCT02696902|473671425|FG000|Overall Study|Transferred to other hospital|1|||
131693183|NCT00001379|474160090|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
131693184|NCT00001379|474160091|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
131693185|NCT00001379|474160088|FG000|Initial Treatment|Received alternative treatment|2|||
131693186|NCT00001379|474160089|FG001|Initial Treatment|Received alternative treatment|1|||
131559050|NCT02696902|473671426|FG001|Overall Study|Transferred to other hospital|0|||
131559051|NCT02696902|473671427|FG002|Overall Study|Transferred to other hospital|0|||
131559052|NCT00514046|473671428|FG000|Overall Study|transferred to another protocol|2|||
131693187|NCT00001379|474160090|FG002|Initial Treatment|Received alternative treatment|0|||
131559053|NCT00514046|473671429|FG001|Overall Study|transferred to another protocol|1|||
131559054|NCT00514046|473671430|FG002|Overall Study|transferred to another protocol|3|||
131559055|NCT00514046|473671431|FG003|Overall Study|transferred to another protocol|0|||
131559056|NCT00514046|473671432|FG004|Overall Study|transferred to another protocol|1|||
131559057|NCT00514046|473671433|FG005|Overall Study|transferred to another protocol|0|||
131559058|NCT00514046|473671434|FG006|Overall Study|transferred to another protocol|0|||
131559059|NCT00514046|473671435|FG007|Overall Study|transferred to another protocol|0|||
131559060|NCT00514046|473671436|FG008|Overall Study|transferred to another protocol|0|||
131559061|NCT00514046|473671428|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
131559062|NCT00514046|473671429|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
131559063|NCT00514046|473671430|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
131559064|NCT00514046|473671431|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
131559065|NCT00514046|473671432|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
131559066|NCT00514046|473671433|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
131559067|NCT00514046|473671434|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
131559068|NCT00514046|473671435|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
131559069|NCT00514046|473671436|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
131559070|NCT00514046|473671428|FG000|Overall Study|Disease progression on study|0|||
131559071|NCT00514046|473671429|FG001|Overall Study|Disease progression on study|0|||
131559072|NCT00514046|473671430|FG002|Overall Study|Disease progression on study|2|||
131559073|NCT00514046|473671431|FG003|Overall Study|Disease progression on study|0|||
131559074|NCT00514046|473671432|FG004|Overall Study|Disease progression on study|0|||
131559075|NCT00514046|473671433|FG005|Overall Study|Disease progression on study|1|||
131559076|NCT00514046|473671434|FG006|Overall Study|Disease progression on study|0|||
131559077|NCT00514046|473671435|FG007|Overall Study|Disease progression on study|0|||
131559078|NCT00514046|473671436|FG008|Overall Study|Disease progression on study|0|||
131559079|NCT00383240|473671438|FG000|Overall Study|Adverse Event|4|||
131559080|NCT00383240|473671439|FG001|Overall Study|Adverse Event|6|||
131559081|NCT00383240|473671440|FG002|Overall Study|Adverse Event|9|||
131559082|NCT00383240|473671441|FG003|Overall Study|Adverse Event|7|||
131559083|NCT00383240|473671438|FG000|Overall Study|Treatment Failure|8|||
131559084|NCT00383240|473671439|FG001|Overall Study|Treatment Failure|13|||
131559085|NCT00383240|473671440|FG002|Overall Study|Treatment Failure|47|||
131559086|NCT00383240|473671441|FG003|Overall Study|Treatment Failure|46|||
131559087|NCT00383240|473671438|FG000|Overall Study|Lost to Follow-up|3|||
131559088|NCT00383240|473671439|FG001|Overall Study|Lost to Follow-up|0|||
131559089|NCT00383240|473671440|FG002|Overall Study|Lost to Follow-up|0|||
131559090|NCT00383240|473671441|FG003|Overall Study|Lost to Follow-up|2|||
131559091|NCT00383240|473671438|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
131559092|NCT00383240|473671439|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
131559093|NCT00383240|473671440|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
131559094|NCT00383240|473671441|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
131559095|NCT00383240|473671438|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
131559096|NCT00383240|473671439|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
131559097|NCT00383240|473671440|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
131559098|NCT00383240|473671441|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
131559099|NCT00383240|473671438|FG000|Overall Study|Protocol Violation|4|||
131559100|NCT00383240|473671439|FG001|Overall Study|Protocol Violation|5|||
131559101|NCT00383240|473671440|FG002|Overall Study|Protocol Violation|9|||
131559102|NCT00383240|473671441|FG003|Overall Study|Protocol Violation|6|||
131559103|NCT00383240|473671438|FG000|Overall Study|Did not meet protocol eligibility|9|||
131559104|NCT00383240|473671439|FG001|Overall Study|Did not meet protocol eligibility|4|||
131559105|NCT00383240|473671440|FG002|Overall Study|Did not meet protocol eligibility|9|||
131559106|NCT00383240|473671441|FG003|Overall Study|Did not meet protocol eligibility|3|||
131559107|NCT00383240|473671438|FG000|Overall Study|Administrative|1|||
131559108|NCT00383240|473671439|FG001|Overall Study|Administrative|1|||
131559109|NCT00383240|473671440|FG002|Overall Study|Administrative|0|||
131559110|NCT00383240|473671441|FG003|Overall Study|Administrative|0|||
131559111|NCT02023879|473671445|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
131559112|NCT02023879|473671446|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
131559113|NCT02023879|473671447|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
131559114|NCT02023879|473671445|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
131693188|NCT00001379|474160091|FG003|Initial Treatment|Received alternative treatment|0|||
131693189|NCT00001379|474160088|FG000|Initial Treatment|Refused further treatment|2|||
131693190|NCT00001379|474160089|FG001|Initial Treatment|Refused further treatment|0|||
131693191|NCT00001379|474160090|FG002|Initial Treatment|Refused further treatment|0|||
131693192|NCT00001379|474160091|FG003|Initial Treatment|Refused further treatment|0|||
131693193|NCT00001379|474160088|FG000|Initial Treatment|Did not receive protocol treatment|0|||
131693194|NCT00001379|474160089|FG001|Initial Treatment|Did not receive protocol treatment|0|||
131898548|NCT02797678|474914125|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
131559115|NCT02023879|473671446|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
131559116|NCT02023879|473671447|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
131559117|NCT02023879|473671445|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
131559118|NCT02023879|473671446|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
131559119|NCT02023879|473671447|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
131559120|NCT02023879|473671445|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
131559121|NCT02023879|473671446|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
131559122|NCT02023879|473671447|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
131559123|NCT02023879|473671445|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
131559124|NCT02023879|473671446|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
131559125|NCT02023879|473671447|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
131559126|NCT02023879|473671445|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
131559127|NCT02023879|473671446|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
131559128|NCT02023879|473671447|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
131559129|NCT02023879|473671445|FG000|Extension Open Label Treatment|Adverse Event|1|||
131559130|NCT02023879|473671446|FG001|Extension Open Label Treatment|Adverse Event|7|||
131559131|NCT02023879|473671447|FG002|Extension Open Label Treatment|Adverse Event|3|||
131559132|NCT02023879|473671445|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
131559133|NCT02023879|473671446|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
131559134|NCT02023879|473671447|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
131559135|NCT02023879|473671445|FG000|Extension Open Label Treatment|Participant moved|1|||
131559136|NCT02023879|473671446|FG001|Extension Open Label Treatment|Participant moved|2|||
131559137|NCT02023879|473671447|FG002|Extension Open Label Treatment|Participant moved|0|||
131559138|NCT02023879|473671445|FG000|Extension Open Label Treatment|Other than specified above|2|||
131559139|NCT02023879|473671446|FG001|Extension Open Label Treatment|Other than specified above|7|||
131559140|NCT02023879|473671447|FG002|Extension Open Label Treatment|Other than specified above|2|||
131559141|NCT02924389|473671448|FG000|Overall Study|Lost to Follow-up|1|||
131559142|NCT02924389|473671449|FG001|Overall Study|Lost to Follow-up|0|||
131559143|NCT02924389|473671448|FG000|Overall Study|Physician Decision|2|||
131559144|NCT02924389|473671449|FG001|Overall Study|Physician Decision|0|||
131559145|NCT02924389|473671448|FG000|Overall Study|Withdrawal by Subject|3|||
131559146|NCT02924389|473671449|FG001|Overall Study|Withdrawal by Subject|0|||
131559147|NCT02924389|473671448|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
131559148|NCT02924389|473671449|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
131559149|NCT01091428|473673828|FG000|Phase 1|Progressive Disease|24|||
131559150|NCT01091428|473673829|FG001|Phase 1|Progressive Disease|8|||
131559151|NCT01091428|473673830|FG002|Phase 1|Progressive Disease|0|||
131559152|NCT01091428|473673831|FG003|Phase 1|Progressive Disease|0|||
131559153|NCT01091428|473673828|FG000|Phase 1|Symptomatic Deterioration|3|||
131559154|NCT01091428|473673829|FG001|Phase 1|Symptomatic Deterioration|2|||
131559155|NCT01091428|473673830|FG002|Phase 1|Symptomatic Deterioration|0|||
131559156|NCT01091428|473673831|FG003|Phase 1|Symptomatic Deterioration|0|||
131559157|NCT01091428|473673828|FG000|Phase 1|Adverse Event|2|||
131559158|NCT01091428|473673829|FG001|Phase 1|Adverse Event|0|||
131559159|NCT01091428|473673830|FG002|Phase 1|Adverse Event|0|||
131559160|NCT01091428|473673831|FG003|Phase 1|Adverse Event|0|||
131559161|NCT01091428|473673828|FG000|Phase 1|Withdrawal by Subject|7|||
131559162|NCT01091428|473673829|FG001|Phase 1|Withdrawal by Subject|0|||
131559163|NCT01091428|473673830|FG002|Phase 1|Withdrawal by Subject|0|||
131559164|NCT01091428|473673831|FG003|Phase 1|Withdrawal by Subject|0|||
131559165|NCT01091428|473673828|FG000|Phase 1|Reason not specified|0|||
131559166|NCT01091428|473673829|FG001|Phase 1|Reason not specified|1|||
131559167|NCT01091428|473673830|FG002|Phase 1|Reason not specified|0|||
131559168|NCT01091428|473673831|FG003|Phase 1|Reason not specified|0|||
131693195|NCT00001379|474160090|FG002|Initial Treatment|Did not receive protocol treatment|5|||
131693196|NCT00001379|474160091|FG003|Initial Treatment|Did not receive protocol treatment|0|||
131693197|NCT00001379|474160088|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
131693198|NCT00001379|474160089|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
131559169|NCT01091428|473673828|FG000|Phase 1|Single-Patient IND|2|||
131559170|NCT01091428|473673829|FG001|Phase 1|Single-Patient IND|0|||
131559171|NCT01091428|473673830|FG002|Phase 1|Single-Patient IND|0|||
131559172|NCT01091428|473673831|FG003|Phase 1|Single-Patient IND|0|||
131559173|NCT01091428|473673828|FG000|Phase 2|Progressive Disease|0|||
131559174|NCT01091428|473673829|FG001|Phase 2|Progressive Disease|0|||
131693199|NCT00001379|474160090|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
131693200|NCT00001379|474160091|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
131693201|NCT00001379|474160088|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
131559175|NCT01091428|473673830|FG002|Phase 2|Progressive Disease|44|||
131559176|NCT01091428|473673831|FG003|Phase 2|Progressive Disease|46|||
131559177|NCT01091428|473673828|FG000|Phase 2|Symptomatic Deterioration|0|||
131559178|NCT01091428|473673829|FG001|Phase 2|Symptomatic Deterioration|0|||
131559179|NCT01091428|473673830|FG002|Phase 2|Symptomatic Deterioration|1|||
131559180|NCT01091428|473673831|FG003|Phase 2|Symptomatic Deterioration|6|||
131559181|NCT01091428|473673828|FG000|Phase 2|Adverse Event|0|||
131559182|NCT01091428|473673829|FG001|Phase 2|Adverse Event|0|||
131559183|NCT01091428|473673830|FG002|Phase 2|Adverse Event|12|||
131559184|NCT01091428|473673831|FG003|Phase 2|Adverse Event|5|||
131559185|NCT01091428|473673828|FG000|Phase 2|Withdrawal by Subject|0|||
131559186|NCT01091428|473673829|FG001|Phase 2|Withdrawal by Subject|0|||
131559187|NCT01091428|473673830|FG002|Phase 2|Withdrawal by Subject|9|||
131559188|NCT01091428|473673831|FG003|Phase 2|Withdrawal by Subject|8|||
131559189|NCT01091428|473673828|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
131559190|NCT01091428|473673829|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
131559191|NCT01091428|473673830|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
131559192|NCT01091428|473673831|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
131559193|NCT01091428|473673828|FG000|Phase 2|Reason not specified|0|||
131559194|NCT01091428|473673829|FG001|Phase 2|Reason not specified|0|||
131559195|NCT01091428|473673830|FG002|Phase 2|Reason not specified|4|||
131559196|NCT01091428|473673831|FG003|Phase 2|Reason not specified|3|||
131559197|NCT01091428|473673828|FG000|Phase 2|Physician Decision|0|||
131559198|NCT01091428|473673829|FG001|Phase 2|Physician Decision|0|||
131559199|NCT01091428|473673830|FG002|Phase 2|Physician Decision|2|||
131559200|NCT01091428|473673831|FG003|Phase 2|Physician Decision|0|||
131559201|NCT00636792|473673832|FG000|Overall Study|Adverse Event|16|||
131559202|NCT00636792|473673832|FG000|Overall Study|Physician Decision|7|||
131559203|NCT00636792|473673832|FG000|Overall Study|Progressive Disease|4|||
131559204|NCT00636792|473673832|FG000|Overall Study|Withdrawal by Subject|3|||
131559205|NCT00636792|473673832|FG000|Overall Study|Other|3|||
131559206|NCT01987596|473673835|FG000|Overall Study|Physician Decision|1|||
131559207|NCT01987596|473673836|FG001|Overall Study|Physician Decision|0|||
131559208|NCT01987596|473673835|FG000|Overall Study|Progressive Disease; missing all period|0|||
131559209|NCT01987596|473673836|FG001|Overall Study|Progressive Disease; missing all period|1|||
131559210|NCT00709592|473673837|FG000|Overall Study|Unable to proceed to transplant|0|||
131559211|NCT00709592|473673838|FG001|Overall Study|Unable to proceed to transplant|1|||
131559212|NCT00179010|473673839|FG000|Overall Study|Muscle probe defective|1|||
131559213|NCT00179010|473673840|FG001|Overall Study|Muscle probe defective|1|||
131559214|NCT00179010|473673839|FG000|Overall Study|Failure to place arterial line|0|||
131559215|NCT00179010|473673840|FG001|Overall Study|Failure to place arterial line|1|||
131559216|NCT01375959|473673846|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
131559217|NCT01375959|473673847|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
131559218|NCT01375959|473673846|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
131559219|NCT01375959|473673847|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
131559220|NCT01375959|473673846|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
131559221|NCT01375959|473673847|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
131559222|NCT00178256|473673848|FG000|Overall Study|Adverse Event|2|||
131559223|NCT00178256|473673849|FG001|Overall Study|Adverse Event|0|||
131559224|NCT00178256|473673850|FG002|Overall Study|Adverse Event|0|||
131559225|NCT00178256|473673851|FG003|Overall Study|Adverse Event|0|||
131559226|NCT00178256|473673848|FG000|Overall Study|Death|0|||
131693202|NCT00001379|474160089|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
131693203|NCT00001379|474160090|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
131693204|NCT00001379|474160091|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
131693205|NCT00001379|474160088|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
131693206|NCT00001379|474160089|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
131693207|NCT00001379|474160090|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
131693208|NCT00001379|474160091|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
131693209|NCT00001379|474160088|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
131693210|NCT00001379|474160089|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
131693211|NCT00001379|474160090|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
131693212|NCT00001379|474160091|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
131559227|NCT00178256|473673849|FG001|Overall Study|Death|1|||
131559228|NCT00178256|473673850|FG002|Overall Study|Death|0|||
131559229|NCT00178256|473673851|FG003|Overall Study|Death|1|||
131559230|NCT00178256|473673848|FG000|Overall Study|Cancer progression|2|||
131559231|NCT00178256|473673849|FG001|Overall Study|Cancer progression|0|||
131559232|NCT00178256|473673850|FG002|Overall Study|Cancer progression|0|||
131559233|NCT00178256|473673851|FG003|Overall Study|Cancer progression|1|||
131559234|NCT01763788|473673852|FG000|Overall Study|Lost to Follow-up|0|||
131559235|NCT01763788|473673853|FG001|Overall Study|Lost to Follow-up|0|||
131559236|NCT01763788|473673854|FG002|Overall Study|Lost to Follow-up|1|||
131559237|NCT01763788|473673855|FG003|Overall Study|Lost to Follow-up|0|||
131559238|NCT00708305|473673858|FG000|Period 1|Protocol Violation|1|||
131559239|NCT00708305|473673859|FG001|Period 1|Protocol Violation|0|||
131559240|NCT00708305|473673860|FG002|Period 1|Protocol Violation|1|||
131559241|NCT00708305|473673861|FG003|Period 1|Protocol Violation|0|||
131559242|NCT00708305|473673858|FG000|Period 1|Other Reason|0|||
131559243|NCT00708305|473673859|FG001|Period 1|Other Reason|0|||
131559244|NCT00708305|473673860|FG002|Period 1|Other Reason|0|||
131559245|NCT00708305|473673861|FG003|Period 1|Other Reason|2|||
131559246|NCT00708305|473673858|FG000|Period 2|Lost to Follow-up|0|||
131559247|NCT00708305|473673859|FG001|Period 2|Lost to Follow-up|1|||
131559248|NCT00708305|473673860|FG002|Period 2|Lost to Follow-up|0|||
131559249|NCT00708305|473673861|FG003|Period 2|Lost to Follow-up|0|||
131559250|NCT00708305|473673858|FG000|Period 2|Protocol Violation|0|||
131559251|NCT00708305|473673859|FG001|Period 2|Protocol Violation|1|||
131559252|NCT00708305|473673860|FG002|Period 2|Protocol Violation|0|||
131559253|NCT00708305|473673861|FG003|Period 2|Protocol Violation|0|||
131559254|NCT00708305|473673858|FG000|Period 2|Other Reason|1|||
131559255|NCT00708305|473673859|FG001|Period 2|Other Reason|0|||
131559256|NCT00708305|473673860|FG002|Period 2|Other Reason|0|||
131559257|NCT00708305|473673861|FG003|Period 2|Other Reason|1|||
131559258|NCT00708305|473673858|FG000|Period 3|Protocol Violation|0|||
131559259|NCT00708305|473673859|FG001|Period 3|Protocol Violation|2|||
131559260|NCT00708305|473673860|FG002|Period 3|Protocol Violation|0|||
131559261|NCT00708305|473673861|FG003|Period 3|Protocol Violation|0|||
131559262|NCT00708305|473673858|FG000|Period 3|Other Reason|1|||
131559263|NCT00708305|473673859|FG001|Period 3|Other Reason|0|||
131559264|NCT00708305|473673860|FG002|Period 3|Other Reason|0|||
131559265|NCT00708305|473673861|FG003|Period 3|Other Reason|0|||
131559266|NCT02771210|473673862|FG000|Period 1|Adverse Event|5|||
131559267|NCT02771210|473673863|FG001|Period 1|Adverse Event|3|||
131559268|NCT02771210|473673862|FG000|Period 1|Lack of Efficacy|3|||
131559269|NCT02771210|473673863|FG001|Period 1|Lack of Efficacy|6|||
131559270|NCT02771210|473673862|FG000|Period 1|Lost to Follow-up|2|||
131559271|NCT02771210|473673863|FG001|Period 1|Lost to Follow-up|0|||
131559272|NCT02771210|473673862|FG000|Period 1|Physician Decision|0|||
131559273|NCT02771210|473673863|FG001|Period 1|Physician Decision|1|||
131559274|NCT02771210|473673862|FG000|Period 1|Withdrawal by Subject|0|||
131559275|NCT02771210|473673863|FG001|Period 1|Withdrawal by Subject|3|||
131559276|NCT02771210|473673862|FG000|Period 1|Withdrawal of informed consent|1|||
131559277|NCT02771210|473673863|FG001|Period 1|Withdrawal of informed consent|5|||
131559278|NCT02771210|473673862|FG000|Period 2|Adverse Event|1|||
131559279|NCT02771210|473673863|FG001|Period 2|Adverse Event|0|||
131559280|NCT02771210|473673862|FG000|Period 2|Lack of Efficacy|0|||
131559281|NCT02771210|473673863|FG001|Period 2|Lack of Efficacy|1|||
131559282|NCT02771210|473673862|FG000|Period 2|Withdrawal by Subject|1|||
131559283|NCT02771210|473673863|FG001|Period 2|Withdrawal by Subject|0|||
131559284|NCT02771210|473673862|FG000|Period 2|Withdrawal of informed consent|0|||
131559285|NCT02771210|473673863|FG001|Period 2|Withdrawal of informed consent|2|||
131559286|NCT02310126|473673866|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
131559287|NCT02310126|473673867|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
131559288|NCT02310126|473673866|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
131559289|NCT02310126|473673867|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
131559290|NCT02441946|473673873|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
131559291|NCT02441946|473673874|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
131559292|NCT02441946|473673875|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
131559293|NCT02441946|473673873|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
131559294|NCT02441946|473673874|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
131559295|NCT02441946|473673875|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
131559296|NCT02441946|473673873|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131559297|NCT02441946|473673874|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
131559298|NCT02441946|473673875|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131559299|NCT02441946|473673873|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
131559300|NCT02441946|473673874|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
131559301|NCT02441946|473673875|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
131559302|NCT02441946|473673873|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
131559303|NCT02441946|473673874|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
131559304|NCT02441946|473673875|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
131559305|NCT02441946|473673873|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
131559306|NCT02441946|473673874|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
131559307|NCT02441946|473673875|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
131559308|NCT02441946|473673873|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
131559309|NCT02441946|473673874|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
131559310|NCT02441946|473673875|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
131559311|NCT02441946|473673873|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
131559312|NCT02441946|473673874|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
131559313|NCT02441946|473673875|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
131559314|NCT02441946|473673873|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
131559315|NCT02441946|473673874|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
131559316|NCT02441946|473673875|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
131559317|NCT02441946|473673873|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
131559318|NCT02441946|473673874|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
131559319|NCT02441946|473673875|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
131559320|NCT02441946|473673873|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
131559321|NCT02441946|473673874|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131559322|NCT02441946|473673875|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131559323|NCT02111213|473673876|FG000|Overall Study|Withdrawal by Subject|3|||
131559324|NCT02111213|473673877|FG001|Overall Study|Withdrawal by Subject|2|||
131559325|NCT02111213|473673876|FG000|Overall Study|Lost to Follow-up|3|||
131559326|NCT02111213|473673877|FG001|Overall Study|Lost to Follow-up|4|||
131559327|NCT00502996|473673880|FG000|Overall Study|Lost to Follow-up|9|||
131559328|NCT00502996|473673880|FG000|Overall Study|Protocol Violation|2|||
131559329|NCT00502996|473673880|FG000|Overall Study|Treatment failure|25|||
131559330|NCT00502996|473673880|FG000|Overall Study|Withdrawal Informed Consent|6|||
131559331|NCT00502996|473673880|FG000|Overall Study|Adverse Event|2|||
131559332|NCT02761629|473673881|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
131559333|NCT02761629|473673882|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
131559334|NCT02761629|473673881|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131559335|NCT02761629|473673882|FG001|Overall Study|Insufficient Therapeutic Response|7|||
131559336|NCT02761629|473673881|FG000|Overall Study|Failure to Return|2|||
131559337|NCT02761629|473673882|FG001|Overall Study|Failure to Return|4|||
131559338|NCT02761629|473673881|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
131559339|NCT02761629|473673882|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
131559340|NCT02761629|473673881|FG000|Overall Study|Protocol Violation|2|||
131559341|NCT02761629|473673882|FG001|Overall Study|Protocol Violation|2|||
131559342|NCT02761629|473673881|FG000|Overall Study|Withdrawal by Subject|0|||
131559343|NCT02761629|473673882|FG001|Overall Study|Withdrawal by Subject|3|||
131559344|NCT02761629|473673881|FG000|Overall Study|Other|0|||
131559345|NCT02761629|473673882|FG001|Overall Study|Other|2|||
131559346|NCT02761629|473673881|FG000|Overall Study|Lost to Follow-up|4|||
131559347|NCT02761629|473673882|FG001|Overall Study|Lost to Follow-up|1|||
131559348|NCT02761629|473673881|FG000|Overall Study|Randomized But Not Treated|8|||
131559349|NCT02761629|473673882|FG001|Overall Study|Randomized But Not Treated|4|||
131559350|NCT02001974|473673883|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
131559351|NCT02001974|473673884|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
131559352|NCT02001974|473673885|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
131559353|NCT02001974|473673883|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
131559354|NCT02001974|473673884|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
131693213|NCT00001379|474160088|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
131693214|NCT00001379|474160089|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
131693215|NCT00001379|474160090|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
131693216|NCT00001379|474160091|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
131693217|NCT01560780|474160095|FG000|Overall Study|Death|2|||
131693218|NCT01560780|474160096|FG001|Overall Study|Death|1|||
131693219|NCT01560780|474160095|FG000|Overall Study|Patient Preference|11|||
131693220|NCT01560780|474160096|FG001|Overall Study|Patient Preference|11|||
131693221|NCT01032915|474160097|FG000|Overall Study|Adverse Event|2|||
131693222|NCT01032915|474160098|FG001|Overall Study|Adverse Event|2|||
131693223|NCT01032915|474160099|FG002|Overall Study|Adverse Event|1|||
131693224|NCT01032915|474160100|FG003|Overall Study|Adverse Event|1|||
131693225|NCT01032915|474160097|FG000|Overall Study|Abnormal test procedure result|0|||
131693226|NCT01032915|474160098|FG001|Overall Study|Abnormal test procedure result|0|||
131693227|NCT01032915|474160099|FG002|Overall Study|Abnormal test procedure result|1|||
131693228|NCT01032915|474160100|FG003|Overall Study|Abnormal test procedure result|0|||
131693229|NCT01032915|474160097|FG000|Overall Study|Withdrawal by Subject|0|||
131693230|NCT01032915|474160098|FG001|Overall Study|Withdrawal by Subject|3|||
131693231|NCT01032915|474160099|FG002|Overall Study|Withdrawal by Subject|1|||
131693232|NCT01032915|474160100|FG003|Overall Study|Withdrawal by Subject|1|||
131693233|NCT01032915|474160097|FG000|Overall Study|Administrative reasons|5|||
131693234|NCT01032915|474160098|FG001|Overall Study|Administrative reasons|6|||
131693235|NCT01032915|474160099|FG002|Overall Study|Administrative reasons|4|||
131693236|NCT01032915|474160100|FG003|Overall Study|Administrative reasons|4|||
131693237|NCT01032915|474160097|FG000|Overall Study|Protocol Violation|1|||
131693238|NCT01032915|474160098|FG001|Overall Study|Protocol Violation|0|||
131693239|NCT01032915|474160099|FG002|Overall Study|Protocol Violation|0|||
131559355|NCT02001974|473673885|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
131559356|NCT02001974|473673883|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
131559357|NCT02001974|473673884|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
131559358|NCT02001974|473673885|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
131559359|NCT02001974|473673883|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
131693240|NCT01032915|474160100|FG003|Overall Study|Protocol Violation|1|||
131559360|NCT02001974|473673884|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
131559361|NCT02001974|473673885|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
131559362|NCT00210119|473673886|FG000|Overall Study|Protocol Violation|1|||
131559363|NCT00210119|473673886|FG000|Overall Study|Withdrawal by Subject|1|||
131559364|NCT01830881|473673887|FG000|Overall Study|Changed decision to have an abortion|0|||
131559365|NCT01830881|473673888|FG001|Overall Study|Changed decision to have an abortion|1|||
131559366|NCT00988351|473673889|FG000|Overall Study|Withdrawal by Subject|8|||
131559367|NCT00988351|473673890|FG001|Overall Study|Withdrawal by Subject|0|||
131559368|NCT00988351|473673889|FG000|Overall Study|Lost to Follow-up|6|||
131559369|NCT00988351|473673890|FG001|Overall Study|Lost to Follow-up|9|||
131559370|NCT00988351|473673889|FG000|Overall Study|not using CPAP|5|||
131559371|NCT00988351|473673890|FG001|Overall Study|not using CPAP|3|||
131559372|NCT00119262|473673891|FG000|Overall Study|Lack of Efficacy|0|||
131559373|NCT00119262|473673892|FG001|Overall Study|Lack of Efficacy|3|||
131559374|NCT00119262|473673891|FG000|Overall Study|Withdrawal by Subject|12|||
131559375|NCT00119262|473673892|FG001|Overall Study|Withdrawal by Subject|11|||
131559376|NCT00119262|473673891|FG000|Overall Study|Adverse Event|33|||
131559377|NCT00119262|473673892|FG001|Overall Study|Adverse Event|35|||
131559378|NCT00119262|473673891|FG000|Overall Study|other disease|0|||
131559379|NCT00119262|473673892|FG001|Overall Study|other disease|2|||
131559380|NCT00119262|473673891|FG000|Overall Study|ineligble|1|||
131559381|NCT00119262|473673892|FG001|Overall Study|ineligble|2|||
131559382|NCT00119262|473673891|FG000|Overall Study|others|0|||
131559383|NCT00119262|473673892|FG001|Overall Study|others|5|||
131559384|NCT00734214|473673893|FG000|Overall Study|Withdrawal by Subject|3|||
131559385|NCT00734214|473673894|FG001|Overall Study|Withdrawal by Subject|4|||
131559386|NCT00734214|473673893|FG000|Overall Study|MD withdrawal|1|||
131559387|NCT00734214|473673894|FG001|Overall Study|MD withdrawal|0|||
131559388|NCT02038764|473673895|FG000|Overall Study|Adverse Event|0|||
131559389|NCT02038764|473673896|FG001|Overall Study|Adverse Event|0|||
131559390|NCT02038764|473673897|FG002|Overall Study|Adverse Event|1|||
131559391|NCT02038764|473673898|FG003|Overall Study|Adverse Event|0|||
131559392|NCT02038764|473673899|FG004|Overall Study|Adverse Event|0|||
131559393|NCT02038764|473673895|FG000|Overall Study|Lost to Follow-up|0|||
131559394|NCT02038764|473673896|FG001|Overall Study|Lost to Follow-up|1|||
131559395|NCT02038764|473673897|FG002|Overall Study|Lost to Follow-up|0|||
131559396|NCT02038764|473673898|FG003|Overall Study|Lost to Follow-up|0|||
131559397|NCT02038764|473673899|FG004|Overall Study|Lost to Follow-up|0|||
131559398|NCT02038764|473673895|FG000|Overall Study|Withdrawal by Subject|0|||
131559399|NCT02038764|473673896|FG001|Overall Study|Withdrawal by Subject|0|||
131559400|NCT02038764|473673897|FG002|Overall Study|Withdrawal by Subject|0|||
131559401|NCT02038764|473673898|FG003|Overall Study|Withdrawal by Subject|0|||
131559402|NCT02038764|473673899|FG004|Overall Study|Withdrawal by Subject|1|||
131559403|NCT02038764|473673895|FG000|Overall Study|Other|1|||
131559404|NCT02038764|473673896|FG001|Overall Study|Other|0|||
131559405|NCT02038764|473673897|FG002|Overall Study|Other|1|||
131559406|NCT02038764|473673898|FG003|Overall Study|Other|0|||
131559407|NCT02038764|473673899|FG004|Overall Study|Other|0|||
131559408|NCT04844918|473673902|FG000|Overall Study|Adverse Event|7|||
131559409|NCT04844918|473673903|FG001|Overall Study|Adverse Event|8|||
131559410|NCT04844918|473673904|FG002|Overall Study|Adverse Event|5|||
131559411|NCT04844918|473673902|FG000|Overall Study|Physician Decision|0|||
131559412|NCT04844918|473673903|FG001|Overall Study|Physician Decision|1|||
131559413|NCT04844918|473673904|FG002|Overall Study|Physician Decision|0|||
131559414|NCT04844918|473673902|FG000|Overall Study|Withdrawal by Subject|6|||
131559415|NCT04844918|473673903|FG001|Overall Study|Withdrawal by Subject|3|||
131559416|NCT04844918|473673904|FG002|Overall Study|Withdrawal by Subject|3|||
131559417|NCT04844918|473673902|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
131559418|NCT04844918|473673903|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
131559419|NCT04844918|473673904|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
131559420|NCT01751113|473673916|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
131559421|NCT01751113|473673917|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
131693241|NCT01577186|474160101|FG000|Overall Study|Adverse Event|23|||
131693242|NCT01577186|474160101|FG000|Overall Study|Death|1|||
131693243|NCT01577186|474160101|FG000|Overall Study|Lost to Follow-up|28|||
131559422|NCT01751113|473673918|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
131559423|NCT01751113|473673919|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
131559424|NCT01751113|473673920|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
131559425|NCT01751113|473673921|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
131559426|NCT01751113|473673916|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
131693244|NCT01577186|474160101|FG000|Overall Study|Withdrawal by Subject|35|||
131559427|NCT01751113|473673917|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
131559428|NCT01751113|473673918|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
131559429|NCT01751113|473673919|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
131559430|NCT01751113|473673920|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
131559431|NCT01751113|473673921|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
131693245|NCT01577186|474160101|FG000|Overall Study|Insufficient Response|18|||
131559432|NCT01551303|473673922|FG000|Overall Study|failed awareness check on vision test|4|||
131559433|NCT01551303|473673923|FG001|Overall Study|failed awareness check on vision test|7|||
131559434|NCT00363896|473673924|FG000|Overall Study|Withdrawal by Subject|29|||
131559435|NCT00363896|473673925|FG001|Overall Study|Withdrawal by Subject|16|||
131559436|NCT00363896|473673924|FG000|Overall Study|Adverse Event|24|||
131559437|NCT00363896|473673925|FG001|Overall Study|Adverse Event|13|||
131559438|NCT00363896|473673924|FG000|Overall Study|COPD exacerbation|13|||
131559439|NCT00363896|473673925|FG001|Overall Study|COPD exacerbation|7|||
131559440|NCT00363896|473673924|FG000|Overall Study|Lack of Efficacy|12|||
131559441|NCT00363896|473673925|FG001|Overall Study|Lack of Efficacy|8|||
131559442|NCT00363896|473673924|FG000|Overall Study|Protocol Violation|6|||
131559443|NCT00363896|473673925|FG001|Overall Study|Protocol Violation|1|||
131559444|NCT00363896|473673924|FG000|Overall Study|Lost to Follow-up|3|||
131559445|NCT00363896|473673925|FG001|Overall Study|Lost to Follow-up|0|||
131559446|NCT00363896|473673924|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
131559447|NCT00363896|473673925|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
131559448|NCT00363896|473673924|FG000|Overall Study|Other|1|||
131693246|NCT01577186|474160101|FG000|Overall Study|Ineligible to Continue|15|||
131693247|NCT01577186|474160101|FG000|Overall Study|Non-Compliant|8|||
131693248|NCT01577186|474160101|FG000|Overall Study|Other|2|||
131693249|NCT03363321|474160102|FG000|Overall Study|Withdrawal by Subject|0|||
131693250|NCT03363321|474160103|FG001|Overall Study|Withdrawal by Subject|1|||
131693251|NCT03363321|474160104|FG002|Overall Study|Withdrawal by Subject|0|||
131693252|NCT03363321|474160105|FG003|Overall Study|Withdrawal by Subject|1|||
131693253|NCT03363321|474160106|FG004|Overall Study|Withdrawal by Subject|0|||
131693254|NCT02915523|474160110|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
131693255|NCT02915523|474160111|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
131693256|NCT02915523|474160112|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
131693257|NCT02915523|474160113|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
131693258|NCT02915523|474160110|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
131693259|NCT02915523|474160111|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
131693260|NCT02915523|474160112|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
131693261|NCT02915523|474160113|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
131693262|NCT02915523|474160110|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
131693263|NCT02915523|474160111|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
131693264|NCT02915523|474160112|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
131693265|NCT02915523|474160113|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
131693266|NCT02915523|474160110|FG000|Expansion Phase (Phase 2)|Death|0|||
131693267|NCT02915523|474160111|FG001|Expansion Phase (Phase 2)|Death|0|||
131693268|NCT02915523|474160112|FG002|Expansion Phase (Phase 2)|Death|26|||
131693269|NCT02915523|474160113|FG003|Expansion Phase (Phase 2)|Death|53|||
131693270|NCT02915523|474160110|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
131693271|NCT02915523|474160111|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
131693272|NCT02915523|474160112|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
131693273|NCT02915523|474160113|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
131693274|NCT02915523|474160110|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
131693275|NCT02915523|474160111|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
131693276|NCT02915523|474160112|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
131693277|NCT02915523|474160113|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
131693278|NCT02915523|474160110|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
131693279|NCT02915523|474160111|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
131693280|NCT02915523|474160112|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
131693281|NCT02915523|474160113|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
131693282|NCT00915681|474160114|FG000|Overall Study|Screening failures|46|||
131693283|NCT00811135|474160115|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
131693284|NCT00811135|474160115|FG000|Overall Study|Death|3|||
131693285|NCT00811135|474160115|FG000|Overall Study|Protocol Violation|2|||
131693286|NCT00811135|474160115|FG000|Overall Study|Violation of Selection Criteria|1|||
131693287|NCT00811135|474160115|FG000|Overall Study|Refused Treatment|1|||
131693288|NCT00811135|474160115|FG000|Overall Study|Withdrawal by Subject|3|||
131693289|NCT00811135|474160115|FG000|Overall Study|Administrative/Other Unspecified|11|||
131693290|NCT00811135|474160115|FG000|Overall Study|Ongoing|59|||
131693291|NCT00414453|474160121|FG000|Overall Study|Abnormal lab work|16|||
131693292|NCT00845728|474160122|FG000|Overall Study|Abnormal laboratory value (s)|2|||
131559449|NCT00363896|473673925|FG001|Overall Study|Other|2|||
131559450|NCT00924469|473673930|FG000|Overall Study|Adverse Event|2|||
131559451|NCT00924469|473673931|FG001|Overall Study|Adverse Event|0|||
131559452|NCT00924469|473673930|FG000|Overall Study|Withdrawal by Subject|0|||
131559453|NCT00924469|473673931|FG001|Overall Study|Withdrawal by Subject|1|||
131559454|NCT00924469|473673930|FG000|Overall Study|Lost to Follow-up|0|||
131559455|NCT00924469|473673931|FG001|Overall Study|Lost to Follow-up|1|||
131559456|NCT00630058|473673932|FG000|Overall Study|Adverse Event|1|||
131693293|NCT00845728|474160123|FG001|Overall Study|Abnormal laboratory value (s)|2|||
131559457|NCT00630058|473673933|FG001|Overall Study|Adverse Event|1|||
131559458|NCT00630058|473673932|FG000|Overall Study|Withdrawal by Subject|0|||
131559459|NCT00630058|473673933|FG001|Overall Study|Withdrawal by Subject|1|||
131559460|NCT00630058|473673932|FG000|Overall Study|stopping criteria|3|||
131559461|NCT00630058|473673933|FG001|Overall Study|stopping criteria|2|||
131559462|NCT01651936|473673934|FG000|Base Study|Adverse Event|3|||
131559463|NCT01651936|473673935|FG001|Base Study|Adverse Event|0|||
131559464|NCT01651936|473673936|FG002|Base Study|Adverse Event|0|||
131559465|NCT01651936|473673934|FG000|Base Study|Withdrawal by Subject|1|||
131559466|NCT01651936|473673935|FG001|Base Study|Withdrawal by Subject|1|||
131559467|NCT01651936|473673936|FG002|Base Study|Withdrawal by Subject|0|||
131559468|NCT01651936|473673934|FG000|Base Study|Early Escape|2|||
131559469|NCT01651936|473673935|FG001|Base Study|Early Escape|8|||
131559470|NCT01651936|473673936|FG002|Base Study|Early Escape|0|||
131559471|NCT01651936|473673934|FG000|Base Study|Study terminated by sponsor|21|||
131559472|NCT01651936|473673935|FG001|Base Study|Study terminated by sponsor|16|||
131559473|NCT01651936|473673936|FG002|Base Study|Study terminated by sponsor|0|||
131559474|NCT01651936|473673934|FG000|Extension Study|Lack of Efficacy|0|||
131559475|NCT01651936|473673935|FG001|Extension Study|Lack of Efficacy|0|||
131559476|NCT01651936|473673936|FG002|Extension Study|Lack of Efficacy|1|||
131559477|NCT01651936|473673934|FG000|Extension Study|Study terminated by sponsor|0|||
131559478|NCT01651936|473673935|FG001|Extension Study|Study terminated by sponsor|0|||
131559479|NCT01651936|473673936|FG002|Extension Study|Study terminated by sponsor|13|||
131559480|NCT03044353|473673937|FG000|Overall Study|Adverse Event|0|||
131559481|NCT03044353|473673938|FG001|Overall Study|Adverse Event|1|||
131559482|NCT03044353|473673939|FG002|Overall Study|Adverse Event|0|||
131559483|NCT02141659|473673946|FG000|Overall Study|Major Protocol Deviation|0|||
131559484|NCT02141659|473673947|FG001|Overall Study|Major Protocol Deviation|1|||
131559485|NCT02141659|473673948|FG002|Overall Study|Major Protocol Deviation|0|||
131559486|NCT02141659|473673949|FG003|Overall Study|Major Protocol Deviation|0|||
131559487|NCT02141659|473673950|FG004|Overall Study|Major Protocol Deviation|0|||
131559488|NCT02141659|473673951|FG005|Overall Study|Major Protocol Deviation|0|||
131559489|NCT02141659|473673946|FG000|Overall Study|Lack of Efficacy|0|||
131559490|NCT02141659|473673947|FG001|Overall Study|Lack of Efficacy|0|||
131559491|NCT02141659|473673948|FG002|Overall Study|Lack of Efficacy|0|||
131559492|NCT02141659|473673949|FG003|Overall Study|Lack of Efficacy|0|||
131559493|NCT02141659|473673950|FG004|Overall Study|Lack of Efficacy|0|||
131559494|NCT02141659|473673951|FG005|Overall Study|Lack of Efficacy|1|||
131559495|NCT02141659|473673946|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
131559496|NCT02141659|473673947|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
131559497|NCT02141659|473673948|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
131559498|NCT02141659|473673949|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
131693294|NCT00845728|474160122|FG000|Overall Study|Patient's inability to use the device|4|||
131693295|NCT00845728|474160123|FG001|Overall Study|Patient's inability to use the device|6|||
131693296|NCT00845728|474160122|FG000|Overall Study|Abnormal test procedure result (s)|7|||
131693297|NCT00845728|474160123|FG001|Overall Study|Abnormal test procedure result (s)|2|||
131693298|NCT00845728|474160122|FG000|Overall Study|Lost to Follow-up|22|||
131693299|NCT00845728|474160123|FG001|Overall Study|Lost to Follow-up|13|||
131693300|NCT00845728|474160122|FG000|Overall Study|Death|24|||
131693301|NCT00845728|474160123|FG001|Overall Study|Death|26|||
131693302|NCT00845728|474160122|FG000|Overall Study|Administrative Problems|34|||
131693303|NCT00845728|474160123|FG001|Overall Study|Administrative Problems|26|||
131693304|NCT00845728|474160122|FG000|Overall Study|Protocol Violation|36|||
131693305|NCT00845728|474160123|FG001|Overall Study|Protocol Violation|24|||
131693306|NCT00845728|474160122|FG000|Overall Study|Lack of Efficacy|51|||
131693307|NCT00845728|474160123|FG001|Overall Study|Lack of Efficacy|39|||
131693308|NCT00845728|474160122|FG000|Overall Study|Adverse Event|101|||
131693309|NCT00845728|474160123|FG001|Overall Study|Adverse Event|96|||
131693310|NCT00845728|474160122|FG000|Overall Study|Withdrawal by Subject|105|||
131693311|NCT00845728|474160123|FG001|Overall Study|Withdrawal by Subject|108|||
131693312|NCT00464334|474160128|FG000|Overall Study|Adverse Event|0|||
131693313|NCT00464334|474160129|FG001|Overall Study|Adverse Event|0|||
131898549|NCT02797678|474914126|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
131559499|NCT02141659|473673950|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
131693314|NCT00464334|474160130|FG002|Overall Study|Adverse Event|0|||
131693315|NCT00464334|474160131|FG003|Overall Study|Adverse Event|1|||
131693316|NCT00464334|474160132|FG004|Overall Study|Adverse Event|1|||
131559500|NCT02141659|473673951|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
131559501|NCT01927731|473673959|FG000|Overall Study|Graft Failure|1|||
131559502|NCT01927731|473673960|FG001|Overall Study|Graft Failure|2|||
131559503|NCT01927731|473673959|FG000|Overall Study|Physician Decision|2|||
131559504|NCT01927731|473673960|FG001|Overall Study|Physician Decision|3|||
131559505|NCT01927731|473673959|FG000|Overall Study|Withdrawal by Subject|0|||
131559506|NCT01927731|473673960|FG001|Overall Study|Withdrawal by Subject|2|||
131559507|NCT01927731|473673959|FG000|Overall Study|Death|0|||
131693317|NCT00464334|474160133|FG005|Overall Study|Adverse Event|1|||
131693318|NCT00464334|474160134|FG006|Overall Study|Adverse Event|0|||
131693319|NCT00464334|474160135|FG007|Overall Study|Adverse Event|0|||
131559508|NCT01927731|473673960|FG001|Overall Study|Death|3|||
131559509|NCT01388530|473673965|FG000|Overall Study|Lost to Follow-up|5|||
131559510|NCT00305864|473673966|FG000|Overall Study|Ineligible / No protocol treatment|0|||
131559511|NCT00305864|473673967|FG001|Overall Study|Ineligible / No protocol treatment|1|||
131559512|NCT00305864|473673968|FG002|Overall Study|Ineligible / No protocol treatment|1|||
131559513|NCT00305864|473673969|FG003|Overall Study|Ineligible / No protocol treatment|13|||
131559514|NCT02836613|473673972|FG000|Overall Study|Accidental drowning|1|||
131559515|NCT02836613|473673973|FG001|Overall Study|Accidental drowning|0|||
131559516|NCT02836613|473673972|FG000|Overall Study|Lost to Follow-up|0|||
131559517|NCT02836613|473673973|FG001|Overall Study|Lost to Follow-up|1|||
131559518|NCT02836613|473673972|FG000|Overall Study|Withdrawal by Subject|0|||
131559519|NCT02836613|473673973|FG001|Overall Study|Withdrawal by Subject|2|||
131559520|NCT03881059|473673974|FG000|Treatment Period - Part A|Adverse Event|1|||
131559521|NCT03881059|473673975|FG001|Treatment Period - Part A|Adverse Event|3|||
131559522|NCT03881059|473673976|FG002|Treatment Period - Part A|Adverse Event|4|||
131559523|NCT03881059|473673974|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
131559524|NCT03881059|473673975|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
131559525|NCT03881059|473673976|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
131559526|NCT03881059|473673974|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
131559527|NCT03881059|473673975|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
131559528|NCT03881059|473673976|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
131559529|NCT03881059|473673974|FG000|Treatment Period - Part A|Other reasons|2|||
131559530|NCT03881059|473673975|FG001|Treatment Period - Part A|Other reasons|1|||
131559531|NCT03881059|473673976|FG002|Treatment Period - Part A|Other reasons|0|||
131559532|NCT03881059|473673974|FG000|Treatment Period - Part B|Adverse Event|0|||
131559533|NCT03881059|473673975|FG001|Treatment Period - Part B|Adverse Event|0|||
131559534|NCT03881059|473673976|FG002|Treatment Period - Part B|Adverse Event|3|||
131559535|NCT03881059|473673974|FG000|Treatment Period - Part B|Death|0|||
131559536|NCT03881059|473673975|FG001|Treatment Period - Part B|Death|1|||
131559537|NCT03881059|473673976|FG002|Treatment Period - Part B|Death|1|||
131559538|NCT03881059|473673974|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
131559539|NCT03881059|473673975|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
131559540|NCT03881059|473673976|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
131559541|NCT03881059|473673974|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
131559542|NCT03881059|473673975|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
131559543|NCT03881059|473673976|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
131559544|NCT03881059|473673974|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
131559545|NCT03881059|473673975|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
131559546|NCT03881059|473673976|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
131559547|NCT03881059|473673974|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
131559548|NCT03881059|473673975|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
131559549|NCT03881059|473673976|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
131559550|NCT03881059|473673974|FG000|Treatment Period - Part B|Other reasons|4|||
131778057|NCT01233284|474467546|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131778058|NCT01233284|474467547|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
131778059|NCT01233284|474467548|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131778060|NCT01233284|474467549|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131778061|NCT01233284|474467545|FG000|Period 3 (4 Weeks)|Other|0|||
131778062|NCT01233284|474467546|FG001|Period 3 (4 Weeks)|Other|0|||
131778063|NCT01233284|474467547|FG002|Period 3 (4 Weeks)|Other|0|||
131778064|NCT01233284|474467548|FG003|Period 3 (4 Weeks)|Other|1|||
131778065|NCT01233284|474467549|FG004|Period 3 (4 Weeks)|Other|0|||
131559551|NCT03881059|473673975|FG001|Treatment Period - Part B|Other reasons|3|||
131559552|NCT03881059|473673976|FG002|Treatment Period - Part B|Other reasons|3|||
131559553|NCT05284019|473673977|FG000|Overall Study|Study terminated|2|||
131559554|NCT05284019|473673978|FG001|Overall Study|Study terminated|2|||
131559555|NCT05284019|473673979|FG002|Overall Study|Study terminated|2|||
131559556|NCT05284019|473673980|FG003|Overall Study|Study terminated|5|||
131559557|NCT05284019|473673981|FG004|Overall Study|Study terminated|15|||
131559558|NCT05284019|473673977|FG000|Overall Study|Withdrawal by Subject|0|||
131778066|NCT01233284|474467545|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
131778067|NCT01233284|474467546|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
131778068|NCT01233284|474467547|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
131778069|NCT01233284|474467548|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
131778070|NCT01233284|474467549|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
131693320|NCT00464334|474160136|FG008|Overall Study|Adverse Event|2|||
131693321|NCT00464334|474160137|FG009|Overall Study|Adverse Event|1|||
131693322|NCT00464334|474160138|FG010|Overall Study|Adverse Event|2|||
131693323|NCT00464334|474160128|FG000|Overall Study|Lack of Efficacy|0|||
131693324|NCT00464334|474160129|FG001|Overall Study|Lack of Efficacy|1|||
131693325|NCT00464334|474160130|FG002|Overall Study|Lack of Efficacy|0|||
131693326|NCT00464334|474160131|FG003|Overall Study|Lack of Efficacy|0|||
131693327|NCT00464334|474160132|FG004|Overall Study|Lack of Efficacy|0|||
131693328|NCT00464334|474160133|FG005|Overall Study|Lack of Efficacy|0|||
131693329|NCT00464334|474160134|FG006|Overall Study|Lack of Efficacy|0|||
131693330|NCT00464334|474160135|FG007|Overall Study|Lack of Efficacy|0|||
131693331|NCT00464334|474160136|FG008|Overall Study|Lack of Efficacy|0|||
131693332|NCT00464334|474160137|FG009|Overall Study|Lack of Efficacy|0|||
131693333|NCT00464334|474160138|FG010|Overall Study|Lack of Efficacy|0|||
131693334|NCT00464334|474160128|FG000|Overall Study|Lost to Follow-up|0|||
131693335|NCT00464334|474160129|FG001|Overall Study|Lost to Follow-up|0|||
131693336|NCT00464334|474160130|FG002|Overall Study|Lost to Follow-up|1|||
131693337|NCT00464334|474160131|FG003|Overall Study|Lost to Follow-up|0|||
131693338|NCT00464334|474160132|FG004|Overall Study|Lost to Follow-up|1|||
131693339|NCT00464334|474160133|FG005|Overall Study|Lost to Follow-up|0|||
131693340|NCT00464334|474160134|FG006|Overall Study|Lost to Follow-up|1|||
131693341|NCT00464334|474160135|FG007|Overall Study|Lost to Follow-up|0|||
131693342|NCT00464334|474160136|FG008|Overall Study|Lost to Follow-up|0|||
131693343|NCT00464334|474160137|FG009|Overall Study|Lost to Follow-up|0|||
131693344|NCT00464334|474160138|FG010|Overall Study|Lost to Follow-up|2|||
131693345|NCT00464334|474160128|FG000|Overall Study|Progressive Disease|0|||
131693346|NCT00464334|474160129|FG001|Overall Study|Progressive Disease|0|||
131693347|NCT00464334|474160130|FG002|Overall Study|Progressive Disease|0|||
131693348|NCT00464334|474160131|FG003|Overall Study|Progressive Disease|0|||
131693349|NCT00464334|474160132|FG004|Overall Study|Progressive Disease|0|||
131693350|NCT00464334|474160133|FG005|Overall Study|Progressive Disease|1|||
131693351|NCT00464334|474160134|FG006|Overall Study|Progressive Disease|0|||
131693352|NCT00464334|474160135|FG007|Overall Study|Progressive Disease|0|||
131693353|NCT00464334|474160136|FG008|Overall Study|Progressive Disease|1|||
131693354|NCT00464334|474160137|FG009|Overall Study|Progressive Disease|0|||
131693355|NCT00464334|474160138|FG010|Overall Study|Progressive Disease|0|||
131693356|NCT00464334|474160128|FG000|Overall Study|Study Terminated by Sponsor|0|||
131693357|NCT00464334|474160129|FG001|Overall Study|Study Terminated by Sponsor|0|||
131693358|NCT00464334|474160130|FG002|Overall Study|Study Terminated by Sponsor|0|||
131693359|NCT00464334|474160131|FG003|Overall Study|Study Terminated by Sponsor|1|||
131693360|NCT00464334|474160132|FG004|Overall Study|Study Terminated by Sponsor|0|||
131693361|NCT00464334|474160133|FG005|Overall Study|Study Terminated by Sponsor|0|||
131693362|NCT00464334|474160134|FG006|Overall Study|Study Terminated by Sponsor|0|||
131693363|NCT00464334|474160135|FG007|Overall Study|Study Terminated by Sponsor|0|||
131693364|NCT00464334|474160136|FG008|Overall Study|Study Terminated by Sponsor|0|||
131693365|NCT00464334|474160137|FG009|Overall Study|Study Terminated by Sponsor|0|||
131693366|NCT00464334|474160138|FG010|Overall Study|Study Terminated by Sponsor|0|||
131693367|NCT00464334|474160128|FG000|Overall Study|Withdrawal by Subject|1|||
131693368|NCT00464334|474160129|FG001|Overall Study|Withdrawal by Subject|7|||
131693369|NCT00464334|474160130|FG002|Overall Study|Withdrawal by Subject|4|||
131693370|NCT00464334|474160131|FG003|Overall Study|Withdrawal by Subject|2|||
131693371|NCT00464334|474160132|FG004|Overall Study|Withdrawal by Subject|2|||
131693372|NCT00464334|474160133|FG005|Overall Study|Withdrawal by Subject|2|||
131693373|NCT00464334|474160134|FG006|Overall Study|Withdrawal by Subject|2|||
131693374|NCT00464334|474160135|FG007|Overall Study|Withdrawal by Subject|1|||
131693375|NCT00464334|474160136|FG008|Overall Study|Withdrawal by Subject|3|||
131693376|NCT00464334|474160137|FG009|Overall Study|Withdrawal by Subject|0|||
131693377|NCT00464334|474160138|FG010|Overall Study|Withdrawal by Subject|0|||
131693378|NCT00794677|474160147|FG000|First Intervention|Withdrawal by Subject|2|||
131693379|NCT00794677|474160148|FG001|First Intervention|Withdrawal by Subject|0|||
131693380|NCT00542269|474160156|FG000|Overall Study|Adverse Event|10|||
131693381|NCT00542269|474160157|FG001|Overall Study|Adverse Event|4|||
131693382|NCT00542269|474160158|FG002|Overall Study|Adverse Event|5|||
131693383|NCT00542269|474160156|FG000|Overall Study|Protocol Violation|1|||
131693384|NCT00542269|474160157|FG001|Overall Study|Protocol Violation|1|||
131693385|NCT00542269|474160158|FG002|Overall Study|Protocol Violation|0|||
131693386|NCT00542269|474160156|FG000|Overall Study|Withdrawal by Subject|1|||
131693387|NCT00542269|474160157|FG001|Overall Study|Withdrawal by Subject|0|||
131693388|NCT00542269|474160158|FG002|Overall Study|Withdrawal by Subject|0|||
131693389|NCT00542269|474160156|FG000|Overall Study|Administrative problems|1|||
131693390|NCT00542269|474160157|FG001|Overall Study|Administrative problems|1|||
131693391|NCT00542269|474160158|FG002|Overall Study|Administrative problems|1|||
131693392|NCT00254501|474160164|FG000|Overall Study|Lost to Follow-up|1|||
131693393|NCT00254501|474160165|FG001|Overall Study|Lost to Follow-up|1|||
131693394|NCT00923130|474160166|FG000|Overall Study|Stopped treatment due to progression|17|||
131693395|NCT00923130|474160166|FG000|Overall Study|Death|1|||
131778071|NCT01233284|474467545|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131778072|NCT01233284|474467546|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131778073|NCT01233284|474467547|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131778074|NCT01233284|474467548|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
131778075|NCT01233284|474467549|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131778076|NCT02756182|474467550|FG000|Overall Study|StudyTechnical Difficulties|4|||
131778077|NCT01058707|474467551|FG000|Overall Study|Disease Progression|15|||
131778078|NCT01058707|474467552|FG001|Overall Study|Disease Progression|20|||
131778079|NCT01058707|474467553|FG002|Overall Study|Disease Progression|20|||
131778080|NCT01058707|474467554|FG003|Overall Study|Disease Progression|15|||
131778081|NCT01058707|474467555|FG004|Overall Study|Disease Progression|23|||
131778082|NCT01058707|474467556|FG005|Overall Study|Disease Progression|10|||
131778083|NCT01058707|474467557|FG006|Overall Study|Disease Progression|12|||
131778084|NCT01058707|474467551|FG000|Overall Study|Adverse Event|11|||
131778085|NCT01058707|474467552|FG001|Overall Study|Adverse Event|4|||
131778086|NCT01058707|474467553|FG002|Overall Study|Adverse Event|7|||
131778087|NCT01058707|474467554|FG003|Overall Study|Adverse Event|6|||
131778088|NCT01058707|474467555|FG004|Overall Study|Adverse Event|7|||
131778089|NCT01058707|474467556|FG005|Overall Study|Adverse Event|3|||
131778090|NCT01058707|474467557|FG006|Overall Study|Adverse Event|1|||
131778091|NCT01058707|474467551|FG000|Overall Study|Subject Decision|5|||
131778092|NCT01058707|474467552|FG001|Overall Study|Subject Decision|3|||
131778093|NCT01058707|474467553|FG002|Overall Study|Subject Decision|3|||
131778094|NCT01058707|474467554|FG003|Overall Study|Subject Decision|1|||
131778095|NCT01058707|474467555|FG004|Overall Study|Subject Decision|2|||
131778096|NCT01058707|474467556|FG005|Overall Study|Subject Decision|3|||
131778097|NCT01058707|474467557|FG006|Overall Study|Subject Decision|6|||
131778098|NCT01058707|474467551|FG000|Overall Study|Lost to Follow-up|0|||
131778099|NCT01058707|474467552|FG001|Overall Study|Lost to Follow-up|0|||
131778100|NCT01058707|474467553|FG002|Overall Study|Lost to Follow-up|1|||
131778101|NCT01058707|474467554|FG003|Overall Study|Lost to Follow-up|0|||
131778102|NCT01058707|474467555|FG004|Overall Study|Lost to Follow-up|0|||
131778103|NCT01058707|474467556|FG005|Overall Study|Lost to Follow-up|0|||
131778104|NCT01058707|474467557|FG006|Overall Study|Lost to Follow-up|0|||
131778105|NCT01058707|474467551|FG000|Overall Study|Reason Not Specified|0|||
131778106|NCT01058707|474467552|FG001|Overall Study|Reason Not Specified|3|||
131778107|NCT01058707|474467553|FG002|Overall Study|Reason Not Specified|2|||
131778108|NCT01058707|474467554|FG003|Overall Study|Reason Not Specified|0|||
131778109|NCT01058707|474467555|FG004|Overall Study|Reason Not Specified|7|||
131778110|NCT01058707|474467556|FG005|Overall Study|Reason Not Specified|1|||
131778111|NCT01058707|474467557|FG006|Overall Study|Reason Not Specified|7|||
131778112|NCT01821391|474467558|FG000|Overall Study|Adverse Event|1|||
131778113|NCT01821391|474467559|FG001|Overall Study|Adverse Event|0|||
131778114|NCT02146365|474467560|FG000|Overall Study|Lost to Follow-up|2|||
131778115|NCT02146365|474467561|FG001|Overall Study|Lost to Follow-up|1|||
131778116|NCT02146365|474467562|FG002|Overall Study|Lost to Follow-up|3|||
131778117|NCT02146365|474467563|FG003|Overall Study|Lost to Follow-up|3|||
131778118|NCT02146365|474467564|FG004|Overall Study|Lost to Follow-up|1|||
131778119|NCT02146365|474467565|FG005|Overall Study|Lost to Follow-up|1|||
131778120|NCT02146365|474467566|FG006|Overall Study|Lost to Follow-up|0|||
131778121|NCT02146365|474467567|FG007|Overall Study|Lost to Follow-up|1|||
131778122|NCT02146365|474467560|FG000|Overall Study|Withdrawal by Subject|1|||
131778123|NCT02146365|474467561|FG001|Overall Study|Withdrawal by Subject|2|||
131778124|NCT02146365|474467562|FG002|Overall Study|Withdrawal by Subject|1|||
131778125|NCT02146365|474467563|FG003|Overall Study|Withdrawal by Subject|5|||
131778126|NCT02146365|474467564|FG004|Overall Study|Withdrawal by Subject|1|||
131778127|NCT02146365|474467565|FG005|Overall Study|Withdrawal by Subject|0|||
131778128|NCT02146365|474467566|FG006|Overall Study|Withdrawal by Subject|0|||
131778129|NCT02146365|474467567|FG007|Overall Study|Withdrawal by Subject|0|||
131778130|NCT02146365|474467560|FG000|Overall Study|Unable to Comply with Protocol|0|||
131778131|NCT02146365|474467561|FG001|Overall Study|Unable to Comply with Protocol|1|||
131778132|NCT02146365|474467562|FG002|Overall Study|Unable to Comply with Protocol|1|||
131778133|NCT02146365|474467563|FG003|Overall Study|Unable to Comply with Protocol|0|||
131778134|NCT02146365|474467564|FG004|Overall Study|Unable to Comply with Protocol|0|||
131778135|NCT02146365|474467565|FG005|Overall Study|Unable to Comply with Protocol|0|||
131778136|NCT02146365|474467566|FG006|Overall Study|Unable to Comply with Protocol|0|||
131778137|NCT02146365|474467567|FG007|Overall Study|Unable to Comply with Protocol|0|||
131778138|NCT02146365|474467560|FG000|Overall Study|Other|1|||
131778139|NCT02146365|474467561|FG001|Overall Study|Other|0|||
131778140|NCT02146365|474467562|FG002|Overall Study|Other|2|||
131778141|NCT02146365|474467563|FG003|Overall Study|Other|1|||
131778142|NCT02146365|474467564|FG004|Overall Study|Other|0|||
131778143|NCT02146365|474467565|FG005|Overall Study|Other|0|||
131778144|NCT02146365|474467566|FG006|Overall Study|Other|0|||
131778145|NCT02146365|474467567|FG007|Overall Study|Other|0|||
131778146|NCT01977482|474467569|FG000|Overall Study|Adverse Event|0|||
131693396|NCT00923130|474160166|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
131693397|NCT00923130|474160166|FG000|Overall Study|Switched to alternative treatment|2|||
131693398|NCT00923130|474160166|FG000|Overall Study|Refused further treatment|2|||
131693399|NCT00159861|474160168|FG000|Core Study - 16 Weeks|Death|3|||
131693400|NCT00159861|474160169|FG001|Core Study - 16 Weeks|Death|0|||
131693401|NCT00159861|474160168|FG000|Core Study - 16 Weeks|Adverse Event|12|||
131693402|NCT00159861|474160169|FG001|Core Study - 16 Weeks|Adverse Event|6|||
131693403|NCT00159861|474160168|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
131693404|NCT00159861|474160169|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
131693405|NCT00159861|474160168|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
131693406|NCT00159861|474160169|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
131693407|NCT00159861|474160168|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
131693408|NCT00159861|474160169|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
131693409|NCT00159861|474160168|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
131693410|NCT00159861|474160169|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
131693411|NCT00159861|474160168|FG000|Extension Study - up to 3 Years|Death|24|||
131693412|NCT00159861|474160169|FG001|Extension Study - up to 3 Years|Death|28|||
131693413|NCT00159861|474160168|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
131693414|NCT00159861|474160169|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
131693415|NCT00159861|474160168|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
131693416|NCT00159861|474160169|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
131693417|NCT00159861|474160168|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
131693418|NCT00159861|474160169|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
131693419|NCT00159861|474160168|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
131693420|NCT00159861|474160169|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
131693421|NCT04194528|474160174|FG000|Overall Study|Adverse Event|1|||
131693422|NCT03921424|474160177|FG000|Overall Study|Lost to Follow-up|0|||
131693423|NCT03921424|474160178|FG001|Overall Study|Lost to Follow-up|1|||
131693424|NCT03921424|474160177|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131693425|NCT03921424|474160178|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
131693426|NCT00522431|474161591|FG000|Overall Study|Adverse Event|5|||
131693427|NCT00522431|474161591|FG000|Overall Study|Protocol Violation|2|||
131693428|NCT00522431|474161591|FG000|Overall Study|Withdrawal by Subject|2|||
131693429|NCT00522431|474161591|FG000|Overall Study|Subject non-compliance|1|||
131693430|NCT00522431|474161591|FG000|Overall Study|Other/unknown|1|||
131693431|NCT00513409|474161597|FG000|Overall Study|Adverse Event|0|||
131693432|NCT00513409|474161598|FG001|Overall Study|Adverse Event|1|||
131693433|NCT00513409|474161597|FG000|Overall Study|Withdrawal by Subject|0|||
131693434|NCT00513409|474161598|FG001|Overall Study|Withdrawal by Subject|2|||
131693435|NCT00513409|474161597|FG000|Overall Study|Lost to Follow-up|0|||
131693436|NCT00513409|474161598|FG001|Overall Study|Lost to Follow-up|1|||
131693437|NCT00513409|474161597|FG000|Overall Study|Physician Decision|1|||
131693438|NCT00513409|474161598|FG001|Overall Study|Physician Decision|0|||
131693439|NCT00513409|474161597|FG000|Overall Study|Visit 3 not done|1|||
131693440|NCT00513409|474161598|FG001|Overall Study|Visit 3 not done|2|||
131693441|NCT01049035|474161599|FG000|Overall Study|Serious adverse event|0|||
131693442|NCT01049035|474161600|FG001|Overall Study|Serious adverse event|1|||
131693443|NCT01049035|474161601|FG002|Overall Study|Serious adverse event|1|||
131693444|NCT01049035|474161602|FG003|Overall Study|Serious adverse event|2|||
131693445|NCT01049035|474161603|FG004|Overall Study|Serious adverse event|0|||
131693446|NCT01049035|474161604|FG005|Overall Study|Serious adverse event|0|||
131693447|NCT01049035|474161605|FG006|Overall Study|Serious adverse event|0|||
131693448|NCT01049035|474161599|FG000|Overall Study|Other adverse event (AE)|0|||
131693449|NCT01049035|474161600|FG001|Overall Study|Other adverse event (AE)|0|||
131693450|NCT01049035|474161601|FG002|Overall Study|Other adverse event (AE)|0|||
131693451|NCT01049035|474161602|FG003|Overall Study|Other adverse event (AE)|1|||
131693452|NCT01049035|474161603|FG004|Overall Study|Other adverse event (AE)|0|||
131693453|NCT01049035|474161604|FG005|Overall Study|Other adverse event (AE)|0|||
131693454|NCT01049035|474161605|FG006|Overall Study|Other adverse event (AE)|0|||
131693455|NCT01049035|474161599|FG000|Overall Study|Non-compliance with the protocol|12|||
131693456|NCT01049035|474161600|FG001|Overall Study|Non-compliance with the protocol|6|||
131693457|NCT01049035|474161601|FG002|Overall Study|Non-compliance with the protocol|14|||
131693458|NCT01049035|474161602|FG003|Overall Study|Non-compliance with the protocol|5|||
131693459|NCT01049035|474161603|FG004|Overall Study|Non-compliance with the protocol|3|||
131693460|NCT01049035|474161604|FG005|Overall Study|Non-compliance with the protocol|4|||
131693461|NCT01049035|474161605|FG006|Overall Study|Non-compliance with the protocol|10|||
131693462|NCT01049035|474161599|FG000|Overall Study|Lost to Follow-up|5|||
131693463|NCT01049035|474161600|FG001|Overall Study|Lost to Follow-up|4|||
131693464|NCT01049035|474161601|FG002|Overall Study|Lost to Follow-up|4|||
131693465|NCT01049035|474161602|FG003|Overall Study|Lost to Follow-up|1|||
131693466|NCT01049035|474161603|FG004|Overall Study|Lost to Follow-up|0|||
131693467|NCT01049035|474161604|FG005|Overall Study|Lost to Follow-up|3|||
131693468|NCT01049035|474161605|FG006|Overall Study|Lost to Follow-up|3|||
131693469|NCT01049035|474161599|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
131693470|NCT01049035|474161600|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
131778147|NCT01977482|474467570|FG001|Overall Study|Adverse Event|1|||
131778148|NCT01977482|474467571|FG002|Overall Study|Adverse Event|1|||
131778149|NCT01977482|474467572|FG003|Overall Study|Adverse Event|0|||
131778150|NCT01977482|474467573|FG004|Overall Study|Adverse Event|2|||
131778151|NCT01977482|474467574|FG005|Overall Study|Adverse Event|0|||
131778152|NCT01977482|474467569|FG000|Overall Study|Lost to Follow-up|1|||
131778153|NCT01977482|474467570|FG001|Overall Study|Lost to Follow-up|0|||
131778154|NCT01977482|474467571|FG002|Overall Study|Lost to Follow-up|0|||
131778155|NCT01977482|474467572|FG003|Overall Study|Lost to Follow-up|0|||
131778156|NCT01977482|474467573|FG004|Overall Study|Lost to Follow-up|0|||
131778157|NCT01977482|474467574|FG005|Overall Study|Lost to Follow-up|0|||
131778158|NCT01977482|474467569|FG000|Overall Study|Physician Decision|0|||
131778159|NCT01977482|474467570|FG001|Overall Study|Physician Decision|1|||
131778160|NCT01977482|474467571|FG002|Overall Study|Physician Decision|0|||
131778161|NCT01977482|474467572|FG003|Overall Study|Physician Decision|0|||
131778162|NCT01977482|474467573|FG004|Overall Study|Physician Decision|0|||
131778163|NCT01977482|474467574|FG005|Overall Study|Physician Decision|0|||
131778164|NCT01977482|474467569|FG000|Overall Study|Protocol Violation|0|||
131778165|NCT01977482|474467570|FG001|Overall Study|Protocol Violation|0|||
131778166|NCT01977482|474467571|FG002|Overall Study|Protocol Violation|1|||
131778167|NCT01977482|474467572|FG003|Overall Study|Protocol Violation|0|||
131778168|NCT01977482|474467573|FG004|Overall Study|Protocol Violation|0|||
131778169|NCT01977482|474467574|FG005|Overall Study|Protocol Violation|0|||
131778170|NCT01977482|474467569|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
131778171|NCT01977482|474467570|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
131778172|NCT01977482|474467571|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
131778173|NCT01977482|474467572|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
131778174|NCT01977482|474467573|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
131778175|NCT01977482|474467574|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
131778176|NCT01977482|474467569|FG000|Overall Study|Withdrawal by Subject|2|||
131778177|NCT01977482|474467570|FG001|Overall Study|Withdrawal by Subject|4|||
131778178|NCT01977482|474467571|FG002|Overall Study|Withdrawal by Subject|1|||
131778179|NCT01977482|474467572|FG003|Overall Study|Withdrawal by Subject|3|||
131778180|NCT01977482|474467573|FG004|Overall Study|Withdrawal by Subject|1|||
131778181|NCT01977482|474467574|FG005|Overall Study|Withdrawal by Subject|5|||
131778182|NCT05554471|474467575|FG000|Overall Study|Physician Decision|2|||
131778183|NCT05554471|474467576|FG001|Overall Study|Physician Decision|1|||
131778184|NCT05554471|474467575|FG000|Overall Study|Lost to Follow-up|2|||
131778185|NCT05554471|474467576|FG001|Overall Study|Lost to Follow-up|1|||
131778186|NCT05554471|474467575|FG000|Overall Study|Death|0|||
131778187|NCT05554471|474467576|FG001|Overall Study|Death|1|||
131778188|NCT04880850|474467579|FG000|Overall Study|Death|2|||
131778189|NCT04880850|474467580|FG001|Overall Study|Death|1|||
131778190|NCT04880850|474467579|FG000|Overall Study|Lost to Follow-up|3|||
131778191|NCT04880850|474467580|FG001|Overall Study|Lost to Follow-up|6|||
131778192|NCT04880850|474467579|FG000|Overall Study|Physician Decision|2|||
131778193|NCT04880850|474467580|FG001|Overall Study|Physician Decision|1|||
131778194|NCT04880850|474467579|FG000|Overall Study|Withdrawal by Subject|9|||
131778195|NCT04880850|474467580|FG001|Overall Study|Withdrawal by Subject|10|||
131778196|NCT01608321|474467581|FG000|Overall Study|Withdrawal by Subject|1|||
131778197|NCT01608321|474467582|FG001|Overall Study|Withdrawal by Subject|0|||
131778198|NCT03417102|474467583|FG000|Overall Study|Adverse Event|0|||
131778199|NCT03417102|474467584|FG001|Overall Study|Adverse Event|1|||
131778200|NCT03417102|474467583|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
131778201|NCT03417102|474467584|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
131778202|NCT03417102|474467583|FG000|Overall Study|Other|0|||
131778203|NCT03417102|474467584|FG001|Overall Study|Other|1|||
131778204|NCT02062385|474467585|FG000|Overall Study|Adverse Event|19|||
131778205|NCT02062385|474467586|FG001|Overall Study|Adverse Event|13|||
131778206|NCT02062385|474467587|FG002|Overall Study|Adverse Event|1|||
131778207|NCT02062385|474467588|FG003|Overall Study|Adverse Event|0|||
131778208|NCT02062385|474467585|FG000|Overall Study|Protocol Violation|1|||
131778209|NCT02062385|474467586|FG001|Overall Study|Protocol Violation|0|||
131778210|NCT02062385|474467587|FG002|Overall Study|Protocol Violation|0|||
131778211|NCT02062385|474467588|FG003|Overall Study|Protocol Violation|0|||
131778212|NCT02062385|474467585|FG000|Overall Study|Incomplete EPI by database lock|2|||
131778213|NCT02062385|474467586|FG001|Overall Study|Incomplete EPI by database lock|0|||
131778214|NCT02062385|474467587|FG002|Overall Study|Incomplete EPI by database lock|0|||
131778215|NCT02062385|474467588|FG003|Overall Study|Incomplete EPI by database lock|0|||
131778216|NCT02062385|474467585|FG000|Overall Study|Moved|10|||
131778217|NCT02062385|474467586|FG001|Overall Study|Moved|11|||
131778218|NCT02062385|474467587|FG002|Overall Study|Moved|1|||
131778219|NCT02062385|474467588|FG003|Overall Study|Moved|0|||
131778220|NCT02062385|474467585|FG000|Overall Study|Withdrawn by parent/guardian|46|||
131778221|NCT02062385|474467586|FG001|Overall Study|Withdrawn by parent/guardian|41|||
131778222|NCT02062385|474467587|FG002|Overall Study|Withdrawn by parent/guardian|9|||
131778223|NCT02062385|474467588|FG003|Overall Study|Withdrawn by parent/guardian|8|||
131778224|NCT02062385|474467585|FG000|Overall Study|Death|0|||
131778225|NCT02062385|474467586|FG001|Overall Study|Death|0|||
131778226|NCT02062385|474467587|FG002|Overall Study|Death|0|||
131778227|NCT02062385|474467588|FG003|Overall Study|Death|1|||
131778228|NCT02062385|474467585|FG000|Overall Study|Lost to Follow-up|0|||
131778229|NCT02062385|474467586|FG001|Overall Study|Lost to Follow-up|0|||
131778230|NCT02062385|474467587|FG002|Overall Study|Lost to Follow-up|1|||
131778231|NCT02062385|474467588|FG003|Overall Study|Lost to Follow-up|0|||
131778232|NCT03188991|474467589|FG000|Overall Study|Withdrawal by Subject|0|||
131778233|NCT03188991|474467590|FG001|Overall Study|Withdrawal by Subject|0|||
131778234|NCT03188991|474467591|FG002|Overall Study|Withdrawal by Subject|0|||
131693471|NCT01049035|474161601|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
131693472|NCT01049035|474161602|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
131693473|NCT01049035|474161603|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
131693474|NCT01049035|474161604|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
131693475|NCT01049035|474161605|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
131693476|NCT03927105|474161606|FG000|Overall Study|Death|1|||
131693477|NCT03927105|474161606|FG000|Overall Study|In observation for potential re-treatment|2|||
131693478|NCT03927105|474161606|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
131693479|NCT03189446|474161610|FG000|Overall Study|Adverse Event|2|||
131693480|NCT03189446|474161610|FG000|Overall Study|Withdrawal by Subject|2|||
131693481|NCT03189446|474161610|FG000|Overall Study|Physician Decision|1|||
131693482|NCT05634577|474161611|FG000|Overall Study|Lost to Follow-up|1|||
131693483|NCT05634577|474161611|FG000|Overall Study|Withdrawal by Subject|1|||
131693484|NCT04839978|474161612|FG000|Overall Study|Lost to Follow-up|135|||
131693485|NCT04839978|474161613|FG001|Overall Study|Lost to Follow-up|147|||
131693486|NCT03865706|474161614|FG000|Overall Study|Death|0|||
131693487|NCT03865706|474161615|FG001|Overall Study|Death|3|||
131693488|NCT03865706|474161616|FG002|Overall Study|Death|1|||
131693489|NCT02412787|474161620|FG000|Overall Study|Withdrawal by Subject|9|||
131693490|NCT02412787|474161620|FG000|Overall Study|Participation Terminated by Investigator|1|||
131693491|NCT02412787|474161620|FG000|Overall Study|Site Terminated by Sponsor|21|||
131693492|NCT02412787|474161620|FG000|Overall Study|Technical Problems|1|||
131693493|NCT02412787|474161620|FG000|Overall Study|Reason Not Specified|1|||
131693494|NCT02311153|474161621|FG000|Overall Study|Lost to Follow-up|5|||
131693495|NCT02311153|474161622|FG001|Overall Study|Lost to Follow-up|7|||
131693496|NCT00957008|474161627|FG000|Overall Study|Withdrawal by Subject|13|||
131693497|NCT00957008|474161628|FG001|Overall Study|Withdrawal by Subject|10|||
131693498|NCT00957008|474161629|FG002|Overall Study|Withdrawal by Subject|12|||
131693499|NCT00957008|474161630|FG003|Overall Study|Withdrawal by Subject|16|||
131693500|NCT00957008|474161627|FG000|Overall Study|Lost to Follow-up|3|||
131693501|NCT00957008|474161628|FG001|Overall Study|Lost to Follow-up|1|||
131693502|NCT00957008|474161629|FG002|Overall Study|Lost to Follow-up|3|||
131693503|NCT00957008|474161630|FG003|Overall Study|Lost to Follow-up|4|||
131693504|NCT00957008|474161627|FG000|Overall Study|Physician Decision|1|||
131693505|NCT00957008|474161628|FG001|Overall Study|Physician Decision|0|||
131693506|NCT00957008|474161629|FG002|Overall Study|Physician Decision|1|||
131693507|NCT00957008|474161630|FG003|Overall Study|Physician Decision|1|||
131693508|NCT00957008|474161627|FG000|Overall Study|Relocated; Family conflict|4|||
131693509|NCT00957008|474161628|FG001|Overall Study|Relocated; Family conflict|1|||
131693510|NCT00957008|474161629|FG002|Overall Study|Relocated; Family conflict|1|||
131693511|NCT00957008|474161630|FG003|Overall Study|Relocated; Family conflict|3|||
131693512|NCT01118351|474161631|FG000|Overall Study|Adverse Event|3|||
131693513|NCT01118351|474161631|FG000|Overall Study|Withdrawal by Subject|1|||
131693514|NCT04951037|474161642|FG000|Overall Study|Lost to Follow-up|16|||
131693515|NCT04951037|474161642|FG000|Overall Study|Withdrawal by Subject|5|||
131693516|NCT04951037|474161642|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
131693517|NCT05630937|474161645|FG000|Overall Study|Study terminated by sponsor|1|||
131693518|NCT05630937|474161646|FG001|Overall Study|Study terminated by sponsor|1|||
131693519|NCT05630937|474161647|FG002|Overall Study|Study terminated by sponsor|8|||
131693520|NCT05630937|474161648|FG003|Overall Study|Study terminated by sponsor|0|||
131693521|NCT05630937|474161645|FG000|Overall Study|Lost to Follow-up|0|||
131693522|NCT05630937|474161646|FG001|Overall Study|Lost to Follow-up|0|||
131778235|NCT03188991|474467592|FG003|Overall Study|Withdrawal by Subject|1|||
131778236|NCT01319994|474468863|FG000|Overall Study|Protocol Violation|7|||
131778237|NCT01319994|474468864|FG001|Overall Study|Protocol Violation|6|||
131778238|NCT01340794|474468865|FG000|Overall Study|Withdrawal by Subject|0|||
131778239|NCT01340794|474468866|FG001|Overall Study|Withdrawal by Subject|1|||
131778240|NCT01035229|474468874|FG000|Overall Study|Adverse Event|61|||
131778241|NCT01035229|474468875|FG001|Overall Study|Adverse Event|14|||
131436792|NCT02079740|473225609|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
131693523|NCT05630937|474161647|FG002|Overall Study|Lost to Follow-up|1|||
131693524|NCT05630937|474161648|FG003|Overall Study|Lost to Follow-up|0|||
131693525|NCT05630937|474161645|FG000|Overall Study|Enrolled but not treated|0|||
131693526|NCT05630937|474161646|FG001|Overall Study|Enrolled but not treated|0|||
131693527|NCT05630937|474161647|FG002|Overall Study|Enrolled but not treated|0|||
131693528|NCT05630937|474161648|FG003|Overall Study|Enrolled but not treated|1|||
131693529|NCT01604265|474161655|FG000|Overall Study|Adverse Event|1|||
131693530|NCT01604265|474161656|FG001|Overall Study|Adverse Event|0|||
131693531|NCT01604265|474161655|FG000|Overall Study|Withdrawal by Subject|1|||
131693532|NCT01604265|474161656|FG001|Overall Study|Withdrawal by Subject|0|||
131693533|NCT02706873|474161657|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
131693534|NCT02706873|474161658|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
131693535|NCT02706873|474161659|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
131693536|NCT02706873|474161660|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
131693537|NCT02706873|474161657|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
131693538|NCT02706873|474161658|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
131693539|NCT02706873|474161659|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
131693540|NCT02706873|474161660|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
131693541|NCT02706873|474161657|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
131693542|NCT02706873|474161658|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
131693543|NCT02706873|474161659|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
131693544|NCT02706873|474161660|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
131693545|NCT02706873|474161657|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
131693546|NCT02706873|474161658|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
131693547|NCT02706873|474161659|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
131693548|NCT02706873|474161660|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
131693549|NCT02706873|474161657|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
131693550|NCT02706873|474161658|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
131693551|NCT02706873|474161659|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
131693552|NCT02706873|474161660|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
131693553|NCT02706873|474161657|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
131693554|NCT02706873|474161658|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
131693555|NCT02706873|474161659|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
131693556|NCT02706873|474161660|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
131693557|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
131693558|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
131693559|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
131693560|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
131693561|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
131693562|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
131693563|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
131693564|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
131693565|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
131693566|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
131693567|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
131693568|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
131693569|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
131693570|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
131693571|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
131693572|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
131693573|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
131693574|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
131693575|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
131693576|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
131693577|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
131693578|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
131693579|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
131693580|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
131693581|NCT02706873|474161657|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
131693582|NCT02706873|474161658|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
131693583|NCT02706873|474161659|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
131693584|NCT02706873|474161660|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
131693585|NCT00143312|474161664|FG000|Overall Study|Death|11|||
131693586|NCT00143312|474161664|FG000|Overall Study|Adverse Event|2|||
131693587|NCT00143312|474161664|FG000|Overall Study|Lost to Follow-up|1|||
131693588|NCT00143312|474161664|FG000|Overall Study|Other|1|||
131693589|NCT00143312|474161664|FG000|Overall Study|Withdrawal by Subject|1|||
131693590|NCT01029366|474161665|FG000|Overall Study|Withdrawal by Subject|1|||
131693591|NCT01029366|474161666|FG001|Overall Study|Withdrawal by Subject|0|||
131693592|NCT01029366|474161665|FG000|Overall Study|Death|1|||
131693593|NCT01029366|474161666|FG001|Overall Study|Death|1|||
131693594|NCT01029366|474161665|FG000|Overall Study|disease progression|2|||
131693595|NCT01029366|474161666|FG001|Overall Study|disease progression|0|||
131693596|NCT01029366|474161665|FG000|Overall Study|manufacturing failure|0|||
131693597|NCT01029366|474161666|FG001|Overall Study|manufacturing failure|1|||
131693598|NCT02898259|474161667|FG000|Overall Study|Adverse Event|0|||
131693599|NCT02898259|474161668|FG001|Overall Study|Adverse Event|0|||
131693600|NCT02898259|474161669|FG002|Overall Study|Adverse Event|1|||
131693601|NCT02898259|474161670|FG003|Overall Study|Adverse Event|0|||
131693602|NCT02898259|474161671|FG004|Overall Study|Adverse Event|0|||
131693603|NCT02898259|474161667|FG000|Overall Study|Lack of Efficacy|1|||
131693604|NCT02898259|474161668|FG001|Overall Study|Lack of Efficacy|1|||
131693605|NCT02898259|474161669|FG002|Overall Study|Lack of Efficacy|3|||
131693606|NCT02898259|474161670|FG003|Overall Study|Lack of Efficacy|0|||
131693607|NCT02898259|474161671|FG004|Overall Study|Lack of Efficacy|0|||
131693608|NCT02898259|474161667|FG000|Overall Study|Lost to Follow-up|0|||
131693609|NCT02898259|474161668|FG001|Overall Study|Lost to Follow-up|0|||
131693610|NCT02898259|474161669|FG002|Overall Study|Lost to Follow-up|1|||
131693611|NCT02898259|474161670|FG003|Overall Study|Lost to Follow-up|0|||
131693612|NCT02898259|474161671|FG004|Overall Study|Lost to Follow-up|0|||
131693613|NCT02898259|474161667|FG000|Overall Study|Transformation before study began|0|||
131693614|NCT02898259|474161668|FG001|Overall Study|Transformation before study began|0|||
131693615|NCT02898259|474161669|FG002|Overall Study|Transformation before study began|0|||
131693616|NCT02898259|474161670|FG003|Overall Study|Transformation before study began|1|||
131693617|NCT02898259|474161671|FG004|Overall Study|Transformation before study began|0|||
131693618|NCT01046877|474161672|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
131693619|NCT01046877|474161672|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
131693620|NCT00391222|474161675|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
131693621|NCT00391222|474161676|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
131693622|NCT00391222|474161677|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
131693623|NCT00391222|474161678|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
131693624|NCT00391222|474161675|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
131693625|NCT00391222|474161676|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
131693626|NCT00391222|474161677|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
131693627|NCT00391222|474161678|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
131693628|NCT00391222|474161675|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
131693629|NCT00391222|474161676|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
131693630|NCT00391222|474161677|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
131693631|NCT00391222|474161678|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
131693632|NCT00391222|474161675|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
131693633|NCT00391222|474161676|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
131693634|NCT00391222|474161677|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
131693635|NCT00391222|474161678|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
131693636|NCT00391222|474161675|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
131693637|NCT00391222|474161676|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
131693638|NCT00391222|474161677|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
131693639|NCT00391222|474161678|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
131693640|NCT00391222|474161675|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
131693641|NCT00391222|474161676|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
131693642|NCT00391222|474161677|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
131693643|NCT00391222|474161678|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
131693644|NCT00391222|474161675|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
131693645|NCT00391222|474161676|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
131693646|NCT00391222|474161677|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
131693647|NCT00391222|474161678|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
131693648|NCT00391222|474161675|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
131693649|NCT00391222|474161676|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
131693650|NCT00391222|474161677|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
131693651|NCT00391222|474161678|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
131693652|NCT00391222|474161675|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
131693653|NCT00391222|474161676|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
131693654|NCT00391222|474161677|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
131693655|NCT00391222|474161678|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
131693656|NCT00391222|474161675|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
131693657|NCT00391222|474161676|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
131693658|NCT00391222|474161677|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
131693659|NCT00391222|474161678|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
131693660|NCT00391222|474161675|FG000|Period III (Double-Blind Treatment)|Other|6|||
131693661|NCT00391222|474161676|FG001|Period III (Double-Blind Treatment)|Other|1|||
131693662|NCT00391222|474161677|FG002|Period III (Double-Blind Treatment)|Other|6|||
131693663|NCT00391222|474161678|FG003|Period III (Double-Blind Treatment)|Other|0|||
131693664|NCT00796315|474161679|FG000|Overall Study|Protocol Violation|0|||
131693665|NCT00796315|474161680|FG001|Overall Study|Protocol Violation|1|||
131693666|NCT00796315|474161681|FG002|Overall Study|Protocol Violation|0|||
131693667|NCT03215771|474161686|FG000|Overall Study|Withdrawal by Subject|2|||
131693668|NCT03215771|474161686|FG000|Overall Study|Physician Decision|1|||
131693669|NCT02039375|474161687|FG000|Overall Study|Lost to Follow-up|2|||
131693670|NCT04770389|474161688|FG000|Overall Study|Adverse Event|1|||
131693671|NCT04770389|474161689|FG001|Overall Study|Adverse Event|2|||
131693672|NCT04770389|474161690|FG002|Overall Study|Adverse Event|0|||
131778242|NCT01035229|474468874|FG000|Overall Study|Withdrawal by Subject|20|||
131778243|NCT01035229|474468875|FG001|Overall Study|Withdrawal by Subject|7|||
131778244|NCT01035229|474468874|FG000|Overall Study|Lost to Follow-up|1|||
131778245|NCT01035229|474468875|FG001|Overall Study|Lost to Follow-up|0|||
131778246|NCT01035229|474468874|FG000|Overall Study|Administrative problems|1|||
131778247|NCT01035229|474468875|FG001|Overall Study|Administrative problems|1|||
131778248|NCT01035229|474468874|FG000|Overall Study|Death|13|||
131778249|NCT01035229|474468875|FG001|Overall Study|Death|5|||
131693673|NCT04770389|474161691|FG003|Overall Study|Adverse Event|1|||
131778250|NCT01035229|474468874|FG000|Overall Study|New cancer therapy|2|||
131778251|NCT01035229|474468875|FG001|Overall Study|New cancer therapy|0|||
131778252|NCT01035229|474468874|FG000|Overall Study|Protocol Violation|0|||
131778253|NCT01035229|474468875|FG001|Overall Study|Protocol Violation|2|||
131778254|NCT01035229|474468874|FG000|Overall Study|Sponsor's decision to end study|3|||
131778255|NCT01035229|474468875|FG001|Overall Study|Sponsor's decision to end study|3|||
131778256|NCT01035229|474468874|FG000|Overall Study|Disease Progression|261|||
131778257|NCT01035229|474468875|FG001|Overall Study|Disease Progression|152|||
131778258|NCT02525627|474468879|FG000|Overall Study|Revision|1|||
131778259|NCT02525627|474468880|FG001|Overall Study|Revision|1|||
131778260|NCT02525627|474468879|FG000|Overall Study|Withdrawal by Subject|1|||
131778261|NCT02525627|474468880|FG001|Overall Study|Withdrawal by Subject|2|||
131778262|NCT02525627|474468879|FG000|Overall Study|Death|1|||
131778263|NCT02525627|474468880|FG001|Overall Study|Death|0|||
131778264|NCT02525627|474468879|FG000|Overall Study|Site terminated|11|||
131778265|NCT02525627|474468880|FG001|Overall Study|Site terminated|10|||
131778266|NCT03746080|474468881|FG000|Overall Study|In follow up|2|||
131778267|NCT03746080|474468881|FG000|Overall Study|Death|15|||
131778268|NCT01473589|474468882|FG000|Overall Study|Adverse Event|1|||
131693674|NCT04770389|474161688|FG000|Overall Study|Withdrawal by Subject|0|||
131693675|NCT04770389|474161689|FG001|Overall Study|Withdrawal by Subject|2|||
131693676|NCT04770389|474161690|FG002|Overall Study|Withdrawal by Subject|1|||
131693677|NCT04770389|474161691|FG003|Overall Study|Withdrawal by Subject|0|||
131693678|NCT04770389|474161688|FG000|Overall Study|Failed attempt to draw blood|1|||
131693679|NCT04770389|474161689|FG001|Overall Study|Failed attempt to draw blood|0|||
131693680|NCT04770389|474161690|FG002|Overall Study|Failed attempt to draw blood|0|||
131693681|NCT04770389|474161691|FG003|Overall Study|Failed attempt to draw blood|0|||
131693682|NCT04770389|474161688|FG000|Overall Study|Left the country|0|||
131693683|NCT04770389|474161689|FG001|Overall Study|Left the country|0|||
131693684|NCT04770389|474161690|FG002|Overall Study|Left the country|1|||
131693685|NCT04770389|474161691|FG003|Overall Study|Left the country|2|||
131693686|NCT04770389|474161688|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
131693687|NCT04770389|474161689|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
131693688|NCT04770389|474161690|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
131693689|NCT04770389|474161691|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
131693690|NCT04770389|474161688|FG000|Overall Study|Lost to Follow-up|0|||
131693691|NCT04770389|474161689|FG001|Overall Study|Lost to Follow-up|0|||
131693692|NCT04770389|474161690|FG002|Overall Study|Lost to Follow-up|0|||
131693693|NCT04770389|474161691|FG003|Overall Study|Lost to Follow-up|1|||
131693694|NCT04770389|474161688|FG000|Overall Study|Moved away from study site|0|||
131693695|NCT04770389|474161689|FG001|Overall Study|Moved away from study site|1|||
131693696|NCT04770389|474161690|FG002|Overall Study|Moved away from study site|0|||
131693697|NCT04770389|474161691|FG003|Overall Study|Moved away from study site|0|||
131693698|NCT00689871|474161694|FG000|Overall Study|Lost to Follow-up|123|||
131693699|NCT00689871|474161695|FG001|Overall Study|Lost to Follow-up|13|||
131693700|NCT00689871|474161696|FG002|Overall Study|Lost to Follow-up|37|||
131693701|NCT00689871|474161697|FG003|Overall Study|Lost to Follow-up|1|||
131693702|NCT00689871|474161694|FG000|Overall Study|Explanted of All Study Devices|36|||
131778269|NCT01473589|474468883|FG001|Overall Study|Adverse Event|1|||
131778270|NCT01473589|474468882|FG000|Overall Study|Death|2|||
131778271|NCT01473589|474468883|FG001|Overall Study|Death|0|||
131778272|NCT01473589|474468882|FG000|Overall Study|Lost to Follow-up|2|||
131778273|NCT01473589|474468883|FG001|Overall Study|Lost to Follow-up|2|||
131778274|NCT01473589|474468882|FG000|Overall Study|Protocol Violation|1|||
131778275|NCT01473589|474468883|FG001|Overall Study|Protocol Violation|0|||
131778276|NCT01473589|474468882|FG000|Overall Study|Withdrawal by Subject|5|||
131778277|NCT01473589|474468883|FG001|Overall Study|Withdrawal by Subject|11|||
131778278|NCT01473589|474468882|FG000|Overall Study|Physician Decision|0|||
131778279|NCT01473589|474468883|FG001|Overall Study|Physician Decision|1|||
131778280|NCT01473589|474468882|FG000|Overall Study|Entry criteria not met|0|||
131778281|NCT01473589|474468883|FG001|Overall Study|Entry criteria not met|1|||
131778282|NCT00297882|474468886|FG000|Day 14|Lack of Efficacy|12|||
131778283|NCT00297882|474468887|FG001|Day 14|Lack of Efficacy|49|||
131778284|NCT00297882|474468886|FG000|Day 28|Lost to Follow-up|13|||
131778285|NCT00297882|474468887|FG001|Day 28|Lost to Follow-up|23|||
131778286|NCT00297882|474468886|FG000|Day 28|Lack of Efficacy|3|||
131778287|NCT00297882|474468887|FG001|Day 28|Lack of Efficacy|0|||
131778288|NCT04484805|474468888|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
131778289|NCT04484805|474468889|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
131778290|NCT04484805|474468888|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
131778291|NCT04484805|474468889|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
131778292|NCT02116309|474468891|FG000|Overall Study|Lost to Follow-up|0|||
131778293|NCT02116309|474468892|FG001|Overall Study|Lost to Follow-up|1|||
131778294|NCT00848965|474468893|FG000|Overall Study|Adverse Event|1|||
131778295|NCT00848965|474468893|FG000|Overall Study|Withdrawal by Subject|1|||
131778296|NCT03710824|474468894|FG000|Overall Study|Withdrawal by Subject|1|||
131778297|NCT03710824|474468894|FG000|Overall Study|Lost to Follow-up|3|||
131778298|NCT03710824|474468894|FG000|Overall Study|Adverse Event|25|||
131778299|NCT03710824|474468894|FG000|Overall Study|Treatment discontinuation|2|||
131778300|NCT02329834|474468895|FG000|Overall Study|Physician Decision|1|||
131778301|NCT02329834|474468896|FG001|Overall Study|Physician Decision|0|||
131778302|NCT01605370|474468897|FG000|Overall Study|Adverse Event|1|||
131778303|NCT01605370|474468898|FG001|Overall Study|Adverse Event|0|||
131778304|NCT00578448|474468899|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
131778305|NCT00578448|474468899|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
131778306|NCT00578448|474468899|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
131778307|NCT00578448|474468899|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
131778308|NCT01976104|474468900|FG000|Overall Study|Adverse Event|0|||
131778309|NCT01976104|474468901|FG001|Overall Study|Adverse Event|0|||
131778310|NCT01976104|474468902|FG002|Overall Study|Adverse Event|1|||
131778311|NCT01976104|474468903|FG003|Overall Study|Adverse Event|0|||
131778312|NCT01976104|474468900|FG000|Overall Study|Lost to Follow-up|3|||
131778313|NCT01976104|474468901|FG001|Overall Study|Lost to Follow-up|0|||
131778314|NCT01976104|474468902|FG002|Overall Study|Lost to Follow-up|1|||
131778315|NCT01976104|474468903|FG003|Overall Study|Lost to Follow-up|1|||
131778316|NCT01976104|474468900|FG000|Overall Study|Subject Choice|0|||
131778317|NCT01976104|474468901|FG001|Overall Study|Subject Choice|1|||
131778318|NCT01976104|474468902|FG002|Overall Study|Subject Choice|0|||
131778319|NCT01976104|474468903|FG003|Overall Study|Subject Choice|1|||
131778320|NCT01976104|474468900|FG000|Overall Study|Withdrawal by Subject|3|||
131778321|NCT01976104|474468901|FG001|Overall Study|Withdrawal by Subject|0|||
131778322|NCT01976104|474468902|FG002|Overall Study|Withdrawal by Subject|0|||
131778323|NCT01976104|474468903|FG003|Overall Study|Withdrawal by Subject|1|||
131778324|NCT01976104|474468900|FG000|Overall Study|Other|0|||
131778325|NCT01976104|474468901|FG001|Overall Study|Other|1|||
131778326|NCT01976104|474468902|FG002|Overall Study|Other|0|||
131778327|NCT01976104|474468903|FG003|Overall Study|Other|0|||
131778328|NCT01317199|474468904|FG000|Dose-escalation Phase 1|Physician Decision|5|||
131778329|NCT01317199|474468905|FG001|Dose-escalation Phase 1|Physician Decision|0|||
131778330|NCT01317199|474468906|FG002|Dose-escalation Phase 1|Physician Decision|0|||
131778331|NCT01317199|474468907|FG003|Dose-escalation Phase 1|Physician Decision|0|||
131778332|NCT01317199|474468904|FG000|Dose-escalation Phase 1|Disease progression|1|||
131778333|NCT01317199|474468905|FG001|Dose-escalation Phase 1|Disease progression|0|||
131778334|NCT01317199|474468906|FG002|Dose-escalation Phase 1|Disease progression|0|||
131778335|NCT01317199|474468907|FG003|Dose-escalation Phase 1|Disease progression|0|||
131778336|NCT01317199|474468904|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
131778337|NCT01317199|474468905|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
131778338|NCT01317199|474468906|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
131778339|NCT01317199|474468907|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
131778340|NCT01317199|474468904|FG000|Randomized Phase 2|Disease progression|0|||
131778341|NCT01317199|474468905|FG001|Randomized Phase 2|Disease progression|3|||
131778342|NCT01317199|474468906|FG002|Randomized Phase 2|Disease progression|7|||
131559559|NCT05284019|473673978|FG001|Overall Study|Withdrawal by Subject|0|||
131559560|NCT05284019|473673979|FG002|Overall Study|Withdrawal by Subject|0|||
131559561|NCT05284019|473673980|FG003|Overall Study|Withdrawal by Subject|1|||
131693703|NCT00689871|474161695|FG001|Overall Study|Explanted of All Study Devices|25|||
131693704|NCT00689871|474161696|FG002|Overall Study|Explanted of All Study Devices|29|||
131693705|NCT00689871|474161697|FG003|Overall Study|Explanted of All Study Devices|3|||
131693706|NCT00689871|474161694|FG000|Overall Study|Withdrawal by Subject|13|||
131693707|NCT00689871|474161695|FG001|Overall Study|Withdrawal by Subject|3|||
131693708|NCT00689871|474161696|FG002|Overall Study|Withdrawal by Subject|4|||
131693709|NCT00689871|474161697|FG003|Overall Study|Withdrawal by Subject|1|||
131693710|NCT00689871|474161694|FG000|Overall Study|Death|1|||
131693711|NCT00689871|474161695|FG001|Overall Study|Death|10|||
131693712|NCT00689871|474161696|FG002|Overall Study|Death|2|||
131693713|NCT00689871|474161697|FG003|Overall Study|Death|2|||
131693714|NCT00689871|474161694|FG000|Overall Study|Physician Decision|2|||
131693715|NCT00689871|474161695|FG001|Overall Study|Physician Decision|1|||
131693716|NCT00689871|474161696|FG002|Overall Study|Physician Decision|1|||
131693717|NCT00689871|474161697|FG003|Overall Study|Physician Decision|0|||
131693718|NCT00889265|474161703|FG000|Overall Study|Adverse Event|1|||
131693719|NCT00889265|474161703|FG000|Overall Study|Lost to Follow-up|5|||
131693720|NCT00889265|474161703|FG000|Overall Study|Protocol Violation|1|||
131693721|NCT00531752|474161704|FG000|First Double-blind Intervention Period|Adverse Event|2|||
131693722|NCT00531752|474161705|FG001|First Double-blind Intervention Period|Adverse Event|0|||
131693723|NCT00531752|474161706|FG002|First Double-blind Intervention Period|Adverse Event|1|||
131693724|NCT00531752|474161707|FG003|First Double-blind Intervention Period|Adverse Event|1|||
131693725|NCT00531752|474161704|FG000|First Double-blind Intervention Period|Other|1|||
131693726|NCT00531752|474161705|FG001|First Double-blind Intervention Period|Other|4|||
131693727|NCT00531752|474161706|FG002|First Double-blind Intervention Period|Other|4|||
131693728|NCT00531752|474161707|FG003|First Double-blind Intervention Period|Other|0|||
131693729|NCT00531752|474161704|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
131693730|NCT00531752|474161705|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
131693731|NCT00531752|474161706|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
131693732|NCT00531752|474161707|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
131693733|NCT00531752|474161704|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
131693734|NCT00531752|474161705|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
131693735|NCT00531752|474161706|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
131693736|NCT00531752|474161707|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
131693737|NCT00531752|474161704|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
131693738|NCT00531752|474161705|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
131693739|NCT00531752|474161706|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
131693740|NCT00531752|474161707|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
131693741|NCT00531752|474161704|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
131693742|NCT00531752|474161705|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
131693743|NCT00531752|474161706|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
131693744|NCT00531752|474161707|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
131693745|NCT00531752|474161704|FG000|Second Double-blind Intervention Period|Other|1|||
131693746|NCT00531752|474161705|FG001|Second Double-blind Intervention Period|Other|1|||
131693747|NCT00531752|474161706|FG002|Second Double-blind Intervention Period|Other|0|||
131693748|NCT00531752|474161707|FG003|Second Double-blind Intervention Period|Other|0|||
131693749|NCT00531752|474161704|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131693750|NCT00531752|474161705|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131693751|NCT00531752|474161706|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131693752|NCT00531752|474161707|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
131693753|NCT00531752|474161704|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131693754|NCT00531752|474161705|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131693755|NCT00531752|474161706|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131693756|NCT00531752|474161707|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
131693757|NCT00950664|474161708|FG000|First Intervention|Lost to Follow-up|1|||
131693758|NCT00950664|474161709|FG001|First Intervention|Lost to Follow-up|3|||
131693759|NCT00950664|474161708|FG000|First Intervention|Withdrawal by Subject|2|||
131693760|NCT00950664|474161709|FG001|First Intervention|Withdrawal by Subject|2|||
131693761|NCT00550680|474161714|FG000|Overall Study|Administrative Reasons|1|||
131693762|NCT00550680|474161714|FG000|Overall Study|Adverse Event|5|||
131693763|NCT00550680|474161714|FG000|Overall Study|Death|3|||
131693764|NCT00550680|474161714|FG000|Overall Study|Early Improvement|1|||
131693765|NCT00550680|474161714|FG000|Overall Study|Lost to Follow-up|3|||
131559562|NCT05284019|473673981|FG004|Overall Study|Withdrawal by Subject|1|||
131693766|NCT00550680|474161714|FG000|Overall Study|Lack of Efficacy|1|||
131693767|NCT00550680|474161714|FG000|Overall Study|Other|10|||
131693768|NCT00550680|474161714|FG000|Overall Study|Protocol Violation|7|||
131693769|NCT00550680|474161714|FG000|Overall Study|Refused Treatment|19|||
131778343|NCT01317199|474468907|FG003|Randomized Phase 2|Disease progression|5|||
131778344|NCT01317199|474468904|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
131778345|NCT01317199|474468905|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
131778346|NCT01317199|474468906|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
131778347|NCT01317199|474468907|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
131778348|NCT01317199|474468904|FG000|Randomized Phase 2|Adverse Event|0|||
131778349|NCT01317199|474468905|FG001|Randomized Phase 2|Adverse Event|0|||
131778350|NCT01317199|474468906|FG002|Randomized Phase 2|Adverse Event|0|||
131778351|NCT01317199|474468907|FG003|Randomized Phase 2|Adverse Event|1|||
131778352|NCT01317199|474468904|FG000|Randomized Phase 2|Comorbidities|0|||
131778353|NCT01317199|474468905|FG001|Randomized Phase 2|Comorbidities|2|||
131778354|NCT01317199|474468906|FG002|Randomized Phase 2|Comorbidities|2|||
131778355|NCT01317199|474468907|FG003|Randomized Phase 2|Comorbidities|2|||
131778356|NCT01317199|474468904|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
131778357|NCT01317199|474468905|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
131778358|NCT01317199|474468906|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
131778359|NCT01317199|474468907|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
131778360|NCT01317199|474468904|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
131778361|NCT01317199|474468905|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
131778362|NCT01317199|474468906|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
131778363|NCT01317199|474468907|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
131778364|NCT01317199|474468904|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
131778365|NCT01317199|474468905|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
131778366|NCT01317199|474468906|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
131778367|NCT01317199|474468907|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
131778368|NCT01317199|474468904|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
131778369|NCT01317199|474468905|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
131778370|NCT01317199|474468906|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
131778371|NCT01317199|474468907|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
131778372|NCT01353209|474468908|FG000|Overall Study|Adverse Event|1|||
131778373|NCT01353209|474468909|FG001|Overall Study|Adverse Event|1|||
131778374|NCT03237325|474468911|FG000|Overall Study|Lost to Follow-up|3|||
131778375|NCT03237325|474468912|FG001|Overall Study|Lost to Follow-up|5|||
131778376|NCT03237325|474468911|FG000|Overall Study|Physician Decision|2|||
131778377|NCT03237325|474468912|FG001|Overall Study|Physician Decision|4|||
131778378|NCT03237325|474468911|FG000|Overall Study|Withdrawal by Subject|9|||
131778379|NCT03237325|474468912|FG001|Overall Study|Withdrawal by Subject|12|||
131778380|NCT03237325|474468911|FG000|Overall Study|Noncompliance with Study Procedures|1|||
131778381|NCT03237325|474468912|FG001|Overall Study|Noncompliance with Study Procedures|1|||
131778382|NCT03237325|474468911|FG000|Overall Study|Termination by Sponsor|0|||
131778383|NCT03237325|474468912|FG001|Overall Study|Termination by Sponsor|1|||
131778384|NCT03237325|474468911|FG000|Overall Study|Reason other than described|0|||
131778385|NCT03237325|474468912|FG001|Overall Study|Reason other than described|2|||
131778386|NCT02684370|474468913|FG000|Part A|Adverse Event|2|||
131778387|NCT02684370|474468914|FG001|Part A|Adverse Event|0|||
131778388|NCT02684370|474468915|FG002|Part A|Adverse Event|1|||
131778389|NCT02684370|474468916|FG003|Part A|Adverse Event|0|||
131778390|NCT02684370|474468917|FG004|Part A|Adverse Event|0|||
131778391|NCT02684370|474468918|FG005|Part A|Adverse Event|0|||
131778392|NCT02684370|474468913|FG000|Part A|Lost to Follow-up|1|||
131778393|NCT02684370|474468914|FG001|Part A|Lost to Follow-up|1|||
131778394|NCT02684370|474468915|FG002|Part A|Lost to Follow-up|0|||
131778395|NCT02684370|474468916|FG003|Part A|Lost to Follow-up|0|||
131778396|NCT02684370|474468917|FG004|Part A|Lost to Follow-up|0|||
131778397|NCT02684370|474468918|FG005|Part A|Lost to Follow-up|0|||
131778398|NCT02684370|474468913|FG000|Part A|Subject Withdrawal|1|||
131778399|NCT02684370|474468914|FG001|Part A|Subject Withdrawal|0|||
131778400|NCT02684370|474468915|FG002|Part A|Subject Withdrawal|3|||
131778401|NCT02684370|474468916|FG003|Part A|Subject Withdrawal|0|||
131778402|NCT02684370|474468917|FG004|Part A|Subject Withdrawal|0|||
131778403|NCT02684370|474468918|FG005|Part A|Subject Withdrawal|0|||
131778404|NCT02684370|474468913|FG000|Part A|Other|0|||
131778405|NCT02684370|474468914|FG001|Part A|Other|0|||
131778406|NCT02684370|474468915|FG002|Part A|Other|1|||
131436793|NCT02079740|473225610|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
131778407|NCT02684370|474468916|FG003|Part A|Other|0|||
131778408|NCT02684370|474468917|FG004|Part A|Other|0|||
131778409|NCT02684370|474468918|FG005|Part A|Other|0|||
131778410|NCT02684370|474468913|FG000|Part B|Adverse Event|0|||
131778411|NCT02684370|474468914|FG001|Part B|Adverse Event|0|||
131778412|NCT02684370|474468915|FG002|Part B|Adverse Event|0|||
131778413|NCT02684370|474468916|FG003|Part B|Adverse Event|0|||
131778414|NCT02684370|474468917|FG004|Part B|Adverse Event|2|||
131778415|NCT02684370|474468918|FG005|Part B|Adverse Event|1|||
131778416|NCT02684370|474468913|FG000|Part B|Lost to Follow-up|0|||
131778417|NCT02684370|474468914|FG001|Part B|Lost to Follow-up|0|||
131778418|NCT02684370|474468915|FG002|Part B|Lost to Follow-up|0|||
131778419|NCT02684370|474468916|FG003|Part B|Lost to Follow-up|1|||
131778420|NCT02684370|474468917|FG004|Part B|Lost to Follow-up|2|||
131778421|NCT02684370|474468918|FG005|Part B|Lost to Follow-up|5|||
131778422|NCT02684370|474468913|FG000|Part B|Subject Withdrawal|0|||
131778423|NCT02684370|474468914|FG001|Part B|Subject Withdrawal|0|||
131778424|NCT02684370|474468915|FG002|Part B|Subject Withdrawal|0|||
131778425|NCT02684370|474468916|FG003|Part B|Subject Withdrawal|1|||
131778426|NCT02684370|474468917|FG004|Part B|Subject Withdrawal|1|||
131778427|NCT02684370|474468918|FG005|Part B|Subject Withdrawal|2|||
131778428|NCT04221373|474468919|FG000|Overall Study|Physician Decision|4|||
131778429|NCT04221373|474468920|FG001|Overall Study|Physician Decision|0|||
131778430|NCT05102162|474468929|FG000|Overall Study|Withdrawal by Subject|3|||
131778431|NCT05102162|474468930|FG001|Overall Study|Withdrawal by Subject|0|||
131778432|NCT05102162|474468929|FG000|Overall Study|Baseline cultures negative|4|||
131778433|NCT05102162|474468930|FG001|Overall Study|Baseline cultures negative|2|||
131778434|NCT05102162|474468929|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
131778435|NCT05102162|474468930|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
131778436|NCT05102162|474468929|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
131778437|NCT05102162|474468930|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
131778438|NCT01165424|474468931|FG000|Overall Study|Clinical adverse experiences|1|||
131778439|NCT01165424|474468931|FG000|Overall Study|Laboratory adverse experiences|1|||
131778440|NCT01165424|474468931|FG000|Overall Study|Did not meet entry criteria|1|||
131778441|NCT01165424|474468931|FG000|Overall Study|Participant moved (relocated)|1|||
131778442|NCT02181673|474468932|FG000|Up to Week 24|Adverse Event|2|||
131778443|NCT02181673|474468933|FG001|Up to Week 24|Adverse Event|0|||
131778444|NCT02181673|474468934|FG002|Up to Week 24|Adverse Event|3|||
131778445|NCT02181673|474468932|FG000|Up to Week 24|Death|1|||
131778446|NCT02181673|474468933|FG001|Up to Week 24|Death|0|||
131778447|NCT02181673|474468934|FG002|Up to Week 24|Death|0|||
131778448|NCT02181673|474468932|FG000|Up to Week 24|Lack of Efficacy|1|||
131778449|NCT02181673|474468933|FG001|Up to Week 24|Lack of Efficacy|0|||
131778450|NCT02181673|474468934|FG002|Up to Week 24|Lack of Efficacy|0|||
131778451|NCT02181673|474468932|FG000|Up to Week 24|Lost to Follow-up|1|||
131778452|NCT02181673|474468933|FG001|Up to Week 24|Lost to Follow-up|0|||
131778453|NCT02181673|474468934|FG002|Up to Week 24|Lost to Follow-up|0|||
131778454|NCT02181673|474468932|FG000|Up to Week 24|Physician Decision|0|||
131778455|NCT02181673|474468933|FG001|Up to Week 24|Physician Decision|0|||
131778456|NCT02181673|474468934|FG002|Up to Week 24|Physician Decision|3|||
131778457|NCT02181673|474468932|FG000|Up to Week 24|Withdrawal by Subject|10|||
131778458|NCT02181673|474468933|FG001|Up to Week 24|Withdrawal by Subject|0|||
131778459|NCT02181673|474468934|FG002|Up to Week 24|Withdrawal by Subject|1|||
131778460|NCT02181673|474468932|FG000|Up to Week 24|Other|2|||
131778461|NCT02181673|474468933|FG001|Up to Week 24|Other|0|||
131778462|NCT02181673|474468934|FG002|Up to Week 24|Other|3|||
131778463|NCT02181673|474468932|FG000|Up to Week 24|Randomized not Treated|0|||
131778464|NCT02181673|474468933|FG001|Up to Week 24|Randomized not Treated|0|||
131778465|NCT02181673|474468934|FG002|Up to Week 24|Randomized not Treated|1|||
131778466|NCT02181673|474468932|FG000|Week 24-Week 60|Adverse Event|0|||
131778467|NCT02181673|474468933|FG001|Week 24-Week 60|Adverse Event|4|||
131778468|NCT02181673|474468934|FG002|Week 24-Week 60|Adverse Event|10|||
131778469|NCT02181673|474468932|FG000|Week 24-Week 60|Other|0|||
131778470|NCT02181673|474468933|FG001|Week 24-Week 60|Other|2|||
131778471|NCT02181673|474468934|FG002|Week 24-Week 60|Other|1|||
131778472|NCT02181673|474468932|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
131778473|NCT02181673|474468933|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
131778474|NCT02181673|474468934|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
131778475|NCT02181673|474468932|FG000|Week 24-Week 60|Pregnancy|0|||
131778476|NCT02181673|474468933|FG001|Week 24-Week 60|Pregnancy|0|||
131778477|NCT02181673|474468934|FG002|Week 24-Week 60|Pregnancy|1|||
131778478|NCT02181673|474468932|FG000|Week 24-Week 60|Lack of Efficacy|0|||
131778479|NCT02181673|474468933|FG001|Week 24-Week 60|Lack of Efficacy|0|||
131778480|NCT02181673|474468934|FG002|Week 24-Week 60|Lack of Efficacy|1|||
131778481|NCT02181673|474468932|FG000|Week 24-Week 60|Lost to Follow-up|0|||
131778482|NCT02181673|474468933|FG001|Week 24-Week 60|Lost to Follow-up|0|||
131778483|NCT02181673|474468934|FG002|Week 24-Week 60|Lost to Follow-up|1|||
131778484|NCT02181673|474468932|FG000|Week 24-Week 60|Physician Decision|0|||
131778485|NCT02181673|474468933|FG001|Week 24-Week 60|Physician Decision|0|||
131778486|NCT02181673|474468934|FG002|Week 24-Week 60|Physician Decision|1|||
131778487|NCT00433771|474468935|FG000|Overall Study|screen fail|14|||
131559563|NCT05284019|473673977|FG000|Overall Study|Lost to Follow-up|1|||
131778488|NCT00433771|474468935|FG000|Overall Study|Treated and later found to be ineligible|2|||
131778489|NCT00433771|474468935|FG000|Overall Study|Death|2|||
131778490|NCT00433771|474468935|FG000|Overall Study|Failure to deploy stent|1|||
131778491|NCT00138658|474468936|FG000|Overall Study|Adverse Event|23|||
131778492|NCT00138658|474468936|FG000|Overall Study|Death|1|||
131778493|NCT00138658|474468936|FG000|Overall Study|Disease Progression|21|||
131778494|NCT00138658|474468936|FG000|Overall Study|Physician Decision|11|||
131778495|NCT00138658|474468936|FG000|Overall Study|Withdrawal by Subject|5|||
131778496|NCT03733301|474468939|FG000|Overall Study|Screen Fail|1|||
131778497|NCT03733301|474468940|FG001|Overall Study|Screen Fail|0|||
131778498|NCT03733301|474468941|FG002|Overall Study|Screen Fail|0|||
131778499|NCT03733301|474468939|FG000|Overall Study|Non-compliance|1|||
131778500|NCT03733301|474468940|FG001|Overall Study|Non-compliance|0|||
131778501|NCT03733301|474468941|FG002|Overall Study|Non-compliance|0|||
131778502|NCT03733301|474468939|FG000|Overall Study|Lack of Efficacy|2|||
131778503|NCT03733301|474468940|FG001|Overall Study|Lack of Efficacy|3|||
131778504|NCT03733301|474468941|FG002|Overall Study|Lack of Efficacy|0|||
131778505|NCT03733301|474468939|FG000|Overall Study|Adverse Event|0|||
131778506|NCT03733301|474468940|FG001|Overall Study|Adverse Event|1|||
131778507|NCT03733301|474468941|FG002|Overall Study|Adverse Event|3|||
131778508|NCT03733301|474468939|FG000|Overall Study|Withdrawal by Subject|3|||
131778509|NCT03733301|474468940|FG001|Overall Study|Withdrawal by Subject|5|||
131778510|NCT03733301|474468941|FG002|Overall Study|Withdrawal by Subject|1|||
131778511|NCT00337727|474468944|FG000|Overall Study|Adverse Event|5|||
131778512|NCT00337727|474468945|FG001|Overall Study|Adverse Event|3|||
131778513|NCT00337727|474468944|FG000|Overall Study|Lost to Follow-up|5|||
131778514|NCT00337727|474468945|FG001|Overall Study|Lost to Follow-up|4|||
131778515|NCT00337727|474468944|FG000|Overall Study|Physician Decision|1|||
131778516|NCT00337727|474468945|FG001|Overall Study|Physician Decision|0|||
131778517|NCT00337727|474468944|FG000|Overall Study|Protocol Violation|4|||
131778518|NCT00337727|474468945|FG001|Overall Study|Protocol Violation|0|||
131778519|NCT00337727|474468944|FG000|Overall Study|Withdrawal by Subject|3|||
131778520|NCT00337727|474468945|FG001|Overall Study|Withdrawal by Subject|5|||
131778521|NCT00320801|474468946|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
131778522|NCT00320801|474468947|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
131778523|NCT00320801|474468948|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
131778524|NCT00320801|474468949|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
131778525|NCT00320801|474468946|FG000|Open-label Run-in Period|Adverse Event|33|||
131778526|NCT00320801|474468947|FG001|Open-label Run-in Period|Adverse Event|0|||
131778527|NCT00320801|474468948|FG002|Open-label Run-in Period|Adverse Event|0|||
131778528|NCT00320801|474468949|FG003|Open-label Run-in Period|Adverse Event|0|||
131778529|NCT00320801|474468946|FG000|Open-label Run-in Period|Administrative|10|||
131778530|NCT00320801|474468947|FG001|Open-label Run-in Period|Administrative|0|||
131778531|NCT00320801|474468948|FG002|Open-label Run-in Period|Administrative|0|||
131778532|NCT00320801|474468949|FG003|Open-label Run-in Period|Administrative|0|||
131778533|NCT00320801|474468946|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
131778534|NCT00320801|474468947|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
131778535|NCT00320801|474468948|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
131778536|NCT00320801|474468949|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
131778537|NCT00320801|474468946|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
131778538|NCT00320801|474468947|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
131778539|NCT00320801|474468948|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
131778540|NCT00320801|474468949|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
131778541|NCT00320801|474468946|FG000|Open-label Run-in Period|Did not qualify|1|||
131778542|NCT00320801|474468947|FG001|Open-label Run-in Period|Did not qualify|0|||
131778543|NCT00320801|474468948|FG002|Open-label Run-in Period|Did not qualify|0|||
131778544|NCT00320801|474468949|FG003|Open-label Run-in Period|Did not qualify|0|||
131778545|NCT00320801|474468946|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131778546|NCT00320801|474468947|FG001|Double-blind Phase|Withdrawal by Subject|0|||
131778547|NCT00320801|474468948|FG002|Double-blind Phase|Withdrawal by Subject|1|||
131778548|NCT00320801|474468949|FG003|Double-blind Phase|Withdrawal by Subject|0|||
131778549|NCT00320801|474468946|FG000|Double-blind Phase|Adverse Event|0|||
131778550|NCT00320801|474468947|FG001|Double-blind Phase|Adverse Event|2|||
131778551|NCT00320801|474468948|FG002|Double-blind Phase|Adverse Event|8|||
131778552|NCT00320801|474468949|FG003|Double-blind Phase|Adverse Event|0|||
131778553|NCT00320801|474468946|FG000|Double-blind Phase|Administrative|0|||
131778554|NCT00320801|474468947|FG001|Double-blind Phase|Administrative|0|||
131778555|NCT00320801|474468948|FG002|Double-blind Phase|Administrative|4|||
131778556|NCT00320801|474468949|FG003|Double-blind Phase|Administrative|0|||
131778557|NCT00320801|474468946|FG000|Double-blind Phase|Lack of Efficacy|0|||
131778558|NCT00320801|474468947|FG001|Double-blind Phase|Lack of Efficacy|9|||
131778559|NCT00320801|474468948|FG002|Double-blind Phase|Lack of Efficacy|1|||
131778560|NCT00320801|474468949|FG003|Double-blind Phase|Lack of Efficacy|0|||
131778561|NCT00320801|474468946|FG000|Extension Phase|Withdrawal by Subject|0|||
131778562|NCT00320801|474468947|FG001|Extension Phase|Withdrawal by Subject|0|||
131559564|NCT05284019|473673978|FG001|Overall Study|Lost to Follow-up|0|||
131778563|NCT00320801|474468948|FG002|Extension Phase|Withdrawal by Subject|0|||
131778564|NCT00320801|474468949|FG003|Extension Phase|Withdrawal by Subject|6|||
131559565|NCT05284019|473673979|FG002|Overall Study|Lost to Follow-up|0|||
131559566|NCT05284019|473673980|FG003|Overall Study|Lost to Follow-up|2|||
131778565|NCT00320801|474468946|FG000|Extension Phase|Adverse Event|0|||
131559567|NCT05284019|473673981|FG004|Overall Study|Lost to Follow-up|1|||
131559568|NCT02743793|473673982|FG000|Overall Study|Death|1|||
131559569|NCT02743793|473673983|FG001|Overall Study|Death|1|||
131559570|NCT02743793|473673982|FG000|Overall Study|Withdrawal by Subject|0|||
131559571|NCT02743793|473673983|FG001|Overall Study|Withdrawal by Subject|1|||
131559572|NCT02743793|473673982|FG000|Overall Study|Screen Failure|4|||
131559573|NCT02743793|473673983|FG001|Overall Study|Screen Failure|0|||
131559574|NCT02743793|473673982|FG000|Overall Study|No Primary Care Physician|0|||
131559575|NCT02743793|473673983|FG001|Overall Study|No Primary Care Physician|1|||
131559576|NCT02743793|473673982|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
131559577|NCT02743793|473673983|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
131559578|NCT02743793|473673982|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
131559579|NCT02743793|473673983|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
131559580|NCT02065570|473673984|FG000|Induction Study|Adverse Event|5|||
131559581|NCT02065570|473673985|FG001|Induction Study|Adverse Event|12|||
131559582|NCT02065570|473673986|FG002|Induction Study|Adverse Event|0|||
131559583|NCT02065570|473673987|FG003|Induction Study|Adverse Event|0|||
131559584|NCT02065570|473673984|FG000|Induction Study|Withdrawal by Subject|2|||
131559585|NCT02065570|473673985|FG001|Induction Study|Withdrawal by Subject|3|||
131559586|NCT02065570|473673986|FG002|Induction Study|Withdrawal by Subject|0|||
131559587|NCT02065570|473673987|FG003|Induction Study|Withdrawal by Subject|0|||
131559588|NCT02065570|473673984|FG000|Induction Study|Lost to Follow-up|1|||
131559589|NCT02065570|473673985|FG001|Induction Study|Lost to Follow-up|1|||
131559590|NCT02065570|473673986|FG002|Induction Study|Lost to Follow-up|0|||
131559591|NCT02065570|473673987|FG003|Induction Study|Lost to Follow-up|0|||
131559592|NCT02065570|473673984|FG000|Induction Study|Other, Not Specified|6|||
131559593|NCT02065570|473673985|FG001|Induction Study|Other, Not Specified|5|||
131559594|NCT02065570|473673986|FG002|Induction Study|Other, Not Specified|0|||
131559595|NCT02065570|473673987|FG003|Induction Study|Other, Not Specified|0|||
131559596|NCT02065570|473673984|FG000|Maintenance Study|Adverse Event|0|||
131559597|NCT02065570|473673985|FG001|Maintenance Study|Adverse Event|0|||
131559598|NCT02065570|473673986|FG002|Maintenance Study|Adverse Event|8|||
131559599|NCT02065570|473673987|FG003|Maintenance Study|Adverse Event|8|||
131559600|NCT02065570|473673984|FG000|Maintenance Study|Withdrawal by Subject|0|||
131559601|NCT02065570|473673985|FG001|Maintenance Study|Withdrawal by Subject|0|||
131559602|NCT02065570|473673986|FG002|Maintenance Study|Withdrawal by Subject|1|||
131559603|NCT02065570|473673987|FG003|Maintenance Study|Withdrawal by Subject|4|||
131559604|NCT02065570|473673984|FG000|Maintenance Study|Lost to Follow-up|0|||
131559605|NCT02065570|473673985|FG001|Maintenance Study|Lost to Follow-up|0|||
131559606|NCT02065570|473673986|FG002|Maintenance Study|Lost to Follow-up|2|||
131559607|NCT02065570|473673987|FG003|Maintenance Study|Lost to Follow-up|2|||
131559608|NCT02065570|473673984|FG000|Maintenance Study|Other, Not Specified|0|||
131559609|NCT02065570|473673985|FG001|Maintenance Study|Other, Not Specified|0|||
131559610|NCT02065570|473673986|FG002|Maintenance Study|Other, Not Specified|11|||
131559611|NCT02065570|473673987|FG003|Maintenance Study|Other, Not Specified|5|||
131559612|NCT01146574|473673990|FG000|Overall Study|Death|0|||
131559613|NCT01146574|473673991|FG001|Overall Study|Death|1|||
131559614|NCT01146574|473673992|FG002|Overall Study|Death|1|||
131559615|NCT01146574|473673993|FG003|Overall Study|Death|0|||
131559616|NCT01146574|473673994|FG004|Overall Study|Death|0|||
131559617|NCT01146574|473673995|FG005|Overall Study|Death|0|||
131778566|NCT00320801|474468947|FG001|Extension Phase|Adverse Event|0|||
131778567|NCT00320801|474468948|FG002|Extension Phase|Adverse Event|0|||
131778568|NCT00320801|474468949|FG003|Extension Phase|Adverse Event|8|||
131778569|NCT00320801|474468946|FG000|Extension Phase|Administrative|0|||
131778570|NCT00320801|474468947|FG001|Extension Phase|Administrative|0|||
131778571|NCT00320801|474468948|FG002|Extension Phase|Administrative|0|||
131778572|NCT00320801|474468949|FG003|Extension Phase|Administrative|29|||
131778573|NCT00320801|474468946|FG000|Extension Phase|Lack of Efficacy|0|||
131778574|NCT00320801|474468947|FG001|Extension Phase|Lack of Efficacy|0|||
131778575|NCT00320801|474468948|FG002|Extension Phase|Lack of Efficacy|0|||
131778576|NCT00320801|474468949|FG003|Extension Phase|Lack of Efficacy|2|||
131778577|NCT00320801|474468946|FG000|Extension Phase|Lost to Follow-up|0|||
131778578|NCT00320801|474468947|FG001|Extension Phase|Lost to Follow-up|0|||
131778579|NCT00320801|474468948|FG002|Extension Phase|Lost to Follow-up|0|||
131778580|NCT00320801|474468949|FG003|Extension Phase|Lost to Follow-up|3|||
131778581|NCT00577031|474468950|FG000|Overall Study|Adverse Event|52|||
131778582|NCT00577031|474468950|FG000|Overall Study|Progression of disease|93|||
131778583|NCT00577031|474468950|FG000|Overall Study|Protocol Violation|5|||
131778584|NCT00577031|474468950|FG000|Overall Study|Participant withdrew consent|13|||
131778585|NCT00577031|474468950|FG000|Overall Study|Participant non-compliance|5|||
131778586|NCT00577031|474468950|FG000|Overall Study|Need for surgery|17|||
131778587|NCT00577031|474468950|FG000|Overall Study|Medical decision|14|||
131778588|NCT00577031|474468950|FG000|Overall Study|Death|6|||
131778589|NCT06067191|474468951|FG000|Overall Study|Withdrawal by Subject|0|||
131778590|NCT06067191|474468952|FG001|Overall Study|Withdrawal by Subject|1|||
131778591|NCT04764669|474468954|FG000|Overall Study|Adverse Event|1|||
131778592|NCT04764669|474468955|FG001|Overall Study|Adverse Event|0|||
131778593|NCT04764669|474468956|FG002|Overall Study|Adverse Event|1|||
131778594|NCT04764669|474468957|FG003|Overall Study|Adverse Event|0|||
131778595|NCT04764669|474468954|FG000|Overall Study|Subject Choice|0|||
131778596|NCT04764669|474468955|FG001|Overall Study|Subject Choice|0|||
131778597|NCT04764669|474468956|FG002|Overall Study|Subject Choice|1|||
131778598|NCT04764669|474468957|FG003|Overall Study|Subject Choice|0|||
131778599|NCT04764669|474468954|FG000|Overall Study|Withdrawal by Subject|2|||
131778600|NCT04764669|474468955|FG001|Overall Study|Withdrawal by Subject|0|||
131778601|NCT04764669|474468956|FG002|Overall Study|Withdrawal by Subject|0|||
131778602|NCT04764669|474468957|FG003|Overall Study|Withdrawal by Subject|0|||
131778603|NCT00625846|474468958|FG000|Overall Study|Withdrawal by Subject|2|||
131778604|NCT00625846|474468959|FG001|Overall Study|Withdrawal by Subject|0|||
131778605|NCT00625846|474468960|FG002|Overall Study|Withdrawal by Subject|1|||
131778606|NCT00625846|474468961|FG003|Overall Study|Withdrawal by Subject|2|||
131778607|NCT00807040|474468962|FG000|Overall Study|Death|24|||
131778608|NCT00807040|474468963|FG001|Overall Study|Death|29|||
131778609|NCT00807040|474468962|FG000|Overall Study|Withdrawal by Subject|8|||
131778610|NCT00807040|474468963|FG001|Overall Study|Withdrawal by Subject|6|||
131559618|NCT01146574|473673996|FG006|Overall Study|Death|0|||
131778611|NCT00807040|474468962|FG000|Overall Study|Lost to Follow-up|4|||
131778612|NCT00807040|474468963|FG001|Overall Study|Lost to Follow-up|6|||
131778613|NCT01067339|474468968|FG000|Overall Study|Withdrawal by Subject|6|||
131778614|NCT01067339|474468969|FG001|Overall Study|Withdrawal by Subject|5|||
131778615|NCT00890409|474468970|FG000|Overall Study|Lost to Follow-up|20|||
131778616|NCT00890409|474468971|FG001|Overall Study|Lost to Follow-up|21|||
131778617|NCT02353572|474468972|FG000|Overall Study|Withdrawal by Subject|1|||
131778618|NCT02353572|474468972|FG000|Overall Study|Study terminated|2|||
131778619|NCT00769132|474468975|FG000|Period 1|Adverse Event|1|||
131778620|NCT00769132|474468976|FG001|Period 1|Adverse Event|0|||
131778621|NCT00769132|474468977|FG002|Period 1|Adverse Event|0|||
131778622|NCT00769132|474468978|FG003|Period 1|Adverse Event|1|||
131778623|NCT00769132|474468975|FG000|Period 2|Withdrawal by Subject|0|||
131778624|NCT00769132|474468976|FG001|Period 2|Withdrawal by Subject|0|||
131559619|NCT01146574|473673990|FG000|Overall Study|Other reasons|0|||
131559620|NCT01146574|473673991|FG001|Overall Study|Other reasons|0|||
131778625|NCT00769132|474468977|FG002|Period 2|Withdrawal by Subject|0|||
131778626|NCT00769132|474468978|FG003|Period 2|Withdrawal by Subject|1|||
131778627|NCT00769132|474468975|FG000|Period 3|Withdrawal by Subject|1|||
131559621|NCT01146574|473673992|FG002|Overall Study|Other reasons|3|||
131778628|NCT00769132|474468976|FG001|Period 3|Withdrawal by Subject|0|||
131778629|NCT00769132|474468977|FG002|Period 3|Withdrawal by Subject|0|||
131559622|NCT01146574|473673993|FG003|Overall Study|Other reasons|0|||
131559623|NCT01146574|473673994|FG004|Overall Study|Other reasons|0|||
131778630|NCT00769132|474468978|FG003|Period 3|Withdrawal by Subject|0|||
131778631|NCT00769132|474468975|FG000|Period 4|Withdrawal by Subject|0|||
131778632|NCT00769132|474468976|FG001|Period 4|Withdrawal by Subject|1|||
131778633|NCT00769132|474468977|FG002|Period 4|Withdrawal by Subject|0|||
131778634|NCT00769132|474468978|FG003|Period 4|Withdrawal by Subject|0|||
131778635|NCT02230332|474468981|FG000|Overall Study|Adverse Event|2|||
131778636|NCT02230332|474468982|FG001|Overall Study|Adverse Event|1|||
131778637|NCT02230332|474468981|FG000|Overall Study|Lost to Follow-up|1|||
131778638|NCT02230332|474468982|FG001|Overall Study|Lost to Follow-up|0|||
131778639|NCT02230332|474468981|FG000|Overall Study|Protocol Violation|1|||
131693770|NCT00550680|474161714|FG000|Overall Study|Screen Failure|6|||
131693771|NCT03693625|474161715|FG000|Overall Study|Adverse Event|2|||
131693772|NCT03693625|474161716|FG001|Overall Study|Adverse Event|0|||
131693773|NCT03693625|474161715|FG000|Overall Study|Study Terminated By Sponsor|20|||
131693774|NCT03693625|474161716|FG001|Overall Study|Study Terminated By Sponsor|7|||
131693775|NCT03693625|474161715|FG000|Overall Study|Withdrawal by Subject|1|||
131693776|NCT03693625|474161716|FG001|Overall Study|Withdrawal by Subject|1|||
131693777|NCT01508702|474161717|FG000|Overall Study|Adverse Event|7|||
131693778|NCT01508702|474161718|FG001|Overall Study|Adverse Event|3|||
131693779|NCT01508702|474161717|FG000|Overall Study|Gout flare|2|||
131693780|NCT01508702|474161718|FG001|Overall Study|Gout flare|0|||
131693781|NCT01508702|474161717|FG000|Overall Study|Protocol Violation|2|||
131693782|NCT01508702|474161718|FG001|Overall Study|Protocol Violation|1|||
131693783|NCT01508702|474161717|FG000|Overall Study|Lost to Follow-up|1|||
131693784|NCT01508702|474161718|FG001|Overall Study|Lost to Follow-up|2|||
131693785|NCT01508702|474161717|FG000|Overall Study|Withdrawal by Subject|11|||
131693786|NCT01508702|474161718|FG001|Overall Study|Withdrawal by Subject|7|||
131693787|NCT00250835|474161720|FG000|Overall Study|Withdrawal by Subject|1|||
131693788|NCT01187953|474161721|FG000|Overall Study|Death|11|||
131693789|NCT01187953|474161722|FG001|Overall Study|Death|13|||
131693790|NCT01187953|474161721|FG000|Overall Study|Adverse Event|1|||
131693791|NCT01187953|474161722|FG001|Overall Study|Adverse Event|2|||
131693792|NCT01187953|474161721|FG000|Overall Study|Lost to Follow-up|0|||
131693793|NCT01187953|474161722|FG001|Overall Study|Lost to Follow-up|3|||
131693794|NCT01187953|474161721|FG000|Overall Study|Withdrawal by Subject|3|||
131693795|NCT01187953|474161722|FG001|Overall Study|Withdrawal by Subject|3|||
131693796|NCT02457637|474161728|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
131693797|NCT04489888|474161731|FG000|Overall Study|Death|75|||
131693798|NCT04489888|474161731|FG000|Overall Study|Sponsor Decision|26|||
131693799|NCT03349099|474161732|FG000|Overall Study|Physician Decision|3|||
131693800|NCT03349099|474161733|FG001|Overall Study|Physician Decision|4|||
131693801|NCT03349099|474161732|FG000|Overall Study|Stone migrated from the kidney|1|||
131693802|NCT03349099|474161733|FG001|Overall Study|Stone migrated from the kidney|0|||
131693803|NCT00278993|474161734|FG000|Overall Study|Adverse Event|24|||
131693804|NCT00278993|474161734|FG000|Overall Study|Withdrawal by Subject|5|||
131693805|NCT00278993|474161734|FG000|Overall Study|Progressive Disease|65|||
131693806|NCT00278993|474161734|FG000|Overall Study|Physician Decision|9|||
131693807|NCT00278993|474161734|FG000|Overall Study|Not Otherwise Specified|4|||
131693808|NCT03829657|474161737|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
131693809|NCT03829657|474161738|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
131693810|NCT03829657|474161739|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
131693811|NCT03829657|474161740|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
131693812|NCT03829657|474161741|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
131693813|NCT03829657|474161737|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
131693814|NCT03829657|474161738|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131693815|NCT03829657|474161739|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131693816|NCT03829657|474161740|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131693817|NCT03829657|474161741|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131693818|NCT03829657|474161737|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
131693819|NCT03829657|474161738|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
131693820|NCT03829657|474161739|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
131693821|NCT03829657|474161740|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
131693822|NCT03829657|474161741|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
131693823|NCT03829657|474161737|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
131693824|NCT03829657|474161738|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
131693825|NCT03829657|474161739|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
131693826|NCT03829657|474161740|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
131693827|NCT03829657|474161741|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
131693828|NCT03829657|474161737|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
131693829|NCT03829657|474161738|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
131693830|NCT03829657|474161739|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
131693831|NCT03829657|474161740|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
131693832|NCT03829657|474161741|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
131693833|NCT03829657|474161737|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
131693834|NCT03829657|474161738|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
131693835|NCT03829657|474161739|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
131693836|NCT03829657|474161740|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
131693837|NCT03829657|474161741|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
131693838|NCT03829657|474161737|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131693839|NCT03829657|474161738|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131693840|NCT03829657|474161739|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131693841|NCT03829657|474161740|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131693842|NCT03829657|474161741|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
131693843|NCT03829657|474161737|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
131693844|NCT03829657|474161738|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
131693845|NCT03829657|474161739|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
131693846|NCT03829657|474161740|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
131693847|NCT03829657|474161741|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
131693848|NCT03829657|474161737|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
131693849|NCT03829657|474161738|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
131693850|NCT03829657|474161739|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
131693851|NCT03829657|474161740|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
131693852|NCT03829657|474161741|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
131693853|NCT03829657|474161737|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131693854|NCT03829657|474161738|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131693855|NCT03829657|474161739|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131693856|NCT03829657|474161740|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131693857|NCT03829657|474161741|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
131693858|NCT01014689|474161742|FG000|Overall Study|Lack of Efficacy|0|||
131693859|NCT01014689|474161743|FG001|Overall Study|Lack of Efficacy|1|||
131693860|NCT01014689|474161742|FG000|Overall Study|Adverse Event|3|||
131693861|NCT01014689|474161743|FG001|Overall Study|Adverse Event|0|||
131693862|NCT01014689|474161742|FG000|Overall Study|Withdrawal by Subject|5|||
131693863|NCT01014689|474161743|FG001|Overall Study|Withdrawal by Subject|4|||
131693864|NCT01014689|474161742|FG000|Overall Study|Protocol Violation|1|||
131693865|NCT01014689|474161743|FG001|Overall Study|Protocol Violation|1|||
131693866|NCT01014689|474161742|FG000|Overall Study|Lost to Follow-up|3|||
131693867|NCT01014689|474161743|FG001|Overall Study|Lost to Follow-up|7|||
131693868|NCT01014689|474161742|FG000|Overall Study|Pregnancy|1|||
131693869|NCT01014689|474161743|FG001|Overall Study|Pregnancy|0|||
131693870|NCT00647556|474163419|FG000|Overall Study|Adverse Event|0|||
131693871|NCT00647556|474163420|FG001|Overall Study|Adverse Event|1|||
131693872|NCT00647556|474163419|FG000|Overall Study|Lost to Follow-up|1|||
131693873|NCT00647556|474163420|FG001|Overall Study|Lost to Follow-up|0|||
131693874|NCT00647556|474163419|FG000|Overall Study|Protocol Violation|0|||
131693875|NCT00647556|474163420|FG001|Overall Study|Protocol Violation|1|||
131693876|NCT00647556|474163419|FG000|Overall Study|Withdrawal by Subject|1|||
131693877|NCT00647556|474163420|FG001|Overall Study|Withdrawal by Subject|0|||
131693878|NCT00647556|474163419|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
131693879|NCT00647556|474163420|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
131693880|NCT05594173|474163421|FG000|Overall Study|Adverse Event|1|||
131693881|NCT05594173|474163421|FG000|Overall Study|COVID-19 Pandemic|2|||
131693882|NCT01877187|474163422|FG000|Overall Study|Death|2|||
131693883|NCT01877187|474163422|FG000|Overall Study|Withdrawal by Subject|4|||
131693884|NCT01877187|474163422|FG000|Overall Study|Lost to Follow-up|3|||
131693885|NCT01877187|474163422|FG000|Overall Study|Declining clinical status|11|||
131693886|NCT01877187|474163422|FG000|Overall Study|Liver transplant|2|||
131693887|NCT03776175|474163424|FG000|Treatment Period (42 Days)|Adverse Event|0|||
131693888|NCT03776175|474163425|FG001|Treatment Period (42 Days)|Adverse Event|1|||
131693889|NCT03776175|474163426|FG002|Treatment Period (42 Days)|Adverse Event|1|||
131693890|NCT03776175|474163427|FG003|Treatment Period (42 Days)|Adverse Event|0|||
131693891|NCT03776175|474163424|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
131693892|NCT03776175|474163425|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
131693893|NCT03776175|474163426|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
131693894|NCT03776175|474163427|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
131693895|NCT03776175|474163424|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
131693896|NCT03776175|474163425|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
131693897|NCT03776175|474163426|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
131693898|NCT03776175|474163427|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
131693899|NCT03776175|474163424|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
131693900|NCT03776175|474163425|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
131693901|NCT03776175|474163426|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
131693902|NCT03776175|474163427|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
131693903|NCT03776175|474163424|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
131693904|NCT03776175|474163425|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
131693905|NCT03776175|474163426|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
131693906|NCT03776175|474163427|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
131693907|NCT03776175|474163424|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
131693908|NCT03776175|474163425|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
131693909|NCT03776175|474163426|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
131693910|NCT03776175|474163427|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
131693911|NCT01780831|474163435|FG000|Overall Study|Withdrawal by Subject|0|||
131693912|NCT01780831|474163436|FG001|Overall Study|Withdrawal by Subject|0|||
131693913|NCT01780831|474163437|FG002|Overall Study|Withdrawal by Subject|4|||
131693914|NCT01780831|474163438|FG003|Overall Study|Withdrawal by Subject|0|||
131693915|NCT01780831|474163435|FG000|Overall Study|Lost to Follow-up|0|||
131693916|NCT01780831|474163436|FG001|Overall Study|Lost to Follow-up|0|||
131693917|NCT01780831|474163437|FG002|Overall Study|Lost to Follow-up|0|||
131693918|NCT01780831|474163438|FG003|Overall Study|Lost to Follow-up|1|||
131693919|NCT02429414|474163439|FG000|Overall Study|Physician Decision|0|||
131693920|NCT02429414|474163440|FG001|Overall Study|Physician Decision|1|||
131693921|NCT03245450|474163441|FG000|Overall Study|Radiological disease progression|3|||
131693922|NCT03245450|474163442|FG001|Overall Study|Radiological disease progression|3|||
131693923|NCT03245450|474163443|FG002|Overall Study|Radiological disease progression|2|||
131693924|NCT03245450|474163444|FG003|Overall Study|Radiological disease progression|2|||
131693925|NCT03245450|474163445|FG004|Overall Study|Radiological disease progression|7|||
131693926|NCT03245450|474163446|FG005|Overall Study|Radiological disease progression|6|||
131693927|NCT03245450|474163447|FG006|Overall Study|Radiological disease progression|6|||
131693928|NCT03245450|474163441|FG000|Overall Study|Clinical disease progression|0|||
131693929|NCT03245450|474163442|FG001|Overall Study|Clinical disease progression|0|||
131693930|NCT03245450|474163443|FG002|Overall Study|Clinical disease progression|1|||
131693931|NCT03245450|474163444|FG003|Overall Study|Clinical disease progression|0|||
131693932|NCT03245450|474163445|FG004|Overall Study|Clinical disease progression|0|||
131693933|NCT03245450|474163446|FG005|Overall Study|Clinical disease progression|2|||
131693934|NCT03245450|474163447|FG006|Overall Study|Clinical disease progression|0|||
131693935|NCT03245450|474163441|FG000|Overall Study|Other|0|||
131693936|NCT03245450|474163442|FG001|Overall Study|Other|0|||
131693937|NCT03245450|474163443|FG002|Overall Study|Other|0|||
131693938|NCT03245450|474163444|FG003|Overall Study|Other|1|||
131693939|NCT03245450|474163445|FG004|Overall Study|Other|1|||
131693940|NCT03245450|474163446|FG005|Overall Study|Other|1|||
131693941|NCT03245450|474163447|FG006|Overall Study|Other|1|||
131693942|NCT03245450|474163441|FG000|Overall Study|Withdrawal by Subject|0|||
131693943|NCT03245450|474163442|FG001|Overall Study|Withdrawal by Subject|1|||
131693944|NCT03245450|474163443|FG002|Overall Study|Withdrawal by Subject|0|||
131693945|NCT03245450|474163444|FG003|Overall Study|Withdrawal by Subject|0|||
131693946|NCT03245450|474163445|FG004|Overall Study|Withdrawal by Subject|0|||
131693947|NCT03245450|474163446|FG005|Overall Study|Withdrawal by Subject|0|||
131693948|NCT03245450|474163447|FG006|Overall Study|Withdrawal by Subject|0|||
131693949|NCT03245450|474163441|FG000|Overall Study|Adverse Event|0|||
131693950|NCT03245450|474163442|FG001|Overall Study|Adverse Event|0|||
131693951|NCT03245450|474163443|FG002|Overall Study|Adverse Event|0|||
131693952|NCT03245450|474163444|FG003|Overall Study|Adverse Event|0|||
131778640|NCT02230332|474468982|FG001|Overall Study|Protocol Violation|0|||
131693953|NCT03245450|474163445|FG004|Overall Study|Adverse Event|1|||
131693954|NCT03245450|474163446|FG005|Overall Study|Adverse Event|0|||
131693955|NCT03245450|474163447|FG006|Overall Study|Adverse Event|2|||
131693956|NCT02599961|474163452|FG000|Overall Study|Withdrawal by Subject|1|||
131693957|NCT02599961|474163452|FG000|Overall Study|Subject Non-Compliance|2|||
131693958|NCT02599961|474163452|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
131693959|NCT02599961|474163452|FG000|Overall Study|Other, Not Specified|3|||
131693960|NCT00906087|474163458|FG000|Initial Washout|Withdrawal by Subject|1|||
131693961|NCT00906087|474163458|FG000|Initial Washout|Physician Decision|1|||
131693962|NCT01827670|474163469|FG000|Overall Study|Withdrawal of Consent|3|||
131693963|NCT01827670|474163470|FG001|Overall Study|Withdrawal of Consent|2|||
131693964|NCT01827670|474163469|FG000|Overall Study|Lost to Follow-up|0|||
131693965|NCT01827670|474163470|FG001|Overall Study|Lost to Follow-up|1|||
131693966|NCT03016325|474163473|FG000|Treatment Period|Participant withdrew consent|0|||
131693967|NCT03016325|474163474|FG001|Treatment Period|Participant withdrew consent|1|||
131693968|NCT03016325|474163475|FG002|Treatment Period|Participant withdrew consent|0|||
131693969|NCT03016325|474163476|FG003|Treatment Period|Participant withdrew consent|0|||
131693970|NCT03016325|474163477|FG004|Treatment Period|Participant withdrew consent|0|||
131693971|NCT03016325|474163478|FG005|Treatment Period|Participant withdrew consent|0|||
131693972|NCT03016325|474163479|FG006|Treatment Period|Participant withdrew consent|0|||
131693973|NCT03016325|474163480|FG007|Treatment Period|Participant withdrew consent|0|||
131693974|NCT03016325|474163473|FG000|Treatment Period|Death|0|||
131693975|NCT03016325|474163474|FG001|Treatment Period|Death|0|||
131693976|NCT03016325|474163475|FG002|Treatment Period|Death|0|||
131693977|NCT03016325|474163476|FG003|Treatment Period|Death|0|||
131693978|NCT03016325|474163477|FG004|Treatment Period|Death|2|||
131693979|NCT03016325|474163478|FG005|Treatment Period|Death|0|||
131693980|NCT03016325|474163479|FG006|Treatment Period|Death|0|||
131693981|NCT03016325|474163480|FG007|Treatment Period|Death|0|||
131693982|NCT03016325|474163473|FG000|Treatment Period|Participant refuses assessments|0|||
131693983|NCT03016325|474163474|FG001|Treatment Period|Participant refuses assessments|0|||
131693984|NCT03016325|474163475|FG002|Treatment Period|Participant refuses assessments|1|||
131693985|NCT03016325|474163476|FG003|Treatment Period|Participant refuses assessments|0|||
131693986|NCT03016325|474163477|FG004|Treatment Period|Participant refuses assessments|0|||
131693987|NCT03016325|474163478|FG005|Treatment Period|Participant refuses assessments|0|||
131693988|NCT03016325|474163479|FG006|Treatment Period|Participant refuses assessments|0|||
131693989|NCT03016325|474163480|FG007|Treatment Period|Participant refuses assessments|0|||
131693990|NCT03016325|474163473|FG000|32-Day Follow-Up Period|Death|2|||
131693991|NCT03016325|474163474|FG001|32-Day Follow-Up Period|Death|0|||
131693992|NCT03016325|474163475|FG002|32-Day Follow-Up Period|Death|5|||
131693993|NCT03016325|474163476|FG003|32-Day Follow-Up Period|Death|6|||
131693994|NCT03016325|474163477|FG004|32-Day Follow-Up Period|Death|3|||
131693995|NCT03016325|474163478|FG005|32-Day Follow-Up Period|Death|0|||
131693996|NCT03016325|474163479|FG006|32-Day Follow-Up Period|Death|0|||
131693997|NCT03016325|474163480|FG007|32-Day Follow-Up Period|Death|0|||
131693998|NCT03016325|474163473|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
131693999|NCT03016325|474163474|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
131694000|NCT03016325|474163475|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
131694001|NCT03016325|474163476|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
131694002|NCT03016325|474163477|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
131694003|NCT03016325|474163478|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
131694004|NCT03016325|474163479|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
131694005|NCT03016325|474163480|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
131694006|NCT03016325|474163473|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
131694007|NCT03016325|474163474|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
131694008|NCT03016325|474163475|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
131694009|NCT03016325|474163476|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
131694010|NCT03016325|474163477|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
131694011|NCT03016325|474163478|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
131694012|NCT03016325|474163479|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
131694013|NCT03016325|474163480|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
131694014|NCT03016325|474163473|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
131694015|NCT03016325|474163474|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
131694016|NCT03016325|474163475|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
131694017|NCT03016325|474163476|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
131694018|NCT03016325|474163477|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
131694019|NCT03016325|474163478|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
131694020|NCT03016325|474163479|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
131694021|NCT03016325|474163480|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
131694022|NCT03016325|474163473|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
131694023|NCT03016325|474163474|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
131694024|NCT03016325|474163475|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
131694025|NCT03016325|474163476|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
131778641|NCT00557830|474468986|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
131778642|NCT00557830|474468987|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
131778643|NCT00557830|474468988|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
131778644|NCT00557830|474468986|FG000|Screening Treatment Phase|Adverse Event|2|||
131778645|NCT00557830|474468987|FG001|Screening Treatment Phase|Adverse Event|0|||
131778646|NCT00557830|474468988|FG002|Screening Treatment Phase|Adverse Event|0|||
131778647|NCT00557830|474468986|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
131778648|NCT00557830|474468987|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
131778649|NCT00557830|474468988|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
131778650|NCT00538473|474468990|FG000|Overall Study|Adverse Event|1|||
131778651|NCT00538473|474468991|FG001|Overall Study|Adverse Event|0|||
131778652|NCT01833897|474468992|FG000|Overall Study|Lack of Efficacy|1|||
131778653|NCT00127192|474468993|FG000|Overall Study|Adverse Event|0|||
131778654|NCT00127192|474468994|FG001|Overall Study|Adverse Event|1|||
131694026|NCT03016325|474163477|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
131694027|NCT03016325|474163478|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
131694028|NCT03016325|474163479|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
131694029|NCT03016325|474163480|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
131694030|NCT03016325|474163473|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694031|NCT03016325|474163474|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694032|NCT03016325|474163475|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
131694033|NCT03016325|474163476|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694034|NCT03016325|474163477|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694035|NCT03016325|474163478|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694036|NCT03016325|474163479|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694037|NCT03016325|474163480|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131694038|NCT03016325|474163473|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694039|NCT03016325|474163474|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
131694040|NCT03016325|474163475|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694041|NCT03016325|474163476|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694042|NCT03016325|474163477|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694043|NCT03016325|474163478|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694044|NCT03016325|474163479|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694045|NCT03016325|474163480|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131694046|NCT03016325|474163473|FG000|182-Day Follow-Up Period|Death|3|||
131694047|NCT03016325|474163474|FG001|182-Day Follow-Up Period|Death|3|||
131694048|NCT03016325|474163475|FG002|182-Day Follow-Up Period|Death|11|||
131694049|NCT03016325|474163476|FG003|182-Day Follow-Up Period|Death|12|||
131778655|NCT00127192|474468995|FG002|Overall Study|Adverse Event|1|||
131778656|NCT00127192|474468996|FG003|Overall Study|Adverse Event|1|||
131778657|NCT00127192|474468997|FG004|Overall Study|Adverse Event|0|||
131778658|NCT00127192|474468993|FG000|Overall Study|Lack of Efficacy|2|||
131778659|NCT00127192|474468994|FG001|Overall Study|Lack of Efficacy|0|||
131694050|NCT03016325|474163477|FG004|182-Day Follow-Up Period|Death|9|||
131694051|NCT03016325|474163478|FG005|182-Day Follow-Up Period|Death|0|||
131694052|NCT03016325|474163479|FG006|182-Day Follow-Up Period|Death|0|||
131694053|NCT03016325|474163480|FG007|182-Day Follow-Up Period|Death|1|||
131694054|NCT03016325|474163473|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
131694055|NCT03016325|474163474|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694056|NCT03016325|474163475|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694057|NCT03016325|474163476|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694058|NCT03016325|474163477|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694059|NCT03016325|474163478|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694060|NCT03016325|474163479|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694061|NCT03016325|474163480|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131694062|NCT03016325|474163473|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
131694063|NCT03016325|474163474|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
131694064|NCT03016325|474163475|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
131694065|NCT03016325|474163476|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
131694066|NCT03016325|474163477|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
131694067|NCT03016325|474163478|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
131694068|NCT03016325|474163479|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
131694069|NCT03016325|474163480|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
131694070|NCT03016325|474163473|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131694071|NCT03016325|474163474|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131694072|NCT03016325|474163475|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131694073|NCT03016325|474163476|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131778660|NCT00127192|474468995|FG002|Overall Study|Lack of Efficacy|0|||
131778661|NCT00127192|474468996|FG003|Overall Study|Lack of Efficacy|0|||
131778662|NCT00127192|474468997|FG004|Overall Study|Lack of Efficacy|2|||
131778663|NCT00127192|474468993|FG000|Overall Study|Withdrawal by Subject|0|||
131778664|NCT00127192|474468994|FG001|Overall Study|Withdrawal by Subject|0|||
131778665|NCT00127192|474468995|FG002|Overall Study|Withdrawal by Subject|1|||
131778666|NCT00127192|474468996|FG003|Overall Study|Withdrawal by Subject|0|||
131778667|NCT00127192|474468997|FG004|Overall Study|Withdrawal by Subject|3|||
131778668|NCT00127192|474468993|FG000|Overall Study|Adverse event in pre-treatment period|1|||
131778669|NCT00127192|474468994|FG001|Overall Study|Adverse event in pre-treatment period|0|||
131778670|NCT00127192|474468995|FG002|Overall Study|Adverse event in pre-treatment period|0|||
131778671|NCT00127192|474468996|FG003|Overall Study|Adverse event in pre-treatment period|0|||
131778672|NCT00127192|474468997|FG004|Overall Study|Adverse event in pre-treatment period|0|||
131778673|NCT03256526|474470135|FG000|Overall Study|Adverse Event|1|||
131778674|NCT03256526|474470136|FG001|Overall Study|Adverse Event|0|||
131778675|NCT03256526|474470137|FG002|Overall Study|Adverse Event|1|||
131778676|NCT03256526|474470135|FG000|Overall Study|Lost to Follow-up|1|||
131778677|NCT03256526|474470136|FG001|Overall Study|Lost to Follow-up|0|||
131778678|NCT03256526|474470137|FG002|Overall Study|Lost to Follow-up|2|||
131778679|NCT01607398|474470138|FG000|Overall Study|Adverse Event|0|||
131778680|NCT01607398|474470139|FG001|Overall Study|Adverse Event|2|||
131778681|NCT01607398|474470138|FG000|Overall Study|Severe COPD|2|||
131778682|NCT01607398|474470139|FG001|Overall Study|Severe COPD|0|||
131778683|NCT03286400|474470150|FG000|Overall Study|Death|10|||
131778684|NCT03286400|474470150|FG000|Overall Study|Lost to Follow-up|10|||
131778685|NCT03286400|474470150|FG000|Overall Study|Physician Decision|1|||
131778686|NCT03286400|474470150|FG000|Overall Study|Scheduling difficulty|4|||
131778687|NCT00826176|474470153|FG000|Overall Study|Lost to Follow-up|1|||
131778688|NCT00826176|474470154|FG001|Overall Study|Lost to Follow-up|0|||
131778689|NCT00826176|474470153|FG000|Overall Study|Subject Withdrew Consent|3|||
131778690|NCT00826176|474470154|FG001|Overall Study|Subject Withdrew Consent|0|||
131778691|NCT00826176|474470153|FG000|Overall Study|Administrative|9|||
131778692|NCT00826176|474470154|FG001|Overall Study|Administrative|0|||
131778693|NCT02871921|474470160|FG000|Overall Study|Withdrawal by Subject|34|||
131778694|NCT02871921|474470161|FG001|Overall Study|Withdrawal by Subject|27|||
131778695|NCT02871921|474470162|FG002|Overall Study|Withdrawal by Subject|27|||
131778696|NCT02871921|474470163|FG003|Overall Study|Withdrawal by Subject|30|||
131778697|NCT01036594|474470170|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
131778698|NCT01036594|474470171|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
131778699|NCT01036594|474470170|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
131778700|NCT01036594|474470171|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
131778701|NCT01036594|474470170|FG000|Week 12 Evaluation|Adverse Event|5|||
131778702|NCT01036594|474470171|FG001|Week 12 Evaluation|Adverse Event|0|||
131778703|NCT01036594|474470170|FG000|Week 12 Evaluation|Physician Decision|1|||
131778704|NCT01036594|474470171|FG001|Week 12 Evaluation|Physician Decision|0|||
131778705|NCT01036594|474470170|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
131778706|NCT01036594|474470171|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
131778707|NCT01036594|474470170|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
131778708|NCT01036594|474470171|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
131778709|NCT01036594|474470170|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
131778710|NCT01036594|474470171|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
131778711|NCT01036594|474470170|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
131778712|NCT01036594|474470171|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
131778713|NCT01036594|474470170|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
131778714|NCT01036594|474470171|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
131778715|NCT00244881|474470172|FG000|Overall Study|Withdrawal by Subject|3|||
131778716|NCT01102972|474470173|FG000|Overall Study|Adverse Event|8|||
131778717|NCT01102972|474470174|FG001|Overall Study|Adverse Event|2|||
131778718|NCT01102972|474470173|FG000|Overall Study|Lack of Efficacy|2|||
131778719|NCT01102972|474470174|FG001|Overall Study|Lack of Efficacy|1|||
131778720|NCT01102972|474470173|FG000|Overall Study|Protocol Violation|1|||
131778721|NCT01102972|474470174|FG001|Overall Study|Protocol Violation|0|||
131559624|NCT01146574|473673995|FG005|Overall Study|Other reasons|0|||
131559625|NCT01146574|473673996|FG006|Overall Study|Other reasons|0|||
131778722|NCT01102972|474470173|FG000|Overall Study|Lost to Follow-up|10|||
131778723|NCT01102972|474470174|FG001|Overall Study|Lost to Follow-up|5|||
131778724|NCT01102972|474470173|FG000|Overall Study|Investigator Discretion|2|||
131778725|NCT01102972|474470174|FG001|Overall Study|Investigator Discretion|0|||
131778726|NCT01102972|474470173|FG000|Overall Study|Withdrawal by Subject|6|||
131778727|NCT01102972|474470174|FG001|Overall Study|Withdrawal by Subject|6|||
131778728|NCT01856257|474470178|FG000|Overall Study|Death|2|||
131778729|NCT01856257|474470179|FG001|Overall Study|Death|0|||
131778730|NCT01856257|474470180|FG002|Overall Study|Death|0|||
131778731|NCT01856257|474470181|FG003|Overall Study|Death|0|||
131778732|NCT01856257|474470178|FG000|Overall Study|Physician Decision|0|||
131778733|NCT01856257|474470179|FG001|Overall Study|Physician Decision|0|||
131778734|NCT01856257|474470180|FG002|Overall Study|Physician Decision|0|||
131778735|NCT01856257|474470181|FG003|Overall Study|Physician Decision|1|||
131778736|NCT01856257|474470178|FG000|Overall Study|Withdrawal by Subject|1|||
131778737|NCT01856257|474470179|FG001|Overall Study|Withdrawal by Subject|1|||
131778738|NCT01856257|474470180|FG002|Overall Study|Withdrawal by Subject|0|||
131778739|NCT01856257|474470181|FG003|Overall Study|Withdrawal by Subject|0|||
131778740|NCT01856257|474470178|FG000|Overall Study|Donor complication|0|||
131778741|NCT01856257|474470179|FG001|Overall Study|Donor complication|0|||
131778742|NCT01856257|474470180|FG002|Overall Study|Donor complication|0|||
131778743|NCT01856257|474470181|FG003|Overall Study|Donor complication|1|||
131778744|NCT04527549|474470182|FG000|Overall Study|Withdrawal by Subject|1|||
131778745|NCT04527549|474470183|FG001|Overall Study|Withdrawal by Subject|1|||
131778746|NCT03159611|474470184|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
131778747|NCT03159611|474470185|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
131778748|NCT03159611|474470184|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
131778749|NCT03159611|474470185|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
131778750|NCT03159611|474470184|FG000|Overall Study|Protocol Violation|7|||
131778751|NCT03159611|474470185|FG001|Overall Study|Protocol Violation|4|||
131778752|NCT03159611|474470184|FG000|Overall Study|Adverse Event|1|||
131778753|NCT03159611|474470185|FG001|Overall Study|Adverse Event|0|||
131778754|NCT03159611|474470184|FG000|Overall Study|Withdrawal by Subject|1|||
131778755|NCT03159611|474470185|FG001|Overall Study|Withdrawal by Subject|1|||
131778756|NCT03159611|474470184|FG000|Overall Study|Non-compliance with protocol requirement|3|||
131778757|NCT03159611|474470185|FG001|Overall Study|Non-compliance with protocol requirement|2|||
131778758|NCT03159611|474470184|FG000|Overall Study|Inability to perform procedures|1|||
131778759|NCT03159611|474470185|FG001|Overall Study|Inability to perform procedures|0|||
131778760|NCT02325739|474470186|FG000|Phase I Part|Adverse Event|1|||
131778761|NCT02325739|474470187|FG001|Phase I Part|Adverse Event|0|||
131778762|NCT02325739|474470188|FG002|Phase I Part|Adverse Event|1|||
131778763|NCT02325739|474470189|FG003|Phase I Part|Adverse Event|2|||
131778764|NCT02325739|474470190|FG004|Phase I Part|Adverse Event|3|||
131778765|NCT02325739|474470191|FG005|Phase I Part|Adverse Event|1|||
131778766|NCT02325739|474470192|FG006|Phase I Part|Adverse Event|0|||
131778767|NCT02325739|474470193|FG007|Phase I Part|Adverse Event|2|||
131778768|NCT02325739|474470194|FG008|Phase I Part|Adverse Event|0|||
131778769|NCT02325739|474470195|FG009|Phase I Part|Adverse Event|0|||
131778770|NCT02325739|474470196|FG010|Phase I Part|Adverse Event|0|||
131778771|NCT02325739|474470186|FG000|Phase I Part|Progressive disease|9|||
131778772|NCT02325739|474470187|FG001|Phase I Part|Progressive disease|6|||
131778773|NCT02325739|474470188|FG002|Phase I Part|Progressive disease|3|||
131778774|NCT02325739|474470189|FG003|Phase I Part|Progressive disease|23|||
131778775|NCT02325739|474470190|FG004|Phase I Part|Progressive disease|14|||
131778776|NCT02325739|474470191|FG005|Phase I Part|Progressive disease|6|||
131778777|NCT02325739|474470192|FG006|Phase I Part|Progressive disease|6|||
131778778|NCT02325739|474470193|FG007|Phase I Part|Progressive disease|3|||
131778779|NCT02325739|474470194|FG008|Phase I Part|Progressive disease|0|||
131778780|NCT02325739|474470195|FG009|Phase I Part|Progressive disease|0|||
131778781|NCT02325739|474470196|FG010|Phase I Part|Progressive disease|0|||
131778782|NCT02325739|474470186|FG000|Phase I Part|Subject/guardian decision|1|||
131778783|NCT02325739|474470187|FG001|Phase I Part|Subject/guardian decision|0|||
131778784|NCT02325739|474470188|FG002|Phase I Part|Subject/guardian decision|1|||
131778785|NCT02325739|474470189|FG003|Phase I Part|Subject/guardian decision|1|||
131778786|NCT02325739|474470190|FG004|Phase I Part|Subject/guardian decision|0|||
131778787|NCT02325739|474470191|FG005|Phase I Part|Subject/guardian decision|0|||
131778788|NCT02325739|474470192|FG006|Phase I Part|Subject/guardian decision|0|||
131778789|NCT02325739|474470193|FG007|Phase I Part|Subject/guardian decision|1|||
131778790|NCT02325739|474470194|FG008|Phase I Part|Subject/guardian decision|0|||
131778791|NCT02325739|474470195|FG009|Phase I Part|Subject/guardian decision|0|||
131778792|NCT02325739|474470196|FG010|Phase I Part|Subject/guardian decision|0|||
131778793|NCT02325739|474470186|FG000|Phase I Part|Death|0|||
131778794|NCT02325739|474470187|FG001|Phase I Part|Death|0|||
131778795|NCT02325739|474470188|FG002|Phase I Part|Death|0|||
131778796|NCT02325739|474470189|FG003|Phase I Part|Death|0|||
131778797|NCT02325739|474470190|FG004|Phase I Part|Death|2|||
131778798|NCT02325739|474470191|FG005|Phase I Part|Death|0|||
131778799|NCT02325739|474470192|FG006|Phase I Part|Death|0|||
131778800|NCT02325739|474470193|FG007|Phase I Part|Death|0|||
131778801|NCT02325739|474470194|FG008|Phase I Part|Death|0|||
131778802|NCT02325739|474470195|FG009|Phase I Part|Death|0|||
131778803|NCT02325739|474470196|FG010|Phase I Part|Death|0|||
131778804|NCT02325739|474470186|FG000|Phase II Part|Adverse Event|0|||
131778805|NCT02325739|474470187|FG001|Phase II Part|Adverse Event|0|||
131778806|NCT02325739|474470188|FG002|Phase II Part|Adverse Event|0|||
131778807|NCT02325739|474470189|FG003|Phase II Part|Adverse Event|0|||
131778808|NCT02325739|474470190|FG004|Phase II Part|Adverse Event|0|||
131778809|NCT02325739|474470191|FG005|Phase II Part|Adverse Event|0|||
131778810|NCT02325739|474470192|FG006|Phase II Part|Adverse Event|0|||
131778811|NCT02325739|474470193|FG007|Phase II Part|Adverse Event|0|||
131778812|NCT02325739|474470194|FG008|Phase II Part|Adverse Event|4|||
131778813|NCT02325739|474470195|FG009|Phase II Part|Adverse Event|5|||
131778814|NCT02325739|474470196|FG010|Phase II Part|Adverse Event|1|||
131778815|NCT02325739|474470186|FG000|Phase II Part|Physician Decision|0|||
131778816|NCT02325739|474470187|FG001|Phase II Part|Physician Decision|0|||
131778817|NCT02325739|474470188|FG002|Phase II Part|Physician Decision|0|||
131778818|NCT02325739|474470189|FG003|Phase II Part|Physician Decision|0|||
131778819|NCT02325739|474470190|FG004|Phase II Part|Physician Decision|0|||
131778820|NCT02325739|474470191|FG005|Phase II Part|Physician Decision|0|||
131778821|NCT02325739|474470192|FG006|Phase II Part|Physician Decision|0|||
131778822|NCT02325739|474470193|FG007|Phase II Part|Physician Decision|0|||
131778823|NCT02325739|474470194|FG008|Phase II Part|Physician Decision|0|||
131778824|NCT02325739|474470195|FG009|Phase II Part|Physician Decision|1|||
131778825|NCT02325739|474470196|FG010|Phase II Part|Physician Decision|0|||
131778826|NCT02325739|474470186|FG000|Phase II Part|Progressive disease|0|||
131778827|NCT02325739|474470187|FG001|Phase II Part|Progressive disease|0|||
131778828|NCT02325739|474470188|FG002|Phase II Part|Progressive disease|0|||
131778829|NCT02325739|474470189|FG003|Phase II Part|Progressive disease|0|||
131778830|NCT02325739|474470190|FG004|Phase II Part|Progressive disease|0|||
131778831|NCT02325739|474470191|FG005|Phase II Part|Progressive disease|0|||
131778832|NCT02325739|474470192|FG006|Phase II Part|Progressive disease|0|||
131778833|NCT02325739|474470193|FG007|Phase II Part|Progressive disease|0|||
131778834|NCT02325739|474470194|FG008|Phase II Part|Progressive disease|22|||
131778835|NCT02325739|474470195|FG009|Phase II Part|Progressive disease|29|||
131778836|NCT02325739|474470196|FG010|Phase II Part|Progressive disease|18|||
131778837|NCT02325739|474470186|FG000|Phase II Part|Subject/guardian decision|0|||
131778838|NCT02325739|474470187|FG001|Phase II Part|Subject/guardian decision|0|||
131778839|NCT02325739|474470188|FG002|Phase II Part|Subject/guardian decision|0|||
131778840|NCT02325739|474470189|FG003|Phase II Part|Subject/guardian decision|0|||
131778841|NCT02325739|474470190|FG004|Phase II Part|Subject/guardian decision|0|||
131778842|NCT02325739|474470191|FG005|Phase II Part|Subject/guardian decision|0|||
131694074|NCT03016325|474163477|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
131694075|NCT03016325|474163478|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131694076|NCT03016325|474163479|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131694077|NCT03016325|474163480|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131694078|NCT03016325|474163473|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694079|NCT03016325|474163474|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694080|NCT03016325|474163475|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694081|NCT03016325|474163476|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694082|NCT03016325|474163477|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
131694083|NCT03016325|474163478|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694084|NCT03016325|474163479|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694085|NCT03016325|474163480|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
131694086|NCT03016325|474163473|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694087|NCT03016325|474163474|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694088|NCT03016325|474163475|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694089|NCT03016325|474163476|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
131694090|NCT03016325|474163477|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694091|NCT03016325|474163478|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694092|NCT03016325|474163479|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694093|NCT03016325|474163480|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131694094|NCT03016325|474163473|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694095|NCT03016325|474163474|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
131694096|NCT03016325|474163475|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694097|NCT03016325|474163476|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694098|NCT03016325|474163477|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694099|NCT03016325|474163478|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694100|NCT03016325|474163479|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694101|NCT03016325|474163480|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131694102|NCT03016325|474163473|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131694103|NCT03016325|474163474|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131694104|NCT03016325|474163475|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131694105|NCT03016325|474163476|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131694106|NCT03016325|474163477|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131694107|NCT03016325|474163478|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
131694108|NCT03016325|474163479|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
131694109|NCT03016325|474163480|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
131778843|NCT02325739|474470192|FG006|Phase II Part|Subject/guardian decision|0|||
131778844|NCT02325739|474470193|FG007|Phase II Part|Subject/guardian decision|0|||
131778845|NCT02325739|474470194|FG008|Phase II Part|Subject/guardian decision|4|||
131778846|NCT02325739|474470195|FG009|Phase II Part|Subject/guardian decision|1|||
131778847|NCT02325739|474470196|FG010|Phase II Part|Subject/guardian decision|1|||
131778848|NCT00227591|474470197|FG000|Overall Study|Withdrawal by Subject|1|||
131778849|NCT02057549|474470199|FG000|Overall Study|Lost to Follow-up|1|||
131778850|NCT02057549|474470200|FG001|Overall Study|Lost to Follow-up|0|||
131778851|NCT02057549|474470199|FG000|Overall Study|Physician Decision|1|||
131778852|NCT02057549|474470200|FG001|Overall Study|Physician Decision|0|||
131778853|NCT02057549|474470199|FG000|Overall Study|Withdrawal by Subject|1|||
131778854|NCT02057549|474470200|FG001|Overall Study|Withdrawal by Subject|0|||
131778855|NCT01418365|474470203|FG000|First Intervention|Withdrawal by Subject|0|||
131778856|NCT01418365|474470204|FG001|First Intervention|Withdrawal by Subject|1|||
131778857|NCT01418365|474470203|FG000|First Intervention|Non-compliance|1|||
131778858|NCT01418365|474470204|FG001|First Intervention|Non-compliance|0|||
131778859|NCT01418365|474470203|FG000|Second Intervention|Withdrawal by Subject|0|||
131778860|NCT01418365|474470204|FG001|Second Intervention|Withdrawal by Subject|1|||
131778861|NCT00530621|474470216|FG000|Overall Study|Adverse Event|11|||
131778862|NCT00530621|474470217|FG001|Overall Study|Adverse Event|8|||
131778863|NCT00530621|474470216|FG000|Overall Study|Physician Decision|2|||
131778864|NCT00530621|474470217|FG001|Overall Study|Physician Decision|4|||
131778865|NCT00530621|474470216|FG000|Overall Study|Progressive Disease (PD)|47|||
131778866|NCT00530621|474470217|FG001|Overall Study|Progressive Disease (PD)|40|||
131778867|NCT00530621|474470216|FG000|Overall Study|Sponsor Decision|12|||
131778868|NCT00530621|474470217|FG001|Overall Study|Sponsor Decision|15|||
131778869|NCT00530621|474470216|FG000|Overall Study|Subject Decision|4|||
131778870|NCT00530621|474470217|FG001|Overall Study|Subject Decision|7|||
131778871|NCT00530621|474470216|FG000|Overall Study|Death|3|||
131778872|NCT00530621|474470217|FG001|Overall Study|Death|6|||
131778873|NCT00530621|474470216|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
131778874|NCT00530621|474470217|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
131778875|NCT03409328|474470218|FG000|Overall Study|Lost to Follow-up|6|||
131778876|NCT03409328|474470219|FG001|Overall Study|Lost to Follow-up|3|||
131778877|NCT02596009|474470220|FG000|Overall Study|Administrative problems|0|||
131778878|NCT02596009|474470221|FG001|Overall Study|Administrative problems|1|||
131778879|NCT02596009|474470222|FG002|Overall Study|Administrative problems|0|||
131778880|NCT02596009|474470223|FG003|Overall Study|Administrative problems|0|||
131778881|NCT02596009|474470224|FG004|Overall Study|Administrative problems|0|||
131778882|NCT02596009|474470225|FG005|Overall Study|Administrative problems|0|||
131778883|NCT00518011|474470226|FG000|Overall Study|Death|1|||
131778884|NCT00518011|474470227|FG001|Overall Study|Death|1|||
131778885|NCT00518011|474470226|FG000|Overall Study|Adverse Event|2|||
131778886|NCT00518011|474470227|FG001|Overall Study|Adverse Event|3|||
131778887|NCT00518011|474470226|FG000|Overall Study|Disease Progression|2|||
131778888|NCT00518011|474470227|FG001|Overall Study|Disease Progression|2|||
131778889|NCT00518011|474470226|FG000|Overall Study|Other Reasons|3|||
131778890|NCT00518011|474470227|FG001|Overall Study|Other Reasons|2|||
131778891|NCT00518011|474470226|FG000|Overall Study|Withdrawal by Subject|1|||
131778892|NCT00518011|474470227|FG001|Overall Study|Withdrawal by Subject|0|||
131778893|NCT02998645|474470228|FG000|Treatment Period 1|Adverse Event|6|||
131778894|NCT02998645|474470228|FG000|Treatment Period 1|Death|5|||
131778895|NCT02998645|474470228|FG000|Treatment Period 1|Technical Problems|4|||
131778896|NCT02998645|474470228|FG000|Treatment Period 1|Lack of Efficacy|2|||
131778897|NCT02998645|474470228|FG000|Treatment Period 1|Progressive disease|1|||
131778898|NCT02998645|474470228|FG000|Treatment Period 1|Subject/guardian decision|1|||
131778899|NCT02998645|474470228|FG000|Treatment Period 2|Lack of Efficacy|5|||
131778900|NCT02998645|474470228|FG000|Treatment Period 2|Adverse Event|2|||
131778901|NCT02998645|474470228|FG000|Treatment Period 2|Progressive disease|2|||
131778902|NCT02998645|474470228|FG000|Treatment Period 2|Physician Decision|1|||
131778903|NCT03930615|474470232|FG000|Overall Study|Death|9|||
131778904|NCT03930615|474470233|FG001|Overall Study|Death|3|||
131778905|NCT03930615|474470232|FG000|Overall Study|Lost to Follow-up|1|||
131778906|NCT03930615|474470233|FG001|Overall Study|Lost to Follow-up|2|||
131778907|NCT03930615|474470232|FG000|Overall Study|Physician Decision|3|||
131778908|NCT03930615|474470233|FG001|Overall Study|Physician Decision|4|||
131778909|NCT03930615|474470232|FG000|Overall Study|Withdrawal by Subject|13|||
131778910|NCT03930615|474470233|FG001|Overall Study|Withdrawal by Subject|2|||
131778911|NCT03930615|474470232|FG000|Overall Study|Not treated|1|||
131778912|NCT03930615|474470233|FG001|Overall Study|Not treated|1|||
131778913|NCT04611152|474470238|FG000|Overall Study|Adverse Event|9|||
131778914|NCT04611152|474470239|FG001|Overall Study|Adverse Event|8|||
131778915|NCT04611152|474470238|FG000|Overall Study|Non-compliance with study schedule|1|||
131778916|NCT04611152|474470239|FG001|Overall Study|Non-compliance with study schedule|3|||
131778917|NCT04611152|474470238|FG000|Overall Study|Withdrawal by Subject|5|||
131778918|NCT04611152|474470239|FG001|Overall Study|Withdrawal by Subject|6|||
131778919|NCT04611152|474470238|FG000|Overall Study|Lost to Follow-up|11|||
131778920|NCT04611152|474470239|FG001|Overall Study|Lost to Follow-up|2|||
131778921|NCT03644927|474470240|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
131778922|NCT03644927|474470241|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
131778923|NCT00956813|474470245|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
131778924|NCT00956813|474470246|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
131694110|NCT02970292|474163481|FG000|Overall Study|Physician Decision|1|||
131694111|NCT02970292|474163482|FG001|Overall Study|Physician Decision|1|||
131694112|NCT02970292|474163481|FG000|Overall Study|Withdrawal by Subject|11|||
131694113|NCT02970292|474163482|FG001|Overall Study|Withdrawal by Subject|5|||
131694114|NCT02970292|474163481|FG000|Overall Study|Noncompliance with study drug|2|||
131694115|NCT02970292|474163482|FG001|Overall Study|Noncompliance with study drug|2|||
131694116|NCT02970292|474163481|FG000|Overall Study|Adverse Event|5|||
131694117|NCT02970292|474163482|FG001|Overall Study|Adverse Event|0|||
131694118|NCT02970292|474163481|FG000|Overall Study|Lack of Efficacy|1|||
131694119|NCT02970292|474163482|FG001|Overall Study|Lack of Efficacy|0|||
131694120|NCT02970292|474163481|FG000|Overall Study|Lost to Follow-up|1|||
131694121|NCT02970292|474163482|FG001|Overall Study|Lost to Follow-up|0|||
131694122|NCT02970292|474163481|FG000|Overall Study|Protocol Violation|2|||
131694123|NCT02970292|474163482|FG001|Overall Study|Protocol Violation|0|||
131694124|NCT02970292|474163481|FG000|Overall Study|Other|1|||
131694125|NCT02970292|474163482|FG001|Overall Study|Other|0|||
131694126|NCT00513500|474163488|FG000|Overall Study|Lost to Follow-up|35|||
131694127|NCT00513500|474163489|FG001|Overall Study|Lost to Follow-up|39|||
131694128|NCT00513500|474163488|FG000|Overall Study|Death|2|||
131694129|NCT00513500|474163489|FG001|Overall Study|Death|1|||
131694130|NCT00513500|474163488|FG000|Overall Study|Hospitalized|4|||
131694131|NCT00513500|474163489|FG001|Overall Study|Hospitalized|14|||
131694132|NCT00749996|474163492|FG000|Overall Study|Lost to Follow-up|7|||
131694133|NCT00749996|474163493|FG001|Overall Study|Lost to Follow-up|4|||
131694134|NCT00749996|474163492|FG000|Overall Study|Withdrawal by Subject|5|||
131694135|NCT00749996|474163493|FG001|Overall Study|Withdrawal by Subject|4|||
131694136|NCT00749996|474163492|FG000|Overall Study|Protocol Violation|2|||
131694137|NCT00749996|474163493|FG001|Overall Study|Protocol Violation|3|||
131694138|NCT00749996|474163492|FG000|Overall Study|Physician Decision|2|||
131694139|NCT00749996|474163493|FG001|Overall Study|Physician Decision|0|||
131694140|NCT00749996|474163492|FG000|Overall Study|Pregnancy|0|||
131694141|NCT00749996|474163493|FG001|Overall Study|Pregnancy|2|||
131694142|NCT00749996|474163492|FG000|Overall Study|Adverse Event|1|||
131694143|NCT00749996|474163493|FG001|Overall Study|Adverse Event|0|||
131694144|NCT00749996|474163492|FG000|Overall Study|Death|1|||
131694145|NCT00749996|474163493|FG001|Overall Study|Death|0|||
131694146|NCT01902290|474163494|FG000|Overall Study|Withdrawal by Subject|19|||
131694147|NCT01902290|474163495|FG001|Overall Study|Withdrawal by Subject|27|||
131694148|NCT01902290|474163494|FG000|Overall Study|Lost to Follow-up|2|||
131694149|NCT01902290|474163495|FG001|Overall Study|Lost to Follow-up|2|||
131694150|NCT01902290|474163494|FG000|Overall Study|Death|1|||
131694151|NCT01902290|474163495|FG001|Overall Study|Death|0|||
131694152|NCT01902290|474163494|FG000|Overall Study|Sponsor Decision|26|||
131694153|NCT01902290|474163495|FG001|Overall Study|Sponsor Decision|24|||
131694154|NCT00517829|474163496|FG000|Overall Study|Adverse Event|22|||
131694155|NCT00517829|474163497|FG001|Overall Study|Adverse Event|34|||
131694156|NCT00517829|474163496|FG000|Overall Study|Disease Progression|39|||
131694157|NCT00517829|474163497|FG001|Overall Study|Disease Progression|32|||
131694158|NCT00517829|474163496|FG000|Overall Study|Patient Request|6|||
131694159|NCT00517829|474163497|FG001|Overall Study|Patient Request|5|||
131694160|NCT00517829|474163496|FG000|Overall Study|Investigator Request|5|||
131694161|NCT00517829|474163497|FG001|Overall Study|Investigator Request|3|||
131694162|NCT00517829|474163496|FG000|Overall Study|Other|3|||
131694163|NCT00517829|474163497|FG001|Overall Study|Other|1|||
131694164|NCT00109707|474163499|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
131694165|NCT00109707|474163500|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
131694166|NCT00109707|474163501|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
131694167|NCT00109707|474163499|FG000|Overall Study|Abnormal laboratory values|1|||
131694168|NCT00109707|474163500|FG001|Overall Study|Abnormal laboratory values|0|||
131694169|NCT00109707|474163501|FG002|Overall Study|Abnormal laboratory values|0|||
131694170|NCT00109707|474163499|FG000|Overall Study|Administrative problems|2|||
131694171|NCT00109707|474163500|FG001|Overall Study|Administrative problems|0|||
131694172|NCT00109707|474163501|FG002|Overall Study|Administrative problems|1|||
131694173|NCT00109707|474163499|FG000|Overall Study|Adverse Event|10|||
131694174|NCT00109707|474163500|FG001|Overall Study|Adverse Event|2|||
131694175|NCT00109707|474163501|FG002|Overall Study|Adverse Event|3|||
131694176|NCT00109707|474163499|FG000|Overall Study|Death|4|||
131694177|NCT00109707|474163500|FG001|Overall Study|Death|0|||
131694178|NCT00109707|474163501|FG002|Overall Study|Death|0|||
131436794|NCT02079740|473225611|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
131436795|NCT02079740|473225612|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
131694179|NCT00109707|474163499|FG000|Overall Study|Disease progression|12|||
131694180|NCT00109707|474163500|FG001|Overall Study|Disease progression|4|||
131694181|NCT00109707|474163501|FG002|Overall Study|Disease progression|3|||
131694182|NCT00109707|474163499|FG000|Overall Study|Lost to Follow-up|3|||
131694183|NCT00109707|474163500|FG001|Overall Study|Lost to Follow-up|0|||
131778925|NCT00956813|474470245|FG000|Flaxseed and Placebo|Ineligible|3|||
131694184|NCT00109707|474163501|FG002|Overall Study|Lost to Follow-up|0|||
131694185|NCT00109707|474163499|FG000|Overall Study|Protocol Violation|1|||
131778926|NCT00956813|474470246|FG001|Flaxseed and Placebo|Ineligible|1|||
131778927|NCT04797637|474470247|FG000|Overall Study|Lost to Follow-up|23|||
131778928|NCT04797637|474470248|FG001|Overall Study|Lost to Follow-up|32|||
131778929|NCT04797637|474470247|FG000|Overall Study|Withdrawal by Subject|0|||
131778930|NCT04797637|474470248|FG001|Overall Study|Withdrawal by Subject|1|||
131778931|NCT00605839|474470253|FG000|Overall Study|Protocol Violation|1|||
131778932|NCT00605839|474470254|FG001|Overall Study|Protocol Violation|0|||
131778933|NCT00605839|474470255|FG002|Overall Study|Protocol Violation|0|||
131778934|NCT04502862|474470256|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
131778935|NCT04502862|474470257|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
131778936|NCT04502862|474470256|FG000|Overall Study|Withdrawal by Subject|1|||
131778937|NCT04502862|474470257|FG001|Overall Study|Withdrawal by Subject|0|||
131778938|NCT04502862|474470256|FG000|Overall Study|Adverse Event|1|||
131778939|NCT04502862|474470257|FG001|Overall Study|Adverse Event|1|||
131778940|NCT03505606|474472113|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
131778941|NCT03505606|474472114|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
131778942|NCT03505606|474472115|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
131778943|NCT03505606|474472113|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
131778944|NCT03505606|474472114|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
131778945|NCT03505606|474472115|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
131778946|NCT03505606|474472113|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
131778947|NCT03505606|474472114|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
131778948|NCT03505606|474472115|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
131778949|NCT03505606|474472113|FG000|Overall Study|Poor compliance with refractive correction|0|||
131778950|NCT03505606|474472114|FG001|Overall Study|Poor compliance with refractive correction|0|||
131778951|NCT03505606|474472115|FG002|Overall Study|Poor compliance with refractive correction|1|||
131778952|NCT03505606|474472113|FG000|Overall Study|Insufficient anisometropia|0|||
131778953|NCT03505606|474472114|FG001|Overall Study|Insufficient anisometropia|0|||
131778954|NCT03505606|474472115|FG002|Overall Study|Insufficient anisometropia|2|||
131778955|NCT03505606|474472113|FG000|Overall Study|Ectopia Lentis|0|||
131778956|NCT03505606|474472114|FG001|Overall Study|Ectopia Lentis|0|||
131778957|NCT03505606|474472115|FG002|Overall Study|Ectopia Lentis|1|||
131778958|NCT03505606|474472113|FG000|Overall Study|alternation of amblyopic eye|0|||
131778959|NCT03505606|474472114|FG001|Overall Study|alternation of amblyopic eye|1|||
131778960|NCT03505606|474472115|FG002|Overall Study|alternation of amblyopic eye|0|||
131778961|NCT02087865|474472116|FG000|Overall Study|Withdrawal by Subject|6|||
131778962|NCT02087865|474472117|FG001|Overall Study|Withdrawal by Subject|0|||
131778963|NCT02087865|474472118|FG002|Overall Study|Withdrawal by Subject|1|||
131778964|NCT02087865|474472116|FG000|Overall Study|Lost to Follow-up|0|||
131778965|NCT02087865|474472117|FG001|Overall Study|Lost to Follow-up|0|||
131778966|NCT02087865|474472118|FG002|Overall Study|Lost to Follow-up|1|||
131778967|NCT02087865|474472116|FG000|Overall Study|Drug Non-compliance|0|||
131778968|NCT02087865|474472117|FG001|Overall Study|Drug Non-compliance|2|||
131778969|NCT02087865|474472118|FG002|Overall Study|Drug Non-compliance|0|||
131778970|NCT02087865|474472116|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
131778971|NCT02087865|474472117|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
131778972|NCT02087865|474472118|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
131778973|NCT01392469|474472121|FG000|Overall Study|Adverse Event|2|||
131778974|NCT01392469|474472121|FG000|Overall Study|Withdrawal by Subject|1|||
131778975|NCT01392469|474472121|FG000|Overall Study|Protocol Violation|1|||
131778976|NCT00648739|474472124|FG000|Overall Study|Adverse Event|1|||
131778977|NCT00648739|474472125|FG001|Overall Study|Adverse Event|0|||
131778978|NCT00648739|474472126|FG002|Overall Study|Adverse Event|1|||
131778979|NCT00648739|474472127|FG003|Overall Study|Adverse Event|2|||
131778980|NCT00648739|474472128|FG004|Overall Study|Adverse Event|1|||
131778981|NCT00648739|474472129|FG005|Overall Study|Adverse Event|0|||
131778982|NCT00648739|474472130|FG006|Overall Study|Adverse Event|0|||
131778983|NCT00648739|474472124|FG000|Overall Study|Withdrawal by Subject|1|||
131778984|NCT00648739|474472125|FG001|Overall Study|Withdrawal by Subject|0|||
131778985|NCT00648739|474472126|FG002|Overall Study|Withdrawal by Subject|1|||
131778986|NCT00648739|474472127|FG003|Overall Study|Withdrawal by Subject|0|||
131778987|NCT00648739|474472128|FG004|Overall Study|Withdrawal by Subject|0|||
131778988|NCT00648739|474472129|FG005|Overall Study|Withdrawal by Subject|2|||
131778989|NCT00648739|474472130|FG006|Overall Study|Withdrawal by Subject|0|||
131778990|NCT00648739|474472124|FG000|Overall Study|Lack of Efficacy|0|||
131436796|NCT02079740|473225613|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
131559626|NCT01146574|473673990|FG000|Overall Study|Kidney transplant|0|||
131559627|NCT01146574|473673991|FG001|Overall Study|Kidney transplant|0|||
131778991|NCT00648739|474472125|FG001|Overall Study|Lack of Efficacy|0|||
131778992|NCT00648739|474472126|FG002|Overall Study|Lack of Efficacy|0|||
131778993|NCT00648739|474472127|FG003|Overall Study|Lack of Efficacy|0|||
131778994|NCT00648739|474472128|FG004|Overall Study|Lack of Efficacy|1|||
131559628|NCT01146574|473673992|FG002|Overall Study|Kidney transplant|1|||
131778995|NCT00648739|474472129|FG005|Overall Study|Lack of Efficacy|2|||
131778996|NCT00648739|474472130|FG006|Overall Study|Lack of Efficacy|0|||
131778997|NCT00648739|474472124|FG000|Overall Study|Investigator Considered it Advisable|0|||
131778998|NCT00648739|474472125|FG001|Overall Study|Investigator Considered it Advisable|0|||
131778999|NCT00648739|474472126|FG002|Overall Study|Investigator Considered it Advisable|0|||
131779000|NCT00648739|474472127|FG003|Overall Study|Investigator Considered it Advisable|0|||
131779001|NCT00648739|474472128|FG004|Overall Study|Investigator Considered it Advisable|0|||
131779002|NCT00648739|474472129|FG005|Overall Study|Investigator Considered it Advisable|1|||
131779003|NCT00648739|474472130|FG006|Overall Study|Investigator Considered it Advisable|1|||
131779004|NCT00648739|474472124|FG000|Overall Study|Death|0|||
131779005|NCT00648739|474472125|FG001|Overall Study|Death|1|||
131779006|NCT00648739|474472126|FG002|Overall Study|Death|0|||
131779007|NCT00648739|474472127|FG003|Overall Study|Death|0|||
131779008|NCT00648739|474472128|FG004|Overall Study|Death|0|||
131779009|NCT00648739|474472129|FG005|Overall Study|Death|0|||
131779010|NCT00648739|474472130|FG006|Overall Study|Death|0|||
131779011|NCT00648739|474472124|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
131779012|NCT00648739|474472125|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
131779013|NCT00648739|474472126|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
131779014|NCT00648739|474472127|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
131779015|NCT00648739|474472128|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
131779016|NCT00648739|474472129|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
131779017|NCT00648739|474472130|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
131779018|NCT00648739|474472124|FG000|Overall Study|Follow-up Visits Not Completed|0|||
131779019|NCT00648739|474472125|FG001|Overall Study|Follow-up Visits Not Completed|1|||
131779020|NCT00648739|474472126|FG002|Overall Study|Follow-up Visits Not Completed|0|||
131779021|NCT00648739|474472127|FG003|Overall Study|Follow-up Visits Not Completed|0|||
131779022|NCT00648739|474472128|FG004|Overall Study|Follow-up Visits Not Completed|0|||
131779023|NCT00648739|474472129|FG005|Overall Study|Follow-up Visits Not Completed|0|||
131779024|NCT00648739|474472130|FG006|Overall Study|Follow-up Visits Not Completed|0|||
131779025|NCT00564486|474472135|FG000|Overall Study|Adverse Event|0|||
131779026|NCT00564486|474472136|FG001|Overall Study|Adverse Event|1|||
131779027|NCT00564486|474472137|FG002|Overall Study|Adverse Event|0|||
131779028|NCT00564486|474472138|FG003|Overall Study|Adverse Event|0|||
131779029|NCT00564486|474472135|FG000|Overall Study|Withdrawal by Subject|4|||
131779030|NCT00564486|474472136|FG001|Overall Study|Withdrawal by Subject|0|||
131779031|NCT00564486|474472137|FG002|Overall Study|Withdrawal by Subject|0|||
131779032|NCT00564486|474472138|FG003|Overall Study|Withdrawal by Subject|5|||
131779033|NCT00564486|474472135|FG000|Overall Study|Subject refused to have blood drawn|0|||
131779034|NCT00564486|474472136|FG001|Overall Study|Subject refused to have blood drawn|0|||
131779035|NCT00564486|474472137|FG002|Overall Study|Subject refused to have blood drawn|1|||
131779036|NCT00564486|474472138|FG003|Overall Study|Subject refused to have blood drawn|0|||
131779037|NCT00564486|474472135|FG000|Overall Study|Lost to Follow-up|3|||
131779038|NCT00564486|474472136|FG001|Overall Study|Lost to Follow-up|0|||
131779039|NCT00564486|474472137|FG002|Overall Study|Lost to Follow-up|2|||
131779040|NCT00564486|474472138|FG003|Overall Study|Lost to Follow-up|2|||
131779041|NCT03862807|474472143|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
131779042|NCT04362761|474472144|FG000|Part A (48 Weeks)|Adverse Event|2|||
131779043|NCT04362761|474472144|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
131779044|NCT04362761|474472144|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
131779045|NCT04362761|474472144|FG000|Part A (48 Weeks)|Other|5|||
131779046|NCT04362761|474472144|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
131779047|NCT04362761|474472144|FG000|Part B (86 Weeks)|Other|4|||
131779048|NCT00684645|474472145|FG000|Overall Study|Death|2|||
131779049|NCT00684645|474472145|FG000|Overall Study|Progressive disease|67|||
131779050|NCT00684645|474472145|FG000|Overall Study|Adverse Event|27|||
131779051|NCT00684645|474472145|FG000|Overall Study|Lost to Follow-up|3|||
131779052|NCT00684645|474472145|FG000|Overall Study|Other|15|||
131779053|NCT01819467|474472159|FG000|Overall Study|Physician Decision|20|||
131779054|NCT01819467|474472160|FG001|Overall Study|Physician Decision|9|||
131779055|NCT03292731|474472163|FG000|Overall Study|Protocol Violation|4|||
131779056|NCT03292731|474472164|FG001|Overall Study|Protocol Violation|11|||
131779057|NCT03292731|474472165|FG002|Overall Study|Protocol Violation|1|||
131779058|NCT04139642|474472166|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
131779059|NCT04139642|474472167|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
131779060|NCT00539006|474472179|FG000|Pre-treatment|Other|0|||
131779061|NCT00539006|474472180|FG001|Pre-treatment|Other|1|||
131779062|NCT00539006|474472181|FG002|Pre-treatment|Other|0|||
131779063|NCT00539006|474472182|FG003|Pre-treatment|Other|0|||
131779064|NCT00539006|474472179|FG000|Treatment Period 1|Lost to Follow-up|0|||
131779065|NCT00539006|474472180|FG001|Treatment Period 1|Lost to Follow-up|0|||
131779066|NCT00539006|474472181|FG002|Treatment Period 1|Lost to Follow-up|1|||
131779067|NCT00539006|474472182|FG003|Treatment Period 1|Lost to Follow-up|0|||
131779068|NCT00539006|474472179|FG000|Treatment Period 1|Protocol Violation|0|||
131779069|NCT00539006|474472180|FG001|Treatment Period 1|Protocol Violation|0|||
131779070|NCT00539006|474472181|FG002|Treatment Period 1|Protocol Violation|1|||
131779071|NCT00539006|474472182|FG003|Treatment Period 1|Protocol Violation|0|||
131779072|NCT00539006|474472179|FG000|Treatment Period 1|Lack of Efficacy|0|||
131779073|NCT00539006|474472180|FG001|Treatment Period 1|Lack of Efficacy|0|||
131779074|NCT00539006|474472181|FG002|Treatment Period 1|Lack of Efficacy|0|||
131779075|NCT00539006|474472182|FG003|Treatment Period 1|Lack of Efficacy|1|||
131779076|NCT00539006|474472179|FG000|Washout|Adverse Event|2|||
131779077|NCT00539006|474472180|FG001|Washout|Adverse Event|1|||
131779078|NCT00539006|474472181|FG002|Washout|Adverse Event|0|||
131779079|NCT00539006|474472182|FG003|Washout|Adverse Event|0|||
131779080|NCT00539006|474472179|FG000|Washout|Protocol Violation|1|||
131779081|NCT00539006|474472180|FG001|Washout|Protocol Violation|1|||
131779082|NCT00539006|474472181|FG002|Washout|Protocol Violation|0|||
131779083|NCT00539006|474472182|FG003|Washout|Protocol Violation|0|||
131779084|NCT00539006|474472179|FG000|Washout|Withdrawal by Subject|0|||
131779085|NCT00539006|474472180|FG001|Washout|Withdrawal by Subject|2|||
131779086|NCT00539006|474472181|FG002|Washout|Withdrawal by Subject|0|||
131779087|NCT00539006|474472182|FG003|Washout|Withdrawal by Subject|0|||
131779088|NCT00539006|474472179|FG000|Washout|Failed to meet continuation criteria|16|||
131779089|NCT00539006|474472180|FG001|Washout|Failed to meet continuation criteria|5|||
131779090|NCT00539006|474472181|FG002|Washout|Failed to meet continuation criteria|14|||
131779091|NCT00539006|474472182|FG003|Washout|Failed to meet continuation criteria|6|||
131779092|NCT00539006|474472179|FG000|Washout|Other|1|||
131779093|NCT00539006|474472180|FG001|Washout|Other|1|||
131779094|NCT00539006|474472181|FG002|Washout|Other|2|||
131779095|NCT00539006|474472182|FG003|Washout|Other|3|||
131779096|NCT00539006|474472179|FG000|Treatment Period 2|Protocol Violation|1|||
131779097|NCT00539006|474472180|FG001|Treatment Period 2|Protocol Violation|0|||
131779098|NCT00539006|474472181|FG002|Treatment Period 2|Protocol Violation|0|||
131779099|NCT00539006|474472182|FG003|Treatment Period 2|Protocol Violation|0|||
131779100|NCT00539006|474472179|FG000|Treatment Period 2|Other|0|||
131779101|NCT00539006|474472180|FG001|Treatment Period 2|Other|1|||
131779102|NCT00539006|474472181|FG002|Treatment Period 2|Other|0|||
131779103|NCT00539006|474472182|FG003|Treatment Period 2|Other|0|||
131779104|NCT01965431|474472183|FG000|Overall Study|Adverse Event|0|||
131779105|NCT01965431|474472184|FG001|Overall Study|Adverse Event|1|||
131779106|NCT01965431|474472185|FG002|Overall Study|Adverse Event|0|||
131779107|NCT01965431|474472186|FG003|Overall Study|Adverse Event|0|||
131779108|NCT01965431|474472187|FG004|Overall Study|Adverse Event|0|||
131779109|NCT01965431|474472188|FG005|Overall Study|Adverse Event|0|||
131779110|NCT01965431|474472183|FG000|Overall Study|Other than stated above|6|||
131779111|NCT01965431|474472184|FG001|Overall Study|Other than stated above|5|||
131779112|NCT01965431|474472185|FG002|Overall Study|Other than stated above|6|||
131779113|NCT01965431|474472186|FG003|Overall Study|Other than stated above|6|||
131779114|NCT01965431|474472187|FG004|Overall Study|Other than stated above|6|||
131779115|NCT01965431|474472188|FG005|Overall Study|Other than stated above|6|||
131779116|NCT01803464|474472189|FG000|Overall Study|Incomplete data|0|||
131779117|NCT01803464|474472190|FG001|Overall Study|Incomplete data|0|||
131779118|NCT01803464|474472191|FG002|Overall Study|Incomplete data|4|||
131779119|NCT01803464|474472192|FG003|Overall Study|Incomplete data|0|||
131779120|NCT01803464|474472189|FG000|Overall Study|Withdrawal by Subject|1|||
131779121|NCT01803464|474472190|FG001|Overall Study|Withdrawal by Subject|0|||
131779122|NCT01803464|474472191|FG002|Overall Study|Withdrawal by Subject|0|||
131779123|NCT01803464|474472192|FG003|Overall Study|Withdrawal by Subject|0|||
131779124|NCT02860039|474472193|FG000|Overall Study|Death|4|||
131779125|NCT02860039|474472194|FG001|Overall Study|Death|0|||
131779126|NCT02860039|474472193|FG000|Overall Study|Lost to Follow-up|2|||
131779127|NCT02860039|474472194|FG001|Overall Study|Lost to Follow-up|2|||
131779128|NCT02860039|474472193|FG000|Overall Study|Protocol Violation|3|||
131779129|NCT02860039|474472194|FG001|Overall Study|Protocol Violation|1|||
131779130|NCT02860039|474472193|FG000|Overall Study|Withdrawal by Subject|1|||
131779131|NCT02860039|474472194|FG001|Overall Study|Withdrawal by Subject|0|||
131779132|NCT02860039|474472193|FG000|Overall Study|Not otherwise eligible|1|||
131779133|NCT02860039|474472194|FG001|Overall Study|Not otherwise eligible|1|||
131779134|NCT03319368|474472198|FG000|Overall Study|Discharge swabs not collected from resident|57|||
131779135|NCT03319368|474472199|FG001|Overall Study|Discharge swabs not collected from resident|46|||
131779136|NCT03000075|474472200|FG000|Part A|Adverse Event|4|||
131779137|NCT03000075|474472201|FG001|Part A|Adverse Event|0|||
131779138|NCT03000075|474472202|FG002|Part A|Adverse Event|0|||
131779139|NCT03000075|474472203|FG003|Part A|Adverse Event|0|||
131779140|NCT03000075|474472204|FG004|Part A|Adverse Event|0|||
131779141|NCT03000075|474472205|FG005|Part A|Adverse Event|0|||
131779142|NCT03000075|474472206|FG006|Part A|Adverse Event|0|||
131779143|NCT03000075|474472200|FG000|Part B|Not dosed due to AE|0|||
131779144|NCT03000075|474472201|FG001|Part B|Not dosed due to AE|0|||
131779145|NCT03000075|474472202|FG002|Part B|Not dosed due to AE|0|||
131779146|NCT03000075|474472203|FG003|Part B|Not dosed due to AE|0|||
131779147|NCT03000075|474472204|FG004|Part B|Not dosed due to AE|0|||
131779148|NCT03000075|474472205|FG005|Part B|Not dosed due to AE|2|||
131779149|NCT03000075|474472206|FG006|Part B|Not dosed due to AE|1|||
131779150|NCT03000075|474472200|FG000|Part B|Adverse Event|0|||
131779151|NCT03000075|474472201|FG001|Part B|Adverse Event|0|||
131779152|NCT03000075|474472202|FG002|Part B|Adverse Event|0|||
131779153|NCT03000075|474472203|FG003|Part B|Adverse Event|0|||
131779154|NCT03000075|474472204|FG004|Part B|Adverse Event|1|||
131779155|NCT03000075|474472205|FG005|Part B|Adverse Event|0|||
131779156|NCT03000075|474472206|FG006|Part B|Adverse Event|0|||
131779157|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
131779158|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
131779159|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Death|5|||
131779160|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Death|2|||
131779161|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
131779162|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
131779163|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
131779164|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
131779165|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
131779166|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
131779167|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Relapse|1|||
131779168|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Relapse|0|||
131779169|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
131779170|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
131779171|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
131779172|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
131779173|NCT00111007|474472207|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
131779174|NCT00111007|474472208|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
131779175|NCT00111007|474472207|FG000|Active Follow-up|Adverse Event|1|||
131779176|NCT00111007|474472208|FG001|Active Follow-up|Adverse Event|0|||
131779177|NCT00111007|474472207|FG000|Active Follow-up|Death|2|||
131779178|NCT00111007|474472208|FG001|Active Follow-up|Death|0|||
131779179|NCT00111007|474472207|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
131779180|NCT00111007|474472208|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
131779181|NCT00111007|474472207|FG000|Long Term Follow-up|Death|34|||
131779182|NCT00111007|474472208|FG001|Long Term Follow-up|Death|39|||
131779183|NCT00111007|474472207|FG000|Long Term Follow-up|Lost to Follow-up|1|||
131779184|NCT00111007|474472208|FG001|Long Term Follow-up|Lost to Follow-up|1|||
131779185|NCT00111007|474472207|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
131779186|NCT00111007|474472208|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
131779187|NCT00111007|474472207|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
131779188|NCT00111007|474472208|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
131779189|NCT00111007|474472207|FG000|Long Term Follow-up|Missing|10|||
131779190|NCT00111007|474472208|FG001|Long Term Follow-up|Missing|3|||
131779191|NCT00824993|474472209|FG000|Overall Study|Withdrawal by Subject|1|||
131779192|NCT00824993|474472210|FG001|Overall Study|Withdrawal by Subject|1|||
131779193|NCT00824993|474472209|FG000|Overall Study|Malignancy Relapse|9|||
131779194|NCT00824993|474472210|FG001|Overall Study|Malignancy Relapse|10|||
131779195|NCT00824993|474472209|FG000|Overall Study|Rapid Bone Loss|0|||
131779196|NCT00824993|474472210|FG001|Overall Study|Rapid Bone Loss|1|||
131779197|NCT00824993|474472209|FG000|Overall Study|Non-Compliant|2|||
131779198|NCT00824993|474472210|FG001|Overall Study|Non-Compliant|1|||
131779199|NCT00824993|474472209|FG000|Overall Study|Insurance Issue|2|||
131779200|NCT00824993|474472210|FG001|Overall Study|Insurance Issue|1|||
131779201|NCT00824993|474472209|FG000|Overall Study|Death|0|||
131779202|NCT00824993|474472210|FG001|Overall Study|Death|3|||
131779203|NCT00440193|474472211|FG000|Treatment Period|Adverse Event|74|||
131779204|NCT00440193|474472212|FG001|Treatment Period|Adverse Event|67|||
131779205|NCT00440193|474472211|FG000|Treatment Period|Death|19|||
131779206|NCT00440193|474472212|FG001|Treatment Period|Death|22|||
131779207|NCT00440193|474472211|FG000|Treatment Period|Lack of Efficacy|0|||
131779208|NCT00440193|474472212|FG001|Treatment Period|Lack of Efficacy|1|||
131779209|NCT00440193|474472211|FG000|Treatment Period|Lost to Follow-up|12|||
131779210|NCT00440193|474472212|FG001|Treatment Period|Lost to Follow-up|18|||
131779211|NCT00440193|474472211|FG000|Treatment Period|Physician Decision|3|||
131779212|NCT00440193|474472212|FG001|Treatment Period|Physician Decision|6|||
131779213|NCT00440193|474472211|FG000|Treatment Period|Protocol Violation|16|||
131779214|NCT00440193|474472212|FG001|Treatment Period|Protocol Violation|19|||
131779215|NCT00440193|474472211|FG000|Treatment Period|Withdrawal by Subject|36|||
131779216|NCT00440193|474472212|FG001|Treatment Period|Withdrawal by Subject|77|||
131779217|NCT00440193|474472211|FG000|Treatment Period|Clinical endpoint reached|28|||
131779218|NCT00440193|474472212|FG001|Treatment Period|Clinical endpoint reached|25|||
131779219|NCT00440193|474472211|FG000|Treatment Period|Study terminated by sponsor|102|||
131779220|NCT00440193|474472212|FG001|Treatment Period|Study terminated by sponsor|94|||
131779221|NCT00440193|474472211|FG000|Treatment Period|Protocol driven decision point|2|||
131779222|NCT00440193|474472212|FG001|Treatment Period|Protocol driven decision point|2|||
131779223|NCT00440193|474472211|FG000|Treatment Period|Switch to commercial drug|0|||
131779224|NCT00440193|474472212|FG001|Treatment Period|Switch to commercial drug|2|||
131779225|NCT00440193|474472211|FG000|Treatment Period|Technical problems|1|||
131779226|NCT00440193|474472212|FG001|Treatment Period|Technical problems|1|||
131779227|NCT00440193|474472211|FG000|Treatment Period|Participant convenience|5|||
131779228|NCT00440193|474472212|FG001|Treatment Period|Participant convenience|2|||
131779229|NCT00440193|474472211|FG000|Treatment Period|Participant did not receive treatment|7|||
131779230|NCT00440193|474472212|FG001|Treatment Period|Participant did not receive treatment|13|||
131779231|NCT00440193|474472211|FG000|Treatment Period|Site closed by investigator|0|||
131779232|NCT00440193|474472212|FG001|Treatment Period|Site closed by investigator|2|||
131779233|NCT00440193|474472211|FG000|Observational Period|Adverse Event|2|||
131779234|NCT00440193|474472212|FG001|Observational Period|Adverse Event|2|||
131779235|NCT00440193|474472211|FG000|Observational Period|Death|15|||
131779236|NCT00440193|474472212|FG001|Observational Period|Death|20|||
131779237|NCT00440193|474472211|FG000|Observational Period|Lost to Follow-up|12|||
131779238|NCT00440193|474472212|FG001|Observational Period|Lost to Follow-up|8|||
131779239|NCT00440193|474472211|FG000|Observational Period|Protocol Violation|1|||
131779240|NCT00440193|474472212|FG001|Observational Period|Protocol Violation|0|||
131779241|NCT00440193|474472211|FG000|Observational Period|Withdrawal by Subject|11|||
131779242|NCT00440193|474472212|FG001|Observational Period|Withdrawal by Subject|8|||
131779243|NCT00440193|474472211|FG000|Observational Period|Physician Decision|1|||
131779244|NCT00440193|474472212|FG001|Observational Period|Physician Decision|0|||
131779245|NCT00440193|474472211|FG000|Observational Period|Clinical endpoint reached|1|||
131779246|NCT00440193|474472212|FG001|Observational Period|Clinical endpoint reached|0|||
131779247|NCT00440193|474472211|FG000|Observational Period|Participant convenience|2|||
131779248|NCT00440193|474472212|FG001|Observational Period|Participant convenience|0|||
131779249|NCT01023022|474472215|FG000|Overall Study|Death|5|||
131779250|NCT01023022|474472215|FG000|Overall Study|Lost to Follow-up|7|||
131779251|NCT01023022|474472215|FG000|Overall Study|due to technical issues|2|||
131779252|NCT03917654|474472216|FG000|Year 1|Withdrawal by Subject|1|||
131779253|NCT03917654|474472217|FG001|Year 1|Withdrawal by Subject|0|||
131779254|NCT03917654|474472218|FG002|Year 1|Withdrawal by Subject|0|||
131779255|NCT03917654|474472219|FG003|Year 1|Withdrawal by Subject|0|||
131779256|NCT03917654|474472220|FG004|Year 1|Withdrawal by Subject|0|||
131779257|NCT03917654|474472221|FG005|Year 1|Withdrawal by Subject|1|||
131779258|NCT03917654|474472222|FG006|Year 1|Withdrawal by Subject|6|||
131779259|NCT03917654|474472223|FG007|Year 1|Withdrawal by Subject|2|||
131779260|NCT03917654|474472224|FG008|Year 1|Withdrawal by Subject|5|||
131779261|NCT03917654|474472225|FG009|Year 1|Withdrawal by Subject|3|||
131779262|NCT03917654|474472226|FG010|Year 1|Withdrawal by Subject|1|||
131779263|NCT03917654|474472227|FG011|Year 1|Withdrawal by Subject|0|||
131779264|NCT03917654|474472216|FG000|Year 1|Travel|0|||
131779265|NCT03917654|474472217|FG001|Year 1|Travel|1|||
131779266|NCT03917654|474472218|FG002|Year 1|Travel|1|||
131779267|NCT03917654|474472219|FG003|Year 1|Travel|0|||
131779268|NCT03917654|474472220|FG004|Year 1|Travel|4|||
131779269|NCT03917654|474472221|FG005|Year 1|Travel|4|||
131779270|NCT03917654|474472222|FG006|Year 1|Travel|10|||
131779271|NCT03917654|474472223|FG007|Year 1|Travel|8|||
131779272|NCT03917654|474472224|FG008|Year 1|Travel|2|||
131779273|NCT03917654|474472225|FG009|Year 1|Travel|5|||
131779274|NCT03917654|474472226|FG010|Year 1|Travel|3|||
131779275|NCT03917654|474472227|FG011|Year 1|Travel|3|||
131779276|NCT03917654|474472216|FG000|Year 1|Subject moved away from site|0|||
131779277|NCT03917654|474472217|FG001|Year 1|Subject moved away from site|1|||
131779278|NCT03917654|474472218|FG002|Year 1|Subject moved away from site|0|||
131779279|NCT03917654|474472219|FG003|Year 1|Subject moved away from site|0|||
131779280|NCT03917654|474472220|FG004|Year 1|Subject moved away from site|0|||
131779281|NCT03917654|474472221|FG005|Year 1|Subject moved away from site|0|||
131779282|NCT03917654|474472222|FG006|Year 1|Subject moved away from site|1|||
131779283|NCT03917654|474472223|FG007|Year 1|Subject moved away from site|2|||
131779284|NCT03917654|474472224|FG008|Year 1|Subject moved away from site|1|||
131779285|NCT03917654|474472225|FG009|Year 1|Subject moved away from site|0|||
131779286|NCT03917654|474472226|FG010|Year 1|Subject moved away from site|0|||
131779287|NCT03917654|474472227|FG011|Year 1|Subject moved away from site|3|||
131779288|NCT03917654|474472216|FG000|Year 1|Spouse/Family member request|0|||
131779289|NCT03917654|474472217|FG001|Year 1|Spouse/Family member request|0|||
131779290|NCT03917654|474472218|FG002|Year 1|Spouse/Family member request|1|||
131779291|NCT03917654|474472219|FG003|Year 1|Spouse/Family member request|0|||
131779292|NCT03917654|474472220|FG004|Year 1|Spouse/Family member request|1|||
131779293|NCT03917654|474472221|FG005|Year 1|Spouse/Family member request|0|||
131779294|NCT03917654|474472222|FG006|Year 1|Spouse/Family member request|0|||
131779295|NCT03917654|474472223|FG007|Year 1|Spouse/Family member request|2|||
131779296|NCT03917654|474472224|FG008|Year 1|Spouse/Family member request|0|||
131779297|NCT03917654|474472225|FG009|Year 1|Spouse/Family member request|0|||
131779298|NCT03917654|474472226|FG010|Year 1|Spouse/Family member request|0|||
131779299|NCT03917654|474472227|FG011|Year 1|Spouse/Family member request|1|||
131779300|NCT03917654|474472216|FG000|Year 1|Death|0|||
131436797|NCT02079740|473225614|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
131779301|NCT03917654|474472217|FG001|Year 1|Death|0|||
131779302|NCT03917654|474472218|FG002|Year 1|Death|0|||
131779303|NCT03917654|474472219|FG003|Year 1|Death|0|||
131779304|NCT03917654|474472220|FG004|Year 1|Death|0|||
131779305|NCT03917654|474472221|FG005|Year 1|Death|0|||
131779306|NCT03917654|474472222|FG006|Year 1|Death|0|||
131779307|NCT03917654|474472223|FG007|Year 1|Death|0|||
131779308|NCT03917654|474472224|FG008|Year 1|Death|1|||
131779309|NCT03917654|474472225|FG009|Year 1|Death|1|||
131779310|NCT03917654|474472226|FG010|Year 1|Death|0|||
131779311|NCT03917654|474472227|FG011|Year 1|Death|0|||
131779312|NCT03917654|474472216|FG000|Year 1|Lost to Follow-up|0|||
131779313|NCT03917654|474472217|FG001|Year 1|Lost to Follow-up|0|||
131779314|NCT03917654|474472218|FG002|Year 1|Lost to Follow-up|0|||
131779315|NCT03917654|474472219|FG003|Year 1|Lost to Follow-up|0|||
131779316|NCT03917654|474472220|FG004|Year 1|Lost to Follow-up|0|||
131779317|NCT03917654|474472221|FG005|Year 1|Lost to Follow-up|0|||
131779318|NCT03917654|474472222|FG006|Year 1|Lost to Follow-up|2|||
131779319|NCT03917654|474472223|FG007|Year 1|Lost to Follow-up|0|||
131779320|NCT03917654|474472224|FG008|Year 1|Lost to Follow-up|0|||
131779321|NCT03917654|474472225|FG009|Year 1|Lost to Follow-up|0|||
131779322|NCT03917654|474472226|FG010|Year 1|Lost to Follow-up|0|||
131779323|NCT03917654|474472227|FG011|Year 1|Lost to Follow-up|0|||
131779324|NCT03917654|474472216|FG000|Year 1|Missed visits|0|||
131779325|NCT03917654|474472217|FG001|Year 1|Missed visits|0|||
131779326|NCT03917654|474472218|FG002|Year 1|Missed visits|0|||
131779327|NCT03917654|474472219|FG003|Year 1|Missed visits|0|||
131779328|NCT03917654|474472220|FG004|Year 1|Missed visits|0|||
131779329|NCT03917654|474472221|FG005|Year 1|Missed visits|0|||
131779330|NCT03917654|474472222|FG006|Year 1|Missed visits|0|||
131779331|NCT03917654|474472223|FG007|Year 1|Missed visits|0|||
131779332|NCT03917654|474472224|FG008|Year 1|Missed visits|0|||
131779333|NCT03917654|474472225|FG009|Year 1|Missed visits|0|||
131779334|NCT03917654|474472226|FG010|Year 1|Missed visits|1|||
131779335|NCT03917654|474472227|FG011|Year 1|Missed visits|1|||
131779336|NCT03917654|474472216|FG000|Year 1|Pregnancy|0|||
131779337|NCT03917654|474472217|FG001|Year 1|Pregnancy|0|||
131779338|NCT03917654|474472218|FG002|Year 1|Pregnancy|0|||
131779339|NCT03917654|474472219|FG003|Year 1|Pregnancy|0|||
131779340|NCT03917654|474472220|FG004|Year 1|Pregnancy|0|||
131779341|NCT03917654|474472221|FG005|Year 1|Pregnancy|0|||
131779342|NCT03917654|474472222|FG006|Year 1|Pregnancy|0|||
131779343|NCT03917654|474472223|FG007|Year 1|Pregnancy|1|||
131779344|NCT03917654|474472224|FG008|Year 1|Pregnancy|0|||
131779345|NCT03917654|474472225|FG009|Year 1|Pregnancy|1|||
131779346|NCT03917654|474472226|FG010|Year 1|Pregnancy|0|||
131779347|NCT03917654|474472227|FG011|Year 1|Pregnancy|0|||
131779348|NCT03917654|474472216|FG000|Year 2|Travel|1|||
131779349|NCT03917654|474472217|FG001|Year 2|Travel|0|||
131779350|NCT03917654|474472218|FG002|Year 2|Travel|0|||
131779351|NCT03917654|474472219|FG003|Year 2|Travel|0|||
131779352|NCT03917654|474472220|FG004|Year 2|Travel|1|||
131779353|NCT03917654|474472221|FG005|Year 2|Travel|1|||
131779354|NCT03917654|474472222|FG006|Year 2|Travel|2|||
131779355|NCT03917654|474472223|FG007|Year 2|Travel|1|||
131779356|NCT03917654|474472224|FG008|Year 2|Travel|0|||
131779357|NCT03917654|474472225|FG009|Year 2|Travel|1|||
131779358|NCT03917654|474472226|FG010|Year 2|Travel|0|||
131779359|NCT03917654|474472227|FG011|Year 2|Travel|1|||
131779360|NCT03917654|474472216|FG000|Year 2|Married|1|||
131779361|NCT03917654|474472217|FG001|Year 2|Married|0|||
131779362|NCT03917654|474472218|FG002|Year 2|Married|0|||
131779363|NCT03917654|474472219|FG003|Year 2|Married|0|||
131779364|NCT03917654|474472220|FG004|Year 2|Married|0|||
131779365|NCT03917654|474472221|FG005|Year 2|Married|0|||
131779366|NCT03917654|474472222|FG006|Year 2|Married|1|||
131779367|NCT03917654|474472223|FG007|Year 2|Married|1|||
131779368|NCT03917654|474472224|FG008|Year 2|Married|0|||
131779369|NCT03917654|474472225|FG009|Year 2|Married|0|||
131779370|NCT03917654|474472226|FG010|Year 2|Married|0|||
131779371|NCT03917654|474472227|FG011|Year 2|Married|0|||
131779372|NCT03917654|474472216|FG000|Year 2|Subject moved away from site|1|||
131779373|NCT03917654|474472217|FG001|Year 2|Subject moved away from site|0|||
131779374|NCT03917654|474472218|FG002|Year 2|Subject moved away from site|0|||
131779375|NCT03917654|474472219|FG003|Year 2|Subject moved away from site|0|||
131779376|NCT03917654|474472220|FG004|Year 2|Subject moved away from site|1|||
131779377|NCT03917654|474472221|FG005|Year 2|Subject moved away from site|0|||
131779378|NCT03917654|474472222|FG006|Year 2|Subject moved away from site|2|||
131779379|NCT03917654|474472223|FG007|Year 2|Subject moved away from site|3|||
131779380|NCT03917654|474472224|FG008|Year 2|Subject moved away from site|0|||
131779381|NCT03917654|474472225|FG009|Year 2|Subject moved away from site|2|||
131779382|NCT03917654|474472226|FG010|Year 2|Subject moved away from site|0|||
131779383|NCT03917654|474472227|FG011|Year 2|Subject moved away from site|1|||
131779384|NCT03917654|474472216|FG000|Year 2|Year 2 Screening failure|0|||
131779385|NCT03917654|474472217|FG001|Year 2|Year 2 Screening failure|1|||
131779386|NCT03917654|474472218|FG002|Year 2|Year 2 Screening failure|0|||
131779387|NCT03917654|474472219|FG003|Year 2|Year 2 Screening failure|0|||
131779388|NCT03917654|474472220|FG004|Year 2|Year 2 Screening failure|2|||
131779389|NCT03917654|474472221|FG005|Year 2|Year 2 Screening failure|0|||
131779390|NCT03917654|474472222|FG006|Year 2|Year 2 Screening failure|4|||
131694186|NCT00109707|474163500|FG001|Overall Study|Protocol Violation|0|||
131694187|NCT00109707|474163501|FG002|Overall Study|Protocol Violation|0|||
131694188|NCT00109707|474163499|FG000|Overall Study|Patient withdrew consent|6|||
131694189|NCT00109707|474163500|FG001|Overall Study|Patient withdrew consent|1|||
131694190|NCT00109707|474163501|FG002|Overall Study|Patient withdrew consent|0|||
131694191|NCT03436862|474163503|FG000|Overall Study|Adverse Event|4|||
131694192|NCT03436862|474163503|FG000|Overall Study|Progressive Disease|2|||
131694193|NCT00606086|474163504|FG000|Overall Study|Adverse Event|1|||
131694194|NCT00606086|474163505|FG001|Overall Study|Adverse Event|1|||
131694195|NCT00606086|474163504|FG000|Overall Study|Lost to Follow-up|4|||
131694196|NCT00606086|474163505|FG001|Overall Study|Lost to Follow-up|8|||
131694197|NCT00606086|474163504|FG000|Overall Study|Protocol Violation|1|||
131694198|NCT00606086|474163505|FG001|Overall Study|Protocol Violation|0|||
131694199|NCT00606086|474163504|FG000|Overall Study|Withdrawal by Subject|5|||
131694200|NCT00606086|474163505|FG001|Overall Study|Withdrawal by Subject|3|||
131694201|NCT00606086|474163504|FG000|Overall Study|Non-compliance|0|||
131694202|NCT00606086|474163505|FG001|Overall Study|Non-compliance|1|||
131694203|NCT00606086|474163504|FG000|Overall Study|Randomized, not treated|1|||
131694204|NCT00606086|474163505|FG001|Overall Study|Randomized, not treated|2|||
131694205|NCT00574275|474163508|FG000|Overall Study|Randomized but not treated|2|||
131694206|NCT00574275|474163509|FG001|Overall Study|Randomized but not treated|3|||
131694207|NCT00574275|474163508|FG000|Overall Study|Adverse Event|32|||
131694208|NCT00574275|474163509|FG001|Overall Study|Adverse Event|76|||
131694209|NCT00574275|474163508|FG000|Overall Study|Disease progression|160|||
131694210|NCT00574275|474163509|FG001|Overall Study|Disease progression|146|||
131694211|NCT00574275|474163508|FG000|Overall Study|Lost to Follow-up|2|||
131694212|NCT00574275|474163509|FG001|Overall Study|Lost to Follow-up|1|||
131694213|NCT00574275|474163508|FG000|Overall Study|Study stopped based on DMC decision|62|||
131694214|NCT00574275|474163509|FG001|Overall Study|Study stopped based on DMC decision|23|||
131694215|NCT00574275|474163508|FG000|Overall Study|Withdrawal by Subject|15|||
131694216|NCT00574275|474163509|FG001|Overall Study|Withdrawal by Subject|17|||
131694217|NCT00574275|474163508|FG000|Overall Study|Error calculating tumor measurement|1|||
131694218|NCT00574275|474163509|FG001|Overall Study|Error calculating tumor measurement|0|||
131694219|NCT00574275|474163508|FG000|Overall Study|Physician Decision|1|||
131694220|NCT00574275|474163509|FG001|Overall Study|Physician Decision|1|||
131694221|NCT00574275|474163508|FG000|Overall Study|Protocol Violation|0|||
131694222|NCT00574275|474163509|FG001|Overall Study|Protocol Violation|1|||
131694223|NCT00574275|474163508|FG000|Overall Study|Patient and Investigator decision|0|||
131694224|NCT00574275|474163509|FG001|Overall Study|Patient and Investigator decision|1|||
131694225|NCT00574275|474163508|FG000|Overall Study|Insurance change|0|||
131694226|NCT00574275|474163509|FG001|Overall Study|Insurance change|1|||
131694227|NCT00574275|474163508|FG000|Overall Study|Operation for curative intent|0|||
131694228|NCT00574275|474163509|FG001|Overall Study|Operation for curative intent|1|||
131694229|NCT03873714|474163511|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
131694230|NCT03028870|474163512|FG000|Overall Study|Adverse Event|7|||
131694231|NCT03028870|474163513|FG001|Overall Study|Adverse Event|4|||
131694232|NCT03028870|474163514|FG002|Overall Study|Adverse Event|3|||
131694233|NCT03028870|474163515|FG003|Overall Study|Adverse Event|3|||
131694234|NCT03028870|474163512|FG000|Overall Study|Withdrawal by Subject|1|||
131694235|NCT03028870|474163513|FG001|Overall Study|Withdrawal by Subject|1|||
131694236|NCT03028870|474163514|FG002|Overall Study|Withdrawal by Subject|1|||
131694237|NCT03028870|474163515|FG003|Overall Study|Withdrawal by Subject|2|||
131694238|NCT03028870|474163512|FG000|Overall Study|Lost to Follow-up|1|||
131694239|NCT03028870|474163513|FG001|Overall Study|Lost to Follow-up|0|||
131694240|NCT03028870|474163514|FG002|Overall Study|Lost to Follow-up|0|||
131694241|NCT03028870|474163515|FG003|Overall Study|Lost to Follow-up|0|||
131694242|NCT03028870|474163512|FG000|Overall Study|Lack of Efficacy|3|||
131694243|NCT03028870|474163513|FG001|Overall Study|Lack of Efficacy|0|||
131694244|NCT03028870|474163514|FG002|Overall Study|Lack of Efficacy|0|||
131694245|NCT03028870|474163515|FG003|Overall Study|Lack of Efficacy|0|||
131694246|NCT03028870|474163512|FG000|Overall Study|Administrative|5|||
131694247|NCT03028870|474163513|FG001|Overall Study|Administrative|5|||
131694248|NCT03028870|474163514|FG002|Overall Study|Administrative|12|||
131694249|NCT03028870|474163515|FG003|Overall Study|Administrative|4|||
131694250|NCT00708123|474163516|FG000|Period 1|Protocol Violation|0|||
131694251|NCT00708123|474163517|FG001|Period 1|Protocol Violation|1|||
131694252|NCT00708123|474163518|FG002|Period 1|Protocol Violation|0|||
131694253|NCT00708123|474163519|FG003|Period 1|Protocol Violation|1|||
131694254|NCT00708123|474163520|FG004|Period 1|Protocol Violation|0|||
131694255|NCT00708123|474163516|FG000|Period 1|Adverse Event|0|||
131694256|NCT00708123|474163517|FG001|Period 1|Adverse Event|0|||
131779391|NCT03917654|474472223|FG007|Year 2|Year 2 Screening failure|3|||
131694257|NCT00708123|474163518|FG002|Period 1|Adverse Event|1|||
131694258|NCT00708123|474163519|FG003|Period 1|Adverse Event|0|||
131694259|NCT00708123|474163520|FG004|Period 1|Adverse Event|0|||
131694260|NCT00708123|474163516|FG000|Period 2|Protocol Violation|0|||
131694261|NCT00708123|474163517|FG001|Period 2|Protocol Violation|0|||
131694262|NCT00708123|474163518|FG002|Period 2|Protocol Violation|0|||
131694263|NCT00708123|474163519|FG003|Period 2|Protocol Violation|1|||
131779392|NCT03917654|474472224|FG008|Year 2|Year 2 Screening failure|10|||
131779393|NCT03917654|474472225|FG009|Year 2|Year 2 Screening failure|2|||
131779394|NCT03917654|474472226|FG010|Year 2|Year 2 Screening failure|1|||
131779395|NCT03917654|474472227|FG011|Year 2|Year 2 Screening failure|1|||
131779396|NCT03917654|474472216|FG000|Year 2|Death|0|||
131779397|NCT03917654|474472217|FG001|Year 2|Death|0|||
131779398|NCT03917654|474472218|FG002|Year 2|Death|0|||
131779399|NCT03917654|474472219|FG003|Year 2|Death|0|||
131779400|NCT03917654|474472220|FG004|Year 2|Death|0|||
131779401|NCT03917654|474472221|FG005|Year 2|Death|1|||
131779402|NCT03917654|474472222|FG006|Year 2|Death|0|||
131779403|NCT03917654|474472223|FG007|Year 2|Death|0|||
131779404|NCT03917654|474472224|FG008|Year 2|Death|1|||
131779405|NCT03917654|474472225|FG009|Year 2|Death|1|||
131779406|NCT03917654|474472226|FG010|Year 2|Death|0|||
131779407|NCT03917654|474472227|FG011|Year 2|Death|0|||
131779408|NCT03917654|474472216|FG000|Year 2|Withdrawal by Subject|0|||
131779409|NCT03917654|474472217|FG001|Year 2|Withdrawal by Subject|0|||
131779410|NCT03917654|474472218|FG002|Year 2|Withdrawal by Subject|0|||
131779411|NCT03917654|474472219|FG003|Year 2|Withdrawal by Subject|0|||
131779412|NCT03917654|474472220|FG004|Year 2|Withdrawal by Subject|0|||
131779413|NCT03917654|474472221|FG005|Year 2|Withdrawal by Subject|0|||
131779414|NCT03917654|474472222|FG006|Year 2|Withdrawal by Subject|3|||
131779415|NCT03917654|474472223|FG007|Year 2|Withdrawal by Subject|0|||
131779416|NCT03917654|474472224|FG008|Year 2|Withdrawal by Subject|2|||
131779417|NCT03917654|474472225|FG009|Year 2|Withdrawal by Subject|5|||
131779418|NCT03917654|474472226|FG010|Year 2|Withdrawal by Subject|0|||
131779419|NCT03917654|474472227|FG011|Year 2|Withdrawal by Subject|0|||
131779420|NCT03917654|474472216|FG000|Year 2|Spouse/family member request|0|||
131779421|NCT03917654|474472217|FG001|Year 2|Spouse/family member request|0|||
131779422|NCT03917654|474472218|FG002|Year 2|Spouse/family member request|0|||
131779423|NCT03917654|474472219|FG003|Year 2|Spouse/family member request|0|||
131779424|NCT03917654|474472220|FG004|Year 2|Spouse/family member request|0|||
131779425|NCT03917654|474472221|FG005|Year 2|Spouse/family member request|0|||
131779426|NCT03917654|474472222|FG006|Year 2|Spouse/family member request|1|||
131779427|NCT03917654|474472223|FG007|Year 2|Spouse/family member request|0|||
131779428|NCT03917654|474472224|FG008|Year 2|Spouse/family member request|0|||
131779429|NCT03917654|474472225|FG009|Year 2|Spouse/family member request|0|||
131779430|NCT03917654|474472226|FG010|Year 2|Spouse/family member request|0|||
131779431|NCT03917654|474472227|FG011|Year 2|Spouse/family member request|0|||
131779432|NCT03917654|474472216|FG000|Year 2|Lost to Follow-up|0|||
131779433|NCT03917654|474472217|FG001|Year 2|Lost to Follow-up|0|||
131779434|NCT03917654|474472218|FG002|Year 2|Lost to Follow-up|0|||
131779435|NCT03917654|474472219|FG003|Year 2|Lost to Follow-up|0|||
131779436|NCT03917654|474472220|FG004|Year 2|Lost to Follow-up|0|||
131779437|NCT03917654|474472221|FG005|Year 2|Lost to Follow-up|0|||
131779438|NCT03917654|474472222|FG006|Year 2|Lost to Follow-up|1|||
131779439|NCT03917654|474472223|FG007|Year 2|Lost to Follow-up|0|||
131779440|NCT03917654|474472224|FG008|Year 2|Lost to Follow-up|1|||
131779441|NCT03917654|474472225|FG009|Year 2|Lost to Follow-up|0|||
131779442|NCT03917654|474472226|FG010|Year 2|Lost to Follow-up|0|||
131779443|NCT03917654|474472227|FG011|Year 2|Lost to Follow-up|1|||
131779444|NCT03917654|474472216|FG000|Year 2|Adverse Event|0|||
131779445|NCT03917654|474472217|FG001|Year 2|Adverse Event|0|||
131779446|NCT03917654|474472218|FG002|Year 2|Adverse Event|0|||
131779447|NCT03917654|474472219|FG003|Year 2|Adverse Event|0|||
131779448|NCT03917654|474472220|FG004|Year 2|Adverse Event|0|||
131779449|NCT03917654|474472221|FG005|Year 2|Adverse Event|0|||
131779450|NCT03917654|474472222|FG006|Year 2|Adverse Event|0|||
131779451|NCT03917654|474472223|FG007|Year 2|Adverse Event|0|||
131779452|NCT03917654|474472224|FG008|Year 2|Adverse Event|0|||
131779453|NCT03917654|474472225|FG009|Year 2|Adverse Event|1|||
131779454|NCT03917654|474472226|FG010|Year 2|Adverse Event|0|||
131779455|NCT03917654|474472227|FG011|Year 2|Adverse Event|0|||
131779456|NCT03728257|474472228|FG000|Overall Study|Death|3|||
131779457|NCT03728257|474472229|FG001|Overall Study|Death|0|||
131779458|NCT00905437|474472232|FG000|Overall Study|Adverse Event|3|||
131779459|NCT00905437|474472233|FG001|Overall Study|Adverse Event|2|||
131779460|NCT00905437|474472232|FG000|Overall Study|Lost to Follow-up|0|||
131779461|NCT00905437|474472233|FG001|Overall Study|Lost to Follow-up|1|||
131779462|NCT00905437|474472232|FG000|Overall Study|Withdrawal by Subject|0|||
131779463|NCT00905437|474472233|FG001|Overall Study|Withdrawal by Subject|1|||
131779464|NCT00905437|474472232|FG000|Overall Study|Other|5|||
131779465|NCT00905437|474472233|FG001|Overall Study|Other|6|||
131779466|NCT01306968|474472236|FG000|Overall Study|Lost to Follow-up|1|||
131779467|NCT01306968|474472237|FG001|Overall Study|Lost to Follow-up|1|||
131779468|NCT01306968|474472238|FG002|Overall Study|Lost to Follow-up|0|||
131779469|NCT01306968|474472239|FG003|Overall Study|Lost to Follow-up|0|||
131779470|NCT01306968|474472236|FG000|Overall Study|Physician Decision|0|||
131779471|NCT01306968|474472237|FG001|Overall Study|Physician Decision|1|||
131779472|NCT01306968|474472238|FG002|Overall Study|Physician Decision|0|||
131779473|NCT01306968|474472239|FG003|Overall Study|Physician Decision|0|||
131779474|NCT01306968|474472236|FG000|Overall Study|Relocated and left active duty|0|||
131779475|NCT01306968|474472237|FG001|Overall Study|Relocated and left active duty|1|||
131694264|NCT00708123|474163520|FG004|Period 2|Protocol Violation|0|||
131694265|NCT00708123|474163516|FG000|Period 2|Other Reason|1|||
131694266|NCT00708123|474163517|FG001|Period 2|Other Reason|0|||
131694267|NCT00708123|474163518|FG002|Period 2|Other Reason|0|||
131694268|NCT00708123|474163519|FG003|Period 2|Other Reason|0|||
131694269|NCT00708123|474163520|FG004|Period 2|Other Reason|0|||
131694270|NCT00708123|474163516|FG000|Period 3|Lost to Follow-up|0|||
131694271|NCT00708123|474163517|FG001|Period 3|Lost to Follow-up|0|||
131694272|NCT00708123|474163518|FG002|Period 3|Lost to Follow-up|1|||
131694273|NCT00708123|474163519|FG003|Period 3|Lost to Follow-up|1|||
131694274|NCT00708123|474163520|FG004|Period 3|Lost to Follow-up|0|||
131694275|NCT00708123|474163516|FG000|Period 4|Protocol Violation|0|||
131694276|NCT00708123|474163517|FG001|Period 4|Protocol Violation|1|||
131694277|NCT00708123|474163518|FG002|Period 4|Protocol Violation|0|||
131694278|NCT00708123|474163519|FG003|Period 4|Protocol Violation|0|||
131694279|NCT00708123|474163520|FG004|Period 4|Protocol Violation|0|||
131694280|NCT01883635|474163521|FG000|Overall Study|Withdrawal by Subject|4|||
131694281|NCT01883635|474163522|FG001|Overall Study|Withdrawal by Subject|0|||
131694282|NCT01464307|474163523|FG000|Main Period|Death|0|||
131694283|NCT01464307|474163524|FG001|Main Period|Death|1|||
131694284|NCT01464307|474163523|FG000|Main Period|Adverse Event|6|||
131694285|NCT01464307|474163524|FG001|Main Period|Adverse Event|1|||
131694286|NCT01464307|474163523|FG000|Main Period|Lack of Efficacy|2|||
131694287|NCT01464307|474163524|FG001|Main Period|Lack of Efficacy|0|||
131694288|NCT01464307|474163523|FG000|Main Period|Withdrawal by Subject|5|||
131694289|NCT01464307|474163524|FG001|Main Period|Withdrawal by Subject|2|||
131694290|NCT01464307|474163523|FG000|Main Period|Predefined discontinuation criteria|2|||
131694291|NCT01464307|474163524|FG001|Main Period|Predefined discontinuation criteria|1|||
131694292|NCT01464307|474163523|FG000|Open-Label Extension Period|Adverse Event|15|||
131694293|NCT01464307|474163524|FG001|Open-Label Extension Period|Adverse Event|0|||
131694294|NCT01464307|474163523|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
131694295|NCT01464307|474163524|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
131694296|NCT01464307|474163523|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
131694297|NCT01464307|474163524|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
131694298|NCT01464307|474163523|FG000|Open-Label Extension Period|Death|1|||
131694299|NCT01464307|474163524|FG001|Open-Label Extension Period|Death|0|||
131694300|NCT01464307|474163523|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
131694301|NCT01464307|474163524|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
131694302|NCT01464307|474163523|FG000|Open-Label Extension Period|Non-compliance|9|||
131694303|NCT01464307|474163524|FG001|Open-Label Extension Period|Non-compliance|0|||
131694304|NCT01464307|474163523|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
131694305|NCT01464307|474163524|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
131694306|NCT00761514|474163525|FG000|Overall Study|Adverse Event|1|||
131694307|NCT00761514|474163525|FG000|Overall Study|Withdrawal by Subject|2|||
131694308|NCT00761514|474163525|FG000|Overall Study|Lost to Follow-up|1|||
131694309|NCT00761514|474163525|FG000|Overall Study|Health insurance didn't cover study drug|1|||
131694310|NCT00761514|474163525|FG000|Overall Study|Problem complying with study visit|1|||
131694311|NCT00761514|474163525|FG000|Overall Study|Unable to pay for medications|1|||
131694312|NCT04942925|474163526|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
131694313|NCT04942925|474163527|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
131694314|NCT04942925|474163526|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
131694315|NCT04942925|474163527|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
131694316|NCT01273883|474163528|FG000|First Intervention|Adverse Event|2|||
131694317|NCT01273883|474163529|FG001|First Intervention|Adverse Event|1|||
131694318|NCT01273883|474163528|FG000|Second Intervention|Lost to Follow-up|1|||
131694319|NCT01273883|474163529|FG001|Second Intervention|Lost to Follow-up|1|||
131694320|NCT01273883|474163528|FG000|Second Intervention|Lack of Efficacy|1|||
131694321|NCT01273883|474163529|FG001|Second Intervention|Lack of Efficacy|0|||
131694322|NCT03885089|474163533|FG000|Overall Study|No informed consent for publication of study results|2|||
131694323|NCT01430455|474163541|FG000|Overall Study|Withdrawal by Subject|1|||
131694324|NCT01430455|474163541|FG000|Overall Study|Switched to follow-up phase|1|||
131694325|NCT01425008|474163543|FG000|Dose Escalation Phase|Progressive Disease|2|||
131694326|NCT01425008|474163544|FG001|Dose Escalation Phase|Progressive Disease|3|||
131694327|NCT01425008|474163545|FG002|Dose Escalation Phase|Progressive Disease|2|||
131694328|NCT01425008|474163546|FG003|Dose Escalation Phase|Progressive Disease|3|||
131694329|NCT01425008|474163547|FG004|Dose Escalation Phase|Progressive Disease|5|||
131694330|NCT01425008|474163548|FG005|Dose Escalation Phase|Progressive Disease|4|||
131694331|NCT01425008|474163549|FG006|Dose Escalation Phase|Progressive Disease|0|||
131694332|NCT01425008|474163550|FG007|Dose Escalation Phase|Progressive Disease|2|||
131694333|NCT01425008|474163551|FG008|Dose Escalation Phase|Progressive Disease|6|||
131694334|NCT01425008|474163552|FG009|Dose Escalation Phase|Progressive Disease|2|||
131694335|NCT01425008|474163553|FG010|Dose Escalation Phase|Progressive Disease|0|||
131694336|NCT01425008|474163554|FG011|Dose Escalation Phase|Progressive Disease|0|||
131694337|NCT01425008|474163555|FG012|Dose Escalation Phase|Progressive Disease|0|||
131694338|NCT01425008|474163556|FG013|Dose Escalation Phase|Progressive Disease|0|||
131694339|NCT01425008|474163557|FG014|Dose Escalation Phase|Progressive Disease|0|||
131559629|NCT01146574|473673993|FG003|Overall Study|Kidney transplant|1|||
131559630|NCT01146574|473673994|FG004|Overall Study|Kidney transplant|0|||
131559631|NCT01146574|473673995|FG005|Overall Study|Kidney transplant|0|||
131559632|NCT01146574|473673996|FG006|Overall Study|Kidney transplant|0|||
131559633|NCT01146574|473673990|FG000|Overall Study|Withdrew consent|0|||
131559634|NCT01146574|473673991|FG001|Overall Study|Withdrew consent|0|||
131559635|NCT01146574|473673992|FG002|Overall Study|Withdrew consent|1|||
131559636|NCT01146574|473673993|FG003|Overall Study|Withdrew consent|1|||
131559637|NCT01146574|473673994|FG004|Overall Study|Withdrew consent|2|||
131559638|NCT01146574|473673995|FG005|Overall Study|Withdrew consent|1|||
131694340|NCT01425008|474163558|FG015|Dose Escalation Phase|Progressive Disease|0|||
131694341|NCT01425008|474163559|FG016|Dose Escalation Phase|Progressive Disease|0|||
131694342|NCT01425008|474163560|FG017|Dose Escalation Phase|Progressive Disease|0|||
131694343|NCT01425008|474163561|FG018|Dose Escalation Phase|Progressive Disease|0|||
131694344|NCT01425008|474163543|FG000|Dose Escalation Phase|Adverse Event|2|||
131694345|NCT01425008|474163544|FG001|Dose Escalation Phase|Adverse Event|0|||
131694346|NCT01425008|474163545|FG002|Dose Escalation Phase|Adverse Event|0|||
131694347|NCT01425008|474163546|FG003|Dose Escalation Phase|Adverse Event|0|||
131694348|NCT01425008|474163547|FG004|Dose Escalation Phase|Adverse Event|0|||
131694349|NCT01425008|474163548|FG005|Dose Escalation Phase|Adverse Event|2|||
131694350|NCT01425008|474163549|FG006|Dose Escalation Phase|Adverse Event|0|||
131694351|NCT01425008|474163550|FG007|Dose Escalation Phase|Adverse Event|0|||
131694352|NCT01425008|474163551|FG008|Dose Escalation Phase|Adverse Event|2|||
131694353|NCT01425008|474163552|FG009|Dose Escalation Phase|Adverse Event|0|||
131694354|NCT01425008|474163553|FG010|Dose Escalation Phase|Adverse Event|0|||
131694355|NCT01425008|474163554|FG011|Dose Escalation Phase|Adverse Event|0|||
131694356|NCT01425008|474163555|FG012|Dose Escalation Phase|Adverse Event|0|||
131694357|NCT01425008|474163556|FG013|Dose Escalation Phase|Adverse Event|0|||
131694358|NCT01425008|474163557|FG014|Dose Escalation Phase|Adverse Event|0|||
131694359|NCT01425008|474163558|FG015|Dose Escalation Phase|Adverse Event|0|||
131694360|NCT01425008|474163559|FG016|Dose Escalation Phase|Adverse Event|0|||
131694361|NCT01425008|474163560|FG017|Dose Escalation Phase|Adverse Event|0|||
131694362|NCT01425008|474163561|FG018|Dose Escalation Phase|Adverse Event|0|||
131694363|NCT01425008|474163543|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694364|NCT01425008|474163544|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694365|NCT01425008|474163545|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694366|NCT01425008|474163546|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694367|NCT01425008|474163547|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131694368|NCT01425008|474163548|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694369|NCT01425008|474163549|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
131694370|NCT01425008|474163550|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131694371|NCT01425008|474163551|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131694372|NCT01425008|474163552|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694373|NCT01425008|474163553|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694374|NCT01425008|474163554|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694375|NCT01425008|474163555|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694376|NCT01425008|474163556|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694377|NCT01425008|474163557|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694378|NCT01425008|474163558|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694379|NCT01425008|474163559|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694380|NCT01425008|474163560|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694381|NCT01425008|474163561|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131694382|NCT01425008|474163543|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131694383|NCT01425008|474163544|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131694384|NCT01425008|474163545|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131694385|NCT01425008|474163546|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131694386|NCT01425008|474163547|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
131694387|NCT01425008|474163548|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
131694388|NCT01425008|474163549|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
131694389|NCT01425008|474163550|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
131694390|NCT01425008|474163551|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
131694391|NCT01425008|474163552|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
131559639|NCT01146574|473673996|FG006|Overall Study|Withdrew consent|1|||
131694392|NCT01425008|474163553|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
131694393|NCT01425008|474163554|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
131694394|NCT01425008|474163555|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
131694395|NCT01425008|474163556|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
131694396|NCT01425008|474163557|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
131694397|NCT01425008|474163558|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
131559640|NCT03051659|473673999|FG000|Treatment Period|Withdrawal by Subject|0|||
131559641|NCT03051659|473674000|FG001|Treatment Period|Withdrawal by Subject|2|||
131559642|NCT03051659|473673999|FG000|Survival Follow-up|Lost to Follow-up|23|||
131559643|NCT03051659|473674000|FG001|Survival Follow-up|Lost to Follow-up|22|||
131559644|NCT01266993|473674001|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
131559645|NCT01266993|473674002|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
131559646|NCT01266993|473674001|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
131559647|NCT01266993|473674002|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
131559648|NCT02293837|473674003|FG000|Overall Study|Lost to Follow-up|0|||
131559649|NCT02293837|473674004|FG001|Overall Study|Lost to Follow-up|2|||
131559650|NCT02293837|473674005|FG002|Overall Study|Lost to Follow-up|1|||
131559651|NCT02293837|473674006|FG003|Overall Study|Lost to Follow-up|0|||
131559652|NCT02293837|473674003|FG000|Overall Study|Withdrawal by Subject|2|||
131559653|NCT02293837|473674004|FG001|Overall Study|Withdrawal by Subject|1|||
131559654|NCT02293837|473674005|FG002|Overall Study|Withdrawal by Subject|2|||
131559655|NCT02293837|473674006|FG003|Overall Study|Withdrawal by Subject|1|||
131559656|NCT02293837|473674003|FG000|Overall Study|COVID-19 Related|1|||
131559657|NCT02293837|473674004|FG001|Overall Study|COVID-19 Related|1|||
131559658|NCT02293837|473674005|FG002|Overall Study|COVID-19 Related|0|||
131694398|NCT01425008|474163559|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
131694399|NCT01425008|474163560|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
131694400|NCT01425008|474163561|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
131694401|NCT01425008|474163543|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694402|NCT01425008|474163544|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694403|NCT01425008|474163545|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
131694404|NCT01425008|474163546|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694405|NCT01425008|474163547|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694406|NCT01425008|474163548|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694407|NCT01425008|474163549|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694408|NCT01425008|474163550|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694409|NCT01425008|474163551|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
131694410|NCT01425008|474163552|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
131694411|NCT01425008|474163553|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694412|NCT01425008|474163554|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694413|NCT01425008|474163555|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694414|NCT01425008|474163556|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694415|NCT01425008|474163557|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694416|NCT01425008|474163558|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694417|NCT01425008|474163559|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694418|NCT01425008|474163560|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694419|NCT01425008|474163561|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
131694420|NCT01425008|474163543|FG000|Dose Escalation Phase|Other|0|||
131694421|NCT01425008|474163544|FG001|Dose Escalation Phase|Other|0|||
131694422|NCT01425008|474163545|FG002|Dose Escalation Phase|Other|0|||
131694423|NCT01425008|474163546|FG003|Dose Escalation Phase|Other|0|||
131694424|NCT01425008|474163547|FG004|Dose Escalation Phase|Other|0|||
131694425|NCT01425008|474163548|FG005|Dose Escalation Phase|Other|0|||
131694426|NCT01425008|474163549|FG006|Dose Escalation Phase|Other|0|||
131694427|NCT01425008|474163550|FG007|Dose Escalation Phase|Other|0|||
131694428|NCT01425008|474163551|FG008|Dose Escalation Phase|Other|1|||
131694429|NCT01425008|474163552|FG009|Dose Escalation Phase|Other|0|||
131694430|NCT01425008|474163553|FG010|Dose Escalation Phase|Other|0|||
131694431|NCT01425008|474163554|FG011|Dose Escalation Phase|Other|0|||
131694432|NCT01425008|474163555|FG012|Dose Escalation Phase|Other|0|||
131694433|NCT01425008|474163556|FG013|Dose Escalation Phase|Other|0|||
131694434|NCT01425008|474163557|FG014|Dose Escalation Phase|Other|0|||
131694435|NCT01425008|474163558|FG015|Dose Escalation Phase|Other|0|||
131694436|NCT01425008|474163559|FG016|Dose Escalation Phase|Other|0|||
131694437|NCT01425008|474163560|FG017|Dose Escalation Phase|Other|0|||
131694438|NCT01425008|474163561|FG018|Dose Escalation Phase|Other|0|||
131694439|NCT01425008|474163543|FG000|Dose Expansion Phase|Progressive Disease|0|||
131559659|NCT02293837|473674006|FG003|Overall Study|COVID-19 Related|0|||
131559660|NCT02293837|473674003|FG000|Overall Study|Participant ill and could not be infused|0|||
131559661|NCT02293837|473674004|FG001|Overall Study|Participant ill and could not be infused|0|||
131694440|NCT01425008|474163544|FG001|Dose Expansion Phase|Progressive Disease|0|||
131694441|NCT01425008|474163545|FG002|Dose Expansion Phase|Progressive Disease|0|||
131694442|NCT01425008|474163546|FG003|Dose Expansion Phase|Progressive Disease|0|||
131694443|NCT01425008|474163547|FG004|Dose Expansion Phase|Progressive Disease|0|||
131694444|NCT01425008|474163548|FG005|Dose Expansion Phase|Progressive Disease|0|||
131694445|NCT01425008|474163549|FG006|Dose Expansion Phase|Progressive Disease|0|||
131694446|NCT01425008|474163550|FG007|Dose Expansion Phase|Progressive Disease|0|||
131694447|NCT01425008|474163551|FG008|Dose Expansion Phase|Progressive Disease|0|||
131694448|NCT01425008|474163552|FG009|Dose Expansion Phase|Progressive Disease|0|||
131694449|NCT01425008|474163553|FG010|Dose Expansion Phase|Progressive Disease|10|||
131559662|NCT02293837|473674005|FG002|Overall Study|Participant ill and could not be infused|1|||
131694450|NCT01425008|474163554|FG011|Dose Expansion Phase|Progressive Disease|4|||
131559663|NCT02293837|473674006|FG003|Overall Study|Participant ill and could not be infused|0|||
131694451|NCT01425008|474163555|FG012|Dose Expansion Phase|Progressive Disease|12|||
131694452|NCT01425008|474163556|FG013|Dose Expansion Phase|Progressive Disease|1|||
131694453|NCT01425008|474163557|FG014|Dose Expansion Phase|Progressive Disease|5|||
131694454|NCT01425008|474163558|FG015|Dose Expansion Phase|Progressive Disease|8|||
131694455|NCT01425008|474163559|FG016|Dose Expansion Phase|Progressive Disease|9|||
131694456|NCT01425008|474163560|FG017|Dose Expansion Phase|Progressive Disease|2|||
131694457|NCT01425008|474163561|FG018|Dose Expansion Phase|Progressive Disease|10|||
131694458|NCT01425008|474163543|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
131694459|NCT01425008|474163544|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
131694460|NCT01425008|474163545|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
131779476|NCT01306968|474472238|FG002|Overall Study|Relocated and left active duty|1|||
131779477|NCT01306968|474472239|FG003|Overall Study|Relocated and left active duty|1|||
131779478|NCT01306968|474472236|FG000|Overall Study|Withdrew - time commitment|0|||
131779479|NCT01306968|474472237|FG001|Overall Study|Withdrew - time commitment|0|||
131779480|NCT01306968|474472238|FG002|Overall Study|Withdrew - time commitment|0|||
131779481|NCT01306968|474472239|FG003|Overall Study|Withdrew - time commitment|2|||
131779482|NCT01306968|474472236|FG000|Overall Study|Withdrew over privacy concerns|0|||
131779483|NCT01306968|474472237|FG001|Overall Study|Withdrew over privacy concerns|0|||
131779484|NCT01306968|474472238|FG002|Overall Study|Withdrew over privacy concerns|0|||
131779485|NCT01306968|474472239|FG003|Overall Study|Withdrew over privacy concerns|1|||
131779486|NCT01329562|474472242|FG000|Overall Study|Protocol Violation|5|||
131779487|NCT01329562|474472243|FG001|Overall Study|Protocol Violation|3|||
131779488|NCT01329562|474472242|FG000|Overall Study|Lost to Follow-up|1|||
131779489|NCT01329562|474472243|FG001|Overall Study|Lost to Follow-up|1|||
131779490|NCT01329562|474472242|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
131779491|NCT01329562|474472243|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
131779492|NCT01329562|474472242|FG000|Overall Study|Physician Decision|0|||
131779493|NCT01329562|474472243|FG001|Overall Study|Physician Decision|1|||
131779494|NCT03128931|474472244|FG000|Overall Study|Physician Decision|1|||
131779495|NCT03128931|474472244|FG000|Overall Study|Equipment Issues|3|||
131779496|NCT03252015|474472245|FG000|Overall Study|Withdrawal by Subject|0|||
131779497|NCT03252015|474472246|FG001|Overall Study|Withdrawal by Subject|1|||
131779498|NCT03252015|474472247|FG002|Overall Study|Withdrawal by Subject|1|||
131779499|NCT03252015|474472248|FG003|Overall Study|Withdrawal by Subject|0|||
131779500|NCT03252015|474472245|FG000|Overall Study|Adverse Event|1|||
131779501|NCT03252015|474472246|FG001|Overall Study|Adverse Event|0|||
131779502|NCT03252015|474472247|FG002|Overall Study|Adverse Event|0|||
131779503|NCT03252015|474472248|FG003|Overall Study|Adverse Event|1|||
131779504|NCT04993339|474472249|FG000|Overall Study|Lost to Follow-up|0|||
131779505|NCT04993339|474472250|FG001|Overall Study|Lost to Follow-up|1|||
131779506|NCT04993339|474472249|FG000|Overall Study|no MRI scan|3|||
131779507|NCT04993339|474472250|FG001|Overall Study|no MRI scan|1|||
131779508|NCT00061568|474472253|FG000|Overall Study|Lost to Follow-up|12|||
131779509|NCT00061568|474472254|FG001|Overall Study|Lost to Follow-up|0|||
131779510|NCT00061568|474472253|FG000|Overall Study|Death|6|||
131779511|NCT00061568|474472254|FG001|Overall Study|Death|0|||
131779512|NCT00061568|474472253|FG000|Overall Study|Withdrawal by Subject|1|||
131779513|NCT00061568|474472254|FG001|Overall Study|Withdrawal by Subject|0|||
131779514|NCT01381068|474472255|FG000|Overall Study|Death|1|||
131779515|NCT01381068|474472256|FG001|Overall Study|Death|0|||
131779516|NCT01071278|474472260|FG000|Overall Study|Premature Discontinuation|254|||
131779517|NCT01071278|474472260|FG000|Overall Study|Completion Status Unknown|459|||
131779518|NCT00903409|474472261|FG000|Overall Study|Adverse Event|11|||
131779519|NCT00903409|474472262|FG001|Overall Study|Adverse Event|9|||
131559664|NCT04779242|473674007|FG000|Overall Study|Adverse Event|1|||
131779520|NCT00903409|474472261|FG000|Overall Study|Non-compliance with Protocol|1|||
131779521|NCT00903409|474472262|FG001|Overall Study|Non-compliance with Protocol|1|||
131779522|NCT00903409|474472261|FG000|Overall Study|Laboratory Abnormality|2|||
131779523|NCT00903409|474472262|FG001|Overall Study|Laboratory Abnormality|0|||
131779524|NCT00903409|474472261|FG000|Overall Study|Withdrawal by Subject|8|||
131779525|NCT00903409|474472262|FG001|Overall Study|Withdrawal by Subject|8|||
131779526|NCT00903409|474472261|FG000|Overall Study|Other|2|||
131779527|NCT00903409|474472262|FG001|Overall Study|Other|3|||
131779528|NCT00903409|474472261|FG000|Overall Study|Lost to Follow-up|2|||
131779529|NCT00903409|474472262|FG001|Overall Study|Lost to Follow-up|6|||
131779530|NCT03868059|474472266|FG000|Overall Study|Adverse Event|3|||
131779531|NCT03868059|474472266|FG000|Overall Study|Lost to Follow-up|3|||
131559665|NCT04779242|473674008|FG001|Overall Study|Adverse Event|1|||
131779532|NCT03868059|474472266|FG000|Overall Study|Withdrawal by Subject|6|||
131779533|NCT02061293|474472267|FG000|Overall Study|Elevated Blood Pressure|1|||
131779534|NCT02061293|474472268|FG001|Overall Study|Elevated Blood Pressure|1|||
131779535|NCT00690573|474472279|FG000|Overall Study|Lack of Efficacy|8|||
131779536|NCT00690573|474472279|FG000|Overall Study|Withdrawal by Subject|1|||
131694461|NCT01425008|474163546|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
131694462|NCT01425008|474163547|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
131559666|NCT04779242|473674007|FG000|Overall Study|Lost to Follow-up|2|||
131559667|NCT04779242|473674008|FG001|Overall Study|Lost to Follow-up|4|||
131694463|NCT01425008|474163548|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
131694464|NCT01425008|474163549|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
131694465|NCT01425008|474163550|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
131694466|NCT01425008|474163551|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
131694467|NCT01425008|474163552|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
131694468|NCT01425008|474163553|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
131694469|NCT01425008|474163554|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
131694470|NCT01425008|474163555|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
131694471|NCT01425008|474163556|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
131694472|NCT01425008|474163557|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
131694473|NCT01425008|474163558|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
131694474|NCT01425008|474163559|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
131694475|NCT01425008|474163560|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
131694476|NCT01425008|474163561|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
131694477|NCT01425008|474163543|FG000|Dose Expansion Phase|Other|0|||
131694478|NCT01425008|474163544|FG001|Dose Expansion Phase|Other|0|||
131694479|NCT01425008|474163545|FG002|Dose Expansion Phase|Other|0|||
131694480|NCT01425008|474163546|FG003|Dose Expansion Phase|Other|0|||
131694481|NCT01425008|474163547|FG004|Dose Expansion Phase|Other|0|||
131694482|NCT01425008|474163548|FG005|Dose Expansion Phase|Other|0|||
131694483|NCT01425008|474163549|FG006|Dose Expansion Phase|Other|0|||
131694484|NCT01425008|474163550|FG007|Dose Expansion Phase|Other|0|||
131694485|NCT01425008|474163551|FG008|Dose Expansion Phase|Other|0|||
131694486|NCT01425008|474163552|FG009|Dose Expansion Phase|Other|0|||
131694487|NCT01425008|474163553|FG010|Dose Expansion Phase|Other|0|||
131694488|NCT01425008|474163554|FG011|Dose Expansion Phase|Other|0|||
131694489|NCT01425008|474163555|FG012|Dose Expansion Phase|Other|1|||
131694490|NCT01425008|474163556|FG013|Dose Expansion Phase|Other|0|||
131694491|NCT01425008|474163557|FG014|Dose Expansion Phase|Other|0|||
131694492|NCT01425008|474163558|FG015|Dose Expansion Phase|Other|0|||
131694493|NCT01425008|474163559|FG016|Dose Expansion Phase|Other|2|||
131694494|NCT01425008|474163560|FG017|Dose Expansion Phase|Other|0|||
131694495|NCT01425008|474163561|FG018|Dose Expansion Phase|Other|4|||
131694496|NCT01425008|474163543|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694497|NCT01425008|474163544|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694498|NCT01425008|474163545|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694499|NCT01425008|474163546|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694500|NCT01425008|474163547|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694501|NCT01425008|474163548|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694502|NCT01425008|474163549|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694503|NCT01425008|474163550|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694504|NCT01425008|474163551|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694505|NCT01425008|474163552|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694506|NCT01425008|474163553|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
131694507|NCT01425008|474163554|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
131694508|NCT01425008|474163555|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694509|NCT01425008|474163556|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694510|NCT01425008|474163557|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694511|NCT01425008|474163558|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
131694512|NCT01425008|474163559|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
131694513|NCT01425008|474163560|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
131694514|NCT01425008|474163561|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
131694515|NCT01425008|474163543|FG000|Dose Expansion Phase|Adverse Event|0|||
131694516|NCT01425008|474163544|FG001|Dose Expansion Phase|Adverse Event|0|||
131694517|NCT01425008|474163545|FG002|Dose Expansion Phase|Adverse Event|0|||
131694518|NCT01425008|474163546|FG003|Dose Expansion Phase|Adverse Event|0|||
131694519|NCT01425008|474163547|FG004|Dose Expansion Phase|Adverse Event|0|||
131694520|NCT01425008|474163548|FG005|Dose Expansion Phase|Adverse Event|0|||
131694521|NCT01425008|474163549|FG006|Dose Expansion Phase|Adverse Event|0|||
131694522|NCT01425008|474163550|FG007|Dose Expansion Phase|Adverse Event|0|||
131559668|NCT04779242|473674007|FG000|Overall Study|Withdrawal by Subject|7|||
131694523|NCT01425008|474163551|FG008|Dose Expansion Phase|Adverse Event|0|||
131694524|NCT01425008|474163552|FG009|Dose Expansion Phase|Adverse Event|0|||
131559669|NCT04779242|473674008|FG001|Overall Study|Withdrawal by Subject|9|||
131694525|NCT01425008|474163553|FG010|Dose Expansion Phase|Adverse Event|2|||
131694526|NCT01425008|474163554|FG011|Dose Expansion Phase|Adverse Event|3|||
131694527|NCT01425008|474163555|FG012|Dose Expansion Phase|Adverse Event|3|||
131694528|NCT01425008|474163556|FG013|Dose Expansion Phase|Adverse Event|0|||
131694529|NCT01425008|474163557|FG014|Dose Expansion Phase|Adverse Event|1|||
131694530|NCT01425008|474163558|FG015|Dose Expansion Phase|Adverse Event|1|||
131694531|NCT01425008|474163559|FG016|Dose Expansion Phase|Adverse Event|5|||
131694532|NCT01425008|474163560|FG017|Dose Expansion Phase|Adverse Event|0|||
131779537|NCT00909857|474472280|FG000|Overall Study|Withdrawal by Subject|6|||
131779538|NCT00909857|474472281|FG001|Overall Study|Withdrawal by Subject|10|||
131779539|NCT00909857|474472280|FG000|Overall Study|Adverse Event|5|||
131779540|NCT00909857|474472281|FG001|Overall Study|Adverse Event|5|||
131779541|NCT00909857|474472280|FG000|Overall Study|Lost to Follow-up|2|||
131779542|NCT00909857|474472281|FG001|Overall Study|Lost to Follow-up|5|||
131779543|NCT00909857|474472280|FG000|Overall Study|Protocol Violation|2|||
131779544|NCT00909857|474472281|FG001|Overall Study|Protocol Violation|1|||
131779545|NCT00909857|474472280|FG000|Overall Study|Pregnancy|1|||
131779546|NCT00909857|474472281|FG001|Overall Study|Pregnancy|0|||
131779547|NCT00909857|474472280|FG000|Overall Study|Other|1|||
131779548|NCT00909857|474472281|FG001|Overall Study|Other|0|||
131779549|NCT00909857|474472280|FG000|Overall Study|Did not receive study medication|19|||
131779550|NCT00909857|474472281|FG001|Overall Study|Did not receive study medication|24|||
131779551|NCT03878108|474472282|FG000|Overall Study|Adverse Event|1|||
131779552|NCT03878108|474472283|FG001|Overall Study|Adverse Event|0|||
131779553|NCT01682681|474472284|FG000|Overall Study|Lack of Efficacy|62|||
131779554|NCT01682681|474472284|FG000|Overall Study|Withdrawal by Subject|1|||
131779555|NCT01682681|474472284|FG000|Overall Study|Moved to other hospital|10|||
131779556|NCT01682681|474472284|FG000|Overall Study|Lost to Follow-up|174|||
131779557|NCT01682681|474472284|FG000|Overall Study|Adverse Event|46|||
131779558|NCT01682681|474472284|FG000|Overall Study|tapering of topiramate|5|||
131779559|NCT01682681|474472284|FG000|Overall Study|Other|21|||
131779560|NCT01682681|474472284|FG000|Overall Study|Low compliance|13|||
131779561|NCT00975000|474472285|FG000|Overall Study|Other|1|||
131779562|NCT00975000|474472286|FG001|Overall Study|Other|0|||
131779563|NCT00975000|474472285|FG000|Overall Study|Adverse Event|1|||
131779564|NCT00975000|474472286|FG001|Overall Study|Adverse Event|1|||
131779565|NCT00975000|474472285|FG000|Overall Study|Withdrawal by Subject|2|||
131779566|NCT00975000|474472286|FG001|Overall Study|Withdrawal by Subject|2|||
131779567|NCT00975000|474472285|FG000|Overall Study|Lost to Follow-up|0|||
131779568|NCT00975000|474472286|FG001|Overall Study|Lost to Follow-up|1|||
131779569|NCT00975000|474472285|FG000|Overall Study|Protocol-specified Criteria|1|||
131779570|NCT00975000|474472286|FG001|Overall Study|Protocol-specified Criteria|0|||
131779571|NCT00975000|474472285|FG000|Overall Study|Non-compliance|0|||
131779572|NCT00975000|474472286|FG001|Overall Study|Non-compliance|1|||
131779573|NCT01126359|474472287|FG000|First Intervention (20-minutes)|Physician Decision|0|||
131779574|NCT01126359|474472288|FG001|First Intervention (20-minutes)|Physician Decision|1|||
131779575|NCT00902486|474472289|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
131779576|NCT00902486|474472290|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
131779577|NCT00902486|474472291|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
131779578|NCT00902486|474472292|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
131779579|NCT00902486|474472293|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
131779580|NCT00902486|474472294|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
131779581|NCT00902486|474472289|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
131779582|NCT00902486|474472290|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131779583|NCT00902486|474472291|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131779584|NCT00902486|474472292|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131779585|NCT00902486|474472293|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131779586|NCT00902486|474472294|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
131779587|NCT00902486|474472289|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131779588|NCT00902486|474472290|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131779589|NCT00902486|474472291|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131779590|NCT00902486|474472292|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131779591|NCT00902486|474472293|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
131779592|NCT00902486|474472294|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
131779593|NCT00902486|474472289|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131779594|NCT00902486|474472290|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131779595|NCT00902486|474472291|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131779596|NCT00902486|474472292|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
131779597|NCT00902486|474472293|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131779598|NCT00902486|474472294|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131779599|NCT00902486|474472289|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131779600|NCT00902486|474472290|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131779601|NCT00902486|474472291|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131779602|NCT00902486|474472292|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
131779603|NCT00902486|474472293|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131779604|NCT00902486|474472294|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131779605|NCT00902486|474472289|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131779606|NCT00902486|474472290|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131779607|NCT00902486|474472291|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131779608|NCT00902486|474472292|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131779609|NCT00902486|474472293|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
131779610|NCT00902486|474472294|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
131779611|NCT00902486|474472289|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131779612|NCT00902486|474472290|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131779613|NCT00902486|474472291|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
131779614|NCT00902486|474472292|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
131779615|NCT00902486|474472293|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131779616|NCT00902486|474472294|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131779617|NCT00902486|474472289|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131779618|NCT00902486|474472290|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131779619|NCT00902486|474472291|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131779620|NCT00902486|474472292|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131779621|NCT00902486|474472293|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131779622|NCT00902486|474472294|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
131779623|NCT00902486|474472289|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131779624|NCT00902486|474472290|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131779625|NCT00902486|474472291|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131779626|NCT00902486|474472292|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
131779627|NCT00902486|474472293|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131779628|NCT00902486|474472294|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131779629|NCT00902486|474472289|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131779630|NCT00902486|474472290|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131779631|NCT00902486|474472291|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
131779632|NCT00902486|474472292|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131779633|NCT00902486|474472293|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131779634|NCT00902486|474472294|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131779635|NCT00902486|474472289|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
131779636|NCT00902486|474472290|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
131779637|NCT00902486|474472291|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
131779638|NCT00902486|474472292|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
131779639|NCT00902486|474472293|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
131779640|NCT00902486|474472294|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
131779641|NCT02332655|474472295|FG000|Overall Study|Lack of Efficacy|1|||
131779642|NCT01298661|474472296|FG000|Overall Study|Withdrawal by Subject|2|||
131779643|NCT01298661|474472297|FG001|Overall Study|Withdrawal by Subject|0|||
131779644|NCT01298661|474472298|FG002|Overall Study|Withdrawal by Subject|2|||
131779645|NCT01525407|474472299|FG000|Overall Study|Change in recipient treatment plan|2|||
131779646|NCT01525407|474472300|FG001|Overall Study|Change in recipient treatment plan|2|||
131779647|NCT01525407|474472299|FG000|Overall Study|Withdrawal by Subject|0|||
131779648|NCT01525407|474472300|FG001|Overall Study|Withdrawal by Subject|1|||
131779649|NCT01525407|474472299|FG000|Overall Study|Transplant was delayed|0|||
131779650|NCT01525407|474472300|FG001|Overall Study|Transplant was delayed|1|||
131779651|NCT01525407|474472299|FG000|Overall Study|Delay in Transplant|1|||
131779652|NCT01525407|474472300|FG001|Overall Study|Delay in Transplant|0|||
131779653|NCT01808508|474473861|FG000|Overall Study|Lost to Follow-up|1|||
131779654|NCT01808508|474473862|FG001|Overall Study|Lost to Follow-up|0|||
131779655|NCT01808508|474473863|FG002|Overall Study|Lost to Follow-up|0|||
131779656|NCT01017731|474473864|FG000|Overall Study|Lost to Follow-up|2|||
131779657|NCT01017731|474473864|FG000|Overall Study|Withdrawal by Subject|3|||
131779658|NCT01017731|474473864|FG000|Overall Study|Physician Decision|2|||
131779659|NCT01017731|474473864|FG000|Overall Study|Adverse Event|1|||
131779660|NCT05378269|474473865|FG000|Overall Study|Protocol Violation|1|||
131779661|NCT05378269|474473866|FG001|Overall Study|Protocol Violation|0|||
131779662|NCT05378269|474473867|FG002|Overall Study|Protocol Violation|2|||
131779663|NCT05378269|474473868|FG003|Overall Study|Protocol Violation|0|||
131779664|NCT05378269|474473869|FG004|Overall Study|Protocol Violation|0|||
131779665|NCT00242567|474473872|FG000|Overall Study|Adverse Event|70|||
131779666|NCT00242567|474473873|FG001|Overall Study|Adverse Event|43|||
131779667|NCT00242567|474473872|FG000|Overall Study|Disease Progression|17|||
131779668|NCT00242567|474473873|FG001|Overall Study|Disease Progression|22|||
131779669|NCT00242567|474473872|FG000|Overall Study|Symptomatic deterioration|9|||
131779670|NCT00242567|474473873|FG001|Overall Study|Symptomatic deterioration|3|||
131779671|NCT00242567|474473872|FG000|Overall Study|Lack of Efficacy|2|||
131779672|NCT00242567|474473873|FG001|Overall Study|Lack of Efficacy|2|||
131779673|NCT00242567|474473872|FG000|Overall Study|Lost to Follow-up|9|||
131779674|NCT00242567|474473873|FG001|Overall Study|Lost to Follow-up|19|||
131779675|NCT00242567|474473872|FG000|Overall Study|Withdrawal by Subject|33|||
131779676|NCT00242567|474473873|FG001|Overall Study|Withdrawal by Subject|28|||
131779677|NCT00242567|474473872|FG000|Overall Study|Protocol Violation|12|||
131779678|NCT00242567|474473873|FG001|Overall Study|Protocol Violation|12|||
131779679|NCT00242567|474473872|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
131559670|NCT04779242|473674007|FG000|Overall Study|Death|6|||
131559671|NCT04779242|473674008|FG001|Overall Study|Death|6|||
131559672|NCT04779242|473674007|FG000|Overall Study|COVID-19 related reasons|2|||
131694533|NCT01425008|474163561|FG018|Dose Expansion Phase|Adverse Event|3|||
131694534|NCT01425008|474163543|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
131694535|NCT01425008|474163544|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
131694536|NCT01425008|474163545|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
131694537|NCT01425008|474163546|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
131694538|NCT01425008|474163547|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
131694539|NCT01425008|474163548|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
131694540|NCT01425008|474163549|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
131694541|NCT01425008|474163550|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
131694542|NCT01425008|474163551|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
131694543|NCT01425008|474163552|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
131694544|NCT01425008|474163553|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
131694545|NCT01425008|474163554|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
131694546|NCT01425008|474163555|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
131694547|NCT01425008|474163556|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
131694548|NCT01425008|474163557|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
131694549|NCT01425008|474163558|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
131694550|NCT01425008|474163559|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
131694551|NCT01425008|474163560|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
131694552|NCT01425008|474163561|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
131694553|NCT01425008|474163543|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694554|NCT01425008|474163544|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694555|NCT01425008|474163545|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694556|NCT01425008|474163546|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694557|NCT01425008|474163547|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694558|NCT01425008|474163548|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694559|NCT01425008|474163549|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694560|NCT01425008|474163550|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694561|NCT01425008|474163551|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694562|NCT01425008|474163552|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694563|NCT01425008|474163553|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694564|NCT01425008|474163554|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694565|NCT01425008|474163555|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694566|NCT01425008|474163556|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694567|NCT01425008|474163557|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694568|NCT01425008|474163558|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694569|NCT01425008|474163559|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694570|NCT01425008|474163560|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131694571|NCT01425008|474163561|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
131694572|NCT00333359|474163563|FG000|Overall Study|Adverse Event|29|||
131694573|NCT00333359|474163564|FG001|Overall Study|Adverse Event|35|||
131694574|NCT00333359|474163563|FG000|Overall Study|Withdrawal by Subject|19|||
131694575|NCT00333359|474163564|FG001|Overall Study|Withdrawal by Subject|37|||
131694576|NCT00333359|474163563|FG000|Overall Study|Physician Decision|2|||
131694577|NCT00333359|474163564|FG001|Overall Study|Physician Decision|2|||
131694578|NCT00333359|474163563|FG000|Overall Study|Protocol Non-compliance|2|||
131694579|NCT00333359|474163564|FG001|Overall Study|Protocol Non-compliance|8|||
131694580|NCT00333359|474163563|FG000|Overall Study|Lost to Follow-up|15|||
131694581|NCT00333359|474163564|FG001|Overall Study|Lost to Follow-up|25|||
131694582|NCT00333359|474163563|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
131694583|NCT00333359|474163564|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
131694584|NCT00333359|474163563|FG000|Overall Study|Treatment Failure|3|||
131694585|NCT00333359|474163564|FG001|Overall Study|Treatment Failure|8|||
131694586|NCT00333359|474163563|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
131694587|NCT00333359|474163564|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
131694588|NCT02867995|474163566|FG000|Overall Study|Withdrawal by Subject|0|||
131694589|NCT02867995|474163567|FG001|Overall Study|Withdrawal by Subject|1|||
131694590|NCT02867995|474163566|FG000|Overall Study|Lost to Follow-up|0|||
131694591|NCT02867995|474163567|FG001|Overall Study|Lost to Follow-up|2|||
131694592|NCT03311711|474165004|FG000|Overall Study|Death|1|||
131694593|NCT03311711|474165005|FG001|Overall Study|Death|0|||
131694594|NCT03311711|474165006|FG002|Overall Study|Death|0|||
131694595|NCT03311711|474165007|FG003|Overall Study|Death|0|||
131694596|NCT03311711|474165008|FG004|Overall Study|Death|0|||
131694597|NCT03311711|474165009|FG005|Overall Study|Death|0|||
131694598|NCT03311711|474165010|FG006|Overall Study|Death|1|||
131694599|NCT03311711|474165011|FG007|Overall Study|Death|0|||
131694600|NCT03311711|474165012|FG008|Overall Study|Death|1|||
131694601|NCT03311711|474165013|FG009|Overall Study|Death|0|||
131694602|NCT03311711|474165004|FG000|Overall Study|Death of dyad partner|0|||
131694603|NCT03311711|474165005|FG001|Overall Study|Death of dyad partner|1|||
131779680|NCT00242567|474473873|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
131779681|NCT00242567|474473872|FG000|Overall Study|Other|14|||
131779682|NCT00242567|474473873|FG001|Overall Study|Other|9|||
131779683|NCT01721200|474473874|FG000|Overall Study|Lost to Follow-up|3|||
131779684|NCT01721200|474473875|FG001|Overall Study|Lost to Follow-up|5|||
131779685|NCT03926728|474473876|FG000|Overall Study|Withdrawal by Subject|0|||
131779686|NCT03926728|474473877|FG001|Overall Study|Withdrawal by Subject|1|||
131779687|NCT03926728|474473878|FG002|Overall Study|Withdrawal by Subject|1|||
131779688|NCT03926728|474473879|FG003|Overall Study|Withdrawal by Subject|0|||
131779689|NCT03926728|474473880|FG004|Overall Study|Withdrawal by Subject|0|||
131779690|NCT03926728|474473881|FG005|Overall Study|Withdrawal by Subject|1|||
131779691|NCT03926728|474473882|FG006|Overall Study|Withdrawal by Subject|1|||
131779692|NCT03926728|474473883|FG007|Overall Study|Withdrawal by Subject|0|||
131779693|NCT03926728|474473884|FG008|Overall Study|Withdrawal by Subject|0|||
131779694|NCT03926728|474473885|FG009|Overall Study|Withdrawal by Subject|1|||
131779695|NCT03926728|474473886|FG010|Overall Study|Withdrawal by Subject|0|||
131779696|NCT03926728|474473887|FG011|Overall Study|Withdrawal by Subject|0|||
131779697|NCT02729545|474473888|FG000|Overall Study|Pregnancy|1|||
131779698|NCT02729545|474473889|FG001|Overall Study|Pregnancy|1|||
131779699|NCT02729545|474473888|FG000|Overall Study|Lost to Follow-up|0|||
131779700|NCT02729545|474473889|FG001|Overall Study|Lost to Follow-up|1|||
131779701|NCT02729545|474473888|FG000|Overall Study|Withdrawal by Subject|2|||
131779702|NCT02729545|474473889|FG001|Overall Study|Withdrawal by Subject|3|||
131779703|NCT00398632|474473890|FG000|Overall Study|Withdrawal by Subject|1|||
131779704|NCT00398632|474473890|FG000|Overall Study|Lack of Efficacy|1|||
131779705|NCT00366678|474473893|FG000|Infant Series|Withdrawal by Subject|8|||
131779706|NCT00366678|474473894|FG001|Infant Series|Withdrawal by Subject|6|||
131779707|NCT00366678|474473895|FG002|Infant Series|Withdrawal by Subject|0|||
131779708|NCT00366678|474473893|FG000|Infant Series|Protocol Violation|4|||
131779709|NCT00366678|474473894|FG001|Infant Series|Protocol Violation|3|||
131779710|NCT00366678|474473895|FG002|Infant Series|Protocol Violation|0|||
131779711|NCT00366678|474473893|FG000|Infant Series|Failed to return|1|||
131779712|NCT00366678|474473894|FG001|Infant Series|Failed to return|1|||
131779713|NCT00366678|474473895|FG002|Infant Series|Failed to return|0|||
131779714|NCT00366678|474473893|FG000|Infant Series|Adverse Event|1|||
131779715|NCT00366678|474473894|FG001|Infant Series|Adverse Event|0|||
131779716|NCT00366678|474473895|FG002|Infant Series|Adverse Event|0|||
131779717|NCT00366678|474473893|FG000|After Infant|Withdrawal by Subject|8|||
131779718|NCT00366678|474473894|FG001|After Infant|Withdrawal by Subject|4|||
131779719|NCT00366678|474473895|FG002|After Infant|Withdrawal by Subject|0|||
131779720|NCT00366678|474473893|FG000|After Infant|Lost to Follow-up|2|||
131779721|NCT00366678|474473894|FG001|After Infant|Lost to Follow-up|1|||
131779722|NCT00366678|474473895|FG002|After Infant|Lost to Follow-up|0|||
131779723|NCT00366678|474473893|FG000|After Infant|Failed to return|5|||
131779724|NCT00366678|474473894|FG001|After Infant|Failed to return|5|||
131779725|NCT00366678|474473895|FG002|After Infant|Failed to return|0|||
131779726|NCT00366678|474473893|FG000|After Infant|Adverse Event|1|||
131779727|NCT00366678|474473894|FG001|After Infant|Adverse Event|0|||
131779728|NCT00366678|474473895|FG002|After Infant|Adverse Event|0|||
131779729|NCT00366678|474473893|FG000|After Infant|Protocol Violation|1|||
131779730|NCT00366678|474473894|FG001|After Infant|Protocol Violation|0|||
131898550|NCT02797678|474914127|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
131898551|NCT02401035|474914128|FG000|Overall Study|Withdrawal by Subject|1|||
131779731|NCT00366678|474473895|FG002|After Infant|Protocol Violation|0|||
131779732|NCT00366678|474473893|FG000|Toddler Dose|Protocol Violation|2|||
131779733|NCT00366678|474473894|FG001|Toddler Dose|Protocol Violation|1|||
131779734|NCT00366678|474473895|FG002|Toddler Dose|Protocol Violation|0|||
131779735|NCT00366678|474473893|FG000|Toddler Dose|Failed to return|1|||
131779736|NCT00366678|474473894|FG001|Toddler Dose|Failed to return|0|||
131779737|NCT00366678|474473895|FG002|Toddler Dose|Failed to return|0|||
131779738|NCT00366678|474473893|FG000|Toddler Dose|Withdrawal by Subject|1|||
131779739|NCT00366678|474473894|FG001|Toddler Dose|Withdrawal by Subject|0|||
131779740|NCT00366678|474473895|FG002|Toddler Dose|Withdrawal by Subject|0|||
131779741|NCT00366678|474473893|FG000|Toddler Dose|protocol deviation|1|||
131779742|NCT00366678|474473894|FG001|Toddler Dose|protocol deviation|0|||
131779743|NCT00366678|474473895|FG002|Toddler Dose|protocol deviation|0|||
131779744|NCT04292171|474473896|FG000|Overall Study|Pharmacy error|2|||
131779745|NCT04292171|474473897|FG001|Overall Study|Pharmacy error|0|||
131898552|NCT02401035|474914129|FG001|Overall Study|Withdrawal by Subject|0|||
131779746|NCT04292171|474473896|FG000|Overall Study|Delivered prior to procedure|0|||
131779747|NCT04292171|474473897|FG001|Overall Study|Delivered prior to procedure|1|||
131779748|NCT03079869|474473900|FG000|Overall Study|Adverse Event|6|||
131779749|NCT03079869|474473901|FG001|Overall Study|Adverse Event|8|||
131779750|NCT03079869|474473900|FG000|Overall Study|Withdrawal by Subject|4|||
131898553|NCT02998996|474914130|FG000|Overall Study|Lost to Follow-up|0|||
131779751|NCT03079869|474473901|FG001|Overall Study|Withdrawal by Subject|1|||
131779752|NCT03079869|474473900|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
131779753|NCT03079869|474473901|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
131779754|NCT02411110|474473902|FG000|Treatment Period 1|Adverse Event|4|||
131779755|NCT02411110|474473903|FG001|Treatment Period 1|Adverse Event|2|||
131779756|NCT02411110|474473902|FG000|Treatment Period 1|Lost to Follow-up|1|||
131779757|NCT02411110|474473903|FG001|Treatment Period 1|Lost to Follow-up|0|||
131779758|NCT02411110|474473902|FG000|Treatment Period 1|Personal Reasons|2|||
131779759|NCT02411110|474473903|FG001|Treatment Period 1|Personal Reasons|5|||
131779760|NCT02411110|474473902|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
131779761|NCT02411110|474473903|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
131779762|NCT02411110|474473902|FG000|Treatment Period 2|Adverse Event|1|||
131779763|NCT02411110|474473903|FG001|Treatment Period 2|Adverse Event|0|||
131779764|NCT02411110|474473902|FG000|Treatment Period 2|Lost to Follow-up|0|||
131779765|NCT02411110|474473903|FG001|Treatment Period 2|Lost to Follow-up|2|||
131779766|NCT02411110|474473902|FG000|Treatment Period 2|Personal Reasons|0|||
131779767|NCT02411110|474473903|FG001|Treatment Period 2|Personal Reasons|2|||
131779768|NCT02118896|474473906|FG000|Overall Study|Death|4|||
131779769|NCT02118896|474473907|FG001|Overall Study|Death|0|||
131779770|NCT02118896|474473908|FG002|Overall Study|Death|4|||
131779771|NCT02118896|474473909|FG003|Overall Study|Death|6|||
131779772|NCT02118896|474473910|FG004|Overall Study|Death|3|||
131779773|NCT02118896|474473911|FG005|Overall Study|Death|1|||
131779774|NCT02118896|474473912|FG006|Overall Study|Death|0|||
131779775|NCT02118896|474473913|FG007|Overall Study|Death|0|||
131779776|NCT02118896|474473914|FG008|Overall Study|Death|0|||
131779777|NCT02118896|474473915|FG009|Overall Study|Death|0|||
131779778|NCT02118896|474473906|FG000|Overall Study|Adverse Event|5|||
131779779|NCT02118896|474473907|FG001|Overall Study|Adverse Event|4|||
131779780|NCT02118896|474473908|FG002|Overall Study|Adverse Event|4|||
131779781|NCT02118896|474473909|FG003|Overall Study|Adverse Event|5|||
131779782|NCT02118896|474473910|FG004|Overall Study|Adverse Event|5|||
131779783|NCT02118896|474473911|FG005|Overall Study|Adverse Event|9|||
131779784|NCT02118896|474473912|FG006|Overall Study|Adverse Event|1|||
131779785|NCT02118896|474473913|FG007|Overall Study|Adverse Event|1|||
131779786|NCT02118896|474473914|FG008|Overall Study|Adverse Event|4|||
131779787|NCT02118896|474473915|FG009|Overall Study|Adverse Event|0|||
131779788|NCT02118896|474473906|FG000|Overall Study|Consent withdrawn|2|||
131779789|NCT02118896|474473907|FG001|Overall Study|Consent withdrawn|0|||
131779790|NCT02118896|474473908|FG002|Overall Study|Consent withdrawn|3|||
131779791|NCT02118896|474473909|FG003|Overall Study|Consent withdrawn|4|||
131779792|NCT02118896|474473910|FG004|Overall Study|Consent withdrawn|1|||
131779793|NCT02118896|474473911|FG005|Overall Study|Consent withdrawn|4|||
131779794|NCT02118896|474473912|FG006|Overall Study|Consent withdrawn|0|||
131779795|NCT02118896|474473913|FG007|Overall Study|Consent withdrawn|0|||
131779796|NCT02118896|474473914|FG008|Overall Study|Consent withdrawn|0|||
131779797|NCT02118896|474473915|FG009|Overall Study|Consent withdrawn|0|||
131779798|NCT02118896|474473906|FG000|Overall Study|Non-compliance|2|||
131779799|NCT02118896|474473907|FG001|Overall Study|Non-compliance|1|||
131779800|NCT02118896|474473908|FG002|Overall Study|Non-compliance|1|||
131779801|NCT02118896|474473909|FG003|Overall Study|Non-compliance|5|||
131779802|NCT02118896|474473910|FG004|Overall Study|Non-compliance|0|||
131779803|NCT02118896|474473911|FG005|Overall Study|Non-compliance|1|||
131779804|NCT02118896|474473912|FG006|Overall Study|Non-compliance|0|||
131779805|NCT02118896|474473913|FG007|Overall Study|Non-compliance|1|||
131779806|NCT02118896|474473914|FG008|Overall Study|Non-compliance|0|||
131779807|NCT02118896|474473915|FG009|Overall Study|Non-compliance|0|||
131779808|NCT02118896|474473906|FG000|Overall Study|Pregnancy|1|||
131779809|NCT02118896|474473907|FG001|Overall Study|Pregnancy|1|||
131779810|NCT02118896|474473908|FG002|Overall Study|Pregnancy|0|||
131779811|NCT02118896|474473909|FG003|Overall Study|Pregnancy|0|||
131779812|NCT02118896|474473910|FG004|Overall Study|Pregnancy|1|||
131779813|NCT02118896|474473911|FG005|Overall Study|Pregnancy|3|||
131779814|NCT02118896|474473912|FG006|Overall Study|Pregnancy|1|||
131779815|NCT02118896|474473913|FG007|Overall Study|Pregnancy|0|||
131779816|NCT02118896|474473914|FG008|Overall Study|Pregnancy|0|||
131779817|NCT02118896|474473915|FG009|Overall Study|Pregnancy|0|||
131779818|NCT02118896|474473906|FG000|Overall Study|Lost to Follow-up|1|||
131779819|NCT02118896|474473907|FG001|Overall Study|Lost to Follow-up|2|||
131779820|NCT02118896|474473908|FG002|Overall Study|Lost to Follow-up|1|||
131898554|NCT02998996|474914131|FG001|Overall Study|Lost to Follow-up|0|||
131779821|NCT02118896|474473909|FG003|Overall Study|Lost to Follow-up|0|||
131779822|NCT02118896|474473910|FG004|Overall Study|Lost to Follow-up|2|||
131779823|NCT02118896|474473911|FG005|Overall Study|Lost to Follow-up|1|||
131779824|NCT02118896|474473912|FG006|Overall Study|Lost to Follow-up|0|||
131779825|NCT02118896|474473913|FG007|Overall Study|Lost to Follow-up|0|||
131779826|NCT02118896|474473914|FG008|Overall Study|Lost to Follow-up|0|||
131779827|NCT02118896|474473915|FG009|Overall Study|Lost to Follow-up|0|||
131779828|NCT02118896|474473906|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
131779829|NCT02118896|474473907|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
131779830|NCT02118896|474473908|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
131779831|NCT02118896|474473909|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
131779832|NCT02118896|474473910|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
131779833|NCT02118896|474473911|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
131779834|NCT02118896|474473912|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
131779835|NCT02118896|474473913|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
131779836|NCT02118896|474473914|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
131779837|NCT02118896|474473915|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
131779838|NCT02118896|474473906|FG000|Overall Study|Prohibited medication|0|||
131779839|NCT02118896|474473907|FG001|Overall Study|Prohibited medication|0|||
131779840|NCT02118896|474473908|FG002|Overall Study|Prohibited medication|0|||
131779841|NCT02118896|474473909|FG003|Overall Study|Prohibited medication|0|||
131779842|NCT02118896|474473910|FG004|Overall Study|Prohibited medication|1|||
131779843|NCT02118896|474473911|FG005|Overall Study|Prohibited medication|3|||
131779844|NCT02118896|474473912|FG006|Overall Study|Prohibited medication|0|||
131779845|NCT02118896|474473913|FG007|Overall Study|Prohibited medication|0|||
131779846|NCT02118896|474473914|FG008|Overall Study|Prohibited medication|0|||
131779847|NCT02118896|474473915|FG009|Overall Study|Prohibited medication|0|||
131779848|NCT02118896|474473906|FG000|Overall Study|Miscellaneous|1|||
131779849|NCT02118896|474473907|FG001|Overall Study|Miscellaneous|2|||
131779850|NCT02118896|474473908|FG002|Overall Study|Miscellaneous|0|||
131779851|NCT02118896|474473909|FG003|Overall Study|Miscellaneous|2|||
131779852|NCT02118896|474473910|FG004|Overall Study|Miscellaneous|0|||
131779853|NCT02118896|474473911|FG005|Overall Study|Miscellaneous|4|||
131779854|NCT02118896|474473912|FG006|Overall Study|Miscellaneous|0|||
131779855|NCT02118896|474473913|FG007|Overall Study|Miscellaneous|0|||
131779856|NCT02118896|474473914|FG008|Overall Study|Miscellaneous|0|||
131779857|NCT02118896|474473915|FG009|Overall Study|Miscellaneous|0|||
131779858|NCT04635631|474473916|FG000|Overall Study|Adverse Event|1|||
131779859|NCT04635631|474473916|FG000|Overall Study|Progressive disease|13|||
131779860|NCT04635631|474473916|FG000|Overall Study|Withdrawal by Subject|1|||
131779861|NCT02050373|474473917|FG000|Overall Study|Adverse Event|4|||
131779862|NCT02050373|474473918|FG001|Overall Study|Adverse Event|7|||
131779863|NCT02050373|474473917|FG000|Overall Study|Death|3|||
131779864|NCT02050373|474473918|FG001|Overall Study|Death|3|||
131779865|NCT01360021|474473929|FG000|Overall Study|Eligibility criteria + other|2|||
131779866|NCT01360021|474473930|FG001|Overall Study|Eligibility criteria + other|1|||
131779867|NCT01360021|474473931|FG002|Overall Study|Eligibility criteria + other|1|||
131779868|NCT01360021|474473929|FG000|Overall Study|Protocol Violation|0|||
131779869|NCT01360021|474473930|FG001|Overall Study|Protocol Violation|0|||
131779870|NCT01360021|474473931|FG002|Overall Study|Protocol Violation|1|||
131779871|NCT01360021|474473929|FG000|Overall Study|Withdrawal by Subject|4|||
131779872|NCT01360021|474473930|FG001|Overall Study|Withdrawal by Subject|0|||
131779873|NCT01360021|474473931|FG002|Overall Study|Withdrawal by Subject|2|||
131779874|NCT01360021|474473929|FG000|Overall Study|Adverse Event|2|||
131779875|NCT01360021|474473930|FG001|Overall Study|Adverse Event|3|||
131779876|NCT01360021|474473931|FG002|Overall Study|Adverse Event|3|||
131779877|NCT01257737|474473933|FG000|Overall Study|Lost to Follow-up|1|||
131779878|NCT01257737|474473934|FG001|Overall Study|Lost to Follow-up|2|||
131779879|NCT01257737|474473933|FG000|Overall Study|Liver transplant|1|||
131779880|NCT01257737|474473934|FG001|Overall Study|Liver transplant|0|||
131779881|NCT01257737|474473933|FG000|Overall Study|Relocation out of the country|0|||
131779882|NCT01257737|474473934|FG001|Overall Study|Relocation out of the country|1|||
131779883|NCT01257737|474473933|FG000|Overall Study|Withdrew from study|0|||
131779884|NCT01257737|474473934|FG001|Overall Study|Withdrew from study|1|||
131779885|NCT03170271|474473938|FG000|Overall Study|Adverse Event|7|||
131779886|NCT03170271|474473939|FG001|Overall Study|Adverse Event|2|||
131779887|NCT03170271|474473938|FG000|Overall Study|Lost to Follow-up|0|||
131779888|NCT03170271|474473939|FG001|Overall Study|Lost to Follow-up|1|||
131779889|NCT03170271|474473938|FG000|Overall Study|Physician Decision|1|||
131779890|NCT03170271|474473939|FG001|Overall Study|Physician Decision|0|||
131779891|NCT03170271|474473938|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
131779892|NCT03170271|474473939|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
131779893|NCT03170271|474473938|FG000|Overall Study|Withdrawal by Subject|17|||
131779894|NCT03170271|474473939|FG001|Overall Study|Withdrawal by Subject|5|||
131779895|NCT03170271|474473938|FG000|Overall Study|Other|2|||
131779896|NCT03170271|474473939|FG001|Overall Study|Other|2|||
131779897|NCT03170271|474473938|FG000|Overall Study|Randomized in error|4|||
131779898|NCT03170271|474473939|FG001|Overall Study|Randomized in error|0|||
131779899|NCT00203892|474473941|FG000|Overall Study|Physician Decision|1|||
131779900|NCT00203892|474473942|FG001|Overall Study|Physician Decision|2|||
131779901|NCT00203892|474473943|FG002|Overall Study|Physician Decision|0|||
131779902|NCT00203892|474473941|FG000|Overall Study|Death|1|||
131779903|NCT00203892|474473942|FG001|Overall Study|Death|0|||
131779904|NCT00203892|474473943|FG002|Overall Study|Death|0|||
131898555|NCT02998996|474914132|FG002|Overall Study|Lost to Follow-up|1|||
131898556|NCT02998996|474914133|FG003|Overall Study|Lost to Follow-up|0|||
131898557|NCT02998996|474914134|FG004|Overall Study|Lost to Follow-up|0|||
131779905|NCT00806416|474473944|FG000|Period 1 - Part I|Adverse Event|0|||
131779906|NCT00806416|474473945|FG001|Period 1 - Part I|Adverse Event|1|||
131779907|NCT00806416|474473946|FG002|Period 1 - Part I|Adverse Event|0|||
131779908|NCT00806416|474473947|FG003|Period 1 - Part I|Adverse Event|0|||
131898558|NCT02998996|474914135|FG005|Overall Study|Lost to Follow-up|0|||
131694604|NCT03311711|474165006|FG002|Overall Study|Death of dyad partner|0|||
131694605|NCT03311711|474165007|FG003|Overall Study|Death of dyad partner|0|||
131694606|NCT03311711|474165008|FG004|Overall Study|Death of dyad partner|0|||
131694607|NCT03311711|474165009|FG005|Overall Study|Death of dyad partner|0|||
131694608|NCT03311711|474165010|FG006|Overall Study|Death of dyad partner|0|||
131694609|NCT03311711|474165011|FG007|Overall Study|Death of dyad partner|1|||
131694610|NCT03311711|474165012|FG008|Overall Study|Death of dyad partner|0|||
131694611|NCT03311711|474165013|FG009|Overall Study|Death of dyad partner|1|||
131694612|NCT03311711|474165004|FG000|Overall Study|Lost to Follow-up|2|||
131694613|NCT03311711|474165005|FG001|Overall Study|Lost to Follow-up|2|||
131694614|NCT03311711|474165006|FG002|Overall Study|Lost to Follow-up|0|||
131694615|NCT03311711|474165007|FG003|Overall Study|Lost to Follow-up|0|||
131694616|NCT03311711|474165008|FG004|Overall Study|Lost to Follow-up|0|||
131694617|NCT03311711|474165009|FG005|Overall Study|Lost to Follow-up|0|||
131694618|NCT03311711|474165010|FG006|Overall Study|Lost to Follow-up|1|||
131694619|NCT03311711|474165011|FG007|Overall Study|Lost to Follow-up|1|||
131694620|NCT03311711|474165012|FG008|Overall Study|Lost to Follow-up|0|||
131694621|NCT03311711|474165013|FG009|Overall Study|Lost to Follow-up|0|||
131694622|NCT03311711|474165004|FG000|Overall Study|Withdrawal by Subject|1|||
131694623|NCT03311711|474165005|FG001|Overall Study|Withdrawal by Subject|1|||
131694624|NCT03311711|474165006|FG002|Overall Study|Withdrawal by Subject|0|||
131694625|NCT03311711|474165007|FG003|Overall Study|Withdrawal by Subject|0|||
131694626|NCT03311711|474165008|FG004|Overall Study|Withdrawal by Subject|0|||
131694627|NCT03311711|474165009|FG005|Overall Study|Withdrawal by Subject|0|||
131694628|NCT03311711|474165010|FG006|Overall Study|Withdrawal by Subject|3|||
131694629|NCT03311711|474165011|FG007|Overall Study|Withdrawal by Subject|3|||
131694630|NCT03311711|474165012|FG008|Overall Study|Withdrawal by Subject|0|||
131694631|NCT03311711|474165013|FG009|Overall Study|Withdrawal by Subject|0|||
131694632|NCT01623271|474165018|FG000|Overall Study|Withdrawal by Subject|2|||
131694633|NCT01339559|474165020|FG000|Overall Study|Adverse Event|92|||
131694634|NCT01339559|474165020|FG000|Overall Study|Death|5|||
131694635|NCT01339559|474165020|FG000|Overall Study|Lack of Efficacy|164|||
131694636|NCT01339559|474165020|FG000|Overall Study|Lost to Follow-up|22|||
131694637|NCT01339559|474165020|FG000|Overall Study|Subject choice|89|||
131694638|NCT01339559|474165020|FG000|Overall Study|Protocol Violation|15|||
131694639|NCT01339559|474165020|FG000|Overall Study|Study closure at site|1|||
131694640|NCT01339559|474165020|FG000|Overall Study|Incarcerated|2|||
131694641|NCT01339559|474165020|FG000|Overall Study|Epilepsy surgery|1|||
131694642|NCT01339559|474165020|FG000|Overall Study|Pregnancy planned|2|||
131694643|NCT01339559|474165020|FG000|Overall Study|Left the country|1|||
131694644|NCT01339559|474165020|FG000|Overall Study|Investigator decision|2|||
131694645|NCT01339559|474165020|FG000|Overall Study|Patient didn't wish to continue|1|||
131694646|NCT01339559|474165020|FG000|Overall Study|PI decision|1|||
131694647|NCT01137773|474165021|FG000|Overall Study|Death|3|||
131694648|NCT01137773|474165022|FG001|Overall Study|Death|3|||
131694649|NCT01137773|474165021|FG000|Overall Study|Lost to Follow-up|6|||
131694650|NCT01137773|474165022|FG001|Overall Study|Lost to Follow-up|0|||
131694651|NCT03548051|474165023|FG000|Overall Study|Death|1|||
131694652|NCT03548051|474165024|FG001|Overall Study|Death|1|||
131694653|NCT03548051|474165023|FG000|Overall Study|Withdrawal by Subject|1|||
131694654|NCT03548051|474165024|FG001|Overall Study|Withdrawal by Subject|0|||
131694655|NCT02684981|474165025|FG000|Overall Study|Permanently discontinued the treatment|157|||
131694656|NCT02684981|474165026|FG001|Overall Study|Permanently discontinued the treatment|161|||
131694657|NCT02684981|474165027|FG002|Overall Study|Permanently discontinued the treatment|110|||
131694658|NCT02684981|474165025|FG000|Overall Study|Other|83|||
131694659|NCT02684981|474165026|FG001|Overall Study|Other|49|||
131694660|NCT02684981|474165027|FG002|Overall Study|Other|17|||
131694661|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
131694662|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
131694663|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
131694664|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
131694665|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
131694666|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
131694667|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
131694668|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
131694669|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
131694670|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
131694671|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
131694672|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
131694673|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
131694674|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
131694675|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
131694676|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
131694677|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
131694678|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
131779909|NCT00806416|474473944|FG000|Period 1 - Part I|Lost to Follow-up|0|||
131779910|NCT00806416|474473945|FG001|Period 1 - Part I|Lost to Follow-up|2|||
131779911|NCT00806416|474473946|FG002|Period 1 - Part I|Lost to Follow-up|0|||
131779912|NCT00806416|474473947|FG003|Period 1 - Part I|Lost to Follow-up|0|||
131779913|NCT00806416|474473944|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
131779914|NCT00806416|474473945|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
131779915|NCT00806416|474473946|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
131779916|NCT00806416|474473947|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
131779917|NCT00806416|474473944|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
131779918|NCT00806416|474473945|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
131779919|NCT00806416|474473946|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
131779920|NCT00806416|474473947|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
131779921|NCT01244516|474473951|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
131779922|NCT01244516|474473952|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
131559673|NCT04779242|473674008|FG001|Overall Study|COVID-19 related reasons|1|||
131559674|NCT04779242|473674007|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
131559675|NCT04779242|473674008|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
131559676|NCT04779242|473674007|FG000|Overall Study|Martial Law in Ukraine|2|||
131559677|NCT04779242|473674008|FG001|Overall Study|Martial Law in Ukraine|3|||
131559678|NCT01076088|473674009|FG000|Overall Study|Adverse Event|1|||
131559679|NCT01076088|473674010|FG001|Overall Study|Adverse Event|6|||
131559680|NCT01076088|473674011|FG002|Overall Study|Adverse Event|3|||
131559681|NCT01076088|473674012|FG003|Overall Study|Adverse Event|2|||
131559682|NCT01076088|473674013|FG004|Overall Study|Adverse Event|3|||
131559683|NCT01076088|473674014|FG005|Overall Study|Adverse Event|3|||
131559684|NCT01076088|473674009|FG000|Overall Study|Lost to Follow-up|1|||
131559685|NCT01076088|473674010|FG001|Overall Study|Lost to Follow-up|1|||
131559686|NCT01076088|473674011|FG002|Overall Study|Lost to Follow-up|0|||
131559687|NCT01076088|473674012|FG003|Overall Study|Lost to Follow-up|1|||
131559688|NCT01076088|473674013|FG004|Overall Study|Lost to Follow-up|1|||
131559689|NCT01076088|473674014|FG005|Overall Study|Lost to Follow-up|2|||
131559690|NCT01076088|473674009|FG000|Overall Study|Non-compliance with study drug|0|||
131559691|NCT01076088|473674010|FG001|Overall Study|Non-compliance with study drug|0|||
131559692|NCT01076088|473674011|FG002|Overall Study|Non-compliance with study drug|0|||
131559693|NCT01076088|473674012|FG003|Overall Study|Non-compliance with study drug|1|||
131559694|NCT01076088|473674013|FG004|Overall Study|Non-compliance with study drug|0|||
131559695|NCT01076088|473674014|FG005|Overall Study|Non-compliance with study drug|0|||
131559696|NCT01076088|473674009|FG000|Overall Study|Physician Decision|1|||
131559697|NCT01076088|473674010|FG001|Overall Study|Physician Decision|3|||
131559698|NCT01076088|473674011|FG002|Overall Study|Physician Decision|0|||
131559699|NCT01076088|473674012|FG003|Overall Study|Physician Decision|1|||
131559700|NCT01076088|473674013|FG004|Overall Study|Physician Decision|1|||
131559701|NCT01076088|473674014|FG005|Overall Study|Physician Decision|0|||
131559702|NCT01076088|473674009|FG000|Overall Study|Withdrawal by Subject|8|||
131559703|NCT01076088|473674010|FG001|Overall Study|Withdrawal by Subject|8|||
131559704|NCT01076088|473674011|FG002|Overall Study|Withdrawal by Subject|14|||
131559705|NCT01076088|473674012|FG003|Overall Study|Withdrawal by Subject|10|||
131559706|NCT01076088|473674013|FG004|Overall Study|Withdrawal by Subject|11|||
131559707|NCT01076088|473674014|FG005|Overall Study|Withdrawal by Subject|17|||
131559708|NCT01076088|473674009|FG000|Overall Study|Other protocol specified criteria|0|||
131559709|NCT01076088|473674010|FG001|Overall Study|Other protocol specified criteria|0|||
131559710|NCT01076088|473674011|FG002|Overall Study|Other protocol specified criteria|0|||
131559711|NCT01076088|473674012|FG003|Overall Study|Other protocol specified criteria|0|||
131559712|NCT01076088|473674013|FG004|Overall Study|Other protocol specified criteria|0|||
131559713|NCT01076088|473674014|FG005|Overall Study|Other protocol specified criteria|1|||
131559714|NCT00786474|473674015|FG000|Overall Study|Death|5|||
131559715|NCT00786474|473674016|FG001|Overall Study|Death|4|||
131559716|NCT00786474|473674015|FG000|Overall Study|Withdrawal by Subject|23|||
131559717|NCT00786474|473674016|FG001|Overall Study|Withdrawal by Subject|31|||
131559718|NCT00786474|473674015|FG000|Overall Study|Lost to Follow-up|3|||
131559719|NCT00786474|473674016|FG001|Overall Study|Lost to Follow-up|3|||
131559720|NCT00786474|473674015|FG000|Overall Study|Physician Decision|2|||
131779923|NCT01244516|474473953|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
131779924|NCT01244516|474473951|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
131779925|NCT01244516|474473952|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
131559721|NCT00786474|473674016|FG001|Overall Study|Physician Decision|1|||
131779926|NCT01244516|474473953|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
131559722|NCT00786474|473674015|FG000|Overall Study|Other|4|||
131559723|NCT00786474|473674016|FG001|Overall Study|Other|4|||
131779927|NCT01244516|474473951|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
131779928|NCT01244516|474473952|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
131779929|NCT01244516|474473953|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
131779930|NCT01244516|474473951|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
131779931|NCT01244516|474473952|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
131559724|NCT03053492|473674017|FG000|Overall Study|Adverse Event|1|||
131779932|NCT01244516|474473953|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
131559725|NCT03053492|473674018|FG001|Overall Study|Adverse Event|1|||
131559726|NCT03053492|473674017|FG000|Overall Study|Withdrawal by Subject|7|||
131559727|NCT03053492|473674018|FG001|Overall Study|Withdrawal by Subject|5|||
131559728|NCT01544491|473674019|FG000|Overall Study|Withdrawal by Subject|3|||
131559729|NCT01544491|473674020|FG001|Overall Study|Withdrawal by Subject|2|||
131559730|NCT01544491|473674019|FG000|Overall Study|Lost to Follow-up|0|||
131559731|NCT01544491|473674020|FG001|Overall Study|Lost to Follow-up|1|||
131559732|NCT01544491|473674019|FG000|Overall Study|administrative problems|2|||
131559733|NCT01544491|473674020|FG001|Overall Study|administrative problems|0|||
131559734|NCT00967018|473674021|FG000|Overall Study|Adverse Event|2|||
131559735|NCT00967018|473674021|FG000|Overall Study|Physician Decision|7|||
131559736|NCT00967018|473674021|FG000|Overall Study|Lost to Follow-up|2|||
131559737|NCT00967018|473674021|FG000|Overall Study|Withdrawal by Subject|1|||
131559738|NCT00967018|473674021|FG000|Overall Study|Miscellaneous Reasons|9|||
131559739|NCT02733042|473674025|FG000|Overall Study|Adverse Event|1|||
131559740|NCT02733042|473674026|FG001|Overall Study|Adverse Event|0|||
131559741|NCT02733042|473674027|FG002|Overall Study|Adverse Event|1|||
131559742|NCT02733042|473674028|FG003|Overall Study|Adverse Event|1|||
131559743|NCT02733042|473674029|FG004|Overall Study|Adverse Event|0|||
131559744|NCT02733042|473674030|FG005|Overall Study|Adverse Event|0|||
131559745|NCT02733042|473674031|FG006|Overall Study|Adverse Event|0|||
131559746|NCT02733042|473674032|FG007|Overall Study|Adverse Event|0|||
131559747|NCT02733042|473674033|FG008|Overall Study|Adverse Event|0|||
131559748|NCT02733042|473674034|FG009|Overall Study|Adverse Event|0|||
131559749|NCT02733042|473674035|FG010|Overall Study|Adverse Event|2|||
131559750|NCT02733042|473674036|FG011|Overall Study|Adverse Event|2|||
131559751|NCT02733042|473674037|FG012|Overall Study|Adverse Event|0|||
131559752|NCT02733042|473674038|FG013|Overall Study|Adverse Event|2|||
131559753|NCT02733042|473674039|FG014|Overall Study|Adverse Event|0|||
131559754|NCT02733042|473674040|FG015|Overall Study|Adverse Event|0|||
131559755|NCT02733042|473674041|FG016|Overall Study|Adverse Event|0|||
131559756|NCT02733042|473674042|FG017|Overall Study|Adverse Event|1|||
131559757|NCT02733042|473674043|FG018|Overall Study|Adverse Event|0|||
131559758|NCT02733042|473674025|FG000|Overall Study|Progressive Disease|2|||
131559759|NCT02733042|473674026|FG001|Overall Study|Progressive Disease|1|||
131559760|NCT02733042|473674027|FG002|Overall Study|Progressive Disease|3|||
131559761|NCT02733042|473674028|FG003|Overall Study|Progressive Disease|1|||
131559762|NCT02733042|473674029|FG004|Overall Study|Progressive Disease|2|||
131559763|NCT02733042|473674030|FG005|Overall Study|Progressive Disease|3|||
131559764|NCT02733042|473674031|FG006|Overall Study|Progressive Disease|0|||
131559765|NCT02733042|473674032|FG007|Overall Study|Progressive Disease|3|||
131559766|NCT02733042|473674033|FG008|Overall Study|Progressive Disease|3|||
131559767|NCT02733042|473674034|FG009|Overall Study|Progressive Disease|2|||
131559768|NCT02733042|473674035|FG010|Overall Study|Progressive Disease|2|||
131559769|NCT02733042|473674036|FG011|Overall Study|Progressive Disease|2|||
131559770|NCT02733042|473674037|FG012|Overall Study|Progressive Disease|8|||
131559771|NCT02733042|473674038|FG013|Overall Study|Progressive Disease|1|||
131559772|NCT02733042|473674039|FG014|Overall Study|Progressive Disease|4|||
131559773|NCT02733042|473674040|FG015|Overall Study|Progressive Disease|7|||
131559774|NCT02733042|473674041|FG016|Overall Study|Progressive Disease|2|||
131559775|NCT02733042|473674042|FG017|Overall Study|Progressive Disease|3|||
131559776|NCT02733042|473674043|FG018|Overall Study|Progressive Disease|4|||
131559777|NCT02733042|473674025|FG000|Overall Study|Withdrawal by Subject|0|||
131559778|NCT02733042|473674026|FG001|Overall Study|Withdrawal by Subject|1|||
131559779|NCT02733042|473674027|FG002|Overall Study|Withdrawal by Subject|2|||
131559780|NCT02733042|473674028|FG003|Overall Study|Withdrawal by Subject|1|||
131559781|NCT02733042|473674029|FG004|Overall Study|Withdrawal by Subject|1|||
131559782|NCT02733042|473674030|FG005|Overall Study|Withdrawal by Subject|0|||
131559783|NCT02733042|473674031|FG006|Overall Study|Withdrawal by Subject|0|||
131559784|NCT02733042|473674032|FG007|Overall Study|Withdrawal by Subject|0|||
131559785|NCT02733042|473674033|FG008|Overall Study|Withdrawal by Subject|1|||
131559786|NCT02733042|473674034|FG009|Overall Study|Withdrawal by Subject|1|||
131559787|NCT02733042|473674035|FG010|Overall Study|Withdrawal by Subject|0|||
131559788|NCT02733042|473674036|FG011|Overall Study|Withdrawal by Subject|2|||
131559789|NCT02733042|473674037|FG012|Overall Study|Withdrawal by Subject|1|||
131559790|NCT02733042|473674038|FG013|Overall Study|Withdrawal by Subject|1|||
131559791|NCT02733042|473674039|FG014|Overall Study|Withdrawal by Subject|0|||
131559792|NCT02733042|473674040|FG015|Overall Study|Withdrawal by Subject|0|||
131559793|NCT02733042|473674041|FG016|Overall Study|Withdrawal by Subject|0|||
131559794|NCT02733042|473674042|FG017|Overall Study|Withdrawal by Subject|0|||
131559795|NCT02733042|473674043|FG018|Overall Study|Withdrawal by Subject|0|||
131779933|NCT01244516|474473951|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
131559796|NCT02733042|473674025|FG000|Overall Study|Other Reasons|0|||
131559797|NCT02733042|473674026|FG001|Overall Study|Other Reasons|0|||
131559798|NCT02733042|473674027|FG002|Overall Study|Other Reasons|1|||
131559799|NCT02733042|473674028|FG003|Overall Study|Other Reasons|0|||
131559800|NCT02733042|473674029|FG004|Overall Study|Other Reasons|0|||
131559801|NCT02733042|473674030|FG005|Overall Study|Other Reasons|0|||
131559802|NCT02733042|473674031|FG006|Overall Study|Other Reasons|0|||
131559803|NCT02733042|473674032|FG007|Overall Study|Other Reasons|0|||
131559804|NCT02733042|473674033|FG008|Overall Study|Other Reasons|0|||
131559805|NCT02733042|473674034|FG009|Overall Study|Other Reasons|1|||
131559806|NCT02733042|473674035|FG010|Overall Study|Other Reasons|1|||
131559807|NCT02733042|473674036|FG011|Overall Study|Other Reasons|0|||
131559808|NCT02733042|473674037|FG012|Overall Study|Other Reasons|0|||
131559809|NCT02733042|473674038|FG013|Overall Study|Other Reasons|0|||
131559810|NCT02733042|473674039|FG014|Overall Study|Other Reasons|0|||
131559811|NCT02733042|473674040|FG015|Overall Study|Other Reasons|1|||
131559812|NCT02733042|473674041|FG016|Overall Study|Other Reasons|0|||
131559813|NCT02733042|473674042|FG017|Overall Study|Other Reasons|1|||
131559814|NCT02733042|473674043|FG018|Overall Study|Other Reasons|0|||
131559815|NCT02733042|473674025|FG000|Overall Study|Death|0|||
131559816|NCT02733042|473674026|FG001|Overall Study|Death|0|||
131559817|NCT02733042|473674027|FG002|Overall Study|Death|0|||
131559818|NCT02733042|473674028|FG003|Overall Study|Death|0|||
131559819|NCT02733042|473674029|FG004|Overall Study|Death|0|||
131559820|NCT02733042|473674030|FG005|Overall Study|Death|0|||
131559821|NCT02733042|473674031|FG006|Overall Study|Death|1|||
131559822|NCT02733042|473674032|FG007|Overall Study|Death|0|||
131559823|NCT02733042|473674033|FG008|Overall Study|Death|1|||
131559824|NCT02733042|473674034|FG009|Overall Study|Death|0|||
131559825|NCT02733042|473674035|FG010|Overall Study|Death|1|||
131559826|NCT02733042|473674036|FG011|Overall Study|Death|0|||
131559827|NCT02733042|473674037|FG012|Overall Study|Death|0|||
131559828|NCT02733042|473674038|FG013|Overall Study|Death|0|||
131559829|NCT02733042|473674039|FG014|Overall Study|Death|1|||
131559830|NCT02733042|473674040|FG015|Overall Study|Death|2|||
131559831|NCT02733042|473674041|FG016|Overall Study|Death|0|||
131559832|NCT02733042|473674042|FG017|Overall Study|Death|0|||
131559833|NCT02733042|473674043|FG018|Overall Study|Death|0|||
131559834|NCT01088529|473674045|FG000|Overall Study|Did not receive study treatment|0|||
131559835|NCT01088529|473674046|FG001|Overall Study|Did not receive study treatment|1|||
131559836|NCT03560245|473674048|FG000|Overall Study|Withdrawal by Subject|3|||
131559837|NCT03560245|473674049|FG001|Overall Study|Withdrawal by Subject|2|||
131559838|NCT03560245|473674048|FG000|Overall Study|Adverse Event|1|||
131559839|NCT03560245|473674049|FG001|Overall Study|Adverse Event|1|||
131559840|NCT03560245|473674048|FG000|Overall Study|Protocol Violation|1|||
131559841|NCT03560245|473674049|FG001|Overall Study|Protocol Violation|0|||
131559842|NCT03560245|473674048|FG000|Overall Study|Death|0|||
131559843|NCT03560245|473674049|FG001|Overall Study|Death|1|||
131559844|NCT03560245|473674048|FG000|Overall Study|Lost to Follow-up|0|||
131559845|NCT03560245|473674049|FG001|Overall Study|Lost to Follow-up|1|||
131559846|NCT03560245|473674048|FG000|Overall Study|Physician Decision|0|||
131559847|NCT03560245|473674049|FG001|Overall Study|Physician Decision|1|||
131559848|NCT03560245|473674048|FG000|Overall Study|Other|0|||
131559849|NCT03560245|473674049|FG001|Overall Study|Other|1|||
131559850|NCT01680458|473674052|FG000|Overall Study|Protocol Violation|3|||
131559851|NCT03864926|473675879|FG000|Overall Study|Death|0|||
131559852|NCT03864926|473675880|FG001|Overall Study|Death|2|||
131559853|NCT00445601|473675881|FG000|Overall Study|Withdrawal by Subject|11|||
131559854|NCT00445601|473675882|FG001|Overall Study|Withdrawal by Subject|11|||
131559855|NCT00445601|473675881|FG000|Overall Study|TURBT Complication|12|||
131559856|NCT00445601|473675882|FG001|Overall Study|TURBT Complication|8|||
131559857|NCT00445601|473675881|FG000|Overall Study|Incorrect Disease Status|6|||
131559858|NCT00445601|473675882|FG001|Overall Study|Incorrect Disease Status|6|||
131559859|NCT00445601|473675881|FG000|Overall Study|Drug Delivery Issue|2|||
131779934|NCT01244516|474473952|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
131779935|NCT01244516|474473953|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
131779936|NCT01244516|474473951|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
131559860|NCT00445601|473675882|FG001|Overall Study|Drug Delivery Issue|2|||
131559861|NCT00445601|473675881|FG000|Overall Study|Adverse Event|2|||
131559862|NCT00445601|473675882|FG001|Overall Study|Adverse Event|0|||
131559863|NCT00445601|473675881|FG000|Overall Study|Death prior to TURBT|0|||
131559864|NCT00445601|473675882|FG001|Overall Study|Death prior to TURBT|1|||
131559865|NCT02391038|473675889|FG000|Overall Study|Progressive disease|3|||
131559866|NCT02391038|473675890|FG001|Overall Study|Progressive disease|3|||
131559867|NCT02391038|473675891|FG002|Overall Study|Progressive disease|6|||
131559868|NCT04424290|473675897|FG000|Overall Study|Not treated|0|||
131779937|NCT01244516|474473952|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
131559869|NCT04424290|473675898|FG001|Overall Study|Not treated|0|||
131559870|NCT04424290|473675899|FG002|Overall Study|Not treated|1|||
131559871|NCT04424290|473675900|FG003|Overall Study|Not treated|0|||
131559872|NCT04424290|473675901|FG004|Overall Study|Not treated|1|||
131559873|NCT04424290|473675897|FG000|Overall Study|Adverse Event|0|||
131559874|NCT04424290|473675898|FG001|Overall Study|Adverse Event|0|||
131559875|NCT04424290|473675899|FG002|Overall Study|Adverse Event|0|||
131559876|NCT04424290|473675900|FG003|Overall Study|Adverse Event|2|||
131559877|NCT04424290|473675901|FG004|Overall Study|Adverse Event|0|||
131559878|NCT04424290|473675897|FG000|Overall Study|Withdrawal by Subject|0|||
131559879|NCT04424290|473675898|FG001|Overall Study|Withdrawal by Subject|0|||
131559880|NCT04424290|473675899|FG002|Overall Study|Withdrawal by Subject|0|||
131559881|NCT04424290|473675900|FG003|Overall Study|Withdrawal by Subject|0|||
131559882|NCT04424290|473675901|FG004|Overall Study|Withdrawal by Subject|1|||
131559883|NCT04424290|473675897|FG000|Overall Study|Other than listed|0|||
131559884|NCT04424290|473675898|FG001|Overall Study|Other than listed|0|||
131559885|NCT04424290|473675899|FG002|Overall Study|Other than listed|0|||
131559886|NCT04424290|473675900|FG003|Overall Study|Other than listed|1|||
131559887|NCT04424290|473675901|FG004|Overall Study|Other than listed|0|||
131559888|NCT03918239|473675902|FG000|Overall Study|Lost to Follow-up|3|||
131559889|NCT03918239|473675903|FG001|Overall Study|Lost to Follow-up|1|||
131559890|NCT03918239|473675902|FG000|Overall Study|Pregnancy|0|||
131559891|NCT03918239|473675903|FG001|Overall Study|Pregnancy|2|||
131559892|NCT03918239|473675902|FG000|Overall Study|Withdrawal by Subject|3|||
131694679|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
131694680|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
131694681|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
131694682|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
131694683|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
131694684|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
131694685|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
131694686|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
131694687|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
131694688|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
131694689|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
131694690|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
131694691|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
131694692|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
131694693|NCT03605680|474165029|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
131694694|NCT03605680|474165030|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
131694695|NCT03605680|474165031|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
131694696|NCT03605680|474165032|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
131694697|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
131694698|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
131694699|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
131694700|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
131694701|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
131694702|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
131694703|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
131694704|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
131694705|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131694706|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131694707|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131694708|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
131694709|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
131694710|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
131694711|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
131694712|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
131694713|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
131694714|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
131694715|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
131694716|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
131694717|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
131694718|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
131694719|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
131694720|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
131694721|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
131694722|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
131694723|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
131694724|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
131694725|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
131694726|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
131694727|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
131559893|NCT03918239|473675903|FG001|Overall Study|Withdrawal by Subject|3|||
131694728|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
131694729|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
131694730|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
131694731|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
131694732|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
131694733|NCT03605680|474165029|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
131694734|NCT03605680|474165030|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
131694735|NCT03605680|474165031|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
131694736|NCT03605680|474165032|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
131694737|NCT02192827|474165034|FG000|Overall Study|Lost to Follow-up|25|||
131694738|NCT02192827|474165035|FG001|Overall Study|Lost to Follow-up|27|||
131694739|NCT02192827|474165034|FG000|Overall Study|Given additional steroids with admission|13|||
131694740|NCT02192827|474165035|FG001|Overall Study|Given additional steroids with admission|11|||
131694741|NCT03509350|474165036|FG000|Overall Study|Withdrawal by Subject|0|||
131694742|NCT03509350|474165037|FG001|Overall Study|Withdrawal by Subject|2|||
131694743|NCT00290433|474165038|FG000|Overall Study|Disease Progression|13|||
131694744|NCT00290433|474165038|FG000|Overall Study|Adverse Event|14|||
131694745|NCT00290433|474165038|FG000|Overall Study|Withdrawal by Subject|1|||
131694746|NCT00290433|474165038|FG000|Overall Study|Non-Compliance|1|||
131694747|NCT00290433|474165038|FG000|Overall Study|Congestive Heart Failure|1|||
131694748|NCT00290433|474165038|FG000|Overall Study|Transplant in CR|5|||
131694749|NCT00290433|474165038|FG000|Overall Study|Unrelated Infection/Death|1|||
131694750|NCT02559687|474165039|FG000|Overall Study|Death|112|||
131694751|NCT02559687|474165039|FG000|Overall Study|Sponsor Decision|5|||
131694752|NCT02559687|474165039|FG000|Overall Study|Withdrawal by Subject|4|||
131694753|NCT03031301|474165046|FG000|Overall Study|Protocol Violation|4|||
131694754|NCT03031301|474165047|FG001|Overall Study|Protocol Violation|8|||
131694755|NCT03031301|474165046|FG000|Overall Study|Withdrawal by Subject|7|||
131694756|NCT03031301|474165047|FG001|Overall Study|Withdrawal by Subject|4|||
131694757|NCT03031301|474165046|FG000|Overall Study|Lost to Follow-up|4|||
131694758|NCT03031301|474165047|FG001|Overall Study|Lost to Follow-up|12|||
131694759|NCT03031301|474165046|FG000|Overall Study|Noncompliance|1|||
131694760|NCT03031301|474165047|FG001|Overall Study|Noncompliance|3|||
131694761|NCT03031301|474165046|FG000|Overall Study|Technical issue|1|||
131694762|NCT03031301|474165047|FG001|Overall Study|Technical issue|1|||
131694763|NCT03031301|474165046|FG000|Overall Study|Adverse Event|1|||
131694764|NCT03031301|474165047|FG001|Overall Study|Adverse Event|0|||
131694765|NCT01784861|474165048|FG000|Overall Study|Adverse Event|0|||
131694766|NCT01784861|474165049|FG001|Overall Study|Adverse Event|0|||
131694767|NCT01784861|474165050|FG002|Overall Study|Adverse Event|1|||
131694768|NCT01784861|474165051|FG003|Overall Study|Adverse Event|2|||
131694769|NCT01784861|474165052|FG004|Overall Study|Adverse Event|1|||
131694770|NCT01784861|474165053|FG005|Overall Study|Adverse Event|0|||
131694771|NCT01784861|474165048|FG000|Overall Study|Withdrawal by Subject|0|||
131694772|NCT01784861|474165049|FG001|Overall Study|Withdrawal by Subject|0|||
131694773|NCT01784861|474165050|FG002|Overall Study|Withdrawal by Subject|0|||
131694774|NCT01784861|474165051|FG003|Overall Study|Withdrawal by Subject|1|||
131694775|NCT01784861|474165052|FG004|Overall Study|Withdrawal by Subject|0|||
131694776|NCT01784861|474165053|FG005|Overall Study|Withdrawal by Subject|0|||
131694777|NCT01784861|474165048|FG000|Overall Study|Physician Decision|0|||
131694778|NCT01784861|474165049|FG001|Overall Study|Physician Decision|0|||
131694779|NCT01784861|474165050|FG002|Overall Study|Physician Decision|0|||
131694780|NCT01784861|474165051|FG003|Overall Study|Physician Decision|2|||
131694781|NCT01784861|474165052|FG004|Overall Study|Physician Decision|0|||
131694782|NCT01784861|474165053|FG005|Overall Study|Physician Decision|1|||
131694783|NCT03948178|474165056|FG000|Overall Study|Protocol Violation|1|||
131694784|NCT03948178|474165056|FG000|Overall Study|Lost to Follow-up|2|||
131694785|NCT03948178|474165056|FG000|Overall Study|Withdrawal by Subject|2|||
131694786|NCT03948178|474165056|FG000|Overall Study|Reason not known|2|||
131694787|NCT03948178|474165056|FG000|Overall Study|Personal reason|14|||
131694788|NCT03948178|474165056|FG000|Overall Study|Disease progression|30|||
131779938|NCT01244516|474473953|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
131559894|NCT03918239|473675902|FG000|Overall Study|positive urine drug screening results|4|||
131694789|NCT03948178|474165056|FG000|Overall Study|Adverse Event|12|||
131694790|NCT03948178|474165056|FG000|Overall Study|Sponsor terminated study|164|||
131694791|NCT02432235|474165057|FG000|Overall Study|Death|1|||
131694792|NCT02432235|474165058|FG001|Overall Study|Death|1|||
131694793|NCT02432235|474165059|FG002|Overall Study|Death|2|||
131694794|NCT02432235|474165060|FG003|Overall Study|Death|2|||
131694795|NCT02432235|474165061|FG004|Overall Study|Death|1|||
131694796|NCT02432235|474165062|FG005|Overall Study|Death|3|||
131694797|NCT02432235|474165063|FG006|Overall Study|Death|11|||
131694798|NCT02432235|474165064|FG007|Overall Study|Death|15|||
131694799|NCT02432235|474165065|FG008|Overall Study|Death|15|||
131694800|NCT02432235|474165066|FG009|Overall Study|Death|3|||
131694801|NCT02432235|474165067|FG010|Overall Study|Death|1|||
131694802|NCT02432235|474165068|FG011|Overall Study|Death|0|||
131779939|NCT01244516|474473951|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
131779940|NCT01244516|474473952|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
131779941|NCT01244516|474473953|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
131779942|NCT03345485|474473956|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
131779943|NCT03345485|474473957|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
131779944|NCT03345485|474473958|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
131779945|NCT03345485|474473959|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
131779946|NCT03345485|474473960|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
131779947|NCT03345485|474473961|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
131779948|NCT03345485|474473962|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
131779949|NCT03345485|474473963|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
131779950|NCT03345485|474473964|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
131779951|NCT03345485|474473965|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
131779952|NCT03345485|474473966|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
131779953|NCT03345485|474473967|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
131779954|NCT03345485|474473968|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
131779955|NCT03359473|474473969|FG000|Overall Study|Adverse Event|0|||
131779956|NCT03359473|474473970|FG001|Overall Study|Adverse Event|2|||
131779957|NCT03359473|474473971|FG002|Overall Study|Adverse Event|5|||
131779958|NCT03359473|474473972|FG003|Overall Study|Adverse Event|3|||
131779959|NCT03359473|474473969|FG000|Overall Study|Lost to Follow-up|0|||
131779960|NCT03359473|474473970|FG001|Overall Study|Lost to Follow-up|1|||
131779961|NCT03359473|474473971|FG002|Overall Study|Lost to Follow-up|0|||
131779962|NCT03359473|474473972|FG003|Overall Study|Lost to Follow-up|0|||
131779963|NCT03359473|474473969|FG000|Overall Study|Physician Decision|0|||
131779964|NCT03359473|474473970|FG001|Overall Study|Physician Decision|1|||
131779965|NCT03359473|474473971|FG002|Overall Study|Physician Decision|0|||
131779966|NCT03359473|474473972|FG003|Overall Study|Physician Decision|1|||
131779967|NCT03359473|474473969|FG000|Overall Study|Withdrawal by Subject|1|||
131779968|NCT03359473|474473970|FG001|Overall Study|Withdrawal by Subject|2|||
131779969|NCT03359473|474473971|FG002|Overall Study|Withdrawal by Subject|1|||
131779970|NCT03359473|474473972|FG003|Overall Study|Withdrawal by Subject|0|||
131779971|NCT03359473|474473969|FG000|Overall Study|Protocol-defined stopping criteria|1|||
131779972|NCT03359473|474473970|FG001|Overall Study|Protocol-defined stopping criteria|0|||
131779973|NCT03359473|474473971|FG002|Overall Study|Protocol-defined stopping criteria|0|||
131779974|NCT03359473|474473972|FG003|Overall Study|Protocol-defined stopping criteria|1|||
131779975|NCT01610284|474473973|FG000|Randomization Phase|Adverse Event|1|||
131779976|NCT01610284|474473974|FG001|Randomization Phase|Adverse Event|0|||
131779977|NCT01610284|474473973|FG000|Randomization Phase|Physician Decision|1|||
131779978|NCT01610284|474473974|FG001|Randomization Phase|Physician Decision|1|||
131779979|NCT01610284|474473973|FG000|Randomization Phase|Death|0|||
131779980|NCT01610284|474473974|FG001|Randomization Phase|Death|1|||
131779981|NCT01610284|474473973|FG000|Treatment Phase|Adverse Event|80|||
131779982|NCT01610284|474473974|FG001|Treatment Phase|Adverse Event|12|||
131779983|NCT01610284|474473973|FG000|Treatment Phase|Lost to Follow-up|1|||
131779984|NCT01610284|474473974|FG001|Treatment Phase|Lost to Follow-up|0|||
131779985|NCT01610284|474473973|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
131779986|NCT01610284|474473974|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
131779987|NCT01610284|474473973|FG000|Treatment Phase|Physician Decision|27|||
131779988|NCT01610284|474473974|FG001|Treatment Phase|Physician Decision|24|||
131779989|NCT01610284|474473973|FG000|Treatment Phase|Progressive Disease|377|||
131779990|NCT01610284|474473974|FG001|Treatment Phase|Progressive Disease|486|||
131779991|NCT01610284|474473973|FG000|Treatment Phase|Protocol Deviation|2|||
131779992|NCT01610284|474473974|FG001|Treatment Phase|Protocol Deviation|3|||
131779993|NCT01610284|474473973|FG000|Treatment Phase|Study terminated by Sponsor|18|||
131779994|NCT01610284|474473974|FG001|Treatment Phase|Study terminated by Sponsor|15|||
131779995|NCT01610284|474473973|FG000|Treatment Phase|Subject/Guardian Decision|55|||
131779996|NCT01610284|474473974|FG001|Treatment Phase|Subject/Guardian Decision|23|||
131779997|NCT01610284|474473973|FG000|Treatment Phase|Death|6|||
131779998|NCT01610284|474473974|FG001|Treatment Phase|Death|5|||
131779999|NCT01610284|474473973|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
131780000|NCT01610284|474473974|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131780001|NCT01610284|474473973|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
131780002|NCT01610284|474473974|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
131780003|NCT01610284|474473973|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
131898559|NCT02998996|474914130|FG000|Overall Study|Pregnancy|0|||
131780004|NCT01610284|474473974|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
131780005|NCT01610284|474473973|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
131780006|NCT01610284|474473974|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
131780007|NCT01610284|474473973|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
131780008|NCT01610284|474473974|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
131898560|NCT02998996|474914131|FG001|Overall Study|Pregnancy|1|||
131898561|NCT02998996|474914132|FG002|Overall Study|Pregnancy|0|||
131694803|NCT02432235|474165057|FG000|Overall Study|Withdrawal by Subject|0|||
131694804|NCT02432235|474165058|FG001|Overall Study|Withdrawal by Subject|1|||
131694805|NCT02432235|474165059|FG002|Overall Study|Withdrawal by Subject|0|||
131694806|NCT02432235|474165060|FG003|Overall Study|Withdrawal by Subject|0|||
131694807|NCT02432235|474165061|FG004|Overall Study|Withdrawal by Subject|0|||
131694808|NCT02432235|474165062|FG005|Overall Study|Withdrawal by Subject|2|||
131694809|NCT02432235|474165063|FG006|Overall Study|Withdrawal by Subject|5|||
131694810|NCT02432235|474165064|FG007|Overall Study|Withdrawal by Subject|3|||
131694811|NCT02432235|474165065|FG008|Overall Study|Withdrawal by Subject|1|||
131694812|NCT02432235|474165066|FG009|Overall Study|Withdrawal by Subject|0|||
131694813|NCT02432235|474165067|FG010|Overall Study|Withdrawal by Subject|0|||
131694814|NCT02432235|474165068|FG011|Overall Study|Withdrawal by Subject|0|||
131694815|NCT02432235|474165057|FG000|Overall Study|Lost to Follow-up|0|||
131694816|NCT02432235|474165058|FG001|Overall Study|Lost to Follow-up|0|||
131694817|NCT02432235|474165059|FG002|Overall Study|Lost to Follow-up|0|||
131694818|NCT02432235|474165060|FG003|Overall Study|Lost to Follow-up|0|||
131694819|NCT02432235|474165061|FG004|Overall Study|Lost to Follow-up|0|||
131694820|NCT02432235|474165062|FG005|Overall Study|Lost to Follow-up|1|||
131694821|NCT02432235|474165063|FG006|Overall Study|Lost to Follow-up|0|||
131694822|NCT02432235|474165064|FG007|Overall Study|Lost to Follow-up|0|||
131694823|NCT02432235|474165065|FG008|Overall Study|Lost to Follow-up|1|||
131694824|NCT02432235|474165066|FG009|Overall Study|Lost to Follow-up|0|||
131694825|NCT02432235|474165067|FG010|Overall Study|Lost to Follow-up|0|||
131694826|NCT02432235|474165068|FG011|Overall Study|Lost to Follow-up|0|||
131694827|NCT02432235|474165057|FG000|Overall Study|Miscellaneous|0|||
131694828|NCT02432235|474165058|FG001|Overall Study|Miscellaneous|0|||
131694829|NCT02432235|474165059|FG002|Overall Study|Miscellaneous|0|||
131694830|NCT02432235|474165060|FG003|Overall Study|Miscellaneous|0|||
131694831|NCT02432235|474165061|FG004|Overall Study|Miscellaneous|1|||
131694832|NCT02432235|474165062|FG005|Overall Study|Miscellaneous|6|||
131694833|NCT02432235|474165063|FG006|Overall Study|Miscellaneous|2|||
131694834|NCT02432235|474165064|FG007|Overall Study|Miscellaneous|2|||
131694835|NCT02432235|474165065|FG008|Overall Study|Miscellaneous|4|||
131694836|NCT02432235|474165066|FG009|Overall Study|Miscellaneous|0|||
131694837|NCT02432235|474165067|FG010|Overall Study|Miscellaneous|0|||
131694838|NCT02432235|474165068|FG011|Overall Study|Miscellaneous|1|||
131694839|NCT00382993|474165069|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
131694840|NCT00382993|474165070|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
131694841|NCT00382993|474165069|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
131694842|NCT00382993|474165070|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
131694843|NCT00382993|474165069|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
131694844|NCT00382993|474165070|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
131694845|NCT00382993|474165069|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
131694846|NCT00382993|474165070|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
131694847|NCT00382993|474165069|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
131694848|NCT00382993|474165070|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
131694849|NCT00382993|474165069|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
131694850|NCT00382993|474165070|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
131694851|NCT00382993|474165069|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
131694852|NCT00382993|474165070|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
131694853|NCT00382993|474165069|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
131694854|NCT00382993|474165070|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
131694855|NCT00382993|474165069|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
131694856|NCT00382993|474165070|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
131694857|NCT00382993|474165069|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
131780009|NCT01610284|474473973|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
131694858|NCT00382993|474165070|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
131694859|NCT01965262|474165083|FG000|Second Intervention (7 Days)|Discontinued|0|||
131694860|NCT01965262|474165084|FG001|Second Intervention (7 Days)|Discontinued|1|||
131694861|NCT01965262|474165083|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
131559895|NCT03918239|473675903|FG001|Overall Study|positive urine drug screening results|1|||
131559896|NCT04249336|473675906|FG000|Overall Study|Lost to Follow-up|3|||
131559897|NCT04249336|473675907|FG001|Overall Study|Lost to Follow-up|3|||
131559898|NCT04249336|473675908|FG002|Overall Study|Lost to Follow-up|3|||
131559899|NCT04249336|473675909|FG003|Overall Study|Lost to Follow-up|3|||
131559900|NCT01242176|473675910|FG000|Washout Period of 7 Days|Adverse Event|0|||
131559901|NCT01242176|473675911|FG001|Washout Period of 7 Days|Adverse Event|2|||
131559902|NCT01242176|473675910|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
131559903|NCT01242176|473675911|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
131559904|NCT03390036|473675912|FG000|Overall Study|Lost to Follow-up|1|||
131559905|NCT03390036|473675913|FG001|Overall Study|Lost to Follow-up|0|||
131559906|NCT03390036|473675914|FG002|Overall Study|Lost to Follow-up|0|||
131559907|NCT03390036|473675912|FG000|Overall Study|Lack of Efficacy|1|||
131559908|NCT03390036|473675913|FG001|Overall Study|Lack of Efficacy|0|||
131559909|NCT03390036|473675914|FG002|Overall Study|Lack of Efficacy|0|||
131559910|NCT00358215|473675917|FG000|Overall Study|Ineligibility determined|4|||
131559911|NCT00358215|473675918|FG001|Overall Study|Ineligibility determined|3|||
131559912|NCT00358215|473675917|FG000|Overall Study|Adverse Event|83|||
131559913|NCT00358215|473675918|FG001|Overall Study|Adverse Event|65|||
131559914|NCT00358215|473675917|FG000|Overall Study|Withdrawal by Subject|111|||
131559915|NCT00358215|473675918|FG001|Overall Study|Withdrawal by Subject|102|||
131559916|NCT00358215|473675917|FG000|Overall Study|Participant request|65|||
131559917|NCT00358215|473675918|FG001|Overall Study|Participant request|64|||
131559918|NCT00358215|473675917|FG000|Overall Study|Physician Decision|47|||
131559919|NCT00358215|473675918|FG001|Overall Study|Physician Decision|39|||
131559920|NCT00358215|473675917|FG000|Overall Study|Lost to Follow-up|16|||
131559921|NCT00358215|473675918|FG001|Overall Study|Lost to Follow-up|22|||
131559922|NCT00358215|473675917|FG000|Overall Study|Death|265|||
131559923|NCT00358215|473675918|FG001|Overall Study|Death|281|||
131694862|NCT01965262|474165084|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
131694863|NCT01965262|474165083|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
131694864|NCT01965262|474165084|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
131694865|NCT02941627|474165085|FG000|Overall Study|Death|1|||
131694866|NCT02941627|474165085|FG000|Overall Study|Surgical failure|1|||
131694867|NCT02941627|474165085|FG000|Overall Study|cholesteatoma prevented implantation|1|||
131694868|NCT03594227|474165090|FG000|Overall Study|Adverse Event|2|||
131694869|NCT03594227|474165091|FG001|Overall Study|Adverse Event|1|||
131694870|NCT03594227|474165092|FG002|Overall Study|Adverse Event|0|||
131694871|NCT03594227|474165093|FG003|Overall Study|Adverse Event|2|||
131694872|NCT03594227|474165090|FG000|Overall Study|Lost to Follow-up|1|||
131694873|NCT03594227|474165091|FG001|Overall Study|Lost to Follow-up|1|||
131694874|NCT03594227|474165092|FG002|Overall Study|Lost to Follow-up|1|||
131559924|NCT00358215|473675917|FG000|Overall Study|Protocol Violation|64|||
131559925|NCT00358215|473675918|FG001|Overall Study|Protocol Violation|59|||
131559926|NCT00358215|473675917|FG000|Overall Study|Pregnancy|1|||
131559927|NCT00358215|473675918|FG001|Overall Study|Pregnancy|0|||
131559928|NCT00358215|473675917|FG000|Overall Study|Other|21|||
131559929|NCT00358215|473675918|FG001|Overall Study|Other|14|||
131559930|NCT00358215|473675917|FG000|Overall Study|Did not receive investigational product|2|||
131559931|NCT00358215|473675918|FG001|Overall Study|Did not receive investigational product|3|||
131559932|NCT01189890|473675921|FG000|Overall Study|Adverse Event|3|||
131559933|NCT01189890|473675922|FG001|Overall Study|Adverse Event|4|||
131559934|NCT01189890|473675921|FG000|Overall Study|Lack of Efficacy|7|||
131559935|NCT01189890|473675922|FG001|Overall Study|Lack of Efficacy|2|||
131559936|NCT01189890|473675921|FG000|Overall Study|Lost to Follow-up|1|||
131559937|NCT01189890|473675922|FG001|Overall Study|Lost to Follow-up|7|||
131559938|NCT01189890|473675921|FG000|Overall Study|Protocol Violation|1|||
131559939|NCT01189890|473675922|FG001|Overall Study|Protocol Violation|5|||
131559940|NCT01189890|473675921|FG000|Overall Study|Withdrawal by Subject|15|||
131559941|NCT01189890|473675922|FG001|Overall Study|Withdrawal by Subject|11|||
131559942|NCT01189890|473675921|FG000|Overall Study|Non Compliance|0|||
131559943|NCT01189890|473675922|FG001|Overall Study|Non Compliance|1|||
131559944|NCT01189890|473675921|FG000|Overall Study|Physician Decision|5|||
131559945|NCT01189890|473675922|FG001|Overall Study|Physician Decision|4|||
131559946|NCT01189890|473675921|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
131559947|NCT01189890|473675922|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
131559948|NCT01807221|473675925|FG000|Overall Study|Progressive disease|1|||
131559949|NCT01807221|473675926|FG001|Overall Study|Progressive disease|0|||
131559950|NCT01807221|473675927|FG002|Overall Study|Progressive disease|1|||
131559951|NCT01807221|473675928|FG003|Overall Study|Progressive disease|0|||
131559952|NCT01807221|473675929|FG004|Overall Study|Progressive disease|0|||
131559953|NCT01807221|473675930|FG005|Overall Study|Progressive disease|0|||
131559954|NCT01807221|473675925|FG000|Overall Study|Death|7|||
131694875|NCT03594227|474165093|FG003|Overall Study|Lost to Follow-up|0|||
131694876|NCT03594227|474165090|FG000|Overall Study|Withdrawal by Subject|1|||
131694877|NCT03594227|474165091|FG001|Overall Study|Withdrawal by Subject|1|||
131694878|NCT03594227|474165092|FG002|Overall Study|Withdrawal by Subject|1|||
131559955|NCT01807221|473675926|FG001|Overall Study|Death|9|||
131559956|NCT01807221|473675927|FG002|Overall Study|Death|4|||
131559957|NCT01807221|473675928|FG003|Overall Study|Death|2|||
131559958|NCT01807221|473675929|FG004|Overall Study|Death|1|||
131559959|NCT01807221|473675930|FG005|Overall Study|Death|6|||
131559960|NCT01807221|473675925|FG000|Overall Study|Physician Decision|2|||
131559961|NCT01807221|473675926|FG001|Overall Study|Physician Decision|1|||
131559962|NCT01807221|473675927|FG002|Overall Study|Physician Decision|0|||
131559963|NCT01807221|473675928|FG003|Overall Study|Physician Decision|0|||
131436798|NCT02079740|473225615|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
131559964|NCT01807221|473675929|FG004|Overall Study|Physician Decision|0|||
131559965|NCT01807221|473675930|FG005|Overall Study|Physician Decision|0|||
131559966|NCT01807221|473675925|FG000|Overall Study|Adverse Event|33|||
131559967|NCT01807221|473675926|FG001|Overall Study|Adverse Event|22|||
131559968|NCT01807221|473675927|FG002|Overall Study|Adverse Event|26|||
131559969|NCT01807221|473675928|FG003|Overall Study|Adverse Event|25|||
131559970|NCT01807221|473675929|FG004|Overall Study|Adverse Event|18|||
131559971|NCT01807221|473675930|FG005|Overall Study|Adverse Event|21|||
131559972|NCT01807221|473675925|FG000|Overall Study|Protocol Violation|0|||
131559973|NCT01807221|473675926|FG001|Overall Study|Protocol Violation|2|||
131559974|NCT01807221|473675927|FG002|Overall Study|Protocol Violation|1|||
131559975|NCT01807221|473675928|FG003|Overall Study|Protocol Violation|2|||
131559976|NCT01807221|473675929|FG004|Overall Study|Protocol Violation|0|||
131559977|NCT01807221|473675930|FG005|Overall Study|Protocol Violation|1|||
131694879|NCT03594227|474165093|FG003|Overall Study|Withdrawal by Subject|1|||
131694880|NCT03594227|474165090|FG000|Overall Study|Pregnancy|0|||
131694881|NCT03594227|474165091|FG001|Overall Study|Pregnancy|1|||
131694882|NCT03594227|474165092|FG002|Overall Study|Pregnancy|0|||
131694883|NCT03594227|474165093|FG003|Overall Study|Pregnancy|0|||
131694884|NCT03594227|474165090|FG000|Overall Study|Sponsor Decision|0|||
131694885|NCT03594227|474165091|FG001|Overall Study|Sponsor Decision|0|||
131694886|NCT03594227|474165092|FG002|Overall Study|Sponsor Decision|0|||
131694887|NCT03594227|474165093|FG003|Overall Study|Sponsor Decision|1|||
131694888|NCT03594227|474165090|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
131694889|NCT03594227|474165091|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
131694890|NCT03594227|474165092|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
131694891|NCT03594227|474165093|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
131694892|NCT00790907|474165094|FG000|Overall Study|Adverse Event|9|||
131694893|NCT00790907|474165095|FG001|Overall Study|Adverse Event|7|||
131694894|NCT00790907|474165096|FG002|Overall Study|Adverse Event|6|||
131694895|NCT00790907|474165094|FG000|Overall Study|Physician Decision|304|||
131694896|NCT00790907|474165095|FG001|Overall Study|Physician Decision|271|||
131694897|NCT00790907|474165096|FG002|Overall Study|Physician Decision|255|||
131694898|NCT00790907|474165094|FG000|Overall Study|Withdrawal by Subject|1|||
131694899|NCT00790907|474165095|FG001|Overall Study|Withdrawal by Subject|7|||
131694900|NCT00790907|474165096|FG002|Overall Study|Withdrawal by Subject|5|||
131694901|NCT00790907|474165094|FG000|Overall Study|Bleeding Event|11|||
131694902|NCT00790907|474165095|FG001|Overall Study|Bleeding Event|16|||
131694903|NCT00790907|474165096|FG002|Overall Study|Bleeding Event|21|||
131694904|NCT00790907|474165094|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
131694905|NCT00790907|474165095|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
131694906|NCT00790907|474165096|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
131694907|NCT00790907|474165094|FG000|Overall Study|Qualifying Condition Not Present|29|||
131694908|NCT00790907|474165095|FG001|Overall Study|Qualifying Condition Not Present|14|||
131694909|NCT00790907|474165096|FG002|Overall Study|Qualifying Condition Not Present|16|||
131694910|NCT00790907|474165094|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
131559978|NCT01807221|473675925|FG000|Overall Study|Non-compliance|1|||
131559979|NCT01807221|473675926|FG001|Overall Study|Non-compliance|2|||
131559980|NCT01807221|473675927|FG002|Overall Study|Non-compliance|0|||
131559981|NCT01807221|473675928|FG003|Overall Study|Non-compliance|1|||
131694911|NCT00790907|474165095|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
131694912|NCT00790907|474165096|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
131694913|NCT00790907|474165094|FG000|Overall Study|Did Not Receive Study Drug|10|||
131694914|NCT00790907|474165095|FG001|Overall Study|Did Not Receive Study Drug|0|||
131559982|NCT01807221|473675929|FG004|Overall Study|Non-compliance|0|||
131559983|NCT01807221|473675930|FG005|Overall Study|Non-compliance|0|||
131898562|NCT02998996|474914133|FG003|Overall Study|Pregnancy|0|||
131694915|NCT00790907|474165096|FG002|Overall Study|Did Not Receive Study Drug|0|||
131694916|NCT02250274|474165097|FG000|Overall Study|Insufficient blood draw amount|7|||
131694917|NCT02250274|474165098|FG001|Overall Study|Insufficient blood draw amount|6|||
131694918|NCT00446511|474165101|FG000|Overall Study|Adverse Event|7|||
131694919|NCT00446511|474165102|FG001|Overall Study|Adverse Event|2|||
131694920|NCT00446511|474165103|FG002|Overall Study|Adverse Event|3|||
131694921|NCT00446511|474165104|FG003|Overall Study|Adverse Event|1|||
131694922|NCT00446511|474165101|FG000|Overall Study|Protocol Violation|0|||
131694923|NCT00446511|474165102|FG001|Overall Study|Protocol Violation|0|||
131694924|NCT00446511|474165103|FG002|Overall Study|Protocol Violation|0|||
131694925|NCT00446511|474165104|FG003|Overall Study|Protocol Violation|1|||
131694926|NCT00446511|474165101|FG000|Overall Study|Withdrawal by Subject|0|||
131694927|NCT00446511|474165102|FG001|Overall Study|Withdrawal by Subject|0|||
131694928|NCT00446511|474165103|FG002|Overall Study|Withdrawal by Subject|0|||
131694929|NCT00446511|474165104|FG003|Overall Study|Withdrawal by Subject|3|||
131694930|NCT00446511|474165101|FG000|Overall Study|Administrative Problems|3|||
131694931|NCT00446511|474165102|FG001|Overall Study|Administrative Problems|0|||
131694932|NCT00446511|474165103|FG002|Overall Study|Administrative Problems|4|||
131694933|NCT00446511|474165104|FG003|Overall Study|Administrative Problems|1|||
131694934|NCT01618214|474165105|FG000|Overall Study|Adverse Event|3|||
131694935|NCT01618214|474165106|FG001|Overall Study|Adverse Event|1|||
131694936|NCT01618214|474165105|FG000|Overall Study|Lack of Efficacy|1|||
131694937|NCT01618214|474165106|FG001|Overall Study|Lack of Efficacy|1|||
131694938|NCT01618214|474165105|FG000|Overall Study|Protocol Violation|1|||
131694939|NCT01618214|474165106|FG001|Overall Study|Protocol Violation|4|||
131694940|NCT01618214|474165105|FG000|Overall Study|Withdrawal Criteria|1|||
131694941|NCT01618214|474165106|FG001|Overall Study|Withdrawal Criteria|2|||
131694942|NCT01618214|474165105|FG000|Overall Study|Unclassified|4|||
131694943|NCT01618214|474165106|FG001|Overall Study|Unclassified|5|||
131694944|NCT02228590|474165108|FG000|Overall Study|Withdrawal by Subject|1|||
131694945|NCT00960843|474165109|FG000|Overall Study|Lost to Follow-up|2|||
131694946|NCT00960843|474165110|FG001|Overall Study|Lost to Follow-up|0|||
131694947|NCT00960843|474165109|FG000|Overall Study|Protocol Violation|0|||
131694948|NCT00960843|474165110|FG001|Overall Study|Protocol Violation|4|||
131694949|NCT00960843|474165109|FG000|Overall Study|Repeated needle dislodgment|0|||
131694950|NCT00960843|474165110|FG001|Overall Study|Repeated needle dislodgment|1|||
131694951|NCT04486950|474165111|FG000|Overall Study|Lost to Follow-up|0|||
131694952|NCT04486950|474165112|FG001|Overall Study|Lost to Follow-up|0|||
131694953|NCT04486950|474165113|FG002|Overall Study|Lost to Follow-up|0|||
131694954|NCT04486950|474165114|FG003|Overall Study|Lost to Follow-up|0|||
131694955|NCT04486950|474165115|FG004|Overall Study|Lost to Follow-up|0|||
131694956|NCT04486950|474165116|FG005|Overall Study|Lost to Follow-up|1|||
131694957|NCT04486950|474165117|FG006|Overall Study|Lost to Follow-up|0|||
131694958|NCT04703075|474165118|FG000|Overall Study|Adverse Event|11|||
131694959|NCT04703075|474165119|FG001|Overall Study|Adverse Event|7|||
131694960|NCT04703075|474165118|FG000|Overall Study|Lost to Follow-up|6|||
131694961|NCT04703075|474165119|FG001|Overall Study|Lost to Follow-up|12|||
131694962|NCT04703075|474165118|FG000|Overall Study|Physician Decision|3|||
131694963|NCT04703075|474165119|FG001|Overall Study|Physician Decision|0|||
131694964|NCT04703075|474165118|FG000|Overall Study|Moved|0|||
131694965|NCT04703075|474165119|FG001|Overall Study|Moved|2|||
131694966|NCT04703075|474165118|FG000|Overall Study|Index INH Resistant|0|||
131694967|NCT04703075|474165119|FG001|Overall Study|Index INH Resistant|1|||
131694968|NCT04703075|474165118|FG000|Overall Study|Lack of Efficacy|6|||
131694969|NCT04703075|474165119|FG001|Overall Study|Lack of Efficacy|18|||
131694970|NCT01119248|474165120|FG000|Overall Study|Physician Decision|5|||
131694971|NCT01967550|474165121|FG000|Overall Study|Withdrawal by Subject|1|||
131694972|NCT01967550|474165122|FG001|Overall Study|Withdrawal by Subject|0|||
131694973|NCT01967550|474165121|FG000|Overall Study|Adverse Event|2|||
131694974|NCT01967550|474165122|FG001|Overall Study|Adverse Event|0|||
131694975|NCT01967550|474165121|FG000|Overall Study|Protocol Violation|2|||
131694976|NCT01967550|474165122|FG001|Overall Study|Protocol Violation|1|||
131694977|NCT01967550|474165121|FG000|Overall Study|Non Compliance|0|||
131694978|NCT01967550|474165122|FG001|Overall Study|Non Compliance|1|||
131694979|NCT00562354|474165123|FG000|Overall Study|Physician Decision|0|||
131694980|NCT00562354|474165124|FG001|Overall Study|Physician Decision|1|||
131694981|NCT00562354|474165123|FG000|Overall Study|Lost to Follow-up|0|||
131694982|NCT00562354|474165124|FG001|Overall Study|Lost to Follow-up|1|||
131694983|NCT00317109|474165125|FG000|Overall Study|Withdrawal by Subject|2|||
131694984|NCT00317109|474165126|FG001|Overall Study|Withdrawal by Subject|0|||
131694985|NCT00317109|474165125|FG000|Overall Study|Migated/moved from study area|1|||
131694986|NCT00317109|474165126|FG001|Overall Study|Migated/moved from study area|0|||
131694987|NCT00805480|474165137|FG000|Overall Study|Withdrawal by Subject|13|||
131694988|NCT00805480|474165138|FG001|Overall Study|Withdrawal by Subject|5|||
131694989|NCT00805480|474165139|FG002|Overall Study|Withdrawal by Subject|11|||
131694990|NCT00805480|474165140|FG003|Overall Study|Withdrawal by Subject|5|||
131694991|NCT00805480|474165137|FG000|Overall Study|Lost to Follow-up|1|||
131694992|NCT00805480|474165138|FG001|Overall Study|Lost to Follow-up|2|||
131559984|NCT01807221|473675925|FG000|Overall Study|Logistical difficulties|0|||
131559985|NCT01807221|473675926|FG001|Overall Study|Logistical difficulties|1|||
131559986|NCT01807221|473675927|FG002|Overall Study|Logistical difficulties|0|||
131559987|NCT01807221|473675928|FG003|Overall Study|Logistical difficulties|0|||
131559988|NCT01807221|473675929|FG004|Overall Study|Logistical difficulties|1|||
131559989|NCT01807221|473675930|FG005|Overall Study|Logistical difficulties|0|||
131559990|NCT01807221|473675925|FG000|Overall Study|Withdrawal by Subject|33|||
131559991|NCT01807221|473675926|FG001|Overall Study|Withdrawal by Subject|15|||
131559992|NCT01807221|473675927|FG002|Overall Study|Withdrawal by Subject|8|||
131559993|NCT01807221|473675928|FG003|Overall Study|Withdrawal by Subject|14|||
131559994|NCT01807221|473675929|FG004|Overall Study|Withdrawal by Subject|16|||
131559995|NCT01807221|473675930|FG005|Overall Study|Withdrawal by Subject|13|||
131559996|NCT01807221|473675925|FG000|Overall Study|Sponsor decision|2|||
131559997|NCT01807221|473675926|FG001|Overall Study|Sponsor decision|0|||
131559998|NCT01807221|473675927|FG002|Overall Study|Sponsor decision|1|||
131559999|NCT01807221|473675928|FG003|Overall Study|Sponsor decision|1|||
131560000|NCT01807221|473675929|FG004|Overall Study|Sponsor decision|0|||
131560001|NCT01807221|473675930|FG005|Overall Study|Sponsor decision|0|||
131560002|NCT01807221|473675925|FG000|Overall Study|Lost to Follow-up|1|||
131560003|NCT01807221|473675926|FG001|Overall Study|Lost to Follow-up|0|||
131560004|NCT01807221|473675927|FG002|Overall Study|Lost to Follow-up|2|||
131560005|NCT01807221|473675928|FG003|Overall Study|Lost to Follow-up|1|||
131560006|NCT01807221|473675929|FG004|Overall Study|Lost to Follow-up|0|||
131560007|NCT01807221|473675930|FG005|Overall Study|Lost to Follow-up|0|||
131560008|NCT02609659|473675931|FG000|Overall Study|Adverse Event|1|||
131560009|NCT02609659|473675931|FG000|Overall Study|Lost to Follow-up|6|||
131560010|NCT02609659|473675931|FG000|Overall Study|Other|1|||
131560011|NCT04329104|473675934|FG000|Efficacy Study|Withdrawal by Subject|0|||
131560012|NCT04329104|473675935|FG001|Efficacy Study|Withdrawal by Subject|0|||
131560013|NCT04329104|473675936|FG002|Efficacy Study|Withdrawal by Subject|0|||
131560014|NCT04329104|473675937|FG003|Efficacy Study|Withdrawal by Subject|5|||
131560015|NCT04329104|473675938|FG004|Efficacy Study|Withdrawal by Subject|6|||
131560016|NCT04329104|473675939|FG005|Efficacy Study|Withdrawal by Subject|8|||
131560017|NCT00593554|473675940|FG000|Overall Study|Death|1|||
131560018|NCT00593554|473675941|FG001|Overall Study|Death|2|||
131560019|NCT00593554|473675940|FG000|Overall Study|Physician Decision|0|||
131560020|NCT00593554|473675941|FG001|Overall Study|Physician Decision|1|||
131560021|NCT00593554|473675940|FG000|Overall Study|Withdrawal by Subject|1|||
131560022|NCT00593554|473675941|FG001|Overall Study|Withdrawal by Subject|0|||
131560023|NCT00593554|473675940|FG000|Overall Study|Disease Progression|1|||
131560024|NCT00593554|473675941|FG001|Overall Study|Disease Progression|2|||
131560025|NCT01024959|473675946|FG000|Overall Study|ineligible|12|||
131560026|NCT01024959|473675946|FG000|Overall Study|results not evaluable|12|||
131560027|NCT01024959|473675946|FG000|Overall Study|missing results required for analysis|17|||
131560028|NCT01129336|473675947|FG000|Overall Study|Protocol Violation|1|||
131560029|NCT01129336|473675948|FG001|Overall Study|Protocol Violation|0|||
131560030|NCT01129336|473675947|FG000|Overall Study|Disease Progression|1|||
131560031|NCT01129336|473675948|FG001|Overall Study|Disease Progression|4|||
131560032|NCT01129336|473675947|FG000|Overall Study|Lost to Follow-up|1|||
131560033|NCT01129336|473675948|FG001|Overall Study|Lost to Follow-up|0|||
131560034|NCT01129336|473675947|FG000|Overall Study|Withdrawal by Subject|7|||
131560035|NCT01129336|473675948|FG001|Overall Study|Withdrawal by Subject|4|||
131560036|NCT01129336|473675947|FG000|Overall Study|Adverse Event|0|||
131560037|NCT01129336|473675948|FG001|Overall Study|Adverse Event|1|||
131560038|NCT01129336|473675947|FG000|Overall Study|Missing Study Completion Status|2|||
131560039|NCT01129336|473675948|FG001|Overall Study|Missing Study Completion Status|3|||
131560040|NCT01129336|473675947|FG000|Overall Study|Death|0|||
131560041|NCT01129336|473675948|FG001|Overall Study|Death|4|||
131560042|NCT00358150|473675949|FG000|Overall Study|Adverse Event|3|||
131560043|NCT00358150|473675949|FG000|Overall Study|Withdrawal by Subject|1|||
131560044|NCT00358150|473675949|FG000|Overall Study|Undefined|3|||
131560045|NCT02086552|473675956|FG000|Overall Study|Withdrawal by Subject|1|||
131560046|NCT02080520|473675962|FG000|Overall Study|Self-reported symptoms|5|||
131560047|NCT02080520|473675963|FG001|Overall Study|Self-reported symptoms|6|||
131560048|NCT02080520|473675962|FG000|Overall Study|Unable to contact|2|||
131560049|NCT02080520|473675963|FG001|Overall Study|Unable to contact|1|||
131560050|NCT02080520|473675962|FG000|Overall Study|Initiated aspirin|2|||
131560051|NCT02080520|473675963|FG001|Overall Study|Initiated aspirin|0|||
131560052|NCT02080520|473675962|FG000|Overall Study|Atrial fibrillation|1|||
131560053|NCT02080520|473675963|FG001|Overall Study|Atrial fibrillation|1|||
131560054|NCT02080520|473675962|FG000|Overall Study|Cancer|1|||
131560055|NCT02080520|473675963|FG001|Overall Study|Cancer|2|||
131560056|NCT02080520|473675962|FG000|Overall Study|Not interested in study|1|||
131560057|NCT02080520|473675963|FG001|Overall Study|Not interested in study|3|||
131560058|NCT02080520|473675962|FG000|Overall Study|Too busy|1|||
131560059|NCT02080520|473675963|FG001|Overall Study|Too busy|1|||
131560060|NCT02080520|473675962|FG000|Overall Study|Work-related injury|1|||
131560061|NCT02080520|473675963|FG001|Overall Study|Work-related injury|0|||
131560062|NCT02080520|473675962|FG000|Overall Study|Personal reasons|0|||
131694993|NCT00805480|474165139|FG002|Overall Study|Lost to Follow-up|0|||
131694994|NCT00805480|474165140|FG003|Overall Study|Lost to Follow-up|0|||
131694995|NCT00805480|474165137|FG000|Overall Study|Adverse Event|0|||
131694996|NCT00805480|474165138|FG001|Overall Study|Adverse Event|0|||
131694997|NCT00805480|474165139|FG002|Overall Study|Adverse Event|1|||
131694998|NCT00805480|474165140|FG003|Overall Study|Adverse Event|0|||
131694999|NCT00562588|474165141|FG000|Overall Study|Adverse Event|40|||
131695000|NCT00562588|474165142|FG001|Overall Study|Adverse Event|58|||
131695001|NCT00562588|474165141|FG000|Overall Study|Protocol Violation|30|||
131695002|NCT00562588|474165142|FG001|Overall Study|Protocol Violation|26|||
131695003|NCT00562588|474165141|FG000|Overall Study|Lost to Follow-up|12|||
131695004|NCT00562588|474165142|FG001|Overall Study|Lost to Follow-up|4|||
131695005|NCT00562588|474165141|FG000|Overall Study|Withdrawal by Subject|10|||
131695006|NCT00562588|474165142|FG001|Overall Study|Withdrawal by Subject|9|||
131695007|NCT00562588|474165141|FG000|Overall Study|Other|0|||
131695008|NCT00562588|474165142|FG001|Overall Study|Other|2|||
131695009|NCT03315871|474165146|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
131695010|NCT03315871|474165147|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
131695011|NCT03315871|474165148|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
131695012|NCT03315871|474165146|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
131695013|NCT03315871|474165147|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
131695014|NCT03315871|474165148|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
131695015|NCT03315871|474165146|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
131695016|NCT03315871|474165147|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
131695017|NCT03315871|474165148|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
131695018|NCT03315871|474165146|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
131695019|NCT03315871|474165147|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
131695020|NCT03315871|474165148|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
131695021|NCT03315871|474165146|FG000|PROSTVAC + CV301|Progressive disease|0|||
131695022|NCT03315871|474165147|FG001|PROSTVAC + CV301|Progressive disease|0|||
131695023|NCT03315871|474165148|FG002|PROSTVAC + CV301|Progressive disease|1|||
131695024|NCT03315871|474165146|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
131695025|NCT03315871|474165147|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
131695026|NCT03315871|474165148|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
131695027|NCT04099251|474168466|FG000|Pre-Treatment|Other reasons|1|||
131695028|NCT04099251|474168467|FG001|Pre-Treatment|Other reasons|0|||
131695029|NCT04099251|474168466|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
131695030|NCT04099251|474168467|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
131695031|NCT04099251|474168466|FG000|Blinded Treatment Phase|Other reasons|16|||
131695032|NCT04099251|474168467|FG001|Blinded Treatment Phase|Other reasons|7|||
131695033|NCT04099251|474168466|FG000|Blinded Treatment Phase|Disease recurrence|26|||
131695034|NCT04099251|474168467|FG001|Blinded Treatment Phase|Disease recurrence|41|||
131695035|NCT04099251|474168466|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
131695036|NCT04099251|474168467|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
131695037|NCT04099251|474168466|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
131695038|NCT04099251|474168467|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
131695039|NCT04099251|474168466|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
131695040|NCT04099251|474168467|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
131695041|NCT04099251|474168466|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
131695042|NCT04099251|474168467|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
131695043|NCT04099251|474168466|FG000|Blinded Treatment Phase|Death|6|||
131695044|NCT04099251|474168467|FG001|Blinded Treatment Phase|Death|2|||
131695045|NCT04099251|474168466|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
131695046|NCT04099251|474168467|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
131695047|NCT04099251|474168466|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
131695048|NCT04099251|474168467|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
131695049|NCT04099251|474168466|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
131695050|NCT04099251|474168467|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
131695051|NCT04099251|474168466|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
131695052|NCT04099251|474168467|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
131695053|NCT04099251|474168466|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
131695054|NCT04099251|474168467|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
131695055|NCT04099251|474168466|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
131695056|NCT04099251|474168467|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
131695057|NCT04099251|474168466|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
131695058|NCT04099251|474168467|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
131695059|NCT04099251|474168466|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
131695060|NCT04099251|474168467|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
131695061|NCT04099251|474168466|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
131560063|NCT02080520|473675963|FG001|Overall Study|Personal reasons|3|||
131560064|NCT04397523|473675964|FG000|Overall Study|Lost to Follow-up|3|||
131560065|NCT04397523|473675964|FG000|Overall Study|Transfer from/to other hospital|8|||
131560066|NCT04076020|473675990|FG000|Overall Study|Death|4|||
131560067|NCT04076020|473675991|FG001|Overall Study|Death|6|||
131560068|NCT04076020|473675990|FG000|Overall Study|Withdrawal by Subject|12|||
131560069|NCT04076020|473675991|FG001|Overall Study|Withdrawal by Subject|8|||
131560070|NCT00684762|473675992|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
131560071|NCT00684762|473675993|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
131560072|NCT01394250|473675994|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
131560073|NCT01394250|473675995|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
131560074|NCT01394250|473675994|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
131560075|NCT01394250|473675995|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
131560076|NCT03537261|473676004|FG000|Overall Study|Lost to Follow-up|4|||
131560077|NCT03537261|473676005|FG001|Overall Study|Lost to Follow-up|5|||
131560078|NCT03537261|473676004|FG000|Overall Study|Withdrawal by Subject|4|||
131560079|NCT03537261|473676005|FG001|Overall Study|Withdrawal by Subject|6|||
131560080|NCT03537261|473676004|FG000|Overall Study|Did not return study questionnaires|0|||
131560081|NCT03537261|473676005|FG001|Overall Study|Did not return study questionnaires|1|||
131560082|NCT01729728|473676006|FG000|Overall Study|Adverse Event|0|||
131560083|NCT01729728|473676007|FG001|Overall Study|Adverse Event|6|||
131560084|NCT01729728|473676008|FG002|Overall Study|Adverse Event|0|||
131560085|NCT01729728|473676006|FG000|Overall Study|Protocol Violation|1|||
131560086|NCT01729728|473676007|FG001|Overall Study|Protocol Violation|0|||
131560087|NCT01729728|473676008|FG002|Overall Study|Protocol Violation|1|||
131560088|NCT02500979|473676009|FG000|Period 1|Hyperglycemia|1|||
131560089|NCT02500979|473676010|FG001|Period 1|Hyperglycemia|0|||
131560090|NCT02500979|473676009|FG000|Period 1|Severe non-compliance to protocol|0|||
131560091|NCT02500979|473676010|FG001|Period 1|Severe non-compliance to protocol|1|||
131560092|NCT02500979|473676009|FG000|Period 1|Adverse Event|1|||
131560093|NCT02500979|473676010|FG001|Period 1|Adverse Event|0|||
131560094|NCT02500979|473676009|FG000|Period 1|Subject decision|2|||
131560095|NCT02500979|473676010|FG001|Period 1|Subject decision|0|||
131560096|NCT02500979|473676009|FG000|Period 2|Change in risk|1|||
131560097|NCT02500979|473676010|FG001|Period 2|Change in risk|0|||
131560098|NCT04267614|473676011|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
131560099|NCT04267614|473676011|FG000|Overall Study|Lost to Follow-up|115|||
131560100|NCT00849680|473676022|FG000|Overall Study|Adverse Event|0|||
131560101|NCT00849680|473676023|FG001|Overall Study|Adverse Event|0|||
131560102|NCT00849680|473676024|FG002|Overall Study|Adverse Event|0|||
131560103|NCT00849680|473676025|FG003|Overall Study|Adverse Event|0|||
131560104|NCT00849680|473676026|FG004|Overall Study|Adverse Event|0|||
131560105|NCT00849680|473676027|FG005|Overall Study|Adverse Event|0|||
131560106|NCT00849680|473676028|FG006|Overall Study|Adverse Event|2|||
131560107|NCT00849680|473676029|FG007|Overall Study|Adverse Event|0|||
131560108|NCT00849680|473676022|FG000|Overall Study|Lost to Follow-up|7|||
131560109|NCT00849680|473676023|FG001|Overall Study|Lost to Follow-up|3|||
131560110|NCT00849680|473676024|FG002|Overall Study|Lost to Follow-up|12|||
131560111|NCT00849680|473676025|FG003|Overall Study|Lost to Follow-up|11|||
131560112|NCT00849680|473676026|FG004|Overall Study|Lost to Follow-up|8|||
131560113|NCT00849680|473676027|FG005|Overall Study|Lost to Follow-up|11|||
131560114|NCT00849680|473676028|FG006|Overall Study|Lost to Follow-up|12|||
131560115|NCT00849680|473676029|FG007|Overall Study|Lost to Follow-up|5|||
131560116|NCT00849680|473676022|FG000|Overall Study|Subject moved|1|||
131560117|NCT00849680|473676023|FG001|Overall Study|Subject moved|0|||
131560118|NCT00849680|473676024|FG002|Overall Study|Subject moved|3|||
131560119|NCT00849680|473676025|FG003|Overall Study|Subject moved|1|||
131560120|NCT00849680|473676026|FG004|Overall Study|Subject moved|0|||
131560121|NCT00849680|473676027|FG005|Overall Study|Subject moved|2|||
131560122|NCT00849680|473676028|FG006|Overall Study|Subject moved|2|||
131560123|NCT00849680|473676029|FG007|Overall Study|Subject moved|2|||
131560124|NCT00849680|473676022|FG000|Overall Study|Withdrawal by Subject|2|||
131560125|NCT00849680|473676023|FG001|Overall Study|Withdrawal by Subject|0|||
131560126|NCT00849680|473676024|FG002|Overall Study|Withdrawal by Subject|0|||
131560127|NCT00849680|473676025|FG003|Overall Study|Withdrawal by Subject|2|||
131560128|NCT00849680|473676026|FG004|Overall Study|Withdrawal by Subject|2|||
131560129|NCT00849680|473676027|FG005|Overall Study|Withdrawal by Subject|2|||
131560130|NCT00849680|473676028|FG006|Overall Study|Withdrawal by Subject|1|||
131560131|NCT00849680|473676029|FG007|Overall Study|Withdrawal by Subject|1|||
131560132|NCT00849680|473676022|FG000|Overall Study|Subject unable to comply with protocol|1|||
131560133|NCT00849680|473676023|FG001|Overall Study|Subject unable to comply with protocol|0|||
131560134|NCT00849680|473676024|FG002|Overall Study|Subject unable to comply with protocol|0|||
131560135|NCT00849680|473676025|FG003|Overall Study|Subject unable to comply with protocol|0|||
131560136|NCT00849680|473676026|FG004|Overall Study|Subject unable to comply with protocol|0|||
131560137|NCT00849680|473676027|FG005|Overall Study|Subject unable to comply with protocol|0|||
131560138|NCT00849680|473676028|FG006|Overall Study|Subject unable to comply with protocol|0|||
131560139|NCT00849680|473676029|FG007|Overall Study|Subject unable to comply with protocol|0|||
131560140|NCT03382600|473676031|FG000|Overall Study|Adverse Event|3|||
131560141|NCT03382600|473676032|FG001|Overall Study|Adverse Event|3|||
131560142|NCT03382600|473676031|FG000|Overall Study|Clinical Disease Progression|2|||
131560143|NCT03382600|473676032|FG001|Overall Study|Clinical Disease Progression|4|||
131560144|NCT03382600|473676031|FG000|Overall Study|Radiological Progression|40|||
131560145|NCT03382600|473676032|FG001|Overall Study|Radiological Progression|31|||
131560146|NCT03382600|473676031|FG000|Overall Study|Withdrawal by Subject|0|||
131560147|NCT03382600|473676032|FG001|Overall Study|Withdrawal by Subject|1|||
131560148|NCT03382600|473676031|FG000|Overall Study|Other|9|||
131780010|NCT01610284|474473974|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
131780011|NCT03186794|474473975|FG000|Overall Study|Physician Decision|2|||
131780012|NCT03186794|474473975|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
131780013|NCT02864953|474473977|FG000|Overall Study|Adverse Event|22|||
131780014|NCT02864953|474473978|FG001|Overall Study|Adverse Event|19|||
131780015|NCT02864953|474473977|FG000|Overall Study|Withdrawal by Subject|1|||
131780016|NCT02864953|474473978|FG001|Overall Study|Withdrawal by Subject|0|||
131780017|NCT02864953|474473977|FG000|Overall Study|Physician Decision|4|||
131780018|NCT02864953|474473978|FG001|Overall Study|Physician Decision|2|||
131780019|NCT02864953|474473977|FG000|Overall Study|Death|3|||
131780020|NCT02864953|474473978|FG001|Overall Study|Death|13|||
131780021|NCT02864953|474473977|FG000|Overall Study|Reason not specified|14|||
131780022|NCT02864953|474473978|FG001|Overall Study|Reason not specified|12|||
131780023|NCT02864953|474473977|FG000|Overall Study|Withdrew Prior to Dosing|9|||
131780024|NCT02864953|474473978|FG001|Overall Study|Withdrew Prior to Dosing|8|||
131780025|NCT00797316|474473979|FG000|Overall Study|Administrative problems|1|||
131780026|NCT00797316|474473980|FG001|Overall Study|Administrative problems|0|||
131780027|NCT00797316|474473979|FG000|Overall Study|Adverse Event|5|||
131780028|NCT00797316|474473980|FG001|Overall Study|Adverse Event|3|||
131780029|NCT00797316|474473979|FG000|Overall Study|Lost to Follow-up|4|||
131780030|NCT00797316|474473980|FG001|Overall Study|Lost to Follow-up|8|||
131780031|NCT00797316|474473979|FG000|Overall Study|Protocol Deviation|1|||
131780032|NCT00797316|474473980|FG001|Overall Study|Protocol Deviation|2|||
131780033|NCT00797316|474473979|FG000|Overall Study|Patient withdrew consent|12|||
131780034|NCT00797316|474473980|FG001|Overall Study|Patient withdrew consent|6|||
131780035|NCT00797316|474473979|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131780036|NCT00797316|474473980|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
131780037|NCT03239340|474473987|FG000|Overall Study|Other|26|||
131780038|NCT03239340|474473987|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
131780039|NCT03239340|474473987|FG000|Overall Study|Death|40|||
131780040|NCT03239340|474473987|FG000|Overall Study|Lost to Follow-up|2|||
131780041|NCT03239340|474473987|FG000|Overall Study|Physician Decision|16|||
131780042|NCT03239340|474473987|FG000|Overall Study|Withdrawal by Subject|27|||
131780043|NCT04066894|474473991|FG000|Overall Study|Lack of Efficacy|1|||
131780044|NCT04066894|474473991|FG000|Overall Study|Screen Failure|1|||
131780045|NCT02949219|474473993|FG000|Overall Study|Withdrawal by Subject|1|||
131780046|NCT03494816|474473994|FG000|Overall Study|Protocol Violation|2|||
131780047|NCT03494816|474473994|FG000|Overall Study|Physician Decision|2|||
131780048|NCT03494816|474473994|FG000|Overall Study|Did not start trial treatment|1|||
131780049|NCT03494816|474473994|FG000|Overall Study|Adverse Event|1|||
131780050|NCT01283282|474473999|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
131780051|NCT01283282|474474000|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
131780052|NCT01283282|474473999|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
131780053|NCT01283282|474474000|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
131780054|NCT01283282|474473999|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
131780055|NCT01283282|474474000|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
131780056|NCT00777920|474474001|FG000|Overall Study|Adverse Event|39|||
131780057|NCT00777920|474474001|FG000|Overall Study|Withdrawal of Consent|4|||
131780058|NCT00777920|474474001|FG000|Overall Study|Lost to Follow-up|1|||
131780059|NCT00777920|474474001|FG000|Overall Study|Investigator's discretion|1|||
131780060|NCT00777920|474474001|FG000|Overall Study|Clinical status did not improve|1|||
131560149|NCT03382600|473676032|FG001|Overall Study|Other|7|||
131560150|NCT01000376|473676033|FG000|Cycle 1 Day 1|Adverse Event|1|||
131560151|NCT01000376|473676034|FG001|Cycle 1 Day 1|Adverse Event|0|||
131780061|NCT00777920|474474001|FG000|Overall Study|Other, not specified|4|||
131780062|NCT00483717|474474002|FG000|Overall Study|Protocol Violation|5|||
131780063|NCT00483717|474474003|FG001|Overall Study|Protocol Violation|7|||
131780064|NCT00483717|474474002|FG000|Overall Study|Time of dosing missing|1|||
131780065|NCT00483717|474474003|FG001|Overall Study|Time of dosing missing|1|||
131780066|NCT00483717|474474002|FG000|Overall Study|No treatment for migraine|16|||
131780067|NCT00483717|474474003|FG001|Overall Study|No treatment for migraine|13|||
131780068|NCT00483717|474474002|FG000|Overall Study|Lost to Follow-up|1|||
131560152|NCT01000376|473676033|FG000|Cycle 1 Day 1|Progressive Disease|1|||
131560153|NCT01000376|473676034|FG001|Cycle 1 Day 1|Progressive Disease|0|||
131560154|NCT00896454|473676035|FG000|Overall Study|Death|10|||
131780069|NCT00483717|474474003|FG001|Overall Study|Lost to Follow-up|0|||
131780070|NCT00483717|474474002|FG000|Overall Study|Withdrawal by Subject|1|||
131560155|NCT00896454|473676035|FG000|Overall Study|Adverse Event|8|||
131560156|NCT00896454|473676035|FG000|Overall Study|Disease Progression|5|||
131560157|NCT00896454|473676035|FG000|Overall Study|Other|4|||
131560158|NCT00896454|473676035|FG000|Overall Study|Requirement for alternative therapy|3|||
131560159|NCT00896454|473676035|FG000|Overall Study|Ongoing in study|2|||
131560160|NCT00896454|473676035|FG000|Overall Study|Withdrawal by Subject|1|||
131560161|NCT03688711|473676036|FG000|Overall Study|Withdrawal by Subject|0|||
131560162|NCT03688711|473676037|FG001|Overall Study|Withdrawal by Subject|1|||
131560163|NCT05033080|473676046|FG000|Overall Study|Adverse Event|4|||
131560164|NCT05033080|473676047|FG001|Overall Study|Adverse Event|4|||
131560165|NCT05033080|473676046|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
131560166|NCT05033080|473676047|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
131560167|NCT05033080|473676046|FG000|Overall Study|Lost to Follow-up|1|||
131560168|NCT05033080|473676047|FG001|Overall Study|Lost to Follow-up|0|||
131560169|NCT05033080|473676046|FG000|Overall Study|Other non-compliance|0|||
131560170|NCT05033080|473676047|FG001|Overall Study|Other non-compliance|1|||
131560171|NCT05033080|473676046|FG000|Overall Study|Physician Decision|0|||
131560172|NCT05033080|473676047|FG001|Overall Study|Physician Decision|1|||
131560173|NCT05033080|473676046|FG000|Overall Study|Other|1|||
131560174|NCT05033080|473676047|FG001|Overall Study|Other|1|||
131560175|NCT01263106|473676048|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
131560176|NCT01263106|473676049|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
131560177|NCT01040780|473677731|FG000|Overall Study|Protocol Violation|1|||
131560178|NCT01040780|473677732|FG001|Overall Study|Protocol Violation|3|||
131560179|NCT00802737|473677733|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
131560180|NCT00802737|473677734|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
131560181|NCT00802737|473677735|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
131560182|NCT00802737|473677733|FG000|Overall Study|Death|6|||
131560183|NCT00802737|473677734|FG001|Overall Study|Death|5|||
131560184|NCT00802737|473677735|FG002|Overall Study|Death|1|||
131560185|NCT00802737|473677733|FG000|Overall Study|Adverse Event|1|||
131560186|NCT00802737|473677734|FG001|Overall Study|Adverse Event|0|||
131560187|NCT00802737|473677735|FG002|Overall Study|Adverse Event|0|||
131560188|NCT00802737|473677733|FG000|Overall Study|Received Prohibited Therapy|1|||
131560189|NCT00802737|473677734|FG001|Overall Study|Received Prohibited Therapy|0|||
131560190|NCT00802737|473677735|FG002|Overall Study|Received Prohibited Therapy|0|||
131560191|NCT00802737|473677733|FG000|Overall Study|Ongoing CLL-Treatment|0|||
131560192|NCT00802737|473677734|FG001|Overall Study|Ongoing CLL-Treatment|1|||
131560193|NCT00802737|473677735|FG002|Overall Study|Ongoing CLL-Treatment|0|||
131560194|NCT00802737|473677733|FG000|Overall Study|Participant too Unwell|0|||
131560195|NCT00802737|473677734|FG001|Overall Study|Participant too Unwell|2|||
131560196|NCT00802737|473677735|FG002|Overall Study|Participant too Unwell|0|||
131560197|NCT04213989|473677736|FG000|Overall Study|Withdrawal by Subject|3|||
131560198|NCT04213989|473677737|FG001|Overall Study|Withdrawal by Subject|2|||
131560199|NCT04213989|473677736|FG000|Overall Study|Physician Decision|1|||
131560200|NCT04213989|473677737|FG001|Overall Study|Physician Decision|0|||
131560201|NCT04213989|473677736|FG000|Overall Study|Lost to Follow-up|0|||
131560202|NCT04213989|473677737|FG001|Overall Study|Lost to Follow-up|4|||
131560203|NCT01811563|473677738|FG000|Overall Study|Lost to Follow-up|5|||
131560204|NCT01811563|473677739|FG001|Overall Study|Lost to Follow-up|2|||
131560205|NCT01811563|473677738|FG000|Overall Study|Incorrect Randomization procedure|0|||
131560206|NCT01811563|473677739|FG001|Overall Study|Incorrect Randomization procedure|1|||
131560207|NCT00329719|473677740|FG000|Overall Study|Lost to Follow-up|0|||
131560208|NCT00329719|473677741|FG001|Overall Study|Lost to Follow-up|0|||
131560209|NCT00329719|473677742|FG002|Overall Study|Lost to Follow-up|0|||
131560210|NCT00329719|473677743|FG003|Overall Study|Lost to Follow-up|1|||
131560211|NCT02930122|473677746|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
131560212|NCT02930122|473677747|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
131560213|NCT01004250|473677749|FG000|Induction Therapy Period|Adverse Event|10|||
131560214|NCT01004250|473677749|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
131560215|NCT01004250|473677749|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
131560216|NCT01004250|473677749|FG000|Induction Therapy Period|Physician Decision|2|||
131560217|NCT01004250|473677749|FG000|Maintenance Therapy Period|Adverse Event|15|||
131560218|NCT01004250|473677749|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
131560219|NCT01004250|473677749|FG000|Maintenance Therapy Period|Protocol Violation|1|||
131560220|NCT01004250|473677749|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
131560221|NCT01004250|473677749|FG000|Maintenance Therapy Period|Physician Decision|4|||
131560222|NCT01004250|473677749|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
131560223|NCT03943589|473677750|FG000|Overall Study|Death|1|||
131560224|NCT03943589|473677750|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
131560225|NCT00830947|473677751|FG000|Overall Study|Lost to Follow-up|4|||
131560226|NCT00830947|473677752|FG001|Overall Study|Lost to Follow-up|4|||
131560227|NCT02462083|473677753|FG000|Overall Study|Sponsor request|39|||
131560228|NCT02462083|473677753|FG000|Overall Study|Withdrawal by Subject|87|||
131560229|NCT02462083|473677753|FG000|Overall Study|Lost to Follow-up|41|||
131560230|NCT02462083|473677753|FG000|Overall Study|Lack of Efficacy|151|||
131560231|NCT02462083|473677753|FG000|Overall Study|Pregnancy|1|||
131560232|NCT02462083|473677753|FG000|Overall Study|Protocol Violation|6|||
131560233|NCT02462083|473677753|FG000|Overall Study|Adverse Event|33|||
131560234|NCT02462083|473677753|FG000|Overall Study|Worsening condition|16|||
131560235|NCT02462083|473677753|FG000|Overall Study|Other than specified|45|||
131560236|NCT02291289|473677754|FG000|Induction Treatment|Withdrawal by Subject|0|||
131560237|NCT02291289|473677755|FG001|Induction Treatment|Withdrawal by Subject|0|||
131560238|NCT02291289|473677756|FG002|Induction Treatment|Withdrawal by Subject|0|||
131560239|NCT02291289|473677757|FG003|Induction Treatment|Withdrawal by Subject|24|||
131560240|NCT02291289|473677758|FG004|Induction Treatment|Withdrawal by Subject|0|||
131560241|NCT02291289|473677759|FG005|Induction Treatment|Withdrawal by Subject|0|||
131560242|NCT02291289|473677760|FG006|Induction Treatment|Withdrawal by Subject|0|||
131560243|NCT02291289|473677761|FG007|Induction Treatment|Withdrawal by Subject|0|||
131560244|NCT02291289|473677762|FG008|Induction Treatment|Withdrawal by Subject|0|||
131560245|NCT02291289|473677763|FG009|Induction Treatment|Withdrawal by Subject|18|||
131560246|NCT02291289|473677764|FG010|Induction Treatment|Withdrawal by Subject|0|||
131560247|NCT02291289|473677765|FG011|Induction Treatment|Withdrawal by Subject|0|||
131560248|NCT02291289|473677766|FG012|Induction Treatment|Withdrawal by Subject|0|||
131560249|NCT02291289|473677754|FG000|Induction Treatment|Adverse Event|0|||
131560250|NCT02291289|473677755|FG001|Induction Treatment|Adverse Event|0|||
131560251|NCT02291289|473677756|FG002|Induction Treatment|Adverse Event|0|||
131560252|NCT02291289|473677757|FG003|Induction Treatment|Adverse Event|3|||
131560253|NCT02291289|473677758|FG004|Induction Treatment|Adverse Event|0|||
131560254|NCT02291289|473677759|FG005|Induction Treatment|Adverse Event|0|||
131560255|NCT02291289|473677760|FG006|Induction Treatment|Adverse Event|0|||
131560256|NCT02291289|473677761|FG007|Induction Treatment|Adverse Event|0|||
131560257|NCT02291289|473677762|FG008|Induction Treatment|Adverse Event|0|||
131560258|NCT02291289|473677763|FG009|Induction Treatment|Adverse Event|1|||
131560259|NCT02291289|473677764|FG010|Induction Treatment|Adverse Event|0|||
131560260|NCT02291289|473677765|FG011|Induction Treatment|Adverse Event|0|||
131560261|NCT02291289|473677766|FG012|Induction Treatment|Adverse Event|0|||
131560262|NCT02291289|473677754|FG000|Induction Treatment|Death|25|||
131560263|NCT02291289|473677755|FG001|Induction Treatment|Death|0|||
131560264|NCT02291289|473677756|FG002|Induction Treatment|Death|0|||
131560265|NCT02291289|473677757|FG003|Induction Treatment|Death|111|||
131560266|NCT02291289|473677758|FG004|Induction Treatment|Death|0|||
131560267|NCT02291289|473677759|FG005|Induction Treatment|Death|0|||
131560268|NCT02291289|473677760|FG006|Induction Treatment|Death|1|||
131560269|NCT02291289|473677761|FG007|Induction Treatment|Death|0|||
131560270|NCT02291289|473677762|FG008|Induction Treatment|Death|0|||
131560271|NCT02291289|473677763|FG009|Induction Treatment|Death|82|||
131560272|NCT02291289|473677764|FG010|Induction Treatment|Death|0|||
131560273|NCT02291289|473677765|FG011|Induction Treatment|Death|0|||
131560274|NCT02291289|473677766|FG012|Induction Treatment|Death|0|||
131560275|NCT02291289|473677754|FG000|Induction Treatment|Lost to Follow-up|1|||
131560276|NCT02291289|473677755|FG001|Induction Treatment|Lost to Follow-up|0|||
131560277|NCT02291289|473677756|FG002|Induction Treatment|Lost to Follow-up|0|||
131560278|NCT02291289|473677757|FG003|Induction Treatment|Lost to Follow-up|12|||
131560279|NCT02291289|473677758|FG004|Induction Treatment|Lost to Follow-up|0|||
131560280|NCT02291289|473677759|FG005|Induction Treatment|Lost to Follow-up|0|||
131560281|NCT02291289|473677760|FG006|Induction Treatment|Lost to Follow-up|0|||
131560282|NCT02291289|473677761|FG007|Induction Treatment|Lost to Follow-up|0|||
131560283|NCT02291289|473677762|FG008|Induction Treatment|Lost to Follow-up|0|||
131560284|NCT02291289|473677763|FG009|Induction Treatment|Lost to Follow-up|9|||
131780071|NCT00483717|474474003|FG001|Overall Study|Withdrawal by Subject|0|||
131780072|NCT02392377|474474004|FG000|Overall Study|Withdrawal by Subject|0|||
131780073|NCT02392377|474474005|FG001|Overall Study|Withdrawal by Subject|1|||
131780074|NCT03205163|474474008|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
131780075|NCT03205163|474474009|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
131780076|NCT03993288|474475690|FG000|Overall Study|Lost to Follow-up|2|||
131780077|NCT03993288|474475691|FG001|Overall Study|Lost to Follow-up|1|||
131780078|NCT03993288|474475690|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
131780079|NCT03993288|474475691|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
131780080|NCT03993288|474475690|FG000|Overall Study|wrong randomization|0|||
131560285|NCT02291289|473677764|FG010|Induction Treatment|Lost to Follow-up|0|||
131560286|NCT02291289|473677765|FG011|Induction Treatment|Lost to Follow-up|0|||
131560287|NCT02291289|473677766|FG012|Induction Treatment|Lost to Follow-up|0|||
131560288|NCT02291289|473677754|FG000|Induction Treatment|Non-Compliance|0|||
131560289|NCT02291289|473677755|FG001|Induction Treatment|Non-Compliance|0|||
131560290|NCT02291289|473677756|FG002|Induction Treatment|Non-Compliance|0|||
131560291|NCT02291289|473677757|FG003|Induction Treatment|Non-Compliance|1|||
131560292|NCT02291289|473677758|FG004|Induction Treatment|Non-Compliance|0|||
131560293|NCT02291289|473677759|FG005|Induction Treatment|Non-Compliance|0|||
131560294|NCT02291289|473677760|FG006|Induction Treatment|Non-Compliance|0|||
131560295|NCT02291289|473677761|FG007|Induction Treatment|Non-Compliance|0|||
131560296|NCT02291289|473677762|FG008|Induction Treatment|Non-Compliance|0|||
131560297|NCT02291289|473677763|FG009|Induction Treatment|Non-Compliance|1|||
131560298|NCT02291289|473677764|FG010|Induction Treatment|Non-Compliance|0|||
131560299|NCT02291289|473677765|FG011|Induction Treatment|Non-Compliance|0|||
131560300|NCT02291289|473677766|FG012|Induction Treatment|Non-Compliance|0|||
131560301|NCT02291289|473677754|FG000|Induction Treatment|Reason Not Specified|0|||
131560302|NCT02291289|473677755|FG001|Induction Treatment|Reason Not Specified|0|||
131560303|NCT02291289|473677756|FG002|Induction Treatment|Reason Not Specified|0|||
131560304|NCT02291289|473677757|FG003|Induction Treatment|Reason Not Specified|4|||
131560305|NCT02291289|473677758|FG004|Induction Treatment|Reason Not Specified|0|||
131560306|NCT02291289|473677759|FG005|Induction Treatment|Reason Not Specified|0|||
131560307|NCT02291289|473677760|FG006|Induction Treatment|Reason Not Specified|0|||
131560308|NCT02291289|473677761|FG007|Induction Treatment|Reason Not Specified|0|||
131560309|NCT02291289|473677762|FG008|Induction Treatment|Reason Not Specified|0|||
131560310|NCT02291289|473677763|FG009|Induction Treatment|Reason Not Specified|7|||
131780081|NCT03993288|474475691|FG001|Overall Study|wrong randomization|1|||
131780082|NCT03993288|474475690|FG000|Overall Study|improper enrollment|0|||
131780083|NCT03993288|474475691|FG001|Overall Study|improper enrollment|1|||
131780084|NCT03993288|474475690|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
131780085|NCT03993288|474475691|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
131780086|NCT03993288|474475690|FG000|Overall Study|developed SAE|2|||
131780087|NCT03993288|474475691|FG001|Overall Study|developed SAE|0|||
131780088|NCT03993288|474475690|FG000|Overall Study|consent withdrawal|1|||
131780089|NCT03993288|474475691|FG001|Overall Study|consent withdrawal|0|||
131780090|NCT03993288|474475690|FG000|Overall Study|did not follow the treatment schedule|1|||
131780091|NCT03993288|474475691|FG001|Overall Study|did not follow the treatment schedule|0|||
131780092|NCT03993288|474475690|FG000|Overall Study|did not follow the treatment regimen|1|||
131780093|NCT03993288|474475691|FG001|Overall Study|did not follow the treatment regimen|0|||
131780094|NCT03993288|474475690|FG000|Overall Study|Adverse Event|1|||
131780095|NCT03993288|474475691|FG001|Overall Study|Adverse Event|0|||
131780096|NCT03993288|474475690|FG000|Overall Study|Withdrawal by Subject|1|||
131780097|NCT03993288|474475691|FG001|Overall Study|Withdrawal by Subject|1|||
131780098|NCT03526679|474475692|FG000|Overall Study|still under treatment|2|||
131780099|NCT04465916|474475697|FG000|Overall Study|Withdrawal by Subject|0|||
131780100|NCT04465916|474475698|FG001|Overall Study|Withdrawal by Subject|1|||
131560311|NCT02291289|473677764|FG010|Induction Treatment|Reason Not Specified|0|||
131560312|NCT02291289|473677765|FG011|Induction Treatment|Reason Not Specified|0|||
131560313|NCT02291289|473677766|FG012|Induction Treatment|Reason Not Specified|0|||
131560314|NCT02291289|473677754|FG000|Induction Treatment|Physician Decision|0|||
131560315|NCT02291289|473677755|FG001|Induction Treatment|Physician Decision|0|||
131560316|NCT02291289|473677756|FG002|Induction Treatment|Physician Decision|0|||
131560317|NCT02291289|473677757|FG003|Induction Treatment|Physician Decision|3|||
131560318|NCT02291289|473677758|FG004|Induction Treatment|Physician Decision|0|||
131560319|NCT02291289|473677759|FG005|Induction Treatment|Physician Decision|0|||
131560320|NCT02291289|473677760|FG006|Induction Treatment|Physician Decision|0|||
131560321|NCT02291289|473677761|FG007|Induction Treatment|Physician Decision|0|||
131560322|NCT02291289|473677762|FG008|Induction Treatment|Physician Decision|0|||
131560323|NCT02291289|473677763|FG009|Induction Treatment|Physician Decision|1|||
131560324|NCT02291289|473677764|FG010|Induction Treatment|Physician Decision|0|||
131560325|NCT02291289|473677765|FG011|Induction Treatment|Physician Decision|0|||
131560326|NCT02291289|473677766|FG012|Induction Treatment|Physician Decision|0|||
131560327|NCT02291289|473677754|FG000|Induction Treatment|Protocol Violation|0|||
131560328|NCT02291289|473677755|FG001|Induction Treatment|Protocol Violation|0|||
131560329|NCT02291289|473677756|FG002|Induction Treatment|Protocol Violation|0|||
131560330|NCT02291289|473677757|FG003|Induction Treatment|Protocol Violation|3|||
131560331|NCT02291289|473677758|FG004|Induction Treatment|Protocol Violation|0|||
131560332|NCT02291289|473677759|FG005|Induction Treatment|Protocol Violation|0|||
131560333|NCT02291289|473677760|FG006|Induction Treatment|Protocol Violation|0|||
131560334|NCT02291289|473677761|FG007|Induction Treatment|Protocol Violation|0|||
131560335|NCT02291289|473677762|FG008|Induction Treatment|Protocol Violation|0|||
131560336|NCT02291289|473677763|FG009|Induction Treatment|Protocol Violation|2|||
131560337|NCT02291289|473677764|FG010|Induction Treatment|Protocol Violation|0|||
131560338|NCT02291289|473677765|FG011|Induction Treatment|Protocol Violation|0|||
131560339|NCT02291289|473677766|FG012|Induction Treatment|Protocol Violation|0|||
131560340|NCT02291289|473677754|FG000|Induction Treatment|Missing|4|||
131560341|NCT02291289|473677755|FG001|Induction Treatment|Missing|0|||
131560342|NCT02291289|473677756|FG002|Induction Treatment|Missing|0|||
131560343|NCT02291289|473677757|FG003|Induction Treatment|Missing|14|||
131560344|NCT02291289|473677758|FG004|Induction Treatment|Missing|0|||
131560345|NCT02291289|473677759|FG005|Induction Treatment|Missing|0|||
131560346|NCT02291289|473677760|FG006|Induction Treatment|Missing|0|||
131560347|NCT02291289|473677761|FG007|Induction Treatment|Missing|0|||
131560348|NCT02291289|473677762|FG008|Induction Treatment|Missing|0|||
131560349|NCT02291289|473677763|FG009|Induction Treatment|Missing|54|||
131560350|NCT02291289|473677764|FG010|Induction Treatment|Missing|0|||
131560351|NCT02291289|473677765|FG011|Induction Treatment|Missing|0|||
131560352|NCT02291289|473677766|FG012|Induction Treatment|Missing|0|||
131560353|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560354|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560355|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560356|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560357|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
131560358|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
131560359|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560360|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131780101|NCT03976076|474475704|FG000|Overall Study|Withdrawal by Subject|2|||
131780102|NCT01325701|474475705|FG000|Overall Study|Adverse Event|12|||
131780103|NCT01325701|474475706|FG001|Overall Study|Adverse Event|0|||
131780104|NCT01325701|474475705|FG000|Overall Study|Protocol Violation|1|||
131780105|NCT01325701|474475706|FG001|Overall Study|Protocol Violation|0|||
131780106|NCT01325701|474475705|FG000|Overall Study|Physician Decision|2|||
131780107|NCT01325701|474475706|FG001|Overall Study|Physician Decision|2|||
131780108|NCT01325701|474475705|FG000|Overall Study|Withdrawal by Subject|2|||
131780109|NCT01325701|474475706|FG001|Overall Study|Withdrawal by Subject|1|||
131780110|NCT01325701|474475705|FG000|Overall Study|Rollerover Extension Study|4|||
131780111|NCT01325701|474475706|FG001|Overall Study|Rollerover Extension Study|0|||
131780112|NCT00388674|474475716|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
131780113|NCT00388674|474475717|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
131780114|NCT00388674|474475716|FG000|Initial Treatment|Adverse Event|22|||
131780115|NCT00388674|474475717|FG001|Initial Treatment|Adverse Event|87|||
131560361|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560362|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560363|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
131560364|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
131560365|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131560366|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Death|0|||
131560367|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Death|29|||
131780116|NCT00388674|474475716|FG000|Initial Treatment|Death|215|||
131780117|NCT00388674|474475717|FG001|Initial Treatment|Death|216|||
131560368|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Death|16|||
131560369|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Death|0|||
131560370|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Death|188|||
131560371|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Death|107|||
131560372|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Death|0|||
131560373|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Death|1|||
131560374|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Death|1|||
131780118|NCT00388674|474475716|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
131780119|NCT00388674|474475717|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
131560375|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Death|0|||
131560376|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Death|46|||
131560377|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Death|19|||
131560378|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Death|0|||
131560379|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Adverse Event|0|||
131560380|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Adverse Event|0|||
131560381|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Adverse Event|0|||
131560382|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Adverse Event|0|||
131560383|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Adverse Event|1|||
131560384|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Adverse Event|1|||
131560385|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Adverse Event|0|||
131560386|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Adverse Event|0|||
131560387|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Adverse Event|0|||
131560388|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Adverse Event|0|||
131560389|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Adverse Event|0|||
131560390|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Adverse Event|0|||
131560391|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Adverse Event|0|||
131560392|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560393|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
131560394|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560395|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560396|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
131560397|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
131560398|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560399|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
131560400|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560401|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560402|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
131560403|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
131560404|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
131560405|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
131560406|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
131560407|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
131560408|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
131560409|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
131560410|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
131560411|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
131560412|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
131560413|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
131560414|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
131560415|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
131560416|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
131560417|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
131560418|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Physician Decision|0|||
131560419|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Physician Decision|2|||
131560420|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Physician Decision|0|||
131560421|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Physician Decision|0|||
131560422|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Physician Decision|3|||
131560423|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Physician Decision|0|||
131560424|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Physician Decision|0|||
131560425|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Physician Decision|0|||
131560426|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Physician Decision|0|||
131560427|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Physician Decision|0|||
131560428|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Physician Decision|1|||
131560429|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Physician Decision|3|||
131560430|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Physician Decision|0|||
131560431|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Not Treated|0|||
131560432|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Not Treated|0|||
131560433|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Not Treated|2|||
131560434|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Not Treated|0|||
131560435|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Not Treated|0|||
131560436|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Not Treated|0|||
131560437|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Not Treated|0|||
131560438|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Not Treated|0|||
131560439|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Not Treated|0|||
131560440|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Not Treated|0|||
131560441|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Not Treated|0|||
131560442|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Not Treated|0|||
131560443|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Not Treated|0|||
131560444|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560445|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
131560446|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560447|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560448|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560449|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560450|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560451|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560452|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560453|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560454|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560455|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560456|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
131560457|NCT02291289|473677754|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
131560458|NCT02291289|473677755|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
131560459|NCT02291289|473677756|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
131560460|NCT02291289|473677757|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
131560461|NCT02291289|473677758|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
131560462|NCT02291289|473677759|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
131560463|NCT02291289|473677760|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
131560464|NCT02291289|473677761|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
131560465|NCT02291289|473677762|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
131560466|NCT02291289|473677763|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
131560467|NCT02291289|473677764|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
131560468|NCT02291289|473677765|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
131560469|NCT02291289|473677766|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
131560470|NCT02291289|473677754|FG000|Early Disease Progression|Death|0|||
131560471|NCT02291289|473677755|FG001|Early Disease Progression|Death|0|||
131560472|NCT02291289|473677756|FG002|Early Disease Progression|Death|0|||
131560473|NCT02291289|473677757|FG003|Early Disease Progression|Death|0|||
131560474|NCT02291289|473677758|FG004|Early Disease Progression|Death|0|||
131560475|NCT02291289|473677759|FG005|Early Disease Progression|Death|0|||
131560476|NCT02291289|473677760|FG006|Early Disease Progression|Death|0|||
131560477|NCT02291289|473677761|FG007|Early Disease Progression|Death|0|||
131560478|NCT02291289|473677762|FG008|Early Disease Progression|Death|0|||
131560479|NCT02291289|473677763|FG009|Early Disease Progression|Death|0|||
131560480|NCT02291289|473677764|FG010|Early Disease Progression|Death|0|||
131560481|NCT02291289|473677765|FG011|Early Disease Progression|Death|0|||
131560482|NCT02291289|473677766|FG012|Early Disease Progression|Death|10|||
131560483|NCT02291289|473677754|FG000|Early Disease Progression|Lost to Follow-up|0|||
131560484|NCT02291289|473677755|FG001|Early Disease Progression|Lost to Follow-up|0|||
131560485|NCT02291289|473677756|FG002|Early Disease Progression|Lost to Follow-up|0|||
131560486|NCT02291289|473677757|FG003|Early Disease Progression|Lost to Follow-up|0|||
131560487|NCT02291289|473677758|FG004|Early Disease Progression|Lost to Follow-up|0|||
131560488|NCT02291289|473677759|FG005|Early Disease Progression|Lost to Follow-up|0|||
131560489|NCT02291289|473677760|FG006|Early Disease Progression|Lost to Follow-up|0|||
131560490|NCT02291289|473677761|FG007|Early Disease Progression|Lost to Follow-up|0|||
131560491|NCT02291289|473677762|FG008|Early Disease Progression|Lost to Follow-up|0|||
131560492|NCT02291289|473677763|FG009|Early Disease Progression|Lost to Follow-up|0|||
131560493|NCT02291289|473677764|FG010|Early Disease Progression|Lost to Follow-up|0|||
131560494|NCT02291289|473677765|FG011|Early Disease Progression|Lost to Follow-up|0|||
131560495|NCT02291289|473677766|FG012|Early Disease Progression|Lost to Follow-up|1|||
131560496|NCT01238575|473677769|FG000|Overall Study|Lack of Efficacy|2|||
131780120|NCT00388674|474475716|FG000|Initial Treatment|HCC|12|||
131560497|NCT01238575|473677770|FG001|Overall Study|Lack of Efficacy|4|||
131560498|NCT01238575|473677769|FG000|Overall Study|Adverse Event|2|||
131560499|NCT01238575|473677770|FG001|Overall Study|Adverse Event|0|||
131560500|NCT00594906|473677775|FG000|Overall Study|Physician Decision|1|||
131560501|NCT00594906|473677776|FG001|Overall Study|Physician Decision|0|||
131560502|NCT00594906|473677775|FG000|Overall Study|Physician Decision|0|||
131560503|NCT00594906|473677776|FG001|Overall Study|Physician Decision|1|||
131560504|NCT00594906|473677775|FG000|Overall Study|Death|0|||
131560505|NCT00594906|473677776|FG001|Overall Study|Death|1|||
131695062|NCT04099251|474168467|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
131695063|NCT05032157|474168468|FG000|Overall Study|Adverse Event|12|||
131695064|NCT05032157|474168469|FG001|Overall Study|Adverse Event|7|||
131695065|NCT05032157|474168468|FG000|Overall Study|Pregnancy|0|||
131695066|NCT05032157|474168469|FG001|Overall Study|Pregnancy|2|||
131695067|NCT05032157|474168468|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131695068|NCT05032157|474168469|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
131560506|NCT01254565|473677777|FG000|Overall Study|Non-compliance to Study Procedures|0|||
131560507|NCT01254565|473677778|FG001|Overall Study|Non-compliance to Study Procedures|0|||
131560508|NCT01254565|473677779|FG002|Overall Study|Non-compliance to Study Procedures|0|||
131695069|NCT05032157|474168468|FG000|Overall Study|Protocol Deviation|8|||
131695070|NCT05032157|474168469|FG001|Overall Study|Protocol Deviation|4|||
131695071|NCT05032157|474168468|FG000|Overall Study|Lost to Follow-up|1|||
131695072|NCT05032157|474168469|FG001|Overall Study|Lost to Follow-up|3|||
131780121|NCT00388674|474475717|FG001|Initial Treatment|HCC|20|||
131780122|NCT00388674|474475716|FG000|Initial Treatment|Lost to Follow-up|526|||
131780123|NCT00388674|474475717|FG001|Initial Treatment|Lost to Follow-up|624|||
131780124|NCT00388674|474475716|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
131780125|NCT00388674|474475717|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
131780126|NCT00388674|474475716|FG000|Initial Treatment|Never Treated with Study Medication|1|||
131780127|NCT00388674|474475717|FG001|Initial Treatment|Never Treated with Study Medication|7|||
131780128|NCT00388674|474475716|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
131780129|NCT00388674|474475717|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
131780130|NCT00388674|474475716|FG000|Initial Treatment|Not Defined|125|||
131780131|NCT00388674|474475717|FG001|Initial Treatment|Not Defined|172|||
131780132|NCT00388674|474475716|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
131780133|NCT00388674|474475717|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
131780134|NCT00388674|474475716|FG000|Initial Treatment|Pregnancy|26|||
131560509|NCT01254565|473677780|FG003|Overall Study|Non-compliance to Study Procedures|0|||
131560510|NCT01254565|473677781|FG004|Overall Study|Non-compliance to Study Procedures|1|||
131780135|NCT00388674|474475717|FG001|Initial Treatment|Pregnancy|16|||
131780136|NCT00388674|474475716|FG000|Initial Treatment|Study Drug Toxicity|5|||
131780137|NCT00388674|474475717|FG001|Initial Treatment|Study Drug Toxicity|92|||
131780138|NCT00388674|474475716|FG000|Initial Treatment|Participant Request|501|||
131780139|NCT00388674|474475717|FG001|Initial Treatment|Participant Request|673|||
131780140|NCT00388674|474475716|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
131780141|NCT00388674|474475717|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
131780142|NCT00388674|474475716|FG000|Initial Treatment|Not Reported|10|||
131780143|NCT00388674|474475717|FG001|Initial Treatment|Not Reported|12|||
131560511|NCT01254565|473677782|FG005|Overall Study|Non-compliance to Study Procedures|0|||
131780144|NCT00388674|474475716|FG000|End of Study|Administrative Reason By Sponsor|299|||
131780145|NCT00388674|474475717|FG001|End of Study|Administrative Reason By Sponsor|253|||
131560512|NCT01254565|473677777|FG000|Overall Study|Did not Receive Treatment|1|||
131560513|NCT01254565|473677778|FG001|Overall Study|Did not Receive Treatment|1|||
131560514|NCT01254565|473677779|FG002|Overall Study|Did not Receive Treatment|0|||
131560515|NCT01254565|473677780|FG003|Overall Study|Did not Receive Treatment|0|||
131560516|NCT01254565|473677781|FG004|Overall Study|Did not Receive Treatment|3|||
131560517|NCT01254565|473677782|FG005|Overall Study|Did not Receive Treatment|4|||
131560518|NCT01254565|473677777|FG000|Overall Study|Other|0|||
131560519|NCT01254565|473677778|FG001|Overall Study|Other|0|||
131560520|NCT01254565|473677779|FG002|Overall Study|Other|0|||
131560521|NCT01254565|473677780|FG003|Overall Study|Other|1|||
131560522|NCT01254565|473677781|FG004|Overall Study|Other|0|||
131560523|NCT01254565|473677782|FG005|Overall Study|Other|0|||
131560524|NCT02726399|473677783|FG000|Overall Study|Participant Non-Compliance|1|||
131560525|NCT02726399|473677783|FG000|Overall Study|Adverse Event|2|||
131560526|NCT02726399|473677783|FG000|Overall Study|Progression of disease|4|||
131560527|NCT04254679|473677805|FG000|Overall Study|Protocol Violation|1|||
131560528|NCT04254679|473677806|FG001|Overall Study|Protocol Violation|1|||
131560529|NCT04254679|473677805|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
131695073|NCT05032157|474168468|FG000|Overall Study|Physician Decision|7|||
131695074|NCT05032157|474168469|FG001|Overall Study|Physician Decision|2|||
131560530|NCT04254679|473677806|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
131780146|NCT00388674|474475716|FG000|End of Study|Death|239|||
131780147|NCT00388674|474475717|FG001|End of Study|Death|262|||
131780148|NCT00388674|474475716|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
131780149|NCT00388674|474475717|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
131780150|NCT00388674|474475716|FG000|End of Study|HCC|8|||
131780151|NCT00388674|474475717|FG001|End of Study|HCC|7|||
131780152|NCT00388674|474475716|FG000|End of Study|Lost to Follow-up|587|||
131780153|NCT00388674|474475717|FG001|End of Study|Lost to Follow-up|715|||
131780154|NCT00388674|474475716|FG000|End of Study|Malignancy (Non-HCC)|1|||
131780155|NCT00388674|474475717|FG001|End of Study|Malignancy (Non-HCC)|1|||
131780156|NCT00388674|474475716|FG000|End of Study|Non-Study Related Comorbidities|3|||
131780157|NCT00388674|474475717|FG001|End of Study|Non-Study Related Comorbidities|4|||
131780158|NCT00388674|474475716|FG000|End of Study|Not Defined|135|||
131780159|NCT00388674|474475717|FG001|End of Study|Not Defined|214|||
131780160|NCT00388674|474475716|FG000|End of Study|Participant Withdrew Consent|437|||
131780161|NCT00388674|474475717|FG001|End of Study|Participant Withdrew Consent|673|||
131780162|NCT00388674|474475716|FG000|End of Study|No Off-Treatment Status Data|22|||
131780163|NCT00388674|474475717|FG001|End of Study|No Off-Treatment Status Data|30|||
131780164|NCT00388674|474475716|FG000|End of Study|Not Reported|0|||
131780165|NCT00388674|474475717|FG001|End of Study|Not Reported|1|||
131780166|NCT00568776|474475720|FG000|Overall Study|Adverse Event|8|||
131780167|NCT00568776|474475721|FG001|Overall Study|Adverse Event|8|||
131780168|NCT00568776|474475722|FG002|Overall Study|Adverse Event|10|||
131780169|NCT00568776|474475723|FG003|Overall Study|Adverse Event|8|||
131780170|NCT00568776|474475720|FG000|Overall Study|Death|0|||
131780171|NCT00568776|474475721|FG001|Overall Study|Death|1|||
131780172|NCT00568776|474475722|FG002|Overall Study|Death|4|||
131780173|NCT00568776|474475723|FG003|Overall Study|Death|3|||
131780174|NCT00568776|474475720|FG000|Overall Study|Physician Decision|0|||
131780175|NCT00568776|474475721|FG001|Overall Study|Physician Decision|2|||
131560531|NCT02823964|473677807|FG000|Overall Study|Adverse Event|2|||
131695075|NCT05032157|474168468|FG000|Overall Study|Patient Decision|38|||
131695076|NCT05032157|474168469|FG001|Overall Study|Patient Decision|19|||
131695077|NCT03047980|474168470|FG000|Overall Study|Adverse Event|1|||
131695078|NCT00880893|474168471|FG000|Overall Study|Protocol Violation|13|||
131695079|NCT00880893|474168472|FG001|Overall Study|Protocol Violation|1|||
131695080|NCT00880893|474168471|FG000|Overall Study|Withdrawal by Subject|15|||
131695081|NCT00880893|474168472|FG001|Overall Study|Withdrawal by Subject|11|||
131780176|NCT00568776|474475722|FG002|Overall Study|Physician Decision|0|||
131780177|NCT00568776|474475723|FG003|Overall Study|Physician Decision|0|||
131780178|NCT00568776|474475720|FG000|Overall Study|Lack of Efficacy|2|||
131780179|NCT00568776|474475721|FG001|Overall Study|Lack of Efficacy|2|||
131780180|NCT00568776|474475722|FG002|Overall Study|Lack of Efficacy|2|||
131780181|NCT00568776|474475723|FG003|Overall Study|Lack of Efficacy|4|||
131780182|NCT00568776|474475720|FG000|Overall Study|Lost to Follow-up|1|||
131560532|NCT02823964|473677807|FG000|Overall Study|Physician Decision|1|||
131560533|NCT02823964|473677807|FG000|Overall Study|Lack of Efficacy|1|||
131780183|NCT00568776|474475721|FG001|Overall Study|Lost to Follow-up|1|||
131780184|NCT00568776|474475722|FG002|Overall Study|Lost to Follow-up|1|||
131560534|NCT02823964|473677807|FG000|Overall Study|Withdrawal by Subject|1|||
131560535|NCT00390455|473677813|FG000|Overall Study|Adverse Event|17|||
131560536|NCT00390455|473677814|FG001|Overall Study|Adverse Event|3|||
131695082|NCT00880893|474168471|FG000|Overall Study|Lost to Follow-up|76|||
131695083|NCT00880893|474168472|FG001|Overall Study|Lost to Follow-up|33|||
131695084|NCT00880893|474168471|FG000|Overall Study|Serious adverse event|3|||
131780185|NCT00568776|474475723|FG003|Overall Study|Lost to Follow-up|1|||
131780186|NCT00568776|474475720|FG000|Overall Study|Protocol Violation|1|||
131780187|NCT00568776|474475721|FG001|Overall Study|Protocol Violation|0|||
131780188|NCT00568776|474475722|FG002|Overall Study|Protocol Violation|1|||
131560537|NCT00390455|473677813|FG000|Overall Study|Withdrawal by Subject|8|||
131560538|NCT00390455|473677814|FG001|Overall Study|Withdrawal by Subject|8|||
131560539|NCT00390455|473677813|FG000|Overall Study|Alternate Treatment|0|||
131560540|NCT00390455|473677814|FG001|Overall Study|Alternate Treatment|1|||
131560541|NCT00390455|473677813|FG000|Overall Study|Other Medical Reasons|7|||
131560542|NCT00390455|473677814|FG001|Overall Study|Other Medical Reasons|11|||
131560543|NCT00794820|473677820|FG000|Overall Study|Adverse Event|11|||
131560544|NCT00794820|473677820|FG000|Overall Study|Secondary Malignancies|2|||
131560545|NCT00794820|473677820|FG000|Overall Study|Resistant Disease|2|||
131560546|NCT00794820|473677820|FG000|Overall Study|Ineligible/Screen Failure|1|||
131560547|NCT00672958|473677824|FG000|Overall Study|Adverse Event|11|||
131560548|NCT00672958|473677825|FG001|Overall Study|Adverse Event|9|||
131560549|NCT00672958|473677824|FG000|Overall Study|Lack of Efficacy|6|||
131560550|NCT00672958|473677825|FG001|Overall Study|Lack of Efficacy|11|||
131560551|NCT00672958|473677824|FG000|Overall Study|Non-compliance with study drug|2|||
131560552|NCT00672958|473677825|FG001|Overall Study|Non-compliance with study drug|3|||
131560553|NCT00672958|473677824|FG000|Overall Study|Protocol deviations|11|||
131560554|NCT00672958|473677825|FG001|Overall Study|Protocol deviations|5|||
131560555|NCT00672958|473677824|FG000|Overall Study|Voluntary withdrawal|12|||
131560556|NCT00672958|473677825|FG001|Overall Study|Voluntary withdrawal|8|||
131560557|NCT00672958|473677824|FG000|Overall Study|Lost to Follow-up|22|||
131560558|NCT00672958|473677825|FG001|Overall Study|Lost to Follow-up|17|||
131560559|NCT00672958|473677824|FG000|Overall Study|Reason not specified|0|||
131560560|NCT00672958|473677825|FG001|Overall Study|Reason not specified|3|||
131560561|NCT01380990|473677826|FG000|Overall Study|Treatment Failure|1|||
131560562|NCT01380990|473677827|FG001|Overall Study|Treatment Failure|0|||
131560563|NCT01380990|473677826|FG000|Overall Study|Death|0|||
131560564|NCT01380990|473677827|FG001|Overall Study|Death|1|||
131560565|NCT01313923|473677833|FG000|Overall Study|Physician Decision|3|||
131560566|NCT02471404|473677834|FG000|Overall Study|Adverse Event|7|||
131560567|NCT02471404|473677835|FG001|Overall Study|Adverse Event|1|||
131560568|NCT02471404|473677836|FG002|Overall Study|Adverse Event|2|||
131560569|NCT02471404|473677834|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
131560570|NCT02471404|473677835|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
131560571|NCT02471404|473677836|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
131560572|NCT02471404|473677834|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
131560573|NCT02471404|473677835|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131560574|NCT02471404|473677836|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
131560575|NCT02471404|473677834|FG000|Overall Study|Lost to Follow-up|1|||
131560576|NCT02471404|473677835|FG001|Overall Study|Lost to Follow-up|1|||
131560577|NCT02471404|473677836|FG002|Overall Study|Lost to Follow-up|3|||
131560578|NCT02471404|473677834|FG000|Overall Study|Protocol Violation|1|||
131560579|NCT02471404|473677835|FG001|Overall Study|Protocol Violation|0|||
131560580|NCT02471404|473677836|FG002|Overall Study|Protocol Violation|0|||
131560581|NCT02471404|473677834|FG000|Overall Study|Withdrawal by Subject|8|||
131560582|NCT02471404|473677835|FG001|Overall Study|Withdrawal by Subject|4|||
131560583|NCT02471404|473677836|FG002|Overall Study|Withdrawal by Subject|5|||
131560584|NCT02471404|473677834|FG000|Overall Study|Other reasons not specified|10|||
131560585|NCT02471404|473677835|FG001|Overall Study|Other reasons not specified|7|||
131560586|NCT02471404|473677836|FG002|Overall Study|Other reasons not specified|12|||
131560587|NCT03285113|473677837|FG000|Overall Study|Unable to implant leads|2|||
131560588|NCT02207374|473677840|FG000|Overall Study|Withdrawal by Subject|5|||
131560589|NCT02207374|473677841|FG001|Overall Study|Withdrawal by Subject|9|||
131560590|NCT02207374|473677842|FG002|Overall Study|Withdrawal by Subject|4|||
131560591|NCT02207374|473677840|FG000|Overall Study|Death|1|||
131560592|NCT02207374|473677841|FG001|Overall Study|Death|0|||
131560593|NCT02207374|473677842|FG002|Overall Study|Death|1|||
131560594|NCT02207374|473677840|FG000|Overall Study|Missing follow-up information|0|||
131560595|NCT02207374|473677841|FG001|Overall Study|Missing follow-up information|1|||
131695085|NCT00880893|474168472|FG001|Overall Study|Serious adverse event|0|||
131695086|NCT02164981|474168473|FG000|Started|Withdrawal by Subject|2|||
131695087|NCT02164981|474168474|FG001|Started|Withdrawal by Subject|1|||
131695088|NCT02164981|474168475|FG002|Started|Withdrawal by Subject|0|||
131695089|NCT02164981|474168473|FG000|Started|Protocol Violation|2|||
131695090|NCT02164981|474168474|FG001|Started|Protocol Violation|0|||
131560596|NCT02207374|473677842|FG002|Overall Study|Missing follow-up information|1|||
131560597|NCT02087150|473677843|FG000|Overall Study|Death|0|||
131695091|NCT02164981|474168475|FG002|Started|Protocol Violation|0|||
131695092|NCT02164981|474168473|FG000|Started|Adverse Event|1|||
131695093|NCT02164981|474168474|FG001|Started|Adverse Event|2|||
131560598|NCT02087150|473677844|FG001|Overall Study|Death|1|||
131560599|NCT02087150|473677845|FG002|Overall Study|Death|0|||
131560600|NCT02087150|473677843|FG000|Overall Study|Lost to Follow-up|6|||
131560601|NCT02087150|473677844|FG001|Overall Study|Lost to Follow-up|13|||
131560602|NCT02087150|473677845|FG002|Overall Study|Lost to Follow-up|7|||
131560603|NCT02087150|473677843|FG000|Overall Study|Withdrawal by Subject|2|||
131560604|NCT02087150|473677844|FG001|Overall Study|Withdrawal by Subject|5|||
131560605|NCT02087150|473677845|FG002|Overall Study|Withdrawal by Subject|3|||
131560606|NCT02087150|473677843|FG000|Overall Study|Physician Decision|0|||
131560607|NCT02087150|473677844|FG001|Overall Study|Physician Decision|1|||
131560608|NCT02087150|473677845|FG002|Overall Study|Physician Decision|0|||
131560609|NCT02087150|473677843|FG000|Overall Study|Procedure not done|1|||
131560610|NCT02087150|473677844|FG001|Overall Study|Procedure not done|13|||
131560611|NCT02087150|473677845|FG002|Overall Study|Procedure not done|0|||
131560612|NCT02087150|473677843|FG000|Overall Study|F/U not completed w/in study window|0|||
131560613|NCT02087150|473677844|FG001|Overall Study|F/U not completed w/in study window|0|||
131560614|NCT02087150|473677845|FG002|Overall Study|F/U not completed w/in study window|1|||
131560615|NCT02087150|473677843|FG000|Overall Study|Other|1|||
131560616|NCT02087150|473677844|FG001|Overall Study|Other|0|||
131560617|NCT02087150|473677845|FG002|Overall Study|Other|0|||
131560618|NCT02087150|473677843|FG000|Overall Study|Pt moved out of town|0|||
131560619|NCT02087150|473677844|FG001|Overall Study|Pt moved out of town|1|||
131560620|NCT02087150|473677845|FG002|Overall Study|Pt moved out of town|0|||
131560621|NCT01448044|473677846|FG000|Treatment Period|Adverse Event|4|||
131560622|NCT01448044|473677847|FG001|Treatment Period|Adverse Event|3|||
131560623|NCT01448044|473677846|FG000|Treatment Period|Lack of Efficacy|5|||
131560624|NCT01448044|473677847|FG001|Treatment Period|Lack of Efficacy|12|||
131560625|NCT01448044|473677846|FG000|Treatment Period|Subject requested discontinue study drug|1|||
131560626|NCT01448044|473677847|FG001|Treatment Period|Subject requested discontinue study drug|0|||
131560627|NCT01448044|473677846|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
131560628|NCT01448044|473677847|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
131560629|NCT01448044|473677846|FG000|Treatment Period|Participant does not meet study criteria|1|||
131560630|NCT01448044|473677847|FG001|Treatment Period|Participant does not meet study criteria|0|||
131560631|NCT01448044|473677846|FG000|Treatment Period|Lost to Follow-up|2|||
131560632|NCT01448044|473677847|FG001|Treatment Period|Lost to Follow-up|1|||
131560633|NCT01448044|473677846|FG000|Treatment Period|Other reason|2|||
131695094|NCT02164981|474168475|FG002|Started|Adverse Event|0|||
131695095|NCT02164981|474168473|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
131695096|NCT02164981|474168474|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
131695097|NCT02164981|474168475|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
131695098|NCT02164981|474168473|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
131695099|NCT02164981|474168474|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
131695100|NCT02164981|474168475|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
131695101|NCT02164981|474168473|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
131695102|NCT02164981|474168474|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
131695103|NCT02164981|474168475|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
131695104|NCT01995071|474168476|FG000|Overall Study|Adverse Event|0|||
131695105|NCT01995071|474168477|FG001|Overall Study|Adverse Event|0|||
131695106|NCT01995071|474168478|FG002|Overall Study|Adverse Event|0|||
131695107|NCT01995071|474168479|FG003|Overall Study|Adverse Event|0|||
131695108|NCT01995071|474168480|FG004|Overall Study|Adverse Event|0|||
131695109|NCT01995071|474168481|FG005|Overall Study|Adverse Event|0|||
131695110|NCT01995071|474168482|FG006|Overall Study|Adverse Event|1|||
131695111|NCT01995071|474168483|FG007|Overall Study|Adverse Event|0|||
131695112|NCT01995071|474168484|FG008|Overall Study|Adverse Event|0|||
131695113|NCT01995071|474168485|FG009|Overall Study|Adverse Event|0|||
131695114|NCT01995071|474168486|FG010|Overall Study|Adverse Event|0|||
131695115|NCT01995071|474168487|FG011|Overall Study|Adverse Event|0|||
131695116|NCT01995071|474168476|FG000|Overall Study|Moved|0|||
131695117|NCT01995071|474168477|FG001|Overall Study|Moved|0|||
131695118|NCT01995071|474168478|FG002|Overall Study|Moved|1|||
131695119|NCT01995071|474168479|FG003|Overall Study|Moved|0|||
131695120|NCT01995071|474168480|FG004|Overall Study|Moved|1|||
131695121|NCT01995071|474168481|FG005|Overall Study|Moved|0|||
131695122|NCT01995071|474168482|FG006|Overall Study|Moved|0|||
131695123|NCT01995071|474168483|FG007|Overall Study|Moved|0|||
131695124|NCT01995071|474168484|FG008|Overall Study|Moved|0|||
131695125|NCT01995071|474168485|FG009|Overall Study|Moved|0|||
131695126|NCT01995071|474168486|FG010|Overall Study|Moved|1|||
131695127|NCT01995071|474168487|FG011|Overall Study|Moved|0|||
131695128|NCT01995071|474168476|FG000|Overall Study|Lost to Follow-up|1|||
131695129|NCT01995071|474168477|FG001|Overall Study|Lost to Follow-up|0|||
131695130|NCT01995071|474168478|FG002|Overall Study|Lost to Follow-up|0|||
131695131|NCT01995071|474168479|FG003|Overall Study|Lost to Follow-up|0|||
131695132|NCT01995071|474168480|FG004|Overall Study|Lost to Follow-up|0|||
131695133|NCT01995071|474168481|FG005|Overall Study|Lost to Follow-up|0|||
131695134|NCT01995071|474168482|FG006|Overall Study|Lost to Follow-up|0|||
131695135|NCT01995071|474168483|FG007|Overall Study|Lost to Follow-up|1|||
131695136|NCT01995071|474168484|FG008|Overall Study|Lost to Follow-up|1|||
131695137|NCT01995071|474168485|FG009|Overall Study|Lost to Follow-up|0|||
131695138|NCT01995071|474168486|FG010|Overall Study|Lost to Follow-up|0|||
131560634|NCT01448044|473677847|FG001|Treatment Period|Other reason|0|||
131560635|NCT01448044|473677846|FG000|Follow Up Period|Withdrawal by Subject|1|||
131560636|NCT01448044|473677847|FG001|Follow Up Period|Withdrawal by Subject|1|||
131560637|NCT01448044|473677846|FG000|Follow Up Period|Lost to Follow-up|6|||
131560638|NCT01448044|473677847|FG001|Follow Up Period|Lost to Follow-up|2|||
131560639|NCT01448044|473677846|FG000|Follow Up Period|Other|5|||
131560640|NCT01448044|473677847|FG001|Follow Up Period|Other|11|||
131560641|NCT02500316|473677850|FG000|Overall Study|Adverse Event|3|||
131560642|NCT02500316|473677850|FG000|Overall Study|Lost to Follow-up|2|||
131560643|NCT02500316|473677850|FG000|Overall Study|Protocol Violation|1|||
131560644|NCT02500316|473677850|FG000|Overall Study|Withdrawal by Subject|15|||
131560645|NCT02500316|473677850|FG000|Overall Study|Final height achieved|5|||
131560646|NCT02500316|473677850|FG000|Overall Study|Due to war activity|1|||
131560647|NCT02611830|473677860|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
131560648|NCT02611830|473677861|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
131560649|NCT02611830|473677862|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
131560650|NCT02611830|473677863|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
131560651|NCT02611830|473677860|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
131560652|NCT02611830|473677861|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
131560653|NCT02611830|473677862|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
131560654|NCT02611830|473677863|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
131560655|NCT02611830|473677860|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
131560656|NCT02611830|473677861|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
131560657|NCT02611830|473677862|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
131560658|NCT02611830|473677863|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
131560659|NCT02611830|473677860|FG000|OL Induction Phase|Lack of Efficacy|9|||
131560660|NCT02611830|473677861|FG001|OL Induction Phase|Lack of Efficacy|0|||
131560661|NCT02611830|473677862|FG002|OL Induction Phase|Lack of Efficacy|0|||
131560662|NCT02611830|473677863|FG003|OL Induction Phase|Lack of Efficacy|0|||
131560663|NCT02611830|473677860|FG000|OL Induction Phase|Reason not specified|3|||
131560664|NCT02611830|473677861|FG001|OL Induction Phase|Reason not specified|0|||
131560665|NCT02611830|473677862|FG002|OL Induction Phase|Reason not specified|0|||
131560666|NCT02611830|473677863|FG003|OL Induction Phase|Reason not specified|0|||
131560667|NCT02611830|473677860|FG000|Maintenance Phase|Lack of Efficacy|0|||
131560668|NCT02611830|473677861|FG001|Maintenance Phase|Lack of Efficacy|29|||
131560669|NCT02611830|473677862|FG002|Maintenance Phase|Lack of Efficacy|18|||
131560670|NCT02611830|473677863|FG003|Maintenance Phase|Lack of Efficacy|6|||
131560671|NCT02611830|473677860|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
131560672|NCT02611830|473677861|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
131560673|NCT02611830|473677862|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
131560674|NCT02611830|473677863|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
131560675|NCT02611830|473677860|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
131560676|NCT02611830|473677861|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
131560677|NCT02611830|473677862|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
131560678|NCT02611830|473677863|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
131560679|NCT02611830|473677860|FG000|Maintenance Phase|Lost to Follow-up|0|||
131560680|NCT02611830|473677861|FG001|Maintenance Phase|Lost to Follow-up|0|||
131560681|NCT02611830|473677862|FG002|Maintenance Phase|Lost to Follow-up|0|||
131560682|NCT02611830|473677863|FG003|Maintenance Phase|Lost to Follow-up|1|||
131560683|NCT02611830|473677860|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
131560684|NCT02611830|473677861|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
131560685|NCT02611830|473677862|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
131560686|NCT02611830|473677863|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
131560687|NCT02611830|473677860|FG000|Maintenance Phase|Pregnancy|0|||
131560688|NCT02611830|473677861|FG001|Maintenance Phase|Pregnancy|0|||
131695139|NCT01995071|474168487|FG011|Overall Study|Lost to Follow-up|0|||
131695140|NCT01995071|474168476|FG000|Overall Study|Incarcerated|0|||
131695141|NCT01995071|474168477|FG001|Overall Study|Incarcerated|0|||
131695142|NCT01995071|474168478|FG002|Overall Study|Incarcerated|0|||
131695143|NCT01995071|474168479|FG003|Overall Study|Incarcerated|0|||
131695144|NCT01995071|474168480|FG004|Overall Study|Incarcerated|0|||
131695145|NCT01995071|474168481|FG005|Overall Study|Incarcerated|0|||
131695146|NCT01995071|474168482|FG006|Overall Study|Incarcerated|0|||
131695147|NCT01995071|474168483|FG007|Overall Study|Incarcerated|1|||
131695148|NCT01995071|474168484|FG008|Overall Study|Incarcerated|0|||
131695149|NCT01995071|474168485|FG009|Overall Study|Incarcerated|0|||
131695150|NCT01995071|474168486|FG010|Overall Study|Incarcerated|0|||
131695151|NCT01995071|474168487|FG011|Overall Study|Incarcerated|0|||
131695152|NCT02404103|474168488|FG000|Overall Study|Adverse Event|1|||
131780189|NCT00568776|474475723|FG003|Overall Study|Protocol Violation|1|||
131560689|NCT02611830|473677862|FG002|Maintenance Phase|Pregnancy|1|||
131560690|NCT02611830|473677863|FG003|Maintenance Phase|Pregnancy|0|||
131560691|NCT02611830|473677860|FG000|Maintenance Phase|Reason not specified|0|||
131560692|NCT02611830|473677861|FG001|Maintenance Phase|Reason not specified|1|||
131560693|NCT02611830|473677862|FG002|Maintenance Phase|Reason not specified|4|||
131560694|NCT02611830|473677863|FG003|Maintenance Phase|Reason not specified|0|||
131560695|NCT02058290|473677864|FG000|Overall Study|Protocol Violation|2|||
131560696|NCT02058290|473677865|FG001|Overall Study|Protocol Violation|1|||
131560697|NCT02058290|473677864|FG000|Overall Study|Physician Decision|1|||
131560698|NCT02058290|473677865|FG001|Overall Study|Physician Decision|0|||
131560699|NCT02058290|473677864|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
131560700|NCT02058290|473677865|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
131560701|NCT02058290|473677864|FG000|Overall Study|Withdrawal by Subject|0|||
131560702|NCT02058290|473677865|FG001|Overall Study|Withdrawal by Subject|1|||
131560703|NCT05822921|473677868|FG000|Overall Study|Lost to Follow-up|1|||
131560704|NCT05822921|473677869|FG001|Overall Study|Lost to Follow-up|1|||
131560705|NCT00544544|473677870|FG000|Overall Study|Withdrawal by Subject|1|||
131560706|NCT00544544|473677870|FG000|Overall Study|Adverse Event|1|||
131560707|NCT00544544|473677870|FG000|Overall Study|Lost to Follow-up|1|||
131560708|NCT03406702|473677871|FG000|Overall Study|Missed Day 27 Dosing|1|||
131560709|NCT01857622|473677876|FG000|Overall Study|Adverse Event|5|||
131560710|NCT01857622|473677877|FG001|Overall Study|Adverse Event|0|||
131560711|NCT01857622|473677878|FG002|Overall Study|Adverse Event|2|||
131560712|NCT01857622|473677876|FG000|Overall Study|Physician Decision|1|||
131560713|NCT01857622|473677877|FG001|Overall Study|Physician Decision|0|||
131560714|NCT01857622|473677878|FG002|Overall Study|Physician Decision|0|||
131560715|NCT01857622|473677876|FG000|Overall Study|Protocol Violation|4|||
131560716|NCT01857622|473677877|FG001|Overall Study|Protocol Violation|1|||
131560717|NCT01857622|473677878|FG002|Overall Study|Protocol Violation|0|||
131560718|NCT01857622|473677876|FG000|Overall Study|Withdrawal by Subject|1|||
131560719|NCT01857622|473677877|FG001|Overall Study|Withdrawal by Subject|0|||
131560720|NCT01857622|473677878|FG002|Overall Study|Withdrawal by Subject|0|||
131560721|NCT01291225|473677880|FG000|Overall Study|Lost to Follow-up|85|||
131560722|NCT01291225|473677881|FG001|Overall Study|Lost to Follow-up|39|||
131560723|NCT01267253|473677882|FG000|Overall Study|Ineligible - required test not done|1|||
131560724|NCT01267253|473677882|FG000|Overall Study|Inevaluable-never received study treatme|2|||
131560725|NCT04318093|473677883|FG000|Overall Study|Adverse Event|2|||
131560726|NCT04318093|473677884|FG001|Overall Study|Adverse Event|2|||
131560727|NCT04318093|473677883|FG000|Overall Study|Participant withdrew consent|1|||
131560728|NCT04318093|473677884|FG001|Overall Study|Participant withdrew consent|0|||
131695153|NCT02404103|474168489|FG001|Overall Study|Adverse Event|0|||
131695154|NCT02404103|474168488|FG000|Overall Study|Lost to Follow-up|3|||
131695155|NCT02404103|474168489|FG001|Overall Study|Lost to Follow-up|3|||
131695156|NCT01783678|474168490|FG000|Overall Study|Randomized but Not Treated|0|||
131780190|NCT00568776|474475720|FG000|Overall Study|Withdrawal by Subject|13|||
131780191|NCT00568776|474475721|FG001|Overall Study|Withdrawal by Subject|15|||
131560729|NCT04318093|473677883|FG000|Overall Study|Other reasons|0|||
131695157|NCT01783678|474168491|FG001|Overall Study|Randomized but Not Treated|0|||
131695158|NCT01783678|474168492|FG002|Overall Study|Randomized but Not Treated|0|||
131695159|NCT01783678|474168493|FG003|Overall Study|Randomized but Not Treated|1|||
131695160|NCT01783678|474168494|FG004|Overall Study|Randomized but Not Treated|0|||
131695161|NCT01783678|474168495|FG005|Overall Study|Randomized but Not Treated|0|||
131695162|NCT01783678|474168490|FG000|Overall Study|Lack of Efficacy|1|||
131695163|NCT01783678|474168491|FG001|Overall Study|Lack of Efficacy|13|||
131695164|NCT01783678|474168492|FG002|Overall Study|Lack of Efficacy|1|||
131695165|NCT01783678|474168493|FG003|Overall Study|Lack of Efficacy|3|||
131695166|NCT01783678|474168494|FG004|Overall Study|Lack of Efficacy|6|||
131695167|NCT01783678|474168495|FG005|Overall Study|Lack of Efficacy|5|||
131695168|NCT01783678|474168490|FG000|Overall Study|Lost to Follow-up|0|||
131695169|NCT01783678|474168491|FG001|Overall Study|Lost to Follow-up|4|||
131695170|NCT01783678|474168492|FG002|Overall Study|Lost to Follow-up|0|||
131695171|NCT01783678|474168493|FG003|Overall Study|Lost to Follow-up|2|||
131695172|NCT01783678|474168494|FG004|Overall Study|Lost to Follow-up|1|||
131695173|NCT01783678|474168495|FG005|Overall Study|Lost to Follow-up|0|||
131695174|NCT01783678|474168490|FG000|Overall Study|Withdrew Consent|1|||
131695175|NCT01783678|474168491|FG001|Overall Study|Withdrew Consent|1|||
131695176|NCT01783678|474168492|FG002|Overall Study|Withdrew Consent|0|||
131695177|NCT01783678|474168493|FG003|Overall Study|Withdrew Consent|2|||
131695178|NCT01783678|474168494|FG004|Overall Study|Withdrew Consent|0|||
131695179|NCT01783678|474168495|FG005|Overall Study|Withdrew Consent|0|||
131695180|NCT00328627|474168496|FG000|Overall Study|Hyperglycemic Rescue|41|||
131695181|NCT00328627|474168497|FG001|Overall Study|Hyperglycemic Rescue|18|||
131780192|NCT00568776|474475722|FG002|Overall Study|Withdrawal by Subject|13|||
131560730|NCT04318093|473677884|FG001|Overall Study|Other reasons|1|||
131560731|NCT02855164|473677887|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
131695182|NCT00328627|474168498|FG002|Overall Study|Hyperglycemic Rescue|16|||
131695183|NCT00328627|474168499|FG003|Overall Study|Hyperglycemic Rescue|13|||
131560732|NCT02855164|473677888|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
131695184|NCT00328627|474168500|FG004|Overall Study|Hyperglycemic Rescue|6|||
131695185|NCT00328627|474168501|FG005|Overall Study|Hyperglycemic Rescue|5|||
131695186|NCT00328627|474168502|FG006|Overall Study|Hyperglycemic Rescue|19|||
131560733|NCT02855164|473677889|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
131560734|NCT02855164|473677890|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
131560735|NCT02855164|473677891|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
131695187|NCT00328627|474168503|FG007|Overall Study|Hyperglycemic Rescue|6|||
131695188|NCT00328627|474168504|FG008|Overall Study|Hyperglycemic Rescue|6|||
131695189|NCT00328627|474168505|FG009|Overall Study|Hyperglycemic Rescue|11|||
131780193|NCT00568776|474475723|FG003|Overall Study|Withdrawal by Subject|7|||
131695190|NCT00328627|474168506|FG010|Overall Study|Hyperglycemic Rescue|3|||
131695191|NCT00328627|474168507|FG011|Overall Study|Hyperglycemic Rescue|2|||
131695192|NCT00328627|474168496|FG000|Overall Study|Adverse Event|3|||
131695193|NCT00328627|474168497|FG001|Overall Study|Adverse Event|1|||
131695194|NCT00328627|474168498|FG002|Overall Study|Adverse Event|2|||
131695195|NCT00328627|474168499|FG003|Overall Study|Adverse Event|3|||
131695196|NCT00328627|474168500|FG004|Overall Study|Adverse Event|1|||
131695197|NCT00328627|474168501|FG005|Overall Study|Adverse Event|2|||
131695198|NCT00328627|474168502|FG006|Overall Study|Adverse Event|1|||
131695199|NCT00328627|474168503|FG007|Overall Study|Adverse Event|2|||
131695200|NCT00328627|474168504|FG008|Overall Study|Adverse Event|0|||
131695201|NCT00328627|474168505|FG009|Overall Study|Adverse Event|7|||
131695202|NCT00328627|474168506|FG010|Overall Study|Adverse Event|5|||
131695203|NCT00328627|474168507|FG011|Overall Study|Adverse Event|4|||
131695204|NCT00328627|474168496|FG000|Overall Study|Protocol Violation|2|||
131695205|NCT00328627|474168497|FG001|Overall Study|Protocol Violation|2|||
131695206|NCT00328627|474168498|FG002|Overall Study|Protocol Violation|2|||
131695207|NCT00328627|474168499|FG003|Overall Study|Protocol Violation|8|||
131695208|NCT00328627|474168500|FG004|Overall Study|Protocol Violation|5|||
131695209|NCT00328627|474168501|FG005|Overall Study|Protocol Violation|5|||
131695210|NCT00328627|474168502|FG006|Overall Study|Protocol Violation|6|||
131695211|NCT00328627|474168503|FG007|Overall Study|Protocol Violation|2|||
131695212|NCT00328627|474168504|FG008|Overall Study|Protocol Violation|1|||
131695213|NCT00328627|474168505|FG009|Overall Study|Protocol Violation|4|||
131695214|NCT00328627|474168506|FG010|Overall Study|Protocol Violation|6|||
131695215|NCT00328627|474168507|FG011|Overall Study|Protocol Violation|2|||
131695216|NCT00328627|474168496|FG000|Overall Study|Lost to Follow-up|4|||
131695217|NCT00328627|474168497|FG001|Overall Study|Lost to Follow-up|2|||
131695218|NCT00328627|474168498|FG002|Overall Study|Lost to Follow-up|2|||
131695219|NCT00328627|474168499|FG003|Overall Study|Lost to Follow-up|4|||
131695220|NCT00328627|474168500|FG004|Overall Study|Lost to Follow-up|0|||
131695221|NCT00328627|474168501|FG005|Overall Study|Lost to Follow-up|2|||
131695222|NCT00328627|474168502|FG006|Overall Study|Lost to Follow-up|3|||
131695223|NCT00328627|474168503|FG007|Overall Study|Lost to Follow-up|0|||
131695224|NCT00328627|474168504|FG008|Overall Study|Lost to Follow-up|3|||
131695225|NCT00328627|474168505|FG009|Overall Study|Lost to Follow-up|2|||
131695226|NCT00328627|474168506|FG010|Overall Study|Lost to Follow-up|0|||
131695227|NCT00328627|474168507|FG011|Overall Study|Lost to Follow-up|1|||
131695228|NCT00328627|474168496|FG000|Overall Study|Withdrawal by Subject|5|||
131695229|NCT00328627|474168497|FG001|Overall Study|Withdrawal by Subject|4|||
131695230|NCT00328627|474168498|FG002|Overall Study|Withdrawal by Subject|5|||
131695231|NCT00328627|474168499|FG003|Overall Study|Withdrawal by Subject|6|||
131695232|NCT00328627|474168500|FG004|Overall Study|Withdrawal by Subject|2|||
131695233|NCT00328627|474168501|FG005|Overall Study|Withdrawal by Subject|5|||
131695234|NCT00328627|474168502|FG006|Overall Study|Withdrawal by Subject|4|||
131695235|NCT00328627|474168503|FG007|Overall Study|Withdrawal by Subject|4|||
131695236|NCT00328627|474168504|FG008|Overall Study|Withdrawal by Subject|4|||
131695237|NCT00328627|474168505|FG009|Overall Study|Withdrawal by Subject|5|||
131695238|NCT00328627|474168506|FG010|Overall Study|Withdrawal by Subject|2|||
131695239|NCT00328627|474168507|FG011|Overall Study|Withdrawal by Subject|7|||
131695240|NCT00328627|474168496|FG000|Overall Study|Pregnancy|0|||
131695241|NCT00328627|474168497|FG001|Overall Study|Pregnancy|1|||
131695242|NCT00328627|474168498|FG002|Overall Study|Pregnancy|0|||
131695243|NCT00328627|474168499|FG003|Overall Study|Pregnancy|0|||
131695244|NCT00328627|474168500|FG004|Overall Study|Pregnancy|0|||
131695245|NCT00328627|474168501|FG005|Overall Study|Pregnancy|0|||
131695246|NCT00328627|474168502|FG006|Overall Study|Pregnancy|0|||
131695247|NCT00328627|474168503|FG007|Overall Study|Pregnancy|0|||
131695248|NCT00328627|474168504|FG008|Overall Study|Pregnancy|0|||
131695249|NCT00328627|474168505|FG009|Overall Study|Pregnancy|0|||
131695250|NCT00328627|474168506|FG010|Overall Study|Pregnancy|0|||
131695251|NCT00328627|474168507|FG011|Overall Study|Pregnancy|0|||
131695252|NCT00328627|474168496|FG000|Overall Study|Physician Decision|4|||
131695253|NCT00328627|474168497|FG001|Overall Study|Physician Decision|3|||
131695254|NCT00328627|474168498|FG002|Overall Study|Physician Decision|1|||
131695255|NCT00328627|474168499|FG003|Overall Study|Physician Decision|2|||
131695256|NCT00328627|474168500|FG004|Overall Study|Physician Decision|1|||
131695257|NCT00328627|474168501|FG005|Overall Study|Physician Decision|1|||
131695258|NCT00328627|474168502|FG006|Overall Study|Physician Decision|1|||
131695259|NCT00328627|474168503|FG007|Overall Study|Physician Decision|0|||
131695260|NCT00328627|474168504|FG008|Overall Study|Physician Decision|3|||
131695261|NCT00328627|474168505|FG009|Overall Study|Physician Decision|2|||
131695262|NCT00328627|474168506|FG010|Overall Study|Physician Decision|1|||
131695263|NCT00328627|474168507|FG011|Overall Study|Physician Decision|0|||
131695264|NCT00328627|474168496|FG000|Overall Study|Other|0|||
131695265|NCT00328627|474168497|FG001|Overall Study|Other|0|||
131695266|NCT00328627|474168498|FG002|Overall Study|Other|0|||
131695267|NCT00328627|474168499|FG003|Overall Study|Other|1|||
131695268|NCT00328627|474168500|FG004|Overall Study|Other|0|||
131695269|NCT00328627|474168501|FG005|Overall Study|Other|0|||
131695270|NCT00328627|474168502|FG006|Overall Study|Other|1|||
131695271|NCT00328627|474168503|FG007|Overall Study|Other|0|||
131780194|NCT00568776|474475720|FG000|Overall Study|Loss of Caregiver|0|||
131780195|NCT00568776|474475721|FG001|Overall Study|Loss of Caregiver|2|||
131780196|NCT00568776|474475722|FG002|Overall Study|Loss of Caregiver|1|||
131780197|NCT00568776|474475723|FG003|Overall Study|Loss of Caregiver|2|||
131780198|NCT00568776|474475720|FG000|Overall Study|Sponsor Decision|2|||
131780199|NCT00568776|474475721|FG001|Overall Study|Sponsor Decision|2|||
131780200|NCT00568776|474475722|FG002|Overall Study|Sponsor Decision|41|||
131780201|NCT00568776|474475723|FG003|Overall Study|Sponsor Decision|42|||
131780202|NCT00568776|474475720|FG000|Overall Study|Miscellaeneous|3|||
131780203|NCT00568776|474475721|FG001|Overall Study|Miscellaeneous|3|||
131780204|NCT00568776|474475722|FG002|Overall Study|Miscellaeneous|1|||
131780205|NCT00568776|474475723|FG003|Overall Study|Miscellaeneous|4|||
131780206|NCT01005680|474475724|FG000|Overall Study|Lost to Follow-up|4|||
131780207|NCT01005680|474475725|FG001|Overall Study|Lost to Follow-up|6|||
131780208|NCT01005680|474475724|FG000|Overall Study|Withdrawal by Subject|1|||
131780209|NCT01005680|474475725|FG001|Overall Study|Withdrawal by Subject|4|||
131780210|NCT01005680|474475724|FG000|Overall Study|Physician Decision|1|||
131780211|NCT01005680|474475725|FG001|Overall Study|Physician Decision|1|||
131780212|NCT03576131|474475726|FG000|Overall Study|Investigator decision|0|||
131780213|NCT03576131|474475727|FG001|Overall Study|Investigator decision|0|||
131780214|NCT03576131|474475728|FG002|Overall Study|Investigator decision|0|||
131780215|NCT03576131|474475729|FG003|Overall Study|Investigator decision|1|||
131780216|NCT03576131|474475730|FG004|Overall Study|Investigator decision|0|||
131780217|NCT03576131|474475731|FG005|Overall Study|Investigator decision|1|||
131780218|NCT03576131|474475732|FG006|Overall Study|Investigator decision|0|||
131780219|NCT03576131|474475733|FG007|Overall Study|Investigator decision|0|||
131780220|NCT03576131|474475726|FG000|Overall Study|Withdrawal by Subject|1|||
131780221|NCT03576131|474475727|FG001|Overall Study|Withdrawal by Subject|1|||
131780222|NCT03576131|474475728|FG002|Overall Study|Withdrawal by Subject|0|||
131780223|NCT03576131|474475729|FG003|Overall Study|Withdrawal by Subject|1|||
131780224|NCT03576131|474475730|FG004|Overall Study|Withdrawal by Subject|2|||
131780225|NCT03576131|474475731|FG005|Overall Study|Withdrawal by Subject|3|||
131780226|NCT03576131|474475732|FG006|Overall Study|Withdrawal by Subject|1|||
131780227|NCT03576131|474475733|FG007|Overall Study|Withdrawal by Subject|0|||
131780228|NCT03576131|474475726|FG000|Overall Study|Death|3|||
131780229|NCT03576131|474475727|FG001|Overall Study|Death|3|||
131780230|NCT03576131|474475728|FG002|Overall Study|Death|1|||
131780231|NCT03576131|474475729|FG003|Overall Study|Death|5|||
131780232|NCT03576131|474475730|FG004|Overall Study|Death|4|||
131780233|NCT03576131|474475731|FG005|Overall Study|Death|1|||
131780234|NCT03576131|474475732|FG006|Overall Study|Death|0|||
131780235|NCT03576131|474475733|FG007|Overall Study|Death|1|||
131780236|NCT03576131|474475726|FG000|Overall Study|New anti-cancer treatment|5|||
131780237|NCT03576131|474475727|FG001|Overall Study|New anti-cancer treatment|1|||
131780238|NCT03576131|474475728|FG002|Overall Study|New anti-cancer treatment|2|||
131560736|NCT02855164|473677892|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
131560737|NCT02855164|473677893|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
131560738|NCT02855164|473677894|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
131560739|NCT02855164|473677887|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
131560740|NCT02855164|473677888|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
131560741|NCT02855164|473677889|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
131560742|NCT02855164|473677890|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
131560743|NCT02855164|473677891|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
131560744|NCT02855164|473677892|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
131560745|NCT02855164|473677893|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
131560746|NCT02855164|473677894|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
131560747|NCT02855164|473677887|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
131560748|NCT02855164|473677888|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
131560749|NCT02855164|473677889|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
131560750|NCT02855164|473677890|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
131560751|NCT02855164|473677891|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
131560752|NCT02855164|473677892|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
131560753|NCT02855164|473677893|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
131560754|NCT02855164|473677894|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
131560755|NCT02855164|473677887|FG000|Part C (Randomized Set)|Adverse Event|0|||
131560756|NCT02855164|473677888|FG001|Part C (Randomized Set)|Adverse Event|0|||
131560757|NCT02855164|473677889|FG002|Part C (Randomized Set)|Adverse Event|0|||
131560758|NCT02855164|473677890|FG003|Part C (Randomized Set)|Adverse Event|0|||
131780239|NCT03576131|474475729|FG003|Overall Study|New anti-cancer treatment|3|||
131780240|NCT03576131|474475730|FG004|Overall Study|New anti-cancer treatment|0|||
131560759|NCT02855164|473677891|FG004|Part C (Randomized Set)|Adverse Event|0|||
131560760|NCT02855164|473677892|FG005|Part C (Randomized Set)|Adverse Event|5|||
131560761|NCT02855164|473677893|FG006|Part C (Randomized Set)|Adverse Event|9|||
131560762|NCT02855164|473677894|FG007|Part C (Randomized Set)|Adverse Event|2|||
131560763|NCT02855164|473677887|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
131560764|NCT02855164|473677888|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
131560765|NCT02855164|473677889|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
131560766|NCT02855164|473677890|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
131560767|NCT02855164|473677891|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
131560768|NCT02855164|473677892|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
131560769|NCT02855164|473677893|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
131560770|NCT02855164|473677894|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
131560771|NCT02855164|473677887|FG000|Part C (Randomized Set)|Physician Decision|0|||
131560772|NCT02855164|473677888|FG001|Part C (Randomized Set)|Physician Decision|0|||
131560773|NCT02855164|473677889|FG002|Part C (Randomized Set)|Physician Decision|0|||
131560774|NCT02855164|473677890|FG003|Part C (Randomized Set)|Physician Decision|0|||
131560775|NCT02855164|473677891|FG004|Part C (Randomized Set)|Physician Decision|0|||
131560776|NCT02855164|473677892|FG005|Part C (Randomized Set)|Physician Decision|1|||
131560777|NCT02855164|473677893|FG006|Part C (Randomized Set)|Physician Decision|0|||
131560778|NCT02855164|473677894|FG007|Part C (Randomized Set)|Physician Decision|1|||
131560779|NCT02855164|473677887|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
131560780|NCT02855164|473677888|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
131560781|NCT02855164|473677889|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
131560782|NCT02855164|473677890|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
131560783|NCT02855164|473677891|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
131560784|NCT02855164|473677892|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
131560785|NCT02855164|473677893|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
131560786|NCT02855164|473677894|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
131560787|NCT00876460|473677895|FG000|Combination Therapy Phase|Progressive disease|2|||
131560788|NCT00876460|473677896|FG001|Combination Therapy Phase|Progressive disease|3|||
131560789|NCT00876460|473677897|FG002|Combination Therapy Phase|Progressive disease|3|||
131780241|NCT03576131|474475731|FG005|Overall Study|New anti-cancer treatment|0|||
131780242|NCT03576131|474475732|FG006|Overall Study|New anti-cancer treatment|0|||
131780243|NCT03576131|474475733|FG007|Overall Study|New anti-cancer treatment|0|||
131780244|NCT03576131|474475726|FG000|Overall Study|Unspecified reason|0|||
131780245|NCT03576131|474475727|FG001|Overall Study|Unspecified reason|0|||
131780246|NCT03576131|474475728|FG002|Overall Study|Unspecified reason|1|||
131780247|NCT03576131|474475729|FG003|Overall Study|Unspecified reason|1|||
131780248|NCT03576131|474475730|FG004|Overall Study|Unspecified reason|1|||
131780249|NCT03576131|474475731|FG005|Overall Study|Unspecified reason|1|||
131560790|NCT00876460|473677898|FG003|Combination Therapy Phase|Progressive disease|3|||
131560791|NCT00876460|473677899|FG004|Combination Therapy Phase|Progressive disease|3|||
131780250|NCT03576131|474475732|FG006|Overall Study|Unspecified reason|0|||
131560792|NCT00876460|473677900|FG005|Combination Therapy Phase|Progressive disease|1|||
131560793|NCT00876460|473677901|FG006|Combination Therapy Phase|Progressive disease|1|||
131780251|NCT03576131|474475733|FG007|Overall Study|Unspecified reason|0|||
131780252|NCT03576131|474475726|FG000|Overall Study|Subject non-compliance|0|||
131560794|NCT00876460|473677902|FG007|Combination Therapy Phase|Progressive disease|1|||
131560795|NCT00876460|473677895|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
131560796|NCT00876460|473677896|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
131560797|NCT00876460|473677897|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
131560798|NCT00876460|473677898|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
131560799|NCT00876460|473677899|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
131560800|NCT00876460|473677900|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
131560801|NCT00876460|473677901|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
131560802|NCT00876460|473677902|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
131560803|NCT00876460|473677895|FG000|Combination Therapy Phase|Adverse Event|0|||
131560804|NCT00876460|473677896|FG001|Combination Therapy Phase|Adverse Event|2|||
131560805|NCT00876460|473677897|FG002|Combination Therapy Phase|Adverse Event|0|||
131560806|NCT00876460|473677898|FG003|Combination Therapy Phase|Adverse Event|2|||
131560807|NCT00876460|473677899|FG004|Combination Therapy Phase|Adverse Event|2|||
131560808|NCT00876460|473677900|FG005|Combination Therapy Phase|Adverse Event|0|||
131560809|NCT00876460|473677901|FG006|Combination Therapy Phase|Adverse Event|3|||
131560810|NCT00876460|473677902|FG007|Combination Therapy Phase|Adverse Event|2|||
131560811|NCT00876460|473677895|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
131560812|NCT00876460|473677896|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
131560813|NCT00876460|473677897|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
131560814|NCT00876460|473677898|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
131560815|NCT00876460|473677899|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
131560816|NCT00876460|473677900|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
131560817|NCT00876460|473677901|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
131560818|NCT00876460|473677902|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
131560819|NCT00876460|473677895|FG000|Combination Therapy Phase|Other reason not defined above|0|||
131560820|NCT00876460|473677896|FG001|Combination Therapy Phase|Other reason not defined above|0|||
131560821|NCT00876460|473677897|FG002|Combination Therapy Phase|Other reason not defined above|0|||
131560822|NCT00876460|473677898|FG003|Combination Therapy Phase|Other reason not defined above|0|||
131560823|NCT00876460|473677899|FG004|Combination Therapy Phase|Other reason not defined above|0|||
131560824|NCT00876460|473677900|FG005|Combination Therapy Phase|Other reason not defined above|0|||
131560825|NCT00876460|473677901|FG006|Combination Therapy Phase|Other reason not defined above|1|||
131560826|NCT00876460|473677902|FG007|Combination Therapy Phase|Other reason not defined above|2|||
131560827|NCT00876460|473677895|FG000|Combination Therapy Phase|Not treated|0|||
131560828|NCT00876460|473677896|FG001|Combination Therapy Phase|Not treated|0|||
131560829|NCT00876460|473677897|FG002|Combination Therapy Phase|Not treated|0|||
131560830|NCT00876460|473677898|FG003|Combination Therapy Phase|Not treated|0|||
131560831|NCT00876460|473677899|FG004|Combination Therapy Phase|Not treated|0|||
131560832|NCT00876460|473677900|FG005|Combination Therapy Phase|Not treated|0|||
131560833|NCT00876460|473677901|FG006|Combination Therapy Phase|Not treated|1|||
131560834|NCT00876460|473677902|FG007|Combination Therapy Phase|Not treated|0|||
131560835|NCT00876460|473677895|FG000|Mono Therapy Phase|Progressive disease|0|||
131560836|NCT00876460|473677896|FG001|Mono Therapy Phase|Progressive disease|0|||
131560837|NCT00876460|473677897|FG002|Mono Therapy Phase|Progressive disease|0|||
131560838|NCT00876460|473677898|FG003|Mono Therapy Phase|Progressive disease|0|||
131560839|NCT00876460|473677899|FG004|Mono Therapy Phase|Progressive disease|2|||
131560840|NCT00876460|473677900|FG005|Mono Therapy Phase|Progressive disease|0|||
131560841|NCT00876460|473677901|FG006|Mono Therapy Phase|Progressive disease|1|||
131560842|NCT00876460|473677902|FG007|Mono Therapy Phase|Progressive disease|3|||
131560843|NCT00876460|473677895|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
131560844|NCT00876460|473677896|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
131560845|NCT00876460|473677897|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
131560846|NCT00876460|473677898|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
131560847|NCT00876460|473677899|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
131560848|NCT00876460|473677900|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
131560849|NCT00876460|473677901|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
131560850|NCT00876460|473677902|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
131560851|NCT00876460|473677895|FG000|Mono Therapy Phase|Adverse Event|0|||
131560852|NCT00876460|473677896|FG001|Mono Therapy Phase|Adverse Event|0|||
131560853|NCT00876460|473677897|FG002|Mono Therapy Phase|Adverse Event|0|||
131560854|NCT00876460|473677898|FG003|Mono Therapy Phase|Adverse Event|1|||
131560855|NCT00876460|473677899|FG004|Mono Therapy Phase|Adverse Event|0|||
131560856|NCT00876460|473677900|FG005|Mono Therapy Phase|Adverse Event|0|||
131560857|NCT00876460|473677901|FG006|Mono Therapy Phase|Adverse Event|0|||
131560858|NCT00876460|473677902|FG007|Mono Therapy Phase|Adverse Event|0|||
131560859|NCT00127413|473677904|FG000|Overall Study|Lost to Follow-up|6|||
131560860|NCT00127413|473677905|FG001|Overall Study|Lost to Follow-up|4|||
131560861|NCT00127413|473677906|FG002|Overall Study|Lost to Follow-up|8|||
131560862|NCT00127413|473677907|FG003|Overall Study|Lost to Follow-up|2|||
131560863|NCT00547911|473677908|FG000|Overall Study|Adverse Event|0|||
131560864|NCT00547911|473677909|FG001|Overall Study|Adverse Event|0|||
131560865|NCT00547911|473677910|FG002|Overall Study|Adverse Event|0|||
131560866|NCT00547911|473677911|FG003|Overall Study|Adverse Event|1|||
131560867|NCT00547911|473677912|FG004|Overall Study|Adverse Event|0|||
131560868|NCT00547911|473677913|FG005|Overall Study|Adverse Event|0|||
131560869|NCT01644474|473677915|FG000|Overall Study|Poor compliance to protocol|1|||
131560870|NCT01644474|473677916|FG001|Overall Study|Poor compliance to protocol|0|||
131560871|NCT01644474|473677915|FG000|Overall Study|Consent withdrawn by participant|0|||
131560872|NCT01644474|473677916|FG001|Overall Study|Consent withdrawn by participant|1|||
131560873|NCT01644474|473677915|FG000|Overall Study|Participant moved|0|||
131560874|NCT01644474|473677916|FG001|Overall Study|Participant moved|1|||
131695272|NCT00328627|474168504|FG008|Overall Study|Other|0|||
131695273|NCT00328627|474168505|FG009|Overall Study|Other|1|||
131695274|NCT00328627|474168506|FG010|Overall Study|Other|1|||
131695275|NCT00328627|474168507|FG011|Overall Study|Other|0|||
131695276|NCT00112905|474168508|FG000|Overall Study|Adverse Event|4|||
131695277|NCT00112905|474168508|FG000|Overall Study|Death|1|||
131695278|NCT00112905|474168508|FG000|Overall Study|Ineligibility|5|||
131695279|NCT00112905|474168508|FG000|Overall Study|Alternative treatment|1|||
131695280|NCT00112905|474168508|FG000|Overall Study|performance status was deteiorating|1|||
131695281|NCT02600507|474168509|FG000|Overall Study|Adverse Event|3|||
131695282|NCT02600507|474168510|FG001|Overall Study|Adverse Event|15|||
131695283|NCT02600507|474168511|FG002|Overall Study|Adverse Event|5|||
131695284|NCT02600507|474168509|FG000|Overall Study|Lack of Efficacy|3|||
131695285|NCT02600507|474168510|FG001|Overall Study|Lack of Efficacy|8|||
131695286|NCT02600507|474168511|FG002|Overall Study|Lack of Efficacy|5|||
131695287|NCT02600507|474168509|FG000|Overall Study|Lost to Follow-up|3|||
131695288|NCT02600507|474168510|FG001|Overall Study|Lost to Follow-up|5|||
131695289|NCT02600507|474168511|FG002|Overall Study|Lost to Follow-up|2|||
131695290|NCT02600507|474168509|FG000|Overall Study|Protocol Violation|12|||
131695291|NCT02600507|474168510|FG001|Overall Study|Protocol Violation|4|||
131695292|NCT02600507|474168511|FG002|Overall Study|Protocol Violation|4|||
131695293|NCT02600507|474168509|FG000|Overall Study|Physician Decision|1|||
131695294|NCT02600507|474168510|FG001|Overall Study|Physician Decision|0|||
131695295|NCT02600507|474168511|FG002|Overall Study|Physician Decision|1|||
131695296|NCT02600507|474168509|FG000|Overall Study|Withdrawal by Subject|7|||
131695297|NCT02600507|474168510|FG001|Overall Study|Withdrawal by Subject|11|||
131695298|NCT02600507|474168511|FG002|Overall Study|Withdrawal by Subject|7|||
131695299|NCT02600507|474168509|FG000|Overall Study|Other|0|||
131695300|NCT02600507|474168510|FG001|Overall Study|Other|1|||
131695301|NCT02600507|474168511|FG002|Overall Study|Other|1|||
131695302|NCT00621504|474168517|FG000|Overall Study|Adverse Event|1|||
131695303|NCT00621504|474168518|FG001|Overall Study|Adverse Event|3|||
131695304|NCT00621504|474168517|FG000|Overall Study|At the request of sponsor/investigator|1|||
131695305|NCT00621504|474168518|FG001|Overall Study|At the request of sponsor/investigator|0|||
131695306|NCT00621504|474168517|FG000|Overall Study|Withdrew consent|9|||
131695307|NCT00621504|474168518|FG001|Overall Study|Withdrew consent|6|||
131695308|NCT00621504|474168517|FG000|Overall Study|Lost to Follow-up|8|||
131695309|NCT00621504|474168518|FG001|Overall Study|Lost to Follow-up|10|||
131695310|NCT00621504|474168517|FG000|Overall Study|Other|1|||
131695311|NCT00621504|474168518|FG001|Overall Study|Other|0|||
131695312|NCT00621504|474168517|FG000|Overall Study|Death|6|||
131695313|NCT00621504|474168518|FG001|Overall Study|Death|6|||
131695314|NCT00605085|474168519|FG000|Overall Study|Withdrawal by Subject|8|||
131695315|NCT00605085|474168520|FG001|Overall Study|Withdrawal by Subject|5|||
131695316|NCT00605085|474168519|FG000|Overall Study|Adverse Event|9|||
131695317|NCT00605085|474168520|FG001|Overall Study|Adverse Event|5|||
131695318|NCT00605085|474168519|FG000|Overall Study|Pregnancy|2|||
131695319|NCT00605085|474168520|FG001|Overall Study|Pregnancy|0|||
131695320|NCT00605085|474168519|FG000|Overall Study|Protocol Violation|3|||
131695321|NCT00605085|474168520|FG001|Overall Study|Protocol Violation|2|||
131695322|NCT00605085|474168519|FG000|Overall Study|Lost to Follow-up|10|||
131695323|NCT00605085|474168520|FG001|Overall Study|Lost to Follow-up|5|||
131695324|NCT00605085|474168519|FG000|Overall Study|administrative reasons|18|||
131560875|NCT01644474|473677915|FG000|Overall Study|Adverse Event|4|||
131560876|NCT01644474|473677916|FG001|Overall Study|Adverse Event|5|||
131695325|NCT00605085|474168520|FG001|Overall Study|administrative reasons|8|||
131695326|NCT01659320|474168523|FG000|Overall Study|Withdrawal by Subject|2|||
131695327|NCT01659320|474168523|FG000|Overall Study|Physician Decision|1|||
131695328|NCT01745146|474168526|FG000|Overall Study|Withdrawal by Subject|1|||
131695329|NCT01745146|474168527|FG001|Overall Study|Withdrawal by Subject|3|||
131695330|NCT01745146|474168526|FG000|Overall Study|Lost to Follow-up|2|||
131695331|NCT01745146|474168527|FG001|Overall Study|Lost to Follow-up|0|||
131695332|NCT00272038|474168528|FG000|Overall Study|withdrew before they received 2 cycles|7|||
131695333|NCT00488982|474168529|FG000|Course 1|Physician Decision|0|||
131695334|NCT00488982|474168530|FG001|Course 1|Physician Decision|2|||
131695335|NCT00488982|474168531|FG002|Course 1|Physician Decision|4|||
131695336|NCT00488982|474168529|FG000|Course 1|Withdrawal by Subject|0|||
131695337|NCT00488982|474168530|FG001|Course 1|Withdrawal by Subject|8|||
131695338|NCT00488982|474168531|FG002|Course 1|Withdrawal by Subject|2|||
131695339|NCT00488982|474168529|FG000|Course 1|nonprotocol therapy|0|||
131695340|NCT00488982|474168530|FG001|Course 1|nonprotocol therapy|2|||
131695341|NCT00488982|474168531|FG002|Course 1|nonprotocol therapy|2|||
131695342|NCT00488982|474168529|FG000|Course 1|Adverse Event|0|||
131780253|NCT03576131|474475727|FG001|Overall Study|Subject non-compliance|0|||
131780254|NCT03576131|474475728|FG002|Overall Study|Subject non-compliance|0|||
131780255|NCT03576131|474475729|FG003|Overall Study|Subject non-compliance|0|||
131780256|NCT03576131|474475730|FG004|Overall Study|Subject non-compliance|0|||
131780257|NCT03576131|474475731|FG005|Overall Study|Subject non-compliance|1|||
131780258|NCT03576131|474475732|FG006|Overall Study|Subject non-compliance|0|||
131780259|NCT03576131|474475733|FG007|Overall Study|Subject non-compliance|0|||
131780260|NCT00996632|474475738|FG000|Overall Study|Physician Decision|0|||
131780261|NCT00996632|474475739|FG001|Overall Study|Physician Decision|0|||
131780262|NCT03901352|474475754|FG000|Double-blind Phase|Adverse Event|6|||
131780263|NCT03901352|474475755|FG001|Double-blind Phase|Adverse Event|4|||
131780264|NCT03901352|474475754|FG000|Double-blind Phase|Death|1|||
131780265|NCT03901352|474475755|FG001|Double-blind Phase|Death|0|||
131780266|NCT03901352|474475754|FG000|Double-blind Phase|Lack of Efficacy|0|||
131780267|NCT03901352|474475755|FG001|Double-blind Phase|Lack of Efficacy|1|||
131780268|NCT03901352|474475754|FG000|Double-blind Phase|Protocol Violation|0|||
131780269|NCT03901352|474475755|FG001|Double-blind Phase|Protocol Violation|1|||
131780270|NCT03901352|474475754|FG000|Double-blind Phase|Withdrawal by Subject|10|||
131780271|NCT03901352|474475755|FG001|Double-blind Phase|Withdrawal by Subject|8|||
131780272|NCT03901352|474475754|FG000|Open-label Extension Phase|Adverse Event|24|||
131780273|NCT03901352|474475755|FG001|Open-label Extension Phase|Adverse Event|0|||
131780274|NCT03901352|474475754|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
131780275|NCT03901352|474475755|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
131780276|NCT03901352|474475754|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
131780277|NCT03901352|474475755|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
131780278|NCT03901352|474475754|FG000|Open-label Extension Phase|Other|1|||
131780279|NCT03901352|474475755|FG001|Open-label Extension Phase|Other|0|||
131780280|NCT03069365|474475756|FG000|Overall Study|Adverse Event|1|||
131780281|NCT03901339|474475757|FG000|Overall Study|Death|220|||
131780282|NCT03901339|474475758|FG001|Overall Study|Death|192|||
131780283|NCT03901339|474475757|FG000|Overall Study|Informed consent withdrawn|13|||
131780284|NCT03901339|474475758|FG001|Overall Study|Informed consent withdrawn|40|||
131780285|NCT03901339|474475757|FG000|Overall Study|Sponsor request|30|||
131780286|NCT03901339|474475758|FG001|Overall Study|Sponsor request|23|||
131780287|NCT03901339|474475757|FG000|Overall Study|Reason not specified|5|||
131780288|NCT03901339|474475758|FG001|Overall Study|Reason not specified|7|||
131780289|NCT03901339|474475757|FG000|Overall Study|Lost to Follow-up|4|||
131780290|NCT03901339|474475758|FG001|Overall Study|Lost to Follow-up|7|||
131780291|NCT03901339|474475757|FG000|Overall Study|Covid19|0|||
131780292|NCT03901339|474475758|FG001|Overall Study|Covid19|2|||
131780293|NCT02886494|474475759|FG000|Overall Study|Adverse Event|1|||
131780294|NCT02886494|474475760|FG001|Overall Study|Adverse Event|0|||
131780295|NCT02886494|474475759|FG000|Overall Study|Withdrawal by Subject|12|||
131780296|NCT02886494|474475760|FG001|Overall Study|Withdrawal by Subject|3|||
131780297|NCT02886494|474475759|FG000|Overall Study|Protocol Violation|4|||
131780298|NCT02886494|474475760|FG001|Overall Study|Protocol Violation|1|||
131780299|NCT02780115|474475761|FG000|Overall Study|Withdrawal by Subject|0|||
131780300|NCT02780115|474475762|FG001|Overall Study|Withdrawal by Subject|1|||
131780301|NCT02780115|474475763|FG002|Overall Study|Withdrawal by Subject|1|||
131780302|NCT02780115|474475764|FG003|Overall Study|Withdrawal by Subject|0|||
131780303|NCT02780115|474475765|FG004|Overall Study|Withdrawal by Subject|0|||
131780304|NCT02780115|474475761|FG000|Overall Study|Adverse Event|0|||
131780305|NCT02780115|474475762|FG001|Overall Study|Adverse Event|0|||
131780306|NCT02780115|474475763|FG002|Overall Study|Adverse Event|0|||
131780307|NCT02780115|474475764|FG003|Overall Study|Adverse Event|1|||
131780308|NCT02780115|474475765|FG004|Overall Study|Adverse Event|1|||
131780309|NCT01179191|474475766|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
131780310|NCT01179191|474475766|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
131780311|NCT01179191|474475766|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
131780312|NCT01179191|474475766|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
131780313|NCT01179191|474475766|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
131780314|NCT01179191|474475766|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
131780315|NCT01179191|474475766|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
131780316|NCT01179191|474475766|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
131780317|NCT01179191|474475766|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
131780318|NCT01179191|474475766|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
131780319|NCT01179191|474475766|FG000|Maintenance Phase (8 Weeks)|Other|66|||
131780320|NCT00572910|474475770|FG000|Overall Study|Adverse Event|1|||
131780321|NCT00572910|474475771|FG001|Overall Study|Adverse Event|2|||
131780322|NCT00572910|474475772|FG002|Overall Study|Adverse Event|0|||
131780323|NCT00572910|474475773|FG003|Overall Study|Adverse Event|2|||
131780324|NCT00572910|474475774|FG004|Overall Study|Adverse Event|0|||
131780325|NCT00572910|474475775|FG005|Overall Study|Adverse Event|0|||
131780326|NCT00572910|474475776|FG006|Overall Study|Adverse Event|4|||
131780327|NCT00572910|474475777|FG007|Overall Study|Adverse Event|2|||
131780328|NCT00572910|474475778|FG008|Overall Study|Adverse Event|1|||
131780329|NCT00572910|474475779|FG009|Overall Study|Adverse Event|3|||
131560877|NCT01644474|473677915|FG000|Overall Study|Site scheduling error|1|||
131560878|NCT01644474|473677916|FG001|Overall Study|Site scheduling error|1|||
131560879|NCT01644474|473677915|FG000|Overall Study|Protocol Violation|1|||
131560880|NCT01644474|473677916|FG001|Overall Study|Protocol Violation|0|||
131560881|NCT02044458|473677920|FG000|Overall Study|Protocol Violation|3|||
131560882|NCT02044458|473677921|FG001|Overall Study|Protocol Violation|8|||
131560883|NCT02601937|473677922|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560884|NCT02601937|473677923|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560885|NCT02601937|473677924|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560886|NCT02601937|473677925|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560887|NCT02601937|473677926|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560888|NCT02601937|473677927|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
131560889|NCT02601937|473677928|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560890|NCT02601937|473677929|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560891|NCT02601937|473677930|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560892|NCT02601937|473677931|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560893|NCT02601937|473677932|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
131560894|NCT02601937|473677922|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
131560895|NCT02601937|473677923|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560896|NCT02601937|473677924|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560897|NCT02601937|473677925|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560898|NCT02601937|473677926|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560899|NCT02601937|473677927|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560900|NCT02601937|473677928|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
131560901|NCT02601937|473677929|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560902|NCT02601937|473677930|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560903|NCT02601937|473677931|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560904|NCT02601937|473677932|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
131560905|NCT02601937|473677922|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560906|NCT02601937|473677923|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560907|NCT02601937|473677924|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
131560908|NCT02601937|473677925|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560909|NCT02601937|473677926|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560910|NCT02601937|473677927|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560911|NCT02601937|473677928|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560912|NCT02601937|473677929|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560913|NCT02601937|473677930|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560914|NCT02601937|473677931|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560915|NCT02601937|473677932|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
131560916|NCT02601937|473677922|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
131560917|NCT02601937|473677923|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
131560918|NCT02601937|473677924|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
131560919|NCT02601937|473677925|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
131560920|NCT02601937|473677926|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
131560921|NCT02601937|473677927|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
131560922|NCT02601937|473677928|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
131560923|NCT02601937|473677929|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
131695343|NCT00488982|474168530|FG001|Course 1|Adverse Event|0|||
131695344|NCT00488982|474168531|FG002|Course 1|Adverse Event|6|||
131695345|NCT03548558|474168532|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
131695346|NCT03548558|474168533|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
131695347|NCT03548558|474168534|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131695348|NCT03548558|474168535|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
131695349|NCT03548558|474168536|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131695350|NCT03548558|474168537|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131695351|NCT03548558|474168538|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131695352|NCT03548558|474168532|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
131695353|NCT03548558|474168533|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
131695354|NCT03548558|474168534|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
131560924|NCT02601937|473677930|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
131560925|NCT02601937|473677931|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
131560926|NCT02601937|473677932|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
131695355|NCT03548558|474168535|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
131695356|NCT03548558|474168536|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
131695357|NCT03548558|474168537|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
131695358|NCT03548558|474168538|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
131560927|NCT02601937|473677922|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560928|NCT02601937|473677923|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560929|NCT02601937|473677924|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560930|NCT02601937|473677925|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560931|NCT02601937|473677926|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560932|NCT02601937|473677927|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560933|NCT02601937|473677928|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560934|NCT02601937|473677929|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560935|NCT02601937|473677930|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560936|NCT02601937|473677931|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
131560937|NCT02601937|473677932|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
131560938|NCT02601937|473677922|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560939|NCT02601937|473677923|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560940|NCT02601937|473677924|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560941|NCT02601937|473677925|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560942|NCT02601937|473677926|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560943|NCT02601937|473677927|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560944|NCT02601937|473677928|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560945|NCT02601937|473677929|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
131560946|NCT02601937|473677930|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560947|NCT02601937|473677931|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560948|NCT02601937|473677932|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
131560949|NCT02601937|473677922|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560950|NCT02601937|473677923|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560951|NCT02601937|473677924|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560952|NCT02601937|473677925|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560953|NCT02601937|473677926|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560954|NCT02601937|473677927|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560955|NCT02601937|473677928|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560956|NCT02601937|473677929|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560957|NCT02601937|473677930|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
131560958|NCT02601937|473677931|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
131560959|NCT02601937|473677932|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
131560960|NCT02601937|473677922|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131560961|NCT02601937|473677923|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131560962|NCT02601937|473677924|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131560963|NCT02601937|473677925|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131560964|NCT02601937|473677926|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131560965|NCT02601937|473677927|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131560966|NCT02601937|473677928|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
131695359|NCT03548558|474168532|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
131695360|NCT03548558|474168533|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
131695361|NCT03548558|474168534|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
131780330|NCT00572910|474475780|FG010|Overall Study|Adverse Event|2|||
131780331|NCT00572910|474475770|FG000|Overall Study|Lost to Follow-up|0|||
131780332|NCT00572910|474475771|FG001|Overall Study|Lost to Follow-up|1|||
131695362|NCT03548558|474168535|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
131695363|NCT03548558|474168536|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
131695364|NCT03548558|474168537|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
131695365|NCT03548558|474168538|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
131695366|NCT03548558|474168532|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131695367|NCT03548558|474168533|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131695368|NCT03548558|474168534|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131695369|NCT03548558|474168535|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131695370|NCT03548558|474168536|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
131695371|NCT03548558|474168537|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
131695372|NCT03548558|474168538|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
131695373|NCT03548558|474168532|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131695374|NCT03548558|474168533|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131695375|NCT03548558|474168534|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131695376|NCT03548558|474168535|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131780333|NCT00572910|474475772|FG002|Overall Study|Lost to Follow-up|1|||
131780334|NCT00572910|474475773|FG003|Overall Study|Lost to Follow-up|2|||
131560967|NCT02601937|473677929|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
131560968|NCT02601937|473677930|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
131560969|NCT02601937|473677931|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
131560970|NCT02601937|473677932|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
131560971|NCT02601937|473677922|FG000|Period 2: Dose Expansion Cohort|Other|0|||
131560972|NCT02601937|473677923|FG001|Period 2: Dose Expansion Cohort|Other|0|||
131560973|NCT02601937|473677924|FG002|Period 2: Dose Expansion Cohort|Other|0|||
131560974|NCT02601937|473677925|FG003|Period 2: Dose Expansion Cohort|Other|0|||
131695377|NCT03548558|474168536|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
131695378|NCT03548558|474168537|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
131695379|NCT03548558|474168538|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
131695380|NCT03548558|474168532|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131695381|NCT03548558|474168533|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131695382|NCT03548558|474168534|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131695383|NCT03548558|474168535|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131695384|NCT03548558|474168536|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
131695385|NCT03548558|474168537|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
131695386|NCT03548558|474168538|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
131695387|NCT03273166|474168544|FG000|Overall Study|Withdrawn prior to Completion|31|||
131695388|NCT02669017|474168545|FG000|Overall Study|Death|1|||
131695389|NCT02669017|474168546|FG001|Overall Study|Death|2|||
131695390|NCT02669017|474168547|FG002|Overall Study|Death|2|||
131695391|NCT02669017|474168548|FG003|Overall Study|Death|3|||
131695392|NCT02669017|474168549|FG004|Overall Study|Death|8|||
131695393|NCT02669017|474168550|FG005|Overall Study|Death|18|||
131695394|NCT02669017|474168551|FG006|Overall Study|Death|10|||
131695395|NCT02669017|474168552|FG007|Overall Study|Death|47|||
131695396|NCT02669017|474168553|FG008|Overall Study|Death|20|||
131695397|NCT02669017|474168545|FG000|Overall Study|Withdrawal by Subject|0|||
131695398|NCT02669017|474168546|FG001|Overall Study|Withdrawal by Subject|0|||
131695399|NCT02669017|474168547|FG002|Overall Study|Withdrawal by Subject|0|||
131695400|NCT02669017|474168548|FG003|Overall Study|Withdrawal by Subject|1|||
131695401|NCT02669017|474168549|FG004|Overall Study|Withdrawal by Subject|2|||
131695402|NCT02669017|474168550|FG005|Overall Study|Withdrawal by Subject|0|||
131695403|NCT02669017|474168551|FG006|Overall Study|Withdrawal by Subject|0|||
131695404|NCT02669017|474168552|FG007|Overall Study|Withdrawal by Subject|2|||
131695405|NCT02669017|474168553|FG008|Overall Study|Withdrawal by Subject|2|||
131780335|NCT00572910|474475774|FG004|Overall Study|Lost to Follow-up|1|||
131780336|NCT00572910|474475775|FG005|Overall Study|Lost to Follow-up|0|||
131780337|NCT00572910|474475776|FG006|Overall Study|Lost to Follow-up|0|||
131780338|NCT00572910|474475777|FG007|Overall Study|Lost to Follow-up|0|||
131780339|NCT00572910|474475778|FG008|Overall Study|Lost to Follow-up|0|||
131780340|NCT00572910|474475779|FG009|Overall Study|Lost to Follow-up|1|||
131780341|NCT00572910|474475780|FG010|Overall Study|Lost to Follow-up|0|||
131780342|NCT00572910|474475770|FG000|Overall Study|Withdrawal by Subject|3|||
131780343|NCT00572910|474475771|FG001|Overall Study|Withdrawal by Subject|0|||
131780344|NCT00572910|474475772|FG002|Overall Study|Withdrawal by Subject|1|||
131780345|NCT00572910|474475773|FG003|Overall Study|Withdrawal by Subject|0|||
131780346|NCT00572910|474475774|FG004|Overall Study|Withdrawal by Subject|1|||
131780347|NCT00572910|474475775|FG005|Overall Study|Withdrawal by Subject|3|||
131780348|NCT00572910|474475776|FG006|Overall Study|Withdrawal by Subject|0|||
131780349|NCT00572910|474475777|FG007|Overall Study|Withdrawal by Subject|2|||
131780350|NCT00572910|474475778|FG008|Overall Study|Withdrawal by Subject|2|||
131780351|NCT00572910|474475779|FG009|Overall Study|Withdrawal by Subject|2|||
131780352|NCT00572910|474475780|FG010|Overall Study|Withdrawal by Subject|1|||
131780353|NCT00592007|474475785|FG000|Overall Study|Withdrawal by Subject|1|||
131780354|NCT00592007|474475785|FG000|Overall Study|patient ineligible (out of lab range)|1|||
131898563|NCT02998996|474914134|FG004|Overall Study|Pregnancy|0|||
131560975|NCT02601937|473677926|FG004|Period 2: Dose Expansion Cohort|Other|0|||
131560976|NCT02601937|473677927|FG005|Period 2: Dose Expansion Cohort|Other|0|||
131780355|NCT00457418|474475786|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
131780356|NCT00457418|474475786|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
131780357|NCT00457418|474475786|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
131780358|NCT00457418|474475786|FG000|Post PK Maintenance|Adverse Event|10|||
131780359|NCT00457418|474475786|FG000|Post PK Maintenance|Progression of Disease|6|||
131898564|NCT02998996|474914135|FG005|Overall Study|Pregnancy|0|||
131898565|NCT02998996|474914130|FG000|Overall Study|Family reasons|0|||
131898566|NCT02998996|474914131|FG001|Overall Study|Family reasons|0|||
131560977|NCT02601937|473677928|FG006|Period 2: Dose Expansion Cohort|Other|0|||
131560978|NCT02601937|473677929|FG007|Period 2: Dose Expansion Cohort|Other|0|||
131560979|NCT02601937|473677930|FG008|Period 2: Dose Expansion Cohort|Other|2|||
131560980|NCT02601937|473677931|FG009|Period 2: Dose Expansion Cohort|Other|2|||
131560981|NCT02601937|473677932|FG010|Period 2: Dose Expansion Cohort|Other|0|||
131560982|NCT02601937|473677922|FG000|Period 2: Dose Expansion Cohort|Death|0|||
131560983|NCT02601937|473677923|FG001|Period 2: Dose Expansion Cohort|Death|0|||
131560984|NCT02601937|473677924|FG002|Period 2: Dose Expansion Cohort|Death|0|||
131560985|NCT02601937|473677925|FG003|Period 2: Dose Expansion Cohort|Death|0|||
131560986|NCT02601937|473677926|FG004|Period 2: Dose Expansion Cohort|Death|0|||
131560987|NCT02601937|473677927|FG005|Period 2: Dose Expansion Cohort|Death|0|||
131560988|NCT02601937|473677928|FG006|Period 2: Dose Expansion Cohort|Death|0|||
131560989|NCT02601937|473677929|FG007|Period 2: Dose Expansion Cohort|Death|0|||
131560990|NCT02601937|473677930|FG008|Period 2: Dose Expansion Cohort|Death|1|||
131560991|NCT02601937|473677931|FG009|Period 2: Dose Expansion Cohort|Death|0|||
131560992|NCT02601937|473677932|FG010|Period 2: Dose Expansion Cohort|Death|0|||
131560993|NCT00581113|473680253|FG000|Overall Study|Withdrawal by Subject|0|||
131560994|NCT00581113|473680254|FG001|Overall Study|Withdrawal by Subject|1|||
131560995|NCT00619476|473680255|FG000|Overall Study|Adverse Event|12|||
131560996|NCT00619476|473680256|FG001|Overall Study|Adverse Event|6|||
131780360|NCT00457418|474475786|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
131780361|NCT00457418|474475786|FG000|Post PK Maintenance|Lost to Follow-up|1|||
131780362|NCT00595127|474475787|FG000|Overall Study|Death|6|||
131780363|NCT00595127|474475787|FG000|Overall Study|Relapsed|3|||
131780364|NCT00595127|474475787|FG000|Overall Study|joined another trial|1|||
131780365|NCT01785472|474475788|FG000|Overall Study|Adverse Event|5|||
131780366|NCT01785472|474475789|FG001|Overall Study|Adverse Event|4|||
131780367|NCT01785472|474475790|FG002|Overall Study|Adverse Event|6|||
131780368|NCT01785472|474475788|FG000|Overall Study|Lack of Efficacy|2|||
131780369|NCT01785472|474475789|FG001|Overall Study|Lack of Efficacy|0|||
131780370|NCT01785472|474475790|FG002|Overall Study|Lack of Efficacy|1|||
131780371|NCT01785472|474475788|FG000|Overall Study|Lost to Follow-up|1|||
131780372|NCT01785472|474475789|FG001|Overall Study|Lost to Follow-up|2|||
131780373|NCT01785472|474475790|FG002|Overall Study|Lost to Follow-up|0|||
131780374|NCT01785472|474475788|FG000|Overall Study|Physician Decision|1|||
131780375|NCT01785472|474475789|FG001|Overall Study|Physician Decision|1|||
131780376|NCT01785472|474475790|FG002|Overall Study|Physician Decision|1|||
131780377|NCT01785472|474475788|FG000|Overall Study|Protocol deviation|0|||
131780378|NCT01785472|474475789|FG001|Overall Study|Protocol deviation|2|||
131780379|NCT01785472|474475790|FG002|Overall Study|Protocol deviation|2|||
131780380|NCT01785472|474475788|FG000|Overall Study|Subject/guardian decision|15|||
131560997|NCT00619476|473680257|FG002|Overall Study|Adverse Event|12|||
131560998|NCT00619476|473680258|FG003|Overall Study|Adverse Event|16|||
131560999|NCT00619476|473680255|FG000|Overall Study|Lack of Efficacy|6|||
131561000|NCT00619476|473680256|FG001|Overall Study|Lack of Efficacy|1|||
131780381|NCT01785472|474475789|FG001|Overall Study|Subject/guardian decision|10|||
131780382|NCT01785472|474475790|FG002|Overall Study|Subject/guardian decision|11|||
131780383|NCT01785472|474475788|FG000|Overall Study|Technical problems|0|||
131780384|NCT01785472|474475789|FG001|Overall Study|Technical problems|0|||
131780385|NCT01785472|474475790|FG002|Overall Study|Technical problems|1|||
131780386|NCT02086968|474475792|FG000|Overall Study|Adverse Event|1|||
131780387|NCT02086968|474475793|FG001|Overall Study|Adverse Event|5|||
131780388|NCT02086968|474475792|FG000|Overall Study|Lost to Follow-up|2|||
131780389|NCT02086968|474475793|FG001|Overall Study|Lost to Follow-up|3|||
131780390|NCT02086968|474475792|FG000|Overall Study|Study drug received outside protocol|0|||
131780391|NCT02086968|474475793|FG001|Overall Study|Study drug received outside protocol|1|||
131780392|NCT02086968|474475792|FG000|Overall Study|Physician Decision|4|||
131780393|NCT02086968|474475793|FG001|Overall Study|Physician Decision|0|||
131780394|NCT02086968|474475792|FG000|Overall Study|Withdrawal by Subject|1|||
131780395|NCT02086968|474475793|FG001|Overall Study|Withdrawal by Subject|4|||
131780396|NCT05302414|474475797|FG000|Pretest to Posttest|Lost to Follow-up|12|||
131780397|NCT05302414|474475798|FG001|Pretest to Posttest|Lost to Follow-up|8|||
131780398|NCT05302414|474475799|FG002|Pretest to Posttest|Lost to Follow-up|8|||
131780399|NCT05302414|474475797|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
131780400|NCT05302414|474475798|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
131780401|NCT05302414|474475799|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
131780402|NCT01125358|474475805|FG000|Overall Study|Adverse Event|3|||
131780403|NCT01125358|474475806|FG001|Overall Study|Adverse Event|0|||
131780404|NCT01125358|474475807|FG002|Overall Study|Adverse Event|0|||
131898567|NCT02998996|474914132|FG002|Overall Study|Family reasons|0|||
131561001|NCT00619476|473680257|FG002|Overall Study|Lack of Efficacy|1|||
131561002|NCT00619476|473680258|FG003|Overall Study|Lack of Efficacy|4|||
131561003|NCT00619476|473680255|FG000|Overall Study|Protocol Violation|5|||
131561004|NCT00619476|473680256|FG001|Overall Study|Protocol Violation|4|||
131561005|NCT00619476|473680257|FG002|Overall Study|Protocol Violation|4|||
131561006|NCT00619476|473680258|FG003|Overall Study|Protocol Violation|9|||
131561007|NCT00619476|473680255|FG000|Overall Study|Lost to Follow-up|1|||
131561008|NCT00619476|473680256|FG001|Overall Study|Lost to Follow-up|2|||
131561009|NCT00619476|473680257|FG002|Overall Study|Lost to Follow-up|0|||
131561010|NCT00619476|473680258|FG003|Overall Study|Lost to Follow-up|1|||
131561011|NCT00619476|473680255|FG000|Overall Study|Investigator Discretion|2|||
131561012|NCT00619476|473680256|FG001|Overall Study|Investigator Discretion|2|||
131561013|NCT00619476|473680257|FG002|Overall Study|Investigator Discretion|2|||
131561014|NCT00619476|473680258|FG003|Overall Study|Investigator Discretion|0|||
131561015|NCT00619476|473680255|FG000|Overall Study|Withdrawal by Subject|5|||
131561016|NCT00619476|473680256|FG001|Overall Study|Withdrawal by Subject|7|||
131561017|NCT00619476|473680257|FG002|Overall Study|Withdrawal by Subject|5|||
131561018|NCT00619476|473680258|FG003|Overall Study|Withdrawal by Subject|4|||
131561019|NCT01625910|473680259|FG000|Overall Study|Lost to Follow-up|3|||
131561020|NCT01625910|473680260|FG001|Overall Study|Lost to Follow-up|4|||
131561021|NCT02959138|473680261|FG000|Overall Study|Enrolled but Never Treated|0|||
131561022|NCT02959138|473680262|FG001|Overall Study|Enrolled but Never Treated|1|||
131561023|NCT02959138|473680263|FG002|Overall Study|Enrolled but Never Treated|0|||
131561024|NCT01327547|473680264|FG000|Overall Study|Adverse Event|4|||
131561025|NCT01327547|473680265|FG001|Overall Study|Adverse Event|1|||
131561026|NCT01327547|473680264|FG000|Overall Study|Death|1|||
131561027|NCT01327547|473680265|FG001|Overall Study|Death|2|||
131561028|NCT01327547|473680264|FG000|Overall Study|Lost to Follow-up|6|||
131561029|NCT01327547|473680265|FG001|Overall Study|Lost to Follow-up|6|||
131561030|NCT01327547|473680264|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
131561031|NCT01327547|473680265|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
131561032|NCT01327547|473680264|FG000|Overall Study|Withdrawal by Subject|3|||
131561033|NCT01327547|473680265|FG001|Overall Study|Withdrawal by Subject|7|||
131561034|NCT01327547|473680264|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
131561035|NCT01327547|473680265|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
131561036|NCT01327547|473680264|FG000|Overall Study|Protocol Violation|1|||
131561037|NCT01327547|473680265|FG001|Overall Study|Protocol Violation|0|||
131561038|NCT01327547|473680264|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
131695406|NCT02669017|474168545|FG000|Overall Study|Lost to Follow-up|0|||
131695407|NCT02669017|474168546|FG001|Overall Study|Lost to Follow-up|0|||
131695408|NCT02669017|474168547|FG002|Overall Study|Lost to Follow-up|0|||
131695409|NCT02669017|474168548|FG003|Overall Study|Lost to Follow-up|0|||
131561039|NCT01327547|473680265|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
131561040|NCT01327547|473680264|FG000|Overall Study|Required prohibited medication|2|||
131561041|NCT01327547|473680265|FG001|Overall Study|Required prohibited medication|0|||
131695410|NCT02669017|474168549|FG004|Overall Study|Lost to Follow-up|0|||
131561042|NCT01327547|473680264|FG000|Overall Study|Non-compliance with study procedures|1|||
131561043|NCT01327547|473680265|FG001|Overall Study|Non-compliance with study procedures|0|||
131695411|NCT02669017|474168550|FG005|Overall Study|Lost to Follow-up|0|||
131695412|NCT02669017|474168551|FG006|Overall Study|Lost to Follow-up|0|||
131561044|NCT01327547|473680264|FG000|Overall Study|By investigator in subject's interest|0|||
131561045|NCT01327547|473680265|FG001|Overall Study|By investigator in subject's interest|1|||
131561046|NCT01681368|473680268|FG000|Overall Study|Refused further treatment|1|||
131561047|NCT01681368|473680268|FG000|Overall Study|Refused further follow up|1|||
131561048|NCT01155388|473680271|FG000|Overall Study|Adverse Event|1|||
131561049|NCT01155388|473680272|FG001|Overall Study|Adverse Event|0|||
131561050|NCT00900627|473680273|FG000|Overall Study|Condition under investigation worsened|4|||
131561051|NCT00900627|473680274|FG001|Overall Study|Condition under investigation worsened|0|||
131561052|NCT00900627|473680275|FG002|Overall Study|Condition under investigation worsened|5|||
131561053|NCT00900627|473680276|FG003|Overall Study|Condition under investigation worsened|3|||
131561054|NCT00900627|473680277|FG004|Overall Study|Condition under investigation worsened|0|||
131561055|NCT00900627|473680278|FG005|Overall Study|Condition under investigation worsened|0|||
131561056|NCT00900627|473680273|FG000|Overall Study|Withdrawal by Subject|1|||
131561057|NCT00900627|473680274|FG001|Overall Study|Withdrawal by Subject|0|||
131561058|NCT00900627|473680275|FG002|Overall Study|Withdrawal by Subject|1|||
131561059|NCT00900627|473680276|FG003|Overall Study|Withdrawal by Subject|0|||
131561060|NCT00900627|473680277|FG004|Overall Study|Withdrawal by Subject|1|||
131561061|NCT00900627|473680278|FG005|Overall Study|Withdrawal by Subject|2|||
131561062|NCT00900627|473680273|FG000|Overall Study|Adverse Event|1|||
131561063|NCT00900627|473680274|FG001|Overall Study|Adverse Event|2|||
131561064|NCT00900627|473680275|FG002|Overall Study|Adverse Event|0|||
131561065|NCT00900627|473680276|FG003|Overall Study|Adverse Event|3|||
131561066|NCT00900627|473680277|FG004|Overall Study|Adverse Event|0|||
131561067|NCT00900627|473680278|FG005|Overall Study|Adverse Event|0|||
131561068|NCT00900627|473680273|FG000|Overall Study|Death|0|||
131561069|NCT00900627|473680274|FG001|Overall Study|Death|0|||
131561070|NCT00900627|473680275|FG002|Overall Study|Death|0|||
131561071|NCT00900627|473680276|FG003|Overall Study|Death|0|||
131561072|NCT00900627|473680277|FG004|Overall Study|Death|28|||
131561073|NCT00900627|473680278|FG005|Overall Study|Death|24|||
131561074|NCT00373295|473680279|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131561075|NCT00373295|473680280|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
131561076|NCT00373295|473680281|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131561077|NCT00373295|473680282|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131561078|NCT00373295|473680283|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131561079|NCT00373295|473680284|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131561080|NCT01642186|473680285|FG000|Overall Study|Death|0|||
131561081|NCT01642186|473680286|FG001|Overall Study|Death|2|||
131561082|NCT01642186|473680287|FG002|Overall Study|Death|2|||
131561083|NCT01642186|473680285|FG000|Overall Study|Lost to Follow-up|0|||
131561084|NCT01642186|473680286|FG001|Overall Study|Lost to Follow-up|0|||
131561085|NCT01642186|473680287|FG002|Overall Study|Lost to Follow-up|1|||
131561086|NCT00506285|473680294|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
131561087|NCT00506285|473680295|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
131561088|NCT00506285|473680294|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
131561089|NCT00506285|473680295|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
131561090|NCT00506285|473680294|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
131561091|NCT00506285|473680295|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
131561092|NCT00506285|473680294|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
131561093|NCT00506285|473680295|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
131561094|NCT00506285|473680294|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
131561095|NCT00506285|473680295|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
131780405|NCT01125358|474475808|FG003|Overall Study|Adverse Event|2|||
131780406|NCT01125358|474475805|FG000|Overall Study|Perceived Lack of Efficacy|6|||
131780407|NCT01125358|474475806|FG001|Overall Study|Perceived Lack of Efficacy|3|||
131780408|NCT01125358|474475807|FG002|Overall Study|Perceived Lack of Efficacy|7|||
131780409|NCT01125358|474475808|FG003|Overall Study|Perceived Lack of Efficacy|4|||
131780410|NCT01125358|474475805|FG000|Overall Study|Protocol Violation|1|||
131780411|NCT01125358|474475806|FG001|Overall Study|Protocol Violation|0|||
131780412|NCT01125358|474475807|FG002|Overall Study|Protocol Violation|0|||
131780413|NCT01125358|474475808|FG003|Overall Study|Protocol Violation|0|||
131780414|NCT01125358|474475805|FG000|Overall Study|Sponsor Decision|0|||
131561096|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
131561097|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
131561098|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
131561099|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
131561100|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
131561101|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
131561102|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
131561103|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
131561104|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
131561105|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
131561106|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
131561107|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
131780415|NCT01125358|474475806|FG001|Overall Study|Sponsor Decision|0|||
131780416|NCT01125358|474475807|FG002|Overall Study|Sponsor Decision|1|||
131561108|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
131561109|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
131561110|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
131561111|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
131561112|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
131561113|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
131561114|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
131561115|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
131561116|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
131561117|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
131561118|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
131561119|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
131561120|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
131561121|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
131561122|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
131561123|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
131561124|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
131561125|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
131561126|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
131561127|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
131561128|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
131561129|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
131561130|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
131561131|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
131561132|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
131561133|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
131561134|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
131561135|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
131561136|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
131561137|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
131561138|NCT01089556|473680296|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
131561139|NCT01089556|473680297|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
131561140|NCT01089556|473680298|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
131561141|NCT01089556|473680299|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
131561142|NCT01089556|473680300|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
131561143|NCT01089556|473680301|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
131561144|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
131561145|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
131561146|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
131561147|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
131561148|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
131561149|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
131561150|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
131561151|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
131561152|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
131561153|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
131561154|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
131561155|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
131561156|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
131561157|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
131561158|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
131561159|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
131561160|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
131561161|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
131561162|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
131561163|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
131561164|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
131561165|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
131561166|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
131561167|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
131561168|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
131561169|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
131561170|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
131695413|NCT02669017|474168552|FG007|Overall Study|Lost to Follow-up|0|||
131695414|NCT02669017|474168553|FG008|Overall Study|Lost to Follow-up|1|||
131695415|NCT02669017|474168545|FG000|Overall Study|Miscellaneous|0|||
131695416|NCT02669017|474168546|FG001|Overall Study|Miscellaneous|0|||
131695417|NCT02669017|474168547|FG002|Overall Study|Miscellaneous|0|||
131695418|NCT02669017|474168548|FG003|Overall Study|Miscellaneous|0|||
131695419|NCT02669017|474168549|FG004|Overall Study|Miscellaneous|2|||
131898568|NCT02998996|474914133|FG003|Overall Study|Family reasons|0|||
131898569|NCT02998996|474914134|FG004|Overall Study|Family reasons|1|||
131898570|NCT02998996|474914135|FG005|Overall Study|Family reasons|0|||
131898571|NCT03046953|474914137|FG000|Overall Study|Relapse/progressive disease|21|||
131898572|NCT03046953|474914137|FG000|Overall Study|Death|2|||
131898573|NCT03046953|474914137|FG000|Overall Study|Withdrawal by Subject|3|||
131898574|NCT04039204|474914138|FG000|Overall Study|Withdrawal by Subject|0|||
131898575|NCT04039204|474914139|FG001|Overall Study|Withdrawal by Subject|2|||
131898576|NCT01189461|474914140|FG000|Overall Study|Lack of Efficacy|13|||
131898577|NCT01189461|474914140|FG000|Overall Study|Lost to Follow-up|1|||
131898578|NCT01189461|474914140|FG000|Overall Study|Withdrawal by Subject|6|||
131898579|NCT01189461|474914140|FG000|Overall Study|Protocol Violation|1|||
131561171|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
131561172|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
131561173|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
131561174|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
131561175|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
131561176|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
131561177|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
131561178|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
131561179|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
131561180|NCT01089556|473680296|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
131561181|NCT01089556|473680297|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
131561182|NCT01089556|473680298|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
131561183|NCT01089556|473680299|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
131561184|NCT01089556|473680300|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
131561185|NCT01089556|473680301|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
131561186|NCT00962585|473680304|FG000|Overall Study|Adverse Event|0|||
131561187|NCT00962585|473680305|FG001|Overall Study|Adverse Event|2|||
131561188|NCT00962585|473680306|FG002|Overall Study|Adverse Event|1|||
131561189|NCT00962585|473680307|FG003|Overall Study|Adverse Event|0|||
131561190|NCT00962585|473680304|FG000|Overall Study|Lost to Follow-up|3|||
131561191|NCT00962585|473680305|FG001|Overall Study|Lost to Follow-up|0|||
131561192|NCT00962585|473680306|FG002|Overall Study|Lost to Follow-up|1|||
131561193|NCT00962585|473680307|FG003|Overall Study|Lost to Follow-up|0|||
131561194|NCT00962585|473680304|FG000|Overall Study|Protocol Violation|0|||
131561195|NCT00962585|473680305|FG001|Overall Study|Protocol Violation|0|||
131561196|NCT00962585|473680306|FG002|Overall Study|Protocol Violation|1|||
131561197|NCT00962585|473680307|FG003|Overall Study|Protocol Violation|0|||
131561198|NCT00962585|473680304|FG000|Overall Study|Withdrawal by Subject|1|||
131561199|NCT00962585|473680305|FG001|Overall Study|Withdrawal by Subject|0|||
131561200|NCT00962585|473680306|FG002|Overall Study|Withdrawal by Subject|0|||
131561201|NCT00962585|473680307|FG003|Overall Study|Withdrawal by Subject|0|||
131561202|NCT00962585|473680304|FG000|Overall Study|Withdrew Consent|2|||
131561203|NCT00962585|473680305|FG001|Overall Study|Withdrew Consent|0|||
131561204|NCT00962585|473680306|FG002|Overall Study|Withdrew Consent|0|||
131561205|NCT00962585|473680307|FG003|Overall Study|Withdrew Consent|0|||
131561206|NCT02254421|473680310|FG000|Overall Study|Randomized but Not Treated|1|||
131561207|NCT02254421|473680311|FG001|Overall Study|Randomized but Not Treated|0|||
131561208|NCT02254421|473680310|FG000|Overall Study|Death|0|||
131561209|NCT02254421|473680311|FG001|Overall Study|Death|2|||
131561210|NCT02254421|473680310|FG000|Overall Study|Withdrew Consent|1|||
131561211|NCT02254421|473680311|FG001|Overall Study|Withdrew Consent|1|||
131561212|NCT00839917|473680316|FG000|Overall Study|Lost to Follow-up|1|||
131561213|NCT00839917|473680317|FG001|Overall Study|Lost to Follow-up|0|||
131561214|NCT00839917|473680316|FG000|Overall Study|Did not receive vaccine|0|||
131561215|NCT00839917|473680317|FG001|Overall Study|Did not receive vaccine|1|||
131561216|NCT00867490|473680318|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
131561217|NCT00867490|473680318|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
131561218|NCT00867490|473680318|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
131561219|NCT00867490|473680318|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
131561220|NCT00867490|473680318|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
131561221|NCT01950273|473680319|FG000|Overall Study|Protocol Violation|1|||
131561222|NCT01950273|473680320|FG001|Overall Study|Protocol Violation|0|||
131561223|NCT01950273|473680319|FG000|Overall Study|Withdrawal by Subject|2|||
131695420|NCT02669017|474168550|FG005|Overall Study|Miscellaneous|1|||
131898580|NCT01189461|474914140|FG000|Overall Study|Adverse Event|2|||
131561224|NCT01950273|473680320|FG001|Overall Study|Withdrawal by Subject|0|||
131561225|NCT01950273|473680319|FG000|Overall Study|Other not defined above|1|||
131561226|NCT01950273|473680320|FG001|Overall Study|Other not defined above|0|||
131898581|NCT01189461|474914140|FG000|Overall Study|Did not meet entrance criteria|3|||
131898582|NCT01189461|474914140|FG000|Overall Study|Other|8|||
131898583|NCT00656175|474914142|FG000|Overall Study|Adverse Event|1|||
131898584|NCT00656175|474914143|FG001|Overall Study|Adverse Event|0|||
131898585|NCT00656175|474914142|FG000|Overall Study|Transportation issues|0|||
131898586|NCT00656175|474914143|FG001|Overall Study|Transportation issues|1|||
131898587|NCT00534638|474914152|FG000|Overall Study|Withdrawal by Subject|3|||
131898588|NCT00534638|474914153|FG001|Overall Study|Withdrawal by Subject|4|||
131898589|NCT00534638|474914152|FG000|Overall Study|Migrated/moved from study area|13|||
131780417|NCT01125358|474475808|FG003|Overall Study|Sponsor Decision|1|||
131780418|NCT01125358|474475805|FG000|Overall Study|Withdrawal by Subject|2|||
131780419|NCT01125358|474475806|FG001|Overall Study|Withdrawal by Subject|1|||
131780420|NCT01125358|474475807|FG002|Overall Study|Withdrawal by Subject|1|||
131780421|NCT01125358|474475808|FG003|Overall Study|Withdrawal by Subject|1|||
131780422|NCT01157065|474475809|FG000|Overall Study|Death|0|||
131780423|NCT01157065|474475810|FG001|Overall Study|Death|1|||
131780424|NCT01060007|474475811|FG000|Overall Study|Withdrawal by Subject|1|||
131780425|NCT01060007|474475811|FG000|Overall Study|Inevaluable for response at surgery|3|||
131780426|NCT05168657|474475814|FG000|Overall Study|Adverse Event|0|||
131780427|NCT05168657|474475815|FG001|Overall Study|Adverse Event|0|||
131898590|NCT00534638|474914153|FG001|Overall Study|Migrated/moved from study area|11|||
131695421|NCT02669017|474168551|FG006|Overall Study|Miscellaneous|1|||
131695422|NCT02669017|474168552|FG007|Overall Study|Miscellaneous|13|||
131695423|NCT02669017|474168553|FG008|Overall Study|Miscellaneous|2|||
131695424|NCT02797808|474168555|FG000|Overall Study|Withdrawal by Subject|1|||
131695425|NCT02797808|474168556|FG001|Overall Study|Withdrawal by Subject|1|||
131695426|NCT02797808|474168555|FG000|Overall Study|Physician Decision|6|||
131695427|NCT02797808|474168556|FG001|Overall Study|Physician Decision|2|||
131695428|NCT01425203|474168557|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
131695429|NCT01425203|474168558|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
131695430|NCT01425203|474168559|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
131695431|NCT01425203|474168557|FG000|Treatment Phase|Failure at futility timepoint|8|||
131695432|NCT01425203|474168558|FG001|Treatment Phase|Failure at futility timepoint|27|||
131695433|NCT01425203|474168559|FG002|Treatment Phase|Failure at futility timepoint|0|||
131695434|NCT01425203|474168557|FG000|Treatment Phase|Other virologic failure criteria|5|||
131695435|NCT01425203|474168558|FG001|Treatment Phase|Other virologic failure criteria|3|||
131695436|NCT01425203|474168559|FG002|Treatment Phase|Other virologic failure criteria|0|||
131695437|NCT01425203|474168557|FG000|Treatment Phase|Unidentified reasons|11|||
131695438|NCT01425203|474168558|FG001|Treatment Phase|Unidentified reasons|5|||
131695439|NCT01425203|474168559|FG002|Treatment Phase|Unidentified reasons|0|||
131695440|NCT01425203|474168557|FG000|Treatment Phase|Did not receive treatment|0|||
131695441|NCT01425203|474168558|FG001|Treatment Phase|Did not receive treatment|1|||
131695442|NCT01425203|474168559|FG002|Treatment Phase|Did not receive treatment|0|||
131695443|NCT01425203|474168557|FG000|Crossover Phase|Failure at futility timepoint|0|||
131695444|NCT01425203|474168558|FG001|Crossover Phase|Failure at futility timepoint|0|||
131780428|NCT05168657|474475816|FG002|Overall Study|Adverse Event|1|||
131780429|NCT05168657|474475817|FG003|Overall Study|Adverse Event|0|||
131780430|NCT05168657|474475818|FG004|Overall Study|Adverse Event|0|||
131780431|NCT05168657|474475819|FG005|Overall Study|Adverse Event|0|||
131898591|NCT00534638|474914152|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
131561227|NCT00472186|473680321|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
131561228|NCT00472186|473680322|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
131561229|NCT03354637|473680327|FG000|Double-blind Period|Protocol Violation|2|||
131561230|NCT03354637|473680328|FG001|Double-blind Period|Protocol Violation|0|||
131561231|NCT03354637|473680329|FG002|Double-blind Period|Protocol Violation|0|||
131561232|NCT03354637|473680327|FG000|Double-blind Period|Adverse Event|1|||
131561233|NCT03354637|473680328|FG001|Double-blind Period|Adverse Event|2|||
131561234|NCT03354637|473680329|FG002|Double-blind Period|Adverse Event|0|||
131561235|NCT03354637|473680327|FG000|Double-blind Period|Lost to Follow-up|3|||
131561236|NCT03354637|473680328|FG001|Double-blind Period|Lost to Follow-up|4|||
131561237|NCT03354637|473680329|FG002|Double-blind Period|Lost to Follow-up|3|||
131561238|NCT03354637|473680327|FG000|Double-blind Period|Withdrawal by Subject|10|||
131561239|NCT03354637|473680328|FG001|Double-blind Period|Withdrawal by Subject|6|||
131561240|NCT03354637|473680329|FG002|Double-blind Period|Withdrawal by Subject|4|||
131561241|NCT03354637|473680327|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
131561242|NCT03354637|473680328|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
131561243|NCT03354637|473680329|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
131561244|NCT03354637|473680327|FG000|Open Label Extension|Adverse Event|0|||
131561245|NCT03354637|473680328|FG001|Open Label Extension|Adverse Event|0|||
131561246|NCT03354637|473680329|FG002|Open Label Extension|Adverse Event|1|||
131561247|NCT03354637|473680327|FG000|Open Label Extension|Lost to Follow-up|0|||
131561248|NCT03354637|473680328|FG001|Open Label Extension|Lost to Follow-up|0|||
131561249|NCT03354637|473680329|FG002|Open Label Extension|Lost to Follow-up|2|||
131561250|NCT03354637|473680327|FG000|Open Label Extension|Withdrawal by Subject|0|||
131561251|NCT03354637|473680328|FG001|Open Label Extension|Withdrawal by Subject|0|||
131561252|NCT03354637|473680329|FG002|Open Label Extension|Withdrawal by Subject|5|||
131561253|NCT03354637|473680327|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
131561254|NCT03354637|473680328|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
131561255|NCT03354637|473680329|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
131561256|NCT03354637|473680327|FG000|Open Label Extension|Subject Noncompliance|0|||
131561257|NCT03354637|473680328|FG001|Open Label Extension|Subject Noncompliance|0|||
131561258|NCT03354637|473680329|FG002|Open Label Extension|Subject Noncompliance|1|||
131561259|NCT03354637|473680327|FG000|Open Label Extension|Lack of Efficacy|0|||
131561260|NCT03354637|473680328|FG001|Open Label Extension|Lack of Efficacy|0|||
131561261|NCT03354637|473680329|FG002|Open Label Extension|Lack of Efficacy|1|||
131561262|NCT03354637|473680327|FG000|Open Label Extension|Physician Decision|0|||
131561263|NCT03354637|473680328|FG001|Open Label Extension|Physician Decision|0|||
131561264|NCT03354637|473680329|FG002|Open Label Extension|Physician Decision|1|||
131561265|NCT02564055|473680333|FG000|Overall Study|Adverse Event|1|||
131561266|NCT02564055|473680334|FG001|Overall Study|Adverse Event|0|||
131561267|NCT02564055|473680335|FG002|Overall Study|Adverse Event|4|||
131561268|NCT02564055|473680336|FG003|Overall Study|Adverse Event|1|||
131561269|NCT02564055|473680337|FG004|Overall Study|Adverse Event|4|||
131561270|NCT02564055|473680338|FG005|Overall Study|Adverse Event|1|||
131561271|NCT02564055|473680333|FG000|Overall Study|Protocol Violation|1|||
131695445|NCT01425203|474168559|FG002|Crossover Phase|Failure at futility timepoint|3|||
131695446|NCT01425203|474168557|FG000|Crossover Phase|Other virologic failure criteria|0|||
131695447|NCT01425203|474168558|FG001|Crossover Phase|Other virologic failure criteria|0|||
131695448|NCT01425203|474168559|FG002|Crossover Phase|Other virologic failure criteria|3|||
131695449|NCT00535132|474168562|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
131695450|NCT00535132|474168563|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
131695451|NCT00535132|474168562|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
131695452|NCT00535132|474168563|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
131695453|NCT02590588|474168564|FG000|Overall Study|Adverse Event|1|||
131695454|NCT00267748|474168565|FG000|Non-randomized Period|Progressive disease|10|||
131695455|NCT00267748|474168566|FG001|Non-randomized Period|Progressive disease|0|||
131695456|NCT00267748|474168567|FG002|Non-randomized Period|Progressive disease|0|||
131695457|NCT00267748|474168565|FG000|Non-randomized Period|Adverse Event|8|||
131695458|NCT00267748|474168566|FG001|Non-randomized Period|Adverse Event|0|||
131695459|NCT00267748|474168567|FG002|Non-randomized Period|Adverse Event|0|||
131695460|NCT00267748|474168565|FG000|Non-randomized Period|Death|1|||
131780432|NCT05168657|474475820|FG006|Overall Study|Adverse Event|0|||
131561272|NCT02564055|473680334|FG001|Overall Study|Protocol Violation|0|||
131561273|NCT02564055|473680335|FG002|Overall Study|Protocol Violation|0|||
131561274|NCT02564055|473680336|FG003|Overall Study|Protocol Violation|0|||
131561275|NCT02564055|473680337|FG004|Overall Study|Protocol Violation|0|||
131561276|NCT02564055|473680338|FG005|Overall Study|Protocol Violation|0|||
131561277|NCT02564055|473680333|FG000|Overall Study|Reached stopping criteria|0|||
131561278|NCT02564055|473680334|FG001|Overall Study|Reached stopping criteria|0|||
131561279|NCT02564055|473680335|FG002|Overall Study|Reached stopping criteria|0|||
131561280|NCT02564055|473680336|FG003|Overall Study|Reached stopping criteria|0|||
131695461|NCT00267748|474168566|FG001|Non-randomized Period|Death|0|||
131695462|NCT00267748|474168567|FG002|Non-randomized Period|Death|0|||
131780433|NCT05168657|474475821|FG007|Overall Study|Adverse Event|0|||
131561281|NCT02564055|473680337|FG004|Overall Study|Reached stopping criteria|0|||
131561282|NCT02564055|473680338|FG005|Overall Study|Reached stopping criteria|1|||
131561283|NCT02564055|473680333|FG000|Overall Study|Lost to Follow-up|0|||
131561284|NCT02564055|473680334|FG001|Overall Study|Lost to Follow-up|1|||
131561285|NCT02564055|473680335|FG002|Overall Study|Lost to Follow-up|4|||
131561286|NCT02564055|473680336|FG003|Overall Study|Lost to Follow-up|2|||
131561287|NCT02564055|473680337|FG004|Overall Study|Lost to Follow-up|1|||
131561288|NCT02564055|473680338|FG005|Overall Study|Lost to Follow-up|0|||
131561289|NCT02564055|473680333|FG000|Overall Study|Physician Decision|0|||
131561290|NCT02564055|473680334|FG001|Overall Study|Physician Decision|0|||
131561291|NCT02564055|473680335|FG002|Overall Study|Physician Decision|1|||
131561292|NCT02564055|473680336|FG003|Overall Study|Physician Decision|0|||
131561293|NCT02564055|473680337|FG004|Overall Study|Physician Decision|0|||
131561294|NCT02564055|473680338|FG005|Overall Study|Physician Decision|0|||
131561295|NCT02564055|473680333|FG000|Overall Study|Withdrawal by Subject|4|||
131561296|NCT02564055|473680334|FG001|Overall Study|Withdrawal by Subject|4|||
131561297|NCT02564055|473680335|FG002|Overall Study|Withdrawal by Subject|3|||
131561298|NCT02564055|473680336|FG003|Overall Study|Withdrawal by Subject|3|||
131561299|NCT02564055|473680337|FG004|Overall Study|Withdrawal by Subject|10|||
131561300|NCT02564055|473680338|FG005|Overall Study|Withdrawal by Subject|10|||
131561301|NCT04747275|473680339|FG000|Overall Study|Study terminated|0|||
131561302|NCT04747275|473680340|FG001|Overall Study|Study terminated|1|||
131561303|NCT00531011|473680344|FG000|Overall Study|Withdrawal by Subject|2|||
131561304|NCT00531011|473680345|FG001|Overall Study|Withdrawal by Subject|4|||
131561305|NCT00531011|473680344|FG000|Overall Study|Death|1|||
131561306|NCT00531011|473680345|FG001|Overall Study|Death|0|||
131561307|NCT00531011|473680344|FG000|Overall Study|Lost to Follow-up|1|||
131561308|NCT00531011|473680345|FG001|Overall Study|Lost to Follow-up|0|||
131561309|NCT00531011|473680344|FG000|Overall Study|Physician Decision|0|||
131561310|NCT00531011|473680345|FG001|Overall Study|Physician Decision|3|||
131561311|NCT03268590|473680346|FG000|Overall Study|Previously unknown exclusion criteria|1|||
131561312|NCT02139982|473680349|FG000|Overall Study|Lack of Efficacy|0|||
131561313|NCT02139982|473680350|FG001|Overall Study|Lack of Efficacy|1|||
131561314|NCT02139982|473680351|FG002|Overall Study|Lack of Efficacy|0|||
131561315|NCT02139982|473680352|FG003|Overall Study|Lack of Efficacy|1|||
131561316|NCT02139982|473680353|FG004|Overall Study|Lack of Efficacy|0|||
131561317|NCT02139982|473680354|FG005|Overall Study|Lack of Efficacy|0|||
131561318|NCT02139982|473680355|FG006|Overall Study|Lack of Efficacy|0|||
131561319|NCT02139982|473680356|FG007|Overall Study|Lack of Efficacy|0|||
131561320|NCT02139982|473680357|FG008|Overall Study|Lack of Efficacy|0|||
131561321|NCT02139982|473680358|FG009|Overall Study|Lack of Efficacy|0|||
131561322|NCT02206152|473680381|FG000|Pre-Randomization|Withdrawal by Subject|2|||
131561323|NCT00478608|473680382|FG000|Overall Study|Adverse Event|1|||
131561324|NCT00478608|473680382|FG000|Overall Study|Serious Adverse Event|14|||
131561325|NCT00478608|473680382|FG000|Overall Study|Withdrawal by Subject|2|||
131561326|NCT00478608|473680382|FG000|Overall Study|Protocol Violation|3|||
131561327|NCT01591460|473680388|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
131561328|NCT01591460|473680388|FG000|Overall Study|Futility Rule (Week 12)|7|||
131561329|NCT01591460|473680388|FG000|Overall Study|Futility Rule (Week 24)|3|||
131561330|NCT01591460|473680388|FG000|Overall Study|Rebound or Breakthrough|3|||
131561331|NCT01591460|473680388|FG000|Overall Study|Treatment Discontinued by Error|1|||
131561332|NCT01591460|473680388|FG000|Overall Study|Lost to Follow-up|1|||
131561333|NCT01591460|473680388|FG000|Overall Study|Noncompliance|1|||
131561334|NCT01591460|473680388|FG000|Overall Study|Participant Refusal|3|||
131561335|NCT01591460|473680388|FG000|Overall Study|Withdrawal by Subject|1|||
131561336|NCT01591460|473680388|FG000|Overall Study|Protocol Violation|1|||
131561337|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
131561338|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
131561339|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
131561340|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
131561341|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
131561342|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
131561343|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
131436799|NCT02079740|473225616|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
131561344|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
131561345|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
131436800|NCT02079740|473225617|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
131561346|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
131561347|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
131561348|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
131561349|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
131561350|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
131695463|NCT00267748|474168565|FG000|Non-randomized Period|Participant not willing to participate|1|||
131561351|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
131561352|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
131561353|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
131561354|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
131561355|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
131561356|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
131561357|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
131561358|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
131561359|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
131561360|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
131561361|NCT03230864|473680389|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
131780434|NCT04935931|474475822|FG000|Overall Study|Withdrawal by Subject|1|||
131780435|NCT00962013|474475823|FG000|Overall Study|Did not have surgery|1|||
131780436|NCT00962013|474475823|FG000|Overall Study|Death|8|||
131780437|NCT00962013|474475823|FG000|Overall Study|Lost to Follow-up|12|||
131780438|NCT00962013|474475823|FG000|Overall Study|Unable/Unwilling to return|6|||
131780439|NCT00962013|474475823|FG000|Overall Study|Withdrawal by Subject|8|||
131780440|NCT00962013|474475823|FG000|Overall Study|Removal of study device|3|||
131780441|NCT00962013|474475823|FG000|Overall Study|Site Termination|24|||
131780442|NCT00962013|474475823|FG000|Overall Study|No 5 year evaluation|6|||
131780443|NCT00424632|474475826|FG000|Overall Study|Death|0|||
131780444|NCT00424632|474475827|FG001|Overall Study|Death|0|||
131780445|NCT00424632|474475828|FG002|Overall Study|Death|0|||
131780446|NCT00424632|474475829|FG003|Overall Study|Death|0|||
131561362|NCT03230864|473680390|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
131780447|NCT00424632|474475830|FG004|Overall Study|Death|0|||
131780448|NCT00424632|474475831|FG005|Overall Study|Death|2|||
131780449|NCT00424632|474475832|FG006|Overall Study|Death|0|||
131780450|NCT00424632|474475833|FG007|Overall Study|Death|0|||
131780451|NCT00424632|474475834|FG008|Overall Study|Death|0|||
131780452|NCT00424632|474475835|FG009|Overall Study|Death|0|||
131780453|NCT00424632|474475826|FG000|Overall Study|Adverse Event|0|||
131780454|NCT00424632|474475827|FG001|Overall Study|Adverse Event|0|||
131780455|NCT00424632|474475828|FG002|Overall Study|Adverse Event|0|||
131780456|NCT00424632|474475829|FG003|Overall Study|Adverse Event|0|||
131780457|NCT00424632|474475830|FG004|Overall Study|Adverse Event|0|||
131780458|NCT00424632|474475831|FG005|Overall Study|Adverse Event|0|||
131780459|NCT00424632|474475832|FG006|Overall Study|Adverse Event|0|||
131780460|NCT00424632|474475833|FG007|Overall Study|Adverse Event|0|||
131780461|NCT00424632|474475834|FG008|Overall Study|Adverse Event|3|||
131780462|NCT00424632|474475835|FG009|Overall Study|Adverse Event|2|||
131780463|NCT00424632|474475826|FG000|Overall Study|Global deterioration of health status|0|||
131780464|NCT00424632|474475827|FG001|Overall Study|Global deterioration of health status|0|||
131780465|NCT00424632|474475828|FG002|Overall Study|Global deterioration of health status|0|||
131780466|NCT00424632|474475829|FG003|Overall Study|Global deterioration of health status|1|||
131780467|NCT00424632|474475830|FG004|Overall Study|Global deterioration of health status|1|||
131780468|NCT00424632|474475831|FG005|Overall Study|Global deterioration of health status|0|||
131780469|NCT00424632|474475832|FG006|Overall Study|Global deterioration of health status|0|||
131780470|NCT00424632|474475833|FG007|Overall Study|Global deterioration of health status|0|||
131780471|NCT00424632|474475834|FG008|Overall Study|Global deterioration of health status|0|||
131780472|NCT00424632|474475835|FG009|Overall Study|Global deterioration of health status|0|||
131780473|NCT00424632|474475826|FG000|Overall Study|Objective progression or relapse|1|||
131780474|NCT00424632|474475827|FG001|Overall Study|Objective progression or relapse|1|||
131780475|NCT00424632|474475828|FG002|Overall Study|Objective progression or relapse|1|||
131780476|NCT00424632|474475829|FG003|Overall Study|Objective progression or relapse|2|||
131780477|NCT00424632|474475830|FG004|Overall Study|Objective progression or relapse|2|||
131780478|NCT00424632|474475831|FG005|Overall Study|Objective progression or relapse|13|||
131780479|NCT00424632|474475832|FG006|Overall Study|Objective progression or relapse|7|||
131780480|NCT00424632|474475833|FG007|Overall Study|Objective progression or relapse|3|||
131780481|NCT00424632|474475834|FG008|Overall Study|Objective progression or relapse|12|||
131780482|NCT00424632|474475835|FG009|Overall Study|Objective progression or relapse|4|||
131780483|NCT00424632|474475826|FG000|Overall Study|Other|0|||
131780484|NCT00424632|474475827|FG001|Overall Study|Other|0|||
131780485|NCT00424632|474475828|FG002|Overall Study|Other|0|||
131780486|NCT00424632|474475829|FG003|Overall Study|Other|1|||
131780487|NCT00424632|474475830|FG004|Overall Study|Other|0|||
131780488|NCT00424632|474475831|FG005|Overall Study|Other|0|||
131780489|NCT00424632|474475832|FG006|Overall Study|Other|0|||
131780490|NCT00424632|474475833|FG007|Overall Study|Other|0|||
131780491|NCT00424632|474475834|FG008|Overall Study|Other|1|||
131780492|NCT00424632|474475835|FG009|Overall Study|Other|0|||
131780493|NCT00445458|474475846|FG000|Overall Study|Disease Progression|3|||
131780494|NCT00445458|474475847|FG001|Overall Study|Disease Progression|4|||
131780495|NCT00445458|474475848|FG002|Overall Study|Disease Progression|54|||
131780496|NCT00445458|474475849|FG003|Overall Study|Disease Progression|27|||
131780497|NCT00445458|474475846|FG000|Overall Study|Withdrawal by Subject|0|||
131780498|NCT00445458|474475847|FG001|Overall Study|Withdrawal by Subject|0|||
131561363|NCT03230864|473680391|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
131561364|NCT03230864|473680392|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
131561365|NCT03230864|473680389|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
131561366|NCT03230864|473680390|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
131561367|NCT03230864|473680391|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
131561368|NCT03230864|473680392|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
131561369|NCT03230864|473680389|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131561370|NCT03230864|473680390|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131561371|NCT03230864|473680391|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
131561372|NCT03230864|473680392|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
131561373|NCT03230864|473680389|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
131561374|NCT03230864|473680390|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
131561375|NCT03230864|473680391|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
131561376|NCT03230864|473680392|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
131561377|NCT00432679|473680399|FG000|Overall Study|Adverse Event|2|||
131561378|NCT00432679|473680400|FG001|Overall Study|Adverse Event|1|||
131561379|NCT00432679|473680399|FG000|Overall Study|Withdrawal by Subject|3|||
131561380|NCT00432679|473680400|FG001|Overall Study|Withdrawal by Subject|2|||
131561381|NCT01744496|473680401|FG000|Titration Period|Adverse Event|2|||
131561382|NCT01744496|473680402|FG001|Titration Period|Adverse Event|1|||
131561383|NCT01744496|473680401|FG000|Titration Period|Personal reasons|0|||
131561384|NCT01744496|473680402|FG001|Titration Period|Personal reasons|1|||
131561385|NCT01744496|473680401|FG000|Maintenance Period|Adverse Event|1|||
131561386|NCT01744496|473680402|FG001|Maintenance Period|Adverse Event|3|||
131561387|NCT01744496|473680401|FG000|Maintenance Period|Protocol Violation|1|||
131561388|NCT01744496|473680402|FG001|Maintenance Period|Protocol Violation|0|||
131561389|NCT01744496|473680401|FG000|Maintenance Period|Withdrawal by Subject|1|||
131561390|NCT01744496|473680402|FG001|Maintenance Period|Withdrawal by Subject|1|||
131561391|NCT01744496|473680401|FG000|Maintenance Period|Subject left town|1|||
131561392|NCT01744496|473680402|FG001|Maintenance Period|Subject left town|0|||
131561393|NCT02374593|473680408|FG000|Overall Study|non-compliant|2|||
131561394|NCT02374593|473680409|FG001|Overall Study|non-compliant|0|||
131561395|NCT00579982|473680410|FG000|Overall Study|Adverse Event|4|||
131561396|NCT00579982|473680410|FG000|Overall Study|Protocol Violation|4|||
131561397|NCT04827134|473680411|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
131561398|NCT04827134|473680412|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
131561399|NCT04827134|473680413|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
131561400|NCT04827134|473680414|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
131561401|NCT00287469|473680421|FG000|Overall Study|serious adverse event|1|||
131561402|NCT00287469|473680422|FG001|Overall Study|serious adverse event|6|||
131561403|NCT00287469|473680421|FG000|Overall Study|Adverse Event|1|||
131561404|NCT00287469|473680422|FG001|Overall Study|Adverse Event|1|||
131561405|NCT00287469|473680421|FG000|Overall Study|moved from area|144|||
131561406|NCT00287469|473680422|FG001|Overall Study|moved from area|138|||
131561407|NCT00287469|473680421|FG000|Overall Study|Lost to Follow-up|74|||
131561408|NCT00287469|473680422|FG001|Overall Study|Lost to Follow-up|69|||
131561409|NCT00065468|473680423|FG000|Overall Study|Death|172|||
131561410|NCT00065468|473680424|FG001|Overall Study|Death|169|||
131561411|NCT00065468|473680425|FG002|Overall Study|Death|171|||
131561412|NCT00065468|473680423|FG000|Overall Study|Withdrawal by Subject|3|||
131780499|NCT00445458|474475848|FG002|Overall Study|Withdrawal by Subject|7|||
131780500|NCT00445458|474475849|FG003|Overall Study|Withdrawal by Subject|0|||
131780501|NCT00445458|474475846|FG000|Overall Study|Adverse Event|0|||
131561413|NCT00065468|473680424|FG001|Overall Study|Withdrawal by Subject|4|||
131561414|NCT00065468|473680425|FG002|Overall Study|Withdrawal by Subject|5|||
131561415|NCT00065468|473680423|FG000|Overall Study|Lost to Follow-up|5|||
131561416|NCT00065468|473680424|FG001|Overall Study|Lost to Follow-up|3|||
131780502|NCT00445458|474475847|FG001|Overall Study|Adverse Event|0|||
131780503|NCT00445458|474475848|FG002|Overall Study|Adverse Event|3|||
131561417|NCT00065468|473680425|FG002|Overall Study|Lost to Follow-up|2|||
131561418|NCT00065468|473680423|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
131561419|NCT00065468|473680424|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
131561420|NCT00065468|473680425|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
131780504|NCT00445458|474475849|FG003|Overall Study|Adverse Event|0|||
131561421|NCT00065468|473680423|FG000|Overall Study|Disease progression|0|||
131561422|NCT00065468|473680424|FG001|Overall Study|Disease progression|0|||
131561423|NCT00065468|473680425|FG002|Overall Study|Disease progression|1|||
131561424|NCT00065468|473680423|FG000|Overall Study|Other|14|||
131561425|NCT00065468|473680424|FG001|Overall Study|Other|24|||
131561426|NCT00065468|473680425|FG002|Overall Study|Other|18|||
131561427|NCT01225835|473680426|FG000|Overall Study|Completed protocol|2|||
131561428|NCT01225835|473680427|FG001|Overall Study|Completed protocol|1|||
131561429|NCT01225835|473680426|FG000|Overall Study|Did not meet hCG criterion|2|||
131561430|NCT01225835|473680427|FG001|Overall Study|Did not meet hCG criterion|0|||
131561431|NCT01225835|473680426|FG000|Overall Study|Adverse Event|2|||
131561432|NCT01225835|473680427|FG001|Overall Study|Adverse Event|1|||
131561433|NCT01225835|473680426|FG000|Overall Study|Other|1|||
131561434|NCT01225835|473680427|FG001|Overall Study|Other|1|||
131561435|NCT00507026|473680433|FG000|Overall Study|Lack of Efficacy|6|||
131561436|NCT00507026|473680434|FG001|Overall Study|Lack of Efficacy|4|||
131561437|NCT00507026|473680435|FG002|Overall Study|Lack of Efficacy|21|||
131561438|NCT00507026|473680433|FG000|Overall Study|Withdrawal by Subject|2|||
131561439|NCT00507026|473680434|FG001|Overall Study|Withdrawal by Subject|0|||
131561440|NCT00507026|473680435|FG002|Overall Study|Withdrawal by Subject|0|||
131561441|NCT00507026|473680433|FG000|Overall Study|Investigator Decision|1|||
131561442|NCT00507026|473680434|FG001|Overall Study|Investigator Decision|0|||
131561443|NCT00507026|473680435|FG002|Overall Study|Investigator Decision|0|||
131561444|NCT00507026|473680433|FG000|Overall Study|Adverse Event|2|||
131561445|NCT00507026|473680434|FG001|Overall Study|Adverse Event|0|||
131561446|NCT00507026|473680435|FG002|Overall Study|Adverse Event|0|||
131561447|NCT00507026|473680433|FG000|Overall Study|Protocol Violation|1|||
131561448|NCT00507026|473680434|FG001|Overall Study|Protocol Violation|0|||
131561449|NCT00507026|473680435|FG002|Overall Study|Protocol Violation|0|||
131561450|NCT00507026|473680433|FG000|Overall Study|Other|1|||
131561451|NCT00507026|473680434|FG001|Overall Study|Other|0|||
131561452|NCT00507026|473680435|FG002|Overall Study|Other|0|||
131561453|NCT02372058|473680436|FG000|Overall Study|Withdrawal by Subject|3|||
131561454|NCT03523871|473680439|FG000|Overall Study|Death|1|||
131561455|NCT00972179|473680441|FG000|Overall Study|Noncompliance|1|||
131561456|NCT00972179|473680442|FG001|Overall Study|Noncompliance|0|||
131561457|NCT00972179|473680443|FG002|Overall Study|Noncompliance|0|||
131561458|NCT00972179|473680444|FG003|Overall Study|Noncompliance|0|||
131561459|NCT00972179|473680445|FG004|Overall Study|Noncompliance|1|||
131561460|NCT00972179|473680446|FG005|Overall Study|Noncompliance|0|||
131561461|NCT00972179|473680447|FG006|Overall Study|Noncompliance|1|||
131561462|NCT00972179|473680441|FG000|Overall Study|Withdrawal by Subject|0|||
131561463|NCT00972179|473680442|FG001|Overall Study|Withdrawal by Subject|3|||
131561464|NCT00972179|473680443|FG002|Overall Study|Withdrawal by Subject|0|||
131561465|NCT00972179|473680444|FG003|Overall Study|Withdrawal by Subject|1|||
131561466|NCT00972179|473680445|FG004|Overall Study|Withdrawal by Subject|0|||
131561467|NCT00972179|473680446|FG005|Overall Study|Withdrawal by Subject|0|||
131561468|NCT00972179|473680447|FG006|Overall Study|Withdrawal by Subject|2|||
131561469|NCT00972179|473680441|FG000|Overall Study|Administrative Decision|0|||
131561470|NCT00972179|473680442|FG001|Overall Study|Administrative Decision|0|||
131561471|NCT00972179|473680443|FG002|Overall Study|Administrative Decision|0|||
131561472|NCT00972179|473680444|FG003|Overall Study|Administrative Decision|0|||
131561473|NCT00972179|473680445|FG004|Overall Study|Administrative Decision|1|||
131561474|NCT00972179|473680446|FG005|Overall Study|Administrative Decision|0|||
131561475|NCT00972179|473680447|FG006|Overall Study|Administrative Decision|0|||
131561476|NCT00972179|473680441|FG000|Overall Study|Lost to Follow-up|0|||
131561477|NCT00972179|473680442|FG001|Overall Study|Lost to Follow-up|0|||
131561478|NCT00972179|473680443|FG002|Overall Study|Lost to Follow-up|1|||
131695464|NCT00267748|474168566|FG001|Non-randomized Period|Participant not willing to participate|0|||
131695465|NCT00267748|474168567|FG002|Non-randomized Period|Participant not willing to participate|0|||
131695466|NCT00267748|474168565|FG000|Non-randomized Period|Other|3|||
131695467|NCT00267748|474168566|FG001|Non-randomized Period|Other|0|||
131695468|NCT00267748|474168567|FG002|Non-randomized Period|Other|0|||
131695469|NCT00267748|474168565|FG000|Randomized Period|Death|0|||
131695470|NCT00267748|474168566|FG001|Randomized Period|Death|2|||
131695471|NCT00267748|474168567|FG002|Randomized Period|Death|3|||
131695472|NCT00267748|474168565|FG000|Randomized Period|Adverse Event|0|||
131695473|NCT00267748|474168566|FG001|Randomized Period|Adverse Event|23|||
131561479|NCT00972179|473680444|FG003|Overall Study|Lost to Follow-up|0|||
131561480|NCT00972179|473680445|FG004|Overall Study|Lost to Follow-up|0|||
131561481|NCT00972179|473680446|FG005|Overall Study|Lost to Follow-up|3|||
131561482|NCT00972179|473680447|FG006|Overall Study|Lost to Follow-up|1|||
131561483|NCT01994720|473680448|FG000|Overall Study|Withdrawal by Subject|46|||
131561484|NCT01994720|473680449|FG001|Overall Study|Withdrawal by Subject|56|||
131561485|NCT04285229|473680451|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131561486|NCT04285229|473680452|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131561487|NCT04285229|473680453|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131695474|NCT00267748|474168567|FG002|Randomized Period|Adverse Event|25|||
131695475|NCT00267748|474168565|FG000|Randomized Period|Global deterioration of health status|0|||
131561488|NCT04285229|473680454|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131561489|NCT04285229|473680455|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131561490|NCT04285229|473680456|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131561491|NCT04285229|473680451|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
131561492|NCT04285229|473680452|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
131561493|NCT04285229|473680453|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
131561494|NCT04285229|473680454|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
131561495|NCT04285229|473680455|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
131561496|NCT04285229|473680456|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
131561497|NCT04285229|473680451|FG000|Extended Treatment Period|Adverse Event|0|||
131561498|NCT04285229|473680452|FG001|Extended Treatment Period|Adverse Event|0|||
131561499|NCT04285229|473680453|FG002|Extended Treatment Period|Adverse Event|0|||
131561500|NCT04285229|473680454|FG003|Extended Treatment Period|Adverse Event|1|||
131561501|NCT04285229|473680455|FG004|Extended Treatment Period|Adverse Event|0|||
131561502|NCT04285229|473680456|FG005|Extended Treatment Period|Adverse Event|0|||
131561503|NCT04285229|473680451|FG000|Extended Treatment Period|Physician Decision|0|||
131561504|NCT04285229|473680452|FG001|Extended Treatment Period|Physician Decision|0|||
131561505|NCT04285229|473680453|FG002|Extended Treatment Period|Physician Decision|1|||
131561506|NCT04285229|473680454|FG003|Extended Treatment Period|Physician Decision|0|||
131561507|NCT04285229|473680455|FG004|Extended Treatment Period|Physician Decision|0|||
131561508|NCT04285229|473680456|FG005|Extended Treatment Period|Physician Decision|0|||
131561509|NCT04285229|473680451|FG000|Follow-up Period|Adverse Event|0|||
131561510|NCT04285229|473680452|FG001|Follow-up Period|Adverse Event|0|||
131561511|NCT04285229|473680453|FG002|Follow-up Period|Adverse Event|0|||
131561512|NCT04285229|473680454|FG003|Follow-up Period|Adverse Event|0|||
131561513|NCT04285229|473680455|FG004|Follow-up Period|Adverse Event|1|||
131561514|NCT04285229|473680456|FG005|Follow-up Period|Adverse Event|4|||
131561515|NCT04285229|473680451|FG000|Follow-up Period|Withdrawal by Subject|0|||
131561516|NCT04285229|473680452|FG001|Follow-up Period|Withdrawal by Subject|0|||
131561517|NCT04285229|473680453|FG002|Follow-up Period|Withdrawal by Subject|0|||
131561518|NCT04285229|473680454|FG003|Follow-up Period|Withdrawal by Subject|0|||
131561519|NCT04285229|473680455|FG004|Follow-up Period|Withdrawal by Subject|0|||
131561520|NCT04285229|473680456|FG005|Follow-up Period|Withdrawal by Subject|5|||
131561521|NCT04285229|473680451|FG000|Follow-up Period|Covid-19|0|||
131561522|NCT04285229|473680452|FG001|Follow-up Period|Covid-19|0|||
131561523|NCT04285229|473680453|FG002|Follow-up Period|Covid-19|0|||
131561524|NCT04285229|473680454|FG003|Follow-up Period|Covid-19|0|||
131561525|NCT04285229|473680455|FG004|Follow-up Period|Covid-19|0|||
131561526|NCT04285229|473680456|FG005|Follow-up Period|Covid-19|2|||
131561527|NCT04285229|473680451|FG000|Follow-up Period|Physician Decision|0|||
131561528|NCT04285229|473680452|FG001|Follow-up Period|Physician Decision|0|||
131561529|NCT04285229|473680453|FG002|Follow-up Period|Physician Decision|0|||
131561530|NCT04285229|473680454|FG003|Follow-up Period|Physician Decision|0|||
131561531|NCT04285229|473680455|FG004|Follow-up Period|Physician Decision|0|||
131561532|NCT04285229|473680456|FG005|Follow-up Period|Physician Decision|1|||
131561533|NCT02061761|473680457|FG000|Overall Study|Disease progression|2|||
131561534|NCT02061761|473680458|FG001|Overall Study|Disease progression|8|||
131561535|NCT02061761|473680459|FG002|Overall Study|Disease progression|4|||
131561536|NCT02061761|473680460|FG003|Overall Study|Disease progression|5|||
131561537|NCT02061761|473680461|FG004|Overall Study|Disease progression|9|||
131561538|NCT02061761|473680462|FG005|Overall Study|Disease progression|3|||
131561539|NCT02061761|473680463|FG006|Overall Study|Disease progression|1|||
131561540|NCT02061761|473680464|FG007|Overall Study|Disease progression|2|||
131561541|NCT02061761|473680465|FG008|Overall Study|Disease progression|28|||
131561542|NCT02061761|473680457|FG000|Overall Study|Study Drug toxicity|0|||
131561543|NCT02061761|473680458|FG001|Overall Study|Study Drug toxicity|0|||
131561544|NCT02061761|473680459|FG002|Overall Study|Study Drug toxicity|0|||
131561545|NCT02061761|473680460|FG003|Overall Study|Study Drug toxicity|0|||
131561546|NCT02061761|473680461|FG004|Overall Study|Study Drug toxicity|0|||
131561547|NCT02061761|473680462|FG005|Overall Study|Study Drug toxicity|1|||
131561548|NCT02061761|473680463|FG006|Overall Study|Study Drug toxicity|0|||
131561549|NCT02061761|473680464|FG007|Overall Study|Study Drug toxicity|2|||
131561550|NCT02061761|473680465|FG008|Overall Study|Study Drug toxicity|6|||
131780505|NCT00445458|474475846|FG000|Overall Study|Death|0|||
131780506|NCT00445458|474475847|FG001|Overall Study|Death|1|||
131780507|NCT00445458|474475848|FG002|Overall Study|Death|2|||
131561551|NCT02061761|473680457|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
131561552|NCT02061761|473680458|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
131561553|NCT02061761|473680459|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
131561554|NCT02061761|473680460|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
131561555|NCT02061761|473680461|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
131561556|NCT02061761|473680462|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
131561557|NCT02061761|473680463|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
131561558|NCT02061761|473680464|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
131561559|NCT02061761|473680465|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
131780508|NCT00445458|474475849|FG003|Overall Study|Death|0|||
131561560|NCT02061761|473680457|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131561561|NCT02061761|473680458|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131561562|NCT02061761|473680459|FG002|Overall Study|Participant request to discontinue study treatment|2|||
131561563|NCT02061761|473680460|FG003|Overall Study|Participant request to discontinue study treatment|2|||
131561564|NCT02061761|473680461|FG004|Overall Study|Participant request to discontinue study treatment|0|||
131561565|NCT02061761|473680462|FG005|Overall Study|Participant request to discontinue study treatment|1|||
131561566|NCT02061761|473680463|FG006|Overall Study|Participant request to discontinue study treatment|0|||
131561567|NCT02061761|473680464|FG007|Overall Study|Participant request to discontinue study treatment|0|||
131561568|NCT02061761|473680465|FG008|Overall Study|Participant request to discontinue study treatment|2|||
131561569|NCT02061761|473680457|FG000|Overall Study|Withdrawal by Subject|0|||
131561570|NCT02061761|473680458|FG001|Overall Study|Withdrawal by Subject|0|||
131561571|NCT02061761|473680459|FG002|Overall Study|Withdrawal by Subject|0|||
131561572|NCT02061761|473680460|FG003|Overall Study|Withdrawal by Subject|0|||
131561573|NCT02061761|473680461|FG004|Overall Study|Withdrawal by Subject|0|||
131561574|NCT02061761|473680462|FG005|Overall Study|Withdrawal by Subject|0|||
131561575|NCT02061761|473680463|FG006|Overall Study|Withdrawal by Subject|0|||
131561576|NCT02061761|473680464|FG007|Overall Study|Withdrawal by Subject|0|||
131561577|NCT02061761|473680465|FG008|Overall Study|Withdrawal by Subject|2|||
131561578|NCT02061761|473680457|FG000|Overall Study|Maximum clinical benefit|0|||
131561579|NCT02061761|473680458|FG001|Overall Study|Maximum clinical benefit|0|||
131561580|NCT02061761|473680459|FG002|Overall Study|Maximum clinical benefit|0|||
131561581|NCT02061761|473680460|FG003|Overall Study|Maximum clinical benefit|1|||
131695476|NCT00267748|474168566|FG001|Randomized Period|Global deterioration of health status|6|||
131695477|NCT00267748|474168567|FG002|Randomized Period|Global deterioration of health status|7|||
131695478|NCT00267748|474168565|FG000|Randomized Period|Lost to Follow-up|0|||
131695479|NCT00267748|474168566|FG001|Randomized Period|Lost to Follow-up|1|||
131695480|NCT00267748|474168567|FG002|Randomized Period|Lost to Follow-up|0|||
131695481|NCT00267748|474168565|FG000|Randomized Period|Objective progression or relapse|0|||
131695482|NCT00267748|474168566|FG001|Randomized Period|Objective progression or relapse|77|||
131695483|NCT00267748|474168567|FG002|Randomized Period|Objective progression or relapse|86|||
131695484|NCT00267748|474168565|FG000|Randomized Period|Withdrawal by Subject|0|||
131695485|NCT00267748|474168566|FG001|Randomized Period|Withdrawal by Subject|9|||
131695486|NCT00267748|474168567|FG002|Randomized Period|Withdrawal by Subject|2|||
131695487|NCT00267748|474168565|FG000|Randomized Period|Other|0|||
131695488|NCT00267748|474168566|FG001|Randomized Period|Other|9|||
131695489|NCT00267748|474168567|FG002|Randomized Period|Other|6|||
131695490|NCT00267748|474168565|FG000|Randomized Period|randomized but not treated|0|||
131695491|NCT00267748|474168566|FG001|Randomized Period|randomized but not treated|0|||
131695492|NCT00267748|474168567|FG002|Randomized Period|randomized but not treated|3|||
131695493|NCT01294800|474168568|FG000|Overall Study|Adverse Event|7|||
131695494|NCT01294800|474168569|FG001|Overall Study|Adverse Event|6|||
131695495|NCT01294800|474168570|FG002|Overall Study|Adverse Event|12|||
131695496|NCT01294800|474168571|FG003|Overall Study|Adverse Event|5|||
131695497|NCT01294800|474168568|FG000|Overall Study|Subject Withdrew Consent|2|||
131695498|NCT01294800|474168569|FG001|Overall Study|Subject Withdrew Consent|2|||
131695499|NCT01294800|474168570|FG002|Overall Study|Subject Withdrew Consent|2|||
131695500|NCT01294800|474168571|FG003|Overall Study|Subject Withdrew Consent|11|||
131695501|NCT01294800|474168568|FG000|Overall Study|Lost to Follow-up|0|||
131695502|NCT01294800|474168569|FG001|Overall Study|Lost to Follow-up|0|||
131695503|NCT01294800|474168570|FG002|Overall Study|Lost to Follow-up|1|||
131695504|NCT01294800|474168571|FG003|Overall Study|Lost to Follow-up|0|||
131695505|NCT01294800|474168568|FG000|Overall Study|Non-compliance With Protocol|0|||
131695506|NCT01294800|474168569|FG001|Overall Study|Non-compliance With Protocol|1|||
131695507|NCT01294800|474168570|FG002|Overall Study|Non-compliance With Protocol|1|||
131695508|NCT01294800|474168571|FG003|Overall Study|Non-compliance With Protocol|0|||
131695509|NCT01294800|474168568|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
131561582|NCT02061761|473680461|FG004|Overall Study|Maximum clinical benefit|0|||
131561583|NCT02061761|473680462|FG005|Overall Study|Maximum clinical benefit|0|||
131561584|NCT02061761|473680463|FG006|Overall Study|Maximum clinical benefit|0|||
131561585|NCT02061761|473680464|FG007|Overall Study|Maximum clinical benefit|0|||
131561586|NCT02061761|473680465|FG008|Overall Study|Maximum clinical benefit|6|||
131561587|NCT02061761|473680457|FG000|Overall Study|Participant no longer meets study criteria|0|||
131561588|NCT02061761|473680458|FG001|Overall Study|Participant no longer meets study criteria|0|||
131561589|NCT02061761|473680459|FG002|Overall Study|Participant no longer meets study criteria|0|||
131561590|NCT02061761|473680460|FG003|Overall Study|Participant no longer meets study criteria|0|||
131561591|NCT02061761|473680461|FG004|Overall Study|Participant no longer meets study criteria|0|||
131561592|NCT02061761|473680462|FG005|Overall Study|Participant no longer meets study criteria|0|||
131561593|NCT02061761|473680463|FG006|Overall Study|Participant no longer meets study criteria|0|||
131561594|NCT02061761|473680464|FG007|Overall Study|Participant no longer meets study criteria|0|||
131695510|NCT01294800|474168569|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
131695511|NCT01294800|474168570|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
131780509|NCT00445458|474475846|FG000|Overall Study|Physician Decision|0|||
131561595|NCT02061761|473680465|FG008|Overall Study|Participant no longer meets study criteria|1|||
131561596|NCT02061761|473680457|FG000|Overall Study|Other reasons|0|||
131561597|NCT02061761|473680458|FG001|Overall Study|Other reasons|0|||
131561598|NCT02061761|473680459|FG002|Overall Study|Other reasons|0|||
131561599|NCT02061761|473680460|FG003|Overall Study|Other reasons|0|||
131561600|NCT02061761|473680461|FG004|Overall Study|Other reasons|2|||
131561601|NCT02061761|473680462|FG005|Overall Study|Other reasons|0|||
131561602|NCT02061761|473680463|FG006|Overall Study|Other reasons|0|||
131561603|NCT02061761|473680464|FG007|Overall Study|Other reasons|0|||
131561604|NCT02061761|473680465|FG008|Overall Study|Other reasons|6|||
131561605|NCT01216293|473680466|FG000|Main Study|Adverse Event|1|||
131561606|NCT01216293|473680467|FG001|Main Study|Adverse Event|4|||
131561607|NCT01216293|473680468|FG002|Main Study|Adverse Event|2|||
131561608|NCT01216293|473680466|FG000|Main Study|Major Protocol Deviation|1|||
131561609|NCT01216293|473680467|FG001|Main Study|Major Protocol Deviation|0|||
131561610|NCT01216293|473680468|FG002|Main Study|Major Protocol Deviation|1|||
131561611|NCT01216293|473680466|FG000|Main Study|Lost to Follow-up|3|||
131561612|NCT01216293|473680467|FG001|Main Study|Lost to Follow-up|1|||
131561613|NCT01216293|473680468|FG002|Main Study|Lost to Follow-up|0|||
131561614|NCT01216293|473680466|FG000|Main Study|Voluntary Withdrawal|2|||
131561615|NCT01216293|473680467|FG001|Main Study|Voluntary Withdrawal|2|||
131561616|NCT01216293|473680468|FG002|Main Study|Voluntary Withdrawal|2|||
131561617|NCT01216293|473680466|FG000|Main Study|Other Reason Not Specified|0|||
131561618|NCT01216293|473680467|FG001|Main Study|Other Reason Not Specified|1|||
131561619|NCT01216293|473680468|FG002|Main Study|Other Reason Not Specified|1|||
131561620|NCT01216293|473680466|FG000|Main Study|Randomized, Not Treated|1|||
131561621|NCT01216293|473680467|FG001|Main Study|Randomized, Not Treated|0|||
131561622|NCT01216293|473680468|FG002|Main Study|Randomized, Not Treated|0|||
131561623|NCT01216293|473680466|FG000|Calcium Absorption Substudy|Adverse Event|0|||
131561624|NCT01216293|473680467|FG001|Calcium Absorption Substudy|Adverse Event|2|||
131561625|NCT01216293|473680468|FG002|Calcium Absorption Substudy|Adverse Event|0|||
131561626|NCT01216293|473680466|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
131561627|NCT01216293|473680467|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
131561628|NCT01216293|473680468|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
131561629|NCT01216293|473680466|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
131561630|NCT01216293|473680467|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
131561631|NCT01216293|473680468|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
131561632|NCT03681639|473682297|FG000|Overall Study|Death|4|||
131561633|NCT03681639|473682297|FG000|Overall Study|Lost to Follow-up|2|||
131561634|NCT03681639|473682297|FG000|Overall Study|Withdrawal by Subject|1|||
131561635|NCT03681639|473682297|FG000|Overall Study|Adverse Event|2|||
131561636|NCT00654940|473682298|FG000|Period 1|Adverse Event|0|||
131561637|NCT00654940|473682299|FG001|Period 1|Adverse Event|1|||
131561638|NCT00654940|473682298|FG000|Period 1|Intolerable Pain Level|1|||
131561639|NCT00654940|473682299|FG001|Period 1|Intolerable Pain Level|0|||
131561640|NCT04714216|473682300|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
131561641|NCT04714216|473682300|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
131561642|NCT01818141|473682301|FG000|Overall Study|Withdrawal by Subject|2|||
131561643|NCT01818141|473682302|FG001|Overall Study|Withdrawal by Subject|0|||
131561644|NCT01818141|473682301|FG000|Overall Study|No baseline C.diff colonies|1|||
131561645|NCT01818141|473682302|FG001|Overall Study|No baseline C.diff colonies|1|||
131561646|NCT01818141|473682301|FG000|Overall Study|Lost to Follow-up|0|||
131561647|NCT01818141|473682302|FG001|Overall Study|Lost to Follow-up|2|||
131561648|NCT00742885|473682308|FG000|Overall Study|Lost to Follow-up|1|||
131561649|NCT00742885|473682309|FG001|Overall Study|Lost to Follow-up|0|||
131561650|NCT04781647|473682310|FG000|Overall Study|Study terminated by Sponsor|11|||
131561651|NCT04781647|473682311|FG001|Overall Study|Study terminated by Sponsor|9|||
131561652|NCT04781647|473682312|FG002|Overall Study|Study terminated by Sponsor|9|||
131561653|NCT04781647|473682310|FG000|Overall Study|Withdrawal by Subject|1|||
131561654|NCT04781647|473682311|FG001|Overall Study|Withdrawal by Subject|2|||
131561655|NCT04781647|473682312|FG002|Overall Study|Withdrawal by Subject|0|||
131561656|NCT04781647|473682310|FG000|Overall Study|Adverse Event|0|||
131561657|NCT04781647|473682311|FG001|Overall Study|Adverse Event|1|||
131561658|NCT04781647|473682312|FG002|Overall Study|Adverse Event|1|||
131561659|NCT04781647|473682310|FG000|Overall Study|Protocol Violation|1|||
131561660|NCT04781647|473682311|FG001|Overall Study|Protocol Violation|0|||
131561661|NCT04781647|473682312|FG002|Overall Study|Protocol Violation|0|||
131561662|NCT04781647|473682310|FG000|Overall Study|Pregnancy|0|||
131561663|NCT04781647|473682311|FG001|Overall Study|Pregnancy|0|||
131780510|NCT00445458|474475847|FG001|Overall Study|Physician Decision|0|||
131780511|NCT00445458|474475848|FG002|Overall Study|Physician Decision|1|||
131780512|NCT00445458|474475849|FG003|Overall Study|Physician Decision|1|||
131780513|NCT00445458|474475846|FG000|Overall Study|Surgery|0|||
131780514|NCT00445458|474475847|FG001|Overall Study|Surgery|0|||
131780515|NCT00445458|474475848|FG002|Overall Study|Surgery|1|||
131780516|NCT00445458|474475849|FG003|Overall Study|Surgery|0|||
131780517|NCT01071083|474475852|FG000|Overall Study|Adverse Event|1|||
131780518|NCT01071083|474475853|FG001|Overall Study|Adverse Event|0|||
131780519|NCT01071083|474475854|FG002|Overall Study|Adverse Event|1|||
131780520|NCT01071083|474475855|FG003|Overall Study|Adverse Event|0|||
131780521|NCT01071083|474475856|FG004|Overall Study|Adverse Event|1|||
131780522|NCT01071083|474475852|FG000|Overall Study|Withdrawal by Subject|3|||
131780523|NCT01071083|474475853|FG001|Overall Study|Withdrawal by Subject|0|||
131780524|NCT01071083|474475854|FG002|Overall Study|Withdrawal by Subject|2|||
131780525|NCT01071083|474475855|FG003|Overall Study|Withdrawal by Subject|0|||
131780526|NCT01071083|474475856|FG004|Overall Study|Withdrawal by Subject|3|||
131780527|NCT01071083|474475852|FG000|Overall Study|Physician Decision|1|||
131780528|NCT01071083|474475853|FG001|Overall Study|Physician Decision|0|||
131780529|NCT01071083|474475854|FG002|Overall Study|Physician Decision|0|||
131780530|NCT01071083|474475855|FG003|Overall Study|Physician Decision|1|||
131780531|NCT01071083|474475856|FG004|Overall Study|Physician Decision|1|||
131780532|NCT01071083|474475852|FG000|Overall Study|Early Rescue|1|||
131780533|NCT01071083|474475853|FG001|Overall Study|Early Rescue|0|||
131780534|NCT01071083|474475854|FG002|Overall Study|Early Rescue|0|||
131780535|NCT01071083|474475855|FG003|Overall Study|Early Rescue|0|||
131780536|NCT01071083|474475856|FG004|Overall Study|Early Rescue|1|||
131780537|NCT01071083|474475852|FG000|Overall Study|Subject Moved|0|||
131780538|NCT01071083|474475853|FG001|Overall Study|Subject Moved|1|||
131780539|NCT01071083|474475854|FG002|Overall Study|Subject Moved|0|||
131780540|NCT01071083|474475855|FG003|Overall Study|Subject Moved|0|||
131780541|NCT01071083|474475856|FG004|Overall Study|Subject Moved|0|||
131780542|NCT01071083|474475852|FG000|Overall Study|Images Not Usable (Motion)|0|||
131780543|NCT01071083|474475853|FG001|Overall Study|Images Not Usable (Motion)|1|||
131780544|NCT01071083|474475854|FG002|Overall Study|Images Not Usable (Motion)|0|||
131780545|NCT01071083|474475855|FG003|Overall Study|Images Not Usable (Motion)|0|||
131780546|NCT01071083|474475856|FG004|Overall Study|Images Not Usable (Motion)|0|||
131780547|NCT01071083|474475852|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
131780548|NCT01071083|474475853|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
131780549|NCT01071083|474475854|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
131780550|NCT01071083|474475855|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
131780551|NCT01071083|474475856|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
131780552|NCT01071083|474475852|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
131780553|NCT01071083|474475853|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
131780554|NCT01071083|474475854|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
131780555|NCT01071083|474475855|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
131780556|NCT01071083|474475856|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
131780557|NCT01071083|474475852|FG000|Overall Study|Subject Refused to Continue|1|||
131780558|NCT01071083|474475853|FG001|Overall Study|Subject Refused to Continue|0|||
131780559|NCT01071083|474475854|FG002|Overall Study|Subject Refused to Continue|0|||
131780560|NCT01071083|474475855|FG003|Overall Study|Subject Refused to Continue|0|||
131780561|NCT01071083|474475856|FG004|Overall Study|Subject Refused to Continue|0|||
131780562|NCT00728988|474475859|FG000|Overall Study|Not Treated|2|||
131780563|NCT00728988|474475860|FG001|Overall Study|Not Treated|2|||
131780564|NCT00728988|474475859|FG000|Overall Study|Death|1|||
131780565|NCT00728988|474475860|FG001|Overall Study|Death|1|||
131780566|NCT00728988|474475859|FG000|Overall Study|Adverse Event|3|||
131780567|NCT00728988|474475860|FG001|Overall Study|Adverse Event|2|||
131780568|NCT00728988|474475859|FG000|Overall Study|Other|85|||
131561664|NCT04781647|473682312|FG002|Overall Study|Pregnancy|1|||
131561665|NCT04781647|473682310|FG000|Overall Study|Virology rebounded|1|||
131561666|NCT04781647|473682311|FG001|Overall Study|Virology rebounded|0|||
131561667|NCT04781647|473682312|FG002|Overall Study|Virology rebounded|0|||
131561668|NCT01755689|473682313|FG000|Overall Study|Withdrawal by Subject|1|||
131561669|NCT01755689|473682314|FG001|Overall Study|Withdrawal by Subject|3|||
131561670|NCT01755689|473682315|FG002|Overall Study|Withdrawal by Subject|2|||
131561671|NCT01755689|473682316|FG003|Overall Study|Withdrawal by Subject|1|||
131561672|NCT01755689|473682317|FG004|Overall Study|Withdrawal by Subject|1|||
131561673|NCT01755689|473682313|FG000|Overall Study|Migrated/moved from study area|0|||
131561674|NCT01755689|473682314|FG001|Overall Study|Migrated/moved from study area|1|||
131561675|NCT01755689|473682315|FG002|Overall Study|Migrated/moved from study area|1|||
131561676|NCT01755689|473682316|FG003|Overall Study|Migrated/moved from study area|1|||
131561677|NCT01755689|473682317|FG004|Overall Study|Migrated/moved from study area|1|||
131561678|NCT01755689|473682313|FG000|Overall Study|Lost to Follow-up|1|||
131561679|NCT01755689|473682314|FG001|Overall Study|Lost to Follow-up|0|||
131561680|NCT01755689|473682315|FG002|Overall Study|Lost to Follow-up|1|||
131561681|NCT01755689|473682316|FG003|Overall Study|Lost to Follow-up|0|||
131561682|NCT01755689|473682317|FG004|Overall Study|Lost to Follow-up|2|||
131561683|NCT01755689|473682313|FG000|Overall Study|Pregnancy|1|||
131561684|NCT01755689|473682314|FG001|Overall Study|Pregnancy|1|||
131561685|NCT01755689|473682315|FG002|Overall Study|Pregnancy|2|||
131561686|NCT01755689|473682316|FG003|Overall Study|Pregnancy|4|||
131561687|NCT01755689|473682317|FG004|Overall Study|Pregnancy|2|||
131561688|NCT03772314|473682319|FG000|Overall Study|Adverse Event|7|||
131561689|NCT03772314|473682320|FG001|Overall Study|Adverse Event|2|||
131561690|NCT01284140|473682325|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
131561691|NCT01284140|473682326|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
131561692|NCT01284140|473682325|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
131561693|NCT01284140|473682326|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
131561694|NCT00088205|473682327|FG000|Overall Study|Adverse Event|4|||
131561695|NCT00088205|473682327|FG000|Overall Study|Progressive Disease|51|||
131561696|NCT00088205|473682327|FG000|Overall Study|Physician Decision|1|||
131561697|NCT00088205|473682327|FG000|Overall Study|Death Due to Study Disease|4|||
131561698|NCT03192215|473682328|FG000|Overall Study|Death|28|||
131561699|NCT03192215|473682329|FG001|Overall Study|Death|23|||
131561700|NCT03192215|473682328|FG000|Overall Study|Lost to Follow-up|10|||
131561701|NCT03192215|473682329|FG001|Overall Study|Lost to Follow-up|15|||
131561702|NCT03192215|473682328|FG000|Overall Study|Withdrawal by Subject|49|||
131561703|NCT03192215|473682329|FG001|Overall Study|Withdrawal by Subject|48|||
131561704|NCT03192215|473682328|FG000|Overall Study|Other as reported in analysis|4|||
131561705|NCT03192215|473682329|FG001|Overall Study|Other as reported in analysis|1|||
131561706|NCT05199233|473682332|FG000|Overall Study|Lack of Efficacy|1|||
131561707|NCT00322374|473682341|FG000|Starting Dose|Physician Decision|2|||
131561708|NCT00322374|473682342|FG001|Starting Dose|Physician Decision|0|||
131561709|NCT00322374|473682343|FG002|Starting Dose|Physician Decision|0|||
131561710|NCT00322374|473682344|FG003|Starting Dose|Physician Decision|0|||
131561711|NCT00322374|473682341|FG000|Starting Dose|Study Drug Toxicity|4|||
131561712|NCT00322374|473682342|FG001|Starting Dose|Study Drug Toxicity|0|||
131561713|NCT00322374|473682343|FG002|Starting Dose|Study Drug Toxicity|0|||
131561714|NCT00322374|473682344|FG003|Starting Dose|Study Drug Toxicity|0|||
131561715|NCT00322374|473682341|FG000|First Escalation|Documented Disease Progression|0|||
131780569|NCT00728988|474475860|FG001|Overall Study|Other|77|||
131780570|NCT00728988|474475859|FG000|Overall Study|Withdrawal by Subject|2|||
131780571|NCT00728988|474475860|FG001|Overall Study|Withdrawal by Subject|6|||
131561716|NCT00322374|473682342|FG001|First Escalation|Documented Disease Progression|6|||
131561717|NCT00322374|473682343|FG002|First Escalation|Documented Disease Progression|0|||
131561718|NCT00322374|473682344|FG003|First Escalation|Documented Disease Progression|0|||
131561719|NCT00322374|473682341|FG000|First Escalation|Physician Decision|0|||
131561720|NCT00322374|473682342|FG001|First Escalation|Physician Decision|12|||
131561721|NCT00322374|473682343|FG002|First Escalation|Physician Decision|0|||
131561722|NCT00322374|473682344|FG003|First Escalation|Physician Decision|0|||
131561723|NCT00322374|473682341|FG000|First Escalation|Study Drug Toxicity|0|||
131561724|NCT00322374|473682342|FG001|First Escalation|Study Drug Toxicity|11|||
131561725|NCT00322374|473682343|FG002|First Escalation|Study Drug Toxicity|0|||
131561726|NCT00322374|473682344|FG003|First Escalation|Study Drug Toxicity|0|||
131561727|NCT00322374|473682341|FG000|First Escalation|Participant Request|0|||
131561728|NCT00322374|473682342|FG001|First Escalation|Participant Request|1|||
131780572|NCT00621309|474475865|FG000|Overall Study|Withdrawal by Subject|2|||
131780573|NCT00621309|474475866|FG001|Overall Study|Withdrawal by Subject|0|||
131780574|NCT00621309|474475867|FG002|Overall Study|Withdrawal by Subject|1|||
131561729|NCT00322374|473682343|FG002|First Escalation|Participant Request|0|||
131561730|NCT00322374|473682344|FG003|First Escalation|Participant Request|0|||
131780575|NCT00621309|474475868|FG003|Overall Study|Withdrawal by Subject|1|||
131561731|NCT00322374|473682341|FG000|Second Escalation|Physician Decision|0|||
131561732|NCT00322374|473682342|FG001|Second Escalation|Physician Decision|0|||
131561733|NCT00322374|473682343|FG002|Second Escalation|Physician Decision|5|||
131561734|NCT00322374|473682344|FG003|Second Escalation|Physician Decision|0|||
131561735|NCT00322374|473682341|FG000|Second Escalation|Study Drug Toxicity|0|||
131561736|NCT00322374|473682342|FG001|Second Escalation|Study Drug Toxicity|0|||
131561737|NCT00322374|473682343|FG002|Second Escalation|Study Drug Toxicity|1|||
131561738|NCT00322374|473682344|FG003|Second Escalation|Study Drug Toxicity|0|||
131561739|NCT04230980|473682345|FG000|Overall Study|Lost to Follow-up|1|||
131561740|NCT04230980|473682346|FG001|Overall Study|Lost to Follow-up|2|||
131561741|NCT04230980|473682345|FG000|Overall Study|Adverse Event|0|||
131561742|NCT04230980|473682346|FG001|Overall Study|Adverse Event|1|||
131561743|NCT03257995|473682350|FG000|Overall Study|Adverse Event|0|||
131561744|NCT03257995|473682351|FG001|Overall Study|Adverse Event|1|||
131561745|NCT03257995|473682352|FG002|Overall Study|Adverse Event|0|||
131561746|NCT03257995|473682353|FG003|Overall Study|Adverse Event|0|||
131561747|NCT03257995|473682354|FG004|Overall Study|Adverse Event|0|||
131561748|NCT03257995|473682355|FG005|Overall Study|Adverse Event|0|||
131561749|NCT03257995|473682350|FG000|Overall Study|Protocol deviation|0|||
131561750|NCT03257995|473682351|FG001|Overall Study|Protocol deviation|0|||
131561751|NCT03257995|473682352|FG002|Overall Study|Protocol deviation|0|||
131561752|NCT03257995|473682353|FG003|Overall Study|Protocol deviation|0|||
131561753|NCT03257995|473682354|FG004|Overall Study|Protocol deviation|0|||
131561754|NCT03257995|473682355|FG005|Overall Study|Protocol deviation|2|||
131561755|NCT01556763|473682359|FG000|Overall Study|Withdrawal by Subject|0|||
131561756|NCT01556763|473682360|FG001|Overall Study|Withdrawal by Subject|1|||
131561757|NCT01556763|473682361|FG002|Overall Study|Withdrawal by Subject|0|||
131780576|NCT00621309|474475869|FG004|Overall Study|Withdrawal by Subject|1|||
131780577|NCT00621309|474475870|FG005|Overall Study|Withdrawal by Subject|1|||
131561758|NCT02258464|473682362|FG000|Overall Study|Progressive disease (PD)|9|||
131780578|NCT03387423|474477770|FG000|Overall Study|Lost to Follow-up|16|||
131780579|NCT03387423|474477771|FG001|Overall Study|Lost to Follow-up|12|||
131780580|NCT03387423|474477772|FG002|Overall Study|Lost to Follow-up|1|||
131780581|NCT03387423|474477773|FG003|Overall Study|Lost to Follow-up|0|||
131780582|NCT03387423|474477770|FG000|Overall Study|Other|0|||
131780583|NCT03387423|474477771|FG001|Overall Study|Other|3|||
131780584|NCT03387423|474477772|FG002|Overall Study|Other|0|||
131780585|NCT03387423|474477773|FG003|Overall Study|Other|0|||
131780586|NCT03387423|474477770|FG000|Overall Study|Administrative Reason|166|||
131780587|NCT03387423|474477771|FG001|Overall Study|Administrative Reason|89|||
131780588|NCT03387423|474477772|FG002|Overall Study|Administrative Reason|17|||
131780589|NCT03387423|474477773|FG003|Overall Study|Administrative Reason|19|||
131780590|NCT03387423|474477770|FG000|Overall Study|Revocation Consent|76|||
131780591|NCT03387423|474477771|FG001|Overall Study|Revocation Consent|32|||
131780592|NCT03387423|474477772|FG002|Overall Study|Revocation Consent|3|||
131780593|NCT03387423|474477773|FG003|Overall Study|Revocation Consent|5|||
131780594|NCT00915473|474477774|FG000|Screening|Withdrawal by Subject|1|||
131780595|NCT00915473|474477775|FG001|Screening|Withdrawal by Subject|0|||
131780596|NCT00915473|474477774|FG000|4-week Follow Up|Lost to Follow-up|1|||
131780597|NCT00915473|474477775|FG001|4-week Follow Up|Lost to Follow-up|5|||
131780598|NCT03443973|474477776|FG000|Double-blind Treatment Period|Adverse Event|5|||
131780599|NCT03443973|474477777|FG001|Double-blind Treatment Period|Adverse Event|19|||
131780600|NCT03443973|474477778|FG002|Double-blind Treatment Period|Adverse Event|0|||
131780601|NCT03443973|474477779|FG003|Double-blind Treatment Period|Adverse Event|0|||
131780602|NCT03443973|474477776|FG000|Double-blind Treatment Period|Death|5|||
131780603|NCT03443973|474477777|FG001|Double-blind Treatment Period|Death|7|||
131780604|NCT03443973|474477778|FG002|Double-blind Treatment Period|Death|0|||
131780605|NCT03443973|474477779|FG003|Double-blind Treatment Period|Death|0|||
131780606|NCT03443973|474477776|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
131780607|NCT03443973|474477777|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
131780608|NCT03443973|474477778|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
131780609|NCT03443973|474477779|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
131780610|NCT03443973|474477776|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131561759|NCT02258464|473682363|FG001|Overall Study|Progressive disease (PD)|17|||
131780611|NCT03443973|474477777|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
131780612|NCT03443973|474477778|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131780613|NCT03443973|474477779|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131561760|NCT02258464|473682362|FG000|Overall Study|Study drug never administered|1|||
131561761|NCT02258464|473682363|FG001|Overall Study|Study drug never administered|1|||
131561762|NCT02258464|473682362|FG000|Overall Study|AE not related to clinical PD|1|||
131561763|NCT02258464|473682363|FG001|Overall Study|AE not related to clinical PD|3|||
131561764|NCT02258464|473682362|FG000|Overall Study|Withdrawal by Subject|5|||
131780614|NCT03443973|474477776|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
131780615|NCT03443973|474477777|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
131780616|NCT03443973|474477778|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
131561765|NCT02258464|473682363|FG001|Overall Study|Withdrawal by Subject|4|||
131780617|NCT03443973|474477779|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
131561766|NCT02258464|473682362|FG000|Overall Study|AE related to clinical PD|1|||
131695512|NCT01294800|474168571|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
131695513|NCT00797732|474168575|FG000|Overall Study|Withdrawal by Subject|3|||
131695514|NCT00797732|474168576|FG001|Overall Study|Withdrawal by Subject|3|||
131695515|NCT00797732|474168577|FG002|Overall Study|Withdrawal by Subject|0|||
131695516|NCT00797732|474168575|FG000|Overall Study|Lost to Follow-up|1|||
131695517|NCT00797732|474168576|FG001|Overall Study|Lost to Follow-up|0|||
131695518|NCT00797732|474168577|FG002|Overall Study|Lost to Follow-up|0|||
131695519|NCT00797732|474168575|FG000|Overall Study|Death|1|||
131695520|NCT00797732|474168576|FG001|Overall Study|Death|0|||
131695521|NCT00797732|474168577|FG002|Overall Study|Death|0|||
131695522|NCT00797732|474168575|FG000|Overall Study|Not meet inclusion criteria|0|||
131695523|NCT00797732|474168576|FG001|Overall Study|Not meet inclusion criteria|0|||
131695524|NCT00797732|474168577|FG002|Overall Study|Not meet inclusion criteria|7|||
131695525|NCT00797732|474168575|FG000|Overall Study|Excluded due to time constraints|0|||
131695526|NCT00797732|474168576|FG001|Overall Study|Excluded due to time constraints|0|||
131695527|NCT00797732|474168577|FG002|Overall Study|Excluded due to time constraints|24|||
131695528|NCT00797732|474168575|FG000|Overall Study|Refused to Participate|0|||
131695529|NCT00797732|474168576|FG001|Overall Study|Refused to Participate|0|||
131695530|NCT00797732|474168577|FG002|Overall Study|Refused to Participate|123|||
131695531|NCT00401752|474168578|FG000|Overall Study|Adverse Event|2|||
131695532|NCT00401752|474168579|FG001|Overall Study|Adverse Event|5|||
131695533|NCT00401752|474168578|FG000|Overall Study|Withdrawal by Subject|2|||
131695534|NCT00401752|474168579|FG001|Overall Study|Withdrawal by Subject|6|||
131695535|NCT00401752|474168578|FG000|Overall Study|Lost to Follow-up|1|||
131695536|NCT00401752|474168579|FG001|Overall Study|Lost to Follow-up|4|||
131695537|NCT00401752|474168578|FG000|Overall Study|Development of any exclusion criteria|4|||
131695538|NCT00401752|474168579|FG001|Overall Study|Development of any exclusion criteria|2|||
131695539|NCT00401752|474168578|FG000|Overall Study|Physician Decision|1|||
131695540|NCT00401752|474168579|FG001|Overall Study|Physician Decision|1|||
131695541|NCT01895322|474168580|FG000|Overall Study|Adverse Event|1|||
131695542|NCT01895322|474168580|FG000|Overall Study|Withdrawal by Subject|2|||
131695543|NCT01895322|474168580|FG000|Overall Study|Protocol Violation|10|||
131695544|NCT02275338|474168581|FG000|Overall Study|Adverse Event|15|||
131695545|NCT02275338|474168581|FG000|Overall Study|Lack of Efficacy|3|||
131695546|NCT02275338|474168581|FG000|Overall Study|Withdrawal by Subject|4|||
131695547|NCT02275338|474168581|FG000|Overall Study|Disease progression (death)|1|||
131695548|NCT02275338|474168581|FG000|Overall Study|Ineligible to start Phase 2|4|||
131695549|NCT02275338|474168581|FG000|Overall Study|Reason not specified|5|||
131695550|NCT02275338|474168581|FG000|Overall Study|Does not meet entry criteria|1|||
131695551|NCT01857869|474168584|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
131695552|NCT01857869|474168585|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
131695553|NCT01857869|474168586|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
131695554|NCT01857869|474168587|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
131695555|NCT01857869|474168588|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
131695556|NCT01857869|474168589|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
131695557|NCT01857869|474168590|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
131695558|NCT01857869|474168591|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
131695559|NCT01857869|474168592|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
131695560|NCT01857869|474168593|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
131695561|NCT01857869|474168584|FG000|Primary/Challenge Phase|Pregnancy|1|||
131695562|NCT01857869|474168585|FG001|Primary/Challenge Phase|Pregnancy|0|||
131695563|NCT01857869|474168586|FG002|Primary/Challenge Phase|Pregnancy|0|||
131695564|NCT01857869|474168587|FG003|Primary/Challenge Phase|Pregnancy|0|||
131695565|NCT01857869|474168588|FG004|Primary/Challenge Phase|Pregnancy|0|||
131695566|NCT01857869|474168589|FG005|Primary/Challenge Phase|Pregnancy|0|||
131695567|NCT01857869|474168590|FG006|Primary/Challenge Phase|Pregnancy|0|||
131695568|NCT01857869|474168591|FG007|Primary/Challenge Phase|Pregnancy|0|||
131695569|NCT01857869|474168592|FG008|Primary/Challenge Phase|Pregnancy|0|||
131695570|NCT01857869|474168593|FG009|Primary/Challenge Phase|Pregnancy|0|||
131695571|NCT01857869|474168584|FG000|Primary/Challenge Phase|Protocol Violation|1|||
131695572|NCT01857869|474168585|FG001|Primary/Challenge Phase|Protocol Violation|0|||
131695573|NCT01857869|474168586|FG002|Primary/Challenge Phase|Protocol Violation|0|||
131695574|NCT01857869|474168587|FG003|Primary/Challenge Phase|Protocol Violation|0|||
131695575|NCT01857869|474168588|FG004|Primary/Challenge Phase|Protocol Violation|0|||
131780618|NCT03443973|474477776|FG000|Double-blind Treatment Period|Physician Decision|5|||
131695576|NCT01857869|474168589|FG005|Primary/Challenge Phase|Protocol Violation|0|||
131695577|NCT01857869|474168590|FG006|Primary/Challenge Phase|Protocol Violation|0|||
131695578|NCT01857869|474168591|FG007|Primary/Challenge Phase|Protocol Violation|0|||
131695579|NCT01857869|474168592|FG008|Primary/Challenge Phase|Protocol Violation|0|||
131695580|NCT01857869|474168593|FG009|Primary/Challenge Phase|Protocol Violation|0|||
131695581|NCT01857869|474168584|FG000|Primary/Challenge Phase|Other|1|||
131695582|NCT01857869|474168585|FG001|Primary/Challenge Phase|Other|1|||
131695583|NCT01857869|474168586|FG002|Primary/Challenge Phase|Other|0|||
131695584|NCT01857869|474168587|FG003|Primary/Challenge Phase|Other|0|||
131695585|NCT01857869|474168588|FG004|Primary/Challenge Phase|Other|0|||
131695586|NCT01857869|474168589|FG005|Primary/Challenge Phase|Other|0|||
131695587|NCT01857869|474168590|FG006|Primary/Challenge Phase|Other|0|||
131695588|NCT01857869|474168591|FG007|Primary/Challenge Phase|Other|0|||
131695589|NCT01857869|474168592|FG008|Primary/Challenge Phase|Other|0|||
131695590|NCT01857869|474168593|FG009|Primary/Challenge Phase|Other|0|||
131695591|NCT01857869|474168584|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695592|NCT01857869|474168585|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695593|NCT01857869|474168586|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695594|NCT01857869|474168587|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
131695595|NCT01857869|474168588|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695596|NCT01857869|474168589|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695597|NCT01857869|474168590|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695598|NCT01857869|474168591|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695599|NCT01857869|474168592|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695600|NCT01857869|474168593|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131695601|NCT01857869|474168584|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695602|NCT01857869|474168585|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695603|NCT01857869|474168586|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695604|NCT01857869|474168587|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
131695605|NCT01857869|474168588|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695606|NCT01857869|474168589|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695607|NCT01857869|474168590|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695608|NCT01857869|474168591|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695609|NCT01857869|474168592|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695610|NCT01857869|474168593|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131695611|NCT03603496|474168596|FG000|Overall Study|Death|19|||
131695612|NCT03603496|474168597|FG001|Overall Study|Death|24|||
131695613|NCT03603496|474168596|FG000|Overall Study|Lost to Follow-up|141|||
131695614|NCT03603496|474168597|FG001|Overall Study|Lost to Follow-up|141|||
131695615|NCT03603496|474168596|FG000|Overall Study|Withdrawal by Subject|26|||
131695616|NCT03603496|474168597|FG001|Overall Study|Withdrawal by Subject|20|||
131695617|NCT01888640|474168598|FG000|Overall Study|Lost to Follow-up|1|||
131695618|NCT01888640|474168599|FG001|Overall Study|Lost to Follow-up|2|||
131695619|NCT01888640|474168600|FG002|Overall Study|Lost to Follow-up|0|||
131695620|NCT01888640|474168598|FG000|Overall Study|Withdrawal by Subject|15|||
131695621|NCT01888640|474168599|FG001|Overall Study|Withdrawal by Subject|11|||
131695622|NCT01888640|474168600|FG002|Overall Study|Withdrawal by Subject|4|||
131695623|NCT01888640|474168598|FG000|Overall Study|Minimum dose not met|10|||
131695624|NCT01888640|474168599|FG001|Overall Study|Minimum dose not met|16|||
131695625|NCT01888640|474168600|FG002|Overall Study|Minimum dose not met|0|||
131695626|NCT01888640|474168598|FG000|Overall Study|Given wrong unit (placebo)|1|||
131695627|NCT01888640|474168599|FG001|Overall Study|Given wrong unit (placebo)|0|||
131695628|NCT01888640|474168600|FG002|Overall Study|Given wrong unit (placebo)|0|||
131695629|NCT01888640|474168598|FG000|Overall Study|Excluded for prior TENS|0|||
131695630|NCT01888640|474168599|FG001|Overall Study|Excluded for prior TENS|1|||
131695631|NCT01888640|474168600|FG002|Overall Study|Excluded for prior TENS|0|||
131695632|NCT01888640|474168598|FG000|Overall Study|Researcher Termination of Participant|0|||
131695633|NCT01888640|474168599|FG001|Overall Study|Researcher Termination of Participant|1|||
131695634|NCT01888640|474168600|FG002|Overall Study|Researcher Termination of Participant|1|||
131695635|NCT02199080|474168607|FG000|Overall Study|Protocol Violation|12|||
131695636|NCT01277549|474168608|FG000|Overall Study|Failed to meet eligibility criteria|13|||
131695637|NCT01277549|474168609|FG001|Overall Study|Failed to meet eligibility criteria|9|||
131695638|NCT01277549|474168608|FG000|Overall Study|Withdrawal by Subject|1|||
131695639|NCT01277549|474168609|FG001|Overall Study|Withdrawal by Subject|3|||
131695640|NCT01277549|474168608|FG000|Overall Study|Protocol Violation|10|||
131695641|NCT01277549|474168609|FG001|Overall Study|Protocol Violation|1|||
131695642|NCT01277549|474168608|FG000|Overall Study|Physician Decision|2|||
131695643|NCT01277549|474168609|FG001|Overall Study|Physician Decision|1|||
131695644|NCT00835237|474168610|FG000|Overall Study|Lost to Follow-up|4|||
131695645|NCT00835237|474168611|FG001|Overall Study|Lost to Follow-up|0|||
131695646|NCT00835237|474168610|FG000|Overall Study|Withdrawal by Subject|2|||
131695647|NCT00835237|474168611|FG001|Overall Study|Withdrawal by Subject|0|||
131695648|NCT01265550|474168614|FG000|Pre Randomization|Withdrawal by Subject|0|||
131695649|NCT01265550|474168615|FG001|Pre Randomization|Withdrawal by Subject|0|||
131695650|NCT01265550|474168616|FG002|Pre Randomization|Withdrawal by Subject|0|||
131695651|NCT01265550|474168617|FG003|Pre Randomization|Withdrawal by Subject|70|||
131561767|NCT02258464|473682363|FG001|Overall Study|AE related to clinical PD|0|||
131561768|NCT02138747|473682364|FG000|Treatment Period 1|Adverse Event|10|||
131561769|NCT02138747|473682365|FG001|Treatment Period 1|Adverse Event|14|||
131561770|NCT02138747|473682366|FG002|Treatment Period 1|Adverse Event|2|||
131561771|NCT02138747|473682367|FG003|Treatment Period 1|Adverse Event|1|||
131561772|NCT02138747|473682364|FG000|Treatment Period 1|Lost to Follow-up|0|||
131561773|NCT02138747|473682365|FG001|Treatment Period 1|Lost to Follow-up|1|||
131561774|NCT02138747|473682366|FG002|Treatment Period 1|Lost to Follow-up|1|||
131561775|NCT02138747|473682367|FG003|Treatment Period 1|Lost to Follow-up|0|||
131561776|NCT02138747|473682364|FG000|Treatment Period 1|Protocol Violation|0|||
131561777|NCT02138747|473682365|FG001|Treatment Period 1|Protocol Violation|2|||
131561778|NCT02138747|473682366|FG002|Treatment Period 1|Protocol Violation|0|||
131561779|NCT02138747|473682367|FG003|Treatment Period 1|Protocol Violation|0|||
131561780|NCT02138747|473682364|FG000|Treatment Period 1|Withdrawal by Subject|8|||
131561781|NCT02138747|473682365|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131561782|NCT02138747|473682366|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131561783|NCT02138747|473682367|FG003|Treatment Period 1|Withdrawal by Subject|3|||
131561784|NCT02138747|473682364|FG000|Treatment Period 1|Other - Miscellaneous|2|||
131561785|NCT02138747|473682365|FG001|Treatment Period 1|Other - Miscellaneous|4|||
131561786|NCT02138747|473682366|FG002|Treatment Period 1|Other - Miscellaneous|0|||
131561787|NCT02138747|473682367|FG003|Treatment Period 1|Other - Miscellaneous|0|||
131561788|NCT02138747|473682364|FG000|Treatment Period 2|Adverse Event|6|||
131561789|NCT02138747|473682365|FG001|Treatment Period 2|Adverse Event|3|||
131561790|NCT02138747|473682366|FG002|Treatment Period 2|Adverse Event|1|||
131561791|NCT02138747|473682367|FG003|Treatment Period 2|Adverse Event|1|||
131561792|NCT02138747|473682364|FG000|Treatment Period 2|Lost to Follow-up|2|||
131561793|NCT02138747|473682365|FG001|Treatment Period 2|Lost to Follow-up|0|||
131561794|NCT02138747|473682366|FG002|Treatment Period 2|Lost to Follow-up|0|||
131561795|NCT02138747|473682367|FG003|Treatment Period 2|Lost to Follow-up|0|||
131561796|NCT02138747|473682364|FG000|Treatment Period 2|Protocol Violation|1|||
131561797|NCT02138747|473682365|FG001|Treatment Period 2|Protocol Violation|0|||
131561798|NCT02138747|473682366|FG002|Treatment Period 2|Protocol Violation|0|||
131561799|NCT02138747|473682367|FG003|Treatment Period 2|Protocol Violation|0|||
131561800|NCT02138747|473682364|FG000|Treatment Period 2|Withdrawal by Subject|5|||
131561801|NCT02138747|473682365|FG001|Treatment Period 2|Withdrawal by Subject|4|||
131561802|NCT02138747|473682366|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131561803|NCT02138747|473682367|FG003|Treatment Period 2|Withdrawal by Subject|2|||
131561804|NCT02138747|473682364|FG000|Treatment Period 2|Other - Miscellaneous|3|||
131561805|NCT02138747|473682365|FG001|Treatment Period 2|Other - Miscellaneous|0|||
131561806|NCT02138747|473682366|FG002|Treatment Period 2|Other - Miscellaneous|0|||
131561807|NCT02138747|473682367|FG003|Treatment Period 2|Other - Miscellaneous|0|||
131561808|NCT04170296|473682368|FG000|Overall Study|Adverse Event|1|||
131561809|NCT04170296|473682369|FG001|Overall Study|Adverse Event|0|||
131561810|NCT04170296|473682368|FG000|Overall Study|Withdrawal by Subject|3|||
131561811|NCT04170296|473682369|FG001|Overall Study|Withdrawal by Subject|2|||
131561812|NCT04170296|473682368|FG000|Overall Study|Lost to Follow-up|4|||
131561813|NCT04170296|473682369|FG001|Overall Study|Lost to Follow-up|2|||
131561814|NCT00932646|473682370|FG000|Overall Study|Adverse Event|2|||
131561815|NCT00932646|473682371|FG001|Overall Study|Adverse Event|1|||
131561816|NCT00932646|473682372|FG002|Overall Study|Adverse Event|1|||
131561817|NCT00932646|473682373|FG003|Overall Study|Adverse Event|1|||
131561818|NCT00932646|473682370|FG000|Overall Study|Lost to Follow-up|2|||
131561819|NCT00932646|473682371|FG001|Overall Study|Lost to Follow-up|1|||
131780619|NCT03443973|474477777|FG001|Double-blind Treatment Period|Physician Decision|6|||
131780620|NCT03443973|474477778|FG002|Double-blind Treatment Period|Physician Decision|0|||
131780621|NCT03443973|474477779|FG003|Double-blind Treatment Period|Physician Decision|0|||
131780622|NCT03443973|474477776|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
131780623|NCT03443973|474477777|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
131561820|NCT00932646|473682372|FG002|Overall Study|Lost to Follow-up|0|||
131561821|NCT00932646|473682373|FG003|Overall Study|Lost to Follow-up|0|||
131561822|NCT00932646|473682370|FG000|Overall Study|Withdrawal by Subject|1|||
131561823|NCT00932646|473682371|FG001|Overall Study|Withdrawal by Subject|1|||
131561824|NCT00932646|473682372|FG002|Overall Study|Withdrawal by Subject|3|||
131561825|NCT00932646|473682373|FG003|Overall Study|Withdrawal by Subject|0|||
131561826|NCT00653263|473682374|FG000|Overall Study|Withdrawal by Subject|1|||
131561827|NCT00653263|473682374|FG000|Overall Study|Physician Decision|1|||
131561828|NCT00776100|473682385|FG000|Overall Study|Disease Progression|1|||
131780624|NCT03443973|474477778|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
131780625|NCT03443973|474477779|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
131780626|NCT03443973|474477776|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
131561829|NCT00776100|473682386|FG001|Overall Study|Disease Progression|0|||
131561830|NCT03567993|473682389|FG000|Overall Study|Lost to Follow-up|4|||
131561831|NCT03567993|473682390|FG001|Overall Study|Lost to Follow-up|2|||
131561832|NCT03567993|473682389|FG000|Overall Study|Death|1|||
131561833|NCT03567993|473682390|FG001|Overall Study|Death|1|||
131561834|NCT03567993|473682389|FG000|Overall Study|Withdrawal by Subject|1|||
131561835|NCT03567993|473682390|FG001|Overall Study|Withdrawal by Subject|0|||
131561836|NCT04793464|473682391|FG000|Overall Study|Lost to Follow-up|458|||
131561837|NCT04793464|473682392|FG001|Overall Study|Lost to Follow-up|168|||
131561838|NCT04793464|473682393|FG002|Overall Study|Lost to Follow-up|5|||
131561839|NCT04793464|473682391|FG000|Overall Study|Withdrawal by Subject|43|||
131561840|NCT04793464|473682392|FG001|Overall Study|Withdrawal by Subject|15|||
131561841|NCT04793464|473682393|FG002|Overall Study|Withdrawal by Subject|0|||
131561842|NCT00903786|473682397|FG000|Overall Study|Physician Decision|6|||
131561843|NCT00903786|473682397|FG000|Overall Study|Lack of Efficacy|5|||
131561844|NCT00903786|473682397|FG000|Overall Study|Reason other than lack of efficacy|4|||
131561845|NCT02285595|473682402|FG000|Overall Study|Lost to Follow-up|14|||
131561846|NCT02285595|473682402|FG000|Overall Study|Withdrawal by Subject|1|||
131561847|NCT00195715|473682403|FG000|Overall Study|Adverse Event|122|||
131561848|NCT00195715|473682403|FG000|Overall Study|Withdrawal by Subject|58|||
131561849|NCT00195715|473682403|FG000|Overall Study|Lost to Follow-up|27|||
131561850|NCT00195715|473682403|FG000|Overall Study|Protocol Violation|13|||
131561851|NCT00195715|473682403|FG000|Overall Study|Lack of Efficacy|93|||
131561852|NCT00195715|473682403|FG000|Overall Study|Pregnancy|14|||
131561853|NCT00195715|473682403|FG000|Overall Study|Investigative site closure|8|||
131561854|NCT00195715|473682403|FG000|Overall Study|Subject moved/relocated|7|||
131561855|NCT00195715|473682403|FG000|Overall Study|Subject non-compliance|6|||
131561856|NCT00195715|473682403|FG000|Overall Study|Subject started commercial Humira|5|||
131561857|NCT00195715|473682403|FG000|Overall Study|Subject choice|3|||
131561858|NCT00195715|473682403|FG000|Overall Study|Loss of response/no improvement|3|||
131561859|NCT00195715|473682403|FG000|Overall Study|Sponsor stopped study|1|||
131561860|NCT00195715|473682403|FG000|Overall Study|Administrative reasons|2|||
131561861|NCT00195715|473682403|FG000|Overall Study|Investigator's decision|2|||
131561862|NCT00195715|473682403|FG000|Overall Study|Subject wants to get pregnant|4|||
131561863|NCT00195715|473682403|FG000|Overall Study|Use of prohibited medication|2|||
131561864|NCT00195715|473682403|FG000|Overall Study|Planned surgery|2|||
131561865|NCT00195715|473682403|FG000|Overall Study|Increased infection rate|1|||
131695652|NCT01265550|474168614|FG000|Pre Randomization|Technical Exclusions|0|||
131695653|NCT01265550|474168615|FG001|Pre Randomization|Technical Exclusions|0|||
131695654|NCT01265550|474168616|FG002|Pre Randomization|Technical Exclusions|0|||
131695655|NCT01265550|474168617|FG003|Pre Randomization|Technical Exclusions|54|||
131695656|NCT01265550|474168614|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
131695657|NCT01265550|474168615|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
131695658|NCT01265550|474168616|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
131695659|NCT01265550|474168617|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
131695660|NCT01265550|474168614|FG000|Pre Randomization|Non-GERD organic disorders|0|||
131695661|NCT01265550|474168615|FG001|Pre Randomization|Non-GERD organic disorders|0|||
131695662|NCT01265550|474168616|FG002|Pre Randomization|Non-GERD organic disorders|0|||
131695663|NCT01265550|474168617|FG003|Pre Randomization|Non-GERD organic disorders|23|||
131695664|NCT01265550|474168614|FG000|Pre Randomization|Functional heartburn|0|||
131695665|NCT01265550|474168615|FG001|Pre Randomization|Functional heartburn|0|||
131695666|NCT01265550|474168616|FG002|Pre Randomization|Functional heartburn|0|||
131695667|NCT01265550|474168617|FG003|Pre Randomization|Functional heartburn|99|||
131695668|NCT01929408|474168618|FG000|Overall Study|received HCT as initial treatment|8|||
131695669|NCT01097863|474168619|FG000|Overall Study|Discomfort|1|||
131695670|NCT01097863|474168620|FG001|Overall Study|Discomfort|0|||
131695671|NCT01097863|474168621|FG002|Overall Study|Discomfort|1|||
131695672|NCT01097863|474168619|FG000|Overall Study|Did not return for final visit|0|||
131695673|NCT01097863|474168620|FG001|Overall Study|Did not return for final visit|0|||
131695674|NCT01097863|474168621|FG002|Overall Study|Did not return for final visit|1|||
131695675|NCT02703311|474168622|FG000|Overall Study|Death|5|||
131695676|NCT02703311|474168622|FG000|Overall Study|Withdrawal by Subject|3|||
131695677|NCT00652366|474168623|FG000|Overall Study|Adverse Event|8|||
131695678|NCT00652366|474168624|FG001|Overall Study|Adverse Event|4|||
131695679|NCT00652366|474168625|FG002|Overall Study|Adverse Event|7|||
131561866|NCT00195715|473682403|FG000|Overall Study|Ineligible|1|||
131561867|NCT00195715|473682403|FG000|Overall Study|Colonic stricture|1|||
131561868|NCT00195715|473682403|FG000|Overall Study|Sponsor discontinued trial|1|||
131561869|NCT00195715|473682403|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
131695680|NCT00652366|474168626|FG003|Overall Study|Adverse Event|17|||
131695681|NCT00652366|474168627|FG004|Overall Study|Adverse Event|13|||
131695682|NCT00652366|474168623|FG000|Overall Study|Death|5|||
131695683|NCT00652366|474168624|FG001|Overall Study|Death|4|||
131561870|NCT00845871|473682408|FG000|Assessment Period|Adverse Event|2|||
131561871|NCT00845871|473682408|FG000|Assessment Period|Abnormal laboratory values|1|||
131561872|NCT00845871|473682408|FG000|Assessment Period|Abnormal test procedure results|1|||
131561873|NCT00845871|473682408|FG000|Assessment Period|Patient withdrew consent|3|||
131695684|NCT00652366|474168625|FG002|Overall Study|Death|1|||
131695685|NCT00652366|474168626|FG003|Overall Study|Death|8|||
131695686|NCT00652366|474168627|FG004|Overall Study|Death|5|||
131695687|NCT00652366|474168623|FG000|Overall Study|Lack of Efficacy|84|||
131780627|NCT03443973|474477777|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
131780628|NCT03443973|474477778|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131780629|NCT03443973|474477779|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
131780630|NCT03443973|474477776|FG000|Open-label Extension Period|Reason Not Specified|0|||
131780631|NCT03443973|474477777|FG001|Open-label Extension Period|Reason Not Specified|0|||
131780632|NCT03443973|474477778|FG002|Open-label Extension Period|Reason Not Specified|3|||
131780633|NCT03443973|474477779|FG003|Open-label Extension Period|Reason Not Specified|0|||
131780634|NCT03443973|474477776|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131780635|NCT03443973|474477777|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
131780636|NCT03443973|474477778|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
131780637|NCT03443973|474477779|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
131780638|NCT01956123|474477780|FG000|COS Cycle 2|Protocol Violation|8|||
131780639|NCT01956123|474477781|FG001|COS Cycle 2|Protocol Violation|3|||
131780640|NCT01956123|474477782|FG002|COS Cycle 2|Protocol Violation|0|||
131780641|NCT01956123|474477783|FG003|COS Cycle 2|Protocol Violation|0|||
131780642|NCT01956123|474477780|FG000|COS Cycle 2|Adverse Event|3|||
131780643|NCT01956123|474477781|FG001|COS Cycle 2|Adverse Event|4|||
131780644|NCT01956123|474477782|FG002|COS Cycle 2|Adverse Event|0|||
131780645|NCT01956123|474477783|FG003|COS Cycle 2|Adverse Event|0|||
131561874|NCT00064025|473682416|FG000|Overall Study|Ineligible|4|||
131561875|NCT00064025|473682416|FG000|Overall Study|Inevaluable|3|||
131561876|NCT02468934|473682419|FG000|Overall Study|Withdrawal by Subject|4|||
131561877|NCT02468934|473682419|FG000|Overall Study|Screen Failure|3|||
131561878|NCT00641186|473682424|FG000|Overall Study|Adverse Event|3|||
131780646|NCT01956123|474477780|FG000|COS Cycle 2|Personal Reasons|2|||
131780647|NCT01956123|474477781|FG001|COS Cycle 2|Personal Reasons|0|||
131561879|NCT05221749|473682427|FG000|Overall Study|Lost to Follow-up|2|||
131561880|NCT05221749|473682428|FG001|Overall Study|Lost to Follow-up|3|||
131561881|NCT02218489|473682429|FG000|Overall Study|Withdrawal by Subject|4|||
131780648|NCT01956123|474477782|FG002|COS Cycle 2|Personal Reasons|0|||
131780649|NCT01956123|474477783|FG003|COS Cycle 2|Personal Reasons|0|||
131561882|NCT02218489|473682430|FG001|Overall Study|Withdrawal by Subject|3|||
131561883|NCT02218489|473682429|FG000|Overall Study|Lost to Follow-up|1|||
131561884|NCT02218489|473682430|FG001|Overall Study|Lost to Follow-up|0|||
131561885|NCT02404493|473682431|FG000|Overall Study|Adverse Event|1|||
131561886|NCT02404493|473682432|FG001|Overall Study|Adverse Event|1|||
131561887|NCT00003458|473682433|FG000|Overall Study|Not evaluable|4|||
131561888|NCT02133924|473682434|FG000|Overall Study|Death|38|||
131561889|NCT02133924|473682434|FG000|Overall Study|Physician Decision|1|||
131561890|NCT02133924|473682434|FG000|Overall Study|Withdrawal by Subject|3|||
131561891|NCT01254890|473682435|FG000|Overall Study|Ineligible|0|||
131561892|NCT01254890|473682436|FG001|Overall Study|Ineligible|3|||
131561893|NCT01254890|473682435|FG000|Overall Study|Withdrawal by Subject|1|||
131561894|NCT01254890|473682436|FG001|Overall Study|Withdrawal by Subject|2|||
131561895|NCT01254890|473682435|FG000|Overall Study|Disease Progression|0|||
131561896|NCT01254890|473682436|FG001|Overall Study|Disease Progression|5|||
131561897|NCT04039503|473682441|FG000|Overall Study|Adverse Event|3|||
131561898|NCT04039503|473682442|FG001|Overall Study|Adverse Event|0|||
131561899|NCT04039503|473682443|FG002|Overall Study|Adverse Event|2|||
131561900|NCT04039503|473682444|FG003|Overall Study|Adverse Event|0|||
131561901|NCT04039503|473682441|FG000|Overall Study|Lost to Follow-up|0|||
131561902|NCT04039503|473682442|FG001|Overall Study|Lost to Follow-up|0|||
131561903|NCT04039503|473682443|FG002|Overall Study|Lost to Follow-up|1|||
131561904|NCT04039503|473682444|FG003|Overall Study|Lost to Follow-up|0|||
131561905|NCT04039503|473682441|FG000|Overall Study|Protocol Violation|0|||
131561906|NCT04039503|473682442|FG001|Overall Study|Protocol Violation|1|||
131561907|NCT04039503|473682443|FG002|Overall Study|Protocol Violation|2|||
131561908|NCT04039503|473682444|FG003|Overall Study|Protocol Violation|1|||
131561909|NCT04039503|473682441|FG000|Overall Study|Withdrawal by Subject|4|||
131561910|NCT04039503|473682442|FG001|Overall Study|Withdrawal by Subject|3|||
131561911|NCT04039503|473682443|FG002|Overall Study|Withdrawal by Subject|5|||
131561912|NCT04039503|473682444|FG003|Overall Study|Withdrawal by Subject|2|||
131561913|NCT01163747|473682446|FG000|Overall Study|Adverse Event|0|||
131561914|NCT01163747|473682447|FG001|Overall Study|Adverse Event|5|||
131695688|NCT00652366|474168624|FG001|Overall Study|Lack of Efficacy|58|||
131695689|NCT00652366|474168625|FG002|Overall Study|Lack of Efficacy|53|||
131695690|NCT00652366|474168626|FG003|Overall Study|Lack of Efficacy|133|||
131695691|NCT00652366|474168627|FG004|Overall Study|Lack of Efficacy|13|||
131695692|NCT00652366|474168623|FG000|Overall Study|Violation of Selection Criteria|0|||
131695693|NCT00652366|474168624|FG001|Overall Study|Violation of Selection Criteria|0|||
131695694|NCT00652366|474168625|FG002|Overall Study|Violation of Selection Criteria|1|||
131695695|NCT00652366|474168626|FG003|Overall Study|Violation of Selection Criteria|0|||
131695696|NCT00652366|474168627|FG004|Overall Study|Violation of Selection Criteria|0|||
131695697|NCT00652366|474168623|FG000|Overall Study|Protocol Violation|1|||
131695698|NCT00652366|474168624|FG001|Overall Study|Protocol Violation|0|||
131695699|NCT00652366|474168625|FG002|Overall Study|Protocol Violation|0|||
131695700|NCT00652366|474168626|FG003|Overall Study|Protocol Violation|0|||
131695701|NCT00652366|474168627|FG004|Overall Study|Protocol Violation|0|||
131695702|NCT00652366|474168623|FG000|Overall Study|Refused treatment|3|||
131695703|NCT00652366|474168624|FG001|Overall Study|Refused treatment|7|||
131695704|NCT00652366|474168625|FG002|Overall Study|Refused treatment|6|||
131695705|NCT00652366|474168626|FG003|Overall Study|Refused treatment|17|||
131695706|NCT00652366|474168627|FG004|Overall Study|Refused treatment|5|||
131695707|NCT00652366|474168623|FG000|Overall Study|Other|5|||
131695708|NCT00652366|474168624|FG001|Overall Study|Other|2|||
131695709|NCT00652366|474168625|FG002|Overall Study|Other|3|||
131695710|NCT00652366|474168626|FG003|Overall Study|Other|4|||
131695711|NCT00652366|474168627|FG004|Overall Study|Other|0|||
131695712|NCT02069899|474168632|FG000|Overall Study|Adverse Event|6|||
131695713|NCT02069899|474168633|FG001|Overall Study|Adverse Event|0|||
131695714|NCT02069899|474168634|FG002|Overall Study|Adverse Event|1|||
131695715|NCT02069899|474168632|FG000|Overall Study|Withdrawal by Participant|2|||
131695716|NCT02069899|474168633|FG001|Overall Study|Withdrawal by Participant|0|||
131695717|NCT02069899|474168634|FG002|Overall Study|Withdrawal by Participant|0|||
131695718|NCT02069899|474168632|FG000|Overall Study|Lost to Follow-up|1|||
131695719|NCT02069899|474168633|FG001|Overall Study|Lost to Follow-up|0|||
131695720|NCT02069899|474168634|FG002|Overall Study|Lost to Follow-up|1|||
131695721|NCT02069899|474168632|FG000|Overall Study|Other|4|||
131561915|NCT01163747|473682446|FG000|Overall Study|Insufficient Therapeutic Response|0|||
131561916|NCT01163747|473682447|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131561917|NCT01163747|473682446|FG000|Overall Study|Protocol Violation|0|||
131561918|NCT01163747|473682447|FG001|Overall Study|Protocol Violation|1|||
131561919|NCT01163747|473682446|FG000|Overall Study|Refused Treatment|6|||
131561920|NCT01163747|473682447|FG001|Overall Study|Refused Treatment|4|||
131561921|NCT03363659|473682448|FG000|Overall Study|Adverse Event|1|||
131561922|NCT03363659|473682448|FG000|Overall Study|Screen fail|1|||
131561923|NCT03363659|473682448|FG000|Overall Study|Withdrawal by Subject|1|||
131695722|NCT02069899|474168633|FG001|Overall Study|Other|0|||
131695723|NCT02069899|474168634|FG002|Overall Study|Other|0|||
131695724|NCT02069899|474168632|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
131561924|NCT01671748|473682449|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
131561925|NCT01671748|473682450|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
131561926|NCT01671748|473682449|FG000|4 Week run-in Phase|Adverse Event|1|||
131561927|NCT01671748|473682450|FG001|4 Week run-in Phase|Adverse Event|0|||
131561928|NCT01671748|473682449|FG000|4 Week run-in Phase|Not eligible|9|||
131561929|NCT01671748|473682450|FG001|4 Week run-in Phase|Not eligible|0|||
131561930|NCT03872388|473682451|FG000|Overall Study|Disease Progression|0|||
131561931|NCT03872388|473682452|FG001|Overall Study|Disease Progression|0|||
131561932|NCT03872388|473682453|FG002|Overall Study|Disease Progression|0|||
131561933|NCT03872388|473682454|FG003|Overall Study|Disease Progression|0|||
131561934|NCT03872388|473682455|FG004|Overall Study|Disease Progression|0|||
131561935|NCT03872388|473682456|FG005|Overall Study|Disease Progression|0|||
131561936|NCT03872388|473682457|FG006|Overall Study|Disease Progression|1|||
131561937|NCT03872388|473682458|FG007|Overall Study|Disease Progression|1|||
131561938|NCT02169830|473684392|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
131561939|NCT02169830|473684393|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
131561940|NCT02169830|473684394|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
131561941|NCT02169830|473684392|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
131561942|NCT02169830|473684393|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
131561943|NCT02169830|473684394|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
131561944|NCT02169830|473684392|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
131561945|NCT02169830|473684393|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
131561946|NCT02169830|473684394|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
131780650|NCT01956123|474477780|FG000|COS Cycle 2|Withdrawal by Subject|1|||
131780651|NCT01956123|474477781|FG001|COS Cycle 2|Withdrawal by Subject|0|||
131780652|NCT01956123|474477782|FG002|COS Cycle 2|Withdrawal by Subject|0|||
131780653|NCT01956123|474477783|FG003|COS Cycle 2|Withdrawal by Subject|0|||
131780654|NCT01956123|474477780|FG000|COS Cycle 3|Protocol Violation|0|||
131780655|NCT01956123|474477781|FG001|COS Cycle 3|Protocol Violation|0|||
131780656|NCT01956123|474477782|FG002|COS Cycle 3|Protocol Violation|2|||
131780657|NCT01956123|474477783|FG003|COS Cycle 3|Protocol Violation|1|||
131780658|NCT01956123|474477780|FG000|COS Cycle 3|Adverse Event|0|||
131780659|NCT01956123|474477781|FG001|COS Cycle 3|Adverse Event|0|||
131780660|NCT01956123|474477782|FG002|COS Cycle 3|Adverse Event|3|||
131780661|NCT01956123|474477783|FG003|COS Cycle 3|Adverse Event|0|||
131780662|NCT01956123|474477780|FG000|COS Cycle 3|Personal Reasons|0|||
131780663|NCT01956123|474477781|FG001|COS Cycle 3|Personal Reasons|0|||
131780664|NCT01956123|474477782|FG002|COS Cycle 3|Personal Reasons|1|||
131780665|NCT01956123|474477783|FG003|COS Cycle 3|Personal Reasons|0|||
131780666|NCT01956123|474477780|FG000|COS Cycle 3|Withdrawal by Subject|0|||
131780667|NCT01956123|474477781|FG001|COS Cycle 3|Withdrawal by Subject|0|||
131780668|NCT01956123|474477782|FG002|COS Cycle 3|Withdrawal by Subject|0|||
131780669|NCT01956123|474477783|FG003|COS Cycle 3|Withdrawal by Subject|1|||
131780670|NCT02545868|474477788|FG000|Overall Study|Lack of Efficacy|1|||
131780671|NCT02545868|474477789|FG001|Overall Study|Lack of Efficacy|1|||
131780672|NCT02545868|474477790|FG002|Overall Study|Lack of Efficacy|0|||
131780673|NCT02545868|474477788|FG000|Overall Study|Lost to Follow-up|1|||
131780674|NCT02545868|474477789|FG001|Overall Study|Lost to Follow-up|5|||
131780675|NCT02545868|474477790|FG002|Overall Study|Lost to Follow-up|1|||
131780676|NCT02545868|474477788|FG000|Overall Study|Non-compliance|1|||
131780677|NCT02545868|474477789|FG001|Overall Study|Non-compliance|1|||
131780678|NCT02545868|474477790|FG002|Overall Study|Non-compliance|1|||
131780679|NCT02545868|474477788|FG000|Overall Study|Treatment change|21|||
131780680|NCT02545868|474477789|FG001|Overall Study|Treatment change|19|||
131780681|NCT02545868|474477790|FG002|Overall Study|Treatment change|22|||
131780682|NCT02545868|474477788|FG000|Overall Study|Physician Decision|1|||
131780683|NCT02545868|474477789|FG001|Overall Study|Physician Decision|1|||
131780684|NCT02545868|474477790|FG002|Overall Study|Physician Decision|1|||
131780685|NCT02545868|474477788|FG000|Overall Study|Withdrawal by Subject|6|||
131780686|NCT02545868|474477789|FG001|Overall Study|Withdrawal by Subject|7|||
131780687|NCT02545868|474477790|FG002|Overall Study|Withdrawal by Subject|9|||
131780688|NCT01777191|474477791|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
131780689|NCT01777191|474477792|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
131780690|NCT01777191|474477791|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
131561947|NCT02169830|473684392|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
131780691|NCT01777191|474477792|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
131780692|NCT01777191|474477791|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
131780693|NCT01777191|474477792|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
131898592|NCT00534638|474914153|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
131561948|NCT02169830|473684393|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
131561949|NCT02169830|473684394|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
131561950|NCT02169830|473684392|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
131780694|NCT01777191|474477791|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
131561951|NCT02169830|473684393|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
131561952|NCT02169830|473684394|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
131561953|NCT03204695|473684395|FG000|Overall Study|Death|1|||
131561954|NCT03204695|473684395|FG000|Overall Study|Participant was treated with another device|1|||
131561955|NCT03204695|473684395|FG000|Overall Study|Physician Decision|2|||
131561956|NCT04834362|473684396|FG000|Overall Study|Death|1|||
131561957|NCT04834362|473684397|FG001|Overall Study|Death|2|||
131561958|NCT01349829|473684400|FG000|Overall Study|Lost to Follow-up|4|||
131561959|NCT01349829|473684401|FG001|Overall Study|Lost to Follow-up|8|||
131561960|NCT01349829|473684400|FG000|Overall Study|Consent withdrawal|3|||
131561961|NCT01349829|473684401|FG001|Overall Study|Consent withdrawal|8|||
131561962|NCT01349829|473684400|FG000|Overall Study|Migrated/moved|2|||
131561963|NCT01349829|473684401|FG001|Overall Study|Migrated/moved|7|||
131561964|NCT02555371|473684402|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
131561965|NCT02555371|473684403|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
131561966|NCT02555371|473684404|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
131561967|NCT02555371|473684405|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
131561968|NCT02555371|473684406|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
131561969|NCT02555371|473684402|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
131561970|NCT02555371|473684403|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
131561971|NCT02555371|473684404|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
131561972|NCT02555371|473684405|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
131561973|NCT02555371|473684406|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
131561974|NCT02555371|473684402|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
131780695|NCT01777191|474477792|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
131780696|NCT01777191|474477791|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
131780697|NCT01777191|474477792|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
131780698|NCT01777191|474477791|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
131780699|NCT01777191|474477792|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
131780700|NCT01777191|474477791|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
131780701|NCT01777191|474477792|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
131561975|NCT02555371|473684403|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
131561976|NCT02555371|473684404|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
131561977|NCT02555371|473684405|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
131561978|NCT02555371|473684406|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
131561979|NCT02555371|473684402|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
131780702|NCT01777191|474477791|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
131561980|NCT02555371|473684403|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
131561981|NCT02555371|473684404|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
131561982|NCT02555371|473684405|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
131561983|NCT02555371|473684406|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
131561984|NCT02555371|473684402|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
131561985|NCT02555371|473684403|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
131561986|NCT02555371|473684404|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
131561987|NCT02555371|473684405|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
131561988|NCT02555371|473684406|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
131561989|NCT02555371|473684402|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
131561990|NCT02555371|473684403|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
131561991|NCT02555371|473684404|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
131561992|NCT02555371|473684405|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
131561993|NCT02555371|473684406|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
131561994|NCT02555371|473684402|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
131561995|NCT02555371|473684403|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
131561996|NCT02555371|473684404|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
131561997|NCT02555371|473684405|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
131561998|NCT02555371|473684406|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
131561999|NCT02555371|473684402|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
131562000|NCT02555371|473684403|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
131562001|NCT02555371|473684404|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
131695725|NCT02069899|474168633|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
131695726|NCT02069899|474168634|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
131695727|NCT02069899|474168632|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
131695728|NCT02069899|474168633|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
131695729|NCT02069899|474168634|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
131695730|NCT00490451|474168637|FG000|Overall Study|Adverse Event|3|||
131695731|NCT00490451|474168638|FG001|Overall Study|Adverse Event|3|||
131695732|NCT00490451|474168637|FG000|Overall Study|Death|3|||
131780703|NCT01777191|474477792|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
131562002|NCT02555371|473684405|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
131562003|NCT02555371|473684406|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
131562004|NCT02555371|473684402|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
131562005|NCT02555371|473684403|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
131562006|NCT02555371|473684404|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
131562007|NCT02555371|473684405|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
131562008|NCT02555371|473684406|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
131562009|NCT02555371|473684402|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
131562010|NCT02555371|473684403|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
131562011|NCT02555371|473684404|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
131562012|NCT02555371|473684405|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
131562013|NCT02555371|473684406|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
131562014|NCT02555371|473684402|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
131562015|NCT02555371|473684403|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
131562016|NCT02555371|473684404|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
131562017|NCT02555371|473684405|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
131562018|NCT02555371|473684406|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
131562019|NCT02555371|473684402|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
131562020|NCT02555371|473684403|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
131562021|NCT02555371|473684404|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
131562022|NCT02555371|473684405|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
131562023|NCT02555371|473684406|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
131562024|NCT02555371|473684402|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
131562025|NCT02555371|473684403|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
131562026|NCT02555371|473684404|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
131562027|NCT02555371|473684405|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
131562028|NCT02555371|473684406|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
131562029|NCT02555371|473684402|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
131562030|NCT02555371|473684403|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
131562031|NCT02555371|473684404|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
131780704|NCT01777191|474477791|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
131780705|NCT01777191|474477792|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
131780706|NCT01777191|474477791|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
131780707|NCT01777191|474477792|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
131780708|NCT01777191|474477791|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
131780709|NCT01777191|474477792|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
131780710|NCT00602979|474477793|FG000|Overall Study|Lost to Follow-up|3|||
131780711|NCT00602979|474477794|FG001|Overall Study|Lost to Follow-up|2|||
131780712|NCT00602979|474477795|FG002|Overall Study|Lost to Follow-up|3|||
131780713|NCT00602979|474477796|FG003|Overall Study|Lost to Follow-up|2|||
131780714|NCT00602979|474477797|FG004|Overall Study|Lost to Follow-up|3|||
131780715|NCT00602979|474477793|FG000|Overall Study|Failed Intubation|0|||
131780716|NCT00602979|474477794|FG001|Overall Study|Failed Intubation|1|||
131780717|NCT00602979|474477795|FG002|Overall Study|Failed Intubation|0|||
131780718|NCT00602979|474477796|FG003|Overall Study|Failed Intubation|1|||
131780719|NCT00602979|474477797|FG004|Overall Study|Failed Intubation|0|||
131780720|NCT01052038|474477798|FG000|Overall Study|Lost to Follow-up|2|||
131780721|NCT01052038|474477799|FG001|Overall Study|Lost to Follow-up|3|||
131780722|NCT01052038|474477800|FG002|Overall Study|Lost to Follow-up|1|||
131780723|NCT01052038|474477798|FG000|Overall Study|Protocol Violation|2|||
131780724|NCT01052038|474477799|FG001|Overall Study|Protocol Violation|3|||
131780725|NCT01052038|474477800|FG002|Overall Study|Protocol Violation|3|||
131780726|NCT03349437|474477801|FG000|Screening|Screen Fail|4|||
131780727|NCT03349437|474477802|FG001|Screening|Screen Fail|0|||
131780728|NCT03349437|474477803|FG002|Screening|Screen Fail|0|||
131562032|NCT02555371|473684405|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
131562033|NCT02555371|473684406|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
131562034|NCT03095599|473684407|FG000|Overall Study|Withdrawal by Subject|1|||
131562035|NCT03095599|473684408|FG001|Overall Study|Withdrawal by Subject|0|||
131562036|NCT03095599|473684407|FG000|Overall Study|Lost to Follow-up|1|||
131562037|NCT03095599|473684408|FG001|Overall Study|Lost to Follow-up|0|||
131562038|NCT03095599|473684407|FG000|Overall Study|Withdrawal prior to vaccination|1|||
131562039|NCT03095599|473684408|FG001|Overall Study|Withdrawal prior to vaccination|0|||
131780729|NCT03349437|474477801|FG000|Screening|Withdrawn|1|||
131780730|NCT03349437|474477802|FG001|Screening|Withdrawn|0|||
131562040|NCT00513019|473684410|FG000|Overall Study|Adverse Event|1|||
131562041|NCT00513019|473684411|FG001|Overall Study|Adverse Event|0|||
131562042|NCT00513019|473684410|FG000|Overall Study|Withdrawal by Subject|4|||
131562043|NCT00513019|473684411|FG001|Overall Study|Withdrawal by Subject|5|||
131562044|NCT01995357|473684412|FG000|Period 5|Lack of Efficacy|1|||
131562045|NCT01995357|473684413|FG001|Period 5|Lack of Efficacy|0|||
131562046|NCT01995357|473684414|FG002|Period 5|Lack of Efficacy|0|||
131562047|NCT01995357|473684415|FG003|Period 5|Lack of Efficacy|0|||
131562048|NCT01995357|473684416|FG004|Period 5|Lack of Efficacy|0|||
131562049|NCT01995357|473684417|FG005|Period 5|Lack of Efficacy|0|||
131562050|NCT01995357|473684412|FG000|Period 5|Adverse Event|1|||
131562051|NCT01995357|473684413|FG001|Period 5|Adverse Event|0|||
131562052|NCT01995357|473684414|FG002|Period 5|Adverse Event|1|||
131562053|NCT01995357|473684415|FG003|Period 5|Adverse Event|0|||
131562054|NCT01995357|473684416|FG004|Period 5|Adverse Event|0|||
131562055|NCT01995357|473684417|FG005|Period 5|Adverse Event|0|||
131562056|NCT03615482|473684418|FG000|Overall Study|Death|1|||
131562057|NCT03615482|473684419|FG001|Overall Study|Death|0|||
131562058|NCT03615482|473684418|FG000|Overall Study|Lost to Follow-up|7|||
131562059|NCT03615482|473684419|FG001|Overall Study|Lost to Follow-up|7|||
131562060|NCT03615482|473684418|FG000|Overall Study|Physician Decision|2|||
131562061|NCT03615482|473684419|FG001|Overall Study|Physician Decision|3|||
131562062|NCT03615482|473684418|FG000|Overall Study|Withdrawal by Subject|7|||
131562063|NCT03615482|473684419|FG001|Overall Study|Withdrawal by Subject|7|||
131562064|NCT01500226|473684422|FG000|Overall Study|Adverse Event|31|||
131562065|NCT01500226|473684423|FG001|Overall Study|Adverse Event|38|||
131562066|NCT01500226|473684422|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
131562067|NCT01500226|473684423|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
131562068|NCT01500226|473684422|FG000|Overall Study|Withdrawal by Subject|93|||
131562069|NCT01500226|473684423|FG001|Overall Study|Withdrawal by Subject|96|||
131562070|NCT01500226|473684422|FG000|Overall Study|Death|12|||
131562071|NCT01500226|473684423|FG001|Overall Study|Death|4|||
131562072|NCT01500226|473684422|FG000|Overall Study|Disease Progression|16|||
131562073|NCT01500226|473684423|FG001|Overall Study|Disease Progression|14|||
131562074|NCT01500226|473684422|FG000|Overall Study|Protocol Violation|53|||
131562075|NCT01500226|473684423|FG001|Overall Study|Protocol Violation|39|||
131562076|NCT01500226|473684422|FG000|Overall Study|Physician Decision|17|||
131562077|NCT01500226|473684423|FG001|Overall Study|Physician Decision|15|||
131562078|NCT01500226|473684422|FG000|Overall Study|Lack of Efficacy|14|||
131562079|NCT01500226|473684423|FG001|Overall Study|Lack of Efficacy|30|||
131562080|NCT01500226|473684422|FG000|Overall Study|Lost to Follow-up|9|||
131562081|NCT01500226|473684423|FG001|Overall Study|Lost to Follow-up|5|||
131562082|NCT01500226|473684422|FG000|Overall Study|Other Reasons|19|||
131562083|NCT01500226|473684423|FG001|Overall Study|Other Reasons|16|||
131562084|NCT02955277|473684424|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
131562085|NCT02955277|473684425|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
131562086|NCT02955277|473684424|FG000|Post to Follow-up|Lost to Follow-up|8|||
131562087|NCT02955277|473684425|FG001|Post to Follow-up|Lost to Follow-up|11|||
131562088|NCT01668147|473684436|FG000|Overall Study|Withdrawal by Subject|6|||
131562089|NCT01809210|473684437|FG000|Overall Study|Withdrawal by Subject|0|||
131562090|NCT01809210|473684438|FG001|Overall Study|Withdrawal by Subject|0|||
131562091|NCT01809210|473684439|FG002|Overall Study|Withdrawal by Subject|1|||
131562092|NCT01809210|473684440|FG003|Overall Study|Withdrawal by Subject|1|||
131562093|NCT01809210|473684441|FG004|Overall Study|Withdrawal by Subject|1|||
131562094|NCT01809210|473684442|FG005|Overall Study|Withdrawal by Subject|0|||
131562095|NCT01809210|473684443|FG006|Overall Study|Withdrawal by Subject|4|||
131562096|NCT01809210|473684437|FG000|Overall Study|Death|1|||
131562097|NCT01809210|473684438|FG001|Overall Study|Death|1|||
131562098|NCT01809210|473684439|FG002|Overall Study|Death|2|||
131562099|NCT01809210|473684440|FG003|Overall Study|Death|0|||
131562100|NCT01809210|473684441|FG004|Overall Study|Death|1|||
131695733|NCT00490451|474168638|FG001|Overall Study|Death|1|||
131695734|NCT00490451|474168637|FG000|Overall Study|Withdrawal by Subject|2|||
131695735|NCT00490451|474168638|FG001|Overall Study|Withdrawal by Subject|0|||
131562101|NCT01809210|473684442|FG005|Overall Study|Death|3|||
131562102|NCT01809210|473684443|FG006|Overall Study|Death|1|||
131562103|NCT00590980|473684444|FG000|Overall Study|Did not meet all inclusion criteria|10|||
131562104|NCT03699124|473684447|FG000|Overall Study|Adverse Event|6|||
131562105|NCT03699124|473684448|FG001|Overall Study|Adverse Event|5|||
131562106|NCT03699124|473684449|FG002|Overall Study|Adverse Event|2|||
131562107|NCT03699124|473684447|FG000|Overall Study|Death|0|||
131562108|NCT03699124|473684448|FG001|Overall Study|Death|2|||
131562109|NCT03699124|473684449|FG002|Overall Study|Death|0|||
131562110|NCT03699124|473684447|FG000|Overall Study|Lost to Follow-up|20|||
131562111|NCT03699124|473684448|FG001|Overall Study|Lost to Follow-up|16|||
131562112|NCT03699124|473684449|FG002|Overall Study|Lost to Follow-up|15|||
131562113|NCT03699124|473684447|FG000|Overall Study|Protocol Violation|1|||
131562114|NCT03699124|473684448|FG001|Overall Study|Protocol Violation|0|||
131562115|NCT03699124|473684449|FG002|Overall Study|Protocol Violation|0|||
131562116|NCT03699124|473684447|FG000|Overall Study|Withdrawal by Subject|13|||
131695736|NCT00490451|474168637|FG000|Overall Study|Investigator Decision|1|||
131780731|NCT03349437|474477803|FG002|Screening|Withdrawn|0|||
131780732|NCT01461369|474477804|FG000|Overall Study|Lack of Efficacy|2|||
131780733|NCT01461369|474477805|FG001|Overall Study|Lack of Efficacy|0|||
131780734|NCT01461369|474477806|FG002|Overall Study|Lack of Efficacy|6|||
131780735|NCT01461369|474477804|FG000|Overall Study|Lost to Follow-up|0|||
131780736|NCT01461369|474477805|FG001|Overall Study|Lost to Follow-up|0|||
131780737|NCT01461369|474477806|FG002|Overall Study|Lost to Follow-up|3|||
131780738|NCT01461369|474477804|FG000|Overall Study|Adverse Event|9|||
131780739|NCT01461369|474477805|FG001|Overall Study|Adverse Event|12|||
131780740|NCT01461369|474477806|FG002|Overall Study|Adverse Event|4|||
131780741|NCT01461369|474477804|FG000|Overall Study|Protocol Violation|1|||
131780742|NCT01461369|474477805|FG001|Overall Study|Protocol Violation|2|||
131780743|NCT01461369|474477806|FG002|Overall Study|Protocol Violation|2|||
131780744|NCT01461369|474477804|FG000|Overall Study|Withdrawal by Subject|1|||
131780745|NCT01461369|474477805|FG001|Overall Study|Withdrawal by Subject|3|||
131780746|NCT01461369|474477806|FG002|Overall Study|Withdrawal by Subject|2|||
131780747|NCT01563029|474477809|FG000|Overall Study|Adverse Event|1|||
131780748|NCT01563029|474477810|FG001|Overall Study|Adverse Event|0|||
131780749|NCT01563029|474477811|FG002|Overall Study|Adverse Event|1|||
131780750|NCT01563029|474477812|FG003|Overall Study|Adverse Event|2|||
131780751|NCT01563029|474477813|FG004|Overall Study|Adverse Event|1|||
131780752|NCT01563029|474477809|FG000|Overall Study|Lack of Efficacy|42|||
131780753|NCT01563029|474477810|FG001|Overall Study|Lack of Efficacy|16|||
131780754|NCT01563029|474477811|FG002|Overall Study|Lack of Efficacy|23|||
131780755|NCT01563029|474477812|FG003|Overall Study|Lack of Efficacy|21|||
131780756|NCT01563029|474477813|FG004|Overall Study|Lack of Efficacy|19|||
131780757|NCT01563029|474477809|FG000|Overall Study|Protocol Violation|1|||
131780758|NCT01563029|474477810|FG001|Overall Study|Protocol Violation|2|||
131780759|NCT01563029|474477811|FG002|Overall Study|Protocol Violation|3|||
131780760|NCT01563029|474477812|FG003|Overall Study|Protocol Violation|1|||
131780761|NCT01563029|474477813|FG004|Overall Study|Protocol Violation|3|||
131780762|NCT01563029|474477809|FG000|Overall Study|Protocol defined stopping criteria|1|||
131780763|NCT01563029|474477810|FG001|Overall Study|Protocol defined stopping criteria|0|||
131780764|NCT01563029|474477811|FG002|Overall Study|Protocol defined stopping criteria|0|||
131780765|NCT01563029|474477812|FG003|Overall Study|Protocol defined stopping criteria|0|||
131780766|NCT01563029|474477813|FG004|Overall Study|Protocol defined stopping criteria|0|||
131780767|NCT01563029|474477809|FG000|Overall Study|Lost to Follow-up|1|||
131780768|NCT01563029|474477810|FG001|Overall Study|Lost to Follow-up|0|||
131780769|NCT01563029|474477811|FG002|Overall Study|Lost to Follow-up|1|||
131780770|NCT01563029|474477812|FG003|Overall Study|Lost to Follow-up|1|||
131780771|NCT01563029|474477813|FG004|Overall Study|Lost to Follow-up|1|||
131780772|NCT01563029|474477809|FG000|Overall Study|Physician Decision|3|||
131780773|NCT01563029|474477810|FG001|Overall Study|Physician Decision|5|||
131780774|NCT01563029|474477811|FG002|Overall Study|Physician Decision|2|||
131780775|NCT01563029|474477812|FG003|Overall Study|Physician Decision|4|||
131780776|NCT01563029|474477813|FG004|Overall Study|Physician Decision|2|||
131780777|NCT01563029|474477809|FG000|Overall Study|Withdrawal by Subject|4|||
131780778|NCT01563029|474477810|FG001|Overall Study|Withdrawal by Subject|1|||
131780779|NCT01563029|474477811|FG002|Overall Study|Withdrawal by Subject|3|||
131780780|NCT01563029|474477812|FG003|Overall Study|Withdrawal by Subject|4|||
131780781|NCT01563029|474477813|FG004|Overall Study|Withdrawal by Subject|3|||
131780782|NCT01569594|474477814|FG000|Overall Study|Physician Decision|4|||
131780783|NCT01569594|474477814|FG000|Overall Study|Death|13|||
131780784|NCT01569594|474477814|FG000|Overall Study|Lost to Follow-up|22|||
131780785|NCT01569594|474477814|FG000|Overall Study|Adverse Event|2|||
131780786|NCT01569594|474477814|FG000|Overall Study|Withdrawal by Subject|13|||
131780787|NCT01569594|474477814|FG000|Overall Study|Other|4|||
131780788|NCT01569594|474477814|FG000|Overall Study|No ECM used|9|||
131780789|NCT01826201|474477817|FG000|Overall Study|Non compliance with protocol|4|||
131780790|NCT01615822|474477818|FG000|Period 1|Withdrawal by Subject|0|||
131780791|NCT01615822|474477819|FG001|Period 1|Withdrawal by Subject|1|||
131780792|NCT01615822|474477820|FG002|Period 1|Withdrawal by Subject|0|||
131780793|NCT01615822|474477818|FG000|Period 1|Adverse Event|1|||
131780794|NCT01615822|474477819|FG001|Period 1|Adverse Event|1|||
131780795|NCT01615822|474477820|FG002|Period 1|Adverse Event|0|||
131780796|NCT01615822|474477818|FG000|Period 2|Lost to Follow-up|0|||
131780797|NCT01615822|474477819|FG001|Period 2|Lost to Follow-up|1|||
131780798|NCT01615822|474477820|FG002|Period 2|Lost to Follow-up|2|||
131780799|NCT02861534|474477821|FG000|Overall Study|Death|541|||
131780800|NCT02861534|474477822|FG001|Overall Study|Death|552|||
131780801|NCT02861534|474477821|FG000|Overall Study|Lost to Follow-up|14|||
131780802|NCT02861534|474477822|FG001|Overall Study|Lost to Follow-up|14|||
131780803|NCT02861534|474477821|FG000|Overall Study|Site Terminated by Sponsor|4|||
131780804|NCT02861534|474477822|FG001|Overall Study|Site Terminated by Sponsor|3|||
131780805|NCT02861534|474477821|FG000|Overall Study|Withdrawal by Subject|15|||
131780806|NCT02861534|474477822|FG001|Overall Study|Withdrawal by Subject|18|||
131780807|NCT00916617|474477825|FG000|Overall Study|Adverse Event|3|||
131780808|NCT00916617|474477826|FG001|Overall Study|Adverse Event|2|||
131780809|NCT00916617|474477827|FG002|Overall Study|Adverse Event|6|||
131780810|NCT00916617|474477828|FG003|Overall Study|Adverse Event|3|||
131780811|NCT00916617|474477825|FG000|Overall Study|Withdrawal by Subject|3|||
131780812|NCT00916617|474477826|FG001|Overall Study|Withdrawal by Subject|2|||
131780813|NCT00916617|474477827|FG002|Overall Study|Withdrawal by Subject|0|||
131780814|NCT00916617|474477828|FG003|Overall Study|Withdrawal by Subject|1|||
131780815|NCT00916617|474477825|FG000|Overall Study|Caregiver Request|3|||
131780816|NCT00916617|474477826|FG001|Overall Study|Caregiver Request|2|||
131780817|NCT00916617|474477827|FG002|Overall Study|Caregiver Request|1|||
131780818|NCT00916617|474477828|FG003|Overall Study|Caregiver Request|0|||
131780819|NCT00916617|474477825|FG000|Overall Study|Physician Decision|1|||
131780820|NCT00916617|474477826|FG001|Overall Study|Physician Decision|1|||
131780821|NCT00916617|474477827|FG002|Overall Study|Physician Decision|0|||
131780822|NCT00916617|474477828|FG003|Overall Study|Physician Decision|0|||
131780823|NCT00916617|474477825|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
131780824|NCT00916617|474477826|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
131780825|NCT00916617|474477827|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
131780826|NCT00916617|474477828|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
131780827|NCT00916617|474477825|FG000|Overall Study|Lost to Follow-up|2|||
131780828|NCT00916617|474477826|FG001|Overall Study|Lost to Follow-up|1|||
131780829|NCT00916617|474477827|FG002|Overall Study|Lost to Follow-up|0|||
131780830|NCT00916617|474477828|FG003|Overall Study|Lost to Follow-up|0|||
131780831|NCT00916617|474477825|FG000|Overall Study|Lack of Efficacy|1|||
131780832|NCT00916617|474477826|FG001|Overall Study|Lack of Efficacy|0|||
131780833|NCT00916617|474477827|FG002|Overall Study|Lack of Efficacy|0|||
131780834|NCT00916617|474477828|FG003|Overall Study|Lack of Efficacy|0|||
131780835|NCT00916617|474477825|FG000|Overall Study|Other|2|||
131780836|NCT00916617|474477826|FG001|Overall Study|Other|0|||
131780837|NCT00916617|474477827|FG002|Overall Study|Other|0|||
131780838|NCT00916617|474477828|FG003|Overall Study|Other|2|||
131780839|NCT01988337|474477831|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
131780840|NCT02742818|474477832|FG000|Overall Study|Adverse Event|0|||
131780841|NCT02742818|474477833|FG001|Overall Study|Adverse Event|1|||
131780842|NCT02742818|474477832|FG000|Overall Study|Protocol Violation|0|||
131780843|NCT02742818|474477833|FG001|Overall Study|Protocol Violation|1|||
131780844|NCT01260194|474477835|FG000|Overall Study|Withdrawal of Consent|1|||
131780845|NCT01569074|474477837|FG000|Overall Study|Study stopped|6|||
131780846|NCT01569074|474477838|FG001|Overall Study|Study stopped|6|||
131780847|NCT01569074|474477839|FG002|Overall Study|Study stopped|8|||
131780848|NCT01569074|474477840|FG003|Overall Study|Study stopped|7|||
131780849|NCT01569074|474477841|FG004|Overall Study|Study stopped|7|||
131780850|NCT01569074|474477837|FG000|Overall Study|Study-specific discontinuation criteria|0|||
131780851|NCT01569074|474477838|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131780852|NCT01569074|474477839|FG002|Overall Study|Study-specific discontinuation criteria|0|||
131780853|NCT01569074|474477840|FG003|Overall Study|Study-specific discontinuation criteria|0|||
131780854|NCT01569074|474477841|FG004|Overall Study|Study-specific discontinuation criteria|0|||
131780855|NCT01569074|474477837|FG000|Overall Study|Severe non-compliance to protocol|0|||
131780856|NCT01569074|474477838|FG001|Overall Study|Severe non-compliance to protocol|0|||
131780857|NCT01569074|474477839|FG002|Overall Study|Severe non-compliance to protocol|1|||
131780858|NCT01569074|474477840|FG003|Overall Study|Severe non-compliance to protocol|0|||
131780859|NCT01569074|474477841|FG004|Overall Study|Severe non-compliance to protocol|0|||
131780860|NCT01569074|474477837|FG000|Overall Study|eg change in circumstances|0|||
131780861|NCT01569074|474477838|FG001|Overall Study|eg change in circumstances|2|||
131780862|NCT01569074|474477839|FG002|Overall Study|eg change in circumstances|0|||
131780863|NCT01569074|474477840|FG003|Overall Study|eg change in circumstances|1|||
131780864|NCT01569074|474477841|FG004|Overall Study|eg change in circumstances|1|||
131780865|NCT01569074|474477837|FG000|Overall Study|Adverse Event|1|||
131780866|NCT01569074|474477838|FG001|Overall Study|Adverse Event|0|||
131780867|NCT01569074|474477839|FG002|Overall Study|Adverse Event|3|||
131780868|NCT01569074|474477840|FG003|Overall Study|Adverse Event|0|||
131780869|NCT01569074|474477841|FG004|Overall Study|Adverse Event|0|||
131898593|NCT00534638|474914152|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
131780870|NCT03099161|474477842|FG000|Overall Study|Adverse Event|0|||
131780871|NCT03099161|474477843|FG001|Overall Study|Adverse Event|0|||
131898594|NCT00534638|474914153|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
131898595|NCT00534638|474914152|FG000|Overall Study|Other|1685|||
131780872|NCT03099161|474477844|FG002|Overall Study|Adverse Event|2|||
131780873|NCT03099161|474477842|FG000|Overall Study|Physician Decision|2|||
131780874|NCT03099161|474477843|FG001|Overall Study|Physician Decision|0|||
131780875|NCT03099161|474477844|FG002|Overall Study|Physician Decision|0|||
131780876|NCT03099161|474477842|FG000|Overall Study|Progressive Disease|1|||
131780877|NCT03099161|474477843|FG001|Overall Study|Progressive Disease|4|||
131780878|NCT03099161|474477844|FG002|Overall Study|Progressive Disease|1|||
131562117|NCT03699124|473684448|FG001|Overall Study|Withdrawal by Subject|14|||
131562118|NCT03699124|473684449|FG002|Overall Study|Withdrawal by Subject|13|||
131562119|NCT03699124|473684447|FG000|Overall Study|Other reasons|5|||
131562120|NCT03699124|473684448|FG001|Overall Study|Other reasons|3|||
131562121|NCT03699124|473684449|FG002|Overall Study|Other reasons|10|||
131562122|NCT01118962|473684452|FG000|Overall Study|Adverse Event|2|||
131562123|NCT01118962|473684452|FG000|Overall Study|Lack of Efficacy|1|||
131562124|NCT01118962|473684452|FG000|Overall Study|Protocol Violation|1|||
131562125|NCT01118962|473684452|FG000|Overall Study|Withdrawal by Subject|4|||
131562126|NCT01118962|473684452|FG000|Overall Study|Pregnancy|1|||
131562127|NCT01118962|473684452|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
131562128|NCT00795132|473684458|FG000|Overall Study|Death|1|||
131562129|NCT00795132|473684458|FG000|Overall Study|Relapse|2|||
131562130|NCT01567163|473684460|FG000|Overall Study|Progressive Disease|2|||
131562131|NCT01567163|473684460|FG000|Overall Study|Lost to Follow-up|2|||
131562132|NCT03405662|473684462|FG000|Overall Study|COVID-19 restriction|1|||
131562133|NCT03405662|473684463|FG001|Overall Study|COVID-19 restriction|0|||
131562134|NCT03405662|473684462|FG000|Overall Study|unblinding|0|||
131562135|NCT03405662|473684463|FG001|Overall Study|unblinding|1|||
131562136|NCT03405662|473684462|FG000|Overall Study|placement in memory care facility|0|||
131562137|NCT03405662|473684463|FG001|Overall Study|placement in memory care facility|2|||
131562138|NCT01177813|473684464|FG000|Overall Study|Adverse Event|8|||
131562139|NCT01177813|473684465|FG001|Overall Study|Adverse Event|2|||
131562140|NCT01177813|473684466|FG002|Overall Study|Adverse Event|4|||
131562141|NCT01177813|473684467|FG003|Overall Study|Adverse Event|6|||
131562142|NCT01177813|473684468|FG004|Overall Study|Adverse Event|3|||
131562143|NCT01177813|473684464|FG000|Overall Study|Lack of Efficacy|1|||
131562144|NCT01177813|473684465|FG001|Overall Study|Lack of Efficacy|0|||
131562145|NCT01177813|473684466|FG002|Overall Study|Lack of Efficacy|0|||
131562146|NCT01177813|473684467|FG003|Overall Study|Lack of Efficacy|0|||
131562147|NCT01177813|473684468|FG004|Overall Study|Lack of Efficacy|0|||
131562148|NCT01177813|473684464|FG000|Overall Study|Protocol Violation|3|||
131562149|NCT01177813|473684465|FG001|Overall Study|Protocol Violation|2|||
131562150|NCT01177813|473684466|FG002|Overall Study|Protocol Violation|2|||
131562151|NCT01177813|473684467|FG003|Overall Study|Protocol Violation|0|||
131562152|NCT01177813|473684468|FG004|Overall Study|Protocol Violation|1|||
131562153|NCT01177813|473684464|FG000|Overall Study|Lost to Follow-up|12|||
131562154|NCT01177813|473684465|FG001|Overall Study|Lost to Follow-up|5|||
131562155|NCT01177813|473684466|FG002|Overall Study|Lost to Follow-up|6|||
131562156|NCT01177813|473684467|FG003|Overall Study|Lost to Follow-up|3|||
131562157|NCT01177813|473684468|FG004|Overall Study|Lost to Follow-up|0|||
131562158|NCT01177813|473684464|FG000|Overall Study|Withdrawal by Subject|12|||
131562159|NCT01177813|473684465|FG001|Overall Study|Withdrawal by Subject|7|||
131562160|NCT01177813|473684466|FG002|Overall Study|Withdrawal by Subject|6|||
131562161|NCT01177813|473684467|FG003|Overall Study|Withdrawal by Subject|5|||
131562162|NCT01177813|473684468|FG004|Overall Study|Withdrawal by Subject|3|||
131562163|NCT01177813|473684464|FG000|Overall Study|Other reason not defined above|5|||
131562164|NCT01177813|473684465|FG001|Overall Study|Other reason not defined above|2|||
131562165|NCT01177813|473684466|FG002|Overall Study|Other reason not defined above|2|||
131562166|NCT01177813|473684467|FG003|Overall Study|Other reason not defined above|3|||
131562167|NCT01177813|473684468|FG004|Overall Study|Other reason not defined above|2|||
131695737|NCT00490451|474168638|FG001|Overall Study|Investigator Decision|0|||
131695738|NCT00490451|474168637|FG000|Overall Study|Protocol Violation|1|||
131695739|NCT00490451|474168638|FG001|Overall Study|Protocol Violation|0|||
131695740|NCT00490451|474168637|FG000|Overall Study|Progressive Disease|53|||
131695741|NCT00490451|474168638|FG001|Overall Study|Progressive Disease|34|||
131695742|NCT01181011|474168639|FG000|Overall Study|Adverse Event|2|||
131695743|NCT01181011|474168639|FG000|Overall Study|Lost to Follow-up|1|||
131695744|NCT00137111|474168640|FG000|Total Therapy|Death|35|||
131695745|NCT00137111|474168641|FG001|Total Therapy|Death|0|||
131695746|NCT00137111|474168642|FG002|Total Therapy|Death|0|||
131695747|NCT00137111|474168643|FG003|Total Therapy|Death|0|||
131695748|NCT00137111|474168640|FG000|Total Therapy|Non Compliance|5|||
131562168|NCT00109928|473684471|FG000|Overall Study|Adverse Event|2|||
131562169|NCT00109928|473684471|FG000|Overall Study|Progression|6|||
131562170|NCT00109928|473684471|FG000|Overall Study|Death|2|||
131562171|NCT00109928|473684471|FG000|Overall Study|not protocol specified|2|||
131562172|NCT00109928|473684471|FG000|Overall Study|not eligible|1|||
131562173|NCT01196104|473684472|FG000|Overall Study|Lost to Follow-up|1|||
131562174|NCT01196104|473684473|FG001|Overall Study|Lost to Follow-up|0|||
131562175|NCT01196104|473684472|FG000|Overall Study|Physician Decision|0|||
131562176|NCT01196104|473684473|FG001|Overall Study|Physician Decision|1|||
131562177|NCT01196104|473684472|FG000|Overall Study|Withdrawal by Subject|3|||
131562178|NCT01196104|473684473|FG001|Overall Study|Withdrawal by Subject|3|||
131562179|NCT01196104|473684472|FG000|Overall Study|Various|0|||
131695749|NCT00137111|474168641|FG001|Total Therapy|Non Compliance|0|||
131695750|NCT00137111|474168642|FG002|Total Therapy|Non Compliance|0|||
131562180|NCT01196104|473684473|FG001|Overall Study|Various|1|||
131562181|NCT00610675|473684474|FG000|Overall Study|Untreated|4|||
131562182|NCT00610675|473684474|FG000|Overall Study|Adverse Event|67|||
131562183|NCT00610675|473684474|FG000|Overall Study|Insufficient Effect|31|||
131562184|NCT00610675|473684474|FG000|Overall Study|Withdrawal by Subject|28|||
131562185|NCT00610675|473684474|FG000|Overall Study|Reasons unrelated to trial|27|||
131562186|NCT00610675|473684474|FG000|Overall Study|Lack of Compliance|7|||
131562187|NCT00610675|473684474|FG000|Overall Study|Lost to Follow-up|31|||
131562188|NCT00610675|473684474|FG000|Overall Study|Other reason (not specified)|25|||
131562189|NCT01316692|473684479|FG000|Overall Study|Adverse Event|5|||
131562190|NCT01316692|473684479|FG000|Overall Study|Disease Progression|7|||
131562191|NCT00983619|473684483|FG000|Overall Study|Lost to Follow-up|0|||
131562192|NCT00983619|473684484|FG001|Overall Study|Lost to Follow-up|1|||
131562193|NCT00983619|473684485|FG002|Overall Study|Lost to Follow-up|0|||
131562194|NCT00983619|473684486|FG003|Overall Study|Lost to Follow-up|0|||
131562195|NCT00983619|473684487|FG004|Overall Study|Lost to Follow-up|0|||
131562196|NCT00983619|473684488|FG005|Overall Study|Lost to Follow-up|2|||
131562197|NCT00983619|473684489|FG006|Overall Study|Lost to Follow-up|0|||
131562198|NCT00983619|473684490|FG007|Overall Study|Lost to Follow-up|0|||
131562199|NCT00983619|473684491|FG008|Overall Study|Lost to Follow-up|0|||
131562200|NCT00983619|473684492|FG009|Overall Study|Lost to Follow-up|0|||
131562201|NCT00983619|473684493|FG010|Overall Study|Lost to Follow-up|0|||
131562202|NCT00983619|473684494|FG011|Overall Study|Lost to Follow-up|2|||
131562203|NCT00983619|473684483|FG000|Overall Study|Withdrawal by Subject|2|||
131562204|NCT00983619|473684484|FG001|Overall Study|Withdrawal by Subject|1|||
131562205|NCT00983619|473684485|FG002|Overall Study|Withdrawal by Subject|1|||
131562206|NCT00983619|473684486|FG003|Overall Study|Withdrawal by Subject|3|||
131562207|NCT00983619|473684487|FG004|Overall Study|Withdrawal by Subject|1|||
131562208|NCT00983619|473684488|FG005|Overall Study|Withdrawal by Subject|23|||
131562209|NCT00983619|473684489|FG006|Overall Study|Withdrawal by Subject|0|||
131562210|NCT00983619|473684490|FG007|Overall Study|Withdrawal by Subject|0|||
131562211|NCT00983619|473684491|FG008|Overall Study|Withdrawal by Subject|0|||
131562212|NCT00983619|473684492|FG009|Overall Study|Withdrawal by Subject|0|||
131562213|NCT00983619|473684493|FG010|Overall Study|Withdrawal by Subject|1|||
131562214|NCT00983619|473684494|FG011|Overall Study|Withdrawal by Subject|1|||
131562215|NCT00983619|473684483|FG000|Overall Study|Death|0|||
131695751|NCT00137111|474168643|FG003|Total Therapy|Non Compliance|0|||
131780879|NCT02723786|474477848|FG000|Overall Study|Lost to Follow-up|1|||
131780880|NCT00556166|474477860|FG000|Overall Study|Withdrawal by Subject|1|||
131562216|NCT00983619|473684484|FG001|Overall Study|Death|2|||
131695752|NCT02788747|474168644|FG000|Overall Study|Adverse Event|1|||
131695753|NCT02788747|474168645|FG001|Overall Study|Adverse Event|0|||
131695754|NCT02788747|474168646|FG002|Overall Study|Adverse Event|0|||
131695755|NCT02425826|474168649|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
131695756|NCT02425826|474168650|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
131695757|NCT02425826|474168651|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
131695758|NCT02425826|474168649|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
131695759|NCT02425826|474168650|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
131695760|NCT02425826|474168651|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
131695761|NCT02425826|474168649|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
131695762|NCT02425826|474168650|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
131695763|NCT02425826|474168651|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
131695764|NCT02425826|474168649|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
131695765|NCT02425826|474168650|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
131695766|NCT02425826|474168651|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
131695767|NCT02425826|474168649|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
131695768|NCT02425826|474168650|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
131695769|NCT02425826|474168651|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
131695770|NCT02425826|474168649|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
131695771|NCT02425826|474168650|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
131695772|NCT02425826|474168651|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
131695773|NCT02425826|474168649|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
131780881|NCT02985515|474477863|FG000|Olfaction Testing|Lost to Follow-up|0|||
131898596|NCT00534638|474914153|FG001|Overall Study|Other|902|||
131562217|NCT00983619|473684485|FG002|Overall Study|Death|2|||
131695774|NCT02425826|474168650|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
131695775|NCT02425826|474168651|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
131898597|NCT04162795|474914156|FG000|Overall Study|Other|16|||
131562218|NCT00983619|473684486|FG003|Overall Study|Death|1|||
131562219|NCT00983619|473684487|FG004|Overall Study|Death|2|||
131562220|NCT00983619|473684488|FG005|Overall Study|Death|30|||
131562221|NCT00983619|473684489|FG006|Overall Study|Death|1|||
131562222|NCT00983619|473684490|FG007|Overall Study|Death|0|||
131562223|NCT00983619|473684491|FG008|Overall Study|Death|1|||
131562224|NCT00983619|473684492|FG009|Overall Study|Death|2|||
131562225|NCT00983619|473684493|FG010|Overall Study|Death|9|||
131562226|NCT00983619|473684494|FG011|Overall Study|Death|8|||
131562227|NCT00983619|473684483|FG000|Overall Study|Other|1|||
131562228|NCT00983619|473684484|FG001|Overall Study|Other|0|||
131562229|NCT00983619|473684485|FG002|Overall Study|Other|0|||
131562230|NCT00983619|473684486|FG003|Overall Study|Other|1|||
131562231|NCT00983619|473684487|FG004|Overall Study|Other|0|||
131562232|NCT00983619|473684488|FG005|Overall Study|Other|12|||
131562233|NCT00983619|473684489|FG006|Overall Study|Other|2|||
131562234|NCT00983619|473684490|FG007|Overall Study|Other|2|||
131562235|NCT00983619|473684491|FG008|Overall Study|Other|0|||
131562236|NCT00983619|473684492|FG009|Overall Study|Other|1|||
131562237|NCT00983619|473684493|FG010|Overall Study|Other|1|||
131562238|NCT00983619|473684494|FG011|Overall Study|Other|0|||
131562239|NCT04011384|473684503|FG000|Overall Study|Withdrawal by Subject|2|||
131562240|NCT04011384|473684504|FG001|Overall Study|Withdrawal by Subject|0|||
131562241|NCT01686932|473684505|FG000|Period 1|Adverse Event|1|||
131562242|NCT01686932|473684506|FG001|Period 1|Adverse Event|1|||
131562243|NCT01536145|473684507|FG000|Overall Study|Progressive disease|3|||
131562244|NCT01536145|473684508|FG001|Overall Study|Progressive disease|4|||
131562245|NCT01536145|473684509|FG002|Overall Study|Progressive disease|1|||
131562246|NCT01536145|473684510|FG003|Overall Study|Progressive disease|2|||
131562247|NCT01536145|473684511|FG004|Overall Study|Progressive disease|1|||
131562248|NCT01536145|473684512|FG005|Overall Study|Progressive disease|2|||
131562249|NCT01536145|473684513|FG006|Overall Study|Progressive disease|1|||
131562250|NCT01536145|473684514|FG007|Overall Study|Progressive disease|2|||
131562251|NCT01536145|473684515|FG008|Overall Study|Progressive disease|1|||
131562252|NCT01536145|473684516|FG009|Overall Study|Progressive disease|3|||
131562253|NCT01536145|473684517|FG010|Overall Study|Progressive disease|3|||
131562254|NCT01536145|473684507|FG000|Overall Study|Withdrawal by Subject|0|||
131562255|NCT01536145|473684508|FG001|Overall Study|Withdrawal by Subject|0|||
131562256|NCT01536145|473684509|FG002|Overall Study|Withdrawal by Subject|1|||
131562257|NCT01536145|473684510|FG003|Overall Study|Withdrawal by Subject|0|||
131562258|NCT01536145|473684511|FG004|Overall Study|Withdrawal by Subject|0|||
131562259|NCT01536145|473684512|FG005|Overall Study|Withdrawal by Subject|1|||
131562260|NCT01536145|473684513|FG006|Overall Study|Withdrawal by Subject|0|||
131562261|NCT01536145|473684514|FG007|Overall Study|Withdrawal by Subject|0|||
131562262|NCT01536145|473684515|FG008|Overall Study|Withdrawal by Subject|2|||
131562263|NCT01536145|473684516|FG009|Overall Study|Withdrawal by Subject|0|||
131562264|NCT01536145|473684517|FG010|Overall Study|Withdrawal by Subject|2|||
131562265|NCT01536145|473684507|FG000|Overall Study|Other|0|||
131562266|NCT01536145|473684508|FG001|Overall Study|Other|0|||
131562267|NCT01536145|473684509|FG002|Overall Study|Other|0|||
131562268|NCT01536145|473684510|FG003|Overall Study|Other|0|||
131562269|NCT01536145|473684511|FG004|Overall Study|Other|1|||
131562270|NCT01536145|473684512|FG005|Overall Study|Other|0|||
131562271|NCT01536145|473684513|FG006|Overall Study|Other|0|||
131562272|NCT01536145|473684514|FG007|Overall Study|Other|0|||
131562273|NCT01536145|473684515|FG008|Overall Study|Other|0|||
131562274|NCT01536145|473684516|FG009|Overall Study|Other|3|||
131562275|NCT01536145|473684517|FG010|Overall Study|Other|2|||
131562276|NCT01536145|473684507|FG000|Overall Study|Death|0|||
131562277|NCT01536145|473684508|FG001|Overall Study|Death|0|||
131562278|NCT01536145|473684509|FG002|Overall Study|Death|0|||
131562279|NCT01536145|473684510|FG003|Overall Study|Death|0|||
131562280|NCT01536145|473684511|FG004|Overall Study|Death|0|||
131562281|NCT01536145|473684512|FG005|Overall Study|Death|0|||
131562282|NCT01536145|473684513|FG006|Overall Study|Death|1|||
131562283|NCT01536145|473684514|FG007|Overall Study|Death|0|||
131562284|NCT01536145|473684515|FG008|Overall Study|Death|0|||
131695776|NCT02425826|474168649|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
131695777|NCT02425826|474168650|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
131695778|NCT02425826|474168651|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
131695779|NCT02425826|474168649|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
131695780|NCT02425826|474168650|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
131695781|NCT02425826|474168651|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
131898598|NCT04162795|474914156|FG000|Overall Study|Screen failures|10|||
131904613|NCT03964207|474937033|FG001|Second Treatment|Lost to Follow-up|1|||
131562285|NCT01536145|473684516|FG009|Overall Study|Death|0|||
131562286|NCT01536145|473684517|FG010|Overall Study|Death|0|||
131562287|NCT01536145|473684507|FG000|Overall Study|Adverse Event|0|||
131562288|NCT01536145|473684508|FG001|Overall Study|Adverse Event|0|||
131562289|NCT01536145|473684509|FG002|Overall Study|Adverse Event|0|||
131562290|NCT01536145|473684510|FG003|Overall Study|Adverse Event|0|||
131562291|NCT01536145|473684511|FG004|Overall Study|Adverse Event|0|||
131562292|NCT01536145|473684512|FG005|Overall Study|Adverse Event|0|||
131562293|NCT01536145|473684513|FG006|Overall Study|Adverse Event|0|||
131562294|NCT01536145|473684514|FG007|Overall Study|Adverse Event|2|||
131562295|NCT01536145|473684515|FG008|Overall Study|Adverse Event|0|||
131562296|NCT01536145|473684516|FG009|Overall Study|Adverse Event|0|||
131562297|NCT01536145|473684517|FG010|Overall Study|Adverse Event|3|||
131695782|NCT02425826|474168649|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
131562298|NCT01364727|473684520|FG000|Overall Study|Not Eligible|2|||
131562299|NCT04716881|473684521|FG000|Overall Study|Adverse Event|1|||
131562300|NCT04716881|473684521|FG000|Overall Study|Lost to Follow-up|1|||
131562301|NCT02443103|473684522|FG000|Overall Study|Adverse Event|2|||
131562302|NCT02443103|473684522|FG000|Overall Study|Noncompliance|1|||
131562303|NCT01630590|473684523|FG000|Overall Study|Adverse Event|9|||
131562304|NCT01630590|473684523|FG000|Overall Study|Lack of Efficacy|37|||
131562305|NCT01630590|473684523|FG000|Overall Study|Withdrawal by Subject|4|||
131562306|NCT01630590|473684523|FG000|Overall Study|2nd primary tumor|2|||
131562307|NCT01630590|473684523|FG000|Overall Study|Automobile accident|1|||
131562308|NCT01630590|473684523|FG000|Overall Study|Maximum benefit|4|||
131562309|NCT02366936|473684524|FG000|Overall Study|Withdrawal by Subject|2|||
131562310|NCT02366936|473684524|FG000|Overall Study|Lost to Follow-up|4|||
131562311|NCT02366936|473684524|FG000|Overall Study|Physician Decision|2|||
131562312|NCT01558674|473684527|FG000|Part 1|Study Terminated by Sponsor|10|||
131562313|NCT01558674|473684528|FG001|Part 1|Study Terminated by Sponsor|0|||
131562314|NCT01558674|473684527|FG000|Part 1|Withdrawal by Subject|1|||
131562315|NCT01558674|473684528|FG001|Part 1|Withdrawal by Subject|0|||
131562316|NCT04147260|473684529|FG000|Overall Study|Adverse Event|1|||
131562317|NCT04147260|473684530|FG001|Overall Study|Adverse Event|0|||
131562318|NCT04147260|473684531|FG002|Overall Study|Adverse Event|1|||
131562319|NCT04147260|473684532|FG003|Overall Study|Adverse Event|2|||
131562320|NCT04147260|473684533|FG004|Overall Study|Adverse Event|0|||
131562321|NCT04147260|473684529|FG000|Overall Study|Withdrawal by Subject|0|||
131562322|NCT04147260|473684530|FG001|Overall Study|Withdrawal by Subject|0|||
131562323|NCT04147260|473684531|FG002|Overall Study|Withdrawal by Subject|1|||
131562324|NCT04147260|473684532|FG003|Overall Study|Withdrawal by Subject|1|||
131562325|NCT04147260|473684533|FG004|Overall Study|Withdrawal by Subject|0|||
131562326|NCT01555021|473684534|FG000|Overall Study|Lost to Follow-up|1|||
131562327|NCT01555021|473684535|FG001|Overall Study|Lost to Follow-up|2|||
131562328|NCT03358329|473684538|FG000|Overall Study|Lost to Follow-up|2|||
131562329|NCT03358329|473684538|FG000|Overall Study|Withdrawal by Subject|2|||
131562330|NCT02982720|473684539|FG000|Overall Study|Adverse Event|3|||
131562331|NCT02982720|473684539|FG000|Overall Study|Death|1|||
131562332|NCT01734850|473684544|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
131562333|NCT01734850|473684545|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
131562334|NCT01734850|473684546|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
131562335|NCT01734850|473684544|FG000|Overall Study|Not infused due to manufacturing failure|0|||
131562336|NCT01734850|473684545|FG001|Overall Study|Not infused due to manufacturing failure|0|||
131562337|NCT01734850|473684546|FG002|Overall Study|Not infused due to manufacturing failure|1|||
131562338|NCT00750893|473684547|FG000|Overall Study|Adverse Event|5|||
131562339|NCT00750893|473684547|FG000|Overall Study|Withdrawal by Subject|10|||
131562340|NCT00750893|473684547|FG000|Overall Study|Lost to Follow-up|510|||
131562341|NCT00750893|473684547|FG000|Overall Study|Other|17|||
131695783|NCT02425826|474168650|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
131898599|NCT05259163|474915301|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
131562342|NCT02420327|473684548|FG000|Overall Study|Adverse Event|7|||
131562343|NCT02420327|473684548|FG000|Overall Study|Pregnancy|1|||
131562344|NCT02420327|473684548|FG000|Overall Study|Withdrawal by Subject|6|||
131562345|NCT02420327|473684548|FG000|Overall Study|Lost to Follow-up|1|||
131562346|NCT02420327|473684548|FG000|Overall Study|Protocol Violation|1|||
131562347|NCT02204293|473684549|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
131562348|NCT02204293|473684550|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
131562349|NCT02204293|473684551|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
131562350|NCT02204293|473684552|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
131562351|NCT02204293|473684553|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
131562352|NCT02204293|473684554|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
131562353|NCT02204293|473684549|FG000|Core Study Part I|Adverse Event|1|||
131562354|NCT02204293|473684550|FG001|Core Study Part I|Adverse Event|0|||
131562355|NCT02204293|473684551|FG002|Core Study Part I|Adverse Event|0|||
131562356|NCT02204293|473684552|FG003|Core Study Part I|Adverse Event|0|||
131562357|NCT02204293|473684553|FG004|Core Study Part I|Adverse Event|0|||
131562358|NCT02204293|473684554|FG005|Core Study Part I|Adverse Event|0|||
131562359|NCT02204293|473684549|FG000|Core Study Part I|Physician Decision|0|||
131562360|NCT02204293|473684550|FG001|Core Study Part I|Physician Decision|3|||
131562361|NCT02204293|473684551|FG002|Core Study Part I|Physician Decision|0|||
131562362|NCT02204293|473684552|FG003|Core Study Part I|Physician Decision|0|||
131562363|NCT02204293|473684553|FG004|Core Study Part I|Physician Decision|0|||
131780882|NCT02985515|474477864|FG001|Olfaction Testing|Lost to Follow-up|5|||
131780883|NCT02985515|474477863|FG000|Olfaction Testing|Protocol Violation|0|||
131780884|NCT02985515|474477864|FG001|Olfaction Testing|Protocol Violation|3|||
131780885|NCT00742859|474477869|FG000|Overall Study|Adverse Event|5|||
131780886|NCT00742859|474477870|FG001|Overall Study|Adverse Event|6|||
131780887|NCT00742859|474477871|FG002|Overall Study|Adverse Event|3|||
131780888|NCT00742859|474477872|FG003|Overall Study|Adverse Event|1|||
131780889|NCT00742859|474477869|FG000|Overall Study|Death|1|||
131780890|NCT00742859|474477870|FG001|Overall Study|Death|0|||
131780891|NCT00742859|474477871|FG002|Overall Study|Death|0|||
131780892|NCT00742859|474477872|FG003|Overall Study|Death|1|||
131780893|NCT00742859|474477869|FG000|Overall Study|Physician Decision|1|||
131780894|NCT00742859|474477870|FG001|Overall Study|Physician Decision|2|||
131780895|NCT00742859|474477871|FG002|Overall Study|Physician Decision|0|||
131780896|NCT00742859|474477872|FG003|Overall Study|Physician Decision|0|||
131780897|NCT00742859|474477869|FG000|Overall Study|Withdrawal by Subject|4|||
131780898|NCT00742859|474477870|FG001|Overall Study|Withdrawal by Subject|2|||
131780899|NCT00742859|474477871|FG002|Overall Study|Withdrawal by Subject|4|||
131780900|NCT00742859|474477872|FG003|Overall Study|Withdrawal by Subject|1|||
131562364|NCT02204293|473684554|FG005|Core Study Part I|Physician Decision|0|||
131562365|NCT02204293|473684549|FG000|LTE Phase|Study Suspended|0|||
131562366|NCT02204293|473684550|FG001|LTE Phase|Study Suspended|0|||
131562367|NCT02204293|473684551|FG002|LTE Phase|Study Suspended|0|||
131562368|NCT02204293|473684552|FG003|LTE Phase|Study Suspended|0|||
131562369|NCT02204293|473684553|FG004|LTE Phase|Study Suspended|0|||
131562370|NCT02204293|473684554|FG005|LTE Phase|Study Suspended|7|||
131562371|NCT02589392|473684556|FG000|Overall Study|Adverse Event|1|||
131562372|NCT02589392|473684557|FG001|Overall Study|Adverse Event|1|||
131562373|NCT02589392|473684556|FG000|Overall Study|Withdrawal by Subject|1|||
131562374|NCT02589392|473684557|FG001|Overall Study|Withdrawal by Subject|2|||
131562375|NCT02589392|473684556|FG000|Overall Study|Protocol Violation|1|||
131562376|NCT02589392|473684557|FG001|Overall Study|Protocol Violation|1|||
131562377|NCT02589392|473684556|FG000|Overall Study|Lost to Follow-up|2|||
131562378|NCT02589392|473684557|FG001|Overall Study|Lost to Follow-up|2|||
131562379|NCT02589392|473684556|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
131562380|NCT02589392|473684557|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
131562381|NCT00393094|473684562|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
131562382|NCT00393094|473684562|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
131562383|NCT02019602|473684563|FG000|Screening Period|Ineligibility|4|||
131562384|NCT02019602|473684564|FG001|Screening Period|Ineligibility|0|||
131562385|NCT02019602|473684563|FG000|Screening Period|Adverse Event|1|||
131562386|NCT02019602|473684564|FG001|Screening Period|Adverse Event|0|||
131562387|NCT01058863|473684565|FG000|Overall Study|Lost to Follow-up|1|||
131562388|NCT01058863|473684565|FG000|Overall Study|Withdrawal by Subject|1|||
131562389|NCT01058863|473684565|FG000|Overall Study|Sponsor requested withdrawal|1|||
131562390|NCT01058863|473684565|FG000|Overall Study|Randomized in error|1|||
131562391|NCT03653416|473684566|FG000|Overall Study|Protocol Violation|6|||
131562392|NCT03653416|473684567|FG001|Overall Study|Protocol Violation|1|||
131562393|NCT01370603|473684570|FG000|Period 1|Adverse Event|5|||
131562394|NCT01370603|473684571|FG001|Period 1|Adverse Event|3|||
131562395|NCT01370603|473684570|FG000|Period 1|Lost to Follow-up|2|||
131562396|NCT01370603|473684571|FG001|Period 1|Lost to Follow-up|0|||
131562397|NCT01370603|473684570|FG000|Period 1|Protocol Violation|2|||
131562398|NCT01370603|473684571|FG001|Period 1|Protocol Violation|2|||
131562399|NCT01370603|473684570|FG000|Period 1|Withdrawal by Subject|5|||
131562400|NCT01370603|473684571|FG001|Period 1|Withdrawal by Subject|5|||
131562401|NCT01370603|473684570|FG000|Crossover Washout|Adverse Event|2|||
131562402|NCT01370603|473684571|FG001|Crossover Washout|Adverse Event|1|||
131562403|NCT01370603|473684570|FG000|Crossover Washout|Lost to Follow-up|2|||
131562404|NCT01370603|473684571|FG001|Crossover Washout|Lost to Follow-up|0|||
131562405|NCT01370603|473684570|FG000|Crossover Washout|Protocol Violation|1|||
131562406|NCT01370603|473684571|FG001|Crossover Washout|Protocol Violation|0|||
131562407|NCT01370603|473684570|FG000|Crossover Washout|Withdrawal by Subject|4|||
131562408|NCT01370603|473684571|FG001|Crossover Washout|Withdrawal by Subject|1|||
131562409|NCT01370603|473684570|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
131562410|NCT01370603|473684571|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
131562411|NCT01370603|473684570|FG000|Period 2|Adverse Event|1|||
131562412|NCT01370603|473684571|FG001|Period 2|Adverse Event|4|||
131562413|NCT01370603|473684570|FG000|Period 2|Lost to Follow-up|1|||
131562414|NCT01370603|473684571|FG001|Period 2|Lost to Follow-up|0|||
131562415|NCT01370603|473684570|FG000|Period 2|Withdrawal by Subject|1|||
131562416|NCT01370603|473684571|FG001|Period 2|Withdrawal by Subject|0|||
131695784|NCT02425826|474168651|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
131695785|NCT00852995|474168653|FG000|Overall Study|Adverse Event|1|||
131695786|NCT00852995|474168654|FG001|Overall Study|Adverse Event|0|||
131695787|NCT00852995|474168655|FG002|Overall Study|Adverse Event|4|||
131695788|NCT00852995|474168656|FG003|Overall Study|Adverse Event|0|||
131695789|NCT00852995|474168657|FG004|Overall Study|Adverse Event|0|||
131695790|NCT00852995|474168653|FG000|Overall Study|Lost to Follow-up|0|||
131695791|NCT00852995|474168654|FG001|Overall Study|Lost to Follow-up|1|||
131695792|NCT00852995|474168655|FG002|Overall Study|Lost to Follow-up|1|||
131562417|NCT02388074|473684572|FG000|Overall Study|Lost in Transit|2|||
131562418|NCT02388074|473684572|FG000|Overall Study|Sample Not Returned|1|||
131562419|NCT04212169|473686188|FG000|Overall Study|Adverse Event|0|||
131562420|NCT04212169|473686189|FG001|Overall Study|Adverse Event|0|||
131562421|NCT04212169|473686190|FG002|Overall Study|Adverse Event|0|||
131562422|NCT04212169|473686191|FG003|Overall Study|Adverse Event|2|||
131562423|NCT04212169|473686188|FG000|Overall Study|Lost to Follow-up|1|||
131562424|NCT04212169|473686189|FG001|Overall Study|Lost to Follow-up|0|||
131562425|NCT04212169|473686190|FG002|Overall Study|Lost to Follow-up|0|||
131562426|NCT04212169|473686191|FG003|Overall Study|Lost to Follow-up|2|||
131562427|NCT04212169|473686188|FG000|Overall Study|Withdrawal by Subject|10|||
131695793|NCT00852995|474168656|FG003|Overall Study|Lost to Follow-up|0|||
131695794|NCT00852995|474168657|FG004|Overall Study|Lost to Follow-up|0|||
131695795|NCT00852995|474168653|FG000|Overall Study|Withdrawal by Subject|4|||
131695796|NCT00852995|474168654|FG001|Overall Study|Withdrawal by Subject|0|||
131695797|NCT00852995|474168655|FG002|Overall Study|Withdrawal by Subject|0|||
131695798|NCT00852995|474168656|FG003|Overall Study|Withdrawal by Subject|1|||
131436801|NCT02079740|473225605|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
131695799|NCT00852995|474168657|FG004|Overall Study|Withdrawal by Subject|2|||
131695800|NCT00852995|474168653|FG000|Overall Study|Non-Compliance|0|||
131695801|NCT00852995|474168654|FG001|Overall Study|Non-Compliance|0|||
131695802|NCT00852995|474168655|FG002|Overall Study|Non-Compliance|0|||
131695803|NCT00852995|474168656|FG003|Overall Study|Non-Compliance|2|||
131695804|NCT00852995|474168657|FG004|Overall Study|Non-Compliance|0|||
131695805|NCT00852995|474168653|FG000|Overall Study|Progressive Disease|1|||
131695806|NCT00852995|474168654|FG001|Overall Study|Progressive Disease|0|||
131695807|NCT00852995|474168655|FG002|Overall Study|Progressive Disease|0|||
131695808|NCT00852995|474168656|FG003|Overall Study|Progressive Disease|2|||
131562428|NCT04212169|473686189|FG001|Overall Study|Withdrawal by Subject|2|||
131562429|NCT04212169|473686190|FG002|Overall Study|Withdrawal by Subject|5|||
131562430|NCT04212169|473686191|FG003|Overall Study|Withdrawal by Subject|7|||
131562431|NCT04212169|473686188|FG000|Overall Study|Other reason, unspecified|3|||
131562432|NCT04212169|473686189|FG001|Overall Study|Other reason, unspecified|1|||
131562433|NCT04212169|473686190|FG002|Overall Study|Other reason, unspecified|0|||
131562434|NCT04212169|473686191|FG003|Overall Study|Other reason, unspecified|2|||
131562435|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
131562436|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
131562437|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
131562438|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
131562439|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
131562440|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
131562441|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
131562442|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
131562443|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
131562444|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
131562445|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562446|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562447|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562448|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
131562449|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
131695809|NCT00852995|474168657|FG004|Overall Study|Progressive Disease|1|||
131695810|NCT00852995|474168653|FG000|Overall Study|Physician Decision|1|||
131695811|NCT00852995|474168654|FG001|Overall Study|Physician Decision|0|||
131695812|NCT00852995|474168655|FG002|Overall Study|Physician Decision|0|||
131695813|NCT00852995|474168656|FG003|Overall Study|Physician Decision|0|||
131695814|NCT00852995|474168657|FG004|Overall Study|Physician Decision|0|||
131695815|NCT00852995|474168653|FG000|Overall Study|Protocol Violation|0|||
131695816|NCT00852995|474168654|FG001|Overall Study|Protocol Violation|0|||
131695817|NCT00852995|474168655|FG002|Overall Study|Protocol Violation|0|||
131695818|NCT00852995|474168656|FG003|Overall Study|Protocol Violation|0|||
131695819|NCT00852995|474168657|FG004|Overall Study|Protocol Violation|1|||
131695820|NCT00852995|474168653|FG000|Overall Study|Moved Out of Area|1|||
131695821|NCT00852995|474168654|FG001|Overall Study|Moved Out of Area|0|||
131695822|NCT00852995|474168655|FG002|Overall Study|Moved Out of Area|0|||
131695823|NCT00852995|474168656|FG003|Overall Study|Moved Out of Area|0|||
131695824|NCT00852995|474168657|FG004|Overall Study|Moved Out of Area|0|||
131695825|NCT01836783|474168658|FG000|Overall Study|Withdrawal by Subject|0|||
131695826|NCT01836783|474168659|FG001|Overall Study|Withdrawal by Subject|2|||
131695827|NCT02124564|474168662|FG000|Treatment Period|Adverse Event|2|||
131695828|NCT02124564|474168662|FG000|Treatment Period|Lack of Efficacy|3|||
131695829|NCT02124564|474168662|FG000|Treatment Period|Withdrawal by Subject|2|||
131695830|NCT02043548|474168665|FG000|Overall Study|Lack of Efficacy|1|||
131695831|NCT02043548|474168666|FG001|Overall Study|Lack of Efficacy|0|||
131695832|NCT02043548|474168665|FG000|Overall Study|Adverse Event|0|||
131695833|NCT02043548|474168666|FG001|Overall Study|Adverse Event|1|||
131695834|NCT01471782|474168670|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
131695835|NCT01471782|474168671|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
131695836|NCT01471782|474168672|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
131695837|NCT01471782|474168673|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
131695838|NCT01471782|474168674|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
131695839|NCT01471782|474168675|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
131695840|NCT01471782|474168670|FG000|Overall Study|Lack of Efficacy|1|||
131695841|NCT01471782|474168671|FG001|Overall Study|Lack of Efficacy|2|||
131695842|NCT01471782|474168672|FG002|Overall Study|Lack of Efficacy|1|||
131695843|NCT01471782|474168673|FG003|Overall Study|Lack of Efficacy|1|||
131695844|NCT01471782|474168674|FG004|Overall Study|Lack of Efficacy|5|||
131695845|NCT01471782|474168675|FG005|Overall Study|Lack of Efficacy|18|||
131695846|NCT01471782|474168670|FG000|Overall Study|Adverse Event|1|||
131695847|NCT01471782|474168671|FG001|Overall Study|Adverse Event|1|||
131695848|NCT01471782|474168672|FG002|Overall Study|Adverse Event|2|||
131695849|NCT01471782|474168673|FG003|Overall Study|Adverse Event|2|||
131695850|NCT01471782|474168674|FG004|Overall Study|Adverse Event|3|||
131695851|NCT01471782|474168675|FG005|Overall Study|Adverse Event|1|||
131695852|NCT01471782|474168670|FG000|Overall Study|Other|0|||
131695853|NCT01471782|474168671|FG001|Overall Study|Other|0|||
131695854|NCT01471782|474168672|FG002|Overall Study|Other|1|||
131695855|NCT01471782|474168673|FG003|Overall Study|Other|1|||
131695856|NCT01471782|474168674|FG004|Overall Study|Other|6|||
131695857|NCT01471782|474168675|FG005|Overall Study|Other|5|||
131695858|NCT01471782|474168670|FG000|Overall Study|Change of Chemotherapy|1|||
131695859|NCT01471782|474168671|FG001|Overall Study|Change of Chemotherapy|1|||
131562450|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562451|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562452|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562453|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562454|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
131562455|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
131562456|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
131562457|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
131562458|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
131562459|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
131562460|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
131562461|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
131562462|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
131562463|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
131562464|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
131562465|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
131562466|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562467|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562468|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
131562469|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
131562470|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562471|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562472|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562473|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562474|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
131562475|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562476|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562477|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
131562478|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
131562479|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562480|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562481|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562482|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562483|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562484|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
131562485|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562486|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562487|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131780901|NCT00742859|474477869|FG000|Overall Study|Endpoint|0|||
131562488|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562489|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
131562490|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562491|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562492|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562493|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562494|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
131562495|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131780902|NCT00742859|474477870|FG001|Overall Study|Endpoint|1|||
131780903|NCT00742859|474477871|FG002|Overall Study|Endpoint|1|||
131780904|NCT00742859|474477872|FG003|Overall Study|Endpoint|2|||
131780905|NCT00742859|474477869|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
131562496|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131562497|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131562498|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
131562499|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
131562500|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
131562501|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131562502|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131562503|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131562504|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131780906|NCT00742859|474477870|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
131562505|NCT02018861|473686194|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562506|NCT02018861|473686195|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131780907|NCT00742859|474477871|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
131562507|NCT02018861|473686196|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562508|NCT02018861|473686197|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
131562509|NCT02018861|473686198|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
131562510|NCT02018861|473686199|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562511|NCT02018861|473686200|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562512|NCT02018861|473686201|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562513|NCT02018861|473686202|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562514|NCT02018861|473686203|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131562515|NCT02018861|473686194|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562516|NCT02018861|473686195|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562517|NCT02018861|473686196|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562518|NCT02018861|473686197|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562519|NCT02018861|473686198|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562520|NCT02018861|473686199|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562521|NCT02018861|473686200|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
131562522|NCT02018861|473686201|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
131562523|NCT02018861|473686202|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562524|NCT02018861|473686203|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131562525|NCT02018861|473686194|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562526|NCT02018861|473686195|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562527|NCT02018861|473686196|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562528|NCT02018861|473686197|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562529|NCT02018861|473686198|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562530|NCT02018861|473686199|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562531|NCT02018861|473686200|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
131562532|NCT02018861|473686201|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
131562533|NCT02018861|473686202|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562534|NCT02018861|473686203|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131562535|NCT02018861|473686194|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562536|NCT02018861|473686195|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562537|NCT02018861|473686196|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562538|NCT02018861|473686197|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562539|NCT02018861|473686198|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562540|NCT02018861|473686199|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562541|NCT02018861|473686200|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562542|NCT02018861|473686201|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562543|NCT02018861|473686202|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
131562544|NCT02018861|473686203|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131562545|NCT02018861|473686194|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562546|NCT02018861|473686195|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562547|NCT02018861|473686196|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562548|NCT02018861|473686197|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562549|NCT02018861|473686198|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562550|NCT02018861|473686199|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562551|NCT02018861|473686200|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562552|NCT02018861|473686201|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562553|NCT02018861|473686202|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
131562554|NCT02018861|473686203|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131562555|NCT02018861|473686194|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131780908|NCT00742859|474477872|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
131780909|NCT00742859|474477869|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
131780910|NCT00742859|474477870|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
131780911|NCT00742859|474477871|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
131780912|NCT00742859|474477872|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
131780913|NCT00742859|474477869|FG000|Overall Study|Sponsor request patient out of town|0|||
131780914|NCT00742859|474477870|FG001|Overall Study|Sponsor request patient out of town|0|||
131780915|NCT00742859|474477871|FG002|Overall Study|Sponsor request patient out of town|1|||
131780916|NCT00742859|474477872|FG003|Overall Study|Sponsor request patient out of town|1|||
131780917|NCT00742859|474477869|FG000|Overall Study|Site error|0|||
131780918|NCT00742859|474477870|FG001|Overall Study|Site error|0|||
131780919|NCT00742859|474477871|FG002|Overall Study|Site error|1|||
131904614|NCT03964207|474937032|FG000|Second Treatment|Adverse Event|1|||
131562556|NCT02018861|473686195|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562557|NCT02018861|473686196|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562558|NCT02018861|473686197|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562559|NCT02018861|473686198|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562560|NCT02018861|473686199|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562561|NCT02018861|473686200|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562562|NCT02018861|473686201|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562563|NCT02018861|473686202|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
131562564|NCT02018861|473686203|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131562565|NCT00504348|473686204|FG000|Overall Study|Adverse Event|3|||
131562566|NCT00504348|473686204|FG000|Overall Study|Lack of Efficacy|4|||
131562567|NCT00504348|473686204|FG000|Overall Study|Physician Decision|1|||
131562568|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
131562569|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
131562570|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
131562571|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
131562572|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
131562573|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
131562574|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
131562575|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
131562576|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
131562577|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
131562578|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
131562579|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
131562580|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
131562581|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
131562582|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
131562583|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
131562584|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
131562585|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
131562586|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
131562587|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
131562588|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
131562589|NCT02718417|473686207|FG000|Chemotherapy Phase (CP)|Other|2|||
131562590|NCT02718417|473686208|FG001|Chemotherapy Phase (CP)|Other|0|||
131562591|NCT02718417|473686209|FG002|Chemotherapy Phase (CP)|Other|1|||
131562592|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Adverse Event|21|||
131562593|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Adverse Event|26|||
131562594|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Adverse Event|0|||
131562595|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
131562596|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
131695860|NCT01471782|474168672|FG002|Overall Study|Change of Chemotherapy|0|||
131695861|NCT01471782|474168673|FG003|Overall Study|Change of Chemotherapy|0|||
131695862|NCT01471782|474168674|FG004|Overall Study|Change of Chemotherapy|1|||
131695863|NCT01471782|474168675|FG005|Overall Study|Change of Chemotherapy|4|||
131695864|NCT01471782|474168670|FG000|Overall Study|Disease Relapse|0|||
131695865|NCT01471782|474168671|FG001|Overall Study|Disease Relapse|0|||
131695866|NCT01471782|474168672|FG002|Overall Study|Disease Relapse|0|||
131695867|NCT01471782|474168673|FG003|Overall Study|Disease Relapse|1|||
131695868|NCT01471782|474168674|FG004|Overall Study|Disease Relapse|2|||
131695869|NCT01471782|474168675|FG005|Overall Study|Disease Relapse|1|||
131695870|NCT01471782|474168670|FG000|Overall Study|Physician Decision|0|||
131695871|NCT01471782|474168671|FG001|Overall Study|Physician Decision|0|||
131695872|NCT01471782|474168672|FG002|Overall Study|Physician Decision|0|||
131695873|NCT01471782|474168673|FG003|Overall Study|Physician Decision|0|||
131695874|NCT01471782|474168674|FG004|Overall Study|Physician Decision|3|||
131695875|NCT01471782|474168675|FG005|Overall Study|Physician Decision|8|||
131695876|NCT01471782|474168670|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131695877|NCT01471782|474168671|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131695878|NCT01471782|474168672|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131695879|NCT01471782|474168673|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131695880|NCT01471782|474168674|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
131695881|NCT01471782|474168675|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131695882|NCT01471782|474168670|FG000|Overall Study|Death|0|||
131695883|NCT01471782|474168671|FG001|Overall Study|Death|0|||
131562597|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
131562598|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
131695884|NCT01471782|474168672|FG002|Overall Study|Death|0|||
131695885|NCT01471782|474168673|FG003|Overall Study|Death|0|||
131695886|NCT01471782|474168674|FG004|Overall Study|Death|0|||
131695887|NCT01471782|474168675|FG005|Overall Study|Death|1|||
131695888|NCT01314716|474168676|FG000|Double-Blind Phase|Randomized but not treated|1|||
131695889|NCT01314716|474168677|FG001|Double-Blind Phase|Randomized but not treated|1|||
131436802|NCT02079740|473225606|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
131562599|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
131695890|NCT01314716|474168676|FG000|Double-Blind Phase|Adverse Event|10|||
131695891|NCT01314716|474168677|FG001|Double-Blind Phase|Adverse Event|4|||
131695892|NCT01314716|474168676|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
131695893|NCT01314716|474168677|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
131695894|NCT01314716|474168676|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131695895|NCT01314716|474168677|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131695896|NCT01314716|474168676|FG000|Double-Blind Phase|Sponsor request|1|||
131695897|NCT01314716|474168677|FG001|Double-Blind Phase|Sponsor request|2|||
131695898|NCT01314716|474168676|FG000|Double-Blind Phase|Physician Decision|0|||
131695899|NCT01314716|474168677|FG001|Double-Blind Phase|Physician Decision|1|||
131695900|NCT01314716|474168676|FG000|Open-Label Phase|Adverse Event|4|||
131695901|NCT01314716|474168677|FG001|Open-Label Phase|Adverse Event|6|||
131695902|NCT01314716|474168676|FG000|Open-Label Phase|Withdrawal by Subject|1|||
131695903|NCT01314716|474168677|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131695904|NCT01314716|474168676|FG000|Open-Label Phase|Physician Decision|5|||
131695905|NCT01314716|474168677|FG001|Open-Label Phase|Physician Decision|4|||
131695906|NCT04311502|474170304|FG000|Overall Study|Death|1|||
131695907|NCT04311502|474170305|FG001|Overall Study|Death|1|||
131695908|NCT04311502|474170306|FG002|Overall Study|Death|1|||
131695909|NCT04311502|474170304|FG000|Overall Study|Lost to Follow-up|2|||
131695910|NCT04311502|474170305|FG001|Overall Study|Lost to Follow-up|3|||
131695911|NCT04311502|474170306|FG002|Overall Study|Lost to Follow-up|0|||
131695912|NCT04311502|474170304|FG000|Overall Study|Participant is in prison|1|||
131695913|NCT04311502|474170305|FG001|Overall Study|Participant is in prison|0|||
131695914|NCT04311502|474170306|FG002|Overall Study|Participant is in prison|0|||
131695915|NCT04311502|474170304|FG000|Overall Study|Participant moved out of country|1|||
131695916|NCT04311502|474170305|FG001|Overall Study|Participant moved out of country|0|||
131695917|NCT04311502|474170306|FG002|Overall Study|Participant moved out of country|0|||
131695918|NCT04311502|474170304|FG000|Overall Study|Withdrawal by Subject|2|||
131695919|NCT04311502|474170305|FG001|Overall Study|Withdrawal by Subject|0|||
131695920|NCT04311502|474170306|FG002|Overall Study|Withdrawal by Subject|0|||
131695921|NCT04311502|474170304|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
131695922|NCT04311502|474170305|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
131695923|NCT04311502|474170306|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
131695924|NCT03040999|474170307|FG000|Overall Study|Lost to Follow-up|2|||
131695925|NCT03040999|474170308|FG001|Overall Study|Lost to Follow-up|2|||
131695926|NCT03040999|474170307|FG000|Overall Study|Withdrawal by Subject|12|||
131695927|NCT03040999|474170308|FG001|Overall Study|Withdrawal by Subject|13|||
131695928|NCT03040999|474170307|FG000|Overall Study|Death|155|||
131695929|NCT03040999|474170308|FG001|Overall Study|Death|171|||
131695930|NCT03040999|474170307|FG000|Overall Study|Physician Decision|0|||
131695931|NCT03040999|474170308|FG001|Overall Study|Physician Decision|3|||
131695932|NCT03657043|474170309|FG000|Overall Study|Withdrawal by Subject|1|||
131695933|NCT03657043|474170310|FG001|Overall Study|Withdrawal by Subject|1|||
131695934|NCT03657043|474170311|FG002|Overall Study|Withdrawal by Subject|0|||
131695935|NCT03657043|474170312|FG003|Overall Study|Withdrawal by Subject|0|||
131695936|NCT03657043|474170313|FG004|Overall Study|Withdrawal by Subject|4|||
131695937|NCT03657043|474170309|FG000|Overall Study|Study closure by Sponsor|0|||
131904615|NCT03964207|474937033|FG001|Second Treatment|Adverse Event|2|||
131436803|NCT02079740|473225607|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
131695938|NCT03657043|474170310|FG001|Overall Study|Study closure by Sponsor|2|||
131695939|NCT03657043|474170311|FG002|Overall Study|Study closure by Sponsor|0|||
131562600|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
131562601|NCT02718417|473686207|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
131562602|NCT02718417|473686208|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
131562603|NCT02718417|473686209|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
131562604|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Physician's decision|6|||
131562605|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Physician's decision|7|||
131562606|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Physician's decision|0|||
131562607|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Progressive disease|100|||
131562608|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Progressive disease|88|||
131562609|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Progressive disease|0|||
131562610|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Other|2|||
131695940|NCT03657043|474170312|FG003|Overall Study|Study closure by Sponsor|0|||
131695941|NCT03657043|474170313|FG004|Overall Study|Study closure by Sponsor|17|||
131695942|NCT03657043|474170309|FG000|Overall Study|Lost to Follow-up|0|||
131695943|NCT03657043|474170310|FG001|Overall Study|Lost to Follow-up|0|||
131695944|NCT03657043|474170311|FG002|Overall Study|Lost to Follow-up|0|||
131695945|NCT03657043|474170312|FG003|Overall Study|Lost to Follow-up|0|||
131695946|NCT03657043|474170313|FG004|Overall Study|Lost to Follow-up|4|||
131695947|NCT03657043|474170309|FG000|Overall Study|Death|6|||
131695948|NCT03657043|474170310|FG001|Overall Study|Death|5|||
131695949|NCT03657043|474170311|FG002|Overall Study|Death|0|||
131695950|NCT03657043|474170312|FG003|Overall Study|Death|0|||
131695951|NCT03657043|474170313|FG004|Overall Study|Death|53|||
131695952|NCT03657043|474170309|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
131695953|NCT03657043|474170310|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
131695954|NCT03657043|474170311|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
131695955|NCT03657043|474170312|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
131695956|NCT03657043|474170313|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
131695957|NCT03657043|474170309|FG000|Overall Study|Adverse Event|0|||
131695958|NCT03657043|474170310|FG001|Overall Study|Adverse Event|0|||
131695959|NCT03657043|474170311|FG002|Overall Study|Adverse Event|0|||
131695960|NCT03657043|474170312|FG003|Overall Study|Adverse Event|0|||
131695961|NCT03657043|474170313|FG004|Overall Study|Adverse Event|2|||
131695962|NCT03657043|474170309|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
131695963|NCT03657043|474170310|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
131695964|NCT03657043|474170311|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
131695965|NCT03657043|474170312|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
131695966|NCT03657043|474170313|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
131695967|NCT03657043|474170309|FG000|Overall Study|Withdrawal - declined follow-up|0|||
131695968|NCT03657043|474170310|FG001|Overall Study|Withdrawal - declined follow-up|0|||
131695969|NCT03657043|474170311|FG002|Overall Study|Withdrawal - declined follow-up|0|||
131695970|NCT03657043|474170312|FG003|Overall Study|Withdrawal - declined follow-up|0|||
131695971|NCT03657043|474170313|FG004|Overall Study|Withdrawal - declined follow-up|1|||
131695972|NCT02627495|474170316|FG000|Overall Study|Withdrawal by Subject|4|||
131695973|NCT02543528|474170324|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131695974|NCT02543528|474170325|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131695975|NCT02543528|474170326|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131695976|NCT02543528|474170327|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131695977|NCT02543528|474170328|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
131695978|NCT02543528|474170324|FG000|Adaptation Period|Lens Handling Difficultes|0|||
131695979|NCT02543528|474170325|FG001|Adaptation Period|Lens Handling Difficultes|0|||
131695980|NCT02543528|474170326|FG002|Adaptation Period|Lens Handling Difficultes|0|||
131695981|NCT02543528|474170327|FG003|Adaptation Period|Lens Handling Difficultes|0|||
131695982|NCT02543528|474170328|FG004|Adaptation Period|Lens Handling Difficultes|8|||
131695983|NCT02543528|474170324|FG000|Adaptation Period|Lost to Follow-up|0|||
131695984|NCT02543528|474170325|FG001|Adaptation Period|Lost to Follow-up|0|||
131695985|NCT02543528|474170326|FG002|Adaptation Period|Lost to Follow-up|0|||
131695986|NCT02543528|474170327|FG003|Adaptation Period|Lost to Follow-up|0|||
131695987|NCT02543528|474170328|FG004|Adaptation Period|Lost to Follow-up|14|||
131695988|NCT02543528|474170324|FG000|Adaptation Period|Adverse Event|0|||
131562611|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Other|1|||
131562612|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Other|0|||
131562613|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
131562614|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
131562615|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
131562616|NCT02718417|473686207|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
131562617|NCT02718417|473686208|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
131562618|NCT02718417|473686209|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
131562619|NCT02718417|473686207|FG000|Observation Phase (OP)|Adverse Event|0|||
131562620|NCT02718417|473686208|FG001|Observation Phase (OP)|Adverse Event|0|||
131562621|NCT02718417|473686209|FG002|Observation Phase (OP)|Adverse Event|1|||
131562622|NCT02718417|473686207|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
131562623|NCT02718417|473686208|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
131562624|NCT02718417|473686209|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
131562625|NCT02718417|473686207|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
131562626|NCT02718417|473686208|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
131562627|NCT02718417|473686209|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
131562628|NCT02718417|473686207|FG000|Observation Phase (OP)|Physician Decision|0|||
131562629|NCT02718417|473686208|FG001|Observation Phase (OP)|Physician Decision|0|||
131562630|NCT02718417|473686209|FG002|Observation Phase (OP)|Physician Decision|9|||
131562631|NCT02718417|473686207|FG000|Observation Phase (OP)|Progressive disease|0|||
131562632|NCT02718417|473686208|FG001|Observation Phase (OP)|Progressive disease|0|||
131562633|NCT02718417|473686209|FG002|Observation Phase (OP)|Progressive disease|92|||
131562634|NCT02718417|473686207|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
131562635|NCT02718417|473686208|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
131562636|NCT02718417|473686209|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
131562637|NCT02718417|473686207|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
131562638|NCT02718417|473686208|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
131562639|NCT02718417|473686209|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
131562640|NCT02718417|473686207|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
131562641|NCT02718417|473686208|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
131562642|NCT02718417|473686209|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
131562643|NCT02718417|473686207|FG000|Observation Phase (OP)|Other|0|||
131562644|NCT02718417|473686208|FG001|Observation Phase (OP)|Other|0|||
131562645|NCT02718417|473686209|FG002|Observation Phase (OP)|Other|7|||
131562646|NCT02718417|473686207|FG000|Follow-up Phase|Adverse Event|3|||
131562647|NCT02718417|473686208|FG001|Follow-up Phase|Adverse Event|1|||
131562648|NCT02718417|473686209|FG002|Follow-up Phase|Adverse Event|1|||
131562649|NCT02718417|473686207|FG000|Follow-up Phase|Other|4|||
131562650|NCT02718417|473686208|FG001|Follow-up Phase|Other|6|||
131562651|NCT02718417|473686209|FG002|Follow-up Phase|Other|4|||
131562652|NCT02718417|473686207|FG000|Follow-up Phase|Withdrawal by Subject|19|||
131562653|NCT02718417|473686208|FG001|Follow-up Phase|Withdrawal by Subject|17|||
131562654|NCT02718417|473686209|FG002|Follow-up Phase|Withdrawal by Subject|5|||
131562655|NCT02718417|473686207|FG000|Follow-up Phase|Study terminated by sponsor|100|||
131562656|NCT02718417|473686208|FG001|Follow-up Phase|Study terminated by sponsor|138|||
131562657|NCT02718417|473686209|FG002|Follow-up Phase|Study terminated by sponsor|6|||
131562658|NCT02718417|473686207|FG000|Follow-up Phase|Lost to Follow-up|2|||
131562659|NCT02718417|473686208|FG001|Follow-up Phase|Lost to Follow-up|3|||
131562660|NCT02718417|473686209|FG002|Follow-up Phase|Lost to Follow-up|0|||
131562661|NCT02718417|473686207|FG000|Follow-up Phase|Death leading to discontinuation|7|||
131562662|NCT02718417|473686208|FG001|Follow-up Phase|Death leading to discontinuation|7|||
131562663|NCT02718417|473686209|FG002|Follow-up Phase|Death leading to discontinuation|3|||
131562664|NCT02718417|473686207|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
131562665|NCT02718417|473686208|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
131562666|NCT02718417|473686209|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
131562667|NCT02718417|473686207|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
131562668|NCT02718417|473686208|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
131562669|NCT02718417|473686209|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
131562670|NCT02718417|473686207|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
131562671|NCT02718417|473686208|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
131562672|NCT02718417|473686209|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
131695989|NCT02543528|474170325|FG001|Adaptation Period|Adverse Event|0|||
131695990|NCT02543528|474170326|FG002|Adaptation Period|Adverse Event|0|||
131695991|NCT02543528|474170327|FG003|Adaptation Period|Adverse Event|0|||
131695992|NCT02543528|474170328|FG004|Adaptation Period|Adverse Event|2|||
131695993|NCT02543528|474170324|FG000|Extended Wear Period|Adverse Event|17|||
131695994|NCT02543528|474170325|FG001|Extended Wear Period|Adverse Event|11|||
131695995|NCT02543528|474170326|FG002|Extended Wear Period|Adverse Event|16|||
131695996|NCT02543528|474170327|FG003|Extended Wear Period|Adverse Event|3|||
131695997|NCT02543528|474170328|FG004|Extended Wear Period|Adverse Event|0|||
131695998|NCT02543528|474170324|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
131562673|NCT02718417|473686207|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
131562674|NCT02718417|473686208|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
131562675|NCT02718417|473686209|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
131562676|NCT02718417|473686207|FG000|Long-term Follow-up Phase|Other|0|||
131562677|NCT02718417|473686208|FG001|Long-term Follow-up Phase|Other|2|||
131562678|NCT02718417|473686209|FG002|Long-term Follow-up Phase|Other|0|||
131562679|NCT01474512|473686210|FG000|Induction Period|Adverse Event|6|||
131562680|NCT01474512|473686211|FG001|Induction Period|Adverse Event|10|||
131562681|NCT01474512|473686212|FG002|Induction Period|Adverse Event|10|||
131562682|NCT01474512|473686213|FG003|Induction Period|Adverse Event|0|||
131562683|NCT01474512|473686214|FG004|Induction Period|Adverse Event|0|||
131562684|NCT01474512|473686215|FG005|Induction Period|Adverse Event|0|||
131562685|NCT01474512|473686216|FG006|Induction Period|Adverse Event|0|||
131562686|NCT01474512|473686217|FG007|Induction Period|Adverse Event|0|||
131562687|NCT01474512|473686218|FG008|Induction Period|Adverse Event|0|||
131562688|NCT01474512|473686219|FG009|Induction Period|Adverse Event|0|||
131562689|NCT01474512|473686220|FG010|Induction Period|Adverse Event|0|||
131562690|NCT01474512|473686221|FG011|Induction Period|Adverse Event|0|||
131562691|NCT01474512|473686222|FG012|Induction Period|Adverse Event|0|||
131562692|NCT01474512|473686223|FG013|Induction Period|Adverse Event|0|||
131562693|NCT01474512|473686224|FG014|Induction Period|Adverse Event|0|||
131562694|NCT01474512|473686225|FG015|Induction Period|Adverse Event|0|||
131562695|NCT01474512|473686226|FG016|Induction Period|Adverse Event|0|||
131562696|NCT01474512|473686227|FG017|Induction Period|Adverse Event|0|||
131562697|NCT01474512|473686210|FG000|Induction Period|Lack of Efficacy|7|||
131562698|NCT01474512|473686211|FG001|Induction Period|Lack of Efficacy|1|||
131562699|NCT01474512|473686212|FG002|Induction Period|Lack of Efficacy|0|||
131562700|NCT01474512|473686213|FG003|Induction Period|Lack of Efficacy|0|||
131562701|NCT01474512|473686214|FG004|Induction Period|Lack of Efficacy|0|||
131562702|NCT01474512|473686215|FG005|Induction Period|Lack of Efficacy|0|||
131562703|NCT01474512|473686216|FG006|Induction Period|Lack of Efficacy|0|||
131562704|NCT01474512|473686217|FG007|Induction Period|Lack of Efficacy|0|||
131562705|NCT01474512|473686218|FG008|Induction Period|Lack of Efficacy|0|||
131562706|NCT01474512|473686219|FG009|Induction Period|Lack of Efficacy|0|||
131780920|NCT00742859|474477872|FG003|Overall Study|Site error|1|||
131780921|NCT03972709|474477877|FG000|Overall Study|Withdrawal by Subject|18|||
131780922|NCT03972709|474477878|FG001|Overall Study|Withdrawal by Subject|7|||
131780923|NCT03972709|474477879|FG002|Overall Study|Withdrawal by Subject|14|||
131780924|NCT03972709|474477877|FG000|Overall Study|Study Terminated by Sponsor|48|||
131780925|NCT03972709|474477878|FG001|Overall Study|Study Terminated by Sponsor|25|||
131562707|NCT01474512|473686220|FG010|Induction Period|Lack of Efficacy|0|||
131562708|NCT01474512|473686221|FG011|Induction Period|Lack of Efficacy|0|||
131562709|NCT01474512|473686222|FG012|Induction Period|Lack of Efficacy|0|||
131562710|NCT01474512|473686223|FG013|Induction Period|Lack of Efficacy|0|||
131562711|NCT01474512|473686224|FG014|Induction Period|Lack of Efficacy|0|||
131562712|NCT01474512|473686225|FG015|Induction Period|Lack of Efficacy|0|||
131562713|NCT01474512|473686226|FG016|Induction Period|Lack of Efficacy|0|||
131562714|NCT01474512|473686227|FG017|Induction Period|Lack of Efficacy|0|||
131562715|NCT01474512|473686210|FG000|Induction Period|Withdrawal by Subject|6|||
131562716|NCT01474512|473686211|FG001|Induction Period|Withdrawal by Subject|6|||
131562717|NCT01474512|473686212|FG002|Induction Period|Withdrawal by Subject|5|||
131562718|NCT01474512|473686213|FG003|Induction Period|Withdrawal by Subject|0|||
131562719|NCT01474512|473686214|FG004|Induction Period|Withdrawal by Subject|0|||
131562720|NCT01474512|473686215|FG005|Induction Period|Withdrawal by Subject|0|||
131562721|NCT01474512|473686216|FG006|Induction Period|Withdrawal by Subject|0|||
131562722|NCT01474512|473686217|FG007|Induction Period|Withdrawal by Subject|0|||
131562723|NCT01474512|473686218|FG008|Induction Period|Withdrawal by Subject|0|||
131562724|NCT01474512|473686219|FG009|Induction Period|Withdrawal by Subject|0|||
131562725|NCT01474512|473686220|FG010|Induction Period|Withdrawal by Subject|0|||
131562726|NCT01474512|473686221|FG011|Induction Period|Withdrawal by Subject|0|||
131562727|NCT01474512|473686222|FG012|Induction Period|Withdrawal by Subject|0|||
131562728|NCT01474512|473686223|FG013|Induction Period|Withdrawal by Subject|0|||
131562729|NCT01474512|473686224|FG014|Induction Period|Withdrawal by Subject|0|||
131562730|NCT01474512|473686225|FG015|Induction Period|Withdrawal by Subject|0|||
131562731|NCT01474512|473686226|FG016|Induction Period|Withdrawal by Subject|0|||
131562732|NCT01474512|473686227|FG017|Induction Period|Withdrawal by Subject|0|||
131562733|NCT01474512|473686210|FG000|Induction Period|Protocol Violation|3|||
131562734|NCT01474512|473686211|FG001|Induction Period|Protocol Violation|6|||
131562735|NCT01474512|473686212|FG002|Induction Period|Protocol Violation|0|||
131562736|NCT01474512|473686213|FG003|Induction Period|Protocol Violation|0|||
131562737|NCT01474512|473686214|FG004|Induction Period|Protocol Violation|0|||
131562738|NCT01474512|473686215|FG005|Induction Period|Protocol Violation|0|||
131562739|NCT01474512|473686216|FG006|Induction Period|Protocol Violation|0|||
131562740|NCT01474512|473686217|FG007|Induction Period|Protocol Violation|0|||
131562741|NCT01474512|473686218|FG008|Induction Period|Protocol Violation|0|||
131562742|NCT01474512|473686219|FG009|Induction Period|Protocol Violation|0|||
131780926|NCT03972709|474477879|FG002|Overall Study|Study Terminated by Sponsor|50|||
131780927|NCT03972709|474477877|FG000|Overall Study|Physician Decision|1|||
131780928|NCT03972709|474477878|FG001|Overall Study|Physician Decision|0|||
131780929|NCT03972709|474477879|FG002|Overall Study|Physician Decision|0|||
131780930|NCT03972709|474477877|FG000|Overall Study|COVID-19|0|||
131780931|NCT03972709|474477878|FG001|Overall Study|COVID-19|1|||
131780932|NCT03972709|474477879|FG002|Overall Study|COVID-19|1|||
131780933|NCT03972709|474477877|FG000|Overall Study|Lost to Follow-up|6|||
131780934|NCT03972709|474477878|FG001|Overall Study|Lost to Follow-up|1|||
131780935|NCT03972709|474477879|FG002|Overall Study|Lost to Follow-up|2|||
131780936|NCT03972709|474477877|FG000|Overall Study|Death|5|||
131780937|NCT03972709|474477878|FG001|Overall Study|Death|1|||
131780938|NCT03972709|474477879|FG002|Overall Study|Death|4|||
131780939|NCT03972709|474477877|FG000|Overall Study|Adverse Event|3|||
131780940|NCT03972709|474477878|FG001|Overall Study|Adverse Event|1|||
131780941|NCT03972709|474477879|FG002|Overall Study|Adverse Event|4|||
131780942|NCT03972709|474477877|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
131780943|NCT03972709|474477878|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
131780944|NCT03972709|474477879|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
131780945|NCT03972709|474477877|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
131780946|NCT03972709|474477878|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
131780947|NCT03972709|474477879|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
131780948|NCT03972709|474477877|FG000|Overall Study|Subject Unable to be Contacted|0|||
131780949|NCT03972709|474477878|FG001|Overall Study|Subject Unable to be Contacted|1|||
131780950|NCT03972709|474477879|FG002|Overall Study|Subject Unable to be Contacted|0|||
131780951|NCT03972709|474477877|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
131780952|NCT03972709|474477878|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
131780953|NCT03972709|474477879|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
131780954|NCT03972709|474477877|FG000|Overall Study|Subject Moved|0|||
131780955|NCT03972709|474477878|FG001|Overall Study|Subject Moved|1|||
131780956|NCT03972709|474477879|FG002|Overall Study|Subject Moved|0|||
131780957|NCT03972709|474477877|FG000|Overall Study|Missed Study Visits|1|||
131780958|NCT03972709|474477878|FG001|Overall Study|Missed Study Visits|0|||
131780959|NCT03972709|474477879|FG002|Overall Study|Missed Study Visits|0|||
131780960|NCT01984229|474477880|FG000|Safety Follow-up Period|Adverse Event|1|||
131780961|NCT01984229|474477881|FG001|Safety Follow-up Period|Adverse Event|1|||
131780962|NCT01984229|474477880|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
131780963|NCT01984229|474477881|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
131780964|NCT02072174|474477882|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
131780965|NCT02072174|474477883|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
131780966|NCT02072174|474477882|FG000|Overall Study|Protocol Violation|16|||
131780967|NCT02072174|474477883|FG001|Overall Study|Protocol Violation|23|||
131780968|NCT02072174|474477882|FG000|Overall Study|Physician Decision|0|||
131780969|NCT02072174|474477883|FG001|Overall Study|Physician Decision|1|||
131780970|NCT02072174|474477882|FG000|Overall Study|Non-compliance with protocol requirement|2|||
131780971|NCT02072174|474477883|FG001|Overall Study|Non-compliance with protocol requirement|0|||
131780972|NCT05674721|474477885|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
131780973|NCT05674721|474477886|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
131780974|NCT05674721|474477885|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
131780975|NCT05674721|474477886|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
131780976|NCT05013749|474477902|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
131780977|NCT05013749|474477903|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
131780978|NCT05013749|474477902|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
131780979|NCT05013749|474477903|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
131780980|NCT02017535|474477904|FG000|Overall Study|Withdrawal by Subject|1|||
131780981|NCT02017535|474477905|FG001|Overall Study|Withdrawal by Subject|0|||
131780982|NCT02017535|474477906|FG002|Overall Study|Withdrawal by Subject|0|||
131780983|NCT02017535|474477907|FG003|Overall Study|Withdrawal by Subject|0|||
131780984|NCT01393626|474477908|FG000|Overall Study|Adverse Event|2|||
131780985|NCT01393626|474477909|FG001|Overall Study|Adverse Event|1|||
131780986|NCT01393626|474477910|FG002|Overall Study|Adverse Event|5|||
131780987|NCT01393626|474477911|FG003|Overall Study|Adverse Event|0|||
131780988|NCT01393626|474477908|FG000|Overall Study|Did not meet entrance criteria|1|||
131780989|NCT01393626|474477909|FG001|Overall Study|Did not meet entrance criteria|0|||
131780990|NCT01393626|474477910|FG002|Overall Study|Did not meet entrance criteria|0|||
131780991|NCT01393626|474477911|FG003|Overall Study|Did not meet entrance criteria|0|||
131780992|NCT01393626|474477908|FG000|Overall Study|Lack of Efficacy|6|||
131780993|NCT01393626|474477909|FG001|Overall Study|Lack of Efficacy|6|||
131780994|NCT01393626|474477910|FG002|Overall Study|Lack of Efficacy|4|||
131780995|NCT01393626|474477911|FG003|Overall Study|Lack of Efficacy|1|||
131436804|NCT02079740|473225608|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
131562743|NCT01474512|473686220|FG010|Induction Period|Protocol Violation|0|||
131695999|NCT02543528|474170325|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
131696000|NCT02543528|474170326|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
131696001|NCT02543528|474170327|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
131696002|NCT02543528|474170328|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
131696003|NCT02543528|474170324|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
131696004|NCT02543528|474170325|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131696005|NCT02543528|474170326|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131696006|NCT02543528|474170327|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131696007|NCT02543528|474170328|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131696008|NCT02543528|474170324|FG000|Extended Wear Period|Lost to Follow-up|0|||
131696009|NCT02543528|474170325|FG001|Extended Wear Period|Lost to Follow-up|1|||
131696010|NCT02543528|474170326|FG002|Extended Wear Period|Lost to Follow-up|2|||
131696011|NCT02543528|474170327|FG003|Extended Wear Period|Lost to Follow-up|1|||
131696012|NCT02543528|474170328|FG004|Extended Wear Period|Lost to Follow-up|0|||
131696013|NCT02543528|474170324|FG000|Extended Wear Period|Withdrawal by Subject|10|||
131696014|NCT02543528|474170325|FG001|Extended Wear Period|Withdrawal by Subject|9|||
131696015|NCT02543528|474170326|FG002|Extended Wear Period|Withdrawal by Subject|4|||
131696016|NCT02543528|474170327|FG003|Extended Wear Period|Withdrawal by Subject|5|||
131696017|NCT02543528|474170328|FG004|Extended Wear Period|Withdrawal by Subject|0|||
131696018|NCT01408147|474170329|FG000|Overall Study|Withdrawal by Subject|0|||
131696019|NCT01408147|474170330|FG001|Overall Study|Withdrawal by Subject|1|||
131696020|NCT05048719|474170331|FG000|Overall Study|Withdrawal by Subject|2|||
131696021|NCT05048719|474170332|FG001|Overall Study|Withdrawal by Subject|1|||
131696022|NCT05048719|474170333|FG002|Overall Study|Withdrawal by Subject|3|||
131696023|NCT05048719|474170334|FG003|Overall Study|Withdrawal by Subject|1|||
131696024|NCT05048719|474170335|FG004|Overall Study|Withdrawal by Subject|0|||
131696025|NCT05048719|474170336|FG005|Overall Study|Withdrawal by Subject|2|||
131696026|NCT05048719|474170337|FG006|Overall Study|Withdrawal by Subject|1|||
131696027|NCT05048719|474170338|FG007|Overall Study|Withdrawal by Subject|1|||
131696028|NCT05048719|474170339|FG008|Overall Study|Withdrawal by Subject|0|||
131696029|NCT05048719|474170331|FG000|Overall Study|Death|1|||
131696030|NCT05048719|474170332|FG001|Overall Study|Death|0|||
131696031|NCT05048719|474170333|FG002|Overall Study|Death|0|||
131696032|NCT05048719|474170334|FG003|Overall Study|Death|0|||
131696033|NCT05048719|474170335|FG004|Overall Study|Death|0|||
131696034|NCT05048719|474170336|FG005|Overall Study|Death|0|||
131696035|NCT05048719|474170337|FG006|Overall Study|Death|0|||
131696036|NCT05048719|474170338|FG007|Overall Study|Death|0|||
131696037|NCT05048719|474170339|FG008|Overall Study|Death|0|||
131696038|NCT05048719|474170331|FG000|Overall Study|Adverse Event|0|||
131696039|NCT05048719|474170332|FG001|Overall Study|Adverse Event|1|||
131696040|NCT05048719|474170333|FG002|Overall Study|Adverse Event|2|||
131696041|NCT05048719|474170334|FG003|Overall Study|Adverse Event|0|||
131696042|NCT05048719|474170335|FG004|Overall Study|Adverse Event|1|||
131696043|NCT05048719|474170336|FG005|Overall Study|Adverse Event|0|||
131696044|NCT05048719|474170337|FG006|Overall Study|Adverse Event|0|||
131696045|NCT05048719|474170338|FG007|Overall Study|Adverse Event|0|||
131696046|NCT05048719|474170339|FG008|Overall Study|Adverse Event|0|||
131696047|NCT05048719|474170331|FG000|Overall Study|Lost to Follow-up|0|||
131696048|NCT05048719|474170332|FG001|Overall Study|Lost to Follow-up|0|||
131696049|NCT05048719|474170333|FG002|Overall Study|Lost to Follow-up|1|||
131696050|NCT05048719|474170334|FG003|Overall Study|Lost to Follow-up|3|||
131696051|NCT05048719|474170335|FG004|Overall Study|Lost to Follow-up|1|||
131696052|NCT05048719|474170336|FG005|Overall Study|Lost to Follow-up|1|||
131696053|NCT05048719|474170337|FG006|Overall Study|Lost to Follow-up|1|||
131696054|NCT05048719|474170338|FG007|Overall Study|Lost to Follow-up|1|||
131696055|NCT05048719|474170339|FG008|Overall Study|Lost to Follow-up|0|||
131696056|NCT05048719|474170331|FG000|Overall Study|Physician Decision|0|||
131696057|NCT05048719|474170332|FG001|Overall Study|Physician Decision|0|||
131696058|NCT05048719|474170333|FG002|Overall Study|Physician Decision|0|||
131696059|NCT05048719|474170334|FG003|Overall Study|Physician Decision|0|||
131696060|NCT05048719|474170335|FG004|Overall Study|Physician Decision|0|||
131696061|NCT05048719|474170336|FG005|Overall Study|Physician Decision|0|||
131696062|NCT05048719|474170337|FG006|Overall Study|Physician Decision|0|||
131696063|NCT05048719|474170338|FG007|Overall Study|Physician Decision|1|||
131696064|NCT05048719|474170339|FG008|Overall Study|Physician Decision|1|||
131696065|NCT05048719|474170331|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
131696066|NCT05048719|474170332|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696067|NCT05048719|474170333|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696068|NCT05048719|474170334|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696069|NCT05048719|474170335|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696070|NCT05048719|474170336|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696071|NCT05048719|474170337|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696072|NCT05048719|474170338|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131562744|NCT01474512|473686221|FG011|Induction Period|Protocol Violation|0|||
131562745|NCT01474512|473686222|FG012|Induction Period|Protocol Violation|0|||
131562746|NCT01474512|473686223|FG013|Induction Period|Protocol Violation|0|||
131562747|NCT01474512|473686224|FG014|Induction Period|Protocol Violation|0|||
131562748|NCT01474512|473686225|FG015|Induction Period|Protocol Violation|0|||
131562749|NCT01474512|473686226|FG016|Induction Period|Protocol Violation|0|||
131562750|NCT01474512|473686227|FG017|Induction Period|Protocol Violation|0|||
131562751|NCT01474512|473686210|FG000|Induction Period|Sponsor Decision|1|||
131562752|NCT01474512|473686211|FG001|Induction Period|Sponsor Decision|1|||
131562753|NCT01474512|473686212|FG002|Induction Period|Sponsor Decision|1|||
131562754|NCT01474512|473686213|FG003|Induction Period|Sponsor Decision|0|||
131562755|NCT01474512|473686214|FG004|Induction Period|Sponsor Decision|0|||
131562756|NCT01474512|473686215|FG005|Induction Period|Sponsor Decision|0|||
131562757|NCT01474512|473686216|FG006|Induction Period|Sponsor Decision|0|||
131562758|NCT01474512|473686217|FG007|Induction Period|Sponsor Decision|0|||
131562759|NCT01474512|473686218|FG008|Induction Period|Sponsor Decision|0|||
131562760|NCT01474512|473686219|FG009|Induction Period|Sponsor Decision|0|||
131562761|NCT01474512|473686220|FG010|Induction Period|Sponsor Decision|0|||
131562762|NCT01474512|473686221|FG011|Induction Period|Sponsor Decision|0|||
131562763|NCT01474512|473686222|FG012|Induction Period|Sponsor Decision|0|||
131562764|NCT01474512|473686223|FG013|Induction Period|Sponsor Decision|0|||
131562765|NCT01474512|473686224|FG014|Induction Period|Sponsor Decision|0|||
131562766|NCT01474512|473686225|FG015|Induction Period|Sponsor Decision|0|||
131562767|NCT01474512|473686226|FG016|Induction Period|Sponsor Decision|0|||
131562768|NCT01474512|473686227|FG017|Induction Period|Sponsor Decision|0|||
131562769|NCT01474512|473686210|FG000|Induction Period|Lost to Follow-up|1|||
131562770|NCT01474512|473686211|FG001|Induction Period|Lost to Follow-up|0|||
131562771|NCT01474512|473686212|FG002|Induction Period|Lost to Follow-up|2|||
131562772|NCT01474512|473686213|FG003|Induction Period|Lost to Follow-up|0|||
131562773|NCT01474512|473686214|FG004|Induction Period|Lost to Follow-up|0|||
131780996|NCT01393626|474477908|FG000|Overall Study|Lost to Follow-up|1|||
131780997|NCT01393626|474477909|FG001|Overall Study|Lost to Follow-up|1|||
131780998|NCT01393626|474477910|FG002|Overall Study|Lost to Follow-up|1|||
131780999|NCT01393626|474477911|FG003|Overall Study|Lost to Follow-up|0|||
131781000|NCT01393626|474477908|FG000|Overall Study|Withdrawal by Subject|6|||
131781001|NCT01393626|474477909|FG001|Overall Study|Withdrawal by Subject|4|||
131781002|NCT01393626|474477910|FG002|Overall Study|Withdrawal by Subject|0|||
131781003|NCT01393626|474477911|FG003|Overall Study|Withdrawal by Subject|0|||
131562774|NCT01474512|473686215|FG005|Induction Period|Lost to Follow-up|0|||
131562775|NCT01474512|473686216|FG006|Induction Period|Lost to Follow-up|0|||
131562776|NCT01474512|473686217|FG007|Induction Period|Lost to Follow-up|0|||
131562777|NCT01474512|473686218|FG008|Induction Period|Lost to Follow-up|0|||
131562778|NCT01474512|473686219|FG009|Induction Period|Lost to Follow-up|0|||
131562779|NCT01474512|473686220|FG010|Induction Period|Lost to Follow-up|0|||
131562780|NCT01474512|473686221|FG011|Induction Period|Lost to Follow-up|0|||
131562781|NCT01474512|473686222|FG012|Induction Period|Lost to Follow-up|0|||
131562782|NCT01474512|473686223|FG013|Induction Period|Lost to Follow-up|0|||
131562783|NCT01474512|473686224|FG014|Induction Period|Lost to Follow-up|0|||
131696073|NCT05048719|474170339|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131696074|NCT05048719|474170331|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696075|NCT05048719|474170332|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
131696076|NCT05048719|474170333|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696077|NCT05048719|474170334|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696078|NCT05048719|474170335|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696079|NCT05048719|474170336|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696080|NCT05048719|474170337|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696081|NCT05048719|474170338|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696082|NCT05048719|474170339|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131696083|NCT05048719|474170331|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696084|NCT05048719|474170332|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
131696085|NCT05048719|474170333|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696086|NCT05048719|474170334|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696087|NCT05048719|474170335|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696088|NCT05048719|474170336|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696089|NCT05048719|474170337|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696090|NCT05048719|474170338|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131696091|NCT05048719|474170339|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131781004|NCT01393626|474477908|FG000|Overall Study|Other|1|||
131781005|NCT01393626|474477909|FG001|Overall Study|Other|0|||
131781006|NCT01393626|474477910|FG002|Overall Study|Other|0|||
131781007|NCT01393626|474477911|FG003|Overall Study|Other|0|||
131898600|NCT05259163|474915302|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
131898601|NCT01381926|474915305|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
131898602|NCT01381926|474915306|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
131898603|NCT01381926|474915305|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
131898604|NCT01381926|474915306|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
131898605|NCT02624947|474915307|FG000|Maternal Participants|Adverse Event|5|||
131898606|NCT02624947|474915308|FG001|Maternal Participants|Adverse Event|0|||
131898607|NCT02624947|474915307|FG000|Maternal Participants|Investigator Decision|5|||
131898608|NCT02624947|474915308|FG001|Maternal Participants|Investigator Decision|3|||
131898609|NCT02624947|474915307|FG000|Maternal Participants|Lost to Follow-up|54|||
131898610|NCT02624947|474915308|FG001|Maternal Participants|Lost to Follow-up|24|||
131898611|NCT02624947|474915307|FG000|Maternal Participants|Non Compliance|8|||
131898612|NCT02624947|474915308|FG001|Maternal Participants|Non Compliance|5|||
131898613|NCT02624947|474915307|FG000|Maternal Participants|Sponsor Request|1|||
131898614|NCT02624947|474915308|FG001|Maternal Participants|Sponsor Request|1|||
131562784|NCT01474512|473686225|FG015|Induction Period|Lost to Follow-up|0|||
131562785|NCT01474512|473686226|FG016|Induction Period|Lost to Follow-up|0|||
131562786|NCT01474512|473686227|FG017|Induction Period|Lost to Follow-up|0|||
131562787|NCT01474512|473686210|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562788|NCT01474512|473686211|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562789|NCT01474512|473686212|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562790|NCT01474512|473686213|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
131562791|NCT01474512|473686214|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
131562792|NCT01474512|473686215|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
131562793|NCT01474512|473686216|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
131562794|NCT01474512|473686217|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562795|NCT01474512|473686218|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562796|NCT01474512|473686219|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562797|NCT01474512|473686220|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562798|NCT01474512|473686221|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562799|NCT01474512|473686222|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562800|NCT01474512|473686223|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562801|NCT01474512|473686224|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562802|NCT01474512|473686225|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562803|NCT01474512|473686226|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562804|NCT01474512|473686227|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131562805|NCT01474512|473686210|FG000|Maintenance Period|Adverse Event|0|||
131562806|NCT01474512|473686211|FG001|Maintenance Period|Adverse Event|0|||
131562807|NCT01474512|473686212|FG002|Maintenance Period|Adverse Event|0|||
131562808|NCT01474512|473686213|FG003|Maintenance Period|Adverse Event|4|||
131562809|NCT01474512|473686214|FG004|Maintenance Period|Adverse Event|2|||
131562810|NCT01474512|473686215|FG005|Maintenance Period|Adverse Event|7|||
131562811|NCT01474512|473686216|FG006|Maintenance Period|Adverse Event|0|||
131562812|NCT01474512|473686217|FG007|Maintenance Period|Adverse Event|19|||
131562813|NCT01474512|473686218|FG008|Maintenance Period|Adverse Event|1|||
131562814|NCT01474512|473686219|FG009|Maintenance Period|Adverse Event|3|||
131562815|NCT01474512|473686220|FG010|Maintenance Period|Adverse Event|0|||
131562816|NCT01474512|473686221|FG011|Maintenance Period|Adverse Event|0|||
131562817|NCT01474512|473686222|FG012|Maintenance Period|Adverse Event|0|||
131562818|NCT01474512|473686223|FG013|Maintenance Period|Adverse Event|0|||
131562819|NCT01474512|473686224|FG014|Maintenance Period|Adverse Event|0|||
131562820|NCT01474512|473686225|FG015|Maintenance Period|Adverse Event|0|||
131562821|NCT01474512|473686226|FG016|Maintenance Period|Adverse Event|0|||
131562822|NCT01474512|473686227|FG017|Maintenance Period|Adverse Event|0|||
131562823|NCT01474512|473686210|FG000|Maintenance Period|Withdrawal by Subject|0|||
131562824|NCT01474512|473686211|FG001|Maintenance Period|Withdrawal by Subject|0|||
131562825|NCT01474512|473686212|FG002|Maintenance Period|Withdrawal by Subject|0|||
131562826|NCT01474512|473686213|FG003|Maintenance Period|Withdrawal by Subject|6|||
131562827|NCT01474512|473686214|FG004|Maintenance Period|Withdrawal by Subject|2|||
131562828|NCT01474512|473686215|FG005|Maintenance Period|Withdrawal by Subject|3|||
131562829|NCT01474512|473686216|FG006|Maintenance Period|Withdrawal by Subject|1|||
131562830|NCT01474512|473686217|FG007|Maintenance Period|Withdrawal by Subject|6|||
131562831|NCT01474512|473686218|FG008|Maintenance Period|Withdrawal by Subject|3|||
131562832|NCT01474512|473686219|FG009|Maintenance Period|Withdrawal by Subject|1|||
131562833|NCT01474512|473686220|FG010|Maintenance Period|Withdrawal by Subject|0|||
131562834|NCT01474512|473686221|FG011|Maintenance Period|Withdrawal by Subject|0|||
131562835|NCT01474512|473686222|FG012|Maintenance Period|Withdrawal by Subject|0|||
131562836|NCT01474512|473686223|FG013|Maintenance Period|Withdrawal by Subject|0|||
131562837|NCT01474512|473686224|FG014|Maintenance Period|Withdrawal by Subject|0|||
131562838|NCT01474512|473686225|FG015|Maintenance Period|Withdrawal by Subject|0|||
131562839|NCT01474512|473686226|FG016|Maintenance Period|Withdrawal by Subject|0|||
131562840|NCT01474512|473686227|FG017|Maintenance Period|Withdrawal by Subject|0|||
131562841|NCT01474512|473686210|FG000|Maintenance Period|Lost to Follow-up|0|||
131562842|NCT01474512|473686211|FG001|Maintenance Period|Lost to Follow-up|0|||
131562843|NCT01474512|473686212|FG002|Maintenance Period|Lost to Follow-up|0|||
131562844|NCT01474512|473686213|FG003|Maintenance Period|Lost to Follow-up|3|||
131562845|NCT01474512|473686214|FG004|Maintenance Period|Lost to Follow-up|3|||
131562846|NCT01474512|473686215|FG005|Maintenance Period|Lost to Follow-up|0|||
131696092|NCT05048719|474170331|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696093|NCT05048719|474170332|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696094|NCT05048719|474170333|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696095|NCT05048719|474170334|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
131696096|NCT05048719|474170335|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696097|NCT05048719|474170336|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131562847|NCT01474512|473686216|FG006|Maintenance Period|Lost to Follow-up|0|||
131562848|NCT01474512|473686217|FG007|Maintenance Period|Lost to Follow-up|2|||
131562849|NCT01474512|473686218|FG008|Maintenance Period|Lost to Follow-up|1|||
131562850|NCT01474512|473686219|FG009|Maintenance Period|Lost to Follow-up|1|||
131562851|NCT01474512|473686220|FG010|Maintenance Period|Lost to Follow-up|0|||
131562852|NCT01474512|473686221|FG011|Maintenance Period|Lost to Follow-up|0|||
131562853|NCT01474512|473686222|FG012|Maintenance Period|Lost to Follow-up|0|||
131562854|NCT01474512|473686223|FG013|Maintenance Period|Lost to Follow-up|0|||
131562855|NCT01474512|473686224|FG014|Maintenance Period|Lost to Follow-up|0|||
131562856|NCT01474512|473686225|FG015|Maintenance Period|Lost to Follow-up|0|||
131562857|NCT01474512|473686226|FG016|Maintenance Period|Lost to Follow-up|0|||
131562858|NCT01474512|473686227|FG017|Maintenance Period|Lost to Follow-up|0|||
131562859|NCT01474512|473686210|FG000|Maintenance Period|Death|0|||
131562860|NCT01474512|473686211|FG001|Maintenance Period|Death|0|||
131562861|NCT01474512|473686212|FG002|Maintenance Period|Death|0|||
131562862|NCT01474512|473686213|FG003|Maintenance Period|Death|0|||
131562863|NCT01474512|473686214|FG004|Maintenance Period|Death|0|||
131562864|NCT01474512|473686215|FG005|Maintenance Period|Death|2|||
131562865|NCT01474512|473686216|FG006|Maintenance Period|Death|0|||
131562866|NCT01474512|473686217|FG007|Maintenance Period|Death|0|||
131562867|NCT01474512|473686218|FG008|Maintenance Period|Death|0|||
131562868|NCT01474512|473686219|FG009|Maintenance Period|Death|0|||
131562869|NCT01474512|473686220|FG010|Maintenance Period|Death|0|||
131562870|NCT01474512|473686221|FG011|Maintenance Period|Death|0|||
131562871|NCT01474512|473686222|FG012|Maintenance Period|Death|0|||
131562872|NCT01474512|473686223|FG013|Maintenance Period|Death|0|||
131562873|NCT01474512|473686224|FG014|Maintenance Period|Death|0|||
131696098|NCT05048719|474170337|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696099|NCT05048719|474170338|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696100|NCT05048719|474170339|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131696101|NCT05048719|474170331|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696102|NCT05048719|474170332|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696103|NCT05048719|474170333|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696104|NCT05048719|474170334|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696105|NCT05048719|474170335|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696106|NCT05048719|474170336|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
131696107|NCT05048719|474170337|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696108|NCT05048719|474170338|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696109|NCT05048719|474170339|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131696110|NCT03257267|474170340|FG000|Overall Study|Adverse Event|17|||
131696111|NCT03257267|474170341|FG001|Overall Study|Adverse Event|7|||
131696112|NCT03257267|474170340|FG000|Overall Study|Death|96|||
131696113|NCT03257267|474170341|FG001|Overall Study|Death|98|||
131696114|NCT03257267|474170340|FG000|Overall Study|Lost to Follow-up|2|||
131696115|NCT03257267|474170341|FG001|Overall Study|Lost to Follow-up|2|||
131696116|NCT03257267|474170340|FG000|Overall Study|Non-compliance with Study Drug|0|||
131696117|NCT03257267|474170341|FG001|Overall Study|Non-compliance with Study Drug|2|||
131696118|NCT03257267|474170340|FG000|Overall Study|Participant Decision|35|||
131696119|NCT03257267|474170341|FG001|Overall Study|Participant Decision|43|||
131696120|NCT03257267|474170340|FG000|Overall Study|Sponsor Decision|1|||
131696121|NCT03257267|474170341|FG001|Overall Study|Sponsor Decision|0|||
131696122|NCT03257267|474170340|FG000|Overall Study|Physician Decision|1|||
131696123|NCT03257267|474170341|FG001|Overall Study|Physician Decision|3|||
131696124|NCT03257267|474170340|FG000|Overall Study|Disease Progression|109|||
131696125|NCT03257267|474170341|FG001|Overall Study|Disease Progression|121|||
131696126|NCT03257267|474170340|FG000|Overall Study|Withdrawal by Subject|8|||
131696127|NCT03257267|474170341|FG001|Overall Study|Withdrawal by Subject|26|||
131696128|NCT03257267|474170340|FG000|Overall Study|Other|0|||
131696129|NCT03257267|474170341|FG001|Overall Study|Other|2|||
131696130|NCT01979523|474170342|FG000|Overall Study|Withdrawal by Subject|1|||
131696131|NCT01979523|474170343|FG001|Overall Study|Withdrawal by Subject|0|||
131696132|NCT00706134|474170344|FG000|Overall Study|Adverse Event|8|||
131696133|NCT00706134|474170345|FG001|Overall Study|Adverse Event|7|||
131562874|NCT01474512|473686225|FG015|Maintenance Period|Death|0|||
131562875|NCT01474512|473686226|FG016|Maintenance Period|Death|0|||
131562876|NCT01474512|473686227|FG017|Maintenance Period|Death|0|||
131562877|NCT01474512|473686210|FG000|Maintenance Period|Physician Decision|0|||
131562878|NCT01474512|473686211|FG001|Maintenance Period|Physician Decision|0|||
131562879|NCT01474512|473686212|FG002|Maintenance Period|Physician Decision|0|||
131562880|NCT01474512|473686213|FG003|Maintenance Period|Physician Decision|0|||
131696134|NCT00706134|474170346|FG002|Overall Study|Adverse Event|2|||
131781008|NCT01393626|474477908|FG000|Overall Study|Protocol Violation|1|||
131781009|NCT01393626|474477909|FG001|Overall Study|Protocol Violation|0|||
131781010|NCT01393626|474477910|FG002|Overall Study|Protocol Violation|2|||
131781011|NCT01393626|474477911|FG003|Overall Study|Protocol Violation|0|||
131781012|NCT02426125|474477912|FG000|Overall Study|Lost to Follow-up|14|||
131781013|NCT02426125|474477913|FG001|Overall Study|Lost to Follow-up|12|||
131781014|NCT02426125|474477912|FG000|Overall Study|Withdrawal by Subject|13|||
131781015|NCT02426125|474477913|FG001|Overall Study|Withdrawal by Subject|14|||
131781016|NCT02426125|474477912|FG000|Overall Study|Death|185|||
131781017|NCT02426125|474477913|FG001|Overall Study|Death|200|||
131781018|NCT02426125|474477912|FG000|Overall Study|Randomized, But Never Treated|5|||
131781019|NCT02426125|474477913|FG001|Overall Study|Randomized, But Never Treated|2|||
131781020|NCT02858076|474477914|FG000|Overall Study|Death|6|||
131781021|NCT02858076|474477915|FG001|Overall Study|Death|3|||
131781022|NCT02858076|474477914|FG000|Overall Study|Withdrawal by Subject|1|||
131781023|NCT02858076|474477915|FG001|Overall Study|Withdrawal by Subject|5|||
131781024|NCT02858076|474477914|FG000|Overall Study|Lost to Follow-up|2|||
131781025|NCT02858076|474477915|FG001|Overall Study|Lost to Follow-up|7|||
131781026|NCT02858076|474477914|FG000|Overall Study|Completed Out of Window|1|||
131781027|NCT02858076|474477915|FG001|Overall Study|Completed Out of Window|3|||
131781028|NCT03506425|474477916|FG000|Overall Study|Adverse Event|1|||
131781029|NCT03506425|474477917|FG001|Overall Study|Adverse Event|3|||
131781030|NCT03506425|474477918|FG002|Overall Study|Adverse Event|0|||
131781031|NCT03506425|474477916|FG000|Overall Study|Death|1|||
131781032|NCT03506425|474477917|FG001|Overall Study|Death|0|||
131781033|NCT03506425|474477918|FG002|Overall Study|Death|0|||
131781034|NCT03506425|474477916|FG000|Overall Study|Withdrawal by Subject|0|||
131781035|NCT03506425|474477917|FG001|Overall Study|Withdrawal by Subject|0|||
131781036|NCT03506425|474477918|FG002|Overall Study|Withdrawal by Subject|1|||
131781037|NCT00834366|474477922|FG000|Treatment Period 1|Adverse Event|1|||
131781038|NCT00834366|474477923|FG001|Treatment Period 1|Adverse Event|1|||
131781039|NCT02380248|474477925|FG000|Overall Study|Lost to Follow-up|11|||
131781040|NCT02380248|474477925|FG000|Overall Study|Withdrawal by Subject|3|||
131781041|NCT01275170|474477926|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
131781042|NCT01275170|474477927|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781043|NCT01275170|474477928|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781044|NCT01275170|474477929|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781045|NCT01275170|474477930|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781046|NCT01275170|474477931|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781047|NCT01275170|474477932|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781048|NCT01275170|474477933|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
131781049|NCT00314262|474477939|FG000|Overall Study|Adverse Event|2|||
131781050|NCT00314262|474477939|FG000|Overall Study|Withdrawal by Subject|2|||
131781051|NCT00314262|474477939|FG000|Overall Study|Physician Decision|1|||
131781052|NCT00083226|474477940|FG000|Overall Study|Lack of Efficacy|19|||
131781053|NCT00083226|474477940|FG000|Overall Study|Adverse Event|9|||
131781054|NCT00083226|474477940|FG000|Overall Study|Death|4|||
131781055|NCT00083226|474477940|FG000|Overall Study|Withdrawal by Subject|4|||
131781056|NCT00083226|474477940|FG000|Overall Study|Other|2|||
131781057|NCT00083226|474477940|FG000|Overall Study|ineligible or not receiving treatment|4|||
131781058|NCT00604175|474477947|FG000|Entry Through Week 28|Death|2|||
131781059|NCT00604175|474477948|FG001|Entry Through Week 28|Death|0|||
131781060|NCT00604175|474477949|FG002|Entry Through Week 28|Death|0|||
131781061|NCT00604175|474477947|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
131781062|NCT00604175|474477948|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
131781063|NCT00604175|474477949|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
131781064|NCT00604175|474477947|FG000|Entry Through Week 28|Lost to Follow-up|4|||
131781065|NCT00604175|474477948|FG001|Entry Through Week 28|Lost to Follow-up|3|||
131781066|NCT00604175|474477949|FG002|Entry Through Week 28|Lost to Follow-up|0|||
131781067|NCT00604175|474477947|FG000|Entry Through Week 28|Ineligible|1|||
131781068|NCT00604175|474477948|FG001|Entry Through Week 28|Ineligible|0|||
131781069|NCT00604175|474477949|FG002|Entry Through Week 28|Ineligible|0|||
131781070|NCT00604175|474477947|FG000|Entry Through Week 28|Did not start intervention|2|||
131781071|NCT00604175|474477948|FG001|Entry Through Week 28|Did not start intervention|0|||
131781072|NCT00604175|474477949|FG002|Entry Through Week 28|Did not start intervention|1|||
131781073|NCT00604175|474477947|FG000|Week 29 Through Week 72|Death|0|||
131781074|NCT00604175|474477948|FG001|Week 29 Through Week 72|Death|0|||
131781075|NCT00604175|474477949|FG002|Week 29 Through Week 72|Death|1|||
131781076|NCT00604175|474477947|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
131781077|NCT00604175|474477948|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
131781078|NCT00604175|474477949|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
131781079|NCT00604175|474477947|FG000|Week 29 Through Week 72|Site closure|0|||
131781080|NCT00604175|474477948|FG001|Week 29 Through Week 72|Site closure|1|||
131781081|NCT00604175|474477949|FG002|Week 29 Through Week 72|Site closure|0|||
131781082|NCT00604175|474477947|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
131781083|NCT00604175|474477948|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
131781084|NCT00604175|474477949|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
131562881|NCT01474512|473686214|FG004|Maintenance Period|Physician Decision|0|||
131562882|NCT01474512|473686215|FG005|Maintenance Period|Physician Decision|1|||
131562883|NCT01474512|473686216|FG006|Maintenance Period|Physician Decision|0|||
131562884|NCT01474512|473686217|FG007|Maintenance Period|Physician Decision|2|||
131781085|NCT02044094|474477950|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
131781086|NCT02044094|474477950|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
131781087|NCT02044094|474477950|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
131781088|NCT02044094|474477950|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
131781089|NCT02044094|474477950|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
131781090|NCT02044094|474477950|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
131781091|NCT02044094|474477950|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
131781092|NCT02044094|474477950|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
131781093|NCT02038959|474479389|FG000|Overall Study|Withdrawal by Subject|6|||
131781094|NCT02038959|474479390|FG001|Overall Study|Withdrawal by Subject|8|||
131781095|NCT03515837|474479397|FG000|Overall Study|Death|219|||
131781096|NCT03515837|474479398|FG001|Overall Study|Death|227|||
131781097|NCT03515837|474479397|FG000|Overall Study|Lost to Follow-up|0|||
131781098|NCT03515837|474479398|FG001|Overall Study|Lost to Follow-up|1|||
131781099|NCT03515837|474479397|FG000|Overall Study|Withdrawal by Subject|0|||
131781100|NCT03515837|474479398|FG001|Overall Study|Withdrawal by Subject|4|||
131781101|NCT03515837|474479397|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
131781102|NCT03515837|474479398|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
131781103|NCT01964898|474479399|FG000|Overall Study|ineligible post-randomization|1|||
131781104|NCT01964898|474479400|FG001|Overall Study|ineligible post-randomization|1|||
131781105|NCT01964898|474479399|FG000|Overall Study|did not receive the allocated interventi|2|||
131781106|NCT01964898|474479400|FG001|Overall Study|did not receive the allocated interventi|1|||
131781107|NCT01964898|474479399|FG000|Overall Study|Lost to Follow-up|3|||
131781108|NCT01964898|474479400|FG001|Overall Study|Lost to Follow-up|5|||
131781109|NCT01964898|474479399|FG000|Overall Study|Withdrawal by Subject|1|||
131781110|NCT01964898|474479400|FG001|Overall Study|Withdrawal by Subject|0|||
131781111|NCT00819091|474479401|FG000|Overall Study|Adverse Event|3|||
131781112|NCT00819091|474479402|FG001|Overall Study|Adverse Event|5|||
131781113|NCT00819091|474479401|FG000|Overall Study|Protocol Violation|0|||
131781114|NCT00819091|474479402|FG001|Overall Study|Protocol Violation|1|||
131781115|NCT00819091|474479401|FG000|Overall Study|Lost to Follow-up|2|||
131781116|NCT00819091|474479402|FG001|Overall Study|Lost to Follow-up|0|||
131781117|NCT00819091|474479401|FG000|Overall Study|Withdrawal by Subject|1|||
131781118|NCT00819091|474479402|FG001|Overall Study|Withdrawal by Subject|2|||
131781119|NCT00819091|474479401|FG000|Overall Study|Other|1|||
131781120|NCT00819091|474479402|FG001|Overall Study|Other|2|||
131781121|NCT02325401|474479405|FG000|Overall Study|Withdrawal by Subject|0|||
131781122|NCT02325401|474479406|FG001|Overall Study|Withdrawal by Subject|1|||
131781123|NCT02325401|474479407|FG002|Overall Study|Withdrawal by Subject|1|||
131781124|NCT02209454|474479413|FG000|Second Period|Adverse Event|1|||
131781125|NCT02209454|474479414|FG001|Second Period|Adverse Event|0|||
131781126|NCT01652573|474479415|FG000|Overall Study|Adverse Event|0|||
131781127|NCT01652573|474479416|FG001|Overall Study|Adverse Event|1|||
131781128|NCT00740480|474479417|FG000|Overall Study|Adverse Event|1|||
131781129|NCT00740480|474479417|FG000|Overall Study|Physician Decision|1|||
131781130|NCT00934622|474479418|FG000|Overall Study|Lost to Follow-up|7|||
131781131|NCT00934622|474479418|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
131781132|NCT01856686|474479422|FG000|Overall Study|Lost to Follow-up|5|||
131781133|NCT01856686|474479423|FG001|Overall Study|Lost to Follow-up|11|||
131781134|NCT00468312|474479426|FG000|Overall Study|Adverse Event|2|||
131781135|NCT00468312|474479427|FG001|Overall Study|Adverse Event|1|||
131781136|NCT00468312|474479426|FG000|Overall Study|Lack of Efficacy|0|||
131781137|NCT00468312|474479427|FG001|Overall Study|Lack of Efficacy|1|||
131781138|NCT00468312|474479426|FG000|Overall Study|Withdrawal by Subject|0|||
131781139|NCT00468312|474479427|FG001|Overall Study|Withdrawal by Subject|1|||
131781140|NCT00468312|474479426|FG000|Overall Study|Protocol Violation|2|||
131781141|NCT00468312|474479427|FG001|Overall Study|Protocol Violation|1|||
131898615|NCT02624947|474915307|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
131781142|NCT00468312|474479426|FG000|Overall Study|Did not meet protocol eligibility|0|||
131781143|NCT00468312|474479427|FG001|Overall Study|Did not meet protocol eligibility|1|||
131781144|NCT03466060|474479430|FG000|Period 1|Test Lens Damage|0|||
131781145|NCT03466060|474479431|FG001|Period 1|Test Lens Damage|2|||
131781146|NCT03466060|474479432|FG002|Period 1|Test Lens Damage|0|||
131781147|NCT03466060|474479433|FG003|Period 1|Test Lens Damage|0|||
131781148|NCT03466060|474479434|FG004|Period 1|Test Lens Damage|0|||
131781149|NCT03466060|474479435|FG005|Period 1|Test Lens Damage|0|||
131781150|NCT03466060|474479430|FG000|Period 1|Withdrawal by Subject|0|||
131781151|NCT03466060|474479431|FG001|Period 1|Withdrawal by Subject|0|||
131781152|NCT03466060|474479432|FG002|Period 1|Withdrawal by Subject|2|||
131781153|NCT03466060|474479433|FG003|Period 1|Withdrawal by Subject|0|||
131781154|NCT03466060|474479434|FG004|Period 1|Withdrawal by Subject|0|||
131781155|NCT03466060|474479435|FG005|Period 1|Withdrawal by Subject|0|||
131781156|NCT03466060|474479430|FG000|Period 1|Lost to Follow-up|0|||
131781157|NCT03466060|474479431|FG001|Period 1|Lost to Follow-up|0|||
131781158|NCT03466060|474479432|FG002|Period 1|Lost to Follow-up|0|||
131781159|NCT03466060|474479433|FG003|Period 1|Lost to Follow-up|1|||
131781160|NCT03466060|474479434|FG004|Period 1|Lost to Follow-up|0|||
131781161|NCT03466060|474479435|FG005|Period 1|Lost to Follow-up|0|||
131781162|NCT03466060|474479430|FG000|Period 1|Grade 2 Conjunctivitis|0|||
131781163|NCT03466060|474479431|FG001|Period 1|Grade 2 Conjunctivitis|0|||
131781164|NCT03466060|474479432|FG002|Period 1|Grade 2 Conjunctivitis|1|||
131781165|NCT03466060|474479433|FG003|Period 1|Grade 2 Conjunctivitis|0|||
131781166|NCT03466060|474479434|FG004|Period 1|Grade 2 Conjunctivitis|0|||
131781167|NCT03466060|474479435|FG005|Period 1|Grade 2 Conjunctivitis|0|||
131781168|NCT03466060|474479430|FG000|Period 2|Lens Handling Difficulties|0|||
131781169|NCT03466060|474479431|FG001|Period 2|Lens Handling Difficulties|0|||
131781170|NCT03466060|474479432|FG002|Period 2|Lens Handling Difficulties|1|||
131781171|NCT03466060|474479433|FG003|Period 2|Lens Handling Difficulties|0|||
131781172|NCT03466060|474479434|FG004|Period 2|Lens Handling Difficulties|0|||
131781173|NCT03466060|474479435|FG005|Period 2|Lens Handling Difficulties|0|||
131781174|NCT01612780|474479436|FG000|Overall Study|Treatment not completed|1|||
131781175|NCT01612780|474479436|FG000|Overall Study|Withdrawal by Subject|5|||
131781176|NCT04732728|474479440|FG000|Overall Study|Death|12|||
131781177|NCT04732728|474479440|FG000|Overall Study|Withdrawn|136|||
131781178|NCT01339000|474479443|FG000|Overall Study|study closed due to lack of drug supply|1|||
131781179|NCT01339000|474479444|FG001|Overall Study|study closed due to lack of drug supply|0|||
131781180|NCT02643394|474479445|FG000|Overall Study|Protocol Violation|4|||
131781181|NCT02643394|474479446|FG001|Overall Study|Protocol Violation|5|||
131781182|NCT04088734|474479447|FG000|Overall Study|Other, Not Specified|5|||
131781183|NCT00096200|474479448|FG000|Overall Study|Adverse Event|0|||
131781184|NCT00096200|474479449|FG001|Overall Study|Adverse Event|4|||
131781185|NCT00096200|474479450|FG002|Overall Study|Adverse Event|0|||
131781186|NCT00096200|474479448|FG000|Overall Study|Withdrawal by Subject|1|||
131781187|NCT00096200|474479449|FG001|Overall Study|Withdrawal by Subject|2|||
131781188|NCT00096200|474479450|FG002|Overall Study|Withdrawal by Subject|0|||
131781189|NCT00096200|474479448|FG000|Overall Study|Ineligible pathology|0|||
131781190|NCT00096200|474479449|FG001|Overall Study|Ineligible pathology|1|||
131781191|NCT00096200|474479450|FG002|Overall Study|Ineligible pathology|0|||
131781192|NCT00938015|474479454|FG000|Overall Study|Death|2|||
131781193|NCT00938015|474479454|FG000|Overall Study|Lost to Follow-up|32|||
131781194|NCT00938015|474479454|FG000|Overall Study|Adverse Event|32|||
131781195|NCT00938015|474479454|FG000|Overall Study|Non-responder|52|||
131781196|NCT00938015|474479454|FG000|Overall Study|Reason not related to Etanercept|29|||
131781197|NCT02341482|474479455|FG000|Overall Study|Adverse Event|1|||
131781198|NCT00664066|474479458|FG000|Overall Study|Study terminated|3|||
131781199|NCT00090259|474479462|FG000|Overall Study|Lost to Follow-up|30|||
131781200|NCT00090259|474479463|FG001|Overall Study|Lost to Follow-up|26|||
131781201|NCT00090259|474479462|FG000|Overall Study|Withdrawal by Subject|21|||
131781202|NCT00090259|474479463|FG001|Overall Study|Withdrawal by Subject|15|||
131781203|NCT00090259|474479462|FG000|Overall Study|Investigator site closed|11|||
131781204|NCT00090259|474479463|FG001|Overall Study|Investigator site closed|7|||
131781205|NCT03701516|474479464|FG000|Period 1|Lost to Follow-up|0|||
131781206|NCT03701516|474479465|FG001|Period 1|Lost to Follow-up|1|||
131781207|NCT03701516|474479464|FG000|Period 1|Adverse Event|0|||
131781208|NCT03701516|474479465|FG001|Period 1|Adverse Event|2|||
131781209|NCT03701516|474479464|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
131781210|NCT03701516|474479465|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
131781211|NCT03701516|474479464|FG000|Period 1|Non Compliance to Protocol|2|||
131781212|NCT03701516|474479465|FG001|Period 1|Non Compliance to Protocol|1|||
131781213|NCT03701516|474479464|FG000|Period 1|Withdrawal by Subject|0|||
131781214|NCT03701516|474479465|FG001|Period 1|Withdrawal by Subject|1|||
131781215|NCT03701516|474479464|FG000|Period 2|failed to meet all eligibility creiteria|1|||
131781216|NCT03701516|474479465|FG001|Period 2|failed to meet all eligibility creiteria|0|||
131781217|NCT03701516|474479464|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
131781218|NCT03701516|474479465|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
131781219|NCT03083639|474479468|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
131781220|NCT03083639|474479469|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
131781221|NCT03083639|474479468|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
131781222|NCT03083639|474479469|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
131562885|NCT01474512|473686218|FG008|Maintenance Period|Physician Decision|0|||
131562886|NCT01474512|473686219|FG009|Maintenance Period|Physician Decision|0|||
131562887|NCT01474512|473686220|FG010|Maintenance Period|Physician Decision|0|||
131562888|NCT01474512|473686221|FG011|Maintenance Period|Physician Decision|0|||
131562889|NCT01474512|473686222|FG012|Maintenance Period|Physician Decision|0|||
131562890|NCT01474512|473686223|FG013|Maintenance Period|Physician Decision|0|||
131562891|NCT01474512|473686224|FG014|Maintenance Period|Physician Decision|0|||
131562892|NCT01474512|473686225|FG015|Maintenance Period|Physician Decision|0|||
131562893|NCT01474512|473686226|FG016|Maintenance Period|Physician Decision|0|||
131562894|NCT01474512|473686227|FG017|Maintenance Period|Physician Decision|0|||
131562895|NCT01474512|473686210|FG000|Maintenance Period|Clinical Relapse|0|||
131562896|NCT01474512|473686211|FG001|Maintenance Period|Clinical Relapse|0|||
131562897|NCT01474512|473686212|FG002|Maintenance Period|Clinical Relapse|0|||
131562898|NCT01474512|473686213|FG003|Maintenance Period|Clinical Relapse|1|||
131562899|NCT01474512|473686214|FG004|Maintenance Period|Clinical Relapse|0|||
131562900|NCT01474512|473686215|FG005|Maintenance Period|Clinical Relapse|0|||
131562901|NCT01474512|473686216|FG006|Maintenance Period|Clinical Relapse|0|||
131562902|NCT01474512|473686217|FG007|Maintenance Period|Clinical Relapse|0|||
131562903|NCT01474512|473686218|FG008|Maintenance Period|Clinical Relapse|0|||
131562904|NCT01474512|473686219|FG009|Maintenance Period|Clinical Relapse|0|||
131562905|NCT01474512|473686220|FG010|Maintenance Period|Clinical Relapse|0|||
131562906|NCT01474512|473686221|FG011|Maintenance Period|Clinical Relapse|0|||
131562907|NCT01474512|473686222|FG012|Maintenance Period|Clinical Relapse|0|||
131562908|NCT01474512|473686223|FG013|Maintenance Period|Clinical Relapse|0|||
131562909|NCT01474512|473686224|FG014|Maintenance Period|Clinical Relapse|0|||
131562910|NCT01474512|473686225|FG015|Maintenance Period|Clinical Relapse|0|||
131562911|NCT01474512|473686226|FG016|Maintenance Period|Clinical Relapse|0|||
131562912|NCT01474512|473686227|FG017|Maintenance Period|Clinical Relapse|0|||
131562913|NCT01474512|473686210|FG000|Maintenance Period|Lack of Efficacy|0|||
131562914|NCT01474512|473686211|FG001|Maintenance Period|Lack of Efficacy|0|||
131562915|NCT01474512|473686212|FG002|Maintenance Period|Lack of Efficacy|0|||
131562916|NCT01474512|473686213|FG003|Maintenance Period|Lack of Efficacy|1|||
131562917|NCT01474512|473686214|FG004|Maintenance Period|Lack of Efficacy|0|||
131562918|NCT01474512|473686215|FG005|Maintenance Period|Lack of Efficacy|0|||
131562919|NCT01474512|473686216|FG006|Maintenance Period|Lack of Efficacy|0|||
131562920|NCT01474512|473686217|FG007|Maintenance Period|Lack of Efficacy|11|||
131562921|NCT01474512|473686218|FG008|Maintenance Period|Lack of Efficacy|11|||
131562922|NCT01474512|473686219|FG009|Maintenance Period|Lack of Efficacy|12|||
131562923|NCT01474512|473686220|FG010|Maintenance Period|Lack of Efficacy|0|||
131562924|NCT01474512|473686221|FG011|Maintenance Period|Lack of Efficacy|0|||
131562925|NCT01474512|473686222|FG012|Maintenance Period|Lack of Efficacy|0|||
131562926|NCT01474512|473686223|FG013|Maintenance Period|Lack of Efficacy|0|||
131562927|NCT01474512|473686224|FG014|Maintenance Period|Lack of Efficacy|0|||
131562928|NCT01474512|473686225|FG015|Maintenance Period|Lack of Efficacy|0|||
131562929|NCT01474512|473686226|FG016|Maintenance Period|Lack of Efficacy|0|||
131562930|NCT01474512|473686227|FG017|Maintenance Period|Lack of Efficacy|0|||
131562931|NCT01474512|473686210|FG000|Maintenance Period|Protocol Violation|0|||
131562932|NCT01474512|473686211|FG001|Maintenance Period|Protocol Violation|0|||
131562933|NCT01474512|473686212|FG002|Maintenance Period|Protocol Violation|0|||
131562934|NCT01474512|473686213|FG003|Maintenance Period|Protocol Violation|1|||
131562935|NCT01474512|473686214|FG004|Maintenance Period|Protocol Violation|0|||
131562936|NCT01474512|473686215|FG005|Maintenance Period|Protocol Violation|0|||
131562937|NCT01474512|473686216|FG006|Maintenance Period|Protocol Violation|0|||
131562938|NCT01474512|473686217|FG007|Maintenance Period|Protocol Violation|1|||
131562939|NCT01474512|473686218|FG008|Maintenance Period|Protocol Violation|0|||
131562940|NCT01474512|473686219|FG009|Maintenance Period|Protocol Violation|1|||
131562941|NCT01474512|473686220|FG010|Maintenance Period|Protocol Violation|0|||
131696135|NCT00706134|474170347|FG003|Overall Study|Adverse Event|3|||
131696136|NCT00706134|474170344|FG000|Overall Study|Lost to Follow-up|0|||
131696137|NCT00706134|474170345|FG001|Overall Study|Lost to Follow-up|1|||
131696138|NCT00706134|474170346|FG002|Overall Study|Lost to Follow-up|0|||
131696139|NCT00706134|474170347|FG003|Overall Study|Lost to Follow-up|0|||
131696140|NCT00706134|474170344|FG000|Overall Study|Protocol Violation|0|||
131696141|NCT00706134|474170345|FG001|Overall Study|Protocol Violation|6|||
131696142|NCT00706134|474170346|FG002|Overall Study|Protocol Violation|0|||
131696143|NCT00706134|474170347|FG003|Overall Study|Protocol Violation|3|||
131696144|NCT00706134|474170344|FG000|Overall Study|Withdrawal by Subject|1|||
131696145|NCT00706134|474170345|FG001|Overall Study|Withdrawal by Subject|2|||
131696146|NCT00706134|474170346|FG002|Overall Study|Withdrawal by Subject|1|||
131562942|NCT01474512|473686221|FG011|Maintenance Period|Protocol Violation|0|||
131562943|NCT01474512|473686222|FG012|Maintenance Period|Protocol Violation|0|||
131562944|NCT01474512|473686223|FG013|Maintenance Period|Protocol Violation|0|||
131562945|NCT01474512|473686224|FG014|Maintenance Period|Protocol Violation|0|||
131696147|NCT00706134|474170347|FG003|Overall Study|Withdrawal by Subject|0|||
131696148|NCT00706134|474170344|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
131696149|NCT00706134|474170345|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131696150|NCT00706134|474170346|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
131696151|NCT00706134|474170347|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
131696152|NCT00706134|474170344|FG000|Overall Study|Did not meet study criteria|2|||
131696153|NCT00706134|474170345|FG001|Overall Study|Did not meet study criteria|0|||
131696154|NCT00706134|474170346|FG002|Overall Study|Did not meet study criteria|0|||
131696155|NCT00706134|474170347|FG003|Overall Study|Did not meet study criteria|0|||
131696156|NCT01982292|474170348|FG000|Overall Study|Adverse Event|2|||
131696157|NCT01982292|474170349|FG001|Overall Study|Adverse Event|0|||
131696158|NCT01982292|474170348|FG000|Overall Study|Death|1|||
131696159|NCT01982292|474170349|FG001|Overall Study|Death|0|||
131696160|NCT01982292|474170348|FG000|Overall Study|Lost to Follow-up|2|||
131696161|NCT01982292|474170349|FG001|Overall Study|Lost to Follow-up|0|||
131696162|NCT01982292|474170348|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
131696163|NCT01982292|474170349|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
131696164|NCT01982292|474170348|FG000|Overall Study|Protocol Deviation|1|||
131696165|NCT01982292|474170349|FG001|Overall Study|Protocol Deviation|0|||
131696166|NCT01982292|474170348|FG000|Overall Study|Patient/Guardian Decision|3|||
131696167|NCT01982292|474170349|FG001|Overall Study|Patient/Guardian Decision|1|||
131696168|NCT01982292|474170348|FG000|Overall Study|Technical Problems|2|||
131696169|NCT01982292|474170349|FG001|Overall Study|Technical Problems|0|||
131696170|NCT00746252|474170350|FG000|Overall Study|weight gain >7.5 %|1|||
131696171|NCT00746252|474170351|FG001|Overall Study|weight gain >7.5 %|2|||
131696172|NCT00082888|474170352|FG000|Overall Study|Ineligible|1|||
131696173|NCT00082888|474170353|FG001|Overall Study|Ineligible|0|||
131696174|NCT00082888|474170354|FG002|Overall Study|Ineligible|0|||
131696175|NCT00817531|474170356|FG000|Overall Study|Adverse Event|1|||
131696176|NCT00817531|474170356|FG000|Overall Study|Lack of Efficacy|1|||
131696177|NCT02239939|474170357|FG000|Overall Study|Adverse Event|1|||
131696178|NCT02239939|474170358|FG001|Overall Study|Adverse Event|0|||
131696179|NCT02239939|474170357|FG000|Overall Study|Withdrawal by Subject|1|||
131696180|NCT02239939|474170358|FG001|Overall Study|Withdrawal by Subject|1|||
131696181|NCT02239939|474170357|FG000|Overall Study|Lost to Follow-up|0|||
131696182|NCT02239939|474170358|FG001|Overall Study|Lost to Follow-up|1|||
131696183|NCT03325673|474170368|FG000|Overall Study|Adverse Event|4|||
131696184|NCT03325673|474170369|FG001|Overall Study|Adverse Event|0|||
131696185|NCT01514682|474170370|FG000|Overall Study|Withdrawal by Subject|2|||
131696186|NCT01514682|474170371|FG001|Overall Study|Withdrawal by Subject|3|||
131696187|NCT01514682|474170370|FG000|Overall Study|Physician Decision|4|||
131696188|NCT01514682|474170371|FG001|Overall Study|Physician Decision|3|||
131696189|NCT00590590|474170372|FG000|Overall Study|Lack of Efficacy|1|||
131696190|NCT00590590|474170373|FG001|Overall Study|Lack of Efficacy|2|||
131696191|NCT00590590|474170374|FG002|Overall Study|Lack of Efficacy|0|||
131696192|NCT00590590|474170372|FG000|Overall Study|Adverse Event|1|||
131696193|NCT00590590|474170373|FG001|Overall Study|Adverse Event|0|||
131696194|NCT00590590|474170374|FG002|Overall Study|Adverse Event|0|||
131696195|NCT00590590|474170372|FG000|Overall Study|Protocol Violation|0|||
131696196|NCT00590590|474170373|FG001|Overall Study|Protocol Violation|0|||
131696197|NCT00590590|474170374|FG002|Overall Study|Protocol Violation|2|||
131696198|NCT00590590|474170372|FG000|Overall Study|Lost to Follow-up|4|||
131696199|NCT00590590|474170373|FG001|Overall Study|Lost to Follow-up|1|||
131696200|NCT00590590|474170374|FG002|Overall Study|Lost to Follow-up|2|||
131696201|NCT00590590|474170372|FG000|Overall Study|Withdrawal by Subject|0|||
131696202|NCT00590590|474170373|FG001|Overall Study|Withdrawal by Subject|1|||
131696203|NCT00590590|474170374|FG002|Overall Study|Withdrawal by Subject|1|||
131696204|NCT00590590|474170372|FG000|Overall Study|Did not complete due to study closure|1|||
131696205|NCT00590590|474170373|FG001|Overall Study|Did not complete due to study closure|1|||
131696206|NCT00590590|474170374|FG002|Overall Study|Did not complete due to study closure|1|||
131696207|NCT00590590|474170372|FG000|Overall Study|Did not complete study|0|||
131696208|NCT00590590|474170373|FG001|Overall Study|Did not complete study|1|||
131696209|NCT00590590|474170374|FG002|Overall Study|Did not complete study|0|||
131696210|NCT00132132|474170375|FG000|Overall Study|Lost to Follow-up|7|||
131696211|NCT00132132|474170376|FG001|Overall Study|Lost to Follow-up|2|||
131696212|NCT01870401|474170377|FG000|Overall Study|Death|48|||
131696213|NCT01870401|474170378|FG001|Overall Study|Death|24|||
131696214|NCT01870401|474170377|FG000|Overall Study|Withdrawal by Subject|39|||
131562946|NCT01474512|473686225|FG015|Maintenance Period|Protocol Violation|0|||
131562947|NCT01474512|473686226|FG016|Maintenance Period|Protocol Violation|0|||
131562948|NCT01474512|473686227|FG017|Maintenance Period|Protocol Violation|0|||
131562949|NCT01474512|473686210|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
131562950|NCT01474512|473686211|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
131562951|NCT01474512|473686212|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
131562952|NCT01474512|473686213|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
131562953|NCT01474512|473686214|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
131562954|NCT01474512|473686215|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
131562955|NCT01474512|473686216|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
131562956|NCT01474512|473686217|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
131562957|NCT01474512|473686218|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
131562958|NCT01474512|473686219|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
131562959|NCT01474512|473686220|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
131562960|NCT01474512|473686221|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
131562961|NCT01474512|473686222|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
131562962|NCT01474512|473686223|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
131562963|NCT01474512|473686224|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
131562964|NCT01474512|473686225|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
131562965|NCT01474512|473686226|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
131562966|NCT01474512|473686227|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
131562967|NCT01474512|473686210|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
131562968|NCT01474512|473686211|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
131562969|NCT01474512|473686212|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
131562970|NCT01474512|473686213|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
131562971|NCT01474512|473686214|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
131562972|NCT01474512|473686215|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
131562973|NCT01474512|473686216|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
131562974|NCT01474512|473686217|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
131562975|NCT01474512|473686218|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
131562976|NCT01474512|473686219|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
131562977|NCT01474512|473686220|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
131562978|NCT01474512|473686221|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
131562979|NCT01474512|473686222|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
131562980|NCT01474512|473686223|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
131562981|NCT01474512|473686224|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
131562982|NCT01474512|473686225|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
131562983|NCT01474512|473686226|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
131562984|NCT01474512|473686227|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
131562985|NCT01474512|473686210|FG000|Long-Term Extension Period|Adverse Event|0|||
131562986|NCT01474512|473686211|FG001|Long-Term Extension Period|Adverse Event|0|||
131562987|NCT01474512|473686212|FG002|Long-Term Extension Period|Adverse Event|0|||
131562988|NCT01474512|473686213|FG003|Long-Term Extension Period|Adverse Event|0|||
131562989|NCT01474512|473686214|FG004|Long-Term Extension Period|Adverse Event|0|||
131562990|NCT01474512|473686215|FG005|Long-Term Extension Period|Adverse Event|0|||
131562991|NCT01474512|473686216|FG006|Long-Term Extension Period|Adverse Event|0|||
131562992|NCT01474512|473686217|FG007|Long-Term Extension Period|Adverse Event|0|||
131562993|NCT01474512|473686218|FG008|Long-Term Extension Period|Adverse Event|0|||
131562994|NCT01474512|473686219|FG009|Long-Term Extension Period|Adverse Event|0|||
131562995|NCT01474512|473686220|FG010|Long-Term Extension Period|Adverse Event|0|||
131562996|NCT01474512|473686221|FG011|Long-Term Extension Period|Adverse Event|1|||
131562997|NCT01474512|473686222|FG012|Long-Term Extension Period|Adverse Event|57|||
131562998|NCT01474512|473686223|FG013|Long-Term Extension Period|Adverse Event|58|||
131562999|NCT01474512|473686224|FG014|Long-Term Extension Period|Adverse Event|0|||
131563000|NCT01474512|473686225|FG015|Long-Term Extension Period|Adverse Event|0|||
131563001|NCT01474512|473686226|FG016|Long-Term Extension Period|Adverse Event|0|||
131563002|NCT01474512|473686227|FG017|Long-Term Extension Period|Adverse Event|0|||
131563003|NCT01474512|473686210|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
131563004|NCT01474512|473686211|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
131563005|NCT01474512|473686212|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
131563006|NCT01474512|473686213|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
131563007|NCT01474512|473686214|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
131563008|NCT01474512|473686215|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
131696215|NCT01870401|474170378|FG001|Overall Study|Withdrawal by Subject|26|||
131696216|NCT01870401|474170377|FG000|Overall Study|Lost to Follow-up|19|||
131696217|NCT01870401|474170378|FG001|Overall Study|Lost to Follow-up|14|||
131696218|NCT01870401|474170377|FG000|Overall Study|Other|9|||
131696219|NCT01870401|474170378|FG001|Overall Study|Other|7|||
131563009|NCT01474512|473686216|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
131563010|NCT01474512|473686217|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
131696220|NCT01870401|474170377|FG000|Overall Study|On-going in the Study|35|||
131696221|NCT01870401|474170378|FG001|Overall Study|On-going in the Study|25|||
131696222|NCT04623242|474170379|FG000|Overall Study|Withdrawal by Subject|7|||
131696223|NCT04623242|474170380|FG001|Overall Study|Withdrawal by Subject|12|||
131696224|NCT04623242|474170381|FG002|Overall Study|Withdrawal by Subject|5|||
131696225|NCT04623242|474170382|FG003|Overall Study|Withdrawal by Subject|7|||
131696226|NCT04623242|474170383|FG004|Overall Study|Withdrawal by Subject|0|||
131696227|NCT04623242|474170379|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
131696228|NCT04623242|474170380|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
131696229|NCT04623242|474170381|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
131696230|NCT04623242|474170382|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
131696231|NCT04623242|474170383|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
131696232|NCT04623242|474170379|FG000|Overall Study|Subject unblinded to mutation status|0|||
131696233|NCT04623242|474170380|FG001|Overall Study|Subject unblinded to mutation status|0|||
131696234|NCT04623242|474170381|FG002|Overall Study|Subject unblinded to mutation status|0|||
131696235|NCT04623242|474170382|FG003|Overall Study|Subject unblinded to mutation status|13|||
131696236|NCT04623242|474170383|FG004|Overall Study|Subject unblinded to mutation status|0|||
131696237|NCT00820898|474170384|FG000|Overall Study|Inelgible - wrong primary site|1|||
131563011|NCT01474512|473686218|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
131563012|NCT01474512|473686219|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
131563013|NCT01474512|473686220|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
131563014|NCT01474512|473686221|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
131563015|NCT01474512|473686222|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
131563016|NCT01474512|473686223|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
131563017|NCT01474512|473686224|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
131563018|NCT01474512|473686225|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
131563019|NCT01474512|473686226|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
131563020|NCT01474512|473686227|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
131563021|NCT01474512|473686210|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
131563022|NCT01474512|473686211|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
131563023|NCT01474512|473686212|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
131563024|NCT01474512|473686213|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
131563025|NCT01474512|473686214|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
131563026|NCT01474512|473686215|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
131563027|NCT01474512|473686216|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
131563028|NCT01474512|473686217|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
131563029|NCT01474512|473686218|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
131563030|NCT01474512|473686219|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
131563031|NCT01474512|473686220|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
131563032|NCT01474512|473686221|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
131563033|NCT01474512|473686222|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
131563034|NCT01474512|473686223|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
131563035|NCT01474512|473686224|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
131563036|NCT01474512|473686225|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
131563037|NCT01474512|473686226|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
131563038|NCT01474512|473686227|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
131563039|NCT01474512|473686210|FG000|Long-Term Extension Period|Physician Decision|0|||
131563040|NCT01474512|473686211|FG001|Long-Term Extension Period|Physician Decision|0|||
131563041|NCT01474512|473686212|FG002|Long-Term Extension Period|Physician Decision|0|||
131563042|NCT01474512|473686213|FG003|Long-Term Extension Period|Physician Decision|0|||
131563043|NCT01474512|473686214|FG004|Long-Term Extension Period|Physician Decision|0|||
131563044|NCT01474512|473686215|FG005|Long-Term Extension Period|Physician Decision|0|||
131563045|NCT01474512|473686216|FG006|Long-Term Extension Period|Physician Decision|0|||
131563046|NCT01474512|473686217|FG007|Long-Term Extension Period|Physician Decision|0|||
131563047|NCT01474512|473686218|FG008|Long-Term Extension Period|Physician Decision|0|||
131563048|NCT01474512|473686219|FG009|Long-Term Extension Period|Physician Decision|0|||
131563049|NCT01474512|473686220|FG010|Long-Term Extension Period|Physician Decision|0|||
131563050|NCT01474512|473686221|FG011|Long-Term Extension Period|Physician Decision|0|||
131563051|NCT01474512|473686222|FG012|Long-Term Extension Period|Physician Decision|21|||
131563052|NCT01474512|473686223|FG013|Long-Term Extension Period|Physician Decision|21|||
131563053|NCT01474512|473686224|FG014|Long-Term Extension Period|Physician Decision|0|||
131563054|NCT01474512|473686225|FG015|Long-Term Extension Period|Physician Decision|0|||
131563055|NCT01474512|473686226|FG016|Long-Term Extension Period|Physician Decision|0|||
131563056|NCT01474512|473686227|FG017|Long-Term Extension Period|Physician Decision|0|||
131563057|NCT01474512|473686210|FG000|Long-Term Extension Period|Clinical Relapse|0|||
131563058|NCT01474512|473686211|FG001|Long-Term Extension Period|Clinical Relapse|0|||
131563059|NCT01474512|473686212|FG002|Long-Term Extension Period|Clinical Relapse|0|||
131563060|NCT01474512|473686213|FG003|Long-Term Extension Period|Clinical Relapse|0|||
131696238|NCT00493870|474170387|FG000|Overall Study|Lost to Follow-up|12|||
131696239|NCT00493870|474170388|FG001|Overall Study|Lost to Follow-up|15|||
131696240|NCT00179309|474170393|FG000|Treatment|Toxicity|2|||
131696241|NCT00179309|474170394|FG001|Treatment|Toxicity|3|||
131696242|NCT00179309|474170393|FG000|Treatment|Withdrawal by Subject|1|||
131696243|NCT00179309|474170394|FG001|Treatment|Withdrawal by Subject|2|||
131696244|NCT00179309|474170393|FG000|Treatment|Allergy|1|||
131696245|NCT00179309|474170394|FG001|Treatment|Allergy|0|||
131696246|NCT01289015|474170398|FG000|Overall Study|Protocol Violation|12|||
131696247|NCT01289015|474170399|FG001|Overall Study|Protocol Violation|9|||
131696248|NCT01289015|474170398|FG000|Overall Study|Adverse Event|3|||
131696249|NCT01289015|474170399|FG001|Overall Study|Adverse Event|0|||
131563061|NCT01474512|473686214|FG004|Long-Term Extension Period|Clinical Relapse|0|||
131563062|NCT01474512|473686215|FG005|Long-Term Extension Period|Clinical Relapse|0|||
131563063|NCT01474512|473686216|FG006|Long-Term Extension Period|Clinical Relapse|0|||
131563064|NCT01474512|473686217|FG007|Long-Term Extension Period|Clinical Relapse|0|||
131563065|NCT01474512|473686218|FG008|Long-Term Extension Period|Clinical Relapse|0|||
131563066|NCT01474512|473686219|FG009|Long-Term Extension Period|Clinical Relapse|0|||
131696250|NCT01289015|474170398|FG000|Overall Study|Lost to Follow-up|33|||
131696251|NCT01289015|474170399|FG001|Overall Study|Lost to Follow-up|17|||
131696252|NCT01289015|474170398|FG000|Overall Study|Withdrawal by Subject|17|||
131696253|NCT01289015|474170399|FG001|Overall Study|Withdrawal by Subject|8|||
131563067|NCT01474512|473686220|FG010|Long-Term Extension Period|Clinical Relapse|0|||
131563068|NCT01474512|473686221|FG011|Long-Term Extension Period|Clinical Relapse|0|||
131563069|NCT01474512|473686222|FG012|Long-Term Extension Period|Clinical Relapse|9|||
131563070|NCT01474512|473686223|FG013|Long-Term Extension Period|Clinical Relapse|9|||
131563071|NCT01474512|473686224|FG014|Long-Term Extension Period|Clinical Relapse|0|||
131563072|NCT01474512|473686225|FG015|Long-Term Extension Period|Clinical Relapse|0|||
131563073|NCT01474512|473686226|FG016|Long-Term Extension Period|Clinical Relapse|0|||
131563074|NCT01474512|473686227|FG017|Long-Term Extension Period|Clinical Relapse|0|||
131563075|NCT01474512|473686210|FG000|Long-Term Extension Period|Death|0|||
131563076|NCT01474512|473686211|FG001|Long-Term Extension Period|Death|0|||
131563077|NCT01474512|473686212|FG002|Long-Term Extension Period|Death|0|||
131563078|NCT01474512|473686213|FG003|Long-Term Extension Period|Death|0|||
131563079|NCT01474512|473686214|FG004|Long-Term Extension Period|Death|0|||
131563080|NCT01474512|473686215|FG005|Long-Term Extension Period|Death|0|||
131563081|NCT01474512|473686216|FG006|Long-Term Extension Period|Death|0|||
131563082|NCT01474512|473686217|FG007|Long-Term Extension Period|Death|0|||
131563083|NCT01474512|473686218|FG008|Long-Term Extension Period|Death|0|||
131563084|NCT01474512|473686219|FG009|Long-Term Extension Period|Death|0|||
131563085|NCT01474512|473686220|FG010|Long-Term Extension Period|Death|0|||
131563086|NCT01474512|473686221|FG011|Long-Term Extension Period|Death|0|||
131563087|NCT01474512|473686222|FG012|Long-Term Extension Period|Death|9|||
131563088|NCT01474512|473686223|FG013|Long-Term Extension Period|Death|9|||
131563089|NCT01474512|473686224|FG014|Long-Term Extension Period|Death|0|||
131563090|NCT01474512|473686225|FG015|Long-Term Extension Period|Death|0|||
131563091|NCT01474512|473686226|FG016|Long-Term Extension Period|Death|0|||
131563092|NCT01474512|473686227|FG017|Long-Term Extension Period|Death|0|||
131563093|NCT01474512|473686210|FG000|Long-Term Extension Period|Sponsor Decision|0|||
131563094|NCT01474512|473686211|FG001|Long-Term Extension Period|Sponsor Decision|0|||
131563095|NCT01474512|473686212|FG002|Long-Term Extension Period|Sponsor Decision|0|||
131563096|NCT01474512|473686213|FG003|Long-Term Extension Period|Sponsor Decision|0|||
131563097|NCT01474512|473686214|FG004|Long-Term Extension Period|Sponsor Decision|0|||
131563098|NCT01474512|473686215|FG005|Long-Term Extension Period|Sponsor Decision|0|||
131563099|NCT01474512|473686216|FG006|Long-Term Extension Period|Sponsor Decision|0|||
131563100|NCT01474512|473686217|FG007|Long-Term Extension Period|Sponsor Decision|0|||
131563101|NCT01474512|473686218|FG008|Long-Term Extension Period|Sponsor Decision|0|||
131563102|NCT01474512|473686219|FG009|Long-Term Extension Period|Sponsor Decision|0|||
131563103|NCT01474512|473686220|FG010|Long-Term Extension Period|Sponsor Decision|0|||
131563104|NCT01474512|473686221|FG011|Long-Term Extension Period|Sponsor Decision|0|||
131563105|NCT01474512|473686222|FG012|Long-Term Extension Period|Sponsor Decision|6|||
131563106|NCT01474512|473686223|FG013|Long-Term Extension Period|Sponsor Decision|6|||
131563107|NCT01474512|473686224|FG014|Long-Term Extension Period|Sponsor Decision|0|||
131563108|NCT01474512|473686225|FG015|Long-Term Extension Period|Sponsor Decision|0|||
131563109|NCT01474512|473686226|FG016|Long-Term Extension Period|Sponsor Decision|0|||
131563110|NCT01474512|473686227|FG017|Long-Term Extension Period|Sponsor Decision|0|||
131563111|NCT01474512|473686210|FG000|Long-Term Extension Period|Protocol Violation|0|||
131563112|NCT01474512|473686211|FG001|Long-Term Extension Period|Protocol Violation|0|||
131563113|NCT01474512|473686212|FG002|Long-Term Extension Period|Protocol Violation|0|||
131563114|NCT01474512|473686213|FG003|Long-Term Extension Period|Protocol Violation|0|||
131563115|NCT01474512|473686214|FG004|Long-Term Extension Period|Protocol Violation|0|||
131563116|NCT01474512|473686215|FG005|Long-Term Extension Period|Protocol Violation|0|||
131563117|NCT01474512|473686216|FG006|Long-Term Extension Period|Protocol Violation|0|||
131563118|NCT01474512|473686217|FG007|Long-Term Extension Period|Protocol Violation|0|||
131563119|NCT01474512|473686218|FG008|Long-Term Extension Period|Protocol Violation|0|||
131696254|NCT01289015|474170398|FG000|Overall Study|Disease progression|1|||
131696255|NCT01289015|474170399|FG001|Overall Study|Disease progression|0|||
131696256|NCT01289015|474170398|FG000|Overall Study|Negative baseline culture and others|33|||
131696257|NCT01289015|474170399|FG001|Overall Study|Negative baseline culture and others|20|||
131696258|NCT01709149|474170403|FG000|Open-label Lead-in Phase|Adverse Event|109|||
131696259|NCT01709149|474170404|FG001|Open-label Lead-in Phase|Adverse Event|0|||
131696260|NCT01709149|474170405|FG002|Open-label Lead-in Phase|Adverse Event|0|||
131696261|NCT01709149|474170403|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
131696262|NCT01709149|474170404|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
131696263|NCT01709149|474170405|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
131696264|NCT01709149|474170403|FG000|Open-label Lead-in Phase|Death|1|||
131696265|NCT01709149|474170404|FG001|Open-label Lead-in Phase|Death|0|||
131696266|NCT01709149|474170405|FG002|Open-label Lead-in Phase|Death|0|||
131563120|NCT01474512|473686219|FG009|Long-Term Extension Period|Protocol Violation|0|||
131563121|NCT01474512|473686220|FG010|Long-Term Extension Period|Protocol Violation|0|||
131696267|NCT01709149|474170403|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
131563122|NCT01474512|473686221|FG011|Long-Term Extension Period|Protocol Violation|0|||
131563123|NCT01474512|473686222|FG012|Long-Term Extension Period|Protocol Violation|5|||
131696268|NCT01709149|474170404|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
131696269|NCT01709149|474170405|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
131696270|NCT01709149|474170403|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
131696271|NCT01709149|474170404|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
131563124|NCT01474512|473686223|FG013|Long-Term Extension Period|Protocol Violation|5|||
131563125|NCT01474512|473686224|FG014|Long-Term Extension Period|Protocol Violation|0|||
131563126|NCT01474512|473686225|FG015|Long-Term Extension Period|Protocol Violation|0|||
131563127|NCT01474512|473686226|FG016|Long-Term Extension Period|Protocol Violation|0|||
131563128|NCT01474512|473686227|FG017|Long-Term Extension Period|Protocol Violation|0|||
131563129|NCT01474512|473686210|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563130|NCT01474512|473686211|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563131|NCT01474512|473686212|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563132|NCT01474512|473686213|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563133|NCT01474512|473686214|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563134|NCT01474512|473686215|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563135|NCT01474512|473686216|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563136|NCT01474512|473686217|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563137|NCT01474512|473686218|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563138|NCT01474512|473686219|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563139|NCT01474512|473686220|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563140|NCT01474512|473686221|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563141|NCT01474512|473686222|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
131563142|NCT01474512|473686223|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
131563143|NCT01474512|473686224|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563144|NCT01474512|473686225|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563145|NCT01474512|473686226|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563146|NCT01474512|473686227|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131563147|NCT01474512|473686210|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563148|NCT01474512|473686211|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563149|NCT01474512|473686212|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563150|NCT01474512|473686213|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563151|NCT01474512|473686214|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563152|NCT01474512|473686215|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563153|NCT01474512|473686216|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563154|NCT01474512|473686217|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563155|NCT01474512|473686218|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563156|NCT01474512|473686219|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563157|NCT01474512|473686220|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563158|NCT01474512|473686221|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
131563159|NCT01474512|473686222|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563160|NCT01474512|473686223|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563161|NCT01474512|473686224|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563162|NCT01474512|473686225|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563163|NCT01474512|473686226|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563164|NCT01474512|473686227|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131563165|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
131563166|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
131563167|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
131563168|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
131696272|NCT01709149|474170405|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
131696273|NCT01709149|474170403|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131696274|NCT01709149|474170404|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
131696275|NCT01709149|474170405|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
131696276|NCT01709149|474170403|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131696277|NCT01709149|474170404|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
131696278|NCT01709149|474170405|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
131696279|NCT01709149|474170403|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
131696280|NCT01709149|474170404|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
131696281|NCT01709149|474170405|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
131696282|NCT01709149|474170403|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
131696283|NCT01709149|474170404|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
131781223|NCT01591499|474479470|FG000|Baseline Visit|Withdrawal by Subject|0|||
131781224|NCT01591499|474479471|FG001|Baseline Visit|Withdrawal by Subject|2|||
131563169|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
131563170|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
131563171|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
131696284|NCT01709149|474170405|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
131781225|NCT01591499|474479472|FG002|Baseline Visit|Withdrawal by Subject|0|||
131563172|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
131563173|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
131563174|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
131563175|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
131563176|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
131563177|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
131563178|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
131563179|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
131563180|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
131563181|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
131563182|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
131563183|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563184|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563185|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563186|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563187|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563188|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563189|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563190|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563191|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563192|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563193|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563194|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563195|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563196|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131563197|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
131563198|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
131563199|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
131563200|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
131563201|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563202|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563203|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563204|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131781226|NCT01591499|474479473|FG003|Baseline Visit|Withdrawal by Subject|2|||
131781227|NCT01591499|474479470|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
131781228|NCT01591499|474479471|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
131781229|NCT01591499|474479472|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
131781230|NCT01591499|474479473|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
131781231|NCT01591499|474479470|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
131781232|NCT01591499|474479471|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
131781233|NCT01591499|474479472|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
131781234|NCT01591499|474479473|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
131781235|NCT00358670|474479474|FG000|Overall Study|Adverse Event|26|||
131781236|NCT00358670|474479475|FG001|Overall Study|Adverse Event|29|||
131781237|NCT00358670|474479474|FG000|Overall Study|Lack of Efficacy|20|||
131781238|NCT00358670|474479475|FG001|Overall Study|Lack of Efficacy|23|||
131781239|NCT00358670|474479474|FG000|Overall Study|Protocol Violation|6|||
131781240|NCT00358670|474479475|FG001|Overall Study|Protocol Violation|9|||
131781241|NCT00358670|474479474|FG000|Overall Study|Lost to Follow-up|4|||
131781242|NCT00358670|474479475|FG001|Overall Study|Lost to Follow-up|5|||
131781243|NCT00358670|474479474|FG000|Overall Study|Withdrawal by Subject|13|||
131781244|NCT00358670|474479475|FG001|Overall Study|Withdrawal by Subject|24|||
131781245|NCT00358670|474479474|FG000|Overall Study|Protocol Defined Clinical Event|0|||
131781246|NCT00358670|474479475|FG001|Overall Study|Protocol Defined Clinical Event|1|||
131781247|NCT00358670|474479474|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131781248|NCT00358670|474479475|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
131781249|NCT00358670|474479474|FG000|Overall Study|Administrative|153|||
131563205|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563206|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563207|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563208|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563209|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563210|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563211|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563212|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563213|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563214|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131563215|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
131781250|NCT00358670|474479475|FG001|Overall Study|Administrative|125|||
131781251|NCT00981019|474479476|FG000|Overall Study|Did not respond|65|||
131781252|NCT00981019|474479476|FG000|Overall Study|Did not match target population|94|||
131781253|NCT00981019|474479476|FG000|Overall Study|Inadvertent exclusion|239|||
131563216|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
131563217|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
131563218|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
131563219|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563220|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563221|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563222|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563223|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563224|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563225|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563226|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563227|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563228|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563229|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563230|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563231|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563232|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563233|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563234|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131563235|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
131563236|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
131563237|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
131563238|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
131563239|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
131563240|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
131563241|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
131563242|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
131563243|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
131563244|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
131563245|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
131563246|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
131563247|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
131563248|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
131563249|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
131563250|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
131563251|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
131563252|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
131563253|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
131563254|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
131563255|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563256|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563257|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563258|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563259|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563260|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563261|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563262|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563263|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563264|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563265|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
131696285|NCT01709149|474170403|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131696286|NCT01709149|474170404|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
131696287|NCT01709149|474170405|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131696288|NCT05098041|474170412|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
131696289|NCT00774345|474170425|FG000|Pre-treatment|Other reasons|2|||
131696290|NCT00774345|474170426|FG001|Pre-treatment|Other reasons|0|||
131563266|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563267|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563268|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563269|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563270|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
131563271|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
131563272|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
131563273|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
131563274|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
131696291|NCT00774345|474170425|FG000|Treatment|Adverse Event|61|||
131696292|NCT00774345|474170426|FG001|Treatment|Adverse Event|15|||
131563275|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
131563276|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
131563277|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
131563278|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
131563279|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
131563280|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
131563281|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
131563282|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
131563283|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
131563284|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
131563285|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
131563286|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
131563287|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
131563288|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
131563289|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
131563290|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
131563291|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563292|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563293|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563294|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563295|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563296|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563297|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563298|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563299|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563300|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563301|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
131781254|NCT00981019|474479476|FG000|Overall Study|Hit the survey after closure|79|||
131781255|NCT00960687|474479477|FG000|Washout Period of 7 Days|Adverse Event|3|||
131781256|NCT00960687|474479478|FG001|Washout Period of 7 Days|Adverse Event|2|||
131781257|NCT00960687|474479477|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131781258|NCT00960687|474479478|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131781259|NCT05083559|474479479|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
131781260|NCT05083559|474479480|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
131781261|NCT05083559|474479479|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
131781262|NCT05083559|474479480|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
131781263|NCT05083559|474479479|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
131781264|NCT05083559|474479480|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
131781265|NCT02704130|474479481|FG000|Overall Study|Physician Decision|5|||
131781266|NCT02704130|474479482|FG001|Overall Study|Physician Decision|3|||
131781267|NCT02666768|474479484|FG000|Overall Study|Withdrawal by Subject|4|||
131781268|NCT03940742|474479487|FG000|Overall Study|Lost to Follow-up|0|||
131563302|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563303|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563304|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563305|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
131563306|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563307|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
131563308|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
131563309|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563310|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563311|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563312|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563313|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563314|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563315|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563316|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563317|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563318|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563319|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563320|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563321|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131781269|NCT03940742|474479488|FG001|Overall Study|Lost to Follow-up|0|||
131781270|NCT03940742|474479489|FG002|Overall Study|Lost to Follow-up|0|||
131781271|NCT03940742|474479490|FG003|Overall Study|Lost to Follow-up|1|||
131781272|NCT02032823|474479491|FG000|Overall Study|Death|75|||
131781273|NCT02032823|474479492|FG001|Overall Study|Death|109|||
131563322|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563323|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
131781274|NCT02032823|474479491|FG000|Overall Study|Lost to Follow-up|18|||
131563324|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131563325|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131696293|NCT00774345|474170425|FG000|Treatment|Progressive Disease without histologic transformation|51|||
131696294|NCT00774345|474170426|FG001|Treatment|Progressive Disease without histologic transformation|111|||
131696295|NCT00774345|474170425|FG000|Treatment|Progressive Disease with histologic transformation|4|||
131696296|NCT00774345|474170426|FG001|Treatment|Progressive Disease with histologic transformation|2|||
131696297|NCT00774345|474170425|FG000|Treatment|Withdrawal by Subject|5|||
131696298|NCT00774345|474170426|FG001|Treatment|Withdrawal by Subject|2|||
131696299|NCT00774345|474170425|FG000|Treatment|Lost to Follow-up|1|||
131696300|NCT00774345|474170426|FG001|Treatment|Lost to Follow-up|1|||
131696301|NCT00774345|474170425|FG000|Treatment|Death|4|||
131696302|NCT00774345|474170426|FG001|Treatment|Death|0|||
131696303|NCT00774345|474170425|FG000|Treatment|Other Reasons|32|||
131696304|NCT00774345|474170426|FG001|Treatment|Other Reasons|26|||
131696305|NCT00075504|474170429|FG000|Overall Study|Withdrawal by Subject|9|||
131696306|NCT00075504|474170430|FG001|Overall Study|Withdrawal by Subject|7|||
131696307|NCT00623428|474170431|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
131696308|NCT00623428|474170432|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
131696309|NCT00623428|474170431|FG000|Treatment Period|Death|0|||
131696310|NCT00623428|474170432|FG001|Treatment Period|Death|1|||
131696311|NCT00623428|474170431|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
131696312|NCT00623428|474170432|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
131696313|NCT00623428|474170431|FG000|Treatment Period|Insufficient therapeutic response|0|||
131696314|NCT00623428|474170432|FG001|Treatment Period|Insufficient therapeutic response|2|||
131696315|NCT00623428|474170431|FG000|Treatment Period|Other|0|||
131696316|NCT00623428|474170432|FG001|Treatment Period|Other|1|||
131696317|NCT00623428|474170431|FG000|Treatment Period|Withdrawal by Subject|0|||
131696318|NCT00623428|474170432|FG001|Treatment Period|Withdrawal by Subject|1|||
131696319|NCT00623428|474170431|FG000|Follow-up Period|Relapse post-treatment|11|||
131696320|NCT00623428|474170432|FG001|Follow-up Period|Relapse post-treatment|3|||
131696321|NCT00623428|474170431|FG000|Follow-up Period|Failure to return|10|||
131696322|NCT00623428|474170432|FG001|Follow-up Period|Failure to return|2|||
131563326|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
131563327|NCT01474512|473686210|FG000|Post-Treatment Follow-Up|Death|0|||
131696323|NCT00623428|474170431|FG000|Follow-up Period|Patient withdrew consent|5|||
131696324|NCT00623428|474170432|FG001|Follow-up Period|Patient withdrew consent|4|||
131696325|NCT00623428|474170431|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
131696326|NCT00623428|474170432|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
131781275|NCT02032823|474479492|FG001|Overall Study|Lost to Follow-up|17|||
131563328|NCT01474512|473686211|FG001|Post-Treatment Follow-Up|Death|0|||
131696327|NCT00623428|474170431|FG000|Follow-up Period|Did not cooperate|0|||
131696328|NCT00623428|474170432|FG001|Follow-up Period|Did not cooperate|3|||
131781276|NCT02032823|474479491|FG000|Overall Study|Withdrawal by Subject|70|||
131563329|NCT01474512|473686212|FG002|Post-Treatment Follow-Up|Death|0|||
131563330|NCT01474512|473686213|FG003|Post-Treatment Follow-Up|Death|0|||
131563331|NCT01474512|473686214|FG004|Post-Treatment Follow-Up|Death|0|||
131563332|NCT01474512|473686215|FG005|Post-Treatment Follow-Up|Death|0|||
131563333|NCT01474512|473686216|FG006|Post-Treatment Follow-Up|Death|0|||
131563334|NCT01474512|473686217|FG007|Post-Treatment Follow-Up|Death|0|||
131563335|NCT01474512|473686218|FG008|Post-Treatment Follow-Up|Death|0|||
131563336|NCT01474512|473686219|FG009|Post-Treatment Follow-Up|Death|0|||
131563337|NCT01474512|473686220|FG010|Post-Treatment Follow-Up|Death|0|||
131563338|NCT01474512|473686221|FG011|Post-Treatment Follow-Up|Death|0|||
131563339|NCT01474512|473686222|FG012|Post-Treatment Follow-Up|Death|0|||
131563340|NCT01474512|473686223|FG013|Post-Treatment Follow-Up|Death|0|||
131563341|NCT01474512|473686224|FG014|Post-Treatment Follow-Up|Death|0|||
131563342|NCT01474512|473686225|FG015|Post-Treatment Follow-Up|Death|0|||
131563343|NCT01474512|473686226|FG016|Post-Treatment Follow-Up|Death|1|||
131563344|NCT01474512|473686227|FG017|Post-Treatment Follow-Up|Death|0|||
131563345|NCT01023308|473686232|FG000|Overall Study|Abnormal test proceedure results|3|||
131563346|NCT01023308|473686233|FG001|Overall Study|Abnormal test proceedure results|8|||
131563347|NCT01023308|473686232|FG000|Overall Study|Administrative problems|2|||
131563348|NCT01023308|473686233|FG001|Overall Study|Administrative problems|1|||
131563349|NCT01023308|473686232|FG000|Overall Study|Adverse Event|130|||
131563350|NCT01023308|473686233|FG001|Overall Study|Adverse Event|66|||
131563351|NCT01023308|473686232|FG000|Overall Study|Death|21|||
131563352|NCT01023308|473686233|FG001|Overall Study|Death|17|||
131563353|NCT01023308|473686232|FG000|Overall Study|Disease progression|82|||
131563354|NCT01023308|473686233|FG001|Overall Study|Disease progression|153|||
131563355|NCT01023308|473686232|FG000|Overall Study|New Cancer therapy|4|||
131563356|NCT01023308|473686233|FG001|Overall Study|New Cancer therapy|7|||
131563357|NCT01023308|473686232|FG000|Overall Study|Protocol Violation|3|||
131563358|NCT01023308|473686233|FG001|Overall Study|Protocol Violation|4|||
131563359|NCT01023308|473686232|FG000|Overall Study|Untreated|5|||
131563360|NCT01023308|473686233|FG001|Overall Study|Untreated|5|||
131563361|NCT01023308|473686232|FG000|Overall Study|Lost to Follow-up|1|||
131563362|NCT01023308|473686233|FG001|Overall Study|Lost to Follow-up|0|||
131563363|NCT01023308|473686232|FG000|Overall Study|Withdrawal by Subject|34|||
131563364|NCT01023308|473686233|FG001|Overall Study|Withdrawal by Subject|18|||
131563365|NCT00551213|473686234|FG000|Overall Study|Adverse Event|6|||
131563366|NCT00551213|473686235|FG001|Overall Study|Adverse Event|3|||
131563367|NCT00551213|473686234|FG000|Overall Study|Progressive Disease|41|||
131563368|NCT00551213|473686235|FG001|Overall Study|Progressive Disease|12|||
131563369|NCT00551213|473686234|FG000|Overall Study|Withdrawal by Subject|2|||
131563370|NCT00551213|473686235|FG001|Overall Study|Withdrawal by Subject|0|||
131563371|NCT00551213|473686234|FG000|Overall Study|Not Treated|1|||
131563372|NCT00551213|473686235|FG001|Overall Study|Not Treated|2|||
131563373|NCT01890967|473686236|FG000|Overall Study|Adverse Event|3|||
131563374|NCT01890967|473686237|FG001|Overall Study|Adverse Event|3|||
131563375|NCT01890967|473686238|FG002|Overall Study|Adverse Event|3|||
131563376|NCT01890967|473686239|FG003|Overall Study|Adverse Event|2|||
131781277|NCT02032823|474479492|FG001|Overall Study|Withdrawal by Subject|53|||
131781278|NCT02032823|474479491|FG000|Overall Study|Ongoing study at data cut-off|755|||
131781279|NCT02032823|474479492|FG001|Overall Study|Ongoing study at data cut-off|731|||
131781280|NCT02032823|474479491|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
131781281|NCT02032823|474479492|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
131781282|NCT03889197|474479493|FG000|Overall Study|Withdrawal by Subject|1|||
131781283|NCT03889197|474479494|FG001|Overall Study|Withdrawal by Subject|0|||
131781284|NCT03889197|474479493|FG000|Overall Study|Physician Decision|0|||
131781285|NCT03889197|474479494|FG001|Overall Study|Physician Decision|1|||
131563377|NCT01890967|473686240|FG004|Overall Study|Adverse Event|1|||
131563378|NCT01890967|473686241|FG005|Overall Study|Adverse Event|7|||
131563379|NCT01890967|473686236|FG000|Overall Study|Death|1|||
131563380|NCT01890967|473686237|FG001|Overall Study|Death|0|||
131563381|NCT01890967|473686238|FG002|Overall Study|Death|0|||
131563382|NCT01890967|473686239|FG003|Overall Study|Death|0|||
131563383|NCT01890967|473686240|FG004|Overall Study|Death|0|||
131563384|NCT01890967|473686241|FG005|Overall Study|Death|0|||
131563385|NCT01890967|473686236|FG000|Overall Study|Lost to Follow-up|1|||
131563386|NCT01890967|473686237|FG001|Overall Study|Lost to Follow-up|1|||
131563387|NCT01890967|473686238|FG002|Overall Study|Lost to Follow-up|1|||
131563388|NCT01890967|473686239|FG003|Overall Study|Lost to Follow-up|1|||
131563389|NCT01890967|473686240|FG004|Overall Study|Lost to Follow-up|0|||
131563390|NCT01890967|473686241|FG005|Overall Study|Lost to Follow-up|1|||
131563391|NCT01890967|473686236|FG000|Overall Study|Protocol Violation|0|||
131563392|NCT01890967|473686237|FG001|Overall Study|Protocol Violation|3|||
131563393|NCT01890967|473686238|FG002|Overall Study|Protocol Violation|3|||
131563394|NCT01890967|473686239|FG003|Overall Study|Protocol Violation|2|||
131563395|NCT01890967|473686240|FG004|Overall Study|Protocol Violation|4|||
131563396|NCT01890967|473686241|FG005|Overall Study|Protocol Violation|1|||
131563397|NCT01890967|473686236|FG000|Overall Study|Sponsor Decision|2|||
131563398|NCT01890967|473686237|FG001|Overall Study|Sponsor Decision|0|||
131563399|NCT01890967|473686238|FG002|Overall Study|Sponsor Decision|1|||
131563400|NCT01890967|473686239|FG003|Overall Study|Sponsor Decision|3|||
131563401|NCT01890967|473686240|FG004|Overall Study|Sponsor Decision|2|||
131563402|NCT01890967|473686241|FG005|Overall Study|Sponsor Decision|3|||
131563403|NCT01890967|473686236|FG000|Overall Study|Withdrawal by Subject|3|||
131563404|NCT01890967|473686237|FG001|Overall Study|Withdrawal by Subject|4|||
131563405|NCT01890967|473686238|FG002|Overall Study|Withdrawal by Subject|2|||
131563406|NCT01890967|473686239|FG003|Overall Study|Withdrawal by Subject|3|||
131563407|NCT01890967|473686240|FG004|Overall Study|Withdrawal by Subject|3|||
131563408|NCT01890967|473686241|FG005|Overall Study|Withdrawal by Subject|1|||
131563409|NCT01383993|473686243|FG000|Overall Study|Adverse Event|1|||
131563410|NCT01383993|473686244|FG001|Overall Study|Adverse Event|1|||
131563411|NCT01383993|473686245|FG002|Overall Study|Adverse Event|0|||
131563412|NCT01383993|473686243|FG000|Overall Study|Withdrawal by Subject|0|||
131563413|NCT01383993|473686244|FG001|Overall Study|Withdrawal by Subject|0|||
131563414|NCT01383993|473686245|FG002|Overall Study|Withdrawal by Subject|1|||
131563415|NCT01383993|473686243|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
131563416|NCT01383993|473686244|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
131563417|NCT01383993|473686245|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
131563418|NCT02561455|473686246|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
131563419|NCT02561455|473686247|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
131563420|NCT02561455|473686248|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
131563421|NCT02561455|473686249|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
131563422|NCT02561455|473686246|FG000|Overall Study|Withdrawal by Subject|1|||
131563423|NCT02561455|473686247|FG001|Overall Study|Withdrawal by Subject|0|||
131563424|NCT02561455|473686248|FG002|Overall Study|Withdrawal by Subject|1|||
131563425|NCT02561455|473686249|FG003|Overall Study|Withdrawal by Subject|0|||
131563426|NCT02561455|473686246|FG000|Overall Study|Disease Progression|0|||
131563427|NCT02561455|473686247|FG001|Overall Study|Disease Progression|1|||
131696329|NCT00623428|474170431|FG000|Follow-up Period|Reason not specified|1|||
131696330|NCT00623428|474170432|FG001|Follow-up Period|Reason not specified|1|||
131696331|NCT00623428|474170431|FG000|Follow-up Period|Death|0|||
131696332|NCT00623428|474170432|FG001|Follow-up Period|Death|1|||
131696333|NCT02109484|474170435|FG000|Overall Study|Lost to Follow-up|0|||
131696334|NCT02109484|474170436|FG001|Overall Study|Lost to Follow-up|0|||
131696335|NCT02109484|474170437|FG002|Overall Study|Lost to Follow-up|0|||
131696336|NCT02109484|474170438|FG003|Overall Study|Lost to Follow-up|1|||
131696337|NCT02109484|474170439|FG004|Overall Study|Lost to Follow-up|1|||
131696338|NCT02109484|474170440|FG005|Overall Study|Lost to Follow-up|0|||
131696339|NCT02109484|474170441|FG006|Overall Study|Lost to Follow-up|1|||
131696340|NCT02109484|474170442|FG007|Overall Study|Lost to Follow-up|0|||
131696341|NCT02109484|474170435|FG000|Overall Study|Withdrawal by Subject|0|||
131696342|NCT02109484|474170436|FG001|Overall Study|Withdrawal by Subject|0|||
131696343|NCT02109484|474170437|FG002|Overall Study|Withdrawal by Subject|0|||
131696344|NCT02109484|474170438|FG003|Overall Study|Withdrawal by Subject|0|||
131696345|NCT02109484|474170439|FG004|Overall Study|Withdrawal by Subject|1|||
131696346|NCT02109484|474170440|FG005|Overall Study|Withdrawal by Subject|1|||
131696347|NCT02109484|474170441|FG006|Overall Study|Withdrawal by Subject|1|||
131696348|NCT02109484|474170442|FG007|Overall Study|Withdrawal by Subject|0|||
131696349|NCT02109484|474170435|FG000|Overall Study|Physician Decision|0|||
131696350|NCT02109484|474170436|FG001|Overall Study|Physician Decision|0|||
131696351|NCT02109484|474170437|FG002|Overall Study|Physician Decision|0|||
131696352|NCT02109484|474170438|FG003|Overall Study|Physician Decision|0|||
131696353|NCT02109484|474170439|FG004|Overall Study|Physician Decision|2|||
131696354|NCT02109484|474170440|FG005|Overall Study|Physician Decision|0|||
131696355|NCT02109484|474170441|FG006|Overall Study|Physician Decision|0|||
131696356|NCT02109484|474170442|FG007|Overall Study|Physician Decision|0|||
131696357|NCT02109484|474170435|FG000|Overall Study|Death|0|||
131563428|NCT02561455|473686248|FG002|Overall Study|Disease Progression|0|||
131563429|NCT02561455|473686249|FG003|Overall Study|Disease Progression|0|||
131696358|NCT02109484|474170436|FG001|Overall Study|Death|0|||
131696359|NCT02109484|474170437|FG002|Overall Study|Death|0|||
131696360|NCT02109484|474170438|FG003|Overall Study|Death|0|||
131696361|NCT02109484|474170439|FG004|Overall Study|Death|0|||
131696362|NCT02109484|474170440|FG005|Overall Study|Death|0|||
131696363|NCT02109484|474170441|FG006|Overall Study|Death|0|||
131563430|NCT02451930|473686252|FG000|Overall Study|Death|0|||
131563431|NCT02451930|473686253|FG001|Overall Study|Death|15|||
131563432|NCT02451930|473686252|FG000|Overall Study|Lost to Follow-up|0|||
131563433|NCT02451930|473686253|FG001|Overall Study|Lost to Follow-up|3|||
131563434|NCT02451930|473686252|FG000|Overall Study|Sponsor Decision|2|||
131696364|NCT02109484|474170442|FG007|Overall Study|Death|2|||
131696365|NCT02109484|474170435|FG000|Overall Study|Moved away from study area|0|||
131696366|NCT02109484|474170436|FG001|Overall Study|Moved away from study area|0|||
131696367|NCT02109484|474170437|FG002|Overall Study|Moved away from study area|0|||
131696368|NCT02109484|474170438|FG003|Overall Study|Moved away from study area|0|||
131563435|NCT02451930|473686253|FG001|Overall Study|Sponsor Decision|10|||
131563436|NCT02451930|473686252|FG000|Overall Study|Withdrawal by Subject|0|||
131563437|NCT02451930|473686253|FG001|Overall Study|Withdrawal by Subject|1|||
131563438|NCT02451930|473686252|FG000|Overall Study|Other|0|||
131563439|NCT02451930|473686253|FG001|Overall Study|Other|1|||
131563440|NCT00262743|473686254|FG000|Overall Study|Adverse Event|0|||
131563441|NCT00262743|473686255|FG001|Overall Study|Adverse Event|9|||
131563442|NCT00262743|473686254|FG000|Overall Study|Disease progression|0|||
131563443|NCT00262743|473686255|FG001|Overall Study|Disease progression|3|||
131563444|NCT03685708|473686264|FG000|Overall Study|Withdrawal by Subject|0|||
131563445|NCT03685708|473686265|FG001|Overall Study|Withdrawal by Subject|0|||
131563446|NCT03685708|473686266|FG002|Overall Study|Withdrawal by Subject|1|||
131563447|NCT03685708|473686264|FG000|Overall Study|Screen Fail|0|||
131563448|NCT03685708|473686265|FG001|Overall Study|Screen Fail|1|||
131563449|NCT03685708|473686266|FG002|Overall Study|Screen Fail|1|||
131696369|NCT02109484|474170439|FG004|Overall Study|Moved away from study area|0|||
131696370|NCT02109484|474170440|FG005|Overall Study|Moved away from study area|0|||
131696371|NCT02109484|474170441|FG006|Overall Study|Moved away from study area|1|||
131696372|NCT02109484|474170442|FG007|Overall Study|Moved away from study area|1|||
131696373|NCT02500121|474170443|FG000|Overall Study|Lost to Follow-up|0|||
131696374|NCT02500121|474170444|FG001|Overall Study|Lost to Follow-up|1|||
131696375|NCT02500121|474170443|FG000|Overall Study|Withdrawal by Subject|1|||
131696376|NCT02500121|474170444|FG001|Overall Study|Withdrawal by Subject|1|||
131696377|NCT02500121|474170443|FG000|Overall Study|Death|26|||
131696378|NCT02500121|474170444|FG001|Overall Study|Death|24|||
131696379|NCT04518462|474170447|FG000|Overall Study|Withdrawal by Subject|0|||
131696380|NCT04518462|474170448|FG001|Overall Study|Withdrawal by Subject|0|||
131696381|NCT04518462|474170449|FG002|Overall Study|Withdrawal by Subject|1|||
131696382|NCT04518462|474170447|FG000|Overall Study|Physician Decision|1|||
131696383|NCT04518462|474170448|FG001|Overall Study|Physician Decision|1|||
131696384|NCT04518462|474170449|FG002|Overall Study|Physician Decision|0|||
131696385|NCT04418076|474170453|FG000|Overall Study|Death|1|||
131696386|NCT04418076|474170454|FG001|Overall Study|Death|0|||
131696387|NCT04418076|474170455|FG002|Overall Study|Death|0|||
131696388|NCT04418076|474170456|FG003|Overall Study|Death|0|||
131696389|NCT04418076|474170453|FG000|Overall Study|Lost to Follow-up|2|||
131696390|NCT04418076|474170454|FG001|Overall Study|Lost to Follow-up|5|||
131696391|NCT04418076|474170455|FG002|Overall Study|Lost to Follow-up|1|||
131696392|NCT04418076|474170456|FG003|Overall Study|Lost to Follow-up|2|||
131696393|NCT04418076|474170453|FG000|Overall Study|Withdrawal by Subject|1|||
131696394|NCT04418076|474170454|FG001|Overall Study|Withdrawal by Subject|0|||
131696395|NCT04418076|474170455|FG002|Overall Study|Withdrawal by Subject|1|||
131696396|NCT04418076|474170456|FG003|Overall Study|Withdrawal by Subject|1|||
131696397|NCT04418076|474170453|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
131696398|NCT04418076|474170454|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
131696399|NCT04418076|474170455|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
131696400|NCT04418076|474170456|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
131696401|NCT01452152|474170457|FG000|Overall Study|Study termination by sponsor|5|||
131696402|NCT01452152|474170458|FG001|Overall Study|Study termination by sponsor|0|||
131696403|NCT01452152|474170459|FG002|Overall Study|Study termination by sponsor|4|||
131696404|NCT02068547|474171970|FG000|Overall Study|Lost to Follow-up|3|||
131696405|NCT02068547|474171971|FG001|Overall Study|Lost to Follow-up|3|||
131696406|NCT02068547|474171970|FG000|Overall Study|Physician Decision|1|||
131696407|NCT02068547|474171971|FG001|Overall Study|Physician Decision|0|||
131696408|NCT01736579|474171972|FG000|Overall Study|Termination of Study by Sponsor|2|||
131696409|NCT01736579|474171973|FG001|Overall Study|Termination of Study by Sponsor|2|||
131696410|NCT02049944|474171974|FG000|Overall Study|Protocol Violation|2|||
131696411|NCT01765673|474171975|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
131696412|NCT01042600|474171976|FG000|Overall Study|Ineligible|1|||
131696413|NCT01042600|474171977|FG001|Overall Study|Ineligible|0|||
131563450|NCT03685708|473686264|FG000|Overall Study|COVID 19 Pandemic|1|||
131563451|NCT03685708|473686265|FG001|Overall Study|COVID 19 Pandemic|1|||
131696414|NCT04541004|474171978|FG000|Overall Study|Adverse Event|2|||
131696415|NCT02229552|474171980|FG000|Baseline|Withdrawal by Subject|6|||
131696416|NCT02229552|474171980|FG000|1-year Follow up|Withdrawal by Subject|7|||
131696417|NCT02229552|474171980|FG000|1-year Follow up|Lost to Follow-up|18|||
131696418|NCT02229552|474171980|FG000|2-Year Follow up|Withdrawal by Subject|9|||
131696419|NCT02229552|474171980|FG000|2-Year Follow up|Lost to Follow-up|17|||
131696420|NCT03354663|474171981|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
131696421|NCT03354663|474171981|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
131563452|NCT03685708|473686266|FG002|Overall Study|COVID 19 Pandemic|6|||
131563453|NCT03685708|473686264|FG000|Overall Study|Disease Progression|0|||
131563454|NCT03685708|473686265|FG001|Overall Study|Disease Progression|0|||
131563455|NCT03685708|473686266|FG002|Overall Study|Disease Progression|1|||
131781286|NCT03889197|474479493|FG000|Overall Study|met exclusion criteria|0|||
131781287|NCT03889197|474479494|FG001|Overall Study|met exclusion criteria|1|||
131781288|NCT03889197|474479493|FG000|Overall Study|Protocol Violation|1|||
131781289|NCT03889197|474479494|FG001|Overall Study|Protocol Violation|0|||
131781290|NCT05899218|474479495|FG000|Overall Study|Lost to Follow-up|2|||
131781291|NCT05899218|474479496|FG001|Overall Study|Lost to Follow-up|2|||
131781292|NCT05899218|474479495|FG000|Overall Study|deemed ineligible out of country|1|||
131781293|NCT05899218|474479496|FG001|Overall Study|deemed ineligible out of country|0|||
131781298|NCT05246111|474479499|FG000|Period 01|NOT ELIGIBLE IC5|1|||
131781299|NCT05246111|474479500|FG001|Period 01|NOT ELIGIBLE IC5|0|||
131781300|NCT03151226|474479501|FG000|Overall Study|Withdrawal by Subject|2|||
131781301|NCT03151226|474479501|FG000|Overall Study|not wear device correctly|1|||
131781302|NCT00285012|474479502|FG000|Assigned to Study Treatment (Tx)|Other|2|||
131781303|NCT00285012|474479503|FG001|Assigned to Study Treatment (Tx)|Other|3|||
131781304|NCT00285012|474479502|FG000|Received Study Tx|Death|2|||
131781305|NCT00285012|474479503|FG001|Received Study Tx|Death|1|||
131781306|NCT00285012|474479502|FG000|Received Study Tx|Adverse Event|5|||
131781307|NCT00285012|474479503|FG001|Received Study Tx|Adverse Event|11|||
131781308|NCT00285012|474479502|FG000|Received Study Tx|Lack of Efficacy|0|||
131781309|NCT00285012|474479503|FG001|Received Study Tx|Lack of Efficacy|3|||
131781310|NCT00285012|474479502|FG000|Received Study Tx|Lost to Follow-up|29|||
131781311|NCT00285012|474479503|FG001|Received Study Tx|Lost to Follow-up|31|||
131781312|NCT00285012|474479502|FG000|Received Study Tx|Withdrawal by Subject|31|||
131781313|NCT00285012|474479503|FG001|Received Study Tx|Withdrawal by Subject|43|||
131781314|NCT00285012|474479502|FG000|Received Study Tx|Other|5|||
131781315|NCT00285012|474479503|FG001|Received Study Tx|Other|5|||
131781316|NCT02873195|474479506|FG000|Overall Study|Ineligible|5|||
131781317|NCT02873195|474479507|FG001|Overall Study|Ineligible|0|||
131781318|NCT05004181|474479509|FG000|Overall Study|Withdrawal of consent|0|||
131781319|NCT05004181|474479510|FG001|Overall Study|Withdrawal of consent|0|||
131781320|NCT05004181|474479511|FG002|Overall Study|Withdrawal of consent|1|||
131781321|NCT05004181|474479512|FG003|Overall Study|Withdrawal of consent|3|||
131781322|NCT05004181|474479513|FG004|Overall Study|Withdrawal of consent|3|||
131781323|NCT05004181|474479514|FG005|Overall Study|Withdrawal of consent|0|||
131781324|NCT05004181|474479515|FG006|Overall Study|Withdrawal of consent|30|||
131781325|NCT05004181|474479516|FG007|Overall Study|Withdrawal of consent|9|||
131781326|NCT05004181|474479517|FG008|Overall Study|Withdrawal of consent|3|||
131781327|NCT05004181|474479518|FG009|Overall Study|Withdrawal of consent|2|||
131781328|NCT05004181|474479519|FG010|Overall Study|Withdrawal of consent|5|||
131781329|NCT05004181|474479520|FG011|Overall Study|Withdrawal of consent|1|||
131781330|NCT05004181|474479509|FG000|Overall Study|Lost to Follow-up|2|||
131781331|NCT05004181|474479510|FG001|Overall Study|Lost to Follow-up|4|||
131781332|NCT05004181|474479511|FG002|Overall Study|Lost to Follow-up|2|||
131781333|NCT05004181|474479512|FG003|Overall Study|Lost to Follow-up|3|||
131781334|NCT05004181|474479513|FG004|Overall Study|Lost to Follow-up|5|||
131781335|NCT05004181|474479514|FG005|Overall Study|Lost to Follow-up|2|||
131781336|NCT05004181|474479515|FG006|Overall Study|Lost to Follow-up|15|||
131781337|NCT05004181|474479516|FG007|Overall Study|Lost to Follow-up|12|||
131781338|NCT05004181|474479517|FG008|Overall Study|Lost to Follow-up|38|||
131781339|NCT05004181|474479518|FG009|Overall Study|Lost to Follow-up|6|||
131781340|NCT05004181|474479519|FG010|Overall Study|Lost to Follow-up|6|||
131781341|NCT05004181|474479520|FG011|Overall Study|Lost to Follow-up|0|||
131781342|NCT05004181|474479509|FG000|Overall Study|Death|0|||
131781343|NCT05004181|474479510|FG001|Overall Study|Death|0|||
131781344|NCT05004181|474479511|FG002|Overall Study|Death|0|||
131781345|NCT05004181|474479512|FG003|Overall Study|Death|0|||
131781346|NCT05004181|474479513|FG004|Overall Study|Death|0|||
131781347|NCT05004181|474479514|FG005|Overall Study|Death|0|||
131781348|NCT05004181|474479515|FG006|Overall Study|Death|1|||
131781349|NCT05004181|474479516|FG007|Overall Study|Death|0|||
131781350|NCT05004181|474479517|FG008|Overall Study|Death|2|||
131781351|NCT05004181|474479518|FG009|Overall Study|Death|0|||
131781352|NCT05004181|474479519|FG010|Overall Study|Death|0|||
131781353|NCT05004181|474479520|FG011|Overall Study|Death|0|||
131781354|NCT05004181|474479509|FG000|Overall Study|Physician Decision|0|||
131781355|NCT05004181|474479510|FG001|Overall Study|Physician Decision|0|||
131781356|NCT05004181|474479511|FG002|Overall Study|Physician Decision|0|||
131781357|NCT05004181|474479512|FG003|Overall Study|Physician Decision|0|||
131781358|NCT05004181|474479513|FG004|Overall Study|Physician Decision|0|||
131781359|NCT05004181|474479514|FG005|Overall Study|Physician Decision|0|||
131781360|NCT05004181|474479515|FG006|Overall Study|Physician Decision|2|||
131781361|NCT05004181|474479516|FG007|Overall Study|Physician Decision|0|||
131781362|NCT05004181|474479517|FG008|Overall Study|Physician Decision|7|||
131781363|NCT05004181|474479518|FG009|Overall Study|Physician Decision|0|||
131781364|NCT05004181|474479519|FG010|Overall Study|Physician Decision|0|||
131781365|NCT05004181|474479520|FG011|Overall Study|Physician Decision|0|||
131563456|NCT04006366|473686267|FG000|Overall Study|Withdrawal by Subject|1|||
131563457|NCT04430335|473686268|FG000|Overall Study|Withdrawal by Subject|1|||
131563458|NCT03249376|473686275|FG000|Overall Study|Adverse Event|11|||
131563459|NCT03249376|473686276|FG001|Overall Study|Adverse Event|5|||
131563460|NCT03249376|473686275|FG000|Overall Study|Lack of Efficacy|2|||
131563461|NCT03249376|473686276|FG001|Overall Study|Lack of Efficacy|4|||
131563462|NCT03249376|473686275|FG000|Overall Study|Protocol Violation|3|||
131563463|NCT03249376|473686276|FG001|Overall Study|Protocol Violation|2|||
131563464|NCT03249376|473686275|FG000|Overall Study|Physician Decision|0|||
131563465|NCT03249376|473686276|FG001|Overall Study|Physician Decision|2|||
131563466|NCT03249376|473686275|FG000|Overall Study|Withdrawal by Subject|3|||
131563467|NCT03249376|473686276|FG001|Overall Study|Withdrawal by Subject|9|||
131563468|NCT03249376|473686275|FG000|Overall Study|LTFU|2|||
131563469|NCT03249376|473686276|FG001|Overall Study|LTFU|1|||
131563470|NCT00627042|473686277|FG000|Overall Study|Withdrawal by Subject|2|||
131563471|NCT01154036|473686278|FG000|Phase I|Physician Decision|0|||
131563472|NCT01154036|473686279|FG001|Phase I|Physician Decision|1|||
131563473|NCT01154036|473686280|FG002|Phase I|Physician Decision|0|||
131563474|NCT01154036|473686281|FG003|Phase I|Physician Decision|0|||
131563475|NCT01154036|473686282|FG004|Phase I|Physician Decision|0|||
131563476|NCT01154036|473686283|FG005|Phase I|Physician Decision|0|||
131563477|NCT01154036|473686284|FG006|Phase I|Physician Decision|0|||
131563478|NCT01154036|473686285|FG007|Phase I|Physician Decision|0|||
131563479|NCT01154036|473686278|FG000|Phase I|Lost to Follow-up|0|||
131563480|NCT01154036|473686279|FG001|Phase I|Lost to Follow-up|3|||
131563481|NCT01154036|473686280|FG002|Phase I|Lost to Follow-up|6|||
131563482|NCT01154036|473686281|FG003|Phase I|Lost to Follow-up|0|||
131563483|NCT01154036|473686282|FG004|Phase I|Lost to Follow-up|0|||
131563484|NCT01154036|473686283|FG005|Phase I|Lost to Follow-up|0|||
131563485|NCT01154036|473686284|FG006|Phase I|Lost to Follow-up|0|||
131563486|NCT01154036|473686285|FG007|Phase I|Lost to Follow-up|0|||
131563487|NCT01154036|473686278|FG000|Phase I|Protocol Violation|0|||
131563488|NCT01154036|473686279|FG001|Phase I|Protocol Violation|3|||
131563489|NCT01154036|473686280|FG002|Phase I|Protocol Violation|9|||
131563490|NCT01154036|473686281|FG003|Phase I|Protocol Violation|0|||
131563491|NCT01154036|473686282|FG004|Phase I|Protocol Violation|0|||
131563492|NCT01154036|473686283|FG005|Phase I|Protocol Violation|0|||
131563493|NCT01154036|473686284|FG006|Phase I|Protocol Violation|0|||
131563494|NCT01154036|473686285|FG007|Phase I|Protocol Violation|0|||
131563495|NCT01154036|473686278|FG000|Phase I|Withdrawal by Subject|2|||
131563496|NCT01154036|473686279|FG001|Phase I|Withdrawal by Subject|10|||
131563497|NCT01154036|473686280|FG002|Phase I|Withdrawal by Subject|29|||
131563498|NCT01154036|473686281|FG003|Phase I|Withdrawal by Subject|0|||
131563499|NCT01154036|473686282|FG004|Phase I|Withdrawal by Subject|0|||
131563500|NCT01154036|473686283|FG005|Phase I|Withdrawal by Subject|0|||
131563501|NCT01154036|473686284|FG006|Phase I|Withdrawal by Subject|0|||
131563502|NCT01154036|473686285|FG007|Phase I|Withdrawal by Subject|0|||
131563503|NCT01154036|473686278|FG000|Phase I|Adverse Event|1|||
131563504|NCT01154036|473686279|FG001|Phase I|Adverse Event|11|||
131563505|NCT01154036|473686280|FG002|Phase I|Adverse Event|12|||
131563506|NCT01154036|473686281|FG003|Phase I|Adverse Event|0|||
131563507|NCT01154036|473686282|FG004|Phase I|Adverse Event|0|||
131696422|NCT03354663|474171981|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
131696423|NCT03354663|474171981|FG000|Completed 30-day Visit|Missed Visit|1|||
131696424|NCT01661140|474171982|FG000|Open-Label Period|Adverse Event|44|||
131696425|NCT01661140|474171983|FG001|Open-Label Period|Adverse Event|0|||
131696426|NCT01661140|474171984|FG002|Open-Label Period|Adverse Event|0|||
131696427|NCT01661140|474171982|FG000|Open-Label Period|Protocol Violation|3|||
131696428|NCT01661140|474171983|FG001|Open-Label Period|Protocol Violation|0|||
131696429|NCT01661140|474171984|FG002|Open-Label Period|Protocol Violation|0|||
131696430|NCT01661140|474171982|FG000|Open-Label Period|Withdrawal by Subject|5|||
131696431|NCT01661140|474171983|FG001|Open-Label Period|Withdrawal by Subject|0|||
131696432|NCT01661140|474171984|FG002|Open-Label Period|Withdrawal by Subject|0|||
131696433|NCT01661140|474171982|FG000|Open-Label Period|Investigator Decision|3|||
131696434|NCT01661140|474171983|FG001|Open-Label Period|Investigator Decision|0|||
131563508|NCT01154036|473686283|FG005|Phase I|Adverse Event|0|||
131563509|NCT01154036|473686284|FG006|Phase I|Adverse Event|0|||
131563510|NCT01154036|473686285|FG007|Phase I|Adverse Event|0|||
131563511|NCT01154036|473686278|FG000|Phase II|Adverse Event|0|||
131563512|NCT01154036|473686279|FG001|Phase II|Adverse Event|0|||
131563513|NCT01154036|473686280|FG002|Phase II|Adverse Event|0|||
131563514|NCT01154036|473686281|FG003|Phase II|Adverse Event|0|||
131563515|NCT01154036|473686282|FG004|Phase II|Adverse Event|1|||
131563516|NCT01154036|473686283|FG005|Phase II|Adverse Event|1|||
131563517|NCT01154036|473686284|FG006|Phase II|Adverse Event|1|||
131563518|NCT01154036|473686285|FG007|Phase II|Adverse Event|1|||
131696435|NCT01661140|474171984|FG002|Open-Label Period|Investigator Decision|0|||
131696436|NCT01661140|474171982|FG000|Open-Label Period|Death|1|||
131696437|NCT01661140|474171983|FG001|Open-Label Period|Death|0|||
131563519|NCT01154036|473686278|FG000|Phase II|Physician Decision|0|||
131563520|NCT01154036|473686279|FG001|Phase II|Physician Decision|0|||
131563521|NCT01154036|473686280|FG002|Phase II|Physician Decision|0|||
131563522|NCT01154036|473686281|FG003|Phase II|Physician Decision|0|||
131563523|NCT01154036|473686282|FG004|Phase II|Physician Decision|0|||
131563524|NCT01154036|473686283|FG005|Phase II|Physician Decision|0|||
131563525|NCT01154036|473686284|FG006|Phase II|Physician Decision|1|||
131563526|NCT01154036|473686285|FG007|Phase II|Physician Decision|0|||
131563527|NCT01154036|473686278|FG000|Phase II|Lost to Follow-up|0|||
131563528|NCT01154036|473686279|FG001|Phase II|Lost to Follow-up|0|||
131781366|NCT05004181|474479509|FG000|Overall Study|Withdrawal by Subject|2|||
131781367|NCT05004181|474479510|FG001|Overall Study|Withdrawal by Subject|3|||
131781368|NCT05004181|474479511|FG002|Overall Study|Withdrawal by Subject|2|||
131781369|NCT05004181|474479512|FG003|Overall Study|Withdrawal by Subject|2|||
131563529|NCT01154036|473686280|FG002|Phase II|Lost to Follow-up|0|||
131563530|NCT01154036|473686281|FG003|Phase II|Lost to Follow-up|1|||
131563531|NCT01154036|473686282|FG004|Phase II|Lost to Follow-up|2|||
131563532|NCT01154036|473686283|FG005|Phase II|Lost to Follow-up|0|||
131563533|NCT01154036|473686284|FG006|Phase II|Lost to Follow-up|2|||
131563534|NCT01154036|473686285|FG007|Phase II|Lost to Follow-up|1|||
131563535|NCT01154036|473686278|FG000|Phase II|Protocol Violation|0|||
131563536|NCT01154036|473686279|FG001|Phase II|Protocol Violation|0|||
131563537|NCT01154036|473686280|FG002|Phase II|Protocol Violation|0|||
131563538|NCT01154036|473686281|FG003|Phase II|Protocol Violation|0|||
131563539|NCT01154036|473686282|FG004|Phase II|Protocol Violation|1|||
131563540|NCT01154036|473686283|FG005|Phase II|Protocol Violation|2|||
131563541|NCT01154036|473686284|FG006|Phase II|Protocol Violation|0|||
131563542|NCT01154036|473686285|FG007|Phase II|Protocol Violation|0|||
131563543|NCT01154036|473686278|FG000|Phase II|Withdrawal by Subject|0|||
131781370|NCT05004181|474479513|FG004|Overall Study|Withdrawal by Subject|4|||
131563544|NCT01154036|473686279|FG001|Phase II|Withdrawal by Subject|0|||
131563545|NCT01154036|473686280|FG002|Phase II|Withdrawal by Subject|0|||
131563546|NCT01154036|473686281|FG003|Phase II|Withdrawal by Subject|0|||
131563547|NCT01154036|473686282|FG004|Phase II|Withdrawal by Subject|4|||
131563548|NCT01154036|473686283|FG005|Phase II|Withdrawal by Subject|2|||
131563549|NCT01154036|473686284|FG006|Phase II|Withdrawal by Subject|5|||
131563550|NCT01154036|473686285|FG007|Phase II|Withdrawal by Subject|4|||
131563551|NCT00594932|473686290|FG000|First 3 Months|Withdrawal by Subject|1|||
131563552|NCT00594932|473686291|FG001|First 3 Months|Withdrawal by Subject|3|||
131563553|NCT00594932|473686290|FG000|Final 3 Months|Withdrawal by Subject|4|||
131563554|NCT00594932|473686291|FG001|Final 3 Months|Withdrawal by Subject|3|||
131563555|NCT01094171|473686292|FG000|Overall Study|Lost to Follow-up|2|||
131563556|NCT01094171|473686292|FG000|Overall Study|Informed consent withdrawal|4|||
131563557|NCT01094171|473686292|FG000|Overall Study|Migration from the study area|3|||
131563558|NCT01094171|473686292|FG000|Overall Study|Other|1|||
131781371|NCT05004181|474479514|FG005|Overall Study|Withdrawal by Subject|2|||
131781372|NCT05004181|474479515|FG006|Overall Study|Withdrawal by Subject|4|||
131781373|NCT05004181|474479516|FG007|Overall Study|Withdrawal by Subject|22|||
131781374|NCT05004181|474479517|FG008|Overall Study|Withdrawal by Subject|8|||
131781375|NCT05004181|474479518|FG009|Overall Study|Withdrawal by Subject|1|||
131781376|NCT05004181|474479519|FG010|Overall Study|Withdrawal by Subject|3|||
131781377|NCT05004181|474479520|FG011|Overall Study|Withdrawal by Subject|2|||
131781378|NCT05004181|474479509|FG000|Overall Study|Protocol Violation|2|||
131781379|NCT05004181|474479510|FG001|Overall Study|Protocol Violation|3|||
131781380|NCT05004181|474479511|FG002|Overall Study|Protocol Violation|0|||
131781381|NCT05004181|474479512|FG003|Overall Study|Protocol Violation|0|||
131781382|NCT05004181|474479513|FG004|Overall Study|Protocol Violation|1|||
131781383|NCT05004181|474479514|FG005|Overall Study|Protocol Violation|0|||
131781384|NCT05004181|474479515|FG006|Overall Study|Protocol Violation|16|||
131781385|NCT05004181|474479516|FG007|Overall Study|Protocol Violation|18|||
131781386|NCT05004181|474479517|FG008|Overall Study|Protocol Violation|2|||
131781387|NCT05004181|474479518|FG009|Overall Study|Protocol Violation|2|||
131781388|NCT05004181|474479519|FG010|Overall Study|Protocol Violation|2|||
131781389|NCT05004181|474479520|FG011|Overall Study|Protocol Violation|1|||
131563559|NCT01009047|473686294|FG000|Overall Study|Adverse Event|5|||
131563560|NCT01009047|473686295|FG001|Overall Study|Adverse Event|0|||
131563561|NCT01009047|473686294|FG000|Overall Study|Lost to Follow-up|0|||
131563562|NCT01009047|473686295|FG001|Overall Study|Lost to Follow-up|2|||
131563563|NCT01009047|473686294|FG000|Overall Study|Lack of Efficacy|4|||
131563564|NCT01009047|473686295|FG001|Overall Study|Lack of Efficacy|11|||
131563565|NCT01009047|473686294|FG000|Overall Study|Withdrawal by consent|16|||
131563566|NCT01009047|473686295|FG001|Overall Study|Withdrawal by consent|11|||
131563567|NCT01009047|473686294|FG000|Overall Study|Other|3|||
131563568|NCT01009047|473686295|FG001|Overall Study|Other|2|||
131563569|NCT01676220|473686296|FG000|Overall Study|Randomized But Not Treated|4|||
131781390|NCT05004181|474479509|FG000|Overall Study|Not further specified|1|||
131781391|NCT05004181|474479510|FG001|Overall Study|Not further specified|0|||
131781392|NCT05004181|474479511|FG002|Overall Study|Not further specified|0|||
131781393|NCT05004181|474479512|FG003|Overall Study|Not further specified|0|||
131781394|NCT05004181|474479513|FG004|Overall Study|Not further specified|0|||
131563570|NCT01676220|473686297|FG001|Overall Study|Randomized But Not Treated|1|||
131563571|NCT01676220|473686296|FG000|Overall Study|Adverse Event|10|||
131563572|NCT01676220|473686297|FG001|Overall Study|Adverse Event|8|||
131563573|NCT01676220|473686296|FG000|Overall Study|Lack of Efficacy|2|||
131563574|NCT01676220|473686297|FG001|Overall Study|Lack of Efficacy|5|||
131563575|NCT01676220|473686296|FG000|Overall Study|Protocol Violation|11|||
131563576|NCT01676220|473686297|FG001|Overall Study|Protocol Violation|12|||
131563577|NCT01676220|473686296|FG000|Overall Study|Received Rescue Therapy|14|||
131563578|NCT01676220|473686297|FG001|Overall Study|Received Rescue Therapy|22|||
131563579|NCT01676220|473686296|FG000|Overall Study|Personal Reason|34|||
131563580|NCT01676220|473686297|FG001|Overall Study|Personal Reason|45|||
131563581|NCT01676220|473686296|FG000|Overall Study|Lost to Follow-up|11|||
131563582|NCT01676220|473686297|FG001|Overall Study|Lost to Follow-up|18|||
131563583|NCT01676220|473686296|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
131563584|NCT01676220|473686297|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
131563585|NCT01676220|473686296|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
131563586|NCT01676220|473686297|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
131563587|NCT01676220|473686296|FG000|Overall Study|Perceived Lack of Efficacy|3|||
131781395|NCT05004181|474479514|FG005|Overall Study|Not further specified|0|||
131781396|NCT05004181|474479515|FG006|Overall Study|Not further specified|1|||
131781397|NCT05004181|474479516|FG007|Overall Study|Not further specified|0|||
131781398|NCT05004181|474479517|FG008|Overall Study|Not further specified|2|||
131781399|NCT05004181|474479518|FG009|Overall Study|Not further specified|1|||
131781400|NCT05004181|474479519|FG010|Overall Study|Not further specified|0|||
131781401|NCT05004181|474479520|FG011|Overall Study|Not further specified|1|||
131781402|NCT04278872|474479522|FG000|Overall Study|Adverse Event|1|||
131781403|NCT04278872|474479523|FG001|Overall Study|Adverse Event|0|||
131781404|NCT04278872|474479522|FG000|Overall Study|Protocol Violation|0|||
131781405|NCT04278872|474479523|FG001|Overall Study|Protocol Violation|1|||
131781406|NCT04278872|474479522|FG000|Overall Study|Study Termination|2|||
131563588|NCT01676220|473686297|FG001|Overall Study|Perceived Lack of Efficacy|1|||
131563589|NCT01676220|473686296|FG000|Overall Study|Non Serious Hypoglycemia|2|||
131563590|NCT01676220|473686297|FG001|Overall Study|Non Serious Hypoglycemia|0|||
131563591|NCT01676220|473686296|FG000|Overall Study|No More Need of Insulin|1|||
131563592|NCT01676220|473686297|FG001|Overall Study|No More Need of Insulin|0|||
131563593|NCT03875911|473686300|FG000|Overall Study|Lost to Follow-up|3|||
131563594|NCT03875911|473686301|FG001|Overall Study|Lost to Follow-up|6|||
131781407|NCT04278872|474479523|FG001|Overall Study|Study Termination|0|||
131781408|NCT00752895|474479524|FG000|Overall Study|Withdrawal by Subject|8|||
131781409|NCT00752895|474479525|FG001|Overall Study|Withdrawal by Subject|3|||
131781410|NCT00096031|474479526|FG000|Overall Study|Adverse Event|3|||
131781411|NCT00096031|474479526|FG000|Overall Study|Lack of Efficacy|42|||
131781412|NCT00096031|474479526|FG000|Overall Study|Death|4|||
131563595|NCT03875911|473686302|FG002|Overall Study|Lost to Follow-up|2|||
131563596|NCT03875911|473686300|FG000|Overall Study|Surgery cancelled|1|||
131563597|NCT03875911|473686301|FG001|Overall Study|Surgery cancelled|0|||
131563598|NCT03875911|473686302|FG002|Overall Study|Surgery cancelled|1|||
131563599|NCT03875911|473686300|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
131563600|NCT03875911|473686301|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
131563601|NCT03875911|473686302|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
131563602|NCT03824938|473686303|FG000|Overall Study|Withdrawal by Subject|2|||
131563603|NCT03824938|473686304|FG001|Overall Study|Withdrawal by Subject|1|||
131563604|NCT03824938|473686305|FG002|Overall Study|Withdrawal by Subject|0|||
131563605|NCT03824938|473686306|FG003|Overall Study|Withdrawal by Subject|2|||
131563606|NCT03824938|473686307|FG004|Overall Study|Withdrawal by Subject|0|||
131563607|NCT03824938|473686308|FG005|Overall Study|Withdrawal by Subject|1|||
131563608|NCT03824938|473686303|FG000|Overall Study|Lost to Follow-up|0|||
131563609|NCT03824938|473686304|FG001|Overall Study|Lost to Follow-up|1|||
131563610|NCT03824938|473686305|FG002|Overall Study|Lost to Follow-up|0|||
131563611|NCT03824938|473686306|FG003|Overall Study|Lost to Follow-up|0|||
131563612|NCT03824938|473686307|FG004|Overall Study|Lost to Follow-up|1|||
131781413|NCT00096031|474479526|FG000|Overall Study|Withdrawal by Subject|1|||
131781414|NCT00096031|474479526|FG000|Overall Study|Ineligible|8|||
131898616|NCT02624947|474915308|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
131563613|NCT03824938|473686308|FG005|Overall Study|Lost to Follow-up|0|||
131563614|NCT01990300|473686312|FG000|Overall Study|Case Report Forms Uncollected|89|||
131563615|NCT01990300|473686312|FG000|Overall Study|Protocol Deviation|53|||
131563616|NCT04496167|473686315|FG000|Overall Study|Adverse Event|6|||
131563617|NCT04496167|473686316|FG001|Overall Study|Adverse Event|2|||
131781415|NCT00096031|474479526|FG000|Overall Study|Not protocol specified|5|||
131781416|NCT03353415|474479529|FG000|Masked CGM Wear|Lost to Follow-up|2|||
131781417|NCT03353415|474479529|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
131781418|NCT05257109|474479530|FG000|Overall Study|Withdrawal by Subject|1|||
131781419|NCT05257109|474479531|FG001|Overall Study|Withdrawal by Subject|0|||
131781420|NCT05257109|474479532|FG002|Overall Study|Withdrawal by Subject|0|||
131781421|NCT05257109|474479533|FG003|Overall Study|Withdrawal by Subject|0|||
131781422|NCT00359073|474481553|FG000|Overall Study|Withdrawal by Subject|1|||
131781423|NCT00359073|474481554|FG001|Overall Study|Withdrawal by Subject|1|||
131781424|NCT00359073|474481553|FG000|Overall Study|Eligibility criteria no longer met|3|||
131781425|NCT00359073|474481554|FG001|Overall Study|Eligibility criteria no longer met|0|||
131781426|NCT00359073|474481553|FG000|Overall Study|developed RV16 antibody|0|||
131781427|NCT00359073|474481554|FG001|Overall Study|developed RV16 antibody|1|||
131781428|NCT01371006|474481555|FG000|Overall Study|Adverse Event|1|||
131781429|NCT01371006|474481556|FG001|Overall Study|Adverse Event|0|||
131781430|NCT02237118|474481558|FG000|Overall Study|Protocol Violation|0|||
131781431|NCT02237118|474481559|FG001|Overall Study|Protocol Violation|1|||
131781432|NCT02237118|474481558|FG000|Overall Study|consent withdrawn|1|||
131781433|NCT02237118|474481559|FG001|Overall Study|consent withdrawn|0|||
131781434|NCT02953262|474481560|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
131781435|NCT02953262|474481561|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
131781436|NCT02953262|474481562|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
131781437|NCT02953262|474481563|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
131563618|NCT04496167|473686315|FG000|Overall Study|Withdrawal by Subject|7|||
131563619|NCT04496167|473686316|FG001|Overall Study|Withdrawal by Subject|6|||
131563620|NCT04496167|473686315|FG000|Overall Study|Lost to Follow-up|3|||
131563621|NCT04496167|473686316|FG001|Overall Study|Lost to Follow-up|5|||
131563622|NCT04496167|473686315|FG000|Overall Study|Not Treated|1|||
131563623|NCT04496167|473686316|FG001|Overall Study|Not Treated|2|||
131563624|NCT04496167|473686315|FG000|Overall Study|Other Than Specified|1|||
131563625|NCT04496167|473686316|FG001|Overall Study|Other Than Specified|1|||
131563626|NCT00681187|473686317|FG000|Overall Study|Withdrawal by Subject|1|||
131563627|NCT00681187|473686318|FG001|Overall Study|Withdrawal by Subject|0|||
131563628|NCT00681187|473686317|FG000|Overall Study|Death|0|||
131781438|NCT03284424|474481565|FG000|Overall Study|Death|70|||
131781439|NCT03284424|474481566|FG001|Overall Study|Death|24|||
131781440|NCT03284424|474481565|FG000|Overall Study|Lost to Follow-up|3|||
131781441|NCT03284424|474481566|FG001|Overall Study|Lost to Follow-up|1|||
131781442|NCT03284424|474481565|FG000|Overall Study|Physician Decision|1|||
131781443|NCT03284424|474481566|FG001|Overall Study|Physician Decision|2|||
131781444|NCT03284424|474481565|FG000|Overall Study|Withdrawal by Subject|4|||
131781445|NCT03284424|474481566|FG001|Overall Study|Withdrawal by Subject|5|||
131781446|NCT03284424|474481565|FG000|Overall Study|Sponsor's decision|27|||
131781447|NCT03284424|474481566|FG001|Overall Study|Sponsor's decision|22|||
131781448|NCT02962739|474481567|FG000|Overall Study|Withdrawal by Subject|0|||
131781449|NCT02962739|474481568|FG001|Overall Study|Withdrawal by Subject|1|||
131781450|NCT02962739|474481569|FG002|Overall Study|Withdrawal by Subject|0|||
131781451|NCT02962739|474481570|FG003|Overall Study|Withdrawal by Subject|0|||
131781452|NCT02962739|474481571|FG004|Overall Study|Withdrawal by Subject|0|||
131781453|NCT02962739|474481572|FG005|Overall Study|Withdrawal by Subject|0|||
131781454|NCT02962739|474481567|FG000|Overall Study|Protocol Violation|0|||
131781455|NCT02962739|474481568|FG001|Overall Study|Protocol Violation|0|||
131781456|NCT02962739|474481569|FG002|Overall Study|Protocol Violation|1|||
131781457|NCT02962739|474481570|FG003|Overall Study|Protocol Violation|0|||
131781458|NCT02962739|474481571|FG004|Overall Study|Protocol Violation|1|||
131781459|NCT02962739|474481572|FG005|Overall Study|Protocol Violation|0|||
131781460|NCT00734617|474481573|FG000|Overall Study|Adverse Event|4|||
131781461|NCT00734617|474481574|FG001|Overall Study|Adverse Event|7|||
131781462|NCT00734617|474481573|FG000|Overall Study|Withdrawal by Subject|103|||
131781463|NCT00734617|474481574|FG001|Overall Study|Withdrawal by Subject|95|||
131781464|NCT02406742|474481575|FG000|Overall Study|Progression of Disease|5|||
131781465|NCT02406742|474481576|FG001|Overall Study|Progression of Disease|1|||
131781466|NCT02406742|474481577|FG002|Overall Study|Progression of Disease|6|||
131781467|NCT02406742|474481575|FG000|Overall Study|Adverse Event|3|||
131781468|NCT02406742|474481576|FG001|Overall Study|Adverse Event|0|||
131781469|NCT02406742|474481577|FG002|Overall Study|Adverse Event|2|||
131781470|NCT02406742|474481575|FG000|Overall Study|Death|1|||
131781471|NCT02406742|474481576|FG001|Overall Study|Death|0|||
131781472|NCT02406742|474481577|FG002|Overall Study|Death|0|||
131781473|NCT02406742|474481575|FG000|Overall Study|Lack of Efficacy|0|||
131563629|NCT00681187|473686318|FG001|Overall Study|Death|1|||
131563630|NCT00681187|473686317|FG000|Overall Study|Adverse Event|0|||
131563631|NCT00681187|473686318|FG001|Overall Study|Adverse Event|1|||
131781474|NCT02406742|474481576|FG001|Overall Study|Lack of Efficacy|0|||
131563632|NCT02788006|473686320|FG000|Overall Study|Patient not treated|1|||
131781475|NCT02406742|474481577|FG002|Overall Study|Lack of Efficacy|1|||
131781476|NCT02406742|474481575|FG000|Overall Study|Withdrawal by Participant|1|||
131781477|NCT02406742|474481576|FG001|Overall Study|Withdrawal by Participant|2|||
131781478|NCT02406742|474481577|FG002|Overall Study|Withdrawal by Participant|0|||
131781479|NCT02406742|474481575|FG000|Overall Study|Physician Decision|1|||
131781480|NCT02406742|474481576|FG001|Overall Study|Physician Decision|2|||
131781481|NCT02406742|474481577|FG002|Overall Study|Physician Decision|1|||
131781482|NCT02406742|474481575|FG000|Overall Study|Transition to other treatment|2|||
131781483|NCT02406742|474481576|FG001|Overall Study|Transition to other treatment|0|||
131781484|NCT02406742|474481577|FG002|Overall Study|Transition to other treatment|1|||
131781485|NCT02406742|474481575|FG000|Overall Study|Other Reasons|1|||
131781486|NCT02406742|474481576|FG001|Overall Study|Other Reasons|11|||
131781487|NCT02406742|474481577|FG002|Overall Study|Other Reasons|5|||
131781488|NCT00765999|474481578|FG000|Overall Study|Adverse Event|203|||
131781489|NCT00765999|474481578|FG000|Overall Study|Insufficient Therapeutic Response|100|||
131563633|NCT02269943|473686321|FG000|Treatment Period|Death|0|||
131563634|NCT02269943|473686322|FG001|Treatment Period|Death|1|||
131563635|NCT02269943|473686321|FG000|Treatment Period|Adverse Event|1|||
131563636|NCT02269943|473686322|FG001|Treatment Period|Adverse Event|10|||
131563637|NCT02269943|473686321|FG000|Treatment Period|Progressive Disease|5|||
131563638|NCT02269943|473686322|FG001|Treatment Period|Progressive Disease|17|||
131563639|NCT02269943|473686321|FG000|Treatment Period|Symptomatic Deterioration|0|||
131563640|NCT02269943|473686322|FG001|Treatment Period|Symptomatic Deterioration|2|||
131563641|NCT02269943|473686321|FG000|Follow-Up Survival Period|Death|3|||
131563642|NCT02269943|473686322|FG001|Follow-Up Survival Period|Death|16|||
131781490|NCT00765999|474481578|FG000|Overall Study|Protocol Violation|95|||
131781491|NCT00765999|474481578|FG000|Overall Study|Consent Withdrawn|202|||
131781492|NCT00765999|474481578|FG000|Overall Study|Lost to Follow-up|131|||
131781493|NCT00765999|474481578|FG000|Overall Study|Study Terminated by Sponsor|2|||
131781494|NCT00765999|474481578|FG000|Overall Study|Other Miscellaneous Reasons|51|||
131781495|NCT02367729|474481579|FG000|Overall Study|Organic disorder diagnosed|2|||
131781496|NCT02367729|474481580|FG001|Overall Study|Organic disorder diagnosed|1|||
131781497|NCT02367729|474481579|FG000|Overall Study|Adverse Event|1|||
131781498|NCT02367729|474481580|FG001|Overall Study|Adverse Event|2|||
131781499|NCT02367729|474481579|FG000|Overall Study|Withdrawal by Subject|0|||
131781500|NCT02367729|474481580|FG001|Overall Study|Withdrawal by Subject|5|||
131781501|NCT00759174|474481585|FG000|Overall Study|Other|0|||
131781502|NCT00759174|474481586|FG001|Overall Study|Other|2|||
131781503|NCT01890109|474481587|FG000|Overall Study|Withdrawal by Subject|0|||
131781504|NCT01890109|474481588|FG001|Overall Study|Withdrawal by Subject|3|||
131781505|NCT01890109|474481587|FG000|Overall Study|Lost to Follow-up|1|||
131781506|NCT01890109|474481588|FG001|Overall Study|Lost to Follow-up|2|||
131781507|NCT01643928|474481589|FG000|Overall Study|Lost to Follow-up|1|||
131781508|NCT01643928|474481590|FG001|Overall Study|Lost to Follow-up|0|||
131781509|NCT01643928|474481591|FG002|Overall Study|Lost to Follow-up|2|||
131781510|NCT01643928|474481592|FG003|Overall Study|Lost to Follow-up|0|||
131781511|NCT01643928|474481593|FG004|Overall Study|Lost to Follow-up|0|||
131781512|NCT01643928|474481589|FG000|Overall Study|Withdrawal by Subject|2|||
131781513|NCT01643928|474481590|FG001|Overall Study|Withdrawal by Subject|0|||
131781514|NCT01643928|474481591|FG002|Overall Study|Withdrawal by Subject|0|||
131781515|NCT01643928|474481592|FG003|Overall Study|Withdrawal by Subject|1|||
131781516|NCT01643928|474481593|FG004|Overall Study|Withdrawal by Subject|0|||
131781517|NCT01643928|474481589|FG000|Overall Study|Pregnancy|0|||
131781518|NCT01643928|474481590|FG001|Overall Study|Pregnancy|0|||
131781519|NCT01643928|474481591|FG002|Overall Study|Pregnancy|0|||
131781520|NCT01643928|474481592|FG003|Overall Study|Pregnancy|1|||
131781521|NCT01643928|474481593|FG004|Overall Study|Pregnancy|0|||
131781522|NCT01643928|474481589|FG000|Overall Study|Other|5|||
131781523|NCT01643928|474481590|FG001|Overall Study|Other|1|||
131781524|NCT01643928|474481591|FG002|Overall Study|Other|1|||
131781525|NCT01643928|474481592|FG003|Overall Study|Other|0|||
131781526|NCT01643928|474481593|FG004|Overall Study|Other|0|||
131781527|NCT01643928|474481589|FG000|Overall Study|Adverse Event|2|||
131781528|NCT01643928|474481590|FG001|Overall Study|Adverse Event|1|||
131781529|NCT01643928|474481591|FG002|Overall Study|Adverse Event|0|||
131781530|NCT01643928|474481592|FG003|Overall Study|Adverse Event|1|||
131781531|NCT01643928|474481593|FG004|Overall Study|Adverse Event|2|||
131781532|NCT03692078|474481595|FG000|Overall Study|Adverse Event|0|||
131781533|NCT03692078|474481596|FG001|Overall Study|Adverse Event|0|||
131781534|NCT03692078|474481597|FG002|Overall Study|Adverse Event|0|||
131781535|NCT03692078|474481598|FG003|Overall Study|Adverse Event|0|||
131781536|NCT03692078|474481599|FG004|Overall Study|Adverse Event|0|||
131781537|NCT03692078|474481600|FG005|Overall Study|Adverse Event|1|||
131781538|NCT03692078|474481601|FG006|Overall Study|Adverse Event|0|||
131563643|NCT02269943|473686321|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
131563644|NCT02269943|473686322|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
131781539|NCT03692078|474481595|FG000|Overall Study|Enrollment Closed|5|||
131781540|NCT03692078|474481596|FG001|Overall Study|Enrollment Closed|0|||
131781541|NCT03692078|474481597|FG002|Overall Study|Enrollment Closed|0|||
131781542|NCT03692078|474481598|FG003|Overall Study|Enrollment Closed|0|||
131781543|NCT03692078|474481599|FG004|Overall Study|Enrollment Closed|0|||
131781544|NCT03692078|474481600|FG005|Overall Study|Enrollment Closed|0|||
131781545|NCT03692078|474481601|FG006|Overall Study|Enrollment Closed|0|||
131781546|NCT03692078|474481595|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
131781547|NCT03692078|474481596|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
131781548|NCT03692078|474481597|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
131781549|NCT03692078|474481598|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
131781550|NCT03692078|474481599|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
131781551|NCT03692078|474481600|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
131781552|NCT03692078|474481601|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
131781553|NCT03692078|474481595|FG000|Overall Study|Withdrawal by Subject|0|||
131781554|NCT03692078|474481596|FG001|Overall Study|Withdrawal by Subject|2|||
131781555|NCT03692078|474481597|FG002|Overall Study|Withdrawal by Subject|0|||
131781556|NCT03692078|474481598|FG003|Overall Study|Withdrawal by Subject|1|||
131781557|NCT03692078|474481599|FG004|Overall Study|Withdrawal by Subject|5|||
131781558|NCT03692078|474481600|FG005|Overall Study|Withdrawal by Subject|3|||
131781559|NCT03692078|474481601|FG006|Overall Study|Withdrawal by Subject|3|||
131781560|NCT03981614|474481604|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
131781561|NCT03981614|474481605|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
131781562|NCT03981614|474481606|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
131781563|NCT00499252|474481607|FG000|Overall Study|Adverse Event|3|||
131781564|NCT00499252|474481607|FG000|Overall Study|Refused further treatment|2|||
131781565|NCT00499252|474481607|FG000|Overall Study|Ineligible|4|||
131781566|NCT00499252|474481607|FG000|Overall Study|<no further label>|3|||
131781567|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
131781568|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
131781569|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
131781570|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
131781571|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
131781572|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
131781573|NCT00566631|474481608|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
131781574|NCT00566631|474481608|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
131781575|NCT00566631|474481608|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
131781576|NCT00566631|474481608|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
131781577|NCT00566631|474481608|FG000|Part 2: Extension Phase|Adverse Event|11|||
131781578|NCT00566631|474481608|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
131781579|NCT00566631|474481608|FG000|Part 2: Extension Phase|Death|1|||
131781580|NCT00566631|474481608|FG000|Part 2: Extension Phase|Other|5|||
131781581|NCT03387735|474481609|FG000|Overall Study|Lost to Follow-up|4|||
131781582|NCT03387735|474481610|FG001|Overall Study|Lost to Follow-up|8|||
131781583|NCT03387735|474481609|FG000|Overall Study|Death|4|||
131781584|NCT03387735|474481610|FG001|Overall Study|Death|8|||
131781585|NCT00110084|474481613|FG000|Overall Study|Adverse Event|9|||
131781586|NCT00110084|474481613|FG000|Overall Study|Death|1|||
131781587|NCT00110084|474481613|FG000|Overall Study|Patient Refusal|10|||
131781588|NCT00110084|474481613|FG000|Overall Study|Alternate Therapy|5|||
131781589|NCT00110084|474481613|FG000|Overall Study|Intercurrent Illness|1|||
131781590|NCT00110084|474481613|FG000|Overall Study|Other|2|||
131781591|NCT04854707|474481614|FG000|Overall Study|Lack of Efficacy|78|||
131781592|NCT04854707|474481615|FG001|Overall Study|Lack of Efficacy|59|||
131563645|NCT02269943|473686321|FG000|Follow-Up Survival Period|Alive|2|||
131563646|NCT02269943|473686322|FG001|Follow-Up Survival Period|Alive|8|||
131563647|NCT03050398|473686325|FG000|Overall Study|Study terminated by sponsor|8|||
131781593|NCT04854707|474481616|FG002|Overall Study|Lack of Efficacy|30|||
131781594|NCT00537056|474481617|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
131781595|NCT03020966|474481626|FG000|Overall Study|Withdrawal by Subject|2|||
131781596|NCT03020966|474481627|FG001|Overall Study|Withdrawal by Subject|0|||
131781597|NCT01346501|474481632|FG000|Overall Study|Initiated Other Biological Agents|3|||
131781598|NCT01346501|474481633|FG001|Overall Study|Initiated Other Biological Agents|1|||
131781599|NCT01346501|474481632|FG000|Overall Study|Other|8|||
131781600|NCT01346501|474481633|FG001|Overall Study|Other|12|||
131563648|NCT00598481|473686326|FG000|Treatment|Physician Decision|1|||
131563649|NCT03018106|473686327|FG000|Overall Study|Lost to Follow-up|0|||
131563650|NCT03018106|473686328|FG001|Overall Study|Lost to Follow-up|1|||
131781601|NCT02628418|474481634|FG000|Overall Study|Lost to Follow-up|1|||
131781602|NCT02628418|474481635|FG001|Overall Study|Lost to Follow-up|2|||
131781603|NCT01216319|474481638|FG000|Overall Study|Lost to Follow-up|2|||
131781604|NCT01216319|474481638|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
131781605|NCT00929864|474481642|FG000|Overall Study|Death|1|||
131781606|NCT00929864|474481643|FG001|Overall Study|Death|1|||
131781607|NCT00929864|474481642|FG000|Overall Study|Adverse Event|11|||
131781608|NCT00929864|474481643|FG001|Overall Study|Adverse Event|30|||
131781609|NCT00929864|474481642|FG000|Overall Study|Lack of Efficacy|19|||
131781610|NCT00929864|474481643|FG001|Overall Study|Lack of Efficacy|16|||
131781611|NCT00929864|474481642|FG000|Overall Study|Lost to Follow-up|7|||
131696438|NCT01661140|474171984|FG002|Open-Label Period|Death|0|||
131696439|NCT01661140|474171982|FG000|Open-Label Period|Administrative/Other|1|||
131696440|NCT01661140|474171983|FG001|Open-Label Period|Administrative/Other|0|||
131696441|NCT01661140|474171984|FG002|Open-Label Period|Administrative/Other|0|||
131696442|NCT01661140|474171982|FG000|Open-Label Period|Sponsor termination|16|||
131696443|NCT01661140|474171983|FG001|Open-Label Period|Sponsor termination|0|||
131696444|NCT01661140|474171984|FG002|Open-Label Period|Sponsor termination|0|||
131696445|NCT01661140|474171982|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
131696446|NCT01661140|474171983|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
131696447|NCT01661140|474171984|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
131696448|NCT01661140|474171982|FG000|Open-Label Period|Lost to Follow-up|2|||
131696449|NCT01661140|474171983|FG001|Open-Label Period|Lost to Follow-up|0|||
131696450|NCT01661140|474171984|FG002|Open-Label Period|Lost to Follow-up|0|||
131696451|NCT01661140|474171982|FG000|Double-Blind Period|Refused Treatment|0|||
131696452|NCT01661140|474171983|FG001|Double-Blind Period|Refused Treatment|0|||
131696453|NCT01661140|474171984|FG002|Double-Blind Period|Refused Treatment|1|||
131696454|NCT01661140|474171982|FG000|Double-Blind Period|Adverse Event|0|||
131696455|NCT01661140|474171983|FG001|Double-Blind Period|Adverse Event|16|||
131696456|NCT01661140|474171984|FG002|Double-Blind Period|Adverse Event|18|||
131696457|NCT01661140|474171982|FG000|Double-Blind Period|Protocol Violation|0|||
131696458|NCT01661140|474171983|FG001|Double-Blind Period|Protocol Violation|2|||
131696459|NCT01661140|474171984|FG002|Double-Blind Period|Protocol Violation|3|||
131696460|NCT01661140|474171982|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131696461|NCT01661140|474171983|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131696462|NCT01661140|474171984|FG002|Double-Blind Period|Withdrawal by Subject|3|||
131696463|NCT01661140|474171982|FG000|Double-Blind Period|Investigator's Decision|0|||
131696464|NCT01661140|474171983|FG001|Double-Blind Period|Investigator's Decision|1|||
131696465|NCT01661140|474171984|FG002|Double-Blind Period|Investigator's Decision|2|||
131696466|NCT01661140|474171982|FG000|Double-Blind Period|Sponsor Termination|0|||
131696467|NCT01661140|474171983|FG001|Double-Blind Period|Sponsor Termination|14|||
131696468|NCT01661140|474171984|FG002|Double-Blind Period|Sponsor Termination|17|||
131563651|NCT03055832|473686329|FG000|Week 2|Withdrawal by Subject|1|||
131563652|NCT03055832|473686330|FG001|Week 2|Withdrawal by Subject|0|||
131563653|NCT03619174|473686331|FG000|Overall Study|Lost to Follow-up|3|||
131563654|NCT03619174|473686332|FG001|Overall Study|Lost to Follow-up|0|||
131563655|NCT03619174|473686331|FG000|Overall Study|Withdrawal by Subject|4|||
131563656|NCT03619174|473686332|FG001|Overall Study|Withdrawal by Subject|3|||
131563657|NCT03619174|473686331|FG000|Overall Study|Pregnancy|1|||
131563658|NCT03619174|473686332|FG001|Overall Study|Pregnancy|1|||
131563659|NCT03619174|473686331|FG000|Overall Study|Discomfort during treatment|1|||
131563660|NCT03619174|473686332|FG001|Overall Study|Discomfort during treatment|0|||
131563661|NCT01991197|473686333|FG000|Overall Study|Lost to Follow-up|1|||
131563662|NCT01991197|473686334|FG001|Overall Study|Lost to Follow-up|1|||
131563663|NCT01991197|473686333|FG000|Overall Study|Physician Decision|0|||
131563664|NCT01991197|473686334|FG001|Overall Study|Physician Decision|2|||
131563665|NCT01991197|473686333|FG000|Overall Study|Withdrawal by Subject|2|||
131563666|NCT01991197|473686334|FG001|Overall Study|Withdrawal by Subject|0|||
131696469|NCT01661140|474171982|FG000|Double-Blind Period|Administrative/Other|0|||
131696470|NCT01661140|474171983|FG001|Double-Blind Period|Administrative/Other|7|||
131696471|NCT01661140|474171984|FG002|Double-Blind Period|Administrative/Other|6|||
131696472|NCT00494091|474171985|FG000|Overall Study|Death|5|||
131696473|NCT00494091|474171986|FG001|Overall Study|Death|54|||
131696474|NCT00494091|474171985|FG000|Overall Study|Lost to Follow-up|0|||
131696475|NCT00494091|474171986|FG001|Overall Study|Lost to Follow-up|4|||
131696476|NCT00494091|474171985|FG000|Overall Study|Other|1|||
131696477|NCT00494091|474171986|FG001|Overall Study|Other|11|||
131696478|NCT00494091|474171985|FG000|Overall Study|Withdrawal by Subject|0|||
131696479|NCT00494091|474171986|FG001|Overall Study|Withdrawal by Subject|7|||
131696480|NCT02105454|474171993|FG000|Overall Study|Withdrawal by Subject|1|||
131696481|NCT02721355|474171996|FG000|Overall Study|Lost to Follow-up|6|||
131696482|NCT02721355|474171997|FG001|Overall Study|Lost to Follow-up|1|||
131696483|NCT00356278|474171998|FG000|Overall Study|Withdrawal by Subject|25|||
131696484|NCT00356278|474171999|FG001|Overall Study|Withdrawal by Subject|15|||
131696485|NCT00356278|474172000|FG002|Overall Study|Withdrawal by Subject|19|||
131696486|NCT01652287|474172003|FG000|Overall Study|Withdrawal by Subject|2|||
131696487|NCT01652287|474172004|FG001|Overall Study|Withdrawal by Subject|0|||
131696488|NCT00527605|474172005|FG000|Overall Study|Adverse Event|3|||
131696489|NCT00527605|474172006|FG001|Overall Study|Adverse Event|0|||
131696490|NCT00527605|474172005|FG000|Overall Study|Withdrawal by Subject|3|||
131696491|NCT00527605|474172006|FG001|Overall Study|Withdrawal by Subject|7|||
131696492|NCT00527605|474172005|FG000|Overall Study|Lost to Follow-up|6|||
131696493|NCT00527605|474172006|FG001|Overall Study|Lost to Follow-up|2|||
131696494|NCT00527605|474172005|FG000|Overall Study|Protocol Violation|1|||
131696495|NCT00527605|474172006|FG001|Overall Study|Protocol Violation|2|||
131696496|NCT00763139|474172007|FG000|Overall Study|Adverse Event|4|||
131696497|NCT00763139|474172008|FG001|Overall Study|Adverse Event|2|||
131696498|NCT00763139|474172007|FG000|Overall Study|Withdrawal by Subject|0|||
131696499|NCT00763139|474172008|FG001|Overall Study|Withdrawal by Subject|1|||
131696500|NCT00763139|474172007|FG000|Overall Study|med change not allowed by protocol|1|||
131696501|NCT00763139|474172008|FG001|Overall Study|med change not allowed by protocol|0|||
131696502|NCT01592760|474172009|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
131696503|NCT01592760|474172010|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
131696504|NCT01592760|474172011|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
131696505|NCT04312009|474172012|FG000|Overall Study|Withdrawal by Subject|2|||
131696506|NCT04312009|474172013|FG001|Overall Study|Withdrawal by Subject|1|||
131696507|NCT01678144|474172024|FG000|Stage 1: MAR Classic|Adverse Event|1|||
131696508|NCT02363686|474172027|FG000|Overall Study|Withdrawal by Subject|22|||
131696509|NCT02363686|474172027|FG000|Overall Study|incomplete FEES examinations|13|||
131696510|NCT01496885|474172031|FG000|Overall Study|Lost to Follow-up|13|||
131696511|NCT01496885|474172031|FG000|Overall Study|Withdrawal by Subject|7|||
131696512|NCT01496885|474172031|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
131696513|NCT01496885|474172031|FG000|Overall Study|Death|1|||
131696514|NCT04607733|474172039|FG000|Overall Study|Lost to Follow-up|1|||
131696515|NCT04607733|474172040|FG001|Overall Study|Lost to Follow-up|0|||
131696516|NCT04607733|474172041|FG002|Overall Study|Lost to Follow-up|0|||
131563667|NCT04707391|473686335|FG000|Overall Study|Adverse Event|5|||
131563668|NCT04707391|473686336|FG001|Overall Study|Adverse Event|8|||
131563669|NCT04707391|473686335|FG000|Overall Study|Lost to Follow-up|44|||
131696517|NCT04607733|474172042|FG003|Overall Study|Lost to Follow-up|1|||
131696518|NCT04607733|474172043|FG004|Overall Study|Lost to Follow-up|1|||
131696519|NCT04607733|474172044|FG005|Overall Study|Lost to Follow-up|0|||
131696520|NCT04607733|474172039|FG000|Overall Study|Withdrawal by Subject|0|||
131696521|NCT04607733|474172040|FG001|Overall Study|Withdrawal by Subject|0|||
131563670|NCT04707391|473686336|FG001|Overall Study|Lost to Follow-up|31|||
131563671|NCT04707391|473686335|FG000|Overall Study|Protocol Violation|1|||
131563672|NCT04707391|473686336|FG001|Overall Study|Protocol Violation|5|||
131563673|NCT04707391|473686335|FG000|Overall Study|Withdrawal by Subject|27|||
131696522|NCT04607733|474172041|FG002|Overall Study|Withdrawal by Subject|0|||
131696523|NCT04607733|474172042|FG003|Overall Study|Withdrawal by Subject|0|||
131781612|NCT00929864|474481643|FG001|Overall Study|Lost to Follow-up|12|||
131781613|NCT00929864|474481642|FG000|Overall Study|Withdrawal by Subject|20|||
131781614|NCT00929864|474481643|FG001|Overall Study|Withdrawal by Subject|9|||
131781615|NCT00929864|474481642|FG000|Overall Study|No longer met criteria|2|||
131781616|NCT00929864|474481643|FG001|Overall Study|No longer met criteria|1|||
131781617|NCT00929864|474481642|FG000|Overall Study|Poor or non-compliance|3|||
131781618|NCT00929864|474481643|FG001|Overall Study|Poor or non-compliance|3|||
131781619|NCT00929864|474481642|FG000|Overall Study|Pregnancy|0|||
131781620|NCT00929864|474481643|FG001|Overall Study|Pregnancy|3|||
131781621|NCT00929864|474481642|FG000|Overall Study|Administrative reason by Sponsor|1|||
131781622|NCT00929864|474481643|FG001|Overall Study|Administrative reason by Sponsor|1|||
131781623|NCT00929864|474481642|FG000|Overall Study|Non-specified|2|||
131781624|NCT00929864|474481643|FG001|Overall Study|Non-specified|7|||
131781625|NCT03428217|474481646|FG000|Overall Study|Death|89|||
131781626|NCT03428217|474481647|FG001|Overall Study|Death|93|||
131781627|NCT03428217|474481646|FG000|Overall Study|Withdrawal by Subject|8|||
131781628|NCT03428217|474481647|FG001|Overall Study|Withdrawal by Subject|7|||
131781629|NCT03428217|474481646|FG000|Overall Study|Lost to Follow-up|1|||
131781630|NCT03428217|474481647|FG001|Overall Study|Lost to Follow-up|3|||
131781631|NCT03428217|474481646|FG000|Overall Study|Study terminated by sponsor|124|||
131781632|NCT03428217|474481647|FG001|Overall Study|Study terminated by sponsor|118|||
131781633|NCT03428217|474481646|FG000|Overall Study|Other, Not Specified|1|||
131781634|NCT03428217|474481647|FG001|Overall Study|Other, Not Specified|0|||
131781635|NCT02304302|474481650|FG000|Overall Study|Adverse Event|2|||
131781636|NCT02304302|474481651|FG001|Overall Study|Adverse Event|3|||
131781637|NCT02304302|474481650|FG000|Overall Study|Lost to Follow-up|1|||
131781638|NCT02304302|474481651|FG001|Overall Study|Lost to Follow-up|4|||
131781639|NCT02304302|474481650|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
131781640|NCT02304302|474481651|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
131781641|NCT00391118|474481652|FG000|Overall Study|Adverse Event|3|||
131781642|NCT00391118|474481653|FG001|Overall Study|Adverse Event|10|||
131781643|NCT00391118|474481654|FG002|Overall Study|Adverse Event|7|||
131781644|NCT00391118|474481652|FG000|Overall Study|Lost to Follow-up|0|||
131781645|NCT00391118|474481653|FG001|Overall Study|Lost to Follow-up|2|||
131781646|NCT00391118|474481654|FG002|Overall Study|Lost to Follow-up|3|||
131781647|NCT00391118|474481652|FG000|Overall Study|Withdrawal by Subject|0|||
131781648|NCT00391118|474481653|FG001|Overall Study|Withdrawal by Subject|9|||
131781649|NCT00391118|474481654|FG002|Overall Study|Withdrawal by Subject|1|||
131781650|NCT00391118|474481652|FG000|Overall Study|Death|0|||
131781651|NCT00391118|474481653|FG001|Overall Study|Death|1|||
131781652|NCT00391118|474481654|FG002|Overall Study|Death|0|||
131781653|NCT00391118|474481652|FG000|Overall Study|Physician Decision|0|||
131781654|NCT00391118|474481653|FG001|Overall Study|Physician Decision|3|||
131781655|NCT00391118|474481654|FG002|Overall Study|Physician Decision|0|||
131781656|NCT00391118|474481652|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
131781657|NCT00391118|474481653|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
131781658|NCT00391118|474481654|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
131781659|NCT00391118|474481652|FG000|Overall Study|Progressive Disease|7|||
131781660|NCT00391118|474481653|FG001|Overall Study|Progressive Disease|26|||
131781661|NCT00391118|474481654|FG002|Overall Study|Progressive Disease|43|||
131781662|NCT00391118|474481652|FG000|Overall Study|Sponsor Decision|0|||
131781663|NCT00391118|474481653|FG001|Overall Study|Sponsor Decision|1|||
131781664|NCT00391118|474481654|FG002|Overall Study|Sponsor Decision|3|||
131781665|NCT00391118|474481652|FG000|Overall Study|Protocol Violation|1|||
131781666|NCT00391118|474481653|FG001|Overall Study|Protocol Violation|0|||
131781667|NCT00391118|474481654|FG002|Overall Study|Protocol Violation|0|||
131781668|NCT05473247|474481655|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
131781669|NCT03078192|474481657|FG000|Overall Study|Withdrawal by Subject|2|||
131563674|NCT04707391|473686336|FG001|Overall Study|Withdrawal by Subject|25|||
131563675|NCT04707391|473686335|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
131696524|NCT04607733|474172043|FG004|Overall Study|Withdrawal by Subject|1|||
131696525|NCT04607733|474172044|FG005|Overall Study|Withdrawal by Subject|0|||
131696526|NCT01665807|474172045|FG000|Overall Study|Withdrawal by Subject|2|||
131696527|NCT01665807|474172046|FG001|Overall Study|Withdrawal by Subject|0|||
131696528|NCT01665807|474172047|FG002|Overall Study|Withdrawal by Subject|1|||
131696529|NCT01692301|474172080|FG000|Overall Study|Adverse Event|15|||
131696530|NCT01692301|474172081|FG001|Overall Study|Adverse Event|12|||
131696531|NCT01692301|474172080|FG000|Overall Study|Death|1|||
131696532|NCT01692301|474172081|FG001|Overall Study|Death|2|||
131696533|NCT01692301|474172080|FG000|Overall Study|Lack of Efficacy|0|||
131696534|NCT01692301|474172081|FG001|Overall Study|Lack of Efficacy|5|||
131696535|NCT01692301|474172080|FG000|Overall Study|Non-compliance with study treatment|1|||
131696536|NCT01692301|474172081|FG001|Overall Study|Non-compliance with study treatment|2|||
131696537|NCT01692301|474172080|FG000|Overall Study|Protocol deviation|9|||
131696538|NCT01692301|474172081|FG001|Overall Study|Protocol deviation|2|||
131696539|NCT01692301|474172080|FG000|Overall Study|Patient/guardian decision|16|||
131696540|NCT01692301|474172081|FG001|Overall Study|Patient/guardian decision|15|||
131696541|NCT01692301|474172080|FG000|Overall Study|Technical problems|0|||
131696542|NCT01692301|474172081|FG001|Overall Study|Technical problems|1|||
131696543|NCT01692301|474172080|FG000|Overall Study|Physician Decision|2|||
131696544|NCT01692301|474172081|FG001|Overall Study|Physician Decision|2|||
131696545|NCT01692301|474172080|FG000|Overall Study|Lost to Follow-up|1|||
131696546|NCT01692301|474172081|FG001|Overall Study|Lost to Follow-up|1|||
131696547|NCT01568593|474172082|FG000|Overall Study|Lack of Efficacy|4|||
131696548|NCT01568593|474172083|FG001|Overall Study|Lack of Efficacy|1|||
131696549|NCT01568593|474172082|FG000|Overall Study|Adverse Event|3|||
131563676|NCT04707391|473686336|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
131563677|NCT04707391|473686335|FG000|Overall Study|Other|0|||
131563678|NCT04707391|473686336|FG001|Overall Study|Other|2|||
131563679|NCT03246672|473686337|FG000|Overall Study|Lost to Follow-up|2|||
131563680|NCT04157686|473686338|FG000|Overall Study|Adverse Event|1|||
131563681|NCT04157686|473686339|FG001|Overall Study|Adverse Event|0|||
131563682|NCT04157686|473686340|FG002|Overall Study|Adverse Event|1|||
131563683|NCT04157686|473686341|FG003|Overall Study|Adverse Event|0|||
131563684|NCT04157686|473686342|FG004|Overall Study|Adverse Event|1|||
131696550|NCT01568593|474172083|FG001|Overall Study|Adverse Event|2|||
131696551|NCT02111993|474172088|FG000|Overall Study|Physician Decision|5|||
131696552|NCT02111993|474172089|FG001|Overall Study|Physician Decision|4|||
131696553|NCT00293579|474172090|FG000|Overall Study|Withdrawal by Subject|1|||
131696554|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
131696555|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
131696556|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
131696557|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
131696558|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
131696559|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
131696560|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
131696561|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
131696562|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
131696563|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
131696564|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
131696565|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
131696566|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
131696567|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
131696568|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
131696569|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
131696570|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
131696571|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
131696572|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
131696573|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
131696574|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
131696575|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
131696576|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
131696577|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
131696578|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
131696579|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
131781670|NCT03078192|474481658|FG001|Overall Study|Withdrawal by Subject|1|||
131696580|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
131696581|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
131781671|NCT03078192|474481657|FG000|Overall Study|screen failure|0|||
131781672|NCT03078192|474481658|FG001|Overall Study|screen failure|3|||
131563685|NCT04157686|473686343|FG005|Overall Study|Adverse Event|0|||
131563686|NCT04157686|473686344|FG006|Overall Study|Adverse Event|0|||
131563687|NCT04157686|473686345|FG007|Overall Study|Adverse Event|0|||
131563688|NCT04157686|473686338|FG000|Overall Study|Pregnancy|0|||
131563689|NCT04157686|473686339|FG001|Overall Study|Pregnancy|1|||
131563690|NCT04157686|473686340|FG002|Overall Study|Pregnancy|3|||
131563691|NCT04157686|473686341|FG003|Overall Study|Pregnancy|0|||
131563692|NCT04157686|473686342|FG004|Overall Study|Pregnancy|0|||
131563693|NCT04157686|473686343|FG005|Overall Study|Pregnancy|0|||
131563694|NCT04157686|473686344|FG006|Overall Study|Pregnancy|3|||
131563695|NCT04157686|473686345|FG007|Overall Study|Pregnancy|0|||
131563696|NCT04157686|473686338|FG000|Overall Study|Lost to Follow-up|1|||
131563697|NCT04157686|473686339|FG001|Overall Study|Lost to Follow-up|2|||
131563698|NCT04157686|473686340|FG002|Overall Study|Lost to Follow-up|8|||
131563699|NCT04157686|473686341|FG003|Overall Study|Lost to Follow-up|6|||
131563700|NCT04157686|473686342|FG004|Overall Study|Lost to Follow-up|6|||
131563701|NCT04157686|473686343|FG005|Overall Study|Lost to Follow-up|3|||
131563702|NCT04157686|473686344|FG006|Overall Study|Lost to Follow-up|7|||
131563703|NCT04157686|473686345|FG007|Overall Study|Lost to Follow-up|9|||
131563704|NCT04157686|473686338|FG000|Overall Study|Lack of Efficacy|0|||
131563705|NCT04157686|473686339|FG001|Overall Study|Lack of Efficacy|0|||
131563706|NCT04157686|473686340|FG002|Overall Study|Lack of Efficacy|0|||
131563707|NCT04157686|473686341|FG003|Overall Study|Lack of Efficacy|0|||
131563708|NCT04157686|473686342|FG004|Overall Study|Lack of Efficacy|0|||
131563709|NCT04157686|473686343|FG005|Overall Study|Lack of Efficacy|2|||
131563710|NCT04157686|473686344|FG006|Overall Study|Lack of Efficacy|0|||
131781673|NCT00402779|474481659|FG000|Overall Study|Screen Failure|77|||
131781674|NCT00402779|474481660|FG001|Overall Study|Screen Failure|76|||
131781675|NCT02508649|474481663|FG000|Overall Study|Withdrawal by Subject|4|||
131781676|NCT02508649|474481664|FG001|Overall Study|Withdrawal by Subject|6|||
131781677|NCT02508649|474481665|FG002|Overall Study|Withdrawal by Subject|5|||
131781678|NCT02508649|474481666|FG003|Overall Study|Withdrawal by Subject|6|||
131781679|NCT02508649|474481663|FG000|Overall Study|Investigator withdrew the subject|1|||
131781680|NCT02508649|474481664|FG001|Overall Study|Investigator withdrew the subject|2|||
131781681|NCT02508649|474481665|FG002|Overall Study|Investigator withdrew the subject|1|||
131781682|NCT02508649|474481666|FG003|Overall Study|Investigator withdrew the subject|0|||
131781683|NCT02508649|474481663|FG000|Overall Study|Post randomization screening failure|12|||
131781684|NCT02508649|474481664|FG001|Overall Study|Post randomization screening failure|4|||
131781685|NCT02508649|474481665|FG002|Overall Study|Post randomization screening failure|9|||
131781686|NCT02508649|474481666|FG003|Overall Study|Post randomization screening failure|3|||
131781687|NCT02508649|474481663|FG000|Overall Study|Lost to Follow-up|1|||
131781688|NCT02508649|474481664|FG001|Overall Study|Lost to Follow-up|1|||
131781689|NCT02508649|474481665|FG002|Overall Study|Lost to Follow-up|0|||
131781690|NCT02508649|474481666|FG003|Overall Study|Lost to Follow-up|1|||
131781691|NCT03107715|474481667|FG000|Overall Study|did not deliver at the home hospital|4|||
131781692|NCT03107715|474481668|FG001|Overall Study|did not deliver at the home hospital|6|||
131781693|NCT03107715|474481667|FG000|Overall Study|infant stillborn|0|||
131781694|NCT03107715|474481668|FG001|Overall Study|infant stillborn|1|||
131781695|NCT02149199|474481672|FG000|Overall Study|Study specific withdrawal criteria|4|||
131781696|NCT02149199|474481673|FG001|Overall Study|Study specific withdrawal criteria|21|||
131781697|NCT02149199|474481674|FG002|Overall Study|Study specific withdrawal criteria|6|||
131781698|NCT02149199|474481672|FG000|Overall Study|Other|20|||
131781699|NCT02149199|474481673|FG001|Overall Study|Other|25|||
131781700|NCT02149199|474481674|FG002|Overall Study|Other|20|||
131781701|NCT02149199|474481672|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
131781702|NCT02149199|474481673|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
131781703|NCT02149199|474481674|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
131781704|NCT02149199|474481672|FG000|Overall Study|Withdrawal by Subject|75|||
131781705|NCT02149199|474481673|FG001|Overall Study|Withdrawal by Subject|93|||
131563711|NCT04157686|473686345|FG007|Overall Study|Lack of Efficacy|1|||
131563712|NCT04157686|473686338|FG000|Overall Study|Withdrawal by Subject|10|||
131563713|NCT04157686|473686339|FG001|Overall Study|Withdrawal by Subject|10|||
131563714|NCT04157686|473686340|FG002|Overall Study|Withdrawal by Subject|12|||
131563715|NCT04157686|473686341|FG003|Overall Study|Withdrawal by Subject|20|||
131781706|NCT02149199|474481674|FG002|Overall Study|Withdrawal by Subject|77|||
131781707|NCT02149199|474481672|FG000|Overall Study|Protocol Violation|16|||
131781708|NCT02149199|474481673|FG001|Overall Study|Protocol Violation|13|||
131781709|NCT02149199|474481674|FG002|Overall Study|Protocol Violation|15|||
131781710|NCT02149199|474481672|FG000|Overall Study|Lost to Follow-up|3|||
131781711|NCT02149199|474481673|FG001|Overall Study|Lost to Follow-up|12|||
131781712|NCT02149199|474481674|FG002|Overall Study|Lost to Follow-up|11|||
131781713|NCT02149199|474481672|FG000|Overall Study|Death|0|||
131781714|NCT02149199|474481673|FG001|Overall Study|Death|0|||
131563716|NCT04157686|473686342|FG004|Overall Study|Withdrawal by Subject|12|||
131563717|NCT04157686|473686343|FG005|Overall Study|Withdrawal by Subject|11|||
131563718|NCT04157686|473686344|FG006|Overall Study|Withdrawal by Subject|18|||
131781715|NCT02149199|474481674|FG002|Overall Study|Death|1|||
131563719|NCT04157686|473686345|FG007|Overall Study|Withdrawal by Subject|24|||
131563720|NCT04157686|473686338|FG000|Overall Study|Physician Decision|0|||
131563721|NCT04157686|473686339|FG001|Overall Study|Physician Decision|0|||
131563722|NCT04157686|473686340|FG002|Overall Study|Physician Decision|1|||
131696582|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
131696583|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
131696584|NCT00784654|474172097|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
131696585|NCT00784654|474172098|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
131696586|NCT00784654|474172099|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
131696587|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
131696588|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
131696589|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
131696590|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
131696591|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
131696592|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
131696593|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131696594|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
131696595|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
131696596|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
131696597|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
131696598|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
131696599|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Adverse Event|0|||
131696600|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Adverse Event|1|||
131696601|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Adverse Event|1|||
131696602|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
131696603|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
131696604|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
131696605|NCT00784654|474172097|FG000|Randomized Withdrawal Period|Family reasons|0|||
131696606|NCT00784654|474172098|FG001|Randomized Withdrawal Period|Family reasons|0|||
131696607|NCT00784654|474172099|FG002|Randomized Withdrawal Period|Family reasons|1|||
131696608|NCT00262873|474172100|FG000|Overall Study|Adverse Event|3|||
131696609|NCT00262873|474172100|FG000|Overall Study|Withdrawal by Subject|5|||
131696610|NCT00844753|474172101|FG000|Overall Study|Lack of Efficacy|1|||
131696611|NCT00844753|474172102|FG001|Overall Study|Lack of Efficacy|0|||
131696612|NCT00844753|474172103|FG002|Overall Study|Lack of Efficacy|2|||
131696613|NCT00844753|474172104|FG003|Overall Study|Lack of Efficacy|2|||
131696614|NCT00844753|474172101|FG000|Overall Study|Adverse Event|3|||
131696615|NCT00844753|474172102|FG001|Overall Study|Adverse Event|2|||
131696616|NCT00844753|474172103|FG002|Overall Study|Adverse Event|5|||
131696617|NCT00844753|474172104|FG003|Overall Study|Adverse Event|5|||
131696618|NCT00844753|474172101|FG000|Overall Study|Lost to Follow-up|1|||
131696619|NCT00844753|474172102|FG001|Overall Study|Lost to Follow-up|1|||
131696620|NCT00844753|474172103|FG002|Overall Study|Lost to Follow-up|0|||
131696621|NCT00844753|474172104|FG003|Overall Study|Lost to Follow-up|1|||
131696622|NCT00844753|474172101|FG000|Overall Study|could not swallow medication|2|||
131696623|NCT00844753|474172102|FG001|Overall Study|could not swallow medication|0|||
131696624|NCT00844753|474172103|FG002|Overall Study|could not swallow medication|0|||
131696625|NCT00844753|474172104|FG003|Overall Study|could not swallow medication|0|||
131696626|NCT00844753|474172101|FG000|Overall Study|Withdrawal by Subject|1|||
131696627|NCT00844753|474172102|FG001|Overall Study|Withdrawal by Subject|0|||
131696628|NCT00844753|474172103|FG002|Overall Study|Withdrawal by Subject|0|||
131696629|NCT00844753|474172104|FG003|Overall Study|Withdrawal by Subject|3|||
131696630|NCT03595553|474172106|FG000|Overall Study|Withdrawal by Subject|20|||
131696631|NCT03595553|474172107|FG001|Overall Study|Withdrawal by Subject|8|||
131696632|NCT03595553|474172106|FG000|Overall Study|Physician Decision|3|||
131696633|NCT03595553|474172107|FG001|Overall Study|Physician Decision|2|||
131696634|NCT03595553|474172106|FG000|Overall Study|Adverse Event|2|||
131696635|NCT03595553|474172107|FG001|Overall Study|Adverse Event|5|||
131696636|NCT03595553|474172106|FG000|Overall Study|Death|24|||
131696637|NCT03595553|474172107|FG001|Overall Study|Death|22|||
131696638|NCT03595553|474172106|FG000|Overall Study|Lost to Follow-up|6|||
131696639|NCT03595553|474172107|FG001|Overall Study|Lost to Follow-up|7|||
131696640|NCT03595553|474172106|FG000|Overall Study|Other as indicated in CSR|3|||
131696641|NCT03595553|474172107|FG001|Overall Study|Other as indicated in CSR|3|||
131563723|NCT04157686|473686341|FG003|Overall Study|Physician Decision|0|||
131781716|NCT02149199|474481672|FG000|Overall Study|Adverse Event|6|||
131781717|NCT02149199|474481673|FG001|Overall Study|Adverse Event|15|||
131781718|NCT02149199|474481674|FG002|Overall Study|Adverse Event|9|||
131781719|NCT03594175|474481676|FG000|Overall Study|Not treated|8|||
131781720|NCT03594175|474481677|FG001|Overall Study|Not treated|1|||
131781721|NCT03594175|474481678|FG002|Overall Study|Not treated|5|||
131781722|NCT03594175|474481676|FG000|Overall Study|Adverse Event|3|||
131781723|NCT03594175|474481677|FG001|Overall Study|Adverse Event|0|||
131781724|NCT03594175|474481678|FG002|Overall Study|Adverse Event|0|||
131781725|NCT03594175|474481676|FG000|Overall Study|Withdrawal by Subject|3|||
131781726|NCT03594175|474481677|FG001|Overall Study|Withdrawal by Subject|0|||
131781727|NCT03594175|474481678|FG002|Overall Study|Withdrawal by Subject|0|||
131781728|NCT03594175|474481676|FG000|Overall Study|Protocol Violation|2|||
131781729|NCT03594175|474481677|FG001|Overall Study|Protocol Violation|2|||
131781730|NCT03594175|474481678|FG002|Overall Study|Protocol Violation|2|||
131781731|NCT00633217|474481679|FG000|Overall Study|Adverse Event|5|||
131781732|NCT00633217|474481680|FG001|Overall Study|Adverse Event|9|||
131781733|NCT00633217|474481679|FG000|Overall Study|Lack of Efficacy|0|||
131781734|NCT00633217|474481680|FG001|Overall Study|Lack of Efficacy|2|||
131781735|NCT00633217|474481679|FG000|Overall Study|Protocol Violation|3|||
131781736|NCT00633217|474481680|FG001|Overall Study|Protocol Violation|7|||
131781737|NCT00633217|474481679|FG000|Overall Study|Lost to Follow-up|2|||
131781738|NCT00633217|474481680|FG001|Overall Study|Lost to Follow-up|2|||
131781739|NCT00633217|474481679|FG000|Overall Study|Investigator Discretion|2|||
131781740|NCT00633217|474481680|FG001|Overall Study|Investigator Discretion|0|||
131781741|NCT00633217|474481679|FG000|Overall Study|Withdrew Consent|3|||
131781742|NCT00633217|474481680|FG001|Overall Study|Withdrew Consent|3|||
131781743|NCT04881448|474481681|FG000|Overall Study|Study cancelled by sponsor|220|||
131781744|NCT04881448|474481681|FG000|Overall Study|Withdrawal by Subject|2|||
131781745|NCT04881448|474481681|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
131781746|NCT00005879|474481686|FG000|Overall Study|Withdrawal by Subject|8|||
131781747|NCT00005879|474481687|FG001|Overall Study|Withdrawal by Subject|10|||
131781748|NCT00689273|474481688|FG000|Overall Study|Adverse Event|3|||
131781749|NCT00689273|474481689|FG001|Overall Study|Adverse Event|1|||
131781750|NCT00689273|474481688|FG000|Overall Study|Lack of Efficacy|3|||
131781751|NCT00689273|474481689|FG001|Overall Study|Lack of Efficacy|0|||
131781752|NCT00689273|474481688|FG000|Overall Study|Lost to Follow-up|0|||
131781753|NCT00689273|474481689|FG001|Overall Study|Lost to Follow-up|2|||
131781754|NCT00689273|474481688|FG000|Overall Study|Other|6|||
131781755|NCT00689273|474481689|FG001|Overall Study|Other|2|||
131781756|NCT00689273|474481688|FG000|Overall Study|Randomized but not Treated|1|||
131781757|NCT00689273|474481689|FG001|Overall Study|Randomized but not Treated|0|||
131781758|NCT01238172|474481691|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
131781759|NCT01238172|474481692|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
131781760|NCT01238172|474481691|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
131563724|NCT04157686|473686342|FG004|Overall Study|Physician Decision|1|||
131563725|NCT04157686|473686343|FG005|Overall Study|Physician Decision|0|||
131563726|NCT04157686|473686344|FG006|Overall Study|Physician Decision|3|||
131563727|NCT04157686|473686345|FG007|Overall Study|Physician Decision|0|||
131563728|NCT04157686|473686338|FG000|Overall Study|Death|0|||
131563729|NCT04157686|473686339|FG001|Overall Study|Death|0|||
131563730|NCT04157686|473686340|FG002|Overall Study|Death|0|||
131781761|NCT01238172|474481692|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
131781762|NCT05022121|474481693|FG000|Overall Study|Lack of Efficacy|1|||
131781763|NCT05022121|474481694|FG001|Overall Study|Lack of Efficacy|0|||
131781764|NCT05022121|474481693|FG000|Overall Study|Lost to Follow-up|0|||
131781765|NCT05022121|474481694|FG001|Overall Study|Lost to Follow-up|2|||
131781766|NCT02531698|474481698|FG000|Overall Study|Adverse Event|2|||
131781767|NCT02531698|474481699|FG001|Overall Study|Adverse Event|1|||
131781768|NCT02531698|474481698|FG000|Overall Study|Withdrawal by Subject|6|||
131781769|NCT02531698|474481699|FG001|Overall Study|Withdrawal by Subject|1|||
131781770|NCT02531698|474481698|FG000|Overall Study|Protocol Violation|2|||
131781771|NCT02531698|474481699|FG001|Overall Study|Protocol Violation|0|||
131436805|NCT02079740|473225609|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
131563731|NCT04157686|473686341|FG003|Overall Study|Death|2|||
131563732|NCT04157686|473686342|FG004|Overall Study|Death|0|||
131563733|NCT04157686|473686343|FG005|Overall Study|Death|0|||
131781772|NCT02531698|474481698|FG000|Overall Study|Lost to Follow-up|1|||
131781773|NCT02531698|474481699|FG001|Overall Study|Lost to Follow-up|0|||
131781774|NCT00891527|474484472|FG000|Overall Study|Withdrawal by Subject|2|||
131781775|NCT01186744|474484473|FG000|Overall Study|Lack of Efficacy|156|||
131781776|NCT01186744|474484474|FG001|Overall Study|Lack of Efficacy|99|||
131781777|NCT01186744|474484475|FG002|Overall Study|Lack of Efficacy|0|||
131563734|NCT04157686|473686344|FG006|Overall Study|Death|0|||
131563735|NCT04157686|473686345|FG007|Overall Study|Death|0|||
131563736|NCT04157686|473686338|FG000|Overall Study|Protocol Violation|0|||
131781778|NCT01186744|474484476|FG003|Overall Study|Lack of Efficacy|2|||
131781779|NCT01186744|474484477|FG004|Overall Study|Lack of Efficacy|2|||
131781780|NCT01186744|474484478|FG005|Overall Study|Lack of Efficacy|5|||
131781781|NCT01186744|474484473|FG000|Overall Study|Protocol Violation|1|||
131563737|NCT04157686|473686339|FG001|Overall Study|Protocol Violation|0|||
131563738|NCT04157686|473686340|FG002|Overall Study|Protocol Violation|0|||
131563739|NCT04157686|473686341|FG003|Overall Study|Protocol Violation|0|||
131563740|NCT04157686|473686342|FG004|Overall Study|Protocol Violation|1|||
131563741|NCT04157686|473686343|FG005|Overall Study|Protocol Violation|0|||
131563742|NCT04157686|473686344|FG006|Overall Study|Protocol Violation|0|||
131563743|NCT04157686|473686345|FG007|Overall Study|Protocol Violation|0|||
131563744|NCT04157686|473686338|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
131563745|NCT04157686|473686339|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
131563746|NCT04157686|473686340|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
131563747|NCT04157686|473686341|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
131563748|NCT04157686|473686342|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
131563749|NCT04157686|473686343|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
131563750|NCT04157686|473686344|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
131563751|NCT04157686|473686345|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
131563752|NCT04129580|473687622|FG000|Overall Study|Lost to Follow-up|14|||
131563753|NCT04129580|473687623|FG001|Overall Study|Lost to Follow-up|25|||
131563754|NCT02268552|473687630|FG000|Part 1|Death|1|||
131696642|NCT03595553|474172106|FG000|Overall Study|Sponsor Decision|0|||
131696643|NCT03595553|474172107|FG001|Overall Study|Sponsor Decision|1|||
131781782|NCT01186744|474484474|FG001|Overall Study|Protocol Violation|2|||
131781783|NCT01186744|474484475|FG002|Overall Study|Protocol Violation|0|||
131781784|NCT01186744|474484476|FG003|Overall Study|Protocol Violation|1|||
131781785|NCT01186744|474484477|FG004|Overall Study|Protocol Violation|1|||
131563755|NCT02268552|473687631|FG001|Part 1|Death|1|||
131696644|NCT01437397|474172108|FG000|Overall Study|Lost to Follow-up|9|||
131696645|NCT01437397|474172109|FG001|Overall Study|Lost to Follow-up|4|||
131696646|NCT01437397|474172110|FG002|Overall Study|Lost to Follow-up|2|||
131696647|NCT01437397|474172111|FG003|Overall Study|Lost to Follow-up|4|||
131696648|NCT01437397|474172112|FG004|Overall Study|Lost to Follow-up|5|||
131696649|NCT01437397|474172108|FG000|Overall Study|Withdrawal by Subject|11|||
131696650|NCT01437397|474172109|FG001|Overall Study|Withdrawal by Subject|12|||
131696651|NCT01437397|474172110|FG002|Overall Study|Withdrawal by Subject|24|||
131696652|NCT01437397|474172111|FG003|Overall Study|Withdrawal by Subject|11|||
131696653|NCT01437397|474172112|FG004|Overall Study|Withdrawal by Subject|22|||
131696654|NCT01437397|474172108|FG000|Overall Study|Protocol Violation|10|||
131696655|NCT01437397|474172109|FG001|Overall Study|Protocol Violation|12|||
131696656|NCT01437397|474172110|FG002|Overall Study|Protocol Violation|13|||
131696657|NCT01437397|474172111|FG003|Overall Study|Protocol Violation|21|||
131696658|NCT01437397|474172112|FG004|Overall Study|Protocol Violation|19|||
131696659|NCT01437397|474172108|FG000|Overall Study|Lack of Efficacy|5|||
131696660|NCT01437397|474172109|FG001|Overall Study|Lack of Efficacy|4|||
131696661|NCT01437397|474172110|FG002|Overall Study|Lack of Efficacy|8|||
131696662|NCT01437397|474172111|FG003|Overall Study|Lack of Efficacy|10|||
131696663|NCT01437397|474172112|FG004|Overall Study|Lack of Efficacy|20|||
131696664|NCT01437397|474172108|FG000|Overall Study|Adverse Event|21|||
131696665|NCT01437397|474172109|FG001|Overall Study|Adverse Event|22|||
131696666|NCT01437397|474172110|FG002|Overall Study|Adverse Event|16|||
131696667|NCT01437397|474172111|FG003|Overall Study|Adverse Event|14|||
131696668|NCT01437397|474172112|FG004|Overall Study|Adverse Event|21|||
131696669|NCT01437397|474172108|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
131696670|NCT01437397|474172109|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
131696671|NCT01437397|474172110|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
131696672|NCT01437397|474172111|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
131696673|NCT01437397|474172112|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
131696674|NCT00903175|474172113|FG000|Period 1 - First Line|Adverse Event|36|||
131696675|NCT00903175|474172114|FG001|Period 1 - First Line|Adverse Event|50|||
131696676|NCT00903175|474172113|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
131696677|NCT00903175|474172114|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
131696678|NCT00903175|474172113|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
131696679|NCT00903175|474172114|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
131696680|NCT00903175|474172113|FG000|Period 1 - First Line|Protocol Violation|3|||
131696681|NCT00903175|474172114|FG001|Period 1 - First Line|Protocol Violation|3|||
131696682|NCT00903175|474172113|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
131696683|NCT00903175|474172114|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
131563756|NCT02268552|473687632|FG002|Part 1|Death|1|||
131563757|NCT02268552|473687633|FG003|Part 1|Death|2|||
131563758|NCT02268552|473687634|FG004|Part 1|Death|0|||
131696684|NCT00903175|474172113|FG000|Period 1 - First Line|Administrative problems|12|||
131696685|NCT00903175|474172114|FG001|Period 1 - First Line|Administrative problems|13|||
131696686|NCT00903175|474172113|FG000|Period 1 - First Line|Death|17|||
131563759|NCT02268552|473687635|FG005|Part 1|Death|0|||
131696687|NCT00903175|474172114|FG001|Period 1 - First Line|Death|10|||
131696688|NCT00903175|474172113|FG000|Period 2 - Second Line|Missing|1|||
131696689|NCT00903175|474172114|FG001|Period 2 - Second Line|Missing|0|||
131781786|NCT01186744|474484478|FG005|Overall Study|Protocol Violation|2|||
131563760|NCT02268552|473687636|FG006|Part 1|Death|0|||
131781787|NCT01186744|474484473|FG000|Overall Study|Lost to Follow-up|15|||
131781788|NCT01186744|474484474|FG001|Overall Study|Lost to Follow-up|16|||
131781789|NCT01186744|474484475|FG002|Overall Study|Lost to Follow-up|2|||
131781790|NCT01186744|474484476|FG003|Overall Study|Lost to Follow-up|1|||
131781791|NCT01186744|474484477|FG004|Overall Study|Lost to Follow-up|1|||
131781792|NCT01186744|474484478|FG005|Overall Study|Lost to Follow-up|4|||
131781793|NCT01186744|474484473|FG000|Overall Study|Screen failure|1|||
131781794|NCT01186744|474484474|FG001|Overall Study|Screen failure|1|||
131781795|NCT01186744|474484475|FG002|Overall Study|Screen failure|0|||
131781796|NCT01186744|474484476|FG003|Overall Study|Screen failure|1|||
131781797|NCT01186744|474484477|FG004|Overall Study|Screen failure|0|||
131781798|NCT01186744|474484478|FG005|Overall Study|Screen failure|0|||
131781799|NCT01186744|474484473|FG000|Overall Study|Withdrawal by Subject|14|||
131781800|NCT01186744|474484474|FG001|Overall Study|Withdrawal by Subject|10|||
131781801|NCT01186744|474484475|FG002|Overall Study|Withdrawal by Subject|2|||
131781802|NCT01186744|474484476|FG003|Overall Study|Withdrawal by Subject|5|||
131781803|NCT01186744|474484477|FG004|Overall Study|Withdrawal by Subject|0|||
131781804|NCT01186744|474484478|FG005|Overall Study|Withdrawal by Subject|6|||
131781805|NCT01186744|474484473|FG000|Overall Study|Study terminated by Sponsor|1|||
131781806|NCT01186744|474484474|FG001|Overall Study|Study terminated by Sponsor|0|||
131781807|NCT01186744|474484475|FG002|Overall Study|Study terminated by Sponsor|0|||
131781808|NCT01186744|474484476|FG003|Overall Study|Study terminated by Sponsor|0|||
131781809|NCT01186744|474484477|FG004|Overall Study|Study terminated by Sponsor|0|||
131781810|NCT01186744|474484478|FG005|Overall Study|Study terminated by Sponsor|0|||
131781811|NCT01186744|474484473|FG000|Overall Study|Other|9|||
131781812|NCT01186744|474484474|FG001|Overall Study|Other|10|||
131781813|NCT01186744|474484475|FG002|Overall Study|Other|1|||
131781814|NCT01186744|474484476|FG003|Overall Study|Other|2|||
131781815|NCT01186744|474484477|FG004|Overall Study|Other|1|||
131781816|NCT01186744|474484478|FG005|Overall Study|Other|5|||
131781817|NCT01186744|474484473|FG000|Overall Study|Adverse Event|10|||
131781818|NCT01186744|474484474|FG001|Overall Study|Adverse Event|14|||
131781819|NCT01186744|474484475|FG002|Overall Study|Adverse Event|1|||
131781820|NCT01186744|474484476|FG003|Overall Study|Adverse Event|0|||
131781821|NCT01186744|474484477|FG004|Overall Study|Adverse Event|1|||
131781822|NCT01186744|474484478|FG005|Overall Study|Adverse Event|4|||
131781823|NCT01186744|474484473|FG000|Overall Study|Death|1|||
131781824|NCT01186744|474484474|FG001|Overall Study|Death|0|||
131781825|NCT01186744|474484475|FG002|Overall Study|Death|0|||
131781826|NCT01186744|474484476|FG003|Overall Study|Death|0|||
131781827|NCT01186744|474484477|FG004|Overall Study|Death|0|||
131781828|NCT01186744|474484478|FG005|Overall Study|Death|0|||
131781829|NCT01020773|474484481|FG000|Overall Study|Withdrawal by Subject|4|||
131781830|NCT01020773|474484482|FG001|Overall Study|Withdrawal by Subject|3|||
131781831|NCT01389024|474484483|FG000|Overall Study|Withdrawal by Subject|0|||
131781832|NCT01389024|474484484|FG001|Overall Study|Withdrawal by Subject|1|||
131781833|NCT01389024|474484483|FG000|Overall Study|Lost to Follow-up|1|||
131781834|NCT01389024|474484484|FG001|Overall Study|Lost to Follow-up|0|||
131781835|NCT01788163|474484488|FG000|Overall Study|Other|53|||
131781836|NCT01788163|474484489|FG001|Overall Study|Other|0|||
131781837|NCT01788163|474484490|FG002|Overall Study|Other|0|||
131781838|NCT01788163|474484491|FG003|Overall Study|Other|0|||
131781839|NCT01788163|474484492|FG004|Overall Study|Other|0|||
131781840|NCT01788163|474484493|FG005|Overall Study|Other|7|||
131781841|NCT01788163|474484494|FG006|Overall Study|Other|1|||
131781842|NCT01788163|474484495|FG007|Overall Study|Other|48|||
131781843|NCT01788163|474484496|FG008|Overall Study|Other|15|||
131781844|NCT01788163|474484488|FG000|Overall Study|Withdrawal by Subject|2|||
131781845|NCT01788163|474484489|FG001|Overall Study|Withdrawal by Subject|0|||
131781846|NCT01788163|474484490|FG002|Overall Study|Withdrawal by Subject|0|||
131781847|NCT01788163|474484491|FG003|Overall Study|Withdrawal by Subject|0|||
131781848|NCT01788163|474484492|FG004|Overall Study|Withdrawal by Subject|0|||
131781849|NCT01788163|474484493|FG005|Overall Study|Withdrawal by Subject|0|||
131781850|NCT01788163|474484494|FG006|Overall Study|Withdrawal by Subject|0|||
131781851|NCT01788163|474484495|FG007|Overall Study|Withdrawal by Subject|0|||
131781852|NCT01788163|474484496|FG008|Overall Study|Withdrawal by Subject|1|||
131781853|NCT00545441|474484497|FG000|Overall Study|Fistula draining at 6 months|2|||
131781854|NCT00545441|474484498|FG001|Overall Study|Fistula draining at 6 months|4|||
131781855|NCT00545441|474484497|FG000|Overall Study|Lost to Follow-up|9|||
131781856|NCT00545441|474484498|FG001|Overall Study|Lost to Follow-up|5|||
131781857|NCT00545441|474484497|FG000|Overall Study|Technical failure|0|||
131781858|NCT00545441|474484498|FG001|Overall Study|Technical failure|1|||
131781859|NCT00545441|474484497|FG000|Overall Study|Withdrawal by Subject|1|||
131781860|NCT00545441|474484498|FG001|Overall Study|Withdrawal by Subject|1|||
131781861|NCT00545441|474484497|FG000|Overall Study|Persistence or recurrence of fistula|5|||
131781862|NCT00545441|474484498|FG001|Overall Study|Persistence or recurrence of fistula|2|||
131781863|NCT00545441|474484497|FG000|Overall Study|Patients were not treated|1|||
131781864|NCT00545441|474484498|FG001|Overall Study|Patients were not treated|3|||
131781865|NCT00265239|474484499|FG000|Overall Study|Adverse Event|2|||
131781866|NCT00265239|474484500|FG001|Overall Study|Adverse Event|1|||
131781867|NCT02803138|474484503|FG000|Overall Study|Failure to return|38|||
131781868|NCT02803138|474484503|FG000|Overall Study|Insufficient virological response|2|||
131781869|NCT02803138|474484503|FG000|Overall Study|Withdrawn consent|1|||
131781870|NCT02803138|474484503|FG000|Overall Study|Death|1|||
131781871|NCT02803138|474484503|FG000|Overall Study|Other, not specified|28|||
131781872|NCT00424515|474484504|FG000|Overall Study|Progressive Disease|10|||
131781873|NCT00424515|474484505|FG001|Overall Study|Progressive Disease|11|||
131781874|NCT00424515|474484504|FG000|Overall Study|Adverse Event|0|||
131781875|NCT00424515|474484505|FG001|Overall Study|Adverse Event|1|||
131781876|NCT00424515|474484504|FG000|Overall Study|Intercurrent Illness|0|||
131781877|NCT00424515|474484505|FG001|Overall Study|Intercurrent Illness|1|||
131781878|NCT00424515|474484504|FG000|Overall Study|Withdrawal by Subject|1|||
131781879|NCT00424515|474484505|FG001|Overall Study|Withdrawal by Subject|0|||
131781880|NCT00267020|474484506|FG000|Overall Study|Adverse Event|22|||
131781881|NCT00267020|474484507|FG001|Overall Study|Adverse Event|5|||
131781882|NCT00267020|474484506|FG000|Overall Study|Death|2|||
131781883|NCT00267020|474484507|FG001|Overall Study|Death|1|||
131781884|NCT00267020|474484506|FG000|Overall Study|Withdrawal by Subject|17|||
131781885|NCT00267020|474484507|FG001|Overall Study|Withdrawal by Subject|7|||
131781886|NCT00267020|474484506|FG000|Overall Study|Physician Decision|3|||
131781887|NCT00267020|474484507|FG001|Overall Study|Physician Decision|2|||
131781888|NCT00267020|474484506|FG000|Overall Study|Disease Progression|39|||
131781889|NCT00267020|474484507|FG001|Overall Study|Disease Progression|25|||
131781890|NCT00267020|474484506|FG000|Overall Study|Unrelated Complication|1|||
131781891|NCT00267020|474484507|FG001|Overall Study|Unrelated Complication|1|||
131781892|NCT00267020|474484506|FG000|Overall Study|Sponsor Request|1|||
131781893|NCT00267020|474484507|FG001|Overall Study|Sponsor Request|0|||
131781894|NCT00267020|474484506|FG000|Overall Study|Other|1|||
131781895|NCT00267020|474484507|FG001|Overall Study|Other|2|||
131563761|NCT02268552|473687630|FG000|Part 1|Subject/guardian decision|0|||
131563762|NCT02268552|473687631|FG001|Part 1|Subject/guardian decision|0|||
131563763|NCT02268552|473687632|FG002|Part 1|Subject/guardian decision|0|||
131563764|NCT02268552|473687633|FG003|Part 1|Subject/guardian decision|1|||
131781896|NCT04071366|474484508|FG000|Part 1: Open-label (29 Days)|Death|4|||
131781897|NCT04071366|474484509|FG001|Part 1: Open-label (29 Days)|Death|2|||
131781898|NCT04071366|474484510|FG002|Part 1: Open-label (29 Days)|Death|8|||
131781899|NCT04071366|474484511|FG003|Part 1: Open-label (29 Days)|Death|0|||
131781900|NCT04071366|474484512|FG004|Part 1: Open-label (29 Days)|Death|0|||
131563765|NCT02268552|473687634|FG004|Part 1|Subject/guardian decision|0|||
131563766|NCT02268552|473687635|FG005|Part 1|Subject/guardian decision|0|||
131563767|NCT02268552|473687636|FG006|Part 1|Subject/guardian decision|0|||
131563768|NCT02268552|473687630|FG000|Part 2|Death|0|||
131563769|NCT02268552|473687631|FG001|Part 2|Death|0|||
131563770|NCT02268552|473687632|FG002|Part 2|Death|0|||
131563771|NCT02268552|473687633|FG003|Part 2|Death|0|||
131781901|NCT04071366|474484508|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131781902|NCT04071366|474484509|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131781903|NCT04071366|474484510|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
131781904|NCT04071366|474484511|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131781905|NCT04071366|474484512|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131563772|NCT02268552|473687634|FG004|Part 2|Death|0|||
131563773|NCT02268552|473687635|FG005|Part 2|Death|0|||
131563774|NCT02268552|473687636|FG006|Part 2|Death|2|||
131563775|NCT02268552|473687630|FG000|Part 2|Subject/guardian decision|0|||
131781906|NCT04071366|474484508|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
131781907|NCT04071366|474484509|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
131781908|NCT04071366|474484510|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
131781909|NCT04071366|474484511|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
131781910|NCT04071366|474484512|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
131781911|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Death|0|||
131781912|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Death|0|||
131781913|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Death|0|||
131781914|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Death|2|||
131781915|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Death|2|||
131781916|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131781917|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131781918|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131781919|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131781920|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
131781921|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
131781922|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
131781923|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
131781924|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
131781925|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
131781926|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
131781927|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
131781928|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
131781929|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
131781930|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
131781931|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131781932|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131781933|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131781934|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131781935|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
131781936|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131781937|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131781938|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131781939|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
131781940|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131781941|NCT04071366|474484508|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131781942|NCT04071366|474484509|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131781943|NCT04071366|474484510|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131781944|NCT04071366|474484511|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
131781945|NCT04071366|474484512|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131781946|NCT00858234|474484513|FG000|Overall Study|Adverse Event|6|||
131781947|NCT00858234|474484513|FG000|Overall Study|Progressive disease|2|||
131781948|NCT00858234|474484513|FG000|Overall Study|Status unknown|1|||
131781949|NCT00640614|474484515|FG000|Overall Study|Lost to Follow-up|1|||
131781950|NCT00640614|474484516|FG001|Overall Study|Lost to Follow-up|0|||
131781951|NCT00529802|474484517|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
131781952|NCT00529802|474484517|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
131781953|NCT00529802|474484517|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
131781954|NCT00529802|474484517|FG000|Evaluable for Primary Endpoint|Death|1|||
131781955|NCT00529802|474484517|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
131781956|NCT00529802|474484517|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
131781957|NCT00529802|474484517|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
131781958|NCT02675426|474484518|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
131781959|NCT02675426|474484519|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
131781960|NCT02675426|474484520|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
131781961|NCT02675426|474484521|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
131781962|NCT02675426|474484518|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
131781963|NCT02675426|474484519|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
131781964|NCT02675426|474484520|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
131781965|NCT02675426|474484521|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
131781966|NCT02675426|474484518|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
131781967|NCT02675426|474484519|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
131781968|NCT02675426|474484520|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
131781969|NCT02675426|474484521|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
131781970|NCT02675426|474484518|FG000|Period 1: Week 1 to Week 12|Other|2|||
131781971|NCT02675426|474484519|FG001|Period 1: Week 1 to Week 12|Other|1|||
131563776|NCT02268552|473687631|FG001|Part 2|Subject/guardian decision|0|||
131696690|NCT00903175|474172113|FG000|Period 2 - Second Line|Adverse Event|16|||
131696691|NCT00903175|474172114|FG001|Period 2 - Second Line|Adverse Event|20|||
131696692|NCT00903175|474172113|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
131696693|NCT00903175|474172114|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
131696694|NCT00903175|474172113|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
131696695|NCT00903175|474172114|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
131696696|NCT00903175|474172113|FG000|Period 2 - Second Line|Administrative problems|19|||
131696697|NCT00903175|474172114|FG001|Period 2 - Second Line|Administrative problems|9|||
131696698|NCT00903175|474172113|FG000|Period 2 - Second Line|Death|5|||
131696699|NCT00903175|474172114|FG001|Period 2 - Second Line|Death|2|||
131696700|NCT01687712|474172115|FG000|Cycle 1|Not Biochemically Pregnant|386|||
131696701|NCT01687712|474172116|FG001|Cycle 1|Not Biochemically Pregnant|348|||
131696702|NCT01687712|474172115|FG000|Cycle 1|Early Pregnancy Loss|43|||
131696703|NCT01687712|474172116|FG001|Cycle 1|Early Pregnancy Loss|60|||
131696704|NCT01687712|474172115|FG000|Cycle 1|Ectopic Pregnancy|5|||
131696705|NCT01687712|474172116|FG001|Cycle 1|Ectopic Pregnancy|5|||
131696706|NCT01687712|474172115|FG000|Cycle 1|Heterotropic Pregnancy|1|||
131696707|NCT01687712|474172116|FG001|Cycle 1|Heterotropic Pregnancy|0|||
131696708|NCT01687712|474172115|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
131696709|NCT01687712|474172116|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
131696710|NCT01687712|474172115|FG000|Cycle 1|Abortion|3|||
131696711|NCT01687712|474172116|FG001|Cycle 1|Abortion|0|||
131696712|NCT01687712|474172115|FG000|Cycle 1|Intrauterine Fetal Death|0|||
131696713|NCT01687712|474172116|FG001|Cycle 1|Intrauterine Fetal Death|1|||
131696714|NCT01687712|474172115|FG000|Cycle 1|Lost to Follow-up|1|||
131696715|NCT01687712|474172116|FG001|Cycle 1|Lost to Follow-up|1|||
131696716|NCT01687712|474172115|FG000|Cycle 2|Not Biochemically Pregnant|74|||
131696717|NCT01687712|474172116|FG001|Cycle 2|Not Biochemically Pregnant|77|||
131696718|NCT01687712|474172115|FG000|Cycle 2|Early Pregnancy Loss|18|||
131696719|NCT01687712|474172116|FG001|Cycle 2|Early Pregnancy Loss|16|||
131696720|NCT01687712|474172115|FG000|Cycle 2|Ectopic Pregnancy|0|||
131563777|NCT02268552|473687632|FG002|Part 2|Subject/guardian decision|0|||
131563778|NCT02268552|473687633|FG003|Part 2|Subject/guardian decision|0|||
131563779|NCT02268552|473687634|FG004|Part 2|Subject/guardian decision|0|||
131563780|NCT02268552|473687635|FG005|Part 2|Subject/guardian decision|0|||
131563781|NCT02268552|473687636|FG006|Part 2|Subject/guardian decision|1|||
131563782|NCT02268552|473687630|FG000|Part 3 Extension|Death|0|||
131563783|NCT02268552|473687631|FG001|Part 3 Extension|Death|1|||
131563784|NCT02268552|473687632|FG002|Part 3 Extension|Death|1|||
131563785|NCT02268552|473687633|FG003|Part 3 Extension|Death|1|||
131563786|NCT02268552|473687634|FG004|Part 3 Extension|Death|1|||
131563787|NCT02268552|473687635|FG005|Part 3 Extension|Death|1|||
131563788|NCT02268552|473687636|FG006|Part 3 Extension|Death|0|||
131563789|NCT02268552|473687630|FG000|Part 3 Extension|Early termination of trial|1|||
131563790|NCT02268552|473687631|FG001|Part 3 Extension|Early termination of trial|0|||
131563791|NCT02268552|473687632|FG002|Part 3 Extension|Early termination of trial|0|||
131563792|NCT02268552|473687633|FG003|Part 3 Extension|Early termination of trial|0|||
131563793|NCT02268552|473687634|FG004|Part 3 Extension|Early termination of trial|2|||
131563794|NCT02268552|473687635|FG005|Part 3 Extension|Early termination of trial|9|||
131563795|NCT02268552|473687636|FG006|Part 3 Extension|Early termination of trial|11|||
131563796|NCT02268552|473687630|FG000|Part 3 Extension|Subject/guardian decision|0|||
131563797|NCT02268552|473687631|FG001|Part 3 Extension|Subject/guardian decision|0|||
131563798|NCT02268552|473687632|FG002|Part 3 Extension|Subject/guardian decision|0|||
131563799|NCT02268552|473687633|FG003|Part 3 Extension|Subject/guardian decision|0|||
131563800|NCT02268552|473687634|FG004|Part 3 Extension|Subject/guardian decision|0|||
131563801|NCT02268552|473687635|FG005|Part 3 Extension|Subject/guardian decision|0|||
131696721|NCT01687712|474172116|FG001|Cycle 2|Ectopic Pregnancy|1|||
131696722|NCT01687712|474172115|FG000|Cycle 2|Still Birth|1|||
131696723|NCT01687712|474172116|FG001|Cycle 2|Still Birth|0|||
131696724|NCT01687712|474172115|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
131696725|NCT01687712|474172116|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
131696726|NCT01687712|474172115|FG000|Cycle 3|Not Biochemically Pregnant|21|||
131696727|NCT01687712|474172116|FG001|Cycle 3|Not Biochemically Pregnant|22|||
131696728|NCT01687712|474172115|FG000|Cycle 3|Early Pregnancy Loss|1|||
131696729|NCT01687712|474172116|FG001|Cycle 3|Early Pregnancy Loss|2|||
131696730|NCT01687712|474172115|FG000|Cycle 3|Ectopic Pregnancy|1|||
131696731|NCT01687712|474172116|FG001|Cycle 3|Ectopic Pregnancy|0|||
131696732|NCT01687712|474172115|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
131696733|NCT01687712|474172116|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
131696734|NCT03074474|474172119|FG000|Overall Study|Lost to Follow-up|10|||
131696735|NCT03074474|474172119|FG000|Overall Study|Withdrawal by Subject|10|||
131696736|NCT03074474|474172119|FG000|Overall Study|Death|4|||
131696737|NCT03074474|474172119|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
131696738|NCT01035905|474172122|FG000|Overall Study|Lack of Efficacy|1|||
131696739|NCT01035905|474172123|FG001|Overall Study|Lack of Efficacy|1|||
131696740|NCT00861744|474172126|FG000|Overall Study|Adverse Event|0|||
131696741|NCT00861744|474172127|FG001|Overall Study|Adverse Event|0|||
131696742|NCT00861744|474172128|FG002|Overall Study|Adverse Event|0|||
131696743|NCT00861744|474172129|FG003|Overall Study|Adverse Event|1|||
131696744|NCT00861744|474172126|FG000|Overall Study|Lost to Follow-up|7|||
131696745|NCT00861744|474172127|FG001|Overall Study|Lost to Follow-up|19|||
131696746|NCT00861744|474172128|FG002|Overall Study|Lost to Follow-up|17|||
131696747|NCT00861744|474172129|FG003|Overall Study|Lost to Follow-up|12|||
131696748|NCT00861744|474172126|FG000|Overall Study|Withdrawal by Subject|10|||
131696749|NCT00861744|474172127|FG001|Overall Study|Withdrawal by Subject|6|||
131696750|NCT00861744|474172128|FG002|Overall Study|Withdrawal by Subject|6|||
131696751|NCT00861744|474172129|FG003|Overall Study|Withdrawal by Subject|19|||
131696752|NCT00861744|474172126|FG000|Overall Study|Protocol Violation|0|||
131696753|NCT00861744|474172127|FG001|Overall Study|Protocol Violation|1|||
131696754|NCT00861744|474172128|FG002|Overall Study|Protocol Violation|0|||
131696755|NCT00861744|474172129|FG003|Overall Study|Protocol Violation|0|||
131696756|NCT00861744|474172126|FG000|Overall Study|Migration from study area|0|||
131696757|NCT00861744|474172127|FG001|Overall Study|Migration from study area|3|||
131696758|NCT00861744|474172128|FG002|Overall Study|Migration from study area|1|||
131898617|NCT02624947|474915307|FG000|Maternal Participants|Miscellaneous|23|||
131563802|NCT02268552|473687636|FG006|Part 3 Extension|Subject/guardian decision|1|||
131563803|NCT00997243|473687637|FG000|Overall Study|Early termination of study by sponsor|7|||
131563804|NCT01349907|473687642|FG000|Overall Study|Adverse Event|37|||
131563805|NCT01349907|473687643|FG001|Overall Study|Adverse Event|11|||
131563806|NCT01349907|473687642|FG000|Overall Study|Treatment failure|13|||
131696759|NCT00861744|474172129|FG003|Overall Study|Migration from study area|0|||
131696760|NCT00861744|474172126|FG000|Overall Study|Blood draws|0|||
131696761|NCT00861744|474172127|FG001|Overall Study|Blood draws|0|||
131696762|NCT00861744|474172128|FG002|Overall Study|Blood draws|0|||
131696763|NCT00861744|474172129|FG003|Overall Study|Blood draws|1|||
131696764|NCT03110224|474172130|FG000|Overall Study|Death|3|||
131696765|NCT03110224|474172130|FG000|Overall Study|Lost to Follow-up|132|||
131696766|NCT03110224|474172130|FG000|Overall Study|Physician Decision|2|||
131696767|NCT03110224|474172130|FG000|Overall Study|Site Closed by Physician|35|||
131563807|NCT01349907|473687643|FG001|Overall Study|Treatment failure|4|||
131563808|NCT01349907|473687642|FG000|Overall Study|Lost to Follow-up|25|||
131563809|NCT01349907|473687643|FG001|Overall Study|Lost to Follow-up|6|||
131563810|NCT01349907|473687642|FG000|Overall Study|Withdrawal by Subject|30|||
131563811|NCT01349907|473687643|FG001|Overall Study|Withdrawal by Subject|8|||
131563812|NCT01349907|473687642|FG000|Overall Study|Protocol Violation|33|||
131563813|NCT01349907|473687643|FG001|Overall Study|Protocol Violation|13|||
131563814|NCT01349907|473687642|FG000|Overall Study|Administrative|1|||
131563815|NCT01349907|473687643|FG001|Overall Study|Administrative|1|||
131563816|NCT03583541|473687651|FG000|Overall Study|Lost to Follow-up|31|||
131563817|NCT03583541|473687652|FG001|Overall Study|Lost to Follow-up|65|||
131563818|NCT04102540|473687653|FG000|Overall Study|Withdrawn by PI|2|||
131563819|NCT04102540|473687653|FG000|Overall Study|Lost to Follow-up|6|||
131563820|NCT00280293|473687654|FG000|Overall Study|Protocol Violation|3|||
131563821|NCT00280293|473687655|FG001|Overall Study|Protocol Violation|0|||
131563822|NCT00280293|473687654|FG000|Overall Study|Physician Decision|5|||
131563823|NCT00280293|473687655|FG001|Overall Study|Physician Decision|4|||
131563824|NCT00280293|473687654|FG000|Overall Study|Lost to Follow-up|14|||
131563825|NCT00280293|473687655|FG001|Overall Study|Lost to Follow-up|12|||
131563826|NCT00280293|473687654|FG000|Overall Study|Withdrawal by Subject|3|||
131563827|NCT00280293|473687655|FG001|Overall Study|Withdrawal by Subject|5|||
131563828|NCT00280293|473687654|FG000|Overall Study|Incarceration/Legal Reasons|1|||
131563829|NCT00280293|473687655|FG001|Overall Study|Incarceration/Legal Reasons|1|||
131563830|NCT00280293|473687654|FG000|Overall Study|Adverse Event|0|||
131563831|NCT00280293|473687655|FG001|Overall Study|Adverse Event|1|||
131563832|NCT01458249|473687656|FG000|Overall Study|Not treated|1|||
131563833|NCT01458249|473687656|FG000|Overall Study|Adverse Event|4|||
131563834|NCT01458249|473687656|FG000|Overall Study|Other|2|||
131563835|NCT01458249|473687656|FG000|Overall Study|Ongoing|1|||
131563836|NCT01348854|473687657|FG000|Overall Study|Lost to Follow-up|2|||
131563837|NCT01348854|473687658|FG001|Overall Study|Lost to Follow-up|1|||
131563838|NCT01348854|473687657|FG000|Overall Study|Withdrawal by Subject|1|||
131781972|NCT02675426|474484520|FG002|Period 1: Week 1 to Week 12|Other|0|||
131436806|NCT02079740|473225610|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
131563839|NCT01348854|473687658|FG001|Overall Study|Withdrawal by Subject|0|||
131563840|NCT01010217|473687659|FG000|Overall Study|Lost to Follow-up|4|||
131563841|NCT01010217|473687660|FG001|Overall Study|Lost to Follow-up|5|||
131563842|NCT01010217|473687661|FG002|Overall Study|Lost to Follow-up|1|||
131563843|NCT01010217|473687662|FG003|Overall Study|Lost to Follow-up|0|||
131563844|NCT01010217|473687663|FG004|Overall Study|Lost to Follow-up|0|||
131563845|NCT01010217|473687659|FG000|Overall Study|Withdrawal by Subject|1|||
131696768|NCT03110224|474172130|FG000|Overall Study|Site Closed by Sponsor|202|||
131696769|NCT03110224|474172130|FG000|Overall Study|Withdrawal by Subject|9|||
131696770|NCT03809611|474172131|FG000|Overall Study|Withdrawal by Subject|1|||
131696771|NCT03809611|474172132|FG001|Overall Study|Withdrawal by Subject|1|||
131696772|NCT03124563|474172133|FG000|Overall Study|Lost to Follow-up|1|||
131696773|NCT03124563|474172134|FG001|Overall Study|Lost to Follow-up|1|||
131696774|NCT03124563|474172133|FG000|Overall Study|Withdrawal by Subject|1|||
131696775|NCT03124563|474172134|FG001|Overall Study|Withdrawal by Subject|1|||
131696776|NCT01534533|474172135|FG000|Overall Study|Lost to Follow-up|3|||
131696777|NCT01534533|474172136|FG001|Overall Study|Lost to Follow-up|0|||
131696778|NCT01534533|474172137|FG002|Overall Study|Lost to Follow-up|4|||
131696779|NCT01534533|474172138|FG003|Overall Study|Lost to Follow-up|3|||
131696780|NCT01534533|474172135|FG000|Overall Study|Withdrawal by Subject|5|||
131696781|NCT01534533|474172136|FG001|Overall Study|Withdrawal by Subject|3|||
131696782|NCT01534533|474172137|FG002|Overall Study|Withdrawal by Subject|4|||
131696783|NCT01534533|474172138|FG003|Overall Study|Withdrawal by Subject|1|||
131696784|NCT02028455|474172139|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131696785|NCT02028455|474172140|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131696786|NCT02028455|474172141|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131696787|NCT02028455|474172142|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131696788|NCT02028455|474172143|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131696789|NCT02028455|474172144|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131696790|NCT02028455|474172145|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
131696791|NCT02028455|474172146|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
131696792|NCT02028455|474172139|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
131696793|NCT02028455|474172140|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
131696794|NCT02028455|474172141|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
131696795|NCT02028455|474172142|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
131696796|NCT02028455|474172143|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
131696797|NCT02028455|474172144|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
131696798|NCT02028455|474172145|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
131696799|NCT02028455|474172146|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
131696800|NCT02028455|474172139|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131696801|NCT02028455|474172140|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131696802|NCT02028455|474172141|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131696803|NCT02028455|474172142|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131696804|NCT02028455|474172143|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131696805|NCT02028455|474172144|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
131696806|NCT02028455|474172145|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131696807|NCT02028455|474172146|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
131696808|NCT02028455|474172139|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131696809|NCT02028455|474172140|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131563846|NCT01010217|473687660|FG001|Overall Study|Withdrawal by Subject|0|||
131563847|NCT01010217|473687661|FG002|Overall Study|Withdrawal by Subject|0|||
131563848|NCT01010217|473687662|FG003|Overall Study|Withdrawal by Subject|0|||
131563849|NCT01010217|473687663|FG004|Overall Study|Withdrawal by Subject|0|||
131563850|NCT01010217|473687659|FG000|Overall Study|Physician Decision|0|||
131563851|NCT01010217|473687660|FG001|Overall Study|Physician Decision|0|||
131563852|NCT01010217|473687661|FG002|Overall Study|Physician Decision|0|||
131563853|NCT01010217|473687662|FG003|Overall Study|Physician Decision|6|||
131563854|NCT01010217|473687663|FG004|Overall Study|Physician Decision|3|||
131563855|NCT01439711|473687664|FG000|Overall Study|Ineligible|13|||
131563856|NCT01439711|473687664|FG000|Overall Study|Cancel|3|||
131563857|NCT01439711|473687664|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
131563858|NCT01439711|473687664|FG000|Overall Study|Adverse Event|5|||
131563859|NCT01439711|473687664|FG000|Overall Study|Withdrawal by Subject|3|||
131563860|NCT01439711|473687664|FG000|Overall Study|Progression During Active Tx|3|||
131563861|NCT01439711|473687664|FG000|Overall Study|Noncompliance|3|||
131563862|NCT01439711|473687664|FG000|Overall Study|No MRI|9|||
131563863|NCT04242875|473687665|FG000|Overall Study|Adverse Event|2|||
131563864|NCT02397460|473687666|FG000|Treatment Period 2|Adverse Event|0|||
131563865|NCT02397460|473687667|FG001|Treatment Period 2|Adverse Event|0|||
131563866|NCT02397460|473687668|FG002|Treatment Period 2|Adverse Event|0|||
131563867|NCT02397460|473687669|FG003|Treatment Period 2|Adverse Event|0|||
131563868|NCT02397460|473687670|FG004|Treatment Period 2|Adverse Event|0|||
131563869|NCT02397460|473687671|FG005|Treatment Period 2|Adverse Event|0|||
131563870|NCT02397460|473687672|FG006|Treatment Period 2|Adverse Event|0|||
131563871|NCT02397460|473687673|FG007|Treatment Period 2|Adverse Event|1|||
131563872|NCT02397460|473687666|FG000|Treatment Period 4|Adverse Event|0|||
131563873|NCT02397460|473687667|FG001|Treatment Period 4|Adverse Event|1|||
131563874|NCT02397460|473687668|FG002|Treatment Period 4|Adverse Event|0|||
131563875|NCT02397460|473687669|FG003|Treatment Period 4|Adverse Event|0|||
131563876|NCT02397460|473687670|FG004|Treatment Period 4|Adverse Event|0|||
131563877|NCT02397460|473687671|FG005|Treatment Period 4|Adverse Event|0|||
131563878|NCT02397460|473687672|FG006|Treatment Period 4|Adverse Event|0|||
131563879|NCT02397460|473687673|FG007|Treatment Period 4|Adverse Event|0|||
131563880|NCT02397460|473687666|FG000|Treatment Period 4|Physician Decision|0|||
131563881|NCT02397460|473687667|FG001|Treatment Period 4|Physician Decision|0|||
131563882|NCT02397460|473687668|FG002|Treatment Period 4|Physician Decision|0|||
131563883|NCT02397460|473687669|FG003|Treatment Period 4|Physician Decision|0|||
131563884|NCT02397460|473687670|FG004|Treatment Period 4|Physician Decision|1|||
131563885|NCT02397460|473687671|FG005|Treatment Period 4|Physician Decision|0|||
131563886|NCT02397460|473687672|FG006|Treatment Period 4|Physician Decision|0|||
131563887|NCT02397460|473687673|FG007|Treatment Period 4|Physician Decision|0|||
131563888|NCT01012973|473687674|FG000|Overall Study|Adverse Event|5|||
131563889|NCT01012973|473687675|FG001|Overall Study|Adverse Event|5|||
131563890|NCT01012973|473687674|FG000|Overall Study|Lack of Efficacy|0|||
131563891|NCT01012973|473687675|FG001|Overall Study|Lack of Efficacy|5|||
131563892|NCT01012973|473687674|FG000|Overall Study|Lost to Follow-up|1|||
131563893|NCT01012973|473687675|FG001|Overall Study|Lost to Follow-up|0|||
131563894|NCT01012973|473687674|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
131563895|NCT01012973|473687675|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
131563896|NCT01012973|473687674|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
131563897|NCT01012973|473687675|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
131563898|NCT01012973|473687674|FG000|Overall Study|Protocol Violation|5|||
131563899|NCT01012973|473687675|FG001|Overall Study|Protocol Violation|2|||
131563900|NCT01012973|473687674|FG000|Overall Study|Withdrawal by Subject|4|||
131563901|NCT01012973|473687675|FG001|Overall Study|Withdrawal by Subject|6|||
131563902|NCT02213055|473687677|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
131563903|NCT02213055|473687678|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
131563904|NCT02213055|473687677|FG000|Overall Study|Protocol was not Followed during Study|1|||
131563905|NCT02213055|473687678|FG001|Overall Study|Protocol was not Followed during Study|0|||
131563906|NCT02213055|473687677|FG000|Overall Study|Documentation Issue at Enrollment|1|||
131563907|NCT02213055|473687678|FG001|Overall Study|Documentation Issue at Enrollment|0|||
131563908|NCT02213055|473687677|FG000|Overall Study|Documentation Issue during Study|10|||
131563909|NCT02213055|473687678|FG001|Overall Study|Documentation Issue during Study|0|||
131563910|NCT02213055|473687677|FG000|Overall Study|Did not have Live Lice|8|||
131563911|NCT02213055|473687678|FG001|Overall Study|Did not have Live Lice|0|||
131563912|NCT02213055|473687677|FG000|Overall Study|Had another Treatment during the Study|3|||
131563913|NCT02213055|473687678|FG001|Overall Study|Had another Treatment during the Study|0|||
131563914|NCT02213055|473687677|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
131563915|NCT02213055|473687678|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
131563916|NCT02213055|473687677|FG000|Overall Study|Did not Return to School|5|||
131563917|NCT02213055|473687678|FG001|Overall Study|Did not Return to School|0|||
131563918|NCT00231894|473687679|FG000|Overall Study|Withdrawal by Subject|1|||
131563919|NCT00231894|473687680|FG001|Overall Study|Withdrawal by Subject|1|||
131563920|NCT02025205|473687682|FG000|Overall Study|Withdrawal by Subject|1|||
131563921|NCT02025205|473687683|FG001|Overall Study|Withdrawal by Subject|1|||
131563922|NCT02025205|473687682|FG000|Overall Study|Protocol Violation|2|||
131563923|NCT02025205|473687683|FG001|Overall Study|Protocol Violation|1|||
131563924|NCT02025205|473687682|FG000|Overall Study|Death|0|||
131563925|NCT02025205|473687683|FG001|Overall Study|Death|1|||
131563926|NCT04172987|473687685|FG000|Lead In Period|Adverse Event|1|||
131563927|NCT04172987|473687685|FG000|Lead In Period|Protocol Violation|1|||
131563928|NCT04172987|473687685|FG000|Period 1|Physician Decision|1|||
131563929|NCT04172987|473687685|FG000|Period 2|Adverse Event|5|||
131563930|NCT04172987|473687685|FG000|Period 2|Dosing Termination by Sponsor|4|||
131563931|NCT00738530|473687695|FG000|Overall Study|Death|220|||
131563932|NCT00738530|473687696|FG001|Overall Study|Death|224|||
131563933|NCT00738530|473687695|FG000|Overall Study|Lost to Follow-up|8|||
131563934|NCT00738530|473687696|FG001|Overall Study|Lost to Follow-up|6|||
131563935|NCT00738530|473687695|FG000|Overall Study|Withdrawal by Subject|6|||
131563936|NCT00738530|473687696|FG001|Overall Study|Withdrawal by Subject|8|||
131563937|NCT01628510|473687697|FG000|Overall Study|Withdrawal by Subject|0|||
131563938|NCT01628510|473687698|FG001|Overall Study|Withdrawal by Subject|4|||
131563939|NCT01628510|473687697|FG000|Overall Study|Death|3|||
131563940|NCT01628510|473687698|FG001|Overall Study|Death|1|||
131563941|NCT04179461|473687699|FG000|Overall Study|Lost to Follow-up|4|||
131563942|NCT01653847|473687700|FG000|Overall Study|Withdrawal by Subject|1|||
131563943|NCT01653847|473687701|FG001|Overall Study|Withdrawal by Subject|0|||
131563944|NCT01406717|473687702|FG000|Overall Study|Subject non-compliance|4|||
131563945|NCT01406717|473687703|FG001|Overall Study|Subject non-compliance|3|||
131563946|NCT01406717|473687702|FG000|Overall Study|Protocol Violation|5|||
131563947|NCT01406717|473687703|FG001|Overall Study|Protocol Violation|1|||
131563948|NCT01406717|473687702|FG000|Overall Study|Lost to Follow-up|14|||
131563949|NCT01406717|473687703|FG001|Overall Study|Lost to Follow-up|8|||
131563950|NCT01406717|473687702|FG000|Overall Study|Withdrawal by Subject|19|||
131563951|NCT01406717|473687703|FG001|Overall Study|Withdrawal by Subject|15|||
131563952|NCT01406717|473687702|FG000|Overall Study|Adverse Event|1|||
131563953|NCT01406717|473687703|FG001|Overall Study|Adverse Event|2|||
131563954|NCT01406717|473687702|FG000|Overall Study|Lack of Efficacy|0|||
131563955|NCT01406717|473687703|FG001|Overall Study|Lack of Efficacy|1|||
131563956|NCT01406717|473687702|FG000|Overall Study|Non-completion of visit activity|0|||
131563957|NCT01406717|473687703|FG001|Overall Study|Non-completion of visit activity|1|||
131563958|NCT02040090|473687704|FG000|Overall Study|Adverse Event|2|||
131563959|NCT02040090|473687705|FG001|Overall Study|Adverse Event|0|||
131563960|NCT02040090|473687704|FG000|Overall Study|Physician Decision|1|||
131563961|NCT02040090|473687705|FG001|Overall Study|Physician Decision|0|||
131563962|NCT02040090|473687704|FG000|Overall Study|Withdrawal by Subject|0|||
131563963|NCT02040090|473687705|FG001|Overall Study|Withdrawal by Subject|1|||
131563964|NCT02040090|473687704|FG000|Overall Study|Lost to Follow-up|0|||
131563965|NCT02040090|473687705|FG001|Overall Study|Lost to Follow-up|1|||
131563966|NCT04894903|473687708|FG000|Overall Study|Death|1|||
131563967|NCT04894903|473687709|FG001|Overall Study|Death|0|||
131563968|NCT04894903|473687708|FG000|Overall Study|Pregnancy|1|||
131563969|NCT04894903|473687709|FG001|Overall Study|Pregnancy|0|||
131563970|NCT04894903|473687708|FG000|Overall Study|Withdrawal by Subject|1|||
131563971|NCT04894903|473687709|FG001|Overall Study|Withdrawal by Subject|1|||
131563972|NCT04894903|473687708|FG000|Overall Study|moved or exited health system|1|||
131563973|NCT04894903|473687709|FG001|Overall Study|moved or exited health system|3|||
131563974|NCT02584855|473687714|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
131563975|NCT02584855|473687715|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
131563976|NCT02584855|473687716|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131563977|NCT02584855|473687717|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
131563978|NCT02584855|473687718|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
131563979|NCT02584855|473687719|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
131563980|NCT02584855|473687714|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
131563981|NCT02584855|473687715|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
131563982|NCT02584855|473687716|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
131563983|NCT02584855|473687717|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
131563984|NCT02584855|473687718|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
131563985|NCT02584855|473687719|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
131563986|NCT02584855|473687714|FG000|Open-Label Treatment Period|Adverse Event|14|||
131563987|NCT02584855|473687715|FG001|Open-Label Treatment Period|Adverse Event|0|||
131563988|NCT02584855|473687716|FG002|Open-Label Treatment Period|Adverse Event|0|||
131563989|NCT02584855|473687717|FG003|Open-Label Treatment Period|Adverse Event|0|||
131563990|NCT02584855|473687718|FG004|Open-Label Treatment Period|Adverse Event|0|||
131563991|NCT02584855|473687719|FG005|Open-Label Treatment Period|Adverse Event|0|||
131563992|NCT02584855|473687714|FG000|Open-Label Treatment Period|Death|2|||
131563993|NCT02584855|473687715|FG001|Open-Label Treatment Period|Death|0|||
131563994|NCT02584855|473687716|FG002|Open-Label Treatment Period|Death|0|||
131563995|NCT02584855|473687717|FG003|Open-Label Treatment Period|Death|0|||
131563996|NCT02584855|473687718|FG004|Open-Label Treatment Period|Death|0|||
131563997|NCT02584855|473687719|FG005|Open-Label Treatment Period|Death|0|||
131563998|NCT02584855|473687714|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
131563999|NCT02584855|473687715|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
131564000|NCT02584855|473687716|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
131564001|NCT02584855|473687717|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
131564002|NCT02584855|473687718|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
131564003|NCT02584855|473687719|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
131564004|NCT02584855|473687714|FG000|Open-Label Treatment Period|Protocol Violation|1|||
131564005|NCT02584855|473687715|FG001|Open-Label Treatment Period|Protocol Violation|0|||
131564006|NCT02584855|473687716|FG002|Open-Label Treatment Period|Protocol Violation|0|||
131564007|NCT02584855|473687717|FG003|Open-Label Treatment Period|Protocol Violation|0|||
131564008|NCT02584855|473687718|FG004|Open-Label Treatment Period|Protocol Violation|0|||
131564009|NCT02584855|473687719|FG005|Open-Label Treatment Period|Protocol Violation|0|||
131564010|NCT02584855|473687714|FG000|Open-Label Treatment Period|No PI Available|2|||
131564011|NCT02584855|473687715|FG001|Open-Label Treatment Period|No PI Available|0|||
131564012|NCT02584855|473687716|FG002|Open-Label Treatment Period|No PI Available|0|||
131564013|NCT02584855|473687717|FG003|Open-Label Treatment Period|No PI Available|0|||
131564014|NCT02584855|473687718|FG004|Open-Label Treatment Period|No PI Available|0|||
131564015|NCT02584855|473687719|FG005|Open-Label Treatment Period|No PI Available|0|||
131564016|NCT02584855|473687714|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
131564017|NCT02584855|473687715|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
131564018|NCT02584855|473687716|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
131564019|NCT02584855|473687717|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
131564020|NCT02584855|473687718|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
131564021|NCT02584855|473687719|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
131564022|NCT02584855|473687714|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131564023|NCT02584855|473687715|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131564024|NCT02584855|473687716|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
131564025|NCT02584855|473687717|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131564026|NCT02584855|473687718|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131564027|NCT02584855|473687719|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131564028|NCT02584855|473687714|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
131564029|NCT02584855|473687715|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
131564030|NCT02584855|473687716|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
131564031|NCT02584855|473687717|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
131564032|NCT02584855|473687718|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
131564033|NCT02584855|473687719|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
131564034|NCT02584855|473687714|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131564035|NCT02584855|473687715|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
131564036|NCT02584855|473687716|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131564037|NCT02584855|473687717|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131564038|NCT02584855|473687718|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131696810|NCT02028455|474172141|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
131696811|NCT02028455|474172142|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
131696812|NCT02028455|474172143|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131564039|NCT02584855|473687719|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131564040|NCT02584855|473687714|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131564041|NCT02584855|473687715|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
131564042|NCT02584855|473687716|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131564043|NCT02584855|473687717|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131564044|NCT02584855|473687718|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131564045|NCT02584855|473687719|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131564046|NCT02584855|473687714|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131564047|NCT02584855|473687715|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131564048|NCT02584855|473687716|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131564049|NCT02584855|473687717|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131564050|NCT02584855|473687718|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
131564051|NCT02584855|473687719|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131564052|NCT02584855|473687714|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
131564053|NCT02584855|473687715|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
131564054|NCT02584855|473687716|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
131564055|NCT02584855|473687717|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
131564056|NCT02584855|473687718|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
131564057|NCT02584855|473687719|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
131564058|NCT02337478|473687720|FG000|Overall Study|Lack of Efficacy|5|||
131564059|NCT04963062|473687725|FG000|Overall Study|withdrew by the study team|4|||
131564060|NCT04963062|473687726|FG001|Overall Study|withdrew by the study team|2|||
131564061|NCT03873246|473687727|FG000|Overall Study|Adverse Event|1|||
131564062|NCT03873246|473687728|FG001|Overall Study|Adverse Event|3|||
131564063|NCT03873246|473687729|FG002|Overall Study|Adverse Event|3|||
131564064|NCT03873246|473687727|FG000|Overall Study|Lost to Follow-up|4|||
131564065|NCT03873246|473687728|FG001|Overall Study|Lost to Follow-up|4|||
131564066|NCT03873246|473687729|FG002|Overall Study|Lost to Follow-up|5|||
131564067|NCT03873246|473687727|FG000|Overall Study|Protocol Violation|0|||
131564068|NCT03873246|473687728|FG001|Overall Study|Protocol Violation|1|||
131564069|NCT03873246|473687729|FG002|Overall Study|Protocol Violation|0|||
131564070|NCT03873246|473687727|FG000|Overall Study|Withdrawal by Subject|0|||
131564071|NCT03873246|473687728|FG001|Overall Study|Withdrawal by Subject|4|||
131564072|NCT03873246|473687729|FG002|Overall Study|Withdrawal by Subject|1|||
131564073|NCT01857323|473687730|FG000|Overall Study|Adverse Event|1|||
131564074|NCT01857323|473687730|FG000|Overall Study|Withdrawal by Subject|3|||
131564075|NCT01857323|473687730|FG000|Overall Study|Non-compliance|1|||
131564076|NCT01857323|473687730|FG000|Overall Study|Protocol Violation|6|||
131564077|NCT01857323|473687730|FG000|Overall Study|Lost to Follow-up|1|||
131564078|NCT01857323|473687730|FG000|Overall Study|Other|4|||
131564079|NCT01857323|473687730|FG000|Overall Study|Did not complete 180 doses|48|||
131564080|NCT00885495|473687735|FG000|Overall Study|Adverse Event|1|||
131564081|NCT00885495|473687736|FG001|Overall Study|Adverse Event|2|||
131564082|NCT00885495|473687735|FG000|Overall Study|Protocol Violation|0|||
131564083|NCT00885495|473687736|FG001|Overall Study|Protocol Violation|1|||
131564084|NCT00885495|473687735|FG000|Overall Study|Withdrawal by Subject|1|||
131564085|NCT00885495|473687736|FG001|Overall Study|Withdrawal by Subject|0|||
131564086|NCT01400893|473687737|FG000|Overall Study|Death|27|||
131564087|NCT01400893|473687738|FG001|Overall Study|Death|21|||
131564088|NCT01400893|473687737|FG000|Overall Study|Lost to Follow-up|0|||
131564089|NCT01400893|473687738|FG001|Overall Study|Lost to Follow-up|6|||
131564090|NCT01368211|473687742|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
131564091|NCT01368211|473687743|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
131564092|NCT01349660|473687744|FG000|Overall Study|Still Receiving Study Treatment|0|||
131564093|NCT01349660|473687745|FG001|Overall Study|Still Receiving Study Treatment|0|||
131564094|NCT01349660|473687746|FG002|Overall Study|Still Receiving Study Treatment|1|||
131564095|NCT01349660|473687744|FG000|Overall Study|Disease Progression|2|||
131564096|NCT01349660|473687745|FG001|Overall Study|Disease Progression|4|||
131564097|NCT01349660|473687746|FG002|Overall Study|Disease Progression|50|||
131564098|NCT01349660|473687744|FG000|Overall Study|Adverse Event|1|||
131564099|NCT01349660|473687745|FG001|Overall Study|Adverse Event|1|||
131564100|NCT01349660|473687746|FG002|Overall Study|Adverse Event|12|||
131564101|NCT01349660|473687744|FG000|Overall Study|Withdrawal by Subject|2|||
131564102|NCT01349660|473687745|FG001|Overall Study|Withdrawal by Subject|0|||
131564103|NCT01349660|473687746|FG002|Overall Study|Withdrawal by Subject|9|||
131564104|NCT01349660|473687744|FG000|Overall Study|Death|1|||
131564105|NCT01349660|473687745|FG001|Overall Study|Death|1|||
131564106|NCT01349660|473687746|FG002|Overall Study|Death|0|||
131564107|NCT01349660|473687744|FG000|Overall Study|Non-Permitted Interventions|0|||
131564108|NCT01349660|473687745|FG001|Overall Study|Non-Permitted Interventions|0|||
131564109|NCT01349660|473687746|FG002|Overall Study|Non-Permitted Interventions|2|||
131564110|NCT01349660|473687744|FG000|Overall Study|Study Compliance|0|||
131564111|NCT01349660|473687745|FG001|Overall Study|Study Compliance|0|||
131436807|NCT02079740|473225611|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
131564112|NCT01349660|473687746|FG002|Overall Study|Study Compliance|1|||
131564113|NCT01349660|473687744|FG000|Overall Study|Declining Performance Status|0|||
131564114|NCT01349660|473687745|FG001|Overall Study|Declining Performance Status|0|||
131564115|NCT01349660|473687746|FG002|Overall Study|Declining Performance Status|1|||
131564116|NCT00519636|473687747|FG000|Treatment Period 1|Adverse Event|1|||
131564117|NCT00519636|473687748|FG001|Treatment Period 1|Adverse Event|0|||
131564118|NCT00519636|473687749|FG002|Treatment Period 1|Adverse Event|1|||
131564119|NCT00519636|473687750|FG003|Treatment Period 1|Adverse Event|0|||
131564120|NCT00519636|473687747|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
131564121|NCT00519636|473687748|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
131564122|NCT00519636|473687749|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
131564123|NCT00519636|473687750|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
131564124|NCT00519636|473687747|FG000|Washout Period|Adverse Event|2|||
131564125|NCT00519636|473687748|FG001|Washout Period|Adverse Event|1|||
131564126|NCT00519636|473687749|FG002|Washout Period|Adverse Event|1|||
131564127|NCT00519636|473687750|FG003|Washout Period|Adverse Event|0|||
131564128|NCT00519636|473687747|FG000|Washout Period|Lost to Follow-up|1|||
131564129|NCT00519636|473687748|FG001|Washout Period|Lost to Follow-up|0|||
131564130|NCT00519636|473687749|FG002|Washout Period|Lost to Follow-up|0|||
131564131|NCT00519636|473687750|FG003|Washout Period|Lost to Follow-up|0|||
131564132|NCT00519636|473687747|FG000|Washout Period|Protocol Violation|0|||
131564133|NCT00519636|473687748|FG001|Washout Period|Protocol Violation|0|||
131564134|NCT00519636|473687749|FG002|Washout Period|Protocol Violation|1|||
131564135|NCT00519636|473687750|FG003|Washout Period|Protocol Violation|2|||
131564136|NCT00519636|473687747|FG000|Washout Period|Withdrawal by Subject|1|||
131564137|NCT00519636|473687748|FG001|Washout Period|Withdrawal by Subject|0|||
131564138|NCT00519636|473687749|FG002|Washout Period|Withdrawal by Subject|1|||
131564139|NCT00519636|473687750|FG003|Washout Period|Withdrawal by Subject|0|||
131564140|NCT00519636|473687747|FG000|Washout Period|Failed to meet continuation criteria|14|||
131564141|NCT00519636|473687748|FG001|Washout Period|Failed to meet continuation criteria|11|||
131564142|NCT00519636|473687749|FG002|Washout Period|Failed to meet continuation criteria|9|||
131564143|NCT00519636|473687750|FG003|Washout Period|Failed to meet continuation criteria|3|||
131564144|NCT00519636|473687747|FG000|Washout Period|Out of pollen area > 48 hours|1|||
131564145|NCT00519636|473687748|FG001|Washout Period|Out of pollen area > 48 hours|0|||
131564146|NCT00519636|473687749|FG002|Washout Period|Out of pollen area > 48 hours|0|||
131564147|NCT00519636|473687750|FG003|Washout Period|Out of pollen area > 48 hours|0|||
131564148|NCT00519636|473687747|FG000|Washout Period|Participating in study at another site|1|||
131564149|NCT00519636|473687748|FG001|Washout Period|Participating in study at another site|0|||
131564150|NCT00519636|473687749|FG002|Washout Period|Participating in study at another site|0|||
131564151|NCT00519636|473687750|FG003|Washout Period|Participating in study at another site|0|||
131564152|NCT00519636|473687747|FG000|Washout Period|Non-compliant|0|||
131564153|NCT00519636|473687748|FG001|Washout Period|Non-compliant|1|||
131564154|NCT00519636|473687749|FG002|Washout Period|Non-compliant|0|||
131564155|NCT00519636|473687750|FG003|Washout Period|Non-compliant|0|||
131564156|NCT00519636|473687747|FG000|Washout Period|Per doctors request|0|||
131564157|NCT00519636|473687748|FG001|Washout Period|Per doctors request|1|||
131564158|NCT00519636|473687749|FG002|Washout Period|Per doctors request|0|||
131564159|NCT00519636|473687750|FG003|Washout Period|Per doctors request|0|||
131564160|NCT00519636|473687747|FG000|Washout Period|Subject randomized in error|0|||
131564161|NCT00519636|473687748|FG001|Washout Period|Subject randomized in error|0|||
131564162|NCT00519636|473687749|FG002|Washout Period|Subject randomized in error|1|||
131564163|NCT00519636|473687750|FG003|Washout Period|Subject randomized in error|0|||
131781973|NCT02675426|474484521|FG003|Period 1: Week 1 to Week 12|Other|2|||
131781974|NCT02675426|474484518|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
131781975|NCT02675426|474484519|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
131781976|NCT02675426|474484520|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
131564164|NCT00519636|473687747|FG000|Washout Period|Prohibited medications|0|||
131564165|NCT00519636|473687748|FG001|Washout Period|Prohibited medications|0|||
131564166|NCT00519636|473687749|FG002|Washout Period|Prohibited medications|1|||
131564167|NCT00519636|473687750|FG003|Washout Period|Prohibited medications|0|||
131564168|NCT00519636|473687747|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
131564169|NCT00519636|473687748|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
131564170|NCT00519636|473687749|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
131564171|NCT00519636|473687750|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
131564172|NCT00519636|473687747|FG000|Treatment Period 2|Subject randomized in error|0|||
131564173|NCT00519636|473687748|FG001|Treatment Period 2|Subject randomized in error|1|||
131564174|NCT00519636|473687749|FG002|Treatment Period 2|Subject randomized in error|0|||
131564175|NCT00519636|473687750|FG003|Treatment Period 2|Subject randomized in error|0|||
131564176|NCT00519636|473687747|FG000|Treatment Period 2|Per doctors request|0|||
131564177|NCT00519636|473687748|FG001|Treatment Period 2|Per doctors request|0|||
131781977|NCT02675426|474484521|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
131781978|NCT02675426|474484518|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
131781979|NCT02675426|474484519|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
131564178|NCT00519636|473687749|FG002|Treatment Period 2|Per doctors request|1|||
131564179|NCT00519636|473687750|FG003|Treatment Period 2|Per doctors request|0|||
131564180|NCT00519636|473687747|FG000|Treatment Period 2|Subject misrandomized|0|||
131564181|NCT00519636|473687748|FG001|Treatment Period 2|Subject misrandomized|0|||
131564182|NCT00519636|473687749|FG002|Treatment Period 2|Subject misrandomized|0|||
131564183|NCT00519636|473687750|FG003|Treatment Period 2|Subject misrandomized|1|||
131564184|NCT00519636|473687747|FG000|Post Study Period|Subject randomized in error|0|||
131564185|NCT00519636|473687748|FG001|Post Study Period|Subject randomized in error|0|||
131564186|NCT00519636|473687749|FG002|Post Study Period|Subject randomized in error|0|||
131564187|NCT00519636|473687750|FG003|Post Study Period|Subject randomized in error|1|||
131564188|NCT02846558|473687755|FG000|Overall Study|Adverse Event|1|||
131564189|NCT02846558|473687756|FG001|Overall Study|Adverse Event|0|||
131564190|NCT02846558|473687757|FG002|Overall Study|Adverse Event|0|||
131564191|NCT02846558|473687758|FG003|Overall Study|Adverse Event|0|||
131564192|NCT02846558|473687755|FG000|Overall Study|Withdrawal by Subject|5|||
131564193|NCT02846558|473687756|FG001|Overall Study|Withdrawal by Subject|4|||
131564194|NCT02846558|473687757|FG002|Overall Study|Withdrawal by Subject|2|||
131564195|NCT02846558|473687758|FG003|Overall Study|Withdrawal by Subject|2|||
131564196|NCT02846558|473687755|FG000|Overall Study|Lost to Follow-up|2|||
131564197|NCT02846558|473687756|FG001|Overall Study|Lost to Follow-up|0|||
131564198|NCT02846558|473687757|FG002|Overall Study|Lost to Follow-up|0|||
131564199|NCT02846558|473687758|FG003|Overall Study|Lost to Follow-up|0|||
131564200|NCT00904150|473687768|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
131564201|NCT00904150|473687769|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
131564202|NCT00904150|473687768|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
131564203|NCT00904150|473687769|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
131564204|NCT00224133|473689517|FG000|Overall Study|Adverse Event|93|||
131564205|NCT00224133|473689517|FG000|Overall Study|Protocol Violation|6|||
131564206|NCT00224133|473689517|FG000|Overall Study|Withdrawal by Subject|33|||
131564207|NCT00224133|473689517|FG000|Overall Study|Lack of Efficacy|58|||
131564208|NCT00224133|473689517|FG000|Overall Study|Lost to Follow-up|21|||
131564209|NCT00224133|473689517|FG000|Overall Study|Physician Decision|1|||
131564210|NCT00224133|473689517|FG000|Overall Study|Other|14|||
131564211|NCT02056119|473689522|FG000|Overall Study|Death|1|||
131564212|NCT02056119|473689523|FG001|Overall Study|Death|2|||
131564213|NCT02056119|473689522|FG000|Overall Study|Intubated for less than 24 hrs|2|||
131564214|NCT02056119|473689523|FG001|Overall Study|Intubated for less than 24 hrs|7|||
131564215|NCT02056119|473689522|FG000|Overall Study|No aerosol treatments were given.|3|||
131564216|NCT02056119|473689523|FG001|Overall Study|No aerosol treatments were given.|2|||
131564217|NCT02056119|473689522|FG000|Overall Study|Received Metaneb treatment|0|||
131564218|NCT02056119|473689523|FG001|Overall Study|Received Metaneb treatment|2|||
131564219|NCT02056119|473689522|FG000|Overall Study|Protocol Violation|4|||
131564220|NCT02056119|473689523|FG001|Overall Study|Protocol Violation|7|||
131564221|NCT03220737|473689524|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
131564222|NCT03220737|473689525|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
131564223|NCT03220737|473689526|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
131564224|NCT03220737|473689527|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
131564225|NCT03220737|473689528|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
131564226|NCT03220737|473689529|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
131564227|NCT03220737|473689530|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
131564228|NCT03220737|473689524|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
131564229|NCT03220737|473689525|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
131564230|NCT03220737|473689526|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
131564231|NCT03220737|473689527|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
131564232|NCT03220737|473689528|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
131564233|NCT03220737|473689529|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
131564234|NCT03220737|473689530|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
131564235|NCT03220737|473689524|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
131564236|NCT03220737|473689525|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
131564237|NCT03220737|473689526|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
131564238|NCT03220737|473689527|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
131781980|NCT02675426|474484520|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
131781981|NCT02675426|474484521|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
131781982|NCT02675426|474484518|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
131781983|NCT02675426|474484519|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
131781984|NCT02675426|474484520|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
131781985|NCT02675426|474484521|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
131781986|NCT02675426|474484518|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
131781987|NCT02675426|474484519|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
131564239|NCT03220737|473689528|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
131564240|NCT03220737|473689529|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
131564241|NCT03220737|473689530|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
131564242|NCT03220737|473689524|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131564243|NCT03220737|473689525|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131564244|NCT03220737|473689526|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
131564245|NCT03220737|473689527|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131564246|NCT03220737|473689528|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131696813|NCT02028455|474172144|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131898618|NCT02624947|474915308|FG001|Maternal Participants|Miscellaneous|15|||
131564247|NCT03220737|473689529|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131564248|NCT03220737|473689530|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131564249|NCT03220737|473689524|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131564250|NCT03220737|473689525|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131564251|NCT03220737|473689526|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131564252|NCT03220737|473689527|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131564253|NCT03220737|473689528|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
131564254|NCT03220737|473689529|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131564255|NCT03220737|473689530|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131564256|NCT03220737|473689524|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
131564257|NCT03220737|473689525|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131564258|NCT03220737|473689526|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131564259|NCT03220737|473689527|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131564260|NCT03220737|473689528|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131564261|NCT03220737|473689529|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131564262|NCT03220737|473689530|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131564263|NCT03220737|473689524|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
131564264|NCT03220737|473689525|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131564265|NCT03220737|473689526|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131564266|NCT03220737|473689527|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131564267|NCT03220737|473689528|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131564268|NCT03220737|473689529|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131564269|NCT03220737|473689530|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131564270|NCT03220737|473689524|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
131564271|NCT03220737|473689525|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131564272|NCT03220737|473689526|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131564273|NCT03220737|473689527|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131564274|NCT03220737|473689528|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131564275|NCT03220737|473689529|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131564276|NCT03220737|473689530|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131564277|NCT01782326|473689537|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
131564278|NCT01782326|473689538|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
131564279|NCT01782326|473689537|FG000|Planned Treatment Epoch|Death|29|||
131564280|NCT01782326|473689538|FG001|Planned Treatment Epoch|Death|30|||
131564281|NCT01782326|473689537|FG000|Planned Treatment Epoch|Physician Decision|18|||
131564282|NCT01782326|473689538|FG001|Planned Treatment Epoch|Physician Decision|16|||
131564283|NCT01782326|473689537|FG000|Planned Treatment Epoch|Protocol deviation|2|||
131564284|NCT01782326|473689538|FG001|Planned Treatment Epoch|Protocol deviation|3|||
131564285|NCT01782326|473689537|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
131564286|NCT01782326|473689538|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
131564287|NCT01782326|473689537|FG000|Planned Treatment Epoch|Technical problems|0|||
131564288|NCT01782326|473689538|FG001|Planned Treatment Epoch|Technical problems|4|||
131564289|NCT01782326|473689537|FG000|Double-blind Treatment|Adverse Event|129|||
131564290|NCT01782326|473689538|FG001|Double-blind Treatment|Adverse Event|145|||
131564291|NCT01782326|473689537|FG000|Double-blind Treatment|Subject/guardian decision|111|||
131564292|NCT01782326|473689538|FG001|Double-blind Treatment|Subject/guardian decision|125|||
131564293|NCT01782326|473689537|FG000|Double-blind Treatment|Lack of Efficacy|17|||
131564294|NCT01782326|473689538|FG001|Double-blind Treatment|Lack of Efficacy|22|||
131564295|NCT01782326|473689537|FG000|Double-blind Treatment|Physician Decision|13|||
131564296|NCT01782326|473689538|FG001|Double-blind Treatment|Physician Decision|16|||
131564297|NCT01782326|473689537|FG000|Double-blind Treatment|Protocol deviation|8|||
131564298|NCT01782326|473689538|FG001|Double-blind Treatment|Protocol deviation|7|||
131564299|NCT01782326|473689537|FG000|Double-blind Treatment|Technical problems|0|||
131564300|NCT01782326|473689538|FG001|Double-blind Treatment|Technical problems|5|||
131564301|NCT01767129|473689539|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
131564302|NCT01767129|473689540|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
131564303|NCT03389893|473689541|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
131564304|NCT03389893|473689542|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
131564305|NCT03389893|473689543|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
131564306|NCT03389893|473689544|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
131696814|NCT02028455|474172145|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
131696815|NCT02028455|474172146|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
131696816|NCT03368170|474173951|FG000|Overall Study|Adverse Event|2|||
131696817|NCT03368170|474173952|FG001|Overall Study|Adverse Event|1|||
131696818|NCT01662440|474173953|FG000|Overall Study|Adverse Event|1|||
131696819|NCT01662440|474173954|FG001|Overall Study|Adverse Event|0|||
131696820|NCT01662440|474173955|FG002|Overall Study|Adverse Event|0|||
131696821|NCT01662440|474173956|FG003|Overall Study|Adverse Event|1|||
131696822|NCT01662440|474173953|FG000|Overall Study|Death|0|||
131564307|NCT03389893|473689541|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
131564308|NCT03389893|473689542|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
131564309|NCT03389893|473689543|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
131564310|NCT03389893|473689544|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
131564311|NCT03389893|473689541|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
131564312|NCT03389893|473689542|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
131564313|NCT03389893|473689543|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
131564314|NCT03389893|473689544|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
131564315|NCT03389893|473689541|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
131564316|NCT03389893|473689542|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
131564317|NCT03389893|473689543|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
131564318|NCT03389893|473689544|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
131564319|NCT01024751|473689547|FG000|Enrolled Participants|Ineligible at baseline|3|||
131564320|NCT01024751|473689548|FG001|Enrolled Participants|Ineligible at baseline|4|||
131564321|NCT01024751|473689547|FG000|Eligible Participants|Withdrawal by Subject|0|||
131564322|NCT01024751|473689548|FG001|Eligible Participants|Withdrawal by Subject|1|||
131564323|NCT01024751|473689547|FG000|Eligible Participants|Lost to Follow-up|0|||
131564324|NCT01024751|473689548|FG001|Eligible Participants|Lost to Follow-up|1|||
131564325|NCT01024751|473689547|FG000|Eligible Participants|Ineligible|0|||
131564326|NCT01024751|473689548|FG001|Eligible Participants|Ineligible|1|||
131564327|NCT02448719|473689549|FG000|Overall Study|Withdrawal by Subject|0|||
131564328|NCT02448719|473689550|FG001|Overall Study|Withdrawal by Subject|0|||
131564329|NCT02448719|473689551|FG002|Overall Study|Withdrawal by Subject|0|||
131564330|NCT02448719|473689552|FG003|Overall Study|Withdrawal by Subject|0|||
131564331|NCT02448719|473689553|FG004|Overall Study|Withdrawal by Subject|1|||
131564332|NCT02448719|473689554|FG005|Overall Study|Withdrawal by Subject|0|||
131564333|NCT02448719|473689555|FG006|Overall Study|Withdrawal by Subject|0|||
131564334|NCT02448719|473689556|FG007|Overall Study|Withdrawal by Subject|0|||
131564335|NCT02448719|473689557|FG008|Overall Study|Withdrawal by Subject|0|||
131564336|NCT02448719|473689558|FG009|Overall Study|Withdrawal by Subject|0|||
131564337|NCT02448719|473689559|FG010|Overall Study|Withdrawal by Subject|0|||
131564338|NCT01232556|473689560|FG000|Overall Study|Withdrawal by Subject|21|||
131564339|NCT01232556|473689561|FG001|Overall Study|Withdrawal by Subject|17|||
131564340|NCT01232556|473689560|FG000|Overall Study|Death|97|||
131564341|NCT01232556|473689561|FG001|Overall Study|Death|97|||
131564342|NCT01232556|473689560|FG000|Overall Study|Lost to Follow-up|0|||
131564343|NCT01232556|473689561|FG001|Overall Study|Lost to Follow-up|2|||
131564344|NCT01232556|473689560|FG000|Overall Study|Terminated by Sponsor|35|||
131564345|NCT01232556|473689561|FG001|Overall Study|Terminated by Sponsor|51|||
131564346|NCT01232556|473689560|FG000|Overall Study|Other|6|||
131564347|NCT01232556|473689561|FG001|Overall Study|Other|4|||
131564348|NCT01473420|473689563|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
131564349|NCT01473420|473689564|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
131564350|NCT01473420|473689563|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
131564351|NCT01473420|473689564|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
131564352|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
131564353|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
131564354|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
131564355|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
131564356|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
131564357|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
131564358|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
131564359|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
131564360|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
131564361|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
131564362|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
131564363|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
131564364|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
131564365|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
131564366|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
131564367|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
131564368|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
131564369|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
131564370|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
131564371|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
131564372|NCT01473420|473689563|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
131564373|NCT01473420|473689564|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
131564374|NCT01347645|473689565|FG000|Overall Study|Death|1|||
131564375|NCT01347645|473689566|FG001|Overall Study|Death|5|||
131564376|NCT01347645|473689567|FG002|Overall Study|Death|2|||
131564377|NCT01347645|473689568|FG003|Overall Study|Death|7|||
131564378|NCT01347645|473689569|FG004|Overall Study|Death|7|||
131564379|NCT01347645|473689565|FG000|Overall Study|Lost to Follow-up|1|||
131564380|NCT01347645|473689566|FG001|Overall Study|Lost to Follow-up|1|||
131564381|NCT01347645|473689567|FG002|Overall Study|Lost to Follow-up|0|||
131564382|NCT01347645|473689568|FG003|Overall Study|Lost to Follow-up|1|||
131564383|NCT01347645|473689569|FG004|Overall Study|Lost to Follow-up|1|||
131564384|NCT01347645|473689565|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
131564385|NCT01347645|473689566|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
131564386|NCT01347645|473689567|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
131564387|NCT01347645|473689568|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
131564388|NCT01347645|473689569|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
131564389|NCT01347645|473689565|FG000|Overall Study|Other|1|||
131564390|NCT01347645|473689566|FG001|Overall Study|Other|0|||
131564391|NCT01347645|473689567|FG002|Overall Study|Other|0|||
131564392|NCT01347645|473689568|FG003|Overall Study|Other|0|||
131564393|NCT01347645|473689569|FG004|Overall Study|Other|1|||
131564394|NCT01347645|473689565|FG000|Overall Study|Withdrawal by Subject|0|||
131564395|NCT01347645|473689566|FG001|Overall Study|Withdrawal by Subject|0|||
131564396|NCT01347645|473689567|FG002|Overall Study|Withdrawal by Subject|0|||
131564397|NCT01347645|473689568|FG003|Overall Study|Withdrawal by Subject|3|||
131564398|NCT01347645|473689569|FG004|Overall Study|Withdrawal by Subject|3|||
131564399|NCT01347645|473689565|FG000|Overall Study|Physician Decision|0|||
131564400|NCT01347645|473689566|FG001|Overall Study|Physician Decision|0|||
131564401|NCT01347645|473689567|FG002|Overall Study|Physician Decision|0|||
131564402|NCT01347645|473689568|FG003|Overall Study|Physician Decision|0|||
131564403|NCT01347645|473689569|FG004|Overall Study|Physician Decision|1|||
131564404|NCT01347645|473689565|FG000|Overall Study|Adverse Event|0|||
131564405|NCT01347645|473689566|FG001|Overall Study|Adverse Event|0|||
131564406|NCT01347645|473689567|FG002|Overall Study|Adverse Event|0|||
131564407|NCT01347645|473689568|FG003|Overall Study|Adverse Event|1|||
131564408|NCT01347645|473689569|FG004|Overall Study|Adverse Event|1|||
131564409|NCT00388362|473689570|FG000|Enrolled|Ineligible|1|||
131564410|NCT00388362|473689570|FG000|Enrolled|Adverse Event|9|||
131564411|NCT00388362|473689570|FG000|Enrolled|Death|1|||
131564412|NCT00388362|473689570|FG000|Enrolled|Loss insurance|1|||
131564413|NCT00388362|473689570|FG000|Enrolled|Withdrawal by Subject|1|||
131564414|NCT00388362|473689570|FG000|Remained on Study Median of 514 Days|Death|2|||
131564415|NCT01141660|473689571|FG000|Overall Study|Physician Decision|0|||
131564416|NCT01141660|473689572|FG001|Overall Study|Physician Decision|12|||
131564417|NCT00209027|473689574|FG000|Overall Study|study terminated|10|||
131564418|NCT00209027|473689575|FG001|Overall Study|study terminated|0|||
131564419|NCT01163149|473689576|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
131564420|NCT01163149|473689577|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131564421|NCT01163149|473689578|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
131564422|NCT01163149|473689576|FG000|Extension Treatment Period|Adverse Event|0|||
131564423|NCT01163149|473689577|FG001|Extension Treatment Period|Adverse Event|1|||
131564424|NCT01163149|473689578|FG002|Extension Treatment Period|Adverse Event|0|||
131564425|NCT01163149|473689576|FG000|Extension Treatment Period|Noncompliance|0|||
131564426|NCT01163149|473689577|FG001|Extension Treatment Period|Noncompliance|0|||
131564427|NCT01163149|473689578|FG002|Extension Treatment Period|Noncompliance|1|||
131564428|NCT01932996|473689579|FG000|Overall Study|Protocol Violation|2|||
131564429|NCT01932996|473689580|FG001|Overall Study|Protocol Violation|0|||
131564430|NCT01848834|473689581|FG000|Overall Study|Adverse Event|3|||
131564431|NCT01848834|473689582|FG001|Overall Study|Adverse Event|11|||
131564432|NCT01848834|473689583|FG002|Overall Study|Adverse Event|3|||
131564433|NCT01848834|473689584|FG003|Overall Study|Adverse Event|5|||
131564434|NCT01848834|473689585|FG004|Overall Study|Adverse Event|9|||
131564435|NCT01848834|473689581|FG000|Overall Study|Death|2|||
131564436|NCT01848834|473689582|FG001|Overall Study|Death|11|||
131564437|NCT01848834|473689583|FG002|Overall Study|Death|1|||
131696823|NCT01662440|474173954|FG001|Overall Study|Death|1|||
131696824|NCT01662440|474173955|FG002|Overall Study|Death|0|||
131696825|NCT01662440|474173956|FG003|Overall Study|Death|0|||
131696826|NCT01662440|474173953|FG000|Overall Study|Lost to Follow-up|2|||
131696827|NCT01662440|474173954|FG001|Overall Study|Lost to Follow-up|2|||
131564438|NCT01848834|473689584|FG003|Overall Study|Death|8|||
131564439|NCT01848834|473689585|FG004|Overall Study|Death|27|||
131564440|NCT01848834|473689581|FG000|Overall Study|Excluded Medication|5|||
131564441|NCT01848834|473689582|FG001|Overall Study|Excluded Medication|4|||
131564442|NCT01848834|473689583|FG002|Overall Study|Excluded Medication|3|||
131564443|NCT01848834|473689584|FG003|Overall Study|Excluded Medication|6|||
131564444|NCT01848834|473689585|FG004|Overall Study|Excluded Medication|6|||
131564445|NCT01848834|473689581|FG000|Overall Study|Lost to Follow-up|5|||
131696828|NCT01662440|474173955|FG002|Overall Study|Lost to Follow-up|4|||
131564446|NCT01848834|473689582|FG001|Overall Study|Lost to Follow-up|5|||
131696829|NCT01662440|474173956|FG003|Overall Study|Lost to Follow-up|1|||
131696830|NCT01662440|474173953|FG000|Overall Study|Subject moved to another country.|0|||
131436808|NCT02079740|473225612|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
131436809|NCT02079740|473225613|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
131436810|NCT02079740|473225614|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
131436811|NCT02079740|473225615|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
131436812|NCT02079740|473225616|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
131436813|NCT02079740|473225617|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
131436814|NCT02079740|473225605|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131696831|NCT01662440|474173954|FG001|Overall Study|Subject moved to another country.|1|||
131696832|NCT01662440|474173955|FG002|Overall Study|Subject moved to another country.|0|||
131696833|NCT01662440|474173956|FG003|Overall Study|Subject moved to another country.|0|||
131696834|NCT01662440|474173953|FG000|Overall Study|Protocol Violation|1|||
131696835|NCT01662440|474173954|FG001|Overall Study|Protocol Violation|0|||
131696836|NCT01662440|474173955|FG002|Overall Study|Protocol Violation|0|||
131696837|NCT01662440|474173956|FG003|Overall Study|Protocol Violation|0|||
131696838|NCT01662440|474173953|FG000|Overall Study|Withdrawal by Subject|5|||
131898619|NCT02624947|474915307|FG000|Infant Participants|Adverse Event|18|||
131781988|NCT02675426|474484520|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
131781989|NCT02675426|474484521|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
131781990|NCT02675426|474484518|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
131781991|NCT02675426|474484519|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
131781992|NCT02675426|474484520|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
131898620|NCT02624947|474915308|FG001|Infant Participants|Adverse Event|11|||
131564447|NCT01848834|473689583|FG002|Overall Study|Lost to Follow-up|3|||
131564448|NCT01848834|473689584|FG003|Overall Study|Lost to Follow-up|0|||
131696839|NCT01662440|474173954|FG001|Overall Study|Withdrawal by Subject|2|||
131696840|NCT01662440|474173955|FG002|Overall Study|Withdrawal by Subject|2|||
131696841|NCT01662440|474173956|FG003|Overall Study|Withdrawal by Subject|2|||
131696842|NCT04872101|474173957|FG000|Overall Study|Withdrawal by Subject|10|||
131696843|NCT04872101|474173958|FG001|Overall Study|Withdrawal by Subject|16|||
131696844|NCT04872101|474173957|FG000|Overall Study|Lack of Efficacy|6|||
131696845|NCT04872101|474173958|FG001|Overall Study|Lack of Efficacy|14|||
131696846|NCT04872101|474173957|FG000|Overall Study|Adverse Event|1|||
131696847|NCT04872101|474173958|FG001|Overall Study|Adverse Event|6|||
131696848|NCT04872101|474173957|FG000|Overall Study|Lost to Follow-up|2|||
131696849|NCT04872101|474173958|FG001|Overall Study|Lost to Follow-up|1|||
131696850|NCT04872101|474173957|FG000|Overall Study|Pregnancy|2|||
131696851|NCT04872101|474173958|FG001|Overall Study|Pregnancy|0|||
131696852|NCT04872101|474173957|FG000|Overall Study|Prohibited Medication|1|||
131564449|NCT01848834|473689585|FG004|Overall Study|Lost to Follow-up|3|||
131564450|NCT01848834|473689581|FG000|Overall Study|Physician Decision|1|||
131564451|NCT01848834|473689582|FG001|Overall Study|Physician Decision|3|||
131564452|NCT01848834|473689583|FG002|Overall Study|Physician Decision|4|||
131564453|NCT01848834|473689584|FG003|Overall Study|Physician Decision|0|||
131564454|NCT01848834|473689585|FG004|Overall Study|Physician Decision|11|||
131564455|NCT01848834|473689581|FG000|Overall Study|Protocol Violation|0|||
131564456|NCT01848834|473689582|FG001|Overall Study|Protocol Violation|0|||
131781993|NCT02675426|474484521|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
131781994|NCT02675426|474484518|FG000|Period 2: Week 12 to Week 260|Other|8|||
131781995|NCT02675426|474484519|FG001|Period 2: Week 12 to Week 260|Other|12|||
131781996|NCT02675426|474484520|FG002|Period 2: Week 12 to Week 260|Other|23|||
131781997|NCT02675426|474484521|FG003|Period 2: Week 12 to Week 260|Other|15|||
131781998|NCT02156466|474484524|FG000|Overall Study|Adverse Event|0|||
131781999|NCT02156466|474484525|FG001|Overall Study|Adverse Event|0|||
131782000|NCT02156466|474484526|FG002|Overall Study|Adverse Event|1|||
131782001|NCT02156466|474484527|FG003|Overall Study|Adverse Event|1|||
131782002|NCT02156466|474484528|FG004|Overall Study|Adverse Event|0|||
131782003|NCT02156466|474484524|FG000|Overall Study|Quantiferon Positivity|0|||
131782004|NCT02156466|474484525|FG001|Overall Study|Quantiferon Positivity|0|||
131782005|NCT02156466|474484526|FG002|Overall Study|Quantiferon Positivity|0|||
131782006|NCT02156466|474484527|FG003|Overall Study|Quantiferon Positivity|1|||
131782007|NCT02156466|474484528|FG004|Overall Study|Quantiferon Positivity|0|||
131782008|NCT00080288|474484529|FG000|Overall Study|Adverse Event|7|||
131782009|NCT00080288|474484530|FG001|Overall Study|Adverse Event|4|||
131782010|NCT00080288|474484529|FG000|Overall Study|Lost to Follow-up|3|||
131782011|NCT00080288|474484530|FG001|Overall Study|Lost to Follow-up|5|||
131782012|NCT00080288|474484529|FG000|Overall Study|Physician Decision|6|||
131782013|NCT00080288|474484530|FG001|Overall Study|Physician Decision|2|||
131782014|NCT00080288|474484529|FG000|Overall Study|Withdrawal by Subject|3|||
131782015|NCT00080288|474484530|FG001|Overall Study|Withdrawal by Subject|16|||
131782016|NCT00080288|474484529|FG000|Overall Study|Miscellaneous|11|||
131782017|NCT00080288|474484530|FG001|Overall Study|Miscellaneous|11|||
131782018|NCT04470622|474484531|FG000|Overall Study|Withdrawal by Subject|0|||
131782019|NCT04470622|474484532|FG001|Overall Study|Withdrawal by Subject|1|||
131782020|NCT04470622|474484531|FG000|Overall Study|Screen Failure|0|||
131782021|NCT04470622|474484532|FG001|Overall Study|Screen Failure|1|||
131782022|NCT04470622|474484531|FG000|Overall Study|Death|0|||
131782023|NCT04470622|474484532|FG001|Overall Study|Death|1|||
131782024|NCT01268683|474484541|FG000|Overall Study|Lost to Follow-up|1|||
131782025|NCT01268683|474484541|FG000|Overall Study|Death|1|||
131782026|NCT02216214|474484542|FG000|Overall Study|Randomized Never Received Study Drug|1|||
131782027|NCT02216214|474484543|FG001|Overall Study|Randomized Never Received Study Drug|0|||
131782028|NCT02216214|474484542|FG000|Overall Study|Adverse Event|10|||
131782029|NCT02216214|474484543|FG001|Overall Study|Adverse Event|8|||
131782030|NCT02216214|474484542|FG000|Overall Study|Lack of Efficacy|2|||
131782031|NCT02216214|474484543|FG001|Overall Study|Lack of Efficacy|2|||
131782032|NCT02216214|474484542|FG000|Overall Study|Lost to Follow-up|3|||
131782033|NCT02216214|474484543|FG001|Overall Study|Lost to Follow-up|2|||
131782034|NCT02216214|474484542|FG000|Overall Study|Protocol Violation|4|||
131782035|NCT02216214|474484543|FG001|Overall Study|Protocol Violation|2|||
131782036|NCT02216214|474484542|FG000|Overall Study|Withdrawal by Subject|22|||
131782037|NCT02216214|474484543|FG001|Overall Study|Withdrawal by Subject|20|||
131564457|NCT01848834|473689583|FG002|Overall Study|Protocol Violation|0|||
131564458|NCT01848834|473689584|FG003|Overall Study|Protocol Violation|0|||
131696853|NCT04872101|474173958|FG001|Overall Study|Prohibited Medication|0|||
131696854|NCT04872101|474173957|FG000|Overall Study|Not dosed|1|||
131696855|NCT04872101|474173958|FG001|Overall Study|Not dosed|0|||
131696856|NCT00971945|474173959|FG000|Overall Study|Progressive Disease|3|||
131696857|NCT00971945|474173959|FG000|Overall Study|Change in treatment policy|1|||
131436815|NCT02079740|473225606|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436816|NCT02079740|473225607|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436817|NCT02079740|473225608|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436818|NCT02079740|473225609|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436819|NCT02079740|473225610|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436820|NCT02079740|473225611|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436821|NCT02079740|473225612|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
131436822|NCT02079740|473225613|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436823|NCT02079740|473225614|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436824|NCT02079740|473225615|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436825|NCT02079740|473225616|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436826|NCT02079740|473225617|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
131436827|NCT02079740|473225605|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436828|NCT02079740|473225606|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436829|NCT02079740|473225607|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436830|NCT02079740|473225608|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436831|NCT02079740|473225609|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436832|NCT02079740|473225610|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436833|NCT02079740|473225611|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436834|NCT02079740|473225612|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436835|NCT02079740|473225613|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436836|NCT02079740|473225614|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
131436837|NCT02079740|473225615|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
131436838|NCT02079740|473225616|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
131436839|NCT02079740|473225617|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
131436840|NCT04617782|473225618|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
131436841|NCT04617782|473225618|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
131436842|NCT04617782|473225618|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
131436843|NCT04617782|473225618|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
131436844|NCT04617782|473225618|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
131436845|NCT04617782|473225618|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
131436846|NCT03493945|473225625|FG000|Phase I Dose Escalation|Ineligible|0|||
131436847|NCT03493945|473225626|FG001|Phase I Dose Escalation|Ineligible|0|||
131436848|NCT03493945|473225627|FG002|Phase I Dose Escalation|Ineligible|1|||
131564459|NCT01848834|473689585|FG004|Overall Study|Protocol Violation|1|||
131436849|NCT03493945|473225628|FG003|Phase I Dose Escalation|Ineligible|0|||
131436850|NCT03493945|473225629|FG004|Phase I Dose Escalation|Ineligible|0|||
131436851|NCT03493945|473225630|FG005|Phase I Dose Escalation|Ineligible|0|||
131436852|NCT03493945|473225631|FG006|Phase I Dose Escalation|Ineligible|0|||
131564460|NCT01848834|473689581|FG000|Overall Study|Sponsor Decision|1|||
131564461|NCT01848834|473689582|FG001|Overall Study|Sponsor Decision|1|||
131564462|NCT01848834|473689583|FG002|Overall Study|Sponsor Decision|0|||
131564463|NCT01848834|473689584|FG003|Overall Study|Sponsor Decision|1|||
131564464|NCT01848834|473689585|FG004|Overall Study|Sponsor Decision|1|||
131564465|NCT01848834|473689581|FG000|Overall Study|Withdrawal by Subject|2|||
131564466|NCT01848834|473689582|FG001|Overall Study|Withdrawal by Subject|13|||
131564467|NCT01848834|473689583|FG002|Overall Study|Withdrawal by Subject|10|||
131436853|NCT03493945|473225625|FG000|Phase I Dose Escalation|New therapy|0|||
131436854|NCT03493945|473225626|FG001|Phase I Dose Escalation|New therapy|1|||
131436855|NCT03493945|473225627|FG002|Phase I Dose Escalation|New therapy|0|||
131436856|NCT03493945|473225628|FG003|Phase I Dose Escalation|New therapy|0|||
131436857|NCT03493945|473225629|FG004|Phase I Dose Escalation|New therapy|0|||
131436858|NCT03493945|473225630|FG005|Phase I Dose Escalation|New therapy|0|||
131436859|NCT03493945|473225631|FG006|Phase I Dose Escalation|New therapy|0|||
131436860|NCT03493945|473225625|FG000|Phase II Dose Expansion|Refused further treatment|0|||
131436861|NCT03493945|473225626|FG001|Phase II Dose Expansion|Refused further treatment|0|||
131436862|NCT03493945|473225627|FG002|Phase II Dose Expansion|Refused further treatment|0|||
131436863|NCT03493945|473225628|FG003|Phase II Dose Expansion|Refused further treatment|0|||
131436864|NCT03493945|473225629|FG004|Phase II Dose Expansion|Refused further treatment|1|||
131436865|NCT03493945|473225630|FG005|Phase II Dose Expansion|Refused further treatment|1|||
131436866|NCT03493945|473225631|FG006|Phase II Dose Expansion|Refused further treatment|0|||
131436867|NCT03493945|473225625|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
131436868|NCT03493945|473225626|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
131436869|NCT03493945|473225627|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
131436870|NCT03493945|473225628|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
131436871|NCT03493945|473225629|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
131436872|NCT03493945|473225630|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
131436873|NCT03493945|473225631|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
131436874|NCT01405768|473225632|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
131436875|NCT01405768|473225633|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
131436876|NCT04233801|473225637|FG000|Overall Study|Other than listed|0|||
131564468|NCT01848834|473689584|FG003|Overall Study|Withdrawal by Subject|6|||
131564469|NCT01848834|473689585|FG004|Overall Study|Withdrawal by Subject|36|||
131696858|NCT00971945|474173959|FG000|Overall Study|Other reasons|2|||
131696859|NCT03691974|474173960|FG000|Overall Study|Physician Decision|1|||
131696860|NCT03691974|474173961|FG001|Overall Study|Physician Decision|0|||
131782038|NCT02216214|474484542|FG000|Overall Study|Study Terminated By Sponsor|0|||
131782039|NCT02216214|474484543|FG001|Overall Study|Study Terminated By Sponsor|1|||
131782040|NCT02216214|474484542|FG000|Overall Study|Miscellaneous|1|||
131782041|NCT02216214|474484543|FG001|Overall Study|Miscellaneous|1|||
131782042|NCT05354206|474484544|FG000|Overall Study|Withdrawal by Subject|1|||
131782043|NCT05354206|474484545|FG001|Overall Study|Withdrawal by Subject|0|||
131782044|NCT00713830|474484546|FG000|Overall Study|Adverse Event|23|||
131782045|NCT00713830|474484547|FG001|Overall Study|Adverse Event|71|||
131782046|NCT00713830|474484546|FG000|Overall Study|Lack of Efficacy|24|||
131782047|NCT00713830|474484547|FG001|Overall Study|Lack of Efficacy|16|||
131782048|NCT00713830|474484546|FG000|Overall Study|Lost to Follow-up|2|||
131782049|NCT00713830|474484547|FG001|Overall Study|Lost to Follow-up|9|||
131782050|NCT00713830|474484546|FG000|Overall Study|Withdrawal by Subject|13|||
131782051|NCT00713830|474484547|FG001|Overall Study|Withdrawal by Subject|23|||
131782052|NCT00713830|474484546|FG000|Overall Study|Poor Compliance to Protocol|7|||
131782053|NCT00713830|474484547|FG001|Overall Study|Poor Compliance to Protocol|14|||
131782054|NCT00713830|474484546|FG000|Overall Study|Familial and Personal Reasons|9|||
131782055|NCT00713830|474484547|FG001|Overall Study|Familial and Personal Reasons|34|||
131782056|NCT00713830|474484546|FG000|Overall Study|Sponsor Decision|4|||
131782057|NCT00713830|474484547|FG001|Overall Study|Sponsor Decision|10|||
131782058|NCT04701658|474484548|FG000|Overall Study|Lost to Follow-up|6|||
131782059|NCT04101721|474484551|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
131782060|NCT04101721|474484552|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
131782061|NCT04101721|474484551|FG000|Overall Study|Death|0|||
131782062|NCT04101721|474484552|FG001|Overall Study|Death|1|||
131782063|NCT04101721|474484551|FG000|Overall Study|Lost to Follow-up|0|||
131782064|NCT04101721|474484552|FG001|Overall Study|Lost to Follow-up|3|||
131782065|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
131782066|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
131782067|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
131782068|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
131782069|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
131782070|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
131782071|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
131782072|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
131782073|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
131782074|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
131782075|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
131782076|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
131782077|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
131782078|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
131782079|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
131436877|NCT04233801|473225638|FG001|Overall Study|Other than listed|0|||
131436878|NCT04233801|473225639|FG002|Overall Study|Other than listed|1|||
131436879|NCT04233801|473225637|FG000|Overall Study|Withdrawal by Subject|0|||
131436880|NCT04233801|473225638|FG001|Overall Study|Withdrawal by Subject|2|||
131436881|NCT04233801|473225639|FG002|Overall Study|Withdrawal by Subject|3|||
131436882|NCT01690052|473225644|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
131436883|NCT01690052|473225645|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
131436884|NCT02421172|473225646|FG000|Period 1|Adverse Event|1|||
131436885|NCT02421172|473225647|FG001|Period 1|Adverse Event|0|||
131436886|NCT02421172|473225648|FG002|Period 1|Adverse Event|0|||
131436887|NCT02421172|473225649|FG003|Period 1|Adverse Event|0|||
131436888|NCT02421172|473225650|FG004|Period 1|Adverse Event|0|||
131436889|NCT02421172|473225646|FG000|Period 1|Lost to Follow-up|3|||
131436890|NCT02421172|473225647|FG001|Period 1|Lost to Follow-up|1|||
131436891|NCT02421172|473225648|FG002|Period 1|Lost to Follow-up|0|||
131436892|NCT02421172|473225649|FG003|Period 1|Lost to Follow-up|0|||
131436893|NCT02421172|473225650|FG004|Period 1|Lost to Follow-up|0|||
131436894|NCT02421172|473225646|FG000|Period 1|Patient/guardian decision|0|||
131436895|NCT02421172|473225647|FG001|Period 1|Patient/guardian decision|1|||
131436896|NCT02421172|473225648|FG002|Period 1|Patient/guardian decision|0|||
131436897|NCT02421172|473225649|FG003|Period 1|Patient/guardian decision|0|||
131436898|NCT02421172|473225650|FG004|Period 1|Patient/guardian decision|0|||
131436899|NCT02421172|473225646|FG000|Period 2|Adverse Event|0|||
131436900|NCT02421172|473225647|FG001|Period 2|Adverse Event|0|||
131564470|NCT03259373|473689597|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
131782080|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
131782081|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
131782082|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
131436901|NCT02421172|473225648|FG002|Period 2|Adverse Event|4|||
131436902|NCT02421172|473225649|FG003|Period 2|Adverse Event|0|||
131782083|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
131804439|NCT02178722|474568529|FG000|Overall Study|Withdrawal by Subject|0|||
131804440|NCT02178722|474568530|FG001|Overall Study|Withdrawal by Subject|0|||
131782084|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
131782085|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
131782086|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
131782087|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
131782088|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
131782089|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
131782090|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
131782091|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
131782092|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
131782093|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
131782094|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
131564471|NCT03259373|473689598|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
131564472|NCT03259373|473689597|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
131564473|NCT03259373|473689598|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
131564474|NCT03259373|473689597|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
131696861|NCT03691974|474173960|FG000|Overall Study|Adverse Event|1|||
131696862|NCT03691974|474173961|FG001|Overall Study|Adverse Event|0|||
131696863|NCT03691974|474173960|FG000|Overall Study|Withdrawal by Subject|11|||
131696864|NCT03691974|474173961|FG001|Overall Study|Withdrawal by Subject|9|||
131696865|NCT03691974|474173960|FG000|Overall Study|Protocol Violation|1|||
131696866|NCT03691974|474173961|FG001|Overall Study|Protocol Violation|0|||
131696867|NCT03691974|474173960|FG000|Overall Study|Lost to Follow-up|8|||
131696868|NCT03691974|474173961|FG001|Overall Study|Lost to Follow-up|7|||
131696869|NCT01391000|474173962|FG000|Overall Study|Lost to Follow-up|2|||
131696870|NCT01391000|474173963|FG001|Overall Study|Lost to Follow-up|0|||
131696871|NCT00883337|474173968|FG000|Core Treatment Period|Adverse Event|9|||
131696872|NCT00883337|474173969|FG001|Core Treatment Period|Adverse Event|12|||
131696873|NCT00883337|474173970|FG002|Core Treatment Period|Adverse Event|22|||
131696874|NCT00883337|474173968|FG000|Core Treatment Period|Lack of Efficacy|7|||
131696875|NCT00883337|474173969|FG001|Core Treatment Period|Lack of Efficacy|4|||
131696876|NCT00883337|474173970|FG002|Core Treatment Period|Lack of Efficacy|2|||
131696877|NCT00883337|474173968|FG000|Core Treatment Period|Lost to Follow-up|1|||
131696878|NCT00883337|474173969|FG001|Core Treatment Period|Lost to Follow-up|1|||
131696879|NCT00883337|474173970|FG002|Core Treatment Period|Lost to Follow-up|0|||
131696880|NCT00883337|474173968|FG000|Core Treatment Period|Withdrawal by Subject|2|||
131696881|NCT00883337|474173969|FG001|Core Treatment Period|Withdrawal by Subject|2|||
131696882|NCT00883337|474173970|FG002|Core Treatment Period|Withdrawal by Subject|6|||
131696883|NCT00883337|474173968|FG000|Core Treatment Period|Wish to be pregnant|1|||
131696884|NCT00883337|474173969|FG001|Core Treatment Period|Wish to be pregnant|2|||
131696885|NCT00883337|474173970|FG002|Core Treatment Period|Wish to be pregnant|1|||
131898621|NCT02624947|474915307|FG000|Infant Participants|Investigator Decision|5|||
131898622|NCT02624947|474915308|FG001|Infant Participants|Investigator Decision|4|||
131898623|NCT02624947|474915307|FG000|Infant Participants|Lost to Follow-up|93|||
131898624|NCT02624947|474915308|FG001|Infant Participants|Lost to Follow-up|58|||
131898625|NCT02624947|474915307|FG000|Infant Participants|Non Compliance|17|||
131898626|NCT02624947|474915308|FG001|Infant Participants|Non Compliance|7|||
131898627|NCT02624947|474915307|FG000|Infant Participants|Sponsor Request|0|||
131898628|NCT02624947|474915308|FG001|Infant Participants|Sponsor Request|1|||
131898629|NCT02624947|474915307|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
131898630|NCT02624947|474915308|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
131898631|NCT02624947|474915307|FG000|Infant Participants|Miscellaneous|50|||
131696886|NCT00883337|474173968|FG000|Core Treatment Period|Poor compliance to protocol|0|||
131696887|NCT00883337|474173969|FG001|Core Treatment Period|Poor compliance to protocol|0|||
131696888|NCT00883337|474173970|FG002|Core Treatment Period|Poor compliance to protocol|1|||
131696889|NCT00883337|474173968|FG000|Core Treatment Period|Other than above|0|||
131696890|NCT00883337|474173969|FG001|Core Treatment Period|Other than above|1|||
131782095|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
131782096|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
131782097|NCT03747939|474484553|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
131782098|NCT03747939|474484554|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
131782099|NCT03747939|474484555|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
131782100|NCT03747939|474484556|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
131782101|NCT03747939|474484553|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
131782102|NCT03747939|474484554|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
131782103|NCT03747939|474484555|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
131782104|NCT03747939|474484556|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
131782105|NCT03747939|474484553|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
131782106|NCT03747939|474484554|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
131782107|NCT03747939|474484555|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
131782108|NCT03747939|474484556|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
131782109|NCT03747939|474484553|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
131898632|NCT02624947|474915308|FG001|Infant Participants|Miscellaneous|26|||
131782110|NCT03747939|474484554|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
131782111|NCT03747939|474484555|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
131782112|NCT03747939|474484556|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
131782113|NCT03747939|474484553|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
131782114|NCT03747939|474484554|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
131782115|NCT03747939|474484555|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
131782116|NCT03747939|474484556|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
131782117|NCT03747939|474484553|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
131782118|NCT03747939|474484554|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
131782119|NCT03747939|474484555|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
131782120|NCT03747939|474484556|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
131782121|NCT01215955|474484557|FG000|Overall Study|Adverse Event|1|||
131782122|NCT01215955|474484558|FG001|Overall Study|Adverse Event|4|||
131782123|NCT01215955|474484559|FG002|Overall Study|Adverse Event|2|||
131782124|NCT01215955|474484560|FG003|Overall Study|Adverse Event|3|||
131782125|NCT01215955|474484557|FG000|Overall Study|Death|2|||
131898633|NCT02250300|474915323|FG000|Expansion Phase|Death|6|||
131782126|NCT01215955|474484558|FG001|Overall Study|Death|0|||
131782127|NCT01215955|474484559|FG002|Overall Study|Death|1|||
131782128|NCT01215955|474484560|FG003|Overall Study|Death|3|||
131782129|NCT01215955|474484557|FG000|Overall Study|Entry Criteria Not Met|1|||
131782130|NCT01215955|474484558|FG001|Overall Study|Entry Criteria Not Met|3|||
131782131|NCT01215955|474484559|FG002|Overall Study|Entry Criteria Not Met|4|||
131782132|NCT01215955|474484560|FG003|Overall Study|Entry Criteria Not Met|7|||
131782133|NCT01215955|474484557|FG000|Overall Study|Lack of Efficacy|1|||
131782134|NCT01215955|474484558|FG001|Overall Study|Lack of Efficacy|2|||
131782135|NCT01215955|474484559|FG002|Overall Study|Lack of Efficacy|1|||
131782136|NCT01215955|474484560|FG003|Overall Study|Lack of Efficacy|0|||
131782137|NCT01215955|474484557|FG000|Overall Study|Lost to Follow-up|4|||
131782138|NCT01215955|474484558|FG001|Overall Study|Lost to Follow-up|4|||
131782139|NCT01215955|474484559|FG002|Overall Study|Lost to Follow-up|8|||
131782140|NCT01215955|474484560|FG003|Overall Study|Lost to Follow-up|9|||
131782141|NCT01215955|474484557|FG000|Overall Study|Physician Decision|4|||
131782142|NCT01215955|474484558|FG001|Overall Study|Physician Decision|10|||
131782143|NCT01215955|474484559|FG002|Overall Study|Physician Decision|8|||
131782144|NCT01215955|474484560|FG003|Overall Study|Physician Decision|11|||
131782145|NCT01215955|474484557|FG000|Overall Study|Protocol Violation|17|||
131782146|NCT01215955|474484558|FG001|Overall Study|Protocol Violation|13|||
131782147|NCT01215955|474484559|FG002|Overall Study|Protocol Violation|8|||
131782148|NCT01215955|474484560|FG003|Overall Study|Protocol Violation|8|||
131782149|NCT01215955|474484557|FG000|Overall Study|Sponsor Decision|1|||
131782150|NCT01215955|474484558|FG001|Overall Study|Sponsor Decision|2|||
131782151|NCT01215955|474484559|FG002|Overall Study|Sponsor Decision|0|||
131782152|NCT01215955|474484560|FG003|Overall Study|Sponsor Decision|1|||
131782153|NCT01215955|474484557|FG000|Overall Study|Withdrawal by Subject|14|||
131782154|NCT01215955|474484558|FG001|Overall Study|Withdrawal by Subject|15|||
131782155|NCT01215955|474484559|FG002|Overall Study|Withdrawal by Subject|13|||
131782156|NCT01215955|474484560|FG003|Overall Study|Withdrawal by Subject|9|||
131782157|NCT01215955|474484557|FG000|Overall Study|Quality Issues|0|||
131782158|NCT01215955|474484558|FG001|Overall Study|Quality Issues|0|||
131782159|NCT01215955|474484559|FG002|Overall Study|Quality Issues|3|||
131782160|NCT01215955|474484560|FG003|Overall Study|Quality Issues|2|||
131782161|NCT01523301|474484561|FG000|Overall Study|Adverse Event|25|||
131782162|NCT01523301|474484562|FG001|Overall Study|Adverse Event|16|||
131782163|NCT01523301|474484561|FG000|Overall Study|Lack of Efficacy|0|||
131782164|NCT01523301|474484562|FG001|Overall Study|Lack of Efficacy|2|||
131782165|NCT01523301|474484561|FG000|Overall Study|Protocol Violation|3|||
131782166|NCT01523301|474484562|FG001|Overall Study|Protocol Violation|4|||
131782167|NCT01523301|474484561|FG000|Overall Study|Lost to Follow-up|1|||
131782168|NCT01523301|474484562|FG001|Overall Study|Lost to Follow-up|0|||
131782169|NCT01523301|474484561|FG000|Overall Study|Withdrawal by Subject|6|||
131782170|NCT01523301|474484562|FG001|Overall Study|Withdrawal by Subject|8|||
131782171|NCT01523301|474484561|FG000|Overall Study|Other Reason|0|||
131782172|NCT01523301|474484562|FG001|Overall Study|Other Reason|2|||
131782173|NCT01447628|474484563|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
131782174|NCT01447628|474484564|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
131782175|NCT01447628|474484565|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
131436903|NCT02421172|473225650|FG004|Period 2|Adverse Event|0|||
131782176|NCT01447628|474484566|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
131782177|NCT03087773|474484567|FG000|Overall Study|Withdrawal by Subject|8|||
131782178|NCT03087773|474484568|FG001|Overall Study|Withdrawal by Subject|4|||
131782179|NCT03087773|474484567|FG000|Overall Study|Lost to Follow-up|12|||
131782180|NCT03087773|474484568|FG001|Overall Study|Lost to Follow-up|8|||
131782181|NCT00185731|474484569|FG000|Overall Study|Withdrawal by Subject|1|||
131782182|NCT00185731|474484569|FG000|Overall Study|Not Eligible|1|||
131436904|NCT02421172|473225646|FG000|Period 2|Lost to Follow-up|0|||
131782183|NCT01787188|474484572|FG000|Overall Study|Adverse Event|2|||
131436905|NCT02421172|473225647|FG001|Period 2|Lost to Follow-up|0|||
131436906|NCT02421172|473225648|FG002|Period 2|Lost to Follow-up|0|||
131436907|NCT02421172|473225649|FG003|Period 2|Lost to Follow-up|1|||
131436908|NCT02421172|473225650|FG004|Period 2|Lost to Follow-up|0|||
131436909|NCT02421172|473225646|FG000|Period 2|Patient/guardian decision|0|||
131436910|NCT02421172|473225647|FG001|Period 2|Patient/guardian decision|0|||
131436911|NCT02421172|473225648|FG002|Period 2|Patient/guardian decision|3|||
131436912|NCT02421172|473225649|FG003|Period 2|Patient/guardian decision|2|||
131436913|NCT02421172|473225650|FG004|Period 2|Patient/guardian decision|1|||
131436914|NCT00928486|473225651|FG000|Overall Study|Adverse Event|2|||
131436915|NCT00928486|473225651|FG000|Overall Study|Disease Progression|7|||
131436916|NCT00928486|473225651|FG000|Overall Study|Withdrawal by Subject|1|||
131436917|NCT00683878|473225654|FG000|Overall Study|Lack of Efficacy|3|||
131782184|NCT01787188|474484573|FG001|Overall Study|Adverse Event|4|||
131782185|NCT01787188|474484574|FG002|Overall Study|Adverse Event|6|||
131436918|NCT00683878|473225655|FG001|Overall Study|Lack of Efficacy|0|||
131436919|NCT00683878|473225656|FG002|Overall Study|Lack of Efficacy|1|||
131436920|NCT00683878|473225654|FG000|Overall Study|Adverse Event|4|||
131436921|NCT00683878|473225655|FG001|Overall Study|Adverse Event|3|||
131782186|NCT01787188|474484572|FG000|Overall Study|Lack of Efficacy|7|||
131782187|NCT01787188|474484573|FG001|Overall Study|Lack of Efficacy|3|||
131782188|NCT01787188|474484574|FG002|Overall Study|Lack of Efficacy|5|||
131653538|NCT02942004|474018398|FG000|Overall Study|Withdrawal by Subject|0|||
131782189|NCT01787188|474484572|FG000|Overall Study|Non-compliance with Study Drug|0|||
131782190|NCT01787188|474484573|FG001|Overall Study|Non-compliance with Study Drug|1|||
131782191|NCT01787188|474484574|FG002|Overall Study|Non-compliance with Study Drug|0|||
131782192|NCT01787188|474484572|FG000|Overall Study|Withdrawal by Subject|4|||
131782193|NCT01787188|474484573|FG001|Overall Study|Withdrawal by Subject|3|||
131782194|NCT01787188|474484574|FG002|Overall Study|Withdrawal by Subject|2|||
131782195|NCT01787188|474484572|FG000|Overall Study|Protocol Violation|3|||
131782196|NCT01787188|474484573|FG001|Overall Study|Protocol Violation|2|||
131782197|NCT01787188|474484574|FG002|Overall Study|Protocol Violation|3|||
131782198|NCT01787188|474484572|FG000|Overall Study|Lost to Follow-up|1|||
131782199|NCT01787188|474484573|FG001|Overall Study|Lost to Follow-up|2|||
131782200|NCT01787188|474484574|FG002|Overall Study|Lost to Follow-up|2|||
131782201|NCT01787188|474484572|FG000|Overall Study|Other, including patient moved|0|||
131782202|NCT01787188|474484573|FG001|Overall Study|Other, including patient moved|3|||
131782203|NCT01787188|474484574|FG002|Overall Study|Other, including patient moved|0|||
131782204|NCT02756078|474484577|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
131782205|NCT02756078|474484578|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
131782206|NCT02756078|474484577|FG000|Period 1|Lost to Follow-up|0|||
131782207|NCT02756078|474484578|FG001|Period 1|Lost to Follow-up|2|||
131782208|NCT02756078|474484577|FG000|Period 1|Protocol Violation|0|||
131782209|NCT02756078|474484578|FG001|Period 1|Protocol Violation|1|||
131782210|NCT02756078|474484577|FG000|Period 1|Adverse Event|1|||
131782211|NCT02756078|474484578|FG001|Period 1|Adverse Event|10|||
131782212|NCT02756078|474484577|FG000|Period 1|Withdrawal by Subject|6|||
131782213|NCT02756078|474484578|FG001|Period 1|Withdrawal by Subject|6|||
131782214|NCT02756078|474484577|FG000|Period 1|Lens Discomfort|2|||
131782215|NCT02756078|474484578|FG001|Period 1|Lens Discomfort|2|||
131782216|NCT02756078|474484577|FG000|Period 2|Adverse Event|3|||
131782217|NCT02756078|474484578|FG001|Period 2|Adverse Event|5|||
131782218|NCT02756078|474484577|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
131782219|NCT02756078|474484578|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
131782220|NCT02756078|474484577|FG000|Period 2|Withdrawal by Subject|3|||
131782221|NCT02756078|474484578|FG001|Period 2|Withdrawal by Subject|1|||
131782222|NCT05349188|474484579|FG000|Overall Study|Withdrawal by Subject|1|||
131782223|NCT05349188|474484580|FG001|Overall Study|Withdrawal by Subject|0|||
131782224|NCT00835068|474484583|FG000|Overall Study|Death|1|||
131782225|NCT00835068|474484584|FG001|Overall Study|Death|0|||
131782226|NCT00835068|474484583|FG000|Overall Study|Adverse Event|0|||
131782227|NCT00835068|474484584|FG001|Overall Study|Adverse Event|1|||
131782228|NCT00835068|474484583|FG000|Overall Study|Other|8|||
131782229|NCT00835068|474484584|FG001|Overall Study|Other|0|||
131782230|NCT00835068|474484583|FG000|Overall Study|Withdrawal by Subject|1|||
131782231|NCT00835068|474484584|FG001|Overall Study|Withdrawal by Subject|0|||
131782232|NCT02575807|474484585|FG000|Overall Study|Death|8|||
131782233|NCT02575807|474484586|FG001|Overall Study|Death|3|||
131782234|NCT02575807|474484587|FG002|Overall Study|Death|7|||
131782235|NCT02575807|474484588|FG003|Overall Study|Death|0|||
131782236|NCT02575807|474484589|FG004|Overall Study|Death|1|||
131782237|NCT02575807|474484585|FG000|Overall Study|Study terminated by Sponsor|0|||
131782238|NCT02575807|474484586|FG001|Overall Study|Study terminated by Sponsor|1|||
131782239|NCT02575807|474484587|FG002|Overall Study|Study terminated by Sponsor|7|||
131782240|NCT02575807|474484588|FG003|Overall Study|Study terminated by Sponsor|0|||
131782241|NCT02575807|474484589|FG004|Overall Study|Study terminated by Sponsor|1|||
131782242|NCT02575807|474484585|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
131782243|NCT02575807|474484586|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
131782244|NCT02575807|474484587|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
131782245|NCT02575807|474484588|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
131782246|NCT02575807|474484589|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
131782247|NCT02575807|474484585|FG000|Overall Study|Terminated due to physician decision|0|||
131782248|NCT02575807|474484586|FG001|Overall Study|Terminated due to physician decision|0|||
131782249|NCT02575807|474484587|FG002|Overall Study|Terminated due to physician decision|1|||
131782250|NCT02575807|474484588|FG003|Overall Study|Terminated due to physician decision|0|||
131782251|NCT02575807|474484589|FG004|Overall Study|Terminated due to physician decision|0|||
131782252|NCT02575807|474484585|FG000|Overall Study|Subject ineligible - medical implant|0|||
131782253|NCT02575807|474484586|FG001|Overall Study|Subject ineligible - medical implant|0|||
131782254|NCT02575807|474484587|FG002|Overall Study|Subject ineligible - medical implant|0|||
131782255|NCT02575807|474484588|FG003|Overall Study|Subject ineligible - medical implant|1|||
131782256|NCT02575807|474484589|FG004|Overall Study|Subject ineligible - medical implant|0|||
131782257|NCT02575807|474484585|FG000|Overall Study|Withdrawal by Subject|0|||
131782258|NCT02575807|474484586|FG001|Overall Study|Withdrawal by Subject|0|||
131782259|NCT02575807|474484587|FG002|Overall Study|Withdrawal by Subject|1|||
131782260|NCT02575807|474484588|FG003|Overall Study|Withdrawal by Subject|1|||
131782261|NCT02575807|474484589|FG004|Overall Study|Withdrawal by Subject|2|||
131782262|NCT02180659|474484590|FG000|Overall Study|Adverse Event|1|||
131782263|NCT02180659|474484591|FG001|Overall Study|Adverse Event|0|||
131782264|NCT02180659|474484590|FG000|Overall Study|Lost to Follow-up|4|||
131782265|NCT02180659|474484591|FG001|Overall Study|Lost to Follow-up|2|||
131782266|NCT02180659|474484590|FG000|Overall Study|Subject incarcerated during conduct|1|||
131782267|NCT02180659|474484591|FG001|Overall Study|Subject incarcerated during conduct|0|||
131782268|NCT02180659|474484590|FG000|Overall Study|Withdrawal by Subject|0|||
131782269|NCT02180659|474484591|FG001|Overall Study|Withdrawal by Subject|2|||
131782270|NCT02180659|474484590|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
131782271|NCT02180659|474484591|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
131782272|NCT01495793|474484592|FG000|Overall Study|Lost to Follow-up|1|||
131782273|NCT01495793|474484592|FG000|Overall Study|Violation of inclusion criteria|1|||
131782274|NCT03014570|474484595|FG000|Overall Study|COVID-19 Restrictions|38|||
131782275|NCT03014570|474484596|FG001|Overall Study|COVID-19 Restrictions|24|||
131782276|NCT03014570|474484595|FG000|Overall Study|Death|70|||
131782277|NCT03014570|474484596|FG001|Overall Study|Death|79|||
131782278|NCT03014570|474484595|FG000|Overall Study|Transfer from facility|11|||
131782279|NCT03014570|474484596|FG001|Overall Study|Transfer from facility|14|||
131782280|NCT03014570|474484595|FG000|Overall Study|Hospitalized|5|||
131782281|NCT03014570|474484596|FG001|Overall Study|Hospitalized|3|||
131782282|NCT03014570|474484595|FG000|Overall Study|Transfer within facility|1|||
131782283|NCT03014570|474484596|FG001|Overall Study|Transfer within facility|0|||
131782284|NCT03014570|474484595|FG000|Overall Study|Site refusal|0|||
131782285|NCT03014570|474484596|FG001|Overall Study|Site refusal|11|||
131782286|NCT00478673|474484602|FG000|30-Days Post-Procedure|Death|2|||
131782287|NCT00478673|474484602|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
131782288|NCT00478673|474484602|FG000|30-Days Post-Procedure|Missed Visit|7|||
131782289|NCT00478673|474484602|FG000|12-Months Post-Procedure|Death|23|||
131782290|NCT00478673|474484602|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
131782291|NCT00478673|474484602|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
131782292|NCT00478673|474484602|FG000|12-Months Post-Procedure|Missed Visit|25|||
131782293|NCT00478673|474484602|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
131782294|NCT03332212|474484603|FG000|Overall Study|Not treated|0|||
131782295|NCT03332212|474484604|FG001|Overall Study|Not treated|1|||
131782296|NCT03332212|474484605|FG002|Overall Study|Not treated|0|||
131782297|NCT03332212|474484606|FG003|Overall Study|Not treated|0|||
131782298|NCT03332212|474484603|FG000|Overall Study|Adverse Event|0|||
131782299|NCT03332212|474484604|FG001|Overall Study|Adverse Event|0|||
131782300|NCT03332212|474484605|FG002|Overall Study|Adverse Event|0|||
131782301|NCT03332212|474484606|FG003|Overall Study|Adverse Event|1|||
131782302|NCT03332212|474484603|FG000|Overall Study|worsening of disease under study|1|||
131782303|NCT03332212|474484604|FG001|Overall Study|worsening of disease under study|1|||
131782304|NCT03332212|474484605|FG002|Overall Study|worsening of disease under study|0|||
131782305|NCT03332212|474484606|FG003|Overall Study|worsening of disease under study|0|||
131782306|NCT02125734|474484610|FG000|Period 2|Adverse Event|0|||
131782307|NCT02125734|474484611|FG001|Period 2|Adverse Event|1|||
131782308|NCT01308762|474484612|FG000|Overall Study|Protocol Violation|0|||
131782309|NCT01308762|474484613|FG001|Overall Study|Protocol Violation|1|||
131782310|NCT01308762|474484614|FG002|Overall Study|Protocol Violation|0|||
131782311|NCT02392559|474484618|FG000|Overall Study|Withdrawal by Subject|0|||
131782312|NCT02392559|474484619|FG001|Overall Study|Withdrawal by Subject|1|||
131782313|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782314|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782315|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782316|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131782317|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131782318|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782319|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782320|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782321|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782322|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131782323|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782324|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782325|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131782326|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
131782327|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131782328|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
131782329|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
131782330|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
131782331|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131782332|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782333|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782334|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782335|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782336|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782337|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
131782338|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782339|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782340|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782341|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131782342|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782343|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782344|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782345|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
131782346|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131782347|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
131782348|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131782349|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131782350|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131782351|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
131782352|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782353|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131564475|NCT03259373|473689598|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
131436922|NCT00683878|473225656|FG002|Overall Study|Adverse Event|3|||
131436923|NCT00683878|473225654|FG000|Overall Study|Withdrawal by Subject|9|||
131436924|NCT00683878|473225655|FG001|Overall Study|Withdrawal by Subject|8|||
131436925|NCT00683878|473225656|FG002|Overall Study|Withdrawal by Subject|6|||
131436926|NCT00683878|473225654|FG000|Overall Study|Death|0|||
131436927|NCT00683878|473225655|FG001|Overall Study|Death|1|||
131436928|NCT00683878|473225656|FG002|Overall Study|Death|0|||
131436929|NCT00683878|473225654|FG000|Overall Study|Lost to Follow-up|4|||
131436930|NCT00683878|473225655|FG001|Overall Study|Lost to Follow-up|2|||
131436931|NCT00683878|473225656|FG002|Overall Study|Lost to Follow-up|4|||
131436932|NCT00683878|473225654|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
131436933|NCT00683878|473225655|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
131436934|NCT00683878|473225656|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
131436935|NCT02869633|473225657|FG000|Overall Study|Death|2|||
131436936|NCT02869633|473225658|FG001|Overall Study|Death|1|||
131436937|NCT02869633|473225657|FG000|Overall Study|Patient refused follow-up|1|||
131436938|NCT02869633|473225658|FG001|Overall Study|Patient refused follow-up|0|||
131436939|NCT02869633|473225657|FG000|Overall Study|Provider discretion|1|||
131436940|NCT02869633|473225658|FG001|Overall Study|Provider discretion|0|||
131436941|NCT02869633|473225657|FG000|Overall Study|Investigator decision|1|||
131436942|NCT02869633|473225658|FG001|Overall Study|Investigator decision|0|||
131436943|NCT02869633|473225657|FG000|Overall Study|Lost to Follow-up|0|||
131436944|NCT02869633|473225658|FG001|Overall Study|Lost to Follow-up|1|||
131436945|NCT02869633|473225657|FG000|Overall Study|Not eligible|6|||
131436946|NCT02869633|473225658|FG001|Overall Study|Not eligible|1|||
131436947|NCT02869633|473225657|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
131436948|NCT02869633|473225658|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
131436949|NCT02869633|473225657|FG000|Overall Study|Withdrawal by Subject|0|||
131436950|NCT02869633|473225658|FG001|Overall Study|Withdrawal by Subject|1|||
131436951|NCT01381016|473225659|FG000|Overall Study|Lost to Follow-up|1|||
131436952|NCT01381016|473225660|FG001|Overall Study|Lost to Follow-up|1|||
131436953|NCT01381016|473225659|FG000|Overall Study|Screen Failure|2|||
131436954|NCT01381016|473225660|FG001|Overall Study|Screen Failure|2|||
131436955|NCT01381016|473225659|FG000|Overall Study|Withdrawal by Subject|0|||
131564476|NCT03259373|473689597|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
131564477|NCT03259373|473689598|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
131653539|NCT02942004|474018399|FG001|Overall Study|Withdrawal by Subject|2|||
131782354|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782355|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782356|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
131782357|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782358|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782359|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782360|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782361|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782362|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782363|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782364|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782365|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
131782366|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782367|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782368|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
131782369|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131782370|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782371|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782372|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782373|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782374|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782375|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782376|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782377|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782378|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782379|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782380|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131782381|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782382|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131564478|NCT03259373|473689597|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
131782383|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131782384|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782385|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782386|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131782387|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131782388|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131782389|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131782390|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
131782391|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782392|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131782393|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782394|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782395|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131782396|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782397|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782398|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782399|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131782400|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782401|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131782402|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
131782403|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
131782404|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
131782405|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
131782406|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
131782407|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131782408|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782409|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782410|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
131782411|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782412|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782413|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782414|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782415|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782416|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782417|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782418|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782419|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782420|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131564479|NCT03259373|473689598|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
131564480|NCT03259373|473689597|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
131782421|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782422|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782423|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131782424|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
131782425|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
131782426|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131782427|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782428|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782429|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782430|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131898634|NCT02250300|474915324|FG001|Expansion Phase|Death|7|||
131564481|NCT03259373|473689598|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
131564482|NCT01923428|473689601|FG000|Overall Study|Adverse Event|8|||
131564483|NCT01923428|473689602|FG001|Overall Study|Adverse Event|6|||
131564484|NCT01923428|473689603|FG002|Overall Study|Adverse Event|3|||
131564485|NCT01923428|473689604|FG003|Overall Study|Adverse Event|3|||
131564486|NCT01923428|473689601|FG000|Overall Study|Withdrawal by Subject|5|||
131564487|NCT01923428|473689602|FG001|Overall Study|Withdrawal by Subject|3|||
131782431|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
131782432|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782433|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782434|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782435|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782436|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
131782437|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782438|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782439|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782440|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782441|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782442|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782443|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782444|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782445|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131782446|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
131782447|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131782448|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131782449|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131782450|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131782451|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
131782452|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131782453|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131782454|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131564488|NCT01923428|473689603|FG002|Overall Study|Withdrawal by Subject|0|||
131564489|NCT01923428|473689604|FG003|Overall Study|Withdrawal by Subject|4|||
131564490|NCT01923428|473689601|FG000|Overall Study|Lost to Follow-up|2|||
131564491|NCT01923428|473689602|FG001|Overall Study|Lost to Follow-up|1|||
131782455|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131782456|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
131564492|NCT01923428|473689603|FG002|Overall Study|Lost to Follow-up|5|||
131564493|NCT01923428|473689604|FG003|Overall Study|Lost to Follow-up|0|||
131436956|NCT01381016|473225660|FG001|Overall Study|Withdrawal by Subject|1|||
131436957|NCT01381016|473225659|FG000|Overall Study|Physician Decision|0|||
131436958|NCT01381016|473225660|FG001|Overall Study|Physician Decision|2|||
131436959|NCT04319198|473225661|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
131436960|NCT04319198|473225662|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
131436961|NCT04319198|473225663|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
131436962|NCT04319198|473225661|FG000|Overall Study|Death|0|||
131436963|NCT04319198|473225662|FG001|Overall Study|Death|3|||
131436964|NCT04319198|473225663|FG002|Overall Study|Death|3|||
131436965|NCT04319198|473225661|FG000|Overall Study|Reason Not Specified|0|||
131436966|NCT04319198|473225662|FG001|Overall Study|Reason Not Specified|2|||
131436967|NCT04319198|473225663|FG002|Overall Study|Reason Not Specified|4|||
131436968|NCT04319198|473225661|FG000|Overall Study|Withdrawal of Consent|0|||
131436969|NCT04319198|473225662|FG001|Overall Study|Withdrawal of Consent|0|||
131436970|NCT04319198|473225663|FG002|Overall Study|Withdrawal of Consent|5|||
131436971|NCT04319198|473225661|FG000|Overall Study|Site Terminated by Sponsor|0|||
131436972|NCT04319198|473225662|FG001|Overall Study|Site Terminated by Sponsor|1|||
131436973|NCT04319198|473225663|FG002|Overall Study|Site Terminated by Sponsor|0|||
131436974|NCT01329263|473225664|FG000|Overall Study|Lost to Follow-up|4|||
131436975|NCT01329263|473225665|FG001|Overall Study|Lost to Follow-up|21|||
131436976|NCT01329263|473225664|FG000|Overall Study|Withdrawal by Subject|1|||
131436977|NCT01329263|473225665|FG001|Overall Study|Withdrawal by Subject|2|||
131436978|NCT01421017|473225666|FG000|Overall Study|Withdrawal by Subject|2|||
131436979|NCT01421017|473225667|FG001|Overall Study|Withdrawal by Subject|0|||
131436980|NCT01421017|473225668|FG002|Overall Study|Withdrawal by Subject|0|||
131436981|NCT01421017|473225666|FG000|Overall Study|POD|0|||
131436982|NCT01421017|473225667|FG001|Overall Study|POD|6|||
131436983|NCT01421017|473225668|FG002|Overall Study|POD|3|||
131436984|NCT02313766|473225671|FG000|Overall Study|surgery cancelled|1|||
131436985|NCT02313766|473225672|FG001|Overall Study|surgery cancelled|0|||
131436986|NCT02313766|473225673|FG002|Overall Study|surgery cancelled|0|||
131436987|NCT02313766|473225671|FG000|Overall Study|Lost to Follow-up|0|||
131436988|NCT02313766|473225672|FG001|Overall Study|Lost to Follow-up|2|||
131436989|NCT02313766|473225673|FG002|Overall Study|Lost to Follow-up|0|||
131436990|NCT02313766|473225671|FG000|Overall Study|Adverse Event|0|||
131436991|NCT02313766|473225672|FG001|Overall Study|Adverse Event|1|||
131436992|NCT02313766|473225673|FG002|Overall Study|Adverse Event|0|||
131436993|NCT02193776|473225674|FG000|Overall Study|Consent withdrawn|1|||
131436994|NCT02193776|473225675|FG001|Overall Study|Consent withdrawn|0|||
131436995|NCT02193776|473225676|FG002|Overall Study|Consent withdrawn|0|||
131436996|NCT02193776|473225677|FG003|Overall Study|Consent withdrawn|0|||
131436997|NCT02193776|473225674|FG000|Overall Study|Failure to comply with protocol|0|||
131436998|NCT02193776|473225675|FG001|Overall Study|Failure to comply with protocol|1|||
131436999|NCT02193776|473225676|FG002|Overall Study|Failure to comply with protocol|0|||
131437000|NCT02193776|473225677|FG003|Overall Study|Failure to comply with protocol|0|||
131437001|NCT02193776|473225674|FG000|Overall Study|Investigator/Sponsor decision|1|||
131437002|NCT02193776|473225675|FG001|Overall Study|Investigator/Sponsor decision|1|||
131437003|NCT02193776|473225676|FG002|Overall Study|Investigator/Sponsor decision|0|||
131437004|NCT02193776|473225677|FG003|Overall Study|Investigator/Sponsor decision|0|||
131437005|NCT02193776|473225674|FG000|Overall Study|Death|1|||
131437006|NCT02193776|473225675|FG001|Overall Study|Death|0|||
131437007|NCT02193776|473225676|FG002|Overall Study|Death|0|||
131437008|NCT02193776|473225677|FG003|Overall Study|Death|0|||
131437009|NCT02193776|473225674|FG000|Overall Study|Adverse event/Specific toxicity|5|||
131437010|NCT02193776|473225675|FG001|Overall Study|Adverse event/Specific toxicity|5|||
131437011|NCT02193776|473225676|FG002|Overall Study|Adverse event/Specific toxicity|2|||
131437012|NCT02193776|473225677|FG003|Overall Study|Adverse event/Specific toxicity|2|||
131437013|NCT00962208|473225679|FG000|Overall Study|Could not achieve good vision|9|||
131437014|NCT00962208|473225680|FG001|Overall Study|Could not achieve good vision|0|||
131437015|NCT00962208|473225679|FG000|Overall Study|Contraindicated to continue study|5|||
131437016|NCT00962208|473225680|FG001|Overall Study|Contraindicated to continue study|1|||
131437017|NCT00962208|473225679|FG000|Overall Study|Lost to Follow-up|0|||
131564494|NCT01923428|473689601|FG000|Overall Study|Protocol Violation|3|||
131437018|NCT00962208|473225680|FG001|Overall Study|Lost to Follow-up|9|||
131437019|NCT00791388|473225681|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
131437020|NCT00791388|473225682|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
131437021|NCT00791388|473225683|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
131437022|NCT00791388|473225684|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
131437023|NCT00791388|473225685|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
131437024|NCT00791388|473225681|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
131437025|NCT00791388|473225682|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
131437026|NCT00791388|473225683|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
131564495|NCT01923428|473689602|FG001|Overall Study|Protocol Violation|0|||
131564496|NCT01923428|473689603|FG002|Overall Study|Protocol Violation|2|||
131782457|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131782458|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131782459|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
131782460|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131782461|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
131782462|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
131782463|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
131782464|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131782465|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782466|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782467|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782468|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782469|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782470|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782471|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782472|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782473|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782474|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782475|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
131782476|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782477|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782478|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782479|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782480|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782481|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782482|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782483|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131782484|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131782485|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131782486|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782487|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782488|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131782489|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131782490|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782491|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
131782492|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782493|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131782494|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782495|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782496|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131782497|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
131782498|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131782499|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
131782500|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131782501|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
131782502|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131782503|NCT01915498|474484623|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
131782504|NCT01915498|474484624|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131782505|NCT01915498|474484625|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131782506|NCT01915498|474484626|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
131782507|NCT01915498|474484627|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
131782508|NCT01915498|474484628|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
131782509|NCT01915498|474484629|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
131782510|NCT01915498|474484630|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
131782511|NCT01915498|474484631|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
131782512|NCT01915498|474484632|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
131782513|NCT01915498|474484633|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131782514|NCT01915498|474484634|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
131782515|NCT01915498|474484635|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131782516|NCT01915498|474484636|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
131782517|NCT01915498|474484637|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
131782518|NCT01915498|474484638|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
131782519|NCT01915498|474484639|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
131782520|NCT01915498|474484640|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
131782521|NCT01915498|474484641|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
131782522|NCT01915498|474484623|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782523|NCT01915498|474484624|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782524|NCT01915498|474484625|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782525|NCT01915498|474484626|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782526|NCT01915498|474484627|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782527|NCT01915498|474484628|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782528|NCT01915498|474484629|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782529|NCT01915498|474484630|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782530|NCT01915498|474484631|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782531|NCT01915498|474484632|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782532|NCT01915498|474484633|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782533|NCT01915498|474484634|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131564497|NCT01923428|473689604|FG003|Overall Study|Protocol Violation|1|||
131564498|NCT01923428|473689601|FG000|Overall Study|Non Compliance to treatment|1|||
131564499|NCT01923428|473689602|FG001|Overall Study|Non Compliance to treatment|2|||
131564500|NCT01923428|473689603|FG002|Overall Study|Non Compliance to treatment|0|||
131564501|NCT01923428|473689604|FG003|Overall Study|Non Compliance to treatment|1|||
131782534|NCT01915498|474484635|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782535|NCT01915498|474484636|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131564502|NCT01923428|473689601|FG000|Overall Study|Lack of Efficacy|0|||
131564503|NCT01923428|473689602|FG001|Overall Study|Lack of Efficacy|0|||
131564504|NCT01923428|473689603|FG002|Overall Study|Lack of Efficacy|1|||
131564505|NCT01923428|473689604|FG003|Overall Study|Lack of Efficacy|1|||
131564506|NCT01822353|473689605|FG000|Overall Study|Adverse Event|1|||
131564507|NCT01822353|473689606|FG001|Overall Study|Adverse Event|3|||
131564508|NCT01822353|473689607|FG002|Overall Study|Adverse Event|1|||
131564509|NCT01822353|473689605|FG000|Overall Study|Pregnancy|0|||
131437027|NCT00791388|473225684|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
131437028|NCT00791388|473225685|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
131437029|NCT00791388|473225681|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
131437030|NCT00791388|473225682|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
131437031|NCT00791388|473225683|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
131437032|NCT00791388|473225684|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
131437033|NCT00791388|473225685|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
131437034|NCT06039579|473225686|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437035|NCT06039579|473225687|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437036|NCT06039579|473225688|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437037|NCT06039579|473225689|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437038|NCT06039579|473225690|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437039|NCT06039579|473225691|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437040|NCT06039579|473225692|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
131437041|NCT06039579|473225693|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
131437042|NCT04073186|473225694|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
131437043|NCT04073186|473225694|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
131437044|NCT04073186|473225694|FG000|First Wearing Cycle|Protocol Violation|1|||
131437045|NCT04073186|473225694|FG000|First Wearing Cycle|Lens Discomfort|2|||
131437046|NCT04073186|473225694|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
131437047|NCT04073186|473225694|FG000|Second Wearing Cycle|Adverse Event|1|||
131437048|NCT00473434|473225695|FG000|Overall Study|Physician Decision|3|||
131437049|NCT00473434|473225695|FG000|Overall Study|Withdrawal by Subject|9|||
131437050|NCT00473434|473225695|FG000|Overall Study|Compliance|3|||
131437051|NCT00473434|473225695|FG000|Overall Study|Lack of Efficacy|3|||
131437052|NCT00473434|473225695|FG000|Overall Study|Adverse Event|3|||
131437053|NCT00473434|473225695|FG000|Overall Study|Patient was selling medication to others|1|||
131437054|NCT00473434|473225695|FG000|Overall Study|Safety evaluation|1|||
131437055|NCT00473434|473225695|FG000|Overall Study|Reason not specified|6|||
131437056|NCT00473434|473225695|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
131437057|NCT00473434|473225695|FG000|Overall Study|Switching to trial medication|1|||
131437058|NCT00473434|473225695|FG000|Overall Study|No longer required|1|||
131437059|NCT02356159|473225698|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
131437060|NCT02356159|473225699|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
131437061|NCT02356159|473225700|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
131437062|NCT02356159|473225701|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
131437063|NCT02356159|473225702|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
131437064|NCT02356159|473225703|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
131437065|NCT00667628|473225704|FG000|Overall Study|Lost to Follow-up|1|||
131437066|NCT00667628|473225705|FG001|Overall Study|Lost to Follow-up|0|||
131437067|NCT00667628|473225704|FG000|Overall Study|Death|6|||
131437068|NCT00667628|473225705|FG001|Overall Study|Death|6|||
131437069|NCT00667628|473225704|FG000|Overall Study|Investigator Considers in Best Interest|1|||
131437070|NCT00667628|473225705|FG001|Overall Study|Investigator Considers in Best Interest|0|||
131564510|NCT01822353|473689606|FG001|Overall Study|Pregnancy|1|||
131564511|NCT01822353|473689607|FG002|Overall Study|Pregnancy|0|||
131437071|NCT00667628|473225704|FG000|Overall Study|Sponsor Terminated Study|17|||
131437072|NCT00667628|473225705|FG001|Overall Study|Sponsor Terminated Study|21|||
131437073|NCT00743249|473225708|FG000|Overall Study|Adverse Event|0|||
131564512|NCT01822353|473689605|FG000|Overall Study|Withdrawal by Subject|3|||
131564513|NCT01822353|473689606|FG001|Overall Study|Withdrawal by Subject|1|||
131564514|NCT01822353|473689607|FG002|Overall Study|Withdrawal by Subject|0|||
131782536|NCT01915498|474484637|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782537|NCT01915498|474484638|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782538|NCT01915498|474484639|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782539|NCT01915498|474484640|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131782540|NCT01915498|474484641|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
131782541|NCT01915498|474484623|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782542|NCT01915498|474484624|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782543|NCT01915498|474484625|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782544|NCT01915498|474484626|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782545|NCT01915498|474484627|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782546|NCT01915498|474484628|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782547|NCT01915498|474484629|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782548|NCT01915498|474484630|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782549|NCT01915498|474484631|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782550|NCT01915498|474484632|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782551|NCT01915498|474484633|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782552|NCT01915498|474484634|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782553|NCT01915498|474484635|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782554|NCT01915498|474484636|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782555|NCT01915498|474484637|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782556|NCT01915498|474484638|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782557|NCT01915498|474484639|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782558|NCT01915498|474484640|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131782559|NCT01915498|474484641|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
131782560|NCT01915498|474484623|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782561|NCT01915498|474484624|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782562|NCT01915498|474484625|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782563|NCT01915498|474484626|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782564|NCT01915498|474484627|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782565|NCT01915498|474484628|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782566|NCT01915498|474484629|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782567|NCT01915498|474484630|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782568|NCT01915498|474484631|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782569|NCT01915498|474484632|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782570|NCT01915498|474484633|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782571|NCT01915498|474484634|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782572|NCT01915498|474484635|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782573|NCT01915498|474484636|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782574|NCT01915498|474484637|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782575|NCT01915498|474484638|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782576|NCT01915498|474484639|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782577|NCT01915498|474484640|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131782578|NCT01915498|474484641|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
131782579|NCT01907516|474484642|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
131782580|NCT01907516|474484643|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
131782581|NCT01907516|474484642|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
131782582|NCT01907516|474484643|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
131782583|NCT01907516|474484642|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
131782584|NCT01907516|474484643|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
131782585|NCT01907516|474484642|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
131782586|NCT01907516|474484643|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
131782587|NCT02395536|474484647|FG000|Overall Study|Lost to Follow-up|4|||
131782588|NCT02395536|474484648|FG001|Overall Study|Lost to Follow-up|4|||
131782589|NCT02395536|474484647|FG000|Overall Study|Death|2|||
131782590|NCT02395536|474484648|FG001|Overall Study|Death|0|||
131782591|NCT02395536|474484647|FG000|Overall Study|Physician Decision|4|||
131782592|NCT02395536|474484648|FG001|Overall Study|Physician Decision|6|||
131782593|NCT02395536|474484647|FG000|Overall Study|Withdrawal by Subject|9|||
131782594|NCT02395536|474484648|FG001|Overall Study|Withdrawal by Subject|17|||
131564515|NCT02550873|473689608|FG000|Randomized Double Blind|Adverse Event|3|||
131782595|NCT02395536|474484647|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
131782596|NCT02395536|474484648|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
131782597|NCT02395536|474484647|FG000|Overall Study|Insurance issue|0|||
131782598|NCT02395536|474484648|FG001|Overall Study|Insurance issue|1|||
131782599|NCT03044431|474486073|FG000|Overall Study|Lost to Follow-up|59|||
131782600|NCT03456726|474486074|FG000|Overall Study|Disease Progression|6|||
131782601|NCT03456726|474486075|FG001|Overall Study|Disease Progression|1|||
131782602|NCT03456726|474486074|FG000|Overall Study|Adverse Event|4|||
131782603|NCT03456726|474486075|FG001|Overall Study|Adverse Event|2|||
131782604|NCT03456726|474486074|FG000|Overall Study|Withdrawal by Subject|1|||
131782605|NCT03456726|474486075|FG001|Overall Study|Withdrawal by Subject|0|||
131782606|NCT03456726|474486074|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
131782607|NCT03456726|474486075|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
131782608|NCT00399490|474486076|FG000|Overall Study|Adverse Event|19|||
131782609|NCT00399490|474486076|FG000|Overall Study|Lack of Efficacy|31|||
131782610|NCT00399490|474486076|FG000|Overall Study|Lost to Follow-up|5|||
131782611|NCT00399490|474486076|FG000|Overall Study|Withdrawal by Subject|18|||
131782612|NCT00399490|474486076|FG000|Overall Study|Other|25|||
131782613|NCT02328547|474486077|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
131782614|NCT02328547|474486078|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
131782615|NCT02328547|474486077|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
131782616|NCT02328547|474486078|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
131782617|NCT02576054|474486082|FG000|Overall Study|Withdrawal by Subject|1|||
131782618|NCT00344305|474486083|FG000|Overall Study|Lost to Follow-up|2|||
131782619|NCT00344305|474486084|FG001|Overall Study|Lost to Follow-up|0|||
131782620|NCT00344305|474486083|FG000|Overall Study|Participant was not contacted in window|0|||
131782621|NCT00344305|474486084|FG001|Overall Study|Participant was not contacted in window|1|||
131437074|NCT00743249|473225709|FG001|Overall Study|Adverse Event|4|||
131782622|NCT01190098|474486085|FG000|Overall Study|Adverse Event|2|||
131782623|NCT01190098|474486086|FG001|Overall Study|Adverse Event|0|||
131782624|NCT01190098|474486085|FG000|Overall Study|Patient coomorbidity|0|||
131782625|NCT01190098|474486086|FG001|Overall Study|Patient coomorbidity|1|||
131782626|NCT01190098|474486085|FG000|Overall Study|Lack of transportation|1|||
131782627|NCT01190098|474486086|FG001|Overall Study|Lack of transportation|0|||
131564516|NCT02550873|473689609|FG001|Randomized Double Blind|Adverse Event|1|||
131564517|NCT02550873|473689610|FG002|Randomized Double Blind|Adverse Event|0|||
131696891|NCT00883337|474173970|FG002|Core Treatment Period|Other than above|1|||
131696892|NCT00883337|474173968|FG000|Extension Treatment Period|Adverse Event|8|||
131696893|NCT00883337|474173969|FG001|Extension Treatment Period|Adverse Event|5|||
131696894|NCT00883337|474173970|FG002|Extension Treatment Period|Adverse Event|5|||
131696895|NCT00883337|474173968|FG000|Extension Treatment Period|Lack of Efficacy|8|||
131696896|NCT00883337|474173969|FG001|Extension Treatment Period|Lack of Efficacy|8|||
131696897|NCT00883337|474173970|FG002|Extension Treatment Period|Lack of Efficacy|8|||
131696898|NCT00883337|474173968|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
131696899|NCT00883337|474173969|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
131696900|NCT00883337|474173970|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
131696901|NCT00883337|474173968|FG000|Extension Treatment Period|Lost to Follow-up|1|||
131696902|NCT00883337|474173969|FG001|Extension Treatment Period|Lost to Follow-up|0|||
131696903|NCT00883337|474173970|FG002|Extension Treatment Period|Lost to Follow-up|0|||
131696904|NCT00883337|474173968|FG000|Extension Treatment Period|Other than above|10|||
131696905|NCT00883337|474173969|FG001|Extension Treatment Period|Other than above|9|||
131696906|NCT00883337|474173970|FG002|Extension Treatment Period|Other than above|5|||
131696907|NCT01637142|474173972|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
131696908|NCT02111564|474173973|FG000|Overall Study|Death|109|||
131696909|NCT02111564|474173974|FG001|Overall Study|Death|120|||
131696910|NCT02111564|474173973|FG000|Overall Study|Lost to Follow-up|2|||
131696911|NCT02111564|474173974|FG001|Overall Study|Lost to Follow-up|3|||
131696912|NCT02111564|474173973|FG000|Overall Study|Withdrawal by Subject|20|||
131696913|NCT02111564|474173974|FG001|Overall Study|Withdrawal by Subject|20|||
131696914|NCT00687362|474173975|FG000|Overall Study|Protocol Violation|2|||
131696915|NCT00687362|474173975|FG000|Overall Study|Withdrawal by Subject|1|||
131696916|NCT03468309|474173978|FG000|Overall Study|Lost to Follow-up|4|||
131696917|NCT03468309|474173978|FG000|Overall Study|Withdrawal by Subject|2|||
131696918|NCT04986202|474173986|FG000|Overall Study|Death|10|||
131696919|NCT04986202|474173987|FG001|Overall Study|Death|3|||
131696920|NCT04986202|474173988|FG002|Overall Study|Death|10|||
131696921|NCT04986202|474173986|FG000|Overall Study|Physician Decision|3|||
131696922|NCT04986202|474173987|FG001|Overall Study|Physician Decision|1|||
131696923|NCT04986202|474173988|FG002|Overall Study|Physician Decision|2|||
131696924|NCT04986202|474173986|FG000|Overall Study|Withdrawal by Subject|4|||
131696925|NCT04986202|474173987|FG001|Overall Study|Withdrawal by Subject|2|||
131696926|NCT04986202|474173988|FG002|Overall Study|Withdrawal by Subject|4|||
131696927|NCT02468648|474173989|FG000|Overall Study|Death|1|||
131696928|NCT02118792|474173990|FG000|Overall Study|Withdrawal by Subject|6|||
131564518|NCT02550873|473689608|FG000|Randomized Double Blind|Disease progression|1|||
131696929|NCT02118792|474173991|FG001|Overall Study|Withdrawal by Subject|3|||
131696930|NCT02118792|474173990|FG000|Overall Study|Lost to Follow-up|4|||
131696931|NCT02118792|474173991|FG001|Overall Study|Lost to Follow-up|4|||
131696932|NCT02118792|474173990|FG000|Overall Study|Adverse Event|5|||
131696933|NCT02118792|474173991|FG001|Overall Study|Adverse Event|4|||
131696934|NCT02118792|474173990|FG000|Overall Study|Withdrawal by parent/guardian|14|||
131696935|NCT02118792|474173991|FG001|Overall Study|Withdrawal by parent/guardian|20|||
131696936|NCT02118792|474173990|FG000|Overall Study|Other|1|||
131696937|NCT02118792|474173991|FG001|Overall Study|Other|6|||
131696938|NCT02118792|474173990|FG000|Overall Study|Randomised but not treated|1|||
131696939|NCT02118792|474173991|FG001|Overall Study|Randomised but not treated|0|||
131696940|NCT05131204|474173992|FG000|Overall Study|Sponsor request|2|||
131696941|NCT05131204|474173993|FG001|Overall Study|Sponsor request|1|||
131696942|NCT02787863|474173994|FG000|Overall Study|Death|1|||
131696943|NCT02787863|474173995|FG001|Overall Study|Death|0|||
131696944|NCT02787863|474173996|FG002|Overall Study|Death|1|||
131696945|NCT02787863|474173997|FG003|Overall Study|Death|0|||
131564519|NCT02550873|473689609|FG001|Randomized Double Blind|Disease progression|1|||
131696946|NCT02787863|474173998|FG004|Overall Study|Death|0|||
131782628|NCT01190098|474486085|FG000|Overall Study|Other|0|||
131782629|NCT01190098|474486086|FG001|Overall Study|Other|1|||
131782630|NCT02957682|474486087|FG000|Overall Study|Adverse Event|64|||
131782631|NCT02957682|474486088|FG001|Overall Study|Adverse Event|67|||
131782632|NCT02957682|474486087|FG000|Overall Study|Poor Compliance to Protocol|30|||
131782633|NCT02957682|474486088|FG001|Overall Study|Poor Compliance to Protocol|26|||
131782634|NCT02957682|474486087|FG000|Overall Study|Physician Decision|4|||
131782635|NCT02957682|474486088|FG001|Overall Study|Physician Decision|4|||
131782636|NCT02957682|474486087|FG000|Overall Study|Study Terminated by Sponsor|4|||
131782637|NCT02957682|474486088|FG001|Overall Study|Study Terminated by Sponsor|3|||
131898635|NCT02250300|474915325|FG002|Expansion Phase|Death|0|||
131898636|NCT02250300|474915326|FG003|Expansion Phase|Death|0|||
131898637|NCT00215644|474915329|FG000|Overall Study|Disease Progression|28|||
131782638|NCT02957682|474486087|FG000|Overall Study|Subject Moved|10|||
131782639|NCT02957682|474486088|FG001|Overall Study|Subject Moved|16|||
131782640|NCT02957682|474486087|FG000|Overall Study|Withdrawal by Subject|64|||
131898638|NCT00215644|474915330|FG001|Overall Study|Disease Progression|10|||
131564520|NCT02550873|473689610|FG002|Randomized Double Blind|Disease progression|0|||
131564521|NCT02550873|473689608|FG000|Open Label Extension|Study ongoing|0|||
131437075|NCT00743249|473225708|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
131437076|NCT00743249|473225709|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
131437077|NCT00743249|473225708|FG000|Overall Study|Unsuccessful insertion of stent|2|||
131437078|NCT00743249|473225709|FG001|Overall Study|Unsuccessful insertion of stent|1|||
131437079|NCT02653326|473225710|FG000|Overall Study|Lost to Follow-up|10|||
131437080|NCT02653326|473225711|FG001|Overall Study|Lost to Follow-up|7|||
131437081|NCT05767021|473225712|FG000|Overall Study|Adverse Event|2|||
131437082|NCT05767021|473225712|FG000|Overall Study|Protocol Deviation|1|||
131437083|NCT05767021|473225712|FG000|Overall Study|Withdrawal by Subject|1|||
131437084|NCT05767021|473225712|FG000|Overall Study|Physician Decision|1|||
131437085|NCT05767021|473225712|FG000|Overall Study|Lack of Efficacy|11|||
131437086|NCT05767021|473225712|FG000|Overall Study|Assigned Treatment by Mistake|1|||
131437087|NCT01239381|473225714|FG000|Overall Study|Protocol Violation|1|||
131437088|NCT01239381|473225714|FG000|Overall Study|Withdrawal by Subject|1|||
131437089|NCT02738008|473225715|FG000|Overall Study|Study Terminated by Sponsor|1|||
131437090|NCT02738008|473225716|FG001|Overall Study|Study Terminated by Sponsor|5|||
131437091|NCT02738008|473225717|FG002|Overall Study|Study Terminated by Sponsor|3|||
131437092|NCT02738008|473225715|FG000|Overall Study|Adverse Event|0|||
131437093|NCT02738008|473225716|FG001|Overall Study|Adverse Event|1|||
131437094|NCT02738008|473225717|FG002|Overall Study|Adverse Event|2|||
131437095|NCT04621448|473225718|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
131437096|NCT04621448|473225719|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
131437097|NCT04621448|473225720|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
131437098|NCT04621448|473225721|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
131437099|NCT04621448|473225718|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
131437100|NCT04621448|473225719|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
131437101|NCT04621448|473225720|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
131437102|NCT04621448|473225721|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
131437103|NCT04621448|473225718|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
131437104|NCT04621448|473225719|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
131437105|NCT04621448|473225720|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
131437106|NCT04621448|473225721|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
131437107|NCT04621448|473225718|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
131437108|NCT04621448|473225719|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
131437109|NCT04621448|473225720|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
131437110|NCT04621448|473225721|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
131564522|NCT02550873|473689609|FG001|Open Label Extension|Study ongoing|0|||
131437111|NCT01917747|473225724|FG000|Overall Study|Withdrawal by Subject|1|||
131437112|NCT01917747|473225725|FG001|Overall Study|Withdrawal by Subject|2|||
131564523|NCT02550873|473689610|FG002|Open Label Extension|Study ongoing|111|||
131782641|NCT02957682|474486088|FG001|Overall Study|Withdrawal by Subject|33|||
131782642|NCT02957682|474486087|FG000|Overall Study|Related to IMP Administration|3|||
131782643|NCT02957682|474486088|FG001|Overall Study|Related to IMP Administration|6|||
131782644|NCT02957682|474486087|FG000|Overall Study|Non-disclosed|16|||
131782645|NCT02957682|474486088|FG001|Overall Study|Non-disclosed|12|||
131782646|NCT02957682|474486087|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
131782647|NCT02957682|474486088|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
131782648|NCT00791154|474486097|FG000|Overall Study|Noncompliance|0|||
131782649|NCT00791154|474486098|FG001|Overall Study|Noncompliance|1|||
131782650|NCT00791154|474486099|FG002|Overall Study|Noncompliance|0|||
131782651|NCT00791154|474486100|FG003|Overall Study|Noncompliance|0|||
131782652|NCT00791154|474486101|FG004|Overall Study|Noncompliance|1|||
131782653|NCT00791154|474486102|FG005|Overall Study|Noncompliance|1|||
131782654|NCT00791154|474486103|FG006|Overall Study|Noncompliance|1|||
131782655|NCT00791154|474486097|FG000|Overall Study|Adverse Event|0|||
131782656|NCT00791154|474486098|FG001|Overall Study|Adverse Event|0|||
131782657|NCT00791154|474486099|FG002|Overall Study|Adverse Event|0|||
131782658|NCT00791154|474486100|FG003|Overall Study|Adverse Event|0|||
131782659|NCT00791154|474486101|FG004|Overall Study|Adverse Event|2|||
131782660|NCT00791154|474486102|FG005|Overall Study|Adverse Event|0|||
131782661|NCT00791154|474486103|FG006|Overall Study|Adverse Event|1|||
131782662|NCT00791154|474486097|FG000|Overall Study|Full Consent withdrawn|1|||
131782663|NCT00791154|474486098|FG001|Overall Study|Full Consent withdrawn|3|||
131782664|NCT00791154|474486099|FG002|Overall Study|Full Consent withdrawn|0|||
131782665|NCT00791154|474486100|FG003|Overall Study|Full Consent withdrawn|0|||
131782666|NCT00791154|474486101|FG004|Overall Study|Full Consent withdrawn|1|||
131782667|NCT00791154|474486102|FG005|Overall Study|Full Consent withdrawn|3|||
131782668|NCT00791154|474486103|FG006|Overall Study|Full Consent withdrawn|1|||
131782669|NCT00791154|474486097|FG000|Overall Study|Lost to Follow-up|0|||
131782670|NCT00791154|474486098|FG001|Overall Study|Lost to Follow-up|0|||
131782671|NCT00791154|474486099|FG002|Overall Study|Lost to Follow-up|0|||
131782672|NCT00791154|474486100|FG003|Overall Study|Lost to Follow-up|1|||
131782673|NCT00791154|474486101|FG004|Overall Study|Lost to Follow-up|2|||
131782674|NCT00791154|474486102|FG005|Overall Study|Lost to Follow-up|0|||
131782675|NCT00791154|474486103|FG006|Overall Study|Lost to Follow-up|4|||
131782676|NCT00791154|474486097|FG000|Overall Study|Death|5|||
131782677|NCT00791154|474486098|FG001|Overall Study|Death|4|||
131782678|NCT00791154|474486099|FG002|Overall Study|Death|4|||
131782679|NCT00791154|474486100|FG003|Overall Study|Death|7|||
131782680|NCT00791154|474486101|FG004|Overall Study|Death|54|||
131782681|NCT00791154|474486102|FG005|Overall Study|Death|54|||
131782682|NCT00791154|474486103|FG006|Overall Study|Death|52|||
131782683|NCT00791154|474486097|FG000|Overall Study|Other event|0|||
131782684|NCT00791154|474486098|FG001|Overall Study|Other event|0|||
131782685|NCT00791154|474486099|FG002|Overall Study|Other event|2|||
131782686|NCT00791154|474486100|FG003|Overall Study|Other event|0|||
131782687|NCT00791154|474486101|FG004|Overall Study|Other event|2|||
131782688|NCT00791154|474486102|FG005|Overall Study|Other event|4|||
131564524|NCT00895843|473689611|FG000|Overall Study|Protocol Violation|12|||
131782689|NCT00791154|474486103|FG006|Overall Study|Other event|2|||
131782690|NCT00953927|474486104|FG000|Overall Study|Lost to Follow-up|61|||
131782691|NCT00953927|474486105|FG001|Overall Study|Lost to Follow-up|65|||
131437113|NCT01917747|473225724|FG000|Overall Study|Lost to Follow-up|18|||
131564525|NCT00895843|473689612|FG001|Overall Study|Protocol Violation|12|||
131782692|NCT00953927|474486104|FG000|Overall Study|Withdrawal by Subject|36|||
131782693|NCT00953927|474486105|FG001|Overall Study|Withdrawal by Subject|25|||
131782694|NCT00953927|474486104|FG000|Overall Study|Death|7|||
131782695|NCT00953927|474486105|FG001|Overall Study|Death|4|||
131782696|NCT00953927|474486104|FG000|Overall Study|Other study discontinuation|1|||
131782697|NCT00953927|474486105|FG001|Overall Study|Other study discontinuation|1|||
131782698|NCT01396161|474486106|FG000|Overall Study|Withdrawal by Subject|0|||
131782699|NCT01396161|474486107|FG001|Overall Study|Withdrawal by Subject|0|||
131782700|NCT01396161|474486108|FG002|Overall Study|Withdrawal by Subject|0|||
131437114|NCT01917747|473225725|FG001|Overall Study|Lost to Follow-up|9|||
131437115|NCT02922725|473225726|FG000|Overall Study|Withdrawal by Subject|1|||
131437116|NCT02922725|473225727|FG001|Overall Study|Withdrawal by Subject|0|||
131696947|NCT02787863|474173999|FG005|Overall Study|Death|0|||
131696948|NCT02787863|474174000|FG006|Overall Study|Death|0|||
131696949|NCT02787863|474174001|FG007|Overall Study|Death|0|||
131696950|NCT02787863|474173994|FG000|Overall Study|Withdrawal by Subject|0|||
131696951|NCT02787863|474173995|FG001|Overall Study|Withdrawal by Subject|1|||
131696952|NCT02787863|474173996|FG002|Overall Study|Withdrawal by Subject|1|||
131696953|NCT02787863|474173997|FG003|Overall Study|Withdrawal by Subject|0|||
131696954|NCT02787863|474173998|FG004|Overall Study|Withdrawal by Subject|0|||
131696955|NCT02787863|474173999|FG005|Overall Study|Withdrawal by Subject|0|||
131696956|NCT02787863|474174000|FG006|Overall Study|Withdrawal by Subject|0|||
131696957|NCT02787863|474174001|FG007|Overall Study|Withdrawal by Subject|0|||
131696958|NCT01368835|474174002|FG000|Overall Study|Inclusion criteria/photography quality|22|||
131696959|NCT01368835|474174002|FG000|Overall Study|Lost to Follow-up|11|||
131696960|NCT03118297|474174003|FG000|Overall Study|Lost to Follow-up|0|||
131696961|NCT03118297|474174004|FG001|Overall Study|Lost to Follow-up|2|||
131696962|NCT03446885|474174007|FG000|Overall Study|Lost to Follow-up|1|||
131696963|NCT03446885|474174008|FG001|Overall Study|Lost to Follow-up|0|||
131696964|NCT03446885|474174007|FG000|Overall Study|Did not complete entire visit|1|||
131696965|NCT03446885|474174008|FG001|Overall Study|Did not complete entire visit|0|||
131696966|NCT01485627|474174011|FG000|Overall Study|Patient withdrew|6|||
131696967|NCT01485627|474174012|FG001|Overall Study|Patient withdrew|5|||
131696968|NCT01485627|474174011|FG000|Overall Study|Patient died|3|||
131696969|NCT01485627|474174012|FG001|Overall Study|Patient died|1|||
131696970|NCT01485627|474174011|FG000|Overall Study|Patient lost to followup|0|||
131898639|NCT00215644|474915329|FG000|Overall Study|Adverse Event|2|||
131437117|NCT02922725|473225728|FG002|Overall Study|Withdrawal by Subject|0|||
131437118|NCT03253679|473225729|FG000|Overall Study|Screen Failure|1|||
131437119|NCT04816214|473225730|FG000|Overall Study|Progressive Disease|4|||
131437120|NCT04816214|473225731|FG001|Overall Study|Progressive Disease|0|||
131437121|NCT04816214|473225732|FG002|Overall Study|Progressive Disease|0|||
131437122|NCT04816214|473225730|FG000|Overall Study|Death|1|||
131437123|NCT04816214|473225731|FG001|Overall Study|Death|0|||
131437124|NCT04816214|473225732|FG002|Overall Study|Death|0|||
131437125|NCT04816214|473225730|FG000|Overall Study|Study Terminated by Sponsor|1|||
131437126|NCT04816214|473225731|FG001|Overall Study|Study Terminated by Sponsor|0|||
131437127|NCT04816214|473225732|FG002|Overall Study|Study Terminated by Sponsor|0|||
131437128|NCT05148234|473225733|FG000|Phase I|Ineligible|0|||
131437129|NCT05148234|473225734|FG001|Phase I|Ineligible|0|||
131437130|NCT05148234|473225735|FG002|Phase I|Ineligible|0|||
131437131|NCT05148234|473225736|FG003|Phase I|Ineligible|0|||
131437132|NCT05148234|473225737|FG004|Phase I|Ineligible|0|||
131437133|NCT05148234|473225738|FG005|Phase I|Ineligible|0|||
131437134|NCT05148234|473225739|FG006|Phase I|Ineligible|0|||
131437135|NCT05148234|473225740|FG007|Phase I|Ineligible|1|||
131437136|NCT05148234|473225733|FG000|Phase I|Company closed the trial.|0|||
131437137|NCT05148234|473225734|FG001|Phase I|Company closed the trial.|1|||
131437138|NCT05148234|473225735|FG002|Phase I|Company closed the trial.|0|||
131437139|NCT05148234|473225736|FG003|Phase I|Company closed the trial.|0|||
131437140|NCT05148234|473225737|FG004|Phase I|Company closed the trial.|0|||
131437141|NCT05148234|473225738|FG005|Phase I|Company closed the trial.|0|||
131437142|NCT05148234|473225739|FG006|Phase I|Company closed the trial.|0|||
131437143|NCT05148234|473225740|FG007|Phase I|Company closed the trial.|0|||
131437144|NCT03061201|473225741|FG000|Overall Study|Participants Terminated at Month 36|0|||
131782701|NCT01396161|474486109|FG003|Overall Study|Withdrawal by Subject|0|||
131782702|NCT01396161|474486110|FG004|Overall Study|Withdrawal by Subject|1|||
131782703|NCT01396161|474486111|FG005|Overall Study|Withdrawal by Subject|0|||
131782704|NCT01396161|474486112|FG006|Overall Study|Withdrawal by Subject|0|||
131782705|NCT01396161|474486106|FG000|Overall Study|Other|0|||
131782706|NCT01396161|474486107|FG001|Overall Study|Other|0|||
131782707|NCT01396161|474486108|FG002|Overall Study|Other|0|||
131782708|NCT01396161|474486109|FG003|Overall Study|Other|0|||
131782709|NCT01396161|474486110|FG004|Overall Study|Other|0|||
131782710|NCT01396161|474486111|FG005|Overall Study|Other|0|||
131782711|NCT01396161|474486112|FG006|Overall Study|Other|1|||
131782712|NCT03578276|474486115|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
131782713|NCT03578276|474486116|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
131782714|NCT00981409|474486117|FG000|Overall Study|Adverse Event|4|||
131782715|NCT00981409|474486118|FG001|Overall Study|Adverse Event|0|||
131782716|NCT00981409|474486117|FG000|Overall Study|Protocol Violation|0|||
131782717|NCT00981409|474486118|FG001|Overall Study|Protocol Violation|1|||
131782718|NCT00981409|474486117|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
131782719|NCT00981409|474486118|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
131782720|NCT03891875|474486133|FG000|Overall Study|Withdrawal by Subject|20|||
131782721|NCT03891875|474486134|FG001|Overall Study|Withdrawal by Subject|3|||
131782722|NCT03891875|474486133|FG000|Overall Study|Adverse Event|10|||
131782723|NCT03891875|474486134|FG001|Overall Study|Adverse Event|4|||
131782724|NCT03891875|474486133|FG000|Overall Study|Physician Decision|1|||
131782725|NCT03891875|474486134|FG001|Overall Study|Physician Decision|1|||
131782726|NCT03891875|474486133|FG000|Overall Study|Protocol Violation|1|||
131782727|NCT03891875|474486134|FG001|Overall Study|Protocol Violation|0|||
131437145|NCT03061201|473225742|FG001|Overall Study|Participants Terminated at Month 36|1|||
131437146|NCT03061201|473225743|FG002|Overall Study|Participants Terminated at Month 36|0|||
131437147|NCT03061201|473225744|FG003|Overall Study|Participants Terminated at Month 36|1|||
131437148|NCT03061201|473225741|FG000|Overall Study|Lost to Follow-up|1|||
131437149|NCT03061201|473225742|FG001|Overall Study|Lost to Follow-up|0|||
131437150|NCT03061201|473225743|FG002|Overall Study|Lost to Follow-up|0|||
131437151|NCT03061201|473225744|FG003|Overall Study|Lost to Follow-up|0|||
131782728|NCT03891875|474486133|FG000|Overall Study|Lost to Follow-up|1|||
131782729|NCT03891875|474486134|FG001|Overall Study|Lost to Follow-up|0|||
131782730|NCT03891875|474486133|FG000|Overall Study|COVID-19 infection|1|||
131782731|NCT03891875|474486134|FG001|Overall Study|COVID-19 infection|0|||
131782732|NCT00943384|474486135|FG000|Overall Study|Dispositioned prior to treatment|23|||
131782733|NCT00943384|474486135|FG000|Overall Study|Treated off protocol-protocol violation|5|||
131782734|NCT00943384|474486135|FG000|Overall Study|Lost to Follow-up|16|||
131782735|NCT00943384|474486135|FG000|Overall Study|Withdrawal by Subject|5|||
131782736|NCT00481871|474486136|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
131782737|NCT00481871|474486137|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
131782738|NCT00481871|474486138|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
131782739|NCT00481871|474486139|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
131782740|NCT00481871|474486140|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
131782741|NCT02362646|474486144|FG000|Overall Study|Death|15|||
131782742|NCT02362646|474486145|FG001|Overall Study|Death|8|||
131782743|NCT02362646|474486144|FG000|Overall Study|Withdrawal by Subject|2|||
131782744|NCT02362646|474486145|FG001|Overall Study|Withdrawal by Subject|2|||
131782745|NCT02362646|474486144|FG000|Overall Study|received transplant|21|||
131782746|NCT02362646|474486145|FG001|Overall Study|received transplant|14|||
131782747|NCT00865306|474486146|FG000|Controlled Trial|Lost to Follow-up|1|||
131782748|NCT00865306|474486147|FG001|Controlled Trial|Lost to Follow-up|1|||
131782749|NCT00865306|474486146|FG000|Controlled Trial|Difficulty commuting|2|||
131782750|NCT00865306|474486147|FG001|Controlled Trial|Difficulty commuting|0|||
131782751|NCT00865306|474486146|FG000|Controlled Trial|Improved btw baseline and first session|1|||
131782752|NCT00865306|474486147|FG001|Controlled Trial|Improved btw baseline and first session|0|||
131782753|NCT00865306|474486146|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
131782754|NCT00865306|474486147|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
131782755|NCT00865306|474486146|FG000|Controlled Trial|Withdrawal by Subject|0|||
131782756|NCT00865306|474486147|FG001|Controlled Trial|Withdrawal by Subject|1|||
131782757|NCT02058368|474486149|FG000|Overall Study|Adverse Event|15|||
131782758|NCT02058368|474486150|FG001|Overall Study|Adverse Event|20|||
131782759|NCT02058368|474486149|FG000|Overall Study|Lack of Efficacy|0|||
131782760|NCT02058368|474486150|FG001|Overall Study|Lack of Efficacy|1|||
131782761|NCT02058368|474486149|FG000|Overall Study|Protocol Violation|0|||
131782762|NCT02058368|474486150|FG001|Overall Study|Protocol Violation|4|||
131782763|NCT02058368|474486149|FG000|Overall Study|Lost to Follow-up|2|||
131782764|NCT02058368|474486150|FG001|Overall Study|Lost to Follow-up|0|||
131782765|NCT02058368|474486149|FG000|Overall Study|Physician Decision|2|||
131782766|NCT02058368|474486150|FG001|Overall Study|Physician Decision|3|||
131782767|NCT02058368|474486149|FG000|Overall Study|Withdrawal by Subject|22|||
131782768|NCT02058368|474486150|FG001|Overall Study|Withdrawal by Subject|26|||
131782769|NCT01652872|474486151|FG000|Overall Study|Death|36|||
131782770|NCT01652872|474486152|FG001|Overall Study|Death|39|||
131782771|NCT01652872|474486151|FG000|Overall Study|Lost to Follow-up|28|||
131782772|NCT01652872|474486152|FG001|Overall Study|Lost to Follow-up|23|||
131782773|NCT01652872|474486151|FG000|Overall Study|Decision by sponsor|5|||
131782774|NCT01652872|474486152|FG001|Overall Study|Decision by sponsor|7|||
131782775|NCT01652872|474486151|FG000|Overall Study|Withdrawal by Subject|76|||
131782776|NCT01652872|474486152|FG001|Overall Study|Withdrawal by Subject|84|||
131782777|NCT03454672|474486153|FG000|Overall Study|Adverse Event|1|||
131782778|NCT03454672|474486154|FG001|Overall Study|Adverse Event|1|||
131782779|NCT03454672|474486153|FG000|Overall Study|Lost to Follow-up|1|||
131782780|NCT03454672|474486154|FG001|Overall Study|Lost to Follow-up|3|||
131782781|NCT03454672|474486153|FG000|Overall Study|painful|1|||
131782782|NCT03454672|474486154|FG001|Overall Study|painful|2|||
131782783|NCT03454672|474486153|FG000|Overall Study|Non-compliance|2|||
131782784|NCT03454672|474486154|FG001|Overall Study|Non-compliance|4|||
131782785|NCT03454672|474486153|FG000|Overall Study|personal reasons|3|||
131782786|NCT03454672|474486154|FG001|Overall Study|personal reasons|2|||
131782787|NCT03454672|474486153|FG000|Overall Study|Withdrawal by Subject|1|||
131782788|NCT03454672|474486154|FG001|Overall Study|Withdrawal by Subject|0|||
131782789|NCT00390572|474486155|FG000|Overall Study|Lost to Follow-up|8|||
131782790|NCT00390572|474486156|FG001|Overall Study|Lost to Follow-up|4|||
131782791|NCT00390572|474486155|FG000|Overall Study|health condition|0|||
131782792|NCT00390572|474486156|FG001|Overall Study|health condition|1|||
131782793|NCT01345058|474486157|FG000|Overall Study|Withdrawal by Subject|1|||
131782794|NCT01345058|474486158|FG001|Overall Study|Withdrawal by Subject|0|||
131564526|NCT03658811|473689616|FG000|Overall Study|Lost to Follow-up|3|||
131564527|NCT00946647|473689617|FG000|Phase 1 Part|Adverse Event|2|||
131437152|NCT03062358|473225745|FG000|Overall Study|Death|269|||
131437153|NCT03062358|473225746|FG001|Overall Study|Death|145|||
131437154|NCT03062358|473225745|FG000|Overall Study|Withdrawal by Subject|2|||
131437155|NCT03062358|473225746|FG001|Overall Study|Withdrawal by Subject|1|||
131437156|NCT03062358|473225745|FG000|Overall Study|Sponsor Decision|29|||
131437157|NCT03062358|473225746|FG001|Overall Study|Sponsor Decision|7|||
131437158|NCT03861273|473225747|FG000|Screening Phase (3 Weeks)|Other|1|||
131437159|NCT03861273|473225747|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
131437160|NCT03861273|473225747|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
131437161|NCT03861273|473225747|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
131437162|NCT03861273|473225747|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
131437163|NCT03799341|473225748|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
131564528|NCT00946647|473689618|FG001|Phase 1 Part|Adverse Event|5|||
131437164|NCT03799341|473225749|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
131564529|NCT00946647|473689619|FG002|Phase 1 Part|Adverse Event|3|||
131564530|NCT00946647|473689620|FG003|Phase 1 Part|Adverse Event|0|||
131564531|NCT00946647|473689621|FG004|Phase 1 Part|Adverse Event|0|||
131564532|NCT00946647|473689617|FG000|Phase 1 Part|Disease progression|3|||
131564533|NCT00946647|473689618|FG001|Phase 1 Part|Disease progression|6|||
131564534|NCT00946647|473689619|FG002|Phase 1 Part|Disease progression|1|||
131564535|NCT00946647|473689620|FG003|Phase 1 Part|Disease progression|0|||
131564536|NCT00946647|473689621|FG004|Phase 1 Part|Disease progression|0|||
131564537|NCT00946647|473689617|FG000|Phase 1 Part|Withdrawal by Subject|1|||
131564538|NCT00946647|473689618|FG001|Phase 1 Part|Withdrawal by Subject|4|||
131564539|NCT00946647|473689619|FG002|Phase 1 Part|Withdrawal by Subject|3|||
131564540|NCT00946647|473689620|FG003|Phase 1 Part|Withdrawal by Subject|0|||
131564541|NCT00946647|473689621|FG004|Phase 1 Part|Withdrawal by Subject|0|||
131564542|NCT00946647|473689617|FG000|Phase 1 Part|Abnormal values|0|||
131564543|NCT00946647|473689618|FG001|Phase 1 Part|Abnormal values|2|||
131564544|NCT00946647|473689619|FG002|Phase 1 Part|Abnormal values|0|||
131564545|NCT00946647|473689620|FG003|Phase 1 Part|Abnormal values|0|||
131564546|NCT00946647|473689621|FG004|Phase 1 Part|Abnormal values|0|||
131564547|NCT00946647|473689617|FG000|Phase 1 Part|Reason missing|0|||
131564548|NCT00946647|473689618|FG001|Phase 1 Part|Reason missing|1|||
131564549|NCT00946647|473689619|FG002|Phase 1 Part|Reason missing|0|||
131564550|NCT00946647|473689620|FG003|Phase 1 Part|Reason missing|0|||
131564551|NCT00946647|473689621|FG004|Phase 1 Part|Reason missing|0|||
131564552|NCT00946647|473689617|FG000|Phase ll Part|Untreated|0|||
131564553|NCT00946647|473689618|FG001|Phase ll Part|Untreated|0|||
131564554|NCT00946647|473689619|FG002|Phase ll Part|Untreated|0|||
131564555|NCT00946647|473689620|FG003|Phase ll Part|Untreated|0|||
131564556|NCT00946647|473689621|FG004|Phase ll Part|Untreated|2|||
131564557|NCT00946647|473689617|FG000|Phase ll Part|Adverse Event|0|||
131564558|NCT00946647|473689618|FG001|Phase ll Part|Adverse Event|0|||
131564559|NCT00946647|473689619|FG002|Phase ll Part|Adverse Event|0|||
131564560|NCT00946647|473689620|FG003|Phase ll Part|Adverse Event|10|||
131564561|NCT00946647|473689621|FG004|Phase ll Part|Adverse Event|6|||
131564562|NCT00946647|473689617|FG000|Phase ll Part|Withdrawal by Subject|0|||
131564563|NCT00946647|473689618|FG001|Phase ll Part|Withdrawal by Subject|0|||
131564564|NCT00946647|473689619|FG002|Phase ll Part|Withdrawal by Subject|0|||
131564565|NCT00946647|473689620|FG003|Phase ll Part|Withdrawal by Subject|8|||
131564566|NCT00946647|473689621|FG004|Phase ll Part|Withdrawal by Subject|6|||
131564567|NCT00946647|473689617|FG000|Phase ll Part|Administrative problems|0|||
131564568|NCT00946647|473689618|FG001|Phase ll Part|Administrative problems|0|||
131564569|NCT00946647|473689619|FG002|Phase ll Part|Administrative problems|0|||
131564570|NCT00946647|473689620|FG003|Phase ll Part|Administrative problems|3|||
131564571|NCT00946647|473689621|FG004|Phase ll Part|Administrative problems|8|||
131564572|NCT00946647|473689617|FG000|Phase ll Part|Death|0|||
131564573|NCT00946647|473689618|FG001|Phase ll Part|Death|0|||
131564574|NCT00946647|473689619|FG002|Phase ll Part|Death|0|||
131564575|NCT00946647|473689620|FG003|Phase ll Part|Death|7|||
131564576|NCT00946647|473689621|FG004|Phase ll Part|Death|4|||
131564577|NCT00946647|473689617|FG000|Phase ll Part|Disease progression|0|||
131564578|NCT00946647|473689618|FG001|Phase ll Part|Disease progression|0|||
131564579|NCT00946647|473689619|FG002|Phase ll Part|Disease progression|0|||
131564580|NCT00946647|473689620|FG003|Phase ll Part|Disease progression|6|||
131564581|NCT00946647|473689621|FG004|Phase ll Part|Disease progression|14|||
131564582|NCT00946647|473689617|FG000|Phase ll Part|Protocol Violation|0|||
131564583|NCT00946647|473689618|FG001|Phase ll Part|Protocol Violation|0|||
131564584|NCT00946647|473689619|FG002|Phase ll Part|Protocol Violation|0|||
131564585|NCT00946647|473689620|FG003|Phase ll Part|Protocol Violation|4|||
131564586|NCT00946647|473689621|FG004|Phase ll Part|Protocol Violation|2|||
131564587|NCT00946647|473689617|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
131564588|NCT00946647|473689618|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
131564589|NCT00946647|473689619|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
131564590|NCT00946647|473689620|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
131564591|NCT00946647|473689621|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
131564592|NCT01513967|473689632|FG000|Overall Study|Pregnancy|0|||
131564593|NCT01513967|473689633|FG001|Overall Study|Pregnancy|0|||
131564594|NCT01513967|473689634|FG002|Overall Study|Pregnancy|0|||
131564595|NCT01513967|473689635|FG003|Overall Study|Pregnancy|0|||
131564596|NCT01513967|473689636|FG004|Overall Study|Pregnancy|0|||
131564597|NCT01513967|473689637|FG005|Overall Study|Pregnancy|0|||
131564598|NCT01513967|473689638|FG006|Overall Study|Pregnancy|1|||
131564599|NCT01513967|473689639|FG007|Overall Study|Pregnancy|0|||
131564600|NCT01513967|473689632|FG000|Overall Study|missed a study visit|0|||
131564601|NCT01513967|473689633|FG001|Overall Study|missed a study visit|0|||
131564602|NCT01513967|473689634|FG002|Overall Study|missed a study visit|0|||
131564603|NCT01513967|473689635|FG003|Overall Study|missed a study visit|0|||
131564604|NCT01513967|473689636|FG004|Overall Study|missed a study visit|0|||
131564605|NCT01513967|473689637|FG005|Overall Study|missed a study visit|0|||
131564606|NCT01513967|473689638|FG006|Overall Study|missed a study visit|1|||
131564607|NCT01513967|473689639|FG007|Overall Study|missed a study visit|0|||
131564608|NCT01513967|473689632|FG000|Overall Study|excluded due to positive drug screen|0|||
131564609|NCT01513967|473689633|FG001|Overall Study|excluded due to positive drug screen|0|||
131564610|NCT01513967|473689634|FG002|Overall Study|excluded due to positive drug screen|0|||
131564611|NCT01513967|473689635|FG003|Overall Study|excluded due to positive drug screen|0|||
131564612|NCT01513967|473689636|FG004|Overall Study|excluded due to positive drug screen|0|||
131564613|NCT01513967|473689637|FG005|Overall Study|excluded due to positive drug screen|0|||
131696971|NCT01485627|474174012|FG001|Overall Study|Patient lost to followup|1|||
131696972|NCT01485627|474174011|FG000|Overall Study|Caregiver withdrew|3|||
131564614|NCT01513967|473689638|FG006|Overall Study|excluded due to positive drug screen|0|||
131564615|NCT01513967|473689639|FG007|Overall Study|excluded due to positive drug screen|2|||
131564616|NCT01513967|473689632|FG000|Overall Study|Physician Decision|0|||
131564617|NCT01513967|473689633|FG001|Overall Study|Physician Decision|0|||
131564618|NCT01513967|473689634|FG002|Overall Study|Physician Decision|0|||
131564619|NCT01513967|473689635|FG003|Overall Study|Physician Decision|0|||
131564620|NCT01513967|473689636|FG004|Overall Study|Physician Decision|0|||
131564621|NCT01513967|473689637|FG005|Overall Study|Physician Decision|1|||
131696973|NCT01485627|474174012|FG001|Overall Study|Caregiver withdrew|3|||
131696974|NCT01485627|474174011|FG000|Overall Study|Caregiver lost to follow up|11|||
131564622|NCT01513967|473689638|FG006|Overall Study|Physician Decision|0|||
131564623|NCT01513967|473689639|FG007|Overall Study|Physician Decision|0|||
131564624|NCT02711826|473689640|FG000|Overall Study|Physician Decision|0|||
131564625|NCT02711826|473689641|FG001|Overall Study|Physician Decision|0|||
131564626|NCT02711826|473689642|FG002|Overall Study|Physician Decision|0|||
131564627|NCT02711826|473689643|FG003|Overall Study|Physician Decision|1|||
131564628|NCT02711826|473689644|FG004|Overall Study|Physician Decision|0|||
131564629|NCT02711826|473689640|FG000|Overall Study|Withdrawal by Subject|0|||
131564630|NCT02711826|473689641|FG001|Overall Study|Withdrawal by Subject|1|||
131564631|NCT02711826|473689642|FG002|Overall Study|Withdrawal by Subject|0|||
131564632|NCT02711826|473689643|FG003|Overall Study|Withdrawal by Subject|4|||
131564633|NCT02711826|473689644|FG004|Overall Study|Withdrawal by Subject|0|||
131564634|NCT02711826|473689640|FG000|Overall Study|Failure to manufacture cellular product|0|||
131564635|NCT02711826|473689641|FG001|Overall Study|Failure to manufacture cellular product|0|||
131564636|NCT02711826|473689642|FG002|Overall Study|Failure to manufacture cellular product|5|||
131564637|NCT02711826|473689643|FG003|Overall Study|Failure to manufacture cellular product|0|||
131564638|NCT02711826|473689644|FG004|Overall Study|Failure to manufacture cellular product|0|||
131564639|NCT02711826|473689640|FG000|Overall Study|Infusion canceled for active infection|0|||
131564640|NCT02711826|473689641|FG001|Overall Study|Infusion canceled for active infection|1|||
131564641|NCT02711826|473689642|FG002|Overall Study|Infusion canceled for active infection|0|||
131564642|NCT02711826|473689643|FG003|Overall Study|Infusion canceled for active infection|0|||
131564643|NCT02711826|473689644|FG004|Overall Study|Infusion canceled for active infection|0|||
131564644|NCT02711826|473689640|FG000|Overall Study|Screen failures|0|||
131564645|NCT02711826|473689641|FG001|Overall Study|Screen failures|0|||
131564646|NCT02711826|473689642|FG002|Overall Study|Screen failures|0|||
131564647|NCT02711826|473689643|FG003|Overall Study|Screen failures|4|||
131564648|NCT02711826|473689644|FG004|Overall Study|Screen failures|0|||
131564649|NCT02906202|473689645|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
131564650|NCT01960790|473689646|FG000|Overall Study|Survey forms could not be recovered|3|||
131564651|NCT01960790|473689646|FG000|Overall Study|Treat with Humira outside survey period|3|||
131564652|NCT01960790|473689646|FG000|Overall Study|Transferred to another hospital|4|||
131564653|NCT01960790|473689646|FG000|Overall Study|Unevaluable for safety|1|||
131564654|NCT01987830|473689647|FG000|Overall Study|Never received baseline scan|1|||
131782795|NCT01345058|474486157|FG000|Overall Study|Participant Reported Increase in Events|1|||
131782796|NCT01345058|474486158|FG001|Overall Study|Participant Reported Increase in Events|0|||
131782797|NCT01345058|474486157|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
131782798|NCT01345058|474486158|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
131782799|NCT01345058|474486157|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
131782800|NCT01345058|474486158|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
131782801|NCT01345058|474486157|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
131782802|NCT01345058|474486158|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
131782803|NCT01892020|474486165|FG000|Period 1|Adverse Event|1|||
131782804|NCT01892020|474486166|FG001|Period 1|Adverse Event|1|||
131782805|NCT01892020|474486165|FG000|Period 1|Protocol Violation|2|||
131782806|NCT01892020|474486166|FG001|Period 1|Protocol Violation|4|||
131782807|NCT01892020|474486165|FG000|Period 1|Unclassified|0|||
131782808|NCT01892020|474486166|FG001|Period 1|Unclassified|1|||
131782809|NCT01892020|474486165|FG000|Period 2|Protocol Violation|1|||
131782810|NCT01892020|474486166|FG001|Period 2|Protocol Violation|0|||
131782811|NCT03252756|474486170|FG000|Overall Study|Protocol Violation|2|||
131782812|NCT03252756|474486171|FG001|Overall Study|Protocol Violation|4|||
131782813|NCT03252756|474486170|FG000|Overall Study|COVID-19 Pandemic|1|||
131564655|NCT03990363|473689648|FG000|Overall Study|Withdrawal by Subject|10|||
131564656|NCT03990363|473689649|FG001|Overall Study|Withdrawal by Subject|9|||
131564657|NCT03990363|473689650|FG002|Overall Study|Withdrawal by Subject|18|||
131564658|NCT03990363|473689651|FG003|Overall Study|Withdrawal by Subject|11|||
131564659|NCT03990363|473689652|FG004|Overall Study|Withdrawal by Subject|9|||
131782814|NCT03252756|474486171|FG001|Overall Study|COVID-19 Pandemic|1|||
131782815|NCT03252756|474486170|FG000|Overall Study|Study Drug Expiration|0|||
131782816|NCT03252756|474486171|FG001|Overall Study|Study Drug Expiration|1|||
131564660|NCT03990363|473689648|FG000|Overall Study|Physician Decision|1|||
131564661|NCT03990363|473689649|FG001|Overall Study|Physician Decision|0|||
131564662|NCT03990363|473689650|FG002|Overall Study|Physician Decision|0|||
131564663|NCT03990363|473689651|FG003|Overall Study|Physician Decision|0|||
131564664|NCT03990363|473689652|FG004|Overall Study|Physician Decision|0|||
131564665|NCT03990363|473689648|FG000|Overall Study|Adverse Event|1|||
131564666|NCT03990363|473689649|FG001|Overall Study|Adverse Event|3|||
131564667|NCT03990363|473689650|FG002|Overall Study|Adverse Event|2|||
131564668|NCT03990363|473689651|FG003|Overall Study|Adverse Event|2|||
131564669|NCT03990363|473689652|FG004|Overall Study|Adverse Event|0|||
131564670|NCT03990363|473689648|FG000|Overall Study|Death|14|||
131564671|NCT03990363|473689649|FG001|Overall Study|Death|8|||
131564672|NCT03990363|473689650|FG002|Overall Study|Death|14|||
131564673|NCT03990363|473689651|FG003|Overall Study|Death|10|||
131564674|NCT03990363|473689652|FG004|Overall Study|Death|11|||
131564675|NCT03990363|473689648|FG000|Overall Study|Failure to meet randomization criteria|0|||
131564676|NCT03990363|473689649|FG001|Overall Study|Failure to meet randomization criteria|1|||
131564677|NCT03990363|473689650|FG002|Overall Study|Failure to meet randomization criteria|1|||
131564678|NCT03990363|473689651|FG003|Overall Study|Failure to meet randomization criteria|0|||
131564679|NCT03990363|473689652|FG004|Overall Study|Failure to meet randomization criteria|0|||
131564680|NCT03990363|473689648|FG000|Overall Study|Lost to Follow-up|0|||
131564681|NCT03990363|473689649|FG001|Overall Study|Lost to Follow-up|0|||
131564682|NCT03990363|473689650|FG002|Overall Study|Lost to Follow-up|0|||
131564683|NCT03990363|473689651|FG003|Overall Study|Lost to Follow-up|1|||
131564684|NCT03990363|473689652|FG004|Overall Study|Lost to Follow-up|2|||
131564685|NCT03990363|473689648|FG000|Overall Study|Non-compliance with study drug|2|||
131564686|NCT03990363|473689649|FG001|Overall Study|Non-compliance with study drug|1|||
131564687|NCT03990363|473689650|FG002|Overall Study|Non-compliance with study drug|2|||
131564688|NCT03990363|473689651|FG003|Overall Study|Non-compliance with study drug|0|||
131564689|NCT03990363|473689652|FG004|Overall Study|Non-compliance with study drug|0|||
131564690|NCT03990363|473689648|FG000|Overall Study|Study terminated by sponsor|0|||
131564691|NCT03990363|473689649|FG001|Overall Study|Study terminated by sponsor|1|||
131564692|NCT03990363|473689650|FG002|Overall Study|Study terminated by sponsor|0|||
131564693|NCT03990363|473689651|FG003|Overall Study|Study terminated by sponsor|0|||
131564694|NCT03990363|473689652|FG004|Overall Study|Study terminated by sponsor|0|||
131564695|NCT03990363|473689648|FG000|Overall Study|Site terminated by sponsor|2|||
131564696|NCT03990363|473689649|FG001|Overall Study|Site terminated by sponsor|1|||
131564697|NCT03990363|473689650|FG002|Overall Study|Site terminated by sponsor|2|||
131437165|NCT03799341|473225750|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
131437166|NCT03799341|473225748|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
131437167|NCT03799341|473225749|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
131437168|NCT03799341|473225750|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
131437169|NCT03799341|473225748|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
131437170|NCT03799341|473225749|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
131437171|NCT03799341|473225750|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
131437172|NCT03799341|473225748|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
131437173|NCT03799341|473225749|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
131437174|NCT03799341|473225750|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
131437175|NCT03799341|473225748|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
131437176|NCT03799341|473225749|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
131437177|NCT03799341|473225750|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
131437178|NCT03799341|473225748|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
131437179|NCT03799341|473225749|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
131564698|NCT03990363|473689651|FG003|Overall Study|Site terminated by sponsor|0|||
131564699|NCT03990363|473689652|FG004|Overall Study|Site terminated by sponsor|2|||
131564700|NCT03990363|473689648|FG000|Overall Study|Not categorized|5|||
131564701|NCT03990363|473689649|FG001|Overall Study|Not categorized|5|||
131564702|NCT03990363|473689650|FG002|Overall Study|Not categorized|3|||
131564703|NCT03990363|473689651|FG003|Overall Study|Not categorized|2|||
131564704|NCT03990363|473689652|FG004|Overall Study|Not categorized|2|||
131564705|NCT00057811|473689662|FG000|Overall Study|Lack of Efficacy|1|||
131564706|NCT00057811|473689663|FG001|Overall Study|Lack of Efficacy|4|||
131696975|NCT01485627|474174012|FG001|Overall Study|Caregiver lost to follow up|12|||
131696976|NCT01485627|474174011|FG000|Overall Study|Caregiver died|1|||
131696977|NCT01485627|474174012|FG001|Overall Study|Caregiver died|0|||
131696978|NCT01485627|474174011|FG000|Overall Study|caregiver was not bereaved|42|||
131696979|NCT01485627|474174012|FG001|Overall Study|caregiver was not bereaved|35|||
131696980|NCT02264990|474174015|FG000|Overall Study|Death|255|||
131696981|NCT02264990|474174016|FG001|Overall Study|Death|250|||
131564707|NCT00057811|473689662|FG000|Overall Study|Physician Decision|1|||
131564708|NCT00057811|473689663|FG001|Overall Study|Physician Decision|0|||
131564709|NCT00057811|473689662|FG000|Overall Study|Withdrawal by Subject|3|||
131564710|NCT00057811|473689663|FG001|Overall Study|Withdrawal by Subject|4|||
131564711|NCT00057811|473689662|FG000|Overall Study|Ineligible|4|||
131564712|NCT00057811|473689663|FG001|Overall Study|Ineligible|2|||
131564713|NCT00057811|473689662|FG000|Overall Study|Inevaluable|1|||
131564714|NCT00057811|473689663|FG001|Overall Study|Inevaluable|2|||
131564715|NCT00556374|473689664|FG000|Overall Study|Withdrawal by Subject|235|||
131564716|NCT00556374|473689665|FG001|Overall Study|Withdrawal by Subject|205|||
131564717|NCT00556374|473689664|FG000|Overall Study|Death|158|||
131564718|NCT00556374|473689665|FG001|Overall Study|Death|127|||
131564719|NCT00556374|473689664|FG000|Overall Study|Lost to Follow-up|24|||
131564720|NCT00556374|473689665|FG001|Overall Study|Lost to Follow-up|17|||
131437180|NCT03799341|473225750|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
131437181|NCT04539938|473225751|FG000|Overall Study|Death|30|||
131437182|NCT04539938|473225751|FG000|Overall Study|Withdrawal by Subject|4|||
131437183|NCT01650194|473225752|FG000|Overall Study|Progressive Disease (PD)|35|||
131437184|NCT01650194|473225752|FG000|Overall Study|Withdrawal by Subject|2|||
131437185|NCT01650194|473225752|FG000|Overall Study|Miscellaneous|10|||
131437186|NCT00880698|473225753|FG000|Overall Study|Death|0|||
131437187|NCT00880698|473225754|FG001|Overall Study|Death|0|||
131437188|NCT00880698|473225755|FG002|Overall Study|Death|1|||
131437189|NCT00880698|473225756|FG003|Overall Study|Death|2|||
131437190|NCT00880698|473225753|FG000|Overall Study|Lost to Follow-up|1|||
131437191|NCT00880698|473225754|FG001|Overall Study|Lost to Follow-up|3|||
131437192|NCT00880698|473225755|FG002|Overall Study|Lost to Follow-up|0|||
131437193|NCT00880698|473225756|FG003|Overall Study|Lost to Follow-up|1|||
131437194|NCT00966654|473226798|FG000|Overall Study|Study was terminated,PI left institution|12|||
131437195|NCT01631435|473226803|FG000|Overall Study|Adverse Event|2|||
131437196|NCT01631435|473226803|FG000|Overall Study|Withdrawal by Subject|2|||
131437197|NCT01631435|473226803|FG000|Overall Study|incomplete study procedure|5|||
131437198|NCT01005251|473226807|FG000|Overall Study|Withdrawal by Subject|2|||
131437199|NCT01005251|473226808|FG001|Overall Study|Withdrawal by Subject|5|||
131437200|NCT01005251|473226809|FG002|Overall Study|Withdrawal by Subject|3|||
131437201|NCT01005251|473226810|FG003|Overall Study|Withdrawal by Subject|4|||
131437202|NCT01005251|473226811|FG004|Overall Study|Withdrawal by Subject|9|||
131437203|NCT01005251|473226807|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
131437204|NCT01005251|473226808|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131437205|NCT01005251|473226809|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
131437206|NCT01005251|473226810|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
131437207|NCT01005251|473226811|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
131437208|NCT01005251|473226807|FG000|Overall Study|Adverse Event|2|||
131437209|NCT01005251|473226808|FG001|Overall Study|Adverse Event|6|||
131437210|NCT01005251|473226809|FG002|Overall Study|Adverse Event|8|||
131437211|NCT01005251|473226810|FG003|Overall Study|Adverse Event|5|||
131437212|NCT01005251|473226811|FG004|Overall Study|Adverse Event|4|||
131437213|NCT01005251|473226807|FG000|Overall Study|Protocol Violation|1|||
131437214|NCT01005251|473226808|FG001|Overall Study|Protocol Violation|0|||
131437215|NCT01005251|473226809|FG002|Overall Study|Protocol Violation|0|||
131437216|NCT01005251|473226810|FG003|Overall Study|Protocol Violation|0|||
131437217|NCT01005251|473226811|FG004|Overall Study|Protocol Violation|2|||
131437218|NCT01005251|473226807|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
131437219|NCT01005251|473226808|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
131437220|NCT01005251|473226809|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
131437221|NCT01005251|473226810|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
131437222|NCT01005251|473226811|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
131437223|NCT01005251|473226807|FG000|Overall Study|Lost to Follow-up|1|||
131437224|NCT01005251|473226808|FG001|Overall Study|Lost to Follow-up|4|||
131437225|NCT01005251|473226809|FG002|Overall Study|Lost to Follow-up|2|||
131437226|NCT01005251|473226810|FG003|Overall Study|Lost to Follow-up|0|||
131437227|NCT01005251|473226811|FG004|Overall Study|Lost to Follow-up|0|||
131437228|NCT01005251|473226807|FG000|Overall Study|Physician Decision|0|||
131437229|NCT01005251|473226808|FG001|Overall Study|Physician Decision|0|||
131437230|NCT01005251|473226809|FG002|Overall Study|Physician Decision|0|||
131564721|NCT00556374|473689664|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
131437231|NCT01005251|473226810|FG003|Overall Study|Physician Decision|0|||
131437232|NCT01005251|473226811|FG004|Overall Study|Physician Decision|2|||
131437233|NCT01005251|473226807|FG000|Overall Study|Patient moved|1|||
131437234|NCT01005251|473226808|FG001|Overall Study|Patient moved|0|||
131564722|NCT00556374|473689665|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
131564723|NCT02169219|473689666|FG000|Overall Study|Lack of Efficacy|6|||
131564724|NCT00238420|473689667|FG000|Overall Study|Protocol Violation|1|||
131437235|NCT01005251|473226809|FG002|Overall Study|Patient moved|0|||
131437236|NCT01005251|473226810|FG003|Overall Study|Patient moved|0|||
131564725|NCT00238420|473689668|FG001|Overall Study|Protocol Violation|1|||
131564726|NCT00442286|473689669|FG000|Overall Study|Death|2|||
131437237|NCT01005251|473226811|FG004|Overall Study|Patient moved|0|||
131564727|NCT00442286|473689670|FG001|Overall Study|Death|2|||
131564728|NCT00442286|473689669|FG000|Overall Study|Lost to Follow-up|1|||
131564729|NCT00442286|473689670|FG001|Overall Study|Lost to Follow-up|0|||
131564730|NCT00442286|473689669|FG000|Overall Study|Withdrawal by Subject|2|||
131564731|NCT00442286|473689670|FG001|Overall Study|Withdrawal by Subject|0|||
131564732|NCT00442286|473689669|FG000|Overall Study|System explanted|1|||
131564733|NCT00442286|473689670|FG001|Overall Study|System explanted|0|||
131564734|NCT00442286|473689669|FG000|Overall Study|Patient Injury|1|||
131564735|NCT00442286|473689670|FG001|Overall Study|Patient Injury|0|||
131564736|NCT03317379|473689673|FG000|Overall Study|Lost to Follow-up|0|||
131564737|NCT03317379|473689674|FG001|Overall Study|Lost to Follow-up|3|||
131564738|NCT03317379|473689675|FG002|Overall Study|Lost to Follow-up|2|||
131564739|NCT03040687|473689676|FG000|Overall Study|Withdrawal by Subject|1|||
131564740|NCT03040687|473689677|FG001|Overall Study|Withdrawal by Subject|0|||
131564741|NCT03040687|473689678|FG002|Overall Study|Withdrawal by Subject|0|||
131564742|NCT00550173|473689679|FG000|Overall Study|Death|45|||
131564743|NCT00550173|473689680|FG001|Overall Study|Death|38|||
131564744|NCT00550173|473689681|FG002|Overall Study|Death|50|||
131564745|NCT00550173|473689679|FG000|Overall Study|Physician Decision|1|||
131564746|NCT00550173|473689680|FG001|Overall Study|Physician Decision|2|||
131564747|NCT00550173|473689681|FG002|Overall Study|Physician Decision|2|||
131564748|NCT00550173|473689679|FG000|Overall Study|Withdrawal by Subject|9|||
131564749|NCT00550173|473689680|FG001|Overall Study|Withdrawal by Subject|12|||
131564750|NCT00550173|473689681|FG002|Overall Study|Withdrawal by Subject|17|||
131564751|NCT00550173|473689679|FG000|Overall Study|Sponsor Decision|13|||
131564752|NCT00550173|473689680|FG001|Overall Study|Sponsor Decision|7|||
131564753|NCT00550173|473689681|FG002|Overall Study|Sponsor Decision|1|||
131564754|NCT00550173|473689679|FG000|Overall Study|Lost to Follow-up|4|||
131564755|NCT00550173|473689680|FG001|Overall Study|Lost to Follow-up|4|||
131564756|NCT00550173|473689681|FG002|Overall Study|Lost to Follow-up|3|||
131564757|NCT00810641|473689683|FG000|Overall Study|Withdrawal by Subject|0|||
131564758|NCT00810641|473689684|FG001|Overall Study|Withdrawal by Subject|1|||
131564759|NCT00810641|473689685|FG002|Overall Study|Withdrawal by Subject|2|||
131782817|NCT01500434|474486174|FG000|Overall Study|Death|1|||
131782818|NCT01500434|474486174|FG000|Overall Study|Withdrawal by Subject|1|||
131782819|NCT01500434|474486174|FG000|Overall Study|Missed 12-month follow-up|5|||
131782820|NCT01966107|474486178|FG000|Overall Study|excluded from FAS|21|||
131782821|NCT01966107|474486179|FG001|Overall Study|excluded from FAS|20|||
131782822|NCT01966107|474486178|FG000|Overall Study|discontinued treatment|345|||
131782823|NCT01966107|474486179|FG001|Overall Study|discontinued treatment|372|||
131782824|NCT01966107|474486178|FG000|Overall Study|due to study closure|164|||
131782825|NCT01966107|474486179|FG001|Overall Study|due to study closure|186|||
131782826|NCT01966107|474486178|FG000|Overall Study|withdrew from the study|272|||
131782827|NCT01966107|474486179|FG001|Overall Study|withdrew from the study|303|||
131782828|NCT00532779|474486180|FG000|Overall Study|Adverse Event|122|||
131782829|NCT00532779|474486181|FG001|Overall Study|Adverse Event|112|||
131782830|NCT00532779|474486182|FG002|Overall Study|Adverse Event|56|||
131782831|NCT00532779|474486180|FG000|Overall Study|Lost to Follow-up|76|||
131782832|NCT00532779|474486181|FG001|Overall Study|Lost to Follow-up|65|||
131782833|NCT00532779|474486182|FG002|Overall Study|Lost to Follow-up|66|||
131782834|NCT00532779|474486180|FG000|Overall Study|Withdrawal by Subject|63|||
131782835|NCT00532779|474486181|FG001|Overall Study|Withdrawal by Subject|60|||
131782836|NCT00532779|474486182|FG002|Overall Study|Withdrawal by Subject|90|||
131782837|NCT00532779|474486180|FG000|Overall Study|Lack of Efficacy|12|||
131782838|NCT00532779|474486181|FG001|Overall Study|Lack of Efficacy|12|||
131782839|NCT00532779|474486182|FG002|Overall Study|Lack of Efficacy|40|||
131782840|NCT00532779|474486180|FG000|Overall Study|Protocol Violation|5|||
131782841|NCT00532779|474486181|FG001|Overall Study|Protocol Violation|9|||
131782842|NCT00532779|474486182|FG002|Overall Study|Protocol Violation|7|||
131782843|NCT00532779|474486180|FG000|Overall Study|Pregnancy|2|||
131782844|NCT00532779|474486181|FG001|Overall Study|Pregnancy|5|||
131564760|NCT01556243|473689686|FG000|Overall Study|Ineligible|34|||
131782845|NCT00532779|474486182|FG002|Overall Study|Pregnancy|3|||
131782846|NCT00532779|474486180|FG000|Overall Study|Death|0|||
131782847|NCT00532779|474486181|FG001|Overall Study|Death|1|||
131782848|NCT00532779|474486182|FG002|Overall Study|Death|0|||
131782849|NCT00532779|474486180|FG000|Overall Study|Drug noncompliance, moved, other|14|||
131564761|NCT01556243|473689686|FG000|Overall Study|Converted to mastectomy|14|||
131564762|NCT01556243|473689686|FG000|Overall Study|Unable to achieve negative margins|2|||
131564763|NCT01556243|473689686|FG000|Overall Study|Withdrawal by Subject|16|||
131564764|NCT02325713|473689689|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564765|NCT02325713|473689690|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131782850|NCT00532779|474486181|FG001|Overall Study|Drug noncompliance, moved, other|23|||
131782851|NCT00532779|474486182|FG002|Overall Study|Drug noncompliance, moved, other|29|||
131782852|NCT02662556|474486183|FG000|Overall Study|Adverse Event|4|||
131564766|NCT02325713|473689691|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131782853|NCT02662556|474486183|FG000|Overall Study|Lack of Efficacy|4|||
131782854|NCT01556165|474486190|FG000|Overall Study|Adverse Event|5|||
131782855|NCT01556165|474486191|FG001|Overall Study|Adverse Event|3|||
131564767|NCT02325713|473689692|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564768|NCT02325713|473689693|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564769|NCT02325713|473689694|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564770|NCT02325713|473689695|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564771|NCT02325713|473689696|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564772|NCT02325713|473689697|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564773|NCT02325713|473689698|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564774|NCT02325713|473689699|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
131564775|NCT02325713|473689700|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564776|NCT02325713|473689701|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564777|NCT02325713|473689702|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564778|NCT02325713|473689703|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564779|NCT02325713|473689704|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131564780|NCT02325713|473689689|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
131564781|NCT02325713|473689690|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564782|NCT02325713|473689691|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564783|NCT02325713|473689692|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564784|NCT02325713|473689693|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564785|NCT02325713|473689694|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564786|NCT02325713|473689695|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564787|NCT02325713|473689696|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564788|NCT02325713|473689697|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564789|NCT02325713|473689698|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564790|NCT02325713|473689699|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564791|NCT02325713|473689700|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564792|NCT02325713|473689701|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564793|NCT02325713|473689702|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564794|NCT02325713|473689703|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564795|NCT02325713|473689704|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131564796|NCT02325713|473689689|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564797|NCT02325713|473689690|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564798|NCT02325713|473689691|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131437238|NCT01005251|473226807|FG000|Overall Study|Wrong drug dispensed|0|||
131437239|NCT01005251|473226808|FG001|Overall Study|Wrong drug dispensed|1|||
131782856|NCT01556165|474486190|FG000|Overall Study|Protocol Violation|0|||
131782857|NCT01556165|474486191|FG001|Overall Study|Protocol Violation|3|||
131782858|NCT01556165|474486190|FG000|Overall Study|Withdrawal of Consent|7|||
131782859|NCT01556165|474486191|FG001|Overall Study|Withdrawal of Consent|1|||
131782860|NCT00701558|474486194|FG000|Overall Study|Death|7|||
131782861|NCT00701558|474486194|FG000|Overall Study|Lost to Follow-up|8|||
131782862|NCT00131937|474486195|FG000|Overall Study|Adverse Event|3|||
131782863|NCT00131937|474486195|FG000|Overall Study|Withdrawal by Subject|2|||
131782864|NCT00131937|474486195|FG000|Overall Study|Physician Decision|1|||
131782865|NCT00131937|474486195|FG000|Overall Study|Disease Progression|7|||
131782866|NCT00131937|474486195|FG000|Overall Study|Alternative therapy|1|||
131782867|NCT01640964|474486196|FG000|Overall Study|Lost to Follow-up|0|||
131782868|NCT01640964|474486197|FG001|Overall Study|Lost to Follow-up|0|||
131782869|NCT01640964|474486198|FG002|Overall Study|Lost to Follow-up|1|||
131782870|NCT01640964|474486196|FG000|Overall Study|Protocol Deviation|1|||
131782871|NCT01640964|474486197|FG001|Overall Study|Protocol Deviation|1|||
131782872|NCT01640964|474486198|FG002|Overall Study|Protocol Deviation|2|||
131782873|NCT02787746|474486199|FG000|Overall Study|Adverse Event|42|||
131782874|NCT02787746|474486199|FG000|Overall Study|Withdrawal by Subject|65|||
131782875|NCT02787746|474486199|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
131564799|NCT02325713|473689692|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564800|NCT02325713|473689693|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564801|NCT02325713|473689694|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564802|NCT02325713|473689695|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564803|NCT02325713|473689696|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564804|NCT02325713|473689697|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564805|NCT02325713|473689698|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
131564806|NCT02325713|473689699|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564807|NCT02325713|473689700|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564808|NCT02325713|473689701|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564809|NCT02325713|473689702|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564810|NCT02325713|473689703|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131564811|NCT02325713|473689704|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131437240|NCT01005251|473226809|FG002|Overall Study|Wrong drug dispensed|0|||
131564812|NCT00322868|473691618|FG000|Overall Study|disease progression|1|||
131564813|NCT00107380|473691621|FG000|Overall Study|Adverse Event|7|||
131564814|NCT00107380|473691621|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
131564815|NCT00107380|473691621|FG000|Overall Study|Progression/relapse|4|||
131564816|NCT00107380|473691621|FG000|Overall Study|Death|3|||
131437241|NCT01005251|473226810|FG003|Overall Study|Wrong drug dispensed|0|||
131437242|NCT01005251|473226811|FG004|Overall Study|Wrong drug dispensed|0|||
131437243|NCT01005251|473226807|FG000|Overall Study|Randomized in error|0|||
131782876|NCT01678924|474487772|FG000|Overall Study|Adverse Event|1|||
131782877|NCT01678924|474487773|FG001|Overall Study|Adverse Event|1|||
131782878|NCT01678924|474487774|FG002|Overall Study|Adverse Event|0|||
131782879|NCT01678924|474487775|FG003|Overall Study|Adverse Event|1|||
131782880|NCT01678924|474487772|FG000|Overall Study|Lack of Efficacy|7|||
131782881|NCT01678924|474487773|FG001|Overall Study|Lack of Efficacy|2|||
131782882|NCT01678924|474487774|FG002|Overall Study|Lack of Efficacy|0|||
131782883|NCT01678924|474487775|FG003|Overall Study|Lack of Efficacy|5|||
131782884|NCT01678924|474487772|FG000|Overall Study|Lost to Follow-up|0|||
131782885|NCT01678924|474487773|FG001|Overall Study|Lost to Follow-up|4|||
131782886|NCT01678924|474487774|FG002|Overall Study|Lost to Follow-up|0|||
131782887|NCT01678924|474487775|FG003|Overall Study|Lost to Follow-up|2|||
131782888|NCT01678924|474487772|FG000|Overall Study|Personal Reasons|2|||
131782889|NCT01678924|474487773|FG001|Overall Study|Personal Reasons|2|||
131782890|NCT01678924|474487774|FG002|Overall Study|Personal Reasons|2|||
131782891|NCT01678924|474487775|FG003|Overall Study|Personal Reasons|7|||
131782892|NCT01678924|474487772|FG000|Overall Study|Withdrawal by Subject|0|||
131782893|NCT01678924|474487773|FG001|Overall Study|Withdrawal by Subject|3|||
131782894|NCT01678924|474487774|FG002|Overall Study|Withdrawal by Subject|0|||
131782895|NCT01678924|474487775|FG003|Overall Study|Withdrawal by Subject|2|||
131782896|NCT01678924|474487772|FG000|Overall Study|Unable to attend scheduled visits|0|||
131782897|NCT01678924|474487773|FG001|Overall Study|Unable to attend scheduled visits|0|||
131782898|NCT01678924|474487774|FG002|Overall Study|Unable to attend scheduled visits|0|||
131782899|NCT01678924|474487775|FG003|Overall Study|Unable to attend scheduled visits|1|||
131564817|NCT00107380|473691621|FG000|Overall Study|Other - not protocol specified|7|||
131564818|NCT00107380|473691621|FG000|Overall Study|Ineligible|2|||
131564819|NCT02176928|473691622|FG000|Overall Study|Lost to Follow-up|2|||
131564820|NCT02176928|473691623|FG001|Overall Study|Lost to Follow-up|4|||
131782900|NCT00021229|474487778|FG000|Overall Study|Adverse Event|10|||
131437244|NCT01005251|473226808|FG001|Overall Study|Randomized in error|0|||
131437245|NCT01005251|473226809|FG002|Overall Study|Randomized in error|1|||
131437246|NCT01005251|473226810|FG003|Overall Study|Randomized in error|1|||
131437247|NCT01005251|473226811|FG004|Overall Study|Randomized in error|0|||
131437248|NCT01005251|473226807|FG000|Overall Study|Lack of Efficacy|0|||
131437249|NCT01005251|473226808|FG001|Overall Study|Lack of Efficacy|0|||
131437250|NCT01005251|473226809|FG002|Overall Study|Lack of Efficacy|1|||
131437251|NCT01005251|473226810|FG003|Overall Study|Lack of Efficacy|1|||
131437252|NCT01005251|473226811|FG004|Overall Study|Lack of Efficacy|0|||
131437253|NCT01169103|473226818|FG000|Overall Study|Lost to Follow-up|3|||
131437254|NCT01169103|473226819|FG001|Overall Study|Lost to Follow-up|3|||
131437255|NCT01169103|473226818|FG000|Overall Study|Withdrawal by Subject|3|||
131437256|NCT01169103|473226819|FG001|Overall Study|Withdrawal by Subject|1|||
131437257|NCT00141453|473226820|FG000|Overall Study|Protocol Violation|6|||
131782901|NCT00021229|474487779|FG001|Overall Study|Adverse Event|5|||
131437258|NCT00141453|473226821|FG001|Overall Study|Protocol Violation|5|||
131437259|NCT02469623|473226826|FG000|Overall Study|Not consented for long-term follow-up|4|||
131437260|NCT02469623|473226826|FG000|Overall Study|Lost to Follow-up|4|||
131782902|NCT00021229|474487780|FG002|Overall Study|Adverse Event|2|||
131437261|NCT02469623|473226826|FG000|Overall Study|Withdrawal by Subject|2|||
131564821|NCT03673098|473691624|FG000|Overall Study|Lost to Follow-up|2|||
131564822|NCT03673098|473691625|FG001|Overall Study|Lost to Follow-up|3|||
131782903|NCT00021229|474487778|FG000|Overall Study|Death|0|||
131437262|NCT02469623|473226826|FG000|Overall Study|Death|3|||
131437263|NCT02763644|473226827|FG000|Overall Study|Patient/guardian decision|1|||
131564823|NCT03673098|473691624|FG000|Overall Study|Withdrawal by Subject|6|||
131564824|NCT03673098|473691625|FG001|Overall Study|Withdrawal by Subject|1|||
131564825|NCT03673098|473691624|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
131564826|NCT03673098|473691625|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
131564827|NCT01440049|473691632|FG000|Overall Study|Adverse Event|5|||
131564828|NCT00688259|473691635|FG000|Overall Study|Lost to Follow-up|2|||
131564829|NCT00688259|473691636|FG001|Overall Study|Lost to Follow-up|4|||
131564830|NCT00688259|473691635|FG000|Overall Study|Physician Decision|1|||
131564831|NCT00688259|473691636|FG001|Overall Study|Physician Decision|0|||
131564832|NCT00688259|473691635|FG000|Overall Study|Withdrawal by Subject|2|||
131564833|NCT00688259|473691636|FG001|Overall Study|Withdrawal by Subject|0|||
131564834|NCT00688259|473691635|FG000|Overall Study|Declined Interview|2|||
131564835|NCT00688259|473691636|FG001|Overall Study|Declined Interview|3|||
131564836|NCT00688259|473691635|FG000|Overall Study|Hospitalized at Follow-up|0|||
131564837|NCT00688259|473691636|FG001|Overall Study|Hospitalized at Follow-up|1|||
131564838|NCT01310868|473691638|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
131564839|NCT02411591|473691639|FG000|Overall Study|Adverse Event|0|||
131564840|NCT02411591|473691640|FG001|Overall Study|Adverse Event|4|||
131564841|NCT02411591|473691641|FG002|Overall Study|Adverse Event|2|||
131564842|NCT02411591|473691639|FG000|Overall Study|Withdrawal by Subject|0|||
131564843|NCT02411591|473691640|FG001|Overall Study|Withdrawal by Subject|3|||
131564844|NCT02411591|473691641|FG002|Overall Study|Withdrawal by Subject|0|||
131564845|NCT02411591|473691639|FG000|Overall Study|Physician Decision|0|||
131564846|NCT02411591|473691640|FG001|Overall Study|Physician Decision|3|||
131564847|NCT02411591|473691641|FG002|Overall Study|Physician Decision|1|||
131564848|NCT02491892|473691642|FG000|Overall Study|Adverse Event|1|||
131564849|NCT02491892|473691643|FG001|Overall Study|Adverse Event|1|||
131564850|NCT02491892|473691642|FG000|Overall Study|Death|1|||
131564851|NCT02491892|473691643|FG001|Overall Study|Death|1|||
131564852|NCT02491892|473691642|FG000|Overall Study|Lack of Efficacy|37|||
131564853|NCT02491892|473691643|FG001|Overall Study|Lack of Efficacy|36|||
131564854|NCT02491892|473691642|FG000|Overall Study|Refused Treatment|1|||
131564855|NCT02491892|473691643|FG001|Overall Study|Refused Treatment|0|||
131564856|NCT02491892|473691642|FG000|Overall Study|Lost to Follow-up|1|||
131564857|NCT02491892|473691643|FG001|Overall Study|Lost to Follow-up|0|||
131564858|NCT04227340|473691644|FG000|Overall Study|Withdrawal by Subject|3|||
131564859|NCT00661258|473691652|FG000|Overall Study|Death|1|||
131564860|NCT00661258|473691653|FG001|Overall Study|Death|0|||
131564861|NCT00661258|473691652|FG000|Overall Study|caught by police and in detox center|2|||
131564862|NCT00661258|473691653|FG001|Overall Study|caught by police and in detox center|1|||
131564863|NCT01628874|473691654|FG000|Overall Study|Physician Decision|1|||
131564864|NCT01628874|473691655|FG001|Overall Study|Physician Decision|1|||
131564865|NCT01628874|473691654|FG000|Overall Study|Age >4 months|4|||
131564866|NCT01628874|473691655|FG001|Overall Study|Age >4 months|2|||
131564867|NCT00683449|473691656|FG000|Overall Study|Lost to Follow-up|0|||
131782904|NCT00021229|474487779|FG001|Overall Study|Death|1|||
131782905|NCT00021229|474487780|FG002|Overall Study|Death|0|||
131782906|NCT00021229|474487778|FG000|Overall Study|Withdrawal by Subject|7|||
131782907|NCT00021229|474487779|FG001|Overall Study|Withdrawal by Subject|7|||
131782908|NCT00021229|474487780|FG002|Overall Study|Withdrawal by Subject|1|||
131782909|NCT00021229|474487778|FG000|Overall Study|Progressive Disease|15|||
131782910|NCT00021229|474487779|FG001|Overall Study|Progressive Disease|19|||
131782911|NCT00021229|474487780|FG002|Overall Study|Progressive Disease|12|||
131564868|NCT00683449|473691657|FG001|Overall Study|Lost to Follow-up|1|||
131564869|NCT00683449|473691658|FG002|Overall Study|Lost to Follow-up|0|||
131564870|NCT00683449|473691659|FG003|Overall Study|Lost to Follow-up|0|||
131564871|NCT00683449|473691660|FG004|Overall Study|Lost to Follow-up|0|||
131564872|NCT03541642|473691663|FG000|Overall Study|Withdrawal by Subject|1|||
131564873|NCT03541642|473691664|FG001|Overall Study|Withdrawal by Subject|2|||
131564874|NCT03541642|473691663|FG000|Overall Study|Lost to Follow-up|16|||
131564875|NCT03541642|473691664|FG001|Overall Study|Lost to Follow-up|12|||
131564876|NCT03541642|473691663|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
131564877|NCT03541642|473691664|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
131564878|NCT01083160|473691669|FG000|Overall Study|Adverse Event|1|||
131782912|NCT00021229|474487778|FG000|Overall Study|Protocol Violation|1|||
131782913|NCT00021229|474487779|FG001|Overall Study|Protocol Violation|1|||
131782914|NCT00021229|474487780|FG002|Overall Study|Protocol Violation|0|||
131782915|NCT00021229|474487778|FG000|Overall Study|Physician Decision|0|||
131782916|NCT00021229|474487779|FG001|Overall Study|Physician Decision|0|||
131782917|NCT00021229|474487780|FG002|Overall Study|Physician Decision|1|||
131782918|NCT00021229|474487778|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
131782919|NCT00021229|474487779|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
131782920|NCT00021229|474487780|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
131782921|NCT02428231|474487786|FG000|Overall Study|Other|10|||
131782922|NCT02428231|474487787|FG001|Overall Study|Other|16|||
131782923|NCT02428231|474487786|FG000|Overall Study|Required Symptomatic Therapy|0|||
131782924|NCT02428231|474487787|FG001|Overall Study|Required Symptomatic Therapy|1|||
131782925|NCT02428231|474487786|FG000|Overall Study|Adverse Event|3|||
131564879|NCT00918749|473691672|FG000|Overall Study|Adverse Event|1|||
131564880|NCT00918749|473691673|FG001|Overall Study|Adverse Event|0|||
131564881|NCT00918749|473691674|FG002|Overall Study|Adverse Event|1|||
131564882|NCT00918749|473691672|FG000|Overall Study|Lost to Follow-up|0|||
131564883|NCT00918749|473691673|FG001|Overall Study|Lost to Follow-up|0|||
131564884|NCT00918749|473691674|FG002|Overall Study|Lost to Follow-up|1|||
131564885|NCT00918749|473691672|FG000|Overall Study|Withdrawal by Subject|5|||
131564886|NCT00918749|473691673|FG001|Overall Study|Withdrawal by Subject|3|||
131564887|NCT00918749|473691674|FG002|Overall Study|Withdrawal by Subject|5|||
131564888|NCT00918749|473691672|FG000|Overall Study|No Study Medication Taken|1|||
131564889|NCT00918749|473691673|FG001|Overall Study|No Study Medication Taken|0|||
131564890|NCT00918749|473691674|FG002|Overall Study|No Study Medication Taken|0|||
131564891|NCT01951092|473691675|FG000|Overall Study|Lost to Follow-up|10|||
131564892|NCT01951092|473691675|FG000|Overall Study|Incarceration|1|||
131564893|NCT01951092|473691675|FG000|Overall Study|Transfer of Care|1|||
131564894|NCT01712789|473691676|FG000|Overall Study|Lack of Efficacy|2|||
131564895|NCT01712789|473691676|FG000|Overall Study|Lost to Follow-up|1|||
131564896|NCT01712789|473691676|FG000|Overall Study|Progressive Disease|504|||
131564897|NCT01712789|473691676|FG000|Overall Study|Death|57|||
131564898|NCT01712789|473691676|FG000|Overall Study|Adverse Event|52|||
131564899|NCT01712789|473691676|FG000|Overall Study|Miscellaneous|31|||
131564900|NCT01712789|473691676|FG000|Overall Study|Withdrawal by Subject|21|||
131564901|NCT01712789|473691676|FG000|Overall Study|Transition to Commercial Treatment|8|||
131564902|NCT01712789|473691676|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
131564903|NCT00873093|473691677|FG000|Overall Study|Adverse Event|0|||
131564904|NCT00873093|473691678|FG001|Overall Study|Adverse Event|2|||
131564905|NCT00873093|473691679|FG002|Overall Study|Adverse Event|0|||
131564906|NCT00873093|473691680|FG003|Overall Study|Adverse Event|0|||
131564907|NCT00873093|473691681|FG004|Overall Study|Adverse Event|0|||
131564908|NCT00873093|473691677|FG000|Overall Study|Death|0|||
131564909|NCT00873093|473691678|FG001|Overall Study|Death|3|||
131564910|NCT00873093|473691679|FG002|Overall Study|Death|2|||
131564911|NCT00873093|473691680|FG003|Overall Study|Death|0|||
131564912|NCT00873093|473691681|FG004|Overall Study|Death|0|||
131564913|NCT00873093|473691677|FG000|Overall Study|Physician Decision|0|||
131564914|NCT00873093|473691678|FG001|Overall Study|Physician Decision|17|||
131564915|NCT00873093|473691679|FG002|Overall Study|Physician Decision|10|||
131564916|NCT00873093|473691680|FG003|Overall Study|Physician Decision|10|||
131564917|NCT00873093|473691681|FG004|Overall Study|Physician Decision|2|||
131564918|NCT00873093|473691677|FG000|Overall Study|Withdrawal by Subject|1|||
131564919|NCT00873093|473691678|FG001|Overall Study|Withdrawal by Subject|4|||
131564920|NCT00873093|473691679|FG002|Overall Study|Withdrawal by Subject|4|||
131564921|NCT00873093|473691680|FG003|Overall Study|Withdrawal by Subject|0|||
131564922|NCT00873093|473691681|FG004|Overall Study|Withdrawal by Subject|0|||
131564923|NCT00873093|473691677|FG000|Overall Study|Ineligible|0|||
131564924|NCT00873093|473691678|FG001|Overall Study|Ineligible|1|||
131564925|NCT00873093|473691679|FG002|Overall Study|Ineligible|0|||
131564926|NCT00873093|473691680|FG003|Overall Study|Ineligible|1|||
131564927|NCT00873093|473691681|FG004|Overall Study|Ineligible|0|||
131564928|NCT01708187|473691682|FG000|Overall Study|Lost to Follow-up|0|||
131564929|NCT01708187|473691683|FG001|Overall Study|Lost to Follow-up|1|||
131564930|NCT00136916|473691685|FG000|Overall Study|Never received study treatment|3|||
131564931|NCT00136916|473691686|FG001|Overall Study|Never received study treatment|5|||
131564932|NCT00136916|473691685|FG000|Overall Study|Death|1|||
131564933|NCT00136916|473691686|FG001|Overall Study|Death|3|||
131564934|NCT00136916|473691685|FG000|Overall Study|Adverse Event|27|||
131564935|NCT00136916|473691686|FG001|Overall Study|Adverse Event|8|||
131564936|NCT00136916|473691685|FG000|Overall Study|Laboratory abnormality|0|||
131564937|NCT00136916|473691686|FG001|Overall Study|Laboratory abnormality|1|||
131782926|NCT02428231|474487787|FG001|Overall Study|Adverse Event|0|||
131564938|NCT00136916|473691685|FG000|Overall Study|Lack of Efficacy|13|||
131564939|NCT00136916|473691686|FG001|Overall Study|Lack of Efficacy|3|||
131564940|NCT00136916|473691685|FG000|Overall Study|Lost to Follow-up|12|||
131564941|NCT00136916|473691686|FG001|Overall Study|Lost to Follow-up|14|||
131564942|NCT00136916|473691685|FG000|Overall Study|Withdrawal by Subject|44|||
131564943|NCT00136916|473691686|FG001|Overall Study|Withdrawal by Subject|46|||
131564944|NCT00136916|473691685|FG000|Overall Study|Other|22|||
131564945|NCT00136916|473691686|FG001|Overall Study|Other|24|||
131564946|NCT00136916|473691685|FG000|Overall Study|Discontinued in follow up period|3|||
131564947|NCT00136916|473691686|FG001|Overall Study|Discontinued in follow up period|0|||
131564948|NCT01152554|473691687|FG000|Overall Study|Withdrawal by Subject|73|||
131564949|NCT01152554|473691688|FG001|Overall Study|Withdrawal by Subject|28|||
131564950|NCT01152554|473691687|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
131564951|NCT01152554|473691688|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
131564952|NCT01152554|473691687|FG000|Overall Study|Adverse Event|67|||
131564953|NCT01152554|473691688|FG001|Overall Study|Adverse Event|14|||
131564954|NCT01152554|473691687|FG000|Overall Study|Severe non-compliance to protocol|36|||
131564955|NCT01152554|473691688|FG001|Overall Study|Severe non-compliance to protocol|14|||
131564956|NCT01152554|473691687|FG000|Overall Study|Condition under investigation worsened|5|||
131437264|NCT02763644|473226828|FG001|Overall Study|Patient/guardian decision|0|||
131437265|NCT02763644|473226827|FG000|Overall Study|Death|1|||
131437266|NCT02763644|473226828|FG001|Overall Study|Death|1|||
131437267|NCT02763644|473226827|FG000|Overall Study|Adverse Event|1|||
131437268|NCT02763644|473226828|FG001|Overall Study|Adverse Event|1|||
131437269|NCT00861705|473226829|FG000|Overall Study|Never Began Treatment|7|||
131437270|NCT00861705|473226830|FG001|Overall Study|Never Began Treatment|3|||
131782927|NCT01784419|474487788|FG000|Overall Study|Adverse Event|3|||
131437271|NCT00861705|473226831|FG002|Overall Study|Never Began Treatment|0|||
131437272|NCT00861705|473226832|FG003|Overall Study|Never Began Treatment|1|||
131437273|NCT06418152|473226833|FG000|Overall Study|Frequent DBS setting changes|1|||
131782928|NCT01336608|474487789|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
131564957|NCT01152554|473691688|FG001|Overall Study|Condition under investigation worsened|2|||
131564958|NCT01152554|473691687|FG000|Overall Study|Lack of Efficacy|20|||
131564959|NCT01152554|473691688|FG001|Overall Study|Lack of Efficacy|3|||
131564960|NCT01152554|473691687|FG000|Overall Study|Study-specific withdrawal criteria|17|||
131564961|NCT01152554|473691688|FG001|Overall Study|Study-specific withdrawal criteria|8|||
131564962|NCT01152554|473691687|FG000|Overall Study|Lost to Follow-up|87|||
131564963|NCT01152554|473691688|FG001|Overall Study|Lost to Follow-up|32|||
131564964|NCT01152554|473691687|FG000|Overall Study|Other|28|||
131564965|NCT01152554|473691688|FG001|Overall Study|Other|8|||
131564966|NCT01152554|473691687|FG000|Overall Study|Death|1|||
131564967|NCT01152554|473691688|FG001|Overall Study|Death|1|||
131564968|NCT02117544|473691689|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
131564969|NCT02117544|473691690|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
131564970|NCT03486899|473691691|FG000|Overall Study|Lost to Follow-up|4|||
131564971|NCT03486899|473691692|FG001|Overall Study|Lost to Follow-up|1|||
131564972|NCT03486899|473691693|FG002|Overall Study|Lost to Follow-up|4|||
131564973|NCT03486899|473691694|FG003|Overall Study|Lost to Follow-up|3|||
131564974|NCT03486899|473691691|FG000|Overall Study|Death|1|||
131564975|NCT03486899|473691692|FG001|Overall Study|Death|0|||
131564976|NCT03486899|473691693|FG002|Overall Study|Death|0|||
131564977|NCT03486899|473691694|FG003|Overall Study|Death|1|||
131564978|NCT03486899|473691691|FG000|Overall Study|Adverse Event|0|||
131564979|NCT03486899|473691692|FG001|Overall Study|Adverse Event|2|||
131564980|NCT03486899|473691693|FG002|Overall Study|Adverse Event|0|||
131564981|NCT03486899|473691694|FG003|Overall Study|Adverse Event|2|||
131564982|NCT03486899|473691691|FG000|Overall Study|Withdrawal by Subject|3|||
131564983|NCT03486899|473691692|FG001|Overall Study|Withdrawal by Subject|7|||
131564984|NCT03486899|473691693|FG002|Overall Study|Withdrawal by Subject|4|||
131564985|NCT03486899|473691694|FG003|Overall Study|Withdrawal by Subject|3|||
131564986|NCT03486899|473691691|FG000|Overall Study|Other Reasons|0|||
131564987|NCT03486899|473691692|FG001|Overall Study|Other Reasons|1|||
131564988|NCT03486899|473691693|FG002|Overall Study|Other Reasons|0|||
131564989|NCT03486899|473691694|FG003|Overall Study|Other Reasons|1|||
131564990|NCT02559817|473691695|FG000|Treatment Period|Adverse Event|1|||
131564991|NCT02559817|473691696|FG001|Treatment Period|Adverse Event|0|||
131564992|NCT02559817|473691697|FG002|Treatment Period|Adverse Event|1|||
131564993|NCT02559817|473691698|FG003|Treatment Period|Adverse Event|0|||
131564994|NCT02559817|473691699|FG004|Treatment Period|Adverse Event|0|||
131564995|NCT02559817|473691695|FG000|Treatment Period|Lack of Efficacy|0|||
131564996|NCT02559817|473691696|FG001|Treatment Period|Lack of Efficacy|1|||
131564997|NCT02559817|473691697|FG002|Treatment Period|Lack of Efficacy|0|||
131564998|NCT02559817|473691698|FG003|Treatment Period|Lack of Efficacy|0|||
131564999|NCT02559817|473691699|FG004|Treatment Period|Lack of Efficacy|0|||
131565000|NCT02559817|473691695|FG000|Treatment Period|Lost to Follow-up|0|||
131565001|NCT02559817|473691696|FG001|Treatment Period|Lost to Follow-up|1|||
131565002|NCT02559817|473691697|FG002|Treatment Period|Lost to Follow-up|0|||
131565003|NCT02559817|473691698|FG003|Treatment Period|Lost to Follow-up|1|||
131565004|NCT02559817|473691699|FG004|Treatment Period|Lost to Follow-up|0|||
131565005|NCT02559817|473691695|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
131565006|NCT02559817|473691696|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
131565007|NCT02559817|473691697|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
131565008|NCT02559817|473691698|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
131565009|NCT02559817|473691699|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
131565010|NCT02559817|473691695|FG000|Treatment Period|Protocol Violation|0|||
131565011|NCT02559817|473691696|FG001|Treatment Period|Protocol Violation|0|||
131565012|NCT02559817|473691697|FG002|Treatment Period|Protocol Violation|0|||
131565013|NCT02559817|473691698|FG003|Treatment Period|Protocol Violation|1|||
131565014|NCT02559817|473691699|FG004|Treatment Period|Protocol Violation|0|||
131565015|NCT00577720|473691713|FG000|Overall Study|Adverse Event|2|||
131565016|NCT00577720|473691714|FG001|Overall Study|Adverse Event|1|||
131565017|NCT00577720|473691715|FG002|Overall Study|Adverse Event|0|||
131565018|NCT00577720|473691716|FG003|Overall Study|Adverse Event|4|||
131565019|NCT00577720|473691713|FG000|Overall Study|Lost to Follow-up|0|||
131565020|NCT00577720|473691714|FG001|Overall Study|Lost to Follow-up|0|||
131565021|NCT00577720|473691715|FG002|Overall Study|Lost to Follow-up|1|||
131565022|NCT00577720|473691716|FG003|Overall Study|Lost to Follow-up|0|||
131565023|NCT00577720|473691713|FG000|Overall Study|Protocol Violation|0|||
131565024|NCT00577720|473691714|FG001|Overall Study|Protocol Violation|0|||
131565025|NCT00577720|473691715|FG002|Overall Study|Protocol Violation|0|||
131565026|NCT00577720|473691716|FG003|Overall Study|Protocol Violation|1|||
131565027|NCT00577720|473691713|FG000|Overall Study|Withdrawal by Subject|2|||
131565028|NCT00577720|473691714|FG001|Overall Study|Withdrawal by Subject|0|||
131565029|NCT00577720|473691715|FG002|Overall Study|Withdrawal by Subject|0|||
131565030|NCT00577720|473691716|FG003|Overall Study|Withdrawal by Subject|2|||
131565031|NCT03100838|473691717|FG000|Overall Study|Adverse Event|1|||
131565032|NCT03100838|473691718|FG001|Overall Study|Adverse Event|0|||
131565033|NCT03100838|473691719|FG002|Overall Study|Adverse Event|0|||
131565034|NCT03100838|473691720|FG003|Overall Study|Adverse Event|0|||
131565035|NCT03100838|473691717|FG000|Overall Study|Physician Decision|1|||
131565036|NCT03100838|473691718|FG001|Overall Study|Physician Decision|1|||
131565037|NCT03100838|473691719|FG002|Overall Study|Physician Decision|1|||
131565038|NCT03100838|473691720|FG003|Overall Study|Physician Decision|1|||
131565039|NCT03100838|473691717|FG000|Overall Study|Pregnancy|0|||
131565040|NCT03100838|473691718|FG001|Overall Study|Pregnancy|1|||
131565041|NCT03100838|473691719|FG002|Overall Study|Pregnancy|0|||
131565042|NCT03100838|473691720|FG003|Overall Study|Pregnancy|0|||
131565043|NCT03100838|473691717|FG000|Overall Study|Lost to Follow-up|0|||
131565044|NCT03100838|473691718|FG001|Overall Study|Lost to Follow-up|0|||
131565045|NCT03100838|473691719|FG002|Overall Study|Lost to Follow-up|1|||
131565046|NCT03100838|473691720|FG003|Overall Study|Lost to Follow-up|0|||
131565047|NCT02806336|473691721|FG000|Overall Study|Physician Decision|1|||
131565048|NCT02806336|473691722|FG001|Overall Study|Physician Decision|0|||
131565049|NCT02806336|473691721|FG000|Overall Study|Withdrawal by Subject|2|||
131565050|NCT02806336|473691722|FG001|Overall Study|Withdrawal by Subject|4|||
131565051|NCT02806336|473691721|FG000|Overall Study|COVID-19 research shut down|3|||
131565052|NCT02806336|473691722|FG001|Overall Study|COVID-19 research shut down|4|||
131565053|NCT02806336|473691721|FG000|Overall Study|Lack of Efficacy|0|||
131565054|NCT02806336|473691722|FG001|Overall Study|Lack of Efficacy|1|||
131565055|NCT03077620|473691727|FG000|Overall Study|Unable to place lumbar catheter|1|||
131565056|NCT03077620|473691728|FG001|Overall Study|Unable to place lumbar catheter|0|||
131565057|NCT03077620|473691729|FG002|Overall Study|Unable to place lumbar catheter|1|||
131565058|NCT03077620|473691730|FG003|Overall Study|Unable to place lumbar catheter|0|||
131565059|NCT03077620|473691727|FG000|Overall Study|Withdrawal by Subject|0|||
131565060|NCT03077620|473691728|FG001|Overall Study|Withdrawal by Subject|1|||
131782929|NCT01336608|474487790|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131782930|NCT01336608|474487791|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131782931|NCT01336608|474487792|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131782932|NCT01336608|474487789|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
131898640|NCT00215644|474915330|FG001|Overall Study|Adverse Event|9|||
131565061|NCT03077620|473691729|FG002|Overall Study|Withdrawal by Subject|0|||
131565062|NCT03077620|473691730|FG003|Overall Study|Withdrawal by Subject|0|||
131565063|NCT03077620|473691727|FG000|Overall Study|Physician Decision|0|||
131565064|NCT03077620|473691728|FG001|Overall Study|Physician Decision|0|||
131565065|NCT03077620|473691729|FG002|Overall Study|Physician Decision|1|||
131565066|NCT03077620|473691730|FG003|Overall Study|Physician Decision|0|||
131565067|NCT03225846|473691731|FG000|Overall Study|Adverse Event|0|||
131565068|NCT03225846|473691732|FG001|Overall Study|Adverse Event|0|||
131565069|NCT03225846|473691733|FG002|Overall Study|Adverse Event|0|||
131565070|NCT03225846|473691734|FG003|Overall Study|Adverse Event|0|||
131565071|NCT03225846|473691735|FG004|Overall Study|Adverse Event|0|||
131565072|NCT03225846|473691736|FG005|Overall Study|Adverse Event|0|||
131565073|NCT03225846|473691737|FG006|Overall Study|Adverse Event|6|||
131565074|NCT03225846|473691731|FG000|Overall Study|Withdrawal by Subject|0|||
131565075|NCT03225846|473691732|FG001|Overall Study|Withdrawal by Subject|1|||
131565076|NCT03225846|473691733|FG002|Overall Study|Withdrawal by Subject|0|||
131565077|NCT03225846|473691734|FG003|Overall Study|Withdrawal by Subject|0|||
131437274|NCT06418152|473226833|FG000|Overall Study|Withdrawal by Subject|2|||
131437275|NCT03360682|473226834|FG000|Overall Study|Adverse Event|3|||
131437276|NCT01962441|473226835|FG000|Randomized Period|Randomized but Never Treated|4|||
131437277|NCT01962441|473226836|FG001|Randomized Period|Randomized but Never Treated|2|||
131437278|NCT01962441|473226837|FG002|Randomized Period|Randomized but Never Treated|3|||
131437279|NCT01962441|473226835|FG000|Randomized Period|Lost to Follow-up|2|||
131437280|NCT01962441|473226836|FG001|Randomized Period|Lost to Follow-up|4|||
131437281|NCT01962441|473226837|FG002|Randomized Period|Lost to Follow-up|4|||
131437282|NCT01962441|473226835|FG000|Randomized Period|Withdrew Consent|3|||
131437283|NCT01962441|473226836|FG001|Randomized Period|Withdrew Consent|3|||
131437284|NCT01962441|473226837|FG002|Randomized Period|Withdrew Consent|2|||
131437285|NCT01962441|473226835|FG000|Randomized Period|Adverse Event|1|||
131437286|NCT01962441|473226836|FG001|Randomized Period|Adverse Event|1|||
131437287|NCT01962441|473226837|FG002|Randomized Period|Adverse Event|0|||
131437288|NCT01962441|473226835|FG000|Randomized Period|Death|0|||
131437289|NCT01962441|473226836|FG001|Randomized Period|Death|0|||
131437290|NCT01962441|473226837|FG002|Randomized Period|Death|2|||
131437291|NCT01962441|473226835|FG000|Randomized Period|Protocol Violation|0|||
131437292|NCT01962441|473226836|FG001|Randomized Period|Protocol Violation|1|||
131437293|NCT01962441|473226837|FG002|Randomized Period|Protocol Violation|0|||
131437294|NCT01962441|473226835|FG000|Retreatment Substudy|Lack of Efficacy|1|||
131437295|NCT01962441|473226836|FG001|Retreatment Substudy|Lack of Efficacy|0|||
131437296|NCT01962441|473226837|FG002|Retreatment Substudy|Lack of Efficacy|0|||
131437297|NCT01962441|473226835|FG000|Retreatment Substudy|Lost to Follow-up|1|||
131437298|NCT01962441|473226836|FG001|Retreatment Substudy|Lost to Follow-up|0|||
131437299|NCT01962441|473226837|FG002|Retreatment Substudy|Lost to Follow-up|0|||
131437300|NCT02055898|473226838|FG000|First Intervention (5 Days)|Physician Decision|2|||
131437301|NCT02055898|473226839|FG001|First Intervention (5 Days)|Physician Decision|0|||
131437302|NCT02055898|473226838|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
131437303|NCT02055898|473226839|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
131437304|NCT01620060|473226842|FG000|Overall Study|Adverse Event|9|||
131437305|NCT01620060|473226842|FG000|Overall Study|Protocol Violation|1|||
131437306|NCT01620060|473226842|FG000|Overall Study|Withdrawal by Subject|1|||
131437307|NCT01620060|473226842|FG000|Overall Study|Did not comply with Study Produre|1|||
131437308|NCT01620060|473226842|FG000|Overall Study|Family emergency|1|||
131437309|NCT01620060|473226842|FG000|Overall Study|Per Sponsor Decision|2|||
131437310|NCT00231777|473226843|FG000|Overall Study|Lost to Follow-up|3|||
131437311|NCT00231777|473226844|FG001|Overall Study|Lost to Follow-up|0|||
131437312|NCT00231777|473226843|FG000|Overall Study|Other|3|||
131437313|NCT00231777|473226844|FG001|Overall Study|Other|2|||
131437314|NCT03550378|473226847|FG000|Overall Study|Death|0|||
131437315|NCT03550378|473226848|FG001|Overall Study|Death|1|||
131437316|NCT04590014|473226851|FG000|Overall Study|Withdrawal by Subject|1|||
131437317|NCT04590014|473226852|FG001|Overall Study|Withdrawal by Subject|0|||
131437318|NCT00468299|473226853|FG000|Overall Study|Withdrawal by Subject|0|||
131437319|NCT00468299|473226854|FG001|Overall Study|Withdrawal by Subject|1|||
131437320|NCT04908397|473226855|FG000|Overall Study|Withdrawal by Subject|2|||
131437321|NCT04264442|473226856|FG000|Overall Study|Lack of Efficacy|6|||
131437322|NCT04264442|473226856|FG000|Overall Study|Lost to Follow-up|2|||
131437323|NCT04264442|473226856|FG000|Overall Study|Sponsor Decision|23|||
131437324|NCT04264442|473226856|FG000|Overall Study|Withdrawal by Subject|11|||
131565078|NCT03225846|473691735|FG004|Overall Study|Withdrawal by Subject|0|||
131437325|NCT04264442|473226856|FG000|Overall Study|Study Termination|5|||
131437326|NCT01384734|473226858|FG000|Overall Study|Adverse Event|0|||
131437327|NCT01384734|473226859|FG001|Overall Study|Adverse Event|3|||
131437328|NCT01384734|473226860|FG002|Overall Study|Adverse Event|0|||
131437329|NCT01384734|473226861|FG003|Overall Study|Adverse Event|2|||
131437330|NCT01384734|473226862|FG004|Overall Study|Adverse Event|7|||
131437331|NCT01384734|473226858|FG000|Overall Study|Death|1|||
131437332|NCT01384734|473226859|FG001|Overall Study|Death|0|||
131437333|NCT01384734|473226860|FG002|Overall Study|Death|1|||
131437334|NCT01384734|473226861|FG003|Overall Study|Death|0|||
131565079|NCT03225846|473691736|FG005|Overall Study|Withdrawal by Subject|0|||
131565080|NCT03225846|473691737|FG006|Overall Study|Withdrawal by Subject|0|||
131565081|NCT03225846|473691731|FG000|Overall Study|Death|0|||
131565082|NCT03225846|473691732|FG001|Overall Study|Death|1|||
131565083|NCT03225846|473691733|FG002|Overall Study|Death|0|||
131565084|NCT03225846|473691734|FG003|Overall Study|Death|0|||
131565085|NCT03225846|473691735|FG004|Overall Study|Death|0|||
131565086|NCT03225846|473691736|FG005|Overall Study|Death|0|||
131565087|NCT03225846|473691737|FG006|Overall Study|Death|0|||
131565088|NCT03225846|473691731|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
131565089|NCT03225846|473691732|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
131565090|NCT03225846|473691733|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
131565091|NCT03225846|473691734|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
131565092|NCT03225846|473691735|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
131565093|NCT03225846|473691736|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
131565094|NCT03225846|473691737|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
131565095|NCT03225846|473691731|FG000|Overall Study|Patient decision|0|||
131565096|NCT03225846|473691732|FG001|Overall Study|Patient decision|0|||
131565097|NCT03225846|473691733|FG002|Overall Study|Patient decision|0|||
131565098|NCT03225846|473691734|FG003|Overall Study|Patient decision|0|||
131565099|NCT03225846|473691735|FG004|Overall Study|Patient decision|0|||
131565100|NCT03225846|473691736|FG005|Overall Study|Patient decision|0|||
131565101|NCT03225846|473691737|FG006|Overall Study|Patient decision|1|||
131565102|NCT00996580|473691738|FG000|Overall Study|Adverse Event|466|||
131565103|NCT00996580|473691738|FG000|Overall Study|Lost to Follow-up|480|||
131565104|NCT00996580|473691738|FG000|Overall Study|Noncompliance with the protocol|137|||
131565105|NCT00996580|473691738|FG000|Overall Study|Physician Decision|5|||
131565106|NCT00996580|473691738|FG000|Overall Study|Pregnancy|68|||
131565107|NCT00996580|473691738|FG000|Overall Study|Protocol Violation|16|||
131565108|NCT00996580|473691738|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
131565109|NCT00996580|473691738|FG000|Overall Study|Withdrawal by Subject|217|||
131565110|NCT00996580|473691738|FG000|Overall Study|Other|29|||
131565111|NCT04248465|473691739|FG000|Randomized-Controlled Period|Death|12|||
131565112|NCT04248465|473691740|FG001|Randomized-Controlled Period|Death|5|||
131565113|NCT04248465|473691739|FG000|Randomized-Controlled Period|Adverse Event|2|||
131565114|NCT04248465|473691740|FG001|Randomized-Controlled Period|Adverse Event|0|||
131565115|NCT04248465|473691739|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
131565116|NCT04248465|473691740|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
131565117|NCT04248465|473691739|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
131565118|NCT04248465|473691740|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
131565119|NCT04248465|473691739|FG000|Randomized-Controlled Period|Physician Decision|1|||
131565120|NCT04248465|473691740|FG001|Randomized-Controlled Period|Physician Decision|1|||
131565121|NCT04248465|473691739|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
131565122|NCT04248465|473691740|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
131565123|NCT04248465|473691739|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
131565124|NCT04248465|473691740|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
131565125|NCT04248465|473691739|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131782933|NCT01336608|474487790|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131782934|NCT01336608|474487791|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131782935|NCT01336608|474487792|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131782936|NCT01336608|474487789|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
131782937|NCT01336608|474487790|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
131782938|NCT01336608|474487791|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
131782939|NCT01336608|474487792|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
131782940|NCT01336608|474487789|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
131782941|NCT01336608|474487790|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
131782942|NCT01336608|474487791|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
131782943|NCT01336608|474487792|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
131782944|NCT01336608|474487789|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
131565126|NCT04248465|473691740|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
131565127|NCT05708846|473691741|FG000|Overall Study|Death|5|||
131565128|NCT05708846|473691741|FG000|Overall Study|Withdrawal by Subject|20|||
131565129|NCT03621982|473691742|FG000|Overall Study|Withdrawal by Subject|1|||
131782945|NCT01336608|474487790|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131565130|NCT03621982|473691743|FG001|Overall Study|Withdrawal by Subject|0|||
131565131|NCT03621982|473691744|FG002|Overall Study|Withdrawal by Subject|0|||
131565132|NCT03621982|473691745|FG003|Overall Study|Withdrawal by Subject|1|||
131437335|NCT01384734|473226862|FG004|Overall Study|Death|0|||
131437336|NCT01384734|473226858|FG000|Overall Study|Continuation criteria not met|0|||
131437337|NCT01384734|473226859|FG001|Overall Study|Continuation criteria not met|0|||
131437338|NCT01384734|473226860|FG002|Overall Study|Continuation criteria not met|1|||
131437339|NCT01384734|473226861|FG003|Overall Study|Continuation criteria not met|1|||
131437340|NCT01384734|473226862|FG004|Overall Study|Continuation criteria not met|0|||
131437341|NCT01384734|473226858|FG000|Overall Study|Lack of Efficacy|3|||
131437342|NCT01384734|473226859|FG001|Overall Study|Lack of Efficacy|7|||
131437343|NCT01384734|473226860|FG002|Overall Study|Lack of Efficacy|4|||
131437344|NCT01384734|473226861|FG003|Overall Study|Lack of Efficacy|4|||
131437345|NCT01384734|473226862|FG004|Overall Study|Lack of Efficacy|2|||
131437346|NCT01384734|473226858|FG000|Overall Study|Lost to Follow-up|5|||
131437347|NCT01384734|473226859|FG001|Overall Study|Lost to Follow-up|3|||
131437348|NCT01384734|473226860|FG002|Overall Study|Lost to Follow-up|3|||
131437349|NCT01384734|473226861|FG003|Overall Study|Lost to Follow-up|8|||
131437350|NCT01384734|473226862|FG004|Overall Study|Lost to Follow-up|5|||
131437351|NCT01384734|473226858|FG000|Overall Study|Non-compliance with study drug|1|||
131437352|NCT01384734|473226859|FG001|Overall Study|Non-compliance with study drug|2|||
131437353|NCT01384734|473226860|FG002|Overall Study|Non-compliance with study drug|6|||
131437354|NCT01384734|473226861|FG003|Overall Study|Non-compliance with study drug|0|||
131437355|NCT01384734|473226862|FG004|Overall Study|Non-compliance with study drug|2|||
131437356|NCT01384734|473226858|FG000|Overall Study|Pregnancy|0|||
131437357|NCT01384734|473226859|FG001|Overall Study|Pregnancy|1|||
131437358|NCT01384734|473226860|FG002|Overall Study|Pregnancy|0|||
131437359|NCT01384734|473226861|FG003|Overall Study|Pregnancy|0|||
131437360|NCT01384734|473226862|FG004|Overall Study|Pregnancy|1|||
131437361|NCT01384734|473226858|FG000|Overall Study|Sponsor terminated|0|||
131437362|NCT01384734|473226859|FG001|Overall Study|Sponsor terminated|0|||
131437363|NCT01384734|473226860|FG002|Overall Study|Sponsor terminated|0|||
131437364|NCT01384734|473226861|FG003|Overall Study|Sponsor terminated|0|||
131437365|NCT01384734|473226862|FG004|Overall Study|Sponsor terminated|1|||
131437366|NCT01384734|473226858|FG000|Overall Study|Withdrawal by Subject|5|||
131437367|NCT01384734|473226859|FG001|Overall Study|Withdrawal by Subject|5|||
131437368|NCT01384734|473226860|FG002|Overall Study|Withdrawal by Subject|6|||
131437369|NCT01384734|473226861|FG003|Overall Study|Withdrawal by Subject|7|||
131437370|NCT01384734|473226862|FG004|Overall Study|Withdrawal by Subject|9|||
131437371|NCT01384734|473226858|FG000|Overall Study|Investigator relocating|0|||
131437372|NCT01384734|473226859|FG001|Overall Study|Investigator relocating|2|||
131437373|NCT01384734|473226860|FG002|Overall Study|Investigator relocating|0|||
131437374|NCT01384734|473226861|FG003|Overall Study|Investigator relocating|3|||
131437375|NCT01384734|473226862|FG004|Overall Study|Investigator relocating|1|||
131437376|NCT01384734|473226858|FG000|Overall Study|Unable to come back for visit|1|||
131437377|NCT01384734|473226859|FG001|Overall Study|Unable to come back for visit|0|||
131437378|NCT01384734|473226860|FG002|Overall Study|Unable to come back for visit|1|||
131437379|NCT01384734|473226861|FG003|Overall Study|Unable to come back for visit|1|||
131437380|NCT01384734|473226862|FG004|Overall Study|Unable to come back for visit|0|||
131437381|NCT01384734|473226858|FG000|Overall Study|Prison|0|||
131437382|NCT01384734|473226859|FG001|Overall Study|Prison|0|||
131437383|NCT01384734|473226860|FG002|Overall Study|Prison|1|||
131437384|NCT01384734|473226861|FG003|Overall Study|Prison|0|||
131437385|NCT01384734|473226862|FG004|Overall Study|Prison|0|||
131437386|NCT01384734|473226858|FG000|Overall Study|As per Exclusion criteria|0|||
131437387|NCT01384734|473226859|FG001|Overall Study|As per Exclusion criteria|1|||
131437388|NCT01384734|473226860|FG002|Overall Study|As per Exclusion criteria|0|||
131437389|NCT01384734|473226861|FG003|Overall Study|As per Exclusion criteria|0|||
131437390|NCT01384734|473226862|FG004|Overall Study|As per Exclusion criteria|0|||
131437391|NCT01384734|473226858|FG000|Overall Study|Missed End of treatment visit|0|||
131437392|NCT01384734|473226859|FG001|Overall Study|Missed End of treatment visit|0|||
131437393|NCT01384734|473226860|FG002|Overall Study|Missed End of treatment visit|0|||
131437394|NCT01384734|473226861|FG003|Overall Study|Missed End of treatment visit|1|||
131782946|NCT01336608|474487791|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131782947|NCT01336608|474487792|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131782948|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
131782949|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
131565133|NCT03621982|473691746|FG004|Overall Study|Withdrawal by Subject|0|||
131565134|NCT03621982|473691747|FG005|Overall Study|Withdrawal by Subject|1|||
131565135|NCT03621982|473691748|FG006|Overall Study|Withdrawal by Subject|1|||
131565136|NCT03621982|473691749|FG007|Overall Study|Withdrawal by Subject|0|||
131565137|NCT03621982|473691750|FG008|Overall Study|Withdrawal by Subject|1|||
131565138|NCT03621982|473691751|FG009|Overall Study|Withdrawal by Subject|0|||
131565139|NCT03621982|473691752|FG010|Overall Study|Withdrawal by Subject|2|||
131565140|NCT03621982|473691753|FG011|Overall Study|Withdrawal by Subject|1|||
131565141|NCT03621982|473691754|FG012|Overall Study|Withdrawal by Subject|2|||
131565142|NCT03621982|473691755|FG013|Overall Study|Withdrawal by Subject|2|||
131565143|NCT03621982|473691742|FG000|Overall Study|Investigator/Sponsor decision|0|||
131565144|NCT03621982|473691743|FG001|Overall Study|Investigator/Sponsor decision|0|||
131565145|NCT03621982|473691744|FG002|Overall Study|Investigator/Sponsor decision|0|||
131565146|NCT03621982|473691745|FG003|Overall Study|Investigator/Sponsor decision|0|||
131565147|NCT03621982|473691746|FG004|Overall Study|Investigator/Sponsor decision|0|||
131565148|NCT03621982|473691747|FG005|Overall Study|Investigator/Sponsor decision|0|||
131565149|NCT03621982|473691748|FG006|Overall Study|Investigator/Sponsor decision|0|||
131565150|NCT03621982|473691749|FG007|Overall Study|Investigator/Sponsor decision|0|||
131565151|NCT03621982|473691750|FG008|Overall Study|Investigator/Sponsor decision|0|||
131565152|NCT03621982|473691751|FG009|Overall Study|Investigator/Sponsor decision|0|||
131565153|NCT03621982|473691752|FG010|Overall Study|Investigator/Sponsor decision|0|||
131565154|NCT03621982|473691753|FG011|Overall Study|Investigator/Sponsor decision|4|||
131565155|NCT03621982|473691754|FG012|Overall Study|Investigator/Sponsor decision|0|||
131565156|NCT03621982|473691755|FG013|Overall Study|Investigator/Sponsor decision|2|||
131565157|NCT03621982|473691742|FG000|Overall Study|Death|2|||
131565158|NCT03621982|473691743|FG001|Overall Study|Death|4|||
131565159|NCT03621982|473691744|FG002|Overall Study|Death|4|||
131565160|NCT03621982|473691745|FG003|Overall Study|Death|3|||
131565161|NCT03621982|473691746|FG004|Overall Study|Death|8|||
131565162|NCT03621982|473691747|FG005|Overall Study|Death|4|||
131565163|NCT03621982|473691748|FG006|Overall Study|Death|6|||
131565164|NCT03621982|473691749|FG007|Overall Study|Death|3|||
131565165|NCT03621982|473691750|FG008|Overall Study|Death|0|||
131565166|NCT03621982|473691751|FG009|Overall Study|Death|3|||
131565167|NCT03621982|473691752|FG010|Overall Study|Death|8|||
131565168|NCT03621982|473691753|FG011|Overall Study|Death|4|||
131565169|NCT03621982|473691754|FG012|Overall Study|Death|2|||
131565170|NCT03621982|473691755|FG013|Overall Study|Death|2|||
131565171|NCT03621982|473691742|FG000|Overall Study|Lost to Follow-up|0|||
131565172|NCT03621982|473691743|FG001|Overall Study|Lost to Follow-up|0|||
131565173|NCT03621982|473691744|FG002|Overall Study|Lost to Follow-up|1|||
131565174|NCT03621982|473691745|FG003|Overall Study|Lost to Follow-up|0|||
131565175|NCT03621982|473691746|FG004|Overall Study|Lost to Follow-up|0|||
131565176|NCT03621982|473691747|FG005|Overall Study|Lost to Follow-up|0|||
131565177|NCT03621982|473691748|FG006|Overall Study|Lost to Follow-up|1|||
131565178|NCT03621982|473691749|FG007|Overall Study|Lost to Follow-up|0|||
131565179|NCT03621982|473691750|FG008|Overall Study|Lost to Follow-up|0|||
131565180|NCT03621982|473691751|FG009|Overall Study|Lost to Follow-up|1|||
131565181|NCT03621982|473691752|FG010|Overall Study|Lost to Follow-up|0|||
131565182|NCT03621982|473691753|FG011|Overall Study|Lost to Follow-up|0|||
131565183|NCT03621982|473691754|FG012|Overall Study|Lost to Follow-up|0|||
131565184|NCT03621982|473691755|FG013|Overall Study|Lost to Follow-up|0|||
131565185|NCT02036515|473691756|FG000|Overall Study|Adverse Event|1|||
131565186|NCT02036515|473691757|FG001|Overall Study|Adverse Event|1|||
131565187|NCT02036515|473691758|FG002|Overall Study|Adverse Event|2|||
131782950|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
131782951|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
131565188|NCT02036515|473691756|FG000|Overall Study|Lost to Follow-up|0|||
131565189|NCT02036515|473691757|FG001|Overall Study|Lost to Follow-up|2|||
131565190|NCT02036515|473691758|FG002|Overall Study|Lost to Follow-up|0|||
131565191|NCT02036515|473691756|FG000|Overall Study|Non-compliance with study drug|0|||
131565192|NCT02036515|473691757|FG001|Overall Study|Non-compliance with study drug|0|||
131565193|NCT02036515|473691758|FG002|Overall Study|Non-compliance with study drug|2|||
131565194|NCT02036515|473691756|FG000|Overall Study|Screen failure|0|||
131565195|NCT02036515|473691757|FG001|Overall Study|Screen failure|2|||
131782952|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131565196|NCT02036515|473691758|FG002|Overall Study|Screen failure|0|||
131565197|NCT02036515|473691756|FG000|Overall Study|Withdrawal by Subject|4|||
131565198|NCT02036515|473691757|FG001|Overall Study|Withdrawal by Subject|7|||
131565199|NCT02036515|473691758|FG002|Overall Study|Withdrawal by Subject|9|||
131565200|NCT02036515|473691756|FG000|Overall Study|Hyperglycemia|0|||
131565201|NCT02036515|473691757|FG001|Overall Study|Hyperglycemia|0|||
131565202|NCT02036515|473691758|FG002|Overall Study|Hyperglycemia|1|||
131565203|NCT00663962|473691761|FG000|Overall Study|somnolence|1|||
131565204|NCT00663962|473691762|FG001|Overall Study|somnolence|0|||
131565205|NCT01544582|473691763|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
131565206|NCT01544582|473691764|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
131565207|NCT01544582|473691765|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
131565208|NCT01544582|473691766|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
131565209|NCT01544582|473691763|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
131565210|NCT01544582|473691764|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
131565211|NCT01544582|473691765|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
131565212|NCT01544582|473691766|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
131565213|NCT01544582|473691763|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
131565214|NCT01544582|473691764|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
131565215|NCT01544582|473691765|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
131565216|NCT01544582|473691766|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
131565217|NCT01544582|473691763|FG000|Analysis Population|Physician Decision|0|||
131565218|NCT01544582|473691764|FG001|Analysis Population|Physician Decision|13|||
131565219|NCT01544582|473691765|FG002|Analysis Population|Physician Decision|10|||
131565220|NCT01544582|473691766|FG003|Analysis Population|Physician Decision|9|||
131565221|NCT01544582|473691763|FG000|Analysis Population|Safety Reason|0|||
131565222|NCT01544582|473691764|FG001|Analysis Population|Safety Reason|33|||
131565223|NCT01544582|473691765|FG002|Analysis Population|Safety Reason|31|||
131565224|NCT01544582|473691766|FG003|Analysis Population|Safety Reason|8|||
131565225|NCT01544582|473691763|FG000|Analysis Population|Effectiveness Reason|0|||
131565226|NCT01544582|473691764|FG001|Analysis Population|Effectiveness Reason|48|||
131565227|NCT01544582|473691765|FG002|Analysis Population|Effectiveness Reason|29|||
131565228|NCT01544582|473691766|FG003|Analysis Population|Effectiveness Reason|12|||
131565229|NCT01544582|473691763|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
131565230|NCT01544582|473691764|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
131565231|NCT01544582|473691765|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
131565232|NCT01544582|473691766|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
131565233|NCT01544582|473691763|FG000|Analysis Population|Lost to Follow-up|0|||
131565234|NCT01544582|473691764|FG001|Analysis Population|Lost to Follow-up|6|||
131565235|NCT01544582|473691765|FG002|Analysis Population|Lost to Follow-up|6|||
131565236|NCT01544582|473691766|FG003|Analysis Population|Lost to Follow-up|5|||
131565237|NCT01544582|473691763|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
131565238|NCT01544582|473691764|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
131565239|NCT01544582|473691765|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
131565240|NCT01544582|473691766|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
131565241|NCT01544582|473691763|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
131565242|NCT01544582|473691764|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
131565243|NCT01544582|473691765|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
131565244|NCT01544582|473691766|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
131565245|NCT01544582|473691763|FG000|Analysis Population|Intolerance|0|||
131565246|NCT01544582|473691764|FG001|Analysis Population|Intolerance|1|||
131565247|NCT01544582|473691765|FG002|Analysis Population|Intolerance|0|||
131565248|NCT01544582|473691766|FG003|Analysis Population|Intolerance|0|||
131565249|NCT01544582|473691763|FG000|Analysis Population|Liver Transplantation|0|||
131565250|NCT01544582|473691764|FG001|Analysis Population|Liver Transplantation|0|||
131565251|NCT01544582|473691765|FG002|Analysis Population|Liver Transplantation|1|||
131565252|NCT01544582|473691766|FG003|Analysis Population|Liver Transplantation|0|||
131565253|NCT01544582|473691763|FG000|Analysis Population|No Social Insurance|0|||
131565254|NCT01544582|473691764|FG001|Analysis Population|No Social Insurance|0|||
131565255|NCT01544582|473691765|FG002|Analysis Population|No Social Insurance|1|||
131565256|NCT01544582|473691766|FG003|Analysis Population|No Social Insurance|0|||
131565257|NCT01544582|473691763|FG000|Analysis Population|Poor Adherence|0|||
131437395|NCT01384734|473226862|FG004|Overall Study|Missed End of treatment visit|0|||
131437396|NCT01384734|473226858|FG000|Overall Study|Adhesion problem|0|||
131437397|NCT01384734|473226859|FG001|Overall Study|Adhesion problem|0|||
131437398|NCT01384734|473226860|FG002|Overall Study|Adhesion problem|0|||
131437399|NCT01384734|473226861|FG003|Overall Study|Adhesion problem|1|||
131437400|NCT01384734|473226862|FG004|Overall Study|Adhesion problem|0|||
131437401|NCT01384734|473226858|FG000|Overall Study|Early termination|0|||
131437402|NCT01384734|473226859|FG001|Overall Study|Early termination|0|||
131437403|NCT01384734|473226860|FG002|Overall Study|Early termination|0|||
131565258|NCT01544582|473691764|FG001|Analysis Population|Poor Adherence|0|||
131565259|NCT01544582|473691765|FG002|Analysis Population|Poor Adherence|1|||
131437404|NCT01384734|473226861|FG003|Overall Study|Early termination|0|||
131437405|NCT01384734|473226862|FG004|Overall Study|Early termination|1|||
131437406|NCT01384734|473226858|FG000|Overall Study|Physician Decision|1|||
131565260|NCT01544582|473691766|FG003|Analysis Population|Poor Adherence|0|||
131565261|NCT01544582|473691763|FG000|Analysis Population|Poor Participant Compliance|0|||
131565262|NCT01544582|473691764|FG001|Analysis Population|Poor Participant Compliance|1|||
131565263|NCT01544582|473691765|FG002|Analysis Population|Poor Participant Compliance|0|||
131565264|NCT01544582|473691766|FG003|Analysis Population|Poor Participant Compliance|0|||
131565265|NCT01544582|473691763|FG000|Analysis Population|Programmed Surgery|0|||
131565266|NCT01544582|473691764|FG001|Analysis Population|Programmed Surgery|1|||
131565267|NCT01544582|473691765|FG002|Analysis Population|Programmed Surgery|0|||
131565268|NCT01544582|473691766|FG003|Analysis Population|Programmed Surgery|0|||
131565269|NCT01544582|473691763|FG000|Analysis Population|Participant in Jail|0|||
131565270|NCT01544582|473691764|FG001|Analysis Population|Participant in Jail|0|||
131565271|NCT01544582|473691765|FG002|Analysis Population|Participant in Jail|1|||
131565272|NCT01544582|473691766|FG003|Analysis Population|Participant in Jail|0|||
131565273|NCT03428815|473691767|FG000|Overall Study|Lost to Follow-up|2|||
131565274|NCT03428815|473691768|FG001|Overall Study|Lost to Follow-up|2|||
131565275|NCT03428815|473691767|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
131565276|NCT03428815|473691768|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
131565277|NCT03428815|473691767|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
131565278|NCT03428815|473691768|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
131565279|NCT02102464|473691769|FG000|Randomized Study|Withdrawal by Subject|0|||
131565280|NCT02102464|473691770|FG001|Randomized Study|Withdrawal by Subject|1|||
131565281|NCT02102464|473691771|FG002|Randomized Study|Withdrawal by Subject|0|||
131565282|NCT04140890|473691772|FG000|Overall Study|Withdrawal by Subject|0|||
131565283|NCT04140890|473691773|FG001|Overall Study|Withdrawal by Subject|1|||
131565284|NCT01700348|473691774|FG000|Overall Study|Withdrawal by Subject|22|||
131565285|NCT01700348|473691774|FG000|Overall Study|Lost to Follow-up|1|||
131565286|NCT03958630|473691777|FG000|Overall Study|Withdrawal by Subject|0|||
131565287|NCT03958630|473691778|FG001|Overall Study|Withdrawal by Subject|0|||
131565288|NCT03958630|473691779|FG002|Overall Study|Withdrawal by Subject|1|||
131565289|NCT03958630|473691777|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
131565290|NCT03958630|473691778|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
131565291|NCT03958630|473691779|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
131565292|NCT01824472|473691784|FG000|Overall Study|Lost to Follow-up|0|||
131565293|NCT01824472|473691785|FG001|Overall Study|Lost to Follow-up|0|||
131437407|NCT01384734|473226859|FG001|Overall Study|Physician Decision|0|||
131437408|NCT01384734|473226860|FG002|Overall Study|Physician Decision|0|||
131437409|NCT01384734|473226861|FG003|Overall Study|Physician Decision|0|||
131437410|NCT01384734|473226862|FG004|Overall Study|Physician Decision|0|||
131437411|NCT01290523|473226863|FG000|Overall Study|Death|3|||
131437412|NCT03071263|473226864|FG000|Overall Study|Adverse Event|1|||
131437413|NCT03071263|473226865|FG001|Overall Study|Adverse Event|3|||
131437414|NCT03071263|473226864|FG000|Overall Study|Withdrawal by Subject|1|||
131437415|NCT03071263|473226865|FG001|Overall Study|Withdrawal by Subject|3|||
131437416|NCT03071263|473226864|FG000|Overall Study|Physician Decision|1|||
131437417|NCT03071263|473226865|FG001|Overall Study|Physician Decision|0|||
131437418|NCT03071263|473226864|FG000|Overall Study|Participant moved to another city|0|||
131437419|NCT03071263|473226865|FG001|Overall Study|Participant moved to another city|1|||
131565294|NCT01824472|473691786|FG002|Overall Study|Lost to Follow-up|1|||
131565295|NCT01824472|473691784|FG000|Overall Study|Withdrawal by Subject|1|||
131437420|NCT00152503|473226868|FG000|Overall Study|Adverse Event|4|||
131437421|NCT01300234|473226869|FG000|Overall Study|Adverse Event|1|||
131565296|NCT01824472|473691785|FG001|Overall Study|Withdrawal by Subject|5|||
131565297|NCT01824472|473691786|FG002|Overall Study|Withdrawal by Subject|3|||
131565298|NCT01824472|473691784|FG000|Overall Study|Ineligible post randomization&screening|0|||
131565299|NCT01824472|473691785|FG001|Overall Study|Ineligible post randomization&screening|2|||
131565300|NCT01824472|473691786|FG002|Overall Study|Ineligible post randomization&screening|0|||
131565301|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
131565302|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
131565303|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
131565304|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
131565305|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
131565306|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
131565307|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
131565308|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
131565309|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
131565310|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
131565311|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
131565312|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
131565313|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
131565314|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
131565315|NCT01815736|473691787|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
131565316|NCT01815736|473691788|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
131565317|NCT01815736|473691787|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
131565318|NCT01815736|473691788|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
131565319|NCT01815736|473691787|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
131565320|NCT01815736|473691788|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
131565321|NCT01815736|473691787|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
131565322|NCT01815736|473691788|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
131565323|NCT01815736|473691787|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
131565324|NCT01815736|473691788|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
131565325|NCT01815736|473691787|FG000|Extension Treatment Phase- After Week 96|Death|1|||
131565326|NCT01815736|473691788|FG001|Extension Treatment Phase- After Week 96|Death|0|||
131565327|NCT02684903|473691790|FG000|Overall Study|COVID-19 shutdown of lab|4|||
131565328|NCT02684903|473691791|FG001|Overall Study|COVID-19 shutdown of lab|6|||
131565329|NCT02684903|473691790|FG000|Overall Study|Lost to Follow-up|31|||
131565330|NCT02684903|473691791|FG001|Overall Study|Lost to Follow-up|41|||
131565331|NCT01354106|473691792|FG000|Overall Study|Withdrawal by Subject|2|||
131565332|NCT02485353|473692936|FG000|Overall Study|Death|1|||
131565333|NCT02485353|473692936|FG000|Overall Study|Disease Progression|1|||
131565334|NCT05343455|473692939|FG000|Overall Study|Withdrawal by Subject|4|||
131565335|NCT05343455|473692940|FG001|Overall Study|Withdrawal by Subject|9|||
131565336|NCT05343455|473692941|FG002|Overall Study|Withdrawal by Subject|7|||
131565337|NCT05343455|473692939|FG000|Overall Study|Adverse Event|2|||
131565338|NCT05343455|473692940|FG001|Overall Study|Adverse Event|1|||
131565339|NCT05343455|473692941|FG002|Overall Study|Adverse Event|2|||
131565340|NCT05343455|473692939|FG000|Overall Study|Lost to Follow-up|1|||
131565341|NCT05343455|473692940|FG001|Overall Study|Lost to Follow-up|1|||
131565342|NCT05343455|473692941|FG002|Overall Study|Lost to Follow-up|3|||
131565343|NCT05343455|473692939|FG000|Overall Study|Pregnancy|1|||
131565344|NCT05343455|473692940|FG001|Overall Study|Pregnancy|0|||
131565345|NCT05343455|473692941|FG002|Overall Study|Pregnancy|0|||
131565346|NCT05343455|473692939|FG000|Overall Study|Physician Decision|0|||
131565347|NCT05343455|473692940|FG001|Overall Study|Physician Decision|0|||
131565348|NCT05343455|473692941|FG002|Overall Study|Physician Decision|1|||
131565349|NCT05343455|473692939|FG000|Overall Study|Protocol Violation|0|||
131565350|NCT05343455|473692940|FG001|Overall Study|Protocol Violation|1|||
131565351|NCT05343455|473692941|FG002|Overall Study|Protocol Violation|1|||
131565352|NCT02748512|473692946|FG000|Overall Study|Lost to Follow-up|1|||
131565353|NCT02748512|473692947|FG001|Overall Study|Lost to Follow-up|1|||
131565354|NCT03930186|473692949|FG000|Weeks 0 to 16|Adverse Event|6|||
131565355|NCT03930186|473692949|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
131782953|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
131782954|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131782955|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131565356|NCT03930186|473692949|FG000|Weeks 16 to 32|Adverse Event|1|||
131804441|NCT02178722|474568531|FG002|Overall Study|Withdrawal by Subject|0|||
131565357|NCT03930186|473692949|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
131565358|NCT02264574|473692952|FG000|Overall Study|Death|21|||
131565359|NCT02264574|473692953|FG001|Overall Study|Death|21|||
131565360|NCT02264574|473692952|FG000|Overall Study|Withdrawal by Subject|8|||
131565361|NCT02264574|473692953|FG001|Overall Study|Withdrawal by Subject|6|||
131565362|NCT02264574|473692952|FG000|Overall Study|Other, Not Specified|0|||
131565363|NCT02264574|473692953|FG001|Overall Study|Other, Not Specified|3|||
131565364|NCT03415022|473692959|FG000|Overall Study|Withdrawal by Subject|1|||
131565365|NCT03415022|473692960|FG001|Overall Study|Withdrawal by Subject|2|||
131565366|NCT03415022|473692959|FG000|Overall Study|COVID-19 Suspension|2|||
131565367|NCT03415022|473692960|FG001|Overall Study|COVID-19 Suspension|3|||
131565368|NCT03415022|473692959|FG000|Overall Study|Lost to Follow-up|2|||
131565369|NCT03415022|473692960|FG001|Overall Study|Lost to Follow-up|0|||
131565370|NCT04466618|473692961|FG000|Overall Study|Withdrawal by Subject|0|||
131565371|NCT04466618|473692962|FG001|Overall Study|Withdrawal by Subject|1|||
131565372|NCT00884286|473692967|FG000|Overall Study|Progressive disease|21|||
131565373|NCT00884286|473692968|FG001|Overall Study|Progressive disease|28|||
131565374|NCT00884286|473692967|FG000|Overall Study|Toxicity|4|||
131565375|NCT00884286|473692968|FG001|Overall Study|Toxicity|1|||
131565376|NCT00884286|473692967|FG000|Overall Study|Death|2|||
131565377|NCT00884286|473692968|FG001|Overall Study|Death|2|||
131565378|NCT00884286|473692967|FG000|Overall Study|Physician Decision|1|||
131565379|NCT00884286|473692968|FG001|Overall Study|Physician Decision|0|||
131565380|NCT00884286|473692967|FG000|Overall Study|Septic shock|1|||
131565381|NCT00884286|473692968|FG001|Overall Study|Septic shock|0|||
131565382|NCT00884286|473692967|FG000|Overall Study|Thrombus in right auricle|1|||
131565383|NCT00884286|473692968|FG001|Overall Study|Thrombus in right auricle|0|||
131565384|NCT00884286|473692967|FG000|Overall Study|Not treated|2|||
131565385|NCT00884286|473692968|FG001|Overall Study|Not treated|1|||
131565386|NCT00884286|473692967|FG000|Overall Study|Comprised lung carcinoma|0|||
131565387|NCT00884286|473692968|FG001|Overall Study|Comprised lung carcinoma|1|||
131565388|NCT01720797|473692969|FG000|Overall Study|Withdrawal by Subject|3|||
131565389|NCT01720797|473692970|FG001|Overall Study|Withdrawal by Subject|0|||
131565390|NCT02724020|473692975|FG000|Overall Study|Death|16|||
131565391|NCT02724020|473692976|FG001|Overall Study|Death|18|||
131565392|NCT02724020|473692977|FG002|Overall Study|Death|19|||
131565393|NCT02724020|473692975|FG000|Overall Study|Lost to Follow-up|0|||
131565394|NCT02724020|473692976|FG001|Overall Study|Lost to Follow-up|3|||
131565395|NCT02724020|473692977|FG002|Overall Study|Lost to Follow-up|0|||
131565396|NCT02724020|473692975|FG000|Overall Study|Site Terminated by Sponsor|15|||
131565397|NCT02724020|473692976|FG001|Overall Study|Site Terminated by Sponsor|8|||
131565398|NCT02724020|473692977|FG002|Overall Study|Site Terminated by Sponsor|8|||
131565399|NCT02724020|473692975|FG000|Overall Study|Withdrawal by Subject|1|||
131565400|NCT02724020|473692976|FG001|Overall Study|Withdrawal by Subject|3|||
131565401|NCT02724020|473692977|FG002|Overall Study|Withdrawal by Subject|5|||
131565402|NCT02015663|473692978|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
131565403|NCT02015663|473692979|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
131565404|NCT02015663|473692978|FG000|Overall Study|Withdrawal by Subject|1|||
131565405|NCT02015663|473692979|FG001|Overall Study|Withdrawal by Subject|0|||
131565406|NCT02015663|473692978|FG000|Overall Study|Protocol Violation|0|||
131565407|NCT02015663|473692979|FG001|Overall Study|Protocol Violation|1|||
131565408|NCT02015663|473692978|FG000|Overall Study|Adverse Event|3|||
131565409|NCT02015663|473692979|FG001|Overall Study|Adverse Event|0|||
131565410|NCT02015663|473692978|FG000|Overall Study|Administrative problems|10|||
131565411|NCT02015663|473692979|FG001|Overall Study|Administrative problems|11|||
131565412|NCT01656759|473692982|FG000|Overall Study|Protocol Violation|2|||
131565413|NCT01656759|473692983|FG001|Overall Study|Protocol Violation|3|||
131565414|NCT02554513|473692986|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
131565415|NCT02554513|473692987|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
131565416|NCT00184028|473692991|FG000|Overall Study|Death|1|||
131565417|NCT00184028|473692991|FG000|Overall Study|Lack of Efficacy|4|||
131565418|NCT00184028|473692991|FG000|Overall Study|Adverse Event|2|||
131565419|NCT00184028|473692991|FG000|Overall Study|Withdrawal by Subject|1|||
131565420|NCT00184028|473692991|FG000|Overall Study|Non-compliance|2|||
131565421|NCT01354938|473692994|FG000|Overall Study|Lost to Follow-up|1|||
131437422|NCT01300234|473226870|FG001|Overall Study|Adverse Event|1|||
131437423|NCT01300234|473226869|FG000|Overall Study|Protocol Violation|2|||
131437424|NCT01300234|473226870|FG001|Overall Study|Protocol Violation|3|||
131565422|NCT01192295|473692998|FG000|Overall Study|Adverse Event|3|||
131565423|NCT01192295|473692999|FG001|Overall Study|Adverse Event|7|||
131565424|NCT01192295|473692998|FG000|Overall Study|Withdrawal by Subject|3|||
131565425|NCT01192295|473692999|FG001|Overall Study|Withdrawal by Subject|4|||
131565426|NCT01192295|473692998|FG000|Overall Study|Lost to Follow-up|0|||
131565427|NCT01192295|473692999|FG001|Overall Study|Lost to Follow-up|1|||
131565428|NCT01192295|473692998|FG000|Overall Study|Lack of Efficacy|0|||
131565429|NCT01192295|473692999|FG001|Overall Study|Lack of Efficacy|5|||
131565430|NCT01192295|473692998|FG000|Overall Study|Administrative|4|||
131565431|NCT01192295|473692999|FG001|Overall Study|Administrative|6|||
131565432|NCT03785340|473693002|FG000|Overall Study|Lost to Follow-up|2|||
131565433|NCT03785340|473693003|FG001|Overall Study|Lost to Follow-up|0|||
131565434|NCT03785340|473693002|FG000|Overall Study|Adverse Event|1|||
131565435|NCT03785340|473693003|FG001|Overall Study|Adverse Event|0|||
131437425|NCT01300234|473226869|FG000|Overall Study|Withdrawal by Subject|5|||
131565436|NCT01670500|473693010|FG000|Overall Study|Withdrawal by Subject|1|||
131565437|NCT01670500|473693011|FG001|Overall Study|Withdrawal by Subject|0|||
131565438|NCT04320615|473693012|FG000|Overall Study|Withdrawal by Subject|4|||
131565439|NCT04320615|473693013|FG001|Overall Study|Withdrawal by Subject|10|||
131565440|NCT04320615|473693012|FG000|Overall Study|Physician Decision|2|||
131565441|NCT04320615|473693013|FG001|Overall Study|Physician Decision|0|||
131565442|NCT04320615|473693012|FG000|Overall Study|Other|2|||
131565443|NCT04320615|473693013|FG001|Overall Study|Other|0|||
131565444|NCT04320615|473693012|FG000|Overall Study|Lost to Follow-up|5|||
131565445|NCT04320615|473693013|FG001|Overall Study|Lost to Follow-up|23|||
131565446|NCT04320615|473693012|FG000|Overall Study|Death|35|||
131565447|NCT04320615|473693013|FG001|Overall Study|Death|71|||
131565448|NCT01449721|473693014|FG000|Overall Study|Physician Decision|0|||
131565449|NCT01449721|473693015|FG001|Overall Study|Physician Decision|1|||
131565450|NCT01449721|473693014|FG000|Overall Study|Physician Decision|0|||
131565451|NCT01449721|473693015|FG001|Overall Study|Physician Decision|1|||
131565452|NCT00003509|473693016|FG000|Overall Study|Not evaluable|5|||
131565453|NCT03285711|473693017|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
131565454|NCT03285711|473693018|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
131565455|NCT03285711|473693019|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
131565456|NCT03285711|473693020|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
131565457|NCT03285711|473693017|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
131565458|NCT03285711|473693018|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
131565459|NCT03285711|473693019|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
131565460|NCT03285711|473693020|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
131565461|NCT03285711|473693017|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
131565462|NCT03285711|473693018|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
131565463|NCT03285711|473693019|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
131565464|NCT03285711|473693020|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
131565465|NCT03285711|473693017|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
131565466|NCT03285711|473693018|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
131565467|NCT03285711|473693019|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
131565468|NCT03285711|473693020|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
131565469|NCT02107443|473693021|FG000|Overall Study|Death|42|||
131565470|NCT02107443|473693022|FG001|Overall Study|Death|30|||
131565471|NCT02107443|473693021|FG000|Overall Study|Study Protocol Violation|3|||
131565472|NCT02107443|473693022|FG001|Overall Study|Study Protocol Violation|1|||
131565473|NCT02107443|473693021|FG000|Overall Study|Registered but Not Eligible|0|||
131565474|NCT02107443|473693022|FG001|Overall Study|Registered but Not Eligible|1|||
131565475|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
131565476|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
131565477|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
131565478|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
131565479|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Changed Mind|2|||
131565480|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Changed Mind|0|||
131565481|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
131565482|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
131565483|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
131565484|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
131565485|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
131565486|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
131565487|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
131565488|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
131565489|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Other Medical|9|||
131565490|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Other Medical|5|||
131565491|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Disease Progression|4|||
131565492|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Disease Progression|2|||
131782956|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
131782957|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
131782958|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
131782959|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
131782960|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131782961|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
131782962|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
131782963|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
131782964|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
131782965|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
131898641|NCT00215644|474915329|FG000|Overall Study|Death|1|||
131565493|NCT02107443|473693021|FG000|Overall Study|Withdrawal: Personal Issues|0|||
131565494|NCT02107443|473693022|FG001|Overall Study|Withdrawal: Personal Issues|3|||
131565495|NCT00333788|473693023|FG000|Overall Study|Adverse Event|44|||
131565496|NCT00333788|473693023|FG000|Overall Study|Lack of Efficacy|80|||
131565497|NCT00333788|473693023|FG000|Overall Study|Lost to Follow-up|2|||
131565498|NCT00333788|473693023|FG000|Overall Study|Withdrawal by Subject|24|||
131565499|NCT00333788|473693023|FG000|Overall Study|Other: Non-compliance|2|||
131565500|NCT00333788|473693023|FG000|Overall Study|Other: Moved|2|||
131565501|NCT00333788|473693023|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
131565502|NCT00333788|473693023|FG000|Overall Study|Other: Investigator decision|1|||
131565503|NCT00333788|473693023|FG000|Overall Study|Other: Quality of life concern|1|||
131565504|NCT00333788|473693023|FG000|Overall Study|Other: Sponsor decision|1|||
131565505|NCT00333788|473693023|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
131565506|NCT00333788|473693023|FG000|Overall Study|Other: Medical monitor decision|1|||
131565507|NCT00333788|473693023|FG000|Overall Study|Other: Physician decision|1|||
131565508|NCT00333788|473693023|FG000|Overall Study|Other: Signed consent for another study|1|||
131565509|NCT01563978|473693024|FG000|Overall Study|Physician Decision|1|||
131565510|NCT01563978|473693025|FG001|Overall Study|Physician Decision|0|||
131565511|NCT01563978|473693024|FG000|Overall Study|Lost to Follow-up|1|||
131565512|NCT01563978|473693025|FG001|Overall Study|Lost to Follow-up|0|||
131565513|NCT01563978|473693024|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
131565514|NCT01563978|473693025|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
131565515|NCT01563978|473693024|FG000|Overall Study|Adverse Event|1|||
131565516|NCT01563978|473693025|FG001|Overall Study|Adverse Event|2|||
131565517|NCT05764239|473693026|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
131565518|NCT05764239|473693026|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
131565519|NCT05764239|473693026|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
131565520|NCT05764239|473693026|FG000|DEP (Part 1)|Adverse Event|1|||
131565521|NCT05764239|473693026|FG000|DEP (Part 1)|Lost to Follow-up|1|||
131565522|NCT05764239|473693026|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
131565523|NCT05764239|473693026|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
131565524|NCT05764239|473693026|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
131565525|NCT05764239|473693026|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
131565526|NCT04562779|473693030|FG000|Overall Study|Lost to Follow-up|7|||
131565527|NCT04562779|473693031|FG001|Overall Study|Lost to Follow-up|5|||
131565528|NCT04562779|473693032|FG002|Overall Study|Lost to Follow-up|10|||
131565529|NCT04562779|473693030|FG000|Overall Study|Protocol Violation|2|||
131565530|NCT04562779|473693031|FG001|Overall Study|Protocol Violation|2|||
131565531|NCT04562779|473693032|FG002|Overall Study|Protocol Violation|0|||
131565532|NCT00333138|473693033|FG000|Core Study (6 Months)|Adverse Event|4|||
131565533|NCT00333138|473693034|FG001|Core Study (6 Months)|Adverse Event|5|||
131565534|NCT00333138|473693035|FG002|Core Study (6 Months)|Adverse Event|8|||
131565535|NCT00333138|473693033|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
131565536|NCT00333138|473693034|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
131565537|NCT00333138|473693035|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
131565538|NCT00333138|473693033|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
131565539|NCT00333138|473693034|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
131565540|NCT00333138|473693035|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
131565541|NCT00333138|473693033|FG000|Core Study (6 Months)|Protocol Violation|1|||
131565542|NCT00333138|473693034|FG001|Core Study (6 Months)|Protocol Violation|0|||
131565543|NCT00333138|473693035|FG002|Core Study (6 Months)|Protocol Violation|1|||
131565544|NCT00333138|473693033|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
131565545|NCT00333138|473693034|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
131565546|NCT00333138|473693035|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
131565547|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
131565548|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
131565549|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
131565550|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
131565551|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
131565552|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
131565553|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
131565554|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
131565555|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
131565556|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
131565557|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
131565558|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
131565559|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
131565560|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
131565561|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
131565562|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
131565563|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
131565564|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
131565565|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
131565566|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
131565567|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
131565568|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
131565569|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
131565570|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
131565571|NCT00333138|473693033|FG000|Extension Study (Month6 to End of Study)|Death|0|||
131565572|NCT00333138|473693034|FG001|Extension Study (Month6 to End of Study)|Death|1|||
131565573|NCT00333138|473693035|FG002|Extension Study (Month6 to End of Study)|Death|0|||
131565574|NCT02320721|473693036|FG000|Overall Study|Adverse Event|6|||
131565575|NCT02320721|473693037|FG001|Overall Study|Adverse Event|6|||
131565576|NCT02320721|473693036|FG000|Overall Study|Lack of Efficacy|2|||
131565577|NCT02320721|473693037|FG001|Overall Study|Lack of Efficacy|0|||
131565578|NCT02320721|473693036|FG000|Overall Study|Poor compliance to protocol|3|||
131565579|NCT02320721|473693037|FG001|Overall Study|Poor compliance to protocol|7|||
131565580|NCT02320721|473693036|FG000|Overall Study|Randomized but not treated|0|||
131565581|NCT02320721|473693037|FG001|Overall Study|Randomized but not treated|1|||
131565582|NCT02320721|473693036|FG000|Overall Study|Hypoglycemia|1|||
131565583|NCT02320721|473693037|FG001|Overall Study|Hypoglycemia|0|||
131565584|NCT02320721|473693036|FG000|Overall Study|Other than specified above|15|||
131565585|NCT02320721|473693037|FG001|Overall Study|Other than specified above|20|||
131565586|NCT04630756|473693038|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
131565587|NCT04630756|473693039|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
131565588|NCT04630756|473693040|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
131565589|NCT04131907|473693041|FG000|Overall Study|Adverse Event|2|||
131565590|NCT04131907|473693042|FG001|Overall Study|Adverse Event|0|||
131565591|NCT04131907|473693043|FG002|Overall Study|Adverse Event|0|||
131565592|NCT04131907|473693041|FG000|Overall Study|Physician Decision|4|||
131565593|NCT04131907|473693042|FG001|Overall Study|Physician Decision|22|||
131565594|NCT04131907|473693043|FG002|Overall Study|Physician Decision|0|||
131565595|NCT04131907|473693041|FG000|Overall Study|Withdrawal by Subject|2|||
131565596|NCT04131907|473693042|FG001|Overall Study|Withdrawal by Subject|0|||
131565597|NCT04131907|473693043|FG002|Overall Study|Withdrawal by Subject|1|||
131565598|NCT04131907|473693041|FG000|Overall Study|Treatment failure|2|||
131565599|NCT04131907|473693042|FG001|Overall Study|Treatment failure|0|||
131565600|NCT04131907|473693043|FG002|Overall Study|Treatment failure|1|||
131565601|NCT00847301|473693044|FG000|Overall Study|Adverse Event|35|||
131565602|NCT00847301|473693044|FG000|Overall Study|Switch to other anticoagulants|16|||
131565603|NCT00847301|473693044|FG000|Overall Study|Lost to Follow-up|1|||
131565604|NCT00847301|473693044|FG000|Overall Study|No prescription after hospital discharge|1|||
131565605|NCT00847301|473693044|FG000|Overall Study|Other reason not defined above|1|||
131565606|NCT05593211|473693045|FG000|Overall Study|Withdrawal by Subject|1|||
131565607|NCT01778062|473693046|FG000|Overall Study|Adverse Event|1|||
131565608|NCT01778062|473693047|FG001|Overall Study|Adverse Event|3|||
131565609|NCT01778062|473693046|FG000|Overall Study|Consent Withdrawal|1|||
131565610|NCT01778062|473693047|FG001|Overall Study|Consent Withdrawal|5|||
131565611|NCT01778062|473693046|FG000|Overall Study|major protocol deviation|4|||
131565612|NCT01778062|473693047|FG001|Overall Study|major protocol deviation|3|||
131565613|NCT03387514|473693048|FG000|Overall Study|Withdrawal by Subject|2|||
131565614|NCT03387514|473693048|FG000|Overall Study|Physician Decision|1|||
131565615|NCT03387514|473693048|FG000|Overall Study|Lost to Follow-up|2|||
131565616|NCT04445155|473693056|FG000|Overall Study|Lost to Follow-up|11|||
131565617|NCT04445155|473693057|FG001|Overall Study|Lost to Follow-up|2|||
131565618|NCT04445155|473693058|FG002|Overall Study|Lost to Follow-up|3|||
131565619|NCT04445155|473693059|FG003|Overall Study|Lost to Follow-up|0|||
131565620|NCT04445155|473693056|FG000|Overall Study|Withdrawal by Subject|8|||
131565621|NCT04445155|473693057|FG001|Overall Study|Withdrawal by Subject|0|||
131565622|NCT04445155|473693058|FG002|Overall Study|Withdrawal by Subject|0|||
131565623|NCT04445155|473693059|FG003|Overall Study|Withdrawal by Subject|0|||
131565624|NCT04445155|473693056|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
131565625|NCT04445155|473693057|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
131565626|NCT04445155|473693058|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
131565627|NCT04445155|473693059|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
131565628|NCT04445155|473693056|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
131565629|NCT04445155|473693057|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
131565630|NCT04445155|473693058|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
131565631|NCT04445155|473693059|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
131565632|NCT01388543|473693065|FG000|Day 14|Adverse Event|1|||
131565633|NCT01388543|473693066|FG001|Day 14|Adverse Event|4|||
131565634|NCT00394095|473694886|FG000|Screening|Withdrawal by Subject|1|||
131565635|NCT00394095|473694887|FG001|Screening|Withdrawal by Subject|0|||
131565636|NCT00394095|473694886|FG000|Randomized|Withdrawal by Subject|5|||
131565637|NCT00394095|473694887|FG001|Randomized|Withdrawal by Subject|1|||
131565638|NCT00394095|473694886|FG000|Randomized|Adverse Event|1|||
131565639|NCT00394095|473694887|FG001|Randomized|Adverse Event|1|||
131565640|NCT00394095|473694886|FG000|Randomized|Overdose|1|||
131565641|NCT00394095|473694887|FG001|Randomized|Overdose|0|||
131565642|NCT00394095|473694886|FG000|Randomized|Lost to Follow-up|1|||
131565643|NCT00394095|473694887|FG001|Randomized|Lost to Follow-up|2|||
131565644|NCT00777803|473694888|FG000|Overall Study|Lost to Follow-up|12|||
131565645|NCT00777803|473694889|FG001|Overall Study|Lost to Follow-up|5|||
131565646|NCT00777803|473694888|FG000|Overall Study|Adverse Event|1|||
131565647|NCT00777803|473694889|FG001|Overall Study|Adverse Event|0|||
131565648|NCT00777803|473694888|FG000|Overall Study|Non-compliance|2|||
131565649|NCT00777803|473694889|FG001|Overall Study|Non-compliance|2|||
131565650|NCT00731042|473694890|FG000|Second Intervention|Did not meet inclusion criteria|0|||
131565651|NCT00731042|473694891|FG001|Second Intervention|Did not meet inclusion criteria|2|||
131565652|NCT04213846|473694892|FG000|Overall Study|Withdrawal by Subject|7|||
131565653|NCT04213846|473694893|FG001|Overall Study|Withdrawal by Subject|6|||
131565654|NCT04213846|473694892|FG000|Overall Study|Lost to Follow-up|15|||
131565655|NCT04213846|473694893|FG001|Overall Study|Lost to Follow-up|21|||
131565656|NCT04423393|473694894|FG000|Overall Study|Withdrawal by Subject|0|||
131565657|NCT04423393|473694895|FG001|Overall Study|Withdrawal by Subject|0|||
131565658|NCT04423393|473694896|FG002|Overall Study|Withdrawal by Subject|0|||
131565659|NCT04423393|473694897|FG003|Overall Study|Withdrawal by Subject|0|||
131565660|NCT04423393|473694898|FG004|Overall Study|Withdrawal by Subject|0|||
131565661|NCT04423393|473694899|FG005|Overall Study|Withdrawal by Subject|1|||
131565662|NCT04423393|473694900|FG006|Overall Study|Withdrawal by Subject|0|||
131565663|NCT04423393|473694901|FG007|Overall Study|Withdrawal by Subject|0|||
131565664|NCT04423393|473694902|FG008|Overall Study|Withdrawal by Subject|0|||
131565665|NCT04423393|473694903|FG009|Overall Study|Withdrawal by Subject|0|||
131565666|NCT04423393|473694904|FG010|Overall Study|Withdrawal by Subject|0|||
131565667|NCT04423393|473694905|FG011|Overall Study|Withdrawal by Subject|0|||
131565668|NCT04423393|473694906|FG012|Overall Study|Withdrawal by Subject|0|||
131565669|NCT04423393|473694907|FG013|Overall Study|Withdrawal by Subject|1|||
131565670|NCT04423393|473694908|FG014|Overall Study|Withdrawal by Subject|0|||
131565671|NCT04423393|473694909|FG015|Overall Study|Withdrawal by Subject|0|||
131565672|NCT04423393|473694910|FG016|Overall Study|Withdrawal by Subject|0|||
131565673|NCT04423393|473694911|FG017|Overall Study|Withdrawal by Subject|0|||
131565674|NCT04423393|473694894|FG000|Overall Study|Sponsor Decision|0|||
131565675|NCT04423393|473694895|FG001|Overall Study|Sponsor Decision|0|||
131565676|NCT04423393|473694896|FG002|Overall Study|Sponsor Decision|0|||
131565677|NCT04423393|473694897|FG003|Overall Study|Sponsor Decision|0|||
131565678|NCT04423393|473694898|FG004|Overall Study|Sponsor Decision|0|||
131565679|NCT04423393|473694899|FG005|Overall Study|Sponsor Decision|0|||
131565680|NCT04423393|473694900|FG006|Overall Study|Sponsor Decision|0|||
131565681|NCT04423393|473694901|FG007|Overall Study|Sponsor Decision|0|||
131565682|NCT04423393|473694902|FG008|Overall Study|Sponsor Decision|0|||
131565683|NCT04423393|473694903|FG009|Overall Study|Sponsor Decision|0|||
131565684|NCT04423393|473694904|FG010|Overall Study|Sponsor Decision|0|||
131565685|NCT04423393|473694905|FG011|Overall Study|Sponsor Decision|0|||
131565686|NCT04423393|473694906|FG012|Overall Study|Sponsor Decision|0|||
131565687|NCT04423393|473694907|FG013|Overall Study|Sponsor Decision|1|||
131782966|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
131437426|NCT01300234|473226870|FG001|Overall Study|Withdrawal by Subject|9|||
131437427|NCT01300234|473226869|FG000|Overall Study|Lost to Follow-up|14|||
131437428|NCT01300234|473226870|FG001|Overall Study|Lost to Follow-up|12|||
131437429|NCT01300234|473226869|FG000|Overall Study|Pregnancy|2|||
131437430|NCT01300234|473226870|FG001|Overall Study|Pregnancy|1|||
131437431|NCT01300234|473226869|FG000|Overall Study|Participant reached stopping critera|2|||
131565688|NCT04423393|473694908|FG014|Overall Study|Sponsor Decision|0|||
131565689|NCT04423393|473694909|FG015|Overall Study|Sponsor Decision|0|||
131565690|NCT04423393|473694910|FG016|Overall Study|Sponsor Decision|0|||
131565691|NCT04423393|473694911|FG017|Overall Study|Sponsor Decision|0|||
131565692|NCT00802841|473694912|FG000|Overall Study|Administrative problems|1|||
131565693|NCT00802841|473694913|FG001|Overall Study|Administrative problems|0|||
131565694|NCT00802841|473694912|FG000|Overall Study|Lost to Follow-up|2|||
131565695|NCT00802841|473694913|FG001|Overall Study|Lost to Follow-up|1|||
131565696|NCT00802841|473694912|FG000|Overall Study|Death|1|||
131565697|NCT00802841|473694913|FG001|Overall Study|Death|2|||
131565698|NCT00802841|473694912|FG000|Overall Study|Adverse Event|8|||
131437432|NCT01300234|473226870|FG001|Overall Study|Participant reached stopping critera|0|||
131565699|NCT00802841|473694913|FG001|Overall Study|Adverse Event|2|||
131565700|NCT00802841|473694912|FG000|Overall Study|Disease progression|7|||
131565701|NCT00802841|473694913|FG001|Overall Study|Disease progression|3|||
131565702|NCT00802841|473694912|FG000|Overall Study|Withdrawal by Subject|9|||
131565703|NCT00802841|473694913|FG001|Overall Study|Withdrawal by Subject|5|||
131565704|NCT00802841|473694912|FG000|Overall Study|Protocol deviation|2|||
131565705|NCT00802841|473694913|FG001|Overall Study|Protocol deviation|6|||
131565706|NCT00802841|473694912|FG000|Overall Study|Treatment duration completed|66|||
131565707|NCT00802841|473694913|FG001|Overall Study|Treatment duration completed|76|||
131565708|NCT01115998|473694919|FG000|Overall Study|Lost to Follow-up|6|||
131565709|NCT01115998|473694920|FG001|Overall Study|Lost to Follow-up|6|||
131565710|NCT02819479|473694921|FG000|Overall Study|Adverse Event|2|||
131565711|NCT03531905|473694922|FG000|Overall Study|Withdrawal by Subject|3|||
131565712|NCT03531905|473694923|FG001|Overall Study|Withdrawal by Subject|3|||
131565713|NCT03531905|473694924|FG002|Overall Study|Withdrawal by Subject|2|||
131565714|NCT03531905|473694922|FG000|Overall Study|Lost to Follow-up|2|||
131565715|NCT03531905|473694923|FG001|Overall Study|Lost to Follow-up|2|||
131565716|NCT03531905|473694924|FG002|Overall Study|Lost to Follow-up|1|||
131565717|NCT03531905|473694922|FG000|Overall Study|Participant was out of town|1|||
131565718|NCT03531905|473694923|FG001|Overall Study|Participant was out of town|0|||
131565719|NCT03531905|473694924|FG002|Overall Study|Participant was out of town|0|||
131565720|NCT03531905|473694922|FG000|Overall Study|Could not speak with the participant|1|||
131565721|NCT03531905|473694923|FG001|Overall Study|Could not speak with the participant|0|||
131565722|NCT03531905|473694924|FG002|Overall Study|Could not speak with the participant|0|||
131565723|NCT01646320|473694932|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
131565724|NCT01646320|473694933|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
131565725|NCT01646320|473694932|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
131565726|NCT01646320|473694933|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
131565727|NCT01646320|473694932|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
131565728|NCT01646320|473694933|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
131565729|NCT01646320|473694932|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
131565730|NCT01646320|473694933|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
131565731|NCT01646320|473694932|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131565732|NCT01646320|473694933|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131565733|NCT01646320|473694932|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
131565734|NCT01646320|473694933|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
131565735|NCT01646320|473694932|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
131565736|NCT01646320|473694933|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
131565737|NCT01646320|473694932|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
131565738|NCT01646320|473694933|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
131565739|NCT01646320|473694932|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
131565740|NCT01646320|473694933|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
131565741|NCT01646320|473694932|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
131565742|NCT01646320|473694933|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
131565743|NCT01646320|473694932|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
131565744|NCT01646320|473694933|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
131565745|NCT01155726|473694934|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
131565746|NCT01155726|473694935|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
131565747|NCT01155726|473694936|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
131565748|NCT01155726|473694937|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
131565749|NCT01489020|473694938|FG000|Overall Study|Withdrawal by Subject|1|||
131565750|NCT01489020|473694939|FG001|Overall Study|Withdrawal by Subject|0|||
131565751|NCT01489020|473694940|FG002|Overall Study|Withdrawal by Subject|0|||
131565752|NCT01489020|473694941|FG003|Overall Study|Withdrawal by Subject|0|||
131565753|NCT01489020|473694942|FG004|Overall Study|Withdrawal by Subject|0|||
131565754|NCT01489020|473694943|FG005|Overall Study|Withdrawal by Subject|0|||
131696982|NCT02264990|474174015|FG000|Overall Study|Withdrawal by Subject|4|||
131565755|NCT01489020|473694938|FG000|Overall Study|Adverse Event|0|||
131565756|NCT01489020|473694939|FG001|Overall Study|Adverse Event|0|||
131565757|NCT01489020|473694940|FG002|Overall Study|Adverse Event|3|||
131565758|NCT01489020|473694941|FG003|Overall Study|Adverse Event|0|||
131565759|NCT01489020|473694942|FG004|Overall Study|Adverse Event|3|||
131565760|NCT01489020|473694943|FG005|Overall Study|Adverse Event|0|||
131565761|NCT01489020|473694938|FG000|Overall Study|Concomitant disease|0|||
131565762|NCT01489020|473694939|FG001|Overall Study|Concomitant disease|0|||
131565763|NCT01489020|473694940|FG002|Overall Study|Concomitant disease|0|||
131565764|NCT01489020|473694941|FG003|Overall Study|Concomitant disease|0|||
131565765|NCT01489020|473694942|FG004|Overall Study|Concomitant disease|3|||
131565766|NCT01489020|473694943|FG005|Overall Study|Concomitant disease|0|||
131565767|NCT01174550|473694944|FG000|Overall Study|Death|75|||
131565768|NCT01174550|473694945|FG001|Overall Study|Death|74|||
131565769|NCT01174550|473694944|FG000|Overall Study|Lost to Follow-up|652|||
131565770|NCT01174550|473694945|FG001|Overall Study|Lost to Follow-up|510|||
131565771|NCT01174550|473694944|FG000|Overall Study|Withdrawal by Subject|543|||
131565772|NCT01174550|473694945|FG001|Overall Study|Withdrawal by Subject|289|||
131565773|NCT01536262|473694946|FG000|Overall Study|Adverse Event|6|||
131565774|NCT01536262|473694947|FG001|Overall Study|Adverse Event|1|||
131565775|NCT01536262|473694948|FG002|Overall Study|Adverse Event|2|||
131565776|NCT01536262|473694946|FG000|Overall Study|Withdrawal by Subject|1|||
131565777|NCT01536262|473694947|FG001|Overall Study|Withdrawal by Subject|1|||
131565778|NCT01536262|473694948|FG002|Overall Study|Withdrawal by Subject|0|||
131565779|NCT01536262|473694946|FG000|Overall Study|Other than stated above|1|||
131565780|NCT01536262|473694947|FG001|Overall Study|Other than stated above|0|||
131565781|NCT01536262|473694948|FG002|Overall Study|Other than stated above|0|||
131565782|NCT05257837|473694952|FG000|Overall Study|Excluded (did not find the guns)|4|||
131565783|NCT05257837|473694953|FG001|Overall Study|Excluded (did not find the guns)|2|||
131565784|NCT05257837|473694954|FG002|Overall Study|Excluded (did not find the guns)|4|||
131565785|NCT05257837|473694955|FG003|Overall Study|Excluded (did not find the guns)|0|||
131565786|NCT01781611|473694956|FG000|Overall Study|Adverse Event|4|||
131565787|NCT01781611|473694957|FG001|Overall Study|Adverse Event|0|||
131565788|NCT01625338|473694958|FG000|Overall Study|Enrolled but not Treated|0|||
131565789|NCT01625338|473694959|FG001|Overall Study|Enrolled but not Treated|0|||
131565790|NCT01625338|473694960|FG002|Overall Study|Enrolled but not Treated|1|||
131565791|NCT01625338|473694958|FG000|Overall Study|Efficacy Failure|27|||
131565792|NCT01625338|473694959|FG001|Overall Study|Efficacy Failure|39|||
131565793|NCT01625338|473694960|FG002|Overall Study|Efficacy Failure|31|||
131565794|NCT01625338|473694958|FG000|Overall Study|Lost to Follow-up|3|||
131565795|NCT01625338|473694959|FG001|Overall Study|Lost to Follow-up|3|||
131565796|NCT01625338|473694960|FG002|Overall Study|Lost to Follow-up|2|||
131565797|NCT01625338|473694958|FG000|Overall Study|Investigator Decision|0|||
131565798|NCT01625338|473694959|FG001|Overall Study|Investigator Decision|2|||
131565799|NCT01625338|473694960|FG002|Overall Study|Investigator Decision|1|||
131565800|NCT01625338|473694958|FG000|Overall Study|Subject Withdrew Consent|1|||
131565801|NCT01625338|473694959|FG001|Overall Study|Subject Withdrew Consent|0|||
131565802|NCT01625338|473694960|FG002|Overall Study|Subject Withdrew Consent|2|||
131565803|NCT01625338|473694958|FG000|Overall Study|Adverse Event|1|||
131565804|NCT01625338|473694959|FG001|Overall Study|Adverse Event|0|||
131565805|NCT01625338|473694960|FG002|Overall Study|Adverse Event|1|||
131565806|NCT01625338|473694958|FG000|Overall Study|Study Discontinued by Sponsor|0|||
131565807|NCT01625338|473694959|FG001|Overall Study|Study Discontinued by Sponsor|0|||
131565808|NCT01625338|473694960|FG002|Overall Study|Study Discontinued by Sponsor|1|||
131565809|NCT03639675|473694961|FG000|Overall Study|Withdrawal by Subject|1|||
131565810|NCT02459587|473694962|FG000|3-Month Follow-up Assessment|Death|0|||
131565811|NCT02459587|473694963|FG001|3-Month Follow-up Assessment|Death|2|||
131565812|NCT02459587|473694962|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
131565813|NCT02459587|473694963|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
131565814|NCT02459587|473694962|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
131437433|NCT01300234|473226869|FG000|Overall Study|Participant stopped medication|1|||
131565815|NCT02459587|473694963|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
131565816|NCT02459587|473694962|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
131565817|NCT02459587|473694963|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
131565818|NCT02459587|473694962|FG000|6-month Follow-up Assessment|Death|2|||
131565819|NCT02459587|473694963|FG001|6-month Follow-up Assessment|Death|1|||
131565820|NCT02459587|473694962|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
131898642|NCT00215644|474915330|FG001|Overall Study|Death|2|||
131565821|NCT02459587|473694963|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
131565822|NCT02459587|473694962|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
131565823|NCT02459587|473694963|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
131565824|NCT02459587|473694962|FG000|12-month Follow-up Assessment|Death|2|||
131565825|NCT02459587|473694963|FG001|12-month Follow-up Assessment|Death|0|||
131565826|NCT02459587|473694962|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
131565827|NCT02459587|473694963|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
131565828|NCT02459587|473694962|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
131565829|NCT02459587|473694963|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
131565830|NCT02459587|473694962|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
131565831|NCT02459587|473694963|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
131565832|NCT01021332|473694964|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
131565833|NCT01021332|473694964|FG000|Overall Study|Adverse Event|43|||
131565834|NCT01021332|473694964|FG000|Overall Study|Lack of Efficacy|19|||
131565835|NCT01021332|473694964|FG000|Overall Study|Withdrawal of Consent|23|||
131565836|NCT01021332|473694964|FG000|Overall Study|Lost to Follow-up|4|||
131565837|NCT01021332|473694964|FG000|Overall Study|Protocol Violation|9|||
131565838|NCT01021332|473694964|FG000|Overall Study|Miscellaneous|3|||
131565839|NCT03487666|473694967|FG000|Overall Study|Disease progression|4|||
131565840|NCT03487666|473694968|FG001|Overall Study|Disease progression|2|||
131565841|NCT03487666|473694969|FG002|Overall Study|Disease progression|0|||
131565842|NCT03487666|473694967|FG000|Overall Study|Adverse Event|0|||
131565843|NCT03487666|473694968|FG001|Overall Study|Adverse Event|0|||
131565844|NCT03487666|473694969|FG002|Overall Study|Adverse Event|1|||
131565845|NCT00031447|473694970|FG000|Overall Study|Lost to Follow-up|0|||
131565846|NCT00031447|473694971|FG001|Overall Study|Lost to Follow-up|1|||
131565847|NCT00031447|473694970|FG000|Overall Study|Non-compliant|1|||
131565848|NCT00031447|473694971|FG001|Overall Study|Non-compliant|1|||
131565849|NCT00031447|473694970|FG000|Overall Study|Re-activation of Disease|2|||
131565850|NCT00031447|473694971|FG001|Overall Study|Re-activation of Disease|1|||
131565851|NCT00031447|473694970|FG000|Overall Study|Disruption of blinded study drug supply|7|||
131565852|NCT00031447|473694971|FG001|Overall Study|Disruption of blinded study drug supply|4|||
131565853|NCT01636362|473694972|FG000|Overall Study|Physician Decision|6|||
131565854|NCT01636362|473694972|FG000|Overall Study|Subject healed, not returning|1|||
131565855|NCT01636362|473694972|FG000|Overall Study|Withdrawal by Subject|1|||
131565856|NCT03302910|473694974|FG000|Overall Study|Protocol Violation|1|||
131565857|NCT03302910|473694975|FG001|Overall Study|Protocol Violation|0|||
131565858|NCT01477749|473694976|FG000|Overall Study|Physician Decision|4|||
131565859|NCT02886728|473694978|FG000|Overall Study|Withdrew Consent|31|||
131565860|NCT02886728|473694979|FG001|Overall Study|Withdrew Consent|13|||
131565861|NCT02886728|473694980|FG002|Overall Study|Withdrew Consent|11|||
131565862|NCT02886728|473694981|FG003|Overall Study|Withdrew Consent|47|||
131565863|NCT02886728|473694978|FG000|Overall Study|Lost to Follow-up|12|||
131565864|NCT02886728|473694979|FG001|Overall Study|Lost to Follow-up|6|||
131565865|NCT02886728|473694980|FG002|Overall Study|Lost to Follow-up|13|||
131565866|NCT02886728|473694981|FG003|Overall Study|Lost to Follow-up|12|||
131565867|NCT02886728|473694978|FG000|Overall Study|Adverse Event|13|||
131565868|NCT02886728|473694979|FG001|Overall Study|Adverse Event|5|||
131565869|NCT02886728|473694980|FG002|Overall Study|Adverse Event|5|||
131565870|NCT02886728|473694981|FG003|Overall Study|Adverse Event|11|||
131565871|NCT02886728|473694978|FG000|Overall Study|Investigator's Discretion|11|||
131565872|NCT02886728|473694979|FG001|Overall Study|Investigator's Discretion|7|||
131565873|NCT02886728|473694980|FG002|Overall Study|Investigator's Discretion|5|||
131565874|NCT02886728|473694981|FG003|Overall Study|Investigator's Discretion|11|||
131565875|NCT02886728|473694978|FG000|Overall Study|Death|3|||
131565876|NCT02886728|473694979|FG001|Overall Study|Death|1|||
131565877|NCT02886728|473694980|FG002|Overall Study|Death|0|||
131565878|NCT02886728|473694981|FG003|Overall Study|Death|0|||
131565879|NCT02886728|473694978|FG000|Overall Study|Protocol Violation|0|||
131565880|NCT02886728|473694979|FG001|Overall Study|Protocol Violation|0|||
131565881|NCT02886728|473694980|FG002|Overall Study|Protocol Violation|0|||
131782967|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
131782968|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131565882|NCT02886728|473694981|FG003|Overall Study|Protocol Violation|4|||
131565883|NCT02886728|473694978|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131565884|NCT02886728|473694979|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131565885|NCT02886728|473694980|FG002|Overall Study|Non-Compliance with Study Drug|1|||
131565886|NCT02886728|473694981|FG003|Overall Study|Non-Compliance with Study Drug|0|||
131782969|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
131782970|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131565887|NCT02886728|473694978|FG000|Overall Study|Pregnancy|0|||
131565888|NCT02886728|473694979|FG001|Overall Study|Pregnancy|0|||
131565889|NCT02886728|473694980|FG002|Overall Study|Pregnancy|1|||
131565890|NCT02886728|473694981|FG003|Overall Study|Pregnancy|0|||
131565891|NCT02886728|473694978|FG000|Overall Study|Randomized but Not Dosed|1|||
131565892|NCT02886728|473694979|FG001|Overall Study|Randomized but Not Dosed|0|||
131565893|NCT02886728|473694980|FG002|Overall Study|Randomized but Not Dosed|0|||
131565894|NCT02886728|473694981|FG003|Overall Study|Randomized but Not Dosed|2|||
131565895|NCT04990440|473694992|FG000|Overall Study|Sponsor's Decision|0|||
131565896|NCT04990440|473694993|FG001|Overall Study|Sponsor's Decision|0|||
131565897|NCT04990440|473694994|FG002|Overall Study|Sponsor's Decision|1|||
131565898|NCT03712098|473694995|FG000|Overall Study|Lost to Follow-up|3|||
131565899|NCT03712098|473694996|FG001|Overall Study|Lost to Follow-up|7|||
131565900|NCT03712098|473694995|FG000|Overall Study|Withdrawal by Subject|9|||
131565901|NCT03712098|473694996|FG001|Overall Study|Withdrawal by Subject|4|||
131565902|NCT03712098|473694995|FG000|Overall Study|Protocol Violation|2|||
131565903|NCT03712098|473694996|FG001|Overall Study|Protocol Violation|1|||
131565904|NCT00724061|473694997|FG000|Dose Escalation Phase|Adverse Event|2|||
131565905|NCT00724061|473694997|FG000|Dose Escalation Phase|Disease Progression|3|||
131565906|NCT00953160|473695000|FG000|Overall Study|Lost to Follow-up|23|||
131565907|NCT00953160|473695000|FG000|Overall Study|Withdrawal by Subject|4|||
131565908|NCT00425503|473695003|FG000|Overall Study|Adverse Event|2|||
131565909|NCT00425503|473695003|FG000|Overall Study|Protocol Violation|1|||
131565910|NCT02118714|473695004|FG000|Overall Study|Lost to Follow-up|2|||
131565911|NCT02118714|473695004|FG000|Overall Study|Protocol Violation|1|||
131565912|NCT02954575|473695005|FG000|Overall Study|Withdrawal by Subject|2|||
131565913|NCT02954575|473695005|FG000|Overall Study|Adverse Event|1|||
131565914|NCT01066156|473695007|FG000|Overall Study|ineligible|2|||
131565915|NCT01066156|473695007|FG000|Overall Study|Lost to Follow-up|7|||
131565916|NCT01066156|473695007|FG000|Overall Study|Withdrawal by Subject|1|||
131565917|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
131565918|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
131565919|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
131565920|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
131565921|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
131565922|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
131565923|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
131565924|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
131565925|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
131565926|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
131565927|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
131565928|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
131565929|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
131565930|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
131565931|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
131565932|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
131565933|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
131565934|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
131565935|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
131565936|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
131565937|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
131565938|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
131565939|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
131565940|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
131565941|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
131565942|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
131565943|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
131565944|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
131565945|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
131565946|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
131565947|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
131565948|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
131565949|NCT03890120|473695011|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
131565950|NCT03890120|473695012|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
131565951|NCT03890120|473695013|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
131565952|NCT03890120|473695014|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
131565953|NCT03890120|473695011|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
131565954|NCT03890120|473695012|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
131565955|NCT03890120|473695013|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
131565956|NCT03890120|473695014|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
131565957|NCT03890120|473695011|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
131565958|NCT03890120|473695012|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
131565959|NCT03890120|473695013|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
131565960|NCT03890120|473695014|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
131565961|NCT03890120|473695011|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
131565962|NCT03890120|473695012|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
131565963|NCT03890120|473695013|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
131565964|NCT03890120|473695014|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
131565965|NCT03890120|473695011|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
131565966|NCT03890120|473695012|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
131565967|NCT03890120|473695013|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
131782971|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131782972|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
131782973|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
131782974|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
131782975|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
131782976|NCT01336608|474487789|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131782977|NCT01336608|474487790|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
131782978|NCT01336608|474487791|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
131782979|NCT01336608|474487792|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
131782980|NCT02253654|474487793|FG000|Overall Study|Withdrawal by Subject|12|||
131782981|NCT02253654|474487794|FG001|Overall Study|Withdrawal by Subject|4|||
131782982|NCT02253654|474487793|FG000|Overall Study|Decision by Sponsor|1|||
131782983|NCT02253654|474487794|FG001|Overall Study|Decision by Sponsor|1|||
131782984|NCT02253654|474487793|FG000|Overall Study|Lost to Follow-up|2|||
131782985|NCT02253654|474487794|FG001|Overall Study|Lost to Follow-up|5|||
131782986|NCT02253654|474487793|FG000|Overall Study|Death|4|||
131782987|NCT02253654|474487794|FG001|Overall Study|Death|7|||
131782988|NCT02253654|474487793|FG000|Overall Study|Did Not Receive Study Treatment|4|||
131782989|NCT02253654|474487794|FG001|Overall Study|Did Not Receive Study Treatment|1|||
131782990|NCT00306852|474487799|FG000|Overall Study|Death|14|||
131782991|NCT00306852|474487800|FG001|Overall Study|Death|14|||
131782992|NCT00306852|474487799|FG000|Overall Study|Lost to Follow-up|15|||
131782993|NCT00306852|474487800|FG001|Overall Study|Lost to Follow-up|24|||
131782994|NCT00883740|474487801|FG000|First Intervention|Lost to Follow-up|1|||
131782995|NCT00883740|474487802|FG001|First Intervention|Lost to Follow-up|0|||
131782996|NCT00883740|474487801|FG000|First Intervention|No longer willing to participate|2|||
131782997|NCT00883740|474487802|FG001|First Intervention|No longer willing to participate|0|||
131782998|NCT00883740|474487801|FG000|First Intervention|Protocol Violation|3|||
131782999|NCT00883740|474487802|FG001|First Intervention|Protocol Violation|6|||
131783000|NCT00883740|474487801|FG000|First Intervention|Adverse Event|1|||
131783001|NCT00883740|474487802|FG001|First Intervention|Adverse Event|2|||
131783002|NCT00883740|474487801|FG000|Second Intervention|Protocol Violation|1|||
131783003|NCT00883740|474487802|FG001|Second Intervention|Protocol Violation|0|||
131783004|NCT00883740|474487801|FG000|Second Intervention|No longer willing to participate|0|||
131783005|NCT00883740|474487802|FG001|Second Intervention|No longer willing to participate|1|||
131783006|NCT03543046|474487807|FG000|Overall Study|Adverse Event|1|||
131783007|NCT03543046|474487808|FG001|Overall Study|Adverse Event|1|||
131783008|NCT03543046|474487807|FG000|Overall Study|Physician Decision|1|||
131565968|NCT03890120|473695014|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
131565969|NCT02400307|473695015|FG000|Overall Study|Enrolled and Never Dosed|1|||
131783009|NCT03543046|474487808|FG001|Overall Study|Physician Decision|1|||
131783010|NCT03543046|474487807|FG000|Overall Study|Protocol Violation|1|||
131783011|NCT03543046|474487808|FG001|Overall Study|Protocol Violation|0|||
131783012|NCT03869684|474487809|FG000|Overall Study|Adverse Event|0|||
131565970|NCT02400307|473695016|FG001|Overall Study|Enrolled and Never Dosed|0|||
131565971|NCT00479674|473695018|FG000|Overall Study|Adverse Event|18|||
131565972|NCT00479674|473695018|FG000|Overall Study|Withdrawal by Subject|6|||
131565973|NCT00479674|473695018|FG000|Overall Study|Physician Decision|14|||
131565974|NCT00479674|473695018|FG000|Overall Study|none provided|3|||
131565975|NCT00146640|473695022|FG000|Overall Study|Adverse Event|12|||
131565976|NCT00146640|473695023|FG001|Overall Study|Adverse Event|10|||
131565977|NCT00146640|473695022|FG000|Overall Study|Medical Reasons|3|||
131565978|NCT00146640|473695023|FG001|Overall Study|Medical Reasons|0|||
131565979|NCT00146640|473695022|FG000|Overall Study|Non-Medical Reasons|8|||
131565980|NCT00146640|473695023|FG001|Overall Study|Non-Medical Reasons|4|||
131565981|NCT02839681|473695024|FG000|Overall Study|Death|2|||
131565982|NCT02687919|473695025|FG000|Overall Study|Withdrawal by Subject|6|||
131565983|NCT02687919|473695026|FG001|Overall Study|Withdrawal by Subject|6|||
131565984|NCT02687919|473695025|FG000|Overall Study|Protocol Violation|2|||
131565985|NCT02687919|473695026|FG001|Overall Study|Protocol Violation|0|||
131565986|NCT00131911|473695032|FG000|Overall Study|Withdrawal by Subject|1|||
131565987|NCT00131911|473695033|FG001|Overall Study|Withdrawal by Subject|0|||
131565988|NCT00329303|473695034|FG000|Overall Study|Lack of Efficacy|1|||
131565989|NCT00329303|473695035|FG001|Overall Study|Lack of Efficacy|0|||
131565990|NCT00329303|473695034|FG000|Overall Study|Decision of the sponsor|0|||
131565991|NCT00329303|473695035|FG001|Overall Study|Decision of the sponsor|1|||
131565992|NCT00329303|473695034|FG000|Overall Study|Patient no longer available|1|||
131565993|NCT00329303|473695035|FG001|Overall Study|Patient no longer available|0|||
131565994|NCT00329303|473695034|FG000|Overall Study|Patient relocated|0|||
131437434|NCT01300234|473226870|FG001|Overall Study|Participant stopped medication|1|||
131437435|NCT01300234|473226869|FG000|Overall Study|Participant refused return to hospital|1|||
131437436|NCT01300234|473226870|FG001|Overall Study|Participant refused return to hospital|0|||
131437437|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
131565995|NCT00329303|473695035|FG001|Overall Study|Patient relocated|1|||
131783013|NCT03869684|474487810|FG001|Overall Study|Adverse Event|3|||
131565996|NCT02335268|473695037|FG000|Overall Study|Physician Decision|5|||
131565997|NCT02335268|473695038|FG001|Overall Study|Physician Decision|1|||
131565998|NCT02335268|473695037|FG000|Overall Study|Lack of Efficacy|2|||
131565999|NCT02335268|473695038|FG001|Overall Study|Lack of Efficacy|1|||
131566000|NCT02335268|473695037|FG000|Overall Study|Adverse Event|5|||
131566001|NCT02335268|473695038|FG001|Overall Study|Adverse Event|2|||
131566002|NCT02335268|473695037|FG000|Overall Study|increase blasts|2|||
131566003|NCT02335268|473695038|FG001|Overall Study|increase blasts|0|||
131566004|NCT02335268|473695037|FG000|Overall Study|Withdrawal by Subject|3|||
131566005|NCT02335268|473695038|FG001|Overall Study|Withdrawal by Subject|2|||
131566006|NCT02431533|473695039|FG000|Overall Study|Withdrawal by Subject|1|||
131566007|NCT02431533|473695040|FG001|Overall Study|Withdrawal by Subject|3|||
131566008|NCT02431533|473695039|FG000|Overall Study|Developed Exclusionary criteria|1|||
131566009|NCT02431533|473695040|FG001|Overall Study|Developed Exclusionary criteria|0|||
131566010|NCT04951479|473695042|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
131566011|NCT00729690|473695043|FG000|Overall Study|IT Catheter Malfunction|0|||
131566012|NCT00729690|473695044|FG001|Overall Study|IT Catheter Malfunction|2|||
131566013|NCT00729690|473695045|FG002|Overall Study|IT Catheter Malfunction|2|||
131566014|NCT02886936|473695051|FG000|Overall Study|Lost to Follow-up|4|||
131566015|NCT02886936|473695052|FG001|Overall Study|Lost to Follow-up|3|||
131566016|NCT02886936|473695053|FG002|Overall Study|Lost to Follow-up|0|||
131566017|NCT00245011|473695058|FG000|Overall Study|Lack of Efficacy|1|||
131566018|NCT02353832|473695063|FG000|Overall Study|Ineligible after enrollment|1|||
131566019|NCT02353832|473695063|FG000|Overall Study|Lost to Follow-up|1|||
131566020|NCT02692235|473696453|FG000|Overall Study|Withdrawal by Subject|2|||
131566021|NCT02692235|473696454|FG001|Overall Study|Withdrawal by Subject|1|||
131566022|NCT02692235|473696453|FG000|Overall Study|Adverse Event|1|||
131566023|NCT02692235|473696454|FG001|Overall Study|Adverse Event|2|||
131566024|NCT02711995|473696455|FG000|Washout (90 Days)|Conflicting medication|1|||
131566025|NCT01268059|473696459|FG000|Overall Study|Lost to Follow-up|0|||
131566026|NCT01268059|473696460|FG001|Overall Study|Lost to Follow-up|1|||
131566027|NCT01268059|473696461|FG002|Overall Study|Lost to Follow-up|0|||
131566028|NCT01268059|473696462|FG003|Overall Study|Lost to Follow-up|0|||
131566029|NCT01268059|473696459|FG000|Overall Study|Withdrawal by Subject|7|||
131566030|NCT01268059|473696460|FG001|Overall Study|Withdrawal by Subject|4|||
131566031|NCT01268059|473696461|FG002|Overall Study|Withdrawal by Subject|0|||
131566032|NCT01268059|473696462|FG003|Overall Study|Withdrawal by Subject|0|||
131566033|NCT01268059|473696459|FG000|Overall Study|Death|20|||
131566034|NCT01268059|473696460|FG001|Overall Study|Death|30|||
131566035|NCT01268059|473696461|FG002|Overall Study|Death|3|||
131566036|NCT01268059|473696462|FG003|Overall Study|Death|5|||
131566037|NCT01268059|473696459|FG000|Overall Study|Progression of disease|1|||
131566038|NCT01268059|473696460|FG001|Overall Study|Progression of disease|0|||
131566039|NCT01268059|473696461|FG002|Overall Study|Progression of disease|0|||
131566040|NCT01268059|473696462|FG003|Overall Study|Progression of disease|0|||
131566041|NCT03850444|473696463|FG000|Overall Study|Adverse Event|16|||
131566042|NCT03850444|473696464|FG001|Overall Study|Adverse Event|10|||
131566043|NCT03850444|473696463|FG000|Overall Study|Death|87|||
131566044|NCT03850444|473696464|FG001|Overall Study|Death|107|||
131566045|NCT03850444|473696463|FG000|Overall Study|Lost to Follow-up|1|||
131566046|NCT03850444|473696464|FG001|Overall Study|Lost to Follow-up|1|||
131566047|NCT03850444|473696463|FG000|Overall Study|Withdrawal by Subject|1|||
131566048|NCT03850444|473696464|FG001|Overall Study|Withdrawal by Subject|5|||
131566049|NCT03850444|473696463|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
131566050|NCT03850444|473696464|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
131566051|NCT01598987|473696465|FG000|Baseline to Month 12|Administrative problems|2|||
131566052|NCT01598987|473696465|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
131566053|NCT01598987|473696465|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
131566054|NCT01598987|473696465|FG000|Baseline to 24 Month|Administrative problems|2|||
131566055|NCT01598987|473696465|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
131566056|NCT02107274|473696466|FG000|Treatment vs. Placebo|Adverse Event|3|||
131566057|NCT02107274|473696467|FG001|Treatment vs. Placebo|Adverse Event|0|||
131566058|NCT02107274|473696466|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
131566059|NCT02107274|473696467|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
131566060|NCT02107274|473696466|FG000|Control Phase|Lost to Follow-up|1|||
131566061|NCT02107274|473696467|FG001|Control Phase|Lost to Follow-up|1|||
131566062|NCT02107274|473696466|FG000|Control Phase|Death|2|||
131566063|NCT02107274|473696467|FG001|Control Phase|Death|0|||
131566064|NCT02107274|473696466|FG000|Control Phase|Adverse Event|0|||
131566065|NCT02107274|473696467|FG001|Control Phase|Adverse Event|1|||
131566066|NCT01036087|473696469|FG000|Overall Study|Adverse Event|2|||
131566067|NCT01036087|473696469|FG000|Overall Study|Lack of Efficacy|1|||
131566068|NCT01021878|473696473|FG000|Overall Study|Lost to Follow-up|4|||
131566069|NCT01021878|473696474|FG001|Overall Study|Lost to Follow-up|3|||
131566070|NCT01021878|473696473|FG000|Overall Study|Death|0|||
131566071|NCT01021878|473696474|FG001|Overall Study|Death|1|||
131566072|NCT01021878|473696473|FG000|Overall Study|Adverse Event|6|||
131566073|NCT01021878|473696474|FG001|Overall Study|Adverse Event|5|||
131566074|NCT01021878|473696473|FG000|Overall Study|Transplantation|6|||
131566075|NCT01021878|473696474|FG001|Overall Study|Transplantation|1|||
131566076|NCT02892409|473696477|FG000|Overall Study|Adverse Event|1|||
131566077|NCT02892409|473696478|FG001|Overall Study|Adverse Event|0|||
131566078|NCT02892409|473696477|FG000|Overall Study|Withdrawal by Subject|2|||
131566079|NCT02892409|473696478|FG001|Overall Study|Withdrawal by Subject|1|||
131566080|NCT02424344|473696479|FG000|Overall Study|Lack of Efficacy|0|||
131566081|NCT02424344|473696480|FG001|Overall Study|Lack of Efficacy|1|||
131566082|NCT02424344|473696479|FG000|Overall Study|Withdrawal by Subject|2|||
131566083|NCT02424344|473696480|FG001|Overall Study|Withdrawal by Subject|1|||
131566084|NCT02424344|473696479|FG000|Overall Study|Lost to Follow-up|1|||
131566085|NCT02424344|473696480|FG001|Overall Study|Lost to Follow-up|0|||
131566086|NCT02424344|473696479|FG000|Overall Study|Adverse Event|4|||
131566087|NCT02424344|473696480|FG001|Overall Study|Adverse Event|8|||
131566088|NCT02123966|473696483|FG000|Overall Study|Intercurrent Illness|1|||
131566089|NCT01460381|473696484|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
131566090|NCT01460381|473696485|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
131566091|NCT00519779|473696490|FG000|Overall Study|Withdrawal by Subject|0|||
131566092|NCT00519779|473696491|FG001|Overall Study|Withdrawal by Subject|1|||
131566093|NCT02059161|473696500|FG000|Overall Study|Pregnancy|0|||
131566094|NCT02059161|473696501|FG001|Overall Study|Pregnancy|2|||
131566095|NCT02059161|473696500|FG000|Overall Study|Adverse Event|2|||
131566096|NCT02059161|473696501|FG001|Overall Study|Adverse Event|6|||
131566097|NCT02059161|473696500|FG000|Overall Study|Lost to Follow-up|20|||
131566098|NCT02059161|473696501|FG001|Overall Study|Lost to Follow-up|12|||
131566099|NCT02059161|473696500|FG000|Overall Study|Physician Decision|4|||
131566100|NCT02059161|473696501|FG001|Overall Study|Physician Decision|4|||
131566101|NCT02059161|473696500|FG000|Overall Study|Protocol Violation|1|||
131566102|NCT02059161|473696501|FG001|Overall Study|Protocol Violation|1|||
131566103|NCT02059161|473696500|FG000|Overall Study|Withdrawal by Subject|16|||
131566104|NCT02059161|473696501|FG001|Overall Study|Withdrawal by Subject|13|||
131566105|NCT02059161|473696500|FG000|Overall Study|Randomized in error, no study drug|0|||
131566106|NCT02059161|473696501|FG001|Overall Study|Randomized in error, no study drug|1|||
131566107|NCT02059161|473696500|FG000|Overall Study|Non-compliance with study drug|6|||
131566108|NCT02059161|473696501|FG001|Overall Study|Non-compliance with study drug|2|||
131566109|NCT03293485|473696503|FG000|Overall Study|Death|1|||
131783014|NCT03869684|474487811|FG002|Overall Study|Adverse Event|1|||
131783015|NCT03869684|474487809|FG000|Overall Study|Withdrawal by Subject|1|||
131783016|NCT03869684|474487810|FG001|Overall Study|Withdrawal by Subject|0|||
131783017|NCT03869684|474487811|FG002|Overall Study|Withdrawal by Subject|0|||
131783018|NCT03869684|474487809|FG000|Overall Study|Lost to Follow-up|1|||
131783019|NCT03869684|474487810|FG001|Overall Study|Lost to Follow-up|0|||
131783020|NCT03869684|474487811|FG002|Overall Study|Lost to Follow-up|0|||
131783021|NCT03869684|474487809|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
131783022|NCT03869684|474487810|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
131783023|NCT03869684|474487811|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
131566110|NCT03293485|473696503|FG000|Overall Study|Screen Failure|2|||
131566111|NCT03293485|473696503|FG000|Overall Study|Withdrawal by Subject|2|||
131566112|NCT01723826|473696507|FG000|Overall Study|Adverse Event|4|||
131566113|NCT01723826|473696508|FG001|Overall Study|Adverse Event|1|||
131566114|NCT01723826|473696509|FG002|Overall Study|Adverse Event|4|||
131566115|NCT01723826|473696510|FG003|Overall Study|Adverse Event|5|||
131566116|NCT01723826|473696507|FG000|Overall Study|Death according to AE eCRF|2|||
131566117|NCT01723826|473696508|FG001|Overall Study|Death according to AE eCRF|3|||
131566118|NCT01723826|473696509|FG002|Overall Study|Death according to AE eCRF|3|||
131566119|NCT01723826|473696510|FG003|Overall Study|Death according to AE eCRF|7|||
131566120|NCT01723826|473696507|FG000|Overall Study|Lost to Follow-up|1|||
131566121|NCT01723826|473696508|FG001|Overall Study|Lost to Follow-up|3|||
131566122|NCT01723826|473696509|FG002|Overall Study|Lost to Follow-up|1|||
131566123|NCT01723826|473696510|FG003|Overall Study|Lost to Follow-up|1|||
131566124|NCT01723826|473696507|FG000|Overall Study|Non-compliance|0|||
131566125|NCT01723826|473696508|FG001|Overall Study|Non-compliance|1|||
131566126|NCT01723826|473696509|FG002|Overall Study|Non-compliance|3|||
131566127|NCT01723826|473696510|FG003|Overall Study|Non-compliance|3|||
131566128|NCT01723826|473696507|FG000|Overall Study|Non-compliance With Study Drug|0|||
131566129|NCT01723826|473696508|FG001|Overall Study|Non-compliance With Study Drug|1|||
131566130|NCT01723826|473696509|FG002|Overall Study|Non-compliance With Study Drug|0|||
131566131|NCT01723826|473696510|FG003|Overall Study|Non-compliance With Study Drug|0|||
131566132|NCT01723826|473696507|FG000|Overall Study|Other Reason|8|||
131566133|NCT01723826|473696508|FG001|Overall Study|Other Reason|6|||
131566134|NCT01723826|473696509|FG002|Overall Study|Other Reason|12|||
131566135|NCT01723826|473696510|FG003|Overall Study|Other Reason|14|||
131566136|NCT01723826|473696507|FG000|Overall Study|Physician Decision|1|||
131566137|NCT01723826|473696508|FG001|Overall Study|Physician Decision|3|||
131566138|NCT01723826|473696509|FG002|Overall Study|Physician Decision|4|||
131566139|NCT01723826|473696510|FG003|Overall Study|Physician Decision|11|||
131566140|NCT01723826|473696507|FG000|Overall Study|Protocol Violation|1|||
131566141|NCT01723826|473696508|FG001|Overall Study|Protocol Violation|1|||
131566142|NCT01723826|473696509|FG002|Overall Study|Protocol Violation|3|||
131566143|NCT01723826|473696510|FG003|Overall Study|Protocol Violation|1|||
131566144|NCT01723826|473696507|FG000|Overall Study|Withdrawal by Subject|10|||
131566145|NCT01723826|473696508|FG001|Overall Study|Withdrawal by Subject|17|||
131566146|NCT01723826|473696509|FG002|Overall Study|Withdrawal by Subject|27|||
131566147|NCT01723826|473696510|FG003|Overall Study|Withdrawal by Subject|48|||
131566148|NCT02408549|473696513|FG000|Overall Study|Adverse Event|15|||
131566149|NCT02408549|473696513|FG000|Overall Study|Death|4|||
131566150|NCT02408549|473696513|FG000|Overall Study|Lack of Efficacy|17|||
131566151|NCT02408549|473696513|FG000|Overall Study|Protocol Violation|4|||
131566152|NCT02408549|473696513|FG000|Overall Study|Lost to Follow-up|6|||
131566153|NCT02408549|473696513|FG000|Overall Study|Consent withdrawn|30|||
131566154|NCT02408549|473696513|FG000|Overall Study|Neurology research program closing at site|1|||
131566155|NCT02408549|473696513|FG000|Overall Study|Site closure|1|||
131566156|NCT02408549|473696513|FG000|Overall Study|Pregnancy|1|||
131566157|NCT02408549|473696513|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
131566158|NCT02408549|473696513|FG000|Overall Study|Subject moved to another place, far from site|1|||
131566159|NCT02408549|473696513|FG000|Overall Study|Study terminated at site|1|||
131566160|NCT01272011|473696514|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
131566161|NCT01272011|473696515|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
131898643|NCT00215644|474915329|FG000|Overall Study|Withdrawal by Subject|1|||
131898644|NCT00215644|474915330|FG001|Overall Study|Withdrawal by Subject|0|||
131566162|NCT01272011|473696516|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
131566163|NCT01627340|473696517|FG000|Overall Study|Adverse Event|1|||
131566164|NCT01627340|473696518|FG001|Overall Study|Adverse Event|0|||
131566165|NCT01627340|473696517|FG000|Overall Study|Lost to Follow-up|8|||
131783024|NCT04056299|474487812|FG000|Overall Study|Sponsor discontinued study|3|||
131783025|NCT04056299|474487813|FG001|Overall Study|Sponsor discontinued study|3|||
131783026|NCT01227954|474487818|FG000|Overall Study|Protocol Violation|6|||
131566166|NCT01627340|473696518|FG001|Overall Study|Lost to Follow-up|4|||
131566167|NCT01627340|473696517|FG000|Overall Study|Pregnancy|1|||
131566168|NCT01627340|473696518|FG001|Overall Study|Pregnancy|0|||
131566169|NCT01627340|473696517|FG000|Overall Study|Withdrawal by Subject|2|||
131566170|NCT01627340|473696518|FG001|Overall Study|Withdrawal by Subject|0|||
131566171|NCT01657032|473696519|FG000|Overall Study|Lost to Follow-up|0|||
131566172|NCT01657032|473696520|FG001|Overall Study|Lost to Follow-up|7|||
131566173|NCT03633903|473696521|FG000|Overall Study|Withdrawal by Subject|1|||
131566174|NCT03633903|473696522|FG001|Overall Study|Withdrawal by Subject|2|||
131566175|NCT03633903|473696521|FG000|Overall Study|Lost to Follow-up|5|||
131566176|NCT03633903|473696522|FG001|Overall Study|Lost to Follow-up|5|||
131566177|NCT01925170|473696524|FG000|Overall Study|Unverified cancer status|53|||
131566178|NCT01077024|473696525|FG000|Overall Study|Lost to Follow-up|20|||
131566179|NCT01077024|473696526|FG001|Overall Study|Lost to Follow-up|14|||
131566180|NCT01077024|473696525|FG000|Overall Study|Withdrawal by Subject|0|||
131566181|NCT01077024|473696526|FG001|Overall Study|Withdrawal by Subject|2|||
131566182|NCT01077024|473696525|FG000|Overall Study|Incarcerated|7|||
131566183|NCT01077024|473696526|FG001|Overall Study|Incarcerated|8|||
131566184|NCT01077024|473696525|FG000|Overall Study|Other|4|||
131566185|NCT01077024|473696526|FG001|Overall Study|Other|4|||
131566186|NCT03379233|473696527|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
131566187|NCT03379233|473696528|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
131566188|NCT01603121|473696529|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
131566189|NCT01603121|473696530|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
131566190|NCT02300311|473696533|FG000|Overall Study|Other than the reason specified|1|||
131566191|NCT02300311|473696534|FG001|Overall Study|Other than the reason specified|0|||
131566192|NCT02300311|473696533|FG000|Overall Study|Refused to continue taking medication|18|||
131566193|NCT02300311|473696534|FG001|Overall Study|Refused to continue taking medication|0|||
131566194|NCT00419003|473696535|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
131566195|NCT00419003|473696536|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
131566196|NCT00419003|473696535|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
131566197|NCT00419003|473696536|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
131566198|NCT02531438|473696537|FG000|Overall Study|Adverse Event|7|||
131566199|NCT02531438|473696538|FG001|Overall Study|Adverse Event|9|||
131566200|NCT02531438|473696537|FG000|Overall Study|Lost to Follow-up|0|||
131566201|NCT02531438|473696538|FG001|Overall Study|Lost to Follow-up|3|||
131566202|NCT02531438|473696537|FG000|Overall Study|Withdrawal by Subject|7|||
131566203|NCT02531438|473696538|FG001|Overall Study|Withdrawal by Subject|8|||
131566204|NCT02531438|473696537|FG000|Overall Study|Physician Decision|0|||
131566205|NCT02531438|473696538|FG001|Overall Study|Physician Decision|1|||
131783027|NCT01227954|474487818|FG000|Overall Study|No protocol treatment|7|||
131566206|NCT02531438|473696537|FG000|Overall Study|Death|6|||
131566207|NCT02531438|473696538|FG001|Overall Study|Death|3|||
131566208|NCT02531438|473696537|FG000|Overall Study|Randomized, but Not Treated|4|||
131566209|NCT02531438|473696538|FG001|Overall Study|Randomized, but Not Treated|0|||
131566210|NCT02531438|473696537|FG000|Overall Study|Missed EOT/PTE Visit|5|||
131566211|NCT02531438|473696538|FG001|Overall Study|Missed EOT/PTE Visit|2|||
131566212|NCT02531438|473696537|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
131566213|NCT02531438|473696538|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
131566214|NCT00772928|473696539|FG000|Overall Study|Lost to Follow-up|9|||
131566215|NCT00772928|473696540|FG001|Overall Study|Lost to Follow-up|6|||
131566216|NCT00772928|473696539|FG000|Overall Study|Protocol Violation|10|||
131566217|NCT00772928|473696540|FG001|Overall Study|Protocol Violation|12|||
131566218|NCT00772928|473696539|FG000|Overall Study|Withdrawal by Subject|25|||
131783028|NCT00078312|474487819|FG000|Overall Study|Adverse Event|43|||
131783029|NCT00078312|474487819|FG000|Overall Study|Lack of Efficacy|15|||
131783030|NCT00078312|474487819|FG000|Overall Study|Lost to Follow-up|41|||
131783031|NCT00078312|474487819|FG000|Overall Study|Physician Decision|9|||
131783032|NCT00078312|474487819|FG000|Overall Study|Protocol Violation|3|||
131437438|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
131437439|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
131566219|NCT00772928|473696540|FG001|Overall Study|Withdrawal by Subject|22|||
131566220|NCT00772928|473696539|FG000|Overall Study|Did not receive vaccine|0|||
131566221|NCT00772928|473696540|FG001|Overall Study|Did not receive vaccine|1|||
131566222|NCT00801242|473696541|FG000|Overall Study|Adverse Event|10|||
131566223|NCT00801242|473696541|FG000|Overall Study|Withdrawal by Subject|13|||
131566224|NCT00801242|473696541|FG000|Overall Study|Protocol Violation|5|||
131566225|NCT00801242|473696541|FG000|Overall Study|Physician Decision|3|||
131566226|NCT00801242|473696541|FG000|Overall Study|Lost to Follow-up|1|||
131566227|NCT00801242|473696541|FG000|Overall Study|Miscellaneous reasons|20|||
131566228|NCT02015195|473696542|FG000|Overall Study|Adverse Event|0|||
131566229|NCT02015195|473696543|FG001|Overall Study|Adverse Event|0|||
131566230|NCT02015195|473696544|FG002|Overall Study|Adverse Event|0|||
131566231|NCT02015195|473696545|FG003|Overall Study|Adverse Event|1|||
131566232|NCT02015195|473696546|FG004|Overall Study|Adverse Event|0|||
131783033|NCT00078312|474487819|FG000|Overall Study|Withdrawal by Subject|33|||
131783034|NCT00078312|474487819|FG000|Overall Study|Miscellaneous|33|||
131566233|NCT02015195|473696547|FG005|Overall Study|Adverse Event|0|||
131566234|NCT02015195|473696548|FG006|Overall Study|Adverse Event|0|||
131566235|NCT01318811|473696549|FG000|Overall Study|Physician Decision|1|||
131566236|NCT01318811|473696550|FG001|Overall Study|Physician Decision|1|||
131566237|NCT01318811|473696549|FG000|Overall Study|CRRT stopped for head CT|0|||
131566238|NCT01318811|473696550|FG001|Overall Study|CRRT stopped for head CT|1|||
131566239|NCT01318811|473696549|FG000|Overall Study|Death|0|||
131566240|NCT01318811|473696550|FG001|Overall Study|Death|1|||
131783035|NCT01296152|474487820|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
131783036|NCT04840901|474487825|FG000|Overall Study|Lost to Follow-up|3|||
131783037|NCT04840901|474487826|FG001|Overall Study|Lost to Follow-up|1|||
131783038|NCT04840901|474487825|FG000|Overall Study|Moved|1|||
131783039|NCT04840901|474487826|FG001|Overall Study|Moved|0|||
131783040|NCT04840901|474487825|FG000|Overall Study|Unable to comply with study schedule|0|||
131783041|NCT04840901|474487826|FG001|Overall Study|Unable to comply with study schedule|1|||
131783042|NCT04840901|474487825|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
131783043|NCT04840901|474487826|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
131783044|NCT01414062|474487827|FG000|Overall Study|Lost to Follow-up|3|||
131783045|NCT01414062|474487828|FG001|Overall Study|Lost to Follow-up|2|||
131783046|NCT01414062|474487827|FG000|Overall Study|Left Country|1|||
131783047|NCT01414062|474487828|FG001|Overall Study|Left Country|1|||
131783048|NCT01414062|474487827|FG000|Overall Study|Family Disapproval|1|||
131783049|NCT01414062|474487828|FG001|Overall Study|Family Disapproval|0|||
131783050|NCT01414062|474487827|FG000|Overall Study|Withdrawal by Subject|0|||
131783051|NCT01414062|474487828|FG001|Overall Study|Withdrawal by Subject|1|||
131783052|NCT04285983|474487829|FG000|Overall Study|Protocol Violation|6|||
131783053|NCT04936334|474487830|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
131783054|NCT00422058|474487831|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
131783055|NCT00422058|474487832|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
131783056|NCT00422058|474487833|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
131783057|NCT00422058|474487834|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
131783058|NCT00422058|474487835|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
131783059|NCT00422058|474487836|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
131783060|NCT00422058|474487831|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
131783061|NCT00422058|474487832|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
131783062|NCT00422058|474487833|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
131783063|NCT00422058|474487834|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
131783064|NCT00422058|474487835|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
131783065|NCT00422058|474487836|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
131783066|NCT00422058|474487831|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
131783067|NCT00422058|474487832|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
131783068|NCT00422058|474487833|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
131783069|NCT00422058|474487834|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
131783070|NCT00422058|474487835|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
131783071|NCT00422058|474487836|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
131783072|NCT00422058|474487831|FG000|Double-Blind, Week 0-20|Other|11|||
131783073|NCT00422058|474487832|FG001|Double-Blind, Week 0-20|Other|3|||
131783074|NCT00422058|474487833|FG002|Double-Blind, Week 0-20|Other|8|||
131783075|NCT00422058|474487834|FG003|Double-Blind, Week 0-20|Other|8|||
131783076|NCT00422058|474487835|FG004|Double-Blind, Week 0-20|Other|4|||
131783077|NCT00422058|474487836|FG005|Double-Blind, Week 0-20|Other|10|||
131783078|NCT00422058|474487831|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
131783079|NCT00422058|474487832|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
131783080|NCT00422058|474487833|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
131783081|NCT00422058|474487834|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
131783082|NCT00422058|474487835|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
131783083|NCT00422058|474487836|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
131783084|NCT00422058|474487831|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
131783085|NCT00422058|474487832|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
131783086|NCT00422058|474487833|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
131783087|NCT00422058|474487834|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
131783088|NCT00422058|474487835|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
131783089|NCT00422058|474487836|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
131566241|NCT01318811|473696549|FG000|Overall Study|CRRT stopped for head MRI|0|||
131783090|NCT00422058|474487831|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
131783091|NCT00422058|474487832|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
131783092|NCT00422058|474487833|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
131783093|NCT00422058|474487834|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
131566242|NCT01318811|473696550|FG001|Overall Study|CRRT stopped for head MRI|1|||
131783094|NCT00422058|474487835|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
131783095|NCT00422058|474487836|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
131566243|NCT00811187|473696551|FG000|Overall Study|Unable to place device / procedure abort|3|||
131566244|NCT00811187|473696552|FG001|Overall Study|Unable to place device / procedure abort|3|||
131566245|NCT00994279|473696555|FG000|Overall Study|Withdrawal by Subject|2|||
131566246|NCT00994279|473696556|FG001|Overall Study|Withdrawal by Subject|2|||
131566247|NCT00994279|473696555|FG000|Overall Study|Toxicity|1|||
131566248|NCT00994279|473696556|FG001|Overall Study|Toxicity|0|||
131566249|NCT00994279|473696555|FG000|Overall Study|Multiple reasons|1|||
131566250|NCT00994279|473696556|FG001|Overall Study|Multiple reasons|3|||
131566251|NCT01606189|473696557|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
131566252|NCT01606189|473696558|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
131566253|NCT01606189|473696559|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
131566254|NCT01606189|473696560|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
131566255|NCT01606189|473696561|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
131566256|NCT01606189|473696562|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
131566257|NCT01606189|473696557|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131566258|NCT01606189|473696558|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131566259|NCT01606189|473696559|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131566260|NCT01606189|473696560|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131566261|NCT01606189|473696561|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131566262|NCT01606189|473696562|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
131566263|NCT00162942|473696563|FG000|Overall Study|Adverse Event|10|||
131566264|NCT00162942|473696564|FG001|Overall Study|Adverse Event|6|||
131566265|NCT00162942|473696563|FG000|Overall Study|Death|1|||
131566266|NCT00162942|473696564|FG001|Overall Study|Death|0|||
131566267|NCT00162942|473696563|FG000|Overall Study|Withdrawal by Subject|3|||
131566268|NCT00162942|473696564|FG001|Overall Study|Withdrawal by Subject|6|||
131566269|NCT00162942|473696563|FG000|Overall Study|Physician Decision|1|||
131566270|NCT00162942|473696564|FG001|Overall Study|Physician Decision|0|||
131566271|NCT00162942|473696563|FG000|Overall Study|Enter Open-Label Study|76|||
131566272|NCT00162942|473696564|FG001|Overall Study|Enter Open-Label Study|35|||
131566273|NCT00162942|473696563|FG000|Overall Study|Alternate Therapy|6|||
131566274|NCT00162942|473696564|FG001|Overall Study|Alternate Therapy|2|||
131566275|NCT00162942|473696563|FG000|Overall Study|Lack of Efficacy|1|||
131566276|NCT00162942|473696564|FG001|Overall Study|Lack of Efficacy|0|||
131566277|NCT00162942|473696563|FG000|Overall Study|Flare During Active Treatment|7|||
131566278|NCT00162942|473696564|FG001|Overall Study|Flare During Active Treatment|3|||
131566279|NCT00162942|473696563|FG000|Overall Study|2 or more consecutive treatments missed|1|||
131566280|NCT00162942|473696564|FG001|Overall Study|2 or more consecutive treatments missed|0|||
131566281|NCT02162732|473696565|FG000|Overall Study|Biopsy not performed.|18|||
131566282|NCT00410384|473696566|FG000|Overall Study|Withdrawal by Subject|28|||
131566283|NCT00410384|473696567|FG001|Overall Study|Withdrawal by Subject|17|||
131566284|NCT00410384|473696568|FG002|Overall Study|Withdrawal by Subject|20|||
131566285|NCT00410384|473696566|FG000|Overall Study|Adverse Event|23|||
131566286|NCT00410384|473696567|FG001|Overall Study|Adverse Event|18|||
131566287|NCT00410384|473696568|FG002|Overall Study|Adverse Event|23|||
131566288|NCT00410384|473696566|FG000|Overall Study|Lack of Efficacy|20|||
131566289|NCT00410384|473696567|FG001|Overall Study|Lack of Efficacy|12|||
131566290|NCT00410384|473696568|FG002|Overall Study|Lack of Efficacy|17|||
131566291|NCT00410384|473696566|FG000|Overall Study|Lack of Compliance|2|||
131566292|NCT00410384|473696567|FG001|Overall Study|Lack of Compliance|2|||
131566293|NCT00410384|473696568|FG002|Overall Study|Lack of Compliance|2|||
131566294|NCT00410384|473696566|FG000|Overall Study|Lost to Follow-up|4|||
131566295|NCT00410384|473696567|FG001|Overall Study|Lost to Follow-up|6|||
131566296|NCT00410384|473696568|FG002|Overall Study|Lost to Follow-up|6|||
131566297|NCT00410384|473696566|FG000|Overall Study|Protocol Violation|6|||
131566298|NCT00410384|473696567|FG001|Overall Study|Protocol Violation|6|||
131566299|NCT00410384|473696568|FG002|Overall Study|Protocol Violation|6|||
131566300|NCT00410384|473696566|FG000|Overall Study|Physician Decision|3|||
131566301|NCT00410384|473696567|FG001|Overall Study|Physician Decision|3|||
131566302|NCT00410384|473696568|FG002|Overall Study|Physician Decision|4|||
131566303|NCT00410384|473696566|FG000|Overall Study|Other|3|||
131566304|NCT00410384|473696567|FG001|Overall Study|Other|8|||
131566305|NCT00410384|473696568|FG002|Overall Study|Other|4|||
131566306|NCT01167023|473696569|FG000|Overall Study|Lost to Follow-up|0|||
131566307|NCT01167023|473696570|FG001|Overall Study|Lost to Follow-up|1|||
131566308|NCT01167023|473696571|FG002|Overall Study|Lost to Follow-up|1|||
131566309|NCT01167023|473696569|FG000|Overall Study|Screen Failure|0|||
131566310|NCT01167023|473696570|FG001|Overall Study|Screen Failure|1|||
131566311|NCT01167023|473696571|FG002|Overall Study|Screen Failure|0|||
131566312|NCT01167023|473696569|FG000|Overall Study|Sponsor Decision|0|||
131566313|NCT01167023|473696570|FG001|Overall Study|Sponsor Decision|1|||
131566314|NCT01167023|473696571|FG002|Overall Study|Sponsor Decision|0|||
131566315|NCT01167023|473696569|FG000|Overall Study|Withdrawal by Subject|0|||
131566316|NCT01167023|473696570|FG001|Overall Study|Withdrawal by Subject|0|||
131566317|NCT01167023|473696571|FG002|Overall Study|Withdrawal by Subject|1|||
131566318|NCT01253200|473696574|FG000|Overall Study|Death|1|||
131566319|NCT01253200|473696575|FG001|Overall Study|Death|0|||
131566320|NCT01253200|473696576|FG002|Overall Study|Death|0|||
131566321|NCT01253200|473696577|FG003|Overall Study|Death|0|||
131566322|NCT01253200|473696578|FG004|Overall Study|Death|0|||
131566323|NCT01253200|473696574|FG000|Overall Study|Lost to Follow-up|1|||
131566324|NCT01253200|473696575|FG001|Overall Study|Lost to Follow-up|1|||
131566325|NCT01253200|473696576|FG002|Overall Study|Lost to Follow-up|0|||
131566326|NCT01253200|473696577|FG003|Overall Study|Lost to Follow-up|0|||
131566327|NCT01253200|473696578|FG004|Overall Study|Lost to Follow-up|0|||
131566328|NCT01253200|473696574|FG000|Overall Study|Withdrawal by Subject|2|||
131566329|NCT01253200|473696575|FG001|Overall Study|Withdrawal by Subject|0|||
131566330|NCT01253200|473696576|FG002|Overall Study|Withdrawal by Subject|0|||
131566331|NCT01253200|473696577|FG003|Overall Study|Withdrawal by Subject|0|||
131566332|NCT01253200|473696578|FG004|Overall Study|Withdrawal by Subject|0|||
131566333|NCT01253200|473696574|FG000|Overall Study|Protocol Violation|1|||
131566334|NCT01253200|473696575|FG001|Overall Study|Protocol Violation|4|||
131566335|NCT01253200|473696576|FG002|Overall Study|Protocol Violation|0|||
131566336|NCT01253200|473696577|FG003|Overall Study|Protocol Violation|0|||
131566337|NCT01253200|473696578|FG004|Overall Study|Protocol Violation|5|||
131566338|NCT01253200|473696574|FG000|Overall Study|intents|10|||
131566339|NCT01253200|473696575|FG001|Overall Study|intents|10|||
131566340|NCT01253200|473696576|FG002|Overall Study|intents|1|||
131566341|NCT01253200|473696577|FG003|Overall Study|intents|3|||
131566342|NCT01253200|473696578|FG004|Overall Study|intents|0|||
131566343|NCT01253200|473696574|FG000|Overall Study|Attempts|6|||
131566344|NCT01253200|473696575|FG001|Overall Study|Attempts|4|||
131566345|NCT01253200|473696576|FG002|Overall Study|Attempts|1|||
131566346|NCT01253200|473696577|FG003|Overall Study|Attempts|2|||
131566347|NCT01253200|473696578|FG004|Overall Study|Attempts|0|||
131566348|NCT02049437|473696579|FG000|Period 1|Adverse Event|1|||
131566349|NCT02049437|473696580|FG001|Period 1|Adverse Event|1|||
131566350|NCT02049437|473696579|FG000|Period 1|Adverse Event|1|||
131566351|NCT02049437|473696580|FG001|Period 1|Adverse Event|0|||
131566352|NCT04529538|473696581|FG000|Overall Study|Lost to Follow-up|3|||
131566353|NCT04529538|473696582|FG001|Overall Study|Lost to Follow-up|2|||
131566354|NCT04529538|473696583|FG002|Overall Study|Lost to Follow-up|1|||
131566355|NCT04529538|473696584|FG003|Overall Study|Lost to Follow-up|0|||
131566356|NCT04529538|473696585|FG004|Overall Study|Lost to Follow-up|1|||
131566357|NCT04529538|473696586|FG005|Overall Study|Lost to Follow-up|1|||
131566358|NCT04529538|473696587|FG006|Overall Study|Lost to Follow-up|2|||
131566359|NCT04529538|473696588|FG007|Overall Study|Lost to Follow-up|0|||
131566360|NCT04529538|473696581|FG000|Overall Study|Not eligible at enrollment|0|||
131566361|NCT04529538|473696582|FG001|Overall Study|Not eligible at enrollment|1|||
131566362|NCT04529538|473696583|FG002|Overall Study|Not eligible at enrollment|2|||
131437440|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
131566363|NCT04529538|473696584|FG003|Overall Study|Not eligible at enrollment|1|||
131566364|NCT04529538|473696585|FG004|Overall Study|Not eligible at enrollment|0|||
131566365|NCT04529538|473696586|FG005|Overall Study|Not eligible at enrollment|0|||
131566366|NCT04529538|473696587|FG006|Overall Study|Not eligible at enrollment|0|||
131566367|NCT04529538|473696588|FG007|Overall Study|Not eligible at enrollment|1|||
131566368|NCT04529538|473696581|FG000|Overall Study|Withdrawal by Subject|0|||
131566369|NCT04529538|473696582|FG001|Overall Study|Withdrawal by Subject|1|||
131566370|NCT04529538|473696583|FG002|Overall Study|Withdrawal by Subject|1|||
131566371|NCT04529538|473696584|FG003|Overall Study|Withdrawal by Subject|2|||
131566372|NCT04529538|473696585|FG004|Overall Study|Withdrawal by Subject|0|||
131437441|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
131437442|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
131437443|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
131566373|NCT04529538|473696586|FG005|Overall Study|Withdrawal by Subject|2|||
131566374|NCT04529538|473696587|FG006|Overall Study|Withdrawal by Subject|3|||
131566375|NCT04529538|473696588|FG007|Overall Study|Withdrawal by Subject|0|||
131566376|NCT04529538|473696581|FG000|Overall Study|Other|0|||
131566377|NCT04529538|473696582|FG001|Overall Study|Other|1|||
131566378|NCT04529538|473696583|FG002|Overall Study|Other|0|||
131566379|NCT04529538|473696584|FG003|Overall Study|Other|0|||
131696983|NCT02264990|474174016|FG001|Overall Study|Withdrawal by Subject|5|||
131696984|NCT02264990|474174015|FG000|Overall Study|Lost to Follow-up|1|||
131696985|NCT02264990|474174016|FG001|Overall Study|Lost to Follow-up|3|||
131566380|NCT04529538|473696585|FG004|Overall Study|Other|0|||
131566381|NCT04529538|473696586|FG005|Overall Study|Other|0|||
131566382|NCT04529538|473696587|FG006|Overall Study|Other|0|||
131566383|NCT04529538|473696588|FG007|Overall Study|Other|0|||
131566384|NCT04529538|473696581|FG000|Overall Study|Adverse Event|0|||
131566385|NCT04529538|473696582|FG001|Overall Study|Adverse Event|0|||
131566386|NCT04529538|473696583|FG002|Overall Study|Adverse Event|0|||
131566387|NCT04529538|473696584|FG003|Overall Study|Adverse Event|1|||
131566388|NCT04529538|473696585|FG004|Overall Study|Adverse Event|0|||
131566389|NCT04529538|473696586|FG005|Overall Study|Adverse Event|0|||
131566390|NCT04529538|473696587|FG006|Overall Study|Adverse Event|0|||
131566391|NCT04529538|473696588|FG007|Overall Study|Adverse Event|0|||
131566392|NCT04529538|473696581|FG000|Overall Study|Protocol Deviation|0|||
131566393|NCT04529538|473696582|FG001|Overall Study|Protocol Deviation|0|||
131566394|NCT04529538|473696583|FG002|Overall Study|Protocol Deviation|0|||
131566395|NCT04529538|473696584|FG003|Overall Study|Protocol Deviation|1|||
131566396|NCT04529538|473696585|FG004|Overall Study|Protocol Deviation|0|||
131566397|NCT04529538|473696586|FG005|Overall Study|Protocol Deviation|0|||
131566398|NCT04529538|473696587|FG006|Overall Study|Protocol Deviation|0|||
131566399|NCT04529538|473696588|FG007|Overall Study|Protocol Deviation|0|||
131566400|NCT04529538|473696581|FG000|Overall Study|Physician Decision|0|||
131566401|NCT04529538|473696582|FG001|Overall Study|Physician Decision|0|||
131566402|NCT04529538|473696583|FG002|Overall Study|Physician Decision|0|||
131566403|NCT04529538|473696584|FG003|Overall Study|Physician Decision|0|||
131566404|NCT04529538|473696585|FG004|Overall Study|Physician Decision|0|||
131566405|NCT04529538|473696586|FG005|Overall Study|Physician Decision|1|||
131566406|NCT04529538|473696587|FG006|Overall Study|Physician Decision|0|||
131566407|NCT04529538|473696588|FG007|Overall Study|Physician Decision|1|||
131566408|NCT03473756|473696591|FG000|Overall Study|Withdrawal by Subject|1|||
131566409|NCT03473756|473696592|FG001|Overall Study|Withdrawal by Subject|4|||
131566410|NCT03473756|473696591|FG000|Overall Study|Adverse Event|6|||
131566411|NCT03473756|473696592|FG001|Overall Study|Adverse Event|7|||
131566412|NCT03473756|473696591|FG000|Overall Study|Lack of Efficacy|3|||
131566413|NCT03473756|473696592|FG001|Overall Study|Lack of Efficacy|10|||
131566414|NCT03473756|473696591|FG000|Overall Study|Physician Decision|0|||
131437444|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
131437445|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
131437446|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
131437447|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
131437448|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
131437449|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
131437450|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
131437451|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
131437452|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
131437453|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
131437454|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
131437455|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
131437456|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
131437457|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
131437458|NCT00550407|473226872|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
131437459|NCT00550407|473226873|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
131437460|NCT00550407|473226874|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
131437461|NCT00550407|473226872|FG000|26-Week Randomized Phase|Adverse Event|0|||
131437462|NCT00550407|473226873|FG001|26-Week Randomized Phase|Adverse Event|5|||
131437463|NCT00550407|473226874|FG002|26-Week Randomized Phase|Adverse Event|2|||
131437464|NCT00550407|473226872|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
131437465|NCT00550407|473226873|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
131437466|NCT00550407|473226874|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
131437467|NCT00550407|473226872|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
131437468|NCT00550407|473226873|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
131437469|NCT00550407|473226874|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
131437470|NCT00550407|473226872|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
131437471|NCT00550407|473226873|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
131437472|NCT00550407|473226874|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
131437473|NCT00584415|473226875|FG000|Overall Study|Adverse Event|7|||
131437474|NCT05051579|473226876|FG000|Overall Study|Withdrawal by Subject|3|||
131437475|NCT05051579|473226877|FG001|Overall Study|Withdrawal by Subject|5|||
131566415|NCT03473756|473696592|FG001|Overall Study|Physician Decision|2|||
131566416|NCT03473756|473696591|FG000|Overall Study|End of study treatment|0|||
131566417|NCT03473756|473696592|FG001|Overall Study|End of study treatment|2|||
131566418|NCT03473756|473696591|FG000|Overall Study|Lost to Follow-up|0|||
131566419|NCT03473756|473696592|FG001|Overall Study|Lost to Follow-up|1|||
131566420|NCT02148718|473696593|FG000|Overall Study|Protocol Violation|26|||
131566421|NCT02148718|473696593|FG000|Overall Study|Discontinued Study Prematurely|5|||
131566422|NCT02192359|473696598|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
131566423|NCT02192359|473696599|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
131566424|NCT02192359|473696600|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
131566425|NCT02192359|473696601|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
131566426|NCT02192359|473696598|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
131566427|NCT02192359|473696599|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
131566428|NCT02192359|473696600|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
131566429|NCT02192359|473696601|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
131566430|NCT02192359|473696598|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
131566431|NCT02192359|473696599|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
131566432|NCT02192359|473696600|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
131566433|NCT02192359|473696601|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
131566434|NCT01213173|473696602|FG000|Overall Study|Protocol Violation|2|||
131566435|NCT01213173|473696603|FG001|Overall Study|Protocol Violation|0|||
131566436|NCT01213173|473696602|FG000|Overall Study|Adverse Event|4|||
131566437|NCT01213173|473696603|FG001|Overall Study|Adverse Event|8|||
131566438|NCT01213173|473696602|FG000|Overall Study|Withdrawal by Subject|5|||
131566439|NCT01213173|473696603|FG001|Overall Study|Withdrawal by Subject|5|||
131566440|NCT01213173|473696602|FG000|Overall Study|Incorrect Enrollment|1|||
131566441|NCT01213173|473696603|FG001|Overall Study|Incorrect Enrollment|3|||
131566442|NCT04880161|473696604|FG000|Overall Study|Withdrawal by Subject|1|||
131566443|NCT04880161|473696605|FG001|Overall Study|Withdrawal by Subject|0|||
131566444|NCT04880161|473696604|FG000|Overall Study|Lack of Compliance|1|||
131566445|NCT04880161|473696605|FG001|Overall Study|Lack of Compliance|1|||
131566446|NCT04880161|473696604|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
131566447|NCT04880161|473696605|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
131566448|NCT04880161|473696604|FG000|Overall Study|Screen Failure|0|||
131566449|NCT04880161|473696605|FG001|Overall Study|Screen Failure|1|||
131566450|NCT05567952|473698120|FG000|Overall Study|Lost to Follow-up|3|||
131566451|NCT05567952|473698121|FG001|Overall Study|Lost to Follow-up|2|||
131566452|NCT05567952|473698120|FG000|Overall Study|Withdrawal by Subject|6|||
131566453|NCT05567952|473698121|FG001|Overall Study|Withdrawal by Subject|3|||
131566454|NCT05567952|473698120|FG000|Overall Study|Other|3|||
131566455|NCT05567952|473698121|FG001|Overall Study|Other|1|||
131566456|NCT01333943|473698122|FG000|Overall Study|Known neuropathy|1|||
131566457|NCT01333943|473698123|FG001|Overall Study|Known neuropathy|0|||
131566458|NCT01511536|473698130|FG000|Phase 1|Other|0|||
131566459|NCT01511536|473698131|FG001|Phase 1|Other|1|||
131566460|NCT01511536|473698132|FG002|Phase 1|Other|0|||
131566461|NCT01511536|473698130|FG000|Phase 2|Other|0|||
131566462|NCT01511536|473698131|FG001|Phase 2|Other|0|||
131566463|NCT01511536|473698132|FG002|Phase 2|Other|9|||
131566464|NCT00765362|473698136|FG000|Overall Study|Death|9|||
131566465|NCT00765362|473698136|FG000|Overall Study|Adverse Event|2|||
131566466|NCT00765362|473698136|FG000|Overall Study|Protocol Violation|18|||
131566467|NCT00765362|473698136|FG000|Overall Study|Withdrawal by Subject|13|||
131566468|NCT00765362|473698136|FG000|Overall Study|Lost to Follow-up|95|||
131566469|NCT03019458|473698140|FG000|Overall Study|Death|0|||
131566470|NCT03019458|473698141|FG001|Overall Study|Death|1|||
131566471|NCT00557505|473698142|FG000|Overall Study|Death|0|||
131566472|NCT00557505|473698143|FG001|Overall Study|Death|0|||
131566473|NCT00557505|473698144|FG002|Overall Study|Death|0|||
131783096|NCT00422058|474487831|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
131783097|NCT00422058|474487832|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
131566474|NCT00557505|473698145|FG003|Overall Study|Death|0|||
131566475|NCT00557505|473698146|FG004|Overall Study|Death|0|||
131566476|NCT00557505|473698147|FG005|Overall Study|Death|0|||
131566477|NCT00557505|473698148|FG006|Overall Study|Death|0|||
131566478|NCT00557505|473698149|FG007|Overall Study|Death|0|||
131566479|NCT00557505|473698150|FG008|Overall Study|Death|1|||
131566480|NCT00557505|473698142|FG000|Overall Study|Adverse Event|0|||
131566481|NCT00557505|473698143|FG001|Overall Study|Adverse Event|0|||
131566482|NCT00557505|473698144|FG002|Overall Study|Adverse Event|1|||
131566483|NCT00557505|473698145|FG003|Overall Study|Adverse Event|0|||
131566484|NCT00557505|473698146|FG004|Overall Study|Adverse Event|0|||
131566485|NCT00557505|473698147|FG005|Overall Study|Adverse Event|0|||
131566486|NCT00557505|473698148|FG006|Overall Study|Adverse Event|1|||
131566487|NCT00557505|473698149|FG007|Overall Study|Adverse Event|0|||
131566488|NCT00557505|473698150|FG008|Overall Study|Adverse Event|0|||
131566489|NCT00557505|473698142|FG000|Overall Study|Global deterioration of health|1|||
131566490|NCT00557505|473698143|FG001|Overall Study|Global deterioration of health|0|||
131566491|NCT00557505|473698144|FG002|Overall Study|Global deterioration of health|0|||
131566492|NCT00557505|473698145|FG003|Overall Study|Global deterioration of health|0|||
131566493|NCT00557505|473698146|FG004|Overall Study|Global deterioration of health|0|||
131566494|NCT00557505|473698147|FG005|Overall Study|Global deterioration of health|0|||
131566495|NCT00557505|473698148|FG006|Overall Study|Global deterioration of health|0|||
131566496|NCT00557505|473698149|FG007|Overall Study|Global deterioration of health|0|||
131566497|NCT00557505|473698150|FG008|Overall Study|Global deterioration of health|0|||
131566498|NCT00557505|473698142|FG000|Overall Study|Objective progression or relapse|2|||
131566499|NCT00557505|473698143|FG001|Overall Study|Objective progression or relapse|3|||
131566500|NCT00557505|473698144|FG002|Overall Study|Objective progression or relapse|3|||
131566501|NCT00557505|473698145|FG003|Overall Study|Objective progression or relapse|2|||
131566502|NCT00557505|473698146|FG004|Overall Study|Objective progression or relapse|2|||
131566503|NCT00557505|473698147|FG005|Overall Study|Objective progression or relapse|3|||
131566504|NCT00557505|473698148|FG006|Overall Study|Objective progression or relapse|2|||
131566505|NCT00557505|473698149|FG007|Overall Study|Objective progression or relapse|5|||
131566506|NCT00557505|473698150|FG008|Overall Study|Objective progression or relapse|15|||
131566507|NCT00557505|473698142|FG000|Overall Study|Withdrawal by Subject|0|||
131566508|NCT00557505|473698143|FG001|Overall Study|Withdrawal by Subject|0|||
131566509|NCT00557505|473698144|FG002|Overall Study|Withdrawal by Subject|0|||
131566510|NCT00557505|473698145|FG003|Overall Study|Withdrawal by Subject|1|||
131566511|NCT00557505|473698146|FG004|Overall Study|Withdrawal by Subject|0|||
131566512|NCT00557505|473698147|FG005|Overall Study|Withdrawal by Subject|0|||
131566513|NCT00557505|473698148|FG006|Overall Study|Withdrawal by Subject|0|||
131566514|NCT00557505|473698149|FG007|Overall Study|Withdrawal by Subject|0|||
131566515|NCT00557505|473698150|FG008|Overall Study|Withdrawal by Subject|1|||
131566516|NCT01244763|473698151|FG000|Overall Study|Adverse Event|1|||
131566517|NCT01244763|473698152|FG001|Overall Study|Adverse Event|0|||
131566518|NCT01244763|473698153|FG002|Overall Study|Adverse Event|0|||
131696986|NCT02264990|474174015|FG000|Overall Study|Other|0|||
131566519|NCT01244763|473698154|FG003|Overall Study|Adverse Event|0|||
131566520|NCT01244763|473698155|FG004|Overall Study|Adverse Event|0|||
131566521|NCT01244763|473698156|FG005|Overall Study|Adverse Event|1|||
131566522|NCT01244763|473698151|FG000|Overall Study|Death|1|||
131566523|NCT01244763|473698152|FG001|Overall Study|Death|0|||
131566524|NCT01244763|473698153|FG002|Overall Study|Death|1|||
131566525|NCT01244763|473698154|FG003|Overall Study|Death|0|||
131566526|NCT01244763|473698155|FG004|Overall Study|Death|2|||
131566527|NCT01244763|473698156|FG005|Overall Study|Death|0|||
131566528|NCT01244763|473698151|FG000|Overall Study|Physician Decision|0|||
131566529|NCT01244763|473698152|FG001|Overall Study|Physician Decision|0|||
131566530|NCT01244763|473698153|FG002|Overall Study|Physician Decision|1|||
131566531|NCT01244763|473698154|FG003|Overall Study|Physician Decision|0|||
131566532|NCT01244763|473698155|FG004|Overall Study|Physician Decision|0|||
131566533|NCT01244763|473698156|FG005|Overall Study|Physician Decision|0|||
131566534|NCT01244763|473698151|FG000|Overall Study|Withdrawal by Subject|1|||
131566535|NCT01244763|473698152|FG001|Overall Study|Withdrawal by Subject|2|||
131566536|NCT01244763|473698153|FG002|Overall Study|Withdrawal by Subject|0|||
131566537|NCT01244763|473698154|FG003|Overall Study|Withdrawal by Subject|1|||
131566538|NCT01244763|473698155|FG004|Overall Study|Withdrawal by Subject|1|||
131566539|NCT01244763|473698156|FG005|Overall Study|Withdrawal by Subject|2|||
131566540|NCT01244763|473698151|FG000|Overall Study|Lost to Follow-up|0|||
131566541|NCT01244763|473698152|FG001|Overall Study|Lost to Follow-up|1|||
131566542|NCT01244763|473698153|FG002|Overall Study|Lost to Follow-up|0|||
131566543|NCT01244763|473698154|FG003|Overall Study|Lost to Follow-up|0|||
131566544|NCT01244763|473698155|FG004|Overall Study|Lost to Follow-up|0|||
131566545|NCT01244763|473698156|FG005|Overall Study|Lost to Follow-up|0|||
131566546|NCT01244763|473698151|FG000|Overall Study|Enrolled into the Extension Study|0|||
131566547|NCT01244763|473698152|FG001|Overall Study|Enrolled into the Extension Study|0|||
131566548|NCT01244763|473698153|FG002|Overall Study|Enrolled into the Extension Study|0|||
131566549|NCT01244763|473698154|FG003|Overall Study|Enrolled into the Extension Study|0|||
131566550|NCT01244763|473698155|FG004|Overall Study|Enrolled into the Extension Study|0|||
131566551|NCT01244763|473698156|FG005|Overall Study|Enrolled into the Extension Study|1|||
131566552|NCT03330119|473698157|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
131566553|NCT03330119|473698158|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
131566554|NCT01561079|473698159|FG000|Overall Study|Physician Decision|17|||
131566555|NCT01561079|473698159|FG000|Overall Study|Withdrawal by Subject|59|||
131566556|NCT01561079|473698159|FG000|Overall Study|Protocol Violation|2|||
131566557|NCT00664521|473698168|FG000|Overall Study|Adverse Event|4|||
131566558|NCT00664521|473698169|FG001|Overall Study|Adverse Event|1|||
131566559|NCT00664521|473698168|FG000|Overall Study|Lost to Follow-up|1|||
131566560|NCT00664521|473698169|FG001|Overall Study|Lost to Follow-up|0|||
131566561|NCT00664521|473698168|FG000|Overall Study|Other|1|||
131566562|NCT00664521|473698169|FG001|Overall Study|Other|0|||
131566563|NCT02459964|473698170|FG000|Overall Study|Withdrawal by Subject|0|||
131566564|NCT02459964|473698171|FG001|Overall Study|Withdrawal by Subject|0|||
131566565|NCT02459964|473698172|FG002|Overall Study|Withdrawal by Subject|1|||
131566566|NCT02459964|473698170|FG000|Overall Study|Abnormal EKG changes|0|||
131566567|NCT02459964|473698171|FG001|Overall Study|Abnormal EKG changes|0|||
131566568|NCT02459964|473698172|FG002|Overall Study|Abnormal EKG changes|1|||
131566569|NCT00367237|473698173|FG000|Overall Study|Adverse Event|7|||
131566570|NCT00367237|473698174|FG001|Overall Study|Adverse Event|2|||
131566571|NCT00367237|473698173|FG000|Overall Study|Lost to Follow-up|1|||
131566572|NCT00367237|473698174|FG001|Overall Study|Lost to Follow-up|0|||
131566573|NCT00367237|473698173|FG000|Overall Study|Withdrawal by Subject|0|||
131566574|NCT00367237|473698174|FG001|Overall Study|Withdrawal by Subject|4|||
131566575|NCT00367237|473698173|FG000|Overall Study|Protocol Violation|2|||
131566576|NCT00367237|473698174|FG001|Overall Study|Protocol Violation|5|||
131566577|NCT00550732|473698175|FG000|Overall Study|Death|4|||
131566578|NCT00550732|473698175|FG000|Overall Study|Withdrawal by Subject|2|||
131566579|NCT00550732|473698175|FG000|Overall Study|Physician Decision|2|||
131566580|NCT00550732|473698175|FG000|Overall Study|Lost to Follow-up|1|||
131566581|NCT00550732|473698175|FG000|Overall Study|Palliative care|1|||
131566582|NCT00550732|473698175|FG000|Overall Study|Adverse Event|1|||
131566583|NCT02800928|473698182|FG000|Overall Study|Withdrawal by Subject|1|||
131566584|NCT02800928|473698183|FG001|Overall Study|Withdrawal by Subject|1|||
131566585|NCT02800928|473698182|FG000|Overall Study|Protocol Violation|1|||
131566586|NCT02800928|473698183|FG001|Overall Study|Protocol Violation|1|||
131566587|NCT04004208|473698189|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131566588|NCT04004208|473698190|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131437476|NCT05051579|473226878|FG002|Overall Study|Withdrawal by Subject|2|||
131437477|NCT05051579|473226879|FG003|Overall Study|Withdrawal by Subject|1|||
131437478|NCT05051579|473226880|FG004|Overall Study|Withdrawal by Subject|4|||
131437479|NCT05051579|473226881|FG005|Overall Study|Withdrawal by Subject|0|||
131566589|NCT04004208|473698189|FG000|Overall Study|Death|3|||
131566590|NCT04004208|473698190|FG001|Overall Study|Death|0|||
131566591|NCT04004208|473698189|FG000|Overall Study|COVID-19 pandemic|1|||
131566592|NCT04004208|473698190|FG001|Overall Study|COVID-19 pandemic|0|||
131566593|NCT04004208|473698189|FG000|Overall Study|Physician Decision|1|||
131566594|NCT04004208|473698190|FG001|Overall Study|Physician Decision|0|||
131566595|NCT04004208|473698189|FG000|Overall Study|Adverse Event|1|||
131566596|NCT04004208|473698190|FG001|Overall Study|Adverse Event|1|||
131437480|NCT05051579|473226882|FG006|Overall Study|Withdrawal by Subject|4|||
131566597|NCT00570661|473698197|FG000|Overall Study|Disease worsening|5|||
131566598|NCT00570661|473698197|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
131566599|NCT00570661|473698197|FG000|Overall Study|Adverse Event|1|||
131566600|NCT01734382|473698198|FG000|Part 1|Adverse Event|2|||
131566601|NCT01734382|473698199|FG001|Part 1|Adverse Event|0|||
131566602|NCT01734382|473698200|FG002|Part 1|Adverse Event|0|||
131566603|NCT01734382|473698198|FG000|Part 2|Adverse Event|0|||
131566604|NCT01734382|473698199|FG001|Part 2|Adverse Event|0|||
131566605|NCT01734382|473698200|FG002|Part 2|Adverse Event|1|||
131566606|NCT01734382|473698198|FG000|Part 2|Lack of Efficacy|0|||
131566607|NCT01734382|473698199|FG001|Part 2|Lack of Efficacy|1|||
131566608|NCT01734382|473698200|FG002|Part 2|Lack of Efficacy|1|||
131566609|NCT01734382|473698198|FG000|Part 2|Other|0|||
131566610|NCT01734382|473698199|FG001|Part 2|Other|0|||
131566611|NCT01734382|473698200|FG002|Part 2|Other|1|||
131566612|NCT01734382|473698198|FG000|Part 2|Physician Decision|0|||
131566613|NCT01734382|473698199|FG001|Part 2|Physician Decision|0|||
131566614|NCT01734382|473698200|FG002|Part 2|Physician Decision|3|||
131566615|NCT01734382|473698198|FG000|Part 2|Protocol Violation|0|||
131566616|NCT01734382|473698199|FG001|Part 2|Protocol Violation|1|||
131566617|NCT01734382|473698200|FG002|Part 2|Protocol Violation|0|||
131566618|NCT01734382|473698198|FG000|Part 2|Withdrawal by Subject|0|||
131566619|NCT01734382|473698199|FG001|Part 2|Withdrawal by Subject|0|||
131566620|NCT01734382|473698200|FG002|Part 2|Withdrawal by Subject|1|||
131566621|NCT01052662|473698203|FG000|Overall Study|Lost to Follow-up|15|||
131566622|NCT01052662|473698204|FG001|Overall Study|Lost to Follow-up|13|||
131566623|NCT01052662|473698205|FG002|Overall Study|Lost to Follow-up|18|||
131566624|NCT01052662|473698203|FG000|Overall Study|Withdrawal by Subject|3|||
131566625|NCT01052662|473698204|FG001|Overall Study|Withdrawal by Subject|2|||
131566626|NCT01052662|473698205|FG002|Overall Study|Withdrawal by Subject|1|||
131566627|NCT01052662|473698203|FG000|Overall Study|Pharmacy issue|1|||
131566628|NCT01052662|473698204|FG001|Overall Study|Pharmacy issue|3|||
131566629|NCT01052662|473698205|FG002|Overall Study|Pharmacy issue|3|||
131566630|NCT01052662|473698203|FG000|Overall Study|Adverse Event|1|||
131566631|NCT01052662|473698204|FG001|Overall Study|Adverse Event|1|||
131566632|NCT01052662|473698205|FG002|Overall Study|Adverse Event|0|||
131566633|NCT01052662|473698203|FG000|Overall Study|Legal Problem|2|||
131566634|NCT01052662|473698204|FG001|Overall Study|Legal Problem|0|||
131566635|NCT01052662|473698205|FG002|Overall Study|Legal Problem|0|||
131566636|NCT01052662|473698203|FG000|Overall Study|Administrative|0|||
131566637|NCT01052662|473698204|FG001|Overall Study|Administrative|3|||
131566638|NCT01052662|473698205|FG002|Overall Study|Administrative|0|||
131566639|NCT02013687|473698206|FG000|Overall Study|Lost to Follow-up|0|||
131566640|NCT02013687|473698207|FG001|Overall Study|Lost to Follow-up|0|||
131566641|NCT02013687|473698208|FG002|Overall Study|Lost to Follow-up|1|||
131566642|NCT02013687|473698209|FG003|Overall Study|Lost to Follow-up|0|||
131566643|NCT02013687|473698206|FG000|Overall Study|Protocol Violation|0|||
131566644|NCT02013687|473698207|FG001|Overall Study|Protocol Violation|0|||
131566645|NCT02013687|473698208|FG002|Overall Study|Protocol Violation|0|||
131566646|NCT02013687|473698209|FG003|Overall Study|Protocol Violation|1|||
131566647|NCT02013687|473698206|FG000|Overall Study|Withdrawal by Subject|0|||
131566648|NCT02013687|473698207|FG001|Overall Study|Withdrawal by Subject|0|||
131566649|NCT02013687|473698208|FG002|Overall Study|Withdrawal by Subject|0|||
131566650|NCT02013687|473698209|FG003|Overall Study|Withdrawal by Subject|1|||
131566651|NCT02013687|473698206|FG000|Overall Study|Missed visits due to patient travel|0|||
131566652|NCT02013687|473698207|FG001|Overall Study|Missed visits due to patient travel|0|||
131566653|NCT02013687|473698208|FG002|Overall Study|Missed visits due to patient travel|1|||
131566654|NCT02013687|473698209|FG003|Overall Study|Missed visits due to patient travel|0|||
131566655|NCT05968482|473698210|FG000|First Crossover Period|Withdrawal by Subject|0|||
131566656|NCT05968482|473698211|FG001|First Crossover Period|Withdrawal by Subject|0|||
131566657|NCT05968482|473698212|FG002|First Crossover Period|Withdrawal by Subject|1|||
131566658|NCT05968482|473698213|FG003|First Crossover Period|Withdrawal by Subject|0|||
131566659|NCT05968482|473698214|FG004|First Crossover Period|Withdrawal by Subject|0|||
131566660|NCT05968482|473698215|FG005|First Crossover Period|Withdrawal by Subject|0|||
131566661|NCT05968482|473698210|FG000|First Crossover Period|Adverse Event|0|||
131566662|NCT05968482|473698211|FG001|First Crossover Period|Adverse Event|0|||
131566663|NCT05968482|473698212|FG002|First Crossover Period|Adverse Event|0|||
131566664|NCT05968482|473698213|FG003|First Crossover Period|Adverse Event|0|||
131566665|NCT05968482|473698214|FG004|First Crossover Period|Adverse Event|0|||
131566666|NCT05968482|473698215|FG005|First Crossover Period|Adverse Event|1|||
131566667|NCT05968482|473698210|FG000|Second Crossover Period|Withdrawal by Subject|0|||
131566668|NCT05968482|473698211|FG001|Second Crossover Period|Withdrawal by Subject|0|||
131566669|NCT05968482|473698212|FG002|Second Crossover Period|Withdrawal by Subject|0|||
131566670|NCT05968482|473698213|FG003|Second Crossover Period|Withdrawal by Subject|0|||
131566671|NCT05968482|473698214|FG004|Second Crossover Period|Withdrawal by Subject|1|||
131566672|NCT05968482|473698215|FG005|Second Crossover Period|Withdrawal by Subject|0|||
131437481|NCT05051579|473226876|FG000|Overall Study|Lost to Follow-up|1|||
131783098|NCT00422058|474487833|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
131783099|NCT00422058|474487834|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
131783100|NCT00422058|474487835|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
131783101|NCT00422058|474487836|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
131783102|NCT00422058|474487831|FG000|Open-Label Extension, Week 20-104|Other|13|||
131783103|NCT00422058|474487832|FG001|Open-Label Extension, Week 20-104|Other|14|||
131783104|NCT00422058|474487833|FG002|Open-Label Extension, Week 20-104|Other|6|||
131783105|NCT00422058|474487834|FG003|Open-Label Extension, Week 20-104|Other|13|||
131566673|NCT05968482|473698210|FG000|Third Crossover Period|Adverse Event|0|||
131566674|NCT05968482|473698211|FG001|Third Crossover Period|Adverse Event|0|||
131566675|NCT05968482|473698212|FG002|Third Crossover Period|Adverse Event|0|||
131566676|NCT05968482|473698213|FG003|Third Crossover Period|Adverse Event|0|||
131566677|NCT05968482|473698214|FG004|Third Crossover Period|Adverse Event|1|||
131566678|NCT05968482|473698215|FG005|Third Crossover Period|Adverse Event|0|||
131566679|NCT05968482|473698210|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
131566680|NCT05968482|473698211|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
131566681|NCT05968482|473698212|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
131566682|NCT05968482|473698213|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
131566683|NCT05968482|473698214|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
131566684|NCT05968482|473698215|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
131566685|NCT00087490|473698216|FG000|Overall Study|Death|6|||
131566686|NCT00087490|473698217|FG001|Overall Study|Death|4|||
131566687|NCT00087490|473698216|FG000|Overall Study|Adverse Event|3|||
131566688|NCT00087490|473698217|FG001|Overall Study|Adverse Event|8|||
131566689|NCT00087490|473698216|FG000|Overall Study|Lack of Efficacy|0|||
131566690|NCT00087490|473698217|FG001|Overall Study|Lack of Efficacy|2|||
131566691|NCT00087490|473698216|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
131566692|NCT00087490|473698217|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
131566693|NCT00087490|473698216|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
131566694|NCT00087490|473698217|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
131566695|NCT00087490|473698216|FG000|Overall Study|Randomized but not treated|7|||
131566696|NCT00087490|473698217|FG001|Overall Study|Randomized but not treated|18|||
131566697|NCT00761774|473698218|FG000|Overall Study|Adverse Event|17|||
131566698|NCT00761774|473698218|FG000|Overall Study|Lack of Efficacy|37|||
131566699|NCT00761774|473698218|FG000|Overall Study|Lost to Follow-up|2|||
131566700|NCT00761774|473698218|FG000|Overall Study|Withdrawal by Subject|9|||
131566701|NCT00761774|473698218|FG000|Overall Study|Non-compliance|4|||
131566702|NCT00761774|473698218|FG000|Overall Study|End of study|2|||
131566703|NCT00761774|473698218|FG000|Overall Study|Reclassification of seizures|1|||
131566704|NCT00761774|473698218|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
131566705|NCT00761774|473698218|FG000|Overall Study|Sponsor decision|1|||
131566706|NCT00761774|473698218|FG000|Overall Study|Investigator clinical judgement|1|||
131566707|NCT00761774|473698218|FG000|Overall Study|Patient moved out of study area|1|||
131566708|NCT00761774|473698218|FG000|Overall Study|Coordinator leaving site|1|||
131566709|NCT00761774|473698218|FG000|Overall Study|Subject IP non-compliance|1|||
131566710|NCT00761774|473698218|FG000|Overall Study|IP stopped by hospital physician|1|||
131566711|NCT02034435|473698221|FG000|Overall Study|Withdrawal by Subject|1|||
131566712|NCT02034435|473698222|FG001|Overall Study|Withdrawal by Subject|0|||
131566713|NCT02034435|473698223|FG002|Overall Study|Withdrawal by Subject|0|||
131566714|NCT02034435|473698224|FG003|Overall Study|Withdrawal by Subject|0|||
131566715|NCT02034435|473698221|FG000|Overall Study|Illness|0|||
131566716|NCT02034435|473698222|FG001|Overall Study|Illness|2|||
131566717|NCT02034435|473698223|FG002|Overall Study|Illness|0|||
131566718|NCT02034435|473698224|FG003|Overall Study|Illness|0|||
131566719|NCT02034435|473698221|FG000|Overall Study|Inadequate IV access|1|||
131566720|NCT02034435|473698222|FG001|Overall Study|Inadequate IV access|0|||
131566721|NCT02034435|473698223|FG002|Overall Study|Inadequate IV access|0|||
131566722|NCT02034435|473698224|FG003|Overall Study|Inadequate IV access|1|||
131566723|NCT00630539|473698225|FG000|Overall Study|Adverse Event|1|||
131566724|NCT00630539|473698226|FG001|Overall Study|Adverse Event|3|||
131566725|NCT00630539|473698227|FG002|Overall Study|Adverse Event|1|||
131566726|NCT00630539|473698228|FG003|Overall Study|Adverse Event|2|||
131566727|NCT00630539|473698225|FG000|Overall Study|Withdrawal by Subject|0|||
131566728|NCT00630539|473698226|FG001|Overall Study|Withdrawal by Subject|1|||
131783106|NCT00422058|474487835|FG004|Open-Label Extension, Week 20-104|Other|16|||
131783107|NCT00422058|474487836|FG005|Open-Label Extension, Week 20-104|Other|18|||
131783108|NCT02787785|474487839|FG000|Overall Study|Death|3|||
131783109|NCT02787785|474487840|FG001|Overall Study|Death|4|||
131783110|NCT02787785|474487839|FG000|Overall Study|Lost to Follow-up|1|||
131783111|NCT02787785|474487840|FG001|Overall Study|Lost to Follow-up|1|||
131783112|NCT02787785|474487839|FG000|Overall Study|Withdrawal by Subject|0|||
131566729|NCT00630539|473698227|FG002|Overall Study|Withdrawal by Subject|0|||
131566730|NCT00630539|473698228|FG003|Overall Study|Withdrawal by Subject|1|||
131566731|NCT01700530|473698229|FG000|Overall Study|Withdrawal by Subject|0|||
131566732|NCT01700530|473698230|FG001|Overall Study|Withdrawal by Subject|3|||
131566733|NCT01700530|473698231|FG002|Overall Study|Withdrawal by Subject|1|||
131566734|NCT02223182|473698238|FG000|Double-Blind Period|Adverse Event|0|||
131566735|NCT02223182|473698239|FG001|Double-Blind Period|Adverse Event|2|||
131566736|NCT02223182|473698240|FG002|Double-Blind Period|Adverse Event|1|||
131566737|NCT02223182|473698241|FG003|Double-Blind Period|Adverse Event|0|||
131783113|NCT02787785|474487840|FG001|Overall Study|Withdrawal by Subject|5|||
131898645|NCT00215644|474915329|FG000|Overall Study|Other|3|||
131566738|NCT02223182|473698238|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131566739|NCT02223182|473698239|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131566740|NCT02223182|473698240|FG002|Double-Blind Period|Withdrawal by Subject|1|||
131566741|NCT02223182|473698241|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131566742|NCT02223182|473698238|FG000|Double-Blind Period|Lost to Follow-up|0|||
131566743|NCT02223182|473698239|FG001|Double-Blind Period|Lost to Follow-up|1|||
131566744|NCT02223182|473698240|FG002|Double-Blind Period|Lost to Follow-up|0|||
131566745|NCT02223182|473698241|FG003|Double-Blind Period|Lost to Follow-up|0|||
131566746|NCT02223182|473698238|FG000|Double-Blind Period|Non Compliance|0|||
131566747|NCT02223182|473698239|FG001|Double-Blind Period|Non Compliance|0|||
131566748|NCT02223182|473698240|FG002|Double-Blind Period|Non Compliance|0|||
131566749|NCT02223182|473698241|FG003|Double-Blind Period|Non Compliance|1|||
131566750|NCT02223182|473698238|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
131566751|NCT02223182|473698239|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
131566752|NCT02223182|473698240|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
131566753|NCT02223182|473698241|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
131566754|NCT02223182|473698238|FG000|Open-Label 500 Period|Adverse Event|1|||
131566755|NCT02223182|473698239|FG001|Open-Label 500 Period|Adverse Event|0|||
131566756|NCT02223182|473698240|FG002|Open-Label 500 Period|Adverse Event|2|||
131566757|NCT02223182|473698241|FG003|Open-Label 500 Period|Adverse Event|1|||
131566758|NCT02223182|473698238|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
131566759|NCT02223182|473698239|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
131566760|NCT02223182|473698240|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
131566761|NCT02223182|473698241|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
131566762|NCT02223182|473698238|FG000|Open-Label 500 Period|Physician Decision|0|||
131566763|NCT02223182|473698239|FG001|Open-Label 500 Period|Physician Decision|0|||
131566764|NCT02223182|473698240|FG002|Open-Label 500 Period|Physician Decision|0|||
131566765|NCT02223182|473698241|FG003|Open-Label 500 Period|Physician Decision|1|||
131783114|NCT00902265|474487841|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
131783115|NCT00902265|474487841|FG000|Overall Study|Adverse Event|2|||
131783116|NCT00902265|474487841|FG000|Overall Study|Lack of Efficacy|2|||
131783117|NCT00902265|474487841|FG000|Overall Study|Protocol Violation|1|||
131783118|NCT00103259|474487845|FG000|Overall Study|Death|3|||
131783119|NCT00103259|474487846|FG001|Overall Study|Death|2|||
131783120|NCT00103259|474487845|FG000|Overall Study|Withdrawal by Subject|2|||
131783121|NCT00103259|474487846|FG001|Overall Study|Withdrawal by Subject|3|||
131783122|NCT00103259|474487845|FG000|Overall Study|alternative therapy|1|||
131783123|NCT00103259|474487846|FG001|Overall Study|alternative therapy|0|||
131783124|NCT00103259|474487845|FG000|Overall Study|other (reasons were not specified)|2|||
131783125|NCT00103259|474487846|FG001|Overall Study|other (reasons were not specified)|1|||
131783126|NCT00103259|474487845|FG000|Overall Study|ineligible/no protocol therapy|4|||
131783127|NCT00103259|474487846|FG001|Overall Study|ineligible/no protocol therapy|6|||
131783128|NCT02866695|474487851|FG000|Overall Study|Adverse Event|1|||
131783129|NCT02866695|474487851|FG000|Overall Study|Lost to Follow-up|1|||
131783130|NCT03224234|474487852|FG000|Main Study|Lost to Follow-up|5|||
131783131|NCT03224234|474487853|FG001|Main Study|Lost to Follow-up|5|||
131783132|NCT05016765|474487854|FG000|Overall Study|Lost to Follow-up|4|||
131783133|NCT02564952|474487855|FG000|Overall Study|Adverse Event|6|||
131783134|NCT02564952|474487855|FG000|Overall Study|Lost to Follow-up|1|||
131783135|NCT02564952|474487855|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
131783136|NCT02564952|474487855|FG000|Overall Study|Withdrawal by Subject|1|||
131783137|NCT02564952|474487855|FG000|Overall Study|Low Efficacy|1|||
131783138|NCT02564952|474487855|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
131783139|NCT00756652|474487856|FG000|Original Phase|Withdrawal by Subject|864|||
131783140|NCT00756652|474487857|FG001|Original Phase|Withdrawal by Subject|23|||
131783141|NCT00756652|474487856|FG000|Original Phase|Lost to Follow-up|601|||
131783142|NCT00756652|474487857|FG001|Original Phase|Lost to Follow-up|0|||
131783143|NCT00756652|474487856|FG000|Original Phase|Other Discontinuation|797|||
131783144|NCT00756652|474487857|FG001|Original Phase|Other Discontinuation|5|||
131783145|NCT00756652|474487856|FG000|Original Phase|Participant Noncompliance|18622|||
131783146|NCT00756652|474487857|FG001|Original Phase|Participant Noncompliance|424|||
131783147|NCT00756652|474487856|FG000|Original Phase|Unknown Discontinuation Reason|2|||
131566766|NCT02223182|473698238|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
131566767|NCT02223182|473698239|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
131566768|NCT02223182|473698240|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
131566769|NCT02223182|473698241|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
131783148|NCT00756652|474487857|FG001|Original Phase|Unknown Discontinuation Reason|0|||
131783149|NCT00756652|474487856|FG000|Original Phase|Participants without data|3259|||
131783150|NCT00756652|474487857|FG001|Original Phase|Participants without data|466|||
131783151|NCT00756652|474487856|FG000|Original Phase|Death|168|||
131783152|NCT00756652|474487857|FG001|Original Phase|Death|1|||
131783153|NCT00756652|474487856|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
131783154|NCT00756652|474487857|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
131783155|NCT00756652|474487856|FG000|Re-Op Phase|Withdrawal by Subject|62|||
131783156|NCT00756652|474487857|FG001|Re-Op Phase|Withdrawal by Subject|0|||
131566770|NCT02223182|473698238|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
131566771|NCT02223182|473698239|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
131566772|NCT02223182|473698240|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
131566773|NCT02223182|473698241|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
131566774|NCT02223182|473698238|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
131566775|NCT02223182|473698239|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
131566776|NCT02223182|473698240|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
131566777|NCT02223182|473698241|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
131566778|NCT02223182|473698238|FG000|Open-Label 300 Period|Non Compliance|0|||
131566779|NCT02223182|473698239|FG001|Open-Label 300 Period|Non Compliance|2|||
131566780|NCT02223182|473698240|FG002|Open-Label 300 Period|Non Compliance|1|||
131566781|NCT02223182|473698241|FG003|Open-Label 300 Period|Non Compliance|0|||
131566782|NCT03714022|473698242|FG000|Overall Study|Adverse Event|1|||
131566783|NCT03714022|473698243|FG001|Overall Study|Adverse Event|0|||
131566784|NCT03714022|473698242|FG000|Overall Study|Consent withdrawal|0|||
131566785|NCT03714022|473698243|FG001|Overall Study|Consent withdrawal|1|||
131566786|NCT03714022|473698242|FG000|Overall Study|Lost to Follow-up|3|||
131566787|NCT03714022|473698243|FG001|Overall Study|Lost to Follow-up|2|||
131566788|NCT00235495|473698252|FG000|Overall Study|Death|52|||
131566789|NCT00235495|473698253|FG001|Overall Study|Death|42|||
131566790|NCT00235495|473698252|FG000|Overall Study|Withdrawal by Subject|5|||
131566791|NCT00235495|473698253|FG001|Overall Study|Withdrawal by Subject|3|||
131566792|NCT00235495|473698252|FG000|Overall Study|Lost to Follow-up|11|||
131566793|NCT00235495|473698253|FG001|Overall Study|Lost to Follow-up|13|||
131566794|NCT00235495|473698252|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
131566795|NCT00235495|473698253|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
131566796|NCT03289455|473698254|FG000|Overall Study|Death|1|||
131566797|NCT03289455|473698255|FG001|Overall Study|Death|0|||
131566798|NCT03289455|473698256|FG002|Overall Study|Death|0|||
131566799|NCT03289455|473698254|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
131566800|NCT03289455|473698255|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
131566801|NCT03289455|473698256|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
131566802|NCT03289455|473698254|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
131566803|NCT03289455|473698255|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
131566804|NCT03289455|473698256|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
131566805|NCT03289455|473698254|FG000|Overall Study|Progressive disease|3|||
131566806|NCT03289455|473698255|FG001|Overall Study|Progressive disease|4|||
131566807|NCT03289455|473698256|FG002|Overall Study|Progressive disease|5|||
131566808|NCT00114959|473698257|FG000|Overall Study|Lack of Efficacy|6|||
131566809|NCT00114959|473698257|FG000|Overall Study|Physician Decision|1|||
131566810|NCT00114959|473698257|FG000|Overall Study|Death|1|||
131566811|NCT02337361|473698262|FG000|3-month Follow-up|Lost to Follow-up|19|||
131566812|NCT02337361|473698263|FG001|3-month Follow-up|Lost to Follow-up|14|||
131566813|NCT02337361|473698262|FG000|6-month Follow-up|Lost to Follow-up|2|||
131566814|NCT02337361|473698263|FG001|6-month Follow-up|Lost to Follow-up|4|||
131566815|NCT02419755|473698264|FG000|Overall Study|Death|1|||
131566816|NCT02419755|473698265|FG001|Overall Study|Death|3|||
131566817|NCT02419755|473698264|FG000|Overall Study|Relapse|0|||
131566818|NCT02419755|473698265|FG001|Overall Study|Relapse|1|||
131566819|NCT02419755|473698264|FG000|Overall Study|Ineligible|1|||
131566820|NCT02419755|473698265|FG001|Overall Study|Ineligible|0|||
131566821|NCT02419755|473698264|FG000|Overall Study|Withdrawal by Subject|1|||
131566822|NCT02419755|473698265|FG001|Overall Study|Withdrawal by Subject|0|||
131566823|NCT02427646|473698266|FG000|Overall Study|Lack of Efficacy|2|||
131566824|NCT02427646|473698267|FG001|Overall Study|Lack of Efficacy|3|||
131566825|NCT02427646|473698266|FG000|Overall Study|Physician Decision|1|||
131566826|NCT02427646|473698267|FG001|Overall Study|Physician Decision|4|||
131437482|NCT05051579|473226877|FG001|Overall Study|Lost to Follow-up|0|||
131437483|NCT05051579|473226878|FG002|Overall Study|Lost to Follow-up|0|||
131437484|NCT05051579|473226879|FG003|Overall Study|Lost to Follow-up|0|||
131437485|NCT05051579|473226880|FG004|Overall Study|Lost to Follow-up|1|||
131437486|NCT05051579|473226881|FG005|Overall Study|Lost to Follow-up|0|||
131437487|NCT05051579|473226882|FG006|Overall Study|Lost to Follow-up|1|||
131437488|NCT05051579|473226876|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
131437489|NCT05051579|473226877|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
131437490|NCT05051579|473226878|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
131437491|NCT05051579|473226879|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
131437492|NCT05051579|473226880|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
131437493|NCT05051579|473226881|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
131566827|NCT02427646|473698266|FG000|Overall Study|Protocol Violation|3|||
131566828|NCT02427646|473698267|FG001|Overall Study|Protocol Violation|3|||
131566829|NCT02427646|473698266|FG000|Overall Study|Bothersome hand weakness|2|||
131566830|NCT02427646|473698267|FG001|Overall Study|Bothersome hand weakness|4|||
131566831|NCT00901485|473698268|FG000|Overall Study|Lack of Efficacy|0|||
131566832|NCT00901485|473698269|FG001|Overall Study|Lack of Efficacy|2|||
131566833|NCT00901485|473698268|FG000|Overall Study|Withdrawal by Subject|1|||
131566834|NCT00901485|473698269|FG001|Overall Study|Withdrawal by Subject|2|||
131566835|NCT01929993|473700554|FG000|Overall Study|Protocol Violation|4|||
131566836|NCT01929993|473700555|FG001|Overall Study|Protocol Violation|6|||
131566837|NCT01929993|473700554|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
131566838|NCT01929993|473700555|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
131566839|NCT01852162|473700556|FG000|Overall Study|Adverse Event|1|||
131566840|NCT01852162|473700557|FG001|Overall Study|Adverse Event|0|||
131566841|NCT01852162|473700556|FG000|Overall Study|Withdrawal by Subject|3|||
131566842|NCT01852162|473700557|FG001|Overall Study|Withdrawal by Subject|1|||
131566843|NCT00163215|473700562|FG000|Overall Study|Lack of Efficacy|3|||
131566844|NCT00163215|473700562|FG000|Overall Study|Withdrawal by Subject|5|||
131566845|NCT00163215|473700562|FG000|Overall Study|Other|7|||
131566846|NCT03660943|473700565|FG000|Overall Study|Adverse Event|5|||
131566847|NCT03660943|473700566|FG001|Overall Study|Adverse Event|3|||
131566848|NCT03660943|473700565|FG000|Overall Study|Death|0|||
131566849|NCT03660943|473700566|FG001|Overall Study|Death|2|||
131566850|NCT03660943|473700565|FG000|Overall Study|Lost to Follow-up|7|||
131566851|NCT03660943|473700566|FG001|Overall Study|Lost to Follow-up|3|||
131566852|NCT03660943|473700565|FG000|Overall Study|Protocol Violation|3|||
131566853|NCT03660943|473700566|FG001|Overall Study|Protocol Violation|5|||
131566854|NCT03660943|473700565|FG000|Overall Study|Withdrawal by Subject|8|||
131566855|NCT03660943|473700566|FG001|Overall Study|Withdrawal by Subject|15|||
131566856|NCT03660943|473700565|FG000|Overall Study|Lack of Efficacy|9|||
131566857|NCT03660943|473700566|FG001|Overall Study|Lack of Efficacy|12|||
131566858|NCT03660943|473700565|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
131566859|NCT03660943|473700566|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
131566860|NCT04096365|473700567|FG000|Overall Study|Adverse Event|1|||
131566861|NCT05310084|473700568|FG000|Overall Study|Withdrawal by Subject|2|||
131566862|NCT05310084|473700569|FG001|Overall Study|Withdrawal by Subject|3|||
131566863|NCT05310084|473700568|FG000|Overall Study|Participant availability|0|||
131566864|NCT05310084|473700569|FG001|Overall Study|Participant availability|4|||
131566865|NCT05310084|473700568|FG000|Overall Study|Lost to Follow-up|1|||
131566866|NCT05310084|473700569|FG001|Overall Study|Lost to Follow-up|1|||
131566867|NCT05310084|473700568|FG000|Overall Study|Adverse Event|1|||
131566868|NCT05310084|473700569|FG001|Overall Study|Adverse Event|1|||
131566869|NCT05310084|473700568|FG000|Overall Study|Randomized but not vaccinated|4|||
131566870|NCT05310084|473700569|FG001|Overall Study|Randomized but not vaccinated|2|||
131566871|NCT01033643|473700573|FG000|Overall Study|Withdrew Consent|0|||
131566872|NCT01033643|473700574|FG001|Overall Study|Withdrew Consent|3|||
131566873|NCT01033643|473700575|FG002|Overall Study|Withdrew Consent|0|||
131566874|NCT01033643|473700576|FG003|Overall Study|Withdrew Consent|0|||
131566875|NCT01033643|473700577|FG004|Overall Study|Withdrew Consent|0|||
131566876|NCT01033643|473700578|FG005|Overall Study|Withdrew Consent|1|||
131566877|NCT00751790|473700585|FG000|Overall Study|Lost to Follow-up|1|||
131566878|NCT00751790|473700585|FG000|Overall Study|Death|3|||
131566879|NCT00751790|473700585|FG000|Overall Study|Withdrawal by Subject|1|||
131566880|NCT01106976|473700586|FG000|Overall Study|Lost to Follow-up|8|||
131566881|NCT03836664|473700589|FG000|Overall Study|Didn't complete forms and lost drug|3|||
131566882|NCT03836664|473700590|FG001|Overall Study|Didn't complete forms and lost drug|3|||
131566883|NCT01427907|473700591|FG000|Overall Study|Withdrawal by Subject|3|||
131566884|NCT01427907|473700592|FG001|Overall Study|Withdrawal by Subject|4|||
131566885|NCT02179918|473700593|FG000|Overall Study|Death|0|||
131566886|NCT02179918|473700594|FG001|Overall Study|Death|0|||
131566887|NCT02179918|473700595|FG002|Overall Study|Death|0|||
131566888|NCT02179918|473700596|FG003|Overall Study|Death|1|||
131566889|NCT02179918|473700597|FG004|Overall Study|Death|0|||
131566890|NCT02179918|473700593|FG000|Overall Study|Lost to Follow-up|0|||
131437494|NCT05051579|473226882|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
131437495|NCT05051579|473226876|FG000|Overall Study|Adverse Event|2|||
131437496|NCT05051579|473226877|FG001|Overall Study|Adverse Event|1|||
131437497|NCT05051579|473226878|FG002|Overall Study|Adverse Event|0|||
131437498|NCT05051579|473226879|FG003|Overall Study|Adverse Event|4|||
131437499|NCT05051579|473226880|FG004|Overall Study|Adverse Event|1|||
131437500|NCT05051579|473226881|FG005|Overall Study|Adverse Event|2|||
131566891|NCT02179918|473700594|FG001|Overall Study|Lost to Follow-up|0|||
131566892|NCT02179918|473700595|FG002|Overall Study|Lost to Follow-up|1|||
131566893|NCT02179918|473700596|FG003|Overall Study|Lost to Follow-up|0|||
131566894|NCT02179918|473700597|FG004|Overall Study|Lost to Follow-up|0|||
131566895|NCT02179918|473700593|FG000|Overall Study|Progressive Disease|4|||
131566896|NCT02179918|473700594|FG001|Overall Study|Progressive Disease|1|||
131566897|NCT02179918|473700595|FG002|Overall Study|Progressive Disease|1|||
131566898|NCT02179918|473700596|FG003|Overall Study|Progressive Disease|2|||
131566899|NCT02179918|473700597|FG004|Overall Study|Progressive Disease|6|||
131566900|NCT02179918|473700593|FG000|Overall Study|Other|0|||
131566901|NCT02179918|473700594|FG001|Overall Study|Other|1|||
131566902|NCT02179918|473700595|FG002|Overall Study|Other|0|||
131437501|NCT05051579|473226882|FG006|Overall Study|Adverse Event|0|||
131566903|NCT02179918|473700596|FG003|Overall Study|Other|0|||
131566904|NCT02179918|473700597|FG004|Overall Study|Other|1|||
131566905|NCT02179918|473700593|FG000|Overall Study|Subject refused further follow-up|0|||
131566906|NCT02179918|473700594|FG001|Overall Study|Subject refused further follow-up|1|||
131566907|NCT02179918|473700595|FG002|Overall Study|Subject refused further follow-up|0|||
131566908|NCT02179918|473700596|FG003|Overall Study|Subject refused further follow-up|0|||
131566909|NCT02179918|473700597|FG004|Overall Study|Subject refused further follow-up|1|||
131566910|NCT04337489|473700602|FG000|Overall Study|Withdrawal by Subject|1|||
131566911|NCT00972543|473700603|FG000|Overall Study|Adverse Event|1|||
131566912|NCT00972543|473700604|FG001|Overall Study|Adverse Event|0|||
131566913|NCT00972543|473700603|FG000|Overall Study|Early study termination by sponsor|4|||
131566914|NCT00972543|473700604|FG001|Overall Study|Early study termination by sponsor|1|||
131566915|NCT04833855|473700612|FG000|Overall Study|Decision by sponsor|0|||
131566916|NCT04833855|473700613|FG001|Overall Study|Decision by sponsor|1|||
131566917|NCT04833855|473700614|FG002|Overall Study|Decision by sponsor|0|||
131566918|NCT04833855|473700615|FG003|Overall Study|Decision by sponsor|0|||
131566919|NCT04833855|473700612|FG000|Overall Study|Withdrawal by Subject|4|||
131566920|NCT04833855|473700613|FG001|Overall Study|Withdrawal by Subject|1|||
131566921|NCT04833855|473700614|FG002|Overall Study|Withdrawal by Subject|3|||
131566922|NCT04833855|473700615|FG003|Overall Study|Withdrawal by Subject|1|||
131566923|NCT04833855|473700612|FG000|Overall Study|Lost to Follow-up|1|||
131566924|NCT04833855|473700613|FG001|Overall Study|Lost to Follow-up|0|||
131566925|NCT04833855|473700614|FG002|Overall Study|Lost to Follow-up|2|||
131566926|NCT04833855|473700615|FG003|Overall Study|Lost to Follow-up|2|||
131566927|NCT04833855|473700612|FG000|Overall Study|Protocol specified criteria|0|||
131566928|NCT04833855|473700613|FG001|Overall Study|Protocol specified criteria|0|||
131566929|NCT04833855|473700614|FG002|Overall Study|Protocol specified criteria|2|||
131566930|NCT04833855|473700615|FG003|Overall Study|Protocol specified criteria|1|||
131566931|NCT03682536|473700617|FG000|Randomization|Withdrawal by Subject|0|||
131566932|NCT03682536|473700618|FG001|Randomization|Withdrawal by Subject|2|||
131566933|NCT03682536|473700617|FG000|Treatment|Other Reasons|8|||
131566934|NCT03682536|473700618|FG001|Treatment|Other Reasons|7|||
131566935|NCT03682536|473700617|FG000|Treatment|Physician Decision|5|||
131566936|NCT03682536|473700618|FG001|Treatment|Physician Decision|5|||
131566937|NCT03682536|473700617|FG000|Treatment|Protocol Violation|1|||
131566938|NCT03682536|473700618|FG001|Treatment|Protocol Violation|0|||
131566939|NCT03682536|473700617|FG000|Treatment|Study Terminated by Sponsor|1|||
131566940|NCT03682536|473700618|FG001|Treatment|Study Terminated by Sponsor|2|||
131566941|NCT03682536|473700617|FG000|Treatment|Lost to Follow-up|0|||
131566942|NCT03682536|473700618|FG001|Treatment|Lost to Follow-up|1|||
131566943|NCT03682536|473700617|FG000|Treatment|Withdrawal by Subject|16|||
131566944|NCT03682536|473700618|FG001|Treatment|Withdrawal by Subject|18|||
131566945|NCT03682536|473700617|FG000|Treatment|Lack of Efficacy|41|||
131566946|NCT03682536|473700618|FG001|Treatment|Lack of Efficacy|68|||
131566947|NCT03682536|473700617|FG000|Treatment|Disease Progression|9|||
131566948|NCT03682536|473700618|FG001|Treatment|Disease Progression|7|||
131566949|NCT03682536|473700617|FG000|Treatment|Adverse Event|9|||
131566950|NCT03682536|473700618|FG001|Treatment|Adverse Event|5|||
131566951|NCT03682536|473700617|FG000|Treatment|Death|14|||
131566952|NCT03682536|473700618|FG001|Treatment|Death|13|||
131566953|NCT03008122|473700619|FG000|Overall Study|Physician Decision|3|||
131566954|NCT03008122|473700620|FG001|Overall Study|Physician Decision|2|||
131566955|NCT03008122|473700621|FG002|Overall Study|Physician Decision|0|||
131566956|NCT03008122|473700619|FG000|Overall Study|Withdrawal by Subject|1|||
131566957|NCT03008122|473700620|FG001|Overall Study|Withdrawal by Subject|3|||
131566958|NCT03008122|473700621|FG002|Overall Study|Withdrawal by Subject|0|||
131566959|NCT03008122|473700619|FG000|Overall Study|Lost to Follow-up|4|||
131566960|NCT03008122|473700620|FG001|Overall Study|Lost to Follow-up|8|||
131566961|NCT03008122|473700621|FG002|Overall Study|Lost to Follow-up|3|||
131566962|NCT03008122|473700619|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
131566963|NCT03008122|473700620|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131566964|NCT03008122|473700621|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
131566965|NCT03008122|473700619|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
131566966|NCT03008122|473700620|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
131566967|NCT03008122|473700621|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
131566968|NCT03008122|473700619|FG000|Overall Study|Death|0|||
131566969|NCT03008122|473700620|FG001|Overall Study|Death|0|||
131566970|NCT03008122|473700621|FG002|Overall Study|Death|1|||
131566971|NCT02338609|473700622|FG000|Overall Study|Physician Decision|1|||
131566972|NCT02338609|473700622|FG000|Overall Study|Death|1|||
131566973|NCT02234310|473700625|FG000|Overall Study|Physician Decision|1|||
131566974|NCT02234310|473700625|FG000|Overall Study|Adverse Event|1|||
131566975|NCT02234310|473700625|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
131566976|NCT02234310|473700625|FG000|Overall Study|Withdrawal by Subject|2|||
131566977|NCT03251378|473700628|FG000|Overall Study|Death|3|||
131566978|NCT03251378|473700629|FG001|Overall Study|Death|2|||
131566979|NCT03251378|473700630|FG002|Overall Study|Death|3|||
131566980|NCT03251378|473700631|FG003|Overall Study|Death|30|||
131566981|NCT03251378|473700632|FG004|Overall Study|Death|24|||
131566982|NCT03251378|473700633|FG005|Overall Study|Death|12|||
131566983|NCT03251378|473700634|FG006|Overall Study|Death|12|||
131566984|NCT03251378|473700628|FG000|Overall Study|Lost to Follow-up|0|||
131566985|NCT03251378|473700629|FG001|Overall Study|Lost to Follow-up|0|||
131566986|NCT03251378|473700630|FG002|Overall Study|Lost to Follow-up|1|||
131566987|NCT03251378|473700631|FG003|Overall Study|Lost to Follow-up|3|||
131566988|NCT03251378|473700632|FG004|Overall Study|Lost to Follow-up|0|||
131566989|NCT03251378|473700633|FG005|Overall Study|Lost to Follow-up|0|||
131566990|NCT03251378|473700634|FG006|Overall Study|Lost to Follow-up|0|||
131566991|NCT03251378|473700628|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
131566992|NCT03251378|473700629|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
131566993|NCT03251378|473700630|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
131566994|NCT03251378|473700631|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
131566995|NCT03251378|473700632|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
131566996|NCT03251378|473700633|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
131566997|NCT03251378|473700634|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
131566998|NCT03251378|473700628|FG000|Overall Study|Progressive disease|2|||
131566999|NCT03251378|473700629|FG001|Overall Study|Progressive disease|0|||
131567000|NCT03251378|473700630|FG002|Overall Study|Progressive disease|0|||
131567001|NCT03251378|473700631|FG003|Overall Study|Progressive disease|1|||
131567002|NCT03251378|473700632|FG004|Overall Study|Progressive disease|0|||
131567003|NCT03251378|473700633|FG005|Overall Study|Progressive disease|0|||
131783157|NCT00756652|474487856|FG000|Re-Op Phase|Death|6|||
131783158|NCT00756652|474487857|FG001|Re-Op Phase|Death|0|||
131783159|NCT00756652|474487856|FG000|Re-Op Phase|Lost to Follow-up|340|||
131783160|NCT00756652|474487857|FG001|Re-Op Phase|Lost to Follow-up|0|||
131783161|NCT00756652|474487856|FG000|Re-Op Phase|Site Closed|2454|||
131783162|NCT00756652|474487857|FG001|Re-Op Phase|Site Closed|0|||
131783163|NCT00756652|474487856|FG000|Re-Op Phase|Withdrawn after explant|14|||
131783164|NCT00756652|474487857|FG001|Re-Op Phase|Withdrawn after explant|0|||
131783165|NCT02610842|474487858|FG000|Overall Study|Lost to Follow-up|5|||
131783166|NCT01850108|474487859|FG000|Overall Study|Lost to Follow-up|4|||
131783167|NCT01850108|474487859|FG000|Overall Study|Not eligible|1|||
131783168|NCT01850108|474487859|FG000|Overall Study|Failed engraftment|2|||
131783169|NCT01850108|474487859|FG000|Overall Study|Physician Decision|1|||
131783170|NCT02494583|474487862|FG000|Overall Study|Death|224|||
131783171|NCT02494583|474487863|FG001|Overall Study|Death|214|||
131783172|NCT02494583|474487864|FG002|Overall Study|Death|225|||
131783173|NCT02494583|474487862|FG000|Overall Study|Lost to Follow-up|1|||
131783174|NCT02494583|474487863|FG001|Overall Study|Lost to Follow-up|0|||
131783175|NCT02494583|474487864|FG002|Overall Study|Lost to Follow-up|0|||
131783176|NCT02494583|474487862|FG000|Overall Study|Protocol Violation|1|||
131783177|NCT02494583|474487863|FG001|Overall Study|Protocol Violation|2|||
131783178|NCT02494583|474487864|FG002|Overall Study|Protocol Violation|0|||
131783179|NCT02494583|474487862|FG000|Overall Study|Screen Failure|0|||
131783180|NCT02494583|474487863|FG001|Overall Study|Screen Failure|1|||
131783181|NCT02494583|474487864|FG002|Overall Study|Screen Failure|0|||
131783182|NCT02494583|474487862|FG000|Overall Study|Transferred to Extension Study|15|||
131783183|NCT02494583|474487863|FG001|Overall Study|Transferred to Extension Study|15|||
131783184|NCT02494583|474487864|FG002|Overall Study|Transferred to Extension Study|6|||
131783185|NCT02494583|474487862|FG000|Overall Study|Did Not Continue on Extension Study|8|||
131783186|NCT02494583|474487863|FG001|Overall Study|Did Not Continue on Extension Study|10|||
131567004|NCT03251378|473700634|FG006|Overall Study|Progressive disease|0|||
131567005|NCT03251378|473700628|FG000|Overall Study|Physician Decision|0|||
131567006|NCT03251378|473700629|FG001|Overall Study|Physician Decision|2|||
131567007|NCT03251378|473700630|FG002|Overall Study|Physician Decision|0|||
131567008|NCT03251378|473700631|FG003|Overall Study|Physician Decision|0|||
131567009|NCT03251378|473700632|FG004|Overall Study|Physician Decision|0|||
131783187|NCT02494583|474487864|FG002|Overall Study|Did Not Continue on Extension Study|4|||
131783188|NCT02494583|474487862|FG000|Overall Study|Withdrawal by Subject|7|||
131783189|NCT02494583|474487863|FG001|Overall Study|Withdrawal by Subject|15|||
131783190|NCT02494583|474487864|FG002|Overall Study|Withdrawal by Subject|15|||
131783191|NCT00627458|474487865|FG000|Overall Study|Migrated from study area|1|||
131783192|NCT00627458|474487866|FG001|Overall Study|Migrated from study area|0|||
131783193|NCT00627458|474487867|FG002|Overall Study|Migrated from study area|1|||
131783194|NCT00627458|474487865|FG000|Overall Study|Withdrawal by Subject|2|||
131783195|NCT00627458|474487866|FG001|Overall Study|Withdrawal by Subject|6|||
131783196|NCT00627458|474487867|FG002|Overall Study|Withdrawal by Subject|5|||
131783197|NCT00627458|474487865|FG000|Overall Study|Lost to Follow-up|1|||
131783198|NCT00627458|474487866|FG001|Overall Study|Lost to Follow-up|1|||
131783199|NCT00627458|474487867|FG002|Overall Study|Lost to Follow-up|0|||
131783200|NCT01766310|474487869|FG000|Overall Study|Lost to Follow-up|1|||
131783201|NCT01766310|474487870|FG001|Overall Study|Lost to Follow-up|3|||
131783202|NCT03151707|474487874|FG000|Overall Study|Lost to Follow-up|6|||
131783203|NCT00902278|474487883|FG000|Overall Study|Physician Decision|1|||
131783204|NCT00902278|474487884|FG001|Overall Study|Physician Decision|0|||
131783205|NCT00902278|474487885|FG002|Overall Study|Physician Decision|2|||
131783206|NCT00902278|474487886|FG003|Overall Study|Physician Decision|0|||
131783207|NCT00902278|474487887|FG004|Overall Study|Physician Decision|1|||
131783208|NCT00902278|474487883|FG000|Overall Study|Lost to Follow-up|3|||
131783209|NCT00902278|474487884|FG001|Overall Study|Lost to Follow-up|2|||
131783210|NCT00902278|474487885|FG002|Overall Study|Lost to Follow-up|3|||
131783211|NCT00902278|474487886|FG003|Overall Study|Lost to Follow-up|0|||
131783212|NCT00902278|474487887|FG004|Overall Study|Lost to Follow-up|1|||
131783213|NCT02181842|474487888|FG000|Overall Study|Case Report Forms Uncollected|2|||
131783214|NCT04529096|474487889|FG000|Overall Study|Adverse Event|6|||
131783215|NCT04529096|474487890|FG001|Overall Study|Adverse Event|1|||
131783216|NCT04529096|474487889|FG000|Overall Study|Lack of Efficacy|1|||
131783217|NCT04529096|474487890|FG001|Overall Study|Lack of Efficacy|0|||
131783218|NCT04529096|474487889|FG000|Overall Study|Lost to Follow-up|1|||
131783219|NCT04529096|474487890|FG001|Overall Study|Lost to Follow-up|1|||
131783220|NCT04529096|474487889|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131783221|NCT04529096|474487890|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131783222|NCT04529096|474487889|FG000|Overall Study|Physician Decision|1|||
131783223|NCT04529096|474487890|FG001|Overall Study|Physician Decision|3|||
131783224|NCT04529096|474487889|FG000|Overall Study|Withdrawal by Subject|5|||
131783225|NCT04529096|474487890|FG001|Overall Study|Withdrawal by Subject|0|||
131783226|NCT03985293|474487901|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
131783227|NCT03985293|474487902|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
131783228|NCT03985293|474487903|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
131783229|NCT03985293|474487904|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
131783230|NCT03985293|474487905|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
131783231|NCT03985293|474487906|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
131783232|NCT03985293|474487901|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
131783233|NCT03985293|474487902|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
131783234|NCT03985293|474487903|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
131783235|NCT03985293|474487904|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
131783236|NCT03985293|474487905|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
131783237|NCT03985293|474487906|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
131783238|NCT03985293|474487901|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
131783239|NCT03985293|474487902|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
131783240|NCT03985293|474487903|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
131783241|NCT03985293|474487904|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
131783242|NCT03985293|474487905|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
131783243|NCT03985293|474487906|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
131783244|NCT03985293|474487901|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
131783245|NCT03985293|474487902|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
131783246|NCT03985293|474487903|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
131783247|NCT03985293|474487904|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
131783248|NCT03985293|474487905|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
131783249|NCT03985293|474487906|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
131783250|NCT03985293|474487901|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
131783251|NCT03985293|474487902|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
131783252|NCT03985293|474487903|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
131783253|NCT03985293|474487904|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
131783254|NCT03985293|474487905|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
131783255|NCT03985293|474487906|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
131783256|NCT03985293|474487901|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
131783257|NCT03985293|474487902|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
131783258|NCT03985293|474487903|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
131783259|NCT03985293|474487904|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
131783260|NCT03985293|474487905|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
131783261|NCT03985293|474487906|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
131783262|NCT03985293|474487901|FG000|FOLLOW-UP|Lost to Follow-up|0|||
131783263|NCT03985293|474487902|FG001|FOLLOW-UP|Lost to Follow-up|0|||
131567010|NCT03251378|473700633|FG005|Overall Study|Physician Decision|0|||
131567011|NCT03251378|473700634|FG006|Overall Study|Physician Decision|0|||
131783264|NCT03985293|474487903|FG002|FOLLOW-UP|Lost to Follow-up|1|||
131783265|NCT03985293|474487904|FG003|FOLLOW-UP|Lost to Follow-up|0|||
131783266|NCT03985293|474487905|FG004|FOLLOW-UP|Lost to Follow-up|0|||
131783267|NCT03985293|474487906|FG005|FOLLOW-UP|Lost to Follow-up|0|||
131783268|NCT00391092|474489860|FG000|Overall Study|Death|78|||
131783269|NCT00391092|474489861|FG001|Overall Study|Death|81|||
131783270|NCT00391092|474489860|FG000|Overall Study|Lost to Follow-up|13|||
131783271|NCT00391092|474489861|FG001|Overall Study|Lost to Follow-up|18|||
131437502|NCT05051579|473226876|FG000|Overall Study|Inadvertent Enrollment|0|||
131437503|NCT05051579|473226877|FG001|Overall Study|Inadvertent Enrollment|0|||
131437504|NCT05051579|473226878|FG002|Overall Study|Inadvertent Enrollment|0|||
131437505|NCT05051579|473226879|FG003|Overall Study|Inadvertent Enrollment|0|||
131437506|NCT05051579|473226880|FG004|Overall Study|Inadvertent Enrollment|0|||
131437507|NCT05051579|473226881|FG005|Overall Study|Inadvertent Enrollment|0|||
131437508|NCT05051579|473226882|FG006|Overall Study|Inadvertent Enrollment|1|||
131437509|NCT05051579|473226876|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
131437510|NCT05051579|473226877|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
131567012|NCT03251378|473700628|FG000|Overall Study|Other|2|||
131567013|NCT03251378|473700629|FG001|Overall Study|Other|3|||
131567014|NCT03251378|473700630|FG002|Overall Study|Other|2|||
131567015|NCT03251378|473700631|FG003|Overall Study|Other|0|||
131567016|NCT03251378|473700632|FG004|Overall Study|Other|1|||
131567017|NCT03251378|473700633|FG005|Overall Study|Other|1|||
131567018|NCT03251378|473700634|FG006|Overall Study|Other|1|||
131567019|NCT03251378|473700628|FG000|Overall Study|Other|0|||
131567020|NCT03251378|473700629|FG001|Overall Study|Other|0|||
131567021|NCT03251378|473700630|FG002|Overall Study|Other|0|||
131567022|NCT03251378|473700631|FG003|Overall Study|Other|4|||
131567023|NCT03251378|473700632|FG004|Overall Study|Other|13|||
131567024|NCT03251378|473700633|FG005|Overall Study|Other|0|||
131567025|NCT03251378|473700634|FG006|Overall Study|Other|0|||
131567026|NCT04060680|473700636|FG000|Overall Study|Unsuccessful implant|17|||
131567027|NCT04060680|473700637|FG001|Overall Study|Unsuccessful implant|2|||
131567028|NCT04060680|473700636|FG000|Overall Study|Adverse Event|3|||
131567029|NCT04060680|473700637|FG001|Overall Study|Adverse Event|0|||
131567030|NCT04060680|473700636|FG000|Overall Study|Death|2|||
131567031|NCT04060680|473700637|FG001|Overall Study|Death|0|||
131567032|NCT04060680|473700636|FG000|Overall Study|Study product no longer in use|1|||
131567033|NCT04060680|473700637|FG001|Overall Study|Study product no longer in use|0|||
131567034|NCT04060680|473700636|FG000|Overall Study|Withdrawal by Subject|1|||
131567035|NCT04060680|473700637|FG001|Overall Study|Withdrawal by Subject|0|||
131567036|NCT02322775|473700641|FG000|Overall Study|Adverse Event|1|||
131567037|NCT02322775|473700642|FG001|Overall Study|Adverse Event|0|||
131567038|NCT02322775|473700641|FG000|Overall Study|Lost to Follow-up|0|||
131567039|NCT02322775|473700642|FG001|Overall Study|Lost to Follow-up|1|||
131567040|NCT02322775|473700641|FG000|Overall Study|Protocol Violation|1|||
131567041|NCT02322775|473700642|FG001|Overall Study|Protocol Violation|0|||
131567042|NCT02322775|473700641|FG000|Overall Study|Withdrawal by Subject|3|||
131567043|NCT02322775|473700642|FG001|Overall Study|Withdrawal by Subject|4|||
131567044|NCT02322775|473700641|FG000|Overall Study|Not willing to perform all FU visits|0|||
131567045|NCT02322775|473700642|FG001|Overall Study|Not willing to perform all FU visits|1|||
131567046|NCT02956967|473700643|FG000|Overall Study|Adverse Event|3|||
131567047|NCT02956967|473700643|FG000|Overall Study|Reason non-related to neutropenia|10|||
131567048|NCT02956967|473700643|FG000|Overall Study|Lost to Follow-up|5|||
131567049|NCT02956967|473700643|FG000|Overall Study|Missing|1|||
131567050|NCT02956967|473700643|FG000|Overall Study|Termination of Nivestim administration|29|||
131567051|NCT04739423|473700644|FG000|Overall Study|Protocol Violation|0|||
131567052|NCT04739423|473700645|FG001|Overall Study|Protocol Violation|1|||
131567053|NCT04739423|473700646|FG002|Overall Study|Protocol Violation|0|||
131567054|NCT04739423|473700647|FG003|Overall Study|Protocol Violation|0|||
131567055|NCT04739423|473700648|FG004|Overall Study|Protocol Violation|0|||
131567056|NCT04739423|473700649|FG005|Overall Study|Protocol Violation|0|||
131567057|NCT04739423|473700644|FG000|Overall Study|Adverse Event|0|||
131567058|NCT04739423|473700645|FG001|Overall Study|Adverse Event|0|||
131567059|NCT04739423|473700646|FG002|Overall Study|Adverse Event|1|||
131567060|NCT04739423|473700647|FG003|Overall Study|Adverse Event|0|||
131567061|NCT04739423|473700648|FG004|Overall Study|Adverse Event|1|||
131567062|NCT04739423|473700649|FG005|Overall Study|Adverse Event|0|||
131567063|NCT04739423|473700644|FG000|Overall Study|Withdrawal by Subject|0|||
131567064|NCT04739423|473700645|FG001|Overall Study|Withdrawal by Subject|0|||
131567065|NCT04739423|473700646|FG002|Overall Study|Withdrawal by Subject|0|||
131567066|NCT04739423|473700647|FG003|Overall Study|Withdrawal by Subject|0|||
131567067|NCT04739423|473700648|FG004|Overall Study|Withdrawal by Subject|0|||
131567068|NCT04739423|473700649|FG005|Overall Study|Withdrawal by Subject|1|||
131567069|NCT01007552|473700653|FG000|Overall Study|Withdrawal by Subject|1|||
131567070|NCT04482855|473700657|FG000|Overall Study|Lost to Follow-up|1|||
131567071|NCT04482855|473700658|FG001|Overall Study|Lost to Follow-up|0|||
131567072|NCT04482855|473700657|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
131696987|NCT02264990|474174016|FG001|Overall Study|Other|1|||
131696988|NCT01098071|474174025|FG000|Overall Study|Surgery (adenoidectomy)|2|||
131437511|NCT05051579|473226878|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
131437512|NCT05051579|473226879|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
131437513|NCT05051579|473226880|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
131437514|NCT05051579|473226881|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
131437515|NCT05051579|473226882|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
131437516|NCT05051579|473226876|FG000|Overall Study|Sponsor Decision|0|||
131437517|NCT05051579|473226877|FG001|Overall Study|Sponsor Decision|0|||
131567073|NCT04482855|473700658|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
131567074|NCT04482855|473700657|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
131567075|NCT04482855|473700658|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
131567076|NCT03212365|473700664|FG000|Overall Study|Discharged prior to Xa level|12|||
131567077|NCT03212365|473700665|FG001|Overall Study|Discharged prior to Xa level|8|||
131567078|NCT03212365|473700664|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
131567079|NCT03212365|473700665|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
131567080|NCT03212365|473700664|FG000|Overall Study|Refused study medication|3|||
131567081|NCT03212365|473700665|FG001|Overall Study|Refused study medication|0|||
131567082|NCT03212365|473700664|FG000|Overall Study|Initiated heparin infusion on floor|1|||
131567083|NCT03212365|473700665|FG001|Overall Study|Initiated heparin infusion on floor|1|||
131567084|NCT03212365|473700664|FG000|Overall Study|Unexpected return to OR|1|||
131567085|NCT03212365|473700665|FG001|Overall Study|Unexpected return to OR|1|||
131567086|NCT03212365|473700664|FG000|Overall Study|Medication distribution error|1|||
131567087|NCT03212365|473700665|FG001|Overall Study|Medication distribution error|0|||
131567088|NCT03212365|473700664|FG000|Overall Study|Required epidural placement|1|||
131567089|NCT03212365|473700665|FG001|Overall Study|Required epidural placement|0|||
131567090|NCT03212365|473700664|FG000|Overall Study|Withdrawal by Subject|0|||
131567091|NCT03212365|473700665|FG001|Overall Study|Withdrawal by Subject|1|||
131567092|NCT03212365|473700664|FG000|Overall Study|developed acute renal failure|0|||
131567093|NCT03212365|473700665|FG001|Overall Study|developed acute renal failure|1|||
131567094|NCT02507219|473700666|FG000|Overall Study|Physician Decision|1|||
131567095|NCT02507219|473700667|FG001|Overall Study|Physician Decision|0|||
131567096|NCT02507219|473700668|FG002|Overall Study|Physician Decision|0|||
131567097|NCT02507219|473700669|FG003|Overall Study|Physician Decision|0|||
131567098|NCT02507219|473700670|FG004|Overall Study|Physician Decision|0|||
131567099|NCT02507219|473700671|FG005|Overall Study|Physician Decision|0|||
131567100|NCT02507219|473700666|FG000|Overall Study|Withdrawal by Subject|0|||
131567101|NCT02507219|473700667|FG001|Overall Study|Withdrawal by Subject|0|||
131567102|NCT02507219|473700668|FG002|Overall Study|Withdrawal by Subject|0|||
131567103|NCT02507219|473700669|FG003|Overall Study|Withdrawal by Subject|0|||
131567104|NCT02507219|473700670|FG004|Overall Study|Withdrawal by Subject|1|||
131567105|NCT02507219|473700671|FG005|Overall Study|Withdrawal by Subject|0|||
131567106|NCT00819234|473700676|FG000|Overall Study|Withdrawal by Subject|8|||
131567107|NCT00819234|473700677|FG001|Overall Study|Withdrawal by Subject|13|||
131567108|NCT00819234|473700678|FG002|Overall Study|Withdrawal by Subject|6|||
131567109|NCT00819234|473700679|FG003|Overall Study|Withdrawal by Subject|3|||
131567110|NCT00819234|473700680|FG004|Overall Study|Withdrawal by Subject|0|||
131567111|NCT00819234|473700681|FG005|Overall Study|Withdrawal by Subject|4|||
131567112|NCT00819234|473700682|FG006|Overall Study|Withdrawal by Subject|4|||
131567113|NCT00819234|473700683|FG007|Overall Study|Withdrawal by Subject|8|||
131567114|NCT00819234|473700684|FG008|Overall Study|Withdrawal by Subject|5|||
131567115|NCT00819234|473700685|FG009|Overall Study|Withdrawal by Subject|3|||
131567116|NCT00819234|473700676|FG000|Overall Study|Adverse Event|0|||
131567117|NCT00819234|473700677|FG001|Overall Study|Adverse Event|0|||
131567118|NCT00819234|473700678|FG002|Overall Study|Adverse Event|1|||
131567119|NCT00819234|473700679|FG003|Overall Study|Adverse Event|0|||
131567120|NCT00819234|473700680|FG004|Overall Study|Adverse Event|0|||
131567121|NCT00819234|473700681|FG005|Overall Study|Adverse Event|2|||
131567122|NCT00819234|473700682|FG006|Overall Study|Adverse Event|0|||
131567123|NCT00819234|473700683|FG007|Overall Study|Adverse Event|0|||
131567124|NCT00819234|473700684|FG008|Overall Study|Adverse Event|0|||
131567125|NCT00819234|473700685|FG009|Overall Study|Adverse Event|0|||
131567126|NCT00819234|473700676|FG000|Overall Study|Physician Decision|0|||
131567127|NCT00819234|473700677|FG001|Overall Study|Physician Decision|0|||
131567128|NCT00819234|473700678|FG002|Overall Study|Physician Decision|0|||
131567129|NCT00819234|473700679|FG003|Overall Study|Physician Decision|1|||
131567130|NCT00819234|473700680|FG004|Overall Study|Physician Decision|0|||
131567131|NCT00819234|473700681|FG005|Overall Study|Physician Decision|0|||
131567132|NCT00819234|473700682|FG006|Overall Study|Physician Decision|0|||
131567133|NCT00819234|473700683|FG007|Overall Study|Physician Decision|0|||
131567134|NCT00819234|473700684|FG008|Overall Study|Physician Decision|0|||
131567135|NCT00819234|473700685|FG009|Overall Study|Physician Decision|2|||
131783272|NCT00391092|474489860|FG000|Overall Study|Alive on treatment|29|||
131783273|NCT00391092|474489861|FG001|Overall Study|Alive on treatment|33|||
131783274|NCT00391092|474489860|FG000|Overall Study|Alive in follow-up|88|||
131783275|NCT00391092|474489861|FG001|Overall Study|Alive in follow-up|84|||
131783276|NCT01796860|474489865|FG000|Overall Study|Withdrawal by Subject|3|||
131567136|NCT00819234|473700676|FG000|Overall Study|Protocol Violation|0|||
131567137|NCT00819234|473700677|FG001|Overall Study|Protocol Violation|0|||
131567138|NCT00819234|473700678|FG002|Overall Study|Protocol Violation|1|||
131567139|NCT00819234|473700679|FG003|Overall Study|Protocol Violation|0|||
131567140|NCT00819234|473700680|FG004|Overall Study|Protocol Violation|0|||
131567141|NCT00819234|473700681|FG005|Overall Study|Protocol Violation|0|||
131567142|NCT00819234|473700682|FG006|Overall Study|Protocol Violation|0|||
131783277|NCT02703454|474489870|FG000|Overall Study|Not treated|1|||
131567143|NCT00819234|473700683|FG007|Overall Study|Protocol Violation|0|||
131567144|NCT00819234|473700684|FG008|Overall Study|Protocol Violation|0|||
131567145|NCT00819234|473700685|FG009|Overall Study|Protocol Violation|0|||
131567146|NCT00819234|473700676|FG000|Overall Study|Lost to Follow-up|2|||
131567147|NCT00819234|473700677|FG001|Overall Study|Lost to Follow-up|2|||
131567148|NCT00819234|473700678|FG002|Overall Study|Lost to Follow-up|0|||
131567149|NCT00819234|473700679|FG003|Overall Study|Lost to Follow-up|2|||
131567150|NCT00819234|473700680|FG004|Overall Study|Lost to Follow-up|1|||
131567151|NCT00819234|473700681|FG005|Overall Study|Lost to Follow-up|1|||
131567152|NCT00819234|473700682|FG006|Overall Study|Lost to Follow-up|1|||
131567153|NCT00819234|473700683|FG007|Overall Study|Lost to Follow-up|1|||
131567154|NCT00819234|473700684|FG008|Overall Study|Lost to Follow-up|1|||
131567155|NCT00819234|473700685|FG009|Overall Study|Lost to Follow-up|2|||
131567156|NCT05174065|473700686|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
131567157|NCT05174065|473700687|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
131567158|NCT05174065|473700688|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
131567159|NCT05174065|473700686|FG000|Placebo-controlled Period|Other|0|||
131567160|NCT05174065|473700687|FG001|Placebo-controlled Period|Other|1|||
131567161|NCT05174065|473700688|FG002|Placebo-controlled Period|Other|0|||
131567162|NCT05174065|473700686|FG000|Placebo-controlled Period|Adverse Event|1|||
131567163|NCT05174065|473700687|FG001|Placebo-controlled Period|Adverse Event|1|||
131567164|NCT05174065|473700688|FG002|Placebo-controlled Period|Adverse Event|0|||
131567165|NCT05174065|473700686|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
131567166|NCT05174065|473700687|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
131567167|NCT05174065|473700688|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
131567168|NCT05174065|473700686|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
131567169|NCT05174065|473700687|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
131567170|NCT05174065|473700688|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
131567171|NCT05174065|473700686|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
131437518|NCT05051579|473226878|FG002|Overall Study|Sponsor Decision|0|||
131437519|NCT05051579|473226879|FG003|Overall Study|Sponsor Decision|0|||
131437520|NCT05051579|473226880|FG004|Overall Study|Sponsor Decision|1|||
131437521|NCT05051579|473226881|FG005|Overall Study|Sponsor Decision|0|||
131437522|NCT05051579|473226882|FG006|Overall Study|Sponsor Decision|0|||
131437523|NCT05051579|473226876|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
131567172|NCT05174065|473700687|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
131567173|NCT05174065|473700688|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
131567174|NCT01342887|473700694|FG000|Overall Study|Death|2|||
131567175|NCT00209274|473700695|FG000|Overall Study|Missed visit|3|||
131567176|NCT00209274|473700696|FG001|Overall Study|Missed visit|2|||
131567177|NCT00209274|473700695|FG000|Overall Study|Death|32|||
131567178|NCT00209274|473700696|FG001|Overall Study|Death|15|||
131567179|NCT00209274|473700695|FG000|Overall Study|Withdrawal by Subject|30|||
131567180|NCT00209274|473700696|FG001|Overall Study|Withdrawal by Subject|15|||
131567181|NCT00209274|473700695|FG000|Overall Study|Randomized not treated (RNT)|6|||
131567182|NCT00209274|473700696|FG001|Overall Study|Randomized not treated (RNT)|15|||
131567183|NCT02753530|473700697|FG000|Overall Study|Adverse Event|7|||
131567184|NCT02753530|473700698|FG001|Overall Study|Adverse Event|1|||
131567185|NCT02753530|473700697|FG000|Overall Study|Death|0|||
131567186|NCT02753530|473700698|FG001|Overall Study|Death|1|||
131567187|NCT02753530|473700697|FG000|Overall Study|Physician Decision|0|||
131567188|NCT02753530|473700698|FG001|Overall Study|Physician Decision|1|||
131567189|NCT02753530|473700697|FG000|Overall Study|Protocol Violation|1|||
131567190|NCT02753530|473700698|FG001|Overall Study|Protocol Violation|0|||
131567191|NCT02753530|473700697|FG000|Overall Study|Withdrawal by Subject|4|||
131567192|NCT02753530|473700698|FG001|Overall Study|Withdrawal by Subject|3|||
131567193|NCT00429793|473700707|FG000|Overall Study|Improper pre-protocol treatment|3|||
131567194|NCT00429793|473700707|FG000|Overall Study|Required test not done|1|||
131567195|NCT00429793|473700707|FG000|Overall Study|Never treated|1|||
131437524|NCT05051579|473226877|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
131437525|NCT05051579|473226878|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
131437526|NCT05051579|473226879|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
131567196|NCT00429793|473700707|FG000|Overall Study|Non-measurable|1|||
131567197|NCT00097370|473700708|FG000|Stage 1|Adverse Event|3|||
131567198|NCT00097370|473700708|FG000|Stage 1|Withdrawal by Subject|1|||
131567199|NCT00097370|473700708|FG000|Stage 1|Lack of Efficacy|2|||
131567200|NCT00097370|473700708|FG000|Stage 2|Adverse Event|5|||
131437527|NCT05051579|473226880|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
131448272|NCT02079246|473272631|FG000|OLEX|Other: Insufficient compliance|2|||
131567201|NCT00097370|473700708|FG000|Stage 2|Withdrawal by Subject|1|||
131567202|NCT00097370|473700708|FG000|Stage 2|Lack of Efficacy|3|||
131567203|NCT00097370|473700708|FG000|Stage 2|Pregnancy|1|||
131567204|NCT00097370|473700708|FG000|Stage 2|Sponsor Terminated Study|2|||
131567205|NCT00097370|473700708|FG000|Stage 2|Lost to Follow-up|1|||
131567206|NCT00097370|473700708|FG000|Stage 3|Adverse Event|2|||
131567207|NCT00097370|473700708|FG000|Stage 3|Withdrawal by Subject|3|||
131567208|NCT00097370|473700708|FG000|Stage 3|Lack of Efficacy|1|||
131696989|NCT01098071|474174025|FG000|Overall Study|Lost to Follow-up|13|||
131696990|NCT01662895|474174027|FG000|Overall Study|Lost to Follow-up|0|||
131696991|NCT01662895|474174028|FG001|Overall Study|Lost to Follow-up|1|||
131567209|NCT00097370|473700708|FG000|Stage 3|Sponsor Terminated Study|52|||
131567210|NCT00097370|473700708|FG000|Stage 3|Lost to Follow-up|1|||
131567211|NCT01641861|473700710|FG000|Overall Study|Lost to Follow-up|21|||
131567212|NCT01641861|473700711|FG001|Overall Study|Lost to Follow-up|16|||
131567213|NCT01641861|473700710|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
131567214|NCT01641861|473700711|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
131567215|NCT01641861|473700710|FG000|Overall Study|Died due to drowning|0|||
131567216|NCT01641861|473700711|FG001|Overall Study|Died due to drowning|1|||
131567217|NCT01101542|473700712|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
131567218|NCT01101542|473700712|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
131567219|NCT01101542|473700712|FG000|Year 4 Surveillance Period|Other|287|||
131567220|NCT01101542|473700712|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
131567221|NCT01101542|473700712|FG000|Year 5 Surveillance Period|Pregnancy|1|||
131567222|NCT01101542|473700712|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
131567223|NCT01101542|473700712|FG000|Year 6 Surveillance Period|Pregnancy|1|||
131567224|NCT01101542|473700712|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
131567225|NCT00432159|473702553|FG000|Overall Study|Death|0|||
131567226|NCT00432159|473702554|FG001|Overall Study|Death|1|||
131567227|NCT00432159|473702555|FG002|Overall Study|Death|0|||
131567228|NCT00432159|473702556|FG003|Overall Study|Death|0|||
131567229|NCT00432159|473702557|FG004|Overall Study|Death|0|||
131567230|NCT00432159|473702553|FG000|Overall Study|Failure|9|||
131567231|NCT00432159|473702554|FG001|Overall Study|Failure|5|||
131567232|NCT00432159|473702555|FG002|Overall Study|Failure|3|||
131567233|NCT00432159|473702556|FG003|Overall Study|Failure|2|||
131567234|NCT00432159|473702557|FG004|Overall Study|Failure|3|||
131567235|NCT00432159|473702553|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
131567236|NCT00432159|473702554|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
131567237|NCT00432159|473702555|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
131567238|NCT00432159|473702556|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
131567239|NCT00432159|473702557|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
131567240|NCT01256476|473702558|FG000|Overall Study|Adverse Event|2|||
131567241|NCT01256476|473702559|FG001|Overall Study|Adverse Event|1|||
131567242|NCT01256476|473702558|FG000|Overall Study|Withdrawal by Subject|2|||
131567243|NCT01256476|473702559|FG001|Overall Study|Withdrawal by Subject|1|||
131567244|NCT01256476|473702558|FG000|Overall Study|Lost to Follow-up|1|||
131567245|NCT01256476|473702559|FG001|Overall Study|Lost to Follow-up|2|||
131567246|NCT01256476|473702558|FG000|Overall Study|Persistent ALT or AST elevation|1|||
131567247|NCT01256476|473702559|FG001|Overall Study|Persistent ALT or AST elevation|0|||
131567248|NCT01256476|473702558|FG000|Overall Study|Physician Decision|0|||
131567249|NCT01256476|473702559|FG001|Overall Study|Physician Decision|1|||
131567250|NCT01256476|473702558|FG000|Overall Study|Subject non-compliance|0|||
131567251|NCT01256476|473702559|FG001|Overall Study|Subject non-compliance|1|||
131567252|NCT01256476|473702558|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
131567253|NCT01256476|473702559|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
131567254|NCT02491411|473702564|FG000|Overall Study|Physician Decision|4|||
131567255|NCT00924664|473702565|FG000|Overall Study|Adverse Event|23|||
131567256|NCT00924664|473702566|FG001|Overall Study|Adverse Event|39|||
131567257|NCT00924664|473702565|FG000|Overall Study|Lack of Efficacy|10|||
131567258|NCT00924664|473702566|FG001|Overall Study|Lack of Efficacy|15|||
131567259|NCT00924664|473702565|FG000|Overall Study|Lost to Follow-up|10|||
131437528|NCT05051579|473226881|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
131437529|NCT05051579|473226882|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
131437530|NCT00717249|473226883|FG000|Overall Study|Lens Discomfort|4|||
131437531|NCT00717249|473226884|FG001|Overall Study|Lens Discomfort|1|||
131437532|NCT00717249|473226883|FG000|Overall Study|Unsatisfactory visual Response|0|||
131437533|NCT00717249|473226884|FG001|Overall Study|Unsatisfactory visual Response|2|||
131437534|NCT00717249|473226883|FG000|Overall Study|Adverse Event|4|||
131437535|NCT00717249|473226884|FG001|Overall Study|Adverse Event|2|||
131437536|NCT00717249|473226883|FG000|Overall Study|Lost to Follow-up|2|||
131898646|NCT00215644|474915330|FG001|Overall Study|Other|15|||
131567260|NCT00924664|473702566|FG001|Overall Study|Lost to Follow-up|12|||
131567261|NCT00924664|473702565|FG000|Overall Study|Withdrawal by Subject|47|||
131567262|NCT00924664|473702566|FG001|Overall Study|Withdrawal by Subject|71|||
131898647|NCT00215644|474915329|FG000|Overall Study|Randomized but Not Treated|1|||
131898648|NCT00215644|474915330|FG001|Overall Study|Randomized but Not Treated|0|||
131437537|NCT00717249|473226884|FG001|Overall Study|Lost to Follow-up|0|||
131567263|NCT00924664|473702565|FG000|Overall Study|Protocol Violation|2|||
131567264|NCT00924664|473702566|FG001|Overall Study|Protocol Violation|5|||
131567265|NCT00924664|473702565|FG000|Overall Study|Pregnancy|1|||
131567266|NCT00924664|473702566|FG001|Overall Study|Pregnancy|1|||
131567267|NCT00924664|473702565|FG000|Overall Study|Death|0|||
131567268|NCT00924664|473702566|FG001|Overall Study|Death|2|||
131567269|NCT00924664|473702565|FG000|Overall Study|Study terminated by sponsor|199|||
131567270|NCT00924664|473702566|FG001|Overall Study|Study terminated by sponsor|330|||
131567271|NCT00924664|473702565|FG000|Overall Study|Other|29|||
131567272|NCT00924664|473702566|FG001|Overall Study|Other|52|||
131567273|NCT00924664|473702565|FG000|Overall Study|Randomized but not Treated|1|||
131567274|NCT00924664|473702566|FG001|Overall Study|Randomized but not Treated|0|||
131567275|NCT03158948|473702568|FG000|Overall Study|Death|1|||
131567276|NCT03158948|473702569|FG001|Overall Study|Death|1|||
131567277|NCT03158948|473702570|FG002|Overall Study|Death|3|||
131567278|NCT03158948|473702571|FG003|Overall Study|Death|2|||
131567279|NCT03158948|473702568|FG000|Overall Study|Physician Decision|0|||
131567280|NCT03158948|473702569|FG001|Overall Study|Physician Decision|0|||
131567281|NCT03158948|473702570|FG002|Overall Study|Physician Decision|0|||
131567282|NCT03158948|473702571|FG003|Overall Study|Physician Decision|1|||
131567283|NCT05305040|473702572|FG000|Overall Study|Not Dosed|37|||
131567284|NCT05305040|473702573|FG001|Overall Study|Not Dosed|37|||
131567285|NCT05305040|473702572|FG000|Overall Study|Study Closure|34|||
131567286|NCT05305040|473702573|FG001|Overall Study|Study Closure|46|||
131567287|NCT05305040|473702572|FG000|Overall Study|Death|14|||
131567288|NCT05305040|473702573|FG001|Overall Study|Death|13|||
131567289|NCT05305040|473702572|FG000|Overall Study|Withdrawal by Subject|15|||
131567290|NCT05305040|473702573|FG001|Overall Study|Withdrawal by Subject|10|||
131567291|NCT05305040|473702572|FG000|Overall Study|Other|13|||
131567292|NCT05305040|473702573|FG001|Overall Study|Other|10|||
131567293|NCT05305040|473702572|FG000|Overall Study|Primary Malignancy Relapse|3|||
131567294|NCT05305040|473702573|FG001|Overall Study|Primary Malignancy Relapse|4|||
131567295|NCT05305040|473702572|FG000|Overall Study|Adverse Event|3|||
131567296|NCT05305040|473702573|FG001|Overall Study|Adverse Event|3|||
131567297|NCT05305040|473702572|FG000|Overall Study|Lost to Follow-up|2|||
131567298|NCT05305040|473702573|FG001|Overall Study|Lost to Follow-up|1|||
131567299|NCT05305040|473702572|FG000|Overall Study|Graft versus host disease|2|||
131567300|NCT05305040|473702573|FG001|Overall Study|Graft versus host disease|0|||
131567301|NCT05305040|473702572|FG000|Overall Study|Investigator's Decision|1|||
131567302|NCT05305040|473702573|FG001|Overall Study|Investigator's Decision|1|||
131567303|NCT05305040|473702572|FG000|Overall Study|COVID-19 Reasons|1|||
131567304|NCT05305040|473702573|FG001|Overall Study|COVID-19 Reasons|0|||
131567305|NCT01876043|473702574|FG000|Overall Study|Death|1|||
131567306|NCT01876043|473702574|FG000|Overall Study|Withdrawal by Subject|1|||
131567307|NCT01616563|473702575|FG000|Overall Study|Lost to Follow-up|40|||
131567308|NCT00079937|473702576|FG000|Overall Study|Adverse Event|2|||
131567309|NCT00079937|473702577|FG001|Overall Study|Adverse Event|1|||
131567310|NCT00079937|473702576|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131567311|NCT00079937|473702577|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131567312|NCT00079937|473702576|FG000|Overall Study|Subject no longer requires study drug|3|||
131567313|NCT00079937|473702577|FG001|Overall Study|Subject no longer requires study drug|0|||
131567314|NCT00079937|473702576|FG000|Overall Study|Protocol Violation|8|||
131567315|NCT00079937|473702577|FG001|Overall Study|Protocol Violation|6|||
131437538|NCT00717249|473226883|FG000|Overall Study|Withdrawal by Subject|1|||
131437539|NCT00717249|473226884|FG001|Overall Study|Withdrawal by Subject|2|||
131437540|NCT00717249|473226883|FG000|Overall Study|Pregnancy|6|||
131437541|NCT00717249|473226884|FG001|Overall Study|Pregnancy|3|||
131437542|NCT00717249|473226883|FG000|Overall Study|Protocol Violation|0|||
131437543|NCT00717249|473226884|FG001|Overall Study|Protocol Violation|2|||
131437544|NCT00717249|473226883|FG000|Overall Study|Subject became Ineligible|1|||
131437545|NCT00717249|473226884|FG001|Overall Study|Subject became Ineligible|1|||
131437546|NCT00717249|473226883|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
131437547|NCT00717249|473226884|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
131437548|NCT00717249|473226883|FG000|Overall Study|Gastric Surgery|0|||
131437549|NCT00717249|473226884|FG001|Overall Study|Gastric Surgery|1|||
131437550|NCT00717249|473226883|FG000|Overall Study|Diagnosed with Diabetes|1|||
131437551|NCT00717249|473226884|FG001|Overall Study|Diagnosed with Diabetes|0|||
131567316|NCT00079937|473702576|FG000|Overall Study|Withdrawal by Subject|21|||
131567317|NCT00079937|473702577|FG001|Overall Study|Withdrawal by Subject|7|||
131567318|NCT00079937|473702576|FG000|Overall Study|Lost to Follow-up|12|||
131567319|NCT00079937|473702577|FG001|Overall Study|Lost to Follow-up|5|||
131567320|NCT00079937|473702576|FG000|Overall Study|Administrative problems|22|||
131567321|NCT00079937|473702577|FG001|Overall Study|Administrative problems|11|||
131567322|NCT01195675|473702581|FG000|Overall Study|Adverse Event|1|||
131567323|NCT01195675|473702581|FG000|Overall Study|Withdrawal by Subject|2|||
131567324|NCT01106287|473702582|FG000|Overall Study|Adverse Event|1|||
131567325|NCT01106287|473702583|FG001|Overall Study|Adverse Event|0|||
131567326|NCT01106287|473702584|FG002|Overall Study|Adverse Event|0|||
131567327|NCT01106287|473702585|FG003|Overall Study|Adverse Event|0|||
131567328|NCT00072475|473702586|FG000|Overall Study|Adverse Event|44|||
131567329|NCT00072475|473702586|FG000|Overall Study|Death|3|||
131567330|NCT00072475|473702586|FG000|Overall Study|Withdrawal by Subject|46|||
131567331|NCT00072475|473702586|FG000|Overall Study|Patient/Investigator Decision|4|||
131567332|NCT04730947|473702587|FG000|Overall Study|Withdrawal by Subject|0|||
131567333|NCT04730947|473702588|FG001|Overall Study|Withdrawal by Subject|1|||
131567334|NCT00940017|473702589|FG000|Overall Study|did not meet entrance criteria|3|||
131567335|NCT00940017|473702589|FG000|Overall Study|Adverse Event|1|||
131567336|NCT01450943|473702592|FG000|Overall Study|Screen failure, loss to follow-up|2|||
131567337|NCT01450943|473702593|FG001|Overall Study|Screen failure, loss to follow-up|7|||
131567338|NCT01450943|473702594|FG002|Overall Study|Screen failure, loss to follow-up|6|||
131567339|NCT00465361|473702595|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
131567340|NCT05406791|473702596|FG000|Overall Study|Lost to Follow-up|13|||
131567341|NCT05406791|473702597|FG001|Overall Study|Lost to Follow-up|10|||
131567342|NCT01789203|473702598|FG000|Overall Study|Adverse Event|2|||
131567343|NCT01789203|473702599|FG001|Overall Study|Adverse Event|2|||
131567344|NCT01789203|473702598|FG000|Overall Study|Withdrawal by Subject|1|||
131567345|NCT01789203|473702599|FG001|Overall Study|Withdrawal by Subject|0|||
131567346|NCT01789203|473702598|FG000|Overall Study|Death|1|||
131567347|NCT01789203|473702599|FG001|Overall Study|Death|0|||
131567348|NCT01789203|473702598|FG000|Overall Study|Protocol Violation|2|||
131567349|NCT01789203|473702599|FG001|Overall Study|Protocol Violation|1|||
131567350|NCT01789203|473702598|FG000|Overall Study|Other|1|||
131567351|NCT01789203|473702599|FG001|Overall Study|Other|1|||
131567352|NCT01789203|473702598|FG000|Overall Study|patient non-adherent|2|||
131567353|NCT01789203|473702599|FG001|Overall Study|patient non-adherent|0|||
131567354|NCT02652130|473702602|FG000|Overall Study|Death|1|||
131567355|NCT00354029|473702603|FG000|Overall Study|Protocol Violation|4|||
131567356|NCT00354029|473702604|FG001|Overall Study|Protocol Violation|2|||
131567357|NCT00826280|473702605|FG000|Overall Study|Randomized but drug not received|1|||
131567358|NCT00826280|473702606|FG001|Overall Study|Randomized but drug not received|0|||
131567359|NCT00826280|473702607|FG002|Overall Study|Randomized but drug not received|1|||
131567360|NCT00826280|473702605|FG000|Overall Study|Adverse Event|1|||
131567361|NCT00826280|473702606|FG001|Overall Study|Adverse Event|3|||
131567362|NCT00826280|473702607|FG002|Overall Study|Adverse Event|0|||
131567363|NCT00826280|473702605|FG000|Overall Study|Lost to Follow-up|0|||
131567364|NCT00826280|473702606|FG001|Overall Study|Lost to Follow-up|1|||
131567365|NCT00826280|473702607|FG002|Overall Study|Lost to Follow-up|0|||
131567366|NCT00826280|473702605|FG000|Overall Study|Sponsor discontinued subject or study|1|||
131567367|NCT00826280|473702606|FG001|Overall Study|Sponsor discontinued subject or study|0|||
131567368|NCT00826280|473702607|FG002|Overall Study|Sponsor discontinued subject or study|0|||
131567369|NCT00826280|473702605|FG000|Overall Study|Reversible ischemic defect not present|43|||
131567370|NCT00826280|473702606|FG001|Overall Study|Reversible ischemic defect not present|40|||
131567371|NCT00826280|473702607|FG002|Overall Study|Reversible ischemic defect not present|44|||
131567372|NCT00826280|473702605|FG000|Overall Study|Interpretation Failure|1|||
131567373|NCT00826280|473702606|FG001|Overall Study|Interpretation Failure|0|||
131567374|NCT00826280|473702607|FG002|Overall Study|Interpretation Failure|0|||
131567375|NCT00826280|473702605|FG000|Overall Study|Machine Failure|1|||
131567376|NCT00826280|473702606|FG001|Overall Study|Machine Failure|1|||
131567377|NCT00826280|473702607|FG002|Overall Study|Machine Failure|0|||
131567378|NCT00826280|473702605|FG000|Overall Study|One or more non-interpretable scan|0|||
131567379|NCT00826280|473702606|FG001|Overall Study|One or more non-interpretable scan|1|||
131567380|NCT00826280|473702607|FG002|Overall Study|One or more non-interpretable scan|1|||
131567381|NCT03201757|473702608|FG000|Overall Study|Withdrawal by Subject|133|||
131567382|NCT03201757|473702608|FG000|Overall Study|Adverse Event|44|||
131567383|NCT03201757|473702608|FG000|Overall Study|Lost to Follow-up|37|||
131567384|NCT03201757|473702608|FG000|Overall Study|Pregnancy|2|||
131567385|NCT03201757|473702608|FG000|Overall Study|Lack of Efficacy|1|||
131567386|NCT03201757|473702608|FG000|Overall Study|Protocol Violation|20|||
131567387|NCT03201757|473702608|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
131567388|NCT03201757|473702608|FG000|Overall Study|Not Yet Determined|5|||
131567389|NCT03201757|473702608|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
131696992|NCT02728830|474174034|FG000|Overall Study|Exclusionary Surgery|9|||
131696993|NCT02728830|474174034|FG000|Overall Study|Exclusionary Pathology|6|||
131696994|NCT02728830|474174034|FG000|Overall Study|Physician Decision|3|||
131696995|NCT02728830|474174034|FG000|Overall Study|Withdrawal by Subject|2|||
131696996|NCT02728830|474174034|FG000|Overall Study|Lost to Follow-up|1|||
131696997|NCT02728830|474174034|FG000|Overall Study|Exclusionary Lab Values|1|||
131696998|NCT02728830|474174034|FG000|Overall Study|Contraindicated Illness|1|||
131567390|NCT03201757|473702608|FG000|Overall Study|Other|20|||
131567391|NCT02297503|473702609|FG000|Overall Study|Withdrawal by Subject|1|||
131567392|NCT02297503|473702610|FG001|Overall Study|Withdrawal by Subject|1|||
131567393|NCT02297503|473702609|FG000|Overall Study|Protocol Violation|1|||
131567394|NCT02297503|473702610|FG001|Overall Study|Protocol Violation|0|||
131567395|NCT02297503|473702609|FG000|Overall Study|Pregnancy|0|||
131567396|NCT02297503|473702610|FG001|Overall Study|Pregnancy|1|||
131567397|NCT02297503|473702609|FG000|Overall Study|Lost to Follow-up|0|||
131567398|NCT02297503|473702610|FG001|Overall Study|Lost to Follow-up|1|||
131567399|NCT02297503|473702609|FG000|Overall Study|Medical reason|0|||
131567400|NCT02297503|473702610|FG001|Overall Study|Medical reason|1|||
131567401|NCT02788656|473702612|FG000|Overall Study|Withdrawal by Subject|1|||
131567402|NCT02788656|473702613|FG001|Overall Study|Withdrawal by Subject|0|||
131567403|NCT01403987|473702617|FG000|Overall Study|Residents forgot their secret PIN|18|||
131567404|NCT01403987|473702618|FG001|Overall Study|Residents forgot their secret PIN|17|||
131567405|NCT01403987|473702619|FG002|Overall Study|Residents forgot their secret PIN|18|||
131567406|NCT00180674|473702621|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
131567407|NCT00180674|473702621|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
131567408|NCT04537949|473702623|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
131567409|NCT04537949|473702624|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
131567410|NCT04537949|473702625|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
131567411|NCT04537949|473702626|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
131567412|NCT04537949|473702627|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
131567413|NCT04537949|473702628|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
131567414|NCT04537949|473702629|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
131567415|NCT04537949|473702630|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
131567416|NCT04537949|473702623|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
131567417|NCT04537949|473702624|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
131567418|NCT04537949|473702625|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
131567419|NCT04537949|473702626|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
131567420|NCT04537949|473702627|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
131567421|NCT04537949|473702628|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
131567422|NCT04537949|473702629|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
131567423|NCT04537949|473702630|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
131567424|NCT04537949|473702623|FG000|Follow-up Phase|Lost to Follow-up|0|||
131437552|NCT00717249|473226883|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
131437553|NCT00717249|473226884|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
131437554|NCT00717249|473226883|FG000|Overall Study|Subject relocated|1|||
131437555|NCT00717249|473226884|FG001|Overall Study|Subject relocated|0|||
131437556|NCT00717249|473226883|FG000|Overall Study|Headaches|1|||
131437557|NCT00717249|473226884|FG001|Overall Study|Headaches|0|||
131437558|NCT00360412|473226885|FG000|Overall Study|Adverse Event|37|||
131437559|NCT00360412|473226886|FG001|Overall Study|Adverse Event|65|||
131437560|NCT00360412|473226885|FG000|Overall Study|Protocol Violation|2|||
131437561|NCT00360412|473226886|FG001|Overall Study|Protocol Violation|5|||
131437562|NCT00360412|473226885|FG000|Overall Study|Patient withdrew consent|27|||
131437563|NCT00360412|473226886|FG001|Overall Study|Patient withdrew consent|52|||
131437564|NCT00360412|473226885|FG000|Overall Study|Lack of therapeutic efficacy|46|||
131437565|NCT00360412|473226886|FG001|Overall Study|Lack of therapeutic efficacy|61|||
131437566|NCT00360412|473226885|FG000|Overall Study|Physician Decision|2|||
131567425|NCT04537949|473702624|FG001|Follow-up Phase|Lost to Follow-up|3|||
131567426|NCT04537949|473702625|FG002|Follow-up Phase|Lost to Follow-up|0|||
131567427|NCT04537949|473702626|FG003|Follow-up Phase|Lost to Follow-up|0|||
131567428|NCT04537949|473702627|FG004|Follow-up Phase|Lost to Follow-up|0|||
131567429|NCT04537949|473702628|FG005|Follow-up Phase|Lost to Follow-up|0|||
131567430|NCT04537949|473702629|FG006|Follow-up Phase|Lost to Follow-up|0|||
131567431|NCT04537949|473702630|FG007|Follow-up Phase|Lost to Follow-up|0|||
131567432|NCT04537949|473702623|FG000|Follow-up Phase|personal reasons|0|||
131567433|NCT04537949|473702624|FG001|Follow-up Phase|personal reasons|0|||
131567434|NCT04537949|473702625|FG002|Follow-up Phase|personal reasons|0|||
131567435|NCT04537949|473702626|FG003|Follow-up Phase|personal reasons|1|||
131567436|NCT04537949|473702627|FG004|Follow-up Phase|personal reasons|1|||
131567437|NCT04537949|473702628|FG005|Follow-up Phase|personal reasons|0|||
131567438|NCT04537949|473702629|FG006|Follow-up Phase|personal reasons|0|||
131567439|NCT04537949|473702630|FG007|Follow-up Phase|personal reasons|0|||
131567440|NCT04537949|473702623|FG000|Follow-up Phase|Withdrawal by Subject|0|||
131567441|NCT04537949|473702624|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131567442|NCT04537949|473702625|FG002|Follow-up Phase|Withdrawal by Subject|0|||
131567443|NCT04537949|473702626|FG003|Follow-up Phase|Withdrawal by Subject|0|||
131567444|NCT04537949|473702627|FG004|Follow-up Phase|Withdrawal by Subject|1|||
131567445|NCT04537949|473702628|FG005|Follow-up Phase|Withdrawal by Subject|0|||
131567446|NCT04537949|473702629|FG006|Follow-up Phase|Withdrawal by Subject|0|||
131567447|NCT04537949|473702630|FG007|Follow-up Phase|Withdrawal by Subject|0|||
131567448|NCT04003974|473702632|FG000|Overall Study|Missing|1|||
131567449|NCT04003974|473702633|FG001|Overall Study|Missing|0|||
131567450|NCT04003974|473702632|FG000|Overall Study|Withdrawal by Subject|0|||
131567451|NCT04003974|473702633|FG001|Overall Study|Withdrawal by Subject|2|||
131567452|NCT04296942|473702634|FG000|Overall Study|Study closure by sponsor|1|||
131567453|NCT04296942|473702635|FG001|Overall Study|Study closure by sponsor|0|||
131567454|NCT04296942|473702636|FG002|Overall Study|Study closure by sponsor|0|||
131567455|NCT00335153|473702637|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
131567456|NCT00335153|473702637|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
131567457|NCT00335153|473702637|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
131567458|NCT00335153|473702637|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
131567459|NCT00335153|473702637|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
131567460|NCT00335153|473702637|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
131567461|NCT00335153|473702637|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
131567462|NCT00335153|473702637|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
131567463|NCT00335153|473702637|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
131567464|NCT00335153|473702637|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
131567465|NCT01113463|473702642|FG000|Overall Study|Physician Decision|5|||
131567466|NCT02478359|473702643|FG000|Overall Study|Disenrolled from health plan|106|||
131567467|NCT02478359|473702644|FG001|Overall Study|Disenrolled from health plan|65|||
131567468|NCT01237678|473702645|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
131567469|NCT01237678|473702646|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
131567470|NCT01237678|473702647|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
131567471|NCT01237678|473702645|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
131567472|NCT01237678|473702646|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
131567473|NCT01237678|473702647|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
131567474|NCT01237678|473702645|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
131567475|NCT01237678|473702646|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
131567476|NCT01237678|473702647|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
131567477|NCT01237678|473702645|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
131567478|NCT01237678|473702646|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
131567479|NCT01237678|473702647|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
131567480|NCT01237678|473702645|FG000|Phase II|Adverse Event|0|||
131567481|NCT01237678|473702646|FG001|Phase II|Adverse Event|39|||
131567482|NCT01237678|473702647|FG002|Phase II|Adverse Event|9|||
131567483|NCT01237678|473702645|FG000|Phase II|Death|0|||
131567484|NCT01237678|473702646|FG001|Phase II|Death|0|||
131567485|NCT01237678|473702647|FG002|Phase II|Death|2|||
131567486|NCT01237678|473702645|FG000|Phase II|Lack of Efficacy|0|||
131567487|NCT01237678|473702646|FG001|Phase II|Lack of Efficacy|25|||
131567488|NCT01237678|473702647|FG002|Phase II|Lack of Efficacy|3|||
131437567|NCT00360412|473226886|FG001|Overall Study|Physician Decision|4|||
131437568|NCT00360412|473226885|FG000|Overall Study|Other|5|||
131437569|NCT00360412|473226886|FG001|Overall Study|Other|6|||
131437570|NCT00360412|473226885|FG000|Overall Study|Study termination by Sponsor|214|||
131567489|NCT01237678|473702645|FG000|Phase II|Withdrawal by Subject|0|||
131567490|NCT01237678|473702646|FG001|Phase II|Withdrawal by Subject|1|||
131567491|NCT01237678|473702647|FG002|Phase II|Withdrawal by Subject|5|||
131567492|NCT01237678|473702645|FG000|Phase II|Completed Cycles 4-6|0|||
131567493|NCT01237678|473702646|FG001|Phase II|Completed Cycles 4-6|11|||
131567494|NCT01237678|473702647|FG002|Phase II|Completed Cycles 4-6|21|||
131567495|NCT01237678|473702645|FG000|Phase II|Sponsor Decision/Study Closed|0|||
131567496|NCT01237678|473702646|FG001|Phase II|Sponsor Decision/Study Closed|18|||
131567497|NCT01237678|473702647|FG002|Phase II|Sponsor Decision/Study Closed|7|||
131567498|NCT01237678|473702645|FG000|Phase II|Randomized but were not treated|0|||
131567499|NCT01237678|473702646|FG001|Phase II|Randomized but were not treated|4|||
131567500|NCT01237678|473702647|FG002|Phase II|Randomized but were not treated|3|||
131567501|NCT00372528|473702648|FG000|Overall Study|Lack of Efficacy|1|||
131567502|NCT00372528|473702648|FG000|Overall Study|Adverse Event|1|||
131567503|NCT00372528|473702648|FG000|Overall Study|Study Terminated by Sponsor|18|||
131567504|NCT00372528|473702648|FG000|Overall Study|Other|1|||
131567505|NCT03023332|473702649|FG000|Overall Study|Withdrawal by Subject|10|||
131567506|NCT03023332|473702650|FG001|Overall Study|Withdrawal by Subject|5|||
131567507|NCT03023332|473702651|FG002|Overall Study|Withdrawal by Subject|4|||
131567508|NCT03023332|473702652|FG003|Overall Study|Withdrawal by Subject|7|||
131567509|NCT03023332|473702649|FG000|Overall Study|Lost to Follow-up|13|||
131567510|NCT03023332|473702650|FG001|Overall Study|Lost to Follow-up|16|||
131567511|NCT03023332|473702651|FG002|Overall Study|Lost to Follow-up|8|||
131567512|NCT03023332|473702652|FG003|Overall Study|Lost to Follow-up|13|||
131567513|NCT03023332|473702649|FG000|Overall Study|Death|1|||
131567514|NCT03023332|473702650|FG001|Overall Study|Death|0|||
131567515|NCT03023332|473702651|FG002|Overall Study|Death|0|||
131567516|NCT03023332|473702652|FG003|Overall Study|Death|0|||
131567517|NCT02412761|473702653|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131567518|NCT02412761|473702654|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131567519|NCT02412761|473702655|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131567520|NCT02412761|473702656|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131567521|NCT02412761|473702657|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131567522|NCT02412761|473702658|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131567523|NCT01818700|473702659|FG000|Overall Study|Adverse Event|67|||
131567524|NCT01818700|473702659|FG000|Overall Study|Lack of Efficacy|2|||
131567525|NCT01818700|473702659|FG000|Overall Study|Lost to Follow-up|5|||
131567526|NCT01818700|473702659|FG000|Overall Study|Withdrawal by Subject|27|||
131567527|NCT01818700|473702659|FG000|Overall Study|Protocol Violation|2|||
131567528|NCT01818700|473702659|FG000|Overall Study|Other|1|||
131567529|NCT02240680|473702660|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
131567530|NCT02240680|473702661|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
131567531|NCT02240680|473702662|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
131567532|NCT02240680|473702663|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
131567533|NCT02240680|473702660|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
131567534|NCT02240680|473702661|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
131567535|NCT02240680|473702662|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
131567536|NCT02240680|473702663|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
131567537|NCT02240680|473702660|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
131567538|NCT02240680|473702661|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
131567539|NCT02240680|473702662|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
131567540|NCT02240680|473702663|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
131567541|NCT02240680|473702660|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
131783278|NCT02703454|474489871|FG001|Overall Study|Not treated|3|||
131783279|NCT02703454|474489870|FG000|Overall Study|Withdrawal by Subject|4|||
131783280|NCT02703454|474489871|FG001|Overall Study|Withdrawal by Subject|3|||
131783281|NCT02703454|474489870|FG000|Overall Study|Lost to Follow-up|1|||
131783282|NCT02703454|474489871|FG001|Overall Study|Lost to Follow-up|2|||
131783283|NCT02703454|474489870|FG000|Overall Study|Study discontinuation|5|||
131783284|NCT02703454|474489871|FG001|Overall Study|Study discontinuation|8|||
131783285|NCT02284373|474489872|FG000|Overall Study|Withdrawal by Subject|0|||
131783286|NCT02284373|474489873|FG001|Overall Study|Withdrawal by Subject|1|||
131783287|NCT02284373|474489874|FG002|Overall Study|Withdrawal by Subject|0|||
131783288|NCT02284373|474489872|FG000|Overall Study|Other|0|||
131783289|NCT02284373|474489873|FG001|Overall Study|Other|1|||
131783290|NCT02284373|474489874|FG002|Overall Study|Other|0|||
131783291|NCT02284373|474489872|FG000|Overall Study|Lost to Follow-up|0|||
131783292|NCT02284373|474489873|FG001|Overall Study|Lost to Follow-up|1|||
131783293|NCT02284373|474489874|FG002|Overall Study|Lost to Follow-up|0|||
131783294|NCT02016755|474489875|FG000|Overall Study|Major amputation of index limb|2|||
131783295|NCT02016755|474489875|FG000|Overall Study|Adverse Event|2|||
131783296|NCT02016755|474489875|FG000|Overall Study|Physician Decision|1|||
131783297|NCT02016755|474489875|FG000|Overall Study|Death|2|||
131783298|NCT02499406|474489876|FG000|Overall Study|missed 3 treatment sessions|4|||
131783299|NCT04651218|474489880|FG000|Overall Study|Withdrawal by Subject|0|||
131783300|NCT04651218|474489881|FG001|Overall Study|Withdrawal by Subject|2|||
131783301|NCT00414011|474489882|FG000|Overall Study|Physician Decision|3|||
131783302|NCT00414011|474489882|FG000|Overall Study|Withdrawal by Subject|2|||
131437571|NCT00360412|473226886|FG001|Overall Study|Study termination by Sponsor|469|||
131437572|NCT01116648|473226890|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
131783303|NCT02476851|474489883|FG000|Overall Study|Protocol Violation|1|||
131783304|NCT02476851|474489884|FG001|Overall Study|Protocol Violation|1|||
131783305|NCT01399125|474489887|FG000|Overall Study|Adverse Event|32|||
131437573|NCT01116648|473226891|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
131567542|NCT02240680|473702661|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
131567543|NCT02240680|473702662|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
131567544|NCT02240680|473702663|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
131567545|NCT02240680|473702660|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
131567546|NCT02240680|473702661|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
131783306|NCT01399125|474489888|FG001|Overall Study|Adverse Event|30|||
131783307|NCT01399125|474489887|FG000|Overall Study|Abnormal Lab values|0|||
131783308|NCT01399125|474489888|FG001|Overall Study|Abnormal Lab values|1|||
131567547|NCT02240680|473702662|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
131567548|NCT02240680|473702663|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
131567549|NCT02240680|473702660|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
131567550|NCT02240680|473702661|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
131567551|NCT02240680|473702662|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
131567552|NCT02240680|473702663|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
131567553|NCT02240680|473702660|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
131567554|NCT02240680|473702661|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
131567555|NCT02240680|473702662|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
131567556|NCT02240680|473702663|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
131567557|NCT02240680|473702660|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
131567558|NCT02240680|473702661|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
131567559|NCT02240680|473702662|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
131567560|NCT02240680|473702663|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
131567561|NCT01657682|473702664|FG000|Overall Study|Lost to Follow-up|1|||
131567562|NCT01657682|473702665|FG001|Overall Study|Lost to Follow-up|0|||
131567563|NCT01657682|473702666|FG002|Overall Study|Lost to Follow-up|0|||
131567564|NCT01657682|473702664|FG000|Overall Study|Withdrawal by Subject|0|||
131567565|NCT01657682|473702665|FG001|Overall Study|Withdrawal by Subject|1|||
131567566|NCT01657682|473702666|FG002|Overall Study|Withdrawal by Subject|1|||
131567567|NCT01657682|473702664|FG000|Overall Study|Adverse Event|0|||
131567568|NCT01657682|473702665|FG001|Overall Study|Adverse Event|1|||
131567569|NCT01657682|473702666|FG002|Overall Study|Adverse Event|0|||
131567570|NCT01719861|473702667|FG000|Cycle 1|Death|4|||
131567571|NCT01719861|473702667|FG000|Cycle 2|Death|1|||
131567572|NCT00965484|473702668|FG000|Overall Study|Protocol Violation|1|||
131567573|NCT00965484|473702668|FG000|Overall Study|Withdrawal by Subject|1|||
131567574|NCT00848211|473702669|FG000|Overall Study|Protocol Violation|0|||
131567575|NCT00848211|473702670|FG001|Overall Study|Protocol Violation|1|||
131567576|NCT00848211|473702671|FG002|Overall Study|Protocol Violation|1|||
131567577|NCT00848211|473702672|FG003|Overall Study|Protocol Violation|0|||
131567578|NCT00848211|473702669|FG000|Overall Study|Adverse Event|0|||
131567579|NCT00848211|473702670|FG001|Overall Study|Adverse Event|0|||
131567580|NCT00848211|473702671|FG002|Overall Study|Adverse Event|0|||
131567581|NCT00848211|473702672|FG003|Overall Study|Adverse Event|0|||
131567582|NCT00619151|473702673|FG000|Overall Study|Study terminated prior to followup|1|||
131567583|NCT00619151|473702674|FG001|Overall Study|Study terminated prior to followup|0|||
131567584|NCT02825043|473702675|FG000|Overall Study|Lost to Follow-up|4|||
131567585|NCT03582137|473702678|FG000|Overall Study|Adverse Event|1|||
131567586|NCT03582137|473702679|FG001|Overall Study|Adverse Event|0|||
131567587|NCT01982760|473702680|FG000|Overall Study|Physician Decision|1|||
131567588|NCT01982760|473702681|FG001|Overall Study|Physician Decision|0|||
131567589|NCT03704298|473702685|FG000|Overall Study|Death|3|||
131567590|NCT03704298|473702686|FG001|Overall Study|Death|1|||
131567591|NCT03704298|473702687|FG002|Overall Study|Death|1|||
131567592|NCT03704298|473702688|FG003|Overall Study|Death|0|||
131567593|NCT03704298|473702685|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
131567594|NCT03704298|473702686|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
131567595|NCT03704298|473702687|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
131567596|NCT03704298|473702688|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
131567597|NCT03704298|473702685|FG000|Overall Study|Withdrawal by Subject|1|||
131567598|NCT03704298|473702686|FG001|Overall Study|Withdrawal by Subject|0|||
131567599|NCT03704298|473702687|FG002|Overall Study|Withdrawal by Subject|0|||
131567600|NCT03704298|473702688|FG003|Overall Study|Withdrawal by Subject|0|||
131567601|NCT03704298|473702685|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
131567602|NCT03704298|473702686|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
131567603|NCT03704298|473702687|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
131567604|NCT03704298|473702688|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
131567605|NCT04796935|473702689|FG000|Overall Study|Withdrawal by Subject|0|||
131567606|NCT04796935|473702690|FG001|Overall Study|Withdrawal by Subject|1|||
131567607|NCT04796935|473702689|FG000|Overall Study|Physician Decision|0|||
131567608|NCT04796935|473702690|FG001|Overall Study|Physician Decision|1|||
131567609|NCT04796935|473702689|FG000|Overall Study|Device not available|1|||
131567610|NCT04796935|473702690|FG001|Overall Study|Device not available|0|||
131567611|NCT04796935|473702689|FG000|Overall Study|Trained provider not available|1|||
131567612|NCT04796935|473702690|FG001|Overall Study|Trained provider not available|0|||
131567613|NCT04159896|473702694|FG000|Overall Study|Lack of Efficacy|7|||
131567614|NCT04159896|473702694|FG000|Overall Study|Withdrawal by Subject|1|||
131567615|NCT04159896|473702694|FG000|Overall Study|Adverse Event|1|||
131783309|NCT01399125|474489887|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131783310|NCT01399125|474489888|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
131783311|NCT01399125|474489887|FG000|Overall Study|Withdrawal by Subject|5|||
131567616|NCT04159896|473702694|FG000|Overall Study|A transient ischaemic attack|1|||
131567617|NCT02084082|473702695|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
131567618|NCT02084082|473702696|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
131567619|NCT02084082|473702697|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
131567620|NCT02084082|473702698|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
131567621|NCT02084082|473702695|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131567622|NCT02084082|473702696|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131567623|NCT02084082|473702697|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131567624|NCT02084082|473702698|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
131567625|NCT05705167|473702699|FG000|Overall Study|Randomised but not Treated|0|||
131567626|NCT05705167|473702700|FG001|Overall Study|Randomised but not Treated|2|||
131567627|NCT05705167|473702701|FG002|Overall Study|Randomised but not Treated|0|||
131567628|NCT05705167|473702702|FG003|Overall Study|Randomised but not Treated|7|||
131567629|NCT05705167|473702703|FG004|Overall Study|Randomised but not Treated|0|||
131567630|NCT05705167|473702704|FG005|Overall Study|Randomised but not Treated|0|||
131567631|NCT05705167|473702705|FG006|Overall Study|Randomised but not Treated|0|||
131567632|NCT05705167|473702699|FG000|Overall Study|Death|0|||
131567633|NCT05705167|473702700|FG001|Overall Study|Death|0|||
131567634|NCT05705167|473702701|FG002|Overall Study|Death|3|||
131567635|NCT05705167|473702702|FG003|Overall Study|Death|0|||
131567636|NCT05705167|473702703|FG004|Overall Study|Death|1|||
131567637|NCT05705167|473702704|FG005|Overall Study|Death|1|||
131567638|NCT05705167|473702705|FG006|Overall Study|Death|1|||
131567639|NCT05705167|473702699|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131567640|NCT05705167|473702700|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131567641|NCT05705167|473702701|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
131567642|NCT05705167|473702702|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
131567643|NCT05705167|473702703|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131567644|NCT05705167|473702704|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131567645|NCT05705167|473702705|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
131567646|NCT02099539|473702708|FG000|Overall Study|Progressive Disease|3|||
131567647|NCT02099539|473702709|FG001|Overall Study|Progressive Disease|2|||
131567648|NCT02099539|473702710|FG002|Overall Study|Progressive Disease|2|||
131567649|NCT02099539|473702711|FG003|Overall Study|Progressive Disease|1|||
131567650|NCT02099539|473702712|FG004|Overall Study|Progressive Disease|4|||
131567651|NCT02099539|473702713|FG005|Overall Study|Progressive Disease|2|||
131567652|NCT02099539|473702714|FG006|Overall Study|Progressive Disease|0|||
131567653|NCT02099539|473702708|FG000|Overall Study|Adverse Event|0|||
131567654|NCT02099539|473702709|FG001|Overall Study|Adverse Event|0|||
131567655|NCT02099539|473702710|FG002|Overall Study|Adverse Event|1|||
131567656|NCT02099539|473702711|FG003|Overall Study|Adverse Event|1|||
131567657|NCT02099539|473702712|FG004|Overall Study|Adverse Event|0|||
131567658|NCT02099539|473702713|FG005|Overall Study|Adverse Event|0|||
131567659|NCT02099539|473702714|FG006|Overall Study|Adverse Event|0|||
131567660|NCT02099539|473702708|FG000|Overall Study|Physician Decision|0|||
131567661|NCT02099539|473702709|FG001|Overall Study|Physician Decision|0|||
131567662|NCT02099539|473702710|FG002|Overall Study|Physician Decision|0|||
131567663|NCT02099539|473702711|FG003|Overall Study|Physician Decision|0|||
131567664|NCT02099539|473702712|FG004|Overall Study|Physician Decision|0|||
131567665|NCT02099539|473702713|FG005|Overall Study|Physician Decision|1|||
131567666|NCT02099539|473702714|FG006|Overall Study|Physician Decision|0|||
131567667|NCT00764868|473702717|FG000|Overall Study|Adverse Event|18|||
131567668|NCT00764868|473702717|FG000|Overall Study|Withdrawal by Subject|31|||
131567669|NCT00764868|473702717|FG000|Overall Study|Non-compliance|16|||
131567670|NCT00764868|473702717|FG000|Overall Study|Lost to Follow-up|25|||
131567671|NCT00764868|473702717|FG000|Overall Study|Lack of Efficacy|5|||
131437574|NCT01116648|473226892|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
131567672|NCT00764868|473702717|FG000|Overall Study|Subject moved|7|||
131567673|NCT00764868|473702717|FG000|Overall Study|Pregnancy|3|||
131567674|NCT00764868|473702717|FG000|Overall Study|Prohibited medication|1|||
131567675|NCT00764868|473702717|FG000|Overall Study|Out of town|1|||
131567676|NCT00764868|473702717|FG000|Overall Study|Misuse and compliance of study drug|1|||
131567677|NCT00764868|473702717|FG000|Overall Study|Subject sent to boarding school|1|||
131567678|NCT00764868|473702717|FG000|Overall Study|Met an exclusion criteria|1|||
131567679|NCT00764868|473702717|FG000|Overall Study|Positive drug screen|2|||
131567680|NCT00764868|473702717|FG000|Overall Study|Sponsor requested withdrawal|1|||
131567681|NCT04438785|473702718|FG000|Overall Study|change of weight, give up intervention|2|||
131567682|NCT04438785|473702719|FG001|Overall Study|change of weight, give up intervention|10|||
131567683|NCT02027935|473702720|FG000|Overall Study|Death|1|||
131567684|NCT02027935|473702720|FG000|Overall Study|Lack of Efficacy|5|||
131567685|NCT02027935|473702720|FG000|Overall Study|Study Closure|1|||
131567686|NCT00689104|473702721|FG000|Overall Study|Eligibility criterion not met|5|||
131567687|NCT00689104|473702722|FG001|Overall Study|Eligibility criterion not met|8|||
131567688|NCT00689104|473702723|FG002|Overall Study|Eligibility criterion not met|0|||
131567689|NCT00689104|473702724|FG003|Overall Study|Eligibility criterion not met|4|||
131567690|NCT00689104|473702721|FG000|Overall Study|Adverse Event|13|||
131567691|NCT00689104|473702722|FG001|Overall Study|Adverse Event|25|||
131567692|NCT00689104|473702723|FG002|Overall Study|Adverse Event|16|||
131567693|NCT00689104|473702724|FG003|Overall Study|Adverse Event|24|||
131567694|NCT00689104|473702721|FG000|Overall Study|Lack of Efficacy|5|||
131567695|NCT00689104|473702722|FG001|Overall Study|Lack of Efficacy|6|||
131567696|NCT00689104|473702723|FG002|Overall Study|Lack of Efficacy|2|||
131567697|NCT00689104|473702724|FG003|Overall Study|Lack of Efficacy|3|||
131567698|NCT00689104|473702721|FG000|Overall Study|Withdrawal by Subject|12|||
131567699|NCT00689104|473702722|FG001|Overall Study|Withdrawal by Subject|11|||
131567700|NCT00689104|473702723|FG002|Overall Study|Withdrawal by Subject|18|||
131567701|NCT00689104|473702724|FG003|Overall Study|Withdrawal by Subject|11|||
131567702|NCT00689104|473702721|FG000|Overall Study|Lost to Follow-up|4|||
131567703|NCT00689104|473702722|FG001|Overall Study|Lost to Follow-up|3|||
131567704|NCT00689104|473702723|FG002|Overall Study|Lost to Follow-up|2|||
131567705|NCT00689104|473702724|FG003|Overall Study|Lost to Follow-up|5|||
131567706|NCT00689104|473702721|FG000|Overall Study|Protocol Violation|2|||
131567707|NCT00689104|473702722|FG001|Overall Study|Protocol Violation|3|||
131567708|NCT00689104|473702723|FG002|Overall Study|Protocol Violation|5|||
131567709|NCT00689104|473702724|FG003|Overall Study|Protocol Violation|3|||
131567710|NCT00689104|473702721|FG000|Overall Study|Randomized but never received study drug|2|||
131567711|NCT00689104|473702722|FG001|Overall Study|Randomized but never received study drug|1|||
131567712|NCT00689104|473702723|FG002|Overall Study|Randomized but never received study drug|1|||
131567713|NCT00689104|473702724|FG003|Overall Study|Randomized but never received study drug|0|||
131567714|NCT00689104|473702721|FG000|Overall Study|Physician Decision|1|||
131567715|NCT00689104|473702722|FG001|Overall Study|Physician Decision|0|||
131567716|NCT00689104|473702723|FG002|Overall Study|Physician Decision|0|||
131567717|NCT00689104|473702724|FG003|Overall Study|Physician Decision|0|||
131567718|NCT00689104|473702721|FG000|Overall Study|Non-compliance with study procedures|0|||
131567719|NCT00689104|473702722|FG001|Overall Study|Non-compliance with study procedures|0|||
131567720|NCT00689104|473702723|FG002|Overall Study|Non-compliance with study procedures|1|||
131567721|NCT00689104|473702724|FG003|Overall Study|Non-compliance with study procedures|0|||
131567722|NCT04091672|473704431|FG000|Overall Study|Death|6|||
131567723|NCT04091672|473704432|FG001|Overall Study|Death|6|||
131567724|NCT04091672|473704431|FG000|Overall Study|Lost to Follow-up|7|||
131567725|NCT04091672|473704432|FG001|Overall Study|Lost to Follow-up|7|||
131567726|NCT04091672|473704431|FG000|Overall Study|Withdrawal by Subject|3|||
131567727|NCT04091672|473704432|FG001|Overall Study|Withdrawal by Subject|3|||
131567728|NCT04091672|473704431|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
131567729|NCT04091672|473704432|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
131567730|NCT05296629|473704433|FG000|Overall Study|Withdrawal by Subject|3|||
131567731|NCT05296629|473704434|FG001|Overall Study|Withdrawal by Subject|10|||
131567732|NCT05296629|473704435|FG002|Overall Study|Withdrawal by Subject|4|||
131567733|NCT05296629|473704433|FG000|Overall Study|Lost to Follow-up|2|||
131567734|NCT05296629|473704434|FG001|Overall Study|Lost to Follow-up|7|||
131567735|NCT05296629|473704435|FG002|Overall Study|Lost to Follow-up|1|||
131567736|NCT05296629|473704433|FG000|Overall Study|Adverse Event|0|||
131567737|NCT05296629|473704434|FG001|Overall Study|Adverse Event|4|||
131567738|NCT05296629|473704435|FG002|Overall Study|Adverse Event|2|||
131567739|NCT05296629|473704433|FG000|Overall Study|Protocol Violation|0|||
131567740|NCT05296629|473704434|FG001|Overall Study|Protocol Violation|2|||
131567741|NCT05296629|473704435|FG002|Overall Study|Protocol Violation|0|||
131567742|NCT02268396|473704439|FG000|Overall Study|Adverse Event|3|||
131567743|NCT02268396|473704439|FG000|Overall Study|Administrative|2|||
131567744|NCT02268396|473704439|FG000|Overall Study|Withdrawal by Subject|1|||
131567745|NCT02268396|473704439|FG000|Overall Study|Lost to Follow-up|2|||
131567746|NCT02268396|473704439|FG000|Overall Study|Protocol-Specified Criteria|2|||
131567747|NCT02268396|473704439|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
131567748|NCT00231179|473704440|FG000|Overall Study|Lost to Follow-up|21|||
131567749|NCT00231179|473704441|FG001|Overall Study|Lost to Follow-up|21|||
131567750|NCT00231179|473704440|FG000|Overall Study|Withdrawal by Subject|3|||
131567751|NCT00231179|473704441|FG001|Overall Study|Withdrawal by Subject|3|||
131567752|NCT02401529|473704442|FG000|Overall Study|Lost to Follow-up|2|||
131567753|NCT02401529|473704443|FG001|Overall Study|Lost to Follow-up|1|||
131567754|NCT02401529|473704442|FG000|Overall Study|Physician Decision|2|||
131567755|NCT02401529|473704443|FG001|Overall Study|Physician Decision|6|||
131567756|NCT02401529|473704442|FG000|Overall Study|Protocol Violation|5|||
131567757|NCT02401529|473704443|FG001|Overall Study|Protocol Violation|0|||
131783312|NCT01399125|474489888|FG001|Overall Study|Withdrawal by Subject|8|||
131567758|NCT04034238|473704446|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
131567759|NCT04034238|473704447|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131567760|NCT04034238|473704448|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131567761|NCT04034238|473704449|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131567762|NCT04034238|473704446|FG000|Dose Escalation Phase|Screen failures|0|||
131567763|NCT04034238|473704447|FG001|Dose Escalation Phase|Screen failures|0|||
131567764|NCT04034238|473704448|FG002|Dose Escalation Phase|Screen failures|0|||
131567765|NCT04034238|473704449|FG003|Dose Escalation Phase|Screen failures|2|||
131567766|NCT04034238|473704446|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
131567767|NCT04034238|473704447|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
131567768|NCT04034238|473704448|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
131567769|NCT04034238|473704449|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
131567770|NCT04034238|473704446|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
131567771|NCT04034238|473704447|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
131567772|NCT04034238|473704448|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
131567773|NCT04034238|473704449|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
131567774|NCT02065245|473704452|FG000|Infusion 1|Lost to Follow-up|0|||
131567775|NCT02065245|473704453|FG001|Infusion 1|Lost to Follow-up|0|||
131567776|NCT02065245|473704454|FG002|Infusion 1|Lost to Follow-up|0|||
131567777|NCT02065245|473704455|FG003|Infusion 1|Lost to Follow-up|0|||
131567778|NCT02065245|473704456|FG004|Infusion 1|Lost to Follow-up|0|||
131567779|NCT02065245|473704457|FG005|Infusion 1|Lost to Follow-up|0|||
131567780|NCT02065245|473704458|FG006|Infusion 1|Lost to Follow-up|1|||
131567781|NCT02065245|473704452|FG000|Infusion 1|Death|0|||
131567782|NCT02065245|473704453|FG001|Infusion 1|Death|0|||
131567783|NCT02065245|473704454|FG002|Infusion 1|Death|1|||
131567784|NCT02065245|473704455|FG003|Infusion 1|Death|0|||
131567785|NCT02065245|473704456|FG004|Infusion 1|Death|1|||
131567786|NCT02065245|473704457|FG005|Infusion 1|Death|0|||
131567787|NCT02065245|473704458|FG006|Infusion 1|Death|0|||
131567788|NCT02065245|473704452|FG000|Infusion 2|Death|0|||
131567789|NCT02065245|473704453|FG001|Infusion 2|Death|0|||
131567790|NCT02065245|473704454|FG002|Infusion 2|Death|0|||
131567791|NCT02065245|473704455|FG003|Infusion 2|Death|0|||
131567792|NCT02065245|473704456|FG004|Infusion 2|Death|0|||
131567793|NCT02065245|473704457|FG005|Infusion 2|Death|0|||
131567794|NCT02065245|473704458|FG006|Infusion 2|Death|1|||
131567795|NCT02065245|473704452|FG000|Infusion 3|Lost to Follow-up|1|||
131567796|NCT02065245|473704453|FG001|Infusion 3|Lost to Follow-up|1|||
131567797|NCT02065245|473704454|FG002|Infusion 3|Lost to Follow-up|0|||
131567798|NCT02065245|473704455|FG003|Infusion 3|Lost to Follow-up|0|||
131567799|NCT02065245|473704456|FG004|Infusion 3|Lost to Follow-up|0|||
131567800|NCT02065245|473704457|FG005|Infusion 3|Lost to Follow-up|0|||
131567801|NCT02065245|473704458|FG006|Infusion 3|Lost to Follow-up|0|||
131567802|NCT01518257|473704459|FG000|Overall Study|Lost to Follow-up|1|||
131567803|NCT01518257|473704460|FG001|Overall Study|Lost to Follow-up|0|||
131567804|NCT01518257|473704459|FG000|Overall Study|Other Miscellaneous Reason|1|||
131567805|NCT01518257|473704460|FG001|Overall Study|Other Miscellaneous Reason|0|||
131567806|NCT01304706|473704461|FG000|Overall Study|Adverse Event|2|||
131567807|NCT01304706|473704461|FG000|Overall Study|Lack of Efficacy|1|||
131567808|NCT01304706|473704461|FG000|Overall Study|Death|3|||
131567809|NCT01304706|473704461|FG000|Overall Study|Withdrawal by Subject|3|||
131567810|NCT01304706|473704461|FG000|Overall Study|Lost to Follow-up|7|||
131567811|NCT01304706|473704461|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
131567812|NCT02206685|473704462|FG000|Overall Study|Surgery cancelled/changed|2|||
131567813|NCT02206685|473704463|FG001|Overall Study|Surgery cancelled/changed|3|||
131567814|NCT02206685|473704462|FG000|Overall Study|Withdrawal by Subject|1|||
131567815|NCT02206685|473704463|FG001|Overall Study|Withdrawal by Subject|2|||
131567816|NCT02206685|473704462|FG000|Overall Study|Protocol Violation|2|||
131567817|NCT02206685|473704463|FG001|Overall Study|Protocol Violation|2|||
131783313|NCT01399125|474489887|FG000|Overall Study|Lost to Follow-up|2|||
131567818|NCT01097655|473704464|FG000|Overall Study|Withdrawal by Subject|1|||
131567819|NCT01097655|473704464|FG000|Overall Study|Subject Documented Twice|1|||
131567820|NCT01097655|473704464|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
131567821|NCT01345292|473704465|FG000|Overall Study|Withdrawal by Subject|2|||
131567822|NCT01345292|473704466|FG001|Overall Study|Withdrawal by Subject|0|||
131567823|NCT01345292|473704467|FG002|Overall Study|Withdrawal by Subject|1|||
131567824|NCT03303105|473704469|FG000|Overall Study|Adverse Event|0|||
131567825|NCT03303105|473704470|FG001|Overall Study|Adverse Event|2|||
131567826|NCT03303105|473704469|FG000|Overall Study|Lack of Efficacy|1|||
131783314|NCT01399125|474489888|FG001|Overall Study|Lost to Follow-up|3|||
131783315|NCT01399125|474489887|FG000|Overall Study|Administrative Problems|7|||
131567827|NCT03303105|473704470|FG001|Overall Study|Lack of Efficacy|0|||
131567828|NCT03303105|473704469|FG000|Overall Study|Protocol Violation|1|||
131567829|NCT03303105|473704470|FG001|Overall Study|Protocol Violation|0|||
131567830|NCT03303105|473704469|FG000|Overall Study|Withdrawal by Subject|0|||
131783316|NCT01399125|474489888|FG001|Overall Study|Administrative Problems|11|||
131783317|NCT01399125|474489887|FG000|Overall Study|Death|0|||
131783318|NCT01399125|474489888|FG001|Overall Study|Death|1|||
131783319|NCT01399125|474489887|FG000|Overall Study|Protocol Deviation|5|||
131783320|NCT01399125|474489888|FG001|Overall Study|Protocol Deviation|2|||
131783321|NCT00647426|474489889|FG000|Overall Study|Withdrawal by Subject|2|||
131783322|NCT00038467|474489892|FG000|Overall Study|Adverse Event|170|||
131783323|NCT00038467|474489893|FG001|Overall Study|Adverse Event|145|||
131783324|NCT00038467|474489892|FG000|Overall Study|Withdrawal by Subject|150|||
131783325|NCT00038467|474489893|FG001|Overall Study|Withdrawal by Subject|107|||
131783326|NCT00038467|474489892|FG000|Overall Study|Protocol Violation|19|||
131783327|NCT00038467|474489893|FG001|Overall Study|Protocol Violation|22|||
131783328|NCT00038467|474489892|FG000|Overall Study|Death|22|||
131783329|NCT00038467|474489893|FG001|Overall Study|Death|16|||
131783330|NCT00038467|474489892|FG000|Overall Study|Lost to Follow-up|15|||
131783331|NCT00038467|474489893|FG001|Overall Study|Lost to Follow-up|10|||
131783332|NCT00038467|474489892|FG000|Overall Study|Recurrence|109|||
131783333|NCT00038467|474489893|FG001|Overall Study|Recurrence|179|||
131783334|NCT00038467|474489892|FG000|Overall Study|Randomized, but not treated|31|||
131783335|NCT00038467|474489893|FG001|Overall Study|Randomized, but not treated|35|||
131783336|NCT00038467|474489892|FG000|Overall Study|Other|26|||
131783337|NCT00038467|474489893|FG001|Overall Study|Other|28|||
131783338|NCT01988493|474489894|FG000|Overall Study|Randomized but not treated|0|||
131783339|NCT01988493|474489895|FG001|Overall Study|Randomized but not treated|0|||
131783340|NCT01988493|474489896|FG002|Overall Study|Randomized but not treated|0|||
131783341|NCT01988493|474489897|FG003|Overall Study|Randomized but not treated|0|||
131783342|NCT01988493|474489898|FG004|Overall Study|Randomized but not treated|1|||
131783343|NCT02268045|474489901|FG000|Overall Study|Death|4|||
131783344|NCT02268045|474489902|FG001|Overall Study|Death|4|||
131783345|NCT02268045|474489901|FG000|Overall Study|Disease Progression|2|||
131783346|NCT02268045|474489902|FG001|Overall Study|Disease Progression|1|||
131783347|NCT02268045|474489901|FG000|Overall Study|Adverse Event|7|||
131783348|NCT02268045|474489902|FG001|Overall Study|Adverse Event|7|||
131783349|NCT02268045|474489901|FG000|Overall Study|Withdrawal by Subject|2|||
131783350|NCT02268045|474489902|FG001|Overall Study|Withdrawal by Subject|6|||
131783351|NCT02268045|474489901|FG000|Overall Study|Physician Decision|0|||
131783352|NCT02268045|474489902|FG001|Overall Study|Physician Decision|1|||
131783353|NCT02268045|474489901|FG000|Overall Study|Protocol Violation|1|||
131783354|NCT02268045|474489902|FG001|Overall Study|Protocol Violation|1|||
131783355|NCT01154673|474489903|FG000|Overall Study|Lost to Follow-up|1|||
131783356|NCT01154673|474489904|FG001|Overall Study|Lost to Follow-up|0|||
131783357|NCT01154673|474489903|FG000|Overall Study|moved out of province|1|||
131783358|NCT01154673|474489904|FG001|Overall Study|moved out of province|0|||
131783359|NCT00646282|474489906|FG000|Overall Study|Protocol terminated|4|||
131783360|NCT00646282|474489907|FG001|Overall Study|Protocol terminated|4|||
131783361|NCT02617446|474489908|FG000|Overall Study|Withdrawal by Subject|0|||
131783362|NCT02617446|474489909|FG001|Overall Study|Withdrawal by Subject|2|||
131783363|NCT02617446|474489910|FG002|Overall Study|Withdrawal by Subject|0|||
131783364|NCT02617446|474489908|FG000|Overall Study|Adverse Event|1|||
131783365|NCT02617446|474489909|FG001|Overall Study|Adverse Event|0|||
131783366|NCT02617446|474489910|FG002|Overall Study|Adverse Event|5|||
131783367|NCT02617446|474489908|FG000|Overall Study|Lost to Follow-up|3|||
131783368|NCT02617446|474489909|FG001|Overall Study|Lost to Follow-up|0|||
131783369|NCT02617446|474489910|FG002|Overall Study|Lost to Follow-up|0|||
131783370|NCT02617446|474489908|FG000|Overall Study|Death|0|||
131783371|NCT02617446|474489909|FG001|Overall Study|Death|0|||
131783372|NCT02617446|474489910|FG002|Overall Study|Death|2|||
131783373|NCT01556490|474489911|FG000|Randomized Patients Summary|Protocol Violation|22|||
131783374|NCT01556490|474489912|FG001|Randomized Patients Summary|Protocol Violation|23|||
131783375|NCT01556490|474489911|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
131783376|NCT01556490|474489912|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
131783377|NCT00530088|474489913|FG000|Overall Study|Disease Progression|4|||
131783378|NCT00530088|474489913|FG000|Overall Study|Physician Decision|4|||
131783379|NCT00530088|474489913|FG000|Overall Study|Other Not Specified|2|||
131783380|NCT00683904|474489916|FG000|Dose Level 1|Disease progression|2|||
131783381|NCT00683904|474489917|FG001|Dose Level 1|Disease progression|0|||
131783382|NCT00683904|474489916|FG000|Dose Level 1|Adverse Event|1|||
131783383|NCT00683904|474489917|FG001|Dose Level 1|Adverse Event|0|||
131783384|NCT00683904|474489916|FG000|Dose Level 2|Adverse Event|0|||
131783385|NCT00683904|474489917|FG001|Dose Level 2|Adverse Event|2|||
131783386|NCT00758706|474489918|FG000|Overall Study|Adverse Event|4|||
131783387|NCT00758706|474489919|FG001|Overall Study|Adverse Event|4|||
131783388|NCT03611751|474489920|FG000|Pre-treatment|Randomized but not treated|1|||
131783389|NCT03611751|474489921|FG001|Pre-treatment|Randomized but not treated|1|||
131783390|NCT03611751|474489922|FG002|Pre-treatment|Randomized but not treated|0|||
131783391|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
131783392|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
131783393|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
131783394|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
131567831|NCT03303105|473704470|FG001|Overall Study|Withdrawal by Subject|2|||
131567832|NCT04822298|473704471|FG000|Overall Study|Death|3|||
131567833|NCT00852475|473704480|FG000|Overall Study|Lost to Follow-up|3|||
131567834|NCT00852475|473704481|FG001|Overall Study|Lost to Follow-up|4|||
131567835|NCT00515086|473704482|FG000|Overall Study|Adverse Event|1|||
131567836|NCT00515086|473704483|FG001|Overall Study|Adverse Event|1|||
131567837|NCT00515086|473704484|FG002|Overall Study|Adverse Event|2|||
131567838|NCT00515086|473704485|FG003|Overall Study|Adverse Event|3|||
131567839|NCT00515086|473704482|FG000|Overall Study|Administrative|1|||
131567840|NCT00515086|473704483|FG001|Overall Study|Administrative|1|||
131567841|NCT00515086|473704484|FG002|Overall Study|Administrative|0|||
131567842|NCT00515086|473704485|FG003|Overall Study|Administrative|0|||
131567843|NCT00515086|473704482|FG000|Overall Study|Withdrawal by Subject|1|||
131567844|NCT00515086|473704483|FG001|Overall Study|Withdrawal by Subject|0|||
131567845|NCT00515086|473704484|FG002|Overall Study|Withdrawal by Subject|0|||
131567846|NCT00515086|473704485|FG003|Overall Study|Withdrawal by Subject|1|||
131567847|NCT00515086|473704482|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
131567848|NCT00515086|473704483|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131567849|NCT00515086|473704484|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
131567850|NCT00515086|473704485|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131567851|NCT00515086|473704482|FG000|Overall Study|Lost to Follow-up|1|||
131567852|NCT00515086|473704483|FG001|Overall Study|Lost to Follow-up|0|||
131567853|NCT00515086|473704484|FG002|Overall Study|Lost to Follow-up|0|||
131567854|NCT00515086|473704485|FG003|Overall Study|Lost to Follow-up|0|||
131567855|NCT00515086|473704482|FG000|Overall Study|Study drug no longer required|0|||
131567856|NCT00515086|473704483|FG001|Overall Study|Study drug no longer required|1|||
131567857|NCT00515086|473704484|FG002|Overall Study|Study drug no longer required|0|||
131567858|NCT00515086|473704485|FG003|Overall Study|Study drug no longer required|0|||
131567859|NCT00515086|473704482|FG000|Overall Study|Death|2|||
131567860|NCT00515086|473704483|FG001|Overall Study|Death|0|||
131567861|NCT00515086|473704484|FG002|Overall Study|Death|0|||
131567862|NCT00515086|473704485|FG003|Overall Study|Death|0|||
131567863|NCT02028884|473704486|FG000|Double-blind Period|Adverse Event|5|||
131567864|NCT02028884|473704487|FG001|Double-blind Period|Adverse Event|3|||
131567865|NCT02028884|473704488|FG002|Double-blind Period|Adverse Event|0|||
131567866|NCT02028884|473704486|FG000|Double-blind Period|Eligibility Violation|1|||
131567867|NCT02028884|473704487|FG001|Double-blind Period|Eligibility Violation|0|||
131567868|NCT02028884|473704488|FG002|Double-blind Period|Eligibility Violation|0|||
131567869|NCT02028884|473704486|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
131567870|NCT02028884|473704487|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
131567871|NCT02028884|473704488|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
131567872|NCT02028884|473704486|FG000|Double-blind Period|Withdrawal by Subject|2|||
131567873|NCT02028884|473704487|FG001|Double-blind Period|Withdrawal by Subject|0|||
131567874|NCT02028884|473704488|FG002|Double-blind Period|Withdrawal by Subject|0|||
131567875|NCT02028884|473704486|FG000|Open-label Extension Period|Adverse Event|3|||
131567876|NCT02028884|473704487|FG001|Open-label Extension Period|Adverse Event|1|||
131567877|NCT02028884|473704488|FG002|Open-label Extension Period|Adverse Event|0|||
131567878|NCT02028884|473704486|FG000|Open-label Extension Period|Lack of Efficacy|3|||
131567879|NCT02028884|473704487|FG001|Open-label Extension Period|Lack of Efficacy|0|||
131567880|NCT02028884|473704488|FG002|Open-label Extension Period|Lack of Efficacy|0|||
131567881|NCT02028884|473704486|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
131567882|NCT02028884|473704487|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
131567883|NCT02028884|473704488|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
131567884|NCT02028884|473704486|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131567885|NCT02028884|473704487|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
131567886|NCT02028884|473704488|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
131567887|NCT02028884|473704486|FG000|Open-label Extension Period|Switched to another treatment option|3|||
131567888|NCT02028884|473704487|FG001|Open-label Extension Period|Switched to another treatment option|0|||
131567889|NCT02028884|473704488|FG002|Open-label Extension Period|Switched to another treatment option|0|||
131783395|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
131783396|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
131783397|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
131567890|NCT02403674|473704489|FG000|Base Study|Death|1|||
131567891|NCT02403674|473704490|FG001|Base Study|Death|4|||
131783398|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
131567892|NCT02403674|473704489|FG000|Base Study|Adverse Event|11|||
131567893|NCT02403674|473704490|FG001|Base Study|Adverse Event|26|||
131567894|NCT02403674|473704489|FG000|Base Study|Lack of Efficacy|31|||
131567895|NCT02403674|473704490|FG001|Base Study|Lack of Efficacy|23|||
131567896|NCT02403674|473704489|FG000|Base Study|Lost to Follow-up|6|||
131567897|NCT02403674|473704490|FG001|Base Study|Lost to Follow-up|8|||
131783399|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
131567898|NCT02403674|473704489|FG000|Base Study|Withdrawal by Subject|10|||
131567899|NCT02403674|473704490|FG001|Base Study|Withdrawal by Subject|17|||
131567900|NCT02403674|473704489|FG000|Base Study|Physician Decision|2|||
131567901|NCT02403674|473704490|FG001|Base Study|Physician Decision|2|||
131567902|NCT02403674|473704489|FG000|Base Study|Pregnancy|2|||
131567903|NCT02403674|473704490|FG001|Base Study|Pregnancy|2|||
131567904|NCT02403674|473704489|FG000|Base Study|Protocol Violation|8|||
131567905|NCT02403674|473704490|FG001|Base Study|Protocol Violation|4|||
131567906|NCT02403674|473704489|FG000|Base Study|Non-Compliance with study drug|1|||
131567907|NCT02403674|473704490|FG001|Base Study|Non-Compliance with study drug|4|||
131567908|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
131567909|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
131567910|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
131567911|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
131567912|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
131567913|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
131567914|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
131567915|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
131567916|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
131567917|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
131567918|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
131567919|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
131567920|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Death|1|||
131567921|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Death|0|||
131567922|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
131567923|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
131567924|NCT02403674|473704489|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
131567925|NCT02403674|473704490|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
131567926|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
131567927|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
131567928|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
131567929|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
131567930|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
131567931|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
131567932|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
131567933|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
131567934|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
131567935|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
131567936|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Death|2|||
131567937|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Death|2|||
131567938|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
131567939|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
131567940|NCT02403674|473704489|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
131567941|NCT02403674|473704490|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
131567942|NCT02403674|473704489|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
131567943|NCT02403674|473704490|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
131567944|NCT02403674|473704489|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
131567945|NCT02403674|473704490|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
131567946|NCT02403674|473704489|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
131567947|NCT02403674|473704490|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
131567948|NCT02403674|473704489|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
131567949|NCT02403674|473704490|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
131567950|NCT02403674|473704489|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
131567951|NCT02403674|473704490|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
131567952|NCT01254305|473704492|FG000|Overall Study|Adverse Event|6|||
131567953|NCT01254305|473704493|FG001|Overall Study|Adverse Event|3|||
131567954|NCT01254305|473704494|FG002|Overall Study|Adverse Event|2|||
131567955|NCT01254305|473704492|FG000|Overall Study|Lack of Efficacy|1|||
131567956|NCT01254305|473704493|FG001|Overall Study|Lack of Efficacy|0|||
131567957|NCT01254305|473704494|FG002|Overall Study|Lack of Efficacy|1|||
131567958|NCT01254305|473704492|FG000|Overall Study|Protocol Violation|1|||
131567959|NCT01254305|473704493|FG001|Overall Study|Protocol Violation|7|||
131567960|NCT01254305|473704494|FG002|Overall Study|Protocol Violation|3|||
131567961|NCT01254305|473704492|FG000|Overall Study|Withdrawal by Subject|4|||
131567962|NCT01254305|473704493|FG001|Overall Study|Withdrawal by Subject|2|||
131567963|NCT01254305|473704494|FG002|Overall Study|Withdrawal by Subject|4|||
131567964|NCT01254305|473704492|FG000|Overall Study|Lost to Follow-up|10|||
131567965|NCT01254305|473704493|FG001|Overall Study|Lost to Follow-up|6|||
131567966|NCT01254305|473704494|FG002|Overall Study|Lost to Follow-up|5|||
131567967|NCT01254305|473704492|FG000|Overall Study|Other Reasons|0|||
131567968|NCT01254305|473704493|FG001|Overall Study|Other Reasons|0|||
131567969|NCT01254305|473704494|FG002|Overall Study|Other Reasons|2|||
131567970|NCT02263885|473704495|FG000|Overall Study|Withdrawal by Subject|7|||
131783400|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
131783401|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
131783402|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
131783403|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
131783404|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
131783405|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
131783406|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
131783407|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
131783408|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
131783409|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
131783410|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
131783411|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
131783412|NCT03611751|474489920|FG000|Treatment Week 0 - Week 16|Death|0|||
131783413|NCT03611751|474489921|FG001|Treatment Week 0 - Week 16|Death|0|||
131783414|NCT03611751|474489922|FG002|Treatment Week 0 - Week 16|Death|1|||
131783415|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
131783416|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
131783417|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
131783418|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
131783419|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
131783420|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
131783421|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
131783422|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
131783423|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
131783424|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
131783425|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
131783426|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
131783427|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
131783428|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
131783429|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
131783430|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
131783431|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
131783432|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
131783433|NCT03611751|474489920|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
131783434|NCT03611751|474489921|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
131783435|NCT03611751|474489922|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
131783436|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
131783437|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
131783438|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
131783439|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
131783440|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
131783441|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
131783442|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
131783443|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
131783444|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
131783445|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
131783446|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
131783447|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
131783448|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
131783449|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
131783450|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
131783451|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
131783452|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
131783453|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
131783454|NCT03611751|474489920|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
131783455|NCT03611751|474489921|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
131783456|NCT03611751|474489922|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
131783457|NCT03467971|474489923|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131783458|NCT03467971|474489924|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131783459|NCT01488071|474489929|FG000|Overall Study|Adverse Event|15|||
131437575|NCT01116648|473226893|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
131437576|NCT01116648|473226894|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
131437577|NCT01116648|473226895|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
131437578|NCT01116648|473226896|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
131437579|NCT01116648|473226897|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
131437580|NCT01116648|473226898|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
131437581|NCT01116648|473226899|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
131437582|NCT01116648|473226900|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
131437583|NCT01116648|473226901|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
131437584|NCT01116648|473226902|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
131437585|NCT01116648|473226903|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
131437586|NCT01116648|473226904|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
131437587|NCT00410956|473226905|FG000|Overall Study|Adverse Event|1|||
131437588|NCT00410956|473226905|FG000|Overall Study|Death|2|||
131437589|NCT00410956|473226905|FG000|Overall Study|Lack of Efficacy|10|||
131437590|NCT00410956|473226905|FG000|Overall Study|Physician Decision|6|||
131437591|NCT03100149|473226906|FG000|Overall Study|Adverse Event|0|||
131437592|NCT03100149|473226907|FG001|Overall Study|Adverse Event|1|||
131437593|NCT03100149|473226908|FG002|Overall Study|Adverse Event|0|||
131898649|NCT01516736|474915331|FG000|Overall Study|Withdrawal by Subject|10|||
131567971|NCT02263885|473704495|FG000|Overall Study|Alternative Treatment|3|||
131567972|NCT00088465|473704500|FG000|Overall Study|Withdrawal by Subject|290|||
131567973|NCT00088465|473704500|FG000|Overall Study|Adverse Event|77|||
131567974|NCT00088465|473704500|FG000|Overall Study|Lost to Follow-up|57|||
131567975|NCT00088465|473704500|FG000|Overall Study|Physician Decision|45|||
131567976|NCT00088465|473704500|FG000|Overall Study|Sponsor Decision|37|||
131567977|NCT00088465|473704500|FG000|Overall Study|Lack of Efficacy|27|||
131567978|NCT00088465|473704500|FG000|Overall Study|Protocol Violation|17|||
131567979|NCT00088465|473704500|FG000|Overall Study|Death|11|||
131567980|NCT04454567|473704502|FG000|Overall Study|Study Terminated by Sponsor|1|||
131567981|NCT04454567|473704503|FG001|Overall Study|Study Terminated by Sponsor|1|||
131567982|NCT01175707|473704506|FG000|Overall Study|Adverse Event|4|||
131567983|NCT01175707|473704507|FG001|Overall Study|Adverse Event|6|||
131567984|NCT03606460|473704510|FG000|Overall Study|Lost to Follow-up|1|||
131567985|NCT03606460|473704511|FG001|Overall Study|Lost to Follow-up|8|||
131567986|NCT04170023|473704512|FG000|LTE Period|Withdrawal by Subject|1|||
131567987|NCT04170023|473704513|FG001|LTE Period|Withdrawal by Subject|0|||
131567988|NCT04170023|473704514|FG002|LTE Period|Withdrawal by Subject|0|||
131567989|NCT04170023|473704512|FG000|LTE Period|Study Termination|11|||
131567990|NCT04170023|473704513|FG001|LTE Period|Study Termination|11|||
131567991|NCT04170023|473704514|FG002|LTE Period|Study Termination|5|||
131567992|NCT00562965|473704515|FG000|Overall Study|Withdrawal by Subject|0|||
131567993|NCT00562965|473704516|FG001|Overall Study|Withdrawal by Subject|1|||
131567994|NCT00562965|473704515|FG000|Overall Study|Death|2|||
131567995|NCT00562965|473704516|FG001|Overall Study|Death|4|||
131567996|NCT00562965|473704515|FG000|Overall Study|Lost to Follow-up|1|||
131567997|NCT00562965|473704516|FG001|Overall Study|Lost to Follow-up|0|||
131783460|NCT01488071|474489930|FG001|Overall Study|Adverse Event|23|||
131567998|NCT00562965|473704515|FG000|Overall Study|Other|0|||
131567999|NCT00562965|473704516|FG001|Overall Study|Other|1|||
131568000|NCT01124617|473704523|FG000|Overall Study|Adverse Event|5|||
131568001|NCT01124617|473704524|FG001|Overall Study|Adverse Event|2|||
131568002|NCT01124617|473704523|FG000|Overall Study|Lack of Efficacy|2|||
131783461|NCT01488071|474489929|FG000|Overall Study|Lack of Efficacy|11|||
131568003|NCT01124617|473704524|FG001|Overall Study|Lack of Efficacy|1|||
131568004|NCT01124617|473704523|FG000|Overall Study|Protocol Violation|1|||
131568005|NCT01124617|473704524|FG001|Overall Study|Protocol Violation|1|||
131568006|NCT01124617|473704523|FG000|Overall Study|Withdrawal by Subject|9|||
131568007|NCT01124617|473704524|FG001|Overall Study|Withdrawal by Subject|1|||
131783462|NCT01488071|474489930|FG001|Overall Study|Lack of Efficacy|17|||
131783463|NCT01488071|474489929|FG000|Overall Study|Non-compliance with study drug|2|||
131783464|NCT01488071|474489930|FG001|Overall Study|Non-compliance with study drug|0|||
131783465|NCT01488071|474489929|FG000|Overall Study|Protocol Violation|5|||
131783466|NCT01488071|474489930|FG001|Overall Study|Protocol Violation|7|||
131783467|NCT01488071|474489929|FG000|Overall Study|Withdrawal of Consent|14|||
131783468|NCT01488071|474489930|FG001|Overall Study|Withdrawal of Consent|12|||
131783469|NCT01488071|474489929|FG000|Overall Study|Lost to Follow-up|1|||
131783470|NCT01488071|474489930|FG001|Overall Study|Lost to Follow-up|0|||
131783471|NCT01488071|474489929|FG000|Overall Study|Administrative or Other Reason(s)|5|||
131783472|NCT01488071|474489930|FG001|Overall Study|Administrative or Other Reason(s)|4|||
131783473|NCT02139306|474489931|FG000|Overall Study|Withdrawal by Subject|4|||
131783474|NCT02139306|474489932|FG001|Overall Study|Withdrawal by Subject|6|||
131783475|NCT02139306|474489931|FG000|Overall Study|Adverse Event|3|||
131783476|NCT02139306|474489932|FG001|Overall Study|Adverse Event|4|||
131783477|NCT02139306|474489931|FG000|Overall Study|Physician Decision|0|||
131783478|NCT02139306|474489932|FG001|Overall Study|Physician Decision|1|||
131783479|NCT02139306|474489931|FG000|Overall Study|Other Unspecified|2|||
131783480|NCT02139306|474489932|FG001|Overall Study|Other Unspecified|3|||
131783481|NCT02139306|474489931|FG000|Overall Study|Protocol Violation|4|||
131783482|NCT02139306|474489932|FG001|Overall Study|Protocol Violation|0|||
131783483|NCT04449354|474489933|FG000|Overall Study|Withdrawal by Subject|1|||
131783484|NCT05789420|474489934|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
131783485|NCT05789420|474489934|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
131783486|NCT02587325|474489935|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
131783487|NCT02587325|474489936|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
131783488|NCT02587325|474489937|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
131783489|NCT02587325|474489938|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
131783490|NCT02587325|474489939|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
131783491|NCT02587325|474489935|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131783492|NCT02587325|474489936|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131783493|NCT02587325|474489937|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131783494|NCT02587325|474489938|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
131783495|NCT02587325|474489939|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131783496|NCT02587325|474489935|FG000|32-Week Optional Extension Part|Adverse Event|0|||
131783497|NCT02587325|474489936|FG001|32-Week Optional Extension Part|Adverse Event|0|||
131783498|NCT02587325|474489937|FG002|32-Week Optional Extension Part|Adverse Event|1|||
131783499|NCT02587325|474489938|FG003|32-Week Optional Extension Part|Adverse Event|0|||
131783500|NCT02587325|474489939|FG004|32-Week Optional Extension Part|Adverse Event|0|||
131783501|NCT02587325|474489935|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
131783502|NCT02587325|474489936|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
131783503|NCT02587325|474489937|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
131783504|NCT02587325|474489938|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
131783505|NCT02587325|474489939|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
131783506|NCT01220128|474489940|FG000|Overall Study|Progressive disease|0|||
131783507|NCT01220128|474489941|FG001|Overall Study|Progressive disease|0|||
131783508|NCT01220128|474489942|FG002|Overall Study|Progressive disease|2|||
131783509|NCT01220128|474489943|FG003|Overall Study|Progressive disease|0|||
131783510|NCT01220128|474489944|FG004|Overall Study|Progressive disease|0|||
131783511|NCT01220128|474489945|FG005|Overall Study|Progressive disease|0|||
131783512|NCT01220128|474489946|FG006|Overall Study|Progressive disease|0|||
131783513|NCT01220128|474489940|FG000|Overall Study|Sponsor study termination|0|||
131783514|NCT01220128|474489941|FG001|Overall Study|Sponsor study termination|1|||
131783515|NCT01220128|474489942|FG002|Overall Study|Sponsor study termination|0|||
131783516|NCT01220128|474489943|FG003|Overall Study|Sponsor study termination|0|||
131783517|NCT01220128|474489944|FG004|Overall Study|Sponsor study termination|0|||
131783518|NCT01220128|474489945|FG005|Overall Study|Sponsor study termination|0|||
131783519|NCT01220128|474489946|FG006|Overall Study|Sponsor study termination|1|||
131783520|NCT01220128|474489940|FG000|Overall Study|Adverse event, serious fatal|2|||
131783521|NCT01220128|474489941|FG001|Overall Study|Adverse event, serious fatal|0|||
131783522|NCT01220128|474489942|FG002|Overall Study|Adverse event, serious fatal|0|||
131783523|NCT01220128|474489943|FG003|Overall Study|Adverse event, serious fatal|0|||
131783524|NCT01220128|474489944|FG004|Overall Study|Adverse event, serious fatal|0|||
131783525|NCT01220128|474489945|FG005|Overall Study|Adverse event, serious fatal|0|||
131783526|NCT01220128|474489946|FG006|Overall Study|Adverse event, serious fatal|1|||
131783527|NCT01220128|474489940|FG000|Overall Study|Adverse event, non-fatal|1|||
131783528|NCT01220128|474489941|FG001|Overall Study|Adverse event, non-fatal|0|||
131783529|NCT01220128|474489942|FG002|Overall Study|Adverse event, non-fatal|0|||
131783530|NCT01220128|474489943|FG003|Overall Study|Adverse event, non-fatal|0|||
131783531|NCT01220128|474489944|FG004|Overall Study|Adverse event, non-fatal|0|||
131783532|NCT01220128|474489945|FG005|Overall Study|Adverse event, non-fatal|0|||
131783533|NCT01220128|474489946|FG006|Overall Study|Adverse event, non-fatal|3|||
131783534|NCT01220128|474489940|FG000|Overall Study|Other|0|||
131783535|NCT01220128|474489941|FG001|Overall Study|Other|0|||
131783536|NCT01220128|474489942|FG002|Overall Study|Other|1|||
131783537|NCT01220128|474489943|FG003|Overall Study|Other|0|||
131783538|NCT01220128|474489944|FG004|Overall Study|Other|0|||
131783539|NCT01220128|474489945|FG005|Overall Study|Other|0|||
131783540|NCT01220128|474489946|FG006|Overall Study|Other|0|||
131783541|NCT01220128|474489940|FG000|Overall Study|Consent withdrawn by subject|1|||
131783542|NCT01220128|474489941|FG001|Overall Study|Consent withdrawn by subject|0|||
131783543|NCT01220128|474489942|FG002|Overall Study|Consent withdrawn by subject|0|||
131783544|NCT01220128|474489943|FG003|Overall Study|Consent withdrawn by subject|0|||
131783545|NCT01220128|474489944|FG004|Overall Study|Consent withdrawn by subject|0|||
131783546|NCT01220128|474489945|FG005|Overall Study|Consent withdrawn by subject|0|||
131783547|NCT01220128|474489946|FG006|Overall Study|Consent withdrawn by subject|0|||
131783548|NCT02913261|474489947|FG000|Overall Study|Technical problems|0|||
131783549|NCT02913261|474489948|FG001|Overall Study|Technical problems|1|||
131783550|NCT02913261|474489947|FG000|Overall Study|Lack of Efficacy|32|||
131783551|NCT02913261|474489948|FG001|Overall Study|Lack of Efficacy|69|||
131783552|NCT02913261|474489947|FG000|Overall Study|Adverse Event|27|||
131783553|NCT02913261|474489948|FG001|Overall Study|Adverse Event|5|||
131783554|NCT02913261|474489947|FG000|Overall Study|Death|25|||
131783555|NCT02913261|474489948|FG001|Overall Study|Death|22|||
131783556|NCT02913261|474489947|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
131568008|NCT01124617|473704523|FG000|Overall Study|Other|2|||
131783557|NCT02913261|474489948|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
131783558|NCT02913261|474489947|FG000|Overall Study|Disease relapse|8|||
131783559|NCT02913261|474489948|FG001|Overall Study|Disease relapse|13|||
131783560|NCT02913261|474489947|FG000|Overall Study|Physician Decision|8|||
131783561|NCT02913261|474489948|FG001|Overall Study|Physician Decision|9|||
131783562|NCT02913261|474489947|FG000|Overall Study|Subject/guardian decision|4|||
131783563|NCT02913261|474489948|FG001|Overall Study|Subject/guardian decision|6|||
131783564|NCT02913261|474489947|FG000|Overall Study|Graft loss|2|||
131783565|NCT02913261|474489948|FG001|Overall Study|Graft loss|0|||
131783566|NCT00000135|474489971|FG000|Overall Study|Death|27|||
131568009|NCT01124617|473704524|FG001|Overall Study|Other|1|||
131568010|NCT00945477|473704525|FG000|Overall Study|Adverse Event|3|||
131568011|NCT00945477|473704525|FG000|Overall Study|Lack of Efficacy|2|||
131568012|NCT00945477|473704525|FG000|Overall Study|Withdrawal by Subject|1|||
131568013|NCT02303574|473704529|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131568014|NCT02303574|473704530|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131568015|NCT02303574|473704531|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
131568016|NCT02303574|473704532|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131568017|NCT02303574|473704533|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131568018|NCT02303574|473704534|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131568019|NCT02303574|473704535|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131783567|NCT00000135|474489972|FG001|Overall Study|Death|14|||
131783568|NCT02340078|474489973|FG000|Overall Study|Protocol Violation|1|||
131783569|NCT01311505|474489974|FG000|First Intervention Period|Protocol Violation|0|||
131568020|NCT02303574|473704536|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131568021|NCT02303574|473704537|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131783570|NCT01311505|474489975|FG001|First Intervention Period|Protocol Violation|1|||
131783571|NCT00567996|474489976|FG000|Overall Study|Adverse Event|18|||
131783572|NCT00567996|474489977|FG001|Overall Study|Adverse Event|16|||
131783573|NCT00567996|474489978|FG002|Overall Study|Adverse Event|13|||
131783574|NCT00567996|474489976|FG000|Overall Study|Protocol Deviation|9|||
131783575|NCT00567996|474489977|FG001|Overall Study|Protocol Deviation|11|||
131783576|NCT00567996|474489978|FG002|Overall Study|Protocol Deviation|13|||
131568022|NCT02303574|473704538|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131783577|NCT00567996|474489976|FG000|Overall Study|Withdrawal by Subject|8|||
131783578|NCT00567996|474489977|FG001|Overall Study|Withdrawal by Subject|12|||
131783579|NCT00567996|474489978|FG002|Overall Study|Withdrawal by Subject|22|||
131783580|NCT00567996|474489976|FG000|Overall Study|Abnormal Lab value(s)|2|||
131437594|NCT03100149|473226906|FG000|Overall Study|Participant Moved out of Country|0|||
131437595|NCT03100149|473226907|FG001|Overall Study|Participant Moved out of Country|0|||
131437596|NCT03100149|473226908|FG002|Overall Study|Participant Moved out of Country|1|||
131437597|NCT03100149|473226906|FG000|Overall Study|Withdrawal by Subject|0|||
131437598|NCT03100149|473226907|FG001|Overall Study|Withdrawal by Subject|3|||
131437599|NCT03100149|473226908|FG002|Overall Study|Withdrawal by Subject|1|||
131437600|NCT00644423|473228086|FG000|Overall Study|Lost to Follow-up|1|||
131437601|NCT00644423|473228087|FG001|Overall Study|Lost to Follow-up|1|||
131437602|NCT01519323|473228092|FG000|Overall Study|Death|3|||
131437603|NCT01519323|473228093|FG001|Overall Study|Death|2|||
131437604|NCT01519323|473228092|FG000|Overall Study|Study terminated by sponsor|0|||
131437605|NCT01519323|473228093|FG001|Overall Study|Study terminated by sponsor|1|||
131437606|NCT00383552|473228104|FG000|Overall Study|Adverse Event|7|||
131437607|NCT00383552|473228105|FG001|Overall Study|Adverse Event|6|||
131437608|NCT00383552|473228106|FG002|Overall Study|Adverse Event|9|||
131437609|NCT00383552|473228107|FG003|Overall Study|Adverse Event|6|||
131437610|NCT00383552|473228104|FG000|Overall Study|Lack of Efficacy|4|||
131437611|NCT00383552|473228105|FG001|Overall Study|Lack of Efficacy|13|||
131437612|NCT00383552|473228106|FG002|Overall Study|Lack of Efficacy|29|||
131437613|NCT00383552|473228107|FG003|Overall Study|Lack of Efficacy|42|||
131437614|NCT00383552|473228104|FG000|Overall Study|Lost to Follow-up|0|||
131437615|NCT00383552|473228105|FG001|Overall Study|Lost to Follow-up|1|||
131437616|NCT00383552|473228106|FG002|Overall Study|Lost to Follow-up|5|||
131437617|NCT00383552|473228107|FG003|Overall Study|Lost to Follow-up|1|||
131437618|NCT00383552|473228104|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
131437619|NCT00383552|473228105|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
131437620|NCT00383552|473228106|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
131437621|NCT00383552|473228107|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
131437622|NCT00383552|473228104|FG000|Overall Study|Did not wish to continue (related)|1|||
131437623|NCT00383552|473228105|FG001|Overall Study|Did not wish to continue (related)|0|||
131437624|NCT00383552|473228106|FG002|Overall Study|Did not wish to continue (related)|2|||
131783581|NCT00567996|474489977|FG001|Overall Study|Abnormal Lab value(s)|1|||
131783582|NCT00567996|474489978|FG002|Overall Study|Abnormal Lab value(s)|2|||
131783583|NCT00567996|474489976|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131783584|NCT00567996|474489977|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131696999|NCT02728830|474174034|FG000|Overall Study|Language Barrier|1|||
131697000|NCT01081795|474174035|FG000|Overall Study|Adverse Event|18|||
131697001|NCT01081795|474174036|FG001|Overall Study|Adverse Event|23|||
131697002|NCT01081795|474174037|FG002|Overall Study|Adverse Event|6|||
131697003|NCT01081795|474174035|FG000|Overall Study|Lack of Efficacy|7|||
131697004|NCT01081795|474174036|FG001|Overall Study|Lack of Efficacy|5|||
131568023|NCT02303574|473704529|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568024|NCT02303574|473704530|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568025|NCT02303574|473704531|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568026|NCT02303574|473704532|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568027|NCT02303574|473704533|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568028|NCT02303574|473704534|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568029|NCT02303574|473704535|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568030|NCT02303574|473704536|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
131568031|NCT02303574|473704537|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568032|NCT02303574|473704538|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131568033|NCT00859014|473704539|FG000|Overall Study|Death|4|||
131568034|NCT00859014|473704539|FG000|Overall Study|Lost to Follow-up|1|||
131568035|NCT00783718|473704540|FG000|Induction Phase|Adverse Event|4|||
131568036|NCT00783718|473704541|FG001|Induction Phase|Adverse Event|0|||
131568037|NCT00783718|473704542|FG002|Induction Phase|Adverse Event|7|||
131568038|NCT00783718|473704543|FG003|Induction Phase|Adverse Event|0|||
131568039|NCT00783718|473704544|FG004|Induction Phase|Adverse Event|0|||
131568040|NCT00783718|473704545|FG005|Induction Phase|Adverse Event|0|||
131568041|NCT00783718|473704546|FG006|Induction Phase|Adverse Event|0|||
131568042|NCT00783718|473704540|FG000|Induction Phase|Protocol Violation|1|||
131568043|NCT00783718|473704541|FG001|Induction Phase|Protocol Violation|1|||
131568044|NCT00783718|473704542|FG002|Induction Phase|Protocol Violation|6|||
131568045|NCT00783718|473704543|FG003|Induction Phase|Protocol Violation|0|||
131568046|NCT00783718|473704544|FG004|Induction Phase|Protocol Violation|0|||
131568047|NCT00783718|473704545|FG005|Induction Phase|Protocol Violation|0|||
131568048|NCT00783718|473704546|FG006|Induction Phase|Protocol Violation|0|||
131568049|NCT00783718|473704540|FG000|Induction Phase|Lack of Efficacy|5|||
131568050|NCT00783718|473704541|FG001|Induction Phase|Lack of Efficacy|2|||
131568051|NCT00783718|473704542|FG002|Induction Phase|Lack of Efficacy|14|||
131568052|NCT00783718|473704543|FG003|Induction Phase|Lack of Efficacy|0|||
131568053|NCT00783718|473704544|FG004|Induction Phase|Lack of Efficacy|0|||
131568054|NCT00783718|473704545|FG005|Induction Phase|Lack of Efficacy|0|||
131568055|NCT00783718|473704546|FG006|Induction Phase|Lack of Efficacy|0|||
131568056|NCT00783718|473704540|FG000|Induction Phase|Withdrawal by Subject|3|||
131568057|NCT00783718|473704541|FG001|Induction Phase|Withdrawal by Subject|4|||
131568058|NCT00783718|473704542|FG002|Induction Phase|Withdrawal by Subject|8|||
131568059|NCT00783718|473704543|FG003|Induction Phase|Withdrawal by Subject|0|||
131568060|NCT00783718|473704544|FG004|Induction Phase|Withdrawal by Subject|0|||
131568061|NCT00783718|473704545|FG005|Induction Phase|Withdrawal by Subject|0|||
131568062|NCT00783718|473704546|FG006|Induction Phase|Withdrawal by Subject|0|||
131568063|NCT00783718|473704540|FG000|Induction Phase|Lost to Follow-up|1|||
131568064|NCT00783718|473704541|FG001|Induction Phase|Lost to Follow-up|0|||
131568065|NCT00783718|473704542|FG002|Induction Phase|Lost to Follow-up|1|||
131568066|NCT00783718|473704543|FG003|Induction Phase|Lost to Follow-up|0|||
131568067|NCT00783718|473704544|FG004|Induction Phase|Lost to Follow-up|0|||
131568068|NCT00783718|473704545|FG005|Induction Phase|Lost to Follow-up|0|||
131568069|NCT00783718|473704546|FG006|Induction Phase|Lost to Follow-up|0|||
131568070|NCT00783718|473704540|FG000|Maintenance Phase|Adverse Event|12|||
131568071|NCT00783718|473704541|FG001|Maintenance Phase|Adverse Event|0|||
131568072|NCT00783718|473704542|FG002|Maintenance Phase|Adverse Event|0|||
131568073|NCT00783718|473704543|FG003|Maintenance Phase|Adverse Event|15|||
131568074|NCT00783718|473704544|FG004|Maintenance Phase|Adverse Event|7|||
131568075|NCT00783718|473704545|FG005|Maintenance Phase|Adverse Event|6|||
131568076|NCT00783718|473704546|FG006|Maintenance Phase|Adverse Event|16|||
131568077|NCT00783718|473704540|FG000|Maintenance Phase|Protocol Violation|1|||
131568078|NCT00783718|473704541|FG001|Maintenance Phase|Protocol Violation|0|||
131568079|NCT00783718|473704542|FG002|Maintenance Phase|Protocol Violation|0|||
131568080|NCT00783718|473704543|FG003|Maintenance Phase|Protocol Violation|0|||
131568081|NCT00783718|473704544|FG004|Maintenance Phase|Protocol Violation|0|||
131568082|NCT00783718|473704545|FG005|Maintenance Phase|Protocol Violation|0|||
131568083|NCT00783718|473704546|FG006|Maintenance Phase|Protocol Violation|2|||
131568084|NCT00783718|473704540|FG000|Maintenance Phase|Lack of Efficacy|83|||
131568085|NCT00783718|473704541|FG001|Maintenance Phase|Lack of Efficacy|0|||
131568086|NCT00783718|473704542|FG002|Maintenance Phase|Lack of Efficacy|0|||
131568087|NCT00783718|473704543|FG003|Maintenance Phase|Lack of Efficacy|61|||
131697005|NCT01081795|474174037|FG002|Overall Study|Lack of Efficacy|19|||
131697006|NCT01081795|474174035|FG000|Overall Study|Subject's schedule|1|||
131568088|NCT00783718|473704544|FG004|Maintenance Phase|Lack of Efficacy|31|||
131568089|NCT00783718|473704545|FG005|Maintenance Phase|Lack of Efficacy|33|||
131568090|NCT00783718|473704546|FG006|Maintenance Phase|Lack of Efficacy|155|||
131568091|NCT00783718|473704540|FG000|Maintenance Phase|Withdrawal by Subject|6|||
131568092|NCT00783718|473704541|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131568093|NCT00783718|473704542|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131568094|NCT00783718|473704543|FG003|Maintenance Phase|Withdrawal by Subject|2|||
131568095|NCT00783718|473704544|FG004|Maintenance Phase|Withdrawal by Subject|5|||
131697007|NCT01081795|474174036|FG001|Overall Study|Subject's schedule|1|||
131568096|NCT00783718|473704545|FG005|Maintenance Phase|Withdrawal by Subject|2|||
131568097|NCT00783718|473704546|FG006|Maintenance Phase|Withdrawal by Subject|20|||
131568098|NCT00783718|473704540|FG000|Maintenance Phase|Lost to Follow-up|3|||
131568099|NCT00783718|473704541|FG001|Maintenance Phase|Lost to Follow-up|0|||
131568100|NCT00783718|473704542|FG002|Maintenance Phase|Lost to Follow-up|0|||
131568101|NCT00783718|473704543|FG003|Maintenance Phase|Lost to Follow-up|0|||
131568102|NCT00783718|473704544|FG004|Maintenance Phase|Lost to Follow-up|2|||
131568103|NCT00783718|473704545|FG005|Maintenance Phase|Lost to Follow-up|0|||
131568104|NCT00783718|473704546|FG006|Maintenance Phase|Lost to Follow-up|2|||
131568105|NCT00578227|473704552|FG000|Overall Study|Lost to Follow-up|0|||
131568106|NCT00578227|473704553|FG001|Overall Study|Lost to Follow-up|1|||
131568107|NCT00578227|473704554|FG002|Overall Study|Lost to Follow-up|1|||
131568108|NCT00578227|473704552|FG000|Overall Study|Withdrawal by Subject|5|||
131568109|NCT00578227|473704553|FG001|Overall Study|Withdrawal by Subject|1|||
131568110|NCT00578227|473704554|FG002|Overall Study|Withdrawal by Subject|3|||
131568111|NCT00577629|473704555|FG000|Treatment Period|Death|1|||
131568112|NCT00577629|473704555|FG000|Long Term Follow-Up|Death|15|||
131568113|NCT00577629|473704555|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
131568114|NCT00577629|473704555|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
131568115|NCT00577629|473704555|FG000|Long Term Follow-Up|Physician Decision|1|||
131568116|NCT01027871|473704556|FG000|Overall Study|Physician Decision|1|||
131568117|NCT01027871|473704557|FG001|Overall Study|Physician Decision|5|||
131568118|NCT01027871|473704558|FG002|Overall Study|Physician Decision|0|||
131568119|NCT01027871|473704556|FG000|Overall Study|Protocol Violation|0|||
131568120|NCT01027871|473704557|FG001|Overall Study|Protocol Violation|2|||
131568121|NCT01027871|473704558|FG002|Overall Study|Protocol Violation|2|||
131568122|NCT01027871|473704556|FG000|Overall Study|Withdrawal by Subject|1|||
131568123|NCT01027871|473704557|FG001|Overall Study|Withdrawal by Subject|2|||
131568124|NCT01027871|473704558|FG002|Overall Study|Withdrawal by Subject|2|||
131568125|NCT01027871|473704556|FG000|Overall Study|Adverse Event|0|||
131568126|NCT01027871|473704557|FG001|Overall Study|Adverse Event|2|||
131568127|NCT01027871|473704558|FG002|Overall Study|Adverse Event|2|||
131568128|NCT01027871|473704556|FG000|Overall Study|Sponsor Decision|0|||
131568129|NCT01027871|473704557|FG001|Overall Study|Sponsor Decision|2|||
131568130|NCT01027871|473704558|FG002|Overall Study|Sponsor Decision|0|||
131568131|NCT01027871|473704556|FG000|Overall Study|Discontinued Prior to Treatment|0|||
131568132|NCT01027871|473704557|FG001|Overall Study|Discontinued Prior to Treatment|0|||
131568133|NCT01027871|473704558|FG002|Overall Study|Discontinued Prior to Treatment|1|||
131568134|NCT01414166|473704559|FG000|Overall Study|Adverse Event|10|||
131568135|NCT01414166|473704560|FG001|Overall Study|Adverse Event|2|||
131568136|NCT01414166|473704559|FG000|Overall Study|Lost to Follow-up|4|||
131568137|NCT01414166|473704560|FG001|Overall Study|Lost to Follow-up|1|||
131568138|NCT01414166|473704559|FG000|Overall Study|Non-compliance with study drug|2|||
131568139|NCT01414166|473704560|FG001|Overall Study|Non-compliance with study drug|0|||
131568140|NCT01414166|473704559|FG000|Overall Study|Physician Decision|2|||
131568141|NCT01414166|473704560|FG001|Overall Study|Physician Decision|0|||
131568142|NCT01414166|473704559|FG000|Overall Study|Protocol Violation|2|||
131568143|NCT01414166|473704560|FG001|Overall Study|Protocol Violation|0|||
131568144|NCT01414166|473704559|FG000|Overall Study|Study terminated by Sponsor|68|||
131568145|NCT01414166|473704560|FG001|Overall Study|Study terminated by Sponsor|75|||
131568146|NCT01414166|473704559|FG000|Overall Study|Withdrawal by Subject|3|||
131568147|NCT01414166|473704560|FG001|Overall Study|Withdrawal by Subject|5|||
131568148|NCT03782727|473704561|FG000|Overall Study|Lost to Follow-up|32|||
131568149|NCT04736056|473704564|FG000|Overall Study|Death|0|||
131568150|NCT04736056|473704565|FG001|Overall Study|Death|0|||
131568151|NCT04736056|473704566|FG002|Overall Study|Death|0|||
131568152|NCT04736056|473704567|FG003|Overall Study|Death|1|||
131568153|NCT04736056|473704564|FG000|Overall Study|Lost to Follow-up|1|||
131568154|NCT04736056|473704565|FG001|Overall Study|Lost to Follow-up|0|||
131568155|NCT04736056|473704566|FG002|Overall Study|Lost to Follow-up|1|||
131568156|NCT04736056|473704567|FG003|Overall Study|Lost to Follow-up|1|||
131568157|NCT04736056|473704564|FG000|Overall Study|Withdrawal by Subject|2|||
131568158|NCT04736056|473704565|FG001|Overall Study|Withdrawal by Subject|0|||
131568159|NCT04736056|473704566|FG002|Overall Study|Withdrawal by Subject|0|||
131568160|NCT04736056|473704567|FG003|Overall Study|Withdrawal by Subject|0|||
131568161|NCT04736056|473704564|FG000|Overall Study|Physician Decision|1|||
131568162|NCT04736056|473704565|FG001|Overall Study|Physician Decision|0|||
131568163|NCT04736056|473704566|FG002|Overall Study|Physician Decision|1|||
131568164|NCT04736056|473704567|FG003|Overall Study|Physician Decision|0|||
131568165|NCT04011033|473704574|FG000|Overall Study|Physician Decision|2|||
131568166|NCT04011033|473704575|FG001|Overall Study|Physician Decision|3|||
131568167|NCT04011033|473704574|FG000|Overall Study|Withdrawal by Subject|1|||
131568168|NCT04011033|473704575|FG001|Overall Study|Withdrawal by Subject|0|||
131568169|NCT01823341|473704576|FG000|Overall Study|Failed run-in|7|||
131697008|NCT01081795|474174037|FG002|Overall Study|Subject's schedule|2|||
131697009|NCT01081795|474174035|FG000|Overall Study|Revocation of informed consent|2|||
131697010|NCT01081795|474174036|FG001|Overall Study|Revocation of informed consent|0|||
131568170|NCT01823341|473704576|FG000|Overall Study|Withdrawal by Subject|7|||
131568171|NCT01823341|473704576|FG000|Overall Study|Adverse Event|1|||
131568172|NCT04873817|473704577|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
131568173|NCT04873817|473704577|FG000|Overall Study|Lost to Follow-up|4|||
131568174|NCT04873817|473704577|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
131568175|NCT04873817|473704577|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
131568176|NCT04873817|473704577|FG000|Overall Study|Other Reasons|3|||
131568177|NCT00924560|473704578|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
131568178|NCT00924560|473704579|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
131568179|NCT00924560|473704580|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
131568180|NCT00924560|473704578|FG000|Overall Study|Non Compliance with the Protocol|20|||
131568181|NCT00924560|473704579|FG001|Overall Study|Non Compliance with the Protocol|15|||
131568182|NCT00924560|473704580|FG002|Overall Study|Non Compliance with the Protocol|4|||
131568183|NCT00924560|473704578|FG000|Overall Study|Physician Decision|2|||
131568184|NCT00924560|473704579|FG001|Overall Study|Physician Decision|3|||
131568185|NCT00924560|473704580|FG002|Overall Study|Physician Decision|4|||
131568186|NCT00924560|473704578|FG000|Overall Study|Withdrawal by Subject|50|||
131568187|NCT00924560|473704579|FG001|Overall Study|Withdrawal by Subject|44|||
131568188|NCT00924560|473704580|FG002|Overall Study|Withdrawal by Subject|18|||
131568189|NCT00924560|473704578|FG000|Overall Study|Adverse Event|39|||
131568190|NCT00924560|473704579|FG001|Overall Study|Adverse Event|33|||
131568191|NCT00924560|473704580|FG002|Overall Study|Adverse Event|0|||
131568192|NCT00924560|473704578|FG000|Overall Study|Pregnancy|5|||
131568193|NCT00924560|473704579|FG001|Overall Study|Pregnancy|7|||
131568194|NCT00924560|473704580|FG002|Overall Study|Pregnancy|1|||
131568195|NCT00924560|473704578|FG000|Overall Study|Lost to Follow-up|78|||
131568196|NCT00924560|473704579|FG001|Overall Study|Lost to Follow-up|94|||
131568197|NCT00924560|473704580|FG002|Overall Study|Lost to Follow-up|45|||
131568198|NCT00924560|473704578|FG000|Overall Study|Miscellaneous Reasons|13|||
131568199|NCT00924560|473704579|FG001|Overall Study|Miscellaneous Reasons|10|||
131568200|NCT00924560|473704580|FG002|Overall Study|Miscellaneous Reasons|10|||
131568201|NCT02696226|473704584|FG000|Overall Study|Study terminated - lack of enrollment|1|||
131568202|NCT02696226|473704585|FG001|Overall Study|Study terminated - lack of enrollment|0|||
131568203|NCT02696226|473704586|FG002|Overall Study|Study terminated - lack of enrollment|2|||
131568204|NCT02696226|473704587|FG003|Overall Study|Study terminated - lack of enrollment|0|||
131568205|NCT02909101|473704595|FG000|Overall Study|Lost to Follow-up|1|||
131568206|NCT02909101|473704596|FG001|Overall Study|Lost to Follow-up|1|||
131568207|NCT01290094|473704597|FG000|Overall Study|Withdrawal by Subject|1|||
131568208|NCT01290094|473704597|FG000|Overall Study|Lost to Follow-up|5|||
131568209|NCT04949399|473704600|FG000|Overall Study|Lost to Follow-up|11|||
131568210|NCT04949399|473704601|FG001|Overall Study|Lost to Follow-up|6|||
131568211|NCT04949399|473704600|FG000|Overall Study|Withdrawal by Subject|2|||
131568212|NCT04949399|473704601|FG001|Overall Study|Withdrawal by Subject|3|||
131568213|NCT01939158|473707014|FG000|Overall Study|Adverse Event|1|||
131568214|NCT01939158|473707015|FG001|Overall Study|Adverse Event|0|||
131568215|NCT01939158|473707016|FG002|Overall Study|Adverse Event|0|||
131568216|NCT01939158|473707017|FG003|Overall Study|Adverse Event|0|||
131697011|NCT01081795|474174037|FG002|Overall Study|Revocation of informed consent|0|||
131697012|NCT01081795|474174035|FG000|Overall Study|Ineligible for participation|1|||
131568217|NCT01939158|473707014|FG000|Overall Study|Withdrawal by Subject|22|||
131697013|NCT01081795|474174036|FG001|Overall Study|Ineligible for participation|0|||
131697014|NCT01081795|474174037|FG002|Overall Study|Ineligible for participation|0|||
131697015|NCT01081795|474174035|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
131697016|NCT01081795|474174036|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
131697017|NCT01081795|474174037|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
131697018|NCT01081795|474174035|FG000|Overall Study|Using drug with restricted days of use|2|||
131697019|NCT01081795|474174036|FG001|Overall Study|Using drug with restricted days of use|3|||
131697020|NCT01081795|474174037|FG002|Overall Study|Using drug with restricted days of use|2|||
131697021|NCT01081795|474174035|FG000|Overall Study|Other|1|||
131697022|NCT01081795|474174036|FG001|Overall Study|Other|2|||
131697023|NCT01081795|474174037|FG002|Overall Study|Other|0|||
131697024|NCT01142726|474174038|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
131568218|NCT01939158|473707015|FG001|Overall Study|Withdrawal by Subject|25|||
131568219|NCT01939158|473707016|FG002|Overall Study|Withdrawal by Subject|15|||
131568220|NCT01939158|473707017|FG003|Overall Study|Withdrawal by Subject|17|||
131568221|NCT01939158|473707014|FG000|Overall Study|Migrated/moved from study area|5|||
131568222|NCT01939158|473707015|FG001|Overall Study|Migrated/moved from study area|7|||
131568223|NCT01939158|473707016|FG002|Overall Study|Migrated/moved from study area|3|||
131568224|NCT01939158|473707017|FG003|Overall Study|Migrated/moved from study area|6|||
131568225|NCT01939158|473707014|FG000|Overall Study|Lost to Follow-up|18|||
131568226|NCT01939158|473707015|FG001|Overall Study|Lost to Follow-up|17|||
131568227|NCT01939158|473707016|FG002|Overall Study|Lost to Follow-up|17|||
131568228|NCT01939158|473707017|FG003|Overall Study|Lost to Follow-up|17|||
131568229|NCT01939158|473707014|FG000|Overall Study|Death|0|||
131568230|NCT01939158|473707015|FG001|Overall Study|Death|0|||
131568231|NCT01939158|473707016|FG002|Overall Study|Death|1|||
131568232|NCT01939158|473707017|FG003|Overall Study|Death|1|||
131568233|NCT01939158|473707014|FG000|Overall Study|No longer meets eligibility criteria|0|||
131568234|NCT01939158|473707015|FG001|Overall Study|No longer meets eligibility criteria|0|||
131568235|NCT01939158|473707016|FG002|Overall Study|No longer meets eligibility criteria|1|||
131568236|NCT01939158|473707017|FG003|Overall Study|No longer meets eligibility criteria|0|||
131568237|NCT01939158|473707014|FG000|Overall Study|Other|1|||
131568238|NCT01939158|473707015|FG001|Overall Study|Other|3|||
131568239|NCT01939158|473707016|FG002|Overall Study|Other|4|||
131568240|NCT01939158|473707017|FG003|Overall Study|Other|3|||
131568241|NCT02373813|473707021|FG000|Run-In Period|Other, Not Specified|5|||
131568242|NCT02373813|473707022|FG001|Run-In Period|Other, Not Specified|0|||
131568243|NCT02373813|473707023|FG002|Run-In Period|Other, Not Specified|0|||
131568244|NCT02373813|473707024|FG003|Run-In Period|Other, Not Specified|0|||
131568245|NCT02373813|473707021|FG000|Run-In Period|Withdrawal by Subject|16|||
131568246|NCT02373813|473707022|FG001|Run-In Period|Withdrawal by Subject|0|||
131568247|NCT02373813|473707023|FG002|Run-In Period|Withdrawal by Subject|0|||
131568248|NCT02373813|473707024|FG003|Run-In Period|Withdrawal by Subject|0|||
131568249|NCT02373813|473707021|FG000|Run-In Period|Decision by Sponsor|11|||
131568250|NCT02373813|473707022|FG001|Run-In Period|Decision by Sponsor|0|||
131568251|NCT02373813|473707023|FG002|Run-In Period|Decision by Sponsor|0|||
131568252|NCT02373813|473707024|FG003|Run-In Period|Decision by Sponsor|0|||
131568253|NCT02373813|473707021|FG000|Run-In Period|Protocol Violation|75|||
131568254|NCT02373813|473707022|FG001|Run-In Period|Protocol Violation|0|||
131568255|NCT02373813|473707023|FG002|Run-In Period|Protocol Violation|0|||
131568256|NCT02373813|473707024|FG003|Run-In Period|Protocol Violation|0|||
131568257|NCT02373813|473707021|FG000|Run-In Period|Lost to Follow-up|2|||
131568258|NCT02373813|473707022|FG001|Run-In Period|Lost to Follow-up|0|||
131568259|NCT02373813|473707023|FG002|Run-In Period|Lost to Follow-up|0|||
131568260|NCT02373813|473707024|FG003|Run-In Period|Lost to Follow-up|0|||
131568261|NCT02373813|473707021|FG000|Run-In Period|Adverse Event|3|||
131568262|NCT02373813|473707022|FG001|Run-In Period|Adverse Event|0|||
131568263|NCT02373813|473707023|FG002|Run-In Period|Adverse Event|0|||
131568264|NCT02373813|473707024|FG003|Run-In Period|Adverse Event|0|||
131568265|NCT02373813|473707021|FG000|Run-In Period|Noncompliance|1|||
131568266|NCT02373813|473707022|FG001|Run-In Period|Noncompliance|0|||
131568267|NCT02373813|473707023|FG002|Run-In Period|Noncompliance|0|||
131568268|NCT02373813|473707024|FG003|Run-In Period|Noncompliance|0|||
131437625|NCT00383552|473228107|FG003|Overall Study|Did not wish to continue (related)|3|||
131437626|NCT00383552|473228104|FG000|Overall Study|Noncompliance with the protocol|11|||
131437627|NCT00383552|473228105|FG001|Overall Study|Noncompliance with the protocol|6|||
131437628|NCT00383552|473228106|FG002|Overall Study|Noncompliance with the protocol|8|||
131437629|NCT00383552|473228107|FG003|Overall Study|Noncompliance with the protocol|10|||
131437630|NCT00383552|473228104|FG000|Overall Study|Did not meet protocol eligibility|8|||
131437631|NCT00383552|473228105|FG001|Overall Study|Did not meet protocol eligibility|6|||
131437632|NCT00383552|473228106|FG002|Overall Study|Did not meet protocol eligibility|2|||
131437633|NCT00383552|473228107|FG003|Overall Study|Did not meet protocol eligibility|3|||
131437634|NCT00383552|473228104|FG000|Overall Study|Administrative|1|||
131568269|NCT02373813|473707021|FG000|Run-In Period|Ineligibility Determined|3|||
131568270|NCT02373813|473707022|FG001|Run-In Period|Ineligibility Determined|0|||
131568271|NCT02373813|473707023|FG002|Run-In Period|Ineligibility Determined|0|||
131568272|NCT02373813|473707024|FG003|Run-In Period|Ineligibility Determined|0|||
131568273|NCT02373813|473707021|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
131568274|NCT02373813|473707022|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
131568275|NCT02373813|473707023|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
131568276|NCT02373813|473707024|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
131437635|NCT00383552|473228105|FG001|Overall Study|Administrative|0|||
131568277|NCT02373813|473707021|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131568278|NCT02373813|473707022|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
131568279|NCT02373813|473707023|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
131568280|NCT02373813|473707024|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
131697025|NCT01142726|474174039|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
131697026|NCT01142726|474174040|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
131437636|NCT00383552|473228106|FG002|Overall Study|Administrative|1|||
131568281|NCT02373813|473707021|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131697027|NCT01142726|474174038|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
131568282|NCT02373813|473707022|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
131568283|NCT02373813|473707023|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
131568284|NCT02373813|473707024|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
131568285|NCT02373813|473707021|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131568286|NCT02373813|473707022|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
131568287|NCT02373813|473707023|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
131568288|NCT02373813|473707024|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
131568289|NCT02703532|473707030|FG000|Overall Study|Withdrawal by Subject|0|||
131568290|NCT02703532|473707031|FG001|Overall Study|Withdrawal by Subject|1|||
131568291|NCT02703532|473707032|FG002|Overall Study|Withdrawal by Subject|0|||
131568292|NCT02703532|473707033|FG003|Overall Study|Withdrawal by Subject|1|||
131568293|NCT02703532|473707030|FG000|Overall Study|Lost to Follow-up|2|||
131568294|NCT02703532|473707031|FG001|Overall Study|Lost to Follow-up|0|||
131568295|NCT02703532|473707032|FG002|Overall Study|Lost to Follow-up|2|||
131568296|NCT02703532|473707033|FG003|Overall Study|Lost to Follow-up|0|||
131568297|NCT03738241|473707039|FG000|Overall Study|Withdrawal by Subject|0|||
131568298|NCT03738241|473707040|FG001|Overall Study|Withdrawal by Subject|0|||
131568299|NCT03738241|473707041|FG002|Overall Study|Withdrawal by Subject|0|||
131568300|NCT03738241|473707042|FG003|Overall Study|Withdrawal by Subject|0|||
131568301|NCT03738241|473707043|FG004|Overall Study|Withdrawal by Subject|0|||
131568302|NCT03738241|473707044|FG005|Overall Study|Withdrawal by Subject|0|||
131568303|NCT03738241|473707045|FG006|Overall Study|Withdrawal by Subject|0|||
131568304|NCT03738241|473707046|FG007|Overall Study|Withdrawal by Subject|0|||
131568305|NCT03738241|473707047|FG008|Overall Study|Withdrawal by Subject|0|||
131568306|NCT03738241|473707048|FG009|Overall Study|Withdrawal by Subject|1|||
131568307|NCT03738241|473707039|FG000|Overall Study|Physician Decision|0|||
131568308|NCT03738241|473707040|FG001|Overall Study|Physician Decision|0|||
131568309|NCT03738241|473707041|FG002|Overall Study|Physician Decision|0|||
131568310|NCT03738241|473707042|FG003|Overall Study|Physician Decision|0|||
131568311|NCT03738241|473707043|FG004|Overall Study|Physician Decision|0|||
131568312|NCT03738241|473707044|FG005|Overall Study|Physician Decision|0|||
131568313|NCT03738241|473707045|FG006|Overall Study|Physician Decision|0|||
131568314|NCT03738241|473707046|FG007|Overall Study|Physician Decision|0|||
131568315|NCT03738241|473707047|FG008|Overall Study|Physician Decision|1|||
131568316|NCT03738241|473707048|FG009|Overall Study|Physician Decision|0|||
131568317|NCT03738241|473707039|FG000|Overall Study|Adverse Event|1|||
131568318|NCT03738241|473707040|FG001|Overall Study|Adverse Event|0|||
131568319|NCT03738241|473707041|FG002|Overall Study|Adverse Event|0|||
131568320|NCT03738241|473707042|FG003|Overall Study|Adverse Event|0|||
131568321|NCT03738241|473707043|FG004|Overall Study|Adverse Event|0|||
131568322|NCT03738241|473707044|FG005|Overall Study|Adverse Event|0|||
131568323|NCT03738241|473707045|FG006|Overall Study|Adverse Event|0|||
131568324|NCT03738241|473707046|FG007|Overall Study|Adverse Event|0|||
131568325|NCT03738241|473707047|FG008|Overall Study|Adverse Event|0|||
131568326|NCT03738241|473707048|FG009|Overall Study|Adverse Event|0|||
131568327|NCT03169361|473707049|FG000|Overall Study|Protocol Violation|32|||
131568328|NCT02271594|473707050|FG000|Overall Study|Study closed; recruiting failure|19|||
131568329|NCT02271594|473707051|FG001|Overall Study|Study closed; recruiting failure|12|||
131568330|NCT00495469|473707052|FG000|Overall Study|Adverse Event|0|||
131568331|NCT00495469|473707053|FG001|Overall Study|Adverse Event|1|||
131568332|NCT00495469|473707054|FG002|Overall Study|Adverse Event|3|||
131568333|NCT00495469|473707055|FG003|Overall Study|Adverse Event|0|||
131568334|NCT00495469|473707056|FG004|Overall Study|Adverse Event|1|||
131568335|NCT00495469|473707057|FG005|Overall Study|Adverse Event|1|||
131568336|NCT00495469|473707058|FG006|Overall Study|Adverse Event|1|||
131568337|NCT00495469|473707052|FG000|Overall Study|Lost to Follow-up|1|||
131568338|NCT00495469|473707053|FG001|Overall Study|Lost to Follow-up|1|||
131568339|NCT00495469|473707054|FG002|Overall Study|Lost to Follow-up|3|||
131568340|NCT00495469|473707055|FG003|Overall Study|Lost to Follow-up|1|||
131568341|NCT00495469|473707056|FG004|Overall Study|Lost to Follow-up|0|||
131568342|NCT00495469|473707057|FG005|Overall Study|Lost to Follow-up|0|||
131568343|NCT00495469|473707058|FG006|Overall Study|Lost to Follow-up|0|||
131568344|NCT00495469|473707052|FG000|Overall Study|Protocol Violation|0|||
131568345|NCT00495469|473707053|FG001|Overall Study|Protocol Violation|0|||
131568346|NCT00495469|473707054|FG002|Overall Study|Protocol Violation|0|||
131568347|NCT00495469|473707055|FG003|Overall Study|Protocol Violation|0|||
131568348|NCT00495469|473707056|FG004|Overall Study|Protocol Violation|1|||
131568349|NCT00495469|473707057|FG005|Overall Study|Protocol Violation|2|||
131568350|NCT00495469|473707058|FG006|Overall Study|Protocol Violation|0|||
131568351|NCT00495469|473707052|FG000|Overall Study|Withdrawal by Subject|5|||
131568352|NCT00495469|473707053|FG001|Overall Study|Withdrawal by Subject|3|||
131568353|NCT00495469|473707054|FG002|Overall Study|Withdrawal by Subject|1|||
131568354|NCT00495469|473707055|FG003|Overall Study|Withdrawal by Subject|3|||
131568355|NCT00495469|473707056|FG004|Overall Study|Withdrawal by Subject|3|||
131568356|NCT00495469|473707057|FG005|Overall Study|Withdrawal by Subject|2|||
131568357|NCT00495469|473707058|FG006|Overall Study|Withdrawal by Subject|3|||
131568358|NCT00495469|473707052|FG000|Overall Study|Lack of Efficacy|0|||
131568359|NCT00495469|473707053|FG001|Overall Study|Lack of Efficacy|0|||
131568360|NCT00495469|473707054|FG002|Overall Study|Lack of Efficacy|0|||
131568361|NCT00495469|473707055|FG003|Overall Study|Lack of Efficacy|0|||
131568362|NCT00495469|473707056|FG004|Overall Study|Lack of Efficacy|0|||
131568363|NCT00495469|473707057|FG005|Overall Study|Lack of Efficacy|0|||
131568364|NCT00495469|473707058|FG006|Overall Study|Lack of Efficacy|1|||
131568365|NCT00495469|473707052|FG000|Overall Study|Liver function test abnormality|0|||
131568366|NCT00495469|473707053|FG001|Overall Study|Liver function test abnormality|1|||
131568367|NCT00495469|473707054|FG002|Overall Study|Liver function test abnormality|0|||
131568368|NCT00495469|473707055|FG003|Overall Study|Liver function test abnormality|0|||
131568369|NCT00495469|473707056|FG004|Overall Study|Liver function test abnormality|0|||
131568370|NCT00495469|473707057|FG005|Overall Study|Liver function test abnormality|0|||
131568371|NCT00495469|473707058|FG006|Overall Study|Liver function test abnormality|0|||
131568372|NCT00495469|473707052|FG000|Overall Study|ST depression at randomisation in ECG|0|||
131568373|NCT00495469|473707053|FG001|Overall Study|ST depression at randomisation in ECG|1|||
131568374|NCT00495469|473707054|FG002|Overall Study|ST depression at randomisation in ECG|0|||
131568375|NCT00495469|473707055|FG003|Overall Study|ST depression at randomisation in ECG|0|||
131568376|NCT00495469|473707056|FG004|Overall Study|ST depression at randomisation in ECG|0|||
131568377|NCT00495469|473707057|FG005|Overall Study|ST depression at randomisation in ECG|0|||
131568378|NCT00495469|473707058|FG006|Overall Study|ST depression at randomisation in ECG|0|||
131568379|NCT00448864|473707061|FG000|Overall Study|Death|1|||
131568380|NCT00448864|473707062|FG001|Overall Study|Death|0|||
131568381|NCT00448864|473707063|FG002|Overall Study|Death|0|||
131568382|NCT00448864|473707061|FG000|Overall Study|Lost to Follow-up|3|||
131568383|NCT00448864|473707062|FG001|Overall Study|Lost to Follow-up|1|||
131568384|NCT00448864|473707063|FG002|Overall Study|Lost to Follow-up|0|||
131568385|NCT00448864|473707061|FG000|Overall Study|Physician Decision|1|||
131568386|NCT00448864|473707062|FG001|Overall Study|Physician Decision|0|||
131568387|NCT00448864|473707063|FG002|Overall Study|Physician Decision|1|||
131568388|NCT00448864|473707061|FG000|Overall Study|Withdrawal by Subject|0|||
131568389|NCT00448864|473707062|FG001|Overall Study|Withdrawal by Subject|2|||
131568390|NCT00448864|473707063|FG002|Overall Study|Withdrawal by Subject|0|||
131568391|NCT00448864|473707061|FG000|Overall Study|Protocol Violation|0|||
131568392|NCT00448864|473707062|FG001|Overall Study|Protocol Violation|2|||
131568393|NCT00448864|473707063|FG002|Overall Study|Protocol Violation|0|||
131568394|NCT01323660|473707066|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
131568395|NCT01323660|473707067|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131568396|NCT01323660|473707068|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131568397|NCT01323660|473707069|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131568398|NCT01323660|473707070|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131568399|NCT01323660|473707071|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
131568400|NCT01323660|473707066|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
131568401|NCT01323660|473707067|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
131568402|NCT01323660|473707068|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
131568403|NCT01323660|473707069|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
131568404|NCT01323660|473707070|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
131568405|NCT01323660|473707071|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
131568406|NCT01323660|473707066|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
131568407|NCT01323660|473707067|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
131568408|NCT01323660|473707068|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131568409|NCT01323660|473707069|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131568410|NCT01323660|473707070|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131568411|NCT01323660|473707071|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
131568412|NCT01323660|473707066|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131568413|NCT01323660|473707067|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131568414|NCT01323660|473707068|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131568415|NCT01323660|473707069|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131568416|NCT01323660|473707070|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
131568417|NCT01323660|473707071|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131568418|NCT01323660|473707066|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131568419|NCT01323660|473707067|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131568420|NCT01323660|473707068|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131568421|NCT01323660|473707069|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131568422|NCT01323660|473707070|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131568423|NCT01323660|473707071|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131568424|NCT01323660|473707066|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
131568425|NCT01323660|473707067|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131568426|NCT01323660|473707068|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131437637|NCT00383552|473228107|FG003|Overall Study|Administrative|1|||
131568427|NCT01323660|473707069|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131568428|NCT01323660|473707070|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
131568429|NCT01323660|473707071|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131568430|NCT01323660|473707066|FG000|Washout Period (14 Days)|Adverse Event|0|||
131568431|NCT01323660|473707067|FG001|Washout Period (14 Days)|Adverse Event|0|||
131568432|NCT01323660|473707068|FG002|Washout Period (14 Days)|Adverse Event|0|||
131568433|NCT01323660|473707069|FG003|Washout Period (14 Days)|Adverse Event|0|||
131568434|NCT01323660|473707070|FG004|Washout Period (14 Days)|Adverse Event|1|||
131568435|NCT01323660|473707071|FG005|Washout Period (14 Days)|Adverse Event|0|||
131568436|NCT01323660|473707066|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
131568437|NCT01323660|473707067|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
131568438|NCT01323660|473707068|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
131568439|NCT01323660|473707069|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
131783585|NCT00567996|474489978|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131783586|NCT00567996|474489976|FG000|Overall Study|Lost to Follow-up|2|||
131783587|NCT00567996|474489977|FG001|Overall Study|Lost to Follow-up|5|||
131783588|NCT00567996|474489978|FG002|Overall Study|Lost to Follow-up|2|||
131783589|NCT00567996|474489976|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131783590|NCT00567996|474489977|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131783591|NCT00567996|474489978|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
131783592|NCT00567996|474489976|FG000|Overall Study|Administrative problems|1|||
131783593|NCT00567996|474489977|FG001|Overall Study|Administrative problems|1|||
131783594|NCT00567996|474489978|FG002|Overall Study|Administrative problems|0|||
131783595|NCT00567996|474489976|FG000|Overall Study|Death|1|||
131783596|NCT00567996|474489977|FG001|Overall Study|Death|0|||
131783597|NCT00567996|474489978|FG002|Overall Study|Death|2|||
131783598|NCT00567996|474489976|FG000|Overall Study|Patient's inability to use the device|0|||
131783599|NCT00567996|474489977|FG001|Overall Study|Patient's inability to use the device|1|||
131783600|NCT00567996|474489978|FG002|Overall Study|Patient's inability to use the device|0|||
131783601|NCT02524665|474489981|FG000|Overall Study|Lost to Follow-up|1|||
131783602|NCT03022799|474489984|FG000|Overall Study|Adverse Event|0|||
131783603|NCT03022799|474489985|FG001|Overall Study|Adverse Event|0|||
131783604|NCT03022799|474489986|FG002|Overall Study|Adverse Event|0|||
131783605|NCT03022799|474489987|FG003|Overall Study|Adverse Event|0|||
131568440|NCT01323660|473707070|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
131783606|NCT03022799|474489988|FG004|Overall Study|Adverse Event|0|||
131783607|NCT03022799|474489989|FG005|Overall Study|Adverse Event|0|||
131568441|NCT01323660|473707071|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
131568442|NCT01323660|473707066|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131568443|NCT01323660|473707067|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131568444|NCT01323660|473707068|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131568445|NCT01323660|473707069|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131568446|NCT01323660|473707070|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131568447|NCT01323660|473707071|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
131568448|NCT01323660|473707066|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
131568449|NCT01323660|473707067|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131568450|NCT01323660|473707068|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
131568451|NCT01323660|473707069|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
131568452|NCT01323660|473707070|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131568453|NCT01323660|473707071|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
131568454|NCT01323660|473707066|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131568455|NCT01323660|473707067|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131568456|NCT01323660|473707068|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131568457|NCT01323660|473707069|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131568458|NCT01323660|473707070|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131568459|NCT01323660|473707071|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
131568460|NCT01323660|473707066|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131568461|NCT01323660|473707067|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131568462|NCT01323660|473707068|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131568463|NCT01323660|473707069|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131568464|NCT01323660|473707070|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131568465|NCT01323660|473707071|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131568466|NCT01323660|473707066|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131568467|NCT01323660|473707067|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131568468|NCT01323660|473707068|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131568469|NCT01323660|473707069|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131568470|NCT01323660|473707070|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
131568471|NCT01323660|473707071|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131697028|NCT01142726|474174039|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
131697029|NCT01142726|474174040|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
131697030|NCT01142726|474174038|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
131697031|NCT01142726|474174039|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
131697032|NCT01142726|474174040|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
131697033|NCT01142726|474174038|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
131697034|NCT01142726|474174039|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
131697035|NCT01142726|474174040|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
131697036|NCT01142726|474174038|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
131697037|NCT01142726|474174039|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
131697038|NCT01142726|474174040|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
131697039|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
131697040|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
131697041|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
131697042|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
131697043|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
131697044|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
131697045|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
131697046|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
131697047|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
131697048|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
131697049|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
131697050|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
131697051|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
131697052|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
131697053|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
131697054|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
131697055|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
131697056|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
131697057|NCT01142726|474174038|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
131697058|NCT01142726|474174039|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
131697059|NCT01142726|474174040|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
131783608|NCT03022799|474489990|FG006|Overall Study|Adverse Event|0|||
131783609|NCT03022799|474489991|FG007|Overall Study|Adverse Event|0|||
131697060|NCT01142726|474174038|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
131697061|NCT01142726|474174039|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
131568472|NCT05349084|473707073|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
131568473|NCT01004263|473707085|FG000|Overall Study|Adverse Event|15|||
131568474|NCT01004263|473707085|FG000|Overall Study|Withdrawal by Subject|58|||
131568475|NCT01004263|473707085|FG000|Overall Study|Protocol Violation|10|||
131568476|NCT01004263|473707085|FG000|Overall Study|Lost to Follow-up|64|||
131568477|NCT01004263|473707085|FG000|Overall Study|Lack of Efficacy|13|||
131568478|NCT01004263|473707085|FG000|Overall Study|Pregnancy|2|||
131568479|NCT01004263|473707085|FG000|Overall Study|Physician Decision|15|||
131568480|NCT01004263|473707085|FG000|Overall Study|Lack of Qualifying Event|2|||
131568481|NCT00958009|473707087|FG000|Overall Study|Adverse Event|1|||
131568482|NCT00958009|473707087|FG000|Overall Study|Subject found device difficult to use|1|||
131568483|NCT01605136|473707088|FG000|Study Period|Withdrawal by Subject|2|||
131568484|NCT01605136|473707089|FG001|Study Period|Withdrawal by Subject|0|||
131568485|NCT01605136|473707088|FG000|Study Period|Physician Decision|1|||
131568486|NCT01605136|473707089|FG001|Study Period|Physician Decision|1|||
131568487|NCT01605136|473707088|FG000|Study Period|Lost to Follow-up|0|||
131568488|NCT01605136|473707089|FG001|Study Period|Lost to Follow-up|2|||
131568489|NCT01605136|473707088|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
131568490|NCT01605136|473707089|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
131568491|NCT01072929|473707090|FG000|Overall Study|Adverse Event|8|||
131568492|NCT01072929|473707091|FG001|Overall Study|Adverse Event|11|||
131568493|NCT01072929|473707092|FG002|Overall Study|Adverse Event|2|||
131568494|NCT01072929|473707090|FG000|Overall Study|Lack of Efficacy|7|||
131568495|NCT01072929|473707091|FG001|Overall Study|Lack of Efficacy|4|||
131568496|NCT01072929|473707092|FG002|Overall Study|Lack of Efficacy|0|||
131568497|NCT01072929|473707090|FG000|Overall Study|Withdrawal by Subject|7|||
131568498|NCT01072929|473707091|FG001|Overall Study|Withdrawal by Subject|15|||
131568499|NCT01072929|473707092|FG002|Overall Study|Withdrawal by Subject|3|||
131568500|NCT01072929|473707090|FG000|Overall Study|Protocol Violation|13|||
131568501|NCT01072929|473707091|FG001|Overall Study|Protocol Violation|11|||
131568502|NCT01072929|473707092|FG002|Overall Study|Protocol Violation|2|||
131568503|NCT01072929|473707090|FG000|Overall Study|Lost to Follow-up|8|||
131568504|NCT01072929|473707091|FG001|Overall Study|Lost to Follow-up|4|||
131568505|NCT01072929|473707092|FG002|Overall Study|Lost to Follow-up|1|||
131568506|NCT01072929|473707090|FG000|Overall Study|Noncompliance with study medication|0|||
131568507|NCT01072929|473707091|FG001|Overall Study|Noncompliance with study medication|3|||
131568508|NCT01072929|473707092|FG002|Overall Study|Noncompliance with study medication|0|||
131568509|NCT01072929|473707090|FG000|Overall Study|Noncompliance with study procedures|1|||
131568510|NCT01072929|473707091|FG001|Overall Study|Noncompliance with study procedures|0|||
131568511|NCT01072929|473707092|FG002|Overall Study|Noncompliance with study procedures|1|||
131568512|NCT01072929|473707090|FG000|Overall Study|Other|0|||
131568513|NCT01072929|473707091|FG001|Overall Study|Other|3|||
131568514|NCT01072929|473707092|FG002|Overall Study|Other|0|||
131568515|NCT04824131|473707093|FG000|CAB LA Oral Phase|Adverse Event|1|||
131568516|NCT04824131|473707093|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
131568517|NCT04824131|473707093|FG000|Step 3|Withdrawal by Subject|2|||
131568518|NCT05489224|473707094|FG000|Treatment Period I|Withdrawal by Subject|6|||
131568519|NCT05489224|473707095|FG001|Treatment Period I|Withdrawal by Subject|5|||
131568520|NCT05489224|473707096|FG002|Treatment Period I|Withdrawal by Subject|0|||
131568521|NCT05489224|473707094|FG000|Treatment Period I|Adverse Event|3|||
131568522|NCT05489224|473707095|FG001|Treatment Period I|Adverse Event|11|||
131568523|NCT05489224|473707096|FG002|Treatment Period I|Adverse Event|0|||
131568524|NCT05489224|473707094|FG000|Treatment Period I|Lost to Follow-up|0|||
131568525|NCT05489224|473707095|FG001|Treatment Period I|Lost to Follow-up|1|||
131568526|NCT05489224|473707096|FG002|Treatment Period I|Lost to Follow-up|0|||
131568527|NCT05489224|473707094|FG000|Treatment Period I|Physician Decision|0|||
131568528|NCT05489224|473707095|FG001|Treatment Period I|Physician Decision|1|||
131568529|NCT05489224|473707096|FG002|Treatment Period I|Physician Decision|0|||
131568530|NCT05489224|473707094|FG000|Treatment Period II up to Week 32|Ongoing|222|||
131568531|NCT05489224|473707095|FG001|Treatment Period II up to Week 32|Ongoing|107|||
131568532|NCT05489224|473707096|FG002|Treatment Period II up to Week 32|Ongoing|107|||
131568533|NCT05489224|473707094|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
131568534|NCT05489224|473707095|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
131568535|NCT05489224|473707096|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
131568536|NCT05489224|473707094|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
131568537|NCT05489224|473707095|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
131568538|NCT05489224|473707096|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
131568539|NCT04887285|473707098|FG000|Overall Study|Lost to Follow-up|0|||
131568540|NCT04887285|473707099|FG001|Overall Study|Lost to Follow-up|2|||
131898650|NCT01516736|474915332|FG001|Overall Study|Withdrawal by Subject|4|||
131568541|NCT04887285|473707100|FG002|Overall Study|Lost to Follow-up|3|||
131568542|NCT04640571|473707101|FG000|Overall Study|Withdrawal by Subject|0|||
131568543|NCT04640571|473707102|FG001|Overall Study|Withdrawal by Subject|0|||
131568544|NCT04640571|473707103|FG002|Overall Study|Withdrawal by Subject|0|||
131568545|NCT04640571|473707104|FG003|Overall Study|Withdrawal by Subject|0|||
131568546|NCT04640571|473707105|FG004|Overall Study|Withdrawal by Subject|0|||
131568547|NCT04640571|473707106|FG005|Overall Study|Withdrawal by Subject|2|||
131568548|NCT01723774|473707111|FG000|Neoadjuvant|Ki67 > 10%|4|||
131568549|NCT01723774|473707112|FG001|Neoadjuvant|Ki67 > 10%|0|||
131568550|NCT01723774|473707113|FG002|Neoadjuvant|Ki67 > 10%|10|||
131568551|NCT01723774|473707114|FG003|Neoadjuvant|Ki67 > 10%|0|||
131568552|NCT01723774|473707111|FG000|Neoadjuvant|Withdrawal by Subject|3|||
131568553|NCT01723774|473707112|FG001|Neoadjuvant|Withdrawal by Subject|1|||
131568554|NCT01723774|473707113|FG002|Neoadjuvant|Withdrawal by Subject|0|||
131568555|NCT01723774|473707114|FG003|Neoadjuvant|Withdrawal by Subject|0|||
131568556|NCT01723774|473707111|FG000|Neoadjuvant|Disease progression|0|||
131568557|NCT01723774|473707112|FG001|Neoadjuvant|Disease progression|1|||
131568558|NCT01723774|473707113|FG002|Neoadjuvant|Disease progression|1|||
131568559|NCT01723774|473707114|FG003|Neoadjuvant|Disease progression|0|||
131568560|NCT01723774|473707111|FG000|Neoadjuvant|Adverse Event|0|||
131568561|NCT01723774|473707112|FG001|Neoadjuvant|Adverse Event|1|||
131568562|NCT01723774|473707113|FG002|Neoadjuvant|Adverse Event|2|||
131568563|NCT01723774|473707114|FG003|Neoadjuvant|Adverse Event|0|||
131568564|NCT01723774|473707111|FG000|Neoadjuvant|High estradiol|0|||
131568565|NCT01723774|473707112|FG001|Neoadjuvant|High estradiol|1|||
131568566|NCT01723774|473707113|FG002|Neoadjuvant|High estradiol|0|||
131568567|NCT01723774|473707114|FG003|Neoadjuvant|High estradiol|0|||
131568568|NCT02487446|473707120|FG000|Period 1|Physician Decision|0|||
131568569|NCT02487446|473707121|FG001|Period 1|Physician Decision|1|||
131568570|NCT02487446|473707120|FG000|Period 1|Lack of Efficacy|1|||
131568571|NCT02487446|473707121|FG001|Period 1|Lack of Efficacy|0|||
131568572|NCT02487446|473707120|FG000|Period 1|Protocol deviation|3|||
131568573|NCT02487446|473707121|FG001|Period 1|Protocol deviation|2|||
131568574|NCT02487446|473707120|FG000|Period 1|Lost to Follow-up|2|||
131568575|NCT02487446|473707121|FG001|Period 1|Lost to Follow-up|0|||
131568576|NCT02487446|473707120|FG000|Period 1|Withdrawal by Subject|2|||
131568577|NCT02487446|473707121|FG001|Period 1|Withdrawal by Subject|0|||
131568578|NCT02487446|473707120|FG000|Period 1|Adverse Event|5|||
131568579|NCT02487446|473707121|FG001|Period 1|Adverse Event|5|||
131568580|NCT02487446|473707120|FG000|Washout|Lost to Follow-up|0|||
131568581|NCT02487446|473707121|FG001|Washout|Lost to Follow-up|2|||
131568582|NCT02487446|473707120|FG000|Washout|Withdrawal by Subject|1|||
131568583|NCT02487446|473707121|FG001|Washout|Withdrawal by Subject|4|||
131568584|NCT02487446|473707120|FG000|Washout|Adverse Event|2|||
131568585|NCT02487446|473707121|FG001|Washout|Adverse Event|2|||
131568586|NCT02487446|473707120|FG000|Period 2|Protocol deviation|0|||
131568587|NCT02487446|473707121|FG001|Period 2|Protocol deviation|1|||
131568588|NCT02487446|473707120|FG000|Period 2|Lost to Follow-up|1|||
131568589|NCT02487446|473707121|FG001|Period 2|Lost to Follow-up|1|||
131568590|NCT02487446|473707120|FG000|Period 2|Withdrawal by Subject|1|||
131568591|NCT02487446|473707121|FG001|Period 2|Withdrawal by Subject|1|||
131568592|NCT02487446|473707120|FG000|Period 2|Adverse Event|6|||
131568593|NCT02487446|473707121|FG001|Period 2|Adverse Event|2|||
131568594|NCT01822821|473707122|FG000|Overall Study|Eligible surgery cancelled|1|||
131568595|NCT01822821|473707123|FG001|Overall Study|Eligible surgery cancelled|1|||
131568596|NCT01822821|473707122|FG000|Overall Study|Other reasons|1|||
131568597|NCT01822821|473707123|FG001|Overall Study|Other reasons|0|||
131568598|NCT05780047|473707124|FG000|Overall Study|Did not submit baseline urine test kit|226|||
131568599|NCT05780047|473707124|FG000|Overall Study|Lost to Follow-up|34|||
131568600|NCT05780047|473707124|FG000|Overall Study|Did not submit second urine test kit|124|||
131697062|NCT01142726|474174040|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
131697063|NCT01142726|474174038|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
131697064|NCT01142726|474174039|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
131697065|NCT01142726|474174040|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
131568601|NCT03590743|473707127|FG000|Overall Study|Withdrawal by Subject|0|||
131568602|NCT03590743|473707128|FG001|Overall Study|Withdrawal by Subject|1|||
131568603|NCT00604786|473707129|FG000|Overall Study|Lost to Follow-up|2|||
131568604|NCT00604786|473707130|FG001|Overall Study|Lost to Follow-up|0|||
131568605|NCT01221181|473707131|FG000|Overall Study|Lost to Follow-up|1|||
131568606|NCT02698436|473707132|FG000|Overall Study|Adverse Event|1|||
131568607|NCT02698436|473707133|FG001|Overall Study|Adverse Event|0|||
131568608|NCT02698436|473707132|FG000|Overall Study|Withdrawal by Subject|3|||
131568609|NCT02698436|473707133|FG001|Overall Study|Withdrawal by Subject|3|||
131568610|NCT02698436|473707132|FG000|Overall Study|Lost to Follow-up|2|||
131568611|NCT02698436|473707133|FG001|Overall Study|Lost to Follow-up|4|||
131568612|NCT02698436|473707132|FG000|Overall Study|Non-compliance with study regimen|1|||
131568613|NCT02698436|473707133|FG001|Overall Study|Non-compliance with study regimen|0|||
131568614|NCT01394991|473707134|FG000|Overall Study|Adverse Event|0|||
131568615|NCT01394991|473707135|FG001|Overall Study|Adverse Event|4|||
131568616|NCT01394991|473707134|FG000|Overall Study|Lack of Efficacy|5|||
131568617|NCT01394991|473707135|FG001|Overall Study|Lack of Efficacy|7|||
131568618|NCT01394991|473707134|FG000|Overall Study|Lost to Follow-up|6|||
131568619|NCT01394991|473707135|FG001|Overall Study|Lost to Follow-up|8|||
131568620|NCT01394991|473707134|FG000|Overall Study|Physician Decision|1|||
131568621|NCT01394991|473707135|FG001|Overall Study|Physician Decision|3|||
131568622|NCT01394991|473707134|FG000|Overall Study|Protocol Violation|1|||
131568623|NCT01394991|473707135|FG001|Overall Study|Protocol Violation|1|||
131568624|NCT01394991|473707134|FG000|Overall Study|Withdrawal by Subject|20|||
131568625|NCT01394991|473707135|FG001|Overall Study|Withdrawal by Subject|17|||
131568626|NCT01394991|473707134|FG000|Overall Study|Chemotherapy Termination|10|||
131568627|NCT01394991|473707135|FG001|Overall Study|Chemotherapy Termination|15|||
131568628|NCT01394991|473707134|FG000|Overall Study|Disease Progression|7|||
131568629|NCT01394991|473707135|FG001|Overall Study|Disease Progression|7|||
131568630|NCT01394991|473707134|FG000|Overall Study|Prematurely Termination of Trial|9|||
131568631|NCT01394991|473707135|FG001|Overall Study|Prematurely Termination of Trial|10|||
131568632|NCT03073005|473707138|FG000|Overall Study|Death|6|||
131568633|NCT03073005|473707139|FG001|Overall Study|Death|0|||
131568634|NCT03073005|473707140|FG002|Overall Study|Death|7|||
131568635|NCT03073005|473707141|FG003|Overall Study|Death|0|||
131568636|NCT03073005|473707138|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
131568637|NCT03073005|473707139|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
131568638|NCT03073005|473707140|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
131568639|NCT03073005|473707141|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
131568640|NCT03073005|473707138|FG000|Overall Study|Lost to Follow-up|2|||
131568641|NCT03073005|473707139|FG001|Overall Study|Lost to Follow-up|2|||
131568642|NCT03073005|473707140|FG002|Overall Study|Lost to Follow-up|1|||
131568643|NCT03073005|473707141|FG003|Overall Study|Lost to Follow-up|2|||
131568644|NCT03073005|473707138|FG000|Overall Study|Withdrawal by Subject|0|||
131568645|NCT03073005|473707139|FG001|Overall Study|Withdrawal by Subject|4|||
131568646|NCT03073005|473707140|FG002|Overall Study|Withdrawal by Subject|4|||
131568647|NCT03073005|473707141|FG003|Overall Study|Withdrawal by Subject|4|||
131568648|NCT01734811|473707149|FG000|Overall Study|Lost to Follow-up|2|||
131568649|NCT01734811|473707150|FG001|Overall Study|Lost to Follow-up|3|||
131568650|NCT01734811|473707149|FG000|Overall Study|Withdrawal by Subject|2|||
131568651|NCT01734811|473707150|FG001|Overall Study|Withdrawal by Subject|0|||
131568652|NCT00062868|473707151|FG000|Dose Level 1|Death|2|||
131568653|NCT00062868|473707152|FG001|Dose Level 1|Death|0|||
131568654|NCT00062868|473707153|FG002|Dose Level 1|Death|0|||
131568655|NCT00062868|473707154|FG003|Dose Level 1|Death|2|||
131568656|NCT00062868|473707155|FG004|Dose Level 1|Death|0|||
131697066|NCT01142726|474174038|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
131697067|NCT01142726|474174039|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
131697068|NCT01142726|474174040|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
131697069|NCT01142726|474174038|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
131697070|NCT01142726|474174039|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
131697071|NCT01142726|474174040|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
131697072|NCT00419380|474174043|FG000|Overall Study|Lack of Efficacy|1|||
131697073|NCT00419380|474174044|FG001|Overall Study|Lack of Efficacy|7|||
131697074|NCT00419380|474174043|FG000|Overall Study|Physician Decision|0|||
131697075|NCT00419380|474174044|FG001|Overall Study|Physician Decision|1|||
131697076|NCT00419380|474174043|FG000|Overall Study|Lost to Follow-up|0|||
131697077|NCT00419380|474174044|FG001|Overall Study|Lost to Follow-up|1|||
131697078|NCT00419380|474174043|FG000|Overall Study|Withdrawal by Subject|0|||
131697079|NCT00419380|474174044|FG001|Overall Study|Withdrawal by Subject|1|||
131697080|NCT01967537|474174059|FG000|Overall Study|Withdrawal by Subject|52|||
131697081|NCT01967537|474174059|FG000|Overall Study|Refuse treatment|2|||
131697082|NCT01967537|474174059|FG000|Overall Study|Lost to Follow-up|6|||
131697083|NCT01026831|474174060|FG000|Overall Study|Adverse Event|4|||
131697084|NCT01026831|474174061|FG001|Overall Study|Adverse Event|3|||
131697085|NCT01026831|474174060|FG000|Overall Study|Lost to Follow-up|2|||
131697086|NCT01026831|474174061|FG001|Overall Study|Lost to Follow-up|0|||
131568657|NCT00062868|473707156|FG005|Dose Level 1|Death|0|||
131568658|NCT00062868|473707157|FG006|Dose Level 1|Death|3|||
131568659|NCT00062868|473707158|FG007|Dose Level 1|Death|0|||
131568660|NCT00062868|473707159|FG008|Dose Level 1|Death|0|||
131568661|NCT00062868|473707160|FG009|Dose Level 1|Death|0|||
131568662|NCT00062868|473707161|FG010|Dose Level 1|Death|0|||
131568663|NCT00062868|473707162|FG011|Dose Level 1|Death|0|||
131568664|NCT00062868|473707163|FG012|Dose Level 1|Death|0|||
131568665|NCT00062868|473707164|FG013|Dose Level 1|Death|0|||
131697087|NCT01026831|474174060|FG000|Overall Study|Physician Decision|1|||
131697088|NCT01026831|474174061|FG001|Overall Study|Physician Decision|1|||
131697089|NCT01026831|474174060|FG000|Overall Study|Protocol Violation|0|||
131697090|NCT01026831|474174061|FG001|Overall Study|Protocol Violation|2|||
131697091|NCT01026831|474174060|FG000|Overall Study|Withdrawal by Subject|7|||
131437638|NCT03096834|473228108|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
131437639|NCT03096834|473228109|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
131568666|NCT00062868|473707165|FG014|Dose Level 1|Death|0|||
131568667|NCT00062868|473707166|FG015|Dose Level 1|Death|0|||
131568668|NCT00062868|473707167|FG016|Dose Level 1|Death|0|||
131437640|NCT03096834|473228110|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
131783610|NCT03022799|474489992|FG008|Overall Study|Adverse Event|0|||
131437641|NCT03096834|473228111|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
131783611|NCT03022799|474489993|FG009|Overall Study|Adverse Event|1|||
131568669|NCT00062868|473707168|FG017|Dose Level 1|Death|0|||
131697092|NCT01026831|474174061|FG001|Overall Study|Withdrawal by Subject|5|||
131697093|NCT04417894|474174062|FG000|Overall Study|Lost to Follow-up|3|||
131697094|NCT04417894|474174063|FG001|Overall Study|Lost to Follow-up|0|||
131697095|NCT04417894|474174062|FG000|Overall Study|Withdrawal by Subject|7|||
131697096|NCT04417894|474174063|FG001|Overall Study|Withdrawal by Subject|6|||
131697097|NCT04417894|474174062|FG000|Overall Study|Lack of Efficacy|3|||
131697098|NCT04417894|474174063|FG001|Overall Study|Lack of Efficacy|1|||
131697099|NCT01180660|474174064|FG000|Overall Study|Changed to open surgery|1|||
131697100|NCT01180660|474174065|FG001|Overall Study|Changed to open surgery|0|||
131697101|NCT05130463|474174066|FG000|Overall Study|Unspecified reasons|2|||
131568670|NCT00062868|473707169|FG018|Dose Level 1|Death|7|||
131568671|NCT00062868|473707170|FG019|Dose Level 1|Death|0|||
131568672|NCT00062868|473707171|FG020|Dose Level 1|Death|1|||
131568673|NCT00062868|473707151|FG000|Dose Level 1|Lost to Follow-up|0|||
131568674|NCT00062868|473707152|FG001|Dose Level 1|Lost to Follow-up|0|||
131568675|NCT00062868|473707153|FG002|Dose Level 1|Lost to Follow-up|0|||
131568676|NCT00062868|473707154|FG003|Dose Level 1|Lost to Follow-up|0|||
131568677|NCT00062868|473707155|FG004|Dose Level 1|Lost to Follow-up|0|||
131568678|NCT00062868|473707156|FG005|Dose Level 1|Lost to Follow-up|0|||
131568679|NCT00062868|473707157|FG006|Dose Level 1|Lost to Follow-up|0|||
131568680|NCT00062868|473707158|FG007|Dose Level 1|Lost to Follow-up|0|||
131568681|NCT00062868|473707159|FG008|Dose Level 1|Lost to Follow-up|0|||
131568682|NCT00062868|473707160|FG009|Dose Level 1|Lost to Follow-up|0|||
131568683|NCT00062868|473707161|FG010|Dose Level 1|Lost to Follow-up|0|||
131568684|NCT00062868|473707162|FG011|Dose Level 1|Lost to Follow-up|0|||
131568685|NCT00062868|473707163|FG012|Dose Level 1|Lost to Follow-up|1|||
131568686|NCT00062868|473707164|FG013|Dose Level 1|Lost to Follow-up|0|||
131568687|NCT00062868|473707165|FG014|Dose Level 1|Lost to Follow-up|0|||
131568688|NCT00062868|473707166|FG015|Dose Level 1|Lost to Follow-up|0|||
131568689|NCT00062868|473707167|FG016|Dose Level 1|Lost to Follow-up|0|||
131568690|NCT00062868|473707168|FG017|Dose Level 1|Lost to Follow-up|0|||
131568691|NCT00062868|473707169|FG018|Dose Level 1|Lost to Follow-up|2|||
131568692|NCT00062868|473707170|FG019|Dose Level 1|Lost to Follow-up|0|||
131568693|NCT00062868|473707171|FG020|Dose Level 1|Lost to Follow-up|1|||
131568694|NCT00062868|473707151|FG000|Dose Level 2|Death|0|||
131898651|NCT01516736|474915331|FG000|Overall Study|Adverse Event|4|||
131898652|NCT01516736|474915332|FG001|Overall Study|Adverse Event|5|||
131568695|NCT00062868|473707152|FG001|Dose Level 2|Death|3|||
131568696|NCT00062868|473707153|FG002|Dose Level 2|Death|0|||
131568697|NCT00062868|473707154|FG003|Dose Level 2|Death|0|||
131568698|NCT00062868|473707155|FG004|Dose Level 2|Death|2|||
131568699|NCT00062868|473707156|FG005|Dose Level 2|Death|0|||
131568700|NCT00062868|473707157|FG006|Dose Level 2|Death|0|||
131568701|NCT00062868|473707158|FG007|Dose Level 2|Death|0|||
131568702|NCT00062868|473707159|FG008|Dose Level 2|Death|0|||
131568703|NCT00062868|473707160|FG009|Dose Level 2|Death|0|||
131568704|NCT00062868|473707161|FG010|Dose Level 2|Death|1|||
131568705|NCT00062868|473707162|FG011|Dose Level 2|Death|0|||
131568706|NCT00062868|473707163|FG012|Dose Level 2|Death|0|||
131568707|NCT00062868|473707164|FG013|Dose Level 2|Death|0|||
131568708|NCT00062868|473707165|FG014|Dose Level 2|Death|0|||
131568709|NCT00062868|473707166|FG015|Dose Level 2|Death|0|||
131568710|NCT00062868|473707167|FG016|Dose Level 2|Death|2|||
131568711|NCT00062868|473707168|FG017|Dose Level 2|Death|0|||
131568712|NCT00062868|473707169|FG018|Dose Level 2|Death|0|||
131568713|NCT00062868|473707170|FG019|Dose Level 2|Death|0|||
131568714|NCT00062868|473707171|FG020|Dose Level 2|Death|0|||
131568715|NCT00062868|473707151|FG000|Dose Level 2|Lost to Follow-up|0|||
131568716|NCT00062868|473707152|FG001|Dose Level 2|Lost to Follow-up|0|||
131568717|NCT00062868|473707153|FG002|Dose Level 2|Lost to Follow-up|0|||
131568718|NCT00062868|473707154|FG003|Dose Level 2|Lost to Follow-up|0|||
131568719|NCT00062868|473707155|FG004|Dose Level 2|Lost to Follow-up|0|||
131568720|NCT00062868|473707156|FG005|Dose Level 2|Lost to Follow-up|0|||
131568721|NCT00062868|473707157|FG006|Dose Level 2|Lost to Follow-up|0|||
131568722|NCT00062868|473707158|FG007|Dose Level 2|Lost to Follow-up|0|||
131568723|NCT00062868|473707159|FG008|Dose Level 2|Lost to Follow-up|0|||
131568724|NCT00062868|473707160|FG009|Dose Level 2|Lost to Follow-up|0|||
131568725|NCT00062868|473707161|FG010|Dose Level 2|Lost to Follow-up|0|||
131568726|NCT00062868|473707162|FG011|Dose Level 2|Lost to Follow-up|0|||
131568727|NCT00062868|473707163|FG012|Dose Level 2|Lost to Follow-up|0|||
131568728|NCT00062868|473707164|FG013|Dose Level 2|Lost to Follow-up|1|||
131568729|NCT00062868|473707165|FG014|Dose Level 2|Lost to Follow-up|0|||
131568730|NCT00062868|473707166|FG015|Dose Level 2|Lost to Follow-up|0|||
131568731|NCT00062868|473707167|FG016|Dose Level 2|Lost to Follow-up|1|||
131568732|NCT00062868|473707168|FG017|Dose Level 2|Lost to Follow-up|0|||
131568733|NCT00062868|473707169|FG018|Dose Level 2|Lost to Follow-up|0|||
131568734|NCT00062868|473707170|FG019|Dose Level 2|Lost to Follow-up|0|||
131568735|NCT00062868|473707171|FG020|Dose Level 2|Lost to Follow-up|0|||
131568736|NCT00062868|473707151|FG000|Dose Level 3|Death|0|||
131568737|NCT00062868|473707152|FG001|Dose Level 3|Death|0|||
131568738|NCT00062868|473707153|FG002|Dose Level 3|Death|0|||
131568739|NCT00062868|473707154|FG003|Dose Level 3|Death|0|||
131568740|NCT00062868|473707155|FG004|Dose Level 3|Death|0|||
131568741|NCT00062868|473707156|FG005|Dose Level 3|Death|0|||
131568742|NCT00062868|473707157|FG006|Dose Level 3|Death|0|||
131568743|NCT00062868|473707158|FG007|Dose Level 3|Death|0|||
131568744|NCT00062868|473707159|FG008|Dose Level 3|Death|0|||
131568745|NCT00062868|473707160|FG009|Dose Level 3|Death|0|||
131568746|NCT00062868|473707161|FG010|Dose Level 3|Death|0|||
131568747|NCT00062868|473707162|FG011|Dose Level 3|Death|1|||
131898653|NCT01516736|474915331|FG000|Overall Study|Death|3|||
131697102|NCT05130463|474174066|FG000|Overall Study|off-label indication dose|435|||
131697103|NCT03461757|474174067|FG000|Overall Study|Adverse Event|1|||
131697104|NCT03461757|474174068|FG001|Overall Study|Adverse Event|0|||
131697105|NCT03461757|474174067|FG000|Overall Study|Lost to Follow-up|13|||
131697106|NCT03461757|474174068|FG001|Overall Study|Lost to Follow-up|7|||
131697107|NCT03461757|474174067|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
131697108|NCT03461757|474174068|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
131697109|NCT03461757|474174067|FG000|Overall Study|Non-compliance with study treatment|0|||
131697110|NCT03461757|474174068|FG001|Overall Study|Non-compliance with study treatment|1|||
131697111|NCT03461757|474174067|FG000|Overall Study|Pregnancy|2|||
131697112|NCT03461757|474174068|FG001|Overall Study|Pregnancy|0|||
131697113|NCT03461757|474174067|FG000|Overall Study|Protocol Violation|1|||
131697114|NCT03461757|474174068|FG001|Overall Study|Protocol Violation|1|||
131568748|NCT00062868|473707163|FG012|Dose Level 3|Death|0|||
131568749|NCT00062868|473707164|FG013|Dose Level 3|Death|0|||
131568750|NCT00062868|473707165|FG014|Dose Level 3|Death|0|||
131568751|NCT00062868|473707166|FG015|Dose Level 3|Death|0|||
131568752|NCT00062868|473707167|FG016|Dose Level 3|Death|0|||
131568753|NCT00062868|473707168|FG017|Dose Level 3|Death|1|||
131568754|NCT00062868|473707169|FG018|Dose Level 3|Death|0|||
131568755|NCT00062868|473707170|FG019|Dose Level 3|Death|0|||
131568756|NCT00062868|473707171|FG020|Dose Level 3|Death|0|||
131568757|NCT00062868|473707151|FG000|Dose Level 3|Lost to Follow-up|0|||
131568758|NCT00062868|473707152|FG001|Dose Level 3|Lost to Follow-up|0|||
131568759|NCT00062868|473707153|FG002|Dose Level 3|Lost to Follow-up|0|||
131568760|NCT00062868|473707154|FG003|Dose Level 3|Lost to Follow-up|0|||
131568761|NCT00062868|473707155|FG004|Dose Level 3|Lost to Follow-up|0|||
131568762|NCT00062868|473707156|FG005|Dose Level 3|Lost to Follow-up|0|||
131568763|NCT00062868|473707157|FG006|Dose Level 3|Lost to Follow-up|0|||
131568764|NCT00062868|473707158|FG007|Dose Level 3|Lost to Follow-up|0|||
131568765|NCT00062868|473707159|FG008|Dose Level 3|Lost to Follow-up|0|||
131568766|NCT00062868|473707160|FG009|Dose Level 3|Lost to Follow-up|0|||
131568767|NCT00062868|473707161|FG010|Dose Level 3|Lost to Follow-up|0|||
131568768|NCT00062868|473707162|FG011|Dose Level 3|Lost to Follow-up|0|||
131568769|NCT00062868|473707163|FG012|Dose Level 3|Lost to Follow-up|0|||
131568770|NCT00062868|473707164|FG013|Dose Level 3|Lost to Follow-up|0|||
131568771|NCT00062868|473707165|FG014|Dose Level 3|Lost to Follow-up|1|||
131568772|NCT00062868|473707166|FG015|Dose Level 3|Lost to Follow-up|0|||
131568773|NCT00062868|473707167|FG016|Dose Level 3|Lost to Follow-up|0|||
131568774|NCT00062868|473707168|FG017|Dose Level 3|Lost to Follow-up|0|||
131568775|NCT00062868|473707169|FG018|Dose Level 3|Lost to Follow-up|0|||
131568776|NCT00062868|473707170|FG019|Dose Level 3|Lost to Follow-up|0|||
131568777|NCT00062868|473707171|FG020|Dose Level 3|Lost to Follow-up|0|||
131568778|NCT00062868|473707151|FG000|Dose Level 3|Withdrew|0|||
131568779|NCT00062868|473707152|FG001|Dose Level 3|Withdrew|0|||
131568780|NCT00062868|473707153|FG002|Dose Level 3|Withdrew|2|||
131568781|NCT00062868|473707154|FG003|Dose Level 3|Withdrew|0|||
131568782|NCT00062868|473707155|FG004|Dose Level 3|Withdrew|0|||
131568783|NCT00062868|473707156|FG005|Dose Level 3|Withdrew|0|||
131568784|NCT00062868|473707157|FG006|Dose Level 3|Withdrew|0|||
131568785|NCT00062868|473707158|FG007|Dose Level 3|Withdrew|0|||
131568786|NCT00062868|473707159|FG008|Dose Level 3|Withdrew|0|||
131568787|NCT00062868|473707160|FG009|Dose Level 3|Withdrew|0|||
131568788|NCT00062868|473707161|FG010|Dose Level 3|Withdrew|0|||
131568789|NCT00062868|473707162|FG011|Dose Level 3|Withdrew|0|||
131568790|NCT00062868|473707163|FG012|Dose Level 3|Withdrew|0|||
131568791|NCT00062868|473707164|FG013|Dose Level 3|Withdrew|0|||
131568792|NCT00062868|473707165|FG014|Dose Level 3|Withdrew|0|||
131568793|NCT00062868|473707166|FG015|Dose Level 3|Withdrew|0|||
131568794|NCT00062868|473707167|FG016|Dose Level 3|Withdrew|0|||
131568795|NCT00062868|473707168|FG017|Dose Level 3|Withdrew|0|||
131568796|NCT00062868|473707169|FG018|Dose Level 3|Withdrew|0|||
131568797|NCT00062868|473707170|FG019|Dose Level 3|Withdrew|0|||
131568798|NCT00062868|473707171|FG020|Dose Level 3|Withdrew|0|||
131568799|NCT03824236|473707174|FG000|Overall Study|Lost to Follow-up|0|||
131697115|NCT03461757|474174067|FG000|Overall Study|Withdrawal by Subject|7|||
131697116|NCT03461757|474174068|FG001|Overall Study|Withdrawal by Subject|7|||
131697117|NCT03461757|474174067|FG000|Overall Study|Other Reasons|1|||
131697118|NCT03461757|474174068|FG001|Overall Study|Other Reasons|4|||
131697119|NCT03861559|474174069|FG000|Overall Study|Adverse Event|0|||
131697120|NCT03861559|474174070|FG001|Overall Study|Adverse Event|2|||
131697121|NCT03861559|474174069|FG000|Overall Study|Treatment failure|0|||
131697122|NCT03861559|474174070|FG001|Overall Study|Treatment failure|2|||
131697123|NCT03861559|474174069|FG000|Overall Study|Noncompliance|1|||
131697124|NCT03861559|474174070|FG001|Overall Study|Noncompliance|1|||
131697125|NCT03861559|474174069|FG000|Overall Study|Did not meet eligibility requirements|1|||
131697126|NCT03861559|474174070|FG001|Overall Study|Did not meet eligibility requirements|0|||
131697127|NCT00487539|474174071|FG000|Overall Study|Adverse Event|3|||
131697128|NCT00487539|474174072|FG001|Overall Study|Adverse Event|2|||
131697129|NCT00487539|474174073|FG002|Overall Study|Adverse Event|1|||
131568800|NCT03824236|473707175|FG001|Overall Study|Lost to Follow-up|0|||
131697130|NCT00487539|474174074|FG003|Overall Study|Adverse Event|1|||
131697131|NCT00487539|474174071|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131783612|NCT03022799|474489994|FG010|Overall Study|Adverse Event|1|||
131568801|NCT03824236|473707176|FG002|Overall Study|Lost to Follow-up|1|||
131568802|NCT00725010|473707177|FG000|Overall Study|Toxicity|9|||
131568803|NCT00725010|473707177|FG000|Overall Study|Tumor Progression|7|||
131783613|NCT03022799|474489995|FG011|Overall Study|Adverse Event|0|||
131568804|NCT00725010|473707177|FG000|Overall Study|Withdrawal by Subject|2|||
131568805|NCT00725010|473707177|FG000|Overall Study|Death|1|||
131568806|NCT00725010|473707177|FG000|Overall Study|Lost to Follow-up|1|||
131568807|NCT00725010|473707177|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
131568808|NCT00725010|473707177|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
131568809|NCT00725010|473707177|FG000|Overall Study|No further documentation|1|||
131697132|NCT00487539|474174072|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131568810|NCT00725010|473707177|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
131568811|NCT02414828|473707178|FG000|Overall Study|Lost to Follow-up|0|||
131568812|NCT02414828|473707179|FG001|Overall Study|Lost to Follow-up|1|||
131568813|NCT02414828|473707180|FG002|Overall Study|Lost to Follow-up|1|||
131568814|NCT02414828|473707181|FG003|Overall Study|Lost to Follow-up|2|||
131568815|NCT00701311|473707184|FG000|Overall Study|Lack of Efficacy|3|||
131568816|NCT00701311|473707184|FG000|Overall Study|Adverse Event|3|||
131568817|NCT00701311|473707184|FG000|Overall Study|Withdrawal by Subject|2|||
131568818|NCT00814489|473707185|FG000|Overall Study|Other|2|||
131568819|NCT00814489|473707186|FG001|Overall Study|Other|0|||
131568820|NCT00814489|473707187|FG002|Overall Study|Other|1|||
131568821|NCT01866917|473707213|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
131568822|NCT01866917|473707214|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
131568823|NCT01712685|473707221|FG000|Overall Study|pt declined to participate before trmt|1|||
131568824|NCT03253653|473707222|FG000|Overall Study|Withdrawal by Subject|4|||
131568825|NCT03253653|473707223|FG001|Overall Study|Withdrawal by Subject|1|||
131568826|NCT03253653|473707222|FG000|Overall Study|Protocol Violation|0|||
131568827|NCT03253653|473707223|FG001|Overall Study|Protocol Violation|5|||
131568828|NCT04610684|473708697|FG000|Study Treatment|Withdrawal by Subject|1|||
131568829|NCT04610684|473708697|FG000|Study Treatment|Disease Progression|2|||
131568830|NCT04610684|473708697|FG000|Follow up|Death|2|||
131568831|NCT04610684|473708697|FG000|Follow up|Withdrawal by Subject|1|||
131568832|NCT01251614|473708701|FG000|Overall Study|Adverse Event|1|||
131568833|NCT01251614|473708702|FG001|Overall Study|Adverse Event|0|||
131568834|NCT01251614|473708703|FG002|Overall Study|Adverse Event|1|||
131568835|NCT01251614|473708701|FG000|Overall Study|Lack of Efficacy|1|||
131568836|NCT01251614|473708702|FG001|Overall Study|Lack of Efficacy|9|||
131568837|NCT01251614|473708703|FG002|Overall Study|Lack of Efficacy|4|||
131568838|NCT01251614|473708701|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
131568839|NCT01251614|473708702|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
131568840|NCT01251614|473708703|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
131568841|NCT01251614|473708701|FG000|Overall Study|Pregnancy|0|||
131568842|NCT01251614|473708702|FG001|Overall Study|Pregnancy|0|||
131568843|NCT01251614|473708703|FG002|Overall Study|Pregnancy|2|||
131568844|NCT01251614|473708701|FG000|Overall Study|Loss of Disease Control|0|||
131568845|NCT01251614|473708702|FG001|Overall Study|Loss of Disease Control|1|||
131568846|NCT01251614|473708703|FG002|Overall Study|Loss of Disease Control|0|||
131568847|NCT01251614|473708701|FG000|Overall Study|Withdrawal by Subject|0|||
131568848|NCT01251614|473708702|FG001|Overall Study|Withdrawal by Subject|2|||
131568849|NCT01251614|473708703|FG002|Overall Study|Withdrawal by Subject|1|||
131568850|NCT01251614|473708701|FG000|Overall Study|Lost to Follow-up|0|||
131568851|NCT01251614|473708702|FG001|Overall Study|Lost to Follow-up|1|||
131568852|NCT01251614|473708703|FG002|Overall Study|Lost to Follow-up|0|||
131568853|NCT00093795|473708705|FG000|Overall Study|No follow up data|20|||
131568854|NCT00093795|473708706|FG001|Overall Study|No follow up data|16|||
131568855|NCT00093795|473708707|FG002|Overall Study|No follow up data|17|||
131568856|NCT02949271|473708710|FG000|Overall Study|Lack of Efficacy|5|||
131568857|NCT02949271|473708711|FG001|Overall Study|Lack of Efficacy|4|||
131568858|NCT02949271|473708710|FG000|Overall Study|Lost to Follow-up|3|||
131697133|NCT00487539|474174073|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131697134|NCT00487539|474174074|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
131697135|NCT00487539|474174071|FG000|Overall Study|Other|3|||
131697136|NCT00487539|474174072|FG001|Overall Study|Other|1|||
131697137|NCT00487539|474174073|FG002|Overall Study|Other|2|||
131697138|NCT00487539|474174074|FG003|Overall Study|Other|2|||
131697139|NCT03440814|474174075|FG000|Overall Study|Adverse Event|2|||
131697140|NCT03440814|474174076|FG001|Overall Study|Adverse Event|1|||
131697141|NCT03440814|474174075|FG000|Overall Study|Lost to Follow-up|2|||
131697142|NCT03440814|474174076|FG001|Overall Study|Lost to Follow-up|0|||
131697143|NCT03440814|474174075|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
131697144|NCT03440814|474174076|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
131697145|NCT00879697|474174077|FG000|Overall Study|Physician Decision|2|||
131697146|NCT00879697|474174078|FG001|Overall Study|Physician Decision|2|||
131697147|NCT02751502|474174079|FG000|Overall Study|Lack of funding|4|||
131697148|NCT00088374|474174080|FG000|Overall Study|patient did not receive any 17AAG|1|||
131697149|NCT00088374|474174080|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
131697150|NCT02678390|474174081|FG000|AE (1 Day)|Withdrawal by Subject|0|||
131568859|NCT02949271|473708711|FG001|Overall Study|Lost to Follow-up|6|||
131568860|NCT02949271|473708710|FG000|Overall Study|Physician Decision|5|||
131568861|NCT02949271|473708711|FG001|Overall Study|Physician Decision|5|||
131568862|NCT02949271|473708710|FG000|Overall Study|Protocol Violation|6|||
131568863|NCT02949271|473708711|FG001|Overall Study|Protocol Violation|3|||
131568864|NCT02949271|473708710|FG000|Overall Study|Withdrawal by Subject|1|||
131697151|NCT02678390|474174082|FG001|AE (1 Day)|Withdrawal by Subject|1|||
131697152|NCT00498173|474174083|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
131568865|NCT02949271|473708711|FG001|Overall Study|Withdrawal by Subject|0|||
131568866|NCT02949271|473708710|FG000|Overall Study|Delivered prior to intervention|7|||
131568867|NCT02949271|473708711|FG001|Overall Study|Delivered prior to intervention|9|||
131568868|NCT02949271|473708710|FG000|Overall Study|Outside the window for cervical dilation|2|||
131568869|NCT02949271|473708711|FG001|Overall Study|Outside the window for cervical dilation|3|||
131568870|NCT05458102|473708712|FG000|Overall Study|Withdrew consent|2|||
131568871|NCT05458102|473708713|FG001|Overall Study|Withdrew consent|0|||
131568872|NCT05458102|473708712|FG000|Overall Study|Adverse Event|1|||
131568873|NCT05458102|473708713|FG001|Overall Study|Adverse Event|0|||
131568874|NCT05458102|473708712|FG000|Overall Study|Enrolled but never treated|1|||
131568875|NCT05458102|473708713|FG001|Overall Study|Enrolled but never treated|0|||
131568876|NCT05458102|473708712|FG000|Overall Study|Protocol Violation|1|||
131568877|NCT05458102|473708713|FG001|Overall Study|Protocol Violation|0|||
131568878|NCT00723294|473708714|FG000|Overall Study|Lobular histology|2|||
131568879|NCT00723294|473708714|FG000|Overall Study|>25% intraductal component|1|||
131568880|NCT00723294|473708714|FG000|Overall Study|No MRI tumor enhancement|1|||
131568881|NCT00723294|473708714|FG000|Overall Study|1.0-Tesla MRI|1|||
131568882|NCT00723294|473708714|FG000|Overall Study|No cryoabalation|2|||
131568883|NCT00723294|473708714|FG000|Overall Study|Did not undergo surgery|1|||
131568884|NCT00723294|473708714|FG000|Overall Study|Treated prior to registration|1|||
131568885|NCT00723294|473708714|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
131568886|NCT00723294|473708714|FG000|Overall Study|Benign lesion|1|||
131568887|NCT00723294|473708714|FG000|Overall Study|Withdrawal by Subject|1|||
131568888|NCT00723294|473708714|FG000|Overall Study|No treatment due to probe failure|1|||
131568889|NCT04531540|473708719|FG000|Overall Study|Adverse Event|1|||
131568890|NCT04531540|473708719|FG000|Overall Study|Protocol Violation|3|||
131568891|NCT04531540|473708719|FG000|Overall Study|Withdrawal by Subject|4|||
131568892|NCT04531540|473708719|FG000|Overall Study|Found to be Ineligible|1|||
131568893|NCT02688621|473708720|FG000|Overall Study|Pregnancy|1|||
131568894|NCT02688621|473708721|FG001|Overall Study|Pregnancy|3|||
131568895|NCT02688621|473708720|FG000|Overall Study|Lost to Follow-up|38|||
131568896|NCT02688621|473708721|FG001|Overall Study|Lost to Follow-up|15|||
131568897|NCT02688621|473708720|FG000|Overall Study|Withdrawal by Subject|1|||
131568898|NCT02688621|473708721|FG001|Overall Study|Withdrawal by Subject|0|||
131568899|NCT01575860|473708722|FG000|Overall Study|Withdrawal by Subject|1|||
131568900|NCT01575860|473708722|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
131568901|NCT00278564|473708724|FG000|Overall Study|Lack of Efficacy|4|||
131568902|NCT01094743|473708725|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
131568903|NCT02851511|473708726|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
131568904|NCT02851511|473708727|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
131568905|NCT02851511|473708728|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
131568906|NCT02851511|473708729|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
131568907|NCT02851511|473708726|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
131568908|NCT02851511|473708727|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
131568909|NCT02851511|473708728|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
131568910|NCT02851511|473708729|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
131568911|NCT02851511|473708726|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
131568912|NCT02851511|473708727|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
131568913|NCT02851511|473708728|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
131568914|NCT02851511|473708729|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
131568915|NCT02851511|473708726|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
131568916|NCT02851511|473708727|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
131568917|NCT02851511|473708728|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
131568918|NCT02851511|473708729|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
131568919|NCT02851511|473708726|FG000|Phase I|Physician Decision|0|||
131568920|NCT02851511|473708727|FG001|Phase I|Physician Decision|0|||
131568921|NCT02851511|473708728|FG002|Phase I|Physician Decision|0|||
131568922|NCT02851511|473708729|FG003|Phase I|Physician Decision|1|||
131568923|NCT02851511|473708726|FG000|Phase I|Withdrawal by Subject|2|||
131568924|NCT02851511|473708727|FG001|Phase I|Withdrawal by Subject|1|||
131568925|NCT02851511|473708728|FG002|Phase I|Withdrawal by Subject|0|||
131568926|NCT02851511|473708729|FG003|Phase I|Withdrawal by Subject|3|||
131568927|NCT02851511|473708726|FG000|Phase II|Physician Decision|18|||
131568928|NCT02851511|473708727|FG001|Phase II|Physician Decision|16|||
131568929|NCT02851511|473708728|FG002|Phase II|Physician Decision|0|||
131568930|NCT02851511|473708729|FG003|Phase II|Physician Decision|0|||
131568931|NCT02851511|473708726|FG000|Phase II|Withdrawal by Subject|18|||
131568932|NCT02851511|473708727|FG001|Phase II|Withdrawal by Subject|16|||
131568933|NCT02851511|473708728|FG002|Phase II|Withdrawal by Subject|0|||
131568934|NCT02851511|473708729|FG003|Phase II|Withdrawal by Subject|0|||
131568935|NCT02851511|473708726|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
131568936|NCT02851511|473708727|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
131568937|NCT02851511|473708728|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
131568938|NCT02851511|473708729|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
131568939|NCT02851511|473708726|FG000|Phase II|Lost to Follow-up|0|||
131568940|NCT02851511|473708727|FG001|Phase II|Lost to Follow-up|1|||
131568941|NCT02851511|473708728|FG002|Phase II|Lost to Follow-up|0|||
131568942|NCT02851511|473708729|FG003|Phase II|Lost to Follow-up|0|||
131568943|NCT00051311|473708730|FG000|Overall Study|Starting new study|0|||
131568944|NCT00051311|473708731|FG001|Overall Study|Starting new study|1|||
131568945|NCT00051311|473708730|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
131568946|NCT00051311|473708731|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
131568947|NCT00051311|473708730|FG000|Overall Study|Death of recipient|8|||
131568948|NCT00051311|473708731|FG001|Overall Study|Death of recipient|8|||
131568949|NCT00051311|473708730|FG000|Overall Study|Recipient taken off study|4|||
131568950|NCT00051311|473708731|FG001|Overall Study|Recipient taken off study|4|||
131568951|NCT00003377|473708732|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
131568952|NCT00003377|473708733|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
131568953|NCT00003377|473708734|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
131568954|NCT00003377|473708735|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
131568955|NCT00003377|473708736|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
131568956|NCT00003377|473708732|FG000|Period II|Ureteral stent complications|0|||
131568957|NCT00003377|473708733|FG001|Period II|Ureteral stent complications|0|||
131568958|NCT00003377|473708734|FG002|Period II|Ureteral stent complications|0|||
131568959|NCT00003377|473708735|FG003|Period II|Ureteral stent complications|0|||
131568960|NCT00003377|473708736|FG004|Period II|Ureteral stent complications|1|||
131568961|NCT02256969|473708744|FG000|Overall Study|Screenfailed or withdrew|2|||
131568962|NCT02256969|473708745|FG001|Overall Study|Screenfailed or withdrew|1|||
131568963|NCT02256969|473708746|FG002|Overall Study|Screenfailed or withdrew|1|||
131568964|NCT00372567|473708749|FG000|Phase 3 Study|Adverse Event|5|||
131568965|NCT00372567|473708750|FG001|Phase 3 Study|Adverse Event|1|||
131568966|NCT00372567|473708751|FG002|Phase 3 Study|Adverse Event|1|||
131568967|NCT00372567|473708749|FG000|Phase 3 Study|Death|1|||
131568968|NCT00372567|473708750|FG001|Phase 3 Study|Death|1|||
131568969|NCT00372567|473708751|FG002|Phase 3 Study|Death|0|||
131568970|NCT00372567|473708749|FG000|Phase 3 Study|Protocol Violation|0|||
131568971|NCT00372567|473708750|FG001|Phase 3 Study|Protocol Violation|0|||
131568972|NCT00372567|473708751|FG002|Phase 3 Study|Protocol Violation|1|||
131568973|NCT00372567|473708749|FG000|Phase 3 Study|Objective progression or relapse|10|||
131568974|NCT00372567|473708750|FG001|Phase 3 Study|Objective progression or relapse|13|||
131568975|NCT00372567|473708751|FG002|Phase 3 Study|Objective progression or relapse|4|||
131568976|NCT00372567|473708749|FG000|Phase 3 Study|Global deterioration of health status|0|||
131568977|NCT00372567|473708750|FG001|Phase 3 Study|Global deterioration of health status|1|||
131568978|NCT00372567|473708751|FG002|Phase 3 Study|Global deterioration of health status|0|||
131568979|NCT00372567|473708749|FG000|Phase 3 Study|Other|2|||
131568980|NCT00372567|473708750|FG001|Phase 3 Study|Other|2|||
131568981|NCT00372567|473708751|FG002|Phase 3 Study|Other|1|||
131568982|NCT00372567|473708749|FG000|Phase 3 Study|study terminated by sponsor|13|||
131568983|NCT00372567|473708750|FG001|Phase 3 Study|study terminated by sponsor|8|||
131568984|NCT00372567|473708751|FG002|Phase 3 Study|study terminated by sponsor|5|||
131568985|NCT02347943|473708753|FG000|Overall Study|Study was cancelled|140|||
131568986|NCT02347943|473708754|FG001|Overall Study|Study was cancelled|67|||
131568987|NCT02347943|473708755|FG002|Overall Study|Study was cancelled|45|||
131568988|NCT00303303|473708758|FG000|Overall Study|Withdrawal by Subject|0|||
131568989|NCT00303303|473708759|FG001|Overall Study|Withdrawal by Subject|0|||
131568990|NCT00303303|473708760|FG002|Overall Study|Withdrawal by Subject|1|||
131568991|NCT03566680|473708764|FG000|Overall Study|Pregnancy|1|||
131568992|NCT03566680|473708764|FG000|Overall Study|Lost to Follow-up|13|||
131697153|NCT00498173|474174084|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
131697154|NCT00498173|474174085|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
131697155|NCT03499028|474174086|FG000|Overall Study|Lost to Follow-up|12|||
131697156|NCT03499028|474174087|FG001|Overall Study|Lost to Follow-up|9|||
131697157|NCT03499028|474174086|FG000|Overall Study|Withdrawal by Subject|5|||
131697158|NCT03499028|474174087|FG001|Overall Study|Withdrawal by Subject|8|||
131697159|NCT03499028|474174086|FG000|Overall Study|Unplanned SNF discharge|5|||
131697160|NCT03499028|474174087|FG001|Overall Study|Unplanned SNF discharge|8|||
131697161|NCT00720109|474174088|FG000|Induction Period|Did not meet eligibility criteria|3|||
131697162|NCT00720109|474174089|FG001|Induction Period|Did not meet eligibility criteria|0|||
131697163|NCT00720109|474174090|FG002|Induction Period|Did not meet eligibility criteria|0|||
131697164|NCT00720109|474174088|FG000|Induction Period|Bone Marrow Transplant|2|||
131697165|NCT00720109|474174089|FG001|Induction Period|Bone Marrow Transplant|0|||
131697166|NCT00720109|474174090|FG002|Induction Period|Bone Marrow Transplant|0|||
131697167|NCT00720109|474174088|FG000|Induction Period|Physician Decision|1|||
131697168|NCT00720109|474174089|FG001|Induction Period|Physician Decision|0|||
131568993|NCT03566680|473708764|FG000|Overall Study|Withdrawal by Subject|3|||
131568994|NCT00582790|473708767|FG000|Overall Study|Rapid progression of disease|1|||
131568995|NCT00480441|473708768|FG000|Screening|Not Eligible|37|||
131568996|NCT00480441|473708769|FG001|Screening|Not Eligible|0|||
131568997|NCT00480441|473708770|FG002|Screening|Not Eligible|0|||
131568998|NCT00480441|473708768|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
131568999|NCT00480441|473708769|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
131569000|NCT00480441|473708770|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
131569001|NCT00480441|473708768|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
131569002|NCT00480441|473708769|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
131569003|NCT00480441|473708770|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
131569004|NCT00480441|473708768|FG000|Baseline Functional MRI|physical contraindication|4|||
131569005|NCT00480441|473708769|FG001|Baseline Functional MRI|physical contraindication|0|||
131569006|NCT00480441|473708770|FG002|Baseline Functional MRI|physical contraindication|0|||
131569007|NCT00480441|473708768|FG000|Randomization|Lost to Follow-up|0|||
131569008|NCT00480441|473708769|FG001|Randomization|Lost to Follow-up|7|||
131569009|NCT00480441|473708770|FG002|Randomization|Lost to Follow-up|2|||
131569010|NCT02374957|473708771|FG000|Overall Study|Patient did not complete forms correctly|1|||
131569011|NCT02374957|473708772|FG001|Overall Study|Patient did not complete forms correctly|0|||
131569012|NCT01687270|473708773|FG000|Overall Study|Lack of Efficacy|11|||
131569013|NCT01687270|473708773|FG000|Overall Study|Lost to Follow-up|1|||
131569014|NCT01417000|473708774|FG000|Overall Study|Death|59|||
131569015|NCT01417000|473708775|FG001|Overall Study|Death|28|||
131569016|NCT01417000|473708774|FG000|Overall Study|Lost to Follow-up|1|||
131569017|NCT01417000|473708775|FG001|Overall Study|Lost to Follow-up|0|||
131569018|NCT01417000|473708774|FG000|Overall Study|Study Terminated by Sponsor|1|||
131569019|NCT01417000|473708775|FG001|Overall Study|Study Terminated by Sponsor|1|||
131569020|NCT00558753|473708777|FG000|Overall Study|Lost to Follow-up|5|||
131569021|NCT00558753|473708778|FG001|Overall Study|Lost to Follow-up|7|||
131569022|NCT01928940|473708780|FG000|Overall Study|Adverse Event|0|||
131569023|NCT01928940|473708781|FG001|Overall Study|Adverse Event|1|||
131569024|NCT04668144|473708788|FG000|Overall Study|Protocol Violation|0|||
131569025|NCT04668144|473708789|FG001|Overall Study|Protocol Violation|1|||
131569026|NCT04668144|473708790|FG002|Overall Study|Protocol Violation|2|||
131569027|NCT00916006|473708792|FG000|Overall Study|Adverse Event|1|||
131569028|NCT00916006|473708793|FG001|Overall Study|Adverse Event|1|||
131569029|NCT00916006|473708792|FG000|Overall Study|Withdrawal by Subject|2|||
131569030|NCT00916006|473708793|FG001|Overall Study|Withdrawal by Subject|5|||
131569031|NCT00916006|473708792|FG000|Overall Study|Protocol Violation|0|||
131569032|NCT00916006|473708793|FG001|Overall Study|Protocol Violation|1|||
131569033|NCT02929108|473708798|FG000|Overall Study|Hospice patient death|100|||
131569034|NCT02929108|473708799|FG001|Overall Study|Hospice patient death|64|||
131569035|NCT02929108|473708800|FG002|Overall Study|Hospice patient death|28|||
131569036|NCT02929108|473708801|FG003|Overall Study|Hospice patient death|46|||
131569037|NCT02929108|473708802|FG004|Overall Study|Hospice patient death|55|||
131569038|NCT02929108|473708803|FG005|Overall Study|Hospice patient death|28|||
131569039|NCT02929108|473708804|FG006|Overall Study|Hospice patient death|78|||
131569040|NCT00052962|473708805|FG000|Overall Study|Not evaluable|0|||
131569041|NCT00052962|473708806|FG001|Overall Study|Not evaluable|2|||
131569042|NCT00052962|473708805|FG000|Overall Study|Not randomized/not evaluable|1|||
131569043|NCT00052962|473708806|FG001|Overall Study|Not randomized/not evaluable|0|||
131569044|NCT04319094|473708812|FG000|Baseline|Lost to Follow-up|4|||
131569045|NCT04319094|473708813|FG001|Baseline|Lost to Follow-up|5|||
131569046|NCT04319094|473708812|FG000|Baseline|Protocol Violation|0|||
131569047|NCT04319094|473708813|FG001|Baseline|Protocol Violation|3|||
131569048|NCT04319094|473708812|FG000|Baseline|Withdrawal by Subject|2|||
131569049|NCT04319094|473708813|FG001|Baseline|Withdrawal by Subject|1|||
131569050|NCT04319094|473708812|FG000|Post-Intervention|Death|0|||
131569051|NCT04319094|473708813|FG001|Post-Intervention|Death|1|||
131569052|NCT04319094|473708812|FG000|Post-Intervention|Lost to Follow-up|4|||
131569053|NCT04319094|473708813|FG001|Post-Intervention|Lost to Follow-up|4|||
131569054|NCT04319094|473708812|FG000|Post-Intervention|Withdrawal by Subject|8|||
131697169|NCT00720109|474174090|FG002|Induction Period|Physician Decision|0|||
131697170|NCT00720109|474174088|FG000|Risk Stratification Period|Adverse Event|0|||
131697171|NCT00720109|474174089|FG001|Risk Stratification Period|Adverse Event|1|||
131697172|NCT00720109|474174090|FG002|Risk Stratification Period|Adverse Event|0|||
131697173|NCT00720109|474174088|FG000|Risk Stratification Period|Physician Decision|0|||
131697174|NCT00720109|474174089|FG001|Risk Stratification Period|Physician Decision|2|||
131697175|NCT00720109|474174090|FG002|Risk Stratification Period|Physician Decision|1|||
131697176|NCT00720109|474174088|FG000|Risk Stratification Period|Bone marrow transplant|0|||
131697177|NCT00720109|474174089|FG001|Risk Stratification Period|Bone marrow transplant|9|||
131697178|NCT00720109|474174090|FG002|Risk Stratification Period|Bone marrow transplant|7|||
131569055|NCT04319094|473708813|FG001|Post-Intervention|Withdrawal by Subject|5|||
131569056|NCT04319094|473708812|FG000|Post-Intervention|Incomplete Data Collection|1|||
131569057|NCT04319094|473708813|FG001|Post-Intervention|Incomplete Data Collection|3|||
131697179|NCT00720109|474174088|FG000|Risk Stratification Period|Disease progression or relapse|0|||
131569058|NCT04319094|473708812|FG000|3-month|Death|1|||
131569059|NCT04319094|473708813|FG001|3-month|Death|0|||
131569060|NCT04319094|473708812|FG000|3-month|Lost to Follow-up|2|||
131569061|NCT04319094|473708813|FG001|3-month|Lost to Follow-up|2|||
131569062|NCT04319094|473708812|FG000|3-month|Withdrawal by Subject|0|||
131569063|NCT04319094|473708813|FG001|3-month|Withdrawal by Subject|3|||
131569064|NCT04319094|473708812|FG000|3-month|Incomplete data collection|9|||
131569065|NCT04319094|473708813|FG001|3-month|Incomplete data collection|7|||
131569066|NCT04319094|473708812|FG000|6-month|Lost to Follow-up|1|||
131569067|NCT04319094|473708813|FG001|6-month|Lost to Follow-up|1|||
131569068|NCT04319094|473708812|FG000|6-month|Withdrawal by Subject|0|||
131569069|NCT04319094|473708813|FG001|6-month|Withdrawal by Subject|3|||
131569070|NCT04319094|473708812|FG000|6-month|Incomplete data collection|14|||
131569071|NCT04319094|473708813|FG001|6-month|Incomplete data collection|9|||
131569072|NCT04319094|473708812|FG000|9-month|Lost to Follow-up|8|||
131569073|NCT04319094|473708813|FG001|9-month|Lost to Follow-up|4|||
131569074|NCT04319094|473708812|FG000|9-month|Withdrawal by Subject|0|||
131569075|NCT04319094|473708813|FG001|9-month|Withdrawal by Subject|1|||
131569076|NCT04319094|473708812|FG000|9-month|Incomplete data collection|8|||
131569077|NCT04319094|473708813|FG001|9-month|Incomplete data collection|5|||
131569078|NCT04319094|473708812|FG000|12-month|Lost to Follow-up|11|||
131569079|NCT04319094|473708813|FG001|12-month|Lost to Follow-up|8|||
131569080|NCT00614744|473708814|FG000|Overall Study|Lost to Follow-up|5|||
131569081|NCT00614744|473708815|FG001|Overall Study|Lost to Follow-up|4|||
131569082|NCT00614744|473708814|FG000|Overall Study|Incomplete for Behavior Issues|0|||
131569083|NCT00614744|473708815|FG001|Overall Study|Incomplete for Behavior Issues|2|||
131569084|NCT00877851|473708816|FG000|Overall Study|Lost to Follow-up|5|||
131569085|NCT00877851|473708817|FG001|Overall Study|Lost to Follow-up|5|||
131569086|NCT00877851|473708816|FG000|Overall Study|computer problem|3|||
131569087|NCT00877851|473708817|FG001|Overall Study|computer problem|0|||
131569088|NCT00877851|473708816|FG000|Overall Study|no longer interested in participating|1|||
131569089|NCT00877851|473708817|FG001|Overall Study|no longer interested in participating|0|||
131569090|NCT00770211|473708825|FG000|Overall Study|Lost to Follow-up|1|||
131569091|NCT00770211|473708826|FG001|Overall Study|Lost to Follow-up|0|||
131569092|NCT00770211|473708825|FG000|Overall Study|Withdrawal by Subject|0|||
131569093|NCT00770211|473708826|FG001|Overall Study|Withdrawal by Subject|2|||
131569094|NCT03005288|473708828|FG000|Overall Study|Withdrawal by Subject|7|||
131569095|NCT03005288|473708829|FG001|Overall Study|Withdrawal by Subject|5|||
131569096|NCT03005288|473708828|FG000|Overall Study|Lost to Follow-up|0|||
131569097|NCT03005288|473708829|FG001|Overall Study|Lost to Follow-up|1|||
131569098|NCT03005288|473708828|FG000|Overall Study|Adverse Event|5|||
131569099|NCT03005288|473708829|FG001|Overall Study|Adverse Event|0|||
131569100|NCT03005288|473708828|FG000|Overall Study|Protocol deviation|0|||
131569101|NCT03005288|473708829|FG001|Overall Study|Protocol deviation|1|||
131569102|NCT03005288|473708828|FG000|Overall Study|Physician Decision|0|||
131569103|NCT03005288|473708829|FG001|Overall Study|Physician Decision|1|||
131569104|NCT00665561|473708830|FG000|Overall Study|Death recorded on subject summary pages|75|||
131569105|NCT00665561|473708831|FG001|Overall Study|Death recorded on subject summary pages|75|||
131569106|NCT00665561|473708830|FG000|Overall Study|Does not meet entrance criteria|19|||
131569107|NCT00665561|473708831|FG001|Overall Study|Does not meet entrance criteria|21|||
131569108|NCT00665561|473708830|FG000|Overall Study|Lost to Follow-up|203|||
131783614|NCT03022799|474489996|FG012|Overall Study|Adverse Event|0|||
131783615|NCT01185639|474490000|FG000|Overall Study|Progressed and didn't receive therapy|2|||
131783616|NCT02200614|474490001|FG000|Double Blind Treatment|Adverse Event|86|||
131783617|NCT02200614|474490002|FG001|Double Blind Treatment|Adverse Event|48|||
131783618|NCT02200614|474490001|FG000|Double Blind Treatment|Confirmed metastasis|120|||
131783619|NCT02200614|474490002|FG001|Double Blind Treatment|Confirmed metastasis|140|||
131783620|NCT02200614|474490001|FG000|Double Blind Treatment|Judgment of the investigator|59|||
131783621|NCT02200614|474490002|FG001|Double Blind Treatment|Judgment of the investigator|99|||
131783622|NCT02200614|474490001|FG000|Double Blind Treatment|Metastasis by local reading|1|||
131783623|NCT02200614|474490002|FG001|Double Blind Treatment|Metastasis by local reading|3|||
131783624|NCT02200614|474490001|FG000|Double Blind Treatment|Other reason|6|||
131783625|NCT02200614|474490002|FG001|Double Blind Treatment|Other reason|2|||
131783626|NCT02200614|474490001|FG000|Double Blind Treatment|Personal reason|77|||
131783627|NCT02200614|474490002|FG001|Double Blind Treatment|Personal reason|85|||
131783628|NCT02200614|474490001|FG000|Double Blind Treatment|Protocol deviation|14|||
131783629|NCT02200614|474490002|FG001|Double Blind Treatment|Protocol deviation|7|||
131783630|NCT02200614|474490001|FG000|Double Blind Treatment|Not treated|1|||
131783631|NCT02200614|474490002|FG001|Double Blind Treatment|Not treated|0|||
131783632|NCT02200614|474490001|FG000|Open Label|Adverse Event|41|||
131783633|NCT02200614|474490002|FG001|Open Label|Adverse Event|11|||
131783634|NCT02200614|474490001|FG000|Open Label|Confirmed metastasis|1|||
131783635|NCT02200614|474490002|FG001|Open Label|Confirmed metastasis|0|||
131898654|NCT01516736|474915332|FG001|Overall Study|Death|1|||
131783636|NCT02200614|474490001|FG000|Open Label|Judgment of the investigator|29|||
131569109|NCT00665561|473708831|FG001|Overall Study|Lost to Follow-up|264|||
131569110|NCT00665561|473708830|FG000|Overall Study|Withdrawal by Subject|74|||
131569111|NCT00665561|473708831|FG001|Overall Study|Withdrawal by Subject|65|||
131569112|NCT00665561|473708830|FG000|Overall Study|Other|123|||
131569113|NCT00665561|473708831|FG001|Overall Study|Other|108|||
131569114|NCT00665561|473708830|FG000|Overall Study|Site closed|8|||
131569115|NCT00665561|473708831|FG001|Overall Study|Site closed|0|||
131569116|NCT00665561|473708830|FG000|Overall Study|Withdrawn due to pregnancy|0|||
131569117|NCT00665561|473708831|FG001|Overall Study|Withdrawn due to pregnancy|1|||
131569118|NCT00670540|473708832|FG000|Overall Study|ineligible|17|||
131569119|NCT00670540|473708832|FG000|Overall Study|not living in France|348|||
131569120|NCT00670540|473708832|FG000|Overall Study|refused to participate|189|||
131569121|NCT00670540|473708832|FG000|Overall Study|controls randomised for no follow up|2770|||
131569122|NCT00670540|473708832|FG000|Overall Study|missing information inclusion criteria|1|||
131569123|NCT01140347|473708833|FG000|Overall Study|Lost to Follow-up|5|||
131569124|NCT01140347|473708834|FG001|Overall Study|Lost to Follow-up|6|||
131569125|NCT01140347|473708833|FG000|Overall Study|Withdrawal by Subject|13|||
131569126|NCT01140347|473708834|FG001|Overall Study|Withdrawal by Subject|8|||
131569127|NCT01515319|473708835|FG000|Overall Study|Withdrawal by Subject|0|||
131569128|NCT01515319|473708836|FG001|Overall Study|Withdrawal by Subject|0|||
131569129|NCT01515319|473708837|FG002|Overall Study|Withdrawal by Subject|0|||
131569130|NCT01515319|473708838|FG003|Overall Study|Withdrawal by Subject|0|||
131569131|NCT01515319|473708839|FG004|Overall Study|Withdrawal by Subject|0|||
131569132|NCT01515319|473708840|FG005|Overall Study|Withdrawal by Subject|0|||
131569133|NCT01515319|473708841|FG006|Overall Study|Withdrawal by Subject|1|||
131569134|NCT01515319|473708842|FG007|Overall Study|Withdrawal by Subject|0|||
131569135|NCT01515319|473708843|FG008|Overall Study|Withdrawal by Subject|0|||
131569136|NCT01515319|473708844|FG009|Overall Study|Withdrawal by Subject|0|||
131569137|NCT01515319|473708835|FG000|Overall Study|Adverse Event|0|||
131569138|NCT01515319|473708836|FG001|Overall Study|Adverse Event|0|||
131569139|NCT01515319|473708837|FG002|Overall Study|Adverse Event|0|||
131569140|NCT01515319|473708838|FG003|Overall Study|Adverse Event|0|||
131569141|NCT01515319|473708839|FG004|Overall Study|Adverse Event|0|||
131569142|NCT01515319|473708840|FG005|Overall Study|Adverse Event|0|||
131569143|NCT01515319|473708841|FG006|Overall Study|Adverse Event|0|||
131569144|NCT01515319|473708842|FG007|Overall Study|Adverse Event|0|||
131569145|NCT01515319|473708843|FG008|Overall Study|Adverse Event|3|||
131569146|NCT01515319|473708844|FG009|Overall Study|Adverse Event|0|||
131569147|NCT01515319|473708835|FG000|Overall Study|Protocol Violation|0|||
131569148|NCT01515319|473708836|FG001|Overall Study|Protocol Violation|0|||
131569149|NCT01515319|473708837|FG002|Overall Study|Protocol Violation|0|||
131569150|NCT01515319|473708838|FG003|Overall Study|Protocol Violation|0|||
131569151|NCT01515319|473708839|FG004|Overall Study|Protocol Violation|0|||
131569152|NCT01515319|473708840|FG005|Overall Study|Protocol Violation|0|||
131569153|NCT01515319|473708841|FG006|Overall Study|Protocol Violation|0|||
131569154|NCT01515319|473708842|FG007|Overall Study|Protocol Violation|0|||
131569155|NCT01515319|473708843|FG008|Overall Study|Protocol Violation|2|||
131569156|NCT01515319|473708844|FG009|Overall Study|Protocol Violation|0|||
131569157|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Adverse Event|5|||
131569158|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Adverse Event|13|||
131569159|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Adverse Event|0|||
131569160|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
131569161|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
131569162|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
131569163|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
131569164|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
131569165|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
131569166|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
131569167|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
131569168|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
131569169|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
131569170|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
131569171|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
131569172|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
131569173|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
131569174|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
131569175|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Physician Decision|2|||
131569176|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Physician Decision|3|||
131569177|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Physician Decision|0|||
131569178|NCT01449929|473708845|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
131569179|NCT01449929|473708846|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
131697180|NCT00720109|474174089|FG001|Risk Stratification Period|Disease progression or relapse|2|||
131697181|NCT00720109|474174090|FG002|Risk Stratification Period|Disease progression or relapse|0|||
131697182|NCT00720109|474174088|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
131697183|NCT00720109|474174089|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
131569180|NCT01449929|473708847|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
131569181|NCT01449929|473708845|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
131569182|NCT01449929|473708846|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
131569183|NCT01449929|473708847|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
131569184|NCT01449929|473708845|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
131569185|NCT01449929|473708846|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
131569186|NCT01449929|473708847|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
131569187|NCT01449929|473708845|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
131569188|NCT01449929|473708846|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
131569189|NCT01449929|473708847|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
131569190|NCT01871285|473708848|FG000|First Intervention (1 Day)|Adverse Event|1|||
131569191|NCT01871285|473708849|FG001|First Intervention (1 Day)|Adverse Event|0|||
131569192|NCT01871285|473708850|FG002|First Intervention (1 Day)|Adverse Event|0|||
131569193|NCT01871285|473708851|FG003|First Intervention (1 Day)|Adverse Event|0|||
131569194|NCT01871285|473708848|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
131569195|NCT01871285|473708849|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
131569196|NCT01871285|473708850|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
131569197|NCT01871285|473708851|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
131569198|NCT01959880|473708852|FG000|Overall Study|Withdrawal by Subject|11|||
131569199|NCT01959880|473708853|FG001|Overall Study|Withdrawal by Subject|13|||
131569200|NCT01959880|473708854|FG002|Overall Study|Withdrawal by Subject|8|||
131569201|NCT01959880|473708855|FG003|Overall Study|Withdrawal by Subject|7|||
131569202|NCT01959880|473708852|FG000|Overall Study|Death|1|||
131569203|NCT01959880|473708853|FG001|Overall Study|Death|10|||
131569204|NCT01959880|473708854|FG002|Overall Study|Death|1|||
131569205|NCT01959880|473708855|FG003|Overall Study|Death|2|||
131569206|NCT01959880|473708852|FG000|Overall Study|Lost to Follow-up|95|||
131569207|NCT01959880|473708853|FG001|Overall Study|Lost to Follow-up|18|||
131569208|NCT01959880|473708854|FG002|Overall Study|Lost to Follow-up|15|||
131569209|NCT01959880|473708855|FG003|Overall Study|Lost to Follow-up|8|||
131569210|NCT01959880|473708852|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
131569211|NCT01959880|473708853|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
131569212|NCT01959880|473708854|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
131569213|NCT01959880|473708855|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
131569214|NCT01959880|473708852|FG000|Overall Study|Study completed early-FDA approved|1003|||
131569215|NCT01959880|473708853|FG001|Overall Study|Study completed early-FDA approved|311|||
131569216|NCT01959880|473708854|FG002|Overall Study|Study completed early-FDA approved|179|||
131569217|NCT01959880|473708855|FG003|Overall Study|Study completed early-FDA approved|152|||
131569218|NCT01919619|473708856|FG000|Overall Study|Physician Decision|1|||
131569219|NCT01919619|473708857|FG001|Overall Study|Physician Decision|1|||
131569220|NCT00662909|473708862|FG000|Overall Study|Adverse Event|17|||
131569221|NCT00662909|473708863|FG001|Overall Study|Adverse Event|18|||
131569222|NCT00662909|473708864|FG002|Overall Study|Adverse Event|19|||
131569223|NCT00662909|473708862|FG000|Overall Study|Lack of Efficacy|9|||
131569224|NCT00662909|473708863|FG001|Overall Study|Lack of Efficacy|1|||
131569225|NCT00662909|473708864|FG002|Overall Study|Lack of Efficacy|5|||
131569226|NCT00662909|473708862|FG000|Overall Study|Withdrawal by Subject|29|||
131569227|NCT00662909|473708863|FG001|Overall Study|Withdrawal by Subject|22|||
131569228|NCT00662909|473708864|FG002|Overall Study|Withdrawal by Subject|16|||
131569229|NCT00662909|473708862|FG000|Overall Study|Lost to Follow-up|2|||
131569230|NCT00662909|473708863|FG001|Overall Study|Lost to Follow-up|9|||
131569231|NCT00662909|473708864|FG002|Overall Study|Lost to Follow-up|3|||
131569232|NCT00662909|473708862|FG000|Overall Study|Protocol Violation|7|||
131569233|NCT00662909|473708863|FG001|Overall Study|Protocol Violation|4|||
131569234|NCT00662909|473708864|FG002|Overall Study|Protocol Violation|5|||
131569235|NCT00662909|473708862|FG000|Overall Study|Randomized- never received study drug|1|||
131569236|NCT00662909|473708863|FG001|Overall Study|Randomized- never received study drug|0|||
131569237|NCT00662909|473708864|FG002|Overall Study|Randomized- never received study drug|0|||
131569238|NCT00662909|473708862|FG000|Overall Study|Non-compliance with study procedures|3|||
131569239|NCT00662909|473708863|FG001|Overall Study|Non-compliance with study procedures|3|||
131569240|NCT00662909|473708864|FG002|Overall Study|Non-compliance with study procedures|2|||
131569241|NCT00662909|473708862|FG000|Overall Study|Physician Decision|1|||
131569242|NCT00662909|473708863|FG001|Overall Study|Physician Decision|1|||
131569243|NCT00662909|473708864|FG002|Overall Study|Physician Decision|2|||
131569244|NCT00662909|473708862|FG000|Overall Study|Eligibility criterion not met|0|||
131569245|NCT00662909|473708863|FG001|Overall Study|Eligibility criterion not met|1|||
131783637|NCT02200614|474490002|FG001|Open Label|Judgment of the investigator|2|||
131569246|NCT00662909|473708864|FG002|Overall Study|Eligibility criterion not met|1|||
131569247|NCT04978363|473710556|FG000|Overall Study|Other medical issues unrelated to the study|0|||
131569248|NCT04978363|473710557|FG001|Overall Study|Other medical issues unrelated to the study|0|||
131569249|NCT04978363|473710558|FG002|Overall Study|Other medical issues unrelated to the study|0|||
131569250|NCT04978363|473710559|FG003|Overall Study|Other medical issues unrelated to the study|0|||
131569251|NCT04978363|473710560|FG004|Overall Study|Other medical issues unrelated to the study|1|||
131569252|NCT04978363|473710561|FG005|Overall Study|Other medical issues unrelated to the study|0|||
131569253|NCT04978363|473710562|FG006|Overall Study|Other medical issues unrelated to the study|0|||
131569254|NCT04978363|473710563|FG007|Overall Study|Other medical issues unrelated to the study|0|||
131569255|NCT04978363|473710564|FG008|Overall Study|Other medical issues unrelated to the study|0|||
131569256|NCT04978363|473710565|FG009|Overall Study|Other medical issues unrelated to the study|0|||
131569257|NCT04978363|473710566|FG010|Overall Study|Other medical issues unrelated to the study|0|||
131569258|NCT04978363|473710556|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
131569259|NCT04978363|473710557|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
131569260|NCT04978363|473710558|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
131569261|NCT04978363|473710559|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
131569262|NCT04978363|473710560|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
131569263|NCT04978363|473710561|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
131569264|NCT04978363|473710562|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
131569265|NCT04978363|473710563|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
131569266|NCT04978363|473710564|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
131569267|NCT04978363|473710565|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
131569268|NCT04978363|473710566|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
131569269|NCT04978363|473710556|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569270|NCT04978363|473710557|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
131569271|NCT04978363|473710558|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569272|NCT04978363|473710559|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569273|NCT04978363|473710560|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569274|NCT04978363|473710561|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569275|NCT04978363|473710562|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569276|NCT04978363|473710563|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569277|NCT04978363|473710564|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569278|NCT04978363|473710565|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569279|NCT04978363|473710566|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131569280|NCT02153788|473710567|FG000|Overall Study|Physician Decision|2|||
131569281|NCT02153788|473710568|FG001|Overall Study|Physician Decision|1|||
131569282|NCT01684046|473710569|FG000|Period 1, First 30 Days|Adverse Event|0|||
131569283|NCT01684046|473710570|FG001|Period 1, First 30 Days|Adverse Event|2|||
131569284|NCT02790606|473710580|FG000|Overall Study|Death|27|||
131569285|NCT02790606|473710580|FG000|Overall Study|Lost to Follow-up|4|||
131569286|NCT02790606|473710580|FG000|Overall Study|Physician Decision|3|||
131569287|NCT02790606|473710580|FG000|Overall Study|Withdrawal by Subject|1|||
131569288|NCT02735915|473710581|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
131569289|NCT02735915|473710581|FG000|Overall Study|Withdrawal following SAE|2|||
131569290|NCT02735915|473710581|FG000|Overall Study|Withdrawal by Subject|1|||
131569291|NCT05328973|473710582|FG000|Overall Study|Withdrawal by Subject|0|||
131569292|NCT05328973|473710583|FG001|Overall Study|Withdrawal by Subject|1|||
131569293|NCT00946114|473710584|FG000|Overall Study|Death|5|||
131569294|NCT00946114|473710585|FG001|Overall Study|Death|2|||
131569295|NCT00946114|473710584|FG000|Overall Study|Other|1|||
131569296|NCT00946114|473710585|FG001|Overall Study|Other|0|||
131569297|NCT00946114|473710584|FG000|Overall Study|Withdrawal by Subject|2|||
131569298|NCT00946114|473710585|FG001|Overall Study|Withdrawal by Subject|0|||
131569299|NCT00498186|473710587|FG000|Overall Study|Protocol Violation|10|||
131569300|NCT00498186|473710587|FG000|Overall Study|Lack of Efficacy|31|||
131569301|NCT00498186|473710587|FG000|Overall Study|Adverse Event|89|||
131569302|NCT00498186|473710587|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
131569303|NCT00498186|473710587|FG000|Overall Study|Withdrawal by Subject|18|||
131569304|NCT00498186|473710587|FG000|Overall Study|Lost to Follow-up|3|||
131569305|NCT00498186|473710587|FG000|Overall Study|Other|10|||
131569306|NCT03929302|473710588|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
131569307|NCT03929302|473710589|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
131569308|NCT03929302|473710590|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
131569309|NCT03929302|473710588|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
131569310|NCT03929302|473710589|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
131569311|NCT03929302|473710590|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
131569312|NCT03929302|473710588|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
131569313|NCT03929302|473710589|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
131697184|NCT00720109|474174090|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
131697185|NCT01110200|474174091|FG000|Overall Study|Adverse Event|28|||
131697186|NCT01110200|474174092|FG001|Overall Study|Adverse Event|28|||
131697187|NCT01110200|474174091|FG000|Overall Study|Withdrawal by Subject|25|||
131697188|NCT01110200|474174092|FG001|Overall Study|Withdrawal by Subject|32|||
131697189|NCT01110200|474174091|FG000|Overall Study|Lack of Efficacy|16|||
131569314|NCT03929302|473710590|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
131697190|NCT01110200|474174092|FG001|Overall Study|Lack of Efficacy|25|||
131569315|NCT02757885|473710591|FG000|Overall Study|Screen Failures|4|||
131569316|NCT03239210|473710593|FG000|Overall Study|Lost to Follow-up|2|||
131697191|NCT01110200|474174091|FG000|Overall Study|Protocol Violation|14|||
131569317|NCT03239210|473710594|FG001|Overall Study|Lost to Follow-up|2|||
131697192|NCT01110200|474174092|FG001|Overall Study|Protocol Violation|12|||
131569318|NCT03239210|473710593|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
131569319|NCT03239210|473710594|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
131569320|NCT03239210|473710593|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
131569321|NCT03239210|473710594|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
131569322|NCT03085017|473710595|FG000|Overall Study|Death|0|||
131569323|NCT03085017|473710596|FG001|Overall Study|Death|3|||
131569324|NCT00058058|473710597|FG000|Overall Study|Withdrawal by Subject|4|||
131569325|NCT00058058|473710597|FG000|Overall Study|Ineligible|20|||
131569326|NCT00058058|473710597|FG000|Overall Study|Claustrophobic|5|||
131569327|NCT00058058|473710597|FG000|Overall Study|technical issues|6|||
131569328|NCT00058058|473710597|FG000|Overall Study|Poor positioning, illness,pain|3|||
131569329|NCT03681691|473710605|FG000|Overall Study|COVID|1|||
131569330|NCT03681691|473710606|FG001|Overall Study|COVID|0|||
131569331|NCT03681691|473710605|FG000|Overall Study|prolonged bleeding|1|||
131569332|NCT03681691|473710606|FG001|Overall Study|prolonged bleeding|0|||
131569333|NCT03681691|473710605|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
131569334|NCT03681691|473710606|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
131569335|NCT00748969|473710607|FG000|Overall Study|Withdrawal by Subject|1|||
131569336|NCT00748969|473710608|FG001|Overall Study|Withdrawal by Subject|0|||
131569337|NCT00748969|473710607|FG000|Overall Study|Withdrawal by Subject|0|||
131569338|NCT00748969|473710608|FG001|Overall Study|Withdrawal by Subject|1|||
131569339|NCT03613129|473710609|FG000|Pre-treatment Assessment|Protocol Violation|2|||
131569340|NCT03613129|473710610|FG001|Pre-treatment Assessment|Protocol Violation|0|||
131569341|NCT03613129|473710611|FG002|Pre-treatment Assessment|Protocol Violation|0|||
131569342|NCT03613129|473710612|FG003|Pre-treatment Assessment|Protocol Violation|0|||
131569343|NCT03613129|473710613|FG004|Pre-treatment Assessment|Protocol Violation|0|||
131569344|NCT03613129|473710609|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
131569345|NCT03613129|473710610|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
131569346|NCT03613129|473710611|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
131569347|NCT03613129|473710612|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
131569348|NCT03613129|473710613|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
131569349|NCT02334306|473710614|FG000|Double-blind Period|Adverse Event|0|||
131569350|NCT02334306|473710615|FG001|Double-blind Period|Adverse Event|1|||
131569351|NCT02334306|473710614|FG000|Double-blind Period|Withdrawal by Subject|1|||
131569352|NCT02334306|473710615|FG001|Double-blind Period|Withdrawal by Subject|1|||
131569353|NCT00465985|473710616|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
131569354|NCT00465985|473710617|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
131569355|NCT00465985|473710616|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
131569356|NCT00465985|473710617|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
131569357|NCT00465985|473710616|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
131569358|NCT00465985|473710617|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
131569359|NCT00465985|473710616|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
131569360|NCT00465985|473710617|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
131569361|NCT03302156|473710618|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
131569362|NCT03302156|473710619|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
131569363|NCT03302156|473710620|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
131569364|NCT03532178|473710621|FG000|First Period|Withdrawal by Subject|1|||
131569365|NCT03532178|473710622|FG001|First Period|Withdrawal by Subject|3|||
131569366|NCT03532178|473710621|FG000|First Period|technical issues in data collection Technical issues|0|||
131569367|NCT03532178|473710622|FG001|First Period|technical issues in data collection Technical issues|1|||
131569368|NCT03532178|473710621|FG000|Second Period|Withdrawal by Subject|1|||
131569369|NCT03532178|473710622|FG001|Second Period|Withdrawal by Subject|1|||
131569370|NCT03532178|473710621|FG000|Second Period|Technical issues|0|||
131569371|NCT03532178|473710622|FG001|Second Period|Technical issues|1|||
131569372|NCT02390557|473710623|FG000|Wave 2|Survey non-respondent|72|||
131569373|NCT02390557|473710624|FG001|Wave 2|Survey non-respondent|41|||
131569374|NCT02390557|473710625|FG002|Wave 2|Survey non-respondent|23|||
131569375|NCT03278028|473710628|FG000|Overall Study|Lost to Follow-up|1|||
131569376|NCT03278028|473710629|FG001|Overall Study|Lost to Follow-up|0|||
131569377|NCT03278028|473710628|FG000|Overall Study|Withdrawal by Subject|3|||
131569378|NCT03278028|473710629|FG001|Overall Study|Withdrawal by Subject|1|||
131569379|NCT03278028|473710628|FG000|Overall Study|Pregnancy|0|||
131898655|NCT01516736|474915331|FG000|Overall Study|Physician Decision|2|||
131569380|NCT03278028|473710629|FG001|Overall Study|Pregnancy|1|||
131569381|NCT00463151|473710631|FG000|Overall Study|Adverse Event|0|||
131569382|NCT00463151|473710632|FG001|Overall Study|Adverse Event|0|||
131569383|NCT00463151|473710633|FG002|Overall Study|Adverse Event|1|||
131569384|NCT00463151|473710634|FG003|Overall Study|Adverse Event|0|||
131569385|NCT00463151|473710631|FG000|Overall Study|Lack of Efficacy|2|||
131569386|NCT00463151|473710632|FG001|Overall Study|Lack of Efficacy|5|||
131569387|NCT00463151|473710633|FG002|Overall Study|Lack of Efficacy|2|||
131569388|NCT00463151|473710634|FG003|Overall Study|Lack of Efficacy|5|||
131569389|NCT00463151|473710631|FG000|Overall Study|Protocol Violation|0|||
131569390|NCT00463151|473710632|FG001|Overall Study|Protocol Violation|0|||
131569391|NCT00463151|473710633|FG002|Overall Study|Protocol Violation|0|||
131569392|NCT00463151|473710634|FG003|Overall Study|Protocol Violation|1|||
131569393|NCT00463151|473710631|FG000|Overall Study|Withdrawal by Subject|0|||
131569394|NCT00463151|473710632|FG001|Overall Study|Withdrawal by Subject|0|||
131569395|NCT00463151|473710633|FG002|Overall Study|Withdrawal by Subject|0|||
131569396|NCT00463151|473710634|FG003|Overall Study|Withdrawal by Subject|1|||
131569397|NCT00293462|473710635|FG000|Overall Study|Withdrawal by Subject|4|||
131569398|NCT00293462|473710636|FG001|Overall Study|Withdrawal by Subject|3|||
131569399|NCT00293462|473710637|FG002|Overall Study|Withdrawal by Subject|8|||
131569400|NCT00293462|473710635|FG000|Overall Study|Death|1|||
131569401|NCT00293462|473710636|FG001|Overall Study|Death|0|||
131569402|NCT00293462|473710637|FG002|Overall Study|Death|0|||
131569403|NCT00293462|473710635|FG000|Overall Study|Lost to Follow-up|0|||
131569404|NCT00293462|473710636|FG001|Overall Study|Lost to Follow-up|1|||
131569405|NCT00293462|473710637|FG002|Overall Study|Lost to Follow-up|0|||
131569406|NCT00293462|473710635|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
131569407|NCT00293462|473710636|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
131569408|NCT00293462|473710637|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
131569409|NCT00293462|473710635|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
131569410|NCT00293462|473710636|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
131569411|NCT00293462|473710637|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
131569412|NCT00293462|473710635|FG000|Overall Study|Refuse Radiation Treatment|1|||
131569413|NCT00293462|473710636|FG001|Overall Study|Refuse Radiation Treatment|0|||
131569414|NCT00293462|473710637|FG002|Overall Study|Refuse Radiation Treatment|0|||
131569415|NCT00293462|473710635|FG000|Overall Study|No Show|0|||
131569416|NCT00293462|473710636|FG001|Overall Study|No Show|0|||
131569417|NCT00293462|473710637|FG002|Overall Study|No Show|1|||
131569418|NCT00293462|473710635|FG000|Overall Study|Went back to his home country|0|||
131569419|NCT00293462|473710636|FG001|Overall Study|Went back to his home country|0|||
131569420|NCT00293462|473710637|FG002|Overall Study|Went back to his home country|1|||
131569421|NCT00293462|473710635|FG000|Overall Study|Blood clot after chemotherapy|0|||
131569422|NCT00293462|473710636|FG001|Overall Study|Blood clot after chemotherapy|0|||
131569423|NCT00293462|473710637|FG002|Overall Study|Blood clot after chemotherapy|1|||
131569424|NCT00293462|473710635|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
131569425|NCT00293462|473710636|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
131569426|NCT00293462|473710637|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
131569427|NCT00293462|473710635|FG000|Overall Study|Possible Tracheostomy leakage|0|||
131569428|NCT00293462|473710636|FG001|Overall Study|Possible Tracheostomy leakage|1|||
131569429|NCT00293462|473710637|FG002|Overall Study|Possible Tracheostomy leakage|0|||
131569430|NCT00293462|473710635|FG000|Overall Study|Low radiation dose in oral cavity|0|||
131569431|NCT00293462|473710636|FG001|Overall Study|Low radiation dose in oral cavity|1|||
131569432|NCT00293462|473710637|FG002|Overall Study|Low radiation dose in oral cavity|0|||
131569433|NCT00293462|473710635|FG000|Overall Study|Physician Decision|0|||
131569434|NCT00293462|473710636|FG001|Overall Study|Physician Decision|1|||
131569435|NCT00293462|473710637|FG002|Overall Study|Physician Decision|0|||
131569436|NCT00688688|473710638|FG000|Overall Study|Eligibility criterion not met|7|||
131569437|NCT00688688|473710639|FG001|Overall Study|Eligibility criterion not met|7|||
131569438|NCT00688688|473710640|FG002|Overall Study|Eligibility criterion not met|10|||
131569439|NCT00688688|473710638|FG000|Overall Study|Adverse Event|52|||
131697193|NCT01110200|474174091|FG000|Overall Study|Physician Decision|13|||
131697194|NCT01110200|474174092|FG001|Overall Study|Physician Decision|17|||
131697195|NCT01110200|474174091|FG000|Overall Study|Lost to Follow-up|10|||
131697196|NCT01110200|474174092|FG001|Overall Study|Lost to Follow-up|7|||
131697197|NCT01632566|474174095|FG000|Overall Study|Withdrawal by Subject|0|||
131697198|NCT01632566|474174096|FG001|Overall Study|Withdrawal by Subject|1|||
131697199|NCT01632566|474174097|FG002|Overall Study|Withdrawal by Subject|0|||
131697200|NCT01632566|474174098|FG003|Overall Study|Withdrawal by Subject|0|||
131697201|NCT01632566|474174099|FG004|Overall Study|Withdrawal by Subject|0|||
131697202|NCT01632566|474174095|FG000|Overall Study|Sponsor Decision|0|||
131697203|NCT01632566|474174096|FG001|Overall Study|Sponsor Decision|2|||
131569440|NCT00688688|473710639|FG001|Overall Study|Adverse Event|51|||
131569441|NCT00688688|473710640|FG002|Overall Study|Adverse Event|50|||
131569442|NCT00688688|473710638|FG000|Overall Study|Lack of Efficacy|34|||
131569443|NCT00688688|473710639|FG001|Overall Study|Lack of Efficacy|25|||
131569444|NCT00688688|473710640|FG002|Overall Study|Lack of Efficacy|45|||
131569445|NCT00688688|473710638|FG000|Overall Study|Withdrawal by Subject|66|||
131569446|NCT00688688|473710639|FG001|Overall Study|Withdrawal by Subject|75|||
131569447|NCT00688688|473710640|FG002|Overall Study|Withdrawal by Subject|65|||
131569448|NCT00688688|473710638|FG000|Overall Study|Lost to Follow-up|14|||
131569449|NCT00688688|473710639|FG001|Overall Study|Lost to Follow-up|7|||
131697204|NCT01632566|474174097|FG002|Overall Study|Sponsor Decision|9|||
131697205|NCT01632566|474174098|FG003|Overall Study|Sponsor Decision|2|||
131697206|NCT01632566|474174099|FG004|Overall Study|Sponsor Decision|2|||
131569450|NCT00688688|473710640|FG002|Overall Study|Lost to Follow-up|7|||
131569451|NCT00688688|473710638|FG000|Overall Study|Protocol Violation|6|||
131569452|NCT00688688|473710639|FG001|Overall Study|Protocol Violation|9|||
131569453|NCT00688688|473710640|FG002|Overall Study|Protocol Violation|11|||
131569454|NCT00688688|473710638|FG000|Overall Study|Randomized but never received study drug|1|||
131569455|NCT00688688|473710639|FG001|Overall Study|Randomized but never received study drug|0|||
131569456|NCT00688688|473710640|FG002|Overall Study|Randomized but never received study drug|0|||
131569457|NCT00688688|473710638|FG000|Overall Study|Non-compliance with study procedures|5|||
131569458|NCT00688688|473710639|FG001|Overall Study|Non-compliance with study procedures|3|||
131569459|NCT00688688|473710640|FG002|Overall Study|Non-compliance with study procedures|4|||
131569460|NCT00688688|473710638|FG000|Overall Study|Taking exclusionary medications|1|||
131569461|NCT00688688|473710639|FG001|Overall Study|Taking exclusionary medications|0|||
131569462|NCT00688688|473710640|FG002|Overall Study|Taking exclusionary medications|0|||
131569463|NCT00688688|473710638|FG000|Overall Study|Site closure|0|||
131569464|NCT00688688|473710639|FG001|Overall Study|Site closure|1|||
131569465|NCT00688688|473710640|FG002|Overall Study|Site closure|0|||
131569466|NCT00688688|473710638|FG000|Overall Study|Violation of exclusion criterion|0|||
131569467|NCT00688688|473710639|FG001|Overall Study|Violation of exclusion criterion|1|||
131569468|NCT00688688|473710640|FG002|Overall Study|Violation of exclusion criterion|0|||
131569469|NCT03283553|473710643|FG000|Patient Participant Flow|Death|5|||
131569470|NCT03283553|473710644|FG001|Patient Participant Flow|Death|10|||
131569471|NCT03283553|473710643|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
131569472|NCT03283553|473710644|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
131569473|NCT03283553|473710643|FG000|Patient Participant Flow|Lost to Follow-up|1|||
131569474|NCT03283553|473710644|FG001|Patient Participant Flow|Lost to Follow-up|1|||
131569475|NCT03283553|473710643|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
131569476|NCT03283553|473710644|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
131569477|NCT03283553|473710643|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
131569478|NCT03283553|473710644|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
131569479|NCT03283553|473710643|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
131569480|NCT03283553|473710644|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
131569481|NCT03686683|473710645|FG000|Overall Study|Withdrawal by Subject|52|||
131697207|NCT02158091|474174101|FG000|Overall Study|DLT|2|||
131569482|NCT03686683|473710646|FG001|Overall Study|Withdrawal by Subject|32|||
131569483|NCT03686683|473710645|FG000|Overall Study|Lost to Follow-up|23|||
131569484|NCT03686683|473710646|FG001|Overall Study|Lost to Follow-up|19|||
131569485|NCT03686683|473710645|FG000|Overall Study|Adverse Event|1|||
131569486|NCT03686683|473710646|FG001|Overall Study|Adverse Event|0|||
131569487|NCT03686683|473710645|FG000|Overall Study|Death|10|||
131569488|NCT03686683|473710646|FG001|Overall Study|Death|5|||
131569489|NCT03686683|473710645|FG000|Overall Study|Progressive Disease|1|||
131569490|NCT03686683|473710646|FG001|Overall Study|Progressive Disease|1|||
131569491|NCT03686683|473710645|FG000|Overall Study|Noncompliance|1|||
131569492|NCT03686683|473710646|FG001|Overall Study|Noncompliance|0|||
131569493|NCT03686683|473710645|FG000|Overall Study|Physician Decision|1|||
131569494|NCT03686683|473710646|FG001|Overall Study|Physician Decision|1|||
131569495|NCT03686683|473710645|FG000|Overall Study|Screen fail post-randomization|1|||
131569496|NCT03686683|473710646|FG001|Overall Study|Screen fail post-randomization|0|||
131569497|NCT03686683|473710645|FG000|Overall Study|Protocol Violation|3|||
131569498|NCT03686683|473710646|FG001|Overall Study|Protocol Violation|0|||
131569499|NCT03686683|473710645|FG000|Overall Study|No data available|1|||
131569500|NCT03686683|473710646|FG001|Overall Study|No data available|0|||
131569501|NCT03255941|473710647|FG000|Overall Study|Not eligible or refused injection|37|||
131569502|NCT03255941|473710648|FG001|Overall Study|Not eligible or refused injection|44|||
131569503|NCT03255941|473710649|FG002|Overall Study|Not eligible or refused injection|5|||
131569504|NCT03255941|473710650|FG003|Overall Study|Not eligible or refused injection|6|||
131569505|NCT03255941|473710647|FG000|Overall Study|Did not complete exit interview|1|||
131569506|NCT03255941|473710648|FG001|Overall Study|Did not complete exit interview|2|||
131569507|NCT03255941|473710649|FG002|Overall Study|Did not complete exit interview|0|||
131569508|NCT03255941|473710650|FG003|Overall Study|Did not complete exit interview|0|||
131569509|NCT00372060|473710651|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
131569510|NCT00372060|473710652|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
131569511|NCT00372060|473710651|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
131569512|NCT00372060|473710652|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
131569513|NCT00372060|473710651|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
131569514|NCT00372060|473710652|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
131569515|NCT00372060|473710651|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
131569516|NCT00372060|473710652|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
131569517|NCT00372060|473710651|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
131569518|NCT00372060|473710652|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
131569519|NCT00372060|473710651|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
131569520|NCT00372060|473710652|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
131569521|NCT01579578|473710653|FG000|Overall Study|Death|4|||
131569522|NCT01579578|473710654|FG001|Overall Study|Death|1|||
131569523|NCT01579578|473710653|FG000|Overall Study|Lost to Follow-up|1|||
131569524|NCT01579578|473710654|FG001|Overall Study|Lost to Follow-up|1|||
131569525|NCT01579578|473710653|FG000|Overall Study|Withdrawal by Subject|2|||
131569526|NCT01579578|473710654|FG001|Overall Study|Withdrawal by Subject|1|||
131569527|NCT01579578|473710653|FG000|Overall Study|Eligibility criteria|3|||
131569528|NCT01579578|473710654|FG001|Overall Study|Eligibility criteria|9|||
131569529|NCT01579578|473710653|FG000|Overall Study|Ongoing|3|||
131569530|NCT01579578|473710654|FG001|Overall Study|Ongoing|0|||
131569531|NCT01528709|473710655|FG000|Overall Study|Death|2|||
131569532|NCT01528709|473710656|FG001|Overall Study|Death|0|||
131569533|NCT01528709|473710655|FG000|Overall Study|Withdrawal by Subject|10|||
131569534|NCT01528709|473710656|FG001|Overall Study|Withdrawal by Subject|15|||
131569535|NCT01528709|473710655|FG000|Overall Study|allergy|1|||
131697208|NCT02158091|474174102|FG001|Overall Study|DLT|1|||
131697209|NCT02158091|474174103|FG002|Overall Study|DLT|0|||
131697210|NCT03977467|474174104|FG000|Overall Study|Disease Progression|1|||
131697211|NCT03977467|474174105|FG001|Overall Study|Disease Progression|1|||
131697212|NCT03977467|474174106|FG002|Overall Study|Disease Progression|30|||
131697213|NCT03977467|474174107|FG003|Overall Study|Disease Progression|0|||
131697214|NCT03977467|474174104|FG000|Overall Study|Adverse Event|0|||
131697215|NCT03977467|474174105|FG001|Overall Study|Adverse Event|1|||
131697216|NCT03977467|474174106|FG002|Overall Study|Adverse Event|0|||
131697217|NCT03977467|474174107|FG003|Overall Study|Adverse Event|0|||
131697218|NCT03977467|474174104|FG000|Overall Study|Death|0|||
131569536|NCT01528709|473710656|FG001|Overall Study|allergy|0|||
131569537|NCT00647348|473710659|FG000|Overall Study|Lost to Follow-up|3|||
131569538|NCT00647348|473710660|FG001|Overall Study|Lost to Follow-up|6|||
131569539|NCT04889118|473710665|FG000|Overall Study|Death|33|||
131569540|NCT04889118|473710666|FG001|Overall Study|Death|37|||
131569541|NCT04889118|473710665|FG000|Overall Study|Ongoing in Study|31|||
131697219|NCT03977467|474174105|FG001|Overall Study|Death|0|||
131569542|NCT04889118|473710666|FG001|Overall Study|Ongoing in Study|30|||
131569543|NCT00821236|473710671|FG000|Overall Study|Lost to Follow-up|3|||
131569544|NCT01582243|473710672|FG000|Overall Study|Withdrawal by Subject|1|||
131697220|NCT03977467|474174106|FG002|Overall Study|Death|3|||
131697221|NCT03977467|474174107|FG003|Overall Study|Death|0|||
131569545|NCT01582243|473710672|FG000|Overall Study|Adverse Event|1|||
131569546|NCT01582243|473710672|FG000|Overall Study|Lost to Follow-up|1|||
131569547|NCT02397889|473710674|FG000|Overall Study|Physician Decision|1|||
131569548|NCT02397889|473710675|FG001|Overall Study|Physician Decision|0|||
131569549|NCT02954055|473710684|FG000|Overall Study|Did not initiate therapy|6|||
131569550|NCT02954055|473710685|FG001|Overall Study|Did not initiate therapy|1|||
131569551|NCT02096003|473710686|FG000|Overall Study|Protocol Violation|0|||
131569552|NCT02096003|473710687|FG001|Overall Study|Protocol Violation|2|||
131569553|NCT02096003|473710686|FG000|Overall Study|additional surgery|2|||
131569554|NCT02096003|473710687|FG001|Overall Study|additional surgery|1|||
131569555|NCT01511250|473710688|FG000|Overall Study|Withdrawal of Consent|1|||
131569556|NCT01511250|473710689|FG001|Overall Study|Withdrawal of Consent|0|||
131569557|NCT01511250|473710690|FG002|Overall Study|Withdrawal of Consent|0|||
131569558|NCT01511250|473710691|FG003|Overall Study|Withdrawal of Consent|0|||
131569559|NCT01511250|473710692|FG004|Overall Study|Withdrawal of Consent|0|||
131569560|NCT01511250|473710693|FG005|Overall Study|Withdrawal of Consent|0|||
131569561|NCT01511250|473710694|FG006|Overall Study|Withdrawal of Consent|0|||
131569562|NCT01511250|473710695|FG007|Overall Study|Withdrawal of Consent|1|||
131569563|NCT01511250|473710696|FG008|Overall Study|Withdrawal of Consent|1|||
131569564|NCT01511250|473710697|FG009|Overall Study|Withdrawal of Consent|0|||
131569565|NCT01511250|473710688|FG000|Overall Study|Sponsor/Investigator Decision|1|||
131569566|NCT01511250|473710689|FG001|Overall Study|Sponsor/Investigator Decision|0|||
131569567|NCT01511250|473710690|FG002|Overall Study|Sponsor/Investigator Decision|0|||
131569568|NCT01511250|473710691|FG003|Overall Study|Sponsor/Investigator Decision|0|||
131569569|NCT01511250|473710692|FG004|Overall Study|Sponsor/Investigator Decision|0|||
131569570|NCT01511250|473710693|FG005|Overall Study|Sponsor/Investigator Decision|0|||
131569571|NCT01511250|473710694|FG006|Overall Study|Sponsor/Investigator Decision|0|||
131569572|NCT01511250|473710695|FG007|Overall Study|Sponsor/Investigator Decision|0|||
131569573|NCT01511250|473710696|FG008|Overall Study|Sponsor/Investigator Decision|0|||
131569574|NCT01511250|473710697|FG009|Overall Study|Sponsor/Investigator Decision|0|||
131569575|NCT01511250|473710688|FG000|Overall Study|Lost to Follow-up|7|||
131569576|NCT01511250|473710689|FG001|Overall Study|Lost to Follow-up|3|||
131569577|NCT01511250|473710690|FG002|Overall Study|Lost to Follow-up|3|||
131569578|NCT01511250|473710691|FG003|Overall Study|Lost to Follow-up|3|||
131569579|NCT01511250|473710692|FG004|Overall Study|Lost to Follow-up|0|||
131569580|NCT01511250|473710693|FG005|Overall Study|Lost to Follow-up|0|||
131569581|NCT01511250|473710694|FG006|Overall Study|Lost to Follow-up|2|||
131569582|NCT01511250|473710695|FG007|Overall Study|Lost to Follow-up|3|||
131569583|NCT01511250|473710696|FG008|Overall Study|Lost to Follow-up|13|||
131569584|NCT01511250|473710697|FG009|Overall Study|Lost to Follow-up|5|||
131569585|NCT01511250|473710688|FG000|Overall Study|Protocol Violation|0|||
131569586|NCT01511250|473710689|FG001|Overall Study|Protocol Violation|2|||
131569587|NCT01511250|473710690|FG002|Overall Study|Protocol Violation|1|||
131569588|NCT01511250|473710691|FG003|Overall Study|Protocol Violation|0|||
131569589|NCT01511250|473710692|FG004|Overall Study|Protocol Violation|0|||
131569590|NCT01511250|473710693|FG005|Overall Study|Protocol Violation|0|||
131569591|NCT01511250|473710694|FG006|Overall Study|Protocol Violation|0|||
131569592|NCT01511250|473710695|FG007|Overall Study|Protocol Violation|0|||
131569593|NCT01511250|473710696|FG008|Overall Study|Protocol Violation|0|||
131569594|NCT01511250|473710697|FG009|Overall Study|Protocol Violation|0|||
131569595|NCT05487703|473710698|FG000|Overall Study|Other|19|||
131569596|NCT05487703|473710698|FG000|Overall Study|Participant not well|5|||
131569597|NCT05487703|473710698|FG000|Overall Study|Insurance Reasons|6|||
131569598|NCT05487703|473710698|FG000|Overall Study|Physician Decision|19|||
131569599|NCT05487703|473710698|FG000|Overall Study|Lack of Efficacy|60|||
131697222|NCT03977467|474174104|FG000|Overall Study|Lack of Efficacy|0|||
131697223|NCT03977467|474174105|FG001|Overall Study|Lack of Efficacy|0|||
131697224|NCT03977467|474174106|FG002|Overall Study|Lack of Efficacy|1|||
131697225|NCT03977467|474174107|FG003|Overall Study|Lack of Efficacy|0|||
131697226|NCT03977467|474174104|FG000|Overall Study|Withdrawal by Subject|2|||
131697227|NCT03977467|474174105|FG001|Overall Study|Withdrawal by Subject|1|||
131697228|NCT03977467|474174106|FG002|Overall Study|Withdrawal by Subject|4|||
131697229|NCT03977467|474174107|FG003|Overall Study|Withdrawal by Subject|0|||
131697230|NCT03977467|474174104|FG000|Overall Study|Study Terminated|1|||
131697231|NCT03977467|474174105|FG001|Overall Study|Study Terminated|0|||
131697232|NCT03977467|474174106|FG002|Overall Study|Study Terminated|0|||
131697233|NCT03977467|474174107|FG003|Overall Study|Study Terminated|1|||
131783638|NCT02200614|474490001|FG000|Open Label|Metastasis by local reading|138|||
131569600|NCT03686384|473710699|FG000|Overall Study|Lack of Efficacy|4|||
131569601|NCT03686384|473710700|FG001|Overall Study|Lack of Efficacy|13|||
131569602|NCT03686384|473710699|FG000|Overall Study|Lost to Follow-up|3|||
131569603|NCT03686384|473710700|FG001|Overall Study|Lost to Follow-up|0|||
131569604|NCT03686384|473710699|FG000|Overall Study|Physician Decision|0|||
131569605|NCT03686384|473710700|FG001|Overall Study|Physician Decision|1|||
131569606|NCT03686384|473710699|FG000|Overall Study|Took prohibited medication|0|||
131569607|NCT03686384|473710700|FG001|Overall Study|Took prohibited medication|1|||
131697234|NCT05913232|474174108|FG000|Overall Study|Adverse Event|0|||
131697235|NCT05913232|474174109|FG001|Overall Study|Adverse Event|2|||
131783639|NCT02200614|474490002|FG001|Open Label|Metastasis by local reading|27|||
131783640|NCT02200614|474490001|FG000|Open Label|Other reason|22|||
131783641|NCT02200614|474490002|FG001|Open Label|Other reason|4|||
131783642|NCT02200614|474490001|FG000|Open Label|Personal reason|60|||
131783643|NCT02200614|474490002|FG001|Open Label|Personal reason|8|||
131783644|NCT02200614|474490001|FG000|Open Label|Protocol deviation|3|||
131783645|NCT02200614|474490002|FG001|Open Label|Protocol deviation|2|||
131569608|NCT02820051|473710703|FG000|Overall Study|Lost to Follow-up|7|||
131569609|NCT02820051|473710704|FG001|Overall Study|Lost to Follow-up|4|||
131569610|NCT01222247|473710708|FG000|Overall Study|Lost to Follow-up|2|||
131569611|NCT01222247|473710709|FG001|Overall Study|Lost to Follow-up|2|||
131569612|NCT00832780|473710710|FG000|Overall Study|Death|16|||
131569613|NCT00832780|473710710|FG000|Overall Study|Lost to Follow-up|4|||
131569614|NCT00832780|473710710|FG000|Overall Study|no reason given|2|||
131569615|NCT00832780|473710710|FG000|Overall Study|other complicating condition|2|||
131569616|NCT00832780|473710710|FG000|Overall Study|Physician Decision|1|||
131569617|NCT01767909|473710713|FG000|Overall Study|Withdrawal by Subject|4|||
131569618|NCT01767909|473710714|FG001|Overall Study|Withdrawal by Subject|7|||
131569619|NCT01767909|473710713|FG000|Overall Study|Adverse Event|3|||
131569620|NCT01767909|473710714|FG001|Overall Study|Adverse Event|1|||
131569621|NCT01767909|473710713|FG000|Overall Study|Withdrawal by Study Partner|3|||
131569622|NCT01767909|473710714|FG001|Overall Study|Withdrawal by Study Partner|1|||
131569623|NCT01767909|473710713|FG000|Overall Study|Non-Compliance|2|||
131569624|NCT01767909|473710714|FG001|Overall Study|Non-Compliance|0|||
131569625|NCT01767909|473710713|FG000|Overall Study|Perceived Lack of Efficacy|1|||
131569626|NCT01767909|473710714|FG001|Overall Study|Perceived Lack of Efficacy|0|||
131569627|NCT01767909|473710713|FG000|Overall Study|Investigator Recommendation|0|||
131569628|NCT01767909|473710714|FG001|Overall Study|Investigator Recommendation|1|||
131569629|NCT01767909|473710713|FG000|Overall Study|Lost to Follow-up|0|||
131569630|NCT01767909|473710714|FG001|Overall Study|Lost to Follow-up|1|||
131569631|NCT01767909|473710713|FG000|Overall Study|LP uncessessful|0|||
131569632|NCT01767909|473710714|FG001|Overall Study|LP uncessessful|1|||
131569633|NCT04939428|473710715|FG000|Overall Study|Death|0|||
131569634|NCT04939428|473710716|FG001|Overall Study|Death|1|||
131569635|NCT04939428|473710717|FG002|Overall Study|Death|0|||
131569636|NCT04939428|473710715|FG000|Overall Study|Lost to Follow-up|0|||
131569637|NCT04939428|473710716|FG001|Overall Study|Lost to Follow-up|5|||
131569638|NCT04939428|473710717|FG002|Overall Study|Lost to Follow-up|0|||
131569639|NCT04939428|473710715|FG000|Overall Study|Physician Decision|1|||
131569640|NCT04939428|473710716|FG001|Overall Study|Physician Decision|0|||
131569641|NCT04939428|473710717|FG002|Overall Study|Physician Decision|0|||
131569642|NCT04939428|473710715|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131569643|NCT04939428|473710716|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131569644|NCT04939428|473710717|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131569645|NCT04939428|473710715|FG000|Overall Study|Withdrawal by Subject|10|||
131569646|NCT04939428|473710716|FG001|Overall Study|Withdrawal by Subject|11|||
131569647|NCT04939428|473710717|FG002|Overall Study|Withdrawal by Subject|0|||
131569648|NCT04939428|473710715|FG000|Overall Study|Unkown|6|||
131569649|NCT04939428|473710716|FG001|Overall Study|Unkown|3|||
131569650|NCT04939428|473710717|FG002|Overall Study|Unkown|0|||
131569651|NCT04939428|473710715|FG000|Overall Study|Discotinued per protocol|0|||
131697236|NCT05913232|474174110|FG002|Overall Study|Adverse Event|1|||
131697237|NCT05913232|474174111|FG003|Overall Study|Adverse Event|1|||
131697238|NCT01318109|474174112|FG000|Overall Study|Adverse Event|0|||
131697239|NCT01318109|474174113|FG001|Overall Study|Adverse Event|2|||
131697240|NCT01318109|474174114|FG002|Overall Study|Adverse Event|0|||
131697241|NCT01318109|474174112|FG000|Overall Study|Withdrawal by Subject|1|||
131697242|NCT01318109|474174113|FG001|Overall Study|Withdrawal by Subject|0|||
131697243|NCT01318109|474174114|FG002|Overall Study|Withdrawal by Subject|0|||
131697244|NCT01318109|474174112|FG000|Overall Study|Schedule Conflict|0|||
131697245|NCT01318109|474174113|FG001|Overall Study|Schedule Conflict|1|||
131697246|NCT01318109|474174114|FG002|Overall Study|Schedule Conflict|0|||
131783646|NCT02200614|474490001|FG000|Open Label|Missing|2|||
131783647|NCT02200614|474490002|FG001|Open Label|Missing|2|||
131569652|NCT04939428|473710716|FG001|Overall Study|Discotinued per protocol|0|||
131569653|NCT04939428|473710717|FG002|Overall Study|Discotinued per protocol|902|||
131697247|NCT01328951|474174115|FG000|Overall Study|Disease Progression|17|||
131569654|NCT04956692|473710719|FG000|Overall Study|Death|115|||
131569655|NCT04956692|473710720|FG001|Overall Study|Death|47|||
131569656|NCT04956692|473710719|FG000|Overall Study|Lost to Follow-up|0|||
131569657|NCT04956692|473710720|FG001|Overall Study|Lost to Follow-up|1|||
131569658|NCT04956692|473710719|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131697248|NCT01328951|474174116|FG001|Overall Study|Disease Progression|14|||
131697249|NCT01328951|474174115|FG000|Overall Study|Adverse Event|2|||
131783648|NCT01898884|474490003|FG000|Multiple Dose Period|Adverse Event|0|||
131783649|NCT01898884|474490004|FG001|Multiple Dose Period|Adverse Event|0|||
131569659|NCT04956692|473710720|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131569660|NCT04956692|473710719|FG000|Overall Study|Withdrawal by Subject|5|||
131569661|NCT04956692|473710720|FG001|Overall Study|Withdrawal by Subject|2|||
131569662|NCT04956692|473710719|FG000|Overall Study|Ongoing in Study|236|||
131569663|NCT04956692|473710720|FG001|Overall Study|Ongoing in Study|123|||
131569664|NCT04639947|473710721|FG000|Overall Study|Screen fail|1|||
131569665|NCT02696785|473710724|FG000|Blinded Treatment Period|Adverse Event|0|||
131569666|NCT02696785|473710725|FG001|Blinded Treatment Period|Adverse Event|1|||
131569667|NCT02696785|473710726|FG002|Blinded Treatment Period|Adverse Event|3|||
131569668|NCT02696785|473710727|FG003|Blinded Treatment Period|Adverse Event|0|||
131569669|NCT02696785|473710724|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
131569670|NCT02696785|473710725|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
131569671|NCT02696785|473710726|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
131569672|NCT02696785|473710727|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
131569673|NCT02696785|473710724|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
131569674|NCT02696785|473710725|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
131569675|NCT02696785|473710726|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
131569676|NCT02696785|473710727|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
131569677|NCT02696785|473710724|FG000|Blinded Treatment Period|Screen Failure|1|||
131569678|NCT02696785|473710725|FG001|Blinded Treatment Period|Screen Failure|0|||
131569679|NCT02696785|473710726|FG002|Blinded Treatment Period|Screen Failure|0|||
131569680|NCT02696785|473710727|FG003|Blinded Treatment Period|Screen Failure|0|||
131569681|NCT02696785|473710724|FG000|Washout Period|Withdrawal by Subject|0|||
131569682|NCT02696785|473710725|FG001|Washout Period|Withdrawal by Subject|1|||
131569683|NCT02696785|473710726|FG002|Washout Period|Withdrawal by Subject|0|||
131569684|NCT02696785|473710727|FG003|Washout Period|Withdrawal by Subject|0|||
131569685|NCT02696785|473710724|FG000|Washout Period|Lack of Efficacy|0|||
131569686|NCT02696785|473710725|FG001|Washout Period|Lack of Efficacy|1|||
131569687|NCT02696785|473710726|FG002|Washout Period|Lack of Efficacy|0|||
131569688|NCT02696785|473710727|FG003|Washout Period|Lack of Efficacy|0|||
131569689|NCT02696785|473710724|FG000|Extended Treatment Period|Adverse Event|2|||
131569690|NCT02696785|473710725|FG001|Extended Treatment Period|Adverse Event|3|||
131569691|NCT02696785|473710726|FG002|Extended Treatment Period|Adverse Event|2|||
131569692|NCT02696785|473710727|FG003|Extended Treatment Period|Adverse Event|1|||
131569693|NCT02696785|473710724|FG000|Extended Treatment Period|Lack of Efficacy|0|||
131569694|NCT02696785|473710725|FG001|Extended Treatment Period|Lack of Efficacy|1|||
131569695|NCT02696785|473710726|FG002|Extended Treatment Period|Lack of Efficacy|0|||
131569696|NCT02696785|473710727|FG003|Extended Treatment Period|Lack of Efficacy|0|||
131569697|NCT02696785|473710724|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
131569698|NCT02696785|473710725|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
131569699|NCT02696785|473710726|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
131569700|NCT02696785|473710727|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
131569701|NCT02696785|473710724|FG000|Follow-up Period|Adverse Event|0|||
131569702|NCT02696785|473710725|FG001|Follow-up Period|Adverse Event|0|||
131569703|NCT02696785|473710726|FG002|Follow-up Period|Adverse Event|8|||
131569704|NCT02696785|473710727|FG003|Follow-up Period|Adverse Event|2|||
131569705|NCT02696785|473710724|FG000|Follow-up Period|Lost to Follow-up|0|||
131569706|NCT02696785|473710725|FG001|Follow-up Period|Lost to Follow-up|0|||
131569707|NCT02696785|473710726|FG002|Follow-up Period|Lost to Follow-up|0|||
131569708|NCT02696785|473710727|FG003|Follow-up Period|Lost to Follow-up|1|||
131569709|NCT02696785|473710724|FG000|Follow-up Period|Lack of Efficacy|0|||
131569710|NCT02696785|473710725|FG001|Follow-up Period|Lack of Efficacy|0|||
131569711|NCT02696785|473710726|FG002|Follow-up Period|Lack of Efficacy|0|||
131569712|NCT02696785|473710727|FG003|Follow-up Period|Lack of Efficacy|1|||
131569713|NCT02696785|473710724|FG000|Follow-up Period|Withdrawal by Subject|1|||
131569714|NCT02696785|473710725|FG001|Follow-up Period|Withdrawal by Subject|0|||
131569715|NCT02696785|473710726|FG002|Follow-up Period|Withdrawal by Subject|5|||
131569716|NCT02696785|473710727|FG003|Follow-up Period|Withdrawal by Subject|4|||
131569717|NCT04863898|473710728|FG000|Overall Study|Away from study clinic during intervention training period|2|||
131569718|NCT04863898|473710728|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
131569719|NCT04863898|473710728|FG000|Overall Study|Lost to Follow-up|3|||
131569720|NCT04863898|473710728|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
131569721|NCT04863898|473710728|FG000|Overall Study|No longer employed at clinic|3|||
131569722|NCT02320253|473710729|FG000|Overall Study|Withdrawal by Subject|3|||
131569723|NCT02320253|473710730|FG001|Overall Study|Withdrawal by Subject|0|||
131569724|NCT02320253|473710731|FG002|Overall Study|Withdrawal by Subject|0|||
131569725|NCT02320253|473710729|FG000|Overall Study|Lost to Follow-up|2|||
131569726|NCT02320253|473710730|FG001|Overall Study|Lost to Follow-up|2|||
131569727|NCT02320253|473710731|FG002|Overall Study|Lost to Follow-up|1|||
131569728|NCT02320253|473710729|FG000|Overall Study|Death|1|||
131569729|NCT02320253|473710730|FG001|Overall Study|Death|0|||
131569730|NCT02320253|473710731|FG002|Overall Study|Death|1|||
131569731|NCT00603538|473710732|FG000|Overall Study|Adverse Event|0|||
131569732|NCT00603538|473710733|FG001|Overall Study|Adverse Event|4|||
131569733|NCT00603538|473710734|FG002|Overall Study|Adverse Event|2|||
131569734|NCT00603538|473710732|FG000|Overall Study|Objective progression or relapse|3|||
131569735|NCT00603538|473710733|FG001|Overall Study|Objective progression or relapse|0|||
131569736|NCT00603538|473710734|FG002|Overall Study|Objective progression or relapse|0|||
131569737|NCT01764386|473712154|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
131569738|NCT01764386|473712155|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
131569739|NCT01764386|473712154|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
131569740|NCT01764386|473712155|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
131569741|NCT01764386|473712154|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
131569742|NCT01764386|473712155|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
131569743|NCT01764386|473712154|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
131569744|NCT01764386|473712155|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
131569745|NCT01764386|473712154|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
131569746|NCT01764386|473712155|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
131569747|NCT01764386|473712154|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
131569748|NCT01764386|473712155|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
131569749|NCT01764386|473712154|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
131569750|NCT01764386|473712155|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
131569751|NCT01764386|473712154|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
131569752|NCT01764386|473712155|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
131569753|NCT00886613|473712156|FG000|Overall Study|Protocol deviation (Part B)|1|||
131569754|NCT00886613|473712157|FG001|Overall Study|Protocol deviation (Part B)|0|||
131569755|NCT00886613|473712158|FG002|Overall Study|Protocol deviation (Part B)|0|||
131569756|NCT00886613|473712156|FG000|Overall Study|Lost to follow-up (Part B)|1|||
131569757|NCT00886613|473712157|FG001|Overall Study|Lost to follow-up (Part B)|0|||
131569758|NCT00886613|473712158|FG002|Overall Study|Lost to follow-up (Part B)|1|||
131569759|NCT00886613|473712156|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
131569760|NCT00886613|473712157|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
131569761|NCT00886613|473712158|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
131569762|NCT04541186|473712161|FG000|Main Study|Adverse Event|0|||
131569763|NCT04541186|473712162|FG001|Main Study|Adverse Event|0|||
131569764|NCT04541186|473712163|FG002|Main Study|Adverse Event|4|||
131569765|NCT04541186|473712164|FG003|Main Study|Adverse Event|0|||
131569766|NCT04541186|473712165|FG004|Main Study|Adverse Event|0|||
131569767|NCT04541186|473712161|FG000|Main Study|Investigator Decision|0|||
131569768|NCT04541186|473712162|FG001|Main Study|Investigator Decision|0|||
131569769|NCT04541186|473712163|FG002|Main Study|Investigator Decision|1|||
131569770|NCT04541186|473712164|FG003|Main Study|Investigator Decision|1|||
131569771|NCT04541186|473712165|FG004|Main Study|Investigator Decision|0|||
131569772|NCT04541186|473712161|FG000|Main Study|Withdrawal by Subject|1|||
131569773|NCT04541186|473712162|FG001|Main Study|Withdrawal by Subject|1|||
131569774|NCT04541186|473712163|FG002|Main Study|Withdrawal by Subject|0|||
131569775|NCT04541186|473712164|FG003|Main Study|Withdrawal by Subject|0|||
131569776|NCT04541186|473712165|FG004|Main Study|Withdrawal by Subject|0|||
131569777|NCT04541186|473712161|FG000|Main Study|COVID-19-related Dose Interruption|0|||
131569778|NCT04541186|473712162|FG001|Main Study|COVID-19-related Dose Interruption|0|||
131569779|NCT04541186|473712163|FG002|Main Study|COVID-19-related Dose Interruption|0|||
131569780|NCT04541186|473712164|FG003|Main Study|COVID-19-related Dose Interruption|0|||
131569781|NCT04541186|473712165|FG004|Main Study|COVID-19-related Dose Interruption|1|||
131569782|NCT04541186|473712161|FG000|Main Study|Randomized in Error Not Treated|0|||
131569783|NCT04541186|473712162|FG001|Main Study|Randomized in Error Not Treated|0|||
131697250|NCT01328951|474174116|FG001|Overall Study|Adverse Event|0|||
131697251|NCT01328951|474174115|FG000|Overall Study|Death|243|||
131697252|NCT01328951|474174116|FG001|Overall Study|Death|258|||
131697253|NCT01328951|474174115|FG000|Overall Study|Lost to Follow-up|6|||
131697254|NCT01328951|474174116|FG001|Overall Study|Lost to Follow-up|7|||
131697255|NCT01328951|474174115|FG000|Overall Study|Withdrawal by Subject|6|||
131697256|NCT01328951|474174116|FG001|Overall Study|Withdrawal by Subject|6|||
131697257|NCT01328951|474174115|FG000|Overall Study|Study Closed by the Sponsor|36|||
131697258|NCT01328951|474174116|FG001|Overall Study|Study Closed by the Sponsor|31|||
131697259|NCT01328951|474174115|FG000|Overall Study|Other|11|||
131697260|NCT01328951|474174116|FG001|Overall Study|Other|6|||
131697261|NCT04042103|474174118|FG000|Overall Study|Lost to Follow-up|1|||
131569784|NCT04541186|473712163|FG002|Main Study|Randomized in Error Not Treated|1|||
131569785|NCT04541186|473712164|FG003|Main Study|Randomized in Error Not Treated|0|||
131569786|NCT04541186|473712165|FG004|Main Study|Randomized in Error Not Treated|0|||
131569787|NCT04541186|473712161|FG000|Fibrate Expansion Study|Other than Specified|0|||
131569788|NCT04541186|473712162|FG001|Fibrate Expansion Study|Other than Specified|0|||
131569789|NCT04541186|473712163|FG002|Fibrate Expansion Study|Other than Specified|0|||
131569790|NCT04541186|473712164|FG003|Fibrate Expansion Study|Other than Specified|0|||
131569791|NCT04541186|473712165|FG004|Fibrate Expansion Study|Other than Specified|1|||
131569792|NCT00691028|473712166|FG000|Open-label Period|Adverse Event|0|||
131569793|NCT00691028|473712167|FG001|Open-label Period|Adverse Event|0|||
131697262|NCT04042103|474174118|FG000|Overall Study|Withdrawal by Subject|1|||
131697263|NCT01003210|474174119|FG000|Overall Study|Lost to Follow-up|1|||
131697264|NCT01003210|474174120|FG001|Overall Study|Lost to Follow-up|3|||
131697265|NCT00271817|474174121|FG000|Part 1|Adverse Event|68|||
131569794|NCT00691028|473712168|FG002|Open-label Period|Adverse Event|0|||
131569795|NCT00691028|473712169|FG003|Open-label Period|Adverse Event|16|||
131569796|NCT00691028|473712166|FG000|Open-label Period|Withdrawal by Subject|0|||
131569797|NCT00691028|473712167|FG001|Open-label Period|Withdrawal by Subject|0|||
131569798|NCT00691028|473712168|FG002|Open-label Period|Withdrawal by Subject|0|||
131569799|NCT00691028|473712169|FG003|Open-label Period|Withdrawal by Subject|3|||
131569800|NCT00691028|473712166|FG000|Open-label Period|not come to a hospital|0|||
131569801|NCT00691028|473712167|FG001|Open-label Period|not come to a hospital|0|||
131569802|NCT00691028|473712168|FG002|Open-label Period|not come to a hospital|0|||
131569803|NCT00691028|473712169|FG003|Open-label Period|not come to a hospital|1|||
131569804|NCT00691028|473712166|FG000|Double-blind Period|Adverse Event|8|||
131569805|NCT00691028|473712167|FG001|Double-blind Period|Adverse Event|9|||
131569806|NCT00691028|473712168|FG002|Double-blind Period|Adverse Event|6|||
131569807|NCT00691028|473712169|FG003|Double-blind Period|Adverse Event|0|||
131569808|NCT00691028|473712166|FG000|Double-blind Period|Lack of Efficacy|4|||
131569809|NCT00691028|473712167|FG001|Double-blind Period|Lack of Efficacy|3|||
131569810|NCT00691028|473712168|FG002|Double-blind Period|Lack of Efficacy|2|||
131569811|NCT00691028|473712169|FG003|Double-blind Period|Lack of Efficacy|0|||
131569812|NCT00691028|473712166|FG000|Double-blind Period|Withdrawal by Subject|1|||
131569813|NCT00691028|473712167|FG001|Double-blind Period|Withdrawal by Subject|0|||
131569814|NCT00691028|473712168|FG002|Double-blind Period|Withdrawal by Subject|1|||
131569815|NCT00691028|473712169|FG003|Double-blind Period|Withdrawal by Subject|0|||
131569816|NCT00691028|473712166|FG000|Double-blind Period|not come to a hospital.|0|||
131569817|NCT00691028|473712167|FG001|Double-blind Period|not come to a hospital.|1|||
131697266|NCT00271817|474174122|FG001|Part 1|Adverse Event|25|||
131697267|NCT00271817|474174123|FG002|Part 1|Adverse Event|156|||
131697268|NCT00271817|474174121|FG000|Part 1|Lost to Follow-up|6|||
131697269|NCT00271817|474174122|FG001|Part 1|Lost to Follow-up|8|||
131697270|NCT00271817|474174123|FG002|Part 1|Lost to Follow-up|24|||
131697271|NCT00271817|474174121|FG000|Part 1|Protocol Violation|5|||
131697272|NCT00271817|474174122|FG001|Part 1|Protocol Violation|4|||
131697273|NCT00271817|474174123|FG002|Part 1|Protocol Violation|7|||
131697274|NCT00271817|474174121|FG000|Part 1|Patient Moved|3|||
131697275|NCT00271817|474174122|FG001|Part 1|Patient Moved|1|||
131697276|NCT00271817|474174123|FG002|Part 1|Patient Moved|5|||
131697277|NCT00271817|474174121|FG000|Part 1|Withdrawal by Subject|23|||
131697278|NCT00271817|474174122|FG001|Part 1|Withdrawal by Subject|17|||
131697279|NCT00271817|474174123|FG002|Part 1|Withdrawal by Subject|45|||
131697280|NCT00271817|474174121|FG000|Part 1|LDL < 50 mg/dL|1|||
131697281|NCT00271817|474174122|FG001|Part 1|LDL < 50 mg/dL|4|||
131697282|NCT00271817|474174123|FG002|Part 1|LDL < 50 mg/dL|48|||
131697283|NCT00271817|474174121|FG000|Part 2|Adverse Event|0|||
131697284|NCT00271817|474174122|FG001|Part 2|Adverse Event|17|||
131697285|NCT00271817|474174123|FG002|Part 2|Adverse Event|33|||
131697286|NCT00271817|474174121|FG000|Part 2|Lack of Efficacy|0|||
131697287|NCT00271817|474174122|FG001|Part 2|Lack of Efficacy|1|||
131697288|NCT00271817|474174123|FG002|Part 2|Lack of Efficacy|6|||
131697289|NCT00271817|474174121|FG000|Part 2|Lost to Follow-up|0|||
131697290|NCT00271817|474174122|FG001|Part 2|Lost to Follow-up|6|||
131697291|NCT00271817|474174123|FG002|Part 2|Lost to Follow-up|18|||
131697292|NCT00271817|474174121|FG000|Part 2|Protocol Violation|0|||
131697293|NCT00271817|474174122|FG001|Part 2|Protocol Violation|3|||
131697294|NCT00271817|474174123|FG002|Part 2|Protocol Violation|5|||
131697295|NCT00271817|474174121|FG000|Part 2|Patient Moved|0|||
131697296|NCT00271817|474174122|FG001|Part 2|Patient Moved|0|||
131697297|NCT00271817|474174123|FG002|Part 2|Patient Moved|5|||
131697298|NCT00271817|474174121|FG000|Part 2|Withdrawal by Subject|0|||
131697299|NCT00271817|474174122|FG001|Part 2|Withdrawal by Subject|2|||
131697300|NCT00271817|474174123|FG002|Part 2|Withdrawal by Subject|13|||
131697301|NCT00271817|474174121|FG000|Part 2|LDL < 50 mg/dL|0|||
131697302|NCT00271817|474174122|FG001|Part 2|LDL < 50 mg/dL|3|||
131697303|NCT00271817|474174123|FG002|Part 2|LDL < 50 mg/dL|4|||
131697304|NCT05107765|474174127|FG000|Overall Study|Lost to Follow-up|4|||
131697305|NCT05107765|474174128|FG001|Overall Study|Lost to Follow-up|1|||
131697306|NCT05107765|474174127|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
131569818|NCT00691028|473712168|FG002|Double-blind Period|not come to a hospital.|0|||
131569819|NCT00691028|473712169|FG003|Double-blind Period|not come to a hospital.|0|||
131569820|NCT03255018|473712177|FG000|Overall Study|Death on study|0|||
131697307|NCT05107765|474174128|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
131697308|NCT05107765|474174127|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
131697309|NCT05107765|474174128|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
131697310|NCT01411085|474174131|FG000|Overall Study|Physician Decision|1|||
131697311|NCT01411085|474174131|FG000|Overall Study|Protocol Violation|1|||
131697312|NCT01411085|474174131|FG000|Overall Study|Adverse Event|1|||
131569821|NCT03255018|473712178|FG001|Overall Study|Death on study|5|||
131569822|NCT03255018|473712177|FG000|Overall Study|Withdrawal by Subject|0|||
131697313|NCT02193074|474174132|FG000|Overall Study|Withdrawal by Subject|1|||
131697314|NCT02193074|474174133|FG001|Overall Study|Withdrawal by Subject|2|||
131697315|NCT02193074|474174132|FG000|Overall Study|Adverse Event|16|||
131697316|NCT02193074|474174133|FG001|Overall Study|Adverse Event|13|||
131569823|NCT03255018|473712178|FG001|Overall Study|Withdrawal by Subject|2|||
131569824|NCT01360840|473712185|FG000|Overall Study|Ongoing at data cut-off|10|||
131569825|NCT01360840|473712186|FG001|Overall Study|Ongoing at data cut-off|10|||
131569826|NCT01360840|473712187|FG002|Overall Study|Ongoing at data cut-off|9|||
131569827|NCT05124899|473712189|FG000|Overall Study|Lost to Follow-up|3|||
131569828|NCT01813422|473712200|FG000|Overall Study|Withdrawal by Subject|14|||
131569829|NCT01813422|473712201|FG001|Overall Study|Withdrawal by Subject|8|||
131569830|NCT01813422|473712200|FG000|Overall Study|Death|2|||
131569831|NCT01813422|473712201|FG001|Overall Study|Death|3|||
131569832|NCT01813422|473712200|FG000|Overall Study|Sponsor Decision|2|||
131569833|NCT01813422|473712201|FG001|Overall Study|Sponsor Decision|1|||
131569834|NCT01813422|473712200|FG000|Overall Study|Lost to Follow-up|2|||
131569835|NCT01813422|473712201|FG001|Overall Study|Lost to Follow-up|4|||
131569836|NCT01653743|473712202|FG000|Overall Study|Withdrawal by Subject|1|||
131569837|NCT01653743|473712203|FG001|Overall Study|Withdrawal by Subject|0|||
131569838|NCT01653743|473712202|FG000|Overall Study|Investigator discretion|3|||
131569839|NCT01653743|473712203|FG001|Overall Study|Investigator discretion|0|||
131569840|NCT00797225|473712210|FG000|Weeks 1 to 12|Adverse Event|0|||
131569841|NCT00797225|473712211|FG001|Weeks 1 to 12|Adverse Event|0|||
131569842|NCT00797225|473712212|FG002|Weeks 1 to 12|Adverse Event|1|||
131569843|NCT00797225|473712213|FG003|Weeks 1 to 12|Adverse Event|0|||
131569844|NCT00797225|473712214|FG004|Weeks 1 to 12|Adverse Event|0|||
131569845|NCT00797225|473712215|FG005|Weeks 1 to 12|Adverse Event|0|||
131569846|NCT00797225|473712216|FG006|Weeks 1 to 12|Adverse Event|0|||
131569847|NCT00797225|473712217|FG007|Weeks 1 to 12|Adverse Event|0|||
131569848|NCT00797225|473712210|FG000|Weeks 1 to 12|Non-compliance|0|||
131569849|NCT00797225|473712211|FG001|Weeks 1 to 12|Non-compliance|1|||
131569850|NCT00797225|473712212|FG002|Weeks 1 to 12|Non-compliance|0|||
131569851|NCT00797225|473712213|FG003|Weeks 1 to 12|Non-compliance|0|||
131569852|NCT00797225|473712214|FG004|Weeks 1 to 12|Non-compliance|0|||
131569853|NCT00797225|473712215|FG005|Weeks 1 to 12|Non-compliance|0|||
131569854|NCT00797225|473712216|FG006|Weeks 1 to 12|Non-compliance|0|||
131569855|NCT00797225|473712217|FG007|Weeks 1 to 12|Non-compliance|0|||
131569856|NCT00797225|473712210|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
131569857|NCT00797225|473712211|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
131569858|NCT00797225|473712212|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
131569859|NCT00797225|473712213|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
131569860|NCT00797225|473712214|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
131569861|NCT00797225|473712215|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
131569862|NCT00797225|473712216|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
131569863|NCT00797225|473712217|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
131569864|NCT00797225|473712210|FG000|Weeks 1 to 12|Sponsor Decision|1|||
131569865|NCT00797225|473712211|FG001|Weeks 1 to 12|Sponsor Decision|0|||
131569866|NCT00797225|473712212|FG002|Weeks 1 to 12|Sponsor Decision|0|||
131569867|NCT00797225|473712213|FG003|Weeks 1 to 12|Sponsor Decision|0|||
131569868|NCT00797225|473712214|FG004|Weeks 1 to 12|Sponsor Decision|0|||
131569869|NCT00797225|473712215|FG005|Weeks 1 to 12|Sponsor Decision|0|||
131569870|NCT00797225|473712216|FG006|Weeks 1 to 12|Sponsor Decision|0|||
131569871|NCT00797225|473712217|FG007|Weeks 1 to 12|Sponsor Decision|0|||
131569872|NCT00797225|473712210|FG000|Weeks 13 to 24|Non-compliance|0|||
131569873|NCT00797225|473712211|FG001|Weeks 13 to 24|Non-compliance|2|||
131569874|NCT00797225|473712212|FG002|Weeks 13 to 24|Non-compliance|0|||
131569875|NCT00797225|473712213|FG003|Weeks 13 to 24|Non-compliance|0|||
131569876|NCT00797225|473712214|FG004|Weeks 13 to 24|Non-compliance|0|||
131569877|NCT00797225|473712215|FG005|Weeks 13 to 24|Non-compliance|0|||
131569878|NCT00797225|473712216|FG006|Weeks 13 to 24|Non-compliance|0|||
131569879|NCT00797225|473712217|FG007|Weeks 13 to 24|Non-compliance|0|||
131569880|NCT00797225|473712210|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
131569881|NCT00797225|473712211|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
131569882|NCT00797225|473712212|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
131569883|NCT00797225|473712213|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
131569884|NCT00797225|473712214|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
131569885|NCT00797225|473712215|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
131569886|NCT00797225|473712216|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
131569887|NCT00797225|473712217|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
131697317|NCT01761266|474175635|FG000|Overall Study|Death|415|||
131697318|NCT01761266|474175636|FG001|Overall Study|Death|402|||
131569888|NCT00797225|473712210|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
131569889|NCT00797225|473712211|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
131569890|NCT00797225|473712212|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
131569891|NCT00797225|473712213|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
131697319|NCT01761266|474175635|FG000|Overall Study|Lost to Follow-up|8|||
131569892|NCT00797225|473712214|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
131569893|NCT00797225|473712215|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
131569894|NCT00797225|473712216|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
131569895|NCT00797225|473712217|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
131569896|NCT00797225|473712210|FG000|Weeks 13 to 24|Adverse Event|0|||
131569897|NCT00797225|473712211|FG001|Weeks 13 to 24|Adverse Event|1|||
131569898|NCT00797225|473712212|FG002|Weeks 13 to 24|Adverse Event|0|||
131569899|NCT00797225|473712213|FG003|Weeks 13 to 24|Adverse Event|0|||
131569900|NCT00797225|473712214|FG004|Weeks 13 to 24|Adverse Event|0|||
131569901|NCT00797225|473712215|FG005|Weeks 13 to 24|Adverse Event|0|||
131569902|NCT00797225|473712216|FG006|Weeks 13 to 24|Adverse Event|1|||
131569903|NCT00797225|473712217|FG007|Weeks 13 to 24|Adverse Event|0|||
131569904|NCT00797225|473712210|FG000|Weeks 13 to 24|Sponsor Decision|0|||
131569905|NCT00797225|473712211|FG001|Weeks 13 to 24|Sponsor Decision|0|||
131569906|NCT00797225|473712212|FG002|Weeks 13 to 24|Sponsor Decision|0|||
131569907|NCT00797225|473712213|FG003|Weeks 13 to 24|Sponsor Decision|0|||
131569908|NCT00797225|473712214|FG004|Weeks 13 to 24|Sponsor Decision|0|||
131569909|NCT00797225|473712215|FG005|Weeks 13 to 24|Sponsor Decision|0|||
131569910|NCT00797225|473712216|FG006|Weeks 13 to 24|Sponsor Decision|1|||
131569911|NCT00797225|473712217|FG007|Weeks 13 to 24|Sponsor Decision|0|||
131569912|NCT01352507|473712220|FG000|Treatment Period 1|Adverse Event|3|||
131569913|NCT01352507|473712221|FG001|Treatment Period 1|Adverse Event|0|||
131569914|NCT01352507|473712220|FG000|Treatment Period 1|Lost to Follow-up|3|||
131569915|NCT01352507|473712221|FG001|Treatment Period 1|Lost to Follow-up|4|||
131569916|NCT01352507|473712220|FG000|Treatment Period 1|Withdrawal by Subject|7|||
131569917|NCT01352507|473712221|FG001|Treatment Period 1|Withdrawal by Subject|5|||
131569918|NCT01352507|473712220|FG000|Treatment Period 1|Physician Decision|1|||
131569919|NCT01352507|473712221|FG001|Treatment Period 1|Physician Decision|0|||
131569920|NCT01352507|473712220|FG000|Washout Period|Withdrawal by Subject|0|||
131569921|NCT01352507|473712221|FG001|Washout Period|Withdrawal by Subject|1|||
131569922|NCT01352507|473712220|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
131569923|NCT01352507|473712221|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
131569924|NCT01352507|473712220|FG000|Treatment Period 2|Withdrawal by Subject|4|||
131569925|NCT01352507|473712221|FG001|Treatment Period 2|Withdrawal by Subject|3|||
131569926|NCT01352507|473712220|FG000|Treatment Period 2|Lack of Efficacy|1|||
131569927|NCT01352507|473712221|FG001|Treatment Period 2|Lack of Efficacy|0|||
131569928|NCT01119703|473712222|FG000|Overall Study|Adverse Event|0|||
131569929|NCT01119703|473712223|FG001|Overall Study|Adverse Event|1|||
131569930|NCT03178201|473712224|FG000|Overall Study|Off study|5|||
131569931|NCT01763047|473712225|FG000|Period 1|Test Article Not Available|4|||
131569932|NCT01763047|473712226|FG001|Period 1|Test Article Not Available|1|||
131569933|NCT01763047|473712225|FG000|Period 1|Protocol Violation|4|||
131569934|NCT01763047|473712226|FG001|Period 1|Protocol Violation|4|||
131569935|NCT01763047|473712225|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
131569936|NCT01763047|473712226|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
131569937|NCT01763047|473712225|FG000|Period 1|Adverse Event|0|||
131569938|NCT01763047|473712226|FG001|Period 1|Adverse Event|1|||
131569939|NCT01763047|473712225|FG000|Period 1|Unsatisfactory Visual Response|0|||
131569940|NCT01763047|473712226|FG001|Period 1|Unsatisfactory Visual Response|3|||
131569941|NCT01763047|473712225|FG000|Period 1|Lens Power Not Available|0|||
131569942|NCT01763047|473712226|FG001|Period 1|Lens Power Not Available|1|||
131569943|NCT01763047|473712225|FG000|Period 1|Study Site office Closed|0|||
131569944|NCT01763047|473712226|FG001|Period 1|Study Site office Closed|1|||
131569945|NCT01763047|473712225|FG000|Period 2|Lens Discomfort|1|||
131569946|NCT01763047|473712226|FG001|Period 2|Lens Discomfort|0|||
131569947|NCT01763047|473712225|FG000|Period 2|No longer meets Eligibility Criteria|1|||
131569948|NCT01763047|473712226|FG001|Period 2|No longer meets Eligibility Criteria|0|||
131569949|NCT01763047|473712225|FG000|Period 2|Study Site office Closed|1|||
131569950|NCT01763047|473712226|FG001|Period 2|Study Site office Closed|1|||
131569951|NCT01763047|473712225|FG000|Period 2|Unsatisfactory Visual Response|1|||
131569952|NCT01763047|473712226|FG001|Period 2|Unsatisfactory Visual Response|1|||
131569953|NCT01763047|473712225|FG000|Period 2|Protocol Violation|0|||
131569954|NCT01763047|473712226|FG001|Period 2|Protocol Violation|2|||
131569955|NCT01763047|473712225|FG000|Period 2|Unsatisfactory lens Fitting|0|||
131569956|NCT01763047|473712226|FG001|Period 2|Unsatisfactory lens Fitting|1|||
131569957|NCT02095158|473712232|FG000|Overall Study|Adverse Event|14|||
131697320|NCT01761266|474175636|FG001|Overall Study|Lost to Follow-up|12|||
131697321|NCT01761266|474175635|FG000|Overall Study|Withdrawal by Subject|14|||
131569958|NCT02095158|473712232|FG000|Overall Study|Lack of Efficacy|3|||
131569959|NCT02095158|473712232|FG000|Overall Study|Pregnancy|1|||
131569960|NCT02095158|473712232|FG000|Overall Study|Lost to Follow-up|20|||
131569961|NCT02095158|473712232|FG000|Overall Study|Personal Reasons|35|||
131569962|NCT02095158|473712232|FG000|Overall Study|Protocol Violation|1|||
131697322|NCT01761266|474175636|FG001|Overall Study|Withdrawal by Subject|10|||
131697323|NCT01761266|474175635|FG000|Overall Study|Sponsor Decision|41|||
131569963|NCT02095158|473712232|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131569964|NCT02282527|473712233|FG000|Overall Study|Lost to Follow-up|0|||
131697324|NCT01761266|474175636|FG001|Overall Study|Sponsor Decision|52|||
131697325|NCT01284114|474175637|FG000|Overall Study|viral infection|1|||
131569965|NCT02282527|473712234|FG001|Overall Study|Lost to Follow-up|1|||
131569966|NCT02282527|473712233|FG000|Overall Study|Lack of home health aid|1|||
131569967|NCT02282527|473712234|FG001|Overall Study|Lack of home health aid|0|||
131569968|NCT00941031|473712235|FG000|Induction Period|Lack of Efficacy|2|||
131697326|NCT01284114|474175637|FG000|Overall Study|From the results of ALLTITUDE study|1|||
131569969|NCT00941031|473712236|FG001|Induction Period|Lack of Efficacy|1|||
131569970|NCT00941031|473712237|FG002|Induction Period|Lack of Efficacy|0|||
131569971|NCT00941031|473712238|FG003|Induction Period|Lack of Efficacy|5|||
131569972|NCT00941031|473712239|FG004|Induction Period|Lack of Efficacy|0|||
131569973|NCT00941031|473712240|FG005|Induction Period|Lack of Efficacy|0|||
131569974|NCT00941031|473712241|FG006|Induction Period|Lack of Efficacy|0|||
131569975|NCT00941031|473712235|FG000|Induction Period|Withdrawal by Subject|1|||
131569976|NCT00941031|473712236|FG001|Induction Period|Withdrawal by Subject|2|||
131569977|NCT00941031|473712237|FG002|Induction Period|Withdrawal by Subject|2|||
131569978|NCT00941031|473712238|FG003|Induction Period|Withdrawal by Subject|2|||
131569979|NCT00941031|473712239|FG004|Induction Period|Withdrawal by Subject|0|||
131569980|NCT00941031|473712240|FG005|Induction Period|Withdrawal by Subject|0|||
131569981|NCT00941031|473712241|FG006|Induction Period|Withdrawal by Subject|0|||
131569982|NCT00941031|473712235|FG000|Induction Period|Adminstative Problems|1|||
131569983|NCT00941031|473712236|FG001|Induction Period|Adminstative Problems|1|||
131569984|NCT00941031|473712237|FG002|Induction Period|Adminstative Problems|1|||
131569985|NCT00941031|473712238|FG003|Induction Period|Adminstative Problems|0|||
131569986|NCT00941031|473712239|FG004|Induction Period|Adminstative Problems|0|||
131569987|NCT00941031|473712240|FG005|Induction Period|Adminstative Problems|0|||
131569988|NCT00941031|473712241|FG006|Induction Period|Adminstative Problems|0|||
131569989|NCT00941031|473712235|FG000|Induction Period|Adverse Event|1|||
131569990|NCT00941031|473712236|FG001|Induction Period|Adverse Event|0|||
131569991|NCT00941031|473712237|FG002|Induction Period|Adverse Event|3|||
131569992|NCT00941031|473712238|FG003|Induction Period|Adverse Event|2|||
131569993|NCT00941031|473712239|FG004|Induction Period|Adverse Event|0|||
131569994|NCT00941031|473712240|FG005|Induction Period|Adverse Event|0|||
131569995|NCT00941031|473712241|FG006|Induction Period|Adverse Event|0|||
131569996|NCT00941031|473712235|FG000|Maintenance Period|Withdrawal by Subject|0|||
131569997|NCT00941031|473712236|FG001|Maintenance Period|Withdrawal by Subject|0|||
131569998|NCT00941031|473712237|FG002|Maintenance Period|Withdrawal by Subject|0|||
131569999|NCT00941031|473712238|FG003|Maintenance Period|Withdrawal by Subject|0|||
131570000|NCT00941031|473712239|FG004|Maintenance Period|Withdrawal by Subject|6|||
131570001|NCT00941031|473712240|FG005|Maintenance Period|Withdrawal by Subject|2|||
131570002|NCT00941031|473712241|FG006|Maintenance Period|Withdrawal by Subject|13|||
131570003|NCT00941031|473712235|FG000|Maintenance Period|Administrative Problems|0|||
131570004|NCT00941031|473712236|FG001|Maintenance Period|Administrative Problems|0|||
131570005|NCT00941031|473712237|FG002|Maintenance Period|Administrative Problems|0|||
131570006|NCT00941031|473712238|FG003|Maintenance Period|Administrative Problems|0|||
131570007|NCT00941031|473712239|FG004|Maintenance Period|Administrative Problems|1|||
131570008|NCT00941031|473712240|FG005|Maintenance Period|Administrative Problems|0|||
131570009|NCT00941031|473712241|FG006|Maintenance Period|Administrative Problems|1|||
131570010|NCT00941031|473712235|FG000|Maintenance Period|Protocol Violation|0|||
131570011|NCT00941031|473712236|FG001|Maintenance Period|Protocol Violation|0|||
131570012|NCT00941031|473712237|FG002|Maintenance Period|Protocol Violation|0|||
131570013|NCT00941031|473712238|FG003|Maintenance Period|Protocol Violation|0|||
131570014|NCT00941031|473712239|FG004|Maintenance Period|Protocol Violation|0|||
131570015|NCT00941031|473712240|FG005|Maintenance Period|Protocol Violation|0|||
131570016|NCT00941031|473712241|FG006|Maintenance Period|Protocol Violation|1|||
131570017|NCT00941031|473712235|FG000|Maintenance Period|Adverse Event|0|||
131570018|NCT00941031|473712236|FG001|Maintenance Period|Adverse Event|0|||
131570019|NCT00941031|473712237|FG002|Maintenance Period|Adverse Event|0|||
131570020|NCT00941031|473712238|FG003|Maintenance Period|Adverse Event|0|||
131570021|NCT00941031|473712239|FG004|Maintenance Period|Adverse Event|0|||
131570022|NCT00941031|473712240|FG005|Maintenance Period|Adverse Event|2|||
131570023|NCT00941031|473712241|FG006|Maintenance Period|Adverse Event|8|||
131570024|NCT00941031|473712235|FG000|Maintenance Period|Lost to Follow-up|0|||
131570025|NCT00941031|473712236|FG001|Maintenance Period|Lost to Follow-up|0|||
131570026|NCT00941031|473712237|FG002|Maintenance Period|Lost to Follow-up|0|||
131697327|NCT01284114|474175637|FG000|Overall Study|Symptomatic hypotension|1|||
131697328|NCT01284114|474175637|FG000|Overall Study|dizziness|1|||
131697329|NCT03445000|474175639|FG000|Overall Study|Disease progression|8|||
131697330|NCT03445000|474175639|FG000|Overall Study|Adverse Event|3|||
131697331|NCT03445000|474175639|FG000|Overall Study|Death|2|||
131570027|NCT00941031|473712238|FG003|Maintenance Period|Lost to Follow-up|0|||
131570028|NCT00941031|473712239|FG004|Maintenance Period|Lost to Follow-up|2|||
131570029|NCT00941031|473712240|FG005|Maintenance Period|Lost to Follow-up|2|||
131570030|NCT00941031|473712241|FG006|Maintenance Period|Lost to Follow-up|7|||
131570031|NCT00941031|473712235|FG000|Maintenance Period|Lack of Efficacy|0|||
131570032|NCT00941031|473712236|FG001|Maintenance Period|Lack of Efficacy|0|||
131570033|NCT00941031|473712237|FG002|Maintenance Period|Lack of Efficacy|0|||
131570034|NCT00941031|473712238|FG003|Maintenance Period|Lack of Efficacy|0|||
131570035|NCT00941031|473712239|FG004|Maintenance Period|Lack of Efficacy|0|||
131570036|NCT00941031|473712240|FG005|Maintenance Period|Lack of Efficacy|0|||
131697332|NCT03445000|474175639|FG000|Overall Study|Physician Decision|1|||
131783650|NCT01898884|474490005|FG002|Multiple Dose Period|Adverse Event|0|||
131783651|NCT01898884|474490006|FG003|Multiple Dose Period|Adverse Event|0|||
131783652|NCT01898884|474490007|FG004|Multiple Dose Period|Adverse Event|0|||
131783653|NCT01898884|474490008|FG005|Multiple Dose Period|Adverse Event|0|||
131783654|NCT01898884|474490009|FG006|Multiple Dose Period|Adverse Event|1|||
131783655|NCT01898884|474490010|FG007|Multiple Dose Period|Adverse Event|0|||
131783656|NCT01898884|474490011|FG008|Multiple Dose Period|Adverse Event|0|||
131783657|NCT01898884|474490003|FG000|Multiple Dose Period|Randomized Not Treated|0|||
131783658|NCT01898884|474490004|FG001|Multiple Dose Period|Randomized Not Treated|0|||
131783659|NCT01898884|474490005|FG002|Multiple Dose Period|Randomized Not Treated|0|||
131783660|NCT01898884|474490006|FG003|Multiple Dose Period|Randomized Not Treated|0|||
131783661|NCT01898884|474490007|FG004|Multiple Dose Period|Randomized Not Treated|0|||
131783662|NCT01898884|474490008|FG005|Multiple Dose Period|Randomized Not Treated|0|||
131783663|NCT01898884|474490009|FG006|Multiple Dose Period|Randomized Not Treated|0|||
131783664|NCT01898884|474490010|FG007|Multiple Dose Period|Randomized Not Treated|0|||
131783665|NCT01898884|474490011|FG008|Multiple Dose Period|Randomized Not Treated|1|||
131783666|NCT00759759|474490012|FG000|Overall Study|didn't return for period 2|1|||
131783667|NCT00759759|474490013|FG001|Overall Study|didn't return for period 2|0|||
131898656|NCT01516736|474915332|FG001|Overall Study|Physician Decision|1|||
131570037|NCT00941031|473712241|FG006|Maintenance Period|Lack of Efficacy|13|||
131570038|NCT01872611|473712242|FG000|Overall Study|Adverse Event|3|||
131570039|NCT01872611|473712243|FG001|Overall Study|Adverse Event|1|||
131570040|NCT01872611|473712242|FG000|Overall Study|Adverse Event, prior to treatment|0|||
131570041|NCT01872611|473712243|FG001|Overall Study|Adverse Event, prior to treatment|1|||
131570042|NCT01872611|473712242|FG000|Overall Study|Death|0|||
131570043|NCT01872611|473712243|FG001|Overall Study|Death|1|||
131570044|NCT01872611|473712242|FG000|Overall Study|Death, prior to treatment|0|||
131570045|NCT01872611|473712243|FG001|Overall Study|Death, prior to treatment|1|||
131570046|NCT01872611|473712242|FG000|Overall Study|Lost to Follow-up|8|||
131570047|NCT01872611|473712243|FG001|Overall Study|Lost to Follow-up|1|||
131570048|NCT01872611|473712242|FG000|Overall Study|Physician Decision|1|||
131570049|NCT01872611|473712243|FG001|Overall Study|Physician Decision|0|||
131570050|NCT01872611|473712242|FG000|Overall Study|Withdrawal by Subject|6|||
131570051|NCT01872611|473712243|FG001|Overall Study|Withdrawal by Subject|1|||
131570052|NCT01872611|473712242|FG000|Overall Study|Reason not provided|6|||
131570053|NCT01872611|473712243|FG001|Overall Study|Reason not provided|6|||
131570054|NCT03124108|473712244|FG000|Overall Study|Adverse Event|0|||
131570055|NCT03124108|473712245|FG001|Overall Study|Adverse Event|1|||
131570056|NCT03124108|473712246|FG002|Overall Study|Adverse Event|0|||
131570057|NCT00631917|473712247|FG000|Overall Study|Adverse Event|34|||
131570058|NCT00631917|473712248|FG001|Overall Study|Adverse Event|45|||
131570059|NCT00631917|473712247|FG000|Overall Study|Abnormal laboratory value(s)|2|||
131570060|NCT00631917|473712248|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131570061|NCT00631917|473712247|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131570062|NCT00631917|473712248|FG001|Overall Study|Abnormal test procedure result(s)|2|||
131570063|NCT00631917|473712247|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
131570064|NCT00631917|473712248|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
131570065|NCT00631917|473712247|FG000|Overall Study|No longer required study drug|0|||
131570066|NCT00631917|473712248|FG001|Overall Study|No longer required study drug|1|||
131570067|NCT00631917|473712247|FG000|Overall Study|Protocol deviation|6|||
131570068|NCT00631917|473712248|FG001|Overall Study|Protocol deviation|5|||
131570069|NCT00631917|473712247|FG000|Overall Study|Subject withdrew consent|25|||
131570070|NCT00631917|473712248|FG001|Overall Study|Subject withdrew consent|33|||
131570071|NCT00631917|473712247|FG000|Overall Study|Lost to Follow-up|7|||
131570072|NCT00631917|473712248|FG001|Overall Study|Lost to Follow-up|7|||
131570073|NCT00631917|473712247|FG000|Overall Study|Administrative problems|2|||
131570074|NCT00631917|473712248|FG001|Overall Study|Administrative problems|0|||
131570075|NCT00631917|473712247|FG000|Overall Study|Death|1|||
131570076|NCT00631917|473712248|FG001|Overall Study|Death|0|||
131570077|NCT05650333|473712249|FG000|Treatment Period (7 Days)|Adverse Event|1|||
131570078|NCT02616263|473712250|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
131570079|NCT02616263|473712251|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
131697333|NCT03409744|474175640|FG000|Overall Study|Death|2|||
131697334|NCT03409744|474175640|FG000|Overall Study|Physician Decision|5|||
131697335|NCT03409744|474175640|FG000|Overall Study|Pregnancy|1|||
131697336|NCT03409744|474175640|FG000|Overall Study|Lost to Follow-up|1|||
131697337|NCT03409744|474175640|FG000|Overall Study|Protocol Violation|1|||
131697338|NCT00264004|474175642|FG000|Overall Study|Adverse Event|2|||
131697339|NCT00264004|474175643|FG001|Overall Study|Adverse Event|3|||
131697340|NCT00264004|474175644|FG002|Overall Study|Adverse Event|6|||
131697341|NCT00264004|474175645|FG003|Overall Study|Adverse Event|4|||
131697342|NCT00264004|474175642|FG000|Overall Study|Withdrawal by Subject|0|||
131697343|NCT00264004|474175643|FG001|Overall Study|Withdrawal by Subject|1|||
131697344|NCT00264004|474175644|FG002|Overall Study|Withdrawal by Subject|2|||
131697345|NCT00264004|474175645|FG003|Overall Study|Withdrawal by Subject|2|||
131697346|NCT00264004|474175642|FG000|Overall Study|Other|2|||
131697347|NCT00264004|474175643|FG001|Overall Study|Other|2|||
131697348|NCT00264004|474175644|FG002|Overall Study|Other|0|||
131697349|NCT00264004|474175645|FG003|Overall Study|Other|3|||
131697350|NCT00264004|474175642|FG000|Overall Study|Development study specific disc. crit.|1|||
131697351|NCT00264004|474175643|FG001|Overall Study|Development study specific disc. crit.|0|||
131697352|NCT00264004|474175644|FG002|Overall Study|Development study specific disc. crit.|1|||
131697353|NCT00264004|474175645|FG003|Overall Study|Development study specific disc. crit.|0|||
131697354|NCT00264004|474175642|FG000|Overall Study|Cond. under inv. worsened|9|||
131697355|NCT00264004|474175643|FG001|Overall Study|Cond. under inv. worsened|5|||
131697356|NCT00264004|474175644|FG002|Overall Study|Cond. under inv. worsened|3|||
131898657|NCT01516736|474915331|FG000|Overall Study|Lack of Efficacy|1|||
131570080|NCT02616263|473712250|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
131570081|NCT02616263|473712251|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
131570082|NCT02616263|473712250|FG000|6 Month to 1.5 Year|Death|1|||
131570083|NCT02616263|473712251|FG001|6 Month to 1.5 Year|Death|0|||
131570084|NCT02616263|473712250|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
131570085|NCT02616263|473712251|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
131570086|NCT02616263|473712250|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
131697357|NCT00264004|474175645|FG003|Overall Study|Cond. under inv. worsened|4|||
131570087|NCT02616263|473712251|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
131570088|NCT02616263|473712250|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
131570089|NCT02616263|473712251|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
131570090|NCT02939183|473712254|FG000|Overall Study|Death|0|||
131570091|NCT02939183|473712255|FG001|Overall Study|Death|0|||
131570092|NCT02939183|473712256|FG002|Overall Study|Death|1|||
131570093|NCT02939183|473712257|FG003|Overall Study|Death|0|||
131570094|NCT02939183|473712258|FG004|Overall Study|Death|0|||
131570095|NCT02939183|473712259|FG005|Overall Study|Death|2|||
131570096|NCT02939183|473712260|FG006|Overall Study|Death|1|||
131570097|NCT02939183|473712261|FG007|Overall Study|Death|0|||
131570098|NCT02939183|473712262|FG008|Overall Study|Death|0|||
131570099|NCT02939183|473712254|FG000|Overall Study|Sponsor decision|0|||
131570100|NCT02939183|473712255|FG001|Overall Study|Sponsor decision|1|||
131570101|NCT02939183|473712256|FG002|Overall Study|Sponsor decision|0|||
131570102|NCT02939183|473712257|FG003|Overall Study|Sponsor decision|1|||
131570103|NCT02939183|473712258|FG004|Overall Study|Sponsor decision|2|||
131570104|NCT02939183|473712259|FG005|Overall Study|Sponsor decision|0|||
131570105|NCT02939183|473712260|FG006|Overall Study|Sponsor decision|3|||
131570106|NCT02939183|473712261|FG007|Overall Study|Sponsor decision|1|||
131570107|NCT02939183|473712262|FG008|Overall Study|Sponsor decision|4|||
131570108|NCT02939183|473712254|FG000|Overall Study|Withdrawal by Subject|0|||
131570109|NCT02939183|473712255|FG001|Overall Study|Withdrawal by Subject|2|||
131570110|NCT02939183|473712256|FG002|Overall Study|Withdrawal by Subject|0|||
131570111|NCT02939183|473712257|FG003|Overall Study|Withdrawal by Subject|1|||
131570112|NCT02939183|473712258|FG004|Overall Study|Withdrawal by Subject|0|||
131570113|NCT02939183|473712259|FG005|Overall Study|Withdrawal by Subject|0|||
131570114|NCT02939183|473712260|FG006|Overall Study|Withdrawal by Subject|2|||
131570115|NCT02939183|473712261|FG007|Overall Study|Withdrawal by Subject|2|||
131570116|NCT02939183|473712262|FG008|Overall Study|Withdrawal by Subject|2|||
131570117|NCT02939183|473712254|FG000|Overall Study|Not treated due to adverse event|0|||
131570118|NCT02939183|473712255|FG001|Overall Study|Not treated due to adverse event|0|||
131570119|NCT02939183|473712256|FG002|Overall Study|Not treated due to adverse event|0|||
131570120|NCT02939183|473712257|FG003|Overall Study|Not treated due to adverse event|1|||
131570121|NCT02939183|473712258|FG004|Overall Study|Not treated due to adverse event|0|||
131570122|NCT02939183|473712259|FG005|Overall Study|Not treated due to adverse event|0|||
131570123|NCT02939183|473712260|FG006|Overall Study|Not treated due to adverse event|1|||
131570124|NCT02939183|473712261|FG007|Overall Study|Not treated due to adverse event|0|||
131570125|NCT02939183|473712262|FG008|Overall Study|Not treated due to adverse event|0|||
131570126|NCT03424239|473712267|FG000|Overall Study|Withdrawal by Subject|2|||
131570127|NCT01446003|473712268|FG000|Period 1|Protocol Violation|2|||
131570128|NCT01446003|473712269|FG001|Period 1|Protocol Violation|0|||
131570129|NCT01446003|473712268|FG000|Period 2|Adverse Event|1|||
131570130|NCT01446003|473712269|FG001|Period 2|Adverse Event|0|||
131570131|NCT03905135|473712270|FG000|Dose Escalation|Adverse Event|1|||
131570132|NCT03905135|473712271|FG001|Dose Escalation|Adverse Event|1|||
131570133|NCT03905135|473712270|FG000|Dose Escalation|Progressive disease|3|||
131570134|NCT03905135|473712271|FG001|Dose Escalation|Progressive disease|1|||
131570135|NCT03905135|473712270|FG000|Dose Escalation|Intercurrent illness|1|||
131570136|NCT03905135|473712271|FG001|Dose Escalation|Intercurrent illness|0|||
131570137|NCT01740557|473712272|FG000|Overall Study|Ineligible|1|||
131570138|NCT01740557|473712272|FG000|Overall Study|Screen failure|1|||
131570139|NCT00783692|473712276|FG000|Induction Phase|Adverse Event|7|||
131570140|NCT00783692|473712277|FG001|Induction Phase|Adverse Event|9|||
131570141|NCT00783692|473712278|FG002|Induction Phase|Adverse Event|24|||
131570142|NCT00783692|473712279|FG003|Induction Phase|Adverse Event|0|||
131570143|NCT00783692|473712280|FG004|Induction Phase|Adverse Event|0|||
131570144|NCT00783692|473712281|FG005|Induction Phase|Adverse Event|0|||
131570145|NCT00783692|473712282|FG006|Induction Phase|Adverse Event|0|||
131570146|NCT00783692|473712276|FG000|Induction Phase|Protocol Violation|0|||
131570147|NCT00783692|473712277|FG001|Induction Phase|Protocol Violation|0|||
131570148|NCT00783692|473712278|FG002|Induction Phase|Protocol Violation|1|||
131570149|NCT00783692|473712279|FG003|Induction Phase|Protocol Violation|0|||
131570150|NCT00783692|473712280|FG004|Induction Phase|Protocol Violation|0|||
131570151|NCT00783692|473712281|FG005|Induction Phase|Protocol Violation|0|||
131570152|NCT00783692|473712282|FG006|Induction Phase|Protocol Violation|0|||
131570153|NCT00783692|473712276|FG000|Induction Phase|Lack of Efficacy|1|||
131570154|NCT00783692|473712277|FG001|Induction Phase|Lack of Efficacy|3|||
131570155|NCT00783692|473712278|FG002|Induction Phase|Lack of Efficacy|28|||
131570156|NCT00783692|473712279|FG003|Induction Phase|Lack of Efficacy|0|||
131570157|NCT00783692|473712280|FG004|Induction Phase|Lack of Efficacy|0|||
131570158|NCT00783692|473712281|FG005|Induction Phase|Lack of Efficacy|0|||
131570159|NCT00783692|473712282|FG006|Induction Phase|Lack of Efficacy|0|||
131697358|NCT00264004|474175642|FG000|Overall Study|Not treated|3|||
131570160|NCT00783692|473712276|FG000|Induction Phase|Withdrawal by Subject|3|||
131570161|NCT00783692|473712277|FG001|Induction Phase|Withdrawal by Subject|9|||
131570162|NCT00783692|473712278|FG002|Induction Phase|Withdrawal by Subject|16|||
131570163|NCT00783692|473712279|FG003|Induction Phase|Withdrawal by Subject|0|||
131570164|NCT00783692|473712280|FG004|Induction Phase|Withdrawal by Subject|0|||
131570165|NCT00783692|473712281|FG005|Induction Phase|Withdrawal by Subject|0|||
131570166|NCT00783692|473712282|FG006|Induction Phase|Withdrawal by Subject|0|||
131570167|NCT00783692|473712276|FG000|Induction Phase|Lost to Follow-up|0|||
131570168|NCT00783692|473712277|FG001|Induction Phase|Lost to Follow-up|0|||
131570169|NCT00783692|473712278|FG002|Induction Phase|Lost to Follow-up|3|||
131570170|NCT00783692|473712279|FG003|Induction Phase|Lost to Follow-up|0|||
131570171|NCT00783692|473712280|FG004|Induction Phase|Lost to Follow-up|0|||
131570172|NCT00783692|473712281|FG005|Induction Phase|Lost to Follow-up|0|||
131570173|NCT00783692|473712282|FG006|Induction Phase|Lost to Follow-up|0|||
131570174|NCT00783692|473712276|FG000|Induction Phase|Other|0|||
131570175|NCT00783692|473712277|FG001|Induction Phase|Other|0|||
131570176|NCT00783692|473712278|FG002|Induction Phase|Other|2|||
131570177|NCT00783692|473712279|FG003|Induction Phase|Other|0|||
131570178|NCT00783692|473712280|FG004|Induction Phase|Other|0|||
131570179|NCT00783692|473712281|FG005|Induction Phase|Other|0|||
131570180|NCT00783692|473712282|FG006|Induction Phase|Other|0|||
131570181|NCT00783692|473712276|FG000|Maintenance Phase|Adverse Event|7|||
131570182|NCT00783692|473712277|FG001|Maintenance Phase|Adverse Event|0|||
131570183|NCT00783692|473712278|FG002|Maintenance Phase|Adverse Event|0|||
131570184|NCT00783692|473712279|FG003|Maintenance Phase|Adverse Event|15|||
131570185|NCT00783692|473712280|FG004|Maintenance Phase|Adverse Event|12|||
131570186|NCT00783692|473712281|FG005|Maintenance Phase|Adverse Event|9|||
131570187|NCT00783692|473712282|FG006|Maintenance Phase|Adverse Event|38|||
131570188|NCT00783692|473712276|FG000|Maintenance Phase|Protocol Violation|0|||
131570189|NCT00783692|473712277|FG001|Maintenance Phase|Protocol Violation|0|||
131570190|NCT00783692|473712278|FG002|Maintenance Phase|Protocol Violation|0|||
131570191|NCT00783692|473712279|FG003|Maintenance Phase|Protocol Violation|1|||
131570192|NCT00783692|473712280|FG004|Maintenance Phase|Protocol Violation|2|||
131570193|NCT00783692|473712281|FG005|Maintenance Phase|Protocol Violation|3|||
131570194|NCT00783692|473712282|FG006|Maintenance Phase|Protocol Violation|4|||
131570195|NCT00783692|473712276|FG000|Maintenance Phase|Lack of Efficacy|79|||
131570196|NCT00783692|473712277|FG001|Maintenance Phase|Lack of Efficacy|0|||
131570197|NCT00783692|473712278|FG002|Maintenance Phase|Lack of Efficacy|0|||
131570198|NCT00783692|473712279|FG003|Maintenance Phase|Lack of Efficacy|64|||
131570199|NCT00783692|473712280|FG004|Maintenance Phase|Lack of Efficacy|58|||
131570200|NCT00783692|473712281|FG005|Maintenance Phase|Lack of Efficacy|48|||
131570201|NCT00783692|473712282|FG006|Maintenance Phase|Lack of Efficacy|177|||
131570202|NCT00783692|473712276|FG000|Maintenance Phase|Withdrawal by Subject|7|||
131570203|NCT00783692|473712277|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131570204|NCT00783692|473712278|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131570205|NCT00783692|473712279|FG003|Maintenance Phase|Withdrawal by Subject|7|||
131570206|NCT00783692|473712280|FG004|Maintenance Phase|Withdrawal by Subject|6|||
131570207|NCT00783692|473712281|FG005|Maintenance Phase|Withdrawal by Subject|9|||
131570208|NCT00783692|473712282|FG006|Maintenance Phase|Withdrawal by Subject|24|||
131570209|NCT00783692|473712276|FG000|Maintenance Phase|Lost to Follow-up|2|||
131570210|NCT00783692|473712277|FG001|Maintenance Phase|Lost to Follow-up|0|||
131570211|NCT00783692|473712278|FG002|Maintenance Phase|Lost to Follow-up|0|||
131570212|NCT00783692|473712279|FG003|Maintenance Phase|Lost to Follow-up|1|||
131570213|NCT00783692|473712280|FG004|Maintenance Phase|Lost to Follow-up|3|||
131570214|NCT00783692|473712281|FG005|Maintenance Phase|Lost to Follow-up|2|||
131570215|NCT00783692|473712282|FG006|Maintenance Phase|Lost to Follow-up|5|||
131570216|NCT00783692|473712276|FG000|Maintenance Phase|Other|0|||
131570217|NCT00783692|473712277|FG001|Maintenance Phase|Other|0|||
131570218|NCT00783692|473712278|FG002|Maintenance Phase|Other|0|||
131570219|NCT00783692|473712279|FG003|Maintenance Phase|Other|1|||
131437642|NCT03096834|473228108|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
131570220|NCT00783692|473712280|FG004|Maintenance Phase|Other|0|||
131570221|NCT00783692|473712281|FG005|Maintenance Phase|Other|1|||
131570222|NCT00783692|473712282|FG006|Maintenance Phase|Other|1|||
131570223|NCT00768066|473712285|FG000|Overall Study|Did not receive study product injection.|3|||
131570224|NCT00768066|473712286|FG001|Overall Study|Did not receive study product injection.|3|||
131570225|NCT00768066|473712287|FG002|Overall Study|Did not receive study product injection.|0|||
131570226|NCT04831775|473712288|FG000|Overall Study|Lost to Follow-up|11|||
131570227|NCT04831775|473712289|FG001|Overall Study|Lost to Follow-up|13|||
131570228|NCT03015740|473712290|FG000|Overall Study|Adverse Event|1|||
131570229|NCT03015740|473712291|FG001|Overall Study|Adverse Event|0|||
131570230|NCT03015740|473712292|FG002|Overall Study|Adverse Event|0|||
131570231|NCT03015740|473712290|FG000|Overall Study|Death|3|||
131570232|NCT03015740|473712291|FG001|Overall Study|Death|5|||
131570233|NCT03015740|473712292|FG002|Overall Study|Death|0|||
131570234|NCT03015740|473712290|FG000|Overall Study|Withdrawal by Subject|2|||
131570235|NCT03015740|473712291|FG001|Overall Study|Withdrawal by Subject|0|||
131570236|NCT03015740|473712292|FG002|Overall Study|Withdrawal by Subject|0|||
131570237|NCT02449044|473712293|FG000|Overall Study|Lost to Follow-up|2|||
131570238|NCT02449044|473712293|FG000|Overall Study|Withdrawal by Subject|13|||
131570239|NCT02449044|473712293|FG000|Overall Study|Adverse Event|30|||
131570240|NCT02449044|473712293|FG000|Overall Study|Met Withdrawal Criteria|7|||
131570241|NCT02449044|473712293|FG000|Overall Study|Physician Decision|9|||
131570242|NCT02449044|473712293|FG000|Overall Study|Sponsor Discontinued Trial|3|||
131570243|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
131570244|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
131570245|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
131570246|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
131570247|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
131570248|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
131570249|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
131570250|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
131570251|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
131570252|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
131570253|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
131570254|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
131570255|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
131570256|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
131570257|NCT04672460|473713736|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
131570258|NCT04672460|473713737|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
131570259|NCT04672460|473713736|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
131570260|NCT04672460|473713737|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
131570261|NCT04672460|473713736|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
131570262|NCT04672460|473713737|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
131570263|NCT04672460|473713736|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
131570264|NCT04672460|473713737|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
131570265|NCT04672460|473713736|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
131570266|NCT04672460|473713737|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
131570267|NCT04672460|473713736|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
131570268|NCT04672460|473713737|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
131570269|NCT04672460|473713736|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
131570270|NCT04672460|473713737|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
131570271|NCT04672460|473713736|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
131570272|NCT04672460|473713737|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
131570273|NCT04672460|473713736|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
131570274|NCT04672460|473713737|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
131570275|NCT04672460|473713736|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
131570276|NCT04672460|473713737|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
131570277|NCT00049517|473713740|FG000|Induction|Disease progression|0|||
131570278|NCT00049517|473713741|FG001|Induction|Disease progression|0|||
131570279|NCT00049517|473713742|FG002|Induction|Disease progression|0|||
131783668|NCT00759759|474490012|FG000|Overall Study|Didn't receive drug in period 2|1|||
131783669|NCT00759759|474490013|FG001|Overall Study|Didn't receive drug in period 2|0|||
131783670|NCT00759759|474490012|FG000|Overall Study|Withdrawal by Subject|2|||
131783671|NCT00759759|474490013|FG001|Overall Study|Withdrawal by Subject|1|||
131783672|NCT04822701|474490019|FG000|Overall Study|Not treated|2|||
131783673|NCT04822701|474490020|FG001|Overall Study|Not treated|0|||
131437643|NCT03096834|473228109|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
131783674|NCT04822701|474490019|FG000|Overall Study|Lost to Follow-up|1|||
131783675|NCT04822701|474490020|FG001|Overall Study|Lost to Follow-up|0|||
131570280|NCT00049517|473713743|FG003|Induction|Disease progression|0|||
131570281|NCT00049517|473713744|FG004|Induction|Disease progression|18|||
131570282|NCT00049517|473713745|FG005|Induction|Disease progression|11|||
131570283|NCT00049517|473713740|FG000|Induction|Adverse Event|0|||
131570284|NCT00049517|473713741|FG001|Induction|Adverse Event|0|||
131570285|NCT00049517|473713742|FG002|Induction|Adverse Event|0|||
131783676|NCT04822701|474490019|FG000|Overall Study|Withdrawal by Subject|1|||
131783677|NCT04822701|474490020|FG001|Overall Study|Withdrawal by Subject|0|||
131898658|NCT01516736|474915332|FG001|Overall Study|Lack of Efficacy|0|||
131570286|NCT00049517|473713743|FG003|Induction|Adverse Event|0|||
131570287|NCT00049517|473713744|FG004|Induction|Adverse Event|5|||
131570288|NCT00049517|473713745|FG005|Induction|Adverse Event|7|||
131570289|NCT00049517|473713740|FG000|Induction|Death|0|||
131570290|NCT00049517|473713741|FG001|Induction|Death|0|||
131570291|NCT00049517|473713742|FG002|Induction|Death|0|||
131570292|NCT00049517|473713743|FG003|Induction|Death|0|||
131570293|NCT00049517|473713744|FG004|Induction|Death|9|||
131570294|NCT00049517|473713745|FG005|Induction|Death|6|||
131570295|NCT00049517|473713740|FG000|Induction|Withdrawal by Subject|0|||
131570296|NCT00049517|473713741|FG001|Induction|Withdrawal by Subject|0|||
131570297|NCT00049517|473713742|FG002|Induction|Withdrawal by Subject|0|||
131570298|NCT00049517|473713743|FG003|Induction|Withdrawal by Subject|0|||
131570299|NCT00049517|473713744|FG004|Induction|Withdrawal by Subject|1|||
131570300|NCT00049517|473713745|FG005|Induction|Withdrawal by Subject|3|||
131570301|NCT00049517|473713740|FG000|Induction|Alternative therapy|0|||
131570302|NCT00049517|473713741|FG001|Induction|Alternative therapy|0|||
131570303|NCT00049517|473713742|FG002|Induction|Alternative therapy|0|||
131570304|NCT00049517|473713743|FG003|Induction|Alternative therapy|0|||
131570305|NCT00049517|473713744|FG004|Induction|Alternative therapy|2|||
131570306|NCT00049517|473713745|FG005|Induction|Alternative therapy|2|||
131570307|NCT00049517|473713740|FG000|Induction|Other complicating disease|0|||
131570308|NCT00049517|473713741|FG001|Induction|Other complicating disease|0|||
131570309|NCT00049517|473713742|FG002|Induction|Other complicating disease|0|||
131570310|NCT00049517|473713743|FG003|Induction|Other complicating disease|0|||
131570311|NCT00049517|473713744|FG004|Induction|Other complicating disease|3|||
131570312|NCT00049517|473713745|FG005|Induction|Other complicating disease|0|||
131570313|NCT00049517|473713740|FG000|Induction|Reasons not reported|0|||
131570314|NCT00049517|473713741|FG001|Induction|Reasons not reported|0|||
131570315|NCT00049517|473713742|FG002|Induction|Reasons not reported|0|||
131570316|NCT00049517|473713743|FG003|Induction|Reasons not reported|0|||
131570317|NCT00049517|473713744|FG004|Induction|Reasons not reported|22|||
131570318|NCT00049517|473713745|FG005|Induction|Reasons not reported|25|||
131570319|NCT00049517|473713740|FG000|Conditioning/Transplant|Disease progression|14|||
131570320|NCT00049517|473713741|FG001|Conditioning/Transplant|Disease progression|6|||
131570321|NCT00049517|473713742|FG002|Conditioning/Transplant|Disease progression|10|||
131570322|NCT00049517|473713743|FG003|Conditioning/Transplant|Disease progression|6|||
131570323|NCT00049517|473713744|FG004|Conditioning/Transplant|Disease progression|0|||
131570324|NCT00049517|473713745|FG005|Conditioning/Transplant|Disease progression|0|||
131570325|NCT00049517|473713740|FG000|Conditioning/Transplant|Adverse Event|2|||
131570326|NCT00049517|473713741|FG001|Conditioning/Transplant|Adverse Event|1|||
131570327|NCT00049517|473713742|FG002|Conditioning/Transplant|Adverse Event|4|||
131570328|NCT00049517|473713743|FG003|Conditioning/Transplant|Adverse Event|8|||
131570329|NCT00049517|473713744|FG004|Conditioning/Transplant|Adverse Event|0|||
131570330|NCT00049517|473713745|FG005|Conditioning/Transplant|Adverse Event|0|||
131570331|NCT00049517|473713740|FG000|Conditioning/Transplant|Death|1|||
131570332|NCT00049517|473713741|FG001|Conditioning/Transplant|Death|0|||
131570333|NCT00049517|473713742|FG002|Conditioning/Transplant|Death|0|||
131570334|NCT00049517|473713743|FG003|Conditioning/Transplant|Death|2|||
131570335|NCT00049517|473713744|FG004|Conditioning/Transplant|Death|0|||
131570336|NCT00049517|473713745|FG005|Conditioning/Transplant|Death|0|||
131570337|NCT00049517|473713740|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
131697359|NCT00264004|474175643|FG001|Overall Study|Not treated|0|||
131697360|NCT00264004|474175644|FG002|Overall Study|Not treated|2|||
131697361|NCT00264004|474175645|FG003|Overall Study|Not treated|2|||
131697362|NCT00691483|474175646|FG000|Overall Study|Adverse Event|14|||
131697363|NCT00691483|474175647|FG001|Overall Study|Adverse Event|6|||
131697364|NCT00691483|474175646|FG000|Overall Study|Lost to Follow-up|17|||
131570338|NCT00049517|473713741|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
131570339|NCT00049517|473713742|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
131570340|NCT00049517|473713743|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
131570341|NCT00049517|473713744|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
131570342|NCT00049517|473713745|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
131570343|NCT00049517|473713740|FG000|Conditioning/Transplant|Alternative therapy|4|||
131570344|NCT00049517|473713741|FG001|Conditioning/Transplant|Alternative therapy|4|||
131570345|NCT00049517|473713742|FG002|Conditioning/Transplant|Alternative therapy|2|||
131570346|NCT00049517|473713743|FG003|Conditioning/Transplant|Alternative therapy|1|||
131570347|NCT00049517|473713744|FG004|Conditioning/Transplant|Alternative therapy|1|||
131570348|NCT00049517|473713745|FG005|Conditioning/Transplant|Alternative therapy|0|||
131570349|NCT00049517|473713740|FG000|Conditioning/Transplant|Other complicating disease|2|||
131697365|NCT00691483|474175647|FG001|Overall Study|Lost to Follow-up|10|||
131697366|NCT00691483|474175646|FG000|Overall Study|Withdrawal by Subject|24|||
131697367|NCT00691483|474175647|FG001|Overall Study|Withdrawal by Subject|7|||
131697368|NCT00691483|474175646|FG000|Overall Study|Other known cause|6|||
131697369|NCT00691483|474175647|FG001|Overall Study|Other known cause|1|||
131697370|NCT00691483|474175646|FG000|Overall Study|Randomized by not treated|7|||
131570350|NCT00049517|473713741|FG001|Conditioning/Transplant|Other complicating disease|0|||
131570351|NCT00049517|473713742|FG002|Conditioning/Transplant|Other complicating disease|0|||
131697371|NCT00691483|474175647|FG001|Overall Study|Randomized by not treated|1|||
131697372|NCT01535729|474175649|FG000|Overall Study|Withdrawal by Subject|2|||
131697373|NCT01535729|474175649|FG000|Overall Study|Disease progression|230|||
131570352|NCT00049517|473713743|FG003|Conditioning/Transplant|Other complicating disease|4|||
131570353|NCT00049517|473713744|FG004|Conditioning/Transplant|Other complicating disease|0|||
131570354|NCT00049517|473713745|FG005|Conditioning/Transplant|Other complicating disease|1|||
131570355|NCT00049517|473713740|FG000|Conditioning/Transplant|Reasons not reported|25|||
131570356|NCT00049517|473713741|FG001|Conditioning/Transplant|Reasons not reported|31|||
131570357|NCT00049517|473713742|FG002|Conditioning/Transplant|Reasons not reported|18|||
131570358|NCT00049517|473713743|FG003|Conditioning/Transplant|Reasons not reported|15|||
131570359|NCT00049517|473713744|FG004|Conditioning/Transplant|Reasons not reported|5|||
131570360|NCT00049517|473713745|FG005|Conditioning/Transplant|Reasons not reported|5|||
131570361|NCT01211665|473713748|FG000|Overall Study|Withdrawal by Subject|1|||
131570362|NCT01211665|473713749|FG001|Overall Study|Withdrawal by Subject|0|||
131570363|NCT01211665|473713748|FG000|Overall Study|Death|1|||
131570364|NCT01211665|473713749|FG001|Overall Study|Death|0|||
131570365|NCT01390857|473713752|FG000|Overall Study|Protocol Violation|2|||
131570366|NCT01390857|473713752|FG000|Overall Study|Lost to Follow-up|1|||
131570367|NCT01390857|473713752|FG000|Overall Study|No Visit after the First Visit|7|||
131570368|NCT01123161|473713753|FG000|Overall Study|Lost to Follow-up|1|||
131697374|NCT01535729|474175649|FG000|Overall Study|Discontinued treatment|25|||
131697375|NCT01535729|474175649|FG000|Overall Study|Lost to Follow-up|8|||
131697376|NCT01535729|474175649|FG000|Overall Study|Death|52|||
131697377|NCT01535729|474175649|FG000|Overall Study|Other|19|||
131697378|NCT01535729|474175649|FG000|Overall Study|Did not sign informed consent|1|||
131697379|NCT01535729|474175649|FG000|Overall Study|No previous chemotherapy|33|||
131697380|NCT01535729|474175649|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
131697381|NCT01535729|474175649|FG000|Overall Study|Protocol Violation|11|||
131697382|NCT01535729|474175649|FG000|Overall Study|Screening failure|1|||
131697383|NCT01535729|474175649|FG000|Overall Study|Not treated|9|||
131697384|NCT01535729|474175649|FG000|Overall Study|No participant record available|5|||
131697385|NCT02787850|474175650|FG000|Overall Study|Withdrawal by Subject|0|||
131697386|NCT02787850|474175651|FG001|Overall Study|Withdrawal by Subject|1|||
131697387|NCT02921971|474175652|FG000|Overall Study|Adverse Event|1|||
131697388|NCT02921971|474175653|FG001|Overall Study|Adverse Event|2|||
131697389|NCT02921971|474175652|FG000|Overall Study|Lack of Efficacy|3|||
131697390|NCT02921971|474175653|FG001|Overall Study|Lack of Efficacy|1|||
131697391|NCT02921971|474175652|FG000|Overall Study|Other than specified above|2|||
131570369|NCT01123161|473713754|FG001|Overall Study|Lost to Follow-up|0|||
131697392|NCT02921971|474175653|FG001|Overall Study|Other than specified above|1|||
131697393|NCT00452699|474175654|FG000|Overall Study|Adverse Event|10|||
131697394|NCT00452699|474175655|FG001|Overall Study|Adverse Event|3|||
131697395|NCT00452699|474175654|FG000|Overall Study|Lack of Efficacy|6|||
131697396|NCT00452699|474175655|FG001|Overall Study|Lack of Efficacy|4|||
131570370|NCT01123161|473713753|FG000|Overall Study|Withdrawal by Subject|1|||
131570371|NCT01123161|473713754|FG001|Overall Study|Withdrawal by Subject|0|||
131570372|NCT01244984|473713763|FG000|Overall Study|Adverse Event|2|||
131697397|NCT00452699|474175654|FG000|Overall Study|Lost to Follow-up|6|||
131697398|NCT00452699|474175655|FG001|Overall Study|Lost to Follow-up|9|||
131570373|NCT01244984|473713764|FG001|Overall Study|Adverse Event|11|||
131570374|NCT01244984|473713765|FG002|Overall Study|Adverse Event|2|||
131570375|NCT01244984|473713763|FG000|Overall Study|Protocol Violation|1|||
131570376|NCT01244984|473713764|FG001|Overall Study|Protocol Violation|0|||
131570377|NCT01244984|473713765|FG002|Overall Study|Protocol Violation|0|||
131570378|NCT01244984|473713763|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
131570379|NCT01244984|473713764|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
131570380|NCT01244984|473713765|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
131570381|NCT01244984|473713763|FG000|Overall Study|Withdrawal by Subject|1|||
131570382|NCT01244984|473713764|FG001|Overall Study|Withdrawal by Subject|2|||
131570383|NCT01244984|473713765|FG002|Overall Study|Withdrawal by Subject|2|||
131570384|NCT02072226|473713767|FG000|Overall Study|Lost to Follow-up|11|||
131570385|NCT02072226|473713768|FG001|Overall Study|Lost to Follow-up|7|||
131570386|NCT02072226|473713767|FG000|Overall Study|Patient Non-compliance|2|||
131570387|NCT02072226|473713768|FG001|Overall Study|Patient Non-compliance|3|||
131570388|NCT02072226|473713767|FG000|Overall Study|Death|1|||
131570389|NCT02072226|473713768|FG001|Overall Study|Death|0|||
131570390|NCT02072226|473713767|FG000|Overall Study|Patient Withdrawal of Consent|1|||
131570391|NCT02072226|473713768|FG001|Overall Study|Patient Withdrawal of Consent|0|||
131570392|NCT01124162|473713774|FG000|First Intervention|Adverse Event|2|||
131570393|NCT01124162|473713775|FG001|First Intervention|Adverse Event|0|||
131570394|NCT01124162|473713774|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131570395|NCT01124162|473713775|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131570396|NCT02680756|473713776|FG000|Overall Study|Adverse Event|10|||
131570397|NCT02680756|473713777|FG001|Overall Study|Adverse Event|2|||
131697399|NCT00452699|474175654|FG000|Overall Study|Protocol Violation|21|||
131697400|NCT00452699|474175655|FG001|Overall Study|Protocol Violation|25|||
131697401|NCT00452699|474175654|FG000|Overall Study|Withdrawal by Subject|26|||
131697402|NCT00452699|474175655|FG001|Overall Study|Withdrawal by Subject|25|||
131697403|NCT00452699|474175654|FG000|Overall Study|Other|12|||
131697404|NCT00452699|474175655|FG001|Overall Study|Other|7|||
131697405|NCT00326898|474175656|FG000|Overall Study|Disease progression|52|||
131697406|NCT00326898|474175657|FG001|Overall Study|Disease progression|54|||
131697407|NCT00326898|474175658|FG002|Overall Study|Disease progression|102|||
131697408|NCT00326898|474175656|FG000|Overall Study|Adverse Event|124|||
131697409|NCT00326898|474175657|FG001|Overall Study|Adverse Event|128|||
131697410|NCT00326898|474175658|FG002|Overall Study|Adverse Event|33|||
131697411|NCT00326898|474175656|FG000|Overall Study|Death|2|||
131697412|NCT00326898|474175657|FG001|Overall Study|Death|0|||
131697413|NCT00326898|474175658|FG002|Overall Study|Death|0|||
131697414|NCT00326898|474175656|FG000|Overall Study|Withdrawal by Subject|134|||
131697415|NCT00326898|474175657|FG001|Overall Study|Withdrawal by Subject|128|||
131697416|NCT00326898|474175658|FG002|Overall Study|Withdrawal by Subject|32|||
131697417|NCT00326898|474175656|FG000|Overall Study|Alternative therapy|1|||
131697418|NCT00326898|474175657|FG001|Overall Study|Alternative therapy|0|||
131697419|NCT00326898|474175658|FG002|Overall Study|Alternative therapy|0|||
131697420|NCT00326898|474175656|FG000|Overall Study|Other complicating disease|5|||
131697421|NCT00326898|474175657|FG001|Overall Study|Other complicating disease|5|||
131697422|NCT00326898|474175658|FG002|Overall Study|Other complicating disease|4|||
131697423|NCT00326898|474175656|FG000|Overall Study|Other/Missing/Unknown|33|||
131697424|NCT00326898|474175657|FG001|Overall Study|Other/Missing/Unknown|28|||
131697425|NCT00326898|474175658|FG002|Overall Study|Other/Missing/Unknown|32|||
131697426|NCT03847987|474175659|FG000|Overall Study|Lost to Follow-up|1|||
131697427|NCT03847987|474175660|FG001|Overall Study|Lost to Follow-up|0|||
131697428|NCT03847987|474175659|FG000|Overall Study|Adverse Event|2|||
131697429|NCT03847987|474175660|FG001|Overall Study|Adverse Event|0|||
131697430|NCT02615990|474175666|FG000|Overall Study|study terminated|1|||
131697431|NCT02615990|474175667|FG001|Overall Study|study terminated|1|||
131697432|NCT01363986|474175668|FG000|Overall Study|Disease progression|1|||
131697433|NCT00130832|474175669|FG000|Overall Study|Adverse Event|1|||
131697434|NCT00130832|474175670|FG001|Overall Study|Adverse Event|1|||
131697435|NCT00130832|474175669|FG000|Overall Study|Lost to Follow-up|1|||
131697436|NCT00130832|474175670|FG001|Overall Study|Lost to Follow-up|2|||
131697437|NCT00130832|474175669|FG000|Overall Study|Protocol Violation|6|||
131697438|NCT00130832|474175670|FG001|Overall Study|Protocol Violation|8|||
131697439|NCT00130832|474175669|FG000|Overall Study|Withdrawal by Subject|6|||
131697440|NCT00130832|474175670|FG001|Overall Study|Withdrawal by Subject|1|||
131437644|NCT03096834|473228110|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
131697441|NCT00130832|474175669|FG000|Overall Study|Moved|2|||
131697442|NCT00130832|474175670|FG001|Overall Study|Moved|2|||
131697443|NCT00130832|474175669|FG000|Overall Study|Other|0|||
131697444|NCT00130832|474175670|FG001|Overall Study|Other|3|||
131570398|NCT02680756|473713776|FG000|Overall Study|Lost to Follow-up|7|||
131570399|NCT02680756|473713777|FG001|Overall Study|Lost to Follow-up|6|||
131570400|NCT02680756|473713776|FG000|Overall Study|Withdrawal by Subject|5|||
131570401|NCT02680756|473713777|FG001|Overall Study|Withdrawal by Subject|5|||
131570402|NCT02680756|473713776|FG000|Overall Study|Physician Decision|4|||
131697445|NCT00925015|474175673|FG000|Overall Study|Adverse Event|1|||
131697446|NCT00925015|474175674|FG001|Overall Study|Adverse Event|2|||
131783678|NCT03853213|474491660|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
131783679|NCT03853213|474491661|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
131570403|NCT02680756|473713777|FG001|Overall Study|Physician Decision|1|||
131570404|NCT02680756|473713776|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
131570405|NCT02680756|473713777|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
131570406|NCT02680756|473713776|FG000|Overall Study|Blood transfusion for any reason|0|||
131570407|NCT02680756|473713777|FG001|Overall Study|Blood transfusion for any reason|1|||
131570408|NCT02680756|473713776|FG000|Overall Study|Death|1|||
131570409|NCT02680756|473713777|FG001|Overall Study|Death|0|||
131570410|NCT02680756|473713776|FG000|Overall Study|Protocol Violation|1|||
131570411|NCT02680756|473713777|FG001|Overall Study|Protocol Violation|0|||
131570412|NCT02680756|473713776|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
131783680|NCT03853213|474491660|FG000|Overall Study|Other (e.g., too busy)|0|||
131783681|NCT03853213|474491661|FG001|Overall Study|Other (e.g., too busy)|2|||
131783682|NCT03302299|474491662|FG000|Overall Study|Protocol Violation|1|||
131783683|NCT03911960|474491663|FG000|Overall Study|Lost to Follow-up|5|||
131783684|NCT03911960|474491664|FG001|Overall Study|Lost to Follow-up|3|||
131783685|NCT02239692|474491665|FG000|Overall Study|Incomplete colonoscopy|1|||
131783686|NCT02239692|474491666|FG001|Overall Study|Incomplete colonoscopy|2|||
131783687|NCT02239692|474491665|FG000|Overall Study|Adverse Event|0|||
131783688|NCT02239692|474491666|FG001|Overall Study|Adverse Event|1|||
131783689|NCT02239692|474491665|FG000|Overall Study|Physician Decision|0|||
131783690|NCT02239692|474491666|FG001|Overall Study|Physician Decision|1|||
131783691|NCT02239692|474491665|FG000|Overall Study|Lost to Follow-up|1|||
131783692|NCT02239692|474491666|FG001|Overall Study|Lost to Follow-up|4|||
131437645|NCT03096834|473228111|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
131570413|NCT02680756|473713777|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
131570414|NCT02680756|473713776|FG000|Overall Study|None of above or not recorded|3|||
131570415|NCT02680756|473713777|FG001|Overall Study|None of above or not recorded|2|||
131570416|NCT01516892|473713779|FG000|Overall Study|Adverse Event|25|||
131783693|NCT02239692|474491665|FG000|Overall Study|Withdrawal by Subject|3|||
131570417|NCT01516892|473713779|FG000|Overall Study|Lack of Efficacy|35|||
131570418|NCT01516892|473713779|FG000|Overall Study|Pregnancy|5|||
131570419|NCT01516892|473713779|FG000|Overall Study|Lost to Follow-up|82|||
131570420|NCT01516892|473713779|FG000|Overall Study|Subject Withdrew Consent|92|||
131570421|NCT01516892|473713779|FG000|Overall Study|Protocol Violation|60|||
131570422|NCT01516892|473713779|FG000|Overall Study|Other Miscellaneous Reasons|43|||
131570423|NCT01516892|473713779|FG000|Overall Study|Missing|1|||
131570424|NCT03635112|473713780|FG000|Overall Study|Adverse Event|5|||
131570425|NCT03635112|473713781|FG001|Overall Study|Adverse Event|9|||
131570426|NCT03635112|473713782|FG002|Overall Study|Adverse Event|14|||
131570427|NCT03635112|473713780|FG000|Overall Study|Lost to Follow-up|1|||
131570428|NCT03635112|473713781|FG001|Overall Study|Lost to Follow-up|0|||
131570429|NCT03635112|473713782|FG002|Overall Study|Lost to Follow-up|1|||
131570430|NCT03635112|473713780|FG000|Overall Study|Physician Decision|5|||
131570431|NCT03635112|473713781|FG001|Overall Study|Physician Decision|7|||
131570432|NCT03635112|473713782|FG002|Overall Study|Physician Decision|5|||
131570433|NCT03635112|473713780|FG000|Overall Study|Protocol Violation|0|||
131570434|NCT03635112|473713781|FG001|Overall Study|Protocol Violation|0|||
131570435|NCT03635112|473713782|FG002|Overall Study|Protocol Violation|1|||
131898659|NCT01516736|474915331|FG000|Overall Study|Protocol Violation|0|||
131570436|NCT03635112|473713780|FG000|Overall Study|Study Terminated by Sponsor|11|||
131570437|NCT03635112|473713781|FG001|Overall Study|Study Terminated by Sponsor|17|||
131570438|NCT03635112|473713782|FG002|Overall Study|Study Terminated by Sponsor|21|||
131570439|NCT03635112|473713780|FG000|Overall Study|Withdrawal by Subject|4|||
131570440|NCT03635112|473713781|FG001|Overall Study|Withdrawal by Subject|9|||
131570441|NCT03635112|473713782|FG002|Overall Study|Withdrawal by Subject|7|||
131570442|NCT03635112|473713780|FG000|Overall Study|Miscellaneous|0|||
131570443|NCT03635112|473713781|FG001|Overall Study|Miscellaneous|0|||
131570444|NCT03635112|473713782|FG002|Overall Study|Miscellaneous|1|||
131570445|NCT03006341|473713786|FG000|Overall Study|Not linked in the EMR|25069|||
131570446|NCT03006341|473713787|FG001|Overall Study|Not linked in the EMR|67505|||
131570447|NCT03006341|473713788|FG002|Overall Study|Not linked in the EMR|30993|||
131697447|NCT00925015|474175675|FG002|Overall Study|Adverse Event|1|||
131697448|NCT00925015|474175673|FG000|Overall Study|Physician Decision|0|||
131697449|NCT00925015|474175674|FG001|Overall Study|Physician Decision|1|||
131697450|NCT00925015|474175675|FG002|Overall Study|Physician Decision|0|||
131697451|NCT00925015|474175673|FG000|Overall Study|Progressive Disease|7|||
131697452|NCT00925015|474175674|FG001|Overall Study|Progressive Disease|3|||
131697453|NCT00925015|474175675|FG002|Overall Study|Progressive Disease|4|||
131697454|NCT00925015|474175673|FG000|Overall Study|Withdrawal by Subject|0|||
131697455|NCT00925015|474175674|FG001|Overall Study|Withdrawal by Subject|0|||
131697456|NCT00925015|474175675|FG002|Overall Study|Withdrawal by Subject|1|||
131697457|NCT05499559|474175676|FG000|Overall Study|Lost to Follow-up|467|||
131697458|NCT04681170|474175677|FG000|Stratified Enrolment & run-in|Death|1|||
131697459|NCT04681170|474175678|FG001|Stratified Enrolment & run-in|Death|0|||
131697460|NCT04681170|474175677|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
131697461|NCT04681170|474175678|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
131697462|NCT04681170|474175677|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
131697463|NCT04681170|474175678|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
131697464|NCT04681170|474175677|FG000|Open Label Efficacy Phase|Adverse Event|0|||
131697465|NCT04681170|474175678|FG001|Open Label Efficacy Phase|Adverse Event|2|||
131697466|NCT04681170|474175677|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
131697467|NCT04681170|474175678|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
131697468|NCT04681170|474175677|FG000|Open Label Safety Phase|AEs and none compliance|0|||
131697469|NCT04681170|474175678|FG001|Open Label Safety Phase|AEs and none compliance|1|||
131697470|NCT02754726|474175679|FG000|Overall Study|Progressive Disease by RECIST|13|||
131697471|NCT02754726|474175679|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
131697472|NCT02754726|474175679|FG000|Overall Study|Clinical Disease Progression|5|||
131697473|NCT02754726|474175679|FG000|Overall Study|Adverse Event|3|||
131697474|NCT02754726|474175679|FG000|Overall Study|Withdrawal by Subject|1|||
131697475|NCT02754726|474175679|FG000|Overall Study|Tolerability|1|||
131697476|NCT00252057|474175692|FG000|Overall Study|Withdrawal by Subject|2|||
131697477|NCT00252057|474175693|FG001|Overall Study|Withdrawal by Subject|5|||
131697478|NCT00252057|474175692|FG000|Overall Study|Death|1|||
131697479|NCT00252057|474175693|FG001|Overall Study|Death|2|||
131697480|NCT00252057|474175692|FG000|Overall Study|Participant previously enrolled|0|||
131697481|NCT00252057|474175693|FG001|Overall Study|Participant previously enrolled|1|||
131697482|NCT01903837|474175695|FG000|Part A|Withdrawal by Subject|4|||
131697483|NCT01903837|474175696|FG001|Part A|Withdrawal by Subject|9|||
131697484|NCT01903837|474175697|FG002|Part A|Withdrawal by Subject|8|||
131697485|NCT01903837|474175698|FG003|Part A|Withdrawal by Subject|5|||
131570448|NCT03006341|473713789|FG003|Overall Study|Not linked in the EMR|10685|||
131570449|NCT02950545|473713792|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131570450|NCT02950545|473713793|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131570451|NCT02950545|473713794|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131570452|NCT02950545|473713795|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131570453|NCT02950545|473713796|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131570454|NCT02950545|473713797|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
131570455|NCT02950545|473713792|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
131570456|NCT02950545|473713793|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
131570457|NCT02950545|473713794|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
131783694|NCT02239692|474491666|FG001|Overall Study|Withdrawal by Subject|5|||
131783695|NCT02239692|474491665|FG000|Overall Study|Other reason|1|||
131783696|NCT02239692|474491666|FG001|Overall Study|Other reason|0|||
131783697|NCT04318535|474491667|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
131783698|NCT04318535|474491668|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
131783699|NCT04318535|474491669|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
131783700|NCT01901146|474491671|FG000|Neoadjuvant Phase|Death|1|||
131783701|NCT01901146|474491672|FG001|Neoadjuvant Phase|Death|2|||
131783702|NCT01901146|474491673|FG002|Neoadjuvant Phase|Death|0|||
131783703|NCT01901146|474491674|FG003|Neoadjuvant Phase|Death|0|||
131783704|NCT01901146|474491675|FG004|Neoadjuvant Phase|Death|0|||
131783705|NCT01901146|474491671|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
131783706|NCT01901146|474491672|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
131783707|NCT01901146|474491673|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
131783708|NCT01901146|474491674|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
131783709|NCT01901146|474491675|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
131783710|NCT01901146|474491671|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
131783711|NCT01901146|474491672|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
131783712|NCT01901146|474491673|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
131783713|NCT01901146|474491674|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
131783714|NCT01901146|474491675|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
131783715|NCT01901146|474491671|FG000|Neoadjuvant Phase|Physician Decision|1|||
131783716|NCT01901146|474491672|FG001|Neoadjuvant Phase|Physician Decision|2|||
131783717|NCT01901146|474491673|FG002|Neoadjuvant Phase|Physician Decision|0|||
131783718|NCT01901146|474491674|FG003|Neoadjuvant Phase|Physician Decision|0|||
131783719|NCT01901146|474491675|FG004|Neoadjuvant Phase|Physician Decision|0|||
131783720|NCT01901146|474491671|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
131783721|NCT01901146|474491672|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
131783722|NCT01901146|474491673|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
131783723|NCT01901146|474491674|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
131783724|NCT01901146|474491675|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
131783725|NCT01901146|474491671|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131783726|NCT01901146|474491672|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
131783727|NCT01901146|474491673|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131783728|NCT01901146|474491674|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131783729|NCT01901146|474491675|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131783730|NCT01901146|474491671|FG000|Adjuvant Phase|Other|0|||
131783731|NCT01901146|474491672|FG001|Adjuvant Phase|Other|0|||
131783732|NCT01901146|474491673|FG002|Adjuvant Phase|Other|1|||
131783733|NCT01901146|474491674|FG003|Adjuvant Phase|Other|0|||
131783734|NCT01901146|474491675|FG004|Adjuvant Phase|Other|0|||
131783735|NCT01901146|474491671|FG000|Adjuvant Phase|Death|0|||
131570458|NCT02950545|473713795|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
131570459|NCT02950545|473713796|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
131570460|NCT02950545|473713797|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
131783736|NCT01901146|474491672|FG001|Adjuvant Phase|Death|0|||
131783737|NCT01901146|474491673|FG002|Adjuvant Phase|Death|0|||
131783738|NCT01901146|474491674|FG003|Adjuvant Phase|Death|0|||
131783739|NCT01901146|474491675|FG004|Adjuvant Phase|Death|3|||
131783740|NCT01901146|474491671|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
131783741|NCT01901146|474491672|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
131437646|NCT03096834|473228108|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
131437647|NCT03096834|473228109|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
131437648|NCT03096834|473228110|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
131437649|NCT03096834|473228111|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
131437650|NCT03096834|473228108|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
131437651|NCT03096834|473228109|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
131437652|NCT03096834|473228110|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
131437653|NCT03096834|473228111|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
131437654|NCT03096834|473228108|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
131437655|NCT03096834|473228109|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
131437656|NCT03096834|473228110|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
131437657|NCT03096834|473228111|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
131437658|NCT03096834|473228108|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
131437659|NCT03096834|473228109|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
131437660|NCT03096834|473228110|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
131437661|NCT03096834|473228111|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
131437662|NCT03096834|473228108|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
131437663|NCT03096834|473228109|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
131437664|NCT03096834|473228110|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
131437665|NCT03096834|473228111|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
131437666|NCT03096834|473228108|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
131437667|NCT03096834|473228109|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
131437668|NCT03096834|473228110|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
131437669|NCT03096834|473228111|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
131437670|NCT03096834|473228108|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
131437671|NCT03096834|473228109|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
131437672|NCT03096834|473228110|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
131437673|NCT03096834|473228111|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
131437674|NCT03096834|473228108|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
131437675|NCT03096834|473228109|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
131437676|NCT03096834|473228110|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
131437677|NCT03096834|473228111|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
131437678|NCT03096834|473228108|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
131437679|NCT03096834|473228109|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
131437680|NCT03096834|473228110|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
131437681|NCT03096834|473228111|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
131437682|NCT03096834|473228108|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
131437683|NCT03096834|473228109|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
131437684|NCT03096834|473228110|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
131437685|NCT03096834|473228111|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
131437686|NCT04416204|473228112|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
131437687|NCT04416204|473228113|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
131437688|NCT04416204|473228114|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
131437689|NCT04416204|473228115|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
131437690|NCT04456504|473228116|FG000|Overall Study|Lost to Follow-up|2|||
131437691|NCT01131507|473228117|FG000|Overall Study|Adverse Event|1|||
131437692|NCT01131507|473228117|FG000|Overall Study|Lost to Follow-up|1|||
131570461|NCT02950545|473713792|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131570462|NCT02950545|473713793|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131570463|NCT02950545|473713794|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131570464|NCT02950545|473713795|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131570465|NCT02950545|473713796|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
131570466|NCT02950545|473713797|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131570467|NCT02950545|473713792|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
131570468|NCT02950545|473713793|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131570469|NCT02950545|473713794|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131570470|NCT02950545|473713795|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131570471|NCT02950545|473713796|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131570472|NCT02950545|473713797|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131570473|NCT02950545|473713792|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131570474|NCT02950545|473713793|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131697486|NCT01903837|474175695|FG000|Part A|Adverse Event|3|||
131697487|NCT01903837|474175696|FG001|Part A|Adverse Event|6|||
131697488|NCT01903837|474175697|FG002|Part A|Adverse Event|9|||
131570475|NCT02950545|473713794|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131570476|NCT02950545|473713795|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131697489|NCT01903837|474175698|FG003|Part A|Adverse Event|6|||
131437693|NCT01131507|473228117|FG000|Overall Study|Withdrawal by Subject|1|||
131437694|NCT01393158|473228126|FG000|Overall Study|Adverse Event|1|||
131437695|NCT01393158|473228127|FG001|Overall Study|Adverse Event|0|||
131570477|NCT02950545|473713796|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131697490|NCT01903837|474175695|FG000|Part A|Lost to Follow-up|9|||
131570478|NCT02950545|473713797|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
131570479|NCT03101592|473713798|FG000|Overall Study|participant files could not be located|111|||
131570480|NCT03101592|473713799|FG001|Overall Study|participant files could not be located|170|||
131570481|NCT03101592|473713800|FG002|Overall Study|participant files could not be located|118|||
131570482|NCT01770860|473713801|FG000|Overall Study|Withdrawal by Subject|4|||
131570483|NCT01770860|473713801|FG000|Overall Study|Lost to Follow-up|1|||
131570484|NCT01770860|473713801|FG000|Overall Study|Administrative decision made by the PI|1|||
131570485|NCT03398356|473713804|FG000|Before Treatment|Lost to Follow-up|1|||
131570486|NCT03398356|473713805|FG001|Before Treatment|Lost to Follow-up|2|||
131570487|NCT03398356|473713806|FG002|Before Treatment|Lost to Follow-up|0|||
131570488|NCT03398356|473713804|FG000|Before Treatment|drug intolerance|2|||
131437696|NCT00762359|473228128|FG000|Overall Study|Adverse Event|20|||
131437697|NCT00762359|473228129|FG001|Overall Study|Adverse Event|23|||
131570489|NCT03398356|473713805|FG001|Before Treatment|drug intolerance|1|||
131570490|NCT03398356|473713806|FG002|Before Treatment|drug intolerance|0|||
131570491|NCT03398356|473713804|FG000|Before Treatment|Withdrawal by Subject|0|||
131570492|NCT03398356|473713805|FG001|Before Treatment|Withdrawal by Subject|5|||
131570493|NCT03398356|473713806|FG002|Before Treatment|Withdrawal by Subject|0|||
131570494|NCT03398356|473713804|FG000|Before Treatment|Physician Decision|0|||
131570495|NCT03398356|473713805|FG001|Before Treatment|Physician Decision|0|||
131570496|NCT03398356|473713806|FG002|Before Treatment|Physician Decision|11|||
131570497|NCT03398356|473713804|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
131570498|NCT03398356|473713805|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
131570499|NCT03398356|473713806|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
131783742|NCT01901146|474491673|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
131783743|NCT01901146|474491674|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
131783744|NCT01901146|474491675|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
131783745|NCT01901146|474491671|FG000|Adjuvant Phase|Physician Decision|0|||
131437698|NCT00762359|473228128|FG000|Overall Study|Protocol Violation|21|||
131437699|NCT00762359|473228129|FG001|Overall Study|Protocol Violation|13|||
131437700|NCT00762359|473228128|FG000|Overall Study|Withdrawal by Subject|13|||
131437701|NCT00762359|473228129|FG001|Overall Study|Withdrawal by Subject|10|||
131437702|NCT00762359|473228128|FG000|Overall Study|Lack of Efficacy|0|||
131437703|NCT00762359|473228129|FG001|Overall Study|Lack of Efficacy|4|||
131437704|NCT00762359|473228128|FG000|Overall Study|Institution closed|2|||
131437705|NCT00762359|473228129|FG001|Overall Study|Institution closed|3|||
131437706|NCT00762359|473228128|FG000|Overall Study|Physician Decision|2|||
131570500|NCT03432533|473713809|FG000|Overall Study|Lost to Follow-up|1|||
131570501|NCT03432533|473713810|FG001|Overall Study|Lost to Follow-up|2|||
131898660|NCT01516736|474915332|FG001|Overall Study|Protocol Violation|1|||
131437707|NCT00762359|473228129|FG001|Overall Study|Physician Decision|3|||
131437708|NCT00762359|473228128|FG000|Overall Study|Removal|0|||
131437709|NCT00762359|473228129|FG001|Overall Study|Removal|1|||
131437710|NCT00762359|473228128|FG000|Overall Study|Withdrew consent|1|||
131437711|NCT00762359|473228129|FG001|Overall Study|Withdrew consent|0|||
131783746|NCT01901146|474491672|FG001|Adjuvant Phase|Physician Decision|0|||
131783747|NCT01901146|474491673|FG002|Adjuvant Phase|Physician Decision|9|||
131783748|NCT01901146|474491674|FG003|Adjuvant Phase|Physician Decision|2|||
131783749|NCT01901146|474491675|FG004|Adjuvant Phase|Physician Decision|4|||
131783750|NCT01901146|474491671|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
131783751|NCT01901146|474491672|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
131783752|NCT01901146|474491673|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
131783753|NCT01901146|474491674|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
131783754|NCT01901146|474491675|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
131783755|NCT01614925|474491676|FG000|Overall Study|Withdrawal by Subject|1|||
131783756|NCT01614925|474491677|FG001|Overall Study|Withdrawal by Subject|0|||
131783757|NCT01614925|474491676|FG000|Overall Study|Protocol Violation|3|||
131783758|NCT01614925|474491677|FG001|Overall Study|Protocol Violation|2|||
131783759|NCT04723173|474491678|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
131783760|NCT02996448|474491679|FG000|Overall Study|Study terminated due to adverse effects|3|||
131783761|NCT01422720|474491680|FG000|Overall Study|Adverse Event|16|||
131783762|NCT01422720|474491680|FG000|Overall Study|Lack of Efficacy|1|||
131783763|NCT01422720|474491680|FG000|Overall Study|Withdrawal by Subject|4|||
131783764|NCT01422720|474491680|FG000|Overall Study|Ineligibility|1|||
131783765|NCT00606801|474491681|FG000|Intervention|Protocol Violation|3|||
131783766|NCT00606801|474491682|FG001|Intervention|Protocol Violation|3|||
131783767|NCT00303316|474491687|FG000|Overall Study|Protocol Violation|1|||
131783768|NCT00303316|474491688|FG001|Overall Study|Protocol Violation|0|||
131783769|NCT00303316|474491687|FG000|Overall Study|Lost to Follow-up|0|||
131783770|NCT00303316|474491688|FG001|Overall Study|Lost to Follow-up|1|||
131783771|NCT00303316|474491687|FG000|Overall Study|Withdrawal by Subject|1|||
131783772|NCT00303316|474491688|FG001|Overall Study|Withdrawal by Subject|2|||
131783773|NCT01726335|474491689|FG000|Overall Study|Lost to Follow-up|2|||
131783774|NCT01726335|474491689|FG000|Overall Study|Withdrawal by Subject|15|||
131783775|NCT01726335|474491689|FG000|Overall Study|Adverse Event|4|||
131783776|NCT01726335|474491689|FG000|Overall Study|Lost to Follow-up|2|||
131783777|NCT01726335|474491689|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
131783778|NCT01586624|474491690|FG000|Overall Study|Adverse Event|3|||
131783779|NCT01586624|474491691|FG001|Overall Study|Adverse Event|0|||
131570502|NCT03432533|473713809|FG000|Overall Study|Withdrawal by Subject|14|||
131570503|NCT03432533|473713810|FG001|Overall Study|Withdrawal by Subject|9|||
131570504|NCT01648283|473713811|FG000|Overall Study|Withdrawal by Subject|14|||
131898661|NCT01516736|474915331|FG000|Overall Study|Other (not specified)|0|||
131570505|NCT03382821|473713813|FG000|Overall Study|Did not receive allocated intervention.|0|||
131570506|NCT03382821|473713814|FG001|Overall Study|Did not receive allocated intervention.|3|||
131570507|NCT00282438|473713815|FG000|Overall Study|Lack of Efficacy|1|||
131697491|NCT01903837|474175696|FG001|Part A|Lost to Follow-up|7|||
131697492|NCT01903837|474175697|FG002|Part A|Lost to Follow-up|7|||
131697493|NCT01903837|474175698|FG003|Part A|Lost to Follow-up|2|||
131697494|NCT01903837|474175695|FG000|Part A|Non-compliance with study drug|1|||
131697495|NCT01903837|474175696|FG001|Part A|Non-compliance with study drug|4|||
131570508|NCT00282438|473713816|FG001|Overall Study|Lack of Efficacy|0|||
131697496|NCT01903837|474175697|FG002|Part A|Non-compliance with study drug|4|||
131697497|NCT01903837|474175698|FG003|Part A|Non-compliance with study drug|0|||
131697498|NCT01903837|474175695|FG000|Part A|Physician Decision|1|||
131697499|NCT01903837|474175696|FG001|Part A|Physician Decision|1|||
131697500|NCT01903837|474175697|FG002|Part A|Physician Decision|0|||
131697501|NCT01903837|474175698|FG003|Part A|Physician Decision|0|||
131570509|NCT00282438|473713815|FG000|Overall Study|Death|0|||
131570510|NCT00282438|473713816|FG001|Overall Study|Death|1|||
131697502|NCT01903837|474175695|FG000|Part A|Protocol Violation|1|||
131697503|NCT01903837|474175696|FG001|Part A|Protocol Violation|1|||
131697504|NCT01903837|474175697|FG002|Part A|Protocol Violation|0|||
131570511|NCT00318656|473713819|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
131697505|NCT01903837|474175698|FG003|Part A|Protocol Violation|0|||
131697506|NCT01903837|474175695|FG000|Part B|Lost to Follow-up|0|||
131697507|NCT01903837|474175696|FG001|Part B|Lost to Follow-up|3|||
131697508|NCT01903837|474175697|FG002|Part B|Lost to Follow-up|3|||
131697509|NCT01903837|474175698|FG003|Part B|Lost to Follow-up|4|||
131697510|NCT01903837|474175695|FG000|Part B|Withdrawal by Subject|1|||
131697511|NCT01903837|474175696|FG001|Part B|Withdrawal by Subject|2|||
131697512|NCT01903837|474175697|FG002|Part B|Withdrawal by Subject|0|||
131697513|NCT01903837|474175698|FG003|Part B|Withdrawal by Subject|3|||
131570512|NCT00318656|473713820|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
131570513|NCT00318656|473713819|FG000|Overall Study|Did not receive any treatment|0|||
131697514|NCT01903837|474175695|FG000|Part B|Adverse Event|3|||
131697515|NCT01903837|474175696|FG001|Part B|Adverse Event|0|||
131697516|NCT01903837|474175697|FG002|Part B|Adverse Event|2|||
131697517|NCT01903837|474175698|FG003|Part B|Adverse Event|0|||
131697518|NCT01903837|474175695|FG000|Part B|Non-compliance with study drug|2|||
131697519|NCT01903837|474175696|FG001|Part B|Non-compliance with study drug|0|||
131783780|NCT01586624|474491692|FG002|Overall Study|Adverse Event|2|||
131783781|NCT01586624|474491693|FG003|Overall Study|Adverse Event|1|||
131783782|NCT01586624|474491694|FG004|Overall Study|Adverse Event|3|||
131783783|NCT01586624|474491695|FG005|Overall Study|Adverse Event|3|||
131783784|NCT01586624|474491696|FG006|Overall Study|Adverse Event|2|||
131783785|NCT01586624|474491697|FG007|Overall Study|Adverse Event|3|||
131783786|NCT01586624|474491690|FG000|Overall Study|Physician Decision|0|||
131783787|NCT01586624|474491691|FG001|Overall Study|Physician Decision|1|||
131783788|NCT01586624|474491692|FG002|Overall Study|Physician Decision|1|||
131783789|NCT01586624|474491693|FG003|Overall Study|Physician Decision|0|||
131783790|NCT01586624|474491694|FG004|Overall Study|Physician Decision|2|||
131783791|NCT01586624|474491695|FG005|Overall Study|Physician Decision|0|||
131783792|NCT01586624|474491696|FG006|Overall Study|Physician Decision|1|||
131783793|NCT01586624|474491697|FG007|Overall Study|Physician Decision|1|||
131783794|NCT01586624|474491690|FG000|Overall Study|Withdrawal by Subject|0|||
131783795|NCT01586624|474491691|FG001|Overall Study|Withdrawal by Subject|0|||
131783796|NCT01586624|474491692|FG002|Overall Study|Withdrawal by Subject|0|||
131783797|NCT01586624|474491693|FG003|Overall Study|Withdrawal by Subject|1|||
131783798|NCT01586624|474491694|FG004|Overall Study|Withdrawal by Subject|0|||
131783799|NCT01586624|474491695|FG005|Overall Study|Withdrawal by Subject|0|||
131783800|NCT01586624|474491696|FG006|Overall Study|Withdrawal by Subject|0|||
131783801|NCT01586624|474491697|FG007|Overall Study|Withdrawal by Subject|0|||
131783802|NCT01586624|474491690|FG000|Overall Study|Evidence of disease progression|1|||
131437712|NCT01453049|473228130|FG000|Overall Study|Protocol Violation|2|||
131437713|NCT01453049|473228131|FG001|Overall Study|Protocol Violation|5|||
131437714|NCT01453049|473228130|FG000|Overall Study|Lost to Follow-up|2|||
131437715|NCT01453049|473228131|FG001|Overall Study|Lost to Follow-up|1|||
131437716|NCT01453049|473228130|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
131437717|NCT01453049|473228131|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
131437718|NCT01453049|473228130|FG000|Overall Study|Withdrawal by Subject|1|||
131437719|NCT01453049|473228131|FG001|Overall Study|Withdrawal by Subject|0|||
131437720|NCT01453049|473228130|FG000|Overall Study|Randomized in Error|1|||
131437721|NCT01453049|473228131|FG001|Overall Study|Randomized in Error|0|||
131437722|NCT00882440|473228132|FG000|Overall Study|Adverse Event|2|||
131437723|NCT00882440|473228133|FG001|Overall Study|Adverse Event|2|||
131437724|NCT00882440|473228134|FG002|Overall Study|Adverse Event|2|||
131437725|NCT00882440|473228135|FG003|Overall Study|Adverse Event|1|||
131437726|NCT00882440|473228136|FG004|Overall Study|Adverse Event|1|||
131437727|NCT00882440|473228137|FG005|Overall Study|Adverse Event|4|||
131437728|NCT00882440|473228138|FG006|Overall Study|Adverse Event|2|||
131437729|NCT00882440|473228132|FG000|Overall Study|Lack of Efficacy|3|||
131437730|NCT00882440|473228133|FG001|Overall Study|Lack of Efficacy|5|||
131437731|NCT00882440|473228134|FG002|Overall Study|Lack of Efficacy|2|||
131437732|NCT00882440|473228135|FG003|Overall Study|Lack of Efficacy|0|||
131437733|NCT00882440|473228136|FG004|Overall Study|Lack of Efficacy|0|||
131437734|NCT00882440|473228137|FG005|Overall Study|Lack of Efficacy|3|||
131437735|NCT00882440|473228138|FG006|Overall Study|Lack of Efficacy|0|||
131437736|NCT00882440|473228132|FG000|Overall Study|Lost to Follow-up|2|||
131437737|NCT00882440|473228133|FG001|Overall Study|Lost to Follow-up|0|||
131437738|NCT00882440|473228134|FG002|Overall Study|Lost to Follow-up|1|||
131437739|NCT00882440|473228135|FG003|Overall Study|Lost to Follow-up|1|||
131437740|NCT00882440|473228136|FG004|Overall Study|Lost to Follow-up|1|||
131437741|NCT00882440|473228137|FG005|Overall Study|Lost to Follow-up|0|||
131437742|NCT00882440|473228138|FG006|Overall Study|Lost to Follow-up|1|||
131437743|NCT00882440|473228132|FG000|Overall Study|Protocol Violation|0|||
131437744|NCT00882440|473228133|FG001|Overall Study|Protocol Violation|0|||
131437745|NCT00882440|473228134|FG002|Overall Study|Protocol Violation|1|||
131697520|NCT01903837|474175697|FG002|Part B|Non-compliance with study drug|0|||
131697521|NCT01903837|474175698|FG003|Part B|Non-compliance with study drug|1|||
131697522|NCT01903837|474175695|FG000|Part B|Incarceration|2|||
131697523|NCT01903837|474175696|FG001|Part B|Incarceration|0|||
131697524|NCT01903837|474175697|FG002|Part B|Incarceration|0|||
131697525|NCT01903837|474175698|FG003|Part B|Incarceration|1|||
131697526|NCT01903837|474175695|FG000|Part B|Physician Decision|1|||
131437746|NCT00882440|473228135|FG003|Overall Study|Protocol Violation|1|||
131437747|NCT00882440|473228136|FG004|Overall Study|Protocol Violation|1|||
131437748|NCT00882440|473228137|FG005|Overall Study|Protocol Violation|0|||
131437749|NCT00882440|473228138|FG006|Overall Study|Protocol Violation|0|||
131437750|NCT00882440|473228132|FG000|Overall Study|Withdrawal by Subject|2|||
131437751|NCT00882440|473228133|FG001|Overall Study|Withdrawal by Subject|1|||
131697527|NCT01903837|474175696|FG001|Part B|Physician Decision|0|||
131437752|NCT00882440|473228134|FG002|Overall Study|Withdrawal by Subject|1|||
131437753|NCT00882440|473228135|FG003|Overall Study|Withdrawal by Subject|0|||
131437754|NCT00882440|473228136|FG004|Overall Study|Withdrawal by Subject|6|||
131697528|NCT01903837|474175697|FG002|Part B|Physician Decision|0|||
131437755|NCT00882440|473228137|FG005|Overall Study|Withdrawal by Subject|0|||
131437756|NCT00882440|473228138|FG006|Overall Study|Withdrawal by Subject|1|||
131437757|NCT00882440|473228132|FG000|Overall Study|Patient Uncooperative|2|||
131697529|NCT01903837|474175698|FG003|Part B|Physician Decision|2|||
131697530|NCT01903837|474175695|FG000|Part B|Lack of Efficacy|0|||
131570514|NCT00318656|473713820|FG001|Overall Study|Did not receive any treatment|1|||
131570515|NCT00490555|473713821|FG000|Overall Study|noncompliant with drug administration|0|||
131570516|NCT00490555|473713822|FG001|Overall Study|noncompliant with drug administration|0|||
131570517|NCT00490555|473713823|FG002|Overall Study|noncompliant with drug administration|2|||
131570518|NCT00490555|473713824|FG003|Overall Study|noncompliant with drug administration|0|||
131570519|NCT02042443|473713827|FG000|Overall Study|Adverse Event|2|||
131570520|NCT02042443|473713828|FG001|Overall Study|Adverse Event|1|||
131570521|NCT02042443|473713827|FG000|Overall Study|Withdrawal by Subject|0|||
131570522|NCT02042443|473713828|FG001|Overall Study|Withdrawal by Subject|1|||
131570523|NCT02042443|473713827|FG000|Overall Study|Progression|21|||
131570524|NCT02042443|473713828|FG001|Overall Study|Progression|17|||
131570525|NCT02042443|473713827|FG000|Overall Study|not protocol specified|1|||
131570526|NCT02042443|473713828|FG001|Overall Study|not protocol specified|1|||
131570527|NCT02042443|473713827|FG000|Overall Study|Not eligible/not analyzable|3|||
131570528|NCT02042443|473713828|FG001|Overall Study|Not eligible/not analyzable|6|||
131570529|NCT01007149|473713831|FG000|Overall Study|Administrative problems|0|||
131570530|NCT01007149|473713832|FG001|Overall Study|Administrative problems|1|||
131570531|NCT02784704|473713833|FG000|Overall Study|Adverse Event|4|||
131570532|NCT02784704|473713834|FG001|Overall Study|Adverse Event|2|||
131570533|NCT02784704|473713833|FG000|Overall Study|Lost to Follow-up|6|||
131570534|NCT02784704|473713834|FG001|Overall Study|Lost to Follow-up|4|||
131570535|NCT02784704|473713833|FG000|Overall Study|Withdrawal by Subject|1|||
131570536|NCT02784704|473713834|FG001|Overall Study|Withdrawal by Subject|3|||
131437758|NCT00882440|473228133|FG001|Overall Study|Patient Uncooperative|0|||
131437759|NCT00882440|473228134|FG002|Overall Study|Patient Uncooperative|0|||
131437760|NCT00882440|473228135|FG003|Overall Study|Patient Uncooperative|0|||
131437761|NCT00882440|473228136|FG004|Overall Study|Patient Uncooperative|1|||
131437762|NCT00882440|473228137|FG005|Overall Study|Patient Uncooperative|0|||
131570537|NCT02784704|473713833|FG000|Overall Study|Subject Non Compliance|2|||
131570538|NCT02784704|473713834|FG001|Overall Study|Subject Non Compliance|0|||
131570539|NCT01913340|473713835|FG000|Overall Study|Death|2|||
131570540|NCT01913340|473713836|FG001|Overall Study|Death|5|||
131570541|NCT01913340|473713835|FG000|Overall Study|Lost to Follow-up|1|||
131570542|NCT01913340|473713836|FG001|Overall Study|Lost to Follow-up|1|||
131570543|NCT05750745|473713837|FG000|Overall Study|Adverse Event|1|||
131570544|NCT05750745|473713838|FG001|Overall Study|Adverse Event|0|||
131570545|NCT05750745|473713839|FG002|Overall Study|Adverse Event|0|||
131570546|NCT05750745|473713837|FG000|Overall Study|Protocol Violation|1|||
131570547|NCT05750745|473713838|FG001|Overall Study|Protocol Violation|0|||
131570548|NCT05750745|473713839|FG002|Overall Study|Protocol Violation|0|||
131570549|NCT05750745|473713837|FG000|Overall Study|Withdrawal by Subject|0|||
131570550|NCT05750745|473713838|FG001|Overall Study|Withdrawal by Subject|1|||
131570551|NCT05750745|473713839|FG002|Overall Study|Withdrawal by Subject|0|||
131570552|NCT05550337|473713842|FG000|Overall Study|Lack of Efficacy|0|||
131570553|NCT05550337|473713843|FG001|Overall Study|Lack of Efficacy|0|||
131570554|NCT05550337|473713844|FG002|Overall Study|Lack of Efficacy|1|||
131570555|NCT05550337|473713842|FG000|Overall Study|Adverse Event|1|||
131570556|NCT05550337|473713843|FG001|Overall Study|Adverse Event|5|||
131570557|NCT05550337|473713844|FG002|Overall Study|Adverse Event|0|||
131570558|NCT05550337|473713842|FG000|Overall Study|Withdrawal by Subject|8|||
131570559|NCT05550337|473713843|FG001|Overall Study|Withdrawal by Subject|14|||
131570560|NCT05550337|473713844|FG002|Overall Study|Withdrawal by Subject|10|||
131570561|NCT05550337|473713842|FG000|Overall Study|Pregnancy|0|||
131570562|NCT05550337|473713843|FG001|Overall Study|Pregnancy|0|||
131570563|NCT05550337|473713844|FG002|Overall Study|Pregnancy|1|||
131570564|NCT05550337|473713842|FG000|Overall Study|Protocol Violation|1|||
131570565|NCT05550337|473713843|FG001|Overall Study|Protocol Violation|3|||
131570566|NCT05550337|473713844|FG002|Overall Study|Protocol Violation|4|||
131570567|NCT05550337|473713842|FG000|Overall Study|Physician Decision|2|||
131697531|NCT01903837|474175696|FG001|Part B|Lack of Efficacy|1|||
131437763|NCT00882440|473228138|FG006|Overall Study|Patient Uncooperative|0|||
131437764|NCT05482308|473228142|FG000|Overall Study|Withdrawal by Subject|1|||
131437765|NCT05482308|473228143|FG001|Overall Study|Withdrawal by Subject|0|||
131437766|NCT05482308|473228142|FG000|Overall Study|No longer meets eligibility criteria|0|||
131570568|NCT05550337|473713843|FG001|Overall Study|Physician Decision|1|||
131570569|NCT05550337|473713844|FG002|Overall Study|Physician Decision|1|||
131570570|NCT05550337|473713842|FG000|Overall Study|Lost to Follow-up|16|||
131570571|NCT05550337|473713843|FG001|Overall Study|Lost to Follow-up|11|||
131570572|NCT05550337|473713844|FG002|Overall Study|Lost to Follow-up|11|||
131570573|NCT03115346|473713846|FG000|Overall Study|Did not have AAA surgery|28|||
131570574|NCT03115346|473713847|FG001|Overall Study|Did not have AAA surgery|15|||
131570575|NCT03115346|473713846|FG000|Overall Study|Death|3|||
131570576|NCT03115346|473713847|FG001|Overall Study|Death|1|||
131697532|NCT01903837|474175697|FG002|Part B|Lack of Efficacy|0|||
131570577|NCT03115346|473713846|FG000|Overall Study|Withdrawal by Subject|0|||
131783803|NCT01586624|474491691|FG001|Overall Study|Evidence of disease progression|3|||
131570578|NCT03115346|473713847|FG001|Overall Study|Withdrawal by Subject|3|||
131570579|NCT03115346|473713846|FG000|Overall Study|Lost to Follow-up|0|||
131570580|NCT03115346|473713847|FG001|Overall Study|Lost to Follow-up|3|||
131570581|NCT01737268|473713849|FG000|Overall Study|Adverse Event|6|||
131570582|NCT01737268|473713849|FG000|Overall Study|Worsening of Target Disease|2|||
131570583|NCT01737268|473713849|FG000|Overall Study|In consideration of the patient's safety|1|||
131570584|NCT02068885|473713853|FG000|Overall Study|Withdrew|3|||
131570585|NCT02068885|473713854|FG001|Overall Study|Withdrew|5|||
131570586|NCT02068885|473713855|FG002|Overall Study|Withdrew|8|||
131570587|NCT00828919|473713861|FG000|Overall Study|Death|0|||
131570588|NCT00828919|473713862|FG001|Overall Study|Death|1|||
131570589|NCT00828919|473713863|FG002|Overall Study|Death|2|||
131570590|NCT00828919|473713864|FG003|Overall Study|Death|0|||
131570591|NCT00828919|473713865|FG004|Overall Study|Death|0|||
131570592|NCT00828919|473713861|FG000|Overall Study|Adverse Event|2|||
131570593|NCT00828919|473713862|FG001|Overall Study|Adverse Event|2|||
131570594|NCT00828919|473713863|FG002|Overall Study|Adverse Event|2|||
131570595|NCT00828919|473713864|FG003|Overall Study|Adverse Event|1|||
131570596|NCT00828919|473713865|FG004|Overall Study|Adverse Event|3|||
131570597|NCT00828919|473713861|FG000|Overall Study|Objective progression or relapse|4|||
131697533|NCT01903837|474175698|FG003|Part B|Lack of Efficacy|0|||
131570598|NCT00828919|473713862|FG001|Overall Study|Objective progression or relapse|4|||
131570599|NCT00828919|473713863|FG002|Overall Study|Objective progression or relapse|11|||
131570600|NCT00828919|473713864|FG003|Overall Study|Objective progression or relapse|0|||
131570601|NCT00828919|473713865|FG004|Overall Study|Objective progression or relapse|5|||
131570602|NCT00828919|473713861|FG000|Overall Study|No longer willing to participate in study|0|||
131570603|NCT00828919|473713862|FG001|Overall Study|No longer willing to participate in study|0|||
131697534|NCT00705939|474175700|FG000|Overall Study|Protocol Violation|0|||
131570604|NCT00828919|473713863|FG002|Overall Study|No longer willing to participate in study|2|||
131570605|NCT00828919|473713864|FG003|Overall Study|No longer willing to participate in study|0|||
131570606|NCT00828919|473713865|FG004|Overall Study|No longer willing to participate in study|0|||
131570607|NCT00828919|473713861|FG000|Overall Study|Insufficient Clinical Response|0|||
131570608|NCT00828919|473713862|FG001|Overall Study|Insufficient Clinical Response|1|||
131570609|NCT00828919|473713863|FG002|Overall Study|Insufficient Clinical Response|2|||
131570610|NCT00828919|473713864|FG003|Overall Study|Insufficient Clinical Response|0|||
131570611|NCT00828919|473713865|FG004|Overall Study|Insufficient Clinical Response|0|||
131570612|NCT00828919|473713861|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131570613|NCT00828919|473713862|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131570614|NCT00828919|473713863|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131570615|NCT00828919|473713864|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131570616|NCT00828919|473713865|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
131570617|NCT00828919|473713861|FG000|Overall Study|Other|1|||
131570618|NCT00828919|473713862|FG001|Overall Study|Other|0|||
131570619|NCT00828919|473713863|FG002|Overall Study|Other|1|||
131570620|NCT00828919|473713864|FG003|Overall Study|Other|1|||
131570621|NCT00828919|473713865|FG004|Overall Study|Other|0|||
131570622|NCT00828919|473713861|FG000|Overall Study|Lost to Follow-up|0|||
131570623|NCT00828919|473713862|FG001|Overall Study|Lost to Follow-up|1|||
131570624|NCT00828919|473713863|FG002|Overall Study|Lost to Follow-up|0|||
131570625|NCT00828919|473713864|FG003|Overall Study|Lost to Follow-up|0|||
131570626|NCT00828919|473713865|FG004|Overall Study|Lost to Follow-up|0|||
131570627|NCT05567159|473713868|FG000|Overall Study|Adverse Event|4|||
131570628|NCT05567159|473713868|FG000|Overall Study|Physician Decision|3|||
131570629|NCT05567159|473713868|FG000|Overall Study|Protocol deviation|1|||
131570630|NCT02501811|473713869|FG000|Overall Study|Death|1|||
131570631|NCT02501811|473713870|FG001|Overall Study|Death|3|||
131783804|NCT01586624|474491692|FG002|Overall Study|Evidence of disease progression|2|||
131570632|NCT02501811|473713871|FG002|Overall Study|Death|2|||
131570633|NCT02501811|473713872|FG003|Overall Study|Death|3|||
131570634|NCT02501811|473713869|FG000|Overall Study|Withdrawal by Subject|3|||
131570635|NCT02501811|473713870|FG001|Overall Study|Withdrawal by Subject|3|||
131570636|NCT02501811|473713871|FG002|Overall Study|Withdrawal by Subject|2|||
131570637|NCT02501811|473713872|FG003|Overall Study|Withdrawal by Subject|3|||
131570638|NCT02501811|473713869|FG000|Overall Study|Lost to Follow-up|0|||
131570639|NCT02501811|473713870|FG001|Overall Study|Lost to Follow-up|0|||
131570640|NCT02501811|473713871|FG002|Overall Study|Lost to Follow-up|2|||
131570641|NCT02501811|473713872|FG003|Overall Study|Lost to Follow-up|1|||
131570642|NCT02624778|473715935|FG000|Overall Study|Lost to Follow-up|0|||
131570643|NCT02624778|473715936|FG001|Overall Study|Lost to Follow-up|0|||
131570644|NCT02624778|473715937|FG002|Overall Study|Lost to Follow-up|1|||
131570645|NCT02624778|473715938|FG003|Overall Study|Lost to Follow-up|0|||
131570646|NCT02624778|473715939|FG004|Overall Study|Lost to Follow-up|0|||
131783805|NCT01586624|474491693|FG003|Overall Study|Evidence of disease progression|5|||
131783806|NCT01586624|474491694|FG004|Overall Study|Evidence of disease progression|3|||
131783807|NCT01586624|474491695|FG005|Overall Study|Evidence of disease progression|5|||
131783808|NCT01586624|474491696|FG006|Overall Study|Evidence of disease progression|4|||
131783809|NCT01586624|474491697|FG007|Overall Study|Evidence of disease progression|6|||
131783810|NCT01586624|474491690|FG000|Overall Study|Screen failure (no treatment received)|0|||
131783811|NCT01586624|474491691|FG001|Overall Study|Screen failure (no treatment received)|0|||
131783812|NCT01586624|474491692|FG002|Overall Study|Screen failure (no treatment received)|0|||
131783813|NCT01586624|474491693|FG003|Overall Study|Screen failure (no treatment received)|0|||
131783814|NCT01586624|474491694|FG004|Overall Study|Screen failure (no treatment received)|0|||
131783815|NCT01586624|474491695|FG005|Overall Study|Screen failure (no treatment received)|0|||
131783816|NCT01586624|474491696|FG006|Overall Study|Screen failure (no treatment received)|1|||
131783817|NCT01586624|474491697|FG007|Overall Study|Screen failure (no treatment received)|0|||
131783818|NCT01160198|474491707|FG000|Overall Study|Withdrawal by Subject|2|||
131783819|NCT01160198|474491708|FG001|Overall Study|Withdrawal by Subject|1|||
131783820|NCT01160198|474491709|FG002|Overall Study|Withdrawal by Subject|0|||
131570647|NCT02624778|473715940|FG005|Overall Study|Lost to Follow-up|0|||
131570648|NCT02624778|473715941|FG006|Overall Study|Lost to Follow-up|0|||
131783821|NCT01160198|474491707|FG000|Overall Study|Adverse Event|0|||
131783822|NCT01160198|474491708|FG001|Overall Study|Adverse Event|1|||
131783823|NCT01160198|474491709|FG002|Overall Study|Adverse Event|0|||
131783824|NCT01160198|474491707|FG000|Overall Study|Lost to Follow-up|0|||
131783825|NCT01160198|474491708|FG001|Overall Study|Lost to Follow-up|1|||
131783826|NCT01160198|474491709|FG002|Overall Study|Lost to Follow-up|0|||
131783827|NCT01160198|474491707|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
131783828|NCT01160198|474491708|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
131570649|NCT02624778|473715942|FG007|Overall Study|Lost to Follow-up|0|||
131570650|NCT02624778|473715943|FG008|Overall Study|Lost to Follow-up|0|||
131697535|NCT00705939|474175701|FG001|Overall Study|Protocol Violation|0|||
131437767|NCT05482308|473228143|FG001|Overall Study|No longer meets eligibility criteria|1|||
131570651|NCT02624778|473715935|FG000|Overall Study|Withdrawal by Subject|0|||
131697536|NCT00705939|474175702|FG002|Overall Study|Protocol Violation|1|||
131697537|NCT00705939|474175700|FG000|Overall Study|Withdrawal by Subject|0|||
131697538|NCT00705939|474175701|FG001|Overall Study|Withdrawal by Subject|1|||
131570652|NCT02624778|473715936|FG001|Overall Study|Withdrawal by Subject|1|||
131697539|NCT00705939|474175702|FG002|Overall Study|Withdrawal by Subject|3|||
131437768|NCT01451723|473228145|FG000|Overall Study|study halted|6|||
131437769|NCT01451723|473228146|FG001|Overall Study|study halted|5|||
131570653|NCT02624778|473715937|FG002|Overall Study|Withdrawal by Subject|0|||
131697540|NCT00705939|474175700|FG000|Overall Study|Physician Decision|0|||
131697541|NCT00705939|474175701|FG001|Overall Study|Physician Decision|1|||
131697542|NCT00705939|474175702|FG002|Overall Study|Physician Decision|0|||
131697543|NCT05048342|474175703|FG000|Overall Study|Adverse Event|1|||
131697544|NCT05048342|474175703|FG000|Overall Study|Subject decision|2|||
131697545|NCT01441063|474175704|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
131697546|NCT01441063|474175704|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
131697547|NCT00143455|474175708|FG000|Cohort 1|Adverse Event|8|||
131697548|NCT00143455|474175709|FG001|Cohort 1|Adverse Event|4|||
131697549|NCT00143455|474175710|FG002|Cohort 1|Adverse Event|0|||
131697550|NCT00143455|474175711|FG003|Cohort 1|Adverse Event|0|||
131697551|NCT00143455|474175708|FG000|Cohort 1|Death|5|||
131697552|NCT00143455|474175709|FG001|Cohort 1|Death|2|||
131697553|NCT00143455|474175710|FG002|Cohort 1|Death|0|||
131697554|NCT00143455|474175711|FG003|Cohort 1|Death|0|||
131697555|NCT00143455|474175708|FG000|Cohort 1|Progressive Disease|0|||
131570654|NCT02624778|473715938|FG003|Overall Study|Withdrawal by Subject|0|||
131570655|NCT02624778|473715939|FG004|Overall Study|Withdrawal by Subject|0|||
131570656|NCT02624778|473715940|FG005|Overall Study|Withdrawal by Subject|1|||
131570657|NCT02624778|473715941|FG006|Overall Study|Withdrawal by Subject|1|||
131570658|NCT02624778|473715942|FG007|Overall Study|Withdrawal by Subject|1|||
131570659|NCT02624778|473715943|FG008|Overall Study|Withdrawal by Subject|1|||
131697556|NCT00143455|474175709|FG001|Cohort 1|Progressive Disease|6|||
131697557|NCT00143455|474175710|FG002|Cohort 1|Progressive Disease|0|||
131697558|NCT00143455|474175711|FG003|Cohort 1|Progressive Disease|0|||
131697559|NCT00143455|474175708|FG000|Cohort 1|Withdrawal by Subject|1|||
131697560|NCT00143455|474175709|FG001|Cohort 1|Withdrawal by Subject|4|||
131570660|NCT02624778|473715935|FG000|Overall Study|Adverse Event|0|||
131697561|NCT00143455|474175710|FG002|Cohort 1|Withdrawal by Subject|0|||
131697562|NCT00143455|474175711|FG003|Cohort 1|Withdrawal by Subject|0|||
131697563|NCT00143455|474175708|FG000|Cohort 1|Randomized But Not Treated|0|||
131697564|NCT00143455|474175709|FG001|Cohort 1|Randomized But Not Treated|1|||
131697565|NCT00143455|474175710|FG002|Cohort 1|Randomized But Not Treated|0|||
131697566|NCT00143455|474175711|FG003|Cohort 1|Randomized But Not Treated|0|||
131697567|NCT00143455|474175708|FG000|Cohort 2|Adverse Event|0|||
131437770|NCT00443040|473228149|FG000|Overall Study|Withdrawal by Subject|1|||
131697568|NCT00143455|474175709|FG001|Cohort 2|Adverse Event|0|||
131697569|NCT00143455|474175710|FG002|Cohort 2|Adverse Event|42|||
131437771|NCT00443040|473228150|FG001|Overall Study|Withdrawal by Subject|0|||
131570661|NCT02624778|473715936|FG001|Overall Study|Adverse Event|0|||
131570662|NCT02624778|473715937|FG002|Overall Study|Adverse Event|0|||
131570663|NCT02624778|473715938|FG003|Overall Study|Adverse Event|0|||
131570664|NCT02624778|473715939|FG004|Overall Study|Adverse Event|0|||
131570665|NCT02624778|473715940|FG005|Overall Study|Adverse Event|0|||
131570666|NCT02624778|473715941|FG006|Overall Study|Adverse Event|0|||
131570667|NCT02624778|473715942|FG007|Overall Study|Adverse Event|0|||
131570668|NCT02624778|473715943|FG008|Overall Study|Adverse Event|2|||
131570669|NCT02624778|473715935|FG000|Overall Study|Death|0|||
131570670|NCT02624778|473715936|FG001|Overall Study|Death|0|||
131570671|NCT02624778|473715937|FG002|Overall Study|Death|0|||
131570672|NCT02624778|473715938|FG003|Overall Study|Death|0|||
131570673|NCT02624778|473715939|FG004|Overall Study|Death|0|||
131570674|NCT02624778|473715940|FG005|Overall Study|Death|0|||
131570675|NCT02624778|473715941|FG006|Overall Study|Death|1|||
131570676|NCT02624778|473715942|FG007|Overall Study|Death|0|||
131570677|NCT02624778|473715943|FG008|Overall Study|Death|0|||
131570678|NCT02624778|473715935|FG000|Overall Study|Physician Decision|0|||
131570679|NCT02624778|473715936|FG001|Overall Study|Physician Decision|0|||
131570680|NCT02624778|473715937|FG002|Overall Study|Physician Decision|0|||
131570681|NCT02624778|473715938|FG003|Overall Study|Physician Decision|0|||
131570682|NCT02624778|473715939|FG004|Overall Study|Physician Decision|0|||
131570683|NCT02624778|473715940|FG005|Overall Study|Physician Decision|0|||
131570684|NCT02624778|473715941|FG006|Overall Study|Physician Decision|0|||
131570685|NCT02624778|473715942|FG007|Overall Study|Physician Decision|3|||
131570686|NCT02624778|473715943|FG008|Overall Study|Physician Decision|3|||
131570687|NCT00359619|473715949|FG000|Overall Study|Adverse Event|0|||
131570688|NCT00359619|473715950|FG001|Overall Study|Adverse Event|0|||
131570689|NCT00359619|473715951|FG002|Overall Study|Adverse Event|1|||
131570690|NCT00359619|473715952|FG003|Overall Study|Adverse Event|0|||
131570691|NCT00359619|473715953|FG004|Overall Study|Adverse Event|0|||
131570692|NCT00359619|473715954|FG005|Overall Study|Adverse Event|0|||
131570693|NCT00359619|473715955|FG006|Overall Study|Adverse Event|1|||
131570694|NCT00359619|473715949|FG000|Overall Study|Withdrawal by Subject|3|||
131570695|NCT00359619|473715950|FG001|Overall Study|Withdrawal by Subject|1|||
131570696|NCT00359619|473715951|FG002|Overall Study|Withdrawal by Subject|4|||
131570697|NCT00359619|473715952|FG003|Overall Study|Withdrawal by Subject|2|||
131570698|NCT00359619|473715953|FG004|Overall Study|Withdrawal by Subject|2|||
131570699|NCT00359619|473715954|FG005|Overall Study|Withdrawal by Subject|0|||
131570700|NCT00359619|473715955|FG006|Overall Study|Withdrawal by Subject|3|||
131570701|NCT00359619|473715949|FG000|Overall Study|Other|1|||
131570702|NCT00359619|473715950|FG001|Overall Study|Other|0|||
131570703|NCT00359619|473715951|FG002|Overall Study|Other|0|||
131570704|NCT00359619|473715952|FG003|Overall Study|Other|0|||
131570705|NCT00359619|473715953|FG004|Overall Study|Other|0|||
131570706|NCT00359619|473715954|FG005|Overall Study|Other|0|||
131570707|NCT00359619|473715955|FG006|Overall Study|Other|0|||
131570708|NCT00359619|473715949|FG000|Overall Study|Lost to Follow-up|4|||
131570709|NCT00359619|473715950|FG001|Overall Study|Lost to Follow-up|4|||
131570710|NCT00359619|473715951|FG002|Overall Study|Lost to Follow-up|2|||
131570711|NCT00359619|473715952|FG003|Overall Study|Lost to Follow-up|1|||
131570712|NCT00359619|473715953|FG004|Overall Study|Lost to Follow-up|1|||
131570713|NCT00359619|473715954|FG005|Overall Study|Lost to Follow-up|5|||
131570714|NCT00359619|473715955|FG006|Overall Study|Lost to Follow-up|0|||
131570715|NCT00256308|473715960|FG000|Overall Study|Death|2|||
131570716|NCT01419717|473715961|FG000|Overall Study|Protocol-specified Criteria|62|||
131570717|NCT01419717|473715961|FG000|Overall Study|Adverse Event|19|||
131570718|NCT01419717|473715961|FG000|Overall Study|Death|17|||
131570719|NCT01419717|473715961|FG000|Overall Study|Withdrawal by Subject|10|||
131570720|NCT01419717|473715961|FG000|Overall Study|Disease Progression|9|||
131570721|NCT01419717|473715961|FG000|Overall Study|Other|4|||
131570722|NCT01419717|473715961|FG000|Overall Study|Lost to Follow-up|2|||
131570723|NCT01419717|473715961|FG000|Overall Study|Administrative Decision|1|||
131570724|NCT01419717|473715961|FG000|Overall Study|Noncompliance|1|||
131570725|NCT02857283|473715962|FG000|First Exposure|Withdrawal by Subject|1|||
131570726|NCT02857283|473715963|FG001|First Exposure|Withdrawal by Subject|0|||
131570727|NCT01537133|473715964|FG000|Overall Study|Withdrawal by Subject|2|||
131570728|NCT01537133|473715965|FG001|Overall Study|Withdrawal by Subject|0|||
131570729|NCT01537133|473715966|FG002|Overall Study|Withdrawal by Subject|0|||
131570730|NCT01537133|473715967|FG003|Overall Study|Withdrawal by Subject|0|||
131570731|NCT01537133|473715964|FG000|Overall Study|Lost to Follow-up|1|||
131570732|NCT01537133|473715965|FG001|Overall Study|Lost to Follow-up|0|||
131570733|NCT01537133|473715966|FG002|Overall Study|Lost to Follow-up|0|||
131570734|NCT01537133|473715967|FG003|Overall Study|Lost to Follow-up|0|||
131570735|NCT00587288|473715968|FG000|Overall Study|Adverse Event|0|||
131570736|NCT00587288|473715969|FG001|Overall Study|Adverse Event|1|||
131570737|NCT00587288|473715968|FG000|Overall Study|Lack of Efficacy|2|||
131570738|NCT00587288|473715969|FG001|Overall Study|Lack of Efficacy|8|||
131570739|NCT00587288|473715968|FG000|Overall Study|Protocol Violation|1|||
131570740|NCT00587288|473715969|FG001|Overall Study|Protocol Violation|0|||
131570741|NCT00531479|473715972|FG000|Overall Study|Death|68|||
131783829|NCT01160198|474491709|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
131783830|NCT03343054|474491711|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
131783831|NCT03343054|474491712|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
131783832|NCT03343054|474491713|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
131783833|NCT03343054|474491711|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
131783834|NCT03343054|474491712|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
131804442|NCT02178722|474568532|FG003|Overall Study|Withdrawal by Subject|2|||
131570742|NCT00531479|473715973|FG001|Overall Study|Death|71|||
131570743|NCT00531479|473715972|FG000|Overall Study|Lost to Follow-up|0|||
131570744|NCT00531479|473715973|FG001|Overall Study|Lost to Follow-up|2|||
131570745|NCT00531479|473715972|FG000|Overall Study|Other|0|||
131570746|NCT00531479|473715973|FG001|Overall Study|Other|1|||
131570747|NCT00531479|473715972|FG000|Overall Study|Withdrawal by Subject|6|||
131570748|NCT00531479|473715973|FG001|Overall Study|Withdrawal by Subject|6|||
131570749|NCT00531479|473715972|FG000|Overall Study|Did not receive treatment|2|||
131570750|NCT00531479|473715973|FG001|Overall Study|Did not receive treatment|3|||
131570751|NCT05074498|473715976|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131697570|NCT00143455|474175711|FG003|Cohort 2|Adverse Event|30|||
131697571|NCT00143455|474175708|FG000|Cohort 2|No Longer Required Study Treatment|0|||
131697572|NCT00143455|474175709|FG001|Cohort 2|No Longer Required Study Treatment|0|||
131697573|NCT00143455|474175710|FG002|Cohort 2|No Longer Required Study Treatment|1|||
131697574|NCT00143455|474175711|FG003|Cohort 2|No Longer Required Study Treatment|0|||
131697575|NCT00143455|474175708|FG000|Cohort 2|Protocol Violation|0|||
131697576|NCT00143455|474175709|FG001|Cohort 2|Protocol Violation|0|||
131697577|NCT00143455|474175710|FG002|Cohort 2|Protocol Violation|1|||
131697578|NCT00143455|474175711|FG003|Cohort 2|Protocol Violation|1|||
131697579|NCT00143455|474175708|FG000|Cohort 2|Lost to Follow-up|0|||
131697580|NCT00143455|474175709|FG001|Cohort 2|Lost to Follow-up|0|||
131697581|NCT00143455|474175710|FG002|Cohort 2|Lost to Follow-up|1|||
131570752|NCT05074498|473715977|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131570753|NCT05074498|473715978|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131570754|NCT05074498|473715979|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
131570755|NCT05074498|473715980|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131570756|NCT05074498|473715981|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131570757|NCT05074498|473715976|FG000|Part 1 (Upto Day 104)|Other|1|||
131570758|NCT05074498|473715977|FG001|Part 1 (Upto Day 104)|Other|0|||
131570759|NCT05074498|473715978|FG002|Part 1 (Upto Day 104)|Other|0|||
131570760|NCT05074498|473715979|FG003|Part 1 (Upto Day 104)|Other|0|||
131570761|NCT05074498|473715980|FG004|Part 1 (Upto Day 104)|Other|0|||
131570762|NCT05074498|473715981|FG005|Part 1 (Upto Day 104)|Other|0|||
131570763|NCT05074498|473715976|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131570764|NCT05074498|473715977|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131570765|NCT05074498|473715978|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131570766|NCT05074498|473715979|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131570767|NCT05074498|473715980|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
131570768|NCT05074498|473715981|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131570769|NCT05074498|473715976|FG000|Part 2 (Upto Day 104)|Death|0|||
131570770|NCT05074498|473715977|FG001|Part 2 (Upto Day 104)|Death|0|||
131570771|NCT05074498|473715978|FG002|Part 2 (Upto Day 104)|Death|0|||
131570772|NCT05074498|473715979|FG003|Part 2 (Upto Day 104)|Death|0|||
131570773|NCT05074498|473715980|FG004|Part 2 (Upto Day 104)|Death|1|||
131570774|NCT05074498|473715981|FG005|Part 2 (Upto Day 104)|Death|0|||
131570775|NCT05074498|473715976|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131570776|NCT05074498|473715977|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131570777|NCT05074498|473715978|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131570778|NCT05074498|473715979|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131570779|NCT05074498|473715980|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
131570780|NCT05074498|473715981|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
131570781|NCT05074498|473715976|FG000|Part 2 (Upto Day 104)|Other|0|||
131570782|NCT05074498|473715977|FG001|Part 2 (Upto Day 104)|Other|0|||
131570783|NCT05074498|473715978|FG002|Part 2 (Upto Day 104)|Other|0|||
131697582|NCT00143455|474175711|FG003|Cohort 2|Lost to Follow-up|4|||
131697583|NCT00143455|474175708|FG000|Cohort 2|Death|0|||
131697584|NCT00143455|474175709|FG001|Cohort 2|Death|0|||
131697585|NCT00143455|474175710|FG002|Cohort 2|Death|20|||
131697586|NCT00143455|474175711|FG003|Cohort 2|Death|12|||
131697587|NCT00143455|474175708|FG000|Cohort 2|Progressive Disease|0|||
131570784|NCT05074498|473715979|FG003|Part 2 (Upto Day 104)|Other|0|||
131697588|NCT00143455|474175709|FG001|Cohort 2|Progressive Disease|0|||
131570785|NCT05074498|473715980|FG004|Part 2 (Upto Day 104)|Other|1|||
131570786|NCT05074498|473715981|FG005|Part 2 (Upto Day 104)|Other|0|||
131570787|NCT01240356|473715982|FG000|Overall Study|Withdrawal by Subject|2|||
131570788|NCT01240356|473715983|FG001|Overall Study|Withdrawal by Subject|0|||
131697589|NCT00143455|474175710|FG002|Cohort 2|Progressive Disease|20|||
131570789|NCT01240356|473715982|FG000|Overall Study|MRI contraindication|1|||
131570790|NCT01240356|473715983|FG001|Overall Study|MRI contraindication|0|||
131570791|NCT02501629|473715993|FG000|Overall Study|Death|0|||
131570792|NCT02501629|473715994|FG001|Overall Study|Death|1|||
131570793|NCT02501629|473715993|FG000|Overall Study|Withdrawn from study by sponsor|1|||
131570794|NCT02501629|473715994|FG001|Overall Study|Withdrawn from study by sponsor|0|||
131570795|NCT02501629|473715993|FG000|Overall Study|Early termination by sponsor|1|||
131570796|NCT02501629|473715994|FG001|Overall Study|Early termination by sponsor|0|||
131570797|NCT02501629|473715993|FG000|Overall Study|Withdrawal by Subject|3|||
131570798|NCT02501629|473715994|FG001|Overall Study|Withdrawal by Subject|5|||
131570799|NCT02501629|473715993|FG000|Overall Study|Subject did not return to site|0|||
131570800|NCT02501629|473715994|FG001|Overall Study|Subject did not return to site|1|||
131570801|NCT00868231|473715997|FG000|Treatment Period 1|Adverse Event|0|||
131570802|NCT00868231|473715998|FG001|Treatment Period 1|Adverse Event|0|||
131570803|NCT00868231|473715999|FG002|Treatment Period 1|Adverse Event|0|||
131570804|NCT00868231|473716000|FG003|Treatment Period 1|Adverse Event|0|||
131570805|NCT00868231|473716001|FG004|Treatment Period 1|Adverse Event|1|||
131570806|NCT00868231|473716002|FG005|Treatment Period 1|Adverse Event|0|||
131570807|NCT00868231|473715997|FG000|Treatment Period 2|Adverse Event|1|||
131570808|NCT00868231|473715998|FG001|Treatment Period 2|Adverse Event|0|||
131570809|NCT00868231|473715999|FG002|Treatment Period 2|Adverse Event|0|||
131570810|NCT00868231|473716000|FG003|Treatment Period 2|Adverse Event|0|||
131570811|NCT00868231|473716001|FG004|Treatment Period 2|Adverse Event|0|||
131570812|NCT00868231|473716002|FG005|Treatment Period 2|Adverse Event|0|||
131570813|NCT00868231|473715997|FG000|Treatment Period 3|Adverse Event|0|||
131570814|NCT00868231|473715998|FG001|Treatment Period 3|Adverse Event|0|||
131570815|NCT00868231|473715999|FG002|Treatment Period 3|Adverse Event|1|||
131570816|NCT00868231|473716000|FG003|Treatment Period 3|Adverse Event|0|||
131570817|NCT00868231|473716001|FG004|Treatment Period 3|Adverse Event|0|||
131570818|NCT00868231|473716002|FG005|Treatment Period 3|Adverse Event|0|||
131570819|NCT04381494|473716006|FG000|Overall Study|Early termination of trial|19|||
131570820|NCT04381494|473716006|FG000|Overall Study|Investigator's discretion|1|||
131570821|NCT04381494|473716006|FG000|Overall Study|Withdrawal by Subject|9|||
131570822|NCT04381494|473716006|FG000|Overall Study|NSCLC disease progression|4|||
131570823|NCT04381494|473716006|FG000|Overall Study|Device-Related Adverse Event|2|||
131570824|NCT04310579|473716007|FG000|Overall Study|Adverse Event|0|||
131570825|NCT04310579|473716008|FG001|Overall Study|Adverse Event|0|||
131570826|NCT04310579|473716009|FG002|Overall Study|Adverse Event|0|||
131570827|NCT04310579|473716010|FG003|Overall Study|Adverse Event|0|||
131570828|NCT04310579|473716011|FG004|Overall Study|Adverse Event|0|||
131570829|NCT04310579|473716012|FG005|Overall Study|Adverse Event|0|||
131570830|NCT04310579|473716013|FG006|Overall Study|Adverse Event|2|||
131570831|NCT04310579|473716014|FG007|Overall Study|Adverse Event|0|||
131570832|NCT04310579|473716015|FG008|Overall Study|Adverse Event|1|||
131570833|NCT04310579|473716016|FG009|Overall Study|Adverse Event|1|||
131570834|NCT04310579|473716017|FG010|Overall Study|Adverse Event|0|||
131570835|NCT04310579|473716007|FG000|Overall Study|Withdrawal by Subject|0|||
131570836|NCT04310579|473716008|FG001|Overall Study|Withdrawal by Subject|0|||
131570837|NCT04310579|473716009|FG002|Overall Study|Withdrawal by Subject|0|||
131570838|NCT04310579|473716010|FG003|Overall Study|Withdrawal by Subject|0|||
131570839|NCT04310579|473716011|FG004|Overall Study|Withdrawal by Subject|0|||
131570840|NCT04310579|473716012|FG005|Overall Study|Withdrawal by Subject|1|||
131570841|NCT04310579|473716013|FG006|Overall Study|Withdrawal by Subject|0|||
131570842|NCT04310579|473716014|FG007|Overall Study|Withdrawal by Subject|0|||
131570843|NCT04310579|473716015|FG008|Overall Study|Withdrawal by Subject|0|||
131570844|NCT04310579|473716016|FG009|Overall Study|Withdrawal by Subject|0|||
131570845|NCT04310579|473716017|FG010|Overall Study|Withdrawal by Subject|0|||
131570846|NCT04310579|473716007|FG000|Overall Study|Positive COVID-19 test|0|||
131570847|NCT04310579|473716008|FG001|Overall Study|Positive COVID-19 test|0|||
131570848|NCT04310579|473716009|FG002|Overall Study|Positive COVID-19 test|0|||
131570849|NCT04310579|473716010|FG003|Overall Study|Positive COVID-19 test|0|||
131570850|NCT04310579|473716011|FG004|Overall Study|Positive COVID-19 test|0|||
131570851|NCT04310579|473716012|FG005|Overall Study|Positive COVID-19 test|0|||
131570852|NCT04310579|473716013|FG006|Overall Study|Positive COVID-19 test|0|||
131570853|NCT04310579|473716014|FG007|Overall Study|Positive COVID-19 test|0|||
131570854|NCT04310579|473716015|FG008|Overall Study|Positive COVID-19 test|0|||
131570855|NCT04310579|473716016|FG009|Overall Study|Positive COVID-19 test|0|||
131570856|NCT04310579|473716017|FG010|Overall Study|Positive COVID-19 test|1|||
131570857|NCT00601640|473716022|FG000|Overall Study|Withdrawal by Subject|3|||
131570858|NCT00601640|473716023|FG001|Overall Study|Withdrawal by Subject|0|||
131570859|NCT00601640|473716024|FG002|Overall Study|Withdrawal by Subject|7|||
131570860|NCT00601640|473716022|FG000|Overall Study|Death|1|||
131570861|NCT00601640|473716023|FG001|Overall Study|Death|0|||
131570862|NCT00601640|473716024|FG002|Overall Study|Death|0|||
131570863|NCT00601640|473716022|FG000|Overall Study|Adverse Event|0|||
131570864|NCT00601640|473716023|FG001|Overall Study|Adverse Event|4|||
131570865|NCT00601640|473716024|FG002|Overall Study|Adverse Event|2|||
131570866|NCT00601640|473716022|FG000|Overall Study|intercurrent illness|1|||
131570867|NCT00601640|473716023|FG001|Overall Study|intercurrent illness|0|||
131570868|NCT00601640|473716024|FG002|Overall Study|intercurrent illness|0|||
131570869|NCT00601640|473716022|FG000|Overall Study|change in eligibility status|0|||
131570870|NCT00601640|473716023|FG001|Overall Study|change in eligibility status|1|||
131570871|NCT00601640|473716024|FG002|Overall Study|change in eligibility status|1|||
131570872|NCT00530777|473716025|FG000|Overall Study|Lost to Follow-up|0|||
131570873|NCT00530777|473716026|FG001|Overall Study|Lost to Follow-up|1|||
131570874|NCT00530777|473716025|FG000|Overall Study|Death|1|||
131570875|NCT00530777|473716026|FG001|Overall Study|Death|2|||
131570876|NCT00530777|473716025|FG000|Overall Study|Physician Decision|1|||
131570877|NCT00530777|473716026|FG001|Overall Study|Physician Decision|0|||
131570878|NCT00530777|473716025|FG000|Overall Study|Withdrawal by Subject|0|||
131570879|NCT00530777|473716026|FG001|Overall Study|Withdrawal by Subject|1|||
131570880|NCT00530777|473716025|FG000|Overall Study|Unable to adhere to visit schedule|5|||
131570881|NCT00530777|473716026|FG001|Overall Study|Unable to adhere to visit schedule|1|||
131570882|NCT01008748|473716042|FG000|Overall Study|Lost to Follow-up|80|||
131570883|NCT01008748|473716042|FG000|Overall Study|Other|1|||
131570884|NCT02775435|473716043|FG000|Overall Study|Adverse Event|32|||
131570885|NCT02775435|473716044|FG001|Overall Study|Adverse Event|27|||
131570886|NCT02775435|473716043|FG000|Overall Study|Lost to Follow-up|2|||
131570887|NCT02775435|473716044|FG001|Overall Study|Lost to Follow-up|2|||
131570888|NCT02775435|473716043|FG000|Overall Study|Sponsor decision|44|||
131570889|NCT02775435|473716044|FG001|Overall Study|Sponsor decision|19|||
131570890|NCT02775435|473716043|FG000|Overall Study|Withdrawal by Subject|4|||
131570891|NCT02775435|473716044|FG001|Overall Study|Withdrawal by Subject|9|||
131570892|NCT02775435|473716043|FG000|Overall Study|Death|196|||
131570893|NCT02775435|473716044|FG001|Overall Study|Death|224|||
131570894|NCT03537651|473716054|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
131570895|NCT03537651|473716054|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
131570896|NCT03537651|473716054|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
131570897|NCT03537651|473716054|FG000|Part A (Up to 96 Weeks)|Other|1|||
131570898|NCT03537651|473716054|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
131570899|NCT03537651|473716054|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
131570900|NCT03537651|473716054|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
131570901|NCT03537651|473716054|FG000|Part B (Up to 192 Weeks)|Other|1|||
131570902|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
131570903|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
131570904|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
131570905|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Death|3|||
131570906|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Death|0|||
131570907|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Death|0|||
131570908|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
131570909|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
131570910|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
131570911|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
131570912|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
131570913|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
131570914|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
131570915|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
131570916|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
131570917|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
131570918|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
131570919|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
131570920|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
131570921|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
131570922|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
131570923|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Other|1|||
131570924|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Other|0|||
131570925|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Other|0|||
131570926|NCT02403323|473716055|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
131570927|NCT02403323|473716056|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
131697590|NCT00143455|474175711|FG003|Cohort 2|Progressive Disease|27|||
131697591|NCT00143455|474175708|FG000|Cohort 2|Withdrawal by Subject|0|||
131697592|NCT00143455|474175709|FG001|Cohort 2|Withdrawal by Subject|0|||
131697593|NCT00143455|474175710|FG002|Cohort 2|Withdrawal by Subject|13|||
131697594|NCT00143455|474175711|FG003|Cohort 2|Withdrawal by Subject|12|||
131570928|NCT02403323|473716057|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
131697595|NCT00143455|474175708|FG000|Cohort 2|Other|0|||
131570929|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131570930|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
131570931|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131570932|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
131570933|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
131570934|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
131570935|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
131570936|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
131570937|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
131570938|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
131570939|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
131570940|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
131570941|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
131570942|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
131570943|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
131570944|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
131570945|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
131570946|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
131570947|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
131570948|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
131570949|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
131570950|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
131570951|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
131570952|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
131570953|NCT02403323|473716055|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
131570954|NCT02403323|473716056|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
131570955|NCT02403323|473716057|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
131570956|NCT01076335|473716061|FG000|Overall Study|Withdrawal by Subject|3|||
131570957|NCT01076335|473716061|FG000|Overall Study|Withdrawal without treatment|1|||
131570958|NCT05015478|473716062|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
131570959|NCT05015478|473716063|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
131570960|NCT05015478|473716064|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
131570961|NCT05015478|473716065|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
131570962|NCT00654238|473716067|FG000|Overall Study|Screen Failures|4|||
131570963|NCT05096884|473716069|FG000|Overall Study|Excluded based on negative tilt table test|4|||
131570964|NCT01096056|473716070|FG000|Overall Study|Lost to Follow-up|0|||
131570965|NCT01096056|473716071|FG001|Overall Study|Lost to Follow-up|1|||
131570966|NCT03781804|473716075|FG000|Overall Study|Adverse Event|2|||
131570967|NCT03781804|473716076|FG001|Overall Study|Adverse Event|2|||
131570968|NCT03781804|473716077|FG002|Overall Study|Adverse Event|3|||
131570969|NCT03781804|473716075|FG000|Overall Study|Lost to Follow-up|1|||
131570970|NCT03781804|473716076|FG001|Overall Study|Lost to Follow-up|1|||
131570971|NCT03781804|473716077|FG002|Overall Study|Lost to Follow-up|2|||
131570972|NCT03781804|473716075|FG000|Overall Study|Lack of Efficacy|4|||
131570973|NCT03781804|473716076|FG001|Overall Study|Lack of Efficacy|2|||
131570974|NCT03781804|473716077|FG002|Overall Study|Lack of Efficacy|9|||
131570975|NCT03781804|473716075|FG000|Overall Study|Protocol Violation|0|||
131570976|NCT03781804|473716076|FG001|Overall Study|Protocol Violation|0|||
131783835|NCT03343054|474491713|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
131783836|NCT03343054|474491711|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
131783837|NCT03343054|474491712|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
131783838|NCT03343054|474491713|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
131570977|NCT03781804|473716077|FG002|Overall Study|Protocol Violation|1|||
131783839|NCT03343054|474491711|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
131783840|NCT03343054|474491712|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
131783841|NCT03343054|474491713|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
131783842|NCT01467570|474491714|FG000|Overall Study|Lost to Follow-up|8|||
131783843|NCT01467570|474491715|FG001|Overall Study|Lost to Follow-up|9|||
131783844|NCT02626182|474491716|FG000|Overall Study|Adverse Event|2|||
131783845|NCT02626182|474491717|FG001|Overall Study|Adverse Event|0|||
131783846|NCT01222715|474491720|FG000|Overall Study|Adverse Event|0|||
131783847|NCT01222715|474491721|FG001|Overall Study|Adverse Event|4|||
131783848|NCT01222715|474491720|FG000|Overall Study|Death|0|||
131570978|NCT03781804|473716075|FG000|Overall Study|Withdrawal by Subject|0|||
131783849|NCT01222715|474491721|FG001|Overall Study|Death|1|||
131570979|NCT03781804|473716076|FG001|Overall Study|Withdrawal by Subject|1|||
131570980|NCT03781804|473716077|FG002|Overall Study|Withdrawal by Subject|1|||
131570981|NCT03781804|473716075|FG000|Overall Study|Reason not provided|2|||
131783850|NCT01222715|474491720|FG000|Overall Study|Lack of Efficacy|22|||
131783851|NCT01222715|474491721|FG001|Overall Study|Lack of Efficacy|14|||
131783852|NCT01222715|474491720|FG000|Overall Study|Physician Decision|12|||
131570982|NCT03781804|473716076|FG001|Overall Study|Reason not provided|2|||
131570983|NCT03781804|473716077|FG002|Overall Study|Reason not provided|0|||
131570984|NCT00337818|473716078|FG000|Overall Study|Lost to Follow-up|289|||
131570985|NCT00337818|473716079|FG001|Overall Study|Lost to Follow-up|91|||
131570986|NCT00337818|473716080|FG002|Overall Study|Lost to Follow-up|107|||
131570987|NCT04678830|473716081|FG000|Overall Study|Lack of Efficacy|2|||
131570988|NCT04678830|473716082|FG001|Overall Study|Lack of Efficacy|0|||
131570989|NCT04678830|473716081|FG000|Overall Study|Withdrawal by Subject|0|||
131570990|NCT04678830|473716082|FG001|Overall Study|Withdrawal by Subject|1|||
131570991|NCT01190176|473716085|FG000|Overall Study|Withdrawal by Subject|1|||
131570992|NCT01190176|473716085|FG000|Overall Study|Lost to Follow-up|1|||
131570993|NCT02189863|473716086|FG000|First 2 Weeks|Motion Sickness|4|||
131570994|NCT02189863|473716087|FG001|First 2 Weeks|Motion Sickness|2|||
131570995|NCT03697460|473716088|FG000|Overall Study|Withdrawal by Subject|3|||
131570996|NCT03369951|473716090|FG000|Overall Study|Withdrawal by Subject|3|||
131570997|NCT03369951|473716090|FG000|Overall Study|Death|1|||
131570998|NCT03369951|473716090|FG000|Overall Study|Lost to Follow-up|1|||
131570999|NCT03369951|473716090|FG000|Overall Study|Protocol Violation|1|||
131571000|NCT03499600|473716096|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
131571001|NCT03499600|473716097|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
131571002|NCT00430677|473716101|FG000|Short-term Period|Death|1|||
131571003|NCT00430677|473716102|FG001|Short-term Period|Death|1|||
131571004|NCT00430677|473716103|FG002|Short-term Period|Death|5|||
131571005|NCT00430677|473716101|FG000|Short-term Period|Adverse Event|15|||
131571006|NCT00430677|473716102|FG001|Short-term Period|Adverse Event|13|||
131571007|NCT00430677|473716103|FG002|Short-term Period|Adverse Event|9|||
131571008|NCT00430677|473716101|FG000|Short-term Period|Lack of Efficacy|5|||
131571009|NCT00430677|473716102|FG001|Short-term Period|Lack of Efficacy|6|||
131571010|NCT00430677|473716103|FG002|Short-term Period|Lack of Efficacy|4|||
131571011|NCT00430677|473716101|FG000|Short-term Period|Withdrawal by Subject|1|||
131571012|NCT00430677|473716102|FG001|Short-term Period|Withdrawal by Subject|1|||
131571013|NCT00430677|473716103|FG002|Short-term Period|Withdrawal by Subject|2|||
131571014|NCT00430677|473716101|FG000|Short-term Period|Participant no longer met study criteria|1|||
131571015|NCT00430677|473716102|FG001|Short-term Period|Participant no longer met study criteria|1|||
131571016|NCT00430677|473716103|FG002|Short-term Period|Participant no longer met study criteria|2|||
131571017|NCT00430677|473716101|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
131571018|NCT00430677|473716102|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
131571019|NCT00430677|473716103|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
131571020|NCT00430677|473716101|FG000|Short-term Period|Pregnancy|0|||
131571021|NCT00430677|473716102|FG001|Short-term Period|Pregnancy|2|||
131571022|NCT00430677|473716103|FG002|Short-term Period|Pregnancy|0|||
131571023|NCT00430677|473716101|FG000|Long-term Extension Period|Death|1|||
131571024|NCT00430677|473716102|FG001|Long-term Extension Period|Death|0|||
131571025|NCT00430677|473716103|FG002|Long-term Extension Period|Death|0|||
131571026|NCT00430677|473716101|FG000|Long-term Extension Period|Adverse Event|3|||
131571027|NCT00430677|473716102|FG001|Long-term Extension Period|Adverse Event|2|||
131571028|NCT00430677|473716103|FG002|Long-term Extension Period|Adverse Event|5|||
131571029|NCT00430677|473716101|FG000|Long-term Extension Period|Lack of Efficacy|5|||
131571030|NCT00430677|473716102|FG001|Long-term Extension Period|Lack of Efficacy|3|||
131571031|NCT00430677|473716103|FG002|Long-term Extension Period|Lack of Efficacy|8|||
131571032|NCT00430677|473716101|FG000|Long-term Extension Period|Lost to Follow-up|1|||
131571033|NCT00430677|473716102|FG001|Long-term Extension Period|Lost to Follow-up|1|||
131571034|NCT00430677|473716103|FG002|Long-term Extension Period|Lost to Follow-up|1|||
131571035|NCT00430677|473716101|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
131571036|NCT00430677|473716102|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
131571037|NCT00430677|473716103|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
131783853|NCT01222715|474491721|FG001|Overall Study|Physician Decision|2|||
131783854|NCT01222715|474491720|FG000|Overall Study|Refusal of further protocol therapy|0|||
131783855|NCT01222715|474491721|FG001|Overall Study|Refusal of further protocol therapy|4|||
131783856|NCT01222715|474491720|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
131783857|NCT01222715|474491721|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
131783858|NCT01222715|474491720|FG000|Overall Study|Ineligible|0|||
131571038|NCT00430677|473716101|FG000|Long-term Extension Period|Pregnancy|1|||
131783859|NCT01222715|474491721|FG001|Overall Study|Ineligible|1|||
131571039|NCT00430677|473716102|FG001|Long-term Extension Period|Pregnancy|1|||
131571040|NCT00430677|473716103|FG002|Long-term Extension Period|Pregnancy|0|||
131571041|NCT00430677|473716101|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
131571042|NCT00430677|473716102|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
131571043|NCT00430677|473716103|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
131571044|NCT00430677|473716101|FG000|Long-term Extension Period|Other|2|||
131571045|NCT00430677|473716102|FG001|Long-term Extension Period|Other|1|||
131571046|NCT00430677|473716103|FG002|Long-term Extension Period|Other|1|||
131571047|NCT00430677|473716101|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
131783860|NCT01222715|474491720|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
131783861|NCT01222715|474491721|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
131783862|NCT02360397|474491722|FG000|Overall Study|Incomplete screening|3|||
131783863|NCT02360397|474491722|FG000|Overall Study|Adverse Event|1|||
131783864|NCT01537549|474491723|FG000|Overall Study|Lost to Follow-up|1|||
131783865|NCT01537549|474491723|FG000|Overall Study|Withdrawal by Subject|2|||
131783866|NCT03555890|474491726|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131783867|NCT03555890|474491727|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131783868|NCT03555890|474491728|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131783869|NCT03555890|474491729|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
131783870|NCT03372369|474491730|FG000|Qualification Period|Withdrawal by Subject|16|||
131783871|NCT03372369|474491731|FG001|Qualification Period|Withdrawal by Subject|13|||
131783872|NCT03372369|474491730|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
131783873|NCT03372369|474491731|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
131783874|NCT03372369|474491730|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
131783875|NCT03372369|474491731|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
131783876|NCT02239601|474491732|FG000|Overall Study|Withdrawal by Subject|3|||
131571048|NCT00430677|473716102|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
131783877|NCT02239601|474491733|FG001|Overall Study|Withdrawal by Subject|4|||
131783878|NCT02239601|474491732|FG000|Overall Study|Protocol Violation|4|||
131783879|NCT02239601|474491733|FG001|Overall Study|Protocol Violation|2|||
131783880|NCT01508325|474491734|FG000|Overall Study|Withdrawal by Subject|8|||
131783881|NCT01508325|474491735|FG001|Overall Study|Withdrawal by Subject|9|||
131783882|NCT01508325|474491734|FG000|Overall Study|Protocol Violation|0|||
131783883|NCT01508325|474491735|FG001|Overall Study|Protocol Violation|3|||
131783884|NCT01508325|474491734|FG000|Overall Study|Physician Decision|2|||
131783885|NCT01508325|474491735|FG001|Overall Study|Physician Decision|1|||
131783886|NCT01508325|474491734|FG000|Overall Study|Adverse Event|1|||
131783887|NCT01508325|474491735|FG001|Overall Study|Adverse Event|0|||
131783888|NCT01508325|474491734|FG000|Overall Study|Lost to Follow-up|5|||
131783889|NCT01508325|474491735|FG001|Overall Study|Lost to Follow-up|6|||
131783890|NCT01508325|474491734|FG000|Overall Study|Other|2|||
131783891|NCT01508325|474491735|FG001|Overall Study|Other|2|||
131783892|NCT04682639|474491736|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
131783893|NCT04682639|474491737|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
131783894|NCT04682639|474491738|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
131783895|NCT04682639|474491739|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
131783896|NCT04682639|474491740|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
131571049|NCT00430677|473716103|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
131571050|NCT01137292|473716104|FG000|Overall Study|Death|30|||
131571051|NCT01137292|473716104|FG000|Overall Study|Adverse Event|3|||
131571052|NCT01137292|473716104|FG000|Overall Study|Lack of Efficacy|13|||
131571053|NCT01137292|473716104|FG000|Overall Study|Lost to Follow-up|1|||
131571054|NCT01137292|473716104|FG000|Overall Study|Other|7|||
131571055|NCT03425539|473716105|FG000|Overall Study|Randomized but not treated|0|||
131571056|NCT03425539|473716106|FG001|Overall Study|Randomized but not treated|1|||
131571057|NCT03425539|473716105|FG000|Overall Study|Adverse Event|2|||
131571058|NCT03425539|473716106|FG001|Overall Study|Adverse Event|2|||
131571059|NCT03425539|473716105|FG000|Overall Study|Withdrawal by Subject|3|||
131571060|NCT03425539|473716106|FG001|Overall Study|Withdrawal by Subject|0|||
131571061|NCT03425539|473716105|FG000|Overall Study|Lost to Follow-up|0|||
131571062|NCT03425539|473716106|FG001|Overall Study|Lost to Follow-up|1|||
131571063|NCT02014558|473716109|FG000|Overall Study|Never Received Study Drug|0|||
131571064|NCT02014558|473716110|FG001|Overall Study|Never Received Study Drug|0|||
131571065|NCT02014558|473716111|FG002|Overall Study|Never Received Study Drug|0|||
131571066|NCT02014558|473716112|FG003|Overall Study|Never Received Study Drug|0|||
131571067|NCT02014558|473716113|FG004|Overall Study|Never Received Study Drug|1|||
131571068|NCT02014558|473716114|FG005|Overall Study|Never Received Study Drug|0|||
131571069|NCT02014558|473716115|FG006|Overall Study|Never Received Study Drug|1|||
131571070|NCT02014558|473716116|FG007|Overall Study|Never Received Study Drug|0|||
131571071|NCT02014558|473716117|FG008|Overall Study|Never Received Study Drug|2|||
131571072|NCT02014558|473716118|FG009|Overall Study|Never Received Study Drug|0|||
131571073|NCT02014558|473716119|FG010|Overall Study|Never Received Study Drug|2|||
131571074|NCT02014558|473716120|FG011|Overall Study|Never Received Study Drug|2|||
131571075|NCT02014558|473716121|FG012|Overall Study|Never Received Study Drug|0|||
131571076|NCT02014558|473716109|FG000|Overall Study|Adverse Event|0|||
131571077|NCT02014558|473716110|FG001|Overall Study|Adverse Event|0|||
131783897|NCT04682639|474491736|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131783898|NCT04682639|474491737|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131783899|NCT04682639|474491738|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131783900|NCT04682639|474491739|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131783901|NCT04682639|474491740|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131571078|NCT02014558|473716111|FG002|Overall Study|Adverse Event|0|||
131571079|NCT02014558|473716112|FG003|Overall Study|Adverse Event|0|||
131571080|NCT02014558|473716113|FG004|Overall Study|Adverse Event|1|||
131571081|NCT02014558|473716114|FG005|Overall Study|Adverse Event|0|||
131571082|NCT02014558|473716115|FG006|Overall Study|Adverse Event|0|||
131571083|NCT02014558|473716116|FG007|Overall Study|Adverse Event|0|||
131571084|NCT02014558|473716117|FG008|Overall Study|Adverse Event|2|||
131571085|NCT02014558|473716118|FG009|Overall Study|Adverse Event|2|||
131571086|NCT02014558|473716119|FG010|Overall Study|Adverse Event|5|||
131571087|NCT02014558|473716120|FG011|Overall Study|Adverse Event|21|||
131571088|NCT02014558|473716121|FG012|Overall Study|Adverse Event|3|||
131571089|NCT02014558|473716109|FG000|Overall Study|Death|1|||
131571090|NCT02014558|473716110|FG001|Overall Study|Death|0|||
131571091|NCT02014558|473716111|FG002|Overall Study|Death|0|||
131571092|NCT02014558|473716112|FG003|Overall Study|Death|0|||
131571093|NCT02014558|473716113|FG004|Overall Study|Death|0|||
131571094|NCT02014558|473716114|FG005|Overall Study|Death|0|||
131571095|NCT02014558|473716115|FG006|Overall Study|Death|1|||
131571096|NCT02014558|473716116|FG007|Overall Study|Death|1|||
131571097|NCT02014558|473716117|FG008|Overall Study|Death|2|||
131571098|NCT02014558|473716118|FG009|Overall Study|Death|5|||
131571099|NCT02014558|473716119|FG010|Overall Study|Death|5|||
131571100|NCT02014558|473716120|FG011|Overall Study|Death|19|||
131571101|NCT02014558|473716121|FG012|Overall Study|Death|2|||
131571102|NCT02014558|473716109|FG000|Overall Study|Lack of Efficacy|1|||
131571103|NCT02014558|473716110|FG001|Overall Study|Lack of Efficacy|2|||
131571104|NCT02014558|473716111|FG002|Overall Study|Lack of Efficacy|1|||
131571105|NCT02014558|473716112|FG003|Overall Study|Lack of Efficacy|1|||
131571106|NCT02014558|473716113|FG004|Overall Study|Lack of Efficacy|0|||
131571107|NCT02014558|473716114|FG005|Overall Study|Lack of Efficacy|0|||
131571108|NCT02014558|473716115|FG006|Overall Study|Lack of Efficacy|1|||
131571109|NCT02014558|473716116|FG007|Overall Study|Lack of Efficacy|3|||
131571110|NCT02014558|473716117|FG008|Overall Study|Lack of Efficacy|3|||
131571111|NCT02014558|473716118|FG009|Overall Study|Lack of Efficacy|3|||
131571112|NCT02014558|473716119|FG010|Overall Study|Lack of Efficacy|16|||
131571113|NCT02014558|473716120|FG011|Overall Study|Lack of Efficacy|8|||
131697596|NCT00143455|474175709|FG001|Cohort 2|Other|0|||
131697597|NCT00143455|474175710|FG002|Cohort 2|Other|7|||
131697598|NCT00143455|474175711|FG003|Cohort 2|Other|6|||
131437772|NCT00443040|473228151|FG002|Overall Study|Withdrawal by Subject|0|||
131571114|NCT02014558|473716121|FG012|Overall Study|Lack of Efficacy|5|||
131571115|NCT02014558|473716109|FG000|Overall Study|Lost to Follow-up|0|||
131571116|NCT02014558|473716110|FG001|Overall Study|Lost to Follow-up|0|||
131571117|NCT02014558|473716111|FG002|Overall Study|Lost to Follow-up|0|||
131697599|NCT00143455|474175708|FG000|Cohort 2|Randomized But Not Treated|0|||
131697600|NCT00143455|474175709|FG001|Cohort 2|Randomized But Not Treated|0|||
131697601|NCT00143455|474175710|FG002|Cohort 2|Randomized But Not Treated|1|||
131697602|NCT00143455|474175711|FG003|Cohort 2|Randomized But Not Treated|1|||
131697603|NCT02682901|474175712|FG000|Overall Study|Adverse Event|10|||
131697604|NCT02682901|474175713|FG001|Overall Study|Adverse Event|3|||
131697605|NCT02682901|474175712|FG000|Overall Study|Lack of Efficacy|0|||
131697606|NCT02682901|474175713|FG001|Overall Study|Lack of Efficacy|1|||
131697607|NCT03713944|474175714|FG000|Study Treatment|Patient non-compliance|1|||
131697608|NCT03713944|474175714|FG000|Study Treatment|Alternative Cancer Therapy|3|||
131697609|NCT03713944|474175714|FG000|Study Treatment|Disease Progression|18|||
131697610|NCT03713944|474175714|FG000|Study Treatment|AE/Side Effects/Complications|2|||
131697611|NCT03713944|474175714|FG000|Study Treatment|Death|2|||
131697612|NCT03713944|474175714|FG000|Study Treatment|Withdrawal by Subject|1|||
131697613|NCT03713944|474175714|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
131697614|NCT03713944|474175714|FG000|Study Treatment|Symptomatic Deterioration|2|||
131697615|NCT03713944|474175714|FG000|Follow up|Withdrawal by Subject|2|||
131697616|NCT03713944|474175714|FG000|Follow up|Death|11|||
131697617|NCT03713944|474175714|FG000|Follow up|Study Terminated|3|||
131697618|NCT03847610|474175715|FG000|Overall Study|Withdrawal by Subject|1|||
131783902|NCT04682639|474491736|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
131783903|NCT04682639|474491737|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131571118|NCT02014558|473716112|FG003|Overall Study|Lost to Follow-up|0|||
131571119|NCT02014558|473716113|FG004|Overall Study|Lost to Follow-up|0|||
131571120|NCT02014558|473716114|FG005|Overall Study|Lost to Follow-up|0|||
131571121|NCT02014558|473716115|FG006|Overall Study|Lost to Follow-up|0|||
131571122|NCT02014558|473716116|FG007|Overall Study|Lost to Follow-up|0|||
131571123|NCT02014558|473716117|FG008|Overall Study|Lost to Follow-up|0|||
131571124|NCT02014558|473716118|FG009|Overall Study|Lost to Follow-up|0|||
131697619|NCT01445769|474175716|FG000|Overall Study|Consent Withdrawn|2|||
131697620|NCT01445769|474175716|FG000|Overall Study|Disease Progression|1|||
131697621|NCT01445769|474175716|FG000|Overall Study|Lost to Follow-up|5|||
131571125|NCT02014558|473716119|FG010|Overall Study|Lost to Follow-up|1|||
131571126|NCT02014558|473716120|FG011|Overall Study|Lost to Follow-up|0|||
131571127|NCT02014558|473716121|FG012|Overall Study|Lost to Follow-up|0|||
131697622|NCT03099707|474175717|FG000|Overall Study|Withdrawal by Subject|0|||
131571128|NCT02014558|473716109|FG000|Overall Study|Progressive Disease|1|||
131697623|NCT03099707|474175718|FG001|Overall Study|Withdrawal by Subject|3|||
131697624|NCT03099707|474175717|FG000|Overall Study|Lost to Follow-up|0|||
131697625|NCT03099707|474175718|FG001|Overall Study|Lost to Follow-up|1|||
131697626|NCT03127384|474175719|FG000|Overall Study|Lost to Follow-up|4|||
131697627|NCT03127384|474175719|FG000|Overall Study|Subject request|2|||
131697628|NCT01079182|474175720|FG000|Overall Study|Lost to Follow-up|1634|||
131697629|NCT01079182|474175720|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
131571129|NCT02014558|473716110|FG001|Overall Study|Progressive Disease|0|||
131571130|NCT02014558|473716111|FG002|Overall Study|Progressive Disease|1|||
131571131|NCT02014558|473716112|FG003|Overall Study|Progressive Disease|1|||
131571132|NCT02014558|473716113|FG004|Overall Study|Progressive Disease|1|||
131571133|NCT02014558|473716114|FG005|Overall Study|Progressive Disease|2|||
131571134|NCT02014558|473716115|FG006|Overall Study|Progressive Disease|1|||
131571135|NCT02014558|473716116|FG007|Overall Study|Progressive Disease|6|||
131571136|NCT02014558|473716117|FG008|Overall Study|Progressive Disease|5|||
131571137|NCT02014558|473716118|FG009|Overall Study|Progressive Disease|6|||
131571138|NCT02014558|473716119|FG010|Overall Study|Progressive Disease|22|||
131571139|NCT02014558|473716120|FG011|Overall Study|Progressive Disease|31|||
131571140|NCT02014558|473716121|FG012|Overall Study|Progressive Disease|6|||
131571141|NCT02014558|473716109|FG000|Overall Study|Withdrawal by Subject|0|||
131571142|NCT02014558|473716110|FG001|Overall Study|Withdrawal by Subject|0|||
131571143|NCT02014558|473716111|FG002|Overall Study|Withdrawal by Subject|0|||
131571144|NCT02014558|473716112|FG003|Overall Study|Withdrawal by Subject|0|||
131571145|NCT02014558|473716113|FG004|Overall Study|Withdrawal by Subject|1|||
131571146|NCT02014558|473716114|FG005|Overall Study|Withdrawal by Subject|0|||
131571147|NCT02014558|473716115|FG006|Overall Study|Withdrawal by Subject|0|||
131571148|NCT02014558|473716116|FG007|Overall Study|Withdrawal by Subject|0|||
131571149|NCT02014558|473716117|FG008|Overall Study|Withdrawal by Subject|0|||
131571150|NCT02014558|473716118|FG009|Overall Study|Withdrawal by Subject|2|||
131571151|NCT02014558|473716119|FG010|Overall Study|Withdrawal by Subject|6|||
131571152|NCT02014558|473716120|FG011|Overall Study|Withdrawal by Subject|10|||
131571153|NCT02014558|473716121|FG012|Overall Study|Withdrawal by Subject|0|||
131571154|NCT02014558|473716109|FG000|Overall Study|Miscellaneous|2|||
131571155|NCT02014558|473716110|FG001|Overall Study|Miscellaneous|1|||
131571156|NCT02014558|473716111|FG002|Overall Study|Miscellaneous|1|||
131571157|NCT02014558|473716112|FG003|Overall Study|Miscellaneous|1|||
131571158|NCT02014558|473716113|FG004|Overall Study|Miscellaneous|0|||
131571159|NCT02014558|473716114|FG005|Overall Study|Miscellaneous|1|||
131571160|NCT02014558|473716115|FG006|Overall Study|Miscellaneous|0|||
131571161|NCT02014558|473716116|FG007|Overall Study|Miscellaneous|1|||
131571162|NCT02014558|473716117|FG008|Overall Study|Miscellaneous|1|||
131571163|NCT02014558|473716118|FG009|Overall Study|Miscellaneous|3|||
131571164|NCT02014558|473716119|FG010|Overall Study|Miscellaneous|12|||
131571165|NCT02014558|473716120|FG011|Overall Study|Miscellaneous|11|||
131571166|NCT02014558|473716121|FG012|Overall Study|Miscellaneous|1|||
131571167|NCT04580407|473716122|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
131571168|NCT00681811|473716127|FG000|Overall Study|Adverse Event|1|||
131571169|NCT00681811|473716128|FG001|Overall Study|Adverse Event|1|||
131571170|NCT00681811|473716127|FG000|Overall Study|Withdrawal by Subject|2|||
131571171|NCT00681811|473716128|FG001|Overall Study|Withdrawal by Subject|2|||
131571172|NCT00681811|473716127|FG000|Overall Study|Non-compliance|0|||
131571173|NCT00681811|473716128|FG001|Overall Study|Non-compliance|1|||
131571174|NCT00797862|473717681|FG000|Overall Study|Adverse Event|86|||
131571175|NCT00797862|473717682|FG001|Overall Study|Adverse Event|44|||
131571176|NCT00797862|473717683|FG002|Overall Study|Adverse Event|58|||
131571177|NCT00797862|473717681|FG000|Overall Study|Abnormal Test Procedure Result|0|||
131571178|NCT00797862|473717682|FG001|Overall Study|Abnormal Test Procedure Result|1|||
131571179|NCT00797862|473717683|FG002|Overall Study|Abnormal Test Procedure Result|1|||
131571180|NCT00797862|473717681|FG000|Overall Study|Lack of Efficacy|1|||
131571181|NCT00797862|473717682|FG001|Overall Study|Lack of Efficacy|7|||
131571182|NCT00797862|473717683|FG002|Overall Study|Lack of Efficacy|6|||
131571183|NCT00797862|473717681|FG000|Overall Study|No longer required study medication|1|||
131571184|NCT00797862|473717682|FG001|Overall Study|No longer required study medication|0|||
131571185|NCT00797862|473717683|FG002|Overall Study|No longer required study medication|0|||
131571186|NCT00797862|473717681|FG000|Overall Study|Withdrawal by Subject|14|||
131571187|NCT00797862|473717682|FG001|Overall Study|Withdrawal by Subject|7|||
131571188|NCT00797862|473717683|FG002|Overall Study|Withdrawal by Subject|7|||
131571189|NCT00797862|473717681|FG000|Overall Study|Lost to Follow-up|11|||
131571190|NCT00797862|473717682|FG001|Overall Study|Lost to Follow-up|0|||
131571191|NCT00797862|473717683|FG002|Overall Study|Lost to Follow-up|5|||
131571192|NCT00797862|473717681|FG000|Overall Study|Administrative Problem|4|||
131697630|NCT01079182|474175720|FG000|Overall Study|Lack of Efficacy|514|||
131697631|NCT01079182|474175720|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
131697632|NCT01079182|474175720|FG000|Overall Study|Reasons not Evaluated|271|||
131697633|NCT03652662|474175726|FG000|Overall Study|Withdrawal by Subject|2|||
131697634|NCT03652662|474175727|FG001|Overall Study|Withdrawal by Subject|1|||
131697635|NCT03652662|474175726|FG000|Overall Study|Lost to Follow-up|1|||
131571193|NCT00797862|473717682|FG001|Overall Study|Administrative Problem|0|||
131571194|NCT00797862|473717683|FG002|Overall Study|Administrative Problem|0|||
131571195|NCT00797862|473717681|FG000|Overall Study|Protocol Violation|4|||
131571196|NCT00797862|473717682|FG001|Overall Study|Protocol Violation|6|||
131571197|NCT00797862|473717683|FG002|Overall Study|Protocol Violation|8|||
131571198|NCT00797862|473717681|FG000|Overall Study|Mis-randomized|3|||
131571199|NCT00797862|473717682|FG001|Overall Study|Mis-randomized|3|||
131571200|NCT00797862|473717683|FG002|Overall Study|Mis-randomized|1|||
131571201|NCT00409708|473717687|FG000|Treatment|Abnormal test procedure result(s)|1|||
131571202|NCT00409708|473717688|FG001|Treatment|Abnormal test procedure result(s)|0|||
131571203|NCT00409708|473717687|FG000|Treatment|Lack of Efficacy|0|||
131783904|NCT04682639|474491738|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131571204|NCT00409708|473717688|FG001|Treatment|Lack of Efficacy|1|||
131571205|NCT00409708|473717687|FG000|Treatment|Protocol Violation|6|||
131783905|NCT04682639|474491739|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131571206|NCT00409708|473717688|FG001|Treatment|Protocol Violation|2|||
131571207|NCT00409708|473717687|FG000|Treatment|Withdrawal by Subject|3|||
131571208|NCT00409708|473717688|FG001|Treatment|Withdrawal by Subject|8|||
131571209|NCT00409708|473717687|FG000|Treatment|Lost to Follow-up|0|||
131571210|NCT00409708|473717688|FG001|Treatment|Lost to Follow-up|6|||
131571211|NCT00409708|473717687|FG000|Treatment|Administrative problems|5|||
131571212|NCT00409708|473717688|FG001|Treatment|Administrative problems|0|||
131571213|NCT00409708|473717687|FG000|Washout|Lack of Efficacy|9|||
131571214|NCT00409708|473717688|FG001|Washout|Lack of Efficacy|1|||
131571215|NCT00409708|473717687|FG000|Washout|Protocol Violation|0|||
131571216|NCT00409708|473717688|FG001|Washout|Protocol Violation|1|||
131571217|NCT00409708|473717687|FG000|Washout|Withdrawal by Subject|11|||
131571218|NCT00409708|473717688|FG001|Washout|Withdrawal by Subject|5|||
131571219|NCT00409708|473717687|FG000|Washout|Lost to Follow-up|1|||
131571220|NCT00409708|473717688|FG001|Washout|Lost to Follow-up|3|||
131571221|NCT01474538|473717690|FG000|Treatment Period 1|Death|1|||
131571222|NCT01474538|473717691|FG001|Treatment Period 1|Death|0|||
131571223|NCT01474538|473717690|FG000|Treatment Period 1|Physician Decision|1|||
131571224|NCT01474538|473717691|FG001|Treatment Period 1|Physician Decision|0|||
131571225|NCT01474538|473717690|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131571226|NCT01474538|473717691|FG001|Treatment Period 1|Withdrawal by Subject|3|||
131571227|NCT01474538|473717690|FG000|Treatment Period 1|Protocol Violation|0|||
131571228|NCT01474538|473717691|FG001|Treatment Period 1|Protocol Violation|1|||
131571229|NCT01474538|473717690|FG000|Treatment Period 2|Death|1|||
131571230|NCT01474538|473717691|FG001|Treatment Period 2|Death|0|||
131571231|NCT01474538|473717690|FG000|Treatment Period 2|Adverse Event|1|||
131571232|NCT01474538|473717691|FG001|Treatment Period 2|Adverse Event|1|||
131571233|NCT01474538|473717690|FG000|Treatment Period 2|Withdrawal by Subject|2|||
131571234|NCT01474538|473717691|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131571235|NCT01474538|473717690|FG000|Treatment Period 2|Sponsor decision|1|||
131571236|NCT01474538|473717691|FG001|Treatment Period 2|Sponsor decision|0|||
131571237|NCT01474538|473717690|FG000|Treatment Period 2|Physician Decision|0|||
131571238|NCT01474538|473717691|FG001|Treatment Period 2|Physician Decision|1|||
131571239|NCT01474538|473717690|FG000|Treatment Period 2|Protocol Violation|1|||
131571240|NCT01474538|473717691|FG001|Treatment Period 2|Protocol Violation|0|||
131571241|NCT03120676|473717694|FG000|Overall Study|Not treated|1|||
131571242|NCT00926393|473717695|FG000|Overall Study|Withdrawal by Subject|1|||
131571243|NCT00926393|473717696|FG001|Overall Study|Withdrawal by Subject|2|||
131571244|NCT00926393|473717695|FG000|Overall Study|Adverse Event|1|||
131571245|NCT00926393|473717696|FG001|Overall Study|Adverse Event|1|||
131571246|NCT02333630|473717697|FG000|Overall Study|Lost to Follow-up|5|||
131571247|NCT02333630|473717698|FG001|Overall Study|Lost to Follow-up|2|||
131571248|NCT02359435|473717700|FG000|Overall Study|Lost to Follow-up|4|||
131571249|NCT02359435|473717701|FG001|Overall Study|Lost to Follow-up|4|||
131571250|NCT00530335|473717704|FG000|Overall Study|Adverse Event|3|||
131571251|NCT00530335|473717704|FG000|Overall Study|Protocol Violation|1|||
131571252|NCT00530335|473717704|FG000|Overall Study|Withdrawal by Subject|1|||
131571253|NCT00530335|473717704|FG000|Overall Study|Physician Decision|1|||
131571254|NCT02321540|473717705|FG000|Overall Study|Death|0|||
131571255|NCT02321540|473717706|FG001|Overall Study|Death|1|||
131571256|NCT02321540|473717705|FG000|Overall Study|Progression|3|||
131571257|NCT02321540|473717706|FG001|Overall Study|Progression|9|||
131571258|NCT02534896|473717708|FG000|Overall Study|Adverse Event|2|||
131571259|NCT02534896|473717709|FG001|Overall Study|Adverse Event|1|||
131571260|NCT02534896|473717710|FG002|Overall Study|Adverse Event|1|||
131571261|NCT02534896|473717708|FG000|Overall Study|Insufficient therapeutic response|2|||
131571262|NCT02534896|473717709|FG001|Overall Study|Insufficient therapeutic response|0|||
131571263|NCT02534896|473717710|FG002|Overall Study|Insufficient therapeutic response|0|||
131571264|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
131571265|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
131571266|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
131571267|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
131571268|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Adverse Event|198|||
131571269|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Adverse Event|0|||
131571270|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Adverse Event|0|||
131571271|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Adverse Event|0|||
131571272|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Death|62|||
131571273|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Death|0|||
131571274|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Death|0|||
131571275|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Death|0|||
131571276|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
131571277|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
131571278|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
131571279|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
131571280|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Complicating disease|13|||
131571281|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Complicating disease|0|||
131571282|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Complicating disease|0|||
131571283|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Complicating disease|0|||
131571284|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
131571285|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
131571286|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
131571287|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
131571288|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
131571289|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
131571290|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
131571291|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
131571292|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Non-compliance|4|||
131571293|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Non-compliance|0|||
131571294|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Non-compliance|0|||
131571295|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Non-compliance|0|||
131571296|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Pain|4|||
131571297|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Pain|0|||
131571298|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Pain|0|||
131571299|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Pain|0|||
131571300|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
131571301|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
131571302|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
131571303|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
131571304|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Hospice care|1|||
131571305|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Hospice care|0|||
131571306|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Hospice care|0|||
131571307|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Hospice care|0|||
131571308|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Physician Decision|1|||
131571309|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Physician Decision|0|||
131571310|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Physician Decision|0|||
131571311|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Physician Decision|0|||
131571312|NCT01107626|473717715|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
131571313|NCT01107626|473717716|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
131571314|NCT01107626|473717717|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
131571315|NCT01107626|473717718|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
131571316|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
131571317|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
131571318|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
131571319|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
131697636|NCT03652662|474175727|FG001|Overall Study|Lost to Follow-up|0|||
131697637|NCT00371865|474175728|FG000|Overall Study|Lack of Efficacy|0|||
131697638|NCT00371865|474175729|FG001|Overall Study|Lack of Efficacy|2|||
131697639|NCT00371865|474175728|FG000|Overall Study|Protocol Violation|3|||
131571320|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
131571321|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
131571322|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
131697640|NCT00371865|474175729|FG001|Overall Study|Protocol Violation|2|||
131697641|NCT00371865|474175728|FG000|Overall Study|Withdrawal by Subject|12|||
131697642|NCT00371865|474175729|FG001|Overall Study|Withdrawal by Subject|10|||
131697643|NCT02508194|474175730|FG000|Overall Study|Death|5|||
131783906|NCT04682639|474491740|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131783907|NCT04682639|474491736|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131571323|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
131437773|NCT00443040|473228149|FG000|Overall Study|Converted to an open laparotomy|3|||
131697644|NCT02508194|474175731|FG001|Overall Study|Death|3|||
131697645|NCT02508194|474175730|FG000|Overall Study|Lost to Follow-up|25|||
131697646|NCT02508194|474175731|FG001|Overall Study|Lost to Follow-up|18|||
131697647|NCT02508194|474175730|FG000|Overall Study|Withdrawal by Subject|20|||
131571324|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Death|0|||
131571325|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Death|8|||
131571326|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Death|2|||
131571327|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Death|13|||
131571328|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
131571329|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
131571330|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
131571331|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
131571332|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
131571333|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
131571334|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
131571335|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
131571336|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
131571337|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
131571338|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
131571339|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
131571340|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
131571341|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
131571342|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
131571343|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
131571344|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
131571345|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
131571346|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
131571347|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
131571348|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
131571349|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
131571350|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
131571351|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
131571352|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
131571353|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
131571354|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
131571355|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
131571356|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
131571357|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
131571358|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
131697648|NCT02508194|474175731|FG001|Overall Study|Withdrawal by Subject|18|||
131697649|NCT02508194|474175730|FG000|Overall Study|Error in Randomization|1|||
131697650|NCT02508194|474175731|FG001|Overall Study|Error in Randomization|3|||
131697651|NCT02508194|474175730|FG000|Overall Study|Principal Investigator Decision|1|||
131697652|NCT02508194|474175731|FG001|Overall Study|Principal Investigator Decision|2|||
131697653|NCT01627899|474175732|FG000|Overall Study|Study terminated early by sponsor.|5|||
131697654|NCT03692052|474175733|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
131697655|NCT03692052|474175733|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
131697656|NCT03692052|474175733|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
131697657|NCT03692052|474175733|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
131697658|NCT05600309|474175736|FG000|Overall Study|Death|41|||
131697659|NCT05600309|474175737|FG001|Overall Study|Death|38|||
131697660|NCT05600309|474175736|FG000|Overall Study|Sponsor Decision|9|||
131697661|NCT05600309|474175737|FG001|Overall Study|Sponsor Decision|6|||
131697662|NCT01358864|474175743|FG000|Overall Study|Adverse Event|0|||
131697663|NCT01358864|474175744|FG001|Overall Study|Adverse Event|6|||
131697664|NCT01358864|474175745|FG002|Overall Study|Adverse Event|9|||
131697665|NCT01358864|474175746|FG003|Overall Study|Adverse Event|0|||
131697666|NCT01358864|474175747|FG004|Overall Study|Adverse Event|4|||
131697667|NCT01358864|474175748|FG005|Overall Study|Adverse Event|8|||
131697668|NCT01358864|474175749|FG006|Overall Study|Adverse Event|12|||
131697669|NCT01358864|474175750|FG007|Overall Study|Adverse Event|7|||
131697670|NCT01358864|474175743|FG000|Overall Study|Lack of Efficacy|26|||
131697671|NCT01358864|474175744|FG001|Overall Study|Lack of Efficacy|3|||
131697672|NCT01358864|474175745|FG002|Overall Study|Lack of Efficacy|4|||
131697673|NCT01358864|474175746|FG003|Overall Study|Lack of Efficacy|19|||
131697674|NCT01358864|474175747|FG004|Overall Study|Lack of Efficacy|7|||
131697675|NCT01358864|474175748|FG005|Overall Study|Lack of Efficacy|4|||
131697676|NCT01358864|474175749|FG006|Overall Study|Lack of Efficacy|49|||
131697677|NCT01358864|474175750|FG007|Overall Study|Lack of Efficacy|44|||
131697678|NCT01358864|474175743|FG000|Overall Study|Lost to Follow-up|0|||
131697679|NCT01358864|474175744|FG001|Overall Study|Lost to Follow-up|0|||
131697680|NCT01358864|474175745|FG002|Overall Study|Lost to Follow-up|1|||
131697681|NCT01358864|474175746|FG003|Overall Study|Lost to Follow-up|0|||
131697682|NCT01358864|474175747|FG004|Overall Study|Lost to Follow-up|0|||
131697683|NCT01358864|474175748|FG005|Overall Study|Lost to Follow-up|0|||
131697684|NCT01358864|474175749|FG006|Overall Study|Lost to Follow-up|0|||
131571359|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
131571360|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
131571361|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
131571362|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
131571363|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
131571364|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
131571365|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
131571366|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
131571367|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
131571368|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Pain|0|||
131571369|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Pain|0|||
131571370|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Pain|0|||
131571371|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Pain|1|||
131571372|NCT01107626|473717715|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
131571373|NCT01107626|473717716|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
131571374|NCT01107626|473717717|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
131571375|NCT01107626|473717718|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
131571376|NCT00817635|473717719|FG000|Overall Study|Adverse Event|1|||
131571377|NCT00817635|473717720|FG001|Overall Study|Adverse Event|0|||
131571378|NCT00817635|473717721|FG002|Overall Study|Adverse Event|0|||
131571379|NCT00817635|473717722|FG003|Overall Study|Adverse Event|1|||
131571380|NCT00817635|473717723|FG004|Overall Study|Adverse Event|1|||
131571381|NCT00817635|473717719|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
131571382|NCT00817635|473717720|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
131571383|NCT00817635|473717721|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131571384|NCT00817635|473717722|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
131571385|NCT00817635|473717723|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
131571386|NCT00817635|473717719|FG000|Overall Study|Withdrawal by Subject|2|||
131571387|NCT00817635|473717720|FG001|Overall Study|Withdrawal by Subject|1|||
131571388|NCT00817635|473717721|FG002|Overall Study|Withdrawal by Subject|0|||
131571389|NCT00817635|473717722|FG003|Overall Study|Withdrawal by Subject|1|||
131571390|NCT00817635|473717723|FG004|Overall Study|Withdrawal by Subject|2|||
131571391|NCT00817635|473717719|FG000|Overall Study|Lost to Follow-up|0|||
131571392|NCT00817635|473717720|FG001|Overall Study|Lost to Follow-up|1|||
131571393|NCT00817635|473717721|FG002|Overall Study|Lost to Follow-up|0|||
131571394|NCT00817635|473717722|FG003|Overall Study|Lost to Follow-up|1|||
131571395|NCT00817635|473717723|FG004|Overall Study|Lost to Follow-up|0|||
131571396|NCT00817635|473717719|FG000|Overall Study|Administrative Problems|0|||
131571397|NCT00817635|473717720|FG001|Overall Study|Administrative Problems|0|||
131571398|NCT00817635|473717721|FG002|Overall Study|Administrative Problems|0|||
131571399|NCT00817635|473717722|FG003|Overall Study|Administrative Problems|0|||
131571400|NCT00817635|473717723|FG004|Overall Study|Administrative Problems|1|||
131571401|NCT00817635|473717719|FG000|Overall Study|Protocol Violation|5|||
131571402|NCT00817635|473717720|FG001|Overall Study|Protocol Violation|1|||
131571403|NCT00817635|473717721|FG002|Overall Study|Protocol Violation|3|||
131571404|NCT00817635|473717722|FG003|Overall Study|Protocol Violation|2|||
131571405|NCT00817635|473717723|FG004|Overall Study|Protocol Violation|3|||
131571406|NCT04353037|473717724|FG000|Overall Study|Lost to Follow-up|0|||
131571407|NCT04353037|473717725|FG001|Overall Study|Lost to Follow-up|1|||
131571408|NCT04353037|473717726|FG002|Overall Study|Lost to Follow-up|2|||
131571409|NCT04353037|473717727|FG003|Overall Study|Lost to Follow-up|3|||
131571410|NCT04353037|473717724|FG000|Overall Study|Withdrawal by Subject|0|||
131571411|NCT04353037|473717725|FG001|Overall Study|Withdrawal by Subject|2|||
131571412|NCT04353037|473717726|FG002|Overall Study|Withdrawal by Subject|3|||
131571413|NCT04353037|473717727|FG003|Overall Study|Withdrawal by Subject|5|||
131571414|NCT04353037|473717724|FG000|Overall Study|Adverse Event|0|||
131571415|NCT04353037|473717725|FG001|Overall Study|Adverse Event|0|||
131571416|NCT04353037|473717726|FG002|Overall Study|Adverse Event|2|||
131571417|NCT04353037|473717727|FG003|Overall Study|Adverse Event|0|||
131571418|NCT04353037|473717724|FG000|Overall Study|Exposure Change|0|||
131697685|NCT01358864|474175750|FG007|Overall Study|Lost to Follow-up|1|||
131697686|NCT01358864|474175743|FG000|Overall Study|Withdrawal by Subject|3|||
131697687|NCT01358864|474175744|FG001|Overall Study|Withdrawal by Subject|4|||
131697688|NCT01358864|474175745|FG002|Overall Study|Withdrawal by Subject|2|||
131697689|NCT01358864|474175746|FG003|Overall Study|Withdrawal by Subject|0|||
131697690|NCT01358864|474175747|FG004|Overall Study|Withdrawal by Subject|0|||
131571419|NCT04353037|473717725|FG001|Overall Study|Exposure Change|0|||
131571420|NCT04353037|473717726|FG002|Overall Study|Exposure Change|0|||
131571421|NCT04353037|473717727|FG003|Overall Study|Exposure Change|2|||
131571422|NCT03710564|473717728|FG000|Overall Study|Study Terminated by Sponsor|104|||
131571423|NCT03710564|473717729|FG001|Overall Study|Study Terminated by Sponsor|55|||
131571424|NCT03710564|473717728|FG000|Overall Study|Withdrawal by Subject|57|||
131571425|NCT03710564|473717729|FG001|Overall Study|Withdrawal by Subject|25|||
131571426|NCT03710564|473717728|FG000|Overall Study|Death|10|||
131571427|NCT03710564|473717729|FG001|Overall Study|Death|4|||
131697691|NCT01358864|474175748|FG005|Overall Study|Withdrawal by Subject|1|||
131571428|NCT03710564|473717728|FG000|Overall Study|Lost to Follow-up|5|||
131571429|NCT03710564|473717729|FG001|Overall Study|Lost to Follow-up|4|||
131571430|NCT03710564|473717728|FG000|Overall Study|Protocol Violation|3|||
131571431|NCT03710564|473717729|FG001|Overall Study|Protocol Violation|2|||
131571432|NCT03710564|473717728|FG000|Overall Study|Adverse Event|3|||
131571433|NCT03710564|473717729|FG001|Overall Study|Adverse Event|0|||
131571434|NCT03710564|473717728|FG000|Overall Study|Physician Decision|2|||
131571435|NCT03710564|473717729|FG001|Overall Study|Physician Decision|3|||
131571436|NCT00003656|473717734|FG000|Overall Study|Adverse Event|0|||
131571437|NCT00003656|473717735|FG001|Overall Study|Adverse Event|1|||
131571438|NCT00763282|473717740|FG000|Overall Study|Withdrawal by Subject|6|||
131571439|NCT00763282|473717741|FG001|Overall Study|Withdrawal by Subject|5|||
131571440|NCT00763282|473717740|FG000|Overall Study|Death|4|||
131571441|NCT00763282|473717741|FG001|Overall Study|Death|3|||
131571442|NCT00763282|473717740|FG000|Overall Study|Lost to Follow-up|22|||
131571443|NCT00763282|473717741|FG001|Overall Study|Lost to Follow-up|26|||
131571444|NCT00742274|473717742|FG000|Overall Study|Death|1|||
131571445|NCT00742274|473717743|FG001|Overall Study|Death|0|||
131571446|NCT00742274|473717742|FG000|Overall Study|Withdrawal by Subject|1|||
131571447|NCT00742274|473717743|FG001|Overall Study|Withdrawal by Subject|2|||
131571448|NCT00742274|473717742|FG000|Overall Study|Removed for medical reasons|1|||
131571449|NCT00742274|473717743|FG001|Overall Study|Removed for medical reasons|1|||
131571450|NCT01941316|473717744|FG000|Overall Study|Adverse Event|0|||
131571451|NCT01941316|473717745|FG001|Overall Study|Adverse Event|1|||
131571452|NCT01941316|473717746|FG002|Overall Study|Adverse Event|0|||
131571453|NCT01941316|473717747|FG003|Overall Study|Adverse Event|7|||
131571454|NCT01941316|473717744|FG000|Overall Study|Progressive Disease|3|||
131571455|NCT01941316|473717745|FG001|Overall Study|Progressive Disease|6|||
131571456|NCT01941316|473717746|FG002|Overall Study|Progressive Disease|2|||
131571457|NCT01941316|473717747|FG003|Overall Study|Progressive Disease|29|||
131571458|NCT01941316|473717744|FG000|Overall Study|Withdrawal by Subject|0|||
131571459|NCT01941316|473717745|FG001|Overall Study|Withdrawal by Subject|2|||
131571460|NCT01941316|473717746|FG002|Overall Study|Withdrawal by Subject|1|||
131571461|NCT01941316|473717747|FG003|Overall Study|Withdrawal by Subject|8|||
131571462|NCT01941316|473717744|FG000|Overall Study|Death|0|||
131571463|NCT01941316|473717745|FG001|Overall Study|Death|0|||
131571464|NCT01941316|473717746|FG002|Overall Study|Death|0|||
131571465|NCT01941316|473717747|FG003|Overall Study|Death|3|||
131571466|NCT01941316|473717744|FG000|Overall Study|Physician Decision|0|||
131571467|NCT01941316|473717745|FG001|Overall Study|Physician Decision|0|||
131571468|NCT01941316|473717746|FG002|Overall Study|Physician Decision|0|||
131571469|NCT01941316|473717747|FG003|Overall Study|Physician Decision|3|||
131571470|NCT01941316|473717744|FG000|Overall Study|Protocol Violation|0|||
131571471|NCT01941316|473717745|FG001|Overall Study|Protocol Violation|0|||
131571472|NCT01941316|473717746|FG002|Overall Study|Protocol Violation|0|||
131571473|NCT01941316|473717747|FG003|Overall Study|Protocol Violation|3|||
131571474|NCT01941316|473717744|FG000|Overall Study|Intercurrent illness|0|||
131571475|NCT01941316|473717745|FG001|Overall Study|Intercurrent illness|0|||
131571476|NCT01941316|473717746|FG002|Overall Study|Intercurrent illness|0|||
131571477|NCT01941316|473717747|FG003|Overall Study|Intercurrent illness|1|||
131571478|NCT01941316|473717744|FG000|Overall Study|Other, not specified|0|||
131571479|NCT01941316|473717745|FG001|Overall Study|Other, not specified|0|||
131571480|NCT01941316|473717746|FG002|Overall Study|Other, not specified|0|||
131571481|NCT01941316|473717747|FG003|Overall Study|Other, not specified|1|||
131697692|NCT01358864|474175749|FG006|Overall Study|Withdrawal by Subject|1|||
131437774|NCT00443040|473228150|FG001|Overall Study|Converted to an open laparotomy|0|||
131437775|NCT00443040|473228151|FG002|Overall Study|Converted to an open laparotomy|1|||
131437776|NCT04551989|473228152|FG000|Overall Study|Adverse Event|4|||
131437777|NCT04551989|473228152|FG000|Overall Study|Protocol Violation|3|||
131437778|NCT04551989|473228152|FG000|Overall Study|Lost to Follow-up|1|||
131571482|NCT00197236|473717749|FG000|Overall Study|Adverse Event|1|||
131571483|NCT00197236|473717750|FG001|Overall Study|Adverse Event|0|||
131571484|NCT00197236|473717751|FG002|Overall Study|Adverse Event|1|||
131571485|NCT00197236|473717749|FG000|Overall Study|Lost to Follow-up|5|||
131571486|NCT00197236|473717750|FG001|Overall Study|Lost to Follow-up|14|||
131571487|NCT00197236|473717751|FG002|Overall Study|Lost to Follow-up|6|||
131571488|NCT00197236|473717749|FG000|Overall Study|Protocol Violation|0|||
131571489|NCT00197236|473717750|FG001|Overall Study|Protocol Violation|0|||
131571490|NCT00197236|473717751|FG002|Overall Study|Protocol Violation|1|||
131571491|NCT00197236|473717749|FG000|Overall Study|Withdrawal by Subject|7|||
131571492|NCT00197236|473717750|FG001|Overall Study|Withdrawal by Subject|3|||
131697693|NCT01358864|474175750|FG007|Overall Study|Withdrawal by Subject|3|||
131437779|NCT04551989|473228152|FG000|Overall Study|Physician Decision|3|||
131437780|NCT04698343|473228153|FG000|Overall Study|Withdrawal by Subject|6|||
131571493|NCT00197236|473717751|FG002|Overall Study|Withdrawal by Subject|11|||
131571494|NCT00197236|473717749|FG000|Overall Study|Study drug/medication expiration|1|||
131571495|NCT00197236|473717750|FG001|Overall Study|Study drug/medication expiration|0|||
131571496|NCT00197236|473717751|FG002|Overall Study|Study drug/medication expiration|3|||
131697694|NCT01358864|474175743|FG000|Overall Study|Other reason not defined above|2|||
131437781|NCT04698343|473228153|FG000|Overall Study|Physician Decision|2|||
131437782|NCT04698343|473228153|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
131437783|NCT04698343|473228153|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
131437784|NCT04698343|473228153|FG000|Overall Study|Personal reasons|3|||
131437785|NCT04698343|473228153|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
131437786|NCT00088530|473228154|FG000|Overall Study|Progressive/Relapsed Disease|28|||
131437787|NCT00088530|473228155|FG001|Overall Study|Progressive/Relapsed Disease|39|||
131437788|NCT00088530|473228154|FG000|Overall Study|Adverse Event|15|||
131437789|NCT00088530|473228155|FG001|Overall Study|Adverse Event|9|||
131437790|NCT00088530|473228154|FG000|Overall Study|Withdrawal by Subject|2|||
131437791|NCT00088530|473228155|FG001|Overall Study|Withdrawal by Subject|5|||
131437792|NCT00088530|473228154|FG000|Overall Study|Lost to Follow-up|2|||
131437793|NCT00088530|473228155|FG001|Overall Study|Lost to Follow-up|0|||
131437794|NCT00088530|473228154|FG000|Overall Study|Physician Decision|2|||
131437795|NCT00088530|473228155|FG001|Overall Study|Physician Decision|0|||
131437796|NCT00088530|473228154|FG000|Overall Study|Sponsor decision|0|||
131437797|NCT00088530|473228155|FG001|Overall Study|Sponsor decision|1|||
131437798|NCT00088530|473228154|FG000|Overall Study|Patient never treated|1|||
131437799|NCT00088530|473228155|FG001|Overall Study|Patient never treated|0|||
131437800|NCT00739401|473228156|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
131437801|NCT00739401|473228156|FG000|Overall Study|Death|3|||
131437802|NCT00739401|473228156|FG000|Overall Study|Withdrawal by Subject|4|||
131437803|NCT04678115|473228157|FG000|Overall Study|Lost to Follow-up|1|||
131437804|NCT04678115|473228158|FG001|Overall Study|Lost to Follow-up|0|||
131437805|NCT01787461|473228159|FG000|Overall Study|Adverse Event|4|||
131437806|NCT01787461|473228160|FG001|Overall Study|Adverse Event|3|||
131437807|NCT01787461|473228159|FG000|Overall Study|Lost to Follow-up|3|||
131437808|NCT01787461|473228160|FG001|Overall Study|Lost to Follow-up|2|||
131571497|NCT00197236|473717749|FG000|Overall Study|Returned out of specified time window|0|||
131571498|NCT00197236|473717750|FG001|Overall Study|Returned out of specified time window|0|||
131571499|NCT00197236|473717751|FG002|Overall Study|Returned out of specified time window|1|||
131571500|NCT03885596|473717752|FG000|Overall Study|Withdrawal by Subject|2|||
131571501|NCT03885596|473717753|FG001|Overall Study|Withdrawal by Subject|1|||
131437809|NCT01787461|473228159|FG000|Overall Study|No longer met eligibility criteria|1|||
131437810|NCT01787461|473228160|FG001|Overall Study|No longer met eligibility criteria|0|||
131437811|NCT01787461|473228159|FG000|Overall Study|Withdrawal by Subject|3|||
131437812|NCT01787461|473228160|FG001|Overall Study|Withdrawal by Subject|4|||
131437813|NCT01787461|473228159|FG000|Overall Study|Protocol Violation|3|||
131437814|NCT01787461|473228160|FG001|Overall Study|Protocol Violation|0|||
131437815|NCT04879628|473228161|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
131437816|NCT04879628|473228162|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
131437817|NCT04879628|473228163|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
131437818|NCT04879628|473228164|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
131437819|NCT04879628|473228161|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
131437820|NCT04879628|473228162|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
131437821|NCT04879628|473228163|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
131437822|NCT04879628|473228164|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
131437823|NCT04879628|473228161|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
131437824|NCT04879628|473228162|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
131437825|NCT04879628|473228163|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
131437826|NCT04879628|473228164|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
131437827|NCT04879628|473228161|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
131437828|NCT04879628|473228162|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
131437829|NCT04879628|473228163|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
131437830|NCT04879628|473228164|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
131437831|NCT03649074|473228165|FG000|Overall Study|Lost to Follow-up|2|||
131437832|NCT03649074|473228166|FG001|Overall Study|Lost to Follow-up|1|||
131437833|NCT03649074|473228165|FG000|Overall Study|Adverse Event|1|||
131437834|NCT03649074|473228166|FG001|Overall Study|Adverse Event|0|||
131437835|NCT03649074|473228165|FG000|Overall Study|Physician Decision|1|||
131437836|NCT03649074|473228166|FG001|Overall Study|Physician Decision|0|||
131571502|NCT03885596|473717754|FG002|Overall Study|Withdrawal by Subject|0|||
131571503|NCT03885596|473717755|FG003|Overall Study|Withdrawal by Subject|0|||
131571504|NCT03852433|473717756|FG000|Overall Study|Withdrawal of consent|5|||
131437837|NCT03649074|473228165|FG000|Overall Study|Withdrawal by Subject|0|||
131437838|NCT03649074|473228166|FG001|Overall Study|Withdrawal by Subject|2|||
131437839|NCT03649074|473228165|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
131571505|NCT03852433|473717757|FG001|Overall Study|Withdrawal of consent|8|||
131571506|NCT03852433|473717758|FG002|Overall Study|Withdrawal of consent|1|||
131697695|NCT01358864|474175744|FG001|Overall Study|Other reason not defined above|0|||
131571507|NCT03852433|473717759|FG003|Overall Study|Withdrawal of consent|1|||
131571508|NCT03852433|473717756|FG000|Overall Study|Adverse Event|1|||
131571509|NCT03852433|473717757|FG001|Overall Study|Adverse Event|1|||
131571510|NCT03852433|473717758|FG002|Overall Study|Adverse Event|1|||
131571511|NCT03852433|473717759|FG003|Overall Study|Adverse Event|1|||
131571512|NCT03852433|473717756|FG000|Overall Study|Lost to Follow-up|0|||
131571513|NCT03852433|473717757|FG001|Overall Study|Lost to Follow-up|1|||
131571514|NCT03852433|473717758|FG002|Overall Study|Lost to Follow-up|0|||
131571515|NCT03852433|473717759|FG003|Overall Study|Lost to Follow-up|1|||
131571516|NCT03852433|473717756|FG000|Overall Study|Pregnancy|0|||
131571517|NCT03852433|473717757|FG001|Overall Study|Pregnancy|1|||
131571518|NCT03852433|473717758|FG002|Overall Study|Pregnancy|1|||
131571519|NCT03852433|473717759|FG003|Overall Study|Pregnancy|0|||
131571520|NCT03852433|473717756|FG000|Overall Study|Protocol Violation|0|||
131571521|NCT03852433|473717757|FG001|Overall Study|Protocol Violation|0|||
131571522|NCT03852433|473717758|FG002|Overall Study|Protocol Violation|1|||
131571523|NCT03852433|473717759|FG003|Overall Study|Protocol Violation|1|||
131571524|NCT03852433|473717756|FG000|Overall Study|Death|0|||
131571525|NCT03852433|473717757|FG001|Overall Study|Death|0|||
131571526|NCT03852433|473717758|FG002|Overall Study|Death|1|||
131571527|NCT03852433|473717759|FG003|Overall Study|Death|0|||
131571528|NCT03852433|473717756|FG000|Overall Study|Lack of Efficacy|0|||
131571529|NCT03852433|473717757|FG001|Overall Study|Lack of Efficacy|1|||
131571530|NCT03852433|473717758|FG002|Overall Study|Lack of Efficacy|0|||
131571531|NCT03852433|473717759|FG003|Overall Study|Lack of Efficacy|0|||
131571532|NCT03852433|473717756|FG000|Overall Study|Non-compliance with study drug|0|||
131571533|NCT03852433|473717757|FG001|Overall Study|Non-compliance with study drug|0|||
131571534|NCT03852433|473717758|FG002|Overall Study|Non-compliance with study drug|0|||
131571535|NCT03852433|473717759|FG003|Overall Study|Non-compliance with study drug|1|||
131571536|NCT03852433|473717756|FG000|Overall Study|Physician Decision|1|||
131571537|NCT03852433|473717757|FG001|Overall Study|Physician Decision|0|||
131571538|NCT03852433|473717758|FG002|Overall Study|Physician Decision|0|||
131571539|NCT03852433|473717759|FG003|Overall Study|Physician Decision|0|||
131571540|NCT03852433|473717756|FG000|Overall Study|Randomized but never treated|1|||
131571541|NCT03852433|473717757|FG001|Overall Study|Randomized but never treated|0|||
131571542|NCT03852433|473717758|FG002|Overall Study|Randomized but never treated|0|||
131571543|NCT03852433|473717759|FG003|Overall Study|Randomized but never treated|0|||
131571544|NCT01835899|473717761|FG000|Overall Study|Adverse Event|0|||
131571545|NCT01835899|473717762|FG001|Overall Study|Adverse Event|0|||
131571546|NCT01835899|473717763|FG002|Overall Study|Adverse Event|1|||
131571547|NCT01835899|473717761|FG000|Overall Study|Other than stated above|0|||
131571548|NCT01835899|473717762|FG001|Overall Study|Other than stated above|1|||
131571549|NCT01835899|473717763|FG002|Overall Study|Other than stated above|0|||
131571550|NCT03168438|473717765|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
131571551|NCT03168438|473717766|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
131571552|NCT01268566|473717776|FG000|Overall Study|Lost to Follow-up|1|||
131571553|NCT01268566|473717776|FG000|Overall Study|Withdrawal by Subject|12|||
131571554|NCT01268566|473717776|FG000|Overall Study|Death|30|||
131571555|NCT02138916|473717781|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
131571556|NCT02138916|473717782|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
131571557|NCT02138916|473717783|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
131571558|NCT02138916|473717781|FG000|Overall Study|Death|14|||
131571559|NCT02138916|473717782|FG001|Overall Study|Death|11|||
131571560|NCT02138916|473717783|FG002|Overall Study|Death|12|||
131571561|NCT02138916|473717781|FG000|Overall Study|Withdrawal by Subject|27|||
131697696|NCT01358864|474175745|FG002|Overall Study|Other reason not defined above|0|||
131697697|NCT01358864|474175746|FG003|Overall Study|Other reason not defined above|0|||
131697698|NCT01358864|474175747|FG004|Overall Study|Other reason not defined above|0|||
131571562|NCT02138916|473717782|FG001|Overall Study|Withdrawal by Subject|31|||
131571563|NCT02138916|473717783|FG002|Overall Study|Withdrawal by Subject|32|||
131571564|NCT02138916|473717781|FG000|Overall Study|Study specific withdrawal criteria|0|||
131571565|NCT02138916|473717782|FG001|Overall Study|Study specific withdrawal criteria|0|||
131571566|NCT02138916|473717783|FG002|Overall Study|Study specific withdrawal criteria|1|||
131571567|NCT02138916|473717781|FG000|Overall Study|incorrect enrolment|1|||
131571568|NCT02138916|473717782|FG001|Overall Study|incorrect enrolment|1|||
131571569|NCT02138916|473717783|FG002|Overall Study|incorrect enrolment|0|||
131571570|NCT02138916|473717781|FG000|Overall Study|Severe non-compliance|1|||
131571571|NCT02138916|473717782|FG001|Overall Study|Severe non-compliance|2|||
131571572|NCT02138916|473717783|FG002|Overall Study|Severe non-compliance|1|||
131571573|NCT02138916|473717781|FG000|Overall Study|Lost to Follow-up|4|||
131571574|NCT02138916|473717782|FG001|Overall Study|Lost to Follow-up|2|||
131571575|NCT02138916|473717783|FG002|Overall Study|Lost to Follow-up|3|||
131571576|NCT02138916|473717781|FG000|Overall Study|Adverse Event|4|||
131697699|NCT01358864|474175748|FG005|Overall Study|Other reason not defined above|0|||
131571577|NCT02138916|473717782|FG001|Overall Study|Adverse Event|4|||
131571578|NCT02138916|473717783|FG002|Overall Study|Adverse Event|3|||
131571579|NCT01348087|473717784|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
131571580|NCT01348087|473717784|FG000|Overall Study|Administrative problems|79|||
131571581|NCT01348087|473717784|FG000|Overall Study|protocol deviation|1|||
131571582|NCT01348087|473717784|FG000|Overall Study|Lost to Follow-up|1|||
131571583|NCT01348087|473717784|FG000|Overall Study|Subject withdrew consent|7|||
131571584|NCT01348087|473717784|FG000|Overall Study|Adverse Event|25|||
131571585|NCT00117988|473717787|FG000|Overall Study|Death|3|||
131571586|NCT00117988|473717787|FG000|Overall Study|Adverse Event|1|||
131571587|NCT04794179|473717788|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
131571588|NCT04794179|473717789|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
131571589|NCT03563053|473717792|FG000|Overall Study|Withdrawal by Subject|17|||
131571590|NCT03563053|473717792|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
131571591|NCT03563053|473717792|FG000|Overall Study|Adverse Event|3|||
131571592|NCT03563053|473717792|FG000|Overall Study|Physician Decision|1|||
131571593|NCT03563053|473717792|FG000|Overall Study|study terminated by sponsor|71|||
131571594|NCT01836458|473717793|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
131571595|NCT01836458|473717794|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131571596|NCT01836458|473717795|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
131571597|NCT01836458|473717796|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
131571598|NCT03677375|473717798|FG000|Overall Study|Incomplete procedure|8|||
131571599|NCT03677375|473717798|FG000|Overall Study|Adverse Event|3|||
131571600|NCT03677375|473717798|FG000|Overall Study|Physician Decision|1|||
131571601|NCT00561574|473717804|FG000|Overall Study|Adverse Event|21|||
131571602|NCT00561574|473717805|FG001|Overall Study|Adverse Event|24|||
131571603|NCT00561574|473717804|FG000|Overall Study|Lack of Efficacy|11|||
131571604|NCT00561574|473717805|FG001|Overall Study|Lack of Efficacy|21|||
131571605|NCT00561574|473717804|FG000|Overall Study|Withdrawal by Subject|4|||
131571606|NCT00561574|473717805|FG001|Overall Study|Withdrawal by Subject|4|||
131571607|NCT00561574|473717804|FG000|Overall Study|Reason Unrelated to Trial|6|||
131571608|NCT00561574|473717805|FG001|Overall Study|Reason Unrelated to Trial|2|||
131571609|NCT00561574|473717804|FG000|Overall Study|Lost to Follow-up|1|||
131571610|NCT00561574|473717805|FG001|Overall Study|Lost to Follow-up|0|||
131571611|NCT00561574|473717804|FG000|Overall Study|Other|5|||
131571612|NCT00561574|473717805|FG001|Overall Study|Other|7|||
131571613|NCT03971357|473717806|FG000|Overall Study|Lack of Efficacy|0|||
131571614|NCT03971357|473717807|FG001|Overall Study|Lack of Efficacy|1|||
131571615|NCT00445692|473717808|FG000|Overall Study|Adverse Event|11|||
131571616|NCT00445692|473717808|FG000|Overall Study|Lack of Efficacy|5|||
131571617|NCT00124982|473717813|FG000|Short-term Period|Death|1|||
131571618|NCT00124982|473717814|FG001|Short-term Period|Death|1|||
131571619|NCT00124982|473717815|FG002|Short-term Period|Death|0|||
131571620|NCT00124982|473717813|FG000|Short-term Period|Adverse Event|17|||
131571621|NCT00124982|473717814|FG001|Short-term Period|Adverse Event|22|||
131571622|NCT00124982|473717815|FG002|Short-term Period|Adverse Event|0|||
131571623|NCT00124982|473717813|FG000|Short-term Period|Lack of Efficacy|32|||
131571624|NCT00124982|473717814|FG001|Short-term Period|Lack of Efficacy|73|||
131571625|NCT00124982|473717815|FG002|Short-term Period|Lack of Efficacy|0|||
131571626|NCT00124982|473717813|FG000|Short-term Period|Lost to Follow-up|8|||
131571627|NCT00124982|473717814|FG001|Short-term Period|Lost to Follow-up|5|||
131571628|NCT00124982|473717815|FG002|Short-term Period|Lost to Follow-up|0|||
131571629|NCT00124982|473717813|FG000|Short-term Period|Withdrawal of Consent|7|||
131571630|NCT00124982|473717814|FG001|Short-term Period|Withdrawal of Consent|9|||
131571631|NCT00124982|473717815|FG002|Short-term Period|Withdrawal of Consent|0|||
131571632|NCT00124982|473717813|FG000|Short-term Period|Poor/Non-compliance|3|||
131571633|NCT00124982|473717814|FG001|Short-term Period|Poor/Non-compliance|1|||
131571634|NCT00124982|473717815|FG002|Short-term Period|Poor/Non-compliance|0|||
131571635|NCT00124982|473717813|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
131571636|NCT00124982|473717814|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
131571637|NCT00124982|473717815|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
131571638|NCT00124982|473717813|FG000|Short-term Period|Participant Decision|1|||
131571639|NCT00124982|473717814|FG001|Short-term Period|Participant Decision|0|||
131571640|NCT00124982|473717815|FG002|Short-term Period|Participant Decision|0|||
131571641|NCT00124982|473717813|FG000|Short-term Period|Participant Chose Own Doctor|0|||
131571642|NCT00124982|473717814|FG001|Short-term Period|Participant Chose Own Doctor|1|||
131571643|NCT00124982|473717815|FG002|Short-term Period|Participant Chose Own Doctor|0|||
131571644|NCT00124982|473717813|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
131571645|NCT00124982|473717814|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
131571646|NCT00124982|473717815|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
131571647|NCT00124982|473717813|FG000|Short-term Period|Participant Had Lymphopenia|1|||
131697700|NCT01358864|474175749|FG006|Overall Study|Other reason not defined above|2|||
131571648|NCT00124982|473717814|FG001|Short-term Period|Participant Had Lymphopenia|0|||
131571649|NCT00124982|473717815|FG002|Short-term Period|Participant Had Lymphopenia|0|||
131571650|NCT00124982|473717813|FG000|Long-term Period|Death|0|||
131571651|NCT00124982|473717814|FG001|Long-term Period|Death|0|||
131571652|NCT00124982|473717815|FG002|Long-term Period|Death|1|||
131571653|NCT00124982|473717813|FG000|Long-term Period|Adverse Event|0|||
131571654|NCT00124982|473717814|FG001|Long-term Period|Adverse Event|0|||
131571655|NCT00124982|473717815|FG002|Long-term Period|Adverse Event|17|||
131571656|NCT00124982|473717813|FG000|Long-term Period|Lack of Efficacy|0|||
131571657|NCT00124982|473717814|FG001|Long-term Period|Lack of Efficacy|0|||
131571658|NCT00124982|473717815|FG002|Long-term Period|Lack of Efficacy|46|||
131571659|NCT00124982|473717813|FG000|Long-term Period|Lost to Follow-up|0|||
131571660|NCT00124982|473717814|FG001|Long-term Period|Lost to Follow-up|0|||
131571661|NCT00124982|473717815|FG002|Long-term Period|Lost to Follow-up|4|||
131571662|NCT00124982|473717813|FG000|Long-term Period|Withdrawal by Subject|0|||
131571663|NCT00124982|473717814|FG001|Long-term Period|Withdrawal by Subject|0|||
131571664|NCT00124982|473717815|FG002|Long-term Period|Withdrawal by Subject|16|||
131571665|NCT00124982|473717813|FG000|Long-term Period|Pregnancy|0|||
131571666|NCT00124982|473717814|FG001|Long-term Period|Pregnancy|0|||
131571667|NCT00124982|473717815|FG002|Long-term Period|Pregnancy|1|||
131571668|NCT00124982|473717813|FG000|Long-term Period|Poor/Non-compliance|0|||
131571669|NCT00124982|473717814|FG001|Long-term Period|Poor/Non-compliance|0|||
131571670|NCT00124982|473717815|FG002|Long-term Period|Poor/Non-compliance|2|||
131571671|NCT00124982|473717813|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
131571672|NCT00124982|473717814|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
131571673|NCT00124982|473717815|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
131571674|NCT00124982|473717813|FG000|Long-term Period|Neurologist Recommendation|0|||
131571675|NCT00124982|473717814|FG001|Long-term Period|Neurologist Recommendation|0|||
131571676|NCT00124982|473717815|FG002|Long-term Period|Neurologist Recommendation|1|||
131571677|NCT00630864|473717816|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
131571678|NCT00630864|473717816|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
131571679|NCT01555762|473717819|FG000|Overall Study|No information on Bevacizumab intake|11|||
131571680|NCT01555762|473717819|FG000|Overall Study|Missing start date of infusion|8|||
131571681|NCT01555762|473717819|FG000|Overall Study|75 years old or more ticked No|1|||
131571682|NCT01555762|473717819|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
131571683|NCT01555762|473717819|FG000|Overall Study|Death linked to progression of disease|165|||
131571684|NCT01555762|473717819|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
131571685|NCT01555762|473717819|FG000|Overall Study|Investigator's decision|10|||
131571686|NCT01555762|473717819|FG000|Overall Study|Participant not wishing to continue|5|||
131571687|NCT01555762|473717819|FG000|Overall Study|Missing data|1|||
131571688|NCT01555762|473717819|FG000|Overall Study|Death linked to an adverse event|14|||
131571689|NCT01333514|473717820|FG000|Overall Study|Withdrawal by Subject|1|||
131571690|NCT01333514|473717821|FG001|Overall Study|Withdrawal by Subject|0|||
131571691|NCT00836810|473717822|FG000|Overall Study|New diagnosis|1|||
131571692|NCT00836810|473717823|FG001|Overall Study|New diagnosis|0|||
131571693|NCT02040844|473717830|FG000|Overall Study|Adverse Event|0|||
131571694|NCT02040844|473717831|FG001|Overall Study|Adverse Event|0|||
131571695|NCT02040844|473717832|FG002|Overall Study|Adverse Event|1|||
131571696|NCT02040844|473717830|FG000|Overall Study|Withdrawal by Subject|16|||
131571697|NCT02040844|473717831|FG001|Overall Study|Withdrawal by Subject|22|||
131571698|NCT02040844|473717832|FG002|Overall Study|Withdrawal by Subject|25|||
131571699|NCT02040844|473717830|FG000|Overall Study|Lost to Follow-up|12|||
131571700|NCT02040844|473717831|FG001|Overall Study|Lost to Follow-up|9|||
131571701|NCT02040844|473717832|FG002|Overall Study|Lost to Follow-up|13|||
131571702|NCT02040844|473717830|FG000|Overall Study|Missing|13|||
131571703|NCT02040844|473717831|FG001|Overall Study|Missing|3|||
131571704|NCT02040844|473717832|FG002|Overall Study|Missing|2|||
131571705|NCT02040844|473717830|FG000|Overall Study|Non-specified|8|||
131571706|NCT02040844|473717831|FG001|Overall Study|Non-specified|2|||
131571707|NCT02040844|473717832|FG002|Overall Study|Non-specified|5|||
131571708|NCT02040844|473717830|FG000|Overall Study|Concomitant medication|1|||
131571709|NCT02040844|473717831|FG001|Overall Study|Concomitant medication|3|||
131571710|NCT02040844|473717832|FG002|Overall Study|Concomitant medication|1|||
131571711|NCT01080131|473717833|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
131571712|NCT01080131|473717834|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
131571713|NCT01080131|473717833|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
131571714|NCT01080131|473717834|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
131571715|NCT01080131|473717833|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
131571716|NCT01080131|473717834|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
131571717|NCT01080131|473717833|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
131571718|NCT01080131|473717834|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
131571719|NCT01080131|473717833|FG000|Core Study (0- 12 Weeks)|Death|1|||
131571720|NCT01080131|473717834|FG001|Core Study (0- 12 Weeks)|Death|0|||
131571721|NCT01080131|473717833|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
131571722|NCT01080131|473717834|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
131571723|NCT01080131|473717833|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
131571724|NCT01080131|473717834|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
131571725|NCT01080131|473717833|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
131571726|NCT01080131|473717834|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
131571727|NCT01080131|473717833|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
131571728|NCT01080131|473717834|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
131571729|NCT01080131|473717833|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
131571730|NCT01080131|473717834|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
131571731|NCT01080131|473717833|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
131571732|NCT01080131|473717834|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
131571733|NCT01080131|473717833|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
131571734|NCT01080131|473717834|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
131571735|NCT01080131|473717833|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
131571736|NCT01080131|473717834|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
131571737|NCT01560949|473717837|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
131571738|NCT01560949|473717837|FG000|Surgery Phase|Physician Decision|3|||
131571739|NCT01562743|473717840|FG000|Overall Study|Adverse Event|29|||
131571740|NCT01562743|473717840|FG000|Overall Study|Lack of Efficacy|3|||
131571741|NCT01562743|473717840|FG000|Overall Study|Withdrawal by Subject|13|||
131571742|NCT01562743|473717840|FG000|Overall Study|Protocol Violation|1|||
131571743|NCT01562743|473717840|FG000|Overall Study|Discontinuation criteria|2|||
131571744|NCT01562743|473717840|FG000|Overall Study|Lost to Follow-up|2|||
131571745|NCT01562743|473717840|FG000|Overall Study|Physician Decision|2|||
131571746|NCT01456780|473719834|FG000|Overall Study|Lost to Follow-up|3|||
131571747|NCT01456780|473719835|FG001|Overall Study|Lost to Follow-up|3|||
131571748|NCT01456780|473719836|FG002|Overall Study|Lost to Follow-up|0|||
131571749|NCT05349864|473719837|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
131571750|NCT05349864|473719838|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
131571751|NCT00984282|473719839|FG000|Double Blind Treatment|Adverse Event|40|||
131571752|NCT00984282|473719840|FG001|Double Blind Treatment|Adverse Event|6|||
131571753|NCT00984282|473719839|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
131571754|NCT00984282|473719840|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
131571755|NCT00984282|473719839|FG000|Double Blind Treatment|Physician Decision|1|||
131571756|NCT00984282|473719840|FG001|Double Blind Treatment|Physician Decision|2|||
131571757|NCT00984282|473719839|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
131571758|NCT00984282|473719840|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
131571759|NCT00984282|473719839|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
131571760|NCT00984282|473719840|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
131571761|NCT00984282|473719839|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
131571762|NCT00984282|473719840|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
131571763|NCT00984282|473719839|FG000|Double Blind Treatment|Lost to Follow-up|3|||
131571764|NCT00984282|473719840|FG001|Double Blind Treatment|Lost to Follow-up|0|||
131571765|NCT00984282|473719839|FG000|Double Blind Treatment|Death|8|||
131571766|NCT00984282|473719840|FG001|Double Blind Treatment|Death|4|||
131571767|NCT00984282|473719839|FG000|Double Blind Treatment|Not treated|0|||
131571768|NCT00984282|473719840|FG001|Double Blind Treatment|Not treated|1|||
131571769|NCT00984282|473719839|FG000|Double Blind Treatment|Switched to commercial drug|6|||
131571770|NCT00984282|473719840|FG001|Double Blind Treatment|Switched to commercial drug|1|||
131571771|NCT00984282|473719839|FG000|Double Blind Treatment|protocol driven decision point|1|||
131571772|NCT00984282|473719840|FG001|Double Blind Treatment|protocol driven decision point|1|||
131571773|NCT00984282|473719839|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
131571774|NCT00984282|473719840|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
131571775|NCT00984282|473719839|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
131571776|NCT00984282|473719840|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
131571777|NCT00984282|473719839|FG000|Open-label Treatment|Adverse Event|20|||
131571778|NCT00984282|473719840|FG001|Open-label Treatment|Adverse Event|30|||
131571779|NCT00984282|473719839|FG000|Open-label Treatment|Withdrawal by Subject|6|||
131571780|NCT00984282|473719840|FG001|Open-label Treatment|Withdrawal by Subject|21|||
131571781|NCT00984282|473719839|FG000|Open-label Treatment|Death|7|||
131571782|NCT00984282|473719840|FG001|Open-label Treatment|Death|15|||
131571783|NCT00984282|473719839|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
131571784|NCT00984282|473719840|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
131571785|NCT00984282|473719839|FG000|Open-label Treatment|Lost to Follow-up|1|||
131571786|NCT00984282|473719840|FG001|Open-label Treatment|Lost to Follow-up|1|||
131783908|NCT04682639|474491737|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
131783909|NCT04682639|474491738|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131571787|NCT00984282|473719839|FG000|Open-label Treatment|Patient convenience|1|||
131571788|NCT00984282|473719840|FG001|Open-label Treatment|Patient convenience|0|||
131571789|NCT00984282|473719839|FG000|Open-label Treatment|Non-compliant with study medication|1|||
131571790|NCT00984282|473719840|FG001|Open-label Treatment|Non-compliant with study medication|0|||
131571791|NCT00984282|473719839|FG000|Open-label Treatment|Target lesion removed|0|||
131571792|NCT00984282|473719840|FG001|Open-label Treatment|Target lesion removed|1|||
131571793|NCT00984282|473719839|FG000|Open-label Treatment|Protocol driven decision point|1|||
131571794|NCT00984282|473719840|FG001|Open-label Treatment|Protocol driven decision point|1|||
131571795|NCT00984282|473719839|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
131571796|NCT00984282|473719840|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
131571797|NCT00984282|473719839|FG000|Open-label Treatment|Switched to commercial drug|6|||
131571798|NCT00984282|473719840|FG001|Open-label Treatment|Switched to commercial drug|7|||
131571799|NCT00984282|473719839|FG000|Open-label Treatment|Physician Decision|1|||
131571800|NCT00984282|473719840|FG001|Open-label Treatment|Physician Decision|0|||
131437840|NCT03649074|473228166|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
131571801|NCT00984282|473719839|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
131571802|NCT00984282|473719840|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
131571803|NCT00984282|473719839|FG000|Long Term Follow-up|Death|27|||
131571804|NCT00984282|473719840|FG001|Long Term Follow-up|Death|68|||
131571805|NCT00984282|473719839|FG000|Long Term Follow-up|Lost to Follow-up|3|||
131571806|NCT00984282|473719840|FG001|Long Term Follow-up|Lost to Follow-up|6|||
131571807|NCT00984282|473719839|FG000|Long Term Follow-up|Protocol driven decision point|25|||
131571808|NCT00984282|473719840|FG001|Long Term Follow-up|Protocol driven decision point|26|||
131571809|NCT00984282|473719839|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
131571810|NCT00984282|473719840|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
131571811|NCT00984282|473719839|FG000|Long Term Follow-up|Switched to commercial drug|4|||
131571812|NCT00984282|473719840|FG001|Long Term Follow-up|Switched to commercial drug|2|||
131571813|NCT00984282|473719839|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
131571814|NCT00984282|473719840|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
131571815|NCT02223793|473719841|FG000|Overall Study|Lost to Follow-up|10|||
131437841|NCT03649074|473228165|FG000|Overall Study|Other|1|||
131437842|NCT03649074|473228166|FG001|Overall Study|Other|0|||
131437843|NCT00556894|473228167|FG000|Overall Study|Adverse Event|2|||
131571816|NCT02223793|473719842|FG001|Overall Study|Lost to Follow-up|1|||
131571817|NCT02223793|473719843|FG002|Overall Study|Lost to Follow-up|2|||
131571818|NCT02223793|473719841|FG000|Overall Study|Withdrawal by Subject|3|||
131571819|NCT02223793|473719842|FG001|Overall Study|Withdrawal by Subject|2|||
131571820|NCT02223793|473719843|FG002|Overall Study|Withdrawal by Subject|3|||
131571821|NCT02223793|473719841|FG000|Overall Study|Moved/studycenter unable to participate|4|||
131571822|NCT02223793|473719842|FG001|Overall Study|Moved/studycenter unable to participate|6|||
131571823|NCT02223793|473719843|FG002|Overall Study|Moved/studycenter unable to participate|8|||
131571824|NCT00315055|473719844|FG000|Overall Study|Protocol Violation|2|||
131571825|NCT00315055|473719845|FG001|Overall Study|Protocol Violation|4|||
131571826|NCT00315055|473719844|FG000|Overall Study|Lost to Follow-up|1|||
131571827|NCT00315055|473719845|FG001|Overall Study|Lost to Follow-up|1|||
131571828|NCT01289119|473719846|FG000|Overall Study|Adverse Event|2|||
131571829|NCT01289119|473719847|FG001|Overall Study|Adverse Event|1|||
131571830|NCT01289119|473719848|FG002|Overall Study|Adverse Event|0|||
131571831|NCT01289119|473719849|FG003|Overall Study|Adverse Event|2|||
131571832|NCT01289119|473719850|FG004|Overall Study|Adverse Event|1|||
131571833|NCT01289119|473719851|FG005|Overall Study|Adverse Event|0|||
131571834|NCT01289119|473719846|FG000|Overall Study|Major Protocol Deviation|2|||
131571835|NCT01289119|473719847|FG001|Overall Study|Major Protocol Deviation|1|||
131571836|NCT01289119|473719848|FG002|Overall Study|Major Protocol Deviation|3|||
131571837|NCT01289119|473719849|FG003|Overall Study|Major Protocol Deviation|0|||
131571838|NCT01289119|473719850|FG004|Overall Study|Major Protocol Deviation|2|||
131571839|NCT01289119|473719851|FG005|Overall Study|Major Protocol Deviation|1|||
131571840|NCT01289119|473719846|FG000|Overall Study|Lost to Follow-up|0|||
131571841|NCT01289119|473719847|FG001|Overall Study|Lost to Follow-up|3|||
131571842|NCT01289119|473719848|FG002|Overall Study|Lost to Follow-up|0|||
131571843|NCT01289119|473719849|FG003|Overall Study|Lost to Follow-up|0|||
131571844|NCT01289119|473719850|FG004|Overall Study|Lost to Follow-up|0|||
131571845|NCT01289119|473719851|FG005|Overall Study|Lost to Follow-up|1|||
131571846|NCT01289119|473719846|FG000|Overall Study|Withdrawal by Subject|4|||
131571847|NCT01289119|473719847|FG001|Overall Study|Withdrawal by Subject|2|||
131571848|NCT01289119|473719848|FG002|Overall Study|Withdrawal by Subject|4|||
131571849|NCT01289119|473719849|FG003|Overall Study|Withdrawal by Subject|3|||
131571850|NCT01289119|473719850|FG004|Overall Study|Withdrawal by Subject|1|||
131571851|NCT01289119|473719851|FG005|Overall Study|Withdrawal by Subject|1|||
131697701|NCT01358864|474175750|FG007|Overall Study|Other reason not defined above|0|||
131697702|NCT01358864|474175743|FG000|Overall Study|Not treated|0|||
131697703|NCT01358864|474175744|FG001|Overall Study|Not treated|0|||
131697704|NCT01358864|474175745|FG002|Overall Study|Not treated|0|||
131697705|NCT01358864|474175746|FG003|Overall Study|Not treated|0|||
131697706|NCT01358864|474175747|FG004|Overall Study|Not treated|0|||
131697707|NCT01358864|474175748|FG005|Overall Study|Not treated|0|||
131697708|NCT01358864|474175749|FG006|Overall Study|Not treated|1|||
131697709|NCT01358864|474175750|FG007|Overall Study|Not treated|0|||
131437844|NCT00556894|473228168|FG001|Overall Study|Adverse Event|3|||
131697710|NCT04209855|474175756|FG000|Overall Study|Death|161|||
131697711|NCT04209855|474175757|FG001|Overall Study|Death|177|||
131697712|NCT04209855|474175756|FG000|Overall Study|PI Discretion|1|||
131571852|NCT01289119|473719846|FG000|Overall Study|Pregnancy|0|||
131571853|NCT01289119|473719847|FG001|Overall Study|Pregnancy|1|||
131571854|NCT01289119|473719848|FG002|Overall Study|Pregnancy|0|||
131571855|NCT01289119|473719849|FG003|Overall Study|Pregnancy|0|||
131571856|NCT01289119|473719850|FG004|Overall Study|Pregnancy|0|||
131571857|NCT01289119|473719851|FG005|Overall Study|Pregnancy|0|||
131697713|NCT04209855|474175757|FG001|Overall Study|PI Discretion|1|||
131697714|NCT04209855|474175756|FG000|Overall Study|Lost to Follow-up|5|||
131697715|NCT04209855|474175757|FG001|Overall Study|Lost to Follow-up|2|||
131697716|NCT04209855|474175756|FG000|Overall Study|Withdrew consent|10|||
131697717|NCT04209855|474175757|FG001|Overall Study|Withdrew consent|24|||
131571858|NCT01289119|473719846|FG000|Overall Study|Lack of Efficacy|0|||
131571859|NCT01289119|473719847|FG001|Overall Study|Lack of Efficacy|1|||
131571860|NCT01289119|473719848|FG002|Overall Study|Lack of Efficacy|1|||
131571861|NCT01289119|473719849|FG003|Overall Study|Lack of Efficacy|1|||
131571862|NCT01289119|473719850|FG004|Overall Study|Lack of Efficacy|1|||
131571863|NCT01289119|473719851|FG005|Overall Study|Lack of Efficacy|1|||
131571864|NCT01289119|473719846|FG000|Overall Study|Other|1|||
131571865|NCT01289119|473719847|FG001|Overall Study|Other|0|||
131571866|NCT01289119|473719848|FG002|Overall Study|Other|1|||
131571867|NCT01289119|473719849|FG003|Overall Study|Other|0|||
131571868|NCT01289119|473719850|FG004|Overall Study|Other|0|||
131571869|NCT01289119|473719851|FG005|Overall Study|Other|0|||
131571870|NCT01704846|473719852|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131571871|NCT01704846|473719853|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131571872|NCT04577183|473719854|FG000|Overall Study|Death|1|||
131571873|NCT04577183|473719854|FG000|Overall Study|Withdrawal by Subject|3|||
131571874|NCT04577183|473719854|FG000|Overall Study|Early termination|2|||
131571875|NCT01168401|473719858|FG000|Overall Study|Lost to Follow-up|1|||
131571876|NCT01168401|473719859|FG001|Overall Study|Lost to Follow-up|1|||
131571877|NCT01168401|473719860|FG002|Overall Study|Lost to Follow-up|2|||
131571878|NCT01168401|473719861|FG003|Overall Study|Lost to Follow-up|1|||
131571879|NCT01168401|473719862|FG004|Overall Study|Lost to Follow-up|0|||
131571880|NCT01168401|473719863|FG005|Overall Study|Lost to Follow-up|0|||
131571881|NCT01168401|473719864|FG006|Overall Study|Lost to Follow-up|0|||
131571882|NCT01168401|473719865|FG007|Overall Study|Lost to Follow-up|0|||
131571883|NCT01168401|473719866|FG008|Overall Study|Lost to Follow-up|0|||
131571884|NCT01168401|473719867|FG009|Overall Study|Lost to Follow-up|0|||
131571885|NCT01168401|473719868|FG010|Overall Study|Lost to Follow-up|0|||
131571886|NCT01168401|473719858|FG000|Overall Study|Withdrawal by Subject|0|||
131571887|NCT01168401|473719859|FG001|Overall Study|Withdrawal by Subject|0|||
131571888|NCT01168401|473719860|FG002|Overall Study|Withdrawal by Subject|0|||
131571889|NCT01168401|473719861|FG003|Overall Study|Withdrawal by Subject|1|||
131571890|NCT01168401|473719862|FG004|Overall Study|Withdrawal by Subject|0|||
131571891|NCT01168401|473719863|FG005|Overall Study|Withdrawal by Subject|0|||
131571892|NCT01168401|473719864|FG006|Overall Study|Withdrawal by Subject|0|||
131571893|NCT01168401|473719865|FG007|Overall Study|Withdrawal by Subject|0|||
131571894|NCT01168401|473719866|FG008|Overall Study|Withdrawal by Subject|0|||
131571895|NCT01168401|473719867|FG009|Overall Study|Withdrawal by Subject|0|||
131571896|NCT01168401|473719868|FG010|Overall Study|Withdrawal by Subject|0|||
131571897|NCT00672256|473719870|FG000|Overall Study|PI dropped, bad data|44|||
131571898|NCT00991276|473719881|FG000|First Intervention Period|Adverse Event|0|||
131571899|NCT00991276|473719882|FG001|First Intervention Period|Adverse Event|1|||
131697718|NCT04209855|474175756|FG000|Overall Study|Sponsor decision|44|||
131697719|NCT04209855|474175757|FG001|Overall Study|Sponsor decision|18|||
131697720|NCT04209855|474175756|FG000|Overall Study|Other than specified|6|||
131697721|NCT04209855|474175757|FG001|Overall Study|Other than specified|4|||
131697722|NCT04153188|474175760|FG000|Overall Study|Lost to Follow-up|1|||
131697723|NCT04153188|474175761|FG001|Overall Study|Lost to Follow-up|1|||
131697724|NCT04153188|474175760|FG000|Overall Study|Withdrawal by Subject|2|||
131697725|NCT04153188|474175761|FG001|Overall Study|Withdrawal by Subject|0|||
131571900|NCT00991276|473719883|FG002|First Intervention Period|Adverse Event|0|||
131571901|NCT00991276|473719884|FG003|First Intervention Period|Adverse Event|1|||
131571902|NCT00991276|473719885|FG004|First Intervention Period|Adverse Event|0|||
131571903|NCT00991276|473719886|FG005|First Intervention Period|Adverse Event|0|||
131571904|NCT00991276|473719881|FG000|First Intervention Period|Protocol Violation|0|||
131571905|NCT00991276|473719882|FG001|First Intervention Period|Protocol Violation|0|||
131571906|NCT00991276|473719883|FG002|First Intervention Period|Protocol Violation|0|||
131437845|NCT00556894|473228169|FG002|Overall Study|Adverse Event|3|||
131437846|NCT00556894|473228167|FG000|Overall Study|Death|1|||
131571907|NCT00991276|473719884|FG003|First Intervention Period|Protocol Violation|0|||
131571908|NCT00991276|473719885|FG004|First Intervention Period|Protocol Violation|2|||
131571909|NCT00991276|473719886|FG005|First Intervention Period|Protocol Violation|0|||
131571910|NCT00991276|473719881|FG000|First Intervention Period|Insufficient clinical response|0|||
131571911|NCT00991276|473719882|FG001|First Intervention Period|Insufficient clinical response|0|||
131697726|NCT04153188|474175760|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
131571912|NCT00991276|473719883|FG002|First Intervention Period|Insufficient clinical response|0|||
131571913|NCT00991276|473719884|FG003|First Intervention Period|Insufficient clinical response|0|||
131571914|NCT00991276|473719885|FG004|First Intervention Period|Insufficient clinical response|1|||
131571915|NCT00991276|473719886|FG005|First Intervention Period|Insufficient clinical response|0|||
131571916|NCT00991276|473719881|FG000|First Intervention Period|Other|0|||
131571917|NCT00991276|473719882|FG001|First Intervention Period|Other|0|||
131571918|NCT00991276|473719883|FG002|First Intervention Period|Other|0|||
131571919|NCT00991276|473719884|FG003|First Intervention Period|Other|1|||
131571920|NCT00991276|473719885|FG004|First Intervention Period|Other|1|||
131571921|NCT00991276|473719886|FG005|First Intervention Period|Other|0|||
131571922|NCT00991276|473719881|FG000|First Intervention Period|Withdrawal by Subject|0|||
131571923|NCT00991276|473719882|FG001|First Intervention Period|Withdrawal by Subject|1|||
131571924|NCT00991276|473719883|FG002|First Intervention Period|Withdrawal by Subject|0|||
131571925|NCT00991276|473719884|FG003|First Intervention Period|Withdrawal by Subject|1|||
131571926|NCT00991276|473719885|FG004|First Intervention Period|Withdrawal by Subject|0|||
131571927|NCT00991276|473719886|FG005|First Intervention Period|Withdrawal by Subject|1|||
131571928|NCT00991276|473719881|FG000|First Intervention Period|Lost to Follow-up|0|||
131571929|NCT00991276|473719882|FG001|First Intervention Period|Lost to Follow-up|1|||
131571930|NCT00991276|473719883|FG002|First Intervention Period|Lost to Follow-up|0|||
131571931|NCT00991276|473719884|FG003|First Intervention Period|Lost to Follow-up|1|||
131571932|NCT00991276|473719885|FG004|First Intervention Period|Lost to Follow-up|0|||
131571933|NCT00991276|473719886|FG005|First Intervention Period|Lost to Follow-up|0|||
131571934|NCT00991276|473719881|FG000|Second Intervention Period|Adverse Event|0|||
131571935|NCT00991276|473719882|FG001|Second Intervention Period|Adverse Event|2|||
131571936|NCT00991276|473719883|FG002|Second Intervention Period|Adverse Event|0|||
131571937|NCT00991276|473719884|FG003|Second Intervention Period|Adverse Event|1|||
131571938|NCT00991276|473719885|FG004|Second Intervention Period|Adverse Event|1|||
131571939|NCT00991276|473719886|FG005|Second Intervention Period|Adverse Event|0|||
131571940|NCT00991276|473719881|FG000|Second Intervention Period|Protocol Violation|1|||
131571941|NCT00991276|473719882|FG001|Second Intervention Period|Protocol Violation|0|||
131571942|NCT00991276|473719883|FG002|Second Intervention Period|Protocol Violation|0|||
131571943|NCT00991276|473719884|FG003|Second Intervention Period|Protocol Violation|0|||
131571944|NCT00991276|473719885|FG004|Second Intervention Period|Protocol Violation|0|||
131571945|NCT00991276|473719886|FG005|Second Intervention Period|Protocol Violation|0|||
131571946|NCT00991276|473719881|FG000|Second Intervention Period|Other|0|||
131571947|NCT00991276|473719882|FG001|Second Intervention Period|Other|0|||
131571948|NCT00991276|473719883|FG002|Second Intervention Period|Other|0|||
131571949|NCT00991276|473719884|FG003|Second Intervention Period|Other|1|||
131571950|NCT00991276|473719885|FG004|Second Intervention Period|Other|0|||
131571951|NCT00991276|473719886|FG005|Second Intervention Period|Other|1|||
131571952|NCT00991276|473719881|FG000|Third Intervention Period|Protocol Violation|1|||
131571953|NCT00991276|473719882|FG001|Third Intervention Period|Protocol Violation|0|||
131571954|NCT00991276|473719883|FG002|Third Intervention Period|Protocol Violation|0|||
131571955|NCT00991276|473719884|FG003|Third Intervention Period|Protocol Violation|0|||
131571956|NCT00991276|473719885|FG004|Third Intervention Period|Protocol Violation|0|||
131571957|NCT00991276|473719886|FG005|Third Intervention Period|Protocol Violation|0|||
131571958|NCT00991276|473719881|FG000|Third Intervention Period|Other|0|||
131571959|NCT00991276|473719882|FG001|Third Intervention Period|Other|0|||
131571960|NCT00991276|473719883|FG002|Third Intervention Period|Other|0|||
131571961|NCT00991276|473719884|FG003|Third Intervention Period|Other|0|||
131697727|NCT04153188|474175761|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
131697728|NCT00264238|474175762|FG000|Overall Study|Protocol Violation|1|||
131697729|NCT04899232|474175763|FG000|Screening Period|Physician Decision|1|||
131697730|NCT04899232|474175764|FG001|Screening Period|Physician Decision|0|||
131571962|NCT00991276|473719885|FG004|Third Intervention Period|Other|0|||
131571963|NCT00991276|473719886|FG005|Third Intervention Period|Other|1|||
131571964|NCT00991276|473719881|FG000|Third Intervention Period|Adverse Event|0|||
131571965|NCT00991276|473719882|FG001|Third Intervention Period|Adverse Event|0|||
131571966|NCT00991276|473719883|FG002|Third Intervention Period|Adverse Event|1|||
131571967|NCT00991276|473719884|FG003|Third Intervention Period|Adverse Event|0|||
131571968|NCT00991276|473719885|FG004|Third Intervention Period|Adverse Event|0|||
131697731|NCT04899232|474175765|FG002|Screening Period|Physician Decision|0|||
131571969|NCT00991276|473719886|FG005|Third Intervention Period|Adverse Event|0|||
131697732|NCT04899232|474175763|FG000|Screening Period|Withdrawal by Subject|1|||
131697733|NCT04899232|474175764|FG001|Screening Period|Withdrawal by Subject|0|||
131898662|NCT01516736|474915332|FG001|Overall Study|Other (not specified)|1|||
131571970|NCT00991276|473719881|FG000|Third Intervention Period|Withdrawal by Subject|0|||
131571971|NCT00991276|473719882|FG001|Third Intervention Period|Withdrawal by Subject|0|||
131571972|NCT00991276|473719883|FG002|Third Intervention Period|Withdrawal by Subject|0|||
131571973|NCT00991276|473719884|FG003|Third Intervention Period|Withdrawal by Subject|1|||
131571974|NCT00991276|473719885|FG004|Third Intervention Period|Withdrawal by Subject|0|||
131571975|NCT00991276|473719886|FG005|Third Intervention Period|Withdrawal by Subject|0|||
131571976|NCT01268891|473719887|FG000|Overall Study|Adverse Event|3|||
131571977|NCT01268891|473719888|FG001|Overall Study|Adverse Event|7|||
131571978|NCT01268891|473719887|FG000|Overall Study|Lack of Efficacy|1|||
131571979|NCT01268891|473719888|FG001|Overall Study|Lack of Efficacy|0|||
131571980|NCT01268891|473719887|FG000|Overall Study|Withdrawal of Consent|3|||
131571981|NCT01268891|473719888|FG001|Overall Study|Withdrawal of Consent|1|||
131571982|NCT01268891|473719887|FG000|Overall Study|Administrative or other reason(s)|1|||
131571983|NCT01268891|473719888|FG001|Overall Study|Administrative or other reason(s)|0|||
131571984|NCT01720043|473719890|FG000|Overall Study|Withdrawal by Subject|1|||
131571985|NCT01688973|473719891|FG000|Overall Study|Ineligible|2|||
131571986|NCT01688973|473719892|FG001|Overall Study|Ineligible|3|||
131571987|NCT00938340|473719894|FG000|Overall Study|Withdrawal by Subject|3|||
131571988|NCT00938340|473719894|FG000|Overall Study|Protocol Violation|1|||
131571989|NCT00938340|473719894|FG000|Overall Study|Adverse Event|1|||
131571990|NCT00269399|473719895|FG000|Overall Study|Lack of Efficacy|27|||
131571991|NCT00269399|473719896|FG001|Overall Study|Lack of Efficacy|10|||
131571992|NCT00269399|473719895|FG000|Overall Study|Adverse Event|10|||
131571993|NCT00269399|473719896|FG001|Overall Study|Adverse Event|4|||
131571994|NCT00269399|473719895|FG000|Overall Study|Withdrawal by Subject|2|||
131571995|NCT00269399|473719896|FG001|Overall Study|Withdrawal by Subject|5|||
131571996|NCT00269399|473719895|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
131571997|NCT00269399|473719896|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
131571998|NCT00269399|473719895|FG000|Overall Study|Other|0|||
131571999|NCT00269399|473719896|FG001|Overall Study|Other|4|||
131572000|NCT00269399|473719895|FG000|Overall Study|Development of exclusion criteria|0|||
131572001|NCT00269399|473719896|FG001|Overall Study|Development of exclusion criteria|1|||
131572002|NCT03441360|473719897|FG000|Overall Study|Radiological disease progression|5|||
131572003|NCT03441360|473719898|FG001|Overall Study|Radiological disease progression|6|||
131572004|NCT03441360|473719899|FG002|Overall Study|Radiological disease progression|4|||
131572005|NCT03441360|473719897|FG000|Overall Study|Clinical disease progression|2|||
131572006|NCT03441360|473719898|FG001|Overall Study|Clinical disease progression|2|||
131572007|NCT03441360|473719899|FG002|Overall Study|Clinical disease progression|0|||
131572008|NCT03441360|473719897|FG000|Overall Study|Adverse Event|1|||
131572009|NCT03441360|473719898|FG001|Overall Study|Adverse Event|0|||
131572010|NCT03441360|473719899|FG002|Overall Study|Adverse Event|1|||
131572011|NCT03396835|473719900|FG000|Overall Study|Withdrawn prior to completion|1|||
131572012|NCT03396835|473719900|FG000|Overall Study|Did not meet criteria for data analysis|1|||
131572013|NCT03467724|473719907|FG000|Overall Study|Lost to Follow-up|5|||
131572014|NCT03467724|473719907|FG000|Overall Study|Withdrawal by Subject|1|||
131572015|NCT03467724|473719907|FG000|Overall Study|Protocol Violation|1|||
131572016|NCT03467724|473719907|FG000|Overall Study|Adverse Event|1|||
131572017|NCT02236559|473719911|FG000|Overall Study|Met Exclusion|3|||
131572018|NCT02236559|473719912|FG001|Overall Study|Met Exclusion|6|||
131572019|NCT02236559|473719911|FG000|Overall Study|Did not Meet Inclusion|3|||
131572020|NCT02236559|473719912|FG001|Overall Study|Did not Meet Inclusion|3|||
131572021|NCT02236559|473719911|FG000|Overall Study|Subject Did Not Consent|4|||
131572022|NCT02236559|473719912|FG001|Overall Study|Subject Did Not Consent|2|||
131572023|NCT02236559|473719911|FG000|Overall Study|Physician Decision|1|||
131572024|NCT02236559|473719912|FG001|Overall Study|Physician Decision|1|||
131572025|NCT02236559|473719911|FG000|Overall Study|Withdrawal by Subject|1|||
131572026|NCT02236559|473719912|FG001|Overall Study|Withdrawal by Subject|0|||
131572027|NCT01149681|473719913|FG000|Overall Study|Withdrawal by Subject|7|||
131572028|NCT01149681|473719913|FG000|Overall Study|Progressive disease|1|||
131572029|NCT01149681|473719913|FG000|Overall Study|Physician Decision|2|||
131572030|NCT01149681|473719913|FG000|Overall Study|adverse events nonrelated study drug|2|||
131572031|NCT00335556|473719916|FG000|Overall Study|Death|0|||
131572032|NCT00335556|473719917|FG001|Overall Study|Death|5|||
131572033|NCT00335556|473719918|FG002|Overall Study|Death|0|||
131572034|NCT00335556|473719919|FG003|Overall Study|Death|0|||
131572035|NCT00335556|473719920|FG004|Overall Study|Death|1|||
131572036|NCT00335556|473719921|FG005|Overall Study|Death|0|||
131572037|NCT00335556|473719916|FG000|Overall Study|Lack of Efficacy|0|||
131572038|NCT00335556|473719917|FG001|Overall Study|Lack of Efficacy|19|||
131572039|NCT00335556|473719918|FG002|Overall Study|Lack of Efficacy|3|||
131572040|NCT00335556|473719919|FG003|Overall Study|Lack of Efficacy|3|||
131572041|NCT00335556|473719920|FG004|Overall Study|Lack of Efficacy|0|||
131572042|NCT00335556|473719921|FG005|Overall Study|Lack of Efficacy|1|||
131572043|NCT00335556|473719916|FG000|Overall Study|Physician Decision|0|||
131572044|NCT00335556|473719917|FG001|Overall Study|Physician Decision|6|||
131572045|NCT00335556|473719918|FG002|Overall Study|Physician Decision|2|||
131572046|NCT00335556|473719919|FG003|Overall Study|Physician Decision|1|||
131572047|NCT00335556|473719920|FG004|Overall Study|Physician Decision|0|||
131572048|NCT00335556|473719921|FG005|Overall Study|Physician Decision|0|||
131572049|NCT00335556|473719916|FG000|Overall Study|Ineligible|2|||
131572050|NCT00335556|473719917|FG001|Overall Study|Ineligible|0|||
131572051|NCT00335556|473719918|FG002|Overall Study|Ineligible|0|||
131572052|NCT00335556|473719919|FG003|Overall Study|Ineligible|0|||
131572053|NCT00335556|473719920|FG004|Overall Study|Ineligible|0|||
131572054|NCT00335556|473719921|FG005|Overall Study|Ineligible|0|||
131572055|NCT00335556|473719916|FG000|Overall Study|Refusal of further protocol therapy|0|||
131572056|NCT00335556|473719917|FG001|Overall Study|Refusal of further protocol therapy|4|||
131572057|NCT00335556|473719918|FG002|Overall Study|Refusal of further protocol therapy|0|||
131572058|NCT00335556|473719919|FG003|Overall Study|Refusal of further protocol therapy|1|||
131572059|NCT00335556|473719920|FG004|Overall Study|Refusal of further protocol therapy|0|||
131572060|NCT00335556|473719921|FG005|Overall Study|Refusal of further protocol therapy|0|||
131572061|NCT04555044|473719928|FG000|Overall Study|Adverse Event|0|||
131572062|NCT04555044|473719929|FG001|Overall Study|Adverse Event|1|||
131572063|NCT04088188|473719931|FG000|Overall Study|Withdrawal by Subject|2|||
131572064|NCT04088188|473719932|FG001|Overall Study|Withdrawal by Subject|0|||
131572065|NCT04088188|473719931|FG000|Overall Study|Adverse Event|2|||
131572066|NCT04088188|473719932|FG001|Overall Study|Adverse Event|0|||
131572067|NCT03601507|473719935|FG000|Overall Study|Adverse Event|1|||
131572068|NCT02107014|473719938|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
131572069|NCT03761784|473719939|FG000|Overall Study|Adverse Event|4|||
131572070|NCT03761784|473719940|FG001|Overall Study|Adverse Event|0|||
131572071|NCT03761784|473719939|FG000|Overall Study|Lost to Follow-up|10|||
131572072|NCT03761784|473719940|FG001|Overall Study|Lost to Follow-up|7|||
131572073|NCT03761784|473719939|FG000|Overall Study|Pregnancy|1|||
131572074|NCT03761784|473719940|FG001|Overall Study|Pregnancy|0|||
131572075|NCT03761784|473719939|FG000|Overall Study|Protocol Violation|2|||
131572076|NCT03761784|473719940|FG001|Overall Study|Protocol Violation|0|||
131572077|NCT03761784|473719939|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
131572078|NCT03761784|473719940|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
131572079|NCT03761784|473719939|FG000|Overall Study|Withdrawal by Subject|9|||
131572080|NCT03761784|473719940|FG001|Overall Study|Withdrawal by Subject|4|||
131572081|NCT03761784|473719939|FG000|Overall Study|Physician Decision|1|||
131572082|NCT03761784|473719940|FG001|Overall Study|Physician Decision|0|||
131572083|NCT03761784|473719939|FG000|Overall Study|Other Than Specified|1|||
131572084|NCT03761784|473719940|FG001|Overall Study|Other Than Specified|0|||
131572085|NCT00586339|473719941|FG000|Overall Study|Withdrawal by Subject|1|||
131572086|NCT00586339|473719942|FG001|Overall Study|Withdrawal by Subject|3|||
131572087|NCT00586339|473719943|FG002|Overall Study|Withdrawal by Subject|1|||
131572088|NCT00586339|473719941|FG000|Overall Study|Migrated/moved from study area|3|||
131572089|NCT00586339|473719942|FG001|Overall Study|Migrated/moved from study area|2|||
131572090|NCT00586339|473719943|FG002|Overall Study|Migrated/moved from study area|4|||
131572091|NCT00586339|473719941|FG000|Overall Study|Lost to Follow-up|3|||
131572092|NCT00586339|473719942|FG001|Overall Study|Lost to Follow-up|2|||
131572093|NCT00586339|473719943|FG002|Overall Study|Lost to Follow-up|1|||
131572094|NCT01649427|473719945|FG000|Overall Study|Adverse Event|1|||
131572095|NCT01649427|473719946|FG001|Overall Study|Adverse Event|1|||
131572096|NCT01649427|473719945|FG000|Overall Study|Withdrawal by Subject|8|||
131572097|NCT01649427|473719946|FG001|Overall Study|Withdrawal by Subject|7|||
131572098|NCT01649427|473719945|FG000|Overall Study|Lost to Follow-up|0|||
131572099|NCT01649427|473719946|FG001|Overall Study|Lost to Follow-up|1|||
131572100|NCT01649427|473719945|FG000|Overall Study|Graft loss|0|||
131572101|NCT01649427|473719946|FG001|Overall Study|Graft loss|1|||
131572102|NCT01649427|473719945|FG000|Overall Study|Surgical problems during nephrectomy|2|||
131572103|NCT01649427|473719946|FG001|Overall Study|Surgical problems during nephrectomy|2|||
131572104|NCT04927975|473719950|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
131697734|NCT04899232|474175765|FG002|Screening Period|Withdrawal by Subject|0|||
131697735|NCT04899232|474175763|FG000|Screening Period|Participant discharged before receiving intervention|3|||
131697736|NCT04899232|474175764|FG001|Screening Period|Participant discharged before receiving intervention|0|||
131697737|NCT04899232|474175765|FG002|Screening Period|Participant discharged before receiving intervention|0|||
131697738|NCT00700271|474175766|FG000|Overall Study|Adverse Event|4|||
131697739|NCT00700271|474175767|FG001|Overall Study|Adverse Event|6|||
131697740|NCT00700271|474175766|FG000|Overall Study|Protocol Violation|1|||
131572105|NCT04927975|473719951|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
131572106|NCT04927975|473719952|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
131572107|NCT04927975|473719953|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
131572108|NCT04927975|473719954|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
131572109|NCT04927975|473719955|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
131572110|NCT04927975|473719950|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131572111|NCT04927975|473719951|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131572112|NCT04927975|473719952|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131572113|NCT04927975|473719953|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
131697741|NCT00700271|474175767|FG001|Overall Study|Protocol Violation|0|||
131572114|NCT04927975|473719954|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
131572115|NCT04927975|473719955|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131572116|NCT04927975|473719950|FG000|Period 1 (Baseline-Week 24)|Death|0|||
131572117|NCT04927975|473719951|FG001|Period 1 (Baseline-Week 24)|Death|0|||
131572118|NCT04927975|473719952|FG002|Period 1 (Baseline-Week 24)|Death|0|||
131572119|NCT04927975|473719953|FG003|Period 1 (Baseline-Week 24)|Death|0|||
131572120|NCT04927975|473719954|FG004|Period 1 (Baseline-Week 24)|Death|0|||
131572121|NCT04927975|473719955|FG005|Period 1 (Baseline-Week 24)|Death|1|||
131572122|NCT04927975|473719950|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
131572123|NCT04927975|473719951|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
131572124|NCT04927975|473719952|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
131572125|NCT04927975|473719953|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
131572126|NCT04927975|473719954|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
131572127|NCT04927975|473719955|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
131572128|NCT04927975|473719950|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
131572129|NCT04927975|473719951|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131572130|NCT04927975|473719952|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131572131|NCT04927975|473719953|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
131572132|NCT04927975|473719954|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131572133|NCT04927975|473719955|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131572134|NCT03568162|473719957|FG000|Overall Study|Adverse Event|0|||
131572135|NCT03568162|473719958|FG001|Overall Study|Adverse Event|1|||
131572136|NCT03568162|473719959|FG002|Overall Study|Adverse Event|2|||
131572137|NCT03568162|473719960|FG003|Overall Study|Adverse Event|0|||
131572138|NCT03568162|473719961|FG004|Overall Study|Adverse Event|0|||
131572139|NCT03568162|473719962|FG005|Overall Study|Adverse Event|1|||
131783910|NCT04682639|474491739|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131783911|NCT04682639|474491740|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131783912|NCT04682639|474491736|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
131697742|NCT00700271|474175766|FG000|Overall Study|Administrative Reasons|1|||
131697743|NCT00700271|474175767|FG001|Overall Study|Administrative Reasons|0|||
131697744|NCT00700271|474175766|FG000|Overall Study|Withdrawal by Subject|6|||
131697745|NCT00700271|474175767|FG001|Overall Study|Withdrawal by Subject|4|||
131697746|NCT00700271|474175766|FG000|Overall Study|Lost to Follow-up|2|||
131697747|NCT00700271|474175767|FG001|Overall Study|Lost to Follow-up|2|||
131697748|NCT01564862|474175768|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
131697749|NCT01564862|474175769|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
131697750|NCT01564862|474175770|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
131697751|NCT01564862|474175768|FG000|Overall Study|Major Protocol Deviation|3|||
131697752|NCT01564862|474175769|FG001|Overall Study|Major Protocol Deviation|3|||
131697753|NCT01564862|474175770|FG002|Overall Study|Major Protocol Deviation|4|||
131697754|NCT01564862|474175768|FG000|Overall Study|Lost to Follow-up|10|||
131697755|NCT01564862|474175769|FG001|Overall Study|Lost to Follow-up|8|||
131697756|NCT01564862|474175770|FG002|Overall Study|Lost to Follow-up|6|||
131697757|NCT01564862|474175768|FG000|Overall Study|Voluntary Withdrawal|9|||
131697758|NCT01564862|474175769|FG001|Overall Study|Voluntary Withdrawal|6|||
131697759|NCT01564862|474175770|FG002|Overall Study|Voluntary Withdrawal|8|||
131697760|NCT01564862|474175768|FG000|Overall Study|Lack of Efficacy|1|||
131697761|NCT01564862|474175769|FG001|Overall Study|Lack of Efficacy|5|||
131697762|NCT01564862|474175770|FG002|Overall Study|Lack of Efficacy|6|||
131697763|NCT01564862|474175768|FG000|Overall Study|Other reason(s)|1|||
131697764|NCT01564862|474175769|FG001|Overall Study|Other reason(s)|0|||
131697765|NCT01564862|474175770|FG002|Overall Study|Other reason(s)|0|||
131697766|NCT02396589|474175776|FG000|Intervention|Lost to Follow-up|1|||
131697767|NCT02396589|474175777|FG001|Intervention|Lost to Follow-up|0|||
131697768|NCT02396589|474175776|FG000|6 Month Follow-up|change in health status|0|||
131697769|NCT02396589|474175777|FG001|6 Month Follow-up|change in health status|1|||
131697770|NCT02396589|474175776|FG000|9 Month Follow-up|Death|0|||
131697771|NCT02396589|474175777|FG001|9 Month Follow-up|Death|1|||
131697772|NCT02396589|474175776|FG000|12 Month Follow up|Lost to Follow-up|0|||
131572140|NCT03568162|473719957|FG000|Overall Study|Death|0|||
131572141|NCT03568162|473719958|FG001|Overall Study|Death|0|||
131697773|NCT02396589|474175777|FG001|12 Month Follow up|Lost to Follow-up|2|||
131697774|NCT04341948|474175778|FG000|Overall Study|Adverse Event|0|||
131697775|NCT04341948|474175779|FG001|Overall Study|Adverse Event|1|||
131697776|NCT04341948|474175778|FG000|Overall Study|Lost to Follow-up|6|||
131572142|NCT03568162|473719959|FG002|Overall Study|Death|0|||
131697777|NCT04341948|474175779|FG001|Overall Study|Lost to Follow-up|1|||
131697778|NCT04341948|474175778|FG000|Overall Study|Physician Decision|1|||
131697779|NCT04341948|474175779|FG001|Overall Study|Physician Decision|2|||
131697780|NCT04341948|474175778|FG000|Overall Study|Withdrawal by Participant|6|||
131697781|NCT04341948|474175779|FG001|Overall Study|Withdrawal by Participant|3|||
131572143|NCT03568162|473719960|FG003|Overall Study|Death|0|||
131572144|NCT03568162|473719961|FG004|Overall Study|Death|1|||
131572145|NCT03568162|473719962|FG005|Overall Study|Death|0|||
131572146|NCT03568162|473719957|FG000|Overall Study|Lost to Follow-up|3|||
131572147|NCT03568162|473719958|FG001|Overall Study|Lost to Follow-up|2|||
131572148|NCT03568162|473719959|FG002|Overall Study|Lost to Follow-up|4|||
131572149|NCT03568162|473719960|FG003|Overall Study|Lost to Follow-up|2|||
131572150|NCT03568162|473719961|FG004|Overall Study|Lost to Follow-up|3|||
131572151|NCT03568162|473719962|FG005|Overall Study|Lost to Follow-up|2|||
131572152|NCT03568162|473719957|FG000|Overall Study|Physician Decision|0|||
131572153|NCT03568162|473719958|FG001|Overall Study|Physician Decision|1|||
131572154|NCT03568162|473719959|FG002|Overall Study|Physician Decision|1|||
131572155|NCT03568162|473719960|FG003|Overall Study|Physician Decision|0|||
131572156|NCT03568162|473719961|FG004|Overall Study|Physician Decision|1|||
131572157|NCT03568162|473719962|FG005|Overall Study|Physician Decision|0|||
131572158|NCT03568162|473719957|FG000|Overall Study|Pregnancy|0|||
131572159|NCT03568162|473719958|FG001|Overall Study|Pregnancy|0|||
131572160|NCT03568162|473719959|FG002|Overall Study|Pregnancy|0|||
131572161|NCT03568162|473719960|FG003|Overall Study|Pregnancy|1|||
131572162|NCT03568162|473719961|FG004|Overall Study|Pregnancy|0|||
131572163|NCT03568162|473719962|FG005|Overall Study|Pregnancy|0|||
131572164|NCT03568162|473719957|FG000|Overall Study|Protocol Violation|1|||
131572165|NCT03568162|473719958|FG001|Overall Study|Protocol Violation|0|||
131572166|NCT03568162|473719959|FG002|Overall Study|Protocol Violation|1|||
131572167|NCT03568162|473719960|FG003|Overall Study|Protocol Violation|1|||
131572168|NCT03568162|473719961|FG004|Overall Study|Protocol Violation|1|||
131572169|NCT03568162|473719962|FG005|Overall Study|Protocol Violation|1|||
131572170|NCT03568162|473719957|FG000|Overall Study|Withdrawal by Subject|15|||
131572171|NCT03568162|473719958|FG001|Overall Study|Withdrawal by Subject|15|||
131572172|NCT03568162|473719959|FG002|Overall Study|Withdrawal by Subject|26|||
131572173|NCT03568162|473719960|FG003|Overall Study|Withdrawal by Subject|22|||
131572174|NCT03568162|473719961|FG004|Overall Study|Withdrawal by Subject|6|||
131572175|NCT03568162|473719962|FG005|Overall Study|Withdrawal by Subject|9|||
131572176|NCT03568162|473719957|FG000|Overall Study|Others|3|||
131572177|NCT03568162|473719958|FG001|Overall Study|Others|4|||
131572178|NCT03568162|473719959|FG002|Overall Study|Others|1|||
131572179|NCT03568162|473719960|FG003|Overall Study|Others|4|||
131572180|NCT03568162|473719961|FG004|Overall Study|Others|2|||
131572181|NCT03568162|473719962|FG005|Overall Study|Others|1|||
131572182|NCT01458275|473719964|FG000|Overall Study|Adverse Event|3|||
131572183|NCT01458275|473719965|FG001|Overall Study|Adverse Event|4|||
131572184|NCT01458275|473719966|FG002|Overall Study|Adverse Event|1|||
131572185|NCT01458275|473719964|FG000|Overall Study|Lost to Follow-up|3|||
131572186|NCT01458275|473719965|FG001|Overall Study|Lost to Follow-up|2|||
131783913|NCT04682639|474491737|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131783914|NCT04682639|474491738|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131572187|NCT01458275|473719966|FG002|Overall Study|Lost to Follow-up|5|||
131572188|NCT01458275|473719964|FG000|Overall Study|Protocol Violation|5|||
131572189|NCT01458275|473719965|FG001|Overall Study|Protocol Violation|5|||
131572190|NCT01458275|473719966|FG002|Overall Study|Protocol Violation|2|||
131572191|NCT01458275|473719964|FG000|Overall Study|Withdrawal by Subject|3|||
131572192|NCT01458275|473719965|FG001|Overall Study|Withdrawal by Subject|2|||
131572193|NCT01458275|473719966|FG002|Overall Study|Withdrawal by Subject|1|||
131572194|NCT03102242|473719969|FG000|Overall Study|Adverse Event|2|||
131572195|NCT00389519|473719970|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
131572196|NCT00389519|473719971|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
131572197|NCT00389519|473719972|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
131572198|NCT00389519|473719973|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
131572199|NCT00389519|473719970|FG000|Placebo Run-In|Withdrawal by Subject|19|||
131572200|NCT00389519|473719971|FG001|Placebo Run-In|Withdrawal by Subject|0|||
131572201|NCT00389519|473719972|FG002|Placebo Run-In|Withdrawal by Subject|0|||
131572202|NCT00389519|473719973|FG003|Placebo Run-In|Withdrawal by Subject|0|||
131572203|NCT00389519|473719970|FG000|Placebo Run-In|Reason not specified|40|||
131572204|NCT00389519|473719971|FG001|Placebo Run-In|Reason not specified|0|||
131572205|NCT00389519|473719972|FG002|Placebo Run-In|Reason not specified|0|||
131572206|NCT00389519|473719973|FG003|Placebo Run-In|Reason not specified|0|||
131572207|NCT00389519|473719970|FG000|Randomized|Did not receive study drug|2|||
131572208|NCT00389519|473719971|FG001|Randomized|Did not receive study drug|0|||
131783915|NCT04682639|474491739|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131572209|NCT00389519|473719972|FG002|Randomized|Did not receive study drug|0|||
131572210|NCT00389519|473719973|FG003|Randomized|Did not receive study drug|0|||
131572211|NCT00389519|473719970|FG000|Treated|Adverse Event|1|||
131572212|NCT00389519|473719971|FG001|Treated|Adverse Event|0|||
131572213|NCT00389519|473719972|FG002|Treated|Adverse Event|0|||
131437847|NCT00556894|473228168|FG001|Overall Study|Death|0|||
131437848|NCT00556894|473228169|FG002|Overall Study|Death|0|||
131437849|NCT00556894|473228167|FG000|Overall Study|regulatory decision in Bulgaria|10|||
131437850|NCT00556894|473228168|FG001|Overall Study|regulatory decision in Bulgaria|14|||
131572214|NCT00389519|473719973|FG003|Treated|Adverse Event|2|||
131572215|NCT00389519|473719970|FG000|Treated|Reason not specified|1|||
131572216|NCT00389519|473719971|FG001|Treated|Reason not specified|1|||
131572217|NCT00389519|473719972|FG002|Treated|Reason not specified|0|||
131572218|NCT00389519|473719973|FG003|Treated|Reason not specified|2|||
131572219|NCT01311713|473719974|FG000|Overall Study|Death|0|||
131572220|NCT01311713|473719975|FG001|Overall Study|Death|0|||
131572221|NCT01311713|473719976|FG002|Overall Study|Death|1|||
131572222|NCT01311713|473719977|FG003|Overall Study|Death|1|||
131572223|NCT01311713|473719978|FG004|Overall Study|Death|0|||
131572224|NCT01311713|473719979|FG005|Overall Study|Death|1|||
131572225|NCT01311713|473719980|FG006|Overall Study|Death|0|||
131572226|NCT01311713|473719974|FG000|Overall Study|Adverse Event|0|||
131572227|NCT01311713|473719975|FG001|Overall Study|Adverse Event|1|||
131572228|NCT01311713|473719976|FG002|Overall Study|Adverse Event|0|||
131572229|NCT01311713|473719977|FG003|Overall Study|Adverse Event|2|||
131572230|NCT01311713|473719978|FG004|Overall Study|Adverse Event|0|||
131572231|NCT01311713|473719979|FG005|Overall Study|Adverse Event|0|||
131572232|NCT01311713|473719980|FG006|Overall Study|Adverse Event|2|||
131572233|NCT01311713|473719974|FG000|Overall Study|Withdrawal by Subject|0|||
131572234|NCT01311713|473719975|FG001|Overall Study|Withdrawal by Subject|1|||
131572235|NCT01311713|473719976|FG002|Overall Study|Withdrawal by Subject|1|||
131572236|NCT01311713|473719977|FG003|Overall Study|Withdrawal by Subject|0|||
131572237|NCT01311713|473719978|FG004|Overall Study|Withdrawal by Subject|0|||
131572238|NCT01311713|473719979|FG005|Overall Study|Withdrawal by Subject|1|||
131572239|NCT01311713|473719980|FG006|Overall Study|Withdrawal by Subject|2|||
131572240|NCT01311713|473719974|FG000|Overall Study|Disease progression|3|||
131572241|NCT01311713|473719975|FG001|Overall Study|Disease progression|4|||
131572242|NCT01311713|473719976|FG002|Overall Study|Disease progression|3|||
131572243|NCT01311713|473719977|FG003|Overall Study|Disease progression|2|||
131572244|NCT01311713|473719978|FG004|Overall Study|Disease progression|4|||
131572245|NCT01311713|473719979|FG005|Overall Study|Disease progression|4|||
131572246|NCT01311713|473719980|FG006|Overall Study|Disease progression|5|||
131572247|NCT01311713|473719974|FG000|Overall Study|Lost to Follow-up|0|||
131572248|NCT01311713|473719975|FG001|Overall Study|Lost to Follow-up|0|||
131572249|NCT01311713|473719976|FG002|Overall Study|Lost to Follow-up|1|||
131572250|NCT01311713|473719977|FG003|Overall Study|Lost to Follow-up|0|||
131572251|NCT01311713|473719978|FG004|Overall Study|Lost to Follow-up|0|||
131572252|NCT01311713|473719979|FG005|Overall Study|Lost to Follow-up|0|||
131572253|NCT01311713|473719980|FG006|Overall Study|Lost to Follow-up|0|||
131572254|NCT01311713|473719974|FG000|Overall Study|Stopped taking study medication|0|||
131572255|NCT01311713|473719975|FG001|Overall Study|Stopped taking study medication|0|||
131572256|NCT01311713|473719976|FG002|Overall Study|Stopped taking study medication|0|||
131572257|NCT01311713|473719977|FG003|Overall Study|Stopped taking study medication|1|||
131572258|NCT01311713|473719978|FG004|Overall Study|Stopped taking study medication|1|||
131572259|NCT01311713|473719979|FG005|Overall Study|Stopped taking study medication|0|||
131572260|NCT01311713|473719980|FG006|Overall Study|Stopped taking study medication|0|||
131572261|NCT01311713|473719974|FG000|Overall Study|Enrolled but not treated|0|||
131572262|NCT01311713|473719975|FG001|Overall Study|Enrolled but not treated|0|||
131572263|NCT01311713|473719976|FG002|Overall Study|Enrolled but not treated|1|||
131783916|NCT04682639|474491740|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131783917|NCT04682639|474491736|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
131572264|NCT01311713|473719977|FG003|Overall Study|Enrolled but not treated|0|||
131572265|NCT01311713|473719978|FG004|Overall Study|Enrolled but not treated|0|||
131572266|NCT01311713|473719979|FG005|Overall Study|Enrolled but not treated|0|||
131572267|NCT01311713|473719980|FG006|Overall Study|Enrolled but not treated|0|||
131572268|NCT01311713|473719974|FG000|Overall Study|Other than specified|0|||
131572269|NCT01311713|473719975|FG001|Overall Study|Other than specified|1|||
131572270|NCT01311713|473719976|FG002|Overall Study|Other than specified|2|||
131572271|NCT01311713|473719977|FG003|Overall Study|Other than specified|0|||
131572272|NCT01311713|473719978|FG004|Overall Study|Other than specified|0|||
131572273|NCT01311713|473719979|FG005|Overall Study|Other than specified|0|||
131572274|NCT01311713|473719980|FG006|Overall Study|Other than specified|0|||
131572275|NCT00946192|473719981|FG000|Overall Study|Lost to Follow-up|6|||
131572276|NCT00946192|473719982|FG001|Overall Study|Lost to Follow-up|11|||
131572277|NCT00946192|473719983|FG002|Overall Study|Lost to Follow-up|9|||
131572278|NCT00946192|473719981|FG000|Overall Study|Withdrawal by Subject|10|||
131572279|NCT00946192|473719982|FG001|Overall Study|Withdrawal by Subject|7|||
131572280|NCT00946192|473719983|FG002|Overall Study|Withdrawal by Subject|3|||
131572281|NCT00946192|473719981|FG000|Overall Study|Did not start medication|2|||
131572282|NCT00946192|473719982|FG001|Overall Study|Did not start medication|0|||
131572283|NCT00946192|473719983|FG002|Overall Study|Did not start medication|0|||
131572284|NCT04155424|473719984|FG000|Overall Study|Other than specified|3|||
131572285|NCT04155424|473719984|FG000|Overall Study|Withdrawal by Subject|1|||
131572286|NCT04155424|473719984|FG000|Overall Study|Adverse Event|1|||
131572287|NCT04159506|473719985|FG000|Overall Study|Lost to Follow-up|2|||
131572288|NCT04159506|473719986|FG001|Overall Study|Lost to Follow-up|5|||
131572289|NCT05526911|473721457|FG000|Overall Study|Adverse Event|2|||
131572290|NCT05025449|473721458|FG000|Overall Study|Withdrawal by Subject|1|||
131572291|NCT05025449|473721458|FG000|Overall Study|Patient emergently taken to operating room|1|||
131572292|NCT00711646|473721461|FG000|Overall Study|Adverse Event|6|||
131572293|NCT00711646|473721462|FG001|Overall Study|Adverse Event|1|||
131572294|NCT00711646|473721461|FG000|Overall Study|Withdrawal by Subject|4|||
131572295|NCT00711646|473721462|FG001|Overall Study|Withdrawal by Subject|0|||
131572296|NCT00711646|473721461|FG000|Overall Study|Protocol Violation|0|||
131572297|NCT00711646|473721462|FG001|Overall Study|Protocol Violation|1|||
131572298|NCT00711646|473721461|FG000|Overall Study|Lost to Follow-up|1|||
131572299|NCT00711646|473721462|FG001|Overall Study|Lost to Follow-up|0|||
131572300|NCT00711646|473721461|FG000|Overall Study|administrative decision|0|||
131572301|NCT00711646|473721462|FG001|Overall Study|administrative decision|1|||
131572302|NCT00711646|473721461|FG000|Overall Study|patient non-compliance|1|||
131572303|NCT00711646|473721462|FG001|Overall Study|patient non-compliance|0|||
131697782|NCT04341948|474175778|FG000|Overall Study|Lack of compliance by Participant|1|||
131697783|NCT04341948|474175779|FG001|Overall Study|Lack of compliance by Participant|0|||
131697784|NCT04705051|474177152|FG000|Overall Study|Enrolled but not treated|1|||
131697785|NCT04705051|474177152|FG000|Overall Study|Study terminated by sponsor|23|||
131697786|NCT02740478|474177156|FG000|Overall Study|Withdrawal by Subject|1|||
131572304|NCT03721016|473721464|FG000|Overall Study|Adverse Event|0|||
131572305|NCT03721016|473721465|FG001|Overall Study|Adverse Event|1|||
131572306|NCT03721016|473721466|FG002|Overall Study|Adverse Event|1|||
131697787|NCT03905863|474177157|FG000|Overall Study|Adverse Event|2|||
131697788|NCT03905863|474177158|FG001|Overall Study|Adverse Event|4|||
131697789|NCT03905863|474177157|FG000|Overall Study|Withdrawal by Subject|2|||
131697790|NCT03905863|474177158|FG001|Overall Study|Withdrawal by Subject|2|||
131572307|NCT03721016|473721464|FG000|Overall Study|Withdrawal by Subject|8|||
131572308|NCT03721016|473721465|FG001|Overall Study|Withdrawal by Subject|16|||
131572309|NCT03721016|473721466|FG002|Overall Study|Withdrawal by Subject|13|||
131572310|NCT03721016|473721464|FG000|Overall Study|Lost to Follow-up|4|||
131572311|NCT03721016|473721465|FG001|Overall Study|Lost to Follow-up|6|||
131572312|NCT03721016|473721466|FG002|Overall Study|Lost to Follow-up|5|||
131572313|NCT03721016|473721464|FG000|Overall Study|Physician Decision|0|||
131572314|NCT03721016|473721465|FG001|Overall Study|Physician Decision|1|||
131572315|NCT03721016|473721466|FG002|Overall Study|Physician Decision|2|||
131572316|NCT03721016|473721464|FG000|Overall Study|Protocol Violation|0|||
131572317|NCT03721016|473721465|FG001|Overall Study|Protocol Violation|1|||
131572318|NCT03721016|473721466|FG002|Overall Study|Protocol Violation|0|||
131572319|NCT03721016|473721464|FG000|Overall Study|Site terminated by sponsor|3|||
131572320|NCT03721016|473721465|FG001|Overall Study|Site terminated by sponsor|7|||
131572321|NCT03721016|473721466|FG002|Overall Study|Site terminated by sponsor|6|||
131572322|NCT03721016|473721464|FG000|Overall Study|Subject exited early due to COVID-19|1|||
131572323|NCT03721016|473721465|FG001|Overall Study|Subject exited early due to COVID-19|0|||
131572324|NCT03721016|473721466|FG002|Overall Study|Subject exited early due to COVID-19|0|||
131572325|NCT02232178|473721469|FG000|Overall Study|Lost to Follow-up|0|||
131572326|NCT02232178|473721470|FG001|Overall Study|Lost to Follow-up|1|||
131572327|NCT02232178|473721471|FG002|Overall Study|Lost to Follow-up|0|||
131697791|NCT03905863|474177157|FG000|Overall Study|Physician Decision|0|||
131697792|NCT03905863|474177158|FG001|Overall Study|Physician Decision|3|||
131697793|NCT03905863|474177157|FG000|Overall Study|Lost to Follow-up|1|||
131697794|NCT03905863|474177158|FG001|Overall Study|Lost to Follow-up|0|||
131697795|NCT03905863|474177157|FG000|Overall Study|Protocol Violation|0|||
131697796|NCT03905863|474177158|FG001|Overall Study|Protocol Violation|2|||
131697797|NCT03905863|474177157|FG000|Overall Study|Death|0|||
131697798|NCT03905863|474177158|FG001|Overall Study|Death|1|||
131697799|NCT02354703|474177160|FG000|Overall Study|Withdrawal by Subject|1|||
131697800|NCT02354703|474177161|FG001|Overall Study|Withdrawal by Subject|1|||
131697801|NCT02354703|474177162|FG002|Overall Study|Withdrawal by Subject|1|||
131697802|NCT02354703|474177163|FG003|Overall Study|Withdrawal by Subject|1|||
131697803|NCT02354703|474177160|FG000|Overall Study|Lost to Follow-up|2|||
131697804|NCT02354703|474177161|FG001|Overall Study|Lost to Follow-up|7|||
131697805|NCT02354703|474177162|FG002|Overall Study|Lost to Follow-up|9|||
131697806|NCT02354703|474177163|FG003|Overall Study|Lost to Follow-up|2|||
131697807|NCT02354703|474177160|FG000|Overall Study|Adverse Event|0|||
131697808|NCT02354703|474177161|FG001|Overall Study|Adverse Event|0|||
131697809|NCT02354703|474177162|FG002|Overall Study|Adverse Event|1|||
131697810|NCT02354703|474177163|FG003|Overall Study|Adverse Event|0|||
131697811|NCT00984204|474177164|FG000|Overall Study|Death|1|||
131697812|NCT00984204|474177164|FG000|Overall Study|Lost to Follow-up|4|||
131697813|NCT00984204|474177164|FG000|Overall Study|Lack of Efficacy|10|||
131697814|NCT02944448|474177165|FG000|Overall Study|Adverse Event|37|||
131697815|NCT02944448|474177166|FG001|Overall Study|Adverse Event|6|||
131697816|NCT02944448|474177165|FG000|Overall Study|Lack of Efficacy|8|||
131697817|NCT02944448|474177166|FG001|Overall Study|Lack of Efficacy|5|||
131697818|NCT02944448|474177165|FG000|Overall Study|Lost to Follow-up|3|||
131697819|NCT02944448|474177166|FG001|Overall Study|Lost to Follow-up|1|||
131697820|NCT02944448|474177165|FG000|Overall Study|Protocol Violation|25|||
131697821|NCT02944448|474177166|FG001|Overall Study|Protocol Violation|7|||
131697822|NCT02944448|474177165|FG000|Overall Study|Withdrawal by Subject|14|||
131697823|NCT02944448|474177166|FG001|Overall Study|Withdrawal by Subject|4|||
131697824|NCT02944448|474177165|FG000|Overall Study|Sponsor did not supply drug in time|0|||
131697825|NCT02944448|474177166|FG001|Overall Study|Sponsor did not supply drug in time|1|||
131697826|NCT02944448|474177165|FG000|Overall Study|Noncompliant with dosing|1|||
131697827|NCT02944448|474177166|FG001|Overall Study|Noncompliant with dosing|0|||
131697828|NCT02944448|474177165|FG000|Overall Study|Abnormal laboratory values|1|||
131697829|NCT02944448|474177166|FG001|Overall Study|Abnormal laboratory values|0|||
131697830|NCT02814565|474177167|FG000|Overall Study|Lack of Efficacy|0|||
131697831|NCT02814565|474177168|FG001|Overall Study|Lack of Efficacy|1|||
131697832|NCT02814565|474177167|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
131697833|NCT02814565|474177168|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
131697834|NCT05702515|474177169|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
131697835|NCT01777152|474177174|FG000|Overall Study|Withdrawal by Subject|22|||
131697836|NCT01777152|474177175|FG001|Overall Study|Withdrawal by Subject|16|||
131697837|NCT01777152|474177174|FG000|Overall Study|Lost to Follow-up|3|||
131697838|NCT01777152|474177175|FG001|Overall Study|Lost to Follow-up|5|||
131572328|NCT02232178|473721469|FG000|Overall Study|ineligibility|0|||
131572329|NCT02232178|473721470|FG001|Overall Study|ineligibility|0|||
131572330|NCT02232178|473721471|FG002|Overall Study|ineligibility|1|||
131572331|NCT02232178|473721469|FG000|Overall Study|surgical complication|1|||
131572332|NCT02232178|473721470|FG001|Overall Study|surgical complication|0|||
131697839|NCT01777152|474177174|FG000|Overall Study|Death|68|||
131697840|NCT01777152|474177175|FG001|Overall Study|Death|89|||
131697841|NCT01777152|474177174|FG000|Overall Study|Not eligible, no study drug received|1|||
131572333|NCT02232178|473721471|FG002|Overall Study|surgical complication|0|||
131572334|NCT01167426|473721473|FG000|Overall Study|Lost to Follow-up|6|||
131572335|NCT01167426|473721473|FG000|Overall Study|Protocol Violation|1|||
131572336|NCT01167426|473721473|FG000|Overall Study|Withdrawal by Subject|2|||
131572337|NCT01167426|473721473|FG000|Overall Study|Sponsor Decision|1|||
131572338|NCT02993471|473721474|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
131572339|NCT02993471|473721474|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
131572340|NCT04176458|473721476|FG000|Overall Study|Covid 19|4|||
131572341|NCT01570751|473721477|FG000|Period A (16 Weeks)|Protocol Violation|1|||
131572342|NCT01570751|473721478|FG001|Period A (16 Weeks)|Protocol Violation|1|||
131572343|NCT01570751|473721477|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
131572344|NCT01570751|473721478|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
131697842|NCT01777152|474177175|FG001|Overall Study|Not eligible, no study drug received|0|||
131697843|NCT01777152|474177174|FG000|Overall Study|Change of diagnosis|1|||
131697844|NCT01777152|474177175|FG001|Overall Study|Change of diagnosis|0|||
131697845|NCT02792842|474177176|FG000|Overall Study|Adverse Event|4|||
131697846|NCT02792842|474177177|FG001|Overall Study|Adverse Event|2|||
131697847|NCT02792842|474177178|FG002|Overall Study|Adverse Event|3|||
131697848|NCT02792842|474177176|FG000|Overall Study|Withdrawal by Subject|0|||
131697849|NCT02792842|474177177|FG001|Overall Study|Withdrawal by Subject|1|||
131697850|NCT02792842|474177178|FG002|Overall Study|Withdrawal by Subject|2|||
131697851|NCT02792842|474177176|FG000|Overall Study|Lost to Follow-up|0|||
131697852|NCT02792842|474177177|FG001|Overall Study|Lost to Follow-up|0|||
131697853|NCT02792842|474177178|FG002|Overall Study|Lost to Follow-up|1|||
131697854|NCT02792842|474177176|FG000|Overall Study|Schedule delay|0|||
131697855|NCT02792842|474177177|FG001|Overall Study|Schedule delay|1|||
131697856|NCT02792842|474177178|FG002|Overall Study|Schedule delay|1|||
131697857|NCT02469090|474177179|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
131572345|NCT01570751|473721477|FG000|Period A (16 Weeks)|Unclassified|2|||
131572346|NCT01570751|473721478|FG001|Period A (16 Weeks)|Unclassified|3|||
131572347|NCT01570751|473721477|FG000|Period B (16 Weeks)|Adverse Event|1|||
131697858|NCT02469090|474177180|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
131572348|NCT01570751|473721478|FG001|Period B (16 Weeks)|Adverse Event|0|||
131572349|NCT01570751|473721477|FG000|Period B (16 Weeks)|Protocol Violation|0|||
131572350|NCT01570751|473721478|FG001|Period B (16 Weeks)|Protocol Violation|1|||
131572351|NCT02317705|473721479|FG000|Overall Study|Withdrawal by Subject|3|||
131572352|NCT02317705|473721479|FG000|Overall Study|Physician Decision|1|||
131572353|NCT02317705|473721479|FG000|Overall Study|Drug not usable|1|||
131572354|NCT02219490|473721480|FG000|Overall Study|Adverse Event|24|||
131572355|NCT02219490|473721480|FG000|Overall Study|Withdrew consent|96|||
131572356|NCT02219490|473721480|FG000|Overall Study|Lost to Follow-up|126|||
131572357|NCT02219490|473721480|FG000|Overall Study|COVID-19 infection|2|||
131572358|NCT02219490|473721480|FG000|Overall Study|COVID-19 logistical restrictions|33|||
131572359|NCT02219490|473721480|FG000|Overall Study|Other, not specified|57|||
131572360|NCT01674569|473721481|FG000|Overall Study|Adverse Event|0|||
131572361|NCT01674569|473721482|FG001|Overall Study|Adverse Event|2|||
131572362|NCT01674569|473721483|FG002|Overall Study|Adverse Event|0|||
131572363|NCT01674569|473721484|FG003|Overall Study|Adverse Event|1|||
131697859|NCT02469090|474177181|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
131697860|NCT02469090|474177179|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
131697861|NCT02469090|474177180|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
131697862|NCT02469090|474177181|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
131697863|NCT02469090|474177179|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
131697864|NCT02469090|474177180|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
131697865|NCT02469090|474177181|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
131697866|NCT02469090|474177179|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
131697867|NCT02469090|474177180|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
131697868|NCT02469090|474177181|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
131697869|NCT02469090|474177179|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
131697870|NCT02469090|474177180|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
131697871|NCT02469090|474177181|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
131697872|NCT02469090|474177179|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
131697873|NCT02469090|474177180|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
131697874|NCT02469090|474177181|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
131697875|NCT02469090|474177179|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
131697876|NCT02469090|474177180|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
131697877|NCT02469090|474177181|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
131697878|NCT02469090|474177179|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
131697879|NCT02469090|474177180|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
131697880|NCT02469090|474177181|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
131697881|NCT01415752|474177183|FG000|Induction (Step 1)|Ineligible|4|||
131697882|NCT01415752|474177184|FG001|Induction (Step 1)|Ineligible|3|||
131697883|NCT01415752|474177185|FG002|Induction (Step 1)|Ineligible|4|||
131697884|NCT01415752|474177186|FG003|Induction (Step 1)|Ineligible|4|||
131697885|NCT01415752|474177183|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
131697886|NCT01415752|474177184|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
131697887|NCT01415752|474177185|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
131697888|NCT01415752|474177186|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
131697889|NCT01415752|474177183|FG000|Maintenance (Step 2)|Adverse Event|3|||
131697890|NCT01415752|474177184|FG001|Maintenance (Step 2)|Adverse Event|4|||
131697891|NCT01415752|474177185|FG002|Maintenance (Step 2)|Adverse Event|9|||
131697892|NCT01415752|474177186|FG003|Maintenance (Step 2)|Adverse Event|6|||
131697893|NCT01415752|474177183|FG000|Maintenance (Step 2)|Death|1|||
131697894|NCT01415752|474177184|FG001|Maintenance (Step 2)|Death|1|||
131697895|NCT01415752|474177185|FG002|Maintenance (Step 2)|Death|2|||
131697896|NCT01415752|474177186|FG003|Maintenance (Step 2)|Death|0|||
131697897|NCT01415752|474177183|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
131572364|NCT01674569|473721485|FG004|Overall Study|Adverse Event|2|||
131572365|NCT01674569|473721486|FG005|Overall Study|Adverse Event|2|||
131572366|NCT01674569|473721481|FG000|Overall Study|Protocol Violation|0|||
131697898|NCT01415752|474177184|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
131572367|NCT01674569|473721482|FG001|Overall Study|Protocol Violation|1|||
131572368|NCT01674569|473721483|FG002|Overall Study|Protocol Violation|1|||
131572369|NCT01674569|473721484|FG003|Overall Study|Protocol Violation|0|||
131572370|NCT01674569|473721485|FG004|Overall Study|Protocol Violation|0|||
131572371|NCT01674569|473721486|FG005|Overall Study|Protocol Violation|0|||
131572372|NCT01674569|473721481|FG000|Overall Study|Withdrawal by Subject|0|||
131572373|NCT01674569|473721482|FG001|Overall Study|Withdrawal by Subject|0|||
131572374|NCT01674569|473721483|FG002|Overall Study|Withdrawal by Subject|1|||
131572375|NCT01674569|473721484|FG003|Overall Study|Withdrawal by Subject|0|||
131572376|NCT01674569|473721485|FG004|Overall Study|Withdrawal by Subject|0|||
131697899|NCT01415752|474177185|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
131572377|NCT01674569|473721486|FG005|Overall Study|Withdrawal by Subject|0|||
131572378|NCT02365298|473721489|FG000|Period 2|incorrect Rx dispensed|1|||
131572379|NCT02365298|473721490|FG001|Period 2|incorrect Rx dispensed|0|||
131572380|NCT02365298|473721489|FG000|Period 2|Discontinued at request of Sponsor|1|||
131572381|NCT02365298|473721490|FG001|Period 2|Discontinued at request of Sponsor|0|||
131572382|NCT02365298|473721489|FG000|Period 2|Test Article longer available|0|||
131572383|NCT02365298|473721490|FG001|Period 2|Test Article longer available|1|||
131572384|NCT02365298|473721489|FG000|Period 2|Protocol Violation|0|||
131572385|NCT02365298|473721490|FG001|Period 2|Protocol Violation|1|||
131572386|NCT01878890|473721491|FG000|Overall Study|Protocol Violation|0|||
131572387|NCT01878890|473721492|FG001|Overall Study|Protocol Violation|1|||
131572388|NCT01878890|473721493|FG002|Overall Study|Protocol Violation|0|||
131572389|NCT01878890|473721494|FG003|Overall Study|Protocol Violation|0|||
131572390|NCT02974010|473721495|FG000|Overall Study|Lost to Follow-up|3|||
131572391|NCT02974010|473721496|FG001|Overall Study|Lost to Follow-up|1|||
131697900|NCT01415752|474177186|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
131697901|NCT01415752|474177183|FG000|Maintenance (Step 2)|Alternative therapy|0|||
131697902|NCT01415752|474177184|FG001|Maintenance (Step 2)|Alternative therapy|1|||
131697903|NCT01415752|474177185|FG002|Maintenance (Step 2)|Alternative therapy|0|||
131697904|NCT01415752|474177186|FG003|Maintenance (Step 2)|Alternative therapy|0|||
131697905|NCT01415752|474177183|FG000|Maintenance (Step 2)|Other reasons|3|||
131697906|NCT01415752|474177184|FG001|Maintenance (Step 2)|Other reasons|6|||
131697907|NCT01415752|474177185|FG002|Maintenance (Step 2)|Other reasons|4|||
131697908|NCT01415752|474177186|FG003|Maintenance (Step 2)|Other reasons|6|||
131697909|NCT01415752|474177183|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
131697910|NCT01415752|474177184|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
131697911|NCT01415752|474177185|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
131697912|NCT01415752|474177186|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
131697913|NCT01415752|474177183|FG000|Maintenance (Step 2)|ineligible|1|||
131697914|NCT01415752|474177184|FG001|Maintenance (Step 2)|ineligible|1|||
131697915|NCT01415752|474177185|FG002|Maintenance (Step 2)|ineligible|1|||
131697916|NCT01415752|474177186|FG003|Maintenance (Step 2)|ineligible|0|||
131697917|NCT01415752|474177183|FG000|Maintenance (Step 2)|Missing|4|||
131697918|NCT01415752|474177184|FG001|Maintenance (Step 2)|Missing|1|||
131697919|NCT01415752|474177185|FG002|Maintenance (Step 2)|Missing|4|||
131697920|NCT01415752|474177186|FG003|Maintenance (Step 2)|Missing|3|||
131697921|NCT01926782|474177188|FG000|Overall Study|Participant moved|2|||
131697922|NCT01926782|474177189|FG001|Overall Study|Participant moved|0|||
131697923|NCT01926782|474177190|FG002|Overall Study|Participant moved|1|||
131697924|NCT01926782|474177191|FG003|Overall Study|Participant moved|1|||
131697925|NCT01926782|474177192|FG004|Overall Study|Participant moved|0|||
131697926|NCT01926782|474177193|FG005|Overall Study|Participant moved|3|||
131697927|NCT01926782|474177188|FG000|Overall Study|Physician Decision|0|||
131697928|NCT01926782|474177189|FG001|Overall Study|Physician Decision|2|||
131697929|NCT01926782|474177190|FG002|Overall Study|Physician Decision|1|||
131697930|NCT01926782|474177191|FG003|Overall Study|Physician Decision|1|||
131697931|NCT01926782|474177192|FG004|Overall Study|Physician Decision|0|||
131697932|NCT01926782|474177193|FG005|Overall Study|Physician Decision|0|||
131697933|NCT01926782|474177188|FG000|Overall Study|Other than specified|2|||
131697934|NCT01926782|474177189|FG001|Overall Study|Other than specified|3|||
131697935|NCT01926782|474177190|FG002|Overall Study|Other than specified|5|||
131697936|NCT01926782|474177191|FG003|Overall Study|Other than specified|12|||
131697937|NCT01926782|474177192|FG004|Overall Study|Other than specified|4|||
131697938|NCT01926782|474177193|FG005|Overall Study|Other than specified|11|||
131697939|NCT01926782|474177188|FG000|Overall Study|Adverse Event|13|||
131697940|NCT01926782|474177189|FG001|Overall Study|Adverse Event|4|||
131697941|NCT01926782|474177190|FG002|Overall Study|Adverse Event|17|||
131697942|NCT01926782|474177191|FG003|Overall Study|Adverse Event|4|||
131697943|NCT01926782|474177192|FG004|Overall Study|Adverse Event|3|||
131697944|NCT01926782|474177193|FG005|Overall Study|Adverse Event|14|||
131697945|NCT01926782|474177188|FG000|Overall Study|Poor compliance to protocol|5|||
131697946|NCT01926782|474177189|FG001|Overall Study|Poor compliance to protocol|3|||
131697947|NCT01926782|474177190|FG002|Overall Study|Poor compliance to protocol|8|||
131697948|NCT01926782|474177191|FG003|Overall Study|Poor compliance to protocol|0|||
131697949|NCT01926782|474177192|FG004|Overall Study|Poor compliance to protocol|1|||
131898663|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
131437851|NCT00556894|473228169|FG002|Overall Study|regulatory decision in Bulgaria|13|||
131437852|NCT00556894|473228167|FG000|Overall Study|Change in therapy|2|||
131437853|NCT00556894|473228168|FG001|Overall Study|Change in therapy|1|||
131697950|NCT01926782|474177193|FG005|Overall Study|Poor compliance to protocol|6|||
131697951|NCT01926782|474177188|FG000|Overall Study|Randomized and not treated|0|||
131697952|NCT01926782|474177189|FG001|Overall Study|Randomized and not treated|0|||
131697953|NCT01926782|474177190|FG002|Overall Study|Randomized and not treated|0|||
131572392|NCT02974010|473721497|FG002|Overall Study|Lost to Follow-up|0|||
131697954|NCT01926782|474177191|FG003|Overall Study|Randomized and not treated|1|||
131697955|NCT01926782|474177192|FG004|Overall Study|Randomized and not treated|0|||
131697956|NCT01926782|474177193|FG005|Overall Study|Randomized and not treated|0|||
131572393|NCT02974010|473721498|FG003|Overall Study|Lost to Follow-up|0|||
131572394|NCT02974010|473721495|FG000|Overall Study|Withdrawal by Subject|2|||
131572395|NCT02974010|473721496|FG001|Overall Study|Withdrawal by Subject|1|||
131572396|NCT02974010|473721497|FG002|Overall Study|Withdrawal by Subject|0|||
131572397|NCT02974010|473721498|FG003|Overall Study|Withdrawal by Subject|0|||
131572398|NCT02974010|473721495|FG000|Overall Study|Adverse Event|0|||
131572399|NCT02974010|473721496|FG001|Overall Study|Adverse Event|1|||
131572400|NCT02974010|473721497|FG002|Overall Study|Adverse Event|0|||
131572401|NCT02974010|473721498|FG003|Overall Study|Adverse Event|0|||
131572402|NCT02974010|473721495|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
131572403|NCT02974010|473721496|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
131572404|NCT02974010|473721497|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
131572405|NCT02974010|473721498|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
131572406|NCT02974010|473721495|FG000|Overall Study|Lack of Efficacy|0|||
131697957|NCT01926782|474177188|FG000|Overall Study|Withdrawal by Subject|6|||
131697958|NCT01926782|474177189|FG001|Overall Study|Withdrawal by Subject|1|||
131697959|NCT01926782|474177190|FG002|Overall Study|Withdrawal by Subject|8|||
131697960|NCT01926782|474177191|FG003|Overall Study|Withdrawal by Subject|1|||
131697961|NCT01926782|474177192|FG004|Overall Study|Withdrawal by Subject|0|||
131697962|NCT01926782|474177193|FG005|Overall Study|Withdrawal by Subject|5|||
131697963|NCT01926782|474177188|FG000|Overall Study|Related to study drug administration|0|||
131697964|NCT01926782|474177189|FG001|Overall Study|Related to study drug administration|0|||
131697965|NCT01926782|474177190|FG002|Overall Study|Related to study drug administration|0|||
131697966|NCT01926782|474177191|FG003|Overall Study|Related to study drug administration|0|||
131697967|NCT01926782|474177192|FG004|Overall Study|Related to study drug administration|0|||
131697968|NCT01926782|474177193|FG005|Overall Study|Related to study drug administration|2|||
131697969|NCT04372927|474177194|FG000|Overall Study|Death|1|||
131697970|NCT00070941|474177195|FG000|Overall Study|Adverse Event|10|||
131697971|NCT00070941|474177196|FG001|Overall Study|Adverse Event|8|||
131697972|NCT00070941|474177197|FG002|Overall Study|Adverse Event|4|||
131697973|NCT00094055|474177198|FG000|Overall Study|Adverse Event|11|||
131697974|NCT00094055|474177198|FG000|Overall Study|Death|4|||
131697975|NCT00094055|474177198|FG000|Overall Study|Lack of Efficacy|17|||
131697976|NCT00094055|474177198|FG000|Overall Study|Lost to Follow-up|2|||
131697977|NCT00094055|474177198|FG000|Overall Study|progressive disease|2|||
131697978|NCT00094055|474177198|FG000|Overall Study|clinical progression|1|||
131697979|NCT00094055|474177198|FG000|Overall Study|roll-over to another study|14|||
131697980|NCT00094055|474177198|FG000|Overall Study|Withdrawal by Subject|9|||
131697981|NCT00661271|474177200|FG000|Overall Study|Lost to Follow-up|28|||
131697982|NCT00661271|474177201|FG001|Overall Study|Lost to Follow-up|25|||
131697983|NCT00430508|474177203|FG000|Overall Study|Adverse Event|2|||
131697984|NCT00430508|474177204|FG001|Overall Study|Adverse Event|3|||
131697985|NCT00430508|474177205|FG002|Overall Study|Adverse Event|5|||
131783918|NCT04682639|474491737|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
131783919|NCT04682639|474491738|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
131783920|NCT04682639|474491739|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131697986|NCT00430508|474177206|FG003|Overall Study|Adverse Event|3|||
131697987|NCT00430508|474177203|FG000|Overall Study|Withdrawal by Subject|0|||
131697988|NCT00430508|474177204|FG001|Overall Study|Withdrawal by Subject|1|||
131697989|NCT00430508|474177205|FG002|Overall Study|Withdrawal by Subject|1|||
131783921|NCT04682639|474491740|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131783922|NCT04682639|474491736|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
131783923|NCT04682639|474491737|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
131783924|NCT04682639|474491738|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
131783925|NCT04682639|474491739|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
131783926|NCT04682639|474491740|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
131783927|NCT04682639|474491736|FG000|OLE Period (28 Weeks)|Other|1|||
131783928|NCT04682639|474491737|FG001|OLE Period (28 Weeks)|Other|2|||
131783929|NCT04682639|474491738|FG002|OLE Period (28 Weeks)|Other|0|||
131783930|NCT04682639|474491739|FG003|OLE Period (28 Weeks)|Other|0|||
131783931|NCT04682639|474491740|FG004|OLE Period (28 Weeks)|Other|1|||
131783932|NCT04682639|474491736|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
131783933|NCT04682639|474491737|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
131783934|NCT04682639|474491738|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
131783935|NCT04682639|474491739|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
131783936|NCT04682639|474491740|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
131783937|NCT04682639|474491736|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
131783938|NCT04682639|474491737|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
131783939|NCT04682639|474491738|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131783940|NCT04682639|474491739|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131783941|NCT04682639|474491740|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131783942|NCT04682639|474491736|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
131783943|NCT04682639|474491737|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
131783944|NCT04682639|474491738|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131783945|NCT04682639|474491739|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131783946|NCT04682639|474491740|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131783947|NCT04682639|474491736|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
131783948|NCT04682639|474491737|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
131783949|NCT04682639|474491738|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
131783950|NCT04682639|474491739|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
131783951|NCT04682639|474491740|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
131783952|NCT01392170|474491741|FG000|Overall Study|Withdrawal by Subject|1|||
131783953|NCT01392170|474491741|FG000|Overall Study|Ineligible|1|||
131783954|NCT01286207|474491742|FG000|Overall Study|Adverse Event|27|||
131783955|NCT01286207|474491743|FG001|Overall Study|Adverse Event|41|||
131783956|NCT01286207|474491744|FG002|Overall Study|Adverse Event|8|||
131783957|NCT01286207|474491742|FG000|Overall Study|Lost to Follow-up|49|||
131783958|NCT01286207|474491743|FG001|Overall Study|Lost to Follow-up|43|||
131783959|NCT01286207|474491744|FG002|Overall Study|Lost to Follow-up|20|||
131783960|NCT01286207|474491742|FG000|Overall Study|Withdrawal by Subject|93|||
131783961|NCT01286207|474491743|FG001|Overall Study|Withdrawal by Subject|79|||
131783962|NCT01286207|474491744|FG002|Overall Study|Withdrawal by Subject|41|||
131783963|NCT01286207|474491742|FG000|Overall Study|Lack of Response|92|||
131697990|NCT00430508|474177206|FG003|Overall Study|Withdrawal by Subject|1|||
131697991|NCT00430508|474177203|FG000|Overall Study|responder at visit 4|0|||
131697992|NCT00430508|474177204|FG001|Overall Study|responder at visit 4|0|||
131697993|NCT00430508|474177205|FG002|Overall Study|responder at visit 4|2|||
131697994|NCT00430508|474177206|FG003|Overall Study|responder at visit 4|0|||
131697995|NCT00430508|474177203|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
131697996|NCT00430508|474177204|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
131697997|NCT00430508|474177205|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
131697998|NCT00430508|474177206|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
131697999|NCT00430508|474177203|FG000|Overall Study|Other|1|||
131698000|NCT00430508|474177204|FG001|Overall Study|Other|1|||
131698001|NCT00430508|474177205|FG002|Overall Study|Other|3|||
131698002|NCT00430508|474177206|FG003|Overall Study|Other|0|||
131698003|NCT01707693|474177211|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
131698004|NCT01707693|474177212|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
131698005|NCT01707693|474177211|FG000|Overall Study Allocation|Protocol Violation|4|||
131698006|NCT01707693|474177212|FG001|Overall Study Allocation|Protocol Violation|3|||
131698007|NCT01707693|474177211|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
131783964|NCT01286207|474491743|FG001|Overall Study|Lack of Response|38|||
131783965|NCT01286207|474491744|FG002|Overall Study|Lack of Response|8|||
131783966|NCT01286207|474491742|FG000|Overall Study|Other|37|||
131783967|NCT01286207|474491743|FG001|Overall Study|Other|47|||
131783968|NCT01286207|474491744|FG002|Overall Study|Other|13|||
131783969|NCT00450177|474491746|FG000|Overall Study|Adverse Event|7|||
131783970|NCT00450177|474491747|FG001|Overall Study|Adverse Event|4|||
131783971|NCT00450177|474491746|FG000|Overall Study|Withdrawal by Subject|1|||
131783972|NCT00450177|474491747|FG001|Overall Study|Withdrawal by Subject|6|||
131783973|NCT00450177|474491746|FG000|Overall Study|Withdrawal by Primary Team|1|||
131783974|NCT00450177|474491747|FG001|Overall Study|Withdrawal by Primary Team|1|||
131783975|NCT04330482|474491765|FG000|Overall Study|Lost to Follow-up|2|||
131783976|NCT04330482|474491766|FG001|Overall Study|Lost to Follow-up|1|||
131783977|NCT04330482|474491765|FG000|Overall Study|Withdrawal by Subject|0|||
131783978|NCT04330482|474491766|FG001|Overall Study|Withdrawal by Subject|3|||
131572407|NCT02974010|473721496|FG001|Overall Study|Lack of Efficacy|0|||
131572408|NCT02974010|473721497|FG002|Overall Study|Lack of Efficacy|1|||
131572409|NCT02974010|473721498|FG003|Overall Study|Lack of Efficacy|0|||
131572410|NCT00320489|473721499|FG000|Overall Study|Adverse Event|26|||
131572411|NCT00320489|473721500|FG001|Overall Study|Adverse Event|25|||
131783979|NCT05144477|474491768|FG000|Overall Study|Withdrawal by Subject|1|||
131783980|NCT05144477|474491769|FG001|Overall Study|Withdrawal by Subject|1|||
131783981|NCT04333199|474491770|FG000|Evaluated Patients|Lost to Follow-up|0|||
131783982|NCT04333199|474491771|FG001|Evaluated Patients|Lost to Follow-up|1|||
131783983|NCT04333199|474491772|FG002|Evaluated Patients|Lost to Follow-up|2|||
131783984|NCT01155284|474491781|FG000|Overall Study|Withdrawal by Subject|4|||
131783985|NCT01155284|474491782|FG001|Overall Study|Withdrawal by Subject|3|||
131783986|NCT01155284|474491781|FG000|Overall Study|Lost to Follow-up|1|||
131783987|NCT01155284|474491782|FG001|Overall Study|Lost to Follow-up|2|||
131698008|NCT01707693|474177212|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
131698009|NCT01707693|474177211|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
131698010|NCT01707693|474177212|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
131698011|NCT04673786|474177213|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
131698012|NCT04673786|474177214|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
131698013|NCT04673786|474177215|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
131698014|NCT04673786|474177213|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
131698015|NCT04673786|474177214|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
131698016|NCT04673786|474177215|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
131698017|NCT04673786|474177213|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
131698018|NCT04673786|474177214|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
131698019|NCT04673786|474177215|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
131698020|NCT04673786|474177213|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
131698021|NCT04673786|474177214|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
131698022|NCT04673786|474177215|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
131698023|NCT04673786|474177213|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
131698024|NCT04673786|474177214|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
131698025|NCT04673786|474177215|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
131698026|NCT04673786|474177213|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
131698027|NCT04673786|474177214|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
131698028|NCT04673786|474177215|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
131698029|NCT01325428|474177216|FG000|Part A|Progressive disease according to RECIST|9|||
131698030|NCT01325428|474177216|FG000|Part A|Clinical signs, symptoms of progression|2|||
131698031|NCT01325428|474177216|FG000|Part A|Other adverse event|1|||
131698032|NCT01325428|474177216|FG000|Part A|Refused continue taking trial medication|2|||
131698033|NCT01325428|474177216|FG000|Part A|Other reason not defined above|2|||
131698034|NCT01325428|474177216|FG000|Part B|Refused continue taking trial medication|2|||
131698035|NCT01325428|474177216|FG000|Part B|Other reason not defined above|1|||
131698036|NCT01400451|474177217|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
131698037|NCT01400451|474177218|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
131698038|NCT01400451|474177219|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
131698039|NCT01400451|474177217|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
131698040|NCT01400451|474177218|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
131698041|NCT01400451|474177219|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
131698042|NCT01400451|474177217|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
131698043|NCT01400451|474177218|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
131698044|NCT01400451|474177219|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
131698045|NCT01400451|474177217|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
131698046|NCT01400451|474177218|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
131698047|NCT01400451|474177219|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
131698048|NCT01400451|474177217|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
131698049|NCT01400451|474177218|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
131698050|NCT01400451|474177219|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
131698051|NCT00044512|474177220|FG000|Follow Up|Lost to Follow-up|2|||
131698052|NCT00343889|474177235|FG000|Overall Study|Lost to Follow-up|2|||
131698053|NCT00343889|474177236|FG001|Overall Study|Lost to Follow-up|0|||
131698054|NCT00343889|474177235|FG000|Overall Study|Withdrawal by Subject|0|||
131698055|NCT00343889|474177236|FG001|Overall Study|Withdrawal by Subject|1|||
131698056|NCT00343889|474177235|FG000|Overall Study|Protocol Violation|1|||
131698057|NCT00343889|474177236|FG001|Overall Study|Protocol Violation|0|||
131698058|NCT01294579|474177239|FG000|Overall Study|Disease progression|12|||
131698059|NCT01294579|474177239|FG000|Overall Study|Adverse Event|11|||
131698060|NCT01294579|474177239|FG000|Overall Study|Study closed/terminated|3|||
131698061|NCT01294579|474177239|FG000|Overall Study|Lost to Follow-up|1|||
131698062|NCT01294579|474177239|FG000|Overall Study|Physician Decision|3|||
131698063|NCT01294579|474177239|FG000|Overall Study|Withdrawal by Subject|5|||
131572412|NCT00320489|473721499|FG000|Overall Study|Clinical Relapse|26|||
131572413|NCT00320489|473721500|FG001|Overall Study|Clinical Relapse|20|||
131698064|NCT02573155|474177240|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
131698065|NCT02573155|474177241|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
131698066|NCT02573155|474177240|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
131698067|NCT02573155|474177241|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
131698068|NCT02573155|474177240|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
131698069|NCT02573155|474177241|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
131698070|NCT02573155|474177240|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
131698071|NCT02573155|474177241|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
131698072|NCT02573155|474177240|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
131572414|NCT00320489|473721499|FG000|Overall Study|Death|0|||
131572415|NCT00320489|473721500|FG001|Overall Study|Death|2|||
131572416|NCT00320489|473721499|FG000|Overall Study|Entry Criteria Exclusion|2|||
131572417|NCT00320489|473721500|FG001|Overall Study|Entry Criteria Exclusion|4|||
131572418|NCT00320489|473721499|FG000|Overall Study|Lack of Efficacy|16|||
131572419|NCT00320489|473721500|FG001|Overall Study|Lack of Efficacy|7|||
131572420|NCT00320489|473721499|FG000|Overall Study|Lost to Follow-up|21|||
131572421|NCT00320489|473721500|FG001|Overall Study|Lost to Follow-up|22|||
131572422|NCT00320489|473721499|FG000|Overall Study|Physician Decision|8|||
131572423|NCT00320489|473721500|FG001|Overall Study|Physician Decision|8|||
131572424|NCT00320489|473721499|FG000|Overall Study|Protocol Violation|4|||
131698073|NCT02573155|474177241|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
131698074|NCT02573155|474177240|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
131698075|NCT02573155|474177241|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
131698076|NCT02573155|474177240|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
131698077|NCT02573155|474177241|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
131698078|NCT02573155|474177240|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
131698079|NCT02573155|474177241|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
131698080|NCT00903929|474177242|FG000|Overall Study|Withdrawal by Subject|0|||
131698081|NCT00903929|474177243|FG001|Overall Study|Withdrawal by Subject|0|||
131698082|NCT00903929|474177244|FG002|Overall Study|Withdrawal by Subject|1|||
131698083|NCT00903929|474177245|FG003|Overall Study|Withdrawal by Subject|2|||
131698084|NCT00903929|474177242|FG000|Overall Study|Adverse Event|0|||
131698085|NCT00903929|474177243|FG001|Overall Study|Adverse Event|0|||
131698086|NCT00903929|474177244|FG002|Overall Study|Adverse Event|0|||
131698087|NCT00903929|474177245|FG003|Overall Study|Adverse Event|1|||
131698088|NCT00516737|474177251|FG000|Overall Study|Lost to Follow-up|2|||
131698089|NCT00516737|474177252|FG001|Overall Study|Lost to Follow-up|0|||
131698090|NCT00516737|474177251|FG000|Overall Study|Physician Decision|0|||
131698091|NCT00516737|474177252|FG001|Overall Study|Physician Decision|1|||
131698092|NCT00516737|474177251|FG000|Overall Study|Withdrawal by Subject|0|||
131698093|NCT00516737|474177252|FG001|Overall Study|Withdrawal by Subject|1|||
131698094|NCT00516737|474177251|FG000|Overall Study|Lack of Qualifying Event|9|||
131698095|NCT00516737|474177252|FG001|Overall Study|Lack of Qualifying Event|6|||
131698096|NCT00512798|474177253|FG000|Overall Study|Death|0|||
131698097|NCT00512798|474177254|FG001|Overall Study|Death|3|||
131698098|NCT00512798|474177253|FG000|Overall Study|Adverse Event|2|||
131698099|NCT00512798|474177254|FG001|Overall Study|Adverse Event|4|||
131698100|NCT00512798|474177253|FG000|Overall Study|Progression of disease|14|||
131698101|NCT00512798|474177254|FG001|Overall Study|Progression of disease|20|||
131698102|NCT00512798|474177253|FG000|Overall Study|Withdrawal by Subject|3|||
131698103|NCT00512798|474177254|FG001|Overall Study|Withdrawal by Subject|0|||
131698104|NCT00454805|474177258|FG000|Overall Study|Withdrawal by Subject|9|||
131698105|NCT00454805|474177259|FG001|Overall Study|Withdrawal by Subject|2|||
131698106|NCT00454805|474177258|FG000|Overall Study|Death|0|||
131698107|NCT00454805|474177259|FG001|Overall Study|Death|2|||
131698108|NCT00454805|474177258|FG000|Overall Study|Disease progression|16|||
131437854|NCT00556894|473228169|FG002|Overall Study|Change in therapy|2|||
131698109|NCT00454805|474177259|FG001|Overall Study|Disease progression|19|||
131698110|NCT00454805|474177258|FG000|Overall Study|In order to begin radiotherapy|1|||
131783988|NCT01155284|474491781|FG000|Overall Study|Physician Decision|1|||
131698111|NCT00454805|474177259|FG001|Overall Study|In order to begin radiotherapy|0|||
131783989|NCT01155284|474491782|FG001|Overall Study|Physician Decision|0|||
131572425|NCT00320489|473721500|FG001|Overall Study|Protocol Violation|4|||
131572426|NCT00320489|473721499|FG000|Overall Study|Sponsor Decision|3|||
131572427|NCT00320489|473721500|FG001|Overall Study|Sponsor Decision|3|||
131572428|NCT00320489|473721499|FG000|Overall Study|Withdrawal by Subject|39|||
131572429|NCT00320489|473721500|FG001|Overall Study|Withdrawal by Subject|41|||
131572430|NCT03441984|473721501|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572431|NCT03441984|473721502|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572432|NCT03441984|473721503|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
131572433|NCT03441984|473721504|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572434|NCT03441984|473721505|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572435|NCT03441984|473721506|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131698112|NCT04158648|474177272|FG000|Overall Study|Ongoing in the Study|69|||
131698113|NCT04158648|474177272|FG000|Overall Study|Withdrawal by Subject|4|||
131698114|NCT01250379|474177273|FG000|Overall Study|Death|141|||
131698115|NCT01250379|474177274|FG001|Overall Study|Death|148|||
131698116|NCT01250379|474177273|FG000|Overall Study|Withdrawal by Subject|32|||
131698117|NCT01250379|474177274|FG001|Overall Study|Withdrawal by Subject|20|||
131698118|NCT01250379|474177273|FG000|Overall Study|Physician Decision|11|||
131698119|NCT01250379|474177274|FG001|Overall Study|Physician Decision|3|||
131698120|NCT01250379|474177273|FG000|Overall Study|Protocol Violation|2|||
131698121|NCT01250379|474177274|FG001|Overall Study|Protocol Violation|8|||
131698122|NCT01250379|474177273|FG000|Overall Study|Lost to Follow-up|9|||
131698123|NCT01250379|474177274|FG001|Overall Study|Lost to Follow-up|6|||
131698124|NCT01250379|474177273|FG000|Overall Study|Adverse Event|5|||
131698125|NCT01250379|474177274|FG001|Overall Study|Adverse Event|4|||
131698126|NCT01250379|474177273|FG000|Overall Study|Other|0|||
131698127|NCT01250379|474177274|FG001|Overall Study|Other|4|||
131698128|NCT01250379|474177273|FG000|Overall Study|Participant noncompliance|2|||
131698129|NCT01250379|474177274|FG001|Overall Study|Participant noncompliance|0|||
131698130|NCT01489527|474177276|FG000|Overall Study|Pregnancy|9|||
131698131|NCT01489527|474177277|FG001|Overall Study|Pregnancy|14|||
131698132|NCT01489527|474177276|FG000|Overall Study|Participant moved|6|||
131698133|NCT01489527|474177277|FG001|Overall Study|Participant moved|7|||
131698134|NCT01489527|474177276|FG000|Overall Study|Withdrawal by Subject|0|||
131698135|NCT01489527|474177277|FG001|Overall Study|Withdrawal by Subject|4|||
131698136|NCT01489527|474177276|FG000|Overall Study|Lost to Follow-up|5|||
131698137|NCT01489527|474177277|FG001|Overall Study|Lost to Follow-up|1|||
131698138|NCT01489527|474177276|FG000|Overall Study|Procedures|1|||
131698139|NCT01489527|474177277|FG001|Overall Study|Procedures|0|||
131698140|NCT01489527|474177276|FG000|Overall Study|Not compliant|1|||
131698141|NCT01489527|474177277|FG001|Overall Study|Not compliant|0|||
131698142|NCT01984268|474177278|FG000|Overall Study|Study Terminated|15|||
131698143|NCT00936208|474177279|FG000|Overall Study|Protocol Violation|37|||
131698144|NCT00936208|474177280|FG001|Overall Study|Protocol Violation|22|||
131698145|NCT01344876|474177284|FG000|Overall Study|Adverse Event|0|||
131698146|NCT01344876|474177285|FG001|Overall Study|Adverse Event|0|||
131698147|NCT01344876|474177286|FG002|Overall Study|Adverse Event|0|||
131698148|NCT01344876|474177287|FG003|Overall Study|Adverse Event|0|||
131698149|NCT01344876|474177288|FG004|Overall Study|Adverse Event|1|||
131698150|NCT01344876|474177284|FG000|Overall Study|Withdrawal by Subject|0|||
131698151|NCT01344876|474177285|FG001|Overall Study|Withdrawal by Subject|0|||
131698152|NCT01344876|474177286|FG002|Overall Study|Withdrawal by Subject|1|||
131698153|NCT01344876|474177287|FG003|Overall Study|Withdrawal by Subject|0|||
131698154|NCT01344876|474177288|FG004|Overall Study|Withdrawal by Subject|0|||
131783990|NCT01155284|474491781|FG000|Overall Study|Adverse Event|1|||
131698155|NCT01344876|474177284|FG000|Overall Study|Definite progression of primary disease|1|||
131698156|NCT01344876|474177285|FG001|Overall Study|Definite progression of primary disease|0|||
131783991|NCT01155284|474491782|FG001|Overall Study|Adverse Event|0|||
131783992|NCT01289990|474491786|FG000|Overall Study|Death|0|||
131783993|NCT01289990|474491787|FG001|Overall Study|Death|0|||
131783994|NCT01289990|474491788|FG002|Overall Study|Death|0|||
131698157|NCT01344876|474177286|FG002|Overall Study|Definite progression of primary disease|0|||
131572436|NCT03441984|473721507|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572437|NCT03441984|473721508|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572438|NCT03441984|473721509|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572439|NCT03441984|473721510|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572440|NCT03441984|473721511|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572441|NCT03441984|473721512|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131572442|NCT00746330|473721515|FG000|Period 1|Abnormal test procedure result|0|||
131572443|NCT00746330|473721516|FG001|Period 1|Abnormal test procedure result|0|||
131572444|NCT00746330|473721517|FG002|Period 1|Abnormal test procedure result|1|||
131572445|NCT00746330|473721518|FG003|Period 1|Abnormal test procedure result|0|||
131572446|NCT01981850|473721519|FG000|Main Phase Stage 1|Death|2|||
131572447|NCT01981850|473721520|FG001|Main Phase Stage 1|Death|0|||
131572448|NCT01981850|473721521|FG002|Main Phase Stage 1|Death|0|||
131572449|NCT01981850|473721522|FG003|Main Phase Stage 1|Death|0|||
131572450|NCT01981850|473721523|FG004|Main Phase Stage 1|Death|0|||
131572451|NCT01981850|473721524|FG005|Main Phase Stage 1|Death|0|||
131572452|NCT01981850|473721525|FG006|Main Phase Stage 1|Death|0|||
131572453|NCT01981850|473721526|FG007|Main Phase Stage 1|Death|0|||
131572454|NCT01981850|473721527|FG008|Main Phase Stage 1|Death|0|||
131572455|NCT01981850|473721528|FG009|Main Phase Stage 1|Death|0|||
131572456|NCT01981850|473721519|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
131572457|NCT01981850|473721520|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572458|NCT01981850|473721521|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572459|NCT01981850|473721522|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572460|NCT01981850|473721523|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572461|NCT01981850|473721524|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572462|NCT01981850|473721525|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572463|NCT01981850|473721526|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572464|NCT01981850|473721527|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572465|NCT01981850|473721528|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131572466|NCT01981850|473721519|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
131572467|NCT01981850|473721520|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
131572468|NCT01981850|473721521|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
131572469|NCT01981850|473721522|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
131572470|NCT01981850|473721523|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
131572471|NCT01981850|473721524|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
131572472|NCT01981850|473721525|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
131572473|NCT01981850|473721526|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
131783995|NCT01289990|474491789|FG003|Overall Study|Death|1|||
131783996|NCT01289990|474491790|FG004|Overall Study|Death|2|||
131783997|NCT01289990|474491791|FG005|Overall Study|Death|1|||
131783998|NCT01289990|474491792|FG006|Overall Study|Death|0|||
131783999|NCT01289990|474491793|FG007|Overall Study|Death|0|||
131784000|NCT01289990|474491794|FG008|Overall Study|Death|0|||
131784001|NCT01289990|474491795|FG009|Overall Study|Death|0|||
131784002|NCT01289990|474491796|FG010|Overall Study|Death|0|||
131698158|NCT01344876|474177287|FG003|Overall Study|Definite progression of primary disease|3|||
131698159|NCT01344876|474177288|FG004|Overall Study|Definite progression of primary disease|0|||
131698160|NCT04428424|474177289|FG000|Overall Study|Does not meet entrance criteria|132|||
131698161|NCT04428424|474177289|FG000|Overall Study|Lost to Follow-up|115|||
131698162|NCT04818593|474177290|FG000|Overall Study|Low Oocyte Yield|8|||
131698163|NCT04818593|474177291|FG001|Overall Study|Low Oocyte Yield|8|||
131698164|NCT04818593|474177290|FG000|Overall Study|Not ICSI Insemination|7|||
131698165|NCT04818593|474177291|FG001|Overall Study|Not ICSI Insemination|7|||
131698166|NCT04818593|474177290|FG000|Overall Study|Poor Sperm Quality|2|||
131698167|NCT04818593|474177291|FG001|Overall Study|Poor Sperm Quality|2|||
131698168|NCT04818593|474177290|FG000|Overall Study|Withdrawal by Subject|2|||
131698169|NCT04818593|474177291|FG001|Overall Study|Withdrawal by Subject|2|||
131698170|NCT04818593|474177290|FG000|Overall Study|Conversion to IUI due to low response|1|||
131698171|NCT04818593|474177291|FG001|Overall Study|Conversion to IUI due to low response|1|||
131572474|NCT01981850|473721527|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
131572475|NCT01981850|473721528|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
131784003|NCT01289990|474491797|FG011|Overall Study|Death|1|||
131572476|NCT01981850|473721519|FG000|Main Phase Stage 1|Various reasons|0|||
131572477|NCT01981850|473721520|FG001|Main Phase Stage 1|Various reasons|0|||
131572478|NCT01981850|473721521|FG002|Main Phase Stage 1|Various reasons|2|||
131572479|NCT01981850|473721522|FG003|Main Phase Stage 1|Various reasons|0|||
131572480|NCT01981850|473721523|FG004|Main Phase Stage 1|Various reasons|0|||
131784004|NCT01289990|474491798|FG012|Overall Study|Death|0|||
131784005|NCT01289990|474491786|FG000|Overall Study|Lost to Follow-up|3|||
131784006|NCT01289990|474491787|FG001|Overall Study|Lost to Follow-up|2|||
131784007|NCT01289990|474491788|FG002|Overall Study|Lost to Follow-up|5|||
131784008|NCT01289990|474491789|FG003|Overall Study|Lost to Follow-up|5|||
131784009|NCT01289990|474491790|FG004|Overall Study|Lost to Follow-up|3|||
131784010|NCT01289990|474491791|FG005|Overall Study|Lost to Follow-up|4|||
131784011|NCT01289990|474491792|FG006|Overall Study|Lost to Follow-up|2|||
131784012|NCT01289990|474491793|FG007|Overall Study|Lost to Follow-up|2|||
131784013|NCT01289990|474491794|FG008|Overall Study|Lost to Follow-up|1|||
131784014|NCT01289990|474491795|FG009|Overall Study|Lost to Follow-up|4|||
131784015|NCT01289990|474491796|FG010|Overall Study|Lost to Follow-up|2|||
131784016|NCT01289990|474491797|FG011|Overall Study|Lost to Follow-up|1|||
131784017|NCT01289990|474491798|FG012|Overall Study|Lost to Follow-up|2|||
131784018|NCT01289990|474491786|FG000|Overall Study|Withdrawal by Subject|15|||
131784019|NCT01289990|474491787|FG001|Overall Study|Withdrawal by Subject|14|||
131784020|NCT01289990|474491788|FG002|Overall Study|Withdrawal by Subject|12|||
131784021|NCT01289990|474491789|FG003|Overall Study|Withdrawal by Subject|13|||
131784022|NCT01289990|474491790|FG004|Overall Study|Withdrawal by Subject|8|||
131784023|NCT01289990|474491791|FG005|Overall Study|Withdrawal by Subject|7|||
131784024|NCT01289990|474491792|FG006|Overall Study|Withdrawal by Subject|13|||
131784025|NCT01289990|474491793|FG007|Overall Study|Withdrawal by Subject|9|||
131784026|NCT01289990|474491794|FG008|Overall Study|Withdrawal by Subject|12|||
131784027|NCT01289990|474491795|FG009|Overall Study|Withdrawal by Subject|13|||
131784028|NCT01289990|474491796|FG010|Overall Study|Withdrawal by Subject|11|||
131784029|NCT01289990|474491797|FG011|Overall Study|Withdrawal by Subject|13|||
131784030|NCT01289990|474491798|FG012|Overall Study|Withdrawal by Subject|16|||
131784031|NCT01289990|474491786|FG000|Overall Study|discontinued in preceding trial|18|||
131784032|NCT01289990|474491787|FG001|Overall Study|discontinued in preceding trial|20|||
131784033|NCT01289990|474491788|FG002|Overall Study|discontinued in preceding trial|41|||
131784034|NCT01289990|474491789|FG003|Overall Study|discontinued in preceding trial|17|||
131572481|NCT01981850|473721524|FG005|Main Phase Stage 1|Various reasons|0|||
131784035|NCT01289990|474491790|FG004|Overall Study|discontinued in preceding trial|11|||
131784036|NCT01289990|474491791|FG005|Overall Study|discontinued in preceding trial|12|||
131784037|NCT01289990|474491792|FG006|Overall Study|discontinued in preceding trial|18|||
131784038|NCT01289990|474491793|FG007|Overall Study|discontinued in preceding trial|8|||
131784039|NCT01289990|474491794|FG008|Overall Study|discontinued in preceding trial|17|||
131784040|NCT01289990|474491795|FG009|Overall Study|discontinued in preceding trial|21|||
131784041|NCT01289990|474491796|FG010|Overall Study|discontinued in preceding trial|17|||
131572482|NCT01981850|473721525|FG006|Main Phase Stage 1|Various reasons|0|||
131572483|NCT01981850|473721526|FG007|Main Phase Stage 1|Various reasons|0|||
131784042|NCT01289990|474491797|FG011|Overall Study|discontinued in preceding trial|17|||
131784043|NCT01289990|474491798|FG012|Overall Study|discontinued in preceding trial|24|||
131784044|NCT01289990|474491786|FG000|Overall Study|did not continue in extension|41|||
131784045|NCT01289990|474491787|FG001|Overall Study|did not continue in extension|45|||
131784046|NCT01289990|474491788|FG002|Overall Study|did not continue in extension|51|||
131784047|NCT01289990|474491789|FG003|Overall Study|did not continue in extension|51|||
131784048|NCT01289990|474491790|FG004|Overall Study|did not continue in extension|48|||
131784049|NCT01289990|474491791|FG005|Overall Study|did not continue in extension|50|||
131784050|NCT01289990|474491792|FG006|Overall Study|did not continue in extension|54|||
131784051|NCT01289990|474491793|FG007|Overall Study|did not continue in extension|36|||
131784052|NCT01289990|474491794|FG008|Overall Study|did not continue in extension|44|||
131784053|NCT01289990|474491795|FG009|Overall Study|did not continue in extension|48|||
131784054|NCT01289990|474491796|FG010|Overall Study|did not continue in extension|45|||
131784055|NCT01289990|474491797|FG011|Overall Study|did not continue in extension|34|||
131784056|NCT01289990|474491798|FG012|Overall Study|did not continue in extension|56|||
131784057|NCT01289990|474491786|FG000|Overall Study|Not treated|0|||
131784058|NCT01289990|474491787|FG001|Overall Study|Not treated|0|||
131784059|NCT01289990|474491788|FG002|Overall Study|Not treated|0|||
131784060|NCT01289990|474491789|FG003|Overall Study|Not treated|0|||
131784061|NCT01289990|474491790|FG004|Overall Study|Not treated|0|||
131784062|NCT01289990|474491791|FG005|Overall Study|Not treated|0|||
131784063|NCT01289990|474491792|FG006|Overall Study|Not treated|1|||
131784064|NCT01289990|474491793|FG007|Overall Study|Not treated|0|||
131784065|NCT01289990|474491794|FG008|Overall Study|Not treated|1|||
131784066|NCT01289990|474491795|FG009|Overall Study|Not treated|0|||
131784067|NCT01289990|474491796|FG010|Overall Study|Not treated|1|||
131784068|NCT01289990|474491797|FG011|Overall Study|Not treated|2|||
131784069|NCT01289990|474491798|FG012|Overall Study|Not treated|0|||
131784070|NCT04529499|474491799|FG000|Overall Study|Withdrawal by Subject|9|||
131784071|NCT04529499|474491800|FG001|Overall Study|Withdrawal by Subject|11|||
131784072|NCT04529499|474491799|FG000|Overall Study|Physician Decision|1|||
131784073|NCT04529499|474491800|FG001|Overall Study|Physician Decision|2|||
131784074|NCT04529499|474491799|FG000|Overall Study|Adverse Event|4|||
131784075|NCT04529499|474491800|FG001|Overall Study|Adverse Event|4|||
131784076|NCT04529499|474491799|FG000|Overall Study|Death|14|||
131784077|NCT04529499|474491800|FG001|Overall Study|Death|11|||
131784078|NCT04529499|474491799|FG000|Overall Study|Lost to Follow-up|1|||
131784079|NCT04529499|474491800|FG001|Overall Study|Lost to Follow-up|1|||
131784080|NCT04529499|474491799|FG000|Overall Study|Others|7|||
131784081|NCT04529499|474491800|FG001|Overall Study|Others|11|||
131784082|NCT01211613|474493180|FG000|Overall Study|Lost to Follow-up|2|||
131784083|NCT01211613|474493181|FG001|Overall Study|Lost to Follow-up|2|||
131784084|NCT01211613|474493182|FG002|Overall Study|Lost to Follow-up|2|||
131784085|NCT01211613|474493180|FG000|Overall Study|Withdrawal by Subject|1|||
131784086|NCT01211613|474493181|FG001|Overall Study|Withdrawal by Subject|0|||
131784087|NCT01211613|474493182|FG002|Overall Study|Withdrawal by Subject|0|||
131572484|NCT01981850|473721527|FG008|Main Phase Stage 1|Various reasons|0|||
131572485|NCT01981850|473721528|FG009|Main Phase Stage 1|Various reasons|0|||
131572486|NCT01981850|473721519|FG000|Main Phase Stage 2|Adverse Event|0|||
131572487|NCT01981850|473721520|FG001|Main Phase Stage 2|Adverse Event|0|||
131572488|NCT01981850|473721521|FG002|Main Phase Stage 2|Adverse Event|0|||
131784088|NCT00297492|474493183|FG000|Set Quit Date|Lost to Follow-up|7|||
131784089|NCT00297492|474493184|FG001|Set Quit Date|Lost to Follow-up|13|||
131784090|NCT00297492|474493185|FG002|Set Quit Date|Lost to Follow-up|5|||
131784091|NCT00297492|474493183|FG000|6 Month Follow-up|Lost to Follow-up|63|||
131784092|NCT00297492|474493184|FG001|6 Month Follow-up|Lost to Follow-up|49|||
131784093|NCT00297492|474493185|FG002|6 Month Follow-up|Lost to Follow-up|27|||
131572489|NCT01981850|473721522|FG003|Main Phase Stage 2|Adverse Event|0|||
131784094|NCT02437890|474493188|FG000|Overall Study|Non-compliance to study drug|0|||
131784095|NCT02437890|474493189|FG001|Overall Study|Non-compliance to study drug|1|||
131784096|NCT02437890|474493190|FG002|Overall Study|Non-compliance to study drug|0|||
131784097|NCT02437890|474493191|FG003|Overall Study|Non-compliance to study drug|0|||
131784098|NCT02437890|474493192|FG004|Overall Study|Non-compliance to study drug|1|||
131784099|NCT02437890|474493188|FG000|Overall Study|Sponsor's decision|1|||
131784100|NCT02437890|474493189|FG001|Overall Study|Sponsor's decision|1|||
131784101|NCT02437890|474493190|FG002|Overall Study|Sponsor's decision|4|||
131784102|NCT02437890|474493191|FG003|Overall Study|Sponsor's decision|0|||
131784103|NCT02437890|474493192|FG004|Overall Study|Sponsor's decision|2|||
131784104|NCT02437890|474493188|FG000|Overall Study|Physician Decision|0|||
131784105|NCT02437890|474493189|FG001|Overall Study|Physician Decision|0|||
131572490|NCT01981850|473721523|FG004|Main Phase Stage 2|Adverse Event|6|||
131572491|NCT01981850|473721524|FG005|Main Phase Stage 2|Adverse Event|5|||
131784106|NCT02437890|474493190|FG002|Overall Study|Physician Decision|0|||
131572492|NCT01981850|473721525|FG006|Main Phase Stage 2|Adverse Event|7|||
131572493|NCT01981850|473721526|FG007|Main Phase Stage 2|Adverse Event|0|||
131572494|NCT01981850|473721527|FG008|Main Phase Stage 2|Adverse Event|0|||
131698172|NCT02926950|474177292|FG000|Overall Study|Adverse Event|4|||
131698173|NCT02926950|474177293|FG001|Overall Study|Adverse Event|6|||
131698174|NCT02926950|474177292|FG000|Overall Study|At the participant's own request|21|||
131698175|NCT02926950|474177293|FG001|Overall Study|At the participant's own request|25|||
131698176|NCT02926950|474177292|FG000|Overall Study|Reason not Specified|17|||
131698177|NCT02926950|474177293|FG001|Overall Study|Reason not Specified|9|||
131698178|NCT02926950|474177292|FG000|Overall Study|Lost to Follow-up|7|||
131698179|NCT02926950|474177293|FG001|Overall Study|Lost to Follow-up|8|||
131698180|NCT05036083|474177294|FG000|Overall Study|Physician Decision|1|||
131698181|NCT05036083|474177294|FG000|Overall Study|Withdrawal by Subject|1|||
131698182|NCT05036083|474177294|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
131698183|NCT05036083|474177294|FG000|Overall Study|IV not sustainable|1|||
131698184|NCT01790503|474179410|FG000|Overall Study|Adverse Event|1|||
131698185|NCT01790503|474179411|FG001|Overall Study|Adverse Event|0|||
131698186|NCT01790503|474179412|FG002|Overall Study|Adverse Event|0|||
131572495|NCT01981850|473721528|FG009|Main Phase Stage 2|Adverse Event|0|||
131698187|NCT01790503|474179413|FG003|Overall Study|Adverse Event|0|||
131698188|NCT01790503|474179414|FG004|Overall Study|Adverse Event|0|||
131698189|NCT01790503|474179415|FG005|Overall Study|Adverse Event|2|||
131698190|NCT01790503|474179416|FG006|Overall Study|Adverse Event|0|||
131698191|NCT01790503|474179417|FG007|Overall Study|Adverse Event|0|||
131572496|NCT01981850|473721519|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131698192|NCT01790503|474179418|FG008|Overall Study|Adverse Event|2|||
131698193|NCT01790503|474179419|FG009|Overall Study|Adverse Event|4|||
131784107|NCT02437890|474493191|FG003|Overall Study|Physician Decision|1|||
131784108|NCT02437890|474493192|FG004|Overall Study|Physician Decision|0|||
131784109|NCT02437890|474493188|FG000|Overall Study|Unable to attend visit(s)|1|||
131784110|NCT02437890|474493189|FG001|Overall Study|Unable to attend visit(s)|0|||
131784111|NCT02437890|474493190|FG002|Overall Study|Unable to attend visit(s)|0|||
131784112|NCT02437890|474493191|FG003|Overall Study|Unable to attend visit(s)|0|||
131784113|NCT02437890|474493192|FG004|Overall Study|Unable to attend visit(s)|0|||
131784114|NCT02437890|474493188|FG000|Overall Study|Lack of Efficacy|1|||
131784115|NCT02437890|474493189|FG001|Overall Study|Lack of Efficacy|3|||
131784116|NCT02437890|474493190|FG002|Overall Study|Lack of Efficacy|0|||
131784117|NCT02437890|474493191|FG003|Overall Study|Lack of Efficacy|3|||
131784118|NCT02437890|474493192|FG004|Overall Study|Lack of Efficacy|1|||
131784119|NCT02437890|474493188|FG000|Overall Study|Adverse Event|4|||
131784120|NCT02437890|474493189|FG001|Overall Study|Adverse Event|9|||
131784121|NCT02437890|474493190|FG002|Overall Study|Adverse Event|5|||
131784122|NCT02437890|474493191|FG003|Overall Study|Adverse Event|11|||
131784123|NCT02437890|474493192|FG004|Overall Study|Adverse Event|7|||
131784124|NCT02437890|474493188|FG000|Overall Study|Withdrawal by Subject|1|||
131784125|NCT02437890|474493189|FG001|Overall Study|Withdrawal by Subject|2|||
131784126|NCT02437890|474493190|FG002|Overall Study|Withdrawal by Subject|6|||
131784127|NCT02437890|474493191|FG003|Overall Study|Withdrawal by Subject|5|||
131784128|NCT02437890|474493192|FG004|Overall Study|Withdrawal by Subject|5|||
131784129|NCT02437890|474493188|FG000|Overall Study|Death|0|||
131784130|NCT02437890|474493189|FG001|Overall Study|Death|0|||
131784131|NCT02437890|474493190|FG002|Overall Study|Death|0|||
131784132|NCT02437890|474493191|FG003|Overall Study|Death|2|||
131784133|NCT02437890|474493192|FG004|Overall Study|Death|0|||
131784134|NCT02414854|474493193|FG000|Overall Study|Adverse Event|9|||
131784135|NCT02414854|474493194|FG001|Overall Study|Adverse Event|7|||
131784136|NCT02414854|474493195|FG002|Overall Study|Adverse Event|1|||
131784137|NCT02414854|474493196|FG003|Overall Study|Adverse Event|12|||
131784138|NCT02414854|474493193|FG000|Overall Study|Poor compliance to protocol|1|||
131784139|NCT02414854|474493194|FG001|Overall Study|Poor compliance to protocol|1|||
131784140|NCT02414854|474493195|FG002|Overall Study|Poor compliance to protocol|2|||
131784141|NCT02414854|474493196|FG003|Overall Study|Poor compliance to protocol|2|||
131698194|NCT01790503|474179420|FG010|Overall Study|Adverse Event|7|||
131698195|NCT01790503|474179410|FG000|Overall Study|Withdrawal by Subject|0|||
131698196|NCT01790503|474179411|FG001|Overall Study|Withdrawal by Subject|0|||
131698197|NCT01790503|474179412|FG002|Overall Study|Withdrawal by Subject|1|||
131698198|NCT01790503|474179413|FG003|Overall Study|Withdrawal by Subject|1|||
131698199|NCT01790503|474179414|FG004|Overall Study|Withdrawal by Subject|1|||
131698200|NCT01790503|474179415|FG005|Overall Study|Withdrawal by Subject|2|||
131698201|NCT01790503|474179416|FG006|Overall Study|Withdrawal by Subject|1|||
131698202|NCT01790503|474179417|FG007|Overall Study|Withdrawal by Subject|0|||
131698203|NCT01790503|474179418|FG008|Overall Study|Withdrawal by Subject|0|||
131698204|NCT01790503|474179419|FG009|Overall Study|Withdrawal by Subject|0|||
131698205|NCT01790503|474179420|FG010|Overall Study|Withdrawal by Subject|1|||
131698206|NCT01790503|474179410|FG000|Overall Study|Disease progression|2|||
131698207|NCT01790503|474179411|FG001|Overall Study|Disease progression|1|||
131698208|NCT01790503|474179412|FG002|Overall Study|Disease progression|0|||
131698209|NCT01790503|474179413|FG003|Overall Study|Disease progression|1|||
131698210|NCT01790503|474179414|FG004|Overall Study|Disease progression|2|||
131698211|NCT01790503|474179415|FG005|Overall Study|Disease progression|1|||
131698212|NCT01790503|474179416|FG006|Overall Study|Disease progression|0|||
131698213|NCT01790503|474179417|FG007|Overall Study|Disease progression|1|||
131698214|NCT01790503|474179418|FG008|Overall Study|Disease progression|0|||
131698215|NCT01790503|474179419|FG009|Overall Study|Disease progression|17|||
131784142|NCT02414854|474493193|FG000|Overall Study|Other than specified above|12|||
131784143|NCT02414854|474493194|FG001|Overall Study|Other than specified above|37|||
131784144|NCT02414854|474493195|FG002|Overall Study|Other than specified above|17|||
131784145|NCT02414854|474493196|FG003|Overall Study|Other than specified above|37|||
131784146|NCT02082262|474493197|FG000|Overall Study|Withdrawal by Subject|3|||
131784147|NCT02082262|474493197|FG000|Overall Study|Adverse Event|48|||
131784148|NCT01074307|474493198|FG000|Overall Study|No primary endpoint evaluation|14|||
131698216|NCT01790503|474179420|FG010|Overall Study|Disease progression|7|||
131698217|NCT01790503|474179410|FG000|Overall Study|Protocol Violation|0|||
131698218|NCT01790503|474179411|FG001|Overall Study|Protocol Violation|0|||
131784149|NCT01074307|474493199|FG001|Overall Study|No primary endpoint evaluation|6|||
131784150|NCT01074307|474493198|FG000|Overall Study|Exclusion criterion|0|||
131784151|NCT01074307|474493199|FG001|Overall Study|Exclusion criterion|1|||
131572497|NCT01981850|473721520|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131572498|NCT01981850|473721521|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131572499|NCT01981850|473721522|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131572500|NCT01981850|473721523|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
131572501|NCT01981850|473721524|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
131572502|NCT01981850|473721525|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
131572503|NCT01981850|473721526|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131572504|NCT01981850|473721527|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131572505|NCT01981850|473721528|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131572506|NCT01981850|473721519|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
131572507|NCT01981850|473721520|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
131572508|NCT01981850|473721521|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
131572509|NCT01981850|473721522|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
131572510|NCT01981850|473721523|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
131572511|NCT01981850|473721524|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
131572512|NCT01981850|473721525|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
131698219|NCT01790503|474179412|FG002|Overall Study|Protocol Violation|0|||
131698220|NCT01790503|474179413|FG003|Overall Study|Protocol Violation|0|||
131698221|NCT01790503|474179414|FG004|Overall Study|Protocol Violation|0|||
131698222|NCT01790503|474179415|FG005|Overall Study|Protocol Violation|0|||
131698223|NCT01790503|474179416|FG006|Overall Study|Protocol Violation|0|||
131698224|NCT01790503|474179417|FG007|Overall Study|Protocol Violation|0|||
131698225|NCT01790503|474179418|FG008|Overall Study|Protocol Violation|0|||
131698226|NCT01790503|474179419|FG009|Overall Study|Protocol Violation|1|||
131698227|NCT01790503|474179420|FG010|Overall Study|Protocol Violation|0|||
131698228|NCT01790503|474179410|FG000|Overall Study|Physician Decision|0|||
131698229|NCT01790503|474179411|FG001|Overall Study|Physician Decision|0|||
131698230|NCT01790503|474179412|FG002|Overall Study|Physician Decision|0|||
131698231|NCT01790503|474179413|FG003|Overall Study|Physician Decision|0|||
131698232|NCT01790503|474179414|FG004|Overall Study|Physician Decision|0|||
131698233|NCT01790503|474179415|FG005|Overall Study|Physician Decision|0|||
131698234|NCT01790503|474179416|FG006|Overall Study|Physician Decision|0|||
131698235|NCT01790503|474179417|FG007|Overall Study|Physician Decision|0|||
131698236|NCT01790503|474179418|FG008|Overall Study|Physician Decision|0|||
131698237|NCT01790503|474179419|FG009|Overall Study|Physician Decision|1|||
131698238|NCT01790503|474179420|FG010|Overall Study|Physician Decision|1|||
131698239|NCT01790503|474179410|FG000|Overall Study|Death|0|||
131698240|NCT01790503|474179411|FG001|Overall Study|Death|0|||
131698241|NCT01790503|474179412|FG002|Overall Study|Death|0|||
131698242|NCT01790503|474179413|FG003|Overall Study|Death|0|||
131698243|NCT01790503|474179414|FG004|Overall Study|Death|0|||
131698244|NCT01790503|474179415|FG005|Overall Study|Death|0|||
131698245|NCT01790503|474179416|FG006|Overall Study|Death|0|||
131698246|NCT01790503|474179417|FG007|Overall Study|Death|0|||
131572513|NCT01981850|473721526|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
131572514|NCT01981850|473721527|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
131572515|NCT01981850|473721528|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
131698247|NCT01790503|474179418|FG008|Overall Study|Death|0|||
131698248|NCT01790503|474179419|FG009|Overall Study|Death|1|||
131698249|NCT01790503|474179420|FG010|Overall Study|Death|0|||
131698250|NCT01790503|474179410|FG000|Overall Study|Non Compliance|0|||
131572516|NCT01981850|473721519|FG000|Main Phase Stage 2|Various reasons|0|||
131698251|NCT01790503|474179411|FG001|Overall Study|Non Compliance|0|||
131698252|NCT01790503|474179412|FG002|Overall Study|Non Compliance|0|||
131698253|NCT01790503|474179413|FG003|Overall Study|Non Compliance|0|||
131698254|NCT01790503|474179414|FG004|Overall Study|Non Compliance|1|||
131698255|NCT01790503|474179415|FG005|Overall Study|Non Compliance|0|||
131698256|NCT01790503|474179416|FG006|Overall Study|Non Compliance|0|||
131698257|NCT01790503|474179417|FG007|Overall Study|Non Compliance|0|||
131698258|NCT01790503|474179418|FG008|Overall Study|Non Compliance|0|||
131784152|NCT01074307|474493198|FG000|Overall Study|Protocol Violation|8|||
131784153|NCT01074307|474493199|FG001|Overall Study|Protocol Violation|5|||
131784154|NCT02162511|474493200|FG000|Overall Study|Lack of Efficacy|0|||
131784155|NCT02162511|474493201|FG001|Overall Study|Lack of Efficacy|0|||
131784156|NCT02162511|474493202|FG002|Overall Study|Lack of Efficacy|2|||
131784157|NCT01408576|474493203|FG000|Overall Study|Lack of Efficacy|17|||
131784158|NCT01408576|474493204|FG001|Overall Study|Lack of Efficacy|30|||
131784159|NCT01408576|474493205|FG002|Overall Study|Lack of Efficacy|48|||
131784160|NCT01408576|474493203|FG000|Overall Study|Protocol Violation|1|||
131784161|NCT01408576|474493204|FG001|Overall Study|Protocol Violation|2|||
131784162|NCT01408576|474493205|FG002|Overall Study|Protocol Violation|2|||
131784163|NCT01408576|474493203|FG000|Overall Study|Lost to Follow-up|10|||
131784164|NCT01408576|474493204|FG001|Overall Study|Lost to Follow-up|9|||
131784165|NCT01408576|474493205|FG002|Overall Study|Lost to Follow-up|17|||
131784166|NCT01408576|474493203|FG000|Overall Study|Withdrawal by Subject|34|||
131784167|NCT01408576|474493204|FG001|Overall Study|Withdrawal by Subject|60|||
131784168|NCT01408576|474493205|FG002|Overall Study|Withdrawal by Subject|66|||
131784169|NCT01408576|474493203|FG000|Overall Study|Sponsor terminated study|89|||
131784170|NCT01408576|474493204|FG001|Overall Study|Sponsor terminated study|333|||
131784171|NCT01408576|474493205|FG002|Overall Study|Sponsor terminated study|330|||
131784172|NCT01408576|474493203|FG000|Overall Study|AE, serious fatal|4|||
131784173|NCT01408576|474493204|FG001|Overall Study|AE, serious fatal|4|||
131784174|NCT01408576|474493205|FG002|Overall Study|AE, serious fatal|1|||
131784175|NCT01408576|474493203|FG000|Overall Study|SAE, non-fatal|11|||
131784176|NCT01408576|474493204|FG001|Overall Study|SAE, non-fatal|23|||
131784177|NCT01408576|474493205|FG002|Overall Study|SAE, non-fatal|14|||
131784178|NCT01408576|474493203|FG000|Overall Study|AE, non-serious non-fatal|12|||
131784179|NCT01408576|474493204|FG001|Overall Study|AE, non-serious non-fatal|19|||
131784180|NCT01408576|474493205|FG002|Overall Study|AE, non-serious non-fatal|11|||
131784181|NCT01408576|474493203|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131784182|NCT01408576|474493204|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131784183|NCT01408576|474493205|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131784184|NCT01408576|474493203|FG000|Overall Study|AE, unknown type|0|||
131784185|NCT01408576|474493204|FG001|Overall Study|AE, unknown type|1|||
131784186|NCT01408576|474493205|FG002|Overall Study|AE, unknown type|0|||
131784187|NCT01408576|474493203|FG000|Overall Study|Other|10|||
131698259|NCT01790503|474179419|FG009|Overall Study|Non Compliance|0|||
131698260|NCT01790503|474179420|FG010|Overall Study|Non Compliance|0|||
131698261|NCT01790503|474179410|FG000|Overall Study|Other|0|||
131698262|NCT01790503|474179411|FG001|Overall Study|Other|0|||
131698263|NCT01790503|474179412|FG002|Overall Study|Other|0|||
131698264|NCT01790503|474179413|FG003|Overall Study|Other|0|||
131698265|NCT01790503|474179414|FG004|Overall Study|Other|1|||
131698266|NCT01790503|474179415|FG005|Overall Study|Other|0|||
131698267|NCT01790503|474179416|FG006|Overall Study|Other|0|||
131698268|NCT01790503|474179417|FG007|Overall Study|Other|0|||
131698269|NCT01790503|474179418|FG008|Overall Study|Other|1|||
131698270|NCT01790503|474179419|FG009|Overall Study|Other|2|||
131784188|NCT01408576|474493204|FG001|Overall Study|Other|16|||
131784189|NCT01408576|474493205|FG002|Overall Study|Other|18|||
131784190|NCT00802529|474493206|FG000|Overall Study|Lost to Follow-up|0|||
131784191|NCT00802529|474493207|FG001|Overall Study|Lost to Follow-up|1|||
131784192|NCT00552617|474493209|FG000|Overall Study|Not Treated|0|||
131784193|NCT00552617|474493210|FG001|Overall Study|Not Treated|0|||
131784194|NCT00552617|474493211|FG002|Overall Study|Not Treated|1|||
131784195|NCT00552617|474493212|FG003|Overall Study|Not Treated|0|||
131698271|NCT01790503|474179420|FG010|Overall Study|Other|0|||
131572517|NCT01981850|473721520|FG001|Main Phase Stage 2|Various reasons|0|||
131572518|NCT01981850|473721521|FG002|Main Phase Stage 2|Various reasons|0|||
131572519|NCT01981850|473721522|FG003|Main Phase Stage 2|Various reasons|0|||
131572520|NCT01981850|473721523|FG004|Main Phase Stage 2|Various reasons|2|||
131572521|NCT01981850|473721524|FG005|Main Phase Stage 2|Various reasons|0|||
131572522|NCT01981850|473721525|FG006|Main Phase Stage 2|Various reasons|1|||
131572523|NCT01981850|473721526|FG007|Main Phase Stage 2|Various reasons|0|||
131572524|NCT01981850|473721527|FG008|Main Phase Stage 2|Various reasons|0|||
131572525|NCT01981850|473721528|FG009|Main Phase Stage 2|Various reasons|0|||
131572526|NCT01981850|473721519|FG000|Main Phase Stage 2|Progressive Disease|0|||
131437855|NCT00556894|473228167|FG000|Overall Study|Withdrawal by Subject|1|||
131437856|NCT00556894|473228168|FG001|Overall Study|Withdrawal by Subject|1|||
131437857|NCT00556894|473228169|FG002|Overall Study|Withdrawal by Subject|1|||
131437858|NCT04612725|473228172|FG000|Overall Study|Adverse Event|1|||
131698272|NCT00049673|474179421|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
131698273|NCT00049673|474179422|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
131698274|NCT02475681|474179423|FG000|Overall Study|Death|16|||
131698275|NCT02475681|474179424|FG001|Overall Study|Death|6|||
131698276|NCT02475681|474179425|FG002|Overall Study|Death|9|||
131698277|NCT02475681|474179423|FG000|Overall Study|Physician Decision|0|||
131698278|NCT02475681|474179424|FG001|Overall Study|Physician Decision|3|||
131698279|NCT02475681|474179425|FG002|Overall Study|Physician Decision|1|||
131698280|NCT02475681|474179423|FG000|Overall Study|Withdrawal by Subject|12|||
131698281|NCT02475681|474179424|FG001|Overall Study|Withdrawal by Subject|6|||
131698282|NCT02475681|474179425|FG002|Overall Study|Withdrawal by Subject|9|||
131698283|NCT02475681|474179423|FG000|Overall Study|Lost to Follow-up|2|||
131698284|NCT02475681|474179424|FG001|Overall Study|Lost to Follow-up|1|||
131698285|NCT02475681|474179425|FG002|Overall Study|Lost to Follow-up|3|||
131698286|NCT02475681|474179423|FG000|Overall Study|Ongoing in Study|0|||
131698287|NCT02475681|474179424|FG001|Overall Study|Ongoing in Study|163|||
131698288|NCT02475681|474179425|FG002|Overall Study|Ongoing in Study|157|||
131698289|NCT02475681|474179423|FG000|Overall Study|Reasons other than above listed|2|||
131698290|NCT02475681|474179424|FG001|Overall Study|Reasons other than above listed|0|||
131698291|NCT02475681|474179425|FG002|Overall Study|Reasons other than above listed|0|||
131698292|NCT01262365|474179428|FG000|Overall Study|Lack of Efficacy|35|||
131698293|NCT01262365|474179429|FG001|Overall Study|Lack of Efficacy|30|||
131698294|NCT01262365|474179430|FG002|Overall Study|Lack of Efficacy|47|||
131698295|NCT01262365|474179428|FG000|Overall Study|Protocol Violation|3|||
131698296|NCT01262365|474179429|FG001|Overall Study|Protocol Violation|1|||
131698297|NCT01262365|474179430|FG002|Overall Study|Protocol Violation|1|||
131698298|NCT01262365|474179428|FG000|Overall Study|Lost to Follow-up|3|||
131698299|NCT01262365|474179429|FG001|Overall Study|Lost to Follow-up|7|||
131698300|NCT01262365|474179430|FG002|Overall Study|Lost to Follow-up|6|||
131572527|NCT01981850|473721520|FG001|Main Phase Stage 2|Progressive Disease|0|||
131698301|NCT01262365|474179428|FG000|Overall Study|Withdrawal by Subject|17|||
131784196|NCT00552617|474493213|FG004|Overall Study|Not Treated|0|||
131572528|NCT01981850|473721521|FG002|Main Phase Stage 2|Progressive Disease|0|||
131698302|NCT01262365|474179429|FG001|Overall Study|Withdrawal by Subject|22|||
131698303|NCT01262365|474179430|FG002|Overall Study|Withdrawal by Subject|22|||
131698304|NCT01262365|474179428|FG000|Overall Study|Death|1|||
131698305|NCT01262365|474179429|FG001|Overall Study|Death|2|||
131698306|NCT01262365|474179430|FG002|Overall Study|Death|1|||
131698307|NCT01262365|474179428|FG000|Overall Study|Adverse Event|26|||
131698308|NCT01262365|474179429|FG001|Overall Study|Adverse Event|16|||
131698309|NCT01262365|474179430|FG002|Overall Study|Adverse Event|11|||
131698310|NCT01262365|474179428|FG000|Overall Study|sponsor decision|1|||
131698311|NCT01262365|474179429|FG001|Overall Study|sponsor decision|1|||
131698312|NCT01262365|474179430|FG002|Overall Study|sponsor decision|0|||
131698313|NCT01262365|474179428|FG000|Overall Study|Randomization error|1|||
131698314|NCT01262365|474179429|FG001|Overall Study|Randomization error|0|||
131784197|NCT00552617|474493214|FG005|Overall Study|Not Treated|0|||
131784198|NCT00552617|474493215|FG006|Overall Study|Not Treated|0|||
131784199|NCT00552617|474493216|FG007|Overall Study|Not Treated|0|||
131784200|NCT00552617|474493217|FG008|Overall Study|Not Treated|0|||
131784201|NCT00552617|474493218|FG009|Overall Study|Not Treated|1|||
131784202|NCT00552617|474493209|FG000|Overall Study|Lost to Follow-up|0|||
131784203|NCT00552617|474493210|FG001|Overall Study|Lost to Follow-up|0|||
131784204|NCT00552617|474493211|FG002|Overall Study|Lost to Follow-up|0|||
131784205|NCT00552617|474493212|FG003|Overall Study|Lost to Follow-up|1|||
131784206|NCT00552617|474493213|FG004|Overall Study|Lost to Follow-up|0|||
131784207|NCT00552617|474493214|FG005|Overall Study|Lost to Follow-up|2|||
131784208|NCT00552617|474493215|FG006|Overall Study|Lost to Follow-up|0|||
131784209|NCT00552617|474493216|FG007|Overall Study|Lost to Follow-up|0|||
131784210|NCT00552617|474493217|FG008|Overall Study|Lost to Follow-up|2|||
131784211|NCT00552617|474493218|FG009|Overall Study|Lost to Follow-up|0|||
131784212|NCT00563524|474493226|FG000|Overall Study|Adverse Event|0|||
131784213|NCT00563524|474493227|FG001|Overall Study|Adverse Event|1|||
131784214|NCT00563524|474493228|FG002|Overall Study|Adverse Event|0|||
131784215|NCT00563524|474493229|FG003|Overall Study|Adverse Event|0|||
131784216|NCT00563524|474493230|FG004|Overall Study|Adverse Event|2|||
131698315|NCT01262365|474179430|FG002|Overall Study|Randomization error|2|||
131698316|NCT01262365|474179428|FG000|Overall Study|Non-compliance|1|||
131698317|NCT01262365|474179429|FG001|Overall Study|Non-compliance|0|||
131698318|NCT01262365|474179430|FG002|Overall Study|Non-compliance|2|||
131698319|NCT01262365|474179428|FG000|Overall Study|Suspected pregnancy|1|||
131698320|NCT01262365|474179429|FG001|Overall Study|Suspected pregnancy|0|||
131784217|NCT00563524|474493231|FG005|Overall Study|Adverse Event|0|||
131784218|NCT00563524|474493226|FG000|Overall Study|Lost to Follow-up|1|||
131784219|NCT00563524|474493227|FG001|Overall Study|Lost to Follow-up|0|||
131784220|NCT00563524|474493228|FG002|Overall Study|Lost to Follow-up|0|||
131784221|NCT00563524|474493229|FG003|Overall Study|Lost to Follow-up|0|||
131784222|NCT00563524|474493230|FG004|Overall Study|Lost to Follow-up|0|||
131784223|NCT00563524|474493231|FG005|Overall Study|Lost to Follow-up|0|||
131784224|NCT00563524|474493226|FG000|Overall Study|Protocol Violation|0|||
131784225|NCT00563524|474493227|FG001|Overall Study|Protocol Violation|1|||
131698321|NCT01262365|474179430|FG002|Overall Study|Suspected pregnancy|0|||
131698322|NCT01262365|474179428|FG000|Overall Study|Patient pregnant|1|||
131698323|NCT01262365|474179429|FG001|Overall Study|Patient pregnant|0|||
131698324|NCT01262365|474179430|FG002|Overall Study|Patient pregnant|1|||
131698325|NCT01262365|474179428|FG000|Overall Study|Toxicity related to study drug|0|||
131784226|NCT00563524|474493228|FG002|Overall Study|Protocol Violation|0|||
131784227|NCT00563524|474493229|FG003|Overall Study|Protocol Violation|0|||
131784228|NCT00563524|474493230|FG004|Overall Study|Protocol Violation|0|||
131784229|NCT00563524|474493231|FG005|Overall Study|Protocol Violation|0|||
131784230|NCT00563524|474493226|FG000|Overall Study|Withdrawal by Subject|1|||
131784231|NCT00563524|474493227|FG001|Overall Study|Withdrawal by Subject|1|||
131784232|NCT00563524|474493228|FG002|Overall Study|Withdrawal by Subject|3|||
131784233|NCT00563524|474493229|FG003|Overall Study|Withdrawal by Subject|0|||
131784234|NCT00563524|474493230|FG004|Overall Study|Withdrawal by Subject|0|||
131784235|NCT00563524|474493231|FG005|Overall Study|Withdrawal by Subject|1|||
131784236|NCT01383954|474493239|FG000|Overall Study|Lack of Efficacy|2|||
131784237|NCT01383954|474493239|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
131784238|NCT01383954|474493239|FG000|Overall Study|Adverse Event|1|||
131784239|NCT01383954|474493239|FG000|Overall Study|Reason Not Specified|9|||
131784240|NCT00763269|474493241|FG000|Overall Study|Lost to Follow-up|12|||
131784241|NCT00763269|474493242|FG001|Overall Study|Lost to Follow-up|13|||
131784242|NCT03174925|474493243|FG000|Overall Study|Elastographic images not retrievable|2|||
131784243|NCT03174925|474493243|FG000|Overall Study|Elastography image not interpretable|1|||
131784244|NCT01791127|474493246|FG000|Overall Study|Death|356|||
131784245|NCT01791127|474493246|FG000|Overall Study|Patient has withdrawn from study|293|||
131784246|NCT01791127|474493246|FG000|Overall Study|Lost to Follow-up|42|||
131784247|NCT01791127|474493246|FG000|Overall Study|All Siello leads are explanted|31|||
131784248|NCT01791127|474493246|FG000|Overall Study|Completion of 30 day safety registry|1|||
131784249|NCT01791127|474493246|FG000|Overall Study|Study terminated for EP Passion|749|||
131784250|NCT04247594|474493249|FG000|Overall Study|Withdrawal by Subject|4|||
131784251|NCT02748616|474493256|FG000|Overall Study|Lost to Follow-up|1|||
131784252|NCT02748616|474493256|FG000|Overall Study|Withdrawal by Subject|2|||
131784253|NCT02748616|474493256|FG000|Overall Study|Physician Decision|2|||
131784254|NCT02748616|474493256|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
131784255|NCT00589693|474493258|FG000|Overall Study|randomized in error|12|||
131784256|NCT00589693|474493259|FG001|Overall Study|randomized in error|6|||
131784257|NCT00589693|474493258|FG000|Overall Study|Adverse Event|4|||
131784258|NCT00589693|474493259|FG001|Overall Study|Adverse Event|4|||
131784259|NCT00589693|474493258|FG000|Overall Study|Death|26|||
131784260|NCT00589693|474493259|FG001|Overall Study|Death|16|||
131784261|NCT00589693|474493258|FG000|Overall Study|Lack of Efficacy|0|||
131784262|NCT00589693|474493259|FG001|Overall Study|Lack of Efficacy|1|||
131784263|NCT00589693|474493258|FG000|Overall Study|Lost to Follow-up|1|||
131784264|NCT00589693|474493259|FG001|Overall Study|Lost to Follow-up|0|||
131784265|NCT00589693|474493258|FG000|Overall Study|Physician Decision|0|||
131784266|NCT00589693|474493259|FG001|Overall Study|Physician Decision|1|||
131784267|NCT00589693|474493258|FG000|Overall Study|Protocol Violation|1|||
131784268|NCT00589693|474493259|FG001|Overall Study|Protocol Violation|1|||
131784269|NCT03231709|474493260|FG000|Treatment Period 1|Reason not Specified|0|||
131784270|NCT03231709|474493261|FG001|Treatment Period 1|Reason not Specified|1|||
131784271|NCT03231709|474493260|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
131784272|NCT03231709|474493261|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
131784273|NCT02609178|474493262|FG000|First Crown|Withdrawal by Subject|0|||
131784274|NCT02609178|474493263|FG001|First Crown|Withdrawal by Subject|0|||
131784275|NCT02609178|474493264|FG002|First Crown|Withdrawal by Subject|1|||
131784276|NCT02609178|474493265|FG003|First Crown|Withdrawal by Subject|1|||
131784277|NCT02609178|474493266|FG004|First Crown|Withdrawal by Subject|0|||
131784278|NCT02609178|474493267|FG005|First Crown|Withdrawal by Subject|0|||
131784279|NCT01128153|474493268|FG000|Overall Study|Adverse Event|1|||
131784280|NCT01128153|474493269|FG001|Overall Study|Adverse Event|3|||
131784281|NCT01128153|474493268|FG000|Overall Study|Condition under investigation worsened|8|||
131784282|NCT01128153|474493269|FG001|Overall Study|Condition under investigation worsened|7|||
131784283|NCT01128153|474493268|FG000|Overall Study|Withdrawal by Subject|2|||
131784284|NCT01128153|474493269|FG001|Overall Study|Withdrawal by Subject|3|||
131784285|NCT01128153|474493268|FG000|Overall Study|Incorrect enrolment to study|2|||
131784286|NCT01128153|474493269|FG001|Overall Study|Incorrect enrolment to study|1|||
131784287|NCT01128153|474493268|FG000|Overall Study|Protocol Violation|2|||
131784288|NCT01128153|474493269|FG001|Overall Study|Protocol Violation|0|||
131784289|NCT01128153|474493268|FG000|Overall Study|Developed discontinuation criteria|1|||
131784290|NCT01128153|474493269|FG001|Overall Study|Developed discontinuation criteria|1|||
131784291|NCT01875991|474493270|FG000|Overall Study|Withdrawal by Subject|6|||
131784292|NCT01875991|474493271|FG001|Overall Study|Withdrawal by Subject|6|||
131784293|NCT01875991|474493270|FG000|Overall Study|Sponsor Decision|1|||
131784294|NCT01875991|474493271|FG001|Overall Study|Sponsor Decision|0|||
131784295|NCT02419469|474493272|FG000|Overall Study|Withdrawal by Subject|1|||
131784296|NCT01682512|474493273|FG000|Overall Study|Adverse Event|6|||
131784297|NCT01682512|474493274|FG001|Overall Study|Adverse Event|5|||
131784298|NCT01682512|474493275|FG002|Overall Study|Adverse Event|2|||
131784299|NCT01682512|474493273|FG000|Overall Study|Withdrawal by Subject|2|||
131784300|NCT01682512|474493274|FG001|Overall Study|Withdrawal by Subject|6|||
131784301|NCT01682512|474493275|FG002|Overall Study|Withdrawal by Subject|3|||
131784302|NCT01682512|474493273|FG000|Overall Study|Physician Decision|0|||
131784303|NCT01682512|474493274|FG001|Overall Study|Physician Decision|2|||
131784304|NCT01682512|474493275|FG002|Overall Study|Physician Decision|0|||
131784305|NCT01682512|474493273|FG000|Overall Study|Study terminated by sponsor|46|||
131784306|NCT01682512|474493274|FG001|Overall Study|Study terminated by sponsor|43|||
131572529|NCT01981850|473721522|FG003|Main Phase Stage 2|Progressive Disease|0|||
131572530|NCT01981850|473721523|FG004|Main Phase Stage 2|Progressive Disease|0|||
131572531|NCT01981850|473721524|FG005|Main Phase Stage 2|Progressive Disease|6|||
131698326|NCT01262365|474179429|FG001|Overall Study|Toxicity related to study drug|1|||
131698327|NCT01262365|474179430|FG002|Overall Study|Toxicity related to study drug|0|||
131698328|NCT01262365|474179428|FG000|Overall Study|Cannot tolerate the protocol|0|||
131698329|NCT01262365|474179429|FG001|Overall Study|Cannot tolerate the protocol|1|||
131698330|NCT01262365|474179430|FG002|Overall Study|Cannot tolerate the protocol|0|||
131698331|NCT01262365|474179428|FG000|Overall Study|Patient unavailable|0|||
131698332|NCT01262365|474179429|FG001|Overall Study|Patient unavailable|0|||
131698333|NCT01262365|474179430|FG002|Overall Study|Patient unavailable|1|||
131698334|NCT02322710|474179432|FG000|Overall Study|No efficacy assessment post-baseline|0|||
131698335|NCT02322710|474179433|FG001|Overall Study|No efficacy assessment post-baseline|1|||
131698336|NCT02322710|474179432|FG000|Overall Study|Protocol Violation|20|||
131698337|NCT02322710|474179433|FG001|Overall Study|Protocol Violation|25|||
131698338|NCT04161131|474179434|FG000|Overall Study|Ineligible|2|||
131698339|NCT04161131|474179434|FG000|Overall Study|Lost to Follow-up|4|||
131698340|NCT03733392|474179435|FG000|Overall Study|Withdrawal by Subject|11|||
131698341|NCT03733392|474179436|FG001|Overall Study|Withdrawal by Subject|1|||
131698342|NCT03733392|474179435|FG000|Overall Study|Death|1|||
131698343|NCT03733392|474179436|FG001|Overall Study|Death|0|||
131698344|NCT03733392|474179435|FG000|Overall Study|Lost to Follow-up|5|||
131698345|NCT03733392|474179436|FG001|Overall Study|Lost to Follow-up|0|||
131698346|NCT03733392|474179435|FG000|Overall Study|Protocol Violation|0|||
131698347|NCT03733392|474179436|FG001|Overall Study|Protocol Violation|1|||
131698348|NCT03733392|474179435|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
131698349|NCT03733392|474179436|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
131698350|NCT03733392|474179435|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
131698351|NCT03733392|474179436|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
131698352|NCT03733392|474179435|FG000|Overall Study|Patient Non-Compliance|2|||
131698353|NCT03733392|474179436|FG001|Overall Study|Patient Non-Compliance|1|||
131698354|NCT03733392|474179435|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
131698355|NCT03733392|474179436|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
131698356|NCT03733392|474179435|FG000|Overall Study|Withdrawal prior to procedure|5|||
131698357|NCT03733392|474179436|FG001|Overall Study|Withdrawal prior to procedure|2|||
131698358|NCT04316585|474179437|FG000|Overall Study|Adverse Event|2|||
131698359|NCT04316585|474179438|FG001|Overall Study|Adverse Event|1|||
131698360|NCT04316585|474179437|FG000|Overall Study|Lost to Follow-up|1|||
131698361|NCT04316585|474179438|FG001|Overall Study|Lost to Follow-up|0|||
131698362|NCT04316585|474179437|FG000|Overall Study|Withdrawal by Subject|2|||
131698363|NCT04316585|474179438|FG001|Overall Study|Withdrawal by Subject|3|||
131698364|NCT04316585|474179437|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
131698365|NCT04316585|474179438|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
131698366|NCT04316585|474179437|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
131698367|NCT04316585|474179438|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
131698368|NCT02605642|474179442|FG000|Overall Study|Other|11|||
131698369|NCT02605642|474179443|FG001|Overall Study|Other|1|||
131698370|NCT02605642|474179442|FG000|Overall Study|Participant non-compliance|2|||
131698371|NCT02605642|474179443|FG001|Overall Study|Participant non-compliance|4|||
131698372|NCT02605642|474179442|FG000|Overall Study|Physician Decision|10|||
131698373|NCT02605642|474179443|FG001|Overall Study|Physician Decision|0|||
131698374|NCT02605642|474179442|FG000|Overall Study|Lost to Follow-up|12|||
131698375|NCT02605642|474179443|FG001|Overall Study|Lost to Follow-up|1|||
131698376|NCT02605642|474179442|FG000|Overall Study|Adverse Event|14|||
131698377|NCT02605642|474179443|FG001|Overall Study|Adverse Event|2|||
131698378|NCT02605642|474179442|FG000|Overall Study|Withdrawal by Subject|23|||
131698379|NCT02605642|474179443|FG001|Overall Study|Withdrawal by Subject|2|||
131698380|NCT02605642|474179442|FG000|Overall Study|Lack of response|24|||
131698381|NCT02605642|474179443|FG001|Overall Study|Lack of response|11|||
131698382|NCT00699348|474179453|FG000|Overall Study|Death|6|||
131698383|NCT00699348|474179453|FG000|Overall Study|Adverse Event|15|||
131698384|NCT00699348|474179453|FG000|Overall Study|Withdrawal by Subject|11|||
131698385|NCT00699348|474179453|FG000|Overall Study|Protocol Violation|10|||
131698386|NCT00699348|474179453|FG000|Overall Study|Lack of Efficacy|8|||
131698387|NCT00699348|474179453|FG000|Overall Study|Failure to return|1|||
131698388|NCT00699348|474179453|FG000|Overall Study|Blood transfusion|24|||
131572532|NCT01981850|473721525|FG006|Main Phase Stage 2|Progressive Disease|6|||
131784307|NCT01682512|474493275|FG002|Overall Study|Study terminated by sponsor|0|||
131784308|NCT01682512|474493273|FG000|Overall Study|Lost to Follow-up|3|||
131784309|NCT01682512|474493274|FG001|Overall Study|Lost to Follow-up|0|||
131784310|NCT01682512|474493275|FG002|Overall Study|Lost to Follow-up|2|||
131784311|NCT01682512|474493273|FG000|Overall Study|Protocol Violation|2|||
131784312|NCT01682512|474493274|FG001|Overall Study|Protocol Violation|3|||
131784313|NCT01682512|474493275|FG002|Overall Study|Protocol Violation|2|||
131784314|NCT01682512|474493273|FG000|Overall Study|Primary lack of efficacy|10|||
131784315|NCT01682512|474493274|FG001|Overall Study|Primary lack of efficacy|7|||
131784316|NCT01682512|474493275|FG002|Overall Study|Primary lack of efficacy|7|||
131784317|NCT01682512|474493273|FG000|Overall Study|Secondary lack of efficacy|1|||
131784318|NCT01682512|474493274|FG001|Overall Study|Secondary lack of efficacy|1|||
131784319|NCT01682512|474493275|FG002|Overall Study|Secondary lack of efficacy|0|||
131784320|NCT01682512|474493273|FG000|Overall Study|Other than stated above|2|||
131572533|NCT01981850|473721526|FG007|Main Phase Stage 2|Progressive Disease|0|||
131572534|NCT01981850|473721527|FG008|Main Phase Stage 2|Progressive Disease|0|||
131784321|NCT01682512|474493274|FG001|Overall Study|Other than stated above|4|||
131784322|NCT01682512|474493275|FG002|Overall Study|Other than stated above|2|||
131784323|NCT04057118|474493276|FG000|Overall Study|Adverse Event|1|||
131784324|NCT04057118|474493277|FG001|Overall Study|Adverse Event|0|||
131784325|NCT04057118|474493278|FG002|Overall Study|Adverse Event|1|||
131784326|NCT04057118|474493279|FG003|Overall Study|Adverse Event|1|||
131784327|NCT04057118|474493276|FG000|Overall Study|Physician Decision|0|||
131784328|NCT04057118|474493277|FG001|Overall Study|Physician Decision|0|||
131784329|NCT04057118|474493278|FG002|Overall Study|Physician Decision|1|||
131784330|NCT04057118|474493279|FG003|Overall Study|Physician Decision|1|||
131784331|NCT04057118|474493276|FG000|Overall Study|Withdrawal by Subject|2|||
131784332|NCT04057118|474493277|FG001|Overall Study|Withdrawal by Subject|2|||
131784333|NCT04057118|474493278|FG002|Overall Study|Withdrawal by Subject|0|||
131784334|NCT04057118|474493279|FG003|Overall Study|Withdrawal by Subject|2|||
131784335|NCT04057118|474493276|FG000|Overall Study|Not Specific|0|||
131784336|NCT04057118|474493277|FG001|Overall Study|Not Specific|0|||
131784337|NCT04057118|474493278|FG002|Overall Study|Not Specific|1|||
131784338|NCT04057118|474493279|FG003|Overall Study|Not Specific|1|||
131784339|NCT03273712|474493280|FG000|Overall Study|Death|5|||
131784340|NCT03273712|474493280|FG000|Overall Study|Adverse Event|1|||
131784341|NCT03273712|474493280|FG000|Overall Study|Disease Progression|1|||
131784342|NCT03959137|474493283|FG000|Overall Study|Protocol Violation|6|||
131784343|NCT00190684|474493284|FG000|Overall Study|Adverse Event|86|||
131784344|NCT00190684|474493284|FG000|Overall Study|Satisfactory response|80|||
131784345|NCT00190684|474493284|FG000|Overall Study|Lack of efficacy|204|||
131784346|NCT00190684|474493284|FG000|Overall Study|Lost to Follow-up|232|||
131784347|NCT00190684|474493284|FG000|Overall Study|Patient moved|60|||
131784348|NCT00190684|474493284|FG000|Overall Study|Patient Decision|432|||
131784349|NCT00190684|474493284|FG000|Overall Study|Clinical relapse|67|||
131784350|NCT00190684|474493284|FG000|Overall Study|Sponsor's decision|17|||
131784351|NCT00190684|474493284|FG000|Overall Study|Physician Decision|84|||
131572535|NCT01981850|473721528|FG009|Main Phase Stage 2|Progressive Disease|0|||
131572536|NCT01981850|473721519|FG000|Open Label Extension (OLE)|Adverse Event|0|||
131784352|NCT00190684|474493284|FG000|Overall Study|Protocol Violation|123|||
131784353|NCT00190684|474493284|FG000|Overall Study|Study Period III Completed|103|||
131784354|NCT00190684|474493284|FG000|Overall Study|Study Period V Completed|1|||
131784355|NCT00995488|474493290|FG000|Overall Study|Withdrawal by Subject|1|||
131784356|NCT02702271|474493291|FG000|Overall Study|Death|36|||
131784357|NCT02702271|474493292|FG001|Overall Study|Death|7|||
131784358|NCT02702271|474493291|FG000|Overall Study|Lost to Follow-up|12|||
131784359|NCT02702271|474493292|FG001|Overall Study|Lost to Follow-up|0|||
131784360|NCT02702271|474493291|FG000|Overall Study|Withdrawal by Subject|8|||
131784361|NCT02702271|474493292|FG001|Overall Study|Withdrawal by Subject|1|||
131784362|NCT02702271|474493291|FG000|Overall Study|Physician Decision|2|||
131784363|NCT02702271|474493292|FG001|Overall Study|Physician Decision|0|||
131784364|NCT02702271|474493291|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
131784365|NCT02702271|474493292|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
131784366|NCT01494649|474493293|FG000|Overall Study|Lost to Follow-up|0|||
131784367|NCT01494649|474493294|FG001|Overall Study|Lost to Follow-up|1|||
131784368|NCT01174368|474493295|FG000|Overall Study|Withdrawal by Subject|1|||
131784369|NCT05166512|474493298|FG000|Randomized|Lost to Follow-up|2|||
131784370|NCT05166512|474493299|FG001|Randomized|Lost to Follow-up|0|||
131784371|NCT05166512|474493298|FG000|Randomized|Withdrawal by Subject|1|||
131784372|NCT05166512|474493299|FG001|Randomized|Withdrawal by Subject|0|||
131784373|NCT05166512|474493298|FG000|Baseline Data Collection|Lost to Follow-up|0|||
131784374|NCT05166512|474493299|FG001|Baseline Data Collection|Lost to Follow-up|3|||
131784375|NCT05166512|474493298|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
131784376|NCT05166512|474493299|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
131784377|NCT05166512|474493298|FG000|Baseline Data Collection|Protocol Violation|2|||
131784378|NCT05166512|474493299|FG001|Baseline Data Collection|Protocol Violation|0|||
131784379|NCT05166512|474493298|FG000|4 Month Data Collection|Lost to Follow-up|1|||
131784380|NCT05166512|474493299|FG001|4 Month Data Collection|Lost to Follow-up|0|||
131784381|NCT05166512|474493298|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
131784382|NCT05166512|474493299|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
131784383|NCT05166512|474493298|FG000|12 Month Data Collection|Lost to Follow-up|3|||
131784384|NCT05166512|474493299|FG001|12 Month Data Collection|Lost to Follow-up|1|||
131784385|NCT05166512|474493298|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
131784386|NCT05166512|474493299|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
131784387|NCT01831596|474493300|FG000|Overall Study|Other|8|||
131784388|NCT02956005|474493304|FG000|Overall Study|Not eligible|1|||
131784389|NCT02956005|474493304|FG000|Overall Study|Withdrawal by Subject|3|||
131784390|NCT02956005|474493304|FG000|Overall Study|Physician Decision|12|||
131784391|NCT02602080|474493305|FG000|Overall Study|Protocol Violation|6|||
131784392|NCT02602080|474493306|FG001|Overall Study|Protocol Violation|1|||
131784393|NCT02602080|474493307|FG002|Overall Study|Protocol Violation|3|||
131784394|NCT00883129|474493308|FG000|Overall Study|Adverse Event|7|||
131784395|NCT00883129|474493309|FG001|Overall Study|Adverse Event|15|||
131784396|NCT00883129|474493308|FG000|Overall Study|Withdrawal by Subject|8|||
131784397|NCT00883129|474493309|FG001|Overall Study|Withdrawal by Subject|9|||
131784398|NCT00883129|474493308|FG000|Overall Study|Non-compliance|3|||
131784399|NCT00883129|474493309|FG001|Overall Study|Non-compliance|6|||
131784400|NCT00883129|474493308|FG000|Overall Study|Lost to Follow-up|1|||
131784401|NCT00883129|474493309|FG001|Overall Study|Lost to Follow-up|2|||
131784402|NCT00883129|474493308|FG000|Overall Study|Death|1|||
131784403|NCT00883129|474493309|FG001|Overall Study|Death|2|||
131784404|NCT00883129|474493308|FG000|Overall Study|Defined Treatment Failure|0|||
131784405|NCT00883129|474493309|FG001|Overall Study|Defined Treatment Failure|2|||
131784406|NCT03273257|474493310|FG000|Overall Study|Death|0|||
131784407|NCT03273257|474493311|FG001|Overall Study|Death|1|||
131784408|NCT03273257|474493310|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
131784409|NCT03273257|474493311|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
131784410|NCT03273257|474493310|FG000|Overall Study|Study terminated|3|||
131784411|NCT03273257|474493311|FG001|Overall Study|Study terminated|2|||
131784412|NCT04355767|474493313|FG000|Overall Study|Withdrawal by Subject|2|||
131784413|NCT04355767|474493314|FG001|Overall Study|Withdrawal by Subject|2|||
131784414|NCT04355767|474493313|FG000|Overall Study|Death|5|||
131784415|NCT04355767|474493314|FG001|Overall Study|Death|1|||
131784416|NCT01999322|474493315|FG000|Overall Study|Adverse Event|1|||
131784417|NCT01999322|474493316|FG001|Overall Study|Adverse Event|0|||
131784418|NCT01458132|474495015|FG000|Overall Study|Other|15|||
131784419|NCT01458132|474495016|FG001|Overall Study|Other|3|||
131784420|NCT00833976|474495021|FG000|Overall Study|Withdrawal by Subject|5|||
131784421|NCT00833976|474495021|FG000|Overall Study|Lost to Follow-up|4|||
131784422|NCT00833976|474495021|FG000|Overall Study|Did not meet eligibility criteria|41|||
131784423|NCT00833976|474495021|FG000|Overall Study|Physician Decision|1|||
131784424|NCT01858558|474495022|FG000|Overall Study|Death|1|||
131784425|NCT01858558|474495023|FG001|Overall Study|Death|1|||
131784426|NCT01858558|474495022|FG000|Overall Study|Lost to Follow-up|1|||
131784427|NCT01858558|474495023|FG001|Overall Study|Lost to Follow-up|0|||
131784428|NCT01858558|474495022|FG000|Overall Study|Disease progression|3|||
131784429|NCT01858558|474495023|FG001|Overall Study|Disease progression|1|||
131784430|NCT01858558|474495022|FG000|Overall Study|Product contamination|2|||
131784431|NCT01858558|474495023|FG001|Overall Study|Product contamination|0|||
131784432|NCT01858558|474495022|FG000|Overall Study|Failed expansion of cell product|2|||
131784433|NCT01858558|474495023|FG001|Overall Study|Failed expansion of cell product|0|||
131784434|NCT01142466|474495024|FG000|Overall Study|Adverse Event|2|||
131784435|NCT01142466|474495025|FG001|Overall Study|Adverse Event|1|||
131784436|NCT01142466|474495024|FG000|Overall Study|Withdrawal by Subject|1|||
131784437|NCT01142466|474495025|FG001|Overall Study|Withdrawal by Subject|1|||
131784438|NCT00569231|474495026|FG000|Overall Study|Study unrelated surgery|1|||
131784439|NCT00569231|474495026|FG000|Overall Study|Airfare expense|2|||
131784440|NCT00569231|474495026|FG000|Overall Study|Withdrawal by Subject|1|||
131784441|NCT00569231|474495026|FG000|Overall Study|Car accident injury|1|||
131784442|NCT00569231|474495026|FG000|Overall Study|Non-compliance|2|||
131784443|NCT00337129|474495040|FG000|Overall Study|Adverse Event|4|||
131784444|NCT00337129|474495040|FG000|Overall Study|Withdrawal by Subject|1|||
131784445|NCT00337129|474495040|FG000|Overall Study|Lack of Efficacy|32|||
131784446|NCT00337129|474495040|FG000|Overall Study|Death|2|||
131784447|NCT00337129|474495040|FG000|Overall Study|not protocol specified|1|||
131784448|NCT00817778|474495044|FG000|Overall Study|Adverse Event|1|||
131784449|NCT00817778|474495045|FG001|Overall Study|Adverse Event|0|||
131784450|NCT00817778|474495044|FG000|Overall Study|Withdrawal by Subject|1|||
131784451|NCT00817778|474495045|FG001|Overall Study|Withdrawal by Subject|1|||
131784452|NCT00817778|474495044|FG000|Overall Study|Protocol Violation|0|||
131784453|NCT00817778|474495045|FG001|Overall Study|Protocol Violation|1|||
131784454|NCT00817778|474495044|FG000|Overall Study|Study-specific discontinuation criteria|0|||
131784455|NCT00817778|474495045|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131784456|NCT00817778|474495044|FG000|Overall Study|Poor venous access|1|||
131784457|NCT00817778|474495045|FG001|Overall Study|Poor venous access|0|||
131784458|NCT02766088|474495046|FG000|Overall Study|Sponsor study termination|498|||
131784459|NCT02766088|474495046|FG000|Overall Study|Migrated/moved from the study area|1|||
131784460|NCT02766088|474495046|FG000|Overall Study|Lost to Follow-up|5|||
131784461|NCT02766088|474495046|FG000|Overall Study|Other|1|||
131784462|NCT02766088|474495046|FG000|Overall Study|Death|1|||
131784463|NCT02923115|474495056|FG000|Overall Study|Lost to Follow-up|0|||
131784464|NCT02923115|474495057|FG001|Overall Study|Lost to Follow-up|0|||
131784465|NCT02923115|474495058|FG002|Overall Study|Lost to Follow-up|0|||
131784466|NCT02923115|474495059|FG003|Overall Study|Lost to Follow-up|1|||
131784467|NCT02923115|474495060|FG004|Overall Study|Lost to Follow-up|0|||
131784468|NCT02923115|474495061|FG005|Overall Study|Lost to Follow-up|0|||
131784469|NCT02923115|474495056|FG000|Overall Study|Withdrawal by Subject|0|||
131698389|NCT00699348|474179453|FG000|Overall Study|Renal transplantation|10|||
131698390|NCT00699348|474179453|FG000|Overall Study|Other|5|||
131698391|NCT02889796|474179460|FG000|Overall Study|Withdrew Consent|18|||
131698392|NCT02889796|474179461|FG001|Overall Study|Withdrew Consent|29|||
131698393|NCT02889796|474179462|FG002|Overall Study|Withdrew Consent|20|||
131698394|NCT02889796|474179463|FG003|Overall Study|Withdrew Consent|1|||
131698395|NCT02889796|474179464|FG004|Overall Study|Withdrew Consent|2|||
131698396|NCT02889796|474179465|FG005|Overall Study|Withdrew Consent|35|||
131698397|NCT02889796|474179460|FG000|Overall Study|Investigator's Discretion|10|||
131784470|NCT02923115|474495057|FG001|Overall Study|Withdrawal by Subject|1|||
131784471|NCT02923115|474495058|FG002|Overall Study|Withdrawal by Subject|0|||
131784472|NCT02923115|474495059|FG003|Overall Study|Withdrawal by Subject|0|||
131698398|NCT02889796|474179461|FG001|Overall Study|Investigator's Discretion|9|||
131784473|NCT02923115|474495060|FG004|Overall Study|Withdrawal by Subject|0|||
131784474|NCT02923115|474495061|FG005|Overall Study|Withdrawal by Subject|0|||
131784475|NCT02923115|474495056|FG000|Overall Study|Randomized, but not dosed|0|||
131784476|NCT02923115|474495057|FG001|Overall Study|Randomized, but not dosed|0|||
131784477|NCT02923115|474495058|FG002|Overall Study|Randomized, but not dosed|3|||
131784478|NCT02923115|474495059|FG003|Overall Study|Randomized, but not dosed|1|||
131784479|NCT02923115|474495060|FG004|Overall Study|Randomized, but not dosed|5|||
131784480|NCT02923115|474495061|FG005|Overall Study|Randomized, but not dosed|0|||
131784481|NCT04388527|474495062|FG000|Overall Study|Death|14|||
131784482|NCT04388527|474495062|FG000|Overall Study|Withdrawal by Subject|2|||
131698399|NCT02889796|474179462|FG002|Overall Study|Investigator's Discretion|10|||
131698400|NCT02889796|474179463|FG003|Overall Study|Investigator's Discretion|3|||
131698401|NCT02889796|474179464|FG004|Overall Study|Investigator's Discretion|0|||
131698402|NCT02889796|474179465|FG005|Overall Study|Investigator's Discretion|15|||
131698403|NCT02889796|474179460|FG000|Overall Study|Adverse Event|17|||
131698404|NCT02889796|474179461|FG001|Overall Study|Adverse Event|8|||
131698405|NCT02889796|474179462|FG002|Overall Study|Adverse Event|8|||
131698406|NCT02889796|474179463|FG003|Overall Study|Adverse Event|4|||
131698407|NCT02889796|474179464|FG004|Overall Study|Adverse Event|1|||
131698408|NCT02889796|474179465|FG005|Overall Study|Adverse Event|7|||
131698409|NCT02889796|474179460|FG000|Overall Study|Lost to Follow-up|5|||
131698410|NCT02889796|474179461|FG001|Overall Study|Lost to Follow-up|7|||
131698411|NCT02889796|474179462|FG002|Overall Study|Lost to Follow-up|2|||
131698412|NCT02889796|474179463|FG003|Overall Study|Lost to Follow-up|0|||
131698413|NCT02889796|474179464|FG004|Overall Study|Lost to Follow-up|2|||
131698414|NCT02889796|474179465|FG005|Overall Study|Lost to Follow-up|6|||
131698415|NCT02889796|474179460|FG000|Overall Study|Protocol Violation|0|||
131698416|NCT02889796|474179461|FG001|Overall Study|Protocol Violation|1|||
131698417|NCT02889796|474179462|FG002|Overall Study|Protocol Violation|3|||
131698418|NCT02889796|474179463|FG003|Overall Study|Protocol Violation|0|||
131698419|NCT02889796|474179464|FG004|Overall Study|Protocol Violation|0|||
131698420|NCT02889796|474179465|FG005|Overall Study|Protocol Violation|4|||
131698421|NCT02889796|474179460|FG000|Overall Study|Non-compliance With Study Drug|0|||
131698422|NCT02889796|474179461|FG001|Overall Study|Non-compliance With Study Drug|2|||
131698423|NCT02889796|474179462|FG002|Overall Study|Non-compliance With Study Drug|0|||
131698424|NCT02889796|474179463|FG003|Overall Study|Non-compliance With Study Drug|0|||
131698425|NCT02889796|474179464|FG004|Overall Study|Non-compliance With Study Drug|1|||
131698426|NCT02889796|474179465|FG005|Overall Study|Non-compliance With Study Drug|2|||
131698427|NCT02889796|474179460|FG000|Overall Study|Death|1|||
131698428|NCT02889796|474179461|FG001|Overall Study|Death|1|||
131698429|NCT02889796|474179462|FG002|Overall Study|Death|0|||
131698430|NCT02889796|474179463|FG003|Overall Study|Death|1|||
131698431|NCT02889796|474179464|FG004|Overall Study|Death|0|||
131698432|NCT02889796|474179465|FG005|Overall Study|Death|1|||
131698433|NCT02889796|474179460|FG000|Overall Study|Pregnancy|0|||
131698434|NCT02889796|474179461|FG001|Overall Study|Pregnancy|1|||
131698435|NCT02889796|474179462|FG002|Overall Study|Pregnancy|1|||
131698436|NCT02889796|474179463|FG003|Overall Study|Pregnancy|0|||
131698437|NCT02889796|474179464|FG004|Overall Study|Pregnancy|0|||
131698438|NCT02889796|474179465|FG005|Overall Study|Pregnancy|0|||
131698439|NCT02889796|474179460|FG000|Overall Study|Randomized but not Dosed|2|||
131698440|NCT02889796|474179461|FG001|Overall Study|Randomized but not Dosed|0|||
131698441|NCT02889796|474179462|FG002|Overall Study|Randomized but not Dosed|0|||
131698442|NCT02889796|474179463|FG003|Overall Study|Randomized but not Dosed|0|||
131698443|NCT02889796|474179464|FG004|Overall Study|Randomized but not Dosed|0|||
131698444|NCT02889796|474179465|FG005|Overall Study|Randomized but not Dosed|2|||
131698445|NCT01407926|474179471|FG000|Overall Study|Lost to Follow-up|55|||
131698446|NCT04656652|474179472|FG000|Overall Study|Lost to Follow-up|2|||
131698447|NCT04656652|474179473|FG001|Overall Study|Lost to Follow-up|2|||
131698448|NCT04656652|474179472|FG000|Overall Study|Death|213|||
131698449|NCT04656652|474179473|FG001|Overall Study|Death|212|||
131698450|NCT04656652|474179472|FG000|Overall Study|Other|1|||
131698451|NCT04656652|474179473|FG001|Overall Study|Other|0|||
131698452|NCT04656652|474179472|FG000|Overall Study|Withdrawal by Subject|15|||
131698453|NCT04656652|474179473|FG001|Overall Study|Withdrawal by Subject|29|||
131698454|NCT02479802|474179476|FG000|Overall Study|Lost to Follow-up|1|||
131698455|NCT02479802|474179476|FG000|Overall Study|Adverse Event|1|||
131698456|NCT01882907|474179477|FG000|Overall Study|Adverse Event|3|||
131698457|NCT01882907|474179478|FG001|Overall Study|Adverse Event|1|||
131698458|NCT01882907|474179477|FG000|Overall Study|Lack of Efficacy|0|||
131698459|NCT01882907|474179478|FG001|Overall Study|Lack of Efficacy|3|||
131698460|NCT01882907|474179477|FG000|Overall Study|Lost to Follow-up|1|||
131698461|NCT01882907|474179478|FG001|Overall Study|Lost to Follow-up|4|||
131698462|NCT01882907|474179477|FG000|Overall Study|Protocol Violation|10|||
131784483|NCT04388527|474495062|FG000|Overall Study|Lost to Follow-up|1|||
131784484|NCT00520494|474495063|FG000|Overall Study|Withdrawal by Subject|1|||
131698463|NCT01882907|474179478|FG001|Overall Study|Protocol Violation|14|||
131698464|NCT01882907|474179477|FG000|Overall Study|Withdrawal by Subject|0|||
131698465|NCT01882907|474179478|FG001|Overall Study|Withdrawal by Subject|6|||
131698466|NCT01978093|474179479|FG000|Overall Study|Death|1|||
131698467|NCT01978093|474179480|FG001|Overall Study|Death|0|||
131698468|NCT01978093|474179479|FG000|Overall Study|Adverse Event|0|||
131698469|NCT01978093|474179480|FG001|Overall Study|Adverse Event|5|||
131698470|NCT01978093|474179479|FG000|Overall Study|Protocol Violation|8|||
131572537|NCT01981850|473721520|FG001|Open Label Extension (OLE)|Adverse Event|0|||
131572538|NCT01981850|473721521|FG002|Open Label Extension (OLE)|Adverse Event|0|||
131572539|NCT01981850|473721522|FG003|Open Label Extension (OLE)|Adverse Event|0|||
131572540|NCT01981850|473721523|FG004|Open Label Extension (OLE)|Adverse Event|0|||
131572541|NCT01981850|473721524|FG005|Open Label Extension (OLE)|Adverse Event|0|||
131572542|NCT01981850|473721525|FG006|Open Label Extension (OLE)|Adverse Event|0|||
131572543|NCT01981850|473721526|FG007|Open Label Extension (OLE)|Adverse Event|2|||
131572544|NCT01981850|473721527|FG008|Open Label Extension (OLE)|Adverse Event|1|||
131784485|NCT03471182|474495066|FG000|Overall Study|Withdrawal by Subject|1|||
131784486|NCT03471182|474495067|FG001|Overall Study|Withdrawal by Subject|1|||
131784487|NCT03471182|474495068|FG002|Overall Study|Withdrawal by Subject|0|||
131784488|NCT03471182|474495066|FG000|Overall Study|Technical failure|2|||
131784489|NCT03471182|474495067|FG001|Overall Study|Technical failure|0|||
131784490|NCT03471182|474495068|FG002|Overall Study|Technical failure|0|||
131784491|NCT00068406|474495071|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
131784492|NCT00068406|474495071|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
131784493|NCT02018042|474495072|FG000|Overall Study|Withdrawal by Subject|1|||
131784494|NCT01954082|474495073|FG000|Overall Study|Study Suspension|42|||
131784495|NCT01954082|474495074|FG001|Overall Study|Study Suspension|36|||
131784496|NCT01954082|474495073|FG000|Overall Study|Adverse Event|10|||
131784497|NCT01954082|474495074|FG001|Overall Study|Adverse Event|4|||
131784498|NCT01954082|474495073|FG000|Overall Study|Intolerance|0|||
131784499|NCT01954082|474495074|FG001|Overall Study|Intolerance|1|||
131784500|NCT01954082|474495073|FG000|Overall Study|Non-compliance|6|||
131784501|NCT01954082|474495074|FG001|Overall Study|Non-compliance|4|||
131784502|NCT01954082|474495073|FG000|Overall Study|Physician Decision|2|||
131784503|NCT01954082|474495074|FG001|Overall Study|Physician Decision|0|||
131784504|NCT01954082|474495073|FG000|Overall Study|Parent Decision|1|||
131784505|NCT01954082|474495074|FG001|Overall Study|Parent Decision|0|||
131784506|NCT01954082|474495073|FG000|Overall Study|Withdrawal by Subject|0|||
131784507|NCT01954082|474495074|FG001|Overall Study|Withdrawal by Subject|1|||
131784508|NCT01954082|474495073|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
131784509|NCT01954082|474495074|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
131784510|NCT01954082|474495073|FG000|Overall Study|Redirection of Care|0|||
131784511|NCT01954082|474495074|FG001|Overall Study|Redirection of Care|2|||
131784512|NCT01954082|474495073|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
131784513|NCT01954082|474495074|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
131784514|NCT01954082|474495073|FG000|Overall Study|Comfort Care|0|||
131784515|NCT01954082|474495074|FG001|Overall Study|Comfort Care|1|||
131784516|NCT01954082|474495073|FG000|Overall Study|Infant Moved|0|||
131784517|NCT01954082|474495074|FG001|Overall Study|Infant Moved|1|||
131784518|NCT01954082|474495073|FG000|Overall Study|Randomized not Treated|4|||
131784519|NCT01954082|474495074|FG001|Overall Study|Randomized not Treated|2|||
131784520|NCT03451331|474495075|FG000|Overall Study|Withdrawal by Subject|1|||
131784521|NCT03451331|474495076|FG001|Overall Study|Withdrawal by Subject|0|||
131784522|NCT03451331|474495075|FG000|Overall Study|Unable to start treatment.|1|||
131784523|NCT03451331|474495076|FG001|Overall Study|Unable to start treatment.|1|||
131784524|NCT02454972|474495077|FG000|Overall Study|Progressive disease|17|||
131784525|NCT02454972|474495078|FG001|Overall Study|Progressive disease|16|||
131784526|NCT02454972|474495079|FG002|Overall Study|Progressive disease|59|||
131784527|NCT02454972|474495080|FG003|Overall Study|Progressive disease|23|||
131784528|NCT02454972|474495081|FG004|Overall Study|Progressive disease|16|||
131784529|NCT02454972|474495082|FG005|Overall Study|Progressive disease|12|||
131784530|NCT02454972|474495083|FG006|Overall Study|Progressive disease|19|||
131784531|NCT02454972|474495084|FG007|Overall Study|Progressive disease|27|||
131572545|NCT01981850|473721528|FG009|Open Label Extension (OLE)|Adverse Event|8|||
131572546|NCT01981850|473721519|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
131572547|NCT01981850|473721520|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
131784532|NCT02454972|474495085|FG008|Overall Study|Progressive disease|0|||
131784533|NCT02454972|474495077|FG000|Overall Study|Death|0|||
131784534|NCT02454972|474495078|FG001|Overall Study|Death|0|||
131784535|NCT02454972|474495079|FG002|Overall Study|Death|5|||
131784536|NCT02454972|474495080|FG003|Overall Study|Death|1|||
131784537|NCT02454972|474495081|FG004|Overall Study|Death|0|||
131784538|NCT02454972|474495082|FG005|Overall Study|Death|0|||
131784539|NCT02454972|474495083|FG006|Overall Study|Death|0|||
131784540|NCT02454972|474495084|FG007|Overall Study|Death|0|||
131572548|NCT01981850|473721521|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
131784541|NCT02454972|474495085|FG008|Overall Study|Death|95|||
131784542|NCT02454972|474495077|FG000|Overall Study|Physician Decision|0|||
131784543|NCT02454972|474495078|FG001|Overall Study|Physician Decision|1|||
131784544|NCT02454972|474495079|FG002|Overall Study|Physician Decision|2|||
131784545|NCT02454972|474495080|FG003|Overall Study|Physician Decision|1|||
131698471|NCT01978093|474179480|FG001|Overall Study|Protocol Violation|2|||
131698472|NCT01978093|474179479|FG000|Overall Study|Withdrawal by Subject|29|||
131698473|NCT01978093|474179480|FG001|Overall Study|Withdrawal by Subject|25|||
131698474|NCT01978093|474179479|FG000|Overall Study|Lost to Follow-up|11|||
131698475|NCT01978093|474179480|FG001|Overall Study|Lost to Follow-up|15|||
131698476|NCT01978093|474179479|FG000|Overall Study|Migrated/moved from study area|11|||
131698477|NCT01978093|474179480|FG001|Overall Study|Migrated/moved from study area|13|||
131698478|NCT01978093|474179479|FG000|Overall Study|Loss of kaiser coverage|4|||
131698479|NCT01978093|474179480|FG001|Overall Study|Loss of kaiser coverage|10|||
131698480|NCT01978093|474179479|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
131698481|NCT01978093|474179480|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
131698482|NCT01978093|474179479|FG000|Overall Study|Mother lost custody of child|0|||
131698483|NCT01978093|474179480|FG001|Overall Study|Mother lost custody of child|1|||
131698484|NCT01978093|474179479|FG000|Overall Study|Child was in care of grandmother|0|||
131698485|NCT01978093|474179480|FG001|Overall Study|Child was in care of grandmother|1|||
131698486|NCT01978093|474179479|FG000|Overall Study|N/A for vaccine administration|0|||
131698487|NCT01978093|474179480|FG001|Overall Study|N/A for vaccine administration|1|||
131698488|NCT01885000|474179481|FG000|Overall Study|Adverse Event|1|||
131698489|NCT01885000|474179482|FG001|Overall Study|Adverse Event|0|||
131698490|NCT01885000|474179481|FG000|Overall Study|Withdrawal by Subject|1|||
131698491|NCT01885000|474179482|FG001|Overall Study|Withdrawal by Subject|1|||
131698492|NCT01885000|474179481|FG000|Overall Study|Protocol Violation|0|||
131698493|NCT01885000|474179482|FG001|Overall Study|Protocol Violation|1|||
131698494|NCT03124784|474179483|FG000|Overall Study|Adverse Event|1|||
131698495|NCT03124784|474179483|FG000|Overall Study|Computer/Equip Malfunction|1|||
131698496|NCT01604512|474179488|FG000|Overall Study|Withdrawal by Subject|3|||
131698497|NCT01604512|474179488|FG000|Overall Study|Not treated|4|||
131698498|NCT01391507|474179490|FG000|Overall Study|Death|0|||
131698499|NCT01391507|474179491|FG001|Overall Study|Death|0|||
131698500|NCT01391507|474179492|FG002|Overall Study|Death|0|||
131698501|NCT01391507|474179493|FG003|Overall Study|Death|1|||
131698502|NCT01391507|474179490|FG000|Overall Study|Adverse Event|1|||
131698503|NCT01391507|474179491|FG001|Overall Study|Adverse Event|1|||
131698504|NCT01391507|474179492|FG002|Overall Study|Adverse Event|2|||
131698505|NCT01391507|474179493|FG003|Overall Study|Adverse Event|2|||
131698506|NCT01391507|474179490|FG000|Overall Study|Withdrawal by Subject|1|||
131698507|NCT01391507|474179491|FG001|Overall Study|Withdrawal by Subject|2|||
131698508|NCT01391507|474179492|FG002|Overall Study|Withdrawal by Subject|1|||
131698509|NCT01391507|474179493|FG003|Overall Study|Withdrawal by Subject|1|||
131698510|NCT01391507|474179490|FG000|Overall Study|Lack of Efficacy|0|||
131698511|NCT01391507|474179491|FG001|Overall Study|Lack of Efficacy|0|||
131698512|NCT01391507|474179492|FG002|Overall Study|Lack of Efficacy|0|||
131698513|NCT01391507|474179493|FG003|Overall Study|Lack of Efficacy|1|||
131698514|NCT01391507|474179490|FG000|Overall Study|Protocol Violation|2|||
131898664|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
131898665|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
131898666|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
131898667|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
131898668|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
131898669|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
131898670|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
131898671|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
131898672|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
131898673|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
131898674|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
131898675|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
131898676|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
131898677|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
131898678|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
131898679|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
131898680|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
131898681|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
131898682|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
131898683|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
131898684|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
131898685|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
131698515|NCT01391507|474179491|FG001|Overall Study|Protocol Violation|1|||
131698516|NCT01391507|474179492|FG002|Overall Study|Protocol Violation|1|||
131698517|NCT01391507|474179493|FG003|Overall Study|Protocol Violation|2|||
131698518|NCT02926209|474179494|FG000|Study Cohort|Poor Bowel Preparation|1|||
131698519|NCT02926209|474179495|FG001|Study Cohort|Poor Bowel Preparation|0|||
131698520|NCT03345472|474179496|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
131572549|NCT01981850|473721522|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
131784546|NCT02454972|474495081|FG004|Overall Study|Physician Decision|2|||
131784547|NCT02454972|474495082|FG005|Overall Study|Physician Decision|0|||
131784548|NCT02454972|474495083|FG006|Overall Study|Physician Decision|0|||
131784549|NCT02454972|474495084|FG007|Overall Study|Physician Decision|1|||
131784550|NCT02454972|474495085|FG008|Overall Study|Physician Decision|0|||
131784551|NCT02454972|474495077|FG000|Overall Study|Non treatment-related adverse event|2|||
131784552|NCT02454972|474495078|FG001|Overall Study|Non treatment-related adverse event|0|||
131784553|NCT02454972|474495079|FG002|Overall Study|Non treatment-related adverse event|1|||
131784554|NCT02454972|474495080|FG003|Overall Study|Non treatment-related adverse event|0|||
131784555|NCT02454972|474495081|FG004|Overall Study|Non treatment-related adverse event|0|||
131784556|NCT02454972|474495082|FG005|Overall Study|Non treatment-related adverse event|1|||
131784557|NCT02454972|474495083|FG006|Overall Study|Non treatment-related adverse event|0|||
131784558|NCT02454972|474495084|FG007|Overall Study|Non treatment-related adverse event|1|||
131784559|NCT02454972|474495085|FG008|Overall Study|Non treatment-related adverse event|0|||
131784560|NCT02454972|474495077|FG000|Overall Study|Treatment-related adverse events|0|||
131784561|NCT02454972|474495078|FG001|Overall Study|Treatment-related adverse events|1|||
131784562|NCT02454972|474495079|FG002|Overall Study|Treatment-related adverse events|1|||
131784563|NCT02454972|474495080|FG003|Overall Study|Treatment-related adverse events|0|||
131784564|NCT02454972|474495081|FG004|Overall Study|Treatment-related adverse events|2|||
131784565|NCT02454972|474495082|FG005|Overall Study|Treatment-related adverse events|0|||
131784566|NCT02454972|474495083|FG006|Overall Study|Treatment-related adverse events|0|||
131572550|NCT01981850|473721523|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
131784567|NCT02454972|474495084|FG007|Overall Study|Treatment-related adverse events|2|||
131784568|NCT02454972|474495085|FG008|Overall Study|Treatment-related adverse events|0|||
131784569|NCT02454972|474495077|FG000|Overall Study|Patient moves to compassionate use|0|||
131437859|NCT04612725|473228173|FG001|Overall Study|Adverse Event|3|||
131437860|NCT04612725|473228174|FG002|Overall Study|Adverse Event|1|||
131437861|NCT04612725|473228175|FG003|Overall Study|Adverse Event|0|||
131437862|NCT04612725|473228176|FG004|Overall Study|Adverse Event|1|||
131437863|NCT04612725|473228172|FG000|Overall Study|Lost to Follow-up|0|||
131437864|NCT04612725|473228173|FG001|Overall Study|Lost to Follow-up|1|||
131437865|NCT04612725|473228174|FG002|Overall Study|Lost to Follow-up|0|||
131437866|NCT04612725|473228175|FG003|Overall Study|Lost to Follow-up|0|||
131437867|NCT04612725|473228176|FG004|Overall Study|Lost to Follow-up|0|||
131437868|NCT04612725|473228172|FG000|Overall Study|Physician Decision|2|||
131437869|NCT04612725|473228173|FG001|Overall Study|Physician Decision|0|||
131437870|NCT04612725|473228174|FG002|Overall Study|Physician Decision|0|||
131437871|NCT04612725|473228175|FG003|Overall Study|Physician Decision|0|||
131437872|NCT04612725|473228176|FG004|Overall Study|Physician Decision|0|||
131437873|NCT04612725|473228172|FG000|Overall Study|Study terminated by sponsor|3|||
131437874|NCT04612725|473228173|FG001|Overall Study|Study terminated by sponsor|1|||
131437875|NCT04612725|473228174|FG002|Overall Study|Study terminated by sponsor|2|||
131437876|NCT04612725|473228175|FG003|Overall Study|Study terminated by sponsor|4|||
131437877|NCT04612725|473228176|FG004|Overall Study|Study terminated by sponsor|5|||
131437878|NCT04612725|473228172|FG000|Overall Study|Withdrawal by Subject|8|||
131437879|NCT04612725|473228173|FG001|Overall Study|Withdrawal by Subject|3|||
131437880|NCT04612725|473228174|FG002|Overall Study|Withdrawal by Subject|5|||
131437881|NCT04612725|473228175|FG003|Overall Study|Withdrawal by Subject|1|||
131437882|NCT04612725|473228176|FG004|Overall Study|Withdrawal by Subject|9|||
131437883|NCT04612725|473228172|FG000|Overall Study|Other|0|||
131437884|NCT04612725|473228173|FG001|Overall Study|Other|0|||
131437885|NCT04612725|473228174|FG002|Overall Study|Other|0|||
131437886|NCT04612725|473228175|FG003|Overall Study|Other|0|||
131437887|NCT04612725|473228176|FG004|Overall Study|Other|1|||
131437888|NCT04875195|473228177|FG000|Overall Study|Death|9|||
131437889|NCT04875195|473228178|FG001|Overall Study|Death|3|||
131437890|NCT04875195|473228177|FG000|Overall Study|Withdrawal by Subject|2|||
131572551|NCT01981850|473721524|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
131572552|NCT01981850|473721525|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
131572553|NCT01981850|473721526|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
131572554|NCT01981850|473721527|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
131572555|NCT01981850|473721528|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
131572556|NCT01981850|473721519|FG000|Open Label Extension (OLE)|Various reasons|0|||
131572557|NCT01981850|473721520|FG001|Open Label Extension (OLE)|Various reasons|0|||
131572558|NCT01981850|473721521|FG002|Open Label Extension (OLE)|Various reasons|0|||
131572559|NCT01981850|473721522|FG003|Open Label Extension (OLE)|Various reasons|0|||
131572560|NCT01981850|473721523|FG004|Open Label Extension (OLE)|Various reasons|0|||
131572561|NCT01981850|473721524|FG005|Open Label Extension (OLE)|Various reasons|0|||
131572562|NCT01981850|473721525|FG006|Open Label Extension (OLE)|Various reasons|0|||
131572563|NCT01981850|473721526|FG007|Open Label Extension (OLE)|Various reasons|3|||
131572564|NCT01981850|473721527|FG008|Open Label Extension (OLE)|Various reasons|1|||
131572565|NCT01981850|473721528|FG009|Open Label Extension (OLE)|Various reasons|3|||
131572566|NCT01981850|473721519|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
131572567|NCT01981850|473721520|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
131572568|NCT01981850|473721521|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
131572569|NCT01981850|473721522|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
131572570|NCT01981850|473721523|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
131572571|NCT01981850|473721524|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
131572572|NCT01981850|473721525|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
131572573|NCT01981850|473721526|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
131572574|NCT01981850|473721527|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
131572575|NCT01981850|473721528|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
131572576|NCT01981850|473721519|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572577|NCT01981850|473721520|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572578|NCT01981850|473721521|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572579|NCT01981850|473721522|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572580|NCT01981850|473721523|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131437891|NCT04875195|473228178|FG001|Overall Study|Withdrawal by Subject|1|||
131437892|NCT04875195|473228177|FG000|Overall Study|Ongoing in study|49|||
131437893|NCT04875195|473228178|FG001|Overall Study|Ongoing in study|2|||
131437894|NCT05190120|473228179|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
131437895|NCT05190120|473228180|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
131437896|NCT05190120|473228181|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
131437897|NCT05190120|473228182|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
131572581|NCT01981850|473721524|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572582|NCT01981850|473721525|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572583|NCT01981850|473721526|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131572584|NCT01981850|473721527|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131784570|NCT02454972|474495078|FG001|Overall Study|Patient moves to compassionate use|0|||
131572585|NCT01981850|473721528|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
131572586|NCT01981850|473721519|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572587|NCT01981850|473721520|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572588|NCT01981850|473721521|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572589|NCT01981850|473721522|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572590|NCT01981850|473721523|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572591|NCT01981850|473721524|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572592|NCT01981850|473721525|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572593|NCT01981850|473721526|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572594|NCT01981850|473721527|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
131572595|NCT01981850|473721528|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
131572596|NCT02524288|473721529|FG000|Overall Study|Adverse Event|115|||
131572597|NCT02524288|473721529|FG000|Overall Study|Lost to Follow-up|216|||
131572598|NCT02524288|473721529|FG000|Overall Study|Non-Compliance With Protocol|32|||
131572599|NCT02524288|473721529|FG000|Overall Study|Non-Compliance With Study Drug|14|||
131572600|NCT02524288|473721529|FG000|Overall Study|Pregnancy Wish|6|||
131572601|NCT02524288|473721529|FG000|Overall Study|Protocol Violation|6|||
131572602|NCT02524288|473721529|FG000|Overall Study|Screen Failure|2|||
131572603|NCT02524288|473721529|FG000|Overall Study|Site Discontinued Study Participation|1|||
131572604|NCT02524288|473721529|FG000|Overall Study|Study Terminated By Sponsor|1417|||
131572605|NCT02524288|473721529|FG000|Overall Study|Subject Moved|32|||
131572606|NCT02524288|473721529|FG000|Overall Study|Withdrawal by Subject|76|||
131572607|NCT02524288|473721529|FG000|Overall Study|Pregnancy|22|||
131572608|NCT02524288|473721529|FG000|Overall Study|Physician Decision|2|||
131572609|NCT00517933|473721530|FG000|Period 1|Death|2|||
131572610|NCT00517933|473721531|FG001|Period 1|Death|1|||
131572611|NCT00517933|473721530|FG000|Period 1|Adverse Event|4|||
131572612|NCT00517933|473721531|FG001|Period 1|Adverse Event|4|||
131572613|NCT00517933|473721530|FG000|Period 1|Lost to Follow-up|2|||
131572614|NCT00517933|473721531|FG001|Period 1|Lost to Follow-up|0|||
131698521|NCT03345472|474179496|FG000|Implant to 3 Months|Physician Decision|1|||
131572615|NCT00517933|473721530|FG000|Period 1|Underwent lung transplant|0|||
131698522|NCT03345472|474179496|FG000|Implant to 3 Months|Adverse Event|1|||
131698523|NCT03345472|474179496|FG000|3 Months to 12 Months|Physician Decision|3|||
131698524|NCT03345472|474179496|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
131698525|NCT03345472|474179496|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
131698526|NCT03345472|474179496|FG000|3 Months to 12 Months|Adverse Event|1|||
131698527|NCT03345472|474179496|FG000|3 Months to 12 Months|Death|1|||
131698528|NCT00577993|474179499|FG000|Overall Study|Adverse Event|1|||
131698529|NCT00577993|474179500|FG001|Overall Study|Adverse Event|0|||
131572616|NCT00517933|473721531|FG001|Period 1|Underwent lung transplant|1|||
131572617|NCT00517933|473721530|FG000|Period 2|Death|2|||
131572618|NCT00517933|473721531|FG001|Period 2|Death|4|||
131572619|NCT00517933|473721530|FG000|Period 2|Adverse Event|2|||
131572620|NCT00517933|473721531|FG001|Period 2|Adverse Event|4|||
131572621|NCT00517933|473721530|FG000|Period 2|Physician Decision|1|||
131572622|NCT00517933|473721531|FG001|Period 2|Physician Decision|0|||
131572623|NCT00517933|473721530|FG000|Period 2|Withdrawal by Subject|1|||
131572624|NCT00517933|473721531|FG001|Period 2|Withdrawal by Subject|3|||
131572625|NCT00517933|473721530|FG000|Period 2|Underwent lung transplant|0|||
131572626|NCT00517933|473721531|FG001|Period 2|Underwent lung transplant|2|||
131572627|NCT00121199|473721533|FG000|Overall Study|Adverse Event|11|||
131572628|NCT00121199|473721533|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131572629|NCT00121199|473721533|FG000|Overall Study|Progression/Relapse|1|||
131572630|NCT00121199|473721533|FG000|Overall Study|Death|3|||
131572631|NCT00121199|473721533|FG000|Overall Study|Other - Not Protocol Specified|3|||
131572632|NCT00121199|473721533|FG000|Overall Study|Ineligible|9|||
131572633|NCT04109118|473721536|FG000|Overall Study|Lost to Follow-up|3|||
131572634|NCT03235349|473721539|FG000|Overall Study|Adverse Event|1|||
131572635|NCT03235349|473721539|FG000|Overall Study|Other|1|||
131572636|NCT04305912|473721542|FG000|First Intervention|COVID-19 Suspension|2|||
131572637|NCT04305912|473721543|FG001|First Intervention|COVID-19 Suspension|0|||
131572638|NCT04305912|473721542|FG000|First Intervention|Withdrawal by Subject|0|||
131572639|NCT04305912|473721543|FG001|First Intervention|Withdrawal by Subject|1|||
131572640|NCT04305912|473721542|FG000|Second Intervention|Adverse Event|0|||
131572641|NCT04305912|473721543|FG001|Second Intervention|Adverse Event|1|||
131572642|NCT05196737|473721544|FG000|Non-intervention Week|Lost to Follow-up|2|||
131572643|NCT05196737|473721544|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
131572644|NCT04888585|473721545|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
131572645|NCT04888585|473721546|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
131698530|NCT00577993|474179501|FG002|Overall Study|Adverse Event|0|||
131698531|NCT00577993|474179499|FG000|Overall Study|Death|0|||
131698532|NCT00577993|474179500|FG001|Overall Study|Death|1|||
131698533|NCT00577993|474179501|FG002|Overall Study|Death|1|||
131698534|NCT00577993|474179499|FG000|Overall Study|Lack of Efficacy|0|||
131698535|NCT00577993|474179500|FG001|Overall Study|Lack of Efficacy|1|||
131698536|NCT00577993|474179501|FG002|Overall Study|Lack of Efficacy|0|||
131698537|NCT00577993|474179499|FG000|Overall Study|Protocol Violation|2|||
131698538|NCT00577993|474179500|FG001|Overall Study|Protocol Violation|3|||
131698539|NCT00577993|474179501|FG002|Overall Study|Protocol Violation|0|||
131698540|NCT00577993|474179499|FG000|Overall Study|Withdrawal by Subject|1|||
131698541|NCT00577993|474179500|FG001|Overall Study|Withdrawal by Subject|0|||
131698542|NCT00577993|474179501|FG002|Overall Study|Withdrawal by Subject|2|||
131698543|NCT00577993|474179499|FG000|Overall Study|Conversion|2|||
131698544|NCT00577993|474179500|FG001|Overall Study|Conversion|5|||
131698545|NCT00577993|474179501|FG002|Overall Study|Conversion|0|||
131698546|NCT00577993|474179499|FG000|Overall Study|Uninsured|1|||
131698547|NCT00577993|474179500|FG001|Overall Study|Uninsured|0|||
131698548|NCT00577993|474179501|FG002|Overall Study|Uninsured|0|||
131698549|NCT01847885|474179502|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
131698550|NCT01847885|474179503|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
131698551|NCT01847885|474179504|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
131698552|NCT01847885|474179502|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
131698553|NCT01847885|474179503|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
131698554|NCT01847885|474179504|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
131698555|NCT01847885|474179502|FG000|Initial Enrollment (Consented)|Screen failure|39|||
131698556|NCT01847885|474179503|FG001|Initial Enrollment (Consented)|Screen failure|0|||
131698557|NCT01847885|474179504|FG002|Initial Enrollment (Consented)|Screen failure|0|||
131698558|NCT01847885|474179502|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
131698559|NCT01847885|474179503|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
131698560|NCT01847885|474179504|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
131698561|NCT01847885|474179502|FG000|Randomization|Protocol Violation|0|||
131698562|NCT01847885|474179503|FG001|Randomization|Protocol Violation|1|||
131698563|NCT01847885|474179504|FG002|Randomization|Protocol Violation|0|||
131698564|NCT01847885|474179502|FG000|Randomization|Withdrawal by Subject|0|||
131698565|NCT01847885|474179503|FG001|Randomization|Withdrawal by Subject|0|||
131698566|NCT01847885|474179504|FG002|Randomization|Withdrawal by Subject|2|||
131698567|NCT01847885|474179502|FG000|Randomization|Screen Failure|0|||
131698568|NCT01847885|474179503|FG001|Randomization|Screen Failure|3|||
131698569|NCT01847885|474179504|FG002|Randomization|Screen Failure|0|||
131698570|NCT04029519|474179506|FG000|Overall Study|Protocol Violation|1|||
131698571|NCT04029519|474179506|FG000|Overall Study|Withdrawal by Subject|3|||
131698572|NCT04029519|474179506|FG000|Overall Study|Lost to Follow-up|1|||
131698573|NCT00411554|474179509|FG000|Overall Study|Adverse Event|2|||
131698574|NCT00411554|474179510|FG001|Overall Study|Adverse Event|4|||
131698575|NCT00411554|474179509|FG000|Overall Study|Lack of Efficacy|2|||
131784571|NCT02454972|474495079|FG002|Overall Study|Patient moves to compassionate use|0|||
131784572|NCT02454972|474495080|FG003|Overall Study|Patient moves to compassionate use|0|||
131784573|NCT02454972|474495081|FG004|Overall Study|Patient moves to compassionate use|0|||
131784574|NCT02454972|474495082|FG005|Overall Study|Patient moves to compassionate use|0|||
131784575|NCT02454972|474495083|FG006|Overall Study|Patient moves to compassionate use|2|||
131784576|NCT02454972|474495084|FG007|Overall Study|Patient moves to compassionate use|0|||
131784577|NCT02454972|474495085|FG008|Overall Study|Patient moves to compassionate use|0|||
131784578|NCT02454972|474495077|FG000|Overall Study|Withdrawal by Subject|0|||
131784579|NCT02454972|474495078|FG001|Overall Study|Withdrawal by Subject|1|||
131784580|NCT02454972|474495079|FG002|Overall Study|Withdrawal by Subject|5|||
131784581|NCT02454972|474495080|FG003|Overall Study|Withdrawal by Subject|2|||
131784582|NCT02454972|474495081|FG004|Overall Study|Withdrawal by Subject|3|||
131784583|NCT02454972|474495082|FG005|Overall Study|Withdrawal by Subject|2|||
131784584|NCT02454972|474495083|FG006|Overall Study|Withdrawal by Subject|0|||
131784585|NCT02454972|474495084|FG007|Overall Study|Withdrawal by Subject|1|||
131784586|NCT02454972|474495085|FG008|Overall Study|Withdrawal by Subject|2|||
131784587|NCT02454972|474495077|FG000|Overall Study|Multiple delay/holds on treatment|0|||
131784588|NCT02454972|474495078|FG001|Overall Study|Multiple delay/holds on treatment|0|||
131784589|NCT02454972|474495079|FG002|Overall Study|Multiple delay/holds on treatment|0|||
131784590|NCT02454972|474495080|FG003|Overall Study|Multiple delay/holds on treatment|1|||
131784591|NCT02454972|474495081|FG004|Overall Study|Multiple delay/holds on treatment|0|||
131784592|NCT02454972|474495082|FG005|Overall Study|Multiple delay/holds on treatment|0|||
131784593|NCT02454972|474495083|FG006|Overall Study|Multiple delay/holds on treatment|0|||
131784594|NCT02454972|474495084|FG007|Overall Study|Multiple delay/holds on treatment|0|||
131784595|NCT02454972|474495085|FG008|Overall Study|Multiple delay/holds on treatment|0|||
131784596|NCT02454972|474495077|FG000|Overall Study|Never treated|0|||
131784597|NCT02454972|474495078|FG001|Overall Study|Never treated|0|||
131784598|NCT02454972|474495079|FG002|Overall Study|Never treated|3|||
131784599|NCT02454972|474495080|FG003|Overall Study|Never treated|1|||
131784600|NCT02454972|474495081|FG004|Overall Study|Never treated|1|||
131784601|NCT02454972|474495082|FG005|Overall Study|Never treated|0|||
131784602|NCT02454972|474495083|FG006|Overall Study|Never treated|0|||
131784603|NCT02454972|474495084|FG007|Overall Study|Never treated|0|||
131784604|NCT02454972|474495085|FG008|Overall Study|Never treated|5|||
131784605|NCT02454972|474495077|FG000|Overall Study|Lost to Follow-up|0|||
131784606|NCT02454972|474495078|FG001|Overall Study|Lost to Follow-up|0|||
131784607|NCT02454972|474495079|FG002|Overall Study|Lost to Follow-up|0|||
131784608|NCT02454972|474495080|FG003|Overall Study|Lost to Follow-up|0|||
131784609|NCT02454972|474495081|FG004|Overall Study|Lost to Follow-up|0|||
131784610|NCT02454972|474495082|FG005|Overall Study|Lost to Follow-up|0|||
131784611|NCT02454972|474495083|FG006|Overall Study|Lost to Follow-up|0|||
131784612|NCT02454972|474495084|FG007|Overall Study|Lost to Follow-up|0|||
131784613|NCT02454972|474495085|FG008|Overall Study|Lost to Follow-up|2|||
131784614|NCT02454972|474495077|FG000|Overall Study|Study termination|0|||
131784615|NCT02454972|474495078|FG001|Overall Study|Study termination|0|||
131784616|NCT02454972|474495079|FG002|Overall Study|Study termination|0|||
131784617|NCT02454972|474495080|FG003|Overall Study|Study termination|0|||
131784618|NCT02454972|474495081|FG004|Overall Study|Study termination|0|||
131784619|NCT02454972|474495082|FG005|Overall Study|Study termination|0|||
131784620|NCT02454972|474495083|FG006|Overall Study|Study termination|0|||
131784621|NCT02454972|474495084|FG007|Overall Study|Study termination|0|||
131784622|NCT02454972|474495085|FG008|Overall Study|Study termination|6|||
131784623|NCT01377233|474495088|FG000|Open-label|Adverse Event|1|||
131784624|NCT01377233|474495089|FG001|Open-label|Adverse Event|0|||
131784625|NCT01377233|474495090|FG002|Open-label|Adverse Event|0|||
131784626|NCT01377233|474495091|FG003|Open-label|Adverse Event|0|||
131784627|NCT01377233|474495092|FG004|Open-label|Adverse Event|0|||
131784628|NCT01377233|474495088|FG000|Open-label|Withdrawal by Subject|3|||
131784629|NCT01377233|474495089|FG001|Open-label|Withdrawal by Subject|0|||
131784630|NCT01377233|474495090|FG002|Open-label|Withdrawal by Subject|0|||
131784631|NCT01377233|474495091|FG003|Open-label|Withdrawal by Subject|0|||
131784632|NCT01377233|474495092|FG004|Open-label|Withdrawal by Subject|0|||
131784633|NCT01377233|474495088|FG000|Double-blind|Adverse Event|0|||
131784634|NCT01377233|474495089|FG001|Double-blind|Adverse Event|1|||
131784635|NCT01377233|474495090|FG002|Double-blind|Adverse Event|2|||
131784636|NCT01377233|474495091|FG003|Double-blind|Adverse Event|2|||
131784637|NCT01377233|474495092|FG004|Double-blind|Adverse Event|0|||
131784638|NCT01377233|474495088|FG000|Double-blind|Protocol Violation|0|||
131784639|NCT01377233|474495089|FG001|Double-blind|Protocol Violation|0|||
131784640|NCT01377233|474495090|FG002|Double-blind|Protocol Violation|0|||
131698576|NCT00411554|474179510|FG001|Overall Study|Lack of Efficacy|5|||
131784641|NCT01377233|474495091|FG003|Double-blind|Protocol Violation|0|||
131784642|NCT01377233|474495092|FG004|Double-blind|Protocol Violation|1|||
131784643|NCT01377233|474495088|FG000|Double-blind|Withdrawal by Subject|0|||
131784644|NCT01377233|474495089|FG001|Double-blind|Withdrawal by Subject|0|||
131784645|NCT01377233|474495090|FG002|Double-blind|Withdrawal by Subject|0|||
131784646|NCT01377233|474495091|FG003|Double-blind|Withdrawal by Subject|1|||
131784647|NCT01377233|474495092|FG004|Double-blind|Withdrawal by Subject|0|||
131784648|NCT01377233|474495088|FG000|Double-blind|Administrative or other|0|||
131784649|NCT01377233|474495089|FG001|Double-blind|Administrative or other|0|||
131784650|NCT01377233|474495090|FG002|Double-blind|Administrative or other|0|||
131784651|NCT01377233|474495091|FG003|Double-blind|Administrative or other|1|||
131784652|NCT01377233|474495092|FG004|Double-blind|Administrative or other|1|||
131784653|NCT01785875|474495093|FG000|Overall Study|Withdrawal by Subject|41|||
131784654|NCT01785875|474495094|FG001|Overall Study|Withdrawal by Subject|34|||
131784655|NCT01785875|474495095|FG002|Overall Study|Withdrawal by Subject|36|||
131784656|NCT01785875|474495093|FG000|Overall Study|Lost to Follow-up|19|||
131784657|NCT01785875|474495094|FG001|Overall Study|Lost to Follow-up|22|||
131784658|NCT01785875|474495095|FG002|Overall Study|Lost to Follow-up|6|||
131784659|NCT01785875|474495093|FG000|Overall Study|Death|27|||
131784660|NCT01785875|474495094|FG001|Overall Study|Death|16|||
131784661|NCT01785875|474495095|FG002|Overall Study|Death|7|||
131784662|NCT01785875|474495093|FG000|Overall Study|Sponsor Decision|0|||
131784663|NCT01785875|474495094|FG001|Overall Study|Sponsor Decision|2|||
131784664|NCT01785875|474495095|FG002|Overall Study|Sponsor Decision|0|||
131698577|NCT00411554|474179509|FG000|Overall Study|Withdrawal by Subject|3|||
131698578|NCT00411554|474179510|FG001|Overall Study|Withdrawal by Subject|0|||
131698579|NCT00411554|474179509|FG000|Overall Study|Patient Moved|1|||
131698580|NCT00411554|474179510|FG001|Overall Study|Patient Moved|0|||
131698581|NCT02462473|474179511|FG000|Overall Study|Death|1|||
131698582|NCT02462473|474179511|FG000|Overall Study|Other|3|||
131698583|NCT03728309|474179512|FG000|Overall Study|Randomized but not Treated|0|||
131698584|NCT03728309|474179513|FG001|Overall Study|Randomized but not Treated|1|||
131698585|NCT03728309|474179512|FG000|Overall Study|Adverse Event|0|||
131698586|NCT03728309|474179513|FG001|Overall Study|Adverse Event|1|||
131698587|NCT03728309|474179512|FG000|Overall Study|Withdrawal by Subject|2|||
131698588|NCT03728309|474179513|FG001|Overall Study|Withdrawal by Subject|8|||
131698589|NCT03728309|474179512|FG000|Overall Study|Lost to Follow-up|9|||
131698590|NCT03728309|474179513|FG001|Overall Study|Lost to Follow-up|10|||
131698591|NCT03728309|474179512|FG000|Overall Study|Protocol Deviation|0|||
131698592|NCT03728309|474179513|FG001|Overall Study|Protocol Deviation|1|||
131698593|NCT03728309|474179512|FG000|Overall Study|Due to COVID|1|||
131698594|NCT03728309|474179513|FG001|Overall Study|Due to COVID|3|||
131698595|NCT00953758|474179516|FG000|Overall Study|Death|2|||
131698596|NCT00953758|474179517|FG001|Overall Study|Death|0|||
131698597|NCT00953758|474179518|FG002|Overall Study|Death|1|||
131698598|NCT00953758|474179519|FG003|Overall Study|Death|1|||
131698599|NCT00953758|474179520|FG004|Overall Study|Death|1|||
131698600|NCT00953758|474179521|FG005|Overall Study|Death|1|||
131698601|NCT00953758|474179522|FG006|Overall Study|Death|1|||
131698602|NCT00953758|474179523|FG007|Overall Study|Death|3|||
131698603|NCT00953758|474179524|FG008|Overall Study|Death|1|||
131698604|NCT00953758|474179525|FG009|Overall Study|Death|0|||
131698605|NCT00953758|474179516|FG000|Overall Study|Participant refused further follow-up|0|||
131698606|NCT00953758|474179517|FG001|Overall Study|Participant refused further follow-up|0|||
131698607|NCT00953758|474179518|FG002|Overall Study|Participant refused further follow-up|1|||
131698608|NCT00953758|474179519|FG003|Overall Study|Participant refused further follow-up|0|||
131698609|NCT00953758|474179520|FG004|Overall Study|Participant refused further follow-up|3|||
131698610|NCT00953758|474179521|FG005|Overall Study|Participant refused further follow-up|0|||
131698611|NCT00953758|474179522|FG006|Overall Study|Participant refused further follow-up|0|||
131784665|NCT01785875|474495093|FG000|Overall Study|Protocol Specified Criteria|207|||
131784666|NCT01785875|474495094|FG001|Overall Study|Protocol Specified Criteria|214|||
131698612|NCT00953758|474179523|FG007|Overall Study|Participant refused further follow-up|0|||
131698613|NCT00953758|474179524|FG008|Overall Study|Participant refused further follow-up|1|||
131784667|NCT01785875|474495095|FG002|Overall Study|Protocol Specified Criteria|55|||
131784668|NCT01785875|474495093|FG000|Overall Study|Missing|0|||
131784669|NCT01785875|474495094|FG001|Overall Study|Missing|1|||
131784670|NCT01785875|474495095|FG002|Overall Study|Missing|3|||
131784671|NCT00417027|474495098|FG000|Overall Study|Protocol Violation|0|||
131784672|NCT00417027|474495099|FG001|Overall Study|Protocol Violation|5|||
131698614|NCT00953758|474179525|FG009|Overall Study|Participant refused further follow-up|0|||
131698615|NCT00953758|474179516|FG000|Overall Study|Lost to Follow-up|0|||
131784673|NCT00417027|474495100|FG002|Overall Study|Protocol Violation|5|||
131784674|NCT00707174|474495101|FG000|Overall Study|Adverse Event|1|||
131698616|NCT00953758|474179517|FG001|Overall Study|Lost to Follow-up|0|||
131698617|NCT00953758|474179518|FG002|Overall Study|Lost to Follow-up|0|||
131698618|NCT00953758|474179519|FG003|Overall Study|Lost to Follow-up|1|||
131698619|NCT00953758|474179520|FG004|Overall Study|Lost to Follow-up|0|||
131698620|NCT00953758|474179521|FG005|Overall Study|Lost to Follow-up|0|||
131698621|NCT00953758|474179522|FG006|Overall Study|Lost to Follow-up|0|||
131698622|NCT00953758|474179523|FG007|Overall Study|Lost to Follow-up|1|||
131698623|NCT00953758|474179524|FG008|Overall Study|Lost to Follow-up|0|||
131698624|NCT00953758|474179525|FG009|Overall Study|Lost to Follow-up|1|||
131698625|NCT00953758|474179516|FG000|Overall Study|Physician Decision|0|||
131698626|NCT00953758|474179517|FG001|Overall Study|Physician Decision|0|||
131698627|NCT00953758|474179518|FG002|Overall Study|Physician Decision|0|||
131698628|NCT00953758|474179519|FG003|Overall Study|Physician Decision|0|||
131698629|NCT00953758|474179520|FG004|Overall Study|Physician Decision|1|||
131698630|NCT00953758|474179521|FG005|Overall Study|Physician Decision|0|||
131698631|NCT00953758|474179522|FG006|Overall Study|Physician Decision|0|||
131698632|NCT00953758|474179523|FG007|Overall Study|Physician Decision|0|||
131698633|NCT00953758|474179524|FG008|Overall Study|Physician Decision|0|||
131698634|NCT00953758|474179525|FG009|Overall Study|Physician Decision|0|||
131698635|NCT00953758|474179516|FG000|Overall Study|Disease progression|0|||
131698636|NCT00953758|474179517|FG001|Overall Study|Disease progression|0|||
131698637|NCT00953758|474179518|FG002|Overall Study|Disease progression|0|||
131698638|NCT00953758|474179519|FG003|Overall Study|Disease progression|0|||
131698639|NCT00953758|474179520|FG004|Overall Study|Disease progression|1|||
131698640|NCT00953758|474179521|FG005|Overall Study|Disease progression|0|||
131698641|NCT00953758|474179522|FG006|Overall Study|Disease progression|0|||
131698642|NCT00953758|474179523|FG007|Overall Study|Disease progression|0|||
131698643|NCT00953758|474179524|FG008|Overall Study|Disease progression|0|||
131698644|NCT00953758|474179525|FG009|Overall Study|Disease progression|0|||
131698645|NCT00953758|474179516|FG000|Overall Study|Participant went for transplant|0|||
131698646|NCT00953758|474179517|FG001|Overall Study|Participant went for transplant|0|||
131698647|NCT00953758|474179518|FG002|Overall Study|Participant went for transplant|0|||
131698648|NCT00953758|474179519|FG003|Overall Study|Participant went for transplant|0|||
131698649|NCT00953758|474179520|FG004|Overall Study|Participant went for transplant|0|||
131698650|NCT00953758|474179521|FG005|Overall Study|Participant went for transplant|0|||
131698651|NCT00953758|474179522|FG006|Overall Study|Participant went for transplant|0|||
131698652|NCT00953758|474179523|FG007|Overall Study|Participant went for transplant|0|||
131698653|NCT00953758|474179524|FG008|Overall Study|Participant went for transplant|1|||
131698654|NCT00953758|474179525|FG009|Overall Study|Participant went for transplant|0|||
131698655|NCT01543087|474179529|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
131698656|NCT01543087|474179530|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
131698657|NCT01543087|474179531|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
131698658|NCT01543087|474179532|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
131698659|NCT01543087|474179533|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
131698660|NCT01543087|474179534|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
131698661|NCT01543087|474179529|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
131698662|NCT01543087|474179530|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
131698663|NCT01543087|474179531|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
131698664|NCT01543087|474179532|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
131698665|NCT01543087|474179533|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
131698666|NCT01543087|474179534|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
131698667|NCT01543087|474179529|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
131698668|NCT01543087|474179530|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
131698669|NCT01543087|474179531|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
131698670|NCT01543087|474179532|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
131698671|NCT01543087|474179533|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
131698672|NCT01543087|474179534|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
131698673|NCT01543087|474179529|FG000|Stage 1 (48 Months)|Other than specified|5|||
131698674|NCT01543087|474179530|FG001|Stage 1 (48 Months)|Other than specified|0|||
131698675|NCT01543087|474179531|FG002|Stage 1 (48 Months)|Other than specified|9|||
131698676|NCT01543087|474179532|FG003|Stage 1 (48 Months)|Other than specified|0|||
131698677|NCT01543087|474179533|FG004|Stage 1 (48 Months)|Other than specified|0|||
131698678|NCT01543087|474179534|FG005|Stage 1 (48 Months)|Other than specified|0|||
131698679|NCT01543087|474179529|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
131698680|NCT01543087|474179530|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
131698681|NCT01543087|474179531|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
131698682|NCT01543087|474179532|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
131572646|NCT04888585|473721547|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
131572647|NCT04888585|473721548|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
131698683|NCT01543087|474179533|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
131698684|NCT01543087|474179534|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
131698685|NCT01543087|474179529|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131698686|NCT01543087|474179530|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
131698687|NCT01543087|474179531|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131698688|NCT01543087|474179532|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131698689|NCT01543087|474179533|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
131698690|NCT01543087|474179534|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131698691|NCT01543087|474179529|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
131698692|NCT01543087|474179530|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
131698693|NCT01543087|474179531|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
131698694|NCT01543087|474179532|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
131698695|NCT01543087|474179533|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
131698696|NCT01543087|474179534|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
131698697|NCT05779072|474179535|FG000|Overall Study|Lost to Follow-up|0|||
131698698|NCT05779072|474179536|FG001|Overall Study|Lost to Follow-up|1|||
131698699|NCT05779072|474179535|FG000|Overall Study|Withdrawal by Subject|1|||
131698700|NCT05779072|474179536|FG001|Overall Study|Withdrawal by Subject|5|||
131698701|NCT03298022|474179537|FG000|Overall Study|Lack of Efficacy|4|||
131698702|NCT03298022|474179537|FG000|Overall Study|Withdrawal by Subject|7|||
131698703|NCT03298022|474179537|FG000|Overall Study|Adverse Event|1|||
131698704|NCT03298022|474179537|FG000|Overall Study|disease relapse|1|||
131698705|NCT01422239|474179540|FG000|Overall Study|Lost to Follow-up|4|||
131698706|NCT01422239|474179541|FG001|Overall Study|Lost to Follow-up|3|||
131698707|NCT03167073|474179542|FG000|Overall Study|Stillbirth|1|||
131698708|NCT03167073|474179543|FG001|Overall Study|Stillbirth|0|||
131698709|NCT01276236|474179544|FG000|Overall Study|Lack of Efficacy|2|||
131698710|NCT01276236|474179544|FG000|Overall Study|Withdrawal by Subject|4|||
131698711|NCT02799069|474179545|FG000|Overall Study|Adverse Event|0|||
131698712|NCT02799069|474179546|FG001|Overall Study|Adverse Event|2|||
131698713|NCT02799069|474179547|FG002|Overall Study|Adverse Event|2|||
131698714|NCT02799069|474179545|FG000|Overall Study|Lack of Efficacy|2|||
131698715|NCT02799069|474179546|FG001|Overall Study|Lack of Efficacy|0|||
131698716|NCT02799069|474179547|FG002|Overall Study|Lack of Efficacy|0|||
131698717|NCT02799069|474179545|FG000|Overall Study|Lost to Follow-up|1|||
131698718|NCT02799069|474179546|FG001|Overall Study|Lost to Follow-up|1|||
131698719|NCT02799069|474179547|FG002|Overall Study|Lost to Follow-up|0|||
131698720|NCT02799069|474179545|FG000|Overall Study|Withdrawal by Subject|4|||
131698721|NCT02799069|474179546|FG001|Overall Study|Withdrawal by Subject|4|||
131698722|NCT02799069|474179547|FG002|Overall Study|Withdrawal by Subject|3|||
131698723|NCT02799069|474179545|FG000|Overall Study|Protocol Violation|1|||
131698724|NCT02799069|474179546|FG001|Overall Study|Protocol Violation|0|||
131698725|NCT02799069|474179547|FG002|Overall Study|Protocol Violation|2|||
131698726|NCT02695628|474179552|FG000|Overall Study|Withdrawal by Subject|1|||
131698727|NCT01681433|474179553|FG000|Overall Study|Lack of Efficacy|23|||
131698728|NCT01681433|474179554|FG001|Overall Study|Lack of Efficacy|23|||
131698729|NCT01681433|474179553|FG000|Overall Study|Withdrawal by Subject|5|||
131698730|NCT01681433|474179554|FG001|Overall Study|Withdrawal by Subject|5|||
131698731|NCT01681433|474179553|FG000|Overall Study|Protocol Violation|2|||
131572648|NCT04888585|473721549|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
131572649|NCT04888585|473721550|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131572650|NCT04888585|473721551|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131572651|NCT04888585|473721552|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131572652|NCT04888585|473721553|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131572653|NCT04888585|473721554|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131572654|NCT04888585|473721555|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131572655|NCT04888585|473721545|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572656|NCT04888585|473721546|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
131572657|NCT04888585|473721547|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
131572658|NCT04888585|473721548|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
131572659|NCT04888585|473721549|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
131572660|NCT04888585|473721550|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572661|NCT04888585|473721551|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572662|NCT04888585|473721552|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572663|NCT04888585|473721553|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572664|NCT04888585|473721554|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572665|NCT04888585|473721555|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131572666|NCT04888585|473721545|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572667|NCT04888585|473721546|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572668|NCT04888585|473721547|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
131572669|NCT04888585|473721548|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572670|NCT04888585|473721549|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
131572671|NCT04888585|473721550|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572672|NCT04888585|473721551|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572673|NCT04888585|473721552|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572674|NCT04888585|473721553|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131698732|NCT01681433|474179554|FG001|Overall Study|Protocol Violation|0|||
131698733|NCT01681433|474179553|FG000|Overall Study|Adverse Event|2|||
131698734|NCT01681433|474179554|FG001|Overall Study|Adverse Event|4|||
131698735|NCT01681433|474179553|FG000|Overall Study|Lost to Follow-up|0|||
131698736|NCT01681433|474179554|FG001|Overall Study|Lost to Follow-up|1|||
131698737|NCT01844895|474179555|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
131698738|NCT01844895|474179555|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
131698739|NCT01844895|474179555|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
131698740|NCT01844895|474179555|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
131698741|NCT01844895|474179555|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
131698742|NCT01844895|474179555|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
131698743|NCT01844895|474179555|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
131698744|NCT00511355|474179559|FG000|Overall Study|Adverse Event|4|||
131698745|NCT00511355|474179560|FG001|Overall Study|Adverse Event|4|||
131698746|NCT00511355|474179559|FG000|Overall Study|Pregnancy Wish|1|||
131698747|NCT00511355|474179560|FG001|Overall Study|Pregnancy Wish|0|||
131698748|NCT00511355|474179559|FG000|Overall Study|Lost to Follow-up|2|||
131698749|NCT00511355|474179560|FG001|Overall Study|Lost to Follow-up|1|||
131698750|NCT00511355|474179559|FG000|Overall Study|Other Reason|0|||
131698751|NCT00511355|474179560|FG001|Overall Study|Other Reason|1|||
131698752|NCT00511355|474179559|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
131698753|NCT00511355|474179560|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
131698754|NCT00511355|474179559|FG000|Overall Study|Withdrawal of informed consent|0|||
131698755|NCT00511355|474179560|FG001|Overall Study|Withdrawal of informed consent|1|||
131698756|NCT00511355|474179559|FG000|Overall Study|Other reason pre-treatment|0|||
131698757|NCT00511355|474179560|FG001|Overall Study|Other reason pre-treatment|1|||
131698758|NCT03208231|474179563|FG000|Overall Study|Death|1|||
131698759|NCT03208231|474179564|FG001|Overall Study|Death|2|||
131698760|NCT03208231|474179563|FG000|Overall Study|Moved and unable to get to clinic|1|||
131698761|NCT03208231|474179564|FG001|Overall Study|Moved and unable to get to clinic|0|||
131698762|NCT03208231|474179563|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
131698763|NCT03208231|474179564|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
131698764|NCT04770779|474179567|FG000|Overall Study|Randomized, never treated|0|||
131698765|NCT04770779|474179568|FG001|Overall Study|Randomized, never treated|1|||
131698766|NCT04770779|474179567|FG000|Overall Study|Adverse Event|9|||
131698767|NCT04770779|474179568|FG001|Overall Study|Adverse Event|1|||
131698768|NCT04770779|474179567|FG000|Overall Study|Withdrawal by Subject|7|||
131698769|NCT04770779|474179568|FG001|Overall Study|Withdrawal by Subject|1|||
131698770|NCT04770779|474179567|FG000|Overall Study|Pregnancy|0|||
131698771|NCT04770779|474179568|FG001|Overall Study|Pregnancy|1|||
131698772|NCT02289950|474179570|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
131698773|NCT02289950|474179571|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
131698774|NCT02289950|474179570|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
131698775|NCT02289950|474179571|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
131698776|NCT02289950|474179570|FG000|Overall Study|Lost to Follow-up|1|||
131698777|NCT02289950|474179571|FG001|Overall Study|Lost to Follow-up|0|||
131698778|NCT02289950|474179570|FG000|Overall Study|Physician Decision|9|||
131698779|NCT02289950|474179571|FG001|Overall Study|Physician Decision|3|||
131698780|NCT02289950|474179570|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
131698781|NCT02289950|474179571|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
131698782|NCT02289950|474179570|FG000|Overall Study|Withdrawal by Subject|1|||
131698783|NCT02289950|474179571|FG001|Overall Study|Withdrawal by Subject|3|||
131698784|NCT02289950|474179570|FG000|Overall Study|Test article held for greater than 28 days|0|||
131572675|NCT04888585|473721554|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131698785|NCT02289950|474179571|FG001|Overall Study|Test article held for greater than 28 days|1|||
131698786|NCT02289950|474179570|FG000|Overall Study|Adverse Event|11|||
131437898|NCT05190120|473228179|FG000|Overall Study|Lost to Follow-up|5|||
131437899|NCT05190120|473228180|FG001|Overall Study|Lost to Follow-up|0|||
131437900|NCT05190120|473228181|FG002|Overall Study|Lost to Follow-up|2|||
131437901|NCT05190120|473228182|FG003|Overall Study|Lost to Follow-up|3|||
131437902|NCT02354235|473228183|FG000|Overall Study|Adverse Event|2|||
131437903|NCT02354235|473228184|FG001|Overall Study|Adverse Event|2|||
131437904|NCT02354235|473228183|FG000|Overall Study|Physician Decision|0|||
131437905|NCT02354235|473228184|FG001|Overall Study|Physician Decision|1|||
131437906|NCT02354235|473228183|FG000|Overall Study|Withdrawal by Subject|1|||
131437907|NCT02354235|473228184|FG001|Overall Study|Withdrawal by Subject|3|||
131437908|NCT02354235|473228183|FG000|Overall Study|Conflict with the stopping criteria|0|||
131437909|NCT02354235|473228184|FG001|Overall Study|Conflict with the stopping criteria|1|||
131698787|NCT02289950|474179571|FG001|Overall Study|Adverse Event|3|||
131698788|NCT02289950|474179570|FG000|Overall Study|Death|1|||
131698789|NCT02289950|474179571|FG001|Overall Study|Death|1|||
131698790|NCT02289950|474179570|FG000|Overall Study|Other|5|||
131698791|NCT02289950|474179571|FG001|Overall Study|Other|2|||
131698792|NCT02289950|474179570|FG000|Overall Study|Not Treated|2|||
131698793|NCT02289950|474179571|FG001|Overall Study|Not Treated|1|||
131698794|NCT05902364|474179574|FG000|Overall Study|Adverse Event|1|||
131698795|NCT05902364|474179575|FG001|Overall Study|Adverse Event|0|||
131698796|NCT00644787|474179576|FG000|Period 1: Titration Phase|Adverse Event|11|||
131698797|NCT00644787|474179577|FG001|Period 1: Titration Phase|Adverse Event|0|||
131698798|NCT00644787|474179578|FG002|Period 1: Titration Phase|Adverse Event|0|||
131698799|NCT00644787|474179576|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
131698800|NCT00644787|474179577|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
131698801|NCT00644787|474179578|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
131698802|NCT00644787|474179576|FG000|Period 1: Titration Phase|Physician Decision|1|||
131698803|NCT00644787|474179577|FG001|Period 1: Titration Phase|Physician Decision|0|||
131698804|NCT00644787|474179578|FG002|Period 1: Titration Phase|Physician Decision|0|||
131698805|NCT00644787|474179576|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
131698806|NCT00644787|474179577|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
131698807|NCT00644787|474179578|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
131698808|NCT00644787|474179576|FG000|Period 1: Titration Phase|Worsening of complications|1|||
131698809|NCT00644787|474179577|FG001|Period 1: Titration Phase|Worsening of complications|0|||
131698810|NCT00644787|474179578|FG002|Period 1: Titration Phase|Worsening of complications|0|||
131698811|NCT00644787|474179576|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
131698812|NCT00644787|474179577|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
131698813|NCT00644787|474179578|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
131698814|NCT00644787|474179576|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
131698815|NCT00644787|474179577|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
131698816|NCT00644787|474179578|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
131698817|NCT00644787|474179576|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
131698818|NCT00644787|474179577|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
131698819|NCT00644787|474179578|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
131698820|NCT00644787|474179576|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
131698821|NCT00644787|474179577|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
131698822|NCT00644787|474179578|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
131698823|NCT00644787|474179576|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
131698824|NCT00644787|474179577|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
131698825|NCT00644787|474179578|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
131698826|NCT00644787|474179576|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
131698827|NCT00644787|474179577|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
131698828|NCT00644787|474179578|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
131698829|NCT00644787|474179576|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
131698830|NCT00644787|474179577|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
131698831|NCT00644787|474179578|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
131698832|NCT02968810|474180869|FG000|Overall Study|Lost to Follow-up|1|||
131698833|NCT02968810|474180870|FG001|Overall Study|Lost to Follow-up|0|||
131698834|NCT02968810|474180869|FG000|Overall Study|Physician Decision|1|||
131698835|NCT02968810|474180870|FG001|Overall Study|Physician Decision|0|||
131698836|NCT02968810|474180869|FG000|Overall Study|Withdrawal by Subject|1|||
131698837|NCT02968810|474180870|FG001|Overall Study|Withdrawal by Subject|3|||
131698838|NCT02968810|474180869|FG000|Overall Study|Disease Progression|0|||
131698839|NCT02968810|474180870|FG001|Overall Study|Disease Progression|1|||
131698840|NCT03269344|474180871|FG000|Overall Study|Protocol Violation|4|||
131698841|NCT03269344|474180872|FG001|Overall Study|Protocol Violation|3|||
131698842|NCT02597855|474180875|FG000|Overall Study|Lost to Follow-up|2|||
131698843|NCT02597855|474180876|FG001|Overall Study|Lost to Follow-up|1|||
131698844|NCT01449708|474180877|FG000|Overall Study|Protocol Violation|0|||
131698845|NCT01449708|474180878|FG001|Overall Study|Protocol Violation|1|||
131698846|NCT01449708|474180877|FG000|Overall Study|surgical complication|1|||
131698847|NCT01449708|474180878|FG001|Overall Study|surgical complication|2|||
131572676|NCT04888585|473721555|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131572677|NCT04888585|473721545|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
131698848|NCT01449708|474180877|FG000|Overall Study|respiratory failure|1|||
131698849|NCT01449708|474180878|FG001|Overall Study|respiratory failure|0|||
131698850|NCT03704194|474180882|FG000|Overall Study|Withdrawal by Subject|0|||
131698851|NCT03704194|474180883|FG001|Overall Study|Withdrawal by Subject|1|||
131698852|NCT00559507|474180884|FG000|Overall Study|Not treated, patient ineligible|3|||
131698853|NCT03823391|474180885|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
131698854|NCT03823391|474180886|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
131698855|NCT03823391|474180885|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
131698856|NCT03823391|474180886|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
131698857|NCT01491178|474180887|FG000|Overall Study|Adverse Event|1016|||
131698858|NCT01491178|474180887|FG000|Overall Study|Improvement of NVAF|210|||
131698859|NCT01491178|474180887|FG000|Overall Study|To conduct invasive treatment|59|||
131698860|NCT01491178|474180887|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
131698861|NCT01491178|474180887|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
131698862|NCT01491178|474180887|FG000|Overall Study|To take a contraindication|20|||
131698863|NCT01491178|474180887|FG000|Overall Study|Other than specified above|657|||
131698864|NCT05689047|474180888|FG000|Overall Study|Lost to Follow-up|0|||
131698865|NCT05689047|474180889|FG001|Overall Study|Lost to Follow-up|1|||
131698866|NCT05689047|474180888|FG000|Overall Study|Protocol Deviation|1|||
131698867|NCT05689047|474180889|FG001|Overall Study|Protocol Deviation|0|||
131698868|NCT03132636|474180890|FG000|Overall Study|Adverse Event|1|||
131698869|NCT03132636|474180891|FG001|Overall Study|Adverse Event|2|||
131698870|NCT03132636|474180890|FG000|Overall Study|Death|4|||
131698871|NCT03132636|474180891|FG001|Overall Study|Death|7|||
131698872|NCT03132636|474180890|FG000|Overall Study|Lost to Follow-up|3|||
131698873|NCT03132636|474180891|FG001|Overall Study|Lost to Follow-up|2|||
131698874|NCT03132636|474180890|FG000|Overall Study|Non compliance with protocol by participant|1|||
131698875|NCT03132636|474180891|FG001|Overall Study|Non compliance with protocol by participant|1|||
131698876|NCT03132636|474180890|FG000|Overall Study|Subject decision|1|||
131698877|NCT03132636|474180891|FG001|Overall Study|Subject decision|9|||
131698878|NCT03132636|474180890|FG000|Overall Study|Sponsor decision|0|||
131698879|NCT03132636|474180891|FG001|Overall Study|Sponsor decision|1|||
131698880|NCT03132636|474180890|FG000|Overall Study|Physician Decision|1|||
131698881|NCT03132636|474180891|FG001|Overall Study|Physician Decision|0|||
131698882|NCT03132636|474180890|FG000|Overall Study|Progressive disease|33|||
131698883|NCT03132636|474180891|FG001|Overall Study|Progressive disease|36|||
131698884|NCT03132636|474180890|FG000|Overall Study|Withdrawal of consent|2|||
131698885|NCT03132636|474180891|FG001|Overall Study|Withdrawal of consent|5|||
131698886|NCT03132636|474180890|FG000|Overall Study|Did not re-consent|1|||
131698887|NCT03132636|474180891|FG001|Overall Study|Did not re-consent|0|||
131698888|NCT03132636|474180890|FG000|Overall Study|Lost insurance coverage|1|||
131698889|NCT03132636|474180891|FG001|Overall Study|Lost insurance coverage|0|||
131698890|NCT03132636|474180890|FG000|Overall Study|Related to radiological outcomes|0|||
131698891|NCT03132636|474180891|FG001|Overall Study|Related to radiological outcomes|1|||
131698892|NCT03132636|474180890|FG000|Overall Study|Unable to come to site for continued visits|0|||
131698893|NCT03132636|474180891|FG001|Overall Study|Unable to come to site for continued visits|1|||
131698894|NCT01764633|474180903|FG000|Overall Study|Withdrawal by Subject|105|||
131698895|NCT01764633|474180904|FG001|Overall Study|Withdrawal by Subject|88|||
131698896|NCT01764633|474180903|FG000|Overall Study|Lost to Follow-up|13|||
131698897|NCT01764633|474180904|FG001|Overall Study|Lost to Follow-up|5|||
131698898|NCT02268058|474180905|FG000|Overall Study|Protocol Violation|1|||
131698899|NCT02268058|474180906|FG001|Overall Study|Protocol Violation|0|||
131698900|NCT02268058|474180907|FG002|Overall Study|Protocol Violation|0|||
131698901|NCT02268058|474180908|FG003|Overall Study|Protocol Violation|0|||
131698902|NCT00493038|474180909|FG000|Treatment|Adverse Event|8|||
131698903|NCT00493038|474180910|FG001|Treatment|Adverse Event|4|||
131698904|NCT00493038|474180909|FG000|Treatment|Lost to Follow-up|5|||
131698905|NCT00493038|474180910|FG001|Treatment|Lost to Follow-up|3|||
131698906|NCT00493038|474180909|FG000|Treatment|Withdrawal by Subject|11|||
131698907|NCT00493038|474180910|FG001|Treatment|Withdrawal by Subject|12|||
131698908|NCT00493038|474180909|FG000|Treatment|Other|0|||
131698909|NCT00493038|474180910|FG001|Treatment|Other|1|||
131698910|NCT00493038|474180909|FG000|Follow-up|Lost to Follow-up|1|||
131698911|NCT00493038|474180910|FG001|Follow-up|Lost to Follow-up|0|||
131784675|NCT00707174|474495102|FG001|Overall Study|Adverse Event|6|||
131698912|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
131698913|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
131698914|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
131698915|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
131698916|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
131698917|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
131698918|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
131698919|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
131698920|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
131784676|NCT00707174|474495101|FG000|Overall Study|Withdrawal by Subject|4|||
131784677|NCT00707174|474495102|FG001|Overall Study|Withdrawal by Subject|1|||
131784678|NCT00618774|474495105|FG000|Overall Study|Adverse Event|5|||
131784679|NCT00618774|474495106|FG001|Overall Study|Adverse Event|3|||
131784680|NCT00618774|474495105|FG000|Overall Study|Withdrawal by Subject|1|||
131784681|NCT00618774|474495106|FG001|Overall Study|Withdrawal by Subject|0|||
131784682|NCT04991311|474495107|FG000|Overall Study|Adverse Event|1|||
131784683|NCT00054275|474495110|FG000|Overall Study|Withdrawal by Subject|4|||
131784684|NCT00054275|474495110|FG000|Overall Study|Adverse Event|5|||
131784685|NCT00054275|474495110|FG000|Overall Study|Progressive disease in cycle 1|1|||
131784686|NCT00054275|474495110|FG000|Overall Study|Physician Decision|1|||
131784687|NCT02030834|474495120|FG000|Overall Study|Death|4|||
131784688|NCT02030834|474495121|FG001|Overall Study|Death|0|||
131784689|NCT02030834|474495122|FG002|Overall Study|Death|0|||
131784690|NCT02030834|474495120|FG000|Overall Study|Manufacturing failure|2|||
131784691|NCT02030834|474495121|FG001|Overall Study|Manufacturing failure|0|||
131784692|NCT02030834|474495122|FG002|Overall Study|Manufacturing failure|1|||
131784693|NCT02030834|474495120|FG000|Overall Study|Disease progression|2|||
131784694|NCT02030834|474495121|FG001|Overall Study|Disease progression|0|||
131784695|NCT02030834|474495122|FG002|Overall Study|Disease progression|2|||
131784696|NCT02030834|474495120|FG000|Overall Study|Lost to Follow-up|1|||
131784697|NCT02030834|474495121|FG001|Overall Study|Lost to Follow-up|0|||
131784698|NCT02030834|474495122|FG002|Overall Study|Lost to Follow-up|0|||
131784699|NCT02030834|474495120|FG000|Overall Study|Withdrawal by Subject|1|||
131784700|NCT02030834|474495121|FG001|Overall Study|Withdrawal by Subject|0|||
131784701|NCT02030834|474495122|FG002|Overall Study|Withdrawal by Subject|0|||
131784702|NCT02030834|474495120|FG000|Overall Study|Lack of funding|1|||
131784703|NCT02030834|474495121|FG001|Overall Study|Lack of funding|0|||
131784704|NCT02030834|474495122|FG002|Overall Study|Lack of funding|0|||
131784705|NCT01440595|474495123|FG000|Overall Study|Lost to Follow-up|0|||
131784706|NCT01440595|474495124|FG001|Overall Study|Lost to Follow-up|1|||
131784707|NCT01440595|474495125|FG002|Overall Study|Lost to Follow-up|0|||
131784708|NCT01440595|474495123|FG000|Overall Study|Study terminated by sponsor.|1|||
131784709|NCT01440595|474495124|FG001|Overall Study|Study terminated by sponsor.|2|||
131784710|NCT01440595|474495125|FG002|Overall Study|Study terminated by sponsor.|1|||
131784711|NCT01347879|474495126|FG000|Overall Study|Adverse Event|0|||
131784712|NCT01347879|474495127|FG001|Overall Study|Adverse Event|12|||
131784713|NCT01347879|474495126|FG000|Overall Study|Lost to Follow-up|2|||
131784714|NCT01347879|474495127|FG001|Overall Study|Lost to Follow-up|0|||
131784715|NCT01347879|474495126|FG000|Overall Study|Withdrawal by Subject|3|||
131784716|NCT01347879|474495127|FG001|Overall Study|Withdrawal by Subject|2|||
131784717|NCT01347879|474495126|FG000|Overall Study|Other|2|||
131784718|NCT01347879|474495127|FG001|Overall Study|Other|3|||
131784719|NCT01238822|474495132|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
131784720|NCT04736576|474495133|FG000|Overall Study|Progressive disease|3|||
131784721|NCT04736576|474495134|FG001|Overall Study|Progressive disease|1|||
131784722|NCT04736576|474495133|FG000|Overall Study|Death|1|||
131784723|NCT04736576|474495134|FG001|Overall Study|Death|0|||
131784724|NCT00996918|474495140|FG000|Overall Study|Lack of Efficacy|1|||
131784725|NCT00996918|474495141|FG001|Overall Study|Lack of Efficacy|1|||
131784726|NCT00996918|474495142|FG002|Overall Study|Lack of Efficacy|2|||
131784727|NCT00996918|474495143|FG003|Overall Study|Lack of Efficacy|2|||
131784728|NCT00996918|474495144|FG004|Overall Study|Lack of Efficacy|0|||
131784729|NCT00996918|474495140|FG000|Overall Study|Adverse Event|2|||
131784730|NCT00996918|474495141|FG001|Overall Study|Adverse Event|5|||
131784731|NCT00996918|474495142|FG002|Overall Study|Adverse Event|2|||
131784732|NCT00996918|474495143|FG003|Overall Study|Adverse Event|6|||
131784733|NCT00996918|474495144|FG004|Overall Study|Adverse Event|0|||
131784734|NCT00996918|474495140|FG000|Overall Study|Withdrawal by Subject|1|||
131784735|NCT00996918|474495141|FG001|Overall Study|Withdrawal by Subject|4|||
131784736|NCT00996918|474495142|FG002|Overall Study|Withdrawal by Subject|3|||
131784737|NCT00996918|474495143|FG003|Overall Study|Withdrawal by Subject|3|||
131784738|NCT00996918|474495144|FG004|Overall Study|Withdrawal by Subject|2|||
131784739|NCT00996918|474495140|FG000|Overall Study|Physician Decision|1|||
131784740|NCT00996918|474495141|FG001|Overall Study|Physician Decision|0|||
131784741|NCT00996918|474495142|FG002|Overall Study|Physician Decision|0|||
131784742|NCT00996918|474495143|FG003|Overall Study|Physician Decision|0|||
131784743|NCT00996918|474495144|FG004|Overall Study|Physician Decision|0|||
131784744|NCT00996918|474495140|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
131784745|NCT00996918|474495141|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
131784746|NCT00996918|474495142|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
131784747|NCT00996918|474495143|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
131784748|NCT00996918|474495144|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
131784749|NCT00996918|474495140|FG000|Overall Study|Loss of Caregiver|0|||
131784750|NCT00996918|474495141|FG001|Overall Study|Loss of Caregiver|1|||
131784751|NCT00996918|474495142|FG002|Overall Study|Loss of Caregiver|0|||
131784752|NCT00996918|474495143|FG003|Overall Study|Loss of Caregiver|0|||
131784753|NCT00996918|474495144|FG004|Overall Study|Loss of Caregiver|0|||
131784754|NCT00996918|474495140|FG000|Overall Study|Other|3|||
131784755|NCT00996918|474495141|FG001|Overall Study|Other|1|||
131784756|NCT00996918|474495142|FG002|Overall Study|Other|0|||
131784757|NCT00996918|474495143|FG003|Overall Study|Other|0|||
131784758|NCT00996918|474495144|FG004|Overall Study|Other|0|||
131784759|NCT04440007|474495152|FG000|Overall Study|Adverse Event|0|||
131784760|NCT04440007|474495153|FG001|Overall Study|Adverse Event|1|||
131784761|NCT04440007|474495152|FG000|Overall Study|Lost to Follow-up|1|||
131784762|NCT04440007|474495153|FG001|Overall Study|Lost to Follow-up|3|||
131784763|NCT04440007|474495152|FG000|Overall Study|Death|7|||
131784764|NCT04440007|474495153|FG001|Overall Study|Death|2|||
131784765|NCT04440007|474495152|FG000|Overall Study|Physician Decision|1|||
131784766|NCT04440007|474495153|FG001|Overall Study|Physician Decision|1|||
131784767|NCT04440007|474495152|FG000|Overall Study|Withdrawal by Subject|2|||
131784768|NCT04440007|474495153|FG001|Overall Study|Withdrawal by Subject|1|||
131784769|NCT04440007|474495152|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
131784770|NCT04440007|474495153|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
131784771|NCT04440007|474495152|FG000|Overall Study|Discontinued prior to dosing|0|||
131784772|NCT04440007|474495153|FG001|Overall Study|Discontinued prior to dosing|2|||
131784773|NCT01466673|474495154|FG000|Overall Study|Non-compliance with study treatment|2|||
131784774|NCT01466673|474495155|FG001|Overall Study|Non-compliance with study treatment|0|||
131784775|NCT01466673|474495154|FG000|Overall Study|Lost to Follow-up|3|||
131784776|NCT01466673|474495155|FG001|Overall Study|Lost to Follow-up|5|||
131784777|NCT01466673|474495154|FG000|Overall Study|Adverse Event|2|||
131784778|NCT01466673|474495155|FG001|Overall Study|Adverse Event|1|||
131784779|NCT00854607|474495156|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
131784780|NCT00965263|474495164|FG000|Overall Study|Physician Decision|2|||
131784781|NCT00965263|474495165|FG001|Overall Study|Physician Decision|0|||
131784782|NCT00965263|474495164|FG000|Overall Study|Family emergency|0|||
131784783|NCT00965263|474495165|FG001|Overall Study|Family emergency|1|||
131784784|NCT00965263|474495164|FG000|Overall Study|Protocol Violation|0|||
131784785|NCT00965263|474495165|FG001|Overall Study|Protocol Violation|2|||
131784786|NCT00829439|474495166|FG000|Overall Study|Adverse Event|0|||
131784787|NCT00829439|474495167|FG001|Overall Study|Adverse Event|0|||
131784788|NCT00829439|474495168|FG002|Overall Study|Adverse Event|1|||
131784789|NCT00829439|474495169|FG003|Overall Study|Adverse Event|0|||
131784790|NCT02567266|474495170|FG000|Overall Study|Withdrawal by Subject|10|||
131784791|NCT02567266|474495171|FG001|Overall Study|Withdrawal by Subject|7|||
131784792|NCT02567266|474495172|FG002|Overall Study|Withdrawal by Subject|6|||
131784793|NCT02567266|474495170|FG000|Overall Study|Lost to Follow-up|13|||
131784794|NCT02567266|474495171|FG001|Overall Study|Lost to Follow-up|8|||
131784795|NCT02567266|474495172|FG002|Overall Study|Lost to Follow-up|10|||
131784796|NCT00123487|474495173|FG000|Randomized|Death prior to starting treatment|0|||
131784797|NCT00123487|474495174|FG001|Randomized|Death prior to starting treatment|1|||
131784798|NCT00123487|474495173|FG000|Randomized|SAE prior to starting treatment|1|||
131784799|NCT00123487|474495174|FG001|Randomized|SAE prior to starting treatment|0|||
131784800|NCT00123487|474495173|FG000|Treated With Study Drug|Adverse Event|23|||
131784801|NCT00123487|474495174|FG001|Treated With Study Drug|Adverse Event|22|||
131784802|NCT00123487|474495173|FG000|Treated With Study Drug|Disease Progression|141|||
131784803|NCT00123487|474495174|FG001|Treated With Study Drug|Disease Progression|122|||
131784804|NCT00123487|474495173|FG000|Treated With Study Drug|Physician Decision|8|||
131784805|NCT00123487|474495174|FG001|Treated With Study Drug|Physician Decision|9|||
131784806|NCT00123487|474495173|FG000|Treated With Study Drug|Other|59|||
131784807|NCT00123487|474495174|FG001|Treated With Study Drug|Other|58|||
131784808|NCT00123487|474495173|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
131784809|NCT00123487|474495174|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
131784810|NCT00123487|474495173|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
131784811|NCT00123487|474495174|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
131784812|NCT00123487|474495173|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
131572678|NCT04888585|473721546|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
131572679|NCT04888585|473721547|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
131572680|NCT04888585|473721548|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
131572681|NCT04888585|473721549|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
131572682|NCT04888585|473721550|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
131784813|NCT00123487|474495174|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
131784814|NCT03835975|474495175|FG000|Overall Study|Lost to Follow-up|1|||
131784815|NCT03835975|474495176|FG001|Overall Study|Lost to Follow-up|1|||
131784816|NCT03835975|474495177|FG002|Overall Study|Lost to Follow-up|0|||
131784817|NCT03835975|474495178|FG003|Overall Study|Lost to Follow-up|0|||
131784818|NCT03835975|474495179|FG004|Overall Study|Lost to Follow-up|0|||
131784819|NCT03835975|474495175|FG000|Overall Study|No longer met eligibility criteria|0|||
131784820|NCT03835975|474495176|FG001|Overall Study|No longer met eligibility criteria|1|||
131784821|NCT03835975|474495177|FG002|Overall Study|No longer met eligibility criteria|0|||
131784822|NCT03835975|474495178|FG003|Overall Study|No longer met eligibility criteria|0|||
131784823|NCT03835975|474495179|FG004|Overall Study|No longer met eligibility criteria|0|||
131784824|NCT03835975|474495175|FG000|Overall Study|Protocol Violation|1|||
131784825|NCT03835975|474495176|FG001|Overall Study|Protocol Violation|1|||
131784826|NCT03835975|474495177|FG002|Overall Study|Protocol Violation|2|||
131784827|NCT03835975|474495178|FG003|Overall Study|Protocol Violation|0|||
131784828|NCT03835975|474495179|FG004|Overall Study|Protocol Violation|0|||
131784829|NCT03835975|474495175|FG000|Overall Study|Withdrawal by Subject|1|||
131784830|NCT03835975|474495176|FG001|Overall Study|Withdrawal by Subject|0|||
131784831|NCT03835975|474495177|FG002|Overall Study|Withdrawal by Subject|1|||
131784832|NCT03835975|474495178|FG003|Overall Study|Withdrawal by Subject|1|||
131784833|NCT03835975|474495179|FG004|Overall Study|Withdrawal by Subject|0|||
131784834|NCT00975884|474495180|FG000|Overall Study|Adverse Event|1|||
131784835|NCT00975884|474495181|FG001|Overall Study|Adverse Event|0|||
131784836|NCT00975884|474495180|FG000|Overall Study|Lost to Follow-up|5|||
131784837|NCT00975884|474495181|FG001|Overall Study|Lost to Follow-up|3|||
131784838|NCT00975884|474495180|FG000|Overall Study|Withdrawal by Subject|9|||
131784839|NCT00975884|474495181|FG001|Overall Study|Withdrawal by Subject|9|||
131784840|NCT00975884|474495180|FG000|Overall Study|Other|1|||
131784841|NCT00975884|474495181|FG001|Overall Study|Other|3|||
131784842|NCT01656967|474495182|FG000|Overall Study|faulty monitor|1|||
131784843|NCT01656967|474495183|FG001|Overall Study|faulty monitor|0|||
131784844|NCT01656967|474495182|FG000|Overall Study|unsuccessful ETT insertion|3|||
131784845|NCT01656967|474495183|FG001|Overall Study|unsuccessful ETT insertion|2|||
131784846|NCT00479765|474495184|FG000|Overall Study|study terminated|4|||
131784847|NCT00420849|474495185|FG000|Overall Study|Lack of Efficacy|154|||
131784848|NCT00420849|474495185|FG000|Overall Study|Adverse Event|107|||
131784849|NCT00420849|474495185|FG000|Overall Study|Withdrawal by Subject|28|||
131784850|NCT00420849|474495185|FG000|Overall Study|Death|18|||
131784851|NCT00420849|474495185|FG000|Overall Study|Other|14|||
131784852|NCT00420849|474495185|FG000|Overall Study|Transplant|8|||
131784853|NCT00420849|474495185|FG000|Overall Study|Protocol Violation|1|||
131784854|NCT00420849|474495185|FG000|Overall Study|Lost to Follow-up|1|||
131784855|NCT00944125|474495186|FG000|3 to 6 Months|Withdrawal by Subject|0|||
131784856|NCT00944125|474495187|FG001|3 to 6 Months|Withdrawal by Subject|2|||
131784857|NCT00944125|474495186|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
131784858|NCT00944125|474495187|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
131784859|NCT00446134|474495188|FG000|Overall Study|Adverse Event|7|||
131784860|NCT00446134|474495189|FG001|Overall Study|Adverse Event|17|||
131784861|NCT00446134|474495190|FG002|Overall Study|Adverse Event|13|||
131784862|NCT00446134|474495191|FG003|Overall Study|Adverse Event|18|||
131784863|NCT00446134|474495188|FG000|Overall Study|Lack of Efficacy|19|||
131784864|NCT00446134|474495189|FG001|Overall Study|Lack of Efficacy|19|||
131784865|NCT00446134|474495190|FG002|Overall Study|Lack of Efficacy|24|||
131784866|NCT00446134|474495191|FG003|Overall Study|Lack of Efficacy|19|||
131784867|NCT00446134|474495188|FG000|Overall Study|Protocol Violation|0|||
131784868|NCT00446134|474495189|FG001|Overall Study|Protocol Violation|2|||
131784869|NCT00446134|474495190|FG002|Overall Study|Protocol Violation|1|||
131784870|NCT00446134|474495191|FG003|Overall Study|Protocol Violation|0|||
131784871|NCT00446134|474495188|FG000|Overall Study|Lost to Follow-up|1|||
131784872|NCT00446134|474495189|FG001|Overall Study|Lost to Follow-up|3|||
131784873|NCT00446134|474495190|FG002|Overall Study|Lost to Follow-up|1|||
131784874|NCT00446134|474495191|FG003|Overall Study|Lost to Follow-up|1|||
131784875|NCT00446134|474495188|FG000|Overall Study|Withdrawal by Subject|3|||
131784876|NCT00446134|474495189|FG001|Overall Study|Withdrawal by Subject|3|||
131784877|NCT00446134|474495190|FG002|Overall Study|Withdrawal by Subject|1|||
131784878|NCT00446134|474495191|FG003|Overall Study|Withdrawal by Subject|3|||
131784879|NCT00446134|474495188|FG000|Overall Study|Physician Decision|0|||
131784880|NCT00446134|474495189|FG001|Overall Study|Physician Decision|0|||
131784881|NCT00446134|474495190|FG002|Overall Study|Physician Decision|0|||
131784882|NCT00446134|474495191|FG003|Overall Study|Physician Decision|2|||
131784883|NCT00446134|474495188|FG000|Overall Study|Adverse Event-Diarrhea|1|||
131784884|NCT00446134|474495189|FG001|Overall Study|Adverse Event-Diarrhea|1|||
131784885|NCT00446134|474495190|FG002|Overall Study|Adverse Event-Diarrhea|2|||
131784886|NCT00446134|474495191|FG003|Overall Study|Adverse Event-Diarrhea|0|||
131784887|NCT00446134|474495188|FG000|Overall Study|Reason Not Completed|3|||
131784888|NCT00446134|474495189|FG001|Overall Study|Reason Not Completed|0|||
131784889|NCT00446134|474495190|FG002|Overall Study|Reason Not Completed|1|||
131784890|NCT00446134|474495191|FG003|Overall Study|Reason Not Completed|2|||
131572683|NCT04888585|473721551|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
131784891|NCT03724968|474496692|FG000|Overall Study|Insurance issues|0|||
131784892|NCT03724968|474496693|FG001|Overall Study|Insurance issues|1|||
131784893|NCT03724968|474496692|FG000|Overall Study|Study closed|0|||
131784894|NCT03724968|474496693|FG001|Overall Study|Study closed|1|||
131784895|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
131784896|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
131784897|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
131784898|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
131784899|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
131698921|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
131698922|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
131698923|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
131698924|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
131698925|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
131698926|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
131698927|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
131698928|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
131698929|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
131698930|NCT04418765|474180911|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
131698931|NCT04418765|474180912|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
131698932|NCT04418765|474180913|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
131698933|NCT04418765|474180911|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
131698934|NCT04418765|474180912|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
131698935|NCT04418765|474180913|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
131698936|NCT04418765|474180911|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
131698937|NCT04418765|474180912|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
131698938|NCT04418765|474180913|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
131698939|NCT04418765|474180911|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
131698940|NCT04418765|474180912|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
131698941|NCT04418765|474180913|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
131698942|NCT04418765|474180911|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
131698943|NCT04418765|474180912|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
131698944|NCT04418765|474180913|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
131698945|NCT04418765|474180911|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
131698946|NCT04418765|474180912|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
131698947|NCT04418765|474180913|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
131698948|NCT04418765|474180911|FG000|Extension Period (48 Weeks)|Other than specified|0|||
131698949|NCT04418765|474180912|FG001|Extension Period (48 Weeks)|Other than specified|5|||
131698950|NCT04418765|474180913|FG002|Extension Period (48 Weeks)|Other than specified|2|||
131698951|NCT01100944|474180914|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
131698952|NCT01100944|474180915|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
131698953|NCT01100944|474180916|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
131698954|NCT01100944|474180914|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
131698955|NCT01100944|474180915|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
131698956|NCT01100944|474180916|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
131698957|NCT01100944|474180914|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
131698958|NCT01100944|474180915|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
131698959|NCT01100944|474180916|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
131698960|NCT01100944|474180914|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
131698961|NCT01100944|474180915|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
131698962|NCT01100944|474180916|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
131698963|NCT02706730|474180920|FG000|Overall Study|Adverse Event|3|||
131698964|NCT02706730|474180920|FG000|Overall Study|Lack of Efficacy|5|||
131698965|NCT02706730|474180920|FG000|Overall Study|Withdrawal by Subject|11|||
131698966|NCT02706730|474180920|FG000|Overall Study|Study Terminated by Sponsor|11|||
131698967|NCT02706730|474180920|FG000|Overall Study|Subject chose not to receive injection|3|||
131698968|NCT02499029|474180925|FG000|Overall Study|Lost to Follow-up|2|||
131698969|NCT02499029|474180926|FG001|Overall Study|Lost to Follow-up|2|||
131698970|NCT02499029|474180925|FG000|Overall Study|Physician Decision|2|||
131698971|NCT02499029|474180926|FG001|Overall Study|Physician Decision|1|||
131698972|NCT02499029|474180925|FG000|Overall Study|Death|1|||
131698973|NCT02499029|474180926|FG001|Overall Study|Death|0|||
131698974|NCT01999582|474180929|FG000|Overall Study|Withdrawal by Subject|0|||
131698975|NCT01999582|474180930|FG001|Overall Study|Withdrawal by Subject|0|||
131698976|NCT01999582|474180931|FG002|Overall Study|Withdrawal by Subject|0|||
131698977|NCT01999582|474180932|FG003|Overall Study|Withdrawal by Subject|1|||
131698978|NCT01999582|474180933|FG004|Overall Study|Withdrawal by Subject|0|||
131698979|NCT01999582|474180934|FG005|Overall Study|Withdrawal by Subject|0|||
131698980|NCT01999582|474180929|FG000|Overall Study|Adverse Event|0|||
131698981|NCT01999582|474180930|FG001|Overall Study|Adverse Event|0|||
131698982|NCT01999582|474180931|FG002|Overall Study|Adverse Event|3|||
131698983|NCT01999582|474180932|FG003|Overall Study|Adverse Event|0|||
131698984|NCT01999582|474180933|FG004|Overall Study|Adverse Event|1|||
131698985|NCT01999582|474180934|FG005|Overall Study|Adverse Event|0|||
131698986|NCT01999582|474180929|FG000|Overall Study|Other Reasons|1|||
131698987|NCT01999582|474180930|FG001|Overall Study|Other Reasons|0|||
131698988|NCT01999582|474180931|FG002|Overall Study|Other Reasons|3|||
131698989|NCT01999582|474180932|FG003|Overall Study|Other Reasons|1|||
131698990|NCT01999582|474180933|FG004|Overall Study|Other Reasons|1|||
131698991|NCT01999582|474180934|FG005|Overall Study|Other Reasons|2|||
131784900|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
131784901|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
131784902|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
131784903|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131784904|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131784905|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131784906|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
131784907|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
131784908|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131784909|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131784910|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131784911|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
131784912|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
131784913|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
131784914|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
131784915|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
131784916|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
131784917|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
131784918|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
131784919|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
131784920|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131784921|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
131784922|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131784923|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
131784924|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131784925|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131784926|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131784927|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
131784928|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131784929|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
131784930|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
131784931|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131784932|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131784933|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
131784934|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131784935|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
131784936|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
131784937|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
131784938|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
131784939|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
131784940|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
131784941|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
131784942|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
131784943|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
131784944|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
131784945|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131784946|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
131784947|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131784948|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131784949|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131784950|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131784951|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
131784952|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
131784953|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
131784954|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
131784955|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
131784956|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
131784957|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
131784958|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
131784959|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
131784960|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
131784961|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
131784962|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
131784963|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
131784964|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
131784965|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
131784966|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
131784967|NCT04440163|474496696|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
131784968|NCT04440163|474496697|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
131784969|NCT04440163|474496698|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
131784970|NCT04440163|474496699|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
131784971|NCT04440163|474496700|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
131784972|NCT04440163|474496701|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
131784973|NCT04440163|474496702|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
131784974|NCT04440163|474496703|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
131784975|NCT04440163|474496696|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
131784976|NCT04440163|474496697|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
131784977|NCT04440163|474496698|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
131784978|NCT04440163|474496699|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
131784979|NCT04440163|474496700|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
131784980|NCT04440163|474496701|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
131784981|NCT04440163|474496702|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
131784982|NCT04440163|474496703|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
131784983|NCT04440163|474496696|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784984|NCT04440163|474496697|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784985|NCT04440163|474496698|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784986|NCT04440163|474496699|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
131784987|NCT04440163|474496700|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784988|NCT04440163|474496701|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784989|NCT04440163|474496702|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784990|NCT04440163|474496703|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131784991|NCT03137082|474496706|FG000|Overall Study|Withdrawal by Subject|1|||
131784992|NCT03137082|474496707|FG001|Overall Study|Withdrawal by Subject|1|||
131784993|NCT03137082|474496706|FG000|Overall Study|Lost to Follow-up|1|||
131784994|NCT03137082|474496707|FG001|Overall Study|Lost to Follow-up|0|||
131784995|NCT00544557|474496708|FG000|Overall Study|Adverse Event|140|||
131784996|NCT00544557|474496708|FG000|Overall Study|Lack of Efficacy|196|||
131784997|NCT00544557|474496708|FG000|Overall Study|Other|98|||
131784998|NCT01020305|474496714|FG000|Overall Study|Adverse Event|2|||
131784999|NCT00467818|474496715|FG000|Overall Study|Adverse Event|1|||
131785000|NCT00467818|474496716|FG001|Overall Study|Adverse Event|0|||
131785001|NCT00467818|474496715|FG000|Overall Study|Lost to Follow-up|2|||
131785002|NCT00467818|474496716|FG001|Overall Study|Lost to Follow-up|2|||
131785003|NCT02753400|474496717|FG000|Overall Study|Adverse Event|3|||
131785004|NCT02753400|474496718|FG001|Overall Study|Adverse Event|0|||
131785005|NCT02753400|474496717|FG000|Overall Study|Withdrawal by Subject|2|||
131785006|NCT02753400|474496718|FG001|Overall Study|Withdrawal by Subject|1|||
131785007|NCT01415921|474496719|FG000|Overall Study|Adverse Event|0|||
131785008|NCT01415921|474496720|FG001|Overall Study|Adverse Event|1|||
131785009|NCT01415921|474496719|FG000|Overall Study|Physician Decision|1|||
131785010|NCT01415921|474496720|FG001|Overall Study|Physician Decision|1|||
131785011|NCT01415921|474496719|FG000|Overall Study|Withdrawal by Subject|0|||
131785012|NCT01415921|474496720|FG001|Overall Study|Withdrawal by Subject|1|||
131785013|NCT01415921|474496719|FG000|Overall Study|Other|2|||
131785014|NCT01415921|474496720|FG001|Overall Study|Other|0|||
131785015|NCT01830920|474496723|FG000|Overall Study|Adverse Event|1|||
131785016|NCT01830920|474496724|FG001|Overall Study|Adverse Event|0|||
131785017|NCT01830920|474496725|FG002|Overall Study|Adverse Event|1|||
131785018|NCT01830920|474496726|FG003|Overall Study|Adverse Event|0|||
131785019|NCT01830920|474496727|FG004|Overall Study|Adverse Event|0|||
131785020|NCT01830920|474496723|FG000|Overall Study|Withdrawal by Subject|2|||
131785021|NCT01830920|474496724|FG001|Overall Study|Withdrawal by Subject|2|||
131785022|NCT01830920|474496725|FG002|Overall Study|Withdrawal by Subject|1|||
131785023|NCT01830920|474496726|FG003|Overall Study|Withdrawal by Subject|7|||
131785024|NCT01830920|474496727|FG004|Overall Study|Withdrawal by Subject|1|||
131698992|NCT01999582|474180929|FG000|Overall Study|Protocol Violation|1|||
131698993|NCT01999582|474180930|FG001|Overall Study|Protocol Violation|0|||
131698994|NCT01999582|474180931|FG002|Overall Study|Protocol Violation|0|||
131698995|NCT01999582|474180932|FG003|Overall Study|Protocol Violation|0|||
131698996|NCT01999582|474180933|FG004|Overall Study|Protocol Violation|0|||
131698997|NCT01999582|474180934|FG005|Overall Study|Protocol Violation|1|||
131698998|NCT01999582|474180929|FG000|Overall Study|Lack of Efficacy|1|||
131698999|NCT01999582|474180930|FG001|Overall Study|Lack of Efficacy|3|||
131699000|NCT01999582|474180931|FG002|Overall Study|Lack of Efficacy|0|||
131699001|NCT01999582|474180932|FG003|Overall Study|Lack of Efficacy|1|||
131699002|NCT01999582|474180933|FG004|Overall Study|Lack of Efficacy|0|||
131699003|NCT01999582|474180934|FG005|Overall Study|Lack of Efficacy|0|||
131699004|NCT00699907|474180937|FG000|Overall Study|Withdrawal by Subject|2|||
131699005|NCT00699907|474180938|FG001|Overall Study|Withdrawal by Subject|1|||
131699006|NCT00699907|474180939|FG002|Overall Study|Withdrawal by Subject|0|||
131699007|NCT00699907|474180937|FG000|Overall Study|No usable sample|0|||
131699008|NCT00699907|474180938|FG001|Overall Study|No usable sample|9|||
131699009|NCT00699907|474180939|FG002|Overall Study|No usable sample|8|||
131699010|NCT02161211|474180940|FG000|Overall Study|Lost to Follow-up|21|||
131699011|NCT02161211|474180941|FG001|Overall Study|Lost to Follow-up|27|||
131699012|NCT02161211|474180942|FG002|Overall Study|Lost to Follow-up|21|||
131699013|NCT02161211|474180940|FG000|Overall Study|Dropped|12|||
131699014|NCT02161211|474180941|FG001|Overall Study|Dropped|5|||
131699015|NCT02161211|474180942|FG002|Overall Study|Dropped|9|||
131699016|NCT01536860|474180943|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
131699017|NCT01536860|474180944|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
131699018|NCT01536860|474180945|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
131699019|NCT01164722|474180946|FG000|Overall Study|Adverse Event|0|||
131699020|NCT01164722|474180947|FG001|Overall Study|Adverse Event|1|||
131699021|NCT01164722|474180946|FG000|Overall Study|Withdrawal by Subject|3|||
131699022|NCT01164722|474180947|FG001|Overall Study|Withdrawal by Subject|4|||
131699023|NCT01164722|474180946|FG000|Overall Study|Lost to Follow-up|3|||
131699024|NCT01164722|474180947|FG001|Overall Study|Lost to Follow-up|6|||
131699025|NCT01164722|474180946|FG000|Overall Study|met protocol criteria for non-treatment|11|||
131699026|NCT01164722|474180947|FG001|Overall Study|met protocol criteria for non-treatment|1|||
131699027|NCT01164722|474180946|FG000|Overall Study|enrolled on other study, concomitant med|1|||
131699028|NCT01164722|474180947|FG001|Overall Study|enrolled on other study, concomitant med|3|||
131699029|NCT00999908|474180948|FG000|Treatment Period 1|Subject withdrew consent|2|||
131699030|NCT00999908|474180949|FG001|Treatment Period 1|Subject withdrew consent|0|||
131699031|NCT00999908|474180950|FG002|Treatment Period 1|Subject withdrew consent|0|||
131699032|NCT00999908|474180948|FG000|Treatment Period 2|Protocol Violation|1|||
131785025|NCT01830920|474496723|FG000|Overall Study|Death|3|||
131785026|NCT01830920|474496724|FG001|Overall Study|Death|3|||
131785027|NCT01830920|474496725|FG002|Overall Study|Death|5|||
131785028|NCT01830920|474496726|FG003|Overall Study|Death|4|||
131785029|NCT01830920|474496727|FG004|Overall Study|Death|4|||
131785030|NCT01830920|474496723|FG000|Overall Study|Other|15|||
131785031|NCT01830920|474496724|FG001|Overall Study|Other|1|||
131785032|NCT01830920|474496725|FG002|Overall Study|Other|1|||
131785033|NCT01830920|474496726|FG003|Overall Study|Other|5|||
131785034|NCT01830920|474496727|FG004|Overall Study|Other|3|||
131785035|NCT01313728|474496728|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
131785036|NCT00755937|474496731|FG000|Recruitment|Unknown if infliximab received|164|||
131785037|NCT00755937|474496731|FG000|Observational Follow-up|Lost to Follow-up|148|||
131785038|NCT00572156|474496732|FG000|Overall Study|Adverse Event|3|||
131785039|NCT00572156|474496733|FG001|Overall Study|Adverse Event|1|||
131785040|NCT00572156|474496734|FG002|Overall Study|Adverse Event|5|||
131785041|NCT00572156|474496735|FG003|Overall Study|Adverse Event|1|||
131699033|NCT00999908|474180949|FG001|Treatment Period 2|Protocol Violation|0|||
131699034|NCT00999908|474180950|FG002|Treatment Period 2|Protocol Violation|0|||
131785042|NCT00572156|474496732|FG000|Overall Study|Lost to Follow-up|1|||
131572684|NCT04888585|473721552|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
131699035|NCT00927095|474180952|FG000|Overall Study|Adverse Event|3|||
131699036|NCT00927095|474180953|FG001|Overall Study|Adverse Event|1|||
131785043|NCT00572156|474496733|FG001|Overall Study|Lost to Follow-up|1|||
131785044|NCT00572156|474496734|FG002|Overall Study|Lost to Follow-up|1|||
131699037|NCT00927095|474180954|FG002|Overall Study|Adverse Event|0|||
131699038|NCT00927095|474180952|FG000|Overall Study|Withdrawal by Subject|2|||
131699039|NCT00927095|474180953|FG001|Overall Study|Withdrawal by Subject|1|||
131699040|NCT00927095|474180954|FG002|Overall Study|Withdrawal by Subject|1|||
131699041|NCT00927095|474180952|FG000|Overall Study|Physician Decision|1|||
131699042|NCT00927095|474180953|FG001|Overall Study|Physician Decision|2|||
131699043|NCT00927095|474180954|FG002|Overall Study|Physician Decision|1|||
131699044|NCT00706030|474180955|FG000|Overall Study|Disease Progression|4|||
131699045|NCT00706030|474180956|FG001|Overall Study|Disease Progression|6|||
131699046|NCT00706030|474180957|FG002|Overall Study|Disease Progression|46|||
131699047|NCT00706030|474180958|FG003|Overall Study|Disease Progression|12|||
131699048|NCT00706030|474180955|FG000|Overall Study|Adverse Event|1|||
131785045|NCT00572156|474496735|FG003|Overall Study|Lost to Follow-up|0|||
131572685|NCT04888585|473721553|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
131572686|NCT04888585|473721554|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
131572687|NCT04888585|473721555|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
131572688|NCT04888585|473721545|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131572689|NCT04888585|473721546|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131572690|NCT04888585|473721547|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131572691|NCT04888585|473721548|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131572692|NCT04888585|473721549|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131572693|NCT04888585|473721550|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
131572694|NCT04888585|473721551|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
131572695|NCT04888585|473721552|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
131699049|NCT00706030|474180956|FG001|Overall Study|Adverse Event|0|||
131699050|NCT00706030|474180957|FG002|Overall Study|Adverse Event|4|||
131699051|NCT00706030|474180958|FG003|Overall Study|Adverse Event|2|||
131699052|NCT00706030|474180955|FG000|Overall Study|Withdrawal by Subject|1|||
131699053|NCT00706030|474180956|FG001|Overall Study|Withdrawal by Subject|0|||
131572696|NCT04888585|473721553|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
131572697|NCT04888585|473721554|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
131572698|NCT04888585|473721555|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
131699054|NCT00706030|474180957|FG002|Overall Study|Withdrawal by Subject|2|||
131699055|NCT00706030|474180958|FG003|Overall Study|Withdrawal by Subject|0|||
131699056|NCT00706030|474180955|FG000|Overall Study|Physician Decision|0|||
131699057|NCT00706030|474180956|FG001|Overall Study|Physician Decision|0|||
131699058|NCT00706030|474180957|FG002|Overall Study|Physician Decision|2|||
131699059|NCT00706030|474180958|FG003|Overall Study|Physician Decision|0|||
131699060|NCT00706030|474180955|FG000|Overall Study|Not recorded|0|||
131699061|NCT00706030|474180956|FG001|Overall Study|Not recorded|0|||
131699062|NCT00706030|474180957|FG002|Overall Study|Not recorded|2|||
131699063|NCT00706030|474180958|FG003|Overall Study|Not recorded|0|||
131699064|NCT00706030|474180955|FG000|Overall Study|Protocol Violation|0|||
131699065|NCT00706030|474180956|FG001|Overall Study|Protocol Violation|0|||
131699066|NCT00706030|474180957|FG002|Overall Study|Protocol Violation|1|||
131699067|NCT00706030|474180958|FG003|Overall Study|Protocol Violation|1|||
131699068|NCT00706030|474180955|FG000|Overall Study|Failed to return|0|||
131699069|NCT00706030|474180956|FG001|Overall Study|Failed to return|0|||
131699070|NCT00706030|474180957|FG002|Overall Study|Failed to return|1|||
131699071|NCT00706030|474180958|FG003|Overall Study|Failed to return|0|||
131699072|NCT00706030|474180955|FG000|Overall Study|Symptomatic Deterioration|0|||
131699073|NCT00706030|474180956|FG001|Overall Study|Symptomatic Deterioration|0|||
131699074|NCT00706030|474180957|FG002|Overall Study|Symptomatic Deterioration|1|||
131699075|NCT00706030|474180958|FG003|Overall Study|Symptomatic Deterioration|0|||
131699076|NCT00706030|474180955|FG000|Overall Study|No treatment received|0|||
131699077|NCT00706030|474180956|FG001|Overall Study|No treatment received|0|||
131699078|NCT00706030|474180957|FG002|Overall Study|No treatment received|0|||
131699079|NCT00706030|474180958|FG003|Overall Study|No treatment received|1|||
131699080|NCT00706030|474180955|FG000|Overall Study|Death|0|||
131699081|NCT00706030|474180956|FG001|Overall Study|Death|0|||
131699082|NCT00706030|474180957|FG002|Overall Study|Death|1|||
131699083|NCT00706030|474180958|FG003|Overall Study|Death|0|||
131699084|NCT00357500|474180979|FG000|Overall Study|Adverse Event|3|||
131699085|NCT00357500|474180979|FG000|Overall Study|Withdrawal by Subject|5|||
131699086|NCT00357500|474180979|FG000|Overall Study|Progressive Disease|65|||
131699087|NCT00357500|474180979|FG000|Overall Study|Not Started Protocol Therapy|4|||
131699088|NCT02301403|474180980|FG000|Overall Study|Withdrawal by Subject|28|||
131699089|NCT02301403|474180981|FG001|Overall Study|Withdrawal by Subject|41|||
131699090|NCT00730639|474180982|FG000|Overall Study|Adverse Event|3|||
131699091|NCT00730639|474180983|FG001|Overall Study|Adverse Event|0|||
131699092|NCT00730639|474180984|FG002|Overall Study|Adverse Event|9|||
131699093|NCT00730639|474180985|FG003|Overall Study|Adverse Event|8|||
131699094|NCT00730639|474180986|FG004|Overall Study|Adverse Event|23|||
131785046|NCT00572156|474496732|FG000|Overall Study|Protocol Violation|1|||
131699095|NCT00730639|474180982|FG000|Overall Study|Complete Response|0|||
131699096|NCT00730639|474180983|FG001|Overall Study|Complete Response|0|||
131699097|NCT00730639|474180984|FG002|Overall Study|Complete Response|2|||
131699098|NCT00730639|474180985|FG003|Overall Study|Complete Response|2|||
131699099|NCT00730639|474180986|FG004|Overall Study|Complete Response|1|||
131699100|NCT00730639|474180982|FG000|Overall Study|Completed Maximum Cycles|0|||
131699101|NCT00730639|474180983|FG001|Overall Study|Completed Maximum Cycles|0|||
131699102|NCT00730639|474180984|FG002|Overall Study|Completed Maximum Cycles|11|||
131437910|NCT03069352|473228185|FG000|Overall Study|Ongoing|12|||
131437911|NCT03069352|473228186|FG001|Overall Study|Ongoing|40|||
131437912|NCT02621424|473228187|FG000|Overall Study|Withdrawal by Subject|1|||
131437913|NCT02621424|473228188|FG001|Overall Study|Withdrawal by Subject|2|||
131437914|NCT04750642|473228191|FG000|Overall Study|Adverse Event|1|||
131437915|NCT04750642|473228192|FG001|Overall Study|Adverse Event|0|||
131437916|NCT04750642|473228191|FG000|Overall Study|Withdrawal by Subject|0|||
131437917|NCT04750642|473228192|FG001|Overall Study|Withdrawal by Subject|1|||
131437918|NCT04750642|473228191|FG000|Overall Study|Protocol Violation|0|||
131437919|NCT04750642|473228192|FG001|Overall Study|Protocol Violation|1|||
131437920|NCT04972162|473228193|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
131437921|NCT04972162|473228194|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
131437922|NCT02926638|473228195|FG000|Overall Study|Progression|2|||
131437923|NCT02926638|473228196|FG001|Overall Study|Progression|5|||
131437924|NCT02926638|473228195|FG000|Overall Study|Ineligible|1|||
131437925|NCT02926638|473228196|FG001|Overall Study|Ineligible|0|||
131437926|NCT02926638|473228195|FG000|Overall Study|Not protocol specified|1|||
131437927|NCT02926638|473228196|FG001|Overall Study|Not protocol specified|0|||
131437928|NCT01928927|473228197|FG000|Overall Study|Lost to Follow-up|1|||
131437929|NCT01928927|473228198|FG001|Overall Study|Lost to Follow-up|0|||
131437930|NCT01928927|473228197|FG000|Overall Study|Withdrawal by Subject|1|||
131437931|NCT01928927|473228198|FG001|Overall Study|Withdrawal by Subject|1|||
131437932|NCT00416624|473229444|FG000|Overall Study|Withdrawal by Subject|1|||
131437933|NCT00416624|473229445|FG001|Overall Study|Withdrawal by Subject|6|||
131437934|NCT00416624|473229446|FG002|Overall Study|Withdrawal by Subject|4|||
131437935|NCT00416624|473229447|FG003|Overall Study|Withdrawal by Subject|9|||
131437936|NCT00416624|473229444|FG000|Overall Study|Death|4|||
131437937|NCT00416624|473229445|FG001|Overall Study|Death|7|||
131437938|NCT00416624|473229446|FG002|Overall Study|Death|7|||
131437939|NCT00416624|473229447|FG003|Overall Study|Death|1|||
131437940|NCT00416624|473229444|FG000|Overall Study|Adverse Event|8|||
131437941|NCT00416624|473229445|FG001|Overall Study|Adverse Event|3|||
131437942|NCT00416624|473229446|FG002|Overall Study|Adverse Event|2|||
131437943|NCT00416624|473229447|FG003|Overall Study|Adverse Event|2|||
131437944|NCT00416624|473229444|FG000|Overall Study|Other|8|||
131437945|NCT00416624|473229445|FG001|Overall Study|Other|11|||
131437946|NCT00416624|473229446|FG002|Overall Study|Other|5|||
131437947|NCT00416624|473229447|FG003|Overall Study|Other|5|||
131437948|NCT00416624|473229444|FG000|Overall Study|Cancel|1|||
131437949|NCT00416624|473229445|FG001|Overall Study|Cancel|0|||
131437950|NCT00416624|473229446|FG002|Overall Study|Cancel|0|||
131437951|NCT00416624|473229447|FG003|Overall Study|Cancel|0|||
131437952|NCT04245111|473229451|FG000|Overall Study|Lost to Follow-up|5|||
131437953|NCT04245111|473229452|FG001|Overall Study|Lost to Follow-up|1|||
131437954|NCT04245111|473229453|FG002|Overall Study|Lost to Follow-up|1|||
131437955|NCT02314052|473229456|FG000|Cycle One|Adverse Event|0|||
131437956|NCT02314052|473229457|FG001|Cycle One|Adverse Event|0|||
131437957|NCT02314052|473229458|FG002|Cycle One|Adverse Event|0|||
131437958|NCT02314052|473229459|FG003|Cycle One|Adverse Event|1|||
131437959|NCT02314052|473229460|FG004|Cycle One|Adverse Event|0|||
131437960|NCT02314052|473229461|FG005|Cycle One|Adverse Event|0|||
131785047|NCT00572156|474496733|FG001|Overall Study|Protocol Violation|2|||
131437961|NCT00117637|473229462|FG000|First Intervention (Period 1)|Adverse Event|11|||
131437962|NCT00117637|473229463|FG001|First Intervention (Period 1)|Adverse Event|16|||
131437963|NCT00117637|473229462|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
131437964|NCT00117637|473229463|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
131437965|NCT00117637|473229462|FG000|First Intervention (Period 1)|Protocol Violation|1|||
131437966|NCT00117637|473229463|FG001|First Intervention (Period 1)|Protocol Violation|0|||
131437967|NCT00117637|473229462|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
131437968|NCT00117637|473229463|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
131572699|NCT04888585|473721545|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131572700|NCT04888585|473721546|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131572701|NCT04888585|473721547|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131572702|NCT04888585|473721548|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131572703|NCT04888585|473721549|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131572704|NCT04888585|473721550|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
131572705|NCT04888585|473721551|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
131572706|NCT04888585|473721552|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
131572707|NCT04888585|473721553|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
131572708|NCT04888585|473721554|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
131572709|NCT04888585|473721555|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
131572710|NCT04888585|473721545|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
131572711|NCT04888585|473721546|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
131572712|NCT04888585|473721547|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
131572713|NCT04888585|473721548|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
131572714|NCT04888585|473721549|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
131572715|NCT04888585|473721550|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
131572716|NCT04888585|473721551|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
131572717|NCT04888585|473721552|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
131572718|NCT04888585|473721553|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
131572719|NCT04888585|473721554|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
131572720|NCT04888585|473721555|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
131785048|NCT00572156|474496734|FG002|Overall Study|Protocol Violation|0|||
131785049|NCT00572156|474496735|FG003|Overall Study|Protocol Violation|2|||
131785050|NCT00572156|474496732|FG000|Overall Study|Patient/Parent Decision|1|||
131785051|NCT00572156|474496733|FG001|Overall Study|Patient/Parent Decision|6|||
131785052|NCT00572156|474496734|FG002|Overall Study|Patient/Parent Decision|4|||
131785053|NCT00572156|474496735|FG003|Overall Study|Patient/Parent Decision|3|||
131785054|NCT00572156|474496732|FG000|Overall Study|Sponsor Decision|20|||
131785055|NCT00572156|474496733|FG001|Overall Study|Sponsor Decision|16|||
131785056|NCT00572156|474496734|FG002|Overall Study|Sponsor Decision|17|||
131785057|NCT00572156|474496735|FG003|Overall Study|Sponsor Decision|19|||
131785058|NCT02261974|474496736|FG000|Overall Study|Withdrawal by Subject|3|||
131785059|NCT02261974|474496737|FG001|Overall Study|Withdrawal by Subject|2|||
131785060|NCT02261974|474496736|FG000|Overall Study|Pregnancy|0|||
131785061|NCT02261974|474496737|FG001|Overall Study|Pregnancy|1|||
131785062|NCT02261974|474496736|FG000|Overall Study|Missed treatment cut-off date|6|||
131785063|NCT02261974|474496737|FG001|Overall Study|Missed treatment cut-off date|3|||
131785064|NCT02261974|474496736|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
131785065|NCT02261974|474496737|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
131785066|NCT02261974|474496736|FG000|Overall Study|Lost to Follow-up|2|||
131785067|NCT02261974|474496737|FG001|Overall Study|Lost to Follow-up|0|||
131785068|NCT02261974|474496736|FG000|Overall Study|Adverse Event|1|||
131785069|NCT02261974|474496737|FG001|Overall Study|Adverse Event|0|||
131785070|NCT01223196|474496738|FG000|Overall Study|Lost to Follow-up|2|||
131785071|NCT01223196|474496739|FG001|Overall Study|Lost to Follow-up|0|||
131785072|NCT01223196|474496738|FG000|Overall Study|Physician Decision|1|||
131785073|NCT01223196|474496739|FG001|Overall Study|Physician Decision|0|||
131785074|NCT01223196|474496738|FG000|Overall Study|Withdrawal by Subject|1|||
131785075|NCT01223196|474496739|FG001|Overall Study|Withdrawal by Subject|0|||
131785076|NCT05180630|474496740|FG000|First Intervention|Physician Decision|0|||
131785077|NCT05180630|474496741|FG001|First Intervention|Physician Decision|0|||
131785078|NCT05180630|474496742|FG002|First Intervention|Physician Decision|3|||
131785079|NCT01542736|474496743|FG000|Overall Study|Death|1|||
131785080|NCT00061945|474496744|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
131785081|NCT00061945|474496745|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
131785082|NCT00061945|474496744|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
131785083|NCT00061945|474496745|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
131785084|NCT00061945|474496744|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
131785085|NCT00061945|474496745|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
131785086|NCT00061945|474496744|FG000|Course IV: Alemtuzumab|Early exits|6|||
131437969|NCT00117637|473229462|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
131437970|NCT00117637|473229463|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
131437971|NCT00117637|473229462|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
131785087|NCT00061945|474496745|FG001|Course IV: Alemtuzumab|Early exits|15|||
131785088|NCT01039584|474496746|FG000|Overall Study|Withdrawal by Subject|4|||
131785089|NCT01039584|474496747|FG001|Overall Study|Withdrawal by Subject|2|||
131785090|NCT01039584|474496748|FG002|Overall Study|Withdrawal by Subject|1|||
131785091|NCT01039584|474496746|FG000|Overall Study|Protocol Violation|10|||
131785092|NCT01039584|474496747|FG001|Overall Study|Protocol Violation|4|||
131785093|NCT01039584|474496748|FG002|Overall Study|Protocol Violation|6|||
131572721|NCT04888585|473721545|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572722|NCT04888585|473721546|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572723|NCT04888585|473721547|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572724|NCT04888585|473721548|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572725|NCT04888585|473721549|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572726|NCT04888585|473721550|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572727|NCT04888585|473721551|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
131572728|NCT04888585|473721552|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
131572729|NCT04888585|473721553|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
131572730|NCT04888585|473721554|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
131572731|NCT04888585|473721555|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131572732|NCT03717194|473721556|FG000|Overall Study|Withdrawal by Subject|2|||
131572733|NCT03717194|473721557|FG001|Overall Study|Withdrawal by Subject|4|||
131572734|NCT03717194|473721556|FG000|Overall Study|Adverse Event|1|||
131572735|NCT03717194|473721557|FG001|Overall Study|Adverse Event|1|||
131572736|NCT02081391|473721558|FG000|12-hour Treatment|Withdrawal by Subject|3|||
131572737|NCT02081391|473721559|FG001|12-hour Treatment|Withdrawal by Subject|2|||
131572738|NCT02081391|473721560|FG002|12-hour Treatment|Withdrawal by Subject|0|||
131572739|NCT02081391|473721561|FG003|12-hour Treatment|Withdrawal by Subject|0|||
131572740|NCT02081391|473721558|FG000|12-hour Treatment|Physician Decision|4|||
131572741|NCT02081391|473721559|FG001|12-hour Treatment|Physician Decision|1|||
131572742|NCT02081391|473721560|FG002|12-hour Treatment|Physician Decision|0|||
131572743|NCT02081391|473721561|FG003|12-hour Treatment|Physician Decision|0|||
131572744|NCT02081391|473721558|FG000|12-hour Treatment|Lack of Efficacy|3|||
131572745|NCT02081391|473721559|FG001|12-hour Treatment|Lack of Efficacy|0|||
131572746|NCT02081391|473721560|FG002|12-hour Treatment|Lack of Efficacy|0|||
131572747|NCT02081391|473721561|FG003|12-hour Treatment|Lack of Efficacy|0|||
131572748|NCT02081391|473721558|FG000|12-hour Treatment|Adverse Event|4|||
131572749|NCT02081391|473721559|FG001|12-hour Treatment|Adverse Event|2|||
131572750|NCT02081391|473721560|FG002|12-hour Treatment|Adverse Event|0|||
131572751|NCT02081391|473721561|FG003|12-hour Treatment|Adverse Event|0|||
131572752|NCT02081391|473721558|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
131572753|NCT02081391|473721559|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
131572754|NCT02081391|473721560|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
131572755|NCT02081391|473721561|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
131572756|NCT02081391|473721558|FG000|12-hour Treatment|Further reasons|2|||
131572757|NCT02081391|473721559|FG001|12-hour Treatment|Further reasons|1|||
131572758|NCT02081391|473721560|FG002|12-hour Treatment|Further reasons|0|||
131572759|NCT02081391|473721561|FG003|12-hour Treatment|Further reasons|0|||
131572760|NCT02081391|473721558|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
131572761|NCT02081391|473721559|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
131572762|NCT02081391|473721560|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
131572763|NCT02081391|473721561|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
131572764|NCT02081391|473721558|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
131572765|NCT02081391|473721559|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
131437972|NCT00117637|473229463|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
131572766|NCT02081391|473721560|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
131572767|NCT02081391|473721561|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
131572768|NCT02081391|473721558|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
131572769|NCT02081391|473721559|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
131572770|NCT02081391|473721560|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
131572771|NCT02081391|473721561|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
131572772|NCT02081391|473721558|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
131572773|NCT02081391|473721559|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
131572774|NCT02081391|473721560|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
131572775|NCT02081391|473721561|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
131572776|NCT02081391|473721558|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
131572777|NCT02081391|473721559|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
131572778|NCT02081391|473721560|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
131572779|NCT02081391|473721561|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
131572780|NCT02081391|473721558|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
131572781|NCT02081391|473721559|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
131572782|NCT02081391|473721560|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
131572783|NCT02081391|473721561|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
131572784|NCT02926937|473721562|FG000|Overall Study|Adverse Event|0|||
131572785|NCT02926937|473721563|FG001|Overall Study|Adverse Event|1|||
131572786|NCT02926937|473721564|FG002|Overall Study|Adverse Event|1|||
131572787|NCT02926937|473721562|FG000|Overall Study|Poor Compliance to Protocol|1|||
131572788|NCT02926937|473721563|FG001|Overall Study|Poor Compliance to Protocol|0|||
131572789|NCT02926937|473721564|FG002|Overall Study|Poor Compliance to Protocol|0|||
131572790|NCT02926937|473721562|FG000|Overall Study|Lost to Follow-up|4|||
131572791|NCT02926937|473721563|FG001|Overall Study|Lost to Follow-up|5|||
131572792|NCT02926937|473721564|FG002|Overall Study|Lost to Follow-up|0|||
131572793|NCT02926937|473721562|FG000|Overall Study|At the Participant's own Request|11|||
131572794|NCT02926937|473721563|FG001|Overall Study|At the Participant's own Request|5|||
131572795|NCT02926937|473721564|FG002|Overall Study|At the Participant's own Request|8|||
131572796|NCT02926937|473721562|FG000|Overall Study|Reason not Specified|3|||
131572797|NCT02926937|473721563|FG001|Overall Study|Reason not Specified|4|||
131572798|NCT02926937|473721564|FG002|Overall Study|Reason not Specified|2|||
131437973|NCT00117637|473229462|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
131572799|NCT01559090|473721565|FG000|Stage I|Withdrawal by Subject|2|||
131572800|NCT01559090|473721566|FG001|Stage I|Withdrawal by Subject|2|||
131572801|NCT01559090|473721567|FG002|Stage I|Withdrawal by Subject|3|||
131572802|NCT01559090|473721565|FG000|Stage II|Withdrawal by Subject|1|||
131572803|NCT01559090|473721566|FG001|Stage II|Withdrawal by Subject|0|||
131785094|NCT01039584|474496746|FG000|Overall Study|Lost to Follow-up|5|||
131785095|NCT01039584|474496747|FG001|Overall Study|Lost to Follow-up|3|||
131785096|NCT01039584|474496748|FG002|Overall Study|Lost to Follow-up|4|||
131785097|NCT01039584|474496746|FG000|Overall Study|Negative Baseline culture for Candida|59|||
131785098|NCT01039584|474496747|FG001|Overall Study|Negative Baseline culture for Candida|59|||
131785099|NCT01039584|474496748|FG002|Overall Study|Negative Baseline culture for Candida|24|||
131785100|NCT01039584|474496746|FG000|Overall Study|Lack of Efficacy|7|||
131785101|NCT01039584|474496747|FG001|Overall Study|Lack of Efficacy|6|||
131785102|NCT01039584|474496748|FG002|Overall Study|Lack of Efficacy|10|||
131785103|NCT01039584|474496746|FG000|Overall Study|other|1|||
131785104|NCT01039584|474496747|FG001|Overall Study|other|3|||
131785105|NCT01039584|474496748|FG002|Overall Study|other|1|||
131785106|NCT01039584|474496746|FG000|Overall Study|Pap smear with significant pathology|10|||
131785107|NCT01039584|474496747|FG001|Overall Study|Pap smear with significant pathology|10|||
131572804|NCT01559090|473721567|FG002|Stage II|Withdrawal by Subject|0|||
131785108|NCT01039584|474496748|FG002|Overall Study|Pap smear with significant pathology|3|||
131785109|NCT01039584|474496746|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
131437974|NCT00117637|473229463|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
131437975|NCT00117637|473229462|FG000|First Intervention (Period 1)|reason not reported|0|||
131437976|NCT00117637|473229463|FG001|First Intervention (Period 1)|reason not reported|1|||
131437977|NCT00117637|473229462|FG000|Second Intervention (Period 2)|Adverse Event|0|||
131437978|NCT00117637|473229463|FG001|Second Intervention (Period 2)|Adverse Event|9|||
131437979|NCT00117637|473229462|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
131437980|NCT00117637|473229463|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
131437981|NCT00117637|473229462|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
131437982|NCT00117637|473229463|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
131437983|NCT00117637|473229462|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
131437984|NCT00117637|473229463|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
131437985|NCT00117637|473229462|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
131437986|NCT00117637|473229463|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
131437987|NCT00117637|473229462|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
131437988|NCT00117637|473229463|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
131572805|NCT03722446|473721568|FG000|Overall Study|Protocol Violation|15|||
131572806|NCT03722446|473721569|FG001|Overall Study|Protocol Violation|2|||
131572807|NCT00819910|473721570|FG000|Overall Study|Adverse Event|0|||
131572808|NCT00819910|473721571|FG001|Overall Study|Adverse Event|0|||
131572809|NCT00819910|473721572|FG002|Overall Study|Adverse Event|2|||
131572810|NCT00819910|473721573|FG003|Overall Study|Adverse Event|1|||
131572811|NCT00819910|473721570|FG000|Overall Study|Withdrawal by Subject|1|||
131572812|NCT00819910|473721571|FG001|Overall Study|Withdrawal by Subject|1|||
131572813|NCT00819910|473721572|FG002|Overall Study|Withdrawal by Subject|1|||
131572814|NCT00819910|473721573|FG003|Overall Study|Withdrawal by Subject|0|||
131572815|NCT00819910|473721570|FG000|Overall Study|Lost to Follow-up|1|||
131572816|NCT00819910|473721571|FG001|Overall Study|Lost to Follow-up|0|||
131437989|NCT00117637|473229462|FG000|Second Intervention (Period 2)|reason not reported|1|||
131437990|NCT00117637|473229463|FG001|Second Intervention (Period 2)|reason not reported|0|||
131437991|NCT01582061|473229464|FG000|Overall Study|Lack of Efficacy|3|||
131572817|NCT00819910|473721572|FG002|Overall Study|Lost to Follow-up|0|||
131572818|NCT00819910|473721573|FG003|Overall Study|Lost to Follow-up|0|||
131572819|NCT00871429|473721575|FG000|Overall Study|Lost to Follow-up|6|||
131572820|NCT00871429|473721575|FG000|Overall Study|Withdrawal by Subject|17|||
131572821|NCT00871429|473721575|FG000|Overall Study|Questionnaire not completed|1|||
131572822|NCT02908464|473721576|FG000|Overall Study|Withdrawal by Subject|2|||
131572823|NCT02908464|473721577|FG001|Overall Study|Withdrawal by Subject|1|||
131572824|NCT02908464|473721576|FG000|Overall Study|Found ineligible after randomization|0|||
131572825|NCT02908464|473721577|FG001|Overall Study|Found ineligible after randomization|2|||
131572826|NCT01772719|473721578|FG000|Overall Study|Withdrawal by Subject|3|||
131572827|NCT01772719|473721578|FG000|Overall Study|Adverse Event|2|||
131699103|NCT00730639|474180985|FG003|Overall Study|Completed Maximum Cycles|3|||
131699104|NCT00730639|474180986|FG004|Overall Study|Completed Maximum Cycles|6|||
131572828|NCT01772719|473721578|FG000|Overall Study|Protocol Violation|1|||
131572829|NCT01772719|473721578|FG000|Overall Study|Lost to Follow-up|1|||
131572830|NCT00477412|473721579|FG000|Overall Study|Death|0|||
131572831|NCT00477412|473721580|FG001|Overall Study|Death|0|||
131699105|NCT00730639|474180982|FG000|Overall Study|Death|0|||
131699106|NCT00730639|474180983|FG001|Overall Study|Death|0|||
131699107|NCT00730639|474180984|FG002|Overall Study|Death|0|||
131572832|NCT00477412|473721581|FG002|Overall Study|Death|0|||
131572833|NCT00477412|473721582|FG003|Overall Study|Death|4|||
131572834|NCT00477412|473721579|FG000|Overall Study|Lost to Follow-up|0|||
131699108|NCT00730639|474180985|FG003|Overall Study|Death|0|||
131572835|NCT00477412|473721580|FG001|Overall Study|Lost to Follow-up|0|||
131699109|NCT00730639|474180986|FG004|Overall Study|Death|2|||
131572836|NCT00477412|473721581|FG002|Overall Study|Lost to Follow-up|0|||
131572837|NCT00477412|473721582|FG003|Overall Study|Lost to Follow-up|1|||
131572838|NCT00477412|473721579|FG000|Overall Study|Withdrawal by Subject|0|||
131572839|NCT00477412|473721580|FG001|Overall Study|Withdrawal by Subject|0|||
131572840|NCT00477412|473721581|FG002|Overall Study|Withdrawal by Subject|0|||
131572841|NCT00477412|473721582|FG003|Overall Study|Withdrawal by Subject|2|||
131572842|NCT00477412|473721579|FG000|Overall Study|Second Malignancy|0|||
131572843|NCT00477412|473721580|FG001|Overall Study|Second Malignancy|0|||
131572844|NCT00477412|473721581|FG002|Overall Study|Second Malignancy|0|||
131572845|NCT00477412|473721582|FG003|Overall Study|Second Malignancy|1|||
131572846|NCT00477412|473721579|FG000|Overall Study|Adverse Event|1|||
131572847|NCT00477412|473721580|FG001|Overall Study|Adverse Event|0|||
131572848|NCT00477412|473721581|FG002|Overall Study|Adverse Event|1|||
131572849|NCT00477412|473721582|FG003|Overall Study|Adverse Event|0|||
131572850|NCT00299702|473721583|FG000|Overall Study|Death|1|||
131572851|NCT00299702|473721584|FG001|Overall Study|Death|0|||
131572852|NCT00299702|473721583|FG000|Overall Study|Adverse Event|0|||
131572853|NCT00299702|473721584|FG001|Overall Study|Adverse Event|4|||
131572854|NCT00299702|473721583|FG000|Overall Study|Lost to Follow-up|18|||
131572855|NCT00299702|473721584|FG001|Overall Study|Lost to Follow-up|10|||
131572856|NCT00299702|473721583|FG000|Overall Study|Withdrawal by Subject|25|||
131572857|NCT00299702|473721584|FG001|Overall Study|Withdrawal by Subject|23|||
131572858|NCT00299702|473721583|FG000|Overall Study|Pregnancy|0|||
131572859|NCT00299702|473721584|FG001|Overall Study|Pregnancy|1|||
131572860|NCT00299702|473721583|FG000|Overall Study|Insufficient Response|4|||
131572861|NCT00299702|473721584|FG001|Overall Study|Insufficient Response|3|||
131572862|NCT00299702|473721583|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
131572863|NCT00299702|473721584|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
131572864|NCT00751036|473721585|FG000|Overall Study|Disease Progression|28|||
131572865|NCT00751036|473721586|FG001|Overall Study|Disease Progression|29|||
131572866|NCT00751036|473721585|FG000|Overall Study|Adverse Event|6|||
131572867|NCT00751036|473721586|FG001|Overall Study|Adverse Event|4|||
131572868|NCT00751036|473721585|FG000|Overall Study|Administrative Problems|3|||
131572869|NCT00751036|473721586|FG001|Overall Study|Administrative Problems|4|||
131572870|NCT00751036|473721585|FG000|Overall Study|Withdrawal by Subject|5|||
131572871|NCT00751036|473721586|FG001|Overall Study|Withdrawal by Subject|2|||
131572872|NCT00751036|473721585|FG000|Overall Study|Death|3|||
131572873|NCT00751036|473721586|FG001|Overall Study|Death|3|||
131572874|NCT00751036|473721585|FG000|Overall Study|Lost to Follow-up|0|||
131572875|NCT00751036|473721586|FG001|Overall Study|Lost to Follow-up|1|||
131572876|NCT00751036|473721585|FG000|Overall Study|Protocol Violation|1|||
131572877|NCT00751036|473721586|FG001|Overall Study|Protocol Violation|0|||
131572878|NCT00751036|473721585|FG000|Overall Study|Missing end of Treatment Page|2|||
131572879|NCT00751036|473721586|FG001|Overall Study|Missing end of Treatment Page|3|||
131572880|NCT05460663|473721587|FG000|Overall Study|Withdrawal by Subject|2|||
131572881|NCT05460663|473721588|FG001|Overall Study|Withdrawal by Subject|5|||
131572882|NCT05273801|473721589|FG000|Overall Study|Physician Decision|1|||
131572883|NCT00613301|473723158|FG000|Overall Study|Adverse Event|49|||
131572884|NCT00613301|473723158|FG000|Overall Study|Lost to Follow-up|88|||
131785110|NCT01039584|474496747|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
131785111|NCT01039584|474496748|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
131785112|NCT03672396|474496751|FG000|Overall Study|Withdrawal by Subject|4|||
131785113|NCT03672396|474496751|FG000|Overall Study|Physician Decision|1|||
131785114|NCT03672396|474496751|FG000|Overall Study|Adverse Event|1|||
131785115|NCT02441179|474496753|FG000|Overall Study|Withdrawal by Subject|1|||
131785116|NCT02441179|474496754|FG001|Overall Study|Withdrawal by Subject|1|||
131785117|NCT03091400|474496755|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
131785118|NCT03091400|474496756|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
131572885|NCT00613301|473723158|FG000|Overall Study|Withdrawal by Subject|5|||
131572886|NCT00613301|473723158|FG000|Overall Study|Death|6|||
131572887|NCT00613301|473723158|FG000|Overall Study|Lack of Efficacy|13|||
131572888|NCT00613301|473723158|FG000|Overall Study|Physician Decision|2|||
131572889|NCT00613301|473723158|FG000|Overall Study|No data was collected|53|||
131572890|NCT00613301|473723158|FG000|Overall Study|Irregularly enrolled patients|12|||
131785119|NCT00051636|474496757|FG000|Period 1 - Core|Adverse Event|2|||
131785120|NCT00051636|474496758|FG001|Period 1 - Core|Adverse Event|2|||
131572891|NCT00569946|473723159|FG000|Overall Study|Adverse Event|16|||
131572892|NCT00569946|473723159|FG000|Overall Study|Objective Progression or Relapse|42|||
131785121|NCT00051636|474496757|FG000|Period 1 - Core|Protocol Violation|1|||
131785122|NCT00051636|474496758|FG001|Period 1 - Core|Protocol Violation|0|||
131572893|NCT00569946|473723159|FG000|Overall Study|Global Deterioration of Health Status|1|||
131572894|NCT00762463|473723161|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
131572895|NCT00762463|473723162|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
131572896|NCT00762463|473723163|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
131572897|NCT00762463|473723164|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
131572898|NCT00762463|473723161|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
131572899|NCT00762463|473723162|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
131572900|NCT00762463|473723163|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
131572901|NCT00762463|473723164|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
131572902|NCT00762463|473723161|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
131572903|NCT00762463|473723162|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
131572904|NCT00762463|473723163|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
131572905|NCT00762463|473723164|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
131572906|NCT00762463|473723161|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
131572907|NCT00762463|473723162|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
131572908|NCT00762463|473723163|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
131572909|NCT00762463|473723164|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
131572910|NCT00762463|473723161|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
131572911|NCT00762463|473723162|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
131572912|NCT00762463|473723163|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
131572913|NCT00762463|473723164|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
131572914|NCT00762463|473723161|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
131572915|NCT00762463|473723162|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
131572916|NCT00762463|473723163|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
131572917|NCT00762463|473723164|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
131572918|NCT00762463|473723161|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
131572919|NCT00762463|473723162|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
131572920|NCT00762463|473723163|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
131572921|NCT00762463|473723164|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
131572922|NCT00762463|473723161|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
131572923|NCT00762463|473723162|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
131572924|NCT00762463|473723163|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
131572925|NCT00762463|473723164|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
131572926|NCT01306331|473723167|FG000|Overall Study|Adverse Event|28|||
131572927|NCT01306331|473723168|FG001|Overall Study|Adverse Event|25|||
131572928|NCT01306331|473723167|FG000|Overall Study|Lost to Follow-up|321|||
131572929|NCT01306331|473723168|FG001|Overall Study|Lost to Follow-up|323|||
131572930|NCT01306331|473723167|FG000|Overall Study|Physician Decision|26|||
131572931|NCT01306331|473723168|FG001|Overall Study|Physician Decision|22|||
131572932|NCT01306331|473723167|FG000|Overall Study|Pregnancy|136|||
131572933|NCT01306331|473723168|FG001|Overall Study|Pregnancy|151|||
131572934|NCT01306331|473723167|FG000|Overall Study|Protocol Violation|154|||
131572935|NCT01306331|473723168|FG001|Overall Study|Protocol Violation|124|||
131572936|NCT01306331|473723167|FG000|Overall Study|Withdrawal by Subject|163|||
131572937|NCT01306331|473723168|FG001|Overall Study|Withdrawal by Subject|152|||
131572938|NCT01306331|473723167|FG000|Overall Study|Not sexually active|29|||
131572939|NCT01306331|473723168|FG001|Overall Study|Not sexually active|28|||
131572940|NCT01306331|473723167|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
131572941|NCT01306331|473723168|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
131572942|NCT01306331|473723167|FG000|Overall Study|Other|34|||
131572943|NCT01306331|473723168|FG001|Overall Study|Other|32|||
131572944|NCT04048135|473723171|FG000|Overall Study|Withdrawal by Subject|1|||
131572945|NCT04048135|473723172|FG001|Overall Study|Withdrawal by Subject|1|||
131572946|NCT04048135|473723173|FG002|Overall Study|Withdrawal by Subject|1|||
131572947|NCT04048135|473723174|FG003|Overall Study|Withdrawal by Subject|2|||
131572948|NCT04048135|473723175|FG004|Overall Study|Withdrawal by Subject|0|||
131699110|NCT00730639|474180982|FG000|Overall Study|Disease Progression|12|||
131699111|NCT00730639|474180983|FG001|Overall Study|Disease Progression|13|||
131699112|NCT00730639|474180984|FG002|Overall Study|Disease Progression|48|||
131699113|NCT00730639|474180985|FG003|Overall Study|Disease Progression|32|||
131699114|NCT00730639|474180986|FG004|Overall Study|Disease Progression|88|||
131699115|NCT00730639|474180982|FG000|Overall Study|non-specified|0|||
131699116|NCT00730639|474180983|FG001|Overall Study|non-specified|0|||
131572949|NCT04048135|473723176|FG005|Overall Study|Withdrawal by Subject|0|||
131572950|NCT04048135|473723177|FG006|Overall Study|Withdrawal by Subject|1|||
131572951|NCT04048135|473723178|FG007|Overall Study|Withdrawal by Subject|1|||
131572952|NCT04048135|473723171|FG000|Overall Study|Adverse Event|0|||
131572953|NCT04048135|473723172|FG001|Overall Study|Adverse Event|0|||
131699117|NCT00730639|474180984|FG002|Overall Study|non-specified|4|||
131572954|NCT04048135|473723173|FG002|Overall Study|Adverse Event|0|||
131572955|NCT04048135|473723174|FG003|Overall Study|Adverse Event|1|||
131572956|NCT04048135|473723175|FG004|Overall Study|Adverse Event|1|||
131572957|NCT04048135|473723176|FG005|Overall Study|Adverse Event|0|||
131572958|NCT04048135|473723177|FG006|Overall Study|Adverse Event|0|||
131572959|NCT04048135|473723178|FG007|Overall Study|Adverse Event|0|||
131572960|NCT04048135|473723171|FG000|Overall Study|Protocol Violation|0|||
131572961|NCT04048135|473723172|FG001|Overall Study|Protocol Violation|0|||
131572962|NCT04048135|473723173|FG002|Overall Study|Protocol Violation|0|||
131572963|NCT04048135|473723174|FG003|Overall Study|Protocol Violation|0|||
131572964|NCT04048135|473723175|FG004|Overall Study|Protocol Violation|0|||
131572965|NCT04048135|473723176|FG005|Overall Study|Protocol Violation|1|||
131572966|NCT04048135|473723177|FG006|Overall Study|Protocol Violation|0|||
131572967|NCT04048135|473723178|FG007|Overall Study|Protocol Violation|0|||
131572968|NCT00172185|473723179|FG000|Overall Study|Adverse Event|0|||
131572969|NCT00172185|473723180|FG001|Overall Study|Adverse Event|1|||
131572970|NCT00172185|473723181|FG002|Overall Study|Adverse Event|3|||
131572971|NCT00172185|473723182|FG003|Overall Study|Adverse Event|4|||
131572972|NCT00172185|473723179|FG000|Overall Study|Physician Decision|0|||
131572973|NCT00172185|473723180|FG001|Overall Study|Physician Decision|0|||
131572974|NCT00172185|473723181|FG002|Overall Study|Physician Decision|1|||
131572975|NCT00172185|473723182|FG003|Overall Study|Physician Decision|0|||
131572976|NCT00172185|473723179|FG000|Overall Study|SPONSOR Decision|0|||
131572977|NCT00172185|473723180|FG001|Overall Study|SPONSOR Decision|1|||
131572978|NCT00172185|473723181|FG002|Overall Study|SPONSOR Decision|0|||
131572979|NCT00172185|473723182|FG003|Overall Study|SPONSOR Decision|0|||
131572980|NCT00172185|473723179|FG000|Overall Study|Withdrawal by Subject|0|||
131572981|NCT00172185|473723180|FG001|Overall Study|Withdrawal by Subject|0|||
131572982|NCT00172185|473723181|FG002|Overall Study|Withdrawal by Subject|1|||
131572983|NCT00172185|473723182|FG003|Overall Study|Withdrawal by Subject|0|||
131572984|NCT01677936|473723183|FG000|Overall Study|Lost to Follow-up|4|||
131572985|NCT01677936|473723184|FG001|Overall Study|Lost to Follow-up|1|||
131785123|NCT00051636|474496757|FG000|Period 1 - Core|Withdrawal by Subject|1|||
131785124|NCT00051636|474496758|FG001|Period 1 - Core|Withdrawal by Subject|2|||
131785125|NCT00051636|474496757|FG000|Period 1 - Core|Lost to Follow-up|0|||
131785126|NCT00051636|474496758|FG001|Period 1 - Core|Lost to Follow-up|2|||
131785127|NCT00051636|474496757|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
131785128|NCT00051636|474496758|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
131785129|NCT00051636|474496757|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
131785130|NCT00051636|474496758|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
131785131|NCT00051636|474496757|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
131785132|NCT00051636|474496758|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
131785133|NCT00051636|474496757|FG000|Period 2- Extended Observation Period|Death|4|||
131785134|NCT00051636|474496758|FG001|Period 2- Extended Observation Period|Death|5|||
131785135|NCT00051636|474496757|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
131785136|NCT00051636|474496758|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
131785137|NCT00743119|474496763|FG000|Overall Study|unreliable|3|||
131785138|NCT00743119|474496763|FG000|Overall Study|Withdrawal by Subject|1|||
131785139|NCT04816877|474496764|FG000|Overall Study|Withdrawal by Subject|1|||
131785140|NCT04816877|474496765|FG001|Overall Study|Withdrawal by Subject|0|||
131785141|NCT02176642|474496766|FG000|Overall Study|Withdrawal by Subject|0|||
131785142|NCT02176642|474496767|FG001|Overall Study|Withdrawal by Subject|1|||
131785143|NCT01309828|474496769|FG000|Overall Study|Adverse Event|10|||
131785144|NCT01309828|474496770|FG001|Overall Study|Adverse Event|11|||
131785145|NCT01309828|474496769|FG000|Overall Study|Voluntary Withdrawal|5|||
131785146|NCT01309828|474496770|FG001|Overall Study|Voluntary Withdrawal|4|||
131437992|NCT01582061|473229465|FG001|Overall Study|Lack of Efficacy|23|||
131572986|NCT01677936|473723183|FG000|Overall Study|Protocol Violation|3|||
131572987|NCT01677936|473723184|FG001|Overall Study|Protocol Violation|0|||
131572988|NCT01677936|473723183|FG000|Overall Study|Adverse Event|1|||
131572989|NCT01677936|473723184|FG001|Overall Study|Adverse Event|0|||
131572990|NCT01677936|473723183|FG000|Overall Study|Lost to Follow-up|1|||
131572991|NCT01677936|473723184|FG001|Overall Study|Lost to Follow-up|0|||
131572992|NCT01677936|473723183|FG000|Overall Study|Protocol Violation|0|||
131572993|NCT01677936|473723184|FG001|Overall Study|Protocol Violation|4|||
131572994|NCT04565249|473723187|FG000|Overall Study|Death|0|||
131572995|NCT04565249|473723188|FG001|Overall Study|Death|0|||
131572996|NCT04565249|473723189|FG002|Overall Study|Death|0|||
131572997|NCT04565249|473723190|FG003|Overall Study|Death|1|||
131572998|NCT01451814|473723195|FG000|Overall Study|Withdrawal by Subject|1|||
131572999|NCT01451814|473723196|FG001|Overall Study|Withdrawal by Subject|1|||
131573000|NCT01451814|473723195|FG000|Overall Study|Lost to Follow-up|5|||
131573001|NCT01451814|473723196|FG001|Overall Study|Lost to Follow-up|4|||
131573002|NCT01020838|473723200|FG000|Overall Study|Death|90|||
131573003|NCT01020838|473723200|FG000|Overall Study|Adverse Event|1|||
131573004|NCT01020838|473723200|FG000|Overall Study|Withdrawal by Subject|9|||
131573005|NCT01020838|473723200|FG000|Overall Study|Lost to Follow-up|6|||
131573006|NCT01020838|473723200|FG000|Overall Study|Most common: Study ended by sponsor|77|||
131573007|NCT01908634|473723201|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
131573008|NCT01908634|473723201|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
131573009|NCT00588666|473723204|FG000|Overall Study|Adverse Event|4|||
131573010|NCT03102710|473723205|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
131573011|NCT03102710|473723206|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
131573012|NCT03102710|473723207|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
131573013|NCT03102710|473723205|FG000|Overall Study|Technical issues during final MRI scan|0|||
131573014|NCT03102710|473723206|FG001|Overall Study|Technical issues during final MRI scan|1|||
131573015|NCT03102710|473723207|FG002|Overall Study|Technical issues during final MRI scan|0|||
131573016|NCT03102710|473723205|FG000|Overall Study|Nausea during MRI scan|0|||
131573017|NCT03102710|473723206|FG001|Overall Study|Nausea during MRI scan|1|||
131573018|NCT03102710|473723207|FG002|Overall Study|Nausea during MRI scan|0|||
131573019|NCT03102710|473723205|FG000|Overall Study|Subject unable to attend final session|0|||
131573020|NCT03102710|473723206|FG001|Overall Study|Subject unable to attend final session|1|||
131573021|NCT03102710|473723207|FG002|Overall Study|Subject unable to attend final session|0|||
131573022|NCT04582877|473723208|FG000|Overall Study|Did not use device measurement|5|||
131573023|NCT04582877|473723208|FG000|Overall Study|No fractional flow reserve test results|2|||
131573024|NCT04582877|473723208|FG000|Overall Study|Protocol Violation|1|||
131573025|NCT04012853|473723209|FG000|Overall Study|Withdrawal by Subject|1|||
131573026|NCT04012853|473723210|FG001|Overall Study|Withdrawal by Subject|1|||
131573027|NCT04012853|473723209|FG000|Overall Study|Protocol Violation|1|||
131573028|NCT04012853|473723210|FG001|Overall Study|Protocol Violation|0|||
131573029|NCT04012853|473723209|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
131573030|NCT04012853|473723210|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
131573031|NCT03055767|473723211|FG000|Open-Label Period|Lost to Follow-up|0|||
131573032|NCT03055767|473723212|FG001|Open-Label Period|Lost to Follow-up|0|||
131573033|NCT03055767|473723213|FG002|Open-Label Period|Lost to Follow-up|2|||
131573034|NCT03055767|473723214|FG003|Open-Label Period|Lost to Follow-up|0|||
131573035|NCT03055767|473723211|FG000|Open-Label Period|Withdrawal by Subject|0|||
131573036|NCT03055767|473723212|FG001|Open-Label Period|Withdrawal by Subject|0|||
131573037|NCT03055767|473723213|FG002|Open-Label Period|Withdrawal by Subject|0|||
131573038|NCT03055767|473723214|FG003|Open-Label Period|Withdrawal by Subject|1|||
131573039|NCT02759731|473723215|FG000|Overall Study|Did not complete treatment.|8|||
131573040|NCT01599325|473723216|FG000|Primary Parent Phase|Adverse Event|5|||
131573041|NCT01599325|473723216|FG000|Primary Parent Phase|Disease Progression|7|||
131573042|NCT01599325|473723216|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
131573043|NCT01599325|473723216|FG000|Primary Parent Phase|Death|13|||
131699118|NCT00730639|474180985|FG003|Overall Study|non-specified|2|||
131699119|NCT00730639|474180986|FG004|Overall Study|non-specified|3|||
131699120|NCT00730639|474180982|FG000|Overall Study|Protocol Violation|0|||
131699121|NCT00730639|474180983|FG001|Overall Study|Protocol Violation|0|||
131699122|NCT00730639|474180984|FG002|Overall Study|Protocol Violation|1|||
131699123|NCT00730639|474180985|FG003|Overall Study|Protocol Violation|0|||
131699124|NCT00730639|474180986|FG004|Overall Study|Protocol Violation|0|||
131699125|NCT00730639|474180982|FG000|Overall Study|Withdrawal by Subject|0|||
131699126|NCT00730639|474180983|FG001|Overall Study|Withdrawal by Subject|0|||
131699127|NCT00730639|474180984|FG002|Overall Study|Withdrawal by Subject|6|||
131699128|NCT00730639|474180985|FG003|Overall Study|Withdrawal by Subject|3|||
131699129|NCT00730639|474180986|FG004|Overall Study|Withdrawal by Subject|4|||
131699130|NCT00730639|474180982|FG000|Overall Study|Treatment on-going|2|||
131699131|NCT00730639|474180983|FG001|Overall Study|Treatment on-going|5|||
131699132|NCT00730639|474180984|FG002|Overall Study|Treatment on-going|5|||
131699133|NCT00730639|474180985|FG003|Overall Study|Treatment on-going|4|||
131699134|NCT00730639|474180986|FG004|Overall Study|Treatment on-going|4|||
131699135|NCT02665286|474180987|FG000|Overall Study|Lost to Follow-up|3|||
131699136|NCT02665286|474180988|FG001|Overall Study|Lost to Follow-up|2|||
131699137|NCT02665286|474180989|FG002|Overall Study|Lost to Follow-up|1|||
131573044|NCT01599325|473723216|FG000|Primary Parent Phase|Protocol Violation|1|||
131573045|NCT01599325|473723216|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
131573046|NCT01599325|473723216|FG000|Primary Parent Phase|Other|2|||
131573047|NCT01599325|473723216|FG000|Extension Phase|Study Closure|1|||
131573048|NCT01599325|473723216|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
131573049|NCT01599325|473723216|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
131573050|NCT01599325|473723216|FG000|Extension Phase|Disease Progression|1|||
131699138|NCT03064841|474180990|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
131699139|NCT03064841|474180990|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
131699140|NCT03064841|474180990|FG000|Overall Study|Screen failure|2|||
131699141|NCT00217087|474180991|FG000|Overall Study|decided to have esophagectomy|1|||
131699142|NCT00217087|474180992|FG001|Overall Study|decided to have esophagectomy|2|||
131699143|NCT00217087|474180991|FG000|Overall Study|completed less than 12 months return|10|||
131699144|NCT00217087|474180992|FG001|Overall Study|completed less than 12 months return|18|||
131699145|NCT04622046|474181009|FG000|Intervention Period|Adverse Event|1|||
131573051|NCT01599325|473723216|FG000|Extension Phase|Withdrawal by Subject|8|||
131573052|NCT03404843|473723218|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
131573053|NCT03404843|473723219|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
131573054|NCT00567164|473723220|FG000|Overall Study|Withdrawal by Subject|171|||
131573055|NCT00567164|473723221|FG001|Overall Study|Withdrawal by Subject|21|||
131573056|NCT00567164|473723222|FG002|Overall Study|Withdrawal by Subject|17|||
131573057|NCT00567164|473723220|FG000|Overall Study|Protocol Violation|23|||
131573058|NCT00567164|473723221|FG001|Overall Study|Protocol Violation|4|||
131573059|NCT00567164|473723222|FG002|Overall Study|Protocol Violation|2|||
131573060|NCT00567164|473723220|FG000|Overall Study|Adverse Event|92|||
131573061|NCT00567164|473723221|FG001|Overall Study|Adverse Event|13|||
131573062|NCT00567164|473723222|FG002|Overall Study|Adverse Event|9|||
131573063|NCT00567164|473723220|FG000|Overall Study|Death|0|||
131573064|NCT00567164|473723221|FG001|Overall Study|Death|0|||
131573065|NCT00567164|473723222|FG002|Overall Study|Death|1|||
131573066|NCT00567164|473723220|FG000|Overall Study|Lost to Follow-up|202|||
131573067|NCT00567164|473723221|FG001|Overall Study|Lost to Follow-up|23|||
131573068|NCT00567164|473723222|FG002|Overall Study|Lost to Follow-up|21|||
131573069|NCT00567164|473723220|FG000|Overall Study|Pregnancy|20|||
131573070|NCT00567164|473723221|FG001|Overall Study|Pregnancy|4|||
131573071|NCT00567164|473723222|FG002|Overall Study|Pregnancy|6|||
131573072|NCT00567164|473723220|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
131573073|NCT00567164|473723221|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
131573074|NCT00567164|473723222|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
131573075|NCT00567164|473723220|FG000|Overall Study|Missing|1|||
131573076|NCT00567164|473723221|FG001|Overall Study|Missing|0|||
131573077|NCT00567164|473723222|FG002|Overall Study|Missing|0|||
131573078|NCT02430532|473723233|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
131573079|NCT02430532|473723234|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
131573080|NCT02430532|473723233|FG000|Overall Study|Consent Withdrawn|0|||
131573081|NCT02430532|473723234|FG001|Overall Study|Consent Withdrawn|2|||
131573082|NCT02430532|473723233|FG000|Overall Study|Adverse Event|0|||
131573083|NCT02430532|473723234|FG001|Overall Study|Adverse Event|1|||
131573084|NCT01190150|473723235|FG000|First Treatment|Withdrawal by Subject|1|||
131573085|NCT01190150|473723236|FG001|First Treatment|Withdrawal by Subject|0|||
131573086|NCT01190150|473723235|FG000|Washout|Withdrawal by Subject|0|||
131573087|NCT01190150|473723236|FG001|Washout|Withdrawal by Subject|1|||
131573088|NCT01190150|473723235|FG000|Washout|Difficulty in adherence|0|||
131573089|NCT01190150|473723236|FG001|Washout|Difficulty in adherence|1|||
131573090|NCT03256344|473723237|FG000|Overall Study|Death|6|||
131573091|NCT03256344|473723238|FG001|Overall Study|Death|22|||
131573092|NCT03256344|473723237|FG000|Overall Study|Withdrawal by Subject|3|||
131573093|NCT03256344|473723238|FG001|Overall Study|Withdrawal by Subject|3|||
131573094|NCT03256344|473723237|FG000|Overall Study|Sponsor Decision|1|||
131573095|NCT03256344|473723238|FG001|Overall Study|Sponsor Decision|0|||
131699146|NCT04622046|474181009|FG000|Intervention Period|Withdrawal by Subject|2|||
131699147|NCT04622046|474181009|FG000|Extension Period|Ongoing in the Extension Period|21|||
131699148|NCT01844986|474181010|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
131699149|NCT01844986|474181011|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
131699150|NCT01844986|474181010|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
131699151|NCT01844986|474181011|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
131699152|NCT01844986|474181010|FG000|Overall Study (Global Cohort)|Death|55|||
131699153|NCT01844986|474181011|FG001|Overall Study (Global Cohort)|Death|26|||
131699154|NCT01844986|474181010|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
131699155|NCT01844986|474181011|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
131699156|NCT01844986|474181010|FG000|Overall Study (China Cohort)|Death|10|||
131699157|NCT01844986|474181011|FG001|Overall Study (China Cohort)|Death|6|||
131699158|NCT02392429|474183177|FG000|Screening|Screen failure|15|||
131699159|NCT02392429|474183177|FG000|Enrolled Participants|Ineligible due to disease|3|||
131699160|NCT02392429|474183177|FG000|Enrolled Participants|Withdrawal by Subject|4|||
131573096|NCT00580801|473723250|FG000|Overall Study|Physician Decision|1|||
131573097|NCT00580801|473723251|FG001|Overall Study|Physician Decision|0|||
131573098|NCT00580801|473723252|FG002|Overall Study|Physician Decision|0|||
131573099|NCT00580801|473723250|FG000|Overall Study|Adverse Event|2|||
131573100|NCT00580801|473723251|FG001|Overall Study|Adverse Event|0|||
131699161|NCT02392429|474183177|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
131699162|NCT02392429|474183177|FG000|Evaluable|Death|5|||
131699163|NCT02392429|474183177|FG000|Evaluable|Withdrawal by Subject|1|||
131699164|NCT02392429|474183177|FG000|Evaluable|Adverse Event|1|||
131699165|NCT02392429|474183177|FG000|Evaluable|remission bone marrow biopsy|3|||
131573101|NCT00580801|473723252|FG002|Overall Study|Adverse Event|0|||
131573102|NCT00580801|473723250|FG000|Overall Study|Lost to Follow-up|2|||
131573103|NCT00580801|473723251|FG001|Overall Study|Lost to Follow-up|0|||
131573104|NCT00580801|473723252|FG002|Overall Study|Lost to Follow-up|0|||
131573105|NCT00580801|473723250|FG000|Overall Study|Reached a virologic endpoint|0|||
131573106|NCT00580801|473723251|FG001|Overall Study|Reached a virologic endpoint|1|||
131699166|NCT03266016|474183181|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
131573107|NCT00580801|473723252|FG002|Overall Study|Reached a virologic endpoint|2|||
131573108|NCT00580801|473723250|FG000|Overall Study|Participant non-compliant|0|||
131573109|NCT00580801|473723251|FG001|Overall Study|Participant non-compliant|0|||
131573110|NCT00580801|473723252|FG002|Overall Study|Participant non-compliant|1|||
131573111|NCT00580801|473723250|FG000|Overall Study|Travel|1|||
131573112|NCT00580801|473723251|FG001|Overall Study|Travel|0|||
131573113|NCT00580801|473723252|FG002|Overall Study|Travel|0|||
131573114|NCT01670019|473723253|FG000|Overall Study|Adverse Event|3|||
131573115|NCT01670019|473723254|FG001|Overall Study|Adverse Event|0|||
131573116|NCT01670019|473723253|FG000|Overall Study|Withdrawal by Subject|6|||
131573117|NCT01670019|473723254|FG001|Overall Study|Withdrawal by Subject|0|||
131573118|NCT01467700|473723257|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
131573119|NCT01467700|473723258|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
131573120|NCT01467700|473723259|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
131573121|NCT01467700|473723260|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
131573122|NCT01467700|473723257|FG000|Overall Study|Major Protocol Deviation|3|||
131573123|NCT01467700|473723258|FG001|Overall Study|Major Protocol Deviation|3|||
131573124|NCT01467700|473723259|FG002|Overall Study|Major Protocol Deviation|2|||
131573125|NCT01467700|473723260|FG003|Overall Study|Major Protocol Deviation|3|||
131573126|NCT01467700|473723257|FG000|Overall Study|Lost to Follow-up|6|||
131573127|NCT01467700|473723258|FG001|Overall Study|Lost to Follow-up|5|||
131573128|NCT01467700|473723259|FG002|Overall Study|Lost to Follow-up|2|||
131573129|NCT01467700|473723260|FG003|Overall Study|Lost to Follow-up|3|||
131573130|NCT01467700|473723257|FG000|Overall Study|Voluntary Withdrawal|5|||
131573131|NCT01467700|473723258|FG001|Overall Study|Voluntary Withdrawal|7|||
131573132|NCT01467700|473723259|FG002|Overall Study|Voluntary Withdrawal|6|||
131573133|NCT01467700|473723260|FG003|Overall Study|Voluntary Withdrawal|2|||
131573134|NCT01467700|473723257|FG000|Overall Study|Study Termination|6|||
131573135|NCT01467700|473723258|FG001|Overall Study|Study Termination|5|||
131573136|NCT01467700|473723259|FG002|Overall Study|Study Termination|10|||
131573137|NCT01467700|473723260|FG003|Overall Study|Study Termination|7|||
131573138|NCT01467700|473723257|FG000|Overall Study|Pregnancy|0|||
131573139|NCT01467700|473723258|FG001|Overall Study|Pregnancy|1|||
131573140|NCT01467700|473723259|FG002|Overall Study|Pregnancy|1|||
131573141|NCT01467700|473723260|FG003|Overall Study|Pregnancy|0|||
131573142|NCT01467700|473723257|FG000|Overall Study|Lack of Efficacy|2|||
131573143|NCT01467700|473723258|FG001|Overall Study|Lack of Efficacy|0|||
131573144|NCT01467700|473723259|FG002|Overall Study|Lack of Efficacy|2|||
131573145|NCT01467700|473723260|FG003|Overall Study|Lack of Efficacy|1|||
131573146|NCT01467700|473723257|FG000|Overall Study|Reason not Specified|1|||
131573147|NCT01467700|473723258|FG001|Overall Study|Reason not Specified|3|||
131437993|NCT01582061|473229464|FG000|Overall Study|Adverse Event|12|||
131437994|NCT01582061|473229465|FG001|Overall Study|Adverse Event|8|||
131573148|NCT01467700|473723259|FG002|Overall Study|Reason not Specified|2|||
131573149|NCT01467700|473723260|FG003|Overall Study|Reason not Specified|8|||
131573150|NCT03523962|473723261|FG000|Closed Fractures|Death|86|||
131573151|NCT03523962|473723262|FG001|Closed Fractures|Death|71|||
131573152|NCT03523962|473723263|FG002|Closed Fractures|Death|0|||
131573153|NCT03523962|473723264|FG003|Closed Fractures|Death|0|||
131573154|NCT03523962|473723261|FG000|Closed Fractures|Lost to Follow-up|62|||
131573155|NCT03523962|473723262|FG001|Closed Fractures|Lost to Follow-up|36|||
131573156|NCT03523962|473723263|FG002|Closed Fractures|Lost to Follow-up|0|||
131573157|NCT03523962|473723264|FG003|Closed Fractures|Lost to Follow-up|0|||
131573158|NCT03523962|473723261|FG000|Closed Fractures|Withdrawal by Subject|19|||
131573159|NCT03523962|473723262|FG001|Closed Fractures|Withdrawal by Subject|29|||
131573160|NCT03523962|473723263|FG002|Closed Fractures|Withdrawal by Subject|0|||
131573161|NCT03523962|473723264|FG003|Closed Fractures|Withdrawal by Subject|0|||
131573162|NCT03523962|473723261|FG000|Closed Fractures|Incarceration|1|||
131573163|NCT03523962|473723262|FG001|Closed Fractures|Incarceration|4|||
131573164|NCT03523962|473723263|FG002|Closed Fractures|Incarceration|0|||
131573165|NCT03523962|473723264|FG003|Closed Fractures|Incarceration|0|||
131573166|NCT03523962|473723261|FG000|Open Fractures|Death|0|||
131573167|NCT03523962|473723262|FG001|Open Fractures|Death|0|||
131573168|NCT03523962|473723263|FG002|Open Fractures|Death|11|||
131699167|NCT03266016|474183182|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
131573169|NCT03523962|473723264|FG003|Open Fractures|Death|6|||
131573170|NCT03523962|473723261|FG000|Open Fractures|Lost to Follow-up|0|||
131573171|NCT03523962|473723262|FG001|Open Fractures|Lost to Follow-up|0|||
131437995|NCT01582061|473229464|FG000|Overall Study|Withdrawal by Subject|10|||
131437996|NCT01582061|473229465|FG001|Overall Study|Withdrawal by Subject|4|||
131573172|NCT03523962|473723263|FG002|Open Fractures|Lost to Follow-up|15|||
131573173|NCT03523962|473723264|FG003|Open Fractures|Lost to Follow-up|8|||
131573174|NCT03523962|473723261|FG000|Open Fractures|Withdrawal by Subject|0|||
131573175|NCT03523962|473723262|FG001|Open Fractures|Withdrawal by Subject|0|||
131573176|NCT03523962|473723263|FG002|Open Fractures|Withdrawal by Subject|6|||
131573177|NCT03523962|473723264|FG003|Open Fractures|Withdrawal by Subject|2|||
131573178|NCT03523962|473723261|FG000|Open Fractures|Incarceration|0|||
131573179|NCT03523962|473723262|FG001|Open Fractures|Incarceration|0|||
131573180|NCT03523962|473723263|FG002|Open Fractures|Incarceration|1|||
131699168|NCT03266016|474183183|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
131699169|NCT03266016|474183184|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
131699170|NCT03266016|474183181|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
131699171|NCT03266016|474183182|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
131699172|NCT03266016|474183183|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
131699173|NCT03266016|474183184|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
131699174|NCT01178138|474183185|FG000|Overall Study|Lost to Follow-up|8|||
131699175|NCT01178138|474183185|FG000|Overall Study|Withdrawal by Subject|7|||
131699176|NCT01178138|474183185|FG000|Overall Study|Physician Decision|8|||
131699177|NCT01241708|474183186|FG000|Overall Study|Withdrawal by Subject|6|||
131699178|NCT01241708|474183186|FG000|Overall Study|Screen Failure|6|||
131699179|NCT01241708|474183186|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
131699180|NCT01241708|474183186|FG000|Overall Study|Lost to Follow-up|5|||
131699181|NCT04183335|474183189|FG000|Overall Study|Adverse Event|1|||
131699182|NCT04183335|474183190|FG001|Overall Study|Adverse Event|0|||
131699183|NCT04183335|474183189|FG000|Overall Study|Withdrawal by Subject|12|||
131699184|NCT04183335|474183190|FG001|Overall Study|Withdrawal by Subject|3|||
131699185|NCT01268293|474183194|FG000|Overall Study|Disease progression|7|||
131699186|NCT01268293|474183194|FG000|Overall Study|Adverse Event|1|||
131699187|NCT01268293|474183194|FG000|Overall Study|Subject choice|1|||
131699188|NCT00223496|474183195|FG000|Overall Study|screen failure|9|||
131699189|NCT00223496|474183195|FG000|Overall Study|Lost to Follow-up|4|||
131573181|NCT03523962|473723264|FG003|Open Fractures|Incarceration|0|||
131573182|NCT01018511|473723267|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
131573183|NCT01018511|473723268|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
131573184|NCT01018511|473723269|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
131573185|NCT01018511|473723270|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
131573186|NCT01018511|473723267|FG000|Overall Study|Adverse Event|5|||
131573187|NCT01018511|473723268|FG001|Overall Study|Adverse Event|9|||
131573188|NCT01018511|473723269|FG002|Overall Study|Adverse Event|13|||
131573189|NCT01018511|473723270|FG003|Overall Study|Adverse Event|10|||
131573190|NCT01018511|473723267|FG000|Overall Study|Lack of Efficacy|4|||
131573191|NCT01018511|473723268|FG001|Overall Study|Lack of Efficacy|1|||
131573192|NCT01018511|473723269|FG002|Overall Study|Lack of Efficacy|1|||
131573193|NCT01018511|473723270|FG003|Overall Study|Lack of Efficacy|2|||
131573194|NCT01018511|473723267|FG000|Overall Study|Withdrawal by Subject|6|||
131573195|NCT01018511|473723268|FG001|Overall Study|Withdrawal by Subject|5|||
131573196|NCT01018511|473723269|FG002|Overall Study|Withdrawal by Subject|11|||
131573197|NCT01018511|473723270|FG003|Overall Study|Withdrawal by Subject|9|||
131573198|NCT01018511|473723267|FG000|Overall Study|Lost to Follow-up|0|||
131573199|NCT01018511|473723268|FG001|Overall Study|Lost to Follow-up|0|||
131573200|NCT01018511|473723269|FG002|Overall Study|Lost to Follow-up|1|||
131573201|NCT01018511|473723270|FG003|Overall Study|Lost to Follow-up|0|||
131573202|NCT01018511|473723267|FG000|Overall Study|Protocol Violation|5|||
131573203|NCT01018511|473723268|FG001|Overall Study|Protocol Violation|8|||
131573204|NCT01018511|473723269|FG002|Overall Study|Protocol Violation|7|||
131573205|NCT01018511|473723270|FG003|Overall Study|Protocol Violation|9|||
131573206|NCT01018511|473723267|FG000|Overall Study|Miscellaneous|0|||
131573207|NCT01018511|473723268|FG001|Overall Study|Miscellaneous|2|||
131573208|NCT01018511|473723269|FG002|Overall Study|Miscellaneous|0|||
131573209|NCT01018511|473723270|FG003|Overall Study|Miscellaneous|0|||
131573210|NCT03396913|473723273|FG000|Overall Study|Lost to Follow-up|0|||
131573211|NCT03396913|473723274|FG001|Overall Study|Lost to Follow-up|6|||
131573212|NCT00813488|473723275|FG000|Titration Period 1|Adverse Event|6|||
131573213|NCT00813488|473723276|FG001|Titration Period 1|Adverse Event|1|||
131573214|NCT00813488|473723275|FG000|Titration Period 1|Lack of Efficacy|9|||
131573215|NCT00813488|473723276|FG001|Titration Period 1|Lack of Efficacy|7|||
131573216|NCT00813488|473723275|FG000|Titration Period 1|Withdrawal by Subject|2|||
131573217|NCT00813488|473723276|FG001|Titration Period 1|Withdrawal by Subject|2|||
131573218|NCT00813488|473723275|FG000|Titration Period 1|Protocol Violation|4|||
131573219|NCT00813488|473723276|FG001|Titration Period 1|Protocol Violation|3|||
131573220|NCT00813488|473723275|FG000|Titration Period 1|Non-compliance to study medication|4|||
131573221|NCT00813488|473723276|FG001|Titration Period 1|Non-compliance to study medication|1|||
131573222|NCT00813488|473723275|FG000|Titration Period 1|Non-compliance to study procedures|2|||
131573223|NCT00813488|473723276|FG001|Titration Period 1|Non-compliance to study procedures|2|||
131573224|NCT00813488|473723275|FG000|Titration Period 1|Technical Difficulties|0|||
131573225|NCT00813488|473723276|FG001|Titration Period 1|Technical Difficulties|1|||
131573226|NCT00813488|473723275|FG000|Titration Period 2|Adverse Event|2|||
131573227|NCT00813488|473723276|FG001|Titration Period 2|Adverse Event|3|||
131573228|NCT00813488|473723275|FG000|Titration Period 2|Lack of Efficacy|8|||
131573229|NCT00813488|473723276|FG001|Titration Period 2|Lack of Efficacy|4|||
131573230|NCT00813488|473723275|FG000|Titration Period 2|Protocol Violation|3|||
131573231|NCT00813488|473723276|FG001|Titration Period 2|Protocol Violation|2|||
131573232|NCT00813488|473723275|FG000|Titration Period 2|Lost to Follow-up|1|||
131573233|NCT00813488|473723276|FG001|Titration Period 2|Lost to Follow-up|0|||
131573234|NCT00813488|473723275|FG000|Titration Period 2|Non-compliance with study procedures|2|||
131573235|NCT00813488|473723276|FG001|Titration Period 2|Non-compliance with study procedures|1|||
131573236|NCT00813488|473723275|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
131573237|NCT00813488|473723276|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
131573238|NCT00813488|473723275|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
131573239|NCT00813488|473723276|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
131573240|NCT00813488|473723275|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
131573241|NCT00813488|473723276|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
131573242|NCT00813488|473723275|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
131573243|NCT00813488|473723276|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
131573244|NCT00813488|473723275|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
131573245|NCT00813488|473723276|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
131573246|NCT00813488|473723275|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
131573247|NCT00813488|473723276|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
131573248|NCT00813488|473723275|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
131573249|NCT00813488|473723276|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
131573250|NCT00813488|473723275|FG000|Double-blind Treatment Period 2|Other|1|||
131573251|NCT00813488|473723276|FG001|Double-blind Treatment Period 2|Other|0|||
131573252|NCT00813488|473723275|FG000|Open-label Extension|Adverse Event|1|||
131699190|NCT00223496|474183195|FG000|Overall Study|Lack of Efficacy|6|||
131573253|NCT00813488|473723276|FG001|Open-label Extension|Adverse Event|2|||
131699191|NCT00223496|474183195|FG000|Overall Study|Withdrawal by Subject|1|||
131699192|NCT00223496|474183195|FG000|Overall Study|Physician Decision|2|||
131699193|NCT01414257|474183196|FG000|Overall Study|No Visit After First Day of Treatment|12|||
131699194|NCT01414257|474183196|FG000|Overall Study|Protocol Violation|10|||
131699195|NCT01784965|474183199|FG000|Overall Study|Withdrawal by Subject|6|||
131699196|NCT01784965|474183200|FG001|Overall Study|Withdrawal by Subject|3|||
131699197|NCT01784965|474183199|FG000|Overall Study|Adverse Event|0|||
131699198|NCT01784965|474183200|FG001|Overall Study|Adverse Event|8|||
131699199|NCT03757988|474183201|FG000|Overall Study|Withdrawal by Subject|1|||
131699200|NCT01562548|474183205|FG000|Overall Study|Lost to Follow-up|0|||
131699201|NCT01562548|474183206|FG001|Overall Study|Lost to Follow-up|0|||
131699202|NCT01562548|474183207|FG002|Overall Study|Lost to Follow-up|1|||
131699203|NCT01562548|474183208|FG003|Overall Study|Lost to Follow-up|0|||
131699204|NCT01496066|474183209|FG000|Overall Study|Lost to Follow-up|8|||
131699205|NCT01496066|474183210|FG001|Overall Study|Lost to Follow-up|5|||
131699206|NCT01496066|474183209|FG000|Overall Study|Explant|3|||
131699207|NCT01496066|474183210|FG001|Overall Study|Explant|0|||
131699208|NCT01496066|474183209|FG000|Overall Study|Death|1|||
131699209|NCT01496066|474183210|FG001|Overall Study|Death|4|||
131699210|NCT03237065|474183211|FG000|Overall Study|Adverse Event|0|||
131699211|NCT03237065|474183212|FG001|Overall Study|Adverse Event|2|||
131699212|NCT03237065|474183211|FG000|Overall Study|Protocol Violation|0|||
131699213|NCT03237065|474183212|FG001|Overall Study|Protocol Violation|1|||
131699214|NCT03237065|474183211|FG000|Overall Study|Withdrawal by Subject|3|||
131699215|NCT03237065|474183212|FG001|Overall Study|Withdrawal by Subject|0|||
131699216|NCT03237065|474183211|FG000|Overall Study|Lost to Follow-up|1|||
131699217|NCT03237065|474183212|FG001|Overall Study|Lost to Follow-up|0|||
131699218|NCT03237065|474183211|FG000|Overall Study|Unable to obtain venous access|0|||
131573254|NCT00813488|473723275|FG000|Open-label Extension|Lack of Efficacy|3|||
131573255|NCT00813488|473723276|FG001|Open-label Extension|Lack of Efficacy|0|||
131573256|NCT00813488|473723275|FG000|Open-label Extension|Withdrawal by Subject|0|||
131573257|NCT00813488|473723276|FG001|Open-label Extension|Withdrawal by Subject|2|||
131573258|NCT00813488|473723275|FG000|Open-label Extension|Protocol Violation|1|||
131573259|NCT00813488|473723276|FG001|Open-label Extension|Protocol Violation|2|||
131573260|NCT00813488|473723275|FG000|Open-label Extension|Non-compliance study medication|4|||
131573261|NCT00813488|473723276|FG001|Open-label Extension|Non-compliance study medication|0|||
131573262|NCT00813488|473723275|FG000|Open-label Extension|Non-compliance study procedures|2|||
131573263|NCT00813488|473723276|FG001|Open-label Extension|Non-compliance study procedures|1|||
131573264|NCT00813488|473723275|FG000|Open-label Extension|Other|1|||
131573265|NCT00813488|473723276|FG001|Open-label Extension|Other|0|||
131573266|NCT01729871|473723278|FG000|Overall Study|Adverse Event|7|||
131573267|NCT01729871|473723279|FG001|Overall Study|Adverse Event|7|||
131573268|NCT01729871|473723278|FG000|Overall Study|Death|0|||
131573269|NCT01729871|473723279|FG001|Overall Study|Death|1|||
131573270|NCT01729871|473723278|FG000|Overall Study|Lack of Efficacy|0|||
131573271|NCT01729871|473723279|FG001|Overall Study|Lack of Efficacy|1|||
131573272|NCT01729871|473723278|FG000|Overall Study|Physician Decision|0|||
131573273|NCT01729871|473723279|FG001|Overall Study|Physician Decision|2|||
131573274|NCT01729871|473723278|FG000|Overall Study|Protocol Violation|1|||
131573275|NCT01729871|473723279|FG001|Overall Study|Protocol Violation|0|||
131699219|NCT03237065|474183212|FG001|Overall Study|Unable to obtain venous access|1|||
131699220|NCT00209339|474183213|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
131699221|NCT00209339|474183213|FG000|At 12 Months Follow-up|Death|1|||
131699222|NCT00209339|474183213|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
131699223|NCT00209339|474183213|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
131699224|NCT00209339|474183213|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
131699225|NCT00209339|474183213|FG000|At 24 Months Follow-up|Death|1|||
131699226|NCT00209339|474183213|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
131573276|NCT01729871|473723278|FG000|Overall Study|Withdrawal by Subject|0|||
131573277|NCT01729871|473723279|FG001|Overall Study|Withdrawal by Subject|3|||
131573278|NCT01729871|473723278|FG000|Overall Study|Other|4|||
131573279|NCT01729871|473723279|FG001|Overall Study|Other|9|||
131699227|NCT00209339|474183213|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
131573280|NCT01143077|473723280|FG000|Overall Study|Lack of Efficacy|0|||
131573281|NCT01143077|473723281|FG001|Overall Study|Lack of Efficacy|2|||
131573282|NCT01143077|473723282|FG002|Overall Study|Lack of Efficacy|1|||
131573283|NCT01143077|473723280|FG000|Overall Study|Adverse Event|5|||
131573284|NCT01143077|473723281|FG001|Overall Study|Adverse Event|6|||
131573285|NCT01143077|473723282|FG002|Overall Study|Adverse Event|5|||
131573286|NCT01143077|473723280|FG000|Overall Study|Lost to Follow-up|2|||
131573287|NCT01143077|473723281|FG001|Overall Study|Lost to Follow-up|3|||
131573288|NCT01143077|473723282|FG002|Overall Study|Lost to Follow-up|4|||
131573289|NCT01143077|473723280|FG000|Overall Study|Protocol Violation|2|||
131573290|NCT01143077|473723281|FG001|Overall Study|Protocol Violation|0|||
131573291|NCT01143077|473723282|FG002|Overall Study|Protocol Violation|0|||
131573292|NCT01143077|473723280|FG000|Overall Study|Withdrawal by Subject|4|||
131573293|NCT01143077|473723281|FG001|Overall Study|Withdrawal by Subject|3|||
131573294|NCT01143077|473723282|FG002|Overall Study|Withdrawal by Subject|3|||
131573295|NCT01143077|473723280|FG000|Overall Study|Non-compliance with study drug|0|||
131573296|NCT01143077|473723281|FG001|Overall Study|Non-compliance with study drug|1|||
131573297|NCT01143077|473723282|FG002|Overall Study|Non-compliance with study drug|1|||
131573298|NCT01143077|473723280|FG000|Overall Study|Administrative|1|||
131573299|NCT01143077|473723281|FG001|Overall Study|Administrative|0|||
131573300|NCT01143077|473723282|FG002|Overall Study|Administrative|0|||
131573301|NCT01143077|473723280|FG000|Overall Study|Principal Investigator Decision|2|||
131573302|NCT01143077|473723281|FG001|Overall Study|Principal Investigator Decision|0|||
131573303|NCT01143077|473723282|FG002|Overall Study|Principal Investigator Decision|1|||
131573304|NCT00708097|473723291|FG000|Period 1|Protocol Violation|0|||
131573305|NCT00708097|473723292|FG001|Period 1|Protocol Violation|1|||
131573306|NCT00708097|473723293|FG002|Period 1|Protocol Violation|0|||
131573307|NCT00708097|473723294|FG003|Period 1|Protocol Violation|2|||
131573308|NCT00708097|473723295|FG004|Period 1|Protocol Violation|0|||
131573309|NCT00708097|473723291|FG000|Period 1|Other Reason|0|||
131573310|NCT00708097|473723292|FG001|Period 1|Other Reason|0|||
131573311|NCT00708097|473723293|FG002|Period 1|Other Reason|0|||
131573312|NCT00708097|473723294|FG003|Period 1|Other Reason|0|||
131573313|NCT00708097|473723295|FG004|Period 1|Other Reason|1|||
131573314|NCT00708097|473723291|FG000|Period 2|Protocol Violation|0|||
131573315|NCT00708097|473723292|FG001|Period 2|Protocol Violation|1|||
131573316|NCT00708097|473723293|FG002|Period 2|Protocol Violation|1|||
131573317|NCT00708097|473723294|FG003|Period 2|Protocol Violation|1|||
131573318|NCT00708097|473723295|FG004|Period 2|Protocol Violation|0|||
131573319|NCT03837028|473725684|FG000|Overall Study|Lost to Follow-up|4|||
131573320|NCT03837028|473725685|FG001|Overall Study|Lost to Follow-up|0|||
131573321|NCT03837028|473725686|FG002|Overall Study|Lost to Follow-up|2|||
131573322|NCT03837028|473725687|FG003|Overall Study|Lost to Follow-up|0|||
131573323|NCT03837028|473725684|FG000|Overall Study|Withdrawal by Subject|12|||
131573324|NCT03837028|473725685|FG001|Overall Study|Withdrawal by Subject|11|||
131573325|NCT03837028|473725686|FG002|Overall Study|Withdrawal by Subject|11|||
131573326|NCT03837028|473725687|FG003|Overall Study|Withdrawal by Subject|7|||
131573327|NCT04867902|473725688|FG000|Overall Study|Lost to Follow-up|1|||
131573328|NCT04867902|473725688|FG000|Overall Study|Withdrawal by Subject|2|||
131573329|NCT04867902|473725688|FG000|Overall Study|Protocol Violation|1|||
131573330|NCT05355116|473725689|FG000|Overall Study|Withdrawal by Subject|2|||
131573331|NCT01090024|473725694|FG000|Period 1|Met exclusion criteria|0|||
131573332|NCT01090024|473725695|FG001|Period 1|Met exclusion criteria|0|||
131573333|NCT01090024|473725696|FG002|Period 1|Met exclusion criteria|0|||
131573334|NCT01090024|473725697|FG003|Period 1|Met exclusion criteria|0|||
131573335|NCT01090024|473725698|FG004|Period 1|Met exclusion criteria|0|||
131573336|NCT01090024|473725699|FG005|Period 1|Met exclusion criteria|0|||
131573337|NCT01090024|473725700|FG006|Period 1|Met exclusion criteria|0|||
131573338|NCT01090024|473725701|FG007|Period 1|Met exclusion criteria|0|||
131573339|NCT01090024|473725702|FG008|Period 1|Met exclusion criteria|0|||
131573340|NCT01090024|473725703|FG009|Period 1|Met exclusion criteria|0|||
131573341|NCT01090024|473725704|FG010|Period 1|Met exclusion criteria|0|||
131573342|NCT01090024|473725705|FG011|Period 1|Met exclusion criteria|0|||
131573343|NCT01090024|473725706|FG012|Period 1|Met exclusion criteria|0|||
131573344|NCT01090024|473725707|FG013|Period 1|Met exclusion criteria|0|||
131573345|NCT01090024|473725708|FG014|Period 1|Met exclusion criteria|1|||
131573346|NCT01090024|473725709|FG015|Period 1|Met exclusion criteria|0|||
131573347|NCT01090024|473725710|FG016|Period 1|Met exclusion criteria|0|||
131573348|NCT01090024|473725711|FG017|Period 1|Met exclusion criteria|0|||
131573349|NCT01090024|473725694|FG000|Period 1|Adverse Event|0|||
131573350|NCT01090024|473725695|FG001|Period 1|Adverse Event|0|||
131573351|NCT01090024|473725696|FG002|Period 1|Adverse Event|0|||
131573352|NCT01090024|473725697|FG003|Period 1|Adverse Event|0|||
131573353|NCT01090024|473725698|FG004|Period 1|Adverse Event|0|||
131573354|NCT01090024|473725699|FG005|Period 1|Adverse Event|0|||
131573355|NCT01090024|473725700|FG006|Period 1|Adverse Event|0|||
131573356|NCT01090024|473725701|FG007|Period 1|Adverse Event|0|||
131573357|NCT01090024|473725702|FG008|Period 1|Adverse Event|0|||
131573358|NCT01090024|473725703|FG009|Period 1|Adverse Event|1|||
131573359|NCT01090024|473725704|FG010|Period 1|Adverse Event|0|||
131573360|NCT01090024|473725705|FG011|Period 1|Adverse Event|1|||
131573361|NCT01090024|473725706|FG012|Period 1|Adverse Event|0|||
131573362|NCT01090024|473725707|FG013|Period 1|Adverse Event|0|||
131573363|NCT01090024|473725708|FG014|Period 1|Adverse Event|0|||
131573364|NCT01090024|473725709|FG015|Period 1|Adverse Event|0|||
131573365|NCT01090024|473725710|FG016|Period 1|Adverse Event|0|||
131573366|NCT01090024|473725711|FG017|Period 1|Adverse Event|1|||
131573367|NCT01090024|473725694|FG000|Period 1|Withdrawal by Subject|0|||
131573368|NCT01090024|473725695|FG001|Period 1|Withdrawal by Subject|0|||
131573369|NCT01090024|473725696|FG002|Period 1|Withdrawal by Subject|0|||
131573370|NCT01090024|473725697|FG003|Period 1|Withdrawal by Subject|1|||
131573371|NCT01090024|473725698|FG004|Period 1|Withdrawal by Subject|0|||
131573372|NCT01090024|473725699|FG005|Period 1|Withdrawal by Subject|0|||
131573373|NCT01090024|473725700|FG006|Period 1|Withdrawal by Subject|0|||
131573374|NCT01090024|473725701|FG007|Period 1|Withdrawal by Subject|0|||
131573375|NCT01090024|473725702|FG008|Period 1|Withdrawal by Subject|0|||
131573376|NCT01090024|473725703|FG009|Period 1|Withdrawal by Subject|0|||
131573377|NCT01090024|473725704|FG010|Period 1|Withdrawal by Subject|0|||
131573378|NCT01090024|473725705|FG011|Period 1|Withdrawal by Subject|0|||
131573379|NCT01090024|473725706|FG012|Period 1|Withdrawal by Subject|0|||
131573380|NCT01090024|473725707|FG013|Period 1|Withdrawal by Subject|0|||
131573381|NCT01090024|473725708|FG014|Period 1|Withdrawal by Subject|0|||
131573382|NCT01090024|473725709|FG015|Period 1|Withdrawal by Subject|0|||
131785147|NCT01309828|474496769|FG000|Overall Study|Major Protocol Deviation|0|||
131785148|NCT01309828|474496770|FG001|Overall Study|Major Protocol Deviation|1|||
131785149|NCT01309828|474496769|FG000|Overall Study|Other|1|||
131785150|NCT01309828|474496770|FG001|Overall Study|Other|0|||
131785151|NCT00295620|474496771|FG000|Overall Study|Lost to Follow-up|9|||
131785152|NCT00295620|474496772|FG001|Overall Study|Lost to Follow-up|5|||
131785153|NCT00295620|474496771|FG000|Overall Study|Withdrawal by Subject|37|||
131785154|NCT00295620|474496772|FG001|Overall Study|Withdrawal by Subject|50|||
131785155|NCT00295620|474496771|FG000|Overall Study|Death|206|||
131785156|NCT00295620|474496772|FG001|Overall Study|Death|207|||
131785157|NCT00295620|474496771|FG000|Overall Study|Other reasons|10|||
131785158|NCT00295620|474496772|FG001|Overall Study|Other reasons|9|||
131785159|NCT00295620|474496771|FG000|Overall Study|Discontinuation by sponsor|580|||
131785160|NCT00295620|474496772|FG001|Overall Study|Discontinuation by sponsor|593|||
131785161|NCT00295620|474496771|FG000|Overall Study|Protocol Violation|30|||
131785162|NCT00295620|474496772|FG001|Overall Study|Protocol Violation|32|||
131785163|NCT00217971|474496773|FG000|Overall Study|Adverse Event|1|||
131785164|NCT00217971|474496774|FG001|Overall Study|Adverse Event|1|||
131785165|NCT00217971|474496773|FG000|Overall Study|Lost to Follow-up|15|||
131785166|NCT00217971|474496774|FG001|Overall Study|Lost to Follow-up|19|||
131785167|NCT00217971|474496773|FG000|Overall Study|Physician Decision|0|||
131785168|NCT00217971|474496774|FG001|Overall Study|Physician Decision|1|||
131785169|NCT00217971|474496773|FG000|Overall Study|Withdrawal by Subject|7|||
131785170|NCT00217971|474496774|FG001|Overall Study|Withdrawal by Subject|12|||
131785171|NCT00217971|474496773|FG000|Overall Study|non compliant|1|||
131785172|NCT00217971|474496774|FG001|Overall Study|non compliant|0|||
131785173|NCT02989610|474496775|FG000|Overall Study|Withdrawal by Subject|20|||
131785174|NCT02989610|474496775|FG000|Overall Study|Departure of PI from Site|8|||
131785175|NCT02989610|474496775|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
131785176|NCT02989610|474496775|FG000|Overall Study|Lost to Follow-up|3|||
131785177|NCT02989610|474496775|FG000|Overall Study|Death|3|||
131785178|NCT02989610|474496775|FG000|Overall Study|System Explant|3|||
131785179|NCT02989610|474496775|FG000|Overall Study|Subject Non-Compliance|2|||
131785180|NCT02989610|474496775|FG000|Overall Study|System Revision|2|||
131785181|NCT02989610|474496775|FG000|Overall Study|PI Left, Study Closing|1|||
131785182|NCT02989610|474496775|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
131785183|NCT02989610|474496775|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
131785184|NCT02556632|474496780|FG000|Overall Study|Lost to Follow-up|1|||
131785185|NCT02556632|474496781|FG001|Overall Study|Lost to Follow-up|0|||
131785186|NCT02556632|474496782|FG002|Overall Study|Lost to Follow-up|0|||
131785187|NCT02556632|474496780|FG000|Overall Study|Disliked Intervention|1|||
131785188|NCT02556632|474496781|FG001|Overall Study|Disliked Intervention|1|||
131785189|NCT02556632|474496782|FG002|Overall Study|Disliked Intervention|1|||
131785190|NCT02556632|474496780|FG000|Overall Study|No Reason|1|||
131785191|NCT02556632|474496781|FG001|Overall Study|No Reason|0|||
131573383|NCT01090024|473725710|FG016|Period 1|Withdrawal by Subject|0|||
131785192|NCT02556632|474496782|FG002|Overall Study|No Reason|1|||
131785193|NCT02556632|474496780|FG000|Overall Study|Personal Issues|0|||
131785194|NCT02556632|474496781|FG001|Overall Study|Personal Issues|1|||
131573384|NCT01090024|473725711|FG017|Period 1|Withdrawal by Subject|0|||
131573385|NCT01090024|473725694|FG000|Period 1|Lost to Follow-up|0|||
131573386|NCT01090024|473725695|FG001|Period 1|Lost to Follow-up|1|||
131573387|NCT01090024|473725696|FG002|Period 1|Lost to Follow-up|0|||
131785195|NCT02556632|474496782|FG002|Overall Study|Personal Issues|1|||
131785196|NCT02556632|474496780|FG000|Overall Study|Changed Mind|0|||
131785197|NCT02556632|474496781|FG001|Overall Study|Changed Mind|1|||
131785198|NCT02556632|474496782|FG002|Overall Study|Changed Mind|0|||
131573388|NCT01090024|473725697|FG003|Period 1|Lost to Follow-up|0|||
131573389|NCT01090024|473725698|FG004|Period 1|Lost to Follow-up|0|||
131573390|NCT01090024|473725699|FG005|Period 1|Lost to Follow-up|0|||
131573391|NCT01090024|473725700|FG006|Period 1|Lost to Follow-up|0|||
131573392|NCT01090024|473725701|FG007|Period 1|Lost to Follow-up|0|||
131573393|NCT01090024|473725702|FG008|Period 1|Lost to Follow-up|0|||
131573394|NCT01090024|473725703|FG009|Period 1|Lost to Follow-up|0|||
131573395|NCT01090024|473725704|FG010|Period 1|Lost to Follow-up|0|||
131573396|NCT01090024|473725705|FG011|Period 1|Lost to Follow-up|0|||
131573397|NCT01090024|473725706|FG012|Period 1|Lost to Follow-up|0|||
131573398|NCT01090024|473725707|FG013|Period 1|Lost to Follow-up|0|||
131573399|NCT01090024|473725708|FG014|Period 1|Lost to Follow-up|0|||
131573400|NCT01090024|473725709|FG015|Period 1|Lost to Follow-up|0|||
131573401|NCT01090024|473725710|FG016|Period 1|Lost to Follow-up|0|||
131573402|NCT01090024|473725711|FG017|Period 1|Lost to Follow-up|0|||
131573403|NCT01090024|473725694|FG000|Period 2|Lost to Follow-up|0|||
131573404|NCT01090024|473725695|FG001|Period 2|Lost to Follow-up|0|||
131573405|NCT01090024|473725696|FG002|Period 2|Lost to Follow-up|0|||
131573406|NCT01090024|473725697|FG003|Period 2|Lost to Follow-up|1|||
131573407|NCT01090024|473725698|FG004|Period 2|Lost to Follow-up|0|||
131573408|NCT01090024|473725699|FG005|Period 2|Lost to Follow-up|0|||
131573409|NCT01090024|473725700|FG006|Period 2|Lost to Follow-up|0|||
131573410|NCT01090024|473725701|FG007|Period 2|Lost to Follow-up|0|||
131573411|NCT01090024|473725702|FG008|Period 2|Lost to Follow-up|0|||
131573412|NCT01090024|473725703|FG009|Period 2|Lost to Follow-up|0|||
131573413|NCT01090024|473725704|FG010|Period 2|Lost to Follow-up|0|||
131573414|NCT01090024|473725705|FG011|Period 2|Lost to Follow-up|0|||
131573415|NCT01090024|473725706|FG012|Period 2|Lost to Follow-up|0|||
131573416|NCT01090024|473725707|FG013|Period 2|Lost to Follow-up|0|||
131573417|NCT01090024|473725708|FG014|Period 2|Lost to Follow-up|0|||
131573418|NCT01090024|473725709|FG015|Period 2|Lost to Follow-up|0|||
131573419|NCT01090024|473725710|FG016|Period 2|Lost to Follow-up|0|||
131573420|NCT01090024|473725711|FG017|Period 2|Lost to Follow-up|0|||
131573421|NCT01090024|473725694|FG000|Period 2|Adverse Event|1|||
131573422|NCT01090024|473725695|FG001|Period 2|Adverse Event|0|||
131573423|NCT01090024|473725696|FG002|Period 2|Adverse Event|0|||
131573424|NCT01090024|473725697|FG003|Period 2|Adverse Event|0|||
131573425|NCT01090024|473725698|FG004|Period 2|Adverse Event|0|||
131573426|NCT01090024|473725699|FG005|Period 2|Adverse Event|0|||
131573427|NCT01090024|473725700|FG006|Period 2|Adverse Event|0|||
131573428|NCT01090024|473725701|FG007|Period 2|Adverse Event|0|||
131573429|NCT01090024|473725702|FG008|Period 2|Adverse Event|0|||
131573430|NCT01090024|473725703|FG009|Period 2|Adverse Event|0|||
131573431|NCT01090024|473725704|FG010|Period 2|Adverse Event|0|||
131573432|NCT01090024|473725705|FG011|Period 2|Adverse Event|0|||
131573433|NCT01090024|473725706|FG012|Period 2|Adverse Event|0|||
131573434|NCT01090024|473725707|FG013|Period 2|Adverse Event|0|||
131573435|NCT01090024|473725708|FG014|Period 2|Adverse Event|0|||
131573436|NCT01090024|473725709|FG015|Period 2|Adverse Event|0|||
131573437|NCT01090024|473725710|FG016|Period 2|Adverse Event|0|||
131573438|NCT01090024|473725711|FG017|Period 2|Adverse Event|0|||
131573439|NCT01090024|473725694|FG000|Period 3|Withdrawal by Subject|0|||
131573440|NCT01090024|473725695|FG001|Period 3|Withdrawal by Subject|0|||
131573441|NCT01090024|473725696|FG002|Period 3|Withdrawal by Subject|0|||
131573442|NCT01090024|473725697|FG003|Period 3|Withdrawal by Subject|0|||
131573443|NCT01090024|473725698|FG004|Period 3|Withdrawal by Subject|0|||
131573444|NCT01090024|473725699|FG005|Period 3|Withdrawal by Subject|0|||
131573445|NCT01090024|473725700|FG006|Period 3|Withdrawal by Subject|0|||
131573446|NCT01090024|473725701|FG007|Period 3|Withdrawal by Subject|0|||
131573447|NCT01090024|473725702|FG008|Period 3|Withdrawal by Subject|0|||
131573448|NCT01090024|473725703|FG009|Period 3|Withdrawal by Subject|0|||
131573449|NCT01090024|473725704|FG010|Period 3|Withdrawal by Subject|0|||
131573450|NCT01090024|473725705|FG011|Period 3|Withdrawal by Subject|0|||
131573451|NCT01090024|473725706|FG012|Period 3|Withdrawal by Subject|0|||
131573452|NCT01090024|473725707|FG013|Period 3|Withdrawal by Subject|0|||
131573453|NCT01090024|473725708|FG014|Period 3|Withdrawal by Subject|0|||
131573454|NCT01090024|473725709|FG015|Period 3|Withdrawal by Subject|1|||
131573455|NCT01090024|473725710|FG016|Period 3|Withdrawal by Subject|0|||
131573456|NCT01090024|473725711|FG017|Period 3|Withdrawal by Subject|0|||
131573457|NCT01090024|473725694|FG000|Period 3|Protocol Violation|0|||
131573458|NCT01090024|473725695|FG001|Period 3|Protocol Violation|0|||
131573459|NCT01090024|473725696|FG002|Period 3|Protocol Violation|0|||
131573460|NCT01090024|473725697|FG003|Period 3|Protocol Violation|0|||
131573461|NCT01090024|473725698|FG004|Period 3|Protocol Violation|0|||
131573462|NCT01090024|473725699|FG005|Period 3|Protocol Violation|0|||
131573463|NCT01090024|473725700|FG006|Period 3|Protocol Violation|0|||
131573464|NCT01090024|473725701|FG007|Period 3|Protocol Violation|0|||
131573465|NCT01090024|473725702|FG008|Period 3|Protocol Violation|1|||
131573466|NCT01090024|473725703|FG009|Period 3|Protocol Violation|0|||
131573467|NCT01090024|473725704|FG010|Period 3|Protocol Violation|0|||
131573468|NCT01090024|473725705|FG011|Period 3|Protocol Violation|0|||
131573469|NCT01090024|473725706|FG012|Period 3|Protocol Violation|0|||
131573470|NCT01090024|473725707|FG013|Period 3|Protocol Violation|0|||
131573471|NCT01090024|473725708|FG014|Period 3|Protocol Violation|0|||
131573472|NCT01090024|473725709|FG015|Period 3|Protocol Violation|0|||
131573473|NCT01090024|473725710|FG016|Period 3|Protocol Violation|0|||
131573474|NCT01090024|473725711|FG017|Period 3|Protocol Violation|0|||
131573475|NCT01090024|473725694|FG000|Period 3|Adverse Event|0|||
131573476|NCT01090024|473725695|FG001|Period 3|Adverse Event|0|||
131573477|NCT01090024|473725696|FG002|Period 3|Adverse Event|0|||
131573478|NCT01090024|473725697|FG003|Period 3|Adverse Event|0|||
131573479|NCT01090024|473725698|FG004|Period 3|Adverse Event|0|||
131573480|NCT01090024|473725699|FG005|Period 3|Adverse Event|1|||
131573481|NCT01090024|473725700|FG006|Period 3|Adverse Event|0|||
131573482|NCT01090024|473725701|FG007|Period 3|Adverse Event|0|||
131573483|NCT01090024|473725702|FG008|Period 3|Adverse Event|0|||
131573484|NCT01090024|473725703|FG009|Period 3|Adverse Event|0|||
131573485|NCT01090024|473725704|FG010|Period 3|Adverse Event|0|||
131573486|NCT01090024|473725705|FG011|Period 3|Adverse Event|0|||
131573487|NCT01090024|473725706|FG012|Period 3|Adverse Event|0|||
131573488|NCT01090024|473725707|FG013|Period 3|Adverse Event|0|||
131573489|NCT01090024|473725708|FG014|Period 3|Adverse Event|0|||
131573490|NCT01090024|473725709|FG015|Period 3|Adverse Event|0|||
131573491|NCT01090024|473725710|FG016|Period 3|Adverse Event|0|||
131573492|NCT01090024|473725711|FG017|Period 3|Adverse Event|0|||
131573493|NCT00349908|473725714|FG000|Overall Study|Withdrawal by Subject|0|||
131573494|NCT00349908|473725715|FG001|Overall Study|Withdrawal by Subject|4|||
131573495|NCT00151996|473725716|FG000|Overall Study|Adverse Event|3|||
131573496|NCT00151996|473725717|FG001|Overall Study|Adverse Event|2|||
131573497|NCT00151996|473725716|FG000|Overall Study|Withdrawal by Subject|1|||
131573498|NCT00151996|473725717|FG001|Overall Study|Withdrawal by Subject|1|||
131573499|NCT00151996|473725716|FG000|Overall Study|Protocol Violation|1|||
131573500|NCT00151996|473725717|FG001|Overall Study|Protocol Violation|2|||
131573501|NCT00151996|473725716|FG000|Overall Study|Sponsor's decision|0|||
131573502|NCT00151996|473725717|FG001|Overall Study|Sponsor's decision|2|||
131573503|NCT01649791|473725721|FG000|Overall Study|Disease Progression|2|||
131573504|NCT01649791|473725721|FG000|Overall Study|Adverse Event|1|||
131573505|NCT03646669|473725722|FG000|Overall Study|Withdrawal by Subject|5|||
131573506|NCT03646669|473725723|FG001|Overall Study|Withdrawal by Subject|0|||
131573507|NCT01801930|473725724|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
131573508|NCT01801930|473725725|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
131573509|NCT01801930|473725726|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
131573510|NCT01801930|473725727|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
131573511|NCT01801930|473725724|FG000|Overall Study|DLT occurs|0|||
131573512|NCT01801930|473725725|FG001|Overall Study|DLT occurs|1|||
131573513|NCT01801930|473725726|FG002|Overall Study|DLT occurs|0|||
131573514|NCT01801930|473725727|FG003|Overall Study|DLT occurs|0|||
131573515|NCT02955069|473725731|FG000|Overall Study|Adverse Event|7|||
131573516|NCT02955069|473725732|FG001|Overall Study|Adverse Event|2|||
131573517|NCT02955069|473725731|FG000|Overall Study|Death|7|||
131573518|NCT02955069|473725732|FG001|Overall Study|Death|3|||
131573519|NCT02955069|473725731|FG000|Overall Study|Physician Decision|10|||
131573520|NCT02955069|473725732|FG001|Overall Study|Physician Decision|2|||
131573521|NCT02955069|473725731|FG000|Overall Study|Progressive disease|64|||
131573522|NCT02955069|473725732|FG001|Overall Study|Progressive disease|13|||
131573523|NCT02955069|473725731|FG000|Overall Study|Study terminated by sponsor|4|||
131573524|NCT02955069|473725732|FG001|Overall Study|Study terminated by sponsor|0|||
131573525|NCT02955069|473725731|FG000|Overall Study|Subject/Guardian decision|3|||
131573526|NCT02955069|473725732|FG001|Overall Study|Subject/Guardian decision|1|||
131573527|NCT00943605|473725734|FG000|Overall Study|Study termination|30|||
131573528|NCT00943605|473725735|FG001|Overall Study|Study termination|30|||
131573529|NCT04148937|473725736|FG000|Overall Study|Withdrawal by Subject|0|||
131573530|NCT04148937|473725737|FG001|Overall Study|Withdrawal by Subject|0|||
131573531|NCT04148937|473725738|FG002|Overall Study|Withdrawal by Subject|0|||
131573532|NCT04148937|473725739|FG003|Overall Study|Withdrawal by Subject|1|||
131573533|NCT04148937|473725740|FG004|Overall Study|Withdrawal by Subject|0|||
131573534|NCT04148937|473725741|FG005|Overall Study|Withdrawal by Subject|1|||
131573535|NCT04148937|473725742|FG006|Overall Study|Withdrawal by Subject|1|||
131573536|NCT04148937|473725743|FG007|Overall Study|Withdrawal by Subject|0|||
131573537|NCT04148937|473725736|FG000|Overall Study|Lost to Follow-up|0|||
131573538|NCT04148937|473725737|FG001|Overall Study|Lost to Follow-up|0|||
131573539|NCT04148937|473725738|FG002|Overall Study|Lost to Follow-up|1|||
131573540|NCT04148937|473725739|FG003|Overall Study|Lost to Follow-up|0|||
131573541|NCT04148937|473725740|FG004|Overall Study|Lost to Follow-up|0|||
131573542|NCT04148937|473725741|FG005|Overall Study|Lost to Follow-up|2|||
131573543|NCT04148937|473725742|FG006|Overall Study|Lost to Follow-up|0|||
131573544|NCT04148937|473725743|FG007|Overall Study|Lost to Follow-up|0|||
131573545|NCT03107611|473725744|FG000|Overall Study|Adverse Event|1|||
131573546|NCT03107611|473725745|FG001|Overall Study|Adverse Event|0|||
131573547|NCT03107611|473725746|FG002|Overall Study|Adverse Event|2|||
131573548|NCT03107611|473725744|FG000|Overall Study|Lost to Follow-up|3|||
131573549|NCT03107611|473725745|FG001|Overall Study|Lost to Follow-up|3|||
131573550|NCT03107611|473725746|FG002|Overall Study|Lost to Follow-up|3|||
131573551|NCT03107611|473725744|FG000|Overall Study|Protocol Violation|0|||
131573552|NCT03107611|473725745|FG001|Overall Study|Protocol Violation|0|||
131573553|NCT03107611|473725746|FG002|Overall Study|Protocol Violation|1|||
131573554|NCT03107611|473725744|FG000|Overall Study|Withdrawal by Subject|1|||
131573555|NCT03107611|473725745|FG001|Overall Study|Withdrawal by Subject|0|||
131573556|NCT03107611|473725746|FG002|Overall Study|Withdrawal by Subject|1|||
131573557|NCT03107611|473725744|FG000|Overall Study|Worsening signs/symptoms|2|||
131573558|NCT03107611|473725745|FG001|Overall Study|Worsening signs/symptoms|1|||
131573559|NCT03107611|473725746|FG002|Overall Study|Worsening signs/symptoms|2|||
131573560|NCT01720446|473725747|FG000|Overall Study|Lost to Follow-up|12|||
131573561|NCT01720446|473725748|FG001|Overall Study|Lost to Follow-up|6|||
131573562|NCT01720446|473725749|FG002|Overall Study|Lost to Follow-up|16|||
131573563|NCT01720446|473725750|FG003|Overall Study|Lost to Follow-up|16|||
131573564|NCT01720446|473725747|FG000|Overall Study|Withdrawal by Subject|2|||
131573565|NCT01720446|473725748|FG001|Overall Study|Withdrawal by Subject|5|||
131573566|NCT01720446|473725749|FG002|Overall Study|Withdrawal by Subject|4|||
131573567|NCT01720446|473725750|FG003|Overall Study|Withdrawal by Subject|4|||
131573568|NCT01956669|473725751|FG000|Overall Study|Disease Progression|12|||
131573569|NCT01956669|473725752|FG001|Overall Study|Disease Progression|7|||
131573570|NCT01956669|473725753|FG002|Overall Study|Disease Progression|7|||
131573571|NCT01956669|473725754|FG003|Overall Study|Disease Progression|8|||
131573572|NCT01956669|473725755|FG004|Overall Study|Disease Progression|4|||
131573573|NCT01956669|473725756|FG005|Overall Study|Disease Progression|3|||
131573574|NCT01956669|473725757|FG006|Overall Study|Disease Progression|5|||
131573575|NCT01956669|473725751|FG000|Overall Study|Adverse Event|0|||
131573576|NCT01956669|473725752|FG001|Overall Study|Adverse Event|2|||
131573577|NCT01956669|473725753|FG002|Overall Study|Adverse Event|2|||
131573578|NCT01956669|473725754|FG003|Overall Study|Adverse Event|1|||
131573579|NCT01956669|473725755|FG004|Overall Study|Adverse Event|0|||
131573580|NCT01956669|473725756|FG005|Overall Study|Adverse Event|0|||
131573581|NCT01956669|473725757|FG006|Overall Study|Adverse Event|0|||
131573582|NCT01956669|473725751|FG000|Overall Study|Physician Decision|0|||
131573583|NCT01956669|473725752|FG001|Overall Study|Physician Decision|2|||
131573584|NCT01956669|473725753|FG002|Overall Study|Physician Decision|0|||
131573585|NCT01956669|473725754|FG003|Overall Study|Physician Decision|0|||
131573586|NCT01956669|473725755|FG004|Overall Study|Physician Decision|0|||
131573587|NCT01956669|473725756|FG005|Overall Study|Physician Decision|1|||
131573588|NCT01956669|473725757|FG006|Overall Study|Physician Decision|0|||
131573589|NCT01956669|473725751|FG000|Overall Study|Withdrawal by Subject|0|||
131573590|NCT01956669|473725752|FG001|Overall Study|Withdrawal by Subject|0|||
131573591|NCT01956669|473725753|FG002|Overall Study|Withdrawal by Subject|1|||
131573592|NCT01956669|473725754|FG003|Overall Study|Withdrawal by Subject|1|||
131699228|NCT00209339|474183213|FG000|At 4 Years Follow-up|Death|1|||
131699229|NCT00209339|474183213|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
131699230|NCT00209339|474183213|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
131699231|NCT00209339|474183213|FG000|At 5 Years Follow-up|Death|1|||
131699232|NCT01587079|474183214|FG000|Overall Study|Protocol-specified criteria|9|||
131699233|NCT01587079|474183214|FG000|Overall Study|Protocol Violation|5|||
131699234|NCT01587079|474183214|FG000|Overall Study|Lost to Follow-up|2|||
131699235|NCT01587079|474183214|FG000|Overall Study|Physician Decision|2|||
131699236|NCT01587079|474183214|FG000|Overall Study|Withdrawal by Subject|7|||
131699237|NCT01587079|474183214|FG000|Overall Study|Adverse Event|14|||
131699238|NCT00704964|474183220|FG000|Overall Study|Not completed on time|328|||
131699239|NCT02217566|474183224|FG000|Overall Study|Lost to Follow-up|2|||
131699240|NCT02217566|474183224|FG000|Overall Study|Death|3|||
131699241|NCT02217566|474183224|FG000|Overall Study|Early study termination|6|||
131699242|NCT02296242|474183225|FG000|Overall Study|Death|1|||
131699243|NCT02296242|474183226|FG001|Overall Study|Death|1|||
131573593|NCT01956669|473725755|FG004|Overall Study|Withdrawal by Subject|0|||
131573594|NCT01956669|473725756|FG005|Overall Study|Withdrawal by Subject|0|||
131573595|NCT01956669|473725757|FG006|Overall Study|Withdrawal by Subject|1|||
131573596|NCT00930813|473725760|FG000|Overall Study|Death|4|||
131573597|NCT00930813|473725761|FG001|Overall Study|Death|5|||
131573598|NCT00930813|473725760|FG000|Overall Study|Withdrawal by Subject|2|||
131573599|NCT00930813|473725761|FG001|Overall Study|Withdrawal by Subject|5|||
131573600|NCT00930813|473725760|FG000|Overall Study|Lost to Follow-up|2|||
131699244|NCT02296242|474183227|FG002|Overall Study|Death|1|||
131699245|NCT02296242|474183228|FG003|Overall Study|Death|1|||
131699246|NCT02296242|474183229|FG004|Overall Study|Death|1|||
131699247|NCT02296242|474183225|FG000|Overall Study|Withdrawal by Subject|0|||
131699248|NCT02296242|474183226|FG001|Overall Study|Withdrawal by Subject|0|||
131573601|NCT00930813|473725761|FG001|Overall Study|Lost to Follow-up|4|||
131573602|NCT02131324|473725766|FG000|Overall Study|Withdrawal by Subject|1|||
131573603|NCT02131324|473725767|FG001|Overall Study|Withdrawal by Subject|2|||
131573604|NCT02131324|473725766|FG000|Overall Study|Lost to Follow-up|1|||
131573605|NCT02131324|473725767|FG001|Overall Study|Lost to Follow-up|1|||
131573606|NCT01693614|473725768|FG000|Overall Study|Adverse Event|7|||
131573607|NCT01693614|473725769|FG001|Overall Study|Adverse Event|11|||
131573608|NCT01693614|473725770|FG002|Overall Study|Adverse Event|5|||
131573609|NCT01693614|473725768|FG000|Overall Study|Disease progression|11|||
131573610|NCT01693614|473725769|FG001|Overall Study|Disease progression|8|||
131785199|NCT02556632|474496780|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
131785200|NCT02556632|474496781|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
131785201|NCT02556632|474496782|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
131785202|NCT02556632|474496780|FG000|Overall Study|Unrelated Adverse Event|1|||
131785203|NCT02556632|474496781|FG001|Overall Study|Unrelated Adverse Event|0|||
131785204|NCT02556632|474496782|FG002|Overall Study|Unrelated Adverse Event|3|||
131785205|NCT02556632|474496780|FG000|Overall Study|Related Adverse Event|0|||
131785206|NCT02556632|474496781|FG001|Overall Study|Related Adverse Event|1|||
131785207|NCT02556632|474496782|FG002|Overall Study|Related Adverse Event|0|||
131785208|NCT02556632|474496780|FG000|Overall Study|Possibly Related Adverse Event|0|||
131785209|NCT02556632|474496781|FG001|Overall Study|Possibly Related Adverse Event|0|||
131785210|NCT02556632|474496782|FG002|Overall Study|Possibly Related Adverse Event|1|||
131785211|NCT02556632|474496780|FG000|Overall Study|Did Not Start RT|0|||
131785212|NCT02556632|474496781|FG001|Overall Study|Did Not Start RT|1|||
131785213|NCT02556632|474496782|FG002|Overall Study|Did Not Start RT|0|||
131785214|NCT02556632|474496780|FG000|Overall Study|Ineligible|0|||
131785215|NCT02556632|474496781|FG001|Overall Study|Ineligible|1|||
131785216|NCT02556632|474496782|FG002|Overall Study|Ineligible|0|||
131785217|NCT02556632|474496780|FG000|Overall Study|Disliked Study Procedures|0|||
131785218|NCT02556632|474496781|FG001|Overall Study|Disliked Study Procedures|0|||
131785219|NCT02556632|474496782|FG002|Overall Study|Disliked Study Procedures|1|||
131785220|NCT02556632|474496780|FG000|Overall Study|Treatment or Change Delay|0|||
131785221|NCT02556632|474496781|FG001|Overall Study|Treatment or Change Delay|0|||
131785222|NCT02556632|474496782|FG002|Overall Study|Treatment or Change Delay|1|||
131785223|NCT00808015|474496787|FG000|Overall Study|Death|1|||
131785224|NCT00808015|474496787|FG000|Overall Study|Lack of Efficacy|58|||
131785225|NCT00808015|474496787|FG000|Overall Study|Lost to Follow-up|76|||
131785226|NCT00808015|474496787|FG000|Overall Study|Participants not willing to participate|158|||
131785227|NCT00808015|474496787|FG000|Overall Study|Adverse Event|22|||
131785228|NCT00808015|474496787|FG000|Overall Study|Other|25|||
131785229|NCT00808015|474496787|FG000|Overall Study|Enrolled but not treated|4|||
131785230|NCT04508621|474496791|FG000|Overall Study|Adverse Event|39|||
131785231|NCT04508621|474496792|FG001|Overall Study|Adverse Event|16|||
131785232|NCT04508621|474496791|FG000|Overall Study|Lack of Efficacy|2|||
131785233|NCT04508621|474496792|FG001|Overall Study|Lack of Efficacy|8|||
131785234|NCT04508621|474496791|FG000|Overall Study|Physician Decision|0|||
131785235|NCT04508621|474496792|FG001|Overall Study|Physician Decision|1|||
131785236|NCT04508621|474496791|FG000|Overall Study|Withdrawal by Subject|10|||
131785237|NCT04508621|474496792|FG001|Overall Study|Withdrawal by Subject|14|||
131785238|NCT04508621|474496791|FG000|Overall Study|Lost to Follow-up|12|||
131785239|NCT04508621|474496792|FG001|Overall Study|Lost to Follow-up|9|||
131573611|NCT01693614|473725770|FG002|Overall Study|Disease progression|7|||
131573612|NCT01693614|473725768|FG000|Overall Study|Protocol Violation|5|||
131699249|NCT02296242|474183227|FG002|Overall Study|Withdrawal by Subject|1|||
131699250|NCT02296242|474183228|FG003|Overall Study|Withdrawal by Subject|1|||
131699251|NCT02296242|474183229|FG004|Overall Study|Withdrawal by Subject|3|||
131699252|NCT02296242|474183225|FG000|Overall Study|Disease Progression|1|||
131699253|NCT02296242|474183226|FG001|Overall Study|Disease Progression|3|||
131699254|NCT02296242|474183227|FG002|Overall Study|Disease Progression|2|||
131699255|NCT02296242|474183228|FG003|Overall Study|Disease Progression|8|||
131699256|NCT02296242|474183229|FG004|Overall Study|Disease Progression|11|||
131699257|NCT02296242|474183225|FG000|Overall Study|Unacceptable Toxicity|0|||
131785240|NCT04508621|474496791|FG000|Overall Study|COVID-19 related crisis|3|||
131785241|NCT04508621|474496792|FG001|Overall Study|COVID-19 related crisis|0|||
131785242|NCT04508621|474496791|FG000|Overall Study|Subject non-compliance|1|||
131699258|NCT02296242|474183226|FG001|Overall Study|Unacceptable Toxicity|0|||
131699259|NCT02296242|474183227|FG002|Overall Study|Unacceptable Toxicity|0|||
131785243|NCT04508621|474496792|FG001|Overall Study|Subject non-compliance|0|||
131785244|NCT01066039|474496794|FG000|Overall Study|Adverse Event|6|||
131573613|NCT01693614|473725769|FG001|Overall Study|Protocol Violation|2|||
131573614|NCT01693614|473725770|FG002|Overall Study|Protocol Violation|1|||
131573615|NCT01693614|473725768|FG000|Overall Study|Death|1|||
131785245|NCT01066039|474496794|FG000|Overall Study|Withdrawal by Subject|17|||
131785246|NCT01066039|474496794|FG000|Overall Study|Protocol Violation|2|||
131785247|NCT01066039|474496794|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
131785248|NCT01066039|474496794|FG000|Overall Study|Investigator's Request|1|||
131573616|NCT01693614|473725769|FG001|Overall Study|Death|0|||
131573617|NCT01693614|473725770|FG002|Overall Study|Death|0|||
131573618|NCT01693614|473725768|FG000|Overall Study|Physician Decision|1|||
131573619|NCT01693614|473725769|FG001|Overall Study|Physician Decision|1|||
131573620|NCT01693614|473725770|FG002|Overall Study|Physician Decision|4|||
131573621|NCT01693614|473725768|FG000|Overall Study|Withdrawal by subject/guardian|0|||
131573622|NCT01693614|473725769|FG001|Overall Study|Withdrawal by subject/guardian|0|||
131573623|NCT01693614|473725770|FG002|Overall Study|Withdrawal by subject/guardian|2|||
131573624|NCT01693614|473725768|FG000|Overall Study|Withdrawal by Subject|1|||
131573625|NCT01693614|473725769|FG001|Overall Study|Withdrawal by Subject|0|||
131573626|NCT01693614|473725770|FG002|Overall Study|Withdrawal by Subject|5|||
131573627|NCT02145182|473725771|FG000|Overall Study|Adverse Event|4|||
131573628|NCT02145182|473725772|FG001|Overall Study|Adverse Event|1|||
131573629|NCT02145182|473725771|FG000|Overall Study|Death|7|||
131573630|NCT02145182|473725772|FG001|Overall Study|Death|7|||
131573631|NCT02145182|473725771|FG000|Overall Study|Lost to Follow-up|2|||
131573632|NCT02145182|473725772|FG001|Overall Study|Lost to Follow-up|2|||
131573633|NCT02145182|473725771|FG000|Overall Study|Pre-transplant Withdrawal|0|||
131573634|NCT02145182|473725772|FG001|Overall Study|Pre-transplant Withdrawal|2|||
131573635|NCT02145182|473725771|FG000|Overall Study|Withdrawal by Subject|5|||
131573636|NCT02145182|473725772|FG001|Overall Study|Withdrawal by Subject|4|||
131573637|NCT00420316|473725773|FG000|Overall Study|Withdrawal by Subject|0|||
131573638|NCT00420316|473725774|FG001|Overall Study|Withdrawal by Subject|1|||
131573639|NCT00420316|473725773|FG000|Overall Study|Lost to Follow-up|12|||
131573640|NCT00420316|473725774|FG001|Overall Study|Lost to Follow-up|8|||
131573641|NCT03999554|473725775|FG000|Overall Study|Lost to Follow-up|4|||
131573642|NCT03999554|473725776|FG001|Overall Study|Lost to Follow-up|5|||
131573643|NCT03999554|473725777|FG002|Overall Study|Lost to Follow-up|4|||
131573644|NCT03999554|473725778|FG003|Overall Study|Lost to Follow-up|5|||
131573645|NCT03999554|473725779|FG004|Overall Study|Lost to Follow-up|8|||
131573646|NCT03999554|473725775|FG000|Overall Study|Protocol Violation|0|||
131573647|NCT03999554|473725776|FG001|Overall Study|Protocol Violation|0|||
131573648|NCT03999554|473725777|FG002|Overall Study|Protocol Violation|5|||
131573649|NCT03999554|473725778|FG003|Overall Study|Protocol Violation|0|||
131573650|NCT03999554|473725779|FG004|Overall Study|Protocol Violation|0|||
131573651|NCT03999554|473725775|FG000|Overall Study|Pregnancy|0|||
131573652|NCT03999554|473725776|FG001|Overall Study|Pregnancy|0|||
131573653|NCT03999554|473725777|FG002|Overall Study|Pregnancy|1|||
131573654|NCT03999554|473725778|FG003|Overall Study|Pregnancy|0|||
131573655|NCT03999554|473725779|FG004|Overall Study|Pregnancy|0|||
131573656|NCT03999554|473725775|FG000|Overall Study|Withdrawal by Subject|2|||
131573657|NCT03999554|473725776|FG001|Overall Study|Withdrawal by Subject|2|||
131573658|NCT03999554|473725777|FG002|Overall Study|Withdrawal by Subject|2|||
131573659|NCT03999554|473725778|FG003|Overall Study|Withdrawal by Subject|1|||
131573660|NCT03999554|473725779|FG004|Overall Study|Withdrawal by Subject|1|||
131573661|NCT03999554|473725775|FG000|Overall Study|failure to comply with protocol requirements|0|||
131573662|NCT03999554|473725776|FG001|Overall Study|failure to comply with protocol requirements|0|||
131573663|NCT03999554|473725777|FG002|Overall Study|failure to comply with protocol requirements|0|||
131573664|NCT03999554|473725778|FG003|Overall Study|failure to comply with protocol requirements|1|||
131573665|NCT03999554|473725779|FG004|Overall Study|failure to comply with protocol requirements|0|||
131573666|NCT02274493|473725780|FG000|Overall Study|Withdrawal by Subject|1|||
131573667|NCT01695317|473725781|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
131573668|NCT01695317|473725782|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
131573669|NCT01695317|473725781|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
131573670|NCT01695317|473725782|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
131573671|NCT00606580|473725783|FG000|Overall Study|Lost to Follow-up|1|||
131573672|NCT00606580|473725784|FG001|Overall Study|Lost to Follow-up|1|||
131573673|NCT00606580|473725785|FG002|Overall Study|Lost to Follow-up|4|||
131573674|NCT00606580|473725783|FG000|Overall Study|Clinical failures|1|||
131573675|NCT00606580|473725784|FG001|Overall Study|Clinical failures|0|||
131573676|NCT00606580|473725785|FG002|Overall Study|Clinical failures|12|||
131573677|NCT00606580|473725783|FG000|Overall Study|Withdrawal by investigator|0|||
131573678|NCT00606580|473725784|FG001|Overall Study|Withdrawal by investigator|1|||
131573679|NCT00606580|473725785|FG002|Overall Study|Withdrawal by investigator|6|||
131573680|NCT00606580|473725783|FG000|Overall Study|Withdrawal by Subject|0|||
131437997|NCT01582061|473229464|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131573681|NCT00606580|473725784|FG001|Overall Study|Withdrawal by Subject|1|||
131573682|NCT00606580|473725785|FG002|Overall Study|Withdrawal by Subject|0|||
131573683|NCT01101165|473725786|FG000|Period 1|Adverse Event|1|||
131573684|NCT01101165|473725787|FG001|Period 1|Adverse Event|2|||
131573685|NCT01101165|473725786|FG000|Period 1|Withdrawal by Subject|0|||
131573686|NCT01101165|473725787|FG001|Period 1|Withdrawal by Subject|2|||
131573687|NCT01101165|473725786|FG000|Period 1|Positive Drug Screen|0|||
131573688|NCT01101165|473725787|FG001|Period 1|Positive Drug Screen|1|||
131573689|NCT01101165|473725786|FG000|Period 1|Lost to Follow-up|1|||
131573690|NCT01101165|473725787|FG001|Period 1|Lost to Follow-up|0|||
131699260|NCT02296242|474183228|FG003|Overall Study|Unacceptable Toxicity|0|||
131573691|NCT01101165|473725786|FG000|Period 2|Withdrawal by Subject|3|||
131573692|NCT01101165|473725787|FG001|Period 2|Withdrawal by Subject|1|||
131573693|NCT01101165|473725786|FG000|Period 2|Adverse Event|1|||
131573694|NCT01101165|473725787|FG001|Period 2|Adverse Event|0|||
131573695|NCT00927823|473725788|FG000|Continuous Dosing Period|Death|0|||
131573696|NCT00927823|473725789|FG001|Continuous Dosing Period|Death|0|||
131573697|NCT00927823|473725790|FG002|Continuous Dosing Period|Death|6|||
131573698|NCT00927823|473725791|FG003|Continuous Dosing Period|Death|0|||
131573699|NCT00927823|473725788|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
131573700|NCT00927823|473725789|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
131573701|NCT00927823|473725790|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
131573702|NCT00927823|473725791|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
131573703|NCT00927823|473725788|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
131573704|NCT00927823|473725789|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
131573705|NCT00927823|473725790|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
131573706|NCT00927823|473725791|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
131573707|NCT00927823|473725788|FG000|Continuous Dosing Period|Other|1|||
131573708|NCT00927823|473725789|FG001|Continuous Dosing Period|Other|2|||
131573709|NCT00927823|473725790|FG002|Continuous Dosing Period|Other|9|||
131573710|NCT00927823|473725791|FG003|Continuous Dosing Period|Other|3|||
131573711|NCT00015457|473725792|FG000|First Intervention|Adverse Event|0|||
131573712|NCT00015457|473725793|FG001|First Intervention|Adverse Event|2|||
131573713|NCT00015457|473725792|FG000|First Intervention|Lack of Efficacy|0|||
131573714|NCT00015457|473725793|FG001|First Intervention|Lack of Efficacy|1|||
131573715|NCT00015457|473725792|FG000|Second Intervention|Withdrawal by Subject|1|||
131573716|NCT00015457|473725793|FG001|Second Intervention|Withdrawal by Subject|0|||
131573717|NCT01744691|473725798|FG000|Overall Study|Progressive Disease|18|||
131573718|NCT01744691|473725798|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
131573719|NCT01744691|473725798|FG000|Overall Study|Withdrawal of consent for treatment|3|||
131573720|NCT01744691|473725798|FG000|Overall Study|Physician Decision|4|||
131573721|NCT00502593|473725802|FG000|Overall Study|Withdrawn unspecified reason|1|||
131573722|NCT00502593|473725803|FG001|Overall Study|Withdrawn unspecified reason|1|||
131573723|NCT00502593|473725804|FG002|Overall Study|Withdrawn unspecified reason|3|||
131573724|NCT00502593|473725805|FG003|Overall Study|Withdrawn unspecified reason|1|||
131573725|NCT00502593|473725806|FG004|Overall Study|Withdrawn unspecified reason|2|||
131573726|NCT00502593|473725807|FG005|Overall Study|Withdrawn unspecified reason|0|||
131573727|NCT00502593|473725808|FG006|Overall Study|Withdrawn unspecified reason|2|||
131573728|NCT00502593|473725809|FG007|Overall Study|Withdrawn unspecified reason|0|||
131573729|NCT00502593|473725810|FG008|Overall Study|Withdrawn unspecified reason|0|||
131573730|NCT00502593|473725811|FG009|Overall Study|Withdrawn unspecified reason|0|||
131573731|NCT00502593|473725812|FG010|Overall Study|Withdrawn unspecified reason|0|||
131573732|NCT00502593|473725813|FG011|Overall Study|Withdrawn unspecified reason|0|||
131699261|NCT02296242|474183229|FG004|Overall Study|Unacceptable Toxicity|1|||
131699262|NCT02296242|474183225|FG000|Overall Study|Patient Condition Changed|0|||
131699263|NCT02296242|474183226|FG001|Overall Study|Patient Condition Changed|0|||
131699264|NCT02296242|474183227|FG002|Overall Study|Patient Condition Changed|2|||
131699265|NCT02296242|474183228|FG003|Overall Study|Patient Condition Changed|0|||
131699266|NCT02296242|474183229|FG004|Overall Study|Patient Condition Changed|1|||
131699267|NCT02296242|474183225|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
131699268|NCT02296242|474183226|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
131699269|NCT02296242|474183227|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
131699270|NCT02296242|474183228|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
131699271|NCT02296242|474183229|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
131699272|NCT02296242|474183225|FG000|Overall Study|Lost to Follow-up|1|||
131699273|NCT02296242|474183226|FG001|Overall Study|Lost to Follow-up|0|||
131699274|NCT02296242|474183227|FG002|Overall Study|Lost to Follow-up|0|||
131699275|NCT02296242|474183228|FG003|Overall Study|Lost to Follow-up|0|||
131699276|NCT02296242|474183229|FG004|Overall Study|Lost to Follow-up|0|||
131699277|NCT02296242|474183225|FG000|Overall Study|Need for Hydroxyurea|2|||
131699278|NCT02296242|474183226|FG001|Overall Study|Need for Hydroxyurea|0|||
131699279|NCT02296242|474183227|FG002|Overall Study|Need for Hydroxyurea|0|||
131699280|NCT02296242|474183228|FG003|Overall Study|Need for Hydroxyurea|0|||
131699281|NCT02296242|474183229|FG004|Overall Study|Need for Hydroxyurea|0|||
131573733|NCT00502593|473725802|FG000|Overall Study|Withdrawal by Subject|0|||
131573734|NCT00502593|473725803|FG001|Overall Study|Withdrawal by Subject|0|||
131699282|NCT02296242|474183225|FG000|Overall Study|Screened for Other Protocol|0|||
131699283|NCT02296242|474183226|FG001|Overall Study|Screened for Other Protocol|1|||
131573735|NCT00502593|473725804|FG002|Overall Study|Withdrawal by Subject|6|||
131573736|NCT00502593|473725805|FG003|Overall Study|Withdrawal by Subject|2|||
131573737|NCT00502593|473725806|FG004|Overall Study|Withdrawal by Subject|2|||
131699284|NCT02296242|474183227|FG002|Overall Study|Screened for Other Protocol|0|||
131699285|NCT02296242|474183228|FG003|Overall Study|Screened for Other Protocol|0|||
131699286|NCT02296242|474183229|FG004|Overall Study|Screened for Other Protocol|0|||
131573738|NCT00502593|473725807|FG005|Overall Study|Withdrawal by Subject|0|||
131573739|NCT00502593|473725808|FG006|Overall Study|Withdrawal by Subject|3|||
131573740|NCT00502593|473725809|FG007|Overall Study|Withdrawal by Subject|0|||
131573741|NCT00502593|473725810|FG008|Overall Study|Withdrawal by Subject|3|||
131573742|NCT00502593|473725811|FG009|Overall Study|Withdrawal by Subject|0|||
131573743|NCT00502593|473725812|FG010|Overall Study|Withdrawal by Subject|1|||
131573744|NCT00502593|473725813|FG011|Overall Study|Withdrawal by Subject|0|||
131573745|NCT00502593|473725802|FG000|Overall Study|Lost to Follow-up|2|||
131573746|NCT00502593|473725803|FG001|Overall Study|Lost to Follow-up|1|||
131573747|NCT00502593|473725804|FG002|Overall Study|Lost to Follow-up|1|||
131573748|NCT00502593|473725805|FG003|Overall Study|Lost to Follow-up|1|||
131573749|NCT00502593|473725806|FG004|Overall Study|Lost to Follow-up|0|||
131573750|NCT00502593|473725807|FG005|Overall Study|Lost to Follow-up|0|||
131573751|NCT00502593|473725808|FG006|Overall Study|Lost to Follow-up|0|||
131573752|NCT00502593|473725809|FG007|Overall Study|Lost to Follow-up|0|||
131573753|NCT00502593|473725810|FG008|Overall Study|Lost to Follow-up|3|||
131573754|NCT00502593|473725811|FG009|Overall Study|Lost to Follow-up|0|||
131573755|NCT00502593|473725812|FG010|Overall Study|Lost to Follow-up|1|||
131573756|NCT00502593|473725813|FG011|Overall Study|Lost to Follow-up|0|||
131573757|NCT04511650|473725814|FG000|Overall Study|Lost to Follow-up|1|||
131573758|NCT04511650|473725815|FG001|Overall Study|Lost to Follow-up|0|||
131573759|NCT04511650|473725816|FG002|Overall Study|Lost to Follow-up|0|||
131573760|NCT04511650|473725814|FG000|Overall Study|Withdrawal by Subject|1|||
131573761|NCT04511650|473725815|FG001|Overall Study|Withdrawal by Subject|0|||
131573762|NCT04511650|473725816|FG002|Overall Study|Withdrawal by Subject|0|||
131573763|NCT04511650|473725814|FG000|Overall Study|reason not provided|0|||
131573764|NCT04511650|473725815|FG001|Overall Study|reason not provided|0|||
131573765|NCT04511650|473725816|FG002|Overall Study|reason not provided|1|||
131573766|NCT04511650|473725814|FG000|Overall Study|Death|1|||
131573767|NCT04511650|473725815|FG001|Overall Study|Death|1|||
131573768|NCT04511650|473725816|FG002|Overall Study|Death|1|||
131573769|NCT01664104|473725818|FG000|Overall Study|Adverse Event|6|||
131573770|NCT01664104|473725818|FG000|Overall Study|Lack of Efficacy|2|||
131573771|NCT01664104|473725818|FG000|Overall Study|Withdrawal by Subject|1|||
131573772|NCT01664104|473725818|FG000|Overall Study|Lost to Follow-up|4|||
131573773|NCT01664104|473725818|FG000|Overall Study|Other|1|||
131573774|NCT01664104|473725818|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
131573775|NCT03586167|473725819|FG000|Overall Study|Other|1|||
131573776|NCT03586167|473725820|FG001|Overall Study|Other|0|||
131573777|NCT00591838|473725821|FG000|Overall Study|Withdrawal by Subject|0|||
131573778|NCT00591838|473725822|FG001|Overall Study|Withdrawal by Subject|0|||
131573779|NCT00591838|473725823|FG002|Overall Study|Withdrawal by Subject|0|||
131573780|NCT00591838|473725824|FG003|Overall Study|Withdrawal by Subject|1|||
131573781|NCT00591838|473725825|FG004|Overall Study|Withdrawal by Subject|0|||
131573782|NCT04163458|473725829|FG000|Overall Study|Protocol Deviation|7|||
131573783|NCT04163458|473725830|FG001|Overall Study|Protocol Deviation|13|||
131573784|NCT04163458|473725829|FG000|Overall Study|Adverse Event|5|||
131573785|NCT04163458|473725830|FG001|Overall Study|Adverse Event|8|||
131573786|NCT04163458|473725829|FG000|Overall Study|Due to COVID-19 pandemic|4|||
131573787|NCT04163458|473725830|FG001|Overall Study|Due to COVID-19 pandemic|2|||
131573788|NCT04163458|473725829|FG000|Overall Study|Participant withdrew consent|2|||
131573789|NCT04163458|473725830|FG001|Overall Study|Participant withdrew consent|3|||
131573790|NCT04163458|473725829|FG000|Overall Study|Randomization failure|2|||
131573791|NCT04163458|473725830|FG001|Overall Study|Randomization failure|2|||
131573792|NCT04163458|473725829|FG000|Overall Study|Other|4|||
131573793|NCT04163458|473725830|FG001|Overall Study|Other|2|||
131573794|NCT03394027|473725833|FG000|Overall Study|Ineligible|3|||
131573795|NCT03394027|473725834|FG001|Overall Study|Ineligible|1|||
131699287|NCT02296242|474183225|FG000|Overall Study|Physician Decision|0|||
131699288|NCT02296242|474183226|FG001|Overall Study|Physician Decision|1|||
131699289|NCT02296242|474183227|FG002|Overall Study|Physician Decision|0|||
131699290|NCT02296242|474183228|FG003|Overall Study|Physician Decision|1|||
131699291|NCT02296242|474183229|FG004|Overall Study|Physician Decision|0|||
131699292|NCT02296242|474183225|FG000|Overall Study|Alternative Treatment|0|||
131573796|NCT03394027|473725835|FG002|Overall Study|Ineligible|3|||
131699293|NCT02296242|474183226|FG001|Overall Study|Alternative Treatment|0|||
131573797|NCT03394027|473725833|FG000|Overall Study|Participant declined to participate before treatment started|0|||
131573798|NCT03394027|473725834|FG001|Overall Study|Participant declined to participate before treatment started|0|||
131573799|NCT03394027|473725835|FG002|Overall Study|Participant declined to participate before treatment started|1|||
131573800|NCT04523181|473725837|FG000|Overall Study|Withdrawal by Subject|4|||
131573801|NCT04523181|473725838|FG001|Overall Study|Withdrawal by Subject|5|||
131573802|NCT04523181|473725837|FG000|Overall Study|Lost to Follow-up|2|||
131573803|NCT04523181|473725838|FG001|Overall Study|Lost to Follow-up|3|||
131573804|NCT04523181|473725837|FG000|Overall Study|Physician Decision|1|||
131573805|NCT04523181|473725838|FG001|Overall Study|Physician Decision|0|||
131699294|NCT02296242|474183227|FG002|Overall Study|Alternative Treatment|0|||
131699295|NCT02296242|474183228|FG003|Overall Study|Alternative Treatment|1|||
131699296|NCT02296242|474183229|FG004|Overall Study|Alternative Treatment|0|||
131573806|NCT04523181|473725837|FG000|Overall Study|Transferred to external facility.|1|||
131573807|NCT04523181|473725838|FG001|Overall Study|Transferred to external facility.|1|||
131573808|NCT04550039|473725839|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
131573809|NCT04550039|473725840|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
131573810|NCT04550039|473725839|FG000|Overall Study|patient self-withdrew from study|0|||
131573811|NCT04550039|473725840|FG001|Overall Study|patient self-withdrew from study|1|||
131573812|NCT04391309|473725841|FG000|Overall Study|Death|1|||
131573813|NCT04391309|473725842|FG001|Overall Study|Death|1|||
131573814|NCT04391309|473725841|FG000|Overall Study|Lost to Follow-up|3|||
131573815|NCT04391309|473725842|FG001|Overall Study|Lost to Follow-up|2|||
131573816|NCT04391309|473725841|FG000|Overall Study|Withdrawal by Subject|2|||
131573817|NCT04391309|473725842|FG001|Overall Study|Withdrawal by Subject|2|||
131573818|NCT00881335|473725851|FG000|Overall Study|Lost to Follow-up|3|||
131573819|NCT00881335|473725852|FG001|Overall Study|Lost to Follow-up|2|||
131573820|NCT05824351|473725853|FG000|Overall Study|Adverse Event|6|||
131573821|NCT00828945|473725854|FG000|Overall Study|Death|4|||
131573822|NCT00828945|473725854|FG000|Overall Study|Participant was missing|1|||
131573823|NCT00828945|473725854|FG000|Overall Study|Other|36|||
131573824|NCT02482233|473725859|FG000|Overall Study|Lost to Follow-up|1|||
131573825|NCT02482233|473725860|FG001|Overall Study|Lost to Follow-up|1|||
131573826|NCT03822351|473725861|FG000|Overall Study|Death|27|||
131573827|NCT03822351|473725862|FG001|Overall Study|Death|23|||
131573828|NCT03822351|473725863|FG002|Overall Study|Death|24|||
131573829|NCT03822351|473725861|FG000|Overall Study|Lost to Follow-up|6|||
131573830|NCT03822351|473725862|FG001|Overall Study|Lost to Follow-up|2|||
131573831|NCT03822351|473725863|FG002|Overall Study|Lost to Follow-up|1|||
131573832|NCT03822351|473725861|FG000|Overall Study|Withdrawal by Subject|10|||
131573833|NCT03822351|473725862|FG001|Overall Study|Withdrawal by Subject|4|||
131573834|NCT03822351|473725863|FG002|Overall Study|Withdrawal by Subject|6|||
131573835|NCT03822351|473725861|FG000|Overall Study|Progressive Disease|2|||
131573836|NCT03822351|473725862|FG001|Overall Study|Progressive Disease|1|||
131573837|NCT03822351|473725863|FG002|Overall Study|Progressive Disease|0|||
131573838|NCT03822351|473725861|FG000|Overall Study|Not Treated|1|||
131573839|NCT03822351|473725862|FG001|Overall Study|Not Treated|1|||
131573840|NCT03822351|473725863|FG002|Overall Study|Not Treated|1|||
131573841|NCT00462943|473725864|FG000|Overall Study|Failure to achieve a response|5|||
131573842|NCT00462943|473725865|FG001|Overall Study|Failure to achieve a response|5|||
131573843|NCT00462943|473725866|FG002|Overall Study|Failure to achieve a response|1|||
131573844|NCT00462943|473725864|FG000|Overall Study|Adverse Event|6|||
131573845|NCT00462943|473725865|FG001|Overall Study|Adverse Event|4|||
131573846|NCT00462943|473725866|FG002|Overall Study|Adverse Event|1|||
131573847|NCT00462943|473725864|FG000|Overall Study|Protocol Violation|1|||
131573848|NCT00462943|473725865|FG001|Overall Study|Protocol Violation|0|||
131573849|NCT00462943|473725866|FG002|Overall Study|Protocol Violation|0|||
131573850|NCT00462943|473725864|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
131573851|NCT00462943|473725865|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
131573852|NCT00462943|473725866|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
131573853|NCT00462943|473725864|FG000|Overall Study|Disease Progression|15|||
131573854|NCT00462943|473725865|FG001|Overall Study|Disease Progression|15|||
131573855|NCT00462943|473725866|FG002|Overall Study|Disease Progression|9|||
131573856|NCT00462943|473725864|FG000|Overall Study|Death|5|||
131573857|NCT00462943|473725865|FG001|Overall Study|Death|2|||
131573858|NCT00462943|473725866|FG002|Overall Study|Death|7|||
131573859|NCT00462943|473725864|FG000|Overall Study|Stem Cell Transplant|1|||
131573860|NCT00462943|473725865|FG001|Overall Study|Stem Cell Transplant|1|||
131573861|NCT00462943|473725866|FG002|Overall Study|Stem Cell Transplant|0|||
131573862|NCT00462943|473725864|FG000|Overall Study|Bone Marrow Transplant|1|||
131699297|NCT02296242|474183225|FG000|Overall Study|Adverse Event|0|||
131699298|NCT02296242|474183226|FG001|Overall Study|Adverse Event|0|||
131699299|NCT02296242|474183227|FG002|Overall Study|Adverse Event|0|||
131573863|NCT00462943|473725865|FG001|Overall Study|Bone Marrow Transplant|0|||
131573864|NCT00462943|473725866|FG002|Overall Study|Bone Marrow Transplant|0|||
131573865|NCT00462943|473725864|FG000|Overall Study|Required Lymphocyte Infusion|1|||
131573866|NCT00462943|473725865|FG001|Overall Study|Required Lymphocyte Infusion|0|||
131573867|NCT00462943|473725866|FG002|Overall Study|Required Lymphocyte Infusion|0|||
131573868|NCT00462943|473725864|FG000|Overall Study|Transplant - not specified|1|||
131573869|NCT00462943|473725865|FG001|Overall Study|Transplant - not specified|0|||
131573870|NCT00462943|473725866|FG002|Overall Study|Transplant - not specified|1|||
131573871|NCT00462943|473725864|FG000|Overall Study|Physician Decision|1|||
131573872|NCT00462943|473725865|FG001|Overall Study|Physician Decision|0|||
131573873|NCT00462943|473725866|FG002|Overall Study|Physician Decision|0|||
131573874|NCT00462943|473725864|FG000|Overall Study|Withdrawal by Subject|0|||
131699300|NCT02296242|474183228|FG003|Overall Study|Adverse Event|1|||
131573875|NCT00462943|473725865|FG001|Overall Study|Withdrawal by Subject|1|||
131573876|NCT00462943|473725866|FG002|Overall Study|Withdrawal by Subject|0|||
131573877|NCT04358549|473727227|FG000|Overall Study|Adverse Event|0|||
131573878|NCT04358549|473727228|FG001|Overall Study|Adverse Event|1|||
131573879|NCT04358549|473727227|FG000|Overall Study|Death|1|||
131573880|NCT04358549|473727228|FG001|Overall Study|Death|0|||
131573881|NCT04358549|473727227|FG000|Overall Study|Lost to Follow-up|2|||
131573882|NCT04358549|473727228|FG001|Overall Study|Lost to Follow-up|1|||
131573883|NCT04358549|473727227|FG000|Overall Study|Withdrawal by Subject|6|||
131573884|NCT04358549|473727228|FG001|Overall Study|Withdrawal by Subject|6|||
131573885|NCT04358549|473727227|FG000|Overall Study|Start remdesivir|1|||
131573886|NCT04358549|473727228|FG001|Overall Study|Start remdesivir|0|||
131573887|NCT00157014|473727229|FG000|Overall Study|Death|4|||
131573888|NCT00157014|473727230|FG001|Overall Study|Death|2|||
131573889|NCT00157014|473727231|FG002|Overall Study|Death|1|||
131573890|NCT00157014|473727232|FG003|Overall Study|Death|1|||
131573891|NCT00157014|473727229|FG000|Overall Study|Physician Decision|0|||
131573892|NCT00157014|473727230|FG001|Overall Study|Physician Decision|1|||
131573893|NCT00157014|473727231|FG002|Overall Study|Physician Decision|0|||
131573894|NCT00157014|473727232|FG003|Overall Study|Physician Decision|0|||
131573895|NCT00157014|473727229|FG000|Overall Study|Medications withdrawn on family request|0|||
131573896|NCT00157014|473727230|FG001|Overall Study|Medications withdrawn on family request|1|||
131573897|NCT00157014|473727231|FG002|Overall Study|Medications withdrawn on family request|0|||
131573898|NCT00157014|473727232|FG003|Overall Study|Medications withdrawn on family request|0|||
131573899|NCT00157014|473727229|FG000|Overall Study|Patient withdrawn by investigator|1|||
131573900|NCT00157014|473727230|FG001|Overall Study|Patient withdrawn by investigator|0|||
131573901|NCT00157014|473727231|FG002|Overall Study|Patient withdrawn by investigator|0|||
131573902|NCT00157014|473727232|FG003|Overall Study|Patient withdrawn by investigator|0|||
131573903|NCT00157014|473727229|FG000|Overall Study|Patient unable to return in nursing home|1|||
131573904|NCT00157014|473727230|FG001|Overall Study|Patient unable to return in nursing home|0|||
131573905|NCT00157014|473727231|FG002|Overall Study|Patient unable to return in nursing home|0|||
131573906|NCT00157014|473727232|FG003|Overall Study|Patient unable to return in nursing home|0|||
131573907|NCT00157014|473727229|FG000|Overall Study|Patient would not receive transplant|0|||
131573908|NCT00157014|473727230|FG001|Overall Study|Patient would not receive transplant|1|||
131573909|NCT00157014|473727231|FG002|Overall Study|Patient would not receive transplant|0|||
131573910|NCT00157014|473727232|FG003|Overall Study|Patient would not receive transplant|0|||
131573911|NCT00157014|473727229|FG000|Overall Study|Withdrawal by Subject|1|||
131573912|NCT00157014|473727230|FG001|Overall Study|Withdrawal by Subject|0|||
131573913|NCT00157014|473727231|FG002|Overall Study|Withdrawal by Subject|0|||
131573914|NCT00157014|473727232|FG003|Overall Study|Withdrawal by Subject|0|||
131573915|NCT01362491|473727233|FG000|Overall Study|Ineligible|1|||
131573916|NCT01362491|473727234|FG001|Overall Study|Ineligible|0|||
131573917|NCT01362491|473727235|FG002|Overall Study|Ineligible|0|||
131573918|NCT01257503|473727236|FG000|Overall Study|Lost to Follow-up|7|||
131573919|NCT01257503|473727237|FG001|Overall Study|Lost to Follow-up|10|||
131573920|NCT01257503|473727236|FG000|Overall Study|Over 5 years old at enrollment|0|||
131573921|NCT01257503|473727237|FG001|Overall Study|Over 5 years old at enrollment|1|||
131573922|NCT01257503|473727236|FG000|Overall Study|strep culture positive at enrollment|1|||
131573923|NCT01257503|473727237|FG001|Overall Study|strep culture positive at enrollment|0|||
131573924|NCT00567879|473727240|FG000|Overall Study|Adverse Event|2|||
131699301|NCT02296242|474183229|FG004|Overall Study|Adverse Event|0|||
131699302|NCT02296242|474183225|FG000|Overall Study|Lack of Efficacy|0|||
131699303|NCT02296242|474183226|FG001|Overall Study|Lack of Efficacy|0|||
131699304|NCT02296242|474183227|FG002|Overall Study|Lack of Efficacy|0|||
131699305|NCT02296242|474183228|FG003|Overall Study|Lack of Efficacy|0|||
131699306|NCT02296242|474183229|FG004|Overall Study|Lack of Efficacy|3|||
131699307|NCT01639833|474183233|FG000|Overall Study|Death|4|||
131699308|NCT01639833|474183234|FG001|Overall Study|Death|2|||
131699309|NCT01639833|474183233|FG000|Overall Study|Withdrawal by Subject|2|||
131699310|NCT01639833|474183234|FG001|Overall Study|Withdrawal by Subject|2|||
131699311|NCT00608985|474183240|FG000|Overall Study|Adverse Event|2|||
131699312|NCT00608985|474183241|FG001|Overall Study|Adverse Event|7|||
131699313|NCT00608985|474183242|FG002|Overall Study|Adverse Event|4|||
131573925|NCT00567879|473727241|FG001|Overall Study|Adverse Event|0|||
131573926|NCT00567879|473727242|FG002|Overall Study|Adverse Event|1|||
131573927|NCT00567879|473727243|FG003|Overall Study|Adverse Event|0|||
131573928|NCT00567879|473727244|FG004|Overall Study|Adverse Event|1|||
131573929|NCT00567879|473727245|FG005|Overall Study|Adverse Event|0|||
131573930|NCT00567879|473727240|FG000|Overall Study|Abnormal test procedure(s)|0|||
131573931|NCT00567879|473727241|FG001|Overall Study|Abnormal test procedure(s)|0|||
131573932|NCT00567879|473727242|FG002|Overall Study|Abnormal test procedure(s)|1|||
131573933|NCT00567879|473727243|FG003|Overall Study|Abnormal test procedure(s)|0|||
131573934|NCT00567879|473727244|FG004|Overall Study|Abnormal test procedure(s)|0|||
131699314|NCT00608985|474183243|FG003|Overall Study|Adverse Event|6|||
131699315|NCT00608985|474183240|FG000|Overall Study|Administrative/Other|7|||
131699316|NCT00608985|474183241|FG001|Overall Study|Administrative/Other|4|||
131573935|NCT00567879|473727245|FG005|Overall Study|Abnormal test procedure(s)|0|||
131573936|NCT00567879|473727240|FG000|Overall Study|Withdrawal by Subject|0|||
131573937|NCT00567879|473727241|FG001|Overall Study|Withdrawal by Subject|0|||
131573938|NCT00567879|473727242|FG002|Overall Study|Withdrawal by Subject|3|||
131573939|NCT00567879|473727243|FG003|Overall Study|Withdrawal by Subject|1|||
131573940|NCT00567879|473727244|FG004|Overall Study|Withdrawal by Subject|0|||
131573941|NCT00567879|473727245|FG005|Overall Study|Withdrawal by Subject|0|||
131573942|NCT00567879|473727240|FG000|Overall Study|New cancer therapy|0|||
131573943|NCT00567879|473727241|FG001|Overall Study|New cancer therapy|0|||
131573944|NCT00567879|473727242|FG002|Overall Study|New cancer therapy|1|||
131573945|NCT00567879|473727243|FG003|Overall Study|New cancer therapy|0|||
131573946|NCT00567879|473727244|FG004|Overall Study|New cancer therapy|0|||
131573947|NCT00567879|473727245|FG005|Overall Study|New cancer therapy|0|||
131573948|NCT00567879|473727240|FG000|Overall Study|Disease progression|5|||
131573949|NCT00567879|473727241|FG001|Overall Study|Disease progression|7|||
131573950|NCT00567879|473727242|FG002|Overall Study|Disease progression|15|||
131573951|NCT00567879|473727243|FG003|Overall Study|Disease progression|5|||
131573952|NCT00567879|473727244|FG004|Overall Study|Disease progression|11|||
131573953|NCT00567879|473727245|FG005|Overall Study|Disease progression|3|||
131573954|NCT00777556|473727246|FG000|Overall Study|Inappropriate self-selection|34|||
131573955|NCT00777556|473727246|FG000|Overall Study|Dispensed but did not use product|12|||
131573956|NCT00777556|473727246|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
131573957|NCT03439124|473727251|FG000|Overall Study|Adverse Event|2|||
131573958|NCT03439124|473727252|FG001|Overall Study|Adverse Event|0|||
131573959|NCT03439124|473727251|FG000|Overall Study|Lost to Follow-up|1|||
131573960|NCT03439124|473727252|FG001|Overall Study|Lost to Follow-up|0|||
131573961|NCT03439124|473727251|FG000|Overall Study|Other reasons|1|||
131573962|NCT03439124|473727252|FG001|Overall Study|Other reasons|0|||
131573963|NCT02049866|473727253|FG000|Overall Study|Withdrawal by Subject|1|||
131573964|NCT01117480|473727254|FG000|Overall Study|Protocol Violation|8|||
131573965|NCT01117480|473727254|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
131573966|NCT04464421|473727258|FG000|Overall Study|Lost to Follow-up|2|||
131573967|NCT04464421|473727259|FG001|Overall Study|Lost to Follow-up|2|||
131573968|NCT01072357|473727260|FG000|Overall Study|Lost to Follow-up|0|||
131573969|NCT01072357|473727261|FG001|Overall Study|Lost to Follow-up|1|||
131573970|NCT00891618|473727262|FG000|Overall Study|Withdrawal by Subject|1|||
131573971|NCT05790408|473727263|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
131573972|NCT05419557|473727264|FG000|Overall Study|Lost to Follow-up|11|||
131573973|NCT05419557|473727265|FG001|Overall Study|Lost to Follow-up|4|||
131573974|NCT01196988|473727266|FG000|Overall Study|Adverse Event|1|||
131573975|NCT01196988|473727267|FG001|Overall Study|Adverse Event|2|||
131573976|NCT01196988|473727268|FG002|Overall Study|Adverse Event|0|||
131573977|NCT01196988|473727269|FG003|Overall Study|Adverse Event|0|||
131573978|NCT01196988|473727266|FG000|Overall Study|Withdrawal by Subject|5|||
131699317|NCT00608985|474183242|FG002|Overall Study|Administrative/Other|1|||
131699318|NCT00608985|474183243|FG003|Overall Study|Administrative/Other|2|||
131699319|NCT00608985|474183240|FG000|Overall Study|Withdrawal of Consent|5|||
131699320|NCT00608985|474183241|FG001|Overall Study|Withdrawal of Consent|1|||
131699321|NCT00608985|474183242|FG002|Overall Study|Withdrawal of Consent|1|||
131699322|NCT00608985|474183243|FG003|Overall Study|Withdrawal of Consent|1|||
131699323|NCT00608985|474183240|FG000|Overall Study|Lost to Follow-up|2|||
131699324|NCT00608985|474183241|FG001|Overall Study|Lost to Follow-up|1|||
131699325|NCT00608985|474183242|FG002|Overall Study|Lost to Follow-up|0|||
131699326|NCT00608985|474183243|FG003|Overall Study|Lost to Follow-up|0|||
131699327|NCT02574637|474183244|FG000|Double-blind Period|Adverse Event|1|||
131699328|NCT02574637|474183245|FG001|Double-blind Period|Adverse Event|0|||
131699329|NCT02574637|474183246|FG002|Double-blind Period|Adverse Event|0|||
131699330|NCT02574637|474183247|FG003|Double-blind Period|Adverse Event|0|||
131699331|NCT02574637|474183248|FG004|Double-blind Period|Adverse Event|0|||
131699332|NCT02574637|474183249|FG005|Double-blind Period|Adverse Event|0|||
131699333|NCT02574637|474183250|FG006|Double-blind Period|Adverse Event|0|||
131699334|NCT02574637|474183251|FG007|Double-blind Period|Adverse Event|0|||
131573979|NCT01196988|473727267|FG001|Overall Study|Withdrawal by Subject|1|||
131573980|NCT01196988|473727268|FG002|Overall Study|Withdrawal by Subject|4|||
131573981|NCT01196988|473727269|FG003|Overall Study|Withdrawal by Subject|0|||
131573982|NCT01196988|473727266|FG000|Overall Study|Lost to Follow-up|16|||
131573983|NCT01196988|473727267|FG001|Overall Study|Lost to Follow-up|29|||
131573984|NCT01196988|473727268|FG002|Overall Study|Lost to Follow-up|21|||
131573985|NCT01196988|473727269|FG003|Overall Study|Lost to Follow-up|1|||
131573986|NCT01196988|473727266|FG000|Overall Study|Other|2|||
131573987|NCT01196988|473727267|FG001|Overall Study|Other|0|||
131573988|NCT01196988|473727268|FG002|Overall Study|Other|0|||
131573989|NCT01196988|473727269|FG003|Overall Study|Other|0|||
131699335|NCT02574637|474183252|FG008|Double-blind Period|Adverse Event|0|||
131699336|NCT02574637|474183253|FG009|Double-blind Period|Adverse Event|0|||
131699337|NCT02574637|474183244|FG000|Double-blind Period|Lack of Efficacy|0|||
131699338|NCT02574637|474183245|FG001|Double-blind Period|Lack of Efficacy|0|||
131699339|NCT02574637|474183246|FG002|Double-blind Period|Lack of Efficacy|2|||
131785249|NCT01066039|474496794|FG000|Overall Study|Dropout due to Insulin Administration|1|||
131785250|NCT01066039|474496794|FG000|Overall Study|Additional Antihypertensive Required|4|||
131573990|NCT00558363|473727271|FG000|Overall Study|Physician Decision|18|||
131573991|NCT00558363|473727272|FG001|Overall Study|Physician Decision|4|||
131573992|NCT00558363|473727271|FG000|Overall Study|Withdrawal by Subject|11|||
131573993|NCT00558363|473727272|FG001|Overall Study|Withdrawal by Subject|4|||
131573994|NCT00558363|473727271|FG000|Overall Study|Adverse Event|5|||
131573995|NCT00558363|473727272|FG001|Overall Study|Adverse Event|5|||
131573996|NCT00558363|473727271|FG000|Overall Study|Lack of Efficacy|2|||
131573997|NCT00558363|473727272|FG001|Overall Study|Lack of Efficacy|2|||
131573998|NCT00558363|473727271|FG000|Overall Study|Protocol Violation|2|||
131573999|NCT00558363|473727272|FG001|Overall Study|Protocol Violation|1|||
131574000|NCT00558363|473727271|FG000|Overall Study|Lost to Follow-up|0|||
131574001|NCT00558363|473727272|FG001|Overall Study|Lost to Follow-up|1|||
131574002|NCT00558363|473727271|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
131574003|NCT00558363|473727272|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
131574004|NCT00558363|473727271|FG000|Overall Study|Randomized in Error|1|||
131574005|NCT00558363|473727272|FG001|Overall Study|Randomized in Error|2|||
131574006|NCT00558363|473727271|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
131574007|NCT00558363|473727272|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
131574008|NCT00920686|473727273|FG000|Overall Study|Lost to Follow-up|2|||
131574009|NCT00920686|473727274|FG001|Overall Study|Lost to Follow-up|3|||
131574010|NCT00920686|473727275|FG002|Overall Study|Lost to Follow-up|1|||
131574011|NCT00920686|473727273|FG000|Overall Study|Study drug dosing criteria not met|17|||
131574012|NCT00920686|473727274|FG001|Overall Study|Study drug dosing criteria not met|19|||
131574013|NCT00920686|473727275|FG002|Overall Study|Study drug dosing criteria not met|12|||
131574014|NCT01313182|473727276|FG000|Overall Study|Protocol Violation|66|||
131699340|NCT02574637|474183247|FG003|Double-blind Period|Lack of Efficacy|0|||
131699341|NCT02574637|474183248|FG004|Double-blind Period|Lack of Efficacy|0|||
131699342|NCT02574637|474183249|FG005|Double-blind Period|Lack of Efficacy|0|||
131699343|NCT02574637|474183250|FG006|Double-blind Period|Lack of Efficacy|0|||
131699344|NCT02574637|474183251|FG007|Double-blind Period|Lack of Efficacy|0|||
131699345|NCT02574637|474183252|FG008|Double-blind Period|Lack of Efficacy|0|||
131699346|NCT02574637|474183253|FG009|Double-blind Period|Lack of Efficacy|0|||
131699347|NCT02574637|474183244|FG000|Double-blind Period|Protocol Deviation|1|||
131699348|NCT02574637|474183245|FG001|Double-blind Period|Protocol Deviation|0|||
131699349|NCT02574637|474183246|FG002|Double-blind Period|Protocol Deviation|0|||
131699350|NCT02574637|474183247|FG003|Double-blind Period|Protocol Deviation|0|||
131699351|NCT02574637|474183248|FG004|Double-blind Period|Protocol Deviation|0|||
131699352|NCT02574637|474183249|FG005|Double-blind Period|Protocol Deviation|0|||
131699353|NCT02574637|474183250|FG006|Double-blind Period|Protocol Deviation|0|||
131699354|NCT02574637|474183251|FG007|Double-blind Period|Protocol Deviation|0|||
131699355|NCT02574637|474183252|FG008|Double-blind Period|Protocol Deviation|0|||
131699356|NCT02574637|474183253|FG009|Double-blind Period|Protocol Deviation|0|||
131699357|NCT02574637|474183244|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
131699358|NCT02574637|474183245|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
131699359|NCT02574637|474183246|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
131699360|NCT02574637|474183247|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
131699361|NCT02574637|474183248|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
131699362|NCT02574637|474183249|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
131699363|NCT02574637|474183250|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
131699364|NCT02574637|474183251|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
131699365|NCT02574637|474183252|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
131699366|NCT02574637|474183253|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
131699367|NCT02574637|474183244|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
131699368|NCT02574637|474183245|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
131699369|NCT02574637|474183246|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
131699370|NCT02574637|474183247|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
131699371|NCT02574637|474183248|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
131699372|NCT02574637|474183249|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
131699373|NCT02574637|474183250|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
131699374|NCT02574637|474183251|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
131699375|NCT02574637|474183252|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
131699376|NCT02574637|474183253|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
131699377|NCT02574637|474183244|FG000|Double-blind Period|Reason Not Specified|0|||
131699378|NCT02574637|474183245|FG001|Double-blind Period|Reason Not Specified|0|||
131699379|NCT02574637|474183246|FG002|Double-blind Period|Reason Not Specified|0|||
131699380|NCT02574637|474183247|FG003|Double-blind Period|Reason Not Specified|1|||
131574015|NCT01313182|473727277|FG001|Overall Study|Protocol Violation|92|||
131574016|NCT00957229|473727279|FG000|Study Start|Adverse Event|0|||
131574017|NCT00957229|473727280|FG001|Study Start|Adverse Event|3|||
131574018|NCT00957229|473727279|FG000|Study Start|Disease Progression|1|||
131574019|NCT00957229|473727280|FG001|Study Start|Disease Progression|0|||
131574020|NCT00957229|473727279|FG000|Reallocated to or Continued Vismodegib|Death|1|||
131574021|NCT00957229|473727280|FG001|Reallocated to or Continued Vismodegib|Death|1|||
131574022|NCT00957229|473727279|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
131574023|NCT00957229|473727280|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
131574024|NCT04580303|473727281|FG000|Overall Study|Adverse Event|0|||
131574025|NCT04580303|473727282|FG001|Overall Study|Adverse Event|1|||
131574026|NCT04580303|473727283|FG002|Overall Study|Adverse Event|0|||
131574027|NCT04580303|473727284|FG003|Overall Study|Adverse Event|0|||
131574028|NCT04580303|473727281|FG000|Overall Study|Withdrawal by Subject|0|||
131574029|NCT04580303|473727282|FG001|Overall Study|Withdrawal by Subject|0|||
131574030|NCT04580303|473727283|FG002|Overall Study|Withdrawal by Subject|1|||
131574031|NCT04580303|473727284|FG003|Overall Study|Withdrawal by Subject|0|||
131574032|NCT04044664|473727295|FG000|Stage 1|Adverse Event|3|||
131574033|NCT04044664|473727296|FG001|Stage 1|Adverse Event|3|||
131574034|NCT04044664|473727297|FG002|Stage 1|Adverse Event|1|||
131574035|NCT04044664|473727295|FG000|Stage 1|Lost to Follow-up|3|||
131574036|NCT04044664|473727296|FG001|Stage 1|Lost to Follow-up|2|||
131574037|NCT04044664|473727297|FG002|Stage 1|Lost to Follow-up|2|||
131574038|NCT04044664|473727295|FG000|Stage 1|Withdrawal by Subject|9|||
131574039|NCT04044664|473727296|FG001|Stage 1|Withdrawal by Subject|1|||
131574040|NCT04044664|473727297|FG002|Stage 1|Withdrawal by Subject|0|||
131574041|NCT04044664|473727295|FG000|Stage 1|noncompliance, personal reason|2|||
131574042|NCT04044664|473727296|FG001|Stage 1|noncompliance, personal reason|0|||
131574043|NCT04044664|473727297|FG002|Stage 1|noncompliance, personal reason|0|||
131574044|NCT04044664|473727295|FG000|Stage 1|randomization error|0|||
131574045|NCT04044664|473727296|FG001|Stage 1|randomization error|1|||
131574046|NCT04044664|473727297|FG002|Stage 1|randomization error|0|||
131574047|NCT04044664|473727295|FG000|Stage 2|Adverse Event|2|||
131574048|NCT04044664|473727296|FG001|Stage 2|Adverse Event|0|||
131574049|NCT04044664|473727297|FG002|Stage 2|Adverse Event|0|||
131574050|NCT04044664|473727295|FG000|Stage 2|Lost to Follow-up|3|||
131574051|NCT04044664|473727296|FG001|Stage 2|Lost to Follow-up|2|||
131574052|NCT04044664|473727297|FG002|Stage 2|Lost to Follow-up|1|||
131574053|NCT04044664|473727295|FG000|Stage 2|Withdrawal by Subject|3|||
131574054|NCT04044664|473727296|FG001|Stage 2|Withdrawal by Subject|0|||
131574055|NCT04044664|473727297|FG002|Stage 2|Withdrawal by Subject|0|||
131574056|NCT04044664|473727295|FG000|Stage 2|protocol deviation|1|||
131574057|NCT04044664|473727296|FG001|Stage 2|protocol deviation|0|||
131574058|NCT04044664|473727297|FG002|Stage 2|protocol deviation|0|||
131574059|NCT03736785|473727298|FG000|Overall Study|Adverse Event|1|||
131574060|NCT03736785|473727299|FG001|Overall Study|Adverse Event|1|||
131574061|NCT03736785|473727300|FG002|Overall Study|Adverse Event|1|||
131574062|NCT03736785|473727298|FG000|Overall Study|Death|1|||
131574063|NCT03736785|473727299|FG001|Overall Study|Death|0|||
131574064|NCT03736785|473727300|FG002|Overall Study|Death|1|||
131574065|NCT03736785|473727298|FG000|Overall Study|Lost to Follow-up|0|||
131574066|NCT03736785|473727299|FG001|Overall Study|Lost to Follow-up|2|||
131574067|NCT03736785|473727300|FG002|Overall Study|Lost to Follow-up|3|||
131574068|NCT03736785|473727298|FG000|Overall Study|Non compliance with study drug|1|||
131574069|NCT03736785|473727299|FG001|Overall Study|Non compliance with study drug|1|||
131574070|NCT03736785|473727300|FG002|Overall Study|Non compliance with study drug|0|||
131574071|NCT03736785|473727298|FG000|Overall Study|Physician Decision|0|||
131574072|NCT03736785|473727299|FG001|Overall Study|Physician Decision|1|||
131574073|NCT03736785|473727300|FG002|Overall Study|Physician Decision|1|||
131574074|NCT03736785|473727298|FG000|Overall Study|Protocol Violation|1|||
131574075|NCT03736785|473727299|FG001|Overall Study|Protocol Violation|4|||
131574076|NCT03736785|473727300|FG002|Overall Study|Protocol Violation|3|||
131574077|NCT03736785|473727298|FG000|Overall Study|Sponsor Decision|1|||
131574078|NCT03736785|473727299|FG001|Overall Study|Sponsor Decision|0|||
131574079|NCT03736785|473727300|FG002|Overall Study|Sponsor Decision|0|||
131574080|NCT03736785|473727298|FG000|Overall Study|Unknown/Missing data|3|||
131574081|NCT03736785|473727299|FG001|Overall Study|Unknown/Missing data|2|||
131574082|NCT03736785|473727300|FG002|Overall Study|Unknown/Missing data|1|||
131574083|NCT03736785|473727298|FG000|Overall Study|Withdrawal by Subject|9|||
131574084|NCT03736785|473727299|FG001|Overall Study|Withdrawal by Subject|6|||
131574085|NCT03736785|473727300|FG002|Overall Study|Withdrawal by Subject|4|||
131574086|NCT02701361|473727303|FG000|Overall Study|Lost to Follow-up|5|||
131574087|NCT02701361|473727304|FG001|Overall Study|Lost to Follow-up|2|||
131574088|NCT02701361|473727305|FG002|Overall Study|Lost to Follow-up|1|||
131574089|NCT02701361|473727303|FG000|Overall Study|Withdrawal by Subject|4|||
131574090|NCT02701361|473727304|FG001|Overall Study|Withdrawal by Subject|0|||
131574091|NCT02701361|473727305|FG002|Overall Study|Withdrawal by Subject|0|||
131574092|NCT02701361|473727303|FG000|Overall Study|timed out in rehab center|0|||
131574093|NCT02701361|473727304|FG001|Overall Study|timed out in rehab center|1|||
131574094|NCT02701361|473727305|FG002|Overall Study|timed out in rehab center|0|||
131574095|NCT02701361|473727303|FG000|Overall Study|incarceration|0|||
131574096|NCT02701361|473727304|FG001|Overall Study|incarceration|0|||
131574097|NCT02701361|473727305|FG002|Overall Study|incarceration|1|||
131574098|NCT04588480|473727306|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
131574099|NCT04588480|473727307|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
131574100|NCT04588480|473727308|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
131574101|NCT04588480|473727306|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
131574102|NCT04588480|473727307|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
131574103|NCT04588480|473727308|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
131574104|NCT02750709|473727309|FG000|Treatment Period 1|Adverse Event|0|||
131574105|NCT02750709|473727310|FG001|Treatment Period 1|Adverse Event|0|||
131574106|NCT02750709|473727311|FG002|Treatment Period 1|Adverse Event|0|||
131574107|NCT02750709|473727312|FG003|Treatment Period 1|Adverse Event|0|||
131574108|NCT02750709|473727313|FG004|Treatment Period 1|Adverse Event|0|||
131574109|NCT02750709|473727314|FG005|Treatment Period 1|Adverse Event|1|||
131574110|NCT00290732|473727316|FG000|Overall Study|Inability to instill drug intraductally.|0|||
131574111|NCT00290732|473727317|FG001|Overall Study|Inability to instill drug intraductally.|1|||
131574112|NCT00290732|473727318|FG002|Overall Study|Inability to instill drug intraductally.|1|||
131574113|NCT00290732|473727319|FG003|Overall Study|Inability to instill drug intraductally.|0|||
131574114|NCT00290732|473727320|FG004|Overall Study|Inability to instill drug intraductally.|0|||
131574115|NCT02595398|473727321|FG000|Overall Study|Non-compliance|1|||
131574116|NCT02595398|473727322|FG001|Overall Study|Non-compliance|0|||
131574117|NCT02595398|473727321|FG000|Overall Study|Withdrawal by Subject|2|||
131574118|NCT02595398|473727322|FG001|Overall Study|Withdrawal by Subject|1|||
131574119|NCT02595398|473727321|FG000|Overall Study|Lost to Follow-up|1|||
131574120|NCT02595398|473727322|FG001|Overall Study|Lost to Follow-up|0|||
131574121|NCT00843193|473727323|FG000|Overall Study|Adverse Event|2|||
131574122|NCT00843193|473727324|FG001|Overall Study|Adverse Event|4|||
131574123|NCT00843193|473727323|FG000|Overall Study|Lack of Efficacy|1|||
131574124|NCT00843193|473727324|FG001|Overall Study|Lack of Efficacy|1|||
131574125|NCT00843193|473727323|FG000|Overall Study|Protocol Violation|1|||
131574126|NCT00843193|473727324|FG001|Overall Study|Protocol Violation|2|||
131574127|NCT00843193|473727323|FG000|Overall Study|Lost to Follow-up|1|||
131574128|NCT00843193|473727324|FG001|Overall Study|Lost to Follow-up|0|||
131574129|NCT00843193|473727323|FG000|Overall Study|Physician Decision|0|||
131574130|NCT00843193|473727324|FG001|Overall Study|Physician Decision|1|||
131574131|NCT00843193|473727323|FG000|Overall Study|Withdrawal by Subject|3|||
131574132|NCT00843193|473727324|FG001|Overall Study|Withdrawal by Subject|3|||
131574133|NCT00542386|473727325|FG000|Overall Study|Adverse Event|1|||
131574134|NCT00542386|473727326|FG001|Overall Study|Adverse Event|7|||
131574135|NCT00542386|473727327|FG002|Overall Study|Adverse Event|7|||
131574136|NCT00542386|473727328|FG003|Overall Study|Adverse Event|8|||
131574137|NCT00542386|473727329|FG004|Overall Study|Adverse Event|13|||
131574138|NCT00542386|473727330|FG005|Overall Study|Adverse Event|4|||
131574139|NCT00542386|473727325|FG000|Overall Study|Death|0|||
131574140|NCT00542386|473727326|FG001|Overall Study|Death|0|||
131574141|NCT00542386|473727327|FG002|Overall Study|Death|1|||
131574142|NCT00542386|473727328|FG003|Overall Study|Death|2|||
131574143|NCT00542386|473727329|FG004|Overall Study|Death|1|||
131574144|NCT00542386|473727330|FG005|Overall Study|Death|2|||
131574145|NCT00542386|473727325|FG000|Overall Study|Lack of Efficacy|32|||
131574146|NCT00542386|473727326|FG001|Overall Study|Lack of Efficacy|12|||
131574147|NCT00542386|473727327|FG002|Overall Study|Lack of Efficacy|10|||
131574148|NCT00542386|473727328|FG003|Overall Study|Lack of Efficacy|13|||
131574149|NCT00542386|473727329|FG004|Overall Study|Lack of Efficacy|7|||
131574150|NCT00542386|473727330|FG005|Overall Study|Lack of Efficacy|31|||
131574151|NCT00542386|473727325|FG000|Overall Study|Physician Decision|1|||
131574152|NCT00542386|473727326|FG001|Overall Study|Physician Decision|0|||
131574153|NCT00542386|473727327|FG002|Overall Study|Physician Decision|0|||
131574154|NCT00542386|473727328|FG003|Overall Study|Physician Decision|1|||
131574155|NCT00542386|473727329|FG004|Overall Study|Physician Decision|0|||
131574156|NCT00542386|473727330|FG005|Overall Study|Physician Decision|0|||
131574157|NCT00542386|473727325|FG000|Overall Study|Protocol Violation|0|||
131574158|NCT00542386|473727326|FG001|Overall Study|Protocol Violation|0|||
131574159|NCT00542386|473727327|FG002|Overall Study|Protocol Violation|1|||
131574160|NCT00542386|473727328|FG003|Overall Study|Protocol Violation|0|||
131574161|NCT00542386|473727329|FG004|Overall Study|Protocol Violation|0|||
131574162|NCT00542386|473727330|FG005|Overall Study|Protocol Violation|4|||
131574163|NCT00542386|473727325|FG000|Overall Study|Withdrawal by Subject|5|||
131574164|NCT00542386|473727326|FG001|Overall Study|Withdrawal by Subject|8|||
131574165|NCT00542386|473727327|FG002|Overall Study|Withdrawal by Subject|10|||
131574166|NCT00542386|473727328|FG003|Overall Study|Withdrawal by Subject|11|||
131574167|NCT00542386|473727329|FG004|Overall Study|Withdrawal by Subject|15|||
131785251|NCT01066039|474496794|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
131574168|NCT00542386|473727330|FG005|Overall Study|Withdrawal by Subject|7|||
131574169|NCT00542386|473727325|FG000|Overall Study|Other Reasons|4|||
131785252|NCT01066039|474496794|FG000|Overall Study|Failure to Control Blood Pressure|1|||
131785253|NCT01066039|474496794|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
131574170|NCT00542386|473727326|FG001|Overall Study|Other Reasons|1|||
131785254|NCT02574260|474496795|FG000|Overall Study|Disease Progression|1|||
131785255|NCT00084617|474496805|FG000|Overall Study|Withdrawal by Subject|7|||
131574171|NCT00542386|473727327|FG002|Overall Study|Other Reasons|4|||
131574172|NCT00542386|473727328|FG003|Overall Study|Other Reasons|3|||
131574173|NCT00542386|473727329|FG004|Overall Study|Other Reasons|4|||
131574174|NCT00542386|473727330|FG005|Overall Study|Other Reasons|2|||
131574175|NCT00197015|473727331|FG000|Overall Study|Adverse Event|3|||
131574176|NCT00197015|473727332|FG001|Overall Study|Adverse Event|0|||
131574177|NCT00197015|473727333|FG002|Overall Study|Adverse Event|1|||
131574178|NCT00197015|473727331|FG000|Overall Study|Protocol Violation|0|||
131574179|NCT00197015|473727332|FG001|Overall Study|Protocol Violation|3|||
131574180|NCT00197015|473727333|FG002|Overall Study|Protocol Violation|3|||
131574181|NCT00197015|473727331|FG000|Overall Study|Withdrawal by Subject|17|||
131574182|NCT00197015|473727332|FG001|Overall Study|Withdrawal by Subject|37|||
131574183|NCT00197015|473727333|FG002|Overall Study|Withdrawal by Subject|34|||
131574184|NCT00197015|473727331|FG000|Overall Study|Lost to Follow-up|28|||
131574185|NCT00197015|473727332|FG001|Overall Study|Lost to Follow-up|46|||
131574186|NCT00197015|473727333|FG002|Overall Study|Lost to Follow-up|37|||
131574187|NCT00197015|473727331|FG000|Overall Study|Other|2|||
131574188|NCT00197015|473727332|FG001|Overall Study|Other|3|||
131574189|NCT00197015|473727333|FG002|Overall Study|Other|2|||
131574190|NCT00544440|473727336|FG000|Overall Study|Other|1|||
131574191|NCT00544440|473727336|FG000|Overall Study|Adverse Event|1|||
131699381|NCT02574637|474183248|FG004|Double-blind Period|Reason Not Specified|0|||
131699382|NCT02574637|474183249|FG005|Double-blind Period|Reason Not Specified|0|||
131699383|NCT02574637|474183250|FG006|Double-blind Period|Reason Not Specified|0|||
131699384|NCT02574637|474183251|FG007|Double-blind Period|Reason Not Specified|0|||
131699385|NCT02574637|474183252|FG008|Double-blind Period|Reason Not Specified|0|||
131699386|NCT02574637|474183253|FG009|Double-blind Period|Reason Not Specified|0|||
131574192|NCT00544440|473727336|FG000|Overall Study|Withdrawal by Subject|2|||
131574193|NCT00544440|473727336|FG000|Overall Study|Subject Non-compliance|1|||
131574194|NCT00544440|473727336|FG000|Overall Study|Progressive Disease|47|||
131574195|NCT00544440|473727336|FG000|Overall Study|Other|5|||
131574196|NCT01549652|473727337|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
131574197|NCT01549652|473727338|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
131574198|NCT01549652|473727339|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
131574199|NCT01549652|473727340|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
131574200|NCT01549652|473727337|FG000|Overall Study|Study Drug Titration Failure|5|||
131574201|NCT01549652|473727338|FG001|Overall Study|Study Drug Titration Failure|6|||
131699387|NCT02574637|474183244|FG000|Open-label (OL) Period|Adverse Event|0|||
131699388|NCT02574637|474183245|FG001|Open-label (OL) Period|Adverse Event|0|||
131699389|NCT02574637|474183246|FG002|Open-label (OL) Period|Adverse Event|0|||
131699390|NCT02574637|474183247|FG003|Open-label (OL) Period|Adverse Event|0|||
131699391|NCT02574637|474183248|FG004|Open-label (OL) Period|Adverse Event|0|||
131699392|NCT02574637|474183249|FG005|Open-label (OL) Period|Adverse Event|0|||
131699393|NCT02574637|474183250|FG006|Open-label (OL) Period|Adverse Event|0|||
131699394|NCT02574637|474183251|FG007|Open-label (OL) Period|Adverse Event|0|||
131699395|NCT02574637|474183252|FG008|Open-label (OL) Period|Adverse Event|1|||
131699396|NCT02574637|474183253|FG009|Open-label (OL) Period|Adverse Event|0|||
131699397|NCT02574637|474183244|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
131699398|NCT02574637|474183245|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
131699399|NCT02574637|474183246|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
131699400|NCT02574637|474183247|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
131699401|NCT02574637|474183248|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
131699402|NCT02574637|474183249|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
131699403|NCT02574637|474183250|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
131699404|NCT02574637|474183251|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
131699405|NCT02574637|474183252|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
131699406|NCT02574637|474183253|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
131699407|NCT02574637|474183244|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131699408|NCT02574637|474183245|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131699409|NCT02574637|474183246|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131699410|NCT02574637|474183247|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131699411|NCT02574637|474183248|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131699412|NCT02574637|474183249|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
131699413|NCT02574637|474183250|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
131699414|NCT02574637|474183251|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
131699415|NCT02574637|474183252|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
131699416|NCT02574637|474183253|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131574202|NCT01549652|473727339|FG002|Overall Study|Study Drug Titration Failure|0|||
131574203|NCT01549652|473727340|FG003|Overall Study|Study Drug Titration Failure|0|||
131574204|NCT01549652|473727337|FG000|Overall Study|Withdrawal Effect|0|||
131574205|NCT01549652|473727338|FG001|Overall Study|Withdrawal Effect|2|||
131574206|NCT01549652|473727339|FG002|Overall Study|Withdrawal Effect|0|||
131574207|NCT01549652|473727340|FG003|Overall Study|Withdrawal Effect|0|||
131699417|NCT04016311|474183254|FG000|Overall Study|Withdrawal by Subject|1|||
131785256|NCT00084617|474496805|FG000|Overall Study|Lack of Efficacy|1|||
131574208|NCT01549652|473727337|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
131574209|NCT01549652|473727338|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
131574210|NCT01549652|473727339|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
131574211|NCT01549652|473727340|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
131574212|NCT01549652|473727337|FG000|Overall Study|Problem with Infusion|1|||
131574213|NCT01549652|473727338|FG001|Overall Study|Problem with Infusion|0|||
131574214|NCT01549652|473727339|FG002|Overall Study|Problem with Infusion|0|||
131574215|NCT01549652|473727340|FG003|Overall Study|Problem with Infusion|0|||
131574216|NCT01549652|473727337|FG000|Overall Study|Titration Non-Compliance|1|||
131574217|NCT01549652|473727338|FG001|Overall Study|Titration Non-Compliance|3|||
131574218|NCT01549652|473727339|FG002|Overall Study|Titration Non-Compliance|4|||
131574219|NCT01549652|473727340|FG003|Overall Study|Titration Non-Compliance|5|||
131574220|NCT01549652|473727337|FG000|Overall Study|Titration Side Effects|0|||
131574221|NCT01549652|473727338|FG001|Overall Study|Titration Side Effects|0|||
131574222|NCT01549652|473727339|FG002|Overall Study|Titration Side Effects|6|||
131574223|NCT01549652|473727340|FG003|Overall Study|Titration Side Effects|3|||
131574224|NCT01549652|473727337|FG000|Overall Study|Withdrawal by Subject|0|||
131574225|NCT01549652|473727338|FG001|Overall Study|Withdrawal by Subject|0|||
131574226|NCT01549652|473727339|FG002|Overall Study|Withdrawal by Subject|5|||
131574227|NCT01549652|473727340|FG003|Overall Study|Withdrawal by Subject|3|||
131574228|NCT01081145|473727353|FG000|Open-Label Phase|Lack of Efficacy|56|||
131574229|NCT01081145|473727354|FG001|Open-Label Phase|Lack of Efficacy|0|||
131574230|NCT01081145|473727353|FG000|Open-Label Phase|Response criteria not met|46|||
131574231|NCT01081145|473727354|FG001|Open-Label Phase|Response criteria not met|0|||
131574232|NCT01081145|473727353|FG000|Open-Label Phase|Adverse Event|42|||
131574233|NCT01081145|473727354|FG001|Open-Label Phase|Adverse Event|0|||
131574234|NCT01081145|473727353|FG000|Open-Label Phase|Withdrawal by Subject|41|||
131574235|NCT01081145|473727354|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131574236|NCT01081145|473727353|FG000|Open-Label Phase|Other|12|||
131574237|NCT01081145|473727354|FG001|Open-Label Phase|Other|0|||
131574238|NCT01081145|473727353|FG000|Open-Label Phase|Lost to Follow-up|11|||
131574239|NCT01081145|473727354|FG001|Open-Label Phase|Lost to Follow-up|0|||
131574240|NCT01081145|473727353|FG000|Open-Label Phase|Protocol Violation|4|||
131574241|NCT01081145|473727354|FG001|Open-Label Phase|Protocol Violation|0|||
131574242|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
131574243|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
131574244|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
131574245|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
131574246|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
131574247|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
131574248|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
131574249|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
131574250|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
131574251|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
131574252|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
131574253|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
131574254|NCT01081145|473727353|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
131574255|NCT01081145|473727354|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
131574256|NCT00988637|473727356|FG000|Overall Study|Lost to Follow-up|2|||
131574257|NCT00988637|473727357|FG001|Overall Study|Lost to Follow-up|1|||
131574258|NCT00988637|473727356|FG000|Overall Study|Withdrawal by Subject|1|||
131574259|NCT00988637|473727357|FG001|Overall Study|Withdrawal by Subject|1|||
131574260|NCT00988637|473727356|FG000|Overall Study|non-compliance with study drug|0|||
131574261|NCT00988637|473727357|FG001|Overall Study|non-compliance with study drug|1|||
131699418|NCT04016311|474183255|FG001|Overall Study|Withdrawal by Subject|0|||
131574262|NCT03593070|473727358|FG000|Overall Study|administrative withdrawal|1|||
131574263|NCT03593070|473727359|FG001|Overall Study|administrative withdrawal|1|||
131574264|NCT01582945|473727360|FG000|Overall Study|Intolerable side-effects|1|||
131574265|NCT01582945|473727360|FG000|Overall Study|Scheduling conflicts|1|||
131574266|NCT04536077|473727361|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
131574267|NCT04536077|473727362|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
131574268|NCT04536077|473727361|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
131574269|NCT04536077|473727362|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
131574270|NCT02197234|473727365|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
131574271|NCT02197234|473727365|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
131574272|NCT02197234|473727365|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
131574273|NCT02197234|473727365|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
131574274|NCT02197234|473727365|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
131699419|NCT02064387|474183256|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131785257|NCT00084617|474496805|FG000|Overall Study|Protocol Violation|1|||
131574275|NCT02197234|473727365|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
131574276|NCT01543685|473727366|FG000|Overall Study|Lack of Efficacy|1|||
131574277|NCT01543685|473727367|FG001|Overall Study|Lack of Efficacy|2|||
131574278|NCT01543685|473727368|FG002|Overall Study|Lack of Efficacy|2|||
131574279|NCT01543685|473727369|FG003|Overall Study|Lack of Efficacy|0|||
131574280|NCT01543685|473727370|FG004|Overall Study|Lack of Efficacy|2|||
131574281|NCT01543685|473727366|FG000|Overall Study|Adverse Event|2|||
131574282|NCT01543685|473727367|FG001|Overall Study|Adverse Event|1|||
131574283|NCT01543685|473727368|FG002|Overall Study|Adverse Event|0|||
131574284|NCT01543685|473727369|FG003|Overall Study|Adverse Event|0|||
131574285|NCT01543685|473727370|FG004|Overall Study|Adverse Event|2|||
131574286|NCT02163915|473727371|FG000|Overall Study|Withdrawal by Subject|2|||
131574287|NCT02163915|473727372|FG001|Overall Study|Withdrawal by Subject|0|||
131574288|NCT02163915|473727373|FG002|Overall Study|Withdrawal by Subject|2|||
131574289|NCT02163915|473727374|FG003|Overall Study|Withdrawal by Subject|2|||
131574290|NCT02163915|473727375|FG004|Overall Study|Withdrawal by Subject|2|||
131574291|NCT02163915|473727371|FG000|Overall Study|Study termination|1|||
131574292|NCT02163915|473727372|FG001|Overall Study|Study termination|0|||
131574293|NCT02163915|473727373|FG002|Overall Study|Study termination|0|||
131574294|NCT02163915|473727374|FG003|Overall Study|Study termination|0|||
131574295|NCT02163915|473727375|FG004|Overall Study|Study termination|2|||
131574296|NCT02163915|473727371|FG000|Overall Study|Physician Decision|0|||
131574297|NCT02163915|473727372|FG001|Overall Study|Physician Decision|0|||
131574298|NCT02163915|473727373|FG002|Overall Study|Physician Decision|0|||
131574299|NCT02163915|473727374|FG003|Overall Study|Physician Decision|1|||
131574300|NCT02163915|473727375|FG004|Overall Study|Physician Decision|0|||
131574301|NCT02931396|473727376|FG000|Overall Study|Lost to Follow-up|3|||
131574302|NCT02931396|473727377|FG001|Overall Study|Lost to Follow-up|0|||
131574303|NCT02931396|473727376|FG000|Overall Study|Withdrawal by Subject|2|||
131574304|NCT02931396|473727377|FG001|Overall Study|Withdrawal by Subject|0|||
131574305|NCT01838200|473727382|FG000|Overall Study|Adverse Event|0|||
131574306|NCT01838200|473727383|FG001|Overall Study|Adverse Event|2|||
131574307|NCT01838200|473727382|FG000|Overall Study|Progressive disease|3|||
131574308|NCT01838200|473727383|FG001|Overall Study|Progressive disease|0|||
131574309|NCT01311648|473728933|FG000|Main Study|Protocol Violation|0|||
131574310|NCT01311648|473728934|FG001|Main Study|Protocol Violation|1|||
131574311|NCT01311648|473728933|FG000|Main Study|Adverse Event|0|||
131574312|NCT01311648|473728934|FG001|Main Study|Adverse Event|1|||
131574313|NCT01311648|473728933|FG000|Main Study|Inhibitor management|0|||
131574314|NCT01311648|473728934|FG001|Main Study|Inhibitor management|17|||
131574315|NCT01311648|473728933|FG000|Main Study|Withdrawal by Subject|0|||
131574316|NCT01311648|473728934|FG001|Main Study|Withdrawal by Subject|2|||
131574317|NCT01311648|473728933|FG000|Extension Study|Physician Decision|0|||
131574318|NCT01311648|473728934|FG001|Extension Study|Physician Decision|1|||
131574319|NCT01311648|473728933|FG000|Extension Study|ITI therapy with marketed product|0|||
131574320|NCT01311648|473728934|FG001|Extension Study|ITI therapy with marketed product|1|||
131574321|NCT01311648|473728933|FG000|Extension Study|Incorrect visit planning|0|||
131574322|NCT01311648|473728934|FG001|Extension Study|Incorrect visit planning|1|||
131574323|NCT01311648|473728933|FG000|Extension Study|Family's decision|0|||
131574324|NCT01311648|473728934|FG001|Extension Study|Family's decision|1|||
131574325|NCT01311648|473728933|FG000|Extension Study|Failure of ITI therapy|0|||
131574326|NCT01311648|473728934|FG001|Extension Study|Failure of ITI therapy|3|||
131574327|NCT01311648|473728933|FG000|Extension Study|Long travel|0|||
131574328|NCT01311648|473728934|FG001|Extension Study|Long travel|1|||
131574329|NCT01311648|473728933|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
131574330|NCT01311648|473728934|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
131574331|NCT01311648|473728933|FG000|Extension Study|Withdrawal by Subject|0|||
131574332|NCT01311648|473728934|FG001|Extension Study|Withdrawal by Subject|1|||
131574333|NCT01311648|473728933|FG000|Extension Study|Inhibitor management|0|||
131574334|NCT01311648|473728934|FG001|Extension Study|Inhibitor management|2|||
131574335|NCT04057196|473728935|FG000|Overall Study|Withdrawal by Subject|3|||
131574336|NCT04057196|473728935|FG000|Overall Study|Death|3|||
131574337|NCT02466516|473728937|FG000|Overall Study|Adverse Event|1|||
131574338|NCT02466516|473728938|FG001|Overall Study|Adverse Event|1|||
131574339|NCT02466516|473728939|FG002|Overall Study|Adverse Event|0|||
131574340|NCT02466516|473728940|FG003|Overall Study|Adverse Event|0|||
131574341|NCT02466516|473728941|FG004|Overall Study|Adverse Event|0|||
131574342|NCT02466516|473728937|FG000|Overall Study|Withdrew Consent|1|||
131574343|NCT02466516|473728938|FG001|Overall Study|Withdrew Consent|0|||
131574344|NCT02466516|473728939|FG002|Overall Study|Withdrew Consent|0|||
131574345|NCT02466516|473728940|FG003|Overall Study|Withdrew Consent|0|||
131574346|NCT02466516|473728941|FG004|Overall Study|Withdrew Consent|0|||
131574347|NCT02466516|473728937|FG000|Overall Study|Lost to Follow-up|2|||
131574348|NCT02466516|473728938|FG001|Overall Study|Lost to Follow-up|0|||
131574349|NCT02466516|473728939|FG002|Overall Study|Lost to Follow-up|1|||
131574350|NCT02466516|473728940|FG003|Overall Study|Lost to Follow-up|0|||
131574351|NCT02466516|473728941|FG004|Overall Study|Lost to Follow-up|0|||
131574352|NCT03895034|473728942|FG000|Overall Study|Lost to Follow-up|2|||
131574353|NCT03712930|473728943|FG000|Overall Study|Death|7|||
131574354|NCT03712930|473728943|FG000|Overall Study|Physician Decision|1|||
131574355|NCT03712930|473728943|FG000|Overall Study|Study Terminated by Sponsor|3|||
131574356|NCT03712930|473728943|FG000|Overall Study|Progressive Disease|2|||
131574357|NCT01118377|473728944|FG000|Overall Study|Did Not Receive Study Medication|1|||
131574358|NCT01118377|473728944|FG000|Overall Study|Death|38|||
131574359|NCT01118377|473728944|FG000|Overall Study|Failure to Return|3|||
131574360|NCT03784963|473728949|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
131574361|NCT03784963|473728950|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
131574362|NCT03784963|473728951|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
131574363|NCT03784963|473728952|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
131574364|NCT03181958|473728953|FG000|Overall Study|Lost to Follow-up|17|||
131574365|NCT03181958|473728954|FG001|Overall Study|Lost to Follow-up|21|||
131574366|NCT03181958|473728955|FG002|Overall Study|Lost to Follow-up|15|||
131574367|NCT00470626|473728956|FG000|Overall Study|Lost to Follow-up|10|||
131574368|NCT00470626|473728956|FG000|Overall Study|Withdrawal by Subject|7|||
131574369|NCT01729819|473728961|FG000|Overall Study|Adverse Event|2|||
131574370|NCT01729819|473728962|FG001|Overall Study|Adverse Event|4|||
131574371|NCT01729819|473728961|FG000|Overall Study|Lack of Efficacy|1|||
131574372|NCT01729819|473728962|FG001|Overall Study|Lack of Efficacy|0|||
131574373|NCT01729819|473728961|FG000|Overall Study|Lost to Follow-up|2|||
131574374|NCT01729819|473728962|FG001|Overall Study|Lost to Follow-up|0|||
131574375|NCT01729819|473728961|FG000|Overall Study|Other reason|1|||
131574376|NCT01729819|473728962|FG001|Overall Study|Other reason|0|||
131574377|NCT01729819|473728961|FG000|Overall Study|Protocol Violation|0|||
131574378|NCT01729819|473728962|FG001|Overall Study|Protocol Violation|1|||
131574379|NCT01729819|473728961|FG000|Overall Study|Withdrawal by Subject|0|||
131574380|NCT01729819|473728962|FG001|Overall Study|Withdrawal by Subject|2|||
131574381|NCT02987543|473728965|FG000|Overall Study|Ongoing study at data cut off|49|||
131574382|NCT02987543|473728966|FG001|Overall Study|Ongoing study at data cut off|21|||
131574383|NCT02987543|473728967|FG002|Overall Study|Ongoing study at data cut off|19|||
131574384|NCT02987543|473728968|FG003|Overall Study|Ongoing study at data cut off|12|||
131785258|NCT01625286|474496806|FG000|Overall Study|Adverse Event|0|||
131785259|NCT01625286|474496807|FG001|Overall Study|Adverse Event|0|||
131785260|NCT01625286|474496808|FG002|Overall Study|Adverse Event|0|||
131785261|NCT01625286|474496809|FG003|Overall Study|Adverse Event|0|||
131785262|NCT01625286|474496810|FG004|Overall Study|Adverse Event|1|||
131785263|NCT01625286|474496811|FG005|Overall Study|Adverse Event|2|||
131785264|NCT01625286|474496812|FG006|Overall Study|Adverse Event|1|||
131785265|NCT01625286|474496806|FG000|Overall Study|Death|0|||
131785266|NCT01625286|474496807|FG001|Overall Study|Death|0|||
131785267|NCT01625286|474496808|FG002|Overall Study|Death|1|||
131785268|NCT01625286|474496809|FG003|Overall Study|Death|1|||
131785269|NCT01625286|474496810|FG004|Overall Study|Death|0|||
131785270|NCT01625286|474496811|FG005|Overall Study|Death|11|||
131785271|NCT01625286|474496812|FG006|Overall Study|Death|16|||
131785272|NCT01625286|474496806|FG000|Overall Study|Withdrawal by Subject|0|||
131785273|NCT01625286|474496807|FG001|Overall Study|Withdrawal by Subject|1|||
131785274|NCT01625286|474496808|FG002|Overall Study|Withdrawal by Subject|0|||
131785275|NCT01625286|474496809|FG003|Overall Study|Withdrawal by Subject|1|||
131785276|NCT01625286|474496810|FG004|Overall Study|Withdrawal by Subject|0|||
131785277|NCT01625286|474496811|FG005|Overall Study|Withdrawal by Subject|0|||
131785278|NCT01625286|474496812|FG006|Overall Study|Withdrawal by Subject|1|||
131785279|NCT01625286|474496806|FG000|Overall Study|Any reason not specifically recorded|0|||
131785280|NCT01625286|474496807|FG001|Overall Study|Any reason not specifically recorded|0|||
131785281|NCT01625286|474496808|FG002|Overall Study|Any reason not specifically recorded|0|||
131785282|NCT01625286|474496809|FG003|Overall Study|Any reason not specifically recorded|0|||
131785283|NCT01625286|474496810|FG004|Overall Study|Any reason not specifically recorded|0|||
131785284|NCT01625286|474496811|FG005|Overall Study|Any reason not specifically recorded|1|||
131785285|NCT01625286|474496812|FG006|Overall Study|Any reason not specifically recorded|0|||
131785286|NCT01625286|474496806|FG000|Overall Study|Progressive disease|6|||
131785287|NCT01625286|474496807|FG001|Overall Study|Progressive disease|3|||
131785288|NCT01625286|474496808|FG002|Overall Study|Progressive disease|4|||
131785289|NCT01625286|474496809|FG003|Overall Study|Progressive disease|5|||
131785290|NCT01625286|474496810|FG004|Overall Study|Progressive disease|5|||
131785291|NCT01625286|474496811|FG005|Overall Study|Progressive disease|0|||
131574385|NCT02987543|473728965|FG000|Overall Study|Death|88|||
131785292|NCT01625286|474496812|FG006|Overall Study|Progressive disease|0|||
131785293|NCT01625286|474496806|FG000|Overall Study|Lost to Follow-up|0|||
131574386|NCT02987543|473728966|FG001|Overall Study|Death|54|||
131574387|NCT02987543|473728967|FG002|Overall Study|Death|67|||
131574388|NCT02987543|473728968|FG003|Overall Study|Death|28|||
131574389|NCT02987543|473728965|FG000|Overall Study|Lost to Follow-up|3|||
131785294|NCT01625286|474496807|FG001|Overall Study|Lost to Follow-up|0|||
131785295|NCT01625286|474496808|FG002|Overall Study|Lost to Follow-up|0|||
131785296|NCT01625286|474496809|FG003|Overall Study|Lost to Follow-up|0|||
131785297|NCT01625286|474496810|FG004|Overall Study|Lost to Follow-up|0|||
131574390|NCT02987543|473728966|FG001|Overall Study|Lost to Follow-up|0|||
131574391|NCT02987543|473728967|FG002|Overall Study|Lost to Follow-up|1|||
131574392|NCT02987543|473728968|FG003|Overall Study|Lost to Follow-up|0|||
131574393|NCT02987543|473728965|FG000|Overall Study|Screen failure|0|||
131574394|NCT02987543|473728966|FG001|Overall Study|Screen failure|0|||
131574395|NCT02987543|473728967|FG002|Overall Study|Screen failure|0|||
131574396|NCT02987543|473728968|FG003|Overall Study|Screen failure|1|||
131574397|NCT02987543|473728965|FG000|Overall Study|Withdrawal by Subject|21|||
131574398|NCT02987543|473728966|FG001|Overall Study|Withdrawal by Subject|7|||
131574399|NCT02987543|473728967|FG002|Overall Study|Withdrawal by Subject|7|||
131574400|NCT02987543|473728968|FG003|Overall Study|Withdrawal by Subject|6|||
131574401|NCT02987543|473728965|FG000|Overall Study|Study terminated by sponsor|1|||
131574402|NCT02987543|473728966|FG001|Overall Study|Study terminated by sponsor|0|||
131574403|NCT02987543|473728967|FG002|Overall Study|Study terminated by sponsor|0|||
131574404|NCT02987543|473728968|FG003|Overall Study|Study terminated by sponsor|0|||
131574405|NCT02987543|473728965|FG000|Overall Study|Investigator decision|0|||
131574406|NCT02987543|473728966|FG001|Overall Study|Investigator decision|1|||
131574407|NCT02987543|473728967|FG002|Overall Study|Investigator decision|0|||
131574408|NCT02987543|473728968|FG003|Overall Study|Investigator decision|0|||
131574409|NCT02987543|473728965|FG000|Overall Study|Disease progression|0|||
131574410|NCT02987543|473728966|FG001|Overall Study|Disease progression|0|||
131574411|NCT02987543|473728967|FG002|Overall Study|Disease progression|0|||
131574412|NCT02987543|473728968|FG003|Overall Study|Disease progression|1|||
131574413|NCT01883492|473728971|FG000|Overall Study|Lost to Follow-up|3|||
131574414|NCT01883492|473728972|FG001|Overall Study|Lost to Follow-up|4|||
131574415|NCT01883492|473728971|FG000|Overall Study|Surgery on contra-lateral hip|0|||
131574416|NCT01883492|473728972|FG001|Overall Study|Surgery on contra-lateral hip|1|||
131574417|NCT01883492|473728971|FG000|Overall Study|Poor X-ray quality|7|||
131574418|NCT01883492|473728972|FG001|Overall Study|Poor X-ray quality|4|||
131574419|NCT01883492|473728971|FG000|Overall Study|Withdrawal by Subject|1|||
131574420|NCT01883492|473728972|FG001|Overall Study|Withdrawal by Subject|0|||
131574421|NCT01883492|473728971|FG000|Overall Study|inappropriate implant used|1|||
131574422|NCT01883492|473728972|FG001|Overall Study|inappropriate implant used|1|||
131574423|NCT01883492|473728971|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
131574424|NCT01883492|473728972|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
131574425|NCT01259102|473728973|FG000|Overall Study|Adverse Event|1|||
131574426|NCT01259102|473728974|FG001|Overall Study|Adverse Event|0|||
131574427|NCT01259102|473728975|FG002|Overall Study|Adverse Event|1|||
131574428|NCT01259102|473728976|FG003|Overall Study|Adverse Event|1|||
131574429|NCT01259102|473728977|FG004|Overall Study|Adverse Event|0|||
131574430|NCT01259102|473728973|FG000|Overall Study|Other|0|||
131574431|NCT01259102|473728974|FG001|Overall Study|Other|0|||
131574432|NCT01259102|473728975|FG002|Overall Study|Other|1|||
131574433|NCT01259102|473728976|FG003|Overall Study|Other|1|||
131574434|NCT01259102|473728977|FG004|Overall Study|Other|1|||
131574435|NCT01803646|473728980|FG000|Overall Study|Protocol Violation|1|||
131574436|NCT01803646|473728981|FG001|Overall Study|Protocol Violation|0|||
131574437|NCT01803646|473728980|FG000|Overall Study|Adverse Event|1|||
131574438|NCT01803646|473728981|FG001|Overall Study|Adverse Event|1|||
131574439|NCT01803646|473728980|FG000|Overall Study|Withdrawal by Subject|9|||
131574440|NCT01803646|473728981|FG001|Overall Study|Withdrawal by Subject|6|||
131574441|NCT01803646|473728980|FG000|Overall Study|Randomization error|1|||
131574442|NCT01803646|473728981|FG001|Overall Study|Randomization error|2|||
131574443|NCT01803646|473728980|FG000|Overall Study|Lost to Follow-up|5|||
131574444|NCT01803646|473728981|FG001|Overall Study|Lost to Follow-up|1|||
131574445|NCT01876511|473728983|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
131574446|NCT01876511|473728984|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
131574447|NCT01876511|473728985|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
131574448|NCT01876511|473728983|FG000|Overall Study|Death (unrelated)|3|||
131574449|NCT01876511|473728984|FG001|Overall Study|Death (unrelated)|0|||
131574450|NCT01876511|473728985|FG002|Overall Study|Death (unrelated)|2|||
131699420|NCT02064387|474183257|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699421|NCT02064387|474183258|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699422|NCT02064387|474183259|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699423|NCT02064387|474183260|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699424|NCT02064387|474183261|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131437998|NCT01582061|473229465|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131574451|NCT01876511|473728983|FG000|Overall Study|Drug-related Toxicity|5|||
131574452|NCT01876511|473728984|FG001|Overall Study|Drug-related Toxicity|1|||
131574453|NCT01876511|473728985|FG002|Overall Study|Drug-related Toxicity|6|||
131574454|NCT01876511|473728983|FG000|Overall Study|Patient Decision|3|||
131699425|NCT02064387|474183262|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699426|NCT02064387|474183263|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
131574455|NCT01876511|473728984|FG001|Overall Study|Patient Decision|0|||
131574456|NCT01876511|473728985|FG002|Overall Study|Patient Decision|6|||
131574457|NCT01876511|473728983|FG000|Overall Study|Physician Decision|1|||
131574458|NCT01876511|473728984|FG001|Overall Study|Physician Decision|0|||
131699427|NCT02064387|474183264|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699428|NCT02064387|474183265|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
131699429|NCT02064387|474183266|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131699430|NCT02064387|474183267|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131437999|NCT01582061|473229464|FG000|Overall Study|Death|0|||
131699431|NCT02064387|474183256|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699432|NCT02064387|474183257|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699433|NCT02064387|474183258|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699434|NCT02064387|474183259|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699435|NCT02064387|474183260|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699436|NCT02064387|474183261|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699437|NCT02064387|474183262|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699438|NCT02064387|474183263|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
131699439|NCT02064387|474183264|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699440|NCT02064387|474183265|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699441|NCT02064387|474183266|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699442|NCT02064387|474183267|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131699443|NCT02064387|474183256|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699444|NCT02064387|474183257|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699445|NCT02064387|474183258|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699446|NCT02064387|474183259|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699447|NCT02064387|474183260|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699448|NCT02064387|474183261|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699449|NCT02064387|474183262|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699450|NCT02064387|474183263|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699451|NCT02064387|474183264|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
131699452|NCT02064387|474183265|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699453|NCT02064387|474183266|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699454|NCT02064387|474183267|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131699455|NCT02064387|474183256|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
131699456|NCT02064387|474183257|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
131699457|NCT02064387|474183258|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
131699458|NCT02064387|474183259|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
131699459|NCT02064387|474183260|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
131699460|NCT02064387|474183261|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
131699461|NCT02064387|474183262|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
131699462|NCT02064387|474183263|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
131699463|NCT02064387|474183264|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
131699464|NCT02064387|474183265|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
131699465|NCT02064387|474183266|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
131699466|NCT02064387|474183267|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
131699467|NCT02064387|474183256|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699468|NCT02064387|474183257|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699469|NCT02064387|474183258|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699470|NCT02064387|474183259|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699471|NCT02064387|474183260|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699472|NCT02064387|474183261|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699473|NCT02064387|474183262|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699474|NCT02064387|474183263|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699475|NCT02064387|474183264|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699476|NCT02064387|474183265|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131699477|NCT02064387|474183266|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
131699478|NCT02064387|474183267|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131438000|NCT01582061|473229465|FG001|Overall Study|Death|1|||
131574459|NCT01876511|473728985|FG002|Overall Study|Physician Decision|1|||
131574460|NCT01064817|473728987|FG000|Study Completion|Physician Decision|1|||
131574461|NCT01064817|473728988|FG001|Study Completion|Physician Decision|0|||
131574462|NCT01064817|473728987|FG000|Study Completion|Withdrawal by Subject|1|||
131574463|NCT01064817|473728988|FG001|Study Completion|Withdrawal by Subject|0|||
131574464|NCT00464672|473728989|FG000|Overall Study|withdrawal of consent|0|||
131574465|NCT00464672|473728990|FG001|Overall Study|withdrawal of consent|0|||
131574466|NCT00464672|473728991|FG002|Overall Study|withdrawal of consent|0|||
131574467|NCT00464672|473728992|FG003|Overall Study|withdrawal of consent|1|||
131574468|NCT00464672|473728993|FG004|Overall Study|withdrawal of consent|9|||
131574469|NCT00464672|473728994|FG005|Overall Study|withdrawal of consent|4|||
131574470|NCT00464672|473728989|FG000|Overall Study|Lost to Follow-up|25|||
131574471|NCT00464672|473728990|FG001|Overall Study|Lost to Follow-up|10|||
131574472|NCT00464672|473728991|FG002|Overall Study|Lost to Follow-up|0|||
131574473|NCT00464672|473728992|FG003|Overall Study|Lost to Follow-up|0|||
131574474|NCT00464672|473728993|FG004|Overall Study|Lost to Follow-up|1|||
131574475|NCT00464672|473728994|FG005|Overall Study|Lost to Follow-up|0|||
131574476|NCT02299635|473728995|FG000|Overall Study|Adverse Event|2|||
131574477|NCT02299635|473728995|FG000|Overall Study|Death|1|||
131574478|NCT02299635|473728995|FG000|Overall Study|Global deterioration of health status|1|||
131574479|NCT02299635|473728995|FG000|Overall Study|Objective progression or relapse|10|||
131574480|NCT02299635|473728995|FG000|Overall Study|Withdrawal by Subject|2|||
131574481|NCT02299635|473728995|FG000|Overall Study|Other|3|||
131574482|NCT00828672|473728996|FG000|Study Treatment|Lost to Follow-up|1|||
131574483|NCT00828672|473728997|FG001|Study Treatment|Lost to Follow-up|0|||
131574484|NCT00828672|473728996|FG000|Study Treatment|Adverse Event|0|||
131574485|NCT00828672|473728997|FG001|Study Treatment|Adverse Event|1|||
131574486|NCT00828672|473728996|FG000|Study Treatment|Complete response, no surgery|1|||
131574487|NCT00828672|473728997|FG001|Study Treatment|Complete response, no surgery|1|||
131574488|NCT00828672|473728996|FG000|Post-surgery (<30 Days)|No central review materials|0|||
131574489|NCT00828672|473728997|FG001|Post-surgery (<30 Days)|No central review materials|1|||
131574490|NCT01456936|473729008|FG000|Overall Study|Other reason|41|||
131574491|NCT01456936|473729009|FG001|Overall Study|Other reason|30|||
131574492|NCT01456936|473729010|FG002|Overall Study|Other reason|36|||
131574493|NCT01456936|473729011|FG003|Overall Study|Other reason|33|||
131574494|NCT01456936|473729008|FG000|Overall Study|No longer meets eligibility criteria|4|||
131574495|NCT01456936|473729009|FG001|Overall Study|No longer meets eligibility criteria|8|||
131574496|NCT01456936|473729010|FG002|Overall Study|No longer meets eligibility criteria|6|||
131574497|NCT01456936|473729011|FG003|Overall Study|No longer meets eligibility criteria|5|||
131574498|NCT01456936|473729008|FG000|Overall Study|Protocol Violation|4|||
131574499|NCT01456936|473729009|FG001|Overall Study|Protocol Violation|2|||
131574500|NCT01456936|473729010|FG002|Overall Study|Protocol Violation|5|||
131574501|NCT01456936|473729011|FG003|Overall Study|Protocol Violation|5|||
131574502|NCT01456936|473729008|FG000|Overall Study|Pregnancy|1|||
131574503|NCT01456936|473729009|FG001|Overall Study|Pregnancy|0|||
131699479|NCT02436876|474183272|FG000|Overall Study|Lost to Follow-up|0|||
131699480|NCT02436876|474183273|FG001|Overall Study|Lost to Follow-up|1|||
131699481|NCT02436876|474183274|FG002|Overall Study|Lost to Follow-up|1|||
131699482|NCT02436876|474183275|FG003|Overall Study|Lost to Follow-up|1|||
131699483|NCT02436876|474183272|FG000|Overall Study|Withdrawal by Subject|1|||
131699484|NCT02436876|474183273|FG001|Overall Study|Withdrawal by Subject|0|||
131699485|NCT02436876|474183274|FG002|Overall Study|Withdrawal by Subject|0|||
131699486|NCT02436876|474183275|FG003|Overall Study|Withdrawal by Subject|1|||
131699487|NCT02436876|474183272|FG000|Overall Study|Physician Decision|0|||
131699488|NCT02436876|474183273|FG001|Overall Study|Physician Decision|2|||
131699489|NCT02436876|474183274|FG002|Overall Study|Physician Decision|1|||
131699490|NCT02436876|474183275|FG003|Overall Study|Physician Decision|0|||
131699491|NCT02436876|474183272|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
131699492|NCT02436876|474183273|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
131699493|NCT02436876|474183274|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
131699494|NCT02436876|474183275|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
131699495|NCT03889639|474183278|FG000|Overall Study|Withdrawal by Subject|0|||
131699496|NCT03889639|474183279|FG001|Overall Study|Withdrawal by Subject|0|||
131699497|NCT03889639|474183280|FG002|Overall Study|Withdrawal by Subject|0|||
131699498|NCT03889639|474183281|FG003|Overall Study|Withdrawal by Subject|0|||
131699499|NCT03889639|474183282|FG004|Overall Study|Withdrawal by Subject|0|||
131699500|NCT03889639|474183283|FG005|Overall Study|Withdrawal by Subject|0|||
131574504|NCT01456936|473729010|FG002|Overall Study|Pregnancy|0|||
131574505|NCT01456936|473729011|FG003|Overall Study|Pregnancy|1|||
131574506|NCT01456936|473729008|FG000|Overall Study|Insufficient clinical response|4|||
131574507|NCT01456936|473729009|FG001|Overall Study|Insufficient clinical response|4|||
131574508|NCT01456936|473729010|FG002|Overall Study|Insufficient clinical response|14|||
131699501|NCT03889639|474183284|FG006|Overall Study|Withdrawal by Subject|0|||
131699502|NCT03889639|474183285|FG007|Overall Study|Withdrawal by Subject|1|||
131699503|NCT01703858|474183287|FG000|Overall Study|Withdrawal by Subject|0|||
131699504|NCT01703858|474183288|FG001|Overall Study|Withdrawal by Subject|1|||
131785298|NCT01625286|474496811|FG005|Overall Study|Lost to Follow-up|0|||
131574509|NCT01456936|473729011|FG003|Overall Study|Insufficient clinical response|13|||
131574510|NCT01456936|473729008|FG000|Overall Study|No longer willing to participate|195|||
131574511|NCT01456936|473729009|FG001|Overall Study|No longer willing to participate|218|||
131574512|NCT01456936|473729010|FG002|Overall Study|No longer willing to participate|224|||
131574513|NCT01456936|473729011|FG003|Overall Study|No longer willing to participate|248|||
131574514|NCT01456936|473729008|FG000|Overall Study|Lost to Follow-up|135|||
131574515|NCT01456936|473729009|FG001|Overall Study|Lost to Follow-up|126|||
131574516|NCT01456936|473729010|FG002|Overall Study|Lost to Follow-up|144|||
131574517|NCT01456936|473729011|FG003|Overall Study|Lost to Follow-up|127|||
131574518|NCT01456936|473729008|FG000|Overall Study|Medication error|0|||
131574519|NCT01456936|473729009|FG001|Overall Study|Medication error|1|||
131574520|NCT01456936|473729010|FG002|Overall Study|Medication error|0|||
131574521|NCT01456936|473729011|FG003|Overall Study|Medication error|1|||
131574522|NCT01456936|473729008|FG000|Overall Study|Adverse event (study drug)|25|||
131574523|NCT01456936|473729009|FG001|Overall Study|Adverse event (study drug)|21|||
131574524|NCT01456936|473729010|FG002|Overall Study|Adverse event (study drug)|26|||
131574525|NCT01456936|473729011|FG003|Overall Study|Adverse event (study drug)|17|||
131574526|NCT01456936|473729008|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
131574527|NCT01456936|473729009|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
131574528|NCT01456936|473729010|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
131574529|NCT01456936|473729011|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
131574530|NCT01456936|473729008|FG000|Overall Study|Death|0|||
131574531|NCT01456936|473729009|FG001|Overall Study|Death|3|||
131574532|NCT01456936|473729010|FG002|Overall Study|Death|1|||
131574533|NCT01456936|473729011|FG003|Overall Study|Death|3|||
131574534|NCT01456936|473729008|FG000|Overall Study|Randomized but not treated|21|||
131574535|NCT01456936|473729009|FG001|Overall Study|Randomized but not treated|28|||
131574536|NCT01456936|473729010|FG002|Overall Study|Randomized but not treated|16|||
131574537|NCT01456936|473729011|FG003|Overall Study|Randomized but not treated|21|||
131574538|NCT01250002|473729012|FG000|Overall Study|Change to open surgical procedure|4|||
131574539|NCT01250002|473729013|FG001|Overall Study|Change to open surgical procedure|3|||
131574540|NCT01710514|473729014|FG000|Overall Study|Adverse Event|6|||
131574541|NCT01710514|473729015|FG001|Overall Study|Adverse Event|7|||
131574542|NCT01710514|473729014|FG000|Overall Study|Withdrawal by Subject|1|||
131574543|NCT01710514|473729015|FG001|Overall Study|Withdrawal by Subject|0|||
131574544|NCT00001575|473729023|FG000|Overall Study|Screening failures-Ph I portion|22|||
131574545|NCT00001575|473729023|FG000|Overall Study|Withdrawn/deaths|23|||
131574546|NCT02982213|473729031|FG000|Overall Study|Did not complete follow up questionnaire|5|||
131574547|NCT02982213|473729032|FG001|Overall Study|Did not complete follow up questionnaire|1|||
131574548|NCT01972152|473729033|FG000|First Treatment Visit|Lost to Follow-up|0|||
131574549|NCT01972152|473729034|FG001|First Treatment Visit|Lost to Follow-up|1|||
131574550|NCT01972152|473729035|FG002|First Treatment Visit|Lost to Follow-up|0|||
131574551|NCT01972152|473729036|FG003|First Treatment Visit|Lost to Follow-up|0|||
131574552|NCT01972152|473729037|FG004|First Treatment Visit|Lost to Follow-up|0|||
131574553|NCT01972152|473729038|FG005|First Treatment Visit|Lost to Follow-up|0|||
131574554|NCT01972152|473729033|FG000|Second Treatment Visit|Protocol Violation|0|||
131574555|NCT01972152|473729034|FG001|Second Treatment Visit|Protocol Violation|1|||
131574556|NCT01972152|473729035|FG002|Second Treatment Visit|Protocol Violation|0|||
131574557|NCT01972152|473729036|FG003|Second Treatment Visit|Protocol Violation|0|||
131574558|NCT01972152|473729037|FG004|Second Treatment Visit|Protocol Violation|0|||
131574559|NCT01972152|473729038|FG005|Second Treatment Visit|Protocol Violation|0|||
131574560|NCT01656304|473729042|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
131574561|NCT01155869|473729043|FG000|Overall Study|Lost to Follow-up|3|||
131574562|NCT01155869|473729044|FG001|Overall Study|Lost to Follow-up|1|||
131574563|NCT02824432|473729045|FG000|Overall Study|Major Protocol Deviation|1|||
131785299|NCT01625286|474496812|FG006|Overall Study|Lost to Follow-up|1|||
131785300|NCT00928135|474496813|FG000|Overall Study|Withdrawal by Subject|1|||
131785301|NCT00928135|474496814|FG001|Overall Study|Withdrawal by Subject|0|||
131785302|NCT03338673|474496817|FG000|Overall Study|Lost to Follow-up|1|||
131785303|NCT03338673|474496818|FG001|Overall Study|Lost to Follow-up|1|||
131574564|NCT02824432|473729046|FG001|Overall Study|Major Protocol Deviation|0|||
131574565|NCT05826431|473729048|FG000|Overall Study|Withdrawal by Subject|1|||
131574566|NCT04771273|473729051|FG000|Dose Escalation Period|Not treated with trial medication|0|||
131574567|NCT04771273|473729052|FG001|Dose Escalation Period|Not treated with trial medication|1|||
131574568|NCT04771273|473729053|FG002|Dose Escalation Period|Not treated with trial medication|1|||
131574569|NCT04771273|473729054|FG003|Dose Escalation Period|Not treated with trial medication|0|||
131574570|NCT04771273|473729051|FG000|Dose Escalation Period|Other reasons than listed|2|||
131574571|NCT04771273|473729052|FG001|Dose Escalation Period|Other reasons than listed|0|||
131574572|NCT04771273|473729053|FG002|Dose Escalation Period|Other reasons than listed|2|||
131574573|NCT04771273|473729054|FG003|Dose Escalation Period|Other reasons than listed|1|||
131574574|NCT04771273|473729051|FG000|Dose Escalation Period|Protocol Violation|0|||
131574575|NCT04771273|473729052|FG001|Dose Escalation Period|Protocol Violation|0|||
131785304|NCT00434148|474496819|FG000|Overall Study|Adverse Event|18|||
131785305|NCT00434148|474496820|FG001|Overall Study|Adverse Event|18|||
131574576|NCT04771273|473729053|FG002|Dose Escalation Period|Protocol Violation|3|||
131574577|NCT04771273|473729054|FG003|Dose Escalation Period|Protocol Violation|1|||
131574578|NCT04771273|473729051|FG000|Dose Escalation Period|Burden of study procedures|1|||
131574579|NCT04771273|473729052|FG001|Dose Escalation Period|Burden of study procedures|0|||
131574580|NCT04771273|473729053|FG002|Dose Escalation Period|Burden of study procedures|0|||
131574581|NCT04771273|473729054|FG003|Dose Escalation Period|Burden of study procedures|0|||
131574582|NCT04771273|473729051|FG000|Dose Escalation Period|Change of residence|0|||
131574583|NCT04771273|473729052|FG001|Dose Escalation Period|Change of residence|0|||
131574584|NCT04771273|473729053|FG002|Dose Escalation Period|Change of residence|0|||
131574585|NCT04771273|473729054|FG003|Dose Escalation Period|Change of residence|1|||
131574586|NCT04771273|473729051|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
131574587|NCT04771273|473729052|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
131574588|NCT04771273|473729053|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
131574589|NCT04771273|473729054|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
131574590|NCT04771273|473729051|FG000|Dose Escalation Period|Adverse Event|8|||
131574591|NCT04771273|473729052|FG001|Dose Escalation Period|Adverse Event|9|||
131574592|NCT04771273|473729053|FG002|Dose Escalation Period|Adverse Event|12|||
131574593|NCT04771273|473729054|FG003|Dose Escalation Period|Adverse Event|2|||
131574594|NCT04771273|473729051|FG000|Maintenance Period|Other than listed|4|||
131574595|NCT04771273|473729052|FG001|Maintenance Period|Other than listed|2|||
131574596|NCT04771273|473729053|FG002|Maintenance Period|Other than listed|0|||
131574597|NCT04771273|473729054|FG003|Maintenance Period|Other than listed|3|||
131574598|NCT04771273|473729051|FG000|Maintenance Period|Burden of study procedures|1|||
131574599|NCT04771273|473729052|FG001|Maintenance Period|Burden of study procedures|0|||
131574600|NCT04771273|473729053|FG002|Maintenance Period|Burden of study procedures|0|||
131574601|NCT04771273|473729054|FG003|Maintenance Period|Burden of study procedures|0|||
131574602|NCT04771273|473729051|FG000|Maintenance Period|Change of residence|0|||
131574603|NCT04771273|473729052|FG001|Maintenance Period|Change of residence|1|||
131574604|NCT04771273|473729053|FG002|Maintenance Period|Change of residence|3|||
131574605|NCT04771273|473729054|FG003|Maintenance Period|Change of residence|0|||
131574606|NCT04771273|473729051|FG000|Maintenance Period|Perceived lack of efficacy|0|||
131574607|NCT04771273|473729052|FG001|Maintenance Period|Perceived lack of efficacy|0|||
131574608|NCT04771273|473729053|FG002|Maintenance Period|Perceived lack of efficacy|0|||
131574609|NCT04771273|473729054|FG003|Maintenance Period|Perceived lack of efficacy|1|||
131574610|NCT04771273|473729051|FG000|Maintenance Period|Adverse Event|4|||
131574611|NCT04771273|473729052|FG001|Maintenance Period|Adverse Event|5|||
131574612|NCT04771273|473729053|FG002|Maintenance Period|Adverse Event|5|||
131574613|NCT04771273|473729054|FG003|Maintenance Period|Adverse Event|0|||
131574614|NCT02698241|473729058|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
131574615|NCT02698241|473729058|FG000|Overall Study|Screening not met|7|||
131574616|NCT02698241|473729058|FG000|Overall Study|Withdrawal by Subject|7|||
131574617|NCT02698241|473729058|FG000|Overall Study|Physician Decision|2|||
131574618|NCT02698241|473729058|FG000|Overall Study|Subject underwent system modification|2|||
131574619|NCT02698241|473729058|FG000|Overall Study|Lost to Follow-up|3|||
131574620|NCT02698241|473729058|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
131574621|NCT02698241|473729058|FG000|Overall Study|geographic and licensing issue|1|||
131574622|NCT02698241|473729058|FG000|Overall Study|Death|2|||
131574623|NCT00906282|473729061|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
131574624|NCT00906282|473729061|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
131574625|NCT00906282|473729061|FG000|Preoperative Chemotherapy|Progressive disease|6|||
131574626|NCT00906282|473729061|FG000|Preoperative Chemotherapy|Toxicity|1|||
131574627|NCT02540213|473729062|FG000|Overall Study|Death/adverse event|18|||
131785306|NCT00434148|474496819|FG000|Overall Study|Lack of Efficacy|25|||
131785307|NCT00434148|474496820|FG001|Overall Study|Lack of Efficacy|28|||
131785308|NCT00434148|474496819|FG000|Overall Study|Withdrawal by Subject|15|||
131785309|NCT00434148|474496820|FG001|Overall Study|Withdrawal by Subject|15|||
131785310|NCT00434148|474496819|FG000|Overall Study|Protocol Violation|4|||
131574628|NCT02540213|473729062|FG000|Overall Study|Administrative reasons|3|||
131574629|NCT02540213|473729062|FG000|Overall Study|Kidney transplant|3|||
131574630|NCT02540213|473729062|FG000|Overall Study|Lack of Efficacy|6|||
131574631|NCT02540213|473729062|FG000|Overall Study|Consent withdrawn|7|||
131574632|NCT02540213|473729062|FG000|Overall Study|Enrolled but not treated|2|||
131574633|NCT00290706|473729069|FG000|Overall Study|Withdrawal by Subject|2|||
131574634|NCT00290706|473729070|FG001|Overall Study|Withdrawal by Subject|0|||
131574635|NCT00290706|473729071|FG002|Overall Study|Withdrawal by Subject|0|||
131574636|NCT00290706|473729072|FG003|Overall Study|Withdrawal by Subject|0|||
131574637|NCT00290706|473729069|FG000|Overall Study|Progressive Disease|3|||
131574638|NCT00290706|473729070|FG001|Overall Study|Progressive Disease|5|||
131574639|NCT00290706|473729071|FG002|Overall Study|Progressive Disease|4|||
131574640|NCT00290706|473729072|FG003|Overall Study|Progressive Disease|10|||
131574641|NCT00290706|473729069|FG000|Overall Study|Adverse Event|0|||
131574642|NCT00290706|473729070|FG001|Overall Study|Adverse Event|1|||
131574643|NCT00290706|473729071|FG002|Overall Study|Adverse Event|2|||
131574644|NCT00290706|473729072|FG003|Overall Study|Adverse Event|0|||
131785311|NCT00434148|474496820|FG001|Overall Study|Protocol Violation|0|||
131699505|NCT01703858|474183289|FG002|Overall Study|Withdrawal by Subject|0|||
131699506|NCT01290692|474183290|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
131699507|NCT02556255|474183294|FG000|Overall Study|Lost to Follow-up|4|||
131699508|NCT00993031|474183295|FG000|Overall Study|Death|0|||
131699509|NCT00993031|474183296|FG001|Overall Study|Death|1|||
131574645|NCT00290706|473729069|FG000|Overall Study|Receive auto transplant or radiation|0|||
131574646|NCT00290706|473729070|FG001|Overall Study|Receive auto transplant or radiation|0|||
131574647|NCT00290706|473729071|FG002|Overall Study|Receive auto transplant or radiation|0|||
131574648|NCT00290706|473729072|FG003|Overall Study|Receive auto transplant or radiation|1|||
131574649|NCT00290706|473729069|FG000|Overall Study|Physician Decision|0|||
131574650|NCT00290706|473729070|FG001|Overall Study|Physician Decision|0|||
131574651|NCT00290706|473729071|FG002|Overall Study|Physician Decision|0|||
131699510|NCT00993031|474183295|FG000|Overall Study|Physician Decision|0|||
131699511|NCT00993031|474183296|FG001|Overall Study|Physician Decision|2|||
131574652|NCT00290706|473729072|FG003|Overall Study|Physician Decision|1|||
131574653|NCT02952261|473729075|FG000|Overall Study|Withdrawal by Subject|4|||
131574654|NCT02952261|473729076|FG001|Overall Study|Withdrawal by Subject|5|||
131574655|NCT02952261|473729075|FG000|Overall Study|Protocol Violation|1|||
131574656|NCT02952261|473729076|FG001|Overall Study|Protocol Violation|0|||
131574657|NCT00603447|473729077|FG000|Overall Study|Adverse Event|0|||
131574658|NCT00603447|473729078|FG001|Overall Study|Adverse Event|1|||
131574659|NCT00603447|473729079|FG002|Overall Study|Adverse Event|1|||
131574660|NCT00603447|473729080|FG003|Overall Study|Adverse Event|2|||
131574661|NCT00603447|473729081|FG004|Overall Study|Adverse Event|1|||
131574662|NCT00603447|473729082|FG005|Overall Study|Adverse Event|2|||
131574663|NCT00603447|473729083|FG006|Overall Study|Adverse Event|10|||
131574664|NCT00603447|473729077|FG000|Overall Study|Other|0|||
131574665|NCT00603447|473729078|FG001|Overall Study|Other|0|||
131699512|NCT00993031|474183295|FG000|Overall Study|Withdrawal by Subject|3|||
131574666|NCT00603447|473729079|FG002|Overall Study|Other|1|||
131574667|NCT00603447|473729080|FG003|Overall Study|Other|0|||
131574668|NCT00603447|473729081|FG004|Overall Study|Other|3|||
131574669|NCT00603447|473729082|FG005|Overall Study|Other|0|||
131574670|NCT00603447|473729083|FG006|Overall Study|Other|13|||
131699513|NCT00993031|474183296|FG001|Overall Study|Withdrawal by Subject|3|||
131699514|NCT00993031|474183295|FG000|Overall Study|Lost to Follow-up|19|||
131699515|NCT00993031|474183296|FG001|Overall Study|Lost to Follow-up|13|||
131699516|NCT03115151|474183297|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
131699517|NCT03115151|474183298|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
131699518|NCT03115151|474183297|FG000|Overall Study|Epidural catheter removal|1|||
131699519|NCT03115151|474183298|FG001|Overall Study|Epidural catheter removal|0|||
131699520|NCT03115151|474183297|FG000|Overall Study|Withdrawal by Subject|0|||
131699521|NCT03115151|474183298|FG001|Overall Study|Withdrawal by Subject|1|||
131699522|NCT03115151|474183297|FG000|Overall Study|Intervention not received according to the protocol.|1|||
131699523|NCT03115151|474183298|FG001|Overall Study|Intervention not received according to the protocol.|1|||
131699524|NCT03115151|474183297|FG000|Overall Study|Physician Decision|1|||
131699525|NCT03115151|474183298|FG001|Overall Study|Physician Decision|0|||
131699526|NCT03115151|474183297|FG000|Overall Study|Randomization not applied|1|||
131699527|NCT03115151|474183298|FG001|Overall Study|Randomization not applied|1|||
131699528|NCT03870555|474183306|FG000|Period 3 (2 Days)|Adverse Event|1|||
131699529|NCT03870555|474183307|FG001|Period 3 (2 Days)|Adverse Event|0|||
131699530|NCT03870555|474183308|FG002|Period 3 (2 Days)|Adverse Event|0|||
131699531|NCT03694925|474183310|FG000|Overall Study|Inadequate laboratory testing|0|||
131699532|NCT03694925|474183311|FG001|Overall Study|Inadequate laboratory testing|3|||
131699533|NCT03694925|474183312|FG002|Overall Study|Inadequate laboratory testing|0|||
131699534|NCT03467958|474183318|FG000|Overall Study|Adverse Event|20|||
131699535|NCT03467958|474183319|FG001|Overall Study|Adverse Event|32|||
131699536|NCT03467958|474183320|FG002|Overall Study|Adverse Event|5|||
131699537|NCT03467958|474183321|FG003|Overall Study|Adverse Event|3|||
131699538|NCT03467958|474183322|FG004|Overall Study|Adverse Event|3|||
131699539|NCT03467958|474183323|FG005|Overall Study|Adverse Event|3|||
131699540|NCT03467958|474183324|FG006|Overall Study|Adverse Event|6|||
131699541|NCT03467958|474183325|FG007|Overall Study|Adverse Event|5|||
131699542|NCT03467958|474183326|FG008|Overall Study|Adverse Event|0|||
131699543|NCT03467958|474183318|FG000|Overall Study|Lack of Efficacy|59|||
131699544|NCT03467958|474183319|FG001|Overall Study|Lack of Efficacy|120|||
131574671|NCT00603447|473729077|FG000|Overall Study|Withdrew Consent|0|||
131574672|NCT00603447|473729078|FG001|Overall Study|Withdrew Consent|2|||
131574673|NCT00603447|473729079|FG002|Overall Study|Withdrew Consent|0|||
131574674|NCT00603447|473729080|FG003|Overall Study|Withdrew Consent|0|||
131574675|NCT00603447|473729081|FG004|Overall Study|Withdrew Consent|1|||
131574676|NCT00603447|473729082|FG005|Overall Study|Withdrew Consent|0|||
131574677|NCT00603447|473729083|FG006|Overall Study|Withdrew Consent|1|||
131574678|NCT05233085|473729084|FG000|Overall Study|Adverse Event|1|||
131574679|NCT05233085|473729085|FG001|Overall Study|Adverse Event|0|||
131574680|NCT05233085|473729086|FG002|Overall Study|Adverse Event|0|||
131574681|NCT05233085|473729087|FG003|Overall Study|Adverse Event|0|||
131574682|NCT00798265|473729088|FG000|Overall Study|Lost to Follow-up|1|||
131574683|NCT00798265|473729089|FG001|Overall Study|Lost to Follow-up|10|||
131574684|NCT00798265|473729088|FG000|Overall Study|Study closing|7|||
131574685|NCT00798265|473729089|FG001|Overall Study|Study closing|6|||
131574686|NCT00798265|473729088|FG000|Overall Study|Withdrawal by Subject|0|||
131574687|NCT00798265|473729089|FG001|Overall Study|Withdrawal by Subject|1|||
131574688|NCT00798265|473729088|FG000|Overall Study|Screen failure|0|||
131574689|NCT00798265|473729089|FG001|Overall Study|Screen failure|1|||
131574690|NCT02738840|473730500|FG000|Overall Study|MRI Scan not Performed|5|||
131574691|NCT02738840|473730500|FG000|Overall Study|Lost to Follow-up|1|||
131574692|NCT02738840|473730500|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
131574693|NCT02738840|473730500|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
131574694|NCT00739102|473730502|FG000|Overall Study|Death|5|||
131574695|NCT00739102|473730502|FG000|Overall Study|Withdrawal by Subject|10|||
131574696|NCT01331824|473730503|FG000|Overall Study|Adverse Event|2|||
131574697|NCT01331824|473730503|FG000|Overall Study|Death|1|||
131574698|NCT01331824|473730503|FG000|Overall Study|Disease Progression|9|||
131574699|NCT01331824|473730503|FG000|Overall Study|Withdrawal by Subject|1|||
131574700|NCT01091454|473730506|FG000|Overall Study|Ineligible|1|||
131574701|NCT03179787|473730507|FG000|Overall Study|Lost to Follow-up|15|||
131574702|NCT03179787|473730507|FG000|Overall Study|Case report failures|2|||
131574703|NCT03179787|473730507|FG000|Overall Study|Treatment not administered|1|||
131574704|NCT01510912|473730508|FG000|Overall Study|Adverse Event|99|||
131574705|NCT01510912|473730508|FG000|Overall Study|Lack of Efficacy|12|||
131574706|NCT01510912|473730508|FG000|Overall Study|Non-compliance with trial drug|23|||
131574707|NCT01510912|473730508|FG000|Overall Study|Withdrawal by Subject|49|||
131574708|NCT01510912|473730508|FG000|Overall Study|Physician Decision|1|||
131574709|NCT01510912|473730508|FG000|Overall Study|Protocol Violation|27|||
131574710|NCT01510912|473730508|FG000|Overall Study|Lost to Follow-up|26|||
131574711|NCT01510912|473730508|FG000|Overall Study|Other, including joint replacement|5|||
131574712|NCT02030028|473730509|FG000|Overall Study|Withdrawal by Subject|4|||
131574713|NCT02030028|473730509|FG000|Overall Study|lack of transportation|1|||
131574714|NCT02380742|473730511|FG000|Overall Study|Withdrawal by Subject|1|||
131574715|NCT02380742|473730512|FG001|Overall Study|Withdrawal by Subject|0|||
131574716|NCT02930343|473730514|FG000|Overall Study|Lost to Follow-up|9|||
131574717|NCT02930343|473730515|FG001|Overall Study|Lost to Follow-up|7|||
131574718|NCT00109967|473730518|FG000|Overall Study|Cancel Prior to Treatment|2|||
131574719|NCT00109967|473730519|FG001|Overall Study|Cancel Prior to Treatment|0|||
131574720|NCT00109967|473730518|FG000|Overall Study|Adverse Event|12|||
131574721|NCT00109967|473730519|FG001|Overall Study|Adverse Event|1|||
131574722|NCT00109967|473730518|FG000|Overall Study|Withdrawal by Subject|5|||
131574723|NCT00109967|473730519|FG001|Overall Study|Withdrawal by Subject|0|||
131574724|NCT00109967|473730518|FG000|Overall Study|Physician Decision|1|||
131574725|NCT00109967|473730519|FG001|Overall Study|Physician Decision|3|||
131574726|NCT00109967|473730518|FG000|Overall Study|Death|0|||
131574727|NCT00109967|473730519|FG001|Overall Study|Death|2|||
131574728|NCT01977612|473730526|FG000|Overall Study|Lost to Follow-up|1|||
131574729|NCT01977612|473730527|FG001|Overall Study|Lost to Follow-up|1|||
131574730|NCT02715258|473730528|FG000|Overall Study|Withdrawal by Subject|6|||
131574731|NCT02715258|473730529|FG001|Overall Study|Withdrawal by Subject|1|||
131574732|NCT02715258|473730528|FG000|Overall Study|Lost to Follow-up|7|||
131574733|NCT02715258|473730529|FG001|Overall Study|Lost to Follow-up|1|||
131574734|NCT02715258|473730528|FG000|Overall Study|Terminated by Sponsor|0|||
131574735|NCT02715258|473730529|FG001|Overall Study|Terminated by Sponsor|1|||
131574736|NCT02715258|473730528|FG000|Overall Study|Death|0|||
131574737|NCT02715258|473730529|FG001|Overall Study|Death|1|||
131574738|NCT02715258|473730528|FG000|Overall Study|Subject non-compliant|1|||
131574739|NCT02715258|473730529|FG001|Overall Study|Subject non-compliant|1|||
131574740|NCT02715258|473730528|FG000|Overall Study|GCP violation|2|||
131574741|NCT02715258|473730529|FG001|Overall Study|GCP violation|1|||
131574742|NCT01280591|473730530|FG000|Overall Study|Withdrawal by Subject|0|||
131574743|NCT01280591|473730531|FG001|Overall Study|Withdrawal by Subject|0|||
131574744|NCT01280591|473730532|FG002|Overall Study|Withdrawal by Subject|0|||
131574745|NCT01280591|473730533|FG003|Overall Study|Withdrawal by Subject|2|||
131574746|NCT01280591|473730530|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
131574747|NCT01280591|473730531|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
131574748|NCT01280591|473730532|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
131574749|NCT01280591|473730533|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
131574750|NCT03265210|473730536|FG000|Overall Study|Withdrawal by Subject|7|||
131574751|NCT03265210|473730537|FG001|Overall Study|Withdrawal by Subject|9|||
131574752|NCT03265210|473730536|FG000|Overall Study|Lost to Follow-up|2|||
131574753|NCT03265210|473730537|FG001|Overall Study|Lost to Follow-up|0|||
131574754|NCT03265210|473730536|FG000|Overall Study|Physician Decision|2|||
131574755|NCT03265210|473730537|FG001|Overall Study|Physician Decision|0|||
131574756|NCT03265210|473730536|FG000|Overall Study|Adverse Event|1|||
131574757|NCT03265210|473730537|FG001|Overall Study|Adverse Event|0|||
131574758|NCT03357341|473730540|FG000|Overall Study|Withdrawal by Subject|3|||
131574759|NCT03357341|473730541|FG001|Overall Study|Withdrawal by Subject|6|||
131574760|NCT03357341|473730540|FG000|Overall Study|Lost to Follow-up|4|||
131574761|NCT03357341|473730541|FG001|Overall Study|Lost to Follow-up|5|||
131574762|NCT03357341|473730540|FG000|Overall Study|Death|0|||
131574763|NCT03357341|473730541|FG001|Overall Study|Death|1|||
131574764|NCT00918957|473730542|FG000|Overall Study|Adverse Event|2|||
131574765|NCT00918957|473730543|FG001|Overall Study|Adverse Event|0|||
131574766|NCT00918957|473730542|FG000|Overall Study|Withdrawal by Subject|1|||
131574767|NCT00918957|473730543|FG001|Overall Study|Withdrawal by Subject|0|||
131574768|NCT00686517|473730544|FG000|Treatment|Serious Adverse Event|1|||
131574769|NCT00686517|473730545|FG001|Treatment|Serious Adverse Event|2|||
131574770|NCT00686517|473730546|FG002|Treatment|Serious Adverse Event|1|||
131574771|NCT00686517|473730544|FG000|Treatment|Adverse Event|2|||
131785312|NCT00434148|474496819|FG000|Overall Study|Administrative problems|6|||
131785313|NCT00434148|474496820|FG001|Overall Study|Administrative problems|10|||
131785314|NCT00434148|474496819|FG000|Overall Study|Lost to Follow-up|0|||
131785315|NCT00434148|474496820|FG001|Overall Study|Lost to Follow-up|1|||
131438001|NCT01582061|473229464|FG000|Overall Study|condition no longer requires study drug|1|||
131785316|NCT00434148|474496819|FG000|Overall Study|Condition no longer requires study drug|1|||
131785317|NCT00434148|474496820|FG001|Overall Study|Condition no longer requires study drug|0|||
131785318|NCT00434148|474496819|FG000|Overall Study|Abnormal test procedure result|0|||
131785319|NCT00434148|474496820|FG001|Overall Study|Abnormal test procedure result|1|||
131785320|NCT00828516|474496824|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
131785321|NCT01861717|474496831|FG000|Overall Study|Lost to Follow-up|1|||
131785322|NCT01861717|474496831|FG000|Overall Study|Withdrawal by Subject|1|||
131785323|NCT03033069|474496832|FG000|Overall Study|Adverse Event|6|||
131785324|NCT03033069|474496833|FG001|Overall Study|Adverse Event|7|||
131785325|NCT03033069|474496834|FG002|Overall Study|Adverse Event|4|||
131785326|NCT03033069|474496835|FG003|Overall Study|Adverse Event|6|||
131785327|NCT03033069|474496832|FG000|Overall Study|Lack of Efficacy|0|||
131785328|NCT03033069|474496833|FG001|Overall Study|Lack of Efficacy|0|||
131785329|NCT03033069|474496834|FG002|Overall Study|Lack of Efficacy|1|||
131785330|NCT03033069|474496835|FG003|Overall Study|Lack of Efficacy|0|||
131785331|NCT03033069|474496832|FG000|Overall Study|Lost to Follow-up|6|||
131785332|NCT03033069|474496833|FG001|Overall Study|Lost to Follow-up|5|||
131785333|NCT03033069|474496834|FG002|Overall Study|Lost to Follow-up|5|||
131898686|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
131438002|NCT01582061|473229465|FG001|Overall Study|condition no longer requires study drug|0|||
131574772|NCT00686517|473730545|FG001|Treatment|Adverse Event|0|||
131574773|NCT00686517|473730546|FG002|Treatment|Adverse Event|0|||
131574774|NCT00686517|473730544|FG000|Treatment|Poor Protocol Compliance|1|||
131574775|NCT00686517|473730545|FG001|Treatment|Poor Protocol Compliance|0|||
131574776|NCT00686517|473730546|FG002|Treatment|Poor Protocol Compliance|0|||
131574777|NCT00686517|473730544|FG000|Treatment|Protocol Violation|2|||
131438003|NCT01582061|473229464|FG000|Overall Study|Lost to Follow-up|1|||
131574778|NCT00686517|473730545|FG001|Treatment|Protocol Violation|1|||
131574779|NCT00686517|473730546|FG002|Treatment|Protocol Violation|0|||
131574780|NCT01048788|473730547|FG000|Overall Study|Adverse Event|5|||
131574781|NCT01048788|473730548|FG001|Overall Study|Adverse Event|1|||
131574782|NCT01048788|473730549|FG002|Overall Study|Adverse Event|1|||
131574783|NCT01048788|473730547|FG000|Overall Study|Lack of Efficacy|0|||
131574784|NCT01048788|473730548|FG001|Overall Study|Lack of Efficacy|0|||
131574785|NCT01048788|473730549|FG002|Overall Study|Lack of Efficacy|1|||
131574786|NCT01048788|473730547|FG000|Overall Study|Withdrawal by Subject|0|||
131574787|NCT01048788|473730548|FG001|Overall Study|Withdrawal by Subject|1|||
131574788|NCT01048788|473730549|FG002|Overall Study|Withdrawal by Subject|0|||
131574789|NCT01131494|473730550|FG000|Overall Study|Withdrawal by Subject|2|||
131574790|NCT01233050|473730553|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
131574791|NCT01233050|473730554|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
131574792|NCT02614560|473730557|FG000|Overall Study|Death|6|||
131574793|NCT02614560|473730558|FG001|Overall Study|Death|2|||
131574794|NCT00703911|473730559|FG000|Overall Study|Death|1|||
131574795|NCT00703911|473730559|FG000|Overall Study|Physician Decision|6|||
131574796|NCT00703911|473730559|FG000|Overall Study|Lost to Follow-up|1|||
131574797|NCT00703911|473730559|FG000|Overall Study|Withdrawal by Subject|2|||
131574798|NCT00868192|473730561|FG000|Overall Study|Ineligible|4|||
131574799|NCT01368406|473730562|FG000|Overall Study|Lost to Follow-up|8|||
131574800|NCT01368406|473730563|FG001|Overall Study|Lost to Follow-up|4|||
131574801|NCT01368406|473730562|FG000|Overall Study|Withdrawal by Subject|8|||
131574802|NCT01368406|473730563|FG001|Overall Study|Withdrawal by Subject|4|||
131574803|NCT01368406|473730562|FG000|Overall Study|relapse of the disease|3|||
131574804|NCT01368406|473730563|FG001|Overall Study|relapse of the disease|2|||
131574805|NCT01368406|473730562|FG000|Overall Study|started working|2|||
131574806|NCT01368406|473730563|FG001|Overall Study|started working|3|||
131574807|NCT04304534|473730564|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
131574808|NCT04304534|473730565|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
131574809|NCT04304534|473730566|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
131574810|NCT04304534|473730567|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
131574811|NCT04304534|473730564|FG000|Overall Study|Non-Compliance with study drug|0|||
131574812|NCT04304534|473730565|FG001|Overall Study|Non-Compliance with study drug|1|||
131574813|NCT04304534|473730566|FG002|Overall Study|Non-Compliance with study drug|1|||
131574814|NCT04304534|473730567|FG003|Overall Study|Non-Compliance with study drug|1|||
131574815|NCT04304534|473730564|FG000|Overall Study|Lost to Follow-up|0|||
131574816|NCT04304534|473730565|FG001|Overall Study|Lost to Follow-up|1|||
131574817|NCT04304534|473730566|FG002|Overall Study|Lost to Follow-up|2|||
131574818|NCT04304534|473730567|FG003|Overall Study|Lost to Follow-up|3|||
131574819|NCT04304534|473730564|FG000|Overall Study|Unspecific|4|||
131574820|NCT04304534|473730565|FG001|Overall Study|Unspecific|2|||
131574821|NCT04304534|473730566|FG002|Overall Study|Unspecific|2|||
131574822|NCT04304534|473730567|FG003|Overall Study|Unspecific|2|||
131574823|NCT04304534|473730564|FG000|Overall Study|Technical Problems|2|||
131574824|NCT04304534|473730565|FG001|Overall Study|Technical Problems|2|||
131574825|NCT04304534|473730566|FG002|Overall Study|Technical Problems|3|||
131574826|NCT04304534|473730567|FG003|Overall Study|Technical Problems|4|||
131574827|NCT04304534|473730564|FG000|Overall Study|Death|7|||
131574828|NCT04304534|473730565|FG001|Overall Study|Death|2|||
131574829|NCT04304534|473730566|FG002|Overall Study|Death|4|||
131574830|NCT04304534|473730567|FG003|Overall Study|Death|3|||
131574831|NCT04304534|473730564|FG000|Overall Study|Withdrawal by Subject|7|||
131574832|NCT04304534|473730565|FG001|Overall Study|Withdrawal by Subject|2|||
131574833|NCT04304534|473730566|FG002|Overall Study|Withdrawal by Subject|7|||
131574834|NCT04304534|473730567|FG003|Overall Study|Withdrawal by Subject|4|||
131574835|NCT04304534|473730564|FG000|Overall Study|Physician Decision|4|||
131574836|NCT04304534|473730565|FG001|Overall Study|Physician Decision|9|||
131574837|NCT04304534|473730566|FG002|Overall Study|Physician Decision|9|||
131574838|NCT04304534|473730567|FG003|Overall Study|Physician Decision|5|||
131574839|NCT04304534|473730564|FG000|Overall Study|Subject Decision|34|||
131574840|NCT04304534|473730565|FG001|Overall Study|Subject Decision|25|||
131574841|NCT04304534|473730566|FG002|Overall Study|Subject Decision|25|||
131574842|NCT04304534|473730567|FG003|Overall Study|Subject Decision|26|||
131574843|NCT04304534|473730564|FG000|Overall Study|Adverse Event|35|||
131574844|NCT04304534|473730565|FG001|Overall Study|Adverse Event|40|||
131574845|NCT04304534|473730566|FG002|Overall Study|Adverse Event|39|||
131574846|NCT04304534|473730567|FG003|Overall Study|Adverse Event|44|||
131574847|NCT01466881|473730573|FG000|Overall Study|Ineligible|5|||
131574848|NCT01466881|473730573|FG000|Overall Study|Adverse Event|6|||
131574849|NCT01466881|473730573|FG000|Overall Study|Progression/relapse|20|||
131574850|NCT01466881|473730573|FG000|Overall Study|Death|4|||
131574851|NCT01466881|473730573|FG000|Overall Study|Other reason not protocol specified|5|||
131574852|NCT03670602|473730577|FG000|Overall Study|Lost to Follow-up|1|||
131574853|NCT03670602|473730578|FG001|Overall Study|Lost to Follow-up|0|||
131574854|NCT03670602|473730577|FG000|Overall Study|Withdrawal by Subject|0|||
131574855|NCT03670602|473730578|FG001|Overall Study|Withdrawal by Subject|3|||
131574856|NCT00543725|473730579|FG000|Overall Study|Adverse Event|18|||
131574857|NCT00543725|473730580|FG001|Overall Study|Adverse Event|27|||
131574858|NCT00543725|473730579|FG000|Overall Study|Sponsor's Decision|0|||
131574859|NCT00543725|473730580|FG001|Overall Study|Sponsor's Decision|1|||
131574860|NCT00543725|473730579|FG000|Overall Study|Subject Non-Compliant|4|||
131574861|NCT00543725|473730580|FG001|Overall Study|Subject Non-Compliant|4|||
131574862|NCT00543725|473730579|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
131574863|NCT00543725|473730580|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
131574864|NCT00543725|473730579|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
131574865|NCT00543725|473730580|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
131574866|NCT00543725|473730579|FG000|Overall Study|Protocol Violation|0|||
131574867|NCT00543725|473730580|FG001|Overall Study|Protocol Violation|1|||
131574868|NCT00543725|473730579|FG000|Overall Study|Withdrawal by Subject|4|||
131574869|NCT00543725|473730580|FG001|Overall Study|Withdrawal by Subject|13|||
131574870|NCT00543725|473730579|FG000|Overall Study|Lost to Follow-up|15|||
131574871|NCT00543725|473730580|FG001|Overall Study|Lost to Follow-up|11|||
131574872|NCT00543725|473730579|FG000|Overall Study|Other|3|||
131574873|NCT00543725|473730580|FG001|Overall Study|Other|3|||
131574874|NCT00906698|473730581|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
131574875|NCT00906698|473730582|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
131574876|NCT00906698|473730583|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
131574877|NCT00906698|473730584|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
131574878|NCT00906698|473730585|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
131574879|NCT00906698|473730586|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
131574880|NCT00906698|473730581|FG000|Overall Study|Adverse Event|0|||
131574881|NCT00906698|473730582|FG001|Overall Study|Adverse Event|0|||
131574882|NCT00906698|473730583|FG002|Overall Study|Adverse Event|2|||
131574883|NCT00906698|473730584|FG003|Overall Study|Adverse Event|0|||
131574884|NCT00906698|473730585|FG004|Overall Study|Adverse Event|4|||
131574885|NCT00906698|473730586|FG005|Overall Study|Adverse Event|1|||
131574886|NCT00906698|473730581|FG000|Overall Study|Disease progression|3|||
131574887|NCT00906698|473730582|FG001|Overall Study|Disease progression|12|||
131574888|NCT00906698|473730583|FG002|Overall Study|Disease progression|4|||
131574889|NCT00906698|473730584|FG003|Overall Study|Disease progression|4|||
131574890|NCT00906698|473730585|FG004|Overall Study|Disease progression|12|||
131574891|NCT00906698|473730586|FG005|Overall Study|Disease progression|4|||
131574892|NCT00906698|473730581|FG000|Overall Study|Withdrawal by Subject|0|||
131574893|NCT00906698|473730582|FG001|Overall Study|Withdrawal by Subject|0|||
131574894|NCT00906698|473730583|FG002|Overall Study|Withdrawal by Subject|0|||
131574895|NCT00906698|473730584|FG003|Overall Study|Withdrawal by Subject|0|||
131574896|NCT00906698|473730585|FG004|Overall Study|Withdrawal by Subject|1|||
131574897|NCT00906698|473730586|FG005|Overall Study|Withdrawal by Subject|0|||
131574898|NCT00906698|473730581|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
131785334|NCT03033069|474496835|FG003|Overall Study|Lost to Follow-up|6|||
131785335|NCT03033069|474496832|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131785336|NCT03033069|474496833|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131785337|NCT03033069|474496834|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131785338|NCT03033069|474496835|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131785339|NCT03033069|474496832|FG000|Overall Study|Protocol Deviation|0|||
131785340|NCT03033069|474496833|FG001|Overall Study|Protocol Deviation|1|||
131785341|NCT03033069|474496834|FG002|Overall Study|Protocol Deviation|0|||
131574899|NCT00906698|473730582|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
131574900|NCT00906698|473730583|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
131574901|NCT00906698|473730584|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
131574902|NCT00906698|473730585|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
131574903|NCT00906698|473730586|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
131574904|NCT03095508|473730587|FG000|Overall Study|Adverse Event|0|||
131574905|NCT03095508|473730588|FG001|Overall Study|Adverse Event|1|||
131574906|NCT01806714|473730589|FG000|Overall Study|No functioning phone number|200|||
131785342|NCT03033069|474496835|FG003|Overall Study|Protocol Deviation|0|||
131785343|NCT03033069|474496832|FG000|Overall Study|Withdrawal by Subject|10|||
131574907|NCT01806714|473730590|FG001|Overall Study|No functioning phone number|170|||
131574908|NCT02469064|473730591|FG000|Overall Study|Request not to receive intervention.|1|||
131574909|NCT02469064|473730592|FG001|Overall Study|Request not to receive intervention.|3|||
131574910|NCT02155829|473730593|FG000|Overall Study|Adverse Event|1|||
131574911|NCT02155829|473730594|FG001|Overall Study|Adverse Event|0|||
131574912|NCT02155829|473730593|FG000|Overall Study|Withdrawal by Subject|3|||
131574913|NCT02155829|473730594|FG001|Overall Study|Withdrawal by Subject|3|||
131574914|NCT02155829|473730593|FG000|Overall Study|Protocol Violation|2|||
131574915|NCT02155829|473730594|FG001|Overall Study|Protocol Violation|0|||
131574916|NCT01585038|473730595|FG000|Overall Study|Adverse Event|2|||
131574917|NCT01585038|473730596|FG001|Overall Study|Adverse Event|2|||
131574918|NCT00678795|473730597|FG000|Overall Study|Adverse Event|7|||
131574919|NCT00678795|473730598|FG001|Overall Study|Adverse Event|3|||
131574920|NCT00678795|473730597|FG000|Overall Study|Withdrawal by Subject|3|||
131574921|NCT00678795|473730598|FG001|Overall Study|Withdrawal by Subject|0|||
131574922|NCT00678795|473730597|FG000|Overall Study|Protocol Violation|0|||
131574923|NCT00678795|473730598|FG001|Overall Study|Protocol Violation|1|||
131574924|NCT00678795|473730597|FG000|Overall Study|Lost to Follow-up|0|||
131574925|NCT00678795|473730598|FG001|Overall Study|Lost to Follow-up|1|||
131574926|NCT00678795|473730597|FG000|Overall Study|Lack of Efficacy|1|||
131574927|NCT00678795|473730598|FG001|Overall Study|Lack of Efficacy|1|||
131574928|NCT04107805|473730599|FG000|Overall Study|Adverse Event|0|||
131574929|NCT04107805|473730600|FG001|Overall Study|Adverse Event|0|||
131574930|NCT04107805|473730601|FG002|Overall Study|Adverse Event|0|||
131574931|NCT04107805|473730602|FG003|Overall Study|Adverse Event|1|||
131574932|NCT04107805|473730603|FG004|Overall Study|Adverse Event|0|||
131574933|NCT04107805|473730604|FG005|Overall Study|Adverse Event|1|||
131574934|NCT04107805|473730605|FG006|Overall Study|Adverse Event|0|||
131574935|NCT04107805|473730606|FG007|Overall Study|Adverse Event|0|||
131574936|NCT04107805|473730607|FG008|Overall Study|Adverse Event|1|||
131574937|NCT02512042|473730608|FG000|Overall Study|Adverse Event|0|||
131574938|NCT02512042|473730609|FG001|Overall Study|Adverse Event|4|||
131574939|NCT02512042|473730608|FG000|Overall Study|Withdrawal by Subject|6|||
131574940|NCT02512042|473730609|FG001|Overall Study|Withdrawal by Subject|6|||
131574941|NCT02512042|473730608|FG000|Overall Study|Non-compliance with study drug|1|||
131574942|NCT02512042|473730609|FG001|Overall Study|Non-compliance with study drug|2|||
131574943|NCT02512042|473730608|FG000|Overall Study|Lost to Follow-up|5|||
131574944|NCT02512042|473730609|FG001|Overall Study|Lost to Follow-up|2|||
131574945|NCT02512042|473730608|FG000|Overall Study|Other|11|||
131574946|NCT02512042|473730609|FG001|Overall Study|Other|11|||
131574947|NCT01194258|473730610|FG000|Titration Period|Withdrawal by Subject|6|||
131574948|NCT01194258|473730611|FG001|Titration Period|Withdrawal by Subject|0|||
131574949|NCT01194258|473730612|FG002|Titration Period|Withdrawal by Subject|0|||
131574950|NCT01194258|473730613|FG003|Titration Period|Withdrawal by Subject|0|||
131574951|NCT01194258|473730614|FG004|Titration Period|Withdrawal by Subject|0|||
131574952|NCT01194258|473730610|FG000|Titration Period|Lost to Follow-up|2|||
131574953|NCT01194258|473730611|FG001|Titration Period|Lost to Follow-up|0|||
131574954|NCT01194258|473730612|FG002|Titration Period|Lost to Follow-up|0|||
131574955|NCT01194258|473730613|FG003|Titration Period|Lost to Follow-up|0|||
131574956|NCT01194258|473730614|FG004|Titration Period|Lost to Follow-up|0|||
131574957|NCT01194258|473730610|FG000|Titration Period|Titration failure|3|||
131574958|NCT01194258|473730611|FG001|Titration Period|Titration failure|0|||
131574959|NCT01194258|473730612|FG002|Titration Period|Titration failure|0|||
131574960|NCT01194258|473730613|FG003|Titration Period|Titration failure|0|||
131574961|NCT01194258|473730614|FG004|Titration Period|Titration failure|0|||
131574962|NCT01194258|473730610|FG000|Period 1 (12 Weeks)|Death|0|||
131574963|NCT01194258|473730611|FG001|Period 1 (12 Weeks)|Death|0|||
131574964|NCT01194258|473730612|FG002|Period 1 (12 Weeks)|Death|0|||
131574965|NCT01194258|473730613|FG003|Period 1 (12 Weeks)|Death|0|||
131574966|NCT01194258|473730614|FG004|Period 1 (12 Weeks)|Death|1|||
131574967|NCT01194258|473730610|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131574968|NCT01194258|473730611|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131574969|NCT01194258|473730612|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131574970|NCT01194258|473730613|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131574971|NCT01194258|473730614|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
131574972|NCT01194258|473730610|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
131574973|NCT01194258|473730611|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
131574974|NCT01194258|473730612|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
131574975|NCT01194258|473730613|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
131574976|NCT01194258|473730614|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
131574977|NCT01194258|473730610|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131574978|NCT01194258|473730611|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131574979|NCT01194258|473730612|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131574980|NCT01194258|473730613|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131574981|NCT01194258|473730614|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131574982|NCT01253226|473730616|FG000|Overall Study|Adverse Event|0|||
131574983|NCT01253226|473730617|FG001|Overall Study|Adverse Event|0|||
131574984|NCT01253226|473730618|FG002|Overall Study|Adverse Event|1|||
131574985|NCT01253226|473730619|FG003|Overall Study|Adverse Event|0|||
131574986|NCT01253226|473730620|FG004|Overall Study|Adverse Event|0|||
131574987|NCT01253226|473730616|FG000|Overall Study|Death|0|||
131574988|NCT01253226|473730617|FG001|Overall Study|Death|1|||
131574989|NCT01253226|473730618|FG002|Overall Study|Death|0|||
131574990|NCT01253226|473730619|FG003|Overall Study|Death|0|||
131574991|NCT01253226|473730620|FG004|Overall Study|Death|0|||
131574992|NCT01253226|473730616|FG000|Overall Study|Physician Decision|0|||
131574993|NCT01253226|473730617|FG001|Overall Study|Physician Decision|0|||
131574994|NCT01253226|473730618|FG002|Overall Study|Physician Decision|0|||
131574995|NCT01253226|473730619|FG003|Overall Study|Physician Decision|0|||
131574996|NCT01253226|473730620|FG004|Overall Study|Physician Decision|2|||
131574997|NCT01253226|473730616|FG000|Overall Study|Withdrawal by Subject|0|||
131574998|NCT01253226|473730617|FG001|Overall Study|Withdrawal by Subject|0|||
131574999|NCT01253226|473730618|FG002|Overall Study|Withdrawal by Subject|0|||
131575000|NCT01253226|473730619|FG003|Overall Study|Withdrawal by Subject|1|||
131575001|NCT01253226|473730620|FG004|Overall Study|Withdrawal by Subject|0|||
131575002|NCT01726023|473730624|FG000|Overall Study|Death|1|||
131575003|NCT01726023|473730625|FG001|Overall Study|Death|1|||
131575004|NCT01726023|473730624|FG000|Overall Study|Lost to Follow-up|5|||
131575005|NCT01726023|473730625|FG001|Overall Study|Lost to Follow-up|10|||
131575006|NCT01726023|473730624|FG000|Overall Study|Other Eligibility criteria|7|||
131575007|NCT01726023|473730625|FG001|Overall Study|Other Eligibility criteria|7|||
131575008|NCT01726023|473730624|FG000|Overall Study|Withdrawal by Subject|16|||
131575009|NCT01726023|473730625|FG001|Overall Study|Withdrawal by Subject|8|||
131575010|NCT04858425|473730626|FG000|Overall Study|Adverse Event|2|||
131575011|NCT04858425|473730627|FG001|Overall Study|Adverse Event|2|||
131575012|NCT04858425|473730626|FG000|Overall Study|Withdrawal by Subject|3|||
131575013|NCT04858425|473730627|FG001|Overall Study|Withdrawal by Subject|1|||
131575014|NCT04858425|473730626|FG000|Overall Study|Lost to Follow-up|4|||
131575015|NCT04858425|473730627|FG001|Overall Study|Lost to Follow-up|2|||
131575016|NCT04858425|473730626|FG000|Overall Study|Lost to Follow-up|1|||
131575017|NCT04858425|473730627|FG001|Overall Study|Lost to Follow-up|0|||
131699545|NCT03467958|474183320|FG002|Overall Study|Lack of Efficacy|6|||
131699546|NCT03467958|474183321|FG003|Overall Study|Lack of Efficacy|9|||
131699547|NCT03467958|474183322|FG004|Overall Study|Lack of Efficacy|8|||
131699548|NCT03467958|474183323|FG005|Overall Study|Lack of Efficacy|9|||
131575022|NCT03310983|473730630|FG000|Overall Study|Lost to Follow-up|15|||
131575023|NCT03310983|473730631|FG001|Overall Study|Lost to Follow-up|17|||
131575024|NCT02465359|473730633|FG000|Overall Study|Lack of Efficacy|1|||
131575025|NCT02465359|473730633|FG000|Overall Study|Withdrawal by Subject|1|||
131575026|NCT02465359|473730633|FG000|Overall Study|Adverse Event|1|||
131575027|NCT01304147|473730634|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
131575028|NCT01304147|473730635|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
131575029|NCT01244828|473730636|FG000|Overall Study|Adverse Event|37|||
131575030|NCT01244828|473730636|FG000|Overall Study|Withdrawal by Subject|31|||
131575031|NCT01244828|473730636|FG000|Overall Study|Lack of Efficacy|7|||
131575032|NCT01244828|473730636|FG000|Overall Study|Lost to Follow-up|2|||
131575033|NCT01244828|473730636|FG000|Overall Study|Other reason (not specified)|1|||
131575034|NCT01278862|473730637|FG000|Overall Study|Lost to Follow-up|1|||
131575035|NCT01278862|473730638|FG001|Overall Study|Lost to Follow-up|1|||
131575036|NCT03227757|473732523|FG000|Overall Study|Death|25|||
131575037|NCT03227757|473732523|FG000|Overall Study|Withdrawal|10|||
131575038|NCT03227757|473732523|FG000|Overall Study|Missed visits|1|||
131575039|NCT03227757|473732523|FG000|Overall Study|Lost to Follow-up|2|||
131575040|NCT02960659|473732524|FG000|Overall Study|Withdrawal by Subject|1|||
131575041|NCT02960659|473732525|FG001|Overall Study|Withdrawal by Subject|0|||
131575042|NCT02960659|473732524|FG000|Overall Study|Poor compliance|0|||
131575043|NCT02960659|473732525|FG001|Overall Study|Poor compliance|1|||
131575044|NCT01645111|473732527|FG000|Overall Study|Did not require Clevidipine|15|||
131575045|NCT03068468|473732533|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
131575046|NCT03068468|473732534|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
131575047|NCT03068468|473732535|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
131575048|NCT03068468|473732536|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
131575049|NCT03068468|473732533|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
131575050|NCT03068468|473732534|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
131575051|NCT03068468|473732535|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
131575052|NCT03068468|473732536|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
131575053|NCT03068468|473732533|FG000|Placebo-Controlled Period|Adverse Event|16|||
131575054|NCT03068468|473732534|FG001|Placebo-Controlled Period|Adverse Event|21|||
131575055|NCT03068468|473732535|FG002|Placebo-Controlled Period|Adverse Event|0|||
131575056|NCT03068468|473732536|FG003|Placebo-Controlled Period|Adverse Event|0|||
131575057|NCT03068468|473732533|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
131575058|NCT03068468|473732534|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
131575059|NCT03068468|473732535|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
131575060|NCT03068468|473732536|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
131575061|NCT03068468|473732533|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131575062|NCT03068468|473732534|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
131575063|NCT03068468|473732535|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131575064|NCT03068468|473732536|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131575065|NCT03068468|473732533|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
131575066|NCT03068468|473732534|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
131575067|NCT03068468|473732535|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
131575068|NCT03068468|473732536|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
131575069|NCT03068468|473732533|FG000|Placebo-Controlled Period|Death|0|||
131575070|NCT03068468|473732534|FG001|Placebo-Controlled Period|Death|1|||
131575071|NCT03068468|473732535|FG002|Placebo-Controlled Period|Death|0|||
131575072|NCT03068468|473732536|FG003|Placebo-Controlled Period|Death|0|||
131575073|NCT03068468|473732533|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
131575074|NCT03068468|473732534|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
131575075|NCT03068468|473732535|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
131575076|NCT03068468|473732536|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
131575077|NCT03068468|473732533|FG000|Open-Label Extension Period|Adverse Event|0|||
131575078|NCT03068468|473732534|FG001|Open-Label Extension Period|Adverse Event|0|||
131575079|NCT03068468|473732535|FG002|Open-Label Extension Period|Adverse Event|13|||
131575080|NCT03068468|473732536|FG003|Open-Label Extension Period|Adverse Event|17|||
131575081|NCT03068468|473732533|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
131575082|NCT03068468|473732534|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
131575083|NCT03068468|473732535|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
131575084|NCT03068468|473732536|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
131575085|NCT03068468|473732533|FG000|Open-Label Extension Period|Death|0|||
131575086|NCT03068468|473732534|FG001|Open-Label Extension Period|Death|0|||
131575087|NCT03068468|473732535|FG002|Open-Label Extension Period|Death|0|||
131575088|NCT03068468|473732536|FG003|Open-Label Extension Period|Death|1|||
131575089|NCT03068468|473732533|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
131575090|NCT03068468|473732534|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
131575091|NCT03068468|473732535|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
131575092|NCT03068468|473732536|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
131575093|NCT03068468|473732533|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
131575094|NCT03068468|473732534|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
131575095|NCT03068468|473732535|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
131575096|NCT03068468|473732536|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
131575097|NCT03068468|473732533|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
131575098|NCT03068468|473732534|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
131575099|NCT03068468|473732535|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
131575100|NCT03068468|473732536|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
131575101|NCT03068468|473732533|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
131575102|NCT03068468|473732534|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
131575103|NCT03068468|473732535|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
131575104|NCT03068468|473732536|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
131575105|NCT03068468|473732533|FG000|Open-Label Extension Period|Reason not Specified|0|||
131575106|NCT03068468|473732534|FG001|Open-Label Extension Period|Reason not Specified|0|||
131575107|NCT03068468|473732535|FG002|Open-Label Extension Period|Reason not Specified|1|||
131785344|NCT03033069|474496833|FG001|Overall Study|Withdrawal by Subject|10|||
131785345|NCT03033069|474496834|FG002|Overall Study|Withdrawal by Subject|11|||
131785346|NCT03033069|474496835|FG003|Overall Study|Withdrawal by Subject|6|||
131785347|NCT03033069|474496832|FG000|Overall Study|Withdrawal By Caregiver|1|||
131575108|NCT03068468|473732536|FG003|Open-Label Extension Period|Reason not Specified|4|||
131575109|NCT01062126|473732541|FG000|Overall Study|Death|209|||
131575110|NCT01062126|473732541|FG000|Overall Study|All Withdrawals|324|||
131785348|NCT03033069|474496833|FG001|Overall Study|Withdrawal By Caregiver|0|||
131575111|NCT00646451|473732542|FG000|Overall Study|Adverse Event|3|||
131575112|NCT00646451|473732543|FG001|Overall Study|Adverse Event|0|||
131575113|NCT00646451|473732542|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
131575114|NCT00646451|473732543|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
131575115|NCT00149630|473732544|FG000|Overall Study|Incarceration|2|||
131575116|NCT00149630|473732545|FG001|Overall Study|Incarceration|0|||
131575117|NCT00149630|473732544|FG000|Overall Study|Treatment Programs|4|||
131575118|NCT00149630|473732545|FG001|Overall Study|Treatment Programs|5|||
131575119|NCT00149630|473732544|FG000|Overall Study|Adverse Event|2|||
131575120|NCT00149630|473732545|FG001|Overall Study|Adverse Event|0|||
131575121|NCT01249092|473732551|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
131575122|NCT01249092|473732551|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
131575123|NCT01185522|473732552|FG000|Overall Study|Lack of Efficacy|28|||
131575124|NCT01185522|473732552|FG000|Overall Study|Lost to Follow-up|19|||
131575125|NCT01185522|473732552|FG000|Overall Study|Withdrawal by Subject|10|||
131575126|NCT01185522|473732552|FG000|Overall Study|Poor tolerance|39|||
131575127|NCT01185522|473732552|FG000|Overall Study|Other reasons|12|||
131575128|NCT02281318|473732553|FG000|Overall Study|Adverse Event|2|||
131575129|NCT02281318|473732554|FG001|Overall Study|Adverse Event|2|||
131575130|NCT02281318|473732553|FG000|Overall Study|Lack of Efficacy|2|||
131575131|NCT02281318|473732554|FG001|Overall Study|Lack of Efficacy|0|||
131575132|NCT02281318|473732553|FG000|Overall Study|Lost to Follow-up|2|||
131575133|NCT02281318|473732554|FG001|Overall Study|Lost to Follow-up|1|||
131575134|NCT02281318|473732553|FG000|Overall Study|Physician Decision|2|||
131575135|NCT02281318|473732554|FG001|Overall Study|Physician Decision|0|||
131575136|NCT02281318|473732553|FG000|Overall Study|Withdrawal by Subject|6|||
131575137|NCT02281318|473732554|FG001|Overall Study|Withdrawal by Subject|2|||
131575138|NCT02846415|473732558|FG000|Overall Study|Lost to Follow-up|2|||
131575139|NCT02846415|473732559|FG001|Overall Study|Lost to Follow-up|0|||
131575140|NCT02846415|473732558|FG000|Overall Study|Withdrawal by Subject|1|||
131575141|NCT02846415|473732559|FG001|Overall Study|Withdrawal by Subject|1|||
131575142|NCT03383887|473732560|FG000|Overall Study|Lost to Follow-up|0|||
131575143|NCT03383887|473732561|FG001|Overall Study|Lost to Follow-up|1|||
131575144|NCT00831792|473732562|FG000|Overall Study|Not Eligible|3|||
131575145|NCT00831792|473732562|FG000|Overall Study|Adverse Event|1|||
131575146|NCT00831792|473732562|FG000|Overall Study|Death|1|||
131575147|NCT00831792|473732562|FG000|Overall Study|Lack of Efficacy|1|||
131575148|NCT01242085|473732565|FG000|Overall Study|Withdrawal by Subject|4|||
131575149|NCT01242085|473732566|FG001|Overall Study|Withdrawal by Subject|2|||
131575150|NCT01242085|473732567|FG002|Overall Study|Withdrawal by Subject|0|||
131575151|NCT01242085|473732565|FG000|Overall Study|medically unable to have surgery|4|||
131575152|NCT01242085|473732566|FG001|Overall Study|medically unable to have surgery|5|||
131575153|NCT01242085|473732567|FG002|Overall Study|medically unable to have surgery|0|||
131575154|NCT01178762|473732568|FG000|Overall Study|Lost to Follow-up|15|||
131575155|NCT02377362|473732569|FG000|Part A Second Treatment|Protocol Violation|0|||
131575156|NCT02377362|473732570|FG001|Part A Second Treatment|Protocol Violation|0|||
131575157|NCT02377362|473732571|FG002|Part A Second Treatment|Protocol Violation|0|||
131575158|NCT02377362|473732572|FG003|Part A Second Treatment|Protocol Violation|0|||
131575159|NCT02377362|473732573|FG004|Part A Second Treatment|Protocol Violation|1|||
131575160|NCT02377362|473732574|FG005|Part A Second Treatment|Protocol Violation|0|||
131575161|NCT02377362|473732575|FG006|Part A Second Treatment|Protocol Violation|0|||
131575162|NCT02377362|473732576|FG007|Part A Second Treatment|Protocol Violation|0|||
131575163|NCT02377362|473732577|FG008|Part A Second Treatment|Protocol Violation|0|||
131575164|NCT02377362|473732578|FG009|Part A Second Treatment|Protocol Violation|0|||
131575165|NCT02377362|473732579|FG010|Part A Second Treatment|Protocol Violation|0|||
131575166|NCT02377362|473732580|FG011|Part A Second Treatment|Protocol Violation|0|||
131575167|NCT02377362|473732581|FG012|Part A Second Treatment|Protocol Violation|0|||
131575168|NCT02377362|473732569|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575169|NCT02377362|473732570|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575170|NCT02377362|473732571|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575171|NCT02377362|473732572|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
131575172|NCT02377362|473732573|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
131575173|NCT02377362|473732574|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
131575174|NCT02377362|473732575|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575175|NCT02377362|473732576|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575176|NCT02377362|473732577|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575177|NCT02377362|473732578|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575178|NCT02377362|473732579|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575179|NCT02377362|473732580|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575180|NCT02377362|473732581|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
131575181|NCT02377362|473732569|FG000|Part B Overall|Protocol Violation|0|||
131575182|NCT02377362|473732570|FG001|Part B Overall|Protocol Violation|0|||
131575183|NCT02377362|473732571|FG002|Part B Overall|Protocol Violation|0|||
131575184|NCT02377362|473732572|FG003|Part B Overall|Protocol Violation|0|||
131575185|NCT02377362|473732573|FG004|Part B Overall|Protocol Violation|0|||
131575186|NCT02377362|473732574|FG005|Part B Overall|Protocol Violation|0|||
131575187|NCT02377362|473732575|FG006|Part B Overall|Protocol Violation|0|||
131438004|NCT01582061|473229465|FG001|Overall Study|Lost to Follow-up|0|||
131575188|NCT02377362|473732576|FG007|Part B Overall|Protocol Violation|0|||
131575189|NCT02377362|473732577|FG008|Part B Overall|Protocol Violation|0|||
131575190|NCT02377362|473732578|FG009|Part B Overall|Protocol Violation|1|||
131575191|NCT02377362|473732579|FG010|Part B Overall|Protocol Violation|0|||
131575192|NCT02377362|473732580|FG011|Part B Overall|Protocol Violation|0|||
131575193|NCT02377362|473732581|FG012|Part B Overall|Protocol Violation|0|||
131575194|NCT02377362|473732569|FG000|Part B Overall|Adverse Event|0|||
131575195|NCT02377362|473732570|FG001|Part B Overall|Adverse Event|0|||
131575196|NCT02377362|473732571|FG002|Part B Overall|Adverse Event|0|||
131575197|NCT02377362|473732572|FG003|Part B Overall|Adverse Event|0|||
131575198|NCT02377362|473732573|FG004|Part B Overall|Adverse Event|0|||
131575199|NCT02377362|473732574|FG005|Part B Overall|Adverse Event|0|||
131575200|NCT02377362|473732575|FG006|Part B Overall|Adverse Event|1|||
131575201|NCT02377362|473732576|FG007|Part B Overall|Adverse Event|1|||
131575202|NCT02377362|473732577|FG008|Part B Overall|Adverse Event|0|||
131575203|NCT02377362|473732578|FG009|Part B Overall|Adverse Event|0|||
131575204|NCT02377362|473732579|FG010|Part B Overall|Adverse Event|0|||
131575205|NCT02377362|473732580|FG011|Part B Overall|Adverse Event|0|||
131575206|NCT02377362|473732581|FG012|Part B Overall|Adverse Event|0|||
131575207|NCT02377362|473732569|FG000|Part B Overall|Withdrawal by Subject|0|||
131575208|NCT02377362|473732570|FG001|Part B Overall|Withdrawal by Subject|0|||
131575209|NCT02377362|473732571|FG002|Part B Overall|Withdrawal by Subject|0|||
131575210|NCT02377362|473732572|FG003|Part B Overall|Withdrawal by Subject|0|||
131575211|NCT02377362|473732573|FG004|Part B Overall|Withdrawal by Subject|0|||
131575212|NCT02377362|473732574|FG005|Part B Overall|Withdrawal by Subject|0|||
131575213|NCT02377362|473732575|FG006|Part B Overall|Withdrawal by Subject|1|||
131575214|NCT02377362|473732576|FG007|Part B Overall|Withdrawal by Subject|0|||
131575215|NCT02377362|473732577|FG008|Part B Overall|Withdrawal by Subject|0|||
131575216|NCT02377362|473732578|FG009|Part B Overall|Withdrawal by Subject|0|||
131575217|NCT02377362|473732579|FG010|Part B Overall|Withdrawal by Subject|0|||
131575218|NCT02377362|473732580|FG011|Part B Overall|Withdrawal by Subject|1|||
131575219|NCT02377362|473732581|FG012|Part B Overall|Withdrawal by Subject|0|||
131575220|NCT02322216|473732582|FG000|Overall Study|Adverse Event|1|||
131575221|NCT02322216|473732583|FG001|Overall Study|Adverse Event|0|||
131575222|NCT02322216|473732582|FG000|Overall Study|Withdrawal by Subject|1|||
131575223|NCT02322216|473732583|FG001|Overall Study|Withdrawal by Subject|4|||
131575224|NCT01651949|473732593|FG000|Overall Study|Unknown status|4|||
131575225|NCT01651949|473732594|FG001|Overall Study|Unknown status|4|||
131575226|NCT01651949|473732595|FG002|Overall Study|Unknown status|0|||
131575227|NCT01651949|473732593|FG000|Overall Study|Lost to Follow-up|30|||
131575228|NCT01651949|473732594|FG001|Overall Study|Lost to Follow-up|56|||
131575229|NCT01651949|473732595|FG002|Overall Study|Lost to Follow-up|20|||
131575230|NCT01651949|473732593|FG000|Overall Study|Protocol Violation|0|||
131575231|NCT01651949|473732594|FG001|Overall Study|Protocol Violation|2|||
131575232|NCT01651949|473732595|FG002|Overall Study|Protocol Violation|1|||
131575233|NCT01651949|473732593|FG000|Overall Study|Physician Decision|0|||
131575234|NCT01651949|473732594|FG001|Overall Study|Physician Decision|2|||
131575235|NCT01651949|473732595|FG002|Overall Study|Physician Decision|0|||
131575236|NCT01651949|473732593|FG000|Overall Study|Adverse Event|0|||
131575237|NCT01651949|473732594|FG001|Overall Study|Adverse Event|2|||
131575238|NCT01651949|473732595|FG002|Overall Study|Adverse Event|1|||
131575239|NCT01651949|473732593|FG000|Overall Study|Screen failure|2|||
131575240|NCT01651949|473732594|FG001|Overall Study|Screen failure|2|||
131575241|NCT01651949|473732595|FG002|Overall Study|Screen failure|0|||
131575242|NCT01651949|473732593|FG000|Overall Study|Withdrawal by Subject|17|||
131575243|NCT01651949|473732594|FG001|Overall Study|Withdrawal by Subject|18|||
131575244|NCT01651949|473732595|FG002|Overall Study|Withdrawal by Subject|9|||
131575245|NCT00404079|473732600|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
131575246|NCT00404079|473732601|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
131575247|NCT01120275|473732602|FG000|Overall Study|Adverse Event|3|||
131575248|NCT01120275|473732602|FG000|Overall Study|Progression|27|||
131575249|NCT01120275|473732602|FG000|Overall Study|Ineligible|3|||
131575250|NCT01120275|473732602|FG000|Overall Study|Withdrawal by Subject|1|||
131575251|NCT01120275|473732602|FG000|Overall Study|Refusal|1|||
131575252|NCT01120275|473732602|FG000|Overall Study|Not specific|1|||
131575253|NCT01191086|473732612|FG000|Overall Study|Adverse Event|20|||
131575254|NCT01191086|473732612|FG000|Overall Study|Lack of Efficacy|10|||
131575255|NCT01191086|473732612|FG000|Overall Study|Lost to Follow-up|4|||
131575256|NCT01191086|473732612|FG000|Overall Study|Physician Decision|2|||
131575257|NCT01191086|473732612|FG000|Overall Study|Withdrawal by Subject|24|||
131575258|NCT01191086|473732612|FG000|Overall Study|Discontinuation criterion met|1|||
131575259|NCT01191086|473732612|FG000|Overall Study|Other|1|||
131575260|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Other|4|||
131575261|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Other|0|||
131575262|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
131575263|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
131575264|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
131575265|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
131575266|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
131575267|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
131575268|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
131575269|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
131575270|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
131575271|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
131575272|NCT00853827|473732613|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
131575273|NCT00853827|473732614|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
131575274|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
131575275|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
131575276|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
131575277|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
131575278|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
131575279|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
131575280|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
131575281|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
131575282|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
131575283|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
131575284|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
131575285|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
131575286|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
131575287|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
131575288|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
131575289|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
131575290|NCT00853827|473732613|FG000|Double Blind Period (103 Weeks)|Death|1|||
131575291|NCT00853827|473732614|FG001|Double Blind Period (103 Weeks)|Death|6|||
131575292|NCT00880906|473732619|FG000|Overall Study|Lost to Follow-up|0|||
131575293|NCT00880906|473732620|FG001|Overall Study|Lost to Follow-up|1|||
131575294|NCT00880906|473732619|FG000|Overall Study|Did not meet criteria following patholog|12|||
131575295|NCT00880906|473732620|FG001|Overall Study|Did not meet criteria following patholog|6|||
131575296|NCT00559949|473732623|FG000|Overall Study|Progressive Disease during cycle 1|1|||
131575297|NCT00559949|473732623|FG000|Overall Study|Adverse Event|1|||
131575298|NCT00559949|473732623|FG000|Overall Study|Withdrawal by Subject|4|||
131575299|NCT00559949|473732623|FG000|Overall Study|No disease evaluation per protocol|1|||
131575300|NCT00414648|473732624|FG000|Overall Study|Adverse Event|5|||
131575301|NCT00414648|473732625|FG001|Overall Study|Adverse Event|5|||
131575302|NCT00414648|473732624|FG000|Overall Study|Death|0|||
131575303|NCT00414648|473732625|FG001|Overall Study|Death|1|||
131575304|NCT00414648|473732624|FG000|Overall Study|Lack of Efficacy|0|||
131575305|NCT00414648|473732625|FG001|Overall Study|Lack of Efficacy|2|||
131575306|NCT00414648|473732624|FG000|Overall Study|Withdrawal by Subject|0|||
131575307|NCT00414648|473732625|FG001|Overall Study|Withdrawal by Subject|1|||
131575308|NCT01235949|473732630|FG000|Primary Phase|Migrated/moved from study area|1|||
131575309|NCT01235949|473732631|FG001|Primary Phase|Migrated/moved from study area|1|||
131575310|NCT01235949|473732632|FG002|Primary Phase|Migrated/moved from study area|0|||
131575311|NCT01235949|473732633|FG003|Primary Phase|Migrated/moved from study area|0|||
131575312|NCT01235949|473732634|FG004|Primary Phase|Migrated/moved from study area|1|||
131575313|NCT01235949|473732635|FG005|Primary Phase|Migrated/moved from study area|2|||
131575314|NCT01235949|473732636|FG006|Primary Phase|Migrated/moved from study area|0|||
131575315|NCT01235949|473732637|FG007|Primary Phase|Migrated/moved from study area|0|||
131575316|NCT01235949|473732638|FG008|Primary Phase|Migrated/moved from study area|0|||
131575317|NCT01235949|473732639|FG009|Primary Phase|Migrated/moved from study area|0|||
131575318|NCT01235949|473732640|FG010|Primary Phase|Migrated/moved from study area|0|||
131575319|NCT01235949|473732641|FG011|Primary Phase|Migrated/moved from study area|0|||
131575320|NCT01235949|473732642|FG012|Primary Phase|Migrated/moved from study area|0|||
131575321|NCT01235949|473732643|FG013|Primary Phase|Migrated/moved from study area|0|||
131575322|NCT01235949|473732644|FG014|Primary Phase|Migrated/moved from study area|0|||
131575323|NCT01235949|473732645|FG015|Primary Phase|Migrated/moved from study area|0|||
131575324|NCT01235949|473732646|FG016|Primary Phase|Migrated/moved from study area|0|||
131575325|NCT01235949|473732647|FG017|Primary Phase|Migrated/moved from study area|0|||
131575326|NCT01235949|473732630|FG000|Primary Phase|Adverse Event|0|||
131575327|NCT01235949|473732631|FG001|Primary Phase|Adverse Event|0|||
131575328|NCT01235949|473732632|FG002|Primary Phase|Adverse Event|0|||
131575329|NCT01235949|473732633|FG003|Primary Phase|Adverse Event|1|||
131575330|NCT01235949|473732634|FG004|Primary Phase|Adverse Event|0|||
131575331|NCT01235949|473732635|FG005|Primary Phase|Adverse Event|0|||
131575332|NCT01235949|473732636|FG006|Primary Phase|Adverse Event|0|||
131575333|NCT01235949|473732637|FG007|Primary Phase|Adverse Event|0|||
131575334|NCT01235949|473732638|FG008|Primary Phase|Adverse Event|0|||
131575335|NCT01235949|473732639|FG009|Primary Phase|Adverse Event|0|||
131575336|NCT01235949|473732640|FG010|Primary Phase|Adverse Event|0|||
131575337|NCT01235949|473732641|FG011|Primary Phase|Adverse Event|0|||
131575338|NCT01235949|473732642|FG012|Primary Phase|Adverse Event|0|||
131575339|NCT01235949|473732643|FG013|Primary Phase|Adverse Event|0|||
131575340|NCT01235949|473732644|FG014|Primary Phase|Adverse Event|0|||
131575341|NCT01235949|473732645|FG015|Primary Phase|Adverse Event|0|||
131575342|NCT01235949|473732646|FG016|Primary Phase|Adverse Event|0|||
131575343|NCT01235949|473732647|FG017|Primary Phase|Adverse Event|0|||
131575344|NCT01235949|473732630|FG000|Primary Phase|Withdrawal by Subject|3|||
131575345|NCT01235949|473732631|FG001|Primary Phase|Withdrawal by Subject|2|||
131575346|NCT01235949|473732632|FG002|Primary Phase|Withdrawal by Subject|2|||
131575347|NCT01235949|473732633|FG003|Primary Phase|Withdrawal by Subject|0|||
131575348|NCT01235949|473732634|FG004|Primary Phase|Withdrawal by Subject|0|||
131575349|NCT01235949|473732635|FG005|Primary Phase|Withdrawal by Subject|3|||
131575350|NCT01235949|473732636|FG006|Primary Phase|Withdrawal by Subject|0|||
131575351|NCT01235949|473732637|FG007|Primary Phase|Withdrawal by Subject|0|||
131575352|NCT01235949|473732638|FG008|Primary Phase|Withdrawal by Subject|0|||
131575353|NCT01235949|473732639|FG009|Primary Phase|Withdrawal by Subject|0|||
131785349|NCT03033069|474496834|FG002|Overall Study|Withdrawal By Caregiver|0|||
131785350|NCT03033069|474496835|FG003|Overall Study|Withdrawal By Caregiver|0|||
131785351|NCT03033069|474496832|FG000|Overall Study|Reason not Specified|0|||
131785352|NCT03033069|474496833|FG001|Overall Study|Reason not Specified|1|||
131785353|NCT03033069|474496834|FG002|Overall Study|Reason not Specified|0|||
131575354|NCT01235949|473732640|FG010|Primary Phase|Withdrawal by Subject|0|||
131785354|NCT03033069|474496835|FG003|Overall Study|Reason not Specified|1|||
131785355|NCT02623426|474496838|FG000|Overall Study|Lost to Follow-up|0|||
131785356|NCT02623426|474496839|FG001|Overall Study|Lost to Follow-up|0|||
131785357|NCT02623426|474496840|FG002|Overall Study|Lost to Follow-up|1|||
131785358|NCT02623426|474496838|FG000|Overall Study|Withdrawal by Subject|1|||
131785359|NCT02623426|474496839|FG001|Overall Study|Withdrawal by Subject|2|||
131785360|NCT02623426|474496840|FG002|Overall Study|Withdrawal by Subject|2|||
131785361|NCT05458895|474496846|FG000|Overall Study|Withdrawal by Subject|8|||
131785362|NCT05458895|474496846|FG000|Overall Study|Lost to Follow-up|17|||
131785363|NCT05458895|474496846|FG000|Overall Study|Pregnancy|2|||
131785364|NCT05458895|474496846|FG000|Overall Study|Withdrawal by Study Team|1|||
131785365|NCT04639310|474496847|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
131785366|NCT04639310|474496848|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
131785367|NCT00700310|474498739|FG000|Overall Study|Adverse Event|6|||
131785368|NCT00700310|474498740|FG001|Overall Study|Adverse Event|10|||
131785369|NCT00700310|474498741|FG002|Overall Study|Adverse Event|5|||
131785370|NCT00700310|474498742|FG003|Overall Study|Adverse Event|11|||
131785371|NCT00700310|474498739|FG000|Overall Study|Lost to Follow-up|4|||
131785372|NCT00700310|474498740|FG001|Overall Study|Lost to Follow-up|1|||
131575355|NCT01235949|473732641|FG011|Primary Phase|Withdrawal by Subject|0|||
131575356|NCT01235949|473732642|FG012|Primary Phase|Withdrawal by Subject|0|||
131785373|NCT00700310|474498741|FG002|Overall Study|Lost to Follow-up|0|||
131575357|NCT01235949|473732643|FG013|Primary Phase|Withdrawal by Subject|0|||
131575358|NCT01235949|473732644|FG014|Primary Phase|Withdrawal by Subject|0|||
131785374|NCT00700310|474498742|FG003|Overall Study|Lost to Follow-up|1|||
131785375|NCT00700310|474498739|FG000|Overall Study|Withdrawal by Subject|8|||
131785376|NCT00700310|474498740|FG001|Overall Study|Withdrawal by Subject|9|||
131785377|NCT00700310|474498741|FG002|Overall Study|Withdrawal by Subject|8|||
131785378|NCT00700310|474498742|FG003|Overall Study|Withdrawal by Subject|8|||
131575359|NCT01235949|473732645|FG015|Primary Phase|Withdrawal by Subject|0|||
131575360|NCT01235949|473732646|FG016|Primary Phase|Withdrawal by Subject|0|||
131575361|NCT01235949|473732647|FG017|Primary Phase|Withdrawal by Subject|0|||
131575362|NCT01235949|473732630|FG000|Primary Phase|Lost to Follow-up|0|||
131575363|NCT01235949|473732631|FG001|Primary Phase|Lost to Follow-up|0|||
131575364|NCT01235949|473732632|FG002|Primary Phase|Lost to Follow-up|1|||
131575365|NCT01235949|473732633|FG003|Primary Phase|Lost to Follow-up|1|||
131575366|NCT01235949|473732634|FG004|Primary Phase|Lost to Follow-up|0|||
131575367|NCT01235949|473732635|FG005|Primary Phase|Lost to Follow-up|2|||
131575368|NCT01235949|473732636|FG006|Primary Phase|Lost to Follow-up|0|||
131575369|NCT01235949|473732637|FG007|Primary Phase|Lost to Follow-up|0|||
131575370|NCT01235949|473732638|FG008|Primary Phase|Lost to Follow-up|0|||
131575371|NCT01235949|473732639|FG009|Primary Phase|Lost to Follow-up|0|||
131575372|NCT01235949|473732640|FG010|Primary Phase|Lost to Follow-up|0|||
131575373|NCT01235949|473732641|FG011|Primary Phase|Lost to Follow-up|0|||
131575374|NCT01235949|473732642|FG012|Primary Phase|Lost to Follow-up|0|||
131575375|NCT01235949|473732643|FG013|Primary Phase|Lost to Follow-up|0|||
131575376|NCT01235949|473732644|FG014|Primary Phase|Lost to Follow-up|0|||
131575377|NCT01235949|473732645|FG015|Primary Phase|Lost to Follow-up|0|||
131575378|NCT01235949|473732646|FG016|Primary Phase|Lost to Follow-up|0|||
131575379|NCT01235949|473732647|FG017|Primary Phase|Lost to Follow-up|0|||
131575380|NCT01235949|473732630|FG000|Booster Phase|Migrated/moved from study area|0|||
131575381|NCT01235949|473732631|FG001|Booster Phase|Migrated/moved from study area|0|||
131575382|NCT01235949|473732632|FG002|Booster Phase|Migrated/moved from study area|0|||
131575383|NCT01235949|473732633|FG003|Booster Phase|Migrated/moved from study area|0|||
131575384|NCT01235949|473732634|FG004|Booster Phase|Migrated/moved from study area|0|||
131575385|NCT01235949|473732635|FG005|Booster Phase|Migrated/moved from study area|0|||
131575386|NCT01235949|473732636|FG006|Booster Phase|Migrated/moved from study area|0|||
131575387|NCT01235949|473732637|FG007|Booster Phase|Migrated/moved from study area|0|||
131575388|NCT01235949|473732638|FG008|Booster Phase|Migrated/moved from study area|0|||
131575389|NCT01235949|473732639|FG009|Booster Phase|Migrated/moved from study area|0|||
131575390|NCT01235949|473732640|FG010|Booster Phase|Migrated/moved from study area|0|||
131575391|NCT01235949|473732641|FG011|Booster Phase|Migrated/moved from study area|1|||
131575392|NCT01235949|473732642|FG012|Booster Phase|Migrated/moved from study area|1|||
131575393|NCT01235949|473732643|FG013|Booster Phase|Migrated/moved from study area|0|||
131575394|NCT01235949|473732644|FG014|Booster Phase|Migrated/moved from study area|0|||
131575395|NCT01235949|473732645|FG015|Booster Phase|Migrated/moved from study area|0|||
131575396|NCT01235949|473732646|FG016|Booster Phase|Migrated/moved from study area|0|||
131575397|NCT01235949|473732647|FG017|Booster Phase|Migrated/moved from study area|1|||
131575398|NCT01235949|473732630|FG000|Booster Phase|Adverse Event|0|||
131575399|NCT01235949|473732631|FG001|Booster Phase|Adverse Event|0|||
131575400|NCT01235949|473732632|FG002|Booster Phase|Adverse Event|0|||
131575401|NCT01235949|473732633|FG003|Booster Phase|Adverse Event|0|||
131575402|NCT01235949|473732634|FG004|Booster Phase|Adverse Event|0|||
131575403|NCT01235949|473732635|FG005|Booster Phase|Adverse Event|0|||
131575404|NCT01235949|473732636|FG006|Booster Phase|Adverse Event|0|||
131575405|NCT01235949|473732637|FG007|Booster Phase|Adverse Event|0|||
131575406|NCT01235949|473732638|FG008|Booster Phase|Adverse Event|0|||
131575407|NCT01235949|473732639|FG009|Booster Phase|Adverse Event|0|||
131575408|NCT01235949|473732640|FG010|Booster Phase|Adverse Event|0|||
131575409|NCT01235949|473732641|FG011|Booster Phase|Adverse Event|0|||
131575410|NCT01235949|473732642|FG012|Booster Phase|Adverse Event|0|||
131575411|NCT01235949|473732643|FG013|Booster Phase|Adverse Event|0|||
131575412|NCT01235949|473732644|FG014|Booster Phase|Adverse Event|0|||
131575413|NCT01235949|473732645|FG015|Booster Phase|Adverse Event|1|||
131575414|NCT01235949|473732646|FG016|Booster Phase|Adverse Event|0|||
131575415|NCT01235949|473732647|FG017|Booster Phase|Adverse Event|0|||
131575416|NCT01235949|473732630|FG000|Booster Phase|Withdrawal by Subject|0|||
131575417|NCT01235949|473732631|FG001|Booster Phase|Withdrawal by Subject|0|||
131575418|NCT01235949|473732632|FG002|Booster Phase|Withdrawal by Subject|0|||
131575419|NCT01235949|473732633|FG003|Booster Phase|Withdrawal by Subject|0|||
131575420|NCT01235949|473732634|FG004|Booster Phase|Withdrawal by Subject|0|||
131575421|NCT01235949|473732635|FG005|Booster Phase|Withdrawal by Subject|0|||
131575422|NCT01235949|473732636|FG006|Booster Phase|Withdrawal by Subject|0|||
131575423|NCT01235949|473732637|FG007|Booster Phase|Withdrawal by Subject|1|||
131575424|NCT01235949|473732638|FG008|Booster Phase|Withdrawal by Subject|1|||
131575425|NCT01235949|473732639|FG009|Booster Phase|Withdrawal by Subject|0|||
131575426|NCT01235949|473732640|FG010|Booster Phase|Withdrawal by Subject|1|||
131575427|NCT01235949|473732641|FG011|Booster Phase|Withdrawal by Subject|1|||
131575428|NCT01235949|473732642|FG012|Booster Phase|Withdrawal by Subject|2|||
131575429|NCT01235949|473732643|FG013|Booster Phase|Withdrawal by Subject|0|||
131575430|NCT01235949|473732644|FG014|Booster Phase|Withdrawal by Subject|2|||
131575431|NCT01235949|473732645|FG015|Booster Phase|Withdrawal by Subject|0|||
131575432|NCT01235949|473732646|FG016|Booster Phase|Withdrawal by Subject|0|||
131575433|NCT01235949|473732647|FG017|Booster Phase|Withdrawal by Subject|0|||
131575434|NCT01235949|473732630|FG000|Booster Phase|Lost to Follow-up|0|||
131575435|NCT01235949|473732631|FG001|Booster Phase|Lost to Follow-up|0|||
131575436|NCT01235949|473732632|FG002|Booster Phase|Lost to Follow-up|0|||
131575437|NCT01235949|473732633|FG003|Booster Phase|Lost to Follow-up|0|||
131575438|NCT01235949|473732634|FG004|Booster Phase|Lost to Follow-up|0|||
131575439|NCT01235949|473732635|FG005|Booster Phase|Lost to Follow-up|0|||
131575440|NCT01235949|473732636|FG006|Booster Phase|Lost to Follow-up|0|||
131575441|NCT01235949|473732637|FG007|Booster Phase|Lost to Follow-up|0|||
131575442|NCT01235949|473732638|FG008|Booster Phase|Lost to Follow-up|1|||
131575443|NCT01235949|473732639|FG009|Booster Phase|Lost to Follow-up|1|||
131575444|NCT01235949|473732640|FG010|Booster Phase|Lost to Follow-up|1|||
131575445|NCT01235949|473732641|FG011|Booster Phase|Lost to Follow-up|1|||
131575446|NCT01235949|473732642|FG012|Booster Phase|Lost to Follow-up|0|||
131575447|NCT01235949|473732643|FG013|Booster Phase|Lost to Follow-up|0|||
131575448|NCT01235949|473732644|FG014|Booster Phase|Lost to Follow-up|0|||
131575449|NCT01235949|473732645|FG015|Booster Phase|Lost to Follow-up|0|||
131575450|NCT01235949|473732646|FG016|Booster Phase|Lost to Follow-up|0|||
131575451|NCT01235949|473732647|FG017|Booster Phase|Lost to Follow-up|1|||
131575452|NCT04173572|473732648|FG000|Overall Study|Withdrawal by Subject|1|||
131575453|NCT04173572|473732649|FG001|Overall Study|Withdrawal by Subject|5|||
131575454|NCT04173572|473732648|FG000|Overall Study|Lost to Follow-up|3|||
131575455|NCT04173572|473732649|FG001|Overall Study|Lost to Follow-up|1|||
131575456|NCT00383188|473732650|FG000|Overall Study|Adverse Event|4|||
131575457|NCT00383188|473732651|FG001|Overall Study|Adverse Event|7|||
131575458|NCT00383188|473732652|FG002|Overall Study|Adverse Event|9|||
131575459|NCT00383188|473732653|FG003|Overall Study|Adverse Event|8|||
131575460|NCT00383188|473732654|FG004|Overall Study|Adverse Event|8|||
131575461|NCT00383188|473732650|FG000|Overall Study|Lack of Efficacy|9|||
131575462|NCT00383188|473732651|FG001|Overall Study|Lack of Efficacy|3|||
131575463|NCT00383188|473732652|FG002|Overall Study|Lack of Efficacy|3|||
131575464|NCT00383188|473732653|FG003|Overall Study|Lack of Efficacy|2|||
131575465|NCT00383188|473732654|FG004|Overall Study|Lack of Efficacy|6|||
131575466|NCT00383188|473732650|FG000|Overall Study|Other|3|||
131575467|NCT00383188|473732651|FG001|Overall Study|Other|1|||
131575468|NCT00383188|473732652|FG002|Overall Study|Other|0|||
131575469|NCT00383188|473732653|FG003|Overall Study|Other|2|||
131575470|NCT00383188|473732654|FG004|Overall Study|Other|6|||
131575471|NCT00383188|473732650|FG000|Overall Study|No longer willing to participate|1|||
131575472|NCT00383188|473732651|FG001|Overall Study|No longer willing to participate|0|||
131575473|NCT00383188|473732652|FG002|Overall Study|No longer willing to participate|1|||
131575474|NCT00383188|473732653|FG003|Overall Study|No longer willing to participate|0|||
131575475|NCT00383188|473732654|FG004|Overall Study|No longer willing to participate|2|||
131575476|NCT00383188|473732650|FG000|Overall Study|Lost to Follow-up|0|||
131575477|NCT00383188|473732651|FG001|Overall Study|Lost to Follow-up|0|||
131575478|NCT00383188|473732652|FG002|Overall Study|Lost to Follow-up|0|||
131575479|NCT00383188|473732653|FG003|Overall Study|Lost to Follow-up|0|||
131575480|NCT00383188|473732654|FG004|Overall Study|Lost to Follow-up|1|||
131575481|NCT00835380|473732659|FG000|Overall Study|Withdrawal by Subject|2|||
131575482|NCT03247543|473732660|FG000|Overall Study|Adverse Event|3|||
131575483|NCT03247543|473732661|FG001|Overall Study|Adverse Event|6|||
131575484|NCT03247543|473732662|FG002|Overall Study|Adverse Event|4|||
131575485|NCT03247543|473732660|FG000|Overall Study|Lost to Follow-up|10|||
131575486|NCT03247543|473732661|FG001|Overall Study|Lost to Follow-up|7|||
131575487|NCT03247543|473732662|FG002|Overall Study|Lost to Follow-up|8|||
131575488|NCT03247543|473732660|FG000|Overall Study|Consent withdrawn by caregiver|2|||
131575489|NCT03247543|473732661|FG001|Overall Study|Consent withdrawn by caregiver|2|||
131575490|NCT03247543|473732662|FG002|Overall Study|Consent withdrawn by caregiver|9|||
131575491|NCT03247543|473732660|FG000|Overall Study|Withdrawal by Subject|0|||
131575492|NCT03247543|473732661|FG001|Overall Study|Withdrawal by Subject|0|||
131575493|NCT03247543|473732662|FG002|Overall Study|Withdrawal by Subject|1|||
131575494|NCT03247543|473732660|FG000|Overall Study|Failure to Follow study procedures|1|||
131575495|NCT03247543|473732661|FG001|Overall Study|Failure to Follow study procedures|3|||
131575496|NCT03247543|473732662|FG002|Overall Study|Failure to Follow study procedures|1|||
131575497|NCT03247543|473732660|FG000|Overall Study|Lack of Efficacy|1|||
131575498|NCT03247543|473732661|FG001|Overall Study|Lack of Efficacy|0|||
131575499|NCT03247543|473732662|FG002|Overall Study|Lack of Efficacy|0|||
131575500|NCT03247543|473732660|FG000|Overall Study|Non-compliance with study visits|0|||
131575501|NCT03247543|473732661|FG001|Overall Study|Non-compliance with study visits|1|||
131575502|NCT03247543|473732662|FG002|Overall Study|Non-compliance with study visits|0|||
131575503|NCT02059980|473732665|FG000|Overall Study|Lost to Follow-up|2|||
131575504|NCT02059980|473732666|FG001|Overall Study|Lost to Follow-up|1|||
131575505|NCT01104415|473732667|FG000|Core Phase|Consent withdrawn by subjects|1|||
131575506|NCT01104415|473732668|FG001|Core Phase|Consent withdrawn by subjects|0|||
131575507|NCT01104415|473732667|FG000|Extension Period|Progressive disease|0|||
131575508|NCT01104415|473732668|FG001|Extension Period|Progressive disease|4|||
131575509|NCT01104415|473732667|FG000|Extension Period|Death|0|||
131575510|NCT01104415|473732668|FG001|Extension Period|Death|1|||
131575511|NCT01104415|473732667|FG000|Extension Period|Physician Decision|0|||
131575512|NCT01104415|473732668|FG001|Extension Period|Physician Decision|1|||
131575513|NCT01104415|473732667|FG000|Extension Period|Transition to Study LX1606.302|0|||
131575514|NCT01104415|473732668|FG001|Extension Period|Transition to Study LX1606.302|4|||
131575515|NCT01104415|473732667|FG000|Extension Period|Heart surgery/feeling miserable|0|||
131575516|NCT01104415|473732668|FG001|Extension Period|Heart surgery/feeling miserable|1|||
131575517|NCT02341625|473732673|FG000|Overall Study|Disease Progression|2|||
131575518|NCT02341625|473732674|FG001|Overall Study|Disease Progression|2|||
131575519|NCT02341625|473732675|FG002|Overall Study|Disease Progression|3|||
131575520|NCT02341625|473732676|FG003|Overall Study|Disease Progression|6|||
131575521|NCT02341625|473732677|FG004|Overall Study|Disease Progression|7|||
131575522|NCT02341625|473732678|FG005|Overall Study|Disease Progression|7|||
131575523|NCT02341625|473732679|FG006|Overall Study|Disease Progression|28|||
131575524|NCT02341625|473732680|FG007|Overall Study|Disease Progression|5|||
131575525|NCT02341625|473732681|FG008|Overall Study|Disease Progression|4|||
131575526|NCT02341625|473732682|FG009|Overall Study|Disease Progression|19|||
131575527|NCT02341625|473732673|FG000|Overall Study|Study Drug Toxicity|0|||
131575528|NCT02341625|473732674|FG001|Overall Study|Study Drug Toxicity|0|||
131575529|NCT02341625|473732675|FG002|Overall Study|Study Drug Toxicity|0|||
131575530|NCT02341625|473732676|FG003|Overall Study|Study Drug Toxicity|1|||
131575531|NCT02341625|473732677|FG004|Overall Study|Study Drug Toxicity|0|||
131575532|NCT02341625|473732678|FG005|Overall Study|Study Drug Toxicity|3|||
131575533|NCT02341625|473732679|FG006|Overall Study|Study Drug Toxicity|10|||
131575534|NCT02341625|473732680|FG007|Overall Study|Study Drug Toxicity|0|||
131575535|NCT02341625|473732681|FG008|Overall Study|Study Drug Toxicity|0|||
131575536|NCT02341625|473732682|FG009|Overall Study|Study Drug Toxicity|3|||
131575537|NCT02341625|473732673|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575538|NCT02341625|473732674|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575539|NCT02341625|473732675|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575540|NCT02341625|473732676|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575541|NCT02341625|473732677|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575542|NCT02341625|473732678|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575543|NCT02341625|473732679|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
131575544|NCT02341625|473732680|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
131575545|NCT02341625|473732681|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131575546|NCT02341625|473732682|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
131438005|NCT01045460|473229468|FG000|Overall Study|Physician Decision|3|||
131438006|NCT01045460|473229469|FG001|Overall Study|Physician Decision|2|||
131438007|NCT01045460|473229468|FG000|Overall Study|Lost to Follow-up|0|||
131438008|NCT01045460|473229469|FG001|Overall Study|Lost to Follow-up|1|||
131438009|NCT01045460|473229468|FG000|Overall Study|Lack of Efficacy|3|||
131438010|NCT01045460|473229469|FG001|Overall Study|Lack of Efficacy|0|||
131438011|NCT00524485|473229470|FG000|Overall Study|Withdrawal by Subject|5|||
131438012|NCT00436332|473229471|FG000|Overall Study|Adverse Event|9|||
131438013|NCT00436332|473229471|FG000|Overall Study|Withdrawal by Subject|2|||
131438014|NCT00436332|473229471|FG000|Overall Study|Progression|59|||
131438015|NCT00436332|473229471|FG000|Overall Study|Death|2|||
131438016|NCT00436332|473229471|FG000|Overall Study|Not Protocol Specified|6|||
131438017|NCT00436332|473229471|FG000|Overall Study|Ineligible|2|||
131438018|NCT00436332|473229471|FG000|Overall Study|Never Received Treatment|3|||
131438019|NCT00472108|473229472|FG000|Overall Study|Lost to Follow-up|0|||
131438020|NCT00472108|473229473|FG001|Overall Study|Lost to Follow-up|1|||
131575547|NCT02341625|473732673|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575548|NCT02341625|473732674|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575549|NCT02341625|473732675|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575550|NCT02341625|473732676|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575551|NCT02341625|473732677|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575552|NCT02341625|473732678|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131699549|NCT03467958|474183324|FG006|Overall Study|Lack of Efficacy|11|||
131699550|NCT03467958|474183325|FG007|Overall Study|Lack of Efficacy|9|||
131699551|NCT03467958|474183326|FG008|Overall Study|Lack of Efficacy|3|||
131699552|NCT03467958|474183318|FG000|Overall Study|Lost to Follow-up|1|||
131699553|NCT03467958|474183319|FG001|Overall Study|Lost to Follow-up|2|||
131699554|NCT03467958|474183320|FG002|Overall Study|Lost to Follow-up|1|||
131699555|NCT03467958|474183321|FG003|Overall Study|Lost to Follow-up|0|||
131699556|NCT03467958|474183322|FG004|Overall Study|Lost to Follow-up|4|||
131699557|NCT03467958|474183323|FG005|Overall Study|Lost to Follow-up|0|||
131699558|NCT03467958|474183324|FG006|Overall Study|Lost to Follow-up|0|||
131785379|NCT00700310|474498739|FG000|Overall Study|Lack of Efficacy|0|||
131438021|NCT02756338|473229474|FG000|Overall Study|Withdrawn by Investigator|1|||
131575553|NCT02341625|473732679|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
131575554|NCT02341625|473732680|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
131575555|NCT02341625|473732681|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575556|NCT02341625|473732682|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131575557|NCT02341625|473732673|FG000|Overall Study|Participant Withdrew Consent|0|||
131575558|NCT02341625|473732674|FG001|Overall Study|Participant Withdrew Consent|0|||
131575559|NCT02341625|473732675|FG002|Overall Study|Participant Withdrew Consent|0|||
131575560|NCT02341625|473732676|FG003|Overall Study|Participant Withdrew Consent|1|||
131575561|NCT02341625|473732677|FG004|Overall Study|Participant Withdrew Consent|0|||
131575562|NCT02341625|473732678|FG005|Overall Study|Participant Withdrew Consent|0|||
131575563|NCT02341625|473732679|FG006|Overall Study|Participant Withdrew Consent|0|||
131575564|NCT02341625|473732680|FG007|Overall Study|Participant Withdrew Consent|0|||
131575565|NCT02341625|473732681|FG008|Overall Study|Participant Withdrew Consent|0|||
131575566|NCT02341625|473732682|FG009|Overall Study|Participant Withdrew Consent|0|||
131575567|NCT02341625|473732673|FG000|Overall Study|Completed Treatment as per Protocol|0|||
131575568|NCT02341625|473732674|FG001|Overall Study|Completed Treatment as per Protocol|0|||
131575569|NCT02341625|473732675|FG002|Overall Study|Completed Treatment as per Protocol|0|||
131575570|NCT02341625|473732676|FG003|Overall Study|Completed Treatment as per Protocol|0|||
131575571|NCT02341625|473732677|FG004|Overall Study|Completed Treatment as per Protocol|0|||
131575572|NCT02341625|473732678|FG005|Overall Study|Completed Treatment as per Protocol|0|||
131575573|NCT02341625|473732679|FG006|Overall Study|Completed Treatment as per Protocol|0|||
131575574|NCT02341625|473732680|FG007|Overall Study|Completed Treatment as per Protocol|0|||
131575575|NCT02341625|473732681|FG008|Overall Study|Completed Treatment as per Protocol|0|||
131575576|NCT02341625|473732682|FG009|Overall Study|Completed Treatment as per Protocol|1|||
131575577|NCT02341625|473732673|FG000|Overall Study|Other Reasons|0|||
131575578|NCT02341625|473732674|FG001|Overall Study|Other Reasons|0|||
131575579|NCT02341625|473732675|FG002|Overall Study|Other Reasons|0|||
131575580|NCT02341625|473732676|FG003|Overall Study|Other Reasons|0|||
131575581|NCT02341625|473732677|FG004|Overall Study|Other Reasons|1|||
131575582|NCT02341625|473732678|FG005|Overall Study|Other Reasons|0|||
131575583|NCT02341625|473732679|FG006|Overall Study|Other Reasons|5|||
131575584|NCT02341625|473732680|FG007|Overall Study|Other Reasons|0|||
131575585|NCT02341625|473732681|FG008|Overall Study|Other Reasons|0|||
131575586|NCT02341625|473732682|FG009|Overall Study|Other Reasons|2|||
131575587|NCT02341625|473732673|FG000|Overall Study|Not Reported|0|||
131575588|NCT02341625|473732674|FG001|Overall Study|Not Reported|0|||
131575589|NCT02341625|473732675|FG002|Overall Study|Not Reported|0|||
131575590|NCT02341625|473732676|FG003|Overall Study|Not Reported|0|||
131575591|NCT02341625|473732677|FG004|Overall Study|Not Reported|0|||
131575592|NCT02341625|473732678|FG005|Overall Study|Not Reported|0|||
131575593|NCT02341625|473732679|FG006|Overall Study|Not Reported|0|||
131575594|NCT02341625|473732680|FG007|Overall Study|Not Reported|0|||
131575595|NCT02341625|473732681|FG008|Overall Study|Not Reported|0|||
131575596|NCT02341625|473732682|FG009|Overall Study|Not Reported|3|||
131575597|NCT01839877|473732685|FG000|Overall Study|Protocol Violation|1|||
131575598|NCT03098030|473732686|FG000|Overall Study|Death|10|||
131575599|NCT03098030|473732687|FG001|Overall Study|Death|156|||
131575600|NCT03098030|473732688|FG002|Overall Study|Death|156|||
131575601|NCT03098030|473732689|FG003|Overall Study|Death|82|||
131575602|NCT03098030|473732686|FG000|Overall Study|Withdrawal by Subject|0|||
131575603|NCT03098030|473732687|FG001|Overall Study|Withdrawal by Subject|7|||
131575604|NCT03098030|473732688|FG002|Overall Study|Withdrawal by Subject|8|||
131575605|NCT03098030|473732689|FG003|Overall Study|Withdrawal by Subject|2|||
131575606|NCT03098030|473732686|FG000|Overall Study|Lost to Follow-up|0|||
131575607|NCT03098030|473732687|FG001|Overall Study|Lost to Follow-up|0|||
131575608|NCT03098030|473732688|FG002|Overall Study|Lost to Follow-up|2|||
131575609|NCT03098030|473732689|FG003|Overall Study|Lost to Follow-up|1|||
131575610|NCT03643211|473732690|FG000|Overall Study|Contract violation/deficiency|12|||
131699559|NCT03467958|474183325|FG007|Overall Study|Lost to Follow-up|0|||
131785380|NCT00700310|474498740|FG001|Overall Study|Lack of Efficacy|3|||
131575611|NCT03643211|473732690|FG000|Overall Study|Invalid registration|3|||
131575612|NCT03643211|473732690|FG000|Overall Study|No treatment information|2|||
131575613|NCT03643211|473732690|FG000|Overall Study|No adverse event information - No revisit|4|||
131575614|NCT03368001|473732691|FG000|Allocation|Lost to Pretest|16|||
131699560|NCT03467958|474183326|FG008|Overall Study|Lost to Follow-up|0|||
131699561|NCT03467958|474183318|FG000|Overall Study|Other reasons|8|||
131699562|NCT03467958|474183319|FG001|Overall Study|Other reasons|14|||
131699563|NCT03467958|474183320|FG002|Overall Study|Other reasons|2|||
131699564|NCT03467958|474183321|FG003|Overall Study|Other reasons|1|||
131699565|NCT03467958|474183322|FG004|Overall Study|Other reasons|4|||
131575615|NCT03368001|473732692|FG001|Allocation|Lost to Pretest|25|||
131575616|NCT03368001|473732691|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
131699566|NCT03467958|474183323|FG005|Overall Study|Other reasons|0|||
131699567|NCT03467958|474183324|FG006|Overall Study|Other reasons|1|||
131699568|NCT03467958|474183325|FG007|Overall Study|Other reasons|0|||
131785381|NCT00700310|474498741|FG002|Overall Study|Lack of Efficacy|0|||
131575617|NCT03368001|473732692|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
131575618|NCT03368001|473732691|FG000|Posttest|Lost to Posttest|7|||
131575619|NCT03368001|473732692|FG001|Posttest|Lost to Posttest|11|||
131575620|NCT03368001|473732691|FG000|Posttest|Discontinued Intervention|6|||
131575621|NCT03368001|473732692|FG001|Posttest|Discontinued Intervention|19|||
131575622|NCT03368001|473732691|FG000|Follow-up|Lost to Follow-up|6|||
131575623|NCT03368001|473732692|FG001|Follow-up|Lost to Follow-up|3|||
131575624|NCT00554801|473732693|FG000|Overall Study|left area before completion|5|||
131575625|NCT00554801|473732694|FG001|Overall Study|left area before completion|0|||
131575626|NCT00554801|473732693|FG000|Overall Study|Withdrawal by Subject|14|||
131575627|NCT00554801|473732694|FG001|Overall Study|Withdrawal by Subject|0|||
131575628|NCT04436120|473732695|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131575629|NCT04436120|473732696|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131575630|NCT04436120|473732697|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131575631|NCT04436120|473732698|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
131575632|NCT04436120|473732699|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131575633|NCT04436120|473732700|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
131575634|NCT04436120|473732701|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131575635|NCT01981356|473732702|FG000|Overall Study|Lost to Follow-up|4|||
131575636|NCT01981356|473732703|FG001|Overall Study|Lost to Follow-up|1|||
131575637|NCT01981356|473732702|FG000|Overall Study|Withdrawal by Subject|1|||
131575638|NCT01981356|473732703|FG001|Overall Study|Withdrawal by Subject|1|||
131575639|NCT01981356|473732702|FG000|Overall Study|Protocol Violation|2|||
131575640|NCT01981356|473732703|FG001|Overall Study|Protocol Violation|0|||
131575641|NCT02685033|473732704|FG000|Overall Study|Withdrawal of Consent|0|||
131575642|NCT02685033|473732705|FG001|Overall Study|Withdrawal of Consent|1|||
131575643|NCT02685033|473732704|FG000|Overall Study|Lost to Follow-up|2|||
131575644|NCT02685033|473732705|FG001|Overall Study|Lost to Follow-up|1|||
131575645|NCT02685033|473732704|FG000|Overall Study|Adverse Event|1|||
131575646|NCT02685033|473732705|FG001|Overall Study|Adverse Event|0|||
131653540|NCT02942004|474018400|FG002|Overall Study|Withdrawal by Subject|3|||
131653541|NCT02942004|474018398|FG000|Overall Study|Lost to Follow-up|1|||
131653542|NCT02942004|474018399|FG001|Overall Study|Lost to Follow-up|1|||
131653543|NCT02942004|474018400|FG002|Overall Study|Lost to Follow-up|2|||
131653544|NCT02942004|474018398|FG000|Overall Study|Randomized but not dosed|3|||
131653545|NCT02942004|474018399|FG001|Overall Study|Randomized but not dosed|9|||
131653546|NCT02942004|474018400|FG002|Overall Study|Randomized but not dosed|4|||
131653547|NCT04517669|474018401|FG000|Overall Study|Lost to Follow-up|2|||
131653548|NCT04517669|474018401|FG000|Overall Study|Withdrawal by Subject|3|||
131653549|NCT04517669|474018401|FG000|Overall Study|Drug withdrawn|44|||
131653550|NCT04517669|474018401|FG000|Overall Study|Other|1|||
131653551|NCT04517669|474018401|FG000|Overall Study|Eligibility criteria not met|4|||
131653552|NCT04517669|474018401|FG000|Overall Study|Did not receive treatment|3|||
131653553|NCT01923662|474018402|FG000|Overall Study|Withdrawal by Subject|1|||
131653554|NCT01294397|474018403|FG000|Overall Study|Withdrawal by Subject|1|||
131653555|NCT01294397|474018403|FG000|Overall Study|Administrative Decision|1|||
131653556|NCT06133348|474018404|FG000|Overall Study|Death|3|||
131653557|NCT06133348|474018404|FG000|Overall Study|Lost to Follow-up|1|||
131653558|NCT06133348|474018404|FG000|Overall Study|Physician Decision|1|||
131653559|NCT06133348|474018404|FG000|Overall Study|Withdrawal by Subject|5|||
131653560|NCT00678301|474018405|FG000|Overall Study|Non-compliance with study procedures|0|||
131653561|NCT00678301|474018406|FG001|Overall Study|Non-compliance with study procedures|1|||
131653562|NCT00678301|474018405|FG000|Overall Study|Adverse Event|1|||
131653563|NCT00678301|474018406|FG001|Overall Study|Adverse Event|0|||
131653564|NCT00678301|474018405|FG000|Overall Study|Withdrawal by Subject|4|||
131653565|NCT00678301|474018406|FG001|Overall Study|Withdrawal by Subject|0|||
131653566|NCT00678301|474018405|FG000|Overall Study|Lost to Follow-up|3|||
131653567|NCT00678301|474018406|FG001|Overall Study|Lost to Follow-up|1|||
131653568|NCT04638660|474018410|FG000|Overall Study|Withdrawal by Subject|2|||
131653569|NCT04638660|474018411|FG001|Overall Study|Withdrawal by Subject|0|||
131653570|NCT04638660|474018410|FG000|Overall Study|Lost to Follow-up|1|||
131653571|NCT04638660|474018411|FG001|Overall Study|Lost to Follow-up|0|||
131653572|NCT04481373|474018412|FG000|Overall Study|Protocol Violation|1|||
131653573|NCT04481373|474018413|FG001|Overall Study|Protocol Violation|0|||
131653574|NCT04481373|474018412|FG000|Overall Study|Viral load in hospital not over 1000|2|||
131653575|NCT04481373|474018413|FG001|Overall Study|Viral load in hospital not over 1000|1|||
131653576|NCT04481373|474018412|FG000|Overall Study|Death before hospital discharge|1|||
131653577|NCT04481373|474018413|FG001|Overall Study|Death before hospital discharge|0|||
131653578|NCT03199469|474018414|FG000|Overall Study|Randomized, not treated|0|||
131653579|NCT03199469|474018415|FG001|Overall Study|Randomized, not treated|3|||
131653580|NCT03199469|474018414|FG000|Overall Study|Withdrawal by Subject|1|||
131653581|NCT03199469|474018415|FG001|Overall Study|Withdrawal by Subject|0|||
131653582|NCT03199469|474018414|FG000|Overall Study|Death|1|||
131653583|NCT03199469|474018415|FG001|Overall Study|Death|3|||
131653584|NCT03199469|474018414|FG000|Overall Study|Ongoing|5|||
131653585|NCT03199469|474018415|FG001|Overall Study|Ongoing|14|||
131575647|NCT01875250|473734349|FG000|Overall Study|Adverse Event|2|||
131575648|NCT01875250|473734350|FG001|Overall Study|Adverse Event|0|||
131575649|NCT03140176|473734351|FG000|Overall Study|Reason missing|23|||
131575650|NCT03140176|473734351|FG000|Overall Study|Death|33|||
131575651|NCT03140176|473734351|FG000|Overall Study|Disease progression|1|||
131575652|NCT03140176|473734351|FG000|Overall Study|Physician Decision|1|||
131575653|NCT03140176|473734351|FG000|Overall Study|Withdrawal by Subject|1|||
131575654|NCT03140176|473734351|FG000|Overall Study|Lost to Follow-up|15|||
131575655|NCT00486759|473734352|FG000|Treatment|Adverse event/intercurrent illness|86|||
131575656|NCT00486759|473734353|FG001|Treatment|Adverse event/intercurrent illness|39|||
131575657|NCT00486759|473734352|FG000|Treatment|Insufficient therapeutic response|37|||
131575658|NCT00486759|473734353|FG001|Treatment|Insufficient therapeutic response|39|||
131575659|NCT00486759|473734352|FG000|Treatment|Death|17|||
131575660|NCT00486759|473734353|FG001|Treatment|Death|10|||
131575661|NCT00486759|473734352|FG000|Treatment|Withdrew consent|15|||
131575662|NCT00486759|473734353|FG001|Treatment|Withdrew consent|12|||
131575663|NCT00486759|473734352|FG000|Treatment|Administrative/reason not specified|17|||
131575664|NCT00486759|473734353|FG001|Treatment|Administrative/reason not specified|21|||
131575665|NCT00486759|473734352|FG000|Treatment|Refused treatment|10|||
131575666|NCT00486759|473734353|FG001|Treatment|Refused treatment|7|||
131575667|NCT00486759|473734352|FG000|Treatment|Violation of selection criteria at entry|3|||
131575668|NCT00486759|473734353|FG001|Treatment|Violation of selection criteria at entry|3|||
131575669|NCT00486759|473734352|FG000|Treatment|Other protocol violation|1|||
131575670|NCT00486759|473734353|FG001|Treatment|Other protocol violation|5|||
131575671|NCT00486759|473734352|FG000|Treatment|Failure to return|1|||
131575672|NCT00486759|473734353|FG001|Treatment|Failure to return|1|||
131575673|NCT00486759|473734352|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
131575674|NCT00486759|473734353|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
131575675|NCT00486759|473734352|FG000|Safety Follow-up|Death|40|||
131575676|NCT00486759|473734353|FG001|Safety Follow-up|Death|29|||
131575677|NCT00486759|473734352|FG000|Safety Follow-up|Withdrew consent|32|||
131575678|NCT00486759|473734353|FG001|Safety Follow-up|Withdrew consent|23|||
131575679|NCT00486759|473734352|FG000|Safety Follow-up|Failure to return|9|||
131575680|NCT00486759|473734353|FG001|Safety Follow-up|Failure to return|6|||
131575681|NCT00486759|473734352|FG000|Safety Follow-up|Administrative/not specified|8|||
131575682|NCT00486759|473734353|FG001|Safety Follow-up|Administrative/not specified|6|||
131575683|NCT00486759|473734352|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
131785382|NCT00700310|474498742|FG003|Overall Study|Lack of Efficacy|1|||
131785383|NCT00700310|474498739|FG000|Overall Study|Administrative/Other|1|||
131785384|NCT00700310|474498740|FG001|Overall Study|Administrative/Other|3|||
131785385|NCT00700310|474498741|FG002|Overall Study|Administrative/Other|1|||
131785386|NCT00700310|474498742|FG003|Overall Study|Administrative/Other|3|||
131785387|NCT00700310|474498739|FG000|Overall Study|Randomized, Not Treated|2|||
131785388|NCT00700310|474498740|FG001|Overall Study|Randomized, Not Treated|0|||
131785389|NCT00700310|474498741|FG002|Overall Study|Randomized, Not Treated|2|||
131785390|NCT00700310|474498742|FG003|Overall Study|Randomized, Not Treated|2|||
131575684|NCT00486759|473734353|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
131575685|NCT00486759|473734352|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
131575686|NCT00486759|473734353|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
131785391|NCT00681824|474498743|FG000|Overall Study|withdrawn by investigator|0|||
131785392|NCT00681824|474498744|FG001|Overall Study|withdrawn by investigator|0|||
131785393|NCT00681824|474498745|FG002|Overall Study|withdrawn by investigator|1|||
131785394|NCT00681824|474498743|FG000|Overall Study|scheduling conflict|1|||
131575687|NCT02001623|473734354|FG000|Overall Study|Disease Progression|2|||
131575688|NCT02001623|473734355|FG001|Overall Study|Disease Progression|2|||
131575689|NCT02001623|473734356|FG002|Overall Study|Disease Progression|3|||
131575690|NCT02001623|473734357|FG003|Overall Study|Disease Progression|2|||
131575691|NCT02001623|473734358|FG004|Overall Study|Disease Progression|3|||
131575692|NCT02001623|473734359|FG005|Overall Study|Disease Progression|2|||
131785395|NCT00681824|474498744|FG001|Overall Study|scheduling conflict|0|||
131785396|NCT00681824|474498745|FG002|Overall Study|scheduling conflict|0|||
131785397|NCT00681824|474498743|FG000|Overall Study|Death|0|||
131785398|NCT00681824|474498744|FG001|Overall Study|Death|1|||
131785399|NCT00681824|474498745|FG002|Overall Study|Death|0|||
131575693|NCT02001623|473734360|FG006|Overall Study|Disease Progression|3|||
131575694|NCT02001623|473734361|FG007|Overall Study|Disease Progression|3|||
131575695|NCT02001623|473734362|FG008|Overall Study|Disease Progression|7|||
131575696|NCT02001623|473734363|FG009|Overall Study|Disease Progression|40|||
131575697|NCT02001623|473734364|FG010|Overall Study|Disease Progression|5|||
131575698|NCT02001623|473734365|FG011|Overall Study|Disease Progression|9|||
131575699|NCT02001623|473734366|FG012|Overall Study|Disease Progression|9|||
131575700|NCT02001623|473734367|FG013|Overall Study|Disease Progression|20|||
131575701|NCT02001623|473734368|FG014|Overall Study|Disease Progression|9|||
131575702|NCT02001623|473734354|FG000|Overall Study|Physician Decision|0|||
131575703|NCT02001623|473734355|FG001|Overall Study|Physician Decision|0|||
131785400|NCT03724916|474498746|FG000|Overall Study|Withdrawal by Subject|0|||
131785401|NCT03724916|474498747|FG001|Overall Study|Withdrawal by Subject|1|||
131575704|NCT02001623|473734356|FG002|Overall Study|Physician Decision|0|||
131575705|NCT02001623|473734357|FG003|Overall Study|Physician Decision|0|||
131575706|NCT02001623|473734358|FG004|Overall Study|Physician Decision|0|||
131575707|NCT02001623|473734359|FG005|Overall Study|Physician Decision|0|||
131575708|NCT02001623|473734360|FG006|Overall Study|Physician Decision|0|||
131575709|NCT02001623|473734361|FG007|Overall Study|Physician Decision|0|||
131575710|NCT02001623|473734362|FG008|Overall Study|Physician Decision|3|||
131575711|NCT02001623|473734363|FG009|Overall Study|Physician Decision|2|||
131575712|NCT02001623|473734364|FG010|Overall Study|Physician Decision|3|||
131575713|NCT02001623|473734365|FG011|Overall Study|Physician Decision|3|||
131575714|NCT02001623|473734366|FG012|Overall Study|Physician Decision|1|||
131575715|NCT02001623|473734367|FG013|Overall Study|Physician Decision|2|||
131575716|NCT02001623|473734368|FG014|Overall Study|Physician Decision|1|||
131575717|NCT02001623|473734354|FG000|Overall Study|Death|0|||
131575718|NCT02001623|473734355|FG001|Overall Study|Death|1|||
131575719|NCT02001623|473734356|FG002|Overall Study|Death|0|||
131575720|NCT02001623|473734357|FG003|Overall Study|Death|0|||
131575721|NCT02001623|473734358|FG004|Overall Study|Death|0|||
131575722|NCT02001623|473734359|FG005|Overall Study|Death|0|||
131575723|NCT02001623|473734360|FG006|Overall Study|Death|0|||
131575724|NCT02001623|473734361|FG007|Overall Study|Death|0|||
131575725|NCT02001623|473734362|FG008|Overall Study|Death|0|||
131575726|NCT02001623|473734363|FG009|Overall Study|Death|0|||
131575727|NCT02001623|473734364|FG010|Overall Study|Death|0|||
131575728|NCT02001623|473734365|FG011|Overall Study|Death|0|||
131575729|NCT02001623|473734366|FG012|Overall Study|Death|0|||
131575730|NCT02001623|473734367|FG013|Overall Study|Death|0|||
131575731|NCT02001623|473734368|FG014|Overall Study|Death|0|||
131575732|NCT02001623|473734354|FG000|Overall Study|Adverse Event|0|||
131575733|NCT02001623|473734355|FG001|Overall Study|Adverse Event|0|||
131575734|NCT02001623|473734356|FG002|Overall Study|Adverse Event|0|||
131575735|NCT02001623|473734357|FG003|Overall Study|Adverse Event|0|||
131575736|NCT02001623|473734358|FG004|Overall Study|Adverse Event|0|||
131575737|NCT02001623|473734359|FG005|Overall Study|Adverse Event|1|||
131575738|NCT02001623|473734360|FG006|Overall Study|Adverse Event|0|||
131575739|NCT02001623|473734361|FG007|Overall Study|Adverse Event|3|||
131575740|NCT02001623|473734362|FG008|Overall Study|Adverse Event|4|||
131575741|NCT02001623|473734363|FG009|Overall Study|Adverse Event|6|||
131575742|NCT02001623|473734364|FG010|Overall Study|Adverse Event|4|||
131575743|NCT02001623|473734365|FG011|Overall Study|Adverse Event|0|||
131575744|NCT02001623|473734366|FG012|Overall Study|Adverse Event|3|||
131575745|NCT02001623|473734367|FG013|Overall Study|Adverse Event|5|||
131575746|NCT02001623|473734368|FG014|Overall Study|Adverse Event|6|||
131575747|NCT02001623|473734354|FG000|Overall Study|Other - Miscellaneous|0|||
131575748|NCT02001623|473734355|FG001|Overall Study|Other - Miscellaneous|0|||
131575749|NCT02001623|473734356|FG002|Overall Study|Other - Miscellaneous|0|||
131575750|NCT02001623|473734357|FG003|Overall Study|Other - Miscellaneous|0|||
131575751|NCT02001623|473734358|FG004|Overall Study|Other - Miscellaneous|0|||
131575752|NCT02001623|473734359|FG005|Overall Study|Other - Miscellaneous|0|||
131575753|NCT02001623|473734360|FG006|Overall Study|Other - Miscellaneous|0|||
131575754|NCT02001623|473734361|FG007|Overall Study|Other - Miscellaneous|0|||
131575755|NCT02001623|473734362|FG008|Overall Study|Other - Miscellaneous|0|||
131575756|NCT02001623|473734363|FG009|Overall Study|Other - Miscellaneous|1|||
131575757|NCT02001623|473734364|FG010|Overall Study|Other - Miscellaneous|0|||
131575758|NCT02001623|473734365|FG011|Overall Study|Other - Miscellaneous|0|||
131575759|NCT02001623|473734366|FG012|Overall Study|Other - Miscellaneous|0|||
131575760|NCT02001623|473734367|FG013|Overall Study|Other - Miscellaneous|1|||
131575761|NCT02001623|473734368|FG014|Overall Study|Other - Miscellaneous|0|||
131575762|NCT02001623|473734354|FG000|Overall Study|Withdrawal by Subject|1|||
131575763|NCT02001623|473734355|FG001|Overall Study|Withdrawal by Subject|0|||
131575764|NCT02001623|473734356|FG002|Overall Study|Withdrawal by Subject|0|||
131575765|NCT02001623|473734357|FG003|Overall Study|Withdrawal by Subject|0|||
131575766|NCT02001623|473734358|FG004|Overall Study|Withdrawal by Subject|0|||
131575767|NCT02001623|473734359|FG005|Overall Study|Withdrawal by Subject|0|||
131575768|NCT02001623|473734360|FG006|Overall Study|Withdrawal by Subject|0|||
131575769|NCT02001623|473734361|FG007|Overall Study|Withdrawal by Subject|0|||
131575770|NCT02001623|473734362|FG008|Overall Study|Withdrawal by Subject|1|||
131575771|NCT02001623|473734363|FG009|Overall Study|Withdrawal by Subject|3|||
131575772|NCT02001623|473734364|FG010|Overall Study|Withdrawal by Subject|2|||
131575773|NCT02001623|473734365|FG011|Overall Study|Withdrawal by Subject|2|||
131575774|NCT02001623|473734366|FG012|Overall Study|Withdrawal by Subject|1|||
131575775|NCT02001623|473734367|FG013|Overall Study|Withdrawal by Subject|5|||
131575776|NCT02001623|473734368|FG014|Overall Study|Withdrawal by Subject|2|||
131575777|NCT02001623|473734354|FG000|Overall Study|Lost to Follow-up|0|||
131575778|NCT02001623|473734355|FG001|Overall Study|Lost to Follow-up|0|||
131575779|NCT02001623|473734356|FG002|Overall Study|Lost to Follow-up|0|||
131575780|NCT02001623|473734357|FG003|Overall Study|Lost to Follow-up|0|||
131575781|NCT02001623|473734358|FG004|Overall Study|Lost to Follow-up|0|||
131575782|NCT02001623|473734359|FG005|Overall Study|Lost to Follow-up|0|||
131575783|NCT02001623|473734360|FG006|Overall Study|Lost to Follow-up|0|||
131575784|NCT02001623|473734361|FG007|Overall Study|Lost to Follow-up|0|||
131575785|NCT02001623|473734362|FG008|Overall Study|Lost to Follow-up|0|||
131575786|NCT02001623|473734363|FG009|Overall Study|Lost to Follow-up|1|||
131575787|NCT02001623|473734364|FG010|Overall Study|Lost to Follow-up|0|||
131575788|NCT02001623|473734365|FG011|Overall Study|Lost to Follow-up|0|||
131575789|NCT02001623|473734366|FG012|Overall Study|Lost to Follow-up|0|||
131575790|NCT02001623|473734367|FG013|Overall Study|Lost to Follow-up|0|||
131575791|NCT02001623|473734368|FG014|Overall Study|Lost to Follow-up|0|||
131575792|NCT02001623|473734354|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
131575793|NCT02001623|473734355|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
131575794|NCT02001623|473734356|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
131575795|NCT02001623|473734357|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
131575796|NCT02001623|473734358|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
131575797|NCT02001623|473734359|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
131575798|NCT02001623|473734360|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
131575799|NCT02001623|473734361|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
131575800|NCT02001623|473734362|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
131575801|NCT02001623|473734363|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
131575802|NCT02001623|473734364|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
131575803|NCT02001623|473734365|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
131575804|NCT02001623|473734366|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
131575805|NCT02001623|473734367|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
131575806|NCT02001623|473734368|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
131575807|NCT02001623|473734354|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
131575808|NCT02001623|473734355|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
131575809|NCT02001623|473734356|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
131575810|NCT02001623|473734357|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
131575811|NCT02001623|473734358|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
131575812|NCT02001623|473734359|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
131575813|NCT02001623|473734360|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
131575814|NCT02001623|473734361|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
131575815|NCT02001623|473734362|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
131575816|NCT02001623|473734363|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
131575817|NCT02001623|473734364|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
131575818|NCT02001623|473734365|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
131785402|NCT03724916|474498748|FG002|Overall Study|Withdrawal by Subject|1|||
131785403|NCT03724916|474498749|FG003|Overall Study|Withdrawal by Subject|2|||
131785404|NCT03724916|474498746|FG000|Overall Study|Randomized but not Treated|1|||
131785405|NCT03724916|474498747|FG001|Overall Study|Randomized but not Treated|0|||
131785406|NCT03724916|474498748|FG002|Overall Study|Randomized but not Treated|0|||
131785407|NCT03724916|474498749|FG003|Overall Study|Randomized but not Treated|0|||
131785408|NCT04575038|474498750|FG000|Overall Study|Withdrawal by Subject|1|||
131785409|NCT04575038|474498751|FG001|Overall Study|Withdrawal by Subject|1|||
131785410|NCT03591107|474498754|FG000|Overall Study|Same patient in both arms|1|||
131785411|NCT03591107|474498755|FG001|Overall Study|Same patient in both arms|1|||
131785412|NCT03591107|474498754|FG000|Overall Study|Sought care at other clinics|0|||
131785413|NCT03591107|474498755|FG001|Overall Study|Sought care at other clinics|2|||
131785414|NCT03591107|474498754|FG000|Overall Study|Discharged from clinic|0|||
131785415|NCT03591107|474498755|FG001|Overall Study|Discharged from clinic|1|||
131785416|NCT03591107|474498754|FG000|Overall Study|Withdrawal by Subject|0|||
131785417|NCT03591107|474498755|FG001|Overall Study|Withdrawal by Subject|1|||
131785418|NCT01902134|474498756|FG000|Overall Study|Adverse Event|3|||
131785419|NCT01902134|474498757|FG001|Overall Study|Adverse Event|1|||
131785420|NCT01902134|474498758|FG002|Overall Study|Adverse Event|2|||
131575819|NCT02001623|473734366|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
131575820|NCT02001623|473734367|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
131575821|NCT02001623|473734368|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
131575822|NCT00309452|473734369|FG000|Overall Study|Withdrawal by Subject|3|||
131575823|NCT00309452|473734370|FG001|Overall Study|Withdrawal by Subject|0|||
131575824|NCT00771667|473734371|FG000|Induction Phase|Adverse Event|5|||
131575825|NCT00771667|473734372|FG001|Induction Phase|Adverse Event|2|||
131785421|NCT01902134|474498759|FG003|Overall Study|Adverse Event|1|||
131575826|NCT00771667|473734373|FG002|Induction Phase|Adverse Event|4|||
131575827|NCT00771667|473734374|FG003|Induction Phase|Adverse Event|1|||
131785422|NCT01902134|474498760|FG004|Overall Study|Adverse Event|1|||
131785423|NCT01902134|474498761|FG005|Overall Study|Adverse Event|3|||
131785424|NCT01902134|474498756|FG000|Overall Study|Lack of Efficacy|0|||
131785425|NCT01902134|474498757|FG001|Overall Study|Lack of Efficacy|0|||
131575828|NCT00771667|473734375|FG004|Induction Phase|Adverse Event|0|||
131575829|NCT00771667|473734376|FG005|Induction Phase|Adverse Event|0|||
131575830|NCT00771667|473734377|FG006|Induction Phase|Adverse Event|0|||
131575831|NCT00771667|473734378|FG007|Induction Phase|Adverse Event|0|||
131575832|NCT00771667|473734379|FG008|Induction Phase|Adverse Event|0|||
131575833|NCT00771667|473734380|FG009|Induction Phase|Adverse Event|0|||
131575834|NCT00771667|473734371|FG000|Induction Phase|Lack of Efficacy|9|||
131575835|NCT00771667|473734372|FG001|Induction Phase|Lack of Efficacy|2|||
131575836|NCT00771667|473734373|FG002|Induction Phase|Lack of Efficacy|4|||
131575837|NCT00771667|473734374|FG003|Induction Phase|Lack of Efficacy|3|||
131575838|NCT00771667|473734375|FG004|Induction Phase|Lack of Efficacy|0|||
131575839|NCT00771667|473734376|FG005|Induction Phase|Lack of Efficacy|0|||
131575840|NCT00771667|473734377|FG006|Induction Phase|Lack of Efficacy|0|||
131575841|NCT00771667|473734378|FG007|Induction Phase|Lack of Efficacy|0|||
131575842|NCT00771667|473734379|FG008|Induction Phase|Lack of Efficacy|0|||
131575843|NCT00771667|473734380|FG009|Induction Phase|Lack of Efficacy|0|||
131575844|NCT00771667|473734371|FG000|Induction Phase|Lost to Follow-up|1|||
131575845|NCT00771667|473734372|FG001|Induction Phase|Lost to Follow-up|0|||
131575846|NCT00771667|473734373|FG002|Induction Phase|Lost to Follow-up|1|||
131575847|NCT00771667|473734374|FG003|Induction Phase|Lost to Follow-up|0|||
131575848|NCT00771667|473734375|FG004|Induction Phase|Lost to Follow-up|0|||
131575849|NCT00771667|473734376|FG005|Induction Phase|Lost to Follow-up|0|||
131785426|NCT01902134|474498758|FG002|Overall Study|Lack of Efficacy|2|||
131785427|NCT01902134|474498759|FG003|Overall Study|Lack of Efficacy|0|||
131785428|NCT01902134|474498760|FG004|Overall Study|Lack of Efficacy|0|||
131785429|NCT01902134|474498761|FG005|Overall Study|Lack of Efficacy|1|||
131785430|NCT01902134|474498756|FG000|Overall Study|Physician Decision|0|||
131785431|NCT01902134|474498757|FG001|Overall Study|Physician Decision|1|||
131785432|NCT01902134|474498758|FG002|Overall Study|Physician Decision|0|||
131785433|NCT01902134|474498759|FG003|Overall Study|Physician Decision|0|||
131438022|NCT02756338|473229474|FG000|Overall Study|Device Replaced with Pacemaker|4|||
131575850|NCT00771667|473734377|FG006|Induction Phase|Lost to Follow-up|0|||
131575851|NCT00771667|473734378|FG007|Induction Phase|Lost to Follow-up|0|||
131575852|NCT00771667|473734379|FG008|Induction Phase|Lost to Follow-up|0|||
131575853|NCT00771667|473734380|FG009|Induction Phase|Lost to Follow-up|0|||
131575854|NCT00771667|473734371|FG000|Induction Phase|Other|4|||
131575855|NCT00771667|473734372|FG001|Induction Phase|Other|6|||
131575856|NCT00771667|473734373|FG002|Induction Phase|Other|3|||
131575857|NCT00771667|473734374|FG003|Induction Phase|Other|4|||
131575858|NCT00771667|473734375|FG004|Induction Phase|Other|0|||
131575859|NCT00771667|473734376|FG005|Induction Phase|Other|0|||
131575860|NCT00771667|473734377|FG006|Induction Phase|Other|0|||
131575861|NCT00771667|473734378|FG007|Induction Phase|Other|0|||
131575862|NCT00771667|473734379|FG008|Induction Phase|Other|0|||
131575863|NCT00771667|473734380|FG009|Induction Phase|Other|0|||
131575864|NCT00771667|473734371|FG000|Maintenance Phase|Adverse Event|0|||
131575865|NCT00771667|473734372|FG001|Maintenance Phase|Adverse Event|0|||
131575866|NCT00771667|473734373|FG002|Maintenance Phase|Adverse Event|0|||
131575867|NCT00771667|473734374|FG003|Maintenance Phase|Adverse Event|0|||
131575868|NCT00771667|473734375|FG004|Maintenance Phase|Adverse Event|1|||
131575869|NCT00771667|473734376|FG005|Maintenance Phase|Adverse Event|3|||
131438023|NCT01339689|473229477|FG000|Overall Study|Adverse Event|1|||
131575870|NCT00771667|473734377|FG006|Maintenance Phase|Adverse Event|5|||
131575871|NCT00771667|473734378|FG007|Maintenance Phase|Adverse Event|1|||
131575872|NCT00771667|473734379|FG008|Maintenance Phase|Adverse Event|8|||
131575873|NCT00771667|473734380|FG009|Maintenance Phase|Adverse Event|7|||
131575874|NCT00771667|473734371|FG000|Maintenance Phase|Lack of Efficacy|0|||
131575875|NCT00771667|473734372|FG001|Maintenance Phase|Lack of Efficacy|0|||
131575876|NCT00771667|473734373|FG002|Maintenance Phase|Lack of Efficacy|0|||
131575877|NCT00771667|473734374|FG003|Maintenance Phase|Lack of Efficacy|0|||
131575878|NCT00771667|473734375|FG004|Maintenance Phase|Lack of Efficacy|1|||
131575879|NCT00771667|473734376|FG005|Maintenance Phase|Lack of Efficacy|3|||
131575880|NCT00771667|473734377|FG006|Maintenance Phase|Lack of Efficacy|3|||
131575881|NCT00771667|473734378|FG007|Maintenance Phase|Lack of Efficacy|2|||
131438024|NCT01339689|473229478|FG001|Overall Study|Adverse Event|2|||
131575882|NCT00771667|473734379|FG008|Maintenance Phase|Lack of Efficacy|11|||
131653586|NCT03596762|474018416|FG000|Overall Study|Protocol Violation|0|||
131653587|NCT03596762|474018417|FG001|Overall Study|Protocol Violation|0|||
131653588|NCT03596762|474018418|FG002|Overall Study|Protocol Violation|0|||
131653589|NCT03596762|474018419|FG003|Overall Study|Protocol Violation|0|||
131653590|NCT03596762|474018420|FG004|Overall Study|Protocol Violation|1|||
131653591|NCT03596762|474018416|FG000|Overall Study|Adverse Event|2|||
131653592|NCT03596762|474018417|FG001|Overall Study|Adverse Event|0|||
131653593|NCT03596762|474018418|FG002|Overall Study|Adverse Event|1|||
131653594|NCT03596762|474018419|FG003|Overall Study|Adverse Event|0|||
131653595|NCT03596762|474018420|FG004|Overall Study|Adverse Event|5|||
131653596|NCT03596762|474018416|FG000|Overall Study|Withdrawal by Subject|2|||
131653597|NCT03596762|474018417|FG001|Overall Study|Withdrawal by Subject|1|||
131653598|NCT03596762|474018418|FG002|Overall Study|Withdrawal by Subject|0|||
131653599|NCT03596762|474018419|FG003|Overall Study|Withdrawal by Subject|1|||
131575883|NCT00771667|473734380|FG009|Maintenance Phase|Lack of Efficacy|7|||
131575884|NCT00771667|473734371|FG000|Maintenance Phase|Other|0|||
131575885|NCT00771667|473734372|FG001|Maintenance Phase|Other|0|||
131575886|NCT00771667|473734373|FG002|Maintenance Phase|Other|0|||
131575887|NCT00771667|473734374|FG003|Maintenance Phase|Other|0|||
131575888|NCT00771667|473734375|FG004|Maintenance Phase|Other|0|||
131575889|NCT00771667|473734376|FG005|Maintenance Phase|Other|1|||
131575890|NCT00771667|473734377|FG006|Maintenance Phase|Other|2|||
131575891|NCT00771667|473734378|FG007|Maintenance Phase|Other|2|||
131575892|NCT00771667|473734379|FG008|Maintenance Phase|Other|3|||
131575893|NCT00771667|473734380|FG009|Maintenance Phase|Other|3|||
131575894|NCT00628862|473734381|FG000|Overall Study|Adverse Event|6|||
131575895|NCT00628862|473734382|FG001|Overall Study|Adverse Event|8|||
131575896|NCT00628862|473734383|FG002|Overall Study|Adverse Event|10|||
131575897|NCT00628862|473734381|FG000|Overall Study|Withdrawal by Subject|4|||
131575898|NCT00628862|473734382|FG001|Overall Study|Withdrawal by Subject|6|||
131575899|NCT00628862|473734383|FG002|Overall Study|Withdrawal by Subject|11|||
131575900|NCT00628862|473734381|FG000|Overall Study|Lost to Follow-up|0|||
131575901|NCT00628862|473734382|FG001|Overall Study|Lost to Follow-up|2|||
131575902|NCT00628862|473734383|FG002|Overall Study|Lost to Follow-up|1|||
131575903|NCT00628862|473734381|FG000|Overall Study|Protocol Violation|1|||
131575904|NCT00628862|473734382|FG001|Overall Study|Protocol Violation|0|||
131575905|NCT00628862|473734383|FG002|Overall Study|Protocol Violation|0|||
131575906|NCT00628862|473734381|FG000|Overall Study|COPD Exacerbation|0|||
131575907|NCT00628862|473734382|FG001|Overall Study|COPD Exacerbation|1|||
131575908|NCT00628862|473734383|FG002|Overall Study|COPD Exacerbation|0|||
131575909|NCT01063036|473734384|FG000|Participants Treated With Study Drug|Adverse Event|1|||
131575910|NCT01063036|473734384|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
131575911|NCT01063036|473734384|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
131575912|NCT01063036|473734384|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
131575913|NCT01063036|473734384|FG000|Participants Treated With Study Drug|Pregnancy|1|||
131575914|NCT01063036|473734384|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
131575915|NCT01063036|473734384|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
131575916|NCT01063036|473734384|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
131575917|NCT02814643|473734385|FG000|Overall Study|Lost to Follow-up|0|||
131575918|NCT02814643|473734386|FG001|Overall Study|Lost to Follow-up|1|||
131575919|NCT02814643|473734385|FG000|Overall Study|Withdrawal by Subject|1|||
131575920|NCT02814643|473734386|FG001|Overall Study|Withdrawal by Subject|2|||
131575921|NCT02263508|473734387|FG000|Overall Study|Withdrawal by Subject|1|||
131575922|NCT02263508|473734388|FG001|Overall Study|Withdrawal by Subject|23|||
131575923|NCT02263508|473734389|FG002|Overall Study|Withdrawal by Subject|17|||
131575924|NCT02263508|473734387|FG000|Overall Study|Sponsor Decision|12|||
131575925|NCT02263508|473734388|FG001|Overall Study|Sponsor Decision|165|||
131575926|NCT02263508|473734389|FG002|Overall Study|Sponsor Decision|182|||
131575927|NCT02263508|473734387|FG000|Overall Study|Lost to Follow-up|2|||
131575928|NCT02263508|473734388|FG001|Overall Study|Lost to Follow-up|7|||
131575929|NCT02263508|473734389|FG002|Overall Study|Lost to Follow-up|7|||
131575930|NCT02263508|473734387|FG000|Overall Study|Death|6|||
131575931|NCT02263508|473734388|FG001|Overall Study|Death|151|||
131575932|NCT02263508|473734389|FG002|Overall Study|Death|140|||
131575933|NCT02174562|473734396|FG000|Overall Study|Withdrawal by Subject|7|||
131575934|NCT02174562|473734397|FG001|Overall Study|Withdrawal by Subject|2|||
131575935|NCT02174562|473734396|FG000|Overall Study|Death|2|||
131575936|NCT02174562|473734397|FG001|Overall Study|Death|0|||
131575937|NCT02174562|473734396|FG000|Overall Study|Lost to Follow-up|0|||
131575938|NCT02174562|473734397|FG001|Overall Study|Lost to Follow-up|3|||
131575939|NCT01833065|473734398|FG000|Overall Study|Adverse Event|6|||
131575940|NCT01833065|473734399|FG001|Overall Study|Adverse Event|1|||
131575941|NCT01833065|473734400|FG002|Overall Study|Adverse Event|0|||
131575942|NCT01833065|473734401|FG003|Overall Study|Adverse Event|2|||
131575943|NCT01833065|473734402|FG004|Overall Study|Adverse Event|3|||
131575944|NCT01833065|473734398|FG000|Overall Study|Protocol Violation|1|||
131575945|NCT01833065|473734399|FG001|Overall Study|Protocol Violation|0|||
131575946|NCT01833065|473734400|FG002|Overall Study|Protocol Violation|0|||
131575947|NCT01833065|473734401|FG003|Overall Study|Protocol Violation|0|||
131575948|NCT01833065|473734402|FG004|Overall Study|Protocol Violation|2|||
131575949|NCT01833065|473734398|FG000|Overall Study|Lost to Follow-up|1|||
131575950|NCT01833065|473734399|FG001|Overall Study|Lost to Follow-up|0|||
131575951|NCT01833065|473734400|FG002|Overall Study|Lost to Follow-up|0|||
131575952|NCT01833065|473734401|FG003|Overall Study|Lost to Follow-up|0|||
131575953|NCT01833065|473734402|FG004|Overall Study|Lost to Follow-up|3|||
131575954|NCT01833065|473734398|FG000|Overall Study|Withdrawal by Subject|6|||
131575955|NCT01833065|473734399|FG001|Overall Study|Withdrawal by Subject|2|||
131575956|NCT01833065|473734400|FG002|Overall Study|Withdrawal by Subject|4|||
131575957|NCT01833065|473734401|FG003|Overall Study|Withdrawal by Subject|3|||
131575958|NCT01833065|473734402|FG004|Overall Study|Withdrawal by Subject|11|||
131575959|NCT01833065|473734398|FG000|Overall Study|Subject's substantial non-compliance|0|||
131575960|NCT01833065|473734399|FG001|Overall Study|Subject's substantial non-compliance|1|||
131575961|NCT01833065|473734400|FG002|Overall Study|Subject's substantial non-compliance|0|||
131575962|NCT01833065|473734401|FG003|Overall Study|Subject's substantial non-compliance|0|||
131575963|NCT01833065|473734402|FG004|Overall Study|Subject's substantial non-compliance|0|||
131575964|NCT01833065|473734398|FG000|Overall Study|Trial terminated by sponsor|8|||
131575965|NCT01833065|473734399|FG001|Overall Study|Trial terminated by sponsor|8|||
131575966|NCT01833065|473734400|FG002|Overall Study|Trial terminated by sponsor|7|||
131575967|NCT01833065|473734401|FG003|Overall Study|Trial terminated by sponsor|3|||
131575968|NCT01833065|473734402|FG004|Overall Study|Trial terminated by sponsor|13|||
131575969|NCT01833065|473734398|FG000|Overall Study|Others|2|||
131575970|NCT01833065|473734399|FG001|Overall Study|Others|1|||
131575971|NCT01833065|473734400|FG002|Overall Study|Others|1|||
131575972|NCT01833065|473734401|FG003|Overall Study|Others|1|||
131575973|NCT01833065|473734402|FG004|Overall Study|Others|4|||
131575974|NCT03201809|473734403|FG000|Overall Study|Lost to Follow-up|2|||
131575975|NCT03201809|473734404|FG001|Overall Study|Lost to Follow-up|0|||
131575976|NCT00864682|473734406|FG000|Overall Study|Protocol Violation|2|||
131575977|NCT00864682|473734407|FG001|Overall Study|Protocol Violation|1|||
131575978|NCT00864682|473734408|FG002|Overall Study|Protocol Violation|2|||
131575979|NCT00957658|473734409|FG000|Overall Study|Death|1|||
131575980|NCT00957658|473734409|FG000|Overall Study|Lost to Follow-up|4|||
131575981|NCT00957658|473734409|FG000|Overall Study|Withdrawal by Subject|12|||
131575982|NCT00957658|473734409|FG000|Overall Study|Revision|1|||
131575983|NCT00957658|473734409|FG000|Overall Study|Incomplete 2 yr data|28|||
131575984|NCT00957658|473734409|FG000|Overall Study|Site termination|10|||
131575985|NCT00957658|473734409|FG000|Overall Study|unwilling/unable to return|2|||
131575986|NCT00957658|473734409|FG000|Overall Study|surgery cancelled|2|||
131575987|NCT00957658|473734409|FG000|Overall Study|Protocol Violation|5|||
131575988|NCT00975806|473734410|FG000|Overall Study|Adverse Event|2|||
131575989|NCT00975806|473734411|FG001|Overall Study|Adverse Event|1|||
131575990|NCT00975806|473734412|FG002|Overall Study|Adverse Event|2|||
131575991|NCT00975806|473734410|FG000|Overall Study|Disease Progression|1|||
131575992|NCT00975806|473734411|FG001|Overall Study|Disease Progression|5|||
131575993|NCT00975806|473734412|FG002|Overall Study|Disease Progression|1|||
131575994|NCT00975806|473734410|FG000|Overall Study|Withdrawal by Subject|1|||
131575995|NCT00975806|473734411|FG001|Overall Study|Withdrawal by Subject|0|||
131575996|NCT00975806|473734412|FG002|Overall Study|Withdrawal by Subject|0|||
131575997|NCT00975806|473734410|FG000|Overall Study|Death|0|||
131575998|NCT00975806|473734411|FG001|Overall Study|Death|1|||
131575999|NCT00975806|473734412|FG002|Overall Study|Death|0|||
131576000|NCT00975806|473734410|FG000|Overall Study|Physician decision and disease related|1|||
131576001|NCT00975806|473734411|FG001|Overall Study|Physician decision and disease related|0|||
131576002|NCT00975806|473734412|FG002|Overall Study|Physician decision and disease related|1|||
131576003|NCT00246012|473734413|FG000|Overall Study|Adverse Event|0|||
131576004|NCT00246012|473734414|FG001|Overall Study|Adverse Event|0|||
131576005|NCT00246012|473734415|FG002|Overall Study|Adverse Event|0|||
131576006|NCT00246012|473734416|FG003|Overall Study|Adverse Event|0|||
131576007|NCT00246012|473734417|FG004|Overall Study|Adverse Event|0|||
131576008|NCT00246012|473734418|FG005|Overall Study|Adverse Event|1|||
131576009|NCT00246012|473734419|FG006|Overall Study|Adverse Event|0|||
131576010|NCT00246012|473734420|FG007|Overall Study|Adverse Event|0|||
131576011|NCT00246012|473734421|FG008|Overall Study|Adverse Event|2|||
131576012|NCT00246012|473734413|FG000|Overall Study|Withdrawal by Subject|0|||
131576013|NCT00246012|473734414|FG001|Overall Study|Withdrawal by Subject|0|||
131576014|NCT00246012|473734415|FG002|Overall Study|Withdrawal by Subject|0|||
131576015|NCT00246012|473734416|FG003|Overall Study|Withdrawal by Subject|0|||
131785434|NCT01902134|474498760|FG004|Overall Study|Physician Decision|0|||
131785435|NCT01902134|474498761|FG005|Overall Study|Physician Decision|0|||
131576016|NCT00246012|473734417|FG004|Overall Study|Withdrawal by Subject|0|||
131576017|NCT00246012|473734418|FG005|Overall Study|Withdrawal by Subject|1|||
131576018|NCT00246012|473734419|FG006|Overall Study|Withdrawal by Subject|0|||
131576019|NCT00246012|473734420|FG007|Overall Study|Withdrawal by Subject|0|||
131576020|NCT00246012|473734421|FG008|Overall Study|Withdrawal by Subject|0|||
131576021|NCT00246012|473734413|FG000|Overall Study|Disease progression|3|||
131576022|NCT00246012|473734414|FG001|Overall Study|Disease progression|1|||
131576023|NCT00246012|473734415|FG002|Overall Study|Disease progression|2|||
131576024|NCT00246012|473734416|FG003|Overall Study|Disease progression|3|||
131576025|NCT00246012|473734417|FG004|Overall Study|Disease progression|3|||
131576026|NCT00246012|473734418|FG005|Overall Study|Disease progression|25|||
131576027|NCT00246012|473734419|FG006|Overall Study|Disease progression|30|||
131576028|NCT00246012|473734420|FG007|Overall Study|Disease progression|27|||
131576029|NCT00246012|473734421|FG008|Overall Study|Disease progression|26|||
131576030|NCT00246012|473734413|FG000|Overall Study|Other|0|||
131576031|NCT00246012|473734414|FG001|Overall Study|Other|0|||
131576032|NCT00246012|473734415|FG002|Overall Study|Other|0|||
131576033|NCT00246012|473734416|FG003|Overall Study|Other|0|||
131576034|NCT00246012|473734417|FG004|Overall Study|Other|0|||
131576035|NCT00246012|473734418|FG005|Overall Study|Other|0|||
131576036|NCT00246012|473734419|FG006|Overall Study|Other|0|||
131576037|NCT00246012|473734420|FG007|Overall Study|Other|1|||
131576038|NCT00246012|473734421|FG008|Overall Study|Other|0|||
131576039|NCT00246012|473734413|FG000|Overall Study|Randomly assigned but not treated|0|||
131576040|NCT00246012|473734414|FG001|Overall Study|Randomly assigned but not treated|0|||
131576041|NCT00246012|473734415|FG002|Overall Study|Randomly assigned but not treated|0|||
131576042|NCT00246012|473734416|FG003|Overall Study|Randomly assigned but not treated|0|||
131576043|NCT00246012|473734417|FG004|Overall Study|Randomly assigned but not treated|0|||
131576044|NCT00246012|473734418|FG005|Overall Study|Randomly assigned but not treated|1|||
131576045|NCT00246012|473734419|FG006|Overall Study|Randomly assigned but not treated|1|||
131576046|NCT00246012|473734420|FG007|Overall Study|Randomly assigned but not treated|0|||
131576047|NCT00246012|473734421|FG008|Overall Study|Randomly assigned but not treated|0|||
131576048|NCT00094809|473734422|FG000|Overall Study|Protocol deviation|2|||
131576049|NCT00094809|473734423|FG001|Overall Study|Protocol deviation|2|||
131576050|NCT00094809|473734422|FG000|Overall Study|Noncompliance|1|||
131576051|NCT00094809|473734423|FG001|Overall Study|Noncompliance|0|||
131576052|NCT00094809|473734422|FG000|Overall Study|Adverse Event|3|||
131576053|NCT00094809|473734423|FG001|Overall Study|Adverse Event|1|||
131576054|NCT00094809|473734422|FG000|Overall Study|Withdrawal by Subject|8|||
131576055|NCT00094809|473734423|FG001|Overall Study|Withdrawal by Subject|9|||
131576056|NCT00094809|473734422|FG000|Overall Study|Disease progression|3|||
131576057|NCT00094809|473734423|FG001|Overall Study|Disease progression|3|||
131576058|NCT00094809|473734422|FG000|Overall Study|Physician Decision|3|||
131576059|NCT00094809|473734423|FG001|Overall Study|Physician Decision|5|||
131576060|NCT00094809|473734422|FG000|Overall Study|Lost to Follow-up|6|||
131576061|NCT00094809|473734423|FG001|Overall Study|Lost to Follow-up|6|||
131576062|NCT00094809|473734422|FG000|Overall Study|Death|19|||
131576063|NCT00094809|473734423|FG001|Overall Study|Death|25|||
131576064|NCT00094809|473734422|FG000|Overall Study|Protocol-specified criteria|1|||
131576065|NCT00094809|473734423|FG001|Overall Study|Protocol-specified criteria|1|||
131576066|NCT00094809|473734422|FG000|Overall Study|Other|2|||
131576067|NCT00094809|473734423|FG001|Overall Study|Other|4|||
131576068|NCT00094809|473734422|FG000|Overall Study|Informed consent signed after treatment|1|||
131576069|NCT00094809|473734423|FG001|Overall Study|Informed consent signed after treatment|0|||
131576070|NCT00094809|473734422|FG000|Overall Study|Study drug not received|2|||
131576071|NCT00094809|473734423|FG001|Overall Study|Study drug not received|8|||
131576072|NCT00094809|473734422|FG000|Overall Study|Other|1|||
131576073|NCT00094809|473734423|FG001|Overall Study|Other|1|||
131576074|NCT04889664|473734424|FG000|Screen|Lost to Follow-up|1|||
131576075|NCT04889664|473734424|FG000|Screen|Failed to meet screening criteria|1|||
131576076|NCT04889664|473734424|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
131576077|NCT00771849|473734428|FG000|Overall Study|Lost to Follow-up|1|||
131576078|NCT00771849|473734429|FG001|Overall Study|Lost to Follow-up|2|||
131576079|NCT00771849|473734428|FG000|Overall Study|Withdrawal by Subject|1|||
131576080|NCT00771849|473734429|FG001|Overall Study|Withdrawal by Subject|1|||
131576081|NCT00771849|473734428|FG000|Overall Study|Not vaccinated|0|||
131576082|NCT00771849|473734429|FG001|Overall Study|Not vaccinated|1|||
131576083|NCT02046616|473734435|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
131438025|NCT01339689|473229477|FG000|Overall Study|Lost to Follow-up|9|||
131699569|NCT03467958|474183326|FG008|Overall Study|Other reasons|1|||
131699570|NCT03467958|474183318|FG000|Overall Study|Pregnancy|1|||
131699571|NCT03467958|474183319|FG001|Overall Study|Pregnancy|0|||
131576084|NCT02046616|473734435|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
131699572|NCT03467958|474183320|FG002|Overall Study|Pregnancy|0|||
131576085|NCT02046616|473734435|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
131576086|NCT02046616|473734435|FG000|24-Week Treatment Period|Physician Decision|3|||
131699573|NCT03467958|474183321|FG003|Overall Study|Pregnancy|0|||
131576087|NCT02046616|473734435|FG000|24-Week Treatment Period|Other|1|||
131576088|NCT02046616|473734435|FG000|8-Week FU Period|Lost to Follow-up|1|||
131576089|NCT02736799|473734436|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
131576090|NCT02736799|473734437|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
131576091|NCT02736799|473734438|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
131699574|NCT03467958|474183322|FG004|Overall Study|Pregnancy|0|||
131699575|NCT03467958|474183323|FG005|Overall Study|Pregnancy|1|||
131699576|NCT03467958|474183324|FG006|Overall Study|Pregnancy|0|||
131699577|NCT03467958|474183325|FG007|Overall Study|Pregnancy|0|||
131699578|NCT03467958|474183326|FG008|Overall Study|Pregnancy|0|||
131699579|NCT03467958|474183318|FG000|Overall Study|Study terminated by sponsor|65|||
131699580|NCT03467958|474183319|FG001|Overall Study|Study terminated by sponsor|117|||
131699581|NCT03467958|474183320|FG002|Overall Study|Study terminated by sponsor|45|||
131699582|NCT03467958|474183321|FG003|Overall Study|Study terminated by sponsor|64|||
131699583|NCT03467958|474183322|FG004|Overall Study|Study terminated by sponsor|66|||
131576092|NCT02736799|473734439|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
131576093|NCT01833832|473734441|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
131576094|NCT01156116|473734443|FG000|Overall Study|Withdrawal by Subject|3|||
131576095|NCT01156116|473734444|FG001|Overall Study|Withdrawal by Subject|1|||
131576096|NCT01156116|473734443|FG000|Overall Study|CPAP intolerance|2|||
131576097|NCT01156116|473734444|FG001|Overall Study|CPAP intolerance|0|||
131576098|NCT00344019|473734445|FG000|Overall Study|did not meet final inclusion criteria|0|||
131576099|NCT00344019|473734446|FG001|Overall Study|did not meet final inclusion criteria|0|||
131576100|NCT00344019|473734447|FG002|Overall Study|did not meet final inclusion criteria|74|||
131576101|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
131576102|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
131576103|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
131576104|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
131576105|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
131576106|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
131576107|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
131576108|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
131576109|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
131576110|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
131576111|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
131576112|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
131576113|NCT02057718|473734448|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
131576114|NCT02057718|473734449|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
131576115|NCT02057718|473734448|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
131576116|NCT02057718|473734449|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
131576117|NCT02057718|473734448|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
131576118|NCT02057718|473734449|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
131576119|NCT02057718|473734448|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
131576120|NCT02057718|473734449|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
131576121|NCT02057718|473734448|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
131576122|NCT02057718|473734449|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
131576123|NCT00608907|473734456|FG000|Overall Study|Adverse Event|6|||
131576124|NCT00608907|473734457|FG001|Overall Study|Adverse Event|0|||
131576125|NCT00608907|473734458|FG002|Overall Study|Adverse Event|1|||
131576126|NCT00608907|473734456|FG000|Overall Study|Death|1|||
131576127|NCT00608907|473734457|FG001|Overall Study|Death|0|||
131576128|NCT00608907|473734458|FG002|Overall Study|Death|0|||
131576129|NCT00608907|473734456|FG000|Overall Study|Withdrawal by Subject|4|||
131576130|NCT00608907|473734457|FG001|Overall Study|Withdrawal by Subject|0|||
131576131|NCT00608907|473734458|FG002|Overall Study|Withdrawal by Subject|0|||
131576132|NCT00608907|473734456|FG000|Overall Study|Progressive Disease|1|||
131576133|NCT00608907|473734457|FG001|Overall Study|Progressive Disease|0|||
131576134|NCT00608907|473734458|FG002|Overall Study|Progressive Disease|0|||
131576135|NCT00906035|473734460|FG000|Overall Study|Withdrawal by Subject|2|||
131576136|NCT00906035|473734461|FG001|Overall Study|Withdrawal by Subject|3|||
131576137|NCT00906035|473734462|FG002|Overall Study|Withdrawal by Subject|0|||
131576138|NCT05046132|473734465|FG000|Overall Study|Adverse Event|4|||
131576139|NCT05046132|473734466|FG001|Overall Study|Adverse Event|0|||
131576140|NCT05046132|473734467|FG002|Overall Study|Adverse Event|0|||
131576141|NCT05046132|473734465|FG000|Overall Study|Withdrawal by Subject|3|||
131576142|NCT05046132|473734466|FG001|Overall Study|Withdrawal by Subject|0|||
131576143|NCT05046132|473734467|FG002|Overall Study|Withdrawal by Subject|0|||
131576144|NCT05046132|473734465|FG000|Overall Study|Positive Covid19 Result.|0|||
131576145|NCT05046132|473734466|FG001|Overall Study|Positive Covid19 Result.|1|||
131576146|NCT05046132|473734467|FG002|Overall Study|Positive Covid19 Result.|0|||
131576147|NCT02596035|473734469|FG000|Overall Study|Disease Progression|64|||
131576148|NCT02596035|473734470|FG001|Overall Study|Disease Progression|32|||
131576149|NCT02596035|473734471|FG002|Overall Study|Disease Progression|1|||
131576150|NCT02596035|473734469|FG000|Overall Study|study drug toxicity|12|||
131576151|NCT02596035|473734470|FG001|Overall Study|study drug toxicity|3|||
131576152|NCT02596035|473734471|FG002|Overall Study|study drug toxicity|0|||
131576153|NCT02596035|473734469|FG000|Overall Study|AE unrelated to study drug|5|||
131576154|NCT02596035|473734470|FG001|Overall Study|AE unrelated to study drug|2|||
131576155|NCT02596035|473734471|FG002|Overall Study|AE unrelated to study drug|0|||
131576156|NCT02596035|473734469|FG000|Overall Study|participant request to discontinue study treatment|2|||
131576157|NCT02596035|473734470|FG001|Overall Study|participant request to discontinue study treatment|0|||
131576158|NCT02596035|473734471|FG002|Overall Study|participant request to discontinue study treatment|0|||
131576159|NCT02596035|473734469|FG000|Overall Study|participant withdrew consent|2|||
131576160|NCT02596035|473734470|FG001|Overall Study|participant withdrew consent|2|||
131576161|NCT02596035|473734471|FG002|Overall Study|participant withdrew consent|0|||
131576162|NCT02596035|473734469|FG000|Overall Study|Poor/Non Comlpiance|0|||
131576163|NCT02596035|473734470|FG001|Overall Study|Poor/Non Comlpiance|1|||
131576164|NCT02596035|473734471|FG002|Overall Study|Poor/Non Comlpiance|0|||
131576165|NCT02596035|473734469|FG000|Overall Study|participant no longer meets study criteria|1|||
131576166|NCT02596035|473734470|FG001|Overall Study|participant no longer meets study criteria|0|||
131576167|NCT02596035|473734471|FG002|Overall Study|participant no longer meets study criteria|0|||
131576168|NCT02596035|473734469|FG000|Overall Study|other reasons|11|||
131576169|NCT02596035|473734470|FG001|Overall Study|other reasons|4|||
131576170|NCT02596035|473734471|FG002|Overall Study|other reasons|0|||
131576171|NCT00754936|473734473|FG000|Overall Study|Lost to Follow-up|3|||
131576172|NCT00754936|473734473|FG000|Overall Study|Physician Decision|1|||
131576173|NCT00754936|473734473|FG000|Overall Study|Withdrawal by Subject|2|||
131576174|NCT00754936|473734473|FG000|Overall Study|Side Effects|3|||
131576175|NCT00754936|473734473|FG000|Overall Study|Inter-current medical events|3|||
131576176|NCT00619645|473734474|FG000|Overall Study|Adverse Event|1|||
131576177|NCT00436644|473734475|FG000|Overall Study|Adverse Event|2|||
131576178|NCT00436644|473734475|FG000|Overall Study|Death|1|||
131576179|NCT04364269|473734477|FG000|Overall Study|Adverse Event|1|||
131576180|NCT04364269|473734478|FG001|Overall Study|Adverse Event|0|||
131576181|NCT04364269|473734479|FG002|Overall Study|Adverse Event|0|||
131576182|NCT04364269|473734477|FG000|Overall Study|Withdrawal by Subject|0|||
131576183|NCT04364269|473734478|FG001|Overall Study|Withdrawal by Subject|1|||
131576184|NCT04364269|473734479|FG002|Overall Study|Withdrawal by Subject|0|||
131576185|NCT02357784|473734484|FG000|Overall Study|Withdrawal by Subject|1|||
131576186|NCT00604721|473734488|FG000|Overall Study|Physician Decision|1|||
131576187|NCT00604721|473734488|FG000|Overall Study|Withdrawal by Subject|1|||
131576188|NCT04776213|473734489|FG000|Overall Study|Other|1|||
131576189|NCT04776213|473734489|FG000|Overall Study|Withdrawal by Subject|7|||
131576190|NCT04776213|473734489|FG000|Overall Study|Protocol Violation|1|||
131576191|NCT04776213|473734489|FG000|Overall Study|Lost to Follow-up|2|||
131576192|NCT01838551|473734491|FG000|Overall Study|Adverse Event|16|||
131576193|NCT01838551|473734491|FG000|Overall Study|Death|1|||
131576194|NCT01838551|473734491|FG000|Overall Study|Lack of Efficacy|10|||
131576195|NCT01838551|473734491|FG000|Overall Study|Physician Decision|4|||
131576196|NCT01838551|473734491|FG000|Overall Study|Withdrawal by Subject|10|||
131576197|NCT01838551|473734491|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
131576198|NCT02289560|473734494|FG000|Overall Study|Lost to Follow-up|6|||
131576199|NCT02289560|473734494|FG000|Overall Study|Alternative Treatment|4|||
131576200|NCT02289560|473734494|FG000|Overall Study|Inadequate Treatment|2|||
131576201|NCT02289560|473734494|FG000|Overall Study|Withdrawal by Subject|23|||
131576202|NCT01768676|473734500|FG000|Overall Study|Adverse Event|3|||
131576203|NCT01768676|473734501|FG001|Overall Study|Adverse Event|3|||
131576204|NCT01768676|473734500|FG000|Overall Study|Lost to Follow-up|13|||
131576205|NCT01768676|473734501|FG001|Overall Study|Lost to Follow-up|16|||
131576206|NCT01768676|473734500|FG000|Overall Study|Protocol Violation|1|||
131576207|NCT01768676|473734501|FG001|Overall Study|Protocol Violation|1|||
131576208|NCT01768676|473734500|FG000|Overall Study|Physician Decision|4|||
131576209|NCT01768676|473734501|FG001|Overall Study|Physician Decision|1|||
131576210|NCT01768676|473734500|FG000|Overall Study|Withdrawal by Subject|3|||
131576211|NCT01768676|473734501|FG001|Overall Study|Withdrawal by Subject|10|||
131576212|NCT03395353|473734503|FG000|Overall Study|Adverse Event|20|||
131576213|NCT03395353|473734503|FG000|Overall Study|Protocol Violation|1|||
131576214|NCT03395353|473734503|FG000|Overall Study|Lack of Efficacy|3|||
131576215|NCT03395353|473734503|FG000|Overall Study|Withdrawal by Subject|24|||
131576216|NCT03395353|473734503|FG000|Overall Study|Discontinued visit|1|||
131576217|NCT03395353|473734503|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
131576218|NCT03395353|473734503|FG000|Overall Study|Physician Decision|4|||
131576219|NCT03395353|473734503|FG000|Overall Study|Early termination of overall study|33|||
131576220|NCT01196429|473734504|FG000|Overall Study|Ineligible - inadequate pathology|1|||
131576221|NCT01196429|473734505|FG001|Overall Study|Ineligible - inadequate pathology|0|||
131576222|NCT01196429|473734504|FG000|Overall Study|Ineligible - wrong cell type|1|||
131576223|NCT01196429|473734505|FG001|Overall Study|Ineligible - wrong cell type|0|||
131576224|NCT01196429|473734504|FG000|Overall Study|Refused - Never Treated|1|||
131576225|NCT01196429|473734505|FG001|Overall Study|Refused - Never Treated|0|||
131576226|NCT02486588|473734506|FG000|Overall Study|Randomized in error- ineligible|738|||
131576227|NCT02486588|473734507|FG001|Overall Study|Randomized in error- ineligible|750|||
131576228|NCT02486588|473734508|FG002|Overall Study|Randomized in error- ineligible|755|||
131576229|NCT02486588|473734509|FG003|Overall Study|Randomized in error- ineligible|738|||
131576230|NCT02486588|473734510|FG004|Overall Study|Randomized in error- ineligible|746|||
131576231|NCT02486588|473734511|FG005|Overall Study|Randomized in error- ineligible|746|||
131576232|NCT04248829|473734512|FG000|Overall Study|Disease progression|44|||
131576233|NCT04248829|473734513|FG001|Overall Study|Disease progression|109|||
131576234|NCT04248829|473734512|FG000|Overall Study|Adverse Event|19|||
131576235|NCT04248829|473734513|FG001|Overall Study|Adverse Event|18|||
131576236|NCT04248829|473734512|FG000|Overall Study|Withdrawal by Subject|11|||
131576237|NCT04248829|473734513|FG001|Overall Study|Withdrawal by Subject|2|||
131576238|NCT04248829|473734512|FG000|Overall Study|Lost to Follow-up|0|||
131576239|NCT04248829|473734513|FG001|Overall Study|Lost to Follow-up|1|||
131576240|NCT04248829|473734512|FG000|Overall Study|Death|12|||
131576241|NCT04248829|473734513|FG001|Overall Study|Death|14|||
131576242|NCT04248829|473734512|FG000|Overall Study|Physician Decision|2|||
131576243|NCT04248829|473734513|FG001|Overall Study|Physician Decision|4|||
131576244|NCT04248829|473734512|FG000|Overall Study|Any reason not specifically recorded|0|||
131576245|NCT04248829|473734513|FG001|Overall Study|Any reason not specifically recorded|2|||
131576246|NCT02132702|473734514|FG000|Overall Study|Protocol Violation|2|||
131576247|NCT02132702|473734514|FG000|Overall Study|Adverse Event|3|||
131576248|NCT02132702|473734514|FG000|Overall Study|Withdrawal by Subject|3|||
131576249|NCT02013037|473734515|FG000|Overall Study|Death|6|||
131576250|NCT02013037|473734515|FG000|Overall Study|Withdrawal by Subject|1|||
131576251|NCT02013037|473734515|FG000|Overall Study|Awaiting Transplantation|7|||
131576252|NCT02013037|473734515|FG000|Overall Study|Transplanted without DSA|2|||
131576253|NCT03354390|473734516|FG000|Level 1|Death|2|||
131576254|NCT03354390|473734517|FG001|Level 1|Death|0|||
131576255|NCT03354390|473734518|FG002|Level 1|Death|0|||
131576256|NCT03354390|473734519|FG003|Level 1|Death|0|||
131576257|NCT03354390|473734516|FG000|Level 1|Physician Decision|1|||
131576258|NCT03354390|473734517|FG001|Level 1|Physician Decision|0|||
131576259|NCT03354390|473734518|FG002|Level 1|Physician Decision|0|||
131576260|NCT03354390|473734519|FG003|Level 1|Physician Decision|0|||
131576261|NCT03354390|473734516|FG000|Level 2|Physician Decision|0|||
131576262|NCT03354390|473734517|FG001|Level 2|Physician Decision|2|||
131576263|NCT03354390|473734518|FG002|Level 2|Physician Decision|0|||
131576264|NCT03354390|473734519|FG003|Level 2|Physician Decision|0|||
131576265|NCT03354390|473734516|FG000|Level 2|Lack of Efficacy|0|||
131576266|NCT03354390|473734517|FG001|Level 2|Lack of Efficacy|1|||
131576267|NCT03354390|473734518|FG002|Level 2|Lack of Efficacy|0|||
131576268|NCT03354390|473734519|FG003|Level 2|Lack of Efficacy|0|||
131576269|NCT03354390|473734516|FG000|Level 2|Lost to Follow-up|0|||
131576270|NCT03354390|473734517|FG001|Level 2|Lost to Follow-up|1|||
131576271|NCT03354390|473734518|FG002|Level 2|Lost to Follow-up|0|||
131576272|NCT03354390|473734519|FG003|Level 2|Lost to Follow-up|0|||
131576273|NCT03354390|473734516|FG000|Level 3|Death|0|||
131576274|NCT03354390|473734517|FG001|Level 3|Death|0|||
131576275|NCT03354390|473734518|FG002|Level 3|Death|1|||
131576276|NCT03354390|473734519|FG003|Level 3|Death|0|||
131576277|NCT03354390|473734516|FG000|Level 3|Physician Decision|0|||
131576278|NCT03354390|473734517|FG001|Level 3|Physician Decision|0|||
131576279|NCT03354390|473734518|FG002|Level 3|Physician Decision|2|||
131576280|NCT03354390|473734519|FG003|Level 3|Physician Decision|0|||
131576281|NCT03354390|473734516|FG000|Level 4|Death|0|||
131576282|NCT03354390|473734517|FG001|Level 4|Death|0|||
131576283|NCT03354390|473734518|FG002|Level 4|Death|0|||
131576284|NCT03354390|473734519|FG003|Level 4|Death|3|||
131576285|NCT01066923|473734520|FG000|Overall Study|Withdrawal by Subject|3|||
131576286|NCT01066923|473734521|FG001|Overall Study|Withdrawal by Subject|3|||
131576287|NCT01066923|473734522|FG002|Overall Study|Withdrawal by Subject|8|||
131576288|NCT01066923|473734523|FG003|Overall Study|Withdrawal by Subject|8|||
131576289|NCT04257058|473735948|FG000|Overall Study|Lost to Follow-up|31|||
131576290|NCT01144468|473735949|FG000|Overall Study|Lost to Follow-up|4|||
131576291|NCT01144468|473735950|FG001|Overall Study|Lost to Follow-up|7|||
131576292|NCT01144468|473735949|FG000|Overall Study|Adverse Event|3|||
131576293|NCT01144468|473735950|FG001|Overall Study|Adverse Event|2|||
131576294|NCT01144468|473735949|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
131576295|NCT01144468|473735950|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
131576296|NCT00661778|473735956|FG000|Overall Study|Disease Progression|23|||
131576297|NCT00661778|473735956|FG000|Overall Study|Adverse Event|18|||
131576298|NCT00661778|473735956|FG000|Overall Study|Reason not Specified|6|||
131576299|NCT00661778|473735956|FG000|Overall Study|Protocol Violation|2|||
131576300|NCT00661778|473735956|FG000|Overall Study|Withdrawal of Consent|1|||
131576301|NCT05298111|473735957|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
131576302|NCT05298111|473735958|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
131576303|NCT02689349|473735961|FG000|Overall Study|Not implanted|4|||
131576304|NCT02689349|473735962|FG001|Overall Study|Not implanted|0|||
131576305|NCT02689349|473735961|FG000|Overall Study|Withdrawal by Subject|9|||
131576306|NCT02689349|473735962|FG001|Overall Study|Withdrawal by Subject|0|||
131576307|NCT03518112|473735963|FG000|Overall Study|Withdrawal by Subject|1|||
131576308|NCT01546155|473735964|FG000|Overall Study|could not tolerate long scan duration|3|||
131576309|NCT00954707|473735968|FG000|Overall Study|Death|34|||
131576310|NCT00954707|473735968|FG000|Overall Study|Withdrawal by Subject|100|||
131576311|NCT00954707|473735968|FG000|Overall Study|Lost to Follow-up|33|||
131576312|NCT01025843|473735969|FG000|Washout 4|Withdrawal by Subject|0|||
131576313|NCT01025843|473735970|FG001|Washout 4|Withdrawal by Subject|0|||
131576314|NCT01025843|473735971|FG002|Washout 4|Withdrawal by Subject|1|||
131576315|NCT01025843|473735972|FG003|Washout 4|Withdrawal by Subject|1|||
131576316|NCT01025843|473735973|FG004|Washout 4|Withdrawal by Subject|0|||
131576317|NCT01025843|473735974|FG005|Washout 4|Withdrawal by Subject|0|||
131576318|NCT01025843|473735975|FG006|Washout 4|Withdrawal by Subject|0|||
131576319|NCT01025843|473735976|FG007|Washout 4|Withdrawal by Subject|0|||
131576320|NCT01025843|473735977|FG008|Washout 4|Withdrawal by Subject|0|||
131576321|NCT01025843|473735978|FG009|Washout 4|Withdrawal by Subject|0|||
131576322|NCT00377455|473735981|FG000|Overall Study|Withdrawal by Subject|1|||
131576323|NCT01897233|473735984|FG000|Part B (24 Weeks)|Adverse Event|1|||
131576324|NCT01897233|473735984|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
131576325|NCT01897233|473735984|FG000|Part B (24 Weeks)|Physician Decision|1|||
131576326|NCT01281813|473735999|FG000|Overall Study|Adverse Event|0|||
131576327|NCT01281813|473736000|FG001|Overall Study|Adverse Event|0|||
131576328|NCT01281813|473736001|FG002|Overall Study|Adverse Event|10|||
131699584|NCT03467958|474183323|FG005|Overall Study|Study terminated by sponsor|17|||
131699585|NCT03467958|474183324|FG006|Overall Study|Study terminated by sponsor|11|||
131699586|NCT03467958|474183325|FG007|Overall Study|Study terminated by sponsor|5|||
131699587|NCT03467958|474183326|FG008|Overall Study|Study terminated by sponsor|5|||
131699588|NCT03467958|474183318|FG000|Overall Study|Withdrawal by Subject|25|||
131576329|NCT01281813|473735999|FG000|Overall Study|Lost to Follow-up|0|||
131576330|NCT01281813|473736000|FG001|Overall Study|Lost to Follow-up|0|||
131576331|NCT01281813|473736001|FG002|Overall Study|Lost to Follow-up|31|||
131576332|NCT01281813|473735999|FG000|Overall Study|Withdrawal by Subject|0|||
131576333|NCT01281813|473736000|FG001|Overall Study|Withdrawal by Subject|0|||
131576334|NCT01281813|473736001|FG002|Overall Study|Withdrawal by Subject|13|||
131576335|NCT01281813|473735999|FG000|Overall Study|Subject Non-Compliant|0|||
131576336|NCT01281813|473736000|FG001|Overall Study|Subject Non-Compliant|0|||
131576337|NCT01281813|473736001|FG002|Overall Study|Subject Non-Compliant|6|||
131576338|NCT01281813|473735999|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
131576339|NCT01281813|473736000|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
131576340|NCT01281813|473736001|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
131699589|NCT03467958|474183319|FG001|Overall Study|Withdrawal by Subject|44|||
131699590|NCT03467958|474183320|FG002|Overall Study|Withdrawal by Subject|7|||
131699591|NCT03467958|474183321|FG003|Overall Study|Withdrawal by Subject|8|||
131576341|NCT01281813|473735999|FG000|Overall Study|Sponsor's Decision|4|||
131576342|NCT01281813|473736000|FG001|Overall Study|Sponsor's Decision|3|||
131576343|NCT01281813|473736001|FG002|Overall Study|Sponsor's Decision|7|||
131576344|NCT01281813|473735999|FG000|Overall Study|Switched to Commercially Available Medication|0|||
131576345|NCT01281813|473736000|FG001|Overall Study|Switched to Commercially Available Medication|0|||
131576346|NCT01281813|473736001|FG002|Overall Study|Switched to Commercially Available Medication|26|||
131576347|NCT01281813|473735999|FG000|Overall Study|Other|0|||
131576348|NCT01281813|473736000|FG001|Overall Study|Other|1|||
131576349|NCT01281813|473736001|FG002|Overall Study|Other|39|||
131576350|NCT03546907|473736002|FG000|Overall Study|Lack of Efficacy|1|||
131576351|NCT03546907|473736003|FG001|Overall Study|Lack of Efficacy|1|||
131576352|NCT03546907|473736002|FG000|Overall Study|Withdrawal by Subject|8|||
131576353|NCT03546907|473736003|FG001|Overall Study|Withdrawal by Subject|9|||
131576354|NCT03546907|473736002|FG000|Overall Study|Adverse events (AEs)|7|||
131576355|NCT03546907|473736003|FG001|Overall Study|Adverse events (AEs)|10|||
131576356|NCT03546907|473736002|FG000|Overall Study|Other-unspecified|1|||
131576357|NCT03546907|473736003|FG001|Overall Study|Other-unspecified|1|||
131576358|NCT05193318|473736005|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
131576359|NCT05193318|473736005|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
131576360|NCT00798096|473736006|FG000|Overall Study|Ongoing|2|||
131576361|NCT00545844|473736010|FG000|Overall Study|Lost to Follow-up|9|||
131576362|NCT00545844|473736010|FG000|Overall Study|Protocol Violation|1|||
131576363|NCT00545844|473736010|FG000|Overall Study|Withdrawal by Subject|2|||
131576364|NCT02503202|473736012|FG000|Base Study: Up to Month 6|Death|1|||
131576365|NCT02503202|473736013|FG001|Base Study: Up to Month 6|Death|1|||
131699592|NCT03467958|474183322|FG004|Overall Study|Withdrawal by Subject|6|||
131699593|NCT03467958|474183323|FG005|Overall Study|Withdrawal by Subject|8|||
131576366|NCT02503202|473736014|FG002|Base Study: Up to Month 6|Death|0|||
131576367|NCT02503202|473736015|FG003|Base Study: Up to Month 6|Death|0|||
131576368|NCT02503202|473736016|FG004|Base Study: Up to Month 6|Death|0|||
131576369|NCT02503202|473736012|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
131699594|NCT03467958|474183324|FG006|Overall Study|Withdrawal by Subject|4|||
131699595|NCT03467958|474183325|FG007|Overall Study|Withdrawal by Subject|1|||
131699596|NCT03467958|474183326|FG008|Overall Study|Withdrawal by Subject|4|||
131699597|NCT02925156|474183327|FG000|Overall Study|Lost to Follow-up|27|||
131699598|NCT02925156|474183328|FG001|Overall Study|Lost to Follow-up|53|||
131438026|NCT01339689|473229478|FG001|Overall Study|Lost to Follow-up|3|||
131576370|NCT02503202|473736013|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
131576371|NCT02503202|473736014|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
131576372|NCT02503202|473736015|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
131576373|NCT02503202|473736016|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
131576374|NCT02503202|473736012|FG000|Base Study: Up to Month 6|Physician Decision|0|||
131576375|NCT02503202|473736013|FG001|Base Study: Up to Month 6|Physician Decision|0|||
131576376|NCT02503202|473736014|FG002|Base Study: Up to Month 6|Physician Decision|0|||
131576377|NCT02503202|473736015|FG003|Base Study: Up to Month 6|Physician Decision|0|||
131576378|NCT02503202|473736016|FG004|Base Study: Up to Month 6|Physician Decision|1|||
131576379|NCT02503202|473736012|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
131576380|NCT02503202|473736013|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
131576381|NCT02503202|473736014|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
131576382|NCT02503202|473736015|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
131576383|NCT02503202|473736016|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
131576384|NCT02503202|473736012|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
131576385|NCT02503202|473736013|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
131576386|NCT02503202|473736014|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
131576387|NCT02503202|473736015|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
131576388|NCT02503202|473736016|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
131576389|NCT02503202|473736012|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
131576390|NCT02503202|473736013|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
131576391|NCT02503202|473736014|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
131576392|NCT02503202|473736015|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
131576393|NCT02503202|473736016|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
131576394|NCT02503202|473736012|FG000|Extension: Month 6 to 24|Death|1|||
131576395|NCT02503202|473736013|FG001|Extension: Month 6 to 24|Death|0|||
131576396|NCT02503202|473736014|FG002|Extension: Month 6 to 24|Death|0|||
131576397|NCT02503202|473736015|FG003|Extension: Month 6 to 24|Death|0|||
131576398|NCT02503202|473736016|FG004|Extension: Month 6 to 24|Death|0|||
131576399|NCT02503202|473736012|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
131576400|NCT02503202|473736013|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
131576401|NCT02503202|473736014|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
131576402|NCT02503202|473736015|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
131576403|NCT02503202|473736016|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
131576404|NCT02503202|473736012|FG000|Extension: Month 6 to 24|Physician Decision|1|||
131576405|NCT02503202|473736013|FG001|Extension: Month 6 to 24|Physician Decision|0|||
131576406|NCT02503202|473736014|FG002|Extension: Month 6 to 24|Physician Decision|1|||
131576407|NCT02503202|473736015|FG003|Extension: Month 6 to 24|Physician Decision|3|||
131576408|NCT02503202|473736016|FG004|Extension: Month 6 to 24|Physician Decision|0|||
131576409|NCT02503202|473736012|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
131576410|NCT02503202|473736013|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
131576411|NCT02503202|473736014|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
131576412|NCT02503202|473736015|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
131576413|NCT02503202|473736016|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
131576414|NCT03058991|473736019|FG000|Overall Study|Lost to Follow-up|17|||
131576415|NCT03058991|473736020|FG001|Overall Study|Lost to Follow-up|12|||
131576416|NCT03058991|473736021|FG002|Overall Study|Lost to Follow-up|12|||
131576417|NCT03058991|473736019|FG000|Overall Study|Withdrawal by Subject|1|||
131576418|NCT03058991|473736020|FG001|Overall Study|Withdrawal by Subject|0|||
131576419|NCT03058991|473736021|FG002|Overall Study|Withdrawal by Subject|0|||
131576420|NCT00130637|473736022|FG000|Overall Study|Adverse Event|2|||
131576421|NCT00130637|473736022|FG000|Overall Study|Withdrawal by Subject|1|||
131576422|NCT01460342|473736024|FG000|Overall Study|Adverse Event|5|||
131576423|NCT01460342|473736025|FG001|Overall Study|Adverse Event|4|||
131576424|NCT01460342|473736024|FG000|Overall Study|Lost to Follow-up|1|||
131576425|NCT01460342|473736025|FG001|Overall Study|Lost to Follow-up|2|||
131576426|NCT01460342|473736024|FG000|Overall Study|Protocol Violation|0|||
131576427|NCT01460342|473736025|FG001|Overall Study|Protocol Violation|1|||
131576428|NCT01460342|473736024|FG000|Overall Study|Withdrawal by Subject|3|||
131576429|NCT01460342|473736025|FG001|Overall Study|Withdrawal by Subject|4|||
131576430|NCT01460342|473736024|FG000|Overall Study|Physician Decision|1|||
131576431|NCT01460342|473736025|FG001|Overall Study|Physician Decision|3|||
131576432|NCT01460342|473736024|FG000|Overall Study|Lack of Efficacy|1|||
131576433|NCT01460342|473736025|FG001|Overall Study|Lack of Efficacy|0|||
131576434|NCT01191788|473736026|FG000|Overall Study|Lost to Follow-up|21|||
131576435|NCT01191788|473736027|FG001|Overall Study|Lost to Follow-up|22|||
131576436|NCT01689519|473736028|FG000|Intent to Treat|Death|157|||
131576437|NCT01689519|473736029|FG001|Intent to Treat|Death|167|||
131576438|NCT01689519|473736028|FG000|Intent to Treat|Lost to Follow-up|4|||
131576439|NCT01689519|473736029|FG001|Intent to Treat|Lost to Follow-up|8|||
131576440|NCT01689519|473736028|FG000|Intent to Treat|Other|2|||
131576441|NCT01689519|473736029|FG001|Intent to Treat|Other|4|||
131576442|NCT01689519|473736028|FG000|Intent to Treat|Physician Decision|4|||
131576443|NCT01689519|473736029|FG001|Intent to Treat|Physician Decision|1|||
131576444|NCT01689519|473736028|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
131576445|NCT01689519|473736029|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
131576446|NCT01689519|473736028|FG000|Intent to Treat|Withdrawal by Subject|21|||
131576447|NCT01689519|473736029|FG001|Intent to Treat|Withdrawal by Subject|20|||
131576448|NCT01689519|473736028|FG000|Safety Population|Death|158|||
131576449|NCT01689519|473736029|FG001|Safety Population|Death|165|||
131576450|NCT01689519|473736028|FG000|Safety Population|Lost to Follow-up|4|||
131576451|NCT01689519|473736029|FG001|Safety Population|Lost to Follow-up|8|||
131576452|NCT01689519|473736028|FG000|Safety Population|Other|2|||
131576453|NCT01689519|473736029|FG001|Safety Population|Other|4|||
131576454|NCT01689519|473736028|FG000|Safety Population|Physician Decision|4|||
131576455|NCT01689519|473736029|FG001|Safety Population|Physician Decision|1|||
131576456|NCT01689519|473736028|FG000|Safety Population|Study Terminated By Sponsor|60|||
131576457|NCT01689519|473736029|FG001|Safety Population|Study Terminated By Sponsor|47|||
131576458|NCT01689519|473736028|FG000|Safety Population|Withdrawal by Subject|20|||
131576459|NCT01689519|473736029|FG001|Safety Population|Withdrawal by Subject|20|||
131576460|NCT01713530|473736034|FG000|Overall Study|Adverse Event|0|||
131576461|NCT01713530|473736035|FG001|Overall Study|Adverse Event|5|||
131576462|NCT01713530|473736034|FG000|Overall Study|Withdrawal criteria|21|||
131576463|NCT01713530|473736035|FG001|Overall Study|Withdrawal criteria|12|||
131576464|NCT01713530|473736034|FG000|Overall Study|Unclassified|4|||
131576465|NCT01713530|473736035|FG001|Overall Study|Unclassified|2|||
131576466|NCT01959412|473736036|FG000|Overall Study|Protocol deviation|1|||
131576467|NCT01959412|473736037|FG001|Overall Study|Protocol deviation|1|||
131576468|NCT01959412|473736038|FG002|Overall Study|Protocol deviation|0|||
131576469|NCT01959412|473736039|FG003|Overall Study|Protocol deviation|1|||
131576470|NCT01959412|473736040|FG004|Overall Study|Protocol deviation|3|||
131576471|NCT01959412|473736041|FG005|Overall Study|Protocol deviation|0|||
131576472|NCT01959412|473736036|FG000|Overall Study|Adverse Event|0|||
131576473|NCT01959412|473736037|FG001|Overall Study|Adverse Event|0|||
131576474|NCT01959412|473736038|FG002|Overall Study|Adverse Event|0|||
131576475|NCT01959412|473736039|FG003|Overall Study|Adverse Event|1|||
131576476|NCT01959412|473736040|FG004|Overall Study|Adverse Event|0|||
131576477|NCT01959412|473736041|FG005|Overall Study|Adverse Event|0|||
131576478|NCT01186848|473736047|FG000|Overall Study|Lost to Follow-up|4|||
131576479|NCT01186848|473736047|FG000|Overall Study|Withdrawal by Subject|2|||
131576480|NCT01186848|473736047|FG000|Overall Study|Adverse Event|2|||
131576481|NCT02148133|473736052|FG000|Overall Study|Investigator discretion|1|||
131576482|NCT02148133|473736052|FG000|Overall Study|Lack of Efficacy|1|||
131576483|NCT02148133|473736052|FG000|Overall Study|Protocol deviation|1|||
131576484|NCT02148133|473736052|FG000|Overall Study|Protocol-defined stopping criteria|2|||
131576485|NCT00855465|473736054|FG000|Treatment Period|Adverse Event|4|||
131576486|NCT00855465|473736055|FG001|Treatment Period|Adverse Event|2|||
131576487|NCT00855465|473736054|FG000|Treatment Period|Death|2|||
131576488|NCT00855465|473736055|FG001|Treatment Period|Death|2|||
131576489|NCT00855465|473736054|FG000|Treatment Period|Lack of Efficacy|2|||
131576490|NCT00855465|473736055|FG001|Treatment Period|Lack of Efficacy|1|||
131576491|NCT00855465|473736054|FG000|Treatment Period|Non-compliance|1|||
131576492|NCT00855465|473736055|FG001|Treatment Period|Non-compliance|0|||
131576493|NCT00855465|473736054|FG000|Treatment Period|Protocol Violation|2|||
131576494|NCT00855465|473736055|FG001|Treatment Period|Protocol Violation|0|||
131576495|NCT00855465|473736054|FG000|Treatment Period|Withdrawal by Subject|2|||
131576496|NCT00855465|473736055|FG001|Treatment Period|Withdrawal by Subject|0|||
131576497|NCT00855465|473736054|FG000|Treatment Period|Not treated|1|||
131576498|NCT00855465|473736055|FG001|Treatment Period|Not treated|0|||
131576499|NCT00855465|473736054|FG000|Follow-up Period (FUP)|Adverse Event|0|||
131576500|NCT00855465|473736055|FG001|Follow-up Period (FUP)|Adverse Event|1|||
131576501|NCT00855465|473736054|FG000|Follow-up Period (FUP)|Death|0|||
131576502|NCT00855465|473736055|FG001|Follow-up Period (FUP)|Death|1|||
131576503|NCT00855465|473736054|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
131576504|NCT00855465|473736055|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
131576505|NCT00855465|473736054|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
131576506|NCT00855465|473736055|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
131576507|NCT00855465|473736054|FG000|Follow-up Period (FUP)|Missing|1|||
131576508|NCT00855465|473736055|FG001|Follow-up Period (FUP)|Missing|0|||
131576509|NCT00509769|473736059|FG000|Overall Study|Progressive disease|77|||
131576510|NCT00509769|473736059|FG000|Overall Study|Adverse Event|4|||
131576511|NCT00509769|473736059|FG000|Overall Study|Patient's decision|1|||
131576512|NCT00509769|473736059|FG000|Overall Study|Physician Decision|8|||
131576513|NCT00509769|473736059|FG000|Overall Study|Use of prohibited therapies during study|1|||
131576514|NCT01490580|473736060|FG000|Overall Study|Parents withdrew consent|0|||
131576515|NCT01490580|473736061|FG001|Overall Study|Parents withdrew consent|2|||
131576516|NCT00972504|473736062|FG000|Overall Study|Adverse Event|2|||
131576517|NCT00972504|473736062|FG000|Overall Study|Investigator discretion|1|||
131576518|NCT00597519|473736063|FG000|Overall Study|Death|1|||
131576519|NCT04246762|473736064|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
131576520|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
131576521|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
131576522|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
131576523|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
131576524|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
131576525|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
131576526|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
131576527|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
131576528|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
131576529|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
131576530|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
131576531|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
131576532|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Death|7|||
131576533|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Death|4|||
131576534|NCT00410124|473736065|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
131576535|NCT00410124|473736066|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
131576536|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
131576537|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
131576538|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
131576539|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
131576540|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
131576541|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
131576542|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
131576543|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
131576544|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
131576545|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
131576546|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
131576547|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
131576548|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
131576549|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
131576550|NCT00410124|473736065|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
131576551|NCT00410124|473736066|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
131576552|NCT05484726|473736069|FG000|Overall Study|Protocol Violation|3|||
131576553|NCT05484726|473736070|FG001|Overall Study|Protocol Violation|3|||
131576554|NCT05484726|473736069|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
131576555|NCT05484726|473736070|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
131576556|NCT05484726|473736069|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
131576557|NCT05484726|473736070|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
131576558|NCT05484726|473736069|FG000|Overall Study|continued need of mechanical ventilation|2|||
131576559|NCT05484726|473736070|FG001|Overall Study|continued need of mechanical ventilation|3|||
131576560|NCT05484726|473736069|FG000|Overall Study|Withdrawal by Subject|2|||
131576561|NCT05484726|473736070|FG001|Overall Study|Withdrawal by Subject|3|||
131576562|NCT05484726|473736069|FG000|Overall Study|IVH (G III & IV)|2|||
131576563|NCT05484726|473736070|FG001|Overall Study|IVH (G III & IV)|1|||
131576564|NCT05484726|473736069|FG000|Overall Study|NEC (stage II & III)|2|||
131576565|NCT05484726|473736070|FG001|Overall Study|NEC (stage II & III)|3|||
131576566|NCT01093534|473736071|FG000|Overall Study|Adverse Event|2|||
131576567|NCT01093534|473736072|FG001|Overall Study|Adverse Event|5|||
131576568|NCT01093534|473736073|FG002|Overall Study|Adverse Event|2|||
131576569|NCT01093534|473736071|FG000|Overall Study|Lack of Efficacy|2|||
131576570|NCT01093534|473736072|FG001|Overall Study|Lack of Efficacy|1|||
131576571|NCT01093534|473736073|FG002|Overall Study|Lack of Efficacy|1|||
131576572|NCT01093534|473736071|FG000|Overall Study|Withdrawal by Subject|5|||
131576573|NCT01093534|473736072|FG001|Overall Study|Withdrawal by Subject|7|||
131699599|NCT02925156|474183329|FG002|Overall Study|Lost to Follow-up|51|||
131576574|NCT01093534|473736073|FG002|Overall Study|Withdrawal by Subject|2|||
131576575|NCT01093534|473736071|FG000|Overall Study|Other|1|||
131576576|NCT01093534|473736072|FG001|Overall Study|Other|3|||
131576577|NCT01093534|473736073|FG002|Overall Study|Other|4|||
131576578|NCT01837641|473736078|FG000|Overall Study|Sponsor decision|1|||
131576579|NCT01837641|473736079|FG001|Overall Study|Sponsor decision|0|||
131576580|NCT01837641|473736080|FG002|Overall Study|Sponsor decision|0|||
131576581|NCT01837641|473736081|FG003|Overall Study|Sponsor decision|0|||
131576582|NCT01837641|473736082|FG004|Overall Study|Sponsor decision|0|||
131576583|NCT01837641|473736083|FG005|Overall Study|Sponsor decision|1|||
131576584|NCT01837641|473736084|FG006|Overall Study|Sponsor decision|0|||
131576585|NCT01837641|473736085|FG007|Overall Study|Sponsor decision|0|||
131576586|NCT01837641|473736078|FG000|Overall Study|Adverse Event|0|||
131576587|NCT01837641|473736079|FG001|Overall Study|Adverse Event|0|||
131576588|NCT01837641|473736080|FG002|Overall Study|Adverse Event|0|||
131576589|NCT01837641|473736081|FG003|Overall Study|Adverse Event|0|||
131576590|NCT01837641|473736082|FG004|Overall Study|Adverse Event|0|||
131576591|NCT01837641|473736083|FG005|Overall Study|Adverse Event|1|||
131576592|NCT01837641|473736084|FG006|Overall Study|Adverse Event|0|||
131576593|NCT01837641|473736085|FG007|Overall Study|Adverse Event|0|||
131576594|NCT01837641|473736078|FG000|Overall Study|Withdrawal by Subject|0|||
131576595|NCT01837641|473736079|FG001|Overall Study|Withdrawal by Subject|0|||
131576596|NCT01837641|473736080|FG002|Overall Study|Withdrawal by Subject|0|||
131576597|NCT01837641|473736081|FG003|Overall Study|Withdrawal by Subject|0|||
131576598|NCT01837641|473736082|FG004|Overall Study|Withdrawal by Subject|1|||
131576599|NCT01837641|473736083|FG005|Overall Study|Withdrawal by Subject|0|||
131576600|NCT01837641|473736084|FG006|Overall Study|Withdrawal by Subject|1|||
131699600|NCT02925156|474183330|FG003|Overall Study|Lost to Follow-up|59|||
131699601|NCT02925156|474183331|FG004|Overall Study|Lost to Follow-up|89|||
131699602|NCT02925156|474183332|FG005|Overall Study|Lost to Follow-up|107|||
131699603|NCT02925156|474183333|FG006|Overall Study|Lost to Follow-up|34|||
131699604|NCT02925156|474183334|FG007|Overall Study|Lost to Follow-up|36|||
131699605|NCT02925156|474183335|FG008|Overall Study|Lost to Follow-up|73|||
131699606|NCT02925156|474183336|FG009|Overall Study|Lost to Follow-up|34|||
131699607|NCT00866307|474183337|FG000|Induction|Adverse Event|5|||
131699608|NCT00866307|474183338|FG001|Induction|Adverse Event|0|||
131699609|NCT00866307|474183339|FG002|Induction|Adverse Event|0|||
131576601|NCT01837641|473736085|FG007|Overall Study|Withdrawal by Subject|0|||
131576602|NCT01769391|473736090|FG000|Overall Study|Death|10|||
131576603|NCT01769391|473736091|FG001|Overall Study|Death|1|||
131699610|NCT00866307|474183337|FG000|Induction|Death|2|||
131699611|NCT00866307|474183338|FG001|Induction|Death|0|||
131699612|NCT00866307|474183339|FG002|Induction|Death|0|||
131699613|NCT00866307|474183337|FG000|Induction|Physician Decision|5|||
131576604|NCT01769391|473736090|FG000|Overall Study|Adverse Event|0|||
131576605|NCT01769391|473736091|FG001|Overall Study|Adverse Event|3|||
131576606|NCT01769391|473736090|FG000|Overall Study|Progressive Disease|1|||
131576607|NCT01769391|473736091|FG001|Overall Study|Progressive Disease|2|||
131576608|NCT01769391|473736090|FG000|Overall Study|Withdrawal by Subject|4|||
131576609|NCT01769391|473736091|FG001|Overall Study|Withdrawal by Subject|3|||
131576610|NCT01769391|473736090|FG000|Overall Study|Investigator Decision|2|||
131576611|NCT01769391|473736091|FG001|Overall Study|Investigator Decision|0|||
131576612|NCT01144182|473736092|FG000|Overall Study|Death|5|||
131576613|NCT01144182|473736093|FG001|Overall Study|Death|6|||
131576614|NCT01144182|473736092|FG000|Overall Study|Withdrawal by Subject|3|||
131576615|NCT01144182|473736093|FG001|Overall Study|Withdrawal by Subject|6|||
131576616|NCT01144182|473736092|FG000|Overall Study|Lost to Follow-up|9|||
131576617|NCT01144182|473736093|FG001|Overall Study|Lost to Follow-up|9|||
131576618|NCT02351180|473736096|FG000|Overall Study|Withdrawal by Subject|1|||
131699614|NCT00866307|474183338|FG001|Induction|Physician Decision|0|||
131699615|NCT00866307|474183339|FG002|Induction|Physician Decision|0|||
131699616|NCT00866307|474183337|FG000|Induction|Progressive Disease|1|||
131699617|NCT00866307|474183338|FG001|Induction|Progressive Disease|0|||
131699618|NCT00866307|474183339|FG002|Induction|Progressive Disease|0|||
131699619|NCT00866307|474183337|FG000|Induction|Identification of Patients with Day 29 M|3|||
131699620|NCT00866307|474183338|FG001|Induction|Identification of Patients with Day 29 M|0|||
131699621|NCT00866307|474183339|FG002|Induction|Identification of Patients with Day 29 M|0|||
131699622|NCT00866307|474183337|FG000|Induction|Inadequate cytognetic samples th|1|||
131699623|NCT00866307|474183338|FG001|Induction|Inadequate cytognetic samples th|0|||
131699624|NCT00866307|474183339|FG002|Induction|Inadequate cytognetic samples th|0|||
131699625|NCT00866307|474183337|FG000|Induction|Improper post-induction consent|2|||
131699626|NCT00866307|474183338|FG001|Induction|Improper post-induction consent|0|||
131785436|NCT01902134|474498756|FG000|Overall Study|Protocol Violation|0|||
131785437|NCT01902134|474498757|FG001|Overall Study|Protocol Violation|0|||
131785438|NCT01902134|474498758|FG002|Overall Study|Protocol Violation|0|||
131576619|NCT02351180|473736097|FG001|Overall Study|Withdrawal by Subject|0|||
131576620|NCT02317016|473736098|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
131576621|NCT02317016|473736098|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
131576622|NCT02317016|473736098|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
131576623|NCT02317016|473736098|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
131576624|NCT02317016|473736098|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
131576625|NCT02317016|473736098|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
131576626|NCT02317016|473736098|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
131576627|NCT00536380|473736099|FG000|Overall Study|Adverse Event|0|||
131576628|NCT00536380|473736100|FG001|Overall Study|Adverse Event|2|||
131699627|NCT00866307|474183339|FG002|Induction|Improper post-induction consent|0|||
131699628|NCT00866307|474183337|FG000|Induction|Study was closed at the time|1|||
131699629|NCT00866307|474183338|FG001|Induction|Study was closed at the time|0|||
131785439|NCT01902134|474498759|FG003|Overall Study|Protocol Violation|0|||
131576629|NCT00536380|473736101|FG002|Overall Study|Adverse Event|2|||
131576630|NCT00536380|473736099|FG000|Overall Study|Lost to Follow-up|0|||
131576631|NCT00536380|473736100|FG001|Overall Study|Lost to Follow-up|0|||
131576632|NCT00536380|473736101|FG002|Overall Study|Lost to Follow-up|1|||
131576633|NCT00536380|473736099|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
131576634|NCT00536380|473736100|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
131576635|NCT00536380|473736101|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
131576636|NCT00536380|473736099|FG000|Overall Study|Withdrawal related to study drug|7|||
131576637|NCT00536380|473736100|FG001|Overall Study|Withdrawal related to study drug|5|||
131576638|NCT00536380|473736101|FG002|Overall Study|Withdrawal related to study drug|2|||
131576639|NCT00536380|473736099|FG000|Overall Study|Noncompliance with protocol|3|||
131576640|NCT00536380|473736100|FG001|Overall Study|Noncompliance with protocol|2|||
131576641|NCT00536380|473736101|FG002|Overall Study|Noncompliance with protocol|2|||
131576642|NCT00536380|473736099|FG000|Overall Study|Did not meet protocol eligibility|0|||
131576643|NCT00536380|473736100|FG001|Overall Study|Did not meet protocol eligibility|0|||
131576644|NCT00536380|473736101|FG002|Overall Study|Did not meet protocol eligibility|1|||
131576645|NCT00536380|473736099|FG000|Overall Study|Administrative|0|||
131576646|NCT00536380|473736100|FG001|Overall Study|Administrative|0|||
131576647|NCT00536380|473736101|FG002|Overall Study|Administrative|1|||
131576648|NCT01867580|473736104|FG000|Overall Study|Withdrawal by Subject|2|||
131576649|NCT01867580|473736105|FG001|Overall Study|Withdrawal by Subject|3|||
131576650|NCT01867580|473736104|FG000|Overall Study|Physician Decision|17|||
131576651|NCT01867580|473736105|FG001|Overall Study|Physician Decision|12|||
131576652|NCT01867580|473736104|FG000|Overall Study|Lost to Follow-up|3|||
131576653|NCT01867580|473736105|FG001|Overall Study|Lost to Follow-up|5|||
131576654|NCT01867580|473736104|FG000|Overall Study|Sponsor terminated study|1|||
131576655|NCT01867580|473736105|FG001|Overall Study|Sponsor terminated study|0|||
131576656|NCT01867580|473736104|FG000|Overall Study|Missed follow-up assessment|2|||
131576657|NCT01867580|473736105|FG001|Overall Study|Missed follow-up assessment|1|||
131576658|NCT01867580|473736104|FG000|Overall Study|Interruption to therapy|3|||
131576659|NCT01867580|473736105|FG001|Overall Study|Interruption to therapy|0|||
131576660|NCT01867580|473736104|FG000|Overall Study|Osteomyelitis|0|||
131576661|NCT01867580|473736105|FG001|Overall Study|Osteomyelitis|1|||
131576662|NCT01867580|473736104|FG000|Overall Study|Continuation of therapy|0|||
131576663|NCT01867580|473736105|FG001|Overall Study|Continuation of therapy|1|||
131576664|NCT01867580|473736104|FG000|Overall Study|Wound recurrence|0|||
131576665|NCT01867580|473736105|FG001|Overall Study|Wound recurrence|1|||
131576666|NCT03141788|473736106|FG000|Overall Study|Lost to Follow-up|1|||
131576667|NCT03141788|473736106|FG000|Overall Study|Protocol Violation|3|||
131576668|NCT03141788|473736106|FG000|Overall Study|Withdrawal by Subject|4|||
131576669|NCT02810080|473737388|FG000|Overall Study|Adverse Event|3|||
131576670|NCT02810080|473737389|FG001|Overall Study|Adverse Event|0|||
131576671|NCT02810080|473737388|FG000|Overall Study|Death|0|||
131576672|NCT02810080|473737389|FG001|Overall Study|Death|2|||
131576673|NCT02810080|473737388|FG000|Overall Study|Physician Decision|4|||
131576674|NCT02810080|473737389|FG001|Overall Study|Physician Decision|0|||
131576675|NCT02810080|473737388|FG000|Overall Study|Withdrawal by Subject|0|||
131576676|NCT02810080|473737389|FG001|Overall Study|Withdrawal by Subject|2|||
131576677|NCT02034916|473737392|FG000|Overall Study|Death|39|||
131576678|NCT02034916|473737393|FG001|Overall Study|Death|28|||
131576679|NCT02034916|473737392|FG000|Overall Study|Withdrawal by Subject|2|||
131576680|NCT02034916|473737393|FG001|Overall Study|Withdrawal by Subject|1|||
131576681|NCT02034916|473737392|FG000|Overall Study|Lost to Follow-up|4|||
131576682|NCT02034916|473737393|FG001|Overall Study|Lost to Follow-up|1|||
131576683|NCT02034916|473737392|FG000|Overall Study|Study terminated by sponsor|4|||
131699630|NCT00866307|474183339|FG002|Induction|Study was closed at the time|0|||
131699631|NCT00866307|474183337|FG000|Consolidation/Maintenance|Adverse Event|0|||
131699632|NCT00866307|474183338|FG001|Consolidation/Maintenance|Adverse Event|0|||
131699633|NCT00866307|474183339|FG002|Consolidation/Maintenance|Adverse Event|8|||
131699634|NCT00866307|474183337|FG000|Consolidation/Maintenance|Death|0|||
131699635|NCT00866307|474183338|FG001|Consolidation/Maintenance|Death|0|||
131699636|NCT00866307|474183339|FG002|Consolidation/Maintenance|Death|1|||
131699637|NCT00866307|474183337|FG000|Consolidation/Maintenance|Physician Decision|0|||
131699638|NCT00866307|474183338|FG001|Consolidation/Maintenance|Physician Decision|3|||
131576684|NCT02034916|473737393|FG001|Overall Study|Study terminated by sponsor|5|||
131576685|NCT01616654|473737398|FG000|Overall Study|Lack of Efficacy|1|||
131576686|NCT01616654|473737399|FG001|Overall Study|Lack of Efficacy|0|||
131576687|NCT01616654|473737400|FG002|Overall Study|Lack of Efficacy|0|||
131576688|NCT01616654|473737401|FG003|Overall Study|Lack of Efficacy|0|||
131576689|NCT01616654|473737402|FG004|Overall Study|Lack of Efficacy|1|||
131576690|NCT01616654|473737398|FG000|Overall Study|Adverse Event|0|||
131576691|NCT01616654|473737399|FG001|Overall Study|Adverse Event|1|||
131576692|NCT01616654|473737400|FG002|Overall Study|Adverse Event|2|||
131576693|NCT01616654|473737401|FG003|Overall Study|Adverse Event|1|||
131576694|NCT01616654|473737402|FG004|Overall Study|Adverse Event|0|||
131576695|NCT01616654|473737398|FG000|Overall Study|Withdrawal by Subject|2|||
131576696|NCT01616654|473737399|FG001|Overall Study|Withdrawal by Subject|2|||
131699639|NCT00866307|474183339|FG002|Consolidation/Maintenance|Physician Decision|2|||
131576697|NCT01616654|473737400|FG002|Overall Study|Withdrawal by Subject|3|||
131576698|NCT01616654|473737401|FG003|Overall Study|Withdrawal by Subject|1|||
131576699|NCT01616654|473737402|FG004|Overall Study|Withdrawal by Subject|5|||
131576700|NCT01616654|473737398|FG000|Overall Study|Protocol Violation|0|||
131576701|NCT01616654|473737399|FG001|Overall Study|Protocol Violation|5|||
131576702|NCT01616654|473737400|FG002|Overall Study|Protocol Violation|2|||
131576703|NCT01616654|473737401|FG003|Overall Study|Protocol Violation|4|||
131576704|NCT01616654|473737402|FG004|Overall Study|Protocol Violation|4|||
131576705|NCT01616654|473737398|FG000|Overall Study|Lost to Follow-up|1|||
131576706|NCT01616654|473737399|FG001|Overall Study|Lost to Follow-up|0|||
131576707|NCT01616654|473737400|FG002|Overall Study|Lost to Follow-up|3|||
131576708|NCT01616654|473737401|FG003|Overall Study|Lost to Follow-up|2|||
131576709|NCT01616654|473737402|FG004|Overall Study|Lost to Follow-up|1|||
131576710|NCT01616654|473737398|FG000|Overall Study|Pregnancy|1|||
131576711|NCT01616654|473737399|FG001|Overall Study|Pregnancy|0|||
131576712|NCT01616654|473737400|FG002|Overall Study|Pregnancy|0|||
131576713|NCT01616654|473737401|FG003|Overall Study|Pregnancy|0|||
131576714|NCT01616654|473737402|FG004|Overall Study|Pregnancy|1|||
131576715|NCT02057692|473737403|FG000|Overall Study|Adverse Event|1|||
131576716|NCT02057692|473737404|FG001|Overall Study|Adverse Event|0|||
131576717|NCT02057692|473737405|FG002|Overall Study|Adverse Event|0|||
131576718|NCT02057692|473737406|FG003|Overall Study|Adverse Event|0|||
131576719|NCT02057692|473737403|FG000|Overall Study|Lost to Follow-up|0|||
131576720|NCT02057692|473737404|FG001|Overall Study|Lost to Follow-up|0|||
131576721|NCT02057692|473737405|FG002|Overall Study|Lost to Follow-up|0|||
131576722|NCT02057692|473737406|FG003|Overall Study|Lost to Follow-up|1|||
131576723|NCT03525119|473737410|FG000|Overall Study|Adverse Event|0|||
131576724|NCT03525119|473737411|FG001|Overall Study|Adverse Event|1|||
131576725|NCT03525119|473737412|FG002|Overall Study|Adverse Event|0|||
131576726|NCT03525119|473737410|FG000|Overall Study|Lost to Follow-up|32|||
131576727|NCT03525119|473737411|FG001|Overall Study|Lost to Follow-up|33|||
131699640|NCT00866307|474183337|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
131699641|NCT00866307|474183338|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
131699642|NCT00866307|474183339|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
131699643|NCT00866307|474183337|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
131699644|NCT00866307|474183338|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
131699645|NCT00866307|474183339|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
131699646|NCT00866307|474183337|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
131699647|NCT00866307|474183338|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
131699648|NCT00866307|474183339|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
131699649|NCT00866307|474183337|FG000|Consolidation/Maintenance|Therapy error|0|||
131699650|NCT00866307|474183338|FG001|Consolidation/Maintenance|Therapy error|1|||
131699651|NCT00866307|474183339|FG002|Consolidation/Maintenance|Therapy error|0|||
131699652|NCT00866307|474183337|FG000|Consolidation/Maintenance|Non-compliance|0|||
131699653|NCT00866307|474183338|FG001|Consolidation/Maintenance|Non-compliance|0|||
131699654|NCT00866307|474183339|FG002|Consolidation/Maintenance|Non-compliance|1|||
131699655|NCT00866307|474183337|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
131699656|NCT00866307|474183338|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
131699657|NCT00866307|474183339|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
131699658|NCT02286947|474183342|FG000|Overall Study|Withdrawal by Subject|2|||
131699659|NCT01972074|474183348|FG000|Overall Study|Adverse Event|4|||
131699660|NCT01972074|474183349|FG001|Overall Study|Adverse Event|1|||
131699661|NCT01972074|474183350|FG002|Overall Study|Adverse Event|0|||
131699662|NCT01972074|474183348|FG000|Overall Study|Lack of Efficacy|1|||
131699663|NCT01972074|474183349|FG001|Overall Study|Lack of Efficacy|1|||
131699664|NCT01972074|474183350|FG002|Overall Study|Lack of Efficacy|0|||
131699665|NCT01972074|474183348|FG000|Overall Study|Lost to Follow-up|0|||
131699666|NCT01972074|474183349|FG001|Overall Study|Lost to Follow-up|1|||
131699667|NCT01972074|474183350|FG002|Overall Study|Lost to Follow-up|1|||
131699668|NCT01972074|474183348|FG000|Overall Study|Withdrawal by Subject|1|||
131699669|NCT01972074|474183349|FG001|Overall Study|Withdrawal by Subject|1|||
131699670|NCT01972074|474183350|FG002|Overall Study|Withdrawal by Subject|1|||
131699671|NCT01972074|474183348|FG000|Overall Study|Scanner Unavailable|0|||
131576728|NCT03525119|473737412|FG002|Overall Study|Lost to Follow-up|37|||
131576729|NCT03525119|473737410|FG000|Overall Study|Withdrawal by Subject|5|||
131576730|NCT03525119|473737411|FG001|Overall Study|Withdrawal by Subject|4|||
131576731|NCT03525119|473737412|FG002|Overall Study|Withdrawal by Subject|2|||
131576732|NCT03525119|473737410|FG000|Overall Study|Reason not Specified|2|||
131576733|NCT03525119|473737411|FG001|Overall Study|Reason not Specified|1|||
131576734|NCT03525119|473737412|FG002|Overall Study|Reason not Specified|2|||
131576735|NCT03525119|473737410|FG000|Overall Study|Randomized but not Vaccinated|1|||
131576736|NCT03525119|473737411|FG001|Overall Study|Randomized but not Vaccinated|0|||
131576737|NCT03525119|473737412|FG002|Overall Study|Randomized but not Vaccinated|2|||
131576738|NCT03939819|473737413|FG000|Overall Study|Death|2|||
131576739|NCT03939819|473737414|FG001|Overall Study|Death|0|||
131576740|NCT00158054|473737419|FG000|Overall Study|Refused to continue|3|||
131576741|NCT00158054|473737420|FG001|Overall Study|Refused to continue|0|||
131576742|NCT00158054|473737419|FG000|Overall Study|Unavailable for follow up|7|||
131576743|NCT00158054|473737420|FG001|Overall Study|Unavailable for follow up|3|||
131576744|NCT00079183|473737429|FG000|Overall Study|Withdrawal by Subject|4|||
131576745|NCT00079183|473737429|FG000|Overall Study|Study medication non-compliance|2|||
131576746|NCT00079183|473737429|FG000|Overall Study|Specimen collection non-compliance|1|||
131785440|NCT01902134|474498760|FG004|Overall Study|Protocol Violation|0|||
131576747|NCT04567888|473737430|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
131576748|NCT04567888|473737431|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
131785441|NCT01902134|474498761|FG005|Overall Study|Protocol Violation|1|||
131785442|NCT01902134|474498756|FG000|Overall Study|Withdrawal by Subject|4|||
131785443|NCT01902134|474498757|FG001|Overall Study|Withdrawal by Subject|8|||
131785444|NCT01902134|474498758|FG002|Overall Study|Withdrawal by Subject|9|||
131785445|NCT01902134|474498759|FG003|Overall Study|Withdrawal by Subject|1|||
131785446|NCT01902134|474498760|FG004|Overall Study|Withdrawal by Subject|5|||
131785447|NCT01902134|474498761|FG005|Overall Study|Withdrawal by Subject|4|||
131785448|NCT01902134|474498756|FG000|Overall Study|no compliance|1|||
131785449|NCT01902134|474498757|FG001|Overall Study|no compliance|0|||
131785450|NCT01902134|474498758|FG002|Overall Study|no compliance|0|||
131785451|NCT01902134|474498759|FG003|Overall Study|no compliance|0|||
131785452|NCT01902134|474498760|FG004|Overall Study|no compliance|0|||
131785453|NCT01902134|474498761|FG005|Overall Study|no compliance|0|||
131785454|NCT01902134|474498756|FG000|Overall Study|Other|0|||
131785455|NCT01902134|474498757|FG001|Overall Study|Other|1|||
131785456|NCT01902134|474498758|FG002|Overall Study|Other|2|||
131785457|NCT01902134|474498759|FG003|Overall Study|Other|0|||
131785458|NCT01902134|474498760|FG004|Overall Study|Other|1|||
131785459|NCT01902134|474498761|FG005|Overall Study|Other|0|||
131785460|NCT00305110|474498762|FG000|Overall Study|Missing data|29|||
131785461|NCT00678379|474498763|FG000|Overall Study|Injection performed after tonsillectomy|2|||
131785462|NCT00678379|474498764|FG001|Overall Study|Injection performed after tonsillectomy|0|||
131785463|NCT00678379|474498765|FG002|Overall Study|Injection performed after tonsillectomy|1|||
131785464|NCT00678379|474498763|FG000|Overall Study|Incomplete Data|4|||
131785465|NCT00678379|474498764|FG001|Overall Study|Incomplete Data|3|||
131785466|NCT00678379|474498765|FG002|Overall Study|Incomplete Data|3|||
131785467|NCT01084603|474498770|FG000|Baseline|Withdrawal by Subject|2|||
131785468|NCT01084603|474498770|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
131785469|NCT01084603|474498770|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
131785470|NCT01084603|474498770|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
131785471|NCT01084603|474498770|FG000|Washout Period 4|Adverse Event|1|||
131785472|NCT03836729|474498773|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
131785473|NCT00948025|474498774|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
131785474|NCT00948025|474498775|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
131785475|NCT00948025|474498774|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
131785476|NCT00948025|474498775|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
131785477|NCT00948025|474498774|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
131785478|NCT00948025|474498775|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
131785479|NCT01637961|474498776|FG000|Overall Study|Ineligible: wrong primary|1|||
131785480|NCT01637961|474498776|FG000|Overall Study|Ineligible: inadequate pathology|1|||
131785481|NCT03101293|474498777|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
131785482|NCT03101293|474498778|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
131785483|NCT01017029|474498785|FG000|Overall Study|Lost to Follow-up|1|||
131785484|NCT01017029|474498786|FG001|Overall Study|Lost to Follow-up|0|||
131785485|NCT01017029|474498785|FG000|Overall Study|Administrative problem|0|||
131785486|NCT01017029|474498786|FG001|Overall Study|Administrative problem|1|||
131785487|NCT01017029|474498785|FG000|Overall Study|Death|3|||
131785488|NCT01017029|474498786|FG001|Overall Study|Death|1|||
131576749|NCT04567888|473737430|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
131576750|NCT04567888|473737431|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
131576751|NCT04567888|473737430|FG000|Overall Study|Reported Unusual Birth Year|2|||
131785489|NCT03547531|474498790|FG000|Overall Study|not coming in data collection : sick|2|||
131785490|NCT03547531|474498791|FG001|Overall Study|not coming in data collection : sick|2|||
131785491|NCT03547531|474498790|FG000|Overall Study|having family occasion|0|||
131785492|NCT03547531|474498791|FG001|Overall Study|having family occasion|2|||
131785493|NCT03402126|474498792|FG000|Overall Study|Lost to Follow-up|6|||
131785494|NCT03402126|474498792|FG000|Overall Study|Protocol Violation|10|||
131785495|NCT03402126|474498792|FG000|Overall Study|Sponsor request/Study termination|29|||
131785496|NCT03402126|474498792|FG000|Overall Study|Study product no longer in use|1|||
131785497|NCT03402126|474498792|FG000|Overall Study|Technical problems|1|||
131785498|NCT03402126|474498792|FG000|Overall Study|Withdrawal by Subject|6|||
131576752|NCT04567888|473737431|FG001|Overall Study|Reported Unusual Birth Year|3|||
131576753|NCT04567888|473737430|FG000|Overall Study|Duplicate Responses|0|||
131785499|NCT03402126|474498792|FG000|Overall Study|Physician Decision|2|||
131785500|NCT03402126|474498792|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
131785501|NCT03402126|474498792|FG000|Overall Study|Death|4|||
131576754|NCT04567888|473737431|FG001|Overall Study|Duplicate Responses|1|||
131576755|NCT02371746|473737432|FG000|Overall Study|Consent withdrawn|0|||
131576756|NCT02371746|473737433|FG001|Overall Study|Consent withdrawn|0|||
131576757|NCT02371746|473737434|FG002|Overall Study|Consent withdrawn|0|||
131576758|NCT02371746|473737435|FG003|Overall Study|Consent withdrawn|0|||
131576759|NCT02371746|473737436|FG004|Overall Study|Consent withdrawn|0|||
131576760|NCT02371746|473737437|FG005|Overall Study|Consent withdrawn|0|||
131576761|NCT02371746|473737438|FG006|Overall Study|Consent withdrawn|1|||
131576762|NCT02613364|473737439|FG000|Overall Study|Other|19|||
131576763|NCT02613364|473737440|FG001|Overall Study|Other|29|||
131576764|NCT02613364|473737441|FG002|Overall Study|Other|17|||
131576765|NCT02613364|473737439|FG000|Overall Study|Too time consuming|21|||
131699672|NCT01972074|474183349|FG001|Overall Study|Scanner Unavailable|0|||
131699673|NCT01972074|474183350|FG002|Overall Study|Scanner Unavailable|1|||
131699674|NCT03434977|474183351|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
131699675|NCT03434977|474183352|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
131699676|NCT03920670|474183353|FG000|Overall Study|Protocol Violation|2|||
131699677|NCT03920670|474183354|FG001|Overall Study|Protocol Violation|2|||
131699678|NCT03920670|474183353|FG000|Overall Study|Adverse Event|1|||
131576766|NCT02613364|473737440|FG001|Overall Study|Too time consuming|26|||
131576767|NCT02613364|473737441|FG002|Overall Study|Too time consuming|26|||
131576768|NCT02613364|473737439|FG000|Overall Study|Withdrawal by Subject|13|||
131576769|NCT02613364|473737440|FG001|Overall Study|Withdrawal by Subject|18|||
131576770|NCT02613364|473737441|FG002|Overall Study|Withdrawal by Subject|17|||
131576771|NCT02613364|473737439|FG000|Overall Study|Medical|12|||
131576772|NCT02613364|473737440|FG001|Overall Study|Medical|13|||
131699679|NCT03920670|474183354|FG001|Overall Study|Adverse Event|0|||
131699680|NCT01777581|474183360|FG000|Overall Study|Lost to Follow-up|1|||
131699681|NCT01777581|474183361|FG001|Overall Study|Lost to Follow-up|1|||
131699682|NCT01777581|474183360|FG000|Overall Study|Adverse Event|2|||
131699683|NCT01777581|474183361|FG001|Overall Study|Adverse Event|0|||
131699684|NCT01777581|474183360|FG000|Overall Study|Lack of Efficacy|0|||
131699685|NCT01777581|474183361|FG001|Overall Study|Lack of Efficacy|1|||
131699686|NCT04820309|474183366|FG000|Overall Study|Adverse Event|96|||
131699687|NCT04820309|474183366|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
131699688|NCT04820309|474183366|FG000|Overall Study|Consent Withdrawn|93|||
131699689|NCT04820309|474183366|FG000|Overall Study|failure to adhere to protocol|32|||
131699690|NCT04820309|474183366|FG000|Overall Study|alcohol or drug use|6|||
131699691|NCT04820309|474183366|FG000|Overall Study|Lost to Follow-up|46|||
131699692|NCT04820309|474183366|FG000|Overall Study|Death|2|||
131699693|NCT04820309|474183366|FG000|Overall Study|Pregnancy|1|||
131699694|NCT04820309|474183366|FG000|Overall Study|Other reasons|12|||
131699695|NCT02270242|474183369|FG000|Overall Study|Withdrawal by Subject|18|||
131699696|NCT02270242|474183370|FG001|Overall Study|Withdrawal by Subject|25|||
131699697|NCT02270242|474183369|FG000|Overall Study|Lost to Follow-up|41|||
131699698|NCT02270242|474183370|FG001|Overall Study|Lost to Follow-up|27|||
131699699|NCT02270242|474183369|FG000|Overall Study|Physician Decision|0|||
131699700|NCT02270242|474183370|FG001|Overall Study|Physician Decision|1|||
131699701|NCT02321436|474183371|FG000|Overall Study|Withdrawal by Subject|1|||
131699702|NCT02321436|474183372|FG001|Overall Study|Withdrawal by Subject|0|||
131699703|NCT02321436|474183371|FG000|Overall Study|Lost to Follow-up|0|||
131699704|NCT02321436|474183372|FG001|Overall Study|Lost to Follow-up|1|||
131699705|NCT03355300|474183373|FG000|Overall Study|Physician Decision|0|||
131699706|NCT03355300|474183374|FG001|Overall Study|Physician Decision|1|||
131699707|NCT03355300|474183373|FG000|Overall Study|Lack of Efficacy|2|||
131785502|NCT02117479|474498793|FG000|Overall Study|Death|13|||
131785503|NCT02117479|474498794|FG001|Overall Study|Death|8|||
131785504|NCT02117479|474498793|FG000|Overall Study|Adverse Event|8|||
131785505|NCT02117479|474498794|FG001|Overall Study|Adverse Event|16|||
131785506|NCT02117479|474498793|FG000|Overall Study|Subject decision|8|||
131785507|NCT02117479|474498794|FG001|Overall Study|Subject decision|9|||
131785508|NCT02117479|474498793|FG000|Overall Study|Disease progression|104|||
131699708|NCT03355300|474183374|FG001|Overall Study|Lack of Efficacy|1|||
131699709|NCT03355300|474183373|FG000|Overall Study|Other reason|1|||
131699710|NCT03355300|474183374|FG001|Overall Study|Other reason|0|||
131699711|NCT00546052|474183375|FG000|Overall Study|Adverse Event|47|||
131699712|NCT00546052|474183375|FG000|Overall Study|Lost to Follow-up|144|||
131699713|NCT00546052|474183375|FG000|Overall Study|Protocol Violation|9|||
131785509|NCT02117479|474498794|FG001|Overall Study|Disease progression|108|||
131576773|NCT02613364|473737441|FG002|Overall Study|Medical|9|||
131699714|NCT00546052|474183375|FG000|Overall Study|Withdrawal by Subject|20|||
131576774|NCT02613364|473737439|FG000|Overall Study|Disliked Study Procedure|1|||
131576775|NCT02613364|473737440|FG001|Overall Study|Disliked Study Procedure|1|||
131576776|NCT02613364|473737441|FG002|Overall Study|Disliked Study Procedure|4|||
131576777|NCT02613364|473737439|FG000|Overall Study|Disliked Intervention|0|||
131576778|NCT02613364|473737440|FG001|Overall Study|Disliked Intervention|3|||
131576779|NCT02613364|473737441|FG002|Overall Study|Disliked Intervention|3|||
131699715|NCT00546052|474183375|FG000|Overall Study|Non Compliance|7|||
131785510|NCT02117479|474498793|FG000|Overall Study|Noncompliance with study treatment|1|||
131785511|NCT02117479|474498794|FG001|Overall Study|Noncompliance with study treatment|0|||
131576780|NCT00371566|473737448|FG000|Treatment Phase|Withdrawal by Subject|0|||
131576781|NCT00371566|473737449|FG001|Treatment Phase|Withdrawal by Subject|1|||
131576782|NCT00371566|473737448|FG000|Treatment Phase|Adverse Event|0|||
131576783|NCT00371566|473737449|FG001|Treatment Phase|Adverse Event|1|||
131576784|NCT00371566|473737448|FG000|Treatment Phase|Protocol Violation|0|||
131576785|NCT00371566|473737449|FG001|Treatment Phase|Protocol Violation|1|||
131576786|NCT00371566|473737448|FG000|Chemoradiation Phase|Physician Decision|2|||
131576787|NCT00371566|473737449|FG001|Chemoradiation Phase|Physician Decision|0|||
131576788|NCT00371566|473737448|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
131576789|NCT00371566|473737449|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
131576790|NCT00371566|473737448|FG000|Chemoradiation Phase|Non compliant|0|||
131576791|NCT00371566|473737449|FG001|Chemoradiation Phase|Non compliant|1|||
131576792|NCT00371566|473737448|FG000|Chemoradiation Phase|Progressive Disease|1|||
131576793|NCT00371566|473737449|FG001|Chemoradiation Phase|Progressive Disease|1|||
131576794|NCT00371566|473737448|FG000|Chemoradiation Phase|Death|2|||
131576795|NCT00371566|473737449|FG001|Chemoradiation Phase|Death|0|||
131576796|NCT00371566|473737448|FG000|Follow Up Phase|Death|0|||
131576797|NCT00371566|473737449|FG001|Follow Up Phase|Death|5|||
131576798|NCT00371566|473737448|FG000|Follow Up Phase|Disease progression|1|||
131576799|NCT00371566|473737449|FG001|Follow Up Phase|Disease progression|0|||
131576800|NCT00371566|473737448|FG000|Follow Up Phase|Withdrawal by Subject|0|||
131576801|NCT00371566|473737449|FG001|Follow Up Phase|Withdrawal by Subject|1|||
131576802|NCT00371566|473737448|FG000|Follow Up Phase|Physician Decision|1|||
131576803|NCT00371566|473737449|FG001|Follow Up Phase|Physician Decision|1|||
131576804|NCT00371566|473737448|FG000|Follow Up Phase|Lost to Follow-up|1|||
131576805|NCT00371566|473737449|FG001|Follow Up Phase|Lost to Follow-up|0|||
131576806|NCT00878722|473737450|FG000|Overall Study|Progressive disease|3|||
131576807|NCT00878722|473737451|FG001|Overall Study|Progressive disease|3|||
131576808|NCT00878722|473737452|FG002|Overall Study|Progressive disease|3|||
131576809|NCT00878722|473737453|FG003|Overall Study|Progressive disease|7|||
131576810|NCT00878722|473737454|FG004|Overall Study|Progressive disease|7|||
131576811|NCT00878722|473737455|FG005|Overall Study|Progressive disease|1|||
131576812|NCT00878722|473737456|FG006|Overall Study|Progressive disease|4|||
131576813|NCT00878722|473737457|FG007|Overall Study|Progressive disease|3|||
131576814|NCT00878722|473737450|FG000|Overall Study|Death|0|||
131576815|NCT00878722|473737451|FG001|Overall Study|Death|0|||
131576816|NCT00878722|473737452|FG002|Overall Study|Death|0|||
131576817|NCT00878722|473737453|FG003|Overall Study|Death|1|||
131576818|NCT00878722|473737454|FG004|Overall Study|Death|0|||
131576819|NCT00878722|473737455|FG005|Overall Study|Death|1|||
131576820|NCT00878722|473737456|FG006|Overall Study|Death|0|||
131576821|NCT00878722|473737457|FG007|Overall Study|Death|2|||
131576822|NCT00878722|473737450|FG000|Overall Study|Adverse Event|0|||
131576823|NCT00878722|473737451|FG001|Overall Study|Adverse Event|0|||
131576824|NCT00878722|473737452|FG002|Overall Study|Adverse Event|0|||
131576825|NCT00878722|473737453|FG003|Overall Study|Adverse Event|0|||
131576826|NCT00878722|473737454|FG004|Overall Study|Adverse Event|0|||
131576827|NCT00878722|473737455|FG005|Overall Study|Adverse Event|0|||
131576828|NCT00878722|473737456|FG006|Overall Study|Adverse Event|2|||
131576829|NCT00878722|473737457|FG007|Overall Study|Adverse Event|0|||
131576830|NCT00878722|473737450|FG000|Overall Study|Withdrawal by Subject|0|||
131576831|NCT00878722|473737451|FG001|Overall Study|Withdrawal by Subject|0|||
131576832|NCT00878722|473737452|FG002|Overall Study|Withdrawal by Subject|0|||
131576833|NCT00878722|473737453|FG003|Overall Study|Withdrawal by Subject|0|||
131699716|NCT03048422|474183378|FG000|Overall Study|Death|1|||
131699717|NCT03048422|474183379|FG001|Overall Study|Death|0|||
131699718|NCT03048422|474183380|FG002|Overall Study|Death|0|||
131699719|NCT03048422|474183378|FG000|Overall Study|Lost to Follow-up|5|||
131699720|NCT03048422|474183379|FG001|Overall Study|Lost to Follow-up|0|||
131576834|NCT00878722|473737454|FG004|Overall Study|Withdrawal by Subject|0|||
131576835|NCT00878722|473737455|FG005|Overall Study|Withdrawal by Subject|0|||
131576836|NCT00878722|473737456|FG006|Overall Study|Withdrawal by Subject|0|||
131576837|NCT00878722|473737457|FG007|Overall Study|Withdrawal by Subject|2|||
131576838|NCT00878722|473737450|FG000|Overall Study|Relapse|0|||
131576839|NCT00878722|473737451|FG001|Overall Study|Relapse|0|||
131576840|NCT00878722|473737452|FG002|Overall Study|Relapse|0|||
131576841|NCT00878722|473737453|FG003|Overall Study|Relapse|1|||
131576842|NCT00878722|473737454|FG004|Overall Study|Relapse|0|||
131576843|NCT00878722|473737455|FG005|Overall Study|Relapse|0|||
131576844|NCT00878722|473737456|FG006|Overall Study|Relapse|0|||
131576845|NCT00878722|473737457|FG007|Overall Study|Relapse|0|||
131699721|NCT03048422|474183380|FG002|Overall Study|Lost to Follow-up|1|||
131576846|NCT02873754|473737458|FG000|Overall Study|Lost to Follow-up|5|||
131576847|NCT02873754|473737458|FG000|Overall Study|Couldn't complete study procedures|1|||
131576848|NCT00082810|473737459|FG000|Overall Study|Adverse Event|3|||
131576849|NCT00082810|473737459|FG000|Overall Study|Progressive disease|24|||
131576850|NCT00082810|473737459|FG000|Overall Study|Withdrawal by Subject|4|||
131576851|NCT02807493|473737464|FG000|Overall Study|Adverse Event|5|||
131576852|NCT02807493|473737465|FG001|Overall Study|Adverse Event|2|||
131576853|NCT02807493|473737464|FG000|Overall Study|Lost to Follow-up|6|||
131576854|NCT02807493|473737465|FG001|Overall Study|Lost to Follow-up|0|||
131576855|NCT02807493|473737464|FG000|Overall Study|Physician Decision|4|||
131576856|NCT02807493|473737465|FG001|Overall Study|Physician Decision|1|||
131576857|NCT02807493|473737464|FG000|Overall Study|Protocol Violation|7|||
131576858|NCT02807493|473737465|FG001|Overall Study|Protocol Violation|0|||
131576859|NCT02807493|473737464|FG000|Overall Study|Withdrawal by Subject|17|||
131576860|NCT02807493|473737465|FG001|Overall Study|Withdrawal by Subject|10|||
131576861|NCT02807493|473737464|FG000|Overall Study|Other withdrawal|17|||
131576862|NCT02807493|473737465|FG001|Overall Study|Other withdrawal|0|||
131576863|NCT02807493|473737464|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
131576864|NCT02807493|473737465|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
131576865|NCT01227707|473737466|FG000|Overall Study|Adverse Event|10|||
131576866|NCT01227707|473737466|FG000|Overall Study|Progression of disease|3|||
131576867|NCT01227707|473737466|FG000|Overall Study|Withdrawal by Subject|1|||
131785512|NCT02117479|474498793|FG000|Overall Study|Study terminated by the sponsor|4|||
131785513|NCT02117479|474498794|FG001|Overall Study|Study terminated by the sponsor|6|||
131785514|NCT02117479|474498793|FG000|Overall Study|Physician Decision|7|||
131785515|NCT02117479|474498794|FG001|Overall Study|Physician Decision|2|||
131785516|NCT02117479|474498793|FG000|Overall Study|Other unspecified|11|||
131785517|NCT02117479|474498794|FG001|Overall Study|Other unspecified|7|||
131785518|NCT01959230|474498795|FG000|Overall Study|Failure to follow study procedures|0|||
131785519|NCT01959230|474498796|FG001|Overall Study|Failure to follow study procedures|1|||
131785520|NCT01959230|474498795|FG000|Overall Study|Administrative reasons|2|||
131785521|NCT01959230|474498796|FG001|Overall Study|Administrative reasons|0|||
131785522|NCT01959230|474498795|FG000|Overall Study|Withdrawal by Subject|2|||
131785523|NCT01959230|474498796|FG001|Overall Study|Withdrawal by Subject|0|||
131785524|NCT01453374|474498797|FG000|Overall Study|Adverse Event|7|||
131785525|NCT01453374|474498797|FG000|Overall Study|Lack of Efficacy|1|||
131785526|NCT01453374|474498797|FG000|Overall Study|Lost to Follow-up|3|||
131785527|NCT01453374|474498797|FG000|Overall Study|Withdrawal by Subject|5|||
131785528|NCT01453374|474498797|FG000|Overall Study|Incarcerated|2|||
131785529|NCT00720304|474498798|FG000|Overall Study|Withdrawal by Subject|14|||
131785530|NCT00720304|474498799|FG001|Overall Study|Withdrawal by Subject|1|||
131785531|NCT00720304|474498798|FG000|Overall Study|Death|1|||
131785532|NCT00720304|474498799|FG001|Overall Study|Death|0|||
131785533|NCT00720304|474498798|FG000|Overall Study|Physician Decision|5|||
131785534|NCT00720304|474498799|FG001|Overall Study|Physician Decision|2|||
131785535|NCT00720304|474498798|FG000|Overall Study|Adverse Event|3|||
131785536|NCT00720304|474498799|FG001|Overall Study|Adverse Event|1|||
131785537|NCT00720304|474498798|FG000|Overall Study|Disease progression|6|||
131785538|NCT00720304|474498799|FG001|Overall Study|Disease progression|1|||
131785539|NCT00709735|474498802|FG000|Overall Study|Lost to Follow-up|1|||
131785540|NCT00709735|474498803|FG001|Overall Study|Lost to Follow-up|1|||
131785541|NCT00709735|474498802|FG000|Overall Study|Relapse into Opioid Abuse|0|||
131785542|NCT00709735|474498803|FG001|Overall Study|Relapse into Opioid Abuse|1|||
131785543|NCT00709735|474498802|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
131785544|NCT00709735|474498803|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
131785545|NCT02981602|474498804|FG000|Overall Study|Adverse Event|0|||
131785546|NCT02981602|474498805|FG001|Overall Study|Adverse Event|0|||
131438027|NCT01339689|473229477|FG000|Overall Study|Withdrawal by Subject|3|||
131438028|NCT01339689|473229478|FG001|Overall Study|Withdrawal by Subject|0|||
131576868|NCT01227707|473737466|FG000|Overall Study|Patient non-compliance|3|||
131576869|NCT01227707|473737466|FG000|Overall Study|Medical decision|6|||
131576870|NCT01227707|473737466|FG000|Overall Study|Death|1|||
131576871|NCT03612804|473737468|FG000|Overall Study|Death|0|||
131576872|NCT03612804|473737469|FG001|Overall Study|Death|7|||
131576873|NCT03612804|473737470|FG002|Overall Study|Death|0|||
131576874|NCT03612804|473737471|FG003|Overall Study|Death|8|||
131576875|NCT03612804|473737468|FG000|Overall Study|Medication copay coverage issues|0|||
131576876|NCT03612804|473737469|FG001|Overall Study|Medication copay coverage issues|0|||
131576877|NCT03612804|473737470|FG002|Overall Study|Medication copay coverage issues|0|||
131785547|NCT02981602|474498806|FG002|Overall Study|Adverse Event|0|||
131785548|NCT02981602|474498807|FG003|Overall Study|Adverse Event|1|||
131785549|NCT02981602|474498808|FG004|Overall Study|Adverse Event|0|||
131785550|NCT02725671|474498809|FG000|Overall Study|Lost to Follow-up|1|||
131785551|NCT00666718|474498810|FG000|Overall Study|Adverse Event|0|||
131785552|NCT00666718|474498811|FG001|Overall Study|Adverse Event|1|||
131785553|NCT00666718|474498810|FG000|Overall Study|Death|1|||
131785554|NCT00666718|474498811|FG001|Overall Study|Death|0|||
131785555|NCT00666718|474498810|FG000|Overall Study|Lost to Follow-up|1|||
131699722|NCT03048422|474183378|FG000|Overall Study|Withdrawal by Subject|5|||
131699723|NCT03048422|474183379|FG001|Overall Study|Withdrawal by Subject|7|||
131699724|NCT03048422|474183380|FG002|Overall Study|Withdrawal by Subject|4|||
131699725|NCT03048422|474183378|FG000|Overall Study|Moved|3|||
131576878|NCT03612804|473737471|FG003|Overall Study|Medication copay coverage issues|17|||
131576879|NCT03612804|473737468|FG000|Overall Study|Not current smoker at time of screening|0|||
131576880|NCT03612804|473737469|FG001|Overall Study|Not current smoker at time of screening|1|||
131576881|NCT03612804|473737470|FG002|Overall Study|Not current smoker at time of screening|0|||
131785556|NCT00666718|474498811|FG001|Overall Study|Lost to Follow-up|0|||
131785557|NCT00666718|474498810|FG000|Overall Study|Entry Criteria Not Met|2|||
131785558|NCT00666718|474498811|FG001|Overall Study|Entry Criteria Not Met|0|||
131785559|NCT00666718|474498810|FG000|Overall Study|Protocol Violation|1|||
131785560|NCT00666718|474498811|FG001|Overall Study|Protocol Violation|3|||
131785561|NCT00666718|474498810|FG000|Overall Study|Withdrawal by Subject|7|||
131785562|NCT00666718|474498811|FG001|Overall Study|Withdrawal by Subject|12|||
131785563|NCT00666718|474498810|FG000|Overall Study|Physician Decision|0|||
131785564|NCT00666718|474498811|FG001|Overall Study|Physician Decision|2|||
131785565|NCT00963599|474498812|FG000|Overall Study|Adverse Event|2|||
131785566|NCT00963599|474498813|FG001|Overall Study|Adverse Event|0|||
131785567|NCT00963599|474498814|FG002|Overall Study|Adverse Event|1|||
131785568|NCT00963599|474498815|FG003|Overall Study|Adverse Event|2|||
131785569|NCT00963599|474498812|FG000|Overall Study|Lack of Efficacy|0|||
131785570|NCT00963599|474498813|FG001|Overall Study|Lack of Efficacy|2|||
131785571|NCT00963599|474498814|FG002|Overall Study|Lack of Efficacy|1|||
131785572|NCT00963599|474498815|FG003|Overall Study|Lack of Efficacy|4|||
131785573|NCT00963599|474498812|FG000|Overall Study|Lost to Follow-up|0|||
131785574|NCT00963599|474498813|FG001|Overall Study|Lost to Follow-up|1|||
131785575|NCT00963599|474498814|FG002|Overall Study|Lost to Follow-up|1|||
131785576|NCT00963599|474498815|FG003|Overall Study|Lost to Follow-up|1|||
131785577|NCT00963599|474498812|FG000|Overall Study|Protocol Violation|2|||
131785578|NCT00963599|474498813|FG001|Overall Study|Protocol Violation|2|||
131785579|NCT00963599|474498814|FG002|Overall Study|Protocol Violation|3|||
131785580|NCT00963599|474498815|FG003|Overall Study|Protocol Violation|4|||
131785581|NCT00963599|474498812|FG000|Overall Study|Withdrawal by Subject|2|||
131785582|NCT00963599|474498813|FG001|Overall Study|Withdrawal by Subject|1|||
131785583|NCT00963599|474498814|FG002|Overall Study|Withdrawal by Subject|3|||
131785584|NCT00963599|474498815|FG003|Overall Study|Withdrawal by Subject|3|||
131785585|NCT03496207|474498818|FG000|Base Study|Adverse Event|0|||
131785586|NCT03496207|474498819|FG001|Base Study|Adverse Event|0|||
131785587|NCT03496207|474498820|FG002|Base Study|Adverse Event|1|||
131785588|NCT03496207|474498821|FG003|Base Study|Adverse Event|1|||
131785589|NCT03496207|474498822|FG004|Base Study|Adverse Event|4|||
131785590|NCT03496207|474498818|FG000|Base Study|Death|0|||
131785591|NCT03496207|474498819|FG001|Base Study|Death|0|||
131785592|NCT03496207|474498820|FG002|Base Study|Death|0|||
131785593|NCT03496207|474498821|FG003|Base Study|Death|0|||
131785594|NCT03496207|474498822|FG004|Base Study|Death|1|||
131785595|NCT03496207|474498818|FG000|Base Study|Withdrawal by Subject|0|||
131785596|NCT03496207|474498819|FG001|Base Study|Withdrawal by Subject|0|||
131785597|NCT03496207|474498820|FG002|Base Study|Withdrawal by Subject|1|||
131785598|NCT03496207|474498821|FG003|Base Study|Withdrawal by Subject|0|||
131785599|NCT03496207|474498822|FG004|Base Study|Withdrawal by Subject|1|||
131785600|NCT03496207|474498818|FG000|Extension Period|Adverse Event|0|||
131785601|NCT03496207|474498819|FG001|Extension Period|Adverse Event|0|||
131785602|NCT03496207|474498820|FG002|Extension Period|Adverse Event|0|||
131785603|NCT03496207|474498821|FG003|Extension Period|Adverse Event|1|||
131785604|NCT03496207|474498822|FG004|Extension Period|Adverse Event|1|||
131785605|NCT03496207|474498818|FG000|Extension Period|Death|1|||
131785606|NCT03496207|474498819|FG001|Extension Period|Death|0|||
131785607|NCT03496207|474498820|FG002|Extension Period|Death|0|||
131785608|NCT03496207|474498821|FG003|Extension Period|Death|1|||
131785609|NCT03496207|474498822|FG004|Extension Period|Death|2|||
131785610|NCT03496207|474498818|FG000|Extension Period|Withdrawal by Subject|1|||
131785611|NCT03496207|474498819|FG001|Extension Period|Withdrawal by Subject|0|||
131785612|NCT03496207|474498820|FG002|Extension Period|Withdrawal by Subject|0|||
131785613|NCT03496207|474498821|FG003|Extension Period|Withdrawal by Subject|1|||
131785614|NCT03496207|474498822|FG004|Extension Period|Withdrawal by Subject|1|||
131785615|NCT03496207|474498818|FG000|Extension Period|Elevated hemoglobin levels|0|||
131785616|NCT03496207|474498819|FG001|Extension Period|Elevated hemoglobin levels|0|||
131785617|NCT03496207|474498820|FG002|Extension Period|Elevated hemoglobin levels|0|||
131785618|NCT03496207|474498821|FG003|Extension Period|Elevated hemoglobin levels|0|||
131898687|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
131576882|NCT03612804|473737471|FG003|Overall Study|Not current smoker at time of screening|3|||
131576883|NCT03612804|473737468|FG000|Overall Study|Non-veteran status|0|||
131785619|NCT03496207|474498822|FG004|Extension Period|Elevated hemoglobin levels|1|||
131785620|NCT00386100|474498825|FG000|Overall Study|Did not receive study medication|6|||
131898688|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
131438029|NCT01339689|473229477|FG000|Overall Study|Noncompliance|1|||
131438030|NCT01339689|473229478|FG001|Overall Study|Noncompliance|0|||
131438031|NCT01339689|473229477|FG000|Overall Study|Relocated out of area|0|||
131576884|NCT03612804|473737469|FG001|Overall Study|Non-veteran status|1|||
131576885|NCT03612804|473737470|FG002|Overall Study|Non-veteran status|0|||
131576886|NCT03612804|473737471|FG003|Overall Study|Non-veteran status|0|||
131576887|NCT03612804|473737468|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
131576888|NCT03612804|473737469|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
131785621|NCT00386100|474498826|FG001|Overall Study|Did not receive study medication|4|||
131438032|NCT01339689|473229478|FG001|Overall Study|Relocated out of area|1|||
131438033|NCT01339689|473229477|FG000|Overall Study|Other|2|||
131576889|NCT03612804|473737470|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
131699726|NCT03048422|474183379|FG001|Overall Study|Moved|2|||
131699727|NCT03048422|474183380|FG002|Overall Study|Moved|2|||
131699728|NCT03048422|474183378|FG000|Overall Study|Noncompliant with Study Requirements|2|||
131699729|NCT03048422|474183379|FG001|Overall Study|Noncompliant with Study Requirements|1|||
131699730|NCT03048422|474183380|FG002|Overall Study|Noncompliant with Study Requirements|2|||
131785622|NCT00386100|474498825|FG000|Overall Study|Adverse Event|15|||
131785623|NCT00386100|474498826|FG001|Overall Study|Adverse Event|25|||
131785624|NCT00386100|474498825|FG000|Overall Study|Death|0|||
131785625|NCT00386100|474498826|FG001|Overall Study|Death|1|||
131785626|NCT00386100|474498825|FG000|Overall Study|Insufficient therapeutic effect|30|||
131785627|NCT00386100|474498826|FG001|Overall Study|Insufficient therapeutic effect|6|||
131785628|NCT00386100|474498825|FG000|Overall Study|Lost to Follow-up|29|||
131785629|NCT00386100|474498826|FG001|Overall Study|Lost to Follow-up|29|||
131785630|NCT00386100|474498825|FG000|Overall Study|Non-compliance|18|||
131785631|NCT00386100|474498826|FG001|Overall Study|Non-compliance|19|||
131785632|NCT00386100|474498825|FG000|Overall Study|Protocol Violation|5|||
131785633|NCT00386100|474498826|FG001|Overall Study|Protocol Violation|3|||
131785634|NCT00386100|474498825|FG000|Overall Study|Withdrawal by Subject|32|||
131785635|NCT00386100|474498826|FG001|Overall Study|Withdrawal by Subject|31|||
131785636|NCT00386100|474498825|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
131785637|NCT00386100|474498826|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
131785638|NCT00386100|474498825|FG000|Overall Study|BMD <2.5|1|||
131785639|NCT00386100|474498826|FG001|Overall Study|BMD <2.5|0|||
131785640|NCT00386100|474498825|FG000|Overall Study|Consecutive elevated Hba1C|1|||
131785641|NCT00386100|474498826|FG001|Overall Study|Consecutive elevated Hba1C|0|||
131785642|NCT00386100|474498825|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
131785643|NCT00386100|474498826|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
131785644|NCT00386100|474498825|FG000|Overall Study|Laboratory findings|1|||
131785645|NCT00386100|474498826|FG001|Overall Study|Laboratory findings|0|||
131576890|NCT03612804|473737471|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
131576891|NCT03612804|473737468|FG000|Overall Study|Provider retired from VA|0|||
131576892|NCT03612804|473737469|FG001|Overall Study|Provider retired from VA|0|||
131576893|NCT03612804|473737470|FG002|Overall Study|Provider retired from VA|2|||
131576894|NCT03612804|473737471|FG003|Overall Study|Provider retired from VA|0|||
131576895|NCT03612804|473737468|FG000|Overall Study|Withdrawal by Subject|0|||
131576896|NCT03612804|473737469|FG001|Overall Study|Withdrawal by Subject|0|||
131576897|NCT03612804|473737470|FG002|Overall Study|Withdrawal by Subject|7|||
131576898|NCT03612804|473737471|FG003|Overall Study|Withdrawal by Subject|0|||
131576899|NCT03612804|473737468|FG000|Overall Study|Provider involved with study activities|1|||
131576900|NCT03612804|473737469|FG001|Overall Study|Provider involved with study activities|0|||
131576901|NCT03612804|473737470|FG002|Overall Study|Provider involved with study activities|0|||
131576902|NCT03612804|473737471|FG003|Overall Study|Provider involved with study activities|0|||
131576903|NCT00741988|473737481|FG000|Overall Study|Adverse Event|2|||
131576904|NCT00741988|473737482|FG001|Overall Study|Adverse Event|4|||
131699731|NCT03048422|474183378|FG000|Overall Study|Not Able to Get to Clinic|1|||
131699732|NCT03048422|474183379|FG001|Overall Study|Not Able to Get to Clinic|0|||
131699733|NCT03048422|474183380|FG002|Overall Study|Not Able to Get to Clinic|0|||
131699734|NCT02482129|474183381|FG000|Overall Study|Adverse Event-prior to treatment|0|||
131699735|NCT02482129|474183382|FG001|Overall Study|Adverse Event-prior to treatment|1|||
131699736|NCT02482129|474183381|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
131699737|NCT02482129|474183382|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
131699738|NCT02482129|474183381|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
131699739|NCT02482129|474183382|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
131699740|NCT02482129|474183381|FG000|Overall Study|Criteria not met-prior to treatment|1|||
131699741|NCT02482129|474183382|FG001|Overall Study|Criteria not met-prior to treatment|0|||
131699742|NCT02482129|474183381|FG000|Overall Study|Adverse Event|1|||
131699743|NCT02482129|474183382|FG001|Overall Study|Adverse Event|0|||
131699744|NCT02482129|474183381|FG000|Overall Study|Withdrawal by Subject|2|||
131699745|NCT02482129|474183382|FG001|Overall Study|Withdrawal by Subject|0|||
131699746|NCT02482129|474183381|FG000|Overall Study|Criteria not met|1|||
131699747|NCT02482129|474183382|FG001|Overall Study|Criteria not met|0|||
131699748|NCT03505021|474183384|FG000|Overall Study|Protocol Violation|1|||
131785646|NCT00386100|474498825|FG000|Overall Study|Participant's concern due to CPK levels|1|||
131576905|NCT00741988|473737481|FG000|Overall Study|Lack of Efficacy|2|||
131576906|NCT00741988|473737482|FG001|Overall Study|Lack of Efficacy|0|||
131699749|NCT03505021|474183385|FG001|Overall Study|Protocol Violation|0|||
131699750|NCT03505021|474183384|FG000|Overall Study|Death|9|||
131699751|NCT03505021|474183385|FG001|Overall Study|Death|8|||
131785647|NCT00386100|474498826|FG001|Overall Study|Participant's concern due to CPK levels|0|||
131785648|NCT00386100|474498825|FG000|Overall Study|Participant moving out of state|2|||
131785649|NCT00386100|474498826|FG001|Overall Study|Participant moving out of state|0|||
131785650|NCT00386100|474498825|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
131699752|NCT03505021|474183384|FG000|Overall Study|Consent withdrawn by subject|6|||
131785651|NCT00386100|474498826|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
131785652|NCT00386100|474498825|FG000|Overall Study|Didn't meet entry criteria|1|||
131785653|NCT00386100|474498826|FG001|Overall Study|Didn't meet entry criteria|1|||
131785654|NCT00386100|474498825|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
131785655|NCT00386100|474498826|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
131785656|NCT00386100|474498825|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
131785657|NCT00386100|474498826|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
131785658|NCT00386100|474498825|FG000|Overall Study|Bad metabolic control & patient security|1|||
131785659|NCT00386100|474498826|FG001|Overall Study|Bad metabolic control & patient security|0|||
131785660|NCT00386100|474498825|FG000|Overall Study|Bone loss by DXA bone scan|1|||
131785661|NCT00386100|474498826|FG001|Overall Study|Bone loss by DXA bone scan|0|||
131785662|NCT00386100|474498825|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
131785663|NCT00386100|474498826|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
131785664|NCT00386100|474498825|FG000|Overall Study|7.6% bone loss|1|||
131785665|NCT00386100|474498826|FG001|Overall Study|7.6% bone loss|0|||
131785666|NCT00386100|474498825|FG000|Overall Study|Osteoporosis|0|||
131785667|NCT00386100|474498826|FG001|Overall Study|Osteoporosis|1|||
131785668|NCT00386100|474498825|FG000|Overall Study|Positive pregnancy test|1|||
131785669|NCT00386100|474498826|FG001|Overall Study|Positive pregnancy test|3|||
131785670|NCT00386100|474498825|FG000|Overall Study|Out of country for 5 months|1|||
131785671|NCT00386100|474498826|FG001|Overall Study|Out of country for 5 months|0|||
131785672|NCT00386100|474498825|FG000|Overall Study|Hb1Ac >8%|0|||
131785673|NCT00386100|474498826|FG001|Overall Study|Hb1Ac >8%|1|||
131785674|NCT00386100|474498825|FG000|Overall Study|Participant randomized in error|1|||
131785675|NCT00386100|474498826|FG001|Overall Study|Participant randomized in error|0|||
131785676|NCT00810615|474498827|FG000|Overall Study|Withdrawal by Subject|1|||
131785677|NCT00810615|474498828|FG001|Overall Study|Withdrawal by Subject|1|||
131785678|NCT02525562|474498829|FG000|Overall Study|Death|9|||
131785679|NCT02525562|474498830|FG001|Overall Study|Death|0|||
131785680|NCT02525562|474498831|FG002|Overall Study|Death|0|||
131785681|NCT02525562|474498829|FG000|Overall Study|Lost to Follow-up|19|||
131785682|NCT02525562|474498830|FG001|Overall Study|Lost to Follow-up|0|||
131785683|NCT02525562|474498831|FG002|Overall Study|Lost to Follow-up|0|||
131785684|NCT02525562|474498829|FG000|Overall Study|Withdrawal by Subject|37|||
131785685|NCT02525562|474498830|FG001|Overall Study|Withdrawal by Subject|0|||
131785686|NCT02525562|474498831|FG002|Overall Study|Withdrawal by Subject|0|||
131785687|NCT02525562|474498829|FG000|Overall Study|Revision/Removal of Study Device|4|||
131785688|NCT02525562|474498830|FG001|Overall Study|Revision/Removal of Study Device|0|||
131785689|NCT02525562|474498831|FG002|Overall Study|Revision/Removal of Study Device|0|||
131785690|NCT02525562|474498829|FG000|Overall Study|Study Closed by Sponsor|154|||
131785691|NCT02525562|474498830|FG001|Overall Study|Study Closed by Sponsor|0|||
131785692|NCT02525562|474498831|FG002|Overall Study|Study Closed by Sponsor|0|||
131785693|NCT01706770|474498832|FG000|Overall Study|Lost to Follow-up|1|||
131785694|NCT01706770|474498833|FG001|Overall Study|Lost to Follow-up|0|||
131785695|NCT01706770|474498832|FG000|Overall Study|Physician Decision|1|||
131785696|NCT01706770|474498833|FG001|Overall Study|Physician Decision|0|||
131785697|NCT01255722|474498836|FG000|Overall Study|Adverse Event|0|||
131785698|NCT01255722|474498837|FG001|Overall Study|Adverse Event|1|||
131785699|NCT01255722|474498838|FG002|Overall Study|Adverse Event|1|||
131785700|NCT01255722|474498836|FG000|Overall Study|asymptomatic patient|1|||
131785701|NCT01255722|474498837|FG001|Overall Study|asymptomatic patient|0|||
131785702|NCT01255722|474498838|FG002|Overall Study|asymptomatic patient|0|||
131785703|NCT01255722|474498836|FG000|Overall Study|beta-blocker contraindicated|2|||
131785704|NCT01255722|474498837|FG001|Overall Study|beta-blocker contraindicated|0|||
131785705|NCT01255722|474498838|FG002|Overall Study|beta-blocker contraindicated|0|||
131785706|NCT02164539|474498839|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
131785707|NCT02164539|474498840|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
131785708|NCT02164539|474498841|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
131785709|NCT02164539|474498842|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
131785710|NCT02164539|474498843|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
131785711|NCT02164539|474498844|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
131438034|NCT01339689|473229478|FG001|Overall Study|Other|2|||
131576907|NCT00712166|473737485|FG000|Overall Study|Noncompliance|0|||
131576908|NCT00712166|473737486|FG001|Overall Study|Noncompliance|1|||
131785712|NCT02164539|474498845|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
131576909|NCT01773122|473737487|FG000|Overall Study|Due to amended age eligibility criteria|3|||
131785713|NCT02164539|474498839|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
131785714|NCT02164539|474498840|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
131785715|NCT02164539|474498841|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
131785716|NCT02164539|474498842|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
131785717|NCT02164539|474498843|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
131576910|NCT01773122|473737488|FG001|Overall Study|Due to amended age eligibility criteria|1|||
131785718|NCT02164539|474498844|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
131785719|NCT02164539|474498845|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
131785720|NCT02164539|474498839|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
131576911|NCT01773122|473737489|FG002|Overall Study|Due to amended age eligibility criteria|0|||
131576912|NCT01773122|473737490|FG003|Overall Study|Due to amended age eligibility criteria|1|||
131576913|NCT01264718|473737491|FG000|Overall Study|Lost to Follow-up|3|||
131576914|NCT01264718|473737492|FG001|Overall Study|Lost to Follow-up|2|||
131576915|NCT01264718|473737491|FG000|Overall Study|Withdrawal by Subject|9|||
131576916|NCT01264718|473737492|FG001|Overall Study|Withdrawal by Subject|15|||
131576917|NCT01264718|473737491|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
131576918|NCT01264718|473737492|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
131576919|NCT03264456|473737499|FG000|Overall Study|Withdrawal by Subject|3|||
131576920|NCT03264456|473737499|FG000|Overall Study|Lost to Follow-up|1|||
131576921|NCT03254394|473737500|FG000|Overall Study|Withdrawal by Subject|0|||
131576922|NCT03254394|473737501|FG001|Overall Study|Withdrawal by Subject|2|||
131576923|NCT01123083|473737502|FG000|Overall Study|Investigator recommendation|1|||
131576924|NCT01123083|473737503|FG001|Overall Study|Investigator recommendation|1|||
131785721|NCT02164539|474498840|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
131785722|NCT02164539|474498841|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
131576925|NCT01123083|473737502|FG000|Overall Study|Administrative reasons|0|||
131699753|NCT03505021|474183385|FG001|Overall Study|Consent withdrawn by subject|1|||
131699754|NCT03505021|474183384|FG000|Overall Study|Lost to Follow-up|5|||
131699755|NCT03505021|474183385|FG001|Overall Study|Lost to Follow-up|3|||
131699756|NCT03505021|474183384|FG000|Overall Study|Adverse Event|26|||
131699757|NCT03505021|474183385|FG001|Overall Study|Adverse Event|9|||
131699758|NCT03505021|474183384|FG000|Overall Study|Disease progression|33|||
131699759|NCT03505021|474183385|FG001|Overall Study|Disease progression|17|||
131699760|NCT03505021|474183384|FG000|Overall Study|Other|11|||
131699761|NCT03505021|474183385|FG001|Overall Study|Other|5|||
131699762|NCT03505021|474183384|FG000|Overall Study|Personal reason|21|||
131699763|NCT03505021|474183385|FG001|Overall Study|Personal reason|12|||
131699764|NCT00482014|474184934|FG000|Overall Study|Withdrawal by Subject|1|||
131699765|NCT00482014|474184935|FG001|Overall Study|Withdrawal by Subject|2|||
131699766|NCT00482014|474184936|FG002|Overall Study|Withdrawal by Subject|3|||
131699767|NCT00482014|474184937|FG003|Overall Study|Withdrawal by Subject|4|||
131699768|NCT00482014|474184934|FG000|Overall Study|Adverse Event|3|||
131699769|NCT00482014|474184935|FG001|Overall Study|Adverse Event|0|||
131699770|NCT00482014|474184936|FG002|Overall Study|Adverse Event|2|||
131785723|NCT02164539|474498842|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
131785724|NCT02164539|474498843|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
131699771|NCT00482014|474184937|FG003|Overall Study|Adverse Event|8|||
131699772|NCT00482014|474184934|FG000|Overall Study|Death|1|||
131699773|NCT00482014|474184935|FG001|Overall Study|Death|2|||
131699774|NCT00482014|474184936|FG002|Overall Study|Death|1|||
131699775|NCT00482014|474184937|FG003|Overall Study|Death|4|||
131699776|NCT00482014|474184934|FG000|Overall Study|Lack of Efficacy|1|||
131699777|NCT00482014|474184935|FG001|Overall Study|Lack of Efficacy|0|||
131699778|NCT00482014|474184936|FG002|Overall Study|Lack of Efficacy|4|||
131699779|NCT00482014|474184937|FG003|Overall Study|Lack of Efficacy|6|||
131699780|NCT00482014|474184934|FG000|Overall Study|Sponsor Decision|1|||
131699781|NCT00482014|474184935|FG001|Overall Study|Sponsor Decision|2|||
131699782|NCT00482014|474184936|FG002|Overall Study|Sponsor Decision|1|||
131699783|NCT00482014|474184937|FG003|Overall Study|Sponsor Decision|1|||
131699784|NCT03686397|474184938|FG000|Overall Study|Lack of Efficacy|3|||
131699785|NCT03686397|474184939|FG001|Overall Study|Lack of Efficacy|5|||
131699786|NCT03686397|474184938|FG000|Overall Study|Adverse Event|0|||
131699787|NCT03686397|474184939|FG001|Overall Study|Adverse Event|1|||
131699788|NCT03686397|474184938|FG000|Overall Study|Protocol Violation|0|||
131699789|NCT03686397|474184939|FG001|Overall Study|Protocol Violation|1|||
131699790|NCT03686397|474184938|FG000|Overall Study|Withdrawal by Subject|0|||
131699791|NCT03686397|474184939|FG001|Overall Study|Withdrawal by Subject|1|||
131699792|NCT03686397|474184938|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
131699793|NCT03686397|474184939|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
131699794|NCT00598975|474184942|FG000|Overall Study|Adverse Event|1|||
131699795|NCT00598975|474184943|FG001|Overall Study|Adverse Event|1|||
131699796|NCT00598975|474184942|FG000|Overall Study|Brain metastases|1|||
131699797|NCT00598975|474184943|FG001|Overall Study|Brain metastases|0|||
131699798|NCT00598975|474184942|FG000|Overall Study|Withdrawal by Subject|1|||
131699799|NCT00598975|474184943|FG001|Overall Study|Withdrawal by Subject|1|||
131699800|NCT00598975|474184942|FG000|Overall Study|Withdrawal of consent|0|||
131699801|NCT00598975|474184943|FG001|Overall Study|Withdrawal of consent|1|||
131699802|NCT00598975|474184942|FG000|Overall Study|Disease progression|8|||
131699803|NCT00598975|474184943|FG001|Overall Study|Disease progression|3|||
131699804|NCT00598975|474184942|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
131699805|NCT00598975|474184943|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
131699806|NCT04137887|474184944|FG000|Overall Study|Death|102|||
131699807|NCT04137887|474184945|FG001|Overall Study|Death|92|||
131699808|NCT04137887|474184944|FG000|Overall Study|Withdrawal by Subject|2|||
131699809|NCT04137887|474184945|FG001|Overall Study|Withdrawal by Subject|3|||
131699810|NCT04137887|474184944|FG000|Overall Study|Randomized but not treated|0|||
131699811|NCT04137887|474184945|FG001|Overall Study|Randomized but not treated|1|||
131699812|NCT01396005|474184953|FG000|Overall Study|Withdrawal by Subject|0|||
131699813|NCT01396005|474184954|FG001|Overall Study|Withdrawal by Subject|1|||
131699814|NCT01396005|474184953|FG000|Overall Study|Non-compliance with protocol|0|||
131576926|NCT01123083|473737503|FG001|Overall Study|Administrative reasons|4|||
131699815|NCT01396005|474184954|FG001|Overall Study|Non-compliance with protocol|1|||
131699816|NCT00424827|474184955|FG000|Overall Study|Adverse Event|1|||
131699817|NCT03806127|474184958|FG000|Overall Study|Withdrawal by Subject|4|||
131699818|NCT03806127|474184959|FG001|Overall Study|Withdrawal by Subject|5|||
131699819|NCT03806127|474184958|FG000|Overall Study|Protocol Violation|3|||
131699820|NCT03806127|474184959|FG001|Overall Study|Protocol Violation|1|||
131699821|NCT03806127|474184958|FG000|Overall Study|Adverse Event|3|||
131785725|NCT02164539|474498844|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
131785726|NCT02164539|474498845|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
131785727|NCT02164539|474498839|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
131785728|NCT02164539|474498840|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131785729|NCT02164539|474498841|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131785730|NCT02164539|474498842|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131785731|NCT02164539|474498843|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131785732|NCT02164539|474498844|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131785733|NCT02164539|474498845|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131785734|NCT02164539|474498839|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
131785735|NCT02164539|474498840|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
131785736|NCT02164539|474498841|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
131785737|NCT02164539|474498842|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
131785738|NCT02164539|474498843|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
131785739|NCT02164539|474498844|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
131785740|NCT02164539|474498845|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
131785741|NCT02164539|474498839|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
131785742|NCT02164539|474498840|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
131785743|NCT02164539|474498841|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
131785744|NCT02164539|474498842|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
131785745|NCT02164539|474498843|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
131785746|NCT02164539|474498844|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
131785747|NCT02164539|474498845|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
131785748|NCT02643966|474498846|FG000|First Screening Round|ineligible|1|||
131785749|NCT02643966|474498846|FG000|First Screening Round|excluded from analysis|2|||
131785750|NCT02643966|474498846|FG000|First Screening Round|Lost to Follow-up|56|||
131785751|NCT02643966|474498846|FG000|First Screening Round|Withdrawal by Subject|28|||
131785752|NCT02643966|474498846|FG000|First Screening Round|Death|1|||
131785753|NCT02643966|474498846|FG000|Between First and Second Screening|Lost to Follow-up|65|||
131785754|NCT02643966|474498846|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
131785755|NCT02643966|474498846|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
131785756|NCT02643966|474498846|FG000|Second Screening Round|Withdrawal by Subject|20|||
131785757|NCT02643966|474498846|FG000|Second Screening Round|Lost to Follow-up|57|||
131785758|NCT02643966|474498846|FG000|Second Screening Round|Physician Decision|2|||
131785759|NCT02643966|474498846|FG000|Second Screening Round|Death|4|||
131785760|NCT02643966|474498846|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
131785761|NCT02643966|474498846|FG000|Between Second and Third Screening|Death|1|||
131785762|NCT02643966|474498846|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
131785763|NCT02643966|474498846|FG000|Third Screening Round|PI excluded|2|||
131785764|NCT02643966|474498846|FG000|Third Screening Round|Lost to Follow-up|241|||
131785765|NCT01612702|474498849|FG000|Overall Study|Protocol Violation|11|||
131785766|NCT01612702|474498850|FG001|Overall Study|Protocol Violation|11|||
131785767|NCT03636542|474498851|FG000|Overall Study|Lost to Follow-up|1|||
131785768|NCT03636542|474498852|FG001|Overall Study|Lost to Follow-up|1|||
131785769|NCT03636542|474498851|FG000|Overall Study|Physician Decision|0|||
131785770|NCT03636542|474498852|FG001|Overall Study|Physician Decision|1|||
131785771|NCT03636542|474498851|FG000|Overall Study|Withdrawal by Subject|1|||
131785772|NCT03636542|474498852|FG001|Overall Study|Withdrawal by Subject|0|||
131785773|NCT03674827|474498855|FG000|Treatment Phase|Adverse Event|0|||
131785774|NCT03674827|474498856|FG001|Treatment Phase|Adverse Event|0|||
131785775|NCT03674827|474498857|FG002|Treatment Phase|Adverse Event|0|||
131785776|NCT03674827|474498858|FG003|Treatment Phase|Adverse Event|0|||
131785777|NCT03674827|474498859|FG004|Treatment Phase|Adverse Event|0|||
131785778|NCT03674827|474498860|FG005|Treatment Phase|Adverse Event|2|||
131785779|NCT03674827|474498855|FG000|Treatment Phase|Death|2|||
131785780|NCT03674827|474498856|FG001|Treatment Phase|Death|0|||
131785781|NCT03674827|474498857|FG002|Treatment Phase|Death|0|||
131785782|NCT03674827|474498858|FG003|Treatment Phase|Death|0|||
131785783|NCT03674827|474498859|FG004|Treatment Phase|Death|1|||
131785784|NCT03674827|474498860|FG005|Treatment Phase|Death|0|||
131785785|NCT03674827|474498855|FG000|Treatment Phase|Progressive Disease|0|||
131785786|NCT03674827|474498856|FG001|Treatment Phase|Progressive Disease|4|||
131785787|NCT03674827|474498857|FG002|Treatment Phase|Progressive Disease|3|||
131785788|NCT03674827|474498858|FG003|Treatment Phase|Progressive Disease|4|||
131785789|NCT03674827|474498859|FG004|Treatment Phase|Progressive Disease|4|||
131785790|NCT03674827|474498860|FG005|Treatment Phase|Progressive Disease|9|||
131785791|NCT03674827|474498855|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
131785792|NCT03674827|474498856|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
131785793|NCT03674827|474498857|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
131785794|NCT03674827|474498858|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
131785795|NCT03674827|474498859|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
131785796|NCT03674827|474498860|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
131785797|NCT03674827|474498855|FG000|Treatment Phase|Withdrawal by Subject|0|||
131785798|NCT03674827|474498856|FG001|Treatment Phase|Withdrawal by Subject|0|||
131785799|NCT03674827|474498857|FG002|Treatment Phase|Withdrawal by Subject|0|||
131576927|NCT01123083|473737502|FG000|Overall Study|Lost to Follow-up|2|||
131576928|NCT01123083|473737503|FG001|Overall Study|Lost to Follow-up|6|||
131576929|NCT01123083|473737502|FG000|Overall Study|Adverse Event|1|||
131576930|NCT01123083|473737503|FG001|Overall Study|Adverse Event|0|||
131576931|NCT01123083|473737502|FG000|Overall Study|Withdrew for another reason not covered|0|||
131576932|NCT01123083|473737503|FG001|Overall Study|Withdrew for another reason not covered|1|||
131576933|NCT01123083|473737502|FG000|Overall Study|Participant/legal representative request|7|||
131576934|NCT01123083|473737503|FG001|Overall Study|Participant/legal representative request|3|||
131576935|NCT00387465|473737504|FG000|Overall Study|Withdrawal by Subject|0|||
131576936|NCT00387465|473737505|FG001|Overall Study|Withdrawal by Subject|1|||
131576937|NCT00387465|473737506|FG002|Overall Study|Withdrawal by Subject|0|||
131576938|NCT03418324|473737507|FG000|Overall Study|Death|0|||
131576939|NCT03418324|473737508|FG001|Overall Study|Death|1|||
131576940|NCT03418324|473737507|FG000|Overall Study|Physician Decision|1|||
131576941|NCT03418324|473737508|FG001|Overall Study|Physician Decision|1|||
131576942|NCT01751724|473737509|FG000|Overall Study|extubated bef.start assigned treatment|1|||
131576943|NCT01751724|473737510|FG001|Overall Study|extubated bef.start assigned treatment|0|||
131576944|NCT01751724|473737509|FG000|Overall Study|withdrawn by parent|0|||
131576945|NCT01751724|473737510|FG001|Overall Study|withdrawn by parent|2|||
131576946|NCT00605033|473737511|FG000|Overall Study|Adverse Event|2|||
131576947|NCT00605033|473737512|FG001|Overall Study|Adverse Event|2|||
131576948|NCT00605033|473737511|FG000|Overall Study|Lost to Follow-up|1|||
131576949|NCT00605033|473737512|FG001|Overall Study|Lost to Follow-up|1|||
131576950|NCT00605033|473737511|FG000|Overall Study|Withdrawal by Subject|3|||
131576951|NCT00605033|473737512|FG001|Overall Study|Withdrawal by Subject|4|||
131699822|NCT03806127|474184959|FG001|Overall Study|Adverse Event|0|||
131699823|NCT03806127|474184958|FG000|Overall Study|Unable to Complete Procedures|0|||
131699824|NCT03806127|474184959|FG001|Overall Study|Unable to Complete Procedures|1|||
131576952|NCT00605033|473737511|FG000|Overall Study|Protocol Violation|1|||
131576953|NCT00605033|473737512|FG001|Overall Study|Protocol Violation|1|||
131576954|NCT03121950|473737514|FG000|Overall Study|Withdrawal by Subject|11|||
131576955|NCT03121950|473737515|FG001|Overall Study|Withdrawal by Subject|2|||
131576956|NCT05052983|473737521|FG000|Overall Study|Lack of Efficacy|3|||
131785800|NCT03674827|474498858|FG003|Treatment Phase|Withdrawal by Subject|0|||
131785801|NCT03674827|474498859|FG004|Treatment Phase|Withdrawal by Subject|0|||
131785802|NCT03674827|474498860|FG005|Treatment Phase|Withdrawal by Subject|1|||
131785803|NCT03674827|474498855|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
131576957|NCT05052983|473737522|FG001|Overall Study|Lack of Efficacy|12|||
131576958|NCT05052983|473737521|FG000|Overall Study|Adverse Event|1|||
131576959|NCT05052983|473737522|FG001|Overall Study|Adverse Event|0|||
131576960|NCT03425643|473737523|FG000|Overall Study|Withdrawal by Subject|10|||
131576961|NCT03425643|473737524|FG001|Overall Study|Withdrawal by Subject|12|||
131576962|NCT03425643|473737523|FG000|Overall Study|Lost to Follow-up|2|||
131699825|NCT03806127|474184958|FG000|Overall Study|Pregnancy|0|||
131699826|NCT03806127|474184959|FG001|Overall Study|Pregnancy|1|||
131699827|NCT03806127|474184958|FG000|Overall Study|Lost to Follow-up|5|||
131699828|NCT03806127|474184959|FG001|Overall Study|Lost to Follow-up|1|||
131699829|NCT03806127|474184958|FG000|Overall Study|Physician Decision|1|||
131699830|NCT03806127|474184959|FG001|Overall Study|Physician Decision|1|||
131699831|NCT03806127|474184958|FG000|Overall Study|Could Not Come Due to Covid|1|||
131699832|NCT03806127|474184959|FG001|Overall Study|Could Not Come Due to Covid|0|||
131699833|NCT03806127|474184958|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
131576963|NCT03425643|473737524|FG001|Overall Study|Lost to Follow-up|0|||
131576964|NCT03425643|473737523|FG000|Overall Study|Death|109|||
131576965|NCT03425643|473737524|FG001|Overall Study|Death|141|||
131576966|NCT03425643|473737523|FG000|Overall Study|Ongoing in study|276|||
131576967|NCT03425643|473737524|FG001|Overall Study|Ongoing in study|247|||
131576968|NCT04133363|473737525|FG000|Overall Study|Lost to Follow-up|2|||
131576969|NCT04133363|473737526|FG001|Overall Study|Lost to Follow-up|1|||
131576970|NCT04133363|473737527|FG002|Overall Study|Lost to Follow-up|4|||
131576971|NCT04199728|473739096|FG000|Overall Study|Adverse Event|1|||
131576972|NCT04199728|473739097|FG001|Overall Study|Adverse Event|0|||
131576973|NCT04199728|473739096|FG000|Overall Study|Withdrawal by Subject|8|||
131576974|NCT04199728|473739097|FG001|Overall Study|Withdrawal by Subject|3|||
131576975|NCT04199728|473739096|FG000|Overall Study|Screen fail after consent|0|||
131576976|NCT04199728|473739097|FG001|Overall Study|Screen fail after consent|1|||
131576977|NCT04199728|473739096|FG000|Overall Study|Early withdraw criteria met|0|||
131576978|NCT04199728|473739097|FG001|Overall Study|Early withdraw criteria met|1|||
131576979|NCT04199728|473739096|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
131576980|NCT04199728|473739097|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
131576981|NCT00482729|473739098|FG000|Overall Study|Adverse Event|29|||
131576982|NCT00482729|473739099|FG001|Overall Study|Adverse Event|33|||
131576983|NCT00482729|473739098|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
131576984|NCT00482729|473739099|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
131576985|NCT00482729|473739098|FG000|Overall Study|Hyperglycemia Criteria|7|||
131576986|NCT00482729|473739099|FG001|Overall Study|Hyperglycemia Criteria|5|||
131576987|NCT00482729|473739098|FG000|Overall Study|Lack of Efficacy|4|||
131576988|NCT00482729|473739099|FG001|Overall Study|Lack of Efficacy|16|||
131576989|NCT00482729|473739098|FG000|Overall Study|Lost to Follow-up|86|||
131576990|NCT00482729|473739099|FG001|Overall Study|Lost to Follow-up|66|||
131576991|NCT00482729|473739098|FG000|Overall Study|Physician Decision|10|||
131576992|NCT00482729|473739099|FG001|Overall Study|Physician Decision|7|||
131576993|NCT00482729|473739098|FG000|Overall Study|Pregnancy|4|||
131576994|NCT00482729|473739099|FG001|Overall Study|Pregnancy|2|||
131576995|NCT00482729|473739098|FG000|Overall Study|Protocol Violation|10|||
131576996|NCT00482729|473739099|FG001|Overall Study|Protocol Violation|18|||
131576997|NCT00482729|473739098|FG000|Overall Study|Withdrawal by Subject|67|||
131576998|NCT00482729|473739099|FG001|Overall Study|Withdrawal by Subject|69|||
131576999|NCT02631148|473739107|FG000|Overall Study|8 were ineligible|8|||
131577000|NCT02631148|473739108|FG001|Overall Study|8 were ineligible|0|||
131577001|NCT02631148|473739107|FG000|Overall Study|Withdrawal by Subject|1|||
131577002|NCT02631148|473739108|FG001|Overall Study|Withdrawal by Subject|0|||
131577003|NCT02631148|473739107|FG000|Overall Study|PAH not available to study participant|1|||
131577004|NCT02631148|473739108|FG001|Overall Study|PAH not available to study participant|0|||
131577005|NCT00487578|473739110|FG000|Overall Study|Adverse Event|1|||
131577006|NCT00487578|473739111|FG001|Overall Study|Adverse Event|2|||
131577007|NCT00487578|473739110|FG000|Overall Study|Lack of Efficacy|0|||
131577008|NCT00487578|473739111|FG001|Overall Study|Lack of Efficacy|1|||
131577009|NCT00487578|473739110|FG000|Overall Study|Lost to Follow-up|0|||
131577010|NCT00487578|473739111|FG001|Overall Study|Lost to Follow-up|1|||
131577011|NCT02525796|473739116|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
131577012|NCT02525796|473739117|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
131577013|NCT02525796|473739118|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
131577014|NCT02525796|473739116|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
131577015|NCT02525796|473739117|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
131577016|NCT02525796|473739118|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
131577017|NCT02525796|473739116|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
131577018|NCT02525796|473739117|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
131577019|NCT02525796|473739118|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
131577020|NCT02525796|473739116|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
131577021|NCT02525796|473739117|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
131577022|NCT02525796|473739118|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
131577023|NCT02525796|473739116|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
131577024|NCT02525796|473739117|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
131577025|NCT02525796|473739118|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
131577026|NCT00726999|473739119|FG000|Overall Study|Physician Decision|0|||
131577027|NCT00726999|473739120|FG001|Overall Study|Physician Decision|1|||
131699834|NCT03806127|474184959|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
131699835|NCT03806127|474184958|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
131699836|NCT03806127|474184959|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
131699837|NCT03806127|474184958|FG000|Overall Study|Covid 19 Restrictions|2|||
131577028|NCT00726999|473739119|FG000|Overall Study|Withdrawal by Subject|2|||
131699838|NCT03806127|474184959|FG001|Overall Study|Covid 19 Restrictions|0|||
131699839|NCT03806127|474184958|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
131699840|NCT03806127|474184959|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
131699841|NCT03806127|474184958|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
131577029|NCT00726999|473739120|FG001|Overall Study|Withdrawal by Subject|0|||
131577030|NCT00726999|473739119|FG000|Overall Study|Protocol Violation|1|||
131577031|NCT00726999|473739120|FG001|Overall Study|Protocol Violation|0|||
131577032|NCT01499134|473739121|FG000|Overall Study|Withdrawal by Subject|0|||
131577033|NCT01499134|473739122|FG001|Overall Study|Withdrawal by Subject|1|||
131577034|NCT01198275|473739123|FG000|Overall Study|Adverse Event|2|||
131577035|NCT01198275|473739124|FG001|Overall Study|Adverse Event|3|||
131577036|NCT01198275|473739123|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
131577037|NCT01198275|473739124|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
131577038|NCT00150176|473739125|FG000|Overall Study|Adverse Event|16|||
131577039|NCT00150176|473739126|FG001|Overall Study|Adverse Event|53|||
131577040|NCT00150176|473739125|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
131577041|NCT00150176|473739126|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
131577042|NCT00150176|473739125|FG000|Overall Study|Withdrawal by Subject|19|||
131577043|NCT00150176|473739126|FG001|Overall Study|Withdrawal by Subject|12|||
131577044|NCT00150176|473739125|FG000|Overall Study|Lost to Follow-up|3|||
131577045|NCT00150176|473739126|FG001|Overall Study|Lost to Follow-up|3|||
131577046|NCT00150176|473739125|FG000|Overall Study|OTHER|11|||
131577047|NCT00150176|473739126|FG001|Overall Study|OTHER|13|||
131577048|NCT02385669|473739130|FG000|Overall Study|Adverse Event|2|||
131577049|NCT00970307|473739131|FG000|Overall Study|Serious Adverse Event|1|||
131577050|NCT00970307|473739132|FG001|Overall Study|Serious Adverse Event|0|||
131577051|NCT00970307|473739133|FG002|Overall Study|Serious Adverse Event|0|||
131577052|NCT00970307|473739131|FG000|Overall Study|Withdrawal by Subject|2|||
131577053|NCT00970307|473739132|FG001|Overall Study|Withdrawal by Subject|3|||
131577054|NCT00970307|473739133|FG002|Overall Study|Withdrawal by Subject|2|||
131577055|NCT05257798|473739134|FG000|Follow-up Phase|Lost to Follow-up|1|||
131577056|NCT05257798|473739135|FG001|Follow-up Phase|Lost to Follow-up|0|||
131577057|NCT04033432|473739138|FG000|Overall Study|Progressive Disease|8|||
131577058|NCT04033432|473739138|FG000|Overall Study|Adverse Event|4|||
131577059|NCT04033432|473739138|FG000|Overall Study|Death|1|||
131577060|NCT00393848|473739139|FG000|Overall Study|Surgical schedule|0|||
131577061|NCT00393848|473739140|FG001|Overall Study|Surgical schedule|0|||
131577062|NCT00393848|473739141|FG002|Overall Study|Surgical schedule|0|||
131577063|NCT00393848|473739142|FG003|Overall Study|Surgical schedule|1|||
131577064|NCT00393848|473739139|FG000|Overall Study|Personal reasons|0|||
131577065|NCT00393848|473739140|FG001|Overall Study|Personal reasons|0|||
131577066|NCT00393848|473739141|FG002|Overall Study|Personal reasons|2|||
131577067|NCT00393848|473739142|FG003|Overall Study|Personal reasons|0|||
131577068|NCT02082158|473739145|FG000|Overall Study|Withdrawal by Subject|0|||
131577069|NCT02082158|473739146|FG001|Overall Study|Withdrawal by Subject|0|||
131577070|NCT02082158|473739147|FG002|Overall Study|Withdrawal by Subject|0|||
131577071|NCT02082158|473739148|FG003|Overall Study|Withdrawal by Subject|0|||
131577072|NCT02082158|473739149|FG004|Overall Study|Withdrawal by Subject|1|||
131577073|NCT02082158|473739150|FG005|Overall Study|Withdrawal by Subject|0|||
131577074|NCT02082158|473739145|FG000|Overall Study|Failed Fit-testing|8|||
131577075|NCT02082158|473739146|FG001|Overall Study|Failed Fit-testing|8|||
131577076|NCT02082158|473739147|FG002|Overall Study|Failed Fit-testing|14|||
131577077|NCT02082158|473739148|FG003|Overall Study|Failed Fit-testing|4|||
131577078|NCT02082158|473739149|FG004|Overall Study|Failed Fit-testing|3|||
131577079|NCT02082158|473739150|FG005|Overall Study|Failed Fit-testing|7|||
131577080|NCT02192606|473739151|FG000|Overall Study|surgery type was changed|1|||
131577081|NCT02192606|473739152|FG001|Overall Study|surgery type was changed|1|||
131577082|NCT02192606|473739151|FG000|Overall Study|Physician Decision|1|||
131577083|NCT02192606|473739152|FG001|Overall Study|Physician Decision|2|||
131577084|NCT02192606|473739151|FG000|Overall Study|3D equipment rep unable to join|0|||
131577085|NCT02192606|473739152|FG001|Overall Study|3D equipment rep unable to join|1|||
131577086|NCT00738699|473739156|FG000|Overall Study|Withdrawal by Subject|5|||
131577087|NCT00738699|473739157|FG001|Overall Study|Withdrawal by Subject|0|||
131699842|NCT03806127|474184959|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
131699843|NCT01467492|474184960|FG000|Overall Study|Withdrawal by Subject|6|||
131699844|NCT01467492|474184961|FG001|Overall Study|Withdrawal by Subject|4|||
131577088|NCT00738699|473739156|FG000|Overall Study|Lost to Follow-up|1|||
131577089|NCT00738699|473739157|FG001|Overall Study|Lost to Follow-up|0|||
131577090|NCT00738699|473739156|FG000|Overall Study|Death|144|||
131577091|NCT00738699|473739157|FG001|Overall Study|Death|68|||
131577092|NCT00738699|473739156|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
131699845|NCT01467492|474184960|FG000|Overall Study|Study Terminated by Sponsor|6|||
131577093|NCT00738699|473739157|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
131699846|NCT01467492|474184961|FG001|Overall Study|Study Terminated by Sponsor|4|||
131699847|NCT01467492|474184960|FG000|Overall Study|Adverse Event|4|||
131699848|NCT01467492|474184961|FG001|Overall Study|Adverse Event|3|||
131577094|NCT00738699|473739156|FG000|Overall Study|Other|2|||
131577095|NCT00738699|473739157|FG001|Overall Study|Other|0|||
131699849|NCT01467492|474184960|FG000|Overall Study|Lost to Follow-up|3|||
131699850|NCT01467492|474184961|FG001|Overall Study|Lost to Follow-up|2|||
131577096|NCT00419094|473739162|FG000|Overall Study|Adverse Event|3|||
131577097|NCT00419094|473739163|FG001|Overall Study|Adverse Event|7|||
131438035|NCT01339689|473229477|FG000|Overall Study|multiple reasons|1|||
131577098|NCT00419094|473739162|FG000|Overall Study|Lack of Efficacy|1|||
131577099|NCT00419094|473739163|FG001|Overall Study|Lack of Efficacy|0|||
131577100|NCT00419094|473739162|FG000|Overall Study|Lost to Follow-up|0|||
131577101|NCT00419094|473739163|FG001|Overall Study|Lost to Follow-up|2|||
131577102|NCT00419094|473739162|FG000|Overall Study|Protocol Violation|1|||
131577103|NCT00419094|473739163|FG001|Overall Study|Protocol Violation|14|||
131577104|NCT00419094|473739162|FG000|Overall Study|Withdrawal of consent|1|||
131577105|NCT00419094|473739163|FG001|Overall Study|Withdrawal of consent|5|||
131577106|NCT00419094|473739162|FG000|Overall Study|Other: Error determining exit criteria|1|||
131577107|NCT00419094|473739163|FG001|Overall Study|Other: Error determining exit criteria|0|||
131438036|NCT01339689|473229478|FG001|Overall Study|multiple reasons|1|||
131438037|NCT00300755|473229479|FG000|Overall Study|Adverse Event|1|||
131438038|NCT00300755|473229480|FG001|Overall Study|Adverse Event|2|||
131438039|NCT00300755|473229481|FG002|Overall Study|Adverse Event|1|||
131438040|NCT00300755|473229479|FG000|Overall Study|Withdrawal by Subject|0|||
131438041|NCT00300755|473229480|FG001|Overall Study|Withdrawal by Subject|2|||
131438042|NCT00300755|473229481|FG002|Overall Study|Withdrawal by Subject|0|||
131577108|NCT00419094|473739162|FG000|Overall Study|Other: Patient non-compliant|0|||
131577109|NCT00419094|473739163|FG001|Overall Study|Other: Patient non-compliant|1|||
131699851|NCT01467492|474184960|FG000|Overall Study|Undefined|2|||
131699852|NCT01467492|474184961|FG001|Overall Study|Undefined|0|||
131699853|NCT01467492|474184960|FG000|Overall Study|Enrolled But Not Treated|1|||
131699854|NCT01467492|474184961|FG001|Overall Study|Enrolled But Not Treated|0|||
131699855|NCT02450487|474184963|FG000|Overall Study|Lost to Follow-up|3|||
131699856|NCT01790048|474184964|FG000|Overall Study|Incorrect Age|9|||
131699857|NCT01790048|474184965|FG001|Overall Study|Incorrect Age|14|||
131699858|NCT01790048|474184964|FG000|Overall Study|data entry error|0|||
131699859|NCT01790048|474184965|FG001|Overall Study|data entry error|1|||
131699860|NCT01790048|474184964|FG000|Overall Study|Other|0|||
131699861|NCT01790048|474184965|FG001|Overall Study|Other|2|||
131699862|NCT01790048|474184964|FG000|Overall Study|SAM at Enrollment|2|||
131699863|NCT01790048|474184965|FG001|Overall Study|SAM at Enrollment|0|||
131699864|NCT01790048|474184964|FG000|Overall Study|Measurement error|1|||
131699865|NCT01790048|474184965|FG001|Overall Study|Measurement error|0|||
131699866|NCT00159432|474184966|FG000|Overall Study|Adverse Event|1|||
131699867|NCT00159432|474184966|FG000|Overall Study|Death|1|||
131699868|NCT00159432|474184966|FG000|Overall Study|Lack of Efficacy|8|||
131699869|NCT05030311|474184967|FG000|Overall Study|Technical problems|0|||
131699870|NCT05030311|474184968|FG001|Overall Study|Technical problems|1|||
131699871|NCT05030311|474184967|FG000|Overall Study|Withdrawal by Subject|31|||
131699872|NCT05030311|474184968|FG001|Overall Study|Withdrawal by Subject|17|||
131699873|NCT05030311|474184967|FG000|Overall Study|Adverse Event|13|||
131699874|NCT05030311|474184968|FG001|Overall Study|Adverse Event|5|||
131699875|NCT05030311|474184967|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131699876|NCT05030311|474184968|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131699877|NCT05030311|474184967|FG000|Overall Study|Physician Decision|5|||
131699878|NCT05030311|474184968|FG001|Overall Study|Physician Decision|2|||
131699879|NCT05030311|474184967|FG000|Overall Study|Lost to Follow-up|5|||
131699880|NCT05030311|474184968|FG001|Overall Study|Lost to Follow-up|1|||
131699881|NCT05030311|474184967|FG000|Overall Study|Protocol Violation|4|||
131699882|NCT05030311|474184968|FG001|Overall Study|Protocol Violation|4|||
131699883|NCT03042468|474184970|FG000|Overall Study|Death|0|||
131699884|NCT03042468|474184971|FG001|Overall Study|Death|1|||
131699885|NCT03042468|474184972|FG002|Overall Study|Death|1|||
131699886|NCT03042468|474184973|FG003|Overall Study|Death|0|||
131699887|NCT03042468|474184974|FG004|Overall Study|Death|0|||
131699888|NCT03042468|474184975|FG005|Overall Study|Death|0|||
131699889|NCT03042468|474184970|FG000|Overall Study|Withdrawal by Subject|0|||
131699890|NCT03042468|474184971|FG001|Overall Study|Withdrawal by Subject|0|||
131699891|NCT03042468|474184972|FG002|Overall Study|Withdrawal by Subject|0|||
131699892|NCT03042468|474184973|FG003|Overall Study|Withdrawal by Subject|0|||
131699893|NCT03042468|474184974|FG004|Overall Study|Withdrawal by Subject|0|||
131699894|NCT03042468|474184975|FG005|Overall Study|Withdrawal by Subject|1|||
131699895|NCT03042468|474184970|FG000|Overall Study|Lost to Follow-up|0|||
131699896|NCT03042468|474184971|FG001|Overall Study|Lost to Follow-up|0|||
131699897|NCT03042468|474184972|FG002|Overall Study|Lost to Follow-up|0|||
131699898|NCT03042468|474184973|FG003|Overall Study|Lost to Follow-up|0|||
131699899|NCT03042468|474184974|FG004|Overall Study|Lost to Follow-up|1|||
131699900|NCT03042468|474184975|FG005|Overall Study|Lost to Follow-up|1|||
131699901|NCT03286842|474184976|FG000|Overall Study|Patients rolled over to another study|80|||
131577110|NCT00419094|473739162|FG000|Overall Study|Other: No contact for extended period|0|||
131699902|NCT03178487|474184977|FG000|Period 1|Adverse Event|1|||
131699903|NCT03178487|474184978|FG001|Period 1|Adverse Event|2|||
131699904|NCT03178487|474184977|FG000|Period 1|Withdrawal by Subject|2|||
131699905|NCT03178487|474184978|FG001|Period 1|Withdrawal by Subject|1|||
131699906|NCT03178487|474184977|FG000|Period 1|Lost to Follow-up|1|||
131577111|NCT00419094|473739163|FG001|Overall Study|Other: No contact for extended period|1|||
131699907|NCT03178487|474184978|FG001|Period 1|Lost to Follow-up|0|||
131577112|NCT01811706|473739164|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
131577113|NCT01811706|473739165|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
131577114|NCT01458210|473739166|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
131577115|NCT01458210|473739166|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
131577116|NCT01458210|473739166|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
131577117|NCT01458210|473739166|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
131577118|NCT03923491|473739168|FG000|Overall Study|Lost to Follow-up|5|||
131577119|NCT03923491|473739169|FG001|Overall Study|Lost to Follow-up|8|||
131577120|NCT03923491|473739168|FG000|Overall Study|Withdrawal by Subject|4|||
131577121|NCT03923491|473739169|FG001|Overall Study|Withdrawal by Subject|6|||
131577122|NCT01027286|473739172|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
131699908|NCT03178487|474184977|FG000|Period 1|Other|0|||
131699909|NCT03178487|474184978|FG001|Period 1|Other|1|||
131699910|NCT03178487|474184977|FG000|Period 2|Adverse Event|4|||
131577123|NCT01027286|473739173|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
131577124|NCT01027286|473739172|FG000|Overall Study|Lost to Follow-up|0|||
131577125|NCT01027286|473739173|FG001|Overall Study|Lost to Follow-up|1|||
131577126|NCT01565928|473739176|FG000|Overall Study|Adverse Event|3|||
131577127|NCT01565928|473739176|FG000|Overall Study|Other|3|||
131577128|NCT01565928|473739176|FG000|Overall Study|Progressive Disease|13|||
131577129|NCT01565928|473739176|FG000|Overall Study|Withdrawal by Subject|1|||
131577130|NCT01565928|473739176|FG000|Overall Study|Death|2|||
131577131|NCT01183780|473739179|FG000|Overall Study|Withdrawal by Subject|25|||
131577132|NCT01183780|473739180|FG001|Overall Study|Withdrawal by Subject|14|||
131577133|NCT01183780|473739179|FG000|Overall Study|Lost to Follow-up|6|||
131577134|NCT01183780|473739180|FG001|Overall Study|Lost to Follow-up|11|||
131577135|NCT03808883|473739182|FG000|Overall Study|Withdrawal by Subject|2|||
131577136|NCT03808883|473739183|FG001|Overall Study|Withdrawal by Subject|0|||
131577137|NCT03808883|473739182|FG000|Overall Study|Did not complete pre test or post test survey|4|||
131577138|NCT03808883|473739183|FG001|Overall Study|Did not complete pre test or post test survey|3|||
131577139|NCT00811057|473739188|FG000|Overall Study|Protocol Violation|5|||
131577140|NCT00811057|473739189|FG001|Overall Study|Protocol Violation|10|||
131577141|NCT00811057|473739190|FG002|Overall Study|Protocol Violation|10|||
131577142|NCT00768651|473739195|FG000|Overall Study|Withdrawal by Subject|1|||
131577143|NCT02104765|473739196|FG000|Overall Study|Lost to Follow-up|0|||
131577144|NCT02104765|473739197|FG001|Overall Study|Lost to Follow-up|0|||
131577145|NCT02104765|473739198|FG002|Overall Study|Lost to Follow-up|1|||
131699911|NCT03178487|474184978|FG001|Period 2|Adverse Event|4|||
131699912|NCT03178487|474184977|FG000|Period 2|Withdrawal by Subject|6|||
131699913|NCT03178487|474184978|FG001|Period 2|Withdrawal by Subject|6|||
131699914|NCT03178487|474184977|FG000|Period 2|Lost to Follow-up|2|||
131699915|NCT03178487|474184978|FG001|Period 2|Lost to Follow-up|2|||
131699916|NCT03178487|474184977|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
131699917|NCT03178487|474184978|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
131699918|NCT03178487|474184977|FG000|Period 2|Other|8|||
131699919|NCT03178487|474184978|FG001|Period 2|Other|7|||
131699920|NCT01453855|474184979|FG000|Overall Study|Adverse Event|3|||
131699921|NCT01453855|474184980|FG001|Overall Study|Adverse Event|4|||
131699922|NCT01453855|474184979|FG000|Overall Study|Lost to Follow-up|2|||
131699923|NCT01453855|474184980|FG001|Overall Study|Lost to Follow-up|1|||
131699924|NCT01453855|474184979|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
131699925|NCT01453855|474184980|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
131699926|NCT01453855|474184979|FG000|Overall Study|Noncompliance|1|||
131699927|NCT01453855|474184980|FG001|Overall Study|Noncompliance|0|||
131699928|NCT01453855|474184979|FG000|Overall Study|Inadequate Control of IOP|1|||
131699929|NCT01453855|474184980|FG001|Overall Study|Inadequate Control of IOP|5|||
131699930|NCT01453855|474184979|FG000|Overall Study|Other|0|||
131699931|NCT01453855|474184980|FG001|Overall Study|Other|1|||
131699932|NCT01239160|474184981|FG000|Overall Study|Lost to Follow-up|3|||
131699933|NCT01239160|474184982|FG001|Overall Study|Lost to Follow-up|5|||
131699934|NCT01239160|474184983|FG002|Overall Study|Lost to Follow-up|0|||
131699935|NCT01239160|474184981|FG000|Overall Study|Withdrawal by Subject|17|||
131699936|NCT01239160|474184982|FG001|Overall Study|Withdrawal by Subject|6|||
131699937|NCT01239160|474184983|FG002|Overall Study|Withdrawal by Subject|2|||
131699938|NCT01239160|474184981|FG000|Overall Study|Physician Decision|5|||
131699939|NCT01239160|474184982|FG001|Overall Study|Physician Decision|7|||
131699940|NCT01239160|474184983|FG002|Overall Study|Physician Decision|2|||
131699941|NCT01239160|474184981|FG000|Overall Study|Early Termination Due to Study Closure|0|||
131577146|NCT02104765|473739199|FG003|Overall Study|Lost to Follow-up|0|||
131577147|NCT02104765|473739200|FG004|Overall Study|Lost to Follow-up|0|||
131577148|NCT02104765|473739201|FG005|Overall Study|Lost to Follow-up|0|||
131438043|NCT00300755|473229479|FG000|Overall Study|Protocol Violation|0|||
131438044|NCT00300755|473229480|FG001|Overall Study|Protocol Violation|0|||
131438045|NCT00300755|473229481|FG002|Overall Study|Protocol Violation|1|||
131438046|NCT02694744|473229485|FG000|Overall Study|Adverse Event|2|||
131438047|NCT02694744|473229486|FG001|Overall Study|Adverse Event|1|||
131438048|NCT02694744|473229485|FG000|Overall Study|Withdrawal by Subject|2|||
131438049|NCT02694744|473229486|FG001|Overall Study|Withdrawal by Subject|1|||
131438050|NCT02694744|473229485|FG000|Overall Study|Physician Decision|1|||
131438051|NCT02694744|473229486|FG001|Overall Study|Physician Decision|2|||
131438052|NCT02694744|473229485|FG000|Overall Study|Lost to Follow-up|1|||
131438053|NCT02694744|473229486|FG001|Overall Study|Lost to Follow-up|0|||
131438054|NCT02694744|473229485|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
131438055|NCT02694744|473229486|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
131438056|NCT00686777|473229487|FG000|Overall Study|Adverse Event|2|||
131438057|NCT00686777|473229487|FG000|Overall Study|Pregnancy|1|||
131438058|NCT00686777|473229487|FG000|Overall Study|Withdrawal by Subject|2|||
131438059|NCT00686777|473229487|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
131438060|NCT00686777|473229487|FG000|Overall Study|No Visit|1|||
131438061|NCT01945021|473229488|FG000|Overall Study|Adverse Event|1|||
131438062|NCT01945021|473229488|FG000|Overall Study|Withdrawal of consent|12|||
131438063|NCT01945021|473229488|FG000|Overall Study|Lost to Follow-up|5|||
131438064|NCT01945021|473229488|FG000|Overall Study|Death|65|||
131438065|NCT03582215|473229489|FG000|Overall Study|Adverse Event|1|||
131438066|NCT03582215|473229490|FG001|Overall Study|Adverse Event|0|||
131438067|NCT03582215|473229491|FG002|Overall Study|Adverse Event|0|||
131438068|NCT03582215|473229492|FG003|Overall Study|Adverse Event|0|||
131438069|NCT03582215|473229493|FG004|Overall Study|Adverse Event|0|||
131438070|NCT03582215|473229494|FG005|Overall Study|Adverse Event|0|||
131438071|NCT03582215|473229495|FG006|Overall Study|Adverse Event|2|||
131438072|NCT03582215|473229496|FG007|Overall Study|Adverse Event|2|||
131438073|NCT02163902|473229497|FG000|Overall Study|Subject's Request|3|||
131438074|NCT02163902|473229498|FG001|Overall Study|Subject's Request|4|||
131438075|NCT02163902|473229497|FG000|Overall Study|Lost to Follow-up|6|||
131699942|NCT01239160|474184982|FG001|Overall Study|Early Termination Due to Study Closure|1|||
131699943|NCT01239160|474184983|FG002|Overall Study|Early Termination Due to Study Closure|6|||
131699944|NCT04781816|474184984|FG000|Overall Study|Adverse Event|0|||
131699945|NCT04781816|474184985|FG001|Overall Study|Adverse Event|1|||
131699946|NCT04781816|474184984|FG000|Overall Study|Withdrawal by Subject|1|||
131699947|NCT04781816|474184985|FG001|Overall Study|Withdrawal by Subject|1|||
131699948|NCT04781816|474184984|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
131699949|NCT04781816|474184985|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
131699950|NCT01789970|474184986|FG000|Open-label Titration Period|Adverse Event|68|||
131699951|NCT01789970|474184987|FG001|Open-label Titration Period|Adverse Event|0|||
131699952|NCT01789970|474184988|FG002|Open-label Titration Period|Adverse Event|0|||
131699953|NCT01789970|474184986|FG000|Open-label Titration Period|Lack of Efficacy|31|||
131699954|NCT01789970|474184987|FG001|Open-label Titration Period|Lack of Efficacy|0|||
131699955|NCT01789970|474184988|FG002|Open-label Titration Period|Lack of Efficacy|0|||
131699956|NCT01789970|474184986|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
131699957|NCT01789970|474184987|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
131699958|NCT01789970|474184988|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
131699959|NCT01789970|474184986|FG000|Open-label Titration Period|Protocol Violation|18|||
131699960|NCT01789970|474184987|FG001|Open-label Titration Period|Protocol Violation|0|||
131699961|NCT01789970|474184988|FG002|Open-label Titration Period|Protocol Violation|0|||
131699962|NCT01789970|474184986|FG000|Open-label Titration Period|Lost to Follow-up|5|||
131699963|NCT01789970|474184987|FG001|Open-label Titration Period|Lost to Follow-up|0|||
131699964|NCT01789970|474184988|FG002|Open-label Titration Period|Lost to Follow-up|0|||
131699965|NCT01789970|474184986|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
131438076|NCT02163902|473229498|FG001|Overall Study|Lost to Follow-up|7|||
131699966|NCT01789970|474184987|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
131577149|NCT02104765|473739202|FG006|Overall Study|Lost to Follow-up|0|||
131577150|NCT02104765|473739196|FG000|Overall Study|Withdrawal by Subject|0|||
131577151|NCT02104765|473739197|FG001|Overall Study|Withdrawal by Subject|0|||
131577152|NCT02104765|473739198|FG002|Overall Study|Withdrawal by Subject|0|||
131577153|NCT02104765|473739199|FG003|Overall Study|Withdrawal by Subject|1|||
131577154|NCT02104765|473739200|FG004|Overall Study|Withdrawal by Subject|1|||
131577155|NCT02104765|473739201|FG005|Overall Study|Withdrawal by Subject|0|||
131577156|NCT02104765|473739202|FG006|Overall Study|Withdrawal by Subject|1|||
131577157|NCT00995709|473739207|FG000|Overall Study|Adverse Event|4|||
131577158|NCT00995709|473739208|FG001|Overall Study|Adverse Event|2|||
131577159|NCT00995709|473739209|FG002|Overall Study|Adverse Event|0|||
131577160|NCT00995709|473739207|FG000|Overall Study|Lack of Efficacy|0|||
131577161|NCT00995709|473739208|FG001|Overall Study|Lack of Efficacy|1|||
131577162|NCT00995709|473739209|FG002|Overall Study|Lack of Efficacy|4|||
131577163|NCT00995709|473739207|FG000|Overall Study|Withdrawal by Subject|0|||
131577164|NCT00995709|473739208|FG001|Overall Study|Withdrawal by Subject|4|||
131577165|NCT00995709|473739209|FG002|Overall Study|Withdrawal by Subject|1|||
131577166|NCT00995709|473739207|FG000|Overall Study|Lost to Follow-up|1|||
131577167|NCT00995709|473739208|FG001|Overall Study|Lost to Follow-up|0|||
131577168|NCT00995709|473739209|FG002|Overall Study|Lost to Follow-up|0|||
131577169|NCT00995709|473739207|FG000|Overall Study|Death|0|||
131577170|NCT00995709|473739208|FG001|Overall Study|Death|1|||
131577171|NCT00995709|473739209|FG002|Overall Study|Death|0|||
131577172|NCT00995709|473739207|FG000|Overall Study|Protocol Violation|2|||
131577173|NCT00995709|473739208|FG001|Overall Study|Protocol Violation|1|||
131577174|NCT00995709|473739209|FG002|Overall Study|Protocol Violation|0|||
131577175|NCT01697319|473739210|FG000|Primary Phase|Withdrawal by Subject|1|||
131577176|NCT01697319|473739210|FG000|Extension Phase|Terminated by Sponsor|15|||
131577177|NCT04222959|473739211|FG000|Overall Study|Lost to Follow-up|76|||
131577178|NCT04222959|473739212|FG001|Overall Study|Lost to Follow-up|28|||
131577179|NCT03008915|473739213|FG000|Treatment 1|Withdrawal by Subject|0|||
131577180|NCT03008915|473739214|FG001|Treatment 1|Withdrawal by Subject|1|||
131577181|NCT03386929|473739217|FG000|Overall Study|Death|0|||
131577182|NCT03386929|473739218|FG001|Overall Study|Death|0|||
131577183|NCT03386929|473739219|FG002|Overall Study|Death|1|||
131577184|NCT03386929|473739217|FG000|Overall Study|Withdrawal by Subject|0|||
131577185|NCT03386929|473739218|FG001|Overall Study|Withdrawal by Subject|1|||
131577186|NCT03386929|473739219|FG002|Overall Study|Withdrawal by Subject|0|||
131577187|NCT03386929|473739217|FG000|Overall Study|Physician Decision|0|||
131577188|NCT03386929|473739218|FG001|Overall Study|Physician Decision|0|||
131577189|NCT03386929|473739219|FG002|Overall Study|Physician Decision|1|||
131577190|NCT03386929|473739217|FG000|Overall Study|Progression|4|||
131577191|NCT03386929|473739218|FG001|Overall Study|Progression|4|||
131577192|NCT03386929|473739219|FG002|Overall Study|Progression|0|||
131577193|NCT03386929|473739217|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
131577194|NCT03386929|473739218|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
131577195|NCT03386929|473739219|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
131577196|NCT03386929|473739217|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
131577197|NCT03386929|473739218|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
131577198|NCT03386929|473739219|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
131577199|NCT00038103|473739220|FG000|Overall Study|Adverse Event|5|||
131785804|NCT03674827|474498856|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
131785805|NCT03674827|474498857|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
131785806|NCT03674827|474498858|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
131785807|NCT03674827|474498859|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
131785808|NCT03674827|474498860|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
131785809|NCT03674827|474498855|FG000|Treatment Phase|Other|0|||
131785810|NCT03674827|474498856|FG001|Treatment Phase|Other|1|||
131785811|NCT03674827|474498857|FG002|Treatment Phase|Other|0|||
131898689|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
131577200|NCT00038103|473739221|FG001|Overall Study|Adverse Event|6|||
131577201|NCT00038103|473739220|FG000|Overall Study|Lack of Efficacy|48|||
131577202|NCT00038103|473739221|FG001|Overall Study|Lack of Efficacy|41|||
131577203|NCT00038103|473739220|FG000|Overall Study|Withdrawal by Subject|0|||
131577204|NCT00038103|473739221|FG001|Overall Study|Withdrawal by Subject|3|||
131577205|NCT00038103|473739220|FG000|Overall Study|Lost to Follow-up|0|||
131577206|NCT00038103|473739221|FG001|Overall Study|Lost to Follow-up|3|||
131577207|NCT00038103|473739220|FG000|Overall Study|Protocol Violation|0|||
131577208|NCT00038103|473739221|FG001|Overall Study|Protocol Violation|2|||
131577209|NCT00038103|473739220|FG000|Overall Study|Sponsor Decision|0|||
131577210|NCT00038103|473739221|FG001|Overall Study|Sponsor Decision|1|||
131577211|NCT00038103|473739220|FG000|Overall Study|Randomized/never treated|2|||
131577212|NCT00038103|473739221|FG001|Overall Study|Randomized/never treated|0|||
131577213|NCT03538054|473739224|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
131577214|NCT03538054|473739224|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
131577215|NCT03538054|473739224|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
131577216|NCT03545984|473739231|FG000|Overall Study|CSF cases not present during rotation|11|||
131577217|NCT03545984|473739232|FG001|Overall Study|CSF cases not present during rotation|9|||
131577218|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
131577219|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
131577220|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
131785812|NCT03674827|474498858|FG003|Treatment Phase|Other|0|||
131785813|NCT03674827|474498859|FG004|Treatment Phase|Other|0|||
131785814|NCT03674827|474498860|FG005|Treatment Phase|Other|1|||
131785815|NCT03674827|474498855|FG000|Long-Term Follow-up Phase|Death|2|||
131785816|NCT03674827|474498856|FG001|Long-Term Follow-up Phase|Death|4|||
131785817|NCT03674827|474498857|FG002|Long-Term Follow-up Phase|Death|2|||
131785818|NCT03674827|474498858|FG003|Long-Term Follow-up Phase|Death|3|||
131785819|NCT03674827|474498859|FG004|Long-Term Follow-up Phase|Death|2|||
131785820|NCT03674827|474498860|FG005|Long-Term Follow-up Phase|Death|6|||
131785821|NCT03674827|474498855|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
131785822|NCT03674827|474498856|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
131785823|NCT03674827|474498857|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
131785824|NCT03674827|474498858|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
131785825|NCT03674827|474498859|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
131785826|NCT03674827|474498860|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
131785827|NCT03674827|474498855|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
131785828|NCT03674827|474498856|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
131785829|NCT03674827|474498857|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
131785830|NCT03674827|474498858|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
131785831|NCT03674827|474498859|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
131785832|NCT03674827|474498860|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
131785833|NCT00527397|474498861|FG000|Overall Study|Adverse Event|3|||
131785834|NCT00527397|474498861|FG000|Overall Study|Lack of Efficacy|1|||
131785835|NCT00527397|474498861|FG000|Overall Study|Protocol Violation|1|||
131785836|NCT00527397|474498861|FG000|Overall Study|Withdrawal by Subject|6|||
131785837|NCT00527397|474498861|FG000|Overall Study|Study terminated by sponsor|13|||
131785838|NCT04130919|474498864|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
131785839|NCT04130919|474498865|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
131785840|NCT04130919|474498866|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
131785841|NCT04130919|474498867|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
131785842|NCT04130919|474498868|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
131785843|NCT04130919|474498869|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
131785844|NCT04130919|474498864|FG000|Blinded Treatment Phase|Adverse Event|0|||
131785845|NCT04130919|474498865|FG001|Blinded Treatment Phase|Adverse Event|0|||
131785846|NCT04130919|474498866|FG002|Blinded Treatment Phase|Adverse Event|1|||
131785847|NCT04130919|474498867|FG003|Blinded Treatment Phase|Adverse Event|0|||
131785848|NCT04130919|474498868|FG004|Blinded Treatment Phase|Adverse Event|0|||
131785849|NCT04130919|474498869|FG005|Blinded Treatment Phase|Adverse Event|0|||
131785850|NCT04130919|474498864|FG000|Blinded Treatment Phase|Disease worsening|0|||
131785851|NCT04130919|474498865|FG001|Blinded Treatment Phase|Disease worsening|0|||
131785852|NCT04130919|474498866|FG002|Blinded Treatment Phase|Disease worsening|1|||
131785853|NCT04130919|474498867|FG003|Blinded Treatment Phase|Disease worsening|0|||
131785854|NCT04130919|474498868|FG004|Blinded Treatment Phase|Disease worsening|0|||
131785855|NCT04130919|474498869|FG005|Blinded Treatment Phase|Disease worsening|0|||
131785856|NCT04130919|474498864|FG000|Blinded Treatment Phase|Investigator's decision|0|||
131785857|NCT04130919|474498865|FG001|Blinded Treatment Phase|Investigator's decision|1|||
131785858|NCT04130919|474498866|FG002|Blinded Treatment Phase|Investigator's decision|0|||
131785859|NCT04130919|474498867|FG003|Blinded Treatment Phase|Investigator's decision|0|||
131785860|NCT04130919|474498868|FG004|Blinded Treatment Phase|Investigator's decision|0|||
131785861|NCT04130919|474498869|FG005|Blinded Treatment Phase|Investigator's decision|0|||
131785862|NCT04130919|474498864|FG000|Blinded Treatment Phase|Withdrew consent|1|||
131785863|NCT04130919|474498865|FG001|Blinded Treatment Phase|Withdrew consent|0|||
131785864|NCT04130919|474498866|FG002|Blinded Treatment Phase|Withdrew consent|0|||
131577221|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131785865|NCT04130919|474498867|FG003|Blinded Treatment Phase|Withdrew consent|0|||
131785866|NCT04130919|474498868|FG004|Blinded Treatment Phase|Withdrew consent|0|||
131785867|NCT04130919|474498869|FG005|Blinded Treatment Phase|Withdrew consent|0|||
131785868|NCT04130919|474498864|FG000|Open-label Treatment Phase|Withdrew consent|0|||
131785869|NCT04130919|474498865|FG001|Open-label Treatment Phase|Withdrew consent|0|||
131785870|NCT04130919|474498866|FG002|Open-label Treatment Phase|Withdrew consent|0|||
131785871|NCT04130919|474498867|FG003|Open-label Treatment Phase|Withdrew consent|1|||
131785872|NCT04130919|474498868|FG004|Open-label Treatment Phase|Withdrew consent|1|||
131785873|NCT04130919|474498869|FG005|Open-label Treatment Phase|Withdrew consent|1|||
131785874|NCT04130919|474498864|FG000|Open-label Treatment Phase|Disease worsening|0|||
131785875|NCT04130919|474498865|FG001|Open-label Treatment Phase|Disease worsening|0|||
131785876|NCT04130919|474498866|FG002|Open-label Treatment Phase|Disease worsening|0|||
131785877|NCT04130919|474498867|FG003|Open-label Treatment Phase|Disease worsening|1|||
131785878|NCT04130919|474498868|FG004|Open-label Treatment Phase|Disease worsening|0|||
131785879|NCT04130919|474498869|FG005|Open-label Treatment Phase|Disease worsening|1|||
131785880|NCT04130919|474498864|FG000|Open-label Treatment Phase|Investigator's decision|0|||
131785881|NCT04130919|474498865|FG001|Open-label Treatment Phase|Investigator's decision|0|||
131785882|NCT04130919|474498866|FG002|Open-label Treatment Phase|Investigator's decision|0|||
131577222|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131577223|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131577224|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131577225|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131577226|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131577227|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
131577228|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
131577229|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
131785883|NCT04130919|474498867|FG003|Open-label Treatment Phase|Investigator's decision|1|||
131785884|NCT04130919|474498868|FG004|Open-label Treatment Phase|Investigator's decision|0|||
131785885|NCT04130919|474498869|FG005|Open-label Treatment Phase|Investigator's decision|0|||
131785886|NCT04130919|474498864|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
131785887|NCT04130919|474498865|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
131785888|NCT04130919|474498866|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
131785889|NCT04130919|474498867|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
131785890|NCT04130919|474498868|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
131785891|NCT04130919|474498869|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
131785892|NCT04130919|474498864|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131785893|NCT04130919|474498865|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131785894|NCT04130919|474498866|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131785895|NCT04130919|474498867|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131785896|NCT04130919|474498868|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
131785897|NCT04130919|474498869|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131785898|NCT02624518|474498873|FG000|Overall Study|Physician Decision|1|||
131785899|NCT00370396|474498876|FG000|Overall Study|Withdrawal by Subject|0|||
131785900|NCT00370396|474498877|FG001|Overall Study|Withdrawal by Subject|0|||
131785901|NCT00370396|474498878|FG002|Overall Study|Withdrawal by Subject|1|||
131785902|NCT00370396|474498876|FG000|Overall Study|Lost to Follow-up|11|||
131785903|NCT00370396|474498877|FG001|Overall Study|Lost to Follow-up|1|||
131785904|NCT00370396|474498878|FG002|Overall Study|Lost to Follow-up|0|||
131785905|NCT01462695|474498879|FG000|Overall Study|Adverse Event|1|||
131785906|NCT01462695|474498880|FG001|Overall Study|Adverse Event|1|||
131785907|NCT01462695|474498879|FG000|Overall Study|Death|2|||
131785908|NCT01462695|474498880|FG001|Overall Study|Death|0|||
131785909|NCT01462695|474498879|FG000|Overall Study|Lack of Efficacy|6|||
131785910|NCT01462695|474498880|FG001|Overall Study|Lack of Efficacy|12|||
131785911|NCT01462695|474498879|FG000|Overall Study|Physician Decision|5|||
131785912|NCT01462695|474498880|FG001|Overall Study|Physician Decision|0|||
131785913|NCT01462695|474498879|FG000|Overall Study|Withdrawal by Subject|2|||
131785914|NCT01462695|474498880|FG001|Overall Study|Withdrawal by Subject|0|||
131785915|NCT01462695|474498879|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
131785916|NCT01462695|474498880|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
131785917|NCT02400905|474498881|FG000|Overall Study|Death|24|||
131785918|NCT02400905|474498881|FG000|Overall Study|Lost to Follow-up|18|||
131785919|NCT02400905|474498881|FG000|Overall Study|Withdrawal by Subject|16|||
131785920|NCT02400905|474498881|FG000|Overall Study|Physician Decision|4|||
131785921|NCT02400905|474498881|FG000|Overall Study|Other|1|||
131785922|NCT01835470|474500421|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
131785923|NCT01835470|474500421|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
131785924|NCT01272193|474500422|FG000|Overall Study|Adverse Event|1|||
131785925|NCT01272193|474500423|FG001|Overall Study|Adverse Event|1|||
131577230|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131577231|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131785926|NCT01272193|474500422|FG000|Overall Study|Lack of Efficacy|0|||
131785927|NCT01272193|474500423|FG001|Overall Study|Lack of Efficacy|3|||
131785928|NCT01272193|474500422|FG000|Overall Study|Withdrawal Criteria|1|||
131785929|NCT01272193|474500423|FG001|Overall Study|Withdrawal Criteria|1|||
131438077|NCT02163902|473229497|FG000|Overall Study|Administrative Decision|2|||
131438078|NCT02163902|473229498|FG001|Overall Study|Administrative Decision|2|||
131438079|NCT02174731|473229499|FG000|Overall Study|Participant decision|67|||
131438080|NCT02174731|473229500|FG001|Overall Study|Participant decision|64|||
131438081|NCT02174731|473229499|FG000|Overall Study|Incorrect enrolment before randomization|0|||
131438082|NCT02174731|473229500|FG001|Overall Study|Incorrect enrolment before randomization|1|||
131577232|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131438083|NCT02174731|473229499|FG000|Overall Study|Missing|2|||
131438084|NCT02174731|473229500|FG001|Overall Study|Missing|0|||
131438085|NCT00079040|473229501|FG000|Overall Study|Withdrew before treatment|1|||
131577233|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131438086|NCT00079040|473229501|FG000|Overall Study|Ineligible|1|||
131785930|NCT01272193|474500422|FG000|Overall Study|Unclassified|8|||
131785931|NCT01272193|474500423|FG001|Overall Study|Unclassified|7|||
131785932|NCT01440647|474500428|FG000|Overall Study|Death|2|||
131785933|NCT01440647|474500429|FG001|Overall Study|Death|3|||
131785934|NCT04335110|474500458|FG000|Overall Study|Withdrawal by Subject|1|||
131785935|NCT04335110|474500459|FG001|Overall Study|Withdrawal by Subject|1|||
131785936|NCT04335110|474500458|FG000|Overall Study|Death|0|||
131785937|NCT04335110|474500459|FG001|Overall Study|Death|1|||
131785938|NCT00350519|474500460|FG000|Overall Study|Death|0|||
131785939|NCT00350519|474500461|FG001|Overall Study|Death|1|||
131785940|NCT00350519|474500460|FG000|Overall Study|Physician Decision|0|||
131785941|NCT00350519|474500461|FG001|Overall Study|Physician Decision|1|||
131785942|NCT00350519|474500460|FG000|Overall Study|Protocol Violation|1|||
131785943|NCT00350519|474500461|FG001|Overall Study|Protocol Violation|2|||
131785944|NCT00350519|474500460|FG000|Overall Study|Withdrawal by Subject|3|||
131785945|NCT00350519|474500461|FG001|Overall Study|Withdrawal by Subject|2|||
131785946|NCT00096382|474500462|FG000|Overall Study|Not treated|1|||
131785947|NCT00096382|474500463|FG001|Overall Study|Not treated|0|||
131785948|NCT00096382|474500462|FG000|Overall Study|Death during treatment|1|||
131785949|NCT00096382|474500463|FG001|Overall Study|Death during treatment|0|||
131785950|NCT01270841|474500467|FG000|Overall Study|Adverse Event|0|||
131785951|NCT01270841|474500468|FG001|Overall Study|Adverse Event|1|||
131785952|NCT01270841|474500469|FG002|Overall Study|Adverse Event|0|||
131785953|NCT01270841|474500470|FG003|Overall Study|Adverse Event|3|||
131785954|NCT01270841|474500467|FG000|Overall Study|Withdrawal by Subject|3|||
131785955|NCT01270841|474500468|FG001|Overall Study|Withdrawal by Subject|2|||
131785956|NCT01270841|474500469|FG002|Overall Study|Withdrawal by Subject|3|||
131785957|NCT01270841|474500470|FG003|Overall Study|Withdrawal by Subject|3|||
131785958|NCT01270841|474500467|FG000|Overall Study|Lost to Follow-up|3|||
131785959|NCT01270841|474500468|FG001|Overall Study|Lost to Follow-up|1|||
131785960|NCT01270841|474500469|FG002|Overall Study|Lost to Follow-up|4|||
131785961|NCT01270841|474500470|FG003|Overall Study|Lost to Follow-up|2|||
131785962|NCT01270841|474500467|FG000|Overall Study|Physician Decision|0|||
131785963|NCT01270841|474500468|FG001|Overall Study|Physician Decision|1|||
131785964|NCT01270841|474500469|FG002|Overall Study|Physician Decision|0|||
131785965|NCT01270841|474500470|FG003|Overall Study|Physician Decision|0|||
131785966|NCT01270841|474500467|FG000|Overall Study|Did not qualify|6|||
131785967|NCT01270841|474500468|FG001|Overall Study|Did not qualify|3|||
131785968|NCT01270841|474500469|FG002|Overall Study|Did not qualify|4|||
131785969|NCT01270841|474500470|FG003|Overall Study|Did not qualify|5|||
131785970|NCT01270841|474500467|FG000|Overall Study|Protocol Violation|1|||
131785971|NCT01270841|474500468|FG001|Overall Study|Protocol Violation|5|||
131785972|NCT01270841|474500469|FG002|Overall Study|Protocol Violation|0|||
131785973|NCT01270841|474500470|FG003|Overall Study|Protocol Violation|0|||
131785974|NCT01270841|474500467|FG000|Overall Study|Enrolled in error|0|||
131785975|NCT01270841|474500468|FG001|Overall Study|Enrolled in error|1|||
131785976|NCT01270841|474500469|FG002|Overall Study|Enrolled in error|0|||
131785977|NCT01270841|474500470|FG003|Overall Study|Enrolled in error|0|||
131785978|NCT02082912|474500471|FG000|Overall Study|Physician Decision|0|||
131785979|NCT02082912|474500472|FG001|Overall Study|Physician Decision|1|||
131785980|NCT00856778|474500485|FG000|Overall Study|Adverse Event|7|||
131785981|NCT00856778|474500485|FG000|Overall Study|Withdrawal by Subject|10|||
131785982|NCT00856778|474500485|FG000|Overall Study|Study deviation|2|||
131785983|NCT00856778|474500485|FG000|Overall Study|Lost to Follow-up|5|||
131785984|NCT00550420|474500487|FG000|Overall Study|Adverse Event|28|||
131785985|NCT00550420|474500487|FG000|Overall Study|Lost to Follow-up|8|||
131785986|NCT00550420|474500487|FG000|Overall Study|Protocol Violation|11|||
131785987|NCT00550420|474500487|FG000|Overall Study|Withdrawal by Subject|30|||
131785988|NCT00550420|474500487|FG000|Overall Study|Still in study at termination|206|||
131785989|NCT00550420|474500487|FG000|Overall Study|Missing|2|||
131785990|NCT00550420|474500487|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
131785991|NCT00550420|474500487|FG000|Overall Study|Investigators opinion|1|||
131785992|NCT00550420|474500487|FG000|Overall Study|Lack of curative effect|1|||
131785993|NCT00550420|474500487|FG000|Overall Study|Unethical stop of enrollment|2|||
131785994|NCT00550420|474500487|FG000|Overall Study|Caregiver's decision to withdraw|1|||
131785995|NCT00550420|474500487|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
131785996|NCT00550420|474500487|FG000|Overall Study|Exclusion criteria|1|||
131785997|NCT00550420|474500487|FG000|Overall Study|Prohibited medicine|1|||
131785998|NCT02773446|474500491|FG000|First Admission|Withdrawal by Subject|0|||
131785999|NCT02773446|474500492|FG001|First Admission|Withdrawal by Subject|0|||
131786000|NCT02773446|474500493|FG002|First Admission|Withdrawal by Subject|0|||
131786001|NCT02773446|474500494|FG003|First Admission|Withdrawal by Subject|1|||
131786002|NCT02773446|474500495|FG004|First Admission|Withdrawal by Subject|0|||
131786003|NCT02773446|474500496|FG005|First Admission|Withdrawal by Subject|0|||
131786004|NCT02773446|474500491|FG000|First Admission|Lost to Follow-up|1|||
131786005|NCT02773446|474500492|FG001|First Admission|Lost to Follow-up|0|||
131786006|NCT02773446|474500493|FG002|First Admission|Lost to Follow-up|0|||
131786007|NCT02773446|474500494|FG003|First Admission|Lost to Follow-up|0|||
131786008|NCT02773446|474500495|FG004|First Admission|Lost to Follow-up|0|||
131577234|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131577235|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131577236|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
131577237|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
131577238|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
131577239|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131577240|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131577241|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131577242|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131577243|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131577244|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131577245|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
131577246|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131577247|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
131577248|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131577249|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131577250|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131577251|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131699967|NCT01789970|474184988|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
131699968|NCT01789970|474184986|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
131699969|NCT01789970|474184987|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
131699970|NCT01789970|474184988|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
131699971|NCT01789970|474184986|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
131699972|NCT01789970|474184987|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
131699973|NCT01789970|474184988|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
131699974|NCT01789970|474184986|FG000|Open-label Titration Period|Pregnancy|2|||
131699975|NCT01789970|474184987|FG001|Open-label Titration Period|Pregnancy|0|||
131699976|NCT01789970|474184988|FG002|Open-label Titration Period|Pregnancy|0|||
131699977|NCT01789970|474184986|FG000|Open-label Titration Period|Other|76|||
131699978|NCT01789970|474184987|FG001|Open-label Titration Period|Other|0|||
131699979|NCT01789970|474184988|FG002|Open-label Titration Period|Other|0|||
131699980|NCT01789970|474184986|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
131699981|NCT01789970|474184987|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
131699982|NCT01789970|474184988|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
131699983|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
131699984|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
131699985|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
131786009|NCT02773446|474500496|FG005|First Admission|Lost to Follow-up|0|||
131577252|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131577253|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131577254|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131577255|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131577256|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
131577257|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131577258|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131577259|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131577260|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131577261|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131577262|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131577263|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577264|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131577265|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131577266|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577267|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577268|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577269|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577270|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577271|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131577272|NCT01212757|473739234|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
131577273|NCT01212757|473739235|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
131577274|NCT01212757|473739236|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577275|NCT01212757|473739237|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577276|NCT01212757|473739238|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577277|NCT01212757|473739239|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577278|NCT01212757|473739240|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577279|NCT01212757|473739241|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577280|NCT01212757|473739242|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131577281|NCT01212757|473739234|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131577282|NCT01212757|473739235|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
131577283|NCT01212757|473739236|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
131577284|NCT01212757|473739237|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
131577285|NCT01212757|473739238|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131577286|NCT01212757|473739239|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
131577287|NCT01212757|473739240|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131577288|NCT01212757|473739241|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131577289|NCT01212757|473739242|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131577290|NCT01212757|473739234|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131577291|NCT01212757|473739235|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
131577292|NCT01212757|473739236|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
131577293|NCT01212757|473739237|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
131577294|NCT01212757|473739238|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131577295|NCT01212757|473739239|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
131577296|NCT01212757|473739240|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131577297|NCT01212757|473739241|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131577298|NCT01212757|473739242|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131577299|NCT01212757|473739234|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577300|NCT01212757|473739235|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577301|NCT01212757|473739236|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
131577302|NCT01212757|473739237|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577303|NCT01212757|473739238|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577304|NCT01212757|473739239|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577305|NCT01212757|473739240|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577306|NCT01212757|473739241|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577307|NCT01212757|473739242|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131577308|NCT01212757|473739234|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131577309|NCT01212757|473739235|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
131577310|NCT01212757|473739236|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
131577311|NCT01212757|473739237|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
131577312|NCT01212757|473739238|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
131577313|NCT01212757|473739239|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
131577314|NCT01212757|473739240|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131577315|NCT01212757|473739241|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131577316|NCT01212757|473739242|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131577317|NCT01212757|473739234|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577318|NCT01212757|473739235|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
131577319|NCT01212757|473739236|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577320|NCT01212757|473739237|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577321|NCT01212757|473739238|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
131699986|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131699987|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
131699988|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
131699989|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131699990|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
131699991|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
131699992|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
131699993|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
131699994|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
131699995|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
131719508|NCT00883753|474253338|FG000|Overall Study|Violation of selection criteria at entry|7|||
131719509|NCT00883753|474253338|FG000|Overall Study|Protocol Violation|2|||
131719510|NCT00883753|474253338|FG000|Overall Study|Refused treatment|4|||
131719511|NCT00883753|474253338|FG000|Overall Study|Withdrew consent|10|||
131719512|NCT00883753|474253338|FG000|Overall Study|Investigator's decision|17|||
131577322|NCT01212757|473739239|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577323|NCT01212757|473739240|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577324|NCT01212757|473739241|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577325|NCT01212757|473739242|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131577326|NCT01212757|473739234|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577327|NCT01212757|473739235|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
131577328|NCT01212757|473739236|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
131577329|NCT01212757|473739237|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577330|NCT01212757|473739238|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577331|NCT01212757|473739239|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577332|NCT01212757|473739240|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577333|NCT01212757|473739241|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577334|NCT01212757|473739242|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131577335|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577336|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577337|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577338|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577339|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577340|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577341|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577342|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131577343|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
131577344|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131577345|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
131577346|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
131577347|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131577348|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131577349|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131577350|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131577351|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
131577352|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
131577353|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131577354|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
131577355|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
131577356|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131577357|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131577358|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131577359|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131577360|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
131577361|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131577362|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131577363|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
131577364|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
131577365|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131577366|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131577367|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131577368|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131577369|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
131577370|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
131577371|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577372|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577373|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
131577374|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577375|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577376|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577377|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577378|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577379|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131577380|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131577381|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
131577382|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
131577383|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131577384|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131577385|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131577386|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131577387|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
131577388|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131577389|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131577390|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
131577391|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
131577392|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131786010|NCT04378010|474500497|FG000|Overall Study|Adverse Event|8|||
131786011|NCT04378010|474500498|FG001|Overall Study|Adverse Event|14|||
131786012|NCT04378010|474500499|FG002|Overall Study|Adverse Event|4|||
131786013|NCT04378010|474500497|FG000|Overall Study|Withdrawal by Subject|0|||
131786014|NCT04378010|474500498|FG001|Overall Study|Withdrawal by Subject|2|||
131786015|NCT04378010|474500499|FG002|Overall Study|Withdrawal by Subject|1|||
131786016|NCT04378010|474500497|FG000|Overall Study|Protocol Violation|2|||
131786017|NCT04378010|474500498|FG001|Overall Study|Protocol Violation|1|||
131786018|NCT04378010|474500499|FG002|Overall Study|Protocol Violation|4|||
131786019|NCT04378010|474500497|FG000|Overall Study|Study terminated by Sponsor|22|||
131786020|NCT04378010|474500498|FG001|Overall Study|Study terminated by Sponsor|16|||
131786021|NCT04378010|474500499|FG002|Overall Study|Study terminated by Sponsor|22|||
131577393|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131786022|NCT04378010|474500497|FG000|Overall Study|Subject inability to complete study visit|0|||
131786023|NCT04378010|474500498|FG001|Overall Study|Subject inability to complete study visit|0|||
131786024|NCT04378010|474500499|FG002|Overall Study|Subject inability to complete study visit|1|||
131786025|NCT04378010|474500497|FG000|Overall Study|Subject never dosed|0|||
131786026|NCT04378010|474500498|FG001|Overall Study|Subject never dosed|1|||
131786027|NCT04378010|474500499|FG002|Overall Study|Subject never dosed|0|||
131786028|NCT02513459|474500500|FG000|Overall Study|Adverse Event|7|||
131786029|NCT02513459|474500500|FG000|Overall Study|Withdrew consent|5|||
131786030|NCT02513459|474500500|FG000|Overall Study|Loss of efficacy|2|||
131786031|NCT02513459|474500500|FG000|Overall Study|Pregnancy|2|||
131786032|NCT02513459|474500500|FG000|Overall Study|Subject decision|2|||
131786033|NCT02513459|474500500|FG000|Overall Study|Lack of response|1|||
131786034|NCT02513459|474500500|FG000|Overall Study|Reproductive plans|1|||
131786035|NCT02513459|474500500|FG000|Overall Study|Surgery planned-- not done|1|||
131786036|NCT03237611|474500501|FG000|Overall Study|Withdrawal by Subject|1|||
131786037|NCT03237611|474500501|FG000|Overall Study|Ineligible|1|||
131786038|NCT04023994|474500502|FG000|Overall Study|Lost to Follow-up|0|||
131786039|NCT04023994|474500503|FG001|Overall Study|Lost to Follow-up|1|||
131786040|NCT04023994|474500504|FG002|Overall Study|Lost to Follow-up|2|||
131786041|NCT04023994|474500505|FG003|Overall Study|Lost to Follow-up|0|||
131786042|NCT04023994|474500506|FG004|Overall Study|Lost to Follow-up|0|||
131786043|NCT04023994|474500507|FG005|Overall Study|Lost to Follow-up|0|||
131786044|NCT04023994|474500502|FG000|Overall Study|Withdrawal by Subject|0|||
131786045|NCT04023994|474500503|FG001|Overall Study|Withdrawal by Subject|0|||
131786046|NCT04023994|474500504|FG002|Overall Study|Withdrawal by Subject|0|||
131786047|NCT04023994|474500505|FG003|Overall Study|Withdrawal by Subject|1|||
131786048|NCT04023994|474500506|FG004|Overall Study|Withdrawal by Subject|0|||
131786049|NCT04023994|474500507|FG005|Overall Study|Withdrawal by Subject|0|||
131786050|NCT00923195|474500508|FG000|Overall Study|Death|0|||
131786051|NCT00923195|474500509|FG001|Overall Study|Death|1|||
131786052|NCT01613131|474500510|FG000|Overall Study|Withdrawal by Subject|3|||
131786053|NCT01613131|474500511|FG001|Overall Study|Withdrawal by Subject|5|||
131786054|NCT01814761|474500514|FG000|Overall Study|Other Reasons|1|||
131786055|NCT01814761|474500515|FG001|Overall Study|Other Reasons|10|||
131786056|NCT01814761|474500514|FG000|Overall Study|Ocular Adverse Event|6|||
131786057|NCT01814761|474500515|FG001|Overall Study|Ocular Adverse Event|15|||
131786058|NCT01814761|474500514|FG000|Overall Study|Lost to Follow-up|1|||
131786059|NCT01814761|474500515|FG001|Overall Study|Lost to Follow-up|5|||
131786060|NCT03876873|474500516|FG000|Overall Study|Physician Decision|0|||
131786061|NCT03876873|474500517|FG001|Overall Study|Physician Decision|1|||
131577394|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131786062|NCT01333475|474500519|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
131786063|NCT01333475|474500520|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
131786064|NCT01333475|474500519|FG000|Overall Study|Toxicity|1|||
131786065|NCT01333475|474500520|FG001|Overall Study|Toxicity|3|||
131786066|NCT01169987|474500521|FG000|Overall Study|Withdrawal by Subject|3|||
131786067|NCT01169987|474500521|FG000|Overall Study|Lost to Follow-up|24|||
131786068|NCT01169987|474500521|FG000|Overall Study|Other|4|||
131786069|NCT01896700|474500522|FG000|Overall Study|Adverse Event|4|||
131577395|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131577396|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
131786070|NCT01896700|474500523|FG001|Overall Study|Adverse Event|5|||
131786071|NCT01896700|474500522|FG000|Overall Study|Withdrawal by Subject|0|||
131786072|NCT01896700|474500523|FG001|Overall Study|Withdrawal by Subject|1|||
131786073|NCT00423488|474500526|FG000|Overall Study|No evidence of study drug intake|2|||
131786074|NCT00423488|474500527|FG001|Overall Study|No evidence of study drug intake|1|||
131786075|NCT00423488|474500526|FG000|Overall Study|No post baseline data|3|||
131786076|NCT00423488|474500527|FG001|Overall Study|No post baseline data|0|||
131786077|NCT00886782|474500528|FG000|Overall Study|Disease progression|3|||
131786078|NCT00886782|474500529|FG001|Overall Study|Disease progression|3|||
131786079|NCT00886782|474500530|FG002|Overall Study|Disease progression|3|||
131786080|NCT00886782|474500528|FG000|Overall Study|Study drug toxicity|0|||
131786081|NCT00886782|474500529|FG001|Overall Study|Study drug toxicity|0|||
131786082|NCT00886782|474500530|FG002|Overall Study|Study drug toxicity|1|||
131786083|NCT00886782|474500528|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
131786084|NCT00886782|474500529|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
131786085|NCT00886782|474500530|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
131786086|NCT03118765|474500531|FG000|Overall Study|Withdrawal by Subject|0|||
131786087|NCT03118765|474500532|FG001|Overall Study|Withdrawal by Subject|0|||
131786088|NCT03118765|474500533|FG002|Overall Study|Withdrawal by Subject|1|||
131786089|NCT03118765|474500534|FG003|Overall Study|Withdrawal by Subject|0|||
131786090|NCT03118765|474500535|FG004|Overall Study|Withdrawal by Subject|0|||
131786091|NCT03118765|474500531|FG000|Overall Study|Adverse Event|1|||
131577397|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
131577398|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577399|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577400|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
131699996|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
131699997|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
131699998|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
131699999|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
131700000|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
131700001|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131700002|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131700003|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
131700004|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
131700005|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
131700006|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
131700007|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
131700008|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
131700009|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
131700010|NCT01789970|474184986|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
131700011|NCT01789970|474184987|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
131700012|NCT01789970|474184988|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
131700013|NCT01121393|474184989|FG000|Overall Study|Progressive disease|201|||
131700014|NCT01121393|474184990|FG001|Overall Study|Progressive disease|20|||
131700015|NCT01121393|474184989|FG000|Overall Study|Other Adverse events|24|||
131700016|NCT01121393|474184990|FG001|Overall Study|Other Adverse events|45|||
131700017|NCT01121393|474184989|FG000|Overall Study|Non-compliant with protocol|0|||
131700018|NCT01121393|474184990|FG001|Overall Study|Non-compliant with protocol|3|||
131700019|NCT01121393|474184989|FG000|Overall Study|Lost to Follow-up|1|||
131700020|NCT01121393|474184990|FG001|Overall Study|Lost to Follow-up|0|||
131700021|NCT01121393|474184989|FG000|Overall Study|Refused cont. medication|7|||
131700022|NCT01121393|474184990|FG001|Overall Study|Refused cont. medication|7|||
131700023|NCT01121393|474184989|FG000|Overall Study|Not treated|3|||
131700024|NCT01121393|474184990|FG001|Overall Study|Not treated|9|||
131700025|NCT01121393|474184989|FG000|Overall Study|Other than listed|6|||
131700026|NCT01121393|474184990|FG001|Overall Study|Other than listed|0|||
131700027|NCT02161562|474184991|FG000|Overall Study|Withdrawal by Subject|5|||
131700028|NCT02161562|474184992|FG001|Overall Study|Withdrawal by Subject|8|||
131700029|NCT02161562|474184991|FG000|Overall Study|Protocol Violation|9|||
131700030|NCT02161562|474184992|FG001|Overall Study|Protocol Violation|4|||
131700031|NCT02161562|474184991|FG000|Overall Study|Pregnancy|1|||
131700032|NCT02161562|474184992|FG001|Overall Study|Pregnancy|2|||
131700033|NCT02161562|474184991|FG000|Overall Study|Lost to Follow-up|3|||
131700034|NCT02161562|474184992|FG001|Overall Study|Lost to Follow-up|1|||
131786092|NCT03118765|474500532|FG001|Overall Study|Adverse Event|1|||
131786093|NCT03118765|474500533|FG002|Overall Study|Adverse Event|1|||
131786094|NCT03118765|474500534|FG003|Overall Study|Adverse Event|1|||
131700035|NCT02161562|474184991|FG000|Overall Study|Lack of Efficacy|4|||
131700036|NCT02161562|474184992|FG001|Overall Study|Lack of Efficacy|1|||
131700037|NCT02161562|474184991|FG000|Overall Study|Adverse Event|1|||
131700038|NCT02161562|474184992|FG001|Overall Study|Adverse Event|1|||
131786095|NCT03118765|474500535|FG004|Overall Study|Adverse Event|1|||
131786096|NCT03118765|474500531|FG000|Overall Study|Non compliance with Study Procedures|0|||
131786097|NCT03118765|474500532|FG001|Overall Study|Non compliance with Study Procedures|0|||
131786098|NCT03118765|474500533|FG002|Overall Study|Non compliance with Study Procedures|0|||
131577401|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577402|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577403|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577404|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577405|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577406|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131577407|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131577408|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
131577409|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131577410|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131577411|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131577412|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131577413|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131577414|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131577415|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131577416|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577417|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577418|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577419|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577420|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577421|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577422|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577423|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131577424|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
131577425|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577426|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
131577427|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577428|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577429|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577430|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577431|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577432|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577433|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131577434|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131577435|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131577436|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
131577437|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131700039|NCT02161562|474184991|FG000|Overall Study|Participant moved back to home country|1|||
131786099|NCT03118765|474500534|FG003|Overall Study|Non compliance with Study Procedures|1|||
131786100|NCT03118765|474500535|FG004|Overall Study|Non compliance with Study Procedures|0|||
131700040|NCT02161562|474184992|FG001|Overall Study|Participant moved back to home country|0|||
131700041|NCT02161562|474184991|FG000|Overall Study|Withdrew due to being out of the country|1|||
131700042|NCT02161562|474184992|FG001|Overall Study|Withdrew due to being out of the country|0|||
131700043|NCT02161562|474184991|FG000|Overall Study|Participant moved out of province|1|||
131700044|NCT02161562|474184992|FG001|Overall Study|Participant moved out of province|0|||
131700045|NCT02475655|474184993|FG000|Overall Study|Lost to Follow-up|0|||
131700046|NCT02475655|474184994|FG001|Overall Study|Lost to Follow-up|1|||
131700047|NCT03033745|474184998|FG000|Overall Study|Protocol Violation|0|||
131700048|NCT03033745|474184999|FG001|Overall Study|Protocol Violation|0|||
131700049|NCT03033745|474185000|FG002|Overall Study|Protocol Violation|1|||
131700050|NCT03033745|474184998|FG000|Overall Study|Adverse Event|1|||
131700051|NCT03033745|474184999|FG001|Overall Study|Adverse Event|0|||
131700052|NCT03033745|474185000|FG002|Overall Study|Adverse Event|1|||
131700053|NCT03033745|474184998|FG000|Overall Study|Withdrawal by Subject|0|||
131700054|NCT03033745|474184999|FG001|Overall Study|Withdrawal by Subject|1|||
131700055|NCT03033745|474185000|FG002|Overall Study|Withdrawal by Subject|0|||
131700056|NCT00441545|474185001|FG000|First Intervention|Adverse Event|6|||
131700057|NCT00441545|474185002|FG001|First Intervention|Adverse Event|5|||
131577438|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131700058|NCT00441545|474185001|FG000|First Intervention|Protocol Violation|2|||
131700059|NCT00441545|474185002|FG001|First Intervention|Protocol Violation|2|||
131700060|NCT00441545|474185001|FG000|First Intervention|Withdrawal by Subject|3|||
131700061|NCT00441545|474185002|FG001|First Intervention|Withdrawal by Subject|3|||
131700062|NCT00441545|474185001|FG000|First Intervention|Kidney transplant|1|||
131577439|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131577440|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131577441|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131577442|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
131577443|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131577444|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
131577445|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131577446|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131577447|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131577448|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131577449|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131700063|NCT00441545|474185002|FG001|First Intervention|Kidney transplant|1|||
131700064|NCT00441545|474185001|FG000|First Intervention|Lack of Efficacy|2|||
131700065|NCT00441545|474185002|FG001|First Intervention|Lack of Efficacy|0|||
131786101|NCT03118765|474500531|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
131786102|NCT03118765|474500532|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
131577450|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131577451|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
131577452|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131577453|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
131577454|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
131577455|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131577456|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131577457|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131577458|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131577459|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
131577460|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
131577461|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131577462|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
131577463|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
131577464|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131577465|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131577466|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131577467|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131577468|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
131577469|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
131577470|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131577471|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
131577472|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
131577473|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131577474|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131577475|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131577476|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131577477|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
131577478|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
131577479|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
131577480|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
131577481|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
131700066|NCT00441545|474185001|FG000|First Intervention|Subject exceeded safety criteria|0|||
131700067|NCT00441545|474185002|FG001|First Intervention|Subject exceeded safety criteria|1|||
131700068|NCT00441545|474185001|FG000|First Intervention|Subject met an exclusionary criteria|1|||
131700069|NCT00441545|474185002|FG001|First Intervention|Subject met an exclusionary criteria|0|||
131700070|NCT00441545|474185001|FG000|First Intervention|Extended hospitalization|1|||
131700071|NCT00441545|474185002|FG001|First Intervention|Extended hospitalization|0|||
131700072|NCT00441545|474185001|FG000|First Intervention|Site error|1|||
131700073|NCT00441545|474185002|FG001|First Intervention|Site error|0|||
131700074|NCT00441545|474185001|FG000|First Intervention|Sponsor's request|1|||
131700075|NCT00441545|474185002|FG001|First Intervention|Sponsor's request|0|||
131700076|NCT00441545|474185001|FG000|Second Intervention|Adverse Event|5|||
131700077|NCT00441545|474185002|FG001|Second Intervention|Adverse Event|2|||
131700078|NCT00441545|474185001|FG000|Second Intervention|Protocol Violation|4|||
131700079|NCT00441545|474185002|FG001|Second Intervention|Protocol Violation|1|||
131700080|NCT00441545|474185001|FG000|Second Intervention|Withdrawal by Subject|1|||
131700081|NCT00441545|474185002|FG001|Second Intervention|Withdrawal by Subject|1|||
131700082|NCT00441545|474185001|FG000|Second Intervention|Kidney Transplant|1|||
131700083|NCT00441545|474185002|FG001|Second Intervention|Kidney Transplant|1|||
131700084|NCT00441545|474185001|FG000|Second Intervention|Lack of Efficacy|0|||
131700085|NCT00441545|474185002|FG001|Second Intervention|Lack of Efficacy|1|||
131700086|NCT00441545|474185001|FG000|Second Intervention|Subject exceeded safety criteria|1|||
131700087|NCT00441545|474185002|FG001|Second Intervention|Subject exceeded safety criteria|0|||
131700088|NCT00441545|474185001|FG000|Second Intervention|Subject moved|0|||
131700089|NCT00441545|474185002|FG001|Second Intervention|Subject moved|1|||
131700090|NCT02347176|474185003|FG000|Overall Study|Lost to Follow-up|2|||
131700091|NCT02347176|474185004|FG001|Overall Study|Lost to Follow-up|3|||
131577482|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
131700092|NCT02347176|474185005|FG002|Overall Study|Lost to Follow-up|1|||
131700093|NCT02347176|474185006|FG003|Overall Study|Lost to Follow-up|1|||
131700094|NCT02347176|474185003|FG000|Overall Study|Withdrawal by Subject|9|||
131700095|NCT02347176|474185004|FG001|Overall Study|Withdrawal by Subject|5|||
131700096|NCT02347176|474185005|FG002|Overall Study|Withdrawal by Subject|5|||
131577483|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
131577484|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
131577485|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
131577486|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
131577487|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
131577488|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577489|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577490|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577491|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577492|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577493|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577494|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577495|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
131577496|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131577497|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131577498|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
131577499|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
131577500|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131577501|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131577502|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131577503|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131577504|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131577505|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131577506|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131577507|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
131577508|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
131577509|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131577510|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131577511|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131577512|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131577513|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
131577514|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131577515|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131577516|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
131577517|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
131577518|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131577519|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131577520|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131577521|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131577522|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
131577523|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
131577524|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577525|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
131577526|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577527|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577528|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577529|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577530|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577531|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577532|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131577533|NCT01212757|473739234|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577534|NCT01212757|473739235|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
131577535|NCT01212757|473739236|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
131577536|NCT01212757|473739237|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577537|NCT01212757|473739238|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577538|NCT01212757|473739239|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577539|NCT01212757|473739240|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577540|NCT01212757|473739241|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577541|NCT01212757|473739242|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131577542|NCT02812966|473739243|FG000|Overall Study|Death|1|||
131577543|NCT02812966|473739244|FG001|Overall Study|Death|0|||
131577544|NCT00849147|473739245|FG000|Overall Study|Withdrawal by Subject|1|||
131577545|NCT00849147|473739245|FG000|Overall Study|Protocol Violation|2|||
131577546|NCT00849147|473739245|FG000|Overall Study|Disease Relapse/Progression|2|||
131577547|NCT05147233|473741261|FG000|Overall Study|Adverse Event|0|||
131577548|NCT05147233|473741262|FG001|Overall Study|Adverse Event|1|||
131577549|NCT05147233|473741261|FG000|Overall Study|Lost to Follow-up|1|||
131786103|NCT03118765|474500533|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
131786104|NCT03118765|474500534|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
131786105|NCT03118765|474500535|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
131786106|NCT03118765|474500531|FG000|Overall Study|COPD Exacerbation|1|||
131786107|NCT03118765|474500532|FG001|Overall Study|COPD Exacerbation|0|||
131786108|NCT03118765|474500533|FG002|Overall Study|COPD Exacerbation|0|||
131786109|NCT03118765|474500534|FG003|Overall Study|COPD Exacerbation|1|||
131786110|NCT03118765|474500535|FG004|Overall Study|COPD Exacerbation|0|||
131786111|NCT03118765|474500531|FG000|Overall Study|Lost to Follow-up|1|||
131786112|NCT03118765|474500532|FG001|Overall Study|Lost to Follow-up|0|||
131786113|NCT03118765|474500533|FG002|Overall Study|Lost to Follow-up|1|||
131786114|NCT03118765|474500534|FG003|Overall Study|Lost to Follow-up|0|||
131786115|NCT03118765|474500535|FG004|Overall Study|Lost to Follow-up|0|||
131786116|NCT03118765|474500531|FG000|Overall Study|Sponsor Decision|1|||
131786117|NCT03118765|474500532|FG001|Overall Study|Sponsor Decision|0|||
131786118|NCT03118765|474500533|FG002|Overall Study|Sponsor Decision|1|||
131786119|NCT03118765|474500534|FG003|Overall Study|Sponsor Decision|0|||
131786120|NCT03118765|474500535|FG004|Overall Study|Sponsor Decision|1|||
131786121|NCT01783483|474500536|FG000|Overall Study|Death|3|||
131786122|NCT01783483|474500537|FG001|Overall Study|Death|3|||
131786123|NCT01783483|474500536|FG000|Overall Study|Lost to Follow-up|14|||
131786124|NCT01783483|474500537|FG001|Overall Study|Lost to Follow-up|10|||
131786125|NCT01783483|474500536|FG000|Overall Study|Withdrawal by Subject|2|||
131786126|NCT01783483|474500537|FG001|Overall Study|Withdrawal by Subject|1|||
131786127|NCT01783483|474500536|FG000|Overall Study|Physician Decision|1|||
131786128|NCT01783483|474500537|FG001|Overall Study|Physician Decision|1|||
131786129|NCT01749033|474500540|FG000|Overall Study|Did not receive allocated intervention|3|||
131786130|NCT01749033|474500541|FG001|Overall Study|Did not receive allocated intervention|3|||
131786131|NCT01749033|474500542|FG002|Overall Study|Did not receive allocated intervention|0|||
131786132|NCT01749033|474500540|FG000|Overall Study|Lost to Follow-up|0|||
131786133|NCT01749033|474500541|FG001|Overall Study|Lost to Follow-up|2|||
131786134|NCT01749033|474500542|FG002|Overall Study|Lost to Follow-up|1|||
131786135|NCT00068237|474500543|FG000|Overall Study|Ineligible|3|||
131786136|NCT00068237|474500543|FG000|Overall Study|No protocol treatment received|2|||
131786137|NCT01364298|474500545|FG000|Overall Study|Adverse Event|3|||
131786138|NCT01364298|474500546|FG001|Overall Study|Adverse Event|4|||
131786139|NCT01364298|474500545|FG000|Overall Study|Lack of adherence to treatment|1|||
131438087|NCT03119259|473229502|FG000|Overall Study|Withdrawn as no longer eligible|1|||
131438088|NCT03119259|473229503|FG001|Overall Study|Withdrawn as no longer eligible|0|||
131438089|NCT03119259|473229502|FG000|Overall Study|Withdrawal by Subject|4|||
131438090|NCT03119259|473229503|FG001|Overall Study|Withdrawal by Subject|2|||
131577550|NCT05147233|473741262|FG001|Overall Study|Lost to Follow-up|1|||
131577551|NCT05147233|473741261|FG000|Overall Study|Protocol Violation|0|||
131577552|NCT05147233|473741262|FG001|Overall Study|Protocol Violation|1|||
131577553|NCT05147233|473741261|FG000|Overall Study|Withdrawal by Subject|2|||
131577554|NCT05147233|473741262|FG001|Overall Study|Withdrawal by Subject|1|||
131577555|NCT01070888|473741268|FG000|First Intervention (14 Days)|Adverse Event|0|||
131577556|NCT01070888|473741269|FG001|First Intervention (14 Days)|Adverse Event|1|||
131577557|NCT01070888|473741268|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
131577558|NCT01070888|473741269|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
131577559|NCT01070888|473741268|FG000|Washout (14 Days)|Physician Decision|1|||
131577560|NCT01070888|473741269|FG001|Washout (14 Days)|Physician Decision|0|||
131577561|NCT02577523|473741273|FG000|Overall Study|Adverse Event|1|||
131577562|NCT02577523|473741274|FG001|Overall Study|Adverse Event|1|||
131577563|NCT02577523|473741273|FG000|Overall Study|Lack of Efficacy|1|||
131577564|NCT02577523|473741274|FG001|Overall Study|Lack of Efficacy|1|||
131577565|NCT02577523|473741273|FG000|Overall Study|Withdrawal by Subject|1|||
131700097|NCT02347176|474185006|FG003|Overall Study|Withdrawal by Subject|3|||
131700098|NCT02347176|474185003|FG000|Overall Study|Other|1|||
131700099|NCT02347176|474185004|FG001|Overall Study|Other|2|||
131577566|NCT02577523|473741274|FG001|Overall Study|Withdrawal by Subject|0|||
131700100|NCT02347176|474185005|FG002|Overall Study|Other|2|||
131700101|NCT02347176|474185006|FG003|Overall Study|Other|0|||
131438091|NCT03119259|473229502|FG000|Overall Study|Lost to Follow-up|0|||
131438092|NCT03119259|473229503|FG001|Overall Study|Lost to Follow-up|1|||
131438093|NCT00325897|473229506|FG000|Overall Study|Lost to Follow-up|12|||
131577567|NCT00955825|473741276|FG000|Overall Study|Adverse Event|15|||
131577568|NCT00955825|473741277|FG001|Overall Study|Adverse Event|2|||
131577569|NCT00955825|473741276|FG000|Overall Study|Withdrawal by Subject|4|||
131577570|NCT00955825|473741277|FG001|Overall Study|Withdrawal by Subject|6|||
131577571|NCT00955825|473741276|FG000|Overall Study|Any other reason not above-mentioned|7|||
131577572|NCT00955825|473741277|FG001|Overall Study|Any other reason not above-mentioned|9|||
131577573|NCT02488980|473741278|FG000|Overall Study|Protocol Violation|2|||
131577574|NCT02488980|473741279|FG001|Overall Study|Protocol Violation|2|||
131577575|NCT02488980|473741280|FG002|Overall Study|Protocol Violation|2|||
131577576|NCT00549848|473741282|FG000|Overall Study|Death|1|||
131577577|NCT00549848|473741283|FG001|Overall Study|Death|4|||
131577578|NCT00549848|473741284|FG002|Overall Study|Death|13|||
131577579|NCT00549848|473741282|FG000|Overall Study|Physician Decision|0|||
131438094|NCT00325897|473229507|FG001|Overall Study|Lost to Follow-up|13|||
131438095|NCT04575155|473229508|FG000|2 Month|Withdrawal by Subject|1|||
131577580|NCT00549848|473741283|FG001|Overall Study|Physician Decision|0|||
131577581|NCT00549848|473741284|FG002|Overall Study|Physician Decision|4|||
131700102|NCT02387580|474185008|FG000|Overall Study|Withdrawal by Subject|0|||
131700103|NCT02387580|474185009|FG001|Overall Study|Withdrawal by Subject|0|||
131700104|NCT02387580|474185010|FG002|Overall Study|Withdrawal by Subject|0|||
131700105|NCT02387580|474185011|FG003|Overall Study|Withdrawal by Subject|1|||
131700106|NCT02387580|474185012|FG004|Overall Study|Withdrawal by Subject|0|||
131700107|NCT02387580|474185013|FG005|Overall Study|Withdrawal by Subject|0|||
131700108|NCT01064167|474185014|FG000|Overall Study|Protocol Violation|14|||
131700109|NCT01064167|474185015|FG001|Overall Study|Protocol Violation|15|||
131700110|NCT02340663|474185017|FG000|Overall Study|Lost to Follow-up|1|||
131700111|NCT02340663|474185018|FG001|Overall Study|Lost to Follow-up|0|||
131700112|NCT02340663|474185017|FG000|Overall Study|Protocol Violation|1|||
131700113|NCT02340663|474185018|FG001|Overall Study|Protocol Violation|0|||
131700114|NCT02340663|474185017|FG000|Overall Study|Withdrawal by Subject|3|||
131700115|NCT02340663|474185018|FG001|Overall Study|Withdrawal by Subject|1|||
131700116|NCT02979431|474185019|FG000|Overall Study|Parent/guardian withdrew consent|2|||
131700117|NCT02979431|474185020|FG001|Overall Study|Parent/guardian withdrew consent|1|||
131700118|NCT02979431|474185021|FG002|Overall Study|Parent/guardian withdrew consent|1|||
131700119|NCT02979431|474185022|FG003|Overall Study|Parent/guardian withdrew consent|1|||
131700120|NCT02979431|474185019|FG000|Overall Study|Randomized but received no study drug|1|||
131700121|NCT02979431|474185020|FG001|Overall Study|Randomized but received no study drug|1|||
131700122|NCT02979431|474185021|FG002|Overall Study|Randomized but received no study drug|0|||
131700123|NCT02979431|474185022|FG003|Overall Study|Randomized but received no study drug|0|||
131700124|NCT02979431|474185019|FG000|Overall Study|Adverse Event|0|||
131700125|NCT02979431|474185020|FG001|Overall Study|Adverse Event|0|||
131700126|NCT02979431|474185021|FG002|Overall Study|Adverse Event|1|||
131438096|NCT04575155|473229509|FG001|2 Month|Withdrawal by Subject|1|||
131700127|NCT02979431|474185022|FG003|Overall Study|Adverse Event|0|||
131700128|NCT02979431|474185019|FG000|Overall Study|Subject left country after Day14|1|||
131700129|NCT02979431|474185020|FG001|Overall Study|Subject left country after Day14|0|||
131577582|NCT00549848|473741282|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
131577583|NCT00549848|473741283|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
131577584|NCT00549848|473741284|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
131577585|NCT00549848|473741282|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
131577586|NCT00549848|473741283|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
131577587|NCT00549848|473741284|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
131577588|NCT00549848|473741282|FG000|Overall Study|Participant/Family Withdraw|2|||
131577589|NCT00549848|473741283|FG001|Overall Study|Participant/Family Withdraw|3|||
131577590|NCT00549848|473741284|FG002|Overall Study|Participant/Family Withdraw|5|||
131577591|NCT00549848|473741282|FG000|Overall Study|Second Malignancy|1|||
131577592|NCT00549848|473741283|FG001|Overall Study|Second Malignancy|0|||
131577593|NCT00549848|473741284|FG002|Overall Study|Second Malignancy|0|||
131577594|NCT00549848|473741282|FG000|Overall Study|Transplant|3|||
131577595|NCT00549848|473741283|FG001|Overall Study|Transplant|3|||
131577596|NCT00549848|473741284|FG002|Overall Study|Transplant|18|||
131577597|NCT00549848|473741282|FG000|Overall Study|Unacceptable Toxicity|1|||
131577598|NCT00549848|473741283|FG001|Overall Study|Unacceptable Toxicity|6|||
131577599|NCT00549848|473741284|FG002|Overall Study|Unacceptable Toxicity|6|||
131577600|NCT03262935|473741285|FG000|Overall Study|Withdrawal by Subject|6|||
131577601|NCT03262935|473741286|FG001|Overall Study|Withdrawal by Subject|7|||
131577602|NCT03262935|473741285|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
131577603|NCT03262935|473741286|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
131577604|NCT03262935|473741285|FG000|Overall Study|Death|181|||
131577605|NCT03262935|473741286|FG001|Overall Study|Death|94|||
131577606|NCT03262935|473741285|FG000|Overall Study|Lost to Follow-up|9|||
131577607|NCT03262935|473741286|FG001|Overall Study|Lost to Follow-up|4|||
131577608|NCT03262935|473741285|FG000|Overall Study|Other reason|5|||
131700130|NCT02979431|474185021|FG002|Overall Study|Subject left country after Day14|0|||
131700131|NCT02979431|474185022|FG003|Overall Study|Subject left country after Day14|0|||
131700132|NCT01580397|474185025|FG000|Overall Study|Lack of Efficacy|14|||
131700133|NCT02004873|474185026|FG000|Overall Study|Implant unsuccessful|6|||
131700134|NCT02004873|474185026|FG000|Overall Study|Awaiting 6-month visit|390|||
131700135|NCT02004873|474185026|FG000|Overall Study|Missed 6-month visit|4|||
131700136|NCT02004873|474185026|FG000|Overall Study|Death|23|||
131700137|NCT02004873|474185026|FG000|Overall Study|Withdrawal by Subject|1|||
131700138|NCT04925752|474185036|FG000|Overall Study|Still on Study|1826|||
131700139|NCT04925752|474185037|FG001|Overall Study|Still on Study|926|||
131700140|NCT04925752|474185036|FG000|Overall Study|Withdrew Consent|128|||
131700141|NCT04925752|474185037|FG001|Overall Study|Withdrew Consent|59|||
131700142|NCT04925752|474185036|FG000|Overall Study|Lost to Follow-up|73|||
131700143|NCT04925752|474185037|FG001|Overall Study|Lost to Follow-up|47|||
131700144|NCT04925752|474185036|FG000|Overall Study|Randomized but Never Treated|12|||
131700145|NCT04925752|474185037|FG001|Overall Study|Randomized but Never Treated|9|||
131700146|NCT04925752|474185036|FG000|Overall Study|Hiv-1 Infection|6|||
131700147|NCT04925752|474185037|FG001|Overall Study|Hiv-1 Infection|7|||
131700148|NCT04925752|474185036|FG000|Overall Study|Investigator's discretion|8|||
131700149|NCT04925752|474185037|FG001|Overall Study|Investigator's discretion|5|||
131700150|NCT04925752|474185036|FG000|Overall Study|Non-compliance with Study Drug|8|||
131700151|NCT04925752|474185037|FG001|Overall Study|Non-compliance with Study Drug|5|||
131700152|NCT04925752|474185036|FG000|Overall Study|Adverse Event|5|||
131700153|NCT04925752|474185037|FG001|Overall Study|Adverse Event|2|||
131700154|NCT04925752|474185036|FG000|Overall Study|Death|4|||
131700155|NCT04925752|474185037|FG001|Overall Study|Death|2|||
131700156|NCT04925752|474185036|FG000|Overall Study|Protocol Violation|1|||
131700157|NCT04925752|474185037|FG001|Overall Study|Protocol Violation|3|||
131700158|NCT04925752|474185036|FG000|Overall Study|Withdrew Assent|1|||
131700159|NCT04925752|474185037|FG001|Overall Study|Withdrew Assent|0|||
131700160|NCT01060059|474185038|FG000|Overall Study|Adverse Event|1|||
131700161|NCT01060059|474185039|FG001|Overall Study|Adverse Event|1|||
131700162|NCT01060059|474185038|FG000|Overall Study|Death|2|||
131700163|NCT01060059|474185039|FG001|Overall Study|Death|3|||
131700164|NCT01060059|474185038|FG000|Overall Study|Lost to Follow-up|18|||
131700165|NCT01060059|474185039|FG001|Overall Study|Lost to Follow-up|34|||
131700166|NCT01060059|474185038|FG000|Overall Study|entry criteria not met|4|||
131700167|NCT01060059|474185039|FG001|Overall Study|entry criteria not met|3|||
131700168|NCT01060059|474185038|FG000|Overall Study|Withdrawal by Subject|35|||
131700169|NCT01060059|474185039|FG001|Overall Study|Withdrawal by Subject|23|||
131700170|NCT01060059|474185038|FG000|Overall Study|lack of glycemic control|2|||
131577609|NCT03262935|473741286|FG001|Overall Study|Other reason|0|||
131577610|NCT02224924|473741287|FG000|Overall Study|Withdrawal by Subject|7|||
131577611|NCT02224924|473741288|FG001|Overall Study|Withdrawal by Subject|6|||
131577612|NCT02224924|473741287|FG000|Overall Study|Biopsy cancelled|20|||
131577613|NCT02224924|473741288|FG001|Overall Study|Biopsy cancelled|14|||
131700171|NCT01060059|474185039|FG001|Overall Study|lack of glycemic control|1|||
131700172|NCT01060059|474185038|FG000|Overall Study|lack of compliance|5|||
131700173|NCT01060059|474185039|FG001|Overall Study|lack of compliance|2|||
131700174|NCT01614093|474185042|FG000|Overall Study|Withdrawal by Subject|1|||
131700175|NCT00848354|474185043|FG000|Phase 1|Adverse Event|5|||
131577614|NCT02224924|473741287|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
131577615|NCT02224924|473741288|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
131577616|NCT02224924|473741287|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
131577617|NCT02224924|473741288|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
131577618|NCT03020745|473741289|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577619|NCT03020745|473741290|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577620|NCT03020745|473741291|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577621|NCT03020745|473741292|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577622|NCT03020745|473741293|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577623|NCT03020745|473741294|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577624|NCT03020745|473741295|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577625|NCT03020745|473741296|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577626|NCT03020745|473741297|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
131577627|NCT03020745|473741298|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
131577628|NCT03020745|473741289|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577629|NCT03020745|473741290|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577630|NCT03020745|473741291|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577631|NCT03020745|473741292|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577632|NCT03020745|473741293|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577633|NCT03020745|473741294|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577634|NCT03020745|473741295|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577635|NCT03020745|473741296|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
131577636|NCT03020745|473741297|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577637|NCT03020745|473741298|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131577638|NCT03020745|473741289|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577639|NCT03020745|473741290|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577640|NCT03020745|473741291|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577641|NCT03020745|473741292|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577642|NCT03020745|473741293|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577643|NCT03020745|473741294|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
131577644|NCT03020745|473741295|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577645|NCT03020745|473741296|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577646|NCT03020745|473741297|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
131577647|NCT03020745|473741298|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131577648|NCT03020745|473741289|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577649|NCT03020745|473741290|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577650|NCT03020745|473741291|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577651|NCT03020745|473741292|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577652|NCT03020745|473741293|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577653|NCT03020745|473741294|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577654|NCT03020745|473741295|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577655|NCT03020745|473741296|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577656|NCT03020745|473741297|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
131577657|NCT03020745|473741298|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131577658|NCT03823300|473741302|FG000|Overall Study|Withdrawal by Subject|16|||
131577659|NCT03823300|473741303|FG001|Overall Study|Withdrawal by Subject|22|||
131577660|NCT03823300|473741302|FG000|Overall Study|Death|10|||
131577661|NCT03823300|473741303|FG001|Overall Study|Death|14|||
131577662|NCT03823300|473741302|FG000|Overall Study|Adverse Event|3|||
131577663|NCT03823300|473741303|FG001|Overall Study|Adverse Event|5|||
131577664|NCT03823300|473741302|FG000|Overall Study|Physician Decision|1|||
131577665|NCT03823300|473741303|FG001|Overall Study|Physician Decision|7|||
131577666|NCT03823300|473741302|FG000|Overall Study|Lost to Follow-up|1|||
131577667|NCT03823300|473741303|FG001|Overall Study|Lost to Follow-up|3|||
131577668|NCT03823300|473741302|FG000|Overall Study|Protocol Violation|1|||
131577669|NCT03823300|473741303|FG001|Overall Study|Protocol Violation|1|||
131577670|NCT03823300|473741302|FG000|Overall Study|Lack of Efficacy|1|||
131577671|NCT03823300|473741303|FG001|Overall Study|Lack of Efficacy|1|||
131577672|NCT03823300|473741302|FG000|Overall Study|Not Eligible|0|||
131577673|NCT03823300|473741303|FG001|Overall Study|Not Eligible|1|||
131577674|NCT03823300|473741302|FG000|Overall Study|Other|1|||
131577675|NCT03823300|473741303|FG001|Overall Study|Other|0|||
131577676|NCT00753012|473741306|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
131577677|NCT00753012|473741307|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
131577678|NCT00753012|473741306|FG000|Overall Study|Adverse Event|2|||
131577679|NCT00753012|473741307|FG001|Overall Study|Adverse Event|0|||
131577680|NCT00753012|473741306|FG000|Overall Study|Withdrawal by Subject|0|||
131577681|NCT00753012|473741307|FG001|Overall Study|Withdrawal by Subject|1|||
131577682|NCT00753012|473741306|FG000|Overall Study|Lost to Follow-up|4|||
131577683|NCT00753012|473741307|FG001|Overall Study|Lost to Follow-up|0|||
131577684|NCT00753012|473741306|FG000|Overall Study|Confounded endpoint data|1|||
131577685|NCT00753012|473741307|FG001|Overall Study|Confounded endpoint data|0|||
131577686|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
131577687|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
131577688|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
131577689|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
131577690|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
131577691|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
131577692|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
131577693|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
131577694|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
131577695|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
131577696|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
131577697|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
131577698|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
131577699|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
131577700|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
131577701|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
131577702|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
131577703|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
131577704|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
131577705|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
131577706|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
131577707|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
131577708|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
131577709|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
131577710|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
131577711|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
131577712|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
131577713|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
131577714|NCT00241644|473741310|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
131577715|NCT00241644|473741311|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
131577716|NCT00241644|473741312|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
131577717|NCT00241644|473741313|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
131577718|NCT00241644|473741310|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
131577719|NCT00241644|473741311|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
131577720|NCT00241644|473741312|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
131577721|NCT00241644|473741313|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
131577722|NCT00241644|473741310|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
131577723|NCT00241644|473741311|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
131577724|NCT00241644|473741312|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
131577725|NCT00241644|473741313|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
131577726|NCT00241644|473741310|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
131577727|NCT00241644|473741311|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
131577728|NCT00241644|473741312|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
131577729|NCT00241644|473741313|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
131700176|NCT00848354|474185044|FG001|Phase 1|Adverse Event|4|||
131700177|NCT00848354|474185043|FG000|Phase 1|Discontinuation of study by sponsor|2|||
131700178|NCT00848354|474185044|FG001|Phase 1|Discontinuation of study by sponsor|1|||
131700179|NCT00848354|474185043|FG000|Phase 1|Failed to return|0|||
131700180|NCT00848354|474185044|FG001|Phase 1|Failed to return|1|||
131700181|NCT00848354|474185043|FG000|Phase 1|Lost to Follow-up|1|||
131700182|NCT00848354|474185044|FG001|Phase 1|Lost to Follow-up|1|||
131898690|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
131438097|NCT04575155|473229508|FG000|2 Month|Lost to Follow-up|5|||
131577730|NCT00241644|473741310|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
131577731|NCT00241644|473741311|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
131577732|NCT00241644|473741312|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
131577733|NCT00241644|473741313|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
131577734|NCT00241644|473741310|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
131700183|NCT00848354|474185043|FG000|Phase 1|Unspecified Reason|1|||
131700184|NCT00848354|474185044|FG001|Phase 1|Unspecified Reason|1|||
131577735|NCT00241644|473741311|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
131577736|NCT00241644|473741312|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
131577737|NCT00241644|473741313|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
131577738|NCT00943735|473741314|FG000|Overall Study|Adverse Event|12|||
131577739|NCT00943735|473741314|FG000|Overall Study|Withdrawal by Subject|8|||
131577740|NCT00943735|473741314|FG000|Overall Study|Death|1|||
131577741|NCT00943735|473741314|FG000|Overall Study|Other|8|||
131577742|NCT00943735|473741314|FG000|Overall Study|Other|3|||
131577743|NCT03804918|473741315|FG000|Overall Study|Participant did not use the app|1|||
131577744|NCT01329328|473741316|FG000|Overall Study|Withdrawal by Subject|2|||
131786140|NCT01364298|474500546|FG001|Overall Study|Lack of adherence to treatment|3|||
131786141|NCT01364298|474500545|FG000|Overall Study|Lack of Efficacy|1|||
131786142|NCT01364298|474500546|FG001|Overall Study|Lack of Efficacy|0|||
131786143|NCT01364298|474500545|FG000|Overall Study|Lost to Follow-up|5|||
131786144|NCT01364298|474500546|FG001|Overall Study|Lost to Follow-up|10|||
131786145|NCT01364298|474500545|FG000|Overall Study|Withdrawal by Subject|3|||
131786146|NCT01364298|474500546|FG001|Overall Study|Withdrawal by Subject|3|||
131786147|NCT01364298|474500545|FG000|Overall Study|Other|1|||
131786148|NCT01364298|474500546|FG001|Overall Study|Other|3|||
131786149|NCT00363129|474500549|FG000|Overall Study|Withdrawal by Subject|11|||
131786150|NCT00363129|474500550|FG001|Overall Study|Withdrawal by Subject|18|||
131786151|NCT00363129|474500549|FG000|Overall Study|Adverse Event|8|||
131786152|NCT00363129|474500550|FG001|Overall Study|Adverse Event|3|||
131786153|NCT00363129|474500549|FG000|Overall Study|Alternate Treatment|2|||
131786154|NCT00363129|474500550|FG001|Overall Study|Alternate Treatment|4|||
131786155|NCT00363129|474500549|FG000|Overall Study|Other Medical Problems|2|||
131786156|NCT00363129|474500550|FG001|Overall Study|Other Medical Problems|4|||
131786157|NCT00363129|474500549|FG000|Overall Study|Death|0|||
131786158|NCT00363129|474500550|FG001|Overall Study|Death|1|||
131786159|NCT00363129|474500549|FG000|Overall Study|Other Reasons|6|||
131786160|NCT00363129|474500550|FG001|Overall Study|Other Reasons|3|||
131786161|NCT03797222|474500551|FG000|Overall Study|Withdrawal by Subject|1|||
131786162|NCT00659581|474500554|FG000|Overall Study|Adverse Event|1006|||
131786163|NCT00659581|474500554|FG000|Overall Study|Lack of Efficacy|1183|||
131786164|NCT00659581|474500554|FG000|Overall Study|Other|6393|||
131786165|NCT00725725|474500558|FG000|Overall Study|Adverse Event|1|||
131786166|NCT00725725|474500559|FG001|Overall Study|Adverse Event|3|||
131786167|NCT00725725|474500560|FG002|Overall Study|Adverse Event|2|||
131786168|NCT00725725|474500558|FG000|Overall Study|Lost to Follow-up|2|||
131786169|NCT00725725|474500559|FG001|Overall Study|Lost to Follow-up|0|||
131786170|NCT00725725|474500560|FG002|Overall Study|Lost to Follow-up|2|||
131786171|NCT00725725|474500558|FG000|Overall Study|Withdrawal by Subject|1|||
131786172|NCT00725725|474500559|FG001|Overall Study|Withdrawal by Subject|0|||
131786173|NCT00725725|474500560|FG002|Overall Study|Withdrawal by Subject|1|||
131438098|NCT04575155|473229509|FG001|2 Month|Lost to Follow-up|3|||
131786174|NCT00725725|474500558|FG000|Overall Study|Protocol Violation|0|||
131786175|NCT00725725|474500559|FG001|Overall Study|Protocol Violation|1|||
131786176|NCT00725725|474500560|FG002|Overall Study|Protocol Violation|0|||
131577745|NCT01329328|473741317|FG001|Overall Study|Withdrawal by Subject|4|||
131577746|NCT01329328|473741318|FG002|Overall Study|Withdrawal by Subject|3|||
131577747|NCT00964366|473741321|FG000|Overall Study|Did not qualify at Day 1|1|||
131577748|NCT00964366|473741322|FG001|Overall Study|Did not qualify at Day 1|0|||
131786177|NCT01619085|474500561|FG000|Overall Study|Adverse Event|231|||
131786178|NCT01619085|474500561|FG000|Overall Study|Protocol Violation|4|||
131786179|NCT01619085|474500561|FG000|Overall Study|Lost to Follow-up|3|||
131786180|NCT01619085|474500561|FG000|Overall Study|Withdrawal by Subject|45|||
131786181|NCT01619085|474500561|FG000|Overall Study|Other than specified|96|||
131786182|NCT01619085|474500561|FG000|Overall Study|Not treated|1|||
131577749|NCT00964366|473741321|FG000|Overall Study|Withdrawal by Subject|0|||
131577750|NCT00964366|473741322|FG001|Overall Study|Withdrawal by Subject|1|||
131577751|NCT01370694|473741323|FG000|Overall Study|Switched to rituximab|4|||
131577752|NCT01370694|473741323|FG000|Overall Study|Progressive disease|2|||
131577753|NCT02393716|473741324|FG000|Overall Study|Death|29|||
131577754|NCT02393716|473741324|FG000|Overall Study|Withdrawal by Subject|8|||
131577755|NCT02393716|473741324|FG000|Overall Study|Device Explanted|8|||
131577756|NCT02393716|473741324|FG000|Overall Study|Missed visit|16|||
131577757|NCT02957539|473741325|FG000|Baseline to Week 16|Lost to Follow-up|8|||
131577758|NCT02957539|473741326|FG001|Baseline to Week 16|Lost to Follow-up|10|||
131577759|NCT02957539|473741327|FG002|Baseline to Week 16|Lost to Follow-up|16|||
131577760|NCT02957539|473741325|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
131577761|NCT02957539|473741326|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
131577762|NCT02957539|473741327|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
131577763|NCT02957539|473741325|FG000|Week 16 to 32|Withdrawal by Subject|3|||
131577764|NCT02957539|473741326|FG001|Week 16 to 32|Withdrawal by Subject|3|||
131577765|NCT02957539|473741327|FG002|Week 16 to 32|Withdrawal by Subject|1|||
131577766|NCT02957539|473741325|FG000|Week 16 to 32|Lost to Follow-up|8|||
131577767|NCT02957539|473741326|FG001|Week 16 to 32|Lost to Follow-up|7|||
131577768|NCT02957539|473741327|FG002|Week 16 to 32|Lost to Follow-up|5|||
131577769|NCT02957539|473741325|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
131577770|NCT02957539|473741326|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
131577771|NCT02957539|473741327|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
131577772|NCT02957539|473741325|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
131577773|NCT02957539|473741326|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
131577774|NCT02957539|473741327|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
131577775|NCT04842604|473741330|FG000|Overall Study|Death|1|||
131577776|NCT04842604|473741331|FG001|Overall Study|Death|0|||
131577777|NCT04842604|473741330|FG000|Overall Study|Other|4|||
131577778|NCT04842604|473741331|FG001|Overall Study|Other|4|||
131577779|NCT04842604|473741330|FG000|Overall Study|Randomized but not treated|1|||
131577780|NCT04842604|473741331|FG001|Overall Study|Randomized but not treated|0|||
131577781|NCT01193153|473741332|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
131577782|NCT01193153|473741333|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
131577783|NCT01193153|473741332|FG000|Open-label Lead in Period|Pregnancy|1|||
131577784|NCT01193153|473741333|FG001|Open-label Lead in Period|Pregnancy|0|||
131577785|NCT01193153|473741332|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
131577786|NCT01193153|473741333|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
131577787|NCT01193153|473741332|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
131577788|NCT01193153|473741333|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
131577789|NCT01193153|473741332|FG000|Open-label Lead in Period|Other|14|||
131577790|NCT01193153|473741333|FG001|Open-label Lead in Period|Other|0|||
131577791|NCT01193153|473741332|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
131577792|NCT01193153|473741333|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
131577793|NCT01193153|473741332|FG000|Open-label Lead in Period|Adverse Event|41|||
131577794|NCT01193153|473741333|FG001|Open-label Lead in Period|Adverse Event|0|||
131577795|NCT01193153|473741332|FG000|Open-label Lead in Period|Death|1|||
131577796|NCT01193153|473741333|FG001|Open-label Lead in Period|Death|0|||
131577797|NCT01193153|473741332|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
131577798|NCT01193153|473741333|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
131577799|NCT01193153|473741332|FG000|Open-label Stabilization Period|Adverse Event|9|||
131577800|NCT01193153|473741333|FG001|Open-label Stabilization Period|Adverse Event|0|||
131577801|NCT01193153|473741332|FG000|Open-label Stabilization Period|Death|2|||
131577802|NCT01193153|473741333|FG001|Open-label Stabilization Period|Death|0|||
131577803|NCT01193153|473741332|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
131577804|NCT01193153|473741333|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
131577805|NCT01193153|473741332|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
131577806|NCT01193153|473741333|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
131700185|NCT00848354|474185043|FG000|Phase 1|Protocol Violation|1|||
131700186|NCT00848354|474185044|FG001|Phase 1|Protocol Violation|1|||
131700187|NCT00848354|474185043|FG000|Phase 1|Withdrawal by Subject|2|||
131700188|NCT00848354|474185044|FG001|Phase 1|Withdrawal by Subject|4|||
131577807|NCT01193153|473741332|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
131577808|NCT01193153|473741333|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
131577809|NCT01193153|473741332|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
131700189|NCT00848354|474185043|FG000|Phase 1|Lack of Efficacy|0|||
131700190|NCT00848354|474185044|FG001|Phase 1|Lack of Efficacy|1|||
131700191|NCT00848354|474185043|FG000|Phase 2 Year 1|Adverse Event|7|||
131700192|NCT00848354|474185044|FG001|Phase 2 Year 1|Adverse Event|2|||
131577810|NCT01193153|473741333|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
131577811|NCT01193153|473741332|FG000|Open-label Stabilization Period|Other|8|||
131577812|NCT01193153|473741333|FG001|Open-label Stabilization Period|Other|0|||
131577813|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Other|2|||
131700193|NCT00848354|474185043|FG000|Phase 2 Year 1|Death|1|||
131700194|NCT00848354|474185044|FG001|Phase 2 Year 1|Death|0|||
131577814|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Other|3|||
131577815|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
131577816|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
131577817|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Death|2|||
131577818|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Death|0|||
131577819|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
131577820|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
131577821|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
131577822|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
131577823|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
131577824|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
131577825|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
131577826|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
131577827|NCT01193153|473741332|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
131577828|NCT01193153|473741333|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
131577829|NCT01648140|473741334|FG000|Overall Study|Physician Decision|1|||
131577830|NCT01648140|473741335|FG001|Overall Study|Physician Decision|0|||
131786183|NCT01619085|474500561|FG000|Overall Study|Death|145|||
131786184|NCT03125629|474500562|FG000|Overall Study|Withdrawal by Subject|2|||
131786185|NCT03125629|474500562|FG000|Overall Study|Equipment malfunction|1|||
131786186|NCT03909971|474500563|FG000|Overall Study|Other Reasons Not Specified|0|||
131786187|NCT03909971|474500564|FG001|Overall Study|Other Reasons Not Specified|1|||
131786188|NCT03909971|474500563|FG000|Overall Study|Global Deterioration of Health Status|2|||
131786189|NCT03909971|474500564|FG001|Overall Study|Global Deterioration of Health Status|1|||
131786190|NCT03909971|474500563|FG000|Overall Study|Progressive Disease|6|||
131786191|NCT03909971|474500564|FG001|Overall Study|Progressive Disease|14|||
131786192|NCT03909971|474500563|FG000|Overall Study|Death|2|||
131786193|NCT03909971|474500564|FG001|Overall Study|Death|6|||
131786194|NCT04556838|474500567|FG000|Overall Study|Withdrawal by Subject|3|||
131786195|NCT04556838|474500568|FG001|Overall Study|Withdrawal by Subject|1|||
131786196|NCT04556838|474500569|FG002|Overall Study|Withdrawal by Subject|2|||
131786197|NCT04556838|474500567|FG000|Overall Study|Adverse Event|0|||
131786198|NCT04556838|474500568|FG001|Overall Study|Adverse Event|1|||
131786199|NCT04556838|474500569|FG002|Overall Study|Adverse Event|1|||
131786200|NCT04556838|474500567|FG000|Overall Study|Lost to Follow-up|0|||
131786201|NCT04556838|474500568|FG001|Overall Study|Lost to Follow-up|0|||
131786202|NCT04556838|474500569|FG002|Overall Study|Lost to Follow-up|2|||
131786203|NCT04556838|474500567|FG000|Overall Study|Subject travel|0|||
131786204|NCT04556838|474500568|FG001|Overall Study|Subject travel|1|||
131786205|NCT04556838|474500569|FG002|Overall Study|Subject travel|0|||
131786206|NCT04556838|474500567|FG000|Overall Study|Physician Decision|1|||
131786207|NCT04556838|474500568|FG001|Overall Study|Physician Decision|0|||
131786208|NCT04556838|474500569|FG002|Overall Study|Physician Decision|0|||
131786209|NCT04523831|474500570|FG000|Overall Study|Lost to Follow-up|15|||
131786210|NCT04523831|474500571|FG001|Overall Study|Lost to Follow-up|17|||
131786211|NCT04523831|474500570|FG000|Overall Study|Death|0|||
131786212|NCT04523831|474500571|FG001|Overall Study|Death|3|||
131786213|NCT04523831|474500570|FG000|Overall Study|Adverse Event|2|||
131786214|NCT04523831|474500571|FG001|Overall Study|Adverse Event|0|||
131786215|NCT03185949|474500574|FG000|ITT Analysis|Withdrawal by Subject|4|||
131786216|NCT03185949|474500575|FG001|ITT Analysis|Withdrawal by Subject|3|||
131786217|NCT03185949|474500574|FG000|PP Analysis|Protocol Violation|2|||
131786218|NCT03185949|474500575|FG001|PP Analysis|Protocol Violation|2|||
131786219|NCT03185949|474500574|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
131786220|NCT03185949|474500575|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
131786221|NCT03053622|474501959|FG000|Overall Study|Lost to Follow-up|0|||
131786222|NCT03053622|474501960|FG001|Overall Study|Lost to Follow-up|0|||
131786223|NCT03053622|474501961|FG002|Overall Study|Lost to Follow-up|0|||
131786224|NCT03053622|474501962|FG003|Overall Study|Lost to Follow-up|1|||
131786225|NCT02598622|474501963|FG000|Overall Study|Withdrawal by Subject|3|||
131577831|NCT01648140|473741336|FG002|Overall Study|Physician Decision|0|||
131577832|NCT01648140|473741337|FG003|Overall Study|Physician Decision|0|||
131577833|NCT01648140|473741334|FG000|Overall Study|Lack of Efficacy|4|||
131577834|NCT01648140|473741335|FG001|Overall Study|Lack of Efficacy|7|||
131786226|NCT02598622|474501964|FG001|Overall Study|Withdrawal by Subject|0|||
131786227|NCT02598622|474501963|FG000|Overall Study|Physician Decision|3|||
131786228|NCT02598622|474501964|FG001|Overall Study|Physician Decision|0|||
131786229|NCT01355523|474501968|FG000|Overall Study|Withdrawal by Subject|1|||
131786230|NCT01355523|474501969|FG001|Overall Study|Withdrawal by Subject|4|||
131786231|NCT01355523|474501968|FG000|Overall Study|Lost to Follow-up|0|||
131786232|NCT01355523|474501969|FG001|Overall Study|Lost to Follow-up|2|||
131786233|NCT01355523|474501968|FG000|Overall Study|Protocol Violation|0|||
131786234|NCT01355523|474501969|FG001|Overall Study|Protocol Violation|2|||
131786235|NCT01355523|474501968|FG000|Overall Study|Adverse Event|0|||
131786236|NCT01355523|474501969|FG001|Overall Study|Adverse Event|2|||
131786237|NCT03627195|474501972|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
131786238|NCT03627195|474501973|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131786239|NCT03627195|474501974|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131786240|NCT03627195|474501975|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131786241|NCT03627195|474501976|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131786242|NCT03627195|474501977|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131786243|NCT02595528|474501980|FG000|Overall Study|Withdrawal by Subject|1|||
131786244|NCT02595528|474501981|FG001|Overall Study|Withdrawal by Subject|2|||
131786245|NCT02595528|474501982|FG002|Overall Study|Withdrawal by Subject|1|||
131786246|NCT02595528|474501983|FG003|Overall Study|Withdrawal by Subject|3|||
131786247|NCT02595528|474501980|FG000|Overall Study|Lost to Follow-up|1|||
131786248|NCT02595528|474501981|FG001|Overall Study|Lost to Follow-up|1|||
131786249|NCT02595528|474501982|FG002|Overall Study|Lost to Follow-up|0|||
131786250|NCT02595528|474501983|FG003|Overall Study|Lost to Follow-up|1|||
131577835|NCT01648140|473741336|FG002|Overall Study|Lack of Efficacy|1|||
131577836|NCT01648140|473741337|FG003|Overall Study|Lack of Efficacy|0|||
131577837|NCT01648140|473741334|FG000|Overall Study|Adverse Event|3|||
131577838|NCT01648140|473741335|FG001|Overall Study|Adverse Event|1|||
131577839|NCT01648140|473741336|FG002|Overall Study|Adverse Event|2|||
131577840|NCT01648140|473741337|FG003|Overall Study|Adverse Event|0|||
131577841|NCT01648140|473741334|FG000|Overall Study|Withdrawal by Subject|2|||
131577842|NCT01648140|473741335|FG001|Overall Study|Withdrawal by Subject|3|||
131577843|NCT01648140|473741336|FG002|Overall Study|Withdrawal by Subject|3|||
131577844|NCT01648140|473741337|FG003|Overall Study|Withdrawal by Subject|2|||
131577845|NCT01648140|473741334|FG000|Overall Study|Lost to Follow-up|2|||
131577846|NCT01648140|473741335|FG001|Overall Study|Lost to Follow-up|1|||
131577847|NCT01648140|473741336|FG002|Overall Study|Lost to Follow-up|2|||
131577848|NCT01648140|473741337|FG003|Overall Study|Lost to Follow-up|0|||
131577849|NCT01563354|473741338|FG000|Core Phase|Adverse Event|5|||
131577850|NCT01563354|473741339|FG001|Core Phase|Adverse Event|15|||
131577851|NCT01563354|473741340|FG002|Core Phase|Adverse Event|13|||
131577852|NCT01563354|473741338|FG000|Core Phase|Withdrawal by Subject|1|||
131577853|NCT01563354|473741339|FG001|Core Phase|Withdrawal by Subject|0|||
131577854|NCT01563354|473741340|FG002|Core Phase|Withdrawal by Subject|3|||
131577855|NCT01563354|473741338|FG000|Core Phase|Lost to Follow-up|1|||
131577856|NCT01563354|473741339|FG001|Core Phase|Lost to Follow-up|0|||
131577857|NCT01563354|473741340|FG002|Core Phase|Lost to Follow-up|0|||
131577858|NCT01563354|473741338|FG000|Core Phase|Death|1|||
131577859|NCT01563354|473741339|FG001|Core Phase|Death|5|||
131577860|NCT01563354|473741340|FG002|Core Phase|Death|2|||
131577861|NCT01563354|473741338|FG000|Core Phase|Diseasse progression|18|||
131577862|NCT01563354|473741339|FG001|Core Phase|Diseasse progression|7|||
131577863|NCT01563354|473741340|FG002|Core Phase|Diseasse progression|8|||
131577864|NCT01563354|473741338|FG000|Core Phase|Protocol deviation|2|||
131577865|NCT01563354|473741339|FG001|Core Phase|Protocol deviation|0|||
131577866|NCT01563354|473741340|FG002|Core Phase|Protocol deviation|0|||
131577867|NCT01563354|473741338|FG000|Core Phase|PI decision - did not enter extension|0|||
131577868|NCT01563354|473741339|FG001|Core Phase|PI decision - did not enter extension|1|||
131577869|NCT01563354|473741340|FG002|Core Phase|PI decision - did not enter extension|0|||
131577870|NCT01563354|473741338|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
131577871|NCT01563354|473741339|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
131577872|NCT01563354|473741340|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
131577873|NCT01563354|473741338|FG000|Extension Phase|Adverse Event|0|||
131577874|NCT01563354|473741339|FG001|Extension Phase|Adverse Event|3|||
131577875|NCT01563354|473741340|FG002|Extension Phase|Adverse Event|2|||
131577876|NCT01563354|473741338|FG000|Extension Phase|Withdrawal by Subject|0|||
131577877|NCT01563354|473741339|FG001|Extension Phase|Withdrawal by Subject|1|||
131577878|NCT01563354|473741340|FG002|Extension Phase|Withdrawal by Subject|0|||
131577879|NCT01563354|473741338|FG000|Extension Phase|Administration problems|3|||
131577880|NCT01563354|473741339|FG001|Extension Phase|Administration problems|2|||
131577881|NCT01563354|473741340|FG002|Extension Phase|Administration problems|3|||
131786251|NCT03862625|474501994|FG000|Overall Study|Lost to Follow-up|0|||
131786252|NCT03862625|474501995|FG001|Overall Study|Lost to Follow-up|1|||
131577882|NCT01563354|473741338|FG000|Extension Phase|Disease progression|9|||
131577883|NCT01563354|473741339|FG001|Extension Phase|Disease progression|8|||
131577884|NCT01563354|473741340|FG002|Extension Phase|Disease progression|10|||
131577885|NCT01119950|473741341|FG000|Overall Study|Adverse Event|25|||
131577886|NCT01119950|473741341|FG000|Overall Study|Withdrawal by Subject|9|||
131577887|NCT01119950|473741341|FG000|Overall Study|Protocol Violation|5|||
131577888|NCT01119950|473741341|FG000|Overall Study|Lost to Follow-up|4|||
131786253|NCT01326702|474501996|FG000|Overall Study|Other|1|||
131577889|NCT01119950|473741341|FG000|Overall Study|Administrative|2|||
131577890|NCT01119950|473741341|FG000|Overall Study|Abnormal lab value|1|||
131577891|NCT01119950|473741341|FG000|Overall Study|Death|1|||
131577892|NCT01988233|473741343|FG000|Overall Study|Lost to Follow-up|64|||
131577893|NCT01988233|473741344|FG001|Overall Study|Lost to Follow-up|51|||
131577894|NCT03621761|473741349|FG000|Overall Study|Lost to Follow-up|1|||
131786254|NCT01326702|474501997|FG001|Overall Study|Other|0|||
131786255|NCT01326702|474501998|FG002|Overall Study|Other|0|||
131786256|NCT01326702|474501999|FG003|Overall Study|Other|0|||
131577895|NCT03621761|473741350|FG001|Overall Study|Lost to Follow-up|1|||
131577896|NCT03621761|473741351|FG002|Overall Study|Lost to Follow-up|2|||
131577897|NCT03621761|473741349|FG000|Overall Study|Withdrawal by Subject|2|||
131577898|NCT03621761|473741350|FG001|Overall Study|Withdrawal by Subject|1|||
131577899|NCT03621761|473741351|FG002|Overall Study|Withdrawal by Subject|1|||
131577900|NCT03621761|473741349|FG000|Overall Study|Became Ineligible|0|||
131577901|NCT03621761|473741350|FG001|Overall Study|Became Ineligible|2|||
131577902|NCT03621761|473741351|FG002|Overall Study|Became Ineligible|0|||
131577903|NCT00217672|473741352|FG000|Allocation|Ineligible|2|||
131577904|NCT00217672|473741353|FG001|Allocation|Ineligible|0|||
131577905|NCT00217672|473741352|FG000|Treatment|disease progression|33|||
131577906|NCT00217672|473741353|FG001|Treatment|disease progression|4|||
131786257|NCT01326702|474502000|FG004|Overall Study|Other|0|||
131786258|NCT01326702|474502001|FG005|Overall Study|Other|1|||
131786259|NCT01326702|474502002|FG006|Overall Study|Other|0|||
131786260|NCT01326702|474501996|FG000|Overall Study|progressive disease|1|||
131786261|NCT01326702|474501997|FG001|Overall Study|progressive disease|1|||
131786262|NCT01326702|474501998|FG002|Overall Study|progressive disease|3|||
131786263|NCT01326702|474501999|FG003|Overall Study|progressive disease|1|||
131786264|NCT01326702|474502000|FG004|Overall Study|progressive disease|3|||
131786265|NCT01326702|474502001|FG005|Overall Study|progressive disease|2|||
131786266|NCT01326702|474502002|FG006|Overall Study|progressive disease|3|||
131786267|NCT01326702|474501996|FG000|Overall Study|Death|0|||
131786268|NCT01326702|474501997|FG001|Overall Study|Death|1|||
131786269|NCT01326702|474501998|FG002|Overall Study|Death|0|||
131786270|NCT01326702|474501999|FG003|Overall Study|Death|0|||
131786271|NCT01326702|474502000|FG004|Overall Study|Death|0|||
131786272|NCT01326702|474502001|FG005|Overall Study|Death|0|||
131786273|NCT01326702|474502002|FG006|Overall Study|Death|0|||
131786274|NCT01326702|474501996|FG000|Overall Study|Adverse Event|0|||
131786275|NCT01326702|474501997|FG001|Overall Study|Adverse Event|0|||
131786276|NCT01326702|474501998|FG002|Overall Study|Adverse Event|1|||
131786277|NCT01326702|474501999|FG003|Overall Study|Adverse Event|1|||
131786278|NCT01326702|474502000|FG004|Overall Study|Adverse Event|0|||
131786279|NCT01326702|474502001|FG005|Overall Study|Adverse Event|3|||
131786280|NCT01326702|474502002|FG006|Overall Study|Adverse Event|1|||
131786281|NCT01326702|474501996|FG000|Overall Study|Withdrawal by Subject|0|||
131786282|NCT01326702|474501997|FG001|Overall Study|Withdrawal by Subject|0|||
131786283|NCT01326702|474501998|FG002|Overall Study|Withdrawal by Subject|1|||
131786284|NCT01326702|474501999|FG003|Overall Study|Withdrawal by Subject|0|||
131786285|NCT01326702|474502000|FG004|Overall Study|Withdrawal by Subject|1|||
131786286|NCT01326702|474502001|FG005|Overall Study|Withdrawal by Subject|1|||
131786287|NCT01326702|474502002|FG006|Overall Study|Withdrawal by Subject|3|||
131786288|NCT01326702|474501996|FG000|Overall Study|Not Treated|0|||
131786289|NCT01326702|474501997|FG001|Overall Study|Not Treated|0|||
131786290|NCT01326702|474501998|FG002|Overall Study|Not Treated|0|||
131786291|NCT01326702|474501999|FG003|Overall Study|Not Treated|1|||
131786292|NCT01326702|474502000|FG004|Overall Study|Not Treated|0|||
131786293|NCT01326702|474502001|FG005|Overall Study|Not Treated|1|||
131786294|NCT01326702|474502002|FG006|Overall Study|Not Treated|0|||
131786295|NCT01835132|474502003|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
131786296|NCT03333382|474502006|FG000|Overall Study|Lost to Follow-up|1|||
131786297|NCT03333382|474502007|FG001|Overall Study|Lost to Follow-up|0|||
131786298|NCT00782275|474502008|FG000|Overall Study|Adverse Event|11|||
131786299|NCT00782275|474502008|FG000|Overall Study|Withdrawal by Subject|1|||
131786300|NCT00782275|474502008|FG000|Overall Study|Progressive Disease|21|||
131786301|NCT00782275|474502008|FG000|Overall Study|Physician Decision|4|||
131786302|NCT00782275|474502008|FG000|Overall Study|Not started treatment|1|||
131786303|NCT00782275|474502008|FG000|Overall Study|Other|3|||
131577907|NCT00217672|473741352|FG000|Treatment|Adverse Event|18|||
131577908|NCT00217672|473741353|FG001|Treatment|Adverse Event|2|||
131577909|NCT00217672|473741352|FG000|Treatment|reqd treatment not permitted by protocol|6|||
131577910|NCT00217672|473741353|FG001|Treatment|reqd treatment not permitted by protocol|0|||
131577911|NCT00217672|473741352|FG000|Treatment|Physician Decision|6|||
131786304|NCT00331773|474502011|FG000|Overall Study|Withdrawal by Subject|6|||
131786305|NCT00331773|474502012|FG001|Overall Study|Withdrawal by Subject|4|||
131786306|NCT00331773|474502011|FG000|Overall Study|Protocol Violation|10|||
131786307|NCT00331773|474502012|FG001|Overall Study|Protocol Violation|3|||
131786308|NCT00289731|474502013|FG000|Overall Study|Adverse Event|1|||
131786309|NCT00289731|474502014|FG001|Overall Study|Adverse Event|2|||
131786310|NCT00289731|474502015|FG002|Overall Study|Adverse Event|2|||
131786311|NCT00289731|474502013|FG000|Overall Study|Other|1|||
131577912|NCT00217672|473741353|FG001|Treatment|Physician Decision|0|||
131786312|NCT00289731|474502014|FG001|Overall Study|Other|0|||
131786313|NCT00289731|474502015|FG002|Overall Study|Other|0|||
131786314|NCT02019979|474502016|FG000|Overall Study|study terminated|14|||
131786315|NCT00525031|474502020|FG000|Overall Study|Disease Progression|1|||
131577913|NCT00217672|473741352|FG000|Treatment|insurance issues|1|||
131577914|NCT00217672|473741353|FG001|Treatment|insurance issues|1|||
131786316|NCT00525031|474502021|FG001|Overall Study|Disease Progression|1|||
131786317|NCT00787566|474502022|FG000|Overall Study|AE related to chemotherapy|0|||
131577915|NCT00217672|473741352|FG000|Treatment|Death|2|||
131577916|NCT00217672|473741353|FG001|Treatment|Death|0|||
131577917|NCT00217672|473741352|FG000|Treatment|secondary malignancy|1|||
131577918|NCT00217672|473741353|FG001|Treatment|secondary malignancy|0|||
131577919|NCT00217672|473741352|FG000|Follow-up|Withdrawal by Subject|4|||
131577920|NCT00217672|473741353|FG001|Follow-up|Withdrawal by Subject|0|||
131577921|NCT00217672|473741352|FG000|Follow-up|Lost to Follow-up|1|||
131577922|NCT00217672|473741353|FG001|Follow-up|Lost to Follow-up|0|||
131577923|NCT01050569|473741354|FG000|Overall Study|Lost to Follow-up|20|||
131577924|NCT01050569|473741355|FG001|Overall Study|Lost to Follow-up|14|||
131577925|NCT01050569|473741356|FG002|Overall Study|Lost to Follow-up|16|||
131577926|NCT01050569|473741354|FG000|Overall Study|Withdrawal by Subject|9|||
131577927|NCT01050569|473741355|FG001|Overall Study|Withdrawal by Subject|3|||
131577928|NCT01050569|473741356|FG002|Overall Study|Withdrawal by Subject|11|||
131577929|NCT01050569|473741354|FG000|Overall Study|Lack of Efficacy|5|||
131577930|NCT01050569|473741355|FG001|Overall Study|Lack of Efficacy|4|||
131577931|NCT01050569|473741356|FG002|Overall Study|Lack of Efficacy|3|||
131577932|NCT01050569|473741354|FG000|Overall Study|Adverse Event|1|||
131577933|NCT01050569|473741355|FG001|Overall Study|Adverse Event|0|||
131577934|NCT01050569|473741356|FG002|Overall Study|Adverse Event|0|||
131577935|NCT01050569|473741354|FG000|Overall Study|Physician Decision|3|||
131577936|NCT01050569|473741355|FG001|Overall Study|Physician Decision|3|||
131577937|NCT01050569|473741356|FG002|Overall Study|Physician Decision|3|||
131577938|NCT01591616|473741364|FG000|Overall Study|Withdrawal by Subject|1|||
131577939|NCT00758602|473741367|FG000|Overall Study|Adverse Event|11|||
131577940|NCT00758602|473741368|FG001|Overall Study|Adverse Event|10|||
131577941|NCT00758602|473741367|FG000|Overall Study|Lost to Follow-up|4|||
131577942|NCT00758602|473741368|FG001|Overall Study|Lost to Follow-up|3|||
131577943|NCT00758602|473741367|FG000|Overall Study|Withdrawal by Subject|1|||
131577944|NCT00758602|473741368|FG001|Overall Study|Withdrawal by Subject|3|||
131577945|NCT00758602|473741367|FG000|Overall Study|Protocol Violation|0|||
131577946|NCT00758602|473741368|FG001|Overall Study|Protocol Violation|2|||
131577947|NCT00758602|473741367|FG000|Overall Study|Death|0|||
131577948|NCT00758602|473741368|FG001|Overall Study|Death|1|||
131577949|NCT00758602|473741367|FG000|Overall Study|Reason not specified|3|||
131577950|NCT00758602|473741368|FG001|Overall Study|Reason not specified|3|||
131577951|NCT04379713|473741369|FG000|Overall Study|Adverse Event|2|||
131577952|NCT04379713|473741370|FG001|Overall Study|Adverse Event|0|||
131577953|NCT04379713|473741369|FG000|Overall Study|Physician Decision|2|||
131577954|NCT04379713|473741370|FG001|Overall Study|Physician Decision|1|||
131577955|NCT04379713|473741369|FG000|Overall Study|Protocol Violation|11|||
131577956|NCT04379713|473741370|FG001|Overall Study|Protocol Violation|6|||
131577957|NCT04379713|473741369|FG000|Overall Study|No longer met eligibility criteria|14|||
131577958|NCT04379713|473741370|FG001|Overall Study|No longer met eligibility criteria|11|||
131577959|NCT04379713|473741369|FG000|Overall Study|Withdrawal by parent/guardian|36|||
131577960|NCT04379713|473741370|FG001|Overall Study|Withdrawal by parent/guardian|15|||
131577961|NCT04379713|473741369|FG000|Overall Study|Lost to Follow-up|31|||
131577962|NCT04379713|473741370|FG001|Overall Study|Lost to Follow-up|21|||
131577963|NCT01909336|473741373|FG000|Overall Study|Lost to Follow-up|4|||
131577964|NCT01909336|473741374|FG001|Overall Study|Lost to Follow-up|2|||
131577965|NCT01909336|473741375|FG002|Overall Study|Lost to Follow-up|2|||
131577966|NCT01909336|473741373|FG000|Overall Study|Physician Decision|0|||
131577967|NCT01909336|473741374|FG001|Overall Study|Physician Decision|1|||
131577968|NCT01909336|473741375|FG002|Overall Study|Physician Decision|1|||
131577969|NCT01157182|473741376|FG000|Washout of 28 Days|Adverse Event|2|||
131700195|NCT00848354|474185043|FG000|Phase 2 Year 1|Failed to Return|1|||
131700196|NCT00848354|474185044|FG001|Phase 2 Year 1|Failed to Return|1|||
131700197|NCT00848354|474185043|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
131577970|NCT01157182|473741377|FG001|Washout of 28 Days|Adverse Event|0|||
131577971|NCT02878330|473741379|FG000|Overall Study|Death|3|||
131577972|NCT02878330|473741380|FG001|Overall Study|Death|2|||
131577973|NCT02878330|473741379|FG000|Overall Study|Lost to Follow-up|11|||
131700198|NCT00848354|474185044|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
131700199|NCT00848354|474185043|FG000|Phase 2 Year 1|Unspecified Reason|3|||
131700200|NCT00848354|474185044|FG001|Phase 2 Year 1|Unspecified Reason|0|||
131700201|NCT00848354|474185043|FG000|Phase 2 Year 1|Protocol Violation|4|||
131700202|NCT00848354|474185044|FG001|Phase 2 Year 1|Protocol Violation|1|||
131700203|NCT00848354|474185043|FG000|Phase 2 Year 1|Subject Request|1|||
131700204|NCT00848354|474185044|FG001|Phase 2 Year 1|Subject Request|2|||
131700205|NCT00848354|474185043|FG000|Phase 2 Year 2|Adverse Event|12|||
131577974|NCT02878330|473741380|FG001|Overall Study|Lost to Follow-up|26|||
131577975|NCT02878330|473741379|FG000|Overall Study|Withdrawal by Subject|11|||
131577976|NCT02878330|473741380|FG001|Overall Study|Withdrawal by Subject|21|||
131577977|NCT02878330|473741379|FG000|Overall Study|Other|4|||
131577978|NCT02878330|473741380|FG001|Overall Study|Other|7|||
131577979|NCT00716144|473741381|FG000|Overall Study|Withdrawal by Subject|4|||
131577980|NCT00716144|473741382|FG001|Overall Study|Withdrawal by Subject|2|||
131577981|NCT00716144|473741383|FG002|Overall Study|Withdrawal by Subject|6|||
131577982|NCT00716144|473741384|FG003|Overall Study|Withdrawal by Subject|6|||
131577983|NCT00716144|473741381|FG000|Overall Study|Lost to Follow-up|2|||
131577984|NCT00716144|473741382|FG001|Overall Study|Lost to Follow-up|2|||
131577985|NCT00716144|473741383|FG002|Overall Study|Lost to Follow-up|1|||
131577986|NCT00716144|473741384|FG003|Overall Study|Lost to Follow-up|2|||
131577987|NCT00716144|473741381|FG000|Overall Study|Adverse Event|0|||
131577988|NCT00716144|473741382|FG001|Overall Study|Adverse Event|0|||
131577989|NCT00716144|473741383|FG002|Overall Study|Adverse Event|0|||
131577990|NCT00716144|473741384|FG003|Overall Study|Adverse Event|2|||
131577991|NCT00716144|473741381|FG000|Overall Study|Non-compliance|1|||
131577992|NCT00716144|473741382|FG001|Overall Study|Non-compliance|0|||
131577993|NCT00716144|473741383|FG002|Overall Study|Non-compliance|0|||
131577994|NCT00716144|473741384|FG003|Overall Study|Non-compliance|0|||
131577995|NCT00716144|473741381|FG000|Overall Study|Protocol Violation|2|||
131577996|NCT00716144|473741382|FG001|Overall Study|Protocol Violation|0|||
131438099|NCT04575155|473229508|FG000|2 Month|Ineligible|1|||
131577997|NCT00716144|473741383|FG002|Overall Study|Protocol Violation|1|||
131577998|NCT00716144|473741384|FG003|Overall Study|Protocol Violation|0|||
131577999|NCT00716144|473741381|FG000|Overall Study|Physician Decision|0|||
131578000|NCT00716144|473741382|FG001|Overall Study|Physician Decision|1|||
131578001|NCT00716144|473741383|FG002|Overall Study|Physician Decision|2|||
131578002|NCT00716144|473741384|FG003|Overall Study|Physician Decision|2|||
131578003|NCT00716144|473741381|FG000|Overall Study|Intercurrent illness|0|||
131578004|NCT00716144|473741382|FG001|Overall Study|Intercurrent illness|0|||
131578005|NCT00716144|473741383|FG002|Overall Study|Intercurrent illness|1|||
131700206|NCT00848354|474185044|FG001|Phase 2 Year 2|Adverse Event|2|||
131700207|NCT00848354|474185043|FG000|Phase 2 Year 2|Death|2|||
131700208|NCT00848354|474185044|FG001|Phase 2 Year 2|Death|0|||
131700209|NCT00848354|474185043|FG000|Phase 2 Year 2|Failed to return|3|||
131700210|NCT00848354|474185044|FG001|Phase 2 Year 2|Failed to return|0|||
131700211|NCT00848354|474185043|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
131700212|NCT00848354|474185044|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
131700213|NCT00848354|474185043|FG000|Phase 2 Year 2|Unspecified Reason|1|||
131700214|NCT00848354|474185044|FG001|Phase 2 Year 2|Unspecified Reason|0|||
131700215|NCT00848354|474185043|FG000|Phase 2 Year 2|Protocol Violation|1|||
131700216|NCT00848354|474185044|FG001|Phase 2 Year 2|Protocol Violation|1|||
131700217|NCT00848354|474185043|FG000|Phase 2 Year 2|Subject Request|1|||
131700218|NCT00848354|474185044|FG001|Phase 2 Year 2|Subject Request|1|||
131700219|NCT00848354|474185043|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
131700220|NCT00848354|474185044|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
131700221|NCT05574062|474185047|FG000|Pre Run-In|Screening failure|3|||
131700222|NCT05574062|474185048|FG001|Pre Run-In|Screening failure|0|||
131700223|NCT05574062|474185049|FG002|Pre Run-In|Screening failure|0|||
131700224|NCT05574062|474185050|FG003|Pre Run-In|Screening failure|0|||
131700225|NCT05574062|474185051|FG004|Pre Run-In|Screening failure|0|||
131700226|NCT05574062|474185047|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
131700227|NCT05574062|474185048|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
131700228|NCT05574062|474185049|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
131700229|NCT05574062|474185050|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
131700230|NCT05574062|474185051|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
131700231|NCT05574062|474185047|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
131700232|NCT05574062|474185048|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
131700233|NCT05574062|474185049|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
131700234|NCT05574062|474185050|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
131700235|NCT05574062|474185051|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
131700236|NCT05574062|474185047|FG000|Continuation Phase Period 1|Physician Decision|1|||
131700237|NCT05574062|474185048|FG001|Continuation Phase Period 1|Physician Decision|0|||
131700238|NCT05574062|474185049|FG002|Continuation Phase Period 1|Physician Decision|0|||
131700239|NCT05574062|474185050|FG003|Continuation Phase Period 1|Physician Decision|0|||
131700240|NCT05574062|474185051|FG004|Continuation Phase Period 1|Physician Decision|0|||
131700241|NCT05574062|474185047|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
131700242|NCT05574062|474185048|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
131700243|NCT05574062|474185049|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
131700244|NCT05574062|474185050|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
131700245|NCT05574062|474185051|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
131700246|NCT05574062|474185047|FG000|Continuation Phase Period 1|Adverse Event|1|||
131700247|NCT05574062|474185048|FG001|Continuation Phase Period 1|Adverse Event|0|||
131700248|NCT05574062|474185049|FG002|Continuation Phase Period 1|Adverse Event|0|||
131700249|NCT05574062|474185050|FG003|Continuation Phase Period 1|Adverse Event|0|||
131700250|NCT05574062|474185051|FG004|Continuation Phase Period 1|Adverse Event|0|||
131700251|NCT05574062|474185047|FG000|Continuation Phase Period 1|Death|1|||
131700252|NCT05574062|474185048|FG001|Continuation Phase Period 1|Death|0|||
131578006|NCT00716144|473741384|FG003|Overall Study|Intercurrent illness|0|||
131578007|NCT00716144|473741381|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
131578008|NCT00716144|473741382|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
131578009|NCT00716144|473741383|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
131578010|NCT00716144|473741384|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
131578011|NCT00716144|473741381|FG000|Overall Study|Adverse event: left foot pain|0|||
131578012|NCT00716144|473741382|FG001|Overall Study|Adverse event: left foot pain|1|||
131578013|NCT00716144|473741383|FG002|Overall Study|Adverse event: left foot pain|0|||
131578014|NCT00716144|473741384|FG003|Overall Study|Adverse event: left foot pain|0|||
131578015|NCT00716144|473741381|FG000|Overall Study|Clinical Depression|0|||
131578016|NCT00716144|473741382|FG001|Overall Study|Clinical Depression|1|||
131578017|NCT00716144|473741383|FG002|Overall Study|Clinical Depression|0|||
131578018|NCT00716144|473741384|FG003|Overall Study|Clinical Depression|0|||
131578019|NCT02950558|473741385|FG000|Overall Study|Lost to Follow-up|2|||
131578020|NCT02950558|473741386|FG001|Overall Study|Lost to Follow-up|0|||
131578021|NCT01321606|473741389|FG000|Overall Study|Lost to Follow-up|0|||
131578022|NCT01321606|473741390|FG001|Overall Study|Lost to Follow-up|0|||
131578023|NCT01321606|473741391|FG002|Overall Study|Lost to Follow-up|0|||
131578024|NCT01321606|473741392|FG003|Overall Study|Lost to Follow-up|1|||
131578025|NCT02781584|473741396|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
131578026|NCT02781584|473741397|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
131578027|NCT02781584|473741398|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
131578028|NCT02781584|473741399|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
131578029|NCT02781584|473741400|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
131578030|NCT02781584|473741401|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
131578031|NCT02781584|473741402|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
131578032|NCT02781584|473741403|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
131578033|NCT02781584|473741404|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
131578034|NCT02781584|473741405|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
131578035|NCT02781584|473741406|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
131578036|NCT02781584|473741407|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
131578037|NCT02781584|473741408|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
131578038|NCT02781584|473741396|FG000|Pre-treatment Phase|Adverse Event|0|||
131578039|NCT02781584|473741397|FG001|Pre-treatment Phase|Adverse Event|0|||
131578040|NCT02781584|473741398|FG002|Pre-treatment Phase|Adverse Event|0|||
131578041|NCT02781584|473741399|FG003|Pre-treatment Phase|Adverse Event|0|||
131578042|NCT02781584|473741400|FG004|Pre-treatment Phase|Adverse Event|0|||
131578043|NCT02781584|473741401|FG005|Pre-treatment Phase|Adverse Event|0|||
131578044|NCT02781584|473741402|FG006|Pre-treatment Phase|Adverse Event|0|||
131578045|NCT02781584|473741403|FG007|Pre-treatment Phase|Adverse Event|0|||
131578046|NCT02781584|473741404|FG008|Pre-treatment Phase|Adverse Event|0|||
131578047|NCT02781584|473741405|FG009|Pre-treatment Phase|Adverse Event|0|||
131578048|NCT02781584|473741406|FG010|Pre-treatment Phase|Adverse Event|0|||
131578049|NCT02781584|473741407|FG011|Pre-treatment Phase|Adverse Event|1|||
131578050|NCT02781584|473741408|FG012|Pre-treatment Phase|Adverse Event|0|||
131578051|NCT02781584|473741396|FG000|Treatment Phase|Withdrew Consent|0|||
131578052|NCT02781584|473741397|FG001|Treatment Phase|Withdrew Consent|0|||
131578053|NCT02781584|473741398|FG002|Treatment Phase|Withdrew Consent|0|||
131578054|NCT02781584|473741399|FG003|Treatment Phase|Withdrew Consent|0|||
131578055|NCT02781584|473741400|FG004|Treatment Phase|Withdrew Consent|0|||
131578056|NCT02781584|473741401|FG005|Treatment Phase|Withdrew Consent|1|||
131578057|NCT02781584|473741402|FG006|Treatment Phase|Withdrew Consent|0|||
131578058|NCT02781584|473741403|FG007|Treatment Phase|Withdrew Consent|0|||
131578059|NCT02781584|473741404|FG008|Treatment Phase|Withdrew Consent|0|||
131578060|NCT02781584|473741405|FG009|Treatment Phase|Withdrew Consent|0|||
131578061|NCT02781584|473741406|FG010|Treatment Phase|Withdrew Consent|1|||
131578062|NCT02781584|473741407|FG011|Treatment Phase|Withdrew Consent|2|||
131578063|NCT02781584|473741408|FG012|Treatment Phase|Withdrew Consent|0|||
131578064|NCT02781584|473741396|FG000|Treatment Phase|Adverse Event|0|||
131578065|NCT02781584|473741397|FG001|Treatment Phase|Adverse Event|0|||
131578066|NCT02781584|473741398|FG002|Treatment Phase|Adverse Event|0|||
131578067|NCT02781584|473741399|FG003|Treatment Phase|Adverse Event|0|||
131578068|NCT02781584|473741400|FG004|Treatment Phase|Adverse Event|0|||
131578069|NCT02781584|473741401|FG005|Treatment Phase|Adverse Event|0|||
131700253|NCT05574062|474185049|FG002|Continuation Phase Period 1|Death|0|||
131700254|NCT05574062|474185050|FG003|Continuation Phase Period 1|Death|0|||
131700255|NCT05574062|474185051|FG004|Continuation Phase Period 1|Death|0|||
131700256|NCT05574062|474185047|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
131700257|NCT05574062|474185048|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
131700258|NCT05574062|474185049|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
131578070|NCT02781584|473741402|FG006|Treatment Phase|Adverse Event|0|||
131578071|NCT02781584|473741403|FG007|Treatment Phase|Adverse Event|1|||
131700259|NCT05574062|474185050|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
131438100|NCT04575155|473229509|FG001|2 Month|Ineligible|0|||
131578072|NCT02781584|473741404|FG008|Treatment Phase|Adverse Event|0|||
131578073|NCT02781584|473741405|FG009|Treatment Phase|Adverse Event|0|||
131578074|NCT02781584|473741406|FG010|Treatment Phase|Adverse Event|0|||
131578075|NCT02781584|473741407|FG011|Treatment Phase|Adverse Event|0|||
131578076|NCT02781584|473741408|FG012|Treatment Phase|Adverse Event|0|||
131578077|NCT00208767|473741413|FG000|Overall Study|Adverse Event|9|||
131700260|NCT05574062|474185051|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
131700261|NCT04202679|474185056|FG000|Overall Study|Adverse Event|2|||
131700262|NCT04202679|474185057|FG001|Overall Study|Adverse Event|0|||
131700263|NCT04202679|474185056|FG000|Overall Study|Poor compliance to protocol|1|||
131578078|NCT00208767|473741414|FG001|Overall Study|Adverse Event|1|||
131578079|NCT00208767|473741413|FG000|Overall Study|Withdrawal by Subject|14|||
131578080|NCT00208767|473741414|FG001|Overall Study|Withdrawal by Subject|3|||
131578081|NCT00208767|473741413|FG000|Overall Study|Death|1|||
131578082|NCT00208767|473741414|FG001|Overall Study|Death|0|||
131578083|NCT00208767|473741413|FG000|Overall Study|Lost to Follow-up|3|||
131578084|NCT00208767|473741414|FG001|Overall Study|Lost to Follow-up|3|||
131578085|NCT04517864|473743633|FG000|Placebo-Controlled Phase|Adverse Event|1|||
131578086|NCT04517864|473743634|FG001|Placebo-Controlled Phase|Adverse Event|0|||
131578087|NCT04517864|473743635|FG002|Placebo-Controlled Phase|Adverse Event|0|||
131578088|NCT04517864|473743633|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
131578089|NCT04517864|473743634|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
131578090|NCT04517864|473743635|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
131578091|NCT04517864|473743633|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
131578092|NCT04517864|473743634|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
131578093|NCT04517864|473743635|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
131578094|NCT04517864|473743633|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
131578095|NCT04517864|473743634|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
131578096|NCT04517864|473743635|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
131578097|NCT04517864|473743633|FG000|Active Therapy Extension Phase|Adverse Event|1|||
131578098|NCT04517864|473743634|FG001|Active Therapy Extension Phase|Adverse Event|0|||
131578099|NCT04517864|473743635|FG002|Active Therapy Extension Phase|Adverse Event|0|||
131578100|NCT04517864|473743633|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
131578101|NCT04517864|473743634|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
131578102|NCT04517864|473743635|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
131578103|NCT04517864|473743633|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
131578104|NCT04517864|473743634|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
131578105|NCT04517864|473743635|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
131578106|NCT04517864|473743633|FG000|Active Therapy Extension Phase|Physician Decision|1|||
131578107|NCT04517864|473743634|FG001|Active Therapy Extension Phase|Physician Decision|0|||
131578108|NCT04517864|473743635|FG002|Active Therapy Extension Phase|Physician Decision|0|||
131578109|NCT04517864|473743633|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
131578110|NCT04517864|473743634|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
131578111|NCT04517864|473743635|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
131578112|NCT04517864|473743633|FG000|Extension Phase|Adverse Event|0|||
131578113|NCT04517864|473743634|FG001|Extension Phase|Adverse Event|0|||
131578114|NCT04517864|473743635|FG002|Extension Phase|Adverse Event|1|||
131578115|NCT04517864|473743633|FG000|Extension Phase|Lack of Efficacy|0|||
131578116|NCT04517864|473743634|FG001|Extension Phase|Lack of Efficacy|0|||
131578117|NCT04517864|473743635|FG002|Extension Phase|Lack of Efficacy|2|||
131578118|NCT04517864|473743633|FG000|Extension Phase|Study Terminated By Sponsor|0|||
131700264|NCT04202679|474185057|FG001|Overall Study|Poor compliance to protocol|0|||
131700265|NCT04202679|474185056|FG000|Overall Study|Withdrawal by Subject|23|||
131700266|NCT04202679|474185057|FG001|Overall Study|Withdrawal by Subject|6|||
131700267|NCT03864653|474185058|FG000|Overall Study|Withdrawal by Subject|1|||
131700268|NCT01928381|474185059|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
131700269|NCT01928381|474185060|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131700270|NCT01928381|474185061|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131700271|NCT01928381|474185062|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131700272|NCT01928381|474185063|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131700273|NCT01928381|474185064|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131700274|NCT01928381|474185065|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131700275|NCT01928381|474185059|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
131700276|NCT01928381|474185060|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
131700277|NCT01928381|474185061|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
131700278|NCT01928381|474185062|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
131700279|NCT01928381|474185063|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
131700280|NCT01928381|474185064|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
131700281|NCT01928381|474185065|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
131700282|NCT01928381|474185059|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
131578119|NCT04517864|473743634|FG001|Extension Phase|Study Terminated By Sponsor|0|||
131578120|NCT04517864|473743635|FG002|Extension Phase|Study Terminated By Sponsor|32|||
131578121|NCT04517864|473743633|FG000|Extension Phase|Withdrawal by Subject|0|||
131578122|NCT04517864|473743634|FG001|Extension Phase|Withdrawal by Subject|0|||
131578123|NCT04517864|473743635|FG002|Extension Phase|Withdrawal by Subject|3|||
131786318|NCT00787566|474502023|FG001|Overall Study|AE related to chemotherapy|1|||
131786319|NCT00787566|474502024|FG002|Overall Study|AE related to chemotherapy|0|||
131786320|NCT02140164|474502025|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
131786321|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
131786322|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
131786323|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
131786324|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
131786325|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
131786326|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
131786327|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
131786328|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
131786329|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
131786330|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
131786331|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
131786332|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
131786333|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
131786334|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
131786335|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
131786336|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
131786337|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
131786338|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
131786339|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
131786340|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
131786341|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
131786342|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
131786343|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
131786344|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
131700283|NCT01928381|474185060|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
131700284|NCT01928381|474185061|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
131700285|NCT01928381|474185062|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
131700286|NCT01928381|474185063|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
131700287|NCT01928381|474185064|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
131700288|NCT01928381|474185065|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
131700289|NCT01928381|474185059|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
131700290|NCT01928381|474185060|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
131700291|NCT01928381|474185061|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
131700292|NCT01928381|474185062|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
131700293|NCT01928381|474185063|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
131700294|NCT01928381|474185064|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
131700295|NCT01928381|474185065|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
131700296|NCT01928381|474185059|FG000|Part 1 - Pain Training|Protocol Violation|1|||
131700297|NCT01928381|474185060|FG001|Part 1 - Pain Training|Protocol Violation|0|||
131700298|NCT01928381|474185061|FG002|Part 1 - Pain Training|Protocol Violation|0|||
131700299|NCT01928381|474185062|FG003|Part 1 - Pain Training|Protocol Violation|0|||
131700300|NCT01928381|474185063|FG004|Part 1 - Pain Training|Protocol Violation|0|||
131700301|NCT01928381|474185064|FG005|Part 1 - Pain Training|Protocol Violation|0|||
131700302|NCT01928381|474185065|FG006|Part 1 - Pain Training|Protocol Violation|0|||
131700303|NCT01928381|474185059|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
131700304|NCT01928381|474185060|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131700305|NCT01928381|474185061|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131700306|NCT01928381|474185062|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131700307|NCT01928381|474185063|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131700308|NCT01928381|474185064|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131700309|NCT01928381|474185065|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131700310|NCT01928381|474185059|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
131700311|NCT01928381|474185060|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131700312|NCT01928381|474185061|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131700313|NCT01928381|474185062|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131700314|NCT01928381|474185063|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131700315|NCT01928381|474185064|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131700316|NCT01928381|474185065|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131700317|NCT01928381|474185059|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
131700318|NCT01928381|474185060|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131578124|NCT04517864|473743633|FG000|Extension Phase|Approved Drug Available for Indication|0|||
131578125|NCT04517864|473743634|FG001|Extension Phase|Approved Drug Available for Indication|0|||
131578126|NCT04517864|473743635|FG002|Extension Phase|Approved Drug Available for Indication|7|||
131578127|NCT04722003|473743636|FG000|Overall Study|Lost to Follow-up|2|||
131578128|NCT04722003|473743637|FG001|Overall Study|Lost to Follow-up|0|||
131578129|NCT04722003|473743636|FG000|Overall Study|Physician Decision|1|||
131578130|NCT04722003|473743637|FG001|Overall Study|Physician Decision|0|||
131578131|NCT04860258|473743638|FG000|Overall Study|Withdrawal by Subject|0|||
131578132|NCT04860258|473743639|FG001|Overall Study|Withdrawal by Subject|0|||
131700319|NCT01928381|474185061|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131700320|NCT01928381|474185062|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131700321|NCT01928381|474185063|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131700322|NCT01928381|474185064|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131700323|NCT01928381|474185065|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131700324|NCT01928381|474185059|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
131700325|NCT01928381|474185060|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131700326|NCT01928381|474185061|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131700327|NCT01928381|474185062|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131700328|NCT01928381|474185063|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131700329|NCT01928381|474185064|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131700330|NCT01928381|474185065|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131700331|NCT01928381|474185059|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
131700332|NCT01928381|474185060|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
131700333|NCT01928381|474185061|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
131700334|NCT01928381|474185062|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
131700335|NCT01928381|474185063|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
131700336|NCT01928381|474185064|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
131700337|NCT01928381|474185065|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
131700338|NCT01928381|474185059|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131700339|NCT01928381|474185060|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131700340|NCT01928381|474185061|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
131700341|NCT01928381|474185062|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131700342|NCT01928381|474185063|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131700343|NCT01928381|474185064|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131700344|NCT01928381|474185065|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131700345|NCT01928381|474185059|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
131700346|NCT01928381|474185060|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
131700347|NCT01928381|474185061|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
131700348|NCT01928381|474185062|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
131700349|NCT01928381|474185063|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
131700350|NCT01928381|474185064|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
131700351|NCT01928381|474185065|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
131700352|NCT01928381|474185059|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
131700353|NCT01928381|474185060|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
131700354|NCT01928381|474185061|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
131700355|NCT01928381|474185062|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
131700356|NCT01928381|474185063|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
131700357|NCT01928381|474185064|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
131700358|NCT01928381|474185065|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
131700359|NCT01928381|474185059|FG000|Washout First Intervention|Protocol Violation|0|||
131700360|NCT01928381|474185060|FG001|Washout First Intervention|Protocol Violation|0|||
131700361|NCT01928381|474185061|FG002|Washout First Intervention|Protocol Violation|0|||
131700362|NCT01928381|474185062|FG003|Washout First Intervention|Protocol Violation|0|||
131700363|NCT01928381|474185063|FG004|Washout First Intervention|Protocol Violation|1|||
131700364|NCT01928381|474185064|FG005|Washout First Intervention|Protocol Violation|0|||
131700365|NCT01928381|474185065|FG006|Washout First Intervention|Protocol Violation|0|||
131700366|NCT01928381|474185059|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
131700367|NCT01928381|474185060|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
131700368|NCT01928381|474185061|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
131700369|NCT01928381|474185062|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
131700370|NCT01928381|474185063|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
131700371|NCT01928381|474185064|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
131700372|NCT01928381|474185065|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
131700373|NCT01928381|474185059|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
131700374|NCT01928381|474185060|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
131700375|NCT01928381|474185061|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
131578133|NCT04860258|473743640|FG002|Overall Study|Withdrawal by Subject|4|||
131700376|NCT01928381|474185062|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
131700377|NCT01928381|474185063|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
131700378|NCT01928381|474185064|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
131700379|NCT01928381|474185065|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
131700380|NCT03406897|474185066|FG000|Overall Study|Lost to Follow-up|1|||
131700381|NCT03406897|474185067|FG001|Overall Study|Lost to Follow-up|2|||
131700382|NCT03406897|474185066|FG000|Overall Study|Withdrawal by Subject|4|||
131700383|NCT03406897|474185067|FG001|Overall Study|Withdrawal by Subject|4|||
131700384|NCT03406897|474185066|FG000|Overall Study|Physician Decision|0|||
131700385|NCT03406897|474185067|FG001|Overall Study|Physician Decision|1|||
131700386|NCT03087955|474187534|FG000|Overall Study|Death|4|||
131700387|NCT03087955|474187535|FG001|Overall Study|Death|0|||
131700388|NCT03087955|474187534|FG000|Overall Study|Lack of Efficacy|2|||
131700389|NCT03087955|474187535|FG001|Overall Study|Lack of Efficacy|0|||
131700390|NCT03087955|474187534|FG000|Overall Study|Lost to Follow-up|1|||
131700391|NCT03087955|474187535|FG001|Overall Study|Lost to Follow-up|0|||
131700392|NCT04441905|474187536|FG000|Overall Study|Lost to Follow-up|1|||
131700393|NCT04441905|474187537|FG001|Overall Study|Lost to Follow-up|0|||
131700394|NCT04441905|474187538|FG002|Overall Study|Lost to Follow-up|0|||
131700395|NCT04441905|474187539|FG003|Overall Study|Lost to Follow-up|0|||
131700396|NCT04441905|474187540|FG004|Overall Study|Lost to Follow-up|0|||
131700397|NCT04441905|474187541|FG005|Overall Study|Lost to Follow-up|0|||
131700398|NCT04441905|474187536|FG000|Overall Study|Enrolled but treatment not administered|0|||
131700399|NCT04441905|474187537|FG001|Overall Study|Enrolled but treatment not administered|1|||
131700400|NCT04441905|474187538|FG002|Overall Study|Enrolled but treatment not administered|0|||
131700401|NCT04441905|474187539|FG003|Overall Study|Enrolled but treatment not administered|0|||
131700402|NCT04441905|474187540|FG004|Overall Study|Enrolled but treatment not administered|0|||
131700403|NCT04441905|474187541|FG005|Overall Study|Enrolled but treatment not administered|0|||
131700404|NCT04441905|474187536|FG000|Overall Study|Became ineligible after enrollment|0|||
131700405|NCT04441905|474187537|FG001|Overall Study|Became ineligible after enrollment|0|||
131700406|NCT04441905|474187538|FG002|Overall Study|Became ineligible after enrollment|0|||
131700407|NCT04441905|474187539|FG003|Overall Study|Became ineligible after enrollment|0|||
131700408|NCT04441905|474187540|FG004|Overall Study|Became ineligible after enrollment|1|||
131700409|NCT04441905|474187541|FG005|Overall Study|Became ineligible after enrollment|0|||
131700410|NCT04770753|474187542|FG000|Overall Study|Randomized, never treated|1|||
131700411|NCT04770753|474187543|FG001|Overall Study|Randomized, never treated|1|||
131700412|NCT04770753|474187542|FG000|Overall Study|Withdrawal by Subject|3|||
131700413|NCT04770753|474187543|FG001|Overall Study|Withdrawal by Subject|1|||
131700414|NCT04770753|474187542|FG000|Overall Study|Adverse Event|2|||
131700415|NCT04770753|474187543|FG001|Overall Study|Adverse Event|0|||
131700416|NCT04770753|474187542|FG000|Overall Study|Pregnancy|1|||
131700417|NCT04770753|474187543|FG001|Overall Study|Pregnancy|0|||
131700418|NCT04770753|474187542|FG000|Overall Study|Other un-specified|1|||
131700419|NCT04770753|474187543|FG001|Overall Study|Other un-specified|0|||
131700420|NCT02775851|474187544|FG000|Overall Study|Adverse Event|1|||
131700421|NCT02775851|474187545|FG001|Overall Study|Adverse Event|10|||
131700422|NCT02775851|474187544|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
131438101|NCT00467740|473229512|FG000|Overall Study|Adverse Event|0|||
131700423|NCT02775851|474187545|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
131700424|NCT02775851|474187544|FG000|Overall Study|Progression/Relapse|0|||
131700425|NCT02775851|474187545|FG001|Overall Study|Progression/Relapse|4|||
131700426|NCT02775851|474187544|FG000|Overall Study|Other - Not Protocol Specified|0|||
131786345|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
131786346|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
131786347|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
131786348|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
131786349|NCT01872689|474502030|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
131786350|NCT01872689|474502031|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
131786351|NCT01872689|474502032|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
131786352|NCT01872689|474502033|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
131786353|NCT01872689|474502030|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
131786354|NCT01872689|474502031|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
131786355|NCT01872689|474502032|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
131786356|NCT01872689|474502033|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
131786357|NCT01872689|474502030|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
131786358|NCT01872689|474502031|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
131786359|NCT01872689|474502032|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
131786360|NCT01872689|474502033|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
131786361|NCT01872689|474502030|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
131786362|NCT01872689|474502031|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
131786363|NCT01872689|474502032|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
131578134|NCT04860258|473743641|FG003|Overall Study|Withdrawal by Subject|1|||
131578135|NCT04860258|473743642|FG004|Overall Study|Withdrawal by Subject|4|||
131578136|NCT04860258|473743643|FG005|Overall Study|Withdrawal by Subject|1|||
131578137|NCT04860258|473743644|FG006|Overall Study|Withdrawal by Subject|0|||
131578138|NCT00357396|473743645|FG000|Overall Study|Adverse Event|1|||
131578139|NCT00357396|473743646|FG001|Overall Study|Adverse Event|0|||
131578140|NCT02496702|473743647|FG000|Overall Study|Lost to Follow-up|8|||
131578141|NCT02496702|473743648|FG001|Overall Study|Lost to Follow-up|6|||
131578142|NCT02496702|473743647|FG000|Overall Study|Only partially tested|0|||
131578143|NCT02496702|473743648|FG001|Overall Study|Only partially tested|2|||
131578144|NCT03743246|473743663|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
131578145|NCT03743246|473743664|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
131578146|NCT03743246|473743665|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
131578147|NCT03743246|473743666|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
131578148|NCT03743246|473743663|FG000|Pre-Treatment Period|Death|0|||
131578149|NCT03743246|473743664|FG001|Pre-Treatment Period|Death|1|||
131578150|NCT03743246|473743665|FG002|Pre-Treatment Period|Death|0|||
131578151|NCT03743246|473743666|FG003|Pre-Treatment Period|Death|1|||
131700427|NCT02775851|474187545|FG001|Overall Study|Other - Not Protocol Specified|7|||
131700428|NCT02775851|474187544|FG000|Overall Study|Withdrawal by Subject|1|||
131700429|NCT02775851|474187545|FG001|Overall Study|Withdrawal by Subject|0|||
131700430|NCT03718143|474187547|FG000|Overall Study|Death|1|||
131700431|NCT03718143|474187548|FG001|Overall Study|Death|0|||
131700432|NCT03718143|474187549|FG002|Overall Study|Death|0|||
131700433|NCT03718143|474187547|FG000|Overall Study|Progression of Disease|1|||
131700434|NCT03718143|474187548|FG001|Overall Study|Progression of Disease|0|||
131700435|NCT03718143|474187549|FG002|Overall Study|Progression of Disease|0|||
131700436|NCT03718143|474187547|FG000|Overall Study|Withdrawal of Informed Consent|1|||
131700437|NCT03718143|474187548|FG001|Overall Study|Withdrawal of Informed Consent|2|||
131700438|NCT03718143|474187549|FG002|Overall Study|Withdrawal of Informed Consent|1|||
131700439|NCT05064059|474187550|FG000|Overall Study|Death|199|||
131700440|NCT05064059|474187551|FG001|Overall Study|Death|196|||
131700441|NCT05064059|474187550|FG000|Overall Study|Physician Decision|4|||
131700442|NCT05064059|474187551|FG001|Overall Study|Physician Decision|2|||
131700443|NCT05064059|474187550|FG000|Overall Study|Sponsor Decision|14|||
131700444|NCT05064059|474187551|FG001|Overall Study|Sponsor Decision|11|||
131700445|NCT05064059|474187550|FG000|Overall Study|Withdrawal by Subject|4|||
131700446|NCT05064059|474187551|FG001|Overall Study|Withdrawal by Subject|11|||
131700447|NCT01934140|474187552|FG000|Persistence Phase (Year 6-10)|Other|24|||
131700448|NCT01934140|474187553|FG001|Persistence Phase (Year 6-10)|Other|6|||
131700449|NCT01934140|474187552|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
131700450|NCT01934140|474187553|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
131578152|NCT03743246|473743663|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
131578153|NCT03743246|473743664|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
131700451|NCT01934140|474187552|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
131700452|NCT01934140|474187553|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
131700453|NCT01934140|474187552|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
131700454|NCT01934140|474187553|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
131700455|NCT01934140|474187552|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
131700456|NCT01934140|474187553|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
131700457|NCT01934140|474187552|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
131700458|NCT01934140|474187553|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
131786364|NCT01872689|474502033|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
131786365|NCT01872689|474502030|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
131786366|NCT01872689|474502031|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
131786367|NCT01872689|474502032|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
131786368|NCT01872689|474502033|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
131786369|NCT01872689|474502030|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
131786370|NCT01872689|474502031|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
131786371|NCT01872689|474502032|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
131786372|NCT01872689|474502033|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
131786373|NCT01872689|474502030|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
131786374|NCT01872689|474502031|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
131786375|NCT01872689|474502032|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
131786376|NCT01872689|474502033|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
131786377|NCT00686374|474502035|FG000|Overall Study|Lack of Efficacy|10|||
131786378|NCT00686374|474502035|FG000|Overall Study|Adverse Event|8|||
131786379|NCT00686374|474502035|FG000|Overall Study|Withdrew consent|5|||
131786380|NCT00686374|474502035|FG000|Overall Study|Lost to Follow-up|1|||
131786381|NCT00686374|474502035|FG000|Overall Study|Missing reason|33|||
131786382|NCT00686374|474502035|FG000|Overall Study|Other, not specified|4|||
131786383|NCT02444182|474502037|FG000|Overall Study|non-compliance|2|||
131786384|NCT02444182|474502038|FG001|Overall Study|non-compliance|1|||
131786385|NCT02444182|474502037|FG000|Overall Study|Lost to Follow-up|0|||
131786386|NCT02444182|474502038|FG001|Overall Study|Lost to Follow-up|4|||
131786387|NCT04126733|474502043|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
131786388|NCT04126733|474502043|FG000|Treatment Period|Adverse Event|8|||
131786389|NCT04126733|474502043|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
131786390|NCT04126733|474502043|FG000|Treatment Period|Physician Decision|5|||
131786391|NCT04126733|474502043|FG000|Treatment Period|Death|1|||
131786392|NCT04126733|474502043|FG000|Treatment Period|Other Reasons|2|||
131786393|NCT04126733|474502043|FG000|Active Follow-up Period|Death|13|||
131786394|NCT04126733|474502043|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
131786395|NCT04126733|474502043|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
131786396|NCT04126733|474502043|FG000|Active Follow-up Period|Other Reasons|1|||
131786397|NCT04126733|474502043|FG000|Long-term Follow-up Period|Death|22|||
131786398|NCT04126733|474502043|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
131786399|NCT04126733|474502043|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
131786400|NCT02598193|474502045|FG000|Overall Study|Adverse Event|13|||
131786401|NCT02598193|474502045|FG000|Overall Study|Withdrawal by Subject|1|||
131786402|NCT02598193|474502045|FG000|Overall Study|Listed in active lung transplant list|1|||
131786403|NCT02598193|474502045|FG000|Overall Study|Does not want to take Nintedanib|1|||
131786404|NCT02487979|474502048|FG000|Overall Study|Physician Decision|2|||
131786405|NCT02487979|474502048|FG000|Overall Study|Withdrawal by Subject|2|||
131786406|NCT02487979|474502048|FG000|Overall Study|Progressive Disease|17|||
131786407|NCT00447694|474502049|FG000|Overall Study|Adverse Event|2|||
131786408|NCT00447694|474502049|FG000|Overall Study|Abnormal laboratory value|1|||
131786409|NCT00447694|474502049|FG000|Overall Study|Abnormal test procedure result|1|||
131786410|NCT00447694|474502049|FG000|Overall Study|Withdrawal by Subject|2|||
131786411|NCT02354976|474502056|FG000|Overall Study|Other - reason not specified|1|||
131578154|NCT03743246|473743665|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
131578155|NCT03743246|473743666|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
131578156|NCT03743246|473743663|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
131578157|NCT03743246|473743664|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
131578158|NCT03743246|473743665|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
131578159|NCT03743246|473743666|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
131578160|NCT03743246|473743663|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
131578161|NCT03743246|473743664|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
131578162|NCT03743246|473743665|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
131578163|NCT03743246|473743666|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
131578164|NCT03743246|473743663|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
131786412|NCT02354976|474502057|FG001|Overall Study|Other - reason not specified|0|||
131786413|NCT02354976|474502058|FG002|Overall Study|Other - reason not specified|1|||
131786414|NCT02354976|474502056|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
131786415|NCT02354976|474502057|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
131786416|NCT02354976|474502058|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
131786417|NCT02354976|474502056|FG000|Overall Study|Adverse Event|1|||
131786418|NCT02354976|474502057|FG001|Overall Study|Adverse Event|0|||
131786419|NCT02354976|474502058|FG002|Overall Study|Adverse Event|2|||
131578165|NCT03743246|473743664|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
131578166|NCT03743246|473743665|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
131578167|NCT03743246|473743666|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
131700459|NCT01934140|474187552|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
131700460|NCT01934140|474187553|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
131700461|NCT01934140|474187552|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
131700462|NCT01934140|474187553|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
131700463|NCT00618748|474187559|FG000|Overall Study|Adverse Event|4|||
131700464|NCT00618748|474187560|FG001|Overall Study|Adverse Event|3|||
131700465|NCT00618748|474187561|FG002|Overall Study|Adverse Event|8|||
131700466|NCT00618748|474187559|FG000|Overall Study|Physician Decision|3|||
131700467|NCT00618748|474187560|FG001|Overall Study|Physician Decision|1|||
131700468|NCT00618748|474187561|FG002|Overall Study|Physician Decision|1|||
131700469|NCT00618748|474187559|FG000|Overall Study|Withdrawal by Subject|4|||
131700470|NCT00618748|474187560|FG001|Overall Study|Withdrawal by Subject|1|||
131700471|NCT00618748|474187561|FG002|Overall Study|Withdrawal by Subject|5|||
131700472|NCT00200850|474187562|FG000|Overall Study|relocation|1|||
131700473|NCT00200850|474187563|FG001|Overall Study|relocation|0|||
131700474|NCT00200850|474187564|FG002|Overall Study|relocation|1|||
131700475|NCT00200850|474187562|FG000|Overall Study|too busy|1|||
131700476|NCT00200850|474187563|FG001|Overall Study|too busy|0|||
131700477|NCT00200850|474187564|FG002|Overall Study|too busy|0|||
131700478|NCT00200850|474187562|FG000|Overall Study|Pregnancy|0|||
131700479|NCT00200850|474187563|FG001|Overall Study|Pregnancy|0|||
131700480|NCT00200850|474187564|FG002|Overall Study|Pregnancy|1|||
131700481|NCT00200850|474187562|FG000|Overall Study|Poor adherence|0|||
131700482|NCT00200850|474187563|FG001|Overall Study|Poor adherence|0|||
131700483|NCT00200850|474187564|FG002|Overall Study|Poor adherence|1|||
131700484|NCT00200850|474187562|FG000|Overall Study|optic neuritis|0|||
131700485|NCT00200850|474187563|FG001|Overall Study|optic neuritis|0|||
131700486|NCT00200850|474187564|FG002|Overall Study|optic neuritis|1|||
131700487|NCT00200850|474187562|FG000|Overall Study|Adverse Event|1|||
131700488|NCT00200850|474187563|FG001|Overall Study|Adverse Event|1|||
131700489|NCT00200850|474187564|FG002|Overall Study|Adverse Event|2|||
131700490|NCT02595879|474187569|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
131700491|NCT02595879|474187570|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
131700492|NCT05227690|474187576|FG000|Overall Study|Adverse Event|5|||
131700493|NCT05227690|474187577|FG001|Overall Study|Adverse Event|6|||
131700494|NCT05227690|474187578|FG002|Overall Study|Adverse Event|10|||
131700495|NCT05227690|474187576|FG000|Overall Study|Lack of Efficacy|2|||
131700496|NCT05227690|474187577|FG001|Overall Study|Lack of Efficacy|4|||
131700497|NCT05227690|474187578|FG002|Overall Study|Lack of Efficacy|1|||
131700498|NCT05227690|474187576|FG000|Overall Study|Physician Decision|6|||
131700499|NCT05227690|474187577|FG001|Overall Study|Physician Decision|0|||
131700500|NCT05227690|474187578|FG002|Overall Study|Physician Decision|4|||
131700501|NCT05227690|474187576|FG000|Overall Study|Withdrawal of consent|28|||
131700502|NCT05227690|474187577|FG001|Overall Study|Withdrawal of consent|27|||
131700503|NCT05227690|474187578|FG002|Overall Study|Withdrawal of consent|21|||
131578168|NCT03743246|473743663|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
131700504|NCT05227690|474187576|FG000|Overall Study|Other, not specified|2|||
131700505|NCT05227690|474187577|FG001|Overall Study|Other, not specified|2|||
131700506|NCT05227690|474187578|FG002|Overall Study|Other, not specified|1|||
131700507|NCT02770326|474187581|FG000|Overall Study|Death|3|||
131700508|NCT02770326|474187581|FG000|Overall Study|Lost to Follow-up|1|||
131700509|NCT02971202|474187582|FG000|Overall Study|Pregnancy|1|||
131700510|NCT02971202|474187583|FG001|Overall Study|Pregnancy|0|||
131700511|NCT02971202|474187584|FG002|Overall Study|Pregnancy|0|||
131700512|NCT02971202|474187582|FG000|Overall Study|screen fail after consent|1|||
131700513|NCT02971202|474187583|FG001|Overall Study|screen fail after consent|0|||
131700514|NCT02971202|474187584|FG002|Overall Study|screen fail after consent|1|||
131700515|NCT04294459|474187585|FG000|Overall Study|Adverse Event|0|||
131700516|NCT04294459|474187586|FG001|Overall Study|Adverse Event|1|||
131700517|NCT01534676|474187587|FG000|Overall Study|Study closed due to poor enrollment|2|||
131700518|NCT01534676|474187588|FG001|Overall Study|Study closed due to poor enrollment|1|||
131700519|NCT02634580|474187589|FG000|Double-blind Treatment Period|Subject Request|1|||
131700520|NCT02634580|474187590|FG001|Double-blind Treatment Period|Subject Request|0|||
131700521|NCT02634580|474187591|FG002|Double-blind Treatment Period|Subject Request|1|||
131700522|NCT02634580|474187592|FG003|Double-blind Treatment Period|Subject Request|1|||
131700523|NCT02634580|474187589|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131700524|NCT02634580|474187590|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
131700525|NCT02634580|474187591|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
131700526|NCT02634580|474187592|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
131700527|NCT02908880|474187594|FG000|Overall Study|Lost to Follow-up|4|||
131700528|NCT02908880|474187594|FG000|Overall Study|Explantation of the device|1|||
131700529|NCT02908880|474187594|FG000|Overall Study|Withdrawal by Subject|17|||
131700530|NCT02908880|474187594|FG000|Overall Study|Death|5|||
131700531|NCT02421887|474187595|FG000|Overall Study|Lost to Follow-up|5|||
131578169|NCT03743246|473743664|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
131578170|NCT03743246|473743665|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
131578171|NCT03743246|473743666|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
131578172|NCT03743246|473743663|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
131578173|NCT03743246|473743664|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
131578174|NCT03743246|473743665|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
131578175|NCT03743246|473743666|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
131578176|NCT03743246|473743663|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
131578177|NCT03743246|473743664|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
131578178|NCT03743246|473743665|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
131578179|NCT03743246|473743666|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
131578180|NCT02026258|473743667|FG000|Randomized|Did not start treatment|2|||
131578181|NCT02026258|473743668|FG001|Randomized|Did not start treatment|1|||
131578182|NCT02026258|473743667|FG000|Randomized|Change in treatment plan|1|||
131578183|NCT02026258|473743668|FG001|Randomized|Change in treatment plan|0|||
131578184|NCT02026258|473743667|FG000|Randomized|Presence of periodontal disease|1|||
131578185|NCT02026258|473743668|FG001|Randomized|Presence of periodontal disease|1|||
131578186|NCT02026258|473743667|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
131578187|NCT02026258|473743668|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
131578188|NCT02026258|473743667|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
131578189|NCT02026258|473743668|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
131578190|NCT00530842|473743669|FG000|Overall Study|Adverse Event|10|||
131578191|NCT00530842|473743670|FG001|Overall Study|Adverse Event|6|||
131578192|NCT00530842|473743669|FG000|Overall Study|Lack of Efficacy|2|||
131578193|NCT00530842|473743670|FG001|Overall Study|Lack of Efficacy|1|||
131578194|NCT00530842|473743669|FG000|Overall Study|Lost to Follow-up|0|||
131578195|NCT00530842|473743670|FG001|Overall Study|Lost to Follow-up|4|||
131578196|NCT00530842|473743669|FG000|Overall Study|Protocol Violation|3|||
131578197|NCT00530842|473743670|FG001|Overall Study|Protocol Violation|2|||
131578198|NCT00530842|473743669|FG000|Overall Study|Withdrawal by Subject|4|||
131578199|NCT00530842|473743670|FG001|Overall Study|Withdrawal by Subject|5|||
131578200|NCT00530842|473743669|FG000|Overall Study|Individual different reasons|4|||
131578201|NCT00530842|473743670|FG001|Overall Study|Individual different reasons|3|||
131578202|NCT00530842|473743669|FG000|Period 1|Adverse Event|7|||
131578203|NCT00530842|473743670|FG001|Period 1|Adverse Event|3|||
131578204|NCT00530842|473743669|FG000|Period 1|Lack of Efficacy|1|||
131578205|NCT00530842|473743670|FG001|Period 1|Lack of Efficacy|1|||
131578206|NCT00530842|473743669|FG000|Period 1|Protocol Violation|2|||
131578207|NCT00530842|473743670|FG001|Period 1|Protocol Violation|1|||
131578208|NCT00530842|473743669|FG000|Period 1|Withdrawal by Subject|2|||
131578209|NCT00530842|473743670|FG001|Period 1|Withdrawal by Subject|3|||
131578210|NCT00530842|473743669|FG000|Period 1|Individual different reasons|2|||
131578211|NCT00530842|473743670|FG001|Period 1|Individual different reasons|3|||
131578212|NCT00530842|473743669|FG000|Period 2|Adverse Event|3|||
131578213|NCT00530842|473743670|FG001|Period 2|Adverse Event|3|||
131578214|NCT00530842|473743669|FG000|Period 2|Lack of Efficacy|1|||
131578215|NCT00530842|473743670|FG001|Period 2|Lack of Efficacy|0|||
131578216|NCT00530842|473743669|FG000|Period 2|Lost to Follow-up|0|||
131578217|NCT00530842|473743670|FG001|Period 2|Lost to Follow-up|4|||
131578218|NCT00530842|473743669|FG000|Period 2|Protocol Violation|1|||
131578219|NCT00530842|473743670|FG001|Period 2|Protocol Violation|0|||
131578220|NCT00530842|473743669|FG000|Period 2|Withdrawal by Subject|1|||
131578221|NCT00530842|473743670|FG001|Period 2|Withdrawal by Subject|2|||
131578222|NCT00530842|473743669|FG000|Period 2|Individual different reasons|2|||
131578223|NCT00530842|473743670|FG001|Period 2|Individual different reasons|0|||
131578224|NCT00949975|473743671|FG000|Overall Study|Voluntary discontinuation|6|||
131578225|NCT00949975|473743672|FG001|Overall Study|Voluntary discontinuation|5|||
131578226|NCT00949975|473743673|FG002|Overall Study|Voluntary discontinuation|3|||
131578227|NCT00949975|473743674|FG003|Overall Study|Voluntary discontinuation|6|||
131578228|NCT00949975|473743671|FG000|Overall Study|Adverse Event|11|||
131578229|NCT00949975|473743672|FG001|Overall Study|Adverse Event|11|||
131578230|NCT00949975|473743673|FG002|Overall Study|Adverse Event|10|||
131578231|NCT00949975|473743674|FG003|Overall Study|Adverse Event|10|||
131578232|NCT00949975|473743671|FG000|Overall Study|Safety reason|0|||
131578233|NCT00949975|473743672|FG001|Overall Study|Safety reason|1|||
131578234|NCT00949975|473743673|FG002|Overall Study|Safety reason|0|||
131578235|NCT00949975|473743674|FG003|Overall Study|Safety reason|0|||
131578236|NCT00949975|473743671|FG000|Overall Study|Study-specific criteria|0|||
131578237|NCT00949975|473743672|FG001|Overall Study|Study-specific criteria|1|||
131578238|NCT00949975|473743673|FG002|Overall Study|Study-specific criteria|1|||
131578239|NCT00949975|473743674|FG003|Overall Study|Study-specific criteria|0|||
131578240|NCT00949975|473743671|FG000|Overall Study|Incorrect enrolment|5|||
131578241|NCT00949975|473743672|FG001|Overall Study|Incorrect enrolment|10|||
131578242|NCT00949975|473743673|FG002|Overall Study|Incorrect enrolment|4|||
131578243|NCT00949975|473743674|FG003|Overall Study|Incorrect enrolment|7|||
131578244|NCT00949975|473743671|FG000|Overall Study|Severe non-compliance|3|||
131578245|NCT00949975|473743672|FG001|Overall Study|Severe non-compliance|1|||
131578246|NCT00949975|473743673|FG002|Overall Study|Severe non-compliance|0|||
131578247|NCT00949975|473743674|FG003|Overall Study|Severe non-compliance|2|||
131578248|NCT00949975|473743671|FG000|Overall Study|Lost to Follow-up|1|||
131578249|NCT00949975|473743672|FG001|Overall Study|Lost to Follow-up|0|||
131578250|NCT00949975|473743673|FG002|Overall Study|Lost to Follow-up|1|||
131578251|NCT00949975|473743674|FG003|Overall Study|Lost to Follow-up|3|||
131578252|NCT00949975|473743671|FG000|Overall Study|Other|1|||
131578253|NCT00949975|473743672|FG001|Overall Study|Other|0|||
131578254|NCT00949975|473743673|FG002|Overall Study|Other|0|||
131578255|NCT00949975|473743674|FG003|Overall Study|Other|0|||
131578256|NCT04347954|473743675|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
131578257|NCT04347954|473743676|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
131578258|NCT04347954|473743677|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
131578259|NCT04347954|473743675|FG000|Overall Study|Lost to Follow-up|0|||
131578260|NCT04347954|473743676|FG001|Overall Study|Lost to Follow-up|1|||
131578261|NCT04347954|473743677|FG002|Overall Study|Lost to Follow-up|0|||
131578262|NCT02534350|473743678|FG000|Overall Study|Randomized But Not Treated|1|||
131578263|NCT02534350|473743679|FG001|Overall Study|Randomized But Not Treated|0|||
131578264|NCT02534350|473743678|FG000|Overall Study|Protocol Violation|1|||
131578265|NCT02534350|473743679|FG001|Overall Study|Protocol Violation|0|||
131578266|NCT02534350|473743678|FG000|Overall Study|Withdrew Consent|2|||
131578267|NCT02534350|473743679|FG001|Overall Study|Withdrew Consent|0|||
131578268|NCT03257813|473743695|FG000|Overall Study|Protocol Violation|6|||
131578269|NCT03257813|473743696|FG001|Overall Study|Protocol Violation|3|||
131578270|NCT00319436|473743701|FG000|Overall Study|Withdrawal by Subject|6|||
131578271|NCT00319436|473743702|FG001|Overall Study|Withdrawal by Subject|7|||
131578272|NCT02194933|473743713|FG000|Overall Study|Lost to Follow-up|1|||
131578273|NCT02194933|473743714|FG001|Overall Study|Lost to Follow-up|2|||
131578274|NCT02194933|473743713|FG000|Overall Study|Participant met withdrawal criteria|1|||
131578275|NCT02194933|473743714|FG001|Overall Study|Participant met withdrawal criteria|3|||
131578276|NCT02194933|473743713|FG000|Overall Study|Withdrawal by Subject|0|||
131578277|NCT02194933|473743714|FG001|Overall Study|Withdrawal by Subject|2|||
131578278|NCT02194933|473743713|FG000|Overall Study|Lack of Efficacy|1|||
131578279|NCT02194933|473743714|FG001|Overall Study|Lack of Efficacy|2|||
131438102|NCT00467740|473229513|FG001|Overall Study|Adverse Event|0|||
131438103|NCT00467740|473229514|FG002|Overall Study|Adverse Event|1|||
131438104|NCT00467740|473229515|FG003|Overall Study|Adverse Event|0|||
131578280|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
131578281|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
131578282|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
131578283|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
131786420|NCT00986154|474502059|FG000|Overall Study|Death|136|||
131438105|NCT00467740|473229516|FG004|Overall Study|Adverse Event|0|||
131578284|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
131578285|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
131578286|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
131578287|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
131578288|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
131578289|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
131578290|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
131578291|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
131578292|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
131578293|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
131578294|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
131578295|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
131578296|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
131578297|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
131578298|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
131578299|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
131578300|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
131578301|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
131578302|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
131578303|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
131578304|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
131578305|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
131578306|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
131578307|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
131578308|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
131578309|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
131578310|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
131578311|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
131578312|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
131578313|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578314|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
131578315|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
131578316|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
131578317|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578318|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578319|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578320|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578321|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578322|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578323|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131578324|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578325|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578326|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578327|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578328|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
131578329|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578330|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578331|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578332|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131578333|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131700532|NCT02421887|474187596|FG001|Overall Study|Lost to Follow-up|0|||
131700533|NCT02421887|474187595|FG000|Overall Study|Withdrawal by Subject|8|||
131700534|NCT02421887|474187596|FG001|Overall Study|Withdrawal by Subject|5|||
131700535|NCT02421887|474187595|FG000|Overall Study|Physician Decision|2|||
131700536|NCT02421887|474187596|FG001|Overall Study|Physician Decision|4|||
131700537|NCT02421887|474187595|FG000|Overall Study|Adverse Event|2|||
131700538|NCT02421887|474187596|FG001|Overall Study|Adverse Event|0|||
131438106|NCT00467740|473229512|FG000|Overall Study|Protocol Violation|0|||
131438107|NCT00467740|473229513|FG001|Overall Study|Protocol Violation|0|||
131438108|NCT00467740|473229514|FG002|Overall Study|Protocol Violation|1|||
131578334|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131700539|NCT04269395|474187600|FG000|Overall Study|Lost to Follow-up|1|||
131438109|NCT00467740|473229515|FG003|Overall Study|Protocol Violation|0|||
131438110|NCT00467740|473229516|FG004|Overall Study|Protocol Violation|0|||
131578335|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
131578336|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578337|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578338|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578339|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131700540|NCT04269395|474187601|FG001|Overall Study|Lost to Follow-up|0|||
131700541|NCT04269395|474187600|FG000|Overall Study|Study terminated by Sponsor|13|||
131438111|NCT00467740|473229512|FG000|Overall Study|Lost to Follow-up|0|||
131578340|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578341|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578342|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578343|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578344|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131786421|NCT00986154|474502060|FG001|Overall Study|Death|127|||
131786422|NCT00986154|474502059|FG000|Overall Study|Lost to Follow-up|7|||
131786423|NCT00986154|474502060|FG001|Overall Study|Lost to Follow-up|4|||
131786424|NCT00986154|474502059|FG000|Overall Study|Withdrawal by Subject|32|||
131786425|NCT00986154|474502060|FG001|Overall Study|Withdrawal by Subject|33|||
131786426|NCT00986154|474502059|FG000|Overall Study|investigator/subject decide not continue|6|||
131786427|NCT00986154|474502060|FG001|Overall Study|investigator/subject decide not continue|3|||
131786428|NCT00986154|474502059|FG000|Overall Study|never received study drug|25|||
131786429|NCT00986154|474502060|FG001|Overall Study|never received study drug|27|||
131786430|NCT00068445|474502062|FG000|Randomization|Cancel|1|||
131786431|NCT00068445|474502063|FG001|Randomization|Cancel|3|||
131786432|NCT00068445|474502062|FG000|Randomization|Ineligible|1|||
131786433|NCT00068445|474502063|FG001|Randomization|Ineligible|1|||
131786434|NCT00068445|474502062|FG000|Treatment|Refused Further Treatment|13|||
131786435|NCT00068445|474502063|FG001|Treatment|Refused Further Treatment|10|||
131786436|NCT00068445|474502062|FG000|Treatment|Adverse Event|7|||
131786437|NCT00068445|474502063|FG001|Treatment|Adverse Event|1|||
131786438|NCT00068445|474502062|FG000|Treatment|Other (Specifics not available)|9|||
131786439|NCT00068445|474502063|FG001|Treatment|Other (Specifics not available)|5|||
131786440|NCT00879970|474502064|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
131786441|NCT00879970|474502065|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
131786442|NCT00879970|474502066|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
131786443|NCT00879970|474502067|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
131786444|NCT00879970|474502068|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
131786445|NCT00879970|474502064|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
131786446|NCT00879970|474502065|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
131786447|NCT00879970|474502066|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
131786448|NCT00879970|474502067|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
131786449|NCT00879970|474502068|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
131786450|NCT00879970|474502064|FG000|Period 1 TZD Randomization|Death|2|||
131786451|NCT00879970|474502065|FG001|Period 1 TZD Randomization|Death|1|||
131786452|NCT00879970|474502066|FG002|Period 1 TZD Randomization|Death|0|||
131786453|NCT00879970|474502067|FG003|Period 1 TZD Randomization|Death|0|||
131786454|NCT00879970|474502068|FG004|Period 1 TZD Randomization|Death|0|||
131786455|NCT00879970|474502064|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
131786456|NCT00879970|474502065|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
131786457|NCT00879970|474502066|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
131786458|NCT00879970|474502067|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
131786459|NCT00879970|474502068|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
131786460|NCT00879970|474502064|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
131786461|NCT00879970|474502065|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
131786462|NCT00879970|474502066|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
131786463|NCT00879970|474502067|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
131786464|NCT00879970|474502068|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
131786465|NCT00879970|474502064|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131786466|NCT00879970|474502065|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131786467|NCT00879970|474502066|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131786468|NCT00879970|474502067|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131786469|NCT00879970|474502068|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
131786470|NCT00879970|474502064|FG000|Period 2 Vitamin D Randomization|Death|0|||
131786471|NCT00879970|474502065|FG001|Period 2 Vitamin D Randomization|Death|0|||
131786472|NCT00879970|474502066|FG002|Period 2 Vitamin D Randomization|Death|0|||
131786473|NCT00879970|474502067|FG003|Period 2 Vitamin D Randomization|Death|2|||
131786474|NCT00879970|474502068|FG004|Period 2 Vitamin D Randomization|Death|0|||
131786475|NCT03125915|474502069|FG000|1 Month Follow up|Lost to Follow-up|3|||
131786476|NCT03125915|474502070|FG001|1 Month Follow up|Lost to Follow-up|3|||
131578345|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131578346|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
131578347|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
131786477|NCT03125915|474502071|FG002|1 Month Follow up|Lost to Follow-up|2|||
131578348|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
131578349|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
131578350|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
131438112|NCT00467740|473229513|FG001|Overall Study|Lost to Follow-up|1|||
131578351|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
131578352|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
131578353|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
131578354|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
131578355|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
131578356|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
131578357|NCT02914522|473743715|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578358|NCT02914522|473743716|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
131578359|NCT02914522|473743717|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578360|NCT02914522|473743718|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578361|NCT02914522|473743719|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
131578362|NCT02914522|473743720|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
131578363|NCT02914522|473743721|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578364|NCT02914522|473743722|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578365|NCT02914522|473743723|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578366|NCT02914522|473743724|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578367|NCT02914522|473743725|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131578368|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131578369|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131578370|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131578371|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131578372|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131578373|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131578374|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
131578375|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
131578376|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
131578377|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
131578378|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
131578379|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131578380|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131578381|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131578382|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131578383|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131578384|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131578385|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
131578386|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
131578387|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
131578388|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
131578389|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
131578390|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131578391|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131578392|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131700542|NCT04269395|474187601|FG001|Overall Study|Study terminated by Sponsor|10|||
131700543|NCT00584233|474187602|FG000|Overall Study|Withdrawal by Subject|5|||
131700544|NCT00584233|474187602|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
131700545|NCT02222714|474187603|FG000|Overall Study|Death|0|||
131700546|NCT02222714|474187604|FG001|Overall Study|Death|2|||
131700547|NCT02222714|474187605|FG002|Overall Study|Death|3|||
131700548|NCT02222714|474187606|FG003|Overall Study|Death|4|||
131700549|NCT02222714|474187607|FG004|Overall Study|Death|6|||
131700550|NCT02222714|474187603|FG000|Overall Study|Withdrawal by Subject|0|||
131700551|NCT02222714|474187604|FG001|Overall Study|Withdrawal by Subject|0|||
131700552|NCT02222714|474187605|FG002|Overall Study|Withdrawal by Subject|1|||
131700553|NCT02222714|474187606|FG003|Overall Study|Withdrawal by Subject|0|||
131700554|NCT02222714|474187607|FG004|Overall Study|Withdrawal by Subject|1|||
131700555|NCT03946670|474187610|FG000|Overall Study|Progressive Disease|26|||
131700556|NCT03946670|474187611|FG001|Overall Study|Progressive Disease|23|||
131700557|NCT03946670|474187610|FG000|Overall Study|Adverse Event|7|||
131700558|NCT03946670|474187611|FG001|Overall Study|Adverse Event|9|||
131700559|NCT03946670|474187610|FG000|Overall Study|Death|5|||
131700560|NCT03946670|474187611|FG001|Overall Study|Death|6|||
131700561|NCT03946670|474187610|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
131700562|NCT03946670|474187611|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
131700563|NCT03946670|474187610|FG000|Overall Study|Subject Decision|4|||
131438113|NCT00467740|473229514|FG002|Overall Study|Lost to Follow-up|0|||
131700564|NCT03946670|474187611|FG001|Overall Study|Subject Decision|4|||
131700565|NCT03946670|474187610|FG000|Overall Study|Physician Decision|3|||
131700566|NCT03946670|474187611|FG001|Overall Study|Physician Decision|3|||
131438114|NCT00467740|473229515|FG003|Overall Study|Lost to Follow-up|0|||
131578393|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131578394|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131578395|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131578396|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
131578397|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
131578398|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
131578399|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131578400|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
131578401|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131578402|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131578403|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131578404|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131578405|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131578406|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131578407|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
131578408|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
131578409|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
131578410|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
131578411|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
131578412|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
131578413|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
131578414|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
131578415|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
131578416|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
131578417|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
131578418|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
131578419|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
131578420|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
131578421|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
131578422|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
131578423|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578424|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578425|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578426|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578427|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578428|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578429|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578430|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
131578431|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
131578432|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578433|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131578434|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131700567|NCT03946670|474187610|FG000|Overall Study|New Therapy for Study Indication|1|||
131700568|NCT03946670|474187611|FG001|Overall Study|New Therapy for Study Indication|0|||
131700569|NCT03946670|474187610|FG000|Overall Study|Not treated|1|||
131700570|NCT03946670|474187611|FG001|Overall Study|Not treated|1|||
131700571|NCT04537208|474187614|FG000|Overall Study|Adverse Event|0|||
131700572|NCT04537208|474187615|FG001|Overall Study|Adverse Event|0|||
131700573|NCT04537208|474187616|FG002|Overall Study|Adverse Event|0|||
131700574|NCT04537208|474187617|FG003|Overall Study|Adverse Event|0|||
131700575|NCT04537208|474187618|FG004|Overall Study|Adverse Event|0|||
131700576|NCT04537208|474187619|FG005|Overall Study|Adverse Event|0|||
131700577|NCT04537208|474187620|FG006|Overall Study|Adverse Event|0|||
131700578|NCT04537208|474187621|FG007|Overall Study|Adverse Event|0|||
131700579|NCT04537208|474187622|FG008|Overall Study|Adverse Event|1|||
131700580|NCT04537208|474187623|FG009|Overall Study|Adverse Event|0|||
131700581|NCT04537208|474187624|FG010|Overall Study|Adverse Event|0|||
131578435|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578436|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578437|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578438|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578439|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131700582|NCT04537208|474187614|FG000|Overall Study|Protocol deviation|0|||
131700583|NCT04537208|474187615|FG001|Overall Study|Protocol deviation|0|||
131700584|NCT04537208|474187616|FG002|Overall Study|Protocol deviation|2|||
131700585|NCT04537208|474187617|FG003|Overall Study|Protocol deviation|0|||
131700586|NCT04537208|474187618|FG004|Overall Study|Protocol deviation|0|||
131578440|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578441|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578442|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
131578443|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
131578444|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131578445|NCT02914522|473743715|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578446|NCT02914522|473743716|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578447|NCT02914522|473743717|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578448|NCT02914522|473743718|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578449|NCT02914522|473743719|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578450|NCT02914522|473743720|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578451|NCT02914522|473743721|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578452|NCT02914522|473743722|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578453|NCT02914522|473743723|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578454|NCT02914522|473743724|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
131578455|NCT02914522|473743725|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131578456|NCT00756730|473743727|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
131700587|NCT04537208|474187619|FG005|Overall Study|Protocol deviation|2|||
131700588|NCT04537208|474187620|FG006|Overall Study|Protocol deviation|4|||
131700589|NCT04537208|474187621|FG007|Overall Study|Protocol deviation|0|||
131700590|NCT04537208|474187622|FG008|Overall Study|Protocol deviation|1|||
131700591|NCT04537208|474187623|FG009|Overall Study|Protocol deviation|0|||
131700592|NCT04537208|474187624|FG010|Overall Study|Protocol deviation|2|||
131700593|NCT04537208|474187614|FG000|Overall Study|Withdrawal by Subject|4|||
131700594|NCT04537208|474187615|FG001|Overall Study|Withdrawal by Subject|2|||
131700595|NCT04537208|474187616|FG002|Overall Study|Withdrawal by Subject|1|||
131700596|NCT04537208|474187617|FG003|Overall Study|Withdrawal by Subject|3|||
131700597|NCT04537208|474187618|FG004|Overall Study|Withdrawal by Subject|5|||
131700598|NCT04537208|474187619|FG005|Overall Study|Withdrawal by Subject|1|||
131700599|NCT04537208|474187620|FG006|Overall Study|Withdrawal by Subject|6|||
131700600|NCT04537208|474187621|FG007|Overall Study|Withdrawal by Subject|1|||
131700601|NCT04537208|474187622|FG008|Overall Study|Withdrawal by Subject|7|||
131578457|NCT00756730|473743728|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
131578458|NCT00756730|473743727|FG000|Overall Study|persistent low-level viremmia|0|||
131578459|NCT00756730|473743728|FG001|Overall Study|persistent low-level viremmia|1|||
131578460|NCT03383146|473743730|FG000|Overall Study|Screen Failure|1|||
131578461|NCT03383146|473743731|FG001|Overall Study|Screen Failure|0|||
131578462|NCT03383146|473743730|FG000|Overall Study|Adverse Event|6|||
131578463|NCT03383146|473743731|FG001|Overall Study|Adverse Event|18|||
131578464|NCT03383146|473743730|FG000|Overall Study|Lack of Efficacy|0|||
131578465|NCT03383146|473743731|FG001|Overall Study|Lack of Efficacy|3|||
131578466|NCT03383146|473743730|FG000|Overall Study|Withdrawal by Subject|20|||
131578467|NCT03383146|473743731|FG001|Overall Study|Withdrawal by Subject|36|||
131578468|NCT03383146|473743730|FG000|Overall Study|Lost to Follow-up|5|||
131578469|NCT03383146|473743731|FG001|Overall Study|Lost to Follow-up|15|||
131578470|NCT03383146|473743730|FG000|Overall Study|Death|0|||
131578471|NCT03383146|473743731|FG001|Overall Study|Death|2|||
131578472|NCT03383146|473743730|FG000|Overall Study|Physician Decision|0|||
131578473|NCT03383146|473743731|FG001|Overall Study|Physician Decision|1|||
131578474|NCT03383146|473743730|FG000|Overall Study|Protocol Deviation|1|||
131578475|NCT03383146|473743731|FG001|Overall Study|Protocol Deviation|8|||
131578476|NCT03383146|473743730|FG000|Overall Study|Study Terminated by the Sponsor|48|||
131578477|NCT03383146|473743731|FG001|Overall Study|Study Terminated by the Sponsor|95|||
131578478|NCT03383146|473743730|FG000|Overall Study|Reason not Specified|4|||
131578479|NCT03383146|473743731|FG001|Overall Study|Reason not Specified|6|||
131578480|NCT00639002|473743734|FG000|Overall Study|Death|1|||
131578481|NCT00639002|473743734|FG000|Overall Study|Adverse Event|1|||
131578482|NCT00639002|473743734|FG000|Overall Study|Protocol Violation|1|||
131578483|NCT00639002|473743734|FG000|Overall Study|Disease progression|3|||
131578484|NCT00639002|473743734|FG000|Overall Study|Physician Decision|6|||
131578485|NCT00639002|473743734|FG000|Overall Study|Lack of Efficacy|1|||
131578486|NCT05382104|473743735|FG000|Period 2 (2 Days)|Adverse Event|0|||
131578487|NCT05382104|473743736|FG001|Period 2 (2 Days)|Adverse Event|1|||
131578488|NCT05382104|473743737|FG002|Period 2 (2 Days)|Adverse Event|0|||
131578489|NCT05382104|473743738|FG003|Period 2 (2 Days)|Adverse Event|0|||
131578490|NCT05382104|473743739|FG004|Period 2 (2 Days)|Adverse Event|0|||
131578491|NCT05382104|473743740|FG005|Period 2 (2 Days)|Adverse Event|0|||
131578492|NCT01161498|473743741|FG000|Overall Study|Disease Progression|0|||
131578493|NCT01161498|473743742|FG001|Overall Study|Disease Progression|1|||
131578494|NCT05686421|473743750|FG000|Overall Study|Screen failure|22|||
131578495|NCT05686421|473743751|FG001|Overall Study|Screen failure|0|||
131578496|NCT05686421|473743752|FG002|Overall Study|Screen failure|0|||
131578497|NCT05686421|473743753|FG003|Overall Study|Screen failure|0|||
131578498|NCT00367055|473743757|FG000|Overall Study|Adverse Event|6|||
131578499|NCT00367055|473743758|FG001|Overall Study|Adverse Event|3|||
131578500|NCT00367055|473743757|FG000|Overall Study|Patient's Willing|3|||
131578501|NCT00367055|473743758|FG001|Overall Study|Patient's Willing|2|||
131578502|NCT00367055|473743757|FG000|Overall Study|Lack of Efficacy|1|||
131578503|NCT00367055|473743758|FG001|Overall Study|Lack of Efficacy|2|||
131578504|NCT00367055|473743757|FG000|Overall Study|Lost to Follow-up|1|||
131578505|NCT00367055|473743758|FG001|Overall Study|Lost to Follow-up|1|||
131578506|NCT00367055|473743757|FG000|Overall Study|Protocol Violation|0|||
131578507|NCT00367055|473743758|FG001|Overall Study|Protocol Violation|1|||
131578508|NCT00367055|473743757|FG000|Overall Study|Stopping Criterion Met|0|||
131578509|NCT00367055|473743758|FG001|Overall Study|Stopping Criterion Met|1|||
131578510|NCT00367055|473743757|FG000|Overall Study|Participant Living too Far from Hospital|0|||
131578511|NCT00367055|473743758|FG001|Overall Study|Participant Living too Far from Hospital|1|||
131578512|NCT00940992|473743761|FG000|Overall Study|Adverse Event|2|||
131578513|NCT00940992|473743762|FG001|Overall Study|Adverse Event|0|||
131578514|NCT00940992|473743763|FG002|Overall Study|Adverse Event|1|||
131578515|NCT00940992|473743761|FG000|Overall Study|subject request|2|||
131578516|NCT00940992|473743762|FG001|Overall Study|subject request|1|||
131578517|NCT00940992|473743763|FG002|Overall Study|subject request|0|||
131578518|NCT00940992|473743761|FG000|Overall Study|Lost to Follow-up|0|||
131700602|NCT04537208|474187623|FG009|Overall Study|Withdrawal by Subject|2|||
131578519|NCT00940992|473743762|FG001|Overall Study|Lost to Follow-up|1|||
131578520|NCT00940992|473743763|FG002|Overall Study|Lost to Follow-up|1|||
131578521|NCT03210402|473743764|FG000|Overall Study|Withdrawal by Subject|0|||
131700603|NCT04537208|474187624|FG010|Overall Study|Withdrawal by Subject|4|||
131578522|NCT03210402|473743765|FG001|Overall Study|Withdrawal by Subject|1|||
131578523|NCT02517307|473743782|FG000|Overall Study|Withdrawal by Subject|1|||
131578524|NCT02517307|473743783|FG001|Overall Study|Withdrawal by Subject|0|||
131578525|NCT02517307|473743784|FG002|Overall Study|Withdrawal by Subject|1|||
131578526|NCT02517307|473743785|FG003|Overall Study|Withdrawal by Subject|0|||
131578527|NCT02517307|473743782|FG000|Overall Study|Protocol Violation|0|||
131578528|NCT02517307|473743783|FG001|Overall Study|Protocol Violation|0|||
131578529|NCT02517307|473743784|FG002|Overall Study|Protocol Violation|1|||
131578530|NCT02517307|473743785|FG003|Overall Study|Protocol Violation|1|||
131578531|NCT00823979|473743786|FG000|Overall Study|Lack of Efficacy|13|||
131700604|NCT04537208|474187614|FG000|Overall Study|Lost to Follow-up|4|||
131578532|NCT00823979|473743787|FG001|Overall Study|Lack of Efficacy|16|||
131578533|NCT00823979|473743788|FG002|Overall Study|Lack of Efficacy|9|||
131578534|NCT00823979|473743786|FG000|Overall Study|Lost to Follow-up|2|||
131578535|NCT00823979|473743787|FG001|Overall Study|Lost to Follow-up|1|||
131578536|NCT00823979|473743788|FG002|Overall Study|Lost to Follow-up|0|||
131578537|NCT00823979|473743786|FG000|Overall Study|Withdrawal by Subject|2|||
131578538|NCT00823979|473743787|FG001|Overall Study|Withdrawal by Subject|3|||
131578539|NCT00823979|473743788|FG002|Overall Study|Withdrawal by Subject|2|||
131578540|NCT00823979|473743786|FG000|Overall Study|Protocol Violation|1|||
131578541|NCT00823979|473743787|FG001|Overall Study|Protocol Violation|1|||
131578542|NCT00823979|473743788|FG002|Overall Study|Protocol Violation|0|||
131578543|NCT00823979|473743786|FG000|Overall Study|Pregnancy|0|||
131578544|NCT00823979|473743787|FG001|Overall Study|Pregnancy|1|||
131578545|NCT00823979|473743788|FG002|Overall Study|Pregnancy|0|||
131578546|NCT00823979|473743786|FG000|Overall Study|Adverse Event|0|||
131578547|NCT00823979|473743787|FG001|Overall Study|Adverse Event|2|||
131578548|NCT00823979|473743788|FG002|Overall Study|Adverse Event|4|||
131578549|NCT00823979|473743786|FG000|Overall Study|Other|2|||
131578550|NCT00823979|473743787|FG001|Overall Study|Other|0|||
131578551|NCT00823979|473743788|FG002|Overall Study|Other|1|||
131578552|NCT00823979|473743786|FG000|Overall Study|Randomized but not Treated|4|||
131578553|NCT00823979|473743787|FG001|Overall Study|Randomized but not Treated|3|||
131578554|NCT00823979|473743788|FG002|Overall Study|Randomized but not Treated|1|||
131578555|NCT00823979|473743786|FG000|Overall Study|Study Terminated by Sponsor|5|||
131578556|NCT00823979|473743787|FG001|Overall Study|Study Terminated by Sponsor|5|||
131578557|NCT00823979|473743788|FG002|Overall Study|Study Terminated by Sponsor|7|||
131578558|NCT03586544|473743789|FG000|First Intervention|Adverse Event|0|||
131578559|NCT03586544|473743790|FG001|First Intervention|Adverse Event|1|||
131578560|NCT03586544|473743789|FG000|Second Intervention|Withdrawal by Subject|0|||
131578561|NCT03586544|473743790|FG001|Second Intervention|Withdrawal by Subject|1|||
131578562|NCT03523091|473743791|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
131578563|NCT03523091|473743792|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
131578564|NCT03523091|473743791|FG000|Overall Study|Withdrawal by Subject|0|||
131578565|NCT03523091|473743792|FG001|Overall Study|Withdrawal by Subject|3|||
131578566|NCT03523091|473743791|FG000|Overall Study|Increase Botox dose|0|||
131578567|NCT03523091|473743792|FG001|Overall Study|Increase Botox dose|1|||
131578568|NCT03863834|473743798|FG000|Overall Study|Lost to Follow-up|3|||
131578569|NCT02685488|473743799|FG000|Overall Study|Withdrawal by Subject|0|||
131578570|NCT02685488|473743800|FG001|Overall Study|Withdrawal by Subject|1|||
131578571|NCT05019729|473743801|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131578572|NCT05019729|473743802|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131578573|NCT05019729|473743803|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131578574|NCT05019729|473743804|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131578575|NCT05019729|473743805|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
131578576|NCT05019729|473743806|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131578577|NCT00361283|473743815|FG000|Overall Study|Lost to Follow-up|27|||
131578578|NCT03768206|473743816|FG000|Overall Study|Lost to Follow-up|2|||
131578579|NCT03768206|473743817|FG001|Overall Study|Lost to Follow-up|1|||
131578580|NCT03768206|473743816|FG000|Overall Study|Withdrawal by Subject|0|||
131578581|NCT03768206|473743817|FG001|Overall Study|Withdrawal by Subject|1|||
131578582|NCT02551055|473743820|FG000|Overall Study|Death|2|||
131578583|NCT02551055|473743821|FG001|Overall Study|Death|4|||
131578584|NCT02551055|473743822|FG002|Overall Study|Death|2|||
131578585|NCT02551055|473743823|FG003|Overall Study|Death|2|||
131578586|NCT02551055|473743824|FG004|Overall Study|Death|2|||
131578587|NCT02551055|473743825|FG005|Overall Study|Death|1|||
131578588|NCT02551055|473743826|FG006|Overall Study|Death|2|||
131578589|NCT02551055|473743827|FG007|Overall Study|Death|0|||
131578590|NCT02551055|473743820|FG000|Overall Study|Study Terminated by Sponsor|1|||
131578591|NCT02551055|473743821|FG001|Overall Study|Study Terminated by Sponsor|1|||
131578592|NCT02551055|473743822|FG002|Overall Study|Study Terminated by Sponsor|0|||
131578593|NCT02551055|473743823|FG003|Overall Study|Study Terminated by Sponsor|2|||
131578594|NCT02551055|473743824|FG004|Overall Study|Study Terminated by Sponsor|2|||
131578595|NCT02551055|473743825|FG005|Overall Study|Study Terminated by Sponsor|0|||
131578596|NCT02551055|473743826|FG006|Overall Study|Study Terminated by Sponsor|0|||
131578597|NCT02551055|473743827|FG007|Overall Study|Study Terminated by Sponsor|0|||
131578598|NCT02551055|473743820|FG000|Overall Study|Withdrawal by Subject|1|||
131578599|NCT02551055|473743821|FG001|Overall Study|Withdrawal by Subject|1|||
131578600|NCT02551055|473743822|FG002|Overall Study|Withdrawal by Subject|0|||
131578601|NCT02551055|473743823|FG003|Overall Study|Withdrawal by Subject|1|||
131578602|NCT02551055|473743824|FG004|Overall Study|Withdrawal by Subject|2|||
131578603|NCT02551055|473743825|FG005|Overall Study|Withdrawal by Subject|0|||
131578604|NCT02551055|473743826|FG006|Overall Study|Withdrawal by Subject|0|||
131578605|NCT02551055|473743827|FG007|Overall Study|Withdrawal by Subject|0|||
131578606|NCT02551055|473743820|FG000|Overall Study|Reason not specified|0|||
131578607|NCT02551055|473743821|FG001|Overall Study|Reason not specified|0|||
131578608|NCT02551055|473743822|FG002|Overall Study|Reason not specified|0|||
131578609|NCT02551055|473743823|FG003|Overall Study|Reason not specified|0|||
131578610|NCT02551055|473743824|FG004|Overall Study|Reason not specified|1|||
131578611|NCT02551055|473743825|FG005|Overall Study|Reason not specified|0|||
131578612|NCT02551055|473743826|FG006|Overall Study|Reason not specified|1|||
131578613|NCT02551055|473743827|FG007|Overall Study|Reason not specified|0|||
131578614|NCT00430300|473743831|FG000|Overall Study|Adverse Event|0|||
131578615|NCT00430300|473743832|FG001|Overall Study|Adverse Event|2|||
131578616|NCT00430300|473743833|FG002|Overall Study|Adverse Event|1|||
131578617|NCT00430300|473743834|FG003|Overall Study|Adverse Event|1|||
131578618|NCT00430300|473743831|FG000|Overall Study|Withdrawal by Subject|1|||
131578619|NCT00430300|473743832|FG001|Overall Study|Withdrawal by Subject|0|||
131786478|NCT03125915|474502072|FG003|1 Month Follow up|Lost to Follow-up|3|||
131786479|NCT03125915|474502069|FG000|3 Month Follow-up|Lost to Follow-up|6|||
131786480|NCT03125915|474502070|FG001|3 Month Follow-up|Lost to Follow-up|4|||
131786481|NCT03125915|474502071|FG002|3 Month Follow-up|Lost to Follow-up|4|||
131786482|NCT03125915|474502072|FG003|3 Month Follow-up|Lost to Follow-up|2|||
131786483|NCT03125915|474502069|FG000|6 Month Follow-up|Lost to Follow-up|7|||
131786484|NCT03125915|474502070|FG001|6 Month Follow-up|Lost to Follow-up|3|||
131786485|NCT03125915|474502071|FG002|6 Month Follow-up|Lost to Follow-up|6|||
131786486|NCT03125915|474502072|FG003|6 Month Follow-up|Lost to Follow-up|3|||
131786487|NCT02475980|474502073|FG000|Overall Study|Lost to Follow-up|4|||
131786488|NCT02475980|474502073|FG000|Overall Study|Withdrawal by Subject|1|||
131786489|NCT00990093|474502074|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
131578620|NCT00430300|473743833|FG002|Overall Study|Withdrawal by Subject|5|||
131578621|NCT00430300|473743834|FG003|Overall Study|Withdrawal by Subject|0|||
131578622|NCT00430300|473743831|FG000|Overall Study|Laboratory abnormality|1|||
131578623|NCT00430300|473743832|FG001|Overall Study|Laboratory abnormality|0|||
131578624|NCT00430300|473743833|FG002|Overall Study|Laboratory abnormality|0|||
131578625|NCT00430300|473743834|FG003|Overall Study|Laboratory abnormality|0|||
131578626|NCT00430300|473743831|FG000|Overall Study|Other|0|||
131578627|NCT00430300|473743832|FG001|Overall Study|Other|0|||
131578628|NCT00430300|473743833|FG002|Overall Study|Other|0|||
131578629|NCT00430300|473743834|FG003|Overall Study|Other|1|||
131578630|NCT02754479|473743835|FG000|Overall Study|Lost to Follow-up|1|||
131786490|NCT00990093|474502075|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
131786491|NCT00990093|474502074|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
131786492|NCT00990093|474502075|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
131786493|NCT00990093|474502074|FG000|Test Period 1 (1-14 Days)|Other|1|||
131786494|NCT00990093|474502075|FG001|Test Period 1 (1-14 Days)|Other|0|||
131786495|NCT00990093|474502074|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
131786496|NCT00990093|474502075|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
131786497|NCT00990093|474502074|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
131786498|NCT00990093|474502075|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
131786499|NCT00990093|474502074|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
131786500|NCT00990093|474502075|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
131578631|NCT01049503|473745617|FG000|Overall Study|Lost to Follow-up|11|||
131578632|NCT01049503|473745618|FG001|Overall Study|Lost to Follow-up|12|||
131578633|NCT01049503|473745619|FG002|Overall Study|Lost to Follow-up|24|||
131578634|NCT01049503|473745620|FG003|Overall Study|Lost to Follow-up|26|||
131578635|NCT01049503|473745621|FG004|Overall Study|Lost to Follow-up|27|||
131578636|NCT01049503|473745622|FG005|Overall Study|Lost to Follow-up|8|||
131578637|NCT00726596|473745623|FG000|Overall Study|Adverse Event|2|||
131578638|NCT00726596|473745624|FG001|Overall Study|Adverse Event|1|||
131578639|NCT00726596|473745623|FG000|Overall Study|Withdrawal by Subject|3|||
131578640|NCT00726596|473745624|FG001|Overall Study|Withdrawal by Subject|3|||
131578641|NCT02974634|473745625|FG000|Overall Study|Advanced disease|12|||
131578642|NCT02974634|473745626|FG001|Overall Study|Advanced disease|3|||
131578643|NCT02974634|473745625|FG000|Overall Study|Noncompliance|3|||
131578644|NCT02974634|473745626|FG001|Overall Study|Noncompliance|7|||
131578645|NCT02974634|473745625|FG000|Overall Study|intervention technology related issues|5|||
131578646|NCT02974634|473745626|FG001|Overall Study|intervention technology related issues|0|||
131578647|NCT02974634|473745625|FG000|Overall Study|Death|8|||
131578648|NCT02974634|473745626|FG001|Overall Study|Death|11|||
131786501|NCT00990093|474502074|FG000|Test Period 2 (15-28 Days)|Other|0|||
131786502|NCT00990093|474502075|FG001|Test Period 2 (15-28 Days)|Other|1|||
131578649|NCT02962674|473745635|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
131578650|NCT00364286|473745636|FG000|Overall Study|Withdrawal by Subject|1|||
131578651|NCT00364286|473745636|FG000|Overall Study|Adverse Event|2|||
131578652|NCT00391846|473745637|FG000|Overall Study|Adverse Event|4|||
131578653|NCT00391846|473745638|FG001|Overall Study|Adverse Event|1|||
131578654|NCT00391846|473745637|FG000|Overall Study|Did not meet the required elig. crit|2|||
131786503|NCT00995930|474502079|FG000|Overall Study|Protocol deviation|2|||
131786504|NCT00995930|474502080|FG001|Overall Study|Protocol deviation|5|||
131786505|NCT00995930|474502079|FG000|Overall Study|Death|0|||
131786506|NCT00995930|474502080|FG001|Overall Study|Death|1|||
131786507|NCT00995930|474502079|FG000|Overall Study|Administrative problems|4|||
131786508|NCT00995930|474502080|FG001|Overall Study|Administrative problems|2|||
131786509|NCT00995930|474502079|FG000|Overall Study|Lost to Follow-up|1|||
131786510|NCT00995930|474502080|FG001|Overall Study|Lost to Follow-up|2|||
131786511|NCT00995930|474502079|FG000|Overall Study|Withdrawal by Subject|3|||
131786512|NCT00995930|474502080|FG001|Overall Study|Withdrawal by Subject|4|||
131786513|NCT00995930|474502079|FG000|Overall Study|Adverse Event|11|||
131786514|NCT00995930|474502080|FG001|Overall Study|Adverse Event|14|||
131786515|NCT01458119|474502083|FG000|Overall Study|Physician Decision|4|||
131786516|NCT01458119|474502083|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
131786517|NCT01458119|474502083|FG000|Overall Study|Pregnancy|1|||
131786518|NCT01458119|474502083|FG000|Overall Study|Death|2|||
131786519|NCT01458119|474502083|FG000|Overall Study|Adverse Event|1|||
131786520|NCT01458119|474502083|FG000|Overall Study|Consent Withdrawn by Participant|8|||
131786521|NCT01458119|474502083|FG000|Overall Study|Non-compliance With Study Drug|3|||
131786522|NCT05003167|474502084|FG000|Overall Study|Withdrawal by Subject|1|||
131786523|NCT00430638|474502085|FG000|Overall Study|Adverse Event|15|||
131786524|NCT00430638|474502086|FG001|Overall Study|Adverse Event|15|||
131786525|NCT00430638|474502085|FG000|Overall Study|Uncontrolled blood pressure|48|||
131786526|NCT00430638|474502086|FG001|Overall Study|Uncontrolled blood pressure|13|||
131786527|NCT00430638|474502085|FG000|Overall Study|Lost to Follow-up|1|||
131786528|NCT00430638|474502086|FG001|Overall Study|Lost to Follow-up|7|||
131786529|NCT00430638|474502085|FG000|Overall Study|Protocol Violation|6|||
131786530|NCT00430638|474502086|FG001|Overall Study|Protocol Violation|4|||
131786531|NCT00430638|474502085|FG000|Overall Study|Withdrawal by Subject|4|||
131786532|NCT00430638|474502086|FG001|Overall Study|Withdrawal by Subject|6|||
131786533|NCT00430638|474502085|FG000|Overall Study|Non-compliant|2|||
131786534|NCT00430638|474502086|FG001|Overall Study|Non-compliant|1|||
131786535|NCT00430638|474502085|FG000|Overall Study|Other|2|||
131786536|NCT00430638|474502086|FG001|Overall Study|Other|2|||
131578655|NCT00391846|473745638|FG001|Overall Study|Did not meet the required elig. crit|2|||
131578656|NCT00391846|473745637|FG000|Overall Study|Withdrawal by Subject|2|||
131578657|NCT00391846|473745638|FG001|Overall Study|Withdrawal by Subject|3|||
131578658|NCT00391846|473745637|FG000|Overall Study|Developed study specific DC criteria|0|||
131578659|NCT00391846|473745638|FG001|Overall Study|Developed study specific DC criteria|1|||
131786537|NCT02367781|474502087|FG000|Overall Study|Withdrawal by Subject|20|||
131786538|NCT02367781|474502088|FG001|Overall Study|Withdrawal by Subject|13|||
131786539|NCT02367781|474502087|FG000|Overall Study|Protocol Violation|0|||
131786540|NCT02367781|474502088|FG001|Overall Study|Protocol Violation|1|||
131786541|NCT02367781|474502087|FG000|Overall Study|Physician Decision|7|||
131786542|NCT02367781|474502088|FG001|Overall Study|Physician Decision|0|||
131786543|NCT02367781|474502087|FG000|Overall Study|Randomized in Error|5|||
131786544|NCT02367781|474502088|FG001|Overall Study|Randomized in Error|4|||
131786545|NCT02367781|474502087|FG000|Overall Study|Non-Compliance|1|||
131786546|NCT02367781|474502088|FG001|Overall Study|Non-Compliance|0|||
131786547|NCT02367781|474502087|FG000|Overall Study|Lost to Follow-up|1|||
131786548|NCT02367781|474502088|FG001|Overall Study|Lost to Follow-up|2|||
131786549|NCT02367781|474502087|FG000|Overall Study|Death|330|||
131786550|NCT02367781|474502088|FG001|Overall Study|Death|176|||
131786551|NCT02367781|474502087|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
131786552|NCT02367781|474502088|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
131786553|NCT02367781|474502087|FG000|Overall Study|Prolonged Hospitalization|1|||
131786554|NCT02367781|474502088|FG001|Overall Study|Prolonged Hospitalization|0|||
131786555|NCT02367781|474502087|FG000|Overall Study|Death Prior First Dose|1|||
131786556|NCT02367781|474502088|FG001|Overall Study|Death Prior First Dose|0|||
131786557|NCT02367781|474502087|FG000|Overall Study|Administrative-Change Facility|1|||
131786558|NCT02367781|474502088|FG001|Overall Study|Administrative-Change Facility|0|||
131578660|NCT01227278|473745639|FG000|Overall Study|Withdrawal by Subject|4|||
131578661|NCT01227278|473745640|FG001|Overall Study|Withdrawal by Subject|4|||
131578662|NCT01227278|473745639|FG000|Overall Study|Death|0|||
131578663|NCT01227278|473745640|FG001|Overall Study|Death|2|||
131578664|NCT01227278|473745639|FG000|Overall Study|Other|1|||
131578665|NCT01227278|473745640|FG001|Overall Study|Other|2|||
131578666|NCT04035668|473745641|FG000|Overall Study|Adverse Event|3|||
131578667|NCT04035668|473745642|FG001|Overall Study|Adverse Event|4|||
131578668|NCT04035668|473745643|FG002|Overall Study|Adverse Event|2|||
131578669|NCT04035668|473745641|FG000|Overall Study|Lost to Follow-up|0|||
131578670|NCT04035668|473745642|FG001|Overall Study|Lost to Follow-up|1|||
131578671|NCT04035668|473745643|FG002|Overall Study|Lost to Follow-up|0|||
131578672|NCT04035668|473745641|FG000|Overall Study|Physician Decision|2|||
131578673|NCT04035668|473745642|FG001|Overall Study|Physician Decision|1|||
131578674|NCT04035668|473745643|FG002|Overall Study|Physician Decision|1|||
131578675|NCT04035668|473745641|FG000|Overall Study|Subject Decision|2|||
131578676|NCT04035668|473745642|FG001|Overall Study|Subject Decision|2|||
131578677|NCT04035668|473745643|FG002|Overall Study|Subject Decision|0|||
131578678|NCT02320123|473745644|FG000|Overall Study|Lost to Follow-up|4|||
131578679|NCT02320123|473745645|FG001|Overall Study|Lost to Follow-up|6|||
131578680|NCT02320123|473745644|FG000|Overall Study|Death|6|||
131578681|NCT02320123|473745645|FG001|Overall Study|Death|5|||
131578682|NCT00516386|473745648|FG000|Overall Study|not interested in the study|4|||
131578683|NCT00516386|473745648|FG000|Overall Study|Lost to Follow-up|2|||
131578684|NCT01376089|473745651|FG000|Overall Study|Patient received no contrast media|3|||
131578685|NCT01376089|473745652|FG001|Overall Study|Patient received no contrast media|4|||
131578686|NCT05174013|473745655|FG000|Overall Study|Lost to Follow-up|0|||
131578687|NCT05174013|473745656|FG001|Overall Study|Lost to Follow-up|0|||
131578688|NCT05174013|473745657|FG002|Overall Study|Lost to Follow-up|0|||
131578689|NCT05174013|473745658|FG003|Overall Study|Lost to Follow-up|1|||
131578690|NCT05174013|473745659|FG004|Overall Study|Lost to Follow-up|0|||
131578691|NCT05174013|473745660|FG005|Overall Study|Lost to Follow-up|0|||
131578692|NCT05174013|473745655|FG000|Overall Study|Withdrawal by Subject|0|||
131578693|NCT05174013|473745656|FG001|Overall Study|Withdrawal by Subject|0|||
131578694|NCT05174013|473745657|FG002|Overall Study|Withdrawal by Subject|1|||
131578695|NCT05174013|473745658|FG003|Overall Study|Withdrawal by Subject|0|||
131578696|NCT05174013|473745659|FG004|Overall Study|Withdrawal by Subject|0|||
131578697|NCT05174013|473745660|FG005|Overall Study|Withdrawal by Subject|0|||
131578698|NCT03287622|473745661|FG000|Overall Study|Withdrawal by Subject|1|||
131578699|NCT03287622|473745662|FG001|Overall Study|Withdrawal by Subject|0|||
131578700|NCT03287622|473745661|FG000|Overall Study|Lost to Follow-up|27|||
131578701|NCT03287622|473745662|FG001|Overall Study|Lost to Follow-up|15|||
131578702|NCT03287622|473745661|FG000|Overall Study|No prescripion after surgery|28|||
131578703|NCT03287622|473745662|FG001|Overall Study|No prescripion after surgery|31|||
131786559|NCT02367781|474502087|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
131786560|NCT02367781|474502088|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
131898691|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
131578704|NCT03287622|473745661|FG000|Overall Study|prolonged Length of stay|2|||
131578705|NCT03287622|473745662|FG001|Overall Study|prolonged Length of stay|0|||
131578706|NCT03287622|473745661|FG000|Overall Study|surgery related|0|||
131578707|NCT03287622|473745662|FG001|Overall Study|surgery related|2|||
131578708|NCT01930045|473745663|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131578709|NCT01930045|473745664|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131578710|NCT01930045|473745665|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131578711|NCT01930045|473745666|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131578712|NCT01930045|473745667|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131578713|NCT01930045|473745668|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
131786561|NCT02367781|474502087|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
131786562|NCT02367781|474502088|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
131898692|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
131898693|NCT01111565|474915335|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
131578714|NCT01930045|473745663|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
131578715|NCT01930045|473745664|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
131578716|NCT01930045|473745665|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
131578717|NCT01930045|473745666|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
131578718|NCT01930045|473745667|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
131578719|NCT01930045|473745668|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
131578720|NCT00486330|473745669|FG000|Overall Study|Adverse Event|2|||
131578721|NCT02506257|473745670|FG000|Overall Study|Adverse Event|0|||
131578722|NCT02506257|473745671|FG001|Overall Study|Adverse Event|2|||
131578723|NCT02506257|473745672|FG002|Overall Study|Adverse Event|3|||
131578724|NCT02506257|473745673|FG003|Overall Study|Adverse Event|0|||
131700605|NCT04537208|474187615|FG001|Overall Study|Lost to Follow-up|1|||
131700606|NCT04537208|474187616|FG002|Overall Study|Lost to Follow-up|3|||
131700607|NCT04537208|474187617|FG003|Overall Study|Lost to Follow-up|4|||
131700608|NCT04537208|474187618|FG004|Overall Study|Lost to Follow-up|3|||
131700609|NCT04537208|474187619|FG005|Overall Study|Lost to Follow-up|2|||
131700610|NCT04537208|474187620|FG006|Overall Study|Lost to Follow-up|3|||
131700611|NCT04537208|474187621|FG007|Overall Study|Lost to Follow-up|2|||
131700612|NCT04537208|474187622|FG008|Overall Study|Lost to Follow-up|7|||
131700613|NCT04537208|474187623|FG009|Overall Study|Lost to Follow-up|2|||
131700614|NCT04537208|474187624|FG010|Overall Study|Lost to Follow-up|2|||
131700615|NCT03083886|474187625|FG000|Overall Study|Withdrawal by Subject|51|||
131700616|NCT03083886|474187626|FG001|Overall Study|Withdrawal by Subject|73|||
131700617|NCT03083886|474187627|FG002|Overall Study|Withdrawal by Subject|104|||
131700618|NCT03083886|474187625|FG000|Overall Study|Missing Baseline data|43|||
131700619|NCT03083886|474187626|FG001|Overall Study|Missing Baseline data|42|||
131700620|NCT03083886|474187627|FG002|Overall Study|Missing Baseline data|31|||
131700621|NCT03083886|474187625|FG000|Overall Study|Investigator terminated|1|||
131700622|NCT03083886|474187626|FG001|Overall Study|Investigator terminated|6|||
131700623|NCT03083886|474187627|FG002|Overall Study|Investigator terminated|3|||
131700624|NCT04161495|474187628|FG000|Overall Study|Withdrawal by Subject|3|||
131700625|NCT04161495|474187629|FG001|Overall Study|Withdrawal by Subject|0|||
131700626|NCT04161495|474187628|FG000|Overall Study|Protocol Violation|1|||
131700627|NCT04161495|474187629|FG001|Overall Study|Protocol Violation|0|||
131700628|NCT04161495|474187628|FG000|Overall Study|Prohibited concomitant medication|3|||
131578725|NCT02506257|473745670|FG000|Overall Study|Protocol Violation|0|||
131578726|NCT02506257|473745671|FG001|Overall Study|Protocol Violation|0|||
131786563|NCT02367781|474502087|FG000|Overall Study|Study Terminated by Sponsor|3|||
131578727|NCT02506257|473745672|FG002|Overall Study|Protocol Violation|1|||
131700629|NCT04161495|474187629|FG001|Overall Study|Prohibited concomitant medication|0|||
131700630|NCT04161495|474187628|FG000|Overall Study|Adverse Event|1|||
131700631|NCT04161495|474187629|FG001|Overall Study|Adverse Event|0|||
131700632|NCT04161495|474187628|FG000|Overall Study|Other - Unspecified|1|||
131438115|NCT00467740|473229516|FG004|Overall Study|Lost to Follow-up|0|||
131438116|NCT00467740|473229512|FG000|Overall Study|Withdrawal by Subject|1|||
131438117|NCT00467740|473229513|FG001|Overall Study|Withdrawal by Subject|1|||
131438118|NCT00467740|473229514|FG002|Overall Study|Withdrawal by Subject|0|||
131786564|NCT02367781|474502088|FG001|Overall Study|Study Terminated by Sponsor|1|||
131578728|NCT02506257|473745673|FG003|Overall Study|Protocol Violation|0|||
131578729|NCT00139737|473745675|FG000|Overall Study|Withdrawal by Subject|190|||
131578730|NCT00139737|473745675|FG000|Overall Study|Adverse Event|58|||
131578731|NCT00139737|473745675|FG000|Overall Study|Lack of Efficacy|40|||
131578732|NCT00139737|473745675|FG000|Overall Study|Lost to Follow-up|8|||
131578733|NCT00139737|473745675|FG000|Overall Study|Death|3|||
131578734|NCT00139737|473745675|FG000|Overall Study|Laboratory Abnormality|2|||
131700633|NCT04161495|474187629|FG001|Overall Study|Other - Unspecified|0|||
131700634|NCT04161495|474187628|FG000|Overall Study|Death|0|||
131700635|NCT04161495|474187629|FG001|Overall Study|Death|1|||
131700636|NCT01285908|474187630|FG000|Baseline Measurement|unable to insert catheter|1|||
131700637|NCT01285908|474187631|FG001|Baseline Measurement|unable to insert catheter|0|||
131700638|NCT01285908|474187632|FG002|Baseline Measurement|unable to insert catheter|0|||
131700639|NCT01285908|474187630|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
131700640|NCT01285908|474187631|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
131700641|NCT01285908|474187632|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
131700642|NCT01285908|474187630|FG000|Baseline Measurement|unable to tolerate procedure|1|||
131700643|NCT01285908|474187631|FG001|Baseline Measurement|unable to tolerate procedure|0|||
131700644|NCT01285908|474187632|FG002|Baseline Measurement|unable to tolerate procedure|0|||
131700645|NCT03655756|474187633|FG000|Overall Study|Death|1|||
131700646|NCT03529773|474187634|FG000|Overall Study|Adverse Event|0|||
131700647|NCT03529773|474187635|FG001|Overall Study|Adverse Event|0|||
131700648|NCT03529773|474187636|FG002|Overall Study|Adverse Event|0|||
131700649|NCT03529773|474187637|FG003|Overall Study|Adverse Event|0|||
131700650|NCT03529773|474187638|FG004|Overall Study|Adverse Event|0|||
131700651|NCT03529773|474187639|FG005|Overall Study|Adverse Event|0|||
131700652|NCT03529773|474187640|FG006|Overall Study|Adverse Event|0|||
131700653|NCT03529773|474187641|FG007|Overall Study|Adverse Event|0|||
131700654|NCT03529773|474187642|FG008|Overall Study|Adverse Event|0|||
131700655|NCT03529773|474187643|FG009|Overall Study|Adverse Event|0|||
131700656|NCT03529773|474187644|FG010|Overall Study|Adverse Event|0|||
131700657|NCT03529773|474187645|FG011|Overall Study|Adverse Event|0|||
131700658|NCT03529773|474187646|FG012|Overall Study|Adverse Event|0|||
131438119|NCT00467740|473229515|FG003|Overall Study|Withdrawal by Subject|1|||
131578735|NCT00139737|473745675|FG000|Overall Study|Protocol Violation|18|||
131700659|NCT03529773|474187647|FG013|Overall Study|Adverse Event|0|||
131700660|NCT03529773|474187648|FG014|Overall Study|Adverse Event|0|||
131700661|NCT03529773|474187649|FG015|Overall Study|Adverse Event|0|||
131700662|NCT03529773|474187650|FG016|Overall Study|Adverse Event|0|||
131700663|NCT03529773|474187651|FG017|Overall Study|Adverse Event|0|||
131578736|NCT00139737|473745675|FG000|Overall Study|Withdrew During Screening Phase|8|||
131578737|NCT00139737|473745675|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131578738|NCT00139737|473745675|FG000|Overall Study|Screened, Not Treated|13|||
131578739|NCT03781336|473745676|FG000|Overall Study|Withdrawal by Subject|2|||
131578740|NCT03781336|473745677|FG001|Overall Study|Withdrawal by Subject|2|||
131578741|NCT01901276|473745681|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
131578742|NCT01901276|473745682|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
131578743|NCT01596504|473745683|FG000|Overall Study|Participant's Private Reason|0|||
131578744|NCT01596504|473745684|FG001|Overall Study|Participant's Private Reason|1|||
131578745|NCT01596504|473745685|FG002|Overall Study|Participant's Private Reason|0|||
131578746|NCT01596504|473745683|FG000|Overall Study|Adverse Event|1|||
131578747|NCT01596504|473745684|FG001|Overall Study|Adverse Event|2|||
131578748|NCT01596504|473745685|FG002|Overall Study|Adverse Event|1|||
131578749|NCT01596504|473745683|FG000|Overall Study|Withdrawal by Subject|1|||
131578750|NCT01596504|473745684|FG001|Overall Study|Withdrawal by Subject|0|||
131578751|NCT01596504|473745685|FG002|Overall Study|Withdrawal by Subject|0|||
131578752|NCT02314117|473745686|FG000|Overall Study|Lost to Follow-up|9|||
131578753|NCT02314117|473745687|FG001|Overall Study|Lost to Follow-up|14|||
131578754|NCT02314117|473745686|FG000|Overall Study|Withdrawal by Subject|3|||
131578755|NCT02314117|473745687|FG001|Overall Study|Withdrawal by Subject|2|||
131578756|NCT05641311|473745688|FG000|Dosing Period 1|Adverse Event|1|||
131578757|NCT05641311|473745689|FG001|Dosing Period 1|Adverse Event|0|||
131578758|NCT00909363|473745690|FG000|Overall Study|Withdrawal by Subject|1|||
131578759|NCT00909363|473745691|FG001|Overall Study|Withdrawal by Subject|0|||
131578760|NCT00909363|473745692|FG002|Overall Study|Withdrawal by Subject|0|||
131578761|NCT00909363|473745690|FG000|Overall Study|Lack of Efficacy|1|||
131578762|NCT00909363|473745691|FG001|Overall Study|Lack of Efficacy|0|||
131578763|NCT00909363|473745692|FG002|Overall Study|Lack of Efficacy|0|||
131578764|NCT00922207|473745695|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
131578765|NCT00922207|473745696|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
131578766|NCT00922207|473745697|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
131578767|NCT00922207|473745695|FG000|Overall Study|Insufficient Therapeutic Response|0|||
131578768|NCT00922207|473745696|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131578769|NCT00922207|473745697|FG002|Overall Study|Insufficient Therapeutic Response|1|||
131578770|NCT00922207|473745695|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
131578771|NCT00922207|473745696|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131578772|NCT00922207|473745697|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
131578773|NCT00922207|473745695|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
131578774|NCT00922207|473745696|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131578775|NCT00922207|473745697|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131578776|NCT00922207|473745695|FG000|Overall Study|Withdrew Consent|2|||
131578777|NCT00922207|473745696|FG001|Overall Study|Withdrew Consent|5|||
131578778|NCT00922207|473745697|FG002|Overall Study|Withdrew Consent|2|||
131578779|NCT00922207|473745695|FG000|Overall Study|Abnormality of Laboratory Test|0|||
131700664|NCT03529773|474187652|FG018|Overall Study|Adverse Event|0|||
131700665|NCT03529773|474187653|FG019|Overall Study|Adverse Event|0|||
131700666|NCT03529773|474187654|FG020|Overall Study|Adverse Event|0|||
131700667|NCT03529773|474187655|FG021|Overall Study|Adverse Event|0|||
131700668|NCT03529773|474187656|FG022|Overall Study|Adverse Event|0|||
131700669|NCT03529773|474187657|FG023|Overall Study|Adverse Event|0|||
131700670|NCT03529773|474187658|FG024|Overall Study|Adverse Event|0|||
131700671|NCT03529773|474187659|FG025|Overall Study|Adverse Event|0|||
131700672|NCT03529773|474187660|FG026|Overall Study|Adverse Event|0|||
131700673|NCT03529773|474187661|FG027|Overall Study|Adverse Event|0|||
131700674|NCT03529773|474187662|FG028|Overall Study|Adverse Event|0|||
131700675|NCT03529773|474187663|FG029|Overall Study|Adverse Event|0|||
131700676|NCT03529773|474187664|FG030|Overall Study|Adverse Event|1|||
131700677|NCT03529773|474187665|FG031|Overall Study|Adverse Event|0|||
131700678|NCT03529773|474187666|FG032|Overall Study|Adverse Event|0|||
131700679|NCT03529773|474187667|FG033|Overall Study|Adverse Event|0|||
131700680|NCT03529773|474187668|FG034|Overall Study|Adverse Event|0|||
131700681|NCT03529773|474187669|FG035|Overall Study|Adverse Event|1|||
131700682|NCT03529773|474187670|FG036|Overall Study|Adverse Event|0|||
131700683|NCT03529773|474187671|FG037|Overall Study|Adverse Event|0|||
131700684|NCT03529773|474187672|FG038|Overall Study|Adverse Event|1|||
131700685|NCT03529773|474187673|FG039|Overall Study|Adverse Event|1|||
131700686|NCT03529773|474187634|FG000|Overall Study|Death|0|||
131578780|NCT00922207|473745696|FG001|Overall Study|Abnormality of Laboratory Test|1|||
131578781|NCT00922207|473745697|FG002|Overall Study|Abnormality of Laboratory Test|1|||
131578782|NCT01802632|473745698|FG000|Overall Study|Death|28|||
131578783|NCT01802632|473745699|FG001|Overall Study|Death|1|||
131700687|NCT03529773|474187635|FG001|Overall Study|Death|0|||
131700688|NCT03529773|474187636|FG002|Overall Study|Death|0|||
131578784|NCT01802632|473745700|FG002|Overall Study|Death|38|||
131700689|NCT03529773|474187637|FG003|Overall Study|Death|0|||
131700690|NCT03529773|474187638|FG004|Overall Study|Death|0|||
131700691|NCT03529773|474187639|FG005|Overall Study|Death|0|||
131700692|NCT03529773|474187640|FG006|Overall Study|Death|0|||
131700693|NCT03529773|474187641|FG007|Overall Study|Death|0|||
131700694|NCT03529773|474187642|FG008|Overall Study|Death|0|||
131700695|NCT03529773|474187643|FG009|Overall Study|Death|0|||
131700696|NCT03529773|474187644|FG010|Overall Study|Death|0|||
131700697|NCT03529773|474187645|FG011|Overall Study|Death|0|||
131700698|NCT03529773|474187646|FG012|Overall Study|Death|1|||
131700699|NCT03529773|474187647|FG013|Overall Study|Death|0|||
131700700|NCT03529773|474187648|FG014|Overall Study|Death|0|||
131700701|NCT03529773|474187649|FG015|Overall Study|Death|0|||
131700702|NCT03529773|474187650|FG016|Overall Study|Death|0|||
131700703|NCT03529773|474187651|FG017|Overall Study|Death|0|||
131700704|NCT03529773|474187652|FG018|Overall Study|Death|0|||
131700705|NCT03529773|474187653|FG019|Overall Study|Death|1|||
131700706|NCT03529773|474187654|FG020|Overall Study|Death|0|||
131700707|NCT03529773|474187655|FG021|Overall Study|Death|0|||
131700708|NCT03529773|474187656|FG022|Overall Study|Death|1|||
131700709|NCT03529773|474187657|FG023|Overall Study|Death|0|||
131700710|NCT03529773|474187658|FG024|Overall Study|Death|0|||
131700711|NCT03529773|474187659|FG025|Overall Study|Death|0|||
131700712|NCT03529773|474187660|FG026|Overall Study|Death|0|||
131700713|NCT03529773|474187661|FG027|Overall Study|Death|0|||
131700714|NCT03529773|474187662|FG028|Overall Study|Death|0|||
131700715|NCT03529773|474187663|FG029|Overall Study|Death|0|||
131700716|NCT03529773|474187664|FG030|Overall Study|Death|0|||
131700717|NCT03529773|474187665|FG031|Overall Study|Death|0|||
131700718|NCT03529773|474187666|FG032|Overall Study|Death|0|||
131700719|NCT03529773|474187667|FG033|Overall Study|Death|1|||
131700720|NCT03529773|474187668|FG034|Overall Study|Death|1|||
131700721|NCT03529773|474187669|FG035|Overall Study|Death|0|||
131700722|NCT03529773|474187670|FG036|Overall Study|Death|1|||
131700723|NCT03529773|474187671|FG037|Overall Study|Death|0|||
131700724|NCT03529773|474187672|FG038|Overall Study|Death|0|||
131700725|NCT03529773|474187673|FG039|Overall Study|Death|0|||
131700726|NCT03529773|474187634|FG000|Overall Study|Lost to Follow-up|0|||
131700727|NCT03529773|474187635|FG001|Overall Study|Lost to Follow-up|0|||
131700728|NCT03529773|474187636|FG002|Overall Study|Lost to Follow-up|1|||
131700729|NCT03529773|474187637|FG003|Overall Study|Lost to Follow-up|0|||
131700730|NCT03529773|474187638|FG004|Overall Study|Lost to Follow-up|1|||
131700731|NCT03529773|474187639|FG005|Overall Study|Lost to Follow-up|1|||
131700732|NCT03529773|474187640|FG006|Overall Study|Lost to Follow-up|0|||
131700733|NCT03529773|474187641|FG007|Overall Study|Lost to Follow-up|0|||
131700734|NCT03529773|474187642|FG008|Overall Study|Lost to Follow-up|0|||
131700735|NCT03529773|474187643|FG009|Overall Study|Lost to Follow-up|0|||
131700736|NCT03529773|474187644|FG010|Overall Study|Lost to Follow-up|0|||
131700737|NCT03529773|474187645|FG011|Overall Study|Lost to Follow-up|0|||
131700738|NCT03529773|474187646|FG012|Overall Study|Lost to Follow-up|0|||
131700739|NCT03529773|474187647|FG013|Overall Study|Lost to Follow-up|1|||
131700740|NCT03529773|474187648|FG014|Overall Study|Lost to Follow-up|4|||
131700741|NCT03529773|474187649|FG015|Overall Study|Lost to Follow-up|1|||
131700742|NCT03529773|474187650|FG016|Overall Study|Lost to Follow-up|1|||
131700743|NCT03529773|474187651|FG017|Overall Study|Lost to Follow-up|0|||
131700744|NCT03529773|474187652|FG018|Overall Study|Lost to Follow-up|1|||
131700745|NCT03529773|474187653|FG019|Overall Study|Lost to Follow-up|1|||
131700746|NCT03529773|474187654|FG020|Overall Study|Lost to Follow-up|2|||
131700747|NCT03529773|474187655|FG021|Overall Study|Lost to Follow-up|4|||
131700748|NCT03529773|474187656|FG022|Overall Study|Lost to Follow-up|3|||
131700749|NCT03529773|474187657|FG023|Overall Study|Lost to Follow-up|4|||
131700750|NCT03529773|474187658|FG024|Overall Study|Lost to Follow-up|3|||
131700751|NCT03529773|474187659|FG025|Overall Study|Lost to Follow-up|5|||
131700752|NCT03529773|474187660|FG026|Overall Study|Lost to Follow-up|5|||
131700753|NCT03529773|474187661|FG027|Overall Study|Lost to Follow-up|0|||
131700754|NCT03529773|474187662|FG028|Overall Study|Lost to Follow-up|0|||
131700755|NCT03529773|474187663|FG029|Overall Study|Lost to Follow-up|0|||
131700756|NCT03529773|474187664|FG030|Overall Study|Lost to Follow-up|1|||
131700757|NCT03529773|474187665|FG031|Overall Study|Lost to Follow-up|0|||
131700758|NCT03529773|474187666|FG032|Overall Study|Lost to Follow-up|0|||
131700759|NCT03529773|474187667|FG033|Overall Study|Lost to Follow-up|1|||
131700760|NCT03529773|474187668|FG034|Overall Study|Lost to Follow-up|1|||
131700761|NCT03529773|474187669|FG035|Overall Study|Lost to Follow-up|0|||
131700762|NCT03529773|474187670|FG036|Overall Study|Lost to Follow-up|0|||
131700763|NCT03529773|474187671|FG037|Overall Study|Lost to Follow-up|3|||
131700764|NCT03529773|474187672|FG038|Overall Study|Lost to Follow-up|1|||
131700765|NCT03529773|474187673|FG039|Overall Study|Lost to Follow-up|1|||
131700766|NCT03529773|474187634|FG000|Overall Study|No longer meets eligibility criteria|0|||
131700767|NCT03529773|474187635|FG001|Overall Study|No longer meets eligibility criteria|0|||
131700768|NCT03529773|474187636|FG002|Overall Study|No longer meets eligibility criteria|0|||
131700769|NCT03529773|474187637|FG003|Overall Study|No longer meets eligibility criteria|0|||
131786565|NCT02367781|474502087|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
131438120|NCT00467740|473229516|FG004|Overall Study|Withdrawal by Subject|0|||
131700770|NCT03529773|474187638|FG004|Overall Study|No longer meets eligibility criteria|0|||
131700771|NCT03529773|474187639|FG005|Overall Study|No longer meets eligibility criteria|0|||
131700772|NCT03529773|474187640|FG006|Overall Study|No longer meets eligibility criteria|0|||
131700773|NCT03529773|474187641|FG007|Overall Study|No longer meets eligibility criteria|0|||
131700774|NCT03529773|474187642|FG008|Overall Study|No longer meets eligibility criteria|0|||
131700775|NCT03529773|474187643|FG009|Overall Study|No longer meets eligibility criteria|0|||
131700776|NCT03529773|474187644|FG010|Overall Study|No longer meets eligibility criteria|0|||
131700777|NCT03529773|474187645|FG011|Overall Study|No longer meets eligibility criteria|0|||
131700778|NCT03529773|474187646|FG012|Overall Study|No longer meets eligibility criteria|0|||
131700779|NCT03529773|474187647|FG013|Overall Study|No longer meets eligibility criteria|0|||
131700780|NCT03529773|474187648|FG014|Overall Study|No longer meets eligibility criteria|0|||
131700781|NCT03529773|474187649|FG015|Overall Study|No longer meets eligibility criteria|0|||
131700782|NCT03529773|474187650|FG016|Overall Study|No longer meets eligibility criteria|0|||
131700783|NCT03529773|474187651|FG017|Overall Study|No longer meets eligibility criteria|0|||
131700784|NCT03529773|474187652|FG018|Overall Study|No longer meets eligibility criteria|0|||
131700785|NCT03529773|474187653|FG019|Overall Study|No longer meets eligibility criteria|0|||
131700786|NCT03529773|474187654|FG020|Overall Study|No longer meets eligibility criteria|0|||
131700787|NCT03529773|474187655|FG021|Overall Study|No longer meets eligibility criteria|0|||
131700788|NCT03529773|474187656|FG022|Overall Study|No longer meets eligibility criteria|1|||
131700789|NCT03529773|474187657|FG023|Overall Study|No longer meets eligibility criteria|0|||
131700790|NCT03529773|474187658|FG024|Overall Study|No longer meets eligibility criteria|0|||
131700791|NCT03529773|474187659|FG025|Overall Study|No longer meets eligibility criteria|0|||
131700792|NCT03529773|474187660|FG026|Overall Study|No longer meets eligibility criteria|0|||
131700793|NCT03529773|474187661|FG027|Overall Study|No longer meets eligibility criteria|0|||
131700794|NCT03529773|474187662|FG028|Overall Study|No longer meets eligibility criteria|0|||
131700795|NCT03529773|474187663|FG029|Overall Study|No longer meets eligibility criteria|0|||
131700796|NCT03529773|474187664|FG030|Overall Study|No longer meets eligibility criteria|0|||
131700797|NCT03529773|474187665|FG031|Overall Study|No longer meets eligibility criteria|0|||
131700798|NCT03529773|474187666|FG032|Overall Study|No longer meets eligibility criteria|0|||
131700799|NCT03529773|474187667|FG033|Overall Study|No longer meets eligibility criteria|0|||
131700800|NCT03529773|474187668|FG034|Overall Study|No longer meets eligibility criteria|0|||
131700801|NCT03529773|474187669|FG035|Overall Study|No longer meets eligibility criteria|0|||
131700802|NCT03529773|474187670|FG036|Overall Study|No longer meets eligibility criteria|0|||
131700803|NCT03529773|474187671|FG037|Overall Study|No longer meets eligibility criteria|0|||
131700804|NCT03529773|474187672|FG038|Overall Study|No longer meets eligibility criteria|1|||
131700805|NCT03529773|474187673|FG039|Overall Study|No longer meets eligibility criteria|0|||
131700806|NCT03529773|474187634|FG000|Overall Study|Other|0|||
131700807|NCT03529773|474187635|FG001|Overall Study|Other|0|||
131700808|NCT03529773|474187636|FG002|Overall Study|Other|0|||
131700809|NCT03529773|474187637|FG003|Overall Study|Other|0|||
131700810|NCT03529773|474187638|FG004|Overall Study|Other|0|||
131700811|NCT03529773|474187639|FG005|Overall Study|Other|0|||
131700812|NCT03529773|474187640|FG006|Overall Study|Other|0|||
131700813|NCT03529773|474187641|FG007|Overall Study|Other|0|||
131700814|NCT03529773|474187642|FG008|Overall Study|Other|0|||
131700815|NCT03529773|474187643|FG009|Overall Study|Other|0|||
131700816|NCT03529773|474187644|FG010|Overall Study|Other|0|||
131700817|NCT03529773|474187645|FG011|Overall Study|Other|0|||
131700818|NCT03529773|474187646|FG012|Overall Study|Other|1|||
131700819|NCT03529773|474187647|FG013|Overall Study|Other|0|||
131700820|NCT03529773|474187648|FG014|Overall Study|Other|2|||
131700821|NCT03529773|474187649|FG015|Overall Study|Other|0|||
131700822|NCT03529773|474187650|FG016|Overall Study|Other|0|||
131700823|NCT03529773|474187651|FG017|Overall Study|Other|3|||
131700824|NCT03529773|474187652|FG018|Overall Study|Other|0|||
131700825|NCT03529773|474187653|FG019|Overall Study|Other|0|||
131700826|NCT03529773|474187654|FG020|Overall Study|Other|1|||
131700827|NCT03529773|474187655|FG021|Overall Study|Other|0|||
131700828|NCT03529773|474187656|FG022|Overall Study|Other|1|||
131700829|NCT03529773|474187657|FG023|Overall Study|Other|0|||
131700830|NCT03529773|474187658|FG024|Overall Study|Other|3|||
131700831|NCT03529773|474187659|FG025|Overall Study|Other|2|||
131700832|NCT03529773|474187660|FG026|Overall Study|Other|2|||
131700833|NCT03529773|474187661|FG027|Overall Study|Other|0|||
131700834|NCT03529773|474187662|FG028|Overall Study|Other|0|||
131700835|NCT03529773|474187663|FG029|Overall Study|Other|0|||
131700836|NCT03529773|474187664|FG030|Overall Study|Other|0|||
131700837|NCT03529773|474187665|FG031|Overall Study|Other|0|||
131700838|NCT03529773|474187666|FG032|Overall Study|Other|0|||
131700839|NCT03529773|474187667|FG033|Overall Study|Other|0|||
131700840|NCT03529773|474187668|FG034|Overall Study|Other|1|||
131700841|NCT03529773|474187669|FG035|Overall Study|Other|1|||
131700842|NCT03529773|474187670|FG036|Overall Study|Other|0|||
131578785|NCT01802632|473745701|FG003|Overall Study|Death|0|||
131578786|NCT01802632|473745702|FG004|Overall Study|Death|2|||
131786566|NCT02367781|474502088|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
131786567|NCT02367781|474502087|FG000|Overall Study|Sponsor Decision|2|||
131786568|NCT02367781|474502088|FG001|Overall Study|Sponsor Decision|0|||
131578787|NCT01802632|473745703|FG005|Overall Study|Death|0|||
131700843|NCT03529773|474187671|FG037|Overall Study|Other|0|||
131700844|NCT03529773|474187672|FG038|Overall Study|Other|0|||
131700845|NCT03529773|474187673|FG039|Overall Study|Other|0|||
131700846|NCT03529773|474187634|FG000|Overall Study|Physician Decision|0|||
131700847|NCT03529773|474187635|FG001|Overall Study|Physician Decision|0|||
131700848|NCT03529773|474187636|FG002|Overall Study|Physician Decision|0|||
131700849|NCT03529773|474187637|FG003|Overall Study|Physician Decision|0|||
131700850|NCT03529773|474187638|FG004|Overall Study|Physician Decision|0|||
131700851|NCT03529773|474187639|FG005|Overall Study|Physician Decision|0|||
131700852|NCT03529773|474187640|FG006|Overall Study|Physician Decision|0|||
131700853|NCT03529773|474187641|FG007|Overall Study|Physician Decision|0|||
131700854|NCT03529773|474187642|FG008|Overall Study|Physician Decision|0|||
131700855|NCT03529773|474187643|FG009|Overall Study|Physician Decision|0|||
131700856|NCT03529773|474187644|FG010|Overall Study|Physician Decision|0|||
131700857|NCT03529773|474187645|FG011|Overall Study|Physician Decision|0|||
131700858|NCT03529773|474187646|FG012|Overall Study|Physician Decision|0|||
131578788|NCT01802632|473745698|FG000|Overall Study|Withdrawal by Subject|4|||
131700859|NCT03529773|474187647|FG013|Overall Study|Physician Decision|0|||
131700860|NCT03529773|474187648|FG014|Overall Study|Physician Decision|0|||
131700861|NCT03529773|474187649|FG015|Overall Study|Physician Decision|0|||
131700862|NCT03529773|474187650|FG016|Overall Study|Physician Decision|0|||
131786569|NCT02367781|474502087|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
131578789|NCT01802632|473745699|FG001|Overall Study|Withdrawal by Subject|2|||
131578790|NCT01802632|473745700|FG002|Overall Study|Withdrawal by Subject|7|||
131700863|NCT03529773|474187651|FG017|Overall Study|Physician Decision|0|||
131700864|NCT03529773|474187652|FG018|Overall Study|Physician Decision|0|||
131438121|NCT00467740|473229512|FG000|Overall Study|Lack of Efficacy|0|||
131578791|NCT01802632|473745701|FG003|Overall Study|Withdrawal by Subject|3|||
131578792|NCT01802632|473745702|FG004|Overall Study|Withdrawal by Subject|0|||
131578793|NCT01802632|473745703|FG005|Overall Study|Withdrawal by Subject|1|||
131578794|NCT01802632|473745698|FG000|Overall Study|Objective Disease Progression|1|||
131578795|NCT01802632|473745699|FG001|Overall Study|Objective Disease Progression|12|||
131578796|NCT01802632|473745700|FG002|Overall Study|Objective Disease Progression|104|||
131578797|NCT01802632|473745701|FG003|Overall Study|Objective Disease Progression|6|||
131578798|NCT01802632|473745702|FG004|Overall Study|Objective Disease Progression|4|||
131578799|NCT01802632|473745703|FG005|Overall Study|Objective Disease Progression|4|||
131578800|NCT01802632|473745698|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
131578801|NCT01802632|473745699|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
131578802|NCT01802632|473745700|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
131578803|NCT01802632|473745701|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
131578804|NCT01802632|473745702|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
131578805|NCT01802632|473745703|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
131578806|NCT01802632|473745698|FG000|Overall Study|Other (not specified)|0|||
131578807|NCT01802632|473745699|FG001|Overall Study|Other (not specified)|0|||
131578808|NCT01802632|473745700|FG002|Overall Study|Other (not specified)|7|||
131578809|NCT01802632|473745701|FG003|Overall Study|Other (not specified)|1|||
131578810|NCT01802632|473745702|FG004|Overall Study|Other (not specified)|0|||
131578811|NCT01802632|473745703|FG005|Overall Study|Other (not specified)|1|||
131578812|NCT02705586|473745707|FG000|Overall Study|Health Issues|2|||
131578813|NCT02705586|473745707|FG000|Overall Study|Transportation Difficulties|5|||
131578814|NCT02705586|473745707|FG000|Overall Study|Vacation/Planned Absence|1|||
131578815|NCT02045836|473745711|FG000|Overall Study|Adverse Event|4|||
131578816|NCT02045836|473745712|FG001|Overall Study|Adverse Event|4|||
131578817|NCT02045836|473745711|FG000|Overall Study|Withdrawal by Subject|1|||
131578818|NCT02045836|473745712|FG001|Overall Study|Withdrawal by Subject|1|||
131578819|NCT02045836|473745711|FG000|Overall Study|Lost to Follow-up|4|||
131578820|NCT02045836|473745712|FG001|Overall Study|Lost to Follow-up|7|||
131578821|NCT02045836|473745711|FG000|Overall Study|Migrated from study area|0|||
131578822|NCT02045836|473745712|FG001|Overall Study|Migrated from study area|2|||
131578823|NCT03920215|473745715|FG000|Overall Study|Lost to Follow-up|1|||
131578824|NCT03920215|473745716|FG001|Overall Study|Lost to Follow-up|2|||
131578825|NCT03920215|473745717|FG002|Overall Study|Lost to Follow-up|0|||
131578826|NCT03920215|473745718|FG003|Overall Study|Lost to Follow-up|0|||
131578827|NCT03920215|473745715|FG000|Overall Study|Death|0|||
131578828|NCT03920215|473745716|FG001|Overall Study|Death|0|||
131578829|NCT03920215|473745717|FG002|Overall Study|Death|0|||
131578830|NCT03920215|473745718|FG003|Overall Study|Death|1|||
131578831|NCT02000817|473745719|FG000|Overall Study|Withdrawal by Subject|2|||
131700865|NCT03529773|474187653|FG019|Overall Study|Physician Decision|1|||
131700866|NCT03529773|474187654|FG020|Overall Study|Physician Decision|1|||
131700867|NCT03529773|474187655|FG021|Overall Study|Physician Decision|0|||
131700868|NCT03529773|474187656|FG022|Overall Study|Physician Decision|0|||
131700869|NCT03529773|474187657|FG023|Overall Study|Physician Decision|0|||
131700870|NCT03529773|474187658|FG024|Overall Study|Physician Decision|0|||
131700871|NCT03529773|474187659|FG025|Overall Study|Physician Decision|0|||
131700872|NCT03529773|474187660|FG026|Overall Study|Physician Decision|0|||
131700873|NCT03529773|474187661|FG027|Overall Study|Physician Decision|0|||
131700874|NCT03529773|474187662|FG028|Overall Study|Physician Decision|0|||
131700875|NCT03529773|474187663|FG029|Overall Study|Physician Decision|0|||
131700876|NCT03529773|474187664|FG030|Overall Study|Physician Decision|0|||
131700877|NCT03529773|474187665|FG031|Overall Study|Physician Decision|0|||
131700878|NCT03529773|474187666|FG032|Overall Study|Physician Decision|0|||
131700879|NCT03529773|474187667|FG033|Overall Study|Physician Decision|0|||
131700880|NCT03529773|474187668|FG034|Overall Study|Physician Decision|0|||
131700881|NCT03529773|474187669|FG035|Overall Study|Physician Decision|0|||
131700882|NCT03529773|474187670|FG036|Overall Study|Physician Decision|0|||
131700883|NCT03529773|474187671|FG037|Overall Study|Physician Decision|0|||
131700884|NCT03529773|474187672|FG038|Overall Study|Physician Decision|0|||
131700885|NCT03529773|474187673|FG039|Overall Study|Physician Decision|0|||
131700886|NCT03529773|474187634|FG000|Overall Study|Protocol Violation|0|||
131700887|NCT03529773|474187635|FG001|Overall Study|Protocol Violation|0|||
131700888|NCT03529773|474187636|FG002|Overall Study|Protocol Violation|0|||
131578832|NCT02000817|473745720|FG001|Overall Study|Withdrawal by Subject|0|||
131578833|NCT02000817|473745721|FG002|Overall Study|Withdrawal by Subject|0|||
131578834|NCT02000817|473745722|FG003|Overall Study|Withdrawal by Subject|0|||
131578835|NCT02000817|473745719|FG000|Overall Study|Adverse Event|0|||
131578836|NCT02000817|473745720|FG001|Overall Study|Adverse Event|1|||
131578837|NCT02000817|473745721|FG002|Overall Study|Adverse Event|0|||
131700889|NCT03529773|474187637|FG003|Overall Study|Protocol Violation|0|||
131700890|NCT03529773|474187638|FG004|Overall Study|Protocol Violation|0|||
131700891|NCT03529773|474187639|FG005|Overall Study|Protocol Violation|0|||
131578838|NCT02000817|473745722|FG003|Overall Study|Adverse Event|0|||
131578839|NCT02000817|473745719|FG000|Overall Study|Lost to Follow-up|0|||
131578840|NCT02000817|473745720|FG001|Overall Study|Lost to Follow-up|0|||
131578841|NCT02000817|473745721|FG002|Overall Study|Lost to Follow-up|1|||
131578842|NCT02000817|473745722|FG003|Overall Study|Lost to Follow-up|0|||
131578843|NCT02798835|473745725|FG000|Overall Study|Protocol Violation|0|||
131578844|NCT02798835|473745726|FG001|Overall Study|Protocol Violation|0|||
131578845|NCT02798835|473745727|FG002|Overall Study|Protocol Violation|3|||
131578846|NCT00177216|473745728|FG000|Overall Study|Withdrawal by Subject|6|||
131578847|NCT00177216|473745729|FG001|Overall Study|Withdrawal by Subject|3|||
131578848|NCT00177216|473745730|FG002|Overall Study|Withdrawal by Subject|1|||
131578849|NCT02459899|473745735|FG000|Overall Study|Adverse Event|1|||
131578850|NCT02459899|473745736|FG001|Overall Study|Adverse Event|1|||
131578851|NCT02459899|473745737|FG002|Overall Study|Adverse Event|0|||
131578852|NCT02459899|473745738|FG003|Overall Study|Adverse Event|0|||
131578853|NCT02459899|473745735|FG000|Overall Study|Lost to Follow-up|1|||
131700892|NCT03529773|474187640|FG006|Overall Study|Protocol Violation|0|||
131700893|NCT03529773|474187641|FG007|Overall Study|Protocol Violation|0|||
131700894|NCT03529773|474187642|FG008|Overall Study|Protocol Violation|0|||
131438122|NCT00467740|473229513|FG001|Overall Study|Lack of Efficacy|1|||
131578854|NCT02459899|473745736|FG001|Overall Study|Lost to Follow-up|2|||
131700895|NCT03529773|474187643|FG009|Overall Study|Protocol Violation|0|||
131700896|NCT03529773|474187644|FG010|Overall Study|Protocol Violation|0|||
131700897|NCT03529773|474187645|FG011|Overall Study|Protocol Violation|0|||
131700898|NCT03529773|474187646|FG012|Overall Study|Protocol Violation|0|||
131700899|NCT03529773|474187647|FG013|Overall Study|Protocol Violation|0|||
131700900|NCT03529773|474187648|FG014|Overall Study|Protocol Violation|0|||
131700901|NCT03529773|474187649|FG015|Overall Study|Protocol Violation|0|||
131700902|NCT03529773|474187650|FG016|Overall Study|Protocol Violation|0|||
131700903|NCT03529773|474187651|FG017|Overall Study|Protocol Violation|0|||
131700904|NCT03529773|474187652|FG018|Overall Study|Protocol Violation|0|||
131700905|NCT03529773|474187653|FG019|Overall Study|Protocol Violation|0|||
131700906|NCT03529773|474187654|FG020|Overall Study|Protocol Violation|0|||
131700907|NCT03529773|474187655|FG021|Overall Study|Protocol Violation|0|||
131700908|NCT03529773|474187656|FG022|Overall Study|Protocol Violation|0|||
131700909|NCT03529773|474187657|FG023|Overall Study|Protocol Violation|0|||
131700910|NCT03529773|474187658|FG024|Overall Study|Protocol Violation|0|||
131700911|NCT03529773|474187659|FG025|Overall Study|Protocol Violation|0|||
131700912|NCT03529773|474187660|FG026|Overall Study|Protocol Violation|0|||
131700913|NCT03529773|474187661|FG027|Overall Study|Protocol Violation|0|||
131700914|NCT03529773|474187662|FG028|Overall Study|Protocol Violation|0|||
131700915|NCT03529773|474187663|FG029|Overall Study|Protocol Violation|0|||
131700916|NCT03529773|474187664|FG030|Overall Study|Protocol Violation|1|||
131700917|NCT03529773|474187665|FG031|Overall Study|Protocol Violation|0|||
131700918|NCT03529773|474187666|FG032|Overall Study|Protocol Violation|0|||
131700919|NCT03529773|474187667|FG033|Overall Study|Protocol Violation|0|||
131700920|NCT03529773|474187668|FG034|Overall Study|Protocol Violation|0|||
131700921|NCT03529773|474187669|FG035|Overall Study|Protocol Violation|0|||
131700922|NCT03529773|474187670|FG036|Overall Study|Protocol Violation|0|||
131700923|NCT03529773|474187671|FG037|Overall Study|Protocol Violation|0|||
131700924|NCT03529773|474187672|FG038|Overall Study|Protocol Violation|0|||
131700925|NCT03529773|474187673|FG039|Overall Study|Protocol Violation|0|||
131700926|NCT03529773|474187634|FG000|Overall Study|Withdrawal by Subject|0|||
131700927|NCT03529773|474187635|FG001|Overall Study|Withdrawal by Subject|0|||
131700928|NCT03529773|474187636|FG002|Overall Study|Withdrawal by Subject|0|||
131700929|NCT03529773|474187637|FG003|Overall Study|Withdrawal by Subject|0|||
131700930|NCT03529773|474187638|FG004|Overall Study|Withdrawal by Subject|0|||
131700931|NCT03529773|474187639|FG005|Overall Study|Withdrawal by Subject|0|||
131700932|NCT03529773|474187640|FG006|Overall Study|Withdrawal by Subject|0|||
131578855|NCT02459899|473745737|FG002|Overall Study|Lost to Follow-up|0|||
131578856|NCT02459899|473745738|FG003|Overall Study|Lost to Follow-up|1|||
131578857|NCT02459899|473745735|FG000|Overall Study|Non-compliance with the treatment|0|||
131700933|NCT03529773|474187641|FG007|Overall Study|Withdrawal by Subject|1|||
131700934|NCT03529773|474187642|FG008|Overall Study|Withdrawal by Subject|0|||
131700935|NCT03529773|474187643|FG009|Overall Study|Withdrawal by Subject|1|||
131700936|NCT03529773|474187644|FG010|Overall Study|Withdrawal by Subject|1|||
131700937|NCT03529773|474187645|FG011|Overall Study|Withdrawal by Subject|0|||
131700938|NCT03529773|474187646|FG012|Overall Study|Withdrawal by Subject|0|||
131700939|NCT03529773|474187647|FG013|Overall Study|Withdrawal by Subject|0|||
131700940|NCT03529773|474187648|FG014|Overall Study|Withdrawal by Subject|0|||
131700941|NCT03529773|474187649|FG015|Overall Study|Withdrawal by Subject|3|||
131700942|NCT03529773|474187650|FG016|Overall Study|Withdrawal by Subject|0|||
131700943|NCT03529773|474187651|FG017|Overall Study|Withdrawal by Subject|2|||
131700944|NCT03529773|474187652|FG018|Overall Study|Withdrawal by Subject|3|||
131700945|NCT03529773|474187653|FG019|Overall Study|Withdrawal by Subject|1|||
131700946|NCT03529773|474187654|FG020|Overall Study|Withdrawal by Subject|3|||
131700947|NCT03529773|474187655|FG021|Overall Study|Withdrawal by Subject|1|||
131700948|NCT03529773|474187656|FG022|Overall Study|Withdrawal by Subject|1|||
131700949|NCT03529773|474187657|FG023|Overall Study|Withdrawal by Subject|2|||
131700950|NCT03529773|474187658|FG024|Overall Study|Withdrawal by Subject|2|||
131700951|NCT03529773|474187659|FG025|Overall Study|Withdrawal by Subject|4|||
131700952|NCT03529773|474187660|FG026|Overall Study|Withdrawal by Subject|2|||
131700953|NCT03529773|474187661|FG027|Overall Study|Withdrawal by Subject|1|||
131700954|NCT03529773|474187662|FG028|Overall Study|Withdrawal by Subject|1|||
131700955|NCT03529773|474187663|FG029|Overall Study|Withdrawal by Subject|0|||
131700956|NCT03529773|474187664|FG030|Overall Study|Withdrawal by Subject|0|||
131700957|NCT03529773|474187665|FG031|Overall Study|Withdrawal by Subject|0|||
131700958|NCT03529773|474187666|FG032|Overall Study|Withdrawal by Subject|0|||
131700959|NCT03529773|474187667|FG033|Overall Study|Withdrawal by Subject|0|||
131700960|NCT03529773|474187668|FG034|Overall Study|Withdrawal by Subject|1|||
131700961|NCT03529773|474187669|FG035|Overall Study|Withdrawal by Subject|2|||
131700962|NCT03529773|474187670|FG036|Overall Study|Withdrawal by Subject|0|||
131700963|NCT03529773|474187671|FG037|Overall Study|Withdrawal by Subject|2|||
131700964|NCT03529773|474187672|FG038|Overall Study|Withdrawal by Subject|1|||
131700965|NCT03529773|474187673|FG039|Overall Study|Withdrawal by Subject|1|||
131700966|NCT03529773|474187634|FG000|Overall Study|Screen Failure|0|||
131700967|NCT03529773|474187635|FG001|Overall Study|Screen Failure|0|||
131700968|NCT03529773|474187636|FG002|Overall Study|Screen Failure|0|||
131700969|NCT03529773|474187637|FG003|Overall Study|Screen Failure|0|||
131700970|NCT03529773|474187638|FG004|Overall Study|Screen Failure|0|||
131700971|NCT03529773|474187639|FG005|Overall Study|Screen Failure|0|||
131700972|NCT03529773|474187640|FG006|Overall Study|Screen Failure|0|||
131700973|NCT03529773|474187641|FG007|Overall Study|Screen Failure|0|||
131700974|NCT03529773|474187642|FG008|Overall Study|Screen Failure|0|||
131700975|NCT03529773|474187643|FG009|Overall Study|Screen Failure|0|||
131700976|NCT03529773|474187644|FG010|Overall Study|Screen Failure|0|||
131700977|NCT03529773|474187645|FG011|Overall Study|Screen Failure|0|||
131700978|NCT03529773|474187646|FG012|Overall Study|Screen Failure|0|||
131700979|NCT03529773|474187647|FG013|Overall Study|Screen Failure|0|||
131700980|NCT03529773|474187648|FG014|Overall Study|Screen Failure|0|||
131700981|NCT03529773|474187649|FG015|Overall Study|Screen Failure|0|||
131700982|NCT03529773|474187650|FG016|Overall Study|Screen Failure|0|||
131700983|NCT03529773|474187651|FG017|Overall Study|Screen Failure|0|||
131700984|NCT03529773|474187652|FG018|Overall Study|Screen Failure|0|||
131700985|NCT03529773|474187653|FG019|Overall Study|Screen Failure|0|||
131700986|NCT03529773|474187654|FG020|Overall Study|Screen Failure|0|||
131700987|NCT03529773|474187655|FG021|Overall Study|Screen Failure|0|||
131700988|NCT03529773|474187656|FG022|Overall Study|Screen Failure|0|||
131700989|NCT03529773|474187657|FG023|Overall Study|Screen Failure|0|||
131700990|NCT03529773|474187658|FG024|Overall Study|Screen Failure|0|||
131700991|NCT03529773|474187659|FG025|Overall Study|Screen Failure|0|||
131700992|NCT03529773|474187660|FG026|Overall Study|Screen Failure|0|||
131700993|NCT03529773|474187661|FG027|Overall Study|Screen Failure|0|||
131700994|NCT03529773|474187662|FG028|Overall Study|Screen Failure|0|||
131700995|NCT03529773|474187663|FG029|Overall Study|Screen Failure|0|||
131700996|NCT03529773|474187664|FG030|Overall Study|Screen Failure|0|||
131700997|NCT03529773|474187665|FG031|Overall Study|Screen Failure|0|||
131700998|NCT03529773|474187666|FG032|Overall Study|Screen Failure|0|||
131700999|NCT03529773|474187667|FG033|Overall Study|Screen Failure|0|||
131701000|NCT03529773|474187668|FG034|Overall Study|Screen Failure|0|||
131701001|NCT03529773|474187669|FG035|Overall Study|Screen Failure|0|||
131701002|NCT03529773|474187670|FG036|Overall Study|Screen Failure|1|||
131701003|NCT03529773|474187671|FG037|Overall Study|Screen Failure|1|||
131701004|NCT03529773|474187672|FG038|Overall Study|Screen Failure|0|||
131701005|NCT03529773|474187673|FG039|Overall Study|Screen Failure|1|||
131701006|NCT03529773|474187634|FG000|Overall Study|Randomized but not vaccinated|0|||
131701007|NCT03529773|474187635|FG001|Overall Study|Randomized but not vaccinated|0|||
131701008|NCT03529773|474187636|FG002|Overall Study|Randomized but not vaccinated|0|||
131701009|NCT03529773|474187637|FG003|Overall Study|Randomized but not vaccinated|0|||
131701010|NCT03529773|474187638|FG004|Overall Study|Randomized but not vaccinated|0|||
131701011|NCT03529773|474187639|FG005|Overall Study|Randomized but not vaccinated|0|||
131701012|NCT03529773|474187640|FG006|Overall Study|Randomized but not vaccinated|0|||
131701013|NCT03529773|474187641|FG007|Overall Study|Randomized but not vaccinated|0|||
131701014|NCT03529773|474187642|FG008|Overall Study|Randomized but not vaccinated|0|||
131701015|NCT03529773|474187643|FG009|Overall Study|Randomized but not vaccinated|0|||
131701016|NCT03529773|474187644|FG010|Overall Study|Randomized but not vaccinated|0|||
131701017|NCT03529773|474187645|FG011|Overall Study|Randomized but not vaccinated|0|||
131701018|NCT03529773|474187646|FG012|Overall Study|Randomized but not vaccinated|0|||
131701019|NCT03529773|474187647|FG013|Overall Study|Randomized but not vaccinated|0|||
131701020|NCT03529773|474187648|FG014|Overall Study|Randomized but not vaccinated|0|||
131701021|NCT03529773|474187649|FG015|Overall Study|Randomized but not vaccinated|0|||
131701022|NCT03529773|474187650|FG016|Overall Study|Randomized but not vaccinated|0|||
131701023|NCT03529773|474187651|FG017|Overall Study|Randomized but not vaccinated|1|||
131701024|NCT03529773|474187652|FG018|Overall Study|Randomized but not vaccinated|0|||
131701025|NCT03529773|474187653|FG019|Overall Study|Randomized but not vaccinated|0|||
131701026|NCT03529773|474187654|FG020|Overall Study|Randomized but not vaccinated|0|||
131701027|NCT03529773|474187655|FG021|Overall Study|Randomized but not vaccinated|0|||
131701028|NCT03529773|474187656|FG022|Overall Study|Randomized but not vaccinated|0|||
131701029|NCT03529773|474187657|FG023|Overall Study|Randomized but not vaccinated|0|||
131701030|NCT03529773|474187658|FG024|Overall Study|Randomized but not vaccinated|0|||
131701031|NCT03529773|474187659|FG025|Overall Study|Randomized but not vaccinated|0|||
131701032|NCT03529773|474187660|FG026|Overall Study|Randomized but not vaccinated|0|||
131701033|NCT03529773|474187661|FG027|Overall Study|Randomized but not vaccinated|1|||
131701034|NCT03529773|474187662|FG028|Overall Study|Randomized but not vaccinated|0|||
131701035|NCT03529773|474187663|FG029|Overall Study|Randomized but not vaccinated|0|||
131701036|NCT03529773|474187664|FG030|Overall Study|Randomized but not vaccinated|0|||
131701037|NCT03529773|474187665|FG031|Overall Study|Randomized but not vaccinated|0|||
131701038|NCT03529773|474187666|FG032|Overall Study|Randomized but not vaccinated|0|||
131701039|NCT03529773|474187667|FG033|Overall Study|Randomized but not vaccinated|0|||
131578858|NCT02459899|473745736|FG001|Overall Study|Non-compliance with the treatment|0|||
131578859|NCT02459899|473745737|FG002|Overall Study|Non-compliance with the treatment|0|||
131578860|NCT02459899|473745738|FG003|Overall Study|Non-compliance with the treatment|1|||
131578861|NCT02459899|473745735|FG000|Overall Study|Withdrawal by Subject|1|||
131578862|NCT02459899|473745736|FG001|Overall Study|Withdrawal by Subject|3|||
131578863|NCT02459899|473745737|FG002|Overall Study|Withdrawal by Subject|0|||
131578864|NCT02459899|473745738|FG003|Overall Study|Withdrawal by Subject|0|||
131578865|NCT02739035|473745739|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
131578866|NCT02739035|473745740|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
131578867|NCT02739035|473745739|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
131578868|NCT02739035|473745740|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
131578869|NCT02739035|473745739|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
131578870|NCT02739035|473745740|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
131578871|NCT02739035|473745739|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
131578872|NCT02739035|473745740|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
131578873|NCT02770248|473745741|FG000|Overall Study|Adverse Event|0|||
131578874|NCT02770248|473745742|FG001|Overall Study|Adverse Event|1|||
131578875|NCT02770248|473745741|FG000|Overall Study|Randomized in error, prior to treatment|0|||
131578876|NCT02770248|473745742|FG001|Overall Study|Randomized in error, prior to treatment|1|||
131578877|NCT01063517|473745755|FG000|Overall Study|Consent withdrawal|1|||
131578878|NCT01063517|473745756|FG001|Overall Study|Consent withdrawal|0|||
131578879|NCT01063517|473745755|FG000|Overall Study|Study reached data cut-off|19|||
131578880|NCT01063517|473745756|FG001|Overall Study|Study reached data cut-off|7|||
131578881|NCT01063517|473745755|FG000|Overall Study|Lost to Follow-up|4|||
131578882|NCT01063517|473745756|FG001|Overall Study|Lost to Follow-up|3|||
131578883|NCT01063517|473745755|FG000|Overall Study|Withdrawal by Subject|1|||
131578884|NCT01063517|473745756|FG001|Overall Study|Withdrawal by Subject|2|||
131578885|NCT01063517|473745755|FG000|Overall Study|Death|33|||
131578886|NCT01063517|473745756|FG001|Overall Study|Death|48|||
131578887|NCT02041104|473745757|FG000|Overall Study|Lost to Follow-up|1|||
131578888|NCT02041104|473745758|FG001|Overall Study|Lost to Follow-up|4|||
131578889|NCT02041104|473745757|FG000|Overall Study|discomfort during OGTT|0|||
131578890|NCT02041104|473745758|FG001|Overall Study|discomfort during OGTT|3|||
131578891|NCT00617201|473745761|FG000|Overall Study|Lost to Follow-up|9|||
131578892|NCT00617201|473745762|FG001|Overall Study|Lost to Follow-up|13|||
131578893|NCT00546871|473745763|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
131578894|NCT00546871|473745764|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
131578895|NCT00546871|473745763|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
131578896|NCT00546871|473745764|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
131578897|NCT00546871|473745763|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
131578898|NCT00546871|473745764|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
131578899|NCT00546871|473745763|FG000|Study Extension Period|Protocol Violation|1|||
131578900|NCT00546871|473745764|FG001|Study Extension Period|Protocol Violation|0|||
131578901|NCT00546871|473745763|FG000|Study Extension Period|Withdrawal by Subject|0|||
131701040|NCT03529773|474187668|FG034|Overall Study|Randomized but not vaccinated|0|||
131701041|NCT03529773|474187669|FG035|Overall Study|Randomized but not vaccinated|0|||
131701042|NCT03529773|474187670|FG036|Overall Study|Randomized but not vaccinated|0|||
131701043|NCT03529773|474187671|FG037|Overall Study|Randomized but not vaccinated|0|||
131701044|NCT03529773|474187672|FG038|Overall Study|Randomized but not vaccinated|0|||
131701045|NCT03529773|474187673|FG039|Overall Study|Randomized but not vaccinated|0|||
131701046|NCT01340209|474187674|FG000|Overall Study|Adverse Event|1|||
131701047|NCT01340209|474187675|FG001|Overall Study|Adverse Event|1|||
131701048|NCT01340209|474187676|FG002|Overall Study|Adverse Event|2|||
131701049|NCT01340209|474187674|FG000|Overall Study|Protocol Violation|1|||
131701050|NCT01340209|474187675|FG001|Overall Study|Protocol Violation|2|||
131701051|NCT01340209|474187676|FG002|Overall Study|Protocol Violation|1|||
131701052|NCT01340209|474187674|FG000|Overall Study|Withdrawal by Subject|0|||
131701053|NCT01340209|474187675|FG001|Overall Study|Withdrawal by Subject|0|||
131701054|NCT01340209|474187676|FG002|Overall Study|Withdrawal by Subject|1|||
131701055|NCT01340209|474187674|FG000|Overall Study|Other reason not defined above|3|||
131701056|NCT01340209|474187675|FG001|Overall Study|Other reason not defined above|5|||
131701057|NCT01340209|474187676|FG002|Overall Study|Other reason not defined above|4|||
131701058|NCT00253630|474187677|FG000|Overall Study|ineligible|2|||
131701059|NCT00429858|474187680|FG000|Overall Study|Withdrawal by Subject|1|||
131578902|NCT00546871|473745764|FG001|Study Extension Period|Withdrawal by Subject|1|||
131578903|NCT01713946|473745765|FG000|Overall Study|Death|0|||
131578904|NCT01713946|473745766|FG001|Overall Study|Death|2|||
131701060|NCT00429858|474187680|FG000|Overall Study|Study Termination|1|||
131786570|NCT02367781|474502088|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
131578905|NCT01713946|473745767|FG002|Overall Study|Death|2|||
131701061|NCT01537211|474187682|FG000|Overall Study|Lost to Follow-up|0|||
131578906|NCT01713946|473745765|FG000|Overall Study|Adverse Event|19|||
131701062|NCT01537211|474187683|FG001|Overall Study|Lost to Follow-up|1|||
131701063|NCT04142983|474187684|FG000|Overall Study|Lost to Follow-up|73|||
131701064|NCT04142983|474187684|FG000|Overall Study|Withdrawal by Subject|10|||
131438123|NCT00467740|473229514|FG002|Overall Study|Lack of Efficacy|0|||
131438124|NCT00467740|473229515|FG003|Overall Study|Lack of Efficacy|0|||
131438125|NCT00467740|473229516|FG004|Overall Study|Lack of Efficacy|0|||
131438126|NCT02903160|473229517|FG000|Overall Study|Adverse Event|2|||
131438127|NCT02903160|473229517|FG000|Overall Study|Death|1|||
131438128|NCT02903160|473229517|FG000|Overall Study|Lost to Follow-up|2|||
131438129|NCT02903160|473229517|FG000|Overall Study|Withdrawal by Subject|1|||
131438130|NCT02903160|473229517|FG000|Overall Study|Medical Insurance Barriers|1|||
131438131|NCT00730158|473229524|FG000|Overall Study|Withdrawal by Subject|1|||
131438132|NCT00730158|473229525|FG001|Overall Study|Withdrawal by Subject|1|||
131438133|NCT00844376|473229526|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
131438134|NCT00844376|473229527|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
131438135|NCT00660192|473229530|FG000|Overall Study|Lost to Follow-up|2|||
131438136|NCT00660192|473229531|FG001|Overall Study|Lost to Follow-up|3|||
131438137|NCT02734693|473229532|FG000|Overall Study|Adverse Event|1|||
131438138|NCT02734693|473229533|FG001|Overall Study|Adverse Event|3|||
131438139|NCT02734693|473229534|FG002|Overall Study|Adverse Event|3|||
131438140|NCT02734693|473229532|FG000|Overall Study|Lack of Efficacy|1|||
131438141|NCT02734693|473229533|FG001|Overall Study|Lack of Efficacy|0|||
131438142|NCT02734693|473229534|FG002|Overall Study|Lack of Efficacy|0|||
131438143|NCT02734693|473229532|FG000|Overall Study|Lost to Follow-up|2|||
131438144|NCT02734693|473229533|FG001|Overall Study|Lost to Follow-up|0|||
131438145|NCT02734693|473229534|FG002|Overall Study|Lost to Follow-up|0|||
131438146|NCT02734693|473229532|FG000|Overall Study|Protocol Violation|1|||
131438147|NCT02734693|473229533|FG001|Overall Study|Protocol Violation|0|||
131438148|NCT02734693|473229534|FG002|Overall Study|Protocol Violation|0|||
131438149|NCT02734693|473229532|FG000|Overall Study|Withdrawal by Subject|1|||
131438150|NCT02734693|473229533|FG001|Overall Study|Withdrawal by Subject|0|||
131438151|NCT02734693|473229534|FG002|Overall Study|Withdrawal by Subject|0|||
131438152|NCT00982735|473229535|FG000|Overall Study|Lost to Follow-up|6|||
131438153|NCT00982735|473229535|FG000|Overall Study|Patient ineligible for trial|224|||
131438154|NCT02898454|473229541|FG000|Overall Study|Adverse Event|4|||
131438155|NCT02898454|473229542|FG001|Overall Study|Adverse Event|1|||
131438156|NCT02898454|473229543|FG002|Overall Study|Adverse Event|2|||
131438157|NCT02898454|473229541|FG000|Overall Study|Protocol Violation|1|||
131438158|NCT02898454|473229542|FG001|Overall Study|Protocol Violation|0|||
131438159|NCT02898454|473229543|FG002|Overall Study|Protocol Violation|1|||
131438160|NCT02898454|473229541|FG000|Overall Study|Lack of Efficacy|4|||
131438161|NCT02898454|473229542|FG001|Overall Study|Lack of Efficacy|1|||
131438162|NCT02898454|473229543|FG002|Overall Study|Lack of Efficacy|0|||
131438163|NCT02898454|473229541|FG000|Overall Study|Withdrawal by Subject|6|||
131438164|NCT02898454|473229542|FG001|Overall Study|Withdrawal by Subject|3|||
131438165|NCT02898454|473229543|FG002|Overall Study|Withdrawal by Subject|3|||
131438166|NCT02898454|473229541|FG000|Overall Study|Lost to Follow-up|1|||
131438167|NCT02898454|473229542|FG001|Overall Study|Lost to Follow-up|0|||
131438168|NCT02898454|473229543|FG002|Overall Study|Lost to Follow-up|0|||
131438169|NCT02898454|473229541|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
131438170|NCT02898454|473229542|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
131438171|NCT02898454|473229543|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
131438172|NCT01601535|473229544|FG000|Phase 1|Adverse Event|1|||
131438173|NCT01601535|473229545|FG001|Phase 1|Adverse Event|0|||
131438174|NCT01601535|473229546|FG002|Phase 1|Adverse Event|2|||
131438175|NCT01601535|473229547|FG003|Phase 1|Adverse Event|1|||
131438176|NCT01601535|473229548|FG004|Phase 1|Adverse Event|0|||
131438177|NCT01601535|473229549|FG005|Phase 1|Adverse Event|0|||
131438178|NCT01601535|473229544|FG000|Phase 1|Withdrawal by Subject|2|||
131438179|NCT01601535|473229545|FG001|Phase 1|Withdrawal by Subject|1|||
131438180|NCT01601535|473229546|FG002|Phase 1|Withdrawal by Subject|1|||
131438181|NCT01601535|473229547|FG003|Phase 1|Withdrawal by Subject|2|||
131438182|NCT01601535|473229548|FG004|Phase 1|Withdrawal by Subject|0|||
131438183|NCT01601535|473229549|FG005|Phase 1|Withdrawal by Subject|0|||
131438184|NCT01601535|473229544|FG000|Phase 1|Progressive Disease|2|||
131438185|NCT01601535|473229545|FG001|Phase 1|Progressive Disease|3|||
131438186|NCT01601535|473229546|FG002|Phase 1|Progressive Disease|2|||
131438187|NCT01601535|473229547|FG003|Phase 1|Progressive Disease|1|||
131438188|NCT01601535|473229548|FG004|Phase 1|Progressive Disease|0|||
131438189|NCT01601535|473229549|FG005|Phase 1|Progressive Disease|0|||
131438190|NCT01601535|473229544|FG000|Phase 1|Started Another Treatment|1|||
131438191|NCT01601535|473229545|FG001|Phase 1|Started Another Treatment|2|||
131438192|NCT01601535|473229546|FG002|Phase 1|Started Another Treatment|0|||
131438193|NCT01601535|473229547|FG003|Phase 1|Started Another Treatment|0|||
131438194|NCT01601535|473229548|FG004|Phase 1|Started Another Treatment|0|||
131438195|NCT01601535|473229549|FG005|Phase 1|Started Another Treatment|0|||
131438196|NCT01601535|473229544|FG000|Phase 2|Adverse Event|0|||
131438197|NCT01601535|473229545|FG001|Phase 2|Adverse Event|0|||
131438198|NCT01601535|473229546|FG002|Phase 2|Adverse Event|0|||
131438199|NCT01601535|473229547|FG003|Phase 2|Adverse Event|0|||
131438200|NCT01601535|473229548|FG004|Phase 2|Adverse Event|5|||
131438201|NCT01601535|473229549|FG005|Phase 2|Adverse Event|1|||
131438202|NCT01601535|473229544|FG000|Phase 2|Withdrawal by Subject|0|||
131438203|NCT01601535|473229545|FG001|Phase 2|Withdrawal by Subject|0|||
131438204|NCT01601535|473229546|FG002|Phase 2|Withdrawal by Subject|0|||
131438205|NCT01601535|473229547|FG003|Phase 2|Withdrawal by Subject|0|||
131438206|NCT01601535|473229548|FG004|Phase 2|Withdrawal by Subject|8|||
131438207|NCT01601535|473229549|FG005|Phase 2|Withdrawal by Subject|2|||
131438208|NCT01601535|473229544|FG000|Phase 2|Progressive Disease|0|||
131438209|NCT01601535|473229545|FG001|Phase 2|Progressive Disease|0|||
131438210|NCT01601535|473229546|FG002|Phase 2|Progressive Disease|0|||
131438211|NCT01601535|473229547|FG003|Phase 2|Progressive Disease|0|||
131438212|NCT01601535|473229548|FG004|Phase 2|Progressive Disease|5|||
131438213|NCT01601535|473229549|FG005|Phase 2|Progressive Disease|7|||
131438214|NCT01601535|473229544|FG000|Phase 2|Started Another Treatment|0|||
131438215|NCT01601535|473229545|FG001|Phase 2|Started Another Treatment|0|||
131438216|NCT01601535|473229546|FG002|Phase 2|Started Another Treatment|0|||
131438217|NCT01601535|473229547|FG003|Phase 2|Started Another Treatment|0|||
131438218|NCT01601535|473229548|FG004|Phase 2|Started Another Treatment|1|||
131438219|NCT01601535|473229549|FG005|Phase 2|Started Another Treatment|2|||
131438220|NCT00647296|473229550|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
131438221|NCT00647296|473229551|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
131438222|NCT00647296|473229552|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
131438223|NCT00647296|473229553|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
131438224|NCT00647296|473229550|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
131438225|NCT00647296|473229551|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
131578907|NCT01713946|473745766|FG001|Overall Study|Adverse Event|14|||
131578908|NCT01713946|473745767|FG002|Overall Study|Adverse Event|13|||
131904616|NCT01930539|474937036|FG000|Overall Study|Withdrawal by Subject|2|||
131438226|NCT00647296|473229552|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
131438227|NCT00647296|473229553|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
131438228|NCT00647296|473229550|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
131438229|NCT00647296|473229551|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
131438230|NCT00647296|473229552|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
131438231|NCT00647296|473229553|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
131438232|NCT00647296|473229550|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
131438233|NCT00647296|473229551|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
131438234|NCT00647296|473229552|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
131438235|NCT00647296|473229553|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
131438236|NCT00647296|473229550|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
131438237|NCT00647296|473229551|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
131438238|NCT00647296|473229552|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
131438239|NCT00647296|473229553|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
131438240|NCT00647296|473229550|FG000|Part 2: 4-week Placebo Washout|Death|3|||
131438241|NCT00647296|473229551|FG001|Part 2: 4-week Placebo Washout|Death|0|||
131438242|NCT00647296|473229552|FG002|Part 2: 4-week Placebo Washout|Death|0|||
131438243|NCT00647296|473229553|FG003|Part 2: 4-week Placebo Washout|Death|0|||
131438244|NCT00647296|473229550|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
131438245|NCT00647296|473229551|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
131438246|NCT00647296|473229552|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
131438247|NCT00647296|473229553|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
131438248|NCT00647296|473229550|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
131438249|NCT00647296|473229551|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
131438250|NCT00647296|473229552|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
131438251|NCT00647296|473229553|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
131438252|NCT00647296|473229550|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
131438253|NCT00647296|473229551|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
131438254|NCT00647296|473229552|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
131438255|NCT00647296|473229553|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
131438256|NCT00647296|473229550|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
131438257|NCT00647296|473229551|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
131438258|NCT00647296|473229552|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
131438259|NCT00647296|473229553|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
131438260|NCT00647296|473229550|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
131438261|NCT00647296|473229551|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
131438262|NCT00647296|473229552|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
131438263|NCT00647296|473229553|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
131438264|NCT03883581|473229556|FG000|Overall Study|Withdrawal by Subject|4|||
131438265|NCT01908426|473231171|FG000|Overall Study|Adverse Event|98|||
131438266|NCT01908426|473231172|FG001|Overall Study|Adverse Event|11|||
131438267|NCT01908426|473231171|FG000|Overall Study|Clinical Deterioration|72|||
131438268|NCT01908426|473231172|FG001|Overall Study|Clinical Deterioration|38|||
131438269|NCT01908426|473231171|FG000|Overall Study|Lack of Efficacy|3|||
131438270|NCT01908426|473231172|FG001|Overall Study|Lack of Efficacy|0|||
131438271|NCT01908426|473231171|FG000|Overall Study|Lost to Follow-up|0|||
131438272|NCT01908426|473231172|FG001|Overall Study|Lost to Follow-up|1|||
131578909|NCT01713946|473745765|FG000|Overall Study|Withdrawal by Subject|12|||
131578910|NCT01713946|473745766|FG001|Overall Study|Withdrawal by Subject|12|||
131578911|NCT01713946|473745767|FG002|Overall Study|Withdrawal by Subject|8|||
131578912|NCT01713946|473745765|FG000|Overall Study|Lack of Efficacy|8|||
131578913|NCT01713946|473745766|FG001|Overall Study|Lack of Efficacy|8|||
131578914|NCT01713946|473745767|FG002|Overall Study|Lack of Efficacy|14|||
131578915|NCT01713946|473745765|FG000|Overall Study|Protocol Violation|2|||
131578916|NCT01713946|473745766|FG001|Overall Study|Protocol Violation|4|||
131578917|NCT01713946|473745767|FG002|Overall Study|Protocol Violation|1|||
131578918|NCT01713946|473745765|FG000|Overall Study|Lost to Follow-up|0|||
131578919|NCT01713946|473745766|FG001|Overall Study|Lost to Follow-up|0|||
131578920|NCT01713946|473745767|FG002|Overall Study|Lost to Follow-up|1|||
131578921|NCT01713946|473745765|FG000|Overall Study|Administrative problems|1|||
131578922|NCT01713946|473745766|FG001|Overall Study|Administrative problems|0|||
131578923|NCT01713946|473745767|FG002|Overall Study|Administrative problems|0|||
131578924|NCT01713946|473745765|FG000|Overall Study|Did not continue in Ext|0|||
131578925|NCT01713946|473745766|FG001|Overall Study|Did not continue in Ext|3|||
131438273|NCT01908426|473231171|FG000|Overall Study|Physician Decision|3|||
131438274|NCT01908426|473231172|FG001|Overall Study|Physician Decision|3|||
131438275|NCT01908426|473231171|FG000|Overall Study|Withdrawal by Subject|11|||
131438276|NCT01908426|473231172|FG001|Overall Study|Withdrawal by Subject|6|||
131438277|NCT01908426|473231171|FG000|Overall Study|Progressive Disease|206|||
131578926|NCT01713946|473745767|FG002|Overall Study|Did not continue in Ext|0|||
131578927|NCT01713946|473745765|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
131578928|NCT01713946|473745766|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
131578929|NCT01713946|473745767|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
131578930|NCT01713946|473745765|FG000|Overall Study|Patients never switched to everolimus|0|||
131578931|NCT01713946|473745766|FG001|Overall Study|Patients never switched to everolimus|0|||
131578932|NCT01713946|473745767|FG002|Overall Study|Patients never switched to everolimus|5|||
131578933|NCT03183518|473745768|FG000|Overall Study|Other (Not specified)|2|||
131578934|NCT03183518|473745768|FG000|Overall Study|Other (Withdrawal of consent)|1|||
131578935|NCT04493242|473745771|FG000|Overall Study|Death|10|||
131578936|NCT04493242|473745772|FG001|Overall Study|Death|14|||
131578937|NCT04493242|473745773|FG002|Overall Study|Death|16|||
131578938|NCT04493242|473745771|FG000|Overall Study|Lost to Follow-up|1|||
131578939|NCT04493242|473745772|FG001|Overall Study|Lost to Follow-up|1|||
131578940|NCT04493242|473745773|FG002|Overall Study|Lost to Follow-up|0|||
131578941|NCT04493242|473745771|FG000|Overall Study|Withdrawal by Subject|1|||
131578942|NCT04493242|473745772|FG001|Overall Study|Withdrawal by Subject|0|||
131578943|NCT04493242|473745773|FG002|Overall Study|Withdrawal by Subject|0|||
131578944|NCT04493242|473745771|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
131578945|NCT04493242|473745772|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
131578946|NCT04493242|473745773|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
131578947|NCT04493242|473745771|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
131578948|NCT04493242|473745772|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
131578949|NCT04493242|473745773|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
131578950|NCT04513522|473747859|FG000|Overall Study|Other reasons|1|||
131578951|NCT04513522|473747859|FG000|Overall Study|Adverse event unrelated to study drug|9|||
131578952|NCT04513522|473747859|FG000|Overall Study|Study drug toxicity|14|||
131578953|NCT04513522|473747859|FG000|Overall Study|Disease progression|39|||
131578954|NCT04513522|473747859|FG000|Overall Study|Participants withdrew consent|2|||
131578955|NCT00589667|473747860|FG000|Overall Study|Adverse Event|2|||
131578956|NCT00589667|473747860|FG000|Overall Study|Withdrawal by Subject|1|||
131578957|NCT03538041|473747861|FG000|12-Week Treatment Period|Adverse Event|1|||
131578958|NCT03538041|473747862|FG001|12-Week Treatment Period|Adverse Event|1|||
131578959|NCT03538041|473747861|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
131578960|NCT03538041|473747862|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
131578961|NCT03538041|473747861|FG000|Treatment Extension Period|Adverse Event|4|||
131578962|NCT03538041|473747862|FG001|Treatment Extension Period|Adverse Event|1|||
131578963|NCT03538041|473747861|FG000|Treatment Extension Period|Physician Decision|1|||
131578964|NCT03538041|473747862|FG001|Treatment Extension Period|Physician Decision|1|||
131578965|NCT03538041|473747861|FG000|Treatment Extension Period|Lack of Efficacy|1|||
131578966|NCT03538041|473747862|FG001|Treatment Extension Period|Lack of Efficacy|4|||
131578967|NCT03538041|473747861|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
131578968|NCT03538041|473747862|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
131578969|NCT03538041|473747861|FG000|Treatment Extension Period|Death|0|||
131578970|NCT03538041|473747862|FG001|Treatment Extension Period|Death|1|||
131578971|NCT00028769|473747865|FG000|Overall Study|Adverse Event|2|||
131578972|NCT00028769|473747865|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
131578973|NCT00028769|473747865|FG000|Overall Study|Progression or Death|31|||
131578974|NCT00028769|473747865|FG000|Overall Study|Other - Not Protocol Specified|1|||
131578975|NCT00028769|473747865|FG000|Overall Study|Ineligible|5|||
131578976|NCT00028769|473747865|FG000|Overall Study|Not Analyzable|1|||
131578977|NCT01134562|473747866|FG000|Overall Study|Adverse Event|0|||
131578978|NCT01134562|473747867|FG001|Overall Study|Adverse Event|1|||
131578979|NCT01134562|473747868|FG002|Overall Study|Adverse Event|0|||
131578980|NCT01134562|473747869|FG003|Overall Study|Adverse Event|0|||
131578981|NCT01134562|473747870|FG004|Overall Study|Adverse Event|0|||
131578982|NCT00708032|473747873|FG000|Overall Study|Adverse Event|0|||
131578983|NCT00708032|473747874|FG001|Overall Study|Adverse Event|2|||
131578984|NCT00708032|473747873|FG000|Overall Study|Lost to Follow-up|1|||
131578985|NCT00708032|473747874|FG001|Overall Study|Lost to Follow-up|2|||
131578986|NCT00708032|473747873|FG000|Overall Study|Pregnancy|0|||
131578987|NCT00708032|473747874|FG001|Overall Study|Pregnancy|1|||
131578988|NCT00708032|473747873|FG000|Overall Study|Poor vision|0|||
131578989|NCT00708032|473747874|FG001|Overall Study|Poor vision|6|||
131578990|NCT00708032|473747873|FG000|Overall Study|Visit out of range at month 12|4|||
131578991|NCT00708032|473747874|FG001|Overall Study|Visit out of range at month 12|1|||
131578992|NCT00708032|473747873|FG000|Overall Study|Did not meet protocol criteria|1|||
131578993|NCT00708032|473747874|FG001|Overall Study|Did not meet protocol criteria|2|||
131578994|NCT00708032|473747873|FG000|Overall Study|Protocol Violation|4|||
131578995|NCT00708032|473747874|FG001|Overall Study|Protocol Violation|1|||
131578996|NCT00708032|473747873|FG000|Overall Study|Withdrawal by Subject|0|||
131578997|NCT00708032|473747874|FG001|Overall Study|Withdrawal by Subject|1|||
131578998|NCT02983617|473747878|FG000|Overall Study|Adverse Event|0|||
131578999|NCT02983617|473747879|FG001|Overall Study|Adverse Event|7|||
131579000|NCT02983617|473747878|FG000|Overall Study|Death|0|||
131579001|NCT02983617|473747879|FG001|Overall Study|Death|1|||
131579002|NCT02983617|473747878|FG000|Overall Study|Investigator's Discretion|0|||
131579003|NCT02983617|473747879|FG001|Overall Study|Investigator's Discretion|1|||
131579004|NCT02027558|473747880|FG000|Overall Study|Death|0|||
131579005|NCT02027558|473747881|FG001|Overall Study|Death|1|||
131579006|NCT02027558|473747880|FG000|Overall Study|Withdrawal by Subject|2|||
131579007|NCT02027558|473747881|FG001|Overall Study|Withdrawal by Subject|0|||
131579008|NCT02027558|473747880|FG000|Overall Study|Lost to Follow-up|4|||
131579009|NCT02027558|473747881|FG001|Overall Study|Lost to Follow-up|1|||
131579010|NCT02027558|473747880|FG000|Overall Study|Refused assessment|3|||
131579011|NCT02027558|473747881|FG001|Overall Study|Refused assessment|0|||
131579012|NCT03720210|473747882|FG000|Overall Study|Lost to Follow-up|1|||
131579013|NCT02698891|473747883|FG000|Overall Study|Withdrawal by Subject|2|||
131579014|NCT02698891|473747883|FG000|Overall Study|deemed ineligible|1|||
131579015|NCT02698891|473747883|FG000|Overall Study|Adverse Event|9|||
131579016|NCT00711958|473747884|FG000|Overall Study|Withdrawal by Subject|6|||
131579017|NCT00711958|473747885|FG001|Overall Study|Withdrawal by Subject|8|||
131579018|NCT00711958|473747884|FG000|Overall Study|Lack of Efficacy|3|||
131579019|NCT00711958|473747885|FG001|Overall Study|Lack of Efficacy|1|||
131579020|NCT00711958|473747884|FG000|Overall Study|Clinical deterioration|1|||
131579021|NCT00711958|473747885|FG001|Overall Study|Clinical deterioration|0|||
131579022|NCT00711958|473747884|FG000|Overall Study|Adverse Event|9|||
131579023|NCT00711958|473747885|FG001|Overall Study|Adverse Event|7|||
131579024|NCT00711958|473747884|FG000|Overall Study|Protocol Violation|1|||
131579025|NCT00711958|473747885|FG001|Overall Study|Protocol Violation|0|||
131579026|NCT00711958|473747884|FG000|Overall Study|Lost to Follow-up|2|||
131579027|NCT00711958|473747885|FG001|Overall Study|Lost to Follow-up|2|||
131438278|NCT01908426|473231172|FG001|Overall Study|Progressive Disease|152|||
131438279|NCT01908426|473231171|FG000|Overall Study|Protocol Violation|1|||
131438280|NCT01908426|473231172|FG001|Overall Study|Protocol Violation|0|||
131438281|NCT01908426|473231171|FG000|Overall Study|No Study Treatment Given|3|||
131579028|NCT00711958|473747884|FG000|Overall Study|Death|10|||
131579029|NCT00711958|473747885|FG001|Overall Study|Death|5|||
131579030|NCT00711958|473747884|FG000|Overall Study|Progression of disease|1|||
131579031|NCT00711958|473747885|FG001|Overall Study|Progression of disease|0|||
131701065|NCT04142983|474187684|FG000|Overall Study|Physician Decision|1|||
131701066|NCT04142983|474187684|FG000|Overall Study|Adverse Event|1|||
131701067|NCT04142983|474187684|FG000|Overall Study|No longer eligible|4|||
131701068|NCT04142983|474187684|FG000|Overall Study|Screen Failure|10|||
131701069|NCT02062658|474187687|FG000|Overall Study|Withdrawal by Subject|1|||
131701070|NCT02062658|474187687|FG000|Overall Study|Lack of Efficacy|1|||
131701071|NCT00643994|474187688|FG000|Overall Study|Death|24|||
131438282|NCT01908426|473231172|FG001|Overall Study|No Study Treatment Given|0|||
131579032|NCT01111526|473747886|FG000|Overall Study|GVHD Disease Progression|0|||
131579033|NCT01111526|473747887|FG001|Overall Study|GVHD Disease Progression|1|||
131579034|NCT01111526|473747888|FG002|Overall Study|GVHD Disease Progression|2|||
131579035|NCT04424641|473747889|FG000|Overall Study|Death|1|||
131579036|NCT04424641|473747890|FG001|Overall Study|Death|2|||
131579037|NCT04424641|473747891|FG002|Overall Study|Death|3|||
131579038|NCT04424641|473747892|FG003|Overall Study|Death|0|||
131701072|NCT00643994|474187688|FG000|Overall Study|Lost to Follow-up|72|||
131701073|NCT00257010|474187707|FG000|Overall Study|Lack of Efficacy|11|||
131579039|NCT04424641|473747893|FG004|Overall Study|Death|3|||
131579040|NCT04424641|473747894|FG005|Overall Study|Death|0|||
131579041|NCT04424641|473747895|FG006|Overall Study|Death|1|||
131579042|NCT04424641|473747896|FG007|Overall Study|Death|2|||
131579043|NCT04424641|473747889|FG000|Overall Study|Sponsor decision|0|||
131579044|NCT04424641|473747890|FG001|Overall Study|Sponsor decision|2|||
131579045|NCT04424641|473747891|FG002|Overall Study|Sponsor decision|3|||
131579046|NCT04424641|473747892|FG003|Overall Study|Sponsor decision|7|||
131579047|NCT04424641|473747893|FG004|Overall Study|Sponsor decision|2|||
131579048|NCT04424641|473747894|FG005|Overall Study|Sponsor decision|2|||
131579049|NCT04424641|473747895|FG006|Overall Study|Sponsor decision|3|||
131579050|NCT04424641|473747896|FG007|Overall Study|Sponsor decision|4|||
131579051|NCT04424641|473747889|FG000|Overall Study|Withdrawal by Subject|0|||
131579052|NCT04424641|473747890|FG001|Overall Study|Withdrawal by Subject|0|||
131579053|NCT04424641|473747891|FG002|Overall Study|Withdrawal by Subject|0|||
131786571|NCT01123980|474502091|FG000|Overall Study|Adverse Event|1|||
131786572|NCT01123980|474502092|FG001|Overall Study|Adverse Event|1|||
131786573|NCT01123980|474502091|FG000|Overall Study|Lack of Efficacy|1|||
131786574|NCT01123980|474502092|FG001|Overall Study|Lack of Efficacy|0|||
131786575|NCT01123980|474502091|FG000|Overall Study|Physician Decision|0|||
131786576|NCT01123980|474502092|FG001|Overall Study|Physician Decision|1|||
131786577|NCT01123980|474502091|FG000|Overall Study|Lost to Follow-up|0|||
131786578|NCT01123980|474502092|FG001|Overall Study|Lost to Follow-up|6|||
131786579|NCT01123980|474502091|FG000|Overall Study|Protocol Violation|6|||
131786580|NCT01123980|474502092|FG001|Overall Study|Protocol Violation|6|||
131786581|NCT01123980|474502091|FG000|Overall Study|Withdrawal by Subject|5|||
131786582|NCT01123980|474502092|FG001|Overall Study|Withdrawal by Subject|3|||
131786583|NCT01123980|474502091|FG000|Overall Study|Unclassified|6|||
131786584|NCT01123980|474502092|FG001|Overall Study|Unclassified|7|||
131579054|NCT04424641|473747892|FG003|Overall Study|Withdrawal by Subject|0|||
131579055|NCT04424641|473747893|FG004|Overall Study|Withdrawal by Subject|1|||
131579056|NCT04424641|473747894|FG005|Overall Study|Withdrawal by Subject|0|||
131579057|NCT04424641|473747895|FG006|Overall Study|Withdrawal by Subject|0|||
131579058|NCT04424641|473747896|FG007|Overall Study|Withdrawal by Subject|0|||
131579059|NCT04424641|473747889|FG000|Overall Study|Other|0|||
131579060|NCT04424641|473747890|FG001|Overall Study|Other|0|||
131579061|NCT04424641|473747891|FG002|Overall Study|Other|1|||
131579062|NCT04424641|473747892|FG003|Overall Study|Other|0|||
131579063|NCT04424641|473747893|FG004|Overall Study|Other|0|||
131579064|NCT04424641|473747894|FG005|Overall Study|Other|0|||
131579065|NCT04424641|473747895|FG006|Overall Study|Other|0|||
131579066|NCT04424641|473747896|FG007|Overall Study|Other|0|||
131579067|NCT02694978|473747901|FG000|Overall Study|Adverse Event|10|||
131579068|NCT02694978|473747902|FG001|Overall Study|Adverse Event|9|||
131579069|NCT02694978|473747901|FG000|Overall Study|Withdrawal by Subject|22|||
131579070|NCT02694978|473747902|FG001|Overall Study|Withdrawal by Subject|19|||
131579071|NCT02694978|473747901|FG000|Overall Study|Lost to Follow-up|14|||
131579072|NCT02694978|473747902|FG001|Overall Study|Lost to Follow-up|17|||
131579073|NCT02694978|473747901|FG000|Overall Study|Death|4|||
131579074|NCT02694978|473747902|FG001|Overall Study|Death|1|||
131579075|NCT02694978|473747901|FG000|Overall Study|Other-Decision of Participant|6|||
131579076|NCT02694978|473747902|FG001|Overall Study|Other-Decision of Participant|1|||
131579077|NCT02694978|473747901|FG000|Overall Study|Other-Investigator's decision|1|||
131579078|NCT02694978|473747902|FG001|Overall Study|Other-Investigator's decision|0|||
131579079|NCT02694978|473747901|FG000|Overall Study|Other-Unable to be reached|0|||
131579080|NCT02694978|473747902|FG001|Overall Study|Other-Unable to be reached|1|||
131579081|NCT02694978|473747901|FG000|Overall Study|Other-Protocol noncompliant|2|||
131579082|NCT02694978|473747902|FG001|Overall Study|Other-Protocol noncompliant|1|||
131579083|NCT02694978|473747901|FG000|Overall Study|Other-Personal reasons|3|||
131579084|NCT02694978|473747902|FG001|Overall Study|Other-Personal reasons|3|||
131701074|NCT00257010|474187707|FG000|Overall Study|Lost to Follow-up|53|||
131701075|NCT00257010|474187707|FG000|Overall Study|Withdrawal by Subject|34|||
131701076|NCT00257010|474187707|FG000|Overall Study|Adverse Event|10|||
131701077|NCT00257010|474187707|FG000|Overall Study|various|11|||
131701078|NCT00257010|474187707|FG000|Overall Study|no headache reported|9|||
131701079|NCT00323557|474187708|FG000|Overall Study|Physician Decision|1|||
131701080|NCT00323557|474187709|FG001|Overall Study|Physician Decision|0|||
131701081|NCT00197054|474187710|FG000|Overall Study|Withdrawal by Subject|9|||
131701082|NCT00197054|474187711|FG001|Overall Study|Withdrawal by Subject|3|||
131701083|NCT00197054|474187712|FG002|Overall Study|Withdrawal by Subject|3|||
131701084|NCT00197054|474187710|FG000|Overall Study|Moved from area|7|||
131786585|NCT01225991|474502093|FG000|Overall Study|Withdrawal by Subject|6|||
131786586|NCT00789828|474502094|FG000|Core Period (48 Weeks)|Administrative problems|0|||
131786587|NCT00789828|474502095|FG001|Core Period (48 Weeks)|Administrative problems|1|||
131786588|NCT00789828|474502094|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
131579085|NCT02694978|473747901|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
131579086|NCT02694978|473747902|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
131701085|NCT00197054|474187711|FG001|Overall Study|Moved from area|14|||
131701086|NCT00197054|474187712|FG002|Overall Study|Moved from area|9|||
131579087|NCT01613716|473747903|FG000|Overall Study|screen failures|3|||
131579088|NCT01613716|473747903|FG000|Overall Study|Lost to Follow-up|4|||
131579089|NCT01171625|473747904|FG000|Overall Study|On-Protocol|67|||
131579090|NCT01171625|473747904|FG000|Overall Study|Death|38|||
131579091|NCT01171625|473747904|FG000|Overall Study|Withdrawal by Subject|31|||
131579092|NCT01171625|473747904|FG000|Overall Study|Explanted|10|||
131579093|NCT01171625|473747904|FG000|Overall Study|Lost to Follow-up|5|||
131579094|NCT01171625|473747904|FG000|Overall Study|Patient received valve-in-valve|3|||
131579095|NCT01171625|473747904|FG000|Overall Study|Other|1|||
131579096|NCT01171625|473747904|FG000|Overall Study|Consented but did not receive device|25|||
131579097|NCT00743444|473747905|FG000|First Intervention|Catheter placement problems|0|||
131579098|NCT00743444|473747906|FG001|First Intervention|Catheter placement problems|1|||
131579099|NCT00743444|473747905|FG000|Washout Period|Adverse Event|0|||
131579100|NCT00743444|473747906|FG001|Washout Period|Adverse Event|1|||
131579101|NCT01786564|473747913|FG000|Overall Study|Lost to Follow-up|47|||
131579102|NCT01786564|473747913|FG000|Overall Study|Ineligible|17|||
131579103|NCT01924767|473747920|FG000|Overall Study|Adverse Event|1|||
131701087|NCT00197054|474187710|FG000|Overall Study|Lost to Follow-up|1|||
131701088|NCT00197054|474187711|FG001|Overall Study|Lost to Follow-up|4|||
131701089|NCT00197054|474187712|FG002|Overall Study|Lost to Follow-up|0|||
131701090|NCT02450578|474187715|FG000|Overall Study|ECG abnormality so not treated|1|||
131701091|NCT02450578|474187716|FG001|Overall Study|ECG abnormality so not treated|0|||
131701092|NCT02450578|474187717|FG002|Overall Study|ECG abnormality so not treated|0|||
131701093|NCT02450578|474187718|FG003|Overall Study|ECG abnormality so not treated|0|||
131701094|NCT00662792|474187719|FG000|Period 1|Personal Reasons|0|||
131701095|NCT00662792|474187720|FG001|Period 1|Personal Reasons|0|||
131701096|NCT00662792|474187721|FG002|Period 1|Personal Reasons|1|||
131701097|NCT00662792|474187722|FG003|Period 1|Personal Reasons|0|||
131701098|NCT00662792|474187719|FG000|Period 1|Refused continuing medication|0|||
131701099|NCT00662792|474187720|FG001|Period 1|Refused continuing medication|1|||
131701100|NCT00662792|474187721|FG002|Period 1|Refused continuing medication|1|||
131701101|NCT00662792|474187722|FG003|Period 1|Refused continuing medication|0|||
131701102|NCT00662792|474187719|FG000|Period 1|Lost to Follow-up|1|||
131701103|NCT00662792|474187720|FG001|Period 1|Lost to Follow-up|0|||
131701104|NCT00662792|474187721|FG002|Period 1|Lost to Follow-up|0|||
131701105|NCT00662792|474187722|FG003|Period 1|Lost to Follow-up|0|||
131701106|NCT00662792|474187719|FG000|Period 1|Other adverse event (AE)|0|||
131701107|NCT00662792|474187720|FG001|Period 1|Other adverse event (AE)|2|||
131701108|NCT00662792|474187721|FG002|Period 1|Other adverse event (AE)|0|||
131701109|NCT00662792|474187722|FG003|Period 1|Other adverse event (AE)|0|||
131701110|NCT00662792|474187719|FG000|Period 1|Worsening of disease under study (AE)|1|||
131701111|NCT00662792|474187720|FG001|Period 1|Worsening of disease under study (AE)|3|||
131701112|NCT00662792|474187721|FG002|Period 1|Worsening of disease under study (AE)|2|||
131701113|NCT00662792|474187722|FG003|Period 1|Worsening of disease under study (AE)|0|||
131701114|NCT00662792|474187719|FG000|Period 1|Not treated|0|||
131701115|NCT00662792|474187720|FG001|Period 1|Not treated|1|||
131701116|NCT00662792|474187721|FG002|Period 1|Not treated|0|||
131701117|NCT00662792|474187722|FG003|Period 1|Not treated|0|||
131701118|NCT00662792|474187719|FG000|Period 2|Worsening of disease under study|1|||
131701119|NCT00662792|474187720|FG001|Period 2|Worsening of disease under study|0|||
131701120|NCT00662792|474187721|FG002|Period 2|Worsening of disease under study|0|||
131701121|NCT00662792|474187722|FG003|Period 2|Worsening of disease under study|3|||
131701122|NCT00662792|474187719|FG000|Period 3|Refused continuing medication|1|||
131701123|NCT00662792|474187720|FG001|Period 3|Refused continuing medication|0|||
131701124|NCT00662792|474187721|FG002|Period 3|Refused continuing medication|1|||
131701125|NCT00662792|474187722|FG003|Period 3|Refused continuing medication|0|||
131701126|NCT00662792|474187719|FG000|Period 3|Other adverse event (AE)|0|||
131701127|NCT00662792|474187720|FG001|Period 3|Other adverse event (AE)|0|||
131701128|NCT00662792|474187721|FG002|Period 3|Other adverse event (AE)|1|||
131701129|NCT00662792|474187722|FG003|Period 3|Other adverse event (AE)|1|||
131701130|NCT00662792|474187719|FG000|Period 4|Refused continuing medication|0|||
131701131|NCT00662792|474187720|FG001|Period 4|Refused continuing medication|1|||
131701132|NCT00662792|474187721|FG002|Period 4|Refused continuing medication|0|||
131701133|NCT00662792|474187722|FG003|Period 4|Refused continuing medication|0|||
131701134|NCT00662792|474187719|FG000|Period 4|Other adverse event (AE)|1|||
131701135|NCT00662792|474187720|FG001|Period 4|Other adverse event (AE)|0|||
131701136|NCT00662792|474187721|FG002|Period 4|Other adverse event (AE)|0|||
131701137|NCT00662792|474187722|FG003|Period 4|Other adverse event (AE)|0|||
131701138|NCT00662792|474187719|FG000|Period 4|Worsening of disease under study (AE)|0|||
131701139|NCT00662792|474187720|FG001|Period 4|Worsening of disease under study (AE)|0|||
131701140|NCT00662792|474187721|FG002|Period 4|Worsening of disease under study (AE)|0|||
131701141|NCT00662792|474187722|FG003|Period 4|Worsening of disease under study (AE)|1|||
131701142|NCT01699087|474187724|FG000|Overall Study|Lost to Follow-up|7|||
131701143|NCT01699087|474187724|FG000|Overall Study|Screen failure (prior to treatment)|15|||
131701144|NCT01699087|474187724|FG000|Overall Study|Unable to make future visits|2|||
131579104|NCT01924767|473747921|FG001|Overall Study|Adverse Event|0|||
131579105|NCT01924767|473747922|FG002|Overall Study|Adverse Event|1|||
131579106|NCT01924767|473747923|FG003|Overall Study|Adverse Event|0|||
131579107|NCT01924767|473747924|FG004|Overall Study|Adverse Event|0|||
131579108|NCT03460756|473747931|FG000|Overall Study|Adverse Event|0|||
131579109|NCT03460756|473747932|FG001|Overall Study|Adverse Event|0|||
131579110|NCT03460756|473747933|FG002|Overall Study|Adverse Event|0|||
131579111|NCT03460756|473747934|FG003|Overall Study|Adverse Event|1|||
131579112|NCT03460756|473747931|FG000|Overall Study|Lack of Efficacy|0|||
131579113|NCT03460756|473747932|FG001|Overall Study|Lack of Efficacy|0|||
131579114|NCT03460756|473747933|FG002|Overall Study|Lack of Efficacy|0|||
131579115|NCT03460756|473747934|FG003|Overall Study|Lack of Efficacy|2|||
131579116|NCT03460756|473747931|FG000|Overall Study|Lost to Follow-up|0|||
131579117|NCT03460756|473747932|FG001|Overall Study|Lost to Follow-up|1|||
131579118|NCT03460756|473747933|FG002|Overall Study|Lost to Follow-up|2|||
131579119|NCT03460756|473747934|FG003|Overall Study|Lost to Follow-up|1|||
131579120|NCT03460756|473747931|FG000|Overall Study|Pregnancy|0|||
131579121|NCT03460756|473747932|FG001|Overall Study|Pregnancy|0|||
131579122|NCT03460756|473747933|FG002|Overall Study|Pregnancy|0|||
131579123|NCT03460756|473747934|FG003|Overall Study|Pregnancy|1|||
131579124|NCT03460756|473747931|FG000|Overall Study|Protocol Violation|0|||
131579125|NCT03460756|473747932|FG001|Overall Study|Protocol Violation|0|||
131579126|NCT03460756|473747933|FG002|Overall Study|Protocol Violation|0|||
131579127|NCT03460756|473747934|FG003|Overall Study|Protocol Violation|1|||
131579128|NCT03460756|473747931|FG000|Overall Study|Withdrawal by Subject|0|||
131701145|NCT03021642|474187727|FG000|Washout Period (21 Days)|Adverse Event|1|||
131701146|NCT03021642|474187728|FG001|Washout Period (21 Days)|Adverse Event|1|||
131701147|NCT00756938|474187729|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
131701148|NCT00756938|474187730|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
131701149|NCT00756938|474187731|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
131701150|NCT00756938|474187732|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
131701151|NCT00756938|474187729|FG000|12-week Base Study|Protocol Violation|0|||
131701152|NCT00756938|474187730|FG001|12-week Base Study|Protocol Violation|0|||
131701153|NCT00756938|474187731|FG002|12-week Base Study|Protocol Violation|1|||
131701154|NCT00756938|474187732|FG003|12-week Base Study|Protocol Violation|0|||
131701155|NCT00756938|474187729|FG000|12-week Base Study|Lost to Follow-up|1|||
131701156|NCT00756938|474187730|FG001|12-week Base Study|Lost to Follow-up|0|||
131701157|NCT00756938|474187731|FG002|12-week Base Study|Lost to Follow-up|0|||
131701158|NCT00756938|474187732|FG003|12-week Base Study|Lost to Follow-up|0|||
131701159|NCT00756938|474187729|FG000|Optional Extension|Lack of Efficacy|0|||
131701160|NCT00756938|474187730|FG001|Optional Extension|Lack of Efficacy|0|||
131701161|NCT00756938|474187731|FG002|Optional Extension|Lack of Efficacy|0|||
131701162|NCT00756938|474187732|FG003|Optional Extension|Lack of Efficacy|1|||
131701163|NCT00756938|474187729|FG000|Optional Extension|End of Study|0|||
131701164|NCT00756938|474187730|FG001|Optional Extension|End of Study|0|||
131701165|NCT00756938|474187731|FG002|Optional Extension|End of Study|0|||
131701166|NCT00756938|474187732|FG003|Optional Extension|End of Study|11|||
131701167|NCT00756938|474187729|FG000|Optional Extension|Protocol-specific criteria met|0|||
131701168|NCT00756938|474187730|FG001|Optional Extension|Protocol-specific criteria met|0|||
131701169|NCT00756938|474187731|FG002|Optional Extension|Protocol-specific criteria met|0|||
131701170|NCT00756938|474187732|FG003|Optional Extension|Protocol-specific criteria met|9|||
131701171|NCT00756938|474187729|FG000|Optional Extension|Physician Decision|0|||
131701172|NCT00756938|474187730|FG001|Optional Extension|Physician Decision|0|||
131701173|NCT00756938|474187731|FG002|Optional Extension|Physician Decision|0|||
131701174|NCT00756938|474187732|FG003|Optional Extension|Physician Decision|3|||
131701175|NCT00756938|474187729|FG000|Optional Extension|Lost to Follow-up|0|||
131701176|NCT00756938|474187730|FG001|Optional Extension|Lost to Follow-up|0|||
131701177|NCT00756938|474187731|FG002|Optional Extension|Lost to Follow-up|0|||
131701178|NCT00756938|474187732|FG003|Optional Extension|Lost to Follow-up|1|||
131701179|NCT00756938|474187729|FG000|Optional Extension|Protocol Violation|0|||
131701180|NCT00756938|474187730|FG001|Optional Extension|Protocol Violation|0|||
131701181|NCT00756938|474187731|FG002|Optional Extension|Protocol Violation|0|||
131701182|NCT00756938|474187732|FG003|Optional Extension|Protocol Violation|1|||
131579129|NCT03460756|473747932|FG001|Overall Study|Withdrawal by Subject|4|||
131579130|NCT03460756|473747933|FG002|Overall Study|Withdrawal by Subject|7|||
131701183|NCT00756938|474187729|FG000|Optional Extension|Withdrawal by Subject|0|||
131701184|NCT00756938|474187730|FG001|Optional Extension|Withdrawal by Subject|0|||
131701185|NCT00756938|474187731|FG002|Optional Extension|Withdrawal by Subject|0|||
131701186|NCT00756938|474187732|FG003|Optional Extension|Withdrawal by Subject|10|||
131701187|NCT00756938|474187729|FG000|Optional Extension|Adverse Event|0|||
131701188|NCT00756938|474187730|FG001|Optional Extension|Adverse Event|0|||
131701189|NCT00756938|474187731|FG002|Optional Extension|Adverse Event|0|||
131701190|NCT00756938|474187732|FG003|Optional Extension|Adverse Event|1|||
131701191|NCT02474082|474187733|FG000|Overall Study|Adverse Event|2|||
131701192|NCT02474082|474187734|FG001|Overall Study|Adverse Event|32|||
131701193|NCT02474082|474187733|FG000|Overall Study|Withdrawal of informed consent|1|||
131701194|NCT02474082|474187734|FG001|Overall Study|Withdrawal of informed consent|11|||
131579131|NCT03460756|473747934|FG003|Overall Study|Withdrawal by Subject|3|||
131701195|NCT02474082|474187733|FG000|Overall Study|Lost to Follow-up|2|||
131701196|NCT02474082|474187734|FG001|Overall Study|Lost to Follow-up|2|||
131701197|NCT02474082|474187733|FG000|Overall Study|Dose tapering not achieved|0|||
131701198|NCT02474082|474187734|FG001|Overall Study|Dose tapering not achieved|4|||
131701199|NCT02474082|474187733|FG000|Overall Study|Participant/guardian decision|1|||
131701200|NCT02474082|474187734|FG001|Overall Study|Participant/guardian decision|2|||
131701201|NCT02474082|474187733|FG000|Overall Study|Non-compliance with study treatment|0|||
131701202|NCT02474082|474187734|FG001|Overall Study|Non-compliance with study treatment|2|||
131701203|NCT02474082|474187733|FG000|Overall Study|Protocol deviation|0|||
131701204|NCT02474082|474187734|FG001|Overall Study|Protocol deviation|1|||
131701205|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
131701206|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
131701207|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
131701208|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
131701209|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131701210|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131701211|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
131701212|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131701213|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
131701214|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131701215|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131701216|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131701217|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
131701218|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
131701219|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
131701220|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
131701221|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
131701222|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
131701223|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
131701224|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
131701225|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131701226|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131701227|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131701228|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131701229|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
131701230|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131701231|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131701232|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131701233|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131701234|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131701235|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131701236|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
131701237|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131701238|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131701239|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131701240|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131701241|NCT03403205|474187739|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
131701242|NCT03403205|474187740|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
131701243|NCT03403205|474187741|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
131701244|NCT03403205|474187742|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
131701245|NCT03403205|474187743|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
131701246|NCT03403205|474187744|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
131701247|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
131701248|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
131701249|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
131701250|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
131701251|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
131701252|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
131701253|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
131701254|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
131701255|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
131701256|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
131701257|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
131701258|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
131701259|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Death|1|||
131701260|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Death|0|||
131701261|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Death|0|||
131786589|NCT00789828|474502095|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
131786590|NCT00789828|474502094|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
131786591|NCT00789828|474502095|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
131786592|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
131786593|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
131786594|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
131786595|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
131786596|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
131786597|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
131786598|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
131786599|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
131786600|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|Death|1|||
131786601|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|Death|0|||
131786602|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
131786603|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
131786604|NCT00789828|474502094|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
131786605|NCT00789828|474502095|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
131579132|NCT03987451|473747935|FG000|Overall Study|Lost to Follow-up|1|||
131579133|NCT03987451|473747936|FG001|Overall Study|Lost to Follow-up|0|||
131579134|NCT03987451|473747935|FG000|Overall Study|Withdrawal by Subject|1|||
131579135|NCT03987451|473747936|FG001|Overall Study|Withdrawal by Subject|1|||
131579136|NCT02441036|473747937|FG000|Overall Study|No tissue resected|0|||
131579137|NCT02441036|473747938|FG001|Overall Study|No tissue resected|1|||
131579138|NCT02441036|473747939|FG002|Overall Study|No tissue resected|0|||
131579139|NCT02441036|473747940|FG003|Overall Study|No tissue resected|1|||
131579140|NCT02441036|473747941|FG004|Overall Study|No tissue resected|0|||
131579141|NCT00612586|473747942|FG000|Overall Study|Adverse Event|6|||
131786606|NCT02094937|474502096|FG000|8 Weeks in Period 1|Adverse Event|9|||
131786607|NCT02094937|474502097|FG001|8 Weeks in Period 1|Adverse Event|0|||
131786608|NCT02094937|474502098|FG002|8 Weeks in Period 1|Adverse Event|0|||
131786609|NCT02094937|474502099|FG003|8 Weeks in Period 1|Adverse Event|0|||
131786610|NCT02094937|474502096|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
131786611|NCT02094937|474502097|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
131786612|NCT02094937|474502098|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
131786613|NCT02094937|474502099|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
131786614|NCT02094937|474502096|FG000|8 Weeks in Period 1|Protocol Violation|2|||
131786615|NCT02094937|474502097|FG001|8 Weeks in Period 1|Protocol Violation|0|||
131786616|NCT02094937|474502098|FG002|8 Weeks in Period 1|Protocol Violation|0|||
131786617|NCT02094937|474502099|FG003|8 Weeks in Period 1|Protocol Violation|0|||
131786618|NCT02094937|474502096|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
131786619|NCT02094937|474502097|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
131786620|NCT02094937|474502098|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
131786621|NCT02094937|474502099|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
131786622|NCT02094937|474502096|FG000|8 Weeks in Period 1|Physician Decision|1|||
131786623|NCT02094937|474502097|FG001|8 Weeks in Period 1|Physician Decision|0|||
131579142|NCT00612586|473747943|FG001|Overall Study|Adverse Event|2|||
131579143|NCT00612586|473747942|FG000|Overall Study|Death|1|||
131579144|NCT00612586|473747943|FG001|Overall Study|Death|0|||
131786624|NCT02094937|474502098|FG002|8 Weeks in Period 1|Physician Decision|0|||
131786625|NCT02094937|474502099|FG003|8 Weeks in Period 1|Physician Decision|0|||
131786626|NCT02094937|474502096|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
131786627|NCT02094937|474502097|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
131786628|NCT02094937|474502098|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
131786629|NCT02094937|474502099|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
131786630|NCT02094937|474502096|FG000|12 Weeks in Period 2|Adverse Event|0|||
131786631|NCT02094937|474502097|FG001|12 Weeks in Period 2|Adverse Event|2|||
131786632|NCT02094937|474502098|FG002|12 Weeks in Period 2|Adverse Event|4|||
131786633|NCT02094937|474502099|FG003|12 Weeks in Period 2|Adverse Event|1|||
131786634|NCT02094937|474502096|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
131786635|NCT02094937|474502097|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
131786636|NCT02094937|474502098|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
131786637|NCT02094937|474502099|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
131786638|NCT02094937|474502096|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
131786639|NCT02094937|474502097|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
131786640|NCT02094937|474502098|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
131786641|NCT02094937|474502099|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
131786642|NCT02094937|474502096|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
131786643|NCT02094937|474502097|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
131786644|NCT02094937|474502098|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
131786645|NCT02094937|474502099|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
131786646|NCT02094937|474502096|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
131786647|NCT02094937|474502097|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
131786648|NCT02094937|474502098|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
131786649|NCT02094937|474502099|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
131579145|NCT00612586|473747942|FG000|Overall Study|Entry Criteria Not Met|0|||
131579146|NCT00612586|473747943|FG001|Overall Study|Entry Criteria Not Met|2|||
131579147|NCT00612586|473747942|FG000|Overall Study|Withdrawal by Subject|7|||
131579148|NCT00612586|473747943|FG001|Overall Study|Withdrawal by Subject|9|||
131579149|NCT00612586|473747942|FG000|Overall Study|Physician Decision|1|||
131579150|NCT00612586|473747943|FG001|Overall Study|Physician Decision|2|||
131579151|NCT00612586|473747942|FG000|Overall Study|Sponsor Decision|1|||
131579152|NCT00612586|473747943|FG001|Overall Study|Sponsor Decision|1|||
131579153|NCT00612586|473747942|FG000|Overall Study|Progressive Disease|26|||
131579154|NCT00612586|473747943|FG001|Overall Study|Progressive Disease|24|||
131579155|NCT00612586|473747942|FG000|Overall Study|Randomized and Not Treated|1|||
131786650|NCT01133392|474502100|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
131786651|NCT01133392|474502101|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
131786652|NCT01133392|474502100|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
131786653|NCT01133392|474502101|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
131786654|NCT05166421|474502112|FG000|Overall Study|Other|3|||
131786655|NCT05166421|474502113|FG001|Overall Study|Other|1|||
131786656|NCT05166421|474502114|FG002|Overall Study|Other|1|||
131786657|NCT05166421|474502112|FG000|Overall Study|Withdrawal by Subject|5|||
131786658|NCT05166421|474502113|FG001|Overall Study|Withdrawal by Subject|3|||
131786659|NCT05166421|474502114|FG002|Overall Study|Withdrawal by Subject|6|||
131786660|NCT05166421|474502112|FG000|Overall Study|Lost to Follow-up|4|||
131786661|NCT05166421|474502113|FG001|Overall Study|Lost to Follow-up|1|||
131786662|NCT05166421|474502114|FG002|Overall Study|Lost to Follow-up|7|||
131786663|NCT00343642|474504314|FG000|Overall Study|Lost to Follow-up|0|||
131786664|NCT00343642|474504315|FG001|Overall Study|Lost to Follow-up|1|||
131786665|NCT00343642|474504316|FG002|Overall Study|Lost to Follow-up|0|||
131786666|NCT00343642|474504314|FG000|Overall Study|Pregnancy|1|||
131786667|NCT00343642|474504315|FG001|Overall Study|Pregnancy|0|||
131786668|NCT00343642|474504316|FG002|Overall Study|Pregnancy|2|||
131786669|NCT00343642|474504314|FG000|Overall Study|Withdrawal by Subject|2|||
131786670|NCT00343642|474504315|FG001|Overall Study|Withdrawal by Subject|3|||
131786671|NCT00343642|474504316|FG002|Overall Study|Withdrawal by Subject|4|||
131786672|NCT00343642|474504314|FG000|Overall Study|Adverse Event|0|||
131786673|NCT00343642|474504315|FG001|Overall Study|Adverse Event|0|||
131786674|NCT00343642|474504316|FG002|Overall Study|Adverse Event|1|||
131786675|NCT00343642|474504314|FG000|Overall Study|Flare up|6|||
131786676|NCT00343642|474504315|FG001|Overall Study|Flare up|4|||
131786677|NCT00343642|474504316|FG002|Overall Study|Flare up|0|||
131786678|NCT00860574|474504317|FG000|Overall Study|Death|2|||
131786679|NCT00860574|474504317|FG000|Overall Study|Relapse|1|||
131786680|NCT01246986|474504318|FG000|Overall Study|Lost to Follow-up|0|||
131786681|NCT01246986|474504319|FG001|Overall Study|Lost to Follow-up|1|||
131786682|NCT01246986|474504320|FG002|Overall Study|Lost to Follow-up|3|||
131786683|NCT01246986|474504321|FG003|Overall Study|Lost to Follow-up|0|||
131786684|NCT01246986|474504322|FG004|Overall Study|Lost to Follow-up|0|||
131786685|NCT01246986|474504323|FG005|Overall Study|Lost to Follow-up|1|||
131786686|NCT01246986|474504324|FG006|Overall Study|Lost to Follow-up|0|||
131786687|NCT01246986|474504318|FG000|Overall Study|Withdrawal by Subject|3|||
131786688|NCT01246986|474504319|FG001|Overall Study|Withdrawal by Subject|4|||
131786689|NCT01246986|474504320|FG002|Overall Study|Withdrawal by Subject|3|||
131786690|NCT01246986|474504321|FG003|Overall Study|Withdrawal by Subject|0|||
131786691|NCT01246986|474504322|FG004|Overall Study|Withdrawal by Subject|4|||
131786692|NCT01246986|474504323|FG005|Overall Study|Withdrawal by Subject|0|||
131786693|NCT01246986|474504324|FG006|Overall Study|Withdrawal by Subject|0|||
131579156|NCT00612586|473747943|FG001|Overall Study|Randomized and Not Treated|1|||
131579157|NCT01194154|473747944|FG000|Overall Study|Adverse Event|12|||
131579158|NCT01194154|473747945|FG001|Overall Study|Adverse Event|7|||
131786694|NCT01416142|474504328|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
131786695|NCT01416142|474504329|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
131786696|NCT01416142|474504330|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
131786697|NCT01335399|474504331|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
131786698|NCT01335399|474504332|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
131786699|NCT01335399|474504331|FG000|Pre-treatment Period|Participant request to discontinue|0|||
131786700|NCT01335399|474504332|FG001|Pre-treatment Period|Participant request to discontinue|1|||
131786701|NCT01335399|474504331|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
131786702|NCT01335399|474504332|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
131579159|NCT01194154|473747944|FG000|Overall Study|Lost to Follow-up|2|||
131786703|NCT01335399|474504331|FG000|Pre-treatment Period|Consent withdrawal|3|||
131786704|NCT01335399|474504332|FG001|Pre-treatment Period|Consent withdrawal|0|||
131786705|NCT01335399|474504331|FG000|Treatment Period|Disease progression|117|||
131786706|NCT01335399|474504332|FG001|Treatment Period|Disease progression|145|||
131786707|NCT01335399|474504331|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
131786708|NCT01335399|474504332|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
131786709|NCT01335399|474504331|FG000|Treatment Period|Study drug toxicity|52|||
131786710|NCT01335399|474504332|FG001|Treatment Period|Study drug toxicity|64|||
131786711|NCT01335399|474504331|FG000|Treatment Period|Participant request to discontinue|30|||
131786712|NCT01335399|474504332|FG001|Treatment Period|Participant request to discontinue|22|||
131786713|NCT01335399|474504331|FG000|Treatment Period|Other reasons|30|||
131786714|NCT01335399|474504332|FG001|Treatment Period|Other reasons|30|||
131786715|NCT01335399|474504331|FG000|Treatment Period|Consent withdrawal|10|||
131786716|NCT01335399|474504332|FG001|Treatment Period|Consent withdrawal|7|||
131786717|NCT01335399|474504331|FG000|Treatment Period|Death|7|||
131786718|NCT01335399|474504332|FG001|Treatment Period|Death|6|||
131786719|NCT01335399|474504331|FG000|Treatment Period|Poor/Non-compliance|3|||
131786720|NCT01335399|474504332|FG001|Treatment Period|Poor/Non-compliance|4|||
131786721|NCT01335399|474504331|FG000|Treatment Period|Lost to Follow-up|2|||
131786722|NCT01335399|474504332|FG001|Treatment Period|Lost to Follow-up|2|||
131786723|NCT01335399|474504331|FG000|Treatment Period|Maximum clinical benefit|1|||
131786724|NCT01335399|474504332|FG001|Treatment Period|Maximum clinical benefit|1|||
131786725|NCT01335399|474504331|FG000|Treatment Period|No longer meet study criteria|1|||
131786726|NCT01335399|474504332|FG001|Treatment Period|No longer meet study criteria|1|||
131786727|NCT01335399|474504331|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
131786728|NCT01335399|474504332|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
131786729|NCT02464059|474504333|FG000|Overall Study|Lost to Follow-up|6|||
131786730|NCT00304954|474504334|FG000|Overall Study|Withdrawal by Subject|0|||
131786731|NCT00304954|474504335|FG001|Overall Study|Withdrawal by Subject|0|||
131786732|NCT00304954|474504336|FG002|Overall Study|Withdrawal by Subject|1|||
131786733|NCT00304954|474504337|FG003|Overall Study|Withdrawal by Subject|0|||
131786734|NCT00304954|474504334|FG000|Overall Study|Adverse Event|1|||
131786735|NCT00304954|474504335|FG001|Overall Study|Adverse Event|0|||
131786736|NCT00304954|474504336|FG002|Overall Study|Adverse Event|0|||
131786737|NCT00304954|474504337|FG003|Overall Study|Adverse Event|0|||
131786738|NCT00207714|474504340|FG000|Overall Study|Adverse Event|6|||
131786739|NCT00207714|474504341|FG001|Overall Study|Adverse Event|2|||
131786740|NCT00207714|474504342|FG002|Overall Study|Adverse Event|4|||
131786741|NCT00207714|474504343|FG003|Overall Study|Adverse Event|3|||
131786742|NCT00207714|474504344|FG004|Overall Study|Adverse Event|1|||
131786743|NCT00207714|474504340|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131786744|NCT00207714|474504341|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131786745|NCT00207714|474504342|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131786746|NCT00207714|474504343|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
131786747|NCT00207714|474504344|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
131786748|NCT00207714|474504340|FG000|Overall Study|Other|3|||
131786749|NCT00207714|474504341|FG001|Overall Study|Other|2|||
131786750|NCT00207714|474504342|FG002|Overall Study|Other|5|||
131786751|NCT00207714|474504343|FG003|Overall Study|Other|1|||
131786752|NCT00207714|474504344|FG004|Overall Study|Other|0|||
131786753|NCT00736099|474504346|FG000|Overall Study|Adverse Event|61|||
131786754|NCT00736099|474504347|FG001|Overall Study|Adverse Event|18|||
131786755|NCT00736099|474504346|FG000|Overall Study|Protocol Violation|10|||
131786756|NCT00736099|474504347|FG001|Overall Study|Protocol Violation|4|||
131786757|NCT00736099|474504346|FG000|Overall Study|Lost to Follow-up|12|||
131786758|NCT00736099|474504347|FG001|Overall Study|Lost to Follow-up|5|||
131786759|NCT00736099|474504346|FG000|Overall Study|Withdrawal by Subject|42|||
131786760|NCT00736099|474504347|FG001|Overall Study|Withdrawal by Subject|13|||
131786761|NCT00736099|474504346|FG000|Overall Study|Lack of Efficacy|15|||
131786762|NCT00736099|474504347|FG001|Overall Study|Lack of Efficacy|8|||
131786763|NCT00736099|474504346|FG000|Overall Study|Other reason|43|||
131786764|NCT00736099|474504347|FG001|Overall Study|Other reason|10|||
131786765|NCT02290028|474504350|FG000|Overall Study|Death|217|||
131786766|NCT02290028|474504350|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
131786767|NCT02290028|474504350|FG000|Overall Study|No longer under care of study physician|76|||
131786768|NCT02290028|474504350|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
131786769|NCT02290028|474504350|FG000|Overall Study|Withdrawal by Subject|52|||
131786770|NCT02290028|474504350|FG000|Overall Study|Study site closure|44|||
131786771|NCT02290028|474504350|FG000|Overall Study|Lost to Follow-up|34|||
131786772|NCT02290028|474504350|FG000|Overall Study|Miscellaneous|10|||
131786773|NCT02290028|474504350|FG000|Overall Study|Transition to EP PASSION|1295|||
131786774|NCT02290028|474504350|FG000|Overall Study|Planned study completion at 12 months|257|||
131786775|NCT03202511|474504351|FG000|Overall Study|Withdrawal by Subject|1|||
131786776|NCT03202511|474504352|FG001|Overall Study|Withdrawal by Subject|0|||
131786777|NCT00833547|474504353|FG000|Overall Study|Withdrawal by Subject|2|||
131786778|NCT00833547|474504354|FG001|Overall Study|Withdrawal by Subject|2|||
131786779|NCT00265083|474504355|FG000|Overall Study|Adverse Event|5|||
131786780|NCT00265083|474504356|FG001|Overall Study|Adverse Event|13|||
131786781|NCT00265083|474504357|FG002|Overall Study|Adverse Event|15|||
131786782|NCT00265083|474504355|FG000|Overall Study|Lost to Follow-up|3|||
131579160|NCT01194154|473747945|FG001|Overall Study|Lost to Follow-up|3|||
131579161|NCT01194154|473747944|FG000|Overall Study|Protocol Violation|0|||
131579162|NCT01194154|473747945|FG001|Overall Study|Protocol Violation|1|||
131579163|NCT01194154|473747944|FG000|Overall Study|Withdrawal by Subject|5|||
131579164|NCT01194154|473747945|FG001|Overall Study|Withdrawal by Subject|6|||
131579165|NCT01194154|473747944|FG000|Overall Study|Blood pressure increase|5|||
131579166|NCT01194154|473747945|FG001|Overall Study|Blood pressure increase|3|||
131579167|NCT01194154|473747944|FG000|Overall Study|Hemoglobin decrease|0|||
131579168|NCT01194154|473747945|FG001|Overall Study|Hemoglobin decrease|1|||
131579169|NCT01194154|473747944|FG000|Overall Study|Hemoglobin increase|12|||
131579170|NCT01194154|473747945|FG001|Overall Study|Hemoglobin increase|3|||
131579171|NCT01194154|473747944|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
131579172|NCT01194154|473747945|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
131579173|NCT01194154|473747944|FG000|Overall Study|Treatment with prohibited medication|4|||
131579174|NCT01194154|473747945|FG001|Overall Study|Treatment with prohibited medication|5|||
131579175|NCT01194154|473747944|FG000|Overall Study|Other|4|||
131579176|NCT01194154|473747945|FG001|Overall Study|Other|0|||
131579177|NCT01194154|473747944|FG000|Overall Study|Did not receive study medication|2|||
131579178|NCT01194154|473747945|FG001|Overall Study|Did not receive study medication|4|||
131579179|NCT00395018|473747946|FG000|On-Treatment|Death|4|||
131579180|NCT00395018|473747946|FG000|On-Treatment|Other Reason|2|||
131579181|NCT00395018|473747946|FG000|On-Treatment|Poor/non-compliance|2|||
131579182|NCT00395018|473747946|FG000|On-Treatment|Subject no longer meets study criteria|2|||
131579183|NCT00395018|473747946|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
131579184|NCT00395018|473747946|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
131579185|NCT00395018|473747946|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
131579186|NCT03478696|473747947|FG000|Overall Study|Adverse Event|1|||
131579187|NCT03478696|473747948|FG001|Overall Study|Adverse Event|5|||
131579188|NCT03478696|473747947|FG000|Overall Study|Lost to Follow-up|1|||
131579189|NCT03478696|473747948|FG001|Overall Study|Lost to Follow-up|0|||
131579190|NCT03478696|473747947|FG000|Overall Study|Physician Decision|6|||
131579191|NCT03478696|473747948|FG001|Overall Study|Physician Decision|3|||
131579192|NCT03478696|473747947|FG000|Overall Study|Withdrawal by Subject|9|||
131579193|NCT03478696|473747948|FG001|Overall Study|Withdrawal by Subject|4|||
131579194|NCT00880048|473747952|FG000|Overall Study|Adverse Event|2|||
131579195|NCT00880048|473747953|FG001|Overall Study|Adverse Event|3|||
131579196|NCT00880048|473747954|FG002|Overall Study|Adverse Event|5|||
131579197|NCT00880048|473747952|FG000|Overall Study|Lack of Efficacy|1|||
131579198|NCT00880048|473747953|FG001|Overall Study|Lack of Efficacy|2|||
131579199|NCT00880048|473747954|FG002|Overall Study|Lack of Efficacy|2|||
131579200|NCT00880048|473747952|FG000|Overall Study|Protocol Violation|4|||
131579201|NCT00880048|473747953|FG001|Overall Study|Protocol Violation|6|||
131579202|NCT00880048|473747954|FG002|Overall Study|Protocol Violation|5|||
131579203|NCT00880048|473747952|FG000|Overall Study|Lost to Follow-up|6|||
131579204|NCT00880048|473747953|FG001|Overall Study|Lost to Follow-up|6|||
131579205|NCT00880048|473747954|FG002|Overall Study|Lost to Follow-up|5|||
131579206|NCT00880048|473747952|FG000|Overall Study|Physician Decision|1|||
131579207|NCT00880048|473747953|FG001|Overall Study|Physician Decision|1|||
131579208|NCT00880048|473747954|FG002|Overall Study|Physician Decision|7|||
131579209|NCT00880048|473747952|FG000|Overall Study|Withdrawal by Subject|5|||
131579210|NCT00880048|473747953|FG001|Overall Study|Withdrawal by Subject|8|||
131579211|NCT00880048|473747954|FG002|Overall Study|Withdrawal by Subject|5|||
131579212|NCT00880048|473747952|FG000|Overall Study|Study closed/terminated|9|||
131579213|NCT00880048|473747953|FG001|Overall Study|Study closed/terminated|7|||
131579214|NCT00880048|473747954|FG002|Overall Study|Study closed/terminated|6|||
131579215|NCT02954848|473747959|FG000|Overall Study|Randomized but Not Treated|0|||
131579216|NCT02954848|473747960|FG001|Overall Study|Randomized but Not Treated|1|||
131579217|NCT02954848|473747959|FG000|Overall Study|Adverse Event|2|||
131579218|NCT02954848|473747960|FG001|Overall Study|Adverse Event|3|||
131579219|NCT02954848|473747959|FG000|Overall Study|Withdrawal by Participant|0|||
131579220|NCT02954848|473747960|FG001|Overall Study|Withdrawal by Participant|1|||
131579221|NCT01069341|473747961|FG000|Overall Study|Lost to Follow-up|1|||
131579222|NCT01184508|473747963|FG000|Overall Study|Adverse Event|4|||
131579223|NCT01184508|473747964|FG001|Overall Study|Adverse Event|6|||
131701262|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Death|0|||
131701263|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Death|0|||
131701264|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Death|0|||
131701265|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
131701266|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131701267|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131701268|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131579224|NCT01184508|473747963|FG000|Overall Study|Lack of Efficacy|1|||
131579225|NCT01184508|473747964|FG001|Overall Study|Lack of Efficacy|1|||
131579226|NCT01184508|473747963|FG000|Overall Study|Lost to Follow-up|1|||
131579227|NCT01184508|473747964|FG001|Overall Study|Lost to Follow-up|1|||
131579228|NCT01184508|473747963|FG000|Overall Study|Physician Decision|1|||
131579229|NCT01184508|473747964|FG001|Overall Study|Physician Decision|0|||
131579230|NCT01184508|473747963|FG000|Overall Study|Protocol Violation|3|||
131579231|NCT01184508|473747964|FG001|Overall Study|Protocol Violation|1|||
131579232|NCT01184508|473747963|FG000|Overall Study|Sponsor Decision|5|||
131579233|NCT01184508|473747964|FG001|Overall Study|Sponsor Decision|2|||
131579234|NCT01184508|473747963|FG000|Overall Study|Withdrawal by Subject|1|||
131579235|NCT01184508|473747964|FG001|Overall Study|Withdrawal by Subject|3|||
131579236|NCT01184508|473747963|FG000|Overall Study|Randomized, Not Treated|0|||
131579237|NCT01184508|473747964|FG001|Overall Study|Randomized, Not Treated|1|||
131579238|NCT02880241|473747972|FG000|Overall Study|Lack of Efficacy|1|||
131579239|NCT02880241|473747973|FG001|Overall Study|Lack of Efficacy|0|||
131579240|NCT02880241|473747974|FG002|Overall Study|Lack of Efficacy|0|||
131579241|NCT02880241|473747975|FG003|Overall Study|Lack of Efficacy|0|||
131579242|NCT02880241|473747976|FG004|Overall Study|Lack of Efficacy|0|||
131579243|NCT02880241|473747977|FG005|Overall Study|Lack of Efficacy|0|||
131579244|NCT00057837|473747978|FG000|Overall Study|Progression/relapse|12|||
131579245|NCT00057837|473747979|FG001|Overall Study|Progression/relapse|14|||
131579246|NCT00057837|473747978|FG000|Overall Study|Adverse Event|2|||
131579247|NCT00057837|473747979|FG001|Overall Study|Adverse Event|12|||
131579248|NCT00057837|473747978|FG000|Overall Study|Death|5|||
131579249|NCT00057837|473747979|FG001|Overall Study|Death|4|||
131579250|NCT00057837|473747978|FG000|Overall Study|Withdrawal by Subject|5|||
131579251|NCT00057837|473747979|FG001|Overall Study|Withdrawal by Subject|3|||
131579252|NCT00057837|473747978|FG000|Overall Study|Alternative therapy|0|||
131579253|NCT00057837|473747979|FG001|Overall Study|Alternative therapy|1|||
131579254|NCT00057837|473747978|FG000|Overall Study|Other complicating disease|2|||
131579255|NCT00057837|473747979|FG001|Overall Study|Other complicating disease|1|||
131579256|NCT00057837|473747978|FG000|Overall Study|Physician Decision|1|||
131579257|NCT00057837|473747979|FG001|Overall Study|Physician Decision|0|||
131579258|NCT00057837|473747978|FG000|Overall Study|Ineligible|3|||
131579259|NCT00057837|473747979|FG001|Overall Study|Ineligible|3|||
131579260|NCT00057837|473747978|FG000|Overall Study|Never started treatment|1|||
131579261|NCT00057837|473747979|FG001|Overall Study|Never started treatment|1|||
131579262|NCT02570711|473747981|FG000|Overall Study|Death|1|||
131579263|NCT02570711|473747982|FG001|Overall Study|Death|0|||
131579264|NCT02570711|473747981|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
131579265|NCT02570711|473747982|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
131579266|NCT01317420|473747994|FG000|Overall Study|Progressive disease according to RECIST|2|||
131579267|NCT01317420|473747995|FG001|Overall Study|Progressive disease according to RECIST|3|||
131579268|NCT01317420|473747996|FG002|Overall Study|Progressive disease according to RECIST|3|||
131579269|NCT01317420|473747997|FG003|Overall Study|Progressive disease according to RECIST|3|||
131579270|NCT01317420|473747998|FG004|Overall Study|Progressive disease according to RECIST|3|||
131579271|NCT01317420|473747999|FG005|Overall Study|Progressive disease according to RECIST|3|||
131579272|NCT01317420|473748000|FG006|Overall Study|Progressive disease according to RECIST|3|||
131579273|NCT01317420|473748001|FG007|Overall Study|Progressive disease according to RECIST|3|||
131579274|NCT01317420|473748002|FG008|Overall Study|Progressive disease according to RECIST|3|||
131701269|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131701270|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131701271|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
131579275|NCT01317420|473748003|FG009|Overall Study|Progressive disease according to RECIST|2|||
131701272|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
131701273|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
131701274|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
131701275|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
131701276|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
131701277|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
131701278|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131701279|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131701280|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131579276|NCT01317420|473748004|FG010|Overall Study|Progressive disease according to RECIST|3|||
131579277|NCT01317420|473748005|FG011|Overall Study|Progressive disease according to RECIST|11|||
131579278|NCT01317420|473748006|FG012|Overall Study|Progressive disease according to RECIST|16|||
131579279|NCT01317420|473747994|FG000|Overall Study|Other adverse event|1|||
131579280|NCT01317420|473747995|FG001|Overall Study|Other adverse event|0|||
131579281|NCT01317420|473747996|FG002|Overall Study|Other adverse event|0|||
131579282|NCT01317420|473747997|FG003|Overall Study|Other adverse event|0|||
131579283|NCT01317420|473747998|FG004|Overall Study|Other adverse event|0|||
131579284|NCT01317420|473747999|FG005|Overall Study|Other adverse event|0|||
131579285|NCT01317420|473748000|FG006|Overall Study|Other adverse event|0|||
131579286|NCT01317420|473748001|FG007|Overall Study|Other adverse event|0|||
131579287|NCT01317420|473748002|FG008|Overall Study|Other adverse event|0|||
131579288|NCT01317420|473748003|FG009|Overall Study|Other adverse event|0|||
131579289|NCT01317420|473748004|FG010|Overall Study|Other adverse event|0|||
131579290|NCT01317420|473748005|FG011|Overall Study|Other adverse event|0|||
131579291|NCT01317420|473748006|FG012|Overall Study|Other adverse event|2|||
131579292|NCT01317420|473747994|FG000|Overall Study|Non-compliant with protocol|0|||
131579293|NCT01317420|473747995|FG001|Overall Study|Non-compliant with protocol|0|||
131579294|NCT01317420|473747996|FG002|Overall Study|Non-compliant with protocol|0|||
131579295|NCT01317420|473747997|FG003|Overall Study|Non-compliant with protocol|0|||
131579296|NCT01317420|473747998|FG004|Overall Study|Non-compliant with protocol|0|||
131579297|NCT01317420|473747999|FG005|Overall Study|Non-compliant with protocol|0|||
131579298|NCT01317420|473748000|FG006|Overall Study|Non-compliant with protocol|0|||
131579299|NCT01317420|473748001|FG007|Overall Study|Non-compliant with protocol|0|||
131579300|NCT01317420|473748002|FG008|Overall Study|Non-compliant with protocol|0|||
131579301|NCT01317420|473748003|FG009|Overall Study|Non-compliant with protocol|0|||
131579302|NCT01317420|473748004|FG010|Overall Study|Non-compliant with protocol|0|||
131579303|NCT01317420|473748005|FG011|Overall Study|Non-compliant with protocol|0|||
131579304|NCT01317420|473748006|FG012|Overall Study|Non-compliant with protocol|1|||
131579305|NCT01317420|473747994|FG000|Overall Study|Refused to cont. taking trial medication|0|||
131579306|NCT01317420|473747995|FG001|Overall Study|Refused to cont. taking trial medication|0|||
131579307|NCT01317420|473747996|FG002|Overall Study|Refused to cont. taking trial medication|0|||
131579308|NCT01317420|473747997|FG003|Overall Study|Refused to cont. taking trial medication|0|||
131579309|NCT01317420|473747998|FG004|Overall Study|Refused to cont. taking trial medication|0|||
131579310|NCT01317420|473747999|FG005|Overall Study|Refused to cont. taking trial medication|0|||
131579311|NCT01317420|473748000|FG006|Overall Study|Refused to cont. taking trial medication|0|||
131579312|NCT01317420|473748001|FG007|Overall Study|Refused to cont. taking trial medication|0|||
131579313|NCT01317420|473748002|FG008|Overall Study|Refused to cont. taking trial medication|0|||
131579314|NCT01317420|473748003|FG009|Overall Study|Refused to cont. taking trial medication|0|||
131579315|NCT01317420|473748004|FG010|Overall Study|Refused to cont. taking trial medication|0|||
131579316|NCT01317420|473748005|FG011|Overall Study|Refused to cont. taking trial medication|0|||
131579317|NCT01317420|473748006|FG012|Overall Study|Refused to cont. taking trial medication|1|||
131579318|NCT01317420|473747994|FG000|Overall Study|Reason other than those specified|0|||
131579319|NCT01317420|473747995|FG001|Overall Study|Reason other than those specified|0|||
131579320|NCT01317420|473747996|FG002|Overall Study|Reason other than those specified|0|||
131579321|NCT01317420|473747997|FG003|Overall Study|Reason other than those specified|0|||
131579322|NCT01317420|473747998|FG004|Overall Study|Reason other than those specified|0|||
131579323|NCT01317420|473747999|FG005|Overall Study|Reason other than those specified|0|||
131579324|NCT01317420|473748000|FG006|Overall Study|Reason other than those specified|0|||
131579325|NCT01317420|473748001|FG007|Overall Study|Reason other than those specified|0|||
131579326|NCT01317420|473748002|FG008|Overall Study|Reason other than those specified|0|||
131579327|NCT01317420|473748003|FG009|Overall Study|Reason other than those specified|1|||
131579328|NCT01317420|473748004|FG010|Overall Study|Reason other than those specified|0|||
131579329|NCT01317420|473748005|FG011|Overall Study|Reason other than those specified|0|||
131579330|NCT01317420|473748006|FG012|Overall Study|Reason other than those specified|0|||
131579331|NCT01493778|473748008|FG000|Overall Study|Withdrawal by Subject|8|||
131579332|NCT04210180|473748009|FG000|Overall Study|Withdrawal by Subject|2|||
131579333|NCT00857649|473748010|FG000|Overall Study|Adverse Event|15|||
131579334|NCT00857649|473748011|FG001|Overall Study|Adverse Event|10|||
131579335|NCT00857649|473748010|FG000|Overall Study|Non-compliance|1|||
131579336|NCT00857649|473748011|FG001|Overall Study|Non-compliance|1|||
131579337|NCT00857649|473748010|FG000|Overall Study|Protocol Violation|2|||
131579338|NCT00857649|473748011|FG001|Overall Study|Protocol Violation|2|||
131579339|NCT00857649|473748010|FG000|Overall Study|Withdrawal of Consent|10|||
131579340|NCT00857649|473748011|FG001|Overall Study|Withdrawal of Consent|7|||
131579341|NCT00857649|473748010|FG000|Overall Study|Nursing Home Placement|2|||
131786783|NCT00265083|474504356|FG001|Overall Study|Lost to Follow-up|4|||
131786784|NCT00265083|474504357|FG002|Overall Study|Lost to Follow-up|4|||
131786785|NCT00265083|474504355|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
131786786|NCT00265083|474504356|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
131786787|NCT00265083|474504357|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
131786788|NCT00265083|474504355|FG000|Overall Study|Other|1|||
131786789|NCT00265083|474504356|FG001|Overall Study|Other|12|||
131786790|NCT00265083|474504357|FG002|Overall Study|Other|9|||
131786791|NCT03208933|474504358|FG000|Overall Study|Death|3|||
131579342|NCT00857649|473748011|FG001|Overall Study|Nursing Home Placement|9|||
131579343|NCT00857649|473748010|FG000|Overall Study|Other Reasons|1|||
131579344|NCT00857649|473748011|FG001|Overall Study|Other Reasons|3|||
131898694|NCT01111565|474915336|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
131579345|NCT05190419|473748012|FG000|Overall Study|Lack of Efficacy|8|||
131786792|NCT03208933|474504358|FG000|Overall Study|Withdrawal by Subject|3|||
131786793|NCT03208933|474504358|FG000|Overall Study|Adverse Event|1|||
131579346|NCT05190419|473748013|FG001|Overall Study|Lack of Efficacy|0|||
131579347|NCT05190419|473748014|FG002|Overall Study|Lack of Efficacy|1|||
131579348|NCT05190419|473748015|FG003|Overall Study|Lack of Efficacy|0|||
131579349|NCT05190419|473748012|FG000|Overall Study|Withdrawal by Subject|7|||
131579350|NCT05190419|473748013|FG001|Overall Study|Withdrawal by Subject|1|||
131579351|NCT05190419|473748014|FG002|Overall Study|Withdrawal by Subject|2|||
131579352|NCT05190419|473748015|FG003|Overall Study|Withdrawal by Subject|2|||
131579353|NCT05190419|473748012|FG000|Overall Study|Adverse Event|2|||
131579354|NCT05190419|473748013|FG001|Overall Study|Adverse Event|10|||
131579355|NCT05190419|473748014|FG002|Overall Study|Adverse Event|11|||
131579356|NCT05190419|473748015|FG003|Overall Study|Adverse Event|21|||
131579357|NCT05190419|473748012|FG000|Overall Study|Lost to Follow-up|1|||
131579358|NCT05190419|473748013|FG001|Overall Study|Lost to Follow-up|2|||
131579359|NCT05190419|473748014|FG002|Overall Study|Lost to Follow-up|3|||
131579360|NCT05190419|473748015|FG003|Overall Study|Lost to Follow-up|1|||
131579361|NCT05190419|473748012|FG000|Overall Study|Other|1|||
131579362|NCT05190419|473748013|FG001|Overall Study|Other|1|||
131579363|NCT05190419|473748014|FG002|Overall Study|Other|0|||
131579364|NCT05190419|473748015|FG003|Overall Study|Other|3|||
131579365|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
131579366|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
131579367|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
131579368|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
131579369|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
131579370|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
131579371|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
131579372|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
131701281|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131701282|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131701283|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
131701284|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
131701285|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
131701286|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
131701287|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
131701288|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
131701289|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
131701290|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
131701291|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
131701292|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
131701293|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
131701294|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
131701295|NCT03403205|474187739|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
131701296|NCT03403205|474187740|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
131701297|NCT03403205|474187741|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
131701298|NCT03403205|474187742|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
131701299|NCT03403205|474187743|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
131701300|NCT03403205|474187744|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
131701301|NCT01834729|474187745|FG000|Overall Study|Did not return bowel diaries|0|||
131701302|NCT01834729|474187746|FG001|Overall Study|Did not return bowel diaries|0|||
131701303|NCT01834729|474187747|FG002|Overall Study|Did not return bowel diaries|3|||
131701304|NCT01834729|474187748|FG003|Overall Study|Did not return bowel diaries|0|||
131701305|NCT01834729|474187745|FG000|Overall Study|Withdrawal by Subject|1|||
131701306|NCT01834729|474187746|FG001|Overall Study|Withdrawal by Subject|1|||
131701307|NCT01834729|474187747|FG002|Overall Study|Withdrawal by Subject|0|||
131701308|NCT01834729|474187748|FG003|Overall Study|Withdrawal by Subject|0|||
131701309|NCT01834729|474187745|FG000|Overall Study|Adverse Event|0|||
131701310|NCT01834729|474187746|FG001|Overall Study|Adverse Event|0|||
131701311|NCT01834729|474187747|FG002|Overall Study|Adverse Event|0|||
131701312|NCT01834729|474187748|FG003|Overall Study|Adverse Event|2|||
131701313|NCT02971670|474187749|FG000|Overall Study|Withdrawal by Subject|4|||
131701314|NCT02971670|474187750|FG001|Overall Study|Withdrawal by Subject|1|||
131701315|NCT02971670|474187751|FG002|Overall Study|Withdrawal by Subject|1|||
131701316|NCT02971670|474187752|FG003|Overall Study|Withdrawal by Subject|2|||
131701317|NCT00288080|474187753|FG000|Overall Study|Withdrawal by Subject|1|||
131579373|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
131579374|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131579375|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131579376|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131579377|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131579378|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
131579379|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
131579380|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579381|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579382|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
131579383|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131786794|NCT03208933|474504358|FG000|Overall Study|Lost to Follow-up|2|||
131579384|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579385|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579386|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579387|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579388|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579389|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579390|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131579391|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
131579392|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
131579393|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
131579394|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
131579395|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
131579396|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
131579397|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
131579398|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
131579399|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
131579400|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131579401|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131579402|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131579403|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131579404|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579405|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
131579406|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
131579407|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579408|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
131579409|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579410|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579411|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579412|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579413|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131786795|NCT03208933|474504358|FG000|Overall Study|Physician Decision|3|||
131786796|NCT03208933|474504358|FG000|Overall Study|Protocol Violation|1|||
131786797|NCT04242186|474504359|FG000|Overall Study|Death|5|||
131786798|NCT00379587|474504364|FG000|Overall Study|Lost to Follow-up|2|||
131786799|NCT01070966|474504375|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
131786800|NCT01070966|474504375|FG000|Participants for Safety Evaluation|Off-label use|9|||
131786801|NCT01070966|474504375|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
131786802|NCT01070966|474504375|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
131786803|NCT01070966|474504375|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
131786804|NCT01070966|474504375|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
131786805|NCT01070966|474504375|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
131786806|NCT01070966|474504375|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
131786807|NCT02770716|474504376|FG000|Overall Study|Death|101|||
131786808|NCT02770716|474504377|FG001|Overall Study|Death|45|||
131786809|NCT02770716|474504376|FG000|Overall Study|Withdrawal by Subject|4|||
131786810|NCT02770716|474504377|FG001|Overall Study|Withdrawal by Subject|2|||
131786811|NCT02770716|474504376|FG000|Overall Study|Lost to Follow-up|1|||
131786812|NCT02770716|474504377|FG001|Overall Study|Lost to Follow-up|0|||
131786813|NCT02770716|474504376|FG000|Overall Study|Various reasons|6|||
131786814|NCT02770716|474504377|FG001|Overall Study|Various reasons|2|||
131786815|NCT01725113|474504378|FG000|Overall Study|Kidney Transplant|1|||
131786816|NCT01725113|474504379|FG001|Overall Study|Kidney Transplant|1|||
131786817|NCT01725113|474504378|FG000|Overall Study|Withdrawal by Subject|0|||
131786818|NCT01725113|474504379|FG001|Overall Study|Withdrawal by Subject|1|||
131786819|NCT03989115|474504380|FG000|Overall Study|Withdrawal by Subject|2|||
131786820|NCT03989115|474504381|FG001|Overall Study|Withdrawal by Subject|1|||
131786821|NCT03989115|474504382|FG002|Overall Study|Withdrawal by Subject|3|||
131786822|NCT03989115|474504383|FG003|Overall Study|Withdrawal by Subject|0|||
131786823|NCT03989115|474504384|FG004|Overall Study|Withdrawal by Subject|17|||
131579414|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579415|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579416|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131579417|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131579418|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
131579419|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131579420|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131579421|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
131579422|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579423|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579424|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579425|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131579426|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579427|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579428|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579429|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131579430|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
131579431|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579432|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579433|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579434|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579435|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
131579436|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
131579437|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
131579438|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579439|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579440|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579441|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579442|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131579443|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
131579444|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
131579445|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
131579446|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
131579447|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
131579448|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
131579449|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
131579450|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
131579451|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
131579452|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131579453|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131579454|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131579455|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131579456|NCT04707313|473748016|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579457|NCT04707313|473748017|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579458|NCT04707313|473748018|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
131579459|NCT04707313|473748019|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579460|NCT04707313|473748020|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579461|NCT04707313|473748021|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579462|NCT04707313|473748022|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579463|NCT04707313|473748023|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
131579464|NCT04707313|473748024|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579465|NCT04707313|473748025|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579466|NCT04707313|473748026|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579467|NCT04707313|473748027|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131579468|NCT04707313|473748028|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131701318|NCT00288080|474187754|FG001|Overall Study|Withdrawal by Subject|3|||
131701319|NCT00288080|474187753|FG000|Overall Study|Protocol Violation|25|||
131701320|NCT00288080|474187754|FG001|Overall Study|Protocol Violation|20|||
131701321|NCT03175549|474187755|FG000|Overall Study|Lost to Follow-up|2|||
131701322|NCT03175549|474187756|FG001|Overall Study|Lost to Follow-up|2|||
131701323|NCT03175549|474187755|FG000|Overall Study|Medication non-compliance|2|||
131701324|NCT03175549|474187756|FG001|Overall Study|Medication non-compliance|2|||
131701325|NCT00763321|474187757|FG000|Open-label Period|Adverse Event|24|||
131701326|NCT00763321|474187758|FG001|Open-label Period|Adverse Event|0|||
131701327|NCT00763321|474187759|FG002|Open-label Period|Adverse Event|0|||
131701328|NCT00763321|474187757|FG000|Open-label Period|Lost to Follow-up|14|||
131701329|NCT00763321|474187758|FG001|Open-label Period|Lost to Follow-up|0|||
131701330|NCT00763321|474187759|FG002|Open-label Period|Lost to Follow-up|0|||
131579469|NCT04707313|473748016|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579470|NCT04707313|473748017|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579471|NCT04707313|473748018|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579472|NCT04707313|473748019|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579473|NCT04707313|473748020|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579474|NCT04707313|473748021|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579475|NCT04707313|473748022|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579476|NCT04707313|473748023|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579477|NCT04707313|473748024|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579478|NCT04707313|473748025|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131579479|NCT04707313|473748026|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
131579480|NCT04707313|473748027|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
131579481|NCT04707313|473748028|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
131579482|NCT04707313|473748016|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579483|NCT04707313|473748017|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579484|NCT04707313|473748018|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579485|NCT04707313|473748019|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579486|NCT04707313|473748020|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579487|NCT04707313|473748021|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579488|NCT04707313|473748022|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579489|NCT04707313|473748023|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579490|NCT04707313|473748024|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579491|NCT04707313|473748025|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
131579492|NCT04707313|473748026|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
131579493|NCT04707313|473748027|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
131579494|NCT04707313|473748028|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131579495|NCT04707313|473748016|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579496|NCT04707313|473748017|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579497|NCT04707313|473748018|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579498|NCT04707313|473748019|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579499|NCT04707313|473748020|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579500|NCT04707313|473748021|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579501|NCT04707313|473748022|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579502|NCT04707313|473748023|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579503|NCT04707313|473748024|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131579504|NCT04707313|473748025|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
131579505|NCT04707313|473748026|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
131579506|NCT04707313|473748027|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
131579507|NCT04707313|473748028|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
131579508|NCT04707313|473748016|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
131579509|NCT04707313|473748017|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
131579510|NCT04707313|473748018|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
131579511|NCT04707313|473748019|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
131579512|NCT04707313|473748020|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
131579513|NCT04707313|473748021|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
131579514|NCT04707313|473748022|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
131701331|NCT00763321|474187757|FG000|Open-label Period|Withdrawal by Subject|7|||
131701332|NCT00763321|474187758|FG001|Open-label Period|Withdrawal by Subject|0|||
131701333|NCT00763321|474187759|FG002|Open-label Period|Withdrawal by Subject|0|||
131701334|NCT00763321|474187757|FG000|Open-label Period|Subject noncompliant|7|||
131701335|NCT00763321|474187758|FG001|Open-label Period|Subject noncompliant|0|||
131701336|NCT00763321|474187759|FG002|Open-label Period|Subject noncompliant|0|||
131701337|NCT00763321|474187757|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
131701338|NCT00763321|474187758|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
131701339|NCT00763321|474187759|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
131701340|NCT00763321|474187757|FG000|Open-label Period|Lack of Efficacy|2|||
131701341|NCT00763321|474187758|FG001|Open-label Period|Lack of Efficacy|0|||
131701342|NCT00763321|474187759|FG002|Open-label Period|Lack of Efficacy|0|||
131701343|NCT00763321|474187757|FG000|Open-label Period|Other|4|||
131701344|NCT00763321|474187758|FG001|Open-label Period|Other|0|||
131701345|NCT00763321|474187759|FG002|Open-label Period|Other|0|||
131438283|NCT02426580|473231173|FG000|Overall Study|Death|2|||
131579515|NCT04707313|473748023|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
131701346|NCT00763321|474187757|FG000|Double-blind Period|Lack of Efficacy|0|||
131579516|NCT04707313|473748024|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
131701347|NCT00763321|474187758|FG001|Double-blind Period|Lack of Efficacy|9|||
131579517|NCT04707313|473748025|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
131701348|NCT00763321|474187759|FG002|Double-blind Period|Lack of Efficacy|17|||
131579518|NCT04707313|473748026|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
131579519|NCT04707313|473748027|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
131786824|NCT03989115|474504385|FG005|Overall Study|Withdrawal by Subject|1|||
131786825|NCT03989115|474504386|FG006|Overall Study|Withdrawal by Subject|0|||
131786826|NCT03989115|474504387|FG007|Overall Study|Withdrawal by Subject|0|||
131786827|NCT03989115|474504380|FG000|Overall Study|Sponsor decision to terminate the study|1|||
131786828|NCT03989115|474504381|FG001|Overall Study|Sponsor decision to terminate the study|1|||
131786829|NCT03989115|474504382|FG002|Overall Study|Sponsor decision to terminate the study|0|||
131786830|NCT03989115|474504383|FG003|Overall Study|Sponsor decision to terminate the study|1|||
131786831|NCT03989115|474504384|FG004|Overall Study|Sponsor decision to terminate the study|11|||
131786832|NCT03989115|474504385|FG005|Overall Study|Sponsor decision to terminate the study|0|||
131786833|NCT03989115|474504386|FG006|Overall Study|Sponsor decision to terminate the study|2|||
131786834|NCT03989115|474504387|FG007|Overall Study|Sponsor decision to terminate the study|1|||
131786835|NCT03989115|474504380|FG000|Overall Study|Lost to Follow-up|2|||
131786836|NCT03989115|474504381|FG001|Overall Study|Lost to Follow-up|0|||
131786837|NCT03989115|474504382|FG002|Overall Study|Lost to Follow-up|0|||
131786838|NCT03989115|474504383|FG003|Overall Study|Lost to Follow-up|0|||
131786839|NCT03989115|474504384|FG004|Overall Study|Lost to Follow-up|1|||
131786840|NCT03989115|474504385|FG005|Overall Study|Lost to Follow-up|0|||
131786841|NCT03989115|474504386|FG006|Overall Study|Lost to Follow-up|0|||
131786842|NCT03989115|474504387|FG007|Overall Study|Lost to Follow-up|0|||
131786843|NCT03989115|474504380|FG000|Overall Study|Death|2|||
131786844|NCT03989115|474504381|FG001|Overall Study|Death|2|||
131786845|NCT03989115|474504382|FG002|Overall Study|Death|9|||
131786846|NCT03989115|474504383|FG003|Overall Study|Death|6|||
131786847|NCT03989115|474504384|FG004|Overall Study|Death|31|||
131786848|NCT03989115|474504385|FG005|Overall Study|Death|6|||
131786849|NCT03989115|474504386|FG006|Overall Study|Death|2|||
131786850|NCT03989115|474504387|FG007|Overall Study|Death|3|||
131786851|NCT03989115|474504380|FG000|Overall Study|Other|1|||
131786852|NCT03989115|474504381|FG001|Overall Study|Other|2|||
131786853|NCT03989115|474504382|FG002|Overall Study|Other|0|||
131786854|NCT03989115|474504383|FG003|Overall Study|Other|0|||
131786855|NCT03989115|474504384|FG004|Overall Study|Other|5|||
131786856|NCT03989115|474504385|FG005|Overall Study|Other|0|||
131786857|NCT03989115|474504386|FG006|Overall Study|Other|0|||
131786858|NCT03989115|474504387|FG007|Overall Study|Other|0|||
131786859|NCT02143947|474504388|FG000|Overall Study|Lost to Follow-up|4|||
131786860|NCT02143947|474504389|FG001|Overall Study|Lost to Follow-up|2|||
131786861|NCT01244815|474504390|FG000|Overall Study|Not Treated|0|||
131786862|NCT01244815|474504391|FG001|Overall Study|Not Treated|1|||
131786863|NCT01244815|474504392|FG002|Overall Study|Not Treated|0|||
131786864|NCT01244815|474504393|FG003|Overall Study|Not Treated|0|||
131786865|NCT01244815|474504390|FG000|Overall Study|Adverse Event|4|||
131786866|NCT01244815|474504391|FG001|Overall Study|Adverse Event|7|||
131786867|NCT01244815|474504392|FG002|Overall Study|Adverse Event|5|||
131786868|NCT01244815|474504393|FG003|Overall Study|Adverse Event|5|||
131786869|NCT01244815|474504390|FG000|Overall Study|Treatment Failure|0|||
131786870|NCT01244815|474504391|FG001|Overall Study|Treatment Failure|0|||
131786871|NCT01244815|474504392|FG002|Overall Study|Treatment Failure|0|||
131786872|NCT01244815|474504393|FG003|Overall Study|Treatment Failure|1|||
131786873|NCT01244815|474504390|FG000|Overall Study|Lost to Follow-up|3|||
131786874|NCT01244815|474504391|FG001|Overall Study|Lost to Follow-up|2|||
131786875|NCT01244815|474504392|FG002|Overall Study|Lost to Follow-up|3|||
131786876|NCT01244815|474504393|FG003|Overall Study|Lost to Follow-up|2|||
131786877|NCT01244815|474504390|FG000|Overall Study|Withdrawal by Subject|0|||
131786878|NCT01244815|474504391|FG001|Overall Study|Withdrawal by Subject|2|||
131786879|NCT01244815|474504392|FG002|Overall Study|Withdrawal by Subject|0|||
131786880|NCT01244815|474504393|FG003|Overall Study|Withdrawal by Subject|3|||
131786881|NCT01244815|474504390|FG000|Overall Study|Protocol Violation|7|||
131786882|NCT01244815|474504391|FG001|Overall Study|Protocol Violation|4|||
131786883|NCT01244815|474504392|FG002|Overall Study|Protocol Violation|3|||
131786884|NCT01244815|474504393|FG003|Overall Study|Protocol Violation|1|||
131786885|NCT01244815|474504390|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131786886|NCT01244815|474504391|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
131786887|NCT01244815|474504392|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
131786888|NCT01244815|474504393|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
131786889|NCT01808209|474504395|FG000|Overall Study|Lost to Follow-up|0|||
131786890|NCT01808209|474504396|FG001|Overall Study|Lost to Follow-up|1|||
131786891|NCT00697112|474504397|FG000|Overall Study|Adverse Event|8|||
131786892|NCT00697112|474504397|FG000|Overall Study|Lost to Follow-up|1|||
131786893|NCT00697112|474504397|FG000|Overall Study|Did not meet inclusion criteria|1|||
131786894|NCT01427920|474504398|FG000|Overall Study|Adverse Event|1|||
131786895|NCT01427920|474504399|FG001|Overall Study|Adverse Event|2|||
131786896|NCT01427920|474504398|FG000|Overall Study|Lack of Efficacy|1|||
131786897|NCT01427920|474504399|FG001|Overall Study|Lack of Efficacy|0|||
131786898|NCT01427920|474504398|FG000|Overall Study|Protocol Violation|1|||
131786899|NCT01427920|474504399|FG001|Overall Study|Protocol Violation|3|||
131786900|NCT01427920|474504398|FG000|Overall Study|Withdrawal Criteria|4|||
131786901|NCT01427920|474504399|FG001|Overall Study|Withdrawal Criteria|4|||
131786902|NCT01427920|474504398|FG000|Overall Study|Unclassified|2|||
131786903|NCT01427920|474504399|FG001|Overall Study|Unclassified|8|||
131579520|NCT04707313|473748028|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
131786904|NCT03066440|474504402|FG000|Overall Study|Physician Decision|1|||
131786905|NCT03066440|474504403|FG001|Overall Study|Physician Decision|1|||
131786906|NCT03066440|474504402|FG000|Overall Study|Protocol Violation|0|||
131786907|NCT03066440|474504403|FG001|Overall Study|Protocol Violation|2|||
131786908|NCT00736333|474504404|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
131786909|NCT00736333|474504404|FG000|Overall Study|Data Missing|2|||
131786910|NCT00736333|474504404|FG000|Overall Study|Tumor Progression|75|||
131786911|NCT00736333|474504404|FG000|Overall Study|Toxicity|6|||
131786912|NCT00736333|474504404|FG000|Overall Study|Withdrawal by Subject|10|||
131786913|NCT00736333|474504404|FG000|Overall Study|Death|7|||
131786914|NCT00736333|474504404|FG000|Overall Study|Other|4|||
131786915|NCT01106352|474504407|FG000|Overall Study|Subjects untreated|0|||
131786916|NCT01106352|474504408|FG001|Overall Study|Subjects untreated|0|||
131579521|NCT04707313|473748016|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579522|NCT04707313|473748017|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579523|NCT04707313|473748018|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579524|NCT04707313|473748019|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579525|NCT04707313|473748020|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579526|NCT04707313|473748021|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579527|NCT04707313|473748022|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579528|NCT04707313|473748023|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579529|NCT04707313|473748024|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579530|NCT04707313|473748025|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
131579531|NCT04707313|473748026|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
131579532|NCT04707313|473748027|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579533|NCT04707313|473748028|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131579534|NCT04707313|473748016|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579535|NCT04707313|473748017|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579536|NCT04707313|473748018|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579537|NCT04707313|473748019|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579538|NCT04707313|473748020|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579539|NCT04707313|473748021|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579540|NCT04707313|473748022|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579541|NCT04707313|473748023|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579542|NCT04707313|473748024|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131579543|NCT04707313|473748025|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
131579544|NCT04707313|473748026|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
131579545|NCT04707313|473748027|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
131579546|NCT04707313|473748028|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
131579547|NCT00324038|473748032|FG000|Overall Study|Adverse Event|38|||
131579548|NCT00324038|473748033|FG001|Overall Study|Adverse Event|23|||
131579549|NCT00324038|473748032|FG000|Overall Study|Lack of Efficacy|5|||
131579550|NCT00324038|473748033|FG001|Overall Study|Lack of Efficacy|13|||
131579551|NCT00324038|473748032|FG000|Overall Study|Lost to Follow-up|0|||
131579552|NCT00324038|473748033|FG001|Overall Study|Lost to Follow-up|2|||
131579553|NCT00324038|473748032|FG000|Overall Study|Other|6|||
131579554|NCT00324038|473748033|FG001|Overall Study|Other|13|||
131579555|NCT03070483|473748034|FG000|Overall Study|Lost to Follow-up|2|||
131579556|NCT01585558|473748035|FG000|Overall Study|Withdrawal by Subject|4|||
131579557|NCT01585558|473748036|FG001|Overall Study|Withdrawal by Subject|5|||
131579558|NCT01585558|473748037|FG002|Overall Study|Withdrawal by Subject|8|||
131579559|NCT01585558|473748035|FG000|Overall Study|Lost to Follow-up|2|||
131579560|NCT01585558|473748036|FG001|Overall Study|Lost to Follow-up|0|||
131579561|NCT01585558|473748037|FG002|Overall Study|Lost to Follow-up|3|||
131579562|NCT01585558|473748035|FG000|Overall Study|Adverse Event|3|||
131579563|NCT01585558|473748036|FG001|Overall Study|Adverse Event|4|||
131579564|NCT01585558|473748037|FG002|Overall Study|Adverse Event|1|||
131579565|NCT01585558|473748035|FG000|Overall Study|Protocol Violation|4|||
131579566|NCT01585558|473748036|FG001|Overall Study|Protocol Violation|3|||
131579567|NCT01585558|473748037|FG002|Overall Study|Protocol Violation|2|||
131579568|NCT01585558|473748035|FG000|Overall Study|Lack of Efficacy|0|||
131786917|NCT01106352|474504409|FG002|Overall Study|Subjects untreated|0|||
131786918|NCT01106352|474504410|FG003|Overall Study|Subjects untreated|3|||
131579569|NCT01585558|473748036|FG001|Overall Study|Lack of Efficacy|0|||
131579570|NCT01585558|473748037|FG002|Overall Study|Lack of Efficacy|1|||
131579571|NCT00841035|473748039|FG000|Phase 1 Overall Study|Physician Decision|13|||
131786919|NCT01106352|474504411|FG004|Overall Study|Subjects untreated|4|||
131579572|NCT01390402|473748044|FG000|Overall Study|Death|1|||
131579573|NCT01390402|473748044|FG000|Overall Study|Disease Progression|4|||
131579574|NCT01266265|473750161|FG000|Overall Study|Death|95|||
131786920|NCT01106352|474504407|FG000|Overall Study|Sponsor Decision|1|||
131786921|NCT01106352|474504408|FG001|Overall Study|Sponsor Decision|0|||
131786922|NCT01106352|474504409|FG002|Overall Study|Sponsor Decision|0|||
131786923|NCT01106352|474504410|FG003|Overall Study|Sponsor Decision|0|||
131786924|NCT01106352|474504411|FG004|Overall Study|Sponsor Decision|0|||
131579575|NCT01266265|473750162|FG001|Overall Study|Death|73|||
131579576|NCT01266265|473750161|FG000|Overall Study|Lost to Follow-up|23|||
131579577|NCT01266265|473750162|FG001|Overall Study|Lost to Follow-up|28|||
131579578|NCT01266265|473750161|FG000|Overall Study|Withdrawal by Subject|13|||
131579579|NCT01266265|473750162|FG001|Overall Study|Withdrawal by Subject|11|||
131579580|NCT01266265|473750161|FG000|Overall Study|Respiratory-related adverse event|2|||
131579581|NCT01266265|473750162|FG001|Overall Study|Respiratory-related adverse event|1|||
131579582|NCT01266265|473750161|FG000|Overall Study|Transferred care to another provider|22|||
131579583|NCT01266265|473750162|FG001|Overall Study|Transferred care to another provider|28|||
131579584|NCT01266265|473750161|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
131579585|NCT01266265|473750162|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
131579586|NCT01266265|473750161|FG000|Overall Study|Enrolled in another clinical study|15|||
131579587|NCT01266265|473750162|FG001|Overall Study|Enrolled in another clinical study|26|||
131579588|NCT01266265|473750161|FG000|Overall Study|Non-compliance|8|||
131579589|NCT01266265|473750162|FG001|Overall Study|Non-compliance|5|||
131579590|NCT01266265|473750161|FG000|Overall Study|Lung transplant|6|||
131579591|NCT01266265|473750162|FG001|Overall Study|Lung transplant|5|||
131579592|NCT01266265|473750161|FG000|Overall Study|Site closed early|4|||
131579593|NCT01266265|473750162|FG001|Overall Study|Site closed early|3|||
131579594|NCT01266265|473750161|FG000|Overall Study|Clinical worsening|1|||
131579595|NCT01266265|473750162|FG001|Overall Study|Clinical worsening|1|||
131579596|NCT01580293|473750163|FG000|Part A_Main Trial|Adverse Event|0|||
131579597|NCT01580293|473750164|FG001|Part A_Main Trial|Adverse Event|2|||
131579598|NCT01580293|473750165|FG002|Part A_Main Trial|Adverse Event|0|||
131579599|NCT01580293|473750163|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
131579600|NCT01580293|473750164|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
131579601|NCT01580293|473750165|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
131579602|NCT01580293|473750163|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
131579603|NCT01580293|473750164|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
131579604|NCT01580293|473750165|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
131579605|NCT01580293|473750163|FG000|Part A_Extension|Adverse Event|0|||
131579606|NCT01580293|473750164|FG001|Part A_Extension|Adverse Event|2|||
131701349|NCT00763321|474187757|FG000|Double-blind Period|Adverse Event|0|||
131701350|NCT00763321|474187758|FG001|Double-blind Period|Adverse Event|4|||
131701351|NCT00763321|474187759|FG002|Double-blind Period|Adverse Event|4|||
131701352|NCT00763321|474187757|FG000|Double-blind Period|Lost to Follow-up|0|||
131701353|NCT00763321|474187758|FG001|Double-blind Period|Lost to Follow-up|4|||
131701354|NCT00763321|474187759|FG002|Double-blind Period|Lost to Follow-up|2|||
131579607|NCT01580293|473750165|FG002|Part A_Extension|Adverse Event|0|||
131579608|NCT01580293|473750163|FG000|Part A_Extension|Withdrawal by Subject|0|||
131579609|NCT01580293|473750164|FG001|Part A_Extension|Withdrawal by Subject|3|||
131701355|NCT00763321|474187757|FG000|Double-blind Period|Withdrawal by Subject|0|||
131701356|NCT00763321|474187758|FG001|Double-blind Period|Withdrawal by Subject|2|||
131701357|NCT00763321|474187759|FG002|Double-blind Period|Withdrawal by Subject|3|||
131701358|NCT00763321|474187757|FG000|Double-blind Period|Other|0|||
131701359|NCT00763321|474187758|FG001|Double-blind Period|Other|2|||
131701360|NCT00763321|474187759|FG002|Double-blind Period|Other|3|||
131701361|NCT01656434|474187760|FG000|Overall Study|Adverse Event|199|||
131701362|NCT01656434|474187761|FG001|Overall Study|Adverse Event|63|||
131701363|NCT01656434|474187760|FG000|Overall Study|Enrollment terminated at trial site|2|||
131701364|NCT01656434|474187761|FG001|Overall Study|Enrollment terminated at trial site|0|||
131701365|NCT01656434|474187760|FG000|Overall Study|Lost to Follow-up|309|||
131701366|NCT01656434|474187761|FG001|Overall Study|Lost to Follow-up|76|||
131701367|NCT01656434|474187760|FG000|Overall Study|Site discontinued study participation|24|||
131701368|NCT01656434|474187761|FG001|Overall Study|Site discontinued study participation|9|||
131701369|NCT01656434|474187760|FG000|Overall Study|Screen failure|2|||
131701370|NCT01656434|474187761|FG001|Overall Study|Screen failure|0|||
131701371|NCT01656434|474187760|FG000|Overall Study|Protocol Violation|7|||
131579610|NCT01580293|473750165|FG002|Part A_Extension|Withdrawal by Subject|0|||
131579611|NCT01580293|473750163|FG000|Part A_Extension|Lost to Follow-up|0|||
131579612|NCT01580293|473750164|FG001|Part A_Extension|Lost to Follow-up|1|||
131579613|NCT01580293|473750165|FG002|Part A_Extension|Lost to Follow-up|0|||
131579614|NCT01580293|473750163|FG000|Part A_Extension|Other Reason|0|||
131579615|NCT01580293|473750164|FG001|Part A_Extension|Other Reason|1|||
131579616|NCT01580293|473750165|FG002|Part A_Extension|Other Reason|0|||
131579617|NCT01580293|473750163|FG000|Part A_Extension|Completed Japan only|0|||
131579618|NCT01580293|473750164|FG001|Part A_Extension|Completed Japan only|5|||
131579619|NCT01580293|473750165|FG002|Part A_Extension|Completed Japan only|0|||
131579620|NCT01580293|473750163|FG000|Part B|Withdrawal by Subject|0|||
131579621|NCT01580293|473750164|FG001|Part B|Withdrawal by Subject|0|||
131701372|NCT01656434|474187761|FG001|Overall Study|Protocol Violation|0|||
131701373|NCT01656434|474187760|FG000|Overall Study|Pregnancy wish|18|||
131701374|NCT01656434|474187761|FG001|Overall Study|Pregnancy wish|6|||
131701375|NCT01656434|474187760|FG000|Overall Study|Pregnancy|45|||
131701376|NCT01656434|474187761|FG001|Overall Study|Pregnancy|10|||
131701377|NCT01656434|474187760|FG000|Overall Study|Physician Decision|7|||
131579622|NCT01580293|473750165|FG002|Part B|Withdrawal by Subject|1|||
131579623|NCT01580293|473750163|FG000|Part B|Other reason|0|||
131579624|NCT01580293|473750164|FG001|Part B|Other reason|0|||
131579625|NCT01580293|473750165|FG002|Part B|Other reason|1|||
131579626|NCT00768664|473750168|FG000|Overall Study|Death|57|||
131579627|NCT00768664|473750168|FG000|Overall Study|Lost to Follow-up|2|||
131579628|NCT00768664|473750168|FG000|Overall Study|Other|9|||
131579629|NCT00768664|473750168|FG000|Overall Study|Participant refused|1|||
131579630|NCT01400776|473750169|FG000|Overall Study|Adverse Event|7|||
131579631|NCT01400776|473750170|FG001|Overall Study|Adverse Event|2|||
131579632|NCT01400776|473750171|FG002|Overall Study|Adverse Event|9|||
131579633|NCT01400776|473750172|FG003|Overall Study|Adverse Event|2|||
131579634|NCT01400776|473750169|FG000|Overall Study|Lost to Follow-up|1|||
131579635|NCT01400776|473750170|FG001|Overall Study|Lost to Follow-up|0|||
131579636|NCT01400776|473750171|FG002|Overall Study|Lost to Follow-up|4|||
131579637|NCT01400776|473750172|FG003|Overall Study|Lost to Follow-up|1|||
131579638|NCT01400776|473750169|FG000|Overall Study|Withdrew Consent|4|||
131579639|NCT01400776|473750170|FG001|Overall Study|Withdrew Consent|2|||
131579640|NCT01400776|473750171|FG002|Overall Study|Withdrew Consent|6|||
131579641|NCT01400776|473750172|FG003|Overall Study|Withdrew Consent|1|||
131579642|NCT01400776|473750169|FG000|Overall Study|Protocol Deviation|6|||
131579643|NCT01400776|473750170|FG001|Overall Study|Protocol Deviation|1|||
131786925|NCT01106352|474504407|FG000|Overall Study|Too ill to come in for the visit|0|||
131786926|NCT01106352|474504408|FG001|Overall Study|Too ill to come in for the visit|0|||
131786927|NCT01106352|474504409|FG002|Overall Study|Too ill to come in for the visit|1|||
131786928|NCT01106352|474504410|FG003|Overall Study|Too ill to come in for the visit|0|||
131786929|NCT01106352|474504411|FG004|Overall Study|Too ill to come in for the visit|0|||
131786930|NCT01106352|474504407|FG000|Overall Study|Lost to Follow-up|0|||
131786931|NCT01106352|474504408|FG001|Overall Study|Lost to Follow-up|0|||
131786932|NCT01106352|474504409|FG002|Overall Study|Lost to Follow-up|0|||
131786933|NCT01106352|474504410|FG003|Overall Study|Lost to Follow-up|0|||
131786934|NCT01106352|474504411|FG004|Overall Study|Lost to Follow-up|1|||
131786935|NCT01106352|474504407|FG000|Overall Study|Death|0|||
131786936|NCT01106352|474504408|FG001|Overall Study|Death|0|||
131786937|NCT01106352|474504409|FG002|Overall Study|Death|1|||
131786938|NCT01106352|474504410|FG003|Overall Study|Death|3|||
131786939|NCT01106352|474504411|FG004|Overall Study|Death|1|||
131786940|NCT01106352|474504407|FG000|Overall Study|Disease progression|0|||
131786941|NCT01106352|474504408|FG001|Overall Study|Disease progression|0|||
131786942|NCT01106352|474504409|FG002|Overall Study|Disease progression|0|||
131786943|NCT01106352|474504410|FG003|Overall Study|Disease progression|1|||
131786944|NCT01106352|474504411|FG004|Overall Study|Disease progression|0|||
131786945|NCT01106352|474504407|FG000|Overall Study|Withdrawal by Subject|0|||
131786946|NCT01106352|474504408|FG001|Overall Study|Withdrawal by Subject|0|||
131786947|NCT01106352|474504409|FG002|Overall Study|Withdrawal by Subject|0|||
131786948|NCT01106352|474504410|FG003|Overall Study|Withdrawal by Subject|3|||
131786949|NCT01106352|474504411|FG004|Overall Study|Withdrawal by Subject|2|||
131786950|NCT01106352|474504407|FG000|Overall Study|Went on hospice|0|||
131786951|NCT01106352|474504408|FG001|Overall Study|Went on hospice|0|||
131786952|NCT01106352|474504409|FG002|Overall Study|Went on hospice|0|||
131786953|NCT01106352|474504410|FG003|Overall Study|Went on hospice|1|||
131786954|NCT01106352|474504411|FG004|Overall Study|Went on hospice|0|||
131786955|NCT01106352|474504407|FG000|Overall Study|Subject entered hospice|0|||
131786956|NCT01106352|474504408|FG001|Overall Study|Subject entered hospice|0|||
131786957|NCT01106352|474504409|FG002|Overall Study|Subject entered hospice|0|||
131786958|NCT01106352|474504410|FG003|Overall Study|Subject entered hospice|1|||
131786959|NCT01106352|474504411|FG004|Overall Study|Subject entered hospice|0|||
131786960|NCT01106352|474504407|FG000|Overall Study|Home hospice since July 2013|0|||
131579644|NCT01400776|473750171|FG002|Overall Study|Protocol Deviation|5|||
131579645|NCT01400776|473750172|FG003|Overall Study|Protocol Deviation|2|||
131579646|NCT01400776|473750169|FG000|Overall Study|Reason not Specified|3|||
131579647|NCT01400776|473750170|FG001|Overall Study|Reason not Specified|0|||
131786961|NCT01106352|474504408|FG001|Overall Study|Home hospice since July 2013|0|||
131579648|NCT01400776|473750171|FG002|Overall Study|Reason not Specified|4|||
131579649|NCT01400776|473750172|FG003|Overall Study|Reason not Specified|3|||
131579650|NCT00423098|473750173|FG000|Overall Study|Adverse Event|1|||
131786962|NCT01106352|474504409|FG002|Overall Study|Home hospice since July 2013|0|||
131786963|NCT01106352|474504410|FG003|Overall Study|Home hospice since July 2013|1|||
131579651|NCT00423098|473750174|FG001|Overall Study|Adverse Event|2|||
131579652|NCT00423098|473750173|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131701378|NCT01656434|474187761|FG001|Overall Study|Physician Decision|2|||
131701379|NCT01656434|474187760|FG000|Overall Study|Non-compliance with study drug|48|||
131701380|NCT01656434|474187761|FG001|Overall Study|Non-compliance with study drug|9|||
131701381|NCT01656434|474187760|FG000|Overall Study|Study terminated by sponsor|1501|||
131701382|NCT01656434|474187761|FG001|Overall Study|Study terminated by sponsor|348|||
131701383|NCT01656434|474187760|FG000|Overall Study|Participant discontinued; drug related|13|||
131701384|NCT01656434|474187761|FG001|Overall Study|Participant discontinued; drug related|4|||
131701385|NCT01656434|474187760|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
131701386|NCT01656434|474187761|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
131701387|NCT01656434|474187760|FG000|Overall Study|Non-compliance with protocol|39|||
131701388|NCT01656434|474187761|FG001|Overall Study|Non-compliance with protocol|15|||
131701389|NCT01656434|474187760|FG000|Overall Study|Participant moved|40|||
131701390|NCT01656434|474187761|FG001|Overall Study|Participant moved|12|||
131701391|NCT01656434|474187760|FG000|Overall Study|Participant withdrew consent|28|||
131701392|NCT01656434|474187761|FG001|Overall Study|Participant withdrew consent|9|||
131701393|NCT01656434|474187760|FG000|Overall Study|Withdrawal by Subject|64|||
131701394|NCT01656434|474187761|FG001|Overall Study|Withdrawal by Subject|7|||
131701395|NCT06098729|474187767|FG000|Overall Study|Withdrawal by Subject|1|||
131701396|NCT03033875|474187768|FG000|Overall Study|Withdrawal by Subject|5|||
131701397|NCT03033875|474187769|FG001|Overall Study|Withdrawal by Subject|9|||
131701398|NCT03033875|474187770|FG002|Overall Study|Withdrawal by Subject|4|||
131701399|NCT03033875|474187768|FG000|Overall Study|Other|14|||
131701400|NCT03033875|474187769|FG001|Overall Study|Other|15|||
131701401|NCT03033875|474187770|FG002|Overall Study|Other|8|||
131701402|NCT00122135|474189408|FG000|Overall Study|Withdrawal by Subject|3|||
131701403|NCT00122135|474189409|FG001|Overall Study|Withdrawal by Subject|0|||
131701404|NCT00805740|474189410|FG000|Overall Study|Death|7|||
131701405|NCT00805740|474189411|FG001|Overall Study|Death|4|||
131701406|NCT00805740|474189410|FG000|Overall Study|Withdrawal by Subject|1|||
131701407|NCT00805740|474189411|FG001|Overall Study|Withdrawal by Subject|0|||
131701408|NCT00805740|474189410|FG000|Overall Study|Lost to Follow-up|1|||
131701409|NCT00805740|474189411|FG001|Overall Study|Lost to Follow-up|0|||
131701410|NCT00805740|474189410|FG000|Overall Study|Randomized, but not treated|2|||
131701411|NCT00805740|474189411|FG001|Overall Study|Randomized, but not treated|0|||
131701412|NCT04033367|474189412|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
131701413|NCT04033367|474189413|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
131701414|NCT04033367|474189412|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
131701415|NCT04033367|474189413|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
131701416|NCT04033367|474189412|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
131701417|NCT04033367|474189413|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
131701418|NCT04033367|474189412|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
131701419|NCT04033367|474189413|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
131701420|NCT02723201|474189414|FG000|Second Intervention Period|Protocol Violation|1|||
131701421|NCT02723201|474189415|FG001|Second Intervention Period|Protocol Violation|0|||
131701422|NCT02723201|474189416|FG002|Second Intervention Period|Protocol Violation|0|||
131701423|NCT02723201|474189414|FG000|Second Intervention Period|Adverse Event|1|||
131701424|NCT02723201|474189415|FG001|Second Intervention Period|Adverse Event|0|||
131701425|NCT02723201|474189416|FG002|Second Intervention Period|Adverse Event|0|||
131701426|NCT01946178|474189417|FG000|Overall Study|Pregnancy|1|||
131701427|NCT01946178|474189417|FG000|Overall Study|Lost to Follow-up|1|||
131701428|NCT00491179|474189418|FG000|Overall Study|Adverse Event|5|||
131701429|NCT00491179|474189419|FG001|Overall Study|Adverse Event|1|||
131701430|NCT00491179|474189418|FG000|Overall Study|Withdrawal by Subject|2|||
131701431|NCT00491179|474189419|FG001|Overall Study|Withdrawal by Subject|1|||
131701432|NCT00090545|474189420|FG000|Overall Study|Disease progression on study|21|||
131701433|NCT00090545|474189421|FG001|Overall Study|Disease progression on study|17|||
131701434|NCT00090545|474189420|FG000|Overall Study|Refused further treatment|1|||
131701435|NCT00090545|474189421|FG001|Overall Study|Refused further treatment|4|||
131701436|NCT00090545|474189420|FG000|Overall Study|Death|0|||
131701437|NCT00090545|474189421|FG001|Overall Study|Death|1|||
131701438|NCT00090545|474189420|FG000|Overall Study|Adverse Event|0|||
131579653|NCT00423098|473750174|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131579654|NCT00423098|473750173|FG000|Overall Study|Administrative problems|0|||
131701439|NCT00090545|474189421|FG001|Overall Study|Adverse Event|2|||
131701440|NCT00797823|474189425|FG000|First Period (Initial Randomization)|Physician Decision|1|||
131701441|NCT00797823|474189426|FG001|First Period (Initial Randomization)|Physician Decision|0|||
131701442|NCT00797823|474189427|FG002|First Period (Initial Randomization)|Physician Decision|0|||
131701443|NCT02809833|474189428|FG000|Overall Study|Death|3|||
131701444|NCT02809833|474189428|FG000|Overall Study|Intolerance|54|||
131701445|NCT02809833|474189428|FG000|Overall Study|Lack of Efficacy|89|||
131701446|NCT02809833|474189428|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
131701447|NCT02809833|474189428|FG000|Overall Study|Noncompliance|1|||
131701448|NCT02809833|474189428|FG000|Overall Study|Withdrawal by Subject|34|||
131701449|NCT02809833|474189428|FG000|Overall Study|Lost to Follow-up|35|||
131701450|NCT02809833|474189428|FG000|Overall Study|Adverse Event (AE)|24|||
131701451|NCT02809833|474189428|FG000|Overall Study|Other|5|||
131701452|NCT02809833|474189428|FG000|Overall Study|Missing Information|52|||
131701453|NCT00523991|474189429|FG000|Overall Study|Adverse Event|6|||
131701454|NCT00523991|474189430|FG001|Overall Study|Adverse Event|5|||
131701455|NCT00523991|474189429|FG000|Overall Study|Protocol Violation|1|||
131701456|NCT00523991|474189430|FG001|Overall Study|Protocol Violation|4|||
131701457|NCT00523991|474189429|FG000|Overall Study|Lost to Follow-up|4|||
131701458|NCT00523991|474189430|FG001|Overall Study|Lost to Follow-up|1|||
131701459|NCT00523991|474189429|FG000|Overall Study|Withdrawal by Subject|7|||
131701460|NCT00523991|474189430|FG001|Overall Study|Withdrawal by Subject|17|||
131701461|NCT00523991|474189429|FG000|Overall Study|Other reason (not specified)|3|||
131701462|NCT00523991|474189430|FG001|Overall Study|Other reason (not specified)|0|||
131701463|NCT00193063|474189431|FG000|Overall Study|Lack of Efficacy|3|||
131701464|NCT00193063|474189431|FG000|Overall Study|Adverse Event|1|||
131701465|NCT00744874|474189434|FG000|Overall Study|Lost to Follow-up|1|||
131701466|NCT00744874|474189434|FG000|Overall Study|Withdrawal by Subject|1|||
131701467|NCT00744874|474189434|FG000|Overall Study|Study Device not available at procedure|1|||
131701468|NCT00744874|474189434|FG000|Overall Study|Unable to accomodate schedule|1|||
131701469|NCT01127165|474189440|FG000|Overall Study|Adverse Event|2|||
131701470|NCT01127165|474189441|FG001|Overall Study|Adverse Event|2|||
131701471|NCT01127165|474189440|FG000|Overall Study|Lack of Efficacy|10|||
131701472|NCT01127165|474189441|FG001|Overall Study|Lack of Efficacy|8|||
131701473|NCT01127165|474189440|FG000|Overall Study|Lost to Follow-up|3|||
131701474|NCT01127165|474189441|FG001|Overall Study|Lost to Follow-up|5|||
131701475|NCT01127165|474189440|FG000|Overall Study|Withdrawal by Subject|1|||
131701476|NCT01127165|474189441|FG001|Overall Study|Withdrawal by Subject|3|||
131701477|NCT01127165|474189440|FG000|Overall Study|Protocol Violation|0|||
131701478|NCT01127165|474189441|FG001|Overall Study|Protocol Violation|1|||
131701479|NCT02435849|474189442|FG000|Overall Study|Death|23|||
131701480|NCT02435849|474189443|FG001|Overall Study|Death|0|||
131701481|NCT02435849|474189442|FG000|Overall Study|Lack of Efficacy|10|||
131701482|NCT02435849|474189443|FG001|Overall Study|Lack of Efficacy|0|||
131701483|NCT02435849|474189442|FG000|Overall Study|New therapy for study indication|8|||
131701484|NCT02435849|474189443|FG001|Overall Study|New therapy for study indication|0|||
131701485|NCT02435849|474189442|FG000|Overall Study|Subject/guardian decision|5|||
131701486|NCT02435849|474189443|FG001|Overall Study|Subject/guardian decision|1|||
131701487|NCT02435849|474189442|FG000|Overall Study|Lost to Follow-up|1|||
131701488|NCT02435849|474189443|FG001|Overall Study|Lost to Follow-up|0|||
131701489|NCT02435849|474189442|FG000|Overall Study|Physician Decision|1|||
131701490|NCT02435849|474189443|FG001|Overall Study|Physician Decision|0|||
131701491|NCT02486757|474189444|FG000|Overall Study|Lost to Follow-up|1|||
131701492|NCT01017952|474189445|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
131701493|NCT01017952|474189446|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131701494|NCT01017952|474189447|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131701495|NCT01017952|474189448|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131701496|NCT01017952|474189449|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131701497|NCT01017952|474189445|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
131701498|NCT01017952|474189446|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
131579655|NCT00423098|473750174|FG001|Overall Study|Administrative problems|1|||
131579656|NCT00423098|473750173|FG000|Overall Study|Death|2|||
131701499|NCT01017952|474189447|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
131701500|NCT01017952|474189448|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
131701501|NCT01017952|474189449|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
131701502|NCT01017952|474189445|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
131701503|NCT01017952|474189446|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
131701504|NCT01017952|474189447|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
131701505|NCT01017952|474189448|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
131786964|NCT01106352|474504411|FG004|Overall Study|Home hospice since July 2013|0|||
131786965|NCT03944707|474504412|FG000|Overall Study|Adverse Event|0|||
131786966|NCT03944707|474504413|FG001|Overall Study|Adverse Event|2|||
131786967|NCT03944707|474504412|FG000|Overall Study|Study terminated by sponsor|12|||
131786968|NCT03944707|474504413|FG001|Overall Study|Study terminated by sponsor|7|||
131786969|NCT03944707|474504412|FG000|Overall Study|Subject decision|0|||
131786970|NCT03944707|474504413|FG001|Overall Study|Subject decision|1|||
131786971|NCT00751998|474504423|FG000|Overall Study|Lost to Follow-up|7|||
131786972|NCT00751998|474504423|FG000|Overall Study|Death|11|||
131786973|NCT00751998|474504423|FG000|Overall Study|Withdrawal by Subject|2|||
131786974|NCT02629133|474504424|FG000|Overall Study|Lost to Follow-up|3|||
131786975|NCT02629133|474504425|FG001|Overall Study|Lost to Follow-up|1|||
131786976|NCT02629133|474504424|FG000|Overall Study|Withdrawal by Subject|1|||
131786977|NCT02629133|474504425|FG001|Overall Study|Withdrawal by Subject|1|||
131786978|NCT03216954|474504426|FG000|Overall Study|Adverse Event|0|||
131786979|NCT03216954|474504427|FG001|Overall Study|Adverse Event|0|||
131786980|NCT03216954|474504428|FG002|Overall Study|Adverse Event|1|||
131786981|NCT03216954|474504429|FG003|Overall Study|Adverse Event|0|||
131786982|NCT03216954|474504430|FG004|Overall Study|Adverse Event|1|||
131786983|NCT03216954|474504426|FG000|Overall Study|Withdrawal by Subject|2|||
131786984|NCT03216954|474504427|FG001|Overall Study|Withdrawal by Subject|0|||
131786985|NCT03216954|474504428|FG002|Overall Study|Withdrawal by Subject|0|||
131786986|NCT03216954|474504429|FG003|Overall Study|Withdrawal by Subject|0|||
131786987|NCT03216954|474504430|FG004|Overall Study|Withdrawal by Subject|0|||
131786988|NCT03216954|474504426|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131786989|NCT03216954|474504427|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
131786990|NCT03216954|474504428|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131786991|NCT03216954|474504429|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131786992|NCT03216954|474504430|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131786993|NCT01965535|474504431|FG000|Overall Study|Lack of Efficacy|2|||
131786994|NCT01965535|474504432|FG001|Overall Study|Lack of Efficacy|1|||
131786995|NCT02983227|474504433|FG000|Overall Study|Adverse Event|21|||
131786996|NCT02983227|474504434|FG001|Overall Study|Adverse Event|3|||
131786997|NCT02983227|474504433|FG000|Overall Study|Death|3|||
131786998|NCT02983227|474504434|FG001|Overall Study|Death|0|||
131786999|NCT02983227|474504433|FG000|Overall Study|Lack of Efficacy|8|||
131787000|NCT02983227|474504434|FG001|Overall Study|Lack of Efficacy|1|||
131787001|NCT02983227|474504433|FG000|Overall Study|Lost to Follow-up|3|||
131787002|NCT02983227|474504434|FG001|Overall Study|Lost to Follow-up|0|||
131787003|NCT02983227|474504433|FG000|Overall Study|Multiple Reasons|2|||
131787004|NCT02983227|474504434|FG001|Overall Study|Multiple Reasons|1|||
131787005|NCT02983227|474504433|FG000|Overall Study|Physician Decision|3|||
131579657|NCT00423098|473750174|FG001|Overall Study|Death|0|||
131787006|NCT02983227|474504434|FG001|Overall Study|Physician Decision|1|||
131787007|NCT02983227|474504433|FG000|Overall Study|Withdrawal by Subject|19|||
131787008|NCT02983227|474504434|FG001|Overall Study|Withdrawal by Subject|8|||
131787009|NCT03726437|474504437|FG000|Overall Study|Lost to Follow-up|85|||
131787010|NCT03726437|474504438|FG001|Overall Study|Lost to Follow-up|76|||
131787011|NCT00849524|474504440|FG000|Overall Study|Lack of Efficacy|3|||
131787012|NCT01946282|474504445|FG000|Year 1|Did not return FIT kit|4186|||
131787013|NCT01946282|474504446|FG001|Year 1|Did not return FIT kit|608|||
131787014|NCT01946282|474504447|FG002|Year 1|Did not return FIT kit|654|||
131787015|NCT01946282|474504445|FG000|Year 2|Did not return FIT kit|803|||
131787016|NCT01946282|474504446|FG001|Year 2|Did not return FIT kit|131|||
131787017|NCT01946282|474504447|FG002|Year 2|Did not return FIT kit|115|||
131787018|NCT01946282|474504445|FG000|Year 3|Did not return FIT kit|288|||
131787019|NCT01946282|474504446|FG001|Year 3|Did not return FIT kit|43|||
131787020|NCT01946282|474504447|FG002|Year 3|Did not return FIT kit|30|||
131787021|NCT01493531|474504448|FG000|Overall Study|Adverse Event|4|||
131787022|NCT01493531|474504449|FG001|Overall Study|Adverse Event|12|||
131787023|NCT01493531|474504450|FG002|Overall Study|Adverse Event|9|||
131787024|NCT01493531|474504448|FG000|Overall Study|Gout flare|3|||
131787025|NCT01493531|474504449|FG001|Overall Study|Gout flare|0|||
131787026|NCT01493531|474504450|FG002|Overall Study|Gout flare|2|||
131787027|NCT01493531|474504448|FG000|Overall Study|Protocol Violation|8|||
131787028|NCT01493531|474504449|FG001|Overall Study|Protocol Violation|15|||
131787029|NCT01493531|474504450|FG002|Overall Study|Protocol Violation|12|||
131787030|NCT01493531|474504448|FG000|Overall Study|Sponsor terminated study|5|||
131787031|NCT01493531|474504449|FG001|Overall Study|Sponsor terminated study|2|||
131787032|NCT01493531|474504450|FG002|Overall Study|Sponsor terminated study|3|||
131579658|NCT04480827|473750176|FG000|Overall Study|Adverse Event|0|||
131787033|NCT01493531|474504448|FG000|Overall Study|Lost to Follow-up|5|||
131787034|NCT01493531|474504449|FG001|Overall Study|Lost to Follow-up|7|||
131787035|NCT01493531|474504450|FG002|Overall Study|Lost to Follow-up|11|||
131787036|NCT01493531|474504448|FG000|Overall Study|Withdrawal by Subject|16|||
131787037|NCT01493531|474504449|FG001|Overall Study|Withdrawal by Subject|13|||
131787038|NCT01493531|474504450|FG002|Overall Study|Withdrawal by Subject|11|||
131787039|NCT01493531|474504448|FG000|Overall Study|Death|0|||
131787040|NCT01493531|474504449|FG001|Overall Study|Death|1|||
131787041|NCT01493531|474504450|FG002|Overall Study|Death|0|||
131787042|NCT01027884|474504456|FG000|Overall Study|Adverse Event|2|||
131787043|NCT01027884|474504457|FG001|Overall Study|Adverse Event|1|||
131787044|NCT01027884|474504456|FG000|Overall Study|Protocol Violation|1|||
131787045|NCT01027884|474504457|FG001|Overall Study|Protocol Violation|0|||
131787046|NCT01027884|474504456|FG000|Overall Study|Non-compliance|1|||
131787047|NCT01027884|474504457|FG001|Overall Study|Non-compliance|1|||
131787048|NCT01027884|474504456|FG000|Overall Study|Withdrawal by Subject|0|||
131787049|NCT01027884|474504457|FG001|Overall Study|Withdrawal by Subject|1|||
131787050|NCT01027884|474504456|FG000|Overall Study|Lost to Follow-up|0|||
131787051|NCT01027884|474504457|FG001|Overall Study|Lost to Follow-up|1|||
131787052|NCT01027884|474504456|FG000|Overall Study|Spinal fixation surgery|0|||
131787053|NCT01027884|474504457|FG001|Overall Study|Spinal fixation surgery|3|||
131787054|NCT03670537|474504459|FG000|Overall Study|Protocol Violation|1|||
131787055|NCT02059187|474504460|FG000|Overall Study|Adverse Event|0|||
131787056|NCT02059187|474504461|FG001|Overall Study|Adverse Event|3|||
131787057|NCT02059187|474504460|FG000|Overall Study|Death|1|||
131787058|NCT02059187|474504461|FG001|Overall Study|Death|1|||
131787059|NCT02059187|474504460|FG000|Overall Study|Lost to Follow-up|9|||
131787060|NCT02059187|474504461|FG001|Overall Study|Lost to Follow-up|8|||
131787061|NCT02059187|474504460|FG000|Overall Study|Non-compliance with study drug|1|||
131787062|NCT02059187|474504461|FG001|Overall Study|Non-compliance with study drug|0|||
131787063|NCT02059187|474504460|FG000|Overall Study|Physician Decision|1|||
131787064|NCT02059187|474504461|FG001|Overall Study|Physician Decision|2|||
131787065|NCT02059187|474504460|FG000|Overall Study|Protocol Violation|1|||
131787066|NCT02059187|474504461|FG001|Overall Study|Protocol Violation|0|||
131787067|NCT02059187|474504460|FG000|Overall Study|Withdrawal by Subject|12|||
131787068|NCT02059187|474504461|FG001|Overall Study|Withdrawal by Subject|8|||
131787069|NCT03070431|474504462|FG000|Overall Study|Withdrawal by Subject|2|||
131787070|NCT03070431|474504462|FG000|Overall Study|Lost to Follow-up|2|||
131787071|NCT01889862|474504463|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
131787072|NCT01889862|474504464|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131787073|NCT01889862|474504465|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131787074|NCT01889862|474504466|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131787075|NCT01889862|474504467|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131787076|NCT01889862|474504463|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
131787077|NCT01889862|474504464|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131787078|NCT01889862|474504465|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131787079|NCT01889862|474504466|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131787080|NCT01889862|474504467|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131787081|NCT01889862|474504463|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
131787082|NCT01889862|474504464|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131787083|NCT01889862|474504465|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131787084|NCT01889862|474504466|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131787085|NCT01889862|474504467|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131787086|NCT01889862|474504463|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
131787087|NCT01889862|474504464|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131787088|NCT01889862|474504465|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131579659|NCT04480827|473750177|FG001|Overall Study|Adverse Event|0|||
131787089|NCT01889862|474504466|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131787090|NCT01889862|474504467|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131787091|NCT01889862|474504463|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131787092|NCT01889862|474504464|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131787093|NCT01889862|474504465|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
131787094|NCT01889862|474504466|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131787095|NCT01889862|474504467|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131787096|NCT01889862|474504463|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131787097|NCT01889862|474504464|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131787098|NCT01889862|474504465|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131787099|NCT01889862|474504466|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131787100|NCT01889862|474504467|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
131787101|NCT01889862|474504463|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131579660|NCT04480827|473750178|FG002|Overall Study|Adverse Event|0|||
131579661|NCT04480827|473750179|FG003|Overall Study|Adverse Event|0|||
131579662|NCT04480827|473750180|FG004|Overall Study|Adverse Event|0|||
131579663|NCT04480827|473750181|FG005|Overall Study|Adverse Event|1|||
131579664|NCT04480827|473750182|FG006|Overall Study|Adverse Event|0|||
131579665|NCT00941655|473750183|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
131579666|NCT00941655|473750184|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
131579667|NCT00941655|473750183|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
131579668|NCT00941655|473750184|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
131579669|NCT00941655|473750183|FG000|Overall Study|progressed while on chemo|0|||
131579670|NCT00941655|473750184|FG001|Overall Study|progressed while on chemo|2|||
131787102|NCT01889862|474504464|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131787103|NCT01889862|474504465|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131787104|NCT01889862|474504466|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131787105|NCT01889862|474504467|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
131787106|NCT01889862|474504463|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131787107|NCT01889862|474504464|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131787108|NCT01889862|474504465|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131787109|NCT01889862|474504466|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131787110|NCT01889862|474504467|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
131787111|NCT01889862|474504463|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131787112|NCT01889862|474504464|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131787113|NCT01889862|474504465|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131787114|NCT01889862|474504466|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131787115|NCT01889862|474504467|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
131787116|NCT01889862|474504463|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131787117|NCT01889862|474504464|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131787118|NCT01889862|474504465|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131787119|NCT01889862|474504466|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131787120|NCT01889862|474504467|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
131787121|NCT00845026|474504468|FG000|Study Period III|Adverse Event|23|||
131787122|NCT00845026|474504469|FG001|Study Period III|Adverse Event|19|||
131787123|NCT00845026|474504468|FG000|Study Period III|Perceived lack of efficacy|27|||
131787124|NCT00845026|474504469|FG001|Study Period III|Perceived lack of efficacy|15|||
131787125|NCT00845026|474504468|FG000|Study Period III|Withdrawal by Subject|19|||
131787126|NCT00845026|474504469|FG001|Study Period III|Withdrawal by Subject|15|||
131787127|NCT00845026|474504468|FG000|Study Period III|Entry Criteria not met|8|||
131787128|NCT00845026|474504469|FG001|Study Period III|Entry Criteria not met|11|||
131787129|NCT00845026|474504468|FG000|Study Period III|Lost to Follow-up|4|||
131787130|NCT00845026|474504469|FG001|Study Period III|Lost to Follow-up|5|||
131787131|NCT00845026|474504468|FG000|Study Period III|Protocol Violation|8|||
131787132|NCT00845026|474504469|FG001|Study Period III|Protocol Violation|1|||
131787133|NCT00845026|474504468|FG000|Study Period III|Scheduled conflict|3|||
131787134|NCT00845026|474504469|FG001|Study Period III|Scheduled conflict|1|||
131787135|NCT00845026|474504468|FG000|Study Period III|Subject is moving or has moved|2|||
131787136|NCT00845026|474504469|FG001|Study Period III|Subject is moving or has moved|4|||
131787137|NCT00845026|474504468|FG000|Study Period III|Transportation issues|1|||
131787138|NCT00845026|474504469|FG001|Study Period III|Transportation issues|1|||
131787139|NCT00845026|474504468|FG000|Study Period IV|Adverse Event|4|||
131787140|NCT00845026|474504469|FG001|Study Period IV|Adverse Event|0|||
131787141|NCT00845026|474504468|FG000|Study Period IV|Perceived lack of efficacy|2|||
131787142|NCT00845026|474504469|FG001|Study Period IV|Perceived lack of efficacy|1|||
131787143|NCT00845026|474504468|FG000|Study Period IV|Protocol Violation|3|||
131787144|NCT00845026|474504469|FG001|Study Period IV|Protocol Violation|1|||
131787145|NCT00845026|474504468|FG000|Study Period IV|Lost to Follow-up|1|||
131579671|NCT00941655|473750183|FG000|Overall Study|refused further treatment|0|||
131579672|NCT00941655|473750184|FG001|Overall Study|refused further treatment|1|||
131579673|NCT00941655|473750183|FG000|Overall Study|withdrew consent|0|||
131787146|NCT00845026|474504469|FG001|Study Period IV|Lost to Follow-up|0|||
131579674|NCT00941655|473750184|FG001|Overall Study|withdrew consent|1|||
131787147|NCT00845026|474504468|FG000|Study Period IV|Withdrawal by Subject|4|||
131787148|NCT00845026|474504469|FG001|Study Period IV|Withdrawal by Subject|1|||
131787149|NCT00845026|474504468|FG000|Study Period IV|Entry Criteria Not Met|1|||
131787150|NCT00845026|474504469|FG001|Study Period IV|Entry Criteria Not Met|0|||
131787151|NCT00845026|474504468|FG000|Study Period IV|Subject is moving or has moved|0|||
131787152|NCT00845026|474504469|FG001|Study Period IV|Subject is moving or has moved|1|||
131787153|NCT00845026|474504468|FG000|Study Period IV|Scheduling conflict|1|||
131787154|NCT00845026|474504469|FG001|Study Period IV|Scheduling conflict|0|||
131787155|NCT01325532|474504470|FG000|Overall Study|Withdrawal by Subject|2|||
131787156|NCT01325532|474504471|FG001|Overall Study|Withdrawal by Subject|0|||
131787157|NCT02065791|474504472|FG000|Overall Study|Closed Site|1|||
131787158|NCT02065791|474504473|FG001|Overall Study|Closed Site|1|||
131787159|NCT02065791|474504472|FG000|Overall Study|Withdrawal by Subject|11|||
131787160|NCT02065791|474504473|FG001|Overall Study|Withdrawal by Subject|5|||
131787161|NCT02065791|474504472|FG000|Overall Study|Lost to Follow-up|13|||
131787162|NCT02065791|474504473|FG001|Overall Study|Lost to Follow-up|9|||
131787163|NCT00272961|474504474|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
131787164|NCT00272961|474504475|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131787165|NCT00272961|474504476|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131787166|NCT00272961|474504477|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131787167|NCT00272961|474504478|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131787168|NCT00272961|474504474|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
131787169|NCT00272961|474504475|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131787170|NCT00272961|474504476|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131787171|NCT00272961|474504477|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131787172|NCT00272961|474504478|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131787173|NCT00272961|474504474|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
131787174|NCT00272961|474504475|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131787175|NCT00272961|474504476|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131787176|NCT00272961|474504477|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131787177|NCT00272961|474504478|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131787178|NCT00272961|474504474|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
131787179|NCT00272961|474504475|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131787180|NCT00272961|474504476|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131787181|NCT00272961|474504477|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131787182|NCT00272961|474504478|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131787183|NCT00272961|474504474|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
131787184|NCT00272961|474504475|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
131787185|NCT00272961|474504476|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
131787186|NCT00272961|474504477|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
131787187|NCT00272961|474504478|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
131787188|NCT00272961|474504474|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
131787189|NCT00272961|474504475|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
131787190|NCT00272961|474504476|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
131787191|NCT00272961|474504477|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
131787192|NCT00272961|474504478|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
131787193|NCT00272961|474504474|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
131787194|NCT00272961|474504475|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
131787195|NCT00272961|474504476|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
131787196|NCT00272961|474504477|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
131787197|NCT00272961|474504478|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
131787198|NCT00272961|474504474|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
131787199|NCT00272961|474504475|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
131787200|NCT00272961|474504476|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
131787201|NCT00272961|474504477|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
131579675|NCT00941655|473750183|FG000|Overall Study|non-compliant|0|||
131579676|NCT00941655|473750184|FG001|Overall Study|non-compliant|1|||
131579677|NCT02477670|473750190|FG000|Stage 1|Adverse Event|2|||
131579678|NCT02477670|473750191|FG001|Stage 1|Adverse Event|7|||
131579679|NCT02477670|473750192|FG002|Stage 1|Adverse Event|0|||
131579680|NCT02477670|473750193|FG003|Stage 1|Adverse Event|0|||
131438284|NCT02426580|473231174|FG001|Overall Study|Death|2|||
131579681|NCT02477670|473750194|FG004|Stage 1|Adverse Event|0|||
131579682|NCT02477670|473750195|FG005|Stage 1|Adverse Event|0|||
131579683|NCT02477670|473750196|FG006|Stage 1|Adverse Event|0|||
131579684|NCT02477670|473750190|FG000|Stage 1|Lost to Follow-up|0|||
131579685|NCT02477670|473750191|FG001|Stage 1|Lost to Follow-up|2|||
131787202|NCT00272961|474504478|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
131787203|NCT01507831|474504479|FG000|Overall Study|Randomized but not treated|0|||
131787204|NCT01507831|474504480|FG001|Overall Study|Randomized but not treated|3|||
131787205|NCT01507831|474504479|FG000|Overall Study|Adverse Event|48|||
131787206|NCT01507831|474504480|FG001|Overall Study|Adverse Event|113|||
131787207|NCT01507831|474504479|FG000|Overall Study|Death|6|||
131787208|NCT01507831|474504480|FG001|Overall Study|Death|2|||
131787209|NCT01507831|474504479|FG000|Overall Study|Poor compliance to protocol|38|||
131787210|NCT01507831|474504480|FG001|Overall Study|Poor compliance to protocol|60|||
131787211|NCT01507831|474504479|FG000|Overall Study|Physician Decision|0|||
131787212|NCT01507831|474504480|FG001|Overall Study|Physician Decision|4|||
131787213|NCT01507831|474504479|FG000|Overall Study|Participant moved|5|||
131787214|NCT01507831|474504480|FG001|Overall Study|Participant moved|19|||
131787215|NCT01507831|474504479|FG000|Overall Study|Consent withdrawn by participant|34|||
131787216|NCT01507831|474504480|FG001|Overall Study|Consent withdrawn by participant|72|||
131787217|NCT01507831|474504479|FG000|Overall Study|Related to study drug administration|5|||
131787218|NCT01507831|474504480|FG001|Overall Study|Related to study drug administration|14|||
131787219|NCT01507831|474504479|FG000|Overall Study|Last visit outside protocol visit window|51|||
131787220|NCT01507831|474504480|FG001|Overall Study|Last visit outside protocol visit window|143|||
131787221|NCT01507831|474504479|FG000|Overall Study|Selection criteria finally not met|0|||
131787222|NCT01507831|474504480|FG001|Overall Study|Selection criteria finally not met|1|||
131787223|NCT01507831|474504479|FG000|Overall Study|Site closure|0|||
131787224|NCT01507831|474504480|FG001|Overall Study|Site closure|3|||
131787225|NCT01507831|474504479|FG000|Overall Study|Potential lost to follow-up|3|||
131787226|NCT01507831|474504480|FG001|Overall Study|Potential lost to follow-up|0|||
131787227|NCT01507831|474504479|FG000|Overall Study|Other|3|||
131787228|NCT01507831|474504480|FG001|Overall Study|Other|6|||
131787229|NCT01358708|474504481|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
131787230|NCT01358708|474504482|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131787231|NCT01358708|474504481|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
131787232|NCT01358708|474504482|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
131787233|NCT03056001|474504483|FG000|Overall Study|Death|24|||
131787234|NCT04380701|474504484|FG000|Overall Study|Pregnancy|0|||
131787235|NCT04380701|474504485|FG001|Overall Study|Pregnancy|0|||
131787236|NCT04380701|474504486|FG002|Overall Study|Pregnancy|0|||
131787237|NCT04380701|474504487|FG003|Overall Study|Pregnancy|0|||
131787238|NCT04380701|474504488|FG004|Overall Study|Pregnancy|0|||
131787239|NCT04380701|474504489|FG005|Overall Study|Pregnancy|0|||
131787240|NCT04380701|474504490|FG006|Overall Study|Pregnancy|0|||
131787241|NCT04380701|474504491|FG007|Overall Study|Pregnancy|0|||
131787242|NCT04380701|474504492|FG008|Overall Study|Pregnancy|0|||
131787243|NCT04380701|474504493|FG009|Overall Study|Pregnancy|0|||
131787244|NCT04380701|474504494|FG010|Overall Study|Pregnancy|0|||
131787245|NCT04380701|474504495|FG011|Overall Study|Pregnancy|0|||
131787246|NCT04380701|474504496|FG012|Overall Study|Pregnancy|0|||
131787247|NCT04380701|474504497|FG013|Overall Study|Pregnancy|0|||
131787248|NCT04380701|474504498|FG014|Overall Study|Pregnancy|0|||
131787249|NCT04380701|474504499|FG015|Overall Study|Pregnancy|0|||
131787250|NCT04380701|474504500|FG016|Overall Study|Pregnancy|0|||
131787251|NCT04380701|474504501|FG017|Overall Study|Pregnancy|0|||
131787252|NCT04380701|474504502|FG018|Overall Study|Pregnancy|0|||
131787253|NCT04380701|474504503|FG019|Overall Study|Pregnancy|0|||
131787254|NCT04380701|474504504|FG020|Overall Study|Pregnancy|0|||
131787255|NCT04380701|474504505|FG021|Overall Study|Pregnancy|0|||
131787256|NCT04380701|474504506|FG022|Overall Study|Pregnancy|0|||
131787257|NCT04380701|474504507|FG023|Overall Study|Pregnancy|0|||
131787258|NCT04380701|474504508|FG024|Overall Study|Pregnancy|0|||
131787259|NCT04380701|474504509|FG025|Overall Study|Pregnancy|0|||
131787260|NCT04380701|474504510|FG026|Overall Study|Pregnancy|0|||
131787261|NCT04380701|474504511|FG027|Overall Study|Pregnancy|0|||
131787262|NCT04380701|474504512|FG028|Overall Study|Pregnancy|0|||
131787263|NCT04380701|474504513|FG029|Overall Study|Pregnancy|0|||
131787264|NCT04380701|474504514|FG030|Overall Study|Pregnancy|0|||
131787265|NCT04380701|474504515|FG031|Overall Study|Pregnancy|0|||
131787266|NCT04380701|474504516|FG032|Overall Study|Pregnancy|1|||
131787267|NCT04380701|474504517|FG033|Overall Study|Pregnancy|0|||
131787268|NCT04380701|474504484|FG000|Overall Study|Lost to Follow-up|0|||
131787269|NCT04380701|474504485|FG001|Overall Study|Lost to Follow-up|0|||
131787270|NCT04380701|474504486|FG002|Overall Study|Lost to Follow-up|0|||
131787271|NCT04380701|474504487|FG003|Overall Study|Lost to Follow-up|0|||
131787272|NCT04380701|474504488|FG004|Overall Study|Lost to Follow-up|0|||
131787273|NCT04380701|474504489|FG005|Overall Study|Lost to Follow-up|0|||
131787274|NCT04380701|474504490|FG006|Overall Study|Lost to Follow-up|0|||
131787275|NCT04380701|474504491|FG007|Overall Study|Lost to Follow-up|0|||
131787276|NCT04380701|474504492|FG008|Overall Study|Lost to Follow-up|0|||
131787277|NCT04380701|474504493|FG009|Overall Study|Lost to Follow-up|0|||
131787278|NCT04380701|474504494|FG010|Overall Study|Lost to Follow-up|0|||
131787279|NCT04380701|474504495|FG011|Overall Study|Lost to Follow-up|0|||
131787280|NCT04380701|474504496|FG012|Overall Study|Lost to Follow-up|0|||
131787281|NCT04380701|474504497|FG013|Overall Study|Lost to Follow-up|0|||
131787282|NCT04380701|474504498|FG014|Overall Study|Lost to Follow-up|0|||
131787283|NCT04380701|474504499|FG015|Overall Study|Lost to Follow-up|0|||
131787284|NCT04380701|474504500|FG016|Overall Study|Lost to Follow-up|0|||
131787285|NCT04380701|474504501|FG017|Overall Study|Lost to Follow-up|0|||
131787286|NCT04380701|474504502|FG018|Overall Study|Lost to Follow-up|0|||
131787287|NCT04380701|474504503|FG019|Overall Study|Lost to Follow-up|0|||
131787288|NCT04380701|474504504|FG020|Overall Study|Lost to Follow-up|1|||
131787289|NCT04380701|474504505|FG021|Overall Study|Lost to Follow-up|0|||
131787290|NCT04380701|474504506|FG022|Overall Study|Lost to Follow-up|0|||
131701506|NCT01017952|474189449|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
131701507|NCT01017952|474189445|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
131701508|NCT01017952|474189446|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131701509|NCT01017952|474189447|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131701510|NCT01017952|474189448|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131701511|NCT01017952|474189449|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131701512|NCT01017952|474189445|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
131701513|NCT01017952|474189446|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
131701514|NCT01017952|474189447|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
131701515|NCT01017952|474189448|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
131701516|NCT01017952|474189449|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
131701517|NCT01017952|474189445|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
131701518|NCT01017952|474189446|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131701519|NCT01017952|474189447|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131701520|NCT01017952|474189448|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131701521|NCT01017952|474189449|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131701522|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
131701523|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
131701524|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
131701525|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
131701526|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
131701527|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131701528|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
131701529|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
131701530|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
131701531|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
131701532|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131701533|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
131701534|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
131701535|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
131701536|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
131701537|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
131701538|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
131701539|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
131701540|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
131701541|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
131701542|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131701543|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
131701544|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
131701545|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
131701546|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
131701547|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131701548|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
131701549|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
131701550|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131701551|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131701552|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131701553|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
131701554|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
131701555|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
131701556|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
131701557|NCT01017952|474189445|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
131701558|NCT01017952|474189446|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
131701559|NCT01017952|474189447|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
131701560|NCT01017952|474189448|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
131701561|NCT01017952|474189449|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
131701562|NCT04849780|474189450|FG000|Period 1|Covid-19 Related|1|||
131701563|NCT04849780|474189451|FG001|Period 1|Covid-19 Related|0|||
131701564|NCT04849780|474189450|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
131701565|NCT04849780|474189451|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
131579686|NCT02477670|473750192|FG002|Stage 1|Lost to Follow-up|0|||
131579687|NCT02477670|473750193|FG003|Stage 1|Lost to Follow-up|0|||
131701566|NCT04849780|474189450|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
131701567|NCT04849780|474189451|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
131701568|NCT00725075|474189452|FG000|Overall Study|Use of Excluded Medication|0|||
131701569|NCT00725075|474189453|FG001|Overall Study|Use of Excluded Medication|1|||
131701570|NCT00725075|474189454|FG002|Overall Study|Use of Excluded Medication|0|||
131701571|NCT00725075|474189452|FG000|Overall Study|Protocol Violation|0|||
131701572|NCT00725075|474189453|FG001|Overall Study|Protocol Violation|0|||
131701573|NCT00725075|474189454|FG002|Overall Study|Protocol Violation|1|||
131701574|NCT00725075|474189452|FG000|Overall Study|Lost to Follow-up|1|||
131701575|NCT00725075|474189453|FG001|Overall Study|Lost to Follow-up|0|||
131701576|NCT00725075|474189454|FG002|Overall Study|Lost to Follow-up|0|||
131701577|NCT00725075|474189452|FG000|Overall Study|Withdrawal by Subject|4|||
131701578|NCT00725075|474189453|FG001|Overall Study|Withdrawal by Subject|5|||
131701579|NCT00725075|474189454|FG002|Overall Study|Withdrawal by Subject|4|||
131701580|NCT00725075|474189452|FG000|Overall Study|Adverse Event|2|||
131701581|NCT00725075|474189453|FG001|Overall Study|Adverse Event|1|||
131701582|NCT00725075|474189454|FG002|Overall Study|Adverse Event|1|||
131701583|NCT00725075|474189452|FG000|Overall Study|Worsening of Disease|2|||
131701584|NCT00725075|474189453|FG001|Overall Study|Worsening of Disease|1|||
131701585|NCT00725075|474189454|FG002|Overall Study|Worsening of Disease|2|||
131701586|NCT00725075|474189452|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
131701587|NCT00725075|474189453|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
131701588|NCT00725075|474189454|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
131701589|NCT00725075|474189452|FG000|Overall Study|Other|1|||
131701590|NCT00725075|474189453|FG001|Overall Study|Other|0|||
131701591|NCT00725075|474189454|FG002|Overall Study|Other|0|||
131701592|NCT01298492|474189455|FG000|Overall Study|Death|2|||
131701593|NCT01298492|474189455|FG000|Overall Study|Insufficient Clinical Response|22|||
131701594|NCT01298492|474189455|FG000|Overall Study|Lost to Follow-up|12|||
131701595|NCT01298492|474189455|FG000|Overall Study|Withdrawal by Subject|47|||
131701596|NCT01298492|474189455|FG000|Overall Study|Other (Unspecified)|7|||
131701597|NCT01298492|474189455|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
131701598|NCT01298492|474189455|FG000|Overall Study|Protocol Violation|2|||
131701599|NCT01298492|474189455|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
131701600|NCT01298492|474189455|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
131701601|NCT03984305|474189456|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
131701602|NCT03984305|474189457|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
131701603|NCT03984305|474189456|FG000|Overall Study|Withdrawal by Subject|3|||
131701604|NCT03984305|474189457|FG001|Overall Study|Withdrawal by Subject|3|||
131701605|NCT03984305|474189456|FG000|Overall Study|Lost to Follow-up|1|||
131701606|NCT03984305|474189457|FG001|Overall Study|Lost to Follow-up|0|||
131701607|NCT00352105|474189458|FG000|Overall Study|Death|5|||
131701608|NCT00352105|474189458|FG000|Overall Study|Withdrawal by Subject|5|||
131701609|NCT00352105|474189458|FG000|Overall Study|Lack of Efficacy|9|||
131701610|NCT00352105|474189458|FG000|Overall Study|Adverse Event|19|||
131701611|NCT00352105|474189458|FG000|Overall Study|Protocol Violation|2|||
131701612|NCT00087646|474189459|FG000|Overall Study|Adverse Event|37|||
131701613|NCT00087646|474189460|FG001|Overall Study|Adverse Event|6|||
131701614|NCT00087646|474189461|FG002|Overall Study|Adverse Event|18|||
131701615|NCT00087646|474189462|FG003|Overall Study|Adverse Event|20|||
131701616|NCT00087646|474189459|FG000|Overall Study|Death|0|||
131701617|NCT00087646|474189460|FG001|Overall Study|Death|1|||
131701618|NCT00087646|474189461|FG002|Overall Study|Death|0|||
131701619|NCT00087646|474189462|FG003|Overall Study|Death|0|||
131701620|NCT00087646|474189459|FG000|Overall Study|Withdrawal by Subject|6|||
131701621|NCT00087646|474189460|FG001|Overall Study|Withdrawal by Subject|1|||
131701622|NCT00087646|474189461|FG002|Overall Study|Withdrawal by Subject|2|||
131701623|NCT00087646|474189462|FG003|Overall Study|Withdrawal by Subject|2|||
131701624|NCT00087646|474189459|FG000|Overall Study|Insufficient therapeutic response|64|||
131701625|NCT00087646|474189460|FG001|Overall Study|Insufficient therapeutic response|24|||
131701626|NCT00087646|474189461|FG002|Overall Study|Insufficient therapeutic response|38|||
131701627|NCT00087646|474189462|FG003|Overall Study|Insufficient therapeutic response|51|||
131701628|NCT00087646|474189459|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
131579688|NCT02477670|473750194|FG004|Stage 1|Lost to Follow-up|0|||
131579689|NCT02477670|473750195|FG005|Stage 1|Lost to Follow-up|0|||
131579690|NCT02477670|473750196|FG006|Stage 1|Lost to Follow-up|0|||
131701629|NCT00087646|474189460|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
131701630|NCT00087646|474189461|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
131701631|NCT00087646|474189462|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
131701632|NCT00087646|474189459|FG000|Overall Study|Failure to Return|5|||
131701633|NCT00087646|474189460|FG001|Overall Study|Failure to Return|2|||
131701634|NCT00087646|474189461|FG002|Overall Study|Failure to Return|2|||
131701635|NCT00087646|474189462|FG003|Overall Study|Failure to Return|3|||
131701636|NCT00087646|474189459|FG000|Overall Study|Administrative/Other|6|||
131701637|NCT00087646|474189460|FG001|Overall Study|Administrative/Other|1|||
131787291|NCT04380701|474504507|FG023|Overall Study|Lost to Follow-up|1|||
131787292|NCT04380701|474504508|FG024|Overall Study|Lost to Follow-up|0|||
131787293|NCT04380701|474504509|FG025|Overall Study|Lost to Follow-up|0|||
131787294|NCT04380701|474504510|FG026|Overall Study|Lost to Follow-up|0|||
131787295|NCT04380701|474504511|FG027|Overall Study|Lost to Follow-up|0|||
131787296|NCT04380701|474504512|FG028|Overall Study|Lost to Follow-up|0|||
131787297|NCT04380701|474504513|FG029|Overall Study|Lost to Follow-up|1|||
131787298|NCT04380701|474504514|FG030|Overall Study|Lost to Follow-up|0|||
131787299|NCT04380701|474504515|FG031|Overall Study|Lost to Follow-up|0|||
131787300|NCT04380701|474504516|FG032|Overall Study|Lost to Follow-up|0|||
131787301|NCT04380701|474504517|FG033|Overall Study|Lost to Follow-up|1|||
131787302|NCT04380701|474504484|FG000|Overall Study|Private reason(s)|0|||
131787303|NCT04380701|474504485|FG001|Overall Study|Private reason(s)|0|||
131787304|NCT04380701|474504486|FG002|Overall Study|Private reason(s)|0|||
131787305|NCT04380701|474504487|FG003|Overall Study|Private reason(s)|0|||
131787306|NCT04380701|474504488|FG004|Overall Study|Private reason(s)|0|||
131787307|NCT04380701|474504489|FG005|Overall Study|Private reason(s)|0|||
131787308|NCT04380701|474504490|FG006|Overall Study|Private reason(s)|1|||
131787309|NCT04380701|474504491|FG007|Overall Study|Private reason(s)|0|||
131787310|NCT04380701|474504492|FG008|Overall Study|Private reason(s)|1|||
131787311|NCT04380701|474504493|FG009|Overall Study|Private reason(s)|1|||
131787312|NCT04380701|474504494|FG010|Overall Study|Private reason(s)|0|||
131787313|NCT04380701|474504495|FG011|Overall Study|Private reason(s)|0|||
131787314|NCT04380701|474504496|FG012|Overall Study|Private reason(s)|0|||
131787315|NCT04380701|474504497|FG013|Overall Study|Private reason(s)|0|||
131787316|NCT04380701|474504498|FG014|Overall Study|Private reason(s)|0|||
131787317|NCT04380701|474504499|FG015|Overall Study|Private reason(s)|0|||
131787318|NCT04380701|474504500|FG016|Overall Study|Private reason(s)|0|||
131787319|NCT04380701|474504501|FG017|Overall Study|Private reason(s)|0|||
131787320|NCT04380701|474504502|FG018|Overall Study|Private reason(s)|0|||
131787321|NCT04380701|474504503|FG019|Overall Study|Private reason(s)|0|||
131787322|NCT04380701|474504504|FG020|Overall Study|Private reason(s)|0|||
131787323|NCT04380701|474504505|FG021|Overall Study|Private reason(s)|0|||
131787324|NCT04380701|474504506|FG022|Overall Study|Private reason(s)|0|||
131787325|NCT04380701|474504507|FG023|Overall Study|Private reason(s)|1|||
131787326|NCT04380701|474504508|FG024|Overall Study|Private reason(s)|0|||
131787327|NCT04380701|474504509|FG025|Overall Study|Private reason(s)|0|||
131787328|NCT04380701|474504510|FG026|Overall Study|Private reason(s)|0|||
131787329|NCT04380701|474504511|FG027|Overall Study|Private reason(s)|0|||
131787330|NCT04380701|474504512|FG028|Overall Study|Private reason(s)|0|||
131787331|NCT04380701|474504513|FG029|Overall Study|Private reason(s)|1|||
131787332|NCT04380701|474504514|FG030|Overall Study|Private reason(s)|0|||
131787333|NCT04380701|474504515|FG031|Overall Study|Private reason(s)|0|||
131787334|NCT04380701|474504516|FG032|Overall Study|Private reason(s)|0|||
131787335|NCT04380701|474504517|FG033|Overall Study|Private reason(s)|0|||
131787336|NCT04380701|474504484|FG000|Overall Study|Withdrawal by Subject|0|||
131787337|NCT04380701|474504485|FG001|Overall Study|Withdrawal by Subject|0|||
131787338|NCT04380701|474504486|FG002|Overall Study|Withdrawal by Subject|0|||
131787339|NCT04380701|474504487|FG003|Overall Study|Withdrawal by Subject|0|||
131787340|NCT04380701|474504488|FG004|Overall Study|Withdrawal by Subject|0|||
131787341|NCT04380701|474504489|FG005|Overall Study|Withdrawal by Subject|0|||
131787342|NCT04380701|474504490|FG006|Overall Study|Withdrawal by Subject|1|||
131787343|NCT04380701|474504491|FG007|Overall Study|Withdrawal by Subject|1|||
131787344|NCT04380701|474504492|FG008|Overall Study|Withdrawal by Subject|0|||
131787345|NCT04380701|474504493|FG009|Overall Study|Withdrawal by Subject|0|||
131787346|NCT04380701|474504494|FG010|Overall Study|Withdrawal by Subject|0|||
131787347|NCT04380701|474504495|FG011|Overall Study|Withdrawal by Subject|1|||
131787348|NCT04380701|474504496|FG012|Overall Study|Withdrawal by Subject|0|||
131787349|NCT04380701|474504497|FG013|Overall Study|Withdrawal by Subject|1|||
131787350|NCT04380701|474504498|FG014|Overall Study|Withdrawal by Subject|0|||
131787351|NCT04380701|474504499|FG015|Overall Study|Withdrawal by Subject|0|||
131787352|NCT04380701|474504500|FG016|Overall Study|Withdrawal by Subject|1|||
131787353|NCT04380701|474504501|FG017|Overall Study|Withdrawal by Subject|0|||
131787354|NCT04380701|474504502|FG018|Overall Study|Withdrawal by Subject|0|||
131787355|NCT04380701|474504503|FG019|Overall Study|Withdrawal by Subject|0|||
131787356|NCT04380701|474504504|FG020|Overall Study|Withdrawal by Subject|0|||
131787357|NCT04380701|474504505|FG021|Overall Study|Withdrawal by Subject|0|||
131787358|NCT04380701|474504506|FG022|Overall Study|Withdrawal by Subject|2|||
131787359|NCT04380701|474504507|FG023|Overall Study|Withdrawal by Subject|2|||
131787360|NCT04380701|474504508|FG024|Overall Study|Withdrawal by Subject|1|||
131787361|NCT04380701|474504509|FG025|Overall Study|Withdrawal by Subject|1|||
131787362|NCT04380701|474504510|FG026|Overall Study|Withdrawal by Subject|0|||
131787363|NCT04380701|474504511|FG027|Overall Study|Withdrawal by Subject|0|||
131787364|NCT04380701|474504512|FG028|Overall Study|Withdrawal by Subject|0|||
131787365|NCT04380701|474504513|FG029|Overall Study|Withdrawal by Subject|0|||
131787366|NCT04380701|474504514|FG030|Overall Study|Withdrawal by Subject|0|||
131787367|NCT04380701|474504515|FG031|Overall Study|Withdrawal by Subject|0|||
131787368|NCT04380701|474504516|FG032|Overall Study|Withdrawal by Subject|0|||
131579691|NCT02477670|473750190|FG000|Stage 1|Withdrawal by Subject|1|||
131579692|NCT02477670|473750191|FG001|Stage 1|Withdrawal by Subject|2|||
131579693|NCT02477670|473750192|FG002|Stage 1|Withdrawal by Subject|0|||
131579694|NCT02477670|473750193|FG003|Stage 1|Withdrawal by Subject|0|||
131579695|NCT02477670|473750194|FG004|Stage 1|Withdrawal by Subject|0|||
131579696|NCT02477670|473750195|FG005|Stage 1|Withdrawal by Subject|0|||
131898695|NCT01111565|474915337|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
131701638|NCT00087646|474189461|FG002|Overall Study|Administrative/Other|1|||
131898696|NCT01111565|474915338|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
131701639|NCT00087646|474189462|FG003|Overall Study|Administrative/Other|2|||
131701640|NCT00087646|474189459|FG000|Overall Study|Other Protocol Violation|3|||
131701641|NCT00087646|474189460|FG001|Overall Study|Other Protocol Violation|1|||
131701642|NCT00087646|474189461|FG002|Overall Study|Other Protocol Violation|0|||
131701643|NCT00087646|474189462|FG003|Overall Study|Other Protocol Violation|0|||
131701644|NCT00087646|474189459|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131701645|NCT00087646|474189460|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
131701646|NCT00087646|474189461|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
131701647|NCT00087646|474189462|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
131701648|NCT01235962|474189463|FG000|Overall Study|Withdrawal by Subject|20|||
131701649|NCT01235962|474189464|FG001|Overall Study|Withdrawal by Subject|19|||
131701650|NCT01235962|474189465|FG002|Overall Study|Withdrawal by Subject|62|||
131701651|NCT01235962|474189466|FG003|Overall Study|Withdrawal by Subject|49|||
131898697|NCT01111565|474915339|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
131701652|NCT01235962|474189463|FG000|Overall Study|Lost to Follow-up|21|||
131701653|NCT01235962|474189464|FG001|Overall Study|Lost to Follow-up|16|||
131701654|NCT01235962|474189465|FG002|Overall Study|Lost to Follow-up|47|||
131701655|NCT01235962|474189466|FG003|Overall Study|Lost to Follow-up|32|||
131701656|NCT01235962|474189463|FG000|Overall Study|Physician Decision|5|||
131787369|NCT04380701|474504517|FG033|Overall Study|Withdrawal by Subject|0|||
131787370|NCT04380701|474504484|FG000|Overall Study|Adverse Event|0|||
131787371|NCT04380701|474504485|FG001|Overall Study|Adverse Event|0|||
131787372|NCT04380701|474504486|FG002|Overall Study|Adverse Event|0|||
131787373|NCT04380701|474504487|FG003|Overall Study|Adverse Event|0|||
131787374|NCT04380701|474504488|FG004|Overall Study|Adverse Event|0|||
131787375|NCT04380701|474504489|FG005|Overall Study|Adverse Event|1|||
131787376|NCT04380701|474504490|FG006|Overall Study|Adverse Event|0|||
131787377|NCT04380701|474504491|FG007|Overall Study|Adverse Event|0|||
131787378|NCT04380701|474504492|FG008|Overall Study|Adverse Event|0|||
131787379|NCT04380701|474504493|FG009|Overall Study|Adverse Event|0|||
131787380|NCT04380701|474504494|FG010|Overall Study|Adverse Event|0|||
131787381|NCT04380701|474504495|FG011|Overall Study|Adverse Event|0|||
131787382|NCT04380701|474504496|FG012|Overall Study|Adverse Event|0|||
131898698|NCT01111565|474915335|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131898699|NCT01111565|474915336|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131898700|NCT01111565|474915337|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131898701|NCT01111565|474915338|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
131898702|NCT01111565|474915339|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131898703|NCT01111565|474915335|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131898704|NCT01111565|474915336|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131898705|NCT01111565|474915337|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
131898706|NCT01111565|474915338|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131898707|NCT01111565|474915339|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131898708|NCT01111565|474915335|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
131898709|NCT01111565|474915336|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
131898710|NCT01111565|474915337|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
131898711|NCT01111565|474915338|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
131898712|NCT01111565|474915339|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
131898713|NCT01111565|474915335|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
131898714|NCT01111565|474915336|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
131898715|NCT01111565|474915337|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
131898716|NCT01111565|474915338|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
131898717|NCT01111565|474915339|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
131898718|NCT01111565|474915335|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
131898719|NCT01111565|474915336|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
131898720|NCT01111565|474915337|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
131898721|NCT01111565|474915338|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
131898722|NCT01111565|474915339|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
131898723|NCT04131712|474915340|FG000|Overall Study|COVID related|0|||
131898724|NCT04131712|474915341|FG001|Overall Study|COVID related|0|||
131898725|NCT04131712|474915342|FG002|Overall Study|COVID related|2|||
131898726|NCT04131712|474915343|FG003|Overall Study|COVID related|0|||
131898727|NCT04131712|474915340|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
131898728|NCT04131712|474915341|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
131579697|NCT02477670|473750196|FG006|Stage 1|Withdrawal by Subject|0|||
131579698|NCT02477670|473750190|FG000|Stage 1|Non-compliance with Study Drug|1|||
131701657|NCT01235962|474189464|FG001|Overall Study|Physician Decision|0|||
131701658|NCT01235962|474189465|FG002|Overall Study|Physician Decision|9|||
131701659|NCT01235962|474189466|FG003|Overall Study|Physician Decision|5|||
131701660|NCT02902120|474189467|FG000|Overall Study|Lack of Efficacy|1|||
131701661|NCT01353703|474189469|FG000|Overall Study|Migrated/moved from study area|1|||
131701662|NCT01353703|474189470|FG001|Overall Study|Migrated/moved from study area|0|||
131701663|NCT01405053|474189476|FG000|Overall Study|Adverse Event|3|||
131701664|NCT01405053|474189477|FG001|Overall Study|Adverse Event|0|||
131701665|NCT01405053|474189476|FG000|Overall Study|Lost to Follow-up|0|||
131701666|NCT01405053|474189477|FG001|Overall Study|Lost to Follow-up|1|||
131701667|NCT01405053|474189476|FG000|Overall Study|Participant choice|2|||
131701668|NCT01405053|474189477|FG001|Overall Study|Participant choice|1|||
131701669|NCT01405053|474189476|FG000|Overall Study|Inadequate therapeutic effect|2|||
131787383|NCT04380701|474504497|FG013|Overall Study|Adverse Event|0|||
131787384|NCT04380701|474504498|FG014|Overall Study|Adverse Event|0|||
131787385|NCT04380701|474504499|FG015|Overall Study|Adverse Event|1|||
131787386|NCT04380701|474504500|FG016|Overall Study|Adverse Event|0|||
131787387|NCT04380701|474504501|FG017|Overall Study|Adverse Event|0|||
131787388|NCT04380701|474504502|FG018|Overall Study|Adverse Event|0|||
131787389|NCT04380701|474504503|FG019|Overall Study|Adverse Event|1|||
131787390|NCT04380701|474504504|FG020|Overall Study|Adverse Event|0|||
131787391|NCT04380701|474504505|FG021|Overall Study|Adverse Event|0|||
131787392|NCT04380701|474504506|FG022|Overall Study|Adverse Event|0|||
131787393|NCT04380701|474504507|FG023|Overall Study|Adverse Event|0|||
131787394|NCT04380701|474504508|FG024|Overall Study|Adverse Event|0|||
131787395|NCT04380701|474504509|FG025|Overall Study|Adverse Event|0|||
131787396|NCT04380701|474504510|FG026|Overall Study|Adverse Event|0|||
131787397|NCT04380701|474504511|FG027|Overall Study|Adverse Event|0|||
131787398|NCT04380701|474504512|FG028|Overall Study|Adverse Event|0|||
131787399|NCT04380701|474504513|FG029|Overall Study|Adverse Event|0|||
131787400|NCT04380701|474504514|FG030|Overall Study|Adverse Event|0|||
131787401|NCT04380701|474504515|FG031|Overall Study|Adverse Event|0|||
131701670|NCT01405053|474189477|FG001|Overall Study|Inadequate therapeutic effect|1|||
131701671|NCT01405053|474189476|FG000|Overall Study|Withdrawal by Subject|3|||
131701672|NCT01405053|474189477|FG001|Overall Study|Withdrawal by Subject|4|||
131701673|NCT01405053|474189476|FG000|Overall Study|Other|0|||
131701674|NCT01405053|474189477|FG001|Overall Study|Other|1|||
131787402|NCT04380701|474504516|FG032|Overall Study|Adverse Event|0|||
131787403|NCT04380701|474504517|FG033|Overall Study|Adverse Event|0|||
131438285|NCT02426580|473231173|FG000|Overall Study|Lost to Follow-up|0|||
131579699|NCT02477670|473750191|FG001|Stage 1|Non-compliance with Study Drug|2|||
131579700|NCT02477670|473750192|FG002|Stage 1|Non-compliance with Study Drug|0|||
131579701|NCT02477670|473750193|FG003|Stage 1|Non-compliance with Study Drug|0|||
131579702|NCT02477670|473750194|FG004|Stage 1|Non-compliance with Study Drug|0|||
131579703|NCT02477670|473750195|FG005|Stage 1|Non-compliance with Study Drug|0|||
131579704|NCT02477670|473750196|FG006|Stage 1|Non-compliance with Study Drug|0|||
131579705|NCT02477670|473750190|FG000|Stage 2|Adverse Event|0|||
131579706|NCT02477670|473750191|FG001|Stage 2|Adverse Event|0|||
131579707|NCT02477670|473750192|FG002|Stage 2|Adverse Event|1|||
131579708|NCT02477670|473750193|FG003|Stage 2|Adverse Event|0|||
131579709|NCT02477670|473750194|FG004|Stage 2|Adverse Event|0|||
131579710|NCT02477670|473750195|FG005|Stage 2|Adverse Event|0|||
131579711|NCT02477670|473750196|FG006|Stage 2|Adverse Event|0|||
131579712|NCT02477670|473750190|FG000|Stage 2|Antipsychotic Medication Changed|0|||
131579713|NCT02477670|473750191|FG001|Stage 2|Antipsychotic Medication Changed|0|||
131579714|NCT02477670|473750192|FG002|Stage 2|Antipsychotic Medication Changed|1|||
131579715|NCT02477670|473750193|FG003|Stage 2|Antipsychotic Medication Changed|0|||
131579716|NCT02477670|473750194|FG004|Stage 2|Antipsychotic Medication Changed|0|||
131579717|NCT02477670|473750195|FG005|Stage 2|Antipsychotic Medication Changed|0|||
131579718|NCT02477670|473750196|FG006|Stage 2|Antipsychotic Medication Changed|0|||
131579719|NCT02477670|473750190|FG000|Stage 2|Withdrawal by Subject|0|||
131579720|NCT02477670|473750191|FG001|Stage 2|Withdrawal by Subject|0|||
131579721|NCT02477670|473750192|FG002|Stage 2|Withdrawal by Subject|0|||
131579722|NCT02477670|473750193|FG003|Stage 2|Withdrawal by Subject|1|||
131579723|NCT02477670|473750194|FG004|Stage 2|Withdrawal by Subject|0|||
131579724|NCT02477670|473750195|FG005|Stage 2|Withdrawal by Subject|0|||
131701675|NCT02175680|474189483|FG000|Overall Study|non-compliance|1|||
131701676|NCT02175680|474189483|FG000|Overall Study|other non-medical reason|1|||
131701677|NCT01913483|474189488|FG000|Overall Study|Withdrawal by Subject|1|||
131701678|NCT01913483|474189489|FG001|Overall Study|Withdrawal by Subject|2|||
131701679|NCT01913483|474189488|FG000|Overall Study|Lost to Follow-up|6|||
131701680|NCT01913483|474189489|FG001|Overall Study|Lost to Follow-up|3|||
131701681|NCT01913483|474189488|FG000|Overall Study|Death|14|||
131701682|NCT01913483|474189489|FG001|Overall Study|Death|17|||
131701683|NCT02302963|474189490|FG000|Overall Study|Withdrawal by Subject|2|||
131701684|NCT02302963|474189491|FG001|Overall Study|Withdrawal by Subject|1|||
131701685|NCT02302963|474189490|FG000|Overall Study|Steroid injection|0|||
131701686|NCT02302963|474189491|FG001|Overall Study|Steroid injection|1|||
131701687|NCT02302963|474189490|FG000|Overall Study|Physician Decision|1|||
131701688|NCT02302963|474189491|FG001|Overall Study|Physician Decision|0|||
131701689|NCT01816243|474189492|FG000|Overall Study|Adverse Event|6|||
131701690|NCT01816243|474189492|FG000|Overall Study|Lost to Follow-up|1|||
131701691|NCT01816243|474189492|FG000|Overall Study|Lack of Efficacy|1|||
131701692|NCT01816243|474189492|FG000|Overall Study|Not eligible for the study|1|||
131701693|NCT01816243|474189492|FG000|Overall Study|Amputation|3|||
131701694|NCT00915343|474189493|FG000|Part B - Open Label Period|Treatment switch|0|||
131701695|NCT00915343|474189494|FG001|Part B - Open Label Period|Treatment switch|0|||
131701696|NCT00915343|474189495|FG002|Part B - Open Label Period|Treatment switch|1|||
131701697|NCT00915343|474189493|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
131701698|NCT00915343|474189494|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
131701699|NCT00915343|474189495|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
131701700|NCT01920711|474189496|FG000|Overall Study|Death|347|||
131701701|NCT01920711|474189497|FG001|Overall Study|Death|356|||
131701702|NCT01920711|474189496|FG000|Overall Study|Lost to Follow-up|13|||
131701703|NCT01920711|474189497|FG001|Overall Study|Lost to Follow-up|14|||
131701704|NCT01920711|474189496|FG000|Overall Study|Withdrawal by Subject|4|||
131701705|NCT01920711|474189497|FG001|Overall Study|Withdrawal by Subject|3|||
131701706|NCT02317562|474189498|FG000|Overall Study|Physician Decision|1|||
131701707|NCT02317562|474189498|FG000|Overall Study|early termination of the study|8|||
131701708|NCT02317562|474189498|FG000|Overall Study|Lack of Efficacy|4|||
131701709|NCT02317562|474189498|FG000|Overall Study|Withdrawal by Subject|1|||
131701710|NCT00911989|474189499|FG000|Overall Study|Adverse Event|1|||
131701711|NCT01724528|474189502|FG000|Overall Study|Death|3|||
131579725|NCT02477670|473750196|FG006|Stage 2|Withdrawal by Subject|0|||
131579726|NCT00004124|473750197|FG000|Overall Study|Received no protocol therapy|12|||
131579727|NCT00004124|473750198|FG001|Overall Study|Received no protocol therapy|20|||
131579728|NCT00446550|473750199|FG000|Overall Study|Adverse Event|1|||
131579729|NCT00446550|473750200|FG001|Overall Study|Adverse Event|0|||
131579730|NCT02937831|473750201|FG000|Overall Study|Protocol Violation|4|||
131579731|NCT00114244|473750204|FG000|Overall Study|Adverse Event|2|||
131579732|NCT00114244|473750205|FG001|Overall Study|Adverse Event|5|||
131579733|NCT00114244|473750204|FG000|Overall Study|Withdrawal by Subject|0|||
131701712|NCT01724528|474189503|FG001|Overall Study|Death|0|||
131701713|NCT01724528|474189502|FG000|Overall Study|Withdrawal by Subject|0|||
131701714|NCT01724528|474189503|FG001|Overall Study|Withdrawal by Subject|2|||
131701715|NCT01724528|474189502|FG000|Overall Study|Protocol Violation|0|||
131701716|NCT01724528|474189503|FG001|Overall Study|Protocol Violation|1|||
131579734|NCT00114244|473750205|FG001|Overall Study|Withdrawal by Subject|2|||
131579735|NCT02383472|473750206|FG000|Overall Study|Withdrawal by Subject|1|||
131579736|NCT02383472|473750207|FG001|Overall Study|Withdrawal by Subject|1|||
131579737|NCT00818454|473750210|FG000|Treatment Period 1|Adverse Event|0|||
131438286|NCT02426580|473231174|FG001|Overall Study|Lost to Follow-up|9|||
131438287|NCT02426580|473231173|FG000|Overall Study|transfer to hemodialysis|5|||
131438288|NCT02426580|473231174|FG001|Overall Study|transfer to hemodialysis|5|||
131438289|NCT02426580|473231173|FG000|Overall Study|Kidney transplant|3|||
131438290|NCT02426580|473231174|FG001|Overall Study|Kidney transplant|0|||
131438291|NCT02426580|473231173|FG000|Overall Study|Allergic to egg white|1|||
131438292|NCT02426580|473231174|FG001|Overall Study|Allergic to egg white|0|||
131438293|NCT00768989|473231185|FG000|Prior to Week 24|Withdrawal by Subject|1|||
131579738|NCT00818454|473750211|FG001|Treatment Period 1|Adverse Event|1|||
131579739|NCT00818454|473750212|FG002|Treatment Period 1|Adverse Event|0|||
131579740|NCT00818454|473750213|FG003|Treatment Period 1|Adverse Event|0|||
131579741|NCT00818454|473750210|FG000|Treatment Period 1|Other|3|||
131579742|NCT00818454|473750211|FG001|Treatment Period 1|Other|0|||
131579743|NCT00818454|473750212|FG002|Treatment Period 1|Other|0|||
131579744|NCT00818454|473750213|FG003|Treatment Period 1|Other|0|||
131579745|NCT00818454|473750210|FG000|Washout Period of 1 Week|Adverse Event|1|||
131579746|NCT00818454|473750211|FG001|Washout Period of 1 Week|Adverse Event|1|||
131579747|NCT00818454|473750212|FG002|Washout Period of 1 Week|Adverse Event|0|||
131579748|NCT00818454|473750213|FG003|Washout Period of 1 Week|Adverse Event|0|||
131579749|NCT00818454|473750210|FG000|Washout Period of 1 Week|Protocol Violation|2|||
131579750|NCT00818454|473750211|FG001|Washout Period of 1 Week|Protocol Violation|0|||
131579751|NCT00818454|473750212|FG002|Washout Period of 1 Week|Protocol Violation|0|||
131579752|NCT00818454|473750213|FG003|Washout Period of 1 Week|Protocol Violation|0|||
131579753|NCT00818454|473750210|FG000|Washout Period of 1 Week|Other|1|||
131579754|NCT00818454|473750211|FG001|Washout Period of 1 Week|Other|2|||
131579755|NCT00818454|473750212|FG002|Washout Period of 1 Week|Other|0|||
131579756|NCT00818454|473750213|FG003|Washout Period of 1 Week|Other|0|||
131701717|NCT01724528|474189502|FG000|Overall Study|Patient refused to attend last visit|1|||
131701718|NCT01724528|474189503|FG001|Overall Study|Patient refused to attend last visit|0|||
131701719|NCT00803179|474189510|FG000|Overall Study|Lost to Follow-up|3|||
131701720|NCT04811716|474189512|FG000|Overall Study|Withdrawal by Subject|2|||
131701721|NCT04811716|474189513|FG001|Overall Study|Withdrawal by Subject|0|||
131701722|NCT01634555|474189514|FG000|Overall Study|Adverse Event|3|||
131701723|NCT01634555|474189514|FG000|Overall Study|Physician Decision|1|||
131701724|NCT01877083|474189518|FG000|Treatment Phase|Disease Progression|10|||
131701725|NCT01877083|474189518|FG000|Treatment Phase|Clinical Progression|1|||
131701726|NCT01877083|474189518|FG000|Treatment Phase|Adverse Event|6|||
131701727|NCT01877083|474189518|FG000|Treatment Phase|Withdrawal by Subject|2|||
131701728|NCT01877083|474189518|FG000|Treatment Phase|Lost to Follow-up|1|||
131701729|NCT01877083|474189518|FG000|Extension Phase|Disease Progression|3|||
131701730|NCT01877083|474189518|FG000|Extension Phase|Adverse Event|2|||
131701731|NCT01582308|474189521|FG000|Period 1|Withdrawal by Subject|0|||
131701732|NCT01582308|474189522|FG001|Period 1|Withdrawal by Subject|0|||
131701733|NCT01582308|474189523|FG002|Period 1|Withdrawal by Subject|0|||
131701734|NCT01582308|474189524|FG003|Period 1|Withdrawal by Subject|0|||
131701735|NCT01582308|474189525|FG004|Period 1|Withdrawal by Subject|0|||
131701736|NCT01582308|474189526|FG005|Period 1|Withdrawal by Subject|0|||
131701737|NCT01582308|474189527|FG006|Period 1|Withdrawal by Subject|1|||
131701738|NCT01582308|474189528|FG007|Period 1|Withdrawal by Subject|0|||
131701739|NCT01582308|474189529|FG008|Period 1|Withdrawal by Subject|0|||
131701740|NCT01582308|474189530|FG009|Period 1|Withdrawal by Subject|0|||
131701741|NCT01582308|474189521|FG000|10-day Washout Following Period 1|Physician Decision|0|||
131701742|NCT01582308|474189522|FG001|10-day Washout Following Period 1|Physician Decision|0|||
131701743|NCT01582308|474189523|FG002|10-day Washout Following Period 1|Physician Decision|0|||
131701744|NCT01582308|474189524|FG003|10-day Washout Following Period 1|Physician Decision|0|||
131701745|NCT01582308|474189525|FG004|10-day Washout Following Period 1|Physician Decision|1|||
131701746|NCT01582308|474189526|FG005|10-day Washout Following Period 1|Physician Decision|0|||
131701747|NCT01582308|474189527|FG006|10-day Washout Following Period 1|Physician Decision|0|||
131701748|NCT01582308|474189528|FG007|10-day Washout Following Period 1|Physician Decision|0|||
131701749|NCT01582308|474189529|FG008|10-day Washout Following Period 1|Physician Decision|0|||
131701750|NCT01582308|474189530|FG009|10-day Washout Following Period 1|Physician Decision|0|||
131701751|NCT01582308|474189521|FG000|Period 4|Physician Decision|1|||
131701752|NCT01582308|474189522|FG001|Period 4|Physician Decision|0|||
131701753|NCT01582308|474189523|FG002|Period 4|Physician Decision|0|||
131701754|NCT01582308|474189524|FG003|Period 4|Physician Decision|0|||
131701755|NCT01582308|474189525|FG004|Period 4|Physician Decision|0|||
131701756|NCT01582308|474189526|FG005|Period 4|Physician Decision|1|||
131701757|NCT01582308|474189527|FG006|Period 4|Physician Decision|0|||
131701758|NCT01582308|474189528|FG007|Period 4|Physician Decision|0|||
131701759|NCT01582308|474189529|FG008|Period 4|Physician Decision|0|||
131701760|NCT01582308|474189530|FG009|Period 4|Physician Decision|1|||
131579757|NCT00818454|473750210|FG000|Treatment Period 2|Other|2|||
131579758|NCT00818454|473750211|FG001|Treatment Period 2|Other|1|||
131579759|NCT00818454|473750212|FG002|Treatment Period 2|Other|0|||
131579760|NCT00818454|473750213|FG003|Treatment Period 2|Other|0|||
131579761|NCT00818454|473750210|FG000|Treatment Period 3|Adverse Event|0|||
131579762|NCT00818454|473750211|FG001|Treatment Period 3|Adverse Event|0|||
131579763|NCT00818454|473750212|FG002|Treatment Period 3|Adverse Event|0|||
131579764|NCT00818454|473750213|FG003|Treatment Period 3|Adverse Event|1|||
131579765|NCT02296424|473750215|FG000|Part 1|New therapy for study indication|0|||
131579766|NCT02296424|473750216|FG001|Part 1|New therapy for study indication|1|||
131579767|NCT02296424|473750217|FG002|Part 1|New therapy for study indication|0|||
131579768|NCT02296424|473750218|FG003|Part 1|New therapy for study indication|0|||
131579769|NCT02296424|473750215|FG000|Part 1|Protocol Violation|0|||
131579770|NCT02296424|473750216|FG001|Part 1|Protocol Violation|1|||
131579771|NCT02296424|473750217|FG002|Part 1|Protocol Violation|0|||
131579772|NCT02296424|473750218|FG003|Part 1|Protocol Violation|0|||
131579773|NCT02296424|473750215|FG000|Part 1|Withdrawal by Subject|0|||
131579774|NCT02296424|473750216|FG001|Part 1|Withdrawal by Subject|2|||
131579775|NCT02296424|473750217|FG002|Part 1|Withdrawal by Subject|0|||
131579776|NCT02296424|473750218|FG003|Part 1|Withdrawal by Subject|0|||
131579777|NCT02296424|473750215|FG000|Part 1|Study terminated by sponsor|0|||
131579778|NCT02296424|473750216|FG001|Part 1|Study terminated by sponsor|1|||
131579779|NCT02296424|473750217|FG002|Part 1|Study terminated by sponsor|0|||
131579780|NCT02296424|473750218|FG003|Part 1|Study terminated by sponsor|0|||
131579781|NCT02296424|473750215|FG000|Part 1|Adverse Event|2|||
131579782|NCT02296424|473750216|FG001|Part 1|Adverse Event|11|||
131579783|NCT02296424|473750217|FG002|Part 1|Adverse Event|0|||
131579784|NCT02296424|473750218|FG003|Part 1|Adverse Event|0|||
131579785|NCT02296424|473750215|FG000|Part 1|Lack of Efficacy|5|||
131579786|NCT02296424|473750216|FG001|Part 1|Lack of Efficacy|17|||
131579787|NCT02296424|473750217|FG002|Part 1|Lack of Efficacy|0|||
131579788|NCT02296424|473750218|FG003|Part 1|Lack of Efficacy|0|||
131579789|NCT02296424|473750215|FG000|Part 1|16 directly started part II|16|||
131579790|NCT02296424|473750216|FG001|Part 1|16 directly started part II|0|||
131579791|NCT02296424|473750217|FG002|Part 1|16 directly started part II|0|||
131579792|NCT02296424|473750218|FG003|Part 1|16 directly started part II|0|||
131579793|NCT02296424|473750215|FG000|Part 2|Lack of Efficacy|0|||
131579794|NCT02296424|473750216|FG001|Part 2|Lack of Efficacy|0|||
131579795|NCT02296424|473750217|FG002|Part 2|Lack of Efficacy|1|||
131579796|NCT02296424|473750218|FG003|Part 2|Lack of Efficacy|0|||
131579797|NCT02296424|473750215|FG000|Part 2|Adverse Event|0|||
131579798|NCT02296424|473750216|FG001|Part 2|Adverse Event|0|||
131579799|NCT02296424|473750217|FG002|Part 2|Adverse Event|1|||
131579800|NCT02296424|473750218|FG003|Part 2|Adverse Event|0|||
131579801|NCT02296424|473750215|FG000|Part 2|Lost to Follow-up|0|||
131701761|NCT06228586|474189533|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
131701762|NCT06228586|474189534|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
131701763|NCT01227902|474190970|FG000|Overall Study|Adverse Event|12|||
131701764|NCT01227902|474190971|FG001|Overall Study|Adverse Event|8|||
131701765|NCT01227902|474190972|FG002|Overall Study|Adverse Event|11|||
131701766|NCT01227902|474190973|FG003|Overall Study|Adverse Event|4|||
131701767|NCT01227902|474190970|FG000|Overall Study|Lack of Efficacy|1|||
131701768|NCT01227902|474190971|FG001|Overall Study|Lack of Efficacy|2|||
131701769|NCT01227902|474190972|FG002|Overall Study|Lack of Efficacy|2|||
131701770|NCT01227902|474190973|FG003|Overall Study|Lack of Efficacy|1|||
131701771|NCT01227902|474190970|FG000|Overall Study|Protocol Violation|1|||
131701772|NCT01227902|474190971|FG001|Overall Study|Protocol Violation|0|||
131701773|NCT01227902|474190972|FG002|Overall Study|Protocol Violation|0|||
131701774|NCT01227902|474190973|FG003|Overall Study|Protocol Violation|0|||
131701775|NCT01227902|474190970|FG000|Overall Study|Lost to Follow-up|0|||
131701776|NCT01227902|474190971|FG001|Overall Study|Lost to Follow-up|0|||
131701777|NCT01227902|474190972|FG002|Overall Study|Lost to Follow-up|1|||
131579802|NCT02296424|473750216|FG001|Part 2|Lost to Follow-up|0|||
131579803|NCT02296424|473750217|FG002|Part 2|Lost to Follow-up|1|||
131579804|NCT02296424|473750218|FG003|Part 2|Lost to Follow-up|0|||
131701778|NCT01227902|474190973|FG003|Overall Study|Lost to Follow-up|2|||
131701779|NCT01227902|474190970|FG000|Overall Study|Physician Decision|0|||
131701780|NCT01227902|474190971|FG001|Overall Study|Physician Decision|1|||
131701781|NCT01227902|474190972|FG002|Overall Study|Physician Decision|1|||
131701782|NCT01227902|474190973|FG003|Overall Study|Physician Decision|0|||
131701783|NCT01227902|474190970|FG000|Overall Study|Withdrawal by Subject|4|||
131787404|NCT04380701|474504484|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
131579805|NCT00807144|473750219|FG000|Overall Study|Lost to Follow-up|0|||
131579806|NCT00807144|473750220|FG001|Overall Study|Lost to Follow-up|1|||
131701784|NCT01227902|474190971|FG001|Overall Study|Withdrawal by Subject|2|||
131701785|NCT01227902|474190972|FG002|Overall Study|Withdrawal by Subject|4|||
131701786|NCT01227902|474190973|FG003|Overall Study|Withdrawal by Subject|3|||
131701787|NCT05280756|474190974|FG000|Overall Study|Lost to Follow-up|1|||
131579807|NCT02567656|473750223|FG000|Overall Study|Premature discontinuation due to PD|1|||
131579808|NCT02567656|473750224|FG001|Overall Study|Premature discontinuation due to PD|1|||
131579809|NCT02567656|473750225|FG002|Overall Study|Premature discontinuation due to PD|2|||
131701788|NCT05280756|474190975|FG001|Overall Study|Lost to Follow-up|1|||
131701789|NCT01299766|474190981|FG000|Overall Study|Death|5|||
131701790|NCT01299766|474190982|FG001|Overall Study|Death|4|||
131701791|NCT01299766|474190981|FG000|Overall Study|Withdrawal by Subject|29|||
131701792|NCT01299766|474190982|FG001|Overall Study|Withdrawal by Subject|19|||
131701793|NCT00403260|474190987|FG000|Overall Study|Adverse Event|5|||
131701794|NCT00403260|474190988|FG001|Overall Study|Adverse Event|4|||
131701795|NCT00403260|474190987|FG000|Overall Study|Withdrawal by Subject|5|||
131701796|NCT00403260|474190988|FG001|Overall Study|Withdrawal by Subject|6|||
131701797|NCT00403260|474190987|FG000|Overall Study|Lost to Follow-up|49|||
131701798|NCT00403260|474190988|FG001|Overall Study|Lost to Follow-up|25|||
131701799|NCT00403260|474190987|FG000|Overall Study|Re-appearance of P. falciparum|34|||
131701800|NCT00403260|474190988|FG001|Overall Study|Re-appearance of P. falciparum|25|||
131701801|NCT00403260|474190987|FG000|Overall Study|P. vivax infection|26|||
131701802|NCT00403260|474190988|FG001|Overall Study|P. vivax infection|4|||
131701803|NCT00403260|474190987|FG000|Overall Study|Mixed infection with P. vivax|2|||
131701804|NCT00403260|474190988|FG001|Overall Study|Mixed infection with P. vivax|0|||
131701805|NCT00403260|474190987|FG000|Overall Study|Mixed infection with P. falciparum|1|||
131701806|NCT00403260|474190988|FG001|Overall Study|Mixed infection with P. falciparum|0|||
131701807|NCT00403260|474190987|FG000|Overall Study|P. vivax infection at screening|1|||
131701808|NCT00403260|474190988|FG001|Overall Study|P. vivax infection at screening|0|||
131701809|NCT00403260|474190987|FG000|Overall Study|P. ovale infection|1|||
131701810|NCT00403260|474190988|FG001|Overall Study|P. ovale infection|0|||
131701811|NCT00403260|474190987|FG000|Overall Study|Gametocyte re-appearance|1|||
131701812|NCT00403260|474190988|FG001|Overall Study|Gametocyte re-appearance|1|||
131701813|NCT00403260|474190987|FG000|Overall Study|Withdrawn from study accidentally|0|||
131701814|NCT00403260|474190988|FG001|Overall Study|Withdrawn from study accidentally|1|||
131701815|NCT01354028|474190989|FG000|Overall Study|Physician Decision|0|||
131701816|NCT01354028|474190990|FG001|Overall Study|Physician Decision|2|||
131701817|NCT01354028|474190989|FG000|Overall Study|Discharged before study start|2|||
131701818|NCT01354028|474190990|FG001|Overall Study|Discharged before study start|2|||
131701819|NCT01354028|474190989|FG000|Overall Study|No quiet alert state|0|||
131579810|NCT02567656|473750226|FG003|Overall Study|Premature discontinuation due to PD|0|||
131579811|NCT02567656|473750227|FG004|Overall Study|Premature discontinuation due to PD|0|||
131579812|NCT02567656|473750228|FG005|Overall Study|Premature discontinuation due to PD|0|||
131579813|NCT00854906|473750229|FG000|Overall Study|One person had no ocular history|1|||
131579814|NCT00814346|473750230|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
131579815|NCT00814346|473750231|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
131579816|NCT00814346|473750230|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
131579817|NCT00814346|473750231|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
131579818|NCT00814346|473750230|FG000|Open Phase (17 Months)|Adverse Event|5|||
131579819|NCT00814346|473750231|FG001|Open Phase (17 Months)|Adverse Event|0|||
131579820|NCT00814346|473750230|FG000|Open Phase (17 Months)|Consent|2|||
131579821|NCT00814346|473750231|FG001|Open Phase (17 Months)|Consent|0|||
131579822|NCT00814346|473750230|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
131579823|NCT00814346|473750231|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
131579824|NCT00814346|473750230|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
131579825|NCT00814346|473750231|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
131579826|NCT03622580|473750232|FG000|Overall Study|Death|16|||
131579827|NCT03622580|473750233|FG001|Overall Study|Death|21|||
131701820|NCT01354028|474190990|FG001|Overall Study|No quiet alert state|1|||
131701821|NCT00935883|474190993|FG000|Treatment Period|Physician Decision|1|||
131701822|NCT00935883|474190994|FG001|Treatment Period|Physician Decision|0|||
131701823|NCT00935883|474190993|FG000|Treatment Period|Withdrawal by Subject|0|||
131701824|NCT00935883|474190994|FG001|Treatment Period|Withdrawal by Subject|2|||
131701825|NCT01072344|474190997|FG000|Overall Study|Relasped-reached end point|7|||
131701826|NCT01072344|474190998|FG001|Overall Study|Relasped-reached end point|12|||
131701827|NCT01072344|474190997|FG000|Overall Study|Protocol Violation|1|||
131701828|NCT01072344|474190998|FG001|Overall Study|Protocol Violation|2|||
131701829|NCT01072344|474190997|FG000|Overall Study|Lost to Follow-up|3|||
131701830|NCT01072344|474190998|FG001|Overall Study|Lost to Follow-up|4|||
131701831|NCT00808444|474191005|FG000|Overall Study|Withdrawal by Subject|1|||
131701832|NCT00808444|474191006|FG001|Overall Study|Withdrawal by Subject|0|||
131701833|NCT00808444|474191005|FG000|Overall Study|Lost to Follow-up|0|||
131701834|NCT00808444|474191006|FG001|Overall Study|Lost to Follow-up|1|||
131701835|NCT01461044|474191007|FG000|Overall Study|Death|58|||
131701836|NCT01461044|474191008|FG001|Overall Study|Death|35|||
131701837|NCT01461044|474191007|FG000|Overall Study|Lost to Follow-up|12|||
131701838|NCT01461044|474191008|FG001|Overall Study|Lost to Follow-up|5|||
131701839|NCT00716976|474191009|FG000|Overall Study|Adverse Event|2|||
131701840|NCT00716976|474191010|FG001|Overall Study|Adverse Event|0|||
131701841|NCT00716976|474191009|FG000|Overall Study|Death|1|||
131701842|NCT00716976|474191010|FG001|Overall Study|Death|0|||
131701843|NCT00716976|474191009|FG000|Overall Study|Physician Decision|2|||
131701844|NCT00716976|474191010|FG001|Overall Study|Physician Decision|2|||
131701845|NCT00716976|474191009|FG000|Overall Study|Withdrawal by Subject|5|||
131701846|NCT00716976|474191010|FG001|Overall Study|Withdrawal by Subject|1|||
131701847|NCT00716976|474191009|FG000|Overall Study|Premature discontinuation cisplatin|5|||
131701848|NCT00716976|474191010|FG001|Overall Study|Premature discontinuation cisplatin|4|||
131701849|NCT00716976|474191009|FG000|Overall Study|Radiation during protocol|1|||
131701850|NCT00716976|474191010|FG001|Overall Study|Radiation during protocol|0|||
131701851|NCT00716976|474191009|FG000|Overall Study|Ineligibles|4|||
131701852|NCT00716976|474191010|FG001|Overall Study|Ineligibles|2|||
131701853|NCT00975156|474191016|FG000|Overall Study|Protocol Violation|0|||
131701854|NCT00975156|474191017|FG001|Overall Study|Protocol Violation|1|||
131787405|NCT04380701|474504485|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
131787406|NCT04380701|474504486|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
131438294|NCT00768989|473231186|FG001|Prior to Week 24|Withdrawal by Subject|0|||
131579828|NCT03622580|473750234|FG002|Overall Study|Death|13|||
131579829|NCT03622580|473750232|FG000|Overall Study|Adverse Event|6|||
131579830|NCT03622580|473750233|FG001|Overall Study|Adverse Event|6|||
131701855|NCT03472560|474191022|FG000|Overall Study|Subject transfer to continuation protocol|0|||
131701856|NCT03472560|474191023|FG001|Overall Study|Subject transfer to continuation protocol|1|||
131701857|NCT03472560|474191022|FG000|Overall Study|Withdrawal by Subject|4|||
131701858|NCT03472560|474191023|FG001|Overall Study|Withdrawal by Subject|0|||
131701859|NCT03472560|474191022|FG000|Overall Study|Progressive disease|24|||
131701860|NCT03472560|474191023|FG001|Overall Study|Progressive disease|8|||
131701861|NCT03472560|474191022|FG000|Overall Study|Physician Decision|1|||
131701862|NCT03472560|474191023|FG001|Overall Study|Physician Decision|0|||
131701863|NCT03472560|474191022|FG000|Overall Study|Death|7|||
131701864|NCT03472560|474191023|FG001|Overall Study|Death|4|||
131579831|NCT03622580|473750234|FG002|Overall Study|Adverse Event|5|||
131579832|NCT03622580|473750232|FG000|Overall Study|Withdrawal by Subject|12|||
131701865|NCT03472560|474191022|FG000|Overall Study|Adverse Event|5|||
131701866|NCT03472560|474191023|FG001|Overall Study|Adverse Event|3|||
131701867|NCT03472560|474191022|FG000|Overall Study|Global deterioration of health status|0|||
131701868|NCT03472560|474191023|FG001|Overall Study|Global deterioration of health status|4|||
131701869|NCT01505894|474191024|FG000|Overall Study|Adverse Event|1|||
131701870|NCT01505894|474191025|FG001|Overall Study|Adverse Event|0|||
131787407|NCT04380701|474504487|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
131787408|NCT04380701|474504488|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
131787409|NCT04380701|474504489|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
131787410|NCT04380701|474504490|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
131787411|NCT04380701|474504491|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
131787412|NCT04380701|474504492|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
131787413|NCT04380701|474504493|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
131787414|NCT04380701|474504494|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
131787415|NCT04380701|474504495|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
131787416|NCT04380701|474504496|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
131787417|NCT04380701|474504497|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
131787418|NCT04380701|474504498|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
131787419|NCT04380701|474504499|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
131787420|NCT04380701|474504500|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
131787421|NCT04380701|474504501|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
131787422|NCT04380701|474504502|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
131787423|NCT04380701|474504503|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
131787424|NCT04380701|474504504|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
131787425|NCT04380701|474504505|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
131787426|NCT04380701|474504506|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
131787427|NCT04380701|474504507|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
131787428|NCT04380701|474504508|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
131787429|NCT04380701|474504509|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
131787430|NCT04380701|474504510|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
131579833|NCT03622580|473750233|FG001|Overall Study|Withdrawal by Subject|7|||
131579834|NCT03622580|473750234|FG002|Overall Study|Withdrawal by Subject|19|||
131579835|NCT03622580|473750232|FG000|Overall Study|Lost to Follow-up|12|||
131579836|NCT03622580|473750233|FG001|Overall Study|Lost to Follow-up|9|||
131579837|NCT03622580|473750234|FG002|Overall Study|Lost to Follow-up|9|||
131579838|NCT03622580|473750232|FG000|Overall Study|Protocol Violation|1|||
131579839|NCT03622580|473750233|FG001|Overall Study|Protocol Violation|0|||
131579840|NCT03622580|473750234|FG002|Overall Study|Protocol Violation|1|||
131579841|NCT03622580|473750232|FG000|Overall Study|Physician Decision|3|||
131579842|NCT03622580|473750233|FG001|Overall Study|Physician Decision|0|||
131579843|NCT03622580|473750234|FG002|Overall Study|Physician Decision|1|||
131579844|NCT03622580|473750232|FG000|Overall Study|Pregnancy|0|||
131579845|NCT03622580|473750233|FG001|Overall Study|Pregnancy|1|||
131579846|NCT03622580|473750234|FG002|Overall Study|Pregnancy|0|||
131579847|NCT03622580|473750232|FG000|Overall Study|Lack of Efficacy|0|||
131579848|NCT03622580|473750233|FG001|Overall Study|Lack of Efficacy|0|||
131579849|NCT03622580|473750234|FG002|Overall Study|Lack of Efficacy|1|||
131579850|NCT03622580|473750232|FG000|Overall Study|Other|2|||
131579851|NCT03622580|473750233|FG001|Overall Study|Other|0|||
131579852|NCT03622580|473750234|FG002|Overall Study|Other|3|||
131579853|NCT02613871|473750237|FG000|Overall Study|Death|2|||
131579854|NCT02613871|473750237|FG000|Overall Study|Withdrew Consent|1|||
131579855|NCT00507689|473750238|FG000|Pre-Randomization Period|Adverse Event|1|||
131579856|NCT00507689|473750239|FG001|Pre-Randomization Period|Adverse Event|0|||
131579857|NCT00507689|473750238|FG000|Pre-Randomization Period|Physician Decision|1|||
131579858|NCT00507689|473750239|FG001|Pre-Randomization Period|Physician Decision|0|||
131579859|NCT00507689|473750238|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
131579860|NCT00507689|473750239|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
131579861|NCT00507689|473750238|FG000|Randomized Period|Adverse Event|1|||
131579862|NCT00507689|473750239|FG001|Randomized Period|Adverse Event|1|||
131579863|NCT00507689|473750238|FG000|Randomized Period|Withdrawal by Subject|0|||
131579864|NCT00507689|473750239|FG001|Randomized Period|Withdrawal by Subject|1|||
131579865|NCT00494442|473750240|FG000|Overall Study|Death|1|||
131579866|NCT00494442|473750241|FG001|Overall Study|Death|1|||
131579867|NCT00494442|473750240|FG000|Overall Study|Lack of Efficacy|16|||
131579868|NCT00494442|473750241|FG001|Overall Study|Lack of Efficacy|10|||
131579869|NCT00494442|473750240|FG000|Overall Study|Adverse Event|0|||
131579870|NCT00494442|473750241|FG001|Overall Study|Adverse Event|2|||
131579871|NCT00494442|473750240|FG000|Overall Study|Physician Decision|0|||
131787431|NCT04380701|474504511|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
131787432|NCT04380701|474504512|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
131787433|NCT04380701|474504513|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
131787434|NCT04380701|474504514|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
131787435|NCT04380701|474504515|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
131787436|NCT04380701|474504516|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
131787437|NCT04380701|474504517|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
131898729|NCT04131712|474915342|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
131898730|NCT04131712|474915343|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
131898731|NCT00873730|474915344|FG000|Overall Study|Protocol Deviation|5|||
131898732|NCT00873730|474915345|FG001|Overall Study|Protocol Deviation|2|||
131898733|NCT00873730|474915344|FG000|Overall Study|Adverse Event|0|||
131898734|NCT00873730|474915345|FG001|Overall Study|Adverse Event|2|||
131898735|NCT00873730|474915344|FG000|Overall Study|Withdrawal by Subject|0|||
131898736|NCT00873730|474915345|FG001|Overall Study|Withdrawal by Subject|1|||
131898737|NCT00873730|474915344|FG000|Overall Study|Sponsor decision|1|||
131898738|NCT00873730|474915345|FG001|Overall Study|Sponsor decision|0|||
131787438|NCT04380701|474504484|FG000|Overall Study|Physician Decision|0|||
131787439|NCT04380701|474504485|FG001|Overall Study|Physician Decision|0|||
131579872|NCT00494442|473750241|FG001|Overall Study|Physician Decision|1|||
131579873|NCT00494442|473750240|FG000|Overall Study|Non-compliance|0|||
131579874|NCT00494442|473750241|FG001|Overall Study|Non-compliance|1|||
131787440|NCT04380701|474504486|FG002|Overall Study|Physician Decision|0|||
131787441|NCT04380701|474504487|FG003|Overall Study|Physician Decision|0|||
131787442|NCT04380701|474504488|FG004|Overall Study|Physician Decision|0|||
131787443|NCT04380701|474504489|FG005|Overall Study|Physician Decision|0|||
131787444|NCT04380701|474504490|FG006|Overall Study|Physician Decision|0|||
131579875|NCT00494442|473750240|FG000|Overall Study|Intercurrent illness|0|||
131579876|NCT00494442|473750241|FG001|Overall Study|Intercurrent illness|1|||
131579877|NCT00831415|473750242|FG000|Overall Study|Adverse Event|14|||
131579878|NCT00831415|473750242|FG000|Overall Study|Failed to return|3|||
131579879|NCT00831415|473750242|FG000|Overall Study|Physician Decision|6|||
131579880|NCT00831415|473750242|FG000|Overall Study|Lost to Follow-up|9|||
131579881|NCT00831415|473750242|FG000|Overall Study|Protocol Violation|3|||
131579882|NCT00831415|473750242|FG000|Overall Study|Withdrawal by Subject|35|||
131579883|NCT00831415|473750242|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
131579884|NCT00831415|473750242|FG000|Overall Study|Death|1|||
131579885|NCT01290224|473750243|FG000|Overall Study|Adverse Event|1|||
131579886|NCT01290224|473750243|FG000|Overall Study|Refused Further Treatment|4|||
131579887|NCT01241292|473750244|FG000|Overall Study|Administrative Reason by Sponsor|1|||
131579888|NCT01241292|473750245|FG001|Overall Study|Administrative Reason by Sponsor|0|||
131579889|NCT01241292|473750244|FG000|Overall Study|Disease Progression|2|||
131579890|NCT01241292|473750245|FG001|Overall Study|Disease Progression|0|||
131579891|NCT01241292|473750244|FG000|Overall Study|Study Drug Toxicity|0|||
131579892|NCT01241292|473750245|FG001|Overall Study|Study Drug Toxicity|1|||
131579893|NCT01241292|473750244|FG000|Overall Study|Participant Discontinued Treatment|0|||
131579894|NCT01241292|473750245|FG001|Overall Study|Participant Discontinued Treatment|2|||
131579895|NCT03034915|473750246|FG000|Overall Study|Adverse Event|29|||
131579896|NCT03034915|473750247|FG001|Overall Study|Adverse Event|32|||
131579897|NCT03034915|473750248|FG002|Overall Study|Adverse Event|22|||
131579898|NCT03034915|473750246|FG000|Overall Study|Lost to Follow-up|5|||
131579899|NCT03034915|473750247|FG001|Overall Study|Lost to Follow-up|13|||
131579900|NCT03034915|473750248|FG002|Overall Study|Lost to Follow-up|3|||
131579901|NCT03034915|473750246|FG000|Overall Study|Withdrawal by Subject|29|||
131579902|NCT03034915|473750247|FG001|Overall Study|Withdrawal by Subject|46|||
131579903|NCT03034915|473750248|FG002|Overall Study|Withdrawal by Subject|41|||
131579904|NCT03034915|473750246|FG000|Overall Study|Protocol Deviation|2|||
131579905|NCT03034915|473750247|FG001|Overall Study|Protocol Deviation|14|||
131579906|NCT03034915|473750248|FG002|Overall Study|Protocol Deviation|7|||
131579907|NCT03034915|473750246|FG000|Overall Study|Lack of Efficacy|8|||
131579908|NCT03034915|473750247|FG001|Overall Study|Lack of Efficacy|16|||
131579909|NCT03034915|473750248|FG002|Overall Study|Lack of Efficacy|18|||
131787445|NCT04380701|474504491|FG007|Overall Study|Physician Decision|0|||
131787446|NCT04380701|474504492|FG008|Overall Study|Physician Decision|0|||
131787447|NCT04380701|474504493|FG009|Overall Study|Physician Decision|0|||
131787448|NCT04380701|474504494|FG010|Overall Study|Physician Decision|0|||
131787449|NCT04380701|474504495|FG011|Overall Study|Physician Decision|0|||
131787450|NCT04380701|474504496|FG012|Overall Study|Physician Decision|0|||
131787451|NCT04380701|474504497|FG013|Overall Study|Physician Decision|0|||
131787452|NCT04380701|474504498|FG014|Overall Study|Physician Decision|0|||
131787453|NCT04380701|474504499|FG015|Overall Study|Physician Decision|0|||
131787454|NCT04380701|474504500|FG016|Overall Study|Physician Decision|0|||
131787455|NCT04380701|474504501|FG017|Overall Study|Physician Decision|0|||
131787456|NCT04380701|474504502|FG018|Overall Study|Physician Decision|0|||
131787457|NCT04380701|474504503|FG019|Overall Study|Physician Decision|0|||
131787458|NCT04380701|474504504|FG020|Overall Study|Physician Decision|0|||
131787459|NCT04380701|474504505|FG021|Overall Study|Physician Decision|0|||
131787460|NCT04380701|474504506|FG022|Overall Study|Physician Decision|0|||
131787461|NCT04380701|474504507|FG023|Overall Study|Physician Decision|0|||
131787462|NCT04380701|474504508|FG024|Overall Study|Physician Decision|2|||
131787463|NCT04380701|474504509|FG025|Overall Study|Physician Decision|0|||
131787464|NCT04380701|474504510|FG026|Overall Study|Physician Decision|0|||
131579910|NCT03034915|473750246|FG000|Overall Study|Site closed|2|||
131787465|NCT04380701|474504511|FG027|Overall Study|Physician Decision|0|||
131787466|NCT04380701|474504512|FG028|Overall Study|Physician Decision|0|||
131787467|NCT04380701|474504513|FG029|Overall Study|Physician Decision|0|||
131787468|NCT04380701|474504514|FG030|Overall Study|Physician Decision|0|||
131787469|NCT04380701|474504515|FG031|Overall Study|Physician Decision|0|||
131787470|NCT04380701|474504516|FG032|Overall Study|Physician Decision|0|||
131787471|NCT04380701|474504517|FG033|Overall Study|Physician Decision|0|||
131787472|NCT04380701|474504484|FG000|Overall Study|Death|0|||
131787473|NCT04380701|474504485|FG001|Overall Study|Death|0|||
131787474|NCT04380701|474504486|FG002|Overall Study|Death|0|||
131787475|NCT04380701|474504487|FG003|Overall Study|Death|0|||
131787476|NCT04380701|474504488|FG004|Overall Study|Death|0|||
131787477|NCT04380701|474504489|FG005|Overall Study|Death|0|||
131787478|NCT04380701|474504490|FG006|Overall Study|Death|0|||
131787479|NCT04380701|474504491|FG007|Overall Study|Death|0|||
131787480|NCT04380701|474504492|FG008|Overall Study|Death|0|||
131579911|NCT03034915|473750247|FG001|Overall Study|Site closed|2|||
131579912|NCT03034915|473750248|FG002|Overall Study|Site closed|4|||
131787481|NCT04380701|474504493|FG009|Overall Study|Death|0|||
131579913|NCT03034915|473750246|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
131579914|NCT03034915|473750247|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
131787482|NCT04380701|474504494|FG010|Overall Study|Death|0|||
131787483|NCT04380701|474504495|FG011|Overall Study|Death|0|||
131579915|NCT03034915|473750248|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
131579916|NCT03034915|473750246|FG000|Overall Study|Physician Decision|1|||
131787484|NCT04380701|474504496|FG012|Overall Study|Death|0|||
131787485|NCT04380701|474504497|FG013|Overall Study|Death|0|||
131787486|NCT04380701|474504498|FG014|Overall Study|Death|0|||
131787487|NCT04380701|474504499|FG015|Overall Study|Death|0|||
131898739|NCT00766597|474915346|FG000|Overall Study|Unexpected closure of study|4|||
131579917|NCT03034915|473750247|FG001|Overall Study|Physician Decision|5|||
131579918|NCT03034915|473750248|FG002|Overall Study|Physician Decision|2|||
131787488|NCT04380701|474504500|FG016|Overall Study|Death|0|||
131787489|NCT04380701|474504501|FG017|Overall Study|Death|0|||
131787490|NCT04380701|474504502|FG018|Overall Study|Death|0|||
131579919|NCT03861767|473750249|FG000|Overall Study|Withdrawal by Subject|2|||
131579920|NCT03861767|473750250|FG001|Overall Study|Withdrawal by Subject|1|||
131787491|NCT04380701|474504503|FG019|Overall Study|Death|0|||
131787492|NCT04380701|474504504|FG020|Overall Study|Death|0|||
131787493|NCT04380701|474504505|FG021|Overall Study|Death|0|||
131787494|NCT04380701|474504506|FG022|Overall Study|Death|0|||
131787495|NCT04380701|474504507|FG023|Overall Study|Death|0|||
131787496|NCT04380701|474504508|FG024|Overall Study|Death|1|||
131787497|NCT04380701|474504509|FG025|Overall Study|Death|0|||
131787498|NCT04380701|474504510|FG026|Overall Study|Death|0|||
131787499|NCT04380701|474504511|FG027|Overall Study|Death|0|||
131787500|NCT04380701|474504512|FG028|Overall Study|Death|0|||
131787501|NCT04380701|474504513|FG029|Overall Study|Death|0|||
131787502|NCT04380701|474504514|FG030|Overall Study|Death|0|||
131787503|NCT04380701|474504515|FG031|Overall Study|Death|0|||
131787504|NCT04380701|474504516|FG032|Overall Study|Death|0|||
131787505|NCT04380701|474504517|FG033|Overall Study|Death|0|||
131787506|NCT04380701|474504484|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787507|NCT04380701|474504485|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787508|NCT04380701|474504486|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787509|NCT04380701|474504487|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787510|NCT04380701|474504488|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787511|NCT04380701|474504489|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787512|NCT04380701|474504490|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787513|NCT04380701|474504491|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131579921|NCT03861767|473750251|FG002|Overall Study|Withdrawal by Subject|0|||
131579922|NCT03861767|473750252|FG003|Overall Study|Withdrawal by Subject|5|||
131787514|NCT04380701|474504492|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787515|NCT04380701|474504493|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787516|NCT04380701|474504494|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787517|NCT04380701|474504495|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787518|NCT04380701|474504496|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787519|NCT04380701|474504497|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787520|NCT04380701|474504498|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787521|NCT04380701|474504499|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787522|NCT04380701|474504500|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787523|NCT04380701|474504501|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787524|NCT04380701|474504502|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787525|NCT04380701|474504503|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787526|NCT04380701|474504504|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787527|NCT04380701|474504505|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
131787528|NCT04380701|474504506|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
131787529|NCT04380701|474504507|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
131787530|NCT04380701|474504508|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
131787531|NCT04380701|474504509|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787532|NCT04380701|474504510|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787533|NCT04380701|474504511|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787534|NCT04380701|474504512|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787535|NCT04380701|474504513|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787536|NCT04380701|474504514|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787537|NCT04380701|474504515|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787538|NCT04380701|474504516|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787539|NCT04380701|474504517|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131787540|NCT03707522|474504518|FG000|Overall Study|Lost to Follow-up|24|||
131787541|NCT03707522|474504519|FG001|Overall Study|Lost to Follow-up|27|||
131787542|NCT03707522|474504520|FG002|Overall Study|Lost to Follow-up|41|||
131787543|NCT03707522|474504521|FG003|Overall Study|Lost to Follow-up|36|||
131787544|NCT04363736|474504522|FG000|Overall Study|Withdrawal by Subject|1|||
131787545|NCT04363736|474504523|FG001|Overall Study|Withdrawal by Subject|0|||
131787546|NCT04363736|474504522|FG000|Overall Study|Lost to Follow-up|10|||
131787547|NCT04363736|474504523|FG001|Overall Study|Lost to Follow-up|7|||
131787548|NCT04363736|474504522|FG000|Overall Study|Death|8|||
131787549|NCT04363736|474504523|FG001|Overall Study|Death|6|||
131787550|NCT00383019|474504524|FG000|Overall Study|Adverse Event|5|||
131787551|NCT00383019|474504525|FG001|Overall Study|Adverse Event|1|||
131787552|NCT00383019|474504524|FG000|Overall Study|Withdrawal by Subject|0|||
131787553|NCT00383019|474504525|FG001|Overall Study|Withdrawal by Subject|1|||
131787554|NCT01374906|474504530|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131787555|NCT01374906|474504531|FG001|Overall Study|Abnormal laboratory value(s)|3|||
131787556|NCT01374906|474504530|FG000|Overall Study|Administrative problems|2|||
131787557|NCT01374906|474504531|FG001|Overall Study|Administrative problems|2|||
131579923|NCT03861767|473750253|FG004|Overall Study|Withdrawal by Subject|2|||
131579924|NCT03861767|473750254|FG005|Overall Study|Withdrawal by Subject|1|||
131579925|NCT03861767|473750255|FG006|Overall Study|Withdrawal by Subject|3|||
131579926|NCT03861767|473750256|FG007|Overall Study|Withdrawal by Subject|1|||
131579927|NCT03861767|473750257|FG008|Overall Study|Withdrawal by Subject|0|||
131579928|NCT03861767|473750258|FG009|Overall Study|Withdrawal by Subject|5|||
131579929|NCT01087762|473750259|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
131579930|NCT01087762|473750260|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
131579931|NCT01087762|473750261|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
131579932|NCT01087762|473750262|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
131579933|NCT01087762|473750263|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
131579934|NCT01087762|473750259|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
131579935|NCT01087762|473750260|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
131579936|NCT01087762|473750261|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
131579937|NCT01087762|473750262|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
131579938|NCT01087762|473750263|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
131579939|NCT01087762|473750259|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
131579940|NCT01087762|473750260|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
131579941|NCT01087762|473750261|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
131579942|NCT01087762|473750262|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
131579943|NCT01087762|473750263|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
131579944|NCT01087762|473750259|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
131579945|NCT01087762|473750260|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
131579946|NCT01087762|473750261|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
131579947|NCT01087762|473750262|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
131579948|NCT01087762|473750263|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
131579949|NCT01087762|473750259|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
131579950|NCT01087762|473750260|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
131579951|NCT01087762|473750261|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
131579952|NCT01087762|473750262|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
131579953|NCT01087762|473750263|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
131579954|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
131579955|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
131579956|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
131579957|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
131579958|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
131579959|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
131579960|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
131701871|NCT01505894|474191026|FG002|Overall Study|Adverse Event|0|||
131701872|NCT01505894|474191027|FG003|Overall Study|Adverse Event|0|||
131701873|NCT01505894|474191028|FG004|Overall Study|Adverse Event|0|||
131701874|NCT01505894|474191029|FG005|Overall Study|Adverse Event|0|||
131701875|NCT01505894|474191030|FG006|Overall Study|Adverse Event|0|||
131701876|NCT01505894|474191031|FG007|Overall Study|Adverse Event|0|||
131701877|NCT01505894|474191032|FG008|Overall Study|Adverse Event|0|||
131701878|NCT01505894|474191024|FG000|Overall Study|Other than specified|0|||
131701879|NCT01505894|474191025|FG001|Overall Study|Other than specified|0|||
131701880|NCT01505894|474191026|FG002|Overall Study|Other than specified|0|||
131701881|NCT01505894|474191027|FG003|Overall Study|Other than specified|0|||
131701882|NCT01505894|474191028|FG004|Overall Study|Other than specified|1|||
131701883|NCT01505894|474191029|FG005|Overall Study|Other than specified|0|||
131701884|NCT01505894|474191030|FG006|Overall Study|Other than specified|0|||
131701885|NCT01505894|474191031|FG007|Overall Study|Other than specified|0|||
131701886|NCT01505894|474191032|FG008|Overall Study|Other than specified|0|||
131701887|NCT01001702|474191033|FG000|Overall Study|Lost to Follow-up|7|||
131701888|NCT01001702|474191033|FG000|Overall Study|Adverse Event|7|||
131701889|NCT01001702|474191033|FG000|Overall Study|Sponsor Discontinued Study|4|||
131701890|NCT01001702|474191033|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
131701891|NCT01001702|474191033|FG000|Overall Study|Investigator withdrew Subject|10|||
131701892|NCT01001702|474191033|FG000|Overall Study|Withdrawal by Subject|19|||
131787558|NCT01374906|474504530|FG000|Overall Study|Adverse Event|10|||
131787559|NCT01374906|474504531|FG001|Overall Study|Adverse Event|11|||
131579961|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
131579962|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
131701893|NCT01001702|474191033|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
131701894|NCT00094757|474191034|FG000|Overall Study|Adverse Event|11|||
131701895|NCT00094757|474191035|FG001|Overall Study|Adverse Event|9|||
131701896|NCT00094757|474191036|FG002|Overall Study|Adverse Event|6|||
131579963|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
131579964|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
131579965|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
131579966|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
131579967|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
131579968|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
131579969|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
131579970|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
131579971|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
131701897|NCT00094757|474191034|FG000|Overall Study|Lack of Efficacy|11|||
131701898|NCT00094757|474191035|FG001|Overall Study|Lack of Efficacy|15|||
131701899|NCT00094757|474191036|FG002|Overall Study|Lack of Efficacy|8|||
131701900|NCT00094757|474191034|FG000|Overall Study|Lost to Follow-up|3|||
131701901|NCT00094757|474191035|FG001|Overall Study|Lost to Follow-up|5|||
131701902|NCT00094757|474191036|FG002|Overall Study|Lost to Follow-up|6|||
131701903|NCT00094757|474191034|FG000|Overall Study|Patient Moved|2|||
131701904|NCT00094757|474191035|FG001|Overall Study|Patient Moved|1|||
131701905|NCT00094757|474191036|FG002|Overall Study|Patient Moved|1|||
131701906|NCT00094757|474191034|FG000|Overall Study|Protocol Violation|8|||
131701907|NCT00094757|474191035|FG001|Overall Study|Protocol Violation|5|||
131701908|NCT00094757|474191036|FG002|Overall Study|Protocol Violation|3|||
131701909|NCT00094757|474191034|FG000|Overall Study|Withdrawal by Subject|14|||
131701910|NCT00094757|474191035|FG001|Overall Study|Withdrawal by Subject|21|||
131701911|NCT00094757|474191036|FG002|Overall Study|Withdrawal by Subject|5|||
131701912|NCT00094757|474191034|FG000|Overall Study|Other|3|||
131701913|NCT00094757|474191035|FG001|Overall Study|Other|3|||
131701914|NCT00094757|474191036|FG002|Overall Study|Other|1|||
131701915|NCT00094757|474191034|FG000|Overall Study|Protocol specified discontinuation|1|||
131701916|NCT00094757|474191035|FG001|Overall Study|Protocol specified discontinuation|3|||
131701917|NCT00094757|474191036|FG002|Overall Study|Protocol specified discontinuation|0|||
131701918|NCT04317274|474191037|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
131701919|NCT04317274|474191038|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
131701920|NCT04317274|474191039|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
131701921|NCT04317274|474191040|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
131701922|NCT02568046|474191041|FG000|Overall Study|Adverse Event|0|||
131701923|NCT02568046|474191042|FG001|Overall Study|Adverse Event|1|||
131701924|NCT02568046|474191041|FG000|Overall Study|Death|2|||
131701925|NCT02568046|474191042|FG001|Overall Study|Death|0|||
131701926|NCT02568046|474191041|FG000|Overall Study|Progressive Disease|1|||
131701927|NCT02568046|474191042|FG001|Overall Study|Progressive Disease|0|||
131701928|NCT02568046|474191041|FG000|Overall Study|Withdrawal by Subject|2|||
131701929|NCT02568046|474191042|FG001|Overall Study|Withdrawal by Subject|1|||
131701930|NCT02568046|474191041|FG000|Overall Study|Other Events|0|||
131701931|NCT02568046|474191042|FG001|Overall Study|Other Events|1|||
131701932|NCT03403192|474191043|FG000|Overall Study|Lost to Follow-up|1|||
131701933|NCT03403192|474191044|FG001|Overall Study|Lost to Follow-up|2|||
131701934|NCT03403192|474191045|FG002|Overall Study|Lost to Follow-up|0|||
131701935|NCT03403192|474191046|FG003|Overall Study|Lost to Follow-up|0|||
131701936|NCT03403192|474191043|FG000|Overall Study|Unable to respond|0|||
131701937|NCT03403192|474191044|FG001|Overall Study|Unable to respond|1|||
131701938|NCT03403192|474191045|FG002|Overall Study|Unable to respond|0|||
131701939|NCT03403192|474191046|FG003|Overall Study|Unable to respond|0|||
131701940|NCT03403192|474191043|FG000|Overall Study|Incomplete|3|||
131701941|NCT03403192|474191044|FG001|Overall Study|Incomplete|1|||
131701942|NCT03403192|474191045|FG002|Overall Study|Incomplete|3|||
131701943|NCT03403192|474191046|FG003|Overall Study|Incomplete|6|||
131701944|NCT00379795|474191047|FG000|Overall Study|Death|31|||
131701945|NCT00379795|474191048|FG001|Overall Study|Death|8|||
131701946|NCT00379795|474191049|FG002|Overall Study|Death|6|||
131701947|NCT00379795|474191050|FG003|Overall Study|Death|4|||
131701948|NCT00379795|474191051|FG004|Overall Study|Death|7|||
131579972|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
131701949|NCT00379795|474191047|FG000|Overall Study|Adverse Event|17|||
131701950|NCT00379795|474191048|FG001|Overall Study|Adverse Event|3|||
131701951|NCT00379795|474191049|FG002|Overall Study|Adverse Event|3|||
131701952|NCT00379795|474191050|FG003|Overall Study|Adverse Event|1|||
131701953|NCT00379795|474191051|FG004|Overall Study|Adverse Event|4|||
131701954|NCT00379795|474191047|FG000|Overall Study|Lost to Follow-up|8|||
131701955|NCT00379795|474191048|FG001|Overall Study|Lost to Follow-up|1|||
131701956|NCT00379795|474191049|FG002|Overall Study|Lost to Follow-up|2|||
131701957|NCT00379795|474191050|FG003|Overall Study|Lost to Follow-up|1|||
131701958|NCT00379795|474191051|FG004|Overall Study|Lost to Follow-up|4|||
131701959|NCT00379795|474191047|FG000|Overall Study|Physician Decision|25|||
131701960|NCT00379795|474191048|FG001|Overall Study|Physician Decision|0|||
131701961|NCT00379795|474191049|FG002|Overall Study|Physician Decision|2|||
131701962|NCT00379795|474191050|FG003|Overall Study|Physician Decision|2|||
131579973|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
131579974|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
131579975|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
131579976|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
131579977|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
131579978|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
131579979|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
131579980|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
131579981|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
131579982|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
131579983|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
131579984|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
131579985|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
131579986|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
131579987|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
131579988|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
131579989|NCT01087762|473750259|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
131579990|NCT01087762|473750260|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
131579991|NCT01087762|473750261|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
131579992|NCT01087762|473750262|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
131579993|NCT01087762|473750263|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
131579994|NCT00813904|473750264|FG000|Overall Study|Death|1|||
131579995|NCT00346333|473750265|FG000|Overall Study|Death|1|||
131579996|NCT00346333|473750266|FG001|Overall Study|Death|0|||
131579997|NCT00346333|473750265|FG000|Overall Study|unwilling or unable to continue|4|||
131579998|NCT00346333|473750266|FG001|Overall Study|unwilling or unable to continue|8|||
131579999|NCT01405924|473750267|FG000|Overall Study|Protocol Violation|8|||
131580000|NCT01405924|473750267|FG000|Overall Study|Missing/Incomplete Data|2|||
131580001|NCT03184558|473750268|FG000|Overall Study|Withdrawal by Subject|2|||
131701963|NCT00379795|474191051|FG004|Overall Study|Physician Decision|2|||
131701964|NCT00379795|474191047|FG000|Overall Study|Withdrawal by Subject|94|||
131701965|NCT00379795|474191048|FG001|Overall Study|Withdrawal by Subject|11|||
131701966|NCT00379795|474191049|FG002|Overall Study|Withdrawal by Subject|19|||
131701967|NCT00379795|474191050|FG003|Overall Study|Withdrawal by Subject|7|||
131701968|NCT00379795|474191051|FG004|Overall Study|Withdrawal by Subject|14|||
131701969|NCT00379795|474191047|FG000|Overall Study|Subject non-compliance|7|||
131701970|NCT00379795|474191048|FG001|Overall Study|Subject non-compliance|2|||
131701971|NCT00379795|474191049|FG002|Overall Study|Subject non-compliance|0|||
131701972|NCT00379795|474191050|FG003|Overall Study|Subject non-compliance|0|||
131701973|NCT00379795|474191051|FG004|Overall Study|Subject non-compliance|1|||
131701974|NCT00379795|474191047|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
131701975|NCT00379795|474191048|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
131701976|NCT00379795|474191049|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
131701977|NCT00379795|474191050|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
131701978|NCT00379795|474191051|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
131701979|NCT00379795|474191047|FG000|Overall Study|Subjects condition mandated intervention|34|||
131701980|NCT00379795|474191048|FG001|Overall Study|Subjects condition mandated intervention|9|||
131701981|NCT00379795|474191049|FG002|Overall Study|Subjects condition mandated intervention|7|||
131701982|NCT00379795|474191050|FG003|Overall Study|Subjects condition mandated intervention|5|||
131701983|NCT00379795|474191051|FG004|Overall Study|Subjects condition mandated intervention|7|||
131701984|NCT00379795|474191047|FG000|Overall Study|Sponsor's decision|257|||
131701985|NCT00379795|474191048|FG001|Overall Study|Sponsor's decision|17|||
131701986|NCT00379795|474191049|FG002|Overall Study|Sponsor's decision|54|||
131701987|NCT00379795|474191050|FG003|Overall Study|Sponsor's decision|47|||
131701988|NCT00379795|474191051|FG004|Overall Study|Sponsor's decision|10|||
131701989|NCT02551159|474191052|FG000|Overall Study|Death|352|||
131701990|NCT02551159|474191053|FG001|Overall Study|Death|174|||
131701991|NCT02551159|474191054|FG002|Overall Study|Death|161|||
131701992|NCT02551159|474191052|FG000|Overall Study|Withdrawal by Subject|8|||
131701993|NCT02551159|474191053|FG001|Overall Study|Withdrawal by Subject|5|||
131701994|NCT02551159|474191054|FG002|Overall Study|Withdrawal by Subject|16|||
131701995|NCT02551159|474191052|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
131580002|NCT03184558|473750268|FG000|Overall Study|Death|16|||
131701996|NCT02551159|474191053|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
131701997|NCT02551159|474191054|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
131701998|NCT00268242|474191055|FG000|Overall Study|Death|1|||
131701999|NCT00993928|474191056|FG000|Overall Study|Withdrawal by Subject|4|||
131702000|NCT00993928|474191057|FG001|Overall Study|Withdrawal by Subject|7|||
131702001|NCT00993928|474191056|FG000|Overall Study|ineligible|1|||
131702002|NCT00993928|474191057|FG001|Overall Study|ineligible|0|||
131580003|NCT03184558|473750268|FG000|Overall Study|Lost to Follow-up|2|||
131580004|NCT03184558|473750268|FG000|Overall Study|Other|9|||
131580005|NCT00723450|473750276|FG000|Open-Label Phase|Adverse Event|26|||
131580006|NCT00723450|473750277|FG001|Open-Label Phase|Adverse Event|0|||
131580007|NCT00723450|473750278|FG002|Open-Label Phase|Adverse Event|0|||
131580008|NCT00723450|473750276|FG000|Open-Label Phase|Lack of Efficacy|18|||
131580009|NCT00723450|473750277|FG001|Open-Label Phase|Lack of Efficacy|0|||
131580010|NCT00723450|473750278|FG002|Open-Label Phase|Lack of Efficacy|0|||
131580011|NCT00723450|473750276|FG000|Open-Label Phase|Protocol Violation|35|||
131580012|NCT00723450|473750277|FG001|Open-Label Phase|Protocol Violation|0|||
131580013|NCT00723450|473750278|FG002|Open-Label Phase|Protocol Violation|0|||
131580014|NCT00723450|473750276|FG000|Open-Label Phase|Lost to Follow-up|7|||
131580015|NCT00723450|473750277|FG001|Open-Label Phase|Lost to Follow-up|0|||
131580016|NCT00723450|473750278|FG002|Open-Label Phase|Lost to Follow-up|0|||
131580017|NCT00723450|473750276|FG000|Open-Label Phase|Physician Decision|2|||
131580018|NCT00723450|473750277|FG001|Open-Label Phase|Physician Decision|0|||
131580019|NCT00723450|473750278|FG002|Open-Label Phase|Physician Decision|0|||
131580020|NCT00723450|473750276|FG000|Open-Label Phase|Withdrawal by Subject|37|||
131580021|NCT00723450|473750277|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131580022|NCT00723450|473750278|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131580023|NCT00723450|473750276|FG000|Randomized Phase|Adverse Event|0|||
131580024|NCT00723450|473750277|FG001|Randomized Phase|Adverse Event|26|||
131580025|NCT00723450|473750278|FG002|Randomized Phase|Adverse Event|17|||
131580026|NCT00723450|473750276|FG000|Randomized Phase|Lack of Efficacy|0|||
131580027|NCT00723450|473750277|FG001|Randomized Phase|Lack of Efficacy|11|||
131580028|NCT00723450|473750278|FG002|Randomized Phase|Lack of Efficacy|11|||
131580029|NCT00723450|473750276|FG000|Randomized Phase|Protocol Violation|0|||
131580030|NCT00723450|473750277|FG001|Randomized Phase|Protocol Violation|9|||
131580031|NCT00723450|473750278|FG002|Randomized Phase|Protocol Violation|13|||
131580032|NCT00723450|473750276|FG000|Randomized Phase|Lost to Follow-up|0|||
131580033|NCT00723450|473750277|FG001|Randomized Phase|Lost to Follow-up|2|||
131580034|NCT00723450|473750278|FG002|Randomized Phase|Lost to Follow-up|3|||
131580035|NCT00723450|473750276|FG000|Randomized Phase|Physician Decision|0|||
131580036|NCT00723450|473750277|FG001|Randomized Phase|Physician Decision|3|||
131580037|NCT00723450|473750278|FG002|Randomized Phase|Physician Decision|1|||
131580038|NCT00723450|473750276|FG000|Randomized Phase|Withdrawal by Subject|0|||
131580039|NCT00723450|473750277|FG001|Randomized Phase|Withdrawal by Subject|14|||
131580040|NCT00723450|473750278|FG002|Randomized Phase|Withdrawal by Subject|22|||
131580041|NCT00770965|473750279|FG000|Safety Set|Withdrawal by Subject|0|||
131580042|NCT00770965|473750280|FG001|Safety Set|Withdrawal by Subject|0|||
131580043|NCT00770965|473750281|FG002|Safety Set|Withdrawal by Subject|0|||
131580044|NCT00770965|473750282|FG003|Safety Set|Withdrawal by Subject|1|||
131580045|NCT00770965|473750279|FG000|Safety Set|Protocol deviation|0|||
131580046|NCT00770965|473750280|FG001|Safety Set|Protocol deviation|0|||
131580047|NCT00770965|473750281|FG002|Safety Set|Protocol deviation|1|||
131580048|NCT00770965|473750282|FG003|Safety Set|Protocol deviation|0|||
131580049|NCT00770965|473750279|FG000|Excluded Set|Administrative problems|14|||
131580050|NCT00770965|473750280|FG001|Excluded Set|Administrative problems|12|||
131580051|NCT00770965|473750281|FG002|Excluded Set|Administrative problems|12|||
131702003|NCT03979274|474191058|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131702004|NCT03979274|474191059|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131702005|NCT01665144|474191060|FG000|Core Part|Withdrawal by Subject|96|||
131702006|NCT01665144|474191061|FG001|Core Part|Withdrawal by Subject|77|||
131702007|NCT01665144|474191062|FG002|Core Part|Withdrawal by Subject|0|||
131438295|NCT00768989|473231185|FG000|Prior to Week 24|Adverse Event|3|||
131438296|NCT00768989|473231186|FG001|Prior to Week 24|Adverse Event|0|||
131438297|NCT00768989|473231185|FG000|Prior to Week 24|Lost to Follow-up|0|||
131438298|NCT00768989|473231186|FG001|Prior to Week 24|Lost to Follow-up|1|||
131438299|NCT00768989|473231185|FG000|Prior to Week 24|Protocol Violation|0|||
131438300|NCT00768989|473231186|FG001|Prior to Week 24|Protocol Violation|2|||
131438301|NCT00768989|473231185|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
131580052|NCT00770965|473750282|FG003|Excluded Set|Administrative problems|10|||
131580053|NCT00770965|473750279|FG000|Excluded Set|Withdrawal by Subject|1|||
131580054|NCT00770965|473750280|FG001|Excluded Set|Withdrawal by Subject|1|||
131580055|NCT00770965|473750281|FG002|Excluded Set|Withdrawal by Subject|2|||
131580056|NCT00770965|473750282|FG003|Excluded Set|Withdrawal by Subject|3|||
131580057|NCT03192046|473750284|FG000|Overall Study|Withdrawal by Subject|1|||
131580058|NCT03192046|473750285|FG001|Overall Study|Withdrawal by Subject|1|||
131702008|NCT01665144|474191060|FG000|Core Part|Adverse Event|45|||
131438302|NCT00768989|473231186|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
131580059|NCT00762606|473750286|FG000|Overall Study|Lost to Follow-up|18|||
131580060|NCT00762606|473750287|FG001|Overall Study|Lost to Follow-up|13|||
131580061|NCT01505881|473750288|FG000|Overall Study|Adverse Event|0|||
131580062|NCT01505881|473750289|FG001|Overall Study|Adverse Event|1|||
131580063|NCT01505881|473750288|FG000|Overall Study|Lost to Follow-up|2|||
131580064|NCT01505881|473750289|FG001|Overall Study|Lost to Follow-up|0|||
131580065|NCT01505881|473750288|FG000|Overall Study|Withdrawal by Subject|2|||
131702009|NCT01665144|474191061|FG001|Core Part|Adverse Event|18|||
131787560|NCT01374906|474504530|FG000|Overall Study|Death|0|||
131787561|NCT01374906|474504531|FG001|Overall Study|Death|2|||
131787562|NCT01374906|474504530|FG000|Overall Study|Protocol Violation|2|||
131787563|NCT01374906|474504531|FG001|Overall Study|Protocol Violation|2|||
131787564|NCT01374906|474504530|FG000|Overall Study|Withdrawal by Subject|15|||
131787565|NCT01374906|474504531|FG001|Overall Study|Withdrawal by Subject|9|||
131787566|NCT01374906|474504530|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
131787567|NCT01374906|474504531|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
131787568|NCT05788237|474504532|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
131787569|NCT05788237|474504533|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
131787570|NCT05788237|474504534|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
131787571|NCT05788237|474504535|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
131787572|NCT05788237|474504532|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
131787573|NCT05788237|474504533|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
131787574|NCT05788237|474504534|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
131787575|NCT05788237|474504535|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
131787576|NCT05788237|474504532|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
131787577|NCT05788237|474504533|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
131787578|NCT05788237|474504534|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
131787579|NCT05788237|474504535|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
131787580|NCT05788237|474504532|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
131787581|NCT05788237|474504533|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
131787582|NCT05788237|474504534|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
131787583|NCT05788237|474504535|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
131787584|NCT05788237|474504532|FG000|SSA (Approximately 2 Months)|Death|0|||
131787585|NCT05788237|474504533|FG001|SSA (Approximately 2 Months)|Death|1|||
131787586|NCT05788237|474504534|FG002|SSA (Approximately 2 Months)|Death|0|||
131787587|NCT05788237|474504535|FG003|SSA (Approximately 2 Months)|Death|0|||
131787588|NCT05788237|474504532|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
131787589|NCT05788237|474504533|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
131787590|NCT05788237|474504534|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
131787591|NCT05788237|474504535|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
131787592|NCT05788237|474504532|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
131787593|NCT05788237|474504533|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
131787594|NCT05788237|474504534|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
131787595|NCT05788237|474504535|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
131787596|NCT05788237|474504532|FG000|SSB (Approximately 1 Month)|Other|0|||
131787597|NCT05788237|474504533|FG001|SSB (Approximately 1 Month)|Other|0|||
131787598|NCT05788237|474504534|FG002|SSB (Approximately 1 Month)|Other|0|||
131787599|NCT05788237|474504535|FG003|SSB (Approximately 1 Month)|Other|1|||
131787600|NCT02842086|474504536|FG000|Overall Study|Randomized but Never Treated|6|||
131787601|NCT02842086|474504537|FG001|Overall Study|Randomized but Never Treated|6|||
131787602|NCT02842086|474504536|FG000|Overall Study|Still in Double-Blind Phase|7|||
131787603|NCT02842086|474504537|FG001|Overall Study|Still in Double-Blind Phase|3|||
131787604|NCT02842086|474504536|FG000|Overall Study|Adverse Event|18|||
131787605|NCT02842086|474504537|FG001|Overall Study|Adverse Event|20|||
131787606|NCT02842086|474504536|FG000|Overall Study|Death|3|||
131787607|NCT02842086|474504537|FG001|Overall Study|Death|3|||
131787608|NCT02842086|474504536|FG000|Overall Study|Investigator's Discretion|9|||
131787609|NCT02842086|474504537|FG001|Overall Study|Investigator's Discretion|13|||
131787610|NCT02842086|474504536|FG000|Overall Study|Non-Compliance with Study Drug|9|||
131787611|NCT02842086|474504537|FG001|Overall Study|Non-Compliance with Study Drug|8|||
131787612|NCT02842086|474504536|FG000|Overall Study|Protocol Violation|8|||
131787613|NCT02842086|474504537|FG001|Overall Study|Protocol Violation|4|||
131580066|NCT01505881|473750289|FG001|Overall Study|Withdrawal by Subject|0|||
131787614|NCT02842086|474504536|FG000|Overall Study|Withdrew Consent|205|||
131787615|NCT02842086|474504537|FG001|Overall Study|Withdrew Consent|194|||
131787616|NCT02842086|474504536|FG000|Overall Study|Lost to Follow-up|274|||
131787617|NCT02842086|474504537|FG001|Overall Study|Lost to Follow-up|236|||
131787618|NCT02842086|474504536|FG000|Overall Study|HIV-1 Infection|5|||
131787619|NCT02842086|474504537|FG001|Overall Study|HIV-1 Infection|6|||
131787620|NCT03751124|474504538|FG000|Overall Study|Adverse Event|4|||
131787621|NCT03751124|474504539|FG001|Overall Study|Adverse Event|3|||
131787622|NCT03751124|474504538|FG000|Overall Study|Protocol Deviation|0|||
131580067|NCT00842257|473750290|FG000|Overall Study|Adverse Event|1|||
131580068|NCT04439799|473750291|FG000|Overall Study|Lost to Follow-up|6|||
131787623|NCT03751124|474504539|FG001|Overall Study|Protocol Deviation|1|||
131580069|NCT04439799|473750292|FG001|Overall Study|Lost to Follow-up|6|||
131787624|NCT03751124|474504538|FG000|Overall Study|Lost to Follow-up|6|||
131787625|NCT03751124|474504539|FG001|Overall Study|Lost to Follow-up|4|||
131580070|NCT04439799|473750291|FG000|Overall Study|Withdrawal by Subject|2|||
131580071|NCT04439799|473750292|FG001|Overall Study|Withdrawal by Subject|6|||
131580072|NCT04439799|473750291|FG000|Overall Study|Adverse Event|2|||
131580073|NCT04439799|473750292|FG001|Overall Study|Adverse Event|5|||
131580074|NCT01391130|473750300|FG000|Overall Study|Withdrawal by Subject|3|||
131580075|NCT01391130|473750301|FG001|Overall Study|Withdrawal by Subject|2|||
131580076|NCT01391130|473750300|FG000|Overall Study|Physician Decision|2|||
131580077|NCT01391130|473750301|FG001|Overall Study|Physician Decision|3|||
131580078|NCT01391130|473750300|FG000|Overall Study|Did not Receive Drug|1|||
131580079|NCT01391130|473750301|FG001|Overall Study|Did not Receive Drug|1|||
131580080|NCT03615924|473750302|FG000|Overall Study|Withdrawal by Subject|2|||
131580081|NCT03615924|473750303|FG001|Overall Study|Withdrawal by Subject|5|||
131580082|NCT03615924|473750302|FG000|Overall Study|Death|3|||
131580083|NCT03615924|473750303|FG001|Overall Study|Death|1|||
131580084|NCT03615924|473750302|FG000|Overall Study|Lost to Follow-up|1|||
131580085|NCT03615924|473750303|FG001|Overall Study|Lost to Follow-up|0|||
131580086|NCT03615924|473750302|FG000|Overall Study|Randomized in error|1|||
131580087|NCT03615924|473750303|FG001|Overall Study|Randomized in error|0|||
131580088|NCT03615924|473750302|FG000|Overall Study|Study termination by Sponsor|94|||
131580089|NCT03615924|473750303|FG001|Overall Study|Study termination by Sponsor|86|||
131580090|NCT00367991|473750308|FG000|Overall Study|Withdrawal by Subject|1|||
131580091|NCT00367991|473750309|FG001|Overall Study|Withdrawal by Subject|1|||
131580092|NCT00367991|473750308|FG000|Overall Study|Adverse Event|1|||
131580093|NCT00367991|473750309|FG001|Overall Study|Adverse Event|1|||
131580094|NCT00790790|473750314|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
131580095|NCT00790790|473750315|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
131580096|NCT00790790|473750316|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
131580097|NCT00790790|473750314|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
131580098|NCT00790790|473750315|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
131580099|NCT00790790|473750316|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
131580100|NCT00790790|473750314|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
131580101|NCT00790790|473750315|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
131580102|NCT00790790|473750316|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
131580103|NCT00790790|473750314|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
131580104|NCT00790790|473750315|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131580105|NCT00790790|473750316|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
131580106|NCT00790790|473750314|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
131580107|NCT00790790|473750315|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
131580108|NCT00790790|473750316|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
131580109|NCT02808338|473750317|FG000|Screening|Screen Failure|10|||
131580110|NCT02808338|473750317|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
131580111|NCT02808338|473750317|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
131580112|NCT02537522|473750318|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
131580113|NCT02537522|473750319|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
131580114|NCT02537522|473750320|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
131580115|NCT02537522|473750321|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
131580116|NCT02537522|473750318|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
131580117|NCT02537522|473750319|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
131580118|NCT02537522|473750320|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
131580119|NCT02537522|473750321|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
131580120|NCT02537522|473750318|FG000|Phase I - Contralateral|incorrect randomization|0|||
131580121|NCT02537522|473750319|FG001|Phase I - Contralateral|incorrect randomization|1|||
131580122|NCT02537522|473750320|FG002|Phase I - Contralateral|incorrect randomization|0|||
131580123|NCT02537522|473750321|FG003|Phase I - Contralateral|incorrect randomization|0|||
131580124|NCT02537522|473750318|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
131702010|NCT01665144|474191062|FG002|Core Part|Adverse Event|0|||
131702011|NCT01665144|474191060|FG000|Core Part|Lack of Efficacy|16|||
131702012|NCT01665144|474191061|FG001|Core Part|Lack of Efficacy|11|||
131702013|NCT01665144|474191062|FG002|Core Part|Lack of Efficacy|0|||
131702014|NCT01665144|474191060|FG000|Core Part|Lost to Follow-up|9|||
131702015|NCT01665144|474191061|FG001|Core Part|Lost to Follow-up|8|||
131702016|NCT01665144|474191062|FG002|Core Part|Lost to Follow-up|0|||
131702017|NCT01665144|474191060|FG000|Core Part|Physician Decision|13|||
131702018|NCT01665144|474191061|FG001|Core Part|Physician Decision|1|||
131702019|NCT01665144|474191062|FG002|Core Part|Physician Decision|0|||
131702020|NCT01665144|474191060|FG000|Core Part|Progressive disease|8|||
131702021|NCT01665144|474191061|FG001|Core Part|Progressive disease|4|||
131702022|NCT01665144|474191062|FG002|Core Part|Progressive disease|0|||
131580125|NCT02537522|473750319|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
131580126|NCT02537522|473750320|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
131580127|NCT02537522|473750321|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
131580128|NCT02537522|473750318|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
131787626|NCT03751124|474504538|FG000|Overall Study|Withdrawal by Subject|6|||
131787627|NCT03751124|474504539|FG001|Overall Study|Withdrawal by Subject|8|||
131787628|NCT03751124|474504538|FG000|Overall Study|Lack of Efficacy|1|||
131787629|NCT03751124|474504539|FG001|Overall Study|Lack of Efficacy|1|||
131787630|NCT03751124|474504538|FG000|Overall Study|Pregnancy|0|||
131787631|NCT03751124|474504539|FG001|Overall Study|Pregnancy|1|||
131787632|NCT03751124|474504538|FG000|Overall Study|Other|9|||
131787633|NCT03751124|474504539|FG001|Overall Study|Other|9|||
131787634|NCT03751124|474504538|FG000|Overall Study|Participants who did not receive any study drug|0|||
131787635|NCT03751124|474504539|FG001|Overall Study|Participants who did not receive any study drug|1|||
131787636|NCT00555399|474504542|FG000|Overall Study|Withdrawal by Subject|0|||
131787637|NCT00555399|474504543|FG001|Overall Study|Withdrawal by Subject|0|||
131787638|NCT00555399|474504544|FG002|Overall Study|Withdrawal by Subject|1|||
131787639|NCT00555399|474504545|FG003|Overall Study|Withdrawal by Subject|0|||
131787640|NCT00555399|474504546|FG004|Overall Study|Withdrawal by Subject|0|||
131787641|NCT00555399|474504547|FG005|Overall Study|Withdrawal by Subject|0|||
131787642|NCT00555399|474504548|FG006|Overall Study|Withdrawal by Subject|0|||
131787643|NCT00555399|474504549|FG007|Overall Study|Withdrawal by Subject|0|||
131787644|NCT00555399|474504550|FG008|Overall Study|Withdrawal by Subject|0|||
131787645|NCT00555399|474504551|FG009|Overall Study|Withdrawal by Subject|0|||
131787646|NCT00555399|474504552|FG010|Overall Study|Withdrawal by Subject|0|||
131787647|NCT00555399|474504553|FG011|Overall Study|Withdrawal by Subject|1|||
131787648|NCT00555399|474504542|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
131787649|NCT00555399|474504543|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
131787650|NCT00555399|474504544|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
131580129|NCT02537522|473750319|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
131580130|NCT02537522|473750320|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
131580131|NCT02537522|473750321|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
131580132|NCT02547922|473750322|FG000|Overall Study|Withdrawal by Subject|9|||
131580133|NCT02547922|473750323|FG001|Overall Study|Withdrawal by Subject|6|||
131580134|NCT02547922|473750324|FG002|Overall Study|Withdrawal by Subject|10|||
131580135|NCT02547922|473750322|FG000|Overall Study|Adverse Event|3|||
131580136|NCT02547922|473750323|FG001|Overall Study|Adverse Event|1|||
131580137|NCT02547922|473750324|FG002|Overall Study|Adverse Event|2|||
131580138|NCT02547922|473750322|FG000|Overall Study|Lost to Follow-up|1|||
131787651|NCT00555399|474504545|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
131787652|NCT00555399|474504546|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
131787653|NCT00555399|474504547|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
131787654|NCT00555399|474504548|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
131787655|NCT00555399|474504549|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
131787656|NCT00555399|474504550|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
131787657|NCT00555399|474504551|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
131787658|NCT00555399|474504552|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
131787659|NCT00555399|474504553|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
131787660|NCT01011907|474505938|FG000|Overall Study|Withdrawal by Subject|13|||
131787661|NCT01011907|474505939|FG001|Overall Study|Withdrawal by Subject|11|||
131580139|NCT02547922|473750323|FG001|Overall Study|Lost to Follow-up|0|||
131580140|NCT02547922|473750324|FG002|Overall Study|Lost to Follow-up|0|||
131580141|NCT02547922|473750322|FG000|Overall Study|Lack of Efficacy|5|||
131580142|NCT02547922|473750323|FG001|Overall Study|Lack of Efficacy|7|||
131580143|NCT02547922|473750324|FG002|Overall Study|Lack of Efficacy|4|||
131580144|NCT02547922|473750322|FG000|Overall Study|Death|1|||
131580145|NCT02547922|473750323|FG001|Overall Study|Death|0|||
131580146|NCT02547922|473750324|FG002|Overall Study|Death|0|||
131580147|NCT02547922|473750322|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
131580148|NCT02547922|473750323|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
131580149|NCT02547922|473750324|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
131580150|NCT02547922|473750322|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
131580151|NCT02547922|473750323|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
131580152|NCT02547922|473750324|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
131580153|NCT02547922|473750322|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
131580154|NCT02547922|473750323|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
131580155|NCT02547922|473750324|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
131787662|NCT01011907|474505938|FG000|Overall Study|Adverse Event|1|||
131787663|NCT01011907|474505939|FG001|Overall Study|Adverse Event|4|||
131787664|NCT01406873|474505942|FG000|Overall Study|Withdrawal by Subject|1|||
131580156|NCT02547922|473750322|FG000|Overall Study|Physician Decision|2|||
131580157|NCT02547922|473750323|FG001|Overall Study|Physician Decision|1|||
131580158|NCT02547922|473750324|FG002|Overall Study|Physician Decision|2|||
131580159|NCT02547922|473750322|FG000|Overall Study|Patients did not receive IP|1|||
131580160|NCT02547922|473750323|FG001|Overall Study|Patients did not receive IP|1|||
131580161|NCT02547922|473750324|FG002|Overall Study|Patients did not receive IP|0|||
131580162|NCT00102063|473750325|FG000|Overall Study|Lack of Efficacy|5|||
131580163|NCT00102063|473750326|FG001|Overall Study|Lack of Efficacy|1|||
131580164|NCT00102063|473750327|FG002|Overall Study|Lack of Efficacy|1|||
131580165|NCT00102063|473750325|FG000|Overall Study|Adverse Event|7|||
131580166|NCT00102063|473750326|FG001|Overall Study|Adverse Event|4|||
131580167|NCT00102063|473750327|FG002|Overall Study|Adverse Event|2|||
131580168|NCT00102063|473750325|FG000|Overall Study|Withdrawal by Subject|4|||
131580169|NCT00102063|473750326|FG001|Overall Study|Withdrawal by Subject|12|||
131580170|NCT00102063|473750327|FG002|Overall Study|Withdrawal by Subject|5|||
131580171|NCT00102063|473750325|FG000|Overall Study|Lost to Follow-up|0|||
131580172|NCT00102063|473750326|FG001|Overall Study|Lost to Follow-up|0|||
131580173|NCT00102063|473750327|FG002|Overall Study|Lost to Follow-up|1|||
131580174|NCT00102063|473750325|FG000|Overall Study|Protocol Violation|0|||
131580175|NCT00102063|473750326|FG001|Overall Study|Protocol Violation|1|||
131580176|NCT00102063|473750327|FG002|Overall Study|Protocol Violation|1|||
131580177|NCT05082025|473750328|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
131580178|NCT03175172|473752217|FG000|Overall Study|Death|3|||
131580179|NCT03175172|473752217|FG000|Overall Study|Withdrawal by Subject|3|||
131580180|NCT03175172|473752217|FG000|Overall Study|Lost to Follow-up|1|||
131580181|NCT03175172|473752217|FG000|Overall Study|Study Terminated by Sponsor|3|||
131787665|NCT01406873|474505943|FG001|Overall Study|Withdrawal by Subject|1|||
131787666|NCT03990389|474505944|FG000|Overall Study|Lost to Follow-up|3|||
131787667|NCT03990389|474505945|FG001|Overall Study|Lost to Follow-up|0|||
131787668|NCT00686790|474505946|FG000|Overall Study|Adverse Event|2|||
131580182|NCT01662336|473752218|FG000|Overall Study|Adverse Event|1|||
131580183|NCT01662336|473752218|FG000|Overall Study|No longer on LPV/r|30|||
131580184|NCT01662336|473752218|FG000|Overall Study|Other|29|||
131580185|NCT01662336|473752218|FG000|Overall Study|Withdrawal by Subject|6|||
131580186|NCT04668339|473752219|FG000|Overall Study|Physician Decision|1|||
131580187|NCT04668339|473752220|FG001|Overall Study|Physician Decision|0|||
131580188|NCT04668339|473752221|FG002|Overall Study|Physician Decision|1|||
131580189|NCT04668339|473752222|FG003|Overall Study|Physician Decision|1|||
131580190|NCT04668339|473752219|FG000|Overall Study|Lost to Follow-up|14|||
131580191|NCT04668339|473752220|FG001|Overall Study|Lost to Follow-up|12|||
131580192|NCT04668339|473752221|FG002|Overall Study|Lost to Follow-up|8|||
131580193|NCT04668339|473752222|FG003|Overall Study|Lost to Follow-up|5|||
131580194|NCT04668339|473752219|FG000|Overall Study|Adverse Event|0|||
131580195|NCT04668339|473752220|FG001|Overall Study|Adverse Event|0|||
131580196|NCT04668339|473752221|FG002|Overall Study|Adverse Event|1|||
131580197|NCT04668339|473752222|FG003|Overall Study|Adverse Event|0|||
131787669|NCT00686790|474505946|FG000|Overall Study|Withdrawal by Subject|1|||
131787670|NCT00686790|474505946|FG000|Overall Study|Death|1|||
131787671|NCT00686790|474505946|FG000|Overall Study|Lost to Follow-up|12|||
131787672|NCT00881959|474505951|FG000|Overall Study|Lost to Follow-up|2|||
131580198|NCT04668339|473752219|FG000|Overall Study|Other than specified|3|||
131580199|NCT04668339|473752220|FG001|Overall Study|Other than specified|0|||
131580200|NCT04668339|473752221|FG002|Overall Study|Other than specified|1|||
131580201|NCT04668339|473752222|FG003|Overall Study|Other than specified|0|||
131580202|NCT04668339|473752219|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
131580203|NCT04668339|473752220|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
131580204|NCT04668339|473752221|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
131787673|NCT00881959|474505952|FG001|Overall Study|Lost to Follow-up|4|||
131787674|NCT04228302|474505960|FG000|Overall Study|Adverse Event|0|||
131787675|NCT04228302|474505961|FG001|Overall Study|Adverse Event|0|||
131580205|NCT04668339|473752222|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
131580206|NCT04668339|473752219|FG000|Overall Study|Vaccine not Administered|0|||
131580207|NCT04668339|473752220|FG001|Overall Study|Vaccine not Administered|0|||
131580208|NCT04668339|473752221|FG002|Overall Study|Vaccine not Administered|1|||
131787676|NCT04228302|474505962|FG002|Overall Study|Adverse Event|0|||
131438303|NCT00768989|473231185|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
131438304|NCT00768989|473231186|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
131438305|NCT00768989|473231185|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
131580209|NCT04668339|473752222|FG003|Overall Study|Vaccine not Administered|0|||
131580210|NCT04668339|473752219|FG000|Overall Study|Protocol Violation|18|||
131580211|NCT04668339|473752220|FG001|Overall Study|Protocol Violation|23|||
131580212|NCT04668339|473752221|FG002|Overall Study|Protocol Violation|12|||
131580213|NCT04668339|473752222|FG003|Overall Study|Protocol Violation|20|||
131580214|NCT04668339|473752219|FG000|Overall Study|Withdrawal by Subject|45|||
131787677|NCT04228302|474505963|FG003|Overall Study|Adverse Event|0|||
131787678|NCT04228302|474505964|FG004|Overall Study|Adverse Event|1|||
131787679|NCT04228302|474505965|FG005|Overall Study|Adverse Event|0|||
131580215|NCT04668339|473752220|FG001|Overall Study|Withdrawal by Subject|46|||
131580216|NCT04668339|473752221|FG002|Overall Study|Withdrawal by Subject|46|||
131580217|NCT04668339|473752222|FG003|Overall Study|Withdrawal by Subject|27|||
131580218|NCT04668339|473752219|FG000|Overall Study|Study Terminated by Sponsor|59|||
131580219|NCT04668339|473752220|FG001|Overall Study|Study Terminated by Sponsor|59|||
131580220|NCT04668339|473752221|FG002|Overall Study|Study Terminated by Sponsor|71|||
131580221|NCT04668339|473752222|FG003|Overall Study|Study Terminated by Sponsor|1|||
131580222|NCT03622593|473752223|FG000|Overall Study|Withdrawal by Subject|11|||
131580223|NCT03622593|473752224|FG001|Overall Study|Withdrawal by Subject|9|||
131580224|NCT03622593|473752225|FG002|Overall Study|Withdrawal by Subject|13|||
131580225|NCT03622593|473752223|FG000|Overall Study|Death|12|||
131580226|NCT03622593|473752224|FG001|Overall Study|Death|9|||
131580227|NCT03622593|473752225|FG002|Overall Study|Death|10|||
131580228|NCT03622593|473752223|FG000|Overall Study|Lost to Follow-up|11|||
131580229|NCT03622593|473752224|FG001|Overall Study|Lost to Follow-up|5|||
131580230|NCT03622593|473752225|FG002|Overall Study|Lost to Follow-up|8|||
131580231|NCT03622593|473752223|FG000|Overall Study|Adverse Event|4|||
131580232|NCT03622593|473752224|FG001|Overall Study|Adverse Event|5|||
131580233|NCT03622593|473752225|FG002|Overall Study|Adverse Event|6|||
131580234|NCT03622593|473752223|FG000|Overall Study|Physician Decision|2|||
131580235|NCT03622593|473752224|FG001|Overall Study|Physician Decision|1|||
131580236|NCT03622593|473752225|FG002|Overall Study|Physician Decision|6|||
131580237|NCT03622593|473752223|FG000|Overall Study|Other|2|||
131580238|NCT03622593|473752224|FG001|Overall Study|Other|2|||
131580239|NCT03622593|473752225|FG002|Overall Study|Other|3|||
131580240|NCT03622593|473752223|FG000|Overall Study|Protocol Violation|0|||
131580241|NCT03622593|473752224|FG001|Overall Study|Protocol Violation|0|||
131580242|NCT03622593|473752225|FG002|Overall Study|Protocol Violation|1|||
131580243|NCT03622593|473752223|FG000|Overall Study|Pregnancy|0|||
131580244|NCT03622593|473752224|FG001|Overall Study|Pregnancy|0|||
131580245|NCT03622593|473752225|FG002|Overall Study|Pregnancy|1|||
131580246|NCT03762668|473752226|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
131580247|NCT03762668|473752227|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
131580248|NCT01393119|473752228|FG000|Overall Study|Adverse Event|1|||
131580249|NCT01393119|473752229|FG001|Overall Study|Adverse Event|1|||
131580250|NCT01393119|473752230|FG002|Overall Study|Adverse Event|0|||
131580251|NCT01393119|473752231|FG003|Overall Study|Adverse Event|1|||
131580252|NCT01393119|473752228|FG000|Overall Study|Withdrawal by Subject|0|||
131580253|NCT01393119|473752229|FG001|Overall Study|Withdrawal by Subject|1|||
131580254|NCT01393119|473752230|FG002|Overall Study|Withdrawal by Subject|1|||
131580255|NCT01393119|473752231|FG003|Overall Study|Withdrawal by Subject|0|||
131580256|NCT01393119|473752228|FG000|Overall Study|Lack of Efficacy|1|||
131580257|NCT01393119|473752229|FG001|Overall Study|Lack of Efficacy|0|||
131580258|NCT01393119|473752230|FG002|Overall Study|Lack of Efficacy|2|||
131580259|NCT01393119|473752231|FG003|Overall Study|Lack of Efficacy|1|||
131580260|NCT01393119|473752228|FG000|Overall Study|Protocol Violation|0|||
131580261|NCT01393119|473752229|FG001|Overall Study|Protocol Violation|0|||
131580262|NCT01393119|473752230|FG002|Overall Study|Protocol Violation|1|||
131580263|NCT01393119|473752231|FG003|Overall Study|Protocol Violation|0|||
131580264|NCT01393119|473752228|FG000|Overall Study|Death|0|||
131580265|NCT01393119|473752229|FG001|Overall Study|Death|0|||
131580266|NCT01393119|473752230|FG002|Overall Study|Death|0|||
131580267|NCT01393119|473752231|FG003|Overall Study|Death|1|||
131580268|NCT01393119|473752228|FG000|Overall Study|Randomized but Not treated|1|||
131580269|NCT01393119|473752229|FG001|Overall Study|Randomized but Not treated|0|||
131580270|NCT01393119|473752230|FG002|Overall Study|Randomized but Not treated|1|||
131580271|NCT01393119|473752231|FG003|Overall Study|Randomized but Not treated|1|||
131580272|NCT01393119|473752228|FG000|Overall Study|Sponsor Termination of Study|11|||
131580273|NCT01393119|473752229|FG001|Overall Study|Sponsor Termination of Study|12|||
131787680|NCT03031431|474505984|FG000|Overall Study|Infant removed by maternal request|1|||
131787681|NCT01205529|474505985|FG000|Overall Study|Procedure Cancelled|4|||
131580274|NCT01393119|473752230|FG002|Overall Study|Sponsor Termination of Study|9|||
131580275|NCT01393119|473752231|FG003|Overall Study|Sponsor Termination of Study|12|||
131580276|NCT00465816|473752233|FG000|Overall Study|Lost to Follow-up|0|||
131580277|NCT00465816|473752234|FG001|Overall Study|Lost to Follow-up|0|||
131580278|NCT00465816|473752235|FG002|Overall Study|Lost to Follow-up|2|||
131580279|NCT01759264|473752236|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
131787682|NCT01205529|474505985|FG000|Overall Study|Withdrawal by Subject|2|||
131580280|NCT01759264|473752236|FG000|Overall Study|Adverse Event|1|||
131580281|NCT01759264|473752236|FG000|Overall Study|Other|2|||
131580282|NCT01759264|473752236|FG000|Overall Study|Lost to Follow-up|2|||
131580283|NCT01759264|473752236|FG000|Overall Study|Withdrawal by Subject|3|||
131580284|NCT01759264|473752236|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
131580285|NCT02013830|473752237|FG000|Overall Study|Adverse Event|3|||
131580286|NCT02013830|473752237|FG000|Overall Study|Death|1|||
131580287|NCT02013830|473752237|FG000|Overall Study|Insufficient therapeutic response|25|||
131580288|NCT02013830|473752237|FG000|Overall Study|Refused treatment|1|||
131580289|NCT00186186|473752241|FG000|Overall Study|Lack of Efficacy|3|||
131787683|NCT01205529|474505985|FG000|Overall Study|Physician Decision|4|||
131787684|NCT01205529|474505985|FG000|Overall Study|Unstable post op|15|||
131787685|NCT01205529|474505985|FG000|Overall Study|No longer met criteria|30|||
131787686|NCT03012815|474505986|FG000|Overall Study|Lost to Follow-up|1|||
131787687|NCT03012815|474505987|FG001|Overall Study|Lost to Follow-up|0|||
131787688|NCT03012815|474505986|FG000|Overall Study|Physician Decision|3|||
131787689|NCT03012815|474505987|FG001|Overall Study|Physician Decision|2|||
131787690|NCT03012815|474505986|FG000|Overall Study|Adverse Event|1|||
131787691|NCT03012815|474505987|FG001|Overall Study|Adverse Event|0|||
131787692|NCT01252238|474505988|FG000|Overall Study|Sponsor terminated study|4|||
131787693|NCT01252238|474505989|FG001|Overall Study|Sponsor terminated study|4|||
131787694|NCT01252238|474505990|FG002|Overall Study|Sponsor terminated study|4|||
131438306|NCT00768989|473231186|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
131438307|NCT00768989|473231185|FG000|On or After Week 36|Lack of Efficacy|1|||
131438308|NCT00768989|473231186|FG001|On or After Week 36|Lack of Efficacy|0|||
131438309|NCT00768989|473231185|FG000|On or After Week 36|Adverse Event|0|||
131438310|NCT00768989|473231186|FG001|On or After Week 36|Adverse Event|1|||
131438311|NCT00768989|473231185|FG000|On or After Week 36|Lost to Follow-up|1|||
131438312|NCT00768989|473231186|FG001|On or After Week 36|Lost to Follow-up|0|||
131438313|NCT00768989|473231185|FG000|On or After Week 36|Poor Compliance|1|||
131438314|NCT00768989|473231186|FG001|On or After Week 36|Poor Compliance|0|||
131438315|NCT00768989|473231185|FG000|On or After Week 36|Protocol Violation|1|||
131438316|NCT00768989|473231186|FG001|On or After Week 36|Protocol Violation|0|||
131438317|NCT00768989|473231185|FG000|On or After Week 36|Did not attend termination visit|2|||
131438318|NCT00768989|473231186|FG001|On or After Week 36|Did not attend termination visit|0|||
131438319|NCT00768989|473231185|FG000|On or After Week 36|Sponsor Termination|45|||
131438320|NCT00768989|473231186|FG001|On or After Week 36|Sponsor Termination|26|||
131438321|NCT03585660|473231187|FG000|Overall Study|operator error|1|||
131438322|NCT03585660|473231187|FG000|Overall Study|technical error|2|||
131438323|NCT03585660|473231187|FG000|Overall Study|hip prosthesis|2|||
131438324|NCT03585660|473231187|FG000|Overall Study|did not undergo biopsy|8|||
131438325|NCT03585660|473231187|FG000|Overall Study|scanner problem|2|||
131438326|NCT05635461|473231190|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
131438327|NCT05635461|473231191|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
131438328|NCT05635461|473231192|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
131438329|NCT05635461|473231193|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
131438330|NCT05635461|473231194|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
131438331|NCT05635461|473231195|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
131438332|NCT05635461|473231190|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
131438333|NCT05635461|473231191|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
131438334|NCT05635461|473231192|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
131438335|NCT05635461|473231193|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
131438336|NCT05635461|473231194|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
131438337|NCT05635461|473231195|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
131438338|NCT05635461|473231190|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
131438339|NCT05635461|473231191|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
131438340|NCT05635461|473231192|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
131438341|NCT05635461|473231193|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
131438342|NCT05635461|473231194|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
131438343|NCT05635461|473231195|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
131438344|NCT04890652|473231204|FG000|Overall Study|Withdrawal by Subject|2|||
131438345|NCT03192176|473231207|FG000|Overall Study|Adverse Event|1|||
131438346|NCT03192176|473231208|FG001|Overall Study|Adverse Event|0|||
131438347|NCT03192176|473231209|FG002|Overall Study|Adverse Event|4|||
131438348|NCT03192176|473231210|FG003|Overall Study|Adverse Event|5|||
131438349|NCT03192176|473231211|FG004|Overall Study|Adverse Event|3|||
131438350|NCT03192176|473231212|FG005|Overall Study|Adverse Event|2|||
131438351|NCT03192176|473231213|FG006|Overall Study|Adverse Event|3|||
131438352|NCT03192176|473231214|FG007|Overall Study|Adverse Event|3|||
131438353|NCT03192176|473231207|FG000|Overall Study|Lost to Follow-up|0|||
131438354|NCT03192176|473231208|FG001|Overall Study|Lost to Follow-up|0|||
131787695|NCT01280981|474505993|FG000|Overall Study|Withdrawal by Subject|11|||
131438355|NCT03192176|473231209|FG002|Overall Study|Lost to Follow-up|1|||
131898740|NCT00766597|474915346|FG000|Overall Study|Without CCR5-tropic virus|5|||
131898741|NCT00943397|474915347|FG000|Overall Study|Adverse Event|0|||
131438356|NCT03192176|473231210|FG003|Overall Study|Lost to Follow-up|2|||
131438357|NCT03192176|473231211|FG004|Overall Study|Lost to Follow-up|3|||
131438358|NCT03192176|473231212|FG005|Overall Study|Lost to Follow-up|1|||
131438359|NCT03192176|473231213|FG006|Overall Study|Lost to Follow-up|1|||
131438360|NCT03192176|473231214|FG007|Overall Study|Lost to Follow-up|1|||
131438361|NCT03192176|473231207|FG000|Overall Study|Physician Decision|1|||
131438362|NCT03192176|473231208|FG001|Overall Study|Physician Decision|0|||
131438363|NCT03192176|473231209|FG002|Overall Study|Physician Decision|0|||
131438364|NCT03192176|473231210|FG003|Overall Study|Physician Decision|0|||
131438365|NCT03192176|473231211|FG004|Overall Study|Physician Decision|0|||
131787696|NCT01280981|474505993|FG000|Overall Study|Protocol Violation|2|||
131787697|NCT01280981|474505993|FG000|Overall Study|Lack of Efficacy|13|||
131787698|NCT01280981|474505993|FG000|Overall Study|Lost to Follow-up|3|||
131787699|NCT01280981|474505993|FG000|Overall Study|Adverse Event|6|||
131787700|NCT01280981|474505993|FG000|Overall Study|Irregular or discontinued menses|3|||
131787701|NCT01280981|474505993|FG000|Overall Study|Failed to return|45|||
131787702|NCT01280981|474505993|FG000|Overall Study|Non-compliance with protocol|3|||
131787703|NCT01280981|474505993|FG000|Overall Study|Withdrawal of consent|3|||
131787704|NCT01280981|474505993|FG000|Overall Study|Elective surgery|2|||
131787705|NCT01280981|474505993|FG000|Overall Study|Study site closure|1|||
131787706|NCT03276962|474505994|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
131787707|NCT03276962|474505995|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
131787708|NCT03276962|474505996|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
131787709|NCT03276962|474505997|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
131787710|NCT03276962|474505998|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
131787711|NCT03276962|474505994|FG000|Overall Study|Protocol Deviation|2|||
131787712|NCT03276962|474505995|FG001|Overall Study|Protocol Deviation|0|||
131787713|NCT03276962|474505996|FG002|Overall Study|Protocol Deviation|1|||
131787714|NCT03276962|474505997|FG003|Overall Study|Protocol Deviation|2|||
131787715|NCT03276962|474505998|FG004|Overall Study|Protocol Deviation|1|||
131787716|NCT03276962|474505994|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
131787717|NCT03276962|474505995|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131787718|NCT03276962|474505996|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
131787719|NCT03276962|474505997|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131787720|NCT03276962|474505998|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
131787721|NCT03276962|474505994|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
131580290|NCT00186186|473752241|FG000|Overall Study|Withdrawal by Subject|3|||
131580291|NCT00186186|473752241|FG000|Overall Study|Not reported as to reason|2|||
131580292|NCT01337635|473752242|FG000|Overall Study|Lost to Follow-up|0|||
131580293|NCT01337635|473752243|FG001|Overall Study|Lost to Follow-up|1|||
131580294|NCT01307267|473752244|FG000|Overall Study|Death|4|||
131787722|NCT03276962|474505995|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
131787723|NCT03276962|474505996|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
131787724|NCT03276962|474505997|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
131787725|NCT03276962|474505998|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
131787726|NCT03276962|474505994|FG000|Overall Study|Lost to Follow-up|10|||
131787727|NCT03276962|474505995|FG001|Overall Study|Lost to Follow-up|10|||
131787728|NCT03276962|474505996|FG002|Overall Study|Lost to Follow-up|4|||
131787729|NCT03276962|474505997|FG003|Overall Study|Lost to Follow-up|6|||
131787730|NCT03276962|474505998|FG004|Overall Study|Lost to Follow-up|10|||
131787731|NCT03276962|474505994|FG000|Overall Study|Other|0|||
131787732|NCT03276962|474505995|FG001|Overall Study|Other|2|||
131787733|NCT03276962|474505996|FG002|Overall Study|Other|0|||
131787734|NCT03276962|474505997|FG003|Overall Study|Other|2|||
131787735|NCT03276962|474505998|FG004|Overall Study|Other|1|||
131787736|NCT01238211|474505999|FG000|Overall Study|Continues active treatment|31|||
131787737|NCT01238211|474505999|FG000|Overall Study|Adverse Event|7|||
131787738|NCT01238211|474505999|FG000|Overall Study|Death|4|||
131787739|NCT01238211|474505999|FG000|Overall Study|Relapse/Progression|2|||
131787740|NCT01238211|474505999|FG000|Overall Study|Withdrawal by Subject|7|||
131787741|NCT01238211|474505999|FG000|Overall Study|Non-protocol treatment|4|||
131787742|NCT01238211|474505999|FG000|Overall Study|Investigator/Patient Decision|3|||
131787743|NCT04428502|474506000|FG000|Overall Study|Did not meet entrance criteria|14|||
131787744|NCT00449930|474506011|FG000|Overall Study|Adverse Event|9|||
131787745|NCT00449930|474506012|FG001|Overall Study|Adverse Event|19|||
131787746|NCT00449930|474506011|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
131580295|NCT01307267|473752245|FG001|Overall Study|Death|3|||
131580296|NCT01307267|473752246|FG002|Overall Study|Death|5|||
131580297|NCT01307267|473752247|FG003|Overall Study|Death|3|||
131580298|NCT01307267|473752248|FG004|Overall Study|Death|1|||
131580299|NCT01307267|473752249|FG005|Overall Study|Death|26|||
131787747|NCT00449930|474506012|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
131787748|NCT00449930|474506011|FG000|Overall Study|Lack of Efficacy|10|||
131787749|NCT00449930|474506012|FG001|Overall Study|Lack of Efficacy|1|||
131787750|NCT00449930|474506011|FG000|Overall Study|Lost to Follow-up|9|||
131787751|NCT00449930|474506012|FG001|Overall Study|Lost to Follow-up|14|||
131787752|NCT00449930|474506011|FG000|Overall Study|Physician Decision|1|||
131787753|NCT00449930|474506012|FG001|Overall Study|Physician Decision|2|||
131580300|NCT01307267|473752250|FG006|Overall Study|Death|2|||
131580301|NCT01307267|473752251|FG007|Overall Study|Death|2|||
131580302|NCT01307267|473752252|FG008|Overall Study|Death|21|||
131787754|NCT00449930|474506011|FG000|Overall Study|Protocol Violation|14|||
131787755|NCT00449930|474506012|FG001|Overall Study|Protocol Violation|15|||
131787756|NCT00449930|474506011|FG000|Overall Study|Withdrawal by Subject|16|||
131787757|NCT00449930|474506012|FG001|Overall Study|Withdrawal by Subject|23|||
131787758|NCT00449930|474506011|FG000|Overall Study|Glycemic discontinuation criteria|1|||
131787759|NCT00449930|474506012|FG001|Overall Study|Glycemic discontinuation criteria|1|||
131787760|NCT03550794|474506013|FG000|Overall Study|No longer met inclusion criteria|1|||
131787761|NCT03550794|474506014|FG001|Overall Study|No longer met inclusion criteria|2|||
131787762|NCT03550794|474506013|FG000|Overall Study|Goals of care changed|1|||
131787763|NCT03550794|474506014|FG001|Overall Study|Goals of care changed|0|||
131787764|NCT03550794|474506013|FG000|Overall Study|Withdrawal by Subject|2|||
131787765|NCT03550794|474506014|FG001|Overall Study|Withdrawal by Subject|0|||
131787766|NCT03550794|474506013|FG000|Overall Study|Death|0|||
131787767|NCT03550794|474506014|FG001|Overall Study|Death|1|||
131580303|NCT01307267|473752253|FG009|Overall Study|Death|2|||
131580304|NCT01307267|473752254|FG010|Overall Study|Death|3|||
131580305|NCT01307267|473752255|FG011|Overall Study|Death|9|||
131580306|NCT01307267|473752256|FG012|Overall Study|Death|0|||
131580307|NCT01307267|473752257|FG013|Overall Study|Death|0|||
131580308|NCT01307267|473752258|FG014|Overall Study|Death|0|||
131580309|NCT01307267|473752259|FG015|Overall Study|Death|0|||
131580310|NCT01307267|473752260|FG016|Overall Study|Death|1|||
131580311|NCT01307267|473752261|FG017|Overall Study|Death|1|||
131580312|NCT01307267|473752262|FG018|Overall Study|Death|2|||
131702023|NCT01665144|474191060|FG000|Core Part|Non-compliance with study treatment|5|||
131702024|NCT01665144|474191061|FG001|Core Part|Non-compliance with study treatment|0|||
131702025|NCT01665144|474191062|FG002|Core Part|Non-compliance with study treatment|0|||
131702026|NCT01665144|474191060|FG000|Core Part|Death|3|||
131702027|NCT01665144|474191061|FG001|Core Part|Death|1|||
131702028|NCT01665144|474191062|FG002|Core Part|Death|0|||
131702029|NCT01665144|474191060|FG000|Core Part|Protocol deviation|3|||
131702030|NCT01665144|474191061|FG001|Core Part|Protocol deviation|1|||
131702031|NCT01665144|474191062|FG002|Core Part|Protocol deviation|0|||
131702032|NCT01665144|474191060|FG000|Core Part|New therapy for study indication|2|||
131702033|NCT01665144|474191061|FG001|Core Part|New therapy for study indication|1|||
131702034|NCT01665144|474191062|FG002|Core Part|New therapy for study indication|0|||
131702035|NCT01665144|474191060|FG000|Core Part|Technical problems|2|||
131702036|NCT01665144|474191061|FG001|Core Part|Technical problems|0|||
131702037|NCT01665144|474191062|FG002|Core Part|Technical problems|0|||
131702038|NCT01665144|474191060|FG000|Extension Part|Patient/guardian decision|180|||
131702039|NCT01665144|474191061|FG001|Extension Part|Patient/guardian decision|0|||
131702040|NCT01665144|474191062|FG002|Extension Part|Patient/guardian decision|98|||
131702041|NCT01665144|474191060|FG000|Extension Part|Adverse Event|104|||
131702042|NCT01665144|474191061|FG001|Extension Part|Adverse Event|0|||
131702043|NCT01665144|474191062|FG002|Extension Part|Adverse Event|59|||
131702044|NCT01665144|474191060|FG000|Extension Part|Study closed early|42|||
131702045|NCT01665144|474191061|FG001|Extension Part|Study closed early|0|||
131702046|NCT01665144|474191062|FG002|Extension Part|Study closed early|19|||
131702047|NCT01665144|474191060|FG000|Extension Part|Progressive disease|36|||
131702048|NCT01665144|474191061|FG001|Extension Part|Progressive disease|0|||
131702049|NCT01665144|474191062|FG002|Extension Part|Progressive disease|14|||
131702050|NCT01665144|474191060|FG000|Extension Part|Lack of Efficacy|37|||
131702051|NCT01665144|474191061|FG001|Extension Part|Lack of Efficacy|0|||
131702052|NCT01665144|474191062|FG002|Extension Part|Lack of Efficacy|12|||
131702053|NCT01665144|474191060|FG000|Extension Part|Physician Decision|29|||
131702054|NCT01665144|474191061|FG001|Extension Part|Physician Decision|0|||
131702055|NCT01665144|474191062|FG002|Extension Part|Physician Decision|13|||
131702056|NCT01665144|474191060|FG000|Extension Part|Technical problems|20|||
131702057|NCT01665144|474191061|FG001|Extension Part|Technical problems|0|||
131702058|NCT01665144|474191062|FG002|Extension Part|Technical problems|8|||
131702059|NCT01665144|474191060|FG000|Extension Part|Death|20|||
131702060|NCT01665144|474191061|FG001|Extension Part|Death|0|||
131702061|NCT01665144|474191062|FG002|Extension Part|Death|4|||
131702062|NCT01665144|474191060|FG000|Extension Part|Missing|12|||
131702063|NCT01665144|474191061|FG001|Extension Part|Missing|0|||
131702064|NCT01665144|474191062|FG002|Extension Part|Missing|6|||
131787768|NCT01864525|474506015|FG000|Overall Study|Adverse Event|1|||
131787769|NCT01864525|474506016|FG001|Overall Study|Adverse Event|0|||
131580313|NCT01307267|473752263|FG019|Overall Study|Death|8|||
131580314|NCT01307267|473752264|FG020|Overall Study|Death|1|||
131580315|NCT01307267|473752265|FG021|Overall Study|Death|2|||
131580316|NCT01307267|473752266|FG022|Overall Study|Death|2|||
131580317|NCT01307267|473752244|FG000|Overall Study|Lost to Follow-up|0|||
131702065|NCT01665144|474191060|FG000|Extension Part|Lost to Follow-up|9|||
131702066|NCT01665144|474191061|FG001|Extension Part|Lost to Follow-up|0|||
131702067|NCT01665144|474191062|FG002|Extension Part|Lost to Follow-up|5|||
131702068|NCT01665144|474191060|FG000|Extension Part|New therapy for study indication|3|||
131702069|NCT01665144|474191061|FG001|Extension Part|New therapy for study indication|0|||
131702070|NCT01665144|474191062|FG002|Extension Part|New therapy for study indication|2|||
131702071|NCT01665144|474191060|FG000|Extension Part|Protocol deviation|3|||
131702072|NCT01665144|474191061|FG001|Extension Part|Protocol deviation|0|||
131702073|NCT01665144|474191062|FG002|Extension Part|Protocol deviation|0|||
131702074|NCT03551743|474191067|FG000|Overall Study|Adverse Event|1|||
131702075|NCT03551743|474191068|FG001|Overall Study|Adverse Event|0|||
131702076|NCT03551743|474191069|FG002|Overall Study|Adverse Event|0|||
131702077|NCT03551743|474191070|FG003|Overall Study|Adverse Event|0|||
131787770|NCT01890785|474506017|FG000|Third Intervention|Withdrawal by Subject|0|||
131787771|NCT01890785|474506018|FG001|Third Intervention|Withdrawal by Subject|1|||
131580318|NCT01307267|473752245|FG001|Overall Study|Lost to Follow-up|0|||
131580319|NCT01307267|473752246|FG002|Overall Study|Lost to Follow-up|0|||
131580320|NCT01307267|473752247|FG003|Overall Study|Lost to Follow-up|0|||
131580321|NCT01307267|473752248|FG004|Overall Study|Lost to Follow-up|0|||
131580322|NCT01307267|473752249|FG005|Overall Study|Lost to Follow-up|7|||
131580323|NCT01307267|473752250|FG006|Overall Study|Lost to Follow-up|0|||
131580324|NCT01307267|473752251|FG007|Overall Study|Lost to Follow-up|0|||
131580325|NCT01307267|473752252|FG008|Overall Study|Lost to Follow-up|1|||
131580326|NCT01307267|473752253|FG009|Overall Study|Lost to Follow-up|2|||
131580327|NCT01307267|473752254|FG010|Overall Study|Lost to Follow-up|1|||
131580328|NCT01307267|473752255|FG011|Overall Study|Lost to Follow-up|0|||
131580329|NCT01307267|473752256|FG012|Overall Study|Lost to Follow-up|0|||
131580330|NCT01307267|473752257|FG013|Overall Study|Lost to Follow-up|0|||
131580331|NCT01307267|473752258|FG014|Overall Study|Lost to Follow-up|0|||
131580332|NCT01307267|473752259|FG015|Overall Study|Lost to Follow-up|0|||
131580333|NCT01307267|473752260|FG016|Overall Study|Lost to Follow-up|0|||
131580334|NCT01307267|473752261|FG017|Overall Study|Lost to Follow-up|0|||
131580335|NCT01307267|473752262|FG018|Overall Study|Lost to Follow-up|0|||
131580336|NCT01307267|473752263|FG019|Overall Study|Lost to Follow-up|2|||
131580337|NCT01307267|473752264|FG020|Overall Study|Lost to Follow-up|0|||
131580338|NCT01307267|473752265|FG021|Overall Study|Lost to Follow-up|0|||
131580339|NCT01307267|473752266|FG022|Overall Study|Lost to Follow-up|0|||
131580340|NCT01307267|473752244|FG000|Overall Study|Withdrawal by Subject|0|||
131580341|NCT01307267|473752245|FG001|Overall Study|Withdrawal by Subject|0|||
131580342|NCT01307267|473752246|FG002|Overall Study|Withdrawal by Subject|0|||
131580343|NCT01307267|473752247|FG003|Overall Study|Withdrawal by Subject|0|||
131580344|NCT01307267|473752248|FG004|Overall Study|Withdrawal by Subject|0|||
131580345|NCT01307267|473752249|FG005|Overall Study|Withdrawal by Subject|1|||
131580346|NCT01307267|473752250|FG006|Overall Study|Withdrawal by Subject|0|||
131580347|NCT01307267|473752251|FG007|Overall Study|Withdrawal by Subject|1|||
131580348|NCT01307267|473752252|FG008|Overall Study|Withdrawal by Subject|5|||
131580349|NCT01307267|473752253|FG009|Overall Study|Withdrawal by Subject|1|||
131580350|NCT01307267|473752254|FG010|Overall Study|Withdrawal by Subject|1|||
131580351|NCT01307267|473752255|FG011|Overall Study|Withdrawal by Subject|1|||
131580352|NCT01307267|473752256|FG012|Overall Study|Withdrawal by Subject|0|||
131580353|NCT01307267|473752257|FG013|Overall Study|Withdrawal by Subject|0|||
131580354|NCT01307267|473752258|FG014|Overall Study|Withdrawal by Subject|0|||
131580355|NCT01307267|473752259|FG015|Overall Study|Withdrawal by Subject|0|||
131580356|NCT01307267|473752260|FG016|Overall Study|Withdrawal by Subject|0|||
131580357|NCT01307267|473752261|FG017|Overall Study|Withdrawal by Subject|0|||
131580358|NCT01307267|473752262|FG018|Overall Study|Withdrawal by Subject|0|||
131580359|NCT01307267|473752263|FG019|Overall Study|Withdrawal by Subject|3|||
131580360|NCT01307267|473752264|FG020|Overall Study|Withdrawal by Subject|0|||
131580361|NCT01307267|473752265|FG021|Overall Study|Withdrawal by Subject|0|||
131580362|NCT01307267|473752266|FG022|Overall Study|Withdrawal by Subject|0|||
131580363|NCT01307267|473752244|FG000|Overall Study|Other|0|||
131580364|NCT01307267|473752245|FG001|Overall Study|Other|0|||
131580365|NCT01307267|473752246|FG002|Overall Study|Other|0|||
131580366|NCT01307267|473752247|FG003|Overall Study|Other|0|||
131580367|NCT01307267|473752248|FG004|Overall Study|Other|0|||
131580368|NCT01307267|473752249|FG005|Overall Study|Other|7|||
131580369|NCT01307267|473752250|FG006|Overall Study|Other|0|||
131580370|NCT01307267|473752251|FG007|Overall Study|Other|1|||
131580371|NCT01307267|473752252|FG008|Overall Study|Other|3|||
131580372|NCT01307267|473752253|FG009|Overall Study|Other|0|||
131580373|NCT01307267|473752254|FG010|Overall Study|Other|1|||
131580374|NCT01307267|473752255|FG011|Overall Study|Other|1|||
131580375|NCT01307267|473752256|FG012|Overall Study|Other|1|||
131580376|NCT01307267|473752257|FG013|Overall Study|Other|0|||
131580377|NCT01307267|473752258|FG014|Overall Study|Other|2|||
131580378|NCT01307267|473752259|FG015|Overall Study|Other|1|||
131580379|NCT01307267|473752260|FG016|Overall Study|Other|0|||
131787772|NCT01890785|474506019|FG002|Third Intervention|Withdrawal by Subject|0|||
131580380|NCT01307267|473752261|FG017|Overall Study|Other|0|||
131580381|NCT01307267|473752262|FG018|Overall Study|Other|0|||
131580382|NCT01307267|473752263|FG019|Overall Study|Other|19|||
131580383|NCT01307267|473752264|FG020|Overall Study|Other|2|||
131580384|NCT01307267|473752265|FG021|Overall Study|Other|3|||
131580385|NCT01307267|473752266|FG022|Overall Study|Other|2|||
131580386|NCT04956575|473752267|FG000|Overall Study|Death|1|||
131580387|NCT04956575|473752268|FG001|Overall Study|Death|0|||
131580388|NCT04956575|473752269|FG002|Overall Study|Death|0|||
131580389|NCT04956575|473752270|FG003|Overall Study|Death|0|||
131580390|NCT04956575|473752271|FG004|Overall Study|Death|0|||
131580391|NCT04956575|473752272|FG005|Overall Study|Death|0|||
131580392|NCT04956575|473752273|FG006|Overall Study|Death|0|||
131580393|NCT04956575|473752274|FG007|Overall Study|Death|1|||
131580394|NCT04956575|473752275|FG008|Overall Study|Death|0|||
131787773|NCT01890785|474506020|FG003|Third Intervention|Withdrawal by Subject|0|||
131580395|NCT04956575|473752276|FG009|Overall Study|Death|1|||
131580396|NCT04956575|473752277|FG010|Overall Study|Death|0|||
131580397|NCT04956575|473752278|FG011|Overall Study|Death|0|||
131580398|NCT04956575|473752267|FG000|Overall Study|Lost to Follow-up|3|||
131580399|NCT04956575|473752268|FG001|Overall Study|Lost to Follow-up|4|||
131580400|NCT04956575|473752269|FG002|Overall Study|Lost to Follow-up|2|||
131580401|NCT04956575|473752270|FG003|Overall Study|Lost to Follow-up|3|||
131580402|NCT04956575|473752271|FG004|Overall Study|Lost to Follow-up|1|||
131580403|NCT04956575|473752272|FG005|Overall Study|Lost to Follow-up|10|||
131580404|NCT04956575|473752273|FG006|Overall Study|Lost to Follow-up|11|||
131580405|NCT04956575|473752274|FG007|Overall Study|Lost to Follow-up|7|||
131580406|NCT04956575|473752275|FG008|Overall Study|Lost to Follow-up|4|||
131580407|NCT04956575|473752276|FG009|Overall Study|Lost to Follow-up|2|||
131580408|NCT04956575|473752277|FG010|Overall Study|Lost to Follow-up|3|||
131580409|NCT04956575|473752278|FG011|Overall Study|Lost to Follow-up|8|||
131580410|NCT04956575|473752267|FG000|Overall Study|Withdrawal by Subject|1|||
131580411|NCT04956575|473752268|FG001|Overall Study|Withdrawal by Subject|2|||
131580412|NCT04956575|473752269|FG002|Overall Study|Withdrawal by Subject|1|||
131580413|NCT04956575|473752270|FG003|Overall Study|Withdrawal by Subject|4|||
131580414|NCT04956575|473752271|FG004|Overall Study|Withdrawal by Subject|2|||
131580415|NCT04956575|473752272|FG005|Overall Study|Withdrawal by Subject|8|||
131580416|NCT04956575|473752273|FG006|Overall Study|Withdrawal by Subject|5|||
131580417|NCT04956575|473752274|FG007|Overall Study|Withdrawal by Subject|1|||
131580418|NCT04956575|473752275|FG008|Overall Study|Withdrawal by Subject|1|||
131580419|NCT04956575|473752276|FG009|Overall Study|Withdrawal by Subject|0|||
131580420|NCT04956575|473752277|FG010|Overall Study|Withdrawal by Subject|3|||
131580421|NCT04956575|473752278|FG011|Overall Study|Withdrawal by Subject|1|||
131580422|NCT03593876|473752279|FG000|Overall Study|Withdrawal by Subject|1|||
131580423|NCT03593876|473752279|FG000|Overall Study|Discharged home before intervention completion|2|||
131580424|NCT05136443|473752290|FG000|Overall Study|Lost to Follow-up|2|||
131580425|NCT05136443|473752290|FG000|Overall Study|Adverse Event|2|||
131580426|NCT00424762|473752306|FG000|Overall Study|Withdrawal by Subject|18|||
131580427|NCT00424762|473752307|FG001|Overall Study|Withdrawal by Subject|19|||
131580428|NCT00424762|473752306|FG000|Overall Study|Lost to Follow-up|2|||
131580429|NCT00424762|473752307|FG001|Overall Study|Lost to Follow-up|3|||
131580430|NCT01147341|473752310|FG000|Double Blind Period|Lack of Efficacy|1|||
131580431|NCT01147341|473752311|FG001|Double Blind Period|Lack of Efficacy|1|||
131580432|NCT01147341|473752310|FG000|Double Blind Period|Withdrawal by Subject|0|||
131580433|NCT01147341|473752311|FG001|Double Blind Period|Withdrawal by Subject|1|||
131580434|NCT01147341|473752310|FG000|Open Label Period|Lack of Efficacy|3|||
131702078|NCT03551743|474191067|FG000|Overall Study|Withdrawal by Subject|1|||
131702079|NCT03551743|474191068|FG001|Overall Study|Withdrawal by Subject|0|||
131702080|NCT03551743|474191069|FG002|Overall Study|Withdrawal by Subject|0|||
131702081|NCT03551743|474191070|FG003|Overall Study|Withdrawal by Subject|0|||
131702082|NCT01145066|474191071|FG000|Overall Study|To resume NSAIDs|2|||
131702083|NCT01145066|474191072|FG001|Overall Study|To resume NSAIDs|2|||
131702084|NCT01145066|474191073|FG002|Overall Study|To resume NSAIDs|1|||
131702085|NCT01145066|474191071|FG000|Overall Study|Non-related surgery|0|||
131702086|NCT01145066|474191072|FG001|Overall Study|Non-related surgery|0|||
131702087|NCT01145066|474191073|FG002|Overall Study|Non-related surgery|1|||
131702088|NCT01145066|474191071|FG000|Overall Study|Withdrawal by Subject|0|||
131702089|NCT01145066|474191072|FG001|Overall Study|Withdrawal by Subject|0|||
131702090|NCT01145066|474191073|FG002|Overall Study|Withdrawal by Subject|2|||
131702091|NCT01145066|474191071|FG000|Overall Study|To start new med|1|||
131702092|NCT01145066|474191072|FG001|Overall Study|To start new med|0|||
131702093|NCT01145066|474191073|FG002|Overall Study|To start new med|0|||
131702094|NCT01145066|474191071|FG000|Overall Study|problems swallowing capsule|1|||
131702095|NCT01145066|474191072|FG001|Overall Study|problems swallowing capsule|0|||
131702096|NCT01145066|474191073|FG002|Overall Study|problems swallowing capsule|0|||
131702097|NCT01145066|474191071|FG000|Overall Study|Abdominal discomfort|0|||
131702098|NCT01145066|474191072|FG001|Overall Study|Abdominal discomfort|1|||
131580435|NCT01147341|473752311|FG001|Open Label Period|Lack of Efficacy|0|||
131702099|NCT01145066|474191073|FG002|Overall Study|Abdominal discomfort|0|||
131702100|NCT01145066|474191071|FG000|Overall Study|Low platelet count|0|||
131702101|NCT01145066|474191072|FG001|Overall Study|Low platelet count|1|||
131702102|NCT01145066|474191073|FG002|Overall Study|Low platelet count|0|||
131702103|NCT02026063|474191074|FG000|Overall Study|Physician Decision|0|||
131580436|NCT01147341|473752310|FG000|Open Label Period|Subject moved|1|||
131580437|NCT01147341|473752311|FG001|Open Label Period|Subject moved|0|||
131580438|NCT03024606|473752314|FG000|Overall Study|Withdrawal by Subject|9|||
131580439|NCT03024606|473752315|FG001|Overall Study|Withdrawal by Subject|10|||
131702104|NCT02026063|474191075|FG001|Overall Study|Physician Decision|10|||
131702105|NCT02026063|474191074|FG000|Overall Study|Noncompliance with Study Drug|1|||
131702106|NCT02026063|474191075|FG001|Overall Study|Noncompliance with Study Drug|1|||
131702107|NCT02026063|474191074|FG000|Overall Study|Withdrawal of Consent|1|||
131702108|NCT02026063|474191075|FG001|Overall Study|Withdrawal of Consent|6|||
131702109|NCT02026063|474191074|FG000|Overall Study|Adverse Event|5|||
131702110|NCT02026063|474191075|FG001|Overall Study|Adverse Event|20|||
131580440|NCT05323734|473752319|FG000|Overall Study|Adverse Event|5|||
131580441|NCT05323734|473752320|FG001|Overall Study|Adverse Event|2|||
131580442|NCT05323734|473752319|FG000|Overall Study|Physician Decision|1|||
131580443|NCT05323734|473752320|FG001|Overall Study|Physician Decision|0|||
131580444|NCT05323734|473752319|FG000|Overall Study|Lack of Efficacy|1|||
131580445|NCT05323734|473752320|FG001|Overall Study|Lack of Efficacy|2|||
131580446|NCT05323734|473752319|FG000|Overall Study|Withdrawal by Subject|2|||
131580447|NCT05323734|473752320|FG001|Overall Study|Withdrawal by Subject|0|||
131580448|NCT05323734|473752319|FG000|Overall Study|Participant Withdrawn Due|0|||
131580449|NCT05323734|473752320|FG001|Overall Study|Participant Withdrawn Due|1|||
131580450|NCT01595321|473752321|FG000|Overall Study|Adverse Event|1|||
131580451|NCT01595321|473752322|FG001|Overall Study|Adverse Event|1|||
131580452|NCT01595321|473752323|FG002|Overall Study|Adverse Event|1|||
131580453|NCT01595321|473752321|FG000|Overall Study|Lack of Efficacy|0|||
131580454|NCT01595321|473752322|FG001|Overall Study|Lack of Efficacy|0|||
131580455|NCT01595321|473752323|FG002|Overall Study|Lack of Efficacy|4|||
131580456|NCT00834834|473752324|FG000|Overall Study|Withdrawal by Subject|4|||
131580457|NCT00834834|473752325|FG001|Overall Study|Withdrawal by Subject|3|||
131580458|NCT00442117|473752326|FG000|Overall Study|Adverse Event|3|||
131580459|NCT00442117|473752327|FG001|Overall Study|Adverse Event|2|||
131580460|NCT00442117|473752326|FG000|Overall Study|Lack of Efficacy|2|||
131580461|NCT00442117|473752327|FG001|Overall Study|Lack of Efficacy|6|||
131580462|NCT00442117|473752326|FG000|Overall Study|Lost to Follow-up|1|||
131580463|NCT00442117|473752327|FG001|Overall Study|Lost to Follow-up|2|||
131580464|NCT00442117|473752326|FG000|Overall Study|Withdrawal by Subject|2|||
131580465|NCT00442117|473752327|FG001|Overall Study|Withdrawal by Subject|2|||
131580466|NCT00442117|473752326|FG000|Overall Study|Major Deviation|25|||
131580467|NCT00442117|473752327|FG001|Overall Study|Major Deviation|20|||
131580468|NCT00442117|473752326|FG000|Overall Study|Non compliance with protocol|3|||
131580469|NCT00442117|473752327|FG001|Overall Study|Non compliance with protocol|5|||
131580470|NCT00442117|473752326|FG000|Overall Study|Met Withdrawal Criteria|2|||
131580471|NCT00442117|473752327|FG001|Overall Study|Met Withdrawal Criteria|1|||
131580472|NCT00094575|473752328|FG000|Overall Study|Death|146|||
131580473|NCT00094575|473752329|FG001|Overall Study|Death|146|||
131580474|NCT00961636|473752336|FG000|Overall Study|Adverse Event|35|||
131580475|NCT00961636|473752337|FG001|Overall Study|Adverse Event|54|||
131580476|NCT00961636|473752338|FG002|Overall Study|Adverse Event|13|||
131580477|NCT00961636|473752336|FG000|Overall Study|Flushing Symptoms|29|||
131580478|NCT00961636|473752337|FG001|Overall Study|Flushing Symptoms|46|||
131580479|NCT00961636|473752338|FG002|Overall Study|Flushing Symptoms|3|||
131580480|NCT00961636|473752336|FG000|Overall Study|Lost to Follow-up|2|||
131580481|NCT00961636|473752337|FG001|Overall Study|Lost to Follow-up|3|||
131580482|NCT00961636|473752338|FG002|Overall Study|Lost to Follow-up|1|||
131580483|NCT00961636|473752336|FG000|Overall Study|Physician Decision|3|||
131580484|NCT00961636|473752337|FG001|Overall Study|Physician Decision|1|||
131580485|NCT00961636|473752338|FG002|Overall Study|Physician Decision|1|||
131580486|NCT00961636|473752336|FG000|Overall Study|Protocol Violation|9|||
131580487|NCT00961636|473752337|FG001|Overall Study|Protocol Violation|5|||
131580488|NCT00961636|473752338|FG002|Overall Study|Protocol Violation|1|||
131702111|NCT02026063|474191074|FG000|Overall Study|Lack of Efficacy|0|||
131702112|NCT02026063|474191075|FG001|Overall Study|Lack of Efficacy|4|||
131702113|NCT02026063|474191074|FG000|Overall Study|Lost to Follow-up|0|||
131702114|NCT02026063|474191075|FG001|Overall Study|Lost to Follow-up|1|||
131702115|NCT02026063|474191074|FG000|Overall Study|Reason not Specified|2|||
131580489|NCT00961636|473752336|FG000|Overall Study|Withdrawal by Subject|29|||
131580490|NCT00961636|473752337|FG001|Overall Study|Withdrawal by Subject|22|||
131702116|NCT02026063|474191075|FG001|Overall Study|Reason not Specified|7|||
131580491|NCT00961636|473752338|FG002|Overall Study|Withdrawal by Subject|13|||
131580492|NCT03603717|473752339|FG000|Overall Study|Lost to Follow-up|20|||
131702117|NCT03687502|474191079|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
131702118|NCT03687502|474191079|FG000|Overall Study|Lumason not available|1|||
131580493|NCT03603717|473752340|FG001|Overall Study|Lost to Follow-up|20|||
131580494|NCT03603717|473752339|FG000|Overall Study|Withdrawal by Subject|16|||
131580495|NCT03603717|473752340|FG001|Overall Study|Withdrawal by Subject|10|||
131580496|NCT00732381|473752341|FG000|Overall Study|Adverse Event|1|||
131580497|NCT00732381|473752342|FG001|Overall Study|Adverse Event|0|||
131580498|NCT00732381|473752341|FG000|Overall Study|Treatment Failure|1|||
131580499|NCT00732381|473752342|FG001|Overall Study|Treatment Failure|1|||
131580500|NCT01350804|473752345|FG000|Core Study|Withdrawal by Subject|11|||
131580501|NCT01350804|473752346|FG001|Core Study|Withdrawal by Subject|17|||
131580502|NCT01350804|473752347|FG002|Core Study|Withdrawal by Subject|16|||
131580503|NCT01350804|473752348|FG003|Core Study|Withdrawal by Subject|7|||
131702119|NCT00486278|474191083|FG000|Overall Study|Adverse Event|5|||
131702120|NCT00486278|474191083|FG000|Overall Study|Withdrawal by Subject|2|||
131580504|NCT01350804|473752345|FG000|Core Study|Study terminated by Sponsor|0|||
131580505|NCT01350804|473752346|FG001|Core Study|Study terminated by Sponsor|0|||
131580506|NCT01350804|473752347|FG002|Core Study|Study terminated by Sponsor|0|||
131580507|NCT01350804|473752348|FG003|Core Study|Study terminated by Sponsor|2|||
131580508|NCT01350804|473752345|FG000|Core Study|Protocol deviation|1|||
131580509|NCT01350804|473752346|FG001|Core Study|Protocol deviation|0|||
131580510|NCT01350804|473752347|FG002|Core Study|Protocol deviation|1|||
131580511|NCT01350804|473752348|FG003|Core Study|Protocol deviation|0|||
131580512|NCT01350804|473752345|FG000|Core Study|Physician Decision|1|||
131580513|NCT01350804|473752346|FG001|Core Study|Physician Decision|0|||
131580514|NCT01350804|473752347|FG002|Core Study|Physician Decision|1|||
131580515|NCT01350804|473752348|FG003|Core Study|Physician Decision|3|||
131580516|NCT01350804|473752345|FG000|Core Study|Lost to Follow-up|3|||
131580517|NCT01350804|473752346|FG001|Core Study|Lost to Follow-up|0|||
131580518|NCT01350804|473752347|FG002|Core Study|Lost to Follow-up|2|||
131580519|NCT01350804|473752348|FG003|Core Study|Lost to Follow-up|1|||
131580520|NCT01350804|473752345|FG000|Core Study|Lack of Efficacy|16|||
131580521|NCT01350804|473752346|FG001|Core Study|Lack of Efficacy|19|||
131580522|NCT01350804|473752347|FG002|Core Study|Lack of Efficacy|18|||
131580523|NCT01350804|473752348|FG003|Core Study|Lack of Efficacy|5|||
131580524|NCT01350804|473752345|FG000|Core Study|Death|1|||
131580525|NCT01350804|473752346|FG001|Core Study|Death|1|||
131580526|NCT01350804|473752347|FG002|Core Study|Death|1|||
131580527|NCT01350804|473752348|FG003|Core Study|Death|0|||
131580528|NCT01350804|473752345|FG000|Core Study|Adverse Event|8|||
131580529|NCT01350804|473752346|FG001|Core Study|Adverse Event|10|||
131580530|NCT01350804|473752347|FG002|Core Study|Adverse Event|8|||
131580531|NCT01350804|473752348|FG003|Core Study|Adverse Event|8|||
131580532|NCT01350804|473752345|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
131580533|NCT01350804|473752346|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
131580534|NCT01350804|473752347|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
131580535|NCT01350804|473752348|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
131580536|NCT01350804|473752345|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
131580537|NCT01350804|473752346|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
131580538|NCT01350804|473752347|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
131580539|NCT01350804|473752348|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
131580540|NCT01350804|473752345|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
131702121|NCT00486278|474191083|FG000|Overall Study|Physician Decision|2|||
131702122|NCT02937350|474191087|FG000|Overall Study|Withdrawal by Subject|0|||
131702123|NCT02937350|474191088|FG001|Overall Study|Withdrawal by Subject|1|||
131702124|NCT02937350|474191089|FG002|Overall Study|Withdrawal by Subject|0|||
131702125|NCT00429585|474191090|FG000|Overall Study|Death|1|||
131702126|NCT00429585|474191091|FG001|Overall Study|Death|0|||
131702127|NCT00429585|474191090|FG000|Overall Study|Lost to Follow-up|27|||
131702128|NCT00429585|474191091|FG001|Overall Study|Lost to Follow-up|20|||
131702129|NCT00429585|474191090|FG000|Overall Study|Physician Decision|2|||
131702130|NCT00429585|474191091|FG001|Overall Study|Physician Decision|0|||
131702131|NCT00930059|474193007|FG000|Overall Study|Death|1|||
131702132|NCT00930059|474193008|FG001|Overall Study|Death|0|||
131702133|NCT00930059|474193007|FG000|Overall Study|Did not meet entrance criteria|1|||
131702134|NCT00930059|474193008|FG001|Overall Study|Did not meet entrance criteria|1|||
131702135|NCT00930059|474193007|FG000|Overall Study|Withdrawal by Subject|3|||
131702136|NCT00930059|474193008|FG001|Overall Study|Withdrawal by Subject|4|||
131702137|NCT00930059|474193007|FG000|Overall Study|Other|1|||
131702138|NCT00930059|474193008|FG001|Overall Study|Other|0|||
131702139|NCT00930059|474193007|FG000|Overall Study|1 site terminated by sponsor|1|||
131702140|NCT00930059|474193008|FG001|Overall Study|1 site terminated by sponsor|1|||
131702141|NCT00930059|474193007|FG000|Overall Study|Adverse Event|1|||
131702142|NCT00930059|474193008|FG001|Overall Study|Adverse Event|6|||
131702143|NCT04002310|474193011|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
131580541|NCT01350804|473752346|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
131580542|NCT01350804|473752347|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
131702144|NCT04002310|474193012|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
131702145|NCT04002310|474193013|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
131438366|NCT03192176|473231212|FG005|Overall Study|Physician Decision|2|||
131580543|NCT01350804|473752348|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
131580544|NCT01350804|473752345|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
131580545|NCT01350804|473752346|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
131580546|NCT01350804|473752347|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
131580547|NCT01350804|473752348|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
131580548|NCT01350804|473752345|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
131580549|NCT01350804|473752346|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
131702146|NCT04002310|474193014|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
131702147|NCT04002310|474193015|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
131702148|NCT02949128|474193018|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
131898742|NCT00943397|474915348|FG001|Overall Study|Adverse Event|6|||
131787774|NCT01890785|474506021|FG004|Third Intervention|Withdrawal by Subject|0|||
131787775|NCT01890785|474506022|FG005|Third Intervention|Withdrawal by Subject|0|||
131787776|NCT03712228|474506023|FG000|Treatment Period 1|Lack of Efficacy|0|||
131787777|NCT03712228|474506024|FG001|Treatment Period 1|Lack of Efficacy|0|||
131787778|NCT03712228|474506025|FG002|Treatment Period 1|Lack of Efficacy|0|||
131787779|NCT03712228|474506026|FG003|Treatment Period 1|Lack of Efficacy|0|||
131787780|NCT03712228|474506027|FG004|Treatment Period 1|Lack of Efficacy|0|||
131787781|NCT03712228|474506028|FG005|Treatment Period 1|Lack of Efficacy|1|||
131787782|NCT03712228|474506023|FG000|Treatment Period 2|Pregnancy|0|||
131787783|NCT03712228|474506024|FG001|Treatment Period 2|Pregnancy|0|||
131787784|NCT03712228|474506025|FG002|Treatment Period 2|Pregnancy|0|||
131787785|NCT03712228|474506026|FG003|Treatment Period 2|Pregnancy|1|||
131787786|NCT03712228|474506027|FG004|Treatment Period 2|Pregnancy|0|||
131787787|NCT03712228|474506028|FG005|Treatment Period 2|Pregnancy|0|||
131787788|NCT03712228|474506023|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131787789|NCT03712228|474506024|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131787790|NCT03712228|474506025|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131787791|NCT03712228|474506026|FG003|Treatment Period 2|Withdrawal by Subject|1|||
131787792|NCT03712228|474506027|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131787793|NCT03712228|474506028|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131787794|NCT01964105|474506029|FG000|Overall Study|Lost to Follow-up|2|||
131787795|NCT01964105|474506030|FG001|Overall Study|Lost to Follow-up|13|||
131787796|NCT01964105|474506031|FG002|Overall Study|Lost to Follow-up|0|||
131787797|NCT03296553|474506033|FG000|Overall Study|Withdrawal by Subject|1|||
131787798|NCT03296553|474506034|FG001|Overall Study|Withdrawal by Subject|1|||
131787799|NCT03296553|474506033|FG000|Overall Study|Death|1|||
131787800|NCT03296553|474506034|FG001|Overall Study|Death|0|||
131787801|NCT02295280|474506035|FG000|Overall Study|Adverse Event|0|||
131787802|NCT02295280|474506036|FG001|Overall Study|Adverse Event|1|||
131787803|NCT00558519|474506037|FG000|Overall Study|Ph+|20|||
131787804|NCT00558519|474506037|FG000|Overall Study|Ineligible|1|||
131787805|NCT00558519|474506037|FG000|Overall Study|Insufficient data|1|||
131787806|NCT00558519|474506037|FG000|Overall Study|Never received treatment|1|||
131787807|NCT03001011|474506038|FG000|Overall Study|Adverse Event|9|||
131787808|NCT03001011|474506039|FG001|Overall Study|Adverse Event|3|||
131787809|NCT03001011|474506038|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
131787810|NCT03001011|474506039|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
131787811|NCT03001011|474506038|FG000|Overall Study|Other than specified above|3|||
131787812|NCT03001011|474506039|FG001|Overall Study|Other than specified above|8|||
131787813|NCT02875067|474506040|FG000|Overall Study|Withdrawal by Subject|1|||
131787814|NCT02875067|474506040|FG000|Overall Study|Withdrawal by Termination of Study|5|||
131787815|NCT00065065|474506041|FG000|Overall Study|Adverse Event|3|||
131787816|NCT00065065|474506042|FG001|Overall Study|Adverse Event|2|||
131787817|NCT00065065|474506041|FG000|Overall Study|Withdrawal by Subject|1|||
131787818|NCT00065065|474506042|FG001|Overall Study|Withdrawal by Subject|5|||
131787819|NCT00065065|474506041|FG000|Overall Study|Lack of Efficacy|4|||
131787820|NCT00065065|474506042|FG001|Overall Study|Lack of Efficacy|11|||
131787821|NCT00065065|474506041|FG000|Overall Study|Other|2|||
131787822|NCT00065065|474506042|FG001|Overall Study|Other|2|||
131787823|NCT02713243|474506046|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
131787824|NCT02713243|474506047|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
131787825|NCT02713243|474506046|FG000|Overall Study|Administrative problems|0|||
131787826|NCT02713243|474506047|FG001|Overall Study|Administrative problems|1|||
131787827|NCT02713243|474506046|FG000|Overall Study|Protocol deviation|0|||
131787828|NCT02713243|474506047|FG001|Overall Study|Protocol deviation|1|||
131787829|NCT01050673|474506048|FG000|Overall Study|Physician Decision|4|||
131787830|NCT01050673|474506049|FG001|Overall Study|Physician Decision|5|||
131787831|NCT00124449|474506050|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
131787832|NCT00124449|474506051|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
131787833|NCT00124449|474506050|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
131787834|NCT00124449|474506051|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
131787835|NCT00124449|474506050|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
131787836|NCT00124449|474506051|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
131787837|NCT00124449|474506050|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
131787838|NCT00124449|474506051|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
131787839|NCT00124449|474506050|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
131787840|NCT00124449|474506051|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
131787841|NCT00124449|474506050|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
131787842|NCT00124449|474506051|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
131787843|NCT00124449|474506050|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
131787844|NCT00124449|474506051|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
131787845|NCT00124449|474506050|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
131787846|NCT00124449|474506051|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
131787847|NCT00124449|474506050|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
131787848|NCT00124449|474506051|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
131787849|NCT00124449|474506050|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
131787850|NCT00124449|474506051|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
131787851|NCT00124449|474506050|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
131787852|NCT00124449|474506051|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
131787853|NCT00124449|474506050|FG000|18-Month Untreated Observation Period|Relocated|1|||
131580550|NCT01350804|473752347|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
131580551|NCT01350804|473752348|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
131580552|NCT01350804|473752345|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
131580553|NCT01350804|473752346|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
131580554|NCT01350804|473752347|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
131580555|NCT01350804|473752348|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
131580556|NCT02299336|473752349|FG000|Overall Study|Withdrawal by Subject|11|||
131580557|NCT02299336|473752349|FG000|Overall Study|Adverse Event|1|||
131580558|NCT02299336|473752349|FG000|Overall Study|Death|1|||
131580559|NCT02299336|473752349|FG000|Overall Study|Lost to Follow-up|1|||
131580560|NCT02106442|473752350|FG000|Overall Study|Case Report Forms Uncollected|7|||
131580561|NCT02106442|473752350|FG000|Overall Study|Protocol Deviation|30|||
131580562|NCT00573833|473752353|FG000|Overall Study|Not Treated|2|||
131580563|NCT05328297|473753572|FG000|Overall Study|Adverse Event|5|||
131580564|NCT05328297|473753573|FG001|Overall Study|Adverse Event|7|||
131580565|NCT05328297|473753572|FG000|Overall Study|Withdrawal by Subject|4|||
131580566|NCT05328297|473753573|FG001|Overall Study|Withdrawal by Subject|3|||
131580567|NCT05328297|473753572|FG000|Overall Study|Lack of Efficacy|1|||
131580568|NCT05328297|473753573|FG001|Overall Study|Lack of Efficacy|0|||
131580569|NCT05328297|473753572|FG000|Overall Study|Lost to Follow-up|1|||
131580570|NCT05328297|473753573|FG001|Overall Study|Lost to Follow-up|0|||
131580571|NCT05328297|473753572|FG000|Overall Study|Protocol Violation|1|||
131580572|NCT05328297|473753573|FG001|Overall Study|Protocol Violation|0|||
131580573|NCT05328297|473753572|FG000|Overall Study|Randomized but not treated|1|||
131580574|NCT05328297|473753573|FG001|Overall Study|Randomized but not treated|1|||
131580575|NCT02015546|473753579|FG000|Overall Study|Withdrawal by Subject|1|||
131580576|NCT02015546|473753580|FG001|Overall Study|Withdrawal by Subject|1|||
131702149|NCT02949128|474193018|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
131702150|NCT02949128|474193018|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
131702151|NCT02949128|474193018|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
131702152|NCT02949128|474193018|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
131702153|NCT02949128|474193018|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
131702154|NCT02949128|474193018|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
131702155|NCT02949128|474193018|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
131702156|NCT02949128|474193018|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
131702157|NCT02949128|474193018|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
131702158|NCT03064763|474193020|FG000|Overall Study|Lost to Follow-up|1|||
131702159|NCT03064763|474193020|FG000|Overall Study|Death|8|||
131702160|NCT03786432|474193021|FG000|Overall Study|Screen Failure after consent|1|||
131702161|NCT03786432|474193021|FG000|Overall Study|Lost to Follow-up|4|||
131702162|NCT03786432|474193021|FG000|Overall Study|did not complete 12 month CT scan|1|||
131702163|NCT03160560|474193022|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
131702164|NCT03160560|474193023|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131702165|NCT03160560|474193024|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131702166|NCT03160560|474193025|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131702167|NCT03160560|474193022|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
131702168|NCT03160560|474193023|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131702169|NCT03160560|474193024|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131702170|NCT03160560|474193025|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131702171|NCT00454779|474193028|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
131702172|NCT00454779|474193029|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
131702173|NCT00454779|474193028|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
131702174|NCT00454779|474193029|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
131787854|NCT00124449|474506051|FG001|18-Month Untreated Observation Period|Relocated|0|||
131580577|NCT02015546|473753581|FG002|Overall Study|Withdrawal by Subject|1|||
131580578|NCT02015546|473753579|FG000|Overall Study|Screem Failure|2|||
131580579|NCT02015546|473753580|FG001|Overall Study|Screem Failure|1|||
131580580|NCT02015546|473753581|FG002|Overall Study|Screem Failure|3|||
131580581|NCT02202499|473753585|FG000|Overall Study|Cancer diagnosis|0|||
131580582|NCT02202499|473753586|FG001|Overall Study|Cancer diagnosis|0|||
131702175|NCT00454779|474193028|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
131580583|NCT02202499|473753587|FG002|Overall Study|Cancer diagnosis|1|||
131580584|NCT02202499|473753585|FG000|Overall Study|Moved from area|0|||
131580585|NCT02202499|473753586|FG001|Overall Study|Moved from area|0|||
131580586|NCT02202499|473753587|FG002|Overall Study|Moved from area|1|||
131580587|NCT02202499|473753585|FG000|Overall Study|Declined before randomization|1|||
131580588|NCT02202499|473753586|FG001|Overall Study|Declined before randomization|0|||
131580589|NCT02202499|473753587|FG002|Overall Study|Declined before randomization|0|||
131580590|NCT02202499|473753585|FG000|Overall Study|Auto accident|1|||
131580591|NCT02202499|473753586|FG001|Overall Study|Auto accident|0|||
131580592|NCT02202499|473753587|FG002|Overall Study|Auto accident|0|||
131580593|NCT05283395|473753590|FG000|Overall Study|Adverse Event|4|||
131580594|NCT05283395|473753591|FG001|Overall Study|Adverse Event|4|||
131580595|NCT05283395|473753592|FG002|Overall Study|Adverse Event|0|||
131580596|NCT05283395|473753590|FG000|Overall Study|Patient Lost to Follow-Up|0|||
131580597|NCT05283395|473753591|FG001|Overall Study|Patient Lost to Follow-Up|0|||
131580598|NCT05283395|473753592|FG002|Overall Study|Patient Lost to Follow-Up|1|||
131580599|NCT05283395|473753590|FG000|Overall Study|Patient Withdrawal|2|||
131580600|NCT05283395|473753591|FG001|Overall Study|Patient Withdrawal|4|||
131580601|NCT05283395|473753592|FG002|Overall Study|Patient Withdrawal|2|||
131580602|NCT05283395|473753590|FG000|Overall Study|Investigator Decision|1|||
131580603|NCT05283395|473753591|FG001|Overall Study|Investigator Decision|0|||
131580604|NCT05283395|473753592|FG002|Overall Study|Investigator Decision|1|||
131580605|NCT05283395|473753590|FG000|Overall Study|Enrolled in error|0|||
131580606|NCT05283395|473753591|FG001|Overall Study|Enrolled in error|0|||
131580607|NCT05283395|473753592|FG002|Overall Study|Enrolled in error|1|||
131580608|NCT00712335|473753593|FG000|Overall Study|Withdrawal by Subject|0|||
131580609|NCT00712335|473753594|FG001|Overall Study|Withdrawal by Subject|7|||
131580610|NCT00712335|473753595|FG002|Overall Study|Withdrawal by Subject|2|||
131580611|NCT00712335|473753596|FG003|Overall Study|Withdrawal by Subject|3|||
131580612|NCT00712335|473753597|FG004|Overall Study|Withdrawal by Subject|0|||
131580613|NCT00712335|473753593|FG000|Overall Study|Lost to Follow-up|2|||
131580614|NCT00712335|473753594|FG001|Overall Study|Lost to Follow-up|5|||
131580615|NCT00712335|473753595|FG002|Overall Study|Lost to Follow-up|0|||
131580616|NCT00712335|473753596|FG003|Overall Study|Lost to Follow-up|1|||
131580617|NCT00712335|473753597|FG004|Overall Study|Lost to Follow-up|0|||
131580618|NCT00712335|473753593|FG000|Overall Study|Protocol Violation|1|||
131580619|NCT00712335|473753594|FG001|Overall Study|Protocol Violation|2|||
131580620|NCT00712335|473753595|FG002|Overall Study|Protocol Violation|1|||
131580621|NCT00712335|473753596|FG003|Overall Study|Protocol Violation|0|||
131580622|NCT00712335|473753597|FG004|Overall Study|Protocol Violation|0|||
131580623|NCT00712335|473753593|FG000|Overall Study|Lack of Efficacy|0|||
131580624|NCT00712335|473753594|FG001|Overall Study|Lack of Efficacy|0|||
131580625|NCT00712335|473753595|FG002|Overall Study|Lack of Efficacy|1|||
131580626|NCT00712335|473753596|FG003|Overall Study|Lack of Efficacy|1|||
131580627|NCT00712335|473753597|FG004|Overall Study|Lack of Efficacy|0|||
131787855|NCT02971605|474506052|FG000|Overall Study|Withdrawal by Subject|1|||
131787856|NCT01021137|474506053|FG000|Overall Study|Lost to Follow-up|9|||
131787857|NCT01021137|474506054|FG001|Overall Study|Lost to Follow-up|4|||
131787858|NCT01021137|474506055|FG002|Overall Study|Lost to Follow-up|2|||
131787859|NCT01021137|474506056|FG003|Overall Study|Lost to Follow-up|6|||
131787860|NCT01021137|474506053|FG000|Overall Study|Withdrawal by Subject|1|||
131787861|NCT01021137|474506054|FG001|Overall Study|Withdrawal by Subject|0|||
131787862|NCT01021137|474506055|FG002|Overall Study|Withdrawal by Subject|0|||
131787863|NCT01021137|474506056|FG003|Overall Study|Withdrawal by Subject|3|||
131787864|NCT03439293|474506057|FG000|Overall Study|Death|22|||
131787865|NCT03439293|474506057|FG000|Overall Study|Withdrawal by Subject|8|||
131787866|NCT03439293|474506057|FG000|Overall Study|Lost to Follow-up|2|||
131580628|NCT00712335|473753593|FG000|Overall Study|Other Reason|0|||
131787867|NCT03439293|474506057|FG000|Overall Study|Reason Not Specified|28|||
131580629|NCT00712335|473753594|FG001|Overall Study|Other Reason|3|||
131580630|NCT00712335|473753595|FG002|Overall Study|Other Reason|1|||
131580631|NCT00712335|473753596|FG003|Overall Study|Other Reason|0|||
131580632|NCT00712335|473753597|FG004|Overall Study|Other Reason|0|||
131580633|NCT03401112|473753598|FG000|Overall Study|Adverse Event|1|||
131580634|NCT03401112|473753599|FG001|Overall Study|Adverse Event|2|||
131580635|NCT03401112|473753600|FG002|Overall Study|Adverse Event|3|||
131580636|NCT03401112|473753601|FG003|Overall Study|Adverse Event|2|||
131580637|NCT03401112|473753602|FG004|Overall Study|Adverse Event|0|||
131787868|NCT03439293|474506057|FG000|Overall Study|Missing|1|||
131580638|NCT03401112|473753598|FG000|Overall Study|Lost to Follow-up|1|||
131580639|NCT03401112|473753599|FG001|Overall Study|Lost to Follow-up|0|||
131580640|NCT03401112|473753600|FG002|Overall Study|Lost to Follow-up|0|||
131787869|NCT02766400|474506062|FG000|Overall Study|Death|1|||
131787870|NCT02766400|474506063|FG001|Overall Study|Death|2|||
131787871|NCT02766400|474506062|FG000|Overall Study|Withdrawal by Subject|1|||
131580641|NCT03401112|473753601|FG003|Overall Study|Lost to Follow-up|0|||
131580642|NCT03401112|473753602|FG004|Overall Study|Lost to Follow-up|0|||
131580643|NCT03401112|473753598|FG000|Overall Study|Noncompliance|1|||
131580644|NCT03401112|473753599|FG001|Overall Study|Noncompliance|2|||
131580645|NCT03401112|473753600|FG002|Overall Study|Noncompliance|3|||
131580646|NCT03401112|473753601|FG003|Overall Study|Noncompliance|0|||
131580647|NCT03401112|473753602|FG004|Overall Study|Noncompliance|0|||
131580648|NCT03401112|473753598|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
131580649|NCT03401112|473753599|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
131580650|NCT03401112|473753600|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
131580651|NCT03401112|473753601|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
131580652|NCT03401112|473753602|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
131580653|NCT03401112|473753598|FG000|Overall Study|Withdrawal by Subject|0|||
131580654|NCT03401112|473753599|FG001|Overall Study|Withdrawal by Subject|3|||
131580655|NCT03401112|473753600|FG002|Overall Study|Withdrawal by Subject|2|||
131580656|NCT03401112|473753601|FG003|Overall Study|Withdrawal by Subject|1|||
131580657|NCT03401112|473753602|FG004|Overall Study|Withdrawal by Subject|0|||
131580658|NCT03401112|473753598|FG000|Overall Study|Physician Decision|0|||
131580659|NCT03401112|473753599|FG001|Overall Study|Physician Decision|0|||
131580660|NCT03401112|473753600|FG002|Overall Study|Physician Decision|0|||
131580661|NCT03401112|473753601|FG003|Overall Study|Physician Decision|2|||
131580662|NCT03401112|473753602|FG004|Overall Study|Physician Decision|0|||
131580663|NCT03401112|473753598|FG000|Overall Study|Study was Terminated by Sponsor|0|||
131580664|NCT03401112|473753599|FG001|Overall Study|Study was Terminated by Sponsor|0|||
131580665|NCT03401112|473753600|FG002|Overall Study|Study was Terminated by Sponsor|0|||
131580666|NCT03401112|473753601|FG003|Overall Study|Study was Terminated by Sponsor|1|||
131580667|NCT03401112|473753602|FG004|Overall Study|Study was Terminated by Sponsor|0|||
131580668|NCT03401112|473753598|FG000|Overall Study|Day 1 Assessment not Done|1|||
131580669|NCT03401112|473753599|FG001|Overall Study|Day 1 Assessment not Done|0|||
131580670|NCT03401112|473753600|FG002|Overall Study|Day 1 Assessment not Done|0|||
131580671|NCT03401112|473753601|FG003|Overall Study|Day 1 Assessment not Done|0|||
131580672|NCT03401112|473753602|FG004|Overall Study|Day 1 Assessment not Done|0|||
131580673|NCT03401112|473753598|FG000|Overall Study|Not Dosed|0|||
131580674|NCT03401112|473753599|FG001|Overall Study|Not Dosed|0|||
131580675|NCT03401112|473753600|FG002|Overall Study|Not Dosed|1|||
131580676|NCT03401112|473753601|FG003|Overall Study|Not Dosed|0|||
131580677|NCT03401112|473753602|FG004|Overall Study|Not Dosed|0|||
131580678|NCT03401112|473753598|FG000|Overall Study|Missed Clinical Visit|0|||
131580679|NCT03401112|473753599|FG001|Overall Study|Missed Clinical Visit|0|||
131580680|NCT03401112|473753600|FG002|Overall Study|Missed Clinical Visit|1|||
131580681|NCT03401112|473753601|FG003|Overall Study|Missed Clinical Visit|0|||
131580682|NCT03401112|473753602|FG004|Overall Study|Missed Clinical Visit|0|||
131580683|NCT03401112|473753598|FG000|Overall Study|Missed Doses|0|||
131580684|NCT03401112|473753599|FG001|Overall Study|Missed Doses|0|||
131580685|NCT03401112|473753600|FG002|Overall Study|Missed Doses|1|||
131580686|NCT03401112|473753601|FG003|Overall Study|Missed Doses|0|||
131580687|NCT03401112|473753602|FG004|Overall Study|Missed Doses|0|||
131580688|NCT03194958|473753603|FG000|Overall Study|Death|0|||
131580689|NCT03194958|473753604|FG001|Overall Study|Death|1|||
131580690|NCT03194958|473753605|FG002|Overall Study|Death|1|||
131580691|NCT03194958|473753606|FG003|Overall Study|Death|1|||
131580692|NCT03194958|473753603|FG000|Overall Study|Withdrawal by Subject|24|||
131580693|NCT03194958|473753604|FG001|Overall Study|Withdrawal by Subject|27|||
131580694|NCT03194958|473753605|FG002|Overall Study|Withdrawal by Subject|7|||
131580695|NCT03194958|473753606|FG003|Overall Study|Withdrawal by Subject|22|||
131580696|NCT03194958|473753603|FG000|Overall Study|Lost to Follow-up|168|||
131787872|NCT02766400|474506063|FG001|Overall Study|Withdrawal by Subject|0|||
131787873|NCT03499249|474506068|FG000|Overall Study|Physician Decision|1|||
131787874|NCT00435825|474506069|FG000|Overall Study|Abnormality of Laboratory Test|0|||
131580697|NCT03194958|473753604|FG001|Overall Study|Lost to Follow-up|196|||
131787875|NCT00435825|474506070|FG001|Overall Study|Abnormality of Laboratory Test|1|||
131580698|NCT03194958|473753605|FG002|Overall Study|Lost to Follow-up|174|||
131580699|NCT03194958|473753606|FG003|Overall Study|Lost to Follow-up|186|||
131580700|NCT01968226|473753608|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
131580701|NCT01202955|473753611|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
131580702|NCT01202955|473753612|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
131580703|NCT04975308|473753617|FG000|Overall Study|Withdrawal by Subject|6|||
131580704|NCT04975308|473753618|FG001|Overall Study|Withdrawal by Subject|16|||
131580705|NCT04975308|473753619|FG002|Overall Study|Withdrawal by Subject|6|||
131580706|NCT04975308|473753617|FG000|Overall Study|Physician Decision|0|||
131787876|NCT00435825|474506071|FG002|Overall Study|Abnormality of Laboratory Test|0|||
131787877|NCT00435825|474506072|FG003|Overall Study|Abnormality of Laboratory Test|0|||
131580707|NCT04975308|473753618|FG001|Overall Study|Physician Decision|3|||
131702176|NCT00454779|474193029|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
131702177|NCT00454779|474193028|FG000|First-line Treatment Phase|Protocol Violation|0|||
131702178|NCT00454779|474193029|FG001|First-line Treatment Phase|Protocol Violation|1|||
131702179|NCT00454779|474193028|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
131702180|NCT00454779|474193029|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
131702181|NCT00454779|474193028|FG000|First-line Treatment Phase|Ongoing|1|||
131702182|NCT00454779|474193029|FG001|First-line Treatment Phase|Ongoing|0|||
131702183|NCT00454779|474193028|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
131702184|NCT00454779|474193029|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
131898743|NCT00943397|474915347|FG000|Overall Study|Lost to Follow-up|0|||
131580708|NCT04975308|473753619|FG002|Overall Study|Physician Decision|1|||
131580709|NCT04975308|473753617|FG000|Overall Study|Adverse Event|10|||
131580710|NCT04975308|473753618|FG001|Overall Study|Adverse Event|1|||
131580711|NCT04975308|473753619|FG002|Overall Study|Adverse Event|12|||
131580712|NCT04975308|473753617|FG000|Overall Study|On study treatment (Ongoing)|65|||
131580713|NCT04975308|473753618|FG001|Overall Study|On study treatment (Ongoing)|43|||
131580714|NCT04975308|473753619|FG002|Overall Study|On study treatment (Ongoing)|75|||
131580715|NCT04975308|473753617|FG000|Overall Study|Protocol Deviation|4|||
131580716|NCT04975308|473753618|FG001|Overall Study|Protocol Deviation|3|||
131580717|NCT04975308|473753619|FG002|Overall Study|Protocol Deviation|2|||
131580718|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
131580719|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131580720|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131580721|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131580722|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131580723|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
131580724|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131580725|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131580726|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131580727|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131580728|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
131580729|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131580730|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131580731|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131580732|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131787878|NCT00435825|474506069|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131787879|NCT00435825|474506070|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131580733|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
131580734|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131580735|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131580736|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131580737|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131787880|NCT00435825|474506071|FG002|Overall Study|Insufficient Therapeutic Response|0|||
131787881|NCT00435825|474506072|FG003|Overall Study|Insufficient Therapeutic Response|3|||
131787882|NCT00435825|474506069|FG000|Overall Study|Other Protocol Violation|1|||
131787883|NCT00435825|474506070|FG001|Overall Study|Other Protocol Violation|0|||
131787884|NCT00435825|474506071|FG002|Overall Study|Other Protocol Violation|0|||
131787885|NCT00435825|474506072|FG003|Overall Study|Other Protocol Violation|0|||
131787886|NCT00435825|474506069|FG000|Overall Study|Refused treatment|2|||
131787887|NCT00435825|474506070|FG001|Overall Study|Refused treatment|0|||
131787888|NCT00435825|474506071|FG002|Overall Study|Refused treatment|0|||
131580738|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
131580739|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131580740|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131580741|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131580742|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131787889|NCT00435825|474506072|FG003|Overall Study|Refused treatment|5|||
131787890|NCT00435825|474506069|FG000|Overall Study|Failure to return|5|||
131787891|NCT00435825|474506070|FG001|Overall Study|Failure to return|0|||
131787892|NCT00435825|474506071|FG002|Overall Study|Failure to return|4|||
131787893|NCT00435825|474506072|FG003|Overall Study|Failure to return|0|||
131787894|NCT00435825|474506069|FG000|Overall Study|Did not receive study drug|1|||
131787895|NCT00435825|474506070|FG001|Overall Study|Did not receive study drug|0|||
131702185|NCT00454779|474193028|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
131702186|NCT00454779|474193029|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
131702187|NCT00454779|474193028|FG000|Second-line Treatment Phase|Ongoing|0|||
131702188|NCT00454779|474193029|FG001|Second-line Treatment Phase|Ongoing|1|||
131702189|NCT05425563|474193032|FG000|Overall Study|Withdrawal by Subject|17|||
131702190|NCT00168831|474193033|FG000|Overall Study|Adverse Event|36|||
131702191|NCT00168831|474193034|FG001|Overall Study|Adverse Event|47|||
131787896|NCT00435825|474506071|FG002|Overall Study|Did not receive study drug|2|||
131787897|NCT00435825|474506072|FG003|Overall Study|Did not receive study drug|0|||
131787898|NCT00435825|474506069|FG000|Overall Study|Did not enter follow-up|0|||
131787899|NCT00435825|474506070|FG001|Overall Study|Did not enter follow-up|4|||
131580743|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
131580744|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131580745|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131702192|NCT00168831|474193035|FG002|Overall Study|Adverse Event|74|||
131702193|NCT00168831|474193033|FG000|Overall Study|Lost to Follow-up|5|||
131787900|NCT00435825|474506071|FG002|Overall Study|Did not enter follow-up|1|||
131787901|NCT00435825|474506072|FG003|Overall Study|Did not enter follow-up|3|||
131787902|NCT00435825|474506069|FG000|Overall Study|Did not complete full follow-up period|6|||
131787903|NCT00435825|474506070|FG001|Overall Study|Did not complete full follow-up period|6|||
131787904|NCT00435825|474506071|FG002|Overall Study|Did not complete full follow-up period|4|||
131580746|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131580747|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131580748|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
131580749|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131580750|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131580751|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131580752|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131580753|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
131580754|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131580755|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131580756|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131580757|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131580758|NCT02709655|473753620|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
131580759|NCT02709655|473753621|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131580760|NCT02709655|473753622|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131580761|NCT02709655|473753623|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131580762|NCT02709655|473753624|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131580763|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
131580764|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
131787905|NCT00435825|474506072|FG003|Overall Study|Did not complete full follow-up period|5|||
131787906|NCT01529749|474506073|FG000|Overall Study|Lost to Follow-up|0|||
131787907|NCT01529749|474506074|FG001|Overall Study|Lost to Follow-up|1|||
131787908|NCT01529749|474506075|FG002|Overall Study|Lost to Follow-up|1|||
131787909|NCT01529749|474506076|FG003|Overall Study|Lost to Follow-up|0|||
131787910|NCT01529749|474506073|FG000|Overall Study|Physician Decision|0|||
131787911|NCT01529749|474506074|FG001|Overall Study|Physician Decision|0|||
131787912|NCT01529749|474506075|FG002|Overall Study|Physician Decision|0|||
131580765|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
131580766|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
131702194|NCT00168831|474193034|FG001|Overall Study|Lost to Follow-up|6|||
131702195|NCT00168831|474193035|FG002|Overall Study|Lost to Follow-up|4|||
131702196|NCT00168831|474193033|FG000|Overall Study|Withdrawal by Subject|7|||
131702197|NCT00168831|474193034|FG001|Overall Study|Withdrawal by Subject|14|||
131702198|NCT00168831|474193035|FG002|Overall Study|Withdrawal by Subject|19|||
131702199|NCT00168831|474193033|FG000|Overall Study|Protocol Violation|6|||
131702200|NCT00168831|474193034|FG001|Overall Study|Protocol Violation|11|||
131702201|NCT00168831|474193035|FG002|Overall Study|Protocol Violation|11|||
131702202|NCT00168831|474193033|FG000|Overall Study|Other|6|||
131702203|NCT00168831|474193034|FG001|Overall Study|Other|3|||
131702204|NCT00168831|474193035|FG002|Overall Study|Other|6|||
131702205|NCT01622569|474193039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
131787913|NCT01529749|474506076|FG003|Overall Study|Physician Decision|1|||
131702206|NCT01622569|474193040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
131702207|NCT01622569|474193041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
131702208|NCT01622569|474193042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
131702209|NCT01622569|474193039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
131702210|NCT01622569|474193040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
131702211|NCT01622569|474193041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
131702212|NCT01622569|474193042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
131702213|NCT01622569|474193039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
131702214|NCT01622569|474193040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
131702215|NCT01622569|474193041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
131702216|NCT01622569|474193042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
131702217|NCT01622569|474193039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131702218|NCT01622569|474193040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
131702219|NCT01622569|474193041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131702220|NCT01622569|474193042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
131702221|NCT01622569|474193039|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
131702222|NCT01622569|474193040|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
131702223|NCT01622569|474193041|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
131702224|NCT01622569|474193042|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
131702225|NCT01622569|474193039|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
131702226|NCT01622569|474193040|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
131702227|NCT01622569|474193041|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131702228|NCT01622569|474193042|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
131702229|NCT01622569|474193039|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
131702230|NCT01622569|474193040|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131702231|NCT01622569|474193041|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
131702232|NCT01622569|474193042|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
131702233|NCT01622569|474193039|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131702234|NCT01622569|474193040|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131702235|NCT01622569|474193041|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131702236|NCT01622569|474193042|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
131702237|NCT02009878|474193043|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
131702238|NCT02009878|474193044|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
131702239|NCT02009878|474193045|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
131702240|NCT01940484|474193049|FG000|Overall Study|Withdrawal by Subject|3|||
131702241|NCT01940484|474193049|FG000|Overall Study|Underwent transplantation|4|||
131702242|NCT01940484|474193049|FG000|Overall Study|Death|2|||
131702243|NCT01940484|474193049|FG000|Overall Study|Adverse Event|1|||
131702244|NCT00343512|474193056|FG000|Overall Study|Withdrawal by Subject|2|||
131702245|NCT00684515|474193057|FG000|Overall Study|Adverse Event|3|||
131702246|NCT00684515|474193058|FG001|Overall Study|Adverse Event|3|||
131702247|NCT00684515|474193059|FG002|Overall Study|Adverse Event|1|||
131702248|NCT00684515|474193057|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
131702249|NCT00684515|474193058|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
131702250|NCT00684515|474193059|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
131702251|NCT04428411|474193060|FG000|Overall Study|Lost to Follow-up|114|||
131702252|NCT00634569|474193061|FG000|Overall Study|Withdrawal by Subject|0|||
131702253|NCT00634569|474193062|FG001|Overall Study|Withdrawal by Subject|4|||
131702254|NCT00634569|474193061|FG000|Overall Study|Physician Decision|0|||
131702255|NCT00634569|474193062|FG001|Overall Study|Physician Decision|1|||
131702256|NCT01163786|474193063|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
131702257|NCT01163786|474193063|FG000|Treatment With Bortezomib|Adverse Event|2|||
131702258|NCT01163786|474193063|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
131702259|NCT02918019|474193064|FG000|Overall Study|Death|0|||
131702260|NCT02918019|474193065|FG001|Overall Study|Death|0|||
131702261|NCT02918019|474193066|FG002|Overall Study|Death|1|||
131702262|NCT02918019|474193067|FG003|Overall Study|Death|0|||
131702263|NCT02918019|474193064|FG000|Overall Study|Lost to Follow-up|1|||
131702264|NCT02918019|474193065|FG001|Overall Study|Lost to Follow-up|1|||
131702265|NCT02918019|474193066|FG002|Overall Study|Lost to Follow-up|0|||
131702266|NCT02918019|474193067|FG003|Overall Study|Lost to Follow-up|1|||
131702267|NCT02918019|474193064|FG000|Overall Study|Principal investigator request|0|||
131702268|NCT02918019|474193065|FG001|Overall Study|Principal investigator request|0|||
131787914|NCT01529749|474506073|FG000|Overall Study|Withdrawal by Subject|0|||
131787915|NCT01529749|474506074|FG001|Overall Study|Withdrawal by Subject|1|||
131787916|NCT01529749|474506075|FG002|Overall Study|Withdrawal by Subject|1|||
131787917|NCT01529749|474506076|FG003|Overall Study|Withdrawal by Subject|0|||
131787918|NCT01529749|474506073|FG000|Overall Study|Protocol Violation|0|||
131787919|NCT01529749|474506074|FG001|Overall Study|Protocol Violation|0|||
131787920|NCT01529749|474506075|FG002|Overall Study|Protocol Violation|0|||
131787921|NCT01529749|474506076|FG003|Overall Study|Protocol Violation|1|||
131787922|NCT01120600|474507465|FG000|Overall Study|Adverse Event|7|||
131787923|NCT01120600|474507466|FG001|Overall Study|Adverse Event|7|||
131787924|NCT01120600|474507465|FG000|Overall Study|Excessive Bone Loss|0|||
131787925|NCT01120600|474507466|FG001|Overall Study|Excessive Bone Loss|4|||
131787926|NCT01120600|474507465|FG000|Overall Study|Lost to Follow-up|1|||
131787927|NCT01120600|474507466|FG001|Overall Study|Lost to Follow-up|3|||
131787928|NCT01120600|474507465|FG000|Overall Study|Physician Decision|1|||
131787929|NCT01120600|474507466|FG001|Overall Study|Physician Decision|3|||
131787930|NCT01120600|474507465|FG000|Overall Study|Protocol Violation|0|||
131787931|NCT01120600|474507466|FG001|Overall Study|Protocol Violation|4|||
131787932|NCT01120600|474507465|FG000|Overall Study|Withdrawal by Subject|10|||
131787933|NCT01120600|474507466|FG001|Overall Study|Withdrawal by Subject|11|||
131787934|NCT01375010|474507467|FG000|Overall Study|Lost to Follow-up|8|||
131787935|NCT01375010|474507468|FG001|Overall Study|Lost to Follow-up|2|||
131787936|NCT01375010|474507467|FG000|Overall Study|Withdrawal by Subject|4|||
131787937|NCT01375010|474507468|FG001|Overall Study|Withdrawal by Subject|2|||
131787938|NCT02614703|474507469|FG000|Overall Study|Withdrawal by Subject|7|||
131787939|NCT02614703|474507470|FG001|Overall Study|Withdrawal by Subject|1|||
131787940|NCT02402933|474507471|FG000|Overall Study|Withdrawal by Subject|4|||
131787941|NCT02402933|474507471|FG000|Overall Study|Discontinued; Site Termination|10|||
131787942|NCT01681771|474507474|FG000|Overall Study|Lost to Follow-up|4|||
131787943|NCT01681771|474507475|FG001|Overall Study|Lost to Follow-up|2|||
131787944|NCT01792284|474507480|FG000|Lead-in Period|Adverse Event|15|||
131787945|NCT01792284|474507481|FG001|Lead-in Period|Adverse Event|0|||
131787946|NCT01792284|474507482|FG002|Lead-in Period|Adverse Event|0|||
131787947|NCT01792284|474507480|FG000|Lead-in Period|Lost to Follow-up|2|||
131787948|NCT01792284|474507481|FG001|Lead-in Period|Lost to Follow-up|0|||
131787949|NCT01792284|474507482|FG002|Lead-in Period|Lost to Follow-up|0|||
131787950|NCT01792284|474507480|FG000|Lead-in Period|Protocol Violation|1|||
131787951|NCT01792284|474507481|FG001|Lead-in Period|Protocol Violation|0|||
131787952|NCT01792284|474507482|FG002|Lead-in Period|Protocol Violation|0|||
131787953|NCT01792284|474507480|FG000|Lead-in Period|Withdrawal by Subject|10|||
131787954|NCT01792284|474507481|FG001|Lead-in Period|Withdrawal by Subject|0|||
131787955|NCT01792284|474507482|FG002|Lead-in Period|Withdrawal by Subject|0|||
131787956|NCT01792284|474507480|FG000|Lead-in Period|Physician Decision|1|||
131787957|NCT01792284|474507481|FG001|Lead-in Period|Physician Decision|0|||
131787958|NCT01792284|474507482|FG002|Lead-in Period|Physician Decision|0|||
131787959|NCT01792284|474507480|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
131787960|NCT01792284|474507481|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
131787961|NCT01792284|474507482|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
131787962|NCT01792284|474507480|FG000|Randomization Period 1|Withdrawal by Subject|0|||
131787963|NCT01792284|474507481|FG001|Randomization Period 1|Withdrawal by Subject|1|||
131787964|NCT01792284|474507482|FG002|Randomization Period 1|Withdrawal by Subject|1|||
131787965|NCT01792284|474507480|FG000|Randomization Period 1|Physician Decision|0|||
131787966|NCT01792284|474507481|FG001|Randomization Period 1|Physician Decision|1|||
131787967|NCT01792284|474507482|FG002|Randomization Period 1|Physician Decision|1|||
131787968|NCT01792284|474507480|FG000|Randomization Period 1|Adverse Event|0|||
131787969|NCT01792284|474507481|FG001|Randomization Period 1|Adverse Event|0|||
131787970|NCT01792284|474507482|FG002|Randomization Period 1|Adverse Event|2|||
131787971|NCT01792284|474507480|FG000|Randomization Period 1|Lost to Follow-up|0|||
131787972|NCT01792284|474507481|FG001|Randomization Period 1|Lost to Follow-up|0|||
131787973|NCT01792284|474507482|FG002|Randomization Period 1|Lost to Follow-up|1|||
131787974|NCT01792284|474507480|FG000|Randomization Period 2|Protocol Violation|0|||
131787975|NCT01792284|474507481|FG001|Randomization Period 2|Protocol Violation|1|||
131787976|NCT01792284|474507482|FG002|Randomization Period 2|Protocol Violation|0|||
131787977|NCT01792284|474507480|FG000|Randomization Period 2|Withdrawal by Subject|0|||
131787978|NCT01792284|474507481|FG001|Randomization Period 2|Withdrawal by Subject|2|||
131787979|NCT01792284|474507482|FG002|Randomization Period 2|Withdrawal by Subject|0|||
131787980|NCT00534092|474507484|FG000|Overall Study|Lost to Follow-up|1|||
131787981|NCT00534092|474507485|FG001|Overall Study|Lost to Follow-up|0|||
131787982|NCT00534092|474507484|FG000|Overall Study|personal reasons/family concerns|1|||
131787983|NCT00534092|474507485|FG001|Overall Study|personal reasons/family concerns|0|||
131787984|NCT02919475|474507486|FG000|Overall Study|Adverse Event|3|||
131787985|NCT02919475|474507487|FG001|Overall Study|Adverse Event|3|||
131787986|NCT02919475|474507488|FG002|Overall Study|Adverse Event|3|||
131787987|NCT02919475|474507489|FG003|Overall Study|Adverse Event|9|||
131787988|NCT02919475|474507490|FG004|Overall Study|Adverse Event|2|||
131787989|NCT02919475|474507486|FG000|Overall Study|Death|0|||
131787990|NCT02919475|474507487|FG001|Overall Study|Death|1|||
131787991|NCT02919475|474507488|FG002|Overall Study|Death|0|||
131787992|NCT02919475|474507489|FG003|Overall Study|Death|0|||
131787993|NCT02919475|474507490|FG004|Overall Study|Death|0|||
131787994|NCT02919475|474507486|FG000|Overall Study|Lost to Follow-up|0|||
131787995|NCT02919475|474507487|FG001|Overall Study|Lost to Follow-up|0|||
131787996|NCT02919475|474507488|FG002|Overall Study|Lost to Follow-up|0|||
131787997|NCT02919475|474507489|FG003|Overall Study|Lost to Follow-up|1|||
131787998|NCT02919475|474507490|FG004|Overall Study|Lost to Follow-up|0|||
131787999|NCT02919475|474507486|FG000|Overall Study|Withdrawal by Subject|2|||
131788000|NCT02919475|474507487|FG001|Overall Study|Withdrawal by Subject|3|||
131788001|NCT02919475|474507488|FG002|Overall Study|Withdrawal by Subject|1|||
131788002|NCT02919475|474507489|FG003|Overall Study|Withdrawal by Subject|2|||
131788003|NCT02919475|474507490|FG004|Overall Study|Withdrawal by Subject|2|||
131788004|NCT02919475|474507486|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131788005|NCT02919475|474507487|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131788006|NCT02919475|474507488|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131788007|NCT02919475|474507489|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131788008|NCT02919475|474507490|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131788009|NCT00830063|474507498|FG000|Overall Study|Adverse Event|7|||
131788010|NCT00830063|474507499|FG001|Overall Study|Adverse Event|13|||
131788011|NCT00830063|474507500|FG002|Overall Study|Adverse Event|16|||
131788012|NCT00830063|474507501|FG003|Overall Study|Adverse Event|13|||
131788013|NCT00830063|474507498|FG000|Overall Study|Death|1|||
131788014|NCT00830063|474507499|FG001|Overall Study|Death|0|||
131788015|NCT00830063|474507500|FG002|Overall Study|Death|0|||
131788016|NCT00830063|474507501|FG003|Overall Study|Death|0|||
131788017|NCT00830063|474507498|FG000|Overall Study|Lost to Follow-up|0|||
131788018|NCT00830063|474507499|FG001|Overall Study|Lost to Follow-up|0|||
131788019|NCT00830063|474507500|FG002|Overall Study|Lost to Follow-up|3|||
131788020|NCT00830063|474507501|FG003|Overall Study|Lost to Follow-up|1|||
131788021|NCT00830063|474507498|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
131788022|NCT00830063|474507499|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
131788023|NCT00830063|474507500|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
131788024|NCT00830063|474507501|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
131788025|NCT00830063|474507498|FG000|Overall Study|Lack of Efficacy|51|||
131788026|NCT00830063|474507499|FG001|Overall Study|Lack of Efficacy|23|||
131788027|NCT00830063|474507500|FG002|Overall Study|Lack of Efficacy|25|||
131788028|NCT00830063|474507501|FG003|Overall Study|Lack of Efficacy|32|||
131788029|NCT00830063|474507498|FG000|Overall Study|Other|5|||
131788030|NCT00830063|474507499|FG001|Overall Study|Other|5|||
131788031|NCT00830063|474507500|FG002|Overall Study|Other|8|||
131788032|NCT00830063|474507501|FG003|Overall Study|Other|6|||
131788033|NCT00830063|474507498|FG000|Overall Study|Withdrawal by Subject|16|||
131788034|NCT00830063|474507499|FG001|Overall Study|Withdrawal by Subject|10|||
131788035|NCT00830063|474507500|FG002|Overall Study|Withdrawal by Subject|16|||
131788036|NCT00830063|474507501|FG003|Overall Study|Withdrawal by Subject|13|||
131788037|NCT00830063|474507498|FG000|Overall Study|Protocol Violation|1|||
131788038|NCT00830063|474507499|FG001|Overall Study|Protocol Violation|0|||
131788039|NCT00830063|474507500|FG002|Overall Study|Protocol Violation|3|||
131580767|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
131788040|NCT00830063|474507501|FG003|Overall Study|Protocol Violation|2|||
131788041|NCT00830063|474507498|FG000|Overall Study|Randomized But Not Treated|0|||
131788042|NCT00830063|474507499|FG001|Overall Study|Randomized But Not Treated|2|||
131788043|NCT00830063|474507500|FG002|Overall Study|Randomized But Not Treated|0|||
131788044|NCT00830063|474507501|FG003|Overall Study|Randomized But Not Treated|2|||
131788045|NCT02323295|474507502|FG000|Overall Study|Adverse Event|0|||
131788046|NCT02323295|474507503|FG001|Overall Study|Adverse Event|1|||
131788047|NCT02323295|474507502|FG000|Overall Study|Withdrawal by Subject|0|||
131580768|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
131580769|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
131580770|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
131580771|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
131580772|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
131580773|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
131580774|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
131580775|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
131580776|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
131580777|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
131580778|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131580779|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
131580780|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131580781|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131580782|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131580783|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
131580784|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
131788048|NCT02323295|474507503|FG001|Overall Study|Withdrawal by Subject|1|||
131580785|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
131580786|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
131580787|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
131580788|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
131580789|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
131580790|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
131580791|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
131580792|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
131580793|NCT02709655|473753620|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
131580794|NCT02709655|473753621|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
131580795|NCT02709655|473753622|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
131580796|NCT02709655|473753623|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
131580797|NCT02709655|473753624|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
131580798|NCT01179334|473753625|FG000|Treatment Period|Adverse Event|1|||
131580799|NCT01179334|473753626|FG001|Treatment Period|Adverse Event|0|||
131702269|NCT02918019|474193066|FG002|Overall Study|Principal investigator request|0|||
131702270|NCT02918019|474193067|FG003|Overall Study|Principal investigator request|1|||
131702271|NCT02918019|474193064|FG000|Overall Study|Physician Decision|1|||
131702272|NCT02918019|474193065|FG001|Overall Study|Physician Decision|3|||
131702273|NCT02918019|474193066|FG002|Overall Study|Physician Decision|2|||
131702274|NCT02918019|474193067|FG003|Overall Study|Physician Decision|0|||
131702275|NCT02918019|474193064|FG000|Overall Study|Protocol deviation|1|||
131702276|NCT02918019|474193065|FG001|Overall Study|Protocol deviation|1|||
131702277|NCT02918019|474193066|FG002|Overall Study|Protocol deviation|0|||
131702278|NCT02918019|474193067|FG003|Overall Study|Protocol deviation|2|||
131702279|NCT02918019|474193064|FG000|Overall Study|Withdrawal by Subject|3|||
131702280|NCT02918019|474193065|FG001|Overall Study|Withdrawal by Subject|4|||
131702281|NCT02918019|474193066|FG002|Overall Study|Withdrawal by Subject|6|||
131702282|NCT02918019|474193067|FG003|Overall Study|Withdrawal by Subject|4|||
131702283|NCT02918019|474193064|FG000|Overall Study|Adverse Event|0|||
131702284|NCT02918019|474193065|FG001|Overall Study|Adverse Event|1|||
131702285|NCT02918019|474193066|FG002|Overall Study|Adverse Event|0|||
131702286|NCT02918019|474193067|FG003|Overall Study|Adverse Event|1|||
131702287|NCT01212185|474193068|FG000|Overall Study|Protocol Violation|2|||
131702288|NCT01212185|474193069|FG001|Overall Study|Protocol Violation|1|||
131702289|NCT04823949|474193073|FG000|Overall Study|Withdrawal by Subject|0|||
131702290|NCT04823949|474193074|FG001|Overall Study|Withdrawal by Subject|4|||
131702291|NCT04823949|474193073|FG000|Overall Study|Physician Decision|0|||
131702292|NCT04823949|474193074|FG001|Overall Study|Physician Decision|1|||
131702293|NCT01463098|474193076|FG000|Part A (11 Days)|Participant Choice|2|||
131702294|NCT01463098|474193077|FG001|Part A (11 Days)|Participant Choice|0|||
131702295|NCT01463098|474193078|FG002|Part A (11 Days)|Participant Choice|0|||
131702296|NCT01463098|474193079|FG003|Part A (11 Days)|Participant Choice|0|||
131702297|NCT01463098|474193080|FG004|Part A (11 Days)|Participant Choice|0|||
131702298|NCT01463098|474193081|FG005|Part A (11 Days)|Participant Choice|0|||
131702299|NCT01463098|474193082|FG006|Part A (11 Days)|Participant Choice|0|||
131702300|NCT01463098|474193083|FG007|Part A (11 Days)|Participant Choice|0|||
131702301|NCT01463098|474193084|FG008|Part A (11 Days)|Participant Choice|1|||
131702302|NCT01463098|474193085|FG009|Part A (11 Days)|Participant Choice|0|||
131702303|NCT01463098|474193086|FG010|Part A (11 Days)|Participant Choice|0|||
131702304|NCT01463098|474193087|FG011|Part A (11 Days)|Participant Choice|0|||
131702305|NCT01463098|474193088|FG012|Part A (11 Days)|Participant Choice|0|||
131702306|NCT01463098|474193089|FG013|Part A (11 Days)|Participant Choice|0|||
131702307|NCT01463098|474193076|FG000|Part A (11 Days)|Lost to Follow-up|0|||
131702308|NCT01463098|474193077|FG001|Part A (11 Days)|Lost to Follow-up|0|||
131580800|NCT01179334|473753625|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
131580801|NCT01179334|473753626|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
131580802|NCT01179334|473753625|FG000|Long-term Extension (LTE) Period|Death|3|||
131580803|NCT01179334|473753626|FG001|Long-term Extension (LTE) Period|Death|0|||
131702309|NCT01463098|474193078|FG002|Part A (11 Days)|Lost to Follow-up|0|||
131702310|NCT01463098|474193079|FG003|Part A (11 Days)|Lost to Follow-up|0|||
131702311|NCT01463098|474193080|FG004|Part A (11 Days)|Lost to Follow-up|1|||
131702312|NCT01463098|474193081|FG005|Part A (11 Days)|Lost to Follow-up|0|||
131702313|NCT01463098|474193082|FG006|Part A (11 Days)|Lost to Follow-up|0|||
131702314|NCT01463098|474193083|FG007|Part A (11 Days)|Lost to Follow-up|0|||
131702315|NCT01463098|474193084|FG008|Part A (11 Days)|Lost to Follow-up|0|||
131702316|NCT01463098|474193085|FG009|Part A (11 Days)|Lost to Follow-up|0|||
131702317|NCT01463098|474193086|FG010|Part A (11 Days)|Lost to Follow-up|0|||
131702318|NCT01463098|474193087|FG011|Part A (11 Days)|Lost to Follow-up|0|||
131702319|NCT01463098|474193088|FG012|Part A (11 Days)|Lost to Follow-up|0|||
131702320|NCT01463098|474193089|FG013|Part A (11 Days)|Lost to Follow-up|0|||
131702321|NCT01463098|474193076|FG000|Part B (11 Days)|Participant Choice|0|||
131702322|NCT01463098|474193077|FG001|Part B (11 Days)|Participant Choice|0|||
131702323|NCT01463098|474193078|FG002|Part B (11 Days)|Participant Choice|0|||
131702324|NCT01463098|474193079|FG003|Part B (11 Days)|Participant Choice|0|||
131702325|NCT01463098|474193080|FG004|Part B (11 Days)|Participant Choice|0|||
131702326|NCT01463098|474193081|FG005|Part B (11 Days)|Participant Choice|0|||
131702327|NCT01463098|474193082|FG006|Part B (11 Days)|Participant Choice|0|||
131702328|NCT01463098|474193083|FG007|Part B (11 Days)|Participant Choice|0|||
131702329|NCT01463098|474193084|FG008|Part B (11 Days)|Participant Choice|0|||
131702330|NCT01463098|474193085|FG009|Part B (11 Days)|Participant Choice|0|||
131702331|NCT01463098|474193086|FG010|Part B (11 Days)|Participant Choice|0|||
131702332|NCT01463098|474193087|FG011|Part B (11 Days)|Participant Choice|1|||
131702333|NCT01463098|474193088|FG012|Part B (11 Days)|Participant Choice|0|||
131702334|NCT01463098|474193089|FG013|Part B (11 Days)|Participant Choice|0|||
131702335|NCT00939692|474193090|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
131702336|NCT00939692|474193091|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
131702337|NCT00939692|474193090|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
131702338|NCT00939692|474193091|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
131702339|NCT01528787|474193096|FG000|Overall Study|Withdrawal by Subject|0|||
131702340|NCT01528787|474193097|FG001|Overall Study|Withdrawal by Subject|0|||
131702341|NCT01528787|474193098|FG002|Overall Study|Withdrawal by Subject|0|||
131702342|NCT01528787|474193099|FG003|Overall Study|Withdrawal by Subject|1|||
131702343|NCT01528787|474193096|FG000|Overall Study|Family Emergency|0|||
131702344|NCT01528787|474193097|FG001|Overall Study|Family Emergency|0|||
131702345|NCT01528787|474193098|FG002|Overall Study|Family Emergency|1|||
131702346|NCT01528787|474193099|FG003|Overall Study|Family Emergency|0|||
131702347|NCT03433781|474193105|FG000|Overall Study|Progression of Disease|1|||
131702348|NCT03433781|474193106|FG001|Overall Study|Progression of Disease|0|||
131702349|NCT03433781|474193107|FG002|Overall Study|Progression of Disease|0|||
131702350|NCT03433781|474193105|FG000|Overall Study|Physician Decision|0|||
131702351|NCT03433781|474193106|FG001|Overall Study|Physician Decision|1|||
131702352|NCT03433781|474193107|FG002|Overall Study|Physician Decision|0|||
131702353|NCT01700192|474193110|FG000|Overall Study|Adverse Event|73|||
131702354|NCT01700192|474193111|FG001|Overall Study|Adverse Event|18|||
131702355|NCT01700192|474193110|FG000|Overall Study|Lack of Efficacy|1|||
131702356|NCT01700192|474193111|FG001|Overall Study|Lack of Efficacy|0|||
131702357|NCT01700192|474193110|FG000|Overall Study|Lost to Follow-up|42|||
131702358|NCT01700192|474193111|FG001|Overall Study|Lost to Follow-up|29|||
131702359|NCT01700192|474193110|FG000|Overall Study|Noncompliance with study drug|0|||
131702360|NCT01700192|474193111|FG001|Overall Study|Noncompliance with study drug|5|||
131702361|NCT01700192|474193110|FG000|Overall Study|Physician Decision|2|||
131702362|NCT01700192|474193111|FG001|Overall Study|Physician Decision|3|||
131702363|NCT01700192|474193110|FG000|Overall Study|Pregnancy|1|||
131702364|NCT01700192|474193111|FG001|Overall Study|Pregnancy|4|||
131702365|NCT01700192|474193110|FG000|Overall Study|Progressive disease|1|||
131702366|NCT01700192|474193111|FG001|Overall Study|Progressive disease|0|||
131702367|NCT01700192|474193110|FG000|Overall Study|Protocol Violation|3|||
131702368|NCT01700192|474193111|FG001|Overall Study|Protocol Violation|4|||
131702369|NCT01700192|474193110|FG000|Overall Study|Technical problems|0|||
131702370|NCT01700192|474193111|FG001|Overall Study|Technical problems|1|||
131702371|NCT01700192|474193110|FG000|Overall Study|Withdrawal by Subject|56|||
131702372|NCT01700192|474193111|FG001|Overall Study|Withdrawal by Subject|64|||
131702373|NCT01700192|474193110|FG000|Overall Study|Never received study drug|1|||
131702374|NCT01700192|474193111|FG001|Overall Study|Never received study drug|0|||
131702375|NCT02793232|474193113|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702376|NCT02793232|474193114|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702377|NCT02793232|474193115|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702378|NCT02793232|474193116|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702379|NCT02793232|474193117|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
131580804|NCT01179334|473753625|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
131580805|NCT01179334|473753626|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
131702380|NCT02793232|474193118|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702381|NCT02793232|474193119|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
131702382|NCT02793232|474193120|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702383|NCT02793232|474193121|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131702384|NCT03543410|474193122|FG000|Overall Study|Adverse Event|10|||
131702385|NCT03543410|474193123|FG001|Overall Study|Adverse Event|8|||
131702386|NCT03543410|474193124|FG002|Overall Study|Adverse Event|2|||
131702387|NCT03543410|474193122|FG000|Overall Study|Lack of Efficacy|0|||
131702388|NCT03543410|474193123|FG001|Overall Study|Lack of Efficacy|1|||
131702389|NCT03543410|474193124|FG002|Overall Study|Lack of Efficacy|0|||
131702390|NCT03543410|474193122|FG000|Overall Study|Lost to Follow-up|0|||
131702391|NCT03543410|474193123|FG001|Overall Study|Lost to Follow-up|1|||
131702392|NCT03543410|474193124|FG002|Overall Study|Lost to Follow-up|0|||
131702393|NCT03543410|474193122|FG000|Overall Study|Withdrawal by Subject|5|||
131702394|NCT03543410|474193123|FG001|Overall Study|Withdrawal by Subject|2|||
131702395|NCT03543410|474193124|FG002|Overall Study|Withdrawal by Subject|8|||
131702396|NCT03543410|474193122|FG000|Overall Study|Protocol Violation|0|||
131702397|NCT03543410|474193123|FG001|Overall Study|Protocol Violation|1|||
131702398|NCT03543410|474193124|FG002|Overall Study|Protocol Violation|0|||
131702399|NCT03543410|474193122|FG000|Overall Study|Due to COVID-19|4|||
131702400|NCT03543410|474193123|FG001|Overall Study|Due to COVID-19|0|||
131702401|NCT03543410|474193124|FG002|Overall Study|Due to COVID-19|2|||
131702402|NCT03543410|474193122|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
131702403|NCT03543410|474193123|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
131702404|NCT03543410|474193124|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
131702405|NCT03543410|474193122|FG000|Overall Study|Not Due to COVID-19|2|||
131702406|NCT03543410|474193123|FG001|Overall Study|Not Due to COVID-19|0|||
131702407|NCT03543410|474193124|FG002|Overall Study|Not Due to COVID-19|1|||
131702408|NCT02435914|474193125|FG000|Overall Study|Ocular Adverse Event|1|||
131702409|NCT02435914|474193126|FG001|Overall Study|Ocular Adverse Event|0|||
131702410|NCT02435914|474193127|FG002|Overall Study|Ocular Adverse Event|0|||
131702411|NCT02435914|474193128|FG003|Overall Study|Ocular Adverse Event|0|||
131702412|NCT02435914|474193125|FG000|Overall Study|Withdrawal by Subject|0|||
131702413|NCT02435914|474193126|FG001|Overall Study|Withdrawal by Subject|1|||
131702414|NCT02435914|474193127|FG002|Overall Study|Withdrawal by Subject|0|||
131702415|NCT02435914|474193128|FG003|Overall Study|Withdrawal by Subject|0|||
131702416|NCT02435914|474193125|FG000|Overall Study|Other Miscellaneous Reason|0|||
131702417|NCT02435914|474193126|FG001|Overall Study|Other Miscellaneous Reason|0|||
131702418|NCT02435914|474193127|FG002|Overall Study|Other Miscellaneous Reason|1|||
131702419|NCT02435914|474193128|FG003|Overall Study|Other Miscellaneous Reason|0|||
131702420|NCT00626093|474193142|FG000|Overall Study|Lost to Follow-up|5|||
131702421|NCT00626093|474193142|FG000|Overall Study|Death|1|||
131702422|NCT00626093|474193142|FG000|Overall Study|Physician Decision|4|||
131702423|NCT00626093|474193142|FG000|Overall Study|Withdrawal by Subject|6|||
131702424|NCT00626093|474193142|FG000|Overall Study|Protocol Violation|1|||
131702425|NCT00626093|474193142|FG000|Overall Study|One of the required devices not implante|6|||
131702426|NCT03891901|474193143|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
131702427|NCT03891901|474193144|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702428|NCT03891901|474193145|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702429|NCT03891901|474193146|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702430|NCT03891901|474193147|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702431|NCT03891901|474193148|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702432|NCT03891901|474193149|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702433|NCT03891901|474193150|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702434|NCT03891901|474193151|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131702435|NCT03891901|474193143|FG000|Overall Study|Adverse Event|2|||
131580806|NCT01909778|473753627|FG000|Overall Study|failed screening|1|||
131702436|NCT03891901|474193144|FG001|Overall Study|Adverse Event|2|||
131702437|NCT03891901|474193145|FG002|Overall Study|Adverse Event|0|||
131702438|NCT03891901|474193146|FG003|Overall Study|Adverse Event|0|||
131702439|NCT03891901|474193147|FG004|Overall Study|Adverse Event|0|||
131702440|NCT03891901|474193148|FG005|Overall Study|Adverse Event|0|||
131702441|NCT03891901|474193149|FG006|Overall Study|Adverse Event|0|||
131702442|NCT03891901|474193150|FG007|Overall Study|Adverse Event|0|||
131702443|NCT03891901|474193151|FG008|Overall Study|Adverse Event|0|||
131788049|NCT02323295|474507502|FG000|Overall Study|Patient did not have surgery as planned.|0|||
131788050|NCT02323295|474507503|FG001|Overall Study|Patient did not have surgery as planned.|1|||
131788051|NCT00775983|474507505|FG000|Overall Study|Protocol Violation|1|||
131788052|NCT00775983|474507506|FG001|Overall Study|Protocol Violation|2|||
131788053|NCT02962882|474507507|FG000|Overall Study|Adverse Event|2|||
131788054|NCT02962882|474507507|FG000|Overall Study|Withdrawal by Subject|2|||
131788055|NCT02962882|474507507|FG000|Overall Study|Transfer from ICU|32|||
131788056|NCT01155063|474507508|FG000|Overall Study|Adverse Event|1|||
131788057|NCT01155063|474507508|FG000|Overall Study|Withdrawal by Subject|1|||
131788058|NCT01155063|474507508|FG000|Overall Study|Study terminated by sponsor|87|||
131788059|NCT01314703|474507509|FG000|Overall Study|screen failure and closed enrollment|8|||
131788060|NCT01663714|474507510|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
131788061|NCT01663714|474507510|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
131788062|NCT01663714|474507510|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
131788063|NCT01663714|474507510|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
131788064|NCT01663714|474507510|FG000|Long-Term Follow-Up|Death|4|||
131788065|NCT01663714|474507510|FG000|Long-Term Follow-Up|Non-compliance|1|||
131788066|NCT00597584|474507511|FG000|Overall Study|Adverse Event|4|||
131788067|NCT00597584|474507512|FG001|Overall Study|Adverse Event|2|||
131788068|NCT00597584|474507511|FG000|Overall Study|Death|53|||
131788069|NCT00597584|474507512|FG001|Overall Study|Death|30|||
131788070|NCT00597584|474507511|FG000|Overall Study|Lack of Efficacy|1|||
131788071|NCT00597584|474507512|FG001|Overall Study|Lack of Efficacy|0|||
131788072|NCT00597584|474507511|FG000|Overall Study|Lost to Follow-up|2|||
131788073|NCT00597584|474507512|FG001|Overall Study|Lost to Follow-up|4|||
131788074|NCT00597584|474507511|FG000|Overall Study|Physician Decision|3|||
131788075|NCT00597584|474507512|FG001|Overall Study|Physician Decision|0|||
131788076|NCT00597584|474507511|FG000|Overall Study|Pregnancy|2|||
131788077|NCT00597584|474507512|FG001|Overall Study|Pregnancy|0|||
131788078|NCT00597584|474507511|FG000|Overall Study|Withdrawal by Subject|44|||
131788079|NCT00597584|474507512|FG001|Overall Study|Withdrawal by Subject|12|||
131788080|NCT00597584|474507511|FG000|Overall Study|Discontinued Dialysis|0|||
131788081|NCT00597584|474507512|FG001|Overall Study|Discontinued Dialysis|1|||
131788082|NCT00597584|474507511|FG000|Overall Study|Lost ability to consent|1|||
131788083|NCT00597584|474507512|FG001|Overall Study|Lost ability to consent|1|||
131788084|NCT00597584|474507511|FG000|Overall Study|Never dosed|1|||
131788085|NCT00597584|474507512|FG001|Overall Study|Never dosed|0|||
131788086|NCT00597584|474507511|FG000|Overall Study|Relocation|8|||
131788087|NCT00597584|474507512|FG001|Overall Study|Relocation|6|||
131788088|NCT00597584|474507511|FG000|Overall Study|Renal transplant|9|||
131788089|NCT00597584|474507512|FG001|Overall Study|Renal transplant|7|||
131788090|NCT00515073|474507513|FG000|Overall Study|Withdrawal by Subject|1|||
131788091|NCT00515073|474507513|FG000|Overall Study|Physician Decision|1|||
131788092|NCT00660790|474507514|FG000|Baseline to 3 Months|Death|1|||
131788093|NCT00660790|474507514|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
131788094|NCT00660790|474507514|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
131788095|NCT02791659|474507515|FG000|Overall Study|Protocol Violation|0|||
131788096|NCT02791659|474507516|FG001|Overall Study|Protocol Violation|1|||
131788097|NCT01456052|474507517|FG000|Overall Study|Adverse Event|1|||
131788098|NCT01456052|474507518|FG001|Overall Study|Adverse Event|1|||
131788099|NCT01456052|474507519|FG002|Overall Study|Adverse Event|2|||
131788100|NCT01456052|474507517|FG000|Overall Study|Consent withdrawn|0|||
131788101|NCT01456052|474507518|FG001|Overall Study|Consent withdrawn|2|||
131788102|NCT01456052|474507519|FG002|Overall Study|Consent withdrawn|1|||
131788103|NCT01456052|474507517|FG000|Overall Study|Protocol Violation|0|||
131788104|NCT01456052|474507518|FG001|Overall Study|Protocol Violation|1|||
131788105|NCT01456052|474507519|FG002|Overall Study|Protocol Violation|0|||
131788106|NCT01456052|474507517|FG000|Overall Study|Physician Decision|1|||
131788107|NCT01456052|474507518|FG001|Overall Study|Physician Decision|0|||
131788108|NCT01456052|474507519|FG002|Overall Study|Physician Decision|1|||
131788109|NCT01456052|474507517|FG000|Overall Study|Treatment Failure|0|||
131788110|NCT01456052|474507518|FG001|Overall Study|Treatment Failure|1|||
131788111|NCT01456052|474507519|FG002|Overall Study|Treatment Failure|1|||
131788112|NCT00106028|474507529|FG000|Overall Study|Adverse Event|3|||
131788113|NCT00106028|474507530|FG001|Overall Study|Adverse Event|2|||
131788114|NCT00106028|474507529|FG000|Overall Study|Protocol Violation|1|||
131788115|NCT00106028|474507530|FG001|Overall Study|Protocol Violation|1|||
131788116|NCT00106028|474507529|FG000|Overall Study|Withdrawal by Subject|2|||
131788117|NCT00106028|474507530|FG001|Overall Study|Withdrawal by Subject|8|||
131788118|NCT00106028|474507529|FG000|Overall Study|Lost to Follow-up|0|||
131788119|NCT00106028|474507530|FG001|Overall Study|Lost to Follow-up|1|||
131788120|NCT01610167|474507531|FG000|Overall Study|Scheduling conflict.|0|||
131788121|NCT01610167|474507532|FG001|Overall Study|Scheduling conflict.|0|||
131788122|NCT01610167|474507533|FG002|Overall Study|Scheduling conflict.|2|||
131788123|NCT06371079|474507535|FG000|Overall Study|Missing data|88|||
131788124|NCT06371079|474507536|FG001|Overall Study|Missing data|247|||
131788125|NCT01256398|474507537|FG000|Overall Study|Withdrawal by Subject|1|||
131788126|NCT00411762|474507539|FG000|Overall Study|Withdrawal by Subject|5|||
131788127|NCT00575328|474507540|FG000|Overall Study|Adverse Event|1|||
131580807|NCT00919763|473753628|FG000|Overall Study|Adverse Event|7|||
131580808|NCT00919763|473753629|FG001|Overall Study|Adverse Event|1|||
131580809|NCT00919763|473753628|FG000|Overall Study|Lost to Follow-up|1|||
131580810|NCT00919763|473753629|FG001|Overall Study|Lost to Follow-up|0|||
131580811|NCT00919763|473753628|FG000|Overall Study|Protocol Violation|1|||
131580812|NCT00919763|473753629|FG001|Overall Study|Protocol Violation|1|||
131580813|NCT00919763|473753628|FG000|Overall Study|Withdrawal by Subject|3|||
131580814|NCT00919763|473753629|FG001|Overall Study|Withdrawal by Subject|1|||
131580815|NCT00919763|473753628|FG000|Overall Study|Non-compliance|0|||
131580816|NCT00919763|473753629|FG001|Overall Study|Non-compliance|1|||
131580817|NCT00256243|473753633|FG000|Overall Study|Lost to Follow-up|2|||
131580818|NCT00256243|473753633|FG000|Overall Study|Death|7|||
131702444|NCT03891901|474193143|FG000|Overall Study|Poor venous access|1|||
131702445|NCT03891901|474193144|FG001|Overall Study|Poor venous access|0|||
131702446|NCT03891901|474193145|FG002|Overall Study|Poor venous access|0|||
131702447|NCT03891901|474193146|FG003|Overall Study|Poor venous access|0|||
131702448|NCT03891901|474193147|FG004|Overall Study|Poor venous access|0|||
131702449|NCT03891901|474193148|FG005|Overall Study|Poor venous access|0|||
131702450|NCT03891901|474193149|FG006|Overall Study|Poor venous access|0|||
131702451|NCT03891901|474193150|FG007|Overall Study|Poor venous access|0|||
131702452|NCT03891901|474193151|FG008|Overall Study|Poor venous access|0|||
131702453|NCT03891901|474193143|FG000|Overall Study|Withdrawal by Subject|0|||
131702454|NCT03891901|474193144|FG001|Overall Study|Withdrawal by Subject|2|||
131702455|NCT03891901|474193145|FG002|Overall Study|Withdrawal by Subject|0|||
131702456|NCT03891901|474193146|FG003|Overall Study|Withdrawal by Subject|0|||
131702457|NCT03891901|474193147|FG004|Overall Study|Withdrawal by Subject|0|||
131702458|NCT03891901|474193148|FG005|Overall Study|Withdrawal by Subject|0|||
131702459|NCT03891901|474193149|FG006|Overall Study|Withdrawal by Subject|0|||
131702460|NCT03891901|474193150|FG007|Overall Study|Withdrawal by Subject|0|||
131702461|NCT03891901|474193151|FG008|Overall Study|Withdrawal by Subject|0|||
131702462|NCT00603915|474193152|FG000|Overall Study|Physician Decision|1|||
131702463|NCT02154087|474193155|FG000|Overall Study|Study Termination|1|||
131702464|NCT01116544|474193156|FG000|Overall Study|Protocol Violation|1|||
131702465|NCT01116544|474193157|FG001|Overall Study|Protocol Violation|0|||
131702466|NCT01116544|474193156|FG000|Overall Study|Withdrawal by Subject|1|||
131702467|NCT01116544|474193157|FG001|Overall Study|Withdrawal by Subject|1|||
131702468|NCT04556617|474193158|FG000|Overall Study|progressive disease|0|||
131702469|NCT04556617|474193159|FG001|Overall Study|progressive disease|2|||
131702470|NCT04556617|474193160|FG002|Overall Study|progressive disease|2|||
131702471|NCT04556617|474193161|FG003|Overall Study|progressive disease|1|||
131702472|NCT04556617|474193162|FG004|Overall Study|progressive disease|1|||
131702473|NCT04556617|474193158|FG000|Overall Study|Physician Decision|0|||
131702474|NCT04556617|474193159|FG001|Overall Study|Physician Decision|0|||
131702475|NCT04556617|474193160|FG002|Overall Study|Physician Decision|2|||
131702476|NCT04556617|474193161|FG003|Overall Study|Physician Decision|0|||
131702477|NCT04556617|474193162|FG004|Overall Study|Physician Decision|0|||
131702478|NCT04556617|474193158|FG000|Overall Study|Adverse Event|0|||
131702479|NCT04556617|474193159|FG001|Overall Study|Adverse Event|0|||
131702480|NCT04556617|474193160|FG002|Overall Study|Adverse Event|2|||
131702481|NCT04556617|474193161|FG003|Overall Study|Adverse Event|3|||
131702482|NCT04556617|474193162|FG004|Overall Study|Adverse Event|0|||
131702483|NCT04556617|474193158|FG000|Overall Study|Withdrawal by Subject|0|||
131702484|NCT04556617|474193159|FG001|Overall Study|Withdrawal by Subject|2|||
131702485|NCT04556617|474193160|FG002|Overall Study|Withdrawal by Subject|1|||
131702486|NCT04556617|474193161|FG003|Overall Study|Withdrawal by Subject|1|||
131702487|NCT04556617|474193162|FG004|Overall Study|Withdrawal by Subject|0|||
131702488|NCT04556617|474193158|FG000|Overall Study|PSA increase|0|||
131702489|NCT04556617|474193159|FG001|Overall Study|PSA increase|1|||
131702490|NCT04556617|474193160|FG002|Overall Study|PSA increase|0|||
131702491|NCT04556617|474193161|FG003|Overall Study|PSA increase|0|||
131702492|NCT04556617|474193162|FG004|Overall Study|PSA increase|0|||
131702493|NCT04556617|474193158|FG000|Overall Study|Sponsor study termination|1|||
131702494|NCT04556617|474193159|FG001|Overall Study|Sponsor study termination|0|||
131702495|NCT04556617|474193160|FG002|Overall Study|Sponsor study termination|0|||
131702496|NCT04556617|474193161|FG003|Overall Study|Sponsor study termination|0|||
131702497|NCT04556617|474193162|FG004|Overall Study|Sponsor study termination|0|||
131702498|NCT04949841|474193163|FG000|Overall Study|Adverse Event|7|||
131702499|NCT04949841|474193163|FG000|Overall Study|Death|1|||
131702500|NCT04949841|474193163|FG000|Overall Study|Withdrawal by Subject|52|||
131702501|NCT04949841|474193163|FG000|Overall Study|Pregnancy|4|||
131702502|NCT04949841|474193163|FG000|Overall Study|Lost to Follow-up|9|||
131580819|NCT00256243|473753633|FG000|Overall Study|Not treated|1|||
131702503|NCT04949841|474193163|FG000|Overall Study|Lack of Efficacy|55|||
131702504|NCT04949841|474193163|FG000|Overall Study|Various reasons|9|||
131702505|NCT05168267|474193164|FG000|Overall Study|Withdrawal by Subject|2|||
131702506|NCT05168267|474193165|FG001|Overall Study|Withdrawal by Subject|1|||
131702507|NCT05168267|474193164|FG000|Overall Study|Withdrawn by Therapist|1|||
131702508|NCT05168267|474193165|FG001|Overall Study|Withdrawn by Therapist|1|||
131702509|NCT05168267|474193164|FG000|Overall Study|Left Facility|1|||
131580820|NCT05061693|473753634|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
131580821|NCT05061693|473753635|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
131580822|NCT05061693|473753636|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
131580823|NCT05061693|473753637|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580824|NCT05061693|473753638|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580825|NCT05061693|473753639|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580826|NCT05061693|473753640|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580827|NCT05061693|473753641|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580828|NCT05061693|473753642|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580829|NCT05061693|473753643|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580830|NCT05061693|473753644|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580831|NCT05061693|473753645|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131580832|NCT05061693|473753634|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
131580833|NCT05061693|473753635|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
131580834|NCT05061693|473753636|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
131580835|NCT05061693|473753637|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
131580836|NCT05061693|473753638|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
131580837|NCT05061693|473753639|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
131580838|NCT05061693|473753640|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
131580839|NCT05061693|473753641|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
131580840|NCT05061693|473753642|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
131580841|NCT05061693|473753643|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
131580842|NCT05061693|473753644|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
131580843|NCT05061693|473753645|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
131580844|NCT05061693|473753634|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
131580845|NCT05061693|473753635|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580846|NCT05061693|473753636|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580847|NCT05061693|473753637|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580848|NCT05061693|473753638|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580849|NCT05061693|473753639|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580850|NCT05061693|473753640|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580851|NCT05061693|473753641|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580852|NCT05061693|473753642|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580853|NCT05061693|473753643|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580854|NCT05061693|473753644|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580855|NCT05061693|473753645|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131580856|NCT05061693|473753634|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580857|NCT05061693|473753635|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580858|NCT05061693|473753636|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
131580859|NCT05061693|473753637|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580860|NCT05061693|473753638|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580861|NCT05061693|473753639|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580862|NCT05061693|473753640|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580863|NCT05061693|473753641|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580864|NCT05061693|473753642|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580865|NCT05061693|473753643|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580866|NCT05061693|473753644|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580867|NCT05061693|473753645|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131580868|NCT05061693|473753634|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
131580869|NCT05061693|473753635|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
131580870|NCT05061693|473753636|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
131580871|NCT05061693|473753637|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
131580872|NCT05061693|473753638|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580873|NCT05061693|473753639|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580874|NCT05061693|473753640|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580875|NCT05061693|473753641|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580876|NCT05061693|473753642|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580877|NCT05061693|473753643|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580878|NCT05061693|473753644|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580879|NCT05061693|473753645|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131580880|NCT05061693|473753634|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
131580881|NCT05061693|473753635|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
131580882|NCT05061693|473753636|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
131580883|NCT05061693|473753637|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
131580884|NCT05061693|473753638|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580885|NCT05061693|473753639|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580886|NCT05061693|473753640|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580887|NCT05061693|473753641|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580888|NCT05061693|473753642|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580889|NCT05061693|473753643|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580890|NCT05061693|473753644|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580891|NCT05061693|473753645|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131580892|NCT05061693|473753634|FG000|24-week Extension Period|Adverse Event|0|||
131580893|NCT05061693|473753635|FG001|24-week Extension Period|Adverse Event|0|||
131580894|NCT05061693|473753636|FG002|24-week Extension Period|Adverse Event|0|||
131580895|NCT05061693|473753637|FG003|24-week Extension Period|Adverse Event|0|||
131580896|NCT05061693|473753638|FG004|24-week Extension Period|Adverse Event|0|||
131580897|NCT05061693|473753639|FG005|24-week Extension Period|Adverse Event|0|||
131580898|NCT05061693|473753640|FG006|24-week Extension Period|Adverse Event|0|||
131580899|NCT05061693|473753641|FG007|24-week Extension Period|Adverse Event|2|||
131580900|NCT05061693|473753642|FG008|24-week Extension Period|Adverse Event|2|||
131580901|NCT05061693|473753643|FG009|24-week Extension Period|Adverse Event|0|||
131580902|NCT05061693|473753644|FG010|24-week Extension Period|Adverse Event|1|||
131580903|NCT05061693|473753645|FG011|24-week Extension Period|Adverse Event|3|||
131580904|NCT05061693|473753634|FG000|24-week Extension Period|Lack of Efficacy|0|||
131580905|NCT05061693|473753635|FG001|24-week Extension Period|Lack of Efficacy|0|||
131580906|NCT05061693|473753636|FG002|24-week Extension Period|Lack of Efficacy|0|||
131580907|NCT05061693|473753637|FG003|24-week Extension Period|Lack of Efficacy|0|||
131438367|NCT03192176|473231213|FG006|Overall Study|Physician Decision|1|||
131580908|NCT05061693|473753638|FG004|24-week Extension Period|Lack of Efficacy|0|||
131580909|NCT05061693|473753639|FG005|24-week Extension Period|Lack of Efficacy|0|||
131580910|NCT05061693|473753640|FG006|24-week Extension Period|Lack of Efficacy|0|||
131580911|NCT05061693|473753641|FG007|24-week Extension Period|Lack of Efficacy|0|||
131580912|NCT05061693|473753642|FG008|24-week Extension Period|Lack of Efficacy|0|||
131580913|NCT05061693|473753643|FG009|24-week Extension Period|Lack of Efficacy|0|||
131580914|NCT05061693|473753644|FG010|24-week Extension Period|Lack of Efficacy|2|||
131580915|NCT05061693|473753645|FG011|24-week Extension Period|Lack of Efficacy|0|||
131580916|NCT05061693|473753634|FG000|24-week Extension Period|Lost to Follow-up|0|||
131580917|NCT05061693|473753635|FG001|24-week Extension Period|Lost to Follow-up|0|||
131580918|NCT05061693|473753636|FG002|24-week Extension Period|Lost to Follow-up|0|||
131580919|NCT05061693|473753637|FG003|24-week Extension Period|Lost to Follow-up|0|||
131580920|NCT05061693|473753638|FG004|24-week Extension Period|Lost to Follow-up|0|||
131580921|NCT05061693|473753639|FG005|24-week Extension Period|Lost to Follow-up|0|||
131580922|NCT05061693|473753640|FG006|24-week Extension Period|Lost to Follow-up|1|||
131580923|NCT05061693|473753641|FG007|24-week Extension Period|Lost to Follow-up|0|||
131580924|NCT05061693|473753642|FG008|24-week Extension Period|Lost to Follow-up|1|||
131580925|NCT05061693|473753643|FG009|24-week Extension Period|Lost to Follow-up|1|||
131580926|NCT05061693|473753644|FG010|24-week Extension Period|Lost to Follow-up|0|||
131580927|NCT05061693|473753645|FG011|24-week Extension Period|Lost to Follow-up|0|||
131580928|NCT05061693|473753634|FG000|24-week Extension Period|Withdrawal by Subject|0|||
131580929|NCT05061693|473753635|FG001|24-week Extension Period|Withdrawal by Subject|0|||
131580930|NCT05061693|473753636|FG002|24-week Extension Period|Withdrawal by Subject|0|||
131580931|NCT05061693|473753637|FG003|24-week Extension Period|Withdrawal by Subject|0|||
131580932|NCT05061693|473753638|FG004|24-week Extension Period|Withdrawal by Subject|0|||
131580933|NCT05061693|473753639|FG005|24-week Extension Period|Withdrawal by Subject|0|||
131580934|NCT05061693|473753640|FG006|24-week Extension Period|Withdrawal by Subject|0|||
131580935|NCT05061693|473753641|FG007|24-week Extension Period|Withdrawal by Subject|0|||
131438368|NCT03192176|473231214|FG007|Overall Study|Physician Decision|0|||
131438369|NCT03192176|473231207|FG000|Overall Study|Protocol Deviation|1|||
131580936|NCT05061693|473753642|FG008|24-week Extension Period|Withdrawal by Subject|1|||
131580937|NCT05061693|473753643|FG009|24-week Extension Period|Withdrawal by Subject|2|||
131580938|NCT05061693|473753644|FG010|24-week Extension Period|Withdrawal by Subject|2|||
131580939|NCT05061693|473753645|FG011|24-week Extension Period|Withdrawal by Subject|1|||
131580940|NCT05061693|473753634|FG000|24-week Extension Period|Sponsor Decision|0|||
131580941|NCT05061693|473753635|FG001|24-week Extension Period|Sponsor Decision|0|||
131580942|NCT05061693|473753636|FG002|24-week Extension Period|Sponsor Decision|0|||
131580943|NCT05061693|473753637|FG003|24-week Extension Period|Sponsor Decision|0|||
131580944|NCT05061693|473753638|FG004|24-week Extension Period|Sponsor Decision|0|||
131580945|NCT05061693|473753639|FG005|24-week Extension Period|Sponsor Decision|0|||
131580946|NCT05061693|473753640|FG006|24-week Extension Period|Sponsor Decision|0|||
131580947|NCT05061693|473753641|FG007|24-week Extension Period|Sponsor Decision|1|||
131580948|NCT05061693|473753642|FG008|24-week Extension Period|Sponsor Decision|0|||
131580949|NCT05061693|473753643|FG009|24-week Extension Period|Sponsor Decision|0|||
131580950|NCT05061693|473753644|FG010|24-week Extension Period|Sponsor Decision|0|||
131580951|NCT05061693|473753645|FG011|24-week Extension Period|Sponsor Decision|0|||
131580952|NCT05061693|473753634|FG000|24-week Extension Period|Site Closure|0|||
131438370|NCT03192176|473231208|FG001|Overall Study|Protocol Deviation|1|||
131438371|NCT03192176|473231209|FG002|Overall Study|Protocol Deviation|0|||
131580953|NCT05061693|473753635|FG001|24-week Extension Period|Site Closure|0|||
131580954|NCT05061693|473753636|FG002|24-week Extension Period|Site Closure|0|||
131580955|NCT05061693|473753637|FG003|24-week Extension Period|Site Closure|0|||
131580956|NCT05061693|473753638|FG004|24-week Extension Period|Site Closure|0|||
131580957|NCT05061693|473753639|FG005|24-week Extension Period|Site Closure|0|||
131580958|NCT05061693|473753640|FG006|24-week Extension Period|Site Closure|0|||
131580959|NCT05061693|473753641|FG007|24-week Extension Period|Site Closure|0|||
131580960|NCT05061693|473753642|FG008|24-week Extension Period|Site Closure|1|||
131580961|NCT05061693|473753643|FG009|24-week Extension Period|Site Closure|0|||
131580962|NCT05061693|473753644|FG010|24-week Extension Period|Site Closure|0|||
131580963|NCT05061693|473753645|FG011|24-week Extension Period|Site Closure|1|||
131580964|NCT00258895|473753646|FG000|Overall Study|Lost to Follow-up|3|||
131580965|NCT00258895|473753647|FG001|Overall Study|Lost to Follow-up|1|||
131580966|NCT00258895|473753646|FG000|Overall Study|Protocol Violation|6|||
131580967|NCT00258895|473753647|FG001|Overall Study|Protocol Violation|2|||
131580968|NCT00258895|473753646|FG000|Overall Study|Withdrawal by Subject|1|||
131580969|NCT00258895|473753647|FG001|Overall Study|Withdrawal by Subject|0|||
131580970|NCT00547118|473753650|FG000|Overall Study|Did not qualify prior to starting drug|1|||
131580971|NCT00547118|473753651|FG001|Overall Study|Did not qualify prior to starting drug|1|||
131580972|NCT00547118|473753650|FG000|Overall Study|Study suspended|7|||
131580973|NCT00547118|473753651|FG001|Overall Study|Study suspended|8|||
131580974|NCT02248480|473753652|FG000|Overall Study|Lack of Efficacy|4|||
131580975|NCT02248480|473753653|FG001|Overall Study|Lack of Efficacy|6|||
131788128|NCT00575328|474507541|FG001|Overall Study|Adverse Event|1|||
131580976|NCT02248480|473753652|FG000|Overall Study|Adverse Event|11|||
131580977|NCT02248480|473753653|FG001|Overall Study|Adverse Event|2|||
131580978|NCT02248480|473753652|FG000|Overall Study|Withdrawal by Subject|2|||
131580979|NCT02248480|473753653|FG001|Overall Study|Withdrawal by Subject|4|||
131580980|NCT02248480|473753652|FG000|Overall Study|Entry Criteria Not Met|0|||
131580981|NCT02248480|473753653|FG001|Overall Study|Entry Criteria Not Met|1|||
131580982|NCT02248480|473753652|FG000|Overall Study|Other:Physician Decision|0|||
131580983|NCT02248480|473753653|FG001|Overall Study|Other:Physician Decision|1|||
131580984|NCT04504916|473753655|FG000|Overall Study|Study terminated|7|||
131580985|NCT04504916|473753656|FG001|Overall Study|Study terminated|8|||
131580986|NCT04504916|473753655|FG000|Overall Study|Death|54|||
131580987|NCT04504916|473753656|FG001|Overall Study|Death|18|||
131580988|NCT04504916|473753655|FG000|Overall Study|Lost to Follow-up|1|||
131580989|NCT04504916|473753656|FG001|Overall Study|Lost to Follow-up|1|||
131580990|NCT04504916|473753655|FG000|Overall Study|Withdrawal by Subject|8|||
131580991|NCT04504916|473753656|FG001|Overall Study|Withdrawal by Subject|4|||
131580992|NCT04504916|473753655|FG000|Overall Study|Did not agree to follow-up|0|||
131580993|NCT04504916|473753656|FG001|Overall Study|Did not agree to follow-up|1|||
131580994|NCT00373529|473753657|FG000|Overall Study|Physician Decision|19|||
131580995|NCT00373529|473753657|FG000|Overall Study|Withdrawal by Subject|7|||
131580996|NCT00373529|473753657|FG000|Overall Study|Adverse Event|7|||
131580997|NCT00373529|473753657|FG000|Overall Study|Treatment failure|36|||
131580998|NCT00373529|473753657|FG000|Overall Study|Disease recurrence|10|||
131580999|NCT00373529|473753657|FG000|Overall Study|Death|16|||
131581000|NCT00373529|473753657|FG000|Overall Study|Need for treatment prohibited by study|1|||
131581001|NCT00373529|473753657|FG000|Overall Study|Other|8|||
131581002|NCT00373529|473753657|FG000|Overall Study|Failed independent confirmation of AML|3|||
131581003|NCT00373529|473753657|FG000|Overall Study|Consent violation|1|||
131581004|NCT00539292|473753658|FG000|Overall Study|Physician Decision|1|||
131581005|NCT00539292|473753659|FG001|Overall Study|Physician Decision|0|||
131581006|NCT00630786|473753660|FG000|Overall Study|Physician Decision|0|||
131581007|NCT00630786|473753661|FG001|Overall Study|Physician Decision|0|||
131581008|NCT00630786|473753662|FG002|Overall Study|Physician Decision|1|||
131581009|NCT00630786|473753660|FG000|Overall Study|Withdrawal by Subject|0|||
131581010|NCT00630786|473753661|FG001|Overall Study|Withdrawal by Subject|1|||
131581011|NCT00630786|473753662|FG002|Overall Study|Withdrawal by Subject|1|||
131581012|NCT00630786|473753660|FG000|Overall Study|Lost to Follow-up|0|||
131581013|NCT00630786|473753661|FG001|Overall Study|Lost to Follow-up|1|||
131581014|NCT00630786|473753662|FG002|Overall Study|Lost to Follow-up|0|||
131581015|NCT00630786|473753660|FG000|Overall Study|Other|1|||
131581016|NCT00630786|473753661|FG001|Overall Study|Other|0|||
131581017|NCT00630786|473753662|FG002|Overall Study|Other|0|||
131581018|NCT04009577|473753663|FG000|Core Study|Adverse Event|1|||
131581019|NCT04009577|473753664|FG001|Core Study|Adverse Event|0|||
131581020|NCT04009577|473753665|FG002|Core Study|Adverse Event|2|||
131581021|NCT04009577|473753666|FG003|Core Study|Adverse Event|4|||
131581022|NCT04009577|473753663|FG000|Core Study|Withdrawal by Subject|0|||
131581023|NCT04009577|473753664|FG001|Core Study|Withdrawal by Subject|0|||
131581024|NCT04009577|473753665|FG002|Core Study|Withdrawal by Subject|2|||
131581025|NCT04009577|473753666|FG003|Core Study|Withdrawal by Subject|0|||
131581026|NCT04009577|473753663|FG000|Core Study|Other|0|||
131581027|NCT04009577|473753664|FG001|Core Study|Other|0|||
131581028|NCT04009577|473753665|FG002|Core Study|Other|0|||
131581029|NCT04009577|473753666|FG003|Core Study|Other|1|||
131581030|NCT04009577|473753663|FG000|Extension Phase|Adverse Event|0|||
131581031|NCT04009577|473753664|FG001|Extension Phase|Adverse Event|0|||
131702510|NCT05168267|474193165|FG001|Overall Study|Left Facility|0|||
131702511|NCT05702736|474193166|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
131702512|NCT05702736|474193167|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
131581032|NCT04009577|473753665|FG002|Extension Phase|Adverse Event|0|||
131581033|NCT04009577|473753666|FG003|Extension Phase|Adverse Event|1|||
131581034|NCT04009577|473753663|FG000|Extension Phase|Inadequate therapeutic effect|0|||
131581035|NCT04009577|473753664|FG001|Extension Phase|Inadequate therapeutic effect|0|||
131581036|NCT04009577|473753665|FG002|Extension Phase|Inadequate therapeutic effect|1|||
131581037|NCT04009577|473753666|FG003|Extension Phase|Inadequate therapeutic effect|0|||
131581038|NCT04009577|473753663|FG000|Extension Phase|Withdrawal by Subject|0|||
131581039|NCT04009577|473753664|FG001|Extension Phase|Withdrawal by Subject|0|||
131581040|NCT04009577|473753665|FG002|Extension Phase|Withdrawal by Subject|1|||
131581041|NCT04009577|473753666|FG003|Extension Phase|Withdrawal by Subject|0|||
131702513|NCT05702736|474193166|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
131702514|NCT05702736|474193167|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
131702515|NCT00500682|474193172|FG000|Overall Study|Adverse Event|37|||
131702516|NCT00500682|474193173|FG001|Overall Study|Adverse Event|29|||
131581042|NCT04009577|473753663|FG000|Extension Phase|Not Treated|0|||
131581043|NCT04009577|473753664|FG001|Extension Phase|Not Treated|0|||
131581044|NCT04009577|473753665|FG002|Extension Phase|Not Treated|2|||
131581045|NCT04009577|473753666|FG003|Extension Phase|Not Treated|0|||
131581046|NCT02020616|473753670|FG000|Overall Study|Adverse Event|0|||
131581047|NCT02020616|473753671|FG001|Overall Study|Adverse Event|0|||
131581048|NCT02020616|473753672|FG002|Overall Study|Adverse Event|0|||
131581049|NCT02020616|473753673|FG003|Overall Study|Adverse Event|0|||
131581050|NCT02020616|473753674|FG004|Overall Study|Adverse Event|0|||
131581051|NCT02020616|473753675|FG005|Overall Study|Adverse Event|1|||
131581052|NCT02020616|473753676|FG006|Overall Study|Adverse Event|1|||
131581053|NCT02020616|473753670|FG000|Overall Study|Physician Decision|0|||
131581054|NCT02020616|473753671|FG001|Overall Study|Physician Decision|0|||
131581055|NCT02020616|473753672|FG002|Overall Study|Physician Decision|0|||
131581056|NCT02020616|473753673|FG003|Overall Study|Physician Decision|0|||
131581057|NCT02020616|473753674|FG004|Overall Study|Physician Decision|0|||
131581058|NCT02020616|473753675|FG005|Overall Study|Physician Decision|1|||
131581059|NCT02020616|473753676|FG006|Overall Study|Physician Decision|2|||
131581060|NCT02020616|473753670|FG000|Overall Study|Withdrawal by Subject|0|||
131581061|NCT02020616|473753671|FG001|Overall Study|Withdrawal by Subject|0|||
131581062|NCT02020616|473753672|FG002|Overall Study|Withdrawal by Subject|1|||
131581063|NCT02020616|473753673|FG003|Overall Study|Withdrawal by Subject|0|||
131581064|NCT02020616|473753674|FG004|Overall Study|Withdrawal by Subject|0|||
131581065|NCT02020616|473753675|FG005|Overall Study|Withdrawal by Subject|1|||
131581066|NCT02020616|473753676|FG006|Overall Study|Withdrawal by Subject|1|||
131581067|NCT02020616|473753670|FG000|Overall Study|Lost to Follow-up|0|||
131581068|NCT02020616|473753671|FG001|Overall Study|Lost to Follow-up|1|||
131581069|NCT02020616|473753672|FG002|Overall Study|Lost to Follow-up|0|||
131581070|NCT02020616|473753673|FG003|Overall Study|Lost to Follow-up|1|||
131581071|NCT02020616|473753674|FG004|Overall Study|Lost to Follow-up|1|||
131581072|NCT02020616|473753675|FG005|Overall Study|Lost to Follow-up|1|||
131581073|NCT02020616|473753676|FG006|Overall Study|Lost to Follow-up|0|||
131581074|NCT02020616|473753670|FG000|Overall Study|Early Termination Criteria Met|0|||
131581075|NCT02020616|473753671|FG001|Overall Study|Early Termination Criteria Met|0|||
131581076|NCT02020616|473753672|FG002|Overall Study|Early Termination Criteria Met|1|||
131581077|NCT02020616|473753673|FG003|Overall Study|Early Termination Criteria Met|0|||
131581078|NCT02020616|473753674|FG004|Overall Study|Early Termination Criteria Met|0|||
131581079|NCT02020616|473753675|FG005|Overall Study|Early Termination Criteria Met|1|||
131581080|NCT02020616|473753676|FG006|Overall Study|Early Termination Criteria Met|0|||
131581081|NCT02020616|473753670|FG000|Overall Study|Randomized in Error|0|||
131581082|NCT02020616|473753671|FG001|Overall Study|Randomized in Error|0|||
131581083|NCT02020616|473753672|FG002|Overall Study|Randomized in Error|0|||
131581084|NCT02020616|473753673|FG003|Overall Study|Randomized in Error|1|||
131581085|NCT02020616|473753674|FG004|Overall Study|Randomized in Error|0|||
131581086|NCT02020616|473753675|FG005|Overall Study|Randomized in Error|0|||
131581087|NCT02020616|473753676|FG006|Overall Study|Randomized in Error|0|||
131581088|NCT02020616|473753670|FG000|Overall Study|Lack of Efficacy|0|||
131581089|NCT02020616|473753671|FG001|Overall Study|Lack of Efficacy|0|||
131581090|NCT02020616|473753672|FG002|Overall Study|Lack of Efficacy|0|||
131581091|NCT02020616|473753673|FG003|Overall Study|Lack of Efficacy|0|||
131581092|NCT02020616|473753674|FG004|Overall Study|Lack of Efficacy|1|||
131581093|NCT02020616|473753675|FG005|Overall Study|Lack of Efficacy|0|||
131581094|NCT02020616|473753676|FG006|Overall Study|Lack of Efficacy|0|||
131581095|NCT02031471|473753681|FG000|24 Week Treatment Period|Adverse Event|6|||
131581096|NCT02031471|473753681|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
131581097|NCT02031471|473753681|FG000|24 Week Treatment Period|Protocol Violation|1|||
131581098|NCT02031471|473753681|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
131581099|NCT02031471|473753681|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
131581100|NCT02031471|473753681|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
131581101|NCT02031471|473753681|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
131581102|NCT00658996|473753685|FG000|First Intervention|Positive slit lamp finding|1|||
131581103|NCT00658996|473753686|FG001|First Intervention|Positive slit lamp finding|0|||
131581104|NCT00658996|473753685|FG000|First Intervention|Lack of lenses|0|||
131581105|NCT00658996|473753686|FG001|First Intervention|Lack of lenses|1|||
131581106|NCT00658996|473753685|FG000|Crossover Period|Physician Decision|1|||
131581107|NCT00658996|473753686|FG001|Crossover Period|Physician Decision|0|||
131581108|NCT00658996|473753685|FG000|Crossover Period|Ineligible|1|||
131581109|NCT00658996|473753686|FG001|Crossover Period|Ineligible|1|||
131581110|NCT00658996|473753685|FG000|Second Intervention|Developed a stye on upper lid|1|||
131581111|NCT00658996|473753686|FG001|Second Intervention|Developed a stye on upper lid|0|||
131581112|NCT00658996|473753685|FG000|Second Intervention|Positive slit lamp finding|0|||
131581113|NCT00658996|473753686|FG001|Second Intervention|Positive slit lamp finding|1|||
131581114|NCT00997386|473753687|FG000|Overall Study|Death|7|||
131581115|NCT01579916|473753689|FG000|Overall Study|Lost to Follow-up|6|||
131581116|NCT01579916|473753690|FG001|Overall Study|Lost to Follow-up|1|||
131581117|NCT01579916|473753689|FG000|Overall Study|Withdrawal by Subject|1|||
131581118|NCT01579916|473753690|FG001|Overall Study|Withdrawal by Subject|1|||
131581119|NCT01579916|473753689|FG000|Overall Study|Death|1|||
131581120|NCT01579916|473753690|FG001|Overall Study|Death|0|||
131581121|NCT02994654|473753691|FG000|Overall Study|Lost to Follow-up|1|||
131581122|NCT01810263|473753698|FG000|Overall Study|Lost to Follow-up|8|||
131581123|NCT01810263|473753699|FG001|Overall Study|Lost to Follow-up|7|||
131581124|NCT00688519|473753700|FG000|Overall Study|Adverse Event|2|||
131581125|NCT00688519|473753701|FG001|Overall Study|Adverse Event|3|||
131581126|NCT00688519|473753700|FG000|Overall Study|Lost to Follow-up|3|||
131581127|NCT00688519|473753701|FG001|Overall Study|Lost to Follow-up|3|||
131581128|NCT00688519|473753700|FG000|Overall Study|Lack of Efficacy|3|||
131581129|NCT00688519|473753701|FG001|Overall Study|Lack of Efficacy|1|||
131581130|NCT00688519|473753700|FG000|Overall Study|Withdrawal by Subject|7|||
131581131|NCT00688519|473753701|FG001|Overall Study|Withdrawal by Subject|6|||
131581132|NCT00688519|473753700|FG000|Overall Study|Prohibited medication|1|||
131581133|NCT00688519|473753701|FG001|Overall Study|Prohibited medication|0|||
131581134|NCT00688519|473753700|FG000|Overall Study|Non-compliance|0|||
131581135|NCT00688519|473753701|FG001|Overall Study|Non-compliance|1|||
131581136|NCT00688519|473753700|FG000|Overall Study|Subject moved out of state|1|||
131581137|NCT00688519|473753701|FG001|Overall Study|Subject moved out of state|0|||
131581138|NCT00688519|473753700|FG000|Overall Study|Investigator decision|1|||
131581139|NCT00688519|473753701|FG001|Overall Study|Investigator decision|0|||
131581140|NCT00688519|473753700|FG000|Overall Study|Subject moved out of area|1|||
131581141|NCT00688519|473753701|FG001|Overall Study|Subject moved out of area|0|||
131581142|NCT00688519|473753700|FG000|Overall Study|Pregnancy|0|||
131581143|NCT00688519|473753701|FG001|Overall Study|Pregnancy|1|||
131581144|NCT01353963|473753702|FG000|Overall Study|Adverse Event|2|||
131581145|NCT03351075|473754689|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
131581146|NCT03351075|473754690|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
131581147|NCT03351075|473754689|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
131581148|NCT03351075|473754690|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
131581149|NCT03351075|473754689|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
131581150|NCT03351075|473754690|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
131581151|NCT03351075|473754689|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
131581152|NCT03351075|473754690|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
131581153|NCT05219253|473754700|FG000|Overall Study|Withdrawal by Subject|1|||
131581154|NCT05219253|473754701|FG001|Overall Study|Withdrawal by Subject|2|||
131581155|NCT03544515|473754702|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
131581156|NCT03544515|473754703|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
131581157|NCT03544515|473754702|FG000|Overall Study|Lost to Follow-up|2|||
131581158|NCT03544515|473754703|FG001|Overall Study|Lost to Follow-up|0|||
131581159|NCT03169244|473754704|FG000|Overall Study|Lost to Follow-up|1|||
131581160|NCT03169244|473754705|FG001|Overall Study|Lost to Follow-up|2|||
131581161|NCT03169244|473754704|FG000|Overall Study|Adverse Event|1|||
131581162|NCT03169244|473754705|FG001|Overall Study|Adverse Event|0|||
131581163|NCT03169244|473754704|FG000|Overall Study|Withdrawal by Subject|2|||
131581164|NCT03169244|473754705|FG001|Overall Study|Withdrawal by Subject|2|||
131581165|NCT03169244|473754704|FG000|Overall Study|Physician Decision|1|||
131581166|NCT03169244|473754705|FG001|Overall Study|Physician Decision|0|||
131581167|NCT00178399|473754708|FG000|Overall Study|Physician Decision|4|||
131581168|NCT00178399|473754708|FG000|Overall Study|Withdrawal by Subject|8|||
131581169|NCT00178399|473754708|FG000|Overall Study|Lost to Follow-up|1|||
131581170|NCT02544152|473754709|FG000|Overall Study|Adverse Event|0|||
131581171|NCT02544152|473754710|FG001|Overall Study|Adverse Event|4|||
131581172|NCT02544152|473754709|FG000|Overall Study|Withdrawal by Subject|0|||
131581173|NCT02544152|473754710|FG001|Overall Study|Withdrawal by Subject|3|||
131581174|NCT02544152|473754709|FG000|Overall Study|Other|1|||
131581175|NCT02544152|473754710|FG001|Overall Study|Other|0|||
131581176|NCT00516321|473754714|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
131581177|NCT00516321|473754715|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
131581178|NCT00516321|473754716|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
131581179|NCT00516321|473754714|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
131581180|NCT00516321|473754715|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
131581181|NCT00516321|473754716|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
131581182|NCT00516321|473754714|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
131581183|NCT00516321|473754715|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
131581184|NCT00516321|473754716|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
131581185|NCT00516321|473754714|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
131581186|NCT00516321|473754715|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
131581187|NCT00516321|473754716|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
131581188|NCT00516321|473754714|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
131581189|NCT00516321|473754715|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
131581190|NCT00516321|473754716|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
131581191|NCT00516321|473754714|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
131581192|NCT00516321|473754715|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
131581193|NCT00516321|473754716|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
131581194|NCT00516321|473754714|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
131581195|NCT00516321|473754715|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
131702517|NCT00500682|474193172|FG000|Overall Study|Death|25|||
131581196|NCT00516321|473754716|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
131581197|NCT00516321|473754714|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
131581198|NCT00516321|473754715|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
131581199|NCT00516321|473754716|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
131581200|NCT00516321|473754714|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
131581201|NCT00516321|473754715|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
131581202|NCT00516321|473754716|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
131581203|NCT00516321|473754714|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
131581204|NCT00516321|473754715|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
131581205|NCT00516321|473754716|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
131581206|NCT00516321|473754714|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
131581207|NCT00516321|473754715|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
131581208|NCT00516321|473754716|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
131581209|NCT01426269|473754720|FG000|Period 1: 12 Weeks|Adverse Event|5|||
131581210|NCT01426269|473754721|FG001|Period 1: 12 Weeks|Adverse Event|0|||
131581211|NCT01426269|473754722|FG002|Period 1: 12 Weeks|Adverse Event|0|||
131581212|NCT01426269|473754720|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
131581213|NCT01426269|473754721|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
131581214|NCT01426269|473754722|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
131581215|NCT01426269|473754720|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
131581216|NCT01426269|473754721|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
131581217|NCT01426269|473754722|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
131581218|NCT01426269|473754720|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
131581219|NCT01426269|473754721|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
131581220|NCT01426269|473754722|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
131581221|NCT01426269|473754720|FG000|Period 1: 12 Weeks|Pregnancy|1|||
131581222|NCT01426269|473754721|FG001|Period 1: 12 Weeks|Pregnancy|0|||
131581223|NCT01426269|473754722|FG002|Period 1: 12 Weeks|Pregnancy|0|||
131581224|NCT01426269|473754720|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
131581225|NCT01426269|473754721|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
131581226|NCT01426269|473754722|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
131581227|NCT01426269|473754720|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
131581228|NCT01426269|473754721|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
131581229|NCT01426269|473754722|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
131581230|NCT01426269|473754720|FG000|Period 2: 40 Weeks|Adverse Event|0|||
131581231|NCT01426269|473754721|FG001|Period 2: 40 Weeks|Adverse Event|1|||
131581232|NCT01426269|473754722|FG002|Period 2: 40 Weeks|Adverse Event|2|||
131581233|NCT01426269|473754720|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
131581234|NCT01426269|473754721|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
131581235|NCT01426269|473754722|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
131581236|NCT01426269|473754720|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
131581237|NCT01426269|473754721|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
131581238|NCT01426269|473754722|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
131581239|NCT01426269|473754720|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
131581240|NCT01426269|473754721|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
131581241|NCT01426269|473754722|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
131581242|NCT01426269|473754720|FG000|Period 2: 40 Weeks|Site closed|0|||
131581243|NCT01426269|473754721|FG001|Period 2: 40 Weeks|Site closed|6|||
131581244|NCT01426269|473754722|FG002|Period 2: 40 Weeks|Site closed|5|||
131581245|NCT01426269|473754720|FG000|Period 2: 40 Weeks|Relapsed|0|||
131581246|NCT01426269|473754721|FG001|Period 2: 40 Weeks|Relapsed|9|||
131581247|NCT01426269|473754722|FG002|Period 2: 40 Weeks|Relapsed|18|||
131581248|NCT03557008|473754723|FG000|Overall Study|Withdrawal by Subject|2|||
131581249|NCT03557008|473754724|FG001|Overall Study|Withdrawal by Subject|2|||
131581250|NCT03557008|473754723|FG000|Overall Study|Early termination from study|3|||
131581251|NCT03557008|473754724|FG001|Overall Study|Early termination from study|1|||
131581252|NCT01113931|473754725|FG000|Overall Study|Adverse Event|2|||
131581253|NCT01113931|473754726|FG001|Overall Study|Adverse Event|2|||
131581254|NCT01113931|473754725|FG000|Overall Study|Physician Decision|0|||
131581255|NCT01113931|473754726|FG001|Overall Study|Physician Decision|2|||
131581256|NCT01113931|473754725|FG000|Overall Study|Lost to Follow-up|12|||
131581257|NCT01113931|473754726|FG001|Overall Study|Lost to Follow-up|9|||
131581258|NCT01113931|473754725|FG000|Overall Study|Various|2|||
131581259|NCT01113931|473754726|FG001|Overall Study|Various|4|||
131581260|NCT01113931|473754725|FG000|Overall Study|Withdrawal by Subject|3|||
131581261|NCT01113931|473754726|FG001|Overall Study|Withdrawal by Subject|0|||
131581262|NCT00071799|473754728|FG000|Overall Study|Adverse Event|19|||
131702518|NCT00500682|474193173|FG001|Overall Study|Death|16|||
131702519|NCT00500682|474193172|FG000|Overall Study|Lost to Follow-up|11|||
131581263|NCT00071799|473754729|FG001|Overall Study|Adverse Event|10|||
131581264|NCT00071799|473754728|FG000|Overall Study|Protocol Violation|1|||
131581265|NCT00071799|473754729|FG001|Overall Study|Protocol Violation|7|||
131702520|NCT00500682|474193173|FG001|Overall Study|Lost to Follow-up|11|||
131702521|NCT00500682|474193172|FG000|Overall Study|Physician Decision|6|||
131581266|NCT00071799|473754728|FG000|Overall Study|Lost to Follow-up|1|||
131581267|NCT00071799|473754729|FG001|Overall Study|Lost to Follow-up|1|||
131581268|NCT00071799|473754728|FG000|Overall Study|Withdrawal by Subject|15|||
131581269|NCT00071799|473754729|FG001|Overall Study|Withdrawal by Subject|37|||
131581270|NCT00071799|473754728|FG000|Overall Study|Physician Decision|0|||
131581271|NCT00071799|473754729|FG001|Overall Study|Physician Decision|2|||
131581272|NCT00071799|473754728|FG000|Overall Study|Lack of Efficacy|11|||
131581273|NCT00071799|473754729|FG001|Overall Study|Lack of Efficacy|18|||
131581274|NCT00071799|473754728|FG000|Overall Study|Disease Progression|23|||
131581275|NCT00071799|473754729|FG001|Overall Study|Disease Progression|20|||
131581276|NCT00071799|473754728|FG000|Overall Study|Different Central+Local Pathology Review|0|||
131581277|NCT00071799|473754729|FG001|Overall Study|Different Central+Local Pathology Review|1|||
131581278|NCT00071799|473754728|FG000|Overall Study|Not Documented|0|||
131581279|NCT00071799|473754729|FG001|Overall Study|Not Documented|2|||
131581280|NCT03959241|473754730|FG000|Overall Study|Withdrawal by Subject|7|||
131581281|NCT03959241|473754731|FG001|Overall Study|Withdrawal by Subject|8|||
131581282|NCT03959241|473754730|FG000|Overall Study|Lost to Follow-up|1|||
131581283|NCT03959241|473754731|FG001|Overall Study|Lost to Follow-up|0|||
131581284|NCT03959241|473754730|FG000|Overall Study|Move to Hospice Care|1|||
131581285|NCT03959241|473754731|FG001|Overall Study|Move to Hospice Care|0|||
131581286|NCT03959241|473754730|FG000|Overall Study|Screen Failure|1|||
131581287|NCT03959241|473754731|FG001|Overall Study|Screen Failure|0|||
131581288|NCT03959241|473754730|FG000|Overall Study|Disease Relapse|0|||
131581289|NCT03959241|473754731|FG001|Overall Study|Disease Relapse|1|||
131581290|NCT03959241|473754730|FG000|Overall Study|Off Study|1|||
131581291|NCT03959241|473754731|FG001|Overall Study|Off Study|0|||
131581292|NCT01145885|473754732|FG000|Overall Study|Progressive Disease|7|||
131581293|NCT00346151|473754735|FG000|Overall Study|Withdrawal by Subject|3|||
131581294|NCT04054635|473754740|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
131581295|NCT04054635|473754741|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
131581296|NCT04054635|473754742|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
131581297|NCT04054635|473754740|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
131581298|NCT04054635|473754741|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
131581299|NCT04054635|473754742|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
131581300|NCT00545077|473754748|FG000|Overall Study|Treatment not received|5|||
131581301|NCT00545077|473754749|FG001|Overall Study|Treatment not received|1|||
131581302|NCT00545077|473754748|FG000|Overall Study|Disease Progression|131|||
131581303|NCT00545077|473754749|FG001|Overall Study|Disease Progression|98|||
131581304|NCT00545077|473754748|FG000|Overall Study|Withdrawal by Subject|3|||
131581305|NCT00545077|473754749|FG001|Overall Study|Withdrawal by Subject|14|||
131581306|NCT00545077|473754748|FG000|Overall Study|Physician Decision|6|||
131581307|NCT00545077|473754749|FG001|Overall Study|Physician Decision|3|||
131581308|NCT00545077|473754748|FG000|Overall Study|Lost to Follow-up|2|||
131581309|NCT00545077|473754749|FG001|Overall Study|Lost to Follow-up|0|||
131581310|NCT00545077|473754748|FG000|Overall Study|Protocol Violation|1|||
131581311|NCT00545077|473754749|FG001|Overall Study|Protocol Violation|0|||
131581312|NCT00545077|473754748|FG000|Overall Study|Adverse Event|0|||
131581313|NCT00545077|473754749|FG001|Overall Study|Adverse Event|31|||
131581314|NCT00545077|473754748|FG000|Overall Study|Death|0|||
131581315|NCT00545077|473754749|FG001|Overall Study|Death|8|||
131581316|NCT00535145|473754751|FG000|Phase I|Adverse Event|3|||
131581317|NCT00535145|473754751|FG000|Phase I|Lost to Follow-up|7|||
131581318|NCT00535145|473754751|FG000|Phase I|Withdrawal by Subject|6|||
131581319|NCT00535145|473754751|FG000|Phase I|(eligibility)|8|||
131581320|NCT00535145|473754751|FG000|Phase I|(protocol violation)|1|||
131581321|NCT00535145|473754751|FG000|Phase I|(PI decision)|1|||
131581322|NCT00535145|473754751|FG000|Phase I|(diagnosis)|3|||
131581323|NCT00535145|473754751|FG000|Phase II|Adverse Event|2|||
131581324|NCT00535145|473754751|FG000|Phase II|Lack of Efficacy|1|||
131581325|NCT00535145|473754751|FG000|Phase II|Lost to Follow-up|5|||
131581326|NCT00535145|473754751|FG000|Phase II|Withdrawal by Subject|5|||
131581327|NCT00535145|473754751|FG000|Phase II|Subject non-compliance|2|||
131581328|NCT03260140|473754752|FG000|Overall Study|Death|4|||
131581329|NCT03260140|473754753|FG001|Overall Study|Death|1|||
131581330|NCT03260140|473754752|FG000|Overall Study|Withdrawal by Subject|1|||
131581331|NCT03260140|473754753|FG001|Overall Study|Withdrawal by Subject|4|||
131581332|NCT00463788|473754754|FG000|Overall Study|Progressive Disease|86|||
131581333|NCT00463788|473754755|FG001|Overall Study|Progressive Disease|42|||
131581334|NCT00463788|473754754|FG000|Overall Study|Adverse Event|6|||
131581335|NCT00463788|473754755|FG001|Overall Study|Adverse Event|2|||
131581336|NCT00463788|473754754|FG000|Overall Study|Withdrawal by Subject|6|||
131581337|NCT00463788|473754755|FG001|Overall Study|Withdrawal by Subject|2|||
131581338|NCT00463788|473754754|FG000|Overall Study|Death|4|||
131581339|NCT00463788|473754755|FG001|Overall Study|Death|3|||
131581340|NCT00463788|473754754|FG000|Overall Study|Symptomatic Deterioration|2|||
131581341|NCT00463788|473754755|FG001|Overall Study|Symptomatic Deterioration|3|||
131581342|NCT00463788|473754754|FG000|Overall Study|Lost to Follow-up|1|||
131581343|NCT00463788|473754755|FG001|Overall Study|Lost to Follow-up|0|||
131581344|NCT00463788|473754754|FG000|Overall Study|Protocol Violation|0|||
131581345|NCT00463788|473754755|FG001|Overall Study|Protocol Violation|1|||
131581346|NCT00463788|473754754|FG000|Overall Study|Other|3|||
131581347|NCT00463788|473754755|FG001|Overall Study|Other|0|||
131581348|NCT00463788|473754754|FG000|Overall Study|Randomized but not treated|1|||
131581349|NCT00463788|473754755|FG001|Overall Study|Randomized but not treated|1|||
131581350|NCT00360698|473754756|FG000|Run-In|Physician Decision|0|||
131581351|NCT00360698|473754757|FG001|Run-In|Physician Decision|1|||
131581352|NCT00360698|473754756|FG000|Run-In|Withdrawal by Subject|0|||
131581353|NCT00360698|473754757|FG001|Run-In|Withdrawal by Subject|2|||
131581354|NCT00360698|473754756|FG000|Run-In|Non compliance with treatment procedure|0|||
131581355|NCT00360698|473754757|FG001|Run-In|Non compliance with treatment procedure|1|||
131581356|NCT00360698|473754756|FG000|Run-In|Sponsor request|0|||
131581357|NCT00360698|473754757|FG001|Run-In|Sponsor request|2|||
131581358|NCT00360698|473754756|FG000|Run-In|Patient did not meet inclusion criteria|0|||
131581359|NCT00360698|473754757|FG001|Run-In|Patient did not meet inclusion criteria|1|||
131581360|NCT00360698|473754756|FG000|Run-In|Patient personal reasons|0|||
131581361|NCT00360698|473754757|FG001|Run-In|Patient personal reasons|2|||
131581362|NCT00360698|473754756|FG000|Run-In|Need of insulin with meals|0|||
131581363|NCT00360698|473754757|FG001|Run-In|Need of insulin with meals|1|||
131581364|NCT00360698|473754756|FG000|Treatment Period|Non compliance with treatment procedure|1|||
131581365|NCT00360698|473754757|FG001|Treatment Period|Non compliance with treatment procedure|0|||
131581366|NCT00360698|473754756|FG000|Treatment Period|Early termination by error|0|||
131581367|NCT00360698|473754757|FG001|Treatment Period|Early termination by error|1|||
131581368|NCT01692938|473754760|FG000|Overall Study|Protocol Deviation|1|||
131581369|NCT01692938|473754761|FG001|Overall Study|Protocol Deviation|1|||
131581370|NCT01692938|473754760|FG000|Overall Study|Study completed prior to site completion|3|||
131581371|NCT01692938|473754761|FG001|Overall Study|Study completed prior to site completion|3|||
131581372|NCT02423291|473754764|FG000|Overall Study|Lack of Efficacy|14|||
131581373|NCT02423291|473754764|FG000|Overall Study|Adverse Event|1|||
131581374|NCT00424645|473754769|FG000|Overall Study|Death|1|||
131581375|NCT00424645|473754770|FG001|Overall Study|Death|0|||
131581376|NCT02115139|473754771|FG000|Overall Study|Protocol Violation|1|||
131581377|NCT02115139|473754771|FG000|Overall Study|treatment discontinuation|6|||
131581378|NCT02471755|473754772|FG000|Overall Study|Withdrawal by Subject|1|||
131581379|NCT02471755|473754773|FG001|Overall Study|Withdrawal by Subject|0|||
131581380|NCT02471755|473754772|FG000|Overall Study|Lost to Follow-up|0|||
131581381|NCT02471755|473754773|FG001|Overall Study|Lost to Follow-up|1|||
131581382|NCT03823911|473754774|FG000|Overall Study|Lost to Follow-up|1|||
131581383|NCT03823911|473754775|FG001|Overall Study|Lost to Follow-up|5|||
131581384|NCT03823911|473754776|FG002|Overall Study|Lost to Follow-up|2|||
131581385|NCT03823911|473754774|FG000|Overall Study|Did not meet eligibility criteria|13|||
131581386|NCT03823911|473754775|FG001|Overall Study|Did not meet eligibility criteria|7|||
131581387|NCT03823911|473754776|FG002|Overall Study|Did not meet eligibility criteria|4|||
131581388|NCT03823911|473754774|FG000|Overall Study|Death|0|||
131581389|NCT03823911|473754775|FG001|Overall Study|Death|1|||
131581390|NCT03823911|473754776|FG002|Overall Study|Death|0|||
131581391|NCT01121549|473754779|FG000|Overall Study|Adverse Event|10|||
131581392|NCT01121549|473754779|FG000|Overall Study|Lack of Efficacy|11|||
131581393|NCT01121549|473754779|FG000|Overall Study|Lost to Follow-up|12|||
131581394|NCT01121549|473754779|FG000|Overall Study|Did not meet entrance criteria|9|||
131581395|NCT01121549|473754779|FG000|Overall Study|Study terminated by sponsor|197|||
131581396|NCT01121549|473754779|FG000|Overall Study|Pregnancy|1|||
131581397|NCT01121549|473754779|FG000|Overall Study|Protocol Violation|33|||
131581398|NCT01121549|473754779|FG000|Overall Study|Withdrawal by Subject|16|||
131581399|NCT01121549|473754779|FG000|Overall Study|Other|58|||
131581400|NCT04789408|473754780|FG000|Overall Study|Death|4|||
131581401|NCT04789408|473754781|FG001|Overall Study|Death|3|||
131581402|NCT04789408|473754782|FG002|Overall Study|Death|6|||
131581403|NCT04789408|473754780|FG000|Overall Study|Did not meet eligibility criteria|1|||
131581404|NCT04789408|473754781|FG001|Overall Study|Did not meet eligibility criteria|0|||
131581405|NCT04789408|473754782|FG002|Overall Study|Did not meet eligibility criteria|0|||
131581406|NCT04789408|473754780|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
131581407|NCT04789408|473754781|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
131581408|NCT04789408|473754782|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
131581409|NCT00493649|473756386|FG000|Overall Study|Adverse Event|44|||
131581410|NCT00493649|473756386|FG000|Overall Study|Patient Request|21|||
131788129|NCT00575328|474507540|FG000|Overall Study|Lost to Follow-up|2|||
131581411|NCT00493649|473756386|FG000|Overall Study|Investigator Request|2|||
131788130|NCT00575328|474507541|FG001|Overall Study|Lost to Follow-up|1|||
131581412|NCT00493649|473756386|FG000|Overall Study|Disease Progression|1|||
131581413|NCT00493649|473756386|FG000|Overall Study|Lost to Follow-up|1|||
131581414|NCT00493649|473756386|FG000|Overall Study|Other|13|||
131581415|NCT03086369|473756387|FG000|Overall Study|Lost to Follow-up|1|||
131581416|NCT03086369|473756388|FG001|Overall Study|Lost to Follow-up|0|||
131581417|NCT03086369|473756389|FG002|Overall Study|Lost to Follow-up|0|||
131581418|NCT03086369|473756390|FG003|Overall Study|Lost to Follow-up|2|||
131581419|NCT03086369|473756391|FG004|Overall Study|Lost to Follow-up|1|||
131581420|NCT03086369|473756387|FG000|Overall Study|Physician Decision|0|||
131581421|NCT03086369|473756388|FG001|Overall Study|Physician Decision|0|||
131581422|NCT03086369|473756389|FG002|Overall Study|Physician Decision|0|||
131581423|NCT03086369|473756390|FG003|Overall Study|Physician Decision|1|||
131581424|NCT03086369|473756391|FG004|Overall Study|Physician Decision|2|||
131581425|NCT03086369|473756387|FG000|Overall Study|Withdrawal by Subject|0|||
131581426|NCT03086369|473756388|FG001|Overall Study|Withdrawal by Subject|0|||
131581427|NCT03086369|473756389|FG002|Overall Study|Withdrawal by Subject|0|||
131581428|NCT03086369|473756390|FG003|Overall Study|Withdrawal by Subject|5|||
131581429|NCT03086369|473756391|FG004|Overall Study|Withdrawal by Subject|3|||
131581430|NCT03086369|473756387|FG000|Overall Study|Progressive Disease|0|||
131581431|NCT03086369|473756388|FG001|Overall Study|Progressive Disease|0|||
131581432|NCT03086369|473756389|FG002|Overall Study|Progressive Disease|0|||
131581433|NCT03086369|473756390|FG003|Overall Study|Progressive Disease|1|||
131581434|NCT03086369|473756391|FG004|Overall Study|Progressive Disease|1|||
131581435|NCT04603924|473756394|FG000|Overall Study|Not Dosed|2|||
131581436|NCT04603924|473756395|FG001|Overall Study|Not Dosed|1|||
131581437|NCT04603924|473756394|FG000|Overall Study|Withdrawal by Subject|6|||
131581438|NCT04603924|473756395|FG001|Overall Study|Withdrawal by Subject|6|||
131581439|NCT04603924|473756394|FG000|Overall Study|Adverse Event|2|||
131581440|NCT04603924|473756395|FG001|Overall Study|Adverse Event|2|||
131581441|NCT02139046|473756398|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
131581442|NCT02139046|473756399|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
131581443|NCT02139046|473756400|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
131581444|NCT02139046|473756401|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
131581445|NCT02139046|473756402|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
131581446|NCT02139046|473756398|FG000|Overall Study|Major Protocol Deviation|9|||
131581447|NCT02139046|473756399|FG001|Overall Study|Major Protocol Deviation|10|||
131581448|NCT02139046|473756400|FG002|Overall Study|Major Protocol Deviation|16|||
131581449|NCT02139046|473756401|FG003|Overall Study|Major Protocol Deviation|12|||
131581450|NCT02139046|473756402|FG004|Overall Study|Major Protocol Deviation|6|||
131581451|NCT02139046|473756398|FG000|Overall Study|Lost to Follow-up|13|||
131581452|NCT02139046|473756399|FG001|Overall Study|Lost to Follow-up|16|||
131581453|NCT02139046|473756400|FG002|Overall Study|Lost to Follow-up|16|||
131581454|NCT02139046|473756401|FG003|Overall Study|Lost to Follow-up|18|||
131581455|NCT02139046|473756402|FG004|Overall Study|Lost to Follow-up|13|||
131581456|NCT02139046|473756398|FG000|Overall Study|Voluntary Withdrawal|20|||
131581457|NCT02139046|473756399|FG001|Overall Study|Voluntary Withdrawal|8|||
131581458|NCT02139046|473756400|FG002|Overall Study|Voluntary Withdrawal|10|||
131581459|NCT02139046|473756401|FG003|Overall Study|Voluntary Withdrawal|15|||
131581460|NCT02139046|473756402|FG004|Overall Study|Voluntary Withdrawal|16|||
131581461|NCT02139046|473756398|FG000|Overall Study|Lack of Efficacy|0|||
131581462|NCT02139046|473756399|FG001|Overall Study|Lack of Efficacy|1|||
131581463|NCT02139046|473756400|FG002|Overall Study|Lack of Efficacy|2|||
131581464|NCT02139046|473756401|FG003|Overall Study|Lack of Efficacy|1|||
131581465|NCT02139046|473756402|FG004|Overall Study|Lack of Efficacy|2|||
131581466|NCT02139046|473756398|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
131581467|NCT02139046|473756399|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
131581468|NCT02139046|473756400|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
131581469|NCT02139046|473756401|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
131581470|NCT02139046|473756402|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
131581471|NCT02139046|473756398|FG000|Overall Study|Other Miscellaneous Reasons|10|||
131581472|NCT02139046|473756399|FG001|Overall Study|Other Miscellaneous Reasons|9|||
131581473|NCT02139046|473756400|FG002|Overall Study|Other Miscellaneous Reasons|4|||
131581474|NCT02139046|473756401|FG003|Overall Study|Other Miscellaneous Reasons|9|||
131581475|NCT02139046|473756402|FG004|Overall Study|Other Miscellaneous Reasons|12|||
131581476|NCT01765543|473756404|FG000|Overall Study|Death|1|||
131581477|NCT01765543|473756404|FG000|Overall Study|Withdrawal by Subject|2|||
131581478|NCT01424397|473756405|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581479|NCT01424397|473756406|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581480|NCT01424397|473756407|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
131581481|NCT01424397|473756408|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581482|NCT01424397|473756409|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581483|NCT01424397|473756410|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581484|NCT01424397|473756411|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581485|NCT01424397|473756412|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581486|NCT01424397|473756413|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581487|NCT01424397|473756414|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581488|NCT01424397|473756415|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581489|NCT01424397|473756416|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
131581490|NCT05876949|473756417|FG000|Overall Study|Withdrawal by Subject|1|||
131581491|NCT05876949|473756418|FG001|Overall Study|Withdrawal by Subject|3|||
131788131|NCT05288673|474507542|FG000|Overall Study|Consent withdrawn by subject|0|||
131581492|NCT05876949|473756417|FG000|Overall Study|Physician Decision|0|||
131581493|NCT05876949|473756418|FG001|Overall Study|Physician Decision|2|||
131581494|NCT05876949|473756417|FG000|Overall Study|Death|0|||
131788132|NCT05288673|474507543|FG001|Overall Study|Consent withdrawn by subject|0|||
131788133|NCT05288673|474507544|FG002|Overall Study|Consent withdrawn by subject|1|||
131788134|NCT03056352|474507545|FG000|Overall Study|Lost to Follow-up|1|||
131788135|NCT01254045|474507550|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
131788136|NCT01254045|474507551|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131788137|NCT01254045|474507552|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131788138|NCT01254045|474507553|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131788139|NCT01254045|474507554|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131788140|NCT01254045|474507555|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131788141|NCT00597207|474507556|FG000|Overall Study|Lost to Follow-up|5|||
131788142|NCT00597207|474507557|FG001|Overall Study|Lost to Follow-up|7|||
131788143|NCT00520351|474507558|FG000|First Intervention|Withdrawal by Subject|1|||
131788144|NCT00520351|474507559|FG001|First Intervention|Withdrawal by Subject|1|||
131788145|NCT03940586|474507563|FG000|Overall Study|Death|3|||
131788146|NCT03940586|474507564|FG001|Overall Study|Death|2|||
131581495|NCT05876949|473756418|FG001|Overall Study|Death|1|||
131581496|NCT03644849|473756419|FG000|Overall Study|Lost to Follow-up|1|||
131581497|NCT03644849|473756420|FG001|Overall Study|Lost to Follow-up|3|||
131581498|NCT02755805|473756421|FG000|Overall Study|Lost to Follow-up|1|||
131581499|NCT02755805|473756422|FG001|Overall Study|Lost to Follow-up|2|||
131581500|NCT02755805|473756421|FG000|Overall Study|Refused assessments|1|||
131581501|NCT02755805|473756422|FG001|Overall Study|Refused assessments|0|||
131581502|NCT02755805|473756421|FG000|Overall Study|Withdrawal by Subject|0|||
131581503|NCT02755805|473756422|FG001|Overall Study|Withdrawal by Subject|2|||
131581504|NCT02252042|473756426|FG000|Overall Study|Adverse Event|9|||
131581505|NCT02252042|473756427|FG001|Overall Study|Adverse Event|6|||
131581506|NCT02252042|473756426|FG000|Overall Study|Death|209|||
131581507|NCT02252042|473756427|FG001|Overall Study|Death|217|||
131581508|NCT02252042|473756426|FG000|Overall Study|Physician Decision|0|||
131581509|NCT02252042|473756427|FG001|Overall Study|Physician Decision|2|||
131581510|NCT02252042|473756426|FG000|Overall Study|Transferred to Extension Study|7|||
131581511|NCT02252042|473756427|FG001|Overall Study|Transferred to Extension Study|1|||
131581512|NCT02252042|473756426|FG000|Overall Study|Did Not Continue on Extension Study|7|||
131581513|NCT02252042|473756427|FG001|Overall Study|Did Not Continue on Extension Study|2|||
131581514|NCT02252042|473756426|FG000|Overall Study|Withdrawal by Subject|15|||
131581515|NCT02252042|473756427|FG001|Overall Study|Withdrawal by Subject|20|||
131581516|NCT02593149|473756428|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
131581517|NCT02593149|473756429|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
131581518|NCT02593149|473756428|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
131581519|NCT02593149|473756429|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
131581520|NCT01177670|473756431|FG000|Overall Study|Study Terminated|115|||
131581521|NCT01177670|473756431|FG000|Overall Study|Physician Decision|50|||
131581522|NCT01177670|473756431|FG000|Overall Study|Withdrawal by Subject|4|||
131581523|NCT00979992|473756432|FG000|Overall Study|Ineligible - inadequate pathology|1|||
131581524|NCT00979992|473756432|FG000|Overall Study|Ineligible - wrong cell type|2|||
131581525|NCT00979992|473756432|FG000|Overall Study|Refused - Never Treated|2|||
131581526|NCT04532528|473756436|FG000|Overall Study|Adverse Event|12|||
131581527|NCT04532528|473756437|FG001|Overall Study|Adverse Event|17|||
131581528|NCT04532528|473756436|FG000|Overall Study|Withdrawal of consent|16|||
131581529|NCT04532528|473756437|FG001|Overall Study|Withdrawal of consent|17|||
131581530|NCT04532528|473756436|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
131581531|NCT04532528|473756437|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
131581532|NCT04532528|473756436|FG000|Overall Study|Lost to Follow-up|69|||
131581533|NCT04532528|473756437|FG001|Overall Study|Lost to Follow-up|68|||
131581534|NCT04532528|473756436|FG000|Overall Study|Administrative problems|12|||
131581535|NCT04532528|473756437|FG001|Overall Study|Administrative problems|14|||
131581536|NCT04532528|473756436|FG000|Overall Study|Death|3|||
131581537|NCT04532528|473756437|FG001|Overall Study|Death|3|||
131702522|NCT00500682|474193173|FG001|Overall Study|Physician Decision|10|||
131702523|NCT00500682|474193172|FG000|Overall Study|Pregnancy|2|||
131702524|NCT00500682|474193173|FG001|Overall Study|Pregnancy|0|||
131702525|NCT00500682|474193172|FG000|Overall Study|Protocol Violation|1|||
131702526|NCT00500682|474193173|FG001|Overall Study|Protocol Violation|3|||
131702527|NCT00500682|474193172|FG000|Overall Study|Withdrawal by Subject|80|||
131702528|NCT00500682|474193173|FG001|Overall Study|Withdrawal by Subject|74|||
131788147|NCT03940586|474507565|FG002|Overall Study|Death|0|||
131788148|NCT03940586|474507563|FG000|Overall Study|Physician Decision|1|||
131581538|NCT04532528|473756436|FG000|Overall Study|Other|38|||
131581539|NCT04532528|473756437|FG001|Overall Study|Other|46|||
131581540|NCT01636687|473756438|FG000|Induction Period|Withdrawal by Subject|1|||
131581541|NCT01636687|473756439|FG001|Induction Period|Withdrawal by Subject|0|||
131581542|NCT01636687|473756440|FG002|Induction Period|Withdrawal by Subject|0|||
131702529|NCT00500682|474193172|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
131581543|NCT01636687|473756441|FG003|Induction Period|Withdrawal by Subject|0|||
131581544|NCT01636687|473756442|FG004|Induction Period|Withdrawal by Subject|0|||
131581545|NCT01636687|473756438|FG000|Induction Period|Adverse Event|1|||
131702530|NCT00500682|474193173|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
131702531|NCT02531646|474193174|FG000|Overall Study|equip. image processing issue|5|||
131702532|NCT02531646|474193175|FG001|Overall Study|equip. image processing issue|1|||
131702533|NCT02531646|474193176|FG002|Overall Study|equip. image processing issue|0|||
131702534|NCT00772668|474193180|FG000|Overall Study|Physician Decision|3|||
131702535|NCT01182428|474193181|FG000|Overall Study|Physician Decision|1|||
131702536|NCT01182428|474193182|FG001|Overall Study|Physician Decision|0|||
131702537|NCT01182428|474193181|FG000|Overall Study|Lost to Follow-up|9|||
131702538|NCT01182428|474193182|FG001|Overall Study|Lost to Follow-up|1|||
131702539|NCT01182428|474193181|FG000|Overall Study|Withdrawal by Subject|1|||
131702540|NCT01182428|474193182|FG001|Overall Study|Withdrawal by Subject|0|||
131702541|NCT04484285|474194623|FG000|Overall Study|Unable to operate stimulator|3|||
131702542|NCT04484285|474194624|FG001|Overall Study|Unable to operate stimulator|0|||
131702543|NCT04439175|474194626|FG000|Overall Study|Never started treatment|4|||
131702544|NCT04439175|474194626|FG000|Overall Study|Ineligible|5|||
131702545|NCT04439175|474194626|FG000|Overall Study|Adverse Event|6|||
131702546|NCT04439175|474194626|FG000|Overall Study|Death|4|||
131702547|NCT04439175|474194626|FG000|Overall Study|Disease progression|44|||
131702548|NCT04439175|474194626|FG000|Overall Study|Withdrawal by Subject|4|||
131702549|NCT04439175|474194626|FG000|Overall Study|Alternative Therapy|1|||
131702550|NCT04439175|474194626|FG000|Overall Study|Other|2|||
131702551|NCT02363478|474194628|FG000|Overall Study|Lost to Follow-up|4|||
131702552|NCT02363478|474194628|FG000|Overall Study|Adverse Event|4|||
131581546|NCT01636687|473756439|FG001|Induction Period|Adverse Event|0|||
131581547|NCT01636687|473756440|FG002|Induction Period|Adverse Event|0|||
131702553|NCT00768898|474194629|FG000|Overall Study|Unrelated injury|1|||
131702554|NCT00768898|474194629|FG000|Overall Study|Headache|1|||
131702555|NCT02527707|474194630|FG000|Overall Study|Adverse Event|1|||
131702556|NCT02527707|474194630|FG000|Overall Study|Adverse Event|1|||
131702557|NCT00542997|474194631|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
131702558|NCT00542997|474194631|FG000|Wash in / Wash Out Period|Adverse Event|3|||
131702559|NCT00542997|474194631|FG000|Efficacy Period|Adverse Event|3|||
131702560|NCT02152345|474194632|FG000|Overall Study|Case Cancellations|2|||
131581548|NCT01636687|473756441|FG003|Induction Period|Adverse Event|0|||
131581549|NCT01636687|473756442|FG004|Induction Period|Adverse Event|1|||
131581550|NCT01636687|473756438|FG000|Induction Period|Lack of Efficacy|0|||
131581551|NCT01636687|473756439|FG001|Induction Period|Lack of Efficacy|0|||
131581552|NCT01636687|473756440|FG002|Induction Period|Lack of Efficacy|0|||
131581553|NCT01636687|473756441|FG003|Induction Period|Lack of Efficacy|0|||
131581554|NCT01636687|473756442|FG004|Induction Period|Lack of Efficacy|1|||
131581555|NCT01636687|473756438|FG000|Induction Period|Physician Decision|1|||
131581556|NCT01636687|473756439|FG001|Induction Period|Physician Decision|0|||
131581557|NCT01636687|473756440|FG002|Induction Period|Physician Decision|0|||
131581558|NCT01636687|473756441|FG003|Induction Period|Physician Decision|0|||
131581559|NCT01636687|473756442|FG004|Induction Period|Physician Decision|0|||
131581560|NCT01636687|473756438|FG000|Maintenance Period|Withdrawal by Subject|2|||
131581561|NCT01636687|473756439|FG001|Maintenance Period|Withdrawal by Subject|0|||
131581562|NCT01636687|473756440|FG002|Maintenance Period|Withdrawal by Subject|2|||
131581563|NCT01636687|473756441|FG003|Maintenance Period|Withdrawal by Subject|0|||
131702561|NCT02152345|474194633|FG001|Overall Study|Case Cancellations|4|||
131702562|NCT02152345|474194632|FG000|Overall Study|Withdrawal by Subject|2|||
131702563|NCT02152345|474194633|FG001|Overall Study|Withdrawal by Subject|1|||
131702564|NCT02554929|474194634|FG000|Overall Study|Lost to Follow-up|4|||
131581564|NCT01636687|473756442|FG004|Maintenance Period|Withdrawal by Subject|0|||
131702565|NCT02554929|474194635|FG001|Overall Study|Lost to Follow-up|4|||
131702566|NCT02554929|474194634|FG000|Overall Study|Withdrawal by Subject|2|||
131702567|NCT02554929|474194635|FG001|Overall Study|Withdrawal by Subject|8|||
131581565|NCT01636687|473756438|FG000|Maintenance Period|Adverse Event|1|||
131581566|NCT01636687|473756439|FG001|Maintenance Period|Adverse Event|0|||
131581567|NCT01636687|473756440|FG002|Maintenance Period|Adverse Event|0|||
131702568|NCT01916980|474194636|FG000|Overall Study|Adverse Event|4|||
131581568|NCT01636687|473756441|FG003|Maintenance Period|Adverse Event|0|||
131702569|NCT01916980|474194637|FG001|Overall Study|Adverse Event|2|||
131581569|NCT01636687|473756442|FG004|Maintenance Period|Adverse Event|0|||
131581570|NCT01636687|473756438|FG000|Maintenance Period|Lack of Efficacy|4|||
131581571|NCT01636687|473756439|FG001|Maintenance Period|Lack of Efficacy|1|||
131581572|NCT01636687|473756440|FG002|Maintenance Period|Lack of Efficacy|0|||
131581573|NCT01636687|473756441|FG003|Maintenance Period|Lack of Efficacy|0|||
131581574|NCT01636687|473756442|FG004|Maintenance Period|Lack of Efficacy|0|||
131581575|NCT01636687|473756438|FG000|Maintenance Period|Lost to Follow-up|1|||
131581576|NCT01636687|473756439|FG001|Maintenance Period|Lost to Follow-up|1|||
131581577|NCT01636687|473756440|FG002|Maintenance Period|Lost to Follow-up|0|||
131581578|NCT01636687|473756441|FG003|Maintenance Period|Lost to Follow-up|0|||
131581579|NCT01636687|473756442|FG004|Maintenance Period|Lost to Follow-up|1|||
131438372|NCT03192176|473231210|FG003|Overall Study|Protocol Deviation|0|||
131438373|NCT03192176|473231211|FG004|Overall Study|Protocol Deviation|2|||
131438374|NCT03192176|473231212|FG005|Overall Study|Protocol Deviation|0|||
131438375|NCT03192176|473231213|FG006|Overall Study|Protocol Deviation|0|||
131438376|NCT03192176|473231214|FG007|Overall Study|Protocol Deviation|0|||
131438377|NCT03192176|473231207|FG000|Overall Study|Withdrawal by Subject|3|||
131438378|NCT03192176|473231208|FG001|Overall Study|Withdrawal by Subject|4|||
131438379|NCT03192176|473231209|FG002|Overall Study|Withdrawal by Subject|0|||
131581580|NCT01636687|473756438|FG000|Maintenance Period|Physician Decision|0|||
131438380|NCT03192176|473231210|FG003|Overall Study|Withdrawal by Subject|4|||
131438381|NCT03192176|473231211|FG004|Overall Study|Withdrawal by Subject|3|||
131438382|NCT03192176|473231212|FG005|Overall Study|Withdrawal by Subject|4|||
131438383|NCT03192176|473231213|FG006|Overall Study|Withdrawal by Subject|4|||
131438384|NCT03192176|473231214|FG007|Overall Study|Withdrawal by Subject|2|||
131438385|NCT03192176|473231207|FG000|Overall Study|Miscellaneous|1|||
131438386|NCT03192176|473231208|FG001|Overall Study|Miscellaneous|0|||
131438387|NCT03192176|473231209|FG002|Overall Study|Miscellaneous|1|||
131438388|NCT03192176|473231210|FG003|Overall Study|Miscellaneous|1|||
131438389|NCT03192176|473231211|FG004|Overall Study|Miscellaneous|1|||
131438390|NCT03192176|473231212|FG005|Overall Study|Miscellaneous|2|||
131438391|NCT03192176|473231213|FG006|Overall Study|Miscellaneous|0|||
131438392|NCT03192176|473231214|FG007|Overall Study|Miscellaneous|1|||
131438393|NCT03532542|473231217|FG000|Overall Study|Death|1|||
131438394|NCT03532542|473231218|FG001|Overall Study|Death|0|||
131438395|NCT03532542|473231217|FG000|Overall Study|Study Terminated by Sponsor|41|||
131438396|NCT03532542|473231218|FG001|Overall Study|Study Terminated by Sponsor|65|||
131438397|NCT03532542|473231217|FG000|Overall Study|Withdrawal by Subject|6|||
131438398|NCT03532542|473231218|FG001|Overall Study|Withdrawal by Subject|5|||
131438399|NCT00718510|473231220|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131438400|NCT00718510|473231221|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131438401|NCT00718510|473231220|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
131581581|NCT01636687|473756439|FG001|Maintenance Period|Physician Decision|0|||
131702570|NCT01916980|474194636|FG000|Overall Study|Lack of Efficacy|2|||
131702571|NCT01916980|474194637|FG001|Overall Study|Lack of Efficacy|2|||
131438402|NCT00718510|473231221|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131438403|NCT02269124|473231228|FG000|Overall Study|Lost to Follow-up|1|||
131438404|NCT02269124|473231229|FG001|Overall Study|Lost to Follow-up|0|||
131438405|NCT02269124|473231228|FG000|Overall Study|Withdrawal by Subject|0|||
131438406|NCT02269124|473231229|FG001|Overall Study|Withdrawal by Subject|2|||
131702572|NCT01916980|474194636|FG000|Overall Study|Withdrawal by Subject|1|||
131581582|NCT01636687|473756440|FG002|Maintenance Period|Physician Decision|0|||
131702573|NCT01916980|474194637|FG001|Overall Study|Withdrawal by Subject|0|||
131702574|NCT02324270|474194638|FG000|Overall Study|Withdrawal by Subject|0|||
131702575|NCT02324270|474194639|FG001|Overall Study|Withdrawal by Subject|1|||
131438407|NCT00614575|473231230|FG000|Overall Study|Adverse Event|106|||
131438408|NCT00614575|473231230|FG000|Overall Study|Lost to Follow-up|55|||
131581583|NCT01636687|473756441|FG003|Maintenance Period|Physician Decision|0|||
131581584|NCT01636687|473756442|FG004|Maintenance Period|Physician Decision|1|||
131581585|NCT01636687|473756438|FG000|Extension Period|technical problems|0|||
131581586|NCT01636687|473756439|FG001|Extension Period|technical problems|1|||
131581587|NCT01636687|473756440|FG002|Extension Period|technical problems|2|||
131581588|NCT01636687|473756441|FG003|Extension Period|technical problems|1|||
131581589|NCT01636687|473756442|FG004|Extension Period|technical problems|0|||
131581590|NCT01636687|473756438|FG000|Extension Period|Adverse Event|4|||
131581591|NCT01636687|473756439|FG001|Extension Period|Adverse Event|3|||
131581592|NCT01636687|473756440|FG002|Extension Period|Adverse Event|2|||
131581593|NCT01636687|473756441|FG003|Extension Period|Adverse Event|1|||
131581594|NCT01636687|473756442|FG004|Extension Period|Adverse Event|0|||
131581595|NCT01636687|473756438|FG000|Extension Period|Lack of Efficacy|7|||
131581596|NCT01636687|473756439|FG001|Extension Period|Lack of Efficacy|0|||
131581597|NCT01636687|473756440|FG002|Extension Period|Lack of Efficacy|2|||
131581598|NCT01636687|473756441|FG003|Extension Period|Lack of Efficacy|1|||
131581599|NCT01636687|473756442|FG004|Extension Period|Lack of Efficacy|0|||
131581600|NCT01636687|473756438|FG000|Extension Period|Lost to Follow-up|1|||
131581601|NCT01636687|473756439|FG001|Extension Period|Lost to Follow-up|0|||
131581602|NCT01636687|473756440|FG002|Extension Period|Lost to Follow-up|1|||
131581603|NCT01636687|473756441|FG003|Extension Period|Lost to Follow-up|0|||
131581604|NCT01636687|473756442|FG004|Extension Period|Lost to Follow-up|0|||
131581605|NCT01636687|473756438|FG000|Extension Period|Physician Decision|1|||
131581606|NCT01636687|473756439|FG001|Extension Period|Physician Decision|0|||
131581607|NCT01636687|473756440|FG002|Extension Period|Physician Decision|0|||
131581608|NCT01636687|473756441|FG003|Extension Period|Physician Decision|1|||
131581609|NCT01636687|473756442|FG004|Extension Period|Physician Decision|0|||
131581610|NCT01636687|473756438|FG000|Extension Period|study terminated by sponsor|33|||
131581611|NCT01636687|473756439|FG001|Extension Period|study terminated by sponsor|50|||
131581612|NCT01636687|473756440|FG002|Extension Period|study terminated by sponsor|17|||
131581613|NCT01636687|473756441|FG003|Extension Period|study terminated by sponsor|23|||
131581614|NCT01636687|473756442|FG004|Extension Period|study terminated by sponsor|0|||
131581615|NCT01636687|473756438|FG000|Extension Period|Withdrawal by Subject|1|||
131581616|NCT01636687|473756439|FG001|Extension Period|Withdrawal by Subject|0|||
131581617|NCT01636687|473756440|FG002|Extension Period|Withdrawal by Subject|1|||
131581618|NCT01636687|473756441|FG003|Extension Period|Withdrawal by Subject|1|||
131581619|NCT01636687|473756442|FG004|Extension Period|Withdrawal by Subject|0|||
131581620|NCT01636687|473756438|FG000|Follow-up Period|Withdrawal by Subject|1|||
131581621|NCT01636687|473756439|FG001|Follow-up Period|Withdrawal by Subject|0|||
131581622|NCT01636687|473756440|FG002|Follow-up Period|Withdrawal by Subject|0|||
131581623|NCT01636687|473756441|FG003|Follow-up Period|Withdrawal by Subject|0|||
131581624|NCT01636687|473756442|FG004|Follow-up Period|Withdrawal by Subject|1|||
131581625|NCT03691428|473756447|FG000|Overall Study|Withdrawal by Subject|6|||
131581626|NCT03691428|473756448|FG001|Overall Study|Withdrawal by Subject|8|||
131581627|NCT02527148|473756449|FG000|Overall Study|Did not receive study intervention|1|||
131581628|NCT02527148|473756450|FG001|Overall Study|Did not receive study intervention|0|||
131581629|NCT01831791|473756455|FG000|Overall Study|Withdrawal by Subject|10|||
131581630|NCT03061474|473756456|FG000|Overall Study|Adverse Event|2|||
131581631|NCT03061474|473756457|FG001|Overall Study|Adverse Event|0|||
131581632|NCT03061474|473756456|FG000|Overall Study|Safety Risk|0|||
131581633|NCT03061474|473756457|FG001|Overall Study|Safety Risk|1|||
131581634|NCT03061474|473756456|FG000|Overall Study|Participant unwilling or unable to participate|0|||
131581635|NCT03061474|473756457|FG001|Overall Study|Participant unwilling or unable to participate|2|||
131581636|NCT03061474|473756456|FG000|Overall Study|Lost to Follow-up|0|||
131581637|NCT03061474|473756457|FG001|Overall Study|Lost to Follow-up|1|||
131702576|NCT02324270|474194640|FG002|Overall Study|Withdrawal by Subject|0|||
131581638|NCT00845832|473756458|FG000|Treatment Period|Adverse Event|0|||
131581639|NCT00845832|473756459|FG001|Treatment Period|Adverse Event|2|||
131581640|NCT00845832|473756460|FG002|Treatment Period|Adverse Event|0|||
131581641|NCT00845832|473756458|FG000|Treatment Period|Protocol Violation|1|||
131702577|NCT02324270|474194638|FG000|Overall Study|Lost to Follow-up|4|||
131702578|NCT02324270|474194639|FG001|Overall Study|Lost to Follow-up|3|||
131702579|NCT02324270|474194640|FG002|Overall Study|Lost to Follow-up|4|||
131702580|NCT02324270|474194638|FG000|Overall Study|Protocol Violation|0|||
131702581|NCT02324270|474194639|FG001|Overall Study|Protocol Violation|1|||
131581642|NCT00845832|473756459|FG001|Treatment Period|Protocol Violation|1|||
131581643|NCT00845832|473756460|FG002|Treatment Period|Protocol Violation|0|||
131581644|NCT00845832|473756458|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
131581645|NCT00845832|473756459|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
131581646|NCT00845832|473756460|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
131581647|NCT00845832|473756458|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
131581648|NCT00845832|473756459|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
131702582|NCT02324270|474194640|FG002|Overall Study|Protocol Violation|1|||
131581649|NCT00845832|473756460|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
131581650|NCT00980330|473756461|FG000|Overall Study|Adverse Event|0|||
131581651|NCT00980330|473756462|FG001|Overall Study|Adverse Event|0|||
131581652|NCT00980330|473756463|FG002|Overall Study|Adverse Event|0|||
131581653|NCT00980330|473756464|FG003|Overall Study|Adverse Event|1|||
131581654|NCT00980330|473756465|FG004|Overall Study|Adverse Event|0|||
131581655|NCT00980330|473756466|FG005|Overall Study|Adverse Event|0|||
131581656|NCT00980330|473756467|FG006|Overall Study|Adverse Event|0|||
131581657|NCT00980330|473756461|FG000|Overall Study|Lost to Follow-up|1|||
131581658|NCT00980330|473756462|FG001|Overall Study|Lost to Follow-up|1|||
131581659|NCT00980330|473756463|FG002|Overall Study|Lost to Follow-up|4|||
131581660|NCT00980330|473756464|FG003|Overall Study|Lost to Follow-up|2|||
131581661|NCT00980330|473756465|FG004|Overall Study|Lost to Follow-up|1|||
131581662|NCT00980330|473756466|FG005|Overall Study|Lost to Follow-up|1|||
131581663|NCT00980330|473756467|FG006|Overall Study|Lost to Follow-up|2|||
131581664|NCT00980330|473756461|FG000|Overall Study|Withdrawal by Subject|2|||
131581665|NCT00980330|473756462|FG001|Overall Study|Withdrawal by Subject|4|||
131581666|NCT00980330|473756463|FG002|Overall Study|Withdrawal by Subject|4|||
131581667|NCT00980330|473756464|FG003|Overall Study|Withdrawal by Subject|1|||
131581668|NCT00980330|473756465|FG004|Overall Study|Withdrawal by Subject|3|||
131581669|NCT00980330|473756466|FG005|Overall Study|Withdrawal by Subject|2|||
131581670|NCT00980330|473756467|FG006|Overall Study|Withdrawal by Subject|5|||
131581671|NCT00980330|473756461|FG000|Overall Study|(not specified)|2|||
131581672|NCT00980330|473756462|FG001|Overall Study|(not specified)|0|||
131581673|NCT00980330|473756463|FG002|Overall Study|(not specified)|0|||
131581674|NCT00980330|473756464|FG003|Overall Study|(not specified)|1|||
131581675|NCT00980330|473756465|FG004|Overall Study|(not specified)|1|||
131581676|NCT00980330|473756466|FG005|Overall Study|(not specified)|1|||
131581677|NCT00980330|473756467|FG006|Overall Study|(not specified)|0|||
131581678|NCT00665444|473756468|FG000|Overall Study|Physician Decision|1|||
131581679|NCT00665444|473756468|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
131581680|NCT00869323|473756471|FG000|Maintenance Therapy|concurrent illness|1|||
131581681|NCT01135511|473756472|FG000|Overall Study|Adverse Event|0|||
131581682|NCT01135511|473756473|FG001|Overall Study|Adverse Event|1|||
131581683|NCT01135511|473756474|FG002|Overall Study|Adverse Event|2|||
131581684|NCT01135511|473756475|FG003|Overall Study|Adverse Event|0|||
131581685|NCT01135511|473756476|FG004|Overall Study|Adverse Event|0|||
131581686|NCT01135511|473756477|FG005|Overall Study|Adverse Event|1|||
131581687|NCT01135511|473756478|FG006|Overall Study|Adverse Event|0|||
131581688|NCT01135511|473756479|FG007|Overall Study|Adverse Event|1|||
131581689|NCT01135511|473756480|FG008|Overall Study|Adverse Event|0|||
131581690|NCT01135511|473756472|FG000|Overall Study|Lack of Efficacy|0|||
131581691|NCT01135511|473756473|FG001|Overall Study|Lack of Efficacy|1|||
131581692|NCT01135511|473756474|FG002|Overall Study|Lack of Efficacy|1|||
131581693|NCT01135511|473756475|FG003|Overall Study|Lack of Efficacy|2|||
131581694|NCT01135511|473756476|FG004|Overall Study|Lack of Efficacy|0|||
131581695|NCT01135511|473756477|FG005|Overall Study|Lack of Efficacy|0|||
131581696|NCT01135511|473756478|FG006|Overall Study|Lack of Efficacy|0|||
131581697|NCT01135511|473756479|FG007|Overall Study|Lack of Efficacy|0|||
131581698|NCT01135511|473756480|FG008|Overall Study|Lack of Efficacy|0|||
131581699|NCT01135511|473756472|FG000|Overall Study|Protocol Violation|0|||
131581700|NCT01135511|473756473|FG001|Overall Study|Protocol Violation|0|||
131581701|NCT01135511|473756474|FG002|Overall Study|Protocol Violation|3|||
131581702|NCT01135511|473756475|FG003|Overall Study|Protocol Violation|0|||
131581703|NCT01135511|473756476|FG004|Overall Study|Protocol Violation|0|||
131581704|NCT01135511|473756477|FG005|Overall Study|Protocol Violation|0|||
131581705|NCT01135511|473756478|FG006|Overall Study|Protocol Violation|0|||
131581706|NCT01135511|473756479|FG007|Overall Study|Protocol Violation|0|||
131581707|NCT01135511|473756480|FG008|Overall Study|Protocol Violation|0|||
131581708|NCT01135511|473756472|FG000|Overall Study|Pregnancy|0|||
131581709|NCT01135511|473756473|FG001|Overall Study|Pregnancy|0|||
131581710|NCT01135511|473756474|FG002|Overall Study|Pregnancy|0|||
131581711|NCT01135511|473756475|FG003|Overall Study|Pregnancy|1|||
131581712|NCT01135511|473756476|FG004|Overall Study|Pregnancy|0|||
131581713|NCT01135511|473756477|FG005|Overall Study|Pregnancy|0|||
131581714|NCT01135511|473756478|FG006|Overall Study|Pregnancy|0|||
131581715|NCT01135511|473756479|FG007|Overall Study|Pregnancy|0|||
131581716|NCT01135511|473756480|FG008|Overall Study|Pregnancy|0|||
131581717|NCT01135511|473756472|FG000|Overall Study|could not visit the clinic|0|||
131581718|NCT01135511|473756473|FG001|Overall Study|could not visit the clinic|1|||
131438409|NCT00614575|473231230|FG000|Overall Study|Lack of Efficacy|14|||
131581719|NCT01135511|473756474|FG002|Overall Study|could not visit the clinic|2|||
131581720|NCT01135511|473756475|FG003|Overall Study|could not visit the clinic|0|||
131581721|NCT01135511|473756476|FG004|Overall Study|could not visit the clinic|0|||
131581722|NCT01135511|473756477|FG005|Overall Study|could not visit the clinic|0|||
131581723|NCT01135511|473756478|FG006|Overall Study|could not visit the clinic|0|||
131581724|NCT01135511|473756479|FG007|Overall Study|could not visit the clinic|0|||
131581725|NCT01135511|473756480|FG008|Overall Study|could not visit the clinic|0|||
131581726|NCT01135511|473756472|FG000|Overall Study|noncompliance with study drug taken|0|||
131581727|NCT01135511|473756473|FG001|Overall Study|noncompliance with study drug taken|0|||
131581728|NCT01135511|473756474|FG002|Overall Study|noncompliance with study drug taken|0|||
131581729|NCT01135511|473756475|FG003|Overall Study|noncompliance with study drug taken|0|||
131581730|NCT01135511|473756476|FG004|Overall Study|noncompliance with study drug taken|1|||
131581731|NCT01135511|473756477|FG005|Overall Study|noncompliance with study drug taken|0|||
131581732|NCT01135511|473756478|FG006|Overall Study|noncompliance with study drug taken|0|||
131581733|NCT01135511|473756479|FG007|Overall Study|noncompliance with study drug taken|0|||
131581734|NCT01135511|473756480|FG008|Overall Study|noncompliance with study drug taken|0|||
131581735|NCT01135511|473756472|FG000|Overall Study|Withdrawal by Subject|0|||
131581736|NCT01135511|473756473|FG001|Overall Study|Withdrawal by Subject|0|||
131581737|NCT01135511|473756474|FG002|Overall Study|Withdrawal by Subject|0|||
131581738|NCT01135511|473756475|FG003|Overall Study|Withdrawal by Subject|0|||
131581739|NCT01135511|473756476|FG004|Overall Study|Withdrawal by Subject|0|||
131581740|NCT01135511|473756477|FG005|Overall Study|Withdrawal by Subject|0|||
131581741|NCT01135511|473756478|FG006|Overall Study|Withdrawal by Subject|1|||
131581742|NCT01135511|473756479|FG007|Overall Study|Withdrawal by Subject|0|||
131581743|NCT01135511|473756480|FG008|Overall Study|Withdrawal by Subject|1|||
131581744|NCT00891930|473756481|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
131581745|NCT00891930|473756481|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
131581746|NCT00891930|473756481|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
131581747|NCT00891930|473756481|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
131581748|NCT00891930|473756481|FG000|Part 2 Panitumumab + AMG479|Death|30|||
131581749|NCT02425111|473756485|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
131581750|NCT02425111|473756485|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
131581751|NCT02425111|473756485|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
131581752|NCT02425111|473756485|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
131581753|NCT02425111|473756485|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
131581754|NCT02425111|473756485|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
131581755|NCT01444417|473756488|FG000|Overall Study|Ineligibility Determined|0|||
131581756|NCT01444417|473756489|FG001|Overall Study|Ineligibility Determined|1|||
131581757|NCT01444417|473756488|FG000|Overall Study|Withdrawal by Subject|2|||
131581758|NCT01444417|473756489|FG001|Overall Study|Withdrawal by Subject|0|||
131581759|NCT02755116|473756490|FG000|Overall Study|surgery converted to open, pt admitted|3|||
131581760|NCT02755116|473756491|FG001|Overall Study|surgery converted to open, pt admitted|1|||
131581761|NCT01124734|473756492|FG000|Overall Study|Disease progression|13|||
131581762|NCT01124734|473756492|FG000|Overall Study|Adverse Event|1|||
131581763|NCT01124734|473756492|FG000|Overall Study|Withdrawal by Subject|1|||
131581764|NCT01124734|473756492|FG000|Overall Study|Elected for alternative treatment|2|||
131581765|NCT01063972|473756493|FG000|Overall Study|Death|12|||
131581766|NCT01063972|473756494|FG001|Overall Study|Death|11|||
131581767|NCT01063972|473756493|FG000|Overall Study|Incarcerated|2|||
131581768|NCT01063972|473756494|FG001|Overall Study|Incarcerated|1|||
131581769|NCT03475316|473756496|FG000|6 Month Intervention|Adverse Event|2|||
131581770|NCT03475316|473756497|FG001|6 Month Intervention|Adverse Event|1|||
131581771|NCT03475316|473756496|FG000|6 Month Intervention|Withdrawal by Subject|2|||
131581772|NCT03475316|473756497|FG001|6 Month Intervention|Withdrawal by Subject|0|||
131581773|NCT03475316|473756496|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
131581774|NCT03475316|473756497|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
131581775|NCT03475316|473756496|FG000|9 Months|Study stopped due to COVID pandemic|3|||
131581776|NCT03475316|473756497|FG001|9 Months|Study stopped due to COVID pandemic|4|||
131581777|NCT00566527|473756502|FG000|Overall Study|Reason not provided|3|||
131581778|NCT00566527|473756503|FG001|Overall Study|Reason not provided|11|||
131581779|NCT00566527|473756504|FG002|Overall Study|Reason not provided|10|||
131581780|NCT00566527|473756502|FG000|Overall Study|Adverse Event|2|||
131581781|NCT00566527|473756503|FG001|Overall Study|Adverse Event|0|||
131702583|NCT02324270|474194638|FG000|Overall Study|Non Compliance with Study Drug|1|||
131702584|NCT02324270|474194639|FG001|Overall Study|Non Compliance with Study Drug|2|||
131702585|NCT02324270|474194640|FG002|Overall Study|Non Compliance with Study Drug|0|||
131702586|NCT00546364|474194641|FG000|Overall Study|Disease progression|5|||
131702587|NCT00546364|474194642|FG001|Overall Study|Disease progression|11|||
131702588|NCT00546364|474194643|FG002|Overall Study|Disease progression|8|||
131702589|NCT00546364|474194641|FG000|Overall Study|Completed and off treatment|1|||
131702590|NCT00546364|474194642|FG001|Overall Study|Completed and off treatment|0|||
131702591|NCT00546364|474194643|FG002|Overall Study|Completed and off treatment|2|||
131581782|NCT00566527|473756504|FG002|Overall Study|Adverse Event|1|||
131581783|NCT00566527|473756502|FG000|Overall Study|Physician Decision|3|||
131581784|NCT00566527|473756503|FG001|Overall Study|Physician Decision|8|||
131581785|NCT00566527|473756504|FG002|Overall Study|Physician Decision|20|||
131581786|NCT00566527|473756502|FG000|Overall Study|Lost to Follow-up|3|||
131581787|NCT00566527|473756503|FG001|Overall Study|Lost to Follow-up|4|||
131581788|NCT00566527|473756504|FG002|Overall Study|Lost to Follow-up|4|||
131702592|NCT00546364|474194641|FG000|Overall Study|Administrative reason by sponsor|1|||
131581789|NCT00566527|473756502|FG000|Overall Study|Withdrawal by Subject|6|||
131581790|NCT00566527|473756503|FG001|Overall Study|Withdrawal by Subject|43|||
131581791|NCT00566527|473756504|FG002|Overall Study|Withdrawal by Subject|43|||
131581792|NCT00959946|473756505|FG000|Overall Study|Adverse Event|0|||
131581793|NCT00959946|473756506|FG001|Overall Study|Adverse Event|0|||
131581794|NCT00959946|473756507|FG002|Overall Study|Adverse Event|2|||
131581795|NCT00959946|473756508|FG003|Overall Study|Adverse Event|1|||
131581796|NCT00959946|473756509|FG004|Overall Study|Adverse Event|0|||
131581797|NCT00959946|473756510|FG005|Overall Study|Adverse Event|1|||
131581798|NCT00959946|473756511|FG006|Overall Study|Adverse Event|0|||
131581799|NCT00959946|473756512|FG007|Overall Study|Adverse Event|0|||
131581800|NCT00959946|473756505|FG000|Overall Study|Death|0|||
131581801|NCT00959946|473756506|FG001|Overall Study|Death|0|||
131581802|NCT00959946|473756507|FG002|Overall Study|Death|0|||
131581803|NCT00959946|473756508|FG003|Overall Study|Death|0|||
131581804|NCT00959946|473756509|FG004|Overall Study|Death|0|||
131581805|NCT00959946|473756510|FG005|Overall Study|Death|1|||
131581806|NCT00959946|473756511|FG006|Overall Study|Death|0|||
131581807|NCT00959946|473756512|FG007|Overall Study|Death|0|||
131581808|NCT00959946|473756505|FG000|Overall Study|Disease Progression|2|||
131702593|NCT00546364|474194642|FG001|Overall Study|Administrative reason by sponsor|0|||
131702594|NCT00546364|474194643|FG002|Overall Study|Administrative reason by sponsor|0|||
131702595|NCT00546364|474194641|FG000|Overall Study|Poor compliance/noncompliance|0|||
131702596|NCT00546364|474194642|FG001|Overall Study|Poor compliance/noncompliance|0|||
131702597|NCT00546364|474194643|FG002|Overall Study|Poor compliance/noncompliance|1|||
131702598|NCT00546364|474194641|FG000|Overall Study|No longer meets study criteria|1|||
131702599|NCT00546364|474194642|FG001|Overall Study|No longer meets study criteria|1|||
131702600|NCT00546364|474194643|FG002|Overall Study|No longer meets study criteria|0|||
131702601|NCT00546364|474194641|FG000|Overall Study|Withdrawal by Subject|5|||
131702602|NCT00546364|474194642|FG001|Overall Study|Withdrawal by Subject|6|||
131702603|NCT00546364|474194643|FG002|Overall Study|Withdrawal by Subject|3|||
131702604|NCT00546364|474194641|FG000|Overall Study|Prior taxotere|1|||
131702605|NCT00546364|474194642|FG001|Overall Study|Prior taxotere|0|||
131702606|NCT00546364|474194643|FG002|Overall Study|Prior taxotere|0|||
131702607|NCT00546364|474194641|FG000|Overall Study|Mixed response|1|||
131702608|NCT00546364|474194642|FG001|Overall Study|Mixed response|0|||
131702609|NCT00546364|474194643|FG002|Overall Study|Mixed response|0|||
131702610|NCT00546364|474194641|FG000|Overall Study|Palliative treatment|1|||
131702611|NCT00546364|474194642|FG001|Overall Study|Palliative treatment|0|||
131702612|NCT00546364|474194643|FG002|Overall Study|Palliative treatment|1|||
131702613|NCT00546364|474194641|FG000|Overall Study|Target lesions resected|1|||
131702614|NCT00546364|474194642|FG001|Overall Study|Target lesions resected|0|||
131702615|NCT00546364|474194643|FG002|Overall Study|Target lesions resected|0|||
131702616|NCT00546364|474194641|FG000|Overall Study|Physician Decision|0|||
131702617|NCT00546364|474194642|FG001|Overall Study|Physician Decision|0|||
131702618|NCT00546364|474194643|FG002|Overall Study|Physician Decision|1|||
131702619|NCT00546364|474194641|FG000|Overall Study|Sponsor decision|0|||
131702620|NCT00546364|474194642|FG001|Overall Study|Sponsor decision|0|||
131702621|NCT00546364|474194643|FG002|Overall Study|Sponsor decision|1|||
131702622|NCT00667576|474194645|FG000|Overall Study|Withdrawal by Subject|1|||
131702623|NCT00667576|474194646|FG001|Overall Study|Withdrawal by Subject|0|||
131702624|NCT00667576|474194647|FG002|Overall Study|Withdrawal by Subject|1|||
131702625|NCT00667576|474194648|FG003|Overall Study|Withdrawal by Subject|1|||
131702626|NCT00667576|474194649|FG004|Overall Study|Withdrawal by Subject|1|||
131702627|NCT00667576|474194645|FG000|Overall Study|Adverse Event|1|||
131702628|NCT00667576|474194646|FG001|Overall Study|Adverse Event|1|||
131702629|NCT00667576|474194647|FG002|Overall Study|Adverse Event|0|||
131702630|NCT00667576|474194648|FG003|Overall Study|Adverse Event|0|||
131702631|NCT00667576|474194649|FG004|Overall Study|Adverse Event|0|||
131702632|NCT00667576|474194645|FG000|Overall Study|Lost to Follow-up|0|||
131702633|NCT00667576|474194646|FG001|Overall Study|Lost to Follow-up|0|||
131702634|NCT00667576|474194647|FG002|Overall Study|Lost to Follow-up|1|||
131702635|NCT00667576|474194648|FG003|Overall Study|Lost to Follow-up|0|||
131702636|NCT00667576|474194649|FG004|Overall Study|Lost to Follow-up|0|||
131702637|NCT00667576|474194645|FG000|Overall Study|Protocol Violation|0|||
131702638|NCT00667576|474194646|FG001|Overall Study|Protocol Violation|0|||
131702639|NCT00667576|474194647|FG002|Overall Study|Protocol Violation|0|||
131702640|NCT00667576|474194648|FG003|Overall Study|Protocol Violation|1|||
131702641|NCT00667576|474194649|FG004|Overall Study|Protocol Violation|0|||
131702642|NCT00667576|474194645|FG000|Overall Study|Physician Decision|0|||
131581809|NCT00959946|473756506|FG001|Overall Study|Disease Progression|4|||
131581810|NCT00959946|473756507|FG002|Overall Study|Disease Progression|2|||
131581811|NCT00959946|473756508|FG003|Overall Study|Disease Progression|4|||
131581812|NCT00959946|473756509|FG004|Overall Study|Disease Progression|4|||
131702643|NCT00667576|474194646|FG001|Overall Study|Physician Decision|0|||
131702644|NCT00667576|474194647|FG002|Overall Study|Physician Decision|0|||
131581813|NCT00959946|473756510|FG005|Overall Study|Disease Progression|6|||
131581814|NCT00959946|473756511|FG006|Overall Study|Disease Progression|2|||
131702645|NCT00667576|474194648|FG003|Overall Study|Physician Decision|1|||
131581815|NCT00959946|473756512|FG007|Overall Study|Disease Progression|2|||
131581816|NCT00959946|473756505|FG000|Overall Study|Withdrawal by Subject|0|||
131581817|NCT00959946|473756506|FG001|Overall Study|Withdrawal by Subject|0|||
131581818|NCT00959946|473756507|FG002|Overall Study|Withdrawal by Subject|0|||
131581819|NCT00959946|473756508|FG003|Overall Study|Withdrawal by Subject|0|||
131581820|NCT00959946|473756509|FG004|Overall Study|Withdrawal by Subject|0|||
131581821|NCT00959946|473756510|FG005|Overall Study|Withdrawal by Subject|1|||
131581822|NCT00959946|473756511|FG006|Overall Study|Withdrawal by Subject|0|||
131581823|NCT00959946|473756512|FG007|Overall Study|Withdrawal by Subject|0|||
131581824|NCT00457743|473756513|FG000|Overall Study|Adverse Event|0|||
131581825|NCT00457743|473756514|FG001|Overall Study|Adverse Event|4|||
131581826|NCT00457743|473756515|FG002|Overall Study|Adverse Event|0|||
131581827|NCT00457743|473756513|FG000|Overall Study|Lack of Efficacy|3|||
131581828|NCT00457743|473756514|FG001|Overall Study|Lack of Efficacy|23|||
131581829|NCT00457743|473756515|FG002|Overall Study|Lack of Efficacy|3|||
131581830|NCT04740164|473756521|FG000|Overall Study|Lack of Efficacy|4|||
131581831|NCT04740164|473756522|FG001|Overall Study|Lack of Efficacy|0|||
131581832|NCT04740164|473756521|FG000|Overall Study|Physician Decision|3|||
131581833|NCT04740164|473756522|FG001|Overall Study|Physician Decision|3|||
131581834|NCT04177394|473756523|FG000|Overall Study|Death|16|||
131581835|NCT04177394|473756523|FG000|Overall Study|Withdrawal by Subject|19|||
131581836|NCT04177394|473756523|FG000|Overall Study|Missed visits|61|||
131581837|NCT04177394|473756523|FG000|Overall Study|Expected Visits|15|||
131581838|NCT01152190|473756524|FG000|Overall Study|Adverse Event|2|||
131581839|NCT01152190|473756525|FG001|Overall Study|Adverse Event|4|||
131581840|NCT01152190|473756524|FG000|Overall Study|Death|1|||
131581841|NCT01152190|473756525|FG001|Overall Study|Death|0|||
131581842|NCT01152190|473756524|FG000|Overall Study|Protocol Violation|1|||
131581843|NCT01152190|473756525|FG001|Overall Study|Protocol Violation|1|||
131581844|NCT01152190|473756524|FG000|Overall Study|Withdrawal by Subject|1|||
131581845|NCT01152190|473756525|FG001|Overall Study|Withdrawal by Subject|3|||
131581846|NCT00305695|473756534|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
131581847|NCT00305695|473756535|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
131581848|NCT00305695|473756534|FG000|Overall Study|Did not have baseline scan|1|||
131581849|NCT00305695|473756535|FG001|Overall Study|Did not have baseline scan|1|||
131581850|NCT00206375|473756536|FG000|Overall Study|Lost to Follow-up|1|||
131581851|NCT00206375|473756537|FG001|Overall Study|Lost to Follow-up|0|||
131581852|NCT00206375|473756538|FG002|Overall Study|Lost to Follow-up|0|||
131581853|NCT00206375|473756536|FG000|Overall Study|Withdrawal by Subject|2|||
131581854|NCT00206375|473756537|FG001|Overall Study|Withdrawal by Subject|1|||
131581855|NCT00206375|473756538|FG002|Overall Study|Withdrawal by Subject|3|||
131581856|NCT00206375|473756536|FG000|Overall Study|Study terminated due to lack of funds|0|||
131581857|NCT00206375|473756537|FG001|Overall Study|Study terminated due to lack of funds|1|||
131581858|NCT00206375|473756538|FG002|Overall Study|Study terminated due to lack of funds|1|||
131581859|NCT01420549|473756541|FG000|Overall Study|Adverse Event|1|||
131581860|NCT01420549|473756542|FG001|Overall Study|Adverse Event|1|||
131581861|NCT01420549|473756541|FG000|Overall Study|Lost to Follow-up|2|||
131581862|NCT01420549|473756542|FG001|Overall Study|Lost to Follow-up|2|||
131581863|NCT01420549|473756541|FG000|Overall Study|Protocol Violation|0|||
131581864|NCT01420549|473756542|FG001|Overall Study|Protocol Violation|1|||
131581865|NCT01420549|473756541|FG000|Overall Study|Non-adherence to medication|4|||
131581866|NCT01420549|473756542|FG001|Overall Study|Non-adherence to medication|1|||
131788149|NCT03940586|474507564|FG001|Overall Study|Physician Decision|0|||
131788150|NCT03940586|474507565|FG002|Overall Study|Physician Decision|1|||
131788151|NCT03940586|474507563|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
131788152|NCT03940586|474507564|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
131788153|NCT03940586|474507565|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
131788154|NCT03940586|474507563|FG000|Overall Study|Not Treated|0|||
131788155|NCT03940586|474507564|FG001|Overall Study|Not Treated|2|||
131788156|NCT03940586|474507565|FG002|Overall Study|Not Treated|0|||
131788157|NCT02278952|474507566|FG000|Overall Study|Insufficient Sample|6|||
131788158|NCT03077828|474507573|FG000|Treatment Cycles|Death|1|||
131581867|NCT03454529|473757982|FG000|Overall Study|Did not receive treatment|6|||
131581868|NCT03454529|473757982|FG000|Overall Study|Received < 80% doses|1|||
131581869|NCT01582100|473757983|FG000|Overall Study|Adverse Event|1|||
131581870|NCT01582100|473757983|FG000|Overall Study|Withdrawal by Subject|1|||
131581871|NCT02564744|473757984|FG000|Overall Study|Investigator decision|0|||
131788159|NCT03077828|474507573|FG000|Treatment Cycles|Withdrawal by Subject|1|||
131788160|NCT03077828|474507573|FG000|Treatment Cycles|Screen Fail|2|||
131788161|NCT03077828|474507573|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
131581872|NCT02564744|473757985|FG001|Overall Study|Investigator decision|0|||
131581873|NCT02564744|473757986|FG002|Overall Study|Investigator decision|0|||
131581874|NCT02564744|473757987|FG003|Overall Study|Investigator decision|0|||
131581875|NCT02564744|473757988|FG004|Overall Study|Investigator decision|1|||
131581876|NCT02564744|473757984|FG000|Overall Study|Death|10|||
131581877|NCT02564744|473757985|FG001|Overall Study|Death|5|||
131581878|NCT02564744|473757986|FG002|Overall Study|Death|4|||
131788162|NCT03077828|474507573|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
131581879|NCT02564744|473757987|FG003|Overall Study|Death|16|||
131581880|NCT02564744|473757988|FG004|Overall Study|Death|16|||
131581881|NCT02564744|473757984|FG000|Overall Study|End of study Page Missing|0|||
131581882|NCT02564744|473757985|FG001|Overall Study|End of study Page Missing|0|||
131581883|NCT02564744|473757986|FG002|Overall Study|End of study Page Missing|3|||
131581884|NCT02564744|473757987|FG003|Overall Study|End of study Page Missing|3|||
131581885|NCT02564744|473757988|FG004|Overall Study|End of study Page Missing|0|||
131581886|NCT02564744|473757984|FG000|Overall Study|Subject Withdrew Consent|1|||
131581887|NCT02564744|473757985|FG001|Overall Study|Subject Withdrew Consent|1|||
131581888|NCT02564744|473757986|FG002|Overall Study|Subject Withdrew Consent|1|||
131581889|NCT02564744|473757987|FG003|Overall Study|Subject Withdrew Consent|0|||
131581890|NCT02564744|473757988|FG004|Overall Study|Subject Withdrew Consent|2|||
131581891|NCT02564744|473757984|FG000|Overall Study|Lost to Follow-up|0|||
131581892|NCT02564744|473757985|FG001|Overall Study|Lost to Follow-up|1|||
131581893|NCT02564744|473757986|FG002|Overall Study|Lost to Follow-up|0|||
131581894|NCT02564744|473757987|FG003|Overall Study|Lost to Follow-up|0|||
131581895|NCT02564744|473757988|FG004|Overall Study|Lost to Follow-up|1|||
131581896|NCT02564744|473757984|FG000|Overall Study|Reason not specified|1|||
131581897|NCT02564744|473757985|FG001|Overall Study|Reason not specified|0|||
131581898|NCT02564744|473757986|FG002|Overall Study|Reason not specified|0|||
131581899|NCT02564744|473757987|FG003|Overall Study|Reason not specified|0|||
131581900|NCT02564744|473757988|FG004|Overall Study|Reason not specified|0|||
131581901|NCT01460290|473757994|FG000|Overall Study|Adverse Event|3|||
131581902|NCT01460290|473757994|FG000|Overall Study|Elevated liver function|1|||
131581903|NCT01140048|473757995|FG000|Overall Study|Physician Decision|1|||
131581904|NCT01140048|473757995|FG000|Overall Study|Withdrawal by Subject|13|||
131581905|NCT01140048|473757995|FG000|Overall Study|Lost to Follow-up|31|||
131581906|NCT00494780|473757996|FG000|Overall Study|Adverse Event|1|||
131581907|NCT00494780|473757997|FG001|Overall Study|Adverse Event|0|||
131581908|NCT00494780|473757996|FG000|Overall Study|Withdrew before Dosed|0|||
131581909|NCT00494780|473757997|FG001|Overall Study|Withdrew before Dosed|1|||
131581910|NCT00494780|473757996|FG000|Overall Study|Progression of Study Disease|7|||
131581911|NCT00494780|473757997|FG001|Overall Study|Progression of Study Disease|8|||
131581912|NCT00494780|473757996|FG000|Overall Study|New Treatment|2|||
131581913|NCT00494780|473757997|FG001|Overall Study|New Treatment|2|||
131581914|NCT00494780|473757996|FG000|Overall Study|Non-compliance|1|||
131581915|NCT00494780|473757997|FG001|Overall Study|Non-compliance|0|||
131581916|NCT00494780|473757996|FG000|Overall Study|Residual Tumour Mass|0|||
131581917|NCT00494780|473757997|FG001|Overall Study|Residual Tumour Mass|1|||
131581918|NCT00494780|473757996|FG000|Overall Study|Insurance Issues|0|||
131581919|NCT00494780|473757997|FG001|Overall Study|Insurance Issues|1|||
131581920|NCT01254019|473757998|FG000|Overall Study|Adverse Event|0|||
131581921|NCT01254019|473757999|FG001|Overall Study|Adverse Event|2|||
131581922|NCT01254019|473757998|FG000|Overall Study|Protocol Violation|1|||
131581923|NCT01254019|473757999|FG001|Overall Study|Protocol Violation|0|||
131581924|NCT01254019|473757998|FG000|Overall Study|Withdrawal by Subject|0|||
131581925|NCT01254019|473757999|FG001|Overall Study|Withdrawal by Subject|2|||
131581926|NCT02888080|473758000|FG000|Overall Study|Subject / Guardian decision|1|||
131581927|NCT02888080|473758001|FG001|Overall Study|Subject / Guardian decision|3|||
131581928|NCT02888080|473758000|FG000|Overall Study|New Therapy for study indication|1|||
131581929|NCT02888080|473758001|FG001|Overall Study|New Therapy for study indication|0|||
131581930|NCT02888080|473758000|FG000|Overall Study|Lack of Efficacy|0|||
131581931|NCT02888080|473758001|FG001|Overall Study|Lack of Efficacy|1|||
131581932|NCT02888080|473758000|FG000|Overall Study|Adverse Event|0|||
131581933|NCT02888080|473758001|FG001|Overall Study|Adverse Event|1|||
131581934|NCT00189202|473758006|FG000|Overall Study|Physician Decision|5|||
131581935|NCT00666276|473758009|FG000|Overall Study|Protocol Violation|34|||
131581936|NCT01039688|473758010|FG000|Overall Study|Adverse Event|38|||
131581937|NCT01039688|473758011|FG001|Overall Study|Adverse Event|39|||
131581938|NCT01039688|473758012|FG002|Overall Study|Adverse Event|24|||
131581939|NCT01039688|473758010|FG000|Overall Study|Lack of Efficacy|20|||
131581940|NCT01039688|473758011|FG001|Overall Study|Lack of Efficacy|11|||
131581941|NCT01039688|473758012|FG002|Overall Study|Lack of Efficacy|26|||
131788163|NCT03077828|474507573|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
131898744|NCT00943397|474915348|FG001|Overall Study|Lost to Follow-up|4|||
131581942|NCT01039688|473758010|FG000|Overall Study|Lost to Follow-up|11|||
131581943|NCT01039688|473758011|FG001|Overall Study|Lost to Follow-up|9|||
131581944|NCT01039688|473758012|FG002|Overall Study|Lost to Follow-up|5|||
131581945|NCT01039688|473758010|FG000|Overall Study|Other|13|||
131581946|NCT01039688|473758011|FG001|Overall Study|Other|25|||
131581947|NCT01039688|473758012|FG002|Overall Study|Other|12|||
131581948|NCT01039688|473758010|FG000|Overall Study|Withdrawal by Subject|23|||
131581949|NCT01039688|473758011|FG001|Overall Study|Withdrawal by Subject|27|||
131581950|NCT01039688|473758012|FG002|Overall Study|Withdrawal by Subject|13|||
131581951|NCT01039688|473758010|FG000|Overall Study|Death|2|||
131581952|NCT01039688|473758011|FG001|Overall Study|Death|0|||
131581953|NCT01039688|473758012|FG002|Overall Study|Death|0|||
131581954|NCT00668863|473758013|FG000|Overall Study|Objective Progression or Relapse|42|||
131581955|NCT00668863|473758013|FG000|Overall Study|Adverse Event|13|||
131581956|NCT00668863|473758013|FG000|Overall Study|Study Terminated by Sponsor|8|||
131581957|NCT00668863|473758013|FG000|Overall Study|Global Deterioration of Health Status|4|||
131581958|NCT00668863|473758013|FG000|Overall Study|Withdrawal by Subject|1|||
131581959|NCT00668863|473758013|FG000|Overall Study|Surgery|1|||
131581960|NCT00668863|473758013|FG000|Overall Study|Subject's work scheduling problem|1|||
131581961|NCT00668863|473758013|FG000|Overall Study|Physician Decision|1|||
131581962|NCT03299816|473758018|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
131581963|NCT03299816|473758019|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
131581964|NCT03299816|473758018|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
131581965|NCT03299816|473758019|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
131581966|NCT03299816|473758018|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
131581967|NCT03299816|473758019|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
131581968|NCT03520413|473758021|FG000|Overall Study|Lost to Follow-up|1|||
131581969|NCT03520413|473758022|FG001|Overall Study|Lost to Follow-up|1|||
131581970|NCT03520413|473758021|FG000|Overall Study|Withdrawal by Subject|1|||
131581971|NCT03520413|473758022|FG001|Overall Study|Withdrawal by Subject|2|||
131581972|NCT03520413|473758021|FG000|Overall Study|Death|0|||
131581973|NCT03520413|473758022|FG001|Overall Study|Death|1|||
131581974|NCT03520413|473758021|FG000|Overall Study|Physician Decision|3|||
131581975|NCT03520413|473758022|FG001|Overall Study|Physician Decision|3|||
131581976|NCT03520413|473758021|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
131581977|NCT03520413|473758022|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
131581978|NCT02969863|473758023|FG000|Overall Study|Physician Decision|1|||
131581979|NCT02969863|473758024|FG001|Overall Study|Physician Decision|0|||
131581980|NCT02969863|473758025|FG002|Overall Study|Physician Decision|0|||
131581981|NCT02969863|473758026|FG003|Overall Study|Physician Decision|0|||
131581982|NCT02969863|473758027|FG004|Overall Study|Physician Decision|0|||
131581983|NCT02969863|473758028|FG005|Overall Study|Physician Decision|0|||
131581984|NCT03737240|473758031|FG000|Overall Study|Lost to Follow-up|16|||
131581985|NCT03737240|473758032|FG001|Overall Study|Lost to Follow-up|15|||
131581986|NCT00638963|473758033|FG000|Overall Study|Withdrawal by Subject|1|||
131581987|NCT00638963|473758034|FG001|Overall Study|Withdrawal by Subject|0|||
131581988|NCT05001945|473758035|FG000|Overall Study|Adverse Event|0|||
131581989|NCT05001945|473758036|FG001|Overall Study|Adverse Event|0|||
131581990|NCT05001945|473758037|FG002|Overall Study|Adverse Event|0|||
131581991|NCT05001945|473758038|FG003|Overall Study|Adverse Event|1|||
131581992|NCT05001945|473758039|FG004|Overall Study|Adverse Event|0|||
131581993|NCT05001945|473758040|FG005|Overall Study|Adverse Event|0|||
131581994|NCT05001945|473758041|FG006|Overall Study|Adverse Event|0|||
131581995|NCT05001945|473758042|FG007|Overall Study|Adverse Event|0|||
131581996|NCT05001945|473758035|FG000|Overall Study|Lost to Follow-up|0|||
131581997|NCT05001945|473758036|FG001|Overall Study|Lost to Follow-up|1|||
131581998|NCT05001945|473758037|FG002|Overall Study|Lost to Follow-up|1|||
131581999|NCT05001945|473758038|FG003|Overall Study|Lost to Follow-up|2|||
131582000|NCT05001945|473758039|FG004|Overall Study|Lost to Follow-up|0|||
131582001|NCT05001945|473758040|FG005|Overall Study|Lost to Follow-up|1|||
131582002|NCT05001945|473758041|FG006|Overall Study|Lost to Follow-up|0|||
131582003|NCT05001945|473758042|FG007|Overall Study|Lost to Follow-up|0|||
131582004|NCT05001945|473758035|FG000|Overall Study|Protocol Violation|1|||
131582005|NCT05001945|473758036|FG001|Overall Study|Protocol Violation|0|||
131582006|NCT05001945|473758037|FG002|Overall Study|Protocol Violation|1|||
131582007|NCT05001945|473758038|FG003|Overall Study|Protocol Violation|1|||
131582008|NCT05001945|473758039|FG004|Overall Study|Protocol Violation|0|||
131582009|NCT05001945|473758040|FG005|Overall Study|Protocol Violation|1|||
131582010|NCT05001945|473758041|FG006|Overall Study|Protocol Violation|0|||
131582011|NCT05001945|473758042|FG007|Overall Study|Protocol Violation|0|||
131582012|NCT05001945|473758035|FG000|Overall Study|Withdrawal by Subject|0|||
131582013|NCT05001945|473758036|FG001|Overall Study|Withdrawal by Subject|0|||
131582014|NCT05001945|473758037|FG002|Overall Study|Withdrawal by Subject|0|||
131582015|NCT05001945|473758038|FG003|Overall Study|Withdrawal by Subject|1|||
131582016|NCT05001945|473758039|FG004|Overall Study|Withdrawal by Subject|1|||
131582017|NCT05001945|473758040|FG005|Overall Study|Withdrawal by Subject|1|||
131582018|NCT05001945|473758041|FG006|Overall Study|Withdrawal by Subject|0|||
131582019|NCT05001945|473758042|FG007|Overall Study|Withdrawal by Subject|1|||
131582020|NCT05001945|473758035|FG000|Overall Study|Not specified by Investigator|0|||
131582021|NCT05001945|473758036|FG001|Overall Study|Not specified by Investigator|3|||
131582022|NCT05001945|473758037|FG002|Overall Study|Not specified by Investigator|0|||
131582023|NCT05001945|473758038|FG003|Overall Study|Not specified by Investigator|0|||
131582024|NCT05001945|473758039|FG004|Overall Study|Not specified by Investigator|1|||
131582025|NCT05001945|473758040|FG005|Overall Study|Not specified by Investigator|0|||
131582026|NCT05001945|473758041|FG006|Overall Study|Not specified by Investigator|0|||
131582027|NCT05001945|473758042|FG007|Overall Study|Not specified by Investigator|0|||
131582028|NCT02448446|473758043|FG000|Overall Study|Withdrawal by Subject|1|||
131582029|NCT02448446|473758044|FG001|Overall Study|Withdrawal by Subject|0|||
131582030|NCT01254188|473758045|FG000|Overall Study|Disease Progression|6|||
131582031|NCT01254188|473758045|FG000|Overall Study|Protocol Violation|6|||
131582032|NCT01254188|473758045|FG000|Overall Study|Pregnancy|2|||
131582033|NCT01254188|473758045|FG000|Overall Study|Death|4|||
131582034|NCT01254188|473758045|FG000|Overall Study|Lost to Follow-up|5|||
131582035|NCT01254188|473758045|FG000|Overall Study|Withdrawal by Subject|7|||
131582036|NCT01254188|473758045|FG000|Overall Study|Adverse Event|43|||
131582037|NCT01254188|473758045|FG000|Overall Study|per investigator discretion|20|||
131582038|NCT02957136|473758058|FG000|Overall Study|Withdrawal by Subject|2|||
131582039|NCT02957136|473758059|FG001|Overall Study|Withdrawal by Subject|1|||
131582040|NCT02200770|473758060|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
131582041|NCT02200770|473758061|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
131582042|NCT02200770|473758060|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
131582043|NCT02200770|473758061|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
131582044|NCT02200770|473758060|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
131582045|NCT02200770|473758061|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
131582046|NCT02200770|473758060|FG000|Randomized-controlled Period (RCP)|Other|1|||
131582047|NCT02200770|473758061|FG001|Randomized-controlled Period (RCP)|Other|2|||
131582048|NCT02200770|473758060|FG000|Open-label Period (OLP)|Adverse Event|1|||
131582049|NCT02200770|473758061|FG001|Open-label Period (OLP)|Adverse Event|2|||
131582050|NCT02200770|473758060|FG000|Open-label Period (OLP)|Death|1|||
131582051|NCT02200770|473758061|FG001|Open-label Period (OLP)|Death|2|||
131582052|NCT02200770|473758060|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
131582053|NCT02200770|473758061|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
131582054|NCT02200770|473758060|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
131582055|NCT02200770|473758061|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
131582056|NCT02200770|473758060|FG000|Open-label Period (OLP)|Other|6|||
131582057|NCT02200770|473758061|FG001|Open-label Period (OLP)|Other|15|||
131582058|NCT02214160|473758066|FG000|Overall Study|Withdrawal by Subject|1|||
131582059|NCT02214160|473758067|FG001|Overall Study|Withdrawal by Subject|0|||
131582060|NCT02214160|473758068|FG002|Overall Study|Withdrawal by Subject|6|||
131582061|NCT02214160|473758066|FG000|Overall Study|Death|2|||
131582062|NCT02214160|473758067|FG001|Overall Study|Death|2|||
131582063|NCT02214160|473758068|FG002|Overall Study|Death|1|||
131582064|NCT02214160|473758066|FG000|Overall Study|Subject Non-Compliance|0|||
131582065|NCT02214160|473758067|FG001|Overall Study|Subject Non-Compliance|3|||
131582066|NCT02214160|473758068|FG002|Overall Study|Subject Non-Compliance|1|||
131582067|NCT02214160|473758066|FG000|Overall Study|Adverse Event|0|||
131582068|NCT02214160|473758067|FG001|Overall Study|Adverse Event|1|||
131582069|NCT02214160|473758068|FG002|Overall Study|Adverse Event|1|||
131582070|NCT02214160|473758066|FG000|Overall Study|Sponsor Decision|0|||
131582071|NCT02214160|473758067|FG001|Overall Study|Sponsor Decision|2|||
131582072|NCT02214160|473758068|FG002|Overall Study|Sponsor Decision|0|||
131582073|NCT02214160|473758066|FG000|Overall Study|Protocol Violation|1|||
131582074|NCT02214160|473758067|FG001|Overall Study|Protocol Violation|0|||
131582075|NCT02214160|473758068|FG002|Overall Study|Protocol Violation|0|||
131582076|NCT02214160|473758066|FG000|Overall Study|Physician Decision|0|||
131582077|NCT02214160|473758067|FG001|Overall Study|Physician Decision|0|||
131582078|NCT02214160|473758068|FG002|Overall Study|Physician Decision|1|||
131582079|NCT02423798|473758069|FG000|Overall Study|Withdrawal by Subject|3|||
131582080|NCT01264679|473758070|FG000|Overall Study|Participation in Another Clinical Trial|1|||
131582081|NCT01264679|473758070|FG000|Overall Study|Physician Decision|1|||
131582082|NCT01264679|473758070|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
131582083|NCT01264679|473758070|FG000|Overall Study|Withdrawal by Subject|1|||
131582084|NCT02555215|473758073|FG000|Overall Study|Other|1|||
131582085|NCT02555215|473758073|FG000|Overall Study|Investigator Decision|2|||
131582086|NCT00468052|473758074|FG000|Overall Study|Protocol Violation|7|||
131582087|NCT00468052|473758075|FG001|Overall Study|Protocol Violation|8|||
131582088|NCT00356265|473758076|FG000|Overall Study|Withdrawal by Subject|0|||
131582089|NCT00356265|473758077|FG001|Overall Study|Withdrawal by Subject|0|||
131582090|NCT00356265|473758078|FG002|Overall Study|Withdrawal by Subject|1|||
131582091|NCT01837966|473758079|FG000|Overall Study|Withdrawal by Subject|2|||
131582092|NCT01837966|473758080|FG001|Overall Study|Withdrawal by Subject|1|||
131582093|NCT00159783|473758081|FG000|Overall Study|Adverse Event|5|||
131582094|NCT00159783|473758082|FG001|Overall Study|Adverse Event|7|||
131582095|NCT00159783|473758083|FG002|Overall Study|Adverse Event|9|||
131582096|NCT00159783|473758081|FG000|Overall Study|Lack of Efficacy|1|||
131582097|NCT00159783|473758082|FG001|Overall Study|Lack of Efficacy|2|||
131582098|NCT00159783|473758083|FG002|Overall Study|Lack of Efficacy|3|||
131582099|NCT00159783|473758081|FG000|Overall Study|Withdrawal by Subject|7|||
131582100|NCT00159783|473758082|FG001|Overall Study|Withdrawal by Subject|11|||
131702646|NCT00667576|474194649|FG004|Overall Study|Physician Decision|0|||
131702647|NCT00667576|474194645|FG000|Overall Study|Missed Visit|0|||
131702648|NCT00667576|474194646|FG001|Overall Study|Missed Visit|0|||
131702649|NCT00667576|474194647|FG002|Overall Study|Missed Visit|0|||
131582101|NCT00159783|473758083|FG002|Overall Study|Withdrawal by Subject|12|||
131582102|NCT00159783|473758081|FG000|Overall Study|Lost to Follow-up|6|||
131582103|NCT00159783|473758082|FG001|Overall Study|Lost to Follow-up|5|||
131582104|NCT00159783|473758083|FG002|Overall Study|Lost to Follow-up|11|||
131582105|NCT00159783|473758081|FG000|Overall Study|Other|0|||
131582106|NCT00159783|473758082|FG001|Overall Study|Other|2|||
131582107|NCT00159783|473758083|FG002|Overall Study|Other|4|||
131582108|NCT02928224|473758084|FG000|Overall Study|Lost to Follow-up|1|||
131582109|NCT02928224|473758085|FG001|Overall Study|Lost to Follow-up|1|||
131582110|NCT02928224|473758086|FG002|Overall Study|Lost to Follow-up|3|||
131582111|NCT02928224|473758087|FG003|Overall Study|Lost to Follow-up|0|||
131582112|NCT02928224|473758084|FG000|Overall Study|Death|30|||
131582113|NCT02928224|473758085|FG001|Overall Study|Death|209|||
131582114|NCT02928224|473758086|FG002|Overall Study|Death|193|||
131582115|NCT02928224|473758087|FG003|Overall Study|Death|198|||
131582116|NCT02928224|473758084|FG000|Overall Study|Withdrawal by Subject|0|||
131582117|NCT02928224|473758085|FG001|Overall Study|Withdrawal by Subject|3|||
131582118|NCT02928224|473758086|FG002|Overall Study|Withdrawal by Subject|7|||
131582119|NCT02928224|473758087|FG003|Overall Study|Withdrawal by Subject|20|||
131582120|NCT02928224|473758084|FG000|Overall Study|Study participation terminated by sponsor|3|||
131582121|NCT02928224|473758085|FG001|Overall Study|Study participation terminated by sponsor|8|||
131582122|NCT02928224|473758086|FG002|Overall Study|Study participation terminated by sponsor|12|||
131582123|NCT02928224|473758087|FG003|Overall Study|Study participation terminated by sponsor|3|||
131582124|NCT02928224|473758084|FG000|Overall Study|Other|3|||
131582125|NCT02928224|473758085|FG001|Overall Study|Other|3|||
131582126|NCT02928224|473758086|FG002|Overall Study|Other|5|||
131582127|NCT02928224|473758087|FG003|Overall Study|Other|0|||
131582128|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
131582129|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
131582130|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
131582131|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
131582132|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
131582133|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
131582134|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
131582135|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
131582136|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
131582137|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
131582138|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
131582139|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
131582140|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
131582141|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
131582142|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
131582143|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
131582144|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
131582145|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
131582146|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
131582147|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
131582148|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
131582149|NCT00304031|473759102|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
131582150|NCT00304031|473759103|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
131582151|NCT00304031|473759104|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
131582152|NCT00304031|473759102|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
131582153|NCT00304031|473759103|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
131582154|NCT00304031|473759104|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
131582155|NCT00683696|473759105|FG000|Overall Study|Withdrawn due to study closure|337|||
131582156|NCT00683696|473759106|FG001|Overall Study|Withdrawn due to study closure|338|||
131438410|NCT00614575|473231230|FG000|Overall Study|Withdrawal by Subject|6|||
131582157|NCT00683696|473759105|FG000|Overall Study|Withdrawn prior to study closure|13|||
131582158|NCT00683696|473759106|FG001|Overall Study|Withdrawn prior to study closure|28|||
131582159|NCT00683696|473759105|FG000|Overall Study|Lost to Follow-up|5|||
131582160|NCT00683696|473759106|FG001|Overall Study|Lost to Follow-up|6|||
131582161|NCT00683696|473759105|FG000|Overall Study|Vital status follow-up only|3|||
131582162|NCT00683696|473759106|FG001|Overall Study|Vital status follow-up only|3|||
131582163|NCT00683696|473759105|FG000|Overall Study|Death|46|||
131582164|NCT00683696|473759106|FG001|Overall Study|Death|30|||
131582165|NCT02396316|473759107|FG000|Overall Study|Physician Decision|1|||
131582166|NCT02396316|473759108|FG001|Overall Study|Physician Decision|0|||
131582167|NCT02396316|473759107|FG000|Overall Study|Progressive disease|6|||
131582168|NCT02396316|473759108|FG001|Overall Study|Progressive disease|3|||
131582169|NCT02396316|473759107|FG000|Overall Study|Protocol Violation|0|||
131582170|NCT02396316|473759108|FG001|Overall Study|Protocol Violation|1|||
131582171|NCT02396316|473759107|FG000|Overall Study|Treatment unblinded|0|||
131582172|NCT02396316|473759108|FG001|Overall Study|Treatment unblinded|1|||
131582173|NCT01823536|473759109|FG000|Overall Study|Lost to Follow-up|1|||
131582174|NCT01823536|473759110|FG001|Overall Study|Lost to Follow-up|0|||
131582175|NCT01823536|473759111|FG002|Overall Study|Lost to Follow-up|0|||
131582176|NCT01823536|473759112|FG003|Overall Study|Lost to Follow-up|1|||
131582177|NCT01823536|473759113|FG004|Overall Study|Lost to Follow-up|1|||
131582178|NCT01823536|473759114|FG005|Overall Study|Lost to Follow-up|0|||
131582179|NCT01823536|473759109|FG000|Overall Study|Protocol Violation|0|||
131582180|NCT01823536|473759110|FG001|Overall Study|Protocol Violation|1|||
131582181|NCT01823536|473759111|FG002|Overall Study|Protocol Violation|0|||
131582182|NCT01823536|473759112|FG003|Overall Study|Protocol Violation|0|||
131582183|NCT01823536|473759113|FG004|Overall Study|Protocol Violation|0|||
131582184|NCT01823536|473759114|FG005|Overall Study|Protocol Violation|0|||
131582185|NCT01823536|473759109|FG000|Overall Study|Withdrawal by Subject|1|||
131582186|NCT01823536|473759110|FG001|Overall Study|Withdrawal by Subject|1|||
131582187|NCT01823536|473759111|FG002|Overall Study|Withdrawal by Subject|0|||
131582188|NCT01823536|473759112|FG003|Overall Study|Withdrawal by Subject|0|||
131582189|NCT01823536|473759113|FG004|Overall Study|Withdrawal by Subject|0|||
131582190|NCT01823536|473759114|FG005|Overall Study|Withdrawal by Subject|0|||
131582191|NCT01823536|473759109|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131582192|NCT01823536|473759110|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131582193|NCT01823536|473759111|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
131582194|NCT01823536|473759112|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131582195|NCT01823536|473759113|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131582196|NCT01823536|473759114|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131582197|NCT01823536|473759109|FG000|Overall Study|Met exclusion criterion No 6|0|||
131582198|NCT01823536|473759110|FG001|Overall Study|Met exclusion criterion No 6|0|||
131582199|NCT01823536|473759111|FG002|Overall Study|Met exclusion criterion No 6|0|||
131582200|NCT01823536|473759112|FG003|Overall Study|Met exclusion criterion No 6|1|||
131788164|NCT03077828|474507573|FG000|Follow-up|Patients still in follow-up|15|||
131788165|NCT04288115|474507577|FG000|Overall Study|Withdrawal by Subject|0|||
131788166|NCT04288115|474507578|FG001|Overall Study|Withdrawal by Subject|1|||
131788167|NCT04288115|474507577|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
131788168|NCT04288115|474507578|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
131788169|NCT00729365|474507580|FG000|Overall Study|Physician Decision|33|||
131788170|NCT00729365|474507581|FG001|Overall Study|Physician Decision|6|||
131788171|NCT00729365|474507582|FG002|Overall Study|Physician Decision|7|||
131788172|NCT00869089|474507583|FG000|Overall Study|Lost to Follow-up|1|||
131788173|NCT00869089|474507583|FG000|Overall Study|Withdrawal by Subject|1|||
131788174|NCT00869089|474507583|FG000|Overall Study|Screen Fail|1|||
131788175|NCT05037409|474507586|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
131788176|NCT05037409|474507587|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
131788177|NCT05037409|474507588|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
131788178|NCT01559818|474507593|FG000|Overall Study|Physician Decision|1|||
131788179|NCT01559818|474507593|FG000|Overall Study|Pregnancy|1|||
131788180|NCT01559818|474507593|FG000|Overall Study|Study terminated by Sponsor|4|||
131788181|NCT01559818|474507593|FG000|Overall Study|Withdrawal by Subject|1|||
131788182|NCT04071626|474507595|FG000|Overall Study|Withdrawal by Subject|1|||
131788183|NCT04071626|474507596|FG001|Overall Study|Withdrawal by Subject|1|||
131788184|NCT04071626|474507595|FG000|Overall Study|Protocol Violation|0|||
131788185|NCT04071626|474507596|FG001|Overall Study|Protocol Violation|1|||
131788186|NCT00665626|474507600|FG000|Overall Study|Lack of Efficacy|8|||
131582201|NCT01823536|473759113|FG004|Overall Study|Met exclusion criterion No 6|0|||
131788187|NCT00665626|474507601|FG001|Overall Study|Lack of Efficacy|5|||
131582202|NCT01823536|473759114|FG005|Overall Study|Met exclusion criterion No 6|0|||
131582203|NCT01823536|473759109|FG000|Overall Study|Subject moved out of the state|0|||
131582204|NCT01823536|473759110|FG001|Overall Study|Subject moved out of the state|0|||
131582205|NCT01823536|473759111|FG002|Overall Study|Subject moved out of the state|0|||
131582206|NCT01823536|473759112|FG003|Overall Study|Subject moved out of the state|0|||
131582207|NCT01823536|473759113|FG004|Overall Study|Subject moved out of the state|1|||
131582208|NCT01823536|473759114|FG005|Overall Study|Subject moved out of the state|0|||
131788188|NCT00665626|474507600|FG000|Overall Study|Lost to Follow-up|0|||
131582209|NCT03648762|473759115|FG000|Overall Study|Lost to Follow-up|1|||
131582210|NCT03648762|473759116|FG001|Overall Study|Lost to Follow-up|2|||
131788189|NCT00665626|474507601|FG001|Overall Study|Lost to Follow-up|2|||
131582211|NCT03648762|473759117|FG002|Overall Study|Lost to Follow-up|0|||
131582212|NCT03648762|473759115|FG000|Overall Study|Withdrawal by Subject|5|||
131582213|NCT03648762|473759116|FG001|Overall Study|Withdrawal by Subject|2|||
131582214|NCT03648762|473759117|FG002|Overall Study|Withdrawal by Subject|1|||
131582215|NCT00686855|473759133|FG000|Overall Study|Lost to Follow-up|1|||
131582216|NCT00686855|473759134|FG001|Overall Study|Lost to Follow-up|0|||
131582217|NCT00686855|473759133|FG000|Overall Study|Progressive GVHD|0|||
131582218|NCT00686855|473759134|FG001|Overall Study|Progressive GVHD|1|||
131582219|NCT02731755|473759142|FG000|First Intervention|Withdrawal by Subject|0|||
131582220|NCT02731755|473759143|FG001|First Intervention|Withdrawal by Subject|2|||
131582221|NCT01460446|473759144|FG000|Overall Study|Non-compliance|2|||
131582222|NCT01460446|473759145|FG001|Overall Study|Non-compliance|9|||
131582223|NCT01460446|473759144|FG000|Overall Study|Consent Withdrawn|0|||
131582224|NCT01460446|473759145|FG001|Overall Study|Consent Withdrawn|4|||
131582225|NCT01460446|473759144|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
131582226|NCT01460446|473759145|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
131582227|NCT01460446|473759144|FG000|Overall Study|Surgery/Illness|1|||
131582228|NCT01460446|473759145|FG001|Overall Study|Surgery/Illness|1|||
131582229|NCT01460446|473759144|FG000|Overall Study|Pregnancy|1|||
131582230|NCT01460446|473759145|FG001|Overall Study|Pregnancy|0|||
131582231|NCT01460446|473759144|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
131582232|NCT01460446|473759145|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
131582233|NCT04218110|473759146|FG000|Overall Study|Withdrawal by Subject|0|||
131582234|NCT04218110|473759147|FG001|Overall Study|Withdrawal by Subject|0|||
131582235|NCT04218110|473759148|FG002|Overall Study|Withdrawal by Subject|0|||
131582236|NCT04218110|473759149|FG003|Overall Study|Withdrawal by Subject|1|||
131582237|NCT00002842|473759150|FG000|Overall Study|ineligible for surgical resection|27|||
131582238|NCT01599104|473759151|FG000|Overall Study|Withdrawal by Subject|1|||
131582239|NCT01599104|473759152|FG001|Overall Study|Withdrawal by Subject|1|||
131582240|NCT01599104|473759153|FG002|Overall Study|Withdrawal by Subject|2|||
131582241|NCT01599104|473759151|FG000|Overall Study|Technical Problems|1|||
131582242|NCT01599104|473759152|FG001|Overall Study|Technical Problems|0|||
131582243|NCT01599104|473759153|FG002|Overall Study|Technical Problems|0|||
131582244|NCT01599104|473759151|FG000|Overall Study|Physician Decision|3|||
131582245|NCT01599104|473759152|FG001|Overall Study|Physician Decision|2|||
131582246|NCT01599104|473759153|FG002|Overall Study|Physician Decision|2|||
131582247|NCT01599104|473759151|FG000|Overall Study|Non-compliance with study treatment|0|||
131582248|NCT01599104|473759152|FG001|Overall Study|Non-compliance with study treatment|1|||
131582249|NCT01599104|473759153|FG002|Overall Study|Non-compliance with study treatment|0|||
131582250|NCT01599104|473759151|FG000|Overall Study|Lack of Efficacy|4|||
131582251|NCT01599104|473759152|FG001|Overall Study|Lack of Efficacy|4|||
131582252|NCT01599104|473759153|FG002|Overall Study|Lack of Efficacy|10|||
131582253|NCT01599104|473759151|FG000|Overall Study|Adverse Event|7|||
131582254|NCT01599104|473759152|FG001|Overall Study|Adverse Event|6|||
131582255|NCT01599104|473759153|FG002|Overall Study|Adverse Event|12|||
131582256|NCT02271854|473759156|FG000|Overall Study|Withdrawal by Subject|2|||
131582257|NCT02271854|473759156|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
131582258|NCT02271854|473759156|FG000|Overall Study|Lost to Follow-up|1|||
131582259|NCT00508924|473759160|FG000|Overall Study|Protocol Violation|0|||
131582260|NCT00508924|473759161|FG001|Overall Study|Protocol Violation|0|||
131582261|NCT00508924|473759162|FG002|Overall Study|Protocol Violation|1|||
131582262|NCT00508924|473759163|FG003|Overall Study|Protocol Violation|1|||
131898745|NCT00943397|474915347|FG000|Overall Study|Protocol Violation|2|||
131898746|NCT00943397|474915348|FG001|Overall Study|Protocol Violation|5|||
131582263|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
131582264|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
131438411|NCT00614575|473231230|FG000|Overall Study|Death|3|||
131582265|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
131582266|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
131582267|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
131582268|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
131582269|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
131582270|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
131702650|NCT00667576|474194648|FG003|Overall Study|Missed Visit|1|||
131702651|NCT00667576|474194649|FG004|Overall Study|Missed Visit|0|||
131702652|NCT03968419|474194650|FG000|Treatment Period|Adverse Event|0|||
131702653|NCT03968419|474194651|FG001|Treatment Period|Adverse Event|0|||
131702654|NCT03968419|474194652|FG002|Treatment Period|Adverse Event|1|||
131702655|NCT03968419|474194650|FG000|Safety Follow-up Period|Death|3|||
131702656|NCT03968419|474194651|FG001|Safety Follow-up Period|Death|2|||
131702657|NCT03968419|474194652|FG002|Safety Follow-up Period|Death|1|||
131702658|NCT03968419|474194650|FG000|Safety Follow-up Period|Subject Decision|2|||
131702659|NCT03968419|474194651|FG001|Safety Follow-up Period|Subject Decision|1|||
131702660|NCT03968419|474194652|FG002|Safety Follow-up Period|Subject Decision|0|||
131702661|NCT01390389|474194653|FG000|Overall Study|Withdrawal by Subject|2|||
131702662|NCT01390389|474194654|FG001|Overall Study|Withdrawal by Subject|0|||
131582271|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
131582272|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
131582273|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
131582274|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
131582275|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
131582276|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
131582277|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
131582278|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
131582279|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
131582280|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
131582281|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
131582282|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
131582283|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
131582284|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
131582285|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
131582286|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
131582287|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
131582288|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
131582289|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
131582290|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
131582291|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
131582292|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
131582293|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
131582294|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
131582295|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
131582296|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
131582297|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
131582298|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
131582299|NCT03593213|473759165|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
131582300|NCT03593213|473759166|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
131582301|NCT03593213|473759167|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
131582302|NCT03593213|473759168|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
131582303|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
131582304|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
131582305|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
131582306|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
131582307|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
131582308|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
131582309|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
131582310|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
131582311|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
131582312|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
131582313|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
131582314|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
131582315|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
131582316|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
131582317|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
131582318|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
131582319|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
131582320|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
131702663|NCT01390389|474194653|FG000|Overall Study|Screen Fail|2|||
131702664|NCT01390389|474194654|FG001|Overall Study|Screen Fail|1|||
131702665|NCT02002975|474194655|FG000|Overall Study|Case Report Forms Uncollected|135|||
131702666|NCT02002975|474194655|FG000|Overall Study|Protocol Deviation|437|||
131702667|NCT01430442|474194658|FG000|Overall Study|Subject Withdrew Consent|3|||
131702668|NCT01430442|474194659|FG001|Overall Study|Subject Withdrew Consent|0|||
131702669|NCT01430442|474194660|FG002|Overall Study|Subject Withdrew Consent|1|||
131702670|NCT01430442|474194661|FG003|Overall Study|Subject Withdrew Consent|0|||
131702671|NCT01430442|474194662|FG004|Overall Study|Subject Withdrew Consent|2|||
131582321|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
131582322|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
131582323|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
131582324|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
131582325|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
131582326|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
131582327|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
131582328|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
131582329|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
131582330|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
131582331|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
131582332|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
131582333|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
131582334|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
131582335|NCT03593213|473759165|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
131582336|NCT03593213|473759166|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
131582337|NCT03593213|473759167|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
131582338|NCT03593213|473759168|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
131788190|NCT00665626|474507600|FG000|Overall Study|Withdrawal by Subject|0|||
131582339|NCT00585533|473759174|FG000|Overall Study|objective or symptomatic progression|9|||
131582340|NCT05082935|473759175|FG000|Overall Study|Lost to Follow-up|549|||
131582341|NCT05082935|473759176|FG001|Overall Study|Lost to Follow-up|631|||
131582342|NCT05082935|473759175|FG000|Overall Study|Withdrawal by Subject|27|||
131788191|NCT00665626|474507601|FG001|Overall Study|Withdrawal by Subject|1|||
131788192|NCT00665626|474507600|FG000|Overall Study|Protocol Violation|0|||
131788193|NCT00665626|474507601|FG001|Overall Study|Protocol Violation|2|||
131788194|NCT00665626|474507600|FG000|Overall Study|Adverse Event|1|||
131788195|NCT00665626|474507601|FG001|Overall Study|Adverse Event|9|||
131788196|NCT00665626|474507600|FG000|Overall Study|Due to exclusion criteria|0|||
131788197|NCT00665626|474507601|FG001|Overall Study|Due to exclusion criteria|1|||
131788198|NCT00665626|474507600|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
131582343|NCT05082935|473759176|FG001|Overall Study|Withdrawal by Subject|58|||
131582344|NCT00439569|473759177|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
131582345|NCT00439569|473759177|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
131582346|NCT00439569|473759177|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
131582347|NCT03482011|473759178|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
131582348|NCT03482011|473759179|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
131582349|NCT03482011|473759180|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
131582350|NCT03482011|473759181|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
131582351|NCT03482011|473759182|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
131582352|NCT03482011|473759183|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
131582353|NCT03482011|473759184|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
131582354|NCT03482011|473759185|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
131582355|NCT03482011|473759178|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
131582356|NCT03482011|473759179|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
131582357|NCT03482011|473759180|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131582358|NCT03482011|473759181|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131582359|NCT03482011|473759182|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131582360|NCT03482011|473759183|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131582361|NCT03482011|473759184|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131582362|NCT03482011|473759185|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131582363|NCT03482011|473759178|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582364|NCT03482011|473759179|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
131582365|NCT03482011|473759180|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582366|NCT03482011|473759181|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582367|NCT03482011|473759182|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582368|NCT03482011|473759183|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582369|NCT03482011|473759184|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582370|NCT03482011|473759185|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131582371|NCT03482011|473759178|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
131582372|NCT03482011|473759179|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
131788199|NCT00665626|474507601|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
131788200|NCT00665626|474507600|FG000|Overall Study|Unably to comply with dosing regimen|0|||
131438412|NCT00614575|473231230|FG000|Overall Study|Physician Decision|2|||
131582373|NCT03482011|473759180|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
131582374|NCT03482011|473759181|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
131788201|NCT00665626|474507601|FG001|Overall Study|Unably to comply with dosing regimen|1|||
131788202|NCT00665626|474507600|FG000|Overall Study|Death|1|||
131582375|NCT03482011|473759182|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
131582376|NCT03482011|473759183|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
131582377|NCT03482011|473759184|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
131582378|NCT03482011|473759185|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
131582379|NCT03482011|473759178|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
131582380|NCT03482011|473759179|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
131582381|NCT03482011|473759180|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131582382|NCT03482011|473759181|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131582383|NCT03482011|473759182|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131582384|NCT03482011|473759183|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131582385|NCT03482011|473759184|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131582386|NCT03482011|473759185|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131582387|NCT03482011|473759178|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
131582388|NCT03482011|473759179|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
131582389|NCT03482011|473759180|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
131582390|NCT03482011|473759181|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
131582391|NCT03482011|473759182|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
131582392|NCT03482011|473759183|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
131582393|NCT03482011|473759184|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
131582394|NCT03482011|473759185|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
131582395|NCT03482011|473759178|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131582396|NCT03482011|473759179|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131582397|NCT03482011|473759180|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
131582398|NCT03482011|473759181|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
131582399|NCT03482011|473759182|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
131582400|NCT03482011|473759183|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
131582401|NCT03482011|473759184|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131582402|NCT03482011|473759185|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
131582403|NCT03482011|473759178|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131582404|NCT03482011|473759179|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131582405|NCT03482011|473759180|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131582406|NCT03482011|473759181|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131582407|NCT03482011|473759182|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
131582408|NCT03482011|473759183|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131582409|NCT03482011|473759184|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131582410|NCT03482011|473759185|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
131582411|NCT03482011|473759178|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
131582412|NCT03482011|473759179|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
131582413|NCT03482011|473759180|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
131582414|NCT03482011|473759181|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
131582415|NCT03482011|473759182|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
131582416|NCT03482011|473759183|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
131582417|NCT03482011|473759184|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
131582418|NCT03482011|473759185|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
131582419|NCT03482011|473759178|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131582420|NCT03482011|473759179|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131582421|NCT03482011|473759180|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131582422|NCT03482011|473759181|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
131582423|NCT03482011|473759182|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131582424|NCT03482011|473759183|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
131582425|NCT03482011|473759184|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131582426|NCT03482011|473759185|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131582427|NCT03482011|473759178|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131582428|NCT03482011|473759179|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131582429|NCT03482011|473759180|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131582430|NCT03482011|473759181|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
131582431|NCT03482011|473759182|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131582432|NCT03482011|473759183|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
131582433|NCT03482011|473759184|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
131582434|NCT03482011|473759185|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
131582435|NCT03482011|473759178|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
131788203|NCT00665626|474507601|FG001|Overall Study|Death|0|||
131788204|NCT04147611|474507602|FG000|Overall Study|Physician Decision|0|||
131582436|NCT03482011|473759179|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
131582437|NCT03482011|473759180|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
131582438|NCT03482011|473759181|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
131582439|NCT03482011|473759182|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
131582440|NCT03482011|473759183|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
131582441|NCT03482011|473759184|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
131582442|NCT03482011|473759185|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
131582443|NCT03482011|473759178|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131582444|NCT03482011|473759179|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131582445|NCT03482011|473759180|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
131582446|NCT03482011|473759181|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
131582447|NCT03482011|473759182|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131582448|NCT03482011|473759183|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131582449|NCT03482011|473759184|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131582450|NCT03482011|473759185|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
131582451|NCT03482011|473759178|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582452|NCT03482011|473759179|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582453|NCT03482011|473759180|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582454|NCT03482011|473759181|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582455|NCT03482011|473759182|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582456|NCT03482011|473759183|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582457|NCT03482011|473759184|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
131582458|NCT03482011|473759185|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
131582459|NCT03482011|473759178|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582460|NCT03482011|473759179|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582461|NCT03482011|473759180|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582462|NCT03482011|473759181|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582463|NCT03482011|473759182|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582464|NCT03482011|473759183|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582465|NCT03482011|473759184|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131582466|NCT03482011|473759185|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
131582467|NCT01595061|473759186|FG000|Overall Study|Never Treated|3|||
131582468|NCT01595061|473759186|FG000|Overall Study|Inadequate Pathology|1|||
131582469|NCT02538107|473759187|FG000|Overall Study|Did not receive any Mircera dose|11|||
131582470|NCT02538107|473759187|FG000|Overall Study|Missing|5|||
131582471|NCT02538107|473759187|FG000|Overall Study|Necessity of dialysis|20|||
131582472|NCT02538107|473759187|FG000|Overall Study|Administration of other ESA|11|||
131582473|NCT02538107|473759187|FG000|Overall Study|No further treatment necessary|18|||
131582474|NCT02538107|473759187|FG000|Overall Study|Withdrawal by Subject|17|||
131582475|NCT02538107|473759187|FG000|Overall Study|Death|4|||
131582476|NCT02538107|473759187|FG000|Overall Study|Administrative reason|5|||
131582477|NCT02538107|473759187|FG000|Overall Study|Adverse Event|4|||
131582478|NCT02538107|473759187|FG000|Overall Study|Surgery|1|||
131582479|NCT02538107|473759187|FG000|Overall Study|Other|7|||
131582480|NCT02538107|473759187|FG000|Overall Study|Not recorded|7|||
131582481|NCT01278394|473759190|FG000|Overall Study|Lost to Follow-up|1|||
131582482|NCT01236560|473759191|FG000|Overall Study|Adverse Event|0|||
131582483|NCT01236560|473759192|FG001|Overall Study|Adverse Event|2|||
131582484|NCT01236560|473759193|FG002|Overall Study|Adverse Event|1|||
131582485|NCT01236560|473759194|FG003|Overall Study|Adverse Event|3|||
131582486|NCT01236560|473759195|FG004|Overall Study|Adverse Event|0|||
131582487|NCT01236560|473759196|FG005|Overall Study|Adverse Event|0|||
131582488|NCT01236560|473759191|FG000|Overall Study|Death|0|||
131582489|NCT01236560|473759192|FG001|Overall Study|Death|1|||
131582490|NCT01236560|473759193|FG002|Overall Study|Death|0|||
131582491|NCT01236560|473759194|FG003|Overall Study|Death|1|||
131582492|NCT01236560|473759195|FG004|Overall Study|Death|0|||
131582493|NCT01236560|473759196|FG005|Overall Study|Death|0|||
131582494|NCT01236560|473759191|FG000|Overall Study|Lost to Follow-up|0|||
131582495|NCT01236560|473759192|FG001|Overall Study|Lost to Follow-up|1|||
131582496|NCT01236560|473759193|FG002|Overall Study|Lost to Follow-up|1|||
131582497|NCT01236560|473759194|FG003|Overall Study|Lost to Follow-up|0|||
131582498|NCT01236560|473759195|FG004|Overall Study|Lost to Follow-up|0|||
131582499|NCT01236560|473759196|FG005|Overall Study|Lost to Follow-up|0|||
131582500|NCT01236560|473759191|FG000|Overall Study|Physician Decision|0|||
131582501|NCT01236560|473759192|FG001|Overall Study|Physician Decision|1|||
131702672|NCT01430442|474194663|FG005|Overall Study|Subject Withdrew Consent|1|||
131702673|NCT01430442|474194664|FG006|Overall Study|Subject Withdrew Consent|5|||
131702674|NCT01430442|474194665|FG007|Overall Study|Subject Withdrew Consent|2|||
131702675|NCT01430442|474194658|FG000|Overall Study|Lost to Follow-up|2|||
131702676|NCT01430442|474194659|FG001|Overall Study|Lost to Follow-up|0|||
131702677|NCT01430442|474194660|FG002|Overall Study|Lost to Follow-up|1|||
131582502|NCT01236560|473759193|FG002|Overall Study|Physician Decision|8|||
131582503|NCT01236560|473759194|FG003|Overall Study|Physician Decision|0|||
131582504|NCT01236560|473759195|FG004|Overall Study|Physician Decision|0|||
131582505|NCT01236560|473759196|FG005|Overall Study|Physician Decision|0|||
131582506|NCT01236560|473759191|FG000|Overall Study|Withdrawal by Subject|0|||
131582507|NCT01236560|473759192|FG001|Overall Study|Withdrawal by Subject|0|||
131582508|NCT01236560|473759193|FG002|Overall Study|Withdrawal by Subject|1|||
131582509|NCT01236560|473759194|FG003|Overall Study|Withdrawal by Subject|2|||
131582510|NCT01236560|473759195|FG004|Overall Study|Withdrawal by Subject|0|||
131582511|NCT01236560|473759196|FG005|Overall Study|Withdrawal by Subject|0|||
131582512|NCT01236560|473759191|FG000|Overall Study|Progressive disease|5|||
131702678|NCT01430442|474194661|FG003|Overall Study|Lost to Follow-up|2|||
131582513|NCT01236560|473759192|FG001|Overall Study|Progressive disease|19|||
131582514|NCT01236560|473759193|FG002|Overall Study|Progressive disease|9|||
131582515|NCT01236560|473759194|FG003|Overall Study|Progressive disease|16|||
131582516|NCT01236560|473759195|FG004|Overall Study|Progressive disease|0|||
131582517|NCT01236560|473759196|FG005|Overall Study|Progressive disease|0|||
131582518|NCT00468910|473759197|FG000|Overall Study|Lost to Follow-up|2|||
131582519|NCT00468910|473759198|FG001|Overall Study|Lost to Follow-up|1|||
131582520|NCT00468910|473759197|FG000|Overall Study|Withdrawal by Subject|2|||
131582521|NCT00468910|473759198|FG001|Overall Study|Withdrawal by Subject|1|||
131582522|NCT00468910|473759197|FG000|Overall Study|Medical Contraindication|0|||
131582523|NCT00468910|473759198|FG001|Overall Study|Medical Contraindication|1|||
131582524|NCT01576484|473759199|FG000|Overall Study|Adverse Event|1|||
131582525|NCT01576484|473759200|FG001|Overall Study|Adverse Event|1|||
131582526|NCT01576484|473759199|FG000|Overall Study|Protocol Violation|0|||
131582527|NCT01576484|473759200|FG001|Overall Study|Protocol Violation|2|||
131582528|NCT01576484|473759199|FG000|Overall Study|Sponsor Decision|2|||
131582529|NCT01576484|473759200|FG001|Overall Study|Sponsor Decision|8|||
131582530|NCT01576484|473759199|FG000|Overall Study|Withdrawal by Subject|0|||
131582531|NCT01576484|473759200|FG001|Overall Study|Withdrawal by Subject|3|||
131582532|NCT01576484|473759199|FG000|Overall Study|Other|2|||
131582533|NCT01576484|473759200|FG001|Overall Study|Other|5|||
131582534|NCT01943799|473759202|FG000|Overall Study|Lost to Follow-up|0|||
131582535|NCT01943799|473759203|FG001|Overall Study|Lost to Follow-up|1|||
131582536|NCT01943799|473759204|FG002|Overall Study|Lost to Follow-up|1|||
131582537|NCT01943799|473759205|FG003|Overall Study|Lost to Follow-up|0|||
131582538|NCT01943799|473759202|FG000|Overall Study|Protocol Violation|1|||
131582539|NCT01943799|473759203|FG001|Overall Study|Protocol Violation|0|||
131582540|NCT01943799|473759204|FG002|Overall Study|Protocol Violation|0|||
131582541|NCT01943799|473759205|FG003|Overall Study|Protocol Violation|0|||
131582542|NCT01943799|473759202|FG000|Overall Study|Withdrawal by Subject|4|||
131582543|NCT01943799|473759203|FG001|Overall Study|Withdrawal by Subject|2|||
131582544|NCT01943799|473759204|FG002|Overall Study|Withdrawal by Subject|1|||
131702679|NCT01430442|474194662|FG004|Overall Study|Lost to Follow-up|2|||
131702680|NCT01430442|474194663|FG005|Overall Study|Lost to Follow-up|1|||
131702681|NCT01430442|474194664|FG006|Overall Study|Lost to Follow-up|5|||
131438413|NCT00614575|473231230|FG000|Overall Study|No data were collected.|18|||
131702682|NCT01430442|474194665|FG007|Overall Study|Lost to Follow-up|1|||
131702683|NCT01430442|474194658|FG000|Overall Study|Pregnancy|1|||
131702684|NCT01430442|474194659|FG001|Overall Study|Pregnancy|0|||
131702685|NCT01430442|474194660|FG002|Overall Study|Pregnancy|0|||
131702686|NCT01430442|474194661|FG003|Overall Study|Pregnancy|0|||
131702687|NCT01430442|474194662|FG004|Overall Study|Pregnancy|0|||
131702688|NCT01430442|474194663|FG005|Overall Study|Pregnancy|1|||
131702689|NCT01430442|474194664|FG006|Overall Study|Pregnancy|0|||
131702690|NCT01430442|474194665|FG007|Overall Study|Pregnancy|0|||
131702691|NCT01430442|474194658|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
131702692|NCT01430442|474194659|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
131702693|NCT01430442|474194660|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
131702694|NCT01430442|474194661|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
131702695|NCT01430442|474194662|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
131702696|NCT01430442|474194663|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
131702697|NCT01430442|474194664|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
131702698|NCT01430442|474194665|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
131702699|NCT01641939|474194666|FG000|Overall Study|Death|90|||
131702700|NCT01641939|474194667|FG001|Overall Study|Death|187|||
131702701|NCT01641939|474194668|FG002|Overall Study|Death|61|||
131582545|NCT01943799|473759205|FG003|Overall Study|Withdrawal by Subject|0|||
131702702|NCT01641939|474194666|FG000|Overall Study|Lost to Follow-up|3|||
131702703|NCT01641939|474194667|FG001|Overall Study|Lost to Follow-up|2|||
131582546|NCT00958633|473759208|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
131582547|NCT00958633|473759209|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
131582548|NCT00958633|473759210|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
131582549|NCT00958633|473759208|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
131582550|NCT00958633|473759209|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
131582551|NCT00958633|473759210|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
131702704|NCT01641939|474194668|FG002|Overall Study|Lost to Follow-up|1|||
131582552|NCT00958633|473759208|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
131582553|NCT00958633|473759209|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
131582554|NCT00958633|473759210|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
131582555|NCT00958633|473759208|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
131582556|NCT00958633|473759209|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
131582557|NCT00958633|473759210|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
131582558|NCT00958633|473759208|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
131582559|NCT00958633|473759209|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
131582560|NCT00958633|473759210|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
131582561|NCT00958633|473759208|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
131582562|NCT00958633|473759209|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
131582563|NCT00958633|473759210|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
131582564|NCT00958633|473759208|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
131582565|NCT00958633|473759209|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
131582566|NCT00958633|473759210|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
131582567|NCT00433199|473759212|FG000|Double-Blind Period|Adverse Event|0|||
131582568|NCT00433199|473759213|FG001|Double-Blind Period|Adverse Event|25|||
131582569|NCT00433199|473759212|FG000|Double-Blind Period|Lack of Efficacy|0|||
131582570|NCT00433199|473759213|FG001|Double-Blind Period|Lack of Efficacy|2|||
131582571|NCT00433199|473759212|FG000|Double-Blind Period|Lost to Follow-up|2|||
131582572|NCT00433199|473759213|FG001|Double-Blind Period|Lost to Follow-up|5|||
131582573|NCT00433199|473759212|FG000|Double-Blind Period|Withdrawal by Subject|8|||
131582574|NCT00433199|473759213|FG001|Double-Blind Period|Withdrawal by Subject|19|||
131582575|NCT00433199|473759212|FG000|Double-Blind Period|Protocol Violation|1|||
131582576|NCT00433199|473759213|FG001|Double-Blind Period|Protocol Violation|10|||
131582577|NCT00433199|473759212|FG000|Double-Blind Period|Administrative|1|||
131582578|NCT00433199|473759213|FG001|Double-Blind Period|Administrative|5|||
131582579|NCT00433199|473759212|FG000|Open-Label Period|Adverse Event|0|||
131582580|NCT00433199|473759213|FG001|Open-Label Period|Adverse Event|19|||
131582581|NCT00433199|473759212|FG000|Open-Label Period|Lack of Efficacy|0|||
131582582|NCT00433199|473759213|FG001|Open-Label Period|Lack of Efficacy|2|||
131702705|NCT01641939|474194666|FG000|Overall Study|Withdrawal by Subject|14|||
131702706|NCT01641939|474194667|FG001|Overall Study|Withdrawal by Subject|11|||
131702707|NCT01641939|474194668|FG002|Overall Study|Withdrawal by Subject|5|||
131702708|NCT01641939|474194666|FG000|Overall Study|Study Terminated by Sponsor|10|||
131702709|NCT01641939|474194667|FG001|Overall Study|Study Terminated by Sponsor|28|||
131702710|NCT01641939|474194668|FG002|Overall Study|Study Terminated by Sponsor|3|||
131702711|NCT00804687|474194674|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
131702712|NCT00804687|474194675|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
131702713|NCT00804687|474194676|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
131702714|NCT00804687|474194677|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
131702715|NCT00804687|474194678|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
131702716|NCT00804687|474194679|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
131702717|NCT00804687|474194674|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
131702718|NCT00804687|474194675|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
131702719|NCT00804687|474194676|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
131702720|NCT00804687|474194677|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
131702721|NCT00804687|474194678|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
131702722|NCT00804687|474194679|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
131702723|NCT00804687|474194674|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
131702724|NCT00804687|474194675|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
131702725|NCT00804687|474194676|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
131702726|NCT00804687|474194677|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
131702727|NCT00804687|474194678|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
131702728|NCT00804687|474194679|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
131702729|NCT00804687|474194674|FG000|Period 5: Treatment Period|Positive drug test|1|||
131702730|NCT00804687|474194675|FG001|Period 5: Treatment Period|Positive drug test|0|||
131702731|NCT00804687|474194676|FG002|Period 5: Treatment Period|Positive drug test|0|||
131702732|NCT00804687|474194677|FG003|Period 5: Treatment Period|Positive drug test|0|||
131702733|NCT00804687|474194678|FG004|Period 5: Treatment Period|Positive drug test|0|||
131582583|NCT00433199|473759212|FG000|Open-Label Period|Lost to Follow-up|0|||
131582584|NCT00433199|473759213|FG001|Open-Label Period|Lost to Follow-up|3|||
131702734|NCT00804687|474194679|FG005|Period 5: Treatment Period|Positive drug test|0|||
131702735|NCT00688909|474194682|FG000|Overall Study|Adverse Event|28|||
131702736|NCT00688909|474194682|FG000|Overall Study|Patient withdrew consent|2|||
131702737|NCT00688909|474194682|FG000|Overall Study|Administrative problems|1|||
131702738|NCT00688909|474194682|FG000|Overall Study|Protocol Violation|2|||
131702739|NCT01220414|474194683|FG000|Overall Study|Withdrawal by Subject|1|||
131582585|NCT00433199|473759212|FG000|Open-Label Period|Withdrawal by Subject|0|||
131582586|NCT00433199|473759213|FG001|Open-Label Period|Withdrawal by Subject|7|||
131582587|NCT00433199|473759212|FG000|Open-Label Period|Protocol Violation|0|||
131582588|NCT00433199|473759213|FG001|Open-Label Period|Protocol Violation|2|||
131582589|NCT00433199|473759212|FG000|Open-Label Period|Administrative|0|||
131582590|NCT00433199|473759213|FG001|Open-Label Period|Administrative|1|||
131582591|NCT04305405|473759216|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131582592|NCT04305405|473759217|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131582593|NCT03368664|473759223|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
131582594|NCT03368664|473759223|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
131582595|NCT03368664|473759223|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
131582596|NCT03368664|473759223|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
131582597|NCT00457691|473759225|FG000|Overall Study|Adverse Event|4|||
131582598|NCT00457691|473759226|FG001|Overall Study|Adverse Event|1|||
131582599|NCT00457691|473759225|FG000|Overall Study|Death|163|||
131582600|NCT00457691|473759226|FG001|Overall Study|Death|148|||
131582601|NCT00457691|473759225|FG000|Overall Study|Protocol Violation|1|||
131582602|NCT00457691|473759226|FG001|Overall Study|Protocol Violation|3|||
131582603|NCT00457691|473759225|FG000|Overall Study|Lost to Follow-up|23|||
131582604|NCT00457691|473759226|FG001|Overall Study|Lost to Follow-up|14|||
131582605|NCT00457691|473759225|FG000|Overall Study|Study terminated by Sponsor|1|||
131582606|NCT00457691|473759226|FG001|Overall Study|Study terminated by Sponsor|1|||
131582607|NCT00457691|473759225|FG000|Overall Study|Subject refused (reason other than AE)|14|||
131582608|NCT00457691|473759226|FG001|Overall Study|Subject refused (reason other than AE)|19|||
131582609|NCT00457691|473759225|FG000|Overall Study|Disease progression, study terminated|180|||
131582610|NCT00457691|473759226|FG001|Overall Study|Disease progression, study terminated|196|||
131582611|NCT01597258|473759227|FG000|Overall Study|No Drug Administration|1|||
131582612|NCT02079844|473759228|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
131582613|NCT02079844|473759229|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
131582614|NCT02079844|473759230|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
131582615|NCT02079844|473759228|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
131582616|NCT02079844|473759229|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
131582617|NCT02079844|473759230|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
131582618|NCT00925899|473761432|FG000|Part 1|Death|1|||
131582619|NCT00925899|473761433|FG001|Part 1|Death|2|||
131582620|NCT00925899|473761432|FG000|Part 1|Withdrawal by Subject|10|||
131582621|NCT00925899|473761433|FG001|Part 1|Withdrawal by Subject|9|||
131582622|NCT01875848|473761434|FG000|Overall Study|Withdrawal by Subject|2|||
131582623|NCT01875848|473761435|FG001|Overall Study|Withdrawal by Subject|0|||
131582624|NCT02189252|473761436|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
131582625|NCT02189252|473761437|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
131582626|NCT02189252|473761438|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
131582627|NCT02189252|473761439|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
131582628|NCT02189252|473761436|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
131582629|NCT02189252|473761437|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
131582630|NCT02189252|473761438|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
131582631|NCT02189252|473761439|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
131582632|NCT00840177|473761440|FG000|Overall Study|Adverse Event|5|||
131582633|NCT00840177|473761441|FG001|Overall Study|Adverse Event|1|||
131582634|NCT00840177|473761442|FG002|Overall Study|Adverse Event|1|||
131582635|NCT00840177|473761440|FG000|Overall Study|Refusal unrelated to adverse events|1|||
131582636|NCT00840177|473761441|FG001|Overall Study|Refusal unrelated to adverse events|0|||
131582637|NCT00840177|473761442|FG002|Overall Study|Refusal unrelated to adverse events|1|||
131582638|NCT00840177|473761440|FG000|Overall Study|Progression/relapse|2|||
131582639|NCT00840177|473761441|FG001|Overall Study|Progression/relapse|0|||
131582640|NCT00840177|473761442|FG002|Overall Study|Progression/relapse|0|||
131582641|NCT00840177|473761440|FG000|Overall Study|Death|4|||
131702740|NCT01220414|474194684|FG001|Overall Study|Withdrawal by Subject|0|||
131702741|NCT01220414|474194685|FG002|Overall Study|Withdrawal by Subject|0|||
131702742|NCT01220414|474194686|FG003|Overall Study|Withdrawal by Subject|1|||
131702743|NCT03068325|474194687|FG000|Overall Study|Lost to Follow-up|5|||
131702744|NCT03569202|474194692|FG000|Part 3|Physician Decision|1|||
131702745|NCT03569202|474194693|FG001|Part 3|Physician Decision|0|||
131702746|NCT03569202|474194692|FG000|Part 3|Other|1|||
131702747|NCT03569202|474194693|FG001|Part 3|Other|1|||
131702748|NCT02415712|474194694|FG000|Overall Study|Protocol Violation|16|||
131702749|NCT04557384|474194695|FG000|Overall Study|Study Terminated by Sponsor|1|||
131702750|NCT04557384|474194695|FG000|Overall Study|Death|1|||
131582642|NCT00840177|473761441|FG001|Overall Study|Death|5|||
131702751|NCT02397473|474194697|FG000|Treatment Phase|Adverse Event|1|||
131702752|NCT02397473|474194698|FG001|Treatment Phase|Adverse Event|2|||
131582643|NCT00840177|473761442|FG002|Overall Study|Death|5|||
131582644|NCT00840177|473761440|FG000|Overall Study|not protocol specified|6|||
131582645|NCT00840177|473761441|FG001|Overall Study|not protocol specified|3|||
131582646|NCT00840177|473761442|FG002|Overall Study|not protocol specified|0|||
131582647|NCT00840177|473761440|FG000|Overall Study|Ineligible|0|||
131582648|NCT00840177|473761441|FG001|Overall Study|Ineligible|0|||
131582649|NCT00840177|473761442|FG002|Overall Study|Ineligible|3|||
131582650|NCT00840177|473761440|FG000|Overall Study|Did not start treatment|0|||
131702753|NCT02397473|474194697|FG000|Treatment Phase|Lack of Efficacy|8|||
131788205|NCT04147611|474507603|FG001|Overall Study|Physician Decision|1|||
131788206|NCT00530439|474507604|FG000|Overall Study|GDM|9|||
131788207|NCT00530439|474507605|FG001|Overall Study|GDM|3|||
131788208|NCT00530439|474507604|FG000|Overall Study|Withdraw|18|||
131788209|NCT00530439|474507605|FG001|Overall Study|Withdraw|14|||
131788210|NCT00530439|474507604|FG000|Overall Study|Missed abortion|1|||
131788211|NCT00530439|474507605|FG001|Overall Study|Missed abortion|4|||
131788212|NCT00530439|474507604|FG000|Overall Study|Misclassification|2|||
131788213|NCT00530439|474507605|FG001|Overall Study|Misclassification|0|||
131788214|NCT00530439|474507604|FG000|Overall Study|Twin pregnancy|0|||
131788215|NCT00530439|474507605|FG001|Overall Study|Twin pregnancy|2|||
131788216|NCT00530439|474507604|FG000|Overall Study|Severe malformation/abortion|0|||
131788217|NCT00530439|474507605|FG001|Overall Study|Severe malformation/abortion|3|||
131788218|NCT00378482|474507606|FG000|Overall Study|Lost to Follow-up|1|||
131788219|NCT00378482|474507606|FG000|Overall Study|Lack of Efficacy|8|||
131788220|NCT00378482|474507606|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
131788221|NCT00378482|474507606|FG000|Overall Study|Withdrawal by Subject|4|||
131788222|NCT00378482|474507606|FG000|Overall Study|Adverse Event|9|||
131788223|NCT01963676|474508978|FG000|Overall Study|Withdrawal by Subject|1|||
131788224|NCT01963676|474508979|FG001|Overall Study|Withdrawal by Subject|0|||
131788225|NCT01246973|474508980|FG000|Overall Study|Other|38|||
131788226|NCT01246973|474508981|FG001|Overall Study|Other|25|||
131788227|NCT01246973|474508980|FG000|Overall Study|Adverse Event|16|||
131788228|NCT01246973|474508981|FG001|Overall Study|Adverse Event|9|||
131788229|NCT01246973|474508980|FG000|Overall Study|Withdrawal by Subject|7|||
131788230|NCT01246973|474508981|FG001|Overall Study|Withdrawal by Subject|13|||
131788231|NCT00766506|474508982|FG000|Overall Study|Use rescue medication after 3 hours|3|||
131788232|NCT00766506|474508983|FG001|Overall Study|Use rescue medication after 3 hours|0|||
131788233|NCT00766506|474508982|FG000|Overall Study|Other|2|||
131788234|NCT00766506|474508983|FG001|Overall Study|Other|2|||
131788235|NCT02496221|474508984|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
131788236|NCT02496221|474508985|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
131788237|NCT02496221|474508984|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
131788238|NCT02496221|474508985|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
131788239|NCT02496221|474508984|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
131788240|NCT02496221|474508985|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
131788241|NCT03262233|474508986|FG000|Overall Study|Withdrawal by Subject|12|||
131788242|NCT03262233|474508987|FG001|Overall Study|Withdrawal by Subject|8|||
131788243|NCT03262233|474508988|FG002|Overall Study|Withdrawal by Subject|21|||
131788244|NCT03262233|474508989|FG003|Overall Study|Withdrawal by Subject|13|||
131788245|NCT03262233|474508986|FG000|Overall Study|Declined due to shock|1|||
131788246|NCT03262233|474508987|FG001|Overall Study|Declined due to shock|2|||
131788247|NCT03262233|474508988|FG002|Overall Study|Declined due to shock|2|||
131788248|NCT03262233|474508989|FG003|Overall Study|Declined due to shock|3|||
131788249|NCT03262233|474508986|FG000|Overall Study|Protocol Violation|5|||
131702754|NCT02397473|474194698|FG001|Treatment Phase|Lack of Efficacy|1|||
131702755|NCT02397473|474194697|FG000|Treatment Phase|Lost to Follow-up|1|||
131702756|NCT02397473|474194698|FG001|Treatment Phase|Lost to Follow-up|0|||
131702757|NCT02397473|474194697|FG000|Treatment Phase|Withdrawal by Subject|2|||
131702758|NCT02397473|474194698|FG001|Treatment Phase|Withdrawal by Subject|1|||
131702759|NCT02397473|474194697|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
131702760|NCT02397473|474194698|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
131702761|NCT02397473|474194697|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
131702762|NCT02397473|474194698|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
131702763|NCT02397473|474194697|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
131702764|NCT02397473|474194698|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
131702765|NCT02397473|474194697|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
131702766|NCT02397473|474194698|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
131702767|NCT02397473|474194697|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
131702768|NCT02397473|474194698|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
131702769|NCT04093531|474194701|FG000|Overall Study|failed screening|4|||
131702770|NCT00272987|474194708|FG000|Overall Study|Adverse Event|1|||
131702771|NCT00272987|474194709|FG001|Overall Study|Adverse Event|0|||
131702772|NCT00272987|474194710|FG002|Overall Study|Adverse Event|0|||
131702773|NCT00272987|474194708|FG000|Overall Study|Lost to Follow-up|3|||
131702774|NCT00272987|474194709|FG001|Overall Study|Lost to Follow-up|1|||
131702775|NCT00272987|474194710|FG002|Overall Study|Lost to Follow-up|1|||
131702776|NCT00272987|474194708|FG000|Overall Study|Withdrawal by Subject|1|||
131702777|NCT00272987|474194709|FG001|Overall Study|Withdrawal by Subject|0|||
131702778|NCT00272987|474194710|FG002|Overall Study|Withdrawal by Subject|3|||
131702779|NCT00272987|474194708|FG000|Overall Study|Sponsor Terminated study|0|||
131788250|NCT03262233|474508987|FG001|Overall Study|Protocol Violation|10|||
131788251|NCT03262233|474508988|FG002|Overall Study|Protocol Violation|2|||
131788252|NCT03262233|474508989|FG003|Overall Study|Protocol Violation|13|||
131788253|NCT03262233|474508986|FG000|Overall Study|data collection artifact|0|||
131582651|NCT00840177|473761441|FG001|Overall Study|Did not start treatment|0|||
131582652|NCT00840177|473761442|FG002|Overall Study|Did not start treatment|1|||
131582653|NCT01391832|473761443|FG000|Overall Study|Withdrawal by Subject|21|||
131582654|NCT01391832|473761444|FG001|Overall Study|Withdrawal by Subject|22|||
131582655|NCT01391832|473761443|FG000|Overall Study|Lost to Follow-up|0|||
131582656|NCT01391832|473761444|FG001|Overall Study|Lost to Follow-up|1|||
131582657|NCT03345901|473761450|FG000|Overall Study|The study was terminated|18|||
131582658|NCT00566735|473761451|FG000|Overall Study|Withdrawal by Subject|0|||
131582659|NCT00566735|473761452|FG001|Overall Study|Withdrawal by Subject|1|||
131582660|NCT00566735|473761451|FG000|Overall Study|Refused neuropsychological testing|2|||
131582661|NCT00566735|473761452|FG001|Overall Study|Refused neuropsychological testing|5|||
131582662|NCT00566735|473761451|FG000|Overall Study|Switched into a manic episode|0|||
131582663|NCT00566735|473761452|FG001|Overall Study|Switched into a manic episode|1|||
131582664|NCT00722046|473761453|FG000|Overall Study|Adverse Event|0|||
131582665|NCT00722046|473761454|FG001|Overall Study|Adverse Event|1|||
131582666|NCT00722046|473761455|FG002|Overall Study|Adverse Event|2|||
131582667|NCT00722046|473761456|FG003|Overall Study|Adverse Event|1|||
131582668|NCT00722046|473761457|FG004|Overall Study|Adverse Event|2|||
131582669|NCT00722046|473761458|FG005|Overall Study|Adverse Event|1|||
131582670|NCT00722046|473761459|FG006|Overall Study|Adverse Event|0|||
131582671|NCT00722046|473761453|FG000|Overall Study|Death|0|||
131582672|NCT00722046|473761454|FG001|Overall Study|Death|1|||
131582673|NCT00722046|473761455|FG002|Overall Study|Death|0|||
131582674|NCT00722046|473761456|FG003|Overall Study|Death|0|||
131582675|NCT00722046|473761457|FG004|Overall Study|Death|0|||
131582676|NCT00722046|473761458|FG005|Overall Study|Death|0|||
131582677|NCT00722046|473761459|FG006|Overall Study|Death|2|||
131582678|NCT00722046|473761453|FG000|Overall Study|Protocol Violation|1|||
131582679|NCT00722046|473761454|FG001|Overall Study|Protocol Violation|0|||
131582680|NCT00722046|473761455|FG002|Overall Study|Protocol Violation|0|||
131582681|NCT00722046|473761456|FG003|Overall Study|Protocol Violation|0|||
131582682|NCT00722046|473761457|FG004|Overall Study|Protocol Violation|0|||
131582683|NCT00722046|473761458|FG005|Overall Study|Protocol Violation|1|||
131582684|NCT00722046|473761459|FG006|Overall Study|Protocol Violation|0|||
131582685|NCT00722046|473761453|FG000|Overall Study|Withdrawal by Subject|3|||
131582686|NCT00722046|473761454|FG001|Overall Study|Withdrawal by Subject|3|||
131582687|NCT00722046|473761455|FG002|Overall Study|Withdrawal by Subject|4|||
131582688|NCT00722046|473761456|FG003|Overall Study|Withdrawal by Subject|4|||
131582689|NCT00722046|473761457|FG004|Overall Study|Withdrawal by Subject|4|||
131582690|NCT00722046|473761458|FG005|Overall Study|Withdrawal by Subject|7|||
131582691|NCT00722046|473761459|FG006|Overall Study|Withdrawal by Subject|3|||
131582692|NCT00722046|473761453|FG000|Overall Study|Randomized, but not treated|1|||
131582693|NCT00722046|473761454|FG001|Overall Study|Randomized, but not treated|1|||
131582694|NCT00722046|473761455|FG002|Overall Study|Randomized, but not treated|0|||
131582695|NCT00722046|473761456|FG003|Overall Study|Randomized, but not treated|2|||
131582696|NCT00722046|473761457|FG004|Overall Study|Randomized, but not treated|0|||
131582697|NCT00722046|473761458|FG005|Overall Study|Randomized, but not treated|0|||
131582698|NCT00722046|473761459|FG006|Overall Study|Randomized, but not treated|0|||
131582699|NCT00722046|473761453|FG000|Overall Study|Other|0|||
131582700|NCT00722046|473761454|FG001|Overall Study|Other|0|||
131582701|NCT00722046|473761455|FG002|Overall Study|Other|1|||
131582702|NCT00722046|473761456|FG003|Overall Study|Other|1|||
131582703|NCT00722046|473761457|FG004|Overall Study|Other|3|||
131582704|NCT00722046|473761458|FG005|Overall Study|Other|2|||
131582705|NCT00722046|473761459|FG006|Overall Study|Other|1|||
131582706|NCT00925587|473761461|FG000|Overall Study|Protocol Specified Criteria|6|||
131582707|NCT00925587|473761462|FG001|Overall Study|Protocol Specified Criteria|6|||
131582708|NCT00925587|473761461|FG000|Overall Study|Physician Decision|4|||
131702780|NCT00272987|474194709|FG001|Overall Study|Sponsor Terminated study|1|||
131702781|NCT00272987|474194710|FG002|Overall Study|Sponsor Terminated study|1|||
131702782|NCT00272987|474194708|FG000|Overall Study|Disease progression|1|||
131702783|NCT00272987|474194709|FG001|Overall Study|Disease progression|1|||
131702784|NCT00272987|474194710|FG002|Overall Study|Disease progression|2|||
131702785|NCT00272987|474194708|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
131582709|NCT00925587|473761462|FG001|Overall Study|Physician Decision|1|||
131582710|NCT00925587|473761461|FG000|Overall Study|Protocol Violation|6|||
131582711|NCT00925587|473761462|FG001|Overall Study|Protocol Violation|4|||
131582712|NCT00925587|473761461|FG000|Overall Study|Withdrawal by Subject|9|||
131582713|NCT00925587|473761462|FG001|Overall Study|Withdrawal by Subject|6|||
131582714|NCT00925587|473761461|FG000|Overall Study|Death|5|||
131582715|NCT00925587|473761462|FG001|Overall Study|Death|5|||
131582716|NCT00925587|473761461|FG000|Overall Study|Adverse Event|6|||
131582717|NCT00925587|473761462|FG001|Overall Study|Adverse Event|2|||
131582718|NCT00925587|473761461|FG000|Overall Study|Lost to Follow-up|0|||
131582719|NCT00925587|473761462|FG001|Overall Study|Lost to Follow-up|1|||
131582720|NCT00799396|473761466|FG000|Clopidogrel Treatment|Adverse Event|6|||
131582721|NCT00799396|473761466|FG000|Clopidogrel Treatment|Physician Decision|5|||
131582722|NCT00799396|473761466|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
131582723|NCT00799396|473761466|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
131582724|NCT00799396|473761466|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
131582725|NCT01318382|473761467|FG000|Overall Study|Physician Decision|2|||
131582726|NCT01318382|473761467|FG000|Overall Study|Device Malfunction|10|||
131582727|NCT01318382|473761467|FG000|Overall Study|Protocol Violation|1|||
131582728|NCT01867216|473761468|FG000|Overall Study|Withdrawal by Subject|2|||
131582729|NCT01867216|473761469|FG001|Overall Study|Withdrawal by Subject|0|||
131582730|NCT01867216|473761470|FG002|Overall Study|Withdrawal by Subject|0|||
131582731|NCT01867216|473761471|FG003|Overall Study|Withdrawal by Subject|0|||
131582732|NCT01867216|473761472|FG004|Overall Study|Withdrawal by Subject|1|||
131582733|NCT01867216|473761473|FG005|Overall Study|Withdrawal by Subject|0|||
131582734|NCT01867216|473761474|FG006|Overall Study|Withdrawal by Subject|1|||
131582735|NCT01867216|473761468|FG000|Overall Study|Physician Decision|1|||
131582736|NCT01867216|473761469|FG001|Overall Study|Physician Decision|0|||
131582737|NCT01867216|473761470|FG002|Overall Study|Physician Decision|0|||
131582738|NCT01867216|473761471|FG003|Overall Study|Physician Decision|0|||
131582739|NCT01867216|473761472|FG004|Overall Study|Physician Decision|0|||
131582740|NCT01867216|473761473|FG005|Overall Study|Physician Decision|0|||
131582741|NCT01867216|473761474|FG006|Overall Study|Physician Decision|0|||
131582742|NCT01867216|473761468|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
131582743|NCT01867216|473761469|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131582744|NCT01867216|473761470|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131582745|NCT01867216|473761471|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131582746|NCT01867216|473761472|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131582747|NCT01867216|473761473|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131582748|NCT01867216|473761474|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131582749|NCT00714714|473761479|FG000|Overall Study|Adverse Event|1|||
131582750|NCT01308567|473761486|FG000|Overall Study|Lost to Follow-up|2|||
131438414|NCT00614575|473231230|FG000|Overall Study|Irregularly enrolled patients|23|||
131438415|NCT00614575|473231230|FG000|Overall Study|No treatment|1|||
131438416|NCT03452540|473231232|FG000|Overall Study|Adverse Event|1|||
131438417|NCT03452540|473231232|FG000|Overall Study|Withdrawal by Subject|1|||
131438418|NCT03452540|473231232|FG000|Overall Study|Other SAE and AE|2|||
131582751|NCT01308567|473761487|FG001|Overall Study|Lost to Follow-up|4|||
131582752|NCT01308567|473761488|FG002|Overall Study|Lost to Follow-up|4|||
131582753|NCT00542789|473761489|FG000|Overall Study|Adverse Event|18|||
131582754|NCT00542789|473761490|FG001|Overall Study|Adverse Event|17|||
131582755|NCT00542789|473761489|FG000|Overall Study|Withdrawal by Subject|7|||
131582756|NCT00542789|473761490|FG001|Overall Study|Withdrawal by Subject|3|||
131582757|NCT00542789|473761489|FG000|Overall Study|Protocol Violation|8|||
131582758|NCT00542789|473761490|FG001|Overall Study|Protocol Violation|1|||
131582759|NCT00542789|473761489|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
131582760|NCT00542789|473761490|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
131582761|NCT01040689|473761494|FG000|Overall Study|Adverse Event|0|||
131582762|NCT01040689|473761495|FG001|Overall Study|Adverse Event|0|||
131702786|NCT00272987|474194709|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
131702787|NCT00272987|474194710|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
131702788|NCT00272987|474194708|FG000|Overall Study|Death|1|||
131702789|NCT00272987|474194709|FG001|Overall Study|Death|0|||
131702790|NCT00272987|474194710|FG002|Overall Study|Death|0|||
131702791|NCT03222349|474194711|FG000|Overall Study|Treatment B not done|5|||
131702792|NCT03222349|474194712|FG001|Overall Study|Treatment B not done|0|||
131702793|NCT03222349|474194711|FG000|Overall Study|Lost to Follow-up|1|||
131702794|NCT03222349|474194712|FG001|Overall Study|Lost to Follow-up|2|||
131702795|NCT03222349|474194711|FG000|Overall Study|Withdrawal by Subject|1|||
131702796|NCT03222349|474194712|FG001|Overall Study|Withdrawal by Subject|0|||
131702797|NCT03222349|474194711|FG000|Overall Study|Treatment A not done|0|||
131702798|NCT03222349|474194712|FG001|Overall Study|Treatment A not done|5|||
131702799|NCT03222349|474194711|FG000|Overall Study|Study terminated by sponsor|1|||
131702800|NCT03222349|474194712|FG001|Overall Study|Study terminated by sponsor|0|||
131702801|NCT01808612|474194716|FG000|Treatment Period|Adverse Event|8|||
131702802|NCT01808612|474194717|FG001|Treatment Period|Adverse Event|4|||
131702803|NCT01808612|474194718|FG002|Treatment Period|Adverse Event|3|||
131702804|NCT01808612|474194716|FG000|Treatment Period|Lost to Follow-up|2|||
131702805|NCT01808612|474194717|FG001|Treatment Period|Lost to Follow-up|2|||
131702806|NCT01808612|474194718|FG002|Treatment Period|Lost to Follow-up|1|||
131702807|NCT01808612|474194716|FG000|Treatment Period|Protocol Violation|1|||
131702808|NCT01808612|474194717|FG001|Treatment Period|Protocol Violation|0|||
131702809|NCT01808612|474194718|FG002|Treatment Period|Protocol Violation|0|||
131702810|NCT01808612|474194716|FG000|Treatment Period|Withdrawal by Subject|1|||
131702811|NCT01808612|474194717|FG001|Treatment Period|Withdrawal by Subject|0|||
131702812|NCT01808612|474194718|FG002|Treatment Period|Withdrawal by Subject|4|||
131702813|NCT01808612|474194716|FG000|Treatment Period|Physician Decision|1|||
131702814|NCT01808612|474194717|FG001|Treatment Period|Physician Decision|0|||
131438419|NCT01600885|473231233|FG000|First Period|Adverse Event|1|||
131702815|NCT01808612|474194718|FG002|Treatment Period|Physician Decision|4|||
131702816|NCT01808612|474194716|FG000|Treatment Period|Sponsor Decision|1|||
131582763|NCT01040689|473761496|FG002|Overall Study|Adverse Event|2|||
131582764|NCT01040689|473761497|FG003|Overall Study|Adverse Event|4|||
131582765|NCT01040689|473761494|FG000|Overall Study|Lack of Efficacy|0|||
131582766|NCT01040689|473761495|FG001|Overall Study|Lack of Efficacy|0|||
131582767|NCT01040689|473761496|FG002|Overall Study|Lack of Efficacy|1|||
131582768|NCT01040689|473761497|FG003|Overall Study|Lack of Efficacy|0|||
131582769|NCT01040689|473761494|FG000|Overall Study|Lost to Follow-up|1|||
131582770|NCT01040689|473761495|FG001|Overall Study|Lost to Follow-up|0|||
131582771|NCT01040689|473761496|FG002|Overall Study|Lost to Follow-up|0|||
131582772|NCT01040689|473761497|FG003|Overall Study|Lost to Follow-up|0|||
131582773|NCT01040689|473761494|FG000|Overall Study|Withdrawal by Subject|2|||
131582774|NCT01040689|473761495|FG001|Overall Study|Withdrawal by Subject|1|||
131582775|NCT01040689|473761496|FG002|Overall Study|Withdrawal by Subject|1|||
131582776|NCT01040689|473761497|FG003|Overall Study|Withdrawal by Subject|0|||
131582777|NCT01040689|473761494|FG000|Overall Study|Other reasons not listed above|0|||
131582778|NCT01040689|473761495|FG001|Overall Study|Other reasons not listed above|1|||
131582779|NCT01040689|473761496|FG002|Overall Study|Other reasons not listed above|0|||
131582780|NCT01040689|473761497|FG003|Overall Study|Other reasons not listed above|0|||
131582781|NCT01185561|473761498|FG000|Overall Study|Lost to Follow-up|0|||
131582782|NCT01185561|473761499|FG001|Overall Study|Lost to Follow-up|4|||
131582783|NCT01185561|473761498|FG000|Overall Study|Withdrawal by Subject|2|||
131582784|NCT01185561|473761499|FG001|Overall Study|Withdrawal by Subject|8|||
131582785|NCT02616900|473761500|FG000|Overall Study|Lack of Efficacy|7|||
131582786|NCT02616900|473761500|FG000|Overall Study|Lost to Follow-up|2|||
131582787|NCT02616900|473761500|FG000|Overall Study|Protocol Violation|5|||
131582788|NCT02616900|473761500|FG000|Overall Study|Withdrawal by Subject|3|||
131582789|NCT02616900|473761500|FG000|Overall Study|Incomplete data|6|||
131582790|NCT02499159|473761501|FG000|Randomization|Protocol Violation|1|||
131582791|NCT02499159|473761502|FG001|Randomization|Protocol Violation|1|||
131582792|NCT02499159|473761501|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
131582793|NCT02499159|473761502|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
131582794|NCT02499159|473761501|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
131582795|NCT02499159|473761502|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
131582796|NCT02499159|473761501|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
131582797|NCT02499159|473761502|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
131582798|NCT02499159|473761501|FG000|30-Day Follow-Up Phone Call|Other|1|||
131582799|NCT02499159|473761502|FG001|30-Day Follow-Up Phone Call|Other|0|||
131582800|NCT01190007|473761503|FG000|Overall Study|Withdrawal by Subject|4|||
131582801|NCT01190007|473761503|FG000|Overall Study|Adverse Event|8|||
131582802|NCT01190007|473761503|FG000|Overall Study|Difficulty of visit for complications|1|||
131582803|NCT01190007|473761503|FG000|Overall Study|Participant was arrested|1|||
131582804|NCT02594735|473761508|FG000|Overall Study|Adverse Event|1|||
131582805|NCT03844269|473761512|FG000|Overall Study|Withdrawal pre-intervention|1|||
131582806|NCT03844269|473761512|FG000|Overall Study|Did not complete the intervention|2|||
131582807|NCT00101010|473761513|FG000|Overall Study|Physician Decision|1|||
131582808|NCT01068743|473761514|FG000|Period 3|Adverse Event|0|||
131582809|NCT01068743|473761515|FG001|Period 3|Adverse Event|1|||
131582810|NCT01068743|473761516|FG002|Period 3|Adverse Event|0|||
131582811|NCT01068743|473761517|FG003|Period 3|Adverse Event|0|||
131582812|NCT00364013|473761518|FG000|Overall Study|Ineligibility determined|4|||
131582813|NCT00364013|473761519|FG001|Overall Study|Ineligibility determined|2|||
131582814|NCT00364013|473761518|FG000|Overall Study|Adverse Event|4|||
131582815|NCT00364013|473761519|FG001|Overall Study|Adverse Event|3|||
131582816|NCT00364013|473761518|FG000|Overall Study|Withdrawal by Subject|13|||
131582817|NCT00364013|473761519|FG001|Overall Study|Withdrawal by Subject|18|||
131582818|NCT00364013|473761518|FG000|Overall Study|Physician Decision|3|||
131582819|NCT00364013|473761519|FG001|Overall Study|Physician Decision|3|||
131788254|NCT03262233|474508987|FG001|Overall Study|data collection artifact|1|||
131582820|NCT00364013|473761518|FG000|Overall Study|Lost to Follow-up|10|||
131582821|NCT00364013|473761519|FG001|Overall Study|Lost to Follow-up|3|||
131582822|NCT00364013|473761518|FG000|Overall Study|Protocol-specified criteria|6|||
131582823|NCT00364013|473761519|FG001|Overall Study|Protocol-specified criteria|6|||
131582824|NCT00364013|473761518|FG000|Overall Study|Other|41|||
131582825|NCT00364013|473761519|FG001|Overall Study|Other|47|||
131582826|NCT00364013|473761518|FG000|Overall Study|Ongoing|20|||
131582827|NCT00364013|473761519|FG001|Overall Study|Ongoing|13|||
131582828|NCT01369498|473761520|FG000|Overall Study|Lack of Efficacy|9|||
131582829|NCT01369498|473761521|FG001|Overall Study|Lack of Efficacy|9|||
131582830|NCT01369498|473761522|FG002|Overall Study|Lack of Efficacy|1|||
131788255|NCT03262233|474508988|FG002|Overall Study|data collection artifact|0|||
131582831|NCT01369498|473761523|FG003|Overall Study|Lack of Efficacy|3|||
131582832|NCT01369498|473761520|FG000|Overall Study|Adverse Event|1|||
131582833|NCT01369498|473761521|FG001|Overall Study|Adverse Event|2|||
131582834|NCT01369498|473761522|FG002|Overall Study|Adverse Event|0|||
131582835|NCT01369498|473761523|FG003|Overall Study|Adverse Event|1|||
131582836|NCT01369498|473761520|FG000|Overall Study|Withdrawal of Consent|0|||
131582837|NCT01369498|473761521|FG001|Overall Study|Withdrawal of Consent|1|||
131582838|NCT01369498|473761522|FG002|Overall Study|Withdrawal of Consent|1|||
131582839|NCT01369498|473761523|FG003|Overall Study|Withdrawal of Consent|1|||
131582840|NCT01369498|473761520|FG000|Overall Study|Death|0|||
131582841|NCT01369498|473761521|FG001|Overall Study|Death|0|||
131582842|NCT01369498|473761522|FG002|Overall Study|Death|1|||
131582843|NCT01369498|473761523|FG003|Overall Study|Death|0|||
131582844|NCT01369498|473761520|FG000|Overall Study|Investigator's Discretion|1|||
131582845|NCT01369498|473761521|FG001|Overall Study|Investigator's Discretion|0|||
131582846|NCT01369498|473761522|FG002|Overall Study|Investigator's Discretion|1|||
131582847|NCT01369498|473761523|FG003|Overall Study|Investigator's Discretion|3|||
131582848|NCT01369498|473761520|FG000|Overall Study|Unknown Reason|1|||
131582849|NCT01369498|473761521|FG001|Overall Study|Unknown Reason|0|||
131582850|NCT01369498|473761522|FG002|Overall Study|Unknown Reason|11|||
131582851|NCT01369498|473761523|FG003|Overall Study|Unknown Reason|6|||
131582852|NCT01369498|473761520|FG000|Overall Study|Disease Progression|0|||
131582853|NCT01369498|473761521|FG001|Overall Study|Disease Progression|0|||
131582854|NCT01369498|473761522|FG002|Overall Study|Disease Progression|0|||
131582855|NCT01369498|473761523|FG003|Overall Study|Disease Progression|1|||
131582856|NCT01510717|473761527|FG000|Overall Study|Adverse Event|1|||
131582857|NCT01510717|473761528|FG001|Overall Study|Adverse Event|2|||
131582858|NCT01510717|473761527|FG000|Overall Study|Death|1|||
131582859|NCT01510717|473761528|FG001|Overall Study|Death|0|||
131702817|NCT01808612|474194717|FG001|Treatment Period|Sponsor Decision|0|||
131702818|NCT01808612|474194718|FG002|Treatment Period|Sponsor Decision|0|||
131702819|NCT01808612|474194716|FG000|Treatment Period|Lack of Efficacy|1|||
131702820|NCT01808612|474194717|FG001|Treatment Period|Lack of Efficacy|1|||
131702821|NCT01808612|474194718|FG002|Treatment Period|Lack of Efficacy|2|||
131702822|NCT01808612|474194716|FG000|Discontinuation Period|Adverse Event|1|||
131702823|NCT01808612|474194717|FG001|Discontinuation Period|Adverse Event|0|||
131702824|NCT01808612|474194718|FG002|Discontinuation Period|Adverse Event|0|||
131702825|NCT01808612|474194716|FG000|Discontinuation Period|Physician Decision|1|||
131702826|NCT01808612|474194717|FG001|Discontinuation Period|Physician Decision|0|||
131702827|NCT01808612|474194718|FG002|Discontinuation Period|Physician Decision|0|||
131702828|NCT01808612|474194716|FG000|Discontinuation Period|Lost to Follow-up|0|||
131702829|NCT01808612|474194717|FG001|Discontinuation Period|Lost to Follow-up|1|||
131702830|NCT01808612|474194718|FG002|Discontinuation Period|Lost to Follow-up|0|||
131702831|NCT02319044|474194730|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
131702832|NCT02319044|474194731|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
131702833|NCT02319044|474194732|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
131702834|NCT02319044|474194730|FG000|Overall Study|Withdrawal by Subject|3|||
131582860|NCT01510717|473761527|FG000|Overall Study|Lost to Follow-up|0|||
131582861|NCT01510717|473761528|FG001|Overall Study|Lost to Follow-up|1|||
131582862|NCT01510717|473761527|FG000|Overall Study|Withdrawal by Subject|0|||
131582863|NCT01510717|473761528|FG001|Overall Study|Withdrawal by Subject|2|||
131582864|NCT00529789|473761532|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
131582865|NCT00529789|473761532|FG000|Study Period II/III|Adverse Event|3|||
131582866|NCT00529789|473761532|FG000|Study Period II/III|Lack of Efficacy|2|||
131582867|NCT00529789|473761532|FG000|Study Period II/III|Withdrawal by Subject|1|||
131582868|NCT00529789|473761532|FG000|Study Period II/III|Protocol Violation|3|||
131582869|NCT00529789|473761532|FG000|Study Period II/III|Physician Decision|3|||
131582870|NCT00529789|473761532|FG000|Study Period II/III|Lost to Follow-up|3|||
131582871|NCT00529789|473761532|FG000|Study Period IV|Parent/Caregiver Decision|1|||
131582872|NCT00529789|473761532|FG000|Study Period IV|Adverse Event|1|||
131582873|NCT00529789|473761532|FG000|Study Period IV|Lack of Efficacy|1|||
131582874|NCT00529789|473761532|FG000|Study Period IV|Lost to Follow-up|3|||
131582875|NCT01430611|473761533|FG000|Overall Study|Adverse Event|0|||
131582876|NCT01430611|473761534|FG001|Overall Study|Adverse Event|1|||
131582877|NCT01430611|473761533|FG000|Overall Study|Protocol Violation|1|||
131582878|NCT01430611|473761534|FG001|Overall Study|Protocol Violation|0|||
131582879|NCT01430611|473761533|FG000|Overall Study|Lost to Follow-up|1|||
131582880|NCT01430611|473761534|FG001|Overall Study|Lost to Follow-up|0|||
131582881|NCT01430611|473761533|FG000|Overall Study|Withdrawal by Subject|15|||
131582882|NCT01430611|473761534|FG001|Overall Study|Withdrawal by Subject|14|||
131582883|NCT02204982|473761535|FG000|Overall Study|Patient ineligible-medical monitor|1|||
131582884|NCT02204982|473761536|FG001|Overall Study|Patient ineligible-medical monitor|0|||
131582885|NCT02204982|473761535|FG000|Overall Study|Withdrawal by Subject|1|||
131582886|NCT02204982|473761536|FG001|Overall Study|Withdrawal by Subject|0|||
131582887|NCT02204982|473761535|FG000|Overall Study|Adverse Event|1|||
131582888|NCT02204982|473761536|FG001|Overall Study|Adverse Event|0|||
131702835|NCT02319044|474194731|FG001|Overall Study|Withdrawal by Subject|3|||
131702836|NCT02319044|474194732|FG002|Overall Study|Withdrawal by Subject|6|||
131702837|NCT02319044|474194730|FG000|Overall Study|Condition under investigation worsened|100|||
131702838|NCT02319044|474194731|FG001|Overall Study|Condition under investigation worsened|50|||
131702839|NCT02319044|474194732|FG002|Overall Study|Condition under investigation worsened|46|||
131702840|NCT02319044|474194730|FG000|Overall Study|Adverse Event|17|||
131702841|NCT02319044|474194731|FG001|Overall Study|Adverse Event|2|||
131702842|NCT02319044|474194732|FG002|Overall Study|Adverse Event|8|||
131702843|NCT02319044|474194730|FG000|Overall Study|Study specific discontinuation criteria|2|||
131702844|NCT02319044|474194731|FG001|Overall Study|Study specific discontinuation criteria|2|||
131702845|NCT02319044|474194732|FG002|Overall Study|Study specific discontinuation criteria|1|||
131702846|NCT02319044|474194730|FG000|Overall Study|Not treated|0|||
131702847|NCT02319044|474194731|FG001|Overall Study|Not treated|2|||
131702848|NCT02319044|474194732|FG002|Overall Study|Not treated|2|||
131702849|NCT03434379|474194733|FG000|Global Period|Lost to Follow-up|3|||
131702850|NCT03434379|474194734|FG001|Global Period|Lost to Follow-up|6|||
131702851|NCT03434379|474194735|FG002|Global Period|Lost to Follow-up|0|||
131702852|NCT03434379|474194736|FG003|Global Period|Lost to Follow-up|0|||
131702853|NCT03434379|474194733|FG000|Global Period|Death|115|||
131702854|NCT03434379|474194734|FG001|Global Period|Death|228|||
131702855|NCT03434379|474194735|FG002|Global Period|Death|0|||
131702856|NCT03434379|474194736|FG003|Global Period|Death|0|||
131702857|NCT03434379|474194733|FG000|Global Period|Withdrawal by Subject|20|||
131702858|NCT03434379|474194734|FG001|Global Period|Withdrawal by Subject|21|||
131702859|NCT03434379|474194735|FG002|Global Period|Withdrawal by Subject|0|||
131702860|NCT03434379|474194736|FG003|Global Period|Withdrawal by Subject|0|||
131702861|NCT03434379|474194733|FG000|Global Period|Reason Unspecified|0|||
131702862|NCT03434379|474194734|FG001|Global Period|Reason Unspecified|1|||
131702863|NCT03434379|474194735|FG002|Global Period|Reason Unspecified|0|||
131702864|NCT03434379|474194736|FG003|Global Period|Reason Unspecified|0|||
131702865|NCT03434379|474194733|FG000|Global Period|Study Ended by Sponsor|26|||
131702866|NCT03434379|474194734|FG001|Global Period|Study Ended by Sponsor|80|||
131702867|NCT03434379|474194735|FG002|Global Period|Study Ended by Sponsor|0|||
131702868|NCT03434379|474194736|FG003|Global Period|Study Ended by Sponsor|0|||
131702869|NCT03434379|474194733|FG000|Global Period|Physician Decision|1|||
131702870|NCT03434379|474194734|FG001|Global Period|Physician Decision|0|||
131702871|NCT03434379|474194735|FG002|Global Period|Physician Decision|0|||
131702872|NCT03434379|474194736|FG003|Global Period|Physician Decision|0|||
131702873|NCT03434379|474194733|FG000|China Extension Period|Lost to Follow-up|0|||
131702874|NCT03434379|474194734|FG001|China Extension Period|Lost to Follow-up|0|||
131702875|NCT03434379|474194735|FG002|China Extension Period|Lost to Follow-up|2|||
131702876|NCT03434379|474194736|FG003|China Extension Period|Lost to Follow-up|3|||
131702877|NCT03434379|474194733|FG000|China Extension Period|Death|0|||
131702878|NCT03434379|474194734|FG001|China Extension Period|Death|0|||
131702879|NCT03434379|474194735|FG002|China Extension Period|Death|46|||
131702880|NCT03434379|474194736|FG003|China Extension Period|Death|88|||
131702881|NCT03434379|474194733|FG000|China Extension Period|Withdrawal by Subject|0|||
131702882|NCT03434379|474194734|FG001|China Extension Period|Withdrawal by Subject|0|||
131582889|NCT02204982|473761535|FG000|Overall Study|Adverse Event and Investigator decision|1|||
131702883|NCT03434379|474194735|FG002|China Extension Period|Withdrawal by Subject|8|||
131702884|NCT03434379|474194736|FG003|China Extension Period|Withdrawal by Subject|6|||
131702885|NCT03434379|474194733|FG000|China Extension Period|Study Ended by Sponsor|0|||
131582890|NCT02204982|473761536|FG001|Overall Study|Adverse Event and Investigator decision|0|||
131582891|NCT02204982|473761535|FG000|Overall Study|Physician Decision|0|||
131582892|NCT02204982|473761536|FG001|Overall Study|Physician Decision|2|||
131582893|NCT02204982|473761535|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
131582894|NCT02204982|473761536|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
131582895|NCT02204982|473761535|FG000|Overall Study|Termination of Study bySponsor|0|||
131582896|NCT02204982|473761536|FG001|Overall Study|Termination of Study bySponsor|1|||
131582897|NCT00960141|473761537|FG000|Overall Study|Adverse Event|4|||
131582898|NCT00960141|473761538|FG001|Overall Study|Adverse Event|8|||
131582899|NCT00960141|473761539|FG002|Overall Study|Adverse Event|2|||
131582900|NCT00960141|473761537|FG000|Overall Study|Lack of Efficacy|3|||
131582901|NCT00960141|473761538|FG001|Overall Study|Lack of Efficacy|4|||
131582902|NCT00960141|473761539|FG002|Overall Study|Lack of Efficacy|2|||
131788256|NCT03262233|474508989|FG003|Overall Study|data collection artifact|0|||
131788257|NCT01904383|474508990|FG000|Overall Study|CRF not collected|117|||
131788258|NCT01904383|474508990|FG000|Overall Study|Reason not listed|147|||
131788259|NCT01904383|474508990|FG000|Overall Study|Lost to Follow-up|674|||
131788260|NCT01904383|474508990|FG000|Overall Study|Lack of Efficacy|370|||
131788261|NCT01904383|474508990|FG000|Overall Study|Improvement|141|||
131788262|NCT01904383|474508990|FG000|Overall Study|Adverse Event|271|||
131788263|NCT01904383|474508990|FG000|Overall Study|No patient visit after entry|54|||
131788264|NCT01294592|474508991|FG000|Overall Study|Adverse Event|28|||
131788265|NCT01294592|474508992|FG001|Overall Study|Adverse Event|13|||
131788266|NCT01294592|474508991|FG000|Overall Study|Lack of Efficacy|7|||
131788267|NCT01294592|474508992|FG001|Overall Study|Lack of Efficacy|5|||
131788268|NCT01294592|474508991|FG000|Overall Study|Protocol Violation|1|||
131788269|NCT01294592|474508992|FG001|Overall Study|Protocol Violation|7|||
131788270|NCT01294592|474508991|FG000|Overall Study|Lost to Follow-up|7|||
131788271|NCT01294592|474508992|FG001|Overall Study|Lost to Follow-up|9|||
131788272|NCT01294592|474508991|FG000|Overall Study|Physician Decision|6|||
131788273|NCT01294592|474508992|FG001|Overall Study|Physician Decision|11|||
131788274|NCT01294592|474508991|FG000|Overall Study|Withdrawal by Subject|28|||
131788275|NCT01294592|474508992|FG001|Overall Study|Withdrawal by Subject|28|||
131788276|NCT02762565|474508993|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
131788277|NCT01113710|474508994|FG000|Overall Study|Adverse Event|64|||
131788278|NCT01113710|474508994|FG000|Overall Study|Lack of Efficacy|41|||
131438420|NCT01600885|473231234|FG001|First Period|Adverse Event|1|||
131438421|NCT01600885|473231233|FG000|First Period|moved out of area|1|||
131438422|NCT01600885|473231234|FG001|First Period|moved out of area|0|||
131438423|NCT00667888|473231239|FG000|Overall Study|Death|1|||
131438424|NCT00667888|473231240|FG001|Overall Study|Death|1|||
131438425|NCT00667888|473231239|FG000|Overall Study|Withdrawal by Subject|6|||
131438426|NCT00667888|473231240|FG001|Overall Study|Withdrawal by Subject|3|||
131788279|NCT01113710|474508994|FG000|Overall Study|No Information Available|40|||
131788280|NCT01113710|474508994|FG000|Overall Study|Withdrawal by Subject|28|||
131788281|NCT01113710|474508994|FG000|Overall Study|Lost to Follow-up|20|||
131788282|NCT01113710|474508994|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
131788283|NCT01113710|474508994|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
131788284|NCT01113710|474508994|FG000|Overall Study|Lack of Patient's Compliance|8|||
131788285|NCT01113710|474508994|FG000|Overall Study|Other|7|||
131788286|NCT01113710|474508994|FG000|Overall Study|Adverse Event/Other|5|||
131788287|NCT01113710|474508994|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
131788288|NCT01113710|474508994|FG000|Overall Study|Lack of Efficacy/Other|4|||
131788289|NCT01113710|474508994|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
131788290|NCT01113710|474508994|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
131788291|NCT01113710|474508994|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
131788292|NCT01113710|474508994|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
131788293|NCT01113710|474508994|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
131788294|NCT01113710|474508994|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
131788295|NCT01113710|474508994|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
131788296|NCT01113710|474508994|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
131788297|NCT01113710|474508994|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
131788298|NCT01113710|474508994|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
131788299|NCT01113710|474508994|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
131788300|NCT01113710|474508994|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
131788301|NCT01113710|474508994|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
131788302|NCT00623623|474508995|FG000|Overall Study|Previous enrolment into this study|1|||
131438427|NCT00667888|473231239|FG000|Overall Study|Proceed with other treatment|3|||
131788303|NCT00623623|474508996|FG001|Overall Study|Previous enrolment into this study|1|||
131438428|NCT00667888|473231240|FG001|Overall Study|Proceed with other treatment|3|||
131438429|NCT00667888|473231239|FG000|Overall Study|Ineligible after SIM|0|||
131438430|NCT00667888|473231240|FG001|Overall Study|Ineligible after SIM|2|||
131582903|NCT00960141|473761537|FG000|Overall Study|Lost to Follow-up|1|||
131582904|NCT00960141|473761538|FG001|Overall Study|Lost to Follow-up|0|||
131582905|NCT00960141|473761539|FG002|Overall Study|Lost to Follow-up|0|||
131438431|NCT00883779|473231241|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
131438432|NCT00883779|473231242|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
131438433|NCT00883779|473231241|FG000|Primary Study Treatment Phase|Disease progression|75|||
131438434|NCT00883779|473231242|FG001|Primary Study Treatment Phase|Disease progression|59|||
131438435|NCT00883779|473231241|FG000|Primary Study Treatment Phase|Adverse Event|16|||
131438436|NCT00883779|473231242|FG001|Primary Study Treatment Phase|Adverse Event|16|||
131438437|NCT00883779|473231241|FG000|Primary Study Treatment Phase|Death|2|||
131438438|NCT00883779|473231242|FG001|Primary Study Treatment Phase|Death|3|||
131438439|NCT00883779|473231241|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
131438440|NCT00883779|473231242|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
131438441|NCT00883779|473231241|FG000|Primary Study Treatment Phase|Other|3|||
131438442|NCT00883779|473231242|FG001|Primary Study Treatment Phase|Other|0|||
131438443|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Adverse Event|2|||
131702886|NCT03434379|474194734|FG001|China Extension Period|Study Ended by Sponsor|0|||
131702887|NCT03434379|474194735|FG002|China Extension Period|Study Ended by Sponsor|5|||
131702888|NCT03434379|474194736|FG003|China Extension Period|Study Ended by Sponsor|36|||
131702889|NCT01469000|474194739|FG000|Overall Study|Withdrawal by Subject|16|||
131702890|NCT01469000|474194740|FG001|Overall Study|Withdrawal by Subject|3|||
131702891|NCT01469000|474194739|FG000|Overall Study|Sponsor Decision|4|||
131702892|NCT01469000|474194740|FG001|Overall Study|Sponsor Decision|1|||
131702893|NCT00573794|474194744|FG000|Overall Study|Adverse Event|81|||
131702894|NCT00573794|474194744|FG000|Overall Study|Withdrew Consent|90|||
131702895|NCT00573794|474194744|FG000|Overall Study|Lost to Follow-up|13|||
131702896|NCT00573794|474194744|FG000|Overall Study|Protocol Violation|6|||
131702897|NCT00573794|474194744|FG000|Overall Study|Lack of Efficacy|94|||
131702898|NCT00573794|474194744|FG000|Overall Study|Other|46|||
131702899|NCT03179436|474194750|FG000|Overall Study|Withdrawal by Subject|1|||
131702900|NCT03179436|474194751|FG001|Overall Study|Withdrawal by Subject|0|||
131702901|NCT03179436|474194752|FG002|Overall Study|Withdrawal by Subject|0|||
131702902|NCT03179436|474194753|FG003|Overall Study|Withdrawal by Subject|4|||
131702903|NCT03179436|474194754|FG004|Overall Study|Withdrawal by Subject|2|||
131702904|NCT03179436|474194755|FG005|Overall Study|Withdrawal by Subject|2|||
131702905|NCT03179436|474194756|FG006|Overall Study|Withdrawal by Subject|5|||
131702906|NCT03179436|474194757|FG007|Overall Study|Withdrawal by Subject|0|||
131702907|NCT03179436|474194758|FG008|Overall Study|Withdrawal by Subject|3|||
131702908|NCT03179436|474194759|FG009|Overall Study|Withdrawal by Subject|0|||
131702909|NCT03179436|474194760|FG010|Overall Study|Withdrawal by Subject|0|||
131702910|NCT03179436|474194761|FG011|Overall Study|Withdrawal by Subject|0|||
131702911|NCT03179436|474194750|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131702912|NCT03179436|474194751|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131702913|NCT03179436|474194752|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131702914|NCT03179436|474194753|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131702915|NCT03179436|474194754|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131702916|NCT03179436|474194755|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131702917|NCT03179436|474194756|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
131702918|NCT03179436|474194757|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
131702919|NCT03179436|474194758|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
131702920|NCT03179436|474194759|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
131702921|NCT03179436|474194760|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
131702922|NCT03179436|474194761|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
131702923|NCT03179436|474194750|FG000|Overall Study|Sponsor Decision|0|||
131702924|NCT03179436|474194751|FG001|Overall Study|Sponsor Decision|0|||
131702925|NCT03179436|474194752|FG002|Overall Study|Sponsor Decision|1|||
131702926|NCT03179436|474194753|FG003|Overall Study|Sponsor Decision|3|||
131702927|NCT03179436|474194754|FG004|Overall Study|Sponsor Decision|9|||
131702928|NCT03179436|474194755|FG005|Overall Study|Sponsor Decision|7|||
131702929|NCT03179436|474194756|FG006|Overall Study|Sponsor Decision|2|||
131702930|NCT03179436|474194757|FG007|Overall Study|Sponsor Decision|4|||
131702931|NCT03179436|474194758|FG008|Overall Study|Sponsor Decision|23|||
131702932|NCT03179436|474194759|FG009|Overall Study|Sponsor Decision|6|||
131702933|NCT03179436|474194760|FG010|Overall Study|Sponsor Decision|7|||
131702934|NCT03179436|474194761|FG011|Overall Study|Sponsor Decision|5|||
131702935|NCT03179436|474194750|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702936|NCT03179436|474194751|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
131702937|NCT03179436|474194752|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702938|NCT03179436|474194753|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702939|NCT03179436|474194754|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702940|NCT03179436|474194755|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
131702941|NCT03179436|474194756|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702942|NCT03179436|474194757|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702943|NCT03179436|474194758|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702944|NCT03179436|474194759|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
131582906|NCT00960141|473761537|FG000|Overall Study|Protocol Violation|1|||
131582907|NCT00960141|473761538|FG001|Overall Study|Protocol Violation|3|||
131702945|NCT03179436|474194760|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702946|NCT03179436|474194761|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
131702947|NCT03179436|474194750|FG000|Overall Study|Lost to Follow-up|1|||
131702948|NCT03179436|474194751|FG001|Overall Study|Lost to Follow-up|0|||
131702949|NCT03179436|474194752|FG002|Overall Study|Lost to Follow-up|0|||
131702950|NCT03179436|474194753|FG003|Overall Study|Lost to Follow-up|1|||
131702951|NCT03179436|474194754|FG004|Overall Study|Lost to Follow-up|0|||
131702952|NCT03179436|474194755|FG005|Overall Study|Lost to Follow-up|1|||
131702953|NCT03179436|474194756|FG006|Overall Study|Lost to Follow-up|0|||
131702954|NCT03179436|474194757|FG007|Overall Study|Lost to Follow-up|0|||
131702955|NCT03179436|474194758|FG008|Overall Study|Lost to Follow-up|1|||
131702956|NCT03179436|474194759|FG009|Overall Study|Lost to Follow-up|1|||
131702957|NCT03179436|474194760|FG010|Overall Study|Lost to Follow-up|0|||
131702958|NCT03179436|474194761|FG011|Overall Study|Lost to Follow-up|0|||
131702959|NCT03179436|474194750|FG000|Overall Study|Death|12|||
131702960|NCT03179436|474194751|FG001|Overall Study|Death|17|||
131702961|NCT03179436|474194752|FG002|Overall Study|Death|7|||
131702962|NCT03179436|474194753|FG003|Overall Study|Death|32|||
131702963|NCT03179436|474194754|FG004|Overall Study|Death|29|||
131702964|NCT03179436|474194755|FG005|Overall Study|Death|30|||
131702965|NCT03179436|474194756|FG006|Overall Study|Death|33|||
131702966|NCT03179436|474194757|FG007|Overall Study|Death|9|||
131702967|NCT03179436|474194758|FG008|Overall Study|Death|84|||
131702968|NCT03179436|474194759|FG009|Overall Study|Death|33|||
131702969|NCT03179436|474194760|FG010|Overall Study|Death|22|||
131702970|NCT03179436|474194761|FG011|Overall Study|Death|15|||
131702971|NCT02320487|474194767|FG000|Overall Study|Reason not Specified|1|||
131702972|NCT02320487|474194767|FG000|Overall Study|Physician Decision|5|||
131702973|NCT02320487|474194767|FG000|Overall Study|Withdrawal by Subject|1|||
131702974|NCT02320487|474194767|FG000|Overall Study|Death|3|||
131702975|NCT02320487|474194767|FG000|Overall Study|Adverse Event|11|||
131702976|NCT00684957|474194772|FG000|Overall Study|Withdrawal by Subject|1|||
131702977|NCT00684957|474194773|FG001|Overall Study|Withdrawal by Subject|1|||
131702978|NCT00684957|474194772|FG000|Overall Study|Lost to Follow-up|1|||
131702979|NCT00684957|474194773|FG001|Overall Study|Lost to Follow-up|0|||
131702980|NCT03593915|474196675|FG000|Overall Study|Adverse Event|0|||
131702981|NCT03593915|474196676|FG001|Overall Study|Adverse Event|0|||
131702982|NCT03593915|474196677|FG002|Overall Study|Adverse Event|0|||
131702983|NCT03593915|474196678|FG003|Overall Study|Adverse Event|1|||
131702984|NCT03593915|474196679|FG004|Overall Study|Adverse Event|0|||
131582908|NCT00960141|473761539|FG002|Overall Study|Protocol Violation|2|||
131702985|NCT03593915|474196680|FG005|Overall Study|Adverse Event|0|||
131702986|NCT03593915|474196675|FG000|Overall Study|Physician Decision|0|||
131702987|NCT03593915|474196676|FG001|Overall Study|Physician Decision|0|||
131702988|NCT03593915|474196677|FG002|Overall Study|Physician Decision|0|||
131702989|NCT03593915|474196678|FG003|Overall Study|Physician Decision|0|||
131702990|NCT03593915|474196679|FG004|Overall Study|Physician Decision|0|||
131702991|NCT03593915|474196680|FG005|Overall Study|Physician Decision|1|||
131702992|NCT00772629|474196683|FG000|Overall Study|Subject was not vaccinated|1|||
131702993|NCT00772629|474196684|FG001|Overall Study|Subject was not vaccinated|0|||
131702994|NCT02894840|474196685|FG000|Overall Study|Lost to Follow-up|1|||
131702995|NCT02894840|474196686|FG001|Overall Study|Lost to Follow-up|0|||
131702996|NCT02894840|474196687|FG002|Overall Study|Lost to Follow-up|3|||
131702997|NCT02894840|474196688|FG003|Overall Study|Lost to Follow-up|0|||
131702998|NCT05162066|474196690|FG000|Overall Study|Adverse Event|1|||
131702999|NCT05162066|474196691|FG001|Overall Study|Adverse Event|0|||
131703000|NCT05162066|474196692|FG002|Overall Study|Adverse Event|0|||
131703001|NCT05162066|474196690|FG000|Overall Study|Perceived lack of efficacy|1|||
131703002|NCT05162066|474196691|FG001|Overall Study|Perceived lack of efficacy|0|||
131703003|NCT05162066|474196692|FG002|Overall Study|Perceived lack of efficacy|0|||
131703004|NCT00167245|474196693|FG000|Overall Study|Lost to Follow-up|20|||
131703005|NCT00167245|474196694|FG001|Overall Study|Lost to Follow-up|31|||
131703006|NCT00167245|474196693|FG000|Overall Study|Withdrawal by Subject|5|||
131703007|NCT00167245|474196694|FG001|Overall Study|Withdrawal by Subject|8|||
131703008|NCT00167245|474196693|FG000|Overall Study|Incarcerated|3|||
131703009|NCT00167245|474196694|FG001|Overall Study|Incarcerated|2|||
131703010|NCT00167245|474196693|FG000|Overall Study|Drowsy|1|||
131703011|NCT00167245|474196694|FG001|Overall Study|Drowsy|0|||
131703012|NCT01871090|474196695|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
131703013|NCT01871090|474196696|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
131703014|NCT01871090|474196695|FG000|Overall Study|Interrogation not completed correctly|1|||
131703015|NCT01871090|474196696|FG001|Overall Study|Interrogation not completed correctly|0|||
131703016|NCT01871090|474196695|FG000|Overall Study|Subject Non-Compliance|0|||
131703017|NCT01871090|474196696|FG001|Overall Study|Subject Non-Compliance|1|||
131703018|NCT00700180|474196704|FG000|Overall Study|Death|99|||
131703019|NCT00700180|474196705|FG001|Overall Study|Death|114|||
131438444|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Adverse Event|3|||
131703020|NCT00700180|474196704|FG000|Overall Study|Alive on treatment|5|||
131703021|NCT00700180|474196705|FG001|Overall Study|Alive on treatment|3|||
131703022|NCT00700180|474196704|FG000|Overall Study|Alive in follow-up|46|||
131703023|NCT00700180|474196705|FG001|Overall Study|Alive in follow-up|27|||
131703024|NCT00700180|474196704|FG000|Overall Study|Lost to Follow-up|4|||
131703025|NCT00700180|474196705|FG001|Overall Study|Lost to Follow-up|5|||
131703026|NCT01613326|474196706|FG000|Overall Study|Adverse Event|7|||
131703027|NCT01613326|474196707|FG001|Overall Study|Adverse Event|5|||
131703028|NCT01613326|474196706|FG000|Overall Study|Withdrawal by Subject|3|||
131703029|NCT01613326|474196707|FG001|Overall Study|Withdrawal by Subject|4|||
131703030|NCT01613326|474196706|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131703031|NCT01613326|474196707|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131703032|NCT01613326|474196706|FG000|Overall Study|inability to use device|1|||
131703033|NCT01613326|474196707|FG001|Overall Study|inability to use device|0|||
131703034|NCT01613326|474196706|FG000|Overall Study|Lack of Efficacy|0|||
131703035|NCT01613326|474196707|FG001|Overall Study|Lack of Efficacy|1|||
131703036|NCT01613326|474196706|FG000|Overall Study|Lost to Follow-up|0|||
131703037|NCT01613326|474196707|FG001|Overall Study|Lost to Follow-up|1|||
131703038|NCT01613326|474196706|FG000|Overall Study|Administrative|0|||
131703039|NCT01613326|474196707|FG001|Overall Study|Administrative|2|||
131703040|NCT01613326|474196706|FG000|Overall Study|Protocol Violation|0|||
131703041|NCT01613326|474196707|FG001|Overall Study|Protocol Violation|1|||
131703042|NCT03980938|474196708|FG000|Treatment Period 1|Study Terminated|1|||
131703043|NCT03980938|474196709|FG001|Treatment Period 1|Study Terminated|1|||
131703044|NCT03980938|474196708|FG000|Treatment Period 2|Study Terminated|2|||
131703045|NCT03980938|474196709|FG001|Treatment Period 2|Study Terminated|2|||
131703046|NCT00840827|474196710|FG000|Overall Study|Adverse Event|1|||
131703047|NCT00840827|474196710|FG000|Overall Study|Lack of Efficacy|4|||
131438445|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Death|1|||
131438446|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Death|3|||
131438447|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
131438448|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
131438449|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
131438450|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
131438451|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Disease progression|103|||
131438452|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Disease progression|122|||
131438453|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Other|3|||
131438454|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Other|0|||
131438455|NCT00883779|473231241|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
131438456|NCT00883779|473231242|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
131438457|NCT00883779|473231241|FG000|Off-study Phase|Death|185|||
131438458|NCT00883779|473231242|FG001|Off-study Phase|Death|174|||
131438459|NCT00883779|473231241|FG000|Off-study Phase|Refused treatment|1|||
131438460|NCT00883779|473231242|FG001|Off-study Phase|Refused treatment|1|||
131438461|NCT00883779|473231241|FG000|Off-study Phase|Failure to return|5|||
131438462|NCT00883779|473231242|FG001|Off-study Phase|Failure to return|6|||
131438463|NCT00883779|473231241|FG000|Off-study Phase|Other|18|||
131438464|NCT00883779|473231242|FG001|Off-study Phase|Other|21|||
131438465|NCT00499681|473231243|FG000|Overall Study|toxicity|0|||
131438466|NCT00499681|473231244|FG001|Overall Study|toxicity|1|||
131438467|NCT00499681|473231243|FG000|Overall Study|disease progression|0|||
131438468|NCT00499681|473231244|FG001|Overall Study|disease progression|1|||
131438469|NCT02140047|473231245|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131438470|NCT02140047|473231246|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131438471|NCT02140047|473231247|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131438472|NCT03915717|473231250|FG000|Overall Study|EchoMark Not Implanted|6|||
131438473|NCT03748823|473231252|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
131438474|NCT03748823|473231253|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
131438475|NCT03748823|473231252|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
131438476|NCT03748823|473231253|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
131438477|NCT03748823|473231252|FG000|Extension Period|Withdrawal by Subject|9|||
131703048|NCT00840827|474196710|FG000|Overall Study|Physician Decision|1|||
131703049|NCT01445535|474196711|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
131438478|NCT03748823|473231253|FG001|Extension Period|Withdrawal by Subject|12|||
131438479|NCT03748823|473231252|FG000|Extension Period|Death|2|||
131438480|NCT03748823|473231253|FG001|Extension Period|Death|2|||
131438481|NCT03748823|473231252|FG000|Extension Period|Other than Specified|0|||
131438482|NCT03748823|473231253|FG001|Extension Period|Other than Specified|1|||
131438483|NCT03748823|473231252|FG000|Extension Period|Protocol Violation|1|||
131438484|NCT03748823|473231253|FG001|Extension Period|Protocol Violation|0|||
131703050|NCT01445535|474196712|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
131703051|NCT01445535|474196713|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
131703052|NCT01445535|474196714|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
131703053|NCT01445535|474196711|FG000|Overall Study|Disease progression|1|||
131703054|NCT01445535|474196712|FG001|Overall Study|Disease progression|0|||
131703055|NCT01445535|474196713|FG002|Overall Study|Disease progression|1|||
131788304|NCT01078623|474508997|FG000|Treatment Period 1|Adverse Event|1|||
131788305|NCT01078623|474508998|FG001|Treatment Period 1|Adverse Event|1|||
131788306|NCT01078623|474508999|FG002|Treatment Period 1|Adverse Event|1|||
131788307|NCT01078623|474509000|FG003|Treatment Period 1|Adverse Event|0|||
131788308|NCT01078623|474509001|FG004|Treatment Period 1|Adverse Event|0|||
131788309|NCT01078623|474509002|FG005|Treatment Period 1|Adverse Event|0|||
131788310|NCT01078623|474509003|FG006|Treatment Period 1|Adverse Event|1|||
131788311|NCT01078623|474509004|FG007|Treatment Period 1|Adverse Event|0|||
131788312|NCT01078623|474509005|FG008|Treatment Period 1|Adverse Event|1|||
131788313|NCT01078623|474509006|FG009|Treatment Period 1|Adverse Event|1|||
131788314|NCT01078623|474509007|FG010|Treatment Period 1|Adverse Event|0|||
131788315|NCT01078623|474509008|FG011|Treatment Period 1|Adverse Event|0|||
131788316|NCT01078623|474509009|FG012|Treatment Period 1|Adverse Event|0|||
131788317|NCT01078623|474509010|FG013|Treatment Period 1|Adverse Event|0|||
131788318|NCT01078623|474509011|FG014|Treatment Period 1|Adverse Event|0|||
131788319|NCT01078623|474509012|FG015|Treatment Period 1|Adverse Event|0|||
131788320|NCT01078623|474509013|FG016|Treatment Period 1|Adverse Event|0|||
131788321|NCT01078623|474509014|FG017|Treatment Period 1|Adverse Event|0|||
131788322|NCT01078623|474509015|FG018|Treatment Period 1|Adverse Event|0|||
131788323|NCT01078623|474509016|FG019|Treatment Period 1|Adverse Event|0|||
131788324|NCT01078623|474508997|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131788325|NCT01078623|474508998|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131788326|NCT01078623|474508999|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131788327|NCT01078623|474509000|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131788328|NCT01078623|474509001|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131788329|NCT01078623|474509002|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131788330|NCT01078623|474509003|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131788331|NCT01078623|474509004|FG007|Treatment Period 1|Withdrawal by Subject|1|||
131788332|NCT01078623|474509005|FG008|Treatment Period 1|Withdrawal by Subject|0|||
131788333|NCT01078623|474509006|FG009|Treatment Period 1|Withdrawal by Subject|0|||
131788334|NCT01078623|474509007|FG010|Treatment Period 1|Withdrawal by Subject|1|||
131788335|NCT01078623|474509008|FG011|Treatment Period 1|Withdrawal by Subject|0|||
131788336|NCT01078623|474509009|FG012|Treatment Period 1|Withdrawal by Subject|0|||
131788337|NCT01078623|474509010|FG013|Treatment Period 1|Withdrawal by Subject|0|||
131788338|NCT01078623|474509011|FG014|Treatment Period 1|Withdrawal by Subject|0|||
131788339|NCT01078623|474509012|FG015|Treatment Period 1|Withdrawal by Subject|0|||
131788340|NCT01078623|474509013|FG016|Treatment Period 1|Withdrawal by Subject|0|||
131788341|NCT01078623|474509014|FG017|Treatment Period 1|Withdrawal by Subject|0|||
131788342|NCT01078623|474509015|FG018|Treatment Period 1|Withdrawal by Subject|0|||
131788343|NCT01078623|474509016|FG019|Treatment Period 1|Withdrawal by Subject|0|||
131788344|NCT01078623|474508997|FG000|Treatment Period 1|Protocol Violation|0|||
131788345|NCT01078623|474508998|FG001|Treatment Period 1|Protocol Violation|0|||
131788346|NCT01078623|474508999|FG002|Treatment Period 1|Protocol Violation|0|||
131788347|NCT01078623|474509000|FG003|Treatment Period 1|Protocol Violation|0|||
131788348|NCT01078623|474509001|FG004|Treatment Period 1|Protocol Violation|0|||
131788349|NCT01078623|474509002|FG005|Treatment Period 1|Protocol Violation|1|||
131788350|NCT01078623|474509003|FG006|Treatment Period 1|Protocol Violation|0|||
131788351|NCT01078623|474509004|FG007|Treatment Period 1|Protocol Violation|0|||
131788352|NCT01078623|474509005|FG008|Treatment Period 1|Protocol Violation|0|||
131788353|NCT01078623|474509006|FG009|Treatment Period 1|Protocol Violation|0|||
131788354|NCT01078623|474509007|FG010|Treatment Period 1|Protocol Violation|0|||
131788355|NCT01078623|474509008|FG011|Treatment Period 1|Protocol Violation|0|||
131788356|NCT01078623|474509009|FG012|Treatment Period 1|Protocol Violation|0|||
131788357|NCT01078623|474509010|FG013|Treatment Period 1|Protocol Violation|0|||
131788358|NCT01078623|474509011|FG014|Treatment Period 1|Protocol Violation|0|||
131788359|NCT01078623|474509012|FG015|Treatment Period 1|Protocol Violation|0|||
131788360|NCT01078623|474509013|FG016|Treatment Period 1|Protocol Violation|0|||
131788361|NCT01078623|474509014|FG017|Treatment Period 1|Protocol Violation|0|||
131788362|NCT01078623|474509015|FG018|Treatment Period 1|Protocol Violation|0|||
131788363|NCT01078623|474509016|FG019|Treatment Period 1|Protocol Violation|0|||
131788364|NCT01078623|474508997|FG000|Treatment Period 2|Adverse Event|0|||
131788365|NCT01078623|474508998|FG001|Treatment Period 2|Adverse Event|0|||
131788366|NCT01078623|474508999|FG002|Treatment Period 2|Adverse Event|0|||
131788367|NCT01078623|474509000|FG003|Treatment Period 2|Adverse Event|0|||
131788368|NCT01078623|474509001|FG004|Treatment Period 2|Adverse Event|0|||
131788369|NCT01078623|474509002|FG005|Treatment Period 2|Adverse Event|0|||
131788370|NCT01078623|474509003|FG006|Treatment Period 2|Adverse Event|1|||
131788371|NCT01078623|474509004|FG007|Treatment Period 2|Adverse Event|0|||
131788372|NCT01078623|474509005|FG008|Treatment Period 2|Adverse Event|0|||
131788373|NCT01078623|474509006|FG009|Treatment Period 2|Adverse Event|0|||
131788374|NCT01078623|474509007|FG010|Treatment Period 2|Adverse Event|0|||
131788375|NCT01078623|474509008|FG011|Treatment Period 2|Adverse Event|0|||
131788376|NCT01078623|474509009|FG012|Treatment Period 2|Adverse Event|0|||
131788377|NCT01078623|474509010|FG013|Treatment Period 2|Adverse Event|0|||
131788378|NCT01078623|474509011|FG014|Treatment Period 2|Adverse Event|0|||
131788379|NCT01078623|474509012|FG015|Treatment Period 2|Adverse Event|0|||
131788380|NCT01078623|474509013|FG016|Treatment Period 2|Adverse Event|0|||
131788381|NCT01078623|474509014|FG017|Treatment Period 2|Adverse Event|0|||
131703056|NCT01445535|474196714|FG003|Overall Study|Disease progression|0|||
131703057|NCT01445535|474196711|FG000|Overall Study|PI discretion|0|||
131703058|NCT01445535|474196712|FG001|Overall Study|PI discretion|0|||
131703059|NCT01445535|474196713|FG002|Overall Study|PI discretion|0|||
131703060|NCT01445535|474196714|FG003|Overall Study|PI discretion|1|||
131703061|NCT00420511|474196720|FG000|Overall Study|Adverse Event|1|||
131703062|NCT00420511|474196721|FG001|Overall Study|Adverse Event|1|||
131703063|NCT00420511|474196720|FG000|Overall Study|Lost to Follow-up|1|||
131703064|NCT00420511|474196721|FG001|Overall Study|Lost to Follow-up|0|||
131703065|NCT01668654|474196722|FG000|Overall Study|Study Closed/Terminated|3|||
131703066|NCT01668654|474196722|FG000|Overall Study|Withdrawal by Subject|1|||
131703067|NCT01337973|474196723|FG000|Overall Study|Lost to Follow-up|2|||
131703068|NCT01337973|474196724|FG001|Overall Study|Lost to Follow-up|4|||
131703069|NCT01337973|474196725|FG002|Overall Study|Lost to Follow-up|3|||
131703070|NCT01337973|474196723|FG000|Overall Study|Death|1|||
131703071|NCT01337973|474196724|FG001|Overall Study|Death|2|||
131703072|NCT01337973|474196725|FG002|Overall Study|Death|1|||
131703073|NCT01337973|474196723|FG000|Overall Study|Withdrawal by Subject|10|||
131703074|NCT01337973|474196724|FG001|Overall Study|Withdrawal by Subject|8|||
131703075|NCT01337973|474196725|FG002|Overall Study|Withdrawal by Subject|4|||
131703076|NCT01337973|474196723|FG000|Overall Study|missing data on primary outcome|3|||
131703077|NCT01337973|474196724|FG001|Overall Study|missing data on primary outcome|1|||
131703078|NCT01337973|474196725|FG002|Overall Study|missing data on primary outcome|3|||
131703079|NCT00254566|474196727|FG000|Overall Study|Death|1|||
131703080|NCT00254566|474196728|FG001|Overall Study|Death|0|||
131703081|NCT00254566|474196727|FG000|Overall Study|Adverse Event|5|||
131898747|NCT00943397|474915347|FG000|Overall Study|Withdrawal by Subject|1|||
131703082|NCT00254566|474196728|FG001|Overall Study|Adverse Event|4|||
131703083|NCT00254566|474196727|FG000|Overall Study|Lack of Efficacy|12|||
131703084|NCT00254566|474196728|FG001|Overall Study|Lack of Efficacy|9|||
131703085|NCT00254566|474196727|FG000|Overall Study|Other|1|||
131703086|NCT00254566|474196728|FG001|Overall Study|Other|5|||
131703087|NCT00254566|474196727|FG000|Overall Study|Withdrawal by Subject|5|||
131703088|NCT00254566|474196728|FG001|Overall Study|Withdrawal by Subject|6|||
131703089|NCT00254566|474196727|FG000|Overall Study|Lost to Follow-up|7|||
131703090|NCT00254566|474196728|FG001|Overall Study|Lost to Follow-up|2|||
131703091|NCT00059202|474196729|FG000|Overall Study|Withdrawal by Subject|5|||
131703092|NCT00059202|474196730|FG001|Overall Study|Withdrawal by Subject|9|||
131703093|NCT00059202|474196729|FG000|Overall Study|Protocol Violation|1|||
131703094|NCT00059202|474196730|FG001|Overall Study|Protocol Violation|3|||
131703095|NCT00059202|474196729|FG000|Overall Study|drug toxicity|0|||
131703096|NCT00059202|474196730|FG001|Overall Study|drug toxicity|3|||
131703097|NCT02658448|474196735|FG000|Overall Study|Lost to Follow-up|1|||
131703098|NCT03106779|474196736|FG000|Overall Study|Lack of Efficacy|33|||
131703099|NCT03106779|474196737|FG001|Overall Study|Lack of Efficacy|24|||
131703100|NCT03106779|474196736|FG000|Overall Study|Adverse Event|8|||
131703101|NCT03106779|474196737|FG001|Overall Study|Adverse Event|16|||
131703102|NCT03106779|474196736|FG000|Overall Study|Physician Decision|10|||
131703103|NCT03106779|474196737|FG001|Overall Study|Physician Decision|6|||
131703104|NCT03106779|474196736|FG000|Overall Study|Patient/guardian decision|4|||
131703105|NCT03106779|474196737|FG001|Overall Study|Patient/guardian decision|3|||
131703106|NCT03106779|474196736|FG000|Overall Study|Progressive disease|1|||
131703107|NCT03106779|474196737|FG001|Overall Study|Progressive disease|3|||
131703108|NCT03106779|474196736|FG000|Overall Study|Lost to Follow-up|1|||
131703109|NCT03106779|474196737|FG001|Overall Study|Lost to Follow-up|2|||
131703110|NCT03106779|474196736|FG000|Overall Study|Death|1|||
131703111|NCT03106779|474196737|FG001|Overall Study|Death|0|||
131703112|NCT03106779|474196736|FG000|Overall Study|Protocol Violation|1|||
131703113|NCT03106779|474196737|FG001|Overall Study|Protocol Violation|0|||
131703114|NCT03106779|474196736|FG000|Overall Study|Not treated|1|||
131703115|NCT03106779|474196737|FG001|Overall Study|Not treated|0|||
131703116|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
131703117|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
131703118|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
131703119|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
131703120|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
131703121|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
131703122|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
131703123|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
131703124|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
131703125|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
131703126|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
131703127|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
131703128|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
131703129|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
131703130|NCT02288247|474196738|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
131703131|NCT02288247|474196739|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
131703132|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
131703133|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
131703134|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
131703135|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
131703136|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
131703137|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
131703138|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
131703139|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
131898748|NCT00943397|474915348|FG001|Overall Study|Withdrawal by Subject|1|||
131703140|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
131703141|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
131703142|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
131703143|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
131703144|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
131703145|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
131703146|NCT02288247|474196738|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
131703147|NCT02288247|474196739|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
131703148|NCT04652804|474196740|FG000|Overall Study|Ineligible post randomization|1|||
131703149|NCT04652804|474196741|FG001|Overall Study|Ineligible post randomization|0|||
131703150|NCT04652804|474196742|FG002|Overall Study|Ineligible post randomization|1|||
131703151|NCT04652804|474196743|FG003|Overall Study|Ineligible post randomization|0|||
131703152|NCT04652804|474196744|FG004|Overall Study|Ineligible post randomization|1|||
131703153|NCT04652804|474196745|FG005|Overall Study|Ineligible post randomization|1|||
131703154|NCT04652804|474196740|FG000|Overall Study|Missing SVR lab results|2|||
131703155|NCT04652804|474196741|FG001|Overall Study|Missing SVR lab results|0|||
131703156|NCT04652804|474196742|FG002|Overall Study|Missing SVR lab results|0|||
131703157|NCT04652804|474196743|FG003|Overall Study|Missing SVR lab results|0|||
131703158|NCT04652804|474196744|FG004|Overall Study|Missing SVR lab results|0|||
131703159|NCT04652804|474196745|FG005|Overall Study|Missing SVR lab results|0|||
131703160|NCT03634800|474196746|FG000|Overall Study|Adverse Event|1|||
131703161|NCT03634800|474196746|FG000|Overall Study|Disease Progression|4|||
131703162|NCT03634800|474196746|FG000|Overall Study|Withdrawal by Subject|1|||
131703163|NCT02624492|474196749|FG000|Overall Study|Adverse Event|2|||
131703164|NCT02624492|474196750|FG001|Overall Study|Adverse Event|2|||
131703165|NCT02624492|474196751|FG002|Overall Study|Adverse Event|2|||
131703166|NCT02624492|474196749|FG000|Overall Study|Progressive disease|0|||
131703167|NCT02624492|474196750|FG001|Overall Study|Progressive disease|2|||
131703168|NCT02624492|474196751|FG002|Overall Study|Progressive disease|3|||
131703169|NCT00364689|474196753|FG000|Overall Study|Lost to Follow-up|1|||
131703170|NCT00191451|474196761|FG000|Overall Study|Withdrawal by Subject|2|||
131703171|NCT00191451|474196762|FG001|Overall Study|Withdrawal by Subject|3|||
131703172|NCT00191451|474196763|FG002|Overall Study|Withdrawal by Subject|5|||
131703173|NCT00191451|474196761|FG000|Overall Study|Physician Decision|2|||
131703174|NCT00191451|474196762|FG001|Overall Study|Physician Decision|9|||
131703175|NCT00191451|474196763|FG002|Overall Study|Physician Decision|6|||
131703176|NCT00191451|474196761|FG000|Overall Study|Sponsor Decision|1|||
131703177|NCT00191451|474196762|FG001|Overall Study|Sponsor Decision|0|||
131703178|NCT00191451|474196763|FG002|Overall Study|Sponsor Decision|0|||
131703179|NCT00191451|474196761|FG000|Overall Study|Ineligible|0|||
131703180|NCT00191451|474196762|FG001|Overall Study|Ineligible|1|||
131703181|NCT00191451|474196763|FG002|Overall Study|Ineligible|0|||
131703182|NCT00191451|474196761|FG000|Overall Study|Reason Not Specified|2|||
131703183|NCT00191451|474196762|FG001|Overall Study|Reason Not Specified|1|||
131703184|NCT00191451|474196763|FG002|Overall Study|Reason Not Specified|3|||
131703185|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
131703186|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
131703187|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
131703188|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
131703189|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
131703190|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
131703191|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
131703192|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
131703193|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
131703194|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
131703195|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
131703196|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
131703197|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
131703198|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
131703199|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
131703200|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
131703201|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
131703202|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
131703203|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
131703204|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
131703205|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
131703206|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
131703207|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
131703208|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
131703209|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Death|2|||
131703210|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Death|1|||
131703211|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Death|2|||
131703212|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Graft loss|0|||
131703213|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Graft loss|2|||
131703214|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Graft loss|0|||
131703215|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
131703216|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
131703217|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
131703218|NCT01114529|474196764|FG000|Completed Study Medication at Month 24|Missing|2|||
131703219|NCT01114529|474196765|FG001|Completed Study Medication at Month 24|Missing|0|||
131703220|NCT01114529|474196766|FG002|Completed Study Medication at Month 24|Missing|0|||
131703221|NCT01114529|474196764|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
131703222|NCT01114529|474196765|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
131703223|NCT01114529|474196766|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
131703224|NCT01114529|474196764|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
131703225|NCT01114529|474196765|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
131703226|NCT01114529|474196766|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
131703227|NCT01114529|474196764|FG000|Completed Study Phase at Month 24|Death|8|||
131703228|NCT01114529|474196765|FG001|Completed Study Phase at Month 24|Death|5|||
131703229|NCT01114529|474196766|FG002|Completed Study Phase at Month 24|Death|4|||
131703230|NCT01114529|474196764|FG000|Completed Study Phase at Month 24|Other|2|||
131703231|NCT01114529|474196765|FG001|Completed Study Phase at Month 24|Other|0|||
131703232|NCT01114529|474196766|FG002|Completed Study Phase at Month 24|Other|0|||
131703233|NCT01114529|474196764|FG000|Completed Study Phase at Month 24|Missing|2|||
131703234|NCT01114529|474196765|FG001|Completed Study Phase at Month 24|Missing|0|||
131703235|NCT01114529|474196766|FG002|Completed Study Phase at Month 24|Missing|0|||
131703236|NCT00132730|474196768|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
131703237|NCT00132730|474196769|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
131703238|NCT00132730|474196770|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
131703239|NCT00132730|474196771|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
131703240|NCT00132730|474196772|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
131703241|NCT00132730|474196773|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
131703242|NCT00132730|474196768|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
131703243|NCT00132730|474196769|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
131703244|NCT00132730|474196770|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131703245|NCT00132730|474196771|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131703246|NCT00132730|474196772|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131703247|NCT00132730|474196773|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131703248|NCT00132730|474196768|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
131703249|NCT00132730|474196769|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
131703250|NCT00132730|474196770|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
131703251|NCT00132730|474196771|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
131703252|NCT00132730|474196772|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
131703253|NCT00132730|474196773|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
131703254|NCT00132730|474196768|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131703255|NCT00132730|474196769|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131703256|NCT00132730|474196770|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
131703257|NCT00132730|474196771|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
131703258|NCT00132730|474196772|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131703259|NCT00132730|474196773|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131703260|NCT00132730|474196768|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131703261|NCT00132730|474196769|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131703262|NCT00132730|474196770|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
131703263|NCT00132730|474196771|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
131703264|NCT00132730|474196772|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131703265|NCT00132730|474196773|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131703266|NCT00132730|474196768|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131703267|NCT00132730|474196769|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131703268|NCT00132730|474196770|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131703269|NCT00132730|474196771|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
131703270|NCT00132730|474196772|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131703271|NCT00132730|474196773|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131703272|NCT00132730|474196768|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131703273|NCT00132730|474196769|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131788382|NCT01078623|474509015|FG018|Treatment Period 2|Adverse Event|1|||
131788383|NCT01078623|474509016|FG019|Treatment Period 2|Adverse Event|0|||
131788384|NCT01078623|474508997|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131703274|NCT00132730|474196770|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
131703275|NCT00132730|474196771|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
131703276|NCT00132730|474196772|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131703277|NCT00132730|474196773|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131703278|NCT00132730|474196768|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131703279|NCT00132730|474196769|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131703280|NCT00132730|474196770|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131703281|NCT00132730|474196771|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131703282|NCT00132730|474196772|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
131703283|NCT00132730|474196773|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
131703284|NCT00132730|474196768|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131703285|NCT00132730|474196769|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131703286|NCT00132730|474196770|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131703287|NCT00132730|474196771|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131703288|NCT00132730|474196772|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
131703289|NCT00132730|474196773|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131703290|NCT00132730|474196768|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131703291|NCT00132730|474196769|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131703292|NCT00132730|474196770|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131703293|NCT00132730|474196771|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131703294|NCT00132730|474196772|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
131703295|NCT00132730|474196773|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131703296|NCT00132730|474196768|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131703297|NCT00132730|474196769|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131703298|NCT00132730|474196770|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131703299|NCT00132730|474196771|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131703300|NCT00132730|474196772|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
131703301|NCT00132730|474196773|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131703302|NCT00132730|474196768|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131703303|NCT00132730|474196769|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131703304|NCT00132730|474196770|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131703305|NCT00132730|474196771|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131703306|NCT00132730|474196772|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
131703307|NCT00132730|474196773|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
131703308|NCT01554579|474196774|FG000|Overall Study|Adverse Event|6|||
131703309|NCT01554579|474196775|FG001|Overall Study|Adverse Event|25|||
131703310|NCT01554579|474196774|FG000|Overall Study|Lack of Efficacy|2|||
131703311|NCT01554579|474196775|FG001|Overall Study|Lack of Efficacy|1|||
131703312|NCT01554579|474196774|FG000|Overall Study|Withdrawal by Subject|2|||
131703313|NCT01554579|474196775|FG001|Overall Study|Withdrawal by Subject|1|||
131703314|NCT01192347|474196776|FG000|Overall Study|Death|3|||
131703315|NCT01192347|474196776|FG000|Overall Study|Lost to Follow-up|3|||
131703316|NCT01192347|474196776|FG000|Overall Study|Withdrawal by Subject|1|||
131703317|NCT01192347|474196776|FG000|Overall Study|Adverse Event|1|||
131703318|NCT01192347|474196776|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
131703319|NCT01192347|474196776|FG000|Overall Study|Patient seen in different hospital|1|||
131703320|NCT01192347|474196776|FG000|Overall Study|Patient not visiting hospital regularly|1|||
131703321|NCT01192347|474196776|FG000|Overall Study|Patient did not show up for visits|1|||
131703322|NCT02623335|474196777|FG000|Overall Study|Death|8|||
131703323|NCT02623335|474196778|FG001|Overall Study|Death|7|||
131703324|NCT02623335|474196777|FG000|Overall Study|Lost to Follow-up|15|||
131703325|NCT02623335|474196778|FG001|Overall Study|Lost to Follow-up|23|||
131703326|NCT02623335|474196777|FG000|Overall Study|Withdrawal by Subject|2|||
131703327|NCT02623335|474196778|FG001|Overall Study|Withdrawal by Subject|5|||
131703328|NCT02623335|474196777|FG000|Overall Study|Protocol Violation|2|||
131703329|NCT02623335|474196778|FG001|Overall Study|Protocol Violation|1|||
131703330|NCT03739528|474196779|FG000|Overall Study|Not treated|8|||
131703331|NCT03739528|474196780|FG001|Overall Study|Not treated|12|||
131703332|NCT03739528|474196779|FG000|Overall Study|Treatment and study discontinued|6|||
131703333|NCT03739528|474196780|FG001|Overall Study|Treatment and study discontinued|2|||
131703334|NCT03739528|474196779|FG000|Overall Study|Treatment discontinued + study completed|1|||
131703335|NCT03739528|474196780|FG001|Overall Study|Treatment discontinued + study completed|3|||
131703336|NCT01046695|474196781|FG000|Overall Study|Subject had a pacemaker|0|||
131703337|NCT01046695|474196782|FG001|Overall Study|Subject had a pacemaker|1|||
131703338|NCT01046695|474196781|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
131703339|NCT01046695|474196782|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
131703340|NCT03072160|474196783|FG000|Overall Study|Adverse Event|3|||
131703341|NCT03072160|474196784|FG001|Overall Study|Adverse Event|1|||
131703342|NCT03072160|474196783|FG000|Overall Study|Refused further treatment|6|||
131703343|NCT03072160|474196784|FG001|Overall Study|Refused further treatment|1|||
131703344|NCT03072160|474196783|FG000|Overall Study|Physician Decision|1|||
131788385|NCT01078623|474508998|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131788386|NCT01078623|474508999|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131788387|NCT01078623|474509000|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131788388|NCT01078623|474509001|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131788389|NCT01078623|474509002|FG005|Treatment Period 2|Withdrawal by Subject|1|||
131788390|NCT01078623|474509003|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131788391|NCT01078623|474509004|FG007|Treatment Period 2|Withdrawal by Subject|0|||
131788392|NCT01078623|474509005|FG008|Treatment Period 2|Withdrawal by Subject|0|||
131788393|NCT01078623|474509006|FG009|Treatment Period 2|Withdrawal by Subject|0|||
131788394|NCT01078623|474509007|FG010|Treatment Period 2|Withdrawal by Subject|0|||
131788395|NCT01078623|474509008|FG011|Treatment Period 2|Withdrawal by Subject|0|||
131788396|NCT01078623|474509009|FG012|Treatment Period 2|Withdrawal by Subject|0|||
131788397|NCT01078623|474509010|FG013|Treatment Period 2|Withdrawal by Subject|0|||
131788398|NCT01078623|474509011|FG014|Treatment Period 2|Withdrawal by Subject|0|||
131788399|NCT01078623|474509012|FG015|Treatment Period 2|Withdrawal by Subject|0|||
131788400|NCT01078623|474509013|FG016|Treatment Period 2|Withdrawal by Subject|0|||
131788401|NCT01078623|474509014|FG017|Treatment Period 2|Withdrawal by Subject|0|||
131788402|NCT01078623|474509015|FG018|Treatment Period 2|Withdrawal by Subject|0|||
131788403|NCT01078623|474509016|FG019|Treatment Period 2|Withdrawal by Subject|0|||
131788404|NCT01078623|474508997|FG000|Treatment Period 3|Adverse Event|0|||
131788405|NCT01078623|474508998|FG001|Treatment Period 3|Adverse Event|0|||
131788406|NCT01078623|474508999|FG002|Treatment Period 3|Adverse Event|0|||
131788407|NCT01078623|474509000|FG003|Treatment Period 3|Adverse Event|0|||
131788408|NCT01078623|474509001|FG004|Treatment Period 3|Adverse Event|1|||
131788409|NCT01078623|474509002|FG005|Treatment Period 3|Adverse Event|0|||
131788410|NCT01078623|474509003|FG006|Treatment Period 3|Adverse Event|0|||
131788411|NCT01078623|474509004|FG007|Treatment Period 3|Adverse Event|0|||
131788412|NCT01078623|474509005|FG008|Treatment Period 3|Adverse Event|0|||
131788413|NCT01078623|474509006|FG009|Treatment Period 3|Adverse Event|0|||
131788414|NCT01078623|474509007|FG010|Treatment Period 3|Adverse Event|0|||
131788415|NCT01078623|474509008|FG011|Treatment Period 3|Adverse Event|0|||
131788416|NCT01078623|474509009|FG012|Treatment Period 3|Adverse Event|0|||
131788417|NCT01078623|474509010|FG013|Treatment Period 3|Adverse Event|1|||
131788418|NCT01078623|474509011|FG014|Treatment Period 3|Adverse Event|0|||
131788419|NCT01078623|474509012|FG015|Treatment Period 3|Adverse Event|0|||
131788420|NCT01078623|474509013|FG016|Treatment Period 3|Adverse Event|0|||
131788421|NCT01078623|474509014|FG017|Treatment Period 3|Adverse Event|0|||
131788422|NCT01078623|474509015|FG018|Treatment Period 3|Adverse Event|0|||
131788423|NCT01078623|474509016|FG019|Treatment Period 3|Adverse Event|0|||
131788424|NCT01078623|474508997|FG000|Treatment Period 4|Adverse Event|0|||
131788425|NCT01078623|474508998|FG001|Treatment Period 4|Adverse Event|0|||
131788426|NCT01078623|474508999|FG002|Treatment Period 4|Adverse Event|1|||
131788427|NCT01078623|474509000|FG003|Treatment Period 4|Adverse Event|0|||
131788428|NCT01078623|474509001|FG004|Treatment Period 4|Adverse Event|0|||
131788429|NCT01078623|474509002|FG005|Treatment Period 4|Adverse Event|0|||
131788430|NCT01078623|474509003|FG006|Treatment Period 4|Adverse Event|0|||
131788431|NCT01078623|474509004|FG007|Treatment Period 4|Adverse Event|0|||
131788432|NCT01078623|474509005|FG008|Treatment Period 4|Adverse Event|0|||
131788433|NCT01078623|474509006|FG009|Treatment Period 4|Adverse Event|0|||
131788434|NCT01078623|474509007|FG010|Treatment Period 4|Adverse Event|0|||
131788435|NCT01078623|474509008|FG011|Treatment Period 4|Adverse Event|0|||
131788436|NCT01078623|474509009|FG012|Treatment Period 4|Adverse Event|0|||
131788437|NCT01078623|474509010|FG013|Treatment Period 4|Adverse Event|0|||
131788438|NCT01078623|474509011|FG014|Treatment Period 4|Adverse Event|0|||
131788439|NCT01078623|474509012|FG015|Treatment Period 4|Adverse Event|0|||
131788440|NCT01078623|474509013|FG016|Treatment Period 4|Adverse Event|0|||
131788441|NCT01078623|474509014|FG017|Treatment Period 4|Adverse Event|0|||
131788442|NCT01078623|474509015|FG018|Treatment Period 4|Adverse Event|0|||
131788443|NCT01078623|474509016|FG019|Treatment Period 4|Adverse Event|0|||
131788444|NCT01078623|474508997|FG000|Treatment Period 4|Withdrawal by Subject|0|||
131788445|NCT01078623|474508998|FG001|Treatment Period 4|Withdrawal by Subject|0|||
131788446|NCT01078623|474508999|FG002|Treatment Period 4|Withdrawal by Subject|0|||
131788447|NCT01078623|474509000|FG003|Treatment Period 4|Withdrawal by Subject|0|||
131788448|NCT01078623|474509001|FG004|Treatment Period 4|Withdrawal by Subject|0|||
131788449|NCT01078623|474509002|FG005|Treatment Period 4|Withdrawal by Subject|0|||
131788450|NCT01078623|474509003|FG006|Treatment Period 4|Withdrawal by Subject|0|||
131788451|NCT01078623|474509004|FG007|Treatment Period 4|Withdrawal by Subject|0|||
131788452|NCT01078623|474509005|FG008|Treatment Period 4|Withdrawal by Subject|0|||
131788453|NCT01078623|474509006|FG009|Treatment Period 4|Withdrawal by Subject|0|||
131788454|NCT01078623|474509007|FG010|Treatment Period 4|Withdrawal by Subject|0|||
131788455|NCT01078623|474509008|FG011|Treatment Period 4|Withdrawal by Subject|0|||
131788456|NCT01078623|474509009|FG012|Treatment Period 4|Withdrawal by Subject|0|||
131788457|NCT01078623|474509010|FG013|Treatment Period 4|Withdrawal by Subject|0|||
131788458|NCT01078623|474509011|FG014|Treatment Period 4|Withdrawal by Subject|0|||
131788459|NCT01078623|474509012|FG015|Treatment Period 4|Withdrawal by Subject|1|||
131788460|NCT01078623|474509013|FG016|Treatment Period 4|Withdrawal by Subject|0|||
131788461|NCT01078623|474509014|FG017|Treatment Period 4|Withdrawal by Subject|0|||
131788462|NCT01078623|474509015|FG018|Treatment Period 4|Withdrawal by Subject|0|||
131788463|NCT01078623|474509016|FG019|Treatment Period 4|Withdrawal by Subject|0|||
131788464|NCT02265952|474509018|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
131788465|NCT02265952|474509019|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
131788466|NCT02265952|474509018|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
131788467|NCT02265952|474509019|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
131788468|NCT01042977|474509020|FG000|Overall Study|Adverse Event|4|||
131788469|NCT01042977|474509021|FG001|Overall Study|Adverse Event|12|||
131788470|NCT01042977|474509020|FG000|Overall Study|Death|2|||
131788471|NCT01042977|474509021|FG001|Overall Study|Death|1|||
131788472|NCT01042977|474509020|FG000|Overall Study|Withdrawal by Subject|8|||
131788473|NCT01042977|474509021|FG001|Overall Study|Withdrawal by Subject|16|||
131788474|NCT01042977|474509020|FG000|Overall Study|Lost to Follow-up|0|||
131788475|NCT01042977|474509021|FG001|Overall Study|Lost to Follow-up|2|||
131788476|NCT01042977|474509020|FG000|Overall Study|Poor/non-compliance|3|||
131788477|NCT01042977|474509021|FG001|Overall Study|Poor/non-compliance|4|||
131788478|NCT01042977|474509020|FG000|Overall Study|Subject no longer meets study criteria|15|||
131788479|NCT01042977|474509021|FG001|Overall Study|Subject no longer meets study criteria|13|||
131788480|NCT01042977|474509020|FG000|Overall Study|Incorrect enrollment|6|||
131788481|NCT01042977|474509021|FG001|Overall Study|Incorrect enrollment|4|||
131582909|NCT00960141|473761537|FG000|Overall Study|Withdrawal by Subject|1|||
131582910|NCT00960141|473761538|FG001|Overall Study|Withdrawal by Subject|2|||
131582911|NCT00960141|473761539|FG002|Overall Study|Withdrawal by Subject|1|||
131788482|NCT01042977|474509020|FG000|Overall Study|Safety|0|||
131788483|NCT01042977|474509021|FG001|Overall Study|Safety|2|||
131788484|NCT01042977|474509020|FG000|Overall Study|Administrative reason by sponsor|0|||
131788485|NCT01042977|474509021|FG001|Overall Study|Administrative reason by sponsor|1|||
131788486|NCT01042977|474509020|FG000|Overall Study|Various|3|||
131788487|NCT01042977|474509021|FG001|Overall Study|Various|0|||
131788488|NCT02499354|474509022|FG000|Overall Study|Withdrawal by Subject|1|||
131788489|NCT02499354|474509023|FG001|Overall Study|Withdrawal by Subject|0|||
131788490|NCT04356573|474509026|FG000|Overall Study|Didn't Qualify|1|||
131788491|NCT04356573|474509027|FG001|Overall Study|Didn't Qualify|0|||
131788492|NCT02424565|474509028|FG000|Period 1 (D0)|Protocol Violation|0|||
131788493|NCT02424565|474509029|FG001|Period 1 (D0)|Protocol Violation|1|||
131788494|NCT03650400|474509030|FG000|Overall Study|Study terminated by sponsor|0|||
131788495|NCT03650400|474509031|FG001|Overall Study|Study terminated by sponsor|5|||
131788496|NCT01759381|474509039|FG000|Overall Study|Death|1|||
131788497|NCT01759381|474509040|FG001|Overall Study|Death|0|||
131788498|NCT00447603|474509042|FG000|Screening|Withdrawal by Subject|1|||
131788499|NCT00447603|474509043|FG001|Screening|Withdrawal by Subject|0|||
131788500|NCT00447603|474509044|FG002|Screening|Withdrawal by Subject|0|||
131788501|NCT00447603|474509042|FG000|Screening|Protocol Violation|1|||
131788502|NCT00447603|474509043|FG001|Screening|Protocol Violation|0|||
131788503|NCT00447603|474509044|FG002|Screening|Protocol Violation|0|||
131788504|NCT00447603|474509042|FG000|Screening|Screen Failure|4|||
131788505|NCT00447603|474509043|FG001|Screening|Screen Failure|0|||
131788506|NCT00447603|474509044|FG002|Screening|Screen Failure|0|||
131788507|NCT00447603|474509042|FG000|Screening|Study Terminated by Sponsor|15|||
131788508|NCT00447603|474509043|FG001|Screening|Study Terminated by Sponsor|0|||
131788509|NCT00447603|474509044|FG002|Screening|Study Terminated by Sponsor|0|||
131788510|NCT00447603|474509042|FG000|Filter Period|Adverse Event|0|||
131788511|NCT00447603|474509043|FG001|Filter Period|Adverse Event|0|||
131788512|NCT00447603|474509044|FG002|Filter Period|Adverse Event|1|||
131582912|NCT01943916|473761540|FG000|Overall Study|Technically invalid images|10|||
131582913|NCT01943916|473761540|FG000|Overall Study|Enrollment Failure|23|||
131788513|NCT00447603|474509042|FG000|Filter Period|Screen Failure|0|||
131788514|NCT00447603|474509043|FG001|Filter Period|Screen Failure|3|||
131788515|NCT00447603|474509044|FG002|Filter Period|Screen Failure|4|||
131788516|NCT00447603|474509042|FG000|Filter Period|Study terminated by Sponsor|0|||
131788517|NCT00447603|474509043|FG001|Filter Period|Study terminated by Sponsor|1|||
131788518|NCT00447603|474509044|FG002|Filter Period|Study terminated by Sponsor|10|||
131788519|NCT04132232|474509045|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
131788520|NCT04132232|474509046|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
131788521|NCT04132232|474509045|FG000|Overall Study|Lost to Follow-up|6|||
131788522|NCT04132232|474509046|FG001|Overall Study|Lost to Follow-up|7|||
131788523|NCT00368537|474509047|FG000|Randomization|No study drug dosed|13|||
131898749|NCT00943397|474915347|FG000|Overall Study|Site terminated and other|12|||
131788524|NCT00368537|474509048|FG001|Randomization|No study drug dosed|6|||
131582914|NCT01943916|473761540|FG000|Overall Study|Pilot Phase exclusion|100|||
131582915|NCT01943916|473761540|FG000|Overall Study|Quality Assurance Reader Fail|130|||
131788525|NCT00368537|474509047|FG000|Baseline Participants|Lost to Follow-up|16|||
131788526|NCT00368537|474509048|FG001|Baseline Participants|Lost to Follow-up|17|||
131788527|NCT00368537|474509047|FG000|Baseline Participants|Withdrawal by Subject|6|||
131703345|NCT03072160|474196784|FG001|Overall Study|Physician Decision|0|||
131703346|NCT03072160|474196783|FG000|Overall Study|Disease progression on study|1|||
131703347|NCT03072160|474196784|FG001|Overall Study|Disease progression on study|1|||
131703348|NCT03072160|474196783|FG000|Overall Study|No contact|0|||
131703349|NCT03072160|474196784|FG001|Overall Study|No contact|1|||
131703350|NCT00179959|474196785|FG000|Overall Study|Lost to Follow-up|3|||
131703351|NCT00179959|474196786|FG001|Overall Study|Lost to Follow-up|1|||
131703352|NCT00179959|474196785|FG000|Overall Study|Withdrawal by Subject|3|||
131703353|NCT00179959|474196786|FG001|Overall Study|Withdrawal by Subject|2|||
131703354|NCT00408694|474196787|FG000|Overall Study|Ineligible|1|||
131703355|NCT00408694|474196787|FG000|Overall Study|No protocol treatment|1|||
131703356|NCT03261531|474196788|FG000|Overall Study|Withdrawal by Subject|4|||
131703357|NCT00666926|474196789|FG000|Overall Study|Adverse Event|0|||
131703358|NCT00666926|474196790|FG001|Overall Study|Adverse Event|0|||
131703359|NCT00666926|474196791|FG002|Overall Study|Adverse Event|0|||
131703360|NCT00666926|474196792|FG003|Overall Study|Adverse Event|0|||
131703361|NCT00666926|474196793|FG004|Overall Study|Adverse Event|0|||
131703362|NCT00666926|474196794|FG005|Overall Study|Adverse Event|0|||
131703363|NCT00666926|474196795|FG006|Overall Study|Adverse Event|0|||
131703364|NCT00666926|474196796|FG007|Overall Study|Adverse Event|0|||
131703365|NCT00666926|474196797|FG008|Overall Study|Adverse Event|0|||
131703366|NCT00666926|474196798|FG009|Overall Study|Adverse Event|2|||
131703367|NCT00666926|474196799|FG010|Overall Study|Adverse Event|2|||
131703368|NCT00666926|474196800|FG011|Overall Study|Adverse Event|2|||
131703369|NCT00666926|474196801|FG012|Overall Study|Adverse Event|0|||
131703370|NCT00666926|474196802|FG013|Overall Study|Adverse Event|1|||
131703371|NCT00666926|474196803|FG014|Overall Study|Adverse Event|0|||
131703372|NCT00666926|474196804|FG015|Overall Study|Adverse Event|0|||
131703373|NCT00666926|474196789|FG000|Overall Study|Laboratory abnormality|0|||
131703374|NCT00666926|474196790|FG001|Overall Study|Laboratory abnormality|0|||
131703375|NCT00666926|474196791|FG002|Overall Study|Laboratory abnormality|0|||
131703376|NCT00666926|474196792|FG003|Overall Study|Laboratory abnormality|0|||
131703377|NCT00666926|474196793|FG004|Overall Study|Laboratory abnormality|0|||
131703378|NCT00666926|474196794|FG005|Overall Study|Laboratory abnormality|0|||
131703379|NCT00666926|474196795|FG006|Overall Study|Laboratory abnormality|0|||
131703380|NCT00666926|474196796|FG007|Overall Study|Laboratory abnormality|0|||
131703381|NCT00666926|474196797|FG008|Overall Study|Laboratory abnormality|0|||
131703382|NCT00666926|474196798|FG009|Overall Study|Laboratory abnormality|0|||
131703383|NCT00666926|474196799|FG010|Overall Study|Laboratory abnormality|1|||
131703384|NCT00666926|474196800|FG011|Overall Study|Laboratory abnormality|0|||
131703385|NCT00666926|474196801|FG012|Overall Study|Laboratory abnormality|0|||
131703386|NCT00666926|474196802|FG013|Overall Study|Laboratory abnormality|0|||
131703387|NCT00666926|474196803|FG014|Overall Study|Laboratory abnormality|0|||
131703388|NCT00666926|474196804|FG015|Overall Study|Laboratory abnormality|1|||
131703389|NCT00666926|474196789|FG000|Overall Study|Lack of Efficacy|0|||
131703390|NCT00666926|474196790|FG001|Overall Study|Lack of Efficacy|0|||
131703391|NCT00666926|474196791|FG002|Overall Study|Lack of Efficacy|0|||
131703392|NCT00666926|474196792|FG003|Overall Study|Lack of Efficacy|0|||
131703393|NCT00666926|474196793|FG004|Overall Study|Lack of Efficacy|0|||
131703394|NCT00666926|474196794|FG005|Overall Study|Lack of Efficacy|1|||
131703395|NCT00666926|474196795|FG006|Overall Study|Lack of Efficacy|0|||
131703396|NCT00666926|474196796|FG007|Overall Study|Lack of Efficacy|0|||
131703397|NCT00666926|474196797|FG008|Overall Study|Lack of Efficacy|0|||
131703398|NCT00666926|474196798|FG009|Overall Study|Lack of Efficacy|0|||
131703399|NCT00666926|474196799|FG010|Overall Study|Lack of Efficacy|0|||
131703400|NCT00666926|474196800|FG011|Overall Study|Lack of Efficacy|1|||
131703401|NCT00666926|474196801|FG012|Overall Study|Lack of Efficacy|0|||
131703402|NCT00666926|474196802|FG013|Overall Study|Lack of Efficacy|0|||
131703403|NCT00666926|474196803|FG014|Overall Study|Lack of Efficacy|0|||
131703404|NCT00666926|474196804|FG015|Overall Study|Lack of Efficacy|0|||
131703405|NCT00666926|474196789|FG000|Overall Study|Lost to Follow-up|0|||
131788528|NCT00368537|474509048|FG001|Baseline Participants|Withdrawal by Subject|4|||
131703406|NCT00666926|474196790|FG001|Overall Study|Lost to Follow-up|0|||
131788529|NCT00368537|474509047|FG000|Baseline Participants|Death|1|||
131703407|NCT00666926|474196791|FG002|Overall Study|Lost to Follow-up|0|||
131788530|NCT00368537|474509048|FG001|Baseline Participants|Death|2|||
131703408|NCT00666926|474196792|FG003|Overall Study|Lost to Follow-up|1|||
131703409|NCT00666926|474196793|FG004|Overall Study|Lost to Follow-up|0|||
131703410|NCT00666926|474196794|FG005|Overall Study|Lost to Follow-up|0|||
131703411|NCT00666926|474196795|FG006|Overall Study|Lost to Follow-up|0|||
131703412|NCT00666926|474196796|FG007|Overall Study|Lost to Follow-up|0|||
131703413|NCT00666926|474196797|FG008|Overall Study|Lost to Follow-up|0|||
131703414|NCT00666926|474196798|FG009|Overall Study|Lost to Follow-up|0|||
131703415|NCT00666926|474196799|FG010|Overall Study|Lost to Follow-up|0|||
131703416|NCT00666926|474196800|FG011|Overall Study|Lost to Follow-up|0|||
131703417|NCT00666926|474196801|FG012|Overall Study|Lost to Follow-up|0|||
131788531|NCT00368537|474509047|FG000|Baseline Participants|No susceptibility|1|||
131788532|NCT00368537|474509048|FG001|Baseline Participants|No susceptibility|0|||
131788533|NCT00368537|474509047|FG000|Baseline Participants|Patient uncompliant|0|||
131788534|NCT00368537|474509048|FG001|Baseline Participants|Patient uncompliant|1|||
131788535|NCT00685919|474509063|FG000|Overall Study|Withdrawal by Subject|0|||
131788536|NCT00685919|474509064|FG001|Overall Study|Withdrawal by Subject|0|||
131788537|NCT00685919|474509065|FG002|Overall Study|Withdrawal by Subject|1|||
131788538|NCT00685919|474509066|FG003|Overall Study|Withdrawal by Subject|0|||
131788539|NCT00685919|474509063|FG000|Overall Study|Physician Decision|1|||
131703418|NCT00666926|474196802|FG013|Overall Study|Lost to Follow-up|0|||
131703419|NCT00666926|474196803|FG014|Overall Study|Lost to Follow-up|0|||
131703420|NCT00666926|474196804|FG015|Overall Study|Lost to Follow-up|0|||
131703421|NCT00666926|474196789|FG000|Overall Study|Other|2|||
131703422|NCT00666926|474196790|FG001|Overall Study|Other|4|||
131703423|NCT00666926|474196791|FG002|Overall Study|Other|3|||
131703424|NCT00666926|474196792|FG003|Overall Study|Other|3|||
131703425|NCT00666926|474196793|FG004|Overall Study|Other|3|||
131703426|NCT00666926|474196794|FG005|Overall Study|Other|3|||
131703427|NCT00666926|474196795|FG006|Overall Study|Other|4|||
131703428|NCT00666926|474196796|FG007|Overall Study|Other|0|||
131703429|NCT00666926|474196797|FG008|Overall Study|Other|3|||
131703430|NCT00666926|474196798|FG009|Overall Study|Other|5|||
131703431|NCT00666926|474196799|FG010|Overall Study|Other|3|||
131703432|NCT00666926|474196800|FG011|Overall Study|Other|26|||
131703433|NCT00666926|474196801|FG012|Overall Study|Other|3|||
131703434|NCT00666926|474196802|FG013|Overall Study|Other|2|||
131703435|NCT00666926|474196803|FG014|Overall Study|Other|4|||
131703436|NCT00666926|474196804|FG015|Overall Study|Other|4|||
131703437|NCT00666926|474196789|FG000|Overall Study|Withdrawal by Subject|0|||
131703438|NCT00666926|474196790|FG001|Overall Study|Withdrawal by Subject|0|||
131703439|NCT00666926|474196791|FG002|Overall Study|Withdrawal by Subject|0|||
131703440|NCT00666926|474196792|FG003|Overall Study|Withdrawal by Subject|0|||
131703441|NCT00666926|474196793|FG004|Overall Study|Withdrawal by Subject|0|||
131703442|NCT00666926|474196794|FG005|Overall Study|Withdrawal by Subject|0|||
131703443|NCT00666926|474196795|FG006|Overall Study|Withdrawal by Subject|0|||
131703444|NCT00666926|474196796|FG007|Overall Study|Withdrawal by Subject|1|||
131703445|NCT00666926|474196797|FG008|Overall Study|Withdrawal by Subject|0|||
131703446|NCT00666926|474196798|FG009|Overall Study|Withdrawal by Subject|3|||
131703447|NCT00666926|474196799|FG010|Overall Study|Withdrawal by Subject|0|||
131703448|NCT00666926|474196800|FG011|Overall Study|Withdrawal by Subject|3|||
131703449|NCT00666926|474196801|FG012|Overall Study|Withdrawal by Subject|0|||
131703450|NCT00666926|474196802|FG013|Overall Study|Withdrawal by Subject|1|||
131703451|NCT00666926|474196803|FG014|Overall Study|Withdrawal by Subject|3|||
131703452|NCT00666926|474196804|FG015|Overall Study|Withdrawal by Subject|3|||
131703453|NCT00666926|474196789|FG000|Overall Study|Death|0|||
131703454|NCT00666926|474196790|FG001|Overall Study|Death|0|||
131703455|NCT00666926|474196791|FG002|Overall Study|Death|0|||
131703456|NCT00666926|474196792|FG003|Overall Study|Death|0|||
131703457|NCT00666926|474196793|FG004|Overall Study|Death|0|||
131703458|NCT00666926|474196794|FG005|Overall Study|Death|0|||
131703459|NCT00666926|474196795|FG006|Overall Study|Death|0|||
131703460|NCT00666926|474196796|FG007|Overall Study|Death|0|||
131703461|NCT00666926|474196797|FG008|Overall Study|Death|0|||
131703462|NCT00666926|474196798|FG009|Overall Study|Death|0|||
131703463|NCT00666926|474196799|FG010|Overall Study|Death|0|||
131703464|NCT00666926|474196800|FG011|Overall Study|Death|1|||
131703465|NCT00666926|474196801|FG012|Overall Study|Death|0|||
131703466|NCT00666926|474196802|FG013|Overall Study|Death|0|||
131703467|NCT00666926|474196803|FG014|Overall Study|Death|0|||
131703468|NCT00666926|474196804|FG015|Overall Study|Death|0|||
131703469|NCT02883244|474196805|FG000|Overall Study|Lost to Follow-up|0|||
131703470|NCT02883244|474196806|FG001|Overall Study|Lost to Follow-up|1|||
131703471|NCT04178772|474196807|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
131788540|NCT00685919|474509064|FG001|Overall Study|Physician Decision|0|||
131788541|NCT00685919|474509065|FG002|Overall Study|Physician Decision|0|||
131788542|NCT00685919|474509066|FG003|Overall Study|Physician Decision|0|||
131703472|NCT04178772|474196807|FG000|Overall Study|study terminated early due to COVID-19|7|||
131703473|NCT00773279|474196808|FG000|Period 1|Adverse Event|2|||
131703474|NCT00773279|474196809|FG001|Period 1|Adverse Event|1|||
131703475|NCT00773279|474196808|FG000|Period 1|Lack of Efficacy|0|||
131703476|NCT00773279|474196809|FG001|Period 1|Lack of Efficacy|2|||
131703477|NCT00773279|474196808|FG000|Period 1|Unclassified|5|||
131703478|NCT00773279|474196809|FG001|Period 1|Unclassified|1|||
131703479|NCT00773279|474196808|FG000|Period 2|Adverse Event|0|||
131703480|NCT00773279|474196809|FG001|Period 2|Adverse Event|1|||
131703481|NCT00773279|474196808|FG000|Period 2|Lack of Efficacy|1|||
131703482|NCT00773279|474196809|FG001|Period 2|Lack of Efficacy|0|||
131703483|NCT00773279|474196808|FG000|Period 2|Protocol Violation|0|||
131703484|NCT00773279|474196809|FG001|Period 2|Protocol Violation|3|||
131703485|NCT00773279|474196808|FG000|Period 2|Unclassified|2|||
131703486|NCT00773279|474196809|FG001|Period 2|Unclassified|2|||
131703487|NCT02817087|474196810|FG000|Overall Study|Withdrawal by Subject|2|||
131788543|NCT02732561|474509074|FG000|Overall Study|Lost to Follow-up|1|||
131788544|NCT02732561|474509075|FG001|Overall Study|Lost to Follow-up|1|||
131788545|NCT02732561|474509074|FG000|Overall Study|Withdrawal by Subject|1|||
131788546|NCT02732561|474509075|FG001|Overall Study|Withdrawal by Subject|0|||
131788547|NCT02410837|474509081|FG000|Overall Study|Death|387|||
131788548|NCT02410837|474509081|FG000|Overall Study|Lost to Follow-up|50|||
131788549|NCT02410837|474509081|FG000|Overall Study|Withdrawal by Subject|44|||
131788550|NCT02410837|474509081|FG000|Overall Study|Physician Decision|6|||
131788551|NCT02410837|474509081|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
131788552|NCT00837577|474509082|FG000|Double-blind Period|Clinical Adverse Event|1|||
131788553|NCT00837577|474509083|FG001|Double-blind Period|Clinical Adverse Event|0|||
131788554|NCT00837577|474509082|FG000|Double-blind Period|Withdrawal by Subject|1|||
131788555|NCT00837577|474509083|FG001|Double-blind Period|Withdrawal by Subject|0|||
131788556|NCT00837577|474509082|FG000|Open-label Period|Clinical Adverse Event|2|||
131788557|NCT00837577|474509083|FG001|Open-label Period|Clinical Adverse Event|2|||
131788558|NCT00837577|474509082|FG000|Open-label Period|Laboratory Adverse Event|0|||
131788559|NCT00837577|474509083|FG001|Open-label Period|Laboratory Adverse Event|1|||
131788560|NCT00837577|474509082|FG000|Open-label Period|Lack of Efficacy|4|||
131788561|NCT00837577|474509083|FG001|Open-label Period|Lack of Efficacy|3|||
131788562|NCT00837577|474509082|FG000|Open-label Period|Withdrawal by Subject|1|||
131788563|NCT00837577|474509083|FG001|Open-label Period|Withdrawal by Subject|2|||
131788564|NCT00837577|474509082|FG000|Open-label Period|Other Reason|1|||
131788565|NCT00837577|474509083|FG001|Open-label Period|Other Reason|1|||
131788566|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
131788567|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
131788568|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
131788569|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
131788570|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
131788571|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
131788572|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
131788573|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
131788574|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
131788575|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
131788576|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
131788577|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
131788578|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
131788579|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131788580|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131788581|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
131788582|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
131788583|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
131788584|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
131788585|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
131788586|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
131788587|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
131788588|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
131788589|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
131788590|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
131788591|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
131788592|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
131788593|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
131788594|NCT00528879|474509086|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
131788595|NCT00528879|474509087|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
131788596|NCT00528879|474509088|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
131788597|NCT00528879|474509089|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
131788598|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
131788599|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
131788600|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
131788601|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
131788602|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
131788603|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
131788604|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
131788605|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
131788606|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
131788607|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
131788608|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
131788609|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
131788610|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
131788611|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
131703488|NCT02817087|474196811|FG001|Overall Study|Withdrawal by Subject|0|||
131703489|NCT00880256|474196812|FG000|Overall Study|Lost to Follow-up|28|||
131703490|NCT01162421|474196813|FG000|Overall Study|Did not receive study drug|2|||
131703491|NCT01162421|474196814|FG001|Overall Study|Did not receive study drug|1|||
131703492|NCT01162421|474196813|FG000|Overall Study|Adverse Event|2|||
131703493|NCT01162421|474196814|FG001|Overall Study|Adverse Event|5|||
131703494|NCT01162421|474196813|FG000|Overall Study|Lost to Follow-up|0|||
131703495|NCT01162421|474196814|FG001|Overall Study|Lost to Follow-up|2|||
131703496|NCT01162421|474196813|FG000|Overall Study|Lack of Efficacy|2|||
131703497|NCT01162421|474196814|FG001|Overall Study|Lack of Efficacy|2|||
131703498|NCT01162421|474196813|FG000|Overall Study|Other|2|||
131703499|NCT01162421|474196814|FG001|Overall Study|Other|3|||
131703500|NCT04871711|474196816|FG000|Overall Study|Withdrawal by Subject|11|||
131703501|NCT04871711|474196817|FG001|Overall Study|Withdrawal by Subject|5|||
131703502|NCT04871711|474196816|FG000|Overall Study|Lack of Efficacy|5|||
131703503|NCT04871711|474196817|FG001|Overall Study|Lack of Efficacy|7|||
131703504|NCT04871711|474196816|FG000|Overall Study|Adverse Event|2|||
131703505|NCT04871711|474196817|FG001|Overall Study|Adverse Event|6|||
131703506|NCT04871711|474196816|FG000|Overall Study|Various reasons|2|||
131703507|NCT04871711|474196817|FG001|Overall Study|Various reasons|1|||
131703508|NCT04871711|474196816|FG000|Overall Study|Lost to Follow-up|0|||
131703509|NCT04871711|474196817|FG001|Overall Study|Lost to Follow-up|2|||
131703510|NCT02183519|474196824|FG000|Overall Study|computer error|3|||
131703511|NCT02183519|474196825|FG001|Overall Study|computer error|0|||
131703512|NCT02183519|474196824|FG000|Overall Study|Did not respond to cough inducter|0|||
131703513|NCT02183519|474196825|FG001|Overall Study|Did not respond to cough inducter|3|||
131703514|NCT00695565|474196826|FG000|Overall Study|Lost to Follow-up|4|||
131703515|NCT00695565|474196827|FG001|Overall Study|Lost to Follow-up|4|||
131703516|NCT00695565|474196826|FG000|Overall Study|Adverse Event|3|||
131703517|NCT00695565|474196827|FG001|Overall Study|Adverse Event|1|||
131703518|NCT00695565|474196826|FG000|Overall Study|Protocol Violation|3|||
131703519|NCT00695565|474196827|FG001|Overall Study|Protocol Violation|1|||
131703520|NCT00695565|474196826|FG000|Overall Study|Withdrawal by Subject|1|||
131703521|NCT00695565|474196827|FG001|Overall Study|Withdrawal by Subject|1|||
131703522|NCT00695565|474196826|FG000|Overall Study|Lack of Efficacy|1|||
131703523|NCT00695565|474196827|FG001|Overall Study|Lack of Efficacy|1|||
131703524|NCT00695565|474196826|FG000|Overall Study|Subject did not follow instructions|1|||
131703525|NCT00695565|474196827|FG001|Overall Study|Subject did not follow instructions|1|||
131703526|NCT01462266|474196828|FG000|Overall Study|Adverse Event|7|||
131703527|NCT01462266|474196829|FG001|Overall Study|Adverse Event|6|||
131703528|NCT01462266|474196828|FG000|Overall Study|Death|2|||
131703529|NCT01462266|474196829|FG001|Overall Study|Death|1|||
131703530|NCT01462266|474196828|FG000|Overall Study|Lack of Efficacy|0|||
131703531|NCT01462266|474196829|FG001|Overall Study|Lack of Efficacy|2|||
131703532|NCT01462266|474196828|FG000|Overall Study|Lost to Follow-up|4|||
131703533|NCT01462266|474196829|FG001|Overall Study|Lost to Follow-up|3|||
131703534|NCT01462266|474196828|FG000|Overall Study|Non-compliance with study drug|3|||
131703535|NCT01462266|474196829|FG001|Overall Study|Non-compliance with study drug|0|||
131788612|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
131703536|NCT01462266|474196828|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
131703537|NCT01462266|474196829|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
131703538|NCT01462266|474196828|FG000|Overall Study|Physician Decision|2|||
131703539|NCT01462266|474196829|FG001|Overall Study|Physician Decision|5|||
131703540|NCT01462266|474196828|FG000|Overall Study|Protocol Violation|1|||
131703541|NCT01462266|474196829|FG001|Overall Study|Protocol Violation|3|||
131703542|NCT01462266|474196828|FG000|Overall Study|Withdrawal by Subject|7|||
131703543|NCT01462266|474196829|FG001|Overall Study|Withdrawal by Subject|2|||
131703544|NCT01462266|474196828|FG000|Overall Study|Screen failure|1|||
131703545|NCT01462266|474196829|FG001|Overall Study|Screen failure|1|||
131703546|NCT01106846|474196830|FG000|Overall Study|Change in surgical procedure|0|||
131703547|NCT01106846|474196831|FG001|Overall Study|Change in surgical procedure|1|||
131703548|NCT02419508|474196842|FG000|Overall Study|Adverse Event|9|||
131703549|NCT02419508|474196843|FG001|Overall Study|Adverse Event|3|||
131703550|NCT02419508|474196842|FG000|Overall Study|Withdrawal by Subject|1|||
131703551|NCT02419508|474196843|FG001|Overall Study|Withdrawal by Subject|0|||
131703552|NCT02419508|474196842|FG000|Overall Study|Other - Reason not specified|0|||
131703553|NCT02419508|474196843|FG001|Overall Study|Other - Reason not specified|1|||
131703554|NCT03110900|474196844|FG000|Overall Study|Sponsor withdrew|1|||
131703555|NCT03110900|474196845|FG001|Overall Study|Sponsor withdrew|1|||
131703556|NCT01738971|474196858|FG000|Overall Study|Lost to Follow-up|19|||
131703557|NCT01738971|474196859|FG001|Overall Study|Lost to Follow-up|30|||
131703558|NCT01738971|474196860|FG002|Overall Study|Lost to Follow-up|17|||
131703559|NCT01031446|474196861|FG000|Overall Study|Disease Progression|38|||
131703560|NCT01031446|474196861|FG000|Overall Study|Adverse Event|9|||
131703561|NCT01031446|474196861|FG000|Overall Study|Physician Decision|4|||
131703562|NCT01031446|474196861|FG000|Overall Study|Withdrawal by Subject|3|||
131703563|NCT01031446|474196861|FG000|Overall Study|Still on treatment|1|||
131703564|NCT02447848|474196862|FG000|Overall Study|Patient discharged|3|||
131703565|NCT02447848|474196862|FG000|Overall Study|Lack of Efficacy|4|||
131703566|NCT02447848|474196862|FG000|Overall Study|Withdrawal by Subject|4|||
131703567|NCT03344003|474196863|FG000|Overall Study|Switched to alternative treatment|1|||
131703568|NCT03344003|474196864|FG001|Overall Study|Switched to alternative treatment|0|||
131703569|NCT03344003|474196863|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
131703570|NCT03344003|474196864|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
131703571|NCT03631706|474196865|FG000|Overall Study|Randomized, not treated|1|||
131703572|NCT03631706|474196866|FG001|Overall Study|Randomized, not treated|0|||
131703573|NCT01583179|474198434|FG000|Overall Study|Screen failure|1|||
131703574|NCT01583179|474198435|FG001|Overall Study|Screen failure|2|||
131703575|NCT01246206|474198436|FG000|Overall Study|Patient did not receive study regiments.|1|||
131703576|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
131703577|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
131703578|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
131703579|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
131703580|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
131703581|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
131703582|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
131703583|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
131703584|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
131703585|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
131703586|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
131703587|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
131703588|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
131703589|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
131703590|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
131703591|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
131703592|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
131703593|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
131703594|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
131703595|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
131703596|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
131703597|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
131703598|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
131703599|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
131703600|NCT04660643|474198437|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
131703601|NCT04660643|474198438|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
131703602|NCT04660643|474198439|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
131703603|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
131703604|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
131703605|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
131703606|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
131703607|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
131703608|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
131703609|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
131703610|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
131703611|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
131582916|NCT01943916|473761540|FG000|Overall Study|Technical Failure|39|||
131703612|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
131788613|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
131788614|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
131788615|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
131582917|NCT01943916|473761540|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
131582918|NCT01943916|473761540|FG000|Overall Study|No Truth Panel Review|38|||
131582919|NCT01943916|473761540|FG000|Overall Study|Protocol Deviation|1|||
131582920|NCT01792830|473761541|FG000|Overall Study|Withdrawal by Subject|22|||
131582921|NCT01792830|473761542|FG001|Overall Study|Withdrawal by Subject|0|||
131582922|NCT01792830|473761543|FG002|Overall Study|Withdrawal by Subject|0|||
131582923|NCT01792830|473761544|FG003|Overall Study|Withdrawal by Subject|2|||
131582924|NCT01792830|473761545|FG004|Overall Study|Withdrawal by Subject|1|||
131582925|NCT01792830|473761546|FG005|Overall Study|Withdrawal by Subject|1|||
131582926|NCT01792830|473761547|FG006|Overall Study|Withdrawal by Subject|1|||
131582927|NCT01792830|473761548|FG007|Overall Study|Withdrawal by Subject|1|||
131582928|NCT01792830|473761549|FG008|Overall Study|Withdrawal by Subject|7|||
131582929|NCT01792830|473761550|FG009|Overall Study|Withdrawal by Subject|0|||
131582930|NCT01792830|473761551|FG010|Overall Study|Withdrawal by Subject|2|||
131582931|NCT01792830|473761541|FG000|Overall Study|Death|3|||
131582932|NCT01792830|473761542|FG001|Overall Study|Death|0|||
131582933|NCT01792830|473761543|FG002|Overall Study|Death|0|||
131582934|NCT01792830|473761544|FG003|Overall Study|Death|1|||
131582935|NCT01792830|473761545|FG004|Overall Study|Death|0|||
131582936|NCT01792830|473761546|FG005|Overall Study|Death|0|||
131582937|NCT01792830|473761547|FG006|Overall Study|Death|1|||
131582938|NCT01792830|473761548|FG007|Overall Study|Death|0|||
131582939|NCT01792830|473761549|FG008|Overall Study|Death|1|||
131582940|NCT01792830|473761550|FG009|Overall Study|Death|0|||
131582941|NCT01792830|473761551|FG010|Overall Study|Death|1|||
131582942|NCT01792830|473761541|FG000|Overall Study|Adverse Event|0|||
131582943|NCT01792830|473761542|FG001|Overall Study|Adverse Event|0|||
131582944|NCT01792830|473761543|FG002|Overall Study|Adverse Event|0|||
131582945|NCT01792830|473761544|FG003|Overall Study|Adverse Event|0|||
131582946|NCT01792830|473761545|FG004|Overall Study|Adverse Event|0|||
131582947|NCT01792830|473761546|FG005|Overall Study|Adverse Event|0|||
131582948|NCT01792830|473761547|FG006|Overall Study|Adverse Event|0|||
131582949|NCT01792830|473761548|FG007|Overall Study|Adverse Event|0|||
131582950|NCT01792830|473761549|FG008|Overall Study|Adverse Event|1|||
131582951|NCT01792830|473761550|FG009|Overall Study|Adverse Event|0|||
131582952|NCT01792830|473761551|FG010|Overall Study|Adverse Event|0|||
131582953|NCT03144674|473761575|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
131582954|NCT03144674|473761576|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
131582955|NCT03144674|473761577|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
131582956|NCT03144674|473761578|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
131582957|NCT03144674|473761575|FG000|Overall Study|Death|3|||
131582958|NCT03144674|473761576|FG001|Overall Study|Death|2|||
131582959|NCT03144674|473761577|FG002|Overall Study|Death|6|||
131582960|NCT03144674|473761578|FG003|Overall Study|Death|24|||
131582961|NCT03144674|473761575|FG000|Overall Study|Lost to Follow-up|0|||
131582962|NCT03144674|473761576|FG001|Overall Study|Lost to Follow-up|1|||
131582963|NCT03144674|473761577|FG002|Overall Study|Lost to Follow-up|0|||
131582964|NCT03144674|473761578|FG003|Overall Study|Lost to Follow-up|4|||
131703613|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
131703614|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
131703615|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
131703616|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
131703617|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
131703618|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
131788616|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
131788617|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
131788618|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
131438485|NCT03748823|473231252|FG000|Extension Period|Lost to Follow-up|0|||
131438486|NCT03748823|473231253|FG001|Extension Period|Lost to Follow-up|1|||
131582965|NCT03144674|473761575|FG000|Overall Study|Withdrawal by Participant|0|||
131582966|NCT03144674|473761576|FG001|Overall Study|Withdrawal by Participant|0|||
131582967|NCT03144674|473761577|FG002|Overall Study|Withdrawal by Participant|2|||
131582968|NCT03144674|473761578|FG003|Overall Study|Withdrawal by Participant|6|||
131582969|NCT03144674|473761575|FG000|Overall Study|Discharged from the Trust|0|||
131582970|NCT03144674|473761576|FG001|Overall Study|Discharged from the Trust|0|||
131438487|NCT03748823|473231252|FG000|Extension Period|Lack of Efficacy|0|||
131582971|NCT03144674|473761577|FG002|Overall Study|Discharged from the Trust|1|||
131582972|NCT03144674|473761578|FG003|Overall Study|Discharged from the Trust|0|||
131582973|NCT03144674|473761575|FG000|Overall Study|Exclusion Criteria Met|0|||
131582974|NCT03144674|473761576|FG001|Overall Study|Exclusion Criteria Met|0|||
131582975|NCT03144674|473761577|FG002|Overall Study|Exclusion Criteria Met|1|||
131582976|NCT03144674|473761578|FG003|Overall Study|Exclusion Criteria Met|0|||
131582977|NCT03144674|473761575|FG000|Overall Study|Changed Physicians|0|||
131582978|NCT03144674|473761576|FG001|Overall Study|Changed Physicians|0|||
131582979|NCT03144674|473761577|FG002|Overall Study|Changed Physicians|0|||
131582980|NCT03144674|473761578|FG003|Overall Study|Changed Physicians|1|||
131582981|NCT03144674|473761575|FG000|Overall Study|Removed for Safety|0|||
131582982|NCT03144674|473761576|FG001|Overall Study|Removed for Safety|0|||
131582983|NCT03144674|473761577|FG002|Overall Study|Removed for Safety|0|||
131582984|NCT03144674|473761578|FG003|Overall Study|Removed for Safety|1|||
131582985|NCT03144674|473761575|FG000|Overall Study|Site Closed|0|||
131582986|NCT03144674|473761576|FG001|Overall Study|Site Closed|0|||
131582987|NCT03144674|473761577|FG002|Overall Study|Site Closed|0|||
131582988|NCT03144674|473761578|FG003|Overall Study|Site Closed|1|||
131582989|NCT03144674|473761575|FG000|Overall Study|Histological Criteria Not Met|0|||
131582990|NCT03144674|473761576|FG001|Overall Study|Histological Criteria Not Met|0|||
131582991|NCT03144674|473761577|FG002|Overall Study|Histological Criteria Not Met|0|||
131582992|NCT03144674|473761578|FG003|Overall Study|Histological Criteria Not Met|1|||
131582993|NCT03144674|473761575|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
131582994|NCT03144674|473761576|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
131582995|NCT03144674|473761577|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
131582996|NCT03144674|473761578|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
131582997|NCT03144674|473761575|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
131582998|NCT03144674|473761576|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
131582999|NCT03144674|473761577|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
131583000|NCT03144674|473761578|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
131583001|NCT01373346|473761582|FG000|Overall Study|Death|1|||
131583002|NCT01198028|473761583|FG000|Overall Study|Adverse Event|5|||
131583003|NCT01198028|473761583|FG000|Overall Study|Death|3|||
131583004|NCT01198028|473761583|FG000|Overall Study|Physician Decision|2|||
131583005|NCT01395758|473761584|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
131583006|NCT01395758|473761585|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131583007|NCT01395758|473761586|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
131583008|NCT00357097|473761587|FG000|Overall Study|Did not meet inclusion criteria|5|||
131583009|NCT00357097|473761588|FG001|Overall Study|Did not meet inclusion criteria|3|||
131583010|NCT00357097|473761587|FG000|Overall Study|Adverse Event|34|||
131583011|NCT00357097|473761588|FG001|Overall Study|Adverse Event|6|||
131583012|NCT00357097|473761587|FG000|Overall Study|Withdrawal by Subject|8|||
131583013|NCT00357097|473761588|FG001|Overall Study|Withdrawal by Subject|7|||
131583014|NCT00357097|473761587|FG000|Overall Study|Non-compliance|1|||
131583015|NCT00357097|473761588|FG001|Overall Study|Non-compliance|2|||
131703619|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
131703620|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
131703621|NCT04660643|474198437|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
131703622|NCT04660643|474198438|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
131703623|NCT04660643|474198439|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
131703624|NCT00860158|474198440|FG000|Overall Study|Study Terminated|1|||
131703625|NCT00669617|474198442|FG000|Period 1|Withdrawal by Subject|0|||
131703626|NCT00669617|474198443|FG001|Period 1|Withdrawal by Subject|0|||
131703627|NCT00669617|474198444|FG002|Period 1|Withdrawal by Subject|1|||
131703628|NCT00669617|474198445|FG003|Period 1|Withdrawal by Subject|0|||
131703629|NCT00669617|474198446|FG004|Period 1|Withdrawal by Subject|0|||
131703630|NCT00669617|474198442|FG000|Period 1|Protocol Deviation|0|||
131703631|NCT00669617|474198443|FG001|Period 1|Protocol Deviation|0|||
131703632|NCT00669617|474198444|FG002|Period 1|Protocol Deviation|0|||
131703633|NCT00669617|474198445|FG003|Period 1|Protocol Deviation|0|||
131703634|NCT00669617|474198446|FG004|Period 1|Protocol Deviation|1|||
131703635|NCT00669617|474198442|FG000|Period 3|Lost to Follow-up|1|||
131703636|NCT00669617|474198443|FG001|Period 3|Lost to Follow-up|0|||
131703637|NCT00669617|474198444|FG002|Period 3|Lost to Follow-up|0|||
131703638|NCT00669617|474198445|FG003|Period 3|Lost to Follow-up|0|||
131703639|NCT00669617|474198446|FG004|Period 3|Lost to Follow-up|0|||
131703640|NCT05499520|474198447|FG000|Overall Study|Lost to Follow-up|0|||
131703641|NCT05499520|474198448|FG001|Overall Study|Lost to Follow-up|0|||
131438488|NCT03748823|473231253|FG001|Extension Period|Lack of Efficacy|1|||
131438489|NCT03748823|473231252|FG000|Extension Period|Physician Decision|1|||
131583016|NCT00357097|473761587|FG000|Overall Study|Lack of Efficacy|2|||
131583017|NCT00357097|473761588|FG001|Overall Study|Lack of Efficacy|8|||
131583018|NCT00357097|473761587|FG000|Overall Study|Met Exclusion Criteria|3|||
131703642|NCT05499520|474198449|FG002|Overall Study|Lost to Follow-up|38|||
131703643|NCT05499520|474198450|FG003|Overall Study|Lost to Follow-up|41|||
131703644|NCT05499520|474198451|FG004|Overall Study|Lost to Follow-up|46|||
131703645|NCT05499520|474198452|FG005|Overall Study|Lost to Follow-up|0|||
131703646|NCT05499520|474198453|FG006|Overall Study|Lost to Follow-up|31|||
131583019|NCT00357097|473761588|FG001|Overall Study|Met Exclusion Criteria|1|||
131583020|NCT00357097|473761587|FG000|Overall Study|Other|1|||
131583021|NCT00357097|473761588|FG001|Overall Study|Other|1|||
131583022|NCT00357097|473761587|FG000|Overall Study|Increase of RLS Symptoms|0|||
131583023|NCT00357097|473761588|FG001|Overall Study|Increase of RLS Symptoms|1|||
131583024|NCT00794118|473761589|FG000|Overall Study|Lost to Follow-up|16|||
131583025|NCT00794118|473761589|FG000|Overall Study|Withdrawal by Subject|9|||
131583026|NCT00794118|473761589|FG000|Overall Study|Changed hospital center|2|||
131583027|NCT01170962|473761591|FG000|Treatment Period|Lack of Efficacy|96|||
131583028|NCT01170962|473761592|FG001|Treatment Period|Lack of Efficacy|91|||
131583029|NCT01170962|473761593|FG002|Treatment Period|Lack of Efficacy|7|||
131583030|NCT01170962|473761591|FG000|Treatment Period|Adverse Event|11|||
131583031|NCT01170962|473761592|FG001|Treatment Period|Adverse Event|12|||
131583032|NCT01170962|473761593|FG002|Treatment Period|Adverse Event|3|||
131583033|NCT01170962|473761591|FG000|Treatment Period|Withdrawal by Subject|2|||
131583034|NCT01170962|473761592|FG001|Treatment Period|Withdrawal by Subject|1|||
131583035|NCT01170962|473761593|FG002|Treatment Period|Withdrawal by Subject|0|||
131583036|NCT01170962|473761591|FG000|Treatment Period|Lost to Follow-up|1|||
131583037|NCT01170962|473761592|FG001|Treatment Period|Lost to Follow-up|1|||
131583038|NCT01170962|473761593|FG002|Treatment Period|Lost to Follow-up|1|||
131583039|NCT01170962|473761591|FG000|Treatment Period|Participant no longer meets criteria|0|||
131583040|NCT01170962|473761592|FG001|Treatment Period|Participant no longer meets criteria|1|||
131583041|NCT01170962|473761593|FG002|Treatment Period|Participant no longer meets criteria|0|||
131583042|NCT01170962|473761591|FG000|Treatment Period|Request to discontinue treatment|7|||
131583043|NCT01170962|473761592|FG001|Treatment Period|Request to discontinue treatment|3|||
131703647|NCT05499520|474198454|FG007|Overall Study|Lost to Follow-up|45|||
131703648|NCT05499520|474198455|FG008|Overall Study|Lost to Follow-up|42|||
131703649|NCT05499520|474198456|FG009|Overall Study|Lost to Follow-up|0|||
131703650|NCT05499520|474198457|FG010|Overall Study|Lost to Follow-up|0|||
131703651|NCT05499520|474198458|FG011|Overall Study|Lost to Follow-up|37|||
131703652|NCT05499520|474198459|FG012|Overall Study|Lost to Follow-up|53|||
131703653|NCT05499520|474198460|FG013|Overall Study|Lost to Follow-up|49|||
131703654|NCT05499520|474198461|FG014|Overall Study|Lost to Follow-up|0|||
131703655|NCT05499520|474198462|FG015|Overall Study|Lost to Follow-up|36|||
131703656|NCT05499520|474198463|FG016|Overall Study|Lost to Follow-up|58|||
131703657|NCT05499520|474198464|FG017|Overall Study|Lost to Follow-up|53|||
131703658|NCT02494596|474198465|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131703659|NCT02494596|474198466|FG001|Overall Study|Insufficient Therapeutic Response|3|||
131703660|NCT02494596|474198467|FG002|Overall Study|Insufficient Therapeutic Response|1|||
131703661|NCT02494596|474198465|FG000|Overall Study|Adverse Event|0|||
131703662|NCT02494596|474198466|FG001|Overall Study|Adverse Event|1|||
131703663|NCT02494596|474198467|FG002|Overall Study|Adverse Event|0|||
131703664|NCT02494596|474198465|FG000|Overall Study|Refused Treatment|0|||
131703665|NCT02494596|474198466|FG001|Overall Study|Refused Treatment|1|||
131703666|NCT02494596|474198467|FG002|Overall Study|Refused Treatment|0|||
131703667|NCT00584194|474198468|FG000|Overall Study|Other|135|||
131703668|NCT03555266|474198475|FG000|Overall Study|Protocol Violation|6|||
131703669|NCT03555266|474198476|FG001|Overall Study|Protocol Violation|4|||
131703670|NCT02167945|474198477|FG000|Overall Study|Adverse Event|16|||
131703671|NCT02167945|474198477|FG000|Overall Study|Withdrew Consent|42|||
131703672|NCT02167945|474198477|FG000|Overall Study|Lost to Follow-up|122|||
131703673|NCT02167945|474198477|FG000|Overall Study|COVID-19 logistical restrictions|6|||
131703674|NCT02167945|474198477|FG000|Overall Study|Other, not specified|63|||
131703675|NCT02239263|474198478|FG000|Overall Study|Protocol Violation|6|||
131703676|NCT01058096|474198480|FG000|Double-blind Treatment Phase|Adverse Event|11|||
131703677|NCT01058096|474198481|FG001|Double-blind Treatment Phase|Adverse Event|15|||
131703678|NCT01058096|474198480|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
131703679|NCT01058096|474198481|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
131703680|NCT01058096|474198480|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
131703681|NCT01058096|474198481|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
131703682|NCT01058096|474198480|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
131703683|NCT01058096|474198481|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
131703684|NCT01058096|474198480|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131703685|NCT01058096|474198481|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
131703686|NCT01058096|474198480|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
131703687|NCT01058096|474198481|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
131703688|NCT04276207|474198482|FG000|Period 1|Withdrawal by Subject|0|||
131703689|NCT04276207|474198483|FG001|Period 1|Withdrawal by Subject|1|||
131703690|NCT02769624|474198484|FG000|Overall Study|Lost to Follow-up|0|||
131703691|NCT02769624|474198485|FG001|Overall Study|Lost to Follow-up|1|||
131703692|NCT04451330|474198486|FG000|Overall Study|Adverse Event|1|||
131703693|NCT04451330|474198487|FG001|Overall Study|Adverse Event|2|||
131703694|NCT04451330|474198486|FG000|Overall Study|Lost to Follow-up|5|||
131703695|NCT04451330|474198487|FG001|Overall Study|Lost to Follow-up|0|||
131703696|NCT04451330|474198486|FG000|Overall Study|Withdrawal by Subject|3|||
131703697|NCT04451330|474198487|FG001|Overall Study|Withdrawal by Subject|1|||
131583044|NCT01170962|473761593|FG002|Treatment Period|Request to discontinue treatment|1|||
131703698|NCT04451330|474198486|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131703699|NCT04451330|474198487|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131703700|NCT04451330|474198486|FG000|Overall Study|Other than specified|0|||
131703701|NCT04451330|474198487|FG001|Overall Study|Other than specified|1|||
131788619|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
131788620|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
131788621|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
131788622|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
131788623|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
131788624|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
131788625|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
131788626|NCT00528879|474509086|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
131788627|NCT00528879|474509087|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
131788628|NCT00528879|474509088|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
131788629|NCT00528879|474509089|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
131788630|NCT04133519|474509090|FG000|Overall Study|Withdrawal by Subject|5|||
131788631|NCT04133519|474509091|FG001|Overall Study|Withdrawal by Subject|4|||
131788632|NCT04133519|474509090|FG000|Overall Study|Protocol Violation|0|||
131788633|NCT04133519|474509091|FG001|Overall Study|Protocol Violation|1|||
131788634|NCT04133519|474509090|FG000|Overall Study|Never started treatment|1|||
131788635|NCT04133519|474509091|FG001|Overall Study|Never started treatment|1|||
131788636|NCT02217345|474509092|FG000|Overall Study|Lost to Follow-up|2|||
131788637|NCT02217345|474509093|FG001|Overall Study|Lost to Follow-up|1|||
131788638|NCT02217345|474509092|FG000|Overall Study|Withdrawal by Subject|3|||
131788639|NCT02217345|474509093|FG001|Overall Study|Withdrawal by Subject|2|||
131788640|NCT02217345|474509092|FG000|Overall Study|Adverse Event|2|||
131788641|NCT02217345|474509093|FG001|Overall Study|Adverse Event|1|||
131788642|NCT02217345|474509092|FG000|Overall Study|Physician Decision|0|||
131788643|NCT02217345|474509093|FG001|Overall Study|Physician Decision|1|||
131788644|NCT02729194|474509094|FG000|Overall Study|Withdrawal by Subject|3|||
131788645|NCT01361607|474509095|FG000|Overall Study|Adverse Event|38|||
131788646|NCT01361607|474509096|FG001|Overall Study|Adverse Event|29|||
131788647|NCT01361607|474509095|FG000|Overall Study|Withdrawal by Subject|19|||
131788648|NCT01361607|474509096|FG001|Overall Study|Withdrawal by Subject|8|||
131788649|NCT01361607|474509095|FG000|Overall Study|Withdrawal by Investigator|5|||
131788650|NCT01361607|474509096|FG001|Overall Study|Withdrawal by Investigator|3|||
131788651|NCT01361607|474509095|FG000|Overall Study|Lost to Follow-up|1|||
131788652|NCT01361607|474509096|FG001|Overall Study|Lost to Follow-up|0|||
131788653|NCT01361607|474509095|FG000|Overall Study|Met Withdrawal Criteria|1|||
131788654|NCT01361607|474509096|FG001|Overall Study|Met Withdrawal Criteria|1|||
131788655|NCT03196791|474509099|FG000|Overall Study|Protocol Violation|7|||
131788656|NCT03196791|474509100|FG001|Overall Study|Protocol Violation|3|||
131788657|NCT03196791|474509099|FG000|Overall Study|Withdrawal by Subject|3|||
131583045|NCT01170962|473761591|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
131583046|NCT01170962|473761592|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
131583047|NCT01170962|473761593|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
131583048|NCT01170962|473761591|FG000|Follow up Period|Withdrawal by Subject|14|||
131583049|NCT01170962|473761592|FG001|Follow up Period|Withdrawal by Subject|10|||
131583050|NCT01170962|473761593|FG002|Follow up Period|Withdrawal by Subject|2|||
131583051|NCT01170962|473761591|FG000|Follow up Period|Lost to Follow-up|13|||
131703702|NCT05099640|474198488|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
131788658|NCT03196791|474509100|FG001|Overall Study|Withdrawal by Subject|2|||
131788659|NCT03412019|474509101|FG000|Overall Study|Withdrawal by Subject|1|||
131788660|NCT03412019|474509102|FG001|Overall Study|Withdrawal by Subject|1|||
131788661|NCT00373685|474509108|FG000|Overall Study|Death|2|||
131703703|NCT05099640|474198489|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
131703704|NCT05099640|474198490|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
131703705|NCT05099640|474198488|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
131703706|NCT05099640|474198489|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
131703707|NCT05099640|474198490|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
131703708|NCT05099640|474198488|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
131703709|NCT05099640|474198489|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
131703710|NCT05099640|474198490|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
131703711|NCT05099640|474198488|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
131703712|NCT05099640|474198489|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
131788662|NCT00373685|474509109|FG001|Overall Study|Death|1|||
131788663|NCT00373685|474509108|FG000|Overall Study|Adverse Event|278|||
131788664|NCT00373685|474509109|FG001|Overall Study|Adverse Event|253|||
131788665|NCT00373685|474509108|FG000|Overall Study|Insufficient clinical response|169|||
131788666|NCT00373685|474509109|FG001|Overall Study|Insufficient clinical response|119|||
131788667|NCT00373685|474509108|FG000|Overall Study|Did not meet entrance criteria|167|||
131788668|NCT00373685|474509109|FG001|Overall Study|Did not meet entrance criteria|184|||
131788669|NCT00373685|474509108|FG000|Overall Study|Lost to follow up|83|||
131788670|NCT00373685|474509109|FG001|Overall Study|Lost to follow up|103|||
131788671|NCT00373685|474509108|FG000|Overall Study|No longer willing to participate|337|||
131583052|NCT01170962|473761592|FG001|Follow up Period|Lost to Follow-up|8|||
131583053|NCT01170962|473761593|FG002|Follow up Period|Lost to Follow-up|1|||
131583054|NCT01170962|473761591|FG000|Follow up Period|Death|2|||
131583055|NCT01170962|473761592|FG001|Follow up Period|Death|2|||
131583056|NCT01170962|473761593|FG002|Follow up Period|Death|0|||
131583057|NCT01170962|473761591|FG000|Follow up Period|Others|10|||
131583058|NCT01170962|473761592|FG001|Follow up Period|Others|7|||
131583059|NCT01170962|473761593|FG002|Follow up Period|Others|3|||
131583060|NCT03887650|473761594|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
131583061|NCT03887650|473761595|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
131583062|NCT03887650|473761594|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
131583063|NCT03887650|473761595|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
131583064|NCT03887650|473761594|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
131583065|NCT03887650|473761595|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
131583066|NCT00837616|473761596|FG000|Overall Study|Withdrawal by Subject|0|||
131583067|NCT00837616|473761597|FG001|Overall Study|Withdrawal by Subject|1|||
131583068|NCT02674750|473761599|FG000|Overall Study|Death|4|||
131583069|NCT02674750|473761600|FG001|Overall Study|Death|5|||
131583070|NCT02674750|473761601|FG002|Overall Study|Death|8|||
131583071|NCT02674750|473761599|FG000|Overall Study|Lost to Follow-up|0|||
131583072|NCT02674750|473761600|FG001|Overall Study|Lost to Follow-up|8|||
131583073|NCT02674750|473761601|FG002|Overall Study|Lost to Follow-up|0|||
131583074|NCT02674750|473761599|FG000|Overall Study|Lack of Efficacy|1|||
131583075|NCT02674750|473761600|FG001|Overall Study|Lack of Efficacy|17|||
131583076|NCT02674750|473761601|FG002|Overall Study|Lack of Efficacy|3|||
131583077|NCT02674750|473761599|FG000|Overall Study|Withdrawal by Subject|0|||
131583078|NCT02674750|473761600|FG001|Overall Study|Withdrawal by Subject|7|||
131583079|NCT02674750|473761601|FG002|Overall Study|Withdrawal by Subject|1|||
131583080|NCT02674750|473761599|FG000|Overall Study|Other|0|||
131583081|NCT02674750|473761600|FG001|Overall Study|Other|8|||
131583082|NCT02674750|473761601|FG002|Overall Study|Other|0|||
131583083|NCT01199705|473761606|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
131583084|NCT01415349|473761607|FG000|Treatment Period 1|Adverse Event|0|||
131583085|NCT01415349|473761608|FG001|Treatment Period 1|Adverse Event|1|||
131583086|NCT01415349|473761607|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131583087|NCT01415349|473761608|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131583088|NCT00716859|473761609|FG000|Overall Study|Adverse Event|4|||
131583089|NCT00716859|473761610|FG001|Overall Study|Adverse Event|1|||
131583090|NCT00716859|473761609|FG000|Overall Study|Lack of Efficacy|3|||
131583091|NCT00716859|473761610|FG001|Overall Study|Lack of Efficacy|0|||
131583092|NCT00716859|473761609|FG000|Overall Study|Withdrawal by Subject|1|||
131583093|NCT00716859|473761610|FG001|Overall Study|Withdrawal by Subject|3|||
131583094|NCT00716859|473761609|FG000|Overall Study|Not treated|1|||
131583095|NCT00716859|473761610|FG001|Overall Study|Not treated|1|||
131583096|NCT01764464|473761611|FG000|First Intervention|Withdrawal by Subject|1|||
131583097|NCT01764464|473761612|FG001|First Intervention|Withdrawal by Subject|0|||
131583098|NCT01764464|473761611|FG000|First Intervention|Lost to Follow-up|1|||
131583099|NCT01764464|473761612|FG001|First Intervention|Lost to Follow-up|0|||
131583100|NCT01764464|473761611|FG000|First Intervention|Adverse Event|0|||
131583101|NCT01764464|473761612|FG001|First Intervention|Adverse Event|2|||
131583102|NCT01764464|473761611|FG000|First Intervention|did not receive study drug|0|||
131583103|NCT01764464|473761612|FG001|First Intervention|did not receive study drug|1|||
131583104|NCT01764464|473761611|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
131583105|NCT01764464|473761612|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
131583106|NCT03473340|473761613|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
131583107|NCT03473340|473761614|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
131583108|NCT03473340|473761613|FG000|Overall Study|Withdrawal by Subject|1|||
131583109|NCT03473340|473761614|FG001|Overall Study|Withdrawal by Subject|0|||
131583110|NCT03473340|473761613|FG000|Overall Study|Lost to Follow-up|1|||
131583111|NCT03473340|473761614|FG001|Overall Study|Lost to Follow-up|2|||
131583112|NCT01616459|473761615|FG000|Overall Study|Adverse Event|1|||
131583113|NCT01616459|473761616|FG001|Overall Study|Adverse Event|1|||
131583114|NCT01616459|473761617|FG002|Overall Study|Adverse Event|2|||
131583115|NCT01616459|473761618|FG003|Overall Study|Adverse Event|0|||
131583116|NCT01616459|473761615|FG000|Overall Study|Lost to Follow-up|1|||
131583117|NCT01616459|473761616|FG001|Overall Study|Lost to Follow-up|11|||
131583118|NCT01616459|473761617|FG002|Overall Study|Lost to Follow-up|3|||
131583119|NCT01616459|473761618|FG003|Overall Study|Lost to Follow-up|2|||
131583120|NCT01616459|473761615|FG000|Overall Study|Protocol Violation|0|||
131583121|NCT01616459|473761616|FG001|Overall Study|Protocol Violation|0|||
131583122|NCT01616459|473761617|FG002|Overall Study|Protocol Violation|0|||
131583123|NCT01616459|473761618|FG003|Overall Study|Protocol Violation|2|||
131583124|NCT01616459|473761615|FG000|Overall Study|Withdrawal by Subject|2|||
131583125|NCT01616459|473761616|FG001|Overall Study|Withdrawal by Subject|4|||
131703713|NCT05099640|474198490|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
131703714|NCT05099640|474198488|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
131703715|NCT05099640|474198489|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
131703716|NCT05099640|474198490|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
131703717|NCT05099640|474198488|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
131703718|NCT05099640|474198489|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
131703719|NCT05099640|474198490|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
131703720|NCT01727258|474198491|FG000|Overall Study|Adverse Event|0|||
131703721|NCT01727258|474198492|FG001|Overall Study|Adverse Event|2|||
131703722|NCT01727258|474198493|FG002|Overall Study|Adverse Event|0|||
131703723|NCT01727258|474198491|FG000|Overall Study|Noncompliance with Study Drug|0|||
131703724|NCT01727258|474198492|FG001|Overall Study|Noncompliance with Study Drug|0|||
131703725|NCT01727258|474198493|FG002|Overall Study|Noncompliance with Study Drug|1|||
131703726|NCT01727258|474198491|FG000|Overall Study|Withdrawal by Subject|1|||
131703727|NCT01727258|474198492|FG001|Overall Study|Withdrawal by Subject|1|||
131703728|NCT01727258|474198493|FG002|Overall Study|Withdrawal by Subject|0|||
131703729|NCT01727258|474198491|FG000|Overall Study|Lost to Follow-up|1|||
131703730|NCT01727258|474198492|FG001|Overall Study|Lost to Follow-up|0|||
131703731|NCT01727258|474198493|FG002|Overall Study|Lost to Follow-up|0|||
131703732|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
131703733|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
131703734|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
131703735|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Death|28|||
131703736|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Death|0|||
131703737|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Death|0|||
131703738|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
131703739|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
131703740|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
131703741|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
131703742|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
131703743|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
131703744|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
131703745|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
131703746|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
131703747|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
131703748|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
131703749|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
131703750|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
131703751|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
131703752|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
131703753|NCT00820755|474198494|FG000|Period 1: Combination Therapy Phase|Other|11|||
131703754|NCT00820755|474198495|FG001|Period 1: Combination Therapy Phase|Other|0|||
131703755|NCT00820755|474198496|FG002|Period 1: Combination Therapy Phase|Other|0|||
131703756|NCT00820755|474198494|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
131703757|NCT00820755|474198495|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
131703758|NCT00820755|474198496|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
131703759|NCT03604445|474198497|FG000|Overall Study|Death|0|||
131703760|NCT03604445|474198498|FG001|Overall Study|Death|0|||
131703761|NCT03604445|474198499|FG002|Overall Study|Death|0|||
131703762|NCT03604445|474198500|FG003|Overall Study|Death|0|||
131703763|NCT03604445|474198501|FG004|Overall Study|Death|0|||
131703764|NCT03604445|474198502|FG005|Overall Study|Death|0|||
131703765|NCT03604445|474198503|FG006|Overall Study|Death|0|||
131703766|NCT03604445|474198504|FG007|Overall Study|Death|0|||
131703767|NCT03604445|474198505|FG008|Overall Study|Death|1|||
131703768|NCT03604445|474198497|FG000|Overall Study|Withdrawal by Subject|0|||
131703769|NCT03604445|474198498|FG001|Overall Study|Withdrawal by Subject|0|||
131703770|NCT03604445|474198499|FG002|Overall Study|Withdrawal by Subject|0|||
131703771|NCT03604445|474198500|FG003|Overall Study|Withdrawal by Subject|0|||
131703772|NCT03604445|474198501|FG004|Overall Study|Withdrawal by Subject|0|||
131703773|NCT03604445|474198502|FG005|Overall Study|Withdrawal by Subject|0|||
131703774|NCT03604445|474198503|FG006|Overall Study|Withdrawal by Subject|1|||
131703775|NCT03604445|474198504|FG007|Overall Study|Withdrawal by Subject|0|||
131703776|NCT03604445|474198505|FG008|Overall Study|Withdrawal by Subject|0|||
131703777|NCT03604445|474198497|FG000|Overall Study|Missing visit|0|||
131583126|NCT01616459|473761617|FG002|Overall Study|Withdrawal by Subject|4|||
131583127|NCT01616459|473761618|FG003|Overall Study|Withdrawal by Subject|4|||
131583128|NCT01616459|473761615|FG000|Overall Study|Other reason|0|||
131583129|NCT01616459|473761616|FG001|Overall Study|Other reason|1|||
131583130|NCT01616459|473761617|FG002|Overall Study|Other reason|1|||
131583131|NCT01616459|473761618|FG003|Overall Study|Other reason|0|||
131583132|NCT05135000|473761626|FG000|Overall Study|Adverse Event|2|||
131583133|NCT05135000|473761627|FG001|Overall Study|Adverse Event|0|||
131583134|NCT05135000|473761626|FG000|Overall Study|Lost to Follow-up|1|||
131583135|NCT05135000|473761627|FG001|Overall Study|Lost to Follow-up|0|||
131583136|NCT05135000|473761626|FG000|Overall Study|Study Terminated by Sponsor|6|||
131583137|NCT05135000|473761627|FG001|Overall Study|Study Terminated by Sponsor|3|||
131583138|NCT01170026|473763164|FG000|Overall Study|Lost to Follow-up|4|||
131583139|NCT01170026|473763165|FG001|Overall Study|Lost to Follow-up|2|||
131583140|NCT03215927|473763169|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
131583141|NCT03215927|473763170|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
131583142|NCT03215927|473763169|FG000|Open Label Extension|Adverse Event|1|||
131583143|NCT03215927|473763170|FG001|Open Label Extension|Adverse Event|0|||
131583144|NCT03215927|473763169|FG000|Open Label Extension|Lack of Efficacy|1|||
131583145|NCT03215927|473763170|FG001|Open Label Extension|Lack of Efficacy|0|||
131583146|NCT03215927|473763169|FG000|Open Label Extension|Death|0|||
131583147|NCT03215927|473763170|FG001|Open Label Extension|Death|1|||
131583148|NCT03785782|473763171|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
131583149|NCT03785782|473763172|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
131583150|NCT03785782|473763171|FG000|Overall Study|Withdrawal by Subject|1|||
131583151|NCT03785782|473763172|FG001|Overall Study|Withdrawal by Subject|1|||
131703778|NCT03604445|474198498|FG001|Overall Study|Missing visit|0|||
131703779|NCT03604445|474198499|FG002|Overall Study|Missing visit|0|||
131703780|NCT03604445|474198500|FG003|Overall Study|Missing visit|0|||
131703781|NCT03604445|474198501|FG004|Overall Study|Missing visit|0|||
131703782|NCT03604445|474198502|FG005|Overall Study|Missing visit|1|||
131583152|NCT03785782|473763171|FG000|Overall Study|insufficient image quality.|3|||
131583153|NCT03785782|473763172|FG001|Overall Study|insufficient image quality.|0|||
131583154|NCT05777785|473763173|FG000|Overall Study|Withdrawal by Subject|5|||
131583155|NCT05777785|473763173|FG000|Overall Study|Lost to Follow-up|1|||
131583156|NCT03073941|473763174|FG000|Overall Study|Received non-study device intraoperatively|0|||
131583157|NCT03073941|473763175|FG001|Overall Study|Received non-study device intraoperatively|2|||
131583158|NCT03073941|473763174|FG000|Overall Study|Death|1|||
131583159|NCT03073941|473763175|FG001|Overall Study|Death|0|||
131583160|NCT03073941|473763174|FG000|Overall Study|Withdrawal by Subject|1|||
131583161|NCT03073941|473763175|FG001|Overall Study|Withdrawal by Subject|3|||
131583162|NCT03073941|473763174|FG000|Overall Study|Lost to Follow-up|5|||
131583163|NCT03073941|473763175|FG001|Overall Study|Lost to Follow-up|4|||
131583164|NCT03073941|473763174|FG000|Overall Study|Adverse Event|4|||
131583165|NCT03073941|473763175|FG001|Overall Study|Adverse Event|2|||
131583166|NCT03073941|473763174|FG000|Overall Study|Met an exclusion criterion|0|||
131583167|NCT03073941|473763175|FG001|Overall Study|Met an exclusion criterion|1|||
131583168|NCT04250883|473763176|FG000|Overall Study|Lost to Follow-up|1|||
131583169|NCT04250883|473763177|FG001|Overall Study|Lost to Follow-up|0|||
131583170|NCT01188655|473763179|FG000|Overall Study|Lack of Efficacy|1|||
131583171|NCT01188655|473763179|FG000|Overall Study|Lost to Follow-up|1|||
131583172|NCT01188655|473763179|FG000|Overall Study|Other|11|||
131583173|NCT00089544|473763180|FG000|Overall Study|Ineligible|1|||
131583174|NCT00089544|473763181|FG001|Overall Study|Ineligible|0|||
131583175|NCT02407249|473763186|FG000|Overall Study|Did not complete 12-month follow-up|13|||
131583176|NCT02407249|473763186|FG000|Overall Study|Not treated|13|||
131583177|NCT04425629|473763187|FG000|Overall Study|Adverse Event|0|||
131583178|NCT04425629|473763188|FG001|Overall Study|Adverse Event|0|||
131583179|NCT04425629|473763189|FG002|Overall Study|Adverse Event|0|||
131583180|NCT04425629|473763190|FG003|Overall Study|Adverse Event|0|||
131583181|NCT04425629|473763191|FG004|Overall Study|Adverse Event|1|||
131583182|NCT04425629|473763192|FG005|Overall Study|Adverse Event|0|||
131583183|NCT04425629|473763193|FG006|Overall Study|Adverse Event|0|||
131583184|NCT04425629|473763194|FG007|Overall Study|Adverse Event|0|||
131583185|NCT04425629|473763195|FG008|Overall Study|Adverse Event|0|||
131703783|NCT03604445|474198503|FG006|Overall Study|Missing visit|0|||
131583186|NCT04425629|473763196|FG009|Overall Study|Adverse Event|3|||
131583187|NCT04425629|473763197|FG010|Overall Study|Adverse Event|2|||
131583188|NCT04425629|473763198|FG011|Overall Study|Adverse Event|1|||
131583189|NCT04425629|473763199|FG012|Overall Study|Adverse Event|1|||
131583190|NCT04425629|473763200|FG013|Overall Study|Adverse Event|0|||
131583191|NCT04425629|473763201|FG014|Overall Study|Adverse Event|0|||
131583192|NCT04425629|473763202|FG015|Overall Study|Adverse Event|0|||
131583193|NCT04425629|473763203|FG016|Overall Study|Adverse Event|0|||
131583194|NCT04425629|473763204|FG017|Overall Study|Adverse Event|0|||
131583195|NCT04425629|473763205|FG018|Overall Study|Adverse Event|0|||
131583196|NCT04425629|473763187|FG000|Overall Study|Lost to Follow-up|1|||
131583197|NCT04425629|473763188|FG001|Overall Study|Lost to Follow-up|3|||
131583198|NCT04425629|473763189|FG002|Overall Study|Lost to Follow-up|1|||
131583199|NCT04425629|473763190|FG003|Overall Study|Lost to Follow-up|7|||
131583200|NCT04425629|473763191|FG004|Overall Study|Lost to Follow-up|1|||
131583201|NCT04425629|473763192|FG005|Overall Study|Lost to Follow-up|2|||
131583202|NCT04425629|473763193|FG006|Overall Study|Lost to Follow-up|1|||
131583203|NCT04425629|473763194|FG007|Overall Study|Lost to Follow-up|0|||
131583204|NCT04425629|473763195|FG008|Overall Study|Lost to Follow-up|1|||
131583205|NCT04425629|473763196|FG009|Overall Study|Lost to Follow-up|64|||
131583206|NCT04425629|473763197|FG010|Overall Study|Lost to Follow-up|70|||
131583207|NCT04425629|473763198|FG011|Overall Study|Lost to Follow-up|98|||
131583208|NCT04425629|473763199|FG012|Overall Study|Lost to Follow-up|30|||
131583209|NCT04425629|473763200|FG013|Overall Study|Lost to Follow-up|0|||
131583210|NCT04425629|473763201|FG014|Overall Study|Lost to Follow-up|5|||
131583211|NCT04425629|473763202|FG015|Overall Study|Lost to Follow-up|4|||
131583212|NCT04425629|473763203|FG016|Overall Study|Lost to Follow-up|0|||
131583213|NCT04425629|473763204|FG017|Overall Study|Lost to Follow-up|3|||
131583214|NCT04425629|473763205|FG018|Overall Study|Lost to Follow-up|1|||
131583215|NCT04425629|473763187|FG000|Overall Study|Subject Decision|0|||
131583216|NCT04425629|473763188|FG001|Overall Study|Subject Decision|2|||
131583217|NCT04425629|473763189|FG002|Overall Study|Subject Decision|1|||
131583218|NCT04425629|473763190|FG003|Overall Study|Subject Decision|3|||
131583219|NCT04425629|473763191|FG004|Overall Study|Subject Decision|6|||
131583220|NCT04425629|473763192|FG005|Overall Study|Subject Decision|6|||
131583221|NCT04425629|473763193|FG006|Overall Study|Subject Decision|3|||
131583222|NCT04425629|473763194|FG007|Overall Study|Subject Decision|3|||
131583223|NCT04425629|473763195|FG008|Overall Study|Subject Decision|1|||
131583224|NCT04425629|473763196|FG009|Overall Study|Subject Decision|70|||
131583225|NCT04425629|473763197|FG010|Overall Study|Subject Decision|95|||
131583226|NCT04425629|473763198|FG011|Overall Study|Subject Decision|124|||
131583227|NCT04425629|473763199|FG012|Overall Study|Subject Decision|25|||
131583228|NCT04425629|473763200|FG013|Overall Study|Subject Decision|0|||
131583229|NCT04425629|473763201|FG014|Overall Study|Subject Decision|1|||
131583230|NCT04425629|473763202|FG015|Overall Study|Subject Decision|4|||
131583231|NCT04425629|473763203|FG016|Overall Study|Subject Decision|1|||
131583232|NCT04425629|473763204|FG017|Overall Study|Subject Decision|0|||
131583233|NCT04425629|473763205|FG018|Overall Study|Subject Decision|2|||
131583234|NCT04425629|473763187|FG000|Overall Study|Death|0|||
131583235|NCT04425629|473763188|FG001|Overall Study|Death|0|||
131583236|NCT04425629|473763189|FG002|Overall Study|Death|0|||
131583237|NCT04425629|473763190|FG003|Overall Study|Death|0|||
131583238|NCT04425629|473763191|FG004|Overall Study|Death|0|||
131583239|NCT04425629|473763192|FG005|Overall Study|Death|0|||
131583240|NCT04425629|473763193|FG006|Overall Study|Death|0|||
131583241|NCT04425629|473763194|FG007|Overall Study|Death|0|||
131583242|NCT04425629|473763195|FG008|Overall Study|Death|0|||
131583243|NCT04425629|473763196|FG009|Overall Study|Death|11|||
131583244|NCT04425629|473763197|FG010|Overall Study|Death|2|||
131583245|NCT04425629|473763198|FG011|Overall Study|Death|4|||
131583246|NCT04425629|473763199|FG012|Overall Study|Death|0|||
131583247|NCT04425629|473763200|FG013|Overall Study|Death|0|||
131583248|NCT04425629|473763201|FG014|Overall Study|Death|0|||
131583249|NCT04425629|473763202|FG015|Overall Study|Death|0|||
131583250|NCT04425629|473763203|FG016|Overall Study|Death|0|||
131583251|NCT04425629|473763204|FG017|Overall Study|Death|0|||
131583252|NCT04425629|473763205|FG018|Overall Study|Death|0|||
131583253|NCT04425629|473763187|FG000|Overall Study|Sponsor Request|0|||
131583254|NCT04425629|473763188|FG001|Overall Study|Sponsor Request|0|||
131583255|NCT04425629|473763189|FG002|Overall Study|Sponsor Request|0|||
131583256|NCT04425629|473763190|FG003|Overall Study|Sponsor Request|2|||
131583257|NCT04425629|473763191|FG004|Overall Study|Sponsor Request|2|||
131583258|NCT04425629|473763192|FG005|Overall Study|Sponsor Request|2|||
131583259|NCT04425629|473763193|FG006|Overall Study|Sponsor Request|1|||
131583260|NCT04425629|473763194|FG007|Overall Study|Sponsor Request|0|||
131583261|NCT04425629|473763195|FG008|Overall Study|Sponsor Request|0|||
131583262|NCT04425629|473763196|FG009|Overall Study|Sponsor Request|9|||
131583263|NCT04425629|473763197|FG010|Overall Study|Sponsor Request|9|||
131583264|NCT04425629|473763198|FG011|Overall Study|Sponsor Request|10|||
131583265|NCT04425629|473763199|FG012|Overall Study|Sponsor Request|8|||
131583266|NCT04425629|473763200|FG013|Overall Study|Sponsor Request|0|||
131583267|NCT04425629|473763201|FG014|Overall Study|Sponsor Request|0|||
131583268|NCT04425629|473763202|FG015|Overall Study|Sponsor Request|1|||
131583269|NCT04425629|473763203|FG016|Overall Study|Sponsor Request|0|||
131583270|NCT04425629|473763204|FG017|Overall Study|Sponsor Request|0|||
131583271|NCT04425629|473763205|FG018|Overall Study|Sponsor Request|0|||
131583272|NCT04425629|473763187|FG000|Overall Study|Physician Decision|0|||
131583273|NCT04425629|473763188|FG001|Overall Study|Physician Decision|0|||
131583274|NCT04425629|473763189|FG002|Overall Study|Physician Decision|0|||
131583275|NCT04425629|473763190|FG003|Overall Study|Physician Decision|0|||
131583276|NCT04425629|473763191|FG004|Overall Study|Physician Decision|0|||
131583277|NCT04425629|473763192|FG005|Overall Study|Physician Decision|0|||
131583278|NCT04425629|473763193|FG006|Overall Study|Physician Decision|0|||
131583279|NCT04425629|473763194|FG007|Overall Study|Physician Decision|0|||
131583280|NCT04425629|473763195|FG008|Overall Study|Physician Decision|0|||
131583281|NCT04425629|473763196|FG009|Overall Study|Physician Decision|4|||
131583282|NCT04425629|473763197|FG010|Overall Study|Physician Decision|3|||
131583283|NCT04425629|473763198|FG011|Overall Study|Physician Decision|5|||
131583284|NCT04425629|473763199|FG012|Overall Study|Physician Decision|1|||
131583285|NCT04425629|473763200|FG013|Overall Study|Physician Decision|0|||
131583286|NCT04425629|473763201|FG014|Overall Study|Physician Decision|0|||
131583287|NCT04425629|473763202|FG015|Overall Study|Physician Decision|1|||
131583288|NCT04425629|473763203|FG016|Overall Study|Physician Decision|0|||
131583289|NCT04425629|473763204|FG017|Overall Study|Physician Decision|0|||
131583290|NCT04425629|473763205|FG018|Overall Study|Physician Decision|0|||
131583291|NCT04425629|473763187|FG000|Overall Study|Lack of Efficacy|0|||
131583292|NCT04425629|473763188|FG001|Overall Study|Lack of Efficacy|0|||
131583293|NCT04425629|473763189|FG002|Overall Study|Lack of Efficacy|0|||
131583294|NCT04425629|473763190|FG003|Overall Study|Lack of Efficacy|0|||
131583295|NCT04425629|473763191|FG004|Overall Study|Lack of Efficacy|0|||
131583296|NCT04425629|473763192|FG005|Overall Study|Lack of Efficacy|0|||
131583297|NCT04425629|473763193|FG006|Overall Study|Lack of Efficacy|0|||
131583298|NCT04425629|473763194|FG007|Overall Study|Lack of Efficacy|0|||
131583299|NCT04425629|473763195|FG008|Overall Study|Lack of Efficacy|0|||
131583300|NCT04425629|473763196|FG009|Overall Study|Lack of Efficacy|0|||
131583301|NCT04425629|473763197|FG010|Overall Study|Lack of Efficacy|1|||
131583302|NCT04425629|473763198|FG011|Overall Study|Lack of Efficacy|0|||
131583303|NCT04425629|473763199|FG012|Overall Study|Lack of Efficacy|0|||
131583304|NCT04425629|473763200|FG013|Overall Study|Lack of Efficacy|0|||
131583305|NCT04425629|473763201|FG014|Overall Study|Lack of Efficacy|0|||
131583306|NCT04425629|473763202|FG015|Overall Study|Lack of Efficacy|0|||
131583307|NCT04425629|473763203|FG016|Overall Study|Lack of Efficacy|0|||
131583308|NCT04425629|473763204|FG017|Overall Study|Lack of Efficacy|0|||
131583309|NCT04425629|473763205|FG018|Overall Study|Lack of Efficacy|0|||
131583310|NCT00610649|473763207|FG000|Overall Study|Adverse Event|1|||
131583311|NCT00610649|473763208|FG001|Overall Study|Adverse Event|0|||
131583312|NCT00610649|473763209|FG002|Overall Study|Adverse Event|0|||
131583313|NCT00610649|473763210|FG003|Overall Study|Adverse Event|0|||
131583314|NCT00610649|473763211|FG004|Overall Study|Adverse Event|0|||
131583315|NCT00610649|473763212|FG005|Overall Study|Adverse Event|0|||
131583316|NCT00610649|473763213|FG006|Overall Study|Adverse Event|0|||
131583317|NCT00610649|473763214|FG007|Overall Study|Adverse Event|0|||
131583318|NCT00610649|473763215|FG008|Overall Study|Adverse Event|0|||
131583319|NCT00610649|473763216|FG009|Overall Study|Adverse Event|0|||
131583320|NCT00610649|473763217|FG010|Overall Study|Adverse Event|1|||
131583321|NCT00610649|473763207|FG000|Overall Study|Family Emergency|0|||
131583322|NCT00610649|473763208|FG001|Overall Study|Family Emergency|1|||
131583323|NCT00610649|473763209|FG002|Overall Study|Family Emergency|0|||
131583324|NCT00610649|473763210|FG003|Overall Study|Family Emergency|0|||
131583325|NCT00610649|473763211|FG004|Overall Study|Family Emergency|0|||
131583326|NCT00610649|473763212|FG005|Overall Study|Family Emergency|0|||
131583327|NCT00610649|473763213|FG006|Overall Study|Family Emergency|0|||
131583328|NCT00610649|473763214|FG007|Overall Study|Family Emergency|0|||
131583329|NCT00610649|473763215|FG008|Overall Study|Family Emergency|0|||
131583330|NCT00610649|473763216|FG009|Overall Study|Family Emergency|0|||
131583331|NCT00610649|473763217|FG010|Overall Study|Family Emergency|0|||
131788672|NCT00373685|474509109|FG001|Overall Study|No longer willing to participate|352|||
131583332|NCT00610649|473763207|FG000|Overall Study|Withdrawal by Subject|0|||
131583333|NCT00610649|473763208|FG001|Overall Study|Withdrawal by Subject|0|||
131703784|NCT03604445|474198504|FG007|Overall Study|Missing visit|1|||
131703785|NCT03604445|474198505|FG008|Overall Study|Missing visit|0|||
131703786|NCT03604445|474198497|FG000|Overall Study|Adverse Event|0|||
131703787|NCT03604445|474198498|FG001|Overall Study|Adverse Event|0|||
131703788|NCT03604445|474198499|FG002|Overall Study|Adverse Event|0|||
131703789|NCT03604445|474198500|FG003|Overall Study|Adverse Event|1|||
131703790|NCT03604445|474198501|FG004|Overall Study|Adverse Event|0|||
131703791|NCT03604445|474198502|FG005|Overall Study|Adverse Event|0|||
131703792|NCT03604445|474198503|FG006|Overall Study|Adverse Event|0|||
131703793|NCT03604445|474198504|FG007|Overall Study|Adverse Event|0|||
131703794|NCT03604445|474198505|FG008|Overall Study|Adverse Event|1|||
131703795|NCT01014585|474198510|FG000|Overall Study|Adverse Event|0|||
131703796|NCT01014585|474198511|FG001|Overall Study|Adverse Event|2|||
131703797|NCT01014585|474198512|FG002|Overall Study|Adverse Event|0|||
131788673|NCT00373685|474509108|FG000|Overall Study|Other|149|||
131583334|NCT00610649|473763209|FG002|Overall Study|Withdrawal by Subject|0|||
131583335|NCT00610649|473763210|FG003|Overall Study|Withdrawal by Subject|0|||
131583336|NCT00610649|473763211|FG004|Overall Study|Withdrawal by Subject|0|||
131583337|NCT00610649|473763212|FG005|Overall Study|Withdrawal by Subject|0|||
131583338|NCT00610649|473763213|FG006|Overall Study|Withdrawal by Subject|0|||
131583339|NCT00610649|473763214|FG007|Overall Study|Withdrawal by Subject|0|||
131583340|NCT00610649|473763215|FG008|Overall Study|Withdrawal by Subject|0|||
131583341|NCT00610649|473763216|FG009|Overall Study|Withdrawal by Subject|1|||
131703798|NCT01014585|474198513|FG003|Overall Study|Adverse Event|3|||
131703799|NCT01014585|474198510|FG000|Overall Study|Withdrawal by Subject|2|||
131703800|NCT01014585|474198511|FG001|Overall Study|Withdrawal by Subject|0|||
131703801|NCT01014585|474198512|FG002|Overall Study|Withdrawal by Subject|1|||
131583342|NCT00610649|473763217|FG010|Overall Study|Withdrawal by Subject|0|||
131583343|NCT04252586|473763220|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131583344|NCT04252586|473763220|FG000|Overall Study|Adverse Event|1|||
131583345|NCT04252586|473763220|FG000|Overall Study|Death|2|||
131583346|NCT04252586|473763220|FG000|Overall Study|Study terminated by sponsor|4|||
131583347|NCT04252586|473763220|FG000|Overall Study|Sponsor request|10|||
131583348|NCT04252586|473763220|FG000|Overall Study|Did not complete treatment period|1|||
131583349|NCT00414544|473763221|FG000|Overall Study|Lost to Follow-up|14|||
131583350|NCT03452189|473763222|FG000|First Intervention (3 Months)|Adverse Event|1|||
131583351|NCT03452189|473763223|FG001|First Intervention (3 Months)|Adverse Event|0|||
131583352|NCT03452189|473763222|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
131583353|NCT03452189|473763223|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
131583354|NCT02601820|473763224|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
131583355|NCT02601820|473763224|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
131583356|NCT02601820|473763224|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
131583357|NCT02601820|473763224|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
131583358|NCT02242487|473763225|FG000|Overall Study|Adverse Event|13|||
131583359|NCT02242487|473763226|FG001|Overall Study|Adverse Event|15|||
131583360|NCT02242487|473763225|FG000|Overall Study|Lack of Efficacy|4|||
131583361|NCT02242487|473763226|FG001|Overall Study|Lack of Efficacy|6|||
131583362|NCT02242487|473763225|FG000|Overall Study|Protocol Violation|2|||
131583363|NCT02242487|473763226|FG001|Overall Study|Protocol Violation|0|||
131583364|NCT02242487|473763225|FG000|Overall Study|Lost to Follow-up|2|||
131583365|NCT02242487|473763226|FG001|Overall Study|Lost to Follow-up|1|||
131583366|NCT02242487|473763225|FG000|Overall Study|Other - Miscellaneous|4|||
131583367|NCT02242487|473763226|FG001|Overall Study|Other - Miscellaneous|6|||
131583368|NCT02242487|473763225|FG000|Overall Study|Withdrawal by Subject|37|||
131788674|NCT00373685|474509109|FG001|Overall Study|Other|146|||
131788675|NCT00373685|474509108|FG000|Overall Study|Protocol Violation|191|||
131788676|NCT00373685|474509109|FG001|Overall Study|Protocol Violation|182|||
131788677|NCT00373685|474509108|FG000|Overall Study|Final Status Unknown|12|||
131788678|NCT00373685|474509109|FG001|Overall Study|Final Status Unknown|4|||
131788679|NCT00373685|474509108|FG000|Overall Study|Randomized, not treated|51|||
131788680|NCT00373685|474509109|FG001|Overall Study|Randomized, not treated|77|||
131788681|NCT02570165|474509110|FG000|Overall Study|Adverse Event|1|||
131788682|NCT02570165|474509111|FG001|Overall Study|Adverse Event|0|||
131788683|NCT02570165|474509112|FG002|Overall Study|Adverse Event|2|||
131788684|NCT02570165|474509113|FG003|Overall Study|Adverse Event|0|||
131788685|NCT02570165|474509114|FG004|Overall Study|Adverse Event|0|||
131788686|NCT02570165|474509115|FG005|Overall Study|Adverse Event|0|||
131788687|NCT02570165|474509116|FG006|Overall Study|Adverse Event|0|||
131583369|NCT02242487|473763226|FG001|Overall Study|Withdrawal by Subject|19|||
131583370|NCT00391898|473763235|FG000|Overall Study|Adverse Event|3|||
131583371|NCT00391898|473763236|FG001|Overall Study|Adverse Event|0|||
131583372|NCT00391898|473763235|FG000|Overall Study|Other|8|||
131583373|NCT00391898|473763236|FG001|Overall Study|Other|10|||
131583374|NCT02918279|473763239|FG000|Overall Study|Lost to Follow-up|3|||
131788688|NCT02570165|474509110|FG000|Overall Study|Lack of Efficacy|0|||
131788689|NCT02570165|474509111|FG001|Overall Study|Lack of Efficacy|1|||
131788690|NCT02570165|474509112|FG002|Overall Study|Lack of Efficacy|0|||
131788691|NCT02570165|474509113|FG003|Overall Study|Lack of Efficacy|0|||
131788692|NCT02570165|474509114|FG004|Overall Study|Lack of Efficacy|4|||
131788693|NCT02570165|474509115|FG005|Overall Study|Lack of Efficacy|0|||
131788694|NCT02570165|474509116|FG006|Overall Study|Lack of Efficacy|0|||
131788695|NCT02570165|474509110|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
131788696|NCT02570165|474509111|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
131788697|NCT02570165|474509112|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
131788698|NCT02570165|474509113|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
131788699|NCT02570165|474509114|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
131788700|NCT02570165|474509115|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
131788701|NCT02570165|474509116|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
131788702|NCT02570165|474509110|FG000|Overall Study|Lost to Follow-up|0|||
131788703|NCT02570165|474509111|FG001|Overall Study|Lost to Follow-up|0|||
131788704|NCT02570165|474509112|FG002|Overall Study|Lost to Follow-up|1|||
131788705|NCT02570165|474509113|FG003|Overall Study|Lost to Follow-up|1|||
131788706|NCT02570165|474509114|FG004|Overall Study|Lost to Follow-up|0|||
131788707|NCT02570165|474509115|FG005|Overall Study|Lost to Follow-up|0|||
131788708|NCT02570165|474509116|FG006|Overall Study|Lost to Follow-up|0|||
131788709|NCT02570165|474509110|FG000|Overall Study|Physician Decision|0|||
131788710|NCT02570165|474509111|FG001|Overall Study|Physician Decision|1|||
131788711|NCT02570165|474509112|FG002|Overall Study|Physician Decision|0|||
131788712|NCT02570165|474509113|FG003|Overall Study|Physician Decision|0|||
131583375|NCT02918279|473763240|FG001|Overall Study|Lost to Follow-up|6|||
131788713|NCT02570165|474509114|FG004|Overall Study|Physician Decision|0|||
131788714|NCT02570165|474509115|FG005|Overall Study|Physician Decision|0|||
131788715|NCT02570165|474509116|FG006|Overall Study|Physician Decision|0|||
131788716|NCT02570165|474509110|FG000|Overall Study|Withdrawal by Subject|0|||
131788717|NCT02570165|474509111|FG001|Overall Study|Withdrawal by Subject|0|||
131583376|NCT02918279|473763239|FG000|Overall Study|Withdrawal by Subject|5|||
131583377|NCT02918279|473763240|FG001|Overall Study|Withdrawal by Subject|15|||
131583378|NCT02918279|473763239|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131583379|NCT02918279|473763240|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131583380|NCT02918279|473763239|FG000|Overall Study|Other|3|||
131583381|NCT02918279|473763240|FG001|Overall Study|Other|1|||
131583382|NCT00309907|473763241|FG000|Overall Study|Death|4|||
131583383|NCT00309907|473763241|FG000|Overall Study|Physician Decision|1|||
131583384|NCT00309907|473763241|FG000|Overall Study|Ineligible|11|||
131583385|NCT00309907|473763241|FG000|Overall Study|Major infectious event|4|||
131583386|NCT00869258|473763242|FG000|Overall Study|Physician Decision|1|||
131703802|NCT01014585|474198513|FG003|Overall Study|Withdrawal by Subject|3|||
131703803|NCT01014585|474198510|FG000|Overall Study|Lost to Follow-up|0|||
131703804|NCT01014585|474198511|FG001|Overall Study|Lost to Follow-up|0|||
131703805|NCT01014585|474198512|FG002|Overall Study|Lost to Follow-up|0|||
131703806|NCT01014585|474198513|FG003|Overall Study|Lost to Follow-up|2|||
131703807|NCT01014585|474198510|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
131703808|NCT01014585|474198511|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
131703809|NCT01014585|474198512|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
131703810|NCT01014585|474198513|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
131703811|NCT00508391|474198519|FG000|First Treatment|Withdrawal by Subject|6|||
131703812|NCT00508391|474198520|FG001|First Treatment|Withdrawal by Subject|3|||
131583387|NCT00636207|473763243|FG000|Overall Study|Adverse Event|1|||
131703813|NCT00508391|474198519|FG000|Second Treatment|Withdrawal by Subject|2|||
131583388|NCT00636207|473763244|FG001|Overall Study|Adverse Event|0|||
131583389|NCT00636207|473763245|FG002|Overall Study|Adverse Event|0|||
131583390|NCT00636207|473763246|FG003|Overall Study|Adverse Event|0|||
131583391|NCT00636207|473763247|FG004|Overall Study|Adverse Event|0|||
131583392|NCT00636207|473763248|FG005|Overall Study|Adverse Event|0|||
131583393|NCT00636207|473763249|FG006|Overall Study|Adverse Event|0|||
131583394|NCT00636207|473763243|FG000|Overall Study|Withdrawal by Subject|0|||
131583395|NCT00636207|473763244|FG001|Overall Study|Withdrawal by Subject|1|||
131583396|NCT00636207|473763245|FG002|Overall Study|Withdrawal by Subject|0|||
131583397|NCT00636207|473763246|FG003|Overall Study|Withdrawal by Subject|0|||
131583398|NCT00636207|473763247|FG004|Overall Study|Withdrawal by Subject|1|||
131583399|NCT00636207|473763248|FG005|Overall Study|Withdrawal by Subject|0|||
131583400|NCT00636207|473763249|FG006|Overall Study|Withdrawal by Subject|0|||
131583401|NCT01641198|473763250|FG000|After 12 Months of Function|Lost to Follow-up|3|||
131583402|NCT01641198|473763251|FG001|After 12 Months of Function|Lost to Follow-up|2|||
131583403|NCT01641198|473763252|FG002|After 12 Months of Function|Lost to Follow-up|2|||
131583404|NCT01641198|473763250|FG000|After 12 Months of Function|Protocol Violation|1|||
131583405|NCT01641198|473763251|FG001|After 12 Months of Function|Protocol Violation|0|||
131583406|NCT01641198|473763252|FG002|After 12 Months of Function|Protocol Violation|0|||
131583407|NCT01641198|473763250|FG000|After 12 Months of Function|Adverse Event|0|||
131583408|NCT01641198|473763251|FG001|After 12 Months of Function|Adverse Event|1|||
131583409|NCT01641198|473763252|FG002|After 12 Months of Function|Adverse Event|0|||
131583410|NCT01641198|473763250|FG000|After 24 Months of Function|Lost to Follow-up|4|||
131583411|NCT01641198|473763251|FG001|After 24 Months of Function|Lost to Follow-up|9|||
131583412|NCT01641198|473763252|FG002|After 24 Months of Function|Lost to Follow-up|6|||
131583413|NCT01641198|473763250|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
131583414|NCT01641198|473763251|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
131583415|NCT01641198|473763252|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
131583416|NCT01641198|473763250|FG000|At 15-20 Years of Function|Death|1|||
131583417|NCT01641198|473763251|FG001|At 15-20 Years of Function|Death|0|||
131583418|NCT01641198|473763252|FG002|At 15-20 Years of Function|Death|1|||
131583419|NCT02529995|473763254|FG000|Part A|Ongoing Study at Data Cut-off|14|||
131788718|NCT02570165|474509112|FG002|Overall Study|Withdrawal by Subject|0|||
131788719|NCT02570165|474509113|FG003|Overall Study|Withdrawal by Subject|2|||
131788720|NCT02570165|474509114|FG004|Overall Study|Withdrawal by Subject|1|||
131788721|NCT02570165|474509115|FG005|Overall Study|Withdrawal by Subject|0|||
131788722|NCT02570165|474509116|FG006|Overall Study|Withdrawal by Subject|0|||
131788723|NCT02570165|474509110|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
131788724|NCT02570165|474509111|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
131788725|NCT02570165|474509112|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
131788726|NCT02570165|474509113|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
131788727|NCT02570165|474509114|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
131583420|NCT02529995|473763255|FG001|Part A|Ongoing Study at Data Cut-off|16|||
131583421|NCT02529995|473763254|FG000|Part A|Discontinued Study|1|||
131583422|NCT02529995|473763255|FG001|Part A|Discontinued Study|0|||
131583423|NCT02529995|473763254|FG000|Part B|Ongoing Study at Data Cut-off|0|||
131583424|NCT02529995|473763255|FG001|Part B|Ongoing Study at Data Cut-off|7|||
131583425|NCT02529995|473763254|FG000|Part B|Discontinued Study|6|||
131583426|NCT02529995|473763255|FG001|Part B|Discontinued Study|5|||
131438490|NCT03748823|473231253|FG001|Extension Period|Physician Decision|2|||
131788728|NCT02570165|474509115|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
131788729|NCT02570165|474509116|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
131788730|NCT02570165|474509110|FG000|Overall Study|Withdrawal Request by GSK|0|||
131788731|NCT02570165|474509111|FG001|Overall Study|Withdrawal Request by GSK|0|||
131788732|NCT02570165|474509112|FG002|Overall Study|Withdrawal Request by GSK|2|||
131788733|NCT02570165|474509113|FG003|Overall Study|Withdrawal Request by GSK|0|||
131788734|NCT02570165|474509114|FG004|Overall Study|Withdrawal Request by GSK|0|||
131788735|NCT02570165|474509115|FG005|Overall Study|Withdrawal Request by GSK|0|||
131788736|NCT02570165|474509116|FG006|Overall Study|Withdrawal Request by GSK|0|||
131788737|NCT01789281|474509117|FG000|Overall Study|Disease progression|15|||
131788738|NCT01789281|474509118|FG001|Overall Study|Disease progression|4|||
131438491|NCT01664910|473231257|FG000|Overall Study|Adverse Event|0|||
131438492|NCT01664910|473231258|FG001|Overall Study|Adverse Event|0|||
131788739|NCT01789281|474509117|FG000|Overall Study|Adverse Event|5|||
131788740|NCT01789281|474509118|FG001|Overall Study|Adverse Event|5|||
131788741|NCT01789281|474509117|FG000|Overall Study|Withdrawal by Subject|1|||
131438493|NCT01664910|473231259|FG002|Overall Study|Adverse Event|1|||
131438494|NCT01168349|473231260|FG000|Overall Study|Death|157|||
131438495|NCT01168349|473231260|FG000|Overall Study|Lost to Follow-up|34|||
131438496|NCT01168349|473231260|FG000|Overall Study|Withdrawal by Subject|9|||
131438497|NCT01168349|473231260|FG000|Overall Study|Kidney transplantation|3|||
131438498|NCT01168349|473231260|FG000|Overall Study|Other|22|||
131438499|NCT01168349|473231260|FG000|Overall Study|Protocol Violation|76|||
131438500|NCT03535974|473231261|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
131438501|NCT03535974|473231262|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
131788742|NCT01789281|474509118|FG001|Overall Study|Withdrawal by Subject|0|||
131438502|NCT03535974|473231263|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
131438503|NCT03535974|473231261|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
131788743|NCT01789281|474509117|FG000|Overall Study|Lost to Follow-up|1|||
131788744|NCT01789281|474509118|FG001|Overall Study|Lost to Follow-up|0|||
131438504|NCT03535974|473231262|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
131788745|NCT01789281|474509117|FG000|Overall Study|Administrative problems|0|||
131583427|NCT01075217|473763258|FG000|Overall Study|Adverse Event|1|||
131583428|NCT01075217|473763259|FG001|Overall Study|Adverse Event|1|||
131583429|NCT01075217|473763258|FG000|Overall Study|Physician Decision|1|||
131703814|NCT00508391|474198520|FG001|Second Treatment|Withdrawal by Subject|0|||
131703815|NCT00802360|474198521|FG000|Overall Study|Stimulation failure|4|||
131703816|NCT00802360|474198522|FG001|Overall Study|Stimulation failure|0|||
131703817|NCT00802360|474198523|FG002|Overall Study|Stimulation failure|3|||
131703818|NCT00802360|474198524|FG003|Overall Study|Stimulation failure|3|||
131703819|NCT00802360|474198521|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
131703820|NCT00802360|474198522|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
131703821|NCT00802360|474198523|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
131703822|NCT00802360|474198524|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
131703823|NCT00802360|474198521|FG000|Overall Study|Cycle cancelled|0|||
131703824|NCT00802360|474198522|FG001|Overall Study|Cycle cancelled|1|||
131703825|NCT00802360|474198523|FG002|Overall Study|Cycle cancelled|1|||
131703826|NCT00802360|474198524|FG003|Overall Study|Cycle cancelled|1|||
131703827|NCT00802360|474198521|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
131703828|NCT00802360|474198522|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
131703829|NCT00802360|474198523|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
131703830|NCT00802360|474198524|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
131703831|NCT00802360|474198521|FG000|Overall Study|No positive serum pregnancy|17|||
131703832|NCT00802360|474198522|FG001|Overall Study|No positive serum pregnancy|20|||
131703833|NCT00802360|474198523|FG002|Overall Study|No positive serum pregnancy|14|||
131703834|NCT00802360|474198524|FG003|Overall Study|No positive serum pregnancy|10|||
131703835|NCT00802360|474198521|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
131703836|NCT00802360|474198522|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131703837|NCT00802360|474198523|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
131703838|NCT00802360|474198524|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131703839|NCT00802360|474198521|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
131703840|NCT00802360|474198522|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
131703841|NCT00802360|474198523|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
131703842|NCT00802360|474198524|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
131703843|NCT00802360|474198521|FG000|Overall Study|Other|2|||
131703844|NCT00802360|474198522|FG001|Overall Study|Other|3|||
131703845|NCT00802360|474198523|FG002|Overall Study|Other|6|||
131703846|NCT00802360|474198524|FG003|Overall Study|Other|3|||
131703847|NCT02041962|474198525|FG000|Overall Study|Lost Aetna Coverage|43|||
131703848|NCT02041962|474198526|FG001|Overall Study|Lost Aetna Coverage|40|||
131703849|NCT02041962|474198525|FG000|Overall Study|Death|1|||
131703850|NCT02041962|474198526|FG001|Overall Study|Death|1|||
131703851|NCT02041962|474198525|FG000|Overall Study|Lost to Follow-up|37|||
131703852|NCT02041962|474198526|FG001|Overall Study|Lost to Follow-up|32|||
131703853|NCT02041962|474198525|FG000|Overall Study|Withdrawal by Subject|0|||
131703854|NCT02041962|474198526|FG001|Overall Study|Withdrawal by Subject|11|||
131703855|NCT01225562|474198529|FG000|Overall Study|Withdrawal by Subject|52|||
131703856|NCT01225562|474198530|FG001|Overall Study|Withdrawal by Subject|50|||
131703857|NCT01225562|474198531|FG002|Overall Study|Withdrawal by Subject|52|||
131703858|NCT01225562|474198529|FG000|Overall Study|Lost to Follow-up|3|||
131703859|NCT01225562|474198530|FG001|Overall Study|Lost to Follow-up|6|||
131703860|NCT01225562|474198531|FG002|Overall Study|Lost to Follow-up|1|||
131703861|NCT01481896|474198535|FG000|Overall Study|Lost to Follow-up|12|||
131703862|NCT01107444|474198536|FG000|Overall Study|Withdrawal by Subject|8|||
131703863|NCT01107444|474198537|FG001|Overall Study|Withdrawal by Subject|12|||
131703864|NCT01107444|474198536|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
131703865|NCT01107444|474198537|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
131703866|NCT00091832|474198539|FG000|Overall Study|Physician Decision|1|||
131703867|NCT00091832|474198540|FG001|Overall Study|Physician Decision|0|||
131703868|NCT00091832|474198541|FG002|Overall Study|Physician Decision|0|||
131703869|NCT00091832|474198542|FG003|Overall Study|Physician Decision|0|||
131703870|NCT00091832|474198543|FG004|Overall Study|Physician Decision|0|||
131703871|NCT00091832|474198544|FG005|Overall Study|Physician Decision|0|||
131703872|NCT00091832|474198539|FG000|Overall Study|Adverse Event|0|||
131788746|NCT01789281|474509118|FG001|Overall Study|Administrative problems|1|||
131788747|NCT01430104|474509121|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
131788748|NCT02124746|474509122|FG000|Overall Study|Adverse Event|2|||
131788749|NCT02124746|474509123|FG001|Overall Study|Adverse Event|1|||
131788750|NCT02124746|474509124|FG002|Overall Study|Adverse Event|2|||
131788751|NCT02124746|474509122|FG000|Overall Study|Death|2|||
131788752|NCT02124746|474509123|FG001|Overall Study|Death|1|||
131788753|NCT02124746|474509124|FG002|Overall Study|Death|3|||
131788754|NCT02124746|474509122|FG000|Overall Study|Lack of Efficacy|3|||
131583430|NCT01075217|473763259|FG001|Overall Study|Physician Decision|0|||
131788755|NCT02124746|474509123|FG001|Overall Study|Lack of Efficacy|2|||
131788756|NCT02124746|474509124|FG002|Overall Study|Lack of Efficacy|2|||
131788757|NCT02124746|474509122|FG000|Overall Study|Physician Decision|6|||
131788758|NCT02124746|474509123|FG001|Overall Study|Physician Decision|4|||
131788759|NCT02124746|474509124|FG002|Overall Study|Physician Decision|5|||
131788760|NCT02124746|474509122|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131788761|NCT02124746|474509123|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131788762|NCT02124746|474509124|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131788763|NCT02124746|474509122|FG000|Overall Study|Withdrawal by Subject|3|||
131788764|NCT02124746|474509123|FG001|Overall Study|Withdrawal by Subject|3|||
131788765|NCT02124746|474509124|FG002|Overall Study|Withdrawal by Subject|0|||
131788766|NCT02124746|474509122|FG000|Overall Study|Study Terminated by Sponsor|0|||
131788767|NCT02124746|474509123|FG001|Overall Study|Study Terminated by Sponsor|0|||
131788768|NCT02124746|474509124|FG002|Overall Study|Study Terminated by Sponsor|6|||
131583431|NCT02507752|473763260|FG000|Overall Study|Adverse Event|1|||
131788769|NCT02124746|474509122|FG000|Overall Study|Disease Progression|3|||
131788770|NCT02124746|474509123|FG001|Overall Study|Disease Progression|6|||
131788771|NCT02124746|474509124|FG002|Overall Study|Disease Progression|4|||
131788772|NCT00964223|474509134|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
131788773|NCT00585039|474509142|FG000|Overall Study|medication spilled|2|||
131788774|NCT00585039|474509143|FG001|Overall Study|medication spilled|0|||
131788775|NCT01010230|474509144|FG000|Overall Study|Withdrawal by Subject|6|||
131788776|NCT01010230|474509145|FG001|Overall Study|Withdrawal by Subject|5|||
131788777|NCT01010230|474509144|FG000|Overall Study|Lost to Follow-up|4|||
131788778|NCT01010230|474509145|FG001|Overall Study|Lost to Follow-up|2|||
131788779|NCT01629693|474509146|FG000|Overall Study|Lost to Follow-up|2|||
131788780|NCT01629693|474509147|FG001|Overall Study|Lost to Follow-up|4|||
131788781|NCT01629693|474509146|FG000|Overall Study|Withdrawal by Subject|2|||
131788782|NCT01629693|474509147|FG001|Overall Study|Withdrawal by Subject|2|||
131788783|NCT01629693|474509146|FG000|Overall Study|Adverse Event|1|||
131788784|NCT01629693|474509147|FG001|Overall Study|Adverse Event|0|||
131788785|NCT01629693|474509146|FG000|Overall Study|Investigator decision|0|||
131788786|NCT01629693|474509147|FG001|Overall Study|Investigator decision|1|||
131788787|NCT01629693|474509146|FG000|Overall Study|Poor comfort of study lenses|0|||
131788788|NCT01629693|474509147|FG001|Overall Study|Poor comfort of study lenses|2|||
131788789|NCT01629693|474509146|FG000|Overall Study|Subject decision unrelated to AE|0|||
131788790|NCT01629693|474509147|FG001|Overall Study|Subject decision unrelated to AE|1|||
131788791|NCT01585831|474509154|FG000|Overall Study|Physician Decision|0|||
131788792|NCT01585831|474509155|FG001|Overall Study|Physician Decision|1|||
131788793|NCT01585831|474509154|FG000|Overall Study|Withdrawal by Subject|2|||
131788794|NCT01585831|474509155|FG001|Overall Study|Withdrawal by Subject|1|||
131788795|NCT04385199|474509156|FG000|Overall Study|Withdrawal by Subject|1|||
131788796|NCT04385199|474509157|FG001|Overall Study|Withdrawal by Subject|0|||
131788797|NCT01759537|474509158|FG000|Overall Study|Death|1|||
131788798|NCT01759537|474509159|FG001|Overall Study|Death|1|||
131788799|NCT01759537|474509158|FG000|Overall Study|Pregnancy|1|||
131788800|NCT01759537|474509159|FG001|Overall Study|Pregnancy|1|||
131788801|NCT01759537|474509158|FG000|Overall Study|Lost to Follow-up|9|||
131788802|NCT01759537|474509159|FG001|Overall Study|Lost to Follow-up|9|||
131788803|NCT01759537|474509158|FG000|Overall Study|Accident involving jaw fracture|1|||
131788804|NCT01759537|474509159|FG001|Overall Study|Accident involving jaw fracture|1|||
131788805|NCT01759537|474509158|FG000|Overall Study|Subcrestal implant too coronal|1|||
131788806|NCT01759537|474509159|FG001|Overall Study|Subcrestal implant too coronal|1|||
131788807|NCT00420290|474509160|FG000|Overall Study|Adverse Event|3|||
131788808|NCT00420290|474509161|FG001|Overall Study|Adverse Event|1|||
131788809|NCT00420290|474509160|FG000|Overall Study|Withdrawal by Subject|0|||
131788810|NCT00420290|474509161|FG001|Overall Study|Withdrawal by Subject|2|||
131788811|NCT00420290|474509160|FG000|Overall Study|did not meet inclusion/exclusion|1|||
131788812|NCT00420290|474509161|FG001|Overall Study|did not meet inclusion/exclusion|1|||
131788813|NCT01165242|474510589|FG000|Overall Study|Unreachable Subjects|1|||
131788814|NCT01165242|474510590|FG001|Overall Study|Unreachable Subjects|0|||
131788815|NCT01165242|474510591|FG002|Overall Study|Unreachable Subjects|0|||
131788816|NCT01165242|474510589|FG000|Overall Study|Incarcerated Subjects|0|||
131788817|NCT01165242|474510590|FG001|Overall Study|Incarcerated Subjects|1|||
131788818|NCT01165242|474510591|FG002|Overall Study|Incarcerated Subjects|0|||
131788819|NCT01165242|474510589|FG000|Overall Study|Visit 2 Declined by Subject|0|||
131788820|NCT01165242|474510590|FG001|Overall Study|Visit 2 Declined by Subject|0|||
131788821|NCT01165242|474510591|FG002|Overall Study|Visit 2 Declined by Subject|1|||
131788822|NCT01165242|474510589|FG000|Overall Study|Withdrawal by Subject|0|||
131788823|NCT01165242|474510590|FG001|Overall Study|Withdrawal by Subject|2|||
131583432|NCT02507752|473763260|FG000|Overall Study|Protocol Violation|6|||
131788824|NCT01165242|474510591|FG002|Overall Study|Withdrawal by Subject|2|||
131788825|NCT01165242|474510589|FG000|Overall Study|Extended Holiday|0|||
131788826|NCT01165242|474510590|FG001|Overall Study|Extended Holiday|0|||
131788827|NCT01165242|474510591|FG002|Overall Study|Extended Holiday|1|||
131788828|NCT01165242|474510589|FG000|Overall Study|Lost to Follow-up|9|||
131788829|NCT01165242|474510590|FG001|Overall Study|Lost to Follow-up|7|||
131788830|NCT01165242|474510591|FG002|Overall Study|Lost to Follow-up|10|||
131788831|NCT03770000|474510592|FG000|Overall Study|Premature discontinuation due to PD|0|||
131788832|NCT03770000|474510593|FG001|Overall Study|Premature discontinuation due to PD|0|||
131788833|NCT03770000|474510594|FG002|Overall Study|Premature discontinuation due to PD|1|||
131788834|NCT03770000|474510595|FG003|Overall Study|Premature discontinuation due to PD|3|||
131788835|NCT03770000|474510596|FG004|Overall Study|Premature discontinuation due to PD|2|||
131788836|NCT01690520|474510599|FG000|Overall Study|Death|25|||
131583433|NCT02507752|473763260|FG000|Overall Study|Lost to Follow-up|7|||
131788837|NCT01690520|474510600|FG001|Overall Study|Death|21|||
131788838|NCT01690520|474510599|FG000|Overall Study|Lost to Follow-up|2|||
131583434|NCT02507752|473763260|FG000|Overall Study|Infusion reaction at first infusion|1|||
131583435|NCT02507752|473763260|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
131583436|NCT02507752|473763260|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
131583437|NCT05274217|473763262|FG000|Overall Study|Study terminated.|11|||
131583438|NCT05274217|473763263|FG001|Overall Study|Study terminated.|0|||
131583439|NCT04594759|473763264|FG000|Overall Study|Lost to Follow-up|3|||
131583440|NCT05609032|473763267|FG000|Overall Study|Lost to Follow-up|3|||
131583441|NCT05609032|473763268|FG001|Overall Study|Lost to Follow-up|1|||
131583442|NCT05609032|473763267|FG000|Overall Study|Withdrawal by Subject|1|||
131583443|NCT05609032|473763268|FG001|Overall Study|Withdrawal by Subject|0|||
131583444|NCT02261467|473763269|FG000|Overall Study|Enrolled in Error|1|||
131583445|NCT02261467|473763270|FG001|Overall Study|Enrolled in Error|0|||
131583446|NCT02261467|473763269|FG000|Overall Study|Protocol Violation|0|||
131583447|NCT02261467|473763270|FG001|Overall Study|Protocol Violation|1|||
131583448|NCT02261467|473763269|FG000|Overall Study|Personal Reasons|17|||
131583449|NCT02261467|473763270|FG001|Overall Study|Personal Reasons|22|||
131583450|NCT02261467|473763269|FG000|Overall Study|Lost to Follow-up|2|||
131583451|NCT02261467|473763270|FG001|Overall Study|Lost to Follow-up|13|||
131583452|NCT02261467|473763269|FG000|Overall Study|Adverse Event|1|||
131583453|NCT02261467|473763270|FG001|Overall Study|Adverse Event|1|||
131583454|NCT00529659|473763271|FG000|Overall Study|Adverse Event|8|||
131583455|NCT00529659|473763272|FG001|Overall Study|Adverse Event|7|||
131583456|NCT00529659|473763271|FG000|Overall Study|Lost to Follow-up|0|||
131583457|NCT00529659|473763272|FG001|Overall Study|Lost to Follow-up|2|||
131583458|NCT00529659|473763271|FG000|Overall Study|Physician Decision|0|||
131583459|NCT00529659|473763272|FG001|Overall Study|Physician Decision|2|||
131583460|NCT00529659|473763271|FG000|Overall Study|Protocol Violation|2|||
131583461|NCT00529659|473763272|FG001|Overall Study|Protocol Violation|6|||
131583462|NCT00529659|473763271|FG000|Overall Study|Withdrawal by Subject|1|||
131583463|NCT00529659|473763272|FG001|Overall Study|Withdrawal by Subject|6|||
131583464|NCT01787760|473763278|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
131583465|NCT01787760|473763279|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
131583466|NCT01787760|473763280|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
131583467|NCT01787760|473763278|FG000|Overall Study|Decompensated on left exotropia|0|||
131583468|NCT01787760|473763279|FG001|Overall Study|Decompensated on left exotropia|0|||
131583469|NCT01787760|473763280|FG002|Overall Study|Decompensated on left exotropia|1|||
131583470|NCT01787760|473763278|FG000|Overall Study|Dryness|0|||
131583471|NCT01787760|473763279|FG001|Overall Study|Dryness|1|||
131583472|NCT01787760|473763280|FG002|Overall Study|Dryness|0|||
131583473|NCT01787760|473763278|FG000|Overall Study|Relocation|1|||
131583474|NCT01787760|473763279|FG001|Overall Study|Relocation|1|||
131583475|NCT01787760|473763280|FG002|Overall Study|Relocation|0|||
131583476|NCT01787760|473763278|FG000|Overall Study|Lens discomfort|3|||
131583477|NCT01787760|473763279|FG001|Overall Study|Lens discomfort|0|||
131583478|NCT01787760|473763280|FG002|Overall Study|Lens discomfort|0|||
131583479|NCT01787760|473763278|FG000|Overall Study|Lens handling difficulty|1|||
131583480|NCT01787760|473763279|FG001|Overall Study|Lens handling difficulty|2|||
131583481|NCT01787760|473763280|FG002|Overall Study|Lens handling difficulty|0|||
131583482|NCT01787760|473763278|FG000|Overall Study|Protocol Violation|6|||
131583483|NCT01787760|473763279|FG001|Overall Study|Protocol Violation|0|||
131583484|NCT01787760|473763280|FG002|Overall Study|Protocol Violation|1|||
131583485|NCT01787760|473763278|FG000|Overall Study|Withdrawal by Subject|5|||
131583486|NCT01787760|473763279|FG001|Overall Study|Withdrawal by Subject|1|||
131583487|NCT01787760|473763280|FG002|Overall Study|Withdrawal by Subject|2|||
131583488|NCT01787760|473763278|FG000|Overall Study|Lost to Follow-up|1|||
131583489|NCT01787760|473763279|FG001|Overall Study|Lost to Follow-up|0|||
131583490|NCT01787760|473763280|FG002|Overall Study|Lost to Follow-up|1|||
131788839|NCT01690520|474510600|FG001|Overall Study|Lost to Follow-up|3|||
131788840|NCT01690520|474510599|FG000|Overall Study|Withdrawal by Subject|2|||
131788841|NCT01690520|474510600|FG001|Overall Study|Withdrawal by Subject|0|||
131788842|NCT01690520|474510599|FG000|Overall Study|Relapse|0|||
131788843|NCT01690520|474510600|FG001|Overall Study|Relapse|1|||
131788844|NCT01690520|474510599|FG000|Overall Study|Other|0|||
131788845|NCT01690520|474510600|FG001|Overall Study|Other|1|||
131788846|NCT01690520|474510599|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
131788847|NCT01690520|474510600|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
131788848|NCT01169649|474510604|FG000|Overall Study|Patient Not Treated|3|||
131788849|NCT03763331|474510605|FG000|Overall Study|Lost to Follow-up|1|||
131788850|NCT03763331|474510606|FG001|Overall Study|Lost to Follow-up|0|||
131788851|NCT03763331|474510605|FG000|Overall Study|Withdrawal by Subject|1|||
131788852|NCT03763331|474510606|FG001|Overall Study|Withdrawal by Subject|0|||
131788853|NCT03763331|474510605|FG000|Overall Study|Non-compliance|0|||
131788854|NCT03763331|474510606|FG001|Overall Study|Non-compliance|3|||
131788855|NCT04741503|474510607|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
131788856|NCT04741503|474510608|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
131788857|NCT04741503|474510609|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
131788858|NCT04741503|474510607|FG000|Initial Enrollment|Overquotas removed|0|||
131788859|NCT04741503|474510608|FG001|Initial Enrollment|Overquotas removed|0|||
131788860|NCT04741503|474510609|FG002|Initial Enrollment|Overquotas removed|186|||
131788861|NCT04741503|474510607|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
131788862|NCT04741503|474510608|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
131788863|NCT04741503|474510609|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
131788864|NCT02280421|474510610|FG000|Washout (2 Weeks)|Adverse Event|0|||
131788865|NCT02280421|474510611|FG001|Washout (2 Weeks)|Adverse Event|1|||
131788866|NCT02280421|474510610|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
131788867|NCT02280421|474510611|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
131788868|NCT03840811|474510618|FG000|Overall Study|Lost to Follow-up|0|||
131788869|NCT03840811|474510619|FG001|Overall Study|Lost to Follow-up|0|||
131788870|NCT03840811|474510620|FG002|Overall Study|Lost to Follow-up|1|||
131788871|NCT01625845|474510621|FG000|Overall Study|Adverse Event|1|||
131788872|NCT01625845|474510622|FG001|Overall Study|Adverse Event|2|||
131788873|NCT01625845|474510621|FG000|Overall Study|Lost to Follow-up|2|||
131788874|NCT01625845|474510622|FG001|Overall Study|Lost to Follow-up|1|||
131788875|NCT01625845|474510621|FG000|Overall Study|Withdrawal by Subject|2|||
131788876|NCT01625845|474510622|FG001|Overall Study|Withdrawal by Subject|0|||
131583491|NCT01787760|473763278|FG000|Overall Study|Stroke|1|||
131583492|NCT01787760|473763279|FG001|Overall Study|Stroke|0|||
131788877|NCT02853929|474510623|FG000|Overall Study|Lost to Follow-up|3|||
131788878|NCT02853929|474510624|FG001|Overall Study|Lost to Follow-up|0|||
131788879|NCT02853929|474510623|FG000|Overall Study|Withdrawal by Subject|1|||
131788880|NCT02853929|474510624|FG001|Overall Study|Withdrawal by Subject|0|||
131583493|NCT01787760|473763280|FG002|Overall Study|Stroke|0|||
131583494|NCT01787760|473763278|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
131583495|NCT01787760|473763279|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
131583496|NCT01787760|473763280|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
131583497|NCT01787760|473763278|FG000|Overall Study|Unsatisfactory physiological response|2|||
131583498|NCT01787760|473763279|FG001|Overall Study|Unsatisfactory physiological response|4|||
131583499|NCT01787760|473763280|FG002|Overall Study|Unsatisfactory physiological response|0|||
131583500|NCT01787760|473763278|FG000|Overall Study|Unsatisfactory visual response|1|||
131583501|NCT01787760|473763279|FG001|Overall Study|Unsatisfactory visual response|1|||
131583502|NCT01787760|473763280|FG002|Overall Study|Unsatisfactory visual response|0|||
131583503|NCT01787760|473763278|FG000|Overall Study|Near vision blur|1|||
131583504|NCT01787760|473763279|FG001|Overall Study|Near vision blur|0|||
131583505|NCT01787760|473763280|FG002|Overall Study|Near vision blur|0|||
131583506|NCT03512756|473763281|FG000|Part 1|Death|23|||
131583507|NCT03512756|473763282|FG001|Part 1|Death|18|||
131583508|NCT03512756|473763283|FG002|Part 1|Death|0|||
131583509|NCT03512756|473763284|FG003|Part 1|Death|0|||
131583510|NCT03512756|473763281|FG000|Part 1|Lost to Follow-up|0|||
131583511|NCT03512756|473763282|FG001|Part 1|Lost to Follow-up|3|||
131583512|NCT03512756|473763283|FG002|Part 1|Lost to Follow-up|0|||
131583513|NCT03512756|473763284|FG003|Part 1|Lost to Follow-up|0|||
131583514|NCT03512756|473763281|FG000|Part 1|Physician Decision|0|||
131583515|NCT03512756|473763282|FG001|Part 1|Physician Decision|1|||
131583516|NCT03512756|473763283|FG002|Part 1|Physician Decision|0|||
131583517|NCT03512756|473763284|FG003|Part 1|Physician Decision|0|||
131583518|NCT03512756|473763281|FG000|Part 1|Withdrawal by Subject|2|||
131583519|NCT03512756|473763282|FG001|Part 1|Withdrawal by Subject|2|||
131583520|NCT03512756|473763283|FG002|Part 1|Withdrawal by Subject|0|||
131583521|NCT03512756|473763284|FG003|Part 1|Withdrawal by Subject|0|||
131703873|NCT00091832|474198540|FG001|Overall Study|Adverse Event|0|||
131703874|NCT00091832|474198541|FG002|Overall Study|Adverse Event|0|||
131788881|NCT02853929|474510623|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
131788882|NCT02853929|474510624|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
131583522|NCT03512756|473763281|FG000|Part 2|Death|0|||
131703875|NCT00091832|474198542|FG003|Overall Study|Adverse Event|1|||
131703876|NCT00091832|474198543|FG004|Overall Study|Adverse Event|3|||
131703877|NCT00091832|474198544|FG005|Overall Study|Adverse Event|0|||
131703878|NCT00091832|474198539|FG000|Overall Study|Withdrawal by Subject|4|||
131703879|NCT00091832|474198540|FG001|Overall Study|Withdrawal by Subject|5|||
131703880|NCT00091832|474198541|FG002|Overall Study|Withdrawal by Subject|0|||
131788883|NCT03549130|474510625|FG000|Overall Study|Adverse Event|0|||
131703881|NCT00091832|474198542|FG003|Overall Study|Withdrawal by Subject|1|||
131703882|NCT00091832|474198543|FG004|Overall Study|Withdrawal by Subject|3|||
131703883|NCT00091832|474198544|FG005|Overall Study|Withdrawal by Subject|1|||
131788884|NCT03549130|474510626|FG001|Overall Study|Adverse Event|1|||
131788885|NCT03549130|474510625|FG000|Overall Study|Lost to Follow-up|0|||
131583523|NCT03512756|473763282|FG001|Part 2|Death|0|||
131583524|NCT03512756|473763283|FG002|Part 2|Death|32|||
131583525|NCT03512756|473763284|FG003|Part 2|Death|21|||
131583526|NCT03512756|473763281|FG000|Part 2|Lost to Follow-up|0|||
131583527|NCT03512756|473763282|FG001|Part 2|Lost to Follow-up|0|||
131583528|NCT03512756|473763283|FG002|Part 2|Lost to Follow-up|1|||
131583529|NCT03512756|473763284|FG003|Part 2|Lost to Follow-up|0|||
131583530|NCT03512756|473763281|FG000|Part 2|Physician Decision|0|||
131583531|NCT03512756|473763282|FG001|Part 2|Physician Decision|0|||
131583532|NCT03512756|473763283|FG002|Part 2|Physician Decision|2|||
131583533|NCT03512756|473763284|FG003|Part 2|Physician Decision|4|||
131583534|NCT03512756|473763281|FG000|Part 2|Study Terminated by Sponsor|0|||
131583535|NCT03512756|473763282|FG001|Part 2|Study Terminated by Sponsor|0|||
131583536|NCT03512756|473763283|FG002|Part 2|Study Terminated by Sponsor|2|||
131583537|NCT03512756|473763284|FG003|Part 2|Study Terminated by Sponsor|6|||
131438505|NCT03535974|473231263|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
131438506|NCT04059549|473231264|FG000|Overall Study|Withdrawal by Subject|2|||
131438507|NCT04059549|473231265|FG001|Overall Study|Withdrawal by Subject|0|||
131438508|NCT02678351|473231267|FG000|Overall Study|Withdrawal by Subject|1|||
131438509|NCT00988884|473231268|FG000|Overall Study|Adverse Event|0|||
131438510|NCT00988884|473231269|FG001|Overall Study|Adverse Event|1|||
131438511|NCT00988884|473231268|FG000|Overall Study|Lost to Follow-up|20|||
131438512|NCT00988884|473231269|FG001|Overall Study|Lost to Follow-up|16|||
131438513|NCT00988884|473231268|FG000|Overall Study|Protocol Violation|0|||
131438514|NCT00988884|473231269|FG001|Overall Study|Protocol Violation|1|||
131438515|NCT00988884|473231268|FG000|Overall Study|Withdrawal by Subject|15|||
131438516|NCT00988884|473231269|FG001|Overall Study|Withdrawal by Subject|18|||
131438517|NCT01919229|473231270|FG000|Overall Study|Subject/guardian decision|0|||
131438518|NCT01919229|473231271|FG001|Overall Study|Subject/guardian decision|0|||
131438519|NCT01919229|473231272|FG002|Overall Study|Subject/guardian decision|1|||
131583538|NCT03512756|473763281|FG000|Part 2|Protocol Violation|0|||
131583539|NCT03512756|473763282|FG001|Part 2|Protocol Violation|0|||
131583540|NCT03512756|473763283|FG002|Part 2|Protocol Violation|1|||
131703884|NCT00091832|474198539|FG000|Overall Study|Death|6|||
131703885|NCT00091832|474198540|FG001|Overall Study|Death|4|||
131703886|NCT00091832|474198541|FG002|Overall Study|Death|5|||
131703887|NCT00091832|474198542|FG003|Overall Study|Death|8|||
131703888|NCT00091832|474198543|FG004|Overall Study|Death|5|||
131703889|NCT00091832|474198544|FG005|Overall Study|Death|6|||
131703890|NCT00091832|474198539|FG000|Overall Study|Disease Progression|2|||
131703891|NCT00091832|474198540|FG001|Overall Study|Disease Progression|0|||
131703892|NCT00091832|474198541|FG002|Overall Study|Disease Progression|0|||
131703893|NCT00091832|474198542|FG003|Overall Study|Disease Progression|1|||
131703894|NCT00091832|474198543|FG004|Overall Study|Disease Progression|1|||
131703895|NCT00091832|474198544|FG005|Overall Study|Disease Progression|2|||
131703896|NCT00091832|474198539|FG000|Overall Study|Ineligibility Determined|0|||
131438520|NCT01011673|473231273|FG000|Randomized|Secondary headache|2|||
131583541|NCT03512756|473763284|FG003|Part 2|Protocol Violation|0|||
131583542|NCT03512756|473763281|FG000|Part 2|Withdrawal by Subject|0|||
131703897|NCT00091832|474198540|FG001|Overall Study|Ineligibility Determined|0|||
131703898|NCT00091832|474198541|FG002|Overall Study|Ineligibility Determined|1|||
131703899|NCT00091832|474198542|FG003|Overall Study|Ineligibility Determined|0|||
131583543|NCT03512756|473763282|FG001|Part 2|Withdrawal by Subject|0|||
131583544|NCT03512756|473763283|FG002|Part 2|Withdrawal by Subject|3|||
131583545|NCT03512756|473763284|FG003|Part 2|Withdrawal by Subject|9|||
131703900|NCT00091832|474198543|FG004|Overall Study|Ineligibility Determined|1|||
131703901|NCT00091832|474198544|FG005|Overall Study|Ineligibility Determined|0|||
131583546|NCT00736853|473763285|FG000|Open-Label Period|Physician Decision|2|||
131583547|NCT00736853|473763286|FG001|Open-Label Period|Physician Decision|0|||
131583548|NCT00736853|473763287|FG002|Open-Label Period|Physician Decision|0|||
131583549|NCT00736853|473763285|FG000|Open-Label Period|Adverse Event|31|||
131583550|NCT00736853|473763286|FG001|Open-Label Period|Adverse Event|0|||
131583551|NCT00736853|473763287|FG002|Open-Label Period|Adverse Event|0|||
131583552|NCT00736853|473763285|FG000|Open-Label Period|Withdrawal by Subject|16|||
131583553|NCT00736853|473763286|FG001|Open-Label Period|Withdrawal by Subject|0|||
131583554|NCT00736853|473763287|FG002|Open-Label Period|Withdrawal by Subject|0|||
131583555|NCT00736853|473763285|FG000|Open-Label Period|Started but not treated|42|||
131438521|NCT01011673|473231274|FG001|Randomized|Secondary headache|1|||
131438522|NCT01011673|473231273|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
131583556|NCT00736853|473763286|FG001|Open-Label Period|Started but not treated|0|||
131583557|NCT00736853|473763287|FG002|Open-Label Period|Started but not treated|0|||
131583558|NCT00736853|473763285|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
131703902|NCT00091832|474198539|FG000|Overall Study|Lost to Follow-up|1|||
131438523|NCT01011673|473231274|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
131438524|NCT01632020|473231275|FG000|Overall Study|Withdrawal by Subject|1|||
131438525|NCT01632020|473231276|FG001|Overall Study|Withdrawal by Subject|0|||
131703903|NCT00091832|474198540|FG001|Overall Study|Lost to Follow-up|0|||
131703904|NCT00091832|474198541|FG002|Overall Study|Lost to Follow-up|3|||
131703905|NCT00091832|474198542|FG003|Overall Study|Lost to Follow-up|3|||
131703906|NCT00091832|474198543|FG004|Overall Study|Lost to Follow-up|2|||
131703907|NCT00091832|474198544|FG005|Overall Study|Lost to Follow-up|1|||
131703908|NCT00091832|474198539|FG000|Overall Study|Noncompliance|0|||
131703909|NCT00091832|474198540|FG001|Overall Study|Noncompliance|1|||
131703910|NCT00091832|474198541|FG002|Overall Study|Noncompliance|0|||
131703911|NCT00091832|474198542|FG003|Overall Study|Noncompliance|0|||
131703912|NCT00091832|474198543|FG004|Overall Study|Noncompliance|0|||
131703913|NCT00091832|474198544|FG005|Overall Study|Noncompliance|0|||
131703914|NCT00091832|474198539|FG000|Overall Study|Other|0|||
131703915|NCT00091832|474198540|FG001|Overall Study|Other|1|||
131703916|NCT00091832|474198541|FG002|Overall Study|Other|2|||
131703917|NCT00091832|474198542|FG003|Overall Study|Other|0|||
131703918|NCT00091832|474198543|FG004|Overall Study|Other|0|||
131703919|NCT00091832|474198544|FG005|Overall Study|Other|0|||
131703920|NCT00091832|474198539|FG000|Overall Study|Protocol Violation|0|||
131703921|NCT00091832|474198540|FG001|Overall Study|Protocol Violation|0|||
131703922|NCT00091832|474198541|FG002|Overall Study|Protocol Violation|1|||
131703923|NCT00091832|474198542|FG003|Overall Study|Protocol Violation|0|||
131703924|NCT00091832|474198543|FG004|Overall Study|Protocol Violation|0|||
131703925|NCT00091832|474198544|FG005|Overall Study|Protocol Violation|1|||
131703926|NCT00464178|474198545|FG000|Overall Study|Protocol Violation|1|||
131703927|NCT00464178|474198545|FG000|Overall Study|Withdrawal by Subject|1|||
131438526|NCT01632020|473231275|FG000|Overall Study|Adverse Event|1|||
131583559|NCT00736853|473763286|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
131703928|NCT01557166|474198548|FG000|Overall Study|Adverse Event|20|||
131703929|NCT01557166|474198549|FG001|Overall Study|Adverse Event|6|||
131703930|NCT01557166|474198548|FG000|Overall Study|Lack of Efficacy|2|||
131583560|NCT00736853|473763287|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
131703931|NCT01557166|474198549|FG001|Overall Study|Lack of Efficacy|1|||
131703932|NCT01557166|474198548|FG000|Overall Study|Protocol Violation|8|||
131703933|NCT01557166|474198549|FG001|Overall Study|Protocol Violation|5|||
131703934|NCT01557166|474198548|FG000|Overall Study|Withdrawn consent|12|||
131703935|NCT01557166|474198549|FG001|Overall Study|Withdrawn consent|20|||
131788886|NCT03549130|474510626|FG001|Overall Study|Lost to Follow-up|1|||
131788887|NCT00463866|474510627|FG000|Overall Study|Adverse Event|70|||
131788888|NCT00463866|474510628|FG001|Overall Study|Adverse Event|93|||
131788889|NCT00463866|474510627|FG000|Overall Study|Withdrawal by Subject|81|||
131788890|NCT00463866|474510628|FG001|Overall Study|Withdrawal by Subject|79|||
131788891|NCT00463866|474510627|FG000|Overall Study|Lost to Follow-up|46|||
131788892|NCT00463866|474510628|FG001|Overall Study|Lost to Follow-up|55|||
131788893|NCT00463866|474510627|FG000|Overall Study|Incorrect Enrolment|64|||
131788894|NCT00463866|474510628|FG001|Overall Study|Incorrect Enrolment|66|||
131788895|NCT00463866|474510627|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
131788896|NCT00463866|474510628|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
131788897|NCT00463866|474510627|FG000|Overall Study|Safety Reason|1|||
131788898|NCT00463866|474510628|FG001|Overall Study|Safety Reason|3|||
131788899|NCT00463866|474510627|FG000|Overall Study|Mis-Randomization of subject|0|||
131788900|NCT00463866|474510628|FG001|Overall Study|Mis-Randomization of subject|1|||
131788901|NCT00463866|474510627|FG000|Overall Study|Other|22|||
131788902|NCT00463866|474510628|FG001|Overall Study|Other|22|||
131788903|NCT00693784|474510629|FG000|Overall Study|Lost to Follow-up|2|||
131788904|NCT00693784|474510629|FG000|Overall Study|Withdrawal by Subject|2|||
131788905|NCT00326885|474510633|FG000|Overall Study|Adverse Event|1|||
131788906|NCT00326885|474510633|FG000|Overall Study|Withdrawal by Subject|3|||
131788907|NCT00326885|474510633|FG000|Overall Study|Physician Decision|1|||
131788908|NCT00326885|474510633|FG000|Overall Study|Hospice withdrew consent|2|||
131788909|NCT01677910|474510635|FG000|Double-Blind Treatment Period|Adverse Event|6|||
131788910|NCT01677910|474510636|FG001|Double-Blind Treatment Period|Adverse Event|2|||
131788911|NCT01677910|474510637|FG002|Double-Blind Treatment Period|Adverse Event|3|||
131788912|NCT01677910|474510638|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131788913|NCT01677910|474510635|FG000|Double-Blind Treatment Period|Physician Decision|0|||
131788914|NCT01677910|474510636|FG001|Double-Blind Treatment Period|Physician Decision|0|||
131788915|NCT01677910|474510637|FG002|Double-Blind Treatment Period|Physician Decision|1|||
131788916|NCT01677910|474510638|FG003|Double-Blind Treatment Period|Physician Decision|0|||
131788917|NCT01677910|474510635|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
131788918|NCT01677910|474510636|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
131788919|NCT01677910|474510637|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
131788920|NCT01677910|474510638|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
131788921|NCT01677910|474510635|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
131788922|NCT01677910|474510636|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
131788923|NCT01677910|474510637|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
131788924|NCT01677910|474510638|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
131788925|NCT01677910|474510635|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
131788926|NCT01677910|474510636|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
131788927|NCT01677910|474510637|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
131788928|NCT01677910|474510638|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
131788929|NCT01677910|474510635|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131788930|NCT01677910|474510636|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131788931|NCT01677910|474510637|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131788932|NCT01677910|474510638|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
131788933|NCT01677910|474510635|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131788934|NCT01677910|474510636|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131788935|NCT01677910|474510637|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131788936|NCT01677910|474510638|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
131788937|NCT01677910|474510635|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131703936|NCT01557166|474198548|FG000|Overall Study|Target dose not tolerated|1|||
131703937|NCT01557166|474198549|FG001|Overall Study|Target dose not tolerated|0|||
131703938|NCT01557166|474198548|FG000|Overall Study|Psychiatric disorder|1|||
131703939|NCT01557166|474198549|FG001|Overall Study|Psychiatric disorder|0|||
131703940|NCT01557166|474198548|FG000|Overall Study|Unclassified|2|||
131703941|NCT01557166|474198549|FG001|Overall Study|Unclassified|5|||
131703942|NCT00946309|474198550|FG000|Overall Study|Protocol Violation|1|||
131703943|NCT00946309|474198551|FG001|Overall Study|Protocol Violation|0|||
131703944|NCT00946309|474198550|FG000|Overall Study|Lost to Follow-up|0|||
131703945|NCT00946309|474198551|FG001|Overall Study|Lost to Follow-up|1|||
131703946|NCT00946309|474198550|FG000|Overall Study|Procedure cancelled/discontinued|0|||
131703947|NCT00946309|474198551|FG001|Overall Study|Procedure cancelled/discontinued|3|||
131703948|NCT01465659|474198553|FG000|Completed 1 Cycle of Treatment|Death|0|||
131703949|NCT01465659|474198554|FG001|Completed 1 Cycle of Treatment|Death|1|||
131703950|NCT01465659|474198555|FG002|Completed 1 Cycle of Treatment|Death|0|||
131703951|NCT01465659|474198556|FG003|Completed 1 Cycle of Treatment|Death|0|||
131703952|NCT01465659|474198553|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
131703953|NCT01465659|474198554|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
131703954|NCT01465659|474198555|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
131703955|NCT01465659|474198556|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
131703956|NCT01465659|474198553|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
131703957|NCT01465659|474198554|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
131703958|NCT01465659|474198555|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
131703959|NCT01465659|474198556|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
131703960|NCT01465659|474198553|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
131703961|NCT01465659|474198554|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
131703962|NCT01465659|474198555|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
131703963|NCT01465659|474198556|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
131703964|NCT01465659|474198553|FG000|Completed Follow for 1 Year|Death|6|||
131703965|NCT01465659|474198554|FG001|Completed Follow for 1 Year|Death|3|||
131703966|NCT01465659|474198555|FG002|Completed Follow for 1 Year|Death|2|||
131703967|NCT01465659|474198556|FG003|Completed Follow for 1 Year|Death|4|||
131703968|NCT02445586|474198559|FG000|Overall Study|Death|14|||
131703969|NCT02445586|474198559|FG000|Overall Study|Withdrawal by Subject|13|||
131703970|NCT02445586|474198559|FG000|Overall Study|Disease Progression|10|||
131703971|NCT02445586|474198559|FG000|Overall Study|Protocol Violation|1|||
131703972|NCT02445586|474198559|FG000|Overall Study|Medical Condition|1|||
131703973|NCT00428597|474198562|FG000|Overall Study|Randomized but not treated|3|||
131703974|NCT00428597|474198563|FG001|Overall Study|Randomized but not treated|3|||
131703975|NCT00428597|474198562|FG000|Overall Study|Objective Progression or Relapse|19|||
131703976|NCT00428597|474198563|FG001|Overall Study|Objective Progression or Relapse|47|||
131703977|NCT00428597|474198562|FG000|Overall Study|Study Terminated by Sponsor|41|||
131703978|NCT00428597|474198563|FG001|Overall Study|Study Terminated by Sponsor|16|||
131703979|NCT00428597|474198562|FG000|Overall Study|Adverse Event|15|||
131703980|NCT00428597|474198563|FG001|Overall Study|Adverse Event|7|||
131703981|NCT00428597|474198562|FG000|Overall Study|Global Deterioration of Health Status|1|||
131703982|NCT00428597|474198563|FG001|Overall Study|Global Deterioration of Health Status|5|||
131703983|NCT00428597|474198562|FG000|Overall Study|Protocol Violation|2|||
131703984|NCT00428597|474198563|FG001|Overall Study|Protocol Violation|1|||
131583561|NCT00736853|473763285|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
131703985|NCT00428597|474198562|FG000|Overall Study|Withdrawal by Subject|2|||
131703986|NCT00428597|474198563|FG001|Overall Study|Withdrawal by Subject|1|||
131703987|NCT00428597|474198562|FG000|Overall Study|Other|1|||
131703988|NCT00428597|474198563|FG001|Overall Study|Other|1|||
131703989|NCT00428597|474198562|FG000|Overall Study|Lost to Follow-up|0|||
131703990|NCT00428597|474198563|FG001|Overall Study|Lost to Follow-up|1|||
131703991|NCT00428597|474198562|FG000|Overall Study|Pregnancy|1|||
131703992|NCT00428597|474198563|FG001|Overall Study|Pregnancy|0|||
131703993|NCT00428597|474198562|FG000|Overall Study|Death|1|||
131438527|NCT01632020|473231276|FG001|Overall Study|Adverse Event|0|||
131438528|NCT00549640|473231278|FG000|Overall Study|Withdrawal by Subject|6|||
131438529|NCT00549640|473231279|FG001|Overall Study|Withdrawal by Subject|12|||
131438530|NCT00549640|473231278|FG000|Overall Study|Adverse Event|5|||
131438531|NCT00549640|473231279|FG001|Overall Study|Adverse Event|0|||
131438532|NCT00549640|473231278|FG000|Overall Study|Lost to Follow-up|7|||
131438533|NCT00549640|473231279|FG001|Overall Study|Lost to Follow-up|4|||
131438534|NCT00626275|473231288|FG000|Part A - Treatment Period 1|Adverse Event|1|||
131438535|NCT00626275|473231289|FG001|Part A - Treatment Period 1|Adverse Event|0|||
131438536|NCT00626275|473231290|FG002|Part A - Treatment Period 1|Adverse Event|0|||
131438537|NCT00626275|473231291|FG003|Part A - Treatment Period 1|Adverse Event|0|||
131438538|NCT00626275|473231292|FG004|Part A - Treatment Period 1|Adverse Event|0|||
131438539|NCT00626275|473231293|FG005|Part A - Treatment Period 1|Adverse Event|0|||
131438540|NCT00626275|473231294|FG006|Part A - Treatment Period 1|Adverse Event|0|||
131703994|NCT00428597|474198563|FG001|Overall Study|Death|3|||
131703995|NCT00686647|474198571|FG000|Overall Study|Lost to Follow-up|1|||
131703996|NCT00686647|474198571|FG000|Overall Study|Death|1|||
131703997|NCT05501119|474198575|FG000|Overall Study|Withdrawal by Subject|2|||
131703998|NCT05501119|474198575|FG000|Overall Study|Lost to Follow-up|5|||
131703999|NCT01725750|474198576|FG000|Overall Study|Adverse Event|1|||
131704000|NCT01725750|474198577|FG001|Overall Study|Adverse Event|0|||
131704001|NCT01725750|474198576|FG000|Overall Study|Lost to Follow-up|1|||
131704002|NCT01725750|474198577|FG001|Overall Study|Lost to Follow-up|1|||
131704003|NCT01725750|474198576|FG000|Overall Study|Withdrawal by Subject|0|||
131704004|NCT01725750|474198577|FG001|Overall Study|Withdrawal by Subject|9|||
131704005|NCT02542072|474198578|FG000|First Intervention (1 Month)|Adverse Event|1|||
131704006|NCT02542072|474198579|FG001|First Intervention (1 Month)|Adverse Event|1|||
131704007|NCT02542072|474198578|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
131704008|NCT02542072|474198579|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
131704009|NCT02542072|474198578|FG000|First Intervention (1 Month)|Lens discomfort|1|||
131704010|NCT02542072|474198579|FG001|First Intervention (1 Month)|Lens discomfort|2|||
131704011|NCT02542072|474198578|FG000|First Intervention (1 Month)|Protocol Violation|1|||
131704012|NCT02542072|474198579|FG001|First Intervention (1 Month)|Protocol Violation|0|||
131704013|NCT02542072|474198578|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
131704014|NCT02542072|474198579|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
131704015|NCT02542072|474198578|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
131704016|NCT02542072|474198579|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
131704017|NCT00654498|474198580|FG000|Overall Study|Not Treated|1|||
131704018|NCT00654498|474198581|FG001|Overall Study|Not Treated|0|||
131704019|NCT00654498|474198580|FG000|Overall Study|Adverse Event|6|||
131704020|NCT00654498|474198581|FG001|Overall Study|Adverse Event|1|||
131704021|NCT00654498|474198580|FG000|Overall Study|Protocol Violation|1|||
131704022|NCT00654498|474198581|FG001|Overall Study|Protocol Violation|1|||
131704023|NCT00654498|474198580|FG000|Overall Study|Lost to Follow-up|1|||
131704024|NCT00654498|474198581|FG001|Overall Study|Lost to Follow-up|5|||
131704025|NCT00654498|474198580|FG000|Overall Study|Withdrawal by Subject|1|||
131704026|NCT00654498|474198581|FG001|Overall Study|Withdrawal by Subject|0|||
131704027|NCT00654498|474198580|FG000|Overall Study|Other reason not defined above|4|||
131704028|NCT00654498|474198581|FG001|Overall Study|Other reason not defined above|5|||
131704029|NCT01990261|474198582|FG000|Overall Study|Death Before Treatment Start|2|||
131704030|NCT01990261|474198582|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
131704031|NCT01990261|474198582|FG000|Overall Study|Death From other Causes|1|||
131704032|NCT01990261|474198582|FG000|Overall Study|Disease Progression (PD)|8|||
131704033|NCT01990261|474198582|FG000|Overall Study|PD Before Treatment Start|1|||
131704034|NCT01990261|474198582|FG000|Overall Study|Dossier not Approved|1|||
131704035|NCT01990261|474198582|FG000|Overall Study|Lost to Follow-up|2|||
131704036|NCT01356589|474198587|FG000|Overall Study|Enrolled, but not treated|3|||
131704037|NCT01356589|474198587|FG000|Overall Study|Dose data not recorded|2|||
131704038|NCT04698629|474198589|FG000|Overall Study|Adverse Event|1|||
131704039|NCT00865020|474198595|FG000|Overall Study|Withdrawal by Subject|22|||
131704040|NCT00865020|474198596|FG001|Overall Study|Withdrawal by Subject|16|||
131704041|NCT00865020|474198595|FG000|Overall Study|Adverse Event|9|||
131704042|NCT00865020|474198596|FG001|Overall Study|Adverse Event|14|||
131704043|NCT00865020|474198595|FG000|Overall Study|Abnormal test procedure result(s)|6|||
131704044|NCT00865020|474198596|FG001|Overall Study|Abnormal test procedure result(s)|8|||
131704045|NCT00865020|474198595|FG000|Overall Study|Lost to Follow-up|6|||
131704046|NCT00865020|474198596|FG001|Overall Study|Lost to Follow-up|4|||
131704047|NCT00865020|474198595|FG000|Overall Study|Protocol deviation|4|||
131704048|NCT00865020|474198596|FG001|Overall Study|Protocol deviation|1|||
131704049|NCT00865020|474198595|FG000|Overall Study|Administrative problems|0|||
131704050|NCT00865020|474198596|FG001|Overall Study|Administrative problems|2|||
131704051|NCT00865020|474198595|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131704052|NCT00865020|474198596|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131704053|NCT00865020|474198595|FG000|Overall Study|Death|0|||
131583562|NCT00736853|473763286|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
131583563|NCT00736853|473763287|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
131583564|NCT00736853|473763285|FG000|Double-Blind Period|Lack of Efficacy|0|||
131583565|NCT00736853|473763286|FG001|Double-Blind Period|Lack of Efficacy|19|||
131583566|NCT00736853|473763287|FG002|Double-Blind Period|Lack of Efficacy|42|||
131438541|NCT00626275|473231295|FG007|Part A - Treatment Period 1|Adverse Event|0|||
131438542|NCT00626275|473231288|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131583567|NCT00736853|473763285|FG000|Double-Blind Period|Adverse Event|0|||
131583568|NCT00736853|473763286|FG001|Double-Blind Period|Adverse Event|3|||
131583569|NCT00736853|473763287|FG002|Double-Blind Period|Adverse Event|2|||
131583570|NCT00736853|473763285|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131583571|NCT00736853|473763286|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131583572|NCT00736853|473763287|FG002|Double-Blind Period|Withdrawal by Subject|4|||
131583573|NCT00736853|473763285|FG000|Double-Blind Period|Ineligible to participate the study|0|||
131583574|NCT00736853|473763286|FG001|Double-Blind Period|Ineligible to participate the study|1|||
131583575|NCT00736853|473763287|FG002|Double-Blind Period|Ineligible to participate the study|0|||
131583576|NCT00933400|473763288|FG000|Overall Study|Withdrawal by Subject|21|||
131583577|NCT00933400|473763289|FG001|Overall Study|Withdrawal by Subject|1|||
131583578|NCT01041417|473763290|FG000|Overall Study|Adverse Event|5|||
131583579|NCT01041417|473763291|FG001|Overall Study|Adverse Event|2|||
131583580|NCT01041417|473763290|FG000|Overall Study|Lost to Follow-up|1|||
131583581|NCT01041417|473763291|FG001|Overall Study|Lost to Follow-up|1|||
131583582|NCT01041417|473763290|FG000|Overall Study|Death|1|||
131583583|NCT01041417|473763291|FG001|Overall Study|Death|0|||
131583584|NCT00704184|473763294|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
131583585|NCT00704184|473763295|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
131583586|NCT00704184|473763296|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
131583587|NCT00704184|473763297|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
131583588|NCT00704184|473763298|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
131583589|NCT00704184|473763294|FG000|Open-Label Treatment|Adverse Event|0|||
131583590|NCT00704184|473763295|FG001|Open-Label Treatment|Adverse Event|0|||
131583591|NCT00704184|473763296|FG002|Open-Label Treatment|Adverse Event|2|||
131583592|NCT00704184|473763297|FG003|Open-Label Treatment|Adverse Event|0|||
131583593|NCT00704184|473763298|FG004|Open-Label Treatment|Adverse Event|1|||
131583594|NCT00704184|473763294|FG000|Open-Label Treatment|Lack of Efficacy|0|||
131583595|NCT00704184|473763295|FG001|Open-Label Treatment|Lack of Efficacy|2|||
131583596|NCT00704184|473763296|FG002|Open-Label Treatment|Lack of Efficacy|2|||
131583597|NCT00704184|473763297|FG003|Open-Label Treatment|Lack of Efficacy|2|||
131583598|NCT00704184|473763298|FG004|Open-Label Treatment|Lack of Efficacy|1|||
131583599|NCT00704184|473763294|FG000|Open-Label Treatment|Physician Decision|0|||
131583600|NCT00704184|473763295|FG001|Open-Label Treatment|Physician Decision|0|||
131583601|NCT00704184|473763296|FG002|Open-Label Treatment|Physician Decision|0|||
131583602|NCT00704184|473763297|FG003|Open-Label Treatment|Physician Decision|0|||
131583603|NCT00704184|473763298|FG004|Open-Label Treatment|Physician Decision|1|||
131583604|NCT00704184|473763294|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
131704054|NCT00865020|474198596|FG001|Overall Study|Death|1|||
131704055|NCT00865020|474198595|FG000|Overall Study|Randomized but discontinued|2|||
131704056|NCT00865020|474198596|FG001|Overall Study|Randomized but discontinued|4|||
131583605|NCT00704184|473763295|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
131583606|NCT00704184|473763296|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
131583607|NCT00704184|473763297|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
131583608|NCT00704184|473763298|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
131583609|NCT03394885|473763300|FG000|Overall Study|Adverse Event|4|||
131583610|NCT03394885|473763300|FG000|Overall Study|Lack of Efficacy|1|||
131583611|NCT03394885|473763300|FG000|Overall Study|Physician Decision|1|||
131583612|NCT03394885|473763300|FG000|Overall Study|Withdrawal by Subject|8|||
131583613|NCT03394885|473763300|FG000|Overall Study|Alternative Therapy|1|||
131583614|NCT04980755|473763301|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
131583615|NCT04980755|473763301|FG000|Body Reprogramming Courses|Work commitment|2|||
131583616|NCT04980755|473763301|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
131583617|NCT04980755|473763301|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
131583618|NCT00801983|473763306|FG000|Period 1|Lost to Follow-up|2|||
131583619|NCT00801983|473763307|FG001|Period 1|Lost to Follow-up|0|||
131583620|NCT00801983|473763306|FG000|Period 1|Withdrawal by Subject|2|||
131583621|NCT00801983|473763307|FG001|Period 1|Withdrawal by Subject|8|||
131583622|NCT00801983|473763306|FG000|Period 2|Withdrawal by Subject|2|||
131583623|NCT00801983|473763307|FG001|Period 2|Withdrawal by Subject|1|||
131583624|NCT04623008|473764691|FG000|Baseline to T2|Withdrawal by Subject|4|||
131583625|NCT04623008|473764692|FG001|Baseline to T2|Withdrawal by Subject|2|||
131583626|NCT04623008|473764691|FG000|Baseline to T3|Withdrawal by Subject|4|||
131583627|NCT04623008|473764692|FG001|Baseline to T3|Withdrawal by Subject|2|||
131583628|NCT03779048|473764698|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
131583629|NCT03779048|473764699|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
131583630|NCT03779048|473764700|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
131583631|NCT03779048|473764698|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
131583632|NCT03779048|473764699|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
131583633|NCT03779048|473764700|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
131583634|NCT03779048|473764698|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
131583635|NCT03779048|473764699|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
131583636|NCT03779048|473764700|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
131583637|NCT03889925|473764701|FG000|Overall Study|Lost to Follow-up|11|||
131583638|NCT03889925|473764702|FG001|Overall Study|Lost to Follow-up|10|||
131583639|NCT04588259|473764704|FG000|Run-in Period|Run-in failure|0|||
131583640|NCT04588259|473764705|FG001|Run-in Period|Run-in failure|23|||
131583641|NCT04588259|473764704|FG000|Run-in Period|Withdrawn before randomisation|0|||
131583642|NCT04588259|473764705|FG001|Run-in Period|Withdrawn before randomisation|8|||
131583643|NCT04588259|473764704|FG000|Treatment Period|Withdrawal by Subject|6|||
131583644|NCT04588259|473764705|FG001|Treatment Period|Withdrawal by Subject|6|||
131583645|NCT02763319|473764709|FG000|Overall Study|Adverse Event|12|||
131583646|NCT02763319|473764710|FG001|Overall Study|Adverse Event|3|||
131583647|NCT02763319|473764709|FG000|Overall Study|Death|123|||
131583648|NCT02763319|473764710|FG001|Overall Study|Death|123|||
131583649|NCT02763319|473764709|FG000|Overall Study|Lost to Follow-up|6|||
131583650|NCT02763319|473764710|FG001|Overall Study|Lost to Follow-up|7|||
131583651|NCT02763319|473764709|FG000|Overall Study|Noncompliance with Study Drug|2|||
131583652|NCT02763319|473764710|FG001|Overall Study|Noncompliance with Study Drug|0|||
131583653|NCT02763319|473764709|FG000|Overall Study|"Captured as Other in Database"|29|||
131583654|NCT02763319|473764710|FG001|Overall Study|"Captured as Other in Database"|34|||
131704057|NCT03641560|474198597|FG000|Overall Study|Withdrawal by Subject|6|||
131704058|NCT03641560|474198597|FG000|Overall Study|Progressive disease|40|||
131704059|NCT03641560|474198597|FG000|Overall Study|Death|6|||
131704060|NCT05847686|474200607|FG000|Overall Study|Withdrawal by Subject|3|||
131704061|NCT06272370|474200608|FG000|Overall Study|Lost to Follow-up|0|||
131704062|NCT06272370|474200609|FG001|Overall Study|Lost to Follow-up|3|||
131704063|NCT06272370|474200610|FG002|Overall Study|Lost to Follow-up|1|||
131583655|NCT02763319|473764709|FG000|Overall Study|Physician Decision|1|||
131583656|NCT02763319|473764710|FG001|Overall Study|Physician Decision|7|||
131583657|NCT02763319|473764709|FG000|Overall Study|Progressive Disease|24|||
131583658|NCT02763319|473764710|FG001|Overall Study|Progressive Disease|27|||
131583659|NCT02763319|473764709|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
131583660|NCT02763319|473764710|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
131583661|NCT02763319|473764709|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
131704064|NCT06272370|474200611|FG003|Overall Study|Lost to Follow-up|1|||
131704065|NCT05888103|474200613|FG000|Overall Study|Participant decision|3|||
131704066|NCT05888103|474200614|FG001|Overall Study|Participant decision|3|||
131704067|NCT00352534|474200615|FG000|Initial Staging|Ineligible|8|||
131704068|NCT00352534|474200616|FG001|Initial Staging|Ineligible|9|||
131704069|NCT00352534|474200617|FG002|Initial Staging|Ineligible|0|||
131704070|NCT00352534|474200618|FG003|Initial Staging|Ineligible|0|||
131704071|NCT00352534|474200619|FG004|Initial Staging|Ineligible|0|||
131704072|NCT00352534|474200620|FG005|Initial Staging|Ineligible|0|||
131704073|NCT00352534|474200621|FG006|Initial Staging|Ineligible|0|||
131704074|NCT00352534|474200615|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
131704075|NCT00352534|474200616|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
131704076|NCT00352534|474200617|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
131704077|NCT00352534|474200618|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
131583662|NCT02763319|473764710|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
131583663|NCT02763319|473764709|FG000|Overall Study|Withdrawal by Subject|26|||
131583664|NCT02763319|473764710|FG001|Overall Study|Withdrawal by Subject|25|||
131583665|NCT01149369|473764715|FG000|Overall Study|Adverse Event|6|||
131583666|NCT01149369|473764716|FG001|Overall Study|Adverse Event|3|||
131583667|NCT01078116|473764723|FG000|Overall Study|Lost to Follow-up|17|||
131583668|NCT01078116|473764723|FG000|Overall Study|Adverse Event|5|||
131583669|NCT01078116|473764723|FG000|Overall Study|Withdrawal by Subject|8|||
131583670|NCT01078116|473764723|FG000|Overall Study|Lack of effectiveness|15|||
131583671|NCT01078116|473764723|FG000|Overall Study|Case report form not completed|3|||
131583672|NCT00446459|473764724|FG000|8 Months|Protocol Violation|12|||
131788938|NCT01677910|474510636|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131788939|NCT01677910|474510637|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131788940|NCT01677910|474510638|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
131788941|NCT01677910|474510635|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
131788942|NCT01677910|474510636|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
131788943|NCT01677910|474510637|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
131788944|NCT01677910|474510638|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
131788945|NCT01677910|474510635|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
131788946|NCT01677910|474510636|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
131788947|NCT01677910|474510637|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
131788948|NCT01677910|474510638|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
131788949|NCT03568500|474510639|FG000|Overall Study|Lost to Follow-up|1|||
131788950|NCT03568500|474510640|FG001|Overall Study|Lost to Follow-up|1|||
131788951|NCT03568500|474510641|FG002|Overall Study|Lost to Follow-up|2|||
131788952|NCT03568500|474510639|FG000|Overall Study|Adverse Event|1|||
131788953|NCT03568500|474510640|FG001|Overall Study|Adverse Event|1|||
131788954|NCT03568500|474510641|FG002|Overall Study|Adverse Event|2|||
131788955|NCT03568500|474510639|FG000|Overall Study|Physician Decision|1|||
131788956|NCT03568500|474510640|FG001|Overall Study|Physician Decision|0|||
131788957|NCT03568500|474510641|FG002|Overall Study|Physician Decision|0|||
131788958|NCT03568500|474510639|FG000|Overall Study|Withdrawal by Subject|4|||
131788959|NCT03568500|474510640|FG001|Overall Study|Withdrawal by Subject|2|||
131788960|NCT03568500|474510641|FG002|Overall Study|Withdrawal by Subject|0|||
131788961|NCT03568500|474510639|FG000|Overall Study|Technical Problems|2|||
131788962|NCT03568500|474510640|FG001|Overall Study|Technical Problems|1|||
131583673|NCT00446459|473764724|FG000|12 Months|Protocol Violation|4|||
131583674|NCT00446459|473764724|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
131583675|NCT01599793|473764725|FG000|Overall Study|Adverse Event|2|||
131583676|NCT00244855|473764733|FG000|Overall Study|Withdrawal by Subject|0|||
131583677|NCT00244855|473764734|FG001|Overall Study|Withdrawal by Subject|1|||
131583678|NCT01236001|473764736|FG000|Overall Study|Adverse Event|5|||
131583679|NCT01236001|473764737|FG001|Overall Study|Adverse Event|14|||
131583680|NCT01236001|473764736|FG000|Overall Study|Lack of Efficacy|6|||
131583681|NCT01236001|473764737|FG001|Overall Study|Lack of Efficacy|6|||
131583682|NCT01236001|473764736|FG000|Overall Study|Lost to Follow-up|6|||
131704078|NCT00352534|474200619|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
131704079|NCT00352534|474200620|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
131704080|NCT00352534|474200621|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
131704081|NCT00352534|474200615|FG000|Final Risk Group Assignment|Physician Decision|0|||
131704082|NCT00352534|474200616|FG001|Final Risk Group Assignment|Physician Decision|0|||
131704083|NCT00352534|474200617|FG002|Final Risk Group Assignment|Physician Decision|0|||
131704084|NCT00352534|474200618|FG003|Final Risk Group Assignment|Physician Decision|0|||
131704085|NCT00352534|474200619|FG004|Final Risk Group Assignment|Physician Decision|0|||
131704086|NCT00352534|474200620|FG005|Final Risk Group Assignment|Physician Decision|8|||
131704087|NCT00352534|474200621|FG006|Final Risk Group Assignment|Physician Decision|0|||
131704088|NCT00352534|474200615|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
131704089|NCT00352534|474200616|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
131704090|NCT00352534|474200617|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
131704091|NCT00352534|474200618|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
131704092|NCT00352534|474200619|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
131704093|NCT00352534|474200620|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
131704094|NCT00352534|474200621|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
131704095|NCT00352534|474200615|FG000|Final Risk Group Assignment|Ineligible|0|||
131704096|NCT00352534|474200616|FG001|Final Risk Group Assignment|Ineligible|0|||
131704097|NCT00352534|474200617|FG002|Final Risk Group Assignment|Ineligible|3|||
131704098|NCT00352534|474200618|FG003|Final Risk Group Assignment|Ineligible|1|||
131788963|NCT03568500|474510641|FG002|Overall Study|Technical Problems|0|||
131788964|NCT03568500|474510639|FG000|Overall Study|Participant Noncompliance|1|||
131788965|NCT03568500|474510640|FG001|Overall Study|Participant Noncompliance|1|||
131788966|NCT03568500|474510641|FG002|Overall Study|Participant Noncompliance|0|||
131788967|NCT01368276|474510648|FG000|Overall Study|Death|1|||
131788968|NCT01368276|474510649|FG001|Overall Study|Death|10|||
131583683|NCT01236001|473764737|FG001|Overall Study|Lost to Follow-up|1|||
131583684|NCT01236001|473764736|FG000|Overall Study|Incompliance|1|||
131583685|NCT01236001|473764737|FG001|Overall Study|Incompliance|0|||
131583686|NCT01236001|473764736|FG000|Overall Study|Planned Visit After End of Study|0|||
131583687|NCT01236001|473764737|FG001|Overall Study|Planned Visit After End of Study|1|||
131583688|NCT03811574|473764740|FG000|Overall Study|Withdrawal by Subject|2|||
131583689|NCT03811574|473764741|FG001|Overall Study|Withdrawal by Subject|4|||
131583690|NCT03811574|473764742|FG002|Overall Study|Withdrawal by Subject|0|||
131583691|NCT01832480|473764743|FG000|Overall Study|Lost to Follow-up|33|||
131583692|NCT01832480|473764744|FG001|Overall Study|Lost to Follow-up|30|||
131583693|NCT01832480|473764743|FG000|Overall Study|Withdrawal by Subject|0|||
131583694|NCT01832480|473764744|FG001|Overall Study|Withdrawal by Subject|2|||
131583695|NCT01832480|473764743|FG000|Overall Study|post randomization ineligible|8|||
131583696|NCT01832480|473764744|FG001|Overall Study|post randomization ineligible|10|||
131583697|NCT03942042|473764746|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
131583698|NCT03942042|473764747|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
131583699|NCT03942042|473764746|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
131788969|NCT03341273|474510650|FG000|Overall Study|Lost to Follow-up|7|||
131788970|NCT03341273|474510651|FG001|Overall Study|Lost to Follow-up|7|||
131788971|NCT03341273|474510650|FG000|Overall Study|Withdrawal by Subject|4|||
131788972|NCT03341273|474510651|FG001|Overall Study|Withdrawal by Subject|2|||
131788973|NCT03341273|474510650|FG000|Overall Study|Physician Decision|1|||
131583700|NCT03942042|473764747|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
131583701|NCT01685606|473764750|FG000|Overall Study|Withdrawal by Subject|1|||
131583702|NCT02299375|473764755|FG000|Overall Study|Adverse Event, serious fatal|1|||
131583703|NCT02299375|473764756|FG001|Overall Study|Adverse Event, serious fatal|3|||
131583704|NCT02299375|473764755|FG000|Overall Study|Adverse Event, non-fatal|8|||
131788974|NCT03341273|474510651|FG001|Overall Study|Physician Decision|0|||
131583705|NCT02299375|473764756|FG001|Overall Study|Adverse Event, non-fatal|9|||
131583706|NCT02299375|473764755|FG000|Overall Study|Lack of Efficacy|1|||
131583707|NCT02299375|473764756|FG001|Overall Study|Lack of Efficacy|3|||
131704099|NCT00352534|474200619|FG004|Final Risk Group Assignment|Ineligible|0|||
131704100|NCT00352534|474200620|FG005|Final Risk Group Assignment|Ineligible|13|||
131583708|NCT02299375|473764755|FG000|Overall Study|Protocol Violation|1|||
131704101|NCT00352534|474200621|FG006|Final Risk Group Assignment|Ineligible|0|||
131704102|NCT00352534|474200615|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131704103|NCT00352534|474200616|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131704104|NCT00352534|474200617|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131704105|NCT00352534|474200618|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131704106|NCT00352534|474200619|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131704107|NCT00352534|474200620|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131704108|NCT00352534|474200621|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
131704109|NCT00352534|474200615|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131704110|NCT00352534|474200616|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131704111|NCT00352534|474200617|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131704112|NCT00352534|474200618|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131704113|NCT00352534|474200619|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131704114|NCT00352534|474200620|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131704115|NCT00352534|474200621|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
131704116|NCT00352534|474200615|FG000|Final Risk Group Assignment|Death|0|||
131583709|NCT02299375|473764756|FG001|Overall Study|Protocol Violation|3|||
131704117|NCT00352534|474200616|FG001|Final Risk Group Assignment|Death|0|||
131583710|NCT02299375|473764755|FG000|Overall Study|Other: Met stopping criteria|1|||
131438543|NCT00626275|473231289|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131438544|NCT00626275|473231290|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
131438545|NCT00626275|473231291|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131438546|NCT00626275|473231292|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131704118|NCT00352534|474200617|FG002|Final Risk Group Assignment|Death|0|||
131704119|NCT00352534|474200618|FG003|Final Risk Group Assignment|Death|0|||
131704120|NCT00352534|474200619|FG004|Final Risk Group Assignment|Death|0|||
131704121|NCT00352534|474200620|FG005|Final Risk Group Assignment|Death|2|||
131704122|NCT00352534|474200621|FG006|Final Risk Group Assignment|Death|0|||
131704123|NCT01602341|474200622|FG000|Overall Study|Adverse Event|0|||
131704124|NCT01602341|474200623|FG001|Overall Study|Adverse Event|1|||
131704125|NCT04439279|474200624|FG000|Overall Study|Adverse Event|7|||
131704126|NCT04439279|474200624|FG000|Overall Study|Death|4|||
131704127|NCT04439279|474200624|FG000|Overall Study|Disease progression|17|||
131704128|NCT04439279|474200624|FG000|Overall Study|Complicating disease|3|||
131704129|NCT04439279|474200624|FG000|Overall Study|Withdrawal by Subject|2|||
131704130|NCT04439279|474200624|FG000|Overall Study|Ineligible|1|||
131704131|NCT04439279|474200624|FG000|Overall Study|Treatment still ongoing|1|||
131704132|NCT03521791|474200625|FG000|Overall Study|Protocol Violation|7|||
131704133|NCT03521791|474200626|FG001|Overall Study|Protocol Violation|17|||
131704134|NCT02090855|474200627|FG000|Overall Study|no evaluable Standard of Truth results|2|||
131704135|NCT00680836|474200629|FG000|Overall Study|Withdrawal by Subject|3|||
131704136|NCT00680836|474200630|FG001|Overall Study|Withdrawal by Subject|0|||
131704137|NCT00680836|474200629|FG000|Overall Study|Lost to Follow-up|3|||
131704138|NCT00680836|474200630|FG001|Overall Study|Lost to Follow-up|1|||
131704139|NCT00680836|474200629|FG000|Overall Study|Physician Decision|2|||
131704140|NCT00680836|474200630|FG001|Overall Study|Physician Decision|1|||
131704141|NCT03038308|474200631|FG000|Overall Study|Surgical resection|1|||
131704142|NCT03038308|474200631|FG000|Overall Study|Withdrawal by Subject|2|||
131704143|NCT03038308|474200631|FG000|Overall Study|Lost to Follow-up|1|||
131704144|NCT00619502|474200643|FG000|Overall Study|Lost to Follow-up|8|||
131704145|NCT00619502|474200644|FG001|Overall Study|Lost to Follow-up|10|||
131704146|NCT01777763|474200645|FG000|Overall Study|Adverse Event|2|||
131704147|NCT01777763|474200646|FG001|Overall Study|Adverse Event|32|||
131704148|NCT01777763|474200645|FG000|Overall Study|Protocol Violation|1|||
131704149|NCT01777763|474200646|FG001|Overall Study|Protocol Violation|7|||
131704150|NCT01777763|474200645|FG000|Overall Study|Withdrawal by Subject|0|||
131704151|NCT01777763|474200646|FG001|Overall Study|Withdrawal by Subject|2|||
131704152|NCT01777763|474200645|FG000|Overall Study|Treatment Failure|1|||
131704153|NCT01777763|474200646|FG001|Overall Study|Treatment Failure|6|||
131704154|NCT01475734|474200647|FG000|Overall Study|Withdrawal by Subject|1|||
131704155|NCT01475734|474200648|FG001|Overall Study|Withdrawal by Subject|0|||
131704156|NCT01475734|474200647|FG000|Overall Study|Protocol Violation|1|||
131704157|NCT01475734|474200648|FG001|Overall Study|Protocol Violation|0|||
131704158|NCT01475734|474200647|FG000|Overall Study|Physician Decision|0|||
131704159|NCT01475734|474200648|FG001|Overall Study|Physician Decision|1|||
131704160|NCT00771472|474200649|FG000|Overall Study|Physician Decision|2|||
131704161|NCT00771472|474200650|FG001|Overall Study|Physician Decision|3|||
131704162|NCT00771472|474200649|FG000|Overall Study|Progressive Disease|3|||
131704163|NCT00771472|474200650|FG001|Overall Study|Progressive Disease|1|||
131704164|NCT00771472|474200649|FG000|Overall Study|Protocol Violation|1|||
131704165|NCT00771472|474200650|FG001|Overall Study|Protocol Violation|0|||
131704166|NCT05512949|474200659|FG000|Overall Study|Lost to Follow-up|4|||
131704167|NCT05512949|474200660|FG001|Overall Study|Lost to Follow-up|6|||
131704168|NCT05512949|474200661|FG002|Overall Study|Lost to Follow-up|2|||
131704169|NCT05512949|474200659|FG000|Overall Study|Protocol Violation|0|||
131704170|NCT05512949|474200660|FG001|Overall Study|Protocol Violation|0|||
131704171|NCT05512949|474200661|FG002|Overall Study|Protocol Violation|1|||
131788975|NCT03341273|474510650|FG000|Overall Study|Protocol Violation|0|||
131788976|NCT03341273|474510651|FG001|Overall Study|Protocol Violation|1|||
131704172|NCT05512949|474200659|FG000|Overall Study|Withdrawal by Subject|1|||
131704173|NCT05512949|474200660|FG001|Overall Study|Withdrawal by Subject|1|||
131583711|NCT02299375|473764756|FG001|Overall Study|Other: Met stopping criteria|0|||
131583712|NCT02299375|473764755|FG000|Overall Study|Other: Study closed/terminated|66|||
131583713|NCT02299375|473764756|FG001|Overall Study|Other: Study closed/terminated|55|||
131583714|NCT02299375|473764755|FG000|Overall Study|Lost to Follow-up|0|||
131583715|NCT02299375|473764756|FG001|Overall Study|Lost to Follow-up|2|||
131583716|NCT02299375|473764755|FG000|Overall Study|Physician Decision|1|||
131583717|NCT02299375|473764756|FG001|Overall Study|Physician Decision|1|||
131583718|NCT02299375|473764755|FG000|Overall Study|Withdrawal by Subject|1|||
131583719|NCT02299375|473764756|FG001|Overall Study|Withdrawal by Subject|4|||
131583720|NCT02918071|473764765|FG000|Overall Study|Withdrawal by Subject|2|||
131583721|NCT02918071|473764765|FG000|Overall Study|Lost to Follow-up|1|||
131583722|NCT00203411|473764767|FG000|Follow-up|Progressive Disease|4|||
131583723|NCT01212991|473764768|FG000|Double-blind|Lost to Follow-up|8|||
131583724|NCT01212991|473764769|FG001|Double-blind|Lost to Follow-up|4|||
131583725|NCT01212991|473764770|FG002|Double-blind|Lost to Follow-up|0|||
131583726|NCT01212991|473764768|FG000|Double-blind|Death|699|||
131583727|NCT01212991|473764769|FG001|Double-blind|Death|550|||
131704174|NCT05512949|474200661|FG002|Overall Study|Withdrawal by Subject|2|||
131704175|NCT05512949|474200659|FG000|Overall Study|Completion status unknown|1|||
131438547|NCT00626275|473231293|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131704176|NCT05512949|474200660|FG001|Overall Study|Completion status unknown|3|||
131704177|NCT05512949|474200661|FG002|Overall Study|Completion status unknown|0|||
131704178|NCT03988907|474200662|FG000|Overall Study|Unable to complete visit|0|||
131704179|NCT03988907|474200663|FG001|Overall Study|Unable to complete visit|1|||
131704180|NCT02810964|474200664|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
131704181|NCT02810964|474200665|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
131704182|NCT02810964|474200664|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
131704183|NCT02810964|474200665|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
131704184|NCT02810964|474200664|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
131438548|NCT00626275|473231294|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131438549|NCT00626275|473231295|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
131704185|NCT02810964|474200665|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
131704186|NCT02810964|474200664|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
131704187|NCT02810964|474200665|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
131583728|NCT01212991|473764770|FG002|Double-blind|Death|0|||
131583729|NCT01212991|473764768|FG000|Double-blind|Withdrawal by Subject|16|||
131583730|NCT01212991|473764769|FG001|Double-blind|Withdrawal by Subject|19|||
131583731|NCT01212991|473764770|FG002|Double-blind|Withdrawal by Subject|0|||
131583732|NCT01212991|473764768|FG000|Double-blind|Other|7|||
131583733|NCT01212991|473764769|FG001|Double-blind|Other|0|||
131583734|NCT01212991|473764770|FG002|Double-blind|Other|0|||
131583735|NCT01212991|473764768|FG000|Double-blind|Sponsor decision|142|||
131583736|NCT01212991|473764769|FG001|Double-blind|Sponsor decision|38|||
131583737|NCT01212991|473764770|FG002|Double-blind|Sponsor decision|0|||
131583738|NCT01212991|473764768|FG000|Open-label|Death|0|||
131583739|NCT01212991|473764769|FG001|Open-label|Death|0|||
131583740|NCT01212991|473764770|FG002|Open-label|Death|166|||
131583741|NCT01212991|473764768|FG000|Open-label|Lost to Follow-up|0|||
131583742|NCT01212991|473764769|FG001|Open-label|Lost to Follow-up|0|||
131583743|NCT01212991|473764770|FG002|Open-label|Lost to Follow-up|5|||
131583744|NCT01212991|473764768|FG000|Open-label|Withdrawal by Subject|0|||
131583745|NCT01212991|473764769|FG001|Open-label|Withdrawal by Subject|0|||
131583746|NCT01212991|473764770|FG002|Open-label|Withdrawal by Subject|7|||
131583747|NCT01212991|473764768|FG000|Open-label|Sponsor decision|0|||
131583748|NCT01212991|473764769|FG001|Open-label|Sponsor decision|0|||
131583749|NCT01212991|473764770|FG002|Open-label|Sponsor decision|53|||
131583750|NCT01212991|473764768|FG000|Open-label|Other|0|||
131583751|NCT01212991|473764769|FG001|Open-label|Other|0|||
131583752|NCT01212991|473764770|FG002|Open-label|Other|3|||
131583753|NCT01622868|473766436|FG000|Overall Study|Protocol Violation|7|||
131583754|NCT01622868|473766437|FG001|Overall Study|Protocol Violation|0|||
131583755|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Death|186|||
131583756|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Death|222|||
131583757|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Death|0|||
131583758|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
131583759|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
131583760|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
131583761|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
131583762|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
131583763|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
131583764|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
131583765|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
131583766|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
131583767|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Adverse Event|83|||
131583768|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Adverse Event|100|||
131583769|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Adverse Event|0|||
131583770|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Other|70|||
131583771|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Other|75|||
131583772|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Other|0|||
131583773|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
131583774|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
131583775|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
131788977|NCT03341273|474510650|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
131583776|NCT00232180|473766440|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
131704188|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
131704189|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
131704190|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
131704191|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131438550|NCT00626275|473231288|FG000|Part B|Lost to Follow-up|0|||
131438551|NCT00626275|473231289|FG001|Part B|Lost to Follow-up|0|||
131438552|NCT00626275|473231290|FG002|Part B|Lost to Follow-up|0|||
131438553|NCT00626275|473231291|FG003|Part B|Lost to Follow-up|0|||
131438554|NCT00626275|473231292|FG004|Part B|Lost to Follow-up|0|||
131438555|NCT00626275|473231293|FG005|Part B|Lost to Follow-up|0|||
131438556|NCT00626275|473231294|FG006|Part B|Lost to Follow-up|1|||
131438557|NCT00626275|473231295|FG007|Part B|Lost to Follow-up|0|||
131438558|NCT00626275|473231288|FG000|Part B|Withdrawal by Subject|0|||
131438559|NCT00626275|473231289|FG001|Part B|Withdrawal by Subject|0|||
131438560|NCT00626275|473231290|FG002|Part B|Withdrawal by Subject|0|||
131438561|NCT00626275|473231291|FG003|Part B|Withdrawal by Subject|0|||
131438562|NCT00626275|473231292|FG004|Part B|Withdrawal by Subject|0|||
131438563|NCT00626275|473231293|FG005|Part B|Withdrawal by Subject|0|||
131438564|NCT00626275|473231294|FG006|Part B|Withdrawal by Subject|0|||
131438565|NCT00626275|473231295|FG007|Part B|Withdrawal by Subject|1|||
131438566|NCT04999839|473231296|FG000|Overall Study|Adverse Event|1|||
131438567|NCT04999839|473231297|FG001|Overall Study|Adverse Event|1|||
131438568|NCT04999839|473231298|FG002|Overall Study|Adverse Event|1|||
131438569|NCT04999839|473231299|FG003|Overall Study|Adverse Event|1|||
131438570|NCT04999839|473231300|FG004|Overall Study|Adverse Event|1|||
131438571|NCT04999839|473231296|FG000|Overall Study|Lost to Follow-up|2|||
131438572|NCT04999839|473231297|FG001|Overall Study|Lost to Follow-up|0|||
131438573|NCT04999839|473231298|FG002|Overall Study|Lost to Follow-up|2|||
131438574|NCT04999839|473231299|FG003|Overall Study|Lost to Follow-up|4|||
131438575|NCT04999839|473231300|FG004|Overall Study|Lost to Follow-up|1|||
131438576|NCT04999839|473231296|FG000|Overall Study|Withdrawal by Subject|6|||
131438577|NCT04999839|473231297|FG001|Overall Study|Withdrawal by Subject|5|||
131438578|NCT04999839|473231298|FG002|Overall Study|Withdrawal by Subject|3|||
131438579|NCT04999839|473231299|FG003|Overall Study|Withdrawal by Subject|2|||
131438580|NCT04999839|473231300|FG004|Overall Study|Withdrawal by Subject|2|||
131438581|NCT04999839|473231296|FG000|Overall Study|Lack of Efficacy|0|||
131438582|NCT04999839|473231297|FG001|Overall Study|Lack of Efficacy|1|||
131438583|NCT04999839|473231298|FG002|Overall Study|Lack of Efficacy|0|||
131438584|NCT04999839|473231299|FG003|Overall Study|Lack of Efficacy|0|||
131438585|NCT04999839|473231300|FG004|Overall Study|Lack of Efficacy|0|||
131438586|NCT04999839|473231296|FG000|Overall Study|Physician Decision|0|||
131438587|NCT04999839|473231297|FG001|Overall Study|Physician Decision|0|||
131438588|NCT04999839|473231298|FG002|Overall Study|Physician Decision|0|||
131438589|NCT04999839|473231299|FG003|Overall Study|Physician Decision|0|||
131438590|NCT04999839|473231300|FG004|Overall Study|Physician Decision|1|||
131438591|NCT04999839|473231296|FG000|Overall Study|Sponsor request|0|||
131438592|NCT04999839|473231297|FG001|Overall Study|Sponsor request|1|||
131438593|NCT04999839|473231298|FG002|Overall Study|Sponsor request|0|||
131438594|NCT04999839|473231299|FG003|Overall Study|Sponsor request|0|||
131438595|NCT04999839|473231300|FG004|Overall Study|Sponsor request|0|||
131438596|NCT04999839|473231296|FG000|Overall Study|Other|0|||
131438597|NCT04999839|473231297|FG001|Overall Study|Other|0|||
131438598|NCT04999839|473231298|FG002|Overall Study|Other|1|||
131438599|NCT04999839|473231299|FG003|Overall Study|Other|0|||
131438600|NCT04999839|473231300|FG004|Overall Study|Other|0|||
131438601|NCT01362348|473231301|FG000|Overall Study|Protocol-defined stopping criteria|9|||
131438602|NCT01362348|473231301|FG000|Overall Study|Study closed/terminated|5|||
131438603|NCT00399516|473231302|FG000|Overall Study|Lost to Follow-up|2|||
131438604|NCT00539981|473231307|FG000|Overall Study|Adverse events (AE)|3|||
131438605|NCT00539981|473231308|FG001|Overall Study|Adverse events (AE)|3|||
131438606|NCT00539981|473231307|FG000|Overall Study|Lost to Follow-up|260|||
131438607|NCT00539981|473231308|FG001|Overall Study|Lost to Follow-up|251|||
131704192|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131704193|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131704194|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131704195|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131438608|NCT00539981|473231307|FG000|Overall Study|Withdrew consent|22|||
131438609|NCT00539981|473231308|FG001|Overall Study|Withdrew consent|14|||
131438610|NCT00539981|473231307|FG000|Overall Study|Death|1|||
131704196|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
131438611|NCT00539981|473231308|FG001|Overall Study|Death|1|||
131438612|NCT00539981|473231307|FG000|Overall Study|Other reason-unspecified|9|||
131438613|NCT00539981|473231308|FG001|Overall Study|Other reason-unspecified|13|||
131438614|NCT02675907|473231309|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
131438615|NCT02675907|473231310|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
131438616|NCT02675907|473231309|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
131438617|NCT02675907|473231310|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
131438618|NCT02675907|473231309|FG000|Study Overall|Lack of Efficacy|1|||
131583777|NCT00232180|473766441|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
131583778|NCT00232180|473766442|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
131583779|NCT00232180|473766440|FG000|Open Label Phase|Death|0|||
131583780|NCT00232180|473766441|FG001|Open Label Phase|Death|0|||
131583781|NCT00232180|473766442|FG002|Open Label Phase|Death|48|||
131583782|NCT00232180|473766440|FG000|Open Label Phase|Lost to Follow-up|0|||
131788978|NCT03341273|474510651|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
131788979|NCT03341273|474510650|FG000|Overall Study|Became ineligible after enrollment|1|||
131788980|NCT03341273|474510651|FG001|Overall Study|Became ineligible after enrollment|0|||
131788981|NCT03341273|474510650|FG000|Overall Study|Not Eligible at Enrollment|0|||
131788982|NCT03341273|474510651|FG001|Overall Study|Not Eligible at Enrollment|1|||
131788983|NCT03341273|474510650|FG000|Overall Study|Participant incarcerated|1|||
131788984|NCT03341273|474510651|FG001|Overall Study|Participant incarcerated|0|||
131788985|NCT01717456|474510652|FG000|End of Treatment|Physician Decision|0|||
131788986|NCT01717456|474510653|FG001|End of Treatment|Physician Decision|1|||
131788987|NCT01717456|474510652|FG000|End of Treatment|Lost to Follow-up|0|||
131788988|NCT01717456|474510653|FG001|End of Treatment|Lost to Follow-up|1|||
131788989|NCT01717456|474510652|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
131788990|NCT01717456|474510653|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
131788991|NCT01886300|474510654|FG000|Overall Study|Trial terminated by sponsor|16|||
131788992|NCT03870997|474510655|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
131788993|NCT03870997|474510656|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
131788994|NCT03870997|474510657|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
131788995|NCT03870997|474510658|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
131788996|NCT03870997|474510659|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
131788997|NCT03870997|474510660|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
131788998|NCT00267007|474510661|FG000|Overall Study|Withdrawal by Subject|6|||
131788999|NCT00267007|474510662|FG001|Overall Study|Withdrawal by Subject|0|||
131789000|NCT00267007|474510661|FG000|Overall Study|Lost to Follow-up|1|||
131789001|NCT00267007|474510662|FG001|Overall Study|Lost to Follow-up|0|||
131789002|NCT00267007|474510661|FG000|Overall Study|Non-compliance|0|||
131789003|NCT00267007|474510662|FG001|Overall Study|Non-compliance|1|||
131789004|NCT00267007|474510661|FG000|Overall Study|Adverse Event|1|||
131789005|NCT00267007|474510662|FG001|Overall Study|Adverse Event|0|||
131789006|NCT01825876|474510666|FG000|Period 2|Withdrawal by Subject|0|||
131789007|NCT01825876|474510667|FG001|Period 2|Withdrawal by Subject|1|||
131789008|NCT03751020|474510668|FG000|Overall Study|Withdrawal by Subject|2|||
131583783|NCT00232180|473766441|FG001|Open Label Phase|Lost to Follow-up|0|||
131789009|NCT03751020|474510669|FG001|Overall Study|Withdrawal by Subject|0|||
131789010|NCT03751020|474510670|FG002|Overall Study|Withdrawal by Subject|0|||
131789011|NCT03751020|474510668|FG000|Overall Study|Lost to Follow-up|7|||
131789012|NCT03751020|474510669|FG001|Overall Study|Lost to Follow-up|4|||
131789013|NCT03751020|474510670|FG002|Overall Study|Lost to Follow-up|10|||
131789014|NCT00475852|474510673|FG000|Overall Study|Death|444|||
131789015|NCT00475852|474510674|FG001|Overall Study|Death|456|||
131583784|NCT00232180|473766442|FG002|Open Label Phase|Lost to Follow-up|5|||
131583785|NCT00232180|473766440|FG000|Open Label Phase|Protocol Violation|0|||
131789016|NCT00475852|474510673|FG000|Overall Study|Withdrawal by Subject|19|||
131789017|NCT00475852|474510674|FG001|Overall Study|Withdrawal by Subject|24|||
131789018|NCT00475852|474510673|FG000|Overall Study|Lost to Follow-up|54|||
131789019|NCT00475852|474510674|FG001|Overall Study|Lost to Follow-up|68|||
131789020|NCT00297479|474510676|FG000|Overall Study|Lost to Follow-up|37|||
131789021|NCT00297479|474510677|FG001|Overall Study|Lost to Follow-up|54|||
131789022|NCT00297479|474510678|FG002|Overall Study|Lost to Follow-up|51|||
131789023|NCT01664494|474510679|FG000|Overall Study|Withdrawal by Subject|27|||
131789024|NCT01664494|474510679|FG000|Overall Study|Death|18|||
131789025|NCT01664494|474510679|FG000|Overall Study|Other|49|||
131789026|NCT01664494|474510679|FG000|Overall Study|Lost to Follow-up|99|||
131789027|NCT03063632|474510680|FG000|Overall Study|Death|4|||
131789028|NCT03063632|474510681|FG001|Overall Study|Death|6|||
131789029|NCT03063632|474510680|FG000|Overall Study|Lost to Follow-up|0|||
131789030|NCT03063632|474510681|FG001|Overall Study|Lost to Follow-up|1|||
131789031|NCT03063632|474510680|FG000|Overall Study|Withdrawal by Subject|0|||
131789032|NCT03063632|474510681|FG001|Overall Study|Withdrawal by Subject|2|||
131789033|NCT03063632|474510680|FG000|Overall Study|Physician Decision|2|||
131789034|NCT03063632|474510681|FG001|Overall Study|Physician Decision|0|||
131789035|NCT03063632|474510680|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
131789036|NCT03063632|474510681|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
131789037|NCT00571922|474510684|FG000|Overall Study|Completion unknown|36|||
131789038|NCT00571922|474510685|FG001|Overall Study|Completion unknown|36|||
131789039|NCT02191579|474510692|FG000|Treatment 1|Multiple Reasons Specified|27|||
131789040|NCT02191579|474510693|FG001|Treatment 1|Multiple Reasons Specified|58|||
131789041|NCT02191579|474510692|FG000|Treatment 2|Multiple Reasons Specified|0|||
131789042|NCT02191579|474510693|FG001|Treatment 2|Multiple Reasons Specified|25|||
131789043|NCT00345683|474510700|FG000|Overall Study|Lost to Follow-up|19|||
131789044|NCT00345683|474510701|FG001|Overall Study|Lost to Follow-up|7|||
131789045|NCT00345683|474510700|FG000|Overall Study|Other|6|||
131789046|NCT00345683|474510701|FG001|Overall Study|Other|2|||
131789047|NCT00931385|474510702|FG000|Overall Study|Adverse Event|2|||
131789048|NCT00931385|474510703|FG001|Overall Study|Adverse Event|1|||
131789049|NCT00931385|474510704|FG002|Overall Study|Adverse Event|0|||
131789050|NCT00931385|474510705|FG003|Overall Study|Adverse Event|3|||
131789051|NCT00931385|474510702|FG000|Overall Study|Protocol Violation|0|||
131583786|NCT00232180|473766441|FG001|Open Label Phase|Protocol Violation|0|||
131583787|NCT00232180|473766442|FG002|Open Label Phase|Protocol Violation|3|||
131583788|NCT00232180|473766440|FG000|Open Label Phase|Study terminated by sponsor|0|||
131789052|NCT00931385|474510703|FG001|Overall Study|Protocol Violation|0|||
131789053|NCT00931385|474510704|FG002|Overall Study|Protocol Violation|1|||
131789054|NCT00931385|474510705|FG003|Overall Study|Protocol Violation|0|||
131438619|NCT02675907|473231310|FG001|Study Overall|Lack of Efficacy|0|||
131583789|NCT00232180|473766441|FG001|Open Label Phase|Study terminated by sponsor|0|||
131583790|NCT00232180|473766442|FG002|Open Label Phase|Study terminated by sponsor|3|||
131789055|NCT00931385|474510702|FG000|Overall Study|Withdrawal by Subject|0|||
131789056|NCT00931385|474510703|FG001|Overall Study|Withdrawal by Subject|1|||
131789057|NCT00931385|474510704|FG002|Overall Study|Withdrawal by Subject|0|||
131789058|NCT00931385|474510705|FG003|Overall Study|Withdrawal by Subject|1|||
131789059|NCT00931385|474510702|FG000|Overall Study|Lost to Follow-up|0|||
131789060|NCT00931385|474510703|FG001|Overall Study|Lost to Follow-up|0|||
131789061|NCT00931385|474510704|FG002|Overall Study|Lost to Follow-up|0|||
131789062|NCT00931385|474510705|FG003|Overall Study|Lost to Follow-up|1|||
131789063|NCT01298596|474510707|FG000|Overall Study|Withdrawal by Subject|1|||
131789064|NCT01298596|474510708|FG001|Overall Study|Withdrawal by Subject|1|||
131789065|NCT01298596|474510707|FG000|Overall Study|Death|5|||
131789066|NCT01298596|474510708|FG001|Overall Study|Death|3|||
131789067|NCT01298596|474510707|FG000|Overall Study|Lost to Follow-up|6|||
131789068|NCT01298596|474510708|FG001|Overall Study|Lost to Follow-up|14|||
131789069|NCT01298596|474510707|FG000|Overall Study|Referred for further management|16|||
131789070|NCT01298596|474510708|FG001|Overall Study|Referred for further management|15|||
131789071|NCT04128696|474510711|FG000|Overall Study|Lost to Follow-up|3|||
131789072|NCT04128696|474510712|FG001|Overall Study|Lost to Follow-up|7|||
131789073|NCT04128696|474510711|FG000|Overall Study|Withdrawal by Subject|12|||
131789074|NCT04128696|474510712|FG001|Overall Study|Withdrawal by Subject|11|||
131789075|NCT04128696|474510711|FG000|Overall Study|Study Closed/Terminated|26|||
131789076|NCT04128696|474510712|FG001|Overall Study|Study Closed/Terminated|38|||
131789077|NCT04128696|474510711|FG000|Overall Study|Physician Decision|2|||
131789078|NCT04128696|474510712|FG001|Overall Study|Physician Decision|3|||
131789079|NCT02046369|474510715|FG000|Overall Study|Adverse Event|3|||
131789080|NCT02046369|474510716|FG001|Overall Study|Adverse Event|3|||
131789081|NCT02046369|474510715|FG000|Overall Study|Lack of Efficacy|3|||
131789082|NCT02046369|474510716|FG001|Overall Study|Lack of Efficacy|3|||
131789083|NCT02046369|474510715|FG000|Overall Study|Lost to Follow-up|3|||
131789084|NCT02046369|474510716|FG001|Overall Study|Lost to Follow-up|3|||
131583791|NCT00232180|473766440|FG000|Open Label Phase|Withdrawal by Subject|0|||
131583792|NCT00232180|473766441|FG001|Open Label Phase|Withdrawal by Subject|0|||
131583793|NCT00232180|473766442|FG002|Open Label Phase|Withdrawal by Subject|37|||
131583794|NCT00232180|473766440|FG000|Open Label Phase|Other|0|||
131583795|NCT00232180|473766441|FG001|Open Label Phase|Other|0|||
131583796|NCT00232180|473766442|FG002|Open Label Phase|Other|16|||
131583797|NCT00232180|473766440|FG000|Open Label Phase|Adverse Event|0|||
131583798|NCT00232180|473766441|FG001|Open Label Phase|Adverse Event|0|||
131583799|NCT00232180|473766442|FG002|Open Label Phase|Adverse Event|25|||
131583800|NCT00232180|473766440|FG000|Open Label Phase|Laboratory abnormality|0|||
131583801|NCT00232180|473766441|FG001|Open Label Phase|Laboratory abnormality|0|||
131789085|NCT02046369|474510715|FG000|Overall Study|Protocol Violation|1|||
131789086|NCT02046369|474510716|FG001|Overall Study|Protocol Violation|2|||
131789087|NCT02046369|474510715|FG000|Overall Study|Withdrawal by Subject|3|||
131583802|NCT00232180|473766442|FG002|Open Label Phase|Laboratory abnormality|10|||
131583803|NCT00232180|473766440|FG000|Open Label Phase|Randomized but not treated|0|||
131789088|NCT02046369|474510716|FG001|Overall Study|Withdrawal by Subject|6|||
131789089|NCT02046369|474510715|FG000|Overall Study|never received study drug|0|||
131789090|NCT02046369|474510716|FG001|Overall Study|never received study drug|1|||
131789091|NCT02046369|474510715|FG000|Overall Study|non compliance|1|||
131789092|NCT02046369|474510716|FG001|Overall Study|non compliance|0|||
131789093|NCT03120520|474510717|FG000|Overall Study|Lost to Follow-up|1|||
131789094|NCT03120520|474510718|FG001|Overall Study|Lost to Follow-up|1|||
131789095|NCT03120520|474510719|FG002|Overall Study|Lost to Follow-up|1|||
131789096|NCT03120520|474510720|FG003|Overall Study|Lost to Follow-up|1|||
131583804|NCT00232180|473766441|FG001|Open Label Phase|Randomized but not treated|0|||
131704197|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
131704198|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
131704199|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131704200|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131704201|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131704202|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131704203|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131704204|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
131704205|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
131704206|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
131704207|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131704208|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131704209|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131704210|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131704211|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131704212|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
131704213|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
131704214|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
131704215|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131704216|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131704217|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131704218|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131704219|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131704220|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
131704221|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
131704222|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
131704223|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131704224|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131704225|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131704226|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131704227|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131704228|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
131704229|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
131704230|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131704231|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131704232|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131704233|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131704234|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131704235|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131789097|NCT03120520|474510717|FG000|Overall Study|Withdrawal by Subject|3|||
131789098|NCT03120520|474510718|FG001|Overall Study|Withdrawal by Subject|2|||
131789099|NCT03120520|474510719|FG002|Overall Study|Withdrawal by Subject|3|||
131789100|NCT03120520|474510720|FG003|Overall Study|Withdrawal by Subject|2|||
131789101|NCT03120520|474510717|FG000|Overall Study|Other|0|||
131789102|NCT03120520|474510718|FG001|Overall Study|Other|1|||
131789103|NCT03120520|474510719|FG002|Overall Study|Other|0|||
131789104|NCT03120520|474510720|FG003|Overall Study|Other|0|||
131789105|NCT02133352|474510724|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
131789106|NCT04444752|474510725|FG000|Overall Study|Adverse Event|1|||
131789107|NCT04444752|474510726|FG001|Overall Study|Adverse Event|0|||
131789108|NCT04444752|474510727|FG002|Overall Study|Adverse Event|0|||
131789109|NCT04444752|474510728|FG003|Overall Study|Adverse Event|2|||
131789110|NCT04444752|474510725|FG000|Overall Study|Lost to Follow-up|2|||
131789111|NCT04444752|474510726|FG001|Overall Study|Lost to Follow-up|6|||
131789112|NCT04444752|474510727|FG002|Overall Study|Lost to Follow-up|2|||
131789113|NCT04444752|474510728|FG003|Overall Study|Lost to Follow-up|5|||
131789114|NCT04444752|474510725|FG000|Overall Study|Physician Decision|0|||
131789115|NCT04444752|474510726|FG001|Overall Study|Physician Decision|0|||
131789116|NCT04444752|474510727|FG002|Overall Study|Physician Decision|0|||
131789117|NCT04444752|474510728|FG003|Overall Study|Physician Decision|2|||
131789118|NCT04444752|474510725|FG000|Overall Study|Pregnancy|0|||
131789119|NCT04444752|474510726|FG001|Overall Study|Pregnancy|0|||
131789120|NCT04444752|474510727|FG002|Overall Study|Pregnancy|0|||
131789121|NCT04444752|474510728|FG003|Overall Study|Pregnancy|1|||
131789122|NCT04444752|474510725|FG000|Overall Study|Withdrawal by Subject|6|||
131789123|NCT04444752|474510726|FG001|Overall Study|Withdrawal by Subject|5|||
131789124|NCT04444752|474510727|FG002|Overall Study|Withdrawal by Subject|3|||
131789125|NCT04444752|474510728|FG003|Overall Study|Withdrawal by Subject|4|||
131789126|NCT04444752|474510725|FG000|Overall Study|Protocol Violation|1|||
131789127|NCT04444752|474510726|FG001|Overall Study|Protocol Violation|1|||
131789128|NCT04444752|474510727|FG002|Overall Study|Protocol Violation|0|||
131789129|NCT04444752|474510728|FG003|Overall Study|Protocol Violation|0|||
131789130|NCT04444752|474510725|FG000|Overall Study|Patient moving out of town|1|||
131789131|NCT04444752|474510726|FG001|Overall Study|Patient moving out of town|0|||
131789132|NCT04444752|474510727|FG002|Overall Study|Patient moving out of town|0|||
131789133|NCT04444752|474510728|FG003|Overall Study|Patient moving out of town|1|||
131789134|NCT04444752|474510725|FG000|Overall Study|Lack of Efficacy|0|||
131789135|NCT04444752|474510726|FG001|Overall Study|Lack of Efficacy|0|||
131789136|NCT04444752|474510727|FG002|Overall Study|Lack of Efficacy|0|||
131789137|NCT04444752|474510728|FG003|Overall Study|Lack of Efficacy|1|||
131789138|NCT04444752|474510725|FG000|Overall Study|Death|0|||
131789139|NCT04444752|474510726|FG001|Overall Study|Death|0|||
131789140|NCT04444752|474510727|FG002|Overall Study|Death|1|||
131789141|NCT04444752|474510728|FG003|Overall Study|Death|0|||
131789142|NCT00579254|474510729|FG000|Overall Study|Lost to Follow-up|39|||
131789143|NCT00579254|474510729|FG000|Overall Study|Discontinued when study terminated|73|||
131789144|NCT02557672|474510730|FG000|Overall Study|Withdrawal by Subject|4|||
131789145|NCT02557672|474510731|FG001|Overall Study|Withdrawal by Subject|2|||
131789146|NCT03705169|474510732|FG000|Overall Study|Lost to Follow-up|0|||
131789147|NCT03705169|474510733|FG001|Overall Study|Lost to Follow-up|0|||
131789148|NCT03705169|474510734|FG002|Overall Study|Lost to Follow-up|0|||
131789149|NCT03705169|474510735|FG003|Overall Study|Lost to Follow-up|2|||
131789150|NCT03705169|474510736|FG004|Overall Study|Lost to Follow-up|0|||
131789151|NCT03705169|474510737|FG005|Overall Study|Lost to Follow-up|2|||
131789152|NCT03705169|474510738|FG006|Overall Study|Lost to Follow-up|1|||
131789153|NCT03705169|474510739|FG007|Overall Study|Lost to Follow-up|0|||
131789154|NCT03705169|474510740|FG008|Overall Study|Lost to Follow-up|0|||
131789155|NCT03705169|474510741|FG009|Overall Study|Lost to Follow-up|1|||
131789156|NCT03705169|474510732|FG000|Overall Study|Adverse Event|0|||
131789157|NCT03705169|474510733|FG001|Overall Study|Adverse Event|0|||
131789158|NCT03705169|474510734|FG002|Overall Study|Adverse Event|0|||
131789159|NCT03705169|474510735|FG003|Overall Study|Adverse Event|1|||
131789160|NCT03705169|474510736|FG004|Overall Study|Adverse Event|0|||
131789161|NCT03705169|474510737|FG005|Overall Study|Adverse Event|0|||
131789162|NCT03705169|474510738|FG006|Overall Study|Adverse Event|0|||
131789163|NCT03705169|474510739|FG007|Overall Study|Adverse Event|0|||
131789164|NCT03705169|474510740|FG008|Overall Study|Adverse Event|0|||
131789165|NCT03705169|474510741|FG009|Overall Study|Adverse Event|0|||
131789166|NCT03705169|474510732|FG000|Overall Study|Site Closure|0|||
131789167|NCT03705169|474510733|FG001|Overall Study|Site Closure|0|||
131789168|NCT03705169|474510734|FG002|Overall Study|Site Closure|0|||
131789169|NCT03705169|474510735|FG003|Overall Study|Site Closure|1|||
131789170|NCT03705169|474510736|FG004|Overall Study|Site Closure|0|||
131789171|NCT03705169|474510737|FG005|Overall Study|Site Closure|0|||
131789172|NCT03705169|474510738|FG006|Overall Study|Site Closure|0|||
131789173|NCT03705169|474510739|FG007|Overall Study|Site Closure|0|||
131789174|NCT03705169|474510740|FG008|Overall Study|Site Closure|0|||
131789175|NCT03705169|474510741|FG009|Overall Study|Site Closure|0|||
131789176|NCT03705169|474510732|FG000|Overall Study|Did not receive study treatment|0|||
131789177|NCT03705169|474510733|FG001|Overall Study|Did not receive study treatment|0|||
131789178|NCT03705169|474510734|FG002|Overall Study|Did not receive study treatment|0|||
131789179|NCT03705169|474510735|FG003|Overall Study|Did not receive study treatment|1|||
131789180|NCT03705169|474510736|FG004|Overall Study|Did not receive study treatment|0|||
131789181|NCT03705169|474510737|FG005|Overall Study|Did not receive study treatment|0|||
131789182|NCT03705169|474510738|FG006|Overall Study|Did not receive study treatment|0|||
131789183|NCT03705169|474510739|FG007|Overall Study|Did not receive study treatment|0|||
131789184|NCT03705169|474510740|FG008|Overall Study|Did not receive study treatment|0|||
131789185|NCT03705169|474510741|FG009|Overall Study|Did not receive study treatment|0|||
131789186|NCT03705169|474510732|FG000|Overall Study|Concerns about study visit compliance|0|||
131789187|NCT03705169|474510733|FG001|Overall Study|Concerns about study visit compliance|0|||
131789188|NCT03705169|474510734|FG002|Overall Study|Concerns about study visit compliance|0|||
131789189|NCT03705169|474510735|FG003|Overall Study|Concerns about study visit compliance|1|||
131789190|NCT03705169|474510736|FG004|Overall Study|Concerns about study visit compliance|0|||
131789191|NCT03705169|474510737|FG005|Overall Study|Concerns about study visit compliance|0|||
131789192|NCT03705169|474510738|FG006|Overall Study|Concerns about study visit compliance|0|||
131789193|NCT03705169|474510739|FG007|Overall Study|Concerns about study visit compliance|0|||
131789194|NCT03705169|474510740|FG008|Overall Study|Concerns about study visit compliance|0|||
131789195|NCT03705169|474510741|FG009|Overall Study|Concerns about study visit compliance|0|||
131789196|NCT00185211|474510742|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
131789197|NCT00185211|474510743|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
131789198|NCT00185211|474510742|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
131789199|NCT00185211|474510743|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
131789200|NCT00185211|474510742|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
131789201|NCT00185211|474510743|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
131789202|NCT00185211|474510742|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
131789203|NCT00185211|474510743|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
131789204|NCT00185211|474510742|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
131789205|NCT00185211|474510743|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
131789206|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
131789207|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
131789208|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
131438620|NCT02675907|473231309|FG000|Study Overall|Withdrawal by Subject|2|||
131438621|NCT02675907|473231310|FG001|Study Overall|Withdrawal by Subject|2|||
131438622|NCT02675907|473231309|FG000|Study Overall|Lost to Follow-up|0|||
131438623|NCT02675907|473231310|FG001|Study Overall|Lost to Follow-up|2|||
131438624|NCT01611792|473231311|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
131438625|NCT01611792|473231312|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
131438626|NCT01611792|473231311|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
131438627|NCT01611792|473231312|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
131438628|NCT01129622|473231313|FG000|Overall Study|Withdrawal by Subject|2|||
131438629|NCT00591006|473231314|FG000|Overall Study|Withdrawal by Subject|0|||
131438630|NCT00591006|473231315|FG001|Overall Study|Withdrawal by Subject|0|||
131438631|NCT00591006|473231316|FG002|Overall Study|Withdrawal by Subject|0|||
131438632|NCT00591006|473231317|FG003|Overall Study|Withdrawal by Subject|0|||
131438633|NCT00591006|473231318|FG004|Overall Study|Withdrawal by Subject|0|||
131438634|NCT00591006|473231319|FG005|Overall Study|Withdrawal by Subject|0|||
131438635|NCT00591006|473231320|FG006|Overall Study|Withdrawal by Subject|0|||
131438636|NCT00591006|473231321|FG007|Overall Study|Withdrawal by Subject|0|||
131438637|NCT00591006|473231322|FG008|Overall Study|Withdrawal by Subject|0|||
131438638|NCT00591006|473231323|FG009|Overall Study|Withdrawal by Subject|0|||
131438639|NCT00591006|473231324|FG010|Overall Study|Withdrawal by Subject|0|||
131438640|NCT00591006|473231325|FG011|Overall Study|Withdrawal by Subject|0|||
131438641|NCT00591006|473231326|FG012|Overall Study|Withdrawal by Subject|0|||
131789209|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
131438642|NCT00591006|473231327|FG013|Overall Study|Withdrawal by Subject|0|||
131438643|NCT00591006|473231328|FG014|Overall Study|Withdrawal by Subject|0|||
131704236|NCT01097629|474200675|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
131704237|NCT01097629|474200676|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
131704238|NCT01097629|474200677|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
131704239|NCT01097629|474200678|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131438644|NCT00591006|473231329|FG015|Overall Study|Withdrawal by Subject|1|||
131438645|NCT00591006|473231330|FG016|Overall Study|Withdrawal by Subject|0|||
131704240|NCT01097629|474200679|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131704241|NCT01097629|474200680|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131704242|NCT01097629|474200681|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131704243|NCT01097629|474200682|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131704244|NCT01097629|474200675|FG000|DB RO Phase|Withdrawal by Subject|0|||
131704245|NCT01097629|474200676|FG001|DB RO Phase|Withdrawal by Subject|0|||
131704246|NCT01097629|474200677|FG002|DB RO Phase|Withdrawal by Subject|0|||
131704247|NCT01097629|474200678|FG003|DB RO Phase|Withdrawal by Subject|0|||
131704248|NCT01097629|474200679|FG004|DB RO Phase|Withdrawal by Subject|0|||
131704249|NCT01097629|474200680|FG005|DB RO Phase|Withdrawal by Subject|0|||
131704250|NCT01097629|474200681|FG006|DB RO Phase|Withdrawal by Subject|0|||
131704251|NCT01097629|474200682|FG007|DB RO Phase|Withdrawal by Subject|1|||
131704252|NCT01097629|474200675|FG000|DB RO Phase|Protocol Violation|0|||
131704253|NCT01097629|474200676|FG001|DB RO Phase|Protocol Violation|0|||
131704254|NCT01097629|474200677|FG002|DB RO Phase|Protocol Violation|0|||
131704255|NCT01097629|474200678|FG003|DB RO Phase|Protocol Violation|1|||
131704256|NCT01097629|474200679|FG004|DB RO Phase|Protocol Violation|0|||
131704257|NCT01097629|474200680|FG005|DB RO Phase|Protocol Violation|1|||
131704258|NCT01097629|474200681|FG006|DB RO Phase|Protocol Violation|1|||
131704259|NCT01097629|474200682|FG007|DB RO Phase|Protocol Violation|0|||
131704260|NCT01097629|474200675|FG000|DB RO Phase|Lost to Follow-up|0|||
131704261|NCT01097629|474200676|FG001|DB RO Phase|Lost to Follow-up|0|||
131704262|NCT01097629|474200677|FG002|DB RO Phase|Lost to Follow-up|0|||
131704263|NCT01097629|474200678|FG003|DB RO Phase|Lost to Follow-up|0|||
131704264|NCT01097629|474200679|FG004|DB RO Phase|Lost to Follow-up|0|||
131704265|NCT01097629|474200680|FG005|DB RO Phase|Lost to Follow-up|0|||
131704266|NCT01097629|474200681|FG006|DB RO Phase|Lost to Follow-up|2|||
131704267|NCT01097629|474200682|FG007|DB RO Phase|Lost to Follow-up|0|||
131704268|NCT01171820|474200683|FG000|Overall Study|Death|3|||
131704269|NCT01171820|474200684|FG001|Overall Study|Death|3|||
131704270|NCT01171820|474200683|FG000|Overall Study|Lost to Follow-up|0|||
131704271|NCT01171820|474200684|FG001|Overall Study|Lost to Follow-up|1|||
131704272|NCT01171820|474200683|FG000|Overall Study|Withdrawal by Subject|2|||
131704273|NCT01171820|474200684|FG001|Overall Study|Withdrawal by Subject|0|||
131704274|NCT01171820|474200683|FG000|Overall Study|Physician Decision|0|||
131704275|NCT01171820|474200684|FG001|Overall Study|Physician Decision|1|||
131789210|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
131704276|NCT01171820|474200683|FG000|Overall Study|1-Year Missed Visit|1|||
131704277|NCT01171820|474200684|FG001|Overall Study|1-Year Missed Visit|1|||
131704278|NCT03969875|474200685|FG000|Overall Study|did not receive allocated intervention|3|||
131704279|NCT03969875|474200686|FG001|Overall Study|did not receive allocated intervention|3|||
131704280|NCT03969875|474200687|FG002|Overall Study|did not receive allocated intervention|4|||
131789211|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
131789212|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
131789213|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
131789214|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
131789215|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
131789216|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
131789217|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
131789218|NCT00185211|474510742|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
131789219|NCT00185211|474510743|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
131789220|NCT03877237|474512586|FG000|Overall Study|Adverse Event|1|||
131789221|NCT03877237|474512587|FG001|Overall Study|Adverse Event|2|||
131789222|NCT03877237|474512586|FG000|Overall Study|Death|3|||
131789223|NCT03877237|474512587|FG001|Overall Study|Death|2|||
131789224|NCT03877237|474512586|FG000|Overall Study|Physician Decision|1|||
131789225|NCT03877237|474512587|FG001|Overall Study|Physician Decision|0|||
131789226|NCT03877237|474512586|FG000|Overall Study|Withdrawal by Subject|0|||
131583805|NCT00232180|473766442|FG002|Open Label Phase|Randomized but not treated|1|||
131583806|NCT01571596|473766443|FG000|Overall Study|Adverse Event|2|||
131583807|NCT01571596|473766444|FG001|Overall Study|Adverse Event|0|||
131583808|NCT01571596|473766445|FG002|Overall Study|Adverse Event|0|||
131583809|NCT01571596|473766443|FG000|Overall Study|Study Terminated by the Sponsor|0|||
131583810|NCT01571596|473766444|FG001|Overall Study|Study Terminated by the Sponsor|1|||
131583811|NCT01571596|473766445|FG002|Overall Study|Study Terminated by the Sponsor|1|||
131583812|NCT02767765|473766447|FG000|Overall Study|Adverse Event|4|||
131789227|NCT03877237|474512587|FG001|Overall Study|Withdrawal by Subject|2|||
131789228|NCT00566098|474512590|FG000|Collection of MILs|Withdrawal by Subject|1|||
131789229|NCT00566098|474512590|FG000|Collection of MILs|Relapsed|1|||
131789230|NCT00566098|474512590|FG000|Generation of MILs Product|Relapsed|1|||
131789231|NCT00566098|474512590|FG000|Administration of ASCT+MILs|Death|10|||
131789232|NCT00566098|474512590|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
131789233|NCT02236754|474512591|FG000|Overall Study|Withdrawal by Subject|1|||
131789234|NCT02236754|474512592|FG001|Overall Study|Withdrawal by Subject|0|||
131583813|NCT02767765|473766447|FG000|Overall Study|Death|1|||
131583814|NCT02767765|473766447|FG000|Overall Study|Insufficient response|1|||
131583815|NCT02767765|473766447|FG000|Overall Study|Lost to Follow-up|2|||
131583816|NCT02767765|473766447|FG000|Overall Study|Investigator decision|1|||
131704281|NCT03969875|474200685|FG000|Overall Study|Protocol Violation|4|||
131704282|NCT03969875|474200686|FG001|Overall Study|Protocol Violation|2|||
131704283|NCT03969875|474200687|FG002|Overall Study|Protocol Violation|2|||
131704284|NCT00568555|474200690|FG000|Overall Study|Withdrawal by Subject|1|||
131704285|NCT00568555|474200691|FG001|Overall Study|Withdrawal by Subject|1|||
131704286|NCT02613208|474200692|FG000|Overall Study|Withdrawal by Subject|1|||
131704287|NCT02613208|474200692|FG000|Overall Study|Change of address|2|||
131704288|NCT02613208|474200692|FG000|Overall Study|Physician Decision|2|||
131704289|NCT02613208|474200692|FG000|Overall Study|Lost to Follow-up|5|||
131704290|NCT02613208|474200692|FG000|Overall Study|Death|37|||
131704291|NCT01307033|474200693|FG000|8-week Double-blind Period|Adverse Event|2|||
131704292|NCT01307033|474200694|FG001|8-week Double-blind Period|Adverse Event|0|||
131704293|NCT01307033|474200695|FG002|8-week Double-blind Period|Adverse Event|0|||
131704294|NCT01307033|474200696|FG003|8-week Double-blind Period|Adverse Event|0|||
131704295|NCT01307033|474200693|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
131704296|NCT01307033|474200694|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
131704297|NCT01307033|474200695|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
131704298|NCT01307033|474200696|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
131704299|NCT01307033|474200693|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
131704300|NCT01307033|474200694|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
131704301|NCT01307033|474200695|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
131704302|NCT01307033|474200696|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
131704303|NCT01307033|474200693|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
131704304|NCT01307033|474200694|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
131704305|NCT01307033|474200695|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
131704306|NCT01307033|474200696|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
131704307|NCT01307033|474200693|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
131704308|NCT01307033|474200694|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
131704309|NCT01307033|474200695|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
131704310|NCT01307033|474200696|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
131704311|NCT01307033|474200693|FG000|44-week Open-label Extension|Adverse Event|0|||
131704312|NCT01307033|474200694|FG001|44-week Open-label Extension|Adverse Event|0|||
131704313|NCT01307033|474200695|FG002|44-week Open-label Extension|Adverse Event|2|||
131704314|NCT01307033|474200696|FG003|44-week Open-label Extension|Adverse Event|1|||
131704315|NCT01307033|474200693|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
131704316|NCT01307033|474200694|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
131704317|NCT01307033|474200695|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
131704318|NCT01307033|474200696|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
131704319|NCT01307033|474200693|FG000|44-week Open-label Extension|Physician Decision|0|||
131704320|NCT01307033|474200694|FG001|44-week Open-label Extension|Physician Decision|0|||
131704321|NCT01307033|474200695|FG002|44-week Open-label Extension|Physician Decision|1|||
131704322|NCT01307033|474200696|FG003|44-week Open-label Extension|Physician Decision|0|||
131789235|NCT04006847|474512593|FG000|Overall Study|Product issue|1|||
131789236|NCT00382291|474512594|FG000|Overall Study|Adverse Event|1|||
131583817|NCT02767765|473766447|FG000|Overall Study|Non-Compliance|1|||
131583818|NCT02767765|473766447|FG000|Overall Study|Withdrawal by Subject|1|||
131583819|NCT01951170|473766449|FG000|Overall Study|Investigator decision|1|||
131583820|NCT04512482|473766452|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
131583821|NCT04512482|473766453|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
131583822|NCT00077675|473766458|FG000|Overall Study|Adverse Event|1|||
131583823|NCT00077675|473766459|FG001|Overall Study|Adverse Event|2|||
131583824|NCT00077675|473766458|FG000|Overall Study|Lost to Follow-up|6|||
131583825|NCT00077675|473766459|FG001|Overall Study|Lost to Follow-up|3|||
131583826|NCT00077675|473766458|FG000|Overall Study|Withdrawal by Subject|1|||
131583827|NCT00077675|473766459|FG001|Overall Study|Withdrawal by Subject|0|||
131583828|NCT00077675|473766458|FG000|Overall Study|Other|0|||
131583829|NCT00077675|473766459|FG001|Overall Study|Other|1|||
131583830|NCT00077675|473766458|FG000|Overall Study|Never received study treatment|3|||
131583831|NCT00077675|473766459|FG001|Overall Study|Never received study treatment|3|||
131583832|NCT02706717|473766465|FG000|Overall Study|Withdrawal by Subject|1|||
131583833|NCT02706717|473766466|FG001|Overall Study|Withdrawal by Subject|8|||
131583834|NCT02706717|473766465|FG000|Overall Study|Lost to Follow-up|0|||
131789237|NCT00382291|474512595|FG001|Overall Study|Adverse Event|2|||
131789238|NCT00382291|474512596|FG002|Overall Study|Adverse Event|2|||
131789239|NCT00382291|474512594|FG000|Overall Study|Protocol Violation|1|||
131789240|NCT00382291|474512595|FG001|Overall Study|Protocol Violation|0|||
131789241|NCT00382291|474512596|FG002|Overall Study|Protocol Violation|0|||
131789242|NCT00382291|474512594|FG000|Overall Study|Temporary study suspension|2|||
131789243|NCT00382291|474512595|FG001|Overall Study|Temporary study suspension|2|||
131789244|NCT00382291|474512596|FG002|Overall Study|Temporary study suspension|5|||
131789245|NCT00382291|474512594|FG000|Overall Study|Withdrawal by Subject|0|||
131789246|NCT00382291|474512595|FG001|Overall Study|Withdrawal by Subject|2|||
131789247|NCT00382291|474512596|FG002|Overall Study|Withdrawal by Subject|0|||
131789248|NCT00382291|474512594|FG000|Overall Study|Physician Decision|0|||
131789249|NCT00382291|474512595|FG001|Overall Study|Physician Decision|1|||
131789250|NCT00382291|474512596|FG002|Overall Study|Physician Decision|0|||
131789251|NCT00382291|474512594|FG000|Overall Study|Lack of Efficacy|0|||
131789252|NCT00382291|474512595|FG001|Overall Study|Lack of Efficacy|0|||
131789253|NCT00382291|474512596|FG002|Overall Study|Lack of Efficacy|1|||
131789254|NCT00409188|474512599|FG000|Overall Study|Ongoing at data cut-off|383|||
131789255|NCT00409188|474512600|FG001|Overall Study|Ongoing at data cut-off|175|||
131789256|NCT02092961|474512601|FG000|Overall Study|Not reported|1|||
131789257|NCT02092961|474512602|FG001|Overall Study|Not reported|0|||
131789258|NCT02092961|474512603|FG002|Overall Study|Not reported|1|||
131789259|NCT02092961|474512601|FG000|Overall Study|Study stopped|13|||
131789260|NCT02092961|474512602|FG001|Overall Study|Study stopped|9|||
131789261|NCT02092961|474512603|FG002|Overall Study|Study stopped|12|||
131789262|NCT02092961|474512601|FG000|Overall Study|Lack of therapeutic response|2|||
131789263|NCT02092961|474512602|FG001|Overall Study|Lack of therapeutic response|1|||
131789264|NCT02092961|474512603|FG002|Overall Study|Lack of therapeutic response|3|||
131789265|NCT02092961|474512601|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
131789266|NCT02092961|474512602|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
131789267|NCT02092961|474512603|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
131789268|NCT02092961|474512601|FG000|Overall Study|Adverse Event|2|||
131789269|NCT02092961|474512602|FG001|Overall Study|Adverse Event|4|||
131789270|NCT02092961|474512603|FG002|Overall Study|Adverse Event|0|||
131789271|NCT02270983|474512604|FG000|Overall Study|Adverse Event|3|||
131789272|NCT02270983|474512605|FG001|Overall Study|Adverse Event|2|||
131789273|NCT02270983|474512606|FG002|Overall Study|Adverse Event|6|||
131789274|NCT02270983|474512604|FG000|Overall Study|Lack of Efficacy|2|||
131789275|NCT02270983|474512605|FG001|Overall Study|Lack of Efficacy|1|||
131789276|NCT02270983|474512606|FG002|Overall Study|Lack of Efficacy|1|||
131789277|NCT02270983|474512604|FG000|Overall Study|Withdrawal by Subject|1|||
131789278|NCT02270983|474512605|FG001|Overall Study|Withdrawal by Subject|0|||
131789279|NCT02270983|474512606|FG002|Overall Study|Withdrawal by Subject|2|||
131789280|NCT02270983|474512604|FG000|Overall Study|Lost to Follow-up|1|||
131789281|NCT02270983|474512605|FG001|Overall Study|Lost to Follow-up|1|||
131789282|NCT02270983|474512606|FG002|Overall Study|Lost to Follow-up|2|||
131789283|NCT02270983|474512604|FG000|Overall Study|Protocol Violation|1|||
131789284|NCT02270983|474512605|FG001|Overall Study|Protocol Violation|1|||
131789285|NCT02270983|474512606|FG002|Overall Study|Protocol Violation|1|||
131789286|NCT02270983|474512604|FG000|Overall Study|family emergency|0|||
131789287|NCT02270983|474512605|FG001|Overall Study|family emergency|1|||
131789288|NCT02270983|474512606|FG002|Overall Study|family emergency|0|||
131789289|NCT02270983|474512604|FG000|Overall Study|study procedure non-compliance|1|||
131789290|NCT02270983|474512605|FG001|Overall Study|study procedure non-compliance|0|||
131789291|NCT02270983|474512606|FG002|Overall Study|study procedure non-compliance|0|||
131789292|NCT02270983|474512604|FG000|Overall Study|moved away from study site|0|||
131789293|NCT02270983|474512605|FG001|Overall Study|moved away from study site|1|||
131789294|NCT02270983|474512606|FG002|Overall Study|moved away from study site|0|||
131789295|NCT00854620|474512609|FG000|Overall Study|Adverse Event|1|||
131789296|NCT01623830|474512613|FG000|Overall Study|Withdrawal by Subject|6|||
131789297|NCT01623830|474512614|FG001|Overall Study|Withdrawal by Subject|7|||
131789298|NCT01623830|474512613|FG000|Overall Study|Exclusion from Study|1|||
131789299|NCT01623830|474512614|FG001|Overall Study|Exclusion from Study|2|||
131789300|NCT00928252|474512615|FG000|Overall Study|Physician Decision|3|||
131789301|NCT01605461|474512617|FG000|Overall Study|Lost to Follow-up|3|||
131789302|NCT01605461|474512617|FG000|Overall Study|Withdrawal by Subject|1|||
131789303|NCT01393990|474512618|FG000|Overall Study|Adverse Event|0|||
131789304|NCT01393990|474512619|FG001|Overall Study|Adverse Event|0|||
131704323|NCT01307033|474200693|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
131704324|NCT01307033|474200694|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
131704325|NCT01307033|474200695|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
131704326|NCT01307033|474200696|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
131704327|NCT01307033|474200693|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
131704328|NCT01307033|474200694|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
131704329|NCT01307033|474200695|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
131704330|NCT01307033|474200696|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
131704331|NCT01307033|474200693|FG000|44-week Open-label Extension|Death|0|||
131704332|NCT01307033|474200694|FG001|44-week Open-label Extension|Death|0|||
131704333|NCT01307033|474200695|FG002|44-week Open-label Extension|Death|0|||
131704334|NCT01307033|474200696|FG003|44-week Open-label Extension|Death|1|||
131704335|NCT01231555|474200697|FG000|Overall Study|Study terminated|8|||
131704336|NCT01231555|474200698|FG001|Overall Study|Study terminated|5|||
131704337|NCT01231555|474200699|FG002|Overall Study|Study terminated|8|||
131704338|NCT01231555|474200697|FG000|Overall Study|Withdrawal by Subject|0|||
131704339|NCT01231555|474200698|FG001|Overall Study|Withdrawal by Subject|2|||
131704340|NCT01231555|474200699|FG002|Overall Study|Withdrawal by Subject|0|||
131789305|NCT01393990|474512620|FG002|Overall Study|Adverse Event|0|||
131789306|NCT01393990|474512621|FG003|Overall Study|Adverse Event|0|||
131789307|NCT01393990|474512622|FG004|Overall Study|Adverse Event|0|||
131789308|NCT01393990|474512623|FG005|Overall Study|Adverse Event|0|||
131438646|NCT00591006|473231331|FG017|Overall Study|Withdrawal by Subject|0|||
131789309|NCT01393990|474512624|FG006|Overall Study|Adverse Event|0|||
131789310|NCT01393990|474512625|FG007|Overall Study|Adverse Event|0|||
131583835|NCT02706717|473766466|FG001|Overall Study|Lost to Follow-up|1|||
131438647|NCT00591006|473231332|FG018|Overall Study|Withdrawal by Subject|0|||
131704341|NCT00947531|474200700|FG000|Overall Study|Withdrawal by Subject|10|||
131704342|NCT00947531|474200701|FG001|Overall Study|Withdrawal by Subject|7|||
131704343|NCT00947531|474200700|FG000|Overall Study|Administrative Reason|0|||
131704344|NCT00947531|474200701|FG001|Overall Study|Administrative Reason|1|||
131704345|NCT00947531|474200700|FG000|Overall Study|Adverse Event|2|||
131789311|NCT01393990|474512626|FG008|Overall Study|Adverse Event|0|||
131789312|NCT01393990|474512627|FG009|Overall Study|Adverse Event|0|||
131789313|NCT01393990|474512628|FG010|Overall Study|Adverse Event|0|||
131789314|NCT01393990|474512629|FG011|Overall Study|Adverse Event|0|||
131789315|NCT01393990|474512630|FG012|Overall Study|Adverse Event|0|||
131789316|NCT01393990|474512631|FG013|Overall Study|Adverse Event|0|||
131789317|NCT01393990|474512632|FG014|Overall Study|Adverse Event|1|||
131789318|NCT01393990|474512633|FG015|Overall Study|Adverse Event|1|||
131789319|NCT01393990|474512634|FG016|Overall Study|Adverse Event|0|||
131789320|NCT01393990|474512635|FG017|Overall Study|Adverse Event|0|||
131789321|NCT01393990|474512618|FG000|Overall Study|Progressive Disease|1|||
131789322|NCT01393990|474512619|FG001|Overall Study|Progressive Disease|0|||
131789323|NCT01393990|474512620|FG002|Overall Study|Progressive Disease|0|||
131789324|NCT01393990|474512621|FG003|Overall Study|Progressive Disease|1|||
131789325|NCT01393990|474512622|FG004|Overall Study|Progressive Disease|1|||
131789326|NCT01393990|474512623|FG005|Overall Study|Progressive Disease|1|||
131789327|NCT01393990|474512624|FG006|Overall Study|Progressive Disease|1|||
131789328|NCT01393990|474512625|FG007|Overall Study|Progressive Disease|1|||
131789329|NCT01393990|474512626|FG008|Overall Study|Progressive Disease|3|||
131789330|NCT01393990|474512627|FG009|Overall Study|Progressive Disease|1|||
131789331|NCT01393990|474512628|FG010|Overall Study|Progressive Disease|0|||
131789332|NCT01393990|474512629|FG011|Overall Study|Progressive Disease|0|||
131789333|NCT01393990|474512630|FG012|Overall Study|Progressive Disease|0|||
131789334|NCT01393990|474512631|FG013|Overall Study|Progressive Disease|1|||
131789335|NCT01393990|474512632|FG014|Overall Study|Progressive Disease|6|||
131789336|NCT01393990|474512633|FG015|Overall Study|Progressive Disease|1|||
131789337|NCT01393990|474512634|FG016|Overall Study|Progressive Disease|0|||
131789338|NCT01393990|474512635|FG017|Overall Study|Progressive Disease|0|||
131789339|NCT01393990|474512618|FG000|Overall Study|Death|0|||
131789340|NCT01393990|474512619|FG001|Overall Study|Death|0|||
131789341|NCT01393990|474512620|FG002|Overall Study|Death|0|||
131789342|NCT01393990|474512621|FG003|Overall Study|Death|0|||
131789343|NCT01393990|474512622|FG004|Overall Study|Death|1|||
131789344|NCT01393990|474512623|FG005|Overall Study|Death|0|||
131789345|NCT01393990|474512624|FG006|Overall Study|Death|0|||
131789346|NCT01393990|474512625|FG007|Overall Study|Death|0|||
131789347|NCT01393990|474512626|FG008|Overall Study|Death|0|||
131789348|NCT01393990|474512627|FG009|Overall Study|Death|0|||
131789349|NCT01393990|474512628|FG010|Overall Study|Death|0|||
131789350|NCT01393990|474512629|FG011|Overall Study|Death|0|||
131789351|NCT01393990|474512630|FG012|Overall Study|Death|0|||
131789352|NCT01393990|474512631|FG013|Overall Study|Death|1|||
131789353|NCT01393990|474512632|FG014|Overall Study|Death|1|||
131789354|NCT01393990|474512633|FG015|Overall Study|Death|0|||
131789355|NCT01393990|474512634|FG016|Overall Study|Death|0|||
131789356|NCT01393990|474512635|FG017|Overall Study|Death|0|||
131789357|NCT01393990|474512618|FG000|Overall Study|Withdrawal by Subject|0|||
131789358|NCT01393990|474512619|FG001|Overall Study|Withdrawal by Subject|0|||
131789359|NCT01393990|474512620|FG002|Overall Study|Withdrawal by Subject|0|||
131789360|NCT01393990|474512621|FG003|Overall Study|Withdrawal by Subject|0|||
131789361|NCT01393990|474512622|FG004|Overall Study|Withdrawal by Subject|0|||
131789362|NCT01393990|474512623|FG005|Overall Study|Withdrawal by Subject|0|||
131789363|NCT01393990|474512624|FG006|Overall Study|Withdrawal by Subject|0|||
131789364|NCT01393990|474512625|FG007|Overall Study|Withdrawal by Subject|0|||
131789365|NCT01393990|474512626|FG008|Overall Study|Withdrawal by Subject|0|||
131789366|NCT01393990|474512627|FG009|Overall Study|Withdrawal by Subject|0|||
131789367|NCT01393990|474512628|FG010|Overall Study|Withdrawal by Subject|0|||
131789368|NCT01393990|474512629|FG011|Overall Study|Withdrawal by Subject|0|||
131789369|NCT01393990|474512630|FG012|Overall Study|Withdrawal by Subject|0|||
131789370|NCT01393990|474512631|FG013|Overall Study|Withdrawal by Subject|0|||
131789371|NCT01393990|474512632|FG014|Overall Study|Withdrawal by Subject|1|||
131789372|NCT01393990|474512633|FG015|Overall Study|Withdrawal by Subject|1|||
131789373|NCT01393990|474512634|FG016|Overall Study|Withdrawal by Subject|0|||
131789374|NCT01393990|474512635|FG017|Overall Study|Withdrawal by Subject|0|||
131789375|NCT01847313|474512638|FG000|Overall Study|Death|0|||
131789376|NCT01847313|474512639|FG001|Overall Study|Death|1|||
131789377|NCT01847313|474512638|FG000|Overall Study|Withdrawal by Subject|0|||
131789378|NCT01847313|474512639|FG001|Overall Study|Withdrawal by Subject|1|||
131789379|NCT01859390|474512642|FG000|Overall Study|Insufficient Sputum Collected|1|||
131789380|NCT01859390|474512643|FG001|Overall Study|Insufficient Sputum Collected|3|||
131789381|NCT01859390|474512642|FG000|Overall Study|Sample Missing Collection Date|0|||
131789382|NCT01859390|474512643|FG001|Overall Study|Sample Missing Collection Date|1|||
131438648|NCT00591006|473231333|FG019|Overall Study|Withdrawal by Subject|0|||
131438649|NCT00591006|473231334|FG020|Overall Study|Withdrawal by Subject|0|||
131438650|NCT00591006|473231335|FG021|Overall Study|Withdrawal by Subject|0|||
131438651|NCT00591006|473231336|FG022|Overall Study|Withdrawal by Subject|0|||
131438652|NCT00591006|473231337|FG023|Overall Study|Withdrawal by Subject|1|||
131438653|NCT00591006|473231314|FG000|Overall Study|Adverse Event|0|||
131438654|NCT00591006|473231315|FG001|Overall Study|Adverse Event|0|||
131438655|NCT00591006|473231316|FG002|Overall Study|Adverse Event|0|||
131438656|NCT00591006|473231317|FG003|Overall Study|Adverse Event|0|||
131438657|NCT00591006|473231318|FG004|Overall Study|Adverse Event|0|||
131438658|NCT00591006|473231319|FG005|Overall Study|Adverse Event|0|||
131438659|NCT00591006|473231320|FG006|Overall Study|Adverse Event|0|||
131438660|NCT00591006|473231321|FG007|Overall Study|Adverse Event|0|||
131789383|NCT01859390|474512642|FG000|Overall Study|Tube Cracked|0|||
131789384|NCT01859390|474512643|FG001|Overall Study|Tube Cracked|2|||
131789385|NCT01859390|474512642|FG000|Overall Study|Shipment Error|0|||
131789386|NCT01859390|474512643|FG001|Overall Study|Shipment Error|1|||
131789387|NCT01706198|474512644|FG000|Overall Study|Adverse Event|12|||
131789388|NCT01706198|474512645|FG001|Overall Study|Adverse Event|15|||
131789389|NCT01706198|474512644|FG000|Overall Study|Protocol Violation|7|||
131789390|NCT01706198|474512645|FG001|Overall Study|Protocol Violation|5|||
131583836|NCT02706717|473766465|FG000|Overall Study|Physician Decision|0|||
131583837|NCT02706717|473766466|FG001|Overall Study|Physician Decision|1|||
131789391|NCT01706198|474512644|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
131789392|NCT01706198|474512645|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
131789393|NCT01706198|474512644|FG000|Overall Study|Lost to Follow-up|97|||
131789394|NCT01706198|474512645|FG001|Overall Study|Lost to Follow-up|93|||
131789395|NCT01706198|474512644|FG000|Overall Study|Physician Decision|23|||
131789396|NCT01706198|474512645|FG001|Overall Study|Physician Decision|37|||
131789397|NCT01706198|474512644|FG000|Overall Study|Withdrawal by Subject|23|||
131438661|NCT00591006|473231322|FG008|Overall Study|Adverse Event|0|||
131789398|NCT01706198|474512645|FG001|Overall Study|Withdrawal by Subject|31|||
131789399|NCT04313283|474512646|FG000|Overall Study|did not complete intervention|4|||
131789400|NCT00910858|474512649|FG000|Pharmacokinetic Phase|Adverse Event|1|||
131789401|NCT00910858|474512650|FG001|Pharmacokinetic Phase|Adverse Event|0|||
131438662|NCT00591006|473231323|FG009|Overall Study|Adverse Event|0|||
131583838|NCT02706717|473766465|FG000|Overall Study|Death|0|||
131789402|NCT00910858|474512651|FG002|Pharmacokinetic Phase|Adverse Event|0|||
131789403|NCT00910858|474512649|FG000|Monotherapy Phase|Adverse Event|3|||
131704346|NCT00947531|474200701|FG001|Overall Study|Adverse Event|2|||
131704347|NCT00947531|474200700|FG000|Overall Study|Lack of Efficacy|1|||
131704348|NCT00947531|474200701|FG001|Overall Study|Lack of Efficacy|0|||
131704349|NCT00947531|474200700|FG000|Overall Study|Other|1|||
131704350|NCT00947531|474200701|FG001|Overall Study|Other|1|||
131704351|NCT01773421|474200703|FG000|Treatment Phase|Other|0|||
131704352|NCT01773421|474200704|FG001|Treatment Phase|Other|0|||
131583839|NCT02706717|473766466|FG001|Overall Study|Death|1|||
131704353|NCT01773421|474200705|FG002|Treatment Phase|Other|2|||
131704354|NCT01773421|474200706|FG003|Treatment Phase|Other|0|||
131704355|NCT01773421|474200707|FG004|Treatment Phase|Other|0|||
131704356|NCT01773421|474200708|FG005|Treatment Phase|Other|0|||
131704357|NCT01773421|474200709|FG006|Treatment Phase|Other|0|||
131704358|NCT01773421|474200703|FG000|Treatment Phase|Adverse Event|0|||
131704359|NCT01773421|474200704|FG001|Treatment Phase|Adverse Event|0|||
131704360|NCT01773421|474200705|FG002|Treatment Phase|Adverse Event|3|||
131704361|NCT01773421|474200706|FG003|Treatment Phase|Adverse Event|1|||
131704362|NCT01773421|474200707|FG004|Treatment Phase|Adverse Event|0|||
131704363|NCT01773421|474200708|FG005|Treatment Phase|Adverse Event|0|||
131704364|NCT01773421|474200709|FG006|Treatment Phase|Adverse Event|0|||
131704365|NCT01773421|474200703|FG000|Treatment Phase|Withdrawal by Subject|0|||
131704366|NCT01773421|474200704|FG001|Treatment Phase|Withdrawal by Subject|0|||
131704367|NCT01773421|474200705|FG002|Treatment Phase|Withdrawal by Subject|1|||
131704368|NCT01773421|474200706|FG003|Treatment Phase|Withdrawal by Subject|1|||
131704369|NCT01773421|474200707|FG004|Treatment Phase|Withdrawal by Subject|0|||
131704370|NCT01773421|474200708|FG005|Treatment Phase|Withdrawal by Subject|0|||
131704371|NCT01773421|474200709|FG006|Treatment Phase|Withdrawal by Subject|0|||
131704372|NCT01773421|474200703|FG000|Extension Phase|Other|0|||
131704373|NCT01773421|474200704|FG001|Extension Phase|Other|0|||
131704374|NCT01773421|474200705|FG002|Extension Phase|Other|0|||
131704375|NCT01773421|474200706|FG003|Extension Phase|Other|0|||
131704376|NCT01773421|474200707|FG004|Extension Phase|Other|1|||
131704377|NCT01773421|474200708|FG005|Extension Phase|Other|2|||
131704378|NCT01773421|474200709|FG006|Extension Phase|Other|0|||
131704379|NCT01773421|474200703|FG000|Extension Phase|Adverse Event|0|||
131704380|NCT01773421|474200704|FG001|Extension Phase|Adverse Event|0|||
131704381|NCT01773421|474200705|FG002|Extension Phase|Adverse Event|0|||
131704382|NCT01773421|474200706|FG003|Extension Phase|Adverse Event|0|||
131704383|NCT01773421|474200707|FG004|Extension Phase|Adverse Event|2|||
131704384|NCT01773421|474200708|FG005|Extension Phase|Adverse Event|0|||
131704385|NCT01773421|474200709|FG006|Extension Phase|Adverse Event|0|||
131704386|NCT03502330|474200710|FG000|Overall Study|Adverse Event|2|||
131789404|NCT00910858|474512650|FG001|Monotherapy Phase|Adverse Event|2|||
131789405|NCT00910858|474512651|FG002|Monotherapy Phase|Adverse Event|0|||
131789406|NCT00910858|474512649|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
131789407|NCT00910858|474512650|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
131789408|NCT00910858|474512651|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
131789409|NCT00910858|474512649|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
131789410|NCT00910858|474512650|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
131789411|NCT00910858|474512651|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
131789412|NCT00910858|474512649|FG000|Monotherapy Phase|Protocol Violation|1|||
131789413|NCT00910858|474512650|FG001|Monotherapy Phase|Protocol Violation|0|||
131438663|NCT00591006|473231324|FG010|Overall Study|Adverse Event|0|||
131438664|NCT00591006|473231325|FG011|Overall Study|Adverse Event|0|||
131704387|NCT03502330|474200711|FG001|Overall Study|Adverse Event|1|||
131789414|NCT00910858|474512651|FG002|Monotherapy Phase|Protocol Violation|0|||
131789415|NCT00910858|474512649|FG000|Monotherapy Phase|Other|3|||
131438665|NCT00591006|473231326|FG012|Overall Study|Adverse Event|0|||
131789416|NCT00910858|474512650|FG001|Monotherapy Phase|Other|4|||
131789417|NCT00910858|474512651|FG002|Monotherapy Phase|Other|2|||
131789418|NCT00910858|474512649|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
131789419|NCT00910858|474512650|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
131789420|NCT00910858|474512651|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
131789421|NCT00910858|474512649|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
131789422|NCT00910858|474512650|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
131789423|NCT00910858|474512651|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
131789424|NCT00910858|474512649|FG000|Combined Treatment Phase|Protocol Violation|1|||
131789425|NCT00910858|474512650|FG001|Combined Treatment Phase|Protocol Violation|0|||
131789426|NCT00910858|474512651|FG002|Combined Treatment Phase|Protocol Violation|0|||
131789427|NCT00910858|474512649|FG000|Combined Treatment Phase|Other|0|||
131789428|NCT00910858|474512650|FG001|Combined Treatment Phase|Other|2|||
131789429|NCT00910858|474512651|FG002|Combined Treatment Phase|Other|1|||
131789430|NCT01703741|474512658|FG000|Overall Study|Withdrawal by Subject|6|||
131789431|NCT01703741|474512658|FG000|Overall Study|Adverse Event|2|||
131789432|NCT01703741|474512658|FG000|Overall Study|Physician Decision|2|||
131789433|NCT01703741|474512658|FG000|Overall Study|Protocol Violation|1|||
131789434|NCT01703741|474512658|FG000|Overall Study|Lost to Follow-up|3|||
131789435|NCT01703741|474512658|FG000|Overall Study|Subject did not want to continue|2|||
131789436|NCT01703741|474512658|FG000|Overall Study|Subject cannot comply with study visits|1|||
131789437|NCT01703741|474512658|FG000|Overall Study|Subject started testosterone injections|1|||
131789438|NCT01170364|474512659|FG000|Overall Study|Protocol Violation|4|||
131789439|NCT01170364|474512660|FG001|Overall Study|Protocol Violation|1|||
131789440|NCT02041494|474512661|FG000|Overall Study|Death|1|||
131789441|NCT02041494|474512662|FG001|Overall Study|Death|3|||
131789442|NCT02041494|474512661|FG000|Overall Study|Lost to Follow-up|2|||
131789443|NCT02041494|474512662|FG001|Overall Study|Lost to Follow-up|6|||
131789444|NCT02041494|474512661|FG000|Overall Study|study terminated|16|||
131789445|NCT02041494|474512662|FG001|Overall Study|study terminated|11|||
131789446|NCT00608205|474512663|FG000|Overall Study|Adverse Event|3|||
131789447|NCT00608205|474512664|FG001|Overall Study|Adverse Event|2|||
131438666|NCT00591006|473231327|FG013|Overall Study|Adverse Event|0|||
131789448|NCT00608205|474512663|FG000|Overall Study|Patient non-compliant|0|||
131789449|NCT00608205|474512664|FG001|Overall Study|Patient non-compliant|1|||
131789450|NCT02008721|474512665|FG000|Overall Study|Withdrawal by Subject|5|||
131438667|NCT00591006|473231328|FG014|Overall Study|Adverse Event|0|||
131704388|NCT03502330|474200712|FG002|Overall Study|Adverse Event|0|||
131704389|NCT03502330|474200713|FG003|Overall Study|Adverse Event|0|||
131704390|NCT03502330|474200714|FG004|Overall Study|Adverse Event|1|||
131704391|NCT03502330|474200715|FG005|Overall Study|Adverse Event|0|||
131704392|NCT03502330|474200716|FG006|Overall Study|Adverse Event|1|||
131704393|NCT03502330|474200717|FG007|Overall Study|Adverse Event|1|||
131704394|NCT03502330|474200718|FG008|Overall Study|Adverse Event|0|||
131704395|NCT03502330|474200710|FG000|Overall Study|Lack of Efficacy|1|||
131704396|NCT03502330|474200711|FG001|Overall Study|Lack of Efficacy|5|||
131704397|NCT03502330|474200712|FG002|Overall Study|Lack of Efficacy|3|||
131704398|NCT03502330|474200713|FG003|Overall Study|Lack of Efficacy|5|||
131704399|NCT03502330|474200714|FG004|Overall Study|Lack of Efficacy|1|||
131704400|NCT03502330|474200715|FG005|Overall Study|Lack of Efficacy|5|||
131704401|NCT03502330|474200716|FG006|Overall Study|Lack of Efficacy|5|||
131704402|NCT03502330|474200717|FG007|Overall Study|Lack of Efficacy|6|||
131704403|NCT03502330|474200718|FG008|Overall Study|Lack of Efficacy|0|||
131704404|NCT03502330|474200710|FG000|Overall Study|Physician Decision|0|||
131704405|NCT03502330|474200711|FG001|Overall Study|Physician Decision|0|||
131704406|NCT03502330|474200712|FG002|Overall Study|Physician Decision|0|||
131704407|NCT03502330|474200713|FG003|Overall Study|Physician Decision|0|||
131704408|NCT03502330|474200714|FG004|Overall Study|Physician Decision|1|||
131704409|NCT03502330|474200715|FG005|Overall Study|Physician Decision|0|||
131704410|NCT03502330|474200716|FG006|Overall Study|Physician Decision|0|||
131704411|NCT03502330|474200717|FG007|Overall Study|Physician Decision|0|||
131704412|NCT03502330|474200718|FG008|Overall Study|Physician Decision|0|||
131704413|NCT03502330|474200710|FG000|Overall Study|Withdrawal by Subject|0|||
131704414|NCT03502330|474200711|FG001|Overall Study|Withdrawal by Subject|0|||
131704415|NCT03502330|474200712|FG002|Overall Study|Withdrawal by Subject|0|||
131704416|NCT03502330|474200713|FG003|Overall Study|Withdrawal by Subject|0|||
131704417|NCT03502330|474200714|FG004|Overall Study|Withdrawal by Subject|0|||
131704418|NCT03502330|474200715|FG005|Overall Study|Withdrawal by Subject|1|||
131704419|NCT03502330|474200716|FG006|Overall Study|Withdrawal by Subject|0|||
131704420|NCT03502330|474200717|FG007|Overall Study|Withdrawal by Subject|1|||
131704421|NCT03502330|474200718|FG008|Overall Study|Withdrawal by Subject|0|||
131704422|NCT03502330|474200710|FG000|Overall Study|Death|0|||
131704423|NCT03502330|474200711|FG001|Overall Study|Death|0|||
131704424|NCT03502330|474200712|FG002|Overall Study|Death|0|||
131704425|NCT03502330|474200713|FG003|Overall Study|Death|0|||
131704426|NCT03502330|474200714|FG004|Overall Study|Death|0|||
131704427|NCT03502330|474200715|FG005|Overall Study|Death|0|||
131704428|NCT03502330|474200716|FG006|Overall Study|Death|2|||
131704429|NCT03502330|474200717|FG007|Overall Study|Death|0|||
131704430|NCT03502330|474200718|FG008|Overall Study|Death|0|||
131704431|NCT02804763|474200722|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
131704432|NCT02804763|474200723|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
131704433|NCT02804763|474200724|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
131704434|NCT02804763|474200725|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
131704435|NCT02804763|474200722|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
131438668|NCT00591006|473231329|FG015|Overall Study|Adverse Event|0|||
131438669|NCT00591006|473231330|FG016|Overall Study|Adverse Event|0|||
131438670|NCT00591006|473231331|FG017|Overall Study|Adverse Event|0|||
131438671|NCT00591006|473231332|FG018|Overall Study|Adverse Event|0|||
131438672|NCT00591006|473231333|FG019|Overall Study|Adverse Event|0|||
131438673|NCT00591006|473231334|FG020|Overall Study|Adverse Event|0|||
131438674|NCT00591006|473231335|FG021|Overall Study|Adverse Event|0|||
131438675|NCT00591006|473231336|FG022|Overall Study|Adverse Event|1|||
131438676|NCT00591006|473231337|FG023|Overall Study|Adverse Event|0|||
131438677|NCT00689390|473231338|FG000|Overall Study|Adverse Event|19|||
131438678|NCT00689390|473231339|FG001|Overall Study|Adverse Event|0|||
131438679|NCT00689390|473231338|FG000|Overall Study|Lost to Follow-up|179|||
131438680|NCT00689390|473231339|FG001|Overall Study|Lost to Follow-up|7|||
131438681|NCT00689390|473231338|FG000|Overall Study|Withdrawal by Subject|117|||
131438682|NCT00689390|473231339|FG001|Overall Study|Withdrawal by Subject|3|||
131438683|NCT00689390|473231338|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
131438684|NCT00689390|473231339|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
131438685|NCT00689390|473231338|FG000|Overall Study|Non-Compliance With Protocol|21|||
131438686|NCT00689390|473231339|FG001|Overall Study|Non-Compliance With Protocol|0|||
131438687|NCT00689390|473231338|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
131438688|NCT00689390|473231339|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
131438689|NCT00689390|473231338|FG000|Overall Study|Administrative|37|||
131438690|NCT00689390|473231339|FG001|Overall Study|Administrative|0|||
131438691|NCT02343263|473231340|FG000|Overall Study|Physician Decision|5|||
131438692|NCT02343263|473231341|FG001|Overall Study|Physician Decision|3|||
131438693|NCT02343263|473231342|FG002|Overall Study|Physician Decision|1|||
131438694|NCT00948064|473233277|FG000|Phase I|No treatment received|1|||
131438695|NCT00948064|473233278|FG001|Phase I|No treatment received|0|||
131704436|NCT02804763|474200723|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
131704437|NCT02804763|474200724|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
131704438|NCT02804763|474200725|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
131704439|NCT02804763|474200722|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
131704440|NCT02804763|474200723|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
131704441|NCT02804763|474200724|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
131704442|NCT02804763|474200725|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
131704443|NCT02804763|474200722|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
131789451|NCT02008721|474512666|FG001|Overall Study|Withdrawal by Subject|1|||
131789452|NCT02008721|474512665|FG000|Overall Study|Death|4|||
131789453|NCT02008721|474512666|FG001|Overall Study|Death|2|||
131789454|NCT02008721|474512665|FG000|Overall Study|Adverse Event|3|||
131789455|NCT02008721|474512666|FG001|Overall Study|Adverse Event|5|||
131789456|NCT02008721|474512665|FG000|Overall Study|Protocol Violation|3|||
131789457|NCT02008721|474512666|FG001|Overall Study|Protocol Violation|2|||
131789458|NCT01797120|474512669|FG000|Overall Study|Disesae progression|37|||
131789459|NCT01797120|474512670|FG001|Overall Study|Disesae progression|49|||
131789460|NCT01797120|474512669|FG000|Overall Study|Adverse Event|13|||
131789461|NCT01797120|474512670|FG001|Overall Study|Adverse Event|5|||
131789462|NCT01797120|474512669|FG000|Overall Study|Withdrawal by Subject|6|||
131789463|NCT01797120|474512670|FG001|Overall Study|Withdrawal by Subject|6|||
131789464|NCT01797120|474512669|FG000|Overall Study|Symptomatic progression|2|||
131789465|NCT01797120|474512670|FG001|Overall Study|Symptomatic progression|1|||
131789466|NCT01797120|474512669|FG000|Overall Study|Non-compliance|1|||
131789467|NCT01797120|474512670|FG001|Overall Study|Non-compliance|0|||
131438696|NCT00948064|473233279|FG002|Phase I|No treatment received|0|||
131438697|NCT00948064|473233277|FG000|Phase II|Physician Decision|0|||
131438698|NCT00948064|473233278|FG001|Phase II|Physician Decision|0|||
131789468|NCT01797120|474512669|FG000|Overall Study|Physician Decision|3|||
131438699|NCT00948064|473233279|FG002|Phase II|Physician Decision|1|||
131704444|NCT02804763|474200723|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
131789469|NCT01797120|474512670|FG001|Overall Study|Physician Decision|0|||
131789470|NCT01797120|474512669|FG000|Overall Study|still on treatment|2|||
131789471|NCT01797120|474512670|FG001|Overall Study|still on treatment|4|||
131789472|NCT01797120|474512669|FG000|Overall Study|never start protocol therapy|2|||
131583840|NCT00293293|473766469|FG000|Overall Study|Withdrawal by Subject|1|||
131583841|NCT00293293|473766470|FG001|Overall Study|Withdrawal by Subject|1|||
131583842|NCT00293293|473766469|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
131583843|NCT00293293|473766470|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
131583844|NCT00293293|473766469|FG000|Overall Study|Patient discontinued chemotherapy|0|||
131583845|NCT00293293|473766470|FG001|Overall Study|Patient discontinued chemotherapy|1|||
131583846|NCT02512965|473766473|FG000|Overall Study|Withdrawal by Subject|0|||
131583847|NCT02512965|473766474|FG001|Overall Study|Withdrawal by Subject|4|||
131583848|NCT00835770|473766475|FG000|Overall Study|MS Relapse|17|||
131583849|NCT00835770|473766476|FG001|Overall Study|MS Relapse|23|||
131583850|NCT00835770|473766475|FG000|Overall Study|MS Progression|14|||
131583851|NCT00835770|473766476|FG001|Overall Study|MS Progression|9|||
131704445|NCT02804763|474200724|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
131704446|NCT02804763|474200725|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
131704447|NCT02804763|474200722|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
131704448|NCT02804763|474200723|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
131704449|NCT02804763|474200724|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
131704450|NCT02804763|474200725|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
131704451|NCT02804763|474200722|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
131704452|NCT02804763|474200723|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
131704453|NCT02804763|474200724|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
131704454|NCT02804763|474200725|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
131704455|NCT01254669|474200726|FG000|Overall Study|Withdrawal by Subject|0|||
131704456|NCT01254669|474200727|FG001|Overall Study|Withdrawal by Subject|1|||
131704457|NCT01254669|474200726|FG000|Overall Study|time constraint|2|||
131704458|NCT01254669|474200727|FG001|Overall Study|time constraint|2|||
131704459|NCT01254669|474200726|FG000|Overall Study|called to clinic during intervention|1|||
131704460|NCT01254669|474200727|FG001|Overall Study|called to clinic during intervention|1|||
131704461|NCT02522767|474200728|FG000|Double-blind|Withdrawal by Subject|8|||
131704462|NCT02522767|474200729|FG001|Double-blind|Withdrawal by Subject|11|||
131704463|NCT02522767|474200728|FG000|Double-blind|Lost to Follow-up|1|||
131704464|NCT02522767|474200729|FG001|Double-blind|Lost to Follow-up|0|||
131704465|NCT02522767|474200728|FG000|Double-blind|Adverse Event|1|||
131704466|NCT02522767|474200729|FG001|Double-blind|Adverse Event|10|||
131704467|NCT02522767|474200728|FG000|Double-blind|Protocol Violation|0|||
131704468|NCT02522767|474200729|FG001|Double-blind|Protocol Violation|1|||
131704469|NCT02522767|474200728|FG000|Double-blind|Lack of Efficacy|0|||
131704470|NCT02522767|474200729|FG001|Double-blind|Lack of Efficacy|2|||
131704471|NCT02522767|474200728|FG000|Double-blind|Protocol Deviation|1|||
131704472|NCT02522767|474200729|FG001|Double-blind|Protocol Deviation|0|||
131704473|NCT02522767|474200728|FG000|Open-label|Withdrawal by Subject|2|||
131704474|NCT02522767|474200729|FG001|Open-label|Withdrawal by Subject|3|||
131583852|NCT00835770|473766475|FG000|Overall Study|Adverse Event|113|||
131583853|NCT00835770|473766476|FG001|Overall Study|Adverse Event|124|||
131583854|NCT00835770|473766475|FG000|Overall Study|Lost to Follow-up|22|||
131583855|NCT00835770|473766476|FG001|Overall Study|Lost to Follow-up|19|||
131704475|NCT02522767|474200728|FG000|Open-label|Lost to Follow-up|0|||
131438700|NCT00948064|473233277|FG000|Phase II|Withdrawal by Subject|0|||
131438701|NCT00948064|473233278|FG001|Phase II|Withdrawal by Subject|1|||
131789473|NCT01797120|474512670|FG001|Overall Study|never start protocol therapy|0|||
131438702|NCT00948064|473233279|FG002|Phase II|Withdrawal by Subject|0|||
131438703|NCT03525444|473233280|FG000|Overall Study|Adverse Event|0|||
131438704|NCT03525444|473233281|FG001|Overall Study|Adverse Event|1|||
131438705|NCT03525444|473233280|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131438706|NCT03525444|473233281|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
131438707|NCT03525444|473233280|FG000|Overall Study|Other|0|||
131438708|NCT03525444|473233281|FG001|Overall Study|Other|1|||
131438709|NCT02741128|473233282|FG000|Overall Study|Protocol Violation|4|||
131438710|NCT02741128|473233283|FG001|Overall Study|Protocol Violation|1|||
131438711|NCT02741128|473233282|FG000|Overall Study|Withdrawal by Subject|2|||
131438712|NCT02741128|473233283|FG001|Overall Study|Withdrawal by Subject|0|||
131438713|NCT02741128|473233282|FG000|Overall Study|Lost to Follow-up|1|||
131438714|NCT02741128|473233283|FG001|Overall Study|Lost to Follow-up|0|||
131438715|NCT02973100|473233284|FG000|Overall Study|Adverse Event|1|||
131438716|NCT02973100|473233285|FG001|Overall Study|Adverse Event|2|||
131438717|NCT02973100|473233286|FG002|Overall Study|Adverse Event|1|||
131438718|NCT02973100|473233287|FG003|Overall Study|Adverse Event|2|||
131438719|NCT02973100|473233284|FG000|Overall Study|Lost to Follow-up|3|||
131438720|NCT02973100|473233285|FG001|Overall Study|Lost to Follow-up|1|||
131438721|NCT02973100|473233286|FG002|Overall Study|Lost to Follow-up|1|||
131438722|NCT02973100|473233287|FG003|Overall Study|Lost to Follow-up|0|||
131438723|NCT02973100|473233284|FG000|Overall Study|Withdrawal by Subject|3|||
131438724|NCT02973100|473233285|FG001|Overall Study|Withdrawal by Subject|5|||
131438725|NCT02973100|473233286|FG002|Overall Study|Withdrawal by Subject|1|||
131438726|NCT02973100|473233287|FG003|Overall Study|Withdrawal by Subject|4|||
131438727|NCT02973100|473233284|FG000|Overall Study|Notification of change in address|0|||
131438728|NCT02973100|473233285|FG001|Overall Study|Notification of change in address|0|||
131438729|NCT02973100|473233286|FG002|Overall Study|Notification of change in address|0|||
131438730|NCT02973100|473233287|FG003|Overall Study|Notification of change in address|1|||
131438731|NCT02973100|473233284|FG000|Overall Study|Failed to attend Safety followup period|0|||
131438732|NCT02973100|473233285|FG001|Overall Study|Failed to attend Safety followup period|0|||
131438733|NCT02973100|473233286|FG002|Overall Study|Failed to attend Safety followup period|1|||
131438734|NCT02973100|473233287|FG003|Overall Study|Failed to attend Safety followup period|0|||
131438735|NCT01419769|473233288|FG000|Overall Study|Did not receive the AXIOS stent|3|||
131438736|NCT01419769|473233288|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
131438737|NCT00878501|473233289|FG000|Overall Study|Adverse Event|11|||
131438738|NCT00878501|473233290|FG001|Overall Study|Adverse Event|3|||
131438739|NCT00878501|473233291|FG002|Overall Study|Adverse Event|3|||
131438740|NCT00878501|473233289|FG000|Overall Study|Lack of Efficacy|2|||
131438741|NCT00878501|473233290|FG001|Overall Study|Lack of Efficacy|1|||
131438742|NCT00878501|473233291|FG002|Overall Study|Lack of Efficacy|0|||
131438743|NCT00878501|473233289|FG000|Overall Study|Withdrawal by Subject|2|||
131438744|NCT00878501|473233290|FG001|Overall Study|Withdrawal by Subject|1|||
131438745|NCT00878501|473233291|FG002|Overall Study|Withdrawal by Subject|2|||
131438746|NCT00878501|473233289|FG000|Overall Study|Protocol Violation|0|||
131438747|NCT00878501|473233290|FG001|Overall Study|Protocol Violation|0|||
131438748|NCT00878501|473233291|FG002|Overall Study|Protocol Violation|1|||
131789474|NCT00033631|474512676|FG000|Overall Study|Protocol Violation|14|||
131789475|NCT00033631|474512677|FG001|Overall Study|Protocol Violation|11|||
131789476|NCT00033631|474512676|FG000|Overall Study|Withdrawal by Subject|4|||
131789477|NCT00033631|474512677|FG001|Overall Study|Withdrawal by Subject|4|||
131789478|NCT00078819|474512678|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
131789479|NCT00078819|474512679|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
131789480|NCT00078819|474512680|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
131789481|NCT00078819|474512681|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
131789482|NCT00078819|474512678|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
131789483|NCT00078819|474512679|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
131789484|NCT00078819|474512680|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
131438749|NCT00878501|473233289|FG000|Overall Study|Incorrect enrolment|1|||
131438750|NCT00878501|473233290|FG001|Overall Study|Incorrect enrolment|2|||
131438751|NCT00878501|473233291|FG002|Overall Study|Incorrect enrolment|0|||
131438752|NCT00878501|473233289|FG000|Overall Study|Intake of prohibited concom. medication|0|||
131438753|NCT00878501|473233290|FG001|Overall Study|Intake of prohibited concom. medication|0|||
131438754|NCT00878501|473233291|FG002|Overall Study|Intake of prohibited concom. medication|1|||
131438755|NCT00878501|473233289|FG000|Overall Study|Mis-randomisation of patient|1|||
131789485|NCT00078819|474512681|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
131438756|NCT00878501|473233290|FG001|Overall Study|Mis-randomisation of patient|0|||
131438757|NCT00878501|473233291|FG002|Overall Study|Mis-randomisation of patient|0|||
131438758|NCT00878501|473233289|FG000|Overall Study|Administrative|0|||
131438759|NCT00878501|473233290|FG001|Overall Study|Administrative|0|||
131438760|NCT00878501|473233291|FG002|Overall Study|Administrative|1|||
131583856|NCT00835770|473766475|FG000|Overall Study|Consent Withdrawn|144|||
131583857|NCT00835770|473766476|FG001|Overall Study|Consent Withdrawn|156|||
131583858|NCT00835770|473766475|FG000|Overall Study|Investigator Decision|42|||
131583859|NCT00835770|473766476|FG001|Overall Study|Investigator Decision|42|||
131583860|NCT00835770|473766475|FG000|Overall Study|Participant Non-Compliance|11|||
131583861|NCT00835770|473766476|FG001|Overall Study|Participant Non-Compliance|9|||
131583862|NCT00835770|473766475|FG000|Overall Study|Death|4|||
131583863|NCT00835770|473766476|FG001|Overall Study|Death|6|||
131583864|NCT00835770|473766475|FG000|Overall Study|Other|115|||
131583865|NCT00835770|473766476|FG001|Overall Study|Other|104|||
131583866|NCT00835770|473766475|FG000|Overall Study|Other|2|||
131583867|NCT00835770|473766476|FG001|Overall Study|Other|1|||
131583868|NCT01185782|473766477|FG000|Overall Study|Adverse Event|0|||
131583869|NCT01185782|473766478|FG001|Overall Study|Adverse Event|1|||
131583870|NCT01185782|473766477|FG000|Overall Study|Protocol Violation|1|||
131583871|NCT01185782|473766478|FG001|Overall Study|Protocol Violation|0|||
131583872|NCT01185782|473766477|FG000|Overall Study|Poor Response to Treatment|3|||
131583873|NCT01185782|473766478|FG001|Overall Study|Poor Response to Treatment|1|||
131583874|NCT01185782|473766477|FG000|Overall Study|Other|2|||
131583875|NCT01185782|473766478|FG001|Overall Study|Other|5|||
131583876|NCT01185782|473766477|FG000|Overall Study|Randomized but not treated|0|||
131583877|NCT01185782|473766478|FG001|Overall Study|Randomized but not treated|4|||
131583878|NCT02988817|473766483|FG000|Overall Study|Withdrawal by Subject|1|||
131583879|NCT02988817|473766484|FG001|Overall Study|Withdrawal by Subject|0|||
131583880|NCT02988817|473766485|FG002|Overall Study|Withdrawal by Subject|0|||
131583881|NCT02988817|473766486|FG003|Overall Study|Withdrawal by Subject|1|||
131583882|NCT02988817|473766487|FG004|Overall Study|Withdrawal by Subject|3|||
131583883|NCT02988817|473766488|FG005|Overall Study|Withdrawal by Subject|1|||
131583884|NCT02988817|473766489|FG006|Overall Study|Withdrawal by Subject|2|||
131583885|NCT02988817|473766490|FG007|Overall Study|Withdrawal by Subject|1|||
131583886|NCT02988817|473766491|FG008|Overall Study|Withdrawal by Subject|1|||
131583887|NCT02988817|473766492|FG009|Overall Study|Withdrawal by Subject|1|||
131583888|NCT02988817|473766493|FG010|Overall Study|Withdrawal by Subject|1|||
131583889|NCT02988817|473766494|FG011|Overall Study|Withdrawal by Subject|12|||
131583890|NCT02988817|473766495|FG012|Overall Study|Withdrawal by Subject|6|||
131583891|NCT02988817|473766496|FG013|Overall Study|Withdrawal by Subject|6|||
131583892|NCT02988817|473766497|FG014|Overall Study|Withdrawal by Subject|4|||
131583893|NCT02988817|473766498|FG015|Overall Study|Withdrawal by Subject|5|||
131583894|NCT02988817|473766499|FG016|Overall Study|Withdrawal by Subject|4|||
131583895|NCT02988817|473766500|FG017|Overall Study|Withdrawal by Subject|11|||
131583896|NCT02988817|473766501|FG018|Overall Study|Withdrawal by Subject|4|||
131583897|NCT02988817|473766502|FG019|Overall Study|Withdrawal by Subject|2|||
131583898|NCT02988817|473766483|FG000|Overall Study|Death|0|||
131583899|NCT02988817|473766484|FG001|Overall Study|Death|1|||
131583900|NCT02988817|473766485|FG002|Overall Study|Death|3|||
131583901|NCT02988817|473766486|FG003|Overall Study|Death|1|||
131583902|NCT02988817|473766487|FG004|Overall Study|Death|6|||
131583903|NCT02988817|473766488|FG005|Overall Study|Death|10|||
131583904|NCT02988817|473766489|FG006|Overall Study|Death|1|||
131583905|NCT02988817|473766490|FG007|Overall Study|Death|2|||
131583906|NCT02988817|473766491|FG008|Overall Study|Death|1|||
131583907|NCT02988817|473766492|FG009|Overall Study|Death|5|||
131583908|NCT02988817|473766493|FG010|Overall Study|Death|1|||
131583909|NCT02988817|473766494|FG011|Overall Study|Death|8|||
131583910|NCT02988817|473766495|FG012|Overall Study|Death|9|||
131583911|NCT02988817|473766496|FG013|Overall Study|Death|17|||
131583912|NCT02988817|473766497|FG014|Overall Study|Death|18|||
131583913|NCT02988817|473766498|FG015|Overall Study|Death|30|||
131583914|NCT02988817|473766499|FG016|Overall Study|Death|17|||
131583915|NCT02988817|473766500|FG017|Overall Study|Death|38|||
131583916|NCT02988817|473766501|FG018|Overall Study|Death|14|||
131583917|NCT02988817|473766502|FG019|Overall Study|Death|16|||
131583918|NCT02988817|473766483|FG000|Overall Study|Other|0|||
131583919|NCT02988817|473766484|FG001|Overall Study|Other|0|||
131583920|NCT02988817|473766485|FG002|Overall Study|Other|0|||
131583921|NCT02988817|473766486|FG003|Overall Study|Other|1|||
131583922|NCT02988817|473766487|FG004|Overall Study|Other|1|||
131583923|NCT02988817|473766488|FG005|Overall Study|Other|0|||
131583924|NCT02988817|473766489|FG006|Overall Study|Other|0|||
131583925|NCT02988817|473766490|FG007|Overall Study|Other|0|||
131583926|NCT02988817|473766491|FG008|Overall Study|Other|0|||
131583927|NCT02988817|473766492|FG009|Overall Study|Other|0|||
131583928|NCT02988817|473766493|FG010|Overall Study|Other|0|||
131583929|NCT02988817|473766494|FG011|Overall Study|Other|0|||
131583930|NCT02988817|473766495|FG012|Overall Study|Other|0|||
131583931|NCT02988817|473766496|FG013|Overall Study|Other|0|||
131583932|NCT02988817|473766497|FG014|Overall Study|Other|0|||
131583933|NCT02988817|473766498|FG015|Overall Study|Other|1|||
131583934|NCT02988817|473766499|FG016|Overall Study|Other|0|||
131583935|NCT02988817|473766500|FG017|Overall Study|Other|0|||
131583936|NCT02988817|473766501|FG018|Overall Study|Other|0|||
131583937|NCT02988817|473766502|FG019|Overall Study|Other|0|||
131583938|NCT02988817|473766483|FG000|Overall Study|Lost to Follow-up|0|||
131583939|NCT02988817|473766484|FG001|Overall Study|Lost to Follow-up|0|||
131583940|NCT02988817|473766485|FG002|Overall Study|Lost to Follow-up|0|||
131583941|NCT02988817|473766486|FG003|Overall Study|Lost to Follow-up|0|||
131583942|NCT02988817|473766487|FG004|Overall Study|Lost to Follow-up|0|||
131583943|NCT02988817|473766488|FG005|Overall Study|Lost to Follow-up|0|||
131583944|NCT02988817|473766489|FG006|Overall Study|Lost to Follow-up|0|||
131583945|NCT02988817|473766490|FG007|Overall Study|Lost to Follow-up|0|||
131583946|NCT02988817|473766491|FG008|Overall Study|Lost to Follow-up|1|||
131583947|NCT02988817|473766492|FG009|Overall Study|Lost to Follow-up|0|||
131583948|NCT02988817|473766493|FG010|Overall Study|Lost to Follow-up|1|||
131583949|NCT02988817|473766494|FG011|Overall Study|Lost to Follow-up|1|||
131583950|NCT02988817|473766495|FG012|Overall Study|Lost to Follow-up|0|||
131583951|NCT02988817|473766496|FG013|Overall Study|Lost to Follow-up|0|||
131583952|NCT02988817|473766497|FG014|Overall Study|Lost to Follow-up|1|||
131583953|NCT02988817|473766498|FG015|Overall Study|Lost to Follow-up|1|||
131583954|NCT02988817|473766499|FG016|Overall Study|Lost to Follow-up|2|||
131583955|NCT02988817|473766500|FG017|Overall Study|Lost to Follow-up|3|||
131583956|NCT02988817|473766501|FG018|Overall Study|Lost to Follow-up|0|||
131583957|NCT02988817|473766502|FG019|Overall Study|Lost to Follow-up|0|||
131583958|NCT02988817|473766483|FG000|Overall Study|Sponsor decision|0|||
131583959|NCT02988817|473766484|FG001|Overall Study|Sponsor decision|0|||
131583960|NCT02988817|473766485|FG002|Overall Study|Sponsor decision|0|||
131583961|NCT02988817|473766486|FG003|Overall Study|Sponsor decision|0|||
131583962|NCT02988817|473766487|FG004|Overall Study|Sponsor decision|0|||
131583963|NCT02988817|473766488|FG005|Overall Study|Sponsor decision|0|||
131583964|NCT02988817|473766489|FG006|Overall Study|Sponsor decision|0|||
131583965|NCT02988817|473766490|FG007|Overall Study|Sponsor decision|0|||
131583966|NCT02988817|473766491|FG008|Overall Study|Sponsor decision|0|||
131583967|NCT02988817|473766492|FG009|Overall Study|Sponsor decision|0|||
131583968|NCT02988817|473766493|FG010|Overall Study|Sponsor decision|0|||
131583969|NCT02988817|473766494|FG011|Overall Study|Sponsor decision|1|||
131583970|NCT02988817|473766495|FG012|Overall Study|Sponsor decision|1|||
131583971|NCT02988817|473766496|FG013|Overall Study|Sponsor decision|2|||
131583972|NCT02988817|473766497|FG014|Overall Study|Sponsor decision|2|||
131583973|NCT02988817|473766498|FG015|Overall Study|Sponsor decision|6|||
131583974|NCT02988817|473766499|FG016|Overall Study|Sponsor decision|2|||
131583975|NCT02988817|473766500|FG017|Overall Study|Sponsor decision|3|||
131583976|NCT02988817|473766501|FG018|Overall Study|Sponsor decision|2|||
131789486|NCT00078819|474512678|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
131789487|NCT00078819|474512679|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
131789488|NCT00078819|474512680|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
131789489|NCT00078819|474512681|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
131789490|NCT00078819|474512678|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
131789491|NCT00078819|474512679|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
131789492|NCT00078819|474512680|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
131789493|NCT00078819|474512681|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
131583977|NCT02988817|473766502|FG019|Overall Study|Sponsor decision|7|||
131789494|NCT00078819|474512678|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
131789495|NCT00078819|474512679|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
131789496|NCT00078819|474512680|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
131789497|NCT00078819|474512681|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
131789498|NCT00078819|474512678|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
131789499|NCT00078819|474512679|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
131789500|NCT00078819|474512680|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
131789501|NCT00078819|474512681|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
131789502|NCT00078819|474512678|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
131789503|NCT00078819|474512679|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
131789504|NCT00078819|474512680|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
131789505|NCT00078819|474512681|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
131583978|NCT02988817|473766483|FG000|Overall Study|Physician Decision|0|||
131789506|NCT00078819|474512678|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
131789507|NCT00078819|474512679|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
131583979|NCT02988817|473766484|FG001|Overall Study|Physician Decision|0|||
131583980|NCT02988817|473766485|FG002|Overall Study|Physician Decision|0|||
131789508|NCT00078819|474512680|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
131583981|NCT02988817|473766486|FG003|Overall Study|Physician Decision|0|||
131583982|NCT02988817|473766487|FG004|Overall Study|Physician Decision|0|||
131789509|NCT00078819|474512681|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
131583983|NCT02988817|473766488|FG005|Overall Study|Physician Decision|0|||
131583984|NCT02988817|473766489|FG006|Overall Study|Physician Decision|0|||
131583985|NCT02988817|473766490|FG007|Overall Study|Physician Decision|0|||
131583986|NCT02988817|473766491|FG008|Overall Study|Physician Decision|0|||
131583987|NCT02988817|473766492|FG009|Overall Study|Physician Decision|0|||
131583988|NCT02988817|473766493|FG010|Overall Study|Physician Decision|0|||
131583989|NCT02988817|473766494|FG011|Overall Study|Physician Decision|0|||
131789510|NCT00667719|474512682|FG000|Overall Study|Adverse Event|39|||
131789511|NCT00667719|474512682|FG000|Overall Study|Abnormal Test Procedure|1|||
131789512|NCT00667719|474512682|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131789513|NCT00667719|474512682|FG000|Overall Study|Protocol Violation|3|||
131789514|NCT00667719|474512682|FG000|Overall Study|Withdrawal by Subject|17|||
131789515|NCT00667719|474512682|FG000|Overall Study|Lost to Follow-up|8|||
131789516|NCT00323609|474512683|FG000|Overall Study|Death|16|||
131583990|NCT02988817|473766495|FG012|Overall Study|Physician Decision|0|||
131583991|NCT02988817|473766496|FG013|Overall Study|Physician Decision|0|||
131583992|NCT02988817|473766497|FG014|Overall Study|Physician Decision|0|||
131583993|NCT02988817|473766498|FG015|Overall Study|Physician Decision|1|||
131583994|NCT02988817|473766499|FG016|Overall Study|Physician Decision|0|||
131583995|NCT02988817|473766500|FG017|Overall Study|Physician Decision|0|||
131583996|NCT02988817|473766501|FG018|Overall Study|Physician Decision|1|||
131583997|NCT02988817|473766502|FG019|Overall Study|Physician Decision|1|||
131583998|NCT04530747|473766511|FG000|Overall Study|Withdrawal by Subject|1|||
131583999|NCT04530747|473766512|FG001|Overall Study|Withdrawal by Subject|0|||
131584000|NCT03292913|473766513|FG000|Overall Study|Death|9|||
131584001|NCT03292913|473766514|FG001|Overall Study|Death|3|||
131584002|NCT03292913|473766513|FG000|Overall Study|Lost to Follow-up|49|||
131584003|NCT03292913|473766514|FG001|Overall Study|Lost to Follow-up|49|||
131584004|NCT03292913|473766513|FG000|Overall Study|Withdrawal by Subject|2|||
131584005|NCT03292913|473766514|FG001|Overall Study|Withdrawal by Subject|0|||
131584006|NCT03292913|473766513|FG000|Overall Study|Clinic closed due to COVID|22|||
131584007|NCT03292913|473766514|FG001|Overall Study|Clinic closed due to COVID|36|||
131584008|NCT03950622|473766515|FG000|Overall Study|Withdrawal by Subject|1|||
131584009|NCT03950622|473766516|FG001|Overall Study|Withdrawal by Subject|0|||
131584010|NCT03950622|473766515|FG000|Overall Study|Protocol Deviation|0|||
131584011|NCT03950622|473766516|FG001|Overall Study|Protocol Deviation|1|||
131584012|NCT03950622|473766515|FG000|Overall Study|Physician Decision|1|||
131584013|NCT03950622|473766516|FG001|Overall Study|Physician Decision|0|||
131584014|NCT03950622|473766515|FG000|Overall Study|Lost to Follow-up|5|||
131584015|NCT03950622|473766516|FG001|Overall Study|Lost to Follow-up|5|||
131584016|NCT03950622|473766515|FG000|Overall Study|Death|1|||
131584017|NCT03950622|473766516|FG001|Overall Study|Death|1|||
131584018|NCT02092116|473766519|FG000|Overall Study|Withdrawal by Subject|0|||
131584019|NCT02092116|473766520|FG001|Overall Study|Withdrawal by Subject|3|||
131584020|NCT02092116|473766519|FG000|Overall Study|Adverse Event|0|||
131584021|NCT02092116|473766520|FG001|Overall Study|Adverse Event|1|||
131584022|NCT01546753|473766523|FG000|Overall Study|anxiety|1|||
131584023|NCT01546753|473766524|FG001|Overall Study|anxiety|1|||
131584024|NCT01546753|473766523|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
131584025|NCT01546753|473766524|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
131584026|NCT00939510|473766525|FG000|Overall Study|Withdrawal by Subject|1|||
131584027|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
131584028|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
131584029|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
131584030|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
131584031|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
131584032|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
131584033|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
131584034|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
131584035|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
131584036|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
131584037|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
131584038|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
131584039|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
131584040|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
131584041|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
131584042|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
131584043|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
131584044|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
131584045|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
131584046|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
131584047|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
131584048|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
131584049|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
131584050|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
131584051|NCT00311363|473766540|FG000|24-Week Single-Blind Treatment Period|Death|1|||
131584052|NCT00311363|473766541|FG001|24-Week Single-Blind Treatment Period|Death|0|||
131584053|NCT00311363|473766542|FG002|24-Week Single-Blind Treatment Period|Death|0|||
131584054|NCT00311363|473766540|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
131584055|NCT00311363|473766541|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
131584056|NCT00311363|473766542|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
131584057|NCT00311363|473766540|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
131584058|NCT00311363|473766541|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
131584059|NCT00311363|473766542|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
131584060|NCT00311363|473766540|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
131584061|NCT00311363|473766541|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
131584062|NCT00311363|473766542|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
131584063|NCT00311363|473766540|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
131584064|NCT00311363|473766541|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
131584065|NCT00311363|473766542|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
131584066|NCT00311363|473766540|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
131584067|NCT00311363|473766541|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
131584068|NCT00311363|473766542|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
131584069|NCT00311363|473766540|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
131584070|NCT00311363|473766541|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
131584071|NCT00311363|473766542|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
131584072|NCT00988858|473766545|FG000|Overall Study|Adverse Event|7|||
131584073|NCT00988858|473766545|FG000|Overall Study|Death|1|||
131584074|NCT00988858|473766545|FG000|Overall Study|Physician Decision|1|||
131584075|NCT00988858|473766545|FG000|Overall Study|Sponsor Decision|1|||
131584076|NCT05510245|473766549|FG000|Overall Study|Withdrawal by Subject|1|||
131584077|NCT05510245|473766550|FG001|Overall Study|Withdrawal by Subject|0|||
131584078|NCT05510245|473766551|FG002|Overall Study|Withdrawal by Subject|0|||
131584079|NCT01759771|473766559|FG000|Overall Study|Withdrawal by Subject|1|||
131584080|NCT01759771|473766560|FG001|Overall Study|Withdrawal by Subject|1|||
131584081|NCT02528188|473766561|FG000|Overall Study|Adverse Event|23|||
131584082|NCT02528188|473766562|FG001|Overall Study|Adverse Event|22|||
131584083|NCT02528188|473766563|FG002|Overall Study|Adverse Event|8|||
131584084|NCT02528188|473766561|FG000|Overall Study|Protocol Violation|4|||
131584085|NCT02528188|473766562|FG001|Overall Study|Protocol Violation|6|||
131584086|NCT02528188|473766563|FG002|Overall Study|Protocol Violation|4|||
131584087|NCT02528188|473766561|FG000|Overall Study|Lack of Efficacy|19|||
131584088|NCT02528188|473766562|FG001|Overall Study|Lack of Efficacy|21|||
131584089|NCT02528188|473766563|FG002|Overall Study|Lack of Efficacy|22|||
131584090|NCT02528188|473766561|FG000|Overall Study|Withdrawal by Subject|97|||
131584091|NCT02528188|473766562|FG001|Overall Study|Withdrawal by Subject|104|||
131584092|NCT02528188|473766563|FG002|Overall Study|Withdrawal by Subject|100|||
131584093|NCT02528188|473766561|FG000|Overall Study|Lost to Follow-up|25|||
131584094|NCT02528188|473766562|FG001|Overall Study|Lost to Follow-up|21|||
131584095|NCT02528188|473766563|FG002|Overall Study|Lost to Follow-up|31|||
131584096|NCT02528188|473766561|FG000|Overall Study|Death|4|||
131584097|NCT02528188|473766562|FG001|Overall Study|Death|4|||
131584098|NCT02528188|473766563|FG002|Overall Study|Death|0|||
131584099|NCT02528188|473766561|FG000|Overall Study|Other|89|||
131584100|NCT02528188|473766562|FG001|Overall Study|Other|91|||
131584101|NCT02528188|473766563|FG002|Overall Study|Other|74|||
131584102|NCT02528188|473766561|FG000|Overall Study|Randomized but not treated|6|||
131584103|NCT02528188|473766562|FG001|Overall Study|Randomized but not treated|7|||
131584104|NCT02528188|473766563|FG002|Overall Study|Randomized but not treated|12|||
131584105|NCT01061671|473766564|FG000|Overall Study|Withdrawal by Subject|16|||
131584106|NCT01061671|473766565|FG001|Overall Study|Withdrawal by Subject|20|||
131584107|NCT01061671|473766564|FG000|Overall Study|Lost to Follow-up|3|||
131584108|NCT01061671|473766565|FG001|Overall Study|Lost to Follow-up|5|||
131584109|NCT01061671|473766564|FG000|Overall Study|Death|28|||
131584110|NCT01061671|473766565|FG001|Overall Study|Death|30|||
131584111|NCT00223795|473766566|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
131584112|NCT00223795|473766567|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
131584113|NCT00223795|473766566|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
131584114|NCT00223795|473766567|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
131704476|NCT02522767|474200729|FG001|Open-label|Lost to Follow-up|1|||
131704477|NCT02522767|474200728|FG000|Open-label|Adverse Event|2|||
131704478|NCT02522767|474200729|FG001|Open-label|Adverse Event|1|||
131704479|NCT02522767|474200728|FG000|Open-label|Lack of Efficacy|1|||
131704480|NCT02522767|474200729|FG001|Open-label|Lack of Efficacy|1|||
131704481|NCT02522767|474200728|FG000|Open-label|Protocol Violation|0|||
131704482|NCT02522767|474200729|FG001|Open-label|Protocol Violation|1|||
131704483|NCT00548548|474200730|FG000|Overall Study|Death|345|||
131704484|NCT00548548|474200731|FG001|Overall Study|Death|348|||
131704485|NCT00548548|474200730|FG000|Overall Study|Lost to Follow-up|17|||
131584115|NCT02139943|473766568|FG000|Overall Study|Adverse Event|0|||
131584116|NCT02139943|473766569|FG001|Overall Study|Adverse Event|1|||
131584117|NCT02139943|473766570|FG002|Overall Study|Adverse Event|2|||
131584118|NCT02139943|473766568|FG000|Overall Study|Lost to Follow-up|3|||
131584119|NCT02139943|473766569|FG001|Overall Study|Lost to Follow-up|2|||
131584120|NCT02139943|473766570|FG002|Overall Study|Lost to Follow-up|2|||
131584121|NCT02139943|473766568|FG000|Overall Study|Withdrawal by Subject|4|||
131584122|NCT02139943|473766569|FG001|Overall Study|Withdrawal by Subject|3|||
131584123|NCT02139943|473766570|FG002|Overall Study|Withdrawal by Subject|0|||
131704486|NCT00548548|474200731|FG001|Overall Study|Lost to Follow-up|18|||
131704487|NCT04088409|474200732|FG000|Part A|Withdrawal by Subject|2|||
131584124|NCT02139943|473766568|FG000|Overall Study|Other|0|||
131584125|NCT02139943|473766569|FG001|Overall Study|Other|0|||
131584126|NCT02139943|473766570|FG002|Overall Study|Other|1|||
131584127|NCT02139943|473766568|FG000|Overall Study|Participant wishes to discontinue|2|||
131584128|NCT02139943|473766569|FG001|Overall Study|Participant wishes to discontinue|0|||
131584129|NCT02139943|473766570|FG002|Overall Study|Participant wishes to discontinue|0|||
131584130|NCT02139943|473766568|FG000|Overall Study|Participant in Poor Compliance|1|||
131584131|NCT02139943|473766569|FG001|Overall Study|Participant in Poor Compliance|0|||
131584132|NCT02139943|473766570|FG002|Overall Study|Participant in Poor Compliance|1|||
131584133|NCT02139943|473766568|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
131438761|NCT00812708|473233292|FG000|Overall Study|Device could not be implanted|2|||
131584134|NCT02139943|473766569|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
131584135|NCT02139943|473766570|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
131584136|NCT04411056|473768100|FG000|Overall Study|surgery cancelled|1|||
131584137|NCT04411056|473768101|FG001|Overall Study|surgery cancelled|0|||
131584138|NCT04411056|473768100|FG000|Overall Study|Equipment problem during intubation|0|||
131584139|NCT04411056|473768101|FG001|Overall Study|Equipment problem during intubation|1|||
131584140|NCT03122886|473768104|FG000|Overall Study|Withdrawal by Subject|1|||
131584141|NCT03122886|473768105|FG001|Overall Study|Withdrawal by Subject|2|||
131584142|NCT03422276|473768106|FG000|Overall Study|Withdrawal by Subject|21|||
131584143|NCT03422276|473768107|FG001|Overall Study|Withdrawal by Subject|25|||
131584144|NCT03422276|473768108|FG002|Overall Study|Withdrawal by Subject|14|||
131584145|NCT03422276|473768109|FG003|Overall Study|Withdrawal by Subject|16|||
131584146|NCT03422276|473768106|FG000|Overall Study|Death|14|||
131584147|NCT03422276|473768107|FG001|Overall Study|Death|21|||
131584148|NCT03422276|473768108|FG002|Overall Study|Death|3|||
131584149|NCT03422276|473768109|FG003|Overall Study|Death|1|||
131584150|NCT03422276|473768106|FG000|Overall Study|Discontinued, ineligible|4|||
131584151|NCT03422276|473768107|FG001|Overall Study|Discontinued, ineligible|3|||
131584152|NCT03422276|473768108|FG002|Overall Study|Discontinued, ineligible|0|||
131584153|NCT03422276|473768109|FG003|Overall Study|Discontinued, ineligible|0|||
131584154|NCT03422276|473768106|FG000|Overall Study|Lost to Follow-up|15|||
131584155|NCT03422276|473768107|FG001|Overall Study|Lost to Follow-up|8|||
131584156|NCT03422276|473768108|FG002|Overall Study|Lost to Follow-up|13|||
131584157|NCT03422276|473768109|FG003|Overall Study|Lost to Follow-up|4|||
131584158|NCT03422276|473768106|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
131584159|NCT03422276|473768107|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
131584160|NCT03422276|473768108|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
131584161|NCT03422276|473768109|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
131584162|NCT03422276|473768106|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
131584163|NCT03422276|473768107|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
131584164|NCT03422276|473768108|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
131584165|NCT03422276|473768109|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
131584166|NCT03422276|473768106|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
131584167|NCT03422276|473768107|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
131584168|NCT03422276|473768108|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
131584169|NCT03422276|473768109|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
131584170|NCT03422276|473768106|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
131584171|NCT03422276|473768107|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
131584172|NCT03422276|473768108|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
131584173|NCT03422276|473768109|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
131584174|NCT03422276|473768106|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
131584175|NCT03422276|473768107|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
131584176|NCT03422276|473768108|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
131584177|NCT03422276|473768109|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
131584178|NCT05985044|473768110|FG000|Overall Study|Death|6|||
131584179|NCT05985044|473768110|FG000|Overall Study|Lost to Follow-up|4|||
131584180|NCT05985044|473768110|FG000|Overall Study|Incapacitation|3|||
131584181|NCT05985044|473768110|FG000|Overall Study|Withdrawal by Subject|2|||
131584182|NCT02279095|473768113|FG000|Overall Study|Non-Compliance|1|||
131584183|NCT02279095|473768113|FG000|Overall Study|Withdrawal by Subject|8|||
131584184|NCT02279095|473768113|FG000|Overall Study|Adverse Event|2|||
131584185|NCT02279095|473768113|FG000|Overall Study|Other|7|||
131704488|NCT04088409|474200733|FG001|Part A|Withdrawal by Subject|1|||
131704489|NCT04088409|474200732|FG000|Part A|Did Not Meet Randomization Criteria|2|||
131704490|NCT04088409|474200733|FG001|Part A|Did Not Meet Randomization Criteria|0|||
131438762|NCT00812708|473233292|FG000|Overall Study|Lack of medical insurance|1|||
131584186|NCT02279095|473768113|FG000|Overall Study|Lost to Follow-up|1|||
131584187|NCT05938413|473768114|FG000|Overall Study|Lost to Follow-up|1|||
131584188|NCT05938413|473768115|FG001|Overall Study|Lost to Follow-up|7|||
131584189|NCT05938413|473768114|FG000|Overall Study|Withdrawal by Subject|1|||
131584190|NCT05938413|473768115|FG001|Overall Study|Withdrawal by Subject|1|||
131584191|NCT02675244|473768125|FG000|Overall Study|Death|9|||
131584192|NCT02675244|473768126|FG001|Overall Study|Death|6|||
131584193|NCT02675244|473768125|FG000|Overall Study|Withdrawal by Subject|3|||
131584194|NCT02675244|473768126|FG001|Overall Study|Withdrawal by Subject|6|||
131584195|NCT02675244|473768125|FG000|Overall Study|Lost to Follow-up|1|||
131584196|NCT02675244|473768126|FG001|Overall Study|Lost to Follow-up|1|||
131584197|NCT02675244|473768125|FG000|Overall Study|Ongoing at 2 Years|190|||
131584198|NCT02675244|473768126|FG001|Overall Study|Ongoing at 2 Years|185|||
131584199|NCT01839331|473768129|FG000|Overall Study|Early Termination|3|||
131584200|NCT01839331|473768130|FG001|Overall Study|Early Termination|0|||
131584201|NCT01839331|473768131|FG002|Overall Study|Early Termination|1|||
131584202|NCT01839331|473768132|FG003|Overall Study|Early Termination|2|||
131584203|NCT01839331|473768129|FG000|Overall Study|Protocol Violation|1|||
131584204|NCT01839331|473768130|FG001|Overall Study|Protocol Violation|6|||
131584205|NCT01839331|473768131|FG002|Overall Study|Protocol Violation|4|||
131584206|NCT01839331|473768132|FG003|Overall Study|Protocol Violation|3|||
131584207|NCT03752151|473768133|FG000|Overall Study|Withdrawal by Subject|1|||
131584208|NCT03752151|473768133|FG000|Overall Study|Protocol Violation|1|||
131584209|NCT04056624|473768134|FG000|Overall Study|Withdrawal by Subject|0|||
131584210|NCT04056624|473768135|FG001|Overall Study|Withdrawal by Subject|0|||
131584211|NCT04056624|473768136|FG002|Overall Study|Withdrawal by Subject|1|||
131584212|NCT04056624|473768134|FG000|Overall Study|Protocol Violation|1|||
131584213|NCT04056624|473768135|FG001|Overall Study|Protocol Violation|2|||
131584214|NCT04056624|473768136|FG002|Overall Study|Protocol Violation|0|||
131584215|NCT03051165|473768139|FG000|Overall Study|Withdrawal by Subject|1|||
131584216|NCT03051165|473768139|FG000|Overall Study|Early termination of study|12|||
131584217|NCT03531840|473768141|FG000|Overall Study|Death on study|3|||
131584218|NCT03531840|473768142|FG001|Overall Study|Death on study|2|||
131584219|NCT03531840|473768143|FG002|Overall Study|Death on study|1|||
131584220|NCT03531840|473768144|FG003|Overall Study|Death on study|2|||
131584221|NCT03531840|473768141|FG000|Overall Study|Death during follow up|2|||
131584222|NCT03531840|473768142|FG001|Overall Study|Death during follow up|3|||
131584223|NCT03531840|473768143|FG002|Overall Study|Death during follow up|4|||
131584224|NCT03531840|473768144|FG003|Overall Study|Death during follow up|1|||
131584225|NCT02267824|473768146|FG000|Overall Study|Pregnancy|1|||
131584226|NCT02267824|473768147|FG001|Overall Study|Pregnancy|1|||
131584227|NCT02267824|473768146|FG000|Overall Study|Lost to Follow-up|4|||
131584228|NCT02267824|473768147|FG001|Overall Study|Lost to Follow-up|0|||
131584229|NCT02267824|473768146|FG000|Overall Study|Protocol Violation|3|||
131584230|NCT02267824|473768147|FG001|Overall Study|Protocol Violation|0|||
131584231|NCT02267824|473768146|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
131584232|NCT02267824|473768147|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
131584233|NCT03074331|473768148|FG000|Overall Study|Enrolled but Not Treated|1|||
131584234|NCT03074331|473768148|FG000|Overall Study|Lost to Follow-up|5|||
131584235|NCT03074331|473768148|FG000|Overall Study|Withdrew Consent|1|||
131584236|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
131704491|NCT04088409|474200732|FG000|Part A|Lack of Efficacy|9|||
131704492|NCT04088409|474200733|FG001|Part A|Lack of Efficacy|0|||
131704493|NCT04088409|474200732|FG000|Part A|Lost to Follow-up|1|||
131704494|NCT04088409|474200733|FG001|Part A|Lost to Follow-up|0|||
131704495|NCT04088409|474200732|FG000|Part A|Adverse Event|1|||
131704496|NCT04088409|474200733|FG001|Part A|Adverse Event|0|||
131704497|NCT04088409|474200732|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
131704498|NCT04088409|474200733|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
131704499|NCT04088409|474200732|FG000|Part B|Ongoing Treatment|10|||
131704500|NCT04088409|474200733|FG001|Part B|Ongoing Treatment|0|||
131704501|NCT00841763|474200734|FG000|Overall Study|Withdrawal by Subject|60|||
131704502|NCT00841763|474200735|FG001|Overall Study|Withdrawal by Subject|17|||
131704503|NCT00841763|474200736|FG002|Overall Study|Withdrawal by Subject|4|||
131704504|NCT00841763|474200737|FG003|Overall Study|Withdrawal by Subject|1|||
131704505|NCT00841763|474200734|FG000|Overall Study|Adverse Event|9|||
131704506|NCT00841763|474200735|FG001|Overall Study|Adverse Event|10|||
131704507|NCT00841763|474200736|FG002|Overall Study|Adverse Event|3|||
131704508|NCT00841763|474200737|FG003|Overall Study|Adverse Event|2|||
131704509|NCT00841763|474200734|FG000|Overall Study|Lost to Follow-up|63|||
131789517|NCT00323609|474512684|FG001|Overall Study|Death|21|||
131584237|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
131584238|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
131584239|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
131584240|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
131584241|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
131704510|NCT00841763|474200735|FG001|Overall Study|Lost to Follow-up|25|||
131704511|NCT00841763|474200736|FG002|Overall Study|Lost to Follow-up|0|||
131584242|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
131584243|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
131584244|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131584245|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131584246|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131584247|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131584248|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
131584249|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
131584250|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131584251|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131584252|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131584253|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131584254|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131584255|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131584256|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131584257|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131584258|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
131584259|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
131584260|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584261|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
131584262|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584263|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584264|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584265|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584266|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584267|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
131584268|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
131584269|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
131584270|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
131584271|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
131584272|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
131584273|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
131584274|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
131584275|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
131584276|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584277|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584278|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584279|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
131584280|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584281|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584282|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584283|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131584284|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131584285|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
131584286|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131584287|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131584288|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
131584289|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131584290|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
131584291|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
131584292|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
131584293|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131584294|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131584295|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131584296|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131584297|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
131584298|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131584299|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131584300|NCT03903822|473768154|FG000|Treatment Phase (6 Weeks)|Other|2|||
131584301|NCT03903822|473768155|FG001|Treatment Phase (6 Weeks)|Other|1|||
131584302|NCT03903822|473768156|FG002|Treatment Phase (6 Weeks)|Other|0|||
131584303|NCT03903822|473768157|FG003|Treatment Phase (6 Weeks)|Other|0|||
131584304|NCT03903822|473768158|FG004|Treatment Phase (6 Weeks)|Other|1|||
131584305|NCT03903822|473768159|FG005|Treatment Phase (6 Weeks)|Other|1|||
131584306|NCT03903822|473768160|FG006|Treatment Phase (6 Weeks)|Other|0|||
131584307|NCT03903822|473768161|FG007|Treatment Phase (6 Weeks)|Other|0|||
131584308|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
131704512|NCT00841763|474200737|FG003|Overall Study|Lost to Follow-up|0|||
131704513|NCT00841763|474200734|FG000|Overall Study|Protocol Violation|20|||
131704514|NCT00841763|474200735|FG001|Overall Study|Protocol Violation|3|||
131704515|NCT00841763|474200736|FG002|Overall Study|Protocol Violation|1|||
131704516|NCT00841763|474200737|FG003|Overall Study|Protocol Violation|0|||
131789518|NCT00323609|474512685|FG002|Overall Study|Death|0|||
131789519|NCT00323609|474512686|FG003|Overall Study|Death|0|||
131789520|NCT00323609|474512683|FG000|Overall Study|Lost to Follow-up|9|||
131789521|NCT00323609|474512684|FG001|Overall Study|Lost to Follow-up|10|||
131789522|NCT00323609|474512685|FG002|Overall Study|Lost to Follow-up|0|||
131789523|NCT00323609|474512686|FG003|Overall Study|Lost to Follow-up|0|||
131789524|NCT00323609|474512683|FG000|Overall Study|Physician Decision|2|||
131789525|NCT00323609|474512684|FG001|Overall Study|Physician Decision|0|||
131789526|NCT00323609|474512685|FG002|Overall Study|Physician Decision|0|||
131789527|NCT00323609|474512686|FG003|Overall Study|Physician Decision|1|||
131789528|NCT00323609|474512683|FG000|Overall Study|Withdrawal by Subject|11|||
131789529|NCT00323609|474512684|FG001|Overall Study|Withdrawal by Subject|23|||
131789530|NCT00323609|474512685|FG002|Overall Study|Withdrawal by Subject|4|||
131789531|NCT00323609|474512686|FG003|Overall Study|Withdrawal by Subject|4|||
131789532|NCT00323609|474512683|FG000|Overall Study|Other non-VCF-related medical condition|3|||
131789533|NCT00323609|474512684|FG001|Overall Study|Other non-VCF-related medical condition|2|||
131789534|NCT00323609|474512685|FG002|Overall Study|Other non-VCF-related medical condition|0|||
131789535|NCT00323609|474512686|FG003|Overall Study|Other non-VCF-related medical condition|0|||
131789536|NCT00323609|474512683|FG000|Overall Study|Sponsor discontinued trial|29|||
131789537|NCT00323609|474512684|FG001|Overall Study|Sponsor discontinued trial|29|||
131789538|NCT00323609|474512685|FG002|Overall Study|Sponsor discontinued trial|0|||
131789539|NCT00323609|474512686|FG003|Overall Study|Sponsor discontinued trial|0|||
131789540|NCT00323609|474512683|FG000|Overall Study|Unrelenting or severe back pain|1|||
131789541|NCT00323609|474512684|FG001|Overall Study|Unrelenting or severe back pain|1|||
131789542|NCT00323609|474512685|FG002|Overall Study|Unrelenting or severe back pain|0|||
131789543|NCT00323609|474512686|FG003|Overall Study|Unrelenting or severe back pain|0|||
131789544|NCT00323609|474512683|FG000|Overall Study|Logistical withdrawal|9|||
131789545|NCT00323609|474512684|FG001|Overall Study|Logistical withdrawal|5|||
131789546|NCT00323609|474512685|FG002|Overall Study|Logistical withdrawal|0|||
131789547|NCT00323609|474512686|FG003|Overall Study|Logistical withdrawal|1|||
131789548|NCT00323609|474512683|FG000|Overall Study|Other reason|11|||
131789549|NCT00323609|474512684|FG001|Overall Study|Other reason|8|||
131789550|NCT00323609|474512685|FG002|Overall Study|Other reason|4|||
131789551|NCT00323609|474512686|FG003|Overall Study|Other reason|9|||
131789552|NCT01827371|474512687|FG000|Overall Study|Adverse Event|0|||
131789553|NCT01827371|474512688|FG001|Overall Study|Adverse Event|0|||
131789554|NCT01827371|474512689|FG002|Overall Study|Adverse Event|4|||
131789555|NCT01827371|474512690|FG003|Overall Study|Adverse Event|2|||
131789556|NCT01827371|474512687|FG000|Overall Study|Lost to Follow-up|0|||
131789557|NCT01827371|474512688|FG001|Overall Study|Lost to Follow-up|2|||
131789558|NCT01827371|474512689|FG002|Overall Study|Lost to Follow-up|0|||
131789559|NCT01827371|474512690|FG003|Overall Study|Lost to Follow-up|4|||
131789560|NCT01827371|474512687|FG000|Overall Study|Protocol Violation|1|||
131789561|NCT01827371|474512688|FG001|Overall Study|Protocol Violation|0|||
131789562|NCT01827371|474512689|FG002|Overall Study|Protocol Violation|0|||
131789563|NCT01827371|474512690|FG003|Overall Study|Protocol Violation|0|||
131789564|NCT01827371|474512687|FG000|Overall Study|Withdrawal by Subject|1|||
131789565|NCT01827371|474512688|FG001|Overall Study|Withdrawal by Subject|2|||
131789566|NCT01827371|474512689|FG002|Overall Study|Withdrawal by Subject|2|||
131789567|NCT01827371|474512690|FG003|Overall Study|Withdrawal by Subject|3|||
131789568|NCT01827371|474512687|FG000|Overall Study|Physician Decision|0|||
131789569|NCT01827371|474512688|FG001|Overall Study|Physician Decision|1|||
131789570|NCT01827371|474512689|FG002|Overall Study|Physician Decision|0|||
131789571|NCT01827371|474512690|FG003|Overall Study|Physician Decision|1|||
131789572|NCT01827371|474512687|FG000|Overall Study|Temporary study halt to vaccinations|11|||
131789573|NCT01827371|474512688|FG001|Overall Study|Temporary study halt to vaccinations|2|||
131789574|NCT01827371|474512689|FG002|Overall Study|Temporary study halt to vaccinations|5|||
131789575|NCT01827371|474512690|FG003|Overall Study|Temporary study halt to vaccinations|13|||
131789576|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789577|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789578|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789579|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
131789580|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789581|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789582|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789583|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789584|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789585|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131789586|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131789587|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131789588|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Adverse Event|1|||
131584309|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
131584310|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
131584311|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
131584312|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
131584313|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
131584314|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
131584315|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
131584316|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584317|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584318|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584319|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584320|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
131584321|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584322|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584323|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131584324|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
131584325|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131584326|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131584327|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131584328|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131584329|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131584330|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
131584331|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
131584332|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
131584333|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
131584334|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
131584335|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
131584336|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
131584337|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
131584338|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
131584339|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
131584340|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131584341|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
131584342|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
131584343|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131584344|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131584345|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131584346|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
131584347|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
131584348|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131584349|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131584350|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131704517|NCT00841763|474200734|FG000|Overall Study|Administrative Reasons|3|||
131704518|NCT00841763|474200735|FG001|Overall Study|Administrative Reasons|1|||
131704519|NCT00841763|474200736|FG002|Overall Study|Administrative Reasons|0|||
131704520|NCT00841763|474200737|FG003|Overall Study|Administrative Reasons|0|||
131704521|NCT00841763|474200734|FG000|Overall Study|Unable to Classify|7|||
131704522|NCT00841763|474200735|FG001|Overall Study|Unable to Classify|1|||
131704523|NCT00841763|474200736|FG002|Overall Study|Unable to Classify|0|||
131704524|NCT00841763|474200737|FG003|Overall Study|Unable to Classify|0|||
131704525|NCT00648167|474200738|FG000|Overall Study|Adverse Event|6|||
131704526|NCT00648167|474200738|FG000|Overall Study|unable to swallow tablets|1|||
131704527|NCT00927368|474200739|FG000|Overall Study|enrollment in another study|1|||
131704528|NCT00927368|474200740|FG001|Overall Study|enrollment in another study|1|||
131704529|NCT00927368|474200741|FG002|Overall Study|enrollment in another study|2|||
131704530|NCT00927368|474200739|FG000|Overall Study|Lost to Follow-up|4|||
131704531|NCT00927368|474200740|FG001|Overall Study|Lost to Follow-up|0|||
131704532|NCT00927368|474200741|FG002|Overall Study|Lost to Follow-up|0|||
131704533|NCT00927368|474200739|FG000|Overall Study|equipment failure|1|||
131704534|NCT00927368|474200740|FG001|Overall Study|equipment failure|0|||
131704535|NCT00927368|474200741|FG002|Overall Study|equipment failure|0|||
131704536|NCT00927368|474200739|FG000|Overall Study|ineligible post randomization|0|||
131704537|NCT00927368|474200740|FG001|Overall Study|ineligible post randomization|3|||
131704538|NCT00927368|474200741|FG002|Overall Study|ineligible post randomization|1|||
131704539|NCT00927368|474200739|FG000|Overall Study|cancellation of surgery|0|||
131704540|NCT00927368|474200740|FG001|Overall Study|cancellation of surgery|1|||
131584351|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131584352|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131704541|NCT00927368|474200741|FG002|Overall Study|cancellation of surgery|2|||
131584353|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
131584354|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131704542|NCT00440726|474200746|FG000|Phase 1|Dose-Limiting Toxicity|0|||
131584355|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131584356|NCT03903822|473768154|FG000|Follow up Phase (4 Weeks)|Other|1|||
131584357|NCT03903822|473768155|FG001|Follow up Phase (4 Weeks)|Other|1|||
131584358|NCT03903822|473768156|FG002|Follow up Phase (4 Weeks)|Other|0|||
131584359|NCT03903822|473768157|FG003|Follow up Phase (4 Weeks)|Other|0|||
131584360|NCT03903822|473768158|FG004|Follow up Phase (4 Weeks)|Other|0|||
131584361|NCT03903822|473768159|FG005|Follow up Phase (4 Weeks)|Other|0|||
131584362|NCT03903822|473768160|FG006|Follow up Phase (4 Weeks)|Other|0|||
131584363|NCT03903822|473768161|FG007|Follow up Phase (4 Weeks)|Other|0|||
131584364|NCT00546754|473768162|FG000|Overall Study|Serious Adverse Event|1|||
131584365|NCT00546754|473768163|FG001|Overall Study|Serious Adverse Event|1|||
131584366|NCT00546754|473768162|FG000|Overall Study|Adverse Event|11|||
131584367|NCT00546754|473768163|FG001|Overall Study|Adverse Event|16|||
131584368|NCT00546754|473768162|FG000|Overall Study|Lack of Efficacy|1|||
131584369|NCT00546754|473768163|FG001|Overall Study|Lack of Efficacy|1|||
131584370|NCT00546754|473768162|FG000|Overall Study|Lost to Follow-up|9|||
131584371|NCT00546754|473768163|FG001|Overall Study|Lost to Follow-up|15|||
131584372|NCT00546754|473768162|FG000|Overall Study|Protocol Violation|3|||
131584373|NCT00546754|473768163|FG001|Overall Study|Protocol Violation|0|||
131584374|NCT00546754|473768162|FG000|Overall Study|Withdrawal by Subject|6|||
131584375|NCT00546754|473768163|FG001|Overall Study|Withdrawal by Subject|7|||
131584376|NCT00546754|473768162|FG000|Overall Study|Dyspnea|1|||
131584377|NCT00546754|473768163|FG001|Overall Study|Dyspnea|0|||
131584378|NCT00546754|473768162|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
131584379|NCT00546754|473768163|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
131584380|NCT00546754|473768162|FG000|Overall Study|Hip Replacement|1|||
131584381|NCT00546754|473768163|FG001|Overall Study|Hip Replacement|0|||
131584382|NCT00546754|473768162|FG000|Overall Study|Suicide|1|||
131584383|NCT00546754|473768163|FG001|Overall Study|Suicide|0|||
131584384|NCT00546754|473768162|FG000|Overall Study|Missing Cooperation|1|||
131584385|NCT00546754|473768163|FG001|Overall Study|Missing Cooperation|0|||
131584386|NCT00546754|473768162|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
131584387|NCT00546754|473768163|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
131584388|NCT00546754|473768162|FG000|Overall Study|Patient's Decision|0|||
131584389|NCT00546754|473768163|FG001|Overall Study|Patient's Decision|1|||
131584390|NCT00546754|473768162|FG000|Overall Study|Missing|14|||
131704543|NCT00440726|474200747|FG001|Phase 1|Dose-Limiting Toxicity|1|||
131704544|NCT00440726|474200748|FG002|Phase 1|Dose-Limiting Toxicity|0|||
131704545|NCT00440726|474200746|FG000|Phase 1|Physician Decision|1|||
131704546|NCT00440726|474200747|FG001|Phase 1|Physician Decision|0|||
131704547|NCT00440726|474200748|FG002|Phase 1|Physician Decision|0|||
131704548|NCT00440726|474200746|FG000|Phase 2|Death|0|||
131789589|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Adverse Event|1|||
131789590|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Adverse Event|1|||
131789591|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Adverse Event|1|||
131789592|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Adverse Event|0|||
131789593|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Adverse Event|0|||
131789594|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Adverse Event|0|||
131789595|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Adverse Event|0|||
131789596|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
131789597|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
131789598|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
131789599|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
131789600|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
131789601|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
131789602|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
131789603|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
131789604|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
131789605|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
131789606|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131438763|NCT00812708|473233292|FG000|Overall Study|Switched to another study|1|||
131584391|NCT00546754|473768163|FG001|Overall Study|Missing|7|||
131704549|NCT00440726|474200747|FG001|Phase 2|Death|0|||
131584392|NCT05782231|473768165|FG000|Overall Study|Withdrawal by Subject|1|||
131584393|NCT03830866|473768166|FG000|Overall Study|Death|90|||
131584394|NCT03830866|473768167|FG001|Overall Study|Death|111|||
131789607|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
131789608|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
131789609|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
131584395|NCT03830866|473768166|FG000|Overall Study|Lost to Follow-up|7|||
131584396|NCT03830866|473768167|FG001|Overall Study|Lost to Follow-up|7|||
131584397|NCT03830866|473768166|FG000|Overall Study|Withdrawal by Subject|19|||
131584398|NCT03830866|473768167|FG001|Overall Study|Withdrawal by Subject|16|||
131584399|NCT03830866|473768166|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
131704550|NCT00440726|474200748|FG002|Phase 2|Death|1|||
131704551|NCT00440726|474200746|FG000|Phase 2|Adverse Event|0|||
131704552|NCT00440726|474200747|FG001|Phase 2|Adverse Event|0|||
131789610|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
131789611|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
131789612|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
131789613|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
131789614|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
131789615|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
131789616|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
131789617|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
131789618|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789619|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789620|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789621|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789622|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789623|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
131789624|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789625|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131789626|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789627|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131584400|NCT03830866|473768167|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
131584401|NCT03830866|473768166|FG000|Overall Study|Other|1|||
131584402|NCT03830866|473768167|FG001|Overall Study|Other|1|||
131584403|NCT00510887|473768169|FG000|Overall Study|Lost to Follow-up|1|||
131584404|NCT03485950|473768172|FG000|Overall Study|Adverse Event|1|||
131584405|NCT03485950|473768173|FG001|Overall Study|Adverse Event|0|||
131584406|NCT03485950|473768172|FG000|Overall Study|Death|3|||
131789628|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789629|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789630|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
131789631|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
131789632|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789633|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789634|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789635|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131789636|NCT00950599|474512695|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
131789637|NCT00950599|474512696|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
131789638|NCT00950599|474512697|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
131789639|NCT00950599|474512698|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
131584407|NCT03485950|473768173|FG001|Overall Study|Death|2|||
131584408|NCT03485950|473768172|FG000|Overall Study|Withdrawal by Subject|3|||
131584409|NCT03485950|473768173|FG001|Overall Study|Withdrawal by Subject|0|||
131584410|NCT03764475|473768175|FG000|Overall Study|Adverse Event|11|||
131584411|NCT03764475|473768176|FG001|Overall Study|Adverse Event|2|||
131584412|NCT03764475|473768175|FG000|Overall Study|Lost to Follow-up|24|||
131584413|NCT03764475|473768176|FG001|Overall Study|Lost to Follow-up|10|||
131584414|NCT03764475|473768175|FG000|Overall Study|Withdrawal by Subject|26|||
131584415|NCT03764475|473768176|FG001|Overall Study|Withdrawal by Subject|10|||
131584416|NCT03764475|473768175|FG000|Overall Study|Lack of Efficacy|3|||
131584417|NCT03764475|473768176|FG001|Overall Study|Lack of Efficacy|0|||
131584418|NCT03764475|473768175|FG000|Overall Study|COVID-19 Disruption|2|||
131584419|NCT03764475|473768176|FG001|Overall Study|COVID-19 Disruption|0|||
131584420|NCT00390299|473768180|FG000|Overall Study|Cancellation|1|||
131584421|NCT00390299|473768181|FG001|Overall Study|Cancellation|0|||
131584422|NCT00390299|473768182|FG002|Overall Study|Cancellation|0|||
131584423|NCT00390299|473768183|FG003|Overall Study|Cancellation|0|||
131584424|NCT00390299|473768184|FG004|Overall Study|Cancellation|0|||
131584425|NCT00970359|473768185|FG000|Overall Study|Not Treated|4|||
131584426|NCT01565148|473768186|FG000|Overall Study|Withdrawal by Subject|1|||
131584427|NCT01565148|473768187|FG001|Overall Study|Withdrawal by Subject|1|||
131584428|NCT01565148|473768188|FG002|Overall Study|Withdrawal by Subject|1|||
131584429|NCT01565148|473768189|FG003|Overall Study|Withdrawal by Subject|2|||
131584430|NCT01565148|473768186|FG000|Overall Study|Lost to Follow-up|4|||
131584431|NCT01565148|473768187|FG001|Overall Study|Lost to Follow-up|4|||
131584432|NCT01565148|473768188|FG002|Overall Study|Lost to Follow-up|0|||
131584433|NCT01565148|473768189|FG003|Overall Study|Lost to Follow-up|3|||
131584434|NCT01565148|473768186|FG000|Overall Study|Rescue Therapy|8|||
131584435|NCT01565148|473768187|FG001|Overall Study|Rescue Therapy|5|||
131584436|NCT01565148|473768188|FG002|Overall Study|Rescue Therapy|5|||
131584437|NCT01565148|473768189|FG003|Overall Study|Rescue Therapy|8|||
131584438|NCT01565148|473768186|FG000|Overall Study|Death|0|||
131584439|NCT01565148|473768187|FG001|Overall Study|Death|0|||
131584440|NCT01565148|473768188|FG002|Overall Study|Death|1|||
131584441|NCT01565148|473768189|FG003|Overall Study|Death|0|||
131584442|NCT01565148|473768186|FG000|Overall Study|Physician Decision|2|||
131584443|NCT01565148|473768187|FG001|Overall Study|Physician Decision|5|||
131584444|NCT01565148|473768188|FG002|Overall Study|Physician Decision|0|||
131584445|NCT01565148|473768189|FG003|Overall Study|Physician Decision|0|||
131584446|NCT05368831|473768190|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
131584447|NCT01692730|473768198|FG000|Overall Study|Lost to Follow-up|225|||
131584448|NCT01692730|473768199|FG001|Overall Study|Lost to Follow-up|227|||
131789640|NCT00950599|474512699|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
131789641|NCT00950599|474512700|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
131789642|NCT00950599|474512701|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
131789643|NCT00950599|474512702|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
131789644|NCT00950599|474512703|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
131789645|NCT00950599|474512704|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
131789646|NCT00950599|474512695|FG000|Follow-Up Period|Adverse Event|0|||
131789647|NCT00950599|474512696|FG001|Follow-Up Period|Adverse Event|0|||
131789648|NCT00950599|474512697|FG002|Follow-Up Period|Adverse Event|0|||
131789649|NCT00950599|474512698|FG003|Follow-Up Period|Adverse Event|0|||
131789650|NCT00950599|474512699|FG004|Follow-Up Period|Adverse Event|0|||
131789651|NCT00950599|474512700|FG005|Follow-Up Period|Adverse Event|0|||
131789652|NCT00950599|474512701|FG006|Follow-Up Period|Adverse Event|0|||
131789653|NCT00950599|474512702|FG007|Follow-Up Period|Adverse Event|0|||
131789654|NCT00950599|474512703|FG008|Follow-Up Period|Adverse Event|1|||
131789655|NCT00950599|474512704|FG009|Follow-Up Period|Adverse Event|0|||
131789656|NCT00950599|474512695|FG000|Follow-Up Period|Lack of Efficacy|0|||
131789657|NCT00950599|474512696|FG001|Follow-Up Period|Lack of Efficacy|0|||
131789658|NCT00950599|474512697|FG002|Follow-Up Period|Lack of Efficacy|0|||
131789659|NCT00950599|474512698|FG003|Follow-Up Period|Lack of Efficacy|0|||
131789660|NCT00950599|474512699|FG004|Follow-Up Period|Lack of Efficacy|0|||
131789661|NCT00950599|474512700|FG005|Follow-Up Period|Lack of Efficacy|0|||
131789662|NCT00950599|474512701|FG006|Follow-Up Period|Lack of Efficacy|0|||
131789663|NCT00950599|474512702|FG007|Follow-Up Period|Lack of Efficacy|0|||
131789664|NCT00950599|474512703|FG008|Follow-Up Period|Lack of Efficacy|3|||
131789665|NCT00950599|474512704|FG009|Follow-Up Period|Lack of Efficacy|0|||
131789666|NCT00950599|474512695|FG000|Follow-Up Period|Lost to Follow-up|0|||
131789667|NCT00950599|474512696|FG001|Follow-Up Period|Lost to Follow-up|0|||
131584449|NCT01849055|473768200|FG000|Overall Study|Withdrawal by Subject|0|||
131584450|NCT01849055|473768201|FG001|Overall Study|Withdrawal by Subject|0|||
131584451|NCT01849055|473768202|FG002|Overall Study|Withdrawal by Subject|1|||
131584452|NCT01849055|473768203|FG003|Overall Study|Withdrawal by Subject|0|||
131584453|NCT01849055|473768204|FG004|Overall Study|Withdrawal by Subject|0|||
131584454|NCT01849055|473768205|FG005|Overall Study|Withdrawal by Subject|0|||
131584455|NCT01199575|473768206|FG000|Overall Study|Withdrawal by Subject|5|||
131584456|NCT01239316|473768207|FG000|Overall Study|Progression/Relapse|11|||
131584457|NCT01239316|473768207|FG000|Overall Study|Adverse Event|1|||
131584458|NCT03750968|473768214|FG000|Overall Study|Adverse Event|2|||
131584459|NCT03750968|473768215|FG001|Overall Study|Adverse Event|0|||
131584460|NCT03750968|473768214|FG000|Overall Study|Lost to Follow-up|1|||
131584461|NCT03750968|473768215|FG001|Overall Study|Lost to Follow-up|3|||
131584462|NCT00088413|473768218|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
131584463|NCT00088413|473768219|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
131584464|NCT00088413|473768220|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
131584465|NCT00088413|473768221|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
131584466|NCT00088413|473768218|FG000|Overall Study|Adverse Events/Side Effects|0|||
131584467|NCT00088413|473768219|FG001|Overall Study|Adverse Events/Side Effects|1|||
131584468|NCT00088413|473768220|FG002|Overall Study|Adverse Events/Side Effects|1|||
131584469|NCT00088413|473768221|FG003|Overall Study|Adverse Events/Side Effects|0|||
131584470|NCT00088413|473768218|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
131584471|NCT00088413|473768219|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
131584472|NCT00088413|473768220|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
131584473|NCT00088413|473768221|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
131584474|NCT00088413|473768218|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
131584475|NCT00088413|473768219|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
131584476|NCT00088413|473768220|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
131584477|NCT00088413|473768221|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
131584478|NCT00088413|473768218|FG000|Overall Study|Death|0|||
131584479|NCT00088413|473768219|FG001|Overall Study|Death|1|||
131584480|NCT00088413|473768220|FG002|Overall Study|Death|0|||
131584481|NCT00088413|473768221|FG003|Overall Study|Death|0|||
131584482|NCT00088413|473768218|FG000|Overall Study|Progressive disease|9|||
131584483|NCT00088413|473768219|FG001|Overall Study|Progressive disease|11|||
131584484|NCT00088413|473768220|FG002|Overall Study|Progressive disease|8|||
131584485|NCT00088413|473768221|FG003|Overall Study|Progressive disease|14|||
131584486|NCT00088413|473768218|FG000|Overall Study|Other|0|||
131584487|NCT00088413|473768219|FG001|Overall Study|Other|1|||
131584488|NCT00088413|473768220|FG002|Overall Study|Other|0|||
131584489|NCT00088413|473768221|FG003|Overall Study|Other|0|||
131584490|NCT00088413|473768218|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
131584491|NCT00088413|473768219|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
131584492|NCT00088413|473768220|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
131584493|NCT00088413|473768221|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
131584494|NCT00411216|473768222|FG000|Overall Study|Ten participants were entered into the c|0|||
131584495|NCT00411216|473768223|FG001|Overall Study|Ten participants were entered into the c|2|||
131584496|NCT02531113|473768227|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
131584497|NCT02531113|473768227|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
131584498|NCT02531113|473768227|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
131584499|NCT02531113|473768227|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
131584500|NCT02531113|473768227|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
131584501|NCT02531113|473768227|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
131584502|NCT02531113|473768227|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
131584503|NCT02531113|473768227|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
131584504|NCT00632424|473768228|FG000|Overall Study|Disease Progression|17|||
131584505|NCT00632424|473768228|FG000|Overall Study|Study Drug Toxicity|1|||
131584506|NCT01251354|473768229|FG000|Overall Study|Adverse Event|1|||
131704553|NCT00440726|474200748|FG002|Phase 2|Adverse Event|1|||
131704554|NCT01482910|474200750|FG000|Overall Study|Adverse Event|6|||
131704555|NCT01482910|474200751|FG001|Overall Study|Adverse Event|5|||
131704556|NCT01482910|474200750|FG000|Overall Study|Lost to Follow-up|0|||
131704557|NCT01482910|474200751|FG001|Overall Study|Lost to Follow-up|1|||
131584507|NCT01251354|473768229|FG000|Overall Study|Investigator's Decision|1|||
131584508|NCT01251354|473768229|FG000|Overall Study|Disease Progression|4|||
131584509|NCT03807778|473768232|FG000|Overall Study|Adverse Event|0|||
131584510|NCT03807778|473768233|FG001|Overall Study|Adverse Event|0|||
131584511|NCT03807778|473768234|FG002|Overall Study|Adverse Event|3|||
131584512|NCT03807778|473768235|FG003|Overall Study|Adverse Event|5|||
131584513|NCT03807778|473768232|FG000|Overall Study|Progressive Disease|4|||
131584514|NCT03807778|473768233|FG001|Overall Study|Progressive Disease|2|||
131584515|NCT03807778|473768234|FG002|Overall Study|Progressive Disease|8|||
131584516|NCT03807778|473768235|FG003|Overall Study|Progressive Disease|15|||
131584517|NCT03807778|473768232|FG000|Overall Study|Symptomatic Deterioration|0|||
131584518|NCT03807778|473768233|FG001|Overall Study|Symptomatic Deterioration|1|||
131704558|NCT01482910|474200750|FG000|Overall Study|Protocol Violation|1|||
131704559|NCT01482910|474200751|FG001|Overall Study|Protocol Violation|1|||
131704560|NCT01482910|474200750|FG000|Overall Study|Withdrawal by Subject|7|||
131704561|NCT01482910|474200751|FG001|Overall Study|Withdrawal by Subject|2|||
131584519|NCT03807778|473768234|FG002|Overall Study|Symptomatic Deterioration|0|||
131584520|NCT03807778|473768235|FG003|Overall Study|Symptomatic Deterioration|1|||
131584521|NCT03807778|473768232|FG000|Overall Study|Withdrawal by Subject|0|||
131584522|NCT03807778|473768233|FG001|Overall Study|Withdrawal by Subject|1|||
131584523|NCT03807778|473768234|FG002|Overall Study|Withdrawal by Subject|0|||
131584524|NCT03807778|473768235|FG003|Overall Study|Withdrawal by Subject|1|||
131584525|NCT03807778|473768232|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
131584526|NCT03807778|473768233|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
131584527|NCT03807778|473768234|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
131584528|NCT03807778|473768235|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
131584529|NCT05094141|473768239|FG000|Overall Study|Death|0|||
131584530|NCT05094141|473768240|FG001|Overall Study|Death|0|||
131789668|NCT00950599|474512697|FG002|Follow-Up Period|Lost to Follow-up|0|||
131789669|NCT00950599|474512698|FG003|Follow-Up Period|Lost to Follow-up|0|||
131789670|NCT00950599|474512699|FG004|Follow-Up Period|Lost to Follow-up|0|||
131789671|NCT00950599|474512700|FG005|Follow-Up Period|Lost to Follow-up|0|||
131789672|NCT00950599|474512701|FG006|Follow-Up Period|Lost to Follow-up|0|||
131789673|NCT00950599|474512702|FG007|Follow-Up Period|Lost to Follow-up|0|||
131789674|NCT00950599|474512703|FG008|Follow-Up Period|Lost to Follow-up|5|||
131789675|NCT00950599|474512704|FG009|Follow-Up Period|Lost to Follow-up|1|||
131789676|NCT00950599|474512695|FG000|Follow-Up Period|Physician Decision|0|||
131789677|NCT00950599|474512696|FG001|Follow-Up Period|Physician Decision|0|||
131789678|NCT00950599|474512697|FG002|Follow-Up Period|Physician Decision|0|||
131789679|NCT00950599|474512698|FG003|Follow-Up Period|Physician Decision|0|||
131789680|NCT00950599|474512699|FG004|Follow-Up Period|Physician Decision|0|||
131789681|NCT00950599|474512700|FG005|Follow-Up Period|Physician Decision|0|||
131789682|NCT00950599|474512701|FG006|Follow-Up Period|Physician Decision|0|||
131789683|NCT00950599|474512702|FG007|Follow-Up Period|Physician Decision|0|||
131789684|NCT00950599|474512703|FG008|Follow-Up Period|Physician Decision|1|||
131789685|NCT00950599|474512704|FG009|Follow-Up Period|Physician Decision|0|||
131789686|NCT00950599|474512695|FG000|Follow-Up Period|Poor/Noncompliance|0|||
131789687|NCT00950599|474512696|FG001|Follow-Up Period|Poor/Noncompliance|0|||
131789688|NCT00950599|474512697|FG002|Follow-Up Period|Poor/Noncompliance|0|||
131789689|NCT00950599|474512698|FG003|Follow-Up Period|Poor/Noncompliance|0|||
131789690|NCT00950599|474512699|FG004|Follow-Up Period|Poor/Noncompliance|0|||
131789691|NCT00950599|474512700|FG005|Follow-Up Period|Poor/Noncompliance|0|||
131789692|NCT00950599|474512701|FG006|Follow-Up Period|Poor/Noncompliance|0|||
131789693|NCT00950599|474512702|FG007|Follow-Up Period|Poor/Noncompliance|0|||
131789694|NCT00950599|474512703|FG008|Follow-Up Period|Poor/Noncompliance|1|||
131789695|NCT00950599|474512704|FG009|Follow-Up Period|Poor/Noncompliance|0|||
131789696|NCT00950599|474512695|FG000|Follow-Up Period|Subject withdrew Consent|0|||
131789697|NCT00950599|474512696|FG001|Follow-Up Period|Subject withdrew Consent|0|||
131789698|NCT00950599|474512697|FG002|Follow-Up Period|Subject withdrew Consent|0|||
131789699|NCT00950599|474512698|FG003|Follow-Up Period|Subject withdrew Consent|0|||
131789700|NCT00950599|474512699|FG004|Follow-Up Period|Subject withdrew Consent|0|||
131789701|NCT00950599|474512700|FG005|Follow-Up Period|Subject withdrew Consent|0|||
131789702|NCT00950599|474512701|FG006|Follow-Up Period|Subject withdrew Consent|0|||
131789703|NCT00950599|474512702|FG007|Follow-Up Period|Subject withdrew Consent|0|||
131789704|NCT00950599|474512703|FG008|Follow-Up Period|Subject withdrew Consent|2|||
131789705|NCT00950599|474512704|FG009|Follow-Up Period|Subject withdrew Consent|1|||
131789706|NCT00971204|474512705|FG000|Overall Study|Did not meet all criteria-not treated|14|||
131789707|NCT00971204|474512705|FG000|Overall Study|Lost to Follow-up|10|||
131789708|NCT02436135|474512706|FG000|Overall Study|Progressive Disease|3|||
131789709|NCT02436135|474512707|FG001|Overall Study|Progressive Disease|1|||
131789710|NCT02436135|474512706|FG000|Overall Study|Investigator Discretion|1|||
131584531|NCT05094141|473768241|FG002|Overall Study|Death|1|||
131584532|NCT05094141|473768239|FG000|Overall Study|Withdrawal by Subject|0|||
131584533|NCT05094141|473768240|FG001|Overall Study|Withdrawal by Subject|0|||
131789711|NCT02436135|474512707|FG001|Overall Study|Investigator Discretion|2|||
131584534|NCT05094141|473768241|FG002|Overall Study|Withdrawal by Subject|1|||
131584535|NCT05094141|473768239|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
131584536|NCT05094141|473768240|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
131584537|NCT05094141|473768241|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
131584538|NCT05094141|473768239|FG000|Overall Study|Did not participate in randomization|0|||
131789712|NCT02436135|474512706|FG000|Overall Study|Adverse Event|1|||
131789713|NCT02436135|474512707|FG001|Overall Study|Adverse Event|0|||
131789714|NCT02436135|474512706|FG000|Overall Study|Withdrawal by Participant|1|||
131789715|NCT02436135|474512707|FG001|Overall Study|Withdrawal by Participant|0|||
131789716|NCT02436135|474512706|FG000|Overall Study|Study Terminated By Sponsor|0|||
131789717|NCT02436135|474512707|FG001|Overall Study|Study Terminated By Sponsor|1|||
131789718|NCT01427803|474512712|FG000|Overall Study|Lost to Follow-up|32|||
131789719|NCT01427803|474512713|FG001|Overall Study|Lost to Follow-up|26|||
131789720|NCT01427803|474512712|FG000|Overall Study|Withdrawal by Subject|20|||
131789721|NCT01427803|474512713|FG001|Overall Study|Withdrawal by Subject|0|||
131789722|NCT01427803|474512712|FG000|Overall Study|Unable to complete full treatment period|6|||
131789723|NCT01427803|474512713|FG001|Overall Study|Unable to complete full treatment period|0|||
131789724|NCT01427803|474512712|FG000|Overall Study|Protocol Violation|1|||
131789725|NCT01427803|474512713|FG001|Overall Study|Protocol Violation|0|||
131789726|NCT01427803|474512712|FG000|Overall Study|Physician Decision|3|||
131789727|NCT01427803|474512713|FG001|Overall Study|Physician Decision|0|||
131789728|NCT01427803|474512712|FG000|Overall Study|did not take product|1|||
131789729|NCT01427803|474512713|FG001|Overall Study|did not take product|0|||
131789730|NCT02746705|474512716|FG000|Overall Study|Physician Decision|1|||
131789731|NCT02746705|474512717|FG001|Overall Study|Physician Decision|1|||
131789732|NCT02746705|474512716|FG000|Overall Study|Lost to Follow-up|1|||
131789733|NCT02746705|474512717|FG001|Overall Study|Lost to Follow-up|0|||
131789734|NCT02746705|474512716|FG000|Overall Study|outlier scores deemed not valid|0|||
131789735|NCT02746705|474512717|FG001|Overall Study|outlier scores deemed not valid|1|||
131789736|NCT00479401|474512718|FG000|Overall Study|Adverse Event|24|||
131789737|NCT00479401|474512719|FG001|Overall Study|Adverse Event|20|||
131789738|NCT00479401|474512720|FG002|Overall Study|Adverse Event|4|||
131789739|NCT00479401|474512718|FG000|Overall Study|Lack of Efficacy|2|||
131789740|NCT00479401|474512719|FG001|Overall Study|Lack of Efficacy|2|||
131789741|NCT00479401|474512720|FG002|Overall Study|Lack of Efficacy|4|||
131789742|NCT00479401|474512718|FG000|Overall Study|Protocol Violation|2|||
131789743|NCT00479401|474512719|FG001|Overall Study|Protocol Violation|1|||
131789744|NCT00479401|474512720|FG002|Overall Study|Protocol Violation|1|||
131789745|NCT00479401|474512718|FG000|Overall Study|Lost to Follow-up|1|||
131789746|NCT00479401|474512719|FG001|Overall Study|Lost to Follow-up|1|||
131789747|NCT00479401|474512720|FG002|Overall Study|Lost to Follow-up|1|||
131789748|NCT00479401|474512718|FG000|Overall Study|Withdrawal by Subject|16|||
131789749|NCT00479401|474512719|FG001|Overall Study|Withdrawal by Subject|10|||
131789750|NCT00479401|474512720|FG002|Overall Study|Withdrawal by Subject|2|||
131789751|NCT00479401|474512718|FG000|Overall Study|Exclusion criteria, relocation|4|||
131789752|NCT00479401|474512719|FG001|Overall Study|Exclusion criteria, relocation|3|||
131789753|NCT00479401|474512720|FG002|Overall Study|Exclusion criteria, relocation|0|||
131789754|NCT01571635|474512723|FG000|Overall Study|Adverse Event|3|||
131789755|NCT01571635|474512724|FG001|Overall Study|Adverse Event|0|||
131789756|NCT01571635|474512725|FG002|Overall Study|Adverse Event|2|||
131789757|NCT01571635|474512726|FG003|Overall Study|Adverse Event|3|||
131789758|NCT01571635|474512727|FG004|Overall Study|Adverse Event|5|||
131789759|NCT01571635|474512723|FG000|Overall Study|Other reasons|2|||
131789760|NCT01571635|474512724|FG001|Overall Study|Other reasons|1|||
131789761|NCT01571635|474512725|FG002|Overall Study|Other reasons|2|||
131789762|NCT01571635|474512726|FG003|Overall Study|Other reasons|2|||
131789763|NCT01571635|474512727|FG004|Overall Study|Other reasons|1|||
131789764|NCT01571635|474512723|FG000|Overall Study|Study terminated by sponsor|0|||
131789765|NCT01571635|474512724|FG001|Overall Study|Study terminated by sponsor|4|||
131789766|NCT01571635|474512725|FG002|Overall Study|Study terminated by sponsor|1|||
131789767|NCT01571635|474512726|FG003|Overall Study|Study terminated by sponsor|3|||
131789768|NCT01571635|474512727|FG004|Overall Study|Study terminated by sponsor|1|||
131789769|NCT01571635|474512723|FG000|Overall Study|Withdrew consent|1|||
131789770|NCT01571635|474512724|FG001|Overall Study|Withdrew consent|1|||
131789771|NCT01571635|474512725|FG002|Overall Study|Withdrew consent|2|||
131789772|NCT01571635|474512726|FG003|Overall Study|Withdrew consent|3|||
131789773|NCT01571635|474512727|FG004|Overall Study|Withdrew consent|0|||
131789774|NCT01571635|474512723|FG000|Overall Study|Lack of Efficacy|0|||
131789775|NCT01571635|474512724|FG001|Overall Study|Lack of Efficacy|2|||
131789776|NCT01571635|474512725|FG002|Overall Study|Lack of Efficacy|0|||
131789777|NCT01571635|474512726|FG003|Overall Study|Lack of Efficacy|1|||
131789778|NCT01571635|474512727|FG004|Overall Study|Lack of Efficacy|2|||
131789779|NCT04304950|474512730|FG000|Overall Study|Lost to Follow-up|1|||
131789780|NCT04304950|474512731|FG001|Overall Study|Lost to Follow-up|1|||
131789781|NCT02418910|474512732|FG000|Overall Study|Lost to Follow-up|3|||
131789782|NCT02418910|474512732|FG000|Overall Study|Withdrawal by Subject|4|||
131789783|NCT03634488|474512734|FG000|Overall Study|Death|1|||
131789784|NCT03634488|474512735|FG001|Overall Study|Death|0|||
131789785|NCT03634488|474512736|FG002|Overall Study|Death|0|||
131789786|NCT03634488|474512734|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
131789787|NCT03634488|474512735|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
131789788|NCT03634488|474512736|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
131789789|NCT03182686|474512737|FG000|Overall Study|Lost to Follow-up|2|||
131584539|NCT05094141|473768240|FG001|Overall Study|Did not participate in randomization|0|||
131789790|NCT03182686|474512738|FG001|Overall Study|Lost to Follow-up|0|||
131789791|NCT03182686|474512737|FG000|Overall Study|Adverse Event|2|||
131789792|NCT03182686|474512738|FG001|Overall Study|Adverse Event|0|||
131789793|NCT03182686|474512737|FG000|Overall Study|Withdrawal by Subject|3|||
131789794|NCT03182686|474512738|FG001|Overall Study|Withdrawal by Subject|0|||
131584540|NCT05094141|473768241|FG002|Overall Study|Did not participate in randomization|33|||
131584541|NCT05644444|473769838|FG000|Tolerance Phase|Adverse Event|0|||
131584542|NCT05644444|473769839|FG001|Tolerance Phase|Adverse Event|2|||
131584543|NCT05644444|473769838|FG000|Treatment Phase|Adverse Event|0|||
131584544|NCT05644444|473769839|FG001|Treatment Phase|Adverse Event|2|||
131584545|NCT04817670|473769840|FG000|Overall Study|Withdrawal by Subject|1|||
131584546|NCT04817670|473769841|FG001|Overall Study|Withdrawal by Subject|0|||
131584547|NCT04817670|473769842|FG002|Overall Study|Withdrawal by Subject|0|||
131584548|NCT04817670|473769843|FG003|Overall Study|Withdrawal by Subject|0|||
131584549|NCT04817670|473769844|FG004|Overall Study|Withdrawal by Subject|0|||
131584550|NCT04817670|473769840|FG000|Overall Study|Lost to Follow-up|0|||
131704562|NCT01482910|474200750|FG000|Overall Study|Death|1|||
131704563|NCT01482910|474200751|FG001|Overall Study|Death|0|||
131704564|NCT00331409|474200752|FG000|Overall Study|Lack of Efficacy|4|||
131704565|NCT02614079|474200755|FG000|Overall Study|Withdrawal by Subject|1|||
131704566|NCT03370770|474200756|FG000|Overall Study|Patient was followed in another hospital center|1|||
131704567|NCT03370770|474200756|FG000|Overall Study|Progressive Disease|98|||
131704568|NCT03370770|474200756|FG000|Overall Study|Adverse Event|2|||
131704569|NCT03370770|474200756|FG000|Overall Study|Death|5|||
131704570|NCT00234039|474200757|FG000|Overall Study|Adverse Event|2|||
131704571|NCT00234039|474200757|FG000|Overall Study|Progression/relapse|34|||
131704572|NCT00234039|474200757|FG000|Overall Study|Other - Not Protocol Specified|3|||
131704573|NCT00234039|474200757|FG000|Overall Study|Ineligible|9|||
131704574|NCT00234039|474200757|FG000|Overall Study|No Protocol Treatment Received|2|||
131704575|NCT03683394|474200760|FG000|Overall Study|Withdrawal by Subject|4|||
131704576|NCT03683394|474200761|FG001|Overall Study|Withdrawal by Subject|8|||
131704577|NCT03683394|474200760|FG000|Overall Study|Lost to Follow-up|7|||
131704578|NCT03683394|474200761|FG001|Overall Study|Lost to Follow-up|0|||
131704579|NCT03683394|474200760|FG000|Overall Study|Death|3|||
131704580|NCT03683394|474200761|FG001|Overall Study|Death|1|||
131704581|NCT00559273|474200762|FG000|Correction Period (20 Weeks)|Death|3|||
131704582|NCT00559273|474200763|FG001|Correction Period (20 Weeks)|Death|4|||
131704583|NCT00559273|474200762|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
131704584|NCT00559273|474200763|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
131704585|NCT00559273|474200762|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
131704586|NCT00559273|474200763|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
131704587|NCT00559273|474200762|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
131704588|NCT00559273|474200763|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
131704589|NCT00559273|474200762|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
131704590|NCT00559273|474200763|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
131704591|NCT00559273|474200762|FG000|Evaluation Period (8 Weeks)|Death|1|||
131704592|NCT00559273|474200763|FG001|Evaluation Period (8 Weeks)|Death|3|||
131704593|NCT00559273|474200762|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
131704594|NCT00559273|474200763|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
131704595|NCT00559273|474200762|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
131704596|NCT00559273|474200763|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
131704597|NCT00559273|474200762|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
131704598|NCT00559273|474200763|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
131704599|NCT00395967|474200764|FG000|Treatment Period|Failed Mobilization|1|||
131704600|NCT00395967|474200764|FG000|Follow-up Period|Death|1|||
131704601|NCT00395967|474200764|FG000|Follow-up Period|Lost to Follow-up|1|||
131704602|NCT03118947|474200766|FG000|Overall Study|Adverse Event|7|||
131704603|NCT03118947|474200766|FG000|Overall Study|Death|3|||
131704604|NCT03118947|474200766|FG000|Overall Study|Lack of Efficacy|4|||
131704605|NCT03118947|474200766|FG000|Overall Study|Non-compliance with study drug|1|||
131704606|NCT03118947|474200766|FG000|Overall Study|Protocol Violation|2|||
131704607|NCT03118947|474200766|FG000|Overall Study|Withdrawal by Subject|3|||
131704608|NCT03118947|474200766|FG000|Overall Study|Withdrawal by caregiver|3|||
131704609|NCT03118947|474200766|FG000|Overall Study|Change in patient's living situation|4|||
131704610|NCT03118947|474200766|FG000|Overall Study|Lost to Follow-up|2|||
131704611|NCT00189462|474200769|FG000|Overall Study|Lack of Efficacy|5|||
131704612|NCT00189462|474200770|FG001|Overall Study|Lack of Efficacy|1|||
131704613|NCT00189462|474200769|FG000|Overall Study|Lost to Follow-up|18|||
131704614|NCT00189462|474200770|FG001|Overall Study|Lost to Follow-up|20|||
131704615|NCT00448708|474200771|FG000|Overall Study|Death|21|||
131704616|NCT00448708|474200772|FG001|Overall Study|Death|17|||
131704617|NCT00448708|474200771|FG000|Overall Study|Withdrawal by Subject|8|||
131704618|NCT00448708|474200772|FG001|Overall Study|Withdrawal by Subject|4|||
131704619|NCT00448708|474200771|FG000|Overall Study|Lost to Follow-up|6|||
131704620|NCT00448708|474200772|FG001|Overall Study|Lost to Follow-up|8|||
131704621|NCT00448708|474200771|FG000|Overall Study|not listed|0|||
131704622|NCT00448708|474200772|FG001|Overall Study|not listed|2|||
131704623|NCT02400255|474200774|FG000|Overall Study|Relapse|4|||
131584551|NCT04817670|473769841|FG001|Overall Study|Lost to Follow-up|0|||
131584552|NCT04817670|473769842|FG002|Overall Study|Lost to Follow-up|1|||
131704624|NCT02400255|474200775|FG001|Overall Study|Relapse|1|||
131704625|NCT02400255|474200776|FG002|Overall Study|Relapse|1|||
131584553|NCT04817670|473769843|FG003|Overall Study|Lost to Follow-up|0|||
131584554|NCT04817670|473769844|FG004|Overall Study|Lost to Follow-up|0|||
131584555|NCT03312907|473769845|FG000|Overall Study|Adverse Event|1|||
131584556|NCT03312907|473769846|FG001|Overall Study|Adverse Event|6|||
131584557|NCT03312907|473769847|FG002|Overall Study|Adverse Event|1|||
131584558|NCT03312907|473769845|FG000|Overall Study|Protocol Violation|2|||
131584559|NCT03312907|473769846|FG001|Overall Study|Protocol Violation|3|||
131584560|NCT03312907|473769847|FG002|Overall Study|Protocol Violation|4|||
131584561|NCT03312907|473769845|FG000|Overall Study|Lost to Follow-up|2|||
131584562|NCT03312907|473769846|FG001|Overall Study|Lost to Follow-up|3|||
131584563|NCT03312907|473769847|FG002|Overall Study|Lost to Follow-up|2|||
131584564|NCT03312907|473769845|FG000|Overall Study|Physician Decision|3|||
131584565|NCT03312907|473769846|FG001|Overall Study|Physician Decision|4|||
131584566|NCT03312907|473769847|FG002|Overall Study|Physician Decision|2|||
131584567|NCT03312907|473769845|FG000|Overall Study|Withdrawal by Subject|9|||
131584568|NCT03312907|473769846|FG001|Overall Study|Withdrawal by Subject|14|||
131584569|NCT03312907|473769847|FG002|Overall Study|Withdrawal by Subject|10|||
131584570|NCT03936660|473769851|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
131584571|NCT03936660|473769852|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
131584572|NCT03112174|473769853|FG000|Overall Study|Withdrawal by Subject|3|||
131584573|NCT03112174|473769854|FG001|Overall Study|Withdrawal by Subject|0|||
131584574|NCT03112174|473769855|FG002|Overall Study|Withdrawal by Subject|11|||
131584575|NCT03112174|473769856|FG003|Overall Study|Withdrawal by Subject|9|||
131584576|NCT03112174|473769857|FG004|Overall Study|Withdrawal by Subject|7|||
131584577|NCT03112174|473769853|FG000|Overall Study|Lost to Follow-up|1|||
131584578|NCT03112174|473769854|FG001|Overall Study|Lost to Follow-up|1|||
131584579|NCT03112174|473769855|FG002|Overall Study|Lost to Follow-up|2|||
131584580|NCT03112174|473769856|FG003|Overall Study|Lost to Follow-up|3|||
131584581|NCT03112174|473769857|FG004|Overall Study|Lost to Follow-up|2|||
131584582|NCT03112174|473769853|FG000|Overall Study|Death|8|||
131584583|NCT03112174|473769854|FG001|Overall Study|Death|3|||
131584584|NCT03112174|473769855|FG002|Overall Study|Death|67|||
131584585|NCT03112174|473769856|FG003|Overall Study|Death|73|||
131584586|NCT03112174|473769857|FG004|Overall Study|Death|18|||
131584587|NCT03112174|473769853|FG000|Overall Study|Other, Not Specified|1|||
131584588|NCT03112174|473769854|FG001|Overall Study|Other, Not Specified|0|||
131704626|NCT02400255|474200777|FG003|Overall Study|Relapse|2|||
131704627|NCT02400255|474200774|FG000|Overall Study|Adverse Event|6|||
131704628|NCT02400255|474200775|FG001|Overall Study|Adverse Event|3|||
131704629|NCT02400255|474200776|FG002|Overall Study|Adverse Event|0|||
131704630|NCT02400255|474200777|FG003|Overall Study|Adverse Event|0|||
131704631|NCT02400255|474200774|FG000|Overall Study|Physician Decision|6|||
131704632|NCT02400255|474200775|FG001|Overall Study|Physician Decision|0|||
131704633|NCT02400255|474200776|FG002|Overall Study|Physician Decision|0|||
131704634|NCT02400255|474200777|FG003|Overall Study|Physician Decision|0|||
131704635|NCT02400255|474200774|FG000|Overall Study|Loss of insurance|1|||
131704636|NCT02400255|474200775|FG001|Overall Study|Loss of insurance|0|||
131704637|NCT02400255|474200776|FG002|Overall Study|Loss of insurance|0|||
131704638|NCT02400255|474200777|FG003|Overall Study|Loss of insurance|0|||
131704639|NCT01961544|474200778|FG000|Overall Study|Protocol Violation|1|||
131704640|NCT01961544|474200778|FG000|Overall Study|Withdrawal by Subject|7|||
131704641|NCT01961544|474200778|FG000|Overall Study|Adverse Event|1|||
131704642|NCT01961544|474200778|FG000|Overall Study|Physician Decision|2|||
131704643|NCT01961544|474200778|FG000|Overall Study|Poor Tolerance|1|||
131704644|NCT01961544|474200778|FG000|Overall Study|Aggravation of Steral Pain|1|||
131704645|NCT03665285|474200779|FG000|Overall Study|Started New Anticancer Treatment|1|||
131704646|NCT03665285|474200780|FG001|Overall Study|Started New Anticancer Treatment|1|||
131704647|NCT03665285|474200781|FG002|Overall Study|Started New Anticancer Treatment|2|||
131704648|NCT03665285|474200782|FG003|Overall Study|Started New Anticancer Treatment|4|||
131704649|NCT03665285|474200783|FG004|Overall Study|Started New Anticancer Treatment|1|||
131704650|NCT03665285|474200784|FG005|Overall Study|Started New Anticancer Treatment|1|||
131704651|NCT03665285|474200785|FG006|Overall Study|Started New Anticancer Treatment|2|||
131704652|NCT03665285|474200786|FG007|Overall Study|Started New Anticancer Treatment|15|||
131704653|NCT03665285|474200787|FG008|Overall Study|Started New Anticancer Treatment|1|||
131704654|NCT03665285|474200779|FG000|Overall Study|Disease Progression|0|||
131704655|NCT03665285|474200780|FG001|Overall Study|Disease Progression|0|||
131584589|NCT03112174|473769855|FG002|Overall Study|Other, Not Specified|1|||
131584590|NCT03112174|473769856|FG003|Overall Study|Other, Not Specified|2|||
131584591|NCT03112174|473769857|FG004|Overall Study|Other, Not Specified|0|||
131584592|NCT04259450|473769860|FG000|Overall Study|Adverse event/ Toxicity|0|||
131584593|NCT04259450|473769861|FG001|Overall Study|Adverse event/ Toxicity|3|||
131584594|NCT04259450|473769862|FG002|Overall Study|Adverse event/ Toxicity|0|||
131584595|NCT04259450|473769863|FG003|Overall Study|Adverse event/ Toxicity|1|||
131584596|NCT04259450|473769864|FG004|Overall Study|Adverse event/ Toxicity|0|||
131584597|NCT04259450|473769865|FG005|Overall Study|Adverse event/ Toxicity|0|||
131584598|NCT04259450|473769866|FG006|Overall Study|Adverse event/ Toxicity|0|||
131584599|NCT04259450|473769867|FG007|Overall Study|Adverse event/ Toxicity|1|||
131584600|NCT04259450|473769868|FG008|Overall Study|Adverse event/ Toxicity|0|||
131584601|NCT04259450|473769869|FG009|Overall Study|Adverse event/ Toxicity|3|||
131584602|NCT04259450|473769860|FG000|Overall Study|Disease progression|2|||
131584603|NCT04259450|473769861|FG001|Overall Study|Disease progression|3|||
131584604|NCT04259450|473769862|FG002|Overall Study|Disease progression|4|||
131584605|NCT04259450|473769863|FG003|Overall Study|Disease progression|4|||
131584606|NCT04259450|473769864|FG004|Overall Study|Disease progression|6|||
131584607|NCT04259450|473769865|FG005|Overall Study|Disease progression|6|||
131584608|NCT04259450|473769866|FG006|Overall Study|Disease progression|6|||
131584609|NCT04259450|473769867|FG007|Overall Study|Disease progression|15|||
131584610|NCT04259450|473769868|FG008|Overall Study|Disease progression|6|||
131584611|NCT04259450|473769869|FG009|Overall Study|Disease progression|18|||
131584612|NCT04259450|473769860|FG000|Overall Study|Death|0|||
131584613|NCT04259450|473769861|FG001|Overall Study|Death|0|||
131584614|NCT04259450|473769862|FG002|Overall Study|Death|0|||
131584615|NCT04259450|473769863|FG003|Overall Study|Death|0|||
131584616|NCT04259450|473769864|FG004|Overall Study|Death|0|||
131584617|NCT04259450|473769865|FG005|Overall Study|Death|0|||
131584618|NCT04259450|473769866|FG006|Overall Study|Death|0|||
131584619|NCT04259450|473769867|FG007|Overall Study|Death|1|||
131584620|NCT04259450|473769868|FG008|Overall Study|Death|1|||
131584621|NCT04259450|473769869|FG009|Overall Study|Death|0|||
131584622|NCT04259450|473769860|FG000|Overall Study|Withdrawal by Subject|0|||
131584623|NCT04259450|473769861|FG001|Overall Study|Withdrawal by Subject|0|||
131584624|NCT04259450|473769862|FG002|Overall Study|Withdrawal by Subject|0|||
131584625|NCT04259450|473769863|FG003|Overall Study|Withdrawal by Subject|0|||
131584626|NCT04259450|473769864|FG004|Overall Study|Withdrawal by Subject|0|||
131584627|NCT04259450|473769865|FG005|Overall Study|Withdrawal by Subject|0|||
131584628|NCT04259450|473769866|FG006|Overall Study|Withdrawal by Subject|0|||
131584629|NCT04259450|473769867|FG007|Overall Study|Withdrawal by Subject|1|||
131584630|NCT04259450|473769868|FG008|Overall Study|Withdrawal by Subject|0|||
131584631|NCT04259450|473769869|FG009|Overall Study|Withdrawal by Subject|0|||
131584632|NCT04259450|473769860|FG000|Overall Study|Other than listed|0|||
131584633|NCT04259450|473769861|FG001|Overall Study|Other than listed|0|||
131584634|NCT04259450|473769862|FG002|Overall Study|Other than listed|0|||
131704656|NCT03665285|474200781|FG002|Overall Study|Disease Progression|3|||
131704657|NCT03665285|474200782|FG003|Overall Study|Disease Progression|1|||
131704658|NCT03665285|474200783|FG004|Overall Study|Disease Progression|0|||
131704659|NCT03665285|474200784|FG005|Overall Study|Disease Progression|0|||
131704660|NCT03665285|474200785|FG006|Overall Study|Disease Progression|0|||
131704661|NCT03665285|474200786|FG007|Overall Study|Disease Progression|7|||
131704662|NCT03665285|474200787|FG008|Overall Study|Disease Progression|1|||
131704663|NCT03665285|474200779|FG000|Overall Study|Hospice|0|||
131704664|NCT03665285|474200780|FG001|Overall Study|Hospice|0|||
131704665|NCT03665285|474200781|FG002|Overall Study|Hospice|0|||
131704666|NCT03665285|474200782|FG003|Overall Study|Hospice|0|||
131704667|NCT03665285|474200783|FG004|Overall Study|Hospice|0|||
131704668|NCT03665285|474200784|FG005|Overall Study|Hospice|0|||
131704669|NCT03665285|474200785|FG006|Overall Study|Hospice|0|||
131704670|NCT03665285|474200786|FG007|Overall Study|Hospice|2|||
131704671|NCT03665285|474200787|FG008|Overall Study|Hospice|0|||
131704672|NCT03665285|474200779|FG000|Overall Study|Withdrawal by Subject|0|||
131704673|NCT03665285|474200780|FG001|Overall Study|Withdrawal by Subject|0|||
131704674|NCT03665285|474200781|FG002|Overall Study|Withdrawal by Subject|0|||
131704675|NCT03665285|474200782|FG003|Overall Study|Withdrawal by Subject|0|||
131704676|NCT03665285|474200783|FG004|Overall Study|Withdrawal by Subject|1|||
131704677|NCT03665285|474200784|FG005|Overall Study|Withdrawal by Subject|0|||
131789795|NCT00529568|474512745|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
131789796|NCT00529568|474512746|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
131789797|NCT00529568|474512747|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
131584635|NCT04259450|473769863|FG003|Overall Study|Other than listed|0|||
131584636|NCT04259450|473769864|FG004|Overall Study|Other than listed|0|||
131584637|NCT04259450|473769865|FG005|Overall Study|Other than listed|0|||
131584638|NCT04259450|473769866|FG006|Overall Study|Other than listed|0|||
131704678|NCT03665285|474200785|FG006|Overall Study|Withdrawal by Subject|0|||
131704679|NCT03665285|474200786|FG007|Overall Study|Withdrawal by Subject|2|||
131704680|NCT03665285|474200787|FG008|Overall Study|Withdrawal by Subject|0|||
131704681|NCT03665285|474200779|FG000|Overall Study|Physician Decision|0|||
131704682|NCT03665285|474200780|FG001|Overall Study|Physician Decision|0|||
131584639|NCT04259450|473769867|FG007|Overall Study|Other than listed|1|||
131584640|NCT04259450|473769868|FG008|Overall Study|Other than listed|1|||
131584641|NCT04259450|473769869|FG009|Overall Study|Other than listed|2|||
131584642|NCT01534494|473769876|FG000|Overall Study|Withdrawal by Subject|1|||
131584643|NCT02724592|473769877|FG000|Overall Study|Lost to Follow-up|4|||
131584644|NCT02724592|473769878|FG001|Overall Study|Lost to Follow-up|1|||
131584645|NCT02584829|473769879|FG000|Overall Study|Physician Decision|1|||
131584646|NCT02584829|473769880|FG001|Overall Study|Physician Decision|0|||
131584647|NCT02584829|473769879|FG000|Overall Study|Withdrawal by Subject|0|||
131789798|NCT00529568|474512745|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
131789799|NCT00529568|474512746|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
131789800|NCT00529568|474512747|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
131789801|NCT00529568|474512745|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
131789802|NCT00529568|474512746|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
131789803|NCT00529568|474512747|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
131789804|NCT00529568|474512745|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
131789805|NCT00529568|474512746|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
131584648|NCT02584829|473769880|FG001|Overall Study|Withdrawal by Subject|1|||
131584649|NCT02584829|473769879|FG000|Overall Study|Progressive Disease|0|||
131584650|NCT02584829|473769880|FG001|Overall Study|Progressive Disease|3|||
131584651|NCT00434304|473769887|FG000|Overall Study|Adverse Event|14|||
131584652|NCT00434304|473769887|FG000|Overall Study|Lack of Efficacy|2|||
131584653|NCT00434304|473769887|FG000|Overall Study|Withdrawal by Subject|4|||
131584654|NCT05262738|473769888|FG000|Overall Study|Withdrawal by Subject|1|||
131584655|NCT05262738|473769889|FG001|Overall Study|Withdrawal by Subject|0|||
131584656|NCT02374463|473769890|FG000|Overall Study|Withdrawal by Subject|3|||
131584657|NCT02374463|473769891|FG001|Overall Study|Withdrawal by Subject|3|||
131584658|NCT01939899|473769898|FG000|Lead-in Dose Finding Phase|Death|0|||
131584659|NCT01939899|473769899|FG001|Lead-in Dose Finding Phase|Death|3|||
131704683|NCT03665285|474200781|FG002|Overall Study|Physician Decision|0|||
131704684|NCT03665285|474200782|FG003|Overall Study|Physician Decision|0|||
131704685|NCT03665285|474200783|FG004|Overall Study|Physician Decision|0|||
131704686|NCT03665285|474200784|FG005|Overall Study|Physician Decision|0|||
131704687|NCT03665285|474200785|FG006|Overall Study|Physician Decision|0|||
131584660|NCT01939899|473769900|FG002|Lead-in Dose Finding Phase|Death|1|||
131584661|NCT01939899|473769901|FG003|Lead-in Dose Finding Phase|Death|0|||
131704688|NCT03665285|474200786|FG007|Overall Study|Physician Decision|2|||
131704689|NCT03665285|474200787|FG008|Overall Study|Physician Decision|0|||
131704690|NCT00354601|474200788|FG000|Overall Study|Protocol Violation|1|||
131704691|NCT00354601|474200788|FG000|Overall Study|progression|1|||
131704692|NCT03603652|474200789|FG000|Overall Study|Death|2|||
131704693|NCT03213366|474200794|FG000|Overall Study|Lost to Follow-up|9|||
131704694|NCT03213366|474200795|FG001|Overall Study|Lost to Follow-up|4|||
131704695|NCT02532855|474200796|FG000|Overall Study|Lost to Follow-up|4|||
131704696|NCT02532855|474200797|FG001|Overall Study|Lost to Follow-up|3|||
131704697|NCT02532855|474200796|FG000|Overall Study|Withdrawal by Subject|4|||
131704698|NCT02532855|474200797|FG001|Overall Study|Withdrawal by Subject|8|||
131704699|NCT01960855|474200798|FG000|Overall Study|Subject noncompliant|1|||
131704700|NCT01960855|474200799|FG001|Overall Study|Subject noncompliant|0|||
131704701|NCT01960855|474200800|FG002|Overall Study|Subject noncompliant|0|||
131704702|NCT01960855|474200801|FG003|Overall Study|Subject noncompliant|0|||
131704703|NCT01960855|474200802|FG004|Overall Study|Subject noncompliant|0|||
131704704|NCT01960855|474200798|FG000|Overall Study|Adverse Event|2|||
131704705|NCT01960855|474200799|FG001|Overall Study|Adverse Event|0|||
131704706|NCT01960855|474200800|FG002|Overall Study|Adverse Event|6|||
131704707|NCT01960855|474200801|FG003|Overall Study|Adverse Event|2|||
131704708|NCT01960855|474200802|FG004|Overall Study|Adverse Event|2|||
131704709|NCT01960855|474200798|FG000|Overall Study|Lack of Efficacy|1|||
131704710|NCT01960855|474200799|FG001|Overall Study|Lack of Efficacy|1|||
131704711|NCT01960855|474200800|FG002|Overall Study|Lack of Efficacy|0|||
131704712|NCT01960855|474200801|FG003|Overall Study|Lack of Efficacy|0|||
131704713|NCT01960855|474200802|FG004|Overall Study|Lack of Efficacy|0|||
131704714|NCT01960855|474200798|FG000|Overall Study|Other|2|||
131704715|NCT01960855|474200799|FG001|Overall Study|Other|1|||
131704716|NCT01960855|474200800|FG002|Overall Study|Other|1|||
131704717|NCT01960855|474200801|FG003|Overall Study|Other|1|||
131704718|NCT01960855|474200802|FG004|Overall Study|Other|0|||
131704719|NCT01960855|474200798|FG000|Overall Study|Consent withdrawn by subject|3|||
131704720|NCT01960855|474200799|FG001|Overall Study|Consent withdrawn by subject|1|||
131704721|NCT01960855|474200800|FG002|Overall Study|Consent withdrawn by subject|2|||
131704722|NCT01960855|474200801|FG003|Overall Study|Consent withdrawn by subject|1|||
131704723|NCT01960855|474200802|FG004|Overall Study|Consent withdrawn by subject|1|||
131704724|NCT01960855|474200798|FG000|Overall Study|Lost to Follow-up|2|||
131584662|NCT01939899|473769902|FG004|Lead-in Dose Finding Phase|Death|0|||
131584663|NCT01939899|473769898|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
131584664|NCT01939899|473769899|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
131704725|NCT01960855|474200799|FG001|Overall Study|Lost to Follow-up|1|||
131704726|NCT01960855|474200800|FG002|Overall Study|Lost to Follow-up|0|||
131704727|NCT01960855|474200801|FG003|Overall Study|Lost to Follow-up|0|||
131704728|NCT01960855|474200802|FG004|Overall Study|Lost to Follow-up|2|||
131789806|NCT00529568|474512747|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
131789807|NCT00529568|474512745|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
131789808|NCT00529568|474512746|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
131789809|NCT00529568|474512747|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
131789810|NCT00529568|474512745|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
131789811|NCT00529568|474512746|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
131789812|NCT00529568|474512747|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
131789813|NCT00529568|474512745|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
131789814|NCT00529568|474512746|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
131789815|NCT00529568|474512747|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
131789816|NCT00529568|474512745|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
131789817|NCT00529568|474512746|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
131789818|NCT00529568|474512747|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
131789819|NCT00529568|474512745|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
131789820|NCT00529568|474512746|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
131789821|NCT00529568|474512747|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
131789822|NCT00529568|474512745|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
131789823|NCT00529568|474512746|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
131789824|NCT00529568|474512747|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
131789825|NCT00529568|474512745|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
131789826|NCT00529568|474512746|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
131789827|NCT00529568|474512747|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
131789828|NCT01201356|474512748|FG000|Overall Study|Adverse Event|170|||
131789829|NCT01201356|474512748|FG000|Overall Study|Abnormal laboratory value(s)|51|||
131789830|NCT01201356|474512748|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131789831|NCT01201356|474512748|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
131789832|NCT01201356|474512748|FG000|Overall Study|Condition no longer requires study drug|12|||
131789833|NCT01201356|474512748|FG000|Overall Study|Withdrawal by Subject|144|||
131789834|NCT01201356|474512748|FG000|Overall Study|Lost to Follow-up|50|||
131789835|NCT01201356|474512748|FG000|Overall Study|administrative problems|74|||
131789836|NCT01201356|474512748|FG000|Overall Study|Death|16|||
131789837|NCT01201356|474512748|FG000|Overall Study|Protocol Violation|12|||
131789838|NCT00811070|474512749|FG000|Overall Study|Death|0|||
131789839|NCT00811070|474512750|FG001|Overall Study|Death|0|||
131789840|NCT00811070|474512751|FG002|Overall Study|Death|0|||
131789841|NCT00811070|474512752|FG003|Overall Study|Death|2|||
131789842|NCT00811070|474512753|FG004|Overall Study|Death|5|||
131789843|NCT00811070|474512754|FG005|Overall Study|Death|0|||
131789844|NCT00811070|474512749|FG000|Overall Study|Other|1|||
131789845|NCT00811070|474512750|FG001|Overall Study|Other|0|||
131789846|NCT00811070|474512751|FG002|Overall Study|Other|0|||
131789847|NCT00811070|474512752|FG003|Overall Study|Other|0|||
131789848|NCT00811070|474512753|FG004|Overall Study|Other|0|||
131789849|NCT00811070|474512754|FG005|Overall Study|Other|0|||
131789850|NCT00811070|474512749|FG000|Overall Study|Withdrawal by Subject|0|||
131789851|NCT00811070|474512750|FG001|Overall Study|Withdrawal by Subject|1|||
131789852|NCT00811070|474512751|FG002|Overall Study|Withdrawal by Subject|0|||
131789853|NCT00811070|474512752|FG003|Overall Study|Withdrawal by Subject|0|||
131789854|NCT00811070|474512753|FG004|Overall Study|Withdrawal by Subject|0|||
131789855|NCT00811070|474512754|FG005|Overall Study|Withdrawal by Subject|0|||
131789856|NCT00811070|474512749|FG000|Overall Study|Physician Decision|0|||
131789857|NCT00811070|474512750|FG001|Overall Study|Physician Decision|0|||
131789858|NCT00811070|474512751|FG002|Overall Study|Physician Decision|0|||
131789859|NCT00811070|474512752|FG003|Overall Study|Physician Decision|0|||
131789860|NCT00811070|474512753|FG004|Overall Study|Physician Decision|0|||
131789861|NCT00811070|474512754|FG005|Overall Study|Physician Decision|1|||
131789862|NCT01025193|474512755|FG000|Overall Study|Protocol Violation|1|||
131789863|NCT01025193|474512755|FG000|Overall Study|Adverse Event|3|||
131789864|NCT04079842|474512756|FG000|Overall Study|Request of subject|2|||
131789865|NCT04079842|474512756|FG000|Overall Study|Unable to draw Arterial samples|1|||
131789866|NCT02904200|474512757|FG000|Overall Study|Withdrawal by Subject|1|||
131789867|NCT02904200|474512758|FG001|Overall Study|Withdrawal by Subject|0|||
131789868|NCT03372083|474514881|FG000|Overall Study|Adverse Event|3|||
131789869|NCT03372083|474514881|FG000|Overall Study|Physician Decision|1|||
131789870|NCT03372083|474514881|FG000|Overall Study|Withdrawal by Subject|1|||
131789871|NCT02266706|474514882|FG000|Overall Study|Withdrawal by Subject|0|||
131789872|NCT02266706|474514883|FG001|Overall Study|Withdrawal by Subject|1|||
131789873|NCT02266706|474514884|FG002|Overall Study|Withdrawal by Subject|1|||
131789874|NCT02266706|474514885|FG003|Overall Study|Withdrawal by Subject|0|||
131789875|NCT02266706|474514886|FG004|Overall Study|Withdrawal by Subject|0|||
131789876|NCT02266706|474514887|FG005|Overall Study|Withdrawal by Subject|1|||
131789877|NCT02266706|474514888|FG006|Overall Study|Withdrawal by Subject|0|||
131789878|NCT02266706|474514889|FG007|Overall Study|Withdrawal by Subject|0|||
131584665|NCT01939899|473769900|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
131584666|NCT01939899|473769901|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
131584667|NCT01939899|473769902|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
131584668|NCT01939899|473769898|FG000|Lead-in Dose Finding Phase|Other|0|||
131584669|NCT01939899|473769899|FG001|Lead-in Dose Finding Phase|Other|0|||
131704729|NCT02058147|474200803|FG000|Overall Study|Randomized but not treated|0|||
131704730|NCT02058147|474200804|FG001|Overall Study|Randomized but not treated|0|||
131704731|NCT02058147|474200805|FG002|Overall Study|Randomized but not treated|1|||
131704732|NCT02058147|474200803|FG000|Overall Study|Adverse Event|12|||
131704733|NCT02058147|474200804|FG001|Overall Study|Adverse Event|9|||
131704734|NCT02058147|474200805|FG002|Overall Study|Adverse Event|21|||
131704735|NCT02058147|474200803|FG000|Overall Study|Lack of Efficacy|1|||
131704736|NCT02058147|474200804|FG001|Overall Study|Lack of Efficacy|0|||
131704737|NCT02058147|474200805|FG002|Overall Study|Lack of Efficacy|3|||
131704738|NCT02058147|474200803|FG000|Overall Study|Poor compliance to protocol|8|||
131704739|NCT02058147|474200804|FG001|Overall Study|Poor compliance to protocol|9|||
131704740|NCT02058147|474200805|FG002|Overall Study|Poor compliance to protocol|4|||
131704741|NCT02058147|474200803|FG000|Overall Study|Other than specified|8|||
131704742|NCT02058147|474200804|FG001|Overall Study|Other than specified|9|||
131704743|NCT02058147|474200805|FG002|Overall Study|Other than specified|0|||
131704744|NCT00713219|474200812|FG000|Overall Study|Death|1|||
131704745|NCT00713219|474200812|FG000|Overall Study|Protocol Violation|1|||
131704746|NCT01890421|474200813|FG000|Overall Study|Adverse Event|1|||
131704747|NCT01890421|474200813|FG000|Overall Study|Other reason|10|||
131704748|NCT01133171|474200814|FG000|Overall Study|Withdrawal by Subject|1|||
131704749|NCT01133171|474200815|FG001|Overall Study|Withdrawal by Subject|2|||
131704750|NCT01133171|474200816|FG002|Overall Study|Withdrawal by Subject|0|||
131704751|NCT03969888|474200817|FG000|Overall Study|Never Received Study Drug|0|||
131704752|NCT03969888|474200818|FG001|Overall Study|Never Received Study Drug|0|||
131704753|NCT03969888|474200819|FG002|Overall Study|Never Received Study Drug|1|||
131704754|NCT03969888|474200820|FG003|Overall Study|Never Received Study Drug|0|||
131704755|NCT03969888|474200821|FG004|Overall Study|Never Received Study Drug|0|||
131704756|NCT03969888|474200822|FG005|Overall Study|Never Received Study Drug|0|||
131704757|NCT03969888|474200823|FG006|Overall Study|Never Received Study Drug|1|||
131704758|NCT03969888|474200824|FG007|Overall Study|Never Received Study Drug|0|||
131704759|NCT03969888|474200817|FG000|Overall Study|Reason Not Specified|0|||
131704760|NCT03969888|474200818|FG001|Overall Study|Reason Not Specified|0|||
131704761|NCT03969888|474200819|FG002|Overall Study|Reason Not Specified|0|||
131704762|NCT03969888|474200820|FG003|Overall Study|Reason Not Specified|0|||
131704763|NCT03969888|474200821|FG004|Overall Study|Reason Not Specified|0|||
131704764|NCT03969888|474200822|FG005|Overall Study|Reason Not Specified|0|||
131704765|NCT03969888|474200823|FG006|Overall Study|Reason Not Specified|0|||
131704766|NCT03969888|474200824|FG007|Overall Study|Reason Not Specified|1|||
131704767|NCT03828487|474200833|FG000|Overall Study|Physician Decision|1|||
131704768|NCT01445678|474200835|FG000|Overall Study|Adverse Event|12|||
131704769|NCT01445678|474200836|FG001|Overall Study|Adverse Event|8|||
131584670|NCT01939899|473769900|FG002|Lead-in Dose Finding Phase|Other|1|||
131584671|NCT01939899|473769901|FG003|Lead-in Dose Finding Phase|Other|0|||
131704770|NCT01445678|474200835|FG000|Overall Study|Lack of Efficacy|0|||
131704771|NCT01445678|474200836|FG001|Overall Study|Lack of Efficacy|2|||
131704772|NCT01445678|474200835|FG000|Overall Study|Lost to Follow-up|8|||
131704773|NCT01445678|474200836|FG001|Overall Study|Lost to Follow-up|5|||
131704774|NCT01445678|474200835|FG000|Overall Study|Protocol Violation|1|||
131704775|NCT01445678|474200836|FG001|Overall Study|Protocol Violation|1|||
131704776|NCT01445678|474200835|FG000|Overall Study|Withdrawal by Subject|9|||
131704777|NCT01445678|474200836|FG001|Overall Study|Withdrawal by Subject|5|||
131704778|NCT02472847|474203359|FG000|Overall Study|Withdrawal by Subject|1|||
131704779|NCT02472847|474203360|FG001|Overall Study|Withdrawal by Subject|5|||
131704780|NCT04656990|474203361|FG000|Baseline|pandemic|20|||
131704781|NCT04656990|474203362|FG001|Baseline|pandemic|24|||
131704782|NCT04656990|474203361|FG000|Follow Up Period|Lost to Follow-up|61|||
131704783|NCT04656990|474203362|FG001|Follow Up Period|Lost to Follow-up|73|||
131704784|NCT03244059|474203363|FG000|Specific Aim 1|Physician Decision|1|||
131704785|NCT03244059|474203364|FG001|Specific Aim 1|Physician Decision|0|||
131704786|NCT03244059|474203363|FG000|Specific Aim 2|Physician Decision|1|||
131704787|NCT03244059|474203364|FG001|Specific Aim 2|Physician Decision|0|||
131704788|NCT00623831|474203367|FG000|Overall Study|Withdrawal by Subject|1|||
131704789|NCT00623831|474203368|FG001|Overall Study|Withdrawal by Subject|0|||
131704790|NCT00623831|474203367|FG000|Overall Study|Progressive Disease|0|||
131704791|NCT00623831|474203368|FG001|Overall Study|Progressive Disease|1|||
131704792|NCT01276821|474203369|FG000|Overall Study|Protocol Violation|0|||
131704793|NCT01276821|474203370|FG001|Overall Study|Protocol Violation|1|||
131584672|NCT01939899|473769902|FG004|Lead-in Dose Finding Phase|Other|0|||
131584673|NCT01939899|473769898|FG000|Phase 2|Withdrawal by Subject|0|||
131704794|NCT00282243|474203371|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
131704795|NCT00282243|474203371|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
131704796|NCT00282243|474203371|FG000|Extension Treatment Period|Adverse Event|15|||
131704797|NCT00282243|474203371|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
131789879|NCT02266706|474514890|FG008|Overall Study|Withdrawal by Subject|0|||
131789880|NCT02266706|474514882|FG000|Overall Study|Screen failure|0|||
131789881|NCT02266706|474514883|FG001|Overall Study|Screen failure|0|||
131789882|NCT02266706|474514884|FG002|Overall Study|Screen failure|0|||
131789883|NCT02266706|474514885|FG003|Overall Study|Screen failure|0|||
131789884|NCT02266706|474514886|FG004|Overall Study|Screen failure|0|||
131789885|NCT02266706|474514887|FG005|Overall Study|Screen failure|1|||
131789886|NCT02266706|474514888|FG006|Overall Study|Screen failure|1|||
131789887|NCT02266706|474514889|FG007|Overall Study|Screen failure|0|||
131789888|NCT02266706|474514890|FG008|Overall Study|Screen failure|0|||
131789889|NCT02266706|474514882|FG000|Overall Study|Enrollment in another study|0|||
131789890|NCT02266706|474514883|FG001|Overall Study|Enrollment in another study|0|||
131789891|NCT02266706|474514884|FG002|Overall Study|Enrollment in another study|0|||
131789892|NCT02266706|474514885|FG003|Overall Study|Enrollment in another study|1|||
131789893|NCT02266706|474514886|FG004|Overall Study|Enrollment in another study|0|||
131789894|NCT02266706|474514887|FG005|Overall Study|Enrollment in another study|0|||
131789895|NCT02266706|474514888|FG006|Overall Study|Enrollment in another study|0|||
131789896|NCT02266706|474514889|FG007|Overall Study|Enrollment in another study|0|||
131789897|NCT02266706|474514890|FG008|Overall Study|Enrollment in another study|0|||
131789898|NCT02544633|474514891|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
131789899|NCT02544633|474514892|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
131789900|NCT02544633|474514893|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
131789901|NCT02544633|474514894|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
131789902|NCT02544633|474514891|FG000|Treatment Period|Adverse Event|7|||
131789903|NCT02544633|474514892|FG001|Treatment Period|Adverse Event|4|||
131789904|NCT02544633|474514893|FG002|Treatment Period|Adverse Event|0|||
131789905|NCT02544633|474514894|FG003|Treatment Period|Adverse Event|5|||
131789906|NCT02544633|474514891|FG000|Treatment Period|Lack of Efficacy|17|||
131789907|NCT02544633|474514892|FG001|Treatment Period|Lack of Efficacy|11|||
131789908|NCT02544633|474514893|FG002|Treatment Period|Lack of Efficacy|5|||
131789909|NCT02544633|474514894|FG003|Treatment Period|Lack of Efficacy|5|||
131789910|NCT02544633|474514891|FG000|Treatment Period|Global Deterioration of Health|3|||
131789911|NCT02544633|474514892|FG001|Treatment Period|Global Deterioration of Health|3|||
131789912|NCT02544633|474514893|FG002|Treatment Period|Global Deterioration of Health|0|||
131789913|NCT02544633|474514894|FG003|Treatment Period|Global Deterioration of Health|1|||
131789914|NCT02544633|474514891|FG000|Treatment Period|Withdrawal by Subject|1|||
131789915|NCT02544633|474514892|FG001|Treatment Period|Withdrawal by Subject|0|||
131789916|NCT02544633|474514893|FG002|Treatment Period|Withdrawal by Subject|0|||
131789917|NCT02544633|474514894|FG003|Treatment Period|Withdrawal by Subject|0|||
131789918|NCT02544633|474514891|FG000|Treatment Period|Lost to Follow-up|0|||
131789919|NCT02544633|474514892|FG001|Treatment Period|Lost to Follow-up|1|||
131789920|NCT02544633|474514893|FG002|Treatment Period|Lost to Follow-up|0|||
131789921|NCT02544633|474514894|FG003|Treatment Period|Lost to Follow-up|0|||
131789922|NCT02544633|474514891|FG000|Treatment Period|Death|0|||
131789923|NCT02544633|474514892|FG001|Treatment Period|Death|0|||
131789924|NCT02544633|474514893|FG002|Treatment Period|Death|1|||
131789925|NCT02544633|474514894|FG003|Treatment Period|Death|0|||
131789926|NCT02544633|474514891|FG000|Treatment Period|Non-compliance|0|||
131789927|NCT02544633|474514892|FG001|Treatment Period|Non-compliance|0|||
131789928|NCT02544633|474514893|FG002|Treatment Period|Non-compliance|1|||
131789929|NCT02544633|474514894|FG003|Treatment Period|Non-compliance|0|||
131789930|NCT02544633|474514891|FG000|Treatment Period|Clinical Disease Progression|0|||
131789931|NCT02544633|474514892|FG001|Treatment Period|Clinical Disease Progression|0|||
131789932|NCT02544633|474514893|FG002|Treatment Period|Clinical Disease Progression|0|||
131789933|NCT02544633|474514894|FG003|Treatment Period|Clinical Disease Progression|1|||
131789934|NCT02544633|474514891|FG000|Survival Follow-up Period|Death|12|||
131789935|NCT02544633|474514892|FG001|Survival Follow-up Period|Death|14|||
131789936|NCT02544633|474514893|FG002|Survival Follow-up Period|Death|3|||
131789937|NCT02544633|474514894|FG003|Survival Follow-up Period|Death|9|||
131789938|NCT02544633|474514891|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
131789939|NCT02544633|474514892|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
131789940|NCT02544633|474514893|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
131789941|NCT02544633|474514894|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
131789942|NCT02544633|474514891|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
131789943|NCT02544633|474514892|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
131789944|NCT02544633|474514893|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
131789945|NCT02544633|474514894|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
131789946|NCT02544633|474514891|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
131789947|NCT02544633|474514892|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
131789948|NCT02544633|474514893|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
131789949|NCT02544633|474514894|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
131789950|NCT01977352|474514895|FG000|Overall Study|Lost to Follow-up|1|||
131789951|NCT01977352|474514896|FG001|Overall Study|Lost to Follow-up|2|||
131789952|NCT02257632|474514902|FG000|Overall Study|Withdrawal by Subject|0|||
131584674|NCT01939899|473769899|FG001|Phase 2|Withdrawal by Subject|0|||
131789953|NCT02257632|474514903|FG001|Overall Study|Withdrawal by Subject|1|||
131789954|NCT02257632|474514902|FG000|Overall Study|Adverse Event|1|||
131789955|NCT02257632|474514903|FG001|Overall Study|Adverse Event|2|||
131789956|NCT02024698|474514904|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
131789957|NCT02024698|474514905|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
131789958|NCT00275028|474514906|FG000|Overall Study|Withdrew consent before treatment began|1|||
131789959|NCT00275028|474514906|FG000|Overall Study|Withdrawal by Subject|5|||
131789960|NCT00275028|474514906|FG000|Overall Study|Adverse Event|9|||
131789961|NCT00275028|474514906|FG000|Overall Study|Progressive Disease|30|||
131789962|NCT00275028|474514906|FG000|Overall Study|Physician Decision|2|||
131789963|NCT02370784|474514908|FG000|Overall Study|Patient started prohibited medication|0|||
131789964|NCT02370784|474514909|FG001|Overall Study|Patient started prohibited medication|1|||
131789965|NCT00331630|474514910|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
131789966|NCT00331630|474514910|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
131789967|NCT00331630|474514910|FG000|Follow up for 5 Years|Death|5|||
131789968|NCT00331630|474514910|FG000|Follow up for 5 Years|Data collection was stopped|24|||
131789969|NCT01312779|474514911|FG000|Overall Study|Withdrawal by Subject|2|||
131789970|NCT01312779|474514911|FG000|Overall Study|Death|3|||
131789971|NCT01312779|474514911|FG000|Overall Study|Not Implanted with Device|27|||
131789972|NCT02764489|474514918|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
131789973|NCT02764489|474514919|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
131789974|NCT02764489|474514918|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
131789975|NCT02764489|474514919|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
131789976|NCT02764489|474514918|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
131789977|NCT02764489|474514919|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
131789978|NCT02764489|474514918|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
131789979|NCT02764489|474514919|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
131789980|NCT01473758|474514924|FG000|Cycle 1|Adverse Event|10|||
131789981|NCT01473758|474514925|FG001|Cycle 1|Adverse Event|2|||
131789982|NCT01473758|474514926|FG002|Cycle 1|Adverse Event|0|||
131789983|NCT01473758|474514927|FG003|Cycle 1|Adverse Event|0|||
131789984|NCT01473758|474514924|FG000|Cycle 1|Withdrawal by Subject|1|||
131789985|NCT01473758|474514925|FG001|Cycle 1|Withdrawal by Subject|1|||
131789986|NCT01473758|474514926|FG002|Cycle 1|Withdrawal by Subject|0|||
131789987|NCT01473758|474514927|FG003|Cycle 1|Withdrawal by Subject|0|||
131789988|NCT01473758|474514924|FG000|Cycle 2|Adverse Event|0|||
131789989|NCT01473758|474514925|FG001|Cycle 2|Adverse Event|0|||
131789990|NCT01473758|474514926|FG002|Cycle 2|Adverse Event|5|||
131789991|NCT01473758|474514927|FG003|Cycle 2|Adverse Event|0|||
131789992|NCT02480010|474514928|FG000|Overall Study|Adverse Event|3|||
131789993|NCT02480010|474514929|FG001|Overall Study|Adverse Event|1|||
131789994|NCT02480010|474514928|FG000|Overall Study|Death|1|||
131789995|NCT02480010|474514929|FG001|Overall Study|Death|0|||
131789996|NCT02480010|474514928|FG000|Overall Study|Insufficient therapeutic response|31|||
131789997|NCT02480010|474514929|FG001|Overall Study|Insufficient therapeutic response|29|||
131789998|NCT02480010|474514928|FG000|Overall Study|Refused Treatment|0|||
131789999|NCT02480010|474514929|FG001|Overall Study|Refused Treatment|3|||
131790000|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
131790001|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131790002|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131790003|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131790004|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131790005|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131790006|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131790007|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
131790008|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131790009|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131790010|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131790011|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131790012|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131790013|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131790014|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
131584675|NCT01939899|473769900|FG002|Phase 2|Withdrawal by Subject|0|||
131790015|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
131790016|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
131790017|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
131790018|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
131790019|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
131790020|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
131790021|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
131790022|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131790023|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131790024|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131790025|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131790026|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131790027|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131790028|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
131790029|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131790030|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131790031|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131790032|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131790033|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131790034|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131790035|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
131790036|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
131790037|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
131790038|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
131790039|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
131790040|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
131790041|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
131790042|NCT00606684|474514939|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
131790043|NCT00606684|474514940|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131790044|NCT00606684|474514941|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131790045|NCT00606684|474514942|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131790046|NCT00606684|474514943|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131790047|NCT00606684|474514944|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131790048|NCT00606684|474514945|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131790049|NCT00606684|474514939|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131790050|NCT00606684|474514940|FG001|Double-Blind Treatment Period|Adverse Event|3|||
131790051|NCT00606684|474514941|FG002|Double-Blind Treatment Period|Adverse Event|2|||
131790052|NCT00606684|474514942|FG003|Double-Blind Treatment Period|Adverse Event|4|||
131790053|NCT00606684|474514943|FG004|Double-Blind Treatment Period|Adverse Event|2|||
131790054|NCT00606684|474514944|FG005|Double-Blind Treatment Period|Adverse Event|0|||
131790055|NCT00606684|474514945|FG006|Double-Blind Treatment Period|Adverse Event|1|||
131790056|NCT00606684|474514939|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
131790057|NCT00606684|474514940|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
131790058|NCT00606684|474514941|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
131790059|NCT00606684|474514942|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
131790060|NCT00606684|474514943|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
131790061|NCT00606684|474514944|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
131790062|NCT00606684|474514945|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
131790063|NCT00606684|474514939|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131790064|NCT00606684|474514940|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
131790065|NCT00606684|474514941|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
131790066|NCT00606684|474514942|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
131790067|NCT00606684|474514943|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
131790068|NCT00606684|474514944|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
131790069|NCT00606684|474514945|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
131790070|NCT00606684|474514939|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
131790071|NCT00606684|474514940|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
131790072|NCT00606684|474514941|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
131790073|NCT00606684|474514942|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
131790074|NCT00606684|474514943|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
131790075|NCT00606684|474514944|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
131790076|NCT00606684|474514945|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
131790077|NCT00606684|474514939|FG000|Double-Blind Treatment Period|Physician Decision|0|||
131790078|NCT00606684|474514940|FG001|Double-Blind Treatment Period|Physician Decision|5|||
131584676|NCT01939899|473769901|FG003|Phase 2|Withdrawal by Subject|2|||
131790079|NCT00606684|474514941|FG002|Double-Blind Treatment Period|Physician Decision|1|||
131790080|NCT00606684|474514942|FG003|Double-Blind Treatment Period|Physician Decision|0|||
131790081|NCT00606684|474514943|FG004|Double-Blind Treatment Period|Physician Decision|3|||
131790082|NCT00606684|474514944|FG005|Double-Blind Treatment Period|Physician Decision|1|||
131584677|NCT01939899|473769902|FG004|Phase 2|Withdrawal by Subject|0|||
131584678|NCT01939899|473769898|FG000|Phase 2|Disease Progression|0|||
131584679|NCT01939899|473769899|FG001|Phase 2|Disease Progression|0|||
131584680|NCT01939899|473769900|FG002|Phase 2|Disease Progression|0|||
131584681|NCT01939899|473769901|FG003|Phase 2|Disease Progression|9|||
131584682|NCT01939899|473769902|FG004|Phase 2|Disease Progression|1|||
131790083|NCT00606684|474514945|FG006|Double-Blind Treatment Period|Physician Decision|2|||
131790084|NCT00606684|474514939|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131584683|NCT00585052|473769903|FG000|Overall Study|Withdrawal by Subject|1|||
131584684|NCT04723394|473769904|FG000|Overall Study|Adverse Event|0|||
131584685|NCT04723394|473769905|FG001|Overall Study|Adverse Event|3|||
131584686|NCT04723394|473769904|FG000|Overall Study|Death|8|||
131584687|NCT04723394|473769905|FG001|Overall Study|Death|8|||
131584688|NCT04723394|473769904|FG000|Overall Study|Lost to Follow-up|20|||
131584689|NCT04723394|473769905|FG001|Overall Study|Lost to Follow-up|17|||
131790085|NCT00606684|474514940|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131790086|NCT00606684|474514941|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131790087|NCT00606684|474514942|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131790088|NCT00606684|474514943|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131790089|NCT00606684|474514944|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131790090|NCT00606684|474514945|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131790091|NCT02763579|474514946|FG000|Global Period|Death|167|||
131790092|NCT02763579|474514947|FG001|Global Period|Death|151|||
131790093|NCT02763579|474514948|FG002|Global Period|Death|0|||
131790094|NCT02763579|474514949|FG003|Global Period|Death|0|||
131790095|NCT02763579|474514946|FG000|Global Period|Lost to Follow-up|2|||
131790096|NCT02763579|474514947|FG001|Global Period|Lost to Follow-up|4|||
131790097|NCT02763579|474514948|FG002|Global Period|Lost to Follow-up|0|||
131790098|NCT02763579|474514949|FG003|Global Period|Lost to Follow-up|0|||
131790099|NCT02763579|474514946|FG000|Global Period|Physician Decision|0|||
131790100|NCT02763579|474514947|FG001|Global Period|Physician Decision|2|||
131790101|NCT02763579|474514948|FG002|Global Period|Physician Decision|0|||
131584690|NCT04723394|473769904|FG000|Overall Study|Physician Decision|1|||
131584691|NCT04723394|473769905|FG001|Overall Study|Physician Decision|0|||
131584692|NCT04723394|473769904|FG000|Overall Study|Withdrawal by Subject|20|||
131584693|NCT04723394|473769905|FG001|Overall Study|Withdrawal by Subject|34|||
131584694|NCT04723394|473769904|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
131584695|NCT04723394|473769905|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
131584696|NCT00774397|473769906|FG000|Overall Study|Adverse Event|1|||
131790102|NCT02763579|474514949|FG003|Global Period|Physician Decision|0|||
131790103|NCT02763579|474514946|FG000|Global Period|Study Terminated By Sponsor|21|||
131790104|NCT02763579|474514947|FG001|Global Period|Study Terminated By Sponsor|26|||
131790105|NCT02763579|474514948|FG002|Global Period|Study Terminated By Sponsor|0|||
131790106|NCT02763579|474514949|FG003|Global Period|Study Terminated By Sponsor|0|||
131790107|NCT02763579|474514946|FG000|Global Period|Withdrawal by Subject|12|||
131790108|NCT02763579|474514947|FG001|Global Period|Withdrawal by Subject|18|||
131790109|NCT02763579|474514948|FG002|Global Period|Withdrawal by Subject|0|||
131790110|NCT02763579|474514949|FG003|Global Period|Withdrawal by Subject|0|||
131790111|NCT02763579|474514946|FG000|China Period|Death|0|||
131790112|NCT02763579|474514947|FG001|China Period|Death|0|||
131790113|NCT02763579|474514948|FG002|China Period|Death|46|||
131790114|NCT02763579|474514949|FG003|China Period|Death|48|||
131790115|NCT02763579|474514946|FG000|China Period|Lost to Follow-up|0|||
131584697|NCT00774397|473769907|FG001|Overall Study|Adverse Event|3|||
131790116|NCT02763579|474514947|FG001|China Period|Lost to Follow-up|0|||
131790117|NCT02763579|474514948|FG002|China Period|Lost to Follow-up|1|||
131790118|NCT02763579|474514949|FG003|China Period|Lost to Follow-up|1|||
131790119|NCT02763579|474514946|FG000|China Period|Physician Decision|0|||
131790120|NCT02763579|474514947|FG001|China Period|Physician Decision|0|||
131790121|NCT02763579|474514948|FG002|China Period|Physician Decision|0|||
131790122|NCT02763579|474514949|FG003|China Period|Physician Decision|1|||
131584698|NCT00774397|473769908|FG002|Overall Study|Adverse Event|16|||
131584699|NCT00774397|473769909|FG003|Overall Study|Adverse Event|8|||
131584700|NCT00774397|473769910|FG004|Overall Study|Adverse Event|8|||
131584701|NCT00774397|473769911|FG005|Overall Study|Adverse Event|3|||
131790123|NCT02763579|474514946|FG000|China Period|Study Terminated By Sponsor|0|||
131790124|NCT02763579|474514947|FG001|China Period|Study Terminated By Sponsor|0|||
131790125|NCT02763579|474514948|FG002|China Period|Study Terminated By Sponsor|3|||
131790126|NCT02763579|474514949|FG003|China Period|Study Terminated By Sponsor|4|||
131438764|NCT00812708|473233292|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
131584702|NCT00774397|473769912|FG006|Overall Study|Adverse Event|16|||
131584703|NCT00774397|473769906|FG000|Overall Study|Lack of Efficacy|11|||
131584704|NCT00774397|473769907|FG001|Overall Study|Lack of Efficacy|4|||
131584705|NCT00774397|473769908|FG002|Overall Study|Lack of Efficacy|5|||
131584706|NCT00774397|473769909|FG003|Overall Study|Lack of Efficacy|3|||
131584707|NCT00774397|473769910|FG004|Overall Study|Lack of Efficacy|27|||
131584708|NCT00774397|473769911|FG005|Overall Study|Lack of Efficacy|15|||
131584709|NCT00774397|473769912|FG006|Overall Study|Lack of Efficacy|9|||
131584710|NCT00774397|473769906|FG000|Overall Study|Protocol Violation|0|||
131584711|NCT00774397|473769907|FG001|Overall Study|Protocol Violation|1|||
131584712|NCT00774397|473769908|FG002|Overall Study|Protocol Violation|3|||
131584713|NCT00774397|473769909|FG003|Overall Study|Protocol Violation|1|||
131584714|NCT00774397|473769910|FG004|Overall Study|Protocol Violation|2|||
131584715|NCT00774397|473769911|FG005|Overall Study|Protocol Violation|1|||
131584716|NCT00774397|473769912|FG006|Overall Study|Protocol Violation|0|||
131584717|NCT00774397|473769906|FG000|Overall Study|Lost to Follow-up|0|||
131584718|NCT00774397|473769907|FG001|Overall Study|Lost to Follow-up|1|||
131584719|NCT00774397|473769908|FG002|Overall Study|Lost to Follow-up|1|||
131584720|NCT00774397|473769909|FG003|Overall Study|Lost to Follow-up|1|||
131584721|NCT00774397|473769910|FG004|Overall Study|Lost to Follow-up|0|||
131584722|NCT00774397|473769911|FG005|Overall Study|Lost to Follow-up|1|||
131584723|NCT00774397|473769912|FG006|Overall Study|Lost to Follow-up|0|||
131584724|NCT00774397|473769906|FG000|Overall Study|Refused to continue trial medication|1|||
131584725|NCT00774397|473769907|FG001|Overall Study|Refused to continue trial medication|3|||
131584726|NCT00774397|473769908|FG002|Overall Study|Refused to continue trial medication|2|||
131584727|NCT00774397|473769909|FG003|Overall Study|Refused to continue trial medication|2|||
131584728|NCT00774397|473769910|FG004|Overall Study|Refused to continue trial medication|6|||
131584729|NCT00774397|473769911|FG005|Overall Study|Refused to continue trial medication|2|||
131584730|NCT00774397|473769912|FG006|Overall Study|Refused to continue trial medication|3|||
131584731|NCT00774397|473769906|FG000|Overall Study|Not treated|0|||
131584732|NCT00774397|473769907|FG001|Overall Study|Not treated|0|||
131584733|NCT00774397|473769908|FG002|Overall Study|Not treated|0|||
131584734|NCT00774397|473769909|FG003|Overall Study|Not treated|0|||
131584735|NCT00774397|473769910|FG004|Overall Study|Not treated|1|||
131584736|NCT00774397|473769911|FG005|Overall Study|Not treated|0|||
131584737|NCT00774397|473769912|FG006|Overall Study|Not treated|1|||
131584738|NCT00774397|473769906|FG000|Overall Study|Other than those stated above|1|||
131584739|NCT00774397|473769907|FG001|Overall Study|Other than those stated above|1|||
131584740|NCT00774397|473769908|FG002|Overall Study|Other than those stated above|3|||
131584741|NCT00774397|473769909|FG003|Overall Study|Other than those stated above|2|||
131584742|NCT00774397|473769910|FG004|Overall Study|Other than those stated above|2|||
131584743|NCT00774397|473769911|FG005|Overall Study|Other than those stated above|0|||
131584744|NCT00774397|473769912|FG006|Overall Study|Other than those stated above|1|||
131584745|NCT00858117|473769914|FG000|Treatment on Study|Adverse Event|2|||
131584746|NCT00858117|473769914|FG000|Follow up for 5 Years|Death|4|||
131584747|NCT00858117|473769914|FG000|Follow up for 5 Years|No further data collected for study|9|||
131584748|NCT00277355|473769919|FG000|Overall Study|Withdrawal by Subject|3|||
131584749|NCT00277355|473769920|FG001|Overall Study|Withdrawal by Subject|3|||
131584750|NCT00277355|473769919|FG000|Overall Study|Lost to Follow-up|2|||
131584751|NCT00277355|473769920|FG001|Overall Study|Lost to Follow-up|2|||
131584752|NCT00277355|473769919|FG000|Overall Study|Adverse Event|5|||
131584753|NCT00277355|473769920|FG001|Overall Study|Adverse Event|0|||
131584754|NCT00277355|473769919|FG000|Overall Study|Death|3|||
131584755|NCT00277355|473769920|FG001|Overall Study|Death|0|||
131584756|NCT00277355|473769919|FG000|Overall Study|Physician Decision|1|||
131584757|NCT00277355|473769920|FG001|Overall Study|Physician Decision|0|||
131584758|NCT02765100|473769921|FG000|Overall Study|subject found ineligible after baseline|1|||
131584759|NCT02765100|473769922|FG001|Overall Study|subject found ineligible after baseline|1|||
131584760|NCT02765100|473769921|FG000|Overall Study|Lost to Follow-up|0|||
131584761|NCT02765100|473769922|FG001|Overall Study|Lost to Follow-up|1|||
131584762|NCT02652442|473769930|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
131584763|NCT00106080|473769936|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
131584764|NCT00106080|473769937|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
131584765|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
131584766|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
131584767|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
131584768|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
131584769|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
131584770|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
131584771|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
131584772|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
131584773|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
131584774|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
131584775|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
131584776|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
131584777|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
131584778|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
131584779|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
131584780|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
131584781|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
131584782|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
131584783|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
131584784|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
131584785|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
131584786|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
131584787|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
131584788|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
131584789|NCT01061151|473769938|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
131584790|NCT01061151|473769939|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
131584791|NCT01061151|473769940|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
131584792|NCT01061151|473769941|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
131584793|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
131584794|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
131584795|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
131584796|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
131584797|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
131584798|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
131584799|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
131584800|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
131584801|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
131584802|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
131584803|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
131584804|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
131584805|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
131584806|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
131584807|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
131584808|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
131584809|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
131584810|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
131584811|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
131584812|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
131584813|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
131584814|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
131584815|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
131584816|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
131584817|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
131584818|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
131584819|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
131584820|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
131584821|NCT01061151|473769938|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
131584822|NCT01061151|473769939|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
131584823|NCT01061151|473769940|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
131584824|NCT01061151|473769941|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
131584825|NCT03740009|473769942|FG000|Overall Study|Physician Decision|9|||
131584826|NCT03740009|473769942|FG000|Overall Study|Lost to Follow-up|1|||
131584827|NCT00529516|473769943|FG000|Overall Study|Adverse Event|2|||
131584828|NCT00529516|473769944|FG001|Overall Study|Adverse Event|1|||
131584829|NCT00529516|473769945|FG002|Overall Study|Adverse Event|0|||
131584830|NCT00529516|473769943|FG000|Overall Study|Withdrawal by Subject|1|||
131584831|NCT00529516|473769944|FG001|Overall Study|Withdrawal by Subject|1|||
131584832|NCT00529516|473769945|FG002|Overall Study|Withdrawal by Subject|0|||
131584833|NCT00529516|473769943|FG000|Overall Study|Lost to Follow-up|0|||
131584834|NCT00529516|473769944|FG001|Overall Study|Lost to Follow-up|0|||
131584835|NCT00529516|473769945|FG002|Overall Study|Lost to Follow-up|1|||
131584836|NCT00761605|473769948|FG000|Overall Study|Adverse Event|26|||
131584837|NCT00761605|473769948|FG000|Overall Study|Death|2|||
131584838|NCT00761605|473769948|FG000|Overall Study|Lack of Efficacy|26|||
131584839|NCT00761605|473769948|FG000|Overall Study|Lost to Follow-up|29|||
131584840|NCT00761605|473769948|FG000|Overall Study|Withdrawal by Subject|37|||
131584841|NCT00761605|473769948|FG000|Overall Study|Other|21|||
131584842|NCT03451721|473769950|FG000|Overall Study|Death|1|||
131584843|NCT01985334|473769951|FG000|Overall Study|Administrative problems|1|||
131584844|NCT01985334|473769952|FG001|Overall Study|Administrative problems|1|||
131584845|NCT01985334|473769953|FG002|Overall Study|Administrative problems|0|||
131584846|NCT01985334|473769954|FG003|Overall Study|Administrative problems|2|||
131584847|NCT01985334|473769955|FG004|Overall Study|Administrative problems|0|||
131584848|NCT01985334|473769956|FG005|Overall Study|Administrative problems|1|||
131584849|NCT01985334|473769957|FG006|Overall Study|Administrative problems|1|||
131584850|NCT01985334|473769958|FG007|Overall Study|Administrative problems|3|||
131584851|NCT01985334|473769951|FG000|Overall Study|Death|1|||
131584852|NCT01985334|473769952|FG001|Overall Study|Death|0|||
131584853|NCT01985334|473769953|FG002|Overall Study|Death|0|||
131584854|NCT01985334|473769954|FG003|Overall Study|Death|3|||
131584855|NCT01985334|473769955|FG004|Overall Study|Death|0|||
131584856|NCT01985334|473769956|FG005|Overall Study|Death|0|||
131584857|NCT01985334|473769957|FG006|Overall Study|Death|1|||
131584858|NCT01985334|473769958|FG007|Overall Study|Death|2|||
131584859|NCT01985334|473769951|FG000|Overall Study|Worsening of disease|0|||
131584860|NCT01985334|473769952|FG001|Overall Study|Worsening of disease|0|||
131584861|NCT01985334|473769953|FG002|Overall Study|Worsening of disease|0|||
131584862|NCT01985334|473769954|FG003|Overall Study|Worsening of disease|1|||
131584863|NCT01985334|473769955|FG004|Overall Study|Worsening of disease|0|||
131584864|NCT01985334|473769956|FG005|Overall Study|Worsening of disease|3|||
131584865|NCT01985334|473769957|FG006|Overall Study|Worsening of disease|0|||
131584866|NCT01985334|473769958|FG007|Overall Study|Worsening of disease|1|||
131584867|NCT01985334|473769951|FG000|Overall Study|Other|2|||
131584868|NCT01985334|473769952|FG001|Overall Study|Other|9|||
131584869|NCT01985334|473769953|FG002|Overall Study|Other|7|||
131584870|NCT01985334|473769954|FG003|Overall Study|Other|17|||
131584871|NCT01985334|473769955|FG004|Overall Study|Other|4|||
131584872|NCT01985334|473769956|FG005|Overall Study|Other|8|||
131584873|NCT01985334|473769957|FG006|Overall Study|Other|4|||
131584874|NCT01985334|473769958|FG007|Overall Study|Other|7|||
131584875|NCT01985334|473769951|FG000|Overall Study|Protocol deviation|6|||
131584876|NCT01985334|473769952|FG001|Overall Study|Protocol deviation|31|||
131584877|NCT01985334|473769953|FG002|Overall Study|Protocol deviation|25|||
131584878|NCT01985334|473769954|FG003|Overall Study|Protocol deviation|84|||
131584879|NCT01985334|473769955|FG004|Overall Study|Protocol deviation|17|||
131584880|NCT01985334|473769956|FG005|Overall Study|Protocol deviation|47|||
131584881|NCT01985334|473769957|FG006|Overall Study|Protocol deviation|15|||
131584882|NCT01985334|473769958|FG007|Overall Study|Protocol deviation|42|||
131584883|NCT01985334|473769951|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
131704798|NCT00282243|474203371|FG000|Extension Treatment Period|Non-compliance|2|||
131704799|NCT00282243|474203371|FG000|Extension Treatment Period|Physician Decision|1|||
131584884|NCT01985334|473769952|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
131584885|NCT01985334|473769953|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
131584886|NCT01985334|473769954|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
131584887|NCT01985334|473769955|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
131584888|NCT01985334|473769956|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
131584889|NCT01985334|473769957|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
131584890|NCT01985334|473769958|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
131584891|NCT01985334|473769951|FG000|Overall Study|Subject withdrawal of consent|3|||
131584892|NCT01985334|473769952|FG001|Overall Study|Subject withdrawal of consent|6|||
131584893|NCT01985334|473769953|FG002|Overall Study|Subject withdrawal of consent|2|||
131584894|NCT01985334|473769954|FG003|Overall Study|Subject withdrawal of consent|28|||
131584895|NCT01985334|473769955|FG004|Overall Study|Subject withdrawal of consent|4|||
131584896|NCT01985334|473769956|FG005|Overall Study|Subject withdrawal of consent|19|||
131584897|NCT01985334|473769957|FG006|Overall Study|Subject withdrawal of consent|0|||
131584898|NCT01985334|473769958|FG007|Overall Study|Subject withdrawal of consent|20|||
131584899|NCT01985334|473769951|FG000|Overall Study|Adverse Event|0|||
131584900|NCT01985334|473769952|FG001|Overall Study|Adverse Event|8|||
131584901|NCT01985334|473769953|FG002|Overall Study|Adverse Event|2|||
131584902|NCT01985334|473769954|FG003|Overall Study|Adverse Event|26|||
131584903|NCT01985334|473769955|FG004|Overall Study|Adverse Event|3|||
131584904|NCT01985334|473769956|FG005|Overall Study|Adverse Event|18|||
131584905|NCT01985334|473769957|FG006|Overall Study|Adverse Event|3|||
131584906|NCT01985334|473769958|FG007|Overall Study|Adverse Event|15|||
131584907|NCT01985334|473769951|FG000|Overall Study|Other|4|||
131584908|NCT01985334|473769952|FG001|Overall Study|Other|2|||
131584909|NCT01985334|473769953|FG002|Overall Study|Other|3|||
131584910|NCT01985334|473769954|FG003|Overall Study|Other|10|||
131584911|NCT01985334|473769955|FG004|Overall Study|Other|1|||
131704800|NCT00270894|474203372|FG000|Overall Study|Adverse Event|1|||
131704801|NCT00270894|474203372|FG000|Overall Study|Withdrawal by Subject|1|||
131704802|NCT01070329|474203373|FG000|Overall Study|Adverse Event|13|||
131704803|NCT01070329|474203374|FG001|Overall Study|Adverse Event|10|||
131704804|NCT01070329|474203373|FG000|Overall Study|Lost to Follow-up|22|||
131704805|NCT01070329|474203374|FG001|Overall Study|Lost to Follow-up|12|||
131704806|NCT01070329|474203373|FG000|Overall Study|Withdrawal by Subject|9|||
131704807|NCT01070329|474203374|FG001|Overall Study|Withdrawal by Subject|11|||
131704808|NCT01070329|474203373|FG000|Overall Study|Protocol Violation|3|||
131704809|NCT01070329|474203374|FG001|Overall Study|Protocol Violation|8|||
131704810|NCT01070329|474203373|FG000|Overall Study|Lack of Efficacy|2|||
131704811|NCT01070329|474203374|FG001|Overall Study|Lack of Efficacy|6|||
131704812|NCT01070329|474203373|FG000|Overall Study|Physician Decision|2|||
131704813|NCT01070329|474203374|FG001|Overall Study|Physician Decision|1|||
131704814|NCT01070329|474203373|FG000|Overall Study|Entry Criteria Not Met|1|||
131704815|NCT01070329|474203374|FG001|Overall Study|Entry Criteria Not Met|0|||
131704816|NCT01070329|474203373|FG000|Overall Study|Sponsor Decision|0|||
131704817|NCT01070329|474203374|FG001|Overall Study|Sponsor Decision|1|||
131704818|NCT01748071|474203377|FG000|Overall Study|Adverse Event|2|||
131704819|NCT01748071|474203378|FG001|Overall Study|Adverse Event|2|||
131704820|NCT01748071|474203379|FG002|Overall Study|Adverse Event|0|||
131704821|NCT02863848|474203380|FG000|Overall Study|Lost to Follow-up|1|||
131704822|NCT02863848|474203381|FG001|Overall Study|Lost to Follow-up|1|||
131704823|NCT02863848|474203380|FG000|Overall Study|Protocol Violation|1|||
131704824|NCT02863848|474203381|FG001|Overall Study|Protocol Violation|2|||
131704825|NCT00605267|474203386|FG000|Overall Study|Adverse Event|0|||
131704826|NCT00605267|474203387|FG001|Overall Study|Adverse Event|1|||
131704827|NCT00605267|474203386|FG000|Overall Study|Lack of Efficacy|1|||
131704828|NCT00605267|474203387|FG001|Overall Study|Lack of Efficacy|5|||
131704829|NCT00605267|474203386|FG000|Overall Study|Withdrawal by Subject|2|||
131704830|NCT00605267|474203387|FG001|Overall Study|Withdrawal by Subject|3|||
131704831|NCT02939131|474203388|FG000|Overall Study|Unable to get to clinic|6|||
131704832|NCT02939131|474203389|FG001|Overall Study|Unable to get to clinic|4|||
131704833|NCT02939131|474203388|FG000|Overall Study|Lost to Follow-up|2|||
131704834|NCT02939131|474203389|FG001|Overall Study|Lost to Follow-up|4|||
131704835|NCT02939131|474203388|FG000|Overall Study|severe debilitation|1|||
131704836|NCT02939131|474203389|FG001|Overall Study|severe debilitation|0|||
131704837|NCT02939131|474203388|FG000|Overall Study|Other|0|||
131704838|NCT02939131|474203389|FG001|Overall Study|Other|1|||
131584912|NCT01985334|473769956|FG005|Overall Study|Other|6|||
131584913|NCT01985334|473769957|FG006|Overall Study|Other|2|||
131704839|NCT02939131|474203388|FG000|Overall Study|not willing to adhere to protocol|2|||
131704840|NCT02939131|474203389|FG001|Overall Study|not willing to adhere to protocol|0|||
131704841|NCT03588741|474203390|FG000|Overall Study|Withdrawal by Subject|1|||
131704842|NCT00950170|474203391|FG000|Overall Study|Parent/Legal Guardian Request|1|||
131704843|NCT00950170|474203391|FG000|Overall Study|Adverse Event|2|||
131704844|NCT00950170|474203391|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
131704845|NCT04173741|474203392|FG000|Overall Study|IVC measurement cannot be done|1|||
131704846|NCT04173741|474203393|FG001|Overall Study|IVC measurement cannot be done|1|||
131704847|NCT01705691|474203394|FG000|Overall Study|Death|1|||
131704848|NCT01705691|474203395|FG001|Overall Study|Death|2|||
131704849|NCT01705691|474203394|FG000|Overall Study|Withdrawal by Subject|1|||
131704850|NCT01705691|474203395|FG001|Overall Study|Withdrawal by Subject|2|||
131584914|NCT01985334|473769958|FG007|Overall Study|Other|2|||
131704851|NCT01705691|474203394|FG000|Overall Study|Lost to Follow-up|1|||
131704852|NCT01705691|474203395|FG001|Overall Study|Lost to Follow-up|1|||
131704853|NCT01705691|474203394|FG000|Overall Study|Other|0|||
131584915|NCT01985334|473769951|FG000|Overall Study|Medication non-compliance|0|||
131584916|NCT01985334|473769952|FG001|Overall Study|Medication non-compliance|4|||
131704854|NCT01705691|474203395|FG001|Overall Study|Other|1|||
131704855|NCT02913313|474203396|FG000|Overall Study|DISEASE PROGRESSION|1|||
131704856|NCT02913313|474203397|FG001|Overall Study|DISEASE PROGRESSION|2|||
131704857|NCT02913313|474203398|FG002|Overall Study|DISEASE PROGRESSION|2|||
131704858|NCT02913313|474203399|FG003|Overall Study|DISEASE PROGRESSION|4|||
131704859|NCT02913313|474203400|FG004|Overall Study|DISEASE PROGRESSION|6|||
131584917|NCT01985334|473769953|FG002|Overall Study|Medication non-compliance|1|||
131584918|NCT01985334|473769954|FG003|Overall Study|Medication non-compliance|6|||
131584919|NCT01985334|473769955|FG004|Overall Study|Medication non-compliance|2|||
131584920|NCT01985334|473769956|FG005|Overall Study|Medication non-compliance|3|||
131584921|NCT01985334|473769957|FG006|Overall Study|Medication non-compliance|1|||
131584922|NCT01985334|473769958|FG007|Overall Study|Medication non-compliance|3|||
131584923|NCT01985334|473769951|FG000|Overall Study|Use of prohibited treatment|1|||
131584924|NCT01985334|473769952|FG001|Overall Study|Use of prohibited treatment|4|||
131584925|NCT01985334|473769953|FG002|Overall Study|Use of prohibited treatment|1|||
131584926|NCT01985334|473769954|FG003|Overall Study|Use of prohibited treatment|2|||
131584927|NCT01985334|473769955|FG004|Overall Study|Use of prohibited treatment|1|||
131790127|NCT02763579|474514946|FG000|China Period|Withdrawal by Subject|0|||
131790128|NCT02763579|474514947|FG001|China Period|Withdrawal by Subject|0|||
131790129|NCT02763579|474514948|FG002|China Period|Withdrawal by Subject|3|||
131790130|NCT02763579|474514949|FG003|China Period|Withdrawal by Subject|3|||
131790131|NCT02965820|474514953|FG000|Period 2, Second 30 Days|Adverse Event|1|||
131584928|NCT01985334|473769956|FG005|Overall Study|Use of prohibited treatment|6|||
131584929|NCT01985334|473769957|FG006|Overall Study|Use of prohibited treatment|2|||
131584930|NCT01985334|473769958|FG007|Overall Study|Use of prohibited treatment|0|||
131584931|NCT01985334|473769951|FG000|Overall Study|Investigator decision|0|||
131584932|NCT01985334|473769952|FG001|Overall Study|Investigator decision|3|||
131584933|NCT01985334|473769953|FG002|Overall Study|Investigator decision|0|||
131584934|NCT01985334|473769954|FG003|Overall Study|Investigator decision|7|||
131584935|NCT01985334|473769955|FG004|Overall Study|Investigator decision|1|||
131584936|NCT01985334|473769956|FG005|Overall Study|Investigator decision|1|||
131584937|NCT01985334|473769957|FG006|Overall Study|Investigator decision|0|||
131584938|NCT01985334|473769958|FG007|Overall Study|Investigator decision|4|||
131584939|NCT01985334|473769951|FG000|Overall Study|Lost to Follow-up|0|||
131584940|NCT01985334|473769952|FG001|Overall Study|Lost to Follow-up|2|||
131584941|NCT01985334|473769953|FG002|Overall Study|Lost to Follow-up|0|||
131584942|NCT01985334|473769954|FG003|Overall Study|Lost to Follow-up|3|||
131584943|NCT01985334|473769955|FG004|Overall Study|Lost to Follow-up|1|||
131584944|NCT01985334|473769956|FG005|Overall Study|Lost to Follow-up|4|||
131584945|NCT01985334|473769957|FG006|Overall Study|Lost to Follow-up|0|||
131584946|NCT01985334|473769958|FG007|Overall Study|Lost to Follow-up|3|||
131584947|NCT01290341|473769959|FG000|Overall Study|Protocol Violation|7|||
131584948|NCT01290341|473769960|FG001|Overall Study|Protocol Violation|3|||
131584949|NCT01290341|473769959|FG000|Overall Study|Adverse Event|1|||
131584950|NCT01290341|473769960|FG001|Overall Study|Adverse Event|0|||
131584951|NCT01290341|473769959|FG000|Overall Study|Lost to Follow-up|21|||
131584952|NCT01290341|473769960|FG001|Overall Study|Lost to Follow-up|10|||
131790132|NCT02965820|474514954|FG001|Period 2, Second 30 Days|Adverse Event|1|||
131790133|NCT00738673|474514959|FG000|Overall Study|Adverse Event|1|||
131790134|NCT00738673|474514960|FG001|Overall Study|Adverse Event|0|||
131790135|NCT00738673|474514959|FG000|Overall Study|Lack of Efficacy|19|||
131790136|NCT00738673|474514960|FG001|Overall Study|Lack of Efficacy|8|||
131790137|NCT00738673|474514959|FG000|Overall Study|Protocol Violation|1|||
131790138|NCT00738673|474514960|FG001|Overall Study|Protocol Violation|2|||
131790139|NCT00738673|474514959|FG000|Overall Study|Withdrawal by Subject|3|||
131790140|NCT00738673|474514960|FG001|Overall Study|Withdrawal by Subject|1|||
131790141|NCT02736227|474514961|FG000|Overall Study|Withdrawal by Subject|0|||
131790142|NCT02736227|474514962|FG001|Overall Study|Withdrawal by Subject|0|||
131790143|NCT02736227|474514963|FG002|Overall Study|Withdrawal by Subject|1|||
131790144|NCT02736227|474514961|FG000|Overall Study|Physician Decision|0|||
131584953|NCT01290341|473769959|FG000|Overall Study|Withdrawal by Subject|19|||
131584954|NCT01290341|473769960|FG001|Overall Study|Withdrawal by Subject|5|||
131584955|NCT01290341|473769959|FG000|Overall Study|Negative baseline culture and others|44|||
131584956|NCT01290341|473769960|FG001|Overall Study|Negative baseline culture and others|11|||
131584957|NCT01102231|473769965|FG000|Overall Study|Protocol Violation|3|||
131584958|NCT01102231|473769965|FG000|Overall Study|Lack of Efficacy|2|||
131584959|NCT01102231|473769965|FG000|Overall Study|Death|2|||
131584960|NCT01102231|473769965|FG000|Overall Study|Adverse Event|3|||
131584961|NCT01102231|473769965|FG000|Overall Study|Withdrawal by Subject|1|||
131584962|NCT01102231|473769965|FG000|Overall Study|Did not received the treatment|4|||
131584963|NCT03733119|473769968|FG000|Overall Study|Physician Decision|2|||
131584964|NCT03733119|473769969|FG001|Overall Study|Physician Decision|1|||
131584965|NCT03733119|473769968|FG000|Overall Study|ineligible to treat per protocol|0|||
131584966|NCT03733119|473769969|FG001|Overall Study|ineligible to treat per protocol|1|||
131584967|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
131790145|NCT02736227|474514962|FG001|Overall Study|Physician Decision|0|||
131790146|NCT02736227|474514963|FG002|Overall Study|Physician Decision|5|||
131790147|NCT02736227|474514961|FG000|Overall Study|Non Compliant|0|||
131584968|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131584969|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131790148|NCT02736227|474514962|FG001|Overall Study|Non Compliant|0|||
131790149|NCT02736227|474514963|FG002|Overall Study|Non Compliant|2|||
131584970|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131584971|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131584972|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
131584973|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131584974|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131584975|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131584976|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131584977|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
131584978|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131584979|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131584980|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131584981|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131584982|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
131584983|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131584984|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131584985|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131584986|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131584987|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
131584988|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131584989|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131584990|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131584991|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131584992|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
131584993|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131584994|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131584995|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131584996|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131584997|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
131584998|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131584999|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131585000|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131585001|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131585002|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
131585003|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131585004|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131585005|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131585006|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131585007|NCT02409667|473769975|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
131585008|NCT02409667|473769976|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131585009|NCT02409667|473769977|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131585010|NCT02409667|473769978|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131585011|NCT02409667|473769979|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131585012|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
131585013|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
131585014|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
131585015|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
131585016|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
131585017|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131585018|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131585019|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131585020|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
131585021|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131585022|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
131585023|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
131585024|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
131585025|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
131585026|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
131585027|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
131585028|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
131585029|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
131585030|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
131585031|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
131704860|NCT02913313|474203401|FG005|Overall Study|DISEASE PROGRESSION|4|||
131585032|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
131585033|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
131585034|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
131585035|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
131585036|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
131585037|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
131585038|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
131585039|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
131790150|NCT01967888|474514964|FG000|Overall Study|Lost to Follow-up|6|||
131790151|NCT01967888|474514965|FG001|Overall Study|Lost to Follow-up|4|||
131790152|NCT01967888|474514964|FG000|Overall Study|Withdrawal by Subject|1|||
131790153|NCT01967888|474514965|FG001|Overall Study|Withdrawal by Subject|1|||
131790154|NCT01967888|474514964|FG000|Overall Study|Did Not Have Transplant|1|||
131790155|NCT01967888|474514965|FG001|Overall Study|Did Not Have Transplant|0|||
131790156|NCT01967888|474514964|FG000|Overall Study|Research visit not done, data recorded|1|||
131790157|NCT01967888|474514965|FG001|Overall Study|Research visit not done, data recorded|0|||
131790158|NCT01967888|474514964|FG000|Overall Study|Subject excluded after randomization|1|||
131790159|NCT01967888|474514965|FG001|Overall Study|Subject excluded after randomization|0|||
131790160|NCT01967888|474514964|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
131790161|NCT01967888|474514965|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
131790162|NCT01967888|474514964|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
131790163|NCT01967888|474514965|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
131790164|NCT04120194|474514966|FG000|Overall Study|Lost to Follow-up|11|||
131790165|NCT04120194|474514967|FG001|Overall Study|Lost to Follow-up|8|||
131790166|NCT04120194|474514966|FG000|Overall Study|Adverse Event|4|||
131790167|NCT04120194|474514967|FG001|Overall Study|Adverse Event|5|||
131585040|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
131585041|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
131585042|NCT02409667|473769975|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131585043|NCT02409667|473769976|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131585044|NCT02409667|473769977|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
131585045|NCT02409667|473769978|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131585046|NCT02409667|473769979|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131585047|NCT03997916|473769981|FG000|Overall Study|Protocol Violation|35|||
131585048|NCT03237481|473771103|FG000|Overall Study|Lost to Follow-up|1|||
131585049|NCT03237481|473771104|FG001|Overall Study|Lost to Follow-up|0|||
131585050|NCT03237481|473771105|FG002|Overall Study|Lost to Follow-up|0|||
131585051|NCT03237481|473771103|FG000|Overall Study|Protocol Violation|1|||
131585052|NCT03237481|473771104|FG001|Overall Study|Protocol Violation|0|||
131585053|NCT03237481|473771105|FG002|Overall Study|Protocol Violation|0|||
131585054|NCT03237481|473771103|FG000|Overall Study|Withdrawal by Subject|3|||
131585055|NCT03237481|473771104|FG001|Overall Study|Withdrawal by Subject|2|||
131585056|NCT03237481|473771105|FG002|Overall Study|Withdrawal by Subject|1|||
131585057|NCT01780298|473771106|FG000|Overall Study|Physician Decision|1|||
131585058|NCT01780298|473771107|FG001|Overall Study|Physician Decision|5|||
131585059|NCT01780298|473771108|FG002|Overall Study|Physician Decision|1|||
131585060|NCT01780298|473771109|FG003|Overall Study|Physician Decision|1|||
131704861|NCT02913313|474203402|FG006|Overall Study|DISEASE PROGRESSION|19|||
131704862|NCT02913313|474203403|FG007|Overall Study|DISEASE PROGRESSION|3|||
131704863|NCT02913313|474203404|FG008|Overall Study|DISEASE PROGRESSION|4|||
131704864|NCT02913313|474203405|FG009|Overall Study|DISEASE PROGRESSION|4|||
131704865|NCT02913313|474203406|FG010|Overall Study|DISEASE PROGRESSION|11|||
131704866|NCT02913313|474203407|FG011|Overall Study|DISEASE PROGRESSION|5|||
131704867|NCT02913313|474203408|FG012|Overall Study|DISEASE PROGRESSION|14|||
131704868|NCT02913313|474203409|FG013|Overall Study|DISEASE PROGRESSION|3|||
131704869|NCT02913313|474203396|FG000|Overall Study|Not Reported|0|||
131704870|NCT02913313|474203397|FG001|Overall Study|Not Reported|0|||
131704871|NCT02913313|474203398|FG002|Overall Study|Not Reported|0|||
131704872|NCT02913313|474203399|FG003|Overall Study|Not Reported|0|||
131704873|NCT02913313|474203400|FG004|Overall Study|Not Reported|1|||
131704874|NCT02913313|474203401|FG005|Overall Study|Not Reported|0|||
131585061|NCT01780298|473771106|FG000|Overall Study|Subject not matched|1|||
131585062|NCT01780298|473771107|FG001|Overall Study|Subject not matched|0|||
131585063|NCT01780298|473771108|FG002|Overall Study|Subject not matched|1|||
131585064|NCT01780298|473771109|FG003|Overall Study|Subject not matched|0|||
131585065|NCT01780298|473771106|FG000|Overall Study|Adverse Event|0|||
131585066|NCT01780298|473771107|FG001|Overall Study|Adverse Event|0|||
131585067|NCT01780298|473771108|FG002|Overall Study|Adverse Event|2|||
131585068|NCT01780298|473771109|FG003|Overall Study|Adverse Event|0|||
131585069|NCT04907474|473771114|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
131585070|NCT04907474|473771115|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
131585071|NCT03873779|473771116|FG000|Overall Study|Withdrawal by Subject|1|||
131585072|NCT02581215|473771117|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
131585073|NCT02581215|473771118|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
131585074|NCT02581215|473771117|FG000|Overall Study|Eligibility Criteria Not Met|0|||
131585075|NCT02581215|473771118|FG001|Overall Study|Eligibility Criteria Not Met|1|||
131585076|NCT04279574|473771121|FG000|Overall Study|Death|1|||
131585077|NCT04279574|473771122|FG001|Overall Study|Death|0|||
131585078|NCT04279574|473771121|FG000|Overall Study|lost restoration, tooth fracture|1|||
131585079|NCT04279574|473771122|FG001|Overall Study|lost restoration, tooth fracture|0|||
131585080|NCT04279574|473771121|FG000|Overall Study|Lost to Follow-up|0|||
131585081|NCT04279574|473771122|FG001|Overall Study|Lost to Follow-up|1|||
131585082|NCT02566902|473771126|FG000|Overall Study|Protocol Violation|2|||
131585083|NCT02566902|473771127|FG001|Overall Study|Protocol Violation|1|||
131585084|NCT05489484|473771128|FG000|Overall Study|withdrawn|1|||
131585085|NCT00444600|473771131|FG000|Overall Study|Death|7|||
131585086|NCT00444600|473771132|FG001|Overall Study|Death|5|||
131585087|NCT00444600|473771133|FG002|Overall Study|Death|3|||
131585088|NCT00444600|473771134|FG003|Overall Study|Death|2|||
131585089|NCT00444600|473771131|FG000|Overall Study|Dropped|11|||
131585090|NCT00444600|473771132|FG001|Overall Study|Dropped|11|||
131585091|NCT00444600|473771133|FG002|Overall Study|Dropped|7|||
131585092|NCT00444600|473771134|FG003|Overall Study|Dropped|7|||
131585093|NCT00444600|473771131|FG000|Overall Study|Missed visit|1|||
131585094|NCT00444600|473771132|FG001|Overall Study|Missed visit|0|||
131585095|NCT00444600|473771133|FG002|Overall Study|Missed visit|0|||
131585096|NCT00444600|473771134|FG003|Overall Study|Missed visit|1|||
131585097|NCT05132478|473771135|FG000|Overall Study|did not complete survey after consent|1|||
131585098|NCT05132478|473771136|FG001|Overall Study|did not complete survey after consent|1|||
131585099|NCT05132478|473771135|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
131790168|NCT04120194|474514966|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
131790169|NCT04120194|474514967|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
131790170|NCT04120194|474514966|FG000|Overall Study|Miscellaneous|4|||
131790171|NCT04120194|474514967|FG001|Overall Study|Miscellaneous|5|||
131790172|NCT00553540|474514968|FG000|Overall Study|discharged after first visit|2|||
131790173|NCT00553540|474514969|FG001|Overall Study|discharged after first visit|5|||
131438765|NCT00812708|473233292|FG000|Overall Study|Signed consent but later withdrew|3|||
131790174|NCT02622074|474514970|FG000|Overall Study|Death|4|||
131790175|NCT02622074|474514971|FG001|Overall Study|Death|0|||
131790176|NCT02622074|474514972|FG002|Overall Study|Death|0|||
131790177|NCT02622074|474514973|FG003|Overall Study|Death|1|||
131790178|NCT02622074|474514974|FG004|Overall Study|Death|1|||
131790179|NCT02622074|474514975|FG005|Overall Study|Death|0|||
131790180|NCT02622074|474514970|FG000|Overall Study|Withdrawal by Subject|0|||
131790181|NCT02622074|474514971|FG001|Overall Study|Withdrawal by Subject|1|||
131790182|NCT02622074|474514972|FG002|Overall Study|Withdrawal by Subject|0|||
131438766|NCT01419236|473233296|FG000|Overall Study|Adverse Event|1|||
131438767|NCT01419236|473233297|FG001|Overall Study|Adverse Event|0|||
131438768|NCT01419236|473233296|FG000|Overall Study|Lack of Efficacy|0|||
131585100|NCT05132478|473771136|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
131585101|NCT02549170|473771137|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
131585102|NCT02549170|473771138|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
131585103|NCT02549170|473771139|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
131585104|NCT02549170|473771140|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
131585105|NCT02549170|473771141|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
131585106|NCT02549170|473771137|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
131585107|NCT02549170|473771138|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
131585108|NCT02549170|473771139|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
131585109|NCT02549170|473771140|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
131585110|NCT02549170|473771141|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
131790183|NCT02622074|474514973|FG003|Overall Study|Withdrawal by Subject|0|||
131790184|NCT02622074|474514974|FG004|Overall Study|Withdrawal by Subject|0|||
131790185|NCT02622074|474514975|FG005|Overall Study|Withdrawal by Subject|0|||
131438769|NCT01419236|473233297|FG001|Overall Study|Lack of Efficacy|1|||
131585111|NCT02549170|473771137|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
131585112|NCT02549170|473771138|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
131585113|NCT02549170|473771139|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
131585114|NCT02549170|473771140|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
131585115|NCT02549170|473771141|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
131585116|NCT01414738|473771143|FG000|Overall Study|Death|26|||
131585117|NCT01414738|473771143|FG000|Overall Study|Refused testing|5|||
131585118|NCT01414738|473771143|FG000|Overall Study|Lost to Follow-up|2|||
131585119|NCT01414738|473771143|FG000|Overall Study|Refused, disease progression|8|||
131585120|NCT01414738|473771143|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
131585121|NCT02379819|473771144|FG000|Overall Study|Withdrawal by Subject|10|||
131585122|NCT02379819|473771144|FG000|Overall Study|Death|2|||
131585123|NCT02379819|473771144|FG000|Overall Study|Lack of Efficacy|1|||
131585124|NCT02379819|473771144|FG000|Overall Study|Lost to Follow-up|1|||
131585125|NCT00350792|473771149|FG000|Overall Study|Adverse Event|11|||
131585126|NCT00350792|473771149|FG000|Overall Study|Death from Study Disease|1|||
131585127|NCT00350792|473771149|FG000|Overall Study|Death from Study Drug Toxicity|1|||
131585128|NCT00350792|473771149|FG000|Overall Study|Death Not Study Drug Related|2|||
131585129|NCT00350792|473771149|FG000|Overall Study|Protocol Violation|1|||
131585130|NCT00350792|473771149|FG000|Overall Study|Withdrawal by Subject|4|||
131585131|NCT00350792|473771149|FG000|Overall Study|Physician Decision|2|||
131585132|NCT00350792|473771149|FG000|Overall Study|Lack of Efficacy|11|||
131585133|NCT00914589|473771150|FG000|Overall Study|Adverse Event|1|||
131585134|NCT00914589|473771151|FG001|Overall Study|Adverse Event|0|||
131585135|NCT00914589|473771152|FG002|Overall Study|Adverse Event|1|||
131585136|NCT00914589|473771150|FG000|Overall Study|Protocol Violation|8|||
131585137|NCT00914589|473771151|FG001|Overall Study|Protocol Violation|6|||
131585138|NCT00914589|473771152|FG002|Overall Study|Protocol Violation|3|||
131585139|NCT00914589|473771150|FG000|Overall Study|unclassified|16|||
131585140|NCT00914589|473771151|FG001|Overall Study|unclassified|9|||
131585141|NCT00914589|473771152|FG002|Overall Study|unclassified|7|||
131585142|NCT00914589|473771150|FG000|Overall Study|Death|0|||
131585143|NCT00914589|473771151|FG001|Overall Study|Death|1|||
131585144|NCT00914589|473771152|FG002|Overall Study|Death|1|||
131585145|NCT03988023|473771153|FG000|Overall Study|Non-compliance|3|||
131585146|NCT03988023|473771154|FG001|Overall Study|Non-compliance|0|||
131585147|NCT03988023|473771153|FG000|Overall Study|Withdrawal by Subject|39|||
131585148|NCT03988023|473771154|FG001|Overall Study|Withdrawal by Subject|37|||
131585149|NCT03988023|473771153|FG000|Overall Study|Adverse Event|0|||
131585150|NCT03988023|473771154|FG001|Overall Study|Adverse Event|2|||
131585151|NCT03988023|473771153|FG000|Overall Study|Physician Decision|0|||
131585152|NCT03988023|473771154|FG001|Overall Study|Physician Decision|1|||
131585153|NCT03988023|473771153|FG000|Overall Study|Lost to Follow-up|5|||
131585154|NCT03988023|473771154|FG001|Overall Study|Lost to Follow-up|8|||
131585155|NCT03988023|473771153|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
131704875|NCT02913313|474203402|FG006|Overall Study|Not Reported|0|||
131704876|NCT02913313|474203403|FG007|Overall Study|Not Reported|0|||
131704877|NCT02913313|474203404|FG008|Overall Study|Not Reported|0|||
131704878|NCT02913313|474203405|FG009|Overall Study|Not Reported|0|||
131704879|NCT02913313|474203406|FG010|Overall Study|Not Reported|4|||
131704880|NCT02913313|474203407|FG011|Overall Study|Not Reported|0|||
131704881|NCT02913313|474203408|FG012|Overall Study|Not Reported|0|||
131704882|NCT02913313|474203409|FG013|Overall Study|Not Reported|0|||
131704883|NCT02913313|474203396|FG000|Overall Study|Other reasons|0|||
131704884|NCT02913313|474203397|FG001|Overall Study|Other reasons|0|||
131704885|NCT02913313|474203398|FG002|Overall Study|Other reasons|0|||
131704886|NCT02913313|474203399|FG003|Overall Study|Other reasons|0|||
131704887|NCT02913313|474203400|FG004|Overall Study|Other reasons|1|||
131704888|NCT02913313|474203401|FG005|Overall Study|Other reasons|0|||
131704889|NCT02913313|474203402|FG006|Overall Study|Other reasons|0|||
131704890|NCT02913313|474203403|FG007|Overall Study|Other reasons|0|||
131704891|NCT02913313|474203404|FG008|Overall Study|Other reasons|0|||
131704892|NCT02913313|474203405|FG009|Overall Study|Other reasons|0|||
131704893|NCT02913313|474203406|FG010|Overall Study|Other reasons|1|||
131704894|NCT02913313|474203407|FG011|Overall Study|Other reasons|0|||
131704895|NCT02913313|474203408|FG012|Overall Study|Other reasons|0|||
131704896|NCT02913313|474203409|FG013|Overall Study|Other reasons|0|||
131704897|NCT02913313|474203396|FG000|Overall Study|Withdrawal by Subject|0|||
131585156|NCT03988023|473771154|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
131585157|NCT03988023|473771153|FG000|Overall Study|Lack of Efficacy|3|||
131585158|NCT03988023|473771154|FG001|Overall Study|Lack of Efficacy|1|||
131704898|NCT02913313|474203397|FG001|Overall Study|Withdrawal by Subject|0|||
131704899|NCT02913313|474203398|FG002|Overall Study|Withdrawal by Subject|1|||
131704900|NCT02913313|474203399|FG003|Overall Study|Withdrawal by Subject|0|||
131704901|NCT02913313|474203400|FG004|Overall Study|Withdrawal by Subject|0|||
131704902|NCT02913313|474203401|FG005|Overall Study|Withdrawal by Subject|0|||
131704903|NCT02913313|474203402|FG006|Overall Study|Withdrawal by Subject|1|||
131585159|NCT03988023|473771153|FG000|Overall Study|COVID-19 pandemic|225|||
131585160|NCT03988023|473771154|FG001|Overall Study|COVID-19 pandemic|227|||
131585161|NCT03036813|473771155|FG000|Overall Study|Adverse Event|6|||
131585162|NCT03036813|473771156|FG001|Overall Study|Adverse Event|11|||
131585163|NCT03036813|473771157|FG002|Overall Study|Adverse Event|6|||
131585164|NCT03036813|473771155|FG000|Overall Study|Withdrawal by Subject|12|||
131585165|NCT03036813|473771156|FG001|Overall Study|Withdrawal by Subject|6|||
131585166|NCT03036813|473771157|FG002|Overall Study|Withdrawal by Subject|10|||
131585167|NCT03036813|473771155|FG000|Overall Study|Lost to Follow-up|1|||
131585168|NCT03036813|473771156|FG001|Overall Study|Lost to Follow-up|1|||
131585169|NCT03036813|473771157|FG002|Overall Study|Lost to Follow-up|0|||
131585170|NCT03036813|473771155|FG000|Overall Study|Physician Decision|2|||
131585171|NCT03036813|473771156|FG001|Overall Study|Physician Decision|1|||
131585172|NCT03036813|473771157|FG002|Overall Study|Physician Decision|1|||
131585173|NCT03036813|473771155|FG000|Overall Study|Non-Compliance|1|||
131585174|NCT03036813|473771156|FG001|Overall Study|Non-Compliance|5|||
131585175|NCT03036813|473771157|FG002|Overall Study|Non-Compliance|3|||
131585176|NCT03036813|473771155|FG000|Overall Study|Pregnancy|0|||
131585177|NCT03036813|473771156|FG001|Overall Study|Pregnancy|0|||
131585178|NCT03036813|473771157|FG002|Overall Study|Pregnancy|1|||
131585179|NCT03036813|473771155|FG000|Overall Study|Other|0|||
131585180|NCT03036813|473771156|FG001|Overall Study|Other|3|||
131585181|NCT03036813|473771157|FG002|Overall Study|Other|5|||
131585182|NCT00529100|473771161|FG000|Overall Study|Adverse Event|0|||
131585183|NCT00529100|473771162|FG001|Overall Study|Adverse Event|5|||
131585184|NCT00529100|473771161|FG000|Overall Study|Protocol Violation|0|||
131585185|NCT00529100|473771162|FG001|Overall Study|Protocol Violation|1|||
131585186|NCT00529100|473771161|FG000|Overall Study|Progressive Disease|0|||
131585187|NCT00529100|473771162|FG001|Overall Study|Progressive Disease|1|||
131585188|NCT00529100|473771161|FG000|Overall Study|Withdrawal by Subject|0|||
131585189|NCT00529100|473771162|FG001|Overall Study|Withdrawal by Subject|1|||
131585190|NCT00529100|473771161|FG000|Overall Study|Participant Ineligibility|0|||
131585191|NCT00529100|473771162|FG001|Overall Study|Participant Ineligibility|1|||
131585192|NCT00807937|473771163|FG000|Overall Study|Adverse Event|12|||
131585193|NCT00807937|473771164|FG001|Overall Study|Adverse Event|12|||
131585194|NCT00807937|473771165|FG002|Overall Study|Adverse Event|5|||
131585195|NCT00807937|473771166|FG003|Overall Study|Adverse Event|4|||
131585196|NCT00807937|473771163|FG000|Overall Study|Protocol Violation|4|||
131585197|NCT00807937|473771164|FG001|Overall Study|Protocol Violation|5|||
131585198|NCT00807937|473771165|FG002|Overall Study|Protocol Violation|3|||
131585199|NCT00807937|473771166|FG003|Overall Study|Protocol Violation|3|||
131585200|NCT00807937|473771163|FG000|Overall Study|Withdrawal by Subject|5|||
131585201|NCT00807937|473771164|FG001|Overall Study|Withdrawal by Subject|4|||
131585202|NCT00807937|473771165|FG002|Overall Study|Withdrawal by Subject|1|||
131585203|NCT00807937|473771166|FG003|Overall Study|Withdrawal by Subject|4|||
131585204|NCT00807937|473771163|FG000|Overall Study|Lost to Follow-up|4|||
131585205|NCT00807937|473771164|FG001|Overall Study|Lost to Follow-up|0|||
131585206|NCT00807937|473771165|FG002|Overall Study|Lost to Follow-up|2|||
131585207|NCT00807937|473771166|FG003|Overall Study|Lost to Follow-up|1|||
131585208|NCT00807937|473771163|FG000|Overall Study|Lack of Efficacy|0|||
131585209|NCT00807937|473771164|FG001|Overall Study|Lack of Efficacy|0|||
131585210|NCT00807937|473771165|FG002|Overall Study|Lack of Efficacy|1|||
131585211|NCT00807937|473771166|FG003|Overall Study|Lack of Efficacy|2|||
131585212|NCT00807937|473771163|FG000|Overall Study|Intake of prohibited medicine|0|||
131585213|NCT00807937|473771164|FG001|Overall Study|Intake of prohibited medicine|0|||
131585214|NCT00807937|473771165|FG002|Overall Study|Intake of prohibited medicine|2|||
131585215|NCT00807937|473771166|FG003|Overall Study|Intake of prohibited medicine|0|||
131585216|NCT00807937|473771163|FG000|Overall Study|All other reasons (not provided)|2|||
131585217|NCT00807937|473771164|FG001|Overall Study|All other reasons (not provided)|4|||
131585218|NCT00807937|473771165|FG002|Overall Study|All other reasons (not provided)|0|||
131585219|NCT00807937|473771166|FG003|Overall Study|All other reasons (not provided)|1|||
131585220|NCT04629950|473771169|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
131704904|NCT02913313|474203403|FG007|Overall Study|Withdrawal by Subject|1|||
131704905|NCT02913313|474203404|FG008|Overall Study|Withdrawal by Subject|0|||
131704906|NCT02913313|474203405|FG009|Overall Study|Withdrawal by Subject|0|||
131704907|NCT02913313|474203406|FG010|Overall Study|Withdrawal by Subject|1|||
131704908|NCT02913313|474203407|FG011|Overall Study|Withdrawal by Subject|0|||
131704909|NCT02913313|474203408|FG012|Overall Study|Withdrawal by Subject|0|||
131704910|NCT02913313|474203409|FG013|Overall Study|Withdrawal by Subject|0|||
131585221|NCT04629950|473771170|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
131585222|NCT04629950|473771171|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
131585223|NCT04629950|473771172|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
131585224|NCT04629950|473771169|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
131585225|NCT04629950|473771170|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
131704911|NCT02913313|474203396|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131704912|NCT02913313|474203397|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131585226|NCT04629950|473771171|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
131585227|NCT04629950|473771172|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
131585228|NCT04629950|473771169|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
131585229|NCT04629950|473771170|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
131585230|NCT04629950|473771171|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
131585231|NCT04629950|473771172|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
131585232|NCT04629950|473771169|FG000|Extension Study|Withdrawal by Subject|0|||
131585233|NCT04629950|473771170|FG001|Extension Study|Withdrawal by Subject|0|||
131585234|NCT04629950|473771171|FG002|Extension Study|Withdrawal by Subject|1|||
131585235|NCT04629950|473771172|FG003|Extension Study|Withdrawal by Subject|0|||
131585236|NCT04629950|473771169|FG000|Extension Study|Adverse Event|0|||
131585237|NCT04629950|473771170|FG001|Extension Study|Adverse Event|0|||
131585238|NCT04629950|473771171|FG002|Extension Study|Adverse Event|0|||
131585239|NCT04629950|473771172|FG003|Extension Study|Adverse Event|1|||
131585240|NCT00396084|473771173|FG000|Overall Study|Adverse Event|0|||
131585241|NCT00396084|473771174|FG001|Overall Study|Adverse Event|0|||
131585242|NCT00396084|473771175|FG002|Overall Study|Adverse Event|0|||
131585243|NCT00396084|473771176|FG003|Overall Study|Adverse Event|0|||
131585244|NCT00396084|473771177|FG004|Overall Study|Adverse Event|1|||
131585245|NCT00396084|473771178|FG005|Overall Study|Adverse Event|2|||
131585246|NCT00396084|473771173|FG000|Overall Study|Withdrawal by Subject|0|||
131585247|NCT00396084|473771174|FG001|Overall Study|Withdrawal by Subject|0|||
131585248|NCT00396084|473771175|FG002|Overall Study|Withdrawal by Subject|0|||
131585249|NCT00396084|473771176|FG003|Overall Study|Withdrawal by Subject|1|||
131585250|NCT00396084|473771177|FG004|Overall Study|Withdrawal by Subject|0|||
131585251|NCT00396084|473771178|FG005|Overall Study|Withdrawal by Subject|0|||
131585252|NCT02568683|473771179|FG000|Overall Study|Death|0|||
131585253|NCT02568683|473771180|FG001|Overall Study|Death|2|||
131585254|NCT02568683|473771179|FG000|Overall Study|Withdrew Consent|1|||
131585255|NCT02568683|473771180|FG001|Overall Study|Withdrew Consent|0|||
131585256|NCT02568683|473771179|FG000|Overall Study|Study Terminated By Sponsor|5|||
131585257|NCT02568683|473771180|FG001|Overall Study|Study Terminated By Sponsor|2|||
131585258|NCT01561989|473771183|FG000|Overall Study|accural target not met.|5|||
131585259|NCT01561989|473771184|FG001|Overall Study|accural target not met.|6|||
131585260|NCT01736215|473771194|FG000|Overall Study|Early termination of erythropoietin use|1|||
131585261|NCT01736215|473771194|FG000|Overall Study|Adverse Event|4|||
131585262|NCT01736215|473771194|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
131585263|NCT01736215|473771194|FG000|Overall Study|Insufficient data to perform analysis|8|||
131585264|NCT03447249|473771202|FG000|Overall Study|Adverse Event|1|||
131585265|NCT03447249|473771203|FG001|Overall Study|Adverse Event|0|||
131585266|NCT03447249|473771202|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
131585267|NCT03447249|473771203|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
131585268|NCT03447249|473771202|FG000|Overall Study|Other|3|||
131585269|NCT03447249|473771203|FG001|Overall Study|Other|0|||
131585270|NCT01248936|473771204|FG000|Overall Study|Sponsor Decision|259|||
131585271|NCT01248936|473771204|FG000|Overall Study|Progression of Disease|50|||
131585272|NCT01248936|473771204|FG000|Overall Study|Death|26|||
131585273|NCT01248936|473771204|FG000|Overall Study|Withdrawal of Consent|20|||
131585274|NCT01248936|473771204|FG000|Overall Study|Adverse Event|8|||
131585275|NCT01248936|473771204|FG000|Overall Study|Lost to Follow-up|7|||
131585276|NCT01248936|473771204|FG000|Overall Study|Refused Treatment|1|||
131585277|NCT01248936|473771204|FG000|Overall Study|Other reason|3|||
131585278|NCT04556981|473771205|FG000|Overall Study|Death|0|||
131585279|NCT04556981|473771206|FG001|Overall Study|Death|1|||
131585280|NCT04556981|473771205|FG000|Overall Study|Lost to Follow-up|2|||
131585281|NCT04556981|473771206|FG001|Overall Study|Lost to Follow-up|11|||
131585282|NCT04556981|473771205|FG000|Overall Study|Moved from the study area|1|||
131585283|NCT04556981|473771206|FG001|Overall Study|Moved from the study area|4|||
131585284|NCT04556981|473771205|FG000|Overall Study|Withdrawal by Subject|2|||
131585285|NCT04556981|473771206|FG001|Overall Study|Withdrawal by Subject|2|||
131585286|NCT04556981|473771205|FG000|Overall Study|Other|2|||
131585287|NCT04556981|473771206|FG001|Overall Study|Other|1|||
131585288|NCT01388361|473771207|FG000|Overall Study|Adverse Event|0|||
131585289|NCT01388361|473771208|FG001|Overall Study|Adverse Event|5|||
131585290|NCT01388361|473771209|FG002|Overall Study|Adverse Event|1|||
131790186|NCT02114931|474514976|FG000|Overall Study|Withdrawal by Subject|15|||
131585291|NCT01388361|473771207|FG000|Overall Study|Protocol Violation|0|||
131585292|NCT01388361|473771208|FG001|Overall Study|Protocol Violation|0|||
131585293|NCT01388361|473771209|FG002|Overall Study|Protocol Violation|2|||
131585294|NCT01388361|473771207|FG000|Overall Study|Withdrawal criteria|12|||
131585295|NCT01388361|473771208|FG001|Overall Study|Withdrawal criteria|7|||
131585296|NCT01388361|473771209|FG002|Overall Study|Withdrawal criteria|10|||
131585297|NCT01388361|473771207|FG000|Overall Study|Unclassified|0|||
131585298|NCT01388361|473771208|FG001|Overall Study|Unclassified|0|||
131585299|NCT01388361|473771209|FG002|Overall Study|Unclassified|1|||
131585300|NCT00774852|473771212|FG000|Overall Study|Adverse Event|9|||
131585301|NCT00774852|473771213|FG001|Overall Study|Adverse Event|6|||
131585302|NCT00774852|473771212|FG000|Overall Study|Death|2|||
131585303|NCT00774852|473771213|FG001|Overall Study|Death|1|||
131585304|NCT00774852|473771212|FG000|Overall Study|Lack of Efficacy|3|||
131585305|NCT00774852|473771213|FG001|Overall Study|Lack of Efficacy|7|||
131585306|NCT00774852|473771212|FG000|Overall Study|Lost to Follow-up|9|||
131585307|NCT00774852|473771213|FG001|Overall Study|Lost to Follow-up|5|||
131585308|NCT00774852|473771212|FG000|Overall Study|Physician Decision|2|||
131585309|NCT00774852|473771213|FG001|Overall Study|Physician Decision|6|||
131585310|NCT00774852|473771212|FG000|Overall Study|Pregnancy|1|||
131585311|NCT00774852|473771213|FG001|Overall Study|Pregnancy|2|||
131585312|NCT00774852|473771212|FG000|Overall Study|Withdrawal by Subject|2|||
131585313|NCT00774852|473771213|FG001|Overall Study|Withdrawal by Subject|2|||
131585314|NCT00774852|473771212|FG000|Overall Study|Non-responder|15|||
131585315|NCT00774852|473771213|FG001|Overall Study|Non-responder|11|||
131585316|NCT00774852|473771212|FG000|Overall Study|Subject non-compliance|0|||
131585317|NCT00774852|473771213|FG001|Overall Study|Subject non-compliance|1|||
131585318|NCT00774852|473771212|FG000|Overall Study|Protocol Violation|1|||
131585319|NCT00774852|473771213|FG001|Overall Study|Protocol Violation|0|||
131585320|NCT00774852|473771212|FG000|Overall Study|Subject received prohibited medication|1|||
131585321|NCT00774852|473771213|FG001|Overall Study|Subject received prohibited medication|0|||
131585322|NCT04922021|473773180|FG000|Overall Study|Withdrawal by Subject|4|||
131585323|NCT04922021|473773181|FG001|Overall Study|Withdrawal by Subject|10|||
131585324|NCT04922021|473773180|FG000|Overall Study|Adverse Event|2|||
131585325|NCT04922021|473773181|FG001|Overall Study|Adverse Event|2|||
131585326|NCT04922021|473773180|FG000|Overall Study|Lack of Efficacy|0|||
131585327|NCT04922021|473773181|FG001|Overall Study|Lack of Efficacy|1|||
131585328|NCT04922021|473773180|FG000|Overall Study|Multiple reasons|1|||
131585329|NCT04922021|473773181|FG001|Overall Study|Multiple reasons|0|||
131585330|NCT04688450|473773191|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
131585331|NCT04688450|473773191|FG000|Overall Study|Withdrawal by Subject|1|||
131585332|NCT02544074|473773192|FG000|Overall Study|Withdrawal by Subject|0|||
131585333|NCT02544074|473773193|FG001|Overall Study|Withdrawal by Subject|1|||
131585334|NCT02544074|473773194|FG002|Overall Study|Withdrawal by Subject|0|||
131585335|NCT02544074|473773195|FG003|Overall Study|Withdrawal by Subject|0|||
131585336|NCT02544074|473773196|FG004|Overall Study|Withdrawal by Subject|0|||
131585337|NCT02544074|473773197|FG005|Overall Study|Withdrawal by Subject|0|||
131585338|NCT02544074|473773198|FG006|Overall Study|Withdrawal by Subject|0|||
131585339|NCT02544074|473773199|FG007|Overall Study|Withdrawal by Subject|0|||
131585340|NCT02544074|473773200|FG008|Overall Study|Withdrawal by Subject|0|||
131585341|NCT02544074|473773201|FG009|Overall Study|Withdrawal by Subject|0|||
131585342|NCT02544074|473773202|FG010|Overall Study|Withdrawal by Subject|0|||
131585343|NCT02544074|473773203|FG011|Overall Study|Withdrawal by Subject|0|||
131585344|NCT02544074|473773204|FG012|Overall Study|Withdrawal by Subject|0|||
131585345|NCT02544074|473773205|FG013|Overall Study|Withdrawal by Subject|0|||
131585346|NCT02544074|473773206|FG014|Overall Study|Withdrawal by Subject|0|||
131585347|NCT02544074|473773207|FG015|Overall Study|Withdrawal by Subject|0|||
131585348|NCT02544074|473773208|FG016|Overall Study|Withdrawal by Subject|0|||
131585349|NCT02544074|473773209|FG017|Overall Study|Withdrawal by Subject|0|||
131585350|NCT02544074|473773210|FG018|Overall Study|Withdrawal by Subject|0|||
131704913|NCT02913313|474203398|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131704914|NCT02913313|474203399|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131585351|NCT02544074|473773211|FG019|Overall Study|Withdrawal by Subject|0|||
131585352|NCT02544074|473773212|FG020|Overall Study|Withdrawal by Subject|0|||
131585353|NCT02544074|473773192|FG000|Overall Study|Tablet error|0|||
131585354|NCT02544074|473773193|FG001|Overall Study|Tablet error|0|||
131585355|NCT02544074|473773194|FG002|Overall Study|Tablet error|0|||
131585356|NCT02544074|473773195|FG003|Overall Study|Tablet error|0|||
131585357|NCT02544074|473773196|FG004|Overall Study|Tablet error|0|||
131585358|NCT02544074|473773197|FG005|Overall Study|Tablet error|1|||
131585359|NCT02544074|473773198|FG006|Overall Study|Tablet error|0|||
131585360|NCT02544074|473773199|FG007|Overall Study|Tablet error|0|||
131585361|NCT02544074|473773200|FG008|Overall Study|Tablet error|0|||
131585362|NCT02544074|473773201|FG009|Overall Study|Tablet error|1|||
131585363|NCT02544074|473773202|FG010|Overall Study|Tablet error|0|||
131585364|NCT02544074|473773203|FG011|Overall Study|Tablet error|0|||
131585365|NCT02544074|473773204|FG012|Overall Study|Tablet error|0|||
131585366|NCT02544074|473773205|FG013|Overall Study|Tablet error|0|||
131585367|NCT02544074|473773206|FG014|Overall Study|Tablet error|0|||
131585368|NCT02544074|473773207|FG015|Overall Study|Tablet error|0|||
131585369|NCT02544074|473773208|FG016|Overall Study|Tablet error|0|||
131438770|NCT01419236|473233296|FG000|Overall Study|Lost to Follow-up|1|||
131438771|NCT01419236|473233297|FG001|Overall Study|Lost to Follow-up|0|||
131438772|NCT01419236|473233296|FG000|Overall Study|Physician Decision|1|||
131438773|NCT01419236|473233297|FG001|Overall Study|Physician Decision|0|||
131438774|NCT01419236|473233296|FG000|Overall Study|Withdrawal by Subject|1|||
131438775|NCT01419236|473233297|FG001|Overall Study|Withdrawal by Subject|4|||
131585370|NCT02544074|473773209|FG017|Overall Study|Tablet error|0|||
131585371|NCT02544074|473773210|FG018|Overall Study|Tablet error|0|||
131585372|NCT02544074|473773211|FG019|Overall Study|Tablet error|0|||
131585373|NCT02544074|473773212|FG020|Overall Study|Tablet error|0|||
131585374|NCT03189524|473773213|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
131438776|NCT01419236|473233296|FG000|Overall Study|Entry Criteria Not Met|1|||
131653600|NCT03596762|474018420|FG004|Overall Study|Withdrawal by Subject|1|||
131438777|NCT01419236|473233297|FG001|Overall Study|Entry Criteria Not Met|0|||
131438778|NCT03224130|473233298|FG000|Overall Study|consent issue|0|||
131585375|NCT03189524|473773214|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
131585376|NCT03189524|473773215|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
131585377|NCT03189524|473773213|FG000|Overall Study|Death|2|||
131585378|NCT03189524|473773214|FG001|Overall Study|Death|2|||
131585379|NCT03189524|473773215|FG002|Overall Study|Death|1|||
131585380|NCT03189524|473773213|FG000|Overall Study|Lost to Follow-up|1|||
131585381|NCT03189524|473773214|FG001|Overall Study|Lost to Follow-up|0|||
131585382|NCT03189524|473773215|FG002|Overall Study|Lost to Follow-up|8|||
131585383|NCT03189524|473773213|FG000|Overall Study|Withdrawal by Subject|1|||
131585384|NCT03189524|473773214|FG001|Overall Study|Withdrawal by Subject|1|||
131585385|NCT03189524|473773215|FG002|Overall Study|Withdrawal by Subject|3|||
131585386|NCT03189524|473773213|FG000|Overall Study|Progressive Disease|0|||
131585387|NCT03189524|473773214|FG001|Overall Study|Progressive Disease|2|||
131585388|NCT03189524|473773215|FG002|Overall Study|Progressive Disease|0|||
131585389|NCT04139668|473773216|FG000|Overall Study|Withdrawal by Subject|1|||
131585390|NCT02723955|473773217|FG000|Escalation Phase|Death|1|||
131585391|NCT02723955|473773218|FG001|Escalation Phase|Death|1|||
131585392|NCT02723955|473773219|FG002|Escalation Phase|Death|2|||
131585393|NCT02723955|473773220|FG003|Escalation Phase|Death|7|||
131585394|NCT02723955|473773221|FG004|Escalation Phase|Death|18|||
131585395|NCT02723955|473773222|FG005|Escalation Phase|Death|17|||
131585396|NCT02723955|473773223|FG006|Escalation Phase|Death|11|||
131585397|NCT02723955|473773224|FG007|Escalation Phase|Death|21|||
131585398|NCT02723955|473773225|FG008|Escalation Phase|Death|3|||
131585399|NCT02723955|473773226|FG009|Escalation Phase|Death|0|||
131585400|NCT02723955|473773227|FG010|Escalation Phase|Death|0|||
131585401|NCT02723955|473773228|FG011|Escalation Phase|Death|0|||
131585402|NCT02723955|473773229|FG012|Escalation Phase|Death|2|||
131585403|NCT02723955|473773230|FG013|Escalation Phase|Death|4|||
131585404|NCT02723955|473773231|FG014|Escalation Phase|Death|5|||
131585405|NCT02723955|473773232|FG015|Escalation Phase|Death|6|||
131585406|NCT02723955|473773233|FG016|Escalation Phase|Death|6|||
131585407|NCT02723955|473773234|FG017|Escalation Phase|Death|7|||
131585408|NCT02723955|473773235|FG018|Escalation Phase|Death|1|||
131585409|NCT02723955|473773236|FG019|Escalation Phase|Death|3|||
131585410|NCT02723955|473773237|FG020|Escalation Phase|Death|13|||
131585411|NCT02723955|473773238|FG021|Escalation Phase|Death|3|||
131585412|NCT02723955|473773239|FG022|Escalation Phase|Death|2|||
131585413|NCT02723955|473773240|FG023|Escalation Phase|Death|4|||
131585414|NCT02723955|473773241|FG024|Escalation Phase|Death|31|||
131585415|NCT02723955|473773242|FG025|Escalation Phase|Death|7|||
131585416|NCT02723955|473773243|FG026|Escalation Phase|Death|13|||
131585417|NCT02723955|473773244|FG027|Escalation Phase|Death|0|||
131585418|NCT02723955|473773245|FG028|Escalation Phase|Death|1|||
131585419|NCT02723955|473773246|FG029|Escalation Phase|Death|0|||
131585420|NCT02723955|473773247|FG030|Escalation Phase|Death|0|||
131585421|NCT02723955|473773248|FG031|Escalation Phase|Death|0|||
131585422|NCT02723955|473773249|FG032|Escalation Phase|Death|0|||
131585423|NCT02723955|473773250|FG033|Escalation Phase|Death|0|||
131585424|NCT02723955|473773251|FG034|Escalation Phase|Death|0|||
131585425|NCT02723955|473773252|FG035|Escalation Phase|Death|0|||
131585426|NCT02723955|473773253|FG036|Escalation Phase|Death|0|||
131585427|NCT02723955|473773254|FG037|Escalation Phase|Death|0|||
131585428|NCT02723955|473773255|FG038|Escalation Phase|Death|0|||
131585429|NCT02723955|473773256|FG039|Escalation Phase|Death|0|||
131585430|NCT02723955|473773257|FG040|Escalation Phase|Death|0|||
131585431|NCT02723955|473773258|FG041|Escalation Phase|Death|0|||
131585432|NCT02723955|473773259|FG042|Escalation Phase|Death|0|||
131585433|NCT02723955|473773217|FG000|Escalation Phase|Lost to Follow-up|0|||
131585434|NCT02723955|473773218|FG001|Escalation Phase|Lost to Follow-up|0|||
131585435|NCT02723955|473773219|FG002|Escalation Phase|Lost to Follow-up|0|||
131585436|NCT02723955|473773220|FG003|Escalation Phase|Lost to Follow-up|0|||
131585437|NCT02723955|473773221|FG004|Escalation Phase|Lost to Follow-up|0|||
131585438|NCT02723955|473773222|FG005|Escalation Phase|Lost to Follow-up|2|||
131585439|NCT02723955|473773223|FG006|Escalation Phase|Lost to Follow-up|1|||
131585440|NCT02723955|473773224|FG007|Escalation Phase|Lost to Follow-up|1|||
131585441|NCT02723955|473773225|FG008|Escalation Phase|Lost to Follow-up|1|||
131585442|NCT02723955|473773226|FG009|Escalation Phase|Lost to Follow-up|0|||
131585443|NCT02723955|473773227|FG010|Escalation Phase|Lost to Follow-up|0|||
131585444|NCT02723955|473773228|FG011|Escalation Phase|Lost to Follow-up|0|||
131585445|NCT02723955|473773229|FG012|Escalation Phase|Lost to Follow-up|1|||
131585446|NCT02723955|473773230|FG013|Escalation Phase|Lost to Follow-up|0|||
131585447|NCT02723955|473773231|FG014|Escalation Phase|Lost to Follow-up|0|||
131585448|NCT02723955|473773232|FG015|Escalation Phase|Lost to Follow-up|0|||
131585449|NCT02723955|473773233|FG016|Escalation Phase|Lost to Follow-up|1|||
131585450|NCT02723955|473773234|FG017|Escalation Phase|Lost to Follow-up|2|||
131585451|NCT02723955|473773235|FG018|Escalation Phase|Lost to Follow-up|0|||
131585452|NCT02723955|473773236|FG019|Escalation Phase|Lost to Follow-up|1|||
131585453|NCT02723955|473773237|FG020|Escalation Phase|Lost to Follow-up|2|||
131585454|NCT02723955|473773238|FG021|Escalation Phase|Lost to Follow-up|1|||
131585455|NCT02723955|473773239|FG022|Escalation Phase|Lost to Follow-up|0|||
131585456|NCT02723955|473773240|FG023|Escalation Phase|Lost to Follow-up|0|||
131585457|NCT02723955|473773241|FG024|Escalation Phase|Lost to Follow-up|1|||
131585458|NCT02723955|473773242|FG025|Escalation Phase|Lost to Follow-up|1|||
131585459|NCT02723955|473773243|FG026|Escalation Phase|Lost to Follow-up|3|||
131585460|NCT02723955|473773244|FG027|Escalation Phase|Lost to Follow-up|0|||
131585461|NCT02723955|473773245|FG028|Escalation Phase|Lost to Follow-up|1|||
131585462|NCT02723955|473773246|FG029|Escalation Phase|Lost to Follow-up|0|||
131585463|NCT02723955|473773247|FG030|Escalation Phase|Lost to Follow-up|0|||
131585464|NCT02723955|473773248|FG031|Escalation Phase|Lost to Follow-up|0|||
131585465|NCT02723955|473773249|FG032|Escalation Phase|Lost to Follow-up|0|||
131585466|NCT02723955|473773250|FG033|Escalation Phase|Lost to Follow-up|0|||
131585467|NCT02723955|473773251|FG034|Escalation Phase|Lost to Follow-up|0|||
131585468|NCT02723955|473773252|FG035|Escalation Phase|Lost to Follow-up|0|||
131585469|NCT02723955|473773253|FG036|Escalation Phase|Lost to Follow-up|0|||
131585470|NCT02723955|473773254|FG037|Escalation Phase|Lost to Follow-up|0|||
131585471|NCT02723955|473773255|FG038|Escalation Phase|Lost to Follow-up|0|||
131585472|NCT02723955|473773256|FG039|Escalation Phase|Lost to Follow-up|0|||
131585473|NCT02723955|473773257|FG040|Escalation Phase|Lost to Follow-up|0|||
131585474|NCT02723955|473773258|FG041|Escalation Phase|Lost to Follow-up|0|||
131438779|NCT03224130|473233299|FG001|Overall Study|consent issue|1|||
131704915|NCT02913313|474203400|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131704916|NCT02913313|474203401|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131704917|NCT02913313|474203402|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131585475|NCT02723955|473773259|FG042|Escalation Phase|Lost to Follow-up|0|||
131585476|NCT02723955|473773217|FG000|Escalation Phase|Physician Decision|0|||
131585477|NCT02723955|473773218|FG001|Escalation Phase|Physician Decision|0|||
131585478|NCT02723955|473773219|FG002|Escalation Phase|Physician Decision|0|||
131585479|NCT02723955|473773220|FG003|Escalation Phase|Physician Decision|0|||
131585480|NCT02723955|473773221|FG004|Escalation Phase|Physician Decision|0|||
131585481|NCT02723955|473773222|FG005|Escalation Phase|Physician Decision|2|||
131704918|NCT02913313|474203403|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131704919|NCT02913313|474203404|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131438780|NCT03287791|473233302|FG000|Overall Study|Insufficient Therapeutic Response|0|||
131585482|NCT02723955|473773223|FG006|Escalation Phase|Physician Decision|0|||
131585483|NCT02723955|473773224|FG007|Escalation Phase|Physician Decision|0|||
131585484|NCT02723955|473773225|FG008|Escalation Phase|Physician Decision|0|||
131585485|NCT02723955|473773226|FG009|Escalation Phase|Physician Decision|0|||
131585486|NCT02723955|473773227|FG010|Escalation Phase|Physician Decision|0|||
131585487|NCT02723955|473773228|FG011|Escalation Phase|Physician Decision|0|||
131585488|NCT02723955|473773229|FG012|Escalation Phase|Physician Decision|0|||
131585489|NCT02723955|473773230|FG013|Escalation Phase|Physician Decision|0|||
131585490|NCT02723955|473773231|FG014|Escalation Phase|Physician Decision|0|||
131585491|NCT02723955|473773232|FG015|Escalation Phase|Physician Decision|0|||
131585492|NCT02723955|473773233|FG016|Escalation Phase|Physician Decision|0|||
131585493|NCT02723955|473773234|FG017|Escalation Phase|Physician Decision|0|||
131585494|NCT02723955|473773235|FG018|Escalation Phase|Physician Decision|0|||
131585495|NCT02723955|473773236|FG019|Escalation Phase|Physician Decision|0|||
131585496|NCT02723955|473773237|FG020|Escalation Phase|Physician Decision|0|||
131585497|NCT02723955|473773238|FG021|Escalation Phase|Physician Decision|0|||
131704920|NCT02913313|474203405|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131585498|NCT02723955|473773239|FG022|Escalation Phase|Physician Decision|0|||
131585499|NCT02723955|473773240|FG023|Escalation Phase|Physician Decision|0|||
131585500|NCT02723955|473773241|FG024|Escalation Phase|Physician Decision|0|||
131704921|NCT02913313|474203406|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
131585501|NCT02723955|473773242|FG025|Escalation Phase|Physician Decision|0|||
131585502|NCT02723955|473773243|FG026|Escalation Phase|Physician Decision|2|||
131585503|NCT02723955|473773244|FG027|Escalation Phase|Physician Decision|0|||
131585504|NCT02723955|473773245|FG028|Escalation Phase|Physician Decision|0|||
131585505|NCT02723955|473773246|FG029|Escalation Phase|Physician Decision|0|||
131585506|NCT02723955|473773247|FG030|Escalation Phase|Physician Decision|0|||
131585507|NCT02723955|473773248|FG031|Escalation Phase|Physician Decision|0|||
131585508|NCT02723955|473773249|FG032|Escalation Phase|Physician Decision|0|||
131585509|NCT02723955|473773250|FG033|Escalation Phase|Physician Decision|0|||
131585510|NCT02723955|473773251|FG034|Escalation Phase|Physician Decision|0|||
131585511|NCT02723955|473773252|FG035|Escalation Phase|Physician Decision|0|||
131585512|NCT02723955|473773253|FG036|Escalation Phase|Physician Decision|0|||
131585513|NCT02723955|473773254|FG037|Escalation Phase|Physician Decision|0|||
131585514|NCT02723955|473773255|FG038|Escalation Phase|Physician Decision|0|||
131585515|NCT02723955|473773256|FG039|Escalation Phase|Physician Decision|0|||
131585516|NCT02723955|473773257|FG040|Escalation Phase|Physician Decision|0|||
131585517|NCT02723955|473773258|FG041|Escalation Phase|Physician Decision|0|||
131585518|NCT02723955|473773259|FG042|Escalation Phase|Physician Decision|0|||
131585519|NCT02723955|473773217|FG000|Escalation Phase|Withdrawal by Subject|0|||
131585520|NCT02723955|473773218|FG001|Escalation Phase|Withdrawal by Subject|0|||
131585521|NCT02723955|473773219|FG002|Escalation Phase|Withdrawal by Subject|0|||
131585522|NCT02723955|473773220|FG003|Escalation Phase|Withdrawal by Subject|0|||
131585523|NCT02723955|473773221|FG004|Escalation Phase|Withdrawal by Subject|1|||
131585524|NCT02723955|473773222|FG005|Escalation Phase|Withdrawal by Subject|1|||
131585525|NCT02723955|473773223|FG006|Escalation Phase|Withdrawal by Subject|1|||
131585526|NCT02723955|473773224|FG007|Escalation Phase|Withdrawal by Subject|1|||
131585527|NCT02723955|473773225|FG008|Escalation Phase|Withdrawal by Subject|0|||
131585528|NCT02723955|473773226|FG009|Escalation Phase|Withdrawal by Subject|0|||
131585529|NCT02723955|473773227|FG010|Escalation Phase|Withdrawal by Subject|0|||
131585530|NCT02723955|473773228|FG011|Escalation Phase|Withdrawal by Subject|0|||
131585531|NCT02723955|473773229|FG012|Escalation Phase|Withdrawal by Subject|1|||
131704922|NCT02913313|474203407|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131704923|NCT02913313|474203408|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
131704924|NCT02913313|474203409|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
131704925|NCT02913313|474203396|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
131704926|NCT02913313|474203397|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
131704927|NCT02913313|474203398|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
131704928|NCT02913313|474203399|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
131704929|NCT02913313|474203400|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
131704930|NCT02913313|474203401|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
131704931|NCT02913313|474203402|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
131704932|NCT02913313|474203403|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
131704933|NCT02913313|474203404|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
131704934|NCT02913313|474203405|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
131704935|NCT02913313|474203406|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
131704936|NCT02913313|474203407|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
131704937|NCT02913313|474203408|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
131704938|NCT02913313|474203409|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
131704939|NCT04233229|474203410|FG000|Overall Study|Withdrawal by Subject|0|||
131704940|NCT04233229|474203411|FG001|Overall Study|Withdrawal by Subject|1|||
131704941|NCT04233229|474203410|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
131704942|NCT04233229|474203411|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
131704943|NCT04233229|474203410|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
131704944|NCT04233229|474203411|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
131704945|NCT00110019|474203412|FG000|Overall Study|Lack of Efficacy|253|||
131704946|NCT00110019|474203413|FG001|Overall Study|Lack of Efficacy|285|||
131704947|NCT00110019|474203412|FG000|Overall Study|Adverse Event|61|||
131704948|NCT00110019|474203413|FG001|Overall Study|Adverse Event|40|||
131585532|NCT02723955|473773230|FG013|Escalation Phase|Withdrawal by Subject|0|||
131585533|NCT02723955|473773231|FG014|Escalation Phase|Withdrawal by Subject|0|||
131585534|NCT02723955|473773232|FG015|Escalation Phase|Withdrawal by Subject|0|||
131704949|NCT00110019|474203412|FG000|Overall Study|Death|13|||
131704950|NCT00110019|474203413|FG001|Overall Study|Death|15|||
131704951|NCT00110019|474203412|FG000|Overall Study|Withdrawal by Subject|21|||
131704952|NCT00110019|474203413|FG001|Overall Study|Withdrawal by Subject|9|||
131790187|NCT02114931|474514977|FG001|Overall Study|Withdrawal by Subject|18|||
131790188|NCT02114931|474514976|FG000|Overall Study|Adverse Event|4|||
131790189|NCT02114931|474514977|FG001|Overall Study|Adverse Event|6|||
131790190|NCT02114931|474514976|FG000|Overall Study|Lost to Follow-up|3|||
131790191|NCT02114931|474514977|FG001|Overall Study|Lost to Follow-up|3|||
131790192|NCT02114931|474514976|FG000|Overall Study|Physician Decision|1|||
131790193|NCT02114931|474514977|FG001|Overall Study|Physician Decision|2|||
131585535|NCT02723955|473773233|FG016|Escalation Phase|Withdrawal by Subject|1|||
131585536|NCT02723955|473773234|FG017|Escalation Phase|Withdrawal by Subject|0|||
131585537|NCT02723955|473773235|FG018|Escalation Phase|Withdrawal by Subject|0|||
131585538|NCT02723955|473773236|FG019|Escalation Phase|Withdrawal by Subject|0|||
131585539|NCT02723955|473773237|FG020|Escalation Phase|Withdrawal by Subject|0|||
131585540|NCT02723955|473773238|FG021|Escalation Phase|Withdrawal by Subject|0|||
131585541|NCT02723955|473773239|FG022|Escalation Phase|Withdrawal by Subject|0|||
131585542|NCT02723955|473773240|FG023|Escalation Phase|Withdrawal by Subject|2|||
131585543|NCT02723955|473773241|FG024|Escalation Phase|Withdrawal by Subject|0|||
131585544|NCT02723955|473773242|FG025|Escalation Phase|Withdrawal by Subject|1|||
131585545|NCT02723955|473773243|FG026|Escalation Phase|Withdrawal by Subject|0|||
131585546|NCT02723955|473773244|FG027|Escalation Phase|Withdrawal by Subject|0|||
131585547|NCT02723955|473773245|FG028|Escalation Phase|Withdrawal by Subject|1|||
131585548|NCT02723955|473773246|FG029|Escalation Phase|Withdrawal by Subject|0|||
131585549|NCT02723955|473773247|FG030|Escalation Phase|Withdrawal by Subject|0|||
131585550|NCT02723955|473773248|FG031|Escalation Phase|Withdrawal by Subject|0|||
131585551|NCT02723955|473773249|FG032|Escalation Phase|Withdrawal by Subject|0|||
131585552|NCT02723955|473773250|FG033|Escalation Phase|Withdrawal by Subject|0|||
131585553|NCT02723955|473773251|FG034|Escalation Phase|Withdrawal by Subject|0|||
131585554|NCT02723955|473773252|FG035|Escalation Phase|Withdrawal by Subject|0|||
131585555|NCT02723955|473773253|FG036|Escalation Phase|Withdrawal by Subject|0|||
131585556|NCT02723955|473773254|FG037|Escalation Phase|Withdrawal by Subject|0|||
131585557|NCT02723955|473773255|FG038|Escalation Phase|Withdrawal by Subject|0|||
131585558|NCT02723955|473773256|FG039|Escalation Phase|Withdrawal by Subject|0|||
131704953|NCT00110019|474203412|FG000|Overall Study|alternative therapy|5|||
131704954|NCT00110019|474203413|FG001|Overall Study|alternative therapy|1|||
131704955|NCT00110019|474203412|FG000|Overall Study|complicating disease|1|||
131704956|NCT00110019|474203413|FG001|Overall Study|complicating disease|1|||
131704957|NCT00110019|474203412|FG000|Overall Study|symptom deterioration|13|||
131704958|NCT00110019|474203413|FG001|Overall Study|symptom deterioration|16|||
131704959|NCT00110019|474203412|FG000|Overall Study|Not start protocol therapy|17|||
131704960|NCT00110019|474203413|FG001|Overall Study|Not start protocol therapy|16|||
131704961|NCT00110019|474203412|FG000|Overall Study|other reasons|22|||
131704962|NCT00110019|474203413|FG001|Overall Study|other reasons|30|||
131704963|NCT04426695|474203416|FG000|Overall Study|Death|2|||
131704964|NCT04426695|474203417|FG001|Overall Study|Death|0|||
131704965|NCT04426695|474203418|FG002|Overall Study|Death|1|||
131704966|NCT04426695|474203419|FG003|Overall Study|Death|27|||
131704967|NCT04426695|474203420|FG004|Overall Study|Death|25|||
131704968|NCT04426695|474203421|FG005|Overall Study|Death|21|||
131704969|NCT04426695|474203422|FG006|Overall Study|Death|42|||
131704970|NCT04426695|474203423|FG007|Overall Study|Death|23|||
131704971|NCT04426695|474203424|FG008|Overall Study|Death|37|||
131704972|NCT04426695|474203425|FG009|Overall Study|Death|14|||
131704973|NCT04426695|474203426|FG010|Overall Study|Death|8|||
131704974|NCT04426695|474203427|FG011|Overall Study|Death|7|||
131704975|NCT04426695|474203428|FG012|Overall Study|Death|13|||
131704976|NCT04426695|474203429|FG013|Overall Study|Death|25|||
131704977|NCT04426695|474203430|FG014|Overall Study|Death|19|||
131704978|NCT04426695|474203431|FG015|Overall Study|Death|7|||
131704979|NCT04426695|474203432|FG016|Overall Study|Death|8|||
131704980|NCT04426695|474203433|FG017|Overall Study|Death|4|||
131585559|NCT02723955|473773257|FG040|Escalation Phase|Withdrawal by Subject|0|||
131585560|NCT02723955|473773258|FG041|Escalation Phase|Withdrawal by Subject|0|||
131585561|NCT02723955|473773259|FG042|Escalation Phase|Withdrawal by Subject|0|||
131704981|NCT04426695|474203416|FG000|Overall Study|Lost to Follow-up|2|||
131704982|NCT04426695|474203417|FG001|Overall Study|Lost to Follow-up|4|||
131704983|NCT04426695|474203418|FG002|Overall Study|Lost to Follow-up|1|||
131704984|NCT04426695|474203419|FG003|Overall Study|Lost to Follow-up|19|||
131704985|NCT04426695|474203420|FG004|Overall Study|Lost to Follow-up|10|||
131704986|NCT04426695|474203421|FG005|Overall Study|Lost to Follow-up|14|||
131704987|NCT04426695|474203422|FG006|Overall Study|Lost to Follow-up|5|||
131704988|NCT04426695|474203423|FG007|Overall Study|Lost to Follow-up|14|||
131704989|NCT04426695|474203424|FG008|Overall Study|Lost to Follow-up|10|||
131704990|NCT04426695|474203425|FG009|Overall Study|Lost to Follow-up|11|||
131790194|NCT02114931|474514976|FG000|Overall Study|Other|2|||
131790195|NCT02114931|474514977|FG001|Overall Study|Other|1|||
131790196|NCT03565211|474514982|FG000|Overall Study|Withdrawal by Subject|2|||
131790197|NCT03565211|474514982|FG000|Overall Study|Lost to Follow-up|1|||
131790198|NCT03565211|474514982|FG000|Overall Study|Adverse Event|44|||
131790199|NCT03565211|474514982|FG000|Overall Study|Personal issues|1|||
131790200|NCT01894984|474514983|FG000|Overall Study|Other|314|||
131790201|NCT01894984|474514984|FG001|Overall Study|Other|175|||
131790202|NCT00827359|474514985|FG000|Overall Study|Progressive Diseas|19|||
131790203|NCT00827359|474514985|FG000|Overall Study|Unacceptable Toxicity|5|||
131790204|NCT00827359|474514985|FG000|Overall Study|Ineligible|1|||
131790205|NCT03840135|474514986|FG000|Overall Study|Protocol Violation|6|||
131790206|NCT03840135|474514987|FG001|Overall Study|Protocol Violation|1|||
131790207|NCT03840135|474514986|FG000|Overall Study|Withdrawal by Subject|1|||
131790208|NCT03840135|474514987|FG001|Overall Study|Withdrawal by Subject|0|||
131790209|NCT01159769|474514988|FG000|Overall Study|Adverse Event|1|||
131790210|NCT02555618|474514989|FG000|Overall Study|Sponsor's Circumstances|1|||
131790211|NCT02555618|474514990|FG001|Overall Study|Sponsor's Circumstances|0|||
131790212|NCT02741271|474514995|FG000|Overall Study|Lost to Follow-up|2|||
131790213|NCT02741271|474514996|FG001|Overall Study|Lost to Follow-up|0|||
131790214|NCT02741271|474514995|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131790215|NCT02741271|474514996|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131790216|NCT03652961|474514997|FG000|Overall Study|Lost to Follow-up|3|||
131790217|NCT03652961|474514997|FG000|Overall Study|Screen Failure|1|||
131790218|NCT01612156|474514998|FG000|Overall Study|Protocol Violation|2|||
131790219|NCT01612156|474514999|FG001|Overall Study|Protocol Violation|0|||
131790220|NCT00410410|474515000|FG000|Induction Period (IP)|Death|1|||
131790221|NCT00410410|474515001|FG001|Induction Period (IP)|Death|0|||
131790222|NCT00410410|474515002|FG002|Induction Period (IP)|Death|0|||
131790223|NCT00410410|474515003|FG003|Induction Period (IP)|Death|0|||
131790224|NCT00410410|474515004|FG004|Induction Period (IP)|Death|0|||
131790225|NCT00410410|474515005|FG005|Induction Period (IP)|Death|0|||
131790226|NCT00410410|474515006|FG006|Induction Period (IP)|Death|0|||
131790227|NCT00410410|474515007|FG007|Induction Period (IP)|Death|0|||
131790228|NCT00410410|474515008|FG008|Induction Period (IP)|Death|0|||
131790229|NCT00410410|474515000|FG000|Induction Period (IP)|Adverse Event|3|||
131790230|NCT00410410|474515001|FG001|Induction Period (IP)|Adverse Event|4|||
131790231|NCT00410410|474515002|FG002|Induction Period (IP)|Adverse Event|2|||
131790232|NCT00410410|474515003|FG003|Induction Period (IP)|Adverse Event|4|||
131790233|NCT00410410|474515004|FG004|Induction Period (IP)|Adverse Event|1|||
131790234|NCT00410410|474515005|FG005|Induction Period (IP)|Adverse Event|0|||
131790235|NCT00410410|474515006|FG006|Induction Period (IP)|Adverse Event|0|||
131790236|NCT00410410|474515007|FG007|Induction Period (IP)|Adverse Event|0|||
131790237|NCT00410410|474515008|FG008|Induction Period (IP)|Adverse Event|0|||
131790238|NCT00410410|474515000|FG000|Induction Period (IP)|Lack of Efficacy|26|||
131790239|NCT00410410|474515001|FG001|Induction Period (IP)|Lack of Efficacy|24|||
131790240|NCT00410410|474515002|FG002|Induction Period (IP)|Lack of Efficacy|8|||
131790241|NCT00410410|474515003|FG003|Induction Period (IP)|Lack of Efficacy|8|||
131790242|NCT00410410|474515004|FG004|Induction Period (IP)|Lack of Efficacy|7|||
131790243|NCT00410410|474515005|FG005|Induction Period (IP)|Lack of Efficacy|7|||
131790244|NCT00410410|474515006|FG006|Induction Period (IP)|Lack of Efficacy|0|||
131790245|NCT00410410|474515007|FG007|Induction Period (IP)|Lack of Efficacy|0|||
131790246|NCT00410410|474515008|FG008|Induction Period (IP)|Lack of Efficacy|0|||
131790247|NCT00410410|474515000|FG000|Induction Period (IP)|Lost to Follow-up|2|||
131790248|NCT00410410|474515001|FG001|Induction Period (IP)|Lost to Follow-up|2|||
131790249|NCT00410410|474515002|FG002|Induction Period (IP)|Lost to Follow-up|2|||
131790250|NCT00410410|474515003|FG003|Induction Period (IP)|Lost to Follow-up|3|||
131790251|NCT00410410|474515004|FG004|Induction Period (IP)|Lost to Follow-up|0|||
131790252|NCT00410410|474515005|FG005|Induction Period (IP)|Lost to Follow-up|1|||
131790253|NCT00410410|474515006|FG006|Induction Period (IP)|Lost to Follow-up|0|||
131790254|NCT00410410|474515007|FG007|Induction Period (IP)|Lost to Follow-up|0|||
131790255|NCT00410410|474515008|FG008|Induction Period (IP)|Lost to Follow-up|0|||
131790256|NCT00410410|474515000|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
131790257|NCT00410410|474515001|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
131790258|NCT00410410|474515002|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
131790259|NCT00410410|474515003|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
131790260|NCT00410410|474515004|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
131790261|NCT00410410|474515005|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
131790262|NCT00410410|474515006|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
131790263|NCT00410410|474515007|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
131790264|NCT00410410|474515008|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
131790265|NCT00410410|474515000|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131790266|NCT00410410|474515001|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131585562|NCT02723955|473773217|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585563|NCT02723955|473773218|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585564|NCT02723955|473773219|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585565|NCT02723955|473773220|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585566|NCT02723955|473773221|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
131585567|NCT02723955|473773222|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
131585568|NCT02723955|473773223|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
131585569|NCT02723955|473773224|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
131585570|NCT02723955|473773225|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
131585571|NCT02723955|473773226|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585572|NCT02723955|473773227|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585573|NCT02723955|473773228|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585574|NCT02723955|473773229|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585575|NCT02723955|473773230|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585576|NCT02723955|473773231|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585577|NCT02723955|473773232|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585578|NCT02723955|473773233|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585579|NCT02723955|473773234|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585580|NCT02723955|473773235|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585581|NCT02723955|473773236|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585582|NCT02723955|473773237|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585583|NCT02723955|473773238|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585584|NCT02723955|473773239|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585585|NCT02723955|473773240|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585586|NCT02723955|473773241|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585587|NCT02723955|473773242|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585588|NCT02723955|473773243|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585589|NCT02723955|473773244|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585590|NCT02723955|473773245|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585591|NCT02723955|473773246|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585592|NCT02723955|473773247|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585593|NCT02723955|473773248|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585594|NCT02723955|473773249|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585595|NCT02723955|473773250|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585596|NCT02723955|473773251|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585597|NCT02723955|473773252|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585598|NCT02723955|473773253|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585599|NCT02723955|473773254|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585600|NCT02723955|473773255|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585601|NCT02723955|473773256|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585602|NCT02723955|473773257|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585603|NCT02723955|473773258|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585604|NCT02723955|473773259|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131585605|NCT02723955|473773217|FG000|Escalation Phase|Site Closed|0|||
131585606|NCT02723955|473773218|FG001|Escalation Phase|Site Closed|0|||
131585607|NCT02723955|473773219|FG002|Escalation Phase|Site Closed|0|||
131585608|NCT02723955|473773220|FG003|Escalation Phase|Site Closed|0|||
131585609|NCT02723955|473773221|FG004|Escalation Phase|Site Closed|0|||
131585610|NCT02723955|473773222|FG005|Escalation Phase|Site Closed|0|||
131585611|NCT02723955|473773223|FG006|Escalation Phase|Site Closed|0|||
131585612|NCT02723955|473773224|FG007|Escalation Phase|Site Closed|0|||
131585613|NCT02723955|473773225|FG008|Escalation Phase|Site Closed|0|||
131585614|NCT02723955|473773226|FG009|Escalation Phase|Site Closed|0|||
131585615|NCT02723955|473773227|FG010|Escalation Phase|Site Closed|0|||
131585616|NCT02723955|473773228|FG011|Escalation Phase|Site Closed|0|||
131585617|NCT02723955|473773229|FG012|Escalation Phase|Site Closed|0|||
131585618|NCT02723955|473773230|FG013|Escalation Phase|Site Closed|0|||
131585619|NCT02723955|473773231|FG014|Escalation Phase|Site Closed|0|||
131585620|NCT02723955|473773232|FG015|Escalation Phase|Site Closed|1|||
131585621|NCT02723955|473773233|FG016|Escalation Phase|Site Closed|0|||
131585622|NCT02723955|473773234|FG017|Escalation Phase|Site Closed|2|||
131585623|NCT02723955|473773235|FG018|Escalation Phase|Site Closed|0|||
131585624|NCT02723955|473773236|FG019|Escalation Phase|Site Closed|0|||
131585625|NCT02723955|473773237|FG020|Escalation Phase|Site Closed|1|||
131585626|NCT02723955|473773238|FG021|Escalation Phase|Site Closed|0|||
131585627|NCT02723955|473773239|FG022|Escalation Phase|Site Closed|0|||
131585628|NCT02723955|473773240|FG023|Escalation Phase|Site Closed|0|||
131585629|NCT02723955|473773241|FG024|Escalation Phase|Site Closed|3|||
131585630|NCT02723955|473773242|FG025|Escalation Phase|Site Closed|1|||
131585631|NCT02723955|473773243|FG026|Escalation Phase|Site Closed|3|||
131585632|NCT02723955|473773244|FG027|Escalation Phase|Site Closed|1|||
131585633|NCT02723955|473773245|FG028|Escalation Phase|Site Closed|1|||
131585634|NCT02723955|473773246|FG029|Escalation Phase|Site Closed|0|||
131585635|NCT02723955|473773247|FG030|Escalation Phase|Site Closed|0|||
131585636|NCT02723955|473773248|FG031|Escalation Phase|Site Closed|0|||
131585637|NCT02723955|473773249|FG032|Escalation Phase|Site Closed|0|||
131585638|NCT02723955|473773250|FG033|Escalation Phase|Site Closed|0|||
131585639|NCT02723955|473773251|FG034|Escalation Phase|Site Closed|0|||
131585640|NCT02723955|473773252|FG035|Escalation Phase|Site Closed|0|||
131585641|NCT02723955|473773253|FG036|Escalation Phase|Site Closed|0|||
131585642|NCT02723955|473773254|FG037|Escalation Phase|Site Closed|0|||
131585643|NCT02723955|473773255|FG038|Escalation Phase|Site Closed|0|||
131585644|NCT02723955|473773256|FG039|Escalation Phase|Site Closed|0|||
131585645|NCT02723955|473773257|FG040|Escalation Phase|Site Closed|0|||
131585646|NCT02723955|473773258|FG041|Escalation Phase|Site Closed|0|||
131585647|NCT02723955|473773259|FG042|Escalation Phase|Site Closed|0|||
131585648|NCT02723955|473773217|FG000|Expansion Phase|Death|0|||
131585649|NCT02723955|473773218|FG001|Expansion Phase|Death|0|||
131585650|NCT02723955|473773219|FG002|Expansion Phase|Death|0|||
131585651|NCT02723955|473773220|FG003|Expansion Phase|Death|0|||
131585652|NCT02723955|473773221|FG004|Expansion Phase|Death|0|||
131790267|NCT00410410|474515002|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
131585653|NCT02723955|473773222|FG005|Expansion Phase|Death|0|||
131585654|NCT02723955|473773223|FG006|Expansion Phase|Death|0|||
131585655|NCT02723955|473773224|FG007|Expansion Phase|Death|0|||
131585656|NCT02723955|473773225|FG008|Expansion Phase|Death|0|||
131585657|NCT02723955|473773226|FG009|Expansion Phase|Death|25|||
131585658|NCT02723955|473773227|FG010|Expansion Phase|Death|69|||
131585659|NCT02723955|473773228|FG011|Expansion Phase|Death|48|||
131585660|NCT02723955|473773229|FG012|Expansion Phase|Death|0|||
131585661|NCT02723955|473773230|FG013|Expansion Phase|Death|0|||
131585662|NCT02723955|473773231|FG014|Expansion Phase|Death|0|||
131585663|NCT02723955|473773232|FG015|Expansion Phase|Death|0|||
131585664|NCT02723955|473773233|FG016|Expansion Phase|Death|0|||
131585665|NCT02723955|473773234|FG017|Expansion Phase|Death|0|||
131585666|NCT02723955|473773235|FG018|Expansion Phase|Death|0|||
131585667|NCT02723955|473773236|FG019|Expansion Phase|Death|0|||
131585668|NCT02723955|473773237|FG020|Expansion Phase|Death|0|||
131585669|NCT02723955|473773238|FG021|Expansion Phase|Death|0|||
131585670|NCT02723955|473773239|FG022|Expansion Phase|Death|0|||
131585671|NCT02723955|473773240|FG023|Expansion Phase|Death|0|||
131585672|NCT02723955|473773241|FG024|Expansion Phase|Death|0|||
131585673|NCT02723955|473773242|FG025|Expansion Phase|Death|0|||
131585674|NCT02723955|473773243|FG026|Expansion Phase|Death|0|||
131585675|NCT02723955|473773244|FG027|Expansion Phase|Death|0|||
131585676|NCT02723955|473773245|FG028|Expansion Phase|Death|0|||
131585677|NCT02723955|473773246|FG029|Expansion Phase|Death|12|||
131585678|NCT02723955|473773247|FG030|Expansion Phase|Death|202|||
131585679|NCT02723955|473773248|FG031|Expansion Phase|Death|31|||
131585680|NCT02723955|473773249|FG032|Expansion Phase|Death|17|||
131585681|NCT02723955|473773250|FG033|Expansion Phase|Death|2|||
131585682|NCT02723955|473773251|FG034|Expansion Phase|Death|3|||
131585683|NCT02723955|473773252|FG035|Expansion Phase|Death|3|||
131585684|NCT02723955|473773253|FG036|Expansion Phase|Death|1|||
131585685|NCT02723955|473773254|FG037|Expansion Phase|Death|0|||
131585686|NCT02723955|473773255|FG038|Expansion Phase|Death|0|||
131585687|NCT02723955|473773256|FG039|Expansion Phase|Death|0|||
131585688|NCT02723955|473773257|FG040|Expansion Phase|Death|0|||
131585689|NCT02723955|473773258|FG041|Expansion Phase|Death|0|||
131585690|NCT02723955|473773259|FG042|Expansion Phase|Death|0|||
131585691|NCT02723955|473773217|FG000|Expansion Phase|Lost to Follow-up|0|||
131585692|NCT02723955|473773218|FG001|Expansion Phase|Lost to Follow-up|0|||
131585693|NCT02723955|473773219|FG002|Expansion Phase|Lost to Follow-up|0|||
131585694|NCT02723955|473773220|FG003|Expansion Phase|Lost to Follow-up|0|||
131585695|NCT02723955|473773221|FG004|Expansion Phase|Lost to Follow-up|0|||
131585696|NCT02723955|473773222|FG005|Expansion Phase|Lost to Follow-up|0|||
131585697|NCT02723955|473773223|FG006|Expansion Phase|Lost to Follow-up|0|||
131585698|NCT02723955|473773224|FG007|Expansion Phase|Lost to Follow-up|0|||
131585699|NCT02723955|473773225|FG008|Expansion Phase|Lost to Follow-up|0|||
131585700|NCT02723955|473773226|FG009|Expansion Phase|Lost to Follow-up|0|||
131585701|NCT02723955|473773227|FG010|Expansion Phase|Lost to Follow-up|4|||
131585702|NCT02723955|473773228|FG011|Expansion Phase|Lost to Follow-up|1|||
131585703|NCT02723955|473773229|FG012|Expansion Phase|Lost to Follow-up|0|||
131585704|NCT02723955|473773230|FG013|Expansion Phase|Lost to Follow-up|0|||
131585705|NCT02723955|473773231|FG014|Expansion Phase|Lost to Follow-up|0|||
131585706|NCT02723955|473773232|FG015|Expansion Phase|Lost to Follow-up|0|||
131585707|NCT02723955|473773233|FG016|Expansion Phase|Lost to Follow-up|0|||
131585708|NCT02723955|473773234|FG017|Expansion Phase|Lost to Follow-up|0|||
131585709|NCT02723955|473773235|FG018|Expansion Phase|Lost to Follow-up|0|||
131585710|NCT02723955|473773236|FG019|Expansion Phase|Lost to Follow-up|0|||
131585711|NCT02723955|473773237|FG020|Expansion Phase|Lost to Follow-up|0|||
131585712|NCT02723955|473773238|FG021|Expansion Phase|Lost to Follow-up|0|||
131585713|NCT02723955|473773239|FG022|Expansion Phase|Lost to Follow-up|0|||
131585714|NCT02723955|473773240|FG023|Expansion Phase|Lost to Follow-up|0|||
131585715|NCT02723955|473773241|FG024|Expansion Phase|Lost to Follow-up|0|||
131585716|NCT02723955|473773242|FG025|Expansion Phase|Lost to Follow-up|0|||
131585717|NCT02723955|473773243|FG026|Expansion Phase|Lost to Follow-up|0|||
131585718|NCT02723955|473773244|FG027|Expansion Phase|Lost to Follow-up|0|||
131585719|NCT02723955|473773245|FG028|Expansion Phase|Lost to Follow-up|0|||
131585720|NCT02723955|473773246|FG029|Expansion Phase|Lost to Follow-up|1|||
131585721|NCT02723955|473773247|FG030|Expansion Phase|Lost to Follow-up|19|||
131790268|NCT00410410|474515003|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131585722|NCT02723955|473773248|FG031|Expansion Phase|Lost to Follow-up|2|||
131585723|NCT02723955|473773249|FG032|Expansion Phase|Lost to Follow-up|1|||
131585724|NCT02723955|473773250|FG033|Expansion Phase|Lost to Follow-up|0|||
131585725|NCT02723955|473773251|FG034|Expansion Phase|Lost to Follow-up|0|||
131585726|NCT02723955|473773252|FG035|Expansion Phase|Lost to Follow-up|0|||
131585727|NCT02723955|473773253|FG036|Expansion Phase|Lost to Follow-up|0|||
131585728|NCT02723955|473773254|FG037|Expansion Phase|Lost to Follow-up|0|||
131585729|NCT02723955|473773255|FG038|Expansion Phase|Lost to Follow-up|0|||
131585730|NCT02723955|473773256|FG039|Expansion Phase|Lost to Follow-up|0|||
131585731|NCT02723955|473773257|FG040|Expansion Phase|Lost to Follow-up|0|||
131585732|NCT02723955|473773258|FG041|Expansion Phase|Lost to Follow-up|0|||
131585733|NCT02723955|473773259|FG042|Expansion Phase|Lost to Follow-up|0|||
131585734|NCT02723955|473773217|FG000|Expansion Phase|Physician Decision|0|||
131585735|NCT02723955|473773218|FG001|Expansion Phase|Physician Decision|0|||
131585736|NCT02723955|473773219|FG002|Expansion Phase|Physician Decision|0|||
131585737|NCT02723955|473773220|FG003|Expansion Phase|Physician Decision|0|||
131585738|NCT02723955|473773221|FG004|Expansion Phase|Physician Decision|0|||
131585739|NCT02723955|473773222|FG005|Expansion Phase|Physician Decision|0|||
131585740|NCT02723955|473773223|FG006|Expansion Phase|Physician Decision|0|||
131585741|NCT02723955|473773224|FG007|Expansion Phase|Physician Decision|0|||
131585742|NCT02723955|473773225|FG008|Expansion Phase|Physician Decision|0|||
131585743|NCT02723955|473773226|FG009|Expansion Phase|Physician Decision|0|||
131585744|NCT02723955|473773227|FG010|Expansion Phase|Physician Decision|0|||
131585745|NCT02723955|473773228|FG011|Expansion Phase|Physician Decision|0|||
131585746|NCT02723955|473773229|FG012|Expansion Phase|Physician Decision|0|||
131585747|NCT02723955|473773230|FG013|Expansion Phase|Physician Decision|0|||
131585748|NCT02723955|473773231|FG014|Expansion Phase|Physician Decision|0|||
131585749|NCT02723955|473773232|FG015|Expansion Phase|Physician Decision|0|||
131585750|NCT02723955|473773233|FG016|Expansion Phase|Physician Decision|0|||
131585751|NCT02723955|473773234|FG017|Expansion Phase|Physician Decision|0|||
131585752|NCT02723955|473773235|FG018|Expansion Phase|Physician Decision|0|||
131585753|NCT02723955|473773236|FG019|Expansion Phase|Physician Decision|0|||
131585754|NCT02723955|473773237|FG020|Expansion Phase|Physician Decision|0|||
131704991|NCT04426695|474203426|FG010|Overall Study|Lost to Follow-up|12|||
131704992|NCT04426695|474203427|FG011|Overall Study|Lost to Follow-up|6|||
131704993|NCT04426695|474203428|FG012|Overall Study|Lost to Follow-up|2|||
131704994|NCT04426695|474203429|FG013|Overall Study|Lost to Follow-up|2|||
131704995|NCT04426695|474203430|FG014|Overall Study|Lost to Follow-up|2|||
131704996|NCT04426695|474203431|FG015|Overall Study|Lost to Follow-up|0|||
131704997|NCT04426695|474203432|FG016|Overall Study|Lost to Follow-up|0|||
131704998|NCT04426695|474203433|FG017|Overall Study|Lost to Follow-up|0|||
131704999|NCT04426695|474203416|FG000|Overall Study|Participant Decision|1|||
131705000|NCT04426695|474203417|FG001|Overall Study|Participant Decision|2|||
131705001|NCT04426695|474203418|FG002|Overall Study|Participant Decision|2|||
131705002|NCT04426695|474203419|FG003|Overall Study|Participant Decision|12|||
131705003|NCT04426695|474203420|FG004|Overall Study|Participant Decision|18|||
131705004|NCT04426695|474203421|FG005|Overall Study|Participant Decision|22|||
131705005|NCT04426695|474203422|FG006|Overall Study|Participant Decision|13|||
131705006|NCT04426695|474203423|FG007|Overall Study|Participant Decision|13|||
131705007|NCT04426695|474203424|FG008|Overall Study|Participant Decision|10|||
131705008|NCT04426695|474203425|FG009|Overall Study|Participant Decision|15|||
131705009|NCT04426695|474203426|FG010|Overall Study|Participant Decision|16|||
131705010|NCT04426695|474203427|FG011|Overall Study|Participant Decision|17|||
131705011|NCT04426695|474203428|FG012|Overall Study|Participant Decision|2|||
131705012|NCT04426695|474203429|FG013|Overall Study|Participant Decision|1|||
131705013|NCT04426695|474203430|FG014|Overall Study|Participant Decision|2|||
131705014|NCT04426695|474203431|FG015|Overall Study|Participant Decision|0|||
131705015|NCT04426695|474203432|FG016|Overall Study|Participant Decision|0|||
131705016|NCT04426695|474203433|FG017|Overall Study|Participant Decision|0|||
131705017|NCT04426695|474203416|FG000|Overall Study|Adverse Event|0|||
131705018|NCT04426695|474203417|FG001|Overall Study|Adverse Event|0|||
131705019|NCT04426695|474203418|FG002|Overall Study|Adverse Event|0|||
131705020|NCT04426695|474203419|FG003|Overall Study|Adverse Event|0|||
131705021|NCT04426695|474203420|FG004|Overall Study|Adverse Event|0|||
131705022|NCT04426695|474203421|FG005|Overall Study|Adverse Event|0|||
131705023|NCT04426695|474203422|FG006|Overall Study|Adverse Event|0|||
131705024|NCT04426695|474203423|FG007|Overall Study|Adverse Event|1|||
131705025|NCT04426695|474203424|FG008|Overall Study|Adverse Event|0|||
131705026|NCT04426695|474203425|FG009|Overall Study|Adverse Event|0|||
131705027|NCT04426695|474203426|FG010|Overall Study|Adverse Event|1|||
131705028|NCT04426695|474203427|FG011|Overall Study|Adverse Event|1|||
131705029|NCT04426695|474203428|FG012|Overall Study|Adverse Event|0|||
131705030|NCT04426695|474203429|FG013|Overall Study|Adverse Event|0|||
131705031|NCT04426695|474203430|FG014|Overall Study|Adverse Event|0|||
131705032|NCT04426695|474203431|FG015|Overall Study|Adverse Event|0|||
131705033|NCT04426695|474203432|FG016|Overall Study|Adverse Event|0|||
131705034|NCT04426695|474203433|FG017|Overall Study|Adverse Event|0|||
131705035|NCT04426695|474203416|FG000|Overall Study|Sponsor Request|0|||
131705036|NCT04426695|474203417|FG001|Overall Study|Sponsor Request|0|||
131705037|NCT04426695|474203418|FG002|Overall Study|Sponsor Request|0|||
131705038|NCT04426695|474203419|FG003|Overall Study|Sponsor Request|0|||
131705039|NCT04426695|474203420|FG004|Overall Study|Sponsor Request|0|||
131705040|NCT04426695|474203421|FG005|Overall Study|Sponsor Request|0|||
131585755|NCT02723955|473773238|FG021|Expansion Phase|Physician Decision|0|||
131585756|NCT02723955|473773239|FG022|Expansion Phase|Physician Decision|0|||
131585757|NCT02723955|473773240|FG023|Expansion Phase|Physician Decision|0|||
131585758|NCT02723955|473773241|FG024|Expansion Phase|Physician Decision|0|||
131705041|NCT04426695|474203422|FG006|Overall Study|Sponsor Request|1|||
131705042|NCT04426695|474203423|FG007|Overall Study|Sponsor Request|0|||
131705043|NCT04426695|474203424|FG008|Overall Study|Sponsor Request|0|||
131705044|NCT04426695|474203425|FG009|Overall Study|Sponsor Request|0|||
131585759|NCT02723955|473773242|FG025|Expansion Phase|Physician Decision|0|||
131585760|NCT02723955|473773243|FG026|Expansion Phase|Physician Decision|0|||
131585761|NCT02723955|473773244|FG027|Expansion Phase|Physician Decision|0|||
131585762|NCT02723955|473773245|FG028|Expansion Phase|Physician Decision|0|||
131585763|NCT02723955|473773246|FG029|Expansion Phase|Physician Decision|0|||
131585764|NCT02723955|473773247|FG030|Expansion Phase|Physician Decision|1|||
131585765|NCT02723955|473773248|FG031|Expansion Phase|Physician Decision|1|||
131585766|NCT02723955|473773249|FG032|Expansion Phase|Physician Decision|0|||
131585767|NCT02723955|473773250|FG033|Expansion Phase|Physician Decision|0|||
131585768|NCT02723955|473773251|FG034|Expansion Phase|Physician Decision|0|||
131585769|NCT02723955|473773252|FG035|Expansion Phase|Physician Decision|0|||
131585770|NCT02723955|473773253|FG036|Expansion Phase|Physician Decision|0|||
131585771|NCT02723955|473773254|FG037|Expansion Phase|Physician Decision|0|||
131585772|NCT02723955|473773255|FG038|Expansion Phase|Physician Decision|0|||
131585773|NCT02723955|473773256|FG039|Expansion Phase|Physician Decision|0|||
131585774|NCT02723955|473773257|FG040|Expansion Phase|Physician Decision|0|||
131585775|NCT02723955|473773258|FG041|Expansion Phase|Physician Decision|0|||
131585776|NCT02723955|473773259|FG042|Expansion Phase|Physician Decision|0|||
131585777|NCT02723955|473773217|FG000|Expansion Phase|Withdrawal by Subject|0|||
131585778|NCT02723955|473773218|FG001|Expansion Phase|Withdrawal by Subject|0|||
131585779|NCT02723955|473773219|FG002|Expansion Phase|Withdrawal by Subject|0|||
131585780|NCT02723955|473773220|FG003|Expansion Phase|Withdrawal by Subject|0|||
131585781|NCT02723955|473773221|FG004|Expansion Phase|Withdrawal by Subject|0|||
131585782|NCT02723955|473773222|FG005|Expansion Phase|Withdrawal by Subject|0|||
131585783|NCT02723955|473773223|FG006|Expansion Phase|Withdrawal by Subject|0|||
131585784|NCT02723955|473773224|FG007|Expansion Phase|Withdrawal by Subject|0|||
131585785|NCT02723955|473773225|FG008|Expansion Phase|Withdrawal by Subject|0|||
131585786|NCT02723955|473773226|FG009|Expansion Phase|Withdrawal by Subject|2|||
131585787|NCT02723955|473773227|FG010|Expansion Phase|Withdrawal by Subject|1|||
131585788|NCT02723955|473773228|FG011|Expansion Phase|Withdrawal by Subject|0|||
131585789|NCT02723955|473773229|FG012|Expansion Phase|Withdrawal by Subject|0|||
131585790|NCT02723955|473773230|FG013|Expansion Phase|Withdrawal by Subject|0|||
131585791|NCT02723955|473773231|FG014|Expansion Phase|Withdrawal by Subject|0|||
131585792|NCT02723955|473773232|FG015|Expansion Phase|Withdrawal by Subject|0|||
131585793|NCT02723955|473773233|FG016|Expansion Phase|Withdrawal by Subject|0|||
131585794|NCT02723955|473773234|FG017|Expansion Phase|Withdrawal by Subject|0|||
131585795|NCT02723955|473773235|FG018|Expansion Phase|Withdrawal by Subject|0|||
131585796|NCT02723955|473773236|FG019|Expansion Phase|Withdrawal by Subject|0|||
131585797|NCT02723955|473773237|FG020|Expansion Phase|Withdrawal by Subject|0|||
131585798|NCT02723955|473773238|FG021|Expansion Phase|Withdrawal by Subject|0|||
131585799|NCT02723955|473773239|FG022|Expansion Phase|Withdrawal by Subject|0|||
131585800|NCT02723955|473773240|FG023|Expansion Phase|Withdrawal by Subject|0|||
131585801|NCT02723955|473773241|FG024|Expansion Phase|Withdrawal by Subject|0|||
131585802|NCT02723955|473773242|FG025|Expansion Phase|Withdrawal by Subject|0|||
131585803|NCT02723955|473773243|FG026|Expansion Phase|Withdrawal by Subject|0|||
131585804|NCT02723955|473773244|FG027|Expansion Phase|Withdrawal by Subject|0|||
131585805|NCT02723955|473773245|FG028|Expansion Phase|Withdrawal by Subject|0|||
131585806|NCT02723955|473773246|FG029|Expansion Phase|Withdrawal by Subject|0|||
131585807|NCT02723955|473773247|FG030|Expansion Phase|Withdrawal by Subject|8|||
131585808|NCT02723955|473773248|FG031|Expansion Phase|Withdrawal by Subject|4|||
131585809|NCT02723955|473773249|FG032|Expansion Phase|Withdrawal by Subject|0|||
131585810|NCT02723955|473773250|FG033|Expansion Phase|Withdrawal by Subject|0|||
131585811|NCT02723955|473773251|FG034|Expansion Phase|Withdrawal by Subject|0|||
131585812|NCT02723955|473773252|FG035|Expansion Phase|Withdrawal by Subject|1|||
131585813|NCT02723955|473773253|FG036|Expansion Phase|Withdrawal by Subject|0|||
131585814|NCT02723955|473773254|FG037|Expansion Phase|Withdrawal by Subject|0|||
131585815|NCT02723955|473773255|FG038|Expansion Phase|Withdrawal by Subject|0|||
131585816|NCT02723955|473773256|FG039|Expansion Phase|Withdrawal by Subject|0|||
131585817|NCT02723955|473773257|FG040|Expansion Phase|Withdrawal by Subject|0|||
131585818|NCT02723955|473773258|FG041|Expansion Phase|Withdrawal by Subject|0|||
131585819|NCT02723955|473773259|FG042|Expansion Phase|Withdrawal by Subject|0|||
131585820|NCT02723955|473773217|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585821|NCT02723955|473773218|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585822|NCT02723955|473773219|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585823|NCT02723955|473773220|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585824|NCT02723955|473773221|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585825|NCT02723955|473773222|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585826|NCT02723955|473773223|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585827|NCT02723955|473773224|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585828|NCT02723955|473773225|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585829|NCT02723955|473773226|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
131585830|NCT02723955|473773227|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
131585831|NCT02723955|473773228|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
131585832|NCT02723955|473773229|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585833|NCT02723955|473773230|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585834|NCT02723955|473773231|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585835|NCT02723955|473773232|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585836|NCT02723955|473773233|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585837|NCT02723955|473773234|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585838|NCT02723955|473773235|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585839|NCT02723955|473773236|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585840|NCT02723955|473773237|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585841|NCT02723955|473773238|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585842|NCT02723955|473773239|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585843|NCT02723955|473773240|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585844|NCT02723955|473773241|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585845|NCT02723955|473773242|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585846|NCT02723955|473773243|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585847|NCT02723955|473773244|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585848|NCT02723955|473773245|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585849|NCT02723955|473773246|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585850|NCT02723955|473773247|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
131585851|NCT02723955|473773248|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585852|NCT02723955|473773249|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585853|NCT02723955|473773250|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585854|NCT02723955|473773251|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585855|NCT02723955|473773252|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585856|NCT02723955|473773253|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585857|NCT02723955|473773254|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585858|NCT02723955|473773255|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585859|NCT02723955|473773256|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585860|NCT02723955|473773257|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585861|NCT02723955|473773258|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131585862|NCT02723955|473773259|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131705045|NCT04426695|474203426|FG010|Overall Study|Sponsor Request|0|||
131705046|NCT04426695|474203427|FG011|Overall Study|Sponsor Request|0|||
131705047|NCT04426695|474203428|FG012|Overall Study|Sponsor Request|0|||
131705048|NCT04426695|474203429|FG013|Overall Study|Sponsor Request|0|||
131705049|NCT04426695|474203430|FG014|Overall Study|Sponsor Request|0|||
131705050|NCT04426695|474203431|FG015|Overall Study|Sponsor Request|0|||
131705051|NCT04426695|474203432|FG016|Overall Study|Sponsor Request|0|||
131585863|NCT02723955|473773217|FG000|Expansion Phase|Site Closed|0|||
131585864|NCT02723955|473773218|FG001|Expansion Phase|Site Closed|0|||
131790269|NCT00410410|474515004|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131790270|NCT00410410|474515005|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131585865|NCT02723955|473773219|FG002|Expansion Phase|Site Closed|0|||
131585866|NCT02723955|473773220|FG003|Expansion Phase|Site Closed|0|||
131585867|NCT02723955|473773221|FG004|Expansion Phase|Site Closed|0|||
131790271|NCT00410410|474515006|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131790272|NCT00410410|474515007|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131790273|NCT00410410|474515008|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131790274|NCT00410410|474515000|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131790275|NCT00410410|474515001|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131790276|NCT00410410|474515002|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131790277|NCT00410410|474515003|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131790278|NCT00410410|474515004|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
131790279|NCT00410410|474515005|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
131790280|NCT00410410|474515006|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131790281|NCT00410410|474515007|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131790282|NCT00410410|474515008|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131585868|NCT02723955|473773222|FG005|Expansion Phase|Site Closed|0|||
131585869|NCT02723955|473773223|FG006|Expansion Phase|Site Closed|0|||
131585870|NCT02723955|473773224|FG007|Expansion Phase|Site Closed|0|||
131585871|NCT02723955|473773225|FG008|Expansion Phase|Site Closed|0|||
131585872|NCT02723955|473773226|FG009|Expansion Phase|Site Closed|1|||
131585873|NCT02723955|473773227|FG010|Expansion Phase|Site Closed|2|||
131585874|NCT02723955|473773228|FG011|Expansion Phase|Site Closed|6|||
131585875|NCT02723955|473773229|FG012|Expansion Phase|Site Closed|0|||
131585876|NCT02723955|473773230|FG013|Expansion Phase|Site Closed|0|||
131585877|NCT02723955|473773231|FG014|Expansion Phase|Site Closed|0|||
131585878|NCT02723955|473773232|FG015|Expansion Phase|Site Closed|0|||
131585879|NCT02723955|473773233|FG016|Expansion Phase|Site Closed|0|||
131585880|NCT02723955|473773234|FG017|Expansion Phase|Site Closed|0|||
131585881|NCT02723955|473773235|FG018|Expansion Phase|Site Closed|0|||
131585882|NCT02723955|473773236|FG019|Expansion Phase|Site Closed|0|||
131790283|NCT00410410|474515000|FG000|Induction Period (IP)|Other|0|||
131790284|NCT00410410|474515001|FG001|Induction Period (IP)|Other|0|||
131790285|NCT00410410|474515002|FG002|Induction Period (IP)|Other|1|||
131790286|NCT00410410|474515003|FG003|Induction Period (IP)|Other|0|||
131790287|NCT00410410|474515004|FG004|Induction Period (IP)|Other|0|||
131790288|NCT00410410|474515005|FG005|Induction Period (IP)|Other|0|||
131790289|NCT00410410|474515006|FG006|Induction Period (IP)|Other|0|||
131790290|NCT00410410|474515007|FG007|Induction Period (IP)|Other|0|||
131790291|NCT00410410|474515008|FG008|Induction Period (IP)|Other|0|||
131790292|NCT00410410|474515000|FG000|Maintenance Period (MP)|Death|0|||
131585883|NCT02723955|473773237|FG020|Expansion Phase|Site Closed|0|||
131585884|NCT02723955|473773238|FG021|Expansion Phase|Site Closed|0|||
131585885|NCT02723955|473773239|FG022|Expansion Phase|Site Closed|0|||
131585886|NCT02723955|473773240|FG023|Expansion Phase|Site Closed|0|||
131585887|NCT02723955|473773241|FG024|Expansion Phase|Site Closed|0|||
131585888|NCT02723955|473773242|FG025|Expansion Phase|Site Closed|0|||
131585889|NCT02723955|473773243|FG026|Expansion Phase|Site Closed|0|||
131585890|NCT02723955|473773244|FG027|Expansion Phase|Site Closed|0|||
131585891|NCT02723955|473773245|FG028|Expansion Phase|Site Closed|0|||
131585892|NCT02723955|473773246|FG029|Expansion Phase|Site Closed|0|||
131585893|NCT02723955|473773247|FG030|Expansion Phase|Site Closed|8|||
131585894|NCT02723955|473773248|FG031|Expansion Phase|Site Closed|4|||
131585895|NCT02723955|473773249|FG032|Expansion Phase|Site Closed|2|||
131585896|NCT02723955|473773250|FG033|Expansion Phase|Site Closed|2|||
131585897|NCT02723955|473773251|FG034|Expansion Phase|Site Closed|0|||
131585898|NCT02723955|473773252|FG035|Expansion Phase|Site Closed|0|||
131585899|NCT02723955|473773253|FG036|Expansion Phase|Site Closed|0|||
131585900|NCT02723955|473773254|FG037|Expansion Phase|Site Closed|0|||
131585901|NCT02723955|473773255|FG038|Expansion Phase|Site Closed|0|||
131790293|NCT00410410|474515001|FG001|Maintenance Period (MP)|Death|0|||
131790294|NCT00410410|474515002|FG002|Maintenance Period (MP)|Death|0|||
131585902|NCT02723955|473773256|FG039|Expansion Phase|Site Closed|0|||
131585903|NCT02723955|473773257|FG040|Expansion Phase|Site Closed|0|||
131790295|NCT00410410|474515003|FG003|Maintenance Period (MP)|Death|0|||
131585904|NCT02723955|473773258|FG041|Expansion Phase|Site Closed|0|||
131585905|NCT02723955|473773259|FG042|Expansion Phase|Site Closed|0|||
131585906|NCT02723955|473773217|FG000|Crossover/ Re-treatment Phase|Death|0|||
131585907|NCT02723955|473773218|FG001|Crossover/ Re-treatment Phase|Death|0|||
131585908|NCT02723955|473773219|FG002|Crossover/ Re-treatment Phase|Death|0|||
131585909|NCT02723955|473773220|FG003|Crossover/ Re-treatment Phase|Death|0|||
131585910|NCT02723955|473773221|FG004|Crossover/ Re-treatment Phase|Death|0|||
131585911|NCT02723955|473773222|FG005|Crossover/ Re-treatment Phase|Death|0|||
131790296|NCT00410410|474515004|FG004|Maintenance Period (MP)|Death|0|||
131585912|NCT02723955|473773223|FG006|Crossover/ Re-treatment Phase|Death|0|||
131585913|NCT02723955|473773224|FG007|Crossover/ Re-treatment Phase|Death|0|||
131585914|NCT02723955|473773225|FG008|Crossover/ Re-treatment Phase|Death|0|||
131585915|NCT02723955|473773226|FG009|Crossover/ Re-treatment Phase|Death|0|||
131585916|NCT02723955|473773227|FG010|Crossover/ Re-treatment Phase|Death|0|||
131585917|NCT02723955|473773228|FG011|Crossover/ Re-treatment Phase|Death|0|||
131585918|NCT02723955|473773229|FG012|Crossover/ Re-treatment Phase|Death|0|||
131585919|NCT02723955|473773230|FG013|Crossover/ Re-treatment Phase|Death|0|||
131585920|NCT02723955|473773231|FG014|Crossover/ Re-treatment Phase|Death|0|||
131585921|NCT02723955|473773232|FG015|Crossover/ Re-treatment Phase|Death|0|||
131585922|NCT02723955|473773233|FG016|Crossover/ Re-treatment Phase|Death|0|||
131585923|NCT02723955|473773234|FG017|Crossover/ Re-treatment Phase|Death|0|||
131585924|NCT02723955|473773235|FG018|Crossover/ Re-treatment Phase|Death|0|||
131585925|NCT02723955|473773236|FG019|Crossover/ Re-treatment Phase|Death|0|||
131585926|NCT02723955|473773237|FG020|Crossover/ Re-treatment Phase|Death|0|||
131585927|NCT02723955|473773238|FG021|Crossover/ Re-treatment Phase|Death|0|||
131585928|NCT02723955|473773239|FG022|Crossover/ Re-treatment Phase|Death|0|||
131585929|NCT02723955|473773240|FG023|Crossover/ Re-treatment Phase|Death|0|||
131585930|NCT02723955|473773241|FG024|Crossover/ Re-treatment Phase|Death|0|||
131585931|NCT02723955|473773242|FG025|Crossover/ Re-treatment Phase|Death|0|||
131585932|NCT02723955|473773243|FG026|Crossover/ Re-treatment Phase|Death|0|||
131585933|NCT02723955|473773244|FG027|Crossover/ Re-treatment Phase|Death|0|||
131585934|NCT02723955|473773245|FG028|Crossover/ Re-treatment Phase|Death|0|||
131585935|NCT02723955|473773246|FG029|Crossover/ Re-treatment Phase|Death|0|||
131585936|NCT02723955|473773247|FG030|Crossover/ Re-treatment Phase|Death|0|||
131585937|NCT02723955|473773248|FG031|Crossover/ Re-treatment Phase|Death|0|||
131585938|NCT02723955|473773249|FG032|Crossover/ Re-treatment Phase|Death|0|||
131585939|NCT02723955|473773250|FG033|Crossover/ Re-treatment Phase|Death|0|||
131585940|NCT02723955|473773251|FG034|Crossover/ Re-treatment Phase|Death|0|||
131585941|NCT02723955|473773252|FG035|Crossover/ Re-treatment Phase|Death|0|||
131585942|NCT02723955|473773253|FG036|Crossover/ Re-treatment Phase|Death|0|||
131585943|NCT02723955|473773254|FG037|Crossover/ Re-treatment Phase|Death|1|||
131585944|NCT02723955|473773255|FG038|Crossover/ Re-treatment Phase|Death|14|||
131585945|NCT02723955|473773256|FG039|Crossover/ Re-treatment Phase|Death|32|||
131585946|NCT02723955|473773257|FG040|Crossover/ Re-treatment Phase|Death|2|||
131585947|NCT02723955|473773258|FG041|Crossover/ Re-treatment Phase|Death|1|||
131585948|NCT02723955|473773259|FG042|Crossover/ Re-treatment Phase|Death|0|||
131585949|NCT02723955|473773217|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585950|NCT02723955|473773218|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585951|NCT02723955|473773219|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585952|NCT02723955|473773220|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585953|NCT02723955|473773221|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585954|NCT02723955|473773222|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585955|NCT02723955|473773223|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585956|NCT02723955|473773224|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585957|NCT02723955|473773225|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585958|NCT02723955|473773226|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585959|NCT02723955|473773227|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585960|NCT02723955|473773228|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585961|NCT02723955|473773229|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585962|NCT02723955|473773230|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585963|NCT02723955|473773231|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585964|NCT02723955|473773232|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585965|NCT02723955|473773233|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585966|NCT02723955|473773234|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585967|NCT02723955|473773235|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585968|NCT02723955|473773236|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585969|NCT02723955|473773237|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585970|NCT02723955|473773238|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585971|NCT02723955|473773239|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585972|NCT02723955|473773240|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131653601|NCT03842228|474018421|FG000|Overall Study|Adverse Event|1|||
131653602|NCT03842228|474018422|FG001|Overall Study|Adverse Event|1|||
131653603|NCT03842228|474018423|FG002|Overall Study|Adverse Event|1|||
131653604|NCT03842228|474018424|FG003|Overall Study|Adverse Event|0|||
131653605|NCT03842228|474018425|FG004|Overall Study|Adverse Event|0|||
131653606|NCT03842228|474018426|FG005|Overall Study|Adverse Event|0|||
131653607|NCT03842228|474018427|FG006|Overall Study|Adverse Event|0|||
131653608|NCT03842228|474018421|FG000|Overall Study|Death|0|||
131653609|NCT03842228|474018422|FG001|Overall Study|Death|1|||
131653610|NCT03842228|474018423|FG002|Overall Study|Death|0|||
131653611|NCT03842228|474018424|FG003|Overall Study|Death|0|||
131653612|NCT03842228|474018425|FG004|Overall Study|Death|0|||
131653613|NCT03842228|474018426|FG005|Overall Study|Death|0|||
131653614|NCT03842228|474018427|FG006|Overall Study|Death|0|||
131585973|NCT02723955|473773241|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585974|NCT02723955|473773242|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585975|NCT02723955|473773243|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585976|NCT02723955|473773244|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585977|NCT02723955|473773245|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585978|NCT02723955|473773246|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585979|NCT02723955|473773247|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585980|NCT02723955|473773248|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585981|NCT02723955|473773249|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585982|NCT02723955|473773250|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585983|NCT02723955|473773251|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585984|NCT02723955|473773252|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585985|NCT02723955|473773253|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585986|NCT02723955|473773254|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585987|NCT02723955|473773255|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585988|NCT02723955|473773256|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
131585989|NCT02723955|473773257|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585990|NCT02723955|473773258|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585991|NCT02723955|473773259|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131585992|NCT02723955|473773217|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
131585993|NCT02723955|473773218|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
131585994|NCT02723955|473773219|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
131705052|NCT04426695|474203433|FG017|Overall Study|Sponsor Request|0|||
131705053|NCT04426695|474203416|FG000|Overall Study|Physician Decision|0|||
131705054|NCT04426695|474203417|FG001|Overall Study|Physician Decision|0|||
131705055|NCT04426695|474203418|FG002|Overall Study|Physician Decision|0|||
131705056|NCT04426695|474203419|FG003|Overall Study|Physician Decision|0|||
131705057|NCT04426695|474203420|FG004|Overall Study|Physician Decision|0|||
131705058|NCT04426695|474203421|FG005|Overall Study|Physician Decision|0|||
131705059|NCT04426695|474203422|FG006|Overall Study|Physician Decision|0|||
131705060|NCT04426695|474203423|FG007|Overall Study|Physician Decision|0|||
131705061|NCT04426695|474203424|FG008|Overall Study|Physician Decision|0|||
131585995|NCT02723955|473773220|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
131585996|NCT02723955|473773221|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
131585997|NCT02723955|473773222|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
131585998|NCT02723955|473773223|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
131585999|NCT02723955|473773224|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586000|NCT02723955|473773225|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586001|NCT02723955|473773226|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586002|NCT02723955|473773227|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586003|NCT02723955|473773228|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586004|NCT02723955|473773229|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586005|NCT02723955|473773230|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586006|NCT02723955|473773231|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586007|NCT02723955|473773232|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586008|NCT02723955|473773233|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
131705062|NCT04426695|474203425|FG009|Overall Study|Physician Decision|1|||
131705063|NCT04426695|474203426|FG010|Overall Study|Physician Decision|0|||
131705064|NCT04426695|474203427|FG011|Overall Study|Physician Decision|0|||
131705065|NCT04426695|474203428|FG012|Overall Study|Physician Decision|1|||
131586009|NCT02723955|473773234|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586010|NCT02723955|473773235|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586011|NCT02723955|473773236|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586012|NCT02723955|473773237|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586013|NCT02723955|473773238|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
131705066|NCT04426695|474203429|FG013|Overall Study|Physician Decision|0|||
131705067|NCT04426695|474203430|FG014|Overall Study|Physician Decision|0|||
131705068|NCT04426695|474203431|FG015|Overall Study|Physician Decision|0|||
131586014|NCT02723955|473773239|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
131705069|NCT04426695|474203432|FG016|Overall Study|Physician Decision|0|||
131705070|NCT04426695|474203433|FG017|Overall Study|Physician Decision|0|||
131586015|NCT02723955|473773240|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586016|NCT02723955|473773241|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
131705071|NCT04426695|474203416|FG000|Overall Study|Randomized but Never Treated|3|||
131705072|NCT04426695|474203417|FG001|Overall Study|Randomized but Never Treated|1|||
131790297|NCT00410410|474515005|FG005|Maintenance Period (MP)|Death|0|||
131586017|NCT02723955|473773242|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586018|NCT02723955|473773243|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586019|NCT02723955|473773244|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586020|NCT02723955|473773245|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586021|NCT02723955|473773246|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586022|NCT02723955|473773247|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
131790298|NCT00410410|474515006|FG006|Maintenance Period (MP)|Death|1|||
131586023|NCT02723955|473773248|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586024|NCT02723955|473773249|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586025|NCT02723955|473773250|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586026|NCT02723955|473773251|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586027|NCT02723955|473773252|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586028|NCT02723955|473773253|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586029|NCT02723955|473773254|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586030|NCT02723955|473773255|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
131586031|NCT02723955|473773256|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
131586032|NCT02723955|473773257|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586033|NCT02723955|473773258|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
131586034|NCT02723955|473773259|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
131586035|NCT02723955|473773217|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
131586036|NCT02723955|473773218|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
131586037|NCT02723955|473773219|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
131586038|NCT02723955|473773220|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
131586039|NCT02723955|473773221|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
131586040|NCT02723955|473773222|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
131586041|NCT02723955|473773223|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
131586042|NCT02723955|473773224|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
131586043|NCT02723955|473773225|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
131586044|NCT02723955|473773226|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
131586045|NCT02723955|473773227|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
131586046|NCT02723955|473773228|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
131586047|NCT02723955|473773229|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
131586048|NCT02723955|473773230|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
131586049|NCT02723955|473773231|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
131586050|NCT02723955|473773232|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
131586051|NCT02723955|473773233|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
131586052|NCT02723955|473773234|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
131586053|NCT02723955|473773235|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
131586054|NCT02723955|473773236|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
131586055|NCT02723955|473773237|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
131586056|NCT02723955|473773238|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
131586057|NCT02723955|473773239|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
131586058|NCT02723955|473773240|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
131586059|NCT02723955|473773241|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
131586060|NCT02723955|473773242|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
131586061|NCT02723955|473773243|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
131586062|NCT02723955|473773244|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
131586063|NCT02723955|473773245|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
131586064|NCT02723955|473773246|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
131586065|NCT02723955|473773247|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
131586066|NCT02723955|473773248|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
131586067|NCT02723955|473773249|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
131586068|NCT02723955|473773250|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
131586069|NCT02723955|473773251|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
131586070|NCT02723955|473773252|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
131586071|NCT02723955|473773253|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
131586072|NCT02723955|473773254|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
131586073|NCT02723955|473773255|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
131586074|NCT02723955|473773256|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
131586075|NCT02723955|473773257|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
131586076|NCT02723955|473773258|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
131586077|NCT02723955|473773259|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
131586078|NCT04188379|473773260|FG000|Overall Study|Withdrawal by Subject|10|||
131586079|NCT04188379|473773261|FG001|Overall Study|Withdrawal by Subject|3|||
131586080|NCT04188379|473773260|FG000|Overall Study|Physician Decision|0|||
131586081|NCT04188379|473773261|FG001|Overall Study|Physician Decision|1|||
131705073|NCT04426695|474203418|FG002|Overall Study|Randomized but Never Treated|0|||
131586082|NCT04188379|473773260|FG000|Overall Study|Adverse Event|3|||
131705074|NCT04426695|474203419|FG003|Overall Study|Randomized but Never Treated|4|||
131705075|NCT04426695|474203420|FG004|Overall Study|Randomized but Never Treated|5|||
131790299|NCT00410410|474515007|FG007|Maintenance Period (MP)|Death|0|||
131586083|NCT04188379|473773261|FG001|Overall Study|Adverse Event|1|||
131586084|NCT04188379|473773260|FG000|Overall Study|Pregnancy|1|||
131586085|NCT04188379|473773261|FG001|Overall Study|Pregnancy|0|||
131586086|NCT04188379|473773260|FG000|Overall Study|Lack of Efficacy|8|||
131586087|NCT04188379|473773261|FG001|Overall Study|Lack of Efficacy|5|||
131586088|NCT04188379|473773260|FG000|Overall Study|Other|0|||
131586089|NCT04188379|473773261|FG001|Overall Study|Other|3|||
131586090|NCT02411084|473773264|FG000|Overall Study|Lack of Efficacy|6|||
131586091|NCT02411084|473773265|FG001|Overall Study|Lack of Efficacy|3|||
131586092|NCT02411084|473773264|FG000|Overall Study|Death|5|||
131586093|NCT02411084|473773265|FG001|Overall Study|Death|4|||
131586094|NCT02411084|473773264|FG000|Overall Study|Adverse Event|2|||
131586095|NCT02411084|473773265|FG001|Overall Study|Adverse Event|1|||
131586096|NCT02411084|473773264|FG000|Overall Study|Other reasons|0|||
131586097|NCT02411084|473773265|FG001|Overall Study|Other reasons|5|||
131586098|NCT05773313|473773270|FG000|Overall Study|Lost to Follow-up|3|||
131586099|NCT02748317|473773271|FG000|Overall Study|Withdrawal by Subject|14|||
131586100|NCT02748317|473773271|FG000|Overall Study|Lost to Follow-up|8|||
131586101|NCT02748317|473773271|FG000|Overall Study|Death|1|||
131586102|NCT00332241|473773273|FG000|Overall Study|Lack of Efficacy|6|||
131586103|NCT00332241|473773274|FG001|Overall Study|Lack of Efficacy|1|||
131586104|NCT00332241|473773273|FG000|Overall Study|Adverse Event|3|||
131586105|NCT00332241|473773274|FG001|Overall Study|Adverse Event|5|||
131586106|NCT00332241|473773273|FG000|Overall Study|Withdrawal by Subject|2|||
131586107|NCT00332241|473773274|FG001|Overall Study|Withdrawal by Subject|1|||
131586108|NCT00332241|473773273|FG000|Overall Study|Lost to Follow-up|4|||
131586109|NCT00332241|473773274|FG001|Overall Study|Lost to Follow-up|1|||
131586110|NCT00802464|473773276|FG000|Month 0 - Month 8|Adverse Event|0|||
131586111|NCT00802464|473773277|FG001|Month 0 - Month 8|Adverse Event|1|||
131586112|NCT00802464|473773278|FG002|Month 0 - Month 8|Adverse Event|1|||
131586113|NCT00802464|473773279|FG003|Month 0 - Month 8|Adverse Event|2|||
131586114|NCT00802464|473773276|FG000|Month 0 - Month 8|Protocol Violation|0|||
131586115|NCT00802464|473773277|FG001|Month 0 - Month 8|Protocol Violation|0|||
131586116|NCT00802464|473773278|FG002|Month 0 - Month 8|Protocol Violation|1|||
131586117|NCT00802464|473773279|FG003|Month 0 - Month 8|Protocol Violation|0|||
131586118|NCT00802464|473773276|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
131586119|NCT00802464|473773277|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
131586120|NCT00802464|473773278|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
131586121|NCT00802464|473773279|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
131586122|NCT00802464|473773276|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
131586123|NCT00802464|473773277|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
131586124|NCT00802464|473773278|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
131586125|NCT00802464|473773279|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
131586126|NCT00802464|473773276|FG000|Month 0 - Month 8|Other|0|||
131586127|NCT00802464|473773277|FG001|Month 0 - Month 8|Other|0|||
131586128|NCT00802464|473773278|FG002|Month 0 - Month 8|Other|1|||
131586129|NCT00802464|473773279|FG003|Month 0 - Month 8|Other|0|||
131586130|NCT00802464|473773276|FG000|Month 8 - Month 14|Adverse Event|0|||
131586131|NCT00802464|473773277|FG001|Month 8 - Month 14|Adverse Event|1|||
131586132|NCT00802464|473773278|FG002|Month 8 - Month 14|Adverse Event|0|||
131586133|NCT00802464|473773279|FG003|Month 8 - Month 14|Adverse Event|0|||
131586134|NCT00802464|473773276|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
131586135|NCT00802464|473773277|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
131586136|NCT00802464|473773278|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
131586137|NCT00802464|473773279|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
131586138|NCT00802464|473773276|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
131586139|NCT00802464|473773277|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
131586140|NCT00802464|473773278|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
131586141|NCT00802464|473773279|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
131586142|NCT00402246|473773280|FG000|Overall Study|Death|62|||
131586143|NCT00402246|473773281|FG001|Overall Study|Death|58|||
131586144|NCT00402246|473773280|FG000|Overall Study|Lost to Follow-up|20|||
131586145|NCT00402246|473773281|FG001|Overall Study|Lost to Follow-up|28|||
131586146|NCT00402246|473773280|FG000|Overall Study|Withdrawal by Subject|72|||
131586147|NCT00402246|473773281|FG001|Overall Study|Withdrawal by Subject|87|||
131586148|NCT00402246|473773280|FG000|Overall Study|Physician Decision|24|||
131586149|NCT00402246|473773281|FG001|Overall Study|Physician Decision|26|||
131586150|NCT00402246|473773280|FG000|Overall Study|Protocol Violation|25|||
131586151|NCT00402246|473773281|FG001|Overall Study|Protocol Violation|24|||
131586152|NCT00402246|473773280|FG000|Overall Study|Missed Final Visit|1|||
131586153|NCT00402246|473773281|FG001|Overall Study|Missed Final Visit|2|||
131586154|NCT00402246|473773280|FG000|Overall Study|Insurance Issues|2|||
131586155|NCT00402246|473773281|FG001|Overall Study|Insurance Issues|1|||
131586156|NCT00402246|473773280|FG000|Overall Study|Heart Transplant|0|||
131586157|NCT00402246|473773281|FG001|Overall Study|Heart Transplant|1|||
131586158|NCT00402246|473773280|FG000|Overall Study|Patient's device explanted|6|||
131586159|NCT00402246|473773281|FG001|Overall Study|Patient's device explanted|2|||
131586160|NCT00402246|473773280|FG000|Overall Study|Center Closure|5|||
131586161|NCT00402246|473773281|FG001|Overall Study|Center Closure|3|||
131586162|NCT00402246|473773280|FG000|Overall Study|Deterioriating Condition|3|||
131586163|NCT00402246|473773281|FG001|Overall Study|Deterioriating Condition|2|||
131586164|NCT01471691|473773285|FG000|Overall Study|Lack of Efficacy|0|||
131586165|NCT01471691|473773286|FG001|Overall Study|Lack of Efficacy|1|||
131586166|NCT01808339|473773287|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586167|NCT01808339|473773288|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586168|NCT01808339|473773289|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586169|NCT01808339|473773290|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
131586170|NCT01808339|473773291|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
131586171|NCT01808339|473773292|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
131586172|NCT01808339|473773287|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131586173|NCT01808339|473773288|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131586174|NCT01808339|473773289|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131586175|NCT01808339|473773290|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131586176|NCT01808339|473773291|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131586177|NCT01808339|473773292|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131586178|NCT01808339|473773287|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586179|NCT01808339|473773288|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586180|NCT01808339|473773289|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
131586181|NCT01808339|473773290|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586182|NCT01808339|473773291|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586183|NCT01808339|473773292|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131586184|NCT02622568|473773295|FG000|Overall Study|Lost to Follow-up|5|||
131586185|NCT02622568|473773296|FG001|Overall Study|Lost to Follow-up|5|||
131586186|NCT00371787|473773297|FG000|Overall Study|Withdrawal by Subject|3|||
131586187|NCT00371787|473773298|FG001|Overall Study|Withdrawal by Subject|1|||
131586188|NCT04425863|473773299|FG000|Overall Study|Death|0|||
131586189|NCT04425863|473773300|FG001|Overall Study|Death|0|||
131586190|NCT04425863|473773301|FG002|Overall Study|Death|1|||
131586191|NCT01854385|473773304|FG000|Pre-Treatment|Withdrawal by Subject|4|||
131586192|NCT01854385|473773304|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
131586193|NCT01854385|473773304|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
131586194|NCT01854385|473773304|FG000|Pre-Treatment|Unable to come for study visits|1|||
131586195|NCT01854385|473773304|FG000|Treatment|Lost to Follow-up|1|||
131586196|NCT02597920|473773306|FG000|Overall Study|Worsening of other pre-existing disease|0|||
131586197|NCT02597920|473773307|FG001|Overall Study|Worsening of other pre-existing disease|1|||
131586198|NCT02597920|473773308|FG002|Overall Study|Worsening of other pre-existing disease|0|||
131586199|NCT02597920|473773306|FG000|Overall Study|Other adverse event|20|||
131586200|NCT02597920|473773307|FG001|Overall Study|Other adverse event|30|||
131586201|NCT02597920|473773308|FG002|Overall Study|Other adverse event|0|||
131586202|NCT02597920|473773306|FG000|Overall Study|Lost to Follow-up|7|||
131586203|NCT02597920|473773307|FG001|Overall Study|Lost to Follow-up|9|||
131586204|NCT02597920|473773308|FG002|Overall Study|Lost to Follow-up|0|||
131586205|NCT02597920|473773306|FG000|Overall Study|Refuse to continue in the study|3|||
131586206|NCT02597920|473773307|FG001|Overall Study|Refuse to continue in the study|13|||
131586207|NCT02597920|473773308|FG002|Overall Study|Refuse to continue in the study|1|||
131586208|NCT02597920|473773306|FG000|Overall Study|Other than specified|10|||
131586209|NCT02597920|473773307|FG001|Overall Study|Other than specified|31|||
131790300|NCT00410410|474515008|FG008|Maintenance Period (MP)|Death|0|||
131790301|NCT00410410|474515000|FG000|Maintenance Period (MP)|Adverse Event|0|||
131790302|NCT00410410|474515001|FG001|Maintenance Period (MP)|Adverse Event|0|||
131790303|NCT00410410|474515002|FG002|Maintenance Period (MP)|Adverse Event|0|||
131586210|NCT02597920|473773308|FG002|Overall Study|Other than specified|5|||
131586211|NCT02597920|473773306|FG000|Overall Study|Other|1|||
131586212|NCT02597920|473773307|FG001|Overall Study|Other|0|||
131586213|NCT02597920|473773308|FG002|Overall Study|Other|0|||
131586214|NCT00642850|473773309|FG000|Overall Study|Death|7|||
131790304|NCT00410410|474515003|FG003|Maintenance Period (MP)|Adverse Event|0|||
131790305|NCT00410410|474515004|FG004|Maintenance Period (MP)|Adverse Event|0|||
131790306|NCT00410410|474515005|FG005|Maintenance Period (MP)|Adverse Event|0|||
131790307|NCT00410410|474515006|FG006|Maintenance Period (MP)|Adverse Event|1|||
131790308|NCT00410410|474515007|FG007|Maintenance Period (MP)|Adverse Event|3|||
131790309|NCT00410410|474515008|FG008|Maintenance Period (MP)|Adverse Event|0|||
131586215|NCT00642850|473773309|FG000|Overall Study|Adverse Event|2|||
131586216|NCT00642850|473773309|FG000|Overall Study|Lack of Efficacy|1|||
131586217|NCT00642850|473773309|FG000|Overall Study|Protocol Violation|2|||
131586218|NCT00642850|473773309|FG000|Overall Study|Kidney transplantation|8|||
131586219|NCT00642850|473773309|FG000|Overall Study|Blood transfusion|6|||
131586220|NCT00642850|473773309|FG000|Overall Study|Other reasons|7|||
131586221|NCT01266122|473773310|FG000|Overall Study|Lost to Follow-up|6|||
131586222|NCT01266122|473773311|FG001|Overall Study|Lost to Follow-up|6|||
131586223|NCT03756571|473773312|FG000|Overall Study|Lost to Follow-up|1|||
131586224|NCT03756571|473773313|FG001|Overall Study|Lost to Follow-up|1|||
131586225|NCT00421889|473773314|FG000|Overall Study|Adverse Event|1|||
131586226|NCT00421889|473773315|FG001|Overall Study|Adverse Event|0|||
131586227|NCT00421889|473773316|FG002|Overall Study|Adverse Event|1|||
131586228|NCT00421889|473773317|FG003|Overall Study|Adverse Event|1|||
131586229|NCT00421889|473773318|FG004|Overall Study|Adverse Event|1|||
131586230|NCT00421889|473773319|FG005|Overall Study|Adverse Event|4|||
131586231|NCT00421889|473773320|FG006|Overall Study|Adverse Event|1|||
131586232|NCT00421889|473773321|FG007|Overall Study|Adverse Event|0|||
131586233|NCT00421889|473773322|FG008|Overall Study|Adverse Event|2|||
131586234|NCT00421889|473773314|FG000|Overall Study|Withdrawal by Subject|1|||
131586235|NCT00421889|473773315|FG001|Overall Study|Withdrawal by Subject|3|||
131586236|NCT00421889|473773316|FG002|Overall Study|Withdrawal by Subject|0|||
131586237|NCT00421889|473773317|FG003|Overall Study|Withdrawal by Subject|0|||
131586238|NCT00421889|473773318|FG004|Overall Study|Withdrawal by Subject|2|||
131586239|NCT00421889|473773319|FG005|Overall Study|Withdrawal by Subject|0|||
131586240|NCT00421889|473773320|FG006|Overall Study|Withdrawal by Subject|0|||
131586241|NCT00421889|473773321|FG007|Overall Study|Withdrawal by Subject|0|||
131586242|NCT00421889|473773322|FG008|Overall Study|Withdrawal by Subject|0|||
131586243|NCT00421889|473773314|FG000|Overall Study|Death|0|||
131586244|NCT00421889|473773315|FG001|Overall Study|Death|0|||
131586245|NCT00421889|473773316|FG002|Overall Study|Death|0|||
131586246|NCT00421889|473773317|FG003|Overall Study|Death|0|||
131586247|NCT00421889|473773318|FG004|Overall Study|Death|1|||
131586248|NCT00421889|473773319|FG005|Overall Study|Death|1|||
131586249|NCT00421889|473773320|FG006|Overall Study|Death|0|||
131586250|NCT00421889|473773321|FG007|Overall Study|Death|0|||
131586251|NCT00421889|473773322|FG008|Overall Study|Death|0|||
131586252|NCT00421889|473773314|FG000|Overall Study|Progressive disease|3|||
131586253|NCT00421889|473773315|FG001|Overall Study|Progressive disease|2|||
131586254|NCT00421889|473773316|FG002|Overall Study|Progressive disease|2|||
131586255|NCT00421889|473773317|FG003|Overall Study|Progressive disease|3|||
131586256|NCT00421889|473773318|FG004|Overall Study|Progressive disease|2|||
131586257|NCT00421889|473773319|FG005|Overall Study|Progressive disease|21|||
131586258|NCT00421889|473773320|FG006|Overall Study|Progressive disease|3|||
131586259|NCT00421889|473773321|FG007|Overall Study|Progressive disease|1|||
131586260|NCT00421889|473773322|FG008|Overall Study|Progressive disease|5|||
131586261|NCT00421889|473773314|FG000|Overall Study|Patient/Investigator request|0|||
131790310|NCT00410410|474515000|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
131586262|NCT00421889|473773315|FG001|Overall Study|Patient/Investigator request|0|||
131790311|NCT00410410|474515001|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
131790312|NCT00410410|474515002|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
131586263|NCT00421889|473773316|FG002|Overall Study|Patient/Investigator request|0|||
131586264|NCT00421889|473773317|FG003|Overall Study|Patient/Investigator request|0|||
131586265|NCT00421889|473773318|FG004|Overall Study|Patient/Investigator request|0|||
131586266|NCT00421889|473773319|FG005|Overall Study|Patient/Investigator request|9|||
131586267|NCT00421889|473773320|FG006|Overall Study|Patient/Investigator request|0|||
131586268|NCT00421889|473773321|FG007|Overall Study|Patient/Investigator request|1|||
131586269|NCT00421889|473773322|FG008|Overall Study|Patient/Investigator request|3|||
131586270|NCT00421889|473773314|FG000|Overall Study|Lost to Follow-up|0|||
131586271|NCT00421889|473773315|FG001|Overall Study|Lost to Follow-up|0|||
131586272|NCT00421889|473773316|FG002|Overall Study|Lost to Follow-up|0|||
131586273|NCT00421889|473773317|FG003|Overall Study|Lost to Follow-up|0|||
131586274|NCT00421889|473773318|FG004|Overall Study|Lost to Follow-up|0|||
131586275|NCT00421889|473773319|FG005|Overall Study|Lost to Follow-up|0|||
131586276|NCT00421889|473773320|FG006|Overall Study|Lost to Follow-up|0|||
131586277|NCT00421889|473773321|FG007|Overall Study|Lost to Follow-up|0|||
131586278|NCT00421889|473773322|FG008|Overall Study|Lost to Follow-up|1|||
131586279|NCT00978042|473773323|FG000|Initial Treatment Period|Treated in Error|0|||
131586280|NCT00978042|473773324|FG001|Initial Treatment Period|Treated in Error|3|||
131586281|NCT00978042|473773323|FG000|Initial Treatment Period|Ineligibility|1|||
131586282|NCT00978042|473773324|FG001|Initial Treatment Period|Ineligibility|0|||
131586283|NCT00978042|473773323|FG000|Initial Treatment Period|Lost to Follow-up|21|||
131586284|NCT00978042|473773324|FG001|Initial Treatment Period|Lost to Follow-up|3|||
131586285|NCT00978042|473773323|FG000|Initial Treatment Period|Adverse Event|2|||
131586286|NCT00978042|473773324|FG001|Initial Treatment Period|Adverse Event|0|||
131586287|NCT00978042|473773323|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
131586288|NCT00978042|473773324|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
131586289|NCT00978042|473773323|FG000|Initial Treatment Period|Consent withdrawn|22|||
131586290|NCT00978042|473773324|FG001|Initial Treatment Period|Consent withdrawn|9|||
131586291|NCT00978042|473773323|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
131586292|NCT00978042|473773324|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
131586293|NCT00703820|473773325|FG000|Overall Study|Adverse Event|12|||
131586294|NCT00703820|473773326|FG001|Overall Study|Adverse Event|17|||
131586295|NCT00703820|473773325|FG000|Overall Study|Death|5|||
131586296|NCT00703820|473773326|FG001|Overall Study|Death|0|||
131586297|NCT00703820|473773325|FG000|Overall Study|Lack of Efficacy|11|||
131586298|NCT00703820|473773326|FG001|Overall Study|Lack of Efficacy|11|||
131586299|NCT00703820|473773325|FG000|Overall Study|Received non-protocol therapy|1|||
131586300|NCT00703820|473773326|FG001|Overall Study|Received non-protocol therapy|0|||
131586301|NCT00703820|473773325|FG000|Overall Study|Physician Decision|4|||
131586302|NCT00703820|473773326|FG001|Overall Study|Physician Decision|5|||
131586303|NCT00703820|473773325|FG000|Overall Study|Withdrawal by Subject|2|||
131586304|NCT00703820|473773326|FG001|Overall Study|Withdrawal by Subject|1|||
131586305|NCT00520546|473773327|FG000|Overall Study|Withdrawal by Subject|1|||
131586306|NCT00520546|473773327|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
131586307|NCT00785512|473773328|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
131586308|NCT00785512|473773329|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
131586309|NCT00785512|473773328|FG000|Overall Study|Adverse Event|0|||
131586310|NCT00785512|473773329|FG001|Overall Study|Adverse Event|0|||
131586311|NCT00785512|473773328|FG000|Overall Study|Lack of Efficacy|0|||
131586312|NCT00785512|473773329|FG001|Overall Study|Lack of Efficacy|2|||
131586313|NCT00785512|473773328|FG000|Overall Study|Withdrawal by Subject|0|||
131586314|NCT00785512|473773329|FG001|Overall Study|Withdrawal by Subject|1|||
131586315|NCT00785512|473773328|FG000|Overall Study|Lost to Follow-up|3|||
131586316|NCT00785512|473773329|FG001|Overall Study|Lost to Follow-up|0|||
131586317|NCT00785512|473773328|FG000|Overall Study|Precedure Refused|0|||
131586318|NCT00785512|473773329|FG001|Overall Study|Precedure Refused|0|||
131586319|NCT00785512|473773328|FG000|Overall Study|IVRS Programing Error|0|||
131586320|NCT00785512|473773329|FG001|Overall Study|IVRS Programing Error|0|||
131586321|NCT00785512|473773328|FG000|Overall Study|Physician Decision|0|||
131586322|NCT00785512|473773329|FG001|Overall Study|Physician Decision|0|||
131586323|NCT00785512|473773328|FG000|Overall Study|Lack of compliance|0|||
131586324|NCT00785512|473773329|FG001|Overall Study|Lack of compliance|1|||
131586325|NCT00595413|473773331|FG000|Overall Study|Adverse Event|0|||
131586326|NCT00595413|473773332|FG001|Overall Study|Adverse Event|2|||
131586327|NCT00595413|473773333|FG002|Overall Study|Adverse Event|1|||
131586328|NCT00595413|473773334|FG003|Overall Study|Adverse Event|1|||
131586329|NCT00595413|473773331|FG000|Overall Study|Lost to Follow-up|2|||
131586330|NCT00595413|473773332|FG001|Overall Study|Lost to Follow-up|2|||
131586331|NCT00595413|473773333|FG002|Overall Study|Lost to Follow-up|1|||
131586332|NCT00595413|473773334|FG003|Overall Study|Lost to Follow-up|3|||
131586333|NCT00595413|473773331|FG000|Overall Study|Death|0|||
131586334|NCT00595413|473773332|FG001|Overall Study|Death|0|||
131586335|NCT00595413|473773333|FG002|Overall Study|Death|1|||
131586336|NCT00595413|473773334|FG003|Overall Study|Death|0|||
131586337|NCT00595413|473773331|FG000|Overall Study|Other|5|||
131586338|NCT00595413|473773332|FG001|Overall Study|Other|1|||
131586339|NCT00595413|473773333|FG002|Overall Study|Other|5|||
131586340|NCT00595413|473773334|FG003|Overall Study|Other|0|||
131586341|NCT03233633|473773335|FG000|Overall Study|Adverse Event|2|||
131586342|NCT03233633|473773335|FG000|Overall Study|Less Than 3 Days of Data|6|||
131586343|NCT02088853|473773336|FG000|Overall Study|Pregnancy|1|||
131586344|NCT02088853|473773337|FG001|Overall Study|Pregnancy|0|||
131586345|NCT00603954|473773340|FG000|Overall Study|Protocol Violation|1|||
131586346|NCT00603954|473773341|FG001|Overall Study|Protocol Violation|2|||
131586347|NCT02708108|473773342|FG000|Overall Study|Death|1|||
131586348|NCT02708108|473773343|FG001|Overall Study|Death|2|||
131586349|NCT02708108|473773342|FG000|Overall Study|Regimen change|1|||
131586350|NCT02708108|473773343|FG001|Overall Study|Regimen change|0|||
131586351|NCT02708108|473773342|FG000|Overall Study|No MRD and no imaging available|0|||
131790313|NCT00410410|474515003|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
131790314|NCT00410410|474515004|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
131790315|NCT00410410|474515005|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
131790316|NCT00410410|474515006|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
131790317|NCT00410410|474515007|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
131790318|NCT00410410|474515008|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
131790319|NCT00410410|474515000|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
131790320|NCT00410410|474515001|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
131790321|NCT00410410|474515002|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
131790322|NCT00410410|474515003|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
131790323|NCT00410410|474515004|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
131790324|NCT00410410|474515005|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
131790325|NCT00410410|474515006|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
131790326|NCT00410410|474515007|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
131790327|NCT00410410|474515008|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
131790328|NCT00410410|474515000|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790329|NCT00410410|474515001|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790330|NCT00410410|474515002|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790331|NCT00410410|474515003|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790332|NCT00410410|474515004|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790333|NCT00410410|474515005|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790334|NCT00410410|474515006|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
131790335|NCT00410410|474515007|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
131790336|NCT00410410|474515008|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
131790337|NCT00410410|474515000|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790338|NCT00410410|474515001|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790339|NCT00410410|474515002|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790340|NCT00410410|474515003|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790341|NCT00410410|474515004|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790342|NCT00410410|474515005|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790343|NCT00410410|474515006|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
131790344|NCT00410410|474515007|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
131790345|NCT00410410|474515008|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131790346|NCT00410410|474515000|FG000|Open-Label Period (OL)|Death|0|||
131790347|NCT00410410|474515001|FG001|Open-Label Period (OL)|Death|0|||
131790348|NCT00410410|474515002|FG002|Open-Label Period (OL)|Death|0|||
131790349|NCT00410410|474515003|FG003|Open-Label Period (OL)|Death|0|||
131790350|NCT00410410|474515004|FG004|Open-Label Period (OL)|Death|0|||
131790351|NCT00410410|474515005|FG005|Open-Label Period (OL)|Death|0|||
131790352|NCT00410410|474515006|FG006|Open-Label Period (OL)|Death|0|||
131790353|NCT00410410|474515007|FG007|Open-Label Period (OL)|Death|0|||
131790354|NCT00410410|474515008|FG008|Open-Label Period (OL)|Death|1|||
131790355|NCT00410410|474515000|FG000|Open-Label Period (OL)|Adverse Event|0|||
131790356|NCT00410410|474515001|FG001|Open-Label Period (OL)|Adverse Event|0|||
131790357|NCT00410410|474515002|FG002|Open-Label Period (OL)|Adverse Event|0|||
131790358|NCT00410410|474515003|FG003|Open-Label Period (OL)|Adverse Event|0|||
131790359|NCT00410410|474515004|FG004|Open-Label Period (OL)|Adverse Event|0|||
131790360|NCT00410410|474515005|FG005|Open-Label Period (OL)|Adverse Event|0|||
131790361|NCT00410410|474515006|FG006|Open-Label Period (OL)|Adverse Event|0|||
131790362|NCT00410410|474515007|FG007|Open-Label Period (OL)|Adverse Event|0|||
131790363|NCT00410410|474515008|FG008|Open-Label Period (OL)|Adverse Event|10|||
131790364|NCT00410410|474515000|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
131790365|NCT00410410|474515001|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
131790366|NCT00410410|474515002|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
131790367|NCT00410410|474515003|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
131790368|NCT00410410|474515004|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
131790369|NCT00410410|474515005|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
131586352|NCT02708108|473773343|FG001|Overall Study|No MRD and no imaging available|1|||
131790370|NCT00410410|474515006|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
131790371|NCT00410410|474515007|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
131790372|NCT00410410|474515008|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
131790373|NCT00410410|474515000|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
131790374|NCT00410410|474515001|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
131790375|NCT00410410|474515002|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
131790376|NCT00410410|474515003|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
131790377|NCT00410410|474515004|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
131790378|NCT00410410|474515005|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
131790379|NCT00410410|474515006|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
131586353|NCT01697969|473773344|FG000|Overall Study|Did not meet inc/exc criteria|3|||
131586354|NCT02574455|473773345|FG000|Overall Study|Death|197|||
131586355|NCT02574455|473773346|FG001|Overall Study|Death|210|||
131586356|NCT02574455|473773345|FG000|Overall Study|Withdrawal of Consent|11|||
131586357|NCT02574455|473773346|FG001|Overall Study|Withdrawal of Consent|28|||
131586358|NCT02574455|473773345|FG000|Overall Study|Lost to Follow-up|4|||
131586359|NCT02574455|473773346|FG001|Overall Study|Lost to Follow-up|4|||
131586360|NCT02574455|473773345|FG000|Overall Study|Sponsor's Decision|55|||
131586361|NCT02574455|473773346|FG001|Overall Study|Sponsor's Decision|20|||
131586362|NCT00068601|473773348|FG000|Overall Study|Ineligible|11|||
131586363|NCT00068601|473773349|FG001|Overall Study|Ineligible|13|||
131586364|NCT00068601|473773348|FG000|Overall Study|Not evaluable: withdrew consent|5|||
131586365|NCT00068601|473773349|FG001|Overall Study|Not evaluable: withdrew consent|4|||
131586366|NCT00068601|473773348|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
131586367|NCT00068601|473773349|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
131586368|NCT00068601|473773348|FG000|Overall Study|Death|11|||
131586369|NCT00068601|473773349|FG001|Overall Study|Death|3|||
131586370|NCT00068601|473773348|FG000|Overall Study|Lost to Follow-up|3|||
131586371|NCT00068601|473773349|FG001|Overall Study|Lost to Follow-up|2|||
131586372|NCT00068601|473773348|FG000|Overall Study|Missing primary outcome data|30|||
131586373|NCT00068601|473773349|FG001|Overall Study|Missing primary outcome data|34|||
131586374|NCT01070069|473773350|FG000|Overall Study|Death|1|||
131586375|NCT01070069|473773351|FG001|Overall Study|Death|0|||
131586376|NCT01070069|473773352|FG002|Overall Study|Death|2|||
131586377|NCT01070069|473773353|FG003|Overall Study|Death|0|||
131586378|NCT01070069|473773354|FG004|Overall Study|Death|1|||
131586379|NCT01070069|473773350|FG000|Overall Study|Withdrawal by Subject|1|||
131586380|NCT01070069|473773351|FG001|Overall Study|Withdrawal by Subject|1|||
131586381|NCT01070069|473773352|FG002|Overall Study|Withdrawal by Subject|4|||
131586382|NCT01070069|473773353|FG003|Overall Study|Withdrawal by Subject|0|||
131586383|NCT01070069|473773354|FG004|Overall Study|Withdrawal by Subject|0|||
131586384|NCT01070069|473773350|FG000|Overall Study|Lost to Follow-up|4|||
131586385|NCT01070069|473773351|FG001|Overall Study|Lost to Follow-up|1|||
131586386|NCT01070069|473773352|FG002|Overall Study|Lost to Follow-up|0|||
131586387|NCT01070069|473773353|FG003|Overall Study|Lost to Follow-up|0|||
131586388|NCT01070069|473773354|FG004|Overall Study|Lost to Follow-up|3|||
131586389|NCT03565315|473773356|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
131586390|NCT03565315|473773357|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
131586391|NCT03565315|473773358|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
131586392|NCT03565315|473773359|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
131586393|NCT00440011|473773367|FG000|Overall Study|Adverse Event|2|||
131586394|NCT00440011|473773368|FG001|Overall Study|Adverse Event|0|||
131586395|NCT00440011|473773367|FG000|Overall Study|Lost to Follow-up|0|||
131586396|NCT00440011|473773368|FG001|Overall Study|Lost to Follow-up|2|||
131586397|NCT00440011|473773367|FG000|Overall Study|Protocol Violation|1|||
131586398|NCT00440011|473773368|FG001|Overall Study|Protocol Violation|1|||
131586399|NCT00440011|473773367|FG000|Overall Study|Withdrawal by Subject|1|||
131586400|NCT00440011|473773368|FG001|Overall Study|Withdrawal by Subject|0|||
131586401|NCT01083316|473773372|FG000|Overall Study|Adverse Event|2|||
131586402|NCT01083316|473773372|FG000|Overall Study|Withdrawal by Subject|1|||
131586403|NCT04732338|473773377|FG000|Overall Study|Lost to Follow-up|3|||
131586404|NCT04732338|473773378|FG001|Overall Study|Lost to Follow-up|3|||
131586405|NCT01803555|473773384|FG000|Overall Study|Adverse Event|3|||
131586406|NCT01803555|473773385|FG001|Overall Study|Adverse Event|2|||
131586407|NCT01803555|473773384|FG000|Overall Study|Withdrawal by Subject|3|||
131586408|NCT01803555|473773385|FG001|Overall Study|Withdrawal by Subject|3|||
131586409|NCT01803555|473773384|FG000|Overall Study|Non-compliance|1|||
131586410|NCT01803555|473773385|FG001|Overall Study|Non-compliance|1|||
131586411|NCT01803555|473773384|FG000|Overall Study|Protocol Violation|3|||
131705076|NCT04426695|474203421|FG005|Overall Study|Randomized but Never Treated|5|||
131705077|NCT04426695|474203422|FG006|Overall Study|Randomized but Never Treated|4|||
131705078|NCT04426695|474203423|FG007|Overall Study|Randomized but Never Treated|6|||
131705079|NCT04426695|474203424|FG008|Overall Study|Randomized but Never Treated|6|||
131705080|NCT04426695|474203425|FG009|Overall Study|Randomized but Never Treated|3|||
131586412|NCT01803555|473773385|FG001|Overall Study|Protocol Violation|5|||
131586413|NCT01803555|473773384|FG000|Overall Study|Lost to Follow-up|0|||
131586414|NCT01803555|473773385|FG001|Overall Study|Lost to Follow-up|2|||
131586415|NCT01803555|473773384|FG000|Overall Study|Other than specified|3|||
131586416|NCT01803555|473773385|FG001|Overall Study|Other than specified|5|||
131705081|NCT04426695|474203426|FG010|Overall Study|Randomized but Never Treated|3|||
131705082|NCT04426695|474203427|FG011|Overall Study|Randomized but Never Treated|6|||
131586417|NCT02539225|473773386|FG000|Part A|Adverse Event|13|||
131586418|NCT02539225|473773387|FG001|Part A|Adverse Event|4|||
131586419|NCT02539225|473773386|FG000|Part A|Withdrawal by Subject|2|||
131586420|NCT02539225|473773387|FG001|Part A|Withdrawal by Subject|4|||
131586421|NCT02539225|473773386|FG000|Part A|Physician Decision|4|||
131586422|NCT02539225|473773387|FG001|Part A|Physician Decision|7|||
131586423|NCT02539225|473773386|FG000|Part A|Did Not Receive study Drug|1|||
131586424|NCT02539225|473773387|FG001|Part A|Did Not Receive study Drug|1|||
131586425|NCT02539225|473773386|FG000|Pre Treatment for Part B|Progressive disease|1|||
131586426|NCT02539225|473773387|FG001|Pre Treatment for Part B|Progressive disease|1|||
131586427|NCT02539225|473773386|FG000|Pre Treatment for Part B|Adverse Event|1|||
131586428|NCT02539225|473773387|FG001|Pre Treatment for Part B|Adverse Event|1|||
131586429|NCT02539225|473773386|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
131586430|NCT02539225|473773387|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
131586431|NCT02539225|473773386|FG000|Pre Treatment for Part B|Physician Decision|2|||
131586432|NCT02539225|473773387|FG001|Pre Treatment for Part B|Physician Decision|0|||
131586433|NCT02539225|473773386|FG000|Part B|Adverse Event|4|||
131586434|NCT02539225|473773387|FG001|Part B|Adverse Event|4|||
131586435|NCT02539225|473773386|FG000|Part B|Withdrawal by Subject|0|||
131586436|NCT02539225|473773387|FG001|Part B|Withdrawal by Subject|3|||
131586437|NCT02539225|473773386|FG000|Part B|Physician Decision|0|||
131586438|NCT02539225|473773387|FG001|Part B|Physician Decision|9|||
131586439|NCT01551355|473773388|FG000|Overall Study|Lost to Follow-up|51|||
131586440|NCT01551355|473773389|FG001|Overall Study|Lost to Follow-up|49|||
131586441|NCT01551355|473773390|FG002|Overall Study|Lost to Follow-up|34|||
131586442|NCT01551355|473773391|FG003|Overall Study|Lost to Follow-up|24|||
131586443|NCT01551355|473773392|FG004|Overall Study|Lost to Follow-up|9|||
131586444|NCT01551355|473773393|FG005|Overall Study|Lost to Follow-up|6|||
131586445|NCT01925339|473773394|FG000|Overall Study|Adverse Event|2|||
131586446|NCT01925339|473773395|FG001|Overall Study|Adverse Event|0|||
131586447|NCT01538719|473773396|FG000|Overall Study|Lost to Follow-up|2|||
131586448|NCT01538719|473773397|FG001|Overall Study|Lost to Follow-up|0|||
131586449|NCT03664960|473773398|FG000|Overall Study|Adverse Event|0|||
131586450|NCT03664960|473773399|FG001|Overall Study|Adverse Event|3|||
131586451|NCT03664960|473773398|FG000|Overall Study|Lost to Follow-up|3|||
131586452|NCT03664960|473773399|FG001|Overall Study|Lost to Follow-up|2|||
131586453|NCT03664960|473773398|FG000|Overall Study|Physician Decision|1|||
131586454|NCT03664960|473773399|FG001|Overall Study|Physician Decision|0|||
131586455|NCT03664960|473773398|FG000|Overall Study|Withdrawal by Subject|3|||
131586456|NCT03664960|473773399|FG001|Overall Study|Withdrawal by Subject|14|||
131586457|NCT03664960|473773398|FG000|Overall Study|Sponsor Decision|1|||
131586458|NCT03664960|473773399|FG001|Overall Study|Sponsor Decision|1|||
131586459|NCT03664960|473773398|FG000|Overall Study|Other|1|||
131586460|NCT03664960|473773399|FG001|Overall Study|Other|2|||
131586461|NCT04814186|473774933|FG000|Treatment Phase|Adverse Event|1|||
131586462|NCT04814186|473774933|FG000|Treatment Phase|Death|6|||
131586463|NCT04814186|473774933|FG000|Treatment Phase|Withdrawal by Subject|2|||
131586464|NCT04814186|473774933|FG000|Treatment Phase|Other|1|||
131586465|NCT04814186|473774933|FG000|Follow-Up Phase|Adverse Event|1|||
131586466|NCT04814186|473774933|FG000|Follow-Up Phase|Death|6|||
131586467|NCT04814186|473774933|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
131586468|NCT04814186|473774933|FG000|Follow-Up Phase|Other|1|||
131586469|NCT03960463|473774966|FG000|Overall Study|Withdrawal by Subject|2|||
131586470|NCT03960463|473774967|FG001|Overall Study|Withdrawal by Subject|0|||
131586471|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
131586472|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
131586473|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
131586474|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
131705083|NCT04426695|474203428|FG012|Overall Study|Randomized but Never Treated|1|||
131586475|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
131586476|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
131586477|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
131586478|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
131586479|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
131586480|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
131586481|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
131586482|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
131586483|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131586484|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
131586485|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
131586486|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131705084|NCT04426695|474203429|FG013|Overall Study|Randomized but Never Treated|2|||
131705085|NCT04426695|474203430|FG014|Overall Study|Randomized but Never Treated|0|||
131790380|NCT00410410|474515007|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
131790381|NCT00410410|474515008|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
131790382|NCT00410410|474515000|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790383|NCT00410410|474515001|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790384|NCT00410410|474515002|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790385|NCT00410410|474515003|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790386|NCT00410410|474515004|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790387|NCT00410410|474515005|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790388|NCT00410410|474515006|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790389|NCT00410410|474515007|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
131790390|NCT00410410|474515008|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
131790391|NCT00410410|474515000|FG000|Open-Label Period (OL)|Pregnancy|0|||
131790392|NCT00410410|474515001|FG001|Open-Label Period (OL)|Pregnancy|0|||
131790393|NCT00410410|474515002|FG002|Open-Label Period (OL)|Pregnancy|0|||
131790394|NCT00410410|474515003|FG003|Open-Label Period (OL)|Pregnancy|0|||
131790395|NCT00410410|474515004|FG004|Open-Label Period (OL)|Pregnancy|0|||
131790396|NCT00410410|474515005|FG005|Open-Label Period (OL)|Pregnancy|0|||
131790397|NCT00410410|474515006|FG006|Open-Label Period (OL)|Pregnancy|0|||
131790398|NCT00410410|474515007|FG007|Open-Label Period (OL)|Pregnancy|0|||
131790399|NCT00410410|474515008|FG008|Open-Label Period (OL)|Pregnancy|1|||
131790400|NCT00410410|474515000|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790401|NCT00410410|474515001|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790402|NCT00410410|474515002|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790403|NCT00410410|474515003|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790404|NCT00410410|474515004|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790405|NCT00410410|474515005|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790406|NCT00410410|474515006|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790407|NCT00410410|474515007|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131790408|NCT00410410|474515008|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
131790409|NCT00410410|474515000|FG000|Open-Label Period (OL)|Other|0|||
131790410|NCT00410410|474515001|FG001|Open-Label Period (OL)|Other|0|||
131790411|NCT00410410|474515002|FG002|Open-Label Period (OL)|Other|0|||
131790412|NCT00410410|474515003|FG003|Open-Label Period (OL)|Other|0|||
131586487|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131586488|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131586489|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
131586490|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
131586491|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
131586492|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
131586493|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
131586494|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
131586495|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131586496|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
131586497|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131586498|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131586499|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131586500|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131790413|NCT00410410|474515004|FG004|Open-Label Period (OL)|Other|0|||
131790414|NCT00410410|474515005|FG005|Open-Label Period (OL)|Other|0|||
131790415|NCT00410410|474515006|FG006|Open-Label Period (OL)|Other|0|||
131790416|NCT00410410|474515007|FG007|Open-Label Period (OL)|Other|0|||
131790417|NCT00410410|474515008|FG008|Open-Label Period (OL)|Other|7|||
131790418|NCT01783496|474515009|FG000|Overall Study|Lost to Follow-up|0|||
131790419|NCT01783496|474515010|FG001|Overall Study|Lost to Follow-up|0|||
131790420|NCT01783496|474515011|FG002|Overall Study|Lost to Follow-up|0|||
131790421|NCT01783496|474515012|FG003|Overall Study|Lost to Follow-up|2|||
131790422|NCT01783496|474515013|FG004|Overall Study|Lost to Follow-up|0|||
131790423|NCT01783496|474515014|FG005|Overall Study|Lost to Follow-up|1|||
131790424|NCT01783496|474515009|FG000|Overall Study|Withdrawal by Subject|1|||
131790425|NCT01783496|474515010|FG001|Overall Study|Withdrawal by Subject|0|||
131790426|NCT01783496|474515011|FG002|Overall Study|Withdrawal by Subject|0|||
131790427|NCT01783496|474515012|FG003|Overall Study|Withdrawal by Subject|0|||
131790428|NCT01783496|474515013|FG004|Overall Study|Withdrawal by Subject|0|||
131790429|NCT01783496|474515014|FG005|Overall Study|Withdrawal by Subject|0|||
131790430|NCT01023269|474515015|FG000|Overall Study|early termination of the study|2|||
131790431|NCT01023269|474515016|FG001|Overall Study|early termination of the study|0|||
131790432|NCT00947011|474515019|FG000|Overall Study|Study was terminated,PI left institution|12|||
131790433|NCT00814658|474515020|FG000|Overall Study|Lost to Follow-up|0|||
131790434|NCT00814658|474515021|FG001|Overall Study|Lost to Follow-up|1|||
131790435|NCT00814658|474515020|FG000|Overall Study|Physician Decision|1|||
131790436|NCT00814658|474515021|FG001|Overall Study|Physician Decision|0|||
131586501|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
131586502|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131586503|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131586504|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131586505|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131586506|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131586507|NCT04043455|473774968|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131586508|NCT04043455|473774969|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
131586509|NCT04043455|473774970|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131586510|NCT04043455|473774971|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131586511|NCT04043455|473774972|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131586512|NCT04043455|473774973|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131586513|NCT04043455|473774968|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
131586514|NCT04043455|473774969|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
131586515|NCT04043455|473774970|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
131586516|NCT04043455|473774971|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
131586517|NCT04043455|473774972|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
131586518|NCT04043455|473774973|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
131586519|NCT04043455|473774968|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131586520|NCT04043455|473774969|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131586521|NCT04043455|473774970|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131586522|NCT04043455|473774971|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131586523|NCT04043455|473774972|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
131586524|NCT04043455|473774973|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
131586525|NCT04043455|473774968|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131586526|NCT04043455|473774969|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131586527|NCT04043455|473774970|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131586528|NCT04043455|473774971|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131586529|NCT04043455|473774972|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
131586530|NCT04043455|473774973|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131586531|NCT04043455|473774968|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131586532|NCT04043455|473774969|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131586533|NCT04043455|473774970|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131586534|NCT04043455|473774971|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131586535|NCT04043455|473774972|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
131586536|NCT04043455|473774973|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
131586537|NCT05568615|473774974|FG000|Overall Study|Death|1|||
131586538|NCT05568615|473774974|FG000|Overall Study|Physician Decision|1|||
131705086|NCT04426695|474203431|FG015|Overall Study|Randomized but Never Treated|0|||
131705087|NCT04426695|474203432|FG016|Overall Study|Randomized but Never Treated|0|||
131705088|NCT04426695|474203433|FG017|Overall Study|Randomized but Never Treated|0|||
131705089|NCT04303000|474203434|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
131705090|NCT04303000|474203435|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
131705091|NCT04303000|474203436|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
131705092|NCT03653390|474203440|FG000|Overall Study|Lost to Follow-up|12|||
131705093|NCT03653390|474203441|FG001|Overall Study|Lost to Follow-up|8|||
131705094|NCT03653390|474203442|FG002|Overall Study|Lost to Follow-up|7|||
131705095|NCT03653390|474203440|FG000|Overall Study|Withdrawal by Subject|6|||
131705096|NCT03653390|474203441|FG001|Overall Study|Withdrawal by Subject|1|||
131705097|NCT03653390|474203442|FG002|Overall Study|Withdrawal by Subject|1|||
131705098|NCT03653390|474203440|FG000|Overall Study|Death|1|||
131586553|NCT05194917|473774977|FG000|Overall Study|Lost to Follow-up|7|||
131586554|NCT05194917|473774978|FG001|Overall Study|Lost to Follow-up|5|||
131586555|NCT05194917|473774979|FG002|Overall Study|Lost to Follow-up|6|||
131586556|NCT05194917|473774980|FG003|Overall Study|Lost to Follow-up|5|||
131586557|NCT03346538|473774992|FG000|Overall Study|Physician Decision|0|||
131586558|NCT03346538|473774993|FG001|Overall Study|Physician Decision|1|||
131586559|NCT03346538|473774994|FG002|Overall Study|Physician Decision|0|||
131586560|NCT03346538|473774992|FG000|Overall Study|Withdrawal by Subject|3|||
131586561|NCT03346538|473774993|FG001|Overall Study|Withdrawal by Subject|2|||
131586562|NCT03346538|473774994|FG002|Overall Study|Withdrawal by Subject|0|||
131586563|NCT03346538|473774992|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
131586564|NCT03346538|473774993|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
131586565|NCT03346538|473774994|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
131586566|NCT02824029|473774996|FG000|Overall Study|Didn't receive treatment|2|||
131586567|NCT02824029|473774996|FG000|Overall Study|Patient decision to discontinue treatment|3|||
131586568|NCT02824029|473774996|FG000|Overall Study|Non-compliant|5|||
131586569|NCT02824029|473774996|FG000|Overall Study|Progression of disease|15|||
131586570|NCT02824029|473774996|FG000|Overall Study|Inadequate response to therapy|2|||
131586571|NCT02824029|473774996|FG000|Overall Study|Possible progression per treating physician|1|||
131586572|NCT04524390|473774997|FG000|Double Blind|Consent Withdrawal by subject|2|||
131586573|NCT04524390|473774998|FG001|Double Blind|Consent Withdrawal by subject|1|||
131586574|NCT04524390|473774999|FG002|Double Blind|Consent Withdrawal by subject|0|||
131586575|NCT04524390|473774997|FG000|Double Blind|Adverse Event|5|||
131586576|NCT04524390|473774998|FG001|Double Blind|Adverse Event|3|||
131586577|NCT04524390|473774999|FG002|Double Blind|Adverse Event|0|||
131586578|NCT04524390|473774997|FG000|Double Blind|Liver Transplant|5|||
131586579|NCT04524390|473774998|FG001|Double Blind|Liver Transplant|6|||
131586580|NCT04524390|473774999|FG002|Double Blind|Liver Transplant|0|||
131586581|NCT04524390|473774997|FG000|Double Blind|Disease Progression|0|||
131586582|NCT04524390|473774998|FG001|Double Blind|Disease Progression|1|||
131586583|NCT04524390|473774999|FG002|Double Blind|Disease Progression|0|||
131586584|NCT04524390|473774997|FG000|Open-Label|Drug interruption criteria|0|||
131586585|NCT04524390|473774998|FG001|Open-Label|Drug interruption criteria|0|||
131586586|NCT04524390|473774999|FG002|Open-Label|Drug interruption criteria|1|||
131586587|NCT04524390|473774997|FG000|Open-Label|Liver Transplant|0|||
131586588|NCT04524390|473774998|FG001|Open-Label|Liver Transplant|0|||
131586589|NCT04524390|473774999|FG002|Open-Label|Liver Transplant|1|||
131586590|NCT04524390|473774997|FG000|Open-Label|Disease Progression|0|||
131586591|NCT04524390|473774998|FG001|Open-Label|Disease Progression|0|||
131586592|NCT04524390|473774999|FG002|Open-Label|Disease Progression|1|||
131586593|NCT04524390|473774997|FG000|Open-Label|Adverse Event|0|||
131586594|NCT04524390|473774998|FG001|Open-Label|Adverse Event|0|||
131586595|NCT04524390|473774999|FG002|Open-Label|Adverse Event|3|||
131586596|NCT04524390|473774997|FG000|Open-Label|Study Termination by sponsor|0|||
131586597|NCT04524390|473774998|FG001|Open-Label|Study Termination by sponsor|0|||
131586598|NCT04524390|473774999|FG002|Open-Label|Study Termination by sponsor|45|||
131586599|NCT02101281|473775005|FG000|Overall Study|Adverse Event|0|||
131586600|NCT02101281|473775006|FG001|Overall Study|Adverse Event|1|||
131586601|NCT00174382|473775007|FG000|Overall Study|Death|2|||
131586602|NCT00174382|473775007|FG000|Overall Study|Adverse Event|19|||
131586603|NCT00174382|473775007|FG000|Overall Study|Withdrawal by Subject|6|||
131586604|NCT00174382|473775007|FG000|Overall Study|Protocol Violation|3|||
131586605|NCT00174382|473775007|FG000|Overall Study|Arrived early for last visit in error|1|||
131586606|NCT00174382|473775007|FG000|Overall Study|Subject felt pill not effective enough|1|||
131586607|NCT00174382|473775007|FG000|Overall Study|Lost to Follow-up|1|||
131586608|NCT00296036|473775008|FG000|Overall Study|Withdrawal by Subject|1|||
131586609|NCT00296036|473775009|FG001|Overall Study|Withdrawal by Subject|0|||
131586610|NCT00296036|473775010|FG002|Overall Study|Withdrawal by Subject|2|||
131586611|NCT00296036|473775011|FG003|Overall Study|Withdrawal by Subject|1|||
131586612|NCT00296036|473775012|FG004|Overall Study|Withdrawal by Subject|2|||
131586613|NCT00296036|473775013|FG005|Overall Study|Withdrawal by Subject|1|||
131586614|NCT00296036|473775008|FG000|Overall Study|Protocol Violation|0|||
131586615|NCT00296036|473775009|FG001|Overall Study|Protocol Violation|0|||
131586616|NCT00296036|473775010|FG002|Overall Study|Protocol Violation|0|||
131586617|NCT00296036|473775011|FG003|Overall Study|Protocol Violation|0|||
131586618|NCT00296036|473775012|FG004|Overall Study|Protocol Violation|0|||
131586619|NCT00296036|473775013|FG005|Overall Study|Protocol Violation|3|||
131790437|NCT00814658|474515020|FG000|Overall Study|Adverse Event|3|||
131790438|NCT00814658|474515021|FG001|Overall Study|Adverse Event|3|||
131586620|NCT03403413|473775016|FG000|Overall Study|Lack of Efficacy|2|||
131586621|NCT03655262|473775017|FG000|Overall Study|Withdrawal by Subject|0|||
131586622|NCT03655262|473775018|FG001|Overall Study|Withdrawal by Subject|0|||
131586623|NCT03655262|473775019|FG002|Overall Study|Withdrawal by Subject|1|||
131586624|NCT04452318|473775020|FG000|Overall Study|Physician Decision|1|||
131586625|NCT04452318|473775021|FG001|Overall Study|Physician Decision|2|||
131586626|NCT04452318|473775022|FG002|Overall Study|Physician Decision|0|||
131586627|NCT04452318|473775023|FG003|Overall Study|Physician Decision|2|||
131586628|NCT04452318|473775024|FG004|Overall Study|Physician Decision|0|||
131586629|NCT04452318|473775025|FG005|Overall Study|Physician Decision|2|||
131586630|NCT04452318|473775026|FG006|Overall Study|Physician Decision|5|||
131586631|NCT04452318|473775020|FG000|Overall Study|Death|2|||
131586632|NCT04452318|473775021|FG001|Overall Study|Death|3|||
131586633|NCT04452318|473775022|FG002|Overall Study|Death|0|||
131586634|NCT04452318|473775023|FG003|Overall Study|Death|0|||
131586635|NCT04452318|473775024|FG004|Overall Study|Death|0|||
131586636|NCT04452318|473775025|FG005|Overall Study|Death|0|||
131586637|NCT04452318|473775026|FG006|Overall Study|Death|0|||
131586638|NCT04452318|473775020|FG000|Overall Study|Lost to Follow-up|38|||
131586639|NCT04452318|473775021|FG001|Overall Study|Lost to Follow-up|28|||
131586640|NCT04452318|473775022|FG002|Overall Study|Lost to Follow-up|0|||
131586641|NCT04452318|473775023|FG003|Overall Study|Lost to Follow-up|3|||
131586642|NCT04452318|473775024|FG004|Overall Study|Lost to Follow-up|3|||
131586643|NCT04452318|473775025|FG005|Overall Study|Lost to Follow-up|2|||
131586644|NCT04452318|473775026|FG006|Overall Study|Lost to Follow-up|1|||
131586645|NCT04452318|473775020|FG000|Overall Study|Withdrawal by Subject|46|||
131586646|NCT04452318|473775021|FG001|Overall Study|Withdrawal by Subject|40|||
131586647|NCT04452318|473775022|FG002|Overall Study|Withdrawal by Subject|0|||
131586648|NCT04452318|473775023|FG003|Overall Study|Withdrawal by Subject|18|||
131586649|NCT04452318|473775024|FG004|Overall Study|Withdrawal by Subject|6|||
131586650|NCT04452318|473775025|FG005|Overall Study|Withdrawal by Subject|8|||
131586651|NCT04452318|473775026|FG006|Overall Study|Withdrawal by Subject|6|||
131586652|NCT00604669|473775028|FG000|Overall Study|lack of information in chart|7|||
131586653|NCT01695954|473775029|FG000|Overall Study|Withdrawal by Subject|4|||
131586654|NCT01695954|473775030|FG001|Overall Study|Withdrawal by Subject|0|||
131586655|NCT01695954|473775029|FG000|Overall Study|Adverse Event|0|||
131586656|NCT01695954|473775030|FG001|Overall Study|Adverse Event|2|||
131586657|NCT04328727|473775032|FG000|Overall Study|Guardian Decision|1|||
131586658|NCT04328727|473775032|FG000|Overall Study|Participant decision|4|||
131586659|NCT04328727|473775032|FG000|Overall Study|Death|3|||
131586660|NCT03684044|473775033|FG000|Overall Study|Adverse Event|3|||
131586661|NCT03684044|473775034|FG001|Overall Study|Adverse Event|0|||
131586662|NCT03684044|473775033|FG000|Overall Study|Death|4|||
131586663|NCT03684044|473775034|FG001|Overall Study|Death|7|||
131586664|NCT03684044|473775033|FG000|Overall Study|Lost to Follow-up|3|||
131586665|NCT03684044|473775034|FG001|Overall Study|Lost to Follow-up|2|||
131586666|NCT03684044|473775033|FG000|Overall Study|Patient Not Available|0|||
131586667|NCT03684044|473775034|FG001|Overall Study|Patient Not Available|2|||
131586668|NCT03684044|473775033|FG000|Overall Study|Physician Decision|1|||
131586669|NCT03684044|473775034|FG001|Overall Study|Physician Decision|0|||
131586670|NCT03684044|473775033|FG000|Overall Study|Withdrawal by Subject|11|||
131586671|NCT03684044|473775034|FG001|Overall Study|Withdrawal by Subject|9|||
131586672|NCT03703336|473775035|FG000|Overall Study|Parent withdrew consent|29|||
131586673|NCT03703336|473775036|FG001|Overall Study|Parent withdrew consent|8|||
131586674|NCT03703336|473775035|FG000|Overall Study|Migration|3|||
131586675|NCT03703336|473775036|FG001|Overall Study|Migration|3|||
131586676|NCT03703336|473775035|FG000|Overall Study|Protocol Violation|3|||
131586677|NCT03703336|473775036|FG001|Overall Study|Protocol Violation|1|||
131586678|NCT03703336|473775035|FG000|Overall Study|Physician Decision|2|||
131586679|NCT03703336|473775036|FG001|Overall Study|Physician Decision|0|||
131586680|NCT03703336|473775035|FG000|Overall Study|Adverse Event|0|||
131586681|NCT03703336|473775036|FG001|Overall Study|Adverse Event|2|||
131586682|NCT03703336|473775035|FG000|Overall Study|Lost to Follow-up|1|||
131586683|NCT03703336|473775036|FG001|Overall Study|Lost to Follow-up|0|||
131586684|NCT04149002|473775037|FG000|Overall Study|Lost to Follow-up|1|||
131586685|NCT04149002|473775038|FG001|Overall Study|Lost to Follow-up|0|||
131586686|NCT04149002|473775037|FG000|Overall Study|Withdrawal by Subject|1|||
131586687|NCT04149002|473775038|FG001|Overall Study|Withdrawal by Subject|0|||
131586688|NCT04583423|473775040|FG000|Overall Study|Lost to Follow-up|0|||
131586689|NCT04583423|473775041|FG001|Overall Study|Lost to Follow-up|1|||
131586690|NCT04583423|473775042|FG002|Overall Study|Lost to Follow-up|0|||
131586691|NCT04583423|473775043|FG003|Overall Study|Lost to Follow-up|2|||
131586692|NCT04583423|473775040|FG000|Overall Study|Study Terminated by Sponsor|32|||
131586693|NCT04583423|473775041|FG001|Overall Study|Study Terminated by Sponsor|35|||
131586694|NCT04583423|473775042|FG002|Overall Study|Study Terminated by Sponsor|36|||
131586695|NCT04583423|473775043|FG003|Overall Study|Study Terminated by Sponsor|33|||
131586696|NCT04583423|473775040|FG000|Overall Study|Withdrawal by Subject|3|||
131586697|NCT04583423|473775041|FG001|Overall Study|Withdrawal by Subject|1|||
131586698|NCT04583423|473775042|FG002|Overall Study|Withdrawal by Subject|2|||
131586699|NCT04583423|473775043|FG003|Overall Study|Withdrawal by Subject|1|||
131586700|NCT01198145|473775044|FG000|Overall Study|Withdrawal by Subject|1|||
131586701|NCT01198145|473775045|FG001|Overall Study|Withdrawal by Subject|1|||
131586702|NCT00580866|473775046|FG000|Overall Study|Lost to Follow-up|2|||
131586703|NCT00580866|473775047|FG001|Overall Study|Lost to Follow-up|2|||
131586704|NCT02477605|473775048|FG000|Overall Study|Discontinued prior to treatment|1|||
131586705|NCT02477605|473775049|FG001|Overall Study|Discontinued prior to treatment|0|||
131586706|NCT02477605|473775048|FG000|Overall Study|Lost to Follow-up|0|||
131586707|NCT02477605|473775049|FG001|Overall Study|Lost to Follow-up|2|||
131586708|NCT02477605|473775048|FG000|Overall Study|Withdrawal by Subject|0|||
131586709|NCT02477605|473775049|FG001|Overall Study|Withdrawal by Subject|1|||
131586710|NCT02477605|473775048|FG000|Overall Study|Administered gas during surgery|0|||
131586711|NCT02477605|473775049|FG001|Overall Study|Administered gas during surgery|1|||
131586712|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Death|117|||
131586713|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Death|197|||
131586714|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
131586715|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
131438781|NCT03287791|473233303|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131438782|NCT03287791|473233304|FG002|Overall Study|Insufficient Therapeutic Response|1|||
131438783|NCT03287791|473233302|FG000|Overall Study|Adverse Event|0|||
131438784|NCT03287791|473233303|FG001|Overall Study|Adverse Event|4|||
131438785|NCT03287791|473233304|FG002|Overall Study|Adverse Event|3|||
131438786|NCT03287791|473233302|FG000|Overall Study|Withdrawal by Subject|12|||
131438787|NCT03287791|473233303|FG001|Overall Study|Withdrawal by Subject|12|||
131438788|NCT03287791|473233304|FG002|Overall Study|Withdrawal by Subject|17|||
131438789|NCT03287791|473233302|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
131438790|NCT03287791|473233303|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
131438791|NCT03287791|473233304|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
131438792|NCT03287791|473233302|FG000|Overall Study|Lost to Follow-up|8|||
131438793|NCT03287791|473233303|FG001|Overall Study|Lost to Follow-up|14|||
131438794|NCT03287791|473233304|FG002|Overall Study|Lost to Follow-up|11|||
131438795|NCT03287791|473233302|FG000|Overall Study|Protocol Violation|7|||
131438796|NCT03287791|473233303|FG001|Overall Study|Protocol Violation|2|||
131438797|NCT03287791|473233304|FG002|Overall Study|Protocol Violation|1|||
131438798|NCT03287791|473233302|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
131438799|NCT03287791|473233303|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
131438800|NCT03287791|473233304|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
131438801|NCT03287791|473233302|FG000|Overall Study|Too much time between 2 visits|0|||
131438802|NCT03287791|473233303|FG001|Overall Study|Too much time between 2 visits|1|||
131438803|NCT03287791|473233304|FG002|Overall Study|Too much time between 2 visits|0|||
131438804|NCT03287791|473233302|FG000|Overall Study|Non-compliance|0|||
131438805|NCT03287791|473233303|FG001|Overall Study|Non-compliance|1|||
131438806|NCT03287791|473233304|FG002|Overall Study|Non-compliance|0|||
131438807|NCT03287791|473233302|FG000|Overall Study|Did not meet inclusion criteria|1|||
131438808|NCT03287791|473233303|FG001|Overall Study|Did not meet inclusion criteria|0|||
131438809|NCT03287791|473233304|FG002|Overall Study|Did not meet inclusion criteria|0|||
131438810|NCT03095651|473233306|FG000|Overall Study|Lost to Follow-up|1|||
131438811|NCT03095651|473233307|FG001|Overall Study|Lost to Follow-up|1|||
131438812|NCT03095651|473233308|FG002|Overall Study|Lost to Follow-up|0|||
131586716|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
131586717|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
131586718|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
131438813|NCT03095651|473233309|FG003|Overall Study|Lost to Follow-up|1|||
131438814|NCT03095651|473233310|FG004|Overall Study|Lost to Follow-up|0|||
131438815|NCT03095651|473233311|FG005|Overall Study|Lost to Follow-up|0|||
131586719|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
131705099|NCT03653390|474203441|FG001|Overall Study|Death|0|||
131438816|NCT03095651|473233312|FG006|Overall Study|Lost to Follow-up|0|||
131586720|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
131586721|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
131586722|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
131586723|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
131586724|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
131586725|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
131586726|NCT02677896|473775050|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
131586727|NCT02677896|473775051|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
131586728|NCT02677896|473775050|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
131586729|NCT02677896|473775051|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
131586730|NCT02677896|473775050|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
131586731|NCT02677896|473775051|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
131586732|NCT02677896|473775050|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
131586733|NCT02677896|473775051|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
131586734|NCT02677896|473775050|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
131586735|NCT02677896|473775051|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
131586736|NCT02677896|473775050|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
131586737|NCT02677896|473775051|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
131586738|NCT02677896|473775050|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
131586739|NCT02677896|473775051|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
131586740|NCT00567489|473775052|FG000|Overall Study|Adverse Event|6|||
131586741|NCT00567489|473775053|FG001|Overall Study|Adverse Event|14|||
131586742|NCT00567489|473775052|FG000|Overall Study|Physician Decision|0|||
131586743|NCT00567489|473775053|FG001|Overall Study|Physician Decision|4|||
131586744|NCT00567489|473775052|FG000|Overall Study|Withdrawal by Subject|0|||
131586745|NCT00567489|473775053|FG001|Overall Study|Withdrawal by Subject|2|||
131586746|NCT00567489|473775052|FG000|Overall Study|Renal Transplantation|0|||
131586747|NCT00567489|473775053|FG001|Overall Study|Renal Transplantation|3|||
131586748|NCT00567489|473775052|FG000|Overall Study|Other|1|||
131586749|NCT00567489|473775053|FG001|Overall Study|Other|0|||
131586750|NCT00419341|473775054|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
131586751|NCT00419341|473775054|FG000|Wash in/Wash Out Period|Adverse Event|2|||
131586752|NCT00419341|473775054|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
131586753|NCT00419341|473775054|FG000|Efficacy Period|Withdrawal by Subject|6|||
131586754|NCT00419341|473775054|FG000|Efficacy Period|Protocol Violation|1|||
131586755|NCT00419341|473775054|FG000|Efficacy Period|Lost to Follow-up|1|||
131586756|NCT00419341|473775054|FG000|Efficacy Period|Non-compliance|1|||
131586757|NCT00419341|473775054|FG000|Efficacy Period|Termination of study site|1|||
131586758|NCT04200365|473775055|FG000|Overall Study|Adverse Event|2|||
131586759|NCT04200365|473775055|FG000|Overall Study|Progressive Disease|4|||
131586760|NCT04200365|473775055|FG000|Overall Study|Lack of Efficacy|1|||
131586761|NCT04200365|473775055|FG000|Overall Study|Study Closure|4|||
131586762|NCT01499199|473775057|FG000|Overall Study|Adverse Event|1|||
131586763|NCT01499199|473775057|FG000|Overall Study|Lack of Efficacy|1|||
131586764|NCT02318134|473775068|FG000|Overall Study|Withdrawal by Subject|2|||
131586765|NCT02318134|473775069|FG001|Overall Study|Withdrawal by Subject|1|||
131586766|NCT04766034|473775070|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131586767|NCT04766034|473775071|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131586768|NCT04766034|473775072|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131586769|NCT04766034|473775073|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131586770|NCT04766034|473775074|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
131586771|NCT04766034|473775070|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131586772|NCT04766034|473775071|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131586773|NCT04766034|473775072|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131586774|NCT04766034|473775073|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131586775|NCT04766034|473775074|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
131586776|NCT04766034|473775070|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
131586777|NCT04766034|473775071|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
131586778|NCT04766034|473775072|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
131653615|NCT03842228|474018421|FG000|Overall Study|Withdrawal by Subject|0|||
131653616|NCT03842228|474018422|FG001|Overall Study|Withdrawal by Subject|0|||
131653617|NCT03842228|474018423|FG002|Overall Study|Withdrawal by Subject|2|||
131705100|NCT03653390|474203442|FG002|Overall Study|Death|0|||
131653618|NCT03842228|474018424|FG003|Overall Study|Withdrawal by Subject|1|||
131653619|NCT03842228|474018425|FG004|Overall Study|Withdrawal by Subject|0|||
131653620|NCT03842228|474018426|FG005|Overall Study|Withdrawal by Subject|0|||
131586779|NCT04766034|473775073|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
131586780|NCT04766034|473775074|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
131586781|NCT04766034|473775070|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
131586782|NCT04766034|473775071|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
131586783|NCT04766034|473775072|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
131586784|NCT04766034|473775073|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
131586785|NCT04766034|473775074|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
131586786|NCT01976312|473775075|FG000|Overall Study|Pregnancy|0|||
131586787|NCT01976312|473775076|FG001|Overall Study|Pregnancy|1|||
131586788|NCT01976312|473775075|FG000|Overall Study|Lost to Follow-up|2|||
131586789|NCT01976312|473775076|FG001|Overall Study|Lost to Follow-up|0|||
131586790|NCT01976312|473775075|FG000|Overall Study|Withdrawal by Subject|7|||
131586791|NCT01976312|473775076|FG001|Overall Study|Withdrawal by Subject|2|||
131586792|NCT01976312|473775075|FG000|Overall Study|Adverse Event|6|||
131586793|NCT01976312|473775076|FG001|Overall Study|Adverse Event|6|||
131586794|NCT01976312|473775075|FG000|Overall Study|Protocol Violation|2|||
131586795|NCT01976312|473775076|FG001|Overall Study|Protocol Violation|0|||
131586796|NCT01609218|473775083|FG000|Period 1|Adverse Event|3|||
131586797|NCT01609218|473775084|FG001|Period 1|Adverse Event|5|||
131586798|NCT01609218|473775083|FG000|Period 1|Sponsor Decision|0|||
131586799|NCT01609218|473775084|FG001|Period 1|Sponsor Decision|1|||
131586800|NCT01609218|473775083|FG000|Period 2|Adverse Event|1|||
131586801|NCT01609218|473775084|FG001|Period 2|Adverse Event|0|||
131586802|NCT04428112|473775090|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
131586803|NCT04428112|473775091|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
131586804|NCT04428112|473775090|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
131586805|NCT04428112|473775091|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
131586806|NCT04428112|473775090|FG000|Overall Study|Withdrawal by Subject|9|||
131586807|NCT04428112|473775091|FG001|Overall Study|Withdrawal by Subject|4|||
131586808|NCT04428112|473775090|FG000|Overall Study|Lost to Follow-up|27|||
131586809|NCT04428112|473775091|FG001|Overall Study|Lost to Follow-up|7|||
131586810|NCT01207492|473775092|FG000|Overall Study|Still on study|1|||
131586811|NCT01207492|473775092|FG000|Overall Study|Withdrawal by Subject|9|||
131586812|NCT01207492|473775092|FG000|Overall Study|Physician Decision|1|||
131586813|NCT01207492|473775092|FG000|Overall Study|Progressive disease|3|||
131586814|NCT01207492|473775092|FG000|Overall Study|Toxicity|1|||
131586815|NCT02769858|473775093|FG000|Overall Study|Withdrawal by Subject|2|||
131586816|NCT02980276|473776444|FG000|Overall Study|Withdrawal by Subject|4|||
131586817|NCT02980276|473776445|FG001|Overall Study|Withdrawal by Subject|4|||
131586818|NCT02980276|473776444|FG000|Overall Study|Physician Decision|0|||
131586819|NCT02980276|473776445|FG001|Overall Study|Physician Decision|1|||
131586820|NCT02980276|473776444|FG000|Overall Study|Lost to Follow-up|18|||
131586821|NCT02980276|473776445|FG001|Overall Study|Lost to Follow-up|18|||
131586822|NCT02980276|473776444|FG000|Overall Study|Death|1|||
131586823|NCT02980276|473776445|FG001|Overall Study|Death|0|||
131586824|NCT02980276|473776444|FG000|Overall Study|Miscellaneous other|10|||
131586825|NCT02980276|473776445|FG001|Overall Study|Miscellaneous other|4|||
131586826|NCT03025789|473776446|FG000|Overall Study|Lack of Efficacy|6|||
131586827|NCT03025789|473776447|FG001|Overall Study|Lack of Efficacy|1|||
131586828|NCT03025789|473776446|FG000|Overall Study|Death|1|||
131586829|NCT03025789|473776447|FG001|Overall Study|Death|0|||
131586830|NCT03025789|473776446|FG000|Overall Study|Withdrawal by Subject|0|||
131586831|NCT03025789|473776447|FG001|Overall Study|Withdrawal by Subject|2|||
131586832|NCT04300647|473776449|FG000|Pre-Crossover|Death|19|||
131586833|NCT04300647|473776450|FG001|Pre-Crossover|Death|58|||
131586834|NCT04300647|473776451|FG002|Pre-Crossover|Death|0|||
131586835|NCT04300647|473776449|FG000|Pre-Crossover|Lost to Follow-up|0|||
131705101|NCT03653390|474203440|FG000|Overall Study|Paper Survey Lost|1|||
131705102|NCT03653390|474203441|FG001|Overall Study|Paper Survey Lost|0|||
131586836|NCT04300647|473776450|FG001|Pre-Crossover|Lost to Follow-up|3|||
131586837|NCT04300647|473776451|FG002|Pre-Crossover|Lost to Follow-up|0|||
131705103|NCT03653390|474203442|FG002|Overall Study|Paper Survey Lost|0|||
131586838|NCT04300647|473776449|FG000|Pre-Crossover|Withdrawal by Subject|2|||
131586839|NCT04300647|473776450|FG001|Pre-Crossover|Withdrawal by Subject|4|||
131586840|NCT04300647|473776451|FG002|Pre-Crossover|Withdrawal by Subject|0|||
131586841|NCT04300647|473776449|FG000|Pre-Crossover|On-going in Study|24|||
131705104|NCT01109940|474203443|FG000|Overall Study|Administrative problems|2|||
131705105|NCT01109940|474203444|FG001|Overall Study|Administrative problems|0|||
131586842|NCT04300647|473776450|FG001|Pre-Crossover|On-going in Study|61|||
131586843|NCT04300647|473776451|FG002|Pre-Crossover|On-going in Study|0|||
131586844|NCT04300647|473776449|FG000|Post-Crossover|Death|0|||
131586845|NCT04300647|473776450|FG001|Post-Crossover|Death|0|||
131705106|NCT01109940|474203445|FG002|Overall Study|Administrative problems|0|||
131705107|NCT01109940|474203446|FG003|Overall Study|Administrative problems|0|||
131586846|NCT04300647|473776451|FG002|Post-Crossover|Death|3|||
131586847|NCT04300647|473776449|FG000|Post-Crossover|Lost to Follow-up|0|||
131586848|NCT04300647|473776450|FG001|Post-Crossover|Lost to Follow-up|0|||
131586849|NCT04300647|473776451|FG002|Post-Crossover|Lost to Follow-up|1|||
131586850|NCT04300647|473776449|FG000|Post-Crossover|Withdrawal by Subject|0|||
131586851|NCT04300647|473776450|FG001|Post-Crossover|Withdrawal by Subject|0|||
131586852|NCT04300647|473776451|FG002|Post-Crossover|Withdrawal by Subject|1|||
131586853|NCT04300647|473776449|FG000|Post-Crossover|On-going in Study|0|||
131438817|NCT03095651|473233313|FG007|Overall Study|Lost to Follow-up|0|||
131586854|NCT04300647|473776450|FG001|Post-Crossover|On-going in Study|0|||
131586855|NCT04300647|473776451|FG002|Post-Crossover|On-going in Study|8|||
131438818|NCT03095651|473233306|FG000|Overall Study|Withdrawal by Subject|0|||
131438819|NCT03095651|473233307|FG001|Overall Study|Withdrawal by Subject|0|||
131438820|NCT03095651|473233308|FG002|Overall Study|Withdrawal by Subject|0|||
131438821|NCT03095651|473233309|FG003|Overall Study|Withdrawal by Subject|0|||
131438822|NCT03095651|473233310|FG004|Overall Study|Withdrawal by Subject|0|||
131438823|NCT03095651|473233311|FG005|Overall Study|Withdrawal by Subject|1|||
131438824|NCT03095651|473233312|FG006|Overall Study|Withdrawal by Subject|0|||
131438825|NCT03095651|473233313|FG007|Overall Study|Withdrawal by Subject|0|||
131438826|NCT02250326|473233314|FG000|Treatment|Death|1|||
131438827|NCT02250326|473233315|FG001|Treatment|Death|13|||
131438828|NCT02250326|473233316|FG002|Treatment|Death|2|||
131438829|NCT02250326|473233314|FG000|Treatment|Adverse Event|8|||
131438830|NCT02250326|473233315|FG001|Treatment|Adverse Event|8|||
131438831|NCT02250326|473233316|FG002|Treatment|Adverse Event|9|||
131438832|NCT02250326|473233314|FG000|Treatment|Progressive Disease|42|||
131438833|NCT02250326|473233315|FG001|Treatment|Progressive Disease|40|||
131438834|NCT02250326|473233316|FG002|Treatment|Progressive Disease|47|||
131438835|NCT02250326|473233314|FG000|Treatment|Symptomatic Deterioration|9|||
131438836|NCT02250326|473233315|FG001|Treatment|Symptomatic Deterioration|4|||
131438837|NCT02250326|473233316|FG002|Treatment|Symptomatic Deterioration|10|||
131438838|NCT02250326|473233314|FG000|Treatment|Withdrawal by Subject|11|||
131438839|NCT02250326|473233315|FG001|Treatment|Withdrawal by Subject|6|||
131438840|NCT02250326|473233316|FG002|Treatment|Withdrawal by Subject|4|||
131438841|NCT02250326|473233314|FG000|Treatment|Other reasons|8|||
131586856|NCT04999085|473776452|FG000|Overall Study|Death|1|||
131790439|NCT05266456|474515022|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
131790440|NCT05266456|474515023|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
131790441|NCT05266456|474515024|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
131790442|NCT05266456|474515025|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
131790443|NCT05266456|474515022|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
131790444|NCT05266456|474515023|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
131790445|NCT05266456|474515024|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
131790446|NCT05266456|474515025|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
131790447|NCT05266456|474515022|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
131790448|NCT05266456|474515023|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
131790449|NCT05266456|474515024|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
131438842|NCT02250326|473233315|FG001|Treatment|Other reasons|7|||
131438843|NCT02250326|473233316|FG002|Treatment|Other reasons|7|||
131586857|NCT01353313|473776453|FG000|Overall Study|Lost to Follow-up|22|||
131586858|NCT01353313|473776454|FG001|Overall Study|Lost to Follow-up|23|||
131586859|NCT01353313|473776453|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
131586860|NCT01353313|473776454|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
131438844|NCT02250326|473233314|FG000|Extension Period|Progressive Disease|0|||
131438845|NCT02250326|473233315|FG001|Extension Period|Progressive Disease|2|||
131705108|NCT01109940|474203443|FG000|Overall Study|Serious Adverse Event|2|||
131705109|NCT01109940|474203444|FG001|Overall Study|Serious Adverse Event|1|||
131705110|NCT01109940|474203445|FG002|Overall Study|Serious Adverse Event|0|||
131705111|NCT01109940|474203446|FG003|Overall Study|Serious Adverse Event|0|||
131705112|NCT01109940|474203443|FG000|Overall Study|Lost to Follow-up|1|||
131705113|NCT01109940|474203444|FG001|Overall Study|Lost to Follow-up|0|||
131705114|NCT01109940|474203445|FG002|Overall Study|Lost to Follow-up|0|||
131705115|NCT01109940|474203446|FG003|Overall Study|Lost to Follow-up|0|||
131705116|NCT01109940|474203443|FG000|Overall Study|Patient withdrew consent|1|||
131705117|NCT01109940|474203444|FG001|Overall Study|Patient withdrew consent|1|||
131705118|NCT01109940|474203445|FG002|Overall Study|Patient withdrew consent|0|||
131705119|NCT01109940|474203446|FG003|Overall Study|Patient withdrew consent|0|||
131705120|NCT01109940|474203443|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131705121|NCT01109940|474203444|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131705122|NCT01109940|474203445|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131705123|NCT01109940|474203446|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131705124|NCT01262976|474203449|FG000|Up to Month 2|Serious Adverse Event|0|||
131705125|NCT01262976|474203450|FG001|Up to Month 2|Serious Adverse Event|0|||
131705126|NCT01262976|474203451|FG002|Up to Month 2|Serious Adverse Event|1|||
131705127|NCT01262976|474203452|FG003|Up to Month 2|Serious Adverse Event|0|||
131705128|NCT01262976|474203453|FG004|Up to Month 2|Serious Adverse Event|0|||
131705129|NCT01262976|474203454|FG005|Up to Month 2|Serious Adverse Event|0|||
131705130|NCT01262976|474203449|FG000|Up to Month 2|Withdrawal by Subject|1|||
131705131|NCT01262976|474203450|FG001|Up to Month 2|Withdrawal by Subject|0|||
131705132|NCT01262976|474203451|FG002|Up to Month 2|Withdrawal by Subject|0|||
131586861|NCT03088813|473776455|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
131586862|NCT03088813|473776456|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
131586863|NCT03088813|473776457|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
131586864|NCT03088813|473776458|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
131586865|NCT03088813|473776455|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
131586866|NCT03088813|473776456|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
131586867|NCT03088813|473776457|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
131586868|NCT03088813|473776458|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
131586869|NCT03088813|473776455|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
131586870|NCT03088813|473776456|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
131586871|NCT03088813|473776457|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
131586872|NCT03088813|473776458|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
131586873|NCT03088813|473776455|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
131586874|NCT03088813|473776456|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
131586875|NCT03088813|473776457|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
131586876|NCT03088813|473776458|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
131586877|NCT03088813|473776455|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
131586878|NCT03088813|473776456|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
131586879|NCT03088813|473776457|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
131586880|NCT03088813|473776458|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
131586881|NCT03088813|473776455|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
131586882|NCT03088813|473776456|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
131586883|NCT03088813|473776457|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
131586884|NCT03088813|473776458|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
131586885|NCT03088813|473776455|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
131586886|NCT03088813|473776456|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
131586887|NCT03088813|473776457|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
131586888|NCT03088813|473776458|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
131586889|NCT03613740|473776464|FG000|Overall Study|Lost to Follow-up|1|||
131705133|NCT01262976|474203452|FG003|Up to Month 2|Withdrawal by Subject|0|||
131705134|NCT01262976|474203453|FG004|Up to Month 2|Withdrawal by Subject|0|||
131705135|NCT01262976|474203454|FG005|Up to Month 2|Withdrawal by Subject|0|||
131705136|NCT01262976|474203449|FG000|Up to Month 2|Migrated/moved from study area|0|||
131586890|NCT03613740|473776465|FG001|Overall Study|Lost to Follow-up|1|||
131586891|NCT01693120|473776466|FG000|Enrollment|Lost to Follow-up|1|||
131586892|NCT01693120|473776466|FG000|Enrollment|Withdrawal by Subject|10|||
131586893|NCT01693120|473776466|FG000|Enrollment|Protocol Violation|46|||
131586894|NCT01693120|473776466|FG000|Enrollment|Physician Decision|3|||
131705137|NCT01262976|474203450|FG001|Up to Month 2|Migrated/moved from study area|1|||
131586895|NCT01693120|473776466|FG000|Enrollment|Adverse Event|1|||
131586896|NCT01693120|473776466|FG000|Enrollment|Study closed|8|||
131586897|NCT01693120|473776466|FG000|Enrollment|Other|1|||
131586898|NCT01693120|473776466|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
131586899|NCT01693120|473776466|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
131586900|NCT01693120|473776466|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
131586901|NCT01693120|473776466|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
131586902|NCT01693120|473776466|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
131586903|NCT01443845|473776473|FG000|Overall Study|Protocol Violation|43|||
131586904|NCT01443845|473776474|FG001|Overall Study|Protocol Violation|45|||
131586905|NCT01443845|473776473|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
131586906|NCT01443845|473776474|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
131586907|NCT01443845|473776473|FG000|Overall Study|Deterioration in pulmonary function|1|||
131586908|NCT01443845|473776474|FG001|Overall Study|Deterioration in pulmonary function|4|||
131586909|NCT01443845|473776473|FG000|Overall Study|Lack of Efficacy|10|||
131586910|NCT01443845|473776474|FG001|Overall Study|Lack of Efficacy|5|||
131586911|NCT01443845|473776473|FG000|Overall Study|Adverse Event|64|||
131586912|NCT01443845|473776474|FG001|Overall Study|Adverse Event|138|||
131586913|NCT01443845|473776473|FG000|Overall Study|Withdrawal by Subject|63|||
131586914|NCT01443845|473776474|FG001|Overall Study|Withdrawal by Subject|67|||
131586915|NCT01443845|473776473|FG000|Overall Study|Military Conflict - Site Terminated|20|||
131586916|NCT01443845|473776474|FG001|Overall Study|Military Conflict - Site Terminated|21|||
131586917|NCT01443845|473776473|FG000|Overall Study|Lost to Follow-up|9|||
131586918|NCT01443845|473776474|FG001|Overall Study|Lost to Follow-up|13|||
131586919|NCT02461628|473776475|FG000|Overall Study|Refused to complete survey|4|||
131586920|NCT02461628|473776476|FG001|Overall Study|Refused to complete survey|7|||
131438846|NCT02250326|473233316|FG002|Extension Period|Progressive Disease|0|||
131438847|NCT02250326|473233314|FG000|Extension Period|Withdrawal by Subject|0|||
131438848|NCT02250326|473233315|FG001|Extension Period|Withdrawal by Subject|1|||
131438849|NCT02250326|473233316|FG002|Extension Period|Withdrawal by Subject|0|||
131438850|NCT02250326|473233314|FG000|Extension Period|Withdrawal by investigator|0|||
131438851|NCT02250326|473233315|FG001|Extension Period|Withdrawal by investigator|1|||
131438852|NCT02250326|473233316|FG002|Extension Period|Withdrawal by investigator|0|||
131438853|NCT00435409|473233319|FG000|Overall Study|Protocol Violation|1|||
131438854|NCT00435409|473233320|FG001|Overall Study|Protocol Violation|2|||
131438855|NCT00435409|473233321|FG002|Overall Study|Protocol Violation|0|||
131438856|NCT00435409|473233319|FG000|Overall Study|Lost to Follow-up|1|||
131438857|NCT00435409|473233320|FG001|Overall Study|Lost to Follow-up|2|||
131438858|NCT00435409|473233321|FG002|Overall Study|Lost to Follow-up|0|||
131438859|NCT00435409|473233319|FG000|Overall Study|Death|8|||
131438860|NCT00435409|473233320|FG001|Overall Study|Death|6|||
131438861|NCT00435409|473233321|FG002|Overall Study|Death|6|||
131438862|NCT00435409|473233319|FG000|Overall Study|Objective progression or relapse|158|||
131438863|NCT00435409|473233320|FG001|Overall Study|Objective progression or relapse|93|||
131438864|NCT00435409|473233321|FG002|Overall Study|Objective progression or relapse|58|||
131586921|NCT02015520|473776477|FG000|Overall Study|Lack of Efficacy|1|||
131586922|NCT02015520|473776478|FG001|Overall Study|Lack of Efficacy|0|||
131586923|NCT02015520|473776479|FG002|Overall Study|Lack of Efficacy|3|||
131586924|NCT02015520|473776480|FG003|Overall Study|Lack of Efficacy|2|||
131586925|NCT02015520|473776477|FG000|Overall Study|Adverse Event|0|||
131586926|NCT02015520|473776478|FG001|Overall Study|Adverse Event|0|||
131586927|NCT02015520|473776479|FG002|Overall Study|Adverse Event|0|||
131586928|NCT02015520|473776480|FG003|Overall Study|Adverse Event|1|||
131586929|NCT02015520|473776477|FG000|Overall Study|Withdrawal by Subject|2|||
131586930|NCT02015520|473776478|FG001|Overall Study|Withdrawal by Subject|2|||
131586931|NCT02015520|473776479|FG002|Overall Study|Withdrawal by Subject|1|||
131586932|NCT02015520|473776480|FG003|Overall Study|Withdrawal by Subject|0|||
131586933|NCT02015520|473776477|FG000|Overall Study|Death|1|||
131586934|NCT02015520|473776478|FG001|Overall Study|Death|0|||
131586935|NCT02015520|473776479|FG002|Overall Study|Death|0|||
131438865|NCT00435409|473233319|FG000|Overall Study|Global deterioration of health status|0|||
131438866|NCT00435409|473233320|FG001|Overall Study|Global deterioration of health status|0|||
131438867|NCT00435409|473233321|FG002|Overall Study|Global deterioration of health status|4|||
131586936|NCT02015520|473776480|FG003|Overall Study|Death|0|||
131586937|NCT02015520|473776477|FG000|Overall Study|Lost to Follow-up|0|||
131586938|NCT02015520|473776478|FG001|Overall Study|Lost to Follow-up|0|||
131586939|NCT02015520|473776479|FG002|Overall Study|Lost to Follow-up|1|||
131586940|NCT02015520|473776480|FG003|Overall Study|Lost to Follow-up|0|||
131705138|NCT01262976|474203451|FG002|Up to Month 2|Migrated/moved from study area|0|||
131705139|NCT01262976|474203452|FG003|Up to Month 2|Migrated/moved from study area|0|||
131705140|NCT01262976|474203453|FG004|Up to Month 2|Migrated/moved from study area|1|||
131705141|NCT01262976|474203454|FG005|Up to Month 2|Migrated/moved from study area|1|||
131705142|NCT01262976|474203449|FG000|Up to Month 2|Lost to Follow-up|1|||
131705143|NCT01262976|474203450|FG001|Up to Month 2|Lost to Follow-up|0|||
131705144|NCT01262976|474203451|FG002|Up to Month 2|Lost to Follow-up|0|||
131705145|NCT01262976|474203452|FG003|Up to Month 2|Lost to Follow-up|1|||
131586941|NCT02015520|473776477|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
131586942|NCT02015520|473776478|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
131586943|NCT02015520|473776479|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
131586944|NCT02015520|473776480|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
131586945|NCT02015520|473776477|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
131586946|NCT02015520|473776478|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
131586947|NCT02015520|473776479|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
131586948|NCT02015520|473776480|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
131586949|NCT05119855|473776482|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
131586950|NCT05119855|473776483|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
131586951|NCT05119855|473776482|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
131586952|NCT05119855|473776483|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
131586953|NCT05119855|473776482|FG000|Overall Study|Lost to Follow-up|6|||
131586954|NCT05119855|473776483|FG001|Overall Study|Lost to Follow-up|8|||
131586955|NCT02932579|473776484|FG000|Overall Study|Withdrawal by Subject|4|||
131586956|NCT02932579|473776485|FG001|Overall Study|Withdrawal by Subject|1|||
131586957|NCT01972724|473776486|FG000|Double-Blind|Rescue Criteria Met|1|||
131586958|NCT01972724|473776487|FG001|Double-Blind|Rescue Criteria Met|0|||
131586959|NCT01972724|473776488|FG002|Double-Blind|Rescue Criteria Met|0|||
131586960|NCT01972724|473776486|FG000|Double-Blind|Adverse Event|1|||
131586961|NCT01972724|473776487|FG001|Double-Blind|Adverse Event|0|||
131586962|NCT01972724|473776488|FG002|Double-Blind|Adverse Event|0|||
131586963|NCT01972724|473776486|FG000|Double-Blind|Withdrawal of Consent|2|||
131586964|NCT01972724|473776487|FG001|Double-Blind|Withdrawal of Consent|1|||
131586965|NCT01972724|473776488|FG002|Double-Blind|Withdrawal of Consent|0|||
131586966|NCT01972724|473776486|FG000|Double-Blind|Significant Protocol Deviation|5|||
131586967|NCT01972724|473776487|FG001|Double-Blind|Significant Protocol Deviation|8|||
131586968|NCT01972724|473776488|FG002|Double-Blind|Significant Protocol Deviation|0|||
131586969|NCT01972724|473776486|FG000|Open-Label|Withdrew Consent|0|||
131586970|NCT01972724|473776487|FG001|Open-Label|Withdrew Consent|0|||
131586971|NCT01972724|473776488|FG002|Open-Label|Withdrew Consent|3|||
131586972|NCT01972724|473776486|FG000|Open-Label|Significant Protocol Deviation|0|||
131586973|NCT01972724|473776487|FG001|Open-Label|Significant Protocol Deviation|0|||
131586974|NCT01972724|473776488|FG002|Open-Label|Significant Protocol Deviation|2|||
131586975|NCT01610297|473776491|FG000|Overall Study|Lost to Follow-up|1|||
131586976|NCT01007396|473776492|FG000|Overall Study|Lost to Follow-up|47|||
131586977|NCT03076515|473776493|FG000|Overall Study|DMC decision based on interim analysis|25|||
131705146|NCT01262976|474203453|FG004|Up to Month 2|Lost to Follow-up|1|||
131705147|NCT01262976|474203454|FG005|Up to Month 2|Lost to Follow-up|1|||
131705148|NCT01262976|474203449|FG000|Up to Month 2|Other|1|||
131705149|NCT01262976|474203450|FG001|Up to Month 2|Other|0|||
131705150|NCT01262976|474203451|FG002|Up to Month 2|Other|0|||
131705151|NCT01262976|474203452|FG003|Up to Month 2|Other|1|||
131705152|NCT01262976|474203453|FG004|Up to Month 2|Other|0|||
131705153|NCT01262976|474203454|FG005|Up to Month 2|Other|2|||
131705154|NCT01262976|474203449|FG000|Up to Month 7|Serious Adverse Event|0|||
131705155|NCT01262976|474203450|FG001|Up to Month 7|Serious Adverse Event|0|||
131705156|NCT01262976|474203451|FG002|Up to Month 7|Serious Adverse Event|2|||
131705157|NCT01262976|474203452|FG003|Up to Month 7|Serious Adverse Event|0|||
131586978|NCT03076515|473776494|FG001|Overall Study|DMC decision based on interim analysis|29|||
131586979|NCT03951805|473776497|FG000|Overall Study|Adverse Event|1|||
131586980|NCT03951805|473776498|FG001|Overall Study|Adverse Event|0|||
131586981|NCT03951805|473776499|FG002|Overall Study|Adverse Event|0|||
131586982|NCT03951805|473776500|FG003|Overall Study|Adverse Event|0|||
131586983|NCT03930420|473776502|FG000|Overall Study|Withdrawal by Subject|7|||
131586984|NCT03930420|473776503|FG001|Overall Study|Withdrawal by Subject|9|||
131586985|NCT00609336|473776504|FG000|Overall Study|Protocol Violation|3|||
131586986|NCT00609336|473776504|FG000|Overall Study|Death|1|||
131586987|NCT00609336|473776504|FG000|Overall Study|LA or Met at Surgery|9|||
131586988|NCT02238483|473776505|FG000|Overall Study|Withdrawal by Subject|2|||
131586989|NCT02238483|473776506|FG001|Overall Study|Withdrawal by Subject|7|||
131586990|NCT02238483|473776505|FG000|Overall Study|Lost to Follow-up|1|||
131586991|NCT02238483|473776506|FG001|Overall Study|Lost to Follow-up|1|||
131705158|NCT01262976|474203453|FG004|Up to Month 7|Serious Adverse Event|0|||
131705159|NCT01262976|474203454|FG005|Up to Month 7|Serious Adverse Event|0|||
131705160|NCT01262976|474203449|FG000|Up to Month 7|Withdrawal by Subject|1|||
131705161|NCT01262976|474203450|FG001|Up to Month 7|Withdrawal by Subject|0|||
131705162|NCT01262976|474203451|FG002|Up to Month 7|Withdrawal by Subject|0|||
131586992|NCT02238483|473776505|FG000|Overall Study|Protocol Violation|1|||
131586993|NCT02238483|473776506|FG001|Overall Study|Protocol Violation|2|||
131586994|NCT02238483|473776505|FG000|Overall Study|Death|1|||
131586995|NCT02238483|473776506|FG001|Overall Study|Death|0|||
131586996|NCT02238483|473776505|FG000|Overall Study|Adverse Event|7|||
131586997|NCT02238483|473776506|FG001|Overall Study|Adverse Event|3|||
131586998|NCT02238483|473776505|FG000|Overall Study|Withdrawn due to physician decision|1|||
131705163|NCT01262976|474203452|FG003|Up to Month 7|Withdrawal by Subject|0|||
131586999|NCT02238483|473776506|FG001|Overall Study|Withdrawn due to physician decision|0|||
131587000|NCT02238483|473776505|FG000|Overall Study|Completion status not recorded|1|||
131587001|NCT02238483|473776506|FG001|Overall Study|Completion status not recorded|1|||
131587002|NCT02238483|473776505|FG000|Overall Study|Illness in family member|1|||
131587003|NCT02238483|473776506|FG001|Overall Study|Illness in family member|0|||
131587004|NCT02692417|473776512|FG000|Overall Study|Withdrawal by Subject|5|||
131587005|NCT02692417|473776513|FG001|Overall Study|Withdrawal by Subject|1|||
131587006|NCT02692417|473776512|FG000|Overall Study|Adverse Event|1|||
131587007|NCT02692417|473776513|FG001|Overall Study|Adverse Event|0|||
131587008|NCT02372253|473776514|FG000|Overall Study|Non Compliance|2|||
131587009|NCT02372253|473776515|FG001|Overall Study|Non Compliance|0|||
131587010|NCT02178098|473776519|FG000|Overall Study|Withdrawal by Subject|0|||
131587011|NCT02178098|473776520|FG001|Overall Study|Withdrawal by Subject|6|||
131587012|NCT02178098|473776519|FG000|Overall Study|Adverse Event|1|||
131587013|NCT02178098|473776520|FG001|Overall Study|Adverse Event|2|||
131587014|NCT02178098|473776519|FG000|Overall Study|Protocol Violation|1|||
131587015|NCT02178098|473776520|FG001|Overall Study|Protocol Violation|1|||
131587016|NCT02178098|473776519|FG000|Overall Study|Lost to Follow-up|0|||
131587017|NCT02178098|473776520|FG001|Overall Study|Lost to Follow-up|1|||
131587018|NCT02178098|473776519|FG000|Overall Study|Sponsor Request|1|||
131587019|NCT02178098|473776520|FG001|Overall Study|Sponsor Request|0|||
131587020|NCT02178098|473776519|FG000|Overall Study|Other|2|||
131587021|NCT02178098|473776520|FG001|Overall Study|Other|2|||
131587022|NCT01044303|473776525|FG000|Overall Study|Lost to Follow-up|2|||
131587023|NCT01109524|473776526|FG000|Overall Study|Disease Progression|29|||
131587024|NCT01109524|473776526|FG000|Overall Study|Study Drug toxicity|6|||
131587025|NCT01109524|473776526|FG000|Overall Study|Adverse Event|4|||
131587026|NCT01109524|473776526|FG000|Overall Study|Withdrawal by Subject|2|||
131587027|NCT01109524|473776526|FG000|Overall Study|Maximum clinical benefit|3|||
131587028|NCT01109524|473776526|FG000|Overall Study|Death|2|||
131587029|NCT01109524|473776526|FG000|Overall Study|No longer meets criteria|2|||
131587030|NCT01109524|473776526|FG000|Overall Study|Participant requested to end treatment|4|||
131587031|NCT01109524|473776526|FG000|Overall Study|Other|5|||
131587032|NCT00031694|473776542|FG000|Overall Study|Adverse Event|12|||
131587033|NCT00031694|473776542|FG000|Overall Study|Death|2|||
131587034|NCT00031694|473776542|FG000|Overall Study|Withdrawal by Subject|5|||
131587035|NCT04048382|473776543|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
131587036|NCT04048382|473776544|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
131587037|NCT04048382|473776543|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
131587038|NCT04048382|473776544|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
131587039|NCT04048382|473776543|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
131587040|NCT04048382|473776544|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
131587041|NCT01205048|473776546|FG000|Overall Study|Withdrawal by Subject|14|||
131587042|NCT01205048|473776546|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
131587043|NCT01205048|473776546|FG000|Overall Study|Lost to Follow-up|4|||
131587044|NCT01205048|473776546|FG000|Overall Study|Other|2|||
131790450|NCT05266456|474515025|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
131790451|NCT05266456|474515022|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
131790452|NCT05266456|474515023|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
131790453|NCT05266456|474515024|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
131587045|NCT01255670|473776547|FG000|Overall Study|Adverse Event|10|||
131587046|NCT01255670|473776548|FG001|Overall Study|Adverse Event|10|||
131587047|NCT01255670|473776547|FG000|Overall Study|Lost to Follow-up|16|||
131587048|NCT01255670|473776548|FG001|Overall Study|Lost to Follow-up|10|||
131587049|NCT02269475|473776549|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
131587050|NCT02269475|473776550|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
131587051|NCT02269475|473776549|FG000|Overall Study|Withdrawal by Subject|0|||
131587052|NCT02269475|473776550|FG001|Overall Study|Withdrawal by Subject|1|||
131587053|NCT01037985|473776551|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
131587054|NCT01037985|473776552|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
131587055|NCT01037985|473776551|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
131587056|NCT01037985|473776552|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
131587057|NCT01037985|473776551|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
131587058|NCT01037985|473776552|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
131587059|NCT01037985|473776551|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
131587060|NCT01037985|473776552|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
131587061|NCT02730871|473776553|FG000|Overall Study|Adverse Event|6|||
131587062|NCT02730871|473776554|FG001|Overall Study|Adverse Event|0|||
131587063|NCT00823472|473776555|FG000|Overall Study|Physician Decision|24|||
131587064|NCT00823472|473776556|FG001|Overall Study|Physician Decision|28|||
131587065|NCT04992390|473776557|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
131587066|NCT04992390|473776558|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
131587067|NCT04992390|473776559|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
131587068|NCT04992390|473776557|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
131587069|NCT04992390|473776558|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
131587070|NCT04992390|473776559|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
131587071|NCT04992390|473776557|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
131587072|NCT04992390|473776558|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
131587073|NCT04992390|473776559|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
131587074|NCT04992390|473776557|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
131587075|NCT04992390|473776558|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
131587076|NCT04992390|473776559|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
131587077|NCT04992390|473776557|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
131587078|NCT04992390|473776558|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
131587079|NCT04992390|473776559|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
131587080|NCT04992390|473776557|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
131587081|NCT04992390|473776558|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
131587082|NCT04992390|473776559|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
131587083|NCT04992390|473776557|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
131705164|NCT01262976|474203453|FG004|Up to Month 7|Withdrawal by Subject|0|||
131705165|NCT01262976|474203454|FG005|Up to Month 7|Withdrawal by Subject|0|||
131705166|NCT01262976|474203449|FG000|Up to Month 7|Migrated/moved from study area|0|||
131705167|NCT01262976|474203450|FG001|Up to Month 7|Migrated/moved from study area|0|||
131587084|NCT04992390|473776558|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
131587085|NCT04992390|473776559|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
131587086|NCT04992390|473776557|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
131587087|NCT04992390|473776558|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
131587088|NCT04992390|473776559|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
131587089|NCT04992390|473776557|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
131587090|NCT04992390|473776558|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
131587091|NCT04992390|473776559|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
131587092|NCT04992390|473776557|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
131587093|NCT04992390|473776558|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
131587094|NCT04992390|473776559|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
131587095|NCT04992390|473776557|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
131587096|NCT04992390|473776558|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
131587097|NCT04992390|473776559|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
131587098|NCT04992390|473776557|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
131587099|NCT04992390|473776558|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
131587100|NCT04992390|473776559|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
131587101|NCT04992390|473776557|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
131587102|NCT04992390|473776558|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
131587103|NCT04992390|473776559|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
131587104|NCT04992390|473776557|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
131587105|NCT04992390|473776558|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
131587106|NCT04992390|473776559|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
131587107|NCT04992390|473776557|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
131587108|NCT04992390|473776558|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
131587109|NCT04992390|473776559|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
131587110|NCT04992390|473776557|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
131587111|NCT04992390|473776558|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
131587112|NCT04992390|473776559|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
131587113|NCT02807779|473776560|FG000|Overall Study|Lost to Follow-up|1|||
131587114|NCT02807779|473776561|FG001|Overall Study|Lost to Follow-up|0|||
131587115|NCT02807779|473776562|FG002|Overall Study|Lost to Follow-up|0|||
131587116|NCT02807779|473776560|FG000|Overall Study|Physician Decision|2|||
131587117|NCT02807779|473776561|FG001|Overall Study|Physician Decision|0|||
131587118|NCT02807779|473776562|FG002|Overall Study|Physician Decision|1|||
131587119|NCT02807779|473776560|FG000|Overall Study|Death|1|||
131587120|NCT02807779|473776561|FG001|Overall Study|Death|1|||
131587121|NCT02807779|473776562|FG002|Overall Study|Death|0|||
131587122|NCT05386238|473777692|FG000|Overall Study|Lost to Follow-up|3|||
131587123|NCT05386238|473777693|FG001|Overall Study|Lost to Follow-up|2|||
131587124|NCT05386238|473777692|FG000|Overall Study|Withdrawal by Subject|0|||
131587125|NCT05386238|473777693|FG001|Overall Study|Withdrawal by Subject|1|||
131587126|NCT04714320|473777695|FG000|Overall Study|Voluntary Withdrawal|4|||
131587127|NCT04714320|473777696|FG001|Overall Study|Voluntary Withdrawal|1|||
131587128|NCT04714320|473777697|FG002|Overall Study|Voluntary Withdrawal|2|||
131587129|NCT04714320|473777695|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
131587130|NCT04714320|473777696|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
131587131|NCT04714320|473777697|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
131587132|NCT04714320|473777695|FG000|Overall Study|Reason Not Specified|1|||
131587133|NCT04714320|473777696|FG001|Overall Study|Reason Not Specified|3|||
131587134|NCT04714320|473777697|FG002|Overall Study|Reason Not Specified|3|||
131587135|NCT04755660|473777698|FG000|Overall Study|Lost to Follow-up|1|||
131587136|NCT04755660|473777699|FG001|Overall Study|Lost to Follow-up|1|||
131587137|NCT04755660|473777700|FG002|Overall Study|Lost to Follow-up|0|||
131587138|NCT04755660|473777698|FG000|Overall Study|Withdrawal by Subject|0|||
131587139|NCT04755660|473777699|FG001|Overall Study|Withdrawal by Subject|1|||
131587140|NCT04755660|473777700|FG002|Overall Study|Withdrawal by Subject|1|||
131587141|NCT04755660|473777698|FG000|Overall Study|Physician Decision|0|||
131705168|NCT01262976|474203451|FG002|Up to Month 7|Migrated/moved from study area|1|||
131705169|NCT01262976|474203452|FG003|Up to Month 7|Migrated/moved from study area|3|||
131705170|NCT01262976|474203453|FG004|Up to Month 7|Migrated/moved from study area|1|||
131705171|NCT01262976|474203454|FG005|Up to Month 7|Migrated/moved from study area|1|||
131705172|NCT01262976|474203449|FG000|Up to Month 7|Lost to Follow-up|1|||
131705173|NCT01262976|474203450|FG001|Up to Month 7|Lost to Follow-up|0|||
131705174|NCT01262976|474203451|FG002|Up to Month 7|Lost to Follow-up|1|||
131705175|NCT01262976|474203452|FG003|Up to Month 7|Lost to Follow-up|3|||
131705176|NCT01262976|474203453|FG004|Up to Month 7|Lost to Follow-up|1|||
131705177|NCT01262976|474203454|FG005|Up to Month 7|Lost to Follow-up|3|||
131705178|NCT01262976|474203449|FG000|Up to Month 7|Other|3|||
131587142|NCT04755660|473777699|FG001|Overall Study|Physician Decision|0|||
131705179|NCT01262976|474203450|FG001|Up to Month 7|Other|0|||
131587143|NCT04755660|473777700|FG002|Overall Study|Physician Decision|1|||
131587144|NCT01903811|473777709|FG000|Overall Study|No measurable disease|1|||
131587145|NCT01903811|473777710|FG001|Overall Study|No measurable disease|1|||
131587146|NCT01903811|473777709|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
131587147|NCT01903811|473777710|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
131587148|NCT01903811|473777709|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
131587149|NCT01903811|473777710|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
131587150|NCT01903811|473777709|FG000|Overall Study|Withdrawal by Subject|0|||
131587151|NCT01903811|473777710|FG001|Overall Study|Withdrawal by Subject|1|||
131587152|NCT04540913|473777711|FG000|Overall Study|Withdrawal by Subject|14|||
131587153|NCT04540913|473777712|FG001|Overall Study|Withdrawal by Subject|3|||
131587154|NCT03575052|473777713|FG000|Overall Study|Adverse Event|6|||
131587155|NCT03575052|473777714|FG001|Overall Study|Adverse Event|10|||
131587156|NCT03575052|473777713|FG000|Overall Study|Not further specified|5|||
131587157|NCT03575052|473777714|FG001|Overall Study|Not further specified|7|||
131587158|NCT03575052|473777713|FG000|Overall Study|Withdrawal by Subject|5|||
131587159|NCT03575052|473777714|FG001|Overall Study|Withdrawal by Subject|6|||
131587160|NCT03575052|473777713|FG000|Overall Study|Lost to Follow-up|3|||
131587161|NCT03575052|473777714|FG001|Overall Study|Lost to Follow-up|0|||
131587162|NCT03575052|473777713|FG000|Overall Study|Death|2|||
131587163|NCT03575052|473777714|FG001|Overall Study|Death|1|||
131587164|NCT03575052|473777713|FG000|Overall Study|Lack of Efficacy|2|||
131587165|NCT03575052|473777714|FG001|Overall Study|Lack of Efficacy|1|||
131587166|NCT03575052|473777713|FG000|Overall Study|Study drug noncompliance|1|||
131587167|NCT03575052|473777714|FG001|Overall Study|Study drug noncompliance|2|||
131587168|NCT03575052|473777713|FG000|Overall Study|Protocol Violation|0|||
131587169|NCT03575052|473777714|FG001|Overall Study|Protocol Violation|2|||
131587170|NCT03575052|473777713|FG000|Overall Study|Physician Decision|1|||
131587171|NCT03575052|473777714|FG001|Overall Study|Physician Decision|0|||
131587172|NCT03438188|473777716|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
131587173|NCT03438188|473777717|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
131587174|NCT03438188|473777718|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
131587175|NCT03438188|473777716|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
131587176|NCT03438188|473777717|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
131587177|NCT03438188|473777718|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
131587178|NCT03438188|473777716|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
131587179|NCT03438188|473777717|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
131587180|NCT03438188|473777718|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
131587181|NCT03438188|473777716|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
131587182|NCT03438188|473777717|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
131587183|NCT03438188|473777718|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
131587184|NCT03438188|473777716|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
131587185|NCT03438188|473777717|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
131587186|NCT03438188|473777718|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
131587187|NCT04153565|473777719|FG000|Overall Study|Death|13|||
131587188|NCT04300231|473777720|FG000|Overall Study|Protocol Violation|4|||
131587189|NCT04300231|473777721|FG001|Overall Study|Protocol Violation|3|||
131587190|NCT04300231|473777722|FG002|Overall Study|Protocol Violation|0|||
131587191|NCT04300231|473777723|FG003|Overall Study|Protocol Violation|2|||
131587192|NCT00670046|473777730|FG000|Overall Study|Lost to Follow-up|1|||
131587193|NCT00670046|473777731|FG001|Overall Study|Lost to Follow-up|1|||
131587194|NCT00670046|473777730|FG000|Overall Study|Withdrawal by Subject|0|||
131587195|NCT00670046|473777731|FG001|Overall Study|Withdrawal by Subject|1|||
131587196|NCT02300298|473777734|FG000|Disposition for Nintedanib|Progressive disease|10|||
131587197|NCT02300298|473777735|FG001|Disposition for Nintedanib|Progressive disease|0|||
131587198|NCT02300298|473777734|FG000|Disposition for Docetaxel|Progressive disease|0|||
131587199|NCT02300298|473777735|FG001|Disposition for Docetaxel|Progressive disease|6|||
131587200|NCT02300298|473777734|FG000|Disposition for Docetaxel|other adverse event|0|||
131587201|NCT02300298|473777735|FG001|Disposition for Docetaxel|other adverse event|4|||
131587202|NCT03285763|473777736|FG000|Overall Study|Death|470|||
131587203|NCT03285763|473777736|FG000|Overall Study|Lost to Follow-up|18|||
131587204|NCT03285763|473777736|FG000|Overall Study|Physician Decision|2|||
131790454|NCT05266456|474515025|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
131790455|NCT05266456|474515022|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
131587205|NCT03285763|473777736|FG000|Overall Study|Study Terminated By Sponsor|79|||
131790456|NCT05266456|474515023|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
131790457|NCT05266456|474515024|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
131790458|NCT05266456|474515025|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
131790459|NCT01141283|474515026|FG000|Overall Study|Adverse Event|56|||
131790460|NCT01141283|474515026|FG000|Overall Study|Lost to Follow-up|4|||
131790461|NCT01141283|474515026|FG000|Overall Study|Withdrawal by Subject|14|||
131790462|NCT01141283|474515026|FG000|Overall Study|Administrative|4|||
131790463|NCT01141283|474515026|FG000|Overall Study|Lack of Efficacy|10|||
131790464|NCT02868281|474515028|FG000|Overall Study|Adverse Event|2|||
131790465|NCT02868281|474515029|FG001|Overall Study|Adverse Event|2|||
131790466|NCT02868281|474515028|FG000|Overall Study|Protocol Violation|13|||
131790467|NCT02868281|474515029|FG001|Overall Study|Protocol Violation|10|||
131790468|NCT02868281|474515028|FG000|Overall Study|Lost to Follow-up|3|||
131790469|NCT02868281|474515029|FG001|Overall Study|Lost to Follow-up|6|||
131790470|NCT02868281|474515028|FG000|Overall Study|Withdrawal by Subject|11|||
131790471|NCT02868281|474515029|FG001|Overall Study|Withdrawal by Subject|15|||
131790472|NCT02868281|474515028|FG000|Overall Study|Physician Decision|2|||
131790473|NCT02868281|474515029|FG001|Overall Study|Physician Decision|0|||
131790474|NCT02868281|474515028|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
131790475|NCT02868281|474515029|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
131790476|NCT02868281|474515028|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
131790477|NCT02868281|474515029|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
131790478|NCT02868281|474515028|FG000|Overall Study|Long journey/moving away|1|||
131790479|NCT02868281|474515029|FG001|Overall Study|Long journey/moving away|1|||
131790480|NCT01722266|474515030|FG000|Overall Study|Withdrawal by Subject|1|||
131790481|NCT01722266|474515031|FG001|Overall Study|Withdrawal by Subject|2|||
131790482|NCT01722266|474515032|FG002|Overall Study|Withdrawal by Subject|0|||
131790483|NCT01722266|474515033|FG003|Overall Study|Withdrawal by Subject|0|||
131790484|NCT01722266|474515030|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
131790485|NCT01722266|474515031|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
131790486|NCT01722266|474515032|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
131790487|NCT01722266|474515033|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
131790488|NCT01722266|474515030|FG000|Overall Study|Dropped out due to Nausea|0|||
131790489|NCT01722266|474515031|FG001|Overall Study|Dropped out due to Nausea|0|||
131790490|NCT01722266|474515032|FG002|Overall Study|Dropped out due to Nausea|2|||
131790491|NCT01722266|474515033|FG003|Overall Study|Dropped out due to Nausea|0|||
131790492|NCT03124381|474515034|FG000|Overall Study|Lost to Follow-up|1|||
131790493|NCT03124381|474515035|FG001|Overall Study|Lost to Follow-up|1|||
131790494|NCT03124381|474515034|FG000|Overall Study|Withdrawal by Subject|6|||
131790495|NCT03124381|474515035|FG001|Overall Study|Withdrawal by Subject|3|||
131790496|NCT03124381|474515034|FG000|Overall Study|Protocol Violation|0|||
131790497|NCT03124381|474515035|FG001|Overall Study|Protocol Violation|1|||
131790498|NCT03124381|474515034|FG000|Overall Study|Adverse Event|1|||
131790499|NCT03124381|474515035|FG001|Overall Study|Adverse Event|1|||
131790500|NCT03124381|474515034|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
131790501|NCT03124381|474515035|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
131790502|NCT01783730|474515037|FG000|Overall Study|Failed to meet inclusion criteria|6|||
131790503|NCT02151461|474515038|FG000|Overall Study|Adverse Event|5|||
131790504|NCT02151461|474515039|FG001|Overall Study|Adverse Event|1|||
131790505|NCT02151461|474515040|FG002|Overall Study|Adverse Event|0|||
131790506|NCT02151461|474515041|FG003|Overall Study|Adverse Event|2|||
131790507|NCT02151461|474515038|FG000|Overall Study|Lost to Follow-up|0|||
131790508|NCT02151461|474515039|FG001|Overall Study|Lost to Follow-up|0|||
131790509|NCT02151461|474515040|FG002|Overall Study|Lost to Follow-up|1|||
131790510|NCT02151461|474515041|FG003|Overall Study|Lost to Follow-up|1|||
131790511|NCT02151461|474515038|FG000|Overall Study|Withdrawal by Subject|1|||
131790512|NCT02151461|474515039|FG001|Overall Study|Withdrawal by Subject|0|||
131790513|NCT02151461|474515040|FG002|Overall Study|Withdrawal by Subject|1|||
131790514|NCT02151461|474515041|FG003|Overall Study|Withdrawal by Subject|1|||
131587206|NCT03285763|473777736|FG000|Overall Study|Withdrawal by Subject|33|||
131790515|NCT02151461|474515038|FG000|Overall Study|Treatment discontinuation|0|||
131790516|NCT02151461|474515039|FG001|Overall Study|Treatment discontinuation|0|||
131790517|NCT02151461|474515040|FG002|Overall Study|Treatment discontinuation|1|||
131790518|NCT02151461|474515041|FG003|Overall Study|Treatment discontinuation|0|||
131790519|NCT02533999|474515044|FG000|Overall Study|Lost to Follow-up|3|||
131790520|NCT02533999|474515045|FG001|Overall Study|Lost to Follow-up|5|||
131790521|NCT02533999|474515044|FG000|Overall Study|Protocol Violation|3|||
131790522|NCT02533999|474515045|FG001|Overall Study|Protocol Violation|0|||
131790523|NCT02533999|474515044|FG000|Overall Study|Adverse Event|0|||
131790524|NCT02533999|474515045|FG001|Overall Study|Adverse Event|1|||
131790525|NCT02533999|474515044|FG000|Overall Study|Randomized but intervention not received|0|||
131790526|NCT02533999|474515045|FG001|Overall Study|Randomized but intervention not received|1|||
131790527|NCT05017493|474515046|FG000|Overall Study|Withdrawal by Subject|26|||
131790528|NCT05017493|474515047|FG001|Overall Study|Withdrawal by Subject|0|||
131790529|NCT05017493|474515046|FG000|Overall Study|Physician Decision|15|||
131790530|NCT05017493|474515047|FG001|Overall Study|Physician Decision|0|||
131587207|NCT03624972|473777737|FG000|Overall Study|Lost to Follow-up|2|||
131587208|NCT03624972|473777738|FG001|Overall Study|Lost to Follow-up|0|||
131587209|NCT03624972|473777739|FG002|Overall Study|Lost to Follow-up|0|||
131587210|NCT03624972|473777737|FG000|Overall Study|Withdrawal by Subject|0|||
131587211|NCT03624972|473777738|FG001|Overall Study|Withdrawal by Subject|2|||
131587212|NCT03624972|473777739|FG002|Overall Study|Withdrawal by Subject|0|||
131705180|NCT01262976|474203451|FG002|Up to Month 7|Other|2|||
131705181|NCT01262976|474203452|FG003|Up to Month 7|Other|0|||
131705182|NCT01262976|474203453|FG004|Up to Month 7|Other|0|||
131705183|NCT01262976|474203454|FG005|Up to Month 7|Other|0|||
131705184|NCT01262976|474203449|FG000|Up to Year 1|Serious Adverse Event|0|||
131705185|NCT01262976|474203450|FG001|Up to Year 1|Serious Adverse Event|0|||
131705186|NCT01262976|474203451|FG002|Up to Year 1|Serious Adverse Event|2|||
131705187|NCT01262976|474203452|FG003|Up to Year 1|Serious Adverse Event|0|||
131705188|NCT01262976|474203453|FG004|Up to Year 1|Serious Adverse Event|0|||
131705189|NCT01262976|474203454|FG005|Up to Year 1|Serious Adverse Event|0|||
131587223|NCT03990649|473777749|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
131587224|NCT03990649|473777750|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
131587225|NCT03990649|473777751|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
131587226|NCT03990649|473777749|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
131587227|NCT03990649|473777750|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
131587228|NCT03990649|473777751|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
131587229|NCT03990649|473777749|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
131587230|NCT03990649|473777750|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
131587231|NCT03990649|473777751|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
131587232|NCT03990649|473777749|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
131587233|NCT03990649|473777750|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
131587234|NCT03990649|473777751|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
131587235|NCT03990649|473777749|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
131790531|NCT05017493|474515046|FG000|Overall Study|Protocol Violation|81|||
131790532|NCT05017493|474515047|FG001|Overall Study|Protocol Violation|0|||
131790533|NCT01154127|474515050|FG000|Period 1 (21 Days)|Adverse Event|3|||
131790534|NCT01154127|474515051|FG001|Period 1 (21 Days)|Adverse Event|4|||
131790535|NCT01154127|474515050|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
131790536|NCT01154127|474515051|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
131790537|NCT01154127|474515050|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
131790538|NCT01154127|474515051|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
131790539|NCT01154127|474515050|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
131790540|NCT01154127|474515051|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
131790541|NCT01154127|474515050|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
131790542|NCT01154127|474515051|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
131790543|NCT01697449|474515052|FG000|Overall Study|Disease progression|47|||
131790544|NCT01697449|474515052|FG000|Overall Study|Adverse Event|7|||
131790545|NCT01697449|474515052|FG000|Overall Study|Lost to Follow-up|5|||
131790546|NCT01697449|474515052|FG000|Overall Study|Withdrawal by Subject|2|||
131790547|NCT01697449|474515052|FG000|Overall Study|Physician Decision|1|||
131790548|NCT01697449|474515052|FG000|Overall Study|Death|2|||
131790549|NCT01697449|474515052|FG000|Overall Study|Other|1|||
131790550|NCT01697449|474515052|FG000|Overall Study|Missing|25|||
131790551|NCT02390219|474515053|FG000|Overall Study|Death|1|||
131790552|NCT02390219|474515053|FG000|Overall Study|Physician Decision|1|||
131790553|NCT02390219|474515053|FG000|Overall Study|Adverse Event|6|||
131790554|NCT02390219|474515053|FG000|Overall Study|Withdrawal by Subject|1|||
131790555|NCT02390219|474515053|FG000|Overall Study|Lost to Follow-up|2|||
131790556|NCT02390219|474515053|FG000|Overall Study|Other|2|||
131790557|NCT01169844|474515054|FG000|Overall Study|Adverse Event|0|||
131790558|NCT01169844|474515055|FG001|Overall Study|Adverse Event|1|||
131790559|NCT01169844|474515054|FG000|Overall Study|Patient withdrew consent|4|||
131790560|NCT01169844|474515055|FG001|Overall Study|Patient withdrew consent|0|||
131790561|NCT01169844|474515054|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131790562|NCT01169844|474515055|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131790563|NCT00598559|474516871|FG000|Overall Study|Adverse Event|11|||
131790564|NCT00598559|474516872|FG001|Overall Study|Adverse Event|7|||
131790565|NCT00598559|474516873|FG002|Overall Study|Adverse Event|0|||
131790566|NCT00598559|474516871|FG000|Overall Study|Withdrawal by Subject|2|||
131790567|NCT00598559|474516872|FG001|Overall Study|Withdrawal by Subject|2|||
131790568|NCT00598559|474516873|FG002|Overall Study|Withdrawal by Subject|0|||
131790569|NCT00598559|474516871|FG000|Overall Study|Protocol Non-compliance|1|||
131790570|NCT00598559|474516872|FG001|Overall Study|Protocol Non-compliance|0|||
131587236|NCT03990649|473777750|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
131587237|NCT03990649|473777751|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
131587238|NCT03990649|473777749|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
131587239|NCT03990649|473777750|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
131790571|NCT00598559|474516873|FG002|Overall Study|Protocol Non-compliance|0|||
131587240|NCT03990649|473777751|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
131587241|NCT03990649|473777749|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
131587242|NCT03990649|473777750|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
131587243|NCT03990649|473777751|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
131587244|NCT00431834|473777756|FG000|Overall Study|Withdrawal by Subject|7|||
131587245|NCT00431834|473777756|FG000|Overall Study|Death|3|||
131587246|NCT00431834|473777756|FG000|Overall Study|Missed Endpoint Visit|2|||
131587247|NCT00431834|473777756|FG000|Overall Study|Lost to Follow-up|1|||
131587248|NCT02647905|473777766|FG000|Overall Study|Lost to Follow-up|1|||
131587249|NCT02647905|473777766|FG000|Overall Study|Withdrawal by Subject|2|||
131587250|NCT00111813|473777771|FG000|Overall Study|Adverse Event|1|||
131587251|NCT00111813|473777772|FG001|Overall Study|Adverse Event|2|||
131587252|NCT00111813|473777773|FG002|Overall Study|Adverse Event|4|||
131587253|NCT00111813|473777774|FG003|Overall Study|Adverse Event|2|||
131587254|NCT00111813|473777775|FG004|Overall Study|Adverse Event|2|||
131587255|NCT00111813|473777776|FG005|Overall Study|Adverse Event|2|||
131587256|NCT00111813|473777771|FG000|Overall Study|Progressive disease|2|||
131587257|NCT00111813|473777772|FG001|Overall Study|Progressive disease|1|||
131587258|NCT00111813|473777773|FG002|Overall Study|Progressive disease|5|||
131587259|NCT00111813|473777774|FG003|Overall Study|Progressive disease|3|||
131587260|NCT00111813|473777775|FG004|Overall Study|Progressive disease|4|||
131587261|NCT00111813|473777776|FG005|Overall Study|Progressive disease|3|||
131587262|NCT00111813|473777771|FG000|Overall Study|Lack of Efficacy|0|||
131587263|NCT00111813|473777772|FG001|Overall Study|Lack of Efficacy|0|||
131587264|NCT00111813|473777773|FG002|Overall Study|Lack of Efficacy|0|||
131587265|NCT00111813|473777774|FG003|Overall Study|Lack of Efficacy|0|||
131587266|NCT00111813|473777775|FG004|Overall Study|Lack of Efficacy|0|||
131587267|NCT00111813|473777776|FG005|Overall Study|Lack of Efficacy|1|||
131587268|NCT00111813|473777771|FG000|Overall Study|Other|0|||
131587269|NCT00111813|473777772|FG001|Overall Study|Other|0|||
131587270|NCT00111813|473777773|FG002|Overall Study|Other|1|||
131587271|NCT00111813|473777774|FG003|Overall Study|Other|0|||
131587272|NCT00111813|473777775|FG004|Overall Study|Other|0|||
131587273|NCT00111813|473777776|FG005|Overall Study|Other|0|||
131587274|NCT03283371|473777781|FG000|Placebo-controlled|Adverse Event|1|||
131587275|NCT03283371|473777782|FG001|Placebo-controlled|Adverse Event|1|||
131587276|NCT03283371|473777783|FG002|Placebo-controlled|Adverse Event|0|||
131587277|NCT03283371|473777784|FG003|Placebo-controlled|Adverse Event|0|||
131587278|NCT03283371|473777781|FG000|Placebo-controlled|Lack of Efficacy|1|||
131587279|NCT03283371|473777782|FG001|Placebo-controlled|Lack of Efficacy|0|||
131587280|NCT03283371|473777783|FG002|Placebo-controlled|Lack of Efficacy|0|||
131587281|NCT03283371|473777784|FG003|Placebo-controlled|Lack of Efficacy|0|||
131587282|NCT03283371|473777781|FG000|Placebo-controlled|Withdrawal by Subject|1|||
131587283|NCT03283371|473777782|FG001|Placebo-controlled|Withdrawal by Subject|1|||
131587284|NCT03283371|473777783|FG002|Placebo-controlled|Withdrawal by Subject|0|||
131587285|NCT03283371|473777784|FG003|Placebo-controlled|Withdrawal by Subject|0|||
131587286|NCT03283371|473777781|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
131587287|NCT03283371|473777782|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
131587288|NCT03283371|473777783|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
131587289|NCT03283371|473777784|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
131587290|NCT03283371|473777781|FG000|Open-label Phase|Adverse Event|0|||
131587291|NCT03283371|473777782|FG001|Open-label Phase|Adverse Event|0|||
131587292|NCT03283371|473777783|FG002|Open-label Phase|Adverse Event|2|||
131587293|NCT03283371|473777784|FG003|Open-label Phase|Adverse Event|0|||
131705190|NCT01262976|474203449|FG000|Up to Year 1|Withdrawal by Subject|1|||
131705191|NCT01262976|474203450|FG001|Up to Year 1|Withdrawal by Subject|0|||
131705192|NCT01262976|474203451|FG002|Up to Year 1|Withdrawal by Subject|0|||
131705193|NCT01262976|474203452|FG003|Up to Year 1|Withdrawal by Subject|0|||
131705194|NCT01262976|474203453|FG004|Up to Year 1|Withdrawal by Subject|0|||
131705195|NCT01262976|474203454|FG005|Up to Year 1|Withdrawal by Subject|0|||
131705196|NCT01262976|474203449|FG000|Up to Year 1|Migrated/moved from study area|1|||
131705197|NCT01262976|474203450|FG001|Up to Year 1|Migrated/moved from study area|0|||
131705198|NCT01262976|474203451|FG002|Up to Year 1|Migrated/moved from study area|0|||
131705199|NCT01262976|474203452|FG003|Up to Year 1|Migrated/moved from study area|3|||
131705200|NCT01262976|474203453|FG004|Up to Year 1|Migrated/moved from study area|3|||
131587294|NCT03283371|473777781|FG000|Open-label Phase|Withdrawal by Subject|0|||
131587295|NCT03283371|473777782|FG001|Open-label Phase|Withdrawal by Subject|0|||
131587296|NCT03283371|473777783|FG002|Open-label Phase|Withdrawal by Subject|1|||
131587297|NCT03283371|473777784|FG003|Open-label Phase|Withdrawal by Subject|0|||
131587298|NCT03283371|473777781|FG000|Open-label Phase|Other|0|||
131587299|NCT03283371|473777782|FG001|Open-label Phase|Other|0|||
131587300|NCT03283371|473777783|FG002|Open-label Phase|Other|1|||
131587301|NCT03283371|473777784|FG003|Open-label Phase|Other|1|||
131587302|NCT02554786|473777786|FG000|Overall Study|Subject/guardian decision|29|||
131587303|NCT02554786|473777787|FG001|Overall Study|Subject/guardian decision|17|||
131587304|NCT02554786|473777788|FG002|Overall Study|Subject/guardian decision|18|||
131587305|NCT02554786|473777789|FG003|Overall Study|Subject/guardian decision|30|||
131587306|NCT02554786|473777790|FG004|Overall Study|Subject/guardian decision|20|||
131587307|NCT02554786|473777786|FG000|Overall Study|Lost to Follow-up|4|||
131587308|NCT02554786|473777787|FG001|Overall Study|Lost to Follow-up|3|||
131587309|NCT02554786|473777788|FG002|Overall Study|Lost to Follow-up|4|||
131587310|NCT02554786|473777789|FG003|Overall Study|Lost to Follow-up|2|||
131587311|NCT02554786|473777790|FG004|Overall Study|Lost to Follow-up|2|||
131587312|NCT02554786|473777786|FG000|Overall Study|Protocol deviation|1|||
131587313|NCT02554786|473777787|FG001|Overall Study|Protocol deviation|3|||
131587314|NCT02554786|473777788|FG002|Overall Study|Protocol deviation|3|||
131587315|NCT02554786|473777789|FG003|Overall Study|Protocol deviation|4|||
131587316|NCT02554786|473777790|FG004|Overall Study|Protocol deviation|2|||
131587317|NCT02554786|473777786|FG000|Overall Study|Technical problems|1|||
131587318|NCT02554786|473777787|FG001|Overall Study|Technical problems|1|||
131587319|NCT02554786|473777788|FG002|Overall Study|Technical problems|0|||
131587320|NCT02554786|473777789|FG003|Overall Study|Technical problems|2|||
131587321|NCT02554786|473777790|FG004|Overall Study|Technical problems|1|||
131587322|NCT02554786|473777786|FG000|Overall Study|Adverse Event|0|||
131587323|NCT02554786|473777787|FG001|Overall Study|Adverse Event|0|||
131587324|NCT02554786|473777788|FG002|Overall Study|Adverse Event|0|||
131587325|NCT02554786|473777789|FG003|Overall Study|Adverse Event|0|||
131587326|NCT02554786|473777790|FG004|Overall Study|Adverse Event|2|||
131587327|NCT02554786|473777786|FG000|Overall Study|Death|0|||
131587328|NCT02554786|473777787|FG001|Overall Study|Death|0|||
131587329|NCT02554786|473777788|FG002|Overall Study|Death|0|||
131587330|NCT02554786|473777789|FG003|Overall Study|Death|1|||
131587331|NCT02554786|473777790|FG004|Overall Study|Death|0|||
131587332|NCT02554786|473777786|FG000|Overall Study|Non-compliance with study treatment|0|||
131587333|NCT02554786|473777787|FG001|Overall Study|Non-compliance with study treatment|1|||
131587334|NCT02554786|473777788|FG002|Overall Study|Non-compliance with study treatment|1|||
131587335|NCT02554786|473777789|FG003|Overall Study|Non-compliance with study treatment|0|||
131587336|NCT02554786|473777790|FG004|Overall Study|Non-compliance with study treatment|1|||
131587337|NCT02554786|473777786|FG000|Overall Study|Physician Decision|0|||
131587338|NCT02554786|473777787|FG001|Overall Study|Physician Decision|1|||
131587339|NCT02554786|473777788|FG002|Overall Study|Physician Decision|4|||
131587340|NCT02554786|473777789|FG003|Overall Study|Physician Decision|1|||
131587341|NCT02554786|473777790|FG004|Overall Study|Physician Decision|1|||
131587342|NCT02554786|473777786|FG000|Overall Study|Pregnancy|0|||
131587343|NCT02554786|473777787|FG001|Overall Study|Pregnancy|0|||
131587344|NCT02554786|473777788|FG002|Overall Study|Pregnancy|0|||
131587345|NCT02554786|473777789|FG003|Overall Study|Pregnancy|1|||
131587346|NCT02554786|473777790|FG004|Overall Study|Pregnancy|1|||
131587347|NCT04704284|473777791|FG000|Overall Study|Withdrawal by Subject|1|||
131587348|NCT00539734|473777797|FG000|Overall Study|Protocol Violation|1|||
131587349|NCT00393484|473777799|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
131587350|NCT00393484|473777800|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
131587351|NCT00393484|473777799|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
131587352|NCT00393484|473777800|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
131587353|NCT00393484|473777799|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
131587354|NCT00393484|473777800|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
131587355|NCT00393484|473777799|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
131587356|NCT00393484|473777800|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
131587357|NCT00393484|473777799|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
131587358|NCT00393484|473777800|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
131587359|NCT00393484|473777799|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
131587360|NCT00393484|473777800|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
131587361|NCT00393484|473777799|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
131587362|NCT00393484|473777800|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
131587363|NCT00393484|473777799|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
131587364|NCT00393484|473777800|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
131587365|NCT00393484|473777799|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
131705201|NCT01262976|474203454|FG005|Up to Year 1|Migrated/moved from study area|2|||
131587366|NCT00393484|473777800|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
131587367|NCT00393484|473777799|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
131587368|NCT00393484|473777800|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
131587369|NCT03201562|473777801|FG000|Overall Study|Physician Decision|0|||
131587370|NCT03201562|473777802|FG001|Overall Study|Physician Decision|0|||
131587371|NCT03201562|473777803|FG002|Overall Study|Physician Decision|1|||
131587372|NCT03201562|473777801|FG000|Overall Study|Adverse Event|0|||
131587373|NCT03201562|473777802|FG001|Overall Study|Adverse Event|0|||
131587374|NCT03201562|473777803|FG002|Overall Study|Adverse Event|1|||
131587375|NCT03201562|473777801|FG000|Overall Study|Lost to Follow-up|0|||
131587376|NCT03201562|473777802|FG001|Overall Study|Lost to Follow-up|1|||
131587377|NCT03201562|473777803|FG002|Overall Study|Lost to Follow-up|2|||
131587378|NCT02556138|473777809|FG000|Overall Study|Withdrawal by Subject|1|||
131587379|NCT04939246|473777810|FG000|After Treatment|Death|4|||
131790572|NCT00598559|474516871|FG000|Overall Study|Early discharge from hospital|9|||
131790573|NCT00598559|474516872|FG001|Overall Study|Early discharge from hospital|12|||
131790574|NCT00598559|474516873|FG002|Overall Study|Early discharge from hospital|3|||
131790575|NCT00598559|474516871|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
131790576|NCT00598559|474516872|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
131790577|NCT00598559|474516873|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
131790578|NCT01059071|474516874|FG000|Overall Study|Lack of Efficacy|1|||
131790579|NCT01059071|474516875|FG001|Overall Study|Lack of Efficacy|4|||
131790580|NCT01059071|474516876|FG002|Overall Study|Lack of Efficacy|2|||
131790581|NCT01059071|474516877|FG003|Overall Study|Lack of Efficacy|3|||
131790582|NCT01059071|474516874|FG000|Overall Study|Withdrawal by Subject|1|||
131790583|NCT01059071|474516875|FG001|Overall Study|Withdrawal by Subject|0|||
131790584|NCT01059071|474516876|FG002|Overall Study|Withdrawal by Subject|0|||
131790585|NCT01059071|474516877|FG003|Overall Study|Withdrawal by Subject|2|||
131790586|NCT01059071|474516874|FG000|Overall Study|Physician Decision|0|||
131790587|NCT01059071|474516875|FG001|Overall Study|Physician Decision|0|||
131790588|NCT01059071|474516876|FG002|Overall Study|Physician Decision|0|||
131790589|NCT01059071|474516877|FG003|Overall Study|Physician Decision|1|||
131790590|NCT00936884|474516882|FG000|Double-blind|Withdrawal by Subject|6|||
131790591|NCT00936884|474516883|FG001|Double-blind|Withdrawal by Subject|4|||
131790592|NCT00936884|474516884|FG002|Double-blind|Withdrawal by Subject|0|||
131790593|NCT00936884|474516882|FG000|Double-blind|Death|2|||
131790594|NCT00936884|474516883|FG001|Double-blind|Death|1|||
131790595|NCT00936884|474516884|FG002|Double-blind|Death|0|||
131790596|NCT00936884|474516882|FG000|Double-blind|Lack of Efficacy|1|||
131790597|NCT00936884|474516883|FG001|Double-blind|Lack of Efficacy|1|||
131790598|NCT00936884|474516884|FG002|Double-blind|Lack of Efficacy|0|||
131790599|NCT00936884|474516882|FG000|Double-blind|Adverse Event|1|||
131790600|NCT00936884|474516883|FG001|Double-blind|Adverse Event|0|||
131790601|NCT00936884|474516884|FG002|Double-blind|Adverse Event|0|||
131790602|NCT00936884|474516882|FG000|Double-blind|Physician Decision|1|||
131790603|NCT00936884|474516883|FG001|Double-blind|Physician Decision|0|||
131790604|NCT00936884|474516884|FG002|Double-blind|Physician Decision|0|||
131790605|NCT00936884|474516882|FG000|Double-blind|No post baseline diary entry|1|||
131790606|NCT00936884|474516883|FG001|Double-blind|No post baseline diary entry|0|||
131790607|NCT00936884|474516884|FG002|Double-blind|No post baseline diary entry|0|||
131790608|NCT00936884|474516882|FG000|Double-blind|Did not receive study drug|0|||
131790609|NCT00936884|474516883|FG001|Double-blind|Did not receive study drug|1|||
131790610|NCT00936884|474516884|FG002|Double-blind|Did not receive study drug|0|||
131790611|NCT02038634|474516885|FG000|Overall Study|Lost to Follow-up|0|||
131790612|NCT02038634|474516886|FG001|Overall Study|Lost to Follow-up|1|||
131790613|NCT01664052|474516888|FG000|Phase 1|No device placement|6|||
131790614|NCT01664052|474516889|FG001|Phase 1|No device placement|0|||
131790615|NCT01664052|474516888|FG000|Phase 1|No HSG 1 hr post placement|1|||
131790616|NCT01664052|474516889|FG001|Phase 1|No HSG 1 hr post placement|0|||
131790617|NCT01664052|474516888|FG000|Phase 2|No device placement|0|||
131790618|NCT01664052|474516889|FG001|Phase 2|No device placement|4|||
131790619|NCT01084005|474516890|FG000|Overall Study|Adverse Event|1|||
131790620|NCT01084005|474516891|FG001|Overall Study|Adverse Event|8|||
131790621|NCT01084005|474516890|FG000|Overall Study|Protocol Violation|3|||
131790622|NCT01084005|474516891|FG001|Overall Study|Protocol Violation|7|||
131790623|NCT01084005|474516890|FG000|Overall Study|Withdrawal by Subject|1|||
131790624|NCT01084005|474516891|FG001|Overall Study|Withdrawal by Subject|1|||
131790625|NCT00549198|474516892|FG000|Overall Study|Adverse Event|28|||
131790626|NCT00549198|474516893|FG001|Overall Study|Adverse Event|26|||
131790627|NCT00549198|474516892|FG000|Overall Study|Insufficient Viral Load Response|4|||
131790628|NCT00549198|474516893|FG001|Overall Study|Insufficient Viral Load Response|2|||
131790629|NCT00549198|474516892|FG000|Overall Study|Protocol-defined Virological Failure|7|||
131790630|NCT00549198|474516893|FG001|Overall Study|Protocol-defined Virological Failure|0|||
131790631|NCT00549198|474516892|FG000|Overall Study|Non-compliance|2|||
131790632|NCT00549198|474516893|FG001|Overall Study|Non-compliance|4|||
131790633|NCT00549198|474516892|FG000|Overall Study|Lost to Follow-up|7|||
131790634|NCT00549198|474516893|FG001|Overall Study|Lost to Follow-up|8|||
131790635|NCT00549198|474516892|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
131790636|NCT00549198|474516893|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131790637|NCT00549198|474516892|FG000|Overall Study|Protocol Violation|7|||
131790638|NCT00549198|474516893|FG001|Overall Study|Protocol Violation|2|||
131587380|NCT04939246|473777810|FG000|After Treatment|Lost to Follow-up|1|||
131587381|NCT04939246|473777810|FG000|After Treatment|Discharged to hospice|2|||
131587382|NCT04994509|473777811|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
131587383|NCT04994509|473777812|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
131587384|NCT04994509|473777813|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
131587385|NCT04994509|473777811|FG000|Overall Study|Withdrew Consent|73|||
131587386|NCT04994509|473777812|FG001|Overall Study|Withdrew Consent|72|||
131587387|NCT04994509|473777813|FG002|Overall Study|Withdrew Consent|46|||
131587388|NCT04994509|473777811|FG000|Overall Study|Lost to Follow-up|39|||
131587389|NCT04994509|473777812|FG001|Overall Study|Lost to Follow-up|36|||
131587390|NCT04994509|473777813|FG002|Overall Study|Lost to Follow-up|26|||
131587391|NCT04994509|473777811|FG000|Overall Study|HIV-1 Infection|4|||
131705202|NCT01262976|474203449|FG000|Up to Year 1|Lost to Follow-up|4|||
131705203|NCT01262976|474203450|FG001|Up to Year 1|Lost to Follow-up|0|||
131705204|NCT01262976|474203451|FG002|Up to Year 1|Lost to Follow-up|0|||
131705205|NCT01262976|474203452|FG003|Up to Year 1|Lost to Follow-up|1|||
131705206|NCT01262976|474203453|FG004|Up to Year 1|Lost to Follow-up|6|||
131705207|NCT01262976|474203454|FG005|Up to Year 1|Lost to Follow-up|5|||
131705208|NCT01262976|474203449|FG000|Up to Year 1|Other|3|||
131705209|NCT01262976|474203450|FG001|Up to Year 1|Other|1|||
131705210|NCT01262976|474203451|FG002|Up to Year 1|Other|0|||
131705211|NCT01262976|474203452|FG003|Up to Year 1|Other|0|||
131705212|NCT01262976|474203453|FG004|Up to Year 1|Other|2|||
131705213|NCT01262976|474203454|FG005|Up to Year 1|Other|1|||
131705214|NCT01262976|474203449|FG000|Up to Year 1|Subjects with unknown completion status|0|||
131705215|NCT01262976|474203450|FG001|Up to Year 1|Subjects with unknown completion status|0|||
131705216|NCT01262976|474203451|FG002|Up to Year 1|Subjects with unknown completion status|1|||
131705217|NCT01262976|474203452|FG003|Up to Year 1|Subjects with unknown completion status|0|||
131705218|NCT01262976|474203453|FG004|Up to Year 1|Subjects with unknown completion status|0|||
131705219|NCT01262976|474203454|FG005|Up to Year 1|Subjects with unknown completion status|1|||
131705220|NCT01262976|474203449|FG000|Up to Year 2|Serious Adverse Event|0|||
131705221|NCT01262976|474203450|FG001|Up to Year 2|Serious Adverse Event|0|||
131705222|NCT01262976|474203451|FG002|Up to Year 2|Serious Adverse Event|2|||
131705223|NCT01262976|474203452|FG003|Up to Year 2|Serious Adverse Event|0|||
131705224|NCT01262976|474203453|FG004|Up to Year 2|Serious Adverse Event|0|||
131705225|NCT01262976|474203454|FG005|Up to Year 2|Serious Adverse Event|0|||
131705226|NCT01262976|474203449|FG000|Up to Year 2|Withdrawal by Subject|1|||
131705227|NCT01262976|474203450|FG001|Up to Year 2|Withdrawal by Subject|0|||
131705228|NCT01262976|474203451|FG002|Up to Year 2|Withdrawal by Subject|0|||
131705229|NCT01262976|474203452|FG003|Up to Year 2|Withdrawal by Subject|0|||
131705230|NCT01262976|474203453|FG004|Up to Year 2|Withdrawal by Subject|0|||
131705231|NCT01262976|474203454|FG005|Up to Year 2|Withdrawal by Subject|0|||
131705232|NCT01262976|474203449|FG000|Up to Year 2|Migrated/moved from study area|0|||
131705233|NCT01262976|474203450|FG001|Up to Year 2|Migrated/moved from study area|0|||
131705234|NCT01262976|474203451|FG002|Up to Year 2|Migrated/moved from study area|0|||
131705235|NCT01262976|474203452|FG003|Up to Year 2|Migrated/moved from study area|2|||
131705236|NCT01262976|474203453|FG004|Up to Year 2|Migrated/moved from study area|1|||
131705237|NCT01262976|474203454|FG005|Up to Year 2|Migrated/moved from study area|2|||
131705238|NCT01262976|474203449|FG000|Up to Year 2|Lost to Follow-up|1|||
131705239|NCT01262976|474203450|FG001|Up to Year 2|Lost to Follow-up|1|||
131705240|NCT01262976|474203451|FG002|Up to Year 2|Lost to Follow-up|2|||
131705241|NCT01262976|474203452|FG003|Up to Year 2|Lost to Follow-up|2|||
131705242|NCT01262976|474203453|FG004|Up to Year 2|Lost to Follow-up|3|||
131705243|NCT01262976|474203454|FG005|Up to Year 2|Lost to Follow-up|3|||
131705244|NCT01262976|474203449|FG000|Up to Year 2|Subjects with unknown completion status|0|||
131705245|NCT01262976|474203450|FG001|Up to Year 2|Subjects with unknown completion status|0|||
131705246|NCT01262976|474203451|FG002|Up to Year 2|Subjects with unknown completion status|1|||
131705247|NCT01262976|474203452|FG003|Up to Year 2|Subjects with unknown completion status|0|||
131705248|NCT01262976|474203453|FG004|Up to Year 2|Subjects with unknown completion status|0|||
131705249|NCT01262976|474203454|FG005|Up to Year 2|Subjects with unknown completion status|0|||
131705250|NCT01262976|474203449|FG000|Up to Year 2|Other|3|||
131705251|NCT01262976|474203450|FG001|Up to Year 2|Other|0|||
131705252|NCT01262976|474203451|FG002|Up to Year 2|Other|0|||
131587392|NCT04994509|473777812|FG001|Overall Study|HIV-1 Infection|20|||
131705253|NCT01262976|474203452|FG003|Up to Year 2|Other|0|||
131705254|NCT01262976|474203453|FG004|Up to Year 2|Other|0|||
131587393|NCT04994509|473777813|FG002|Overall Study|HIV-1 Infection|12|||
131705255|NCT01262976|474203454|FG005|Up to Year 2|Other|0|||
131705256|NCT01262976|474203449|FG000|Up to Year 3|Serious Adverse Event|0|||
131705257|NCT01262976|474203450|FG001|Up to Year 3|Serious Adverse Event|0|||
131587394|NCT04994509|473777811|FG000|Overall Study|Investigator's Discretion|9|||
131587395|NCT04994509|473777812|FG001|Overall Study|Investigator's Discretion|8|||
131587396|NCT04994509|473777813|FG002|Overall Study|Investigator's Discretion|11|||
131587397|NCT04994509|473777811|FG000|Overall Study|Randomized but Never Treated|10|||
131587398|NCT04994509|473777812|FG001|Overall Study|Randomized but Never Treated|10|||
131587399|NCT04994509|473777813|FG002|Overall Study|Randomized but Never Treated|3|||
131587400|NCT04994509|473777811|FG000|Overall Study|Pregnancy|5|||
131587401|NCT04994509|473777812|FG001|Overall Study|Pregnancy|5|||
131587402|NCT04994509|473777813|FG002|Overall Study|Pregnancy|0|||
131587403|NCT04994509|473777811|FG000|Overall Study|Death|0|||
131587404|NCT04994509|473777812|FG001|Overall Study|Death|5|||
131587405|NCT04994509|473777813|FG002|Overall Study|Death|0|||
131587406|NCT04994509|473777811|FG000|Overall Study|Adverse Event|2|||
131587407|NCT04994509|473777812|FG001|Overall Study|Adverse Event|1|||
131587408|NCT04994509|473777813|FG002|Overall Study|Adverse Event|0|||
131587409|NCT04994509|473777811|FG000|Overall Study|Non-compliance With Study Drug|1|||
131587410|NCT04994509|473777812|FG001|Overall Study|Non-compliance With Study Drug|1|||
131587411|NCT04994509|473777813|FG002|Overall Study|Non-compliance With Study Drug|1|||
131587412|NCT04994509|473777811|FG000|Overall Study|Withdrew Assent|3|||
131587413|NCT04994509|473777812|FG001|Overall Study|Withdrew Assent|0|||
131587414|NCT04994509|473777813|FG002|Overall Study|Withdrew Assent|0|||
131587415|NCT04994509|473777811|FG000|Overall Study|Protocol Violation|1|||
131587416|NCT04994509|473777812|FG001|Overall Study|Protocol Violation|0|||
131587417|NCT04994509|473777813|FG002|Overall Study|Protocol Violation|0|||
131790639|NCT00549198|474516892|FG000|Overall Study|Investigator Decision|4|||
131790640|NCT00549198|474516893|FG001|Overall Study|Investigator Decision|3|||
131790641|NCT00549198|474516892|FG000|Overall Study|Withdrawal by Subject|7|||
131790642|NCT00549198|474516893|FG001|Overall Study|Withdrawal by Subject|7|||
131790643|NCT00549198|474516892|FG000|Overall Study|Disease Progression|1|||
131790644|NCT00549198|474516893|FG001|Overall Study|Disease Progression|0|||
131790645|NCT00549198|474516892|FG000|Overall Study|Participant Moved|2|||
131790646|NCT00549198|474516893|FG001|Overall Study|Participant Moved|0|||
131790647|NCT00549198|474516892|FG000|Overall Study|Participant not able to perform Week 96|1|||
131790648|NCT00549198|474516893|FG001|Overall Study|Participant not able to perform Week 96|0|||
131790649|NCT00549198|474516892|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
131790650|NCT00549198|474516893|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
131790651|NCT00549198|474516892|FG000|Overall Study|Prohibited Medication|1|||
131790652|NCT00549198|474516893|FG001|Overall Study|Prohibited Medication|2|||
131790653|NCT00549198|474516892|FG000|Overall Study|Participant planning pregnancy|1|||
131790654|NCT00549198|474516893|FG001|Overall Study|Participant planning pregnancy|0|||
131790655|NCT00549198|474516892|FG000|Overall Study|Participant overweight, no scan possible|1|||
131790656|NCT00549198|474516893|FG001|Overall Study|Participant overweight, no scan possible|0|||
131587418|NCT03783026|473779729|FG000|Treatment Phase|Adverse Event|15|||
131790657|NCT00549198|474516892|FG000|Overall Study|No scan facilities|0|||
131790658|NCT00549198|474516893|FG001|Overall Study|No scan facilities|2|||
131790659|NCT00549198|474516892|FG000|Overall Study|Pregnancy|0|||
131587419|NCT03783026|473779729|FG000|Treatment Phase|Lack of Efficacy|11|||
131587420|NCT03783026|473779729|FG000|Treatment Phase|Withdrawal by Subject|6|||
131587421|NCT03783026|473779729|FG000|Treatment Phase|Lost to Follow-up|2|||
131898750|NCT00943397|474915348|FG001|Overall Study|Site terminated and other|56|||
131898751|NCT04878055|474915349|FG000|Overall Study|Patient transferred in another department|0|||
131898752|NCT04878055|474915350|FG001|Overall Study|Patient transferred in another department|2|||
131898753|NCT04878055|474915349|FG000|Overall Study|Physician Decision|1|||
131898754|NCT04878055|474915350|FG001|Overall Study|Physician Decision|1|||
131898755|NCT04878055|474915349|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
131898756|NCT04878055|474915350|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
131898757|NCT04878055|474915349|FG000|Overall Study|Adverse Event|12|||
131898758|NCT04878055|474915350|FG001|Overall Study|Adverse Event|7|||
131898759|NCT04878055|474915349|FG000|Overall Study|Other|5|||
131898760|NCT04878055|474915350|FG001|Overall Study|Other|0|||
131898761|NCT04878055|474915349|FG000|Overall Study|Withdrawal by Subject|7|||
131898762|NCT04878055|474915350|FG001|Overall Study|Withdrawal by Subject|3|||
131898763|NCT04878055|474915349|FG000|Overall Study|Lost to Follow-up|10|||
131898764|NCT04878055|474915350|FG001|Overall Study|Lost to Follow-up|1|||
131898765|NCT02907463|474915351|FG000|Overall Study|Lost to Follow-up|17|||
131898766|NCT02907463|474915351|FG000|Overall Study|Death|10|||
131898767|NCT02907463|474915351|FG000|Overall Study|Withdrawal by Subject|4|||
131898768|NCT02907463|474915351|FG000|Overall Study|MIS Approach was not used|2|||
131898769|NCT02907463|474915351|FG000|Overall Study|Not Implanted with Study Device|2|||
131898770|NCT02907463|474915351|FG000|Overall Study|Device Explanted|1|||
131898771|NCT02907463|474915351|FG000|Overall Study|Missing Exit Form|1|||
131898772|NCT01968811|474915352|FG000|Overall Study|Protocol Violation|4|||
131898773|NCT01968811|474915352|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
131898774|NCT00411450|474915353|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
131898775|NCT01716663|474915354|FG000|Overall Study|Withdrawn prior to procedure|4|||
131898776|NCT01716663|474915354|FG000|Overall Study|Treated with non-study catheter|2|||
131898777|NCT00614874|474915361|FG000|Overall Study|Protocol Violation|1|||
131898778|NCT00614874|474915361|FG000|Overall Study|Withdrawal by Subject|1|||
131898779|NCT03904420|474915362|FG000|Overall Study|Study terminated|2|||
131898780|NCT03904420|474915363|FG001|Overall Study|Study terminated|2|||
131898781|NCT01001910|474915364|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
131898782|NCT03006562|474915365|FG000|Overall Study|Lost to Follow-up|0|||
131898783|NCT03006562|474915366|FG001|Overall Study|Lost to Follow-up|1|||
131898784|NCT01089127|474915371|FG000|Overall Study|Adverse Event|5|||
131898785|NCT01089127|474915372|FG001|Overall Study|Adverse Event|1|||
131898786|NCT01089127|474915373|FG002|Overall Study|Adverse Event|1|||
131898787|NCT01089127|474915374|FG003|Overall Study|Adverse Event|0|||
131898788|NCT01089127|474915375|FG004|Overall Study|Adverse Event|0|||
131898789|NCT01089127|474915376|FG005|Overall Study|Adverse Event|1|||
131898790|NCT01089127|474915371|FG000|Overall Study|Subject withdrew consent|0|||
131898791|NCT01089127|474915372|FG001|Overall Study|Subject withdrew consent|1|||
131898792|NCT01089127|474915373|FG002|Overall Study|Subject withdrew consent|1|||
131898793|NCT01089127|474915374|FG003|Overall Study|Subject withdrew consent|1|||
131898794|NCT01089127|474915375|FG004|Overall Study|Subject withdrew consent|0|||
131898795|NCT01089127|474915376|FG005|Overall Study|Subject withdrew consent|2|||
131898796|NCT01089127|474915371|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131898797|NCT01089127|474915372|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131898798|NCT01089127|474915373|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131898799|NCT01089127|474915374|FG003|Overall Study|Abnormal test procedure result(s)|0|||
131587422|NCT03783026|473779729|FG000|Treatment Phase|Protocol Deviation|8|||
131587423|NCT03783026|473779729|FG000|Treatment Phase|Did Not Receive Treatment|1|||
131705258|NCT01262976|474203451|FG002|Up to Year 3|Serious Adverse Event|2|||
131587424|NCT03783026|473779729|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
131587425|NCT01853748|473779730|FG000|Allocation|Withdrawal by Subject|1|||
131587426|NCT01853748|473779731|FG001|Allocation|Withdrawal by Subject|13|||
131587427|NCT01853748|473779730|FG000|Allocation|not sufficient to receive intervention|0|||
131587428|NCT01853748|473779731|FG001|Allocation|not sufficient to receive intervention|1|||
131705259|NCT01262976|474203452|FG003|Up to Year 3|Serious Adverse Event|0|||
131705260|NCT01262976|474203453|FG004|Up to Year 3|Serious Adverse Event|0|||
131705261|NCT01262976|474203454|FG005|Up to Year 3|Serious Adverse Event|0|||
131705262|NCT01262976|474203449|FG000|Up to Year 3|Withdrawal by Subject|1|||
131898800|NCT01089127|474915375|FG004|Overall Study|Abnormal test procedure result(s)|0|||
131898801|NCT01089127|474915376|FG005|Overall Study|Abnormal test procedure result(s)|0|||
131898802|NCT01089127|474915371|FG000|Overall Study|Lost to Follow-up|1|||
131898803|NCT01089127|474915372|FG001|Overall Study|Lost to Follow-up|1|||
131898804|NCT01089127|474915373|FG002|Overall Study|Lost to Follow-up|0|||
131898805|NCT01089127|474915374|FG003|Overall Study|Lost to Follow-up|0|||
131898806|NCT01089127|474915375|FG004|Overall Study|Lost to Follow-up|1|||
131898807|NCT01089127|474915376|FG005|Overall Study|Lost to Follow-up|0|||
131898808|NCT01089127|474915371|FG000|Overall Study|Protocol deviation|0|||
131898809|NCT01089127|474915372|FG001|Overall Study|Protocol deviation|1|||
131587429|NCT01853748|473779730|FG000|Follow-Up|Withdrawal by Subject|7|||
131587430|NCT01853748|473779731|FG001|Follow-Up|Withdrawal by Subject|6|||
131587431|NCT01853748|473779730|FG000|Follow-Up|Adverse Event|67|||
131587432|NCT01853748|473779731|FG001|Follow-Up|Adverse Event|7|||
131587433|NCT01853748|473779730|FG000|Follow-Up|not available for data collection|16|||
131587434|NCT01853748|473779731|FG001|Follow-Up|not available for data collection|4|||
131587435|NCT02576509|473779736|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
131587436|NCT02576509|473779737|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
131587437|NCT02576509|473779736|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
131587438|NCT02576509|473779737|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
131587439|NCT02576509|473779736|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
131587440|NCT02576509|473779737|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
131587441|NCT02576509|473779736|FG000|Treatment Period|Disease progression|263|||
131587442|NCT02576509|473779737|FG001|Treatment Period|Disease progression|244|||
131587443|NCT02576509|473779736|FG000|Treatment Period|Study drug toxicity|37|||
131587444|NCT02576509|473779737|FG001|Treatment Period|Study drug toxicity|41|||
131587445|NCT02576509|473779736|FG000|Treatment Period|Death|1|||
131587446|NCT02576509|473779737|FG001|Treatment Period|Death|1|||
131587447|NCT02576509|473779736|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
131587448|NCT02576509|473779737|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
131587449|NCT02576509|473779736|FG000|Treatment Period|Participant request to stop treatment|8|||
131587450|NCT02576509|473779737|FG001|Treatment Period|Participant request to stop treatment|18|||
131587451|NCT02576509|473779736|FG000|Treatment Period|Participant withdrew consent|3|||
131587452|NCT02576509|473779737|FG001|Treatment Period|Participant withdrew consent|7|||
131587453|NCT02576509|473779736|FG000|Treatment Period|Lost to Follow-up|0|||
131587454|NCT02576509|473779737|FG001|Treatment Period|Lost to Follow-up|1|||
131587455|NCT02576509|473779736|FG000|Treatment Period|Maximum clinical benefit|1|||
131587456|NCT02576509|473779737|FG001|Treatment Period|Maximum clinical benefit|0|||
131587457|NCT02576509|473779736|FG000|Treatment Period|Poor/non-compliance|1|||
131587458|NCT02576509|473779737|FG001|Treatment Period|Poor/non-compliance|1|||
131587459|NCT02576509|473779736|FG000|Treatment Period|Participant no longer meets criteria|1|||
131587460|NCT02576509|473779737|FG001|Treatment Period|Participant no longer meets criteria|0|||
131587461|NCT02576509|473779736|FG000|Treatment Period|Other reason|12|||
131587462|NCT02576509|473779737|FG001|Treatment Period|Other reason|8|||
131587463|NCT02576509|473779736|FG000|Treatment Period|NOT REPORTED|1|||
131587464|NCT02576509|473779737|FG001|Treatment Period|NOT REPORTED|0|||
131587465|NCT02576509|473779736|FG000|Treatment Period|Administrative reason by sponsor|0|||
131587466|NCT02576509|473779737|FG001|Treatment Period|Administrative reason by sponsor|1|||
131587467|NCT03725722|473779743|FG000|Overall Study|Lack of Efficacy|2|||
131587468|NCT03725722|473779744|FG001|Overall Study|Lack of Efficacy|1|||
131587469|NCT03725722|473779745|FG002|Overall Study|Lack of Efficacy|2|||
131587470|NCT03725722|473779746|FG003|Overall Study|Lack of Efficacy|0|||
131587471|NCT03725722|473779747|FG004|Overall Study|Lack of Efficacy|2|||
131587472|NCT03725722|473779743|FG000|Overall Study|Adverse Event|2|||
131587473|NCT03725722|473779744|FG001|Overall Study|Adverse Event|2|||
131587474|NCT03725722|473779745|FG002|Overall Study|Adverse Event|1|||
131587475|NCT03725722|473779746|FG003|Overall Study|Adverse Event|0|||
131587476|NCT03725722|473779747|FG004|Overall Study|Adverse Event|6|||
131587477|NCT03725722|473779743|FG000|Overall Study|Withdrawal by Subject|4|||
131587478|NCT03725722|473779744|FG001|Overall Study|Withdrawal by Subject|1|||
131587479|NCT03725722|473779745|FG002|Overall Study|Withdrawal by Subject|0|||
131587480|NCT03725722|473779746|FG003|Overall Study|Withdrawal by Subject|4|||
131587481|NCT03725722|473779747|FG004|Overall Study|Withdrawal by Subject|4|||
131587482|NCT03725722|473779743|FG000|Overall Study|Lost to Follow-up|3|||
131587483|NCT03725722|473779744|FG001|Overall Study|Lost to Follow-up|1|||
131587484|NCT03725722|473779745|FG002|Overall Study|Lost to Follow-up|2|||
131587485|NCT03725722|473779746|FG003|Overall Study|Lost to Follow-up|2|||
131587486|NCT03725722|473779747|FG004|Overall Study|Lost to Follow-up|1|||
131587487|NCT03725722|473779743|FG000|Overall Study|Personal reasons|0|||
131587488|NCT03725722|473779744|FG001|Overall Study|Personal reasons|0|||
131587489|NCT03725722|473779745|FG002|Overall Study|Personal reasons|1|||
131587490|NCT03725722|473779746|FG003|Overall Study|Personal reasons|0|||
131587491|NCT03725722|473779747|FG004|Overall Study|Personal reasons|1|||
131587492|NCT03725722|473779743|FG000|Overall Study|COVID-19 situation|0|||
131587493|NCT03725722|473779744|FG001|Overall Study|COVID-19 situation|1|||
131587494|NCT03725722|473779745|FG002|Overall Study|COVID-19 situation|0|||
131587495|NCT03725722|473779746|FG003|Overall Study|COVID-19 situation|0|||
131587496|NCT03725722|473779747|FG004|Overall Study|COVID-19 situation|0|||
131790660|NCT00549198|474516893|FG001|Overall Study|Pregnancy|3|||
131587497|NCT05505045|473779748|FG000|Overall Study|Withdrawal by Subject|2|||
131587498|NCT05505045|473779749|FG001|Overall Study|Withdrawal by Subject|1|||
131587499|NCT01643070|473779750|FG000|Overall Study|Withdrawal by Subject|3|||
131587500|NCT01643070|473779751|FG001|Overall Study|Withdrawal by Subject|1|||
131587501|NCT01643070|473779750|FG000|Overall Study|Death|1|||
131587502|NCT01643070|473779751|FG001|Overall Study|Death|0|||
131587503|NCT01643070|473779750|FG000|Overall Study|Pregressive disease|0|||
131587504|NCT01643070|473779751|FG001|Overall Study|Pregressive disease|2|||
131587505|NCT02791230|473779752|FG000|Overall Study|Adverse Event|10|||
131587506|NCT02791230|473779753|FG001|Overall Study|Adverse Event|9|||
131587507|NCT02791230|473779754|FG002|Overall Study|Adverse Event|66|||
131587508|NCT02791230|473779752|FG000|Overall Study|Death|38|||
131587509|NCT02791230|473779753|FG001|Overall Study|Death|25|||
131587510|NCT02791230|473779754|FG002|Overall Study|Death|184|||
131587511|NCT02791230|473779752|FG000|Overall Study|Lack of Efficacy|1|||
131587512|NCT02791230|473779753|FG001|Overall Study|Lack of Efficacy|0|||
131587513|NCT02791230|473779754|FG002|Overall Study|Lack of Efficacy|3|||
131790661|NCT00549198|474516892|FG000|Overall Study|Not Exposed to Study Drug|3|||
131790662|NCT00549198|474516893|FG001|Overall Study|Not Exposed to Study Drug|4|||
131790663|NCT01034137|474516894|FG000|Overall Study|Adverse Event|9|||
131790664|NCT01034137|474516895|FG001|Overall Study|Adverse Event|10|||
131790665|NCT01034137|474516896|FG002|Overall Study|Adverse Event|8|||
131790666|NCT01034137|474516894|FG000|Overall Study|Withdrawal by Subject|4|||
131790667|NCT01034137|474516895|FG001|Overall Study|Withdrawal by Subject|3|||
131790668|NCT01034137|474516896|FG002|Overall Study|Withdrawal by Subject|3|||
131790669|NCT01034137|474516894|FG000|Overall Study|Lack of Efficacy|9|||
131790670|NCT01034137|474516895|FG001|Overall Study|Lack of Efficacy|4|||
131790671|NCT01034137|474516896|FG002|Overall Study|Lack of Efficacy|13|||
131790672|NCT01034137|474516894|FG000|Overall Study|Protocol Violation|2|||
131790673|NCT01034137|474516895|FG001|Overall Study|Protocol Violation|2|||
131790674|NCT01034137|474516896|FG002|Overall Study|Protocol Violation|1|||
131790675|NCT01034137|474516894|FG000|Overall Study|Refused treatment or did not cooperate|2|||
131790676|NCT01034137|474516895|FG001|Overall Study|Refused treatment or did not cooperate|0|||
131790677|NCT01034137|474516896|FG002|Overall Study|Refused treatment or did not cooperate|1|||
131790678|NCT01034137|474516894|FG000|Overall Study|Administrative or other|2|||
131790679|NCT01034137|474516895|FG001|Overall Study|Administrative or other|3|||
131790680|NCT01034137|474516896|FG002|Overall Study|Administrative or other|4|||
131790681|NCT01764854|474516897|FG000|Overall Study|Adverse Event|0|||
131790682|NCT01764854|474516898|FG001|Overall Study|Adverse Event|0|||
131790683|NCT01764854|474516899|FG002|Overall Study|Adverse Event|2|||
131790684|NCT01764854|474516900|FG003|Overall Study|Adverse Event|0|||
131790685|NCT01764854|474516897|FG000|Overall Study|Withdrawal by Subject|0|||
131790686|NCT01764854|474516898|FG001|Overall Study|Withdrawal by Subject|0|||
131790687|NCT01764854|474516899|FG002|Overall Study|Withdrawal by Subject|1|||
131790688|NCT01764854|474516900|FG003|Overall Study|Withdrawal by Subject|0|||
131790689|NCT01764854|474516897|FG000|Overall Study|relocation|0|||
131790690|NCT01764854|474516898|FG001|Overall Study|relocation|0|||
131790691|NCT01764854|474516899|FG002|Overall Study|relocation|2|||
131790692|NCT01764854|474516900|FG003|Overall Study|relocation|0|||
131790693|NCT01764854|474516897|FG000|Overall Study|Protocol Violation|0|||
131790694|NCT01764854|474516898|FG001|Overall Study|Protocol Violation|0|||
131790695|NCT01764854|474516899|FG002|Overall Study|Protocol Violation|1|||
131790696|NCT01764854|474516900|FG003|Overall Study|Protocol Violation|2|||
131790697|NCT03377556|474516912|FG000|Overall Study|Adverse Event|5|||
131790698|NCT03377556|474516912|FG000|Overall Study|Refusal unrelated to adverse events|1|||
131790699|NCT03377556|474516912|FG000|Overall Study|Progression/relapse|38|||
131790700|NCT03377556|474516912|FG000|Overall Study|Death|3|||
131790701|NCT00472446|474516913|FG000|Overall Study|Protocol Violation|0|||
131790702|NCT00472446|474516914|FG001|Overall Study|Protocol Violation|0|||
131790703|NCT00472446|474516915|FG002|Overall Study|Protocol Violation|0|||
131790704|NCT00472446|474516916|FG003|Overall Study|Protocol Violation|1|||
131790705|NCT00472446|474516913|FG000|Overall Study|Reintervention|0|||
131790706|NCT00472446|474516914|FG001|Overall Study|Reintervention|0|||
131790707|NCT00472446|474516915|FG002|Overall Study|Reintervention|1|||
131790708|NCT00472446|474516916|FG003|Overall Study|Reintervention|1|||
131790709|NCT00472446|474516913|FG000|Overall Study|Questionnaires not returned|5|||
131790710|NCT00472446|474516914|FG001|Overall Study|Questionnaires not returned|6|||
131790711|NCT00472446|474516915|FG002|Overall Study|Questionnaires not returned|6|||
131790712|NCT00472446|474516916|FG003|Overall Study|Questionnaires not returned|4|||
131790713|NCT00827827|474516917|FG000|Overall Study|Lost to Follow-up|3|||
131790714|NCT00827827|474516918|FG001|Overall Study|Lost to Follow-up|0|||
131790715|NCT00827827|474516917|FG000|Overall Study|Fall at home- hospitalization|1|||
131587514|NCT02791230|473779752|FG000|Overall Study|Lost to Follow-up|0|||
131587515|NCT02791230|473779753|FG001|Overall Study|Lost to Follow-up|0|||
131790716|NCT00827827|474516918|FG001|Overall Study|Fall at home- hospitalization|0|||
131790717|NCT00827827|474516917|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
131790718|NCT00827827|474516918|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
131790719|NCT00827827|474516917|FG000|Overall Study|Gout|1|||
131790720|NCT00827827|474516918|FG001|Overall Study|Gout|0|||
131790721|NCT00827827|474516917|FG000|Overall Study|Transportation issues|1|||
131790722|NCT00827827|474516918|FG001|Overall Study|Transportation issues|0|||
131587516|NCT02791230|473779754|FG002|Overall Study|Lost to Follow-up|10|||
131587517|NCT02791230|473779752|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
131790723|NCT00827827|474516917|FG000|Overall Study|Burned with water at home|1|||
131587518|NCT02791230|473779753|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
131587519|NCT02791230|473779754|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
131587520|NCT02791230|473779752|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
131587521|NCT02791230|473779753|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
131587522|NCT02791230|473779754|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
131587523|NCT02791230|473779752|FG000|Overall Study|Study sites terminated by sponsor|1|||
131587524|NCT02791230|473779753|FG001|Overall Study|Study sites terminated by sponsor|0|||
131587525|NCT02791230|473779754|FG002|Overall Study|Study sites terminated by sponsor|5|||
131587526|NCT02791230|473779752|FG000|Overall Study|Other|9|||
131587527|NCT02791230|473779753|FG001|Overall Study|Other|1|||
131587528|NCT02791230|473779754|FG002|Overall Study|Other|28|||
131587529|NCT02791230|473779752|FG000|Overall Study|Protocol Violation|0|||
131587530|NCT02791230|473779753|FG001|Overall Study|Protocol Violation|0|||
131587531|NCT02791230|473779754|FG002|Overall Study|Protocol Violation|4|||
131587532|NCT02791230|473779752|FG000|Overall Study|Withdrawal by Subject|24|||
131587533|NCT02791230|473779753|FG001|Overall Study|Withdrawal by Subject|13|||
131587534|NCT02791230|473779754|FG002|Overall Study|Withdrawal by Subject|172|||
131587535|NCT02791230|473779752|FG000|Overall Study|Enrolled but not treated|0|||
131587536|NCT02791230|473779753|FG001|Overall Study|Enrolled but not treated|0|||
131587537|NCT02791230|473779754|FG002|Overall Study|Enrolled but not treated|5|||
131587538|NCT04201834|473779756|FG000|Overall Study|Screen fail|1|||
131587539|NCT04310735|473779764|FG000|Overall Study|Withdrawal by Subject|1|||
131587540|NCT04310735|473779765|FG001|Overall Study|Withdrawal by Subject|3|||
131587541|NCT04310735|473779766|FG002|Overall Study|Withdrawal by Subject|8|||
131587542|NCT04310735|473779764|FG000|Overall Study|Equipment malfunction|0|||
131587543|NCT04310735|473779765|FG001|Overall Study|Equipment malfunction|1|||
131587544|NCT04310735|473779766|FG002|Overall Study|Equipment malfunction|0|||
131587545|NCT04104321|473779767|FG000|Overall Study|didn't take the study drug|3|||
131587546|NCT03481777|473779768|FG000|Overall Study|Withdrawal by Subject|36|||
131587547|NCT03481777|473779769|FG001|Overall Study|Withdrawal by Subject|31|||
131587548|NCT03481777|473779768|FG000|Overall Study|Non stroke = non target population|277|||
131587549|NCT03481777|473779769|FG001|Overall Study|Non stroke = non target population|254|||
131587550|NCT04038957|473779772|FG000|Overall Study|Withdrawal by Subject|1|||
131587551|NCT04038957|473779772|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
131587552|NCT01998984|473779777|FG000|Overall Study|Adverse Event|0|||
131587553|NCT01998984|473779778|FG001|Overall Study|Adverse Event|0|||
131587554|NCT01998984|473779779|FG002|Overall Study|Adverse Event|0|||
131587555|NCT01998984|473779780|FG003|Overall Study|Adverse Event|1|||
131587556|NCT01998984|473779777|FG000|Overall Study|Lost to Follow-up|0|||
131587557|NCT01998984|473779778|FG001|Overall Study|Lost to Follow-up|1|||
131587558|NCT01998984|473779779|FG002|Overall Study|Lost to Follow-up|0|||
131587559|NCT01998984|473779780|FG003|Overall Study|Lost to Follow-up|1|||
131587560|NCT01998984|473779777|FG000|Overall Study|Withdrawal by Subject|0|||
131587561|NCT01998984|473779778|FG001|Overall Study|Withdrawal by Subject|0|||
131587562|NCT01998984|473779779|FG002|Overall Study|Withdrawal by Subject|1|||
131587563|NCT01998984|473779780|FG003|Overall Study|Withdrawal by Subject|0|||
131587564|NCT01998984|473779777|FG000|Overall Study|Other|0|||
131587565|NCT01998984|473779778|FG001|Overall Study|Other|0|||
131587566|NCT01998984|473779779|FG002|Overall Study|Other|0|||
131587567|NCT01998984|473779780|FG003|Overall Study|Other|1|||
131587568|NCT01843374|473779782|FG000|Overall Study|Death|155|||
131587569|NCT01843374|473779783|FG001|Overall Study|Death|313|||
131587570|NCT01843374|473779782|FG000|Overall Study|Withdrawal by Subject|14|||
131587571|NCT01843374|473779783|FG001|Overall Study|Withdrawal by Subject|20|||
131587572|NCT01843374|473779782|FG000|Overall Study|Withdrawing due to Other reason|20|||
131587573|NCT01843374|473779783|FG001|Overall Study|Withdrawing due to Other reason|46|||
131587574|NCT03397108|473779784|FG000|Overall Study|Lost to Follow-up|15|||
131587575|NCT03397108|473779785|FG001|Overall Study|Lost to Follow-up|0|||
131587576|NCT03397108|473779784|FG000|Overall Study|Insufficient milk production|3|||
131587577|NCT03397108|473779785|FG001|Overall Study|Insufficient milk production|2|||
131587578|NCT03397108|473779784|FG000|Overall Study|Withdrawal by Subject|2|||
131587579|NCT03397108|473779785|FG001|Overall Study|Withdrawal by Subject|0|||
131587580|NCT03554265|473779786|FG000|Overall Study|Withdrawal by Subject|2|||
131587581|NCT03554265|473779787|FG001|Overall Study|Withdrawal by Subject|2|||
131587582|NCT03554265|473779788|FG002|Overall Study|Withdrawal by Subject|3|||
131587583|NCT03554265|473779786|FG000|Overall Study|Physician Decision|0|||
131587584|NCT03554265|473779787|FG001|Overall Study|Physician Decision|0|||
131587585|NCT03554265|473779788|FG002|Overall Study|Physician Decision|1|||
131587586|NCT05672667|473779789|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
131587587|NCT00505934|473779790|FG000|Overall Study|Adverse Event|1|||
131587588|NCT00505934|473779790|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
131587589|NCT00505934|473779790|FG000|Overall Study|Other: IV dose needed to be changed|1|||
131587590|NCT03050814|473779791|FG000|Overall Study|Screen failures|0|||
131587591|NCT03050814|473779792|FG001|Overall Study|Screen failures|0|||
131587592|NCT03050814|473779793|FG002|Overall Study|Screen failures|4|||
131587593|NCT05137236|473779797|FG000|Part A|Other than Specified|1|||
131898810|NCT01089127|474915373|FG002|Overall Study|Protocol deviation|0|||
131898811|NCT01089127|474915374|FG003|Overall Study|Protocol deviation|0|||
131898812|NCT01089127|474915375|FG004|Overall Study|Protocol deviation|1|||
131898813|NCT01089127|474915376|FG005|Overall Study|Protocol deviation|0|||
131898814|NCT00447772|474915377|FG000|Overall Study|Lack of Efficacy|3|||
131898815|NCT00447772|474915377|FG000|Overall Study|Insufficient compliance|6|||
131898816|NCT00447772|474915377|FG000|Overall Study|Discontinuation of drug therapy|1|||
131898817|NCT00447772|474915377|FG000|Overall Study|Lost to Follow-up|9|||
131898818|NCT00447772|474915377|FG000|Overall Study|Withdrawal by Subject|1|||
131898819|NCT00447772|474915377|FG000|Overall Study|Unable to attend all study visits|2|||
131898820|NCT00447772|474915377|FG000|Overall Study|Adverse Event|1|||
131898821|NCT00447772|474915377|FG000|Overall Study|Patient relocated|1|||
131898822|NCT00447772|474915377|FG000|Overall Study|Incomplete documentation at visit 1|1|||
131898823|NCT00447772|474915377|FG000|Overall Study|Chemotherapy for lung cancer|1|||
131898824|NCT00447772|474915377|FG000|Overall Study|Premature re-injection required|1|||
131898825|NCT00716456|474915378|FG000|Overall Study|Adverse Event|0|||
131898826|NCT00716456|474915379|FG001|Overall Study|Adverse Event|2|||
131898827|NCT00716456|474915380|FG002|Overall Study|Adverse Event|0|||
131898828|NCT00875563|474915382|FG000|Overall Study|Death|4|||
131898829|NCT00875563|474915382|FG000|Overall Study|Withdrawal by Subject|7|||
131898830|NCT00875563|474915382|FG000|Overall Study|No long-term (3-5 year) consent|6|||
131898831|NCT00875563|474915382|FG000|Overall Study|Still be eligible for follow-up|7|||
131898832|NCT00511810|474915385|FG000|Overall Study|Lost to Follow-up|1|||
131898833|NCT00511810|474915386|FG001|Overall Study|Lost to Follow-up|2|||
131898834|NCT00511810|474915385|FG000|Overall Study|Lack of Efficacy|0|||
131898835|NCT00511810|474915386|FG001|Overall Study|Lack of Efficacy|2|||
131898836|NCT00511810|474915385|FG000|Overall Study|Refused second scn|0|||
131898837|NCT00511810|474915386|FG001|Overall Study|Refused second scn|1|||
131898838|NCT02427841|474915387|FG000|Overall Study|Lack of Efficacy|5|||
131898839|NCT02427841|474915387|FG000|Overall Study|Physician Decision|2|||
131898840|NCT02427841|474915387|FG000|Overall Study|Withdrawal by Subject|1|||
131898841|NCT02896569|474915388|FG000|Overall Study|Lost to Follow-up|2|||
131898842|NCT02896569|474915389|FG001|Overall Study|Lost to Follow-up|1|||
131898843|NCT02896569|474915388|FG000|Overall Study|Physician Decision|1|||
131587594|NCT05137236|473779798|FG001|Part A|Other than Specified|0|||
131587595|NCT05137236|473779799|FG002|Part A|Other than Specified|0|||
131587596|NCT05137236|473779800|FG003|Part A|Other than Specified|0|||
131587597|NCT05137236|473779801|FG004|Part A|Other than Specified|0|||
131587598|NCT05137236|473779802|FG005|Part A|Other than Specified|0|||
131587599|NCT05137236|473779803|FG006|Part A|Other than Specified|0|||
131587600|NCT05137236|473779804|FG007|Part A|Other than Specified|0|||
131587601|NCT05137236|473779797|FG000|Part A|Withdrawal by Subject|0|||
131587602|NCT05137236|473779798|FG001|Part A|Withdrawal by Subject|4|||
131587603|NCT05137236|473779799|FG002|Part A|Withdrawal by Subject|1|||
131587604|NCT05137236|473779800|FG003|Part A|Withdrawal by Subject|1|||
131587605|NCT05137236|473779801|FG004|Part A|Withdrawal by Subject|3|||
131587606|NCT05137236|473779802|FG005|Part A|Withdrawal by Subject|2|||
131587607|NCT05137236|473779803|FG006|Part A|Withdrawal by Subject|0|||
131587608|NCT05137236|473779804|FG007|Part A|Withdrawal by Subject|0|||
131587609|NCT05137236|473779797|FG000|Part A|Lost to Follow-up|5|||
131587610|NCT05137236|473779798|FG001|Part A|Lost to Follow-up|7|||
131587611|NCT05137236|473779799|FG002|Part A|Lost to Follow-up|1|||
131587612|NCT05137236|473779800|FG003|Part A|Lost to Follow-up|3|||
131587613|NCT05137236|473779801|FG004|Part A|Lost to Follow-up|3|||
131587614|NCT05137236|473779802|FG005|Part A|Lost to Follow-up|8|||
131587615|NCT05137236|473779803|FG006|Part A|Lost to Follow-up|0|||
131587616|NCT05137236|473779804|FG007|Part A|Lost to Follow-up|0|||
131587617|NCT05137236|473779797|FG000|Part B|Withdrawal by Subject|0|||
131587618|NCT05137236|473779798|FG001|Part B|Withdrawal by Subject|0|||
131587619|NCT05137236|473779799|FG002|Part B|Withdrawal by Subject|0|||
131587620|NCT05137236|473779800|FG003|Part B|Withdrawal by Subject|0|||
131587621|NCT05137236|473779801|FG004|Part B|Withdrawal by Subject|0|||
131587622|NCT05137236|473779802|FG005|Part B|Withdrawal by Subject|0|||
131705263|NCT01262976|474203450|FG001|Up to Year 3|Withdrawal by Subject|0|||
131705264|NCT01262976|474203451|FG002|Up to Year 3|Withdrawal by Subject|0|||
131705265|NCT01262976|474203452|FG003|Up to Year 3|Withdrawal by Subject|0|||
131898844|NCT02896569|474915389|FG001|Overall Study|Physician Decision|3|||
131898845|NCT02896569|474915388|FG000|Overall Study|Adverse Event|0|||
131898846|NCT02896569|474915389|FG001|Overall Study|Adverse Event|1|||
131898847|NCT02896569|474915388|FG000|Overall Study|Withdrawal by Subject|1|||
131587623|NCT05137236|473779803|FG006|Part B|Withdrawal by Subject|0|||
131587624|NCT05137236|473779804|FG007|Part B|Withdrawal by Subject|2|||
131898848|NCT02896569|474915389|FG001|Overall Study|Withdrawal by Subject|0|||
131898849|NCT01462630|474915390|FG000|Overall Study|Did not initiate therapy|3|||
131898850|NCT01462630|474915390|FG000|Overall Study|Death|1|||
131898851|NCT01462630|474915390|FG000|Overall Study|Protocol Violation|2|||
131587625|NCT05137236|473779797|FG000|Part B|Lost to Follow-up|0|||
131587626|NCT05137236|473779798|FG001|Part B|Lost to Follow-up|0|||
131587627|NCT05137236|473779799|FG002|Part B|Lost to Follow-up|0|||
131587628|NCT05137236|473779800|FG003|Part B|Lost to Follow-up|0|||
131587629|NCT05137236|473779801|FG004|Part B|Lost to Follow-up|0|||
131587630|NCT05137236|473779802|FG005|Part B|Lost to Follow-up|0|||
131587631|NCT05137236|473779803|FG006|Part B|Lost to Follow-up|5|||
131587632|NCT05137236|473779804|FG007|Part B|Lost to Follow-up|5|||
131587633|NCT05137236|473779797|FG000|Part B|Death|0|||
131587634|NCT05137236|473779798|FG001|Part B|Death|0|||
131587635|NCT05137236|473779799|FG002|Part B|Death|0|||
131587636|NCT05137236|473779800|FG003|Part B|Death|0|||
131587637|NCT05137236|473779801|FG004|Part B|Death|0|||
131587638|NCT05137236|473779802|FG005|Part B|Death|0|||
131587639|NCT05137236|473779803|FG006|Part B|Death|0|||
131587640|NCT05137236|473779804|FG007|Part B|Death|2|||
131587641|NCT02121002|473779813|FG000|Overall Study|Physician Decision|2|||
131587642|NCT02121002|473779814|FG001|Overall Study|Physician Decision|0|||
131587643|NCT02121002|473779815|FG002|Overall Study|Physician Decision|0|||
131587644|NCT02121002|473779813|FG000|Overall Study|Withdrawal by Subject|3|||
131587645|NCT02121002|473779814|FG001|Overall Study|Withdrawal by Subject|1|||
131587646|NCT02121002|473779815|FG002|Overall Study|Withdrawal by Subject|4|||
131587647|NCT02121002|473779813|FG000|Overall Study|Protocol Violation|1|||
131587648|NCT02121002|473779814|FG001|Overall Study|Protocol Violation|2|||
131587649|NCT02121002|473779815|FG002|Overall Study|Protocol Violation|4|||
131587650|NCT02121002|473779813|FG000|Overall Study|Concomitant therapy|0|||
131587651|NCT02121002|473779814|FG001|Overall Study|Concomitant therapy|1|||
131587652|NCT02121002|473779815|FG002|Overall Study|Concomitant therapy|1|||
131587653|NCT02121002|473779813|FG000|Overall Study|Others|1|||
131587654|NCT02121002|473779814|FG001|Overall Study|Others|0|||
131587655|NCT02121002|473779815|FG002|Overall Study|Others|1|||
131587656|NCT02590432|473779816|FG000|Open-label Treatment Period|Adverse Event|97|||
131587657|NCT02590432|473779817|FG001|Open-label Treatment Period|Adverse Event|79|||
131587658|NCT02590432|473779818|FG002|Open-label Treatment Period|Adverse Event|0|||
131587659|NCT02590432|473779819|FG003|Open-label Treatment Period|Adverse Event|0|||
131587660|NCT02590432|473779820|FG004|Open-label Treatment Period|Adverse Event|0|||
131587661|NCT02590432|473779821|FG005|Open-label Treatment Period|Adverse Event|0|||
131587662|NCT02590432|473779822|FG006|Open-label Treatment Period|Adverse Event|0|||
131587663|NCT02590432|473779823|FG007|Open-label Treatment Period|Adverse Event|0|||
131587664|NCT02590432|473779824|FG008|Open-label Treatment Period|Adverse Event|0|||
131587665|NCT02590432|473779816|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
131587666|NCT02590432|473779817|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
131587667|NCT02590432|473779818|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
131587668|NCT02590432|473779819|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
131587669|NCT02590432|473779820|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
131587670|NCT02590432|473779821|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
131587671|NCT02590432|473779822|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
131587672|NCT02590432|473779823|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
131587673|NCT02590432|473779824|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
131587674|NCT02590432|473779816|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
131587675|NCT02590432|473779817|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
131587676|NCT02590432|473779818|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
131587677|NCT02590432|473779819|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
131587678|NCT02590432|473779820|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
131587679|NCT02590432|473779821|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
131587680|NCT02590432|473779822|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
131587681|NCT02590432|473779823|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
131587682|NCT02590432|473779824|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
131587683|NCT02590432|473779816|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
131587684|NCT02590432|473779817|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
131790724|NCT00827827|474516918|FG001|Overall Study|Burned with water at home|0|||
131587685|NCT02590432|473779818|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
131587686|NCT02590432|473779819|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
131587687|NCT02590432|473779820|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
131587688|NCT02590432|473779821|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
131587689|NCT02590432|473779822|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
131587690|NCT02590432|473779823|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
131587691|NCT02590432|473779824|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
131587692|NCT02590432|473779816|FG000|Open-label Treatment Period|Protocol Violation|10|||
131587693|NCT02590432|473779817|FG001|Open-label Treatment Period|Protocol Violation|4|||
131587694|NCT02590432|473779818|FG002|Open-label Treatment Period|Protocol Violation|0|||
131587695|NCT02590432|473779819|FG003|Open-label Treatment Period|Protocol Violation|0|||
131587696|NCT02590432|473779820|FG004|Open-label Treatment Period|Protocol Violation|0|||
131587697|NCT02590432|473779821|FG005|Open-label Treatment Period|Protocol Violation|0|||
131587698|NCT02590432|473779822|FG006|Open-label Treatment Period|Protocol Violation|0|||
131587699|NCT02590432|473779823|FG007|Open-label Treatment Period|Protocol Violation|0|||
131587700|NCT02590432|473779824|FG008|Open-label Treatment Period|Protocol Violation|0|||
131587701|NCT02590432|473779816|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
131705266|NCT01262976|474203453|FG004|Up to Year 3|Withdrawal by Subject|0|||
131705267|NCT01262976|474203454|FG005|Up to Year 3|Withdrawal by Subject|0|||
131705268|NCT01262976|474203449|FG000|Up to Year 3|Migrated/moved from study area|0|||
131705269|NCT01262976|474203450|FG001|Up to Year 3|Migrated/moved from study area|0|||
131705270|NCT01262976|474203451|FG002|Up to Year 3|Migrated/moved from study area|0|||
131705271|NCT01262976|474203452|FG003|Up to Year 3|Migrated/moved from study area|2|||
131705272|NCT01262976|474203453|FG004|Up to Year 3|Migrated/moved from study area|1|||
131705273|NCT01262976|474203454|FG005|Up to Year 3|Migrated/moved from study area|1|||
131705274|NCT01262976|474203449|FG000|Up to Year 3|Lost to Follow-up|2|||
131705275|NCT01262976|474203450|FG001|Up to Year 3|Lost to Follow-up|2|||
131705276|NCT01262976|474203451|FG002|Up to Year 3|Lost to Follow-up|4|||
131705277|NCT01262976|474203452|FG003|Up to Year 3|Lost to Follow-up|3|||
131705278|NCT01262976|474203453|FG004|Up to Year 3|Lost to Follow-up|1|||
131705279|NCT01262976|474203454|FG005|Up to Year 3|Lost to Follow-up|3|||
131705280|NCT01262976|474203449|FG000|Up to Year 3|Subjects with unknown completion status|0|||
131705281|NCT01262976|474203450|FG001|Up to Year 3|Subjects with unknown completion status|0|||
131705282|NCT01262976|474203451|FG002|Up to Year 3|Subjects with unknown completion status|1|||
131705283|NCT01262976|474203452|FG003|Up to Year 3|Subjects with unknown completion status|0|||
131705284|NCT01262976|474203453|FG004|Up to Year 3|Subjects with unknown completion status|0|||
131705285|NCT01262976|474203454|FG005|Up to Year 3|Subjects with unknown completion status|0|||
131705286|NCT01262976|474203449|FG000|Up to Year 3|Other|3|||
131705287|NCT01262976|474203450|FG001|Up to Year 3|Other|0|||
131705288|NCT01262976|474203451|FG002|Up to Year 3|Other|0|||
131705289|NCT01262976|474203452|FG003|Up to Year 3|Other|0|||
131705290|NCT01262976|474203453|FG004|Up to Year 3|Other|0|||
131705291|NCT01262976|474203454|FG005|Up to Year 3|Other|0|||
131705292|NCT01552681|474203455|FG000|Overall Study|Withdrawal by Subject|4|||
131705293|NCT01552681|474203456|FG001|Overall Study|Withdrawal by Subject|0|||
131705294|NCT01552681|474203455|FG000|Overall Study|Physician Decision|1|||
131705295|NCT01552681|474203456|FG001|Overall Study|Physician Decision|0|||
131705296|NCT01552681|474203455|FG000|Overall Study|Subject moved away|0|||
131705297|NCT01552681|474203456|FG001|Overall Study|Subject moved away|1|||
131705298|NCT02690194|474203457|FG000|Overall Study|Withdrawal by Subject|1|||
131705299|NCT02690194|474203458|FG001|Overall Study|Withdrawal by Subject|4|||
131705300|NCT02690194|474203459|FG002|Overall Study|Withdrawal by Subject|0|||
131705301|NCT01987908|474203461|FG000|Placebo Lead-in Period|Adverse Event|2|||
131705302|NCT01987908|474203462|FG001|Placebo Lead-in Period|Adverse Event|0|||
131705303|NCT01987908|474203463|FG002|Placebo Lead-in Period|Adverse Event|0|||
131705304|NCT01987908|474203461|FG000|Placebo Lead-in Period|Physician Decision|2|||
131705305|NCT01987908|474203462|FG001|Placebo Lead-in Period|Physician Decision|0|||
131705306|NCT01987908|474203463|FG002|Placebo Lead-in Period|Physician Decision|0|||
131705307|NCT01987908|474203461|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
131705308|NCT01987908|474203462|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
131705309|NCT01987908|474203463|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
131705310|NCT01987908|474203461|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
131705311|NCT01987908|474203462|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
131705312|NCT01987908|474203463|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
131705313|NCT01987908|474203461|FG000|Treatment Period|Adverse Event|0|||
131705314|NCT01987908|474203462|FG001|Treatment Period|Adverse Event|1|||
131705315|NCT01987908|474203463|FG002|Treatment Period|Adverse Event|1|||
131705316|NCT01987908|474203461|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
131705317|NCT01987908|474203462|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
131705318|NCT01987908|474203463|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
131705319|NCT01987908|474203461|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
131705320|NCT01987908|474203462|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
131705321|NCT01987908|474203463|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
131705322|NCT01262625|474203466|FG000|Overall Study|Administrative Error|1|||
131705323|NCT01262625|474203467|FG001|Overall Study|Administrative Error|1|||
131705324|NCT01262625|474203466|FG000|Overall Study|Site Closed|1|||
131705325|NCT01262625|474203467|FG001|Overall Study|Site Closed|0|||
131705326|NCT02789657|474203468|FG000|Overall Study|Withdrawal by Subject|2|||
131587702|NCT02590432|473779817|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
131705327|NCT02789657|474203469|FG001|Overall Study|Withdrawal by Subject|0|||
131587703|NCT02590432|473779818|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587704|NCT02590432|473779819|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587705|NCT02590432|473779820|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587706|NCT02590432|473779821|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587707|NCT02590432|473779822|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587708|NCT02590432|473779823|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587709|NCT02590432|473779824|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131587710|NCT02590432|473779816|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
131587711|NCT02590432|473779817|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
131587712|NCT02590432|473779818|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587713|NCT02590432|473779819|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587714|NCT02590432|473779820|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587715|NCT02590432|473779821|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587716|NCT02590432|473779822|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587717|NCT02590432|473779823|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587718|NCT02590432|473779824|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131587719|NCT02590432|473779816|FG000|Double-blind Treatment Period|Adverse Event|0|||
131587720|NCT02590432|473779817|FG001|Double-blind Treatment Period|Adverse Event|0|||
131587721|NCT02590432|473779818|FG002|Double-blind Treatment Period|Adverse Event|14|||
131587722|NCT02590432|473779819|FG003|Double-blind Treatment Period|Adverse Event|12|||
131587723|NCT02590432|473779820|FG004|Double-blind Treatment Period|Adverse Event|6|||
131587724|NCT02590432|473779821|FG005|Double-blind Treatment Period|Adverse Event|22|||
131587725|NCT02590432|473779822|FG006|Double-blind Treatment Period|Adverse Event|20|||
131587726|NCT02590432|473779823|FG007|Double-blind Treatment Period|Adverse Event|0|||
131587727|NCT02590432|473779824|FG008|Double-blind Treatment Period|Adverse Event|0|||
131587728|NCT02590432|473779816|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
131587729|NCT02590432|473779817|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
131587730|NCT02590432|473779818|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
131587731|NCT02590432|473779819|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
131587732|NCT02590432|473779820|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
131587733|NCT02590432|473779821|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
131587734|NCT02590432|473779822|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
131587735|NCT02590432|473779823|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
131587736|NCT02590432|473779824|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
131587737|NCT02590432|473779816|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
131587738|NCT02590432|473779817|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
131587739|NCT02590432|473779818|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
131587740|NCT02590432|473779819|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
131587741|NCT02590432|473779820|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
131587742|NCT02590432|473779821|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
131587743|NCT02590432|473779822|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
131587744|NCT02590432|473779823|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
131587745|NCT02590432|473779824|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
131587746|NCT02590432|473779816|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131587747|NCT02590432|473779817|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131587748|NCT02590432|473779818|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
131587749|NCT02590432|473779819|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131587750|NCT02590432|473779820|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
131587751|NCT02590432|473779821|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
131587752|NCT02590432|473779822|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
131587753|NCT02590432|473779823|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
131587754|NCT02590432|473779824|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
131587755|NCT02590432|473779816|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587756|NCT02590432|473779817|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587757|NCT02590432|473779818|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587758|NCT02590432|473779819|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587759|NCT02590432|473779820|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587760|NCT02590432|473779821|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
131705328|NCT02789657|474203470|FG002|Overall Study|Withdrawal by Subject|0|||
131705329|NCT02789657|474203471|FG003|Overall Study|Withdrawal by Subject|0|||
131705330|NCT00236080|474203472|FG000|Overall Study|Adverse Event|0|||
131705331|NCT00236080|474203473|FG001|Overall Study|Adverse Event|0|||
131705332|NCT00236080|474203474|FG002|Overall Study|Adverse Event|3|||
131705333|NCT00236080|474203475|FG003|Overall Study|Adverse Event|1|||
131587761|NCT02590432|473779822|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131705334|NCT00236080|474203476|FG004|Overall Study|Adverse Event|0|||
131705335|NCT00236080|474203472|FG000|Overall Study|Lost to Follow-up|0|||
131705336|NCT00236080|474203473|FG001|Overall Study|Lost to Follow-up|1|||
131587762|NCT02590432|473779823|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587763|NCT02590432|473779824|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131587764|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587765|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587766|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587767|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587768|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587769|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587770|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131587771|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
131587772|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
131587773|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587774|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587775|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587776|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587777|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587778|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587779|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587780|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
131587781|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131587782|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587783|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587784|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587785|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587786|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587787|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587788|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131587789|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
131587790|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
131587791|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587792|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587793|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587794|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587795|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587796|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587797|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587798|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131587799|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
131587800|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587801|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587802|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587803|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587804|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587805|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587806|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587807|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131587808|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
131587809|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587810|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587811|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587812|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587813|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587814|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131790725|NCT01381900|474516919|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
131790726|NCT01381900|474516920|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
131790727|NCT01381900|474516921|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
131587815|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587816|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
131587817|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131587818|NCT02590432|473779816|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587819|NCT02590432|473779817|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587820|NCT02590432|473779818|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587821|NCT02590432|473779819|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587822|NCT02590432|473779820|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587823|NCT02590432|473779821|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587824|NCT02590432|473779822|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587825|NCT02590432|473779823|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
131587826|NCT02590432|473779824|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131587827|NCT02006758|473779825|FG000|Overall Study|Protocol Violation|1|||
131587828|NCT02006758|473779825|FG000|Overall Study|Death|1|||
131587829|NCT02006758|473779825|FG000|Overall Study|Lost to Follow-up|4|||
131587830|NCT02006758|473779825|FG000|Overall Study|Withdrawal by Subject|4|||
131587831|NCT02006758|473779825|FG000|Overall Study|Procedurally excluded|1|||
131587832|NCT02006758|473779825|FG000|Overall Study|Other|2|||
131587833|NCT00409838|473779826|FG000|Short-term Period|Adverse Event|0|||
131587834|NCT00409838|473779827|FG001|Short-term Period|Adverse Event|1|||
131587835|NCT00409838|473779826|FG000|Short-term Period|Lost to Follow-up|0|||
131587836|NCT00409838|473779827|FG001|Short-term Period|Lost to Follow-up|1|||
131587837|NCT00409838|473779826|FG000|Short-term Period|Withdrawal by Subject|2|||
131587838|NCT00409838|473779827|FG001|Short-term Period|Withdrawal by Subject|3|||
131587839|NCT00409838|473779826|FG000|Short-term Period|Never Treated|1|||
131587840|NCT00409838|473779827|FG001|Short-term Period|Never Treated|0|||
131587841|NCT00409838|473779826|FG000|Long-term Extension Period|Adverse Event|10|||
131587842|NCT00409838|473779827|FG001|Long-term Extension Period|Adverse Event|0|||
131587843|NCT00409838|473779826|FG000|Long-term Extension Period|Death|1|||
131587844|NCT00409838|473779827|FG001|Long-term Extension Period|Death|0|||
131587845|NCT00409838|473779826|FG000|Long-term Extension Period|Lack of Efficacy|2|||
131587846|NCT00409838|473779827|FG001|Long-term Extension Period|Lack of Efficacy|0|||
131587847|NCT00409838|473779826|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
131587848|NCT00409838|473779827|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
131587849|NCT00409838|473779826|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
131587850|NCT00409838|473779827|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
131587851|NCT00409838|473779826|FG000|Long-term Extension Period|Pregnancy|1|||
131587852|NCT00409838|473779827|FG001|Long-term Extension Period|Pregnancy|0|||
131587853|NCT04788641|473779833|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
131587854|NCT04788641|473779834|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
131587855|NCT04788641|473779835|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
131587856|NCT04788641|473779836|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
131587857|NCT04788641|473779833|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
131587858|NCT04788641|473779834|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
131587859|NCT04788641|473779835|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
131587860|NCT04788641|473779836|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
131587861|NCT04788641|473779833|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
131587862|NCT04788641|473779834|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
131587863|NCT04788641|473779835|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
131705337|NCT00236080|474203474|FG002|Overall Study|Lost to Follow-up|0|||
131705338|NCT00236080|474203475|FG003|Overall Study|Lost to Follow-up|0|||
131705339|NCT00236080|474203476|FG004|Overall Study|Lost to Follow-up|0|||
131705340|NCT00236080|474203472|FG000|Overall Study|Physician Decision|1|||
131705341|NCT00236080|474203473|FG001|Overall Study|Physician Decision|0|||
131705342|NCT00236080|474203474|FG002|Overall Study|Physician Decision|1|||
131705343|NCT00236080|474203475|FG003|Overall Study|Physician Decision|1|||
131705344|NCT00236080|474203476|FG004|Overall Study|Physician Decision|1|||
131705345|NCT00236080|474203472|FG000|Overall Study|Withdrawal by Subject|1|||
131705346|NCT00236080|474203473|FG001|Overall Study|Withdrawal by Subject|0|||
131705347|NCT00236080|474203474|FG002|Overall Study|Withdrawal by Subject|0|||
131790728|NCT01381900|474516919|FG000|Overall Study|Adverse Event|4|||
131790729|NCT01381900|474516920|FG001|Overall Study|Adverse Event|6|||
131790730|NCT01381900|474516921|FG002|Overall Study|Adverse Event|7|||
131790731|NCT01381900|474516919|FG000|Overall Study|Noncompliance with study drug|0|||
131790732|NCT01381900|474516920|FG001|Overall Study|Noncompliance with study drug|0|||
131587864|NCT04788641|473779836|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
131587865|NCT01250769|473779837|FG000|Overall Study|Withdrawal by Subject|0|||
131705348|NCT00236080|474203475|FG003|Overall Study|Withdrawal by Subject|0|||
131705349|NCT00236080|474203476|FG004|Overall Study|Withdrawal by Subject|0|||
131705350|NCT00236080|474203472|FG000|Overall Study|Miscellaneous|0|||
131705351|NCT00236080|474203473|FG001|Overall Study|Miscellaneous|0|||
131587866|NCT01250769|473779838|FG001|Overall Study|Withdrawal by Subject|1|||
131587867|NCT01250769|473779839|FG002|Overall Study|Withdrawal by Subject|1|||
131587868|NCT01250769|473779840|FG003|Overall Study|Withdrawal by Subject|0|||
131587869|NCT01250769|473779837|FG000|Overall Study|Adverse Event|0|||
131587870|NCT01250769|473779838|FG001|Overall Study|Adverse Event|0|||
131587871|NCT01250769|473779839|FG002|Overall Study|Adverse Event|1|||
131587872|NCT01250769|473779840|FG003|Overall Study|Adverse Event|0|||
131587873|NCT00243503|473779843|FG000|Overall Study|Adverse Event|11|||
131587874|NCT00243503|473779843|FG000|Overall Study|Withdrawal by Subject|1|||
131587875|NCT00243503|473779843|FG000|Overall Study|Lack of Efficacy|44|||
131587876|NCT00243503|473779843|FG000|Overall Study|Death|1|||
131587877|NCT00243503|473779843|FG000|Overall Study|Other|1|||
131587878|NCT02374307|473779849|FG000|3-months Follow-up|Lost to Follow-up|1|||
131587879|NCT02374307|473779850|FG001|3-months Follow-up|Lost to Follow-up|2|||
131587880|NCT02374307|473779849|FG000|3-months Follow-up|Withdrawal by Subject|1|||
131587881|NCT02374307|473779850|FG001|3-months Follow-up|Withdrawal by Subject|4|||
131587882|NCT02374307|473779849|FG000|3-months Follow-up|Death|1|||
131587883|NCT02374307|473779850|FG001|3-months Follow-up|Death|2|||
131587884|NCT02374307|473779849|FG000|3-months Follow-up|Missed first follow-up|5|||
131587885|NCT02374307|473779850|FG001|3-months Follow-up|Missed first follow-up|1|||
131587886|NCT02374307|473779849|FG000|6-months Follow-up|Lost to Follow-up|1|||
131587887|NCT02374307|473779850|FG001|6-months Follow-up|Lost to Follow-up|2|||
131587888|NCT02374307|473779849|FG000|6-months Follow-up|Death|2|||
131587889|NCT02374307|473779850|FG001|6-months Follow-up|Death|1|||
131587890|NCT02374307|473779849|FG000|6-months Follow-up|Withdrawal by Subject|0|||
131587891|NCT02374307|473779850|FG001|6-months Follow-up|Withdrawal by Subject|3|||
131587892|NCT01771731|473779865|FG000|Overall Study|Physician Decision|1|||
131587893|NCT01771731|473779866|FG001|Overall Study|Physician Decision|0|||
131587894|NCT01771731|473779865|FG000|Overall Study|Protocol Violation|0|||
131587895|NCT01771731|473779866|FG001|Overall Study|Protocol Violation|1|||
131587896|NCT01771731|473779865|FG000|Overall Study|Adverse event: Pain Crisis|1|||
131587897|NCT01771731|473779866|FG001|Overall Study|Adverse event: Pain Crisis|1|||
131587898|NCT01747486|473779867|FG000|Stage 1|Physician Decision|3|||
131587899|NCT01747486|473779868|FG001|Stage 1|Physician Decision|0|||
131587900|NCT01747486|473779867|FG000|Stage 1|Withdrawal by Subject|4|||
131587901|NCT01747486|473779868|FG001|Stage 1|Withdrawal by Subject|3|||
131587902|NCT01747486|473779867|FG000|Stage 1|Disease progression|4|||
131587903|NCT01747486|473779868|FG001|Stage 1|Disease progression|9|||
131587904|NCT01747486|473779867|FG000|Stage 1|Death|1|||
131587905|NCT01747486|473779868|FG001|Stage 1|Death|1|||
131587906|NCT01747486|473779867|FG000|Stage 2|Physician Decision|2|||
131587907|NCT01747486|473779868|FG001|Stage 2|Physician Decision|0|||
131587908|NCT01747486|473779867|FG000|Stage 2|Withdrawal by Subject|1|||
131587909|NCT01747486|473779868|FG001|Stage 2|Withdrawal by Subject|0|||
131587910|NCT01747486|473779867|FG000|Stage 2|New Cancer Therapy|3|||
131587911|NCT01747486|473779868|FG001|Stage 2|New Cancer Therapy|0|||
131587912|NCT01747486|473779867|FG000|Stage 2|Disease Progression|3|||
131587913|NCT01747486|473779868|FG001|Stage 2|Disease Progression|0|||
131587914|NCT00087139|473779869|FG000|Overall Study|Adverse Event|18|||
131587915|NCT00087139|473779870|FG001|Overall Study|Adverse Event|17|||
131587916|NCT00087139|473779871|FG002|Overall Study|Adverse Event|13|||
131587917|NCT00087139|473779869|FG000|Overall Study|Death|2|||
131587918|NCT00087139|473779870|FG001|Overall Study|Death|1|||
131587919|NCT00087139|473779871|FG002|Overall Study|Death|0|||
131587920|NCT00087139|473779869|FG000|Overall Study|Withdrawal by Subject|3|||
131587921|NCT00087139|473779870|FG001|Overall Study|Withdrawal by Subject|2|||
131587922|NCT00087139|473779871|FG002|Overall Study|Withdrawal by Subject|2|||
131587923|NCT00087139|473779869|FG000|Overall Study|Physician Decision|1|||
131587924|NCT00087139|473779870|FG001|Overall Study|Physician Decision|1|||
131587925|NCT00087139|473779871|FG002|Overall Study|Physician Decision|1|||
131790733|NCT01381900|474516921|FG002|Overall Study|Noncompliance with study drug|1|||
131790734|NCT01381900|474516919|FG000|Overall Study|Physician Decision|0|||
131790735|NCT01381900|474516920|FG001|Overall Study|Physician Decision|1|||
131790736|NCT01381900|474516921|FG002|Overall Study|Physician Decision|1|||
131790737|NCT01381900|474516919|FG000|Overall Study|Protocol Violation|0|||
131790738|NCT01381900|474516920|FG001|Overall Study|Protocol Violation|1|||
131790739|NCT01381900|474516921|FG002|Overall Study|Protocol Violation|1|||
131587926|NCT00087139|473779869|FG000|Overall Study|Disease progression|9|||
131587927|NCT00087139|473779870|FG001|Overall Study|Disease progression|19|||
131587928|NCT00087139|473779871|FG002|Overall Study|Disease progression|12|||
131587929|NCT00087139|473779869|FG000|Overall Study|Ineligible|4|||
131587930|NCT00087139|473779870|FG001|Overall Study|Ineligible|7|||
131587931|NCT00087139|473779871|FG002|Overall Study|Ineligible|4|||
131587932|NCT00087139|473779869|FG000|Overall Study|Symptomatic deterioration|1|||
131790740|NCT01381900|474516919|FG000|Overall Study|Withdrawal by Subject|0|||
131790741|NCT01381900|474516920|FG001|Overall Study|Withdrawal by Subject|0|||
131587933|NCT00087139|473779870|FG001|Overall Study|Symptomatic deterioration|1|||
131587934|NCT00087139|473779871|FG002|Overall Study|Symptomatic deterioration|3|||
131587935|NCT00087139|473779869|FG000|Overall Study|Use of coumadin|1|||
131587936|NCT00087139|473779870|FG001|Overall Study|Use of coumadin|0|||
131587937|NCT00087139|473779871|FG002|Overall Study|Use of coumadin|0|||
131587938|NCT00087139|473779869|FG000|Overall Study|Response achieved|0|||
131587939|NCT00087139|473779870|FG001|Overall Study|Response achieved|1|||
131587940|NCT00087139|473779871|FG002|Overall Study|Response achieved|0|||
131587941|NCT00087139|473779869|FG000|Overall Study|Extradural disease|0|||
131587942|NCT00087139|473779870|FG001|Overall Study|Extradural disease|0|||
131587943|NCT00087139|473779871|FG002|Overall Study|Extradural disease|1|||
131587944|NCT00001277|473779874|FG000|Overall Study|Adverse Event|0|||
131587945|NCT00001277|473779875|FG001|Overall Study|Adverse Event|0|||
131587946|NCT00001277|473779876|FG002|Overall Study|Adverse Event|1|||
131587947|NCT00001277|473779874|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
131587948|NCT00001277|473779875|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
131587949|NCT00001277|473779876|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
131587950|NCT00065260|473779877|FG000|Overall Study|Death|0|||
131587951|NCT00065260|473779878|FG001|Overall Study|Death|1|||
131587952|NCT04484935|473779879|FG000|Overall Study|Other|0|||
131587953|NCT04484935|473779880|FG001|Overall Study|Other|1|||
131587954|NCT04484935|473779879|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131587955|NCT04484935|473779880|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131587956|NCT04484935|473779879|FG000|Overall Study|Lost to Follow-up|1|||
131587957|NCT04484935|473779880|FG001|Overall Study|Lost to Follow-up|0|||
131587958|NCT04484935|473779879|FG000|Overall Study|Death|2|||
131587959|NCT04484935|473779880|FG001|Overall Study|Death|1|||
131587960|NCT03101371|473779886|FG000|Overall Study|Physician Decision|0|||
131587961|NCT03101371|473779887|FG001|Overall Study|Physician Decision|1|||
131587962|NCT03101371|473779886|FG000|Overall Study|Lost to Follow-up|1|||
131587963|NCT03101371|473779887|FG001|Overall Study|Lost to Follow-up|4|||
131587964|NCT03101371|473779886|FG000|Overall Study|Did not meet eligibility criteria|2|||
131587965|NCT03101371|473779887|FG001|Overall Study|Did not meet eligibility criteria|1|||
131587966|NCT01094184|473779888|FG000|Overall Study|Death|35|||
131587967|NCT01094184|473779889|FG001|Overall Study|Death|11|||
131587968|NCT03892564|473779891|FG000|Overall Study|Withdrawal by Subject|2|||
131587969|NCT04019444|473779892|FG000|Overall Study|Withdrawal by Subject|0|||
131587970|NCT04019444|473779893|FG001|Overall Study|Withdrawal by Subject|1|||
131587971|NCT04019444|473779894|FG002|Overall Study|Withdrawal by Subject|0|||
131587972|NCT04019444|473779895|FG003|Overall Study|Withdrawal by Subject|1|||
131587973|NCT04019444|473779892|FG000|Overall Study|Solicited Event|0|||
131587974|NCT04019444|473779893|FG001|Overall Study|Solicited Event|0|||
131587975|NCT04019444|473779894|FG002|Overall Study|Solicited Event|2|||
131587976|NCT04019444|473779895|FG003|Overall Study|Solicited Event|0|||
131587977|NCT01303445|473779907|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
131587978|NCT01303445|473779908|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
131587979|NCT01303445|473779907|FG000|Second Intervention (7 Days)|Adverse Event|0|||
131587980|NCT01303445|473779908|FG001|Second Intervention (7 Days)|Adverse Event|2|||
131587981|NCT01303445|473779907|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
131587982|NCT01303445|473779908|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
131587983|NCT01303445|473779907|FG000|Washout (14 Days)|Protocol Violation|1|||
131587984|NCT01303445|473779908|FG001|Washout (14 Days)|Protocol Violation|0|||
131587985|NCT01303445|473779907|FG000|Washout (14 Days)|Lost to Follow-up|0|||
131587986|NCT01303445|473779908|FG001|Washout (14 Days)|Lost to Follow-up|2|||
131587987|NCT01303445|473779907|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
131587988|NCT01303445|473779908|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
131587989|NCT01303445|473779907|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
131587990|NCT01303445|473779908|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
131587991|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
131587992|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
131587993|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
131587994|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
131587995|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
131587996|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
131587997|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
131587998|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
131587999|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
131588000|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
131588001|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
131588002|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
131588003|NCT01600014|473781693|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
131588004|NCT01600014|473781694|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
131588005|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
131588006|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
131588007|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
131588008|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
131705352|NCT00236080|474203474|FG002|Overall Study|Miscellaneous|1|||
131588009|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
131588010|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
131588011|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
131588012|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
131588013|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
131588014|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
131588015|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
131588016|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
131588017|NCT01600014|473781693|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
131588018|NCT01600014|473781694|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
131588019|NCT01600014|473781693|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
131588020|NCT01600014|473781694|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
131588021|NCT01600014|473781693|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
131588022|NCT01600014|473781694|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
131588023|NCT01600014|473781693|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
131588024|NCT01600014|473781694|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
131588025|NCT03398148|473781695|FG000|Substudy 1 Period 1|Adverse Event|5|||
131588026|NCT03398148|473781696|FG001|Substudy 1 Period 1|Adverse Event|2|||
131588027|NCT03398148|473781697|FG002|Substudy 1 Period 1|Adverse Event|2|||
131588028|NCT03398148|473781698|FG003|Substudy 1 Period 1|Adverse Event|0|||
131588029|NCT03398148|473781699|FG004|Substudy 1 Period 1|Adverse Event|8|||
131588030|NCT03398148|473781700|FG005|Substudy 1 Period 1|Adverse Event|0|||
131588031|NCT03398148|473781701|FG006|Substudy 1 Period 1|Adverse Event|0|||
131588032|NCT03398148|473781702|FG007|Substudy 1 Period 1|Adverse Event|0|||
131588033|NCT03398148|473781703|FG008|Substudy 1 Period 1|Adverse Event|0|||
131588034|NCT03398148|473781704|FG009|Substudy 1 Period 1|Adverse Event|0|||
131588035|NCT03398148|473781705|FG010|Substudy 1 Period 1|Adverse Event|0|||
131588036|NCT03398148|473781706|FG011|Substudy 1 Period 1|Adverse Event|0|||
131588037|NCT03398148|473781707|FG012|Substudy 1 Period 1|Adverse Event|0|||
131588038|NCT03398148|473781708|FG013|Substudy 1 Period 1|Adverse Event|0|||
131588039|NCT03398148|473781709|FG014|Substudy 1 Period 1|Adverse Event|0|||
131588040|NCT03398148|473781695|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
131588041|NCT03398148|473781696|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
131588042|NCT03398148|473781697|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588043|NCT03398148|473781698|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
131588044|NCT03398148|473781699|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
131588045|NCT03398148|473781700|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588046|NCT03398148|473781701|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588047|NCT03398148|473781702|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588048|NCT03398148|473781703|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588049|NCT03398148|473781704|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588050|NCT03398148|473781705|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588051|NCT03398148|473781706|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588052|NCT03398148|473781707|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588053|NCT03398148|473781708|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588054|NCT03398148|473781709|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131588055|NCT03398148|473781695|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
131588056|NCT03398148|473781696|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
131588057|NCT03398148|473781697|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
131588058|NCT03398148|473781698|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
131588059|NCT03398148|473781699|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
131588060|NCT03398148|473781700|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
131588061|NCT03398148|473781701|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
131588062|NCT03398148|473781702|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
131588063|NCT03398148|473781703|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
131588064|NCT03398148|473781704|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
131588065|NCT03398148|473781705|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
131588066|NCT03398148|473781706|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
131588067|NCT03398148|473781707|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
131588068|NCT03398148|473781708|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
131588069|NCT03398148|473781709|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
131588070|NCT03398148|473781695|FG000|Substudy 1 Period 1|Other|0|||
131588071|NCT03398148|473781696|FG001|Substudy 1 Period 1|Other|1|||
131588072|NCT03398148|473781697|FG002|Substudy 1 Period 1|Other|0|||
131588073|NCT03398148|473781698|FG003|Substudy 1 Period 1|Other|0|||
131588074|NCT03398148|473781699|FG004|Substudy 1 Period 1|Other|3|||
131588075|NCT03398148|473781700|FG005|Substudy 1 Period 1|Other|0|||
131588076|NCT03398148|473781701|FG006|Substudy 1 Period 1|Other|0|||
131588077|NCT03398148|473781702|FG007|Substudy 1 Period 1|Other|0|||
131588078|NCT03398148|473781703|FG008|Substudy 1 Period 1|Other|0|||
131588079|NCT03398148|473781704|FG009|Substudy 1 Period 1|Other|0|||
131588080|NCT03398148|473781705|FG010|Substudy 1 Period 1|Other|0|||
131588081|NCT03398148|473781706|FG011|Substudy 1 Period 1|Other|0|||
131588082|NCT03398148|473781707|FG012|Substudy 1 Period 1|Other|0|||
131588083|NCT03398148|473781708|FG013|Substudy 1 Period 1|Other|0|||
131588084|NCT03398148|473781709|FG014|Substudy 1 Period 1|Other|0|||
131588085|NCT03398148|473781695|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588086|NCT03398148|473781696|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588087|NCT03398148|473781697|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588088|NCT03398148|473781698|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588089|NCT03398148|473781699|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
131588090|NCT03398148|473781700|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588091|NCT03398148|473781701|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588092|NCT03398148|473781702|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588093|NCT03398148|473781703|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588094|NCT03398148|473781704|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588095|NCT03398148|473781705|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588096|NCT03398148|473781706|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588097|NCT03398148|473781707|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588098|NCT03398148|473781708|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588099|NCT03398148|473781709|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
131588100|NCT03398148|473781695|FG000|Substudy 1 Period 2|Adverse Event|0|||
131588101|NCT03398148|473781696|FG001|Substudy 1 Period 2|Adverse Event|0|||
131588102|NCT03398148|473781697|FG002|Substudy 1 Period 2|Adverse Event|0|||
131588103|NCT03398148|473781698|FG003|Substudy 1 Period 2|Adverse Event|0|||
131588104|NCT03398148|473781699|FG004|Substudy 1 Period 2|Adverse Event|0|||
131588105|NCT03398148|473781700|FG005|Substudy 1 Period 2|Adverse Event|2|||
131588106|NCT03398148|473781701|FG006|Substudy 1 Period 2|Adverse Event|4|||
131588107|NCT03398148|473781702|FG007|Substudy 1 Period 2|Adverse Event|0|||
131588108|NCT03398148|473781703|FG008|Substudy 1 Period 2|Adverse Event|0|||
131588109|NCT03398148|473781704|FG009|Substudy 1 Period 2|Adverse Event|0|||
131588110|NCT03398148|473781705|FG010|Substudy 1 Period 2|Adverse Event|0|||
131588111|NCT03398148|473781706|FG011|Substudy 1 Period 2|Adverse Event|0|||
131588112|NCT03398148|473781707|FG012|Substudy 1 Period 2|Adverse Event|0|||
131588113|NCT03398148|473781708|FG013|Substudy 1 Period 2|Adverse Event|0|||
131588114|NCT03398148|473781709|FG014|Substudy 1 Period 2|Adverse Event|0|||
131588115|NCT03398148|473781695|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588116|NCT03398148|473781696|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588117|NCT03398148|473781697|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588118|NCT03398148|473781698|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588119|NCT03398148|473781699|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588120|NCT03398148|473781700|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588121|NCT03398148|473781701|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
131588122|NCT03398148|473781702|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
131588123|NCT03398148|473781703|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588124|NCT03398148|473781704|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588125|NCT03398148|473781705|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588126|NCT03398148|473781706|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588127|NCT03398148|473781707|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588128|NCT03398148|473781708|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588129|NCT03398148|473781709|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131588130|NCT03398148|473781695|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
131588131|NCT03398148|473781696|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
131588132|NCT03398148|473781697|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
131588133|NCT03398148|473781698|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
131588134|NCT03398148|473781699|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
131588135|NCT03398148|473781700|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
131588136|NCT03398148|473781701|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
131588137|NCT03398148|473781702|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
131588138|NCT03398148|473781703|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
131588139|NCT03398148|473781704|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
131588140|NCT03398148|473781705|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
131588141|NCT03398148|473781706|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
131588142|NCT03398148|473781707|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
131588143|NCT03398148|473781708|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
131588144|NCT03398148|473781709|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
131588145|NCT03398148|473781695|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588146|NCT03398148|473781696|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588147|NCT03398148|473781697|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588148|NCT03398148|473781698|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131705353|NCT00236080|474203475|FG003|Overall Study|Miscellaneous|0|||
131705354|NCT00236080|474203476|FG004|Overall Study|Miscellaneous|0|||
131705355|NCT03882424|474203477|FG000|Overall Study|Lost to Follow-up|3|||
131705356|NCT03882424|474203478|FG001|Overall Study|Lost to Follow-up|0|||
131705357|NCT03882424|474203479|FG002|Overall Study|Lost to Follow-up|0|||
131705358|NCT03882424|474203477|FG000|Overall Study|schedule conflict|1|||
131588149|NCT03398148|473781699|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588150|NCT03398148|473781700|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131705359|NCT03882424|474203478|FG001|Overall Study|schedule conflict|0|||
131705360|NCT03882424|474203479|FG002|Overall Study|schedule conflict|0|||
131588151|NCT03398148|473781701|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
131588152|NCT03398148|473781702|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588153|NCT03398148|473781703|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588154|NCT03398148|473781704|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588155|NCT03398148|473781705|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588156|NCT03398148|473781706|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588157|NCT03398148|473781707|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588158|NCT03398148|473781708|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588159|NCT03398148|473781709|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588160|NCT03398148|473781695|FG000|Substudy 1 Period 2|Other|0|||
131588161|NCT03398148|473781696|FG001|Substudy 1 Period 2|Other|0|||
131588162|NCT03398148|473781697|FG002|Substudy 1 Period 2|Other|0|||
131588163|NCT03398148|473781698|FG003|Substudy 1 Period 2|Other|0|||
131588164|NCT03398148|473781699|FG004|Substudy 1 Period 2|Other|0|||
131588165|NCT03398148|473781700|FG005|Substudy 1 Period 2|Other|0|||
131588166|NCT03398148|473781701|FG006|Substudy 1 Period 2|Other|1|||
131588167|NCT03398148|473781702|FG007|Substudy 1 Period 2|Other|0|||
131588168|NCT03398148|473781703|FG008|Substudy 1 Period 2|Other|0|||
131588169|NCT03398148|473781704|FG009|Substudy 1 Period 2|Other|0|||
131588170|NCT03398148|473781705|FG010|Substudy 1 Period 2|Other|0|||
131588171|NCT03398148|473781706|FG011|Substudy 1 Period 2|Other|0|||
131588172|NCT03398148|473781707|FG012|Substudy 1 Period 2|Other|0|||
131588173|NCT03398148|473781708|FG013|Substudy 1 Period 2|Other|0|||
131588174|NCT03398148|473781709|FG014|Substudy 1 Period 2|Other|0|||
131588175|NCT03398148|473781695|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588176|NCT03398148|473781696|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588177|NCT03398148|473781697|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588178|NCT03398148|473781698|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588179|NCT03398148|473781699|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588180|NCT03398148|473781700|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588181|NCT03398148|473781701|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
131588182|NCT03398148|473781702|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588183|NCT03398148|473781703|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588184|NCT03398148|473781704|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588185|NCT03398148|473781705|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588186|NCT03398148|473781706|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588187|NCT03398148|473781707|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588188|NCT03398148|473781708|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588189|NCT03398148|473781709|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
131588190|NCT03398148|473781695|FG000|Substudy 2 Period 1|Adverse Event|0|||
131588191|NCT03398148|473781696|FG001|Substudy 2 Period 1|Adverse Event|0|||
131588192|NCT03398148|473781697|FG002|Substudy 2 Period 1|Adverse Event|0|||
131588193|NCT03398148|473781698|FG003|Substudy 2 Period 1|Adverse Event|0|||
131588194|NCT03398148|473781699|FG004|Substudy 2 Period 1|Adverse Event|0|||
131588195|NCT03398148|473781700|FG005|Substudy 2 Period 1|Adverse Event|0|||
131588196|NCT03398148|473781701|FG006|Substudy 2 Period 1|Adverse Event|0|||
131588197|NCT03398148|473781702|FG007|Substudy 2 Period 1|Adverse Event|0|||
131588198|NCT03398148|473781703|FG008|Substudy 2 Period 1|Adverse Event|0|||
131588199|NCT03398148|473781704|FG009|Substudy 2 Period 1|Adverse Event|12|||
131588200|NCT03398148|473781705|FG010|Substudy 2 Period 1|Adverse Event|2|||
131588201|NCT03398148|473781706|FG011|Substudy 2 Period 1|Adverse Event|0|||
131588202|NCT03398148|473781707|FG012|Substudy 2 Period 1|Adverse Event|0|||
131588203|NCT03398148|473781708|FG013|Substudy 2 Period 1|Adverse Event|0|||
131588204|NCT03398148|473781709|FG014|Substudy 2 Period 1|Adverse Event|0|||
131588205|NCT03398148|473781695|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588206|NCT03398148|473781696|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588207|NCT03398148|473781697|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588208|NCT03398148|473781698|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588209|NCT03398148|473781699|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588210|NCT03398148|473781700|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588211|NCT03398148|473781701|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588212|NCT03398148|473781702|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588213|NCT03398148|473781703|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588214|NCT03398148|473781704|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
131588215|NCT03398148|473781705|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
131588216|NCT03398148|473781706|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588217|NCT03398148|473781707|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588218|NCT03398148|473781708|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588219|NCT03398148|473781709|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131588220|NCT03398148|473781695|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
131588221|NCT03398148|473781696|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
131588222|NCT03398148|473781697|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
131588223|NCT03398148|473781698|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
131588224|NCT03398148|473781699|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
131588225|NCT03398148|473781700|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
131588226|NCT03398148|473781701|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
131588227|NCT03398148|473781702|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
131588228|NCT03398148|473781703|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
131588229|NCT03398148|473781704|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
131588230|NCT03398148|473781705|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
131588231|NCT03398148|473781706|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
131438868|NCT00435409|473233319|FG000|Overall Study|Withdrawal by Subject|8|||
131588232|NCT03398148|473781707|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
131588233|NCT03398148|473781708|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
131790742|NCT01381900|474516921|FG002|Overall Study|Withdrawal by Subject|1|||
131588234|NCT03398148|473781709|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
131588235|NCT03398148|473781695|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588236|NCT03398148|473781696|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588237|NCT03398148|473781697|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588238|NCT03398148|473781698|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588239|NCT03398148|473781699|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588240|NCT03398148|473781700|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588241|NCT03398148|473781701|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588242|NCT03398148|473781702|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588243|NCT03398148|473781703|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588244|NCT03398148|473781704|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588245|NCT03398148|473781705|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
131588246|NCT03398148|473781706|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588247|NCT03398148|473781707|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588248|NCT03398148|473781708|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588249|NCT03398148|473781709|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131588250|NCT03398148|473781695|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588251|NCT03398148|473781696|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588252|NCT03398148|473781697|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588253|NCT03398148|473781698|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588254|NCT03398148|473781699|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588255|NCT03398148|473781700|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588256|NCT03398148|473781701|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588257|NCT03398148|473781702|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588258|NCT03398148|473781703|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588259|NCT03398148|473781704|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588260|NCT03398148|473781705|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
131588261|NCT03398148|473781706|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588262|NCT03398148|473781707|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588263|NCT03398148|473781708|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588264|NCT03398148|473781709|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131588265|NCT03398148|473781695|FG000|Substudy 2 Period 1|Other|0|||
131588266|NCT03398148|473781696|FG001|Substudy 2 Period 1|Other|0|||
131588267|NCT03398148|473781697|FG002|Substudy 2 Period 1|Other|0|||
131588268|NCT03398148|473781698|FG003|Substudy 2 Period 1|Other|0|||
131588269|NCT03398148|473781699|FG004|Substudy 2 Period 1|Other|0|||
131588270|NCT03398148|473781700|FG005|Substudy 2 Period 1|Other|0|||
131588271|NCT03398148|473781701|FG006|Substudy 2 Period 1|Other|0|||
131588272|NCT03398148|473781702|FG007|Substudy 2 Period 1|Other|0|||
131588273|NCT03398148|473781703|FG008|Substudy 2 Period 1|Other|0|||
131588274|NCT03398148|473781704|FG009|Substudy 2 Period 1|Other|4|||
131588275|NCT03398148|473781705|FG010|Substudy 2 Period 1|Other|4|||
131588276|NCT03398148|473781706|FG011|Substudy 2 Period 1|Other|0|||
131588277|NCT03398148|473781707|FG012|Substudy 2 Period 1|Other|0|||
131588278|NCT03398148|473781708|FG013|Substudy 2 Period 1|Other|0|||
131588279|NCT03398148|473781709|FG014|Substudy 2 Period 1|Other|0|||
131588280|NCT03398148|473781695|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588281|NCT03398148|473781696|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588282|NCT03398148|473781697|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
131790743|NCT01381900|474516919|FG000|Overall Study|Early withdraw|3|||
131790744|NCT01381900|474516920|FG001|Overall Study|Early withdraw|1|||
131790745|NCT01381900|474516921|FG002|Overall Study|Early withdraw|1|||
131790746|NCT01165684|474516924|FG000|Overall Study|Adverse Event|1|||
131790747|NCT01165684|474516925|FG001|Overall Study|Adverse Event|1|||
131790748|NCT01165684|474516924|FG000|Overall Study|Lack of Efficacy|2|||
131790749|NCT01165684|474516925|FG001|Overall Study|Lack of Efficacy|1|||
131790750|NCT01165684|474516924|FG000|Overall Study|Protocol Violation|7|||
131790751|NCT01165684|474516925|FG001|Overall Study|Protocol Violation|15|||
131790752|NCT01165684|474516924|FG000|Overall Study|Withdrawal Criteria|2|||
131790753|NCT01165684|474516925|FG001|Overall Study|Withdrawal Criteria|13|||
131790754|NCT01165684|474516924|FG000|Overall Study|Unclassified|16|||
131790755|NCT01165684|474516925|FG001|Overall Study|Unclassified|22|||
131790756|NCT00671879|474516928|FG000|Overall Study|Withdrawal by Subject|0|||
131790757|NCT00671879|474516929|FG001|Overall Study|Withdrawal by Subject|4|||
131790758|NCT00671879|474516930|FG002|Overall Study|Withdrawal by Subject|6|||
131588283|NCT03398148|473781698|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
131790759|NCT04633837|474516931|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
131588284|NCT03398148|473781699|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588285|NCT03398148|473781700|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588286|NCT03398148|473781701|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588287|NCT03398148|473781702|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588288|NCT03398148|473781703|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
131790760|NCT04633837|474516932|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
131790761|NCT00901628|474516933|FG000|Overall Study|disconnection of catheter|4|||
131790762|NCT00901628|474516934|FG001|Overall Study|disconnection of catheter|8|||
131588289|NCT03398148|473781704|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588290|NCT03398148|473781705|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
131588291|NCT03398148|473781706|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588292|NCT03398148|473781707|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588293|NCT03398148|473781708|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588294|NCT03398148|473781709|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
131588295|NCT03398148|473781695|FG000|Substudy 2 Period 2|Adverse Event|0|||
131588296|NCT03398148|473781696|FG001|Substudy 2 Period 2|Adverse Event|0|||
131588297|NCT03398148|473781697|FG002|Substudy 2 Period 2|Adverse Event|0|||
131588298|NCT03398148|473781698|FG003|Substudy 2 Period 2|Adverse Event|0|||
131588299|NCT03398148|473781699|FG004|Substudy 2 Period 2|Adverse Event|0|||
131588300|NCT03398148|473781700|FG005|Substudy 2 Period 2|Adverse Event|0|||
131588301|NCT03398148|473781701|FG006|Substudy 2 Period 2|Adverse Event|0|||
131588302|NCT03398148|473781702|FG007|Substudy 2 Period 2|Adverse Event|0|||
131588303|NCT03398148|473781703|FG008|Substudy 2 Period 2|Adverse Event|0|||
131588304|NCT03398148|473781704|FG009|Substudy 2 Period 2|Adverse Event|0|||
131588305|NCT03398148|473781705|FG010|Substudy 2 Period 2|Adverse Event|0|||
131588306|NCT03398148|473781706|FG011|Substudy 2 Period 2|Adverse Event|0|||
131588307|NCT03398148|473781707|FG012|Substudy 2 Period 2|Adverse Event|0|||
131588308|NCT03398148|473781708|FG013|Substudy 2 Period 2|Adverse Event|1|||
131790763|NCT00901628|474516933|FG000|Overall Study|disconnection of drain|0|||
131588309|NCT03398148|473781709|FG014|Substudy 2 Period 2|Adverse Event|3|||
131588310|NCT03398148|473781695|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
131588311|NCT03398148|473781696|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
131588312|NCT03398148|473781697|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
131588313|NCT03398148|473781698|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
131588314|NCT03398148|473781699|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
131588315|NCT03398148|473781700|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
131588316|NCT03398148|473781701|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
131588317|NCT03398148|473781702|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
131588318|NCT03398148|473781703|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
131588319|NCT03398148|473781704|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
131588320|NCT03398148|473781705|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
131588321|NCT03398148|473781706|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
131588322|NCT03398148|473781707|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
131588323|NCT03398148|473781708|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
131588324|NCT03398148|473781709|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
131588325|NCT03398148|473781695|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588326|NCT03398148|473781696|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588327|NCT03398148|473781697|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588328|NCT03398148|473781698|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588329|NCT03398148|473781699|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588330|NCT03398148|473781700|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588331|NCT03398148|473781701|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588332|NCT03398148|473781702|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588333|NCT03398148|473781703|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588334|NCT03398148|473781704|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588335|NCT03398148|473781705|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588336|NCT03398148|473781706|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
131588337|NCT03398148|473781707|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131588338|NCT03398148|473781708|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
131588339|NCT03398148|473781709|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
131588340|NCT03398148|473781695|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
131588341|NCT03398148|473781696|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
131588342|NCT03398148|473781697|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
131588343|NCT03398148|473781698|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
131588344|NCT03398148|473781699|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
131588345|NCT03398148|473781700|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
131588346|NCT03398148|473781701|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
131588347|NCT03398148|473781702|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
131588348|NCT03398148|473781703|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
131588349|NCT03398148|473781704|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
131790764|NCT00901628|474516934|FG001|Overall Study|disconnection of drain|1|||
131790765|NCT00901628|474516933|FG000|Overall Study|peroneal nerve palsy|0|||
131588350|NCT03398148|473781705|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
131588351|NCT03398148|473781706|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
131588352|NCT03398148|473781707|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
131588353|NCT03398148|473781708|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
131588354|NCT03398148|473781709|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
131588355|NCT03398148|473781695|FG000|Substudy 2 Period 2|Other|0|||
131588356|NCT03398148|473781696|FG001|Substudy 2 Period 2|Other|0|||
131588357|NCT03398148|473781697|FG002|Substudy 2 Period 2|Other|0|||
131588358|NCT03398148|473781698|FG003|Substudy 2 Period 2|Other|0|||
131588359|NCT03398148|473781699|FG004|Substudy 2 Period 2|Other|0|||
131588360|NCT03398148|473781700|FG005|Substudy 2 Period 2|Other|0|||
131588361|NCT03398148|473781701|FG006|Substudy 2 Period 2|Other|0|||
131790766|NCT00901628|474516934|FG001|Overall Study|peroneal nerve palsy|1|||
131588362|NCT03398148|473781702|FG007|Substudy 2 Period 2|Other|0|||
131588363|NCT03398148|473781703|FG008|Substudy 2 Period 2|Other|0|||
131588364|NCT03398148|473781704|FG009|Substudy 2 Period 2|Other|0|||
131588365|NCT03398148|473781705|FG010|Substudy 2 Period 2|Other|0|||
131588366|NCT03398148|473781706|FG011|Substudy 2 Period 2|Other|0|||
131588367|NCT03398148|473781707|FG012|Substudy 2 Period 2|Other|0|||
131588368|NCT03398148|473781708|FG013|Substudy 2 Period 2|Other|1|||
131588369|NCT03398148|473781709|FG014|Substudy 2 Period 2|Other|1|||
131588370|NCT03398148|473781695|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588371|NCT03398148|473781696|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588372|NCT03398148|473781697|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588373|NCT03398148|473781698|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588374|NCT03398148|473781699|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588375|NCT03398148|473781700|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588376|NCT03398148|473781701|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588377|NCT03398148|473781702|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588378|NCT03398148|473781703|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588379|NCT03398148|473781704|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588380|NCT03398148|473781705|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588381|NCT03398148|473781706|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588382|NCT03398148|473781707|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
131588383|NCT03398148|473781708|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
131588384|NCT03398148|473781709|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
131588385|NCT04278586|473781710|FG000|Overall Study|Withdrawal by Subject|13|||
131588386|NCT04278586|473781711|FG001|Overall Study|Withdrawal by Subject|6|||
131588387|NCT04278586|473781710|FG000|Overall Study|Lost to Follow-up|37|||
131588388|NCT04278586|473781711|FG001|Overall Study|Lost to Follow-up|24|||
131588389|NCT05696080|473781718|FG000|Overall Study|Lost to Follow-up|2|||
131588390|NCT05696080|473781719|FG001|Overall Study|Lost to Follow-up|1|||
131588391|NCT05696080|473781718|FG000|Overall Study|Physician Decision|1|||
131588392|NCT05696080|473781719|FG001|Overall Study|Physician Decision|0|||
131588393|NCT05696080|473781718|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131790767|NCT01909466|474516942|FG000|Overall Study|Lost to Follow-up|5|||
131790768|NCT01909466|474516943|FG001|Overall Study|Lost to Follow-up|7|||
131790769|NCT01909466|474516942|FG000|Overall Study|Adverse Event|3|||
131790770|NCT01909466|474516943|FG001|Overall Study|Adverse Event|4|||
131790771|NCT01909466|474516942|FG000|Overall Study|Met Withdrawal Criteria|0|||
131790772|NCT01909466|474516943|FG001|Overall Study|Met Withdrawal Criteria|3|||
131790773|NCT01909466|474516942|FG000|Overall Study|Physician Decision|2|||
131790774|NCT01909466|474516943|FG001|Overall Study|Physician Decision|0|||
131790775|NCT01909466|474516942|FG000|Overall Study|Withdrawal by Subject|11|||
131790776|NCT01909466|474516943|FG001|Overall Study|Withdrawal by Subject|9|||
131790777|NCT01909466|474516942|FG000|Overall Study|Lack of Efficacy|1|||
131790778|NCT01909466|474516943|FG001|Overall Study|Lack of Efficacy|0|||
131790779|NCT01339910|474516944|FG000|Overall Study|Withdrawal by Subject|1|||
131790780|NCT01339910|474516945|FG001|Overall Study|Withdrawal by Subject|0|||
131790781|NCT01339910|474516944|FG000|Overall Study|Physician Decision|1|||
131790782|NCT01339910|474516945|FG001|Overall Study|Physician Decision|0|||
131790783|NCT01339910|474516944|FG000|Overall Study|Disease relapse|1|||
131790784|NCT01339910|474516945|FG001|Overall Study|Disease relapse|4|||
131790785|NCT01567306|474516947|FG000|Overall Study|Protocol Violation|2|||
131438869|NCT00435409|473233320|FG001|Overall Study|Withdrawal by Subject|7|||
131588394|NCT05696080|473781719|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131790786|NCT01567306|474516948|FG001|Overall Study|Protocol Violation|2|||
131790787|NCT01567306|474516949|FG002|Overall Study|Protocol Violation|0|||
131790788|NCT01567306|474516950|FG003|Overall Study|Protocol Violation|3|||
131790789|NCT01567306|474516951|FG004|Overall Study|Protocol Violation|1|||
131790790|NCT01567306|474516952|FG005|Overall Study|Protocol Violation|1|||
131790791|NCT01567306|474516947|FG000|Overall Study|Change site living|1|||
131438870|NCT00435409|473233321|FG002|Overall Study|Withdrawal by Subject|1|||
131790792|NCT01567306|474516948|FG001|Overall Study|Change site living|0|||
131588395|NCT05696080|473781718|FG000|Overall Study|Withdrawal by Subject|12|||
131588396|NCT05696080|473781719|FG001|Overall Study|Withdrawal by Subject|0|||
131588397|NCT05478525|473781720|FG000|Overall Study|Withdrawal by Subject|0|||
131790793|NCT01567306|474516949|FG002|Overall Study|Change site living|0|||
131438871|NCT00435409|473233319|FG000|Overall Study|Other|45|||
131898852|NCT01462630|474915390|FG000|Overall Study|Adverse Event|1|||
131438872|NCT00435409|473233320|FG001|Overall Study|Other|30|||
131438873|NCT00435409|473233321|FG002|Overall Study|Other|1|||
131438874|NCT00435409|473233319|FG000|Overall Study|Adverse Event|0|||
131438875|NCT00435409|473233320|FG001|Overall Study|Adverse Event|0|||
131438876|NCT00435409|473233321|FG002|Overall Study|Adverse Event|8|||
131438877|NCT00435409|473233319|FG000|Overall Study|Sponsor decision|0|||
131438878|NCT00435409|473233320|FG001|Overall Study|Sponsor decision|3|||
131438879|NCT00435409|473233321|FG002|Overall Study|Sponsor decision|0|||
131438880|NCT03661723|473233322|FG000|Overall Study|Disease Progression|4|||
131438881|NCT03661723|473233323|FG001|Overall Study|Disease Progression|24|||
131438882|NCT03661723|473233324|FG002|Overall Study|Disease Progression|4|||
131438883|NCT03661723|473233325|FG003|Overall Study|Disease Progression|19|||
131438884|NCT03661723|473233322|FG000|Overall Study|Withdrawal by Subject|1|||
131438885|NCT03661723|473233323|FG001|Overall Study|Withdrawal by Subject|0|||
131438886|NCT03661723|473233324|FG002|Overall Study|Withdrawal by Subject|2|||
131588398|NCT05478525|473781721|FG001|Overall Study|Withdrawal by Subject|1|||
131588399|NCT05478525|473781722|FG002|Overall Study|Withdrawal by Subject|2|||
131588400|NCT05478525|473781723|FG003|Overall Study|Withdrawal by Subject|0|||
131588401|NCT05478525|473781720|FG000|Overall Study|COVID-19 Infection|2|||
131588402|NCT05478525|473781721|FG001|Overall Study|COVID-19 Infection|0|||
131898853|NCT00970489|474915393|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
131898854|NCT00970489|474915394|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
131898855|NCT01841970|474915397|FG000|Overall Study|Withdrawal by Subject|1|||
131898856|NCT01841970|474915397|FG000|Overall Study|Physician Decision|2|||
131898857|NCT01841970|474915397|FG000|Overall Study|Lost to Follow-up|8|||
131898858|NCT02592447|474915398|FG000|Overall Study|Lost to Follow-up|1|||
131898859|NCT02592447|474915399|FG001|Overall Study|Lost to Follow-up|0|||
131898860|NCT02592447|474915398|FG000|Overall Study|Ineligible after randomization|1|||
131898861|NCT02592447|474915399|FG001|Overall Study|Ineligible after randomization|0|||
131898862|NCT02592447|474915398|FG000|Overall Study|Withdrawal by Subject|0|||
131898863|NCT02592447|474915399|FG001|Overall Study|Withdrawal by Subject|1|||
131898864|NCT01048541|474915408|FG000|Overall Study|Withdrawal by Subject|1|||
131898865|NCT01048541|474915409|FG001|Overall Study|Withdrawal by Subject|0|||
131898866|NCT00627497|474915410|FG000|Overall Study|Lost to Follow-up|1|||
131898867|NCT00627497|474915411|FG001|Overall Study|Lost to Follow-up|1|||
131898868|NCT00627497|474915412|FG002|Overall Study|Lost to Follow-up|0|||
131898869|NCT00627497|474915413|FG003|Overall Study|Lost to Follow-up|0|||
131898870|NCT00327717|474915414|FG000|Overall Study|Adverse Event|6|||
131588403|NCT05478525|473781722|FG002|Overall Study|COVID-19 Infection|1|||
131588404|NCT05478525|473781723|FG003|Overall Study|COVID-19 Infection|1|||
131588405|NCT02605837|473781727|FG000|Overall Study|Adverse Event|3|||
131588406|NCT02605837|473781728|FG001|Overall Study|Adverse Event|1|||
131588407|NCT02605837|473781727|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131588408|NCT02605837|473781728|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131588409|NCT02605837|473781727|FG000|Overall Study|Withdrawal by Subject|8|||
131588410|NCT02605837|473781728|FG001|Overall Study|Withdrawal by Subject|8|||
131588411|NCT02605837|473781727|FG000|Overall Study|Physician Decision|0|||
131588412|NCT02605837|473781728|FG001|Overall Study|Physician Decision|1|||
131588413|NCT02652260|473781729|FG000|Base Study|Pregnancy|0|||
131588414|NCT02652260|473781730|FG001|Base Study|Pregnancy|1|||
131898871|NCT00327717|474915415|FG001|Overall Study|Adverse Event|6|||
131898872|NCT00327717|474915414|FG000|Overall Study|Lack of Efficacy|0|||
131438887|NCT03661723|473233325|FG003|Overall Study|Withdrawal by Subject|4|||
131438888|NCT03661723|473233322|FG000|Overall Study|Physician Decision|1|||
131438889|NCT03661723|473233323|FG001|Overall Study|Physician Decision|0|||
131438890|NCT03661723|473233324|FG002|Overall Study|Physician Decision|0|||
131438891|NCT03661723|473233325|FG003|Overall Study|Physician Decision|0|||
131438892|NCT03661723|473233322|FG000|Overall Study|Clinical Deterioration|0|||
131588415|NCT02652260|473781729|FG000|Base Study|Withdrawal by Subject|0|||
131588416|NCT02652260|473781730|FG001|Base Study|Withdrawal by Subject|1|||
131588417|NCT02652260|473781729|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
131588418|NCT02652260|473781730|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
131588419|NCT02652260|473781729|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
131588420|NCT02652260|473781730|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
131588421|NCT02652260|473781729|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
131898873|NCT00327717|474915415|FG001|Overall Study|Lack of Efficacy|1|||
131898874|NCT00327717|474915414|FG000|Overall Study|Withdrawal by Subject|3|||
131898875|NCT00327717|474915415|FG001|Overall Study|Withdrawal by Subject|7|||
131438893|NCT03661723|473233323|FG001|Overall Study|Clinical Deterioration|0|||
131438894|NCT03661723|473233324|FG002|Overall Study|Clinical Deterioration|0|||
131588422|NCT02652260|473781730|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
131588423|NCT02652260|473781729|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
131588424|NCT02652260|473781730|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
131898876|NCT00571662|474915416|FG000|Overall Study|Withdrawal by Subject|2|||
131898877|NCT00571662|474915416|FG000|Overall Study|psychiatric instability|1|||
131438895|NCT03661723|473233325|FG003|Overall Study|Clinical Deterioration|1|||
131588425|NCT02652260|473781729|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
131588426|NCT02652260|473781730|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
131588427|NCT02652260|473781729|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
131588428|NCT02652260|473781730|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
131588429|NCT02652260|473781729|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
131588430|NCT02652260|473781730|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
131588431|NCT02652260|473781729|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
131588432|NCT02652260|473781730|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
131588433|NCT02652260|473781729|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
131588434|NCT02652260|473781730|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
131588435|NCT02652260|473781729|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
131588436|NCT02652260|473781730|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
131588437|NCT02652260|473781729|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
131588438|NCT02652260|473781730|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
131588439|NCT02652260|473781729|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
131588440|NCT02652260|473781730|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
131588441|NCT05104697|473781731|FG000|Overall Study|Withdrawal by Subject|0|||
131588442|NCT05104697|473781732|FG001|Overall Study|Withdrawal by Subject|1|||
131588443|NCT05056246|473781735|FG000|Overall Study|Adverse Event|0|||
131588444|NCT05056246|473781736|FG001|Overall Study|Adverse Event|0|||
131588445|NCT05056246|473781737|FG002|Overall Study|Adverse Event|0|||
131705361|NCT01214044|474203480|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
131705362|NCT01214044|474203480|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
131705363|NCT01214044|474203480|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
131705364|NCT01214044|474203480|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
131705365|NCT01214044|474203480|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
131705366|NCT01214044|474203480|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
131705367|NCT02772757|474203484|FG000|Overall Study|Withdrawal by Subject|1|||
131705368|NCT02772757|474203485|FG001|Overall Study|Withdrawal by Subject|0|||
131705369|NCT02772757|474203486|FG002|Overall Study|Withdrawal by Subject|1|||
131705370|NCT02772757|474203484|FG000|Overall Study|Protocol Violation|0|||
131705371|NCT02772757|474203485|FG001|Overall Study|Protocol Violation|0|||
131705372|NCT02772757|474203486|FG002|Overall Study|Protocol Violation|1|||
131705373|NCT02772757|474203484|FG000|Overall Study|Physician Decision|0|||
131705374|NCT02772757|474203485|FG001|Overall Study|Physician Decision|3|||
131705375|NCT02772757|474203486|FG002|Overall Study|Physician Decision|3|||
131705376|NCT04698525|474203489|FG000|Overall Study|Lost to Follow-up|1|||
131705377|NCT04698525|474203490|FG001|Overall Study|Lost to Follow-up|2|||
131705378|NCT04698525|474203489|FG000|Overall Study|Three suffered of Covid-19|2|||
131705379|NCT04698525|474203490|FG001|Overall Study|Three suffered of Covid-19|1|||
131705380|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Adverse Event|21|||
131705381|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Adverse Event|6|||
131705382|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
131705383|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
131705384|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
131705385|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
131705386|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
131705387|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
131705388|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Physician Decision|0|||
131705389|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Physician Decision|3|||
131705390|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
131705391|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
131705392|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
131705393|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
131705394|NCT00510276|474203492|FG000|Acute Double-Blind Phase|Subject Decision|26|||
131705395|NCT00510276|474203493|FG001|Acute Double-Blind Phase|Subject Decision|28|||
131438896|NCT03760029|473233326|FG000|Overall Study|Death|1|||
131705396|NCT00510276|474203492|FG000|Extension Open-Label Phase|Adverse Event|9|||
131705397|NCT00510276|474203493|FG001|Extension Open-Label Phase|Adverse Event|18|||
131790794|NCT01567306|474516950|FG003|Overall Study|Change site living|0|||
131438897|NCT03760029|473233327|FG001|Overall Study|Death|0|||
131588446|NCT05056246|473781738|FG003|Overall Study|Adverse Event|0|||
131588447|NCT05056246|473781739|FG004|Overall Study|Adverse Event|1|||
131790795|NCT01567306|474516951|FG004|Overall Study|Change site living|0|||
131790796|NCT01567306|474516952|FG005|Overall Study|Change site living|0|||
131790797|NCT01567306|474516947|FG000|Overall Study|Adverse Event|0|||
131438898|NCT03760029|473233328|FG002|Overall Study|Death|0|||
131588448|NCT05056246|473781735|FG000|Overall Study|Lost to Follow-up|0|||
131588449|NCT05056246|473781736|FG001|Overall Study|Lost to Follow-up|0|||
131588450|NCT05056246|473781737|FG002|Overall Study|Lost to Follow-up|0|||
131588451|NCT05056246|473781738|FG003|Overall Study|Lost to Follow-up|2|||
131588452|NCT05056246|473781739|FG004|Overall Study|Lost to Follow-up|0|||
131588453|NCT05056246|473781735|FG000|Overall Study|Withdrawal by Subject|0|||
131588454|NCT05056246|473781736|FG001|Overall Study|Withdrawal by Subject|1|||
131588455|NCT05056246|473781737|FG002|Overall Study|Withdrawal by Subject|0|||
131588456|NCT05056246|473781738|FG003|Overall Study|Withdrawal by Subject|0|||
131588457|NCT05056246|473781739|FG004|Overall Study|Withdrawal by Subject|0|||
131588458|NCT05057897|473781749|FG000|Overall Study|Site closure|2|||
131588459|NCT05057897|473781750|FG001|Overall Study|Site closure|2|||
131588460|NCT05057897|473781749|FG000|Overall Study|Death|1|||
131588461|NCT05057897|473781750|FG001|Overall Study|Death|0|||
131588462|NCT05307978|473781755|FG000|Overall Study|Lost to Follow-up|0|||
131588463|NCT05307978|473781756|FG001|Overall Study|Lost to Follow-up|1|||
131588464|NCT05307978|473781757|FG002|Overall Study|Lost to Follow-up|0|||
131588465|NCT05307978|473781758|FG003|Overall Study|Lost to Follow-up|4|||
131588466|NCT05307978|473781759|FG004|Overall Study|Lost to Follow-up|0|||
131588467|NCT05307978|473781760|FG005|Overall Study|Lost to Follow-up|0|||
131588468|NCT05307978|473781761|FG006|Overall Study|Lost to Follow-up|1|||
131588469|NCT03324984|473781762|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
131588470|NCT03324984|473781763|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
131588471|NCT05656911|473781764|FG000|Treatment Phase|Physician Decision|2|||
131588472|NCT05656911|473781765|FG001|Treatment Phase|Physician Decision|0|||
131588473|NCT05656911|473781764|FG000|Treatment Phase|Lack of Efficacy|6|||
131588474|NCT05656911|473781765|FG001|Treatment Phase|Lack of Efficacy|3|||
131588475|NCT05656911|473781764|FG000|Treatment Phase|Subject Decision|4|||
131588476|NCT05656911|473781765|FG001|Treatment Phase|Subject Decision|2|||
131588477|NCT05656911|473781764|FG000|Treatment Phase|Other Reasons|1|||
131588478|NCT05656911|473781765|FG001|Treatment Phase|Other Reasons|0|||
131588479|NCT05656911|473781764|FG000|Treatment Phase|Adverse Event|3|||
131790798|NCT01567306|474516948|FG001|Overall Study|Adverse Event|0|||
131790799|NCT01567306|474516949|FG002|Overall Study|Adverse Event|0|||
131790800|NCT01567306|474516950|FG003|Overall Study|Adverse Event|2|||
131790801|NCT01567306|474516951|FG004|Overall Study|Adverse Event|4|||
131790802|NCT01567306|474516952|FG005|Overall Study|Adverse Event|1|||
131790803|NCT01567306|474516947|FG000|Overall Study|Lost to Follow-up|0|||
131790804|NCT01567306|474516948|FG001|Overall Study|Lost to Follow-up|0|||
131790805|NCT01567306|474516949|FG002|Overall Study|Lost to Follow-up|0|||
131790806|NCT01567306|474516950|FG003|Overall Study|Lost to Follow-up|0|||
131790807|NCT01567306|474516951|FG004|Overall Study|Lost to Follow-up|2|||
131790808|NCT01567306|474516952|FG005|Overall Study|Lost to Follow-up|0|||
131790809|NCT01567306|474516947|FG000|Overall Study|Withdrawal by Subject|0|||
131790810|NCT01567306|474516948|FG001|Overall Study|Withdrawal by Subject|0|||
131790811|NCT01567306|474516949|FG002|Overall Study|Withdrawal by Subject|0|||
131790812|NCT01567306|474516950|FG003|Overall Study|Withdrawal by Subject|0|||
131790813|NCT01567306|474516951|FG004|Overall Study|Withdrawal by Subject|0|||
131790814|NCT01567306|474516952|FG005|Overall Study|Withdrawal by Subject|1|||
131790815|NCT02063698|474516955|FG000|Overall Study|did not complete booklet for days 2-8|1|||
131790816|NCT02063698|474516956|FG001|Overall Study|did not complete booklet for days 2-8|2|||
131790817|NCT01401478|474516957|FG000|Overall Study|Study drug not available|6|||
131438899|NCT03760029|473233326|FG000|Overall Study|Lost to Follow-up|0|||
131588480|NCT05656911|473781765|FG001|Treatment Phase|Adverse Event|1|||
131588481|NCT05656911|473781764|FG000|Follow-up Phase|Subject Decision|0|||
131790818|NCT01401478|474516957|FG000|Overall Study|Adverse Event|5|||
131790819|NCT01401478|474516957|FG000|Overall Study|Hyperphosphatemia|5|||
131588482|NCT05656911|473781765|FG001|Follow-up Phase|Subject Decision|1|||
131588483|NCT05656911|473781764|FG000|Follow-up Phase|Missing|1|||
131588484|NCT05656911|473781765|FG001|Follow-up Phase|Missing|0|||
131588485|NCT05075408|473781766|FG000|Overall Study|Withdrawal by Subject|5|||
131588486|NCT05075408|473781767|FG001|Overall Study|Withdrawal by Subject|3|||
131588487|NCT05075408|473781768|FG002|Overall Study|Withdrawal by Subject|4|||
131588488|NCT05075408|473781766|FG000|Overall Study|Adverse Event|5|||
131588489|NCT05075408|473781767|FG001|Overall Study|Adverse Event|7|||
131588490|NCT05075408|473781768|FG002|Overall Study|Adverse Event|8|||
131588491|NCT05075408|473781766|FG000|Overall Study|Protocol Violation|0|||
131588492|NCT05075408|473781767|FG001|Overall Study|Protocol Violation|1|||
131588493|NCT05075408|473781768|FG002|Overall Study|Protocol Violation|0|||
131588494|NCT05075408|473781766|FG000|Overall Study|Lost to Follow-up|2|||
131588495|NCT05075408|473781767|FG001|Overall Study|Lost to Follow-up|1|||
131588496|NCT05075408|473781768|FG002|Overall Study|Lost to Follow-up|1|||
131588497|NCT05075408|473781766|FG000|Overall Study|Physician Decision|1|||
131588498|NCT05075408|473781767|FG001|Overall Study|Physician Decision|0|||
131588499|NCT05075408|473781768|FG002|Overall Study|Physician Decision|0|||
131588500|NCT05075408|473781766|FG000|Overall Study|Other-unspecified|3|||
131588501|NCT05075408|473781767|FG001|Overall Study|Other-unspecified|2|||
131588502|NCT05075408|473781768|FG002|Overall Study|Other-unspecified|0|||
131588503|NCT02837510|473781769|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
131588504|NCT02837510|473781770|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
131588505|NCT02837510|473781769|FG000|Washout (2 Weeks)|Adverse Event|0|||
131588506|NCT02837510|473781770|FG001|Washout (2 Weeks)|Adverse Event|1|||
131790820|NCT01401478|474516957|FG000|Overall Study|Lost to Follow-up|5|||
131790821|NCT01401478|474516957|FG000|Overall Study|Kidney transplantation|3|||
131790822|NCT01401478|474516957|FG000|Overall Study|Withdrawal by Subject|3|||
131790823|NCT01401478|474516957|FG000|Overall Study|Blood samples not available|1|||
131790824|NCT01401478|474516957|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
131790825|NCT01401478|474516957|FG000|Overall Study|Low intact parathyroid hormone|1|||
131790826|NCT01401478|474516957|FG000|Overall Study|Serious adverse event|1|||
131790827|NCT01809314|474516958|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
131790828|NCT01809314|474516958|FG000|Overall Study|Adverse Event|6|||
131790829|NCT01809314|474516958|FG000|Overall Study|Insufficient Therapeutic Response|14|||
131790830|NCT01809314|474516958|FG000|Overall Study|Lost to Follow-up|724|||
131790831|NCT01684722|474516959|FG000|Overall Study|Lost to Follow-up|78|||
131790832|NCT01684722|474516960|FG001|Overall Study|Lost to Follow-up|56|||
131790833|NCT01684722|474516961|FG002|Overall Study|Lost to Follow-up|75|||
131790834|NCT01684722|474516962|FG003|Overall Study|Lost to Follow-up|89|||
131790835|NCT01684722|474516959|FG000|Overall Study|Death|19|||
131790836|NCT01684722|474516960|FG001|Overall Study|Death|21|||
131790837|NCT01684722|474516961|FG002|Overall Study|Death|19|||
131790838|NCT01684722|474516962|FG003|Overall Study|Death|21|||
131790839|NCT01814137|474516963|FG000|Overall Study|Adverse Event|0|||
131790840|NCT01814137|474516964|FG001|Overall Study|Adverse Event|1|||
131790841|NCT01814137|474516963|FG000|Overall Study|Withdrawal by Subject|2|||
131790842|NCT01814137|474516964|FG001|Overall Study|Withdrawal by Subject|2|||
131790843|NCT01814137|474516963|FG000|Overall Study|Physician Decision|1|||
131790844|NCT01814137|474516964|FG001|Overall Study|Physician Decision|1|||
131790845|NCT01814137|474516963|FG000|Overall Study|Unclassified|2|||
131790846|NCT01814137|474516964|FG001|Overall Study|Unclassified|1|||
131790847|NCT00219557|474516965|FG000|Phase 1|Lack of Efficacy|3|||
131790848|NCT00219557|474516966|FG001|Phase 1|Lack of Efficacy|0|||
131790849|NCT00219557|474516967|FG002|Phase 1|Lack of Efficacy|0|||
131790850|NCT00219557|474516965|FG000|Phase 1|Adverse Event|2|||
131790851|NCT00219557|474516966|FG001|Phase 1|Adverse Event|0|||
131790852|NCT00219557|474516967|FG002|Phase 1|Adverse Event|0|||
131790853|NCT00219557|474516965|FG000|Phase 1|Withdrawal by Subject|1|||
131790854|NCT00219557|474516966|FG001|Phase 1|Withdrawal by Subject|0|||
131790855|NCT00219557|474516967|FG002|Phase 1|Withdrawal by Subject|0|||
131790856|NCT00219557|474516965|FG000|Phase 1|Started chemotherapy at other institute|1|||
131790857|NCT00219557|474516966|FG001|Phase 1|Started chemotherapy at other institute|0|||
131790858|NCT00219557|474516967|FG002|Phase 1|Started chemotherapy at other institute|0|||
131790859|NCT00219557|474516965|FG000|Phase 2|Lack of Efficacy|0|||
131438900|NCT03760029|473233327|FG001|Overall Study|Lost to Follow-up|2|||
131588507|NCT02837510|473781769|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
131588508|NCT02837510|473781770|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
131588509|NCT02837510|473781769|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
131588510|NCT02837510|473781770|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
131790860|NCT00219557|474516966|FG001|Phase 2|Lack of Efficacy|21|||
131790861|NCT00219557|474516967|FG002|Phase 2|Lack of Efficacy|15|||
131790862|NCT00219557|474516965|FG000|Phase 2|Adverse Event|0|||
131790863|NCT00219557|474516966|FG001|Phase 2|Adverse Event|22|||
131790864|NCT00219557|474516967|FG002|Phase 2|Adverse Event|2|||
131790865|NCT00219557|474516965|FG000|Phase 2|Death|0|||
131790866|NCT00219557|474516966|FG001|Phase 2|Death|8|||
131790867|NCT00219557|474516967|FG002|Phase 2|Death|2|||
131790868|NCT00219557|474516965|FG000|Phase 2|Other|0|||
131588511|NCT02837510|473781769|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
131588512|NCT02837510|473781770|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
131588513|NCT02837510|473781769|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
131588514|NCT02837510|473781770|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
131588515|NCT05419505|473781771|FG000|Overall Study|Adverse Event|0|||
131588516|NCT05419505|473781772|FG001|Overall Study|Adverse Event|0|||
131588517|NCT05419505|473781773|FG002|Overall Study|Adverse Event|0|||
131588518|NCT05419505|473781774|FG003|Overall Study|Adverse Event|1|||
131588519|NCT05419505|473781775|FG004|Overall Study|Adverse Event|0|||
131588520|NCT05419505|473781776|FG005|Overall Study|Adverse Event|0|||
131588521|NCT05419505|473781777|FG006|Overall Study|Adverse Event|0|||
131588522|NCT05419505|473781778|FG007|Overall Study|Adverse Event|0|||
131588523|NCT05419505|473781771|FG000|Overall Study|Withdrawal by Subject|1|||
131588524|NCT05419505|473781772|FG001|Overall Study|Withdrawal by Subject|2|||
131588525|NCT05419505|473781773|FG002|Overall Study|Withdrawal by Subject|0|||
131588526|NCT05419505|473781774|FG003|Overall Study|Withdrawal by Subject|0|||
131588527|NCT05419505|473781775|FG004|Overall Study|Withdrawal by Subject|0|||
131588528|NCT05419505|473781776|FG005|Overall Study|Withdrawal by Subject|0|||
131588529|NCT05419505|473781777|FG006|Overall Study|Withdrawal by Subject|1|||
131588530|NCT05419505|473781778|FG007|Overall Study|Withdrawal by Subject|0|||
131588531|NCT05419505|473781771|FG000|Overall Study|Lost to Follow-up|2|||
131588532|NCT05419505|473781772|FG001|Overall Study|Lost to Follow-up|1|||
131588533|NCT05419505|473781773|FG002|Overall Study|Lost to Follow-up|0|||
131588534|NCT05419505|473781774|FG003|Overall Study|Lost to Follow-up|0|||
131588535|NCT05419505|473781775|FG004|Overall Study|Lost to Follow-up|1|||
131588536|NCT05419505|473781776|FG005|Overall Study|Lost to Follow-up|2|||
131588537|NCT05419505|473781777|FG006|Overall Study|Lost to Follow-up|0|||
131588538|NCT05419505|473781778|FG007|Overall Study|Lost to Follow-up|1|||
131588539|NCT02780388|473781781|FG000|Overall Study|Lost to Follow-up|0|||
131588540|NCT02780388|473781782|FG001|Overall Study|Lost to Follow-up|1|||
131588541|NCT02780388|473781783|FG002|Overall Study|Lost to Follow-up|0|||
131588542|NCT02780388|473781784|FG003|Overall Study|Lost to Follow-up|0|||
131588543|NCT02780388|473781785|FG004|Overall Study|Lost to Follow-up|0|||
131588544|NCT02780388|473781781|FG000|Overall Study|Withdrawal by Subject|1|||
131588545|NCT02780388|473781782|FG001|Overall Study|Withdrawal by Subject|1|||
131705398|NCT00510276|474203492|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
131705399|NCT00510276|474203493|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
131705400|NCT00510276|474203492|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
131705401|NCT00510276|474203493|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
131705402|NCT00510276|474203492|FG000|Extension Open-Label Phase|Physician Decision|2|||
131705403|NCT00510276|474203493|FG001|Extension Open-Label Phase|Physician Decision|3|||
131705404|NCT00510276|474203492|FG000|Extension Open-Label Phase|Protocol Violation|0|||
131705405|NCT00510276|474203493|FG001|Extension Open-Label Phase|Protocol Violation|1|||
131705406|NCT00510276|474203492|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
131705407|NCT00510276|474203493|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
131705408|NCT00510276|474203492|FG000|Extension Open-Label Phase|Subject Decision|7|||
131705409|NCT00510276|474203493|FG001|Extension Open-Label Phase|Subject Decision|9|||
131705410|NCT03486392|474203496|FG000|Overall Study|Lost to Follow-up|0|||
131705411|NCT03486392|474203497|FG001|Overall Study|Lost to Follow-up|0|||
131705412|NCT03486392|474203498|FG002|Overall Study|Lost to Follow-up|8|||
131705413|NCT03486392|474203499|FG003|Overall Study|Lost to Follow-up|5|||
131705414|NCT03486392|474203500|FG004|Overall Study|Lost to Follow-up|2|||
131705415|NCT03486392|474203496|FG000|Overall Study|Withdrawal by Subject|3|||
131705416|NCT03486392|474203497|FG001|Overall Study|Withdrawal by Subject|0|||
131705417|NCT03486392|474203498|FG002|Overall Study|Withdrawal by Subject|6|||
131705418|NCT03486392|474203499|FG003|Overall Study|Withdrawal by Subject|4|||
131705419|NCT03486392|474203500|FG004|Overall Study|Withdrawal by Subject|1|||
131705420|NCT03486392|474203496|FG000|Overall Study|Death|0|||
131705421|NCT03486392|474203497|FG001|Overall Study|Death|0|||
131705422|NCT03486392|474203498|FG002|Overall Study|Death|0|||
131790869|NCT00219557|474516966|FG001|Phase 2|Other|8|||
131790870|NCT00219557|474516967|FG002|Phase 2|Other|6|||
131588546|NCT02780388|473781783|FG002|Overall Study|Withdrawal by Subject|0|||
131588547|NCT02780388|473781784|FG003|Overall Study|Withdrawal by Subject|0|||
131588548|NCT02780388|473781785|FG004|Overall Study|Withdrawal by Subject|0|||
131588549|NCT05107401|473781786|FG000|Overall Study|Lost to Follow-up|13|||
131588550|NCT05107401|473781787|FG001|Overall Study|Lost to Follow-up|12|||
131588551|NCT02724956|473781797|FG000|Overall Study|Physician Decision|1|||
131588552|NCT02724956|473781798|FG001|Overall Study|Physician Decision|0|||
131588553|NCT02724956|473781797|FG000|Overall Study|Lack of Efficacy|0|||
131588554|NCT02724956|473781798|FG001|Overall Study|Lack of Efficacy|1|||
131705423|NCT03486392|474203499|FG003|Overall Study|Death|0|||
131705424|NCT03486392|474203500|FG004|Overall Study|Death|1|||
131705425|NCT00441792|474203501|FG000|Overall Study|Lost to Follow-up|0|||
131705426|NCT00441792|474203502|FG001|Overall Study|Lost to Follow-up|2|||
131705427|NCT00888355|474203509|FG000|Overall Study|Adverse Event|10|||
131705428|NCT00888355|474203510|FG001|Overall Study|Adverse Event|0|||
131705429|NCT00888355|474203511|FG002|Overall Study|Adverse Event|3|||
131588555|NCT02724956|473781797|FG000|Overall Study|Withdrawal by Subject|0|||
131588556|NCT02724956|473781798|FG001|Overall Study|Withdrawal by Subject|1|||
131588557|NCT02058108|473781799|FG000|Overall Study|Abnormal Laboratory Values|0|||
131588558|NCT02058108|473781800|FG001|Overall Study|Abnormal Laboratory Values|1|||
131588559|NCT02058108|473781799|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
131588560|NCT02058108|473781800|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131588561|NCT02058108|473781799|FG000|Overall Study|No longer requires study drug|0|||
131588562|NCT02058108|473781800|FG001|Overall Study|No longer requires study drug|1|||
131588563|NCT02058108|473781799|FG000|Overall Study|Withdrawal by Subject|1|||
131588564|NCT02058108|473781800|FG001|Overall Study|Withdrawal by Subject|0|||
131588565|NCT02058108|473781799|FG000|Overall Study|Administrative problems|3|||
131588566|NCT02058108|473781800|FG001|Overall Study|Administrative problems|3|||
131588567|NCT02058108|473781799|FG000|Overall Study|Protocol Violation|0|||
131588568|NCT02058108|473781800|FG001|Overall Study|Protocol Violation|1|||
131588569|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
131588570|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
131588571|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
131588572|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
131588573|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
131588574|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131588575|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131588576|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
131588577|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131588578|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131588579|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
131588580|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
131588581|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
131588582|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
131588583|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
131588584|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
131588585|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
131588586|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
131588587|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
131588588|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
131588589|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
131588590|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
131588591|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
131588592|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
131588593|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
131588594|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131588595|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131588596|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
131588597|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131588598|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131588599|NCT04759833|473781804|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131705430|NCT00888355|474203512|FG003|Overall Study|Adverse Event|3|||
131705431|NCT00888355|474203509|FG000|Overall Study|Lack of Efficacy|9|||
131705432|NCT00888355|474203510|FG001|Overall Study|Lack of Efficacy|2|||
131705433|NCT00888355|474203511|FG002|Overall Study|Lack of Efficacy|5|||
131705434|NCT00888355|474203512|FG003|Overall Study|Lack of Efficacy|2|||
131705435|NCT00888355|474203509|FG000|Overall Study|Lost to Follow-up|0|||
131705436|NCT00888355|474203510|FG001|Overall Study|Lost to Follow-up|2|||
131705437|NCT00888355|474203511|FG002|Overall Study|Lost to Follow-up|2|||
131705438|NCT00888355|474203512|FG003|Overall Study|Lost to Follow-up|0|||
131705439|NCT00888355|474203509|FG000|Overall Study|Protocol Violation|3|||
131705440|NCT00888355|474203510|FG001|Overall Study|Protocol Violation|2|||
131705441|NCT00888355|474203511|FG002|Overall Study|Protocol Violation|1|||
131705442|NCT00888355|474203512|FG003|Overall Study|Protocol Violation|2|||
131705443|NCT00888355|474203509|FG000|Overall Study|Withdrawal by Subject|0|||
131705444|NCT00888355|474203510|FG001|Overall Study|Withdrawal by Subject|3|||
131705445|NCT00888355|474203511|FG002|Overall Study|Withdrawal by Subject|1|||
131705446|NCT00888355|474203512|FG003|Overall Study|Withdrawal by Subject|3|||
131705447|NCT01360645|474203513|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
131705448|NCT01360645|474203514|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
131705449|NCT01360645|474203515|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
131898878|NCT00571662|474915416|FG000|Overall Study|Adverse Event|5|||
131898879|NCT03472521|474915417|FG000|Overall Study|Lost to Follow-up|3|||
131898880|NCT03472521|474915418|FG001|Overall Study|Lost to Follow-up|2|||
131898881|NCT03472521|474915417|FG000|Overall Study|Discontinued intervention|3|||
131898882|NCT03472521|474915418|FG001|Overall Study|Discontinued intervention|1|||
131898883|NCT00181883|474915423|FG000|Overall Study|Lack of Efficacy|2|||
131898884|NCT00181883|474915423|FG000|Overall Study|Treatment Limiting AEs|3|||
131898885|NCT00181883|474915423|FG000|Overall Study|Withdrawal by Subject|4|||
131898886|NCT00181883|474915423|FG000|Overall Study|Lost to Follow-up|1|||
131898887|NCT00765817|474915424|FG000|Overall Study|Adverse Event|13|||
131898888|NCT00765817|474915425|FG001|Overall Study|Adverse Event|1|||
131898889|NCT00765817|474915424|FG000|Overall Study|Death|0|||
131898890|NCT00765817|474915425|FG001|Overall Study|Death|1|||
131898891|NCT00765817|474915424|FG000|Overall Study|Entry criteria not met|2|||
131898892|NCT00765817|474915425|FG001|Overall Study|Entry criteria not met|2|||
131898893|NCT00765817|474915424|FG000|Overall Study|Loss of glucose control|0|||
131898894|NCT00765817|474915425|FG001|Overall Study|Loss of glucose control|2|||
131898895|NCT00765817|474915424|FG000|Overall Study|Lost to Follow-up|1|||
131898896|NCT00765817|474915425|FG001|Overall Study|Lost to Follow-up|3|||
131898897|NCT00765817|474915424|FG000|Overall Study|Physician Decision|2|||
131898898|NCT00765817|474915425|FG001|Overall Study|Physician Decision|1|||
131898899|NCT00765817|474915424|FG000|Overall Study|Protocol Violation|1|||
131898900|NCT00765817|474915425|FG001|Overall Study|Protocol Violation|1|||
131898901|NCT00765817|474915424|FG000|Overall Study|Subject decision|7|||
131898902|NCT00765817|474915425|FG001|Overall Study|Subject decision|11|||
131898903|NCT00103285|474917477|FG000|Induction|Adverse Event|14|||
131898904|NCT00103285|474917478|FG001|Induction|Adverse Event|0|||
131898905|NCT00103285|474917479|FG002|Induction|Adverse Event|0|||
131898906|NCT00103285|474917480|FG003|Induction|Adverse Event|0|||
131898907|NCT00103285|474917481|FG004|Induction|Adverse Event|0|||
131898908|NCT00103285|474917482|FG005|Induction|Adverse Event|0|||
131898909|NCT00103285|474917483|FG006|Induction|Adverse Event|0|||
131898910|NCT00103285|474917484|FG007|Induction|Adverse Event|0|||
131898911|NCT00103285|474917477|FG000|Induction|Death|24|||
131898912|NCT00103285|474917478|FG001|Induction|Death|0|||
131898913|NCT00103285|474917479|FG002|Induction|Death|0|||
131898914|NCT00103285|474917480|FG003|Induction|Death|0|||
131898915|NCT00103285|474917481|FG004|Induction|Death|0|||
131898916|NCT00103285|474917482|FG005|Induction|Death|0|||
131898917|NCT00103285|474917483|FG006|Induction|Death|0|||
131898918|NCT00103285|474917484|FG007|Induction|Death|0|||
131898919|NCT00103285|474917477|FG000|Induction|Physician Decision|103|||
131898920|NCT00103285|474917478|FG001|Induction|Physician Decision|0|||
131898921|NCT00103285|474917479|FG002|Induction|Physician Decision|0|||
131898922|NCT00103285|474917480|FG003|Induction|Physician Decision|0|||
131898923|NCT00103285|474917481|FG004|Induction|Physician Decision|0|||
131898924|NCT00103285|474917482|FG005|Induction|Physician Decision|0|||
131898925|NCT00103285|474917483|FG006|Induction|Physician Decision|0|||
131898926|NCT00103285|474917484|FG007|Induction|Physician Decision|0|||
131898927|NCT00103285|474917477|FG000|Induction|Withdrawal by Subject|1|||
131898928|NCT00103285|474917478|FG001|Induction|Withdrawal by Subject|0|||
131898929|NCT00103285|474917479|FG002|Induction|Withdrawal by Subject|0|||
131898930|NCT00103285|474917480|FG003|Induction|Withdrawal by Subject|0|||
131898931|NCT00103285|474917481|FG004|Induction|Withdrawal by Subject|0|||
131898932|NCT00103285|474917482|FG005|Induction|Withdrawal by Subject|0|||
131898933|NCT00103285|474917483|FG006|Induction|Withdrawal by Subject|0|||
131898934|NCT00103285|474917484|FG007|Induction|Withdrawal by Subject|0|||
131898935|NCT00103285|474917477|FG000|Induction|Ineligible|43|||
131898936|NCT00103285|474917478|FG001|Induction|Ineligible|0|||
131898937|NCT00103285|474917479|FG002|Induction|Ineligible|0|||
131898938|NCT00103285|474917480|FG003|Induction|Ineligible|0|||
131898939|NCT00103285|474917481|FG004|Induction|Ineligible|0|||
131898940|NCT00103285|474917482|FG005|Induction|Ineligible|0|||
131898941|NCT00103285|474917483|FG006|Induction|Ineligible|0|||
131898942|NCT00103285|474917484|FG007|Induction|Ineligible|0|||
131898943|NCT00103285|474917477|FG000|Induction|Refusal|906|||
131898944|NCT00103285|474917478|FG001|Induction|Refusal|0|||
131898945|NCT00103285|474917479|FG002|Induction|Refusal|0|||
131898946|NCT00103285|474917480|FG003|Induction|Refusal|0|||
131898947|NCT00103285|474917481|FG004|Induction|Refusal|0|||
131898948|NCT00103285|474917482|FG005|Induction|Refusal|0|||
131898949|NCT00103285|474917483|FG006|Induction|Refusal|0|||
131898950|NCT00103285|474917484|FG007|Induction|Refusal|0|||
131898951|NCT00103285|474917477|FG000|Induction|Other|258|||
131898952|NCT00103285|474917478|FG001|Induction|Other|0|||
131898953|NCT00103285|474917479|FG002|Induction|Other|0|||
131898954|NCT00103285|474917480|FG003|Induction|Other|0|||
131898955|NCT00103285|474917481|FG004|Induction|Other|0|||
131898956|NCT00103285|474917482|FG005|Induction|Other|0|||
131898957|NCT00103285|474917483|FG006|Induction|Other|0|||
131898958|NCT00103285|474917484|FG007|Induction|Other|0|||
131898959|NCT00103285|474917477|FG000|Response Assignment|Adverse Event|0|||
131898960|NCT00103285|474917478|FG001|Response Assignment|Adverse Event|8|||
131898961|NCT00103285|474917479|FG002|Response Assignment|Adverse Event|3|||
131898962|NCT00103285|474917480|FG003|Response Assignment|Adverse Event|2|||
131898963|NCT00103285|474917481|FG004|Response Assignment|Adverse Event|3|||
131898964|NCT00103285|474917482|FG005|Response Assignment|Adverse Event|1|||
131898965|NCT00103285|474917483|FG006|Response Assignment|Adverse Event|1|||
131898966|NCT00103285|474917484|FG007|Response Assignment|Adverse Event|2|||
131898967|NCT00103285|474917477|FG000|Response Assignment|Death|0|||
131898968|NCT00103285|474917478|FG001|Response Assignment|Death|5|||
131898969|NCT00103285|474917479|FG002|Response Assignment|Death|2|||
131898970|NCT00103285|474917480|FG003|Response Assignment|Death|2|||
131898971|NCT00103285|474917481|FG004|Response Assignment|Death|3|||
131898972|NCT00103285|474917482|FG005|Response Assignment|Death|1|||
131898973|NCT00103285|474917483|FG006|Response Assignment|Death|0|||
131898974|NCT00103285|474917484|FG007|Response Assignment|Death|8|||
131898975|NCT00103285|474917477|FG000|Response Assignment|Lost to Follow-up|0|||
131898976|NCT00103285|474917478|FG001|Response Assignment|Lost to Follow-up|9|||
131898977|NCT00103285|474917479|FG002|Response Assignment|Lost to Follow-up|5|||
131898978|NCT00103285|474917480|FG003|Response Assignment|Lost to Follow-up|5|||
131898979|NCT00103285|474917481|FG004|Response Assignment|Lost to Follow-up|1|||
131898980|NCT00103285|474917482|FG005|Response Assignment|Lost to Follow-up|2|||
131898981|NCT00103285|474917483|FG006|Response Assignment|Lost to Follow-up|2|||
131898982|NCT00103285|474917484|FG007|Response Assignment|Lost to Follow-up|5|||
131898983|NCT00103285|474917477|FG000|Response Assignment|Physician Decision|0|||
131898984|NCT00103285|474917478|FG001|Response Assignment|Physician Decision|13|||
131898985|NCT00103285|474917479|FG002|Response Assignment|Physician Decision|14|||
131898986|NCT00103285|474917480|FG003|Response Assignment|Physician Decision|9|||
131898987|NCT00103285|474917481|FG004|Response Assignment|Physician Decision|13|||
131898988|NCT00103285|474917482|FG005|Response Assignment|Physician Decision|7|||
131898989|NCT00103285|474917483|FG006|Response Assignment|Physician Decision|4|||
131898990|NCT00103285|474917484|FG007|Response Assignment|Physician Decision|35|||
131588600|NCT04759833|473781805|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
131588601|NCT04759833|473781806|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131588602|NCT04759833|473781807|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131588603|NCT04759833|473781808|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131588604|NCT04759833|473781804|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
131588605|NCT04759833|473781805|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
131588606|NCT04759833|473781806|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
131588607|NCT04759833|473781807|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
131588608|NCT04759833|473781808|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
131588609|NCT04759833|473781804|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
131588610|NCT04759833|473781805|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
131790871|NCT00219557|474516965|FG000|Phase 2|Withdrawal by Subject|0|||
131790872|NCT00219557|474516966|FG001|Phase 2|Withdrawal by Subject|9|||
131790873|NCT00219557|474516967|FG002|Phase 2|Withdrawal by Subject|5|||
131790874|NCT00219557|474516965|FG000|Phase 2|Treatment not received|0|||
131790875|NCT00219557|474516966|FG001|Phase 2|Treatment not received|1|||
131790876|NCT00219557|474516967|FG002|Phase 2|Treatment not received|3|||
131790877|NCT00863057|474516970|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
131790878|NCT00863057|474516971|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
131790879|NCT00863057|474516972|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
131790880|NCT00863057|474516973|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
131588611|NCT04759833|473781806|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
131588612|NCT04759833|473781807|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
131588613|NCT04759833|473781808|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
131588614|NCT04759833|473781804|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
131588615|NCT04759833|473781805|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
131588616|NCT04759833|473781806|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
131588617|NCT04759833|473781807|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
131588618|NCT04759833|473781808|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
131588619|NCT04759833|473781804|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
131588620|NCT04759833|473781805|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
131898991|NCT00103285|474917477|FG000|Response Assignment|Protocol Violation|0|||
131898992|NCT00103285|474917478|FG001|Response Assignment|Protocol Violation|2|||
131898993|NCT00103285|474917479|FG002|Response Assignment|Protocol Violation|0|||
131898994|NCT00103285|474917480|FG003|Response Assignment|Protocol Violation|0|||
131588621|NCT04759833|473781806|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
131898995|NCT00103285|474917481|FG004|Response Assignment|Protocol Violation|0|||
131898996|NCT00103285|474917482|FG005|Response Assignment|Protocol Violation|0|||
131588622|NCT04759833|473781807|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
131898997|NCT00103285|474917483|FG006|Response Assignment|Protocol Violation|0|||
131898998|NCT00103285|474917484|FG007|Response Assignment|Protocol Violation|0|||
131898999|NCT00103285|474917477|FG000|Response Assignment|Withdrawal by Subject|0|||
131899000|NCT00103285|474917478|FG001|Response Assignment|Withdrawal by Subject|4|||
131899001|NCT00103285|474917479|FG002|Response Assignment|Withdrawal by Subject|1|||
131790881|NCT00863057|474516970|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
131790882|NCT00863057|474516971|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
131790883|NCT00863057|474516972|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
131790884|NCT00863057|474516973|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
131790885|NCT00863057|474516970|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
131790886|NCT00863057|474516971|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
131790887|NCT00863057|474516972|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
131790888|NCT00863057|474516973|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
131790889|NCT00863057|474516970|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
131790890|NCT00863057|474516971|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
131790891|NCT00863057|474516972|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
131790892|NCT00863057|474516973|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
131790893|NCT01953783|474516980|FG000|Overall Study|Progressive disease|2|||
131790894|NCT00686920|474516981|FG000|Overall Study|Death|45|||
131790895|NCT00686920|474516982|FG001|Overall Study|Death|14|||
131790896|NCT00686920|474516981|FG000|Overall Study|Liver Transplant|23|||
131790897|NCT00686920|474516982|FG001|Overall Study|Liver Transplant|8|||
131790898|NCT00686920|474516981|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
131790899|NCT00686920|474516982|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
131790900|NCT00686920|474516981|FG000|Overall Study|Withdrawal by Subject|23|||
131790901|NCT00686920|474516982|FG001|Overall Study|Withdrawal by Subject|5|||
131790902|NCT00686920|474516981|FG000|Overall Study|Protocol Violation|2|||
131790903|NCT00686920|474516982|FG001|Overall Study|Protocol Violation|1|||
131790904|NCT00686920|474516981|FG000|Overall Study|Adverse Event|10|||
131790905|NCT00686920|474516982|FG001|Overall Study|Adverse Event|2|||
131790906|NCT00686920|474516981|FG000|Overall Study|Personal Reason|0|||
131790907|NCT00686920|474516982|FG001|Overall Study|Personal Reason|1|||
131790908|NCT00686920|474516981|FG000|Overall Study|Lost to Follow-up|15|||
131790909|NCT00686920|474516982|FG001|Overall Study|Lost to Follow-up|3|||
131790910|NCT00686920|474516981|FG000|Overall Study|Moved to Another State|1|||
131790911|NCT00686920|474516982|FG001|Overall Study|Moved to Another State|0|||
131790912|NCT00686920|474516981|FG000|Overall Study|Transferred to Nursing Home|1|||
131790913|NCT00686920|474516982|FG001|Overall Study|Transferred to Nursing Home|0|||
131790914|NCT00686920|474516981|FG000|Overall Study|Noncompliance|9|||
131790915|NCT00686920|474516982|FG001|Overall Study|Noncompliance|0|||
131790916|NCT00686920|474516981|FG000|Overall Study|Principal Investigator Decision|2|||
131790917|NCT00686920|474516982|FG001|Overall Study|Principal Investigator Decision|0|||
131790918|NCT00591253|474516985|FG000|Overall Study|Adverse Event|3|||
131790919|NCT00591253|474516986|FG001|Overall Study|Adverse Event|3|||
131790920|NCT00591253|474516987|FG002|Overall Study|Adverse Event|1|||
131790921|NCT00591253|474516985|FG000|Overall Study|Protocol Violation|2|||
131790922|NCT00591253|474516986|FG001|Overall Study|Protocol Violation|2|||
131790923|NCT00591253|474516987|FG002|Overall Study|Protocol Violation|2|||
131790924|NCT00591253|474516985|FG000|Overall Study|Lost to Follow-up|2|||
131790925|NCT00591253|474516986|FG001|Overall Study|Lost to Follow-up|4|||
131790926|NCT00591253|474516987|FG002|Overall Study|Lost to Follow-up|0|||
131588623|NCT04759833|473781808|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
131588624|NCT04759833|473781804|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
131588625|NCT04759833|473781805|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
131588626|NCT04759833|473781806|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
131588627|NCT04759833|473781807|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
131588628|NCT04759833|473781808|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
131588629|NCT04759833|473781804|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
131588630|NCT04759833|473781805|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
131588631|NCT04759833|473781806|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
131588632|NCT04759833|473781807|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
131588633|NCT04759833|473781808|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
131588634|NCT04711135|473781809|FG000|Overall Study|Physician Decision|0|||
131588635|NCT04711135|473781810|FG001|Overall Study|Physician Decision|1|||
131588636|NCT04711135|473781809|FG000|Overall Study|Ongoing treatment|0|||
131790927|NCT00591253|474516985|FG000|Overall Study|Withdrawal by Subject|1|||
131790928|NCT00591253|474516986|FG001|Overall Study|Withdrawal by Subject|7|||
131790929|NCT00591253|474516987|FG002|Overall Study|Withdrawal by Subject|6|||
131790930|NCT00591253|474516985|FG000|Overall Study|Lack of Efficacy|1|||
131790931|NCT00591253|474516986|FG001|Overall Study|Lack of Efficacy|0|||
131790932|NCT00591253|474516987|FG002|Overall Study|Lack of Efficacy|3|||
131790933|NCT00591253|474516985|FG000|Overall Study|Other|5|||
131790934|NCT00591253|474516986|FG001|Overall Study|Other|5|||
131790935|NCT00591253|474516987|FG002|Overall Study|Other|3|||
131790936|NCT03811249|474516988|FG000|Overall Study|Withdrawal by Subject|44|||
131588637|NCT04711135|473781810|FG001|Overall Study|Ongoing treatment|1|||
131588638|NCT00998881|473781813|FG000|Overall Study|Adverse Event|2|||
131588639|NCT00998881|473781814|FG001|Overall Study|Adverse Event|2|||
131588640|NCT00998881|473781813|FG000|Overall Study|Lack of Efficacy|1|||
131588641|NCT00998881|473781814|FG001|Overall Study|Lack of Efficacy|0|||
131588642|NCT00998881|473781813|FG000|Overall Study|Physician Decision|3|||
131588643|NCT00998881|473781814|FG001|Overall Study|Physician Decision|0|||
131588644|NCT00998881|473781813|FG000|Overall Study|Withdrawal by Subject|1|||
131588645|NCT00998881|473781814|FG001|Overall Study|Withdrawal by Subject|0|||
131588646|NCT00998881|473781813|FG000|Overall Study|Personal matter|1|||
131588647|NCT00998881|473781814|FG001|Overall Study|Personal matter|0|||
131588648|NCT00818246|473781815|FG000|Overall Study|Impossible to match pictures|5|||
131588649|NCT01121991|473781816|FG000|Overall Study|Lack of Ovarian Response|2|||
131588650|NCT01121991|473781816|FG000|Overall Study|No Oocytes Retrieved|3|||
131588651|NCT01121991|473781816|FG000|Overall Study|No Fertilization|1|||
131588652|NCT01619410|473781817|FG000|Overall Study|Lost to Follow-up|7|||
131588653|NCT01619410|473781818|FG001|Overall Study|Lost to Follow-up|4|||
131588654|NCT02462759|473781819|FG000|Part 1: Double Blind|Death|1|||
131588655|NCT02462759|473781820|FG001|Part 1: Double Blind|Death|0|||
131588656|NCT02462759|473781821|FG002|Part 1: Double Blind|Death|0|||
131588657|NCT02740231|473781822|FG000|Overall Study|Withdrawal by Subject|1|||
131588658|NCT02740231|473781823|FG001|Overall Study|Withdrawal by Subject|1|||
131588659|NCT02740231|473781824|FG002|Overall Study|Withdrawal by Subject|1|||
131588660|NCT02740231|473781825|FG003|Overall Study|Withdrawal by Subject|0|||
131588661|NCT02740231|473781822|FG000|Overall Study|Lack of Efficacy|0|||
131588662|NCT02740231|473781823|FG001|Overall Study|Lack of Efficacy|1|||
131588663|NCT02740231|473781824|FG002|Overall Study|Lack of Efficacy|0|||
131588664|NCT02740231|473781825|FG003|Overall Study|Lack of Efficacy|4|||
131588665|NCT02740231|473781822|FG000|Overall Study|Lost to Follow-up|1|||
131588666|NCT02740231|473781823|FG001|Overall Study|Lost to Follow-up|3|||
131588667|NCT02740231|473781824|FG002|Overall Study|Lost to Follow-up|0|||
131588668|NCT02740231|473781825|FG003|Overall Study|Lost to Follow-up|3|||
131588669|NCT02740231|473781822|FG000|Overall Study|Adverse Event|0|||
131588670|NCT02740231|473781823|FG001|Overall Study|Adverse Event|1|||
131588671|NCT02740231|473781824|FG002|Overall Study|Adverse Event|0|||
131588672|NCT02740231|473781825|FG003|Overall Study|Adverse Event|1|||
131588673|NCT01000480|473781826|FG000|Induction Phase|Adverse Event|2|||
131588674|NCT01000480|473781826|FG000|Induction Phase|Lost to Follow-up|1|||
131588675|NCT01000480|473781826|FG000|Induction Phase|Physician Decision|1|||
131588676|NCT01000480|473781826|FG000|Induction Phase|Entry Criteria Not Met|3|||
131588677|NCT01000480|473781826|FG000|Concurrent Therapy Phase|Adverse Event|4|||
131588678|NCT01000480|473781826|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
131588679|NCT01000480|473781826|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
131588680|NCT01000480|473781826|FG000|Concurrent Therapy Phase|Physician Decision|1|||
131588681|NCT04600752|473781827|FG000|Overall Study|Physician Decision|0|||
131588682|NCT04600752|473781828|FG001|Overall Study|Physician Decision|0|||
131705450|NCT01360645|474203516|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
131705451|NCT01360645|474203513|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
131705452|NCT01360645|474203514|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
131705453|NCT01360645|474203515|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
131705454|NCT01360645|474203516|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
131705455|NCT01360645|474203513|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
131705456|NCT01360645|474203514|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
131705457|NCT01360645|474203515|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
131705458|NCT01360645|474203516|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
131705459|NCT01360645|474203513|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
131705460|NCT01360645|474203514|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
131899002|NCT00103285|474917480|FG003|Response Assignment|Withdrawal by Subject|1|||
131588683|NCT04600752|473781829|FG002|Overall Study|Physician Decision|1|||
131588684|NCT04600752|473781827|FG000|Overall Study|Adverse Event|0|||
131588685|NCT04600752|473781828|FG001|Overall Study|Adverse Event|1|||
131588686|NCT04600752|473781829|FG002|Overall Study|Adverse Event|0|||
131588687|NCT04600752|473781827|FG000|Overall Study|Withdrawal by Subject|2|||
131588688|NCT04600752|473781828|FG001|Overall Study|Withdrawal by Subject|1|||
131588689|NCT04600752|473781829|FG002|Overall Study|Withdrawal by Subject|0|||
131588690|NCT04600752|473781827|FG000|Overall Study|Lack of Efficacy|1|||
131588691|NCT04600752|473781828|FG001|Overall Study|Lack of Efficacy|0|||
131588692|NCT04600752|473781829|FG002|Overall Study|Lack of Efficacy|0|||
131588693|NCT00999167|473781830|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
131588694|NCT00999167|473781831|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
131588695|NCT00999167|473781832|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
131588696|NCT00999167|473781830|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
131588697|NCT00999167|473781831|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
131588698|NCT00999167|473781832|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
131588699|NCT00999167|473781830|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
131588700|NCT00999167|473781831|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
131588701|NCT00999167|473781832|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
131588702|NCT00999167|473781830|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
131588703|NCT00999167|473781831|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
131588704|NCT00999167|473781832|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
131588705|NCT00999167|473781830|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
131588706|NCT00999167|473781831|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
131588707|NCT00999167|473781832|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
131588708|NCT00999167|473781830|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
131588709|NCT00999167|473781831|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
131588710|NCT00999167|473781832|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
131588711|NCT00999167|473781830|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
131588712|NCT00999167|473781831|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
131588713|NCT00999167|473781832|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
131588714|NCT00999167|473781830|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
131588715|NCT00999167|473781831|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
131588716|NCT00999167|473781832|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
131588717|NCT05052996|473781835|FG000|Overall Study|Still on study|0|||
131588718|NCT05052996|473781836|FG001|Overall Study|Still on study|0|||
131588719|NCT05052996|473781837|FG002|Overall Study|Still on study|47|||
131588720|NCT05052996|473781838|FG003|Overall Study|Still on study|44|||
131588721|NCT05052996|473781835|FG000|Overall Study|Cohort terminated by sponsor|21|||
131588722|NCT05052996|473781836|FG001|Overall Study|Cohort terminated by sponsor|12|||
131588723|NCT05052996|473781837|FG002|Overall Study|Cohort terminated by sponsor|0|||
131588724|NCT05052996|473781838|FG003|Overall Study|Cohort terminated by sponsor|0|||
131588725|NCT05052996|473781835|FG000|Overall Study|Withdrew consent|1|||
131588726|NCT05052996|473781836|FG001|Overall Study|Withdrew consent|0|||
131588727|NCT05052996|473781837|FG002|Overall Study|Withdrew consent|1|||
131588728|NCT05052996|473781838|FG003|Overall Study|Withdrew consent|2|||
131588729|NCT05052996|473781835|FG000|Overall Study|Lost to Follow-up|1|||
131588730|NCT05052996|473781836|FG001|Overall Study|Lost to Follow-up|0|||
131588731|NCT05052996|473781837|FG002|Overall Study|Lost to Follow-up|0|||
131588732|NCT05052996|473781838|FG003|Overall Study|Lost to Follow-up|2|||
131588733|NCT05052996|473781835|FG000|Overall Study|Adverse Event|0|||
131588734|NCT05052996|473781836|FG001|Overall Study|Adverse Event|0|||
131588735|NCT05052996|473781837|FG002|Overall Study|Adverse Event|2|||
131588736|NCT05052996|473781838|FG003|Overall Study|Adverse Event|0|||
131588737|NCT05052996|473781835|FG000|Overall Study|Randomized but never treated|0|||
131588738|NCT05052996|473781836|FG001|Overall Study|Randomized but never treated|0|||
131588739|NCT05052996|473781837|FG002|Overall Study|Randomized but never treated|1|||
131588740|NCT05052996|473781838|FG003|Overall Study|Randomized but never treated|1|||
131588741|NCT05052996|473781835|FG000|Overall Study|Protocol Violation|1|||
131588742|NCT05052996|473781836|FG001|Overall Study|Protocol Violation|0|||
131588743|NCT05052996|473781837|FG002|Overall Study|Protocol Violation|0|||
131790937|NCT03811249|474516988|FG000|Overall Study|Missed Visit|24|||
131790938|NCT01504867|474516989|FG000|Overall Study|Inclusion criteria not met|2|||
131790939|NCT01504867|474516990|FG001|Overall Study|Inclusion criteria not met|2|||
131790940|NCT01504867|474516989|FG000|Overall Study|Consent revoked|5|||
131790941|NCT01504867|474516990|FG001|Overall Study|Consent revoked|1|||
131790942|NCT01841359|474516991|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
131790943|NCT01841359|474516991|FG000|Overall Study|Concommitant medical issues|2|||
131790944|NCT01841359|474516991|FG000|Overall Study|Adverse Event|3|||
131790945|NCT01841359|474516991|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
131790946|NCT02168270|474516992|FG000|Overall Study|Lack of Efficacy|4|||
131790947|NCT03210259|474516996|FG000|12-Week Run-in Period|Adverse Event|1|||
131790948|NCT03210259|474516997|FG001|12-Week Run-in Period|Adverse Event|0|||
131790949|NCT03210259|474516998|FG002|12-Week Run-in Period|Adverse Event|0|||
131790950|NCT03210259|474516996|FG000|12-Week Run-in Period|Death|1|||
131790951|NCT03210259|474516997|FG001|12-Week Run-in Period|Death|0|||
131588744|NCT05052996|473781838|FG003|Overall Study|Protocol Violation|0|||
131588745|NCT00522951|473781839|FG000|Period 1|body motion|0|||
131588746|NCT00522951|473781840|FG001|Period 1|body motion|1|||
131588747|NCT00522951|473781839|FG000|Washout Period|Adverse Event|0|||
131790952|NCT03210259|474516998|FG002|12-Week Run-in Period|Death|0|||
131790953|NCT03210259|474516996|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
131588748|NCT00522951|473781840|FG001|Washout Period|Adverse Event|1|||
131588749|NCT00522951|473781839|FG000|Washout Period|Death|0|||
131588750|NCT00522951|473781840|FG001|Washout Period|Death|1|||
131588751|NCT00522951|473781839|FG000|Period 2|Withdrawal by Subject|1|||
131588752|NCT00522951|473781840|FG001|Period 2|Withdrawal by Subject|0|||
131588753|NCT00522951|473781839|FG000|Period 2|residual contrast medium|1|||
131588754|NCT00522951|473781840|FG001|Period 2|residual contrast medium|1|||
131588755|NCT03101930|473781841|FG000|Overall Study|Withdrawal by Subject|2|||
131588756|NCT03101930|473781842|FG001|Overall Study|Withdrawal by Subject|1|||
131588757|NCT03101930|473781843|FG002|Overall Study|Withdrawal by Subject|2|||
131588758|NCT00976495|473781844|FG000|Overall Study|Withdrawal by Subject|0|||
131588759|NCT00976495|473781845|FG001|Overall Study|Withdrawal by Subject|1|||
131588760|NCT00976495|473781846|FG002|Overall Study|Withdrawal by Subject|0|||
131588761|NCT02538341|473781847|FG000|Overall Study|Lost to Follow-up|51|||
131588762|NCT02538341|473781848|FG001|Overall Study|Lost to Follow-up|46|||
131588763|NCT02538341|473781847|FG000|Overall Study|Withdrawal by Subject|3|||
131588764|NCT02538341|473781848|FG001|Overall Study|Withdrawal by Subject|1|||
131588765|NCT02538341|473781847|FG000|Overall Study|Death|2|||
131588766|NCT02538341|473781848|FG001|Overall Study|Death|0|||
131588767|NCT00331136|473781849|FG000|Overall Study|Adverse Event|3|||
131588768|NCT00331136|473781850|FG001|Overall Study|Adverse Event|5|||
131705461|NCT01360645|474203515|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
131705462|NCT01360645|474203516|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
131705463|NCT01360645|474203513|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
131705464|NCT01360645|474203514|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
131705465|NCT01360645|474203515|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
131705466|NCT01360645|474203516|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
131705467|NCT01360645|474203513|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
131705468|NCT01360645|474203514|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
131705469|NCT01360645|474203515|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
131705470|NCT01360645|474203516|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
131705471|NCT01360645|474203513|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
131705472|NCT01360645|474203514|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
131705473|NCT01360645|474203515|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
131705474|NCT01360645|474203516|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
131705475|NCT01360645|474203513|FG000|Phase B (6 Weeks)|Adverse Event|0|||
131705476|NCT01360645|474203514|FG001|Phase B (6 Weeks)|Adverse Event|6|||
131705477|NCT01360645|474203515|FG002|Phase B (6 Weeks)|Adverse Event|0|||
131705478|NCT01360645|474203516|FG003|Phase B (6 Weeks)|Adverse Event|0|||
131705479|NCT01360645|474203513|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131705480|NCT01360645|474203514|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
131705481|NCT01360645|474203515|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
131705482|NCT01360645|474203516|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131705483|NCT01360645|474203513|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131705484|NCT01360645|474203514|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
131705485|NCT01360645|474203515|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
131705486|NCT01360645|474203516|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131705487|NCT01360645|474203513|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
131705488|NCT01360645|474203514|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
131705489|NCT01360645|474203515|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
131705490|NCT01360645|474203516|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
131705491|NCT01360645|474203513|FG000|Phase A+|Lost to Follow-up|0|||
131705492|NCT01360645|474203514|FG001|Phase A+|Lost to Follow-up|0|||
131705493|NCT01360645|474203515|FG002|Phase A+|Lost to Follow-up|0|||
131705494|NCT01360645|474203516|FG003|Phase A+|Lost to Follow-up|7|||
131705495|NCT01360645|474203513|FG000|Phase A+|Adverse Event|0|||
131705496|NCT01360645|474203514|FG001|Phase A+|Adverse Event|0|||
131705497|NCT01360645|474203515|FG002|Phase A+|Adverse Event|0|||
131705498|NCT01360645|474203516|FG003|Phase A+|Adverse Event|2|||
131705499|NCT01360645|474203513|FG000|Phase A+|Met Withdrawal Criteria|0|||
131705500|NCT01360645|474203514|FG001|Phase A+|Met Withdrawal Criteria|0|||
131705501|NCT01360645|474203515|FG002|Phase A+|Met Withdrawal Criteria|0|||
131438901|NCT03760029|473233328|FG002|Overall Study|Lost to Follow-up|1|||
131588769|NCT00331136|473781851|FG002|Overall Study|Adverse Event|0|||
131705502|NCT01360645|474203516|FG003|Phase A+|Met Withdrawal Criteria|4|||
131705503|NCT01360645|474203513|FG000|Phase A+|Physician Decision|0|||
131705504|NCT01360645|474203514|FG001|Phase A+|Physician Decision|0|||
131705505|NCT01360645|474203515|FG002|Phase A+|Physician Decision|0|||
131588770|NCT00331136|473781852|FG003|Overall Study|Adverse Event|1|||
131588771|NCT00331136|473781849|FG000|Overall Study|Withdrawal by Subject|0|||
131588772|NCT00331136|473781850|FG001|Overall Study|Withdrawal by Subject|1|||
131588773|NCT00331136|473781851|FG002|Overall Study|Withdrawal by Subject|0|||
131588774|NCT00331136|473781852|FG003|Overall Study|Withdrawal by Subject|0|||
131588775|NCT00331136|473781849|FG000|Overall Study|Lost to Follow-up|0|||
131588776|NCT00331136|473781850|FG001|Overall Study|Lost to Follow-up|1|||
131588777|NCT00331136|473781851|FG002|Overall Study|Lost to Follow-up|0|||
131588778|NCT00331136|473781852|FG003|Overall Study|Lost to Follow-up|0|||
131588779|NCT00331136|473781849|FG000|Overall Study|Protocol Violation|1|||
131588780|NCT00331136|473781850|FG001|Overall Study|Protocol Violation|0|||
131588781|NCT00331136|473781851|FG002|Overall Study|Protocol Violation|0|||
131588782|NCT00331136|473781852|FG003|Overall Study|Protocol Violation|0|||
131588783|NCT00331136|473781849|FG000|Overall Study|Not treated|1|||
131588784|NCT00331136|473781850|FG001|Overall Study|Not treated|0|||
131588785|NCT00331136|473781851|FG002|Overall Study|Not treated|0|||
131588786|NCT00331136|473781852|FG003|Overall Study|Not treated|0|||
131588787|NCT02321514|473781853|FG000|Overall Study|Death|15|||
131588788|NCT02321514|473781853|FG000|Overall Study|Missed Visit|7|||
131588789|NCT02321514|473781853|FG000|Overall Study|Study Exit|3|||
131588790|NCT03432858|473781858|FG000|Overall Study|Protocol Violation|2|||
131588791|NCT03432858|473781859|FG001|Overall Study|Protocol Violation|1|||
131588792|NCT03432858|473781860|FG002|Overall Study|Protocol Violation|9|||
131588793|NCT03432858|473781858|FG000|Overall Study|Withdrawal by Subject|0|||
131588794|NCT03432858|473781859|FG001|Overall Study|Withdrawal by Subject|1|||
131588795|NCT03432858|473781860|FG002|Overall Study|Withdrawal by Subject|1|||
131588796|NCT03432858|473781858|FG000|Overall Study|Procedure canceled/rescheduled|0|||
131588797|NCT03432858|473781859|FG001|Overall Study|Procedure canceled/rescheduled|9|||
131588798|NCT03432858|473781860|FG002|Overall Study|Procedure canceled/rescheduled|6|||
131588799|NCT03432858|473781858|FG000|Overall Study|Required postop mobilization with splinting|0|||
131588800|NCT03432858|473781859|FG001|Overall Study|Required postop mobilization with splinting|0|||
131588801|NCT03432858|473781860|FG002|Overall Study|Required postop mobilization with splinting|1|||
131588802|NCT04402294|473781861|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
131588803|NCT04402294|473781862|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
131588804|NCT04402294|473781861|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
131588805|NCT04402294|473781862|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
131588806|NCT01216176|473784016|FG000|Overall Study|Adverse Event|0|||
131588807|NCT01216176|473784017|FG001|Overall Study|Adverse Event|8|||
131588808|NCT01216176|473784018|FG002|Overall Study|Adverse Event|0|||
131588809|NCT01216176|473784016|FG000|Overall Study|Physician Decision|0|||
131588810|NCT01216176|473784017|FG001|Overall Study|Physician Decision|0|||
131588811|NCT01216176|473784018|FG002|Overall Study|Physician Decision|1|||
131588812|NCT03481660|473784021|FG000|Overall Study|Adverse Event|5|||
131588813|NCT03481660|473784022|FG001|Overall Study|Adverse Event|4|||
131588814|NCT03481660|473784021|FG000|Overall Study|Death|13|||
131588815|NCT03481660|473784022|FG001|Overall Study|Death|9|||
131705506|NCT01360645|474203516|FG003|Phase A+|Physician Decision|2|||
131705507|NCT01360645|474203513|FG000|Phase A+|Withdrawal by Subject|0|||
131705508|NCT01360645|474203514|FG001|Phase A+|Withdrawal by Subject|0|||
131705509|NCT01360645|474203515|FG002|Phase A+|Withdrawal by Subject|0|||
131705510|NCT01360645|474203516|FG003|Phase A+|Withdrawal by Subject|5|||
131705511|NCT01360645|474203513|FG000|Phase A+|Protocol Deviation|0|||
131705512|NCT01360645|474203514|FG001|Phase A+|Protocol Deviation|0|||
131705513|NCT01360645|474203515|FG002|Phase A+|Protocol Deviation|0|||
131705514|NCT01360645|474203516|FG003|Phase A+|Protocol Deviation|4|||
131705515|NCT02251912|474203517|FG000|Overall Study|Withdrawal by Subject|2|||
131705516|NCT02251912|474203518|FG001|Overall Study|Withdrawal by Subject|3|||
131705517|NCT02251912|474203517|FG000|Overall Study|Adverse Event|0|||
131705518|NCT02251912|474203518|FG001|Overall Study|Adverse Event|2|||
131705519|NCT01818726|474203519|FG000|Overall Study|Administrative reasons|5|||
131705520|NCT01818726|474203520|FG001|Overall Study|Administrative reasons|1|||
131705521|NCT01818726|474203519|FG000|Overall Study|Withdrawal by Subject|0|||
131705522|NCT01818726|474203520|FG001|Overall Study|Withdrawal by Subject|1|||
131705523|NCT01818726|474203519|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
131705524|NCT01818726|474203520|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
131705525|NCT03336502|474203521|FG000|Overall Study|Physician Decision|0|||
131705526|NCT03336502|474203522|FG001|Overall Study|Physician Decision|1|||
131705527|NCT03336502|474203521|FG000|Overall Study|Prohibited Drugs|1|||
131705528|NCT03336502|474203522|FG001|Overall Study|Prohibited Drugs|1|||
131705529|NCT03336502|474203521|FG000|Overall Study|Death|1|||
131705530|NCT03336502|474203522|FG001|Overall Study|Death|2|||
131705531|NCT03336502|474203521|FG000|Overall Study|Adverse Event|2|||
131705532|NCT03336502|474203522|FG001|Overall Study|Adverse Event|5|||
131705533|NCT00480857|474203523|FG000|Overall Study|Lack of Efficacy|2|||
131705534|NCT00611247|474203524|FG000|Overall Study|Death|1|||
131705535|NCT00611247|474203525|FG001|Overall Study|Death|5|||
131705536|NCT00611247|474203524|FG000|Overall Study|Lack of Efficacy|1|||
131588816|NCT03481660|473784021|FG000|Overall Study|Lost to Follow-up|2|||
131588817|NCT03481660|473784022|FG001|Overall Study|Lost to Follow-up|2|||
131588818|NCT03481660|473784021|FG000|Overall Study|Physician Decision|2|||
131588819|NCT03481660|473784022|FG001|Overall Study|Physician Decision|3|||
131588820|NCT03481660|473784021|FG000|Overall Study|Withdrawal by Subject|14|||
131588821|NCT03481660|473784022|FG001|Overall Study|Withdrawal by Subject|7|||
131588822|NCT01259401|473784023|FG000|4-month Follow-up|Death|0|||
131588823|NCT01259401|473784024|FG001|4-month Follow-up|Death|1|||
131588824|NCT01259401|473784023|FG000|4-month Follow-up|Lost to Follow-up|0|||
131588825|NCT01259401|473784024|FG001|4-month Follow-up|Lost to Follow-up|1|||
131588826|NCT00212355|473784025|FG000|Overall Study|Adverse Event|1|||
131588827|NCT00212355|473784025|FG000|Overall Study|Withdrawal by Subject|1|||
131588828|NCT00212355|473784025|FG000|Overall Study|A change of address|1|||
131588829|NCT00186992|473784029|FG000|Overall Study|Withdrawal by Subject|5|||
131588830|NCT00186992|473784029|FG000|Overall Study|Physician's discretion|13|||
131588831|NCT00186992|473784029|FG000|Overall Study|PI Discretion|4|||
131588832|NCT00186992|473784029|FG000|Overall Study|Ineligible|2|||
131588833|NCT00186992|473784029|FG000|Overall Study|Lost to Follow-up|2|||
131588834|NCT00186992|473784029|FG000|Overall Study|Still on Study|9|||
131588835|NCT03683069|473784030|FG000|Overall Study|see limitations|12|||
131588836|NCT03683069|473784031|FG001|Overall Study|see limitations|13|||
131588837|NCT03954184|473784034|FG000|Overall Study|Lost to Follow-up|500|||
131588838|NCT03954184|473784035|FG001|Overall Study|Lost to Follow-up|0|||
131588839|NCT03398200|473784036|FG000|Overall Study|Withdrawal by Subject|0|||
131588840|NCT03398200|473784037|FG001|Overall Study|Withdrawal by Subject|1|||
131588841|NCT04941287|473784038|FG000|Overall Study|Rapid decline before starting treatment|3|||
131588842|NCT04941287|473784039|FG001|Overall Study|Rapid decline before starting treatment|1|||
131588843|NCT01649271|473784040|FG000|Overall Study|Progressive disease|4|||
131588844|NCT01649271|473784041|FG001|Overall Study|Progressive disease|5|||
131588845|NCT01649271|473784040|FG000|Overall Study|Other Adverse Event|0|||
131588846|NCT01649271|473784041|FG001|Overall Study|Other Adverse Event|2|||
131588847|NCT01649271|473784040|FG000|Overall Study|Withdrawal by Subject|1|||
131588848|NCT01649271|473784041|FG001|Overall Study|Withdrawal by Subject|0|||
131588849|NCT01649271|473784040|FG000|Overall Study|Other than stated above|1|||
131588850|NCT01649271|473784041|FG001|Overall Study|Other than stated above|0|||
131588851|NCT05644002|473784042|FG000|Overall Study|Lost to Follow-up|1|||
131588852|NCT05644002|473784043|FG001|Overall Study|Lost to Follow-up|2|||
131588853|NCT05644002|473784042|FG000|Overall Study|Withdrawal by Subject|0|||
131588854|NCT05644002|473784043|FG001|Overall Study|Withdrawal by Subject|1|||
131588855|NCT04842500|473784044|FG000|Overall Study|Withdrawal by Subject|4|||
131588856|NCT04842500|473784045|FG001|Overall Study|Withdrawal by Subject|1|||
131588857|NCT04842500|473784046|FG002|Overall Study|Withdrawal by Subject|2|||
131588858|NCT04842500|473784047|FG003|Overall Study|Withdrawal by Subject|3|||
131588859|NCT04842500|473784044|FG000|Overall Study|Protocol Violation|1|||
131588860|NCT04842500|473784045|FG001|Overall Study|Protocol Violation|0|||
131588861|NCT04842500|473784046|FG002|Overall Study|Protocol Violation|0|||
131588862|NCT04842500|473784047|FG003|Overall Study|Protocol Violation|1|||
131588863|NCT05756075|473784050|FG000|Overall Study|Withdrawal by Subject|16|||
131588864|NCT05756075|473784051|FG001|Overall Study|Withdrawal by Subject|9|||
131588865|NCT03821844|473784052|FG000|Overall Study|Death|37|||
131588866|NCT03821844|473784053|FG001|Overall Study|Death|31|||
131588867|NCT03821844|473784052|FG000|Overall Study|Discharged|10|||
131588868|NCT03821844|473784053|FG001|Overall Study|Discharged|14|||
131588869|NCT03821844|473784052|FG000|Overall Study|Not present in facility at followup|2|||
131588870|NCT03821844|473784053|FG001|Overall Study|Not present in facility at followup|3|||
131588871|NCT04065048|473784054|FG000|Overall Study|Withdrawal by Subject|1|||
131588872|NCT04065048|473784055|FG001|Overall Study|Withdrawal by Subject|2|||
131588873|NCT04065048|473784056|FG002|Overall Study|Withdrawal by Subject|1|||
131588874|NCT04065048|473784057|FG003|Overall Study|Withdrawal by Subject|1|||
131588875|NCT04065048|473784054|FG000|Overall Study|Adverse Event|1|||
131588876|NCT04065048|473784055|FG001|Overall Study|Adverse Event|0|||
131588877|NCT04065048|473784056|FG002|Overall Study|Adverse Event|1|||
131588878|NCT04065048|473784057|FG003|Overall Study|Adverse Event|0|||
131705537|NCT00611247|474203525|FG001|Overall Study|Lack of Efficacy|16|||
131705538|NCT01948830|474203526|FG000|Overall Study|Physician Decision|1|||
131588879|NCT03845465|473784060|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
131588880|NCT03845465|473784061|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
131588881|NCT03845465|473784060|FG000|6-month Data Collection|Withdrawal by Subject|0|||
131588882|NCT03845465|473784061|FG001|6-month Data Collection|Withdrawal by Subject|2|||
131588883|NCT03845465|473784060|FG000|12-month Data Collection|Withdrawal by Subject|0|||
131705539|NCT01948830|474203527|FG001|Overall Study|Physician Decision|3|||
131588884|NCT03845465|473784061|FG001|12-month Data Collection|Withdrawal by Subject|2|||
131588885|NCT03899961|473784062|FG000|Overall Study|-delivery prior to|2|||
131705540|NCT01948830|474203526|FG000|Overall Study|Protocol deviation|1|||
131705541|NCT01948830|474203527|FG001|Overall Study|Protocol deviation|2|||
131705542|NCT01948830|474203526|FG000|Overall Study|Lost to Follow-up|5|||
131705543|NCT01948830|474203527|FG001|Overall Study|Lost to Follow-up|4|||
131705544|NCT01948830|474203526|FG000|Overall Study|Withdrawal by Subject|14|||
131588886|NCT03899961|473784063|FG001|Overall Study|-delivery prior to|7|||
131588887|NCT03899961|473784062|FG000|Overall Study|req general anesth|1|||
131588888|NCT03899961|473784063|FG001|Overall Study|req general anesth|2|||
131588889|NCT03899961|473784062|FG000|Overall Study|capacity|5|||
131588890|NCT03899961|473784063|FG001|Overall Study|capacity|6|||
131588891|NCT03899961|473784062|FG000|Overall Study|Withdrawal by Subject|1|||
131588892|NCT03899961|473784063|FG001|Overall Study|Withdrawal by Subject|1|||
131588893|NCT04527146|473784064|FG000|Overall Study|Withdrawal by Subject|12|||
131588894|NCT04527146|473784065|FG001|Overall Study|Withdrawal by Subject|15|||
131588895|NCT04527146|473784066|FG002|Overall Study|Withdrawal by Subject|7|||
131588896|NCT04527146|473784067|FG003|Overall Study|Withdrawal by Subject|16|||
131588897|NCT04527146|473784064|FG000|Overall Study|Lost to Follow-up|13|||
131588898|NCT04527146|473784065|FG001|Overall Study|Lost to Follow-up|9|||
131588899|NCT04527146|473784066|FG002|Overall Study|Lost to Follow-up|16|||
131588900|NCT04527146|473784067|FG003|Overall Study|Lost to Follow-up|13|||
131588901|NCT04527146|473784064|FG000|Overall Study|Death|0|||
131588902|NCT04527146|473784065|FG001|Overall Study|Death|1|||
131588903|NCT04527146|473784066|FG002|Overall Study|Death|1|||
131588904|NCT04527146|473784067|FG003|Overall Study|Death|0|||
131588905|NCT04527146|473784064|FG000|Overall Study|Adverse Event|0|||
131588906|NCT04527146|473784065|FG001|Overall Study|Adverse Event|0|||
131588907|NCT04527146|473784066|FG002|Overall Study|Adverse Event|1|||
131588908|NCT04527146|473784067|FG003|Overall Study|Adverse Event|0|||
131588909|NCT04527146|473784064|FG000|Overall Study|Ineligible after randomization|2|||
131588910|NCT04527146|473784065|FG001|Overall Study|Ineligible after randomization|0|||
131588911|NCT04527146|473784066|FG002|Overall Study|Ineligible after randomization|2|||
131588912|NCT04527146|473784067|FG003|Overall Study|Ineligible after randomization|2|||
131588913|NCT04527146|473784064|FG000|Overall Study|Moved to a different group|6|||
131588914|NCT04527146|473784065|FG001|Overall Study|Moved to a different group|3|||
131588915|NCT04527146|473784066|FG002|Overall Study|Moved to a different group|0|||
131588916|NCT04527146|473784067|FG003|Overall Study|Moved to a different group|2|||
131588917|NCT04468776|473784073|FG000|Overall Study|Lost to Follow-up|4|||
131588918|NCT04468776|473784074|FG001|Overall Study|Lost to Follow-up|3|||
131588919|NCT04468776|473784075|FG002|Overall Study|Lost to Follow-up|4|||
131588920|NCT04468776|473784073|FG000|Overall Study|Withdrawal by Subject|1|||
131588921|NCT04468776|473784074|FG001|Overall Study|Withdrawal by Subject|10|||
131588922|NCT04468776|473784075|FG002|Overall Study|Withdrawal by Subject|4|||
131588923|NCT04468776|473784073|FG000|Overall Study|Physician Decision|0|||
131588924|NCT04468776|473784074|FG001|Overall Study|Physician Decision|1|||
131588925|NCT04468776|473784075|FG002|Overall Study|Physician Decision|1|||
131588926|NCT05687903|473784076|FG000|Overall Study|Protocol Deviation|1|||
131588927|NCT05687903|473784077|FG001|Overall Study|Protocol Deviation|1|||
131588928|NCT05687903|473784078|FG002|Overall Study|Protocol Deviation|0|||
131588929|NCT05687903|473784079|FG003|Overall Study|Protocol Deviation|1|||
131588930|NCT05687903|473784080|FG004|Overall Study|Protocol Deviation|0|||
131588931|NCT05613205|473784081|FG000|Overall Study|Lost to Follow-up|0|||
131588932|NCT05613205|473784082|FG001|Overall Study|Lost to Follow-up|0|||
131588933|NCT05613205|473784083|FG002|Overall Study|Lost to Follow-up|1|||
131588934|NCT05613205|473784084|FG003|Overall Study|Lost to Follow-up|1|||
131588935|NCT05613205|473784085|FG004|Overall Study|Lost to Follow-up|0|||
131588936|NCT05613205|473784081|FG000|Overall Study|Withdrawal by Subject|0|||
131588937|NCT05613205|473784082|FG001|Overall Study|Withdrawal by Subject|0|||
131588938|NCT05613205|473784083|FG002|Overall Study|Withdrawal by Subject|1|||
131588939|NCT05613205|473784084|FG003|Overall Study|Withdrawal by Subject|1|||
131588940|NCT05613205|473784085|FG004|Overall Study|Withdrawal by Subject|0|||
131588941|NCT04440176|473784088|FG000|Overall Study|Withdrawal by Subject|5|||
131588942|NCT04440176|473784089|FG001|Overall Study|Withdrawal by Subject|3|||
131588943|NCT04440176|473784088|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131588944|NCT04440176|473784089|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131790954|NCT03210259|474516997|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
131790955|NCT03210259|474516998|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
131790956|NCT03210259|474516996|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
131790957|NCT03210259|474516997|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
131790958|NCT03210259|474516998|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
131790959|NCT03210259|474516996|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
131790960|NCT03210259|474516997|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
131790961|NCT03210259|474516998|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
131790962|NCT03210259|474516996|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
131790963|NCT03210259|474516997|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
131588945|NCT04440176|473784088|FG000|Overall Study|Adverse Event|2|||
131588946|NCT04440176|473784089|FG001|Overall Study|Adverse Event|6|||
131790964|NCT03210259|474516998|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
131899003|NCT00103285|474917481|FG004|Response Assignment|Withdrawal by Subject|2|||
131588947|NCT04440176|473784088|FG000|Overall Study|Lost to Follow-up|22|||
131588948|NCT04440176|473784089|FG001|Overall Study|Lost to Follow-up|23|||
131588949|NCT04440176|473784088|FG000|Overall Study|Medication error without associated adverse event|0|||
131588950|NCT04440176|473784089|FG001|Overall Study|Medication error without associated adverse event|1|||
131588951|NCT04440176|473784088|FG000|Overall Study|No longer met eligibility criteria|7|||
131588952|NCT04440176|473784089|FG001|Overall Study|No longer met eligibility criteria|1|||
131588953|NCT04440176|473784088|FG000|Overall Study|Other|1|||
131588954|NCT04440176|473784089|FG001|Overall Study|Other|2|||
131588955|NCT04440176|473784088|FG000|Overall Study|Protocol deviation|6|||
131588956|NCT04440176|473784089|FG001|Overall Study|Protocol deviation|8|||
131588957|NCT04440176|473784088|FG000|Overall Study|Randomized but not vaccinated|6|||
131588958|NCT04440176|473784089|FG001|Overall Study|Randomized but not vaccinated|3|||
131588959|NCT04608045|473784096|FG000|Overall Study|Physician Decision|1|||
131588960|NCT03103321|473784098|FG000|Overall Study|Protocol Violation|1|||
131588961|NCT03103321|473784099|FG001|Overall Study|Protocol Violation|1|||
131588962|NCT03103321|473784100|FG002|Overall Study|Protocol Violation|1|||
131588963|NCT03103321|473784101|FG003|Overall Study|Protocol Violation|0|||
131588964|NCT04247542|473784102|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
131588965|NCT04247542|473784103|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
131588966|NCT04247542|473784104|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
131588967|NCT04247542|473784102|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
131588968|NCT04247542|473784103|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
131588969|NCT04247542|473784104|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
131588970|NCT04118452|473784105|FG000|Overall Study|Lost to Follow-up|5|||
131588971|NCT04118452|473784106|FG001|Overall Study|Lost to Follow-up|5|||
131588972|NCT04118452|473784105|FG000|Overall Study|Withdrawal by Subject|17|||
131588973|NCT04118452|473784106|FG001|Overall Study|Withdrawal by Subject|17|||
131588974|NCT04847999|473784107|FG000|Overall Study|Lost to Follow-up|0|||
131588975|NCT04847999|473784108|FG001|Overall Study|Lost to Follow-up|1|||
131588976|NCT02879448|473784109|FG000|Overall Study|Death|251|||
131588977|NCT02879448|473784110|FG001|Overall Study|Death|263|||
131588978|NCT02879448|473784109|FG000|Overall Study|Lost to Follow-up|23|||
131438902|NCT03760029|473233326|FG000|Overall Study|Withdrawal by Subject|1|||
131438903|NCT03760029|473233327|FG001|Overall Study|Withdrawal by Subject|4|||
131438904|NCT03760029|473233328|FG002|Overall Study|Withdrawal by Subject|1|||
131438905|NCT03760029|473233326|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131588979|NCT02879448|473784110|FG001|Overall Study|Lost to Follow-up|28|||
131705545|NCT01948830|474203527|FG001|Overall Study|Withdrawal by Subject|17|||
131438906|NCT03760029|473233327|FG001|Overall Study|Withdrawal by parent/guardian|4|||
131438907|NCT03760029|473233328|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131438908|NCT03760029|473233326|FG000|Overall Study|Other|2|||
131705546|NCT01948830|474203526|FG000|Overall Study|Adverse Event|9|||
131705547|NCT01948830|474203527|FG001|Overall Study|Adverse Event|2|||
131705548|NCT01948830|474203526|FG000|Overall Study|Death|3|||
131705549|NCT01948830|474203527|FG001|Overall Study|Death|4|||
131705550|NCT02526550|474203528|FG000|Overall Study|Lost to Follow-up|1|||
131705551|NCT01446419|474203532|FG000|Overall Study|Death|1|||
131705552|NCT01446419|474203533|FG001|Overall Study|Death|0|||
131705553|NCT01446419|474203532|FG000|Overall Study|Withdrawal by Subject|1|||
131705554|NCT01446419|474203533|FG001|Overall Study|Withdrawal by Subject|1|||
131705555|NCT01446419|474203532|FG000|Overall Study|Terminated per protocol|3|||
131705556|NCT01446419|474203533|FG001|Overall Study|Terminated per protocol|0|||
131705557|NCT02867761|474203536|FG000|Overall Study|Participant withdrawn by investigator|0|||
131705558|NCT02867761|474203537|FG001|Overall Study|Participant withdrawn by investigator|1|||
131705559|NCT02867761|474203536|FG000|Overall Study|Lost to Follow-up|25|||
131705560|NCT02867761|474203537|FG001|Overall Study|Lost to Follow-up|18|||
131705561|NCT02867761|474203536|FG000|Overall Study|Unable to complete protocol|3|||
131705562|NCT02867761|474203537|FG001|Overall Study|Unable to complete protocol|7|||
131705563|NCT04506294|474203538|FG000|Overall Study|Lost to Follow-up|70|||
131705564|NCT04506294|474203539|FG001|Overall Study|Lost to Follow-up|20|||
131705565|NCT04506294|474203538|FG000|Overall Study|Withdrawal by Subject|16|||
131705566|NCT04506294|474203539|FG001|Overall Study|Withdrawal by Subject|2|||
131705567|NCT01931059|474203540|FG000|Day 1|Pregnancy|0|||
131705568|NCT01931059|474203541|FG001|Day 1|Pregnancy|1|||
131705569|NCT01931059|474203540|FG000|Day3|Lost to Follow-up|1|||
131705570|NCT01931059|474203541|FG001|Day3|Lost to Follow-up|0|||
131705571|NCT00769119|474203542|FG000|Overall Study|Voluntary discontinuation|0|||
131705572|NCT00769119|474203543|FG001|Overall Study|Voluntary discontinuation|2|||
131438909|NCT03760029|473233327|FG001|Overall Study|Other|1|||
131438910|NCT03760029|473233328|FG002|Overall Study|Other|0|||
131438911|NCT04664153|473233329|FG000|Overall Study|Lack of Efficacy|0|||
131438912|NCT04664153|473233330|FG001|Overall Study|Lack of Efficacy|0|||
131588980|NCT02879448|473784109|FG000|Overall Study|Withdrawal by Subject|42|||
131588981|NCT02879448|473784110|FG001|Overall Study|Withdrawal by Subject|79|||
131705573|NCT00769119|474203542|FG000|Overall Study|Adverse Event|1|||
131705574|NCT00769119|474203543|FG001|Overall Study|Adverse Event|1|||
131705575|NCT00769119|474203542|FG000|Overall Study|Disallowed medication|1|||
131705576|NCT00769119|474203543|FG001|Overall Study|Disallowed medication|0|||
131705577|NCT01961115|474203547|FG000|Overall Study|Disease Progression|1|||
131705578|NCT01961115|474203548|FG001|Overall Study|Disease Progression|0|||
131588982|NCT02879448|473784109|FG000|Overall Study|Other Reasons|8|||
131588983|NCT02879448|473784110|FG001|Overall Study|Other Reasons|12|||
131588984|NCT05952076|473784111|FG000|Overall Study|Death|1|||
131588985|NCT05952076|473784112|FG001|Overall Study|Death|1|||
131588986|NCT05952076|473784111|FG000|Overall Study|Lost to Follow-up|0|||
131588987|NCT05952076|473784112|FG001|Overall Study|Lost to Follow-up|1|||
131588988|NCT05288283|473784113|FG000|Overall Study|Study Terminated Early|1|||
131588989|NCT05288283|473784114|FG001|Overall Study|Study Terminated Early|1|||
131588990|NCT01704079|473784115|FG000|Overall Study|Withdrawal by Subject|5|||
131705579|NCT01961115|474203549|FG002|Overall Study|Disease Progression|3|||
131705580|NCT01961115|474203547|FG000|Overall Study|Adverse Event|1|||
131705581|NCT01961115|474203548|FG001|Overall Study|Adverse Event|0|||
131705582|NCT01961115|474203549|FG002|Overall Study|Adverse Event|1|||
131705583|NCT00578643|474203550|FG000|Overall Study|Death|1|||
131705584|NCT00578643|474203550|FG000|Overall Study|Lost to Follow-up|1|||
131705585|NCT02307370|474203551|FG000|Overall Study|Death|5|||
131705586|NCT02307370|474203551|FG000|Overall Study|Lost to Follow-up|1|||
131705587|NCT02307370|474203551|FG000|Overall Study|Withdrawal by Subject|1|||
131705588|NCT02307370|474203551|FG000|Overall Study|Declined Addendum ICF|6|||
131705589|NCT02307370|474203551|FG000|Overall Study|No response during telephone contact|5|||
131705590|NCT02307370|474203551|FG000|Overall Study|Protocol Violation|1|||
131705591|NCT05900115|474205419|FG000|Overall Study|Lost to Follow-up|129|||
131705592|NCT05900115|474205420|FG001|Overall Study|Lost to Follow-up|98|||
131705593|NCT00388947|474205423|FG000|Overall Study|Protocol Violation|47|||
131705594|NCT04187092|474205424|FG000|Overall Study|Lost to Follow-up|1|||
131705595|NCT04187092|474205425|FG001|Overall Study|Lost to Follow-up|1|||
131705596|NCT04187092|474205424|FG000|Overall Study|Withdrawal by Subject|1|||
131705597|NCT04187092|474205425|FG001|Overall Study|Withdrawal by Subject|1|||
131705598|NCT04187092|474205424|FG000|Overall Study|Adverse Event|0|||
131705599|NCT04187092|474205425|FG001|Overall Study|Adverse Event|1|||
131705600|NCT00544869|474205427|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
131705601|NCT00544869|474205428|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
131705602|NCT00544869|474205429|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
131705603|NCT00544869|474205427|FG000|Overall Study|Adverse Event|6|||
131705604|NCT00544869|474205428|FG001|Overall Study|Adverse Event|1|||
131705605|NCT00544869|474205429|FG002|Overall Study|Adverse Event|0|||
131705606|NCT00544869|474205427|FG000|Overall Study|Lack of Efficacy|1|||
131705607|NCT00544869|474205428|FG001|Overall Study|Lack of Efficacy|1|||
131705608|NCT00544869|474205429|FG002|Overall Study|Lack of Efficacy|0|||
131705609|NCT00544869|474205427|FG000|Overall Study|Physician Decision|2|||
131705610|NCT00544869|474205428|FG001|Overall Study|Physician Decision|0|||
131705611|NCT00544869|474205429|FG002|Overall Study|Physician Decision|0|||
131705612|NCT00880750|474205434|FG000|First Intervention|Adverse Event|1|||
131705613|NCT00880750|474205435|FG001|First Intervention|Adverse Event|0|||
131705614|NCT00880750|474205434|FG000|First Intervention|Unable to collect urine|4|||
131705615|NCT00880750|474205435|FG001|First Intervention|Unable to collect urine|0|||
131705616|NCT00880750|474205434|FG000|First Intervention|Non-compliance with meals|0|||
131705617|NCT00880750|474205435|FG001|First Intervention|Non-compliance with meals|1|||
131705618|NCT00880750|474205434|FG000|First Intervention|Withdrawal by Subject|2|||
131705619|NCT00880750|474205435|FG001|First Intervention|Withdrawal by Subject|0|||
131705620|NCT00880750|474205434|FG000|First Intervention|Lost to Follow-up|2|||
131705621|NCT00880750|474205435|FG001|First Intervention|Lost to Follow-up|0|||
131705622|NCT00880750|474205434|FG000|Second Intervention|Withdrawal by Subject|2|||
131705623|NCT00880750|474205435|FG001|Second Intervention|Withdrawal by Subject|2|||
131705624|NCT00880750|474205434|FG000|Second Intervention|Protocol Violation|1|||
131705625|NCT00880750|474205435|FG001|Second Intervention|Protocol Violation|0|||
131705626|NCT00880750|474205434|FG000|Second Intervention|Unable to collect urine|1|||
131705627|NCT00880750|474205435|FG001|Second Intervention|Unable to collect urine|0|||
131705628|NCT00483327|474205439|FG000|Overall Study|Adverse Event|1|||
131705629|NCT00483327|474205439|FG000|Overall Study|Withdrawal by Subject|3|||
131705630|NCT00483327|474205439|FG000|Overall Study|Lost to Follow-up|4|||
131705631|NCT00483327|474205439|FG000|Overall Study|Patient Non Compliance|2|||
131705632|NCT00670007|474205440|FG000|Overall Study|Drug abuse|1|||
131588991|NCT01704079|473784116|FG001|Overall Study|Withdrawal by Subject|7|||
131588992|NCT01704079|473784115|FG000|Overall Study|Lost to Follow-up|2|||
131588993|NCT01704079|473784116|FG001|Overall Study|Lost to Follow-up|5|||
131705633|NCT00670007|474205440|FG000|Overall Study|Lung transplant|1|||
131705634|NCT00670007|474205440|FG000|Overall Study|Travel/Vacation|1|||
131705635|NCT00670007|474205440|FG000|Overall Study|Adverse event, serious fatal|1|||
131705636|NCT00670007|474205440|FG000|Overall Study|Adverse Event|1|||
131705637|NCT00670007|474205440|FG000|Overall Study|Withdrawal by Subject|4|||
131705638|NCT00618722|474205441|FG000|Overall Study|Refusal of Treatment|0|||
131899004|NCT00103285|474917482|FG005|Response Assignment|Withdrawal by Subject|2|||
131588994|NCT01704079|473784115|FG000|Overall Study|Adverse Event|4|||
131588995|NCT01704079|473784116|FG001|Overall Study|Adverse Event|7|||
131705639|NCT00618722|474205442|FG001|Overall Study|Refusal of Treatment|0|||
131705640|NCT00618722|474205443|FG002|Overall Study|Refusal of Treatment|1|||
131705641|NCT00618722|474205444|FG003|Overall Study|Refusal of Treatment|0|||
131899005|NCT00103285|474917483|FG006|Response Assignment|Withdrawal by Subject|0|||
131899006|NCT00103285|474917484|FG007|Response Assignment|Withdrawal by Subject|2|||
131899007|NCT00103285|474917477|FG000|Response Assignment|Ineligible|0|||
131705642|NCT00618722|474205441|FG000|Overall Study|Patient Request|1|||
131705643|NCT00618722|474205442|FG001|Overall Study|Patient Request|1|||
131705644|NCT00618722|474205443|FG002|Overall Study|Patient Request|1|||
131705645|NCT00618722|474205444|FG003|Overall Study|Patient Request|1|||
131705646|NCT00618722|474205441|FG000|Overall Study|Inability to Complete Study Procedure|0|||
131705647|NCT00618722|474205442|FG001|Overall Study|Inability to Complete Study Procedure|1|||
131705648|NCT00618722|474205443|FG002|Overall Study|Inability to Complete Study Procedure|0|||
131705649|NCT00618722|474205444|FG003|Overall Study|Inability to Complete Study Procedure|0|||
131705650|NCT00618722|474205441|FG000|Overall Study|Lost to Follow-up|2|||
131705651|NCT00618722|474205442|FG001|Overall Study|Lost to Follow-up|0|||
131705652|NCT00618722|474205443|FG002|Overall Study|Lost to Follow-up|0|||
131705653|NCT00618722|474205444|FG003|Overall Study|Lost to Follow-up|2|||
131705654|NCT00618722|474205441|FG000|Overall Study|Miscellaneous Reasons|0|||
131705655|NCT00618722|474205442|FG001|Overall Study|Miscellaneous Reasons|0|||
131705656|NCT00618722|474205443|FG002|Overall Study|Miscellaneous Reasons|1|||
131705657|NCT00618722|474205444|FG003|Overall Study|Miscellaneous Reasons|1|||
131705658|NCT00925600|474205445|FG000|Overall Study|Withdrawal by Subject|16|||
131705659|NCT00925600|474205446|FG001|Overall Study|Withdrawal by Subject|14|||
131705660|NCT00925600|474205445|FG000|Overall Study|Death|4|||
131705661|NCT00925600|474205446|FG001|Overall Study|Death|3|||
131705662|NCT00925600|474205445|FG000|Overall Study|Lost to Follow-up|2|||
131705663|NCT00925600|474205446|FG001|Overall Study|Lost to Follow-up|2|||
131705664|NCT00925600|474205445|FG000|Overall Study|Disease Progression|1|||
131705665|NCT00925600|474205446|FG001|Overall Study|Disease Progression|3|||
131705666|NCT00925600|474205445|FG000|Overall Study|Administrative Decision|1|||
131705667|NCT00925600|474205446|FG001|Overall Study|Administrative Decision|1|||
131705668|NCT00925600|474205445|FG000|Overall Study|Noncompliance|2|||
131705669|NCT00925600|474205446|FG001|Overall Study|Noncompliance|0|||
131705670|NCT00925600|474205445|FG000|Overall Study|Ineligibility Determined|2|||
131705671|NCT00925600|474205446|FG001|Overall Study|Ineligibility Determined|0|||
131705672|NCT00925600|474205445|FG000|Overall Study|Protocol Deviation|0|||
131705673|NCT00925600|474205446|FG001|Overall Study|Protocol Deviation|1|||
131705674|NCT00925600|474205445|FG000|Overall Study|Requirement for Alternative Therapy|0|||
131705675|NCT00925600|474205446|FG001|Overall Study|Requirement for Alternative Therapy|1|||
131705676|NCT00925600|474205445|FG000|Overall Study|Other|3|||
131705677|NCT00925600|474205446|FG001|Overall Study|Other|1|||
131705678|NCT00925600|474205445|FG000|Overall Study|Adverse Event|1|||
131705679|NCT00925600|474205446|FG001|Overall Study|Adverse Event|2|||
131705680|NCT00200057|474205451|FG000|Overall Study|Lack of Efficacy|3|||
131705681|NCT00200057|474205451|FG000|Overall Study|Exited due to terminal illness of PI|2|||
131705682|NCT00200057|474205451|FG000|Overall Study|Withdrawal by Subject|1|||
131705683|NCT00200057|474205451|FG000|Overall Study|Change in medical condition|1|||
131705684|NCT00200057|474205451|FG000|Overall Study|Infection|1|||
131705685|NCT00200057|474205451|FG000|Overall Study|Death|1|||
131705686|NCT01059448|474205452|FG000|Overall Study|Adverse Event|1|||
131705687|NCT01059448|474205453|FG001|Overall Study|Adverse Event|3|||
131705688|NCT01059448|474205454|FG002|Overall Study|Adverse Event|0|||
131705689|NCT01059448|474205455|FG003|Overall Study|Adverse Event|1|||
131705690|NCT01059448|474205452|FG000|Overall Study|Withdrawal by Subject|2|||
131705691|NCT01059448|474205453|FG001|Overall Study|Withdrawal by Subject|0|||
131705692|NCT01059448|474205454|FG002|Overall Study|Withdrawal by Subject|2|||
131705693|NCT01059448|474205455|FG003|Overall Study|Withdrawal by Subject|4|||
131705694|NCT01059448|474205452|FG000|Overall Study|Disease Progression|2|||
131705695|NCT01059448|474205453|FG001|Overall Study|Disease Progression|1|||
131705696|NCT01059448|474205454|FG002|Overall Study|Disease Progression|4|||
131705697|NCT01059448|474205455|FG003|Overall Study|Disease Progression|2|||
131705698|NCT01059448|474205452|FG000|Overall Study|Administrative Decision|43|||
131705699|NCT01059448|474205453|FG001|Overall Study|Administrative Decision|49|||
131705700|NCT01059448|474205454|FG002|Overall Study|Administrative Decision|45|||
131705701|NCT01059448|474205455|FG003|Overall Study|Administrative Decision|46|||
131705702|NCT01059448|474205452|FG000|Overall Study|Lost to Follow-up|0|||
131705703|NCT01059448|474205453|FG001|Overall Study|Lost to Follow-up|0|||
131705704|NCT01059448|474205454|FG002|Overall Study|Lost to Follow-up|2|||
131705705|NCT01059448|474205455|FG003|Overall Study|Lost to Follow-up|0|||
131705706|NCT01059448|474205452|FG000|Overall Study|Death|0|||
131705707|NCT01059448|474205453|FG001|Overall Study|Death|1|||
131705708|NCT01059448|474205454|FG002|Overall Study|Death|0|||
131705709|NCT01059448|474205455|FG003|Overall Study|Death|0|||
131705710|NCT01059448|474205452|FG000|Overall Study|Other|1|||
131705711|NCT01059448|474205453|FG001|Overall Study|Other|1|||
131705712|NCT01059448|474205454|FG002|Overall Study|Other|0|||
131705713|NCT01059448|474205455|FG003|Overall Study|Other|1|||
131705714|NCT01974817|474205456|FG000|Overall Study|Death|4|||
131899008|NCT00103285|474917478|FG001|Response Assignment|Ineligible|8|||
131438913|NCT04664153|473233331|FG002|Overall Study|Lack of Efficacy|1|||
131705715|NCT01974817|474205456|FG000|Overall Study|Lost to Follow-up|2|||
131588996|NCT01704079|473784115|FG000|Overall Study|Protocol Violation|1|||
131588997|NCT01704079|473784116|FG001|Overall Study|Protocol Violation|0|||
131588998|NCT01704079|473784115|FG000|Overall Study|Subject noncompliance|2|||
131588999|NCT01704079|473784116|FG001|Overall Study|Subject noncompliance|3|||
131589000|NCT01704079|473784115|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
131589001|NCT01704079|473784116|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
131589002|NCT05986565|473784117|FG000|Overall Study|Lost to Follow-up|8|||
131790965|NCT03210259|474516996|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
131790966|NCT03210259|474516997|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
131790967|NCT03210259|474516998|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
131790968|NCT03210259|474516996|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
131790969|NCT03210259|474516997|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
131790970|NCT03210259|474516998|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
131790971|NCT03210259|474516996|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
131790972|NCT03210259|474516997|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
131790973|NCT03210259|474516998|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
131790974|NCT03210259|474516996|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
131790975|NCT03210259|474516997|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
131790976|NCT03210259|474516998|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
131790977|NCT03210259|474516996|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
131790978|NCT03210259|474516997|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
131790979|NCT03210259|474516998|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
131790980|NCT01102777|474517001|FG000|Overall Study|Death|2|||
131790981|NCT01102777|474517002|FG001|Overall Study|Death|6|||
131790982|NCT01102777|474517001|FG000|Overall Study|Lost to Follow-up|7|||
131790983|NCT01102777|474517002|FG001|Overall Study|Lost to Follow-up|10|||
131790984|NCT00706706|474517003|FG000|Overall Study|Death|53|||
131790985|NCT00706706|474517003|FG000|Overall Study|Lost to Follow-up|7|||
131790986|NCT00706706|474517003|FG000|Overall Study|Study endpoint had reached|45|||
131790987|NCT01154153|474517010|FG000|Overall Study|Poor compliance to protocol|2|||
131790988|NCT01154153|474517011|FG001|Overall Study|Poor compliance to protocol|0|||
131790989|NCT01154153|474517010|FG000|Overall Study|Unable to use labs|2|||
131790990|NCT01154153|474517011|FG001|Overall Study|Unable to use labs|3|||
131790991|NCT01154153|474517010|FG000|Overall Study|Withdrew consent|1|||
131790992|NCT01154153|474517011|FG001|Overall Study|Withdrew consent|0|||
131790993|NCT02473510|474517016|FG000|Overall Study|Lost to Follow-up|1|||
131790994|NCT02473510|474517017|FG001|Overall Study|Lost to Follow-up|2|||
131790995|NCT00771901|474517018|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
131790996|NCT00771901|474517019|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
131790997|NCT00771901|474517020|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
131790998|NCT02862535|474517021|FG000|Overall Study|Death|7|||
131790999|NCT02862535|474517022|FG001|Overall Study|Death|3|||
131791000|NCT02862535|474517023|FG002|Overall Study|Death|2|||
131791001|NCT02862535|474517024|FG003|Overall Study|Death|5|||
131791002|NCT02862535|474517021|FG000|Overall Study|Study Terminated by Sponsor|1|||
131791003|NCT02862535|474517022|FG001|Overall Study|Study Terminated by Sponsor|3|||
131791004|NCT02862535|474517023|FG002|Overall Study|Study Terminated by Sponsor|8|||
131791005|NCT02862535|474517024|FG003|Overall Study|Study Terminated by Sponsor|5|||
131791006|NCT02862535|474517021|FG000|Overall Study|Enrolled, not Treated|1|||
131791007|NCT02862535|474517022|FG001|Overall Study|Enrolled, not Treated|0|||
131791008|NCT02862535|474517023|FG002|Overall Study|Enrolled, not Treated|0|||
131791009|NCT02862535|474517024|FG003|Overall Study|Enrolled, not Treated|1|||
131791010|NCT02280356|474517027|FG000|Overall Study|Not Treated|2|||
131791011|NCT02280356|474517027|FG000|Overall Study|Withdrawal by Subject|1|||
131791012|NCT02280356|474517027|FG000|Overall Study|Not evaluable|2|||
131791013|NCT05478603|474517033|FG000|Overall Study|Withdrawal by Subject|0|||
131791014|NCT05478603|474517034|FG001|Overall Study|Withdrawal by Subject|1|||
131791015|NCT05478603|474517035|FG002|Overall Study|Withdrawal by Subject|0|||
131791016|NCT05478603|474517036|FG003|Overall Study|Withdrawal by Subject|0|||
131791017|NCT02472977|474517039|FG000|Overall Study|Disease progression|4|||
131791018|NCT02472977|474517040|FG001|Overall Study|Disease progression|25|||
131791019|NCT02472977|474517041|FG002|Overall Study|Disease progression|6|||
131791020|NCT02472977|474517039|FG000|Overall Study|Withdrawal by Subject|0|||
131791021|NCT02472977|474517040|FG001|Overall Study|Withdrawal by Subject|1|||
131791022|NCT02472977|474517041|FG002|Overall Study|Withdrawal by Subject|0|||
131791023|NCT02472977|474517039|FG000|Overall Study|Study drug toxicity|2|||
131791024|NCT02472977|474517040|FG001|Overall Study|Study drug toxicity|0|||
131791025|NCT02472977|474517041|FG002|Overall Study|Study drug toxicity|2|||
131791026|NCT02472977|474517039|FG000|Overall Study|Subject request to discontinue treatment|0|||
131791027|NCT02472977|474517040|FG001|Overall Study|Subject request to discontinue treatment|1|||
131791028|NCT02472977|474517041|FG002|Overall Study|Subject request to discontinue treatment|0|||
131791029|NCT00291330|474517042|FG000|Overall Study|Adverse Event|47|||
131791030|NCT00291330|474517043|FG001|Overall Study|Adverse Event|40|||
131791031|NCT00291330|474517042|FG000|Overall Study|Protocol Violation|13|||
131791032|NCT00291330|474517043|FG001|Overall Study|Protocol Violation|20|||
131589003|NCT05986565|473784118|FG001|Overall Study|Lost to Follow-up|3|||
131589004|NCT05986565|473784117|FG000|Overall Study|Withdrawal by Subject|0|||
131589005|NCT05986565|473784118|FG001|Overall Study|Withdrawal by Subject|1|||
131589006|NCT02991807|473784120|FG000|Overall Study|Withdrawal by Subject|2|||
131589007|NCT02991807|473784121|FG001|Overall Study|Withdrawal by Subject|1|||
131589008|NCT02991807|473784120|FG000|Overall Study|Physician Decision|0|||
131791033|NCT00291330|474517042|FG000|Overall Study|Lost to Follow-up|16|||
131791034|NCT00291330|474517043|FG001|Overall Study|Lost to Follow-up|11|||
131791035|NCT00291330|474517042|FG000|Overall Study|Withdrawal by Subject|22|||
131791036|NCT00291330|474517043|FG001|Overall Study|Withdrawal by Subject|25|||
131791037|NCT00291330|474517042|FG000|Overall Study|Other|3|||
131791038|NCT00291330|474517043|FG001|Overall Study|Other|1|||
131791039|NCT00566709|474517046|FG000|Overall Study|Protocol Violation|5|||
131791040|NCT00566709|474517047|FG001|Overall Study|Protocol Violation|0|||
131791041|NCT03443869|474517050|FG000|Overall Study|Death|3|||
131791042|NCT03443869|474517051|FG001|Overall Study|Death|3|||
131791043|NCT03443869|474517050|FG000|Overall Study|Withdrawal by Subject|34|||
131791044|NCT03443869|474517051|FG001|Overall Study|Withdrawal by Subject|22|||
131791045|NCT03443869|474517050|FG000|Overall Study|Lost to Follow-up|1|||
131791046|NCT03443869|474517051|FG001|Overall Study|Lost to Follow-up|2|||
131791047|NCT03443869|474517050|FG000|Overall Study|Physician Decision|3|||
131791048|NCT03443869|474517051|FG001|Overall Study|Physician Decision|3|||
131791049|NCT03443869|474517050|FG000|Overall Study|Other|4|||
131791050|NCT03443869|474517051|FG001|Overall Study|Other|4|||
131791051|NCT00299728|474517052|FG000|Overall Study|Lost to Follow-up|0|||
131791052|NCT00299728|474517053|FG001|Overall Study|Lost to Follow-up|1|||
131791053|NCT00299728|474517052|FG000|Overall Study|Withdrawal by Subject|0|||
131791054|NCT00299728|474517053|FG001|Overall Study|Withdrawal by Subject|1|||
131791055|NCT00299728|474517052|FG000|Overall Study|Progressive disease|0|||
131791056|NCT00299728|474517053|FG001|Overall Study|Progressive disease|1|||
131791057|NCT00738920|474517054|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
131791058|NCT00738920|474517055|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
131791059|NCT00738920|474517056|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
131791060|NCT00738920|474517054|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
131791061|NCT00738920|474517055|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
131791062|NCT00738920|474517056|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
131791063|NCT00738920|474517054|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
131791064|NCT00738920|474517055|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
131791065|NCT00738920|474517056|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
131791066|NCT00738920|474517054|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
131791067|NCT00738920|474517055|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
131791068|NCT00738920|474517056|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
131791069|NCT00738920|474517054|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
131791070|NCT00738920|474517055|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
131791071|NCT00738920|474517056|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
131791072|NCT00738920|474517054|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
131791073|NCT00738920|474517055|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
131791074|NCT00738920|474517056|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
131791075|NCT00738920|474517054|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
131791076|NCT00738920|474517055|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
131589009|NCT02991807|473784121|FG001|Overall Study|Physician Decision|1|||
131589010|NCT02991807|473784120|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
131589011|NCT02991807|473784121|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
131589012|NCT00792636|473784123|FG000|Overall Study|Protocol Violation|17|||
131589013|NCT00792636|473784124|FG001|Overall Study|Protocol Violation|23|||
131589014|NCT00792636|473784125|FG002|Overall Study|Protocol Violation|20|||
131589015|NCT00792636|473784123|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
131589016|NCT00792636|473784124|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
131589017|NCT00792636|473784125|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
131589018|NCT00792636|473784123|FG000|Overall Study|Lost to Follow-up|13|||
131791077|NCT00738920|474517056|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
131791078|NCT00738920|474517054|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
131791079|NCT00738920|474517055|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
131791080|NCT00738920|474517056|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
131589019|NCT00792636|473784124|FG001|Overall Study|Lost to Follow-up|19|||
131589020|NCT00792636|473784125|FG002|Overall Study|Lost to Follow-up|14|||
131589021|NCT00792636|473784123|FG000|Overall Study|Withdrew Consent|10|||
131791081|NCT00738920|474517054|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
131791082|NCT00738920|474517055|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
131791083|NCT00738920|474517056|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
131791084|NCT00738920|474517054|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
131589022|NCT00792636|473784124|FG001|Overall Study|Withdrew Consent|13|||
131589023|NCT00792636|473784125|FG002|Overall Study|Withdrew Consent|9|||
131589024|NCT00792636|473784123|FG000|Overall Study|Lack of Efficacy|3|||
131589025|NCT00792636|473784124|FG001|Overall Study|Lack of Efficacy|4|||
131589026|NCT00792636|473784125|FG002|Overall Study|Lack of Efficacy|13|||
131589027|NCT00792636|473784123|FG000|Overall Study|Adverse Event|4|||
131589028|NCT00792636|473784124|FG001|Overall Study|Adverse Event|2|||
131589029|NCT00792636|473784125|FG002|Overall Study|Adverse Event|3|||
131589030|NCT00792636|473784123|FG000|Overall Study|Investigator Discretion|2|||
131589031|NCT00792636|473784124|FG001|Overall Study|Investigator Discretion|0|||
131589032|NCT00792636|473784125|FG002|Overall Study|Investigator Discretion|2|||
131589033|NCT01046136|473784126|FG000|Overall Study|Withdrawal by Subject|0|||
131589034|NCT01046136|473784127|FG001|Overall Study|Withdrawal by Subject|4|||
131589035|NCT01046136|473784126|FG000|Overall Study|Physician Decision|1|||
131589036|NCT01046136|473784127|FG001|Overall Study|Physician Decision|1|||
131589037|NCT01046136|473784126|FG000|Overall Study|Lost to Follow-up|3|||
131589038|NCT01046136|473784127|FG001|Overall Study|Lost to Follow-up|3|||
131589039|NCT04579250|473784128|FG000|Overall Study|Withdrawal by Subject|1|||
131589040|NCT04579250|473784129|FG001|Overall Study|Withdrawal by Subject|1|||
131589041|NCT04579250|473784130|FG002|Overall Study|Withdrawal by Subject|0|||
131589042|NCT04579250|473784128|FG000|Overall Study|Lost to Follow-up|1|||
131589043|NCT04579250|473784129|FG001|Overall Study|Lost to Follow-up|1|||
131589044|NCT04579250|473784130|FG002|Overall Study|Lost to Follow-up|0|||
131589045|NCT04579250|473784128|FG000|Overall Study|Moved from area|0|||
131705716|NCT01974817|474205456|FG000|Overall Study|Protocol Violation|2|||
131705717|NCT00778830|474205457|FG000|Overall Study|Ongoing at data cut-off|0|||
131705718|NCT00778830|474205458|FG001|Overall Study|Ongoing at data cut-off|1|||
131705719|NCT01891643|474205459|FG000|Overall Study|Adverse event unrelated to study drug|2|||
131705720|NCT01891643|474205460|FG001|Overall Study|Adverse event unrelated to study drug|5|||
131705721|NCT01891643|474205459|FG000|Overall Study|Disease Progression|4|||
131705722|NCT01891643|474205460|FG001|Overall Study|Disease Progression|3|||
131705723|NCT01891643|474205459|FG000|Overall Study|Study Drug Toxicity|3|||
131705724|NCT01891643|474205460|FG001|Overall Study|Study Drug Toxicity|0|||
131705725|NCT01891643|474205459|FG000|Overall Study|Maximum Clinical Benefit|0|||
131705726|NCT01891643|474205460|FG001|Overall Study|Maximum Clinical Benefit|1|||
131705727|NCT01891643|474205459|FG000|Overall Study|Poor/Non-compliance|0|||
131705728|NCT01891643|474205460|FG001|Overall Study|Poor/Non-compliance|1|||
131705729|NCT01891643|474205459|FG000|Overall Study|Participant request to discontinue|1|||
131705730|NCT01891643|474205460|FG001|Overall Study|Participant request to discontinue|0|||
131705731|NCT02591615|474205461|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
131705732|NCT02591615|474205462|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
131705733|NCT02591615|474205463|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
131705734|NCT02591615|474205464|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
131705735|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
131705736|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
131705737|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
131705738|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
131705739|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
131705740|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
131705741|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
131705742|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
131705743|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
131705744|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
131705745|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
131705746|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
131705747|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
131705748|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
131705749|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
131705750|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
131705751|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
131705752|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
131705753|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
131705754|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
131705755|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
131705756|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
131705757|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
131589046|NCT04579250|473784129|FG001|Overall Study|Moved from area|1|||
131705758|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
131438914|NCT04664153|473233332|FG003|Overall Study|Lack of Efficacy|0|||
131589047|NCT04579250|473784130|FG002|Overall Study|Moved from area|2|||
131589048|NCT00727909|473784131|FG000|Overall Study|Withdrawal by Subject|5|||
131589049|NCT00727909|473784132|FG001|Overall Study|Withdrawal by Subject|11|||
131589050|NCT00727909|473784133|FG002|Overall Study|Withdrawal by Subject|8|||
131589051|NCT00727909|473784134|FG003|Overall Study|Withdrawal by Subject|5|||
131589052|NCT00727909|473784131|FG000|Overall Study|Death|0|||
131589053|NCT00727909|473784132|FG001|Overall Study|Death|0|||
131589054|NCT00727909|473784133|FG002|Overall Study|Death|1|||
131589055|NCT00727909|473784134|FG003|Overall Study|Death|0|||
131589056|NCT03446157|473784135|FG000|Overall Study|Death|11|||
131589057|NCT03446157|473784136|FG001|Overall Study|Death|9|||
131589058|NCT03446157|473784135|FG000|Overall Study|Lost to Follow-up|0|||
131589059|NCT03446157|473784136|FG001|Overall Study|Lost to Follow-up|1|||
131589060|NCT03446157|473784135|FG000|Overall Study|Withdrawal by Subject|2|||
131589061|NCT03446157|473784136|FG001|Overall Study|Withdrawal by Subject|1|||
131589062|NCT00411151|473784137|FG000|Overall Study|Death|38|||
131589063|NCT00411151|473784137|FG000|Overall Study|Withdrawal by Subject|2|||
131589064|NCT00411151|473784137|FG000|Overall Study|Lost to Follow-up|2|||
131589065|NCT00411151|473784137|FG000|Overall Study|Protocol Violation|1|||
131589066|NCT00411151|473784137|FG000|Overall Study|Trial prematurely closed|4|||
131589067|NCT04110054|473784138|FG000|Overall Study|COVID-19 reason other than AE|0|||
131791085|NCT00738920|474517055|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
131589068|NCT04110054|473784139|FG001|Overall Study|COVID-19 reason other than AE|0|||
131589069|NCT04110054|473784140|FG002|Overall Study|COVID-19 reason other than AE|2|||
131589070|NCT04110054|473784141|FG003|Overall Study|COVID-19 reason other than AE|0|||
131589071|NCT04110054|473784138|FG000|Overall Study|Withdrawal by Subject|0|||
131705759|NCT02591615|474205461|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
131705760|NCT02591615|474205462|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
131705761|NCT02591615|474205463|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
131705762|NCT02591615|474205464|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
131705763|NCT02591615|474205461|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
131705764|NCT02591615|474205462|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
131705765|NCT02591615|474205463|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
131705766|NCT02591615|474205464|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
131705767|NCT02591615|474205461|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
131705768|NCT02591615|474205462|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
131705769|NCT02591615|474205463|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
131705770|NCT02591615|474205464|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
131705771|NCT02591615|474205461|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
131705772|NCT02591615|474205462|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
131705773|NCT02591615|474205463|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
131705774|NCT02591615|474205464|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
131705775|NCT02591615|474205461|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
131705776|NCT02591615|474205462|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
131705777|NCT02591615|474205463|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
131705778|NCT02591615|474205464|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
131705779|NCT02591615|474205461|FG000|Maintenance MK-3475|Adverse Event|0|||
131705780|NCT02591615|474205462|FG001|Maintenance MK-3475|Adverse Event|3|||
131705781|NCT02591615|474205463|FG002|Maintenance MK-3475|Adverse Event|1|||
131705782|NCT02591615|474205464|FG003|Maintenance MK-3475|Adverse Event|2|||
131705783|NCT02591615|474205461|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
131705784|NCT02591615|474205462|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
131705785|NCT02591615|474205463|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
131705786|NCT02591615|474205464|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
131705787|NCT02591615|474205461|FG000|Maintenance MK-3475|Death|0|||
131705788|NCT02591615|474205462|FG001|Maintenance MK-3475|Death|1|||
131705789|NCT02591615|474205463|FG002|Maintenance MK-3475|Death|1|||
131705790|NCT02591615|474205464|FG003|Maintenance MK-3475|Death|0|||
131705791|NCT02591615|474205461|FG000|Maintenance MK-3475|Physician discretion|0|||
131705792|NCT02591615|474205462|FG001|Maintenance MK-3475|Physician discretion|0|||
131705793|NCT02591615|474205463|FG002|Maintenance MK-3475|Physician discretion|1|||
131705794|NCT02591615|474205464|FG003|Maintenance MK-3475|Physician discretion|0|||
131705795|NCT02591615|474205461|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
131705796|NCT02591615|474205462|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
131705797|NCT02591615|474205463|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
131705798|NCT02591615|474205464|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
131705799|NCT02591615|474205461|FG000|Maintenance MK-3475|In active treatment|2|||
131705800|NCT02591615|474205462|FG001|Maintenance MK-3475|In active treatment|0|||
131705801|NCT02591615|474205463|FG002|Maintenance MK-3475|In active treatment|0|||
131705802|NCT02591615|474205464|FG003|Maintenance MK-3475|In active treatment|1|||
131705803|NCT04188197|474205465|FG000|Overall Study|Lost to Follow-up|4|||
131705804|NCT04188197|474205466|FG001|Overall Study|Lost to Follow-up|1|||
131705805|NCT04188197|474205465|FG000|Overall Study|Withdrawal by Subject|1|||
131705806|NCT04188197|474205466|FG001|Overall Study|Withdrawal by Subject|1|||
131705807|NCT04188197|474205465|FG000|Overall Study|Pregnancy|0|||
131705808|NCT04188197|474205466|FG001|Overall Study|Pregnancy|1|||
131705809|NCT02965716|474205469|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131589072|NCT04110054|473784139|FG001|Overall Study|Withdrawal by Subject|3|||
131899009|NCT00103285|474917479|FG002|Response Assignment|Ineligible|6|||
131899010|NCT00103285|474917480|FG003|Response Assignment|Ineligible|2|||
131899011|NCT00103285|474917481|FG004|Response Assignment|Ineligible|0|||
131899012|NCT00103285|474917482|FG005|Response Assignment|Ineligible|3|||
131589073|NCT04110054|473784140|FG002|Overall Study|Withdrawal by Subject|2|||
131589074|NCT04110054|473784141|FG003|Overall Study|Withdrawal by Subject|0|||
131589075|NCT04110054|473784138|FG000|Overall Study|Adverse Event|1|||
131589076|NCT04110054|473784139|FG001|Overall Study|Adverse Event|1|||
131589077|NCT04110054|473784140|FG002|Overall Study|Adverse Event|4|||
131589078|NCT04110054|473784141|FG003|Overall Study|Adverse Event|3|||
131899013|NCT00103285|474917483|FG006|Response Assignment|Ineligible|1|||
131899014|NCT00103285|474917484|FG007|Response Assignment|Ineligible|5|||
131899015|NCT00103285|474917477|FG000|Response Assignment|Refusal|0|||
131899016|NCT00103285|474917478|FG001|Response Assignment|Refusal|53|||
131899017|NCT00103285|474917479|FG002|Response Assignment|Refusal|5|||
131899018|NCT00103285|474917480|FG003|Response Assignment|Refusal|3|||
131899019|NCT00103285|474917481|FG004|Response Assignment|Refusal|25|||
131899020|NCT00103285|474917482|FG005|Response Assignment|Refusal|15|||
131899021|NCT00103285|474917483|FG006|Response Assignment|Refusal|30|||
131899022|NCT00103285|474917484|FG007|Response Assignment|Refusal|10|||
131899023|NCT00103285|474917477|FG000|Response Assignment|Other|0|||
131899024|NCT00103285|474917478|FG001|Response Assignment|Other|30|||
131899025|NCT00103285|474917479|FG002|Response Assignment|Other|48|||
131899026|NCT00103285|474917480|FG003|Response Assignment|Other|38|||
131899027|NCT00103285|474917481|FG004|Response Assignment|Other|37|||
131899028|NCT00103285|474917482|FG005|Response Assignment|Other|17|||
131899029|NCT00103285|474917483|FG006|Response Assignment|Other|11|||
131899030|NCT00103285|474917484|FG007|Response Assignment|Other|53|||
131899031|NCT01971567|474917486|FG000|Overall Study|Withdrawal by Subject|3|||
131899032|NCT01971567|474917487|FG001|Overall Study|Withdrawal by Subject|2|||
131899033|NCT01971567|474917486|FG000|Overall Study|Lost to Follow-up|1|||
131899034|NCT01971567|474917487|FG001|Overall Study|Lost to Follow-up|0|||
131899035|NCT01409915|474917488|FG000|Overall Study|Adverse Event|0|||
131899036|NCT01409915|474917489|FG001|Overall Study|Adverse Event|2|||
131899037|NCT01409915|474917488|FG000|Overall Study|Withdrawal by Subject|0|||
131899038|NCT01409915|474917489|FG001|Overall Study|Withdrawal by Subject|1|||
131899039|NCT01409915|474917488|FG000|Overall Study|Protocol Violation|1|||
131899040|NCT01409915|474917489|FG001|Overall Study|Protocol Violation|0|||
131899041|NCT04826484|474917490|FG000|Overall Study|Lost to Follow-up|2|||
131899042|NCT04826484|474917491|FG001|Overall Study|Lost to Follow-up|0|||
131899043|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
131899044|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
131899045|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
131899046|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
131899047|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
131899048|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
131899049|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
131899050|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
131899051|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
131899052|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
131589079|NCT00093015|473784142|FG000|Overall Study|Withdrawal by Subject|194|||
131589080|NCT00093015|473784143|FG001|Overall Study|Withdrawal by Subject|171|||
131589081|NCT00093015|473784142|FG000|Overall Study|Lost to Follow-up|96|||
131589082|NCT00093015|473784143|FG001|Overall Study|Lost to Follow-up|108|||
131589083|NCT00093015|473784142|FG000|Overall Study|Death|375|||
131589084|NCT00093015|473784143|FG001|Overall Study|Death|385|||
131899053|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
131899054|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
131899055|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
131899056|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
131589085|NCT00632203|473784145|FG000|Overall Study|Did not start study treatment|1|||
131589086|NCT00632203|473784146|FG001|Overall Study|Did not start study treatment|0|||
131589087|NCT03771352|473784163|FG000|Overall Study|Screen failure|2|||
131899057|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
131438915|NCT04664153|473233329|FG000|Overall Study|Physician Decision|0|||
131899058|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
131899059|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
131899060|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
131899061|NCT03569098|474917492|FG000|Double-Blind Treatment Cycle 1|Other|1|||
131899062|NCT03569098|474917493|FG001|Double-Blind Treatment Cycle 1|Other|0|||
131899063|NCT03569098|474917494|FG002|Double-Blind Treatment Cycle 1|Other|1|||
131899064|NCT03569098|474917492|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
131438916|NCT04664153|473233330|FG001|Overall Study|Physician Decision|0|||
131589088|NCT03771352|473784163|FG000|Overall Study|Withdrawal by Subject|2|||
131589089|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
131589090|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
131589091|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
131589092|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
131589093|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
131589094|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
131589095|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
131589096|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
131589097|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
131589098|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
131589099|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
131589100|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
131589101|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
131589102|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
131589103|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
131589104|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
131589105|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
131589106|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
131589107|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
131589108|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
131589109|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
131589110|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
131589111|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
131589112|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
131589113|NCT03338816|473784169|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
131589114|NCT03338816|473784170|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
131589115|NCT03338816|473784171|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
131589116|NCT03338816|473784172|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
131589117|NCT04238247|473784177|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
131589118|NCT04238247|473784178|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
131589119|NCT04238247|473784179|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
131589120|NCT04238247|473784180|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
131589121|NCT04238247|473784177|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
131589122|NCT04238247|473784178|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
131589123|NCT04238247|473784179|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
131589124|NCT04238247|473784180|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
131589125|NCT04238247|473784177|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
131589126|NCT04238247|473784178|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
131589127|NCT04238247|473784179|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
131589128|NCT04238247|473784180|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
131589129|NCT04238247|473784177|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
131589130|NCT04238247|473784178|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
131589131|NCT04238247|473784179|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
131589132|NCT04238247|473784180|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
131589133|NCT03833167|473784185|FG000|Overall Study|Withdrawal by Subject|4|||
131589134|NCT03833167|473784186|FG001|Overall Study|Withdrawal by Subject|6|||
131589135|NCT03833167|473784185|FG000|Overall Study|Ongoing|186|||
131589136|NCT03833167|473784186|FG001|Overall Study|Ongoing|194|||
131589137|NCT03833167|473784185|FG000|Overall Study|Lost to Follow-up|1|||
131589138|NCT03833167|473784186|FG001|Overall Study|Lost to Follow-up|1|||
131589139|NCT03833167|473784185|FG000|Overall Study|Physician Decision|0|||
131589140|NCT03833167|473784186|FG001|Overall Study|Physician Decision|2|||
131589141|NCT03833167|473784185|FG000|Overall Study|Death|34|||
131589142|NCT03833167|473784186|FG001|Overall Study|Death|22|||
131589143|NCT01948661|473784187|FG000|Overall Study|Withdrawal by Subject|2|||
131589144|NCT01948661|473784188|FG001|Overall Study|Withdrawal by Subject|4|||
131589145|NCT03330795|473784189|FG000|Overall Study|Death|3|||
131589146|NCT03330795|473784189|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
131589147|NCT03014453|473784190|FG000|Overall Study|Lost to Follow-up|12|||
131589148|NCT03014453|473784190|FG000|Overall Study|Discontinued GER|3|||
131589149|NCT03014453|473784190|FG000|Overall Study|Excluded|19|||
131589150|NCT03014453|473784190|FG000|Overall Study|Refused to take part in|37|||
131589151|NCT01017146|473784191|FG000|Overall Study|Adverse Event|11|||
131589152|NCT01017146|473784192|FG001|Overall Study|Adverse Event|1|||
131589153|NCT01017146|473784191|FG000|Overall Study|Lost to Follow-up|14|||
131589154|NCT01017146|473784192|FG001|Overall Study|Lost to Follow-up|14|||
131589155|NCT01017146|473784191|FG000|Overall Study|Noncompliance with Study Product|1|||
131589156|NCT01017146|473784192|FG001|Overall Study|Noncompliance with Study Product|1|||
131589157|NCT01017146|473784191|FG000|Overall Study|Withdrawal by Subject|32|||
131589158|NCT01017146|473784192|FG001|Overall Study|Withdrawal by Subject|16|||
131589159|NCT01017146|473784191|FG000|Overall Study|Relocation|0|||
131589160|NCT01017146|473784192|FG001|Overall Study|Relocation|4|||
131589161|NCT01017146|473784191|FG000|Overall Study|Pregnancy|2|||
131589162|NCT01017146|473784192|FG001|Overall Study|Pregnancy|1|||
131589163|NCT01017146|473784191|FG000|Overall Study|Protocol Violation|2|||
131589164|NCT01017146|473784192|FG001|Overall Study|Protocol Violation|0|||
131589165|NCT01017146|473784191|FG000|Overall Study|Took Excluded Medication|2|||
131589166|NCT01017146|473784192|FG001|Overall Study|Took Excluded Medication|0|||
131589167|NCT01017146|473784191|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
131589168|NCT01017146|473784192|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
131589169|NCT01017146|473784191|FG000|Overall Study|Change in Work Situation|1|||
131589170|NCT01017146|473784192|FG001|Overall Study|Change in Work Situation|0|||
131589171|NCT03012841|473786741|FG000|Overall Study|Protocol Violation|0|||
131589172|NCT03012841|473786742|FG001|Overall Study|Protocol Violation|10|||
131589173|NCT03012841|473786741|FG000|Overall Study|Lost to Follow-up|6|||
131589174|NCT03012841|473786742|FG001|Overall Study|Lost to Follow-up|1|||
131589175|NCT03012841|473786741|FG000|Overall Study|Withdrawal by Subject|6|||
131589176|NCT03012841|473786742|FG001|Overall Study|Withdrawal by Subject|0|||
131589177|NCT03012841|473786741|FG000|Overall Study|Unable to complete 12 month visit|6|||
131589178|NCT03012841|473786742|FG001|Overall Study|Unable to complete 12 month visit|0|||
131589179|NCT03012841|473786741|FG000|Overall Study|Subject relocation|1|||
131589180|NCT03012841|473786742|FG001|Overall Study|Subject relocation|0|||
131589181|NCT03012841|473786741|FG000|Overall Study|Seasonal winter travel|1|||
131589182|NCT03012841|473786742|FG001|Overall Study|Seasonal winter travel|0|||
131589183|NCT03012841|473786741|FG000|Overall Study|Physician Decision|0|||
131589184|NCT03012841|473786742|FG001|Overall Study|Physician Decision|2|||
131589185|NCT03012841|473786741|FG000|Overall Study|No ablation performed|0|||
131589186|NCT03012841|473786742|FG001|Overall Study|No ablation performed|2|||
131589187|NCT03012841|473786741|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
131589188|NCT03012841|473786742|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
131589189|NCT03012841|473786741|FG000|Overall Study|Insurance change|0|||
131589190|NCT03012841|473786742|FG001|Overall Study|Insurance change|1|||
131589191|NCT05096819|473786743|FG000|Overall Study|Withdrawal by Subject|3|||
131589192|NCT05096819|473786744|FG001|Overall Study|Withdrawal by Subject|0|||
131589193|NCT03547908|473786745|FG000|Blinded Phase|Lost to Follow-up|3|||
131589194|NCT03547908|473786746|FG001|Blinded Phase|Lost to Follow-up|3|||
131589195|NCT03547908|473786747|FG002|Blinded Phase|Lost to Follow-up|0|||
131589196|NCT03547908|473786748|FG003|Blinded Phase|Lost to Follow-up|0|||
131589197|NCT03547908|473786745|FG000|Blinded Phase|Withdrew Consent|2|||
131589198|NCT03547908|473786746|FG001|Blinded Phase|Withdrew Consent|3|||
131589199|NCT03547908|473786747|FG002|Blinded Phase|Withdrew Consent|0|||
131589200|NCT03547908|473786748|FG003|Blinded Phase|Withdrew Consent|0|||
131589201|NCT03547908|473786745|FG000|Blinded Phase|Investigator's Discretion|2|||
131589202|NCT03547908|473786746|FG001|Blinded Phase|Investigator's Discretion|1|||
131589203|NCT03547908|473786747|FG002|Blinded Phase|Investigator's Discretion|0|||
131589204|NCT03547908|473786748|FG003|Blinded Phase|Investigator's Discretion|0|||
131589205|NCT03547908|473786745|FG000|Blinded Phase|Death|2|||
131589206|NCT03547908|473786746|FG001|Blinded Phase|Death|0|||
131705810|NCT02965716|474205470|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
131705811|NCT02965716|474205469|FG000|Overall Study|Progression/Relapse|8|||
131705812|NCT02965716|474205470|FG001|Overall Study|Progression/Relapse|16|||
131705813|NCT02965716|474205469|FG000|Overall Study|Death|1|||
131705814|NCT02965716|474205470|FG001|Overall Study|Death|0|||
131705815|NCT02965716|474205469|FG000|Overall Study|Not Protocol Specified|1|||
131705816|NCT02965716|474205470|FG001|Overall Study|Not Protocol Specified|3|||
131705817|NCT04047797|474205471|FG000|Overall Study|Progressive Disease|1|||
131705818|NCT03523351|474205472|FG000|Overall Study|Death|13|||
131705819|NCT03523351|474205473|FG001|Overall Study|Death|11|||
131705820|NCT03523351|474205472|FG000|Overall Study|Lost to Follow-up|2|||
131705821|NCT03523351|474205473|FG001|Overall Study|Lost to Follow-up|3|||
131705822|NCT03523351|474205472|FG000|Overall Study|Withdrawal by Subject|4|||
131705823|NCT03523351|474205473|FG001|Overall Study|Withdrawal by Subject|0|||
131705824|NCT03523351|474205472|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
131705825|NCT03523351|474205473|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
131705826|NCT00132041|474205483|FG000|Baseline|Ineligible|6|||
131705827|NCT00132041|474205483|FG000|3 Months Post Ablation|Transplant|1|||
131705828|NCT00132041|474205483|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
131705829|NCT00132041|474205483|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
131705830|NCT00132041|474205483|FG000|6 Months Post Ablation|Death|2|||
131705831|NCT00132041|474205483|FG000|6 Months Post Ablation|Transplant|6|||
131899065|NCT03569098|474917493|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
131705832|NCT00132041|474205483|FG000|9 Months Post Ablation|Death|1|||
131705833|NCT00132041|474205483|FG000|9 Months Post Ablation|Transplant|1|||
131705834|NCT00132041|474205483|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
131705835|NCT00132041|474205483|FG000|12 Months Post Ablation|Death|1|||
131589207|NCT03547908|473786747|FG002|Blinded Phase|Death|0|||
131589208|NCT03547908|473786748|FG003|Blinded Phase|Death|0|||
131589209|NCT03547908|473786745|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
131589210|NCT03547908|473786746|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
131589211|NCT03547908|473786747|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
131589212|NCT03547908|473786748|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
131589213|NCT03547908|473786745|FG000|Blinded Phase|Adverse Event|1|||
131589214|NCT03547908|473786746|FG001|Blinded Phase|Adverse Event|0|||
131589215|NCT03547908|473786747|FG002|Blinded Phase|Adverse Event|0|||
131589216|NCT03547908|473786748|FG003|Blinded Phase|Adverse Event|0|||
131589217|NCT03547908|473786745|FG000|Blinded Phase|Randomized But Never Treated|1|||
131589218|NCT03547908|473786746|FG001|Blinded Phase|Randomized But Never Treated|0|||
131589219|NCT03547908|473786747|FG002|Blinded Phase|Randomized But Never Treated|0|||
131589220|NCT03547908|473786748|FG003|Blinded Phase|Randomized But Never Treated|0|||
131589221|NCT03547908|473786745|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
131589222|NCT03547908|473786746|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
131589223|NCT03547908|473786747|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
131589224|NCT03547908|473786748|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
131589225|NCT03547908|473786745|FG000|Open-label Extension Phase|Death|0|||
131589226|NCT03547908|473786746|FG001|Open-label Extension Phase|Death|0|||
131589227|NCT03547908|473786747|FG002|Open-label Extension Phase|Death|1|||
131589228|NCT03547908|473786748|FG003|Open-label Extension Phase|Death|0|||
131589229|NCT03416023|473786755|FG000|Overall Study|Exclusion criteria failure|1|||
131589230|NCT03416023|473786755|FG000|Overall Study|Withdrawal by Subject|6|||
131589231|NCT03416023|473786755|FG000|Overall Study|Explanted|7|||
131589232|NCT03416023|473786755|FG000|Overall Study|Physician Decision|1|||
131589233|NCT03416023|473786755|FG000|Overall Study|Lost to Follow-up|1|||
131589234|NCT03416023|473786755|FG000|Overall Study|Death|1|||
131589235|NCT02152137|473786757|FG000|Overall Study|Withdrawal by Subject|1|||
131589236|NCT02152137|473786757|FG000|Overall Study|Originally assigned to Arm B|3|||
131589237|NCT04878354|473786758|FG000|Overall Study|Adverse Event|4|||
131589238|NCT04878354|473786759|FG001|Overall Study|Adverse Event|13|||
131589239|NCT04878354|473786758|FG000|Overall Study|Withdrawal by Subject|14|||
131589240|NCT04878354|473786759|FG001|Overall Study|Withdrawal by Subject|12|||
131589241|NCT04878354|473786758|FG000|Overall Study|Lost to Follow-up|4|||
131589242|NCT04878354|473786759|FG001|Overall Study|Lost to Follow-up|1|||
131589243|NCT04878354|473786758|FG000|Overall Study|Lack of Efficacy|1|||
131589244|NCT04878354|473786759|FG001|Overall Study|Lack of Efficacy|0|||
131589245|NCT04878354|473786758|FG000|Overall Study|Protocol Violation|0|||
131589246|NCT04878354|473786759|FG001|Overall Study|Protocol Violation|1|||
131589247|NCT04878354|473786758|FG000|Overall Study|"Reason stated as other in CRF"|2|||
131589248|NCT04878354|473786759|FG001|Overall Study|"Reason stated as other in CRF"|3|||
131589249|NCT03358875|473786760|FG000|Overall Study|Death|409|||
131589250|NCT03358875|473786761|FG001|Overall Study|Death|223|||
131589251|NCT03358875|473786760|FG000|Overall Study|Study Closed by Sponsor|66|||
131589252|NCT03358875|473786761|FG001|Overall Study|Study Closed by Sponsor|29|||
131589253|NCT03358875|473786760|FG000|Overall Study|Withdrawal by Subject|13|||
131589254|NCT03358875|473786761|FG001|Overall Study|Withdrawal by Subject|16|||
131589255|NCT03358875|473786760|FG000|Overall Study|Lost to Follow-up|13|||
131589256|NCT03358875|473786761|FG001|Overall Study|Lost to Follow-up|2|||
131589257|NCT03358875|473786760|FG000|Overall Study|Miscellaneous|33|||
131589258|NCT03358875|473786761|FG001|Overall Study|Miscellaneous|0|||
131705836|NCT00132041|474205483|FG000|12 Months Post Ablation|Transplant|1|||
131705837|NCT00132041|474205483|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
131705838|NCT00132041|474205483|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
131705839|NCT00132041|474205483|FG000|15 Months Post Ablation|Death|1|||
131705840|NCT00132041|474205483|FG000|15 Months Post Ablation|Transplant|5|||
131705841|NCT00132041|474205483|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
131705842|NCT00132041|474205483|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
131705843|NCT00132041|474205483|FG000|18 Months Post Ablation|Transplant|1|||
131705844|NCT00132041|474205483|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
131705845|NCT00132041|474205483|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
131705846|NCT03609619|474205484|FG000|Overall Study|Adverse Event|1|||
131705847|NCT03609619|474205485|FG001|Overall Study|Adverse Event|0|||
131705848|NCT03609619|474205484|FG000|Overall Study|Lack of Efficacy|1|||
131705849|NCT03609619|474205485|FG001|Overall Study|Lack of Efficacy|2|||
131705850|NCT03609619|474205484|FG000|Overall Study|Protocol Violation|5|||
131705851|NCT03609619|474205485|FG001|Overall Study|Protocol Violation|0|||
131705852|NCT03609619|474205484|FG000|Overall Study|Withdrawal by Subject|2|||
131589259|NCT03358875|473786760|FG000|Overall Study|Remained on Study|1|||
131589260|NCT03358875|473786761|FG001|Overall Study|Remained on Study|0|||
131589261|NCT06194214|473786765|FG000|Overall Study|Adverse Event|1|||
131705853|NCT03609619|474205485|FG001|Overall Study|Withdrawal by Subject|3|||
131589262|NCT04112316|473786775|FG000|First Period (8 Weeks)|Protocol Violation|1|||
131589263|NCT04112316|473786776|FG001|First Period (8 Weeks)|Protocol Violation|0|||
131705854|NCT03609619|474205484|FG000|Overall Study|Lost to Follow-up|1|||
131705855|NCT03609619|474205485|FG001|Overall Study|Lost to Follow-up|1|||
131589264|NCT04112316|473786775|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
131589265|NCT04112316|473786776|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
131589266|NCT03857620|473786777|FG000|Overall Study|Death|4|||
131791086|NCT00738920|474517056|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
131791087|NCT02378506|474517057|FG000|Overall Study|Lack of Efficacy|3|||
131791088|NCT02378506|474517057|FG000|Overall Study|Withdrawal by Subject|4|||
131791089|NCT02378506|474517057|FG000|Overall Study|Protocol Violation|2|||
131791090|NCT02378506|474517057|FG000|Overall Study|Death|1|||
131791091|NCT02378506|474517057|FG000|Overall Study|Adverse Event|14|||
131589267|NCT03857620|473786778|FG001|Overall Study|Death|5|||
131589268|NCT03857620|473786779|FG002|Overall Study|Death|7|||
131589269|NCT03857620|473786777|FG000|Overall Study|Lost to Follow-up|2|||
131589270|NCT03857620|473786778|FG001|Overall Study|Lost to Follow-up|5|||
131589271|NCT03857620|473786779|FG002|Overall Study|Lost to Follow-up|3|||
131589272|NCT03857620|473786777|FG000|Overall Study|Disease progression or relapse after study registration|1|||
131589273|NCT03857620|473786778|FG001|Overall Study|Disease progression or relapse after study registration|5|||
131589274|NCT03857620|473786779|FG002|Overall Study|Disease progression or relapse after study registration|1|||
131589275|NCT03857620|473786777|FG000|Overall Study|Ineligible|5|||
131589276|NCT03857620|473786778|FG001|Overall Study|Ineligible|0|||
131589277|NCT03857620|473786779|FG002|Overall Study|Ineligible|2|||
131589278|NCT03857620|473786777|FG000|Overall Study|No malignancy|1|||
131589279|NCT03857620|473786778|FG001|Overall Study|No malignancy|0|||
131589280|NCT03857620|473786779|FG002|Overall Study|No malignancy|1|||
131589281|NCT03857620|473786777|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
131589282|NCT03857620|473786778|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
131589283|NCT03857620|473786779|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
131589284|NCT03857620|473786777|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
131589285|NCT03857620|473786778|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
131589286|NCT03857620|473786779|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
131589287|NCT03857620|473786777|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
131589288|NCT03857620|473786778|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
131589289|NCT03857620|473786779|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
131589290|NCT03857620|473786777|FG000|Overall Study|Surgery not performed, patient decision|0|||
131589291|NCT03857620|473786778|FG001|Overall Study|Surgery not performed, patient decision|3|||
131589292|NCT03857620|473786779|FG002|Overall Study|Surgery not performed, patient decision|1|||
131589293|NCT03857620|473786777|FG000|Overall Study|Surgery not performed, other reason|3|||
131589294|NCT03857620|473786778|FG001|Overall Study|Surgery not performed, other reason|1|||
131589295|NCT03857620|473786779|FG002|Overall Study|Surgery not performed, other reason|4|||
131589296|NCT03857620|473786777|FG000|Overall Study|Worsening performance status after surgery performed|0|||
131589297|NCT03857620|473786778|FG001|Overall Study|Worsening performance status after surgery performed|1|||
131589298|NCT03857620|473786779|FG002|Overall Study|Worsening performance status after surgery performed|1|||
131589299|NCT03433339|473786780|FG000|Overall Study|Lost to Follow-up|2|||
131589300|NCT03433339|473786781|FG001|Overall Study|Lost to Follow-up|0|||
131589301|NCT03433339|473786780|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
131589302|NCT03433339|473786781|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
131589303|NCT03433339|473786780|FG000|Overall Study|Withdrawal by Subject|0|||
131589304|NCT03433339|473786781|FG001|Overall Study|Withdrawal by Subject|2|||
131589305|NCT04732494|473786792|FG000|Overall Study|Death|39|||
131589306|NCT04732494|473786793|FG001|Overall Study|Death|36|||
131589307|NCT04732494|473786792|FG000|Overall Study|Study Closed by Sponsor|20|||
131589308|NCT04732494|473786793|FG001|Overall Study|Study Closed by Sponsor|15|||
131589309|NCT04732494|473786792|FG000|Overall Study|Withdrawal by Subject|2|||
131589310|NCT04732494|473786793|FG001|Overall Study|Withdrawal by Subject|7|||
131589311|NCT04732494|473786792|FG000|Overall Study|Lost to Follow-up|1|||
131589312|NCT04732494|473786793|FG001|Overall Study|Lost to Follow-up|5|||
131589313|NCT05136404|473786794|FG000|Period 1|Adverse Event|0|||
131791092|NCT02378506|474517057|FG000|Overall Study|Randomized But Not Treated|1|||
131791093|NCT01606137|474517058|FG000|Overall Study|Adverse Event|85|||
131791094|NCT01606137|474517058|FG000|Overall Study|Withdrawal by Subject|74|||
131589314|NCT05136404|473786795|FG001|Period 1|Adverse Event|1|||
131589315|NCT05136404|473786796|FG002|Period 1|Adverse Event|1|||
131589316|NCT05136404|473786794|FG000|Period 2|Inappropriate Behavior|0|||
131589317|NCT05136404|473786795|FG001|Period 2|Inappropriate Behavior|0|||
131589318|NCT05136404|473786796|FG002|Period 2|Inappropriate Behavior|1|||
131589319|NCT05136404|473786794|FG000|Period 3|Adverse Event|0|||
131589320|NCT05136404|473786795|FG001|Period 3|Adverse Event|0|||
131589321|NCT05136404|473786796|FG002|Period 3|Adverse Event|1|||
131589322|NCT00448669|473786798|FG000|Overall Study|Lost to Follow-up|52|||
131791095|NCT01606137|474517058|FG000|Overall Study|Lack of Efficacy|56|||
131791096|NCT01606137|474517058|FG000|Overall Study|Lost to Follow-up|15|||
131589323|NCT00448669|473786799|FG001|Overall Study|Lost to Follow-up|63|||
131589324|NCT00448669|473786798|FG000|Overall Study|Withdrawal by Subject|90|||
131589325|NCT00448669|473786799|FG001|Overall Study|Withdrawal by Subject|74|||
131589326|NCT00448669|473786798|FG000|Overall Study|Relocated|49|||
131589327|NCT00448669|473786799|FG001|Overall Study|Relocated|36|||
131589328|NCT00448669|473786798|FG000|Overall Study|Were withdrawn by investigator|10|||
131589329|NCT00448669|473786799|FG001|Overall Study|Were withdrawn by investigator|6|||
131589330|NCT00448669|473786798|FG000|Overall Study|Death|2|||
131589331|NCT00448669|473786799|FG001|Overall Study|Death|4|||
131589332|NCT00448669|473786798|FG000|Overall Study|Had other reasons|5|||
131589333|NCT00448669|473786799|FG001|Overall Study|Had other reasons|6|||
131589334|NCT00448669|473786798|FG000|Overall Study|HIV-infected at enrollment|1|||
131589335|NCT00448669|473786799|FG001|Overall Study|HIV-infected at enrollment|2|||
131589336|NCT00448669|473786798|FG000|Overall Study|Never started drug|9|||
131589337|NCT00448669|473786799|FG001|Overall Study|Never started drug|7|||
131589338|NCT04287985|473786800|FG000|Overall Study|Adverse Event|1|||
131589339|NCT04287985|473786801|FG001|Overall Study|Adverse Event|0|||
131589340|NCT04287985|473786802|FG002|Overall Study|Adverse Event|0|||
131589341|NCT04287985|473786803|FG003|Overall Study|Adverse Event|0|||
131589342|NCT04287985|473786800|FG000|Overall Study|Protocol Violation|0|||
131589343|NCT04287985|473786801|FG001|Overall Study|Protocol Violation|1|||
131589344|NCT04287985|473786802|FG002|Overall Study|Protocol Violation|0|||
131589345|NCT04287985|473786803|FG003|Overall Study|Protocol Violation|0|||
131589346|NCT04287985|473786800|FG000|Overall Study|Physician Decision|0|||
131589347|NCT04287985|473786801|FG001|Overall Study|Physician Decision|0|||
131589348|NCT04287985|473786802|FG002|Overall Study|Physician Decision|0|||
131589349|NCT04287985|473786803|FG003|Overall Study|Physician Decision|1|||
131589350|NCT04287985|473786800|FG000|Overall Study|Withdrawal by Subject|2|||
131589351|NCT04287985|473786801|FG001|Overall Study|Withdrawal by Subject|1|||
131589352|NCT04287985|473786802|FG002|Overall Study|Withdrawal by Subject|1|||
131589353|NCT04287985|473786803|FG003|Overall Study|Withdrawal by Subject|2|||
131589354|NCT01340066|473786808|FG000|Placebo Run in Period|Screen Failures|27|||
131589355|NCT01340066|473786809|FG001|Placebo Run in Period|Screen Failures|0|||
131589356|NCT01340066|473786810|FG002|Placebo Run in Period|Screen Failures|0|||
131589357|NCT01340066|473786808|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
131589358|NCT01340066|473786809|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
131589359|NCT01340066|473786810|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
131589360|NCT01340066|473786808|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
131589361|NCT01340066|473786809|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
131589362|NCT01340066|473786810|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
131589363|NCT01340066|473786808|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
131589364|NCT01340066|473786809|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
131589365|NCT01340066|473786810|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
131589366|NCT02789020|473786811|FG000|Overall Study|Withdrawal by Subject|6|||
131589367|NCT02789020|473786812|FG001|Overall Study|Withdrawal by Subject|5|||
131791097|NCT01606137|474517058|FG000|Overall Study|Protocol Violation|1|||
131791098|NCT01606137|474517058|FG000|Overall Study|Patient non-compliance|9|||
131791099|NCT01606137|474517058|FG000|Overall Study|Death|1|||
131589368|NCT03092726|473786819|FG000|Overall Study|Adverse Event|3|||
131589369|NCT03092726|473786820|FG001|Overall Study|Adverse Event|10|||
131589370|NCT03092726|473786819|FG000|Overall Study|Lack of Efficacy|0|||
131589371|NCT03092726|473786820|FG001|Overall Study|Lack of Efficacy|1|||
131589372|NCT03092726|473786819|FG000|Overall Study|Lost to Follow-up|1|||
131589373|NCT03092726|473786820|FG001|Overall Study|Lost to Follow-up|0|||
131589374|NCT03092726|473786819|FG000|Overall Study|Withdrawal by Subject|5|||
131589375|NCT03092726|473786820|FG001|Overall Study|Withdrawal by Subject|3|||
131589376|NCT04950127|473786821|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
131589377|NCT04950127|473786822|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
131589378|NCT04950127|473786823|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
131589379|NCT04950127|473786824|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
131589380|NCT04950127|473786825|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
131589381|NCT04950127|473786826|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
131589382|NCT04950127|473786821|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
131791100|NCT01606137|474517058|FG000|Overall Study|Decreased/no pain|4|||
131791101|NCT01606137|474517058|FG000|Overall Study|Issues with driving|4|||
131791102|NCT01606137|474517058|FG000|Overall Study|multiple sclerosis less stable|1|||
131589383|NCT04950127|473786822|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
131589384|NCT04950127|473786823|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
131589385|NCT04950127|473786824|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
131589386|NCT04950127|473786825|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
131589387|NCT04950127|473786826|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
131589388|NCT04950127|473786821|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
131589389|NCT04950127|473786822|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
131589390|NCT04950127|473786823|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131791103|NCT01606137|474517058|FG000|Overall Study|Increased bilirubin|1|||
131705856|NCT00956943|474205486|FG000|Overall Study|Lost to Follow-up|9|||
131705857|NCT00956943|474205487|FG001|Overall Study|Lost to Follow-up|10|||
131589391|NCT04950127|473786824|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131589392|NCT04950127|473786825|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131589393|NCT04950127|473786826|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131589394|NCT04950127|473786821|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131589395|NCT04950127|473786822|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131589396|NCT04950127|473786823|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131589397|NCT04950127|473786824|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131589398|NCT04950127|473786825|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131589399|NCT04950127|473786826|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
131589400|NCT04950127|473786821|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
131705858|NCT02663895|474205488|FG000|Overall Study|Adverse Event|3|||
131705859|NCT02663895|474205488|FG000|Overall Study|Physician Decision|2|||
131705860|NCT02663895|474205488|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
131705861|NCT02663895|474205488|FG000|Overall Study|Withdrawal by Subject|1|||
131705862|NCT02327260|474205489|FG000|Overall Study|Lost to Follow-up|2|||
131705863|NCT02327260|474205490|FG001|Overall Study|Lost to Follow-up|3|||
131705864|NCT02327260|474205491|FG002|Overall Study|Lost to Follow-up|2|||
131705865|NCT02327260|474205489|FG000|Overall Study|invalid phone number|1|||
131705866|NCT02327260|474205490|FG001|Overall Study|invalid phone number|1|||
131589401|NCT04950127|473786822|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
131589402|NCT04950127|473786823|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
131705867|NCT02327260|474205491|FG002|Overall Study|invalid phone number|0|||
131791104|NCT01606137|474517058|FG000|Overall Study|Spray causes nausea|1|||
131791105|NCT01606137|474517058|FG000|Overall Study|Not enough improvement|4|||
131589403|NCT04950127|473786824|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
131791106|NCT01606137|474517058|FG000|Overall Study|Wanted to try another treatment|1|||
131791107|NCT01606137|474517058|FG000|Overall Study|Patient leaving country|1|||
131791108|NCT01606137|474517058|FG000|Overall Study|Personal reasons|1|||
131589404|NCT04950127|473786825|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
131589405|NCT04950127|473786826|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
131589406|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Adverse Event|4|||
131589407|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Adverse Event|1|||
131589408|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
131589409|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
131589410|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
131589411|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
131589412|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
131705868|NCT02327260|474205489|FG000|Overall Study|non-adherence to protocol|2|||
131791109|NCT01606137|474517058|FG000|Overall Study|Unable to tolerate study med. taste|1|||
131791110|NCT01606137|474517058|FG000|Overall Study|Patient moving|1|||
131791111|NCT01606137|474517058|FG000|Overall Study|Unable to collect consistent data|1|||
131791112|NCT00720798|474518588|FG000|Overall Study|Adverse Event|304|||
131791113|NCT00720798|474518588|FG000|Overall Study|Death|39|||
131791114|NCT00720798|474518588|FG000|Overall Study|Insufficient Therapeutic Response|129|||
131791115|NCT00720798|474518588|FG000|Overall Study|Protocol Violation|4|||
131791116|NCT00720798|474518588|FG000|Overall Study|Refused Treatment|151|||
131791117|NCT00720798|474518588|FG000|Overall Study|Failure to Return|46|||
131791118|NCT00720798|474518588|FG000|Overall Study|Reason not Specified|83|||
131791119|NCT00433381|474518589|FG000|Overall Study|Ineligible / no protocol treatment|3|||
131791120|NCT00433381|474518590|FG001|Overall Study|Ineligible / no protocol treatment|3|||
131791121|NCT00909727|474518614|FG000|Overall Study|Adverse Event|1|||
131791122|NCT00909727|474518615|FG001|Overall Study|Adverse Event|0|||
131791123|NCT00909727|474518614|FG000|Overall Study|Wrong Genotype|1|||
131791124|NCT00909727|474518615|FG001|Overall Study|Wrong Genotype|0|||
131791125|NCT00909727|474518614|FG000|Overall Study|Withdrawal of Consent|1|||
131791126|NCT00909727|474518615|FG001|Overall Study|Withdrawal of Consent|0|||
131791127|NCT00909727|474518614|FG000|Overall Study|Prohibited Medication|1|||
131791128|NCT00909727|474518615|FG001|Overall Study|Prohibited Medication|0|||
131791129|NCT00295854|474518620|FG000|Overall Study|Adverse Event|7|||
131899066|NCT03569098|474917494|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
131589413|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
131705869|NCT02327260|474205490|FG001|Overall Study|non-adherence to protocol|0|||
131705870|NCT02327260|474205491|FG002|Overall Study|non-adherence to protocol|0|||
131705871|NCT02327260|474205489|FG000|Overall Study|cognitive concerns|1|||
131705872|NCT02327260|474205490|FG001|Overall Study|cognitive concerns|0|||
131705873|NCT02327260|474205491|FG002|Overall Study|cognitive concerns|0|||
131705874|NCT01400932|474205492|FG000|Overall Study|Adverse Event|10|||
131705875|NCT01400932|474205493|FG001|Overall Study|Adverse Event|5|||
131705876|NCT01400932|474205492|FG000|Overall Study|Lack of Efficacy|0|||
131791130|NCT00295854|474518621|FG001|Overall Study|Adverse Event|7|||
131791131|NCT00295854|474518622|FG002|Overall Study|Adverse Event|6|||
131791132|NCT00295854|474518620|FG000|Overall Study|Protocol Violation|1|||
131705877|NCT01400932|474205493|FG001|Overall Study|Lack of Efficacy|3|||
131705878|NCT01400932|474205492|FG000|Overall Study|Withdrawal by Subject|2|||
131705879|NCT01400932|474205493|FG001|Overall Study|Withdrawal by Subject|6|||
131705880|NCT01400932|474205492|FG000|Overall Study|Lost to Follow-up|1|||
131705881|NCT01400932|474205493|FG001|Overall Study|Lost to Follow-up|0|||
131705882|NCT01400932|474205492|FG000|Overall Study|Protocol Deviation|0|||
131705883|NCT01400932|474205493|FG001|Overall Study|Protocol Deviation|1|||
131705884|NCT01400932|474205492|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131705885|NCT01400932|474205493|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131705886|NCT00066690|474205494|FG000|Overall Study|Adverse Event|145|||
131705887|NCT00066690|474205495|FG001|Overall Study|Adverse Event|58|||
131705888|NCT00066690|474205496|FG002|Overall Study|Adverse Event|126|||
131705889|NCT00066690|474205494|FG000|Overall Study|Death|3|||
131705890|NCT00066690|474205495|FG001|Overall Study|Death|0|||
131705891|NCT00066690|474205496|FG002|Overall Study|Death|2|||
131705892|NCT00066690|474205494|FG000|Overall Study|Lack of Efficacy|114|||
131705893|NCT00066690|474205495|FG001|Overall Study|Lack of Efficacy|110|||
131705894|NCT00066690|474205496|FG002|Overall Study|Lack of Efficacy|76|||
131705895|NCT00066690|474205494|FG000|Overall Study|Lost to Follow-up|40|||
131705896|NCT00066690|474205495|FG001|Overall Study|Lost to Follow-up|21|||
131705897|NCT00066690|474205496|FG002|Overall Study|Lost to Follow-up|29|||
131705898|NCT00066690|474205494|FG000|Overall Study|Withdrawal by Subject|50|||
131705899|NCT00066690|474205495|FG001|Overall Study|Withdrawal by Subject|55|||
131705900|NCT00066690|474205496|FG002|Overall Study|Withdrawal by Subject|49|||
131705901|NCT00066690|474205494|FG000|Overall Study|Treatment Ongoing|246|||
131705902|NCT00066690|474205495|FG001|Overall Study|Treatment Ongoing|278|||
131705903|NCT00066690|474205496|FG002|Overall Study|Treatment Ongoing|282|||
131705904|NCT00793793|474205499|FG000|Overall Study|Adverse Event|0|||
131705905|NCT00793793|474205500|FG001|Overall Study|Adverse Event|0|||
131705906|NCT00793793|474205501|FG002|Overall Study|Adverse Event|1|||
131705907|NCT00793793|474205502|FG003|Overall Study|Adverse Event|1|||
131705908|NCT00793793|474205503|FG004|Overall Study|Adverse Event|0|||
131705909|NCT00793793|474205504|FG005|Overall Study|Adverse Event|1|||
131705910|NCT00793793|474205505|FG006|Overall Study|Adverse Event|2|||
131705911|NCT00793793|474205506|FG007|Overall Study|Adverse Event|0|||
131705912|NCT00793793|474205507|FG008|Overall Study|Adverse Event|0|||
131705913|NCT00793793|474205508|FG009|Overall Study|Adverse Event|0|||
131705914|NCT00793793|474205509|FG010|Overall Study|Adverse Event|0|||
131705915|NCT00793793|474205510|FG011|Overall Study|Adverse Event|2|||
131791133|NCT00295854|474518621|FG001|Overall Study|Protocol Violation|1|||
131791134|NCT00295854|474518622|FG002|Overall Study|Protocol Violation|1|||
131791135|NCT00295854|474518620|FG000|Overall Study|Lost to Follow-up|2|||
131791136|NCT00295854|474518621|FG001|Overall Study|Lost to Follow-up|0|||
131791137|NCT00295854|474518622|FG002|Overall Study|Lost to Follow-up|1|||
131791138|NCT00295854|474518620|FG000|Overall Study|Withdrawal by Subject|3|||
131791139|NCT00295854|474518621|FG001|Overall Study|Withdrawal by Subject|7|||
131791140|NCT00295854|474518622|FG002|Overall Study|Withdrawal by Subject|4|||
131705916|NCT00793793|474205499|FG000|Overall Study|Protocol Violation|0|||
131705917|NCT00793793|474205500|FG001|Overall Study|Protocol Violation|0|||
131705918|NCT00793793|474205501|FG002|Overall Study|Protocol Violation|0|||
131705919|NCT00793793|474205502|FG003|Overall Study|Protocol Violation|1|||
131705920|NCT00793793|474205503|FG004|Overall Study|Protocol Violation|0|||
131705921|NCT00793793|474205504|FG005|Overall Study|Protocol Violation|0|||
131705922|NCT00793793|474205505|FG006|Overall Study|Protocol Violation|0|||
131705923|NCT00793793|474205506|FG007|Overall Study|Protocol Violation|0|||
131705924|NCT00793793|474205507|FG008|Overall Study|Protocol Violation|0|||
131705925|NCT00793793|474205508|FG009|Overall Study|Protocol Violation|0|||
131705926|NCT00793793|474205509|FG010|Overall Study|Protocol Violation|0|||
131705927|NCT00793793|474205510|FG011|Overall Study|Protocol Violation|0|||
131705928|NCT00793793|474205499|FG000|Overall Study|Lost to Follow-up|0|||
131705929|NCT00793793|474205500|FG001|Overall Study|Lost to Follow-up|0|||
131791141|NCT00295854|474518620|FG000|Overall Study|did not continue to meet criteria|1|||
131791142|NCT00295854|474518621|FG001|Overall Study|did not continue to meet criteria|1|||
131705930|NCT00793793|474205501|FG002|Overall Study|Lost to Follow-up|1|||
131705931|NCT00793793|474205502|FG003|Overall Study|Lost to Follow-up|0|||
131705932|NCT00793793|474205503|FG004|Overall Study|Lost to Follow-up|0|||
131705933|NCT00793793|474205504|FG005|Overall Study|Lost to Follow-up|0|||
131705934|NCT00793793|474205505|FG006|Overall Study|Lost to Follow-up|0|||
131705935|NCT00793793|474205506|FG007|Overall Study|Lost to Follow-up|0|||
131705936|NCT00793793|474205507|FG008|Overall Study|Lost to Follow-up|1|||
131705937|NCT00793793|474205508|FG009|Overall Study|Lost to Follow-up|3|||
131791143|NCT00295854|474518622|FG002|Overall Study|did not continue to meet criteria|2|||
131791144|NCT00295854|474518620|FG000|Overall Study|required a prohibited medication|1|||
131589414|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
131589415|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
131589416|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Other|6|||
131589417|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Other|1|||
131589418|NCT03271489|473786828|FG000|Double-Blind (DB) Period|Missing|1|||
131589419|NCT03271489|473786829|FG001|Double-Blind (DB) Period|Missing|0|||
131589420|NCT03271489|473786828|FG000|Open-Label (OL) Period|Adverse Event|2|||
131589421|NCT03271489|473786829|FG001|Open-Label (OL) Period|Adverse Event|0|||
131589422|NCT03271489|473786828|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
131589423|NCT03271489|473786829|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
131589424|NCT03271489|473786828|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
131589425|NCT03271489|473786829|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
131589426|NCT03271489|473786828|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
131589427|NCT03271489|473786829|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
131589428|NCT03271489|473786828|FG000|Open-Label (OL) Period|No Specified|2|||
131589429|NCT03271489|473786829|FG001|Open-Label (OL) Period|No Specified|2|||
131589430|NCT03271489|473786828|FG000|Open-Label (OL) Period|Missing|2|||
131589431|NCT03271489|473786829|FG001|Open-Label (OL) Period|Missing|0|||
131589432|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
131589433|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
131589434|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
131589435|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
131589436|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
131589437|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
131589438|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
131589439|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
131589440|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
131589441|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
131589442|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
131589443|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
131589444|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
131589445|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
131589446|NCT03271489|473786828|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
131589447|NCT03271489|473786829|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
131589448|NCT05064735|473786830|FG000|Overall Study|Withdrawal by Subject|7|||
131589449|NCT05064735|473786831|FG001|Overall Study|Withdrawal by Subject|8|||
131589450|NCT05064735|473786830|FG000|Overall Study|Lost to Follow-up|7|||
131589451|NCT05064735|473786831|FG001|Overall Study|Lost to Follow-up|2|||
131589452|NCT05064735|473786830|FG000|Overall Study|Physician Decision|2|||
131589453|NCT05064735|473786831|FG001|Overall Study|Physician Decision|1|||
131589454|NCT05064735|473786830|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
131589455|NCT05064735|473786831|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
131589456|NCT05064735|473786830|FG000|Overall Study|Site Closure|7|||
131589457|NCT05064735|473786831|FG001|Overall Study|Site Closure|2|||
131589458|NCT05575076|473786832|FG000|Overall Study|Adverse Event|24|||
131589459|NCT05575076|473786832|FG000|Overall Study|Death|7|||
131589460|NCT05575076|473786832|FG000|Overall Study|Lost to Follow-up|16|||
131589461|NCT05575076|473786832|FG000|Overall Study|Non-Compliance|3|||
131589462|NCT05575076|473786832|FG000|Overall Study|Physician Decision|6|||
131589463|NCT05575076|473786832|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
131589464|NCT05575076|473786832|FG000|Overall Study|Withdrawal by Subject|71|||
131589465|NCT05575076|473786832|FG000|Overall Study|Study Terminated by Sponsor|630|||
131589466|NCT05575076|473786832|FG000|Overall Study|Other|17|||
131589467|NCT02886286|473786833|FG000|Overall Study|pump motor stall|0|||
131589468|NCT02886286|473786834|FG001|Overall Study|pump motor stall|1|||
131589469|NCT02376790|473786841|FG000|Overall Study|Withdrawal by Subject|43|||
131589470|NCT02376790|473786842|FG001|Overall Study|Withdrawal by Subject|36|||
131589471|NCT02376790|473786843|FG002|Overall Study|Withdrawal by Subject|37|||
131589472|NCT02376790|473786841|FG000|Overall Study|Decision by Sponsor|2|||
131589473|NCT02376790|473786842|FG001|Overall Study|Decision by Sponsor|1|||
131589474|NCT02376790|473786843|FG002|Overall Study|Decision by Sponsor|4|||
131791145|NCT00295854|474518621|FG001|Overall Study|required a prohibited medication|0|||
131791146|NCT00295854|474518622|FG002|Overall Study|required a prohibited medication|0|||
131791147|NCT00295854|474518620|FG000|Overall Study|Other|3|||
131589475|NCT02376790|473786841|FG000|Overall Study|Lost to Follow-up|15|||
131589476|NCT02376790|473786842|FG001|Overall Study|Lost to Follow-up|10|||
131589477|NCT02376790|473786843|FG002|Overall Study|Lost to Follow-up|12|||
131589478|NCT05450458|473786844|FG000|Overall Study|Lost to Follow-up|4|||
131589479|NCT01084707|473786845|FG000|Overall Study|Withdrawal by Subject|6|||
131791148|NCT00295854|474518621|FG001|Overall Study|Other|5|||
131791149|NCT00295854|474518622|FG002|Overall Study|Other|1|||
131791150|NCT00672620|474518623|FG000|Overall Study|Adverse Event|7|||
131705938|NCT00793793|474205509|FG010|Overall Study|Lost to Follow-up|1|||
131705939|NCT00793793|474205510|FG011|Overall Study|Lost to Follow-up|0|||
131705940|NCT00793793|474205499|FG000|Overall Study|Withdrawal by Subject|0|||
131705941|NCT00793793|474205500|FG001|Overall Study|Withdrawal by Subject|0|||
131705942|NCT00793793|474205501|FG002|Overall Study|Withdrawal by Subject|0|||
131705943|NCT00793793|474205502|FG003|Overall Study|Withdrawal by Subject|0|||
131705944|NCT00793793|474205503|FG004|Overall Study|Withdrawal by Subject|1|||
131705945|NCT00793793|474205504|FG005|Overall Study|Withdrawal by Subject|0|||
131705946|NCT00793793|474205505|FG006|Overall Study|Withdrawal by Subject|0|||
131705947|NCT00793793|474205506|FG007|Overall Study|Withdrawal by Subject|0|||
131705948|NCT00793793|474205507|FG008|Overall Study|Withdrawal by Subject|1|||
131705949|NCT00793793|474205508|FG009|Overall Study|Withdrawal by Subject|0|||
131705950|NCT00793793|474205509|FG010|Overall Study|Withdrawal by Subject|0|||
131705951|NCT00793793|474205510|FG011|Overall Study|Withdrawal by Subject|0|||
131705952|NCT00793793|474205499|FG000|Overall Study|reason not specified|0|||
131705953|NCT00793793|474205500|FG001|Overall Study|reason not specified|1|||
131705954|NCT00793793|474205501|FG002|Overall Study|reason not specified|0|||
131705955|NCT00793793|474205502|FG003|Overall Study|reason not specified|1|||
131705956|NCT00793793|474205503|FG004|Overall Study|reason not specified|1|||
131705957|NCT00793793|474205504|FG005|Overall Study|reason not specified|1|||
131705958|NCT00793793|474205505|FG006|Overall Study|reason not specified|2|||
131705959|NCT00793793|474205506|FG007|Overall Study|reason not specified|0|||
131705960|NCT00793793|474205507|FG008|Overall Study|reason not specified|7|||
131705961|NCT00793793|474205508|FG009|Overall Study|reason not specified|6|||
131705962|NCT00793793|474205509|FG010|Overall Study|reason not specified|2|||
131705963|NCT00793793|474205510|FG011|Overall Study|reason not specified|4|||
131705964|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
131705965|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
131705966|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
131705967|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
131705968|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
131705969|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
131705970|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
131705971|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
131705972|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131705973|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131705974|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131705975|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
131705976|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
131705977|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131705978|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131705979|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
131705980|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
131705981|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
131791151|NCT00672620|474518624|FG001|Overall Study|Adverse Event|7|||
131791152|NCT00672620|474518625|FG002|Overall Study|Adverse Event|12|||
131791153|NCT00672620|474518626|FG003|Overall Study|Adverse Event|17|||
131438917|NCT04664153|473233331|FG002|Overall Study|Physician Decision|1|||
131705982|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131791154|NCT00672620|474518623|FG000|Overall Study|Lack of Efficacy|1|||
131705983|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131791155|NCT00672620|474518624|FG001|Overall Study|Lack of Efficacy|2|||
131589480|NCT00901901|473786846|FG000|Treatment Period|Adverse Event|120|||
131589481|NCT00901901|473786847|FG001|Treatment Period|Adverse Event|128|||
131589482|NCT00901901|473786846|FG000|Treatment Period|Withdrawal by Subject|26|||
131589483|NCT00901901|473786847|FG001|Treatment Period|Withdrawal by Subject|24|||
131589484|NCT00901901|473786846|FG000|Treatment Period|Physician Decision|2|||
131589485|NCT00901901|473786847|FG001|Treatment Period|Physician Decision|2|||
131589486|NCT00901901|473786846|FG000|Treatment Period|Lost to Follow-up|3|||
131589487|NCT00901901|473786847|FG001|Treatment Period|Lost to Follow-up|5|||
131589488|NCT00901901|473786846|FG000|Treatment Period|Noncompliance with study medication|4|||
131589489|NCT00901901|473786847|FG001|Treatment Period|Noncompliance with study medication|1|||
131589490|NCT00901901|473786846|FG000|Treatment Period|Missing|1|||
131589491|NCT00901901|473786847|FG001|Treatment Period|Missing|0|||
131589492|NCT00901901|473786846|FG000|Treatment Period|Never treated|0|||
131589493|NCT00901901|473786847|FG001|Treatment Period|Never treated|3|||
131589494|NCT00901901|473786846|FG000|Treatment Period|Protocol driven decision point|0|||
131589495|NCT00901901|473786847|FG001|Treatment Period|Protocol driven decision point|2|||
131589496|NCT00901901|473786846|FG000|Treatment Period|Study terminated by sponsor|2|||
131589497|NCT00901901|473786847|FG001|Treatment Period|Study terminated by sponsor|0|||
131589498|NCT00901901|473786846|FG000|Treatment Period|Protocol Violation|5|||
131589499|NCT00901901|473786847|FG001|Treatment Period|Protocol Violation|9|||
131589500|NCT00901901|473786846|FG000|Treatment Period|Switch to commercial drug|1|||
131589501|NCT00901901|473786847|FG001|Treatment Period|Switch to commercial drug|1|||
131589502|NCT00901901|473786846|FG000|Treatment Period|Transfer to treatment continuation study|5|||
131589503|NCT00901901|473786847|FG001|Treatment Period|Transfer to treatment continuation study|2|||
131589504|NCT00901901|473786846|FG000|Follow-up Period|Death|181|||
131589505|NCT00901901|473786847|FG001|Follow-up Period|Death|208|||
131438918|NCT04664153|473233332|FG003|Overall Study|Physician Decision|0|||
131438919|NCT04664153|473233329|FG000|Overall Study|Withdrawal by Subject|3|||
131589506|NCT00901901|473786846|FG000|Follow-up Period|Protocol driven decision point|47|||
131589507|NCT00901901|473786847|FG001|Follow-up Period|Protocol driven decision point|36|||
131589508|NCT00901901|473786846|FG000|Follow-up Period|Withdrawal by Subject|6|||
131589509|NCT00901901|473786847|FG001|Follow-up Period|Withdrawal by Subject|9|||
131589510|NCT00901901|473786846|FG000|Follow-up Period|Lost to Follow-up|12|||
131589511|NCT00901901|473786847|FG001|Follow-up Period|Lost to Follow-up|8|||
131589512|NCT00901901|473786846|FG000|Follow-up Period|Missing|94|||
131589513|NCT00901901|473786847|FG001|Follow-up Period|Missing|80|||
131589514|NCT05171777|473786850|FG000|Treatment Crossover Period|Adverse Event|9|||
131589515|NCT05171777|473786851|FG001|Treatment Crossover Period|Adverse Event|6|||
131589516|NCT05171777|473786852|FG002|Treatment Crossover Period|Adverse Event|0|||
131589517|NCT05171777|473786853|FG003|Treatment Crossover Period|Adverse Event|0|||
131589518|NCT05171777|473786850|FG000|Treatment Crossover Period|Death|5|||
131589519|NCT05171777|473786851|FG001|Treatment Crossover Period|Death|5|||
131589520|NCT05171777|473786852|FG002|Treatment Crossover Period|Death|0|||
131589521|NCT05171777|473786853|FG003|Treatment Crossover Period|Death|0|||
131589522|NCT05171777|473786850|FG000|Treatment Crossover Period|Disease Relapse|0|||
131589523|NCT05171777|473786851|FG001|Treatment Crossover Period|Disease Relapse|1|||
131589524|NCT05171777|473786852|FG002|Treatment Crossover Period|Disease Relapse|0|||
131589525|NCT05171777|473786853|FG003|Treatment Crossover Period|Disease Relapse|0|||
131705984|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
131705985|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131705986|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131589526|NCT05171777|473786850|FG000|Treatment Crossover Period|Reason not Specified|2|||
131589527|NCT05171777|473786851|FG001|Treatment Crossover Period|Reason not Specified|1|||
131589528|NCT05171777|473786852|FG002|Treatment Crossover Period|Reason not Specified|0|||
131589529|NCT05171777|473786853|FG003|Treatment Crossover Period|Reason not Specified|0|||
131589530|NCT05171777|473786850|FG000|Treatment Crossover Period|Physician Decision|0|||
131589531|NCT05171777|473786851|FG001|Treatment Crossover Period|Physician Decision|1|||
131589532|NCT05171777|473786852|FG002|Treatment Crossover Period|Physician Decision|0|||
131589533|NCT05171777|473786853|FG003|Treatment Crossover Period|Physician Decision|0|||
131589534|NCT05171777|473786850|FG000|Treatment Crossover Period|Progressive Disease|13|||
131589535|NCT05171777|473786851|FG001|Treatment Crossover Period|Progressive Disease|9|||
131589536|NCT05171777|473786852|FG002|Treatment Crossover Period|Progressive Disease|0|||
131589537|NCT05171777|473786853|FG003|Treatment Crossover Period|Progressive Disease|0|||
131589538|NCT05171777|473786850|FG000|Treatment Crossover Period|Protocol Violation|0|||
131589539|NCT05171777|473786851|FG001|Treatment Crossover Period|Protocol Violation|2|||
131589540|NCT05171777|473786852|FG002|Treatment Crossover Period|Protocol Violation|0|||
131589541|NCT05171777|473786853|FG003|Treatment Crossover Period|Protocol Violation|0|||
131589542|NCT05171777|473786850|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
131589543|NCT05171777|473786851|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
131589544|NCT05171777|473786852|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
131589545|NCT05171777|473786853|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
131589546|NCT05171777|473786850|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
131589547|NCT05171777|473786851|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
131589548|NCT05171777|473786852|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
131589549|NCT05171777|473786853|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
131589550|NCT05171777|473786850|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
131589551|NCT05171777|473786851|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
131589552|NCT05171777|473786852|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
131589553|NCT05171777|473786853|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
131589554|NCT05171777|473786850|FG000|Treatment Continuation Period|Death|0|||
131589555|NCT05171777|473786851|FG001|Treatment Continuation Period|Death|0|||
131589556|NCT05171777|473786852|FG002|Treatment Continuation Period|Death|1|||
131589557|NCT05171777|473786853|FG003|Treatment Continuation Period|Death|6|||
131589558|NCT05171777|473786850|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
131589559|NCT05171777|473786851|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
131589560|NCT05171777|473786852|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
131589561|NCT05171777|473786853|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
131589562|NCT02272816|473786854|FG000|Overall Study|Adverse Event|1|||
131589563|NCT00632749|473786855|FG000|Overall Study|Progressive disease|3|||
131589564|NCT00632749|473786856|FG001|Overall Study|Progressive disease|2|||
131589565|NCT00632749|473786857|FG002|Overall Study|Progressive disease|2|||
131589566|NCT00632749|473786858|FG003|Overall Study|Progressive disease|2|||
131589567|NCT00632749|473786859|FG004|Overall Study|Progressive disease|4|||
131589568|NCT00632749|473786860|FG005|Overall Study|Progressive disease|4|||
131589569|NCT00632749|473786861|FG006|Overall Study|Progressive disease|3|||
131589570|NCT00632749|473786862|FG007|Overall Study|Progressive disease|2|||
131589571|NCT00632749|473786863|FG008|Overall Study|Progressive disease|3|||
131589572|NCT00632749|473786864|FG009|Overall Study|Progressive disease|2|||
131589573|NCT00632749|473786865|FG010|Overall Study|Progressive disease|4|||
131589574|NCT00632749|473786866|FG011|Overall Study|Progressive disease|3|||
131589575|NCT00632749|473786867|FG012|Overall Study|Progressive disease|2|||
131589576|NCT00632749|473786868|FG013|Overall Study|Progressive disease|4|||
131589577|NCT00632749|473786855|FG000|Overall Study|Other Adverse event|1|||
131589578|NCT00632749|473786856|FG001|Overall Study|Other Adverse event|1|||
131589579|NCT00632749|473786857|FG002|Overall Study|Other Adverse event|1|||
131791156|NCT00672620|474518625|FG002|Overall Study|Lack of Efficacy|2|||
131791157|NCT00672620|474518626|FG003|Overall Study|Lack of Efficacy|0|||
131791158|NCT00672620|474518623|FG000|Overall Study|Noncompliance with Study Drug|3|||
131791159|NCT00672620|474518624|FG001|Overall Study|Noncompliance with Study Drug|4|||
131791160|NCT00672620|474518625|FG002|Overall Study|Noncompliance with Study Drug|0|||
131791161|NCT00672620|474518626|FG003|Overall Study|Noncompliance with Study Drug|2|||
131791162|NCT00672620|474518623|FG000|Overall Study|Protocol Deviations|5|||
131791163|NCT00672620|474518624|FG001|Overall Study|Protocol Deviations|7|||
131791164|NCT00672620|474518625|FG002|Overall Study|Protocol Deviations|2|||
131791165|NCT00672620|474518626|FG003|Overall Study|Protocol Deviations|5|||
131791166|NCT00672620|474518623|FG000|Overall Study|Withdrawal of Consent|6|||
131791167|NCT00672620|474518624|FG001|Overall Study|Withdrawal of Consent|12|||
131589580|NCT00632749|473786858|FG003|Overall Study|Other Adverse event|1|||
131589581|NCT00632749|473786859|FG004|Overall Study|Other Adverse event|2|||
131589582|NCT00632749|473786860|FG005|Overall Study|Other Adverse event|4|||
131589583|NCT00632749|473786861|FG006|Overall Study|Other Adverse event|1|||
131791168|NCT00672620|474518625|FG002|Overall Study|Withdrawal of Consent|5|||
131791169|NCT00672620|474518626|FG003|Overall Study|Withdrawal of Consent|6|||
131791170|NCT00672620|474518623|FG000|Overall Study|Lost to Follow-up|8|||
131791171|NCT00672620|474518624|FG001|Overall Study|Lost to Follow-up|19|||
131438920|NCT04664153|473233330|FG001|Overall Study|Withdrawal by Subject|2|||
131589584|NCT00632749|473786862|FG007|Overall Study|Other Adverse event|2|||
131589585|NCT00632749|473786863|FG008|Overall Study|Other Adverse event|2|||
131589586|NCT00632749|473786864|FG009|Overall Study|Other Adverse event|0|||
131791172|NCT00672620|474518625|FG002|Overall Study|Lost to Follow-up|8|||
131791173|NCT00672620|474518626|FG003|Overall Study|Lost to Follow-up|11|||
131791174|NCT00672620|474518623|FG000|Overall Study|Reason not Specified|3|||
131589587|NCT00632749|473786865|FG010|Overall Study|Other Adverse event|1|||
131589588|NCT00632749|473786866|FG011|Overall Study|Other Adverse event|0|||
131589589|NCT00632749|473786867|FG012|Overall Study|Other Adverse event|1|||
131589590|NCT00632749|473786868|FG013|Overall Study|Other Adverse event|0|||
131589591|NCT00632749|473786855|FG000|Overall Study|Refuse to continue medication|0|||
131589592|NCT00632749|473786856|FG001|Overall Study|Refuse to continue medication|0|||
131589593|NCT00632749|473786857|FG002|Overall Study|Refuse to continue medication|0|||
131589594|NCT00632749|473786858|FG003|Overall Study|Refuse to continue medication|1|||
131589595|NCT00632749|473786859|FG004|Overall Study|Refuse to continue medication|0|||
131589596|NCT00632749|473786860|FG005|Overall Study|Refuse to continue medication|0|||
131589597|NCT00632749|473786861|FG006|Overall Study|Refuse to continue medication|0|||
131589598|NCT00632749|473786862|FG007|Overall Study|Refuse to continue medication|0|||
131589599|NCT00632749|473786863|FG008|Overall Study|Refuse to continue medication|0|||
131589600|NCT00632749|473786864|FG009|Overall Study|Refuse to continue medication|1|||
131589601|NCT00632749|473786865|FG010|Overall Study|Refuse to continue medication|0|||
131589602|NCT00632749|473786866|FG011|Overall Study|Refuse to continue medication|0|||
131589603|NCT00632749|473786867|FG012|Overall Study|Refuse to continue medication|0|||
131589604|NCT00632749|473786868|FG013|Overall Study|Refuse to continue medication|0|||
131589605|NCT00632749|473786855|FG000|Overall Study|Reason other than those specified above|0|||
131589606|NCT00632749|473786856|FG001|Overall Study|Reason other than those specified above|2|||
131589607|NCT00632749|473786857|FG002|Overall Study|Reason other than those specified above|0|||
131589608|NCT00632749|473786858|FG003|Overall Study|Reason other than those specified above|0|||
131589609|NCT00632749|473786859|FG004|Overall Study|Reason other than those specified above|1|||
131589610|NCT00632749|473786860|FG005|Overall Study|Reason other than those specified above|0|||
131589611|NCT00632749|473786861|FG006|Overall Study|Reason other than those specified above|1|||
131589612|NCT00632749|473786862|FG007|Overall Study|Reason other than those specified above|0|||
131589613|NCT00632749|473786863|FG008|Overall Study|Reason other than those specified above|0|||
131589614|NCT00632749|473786864|FG009|Overall Study|Reason other than those specified above|0|||
131589615|NCT00632749|473786865|FG010|Overall Study|Reason other than those specified above|2|||
131589616|NCT00632749|473786866|FG011|Overall Study|Reason other than those specified above|1|||
131589617|NCT00632749|473786867|FG012|Overall Study|Reason other than those specified above|0|||
131589618|NCT00632749|473786868|FG013|Overall Study|Reason other than those specified above|2|||
131589619|NCT02671435|473786869|FG000|Overall Study|Death|1|||
131589620|NCT02671435|473786870|FG001|Overall Study|Death|3|||
131589621|NCT02671435|473786871|FG002|Overall Study|Death|0|||
131589622|NCT02671435|473786872|FG003|Overall Study|Death|16|||
131589623|NCT02671435|473786873|FG004|Overall Study|Death|14|||
131589624|NCT02671435|473786874|FG005|Overall Study|Death|29|||
131589625|NCT02671435|473786875|FG006|Overall Study|Death|34|||
131589626|NCT02671435|473786876|FG007|Overall Study|Death|28|||
131589627|NCT02671435|473786877|FG008|Overall Study|Death|19|||
131589628|NCT02671435|473786878|FG009|Overall Study|Death|10|||
131589629|NCT02671435|473786879|FG010|Overall Study|Death|8|||
131589630|NCT02671435|473786880|FG011|Overall Study|Death|29|||
131589631|NCT02671435|473786881|FG012|Overall Study|Death|29|||
131589632|NCT02671435|473786882|FG013|Overall Study|Death|29|||
131589633|NCT02671435|473786883|FG014|Overall Study|Death|27|||
131705987|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131589634|NCT02671435|473786869|FG000|Overall Study|Lost to Follow-up|0|||
131589635|NCT02671435|473786870|FG001|Overall Study|Lost to Follow-up|0|||
131589636|NCT02671435|473786871|FG002|Overall Study|Lost to Follow-up|1|||
131705988|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131705989|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
131705990|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
131705991|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
131589637|NCT02671435|473786872|FG003|Overall Study|Lost to Follow-up|0|||
131705992|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
131589638|NCT02671435|473786873|FG004|Overall Study|Lost to Follow-up|1|||
131589639|NCT02671435|473786874|FG005|Overall Study|Lost to Follow-up|1|||
131589640|NCT02671435|473786875|FG006|Overall Study|Lost to Follow-up|2|||
131589641|NCT02671435|473786876|FG007|Overall Study|Lost to Follow-up|2|||
131589642|NCT02671435|473786877|FG008|Overall Study|Lost to Follow-up|0|||
131589643|NCT02671435|473786878|FG009|Overall Study|Lost to Follow-up|2|||
131589644|NCT02671435|473786879|FG010|Overall Study|Lost to Follow-up|0|||
131589645|NCT02671435|473786880|FG011|Overall Study|Lost to Follow-up|3|||
131589646|NCT02671435|473786881|FG012|Overall Study|Lost to Follow-up|3|||
131589647|NCT02671435|473786882|FG013|Overall Study|Lost to Follow-up|2|||
131589648|NCT02671435|473786883|FG014|Overall Study|Lost to Follow-up|0|||
131589649|NCT02671435|473786869|FG000|Overall Study|Withdrawal by Subject|2|||
131589650|NCT02671435|473786870|FG001|Overall Study|Withdrawal by Subject|0|||
131589651|NCT02671435|473786871|FG002|Overall Study|Withdrawal by Subject|2|||
131589652|NCT02671435|473786872|FG003|Overall Study|Withdrawal by Subject|2|||
131589653|NCT02671435|473786873|FG004|Overall Study|Withdrawal by Subject|2|||
131589654|NCT02671435|473786874|FG005|Overall Study|Withdrawal by Subject|7|||
131705993|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
131705994|NCT05195528|474205511|FG000|Placebo-controlled Treatment Period|Other|0|||
131705995|NCT05195528|474205512|FG001|Placebo-controlled Treatment Period|Other|0|||
131705996|NCT05195528|474205513|FG002|Placebo-controlled Treatment Period|Other|1|||
131705997|NCT05195528|474205514|FG003|Placebo-controlled Treatment Period|Other|0|||
131705998|NCT05195528|474205515|FG004|Placebo-controlled Treatment Period|Other|0|||
131705999|NCT05195528|474205511|FG000|Extension Period|PTE or AE or SAE|0|||
131706000|NCT05195528|474205512|FG001|Extension Period|PTE or AE or SAE|4|||
131706001|NCT05195528|474205513|FG002|Extension Period|PTE or AE or SAE|5|||
131706002|NCT05195528|474205514|FG003|Extension Period|PTE or AE or SAE|4|||
131706003|NCT05195528|474205515|FG004|Extension Period|PTE or AE or SAE|4|||
131706004|NCT05195528|474205511|FG000|Extension Period|Protocol Violation|0|||
131706005|NCT05195528|474205512|FG001|Extension Period|Protocol Violation|2|||
131706006|NCT05195528|474205513|FG002|Extension Period|Protocol Violation|1|||
131706007|NCT05195528|474205514|FG003|Extension Period|Protocol Violation|0|||
131706008|NCT05195528|474205515|FG004|Extension Period|Protocol Violation|1|||
131706009|NCT05195528|474205511|FG000|Extension Period|Lost to Follow-up|0|||
131706010|NCT05195528|474205512|FG001|Extension Period|Lost to Follow-up|6|||
131706011|NCT05195528|474205513|FG002|Extension Period|Lost to Follow-up|13|||
131706012|NCT05195528|474205514|FG003|Extension Period|Lost to Follow-up|3|||
131706013|NCT05195528|474205515|FG004|Extension Period|Lost to Follow-up|7|||
131438921|NCT04664153|473233331|FG002|Overall Study|Withdrawal by Subject|1|||
131589655|NCT02671435|473786875|FG006|Overall Study|Withdrawal by Subject|2|||
131589656|NCT02671435|473786876|FG007|Overall Study|Withdrawal by Subject|7|||
131589657|NCT02671435|473786877|FG008|Overall Study|Withdrawal by Subject|1|||
131589658|NCT02671435|473786878|FG009|Overall Study|Withdrawal by Subject|1|||
131589659|NCT02671435|473786879|FG010|Overall Study|Withdrawal by Subject|2|||
131706014|NCT05195528|474205511|FG000|Extension Period|Withdrawal by Subject|0|||
131706015|NCT05195528|474205512|FG001|Extension Period|Withdrawal by Subject|12|||
131589660|NCT02671435|473786880|FG011|Overall Study|Withdrawal by Subject|4|||
131589661|NCT02671435|473786881|FG012|Overall Study|Withdrawal by Subject|4|||
131706016|NCT05195528|474205513|FG002|Extension Period|Withdrawal by Subject|9|||
131589662|NCT02671435|473786882|FG013|Overall Study|Withdrawal by Subject|4|||
131589663|NCT02671435|473786883|FG014|Overall Study|Withdrawal by Subject|2|||
131589664|NCT02671435|473786869|FG000|Overall Study|Un-specified|0|||
131589665|NCT02671435|473786870|FG001|Overall Study|Un-specified|0|||
131589666|NCT02671435|473786871|FG002|Overall Study|Un-specified|0|||
131589667|NCT02671435|473786872|FG003|Overall Study|Un-specified|0|||
131589668|NCT02671435|473786873|FG004|Overall Study|Un-specified|1|||
131589669|NCT02671435|473786874|FG005|Overall Study|Un-specified|3|||
131589670|NCT02671435|473786875|FG006|Overall Study|Un-specified|2|||
131589671|NCT02671435|473786876|FG007|Overall Study|Un-specified|3|||
131589672|NCT02671435|473786877|FG008|Overall Study|Un-specified|0|||
131589673|NCT02671435|473786878|FG009|Overall Study|Un-specified|5|||
131589674|NCT02671435|473786879|FG010|Overall Study|Un-specified|8|||
131589675|NCT02671435|473786880|FG011|Overall Study|Un-specified|4|||
131589676|NCT02671435|473786881|FG012|Overall Study|Un-specified|5|||
131589677|NCT02671435|473786882|FG013|Overall Study|Un-specified|9|||
131589678|NCT02671435|473786883|FG014|Overall Study|Un-specified|8|||
131589679|NCT02412748|473786886|FG000|Overall Study|Lost to Follow-up|38|||
131589680|NCT02412748|473786887|FG001|Overall Study|Lost to Follow-up|39|||
131589681|NCT04128319|473786888|FG000|Overall Study|Death|3|||
131589682|NCT01011946|473786890|FG000|Overall Study|Transferred to another hospital|2|||
131589683|NCT01011946|473786890|FG000|Overall Study|No pathological lab value|1|||
131589684|NCT04820686|473786891|FG000|Overall Study|Withdrawal by Subject|5|||
131589685|NCT04820686|473786892|FG001|Overall Study|Withdrawal by Subject|2|||
131589686|NCT04820686|473786893|FG002|Overall Study|Withdrawal by Subject|3|||
131589687|NCT04820686|473786891|FG000|Overall Study|Study Termination|25|||
131589688|NCT04820686|473786892|FG001|Overall Study|Study Termination|13|||
131589689|NCT04820686|473786893|FG002|Overall Study|Study Termination|14|||
131589690|NCT04820686|473786891|FG000|Overall Study|Adverse Event|0|||
131589691|NCT04820686|473786892|FG001|Overall Study|Adverse Event|1|||
131589692|NCT04820686|473786893|FG002|Overall Study|Adverse Event|0|||
131589693|NCT01872078|473786894|FG000|Overall Study|Adverse Event|0|||
131589694|NCT01872078|473786895|FG001|Overall Study|Adverse Event|0|||
131589695|NCT01872078|473786896|FG002|Overall Study|Adverse Event|1|||
131589696|NCT01872078|473786897|FG003|Overall Study|Adverse Event|0|||
131589697|NCT01872078|473786894|FG000|Overall Study|Dose administration non-compliance|0|||
131589698|NCT01872078|473786895|FG001|Overall Study|Dose administration non-compliance|0|||
131589699|NCT01872078|473786896|FG002|Overall Study|Dose administration non-compliance|0|||
131589700|NCT01872078|473786897|FG003|Overall Study|Dose administration non-compliance|1|||
131589701|NCT01872078|473786894|FG000|Overall Study|Protocol Violation|0|||
131589702|NCT01872078|473786895|FG001|Overall Study|Protocol Violation|0|||
131589703|NCT01872078|473786896|FG002|Overall Study|Protocol Violation|1|||
131589704|NCT01872078|473786897|FG003|Overall Study|Protocol Violation|0|||
131589705|NCT01872078|473786894|FG000|Overall Study|Withdrawal by Subject|0|||
131589706|NCT01872078|473786895|FG001|Overall Study|Withdrawal by Subject|0|||
131589707|NCT01872078|473786896|FG002|Overall Study|Withdrawal by Subject|1|||
131589708|NCT01872078|473786897|FG003|Overall Study|Withdrawal by Subject|0|||
131589709|NCT01872078|473786894|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
131589710|NCT01872078|473786895|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
131589711|NCT01872078|473786896|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
131589712|NCT01872078|473786897|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
131589713|NCT01424670|473786898|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
131589714|NCT01424670|473786899|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
131589715|NCT01424670|473786898|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
131899067|NCT03569098|474917492|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
131899068|NCT03569098|474917493|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
131899069|NCT03569098|474917494|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
131899070|NCT03569098|474917492|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
131899071|NCT03569098|474917493|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
131899072|NCT03569098|474917494|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
131589716|NCT01424670|473786899|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
131589717|NCT01424670|473786898|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
131589718|NCT01424670|473786899|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
131589719|NCT01424670|473786898|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
131589720|NCT01424670|473786899|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
131589721|NCT01424670|473786898|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
131589722|NCT01424670|473786899|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
131589723|NCT01424670|473786898|FG000|Continuation Period|Adverse Event|13|||
131589724|NCT01424670|473786899|FG001|Continuation Period|Adverse Event|5|||
131589725|NCT01424670|473786898|FG000|Continuation Period|Lost to Follow-up|2|||
131589726|NCT01424670|473786899|FG001|Continuation Period|Lost to Follow-up|0|||
131899073|NCT03569098|474917492|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
131589727|NCT01424670|473786898|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
131589728|NCT01424670|473786899|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
131589729|NCT01424670|473786898|FG000|Continuation Period|Physician Decision|5|||
131589730|NCT01424670|473786899|FG001|Continuation Period|Physician Decision|4|||
131589731|NCT01424670|473786898|FG000|Continuation Period|Withdrawal by Subject|13|||
131589732|NCT01424670|473786899|FG001|Continuation Period|Withdrawal by Subject|4|||
131589733|NCT00761189|473786900|FG000|Overall Study|Adverse Event|42|||
131589734|NCT00761189|473786900|FG000|Overall Study|Lack of Efficacy|45|||
131589735|NCT00761189|473786900|FG000|Overall Study|Lost to Follow-up|36|||
131589736|NCT00761189|473786900|FG000|Overall Study|Withdrawal by Subject|49|||
131589737|NCT00761189|473786900|FG000|Overall Study|Other|13|||
131589738|NCT03988842|473786903|FG000|Overall Study|Death|1|||
131589739|NCT00709098|473786906|FG000|Double-blind Period|Withdrawal of consent|3|||
131589740|NCT00709098|473786907|FG001|Double-blind Period|Withdrawal of consent|3|||
131589741|NCT00709098|473786908|FG002|Double-blind Period|Withdrawal of consent|0|||
131589742|NCT00709098|473786906|FG000|Double-blind Period|Administrative reason|1|||
131589743|NCT00709098|473786907|FG001|Double-blind Period|Administrative reason|3|||
131589744|NCT00709098|473786908|FG002|Double-blind Period|Administrative reason|0|||
131589745|NCT00709098|473786906|FG000|Double-blind Period|Death|1|||
131589746|NCT00709098|473786907|FG001|Double-blind Period|Death|1|||
131589747|NCT00709098|473786908|FG002|Double-blind Period|Death|0|||
131589748|NCT00709098|473786906|FG000|Double-blind Period|Lost to Follow-up|1|||
131589749|NCT00709098|473786907|FG001|Double-blind Period|Lost to Follow-up|1|||
131589750|NCT00709098|473786908|FG002|Double-blind Period|Lost to Follow-up|0|||
131589751|NCT00709098|473786906|FG000|Open-label Period|Withdrawal of consent|0|||
131589752|NCT00709098|473786907|FG001|Open-label Period|Withdrawal of consent|0|||
131589753|NCT00709098|473786908|FG002|Open-label Period|Withdrawal of consent|7|||
131589754|NCT00709098|473786906|FG000|Open-label Period|Administrative reason|0|||
131589755|NCT00709098|473786907|FG001|Open-label Period|Administrative reason|0|||
131589756|NCT00709098|473786908|FG002|Open-label Period|Administrative reason|5|||
131589757|NCT00709098|473786906|FG000|Open-label Period|Death|0|||
131589758|NCT00709098|473786907|FG001|Open-label Period|Death|0|||
131589759|NCT00709098|473786908|FG002|Open-label Period|Death|1|||
131589760|NCT00709098|473786906|FG000|Open-label Period|Lost to Follow-up|0|||
131589761|NCT00709098|473786907|FG001|Open-label Period|Lost to Follow-up|0|||
131589762|NCT00709098|473786908|FG002|Open-label Period|Lost to Follow-up|1|||
131589763|NCT01227265|473786910|FG000|Overall Study|Did Not Receive Treatment|1|||
131589764|NCT01227265|473786911|FG001|Overall Study|Did Not Receive Treatment|2|||
131589765|NCT01227265|473786912|FG002|Overall Study|Did Not Receive Treatment|0|||
131589766|NCT01227265|473786910|FG000|Overall Study|Administrative|1|||
131589767|NCT01227265|473786911|FG001|Overall Study|Administrative|0|||
131589768|NCT01227265|473786912|FG002|Overall Study|Administrative|2|||
131589769|NCT01227265|473786910|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131589770|NCT01227265|473786911|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
131589771|NCT01227265|473786912|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
131589772|NCT01227265|473786910|FG000|Overall Study|Protocol Violation|2|||
131589773|NCT01227265|473786911|FG001|Overall Study|Protocol Violation|1|||
131589774|NCT01227265|473786912|FG002|Overall Study|Protocol Violation|0|||
131589775|NCT01227265|473786910|FG000|Overall Study|Withdrawal by Subject|7|||
131589776|NCT01227265|473786911|FG001|Overall Study|Withdrawal by Subject|7|||
131589777|NCT01227265|473786912|FG002|Overall Study|Withdrawal by Subject|3|||
131589778|NCT01227265|473786910|FG000|Overall Study|Lost to Follow-up|2|||
131589779|NCT01227265|473786911|FG001|Overall Study|Lost to Follow-up|0|||
131589780|NCT01227265|473786912|FG002|Overall Study|Lost to Follow-up|3|||
131589781|NCT01227265|473786910|FG000|Overall Study|Adverse Event|6|||
131589782|NCT01227265|473786911|FG001|Overall Study|Adverse Event|10|||
131589783|NCT01227265|473786912|FG002|Overall Study|Adverse Event|5|||
131589784|NCT03481816|473786914|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
131589785|NCT03481816|473786915|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
131589786|NCT03481816|473786914|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
131589787|NCT03481816|473786915|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
131589788|NCT03481816|473786914|FG000|Dose Expansion|Withdrawal by Subject|0|||
131589789|NCT03481816|473786915|FG001|Dose Expansion|Withdrawal by Subject|2|||
131589790|NCT03481816|473786914|FG000|Dose Expansion|Physician Decision|0|||
131589791|NCT03481816|473786915|FG001|Dose Expansion|Physician Decision|5|||
131589792|NCT03582722|473786921|FG000|Overall Study|Lost to Follow-up|1|||
131589793|NCT03582722|473786922|FG001|Overall Study|Lost to Follow-up|4|||
131589794|NCT03582722|473786921|FG000|Overall Study|Withdrawal by Subject|3|||
131589795|NCT03582722|473786922|FG001|Overall Study|Withdrawal by Subject|3|||
131589796|NCT03690206|473786923|FG000|Overall Study|Withdrawal by Subject|2|||
131589797|NCT03690206|473786924|FG001|Overall Study|Withdrawal by Subject|0|||
131438922|NCT04664153|473233332|FG003|Overall Study|Withdrawal by Subject|2|||
131589798|NCT03690206|473786925|FG002|Overall Study|Withdrawal by Subject|0|||
131589799|NCT03690206|473786923|FG000|Overall Study|ICF withdrawal|2|||
131589800|NCT03690206|473786924|FG001|Overall Study|ICF withdrawal|0|||
131589801|NCT03690206|473786925|FG002|Overall Study|ICF withdrawal|0|||
131589802|NCT06024174|473786926|FG000|Overall Study|Other Reasons|1|||
131589803|NCT06024174|473786926|FG000|Overall Study|Study terminated by Sponsor|4|||
131589804|NCT05028582|473786927|FG000|Overall Study|Lost to Follow-up|11|||
131589805|NCT05028582|473786928|FG001|Overall Study|Lost to Follow-up|9|||
131589806|NCT05028582|473786927|FG000|Overall Study|Withdrawal by Subject|9|||
131589807|NCT05028582|473786928|FG001|Overall Study|Withdrawal by Subject|10|||
131589808|NCT05028582|473786927|FG000|Overall Study|Adverse Event|5|||
131589809|NCT05028582|473786928|FG001|Overall Study|Adverse Event|2|||
131589810|NCT05028582|473786927|FG000|Overall Study|Miscellaneous|3|||
131589811|NCT05028582|473786928|FG001|Overall Study|Miscellaneous|2|||
131589812|NCT05028582|473786927|FG000|Overall Study|Lack of Efficacy|3|||
131589813|NCT05028582|473786928|FG001|Overall Study|Lack of Efficacy|1|||
131589814|NCT05028582|473786927|FG000|Overall Study|Physician Decision|0|||
131589815|NCT05028582|473786928|FG001|Overall Study|Physician Decision|1|||
131589816|NCT01959698|473786929|FG000|Overall Study|Adverse Event|0|||
131589817|NCT01959698|473786930|FG001|Overall Study|Adverse Event|0|||
131589818|NCT01959698|473786931|FG002|Overall Study|Adverse Event|0|||
131589819|NCT01959698|473786932|FG003|Overall Study|Adverse Event|0|||
131589820|NCT01959698|473786933|FG004|Overall Study|Adverse Event|0|||
131589821|NCT01959698|473786934|FG005|Overall Study|Adverse Event|0|||
131589822|NCT01959698|473786935|FG006|Overall Study|Adverse Event|1|||
131589823|NCT01959698|473786929|FG000|Overall Study|Physician Decision|1|||
131589824|NCT01959698|473786930|FG001|Overall Study|Physician Decision|0|||
131589825|NCT01959698|473786931|FG002|Overall Study|Physician Decision|1|||
131589826|NCT01959698|473786932|FG003|Overall Study|Physician Decision|2|||
131589827|NCT01959698|473786933|FG004|Overall Study|Physician Decision|0|||
131589828|NCT01959698|473786934|FG005|Overall Study|Physician Decision|3|||
131589829|NCT01959698|473786935|FG006|Overall Study|Physician Decision|3|||
131589830|NCT04840199|473788635|FG000|Overall Study|Study Terminated by Sponsor|8|||
131589831|NCT04840199|473788636|FG001|Overall Study|Study Terminated by Sponsor|9|||
131589832|NCT04840199|473788635|FG000|Overall Study|Lost to Follow-up|0|||
131589833|NCT04840199|473788636|FG001|Overall Study|Lost to Follow-up|2|||
131589834|NCT04840199|473788635|FG000|Overall Study|Withdrawal by Subject|2|||
131589835|NCT04840199|473788636|FG001|Overall Study|Withdrawal by Subject|0|||
131589836|NCT04840199|473788635|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
131589837|NCT04840199|473788636|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
131589838|NCT04869982|473788639|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
131589839|NCT04869982|473788640|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
131589840|NCT04869982|473788639|FG000|Overall Study|Migrated / moved from the study area|1|||
131589841|NCT04869982|473788640|FG001|Overall Study|Migrated / moved from the study area|1|||
131589842|NCT04869982|473788639|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
131589843|NCT04869982|473788640|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
131589844|NCT04869982|473788639|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
131589845|NCT04869982|473788640|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
131589846|NCT04869982|473788639|FG000|Overall Study|Solicited adverse event|2|||
131589847|NCT04869982|473788640|FG001|Overall Study|Solicited adverse event|1|||
131589848|NCT01631214|473788641|FG000|Overall Study|Withdrawal by Subject|276|||
131589849|NCT01631214|473788642|FG001|Overall Study|Withdrawal by Subject|290|||
131589850|NCT01631214|473788641|FG000|Overall Study|Death|113|||
131589851|NCT01631214|473788642|FG001|Overall Study|Death|106|||
131589852|NCT01631214|473788641|FG000|Overall Study|Lost to Follow-up|54|||
131589853|NCT01631214|473788642|FG001|Overall Study|Lost to Follow-up|40|||
131589854|NCT01631214|473788641|FG000|Overall Study|Adverse Event|45|||
131589855|NCT01631214|473788642|FG001|Overall Study|Adverse Event|45|||
131589856|NCT01631214|473788641|FG000|Overall Study|Other|22|||
131589857|NCT01631214|473788642|FG001|Overall Study|Other|19|||
131589858|NCT01631214|473788641|FG000|Overall Study|Noncompliance|16|||
131589859|NCT01631214|473788642|FG001|Overall Study|Noncompliance|15|||
131589860|NCT01631214|473788641|FG000|Overall Study|Requirement for Alternative Therapy|8|||
131706017|NCT05195528|474205514|FG003|Extension Period|Withdrawal by Subject|6|||
131706018|NCT05195528|474205515|FG004|Extension Period|Withdrawal by Subject|5|||
131589861|NCT01631214|473788642|FG001|Overall Study|Requirement for Alternative Therapy|3|||
131589862|NCT01631214|473788641|FG000|Overall Study|Protocol Deviation|4|||
131589863|NCT01631214|473788642|FG001|Overall Study|Protocol Deviation|3|||
131589864|NCT01631214|473788641|FG000|Overall Study|Ineligibility determined|5|||
131589865|NCT01631214|473788642|FG001|Overall Study|Ineligibility determined|2|||
131589866|NCT01631214|473788641|FG000|Overall Study|Administrative Decision|1|||
131589867|NCT01631214|473788642|FG001|Overall Study|Administrative Decision|0|||
131706019|NCT05195528|474205511|FG000|Extension Period|Lack of Efficacy|0|||
131706020|NCT05195528|474205512|FG001|Extension Period|Lack of Efficacy|3|||
131706021|NCT05195528|474205513|FG002|Extension Period|Lack of Efficacy|0|||
131589868|NCT02473250|473788643|FG000|Overall Study|Lost to Follow-up|10|||
131589869|NCT02473250|473788643|FG000|Overall Study|Physician Decision|5|||
131589870|NCT02473250|473788643|FG000|Overall Study|Did not tolerate medication washout|3|||
131706022|NCT05195528|474205514|FG003|Extension Period|Lack of Efficacy|0|||
131438923|NCT04664153|473233329|FG000|Overall Study|Other|0|||
131438924|NCT04664153|473233330|FG001|Overall Study|Other|1|||
131438925|NCT04664153|473233331|FG002|Overall Study|Other|0|||
131438926|NCT04664153|473233332|FG003|Overall Study|Other|0|||
131438927|NCT04664153|473233329|FG000|Overall Study|Adverse Event|4|||
131438928|NCT04664153|473233330|FG001|Overall Study|Adverse Event|0|||
131438929|NCT04664153|473233331|FG002|Overall Study|Adverse Event|1|||
131438930|NCT04664153|473233332|FG003|Overall Study|Adverse Event|0|||
131589871|NCT02473250|473788643|FG000|Overall Study|Antidepressant effect of divalproex|2|||
131589872|NCT00567398|473788644|FG000|Overall Study|Adverse Event|6|||
131589873|NCT00567398|473788645|FG001|Overall Study|Adverse Event|14|||
131589874|NCT00567398|473788644|FG000|Overall Study|Physician Decision|0|||
131589875|NCT00567398|473788645|FG001|Overall Study|Physician Decision|4|||
131589876|NCT00567398|473788644|FG000|Overall Study|Withdrawal by Subject|0|||
131589877|NCT00567398|473788645|FG001|Overall Study|Withdrawal by Subject|2|||
131589878|NCT00567398|473788644|FG000|Overall Study|Renal Transplantation|0|||
131589879|NCT00567398|473788645|FG001|Overall Study|Renal Transplantation|3|||
131589880|NCT00567398|473788644|FG000|Overall Study|Other|1|||
131589881|NCT00567398|473788645|FG001|Overall Study|Other|0|||
131589882|NCT03517553|473788646|FG000|Overall Study|Withdrawal by Subject|2|||
131589883|NCT03271151|473788647|FG000|Overall Study|Lost to Follow-up|1|||
131438931|NCT00097500|473233333|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
131438932|NCT00097500|473233334|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
131589884|NCT03271151|473788648|FG001|Overall Study|Lost to Follow-up|3|||
131589885|NCT03271151|473788647|FG000|Overall Study|Withdrawal by Subject|1|||
131589886|NCT03271151|473788648|FG001|Overall Study|Withdrawal by Subject|0|||
131589887|NCT04093362|473788651|FG000|Overall Study|Study Termination|1|||
131589888|NCT04093362|473788652|FG001|Overall Study|Study Termination|1|||
131589889|NCT04093362|473788651|FG000|Overall Study|Withdrawal of Consent|1|||
131438933|NCT00097500|473233333|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
131438934|NCT00097500|473233334|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
131438935|NCT00097500|473233333|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
131589890|NCT04093362|473788652|FG001|Overall Study|Withdrawal of Consent|0|||
131438936|NCT00097500|473233334|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
131438937|NCT00097500|473233333|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131438938|NCT00097500|473233334|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
131438939|NCT00097500|473233333|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
131589891|NCT04093362|473788651|FG000|Overall Study|Death|1|||
131589892|NCT04093362|473788652|FG001|Overall Study|Death|3|||
131589893|NCT04093362|473788651|FG000|Overall Study|Reason not Specified|1|||
131589894|NCT04093362|473788652|FG001|Overall Study|Reason not Specified|2|||
131589895|NCT02201108|473788655|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
131589896|NCT02201108|473788656|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
131589897|NCT02201108|473788657|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
131706023|NCT05195528|474205515|FG004|Extension Period|Lack of Efficacy|2|||
131706024|NCT05195528|474205511|FG000|Extension Period|Not Treated|0|||
131438940|NCT00097500|473233334|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
131438941|NCT00097500|473233333|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
131438942|NCT00097500|473233334|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
131438943|NCT00097500|473233333|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
131438944|NCT00097500|473233334|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
131438945|NCT01009060|473233338|FG000|Overall Study|Adverse Event|1|||
131438946|NCT01009060|473233339|FG001|Overall Study|Adverse Event|2|||
131438947|NCT01009060|473233338|FG000|Overall Study|Protocol Violation|0|||
131438948|NCT01009060|473233339|FG001|Overall Study|Protocol Violation|1|||
131438949|NCT01009060|473233338|FG000|Overall Study|Lost to Follow-up|1|||
131438950|NCT01009060|473233339|FG001|Overall Study|Lost to Follow-up|0|||
131438951|NCT01009060|473233338|FG000|Overall Study|Physician Decision|1|||
131438952|NCT01009060|473233339|FG001|Overall Study|Physician Decision|1|||
131438953|NCT01009060|473233338|FG000|Overall Study|Withdrawal by Subject|1|||
131438954|NCT01009060|473233339|FG001|Overall Study|Withdrawal by Subject|1|||
131438955|NCT00005906|473233340|FG000|Overall Study|Lack of Efficacy|3|||
131706025|NCT05195528|474205512|FG001|Extension Period|Not Treated|0|||
131438956|NCT00265564|473233341|FG000|Overall Study|Lost to Follow-up|5|||
131589898|NCT02201108|473788655|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
131589899|NCT02201108|473788656|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
131589900|NCT02201108|473788657|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
131589901|NCT02201108|473788655|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
131706026|NCT05195528|474205513|FG002|Extension Period|Not Treated|2|||
131438957|NCT00265564|473233342|FG001|Overall Study|Lost to Follow-up|7|||
131438958|NCT00265564|473233341|FG000|Overall Study|met exclusion criteria|5|||
131589902|NCT02201108|473788656|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
131589903|NCT02201108|473788657|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
131706027|NCT05195528|474205514|FG003|Extension Period|Not Treated|3|||
131589904|NCT02201108|473788655|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
131589905|NCT02201108|473788656|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
131589906|NCT02201108|473788657|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
131589907|NCT02201108|473788655|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
131589908|NCT02201108|473788656|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
131589909|NCT02201108|473788657|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
131589910|NCT02201108|473788655|FG000|Open Label Period (up to Week 192)|Other reason|4|||
131438959|NCT00265564|473233342|FG001|Overall Study|met exclusion criteria|2|||
131589911|NCT02201108|473788656|FG001|Open Label Period (up to Week 192)|Other reason|7|||
131589912|NCT02201108|473788657|FG002|Open Label Period (up to Week 192)|Other reason|0|||
131589913|NCT02201108|473788655|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
131589914|NCT02201108|473788656|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
131589915|NCT02201108|473788657|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
131589916|NCT02201108|473788655|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
131589917|NCT02201108|473788656|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
131589918|NCT02201108|473788657|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
131589919|NCT02201108|473788655|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
131589920|NCT02201108|473788656|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
131589921|NCT02201108|473788657|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
131589922|NCT03055377|473788667|FG000|Treatment Phase|Lost to Follow-up|28|||
131589923|NCT03055377|473788668|FG001|Treatment Phase|Lost to Follow-up|24|||
131589924|NCT03055377|473788667|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
131589925|NCT03055377|473788668|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
131589926|NCT04143061|473788670|FG000|Overall Study|Protocol Deviation|0|||
131589927|NCT04143061|473788671|FG001|Overall Study|Protocol Deviation|0|||
131589928|NCT04143061|473788672|FG002|Overall Study|Protocol Deviation|0|||
131589929|NCT04143061|473788673|FG003|Overall Study|Protocol Deviation|0|||
131589930|NCT04143061|473788674|FG004|Overall Study|Protocol Deviation|0|||
131589931|NCT04143061|473788675|FG005|Overall Study|Protocol Deviation|0|||
131589932|NCT04143061|473788676|FG006|Overall Study|Protocol Deviation|5|||
131589933|NCT04143061|473788677|FG007|Overall Study|Protocol Deviation|5|||
131589934|NCT04143061|473788670|FG000|Overall Study|Withdrawal by Subject|2|||
131589935|NCT04143061|473788671|FG001|Overall Study|Withdrawal by Subject|0|||
131589936|NCT04143061|473788672|FG002|Overall Study|Withdrawal by Subject|0|||
131589937|NCT04143061|473788673|FG003|Overall Study|Withdrawal by Subject|0|||
131589938|NCT04143061|473788674|FG004|Overall Study|Withdrawal by Subject|0|||
131589939|NCT04143061|473788675|FG005|Overall Study|Withdrawal by Subject|1|||
131706028|NCT05195528|474205515|FG004|Extension Period|Not Treated|0|||
131706029|NCT05195528|474205511|FG000|Extension Period|Other|0|||
131706030|NCT05195528|474205512|FG001|Extension Period|Other|1|||
131706031|NCT05195528|474205513|FG002|Extension Period|Other|1|||
131706032|NCT05195528|474205514|FG003|Extension Period|Other|0|||
131706033|NCT05195528|474205515|FG004|Extension Period|Other|0|||
131706034|NCT02487108|474205518|FG000|Overall Study|Adverse Event|1|||
131706035|NCT02487108|474205519|FG001|Overall Study|Adverse Event|6|||
131706036|NCT02487108|474205520|FG002|Overall Study|Adverse Event|12|||
131706037|NCT02487108|474205521|FG003|Overall Study|Adverse Event|6|||
131706038|NCT02487108|474205518|FG000|Overall Study|Withdrawal by Subject|8|||
131706039|NCT02487108|474205519|FG001|Overall Study|Withdrawal by Subject|5|||
131706040|NCT02487108|474205520|FG002|Overall Study|Withdrawal by Subject|5|||
131706041|NCT02487108|474205521|FG003|Overall Study|Withdrawal by Subject|0|||
131706042|NCT02487108|474205518|FG000|Overall Study|Non-compliance to study medication|3|||
131706043|NCT02487108|474205519|FG001|Overall Study|Non-compliance to study medication|2|||
131706044|NCT02487108|474205520|FG002|Overall Study|Non-compliance to study medication|5|||
131706045|NCT02487108|474205521|FG003|Overall Study|Non-compliance to study medication|4|||
131706046|NCT02487108|474205518|FG000|Overall Study|Protocol Violation|1|||
131706047|NCT02487108|474205519|FG001|Overall Study|Protocol Violation|1|||
131706048|NCT02487108|474205520|FG002|Overall Study|Protocol Violation|2|||
131706049|NCT02487108|474205521|FG003|Overall Study|Protocol Violation|0|||
131706050|NCT02487108|474205518|FG000|Overall Study|Non-compliance to study procedures|0|||
131706051|NCT02487108|474205519|FG001|Overall Study|Non-compliance to study procedures|0|||
131706052|NCT02487108|474205520|FG002|Overall Study|Non-compliance to study procedures|0|||
131706053|NCT02487108|474205521|FG003|Overall Study|Non-compliance to study procedures|1|||
131706054|NCT02487108|474205518|FG000|Overall Study|Other than specified|3|||
131706055|NCT02487108|474205519|FG001|Overall Study|Other than specified|2|||
131899074|NCT03569098|474917493|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
131589940|NCT04143061|473788676|FG006|Overall Study|Withdrawal by Subject|0|||
131589941|NCT04143061|473788677|FG007|Overall Study|Withdrawal by Subject|0|||
131706056|NCT02487108|474205520|FG002|Overall Study|Other than specified|2|||
131706057|NCT02487108|474205521|FG003|Overall Study|Other than specified|0|||
131706058|NCT00883493|474205522|FG000|Overall Study|Adverse Event|11|||
131706059|NCT00883493|474205523|FG001|Overall Study|Adverse Event|12|||
131706060|NCT00883493|474205522|FG000|Overall Study|Lack of Efficacy|4|||
131438960|NCT01476722|473233347|FG000|Overall Study|Adverse Event|1|||
131791175|NCT00672620|474518624|FG001|Overall Study|Reason not Specified|3|||
131791176|NCT00672620|474518625|FG002|Overall Study|Reason not Specified|2|||
131791177|NCT00672620|474518626|FG003|Overall Study|Reason not Specified|1|||
131791178|NCT00772577|474518627|FG000|Overall Study|Adverse Event|6|||
131791179|NCT00772577|474518628|FG001|Overall Study|Adverse Event|3|||
131791180|NCT00772577|474518627|FG000|Overall Study|Abnormal laboratory values|0|||
131791181|NCT00772577|474518628|FG001|Overall Study|Abnormal laboratory values|1|||
131791182|NCT00772577|474518627|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131791183|NCT00772577|474518628|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131791184|NCT00772577|474518627|FG000|Overall Study|Patient withdrew consent|8|||
131791185|NCT00772577|474518628|FG001|Overall Study|Patient withdrew consent|5|||
131589942|NCT04143061|473788670|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131589943|NCT04143061|473788671|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131589944|NCT04143061|473788672|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131589945|NCT04143061|473788673|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131589946|NCT04143061|473788674|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
131589947|NCT04143061|473788675|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
131589948|NCT04143061|473788676|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
131589949|NCT04143061|473788677|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
131589950|NCT03602014|473788683|FG000|Overall Study|Lost to Follow-up|2|||
131589951|NCT03602014|473788684|FG001|Overall Study|Lost to Follow-up|0|||
131589952|NCT03602014|473788685|FG002|Overall Study|Lost to Follow-up|0|||
131589953|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131589954|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131589955|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131589956|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131589957|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
131589958|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131589959|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131589960|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131589961|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131589962|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
131589963|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131589964|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131589965|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131589966|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131589967|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
131589968|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131589969|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131589970|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131589971|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131589972|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
131589973|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131589974|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131589975|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131589976|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131589977|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
131589978|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131589979|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131589980|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131589981|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131589982|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
131589983|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131589984|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131589985|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131589986|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131589987|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
131589988|NCT01898494|473788686|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131589989|NCT01898494|473788687|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131589990|NCT01898494|473788688|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131791186|NCT00772577|474518627|FG000|Overall Study|Lost to Follow-up|4|||
131791187|NCT00772577|474518628|FG001|Overall Study|Lost to Follow-up|3|||
131791188|NCT00772577|474518627|FG000|Overall Study|Administrative problems|2|||
131589991|NCT01898494|473788689|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131589992|NCT01898494|473788690|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
131791189|NCT00772577|474518628|FG001|Overall Study|Administrative problems|1|||
131791190|NCT00772577|474518627|FG000|Overall Study|Protocol Deviation|3|||
131791191|NCT00772577|474518628|FG001|Overall Study|Protocol Deviation|2|||
131791192|NCT03211156|474518629|FG000|Overall Study|Withdrawal by Subject|0|||
131791193|NCT03211156|474518630|FG001|Overall Study|Withdrawal by Subject|2|||
131589993|NCT01898494|473788686|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
131589994|NCT01898494|473788687|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
131589995|NCT01898494|473788688|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
131589996|NCT01898494|473788689|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
131589997|NCT01898494|473788690|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
131589998|NCT01898494|473788686|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
131589999|NCT01898494|473788687|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
131590000|NCT01898494|473788688|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
131590001|NCT01898494|473788689|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
131590002|NCT01898494|473788690|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
131590003|NCT01898494|473788686|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
131590004|NCT01898494|473788687|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
131590005|NCT01898494|473788688|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
131590006|NCT01898494|473788689|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
131590007|NCT01898494|473788690|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
131590008|NCT01898494|473788686|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131590009|NCT01898494|473788687|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
131590010|NCT01898494|473788688|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131590011|NCT01898494|473788689|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131590012|NCT01898494|473788690|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131590013|NCT01898494|473788686|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131590014|NCT01898494|473788687|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131590015|NCT01898494|473788688|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
131590016|NCT01898494|473788689|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131590017|NCT01898494|473788690|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131590018|NCT01898494|473788686|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
131590019|NCT01898494|473788687|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
131590020|NCT01898494|473788688|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
131590021|NCT01898494|473788689|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
131590022|NCT01898494|473788690|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
131590023|NCT03289039|473788693|FG000|Overall Study|Withdrawal by Subject|0|||
131590024|NCT03289039|473788694|FG001|Overall Study|Withdrawal by Subject|1|||
131590025|NCT03289039|473788693|FG000|Overall Study|Became ineligible prior to treatment start|0|||
131590026|NCT03289039|473788694|FG001|Overall Study|Became ineligible prior to treatment start|1|||
131590027|NCT03289039|473788693|FG000|Overall Study|progressed before treatment start|1|||
131590028|NCT03289039|473788694|FG001|Overall Study|progressed before treatment start|0|||
131590029|NCT01718743|473788695|FG000|Overall Study|Physician Decision|7|||
131590030|NCT01718743|473788695|FG000|Overall Study|Withdrawal by Subject|14|||
131590031|NCT01718743|473788695|FG000|Overall Study|Progressive Disease|22|||
131590032|NCT01718743|473788695|FG000|Overall Study|Toxicity|1|||
131590033|NCT01718743|473788695|FG000|Overall Study|Malignancy|1|||
131590034|NCT06023082|473788702|FG000|Overall Study|Withdrawal by Subject|2|||
131590035|NCT06023082|473788702|FG000|Overall Study|Lost to Follow-up|15|||
131590036|NCT06023082|473788702|FG000|Overall Study|Side effects|5|||
131590037|NCT03263026|473788703|FG000|Overall Study|Withdrawal by Subject|1|||
131590038|NCT03263026|473788704|FG001|Overall Study|Withdrawal by Subject|0|||
131590039|NCT03263026|473788703|FG000|Overall Study|Death|1|||
131590040|NCT03263026|473788704|FG001|Overall Study|Death|0|||
131590041|NCT03263026|473788703|FG000|Overall Study|Other/ Various|41|||
131590042|NCT03263026|473788704|FG001|Overall Study|Other/ Various|29|||
131590043|NCT03739996|473788707|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
131590044|NCT03739996|473788707|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
131590045|NCT03739996|473788707|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
131590046|NCT03739996|473788707|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
131590047|NCT03739996|473788707|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
131590048|NCT03739996|473788707|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
131590049|NCT03739996|473788707|FG000|Step 3 (SOC ART)|Death|1|||
131590050|NCT03739996|473788707|FG000|Step 3 (SOC ART)|Participant moved|1|||
131590051|NCT02553642|473788708|FG000|Overall Study|Withdrawal by Subject|0|||
131706061|NCT00883493|474205523|FG001|Overall Study|Lack of Efficacy|3|||
131706062|NCT00883493|474205522|FG000|Overall Study|Lost to Follow-up|7|||
131706063|NCT00883493|474205523|FG001|Overall Study|Lost to Follow-up|6|||
131706064|NCT00883493|474205522|FG000|Overall Study|Withdrawal by Subject|11|||
131706065|NCT00883493|474205523|FG001|Overall Study|Withdrawal by Subject|20|||
131706066|NCT00883493|474205522|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
131706067|NCT00883493|474205523|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
131706068|NCT00883493|474205522|FG000|Overall Study|Study specific disc. criteria|2|||
131706069|NCT00883493|474205523|FG001|Overall Study|Study specific disc. criteria|0|||
131706070|NCT00883493|474205522|FG000|Overall Study|Other|5|||
131706071|NCT00883493|474205523|FG001|Overall Study|Other|3|||
131706072|NCT02631538|474205524|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
131590052|NCT02553642|473788709|FG001|Overall Study|Withdrawal by Subject|3|||
131590053|NCT02553642|473788708|FG000|Overall Study|Physician Decision|0|||
131590054|NCT02553642|473788709|FG001|Overall Study|Physician Decision|1|||
131590055|NCT02553642|473788708|FG000|Overall Study|Additional cancer dx|0|||
131590056|NCT02553642|473788709|FG001|Overall Study|Additional cancer dx|1|||
131590057|NCT02553642|473788708|FG000|Overall Study|Never started treatment|0|||
131590058|NCT02553642|473788709|FG001|Overall Study|Never started treatment|1|||
131590059|NCT05444192|473788710|FG000|Overall Study|Lost to Follow-up|1|||
131590060|NCT05444192|473788711|FG001|Overall Study|Lost to Follow-up|0|||
131590061|NCT00894543|473788715|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
131590062|NCT00894543|473788716|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
131590063|NCT00894543|473788715|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
131590064|NCT00894543|473788716|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
131590065|NCT01532388|473788717|FG000|3-month Follow-up|Lost to Follow-up|68|||
131590066|NCT01532388|473788718|FG001|3-month Follow-up|Lost to Follow-up|68|||
131590067|NCT01532388|473788717|FG000|6-month Follow-up|Lost to Follow-up|74|||
131590068|NCT01532388|473788718|FG001|6-month Follow-up|Lost to Follow-up|66|||
131590069|NCT01532388|473788717|FG000|12-month Follow-up|Lost to Follow-up|69|||
131590070|NCT01532388|473788718|FG001|12-month Follow-up|Lost to Follow-up|67|||
131590071|NCT02919449|473788719|FG000|Overall Study|Withdrawal by Subject|1|||
131590072|NCT02919449|473788719|FG000|Overall Study|Investigator decision|1|||
131590073|NCT05623345|473788720|FG000|Overall Study|Withdrawal by Subject|14|||
131590074|NCT05623345|473788721|FG001|Overall Study|Withdrawal by Subject|0|||
131590075|NCT05623345|473788722|FG002|Overall Study|Withdrawal by Subject|9|||
131590076|NCT05623345|473788723|FG003|Overall Study|Withdrawal by Subject|20|||
131590077|NCT05623345|473788720|FG000|Overall Study|Lost to Follow-up|3|||
131590078|NCT05623345|473788721|FG001|Overall Study|Lost to Follow-up|0|||
131590079|NCT05623345|473788722|FG002|Overall Study|Lost to Follow-up|7|||
131590080|NCT05623345|473788723|FG003|Overall Study|Lost to Follow-up|2|||
131590081|NCT05623345|473788720|FG000|Overall Study|Termination of Study By Sponsor|37|||
131590082|NCT05623345|473788721|FG001|Overall Study|Termination of Study By Sponsor|4|||
131590083|NCT05623345|473788722|FG002|Overall Study|Termination of Study By Sponsor|40|||
131590084|NCT05623345|473788723|FG003|Overall Study|Termination of Study By Sponsor|38|||
131590085|NCT01772472|473788725|FG000|Overall Study|Death|126|||
131590086|NCT01772472|473788726|FG001|Overall Study|Death|94|||
131590087|NCT01772472|473788725|FG000|Overall Study|Lost to Follow-up|51|||
131590088|NCT01772472|473788726|FG001|Overall Study|Lost to Follow-up|50|||
131590089|NCT01772472|473788725|FG000|Overall Study|Other|9|||
131590090|NCT01772472|473788726|FG001|Overall Study|Other|7|||
131590091|NCT01772472|473788725|FG000|Overall Study|Physician Decision|1|||
131590092|NCT01772472|473788726|FG001|Overall Study|Physician Decision|7|||
131590093|NCT01772472|473788725|FG000|Overall Study|Withdrawal by Subject|115|||
131590094|NCT01772472|473788726|FG001|Overall Study|Withdrawal by Subject|90|||
131590095|NCT01772472|473788725|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
131590096|NCT01772472|473788726|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
131590097|NCT02697136|473788727|FG000|Overall Study|Adverse Event|3|||
131590098|NCT02697136|473788728|FG001|Overall Study|Adverse Event|0|||
131590099|NCT03578536|473788731|FG000|Overall Study|Lost to Follow-up|1|||
131590100|NCT02538900|473788732|FG000|Overall Study|Death|2|||
131706073|NCT02631538|474205525|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
131706074|NCT02631538|474205526|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
131706075|NCT02631538|474205527|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
131706076|NCT02631538|474205524|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
131706077|NCT02631538|474205525|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
131706078|NCT02631538|474205526|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
131706079|NCT02631538|474205527|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
131706080|NCT02631538|474205524|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
131706081|NCT02631538|474205525|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
131706082|NCT02631538|474205526|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
131706083|NCT02631538|474205527|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
131706084|NCT02631538|474205524|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
131706085|NCT02631538|474205525|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
131438961|NCT00651924|473233348|FG000|Overall Study|Withdrawal by PI|0|||
131590101|NCT02538900|473788733|FG001|Overall Study|Death|2|||
131706086|NCT02631538|474205526|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
131590102|NCT02538900|473788734|FG002|Overall Study|Death|2|||
131590103|NCT02538900|473788732|FG000|Overall Study|Withdrawal by Subject|18|||
131590104|NCT02538900|473788733|FG001|Overall Study|Withdrawal by Subject|16|||
131590105|NCT02538900|473788734|FG002|Overall Study|Withdrawal by Subject|15|||
131590106|NCT02874534|473788735|FG000|Overall Study|Withdrawal by Subject|5|||
131590107|NCT02874534|473788736|FG001|Overall Study|Withdrawal by Subject|8|||
131590108|NCT02874534|473788735|FG000|Overall Study|Lost to Follow-up|2|||
131590109|NCT02874534|473788736|FG001|Overall Study|Lost to Follow-up|2|||
131590110|NCT02874534|473788735|FG000|Overall Study|Ongoing in study|1|||
131590111|NCT02874534|473788736|FG001|Overall Study|Ongoing in study|1|||
131590112|NCT02923180|473788737|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
131590113|NCT02923180|473788737|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
131590114|NCT05198310|473788738|FG000|Overall Study|Lost to Follow-up|0|||
131590115|NCT05198310|473788739|FG001|Overall Study|Lost to Follow-up|1|||
131590116|NCT05198310|473788740|FG002|Overall Study|Lost to Follow-up|0|||
131590117|NCT05198310|473788741|FG003|Overall Study|Lost to Follow-up|0|||
131590118|NCT05198310|473788742|FG004|Overall Study|Lost to Follow-up|0|||
131590119|NCT05198310|473788743|FG005|Overall Study|Lost to Follow-up|0|||
131590120|NCT05198310|473788744|FG006|Overall Study|Lost to Follow-up|0|||
131590121|NCT05198310|473788745|FG007|Overall Study|Lost to Follow-up|0|||
131590122|NCT05198310|473788738|FG000|Overall Study|Withdrawal by Subject|0|||
131590123|NCT05198310|473788739|FG001|Overall Study|Withdrawal by Subject|0|||
131590124|NCT05198310|473788740|FG002|Overall Study|Withdrawal by Subject|0|||
131590125|NCT05198310|473788741|FG003|Overall Study|Withdrawal by Subject|2|||
131590126|NCT05198310|473788742|FG004|Overall Study|Withdrawal by Subject|0|||
131590127|NCT05198310|473788743|FG005|Overall Study|Withdrawal by Subject|2|||
131590128|NCT05198310|473788744|FG006|Overall Study|Withdrawal by Subject|1|||
131590129|NCT05198310|473788745|FG007|Overall Study|Withdrawal by Subject|3|||
131590130|NCT01095796|473788746|FG000|Overall Study|Randomized but Not Treated|5|||
131590131|NCT01095796|473788747|FG001|Overall Study|Randomized but Not Treated|2|||
131590132|NCT01095796|473788746|FG000|Overall Study|Adverse Event|9|||
131590133|NCT01095796|473788747|FG001|Overall Study|Adverse Event|19|||
131590134|NCT01095796|473788746|FG000|Overall Study|Death|3|||
131590135|NCT01095796|473788747|FG001|Overall Study|Death|2|||
131791194|NCT03211156|474518629|FG000|Overall Study|Lost to Follow-up|1|||
131791195|NCT03211156|474518630|FG001|Overall Study|Lost to Follow-up|1|||
131791196|NCT03211156|474518629|FG000|Overall Study|Adverse Event|1|||
131791197|NCT03211156|474518630|FG001|Overall Study|Adverse Event|0|||
131791198|NCT04272775|474518631|FG000|Overall Study|Study Terminated by Sponsor|1|||
131791199|NCT04272775|474518632|FG001|Overall Study|Study Terminated by Sponsor|0|||
131791200|NCT04272775|474518631|FG000|Overall Study|Protocol Violation|0|||
131791201|NCT04272775|474518632|FG001|Overall Study|Protocol Violation|1|||
131791202|NCT04272775|474518631|FG000|Overall Study|Symptomatic Deterioration|1|||
131791203|NCT04272775|474518632|FG001|Overall Study|Symptomatic Deterioration|1|||
131791204|NCT04272775|474518631|FG000|Overall Study|Withdrawal by Subject|1|||
131791205|NCT04272775|474518632|FG001|Overall Study|Withdrawal by Subject|2|||
131791206|NCT04272775|474518631|FG000|Overall Study|Adverse Event|1|||
131791207|NCT04272775|474518632|FG001|Overall Study|Adverse Event|2|||
131791208|NCT04272775|474518631|FG000|Overall Study|Progressive Disease|3|||
131791209|NCT04272775|474518632|FG001|Overall Study|Progressive Disease|1|||
131791210|NCT00678392|474518633|FG000|Overall Study|Adverse Event|0|||
131791211|NCT00678392|474518634|FG001|Overall Study|Adverse Event|6|||
131791212|NCT00678392|474518633|FG000|Overall Study|Death|280|||
131791213|NCT00678392|474518634|FG001|Overall Study|Death|269|||
131791214|NCT00678392|474518633|FG000|Overall Study|Lost to Follow-up|15|||
131791215|NCT00678392|474518634|FG001|Overall Study|Lost to Follow-up|13|||
131791216|NCT00678392|474518633|FG000|Overall Study|Objective Progression or Relapse|3|||
131791217|NCT00678392|474518634|FG001|Overall Study|Objective Progression or Relapse|8|||
131791218|NCT00678392|474518633|FG000|Overall Study|Sponsor's Decision|1|||
131791219|NCT00678392|474518634|FG001|Overall Study|Sponsor's Decision|2|||
131791220|NCT00678392|474518633|FG000|Overall Study|Withdrawal by Subject|4|||
131791221|NCT00678392|474518634|FG001|Overall Study|Withdrawal by Subject|4|||
131791222|NCT00678392|474518633|FG000|Overall Study|Randomized But Not Treated|2|||
131791223|NCT00678392|474518634|FG001|Overall Study|Randomized But Not Treated|7|||
131590136|NCT01095796|473788746|FG000|Overall Study|Pregnancy|2|||
131791224|NCT00678392|474518633|FG000|Overall Study|Other|56|||
131590137|NCT01095796|473788747|FG001|Overall Study|Pregnancy|0|||
131590138|NCT01095796|473788746|FG000|Overall Study|Lack of Efficacy|5|||
131590139|NCT01095796|473788747|FG001|Overall Study|Lack of Efficacy|3|||
131590140|NCT01095796|473788746|FG000|Overall Study|Investigator's Discretion|7|||
131590141|NCT01095796|473788747|FG001|Overall Study|Investigator's Discretion|2|||
131590142|NCT01095796|473788746|FG000|Overall Study|Withdrew Consent|16|||
131590143|NCT01095796|473788747|FG001|Overall Study|Withdrew Consent|22|||
131791225|NCT00678392|474518634|FG001|Overall Study|Other|53|||
131791226|NCT01405820|474518637|FG000|Randomized Treatment Period|Adverse Event|3|||
131791227|NCT01405820|474518638|FG001|Randomized Treatment Period|Adverse Event|3|||
131791228|NCT01405820|474518639|FG002|Randomized Treatment Period|Adverse Event|3|||
131791229|NCT01405820|474518640|FG003|Randomized Treatment Period|Adverse Event|0|||
131590144|NCT01095796|473788746|FG000|Overall Study|Lost to Follow-up|27|||
131791230|NCT01405820|474518641|FG004|Randomized Treatment Period|Adverse Event|2|||
131791231|NCT01405820|474518642|FG005|Randomized Treatment Period|Adverse Event|1|||
131590145|NCT01095796|473788747|FG001|Overall Study|Lost to Follow-up|29|||
131590146|NCT01095796|473788746|FG000|Overall Study|Participant Noncompliance|5|||
131590147|NCT01095796|473788747|FG001|Overall Study|Participant Noncompliance|10|||
131590148|NCT01095796|473788746|FG000|Overall Study|Protocol Violation|1|||
131590149|NCT01095796|473788747|FG001|Overall Study|Protocol Violation|0|||
131590150|NCT01095796|473788746|FG000|Overall Study|Participant Transferred to Another Study|215|||
131590151|NCT01095796|473788747|FG001|Overall Study|Participant Transferred to Another Study|200|||
131706087|NCT02631538|474205527|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
131899075|NCT03569098|474917494|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
131438962|NCT00651924|473233349|FG001|Overall Study|Withdrawal by PI|2|||
131590152|NCT01989455|473788752|FG000|Overall Study|Adverse Event|0|||
131590153|NCT01989455|473788753|FG001|Overall Study|Adverse Event|1|||
131590154|NCT01989455|473788754|FG002|Overall Study|Adverse Event|0|||
131590155|NCT01989455|473788755|FG003|Overall Study|Adverse Event|0|||
131590156|NCT01989455|473788756|FG004|Overall Study|Adverse Event|0|||
131590157|NCT01989455|473788752|FG000|Overall Study|Withdrawal by Subject|0|||
131590158|NCT01989455|473788753|FG001|Overall Study|Withdrawal by Subject|1|||
131590159|NCT01989455|473788754|FG002|Overall Study|Withdrawal by Subject|0|||
131590160|NCT01989455|473788755|FG003|Overall Study|Withdrawal by Subject|0|||
131590161|NCT01989455|473788756|FG004|Overall Study|Withdrawal by Subject|0|||
131590162|NCT01989455|473788752|FG000|Overall Study|Technical problems with infusion|0|||
131590163|NCT01989455|473788753|FG001|Overall Study|Technical problems with infusion|0|||
131590164|NCT01989455|473788754|FG002|Overall Study|Technical problems with infusion|1|||
131590165|NCT01989455|473788755|FG003|Overall Study|Technical problems with infusion|0|||
131590166|NCT01989455|473788756|FG004|Overall Study|Technical problems with infusion|1|||
131590167|NCT02638337|473788757|FG000|Overall Study|Adverse Event|6|||
131590168|NCT02638337|473788758|FG001|Overall Study|Adverse Event|10|||
131590169|NCT02638337|473788757|FG000|Overall Study|Protocol Violation|3|||
131590170|NCT02638337|473788758|FG001|Overall Study|Protocol Violation|0|||
131590171|NCT02638337|473788757|FG000|Overall Study|Withdrawal by Subject|13|||
131590172|NCT02638337|473788758|FG001|Overall Study|Withdrawal by Subject|16|||
131590173|NCT02638337|473788757|FG000|Overall Study|Lost to Follow-up|7|||
131590174|NCT02638337|473788758|FG001|Overall Study|Lost to Follow-up|7|||
131590175|NCT02638337|473788757|FG000|Overall Study|Other - Miscellaneous|4|||
131590176|NCT02638337|473788758|FG001|Overall Study|Other - Miscellaneous|3|||
131590177|NCT04116736|473788759|FG000|Overall Study|Withdrew consent during study|3|||
131590178|NCT04116736|473788760|FG001|Overall Study|Withdrew consent during study|1|||
131590179|NCT04116736|473788759|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
131590180|NCT04116736|473788760|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
131590181|NCT04116736|473788759|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
131590182|NCT04116736|473788760|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
131590183|NCT04116736|473788759|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
131590184|NCT04116736|473788760|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
131590185|NCT04116736|473788759|FG000|Overall Study|Subject was enrolled in error|2|||
131590186|NCT04116736|473788760|FG001|Overall Study|Subject was enrolled in error|0|||
131590187|NCT04116736|473788759|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
131590188|NCT04116736|473788760|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
131590189|NCT04116736|473788759|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
131590190|NCT04116736|473788760|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
131590191|NCT04116736|473788759|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
131590192|NCT04116736|473788760|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
131590193|NCT05512962|473788763|FG000|Overall Study|Withdrawal by Subject|1|||
131590194|NCT05512962|473788764|FG001|Overall Study|Withdrawal by Subject|0|||
131590195|NCT02860130|473788765|FG000|Overall Study|Adverse Event|2|||
131590196|NCT02860130|473788766|FG001|Overall Study|Adverse Event|3|||
131590197|NCT02860130|473788765|FG000|Overall Study|Protocol Violation|1|||
131590198|NCT02860130|473788766|FG001|Overall Study|Protocol Violation|1|||
131590199|NCT02860130|473788765|FG000|Overall Study|Withdrawal by Subject|0|||
131590200|NCT02860130|473788766|FG001|Overall Study|Withdrawal by Subject|2|||
131590201|NCT02860130|473788765|FG000|Overall Study|Physician Decision|2|||
131590202|NCT02860130|473788766|FG001|Overall Study|Physician Decision|2|||
131590203|NCT02860130|473788765|FG000|Overall Study|Other|2|||
131590204|NCT02860130|473788766|FG001|Overall Study|Other|1|||
131590205|NCT03380390|473788768|FG000|Overall Study|Adverse Event|3|||
131590206|NCT01127373|473788769|FG000|Overall Study|Not Treated|3|||
131590207|NCT01127373|473788769|FG000|Overall Study|Lost to Follow-up|7|||
131590208|NCT01127373|473788769|FG000|Overall Study|Withdrawal by Subject|1|||
131590209|NCT01127373|473788769|FG000|Overall Study|Disease progression|1|||
131590210|NCT01426412|473788770|FG000|Overall Study|Withdrawal by Subject|1|||
131590211|NCT01426412|473788771|FG001|Overall Study|Withdrawal by Subject|0|||
131590212|NCT01426412|473788772|FG002|Overall Study|Withdrawal by Subject|0|||
131590213|NCT01426412|473788773|FG003|Overall Study|Withdrawal by Subject|0|||
131590214|NCT01426412|473788774|FG004|Overall Study|Withdrawal by Subject|1|||
131590215|NCT01426412|473788775|FG005|Overall Study|Withdrawal by Subject|0|||
131590216|NCT01426412|473788776|FG006|Overall Study|Withdrawal by Subject|0|||
131590217|NCT01426412|473788777|FG007|Overall Study|Withdrawal by Subject|3|||
131590218|NCT01426412|473788778|FG008|Overall Study|Withdrawal by Subject|1|||
131590219|NCT02794480|473788780|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
131590220|NCT02794480|473788781|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
131590221|NCT02794480|473788782|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
131590222|NCT02794480|473788783|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
131590223|NCT02794480|473788780|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
131590224|NCT02794480|473788781|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
131590225|NCT02794480|473788782|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
131590226|NCT02794480|473788783|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
131590227|NCT02794480|473788780|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131590228|NCT02794480|473788781|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131590229|NCT02794480|473788782|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131590230|NCT02794480|473788783|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
131590231|NCT02794480|473788780|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131590232|NCT02794480|473788781|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
131590233|NCT02794480|473788782|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131590234|NCT02794480|473788783|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131590235|NCT02794480|473788780|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
131590236|NCT02794480|473788781|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131590237|NCT02794480|473788782|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131590238|NCT02794480|473788783|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
131590239|NCT00262301|473788784|FG000|Double-blind Phase|Lost to Follow-up|1|||
131590240|NCT00262301|473788785|FG001|Double-blind Phase|Lost to Follow-up|0|||
131590241|NCT00262301|473788786|FG002|Double-blind Phase|Lost to Follow-up|0|||
131590242|NCT00262301|473788784|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
131590243|NCT00262301|473788785|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
131590244|NCT00262301|473788786|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
131590245|NCT01136876|473788789|FG000|Overall Study|Lost to Follow-up|0|||
131590246|NCT01136876|473788790|FG001|Overall Study|Lost to Follow-up|1|||
131590247|NCT01136876|473788789|FG000|Overall Study|Physician Decision|3|||
131590248|NCT01136876|473788790|FG001|Overall Study|Physician Decision|5|||
131590249|NCT01136876|473788789|FG000|Overall Study|Missing NGAL measurement|2|||
131590250|NCT01136876|473788790|FG001|Overall Study|Missing NGAL measurement|5|||
131590251|NCT00976937|473788793|FG000|Overall Study|Adverse Event|4|||
131590252|NCT00976937|473788794|FG001|Overall Study|Adverse Event|5|||
131590253|NCT00976937|473788793|FG000|Overall Study|Lost to Follow-up|2|||
131590254|NCT00976937|473788794|FG001|Overall Study|Lost to Follow-up|1|||
131590255|NCT00976937|473788793|FG000|Overall Study|Withdrawal by Subject|5|||
131590256|NCT00976937|473788794|FG001|Overall Study|Withdrawal by Subject|3|||
131590257|NCT00976937|473788793|FG000|Overall Study|Poor compliance to protocol|3|||
131590258|NCT00976937|473788794|FG001|Overall Study|Poor compliance to protocol|0|||
131590259|NCT00976937|473788793|FG000|Overall Study|Personal and Familial Reason|2|||
131590260|NCT00976937|473788794|FG001|Overall Study|Personal and Familial Reason|2|||
131590261|NCT03069313|473788795|FG000|Overall Study|Adverse Event|5|||
131590262|NCT03744312|473789876|FG000|Overall Study|Withdrawal by Subject|0|||
131590263|NCT03744312|473789877|FG001|Overall Study|Withdrawal by Subject|1|||
131590264|NCT03744312|473789876|FG000|Overall Study|Screen fail|0|||
131590265|NCT03744312|473789877|FG001|Overall Study|Screen fail|1|||
131590266|NCT04924062|473789878|FG000|Overall Study|Death|49|||
131590267|NCT04924062|473789879|FG001|Overall Study|Death|63|||
131590268|NCT04924062|473789878|FG000|Overall Study|Participant On-going|26|||
131590269|NCT04924062|473789879|FG001|Overall Study|Participant On-going|20|||
131590270|NCT04607044|473789888|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
131590271|NCT04607044|473789888|FG000|Overall Study|Adverse Event|1|||
131590272|NCT04607044|473789888|FG000|Overall Study|Did not receive study device|3|||
131590273|NCT04607044|473789888|FG000|Overall Study|Death|1|||
131590274|NCT05403801|473789889|FG000|Overall Study|Withdrawal by Subject|2|||
131590275|NCT03651895|473789890|FG000|First Drug Assignment|Adverse Event|4|||
131590276|NCT03651895|473789891|FG001|First Drug Assignment|Adverse Event|5|||
131590277|NCT03651895|473789890|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
131590278|NCT03651895|473789891|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
131590279|NCT02525692|473789892|FG000|Overall Study|Withdrawal by Subject|1|||
131590280|NCT02525692|473789893|FG001|Overall Study|Withdrawal by Subject|1|||
131590281|NCT02525692|473789894|FG002|Overall Study|Withdrawal by Subject|0|||
131590282|NCT02525692|473789895|FG003|Overall Study|Withdrawal by Subject|5|||
131590283|NCT02525692|473789896|FG004|Overall Study|Withdrawal by Subject|0|||
131590284|NCT02525692|473789897|FG005|Overall Study|Withdrawal by Subject|1|||
131590285|NCT02525692|473789892|FG000|Overall Study|Death|16|||
131590286|NCT02525692|473789893|FG001|Overall Study|Death|18|||
131899076|NCT03569098|474917492|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
131590287|NCT02525692|473789894|FG002|Overall Study|Death|7|||
131590288|NCT02525692|473789895|FG003|Overall Study|Death|20|||
131590289|NCT02525692|473789896|FG004|Overall Study|Death|3|||
131590290|NCT02525692|473789897|FG005|Overall Study|Death|6|||
131590291|NCT02525692|473789892|FG000|Overall Study|Lost to Follow-up|0|||
131590292|NCT02525692|473789893|FG001|Overall Study|Lost to Follow-up|0|||
131590293|NCT02525692|473789894|FG002|Overall Study|Lost to Follow-up|1|||
131590294|NCT02525692|473789895|FG003|Overall Study|Lost to Follow-up|5|||
131590295|NCT02525692|473789896|FG004|Overall Study|Lost to Follow-up|0|||
131590296|NCT02525692|473789897|FG005|Overall Study|Lost to Follow-up|0|||
131590297|NCT02396199|473789898|FG000|Overall Study|Lost to Follow-up|1|||
131590298|NCT02396199|473789898|FG000|Overall Study|Death|4|||
131590299|NCT05510232|473789899|FG000|Overall Study|Withdrawal by Subject|2|||
131590300|NCT05510232|473789900|FG001|Overall Study|Withdrawal by Subject|7|||
131590301|NCT05510232|473789901|FG002|Overall Study|Withdrawal by Subject|6|||
131590302|NCT02349412|473789912|FG000|Overall Study|Withdrawal by Subject|7|||
131590303|NCT02349412|473789913|FG001|Overall Study|Withdrawal by Subject|7|||
131590304|NCT04337372|473789914|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
131590305|NCT04337372|473789915|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
131590306|NCT04337372|473789916|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
131590307|NCT04337372|473789917|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
131590308|NCT04337372|473789914|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
131590309|NCT04337372|473789915|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
131590310|NCT04337372|473789916|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
131590311|NCT04337372|473789917|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
131590312|NCT04337372|473789914|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
131590313|NCT04337372|473789915|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
131590314|NCT04337372|473789916|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
131590315|NCT04337372|473789917|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
131590316|NCT04337372|473789914|FG000|Day 2: EEG Measures|Protocol Violation|6|||
131590317|NCT04337372|473789915|FG001|Day 2: EEG Measures|Protocol Violation|6|||
131590318|NCT04337372|473789916|FG002|Day 2: EEG Measures|Protocol Violation|5|||
131590319|NCT04337372|473789917|FG003|Day 2: EEG Measures|Protocol Violation|17|||
131590320|NCT05307783|473789918|FG000|Overall Study|Death|7|||
131590321|NCT05307783|473789918|FG000|Overall Study|Lost to Follow-up|4|||
131590322|NCT04883645|473789919|FG000|Overall Study|Death|1|||
131706088|NCT02631538|474205524|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
131706089|NCT02631538|474205525|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
131706090|NCT02631538|474205526|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
131706091|NCT02631538|474205527|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
131706092|NCT02631538|474205524|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
131706093|NCT02631538|474205525|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
131706094|NCT02631538|474205526|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
131438963|NCT00651924|473233348|FG000|Overall Study|Withdrawal by Subject|0|||
131438964|NCT00651924|473233349|FG001|Overall Study|Withdrawal by Subject|5|||
131438965|NCT00960063|473233350|FG000|Overall Study|Adverse Event|1|||
131438966|NCT00960063|473233351|FG001|Overall Study|Adverse Event|0|||
131438967|NCT00960063|473233352|FG002|Overall Study|Adverse Event|0|||
131438968|NCT00960063|473233350|FG000|Overall Study|Progression of Disease|0|||
131438969|NCT00960063|473233351|FG001|Overall Study|Progression of Disease|0|||
131438970|NCT00960063|473233352|FG002|Overall Study|Progression of Disease|3|||
131438971|NCT00525512|473233371|FG000|Double-Blind Phase|Adverse Event|48|||
131438972|NCT00525512|473233372|FG001|Double-Blind Phase|Adverse Event|28|||
131438973|NCT00525512|473233373|FG002|Double-Blind Phase|Adverse Event|0|||
131438974|NCT00525512|473233374|FG003|Double-Blind Phase|Adverse Event|0|||
131438975|NCT00525512|473233371|FG000|Double-Blind Phase|Protocol Violation|3|||
131438976|NCT00525512|473233372|FG001|Double-Blind Phase|Protocol Violation|1|||
131438977|NCT00525512|473233373|FG002|Double-Blind Phase|Protocol Violation|0|||
131438978|NCT00525512|473233374|FG003|Double-Blind Phase|Protocol Violation|0|||
131438979|NCT00525512|473233371|FG000|Double-Blind Phase|Lost to Follow-up|3|||
131438980|NCT00525512|473233372|FG001|Double-Blind Phase|Lost to Follow-up|7|||
131438981|NCT00525512|473233373|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131438982|NCT00525512|473233374|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131438983|NCT00525512|473233371|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
131438984|NCT00525512|473233372|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
131438985|NCT00525512|473233373|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131438986|NCT00525512|473233374|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131438987|NCT00525512|473233371|FG000|Double-Blind Phase|Lack of Efficacy|13|||
131438988|NCT00525512|473233372|FG001|Double-Blind Phase|Lack of Efficacy|5|||
131438989|NCT00525512|473233373|FG002|Double-Blind Phase|Lack of Efficacy|0|||
131438990|NCT00525512|473233374|FG003|Double-Blind Phase|Lack of Efficacy|0|||
131438991|NCT00525512|473233371|FG000|Double-Blind Phase|Other reason (not specified)|12|||
131438992|NCT00525512|473233372|FG001|Double-Blind Phase|Other reason (not specified)|13|||
131438993|NCT00525512|473233373|FG002|Double-Blind Phase|Other reason (not specified)|0|||
131438994|NCT00525512|473233374|FG003|Double-Blind Phase|Other reason (not specified)|0|||
131438995|NCT00525512|473233371|FG000|Open-Label Phase|Adverse Event|0|||
131438996|NCT00525512|473233372|FG001|Open-Label Phase|Adverse Event|0|||
131438997|NCT00525512|473233373|FG002|Open-Label Phase|Adverse Event|1|||
131438998|NCT00525512|473233374|FG003|Open-Label Phase|Adverse Event|0|||
131438999|NCT00525512|473233371|FG000|Open-Label Phase|Lost to Follow-up|0|||
131439000|NCT00525512|473233372|FG001|Open-Label Phase|Lost to Follow-up|0|||
131439001|NCT00525512|473233373|FG002|Open-Label Phase|Lost to Follow-up|1|||
131439002|NCT00525512|473233374|FG003|Open-Label Phase|Lost to Follow-up|0|||
131439003|NCT00525512|473233371|FG000|Open-Label Phase|Other reason (not specified)|0|||
131439004|NCT00525512|473233372|FG001|Open-Label Phase|Other reason (not specified)|0|||
131439005|NCT00525512|473233373|FG002|Open-Label Phase|Other reason (not specified)|4|||
131439006|NCT00525512|473233374|FG003|Open-Label Phase|Other reason (not specified)|5|||
131439007|NCT03289208|473233375|FG000|Overall Study|Adverse Event|1|||
131439008|NCT03289208|473233376|FG001|Overall Study|Adverse Event|0|||
131439009|NCT03289208|473233377|FG002|Overall Study|Adverse Event|0|||
131439010|NCT03353675|473233382|FG000|Overall Study|Adverse Event|4|||
131439011|NCT00395746|473233385|FG000|Overall Study|Adverse Event|5|||
131899077|NCT03569098|474917493|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
131439012|NCT00395746|473233386|FG001|Overall Study|Adverse Event|2|||
131439013|NCT00395746|473233387|FG002|Overall Study|Adverse Event|2|||
131439014|NCT00395746|473233385|FG000|Overall Study|Protocol Violation|0|||
131439015|NCT00395746|473233386|FG001|Overall Study|Protocol Violation|1|||
131439016|NCT00395746|473233387|FG002|Overall Study|Protocol Violation|0|||
131439017|NCT00395746|473233385|FG000|Overall Study|Lack of Efficacy|2|||
131439018|NCT00395746|473233386|FG001|Overall Study|Lack of Efficacy|0|||
131439019|NCT00395746|473233387|FG002|Overall Study|Lack of Efficacy|17|||
131439020|NCT00395746|473233385|FG000|Overall Study|Hypoglycaemia|2|||
131439021|NCT00395746|473233386|FG001|Overall Study|Hypoglycaemia|1|||
131439022|NCT00395746|473233387|FG002|Overall Study|Hypoglycaemia|0|||
131899078|NCT03569098|474917494|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
131706095|NCT02631538|474205527|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
131706096|NCT00849667|474205528|FG000|Overall Study|Withdrawal by Subject|16|||
131706097|NCT00849667|474205529|FG001|Overall Study|Withdrawal by Subject|33|||
131706098|NCT00849667|474205530|FG002|Overall Study|Withdrawal by Subject|35|||
131706099|NCT00849667|474205528|FG000|Overall Study|Lost to Follow-up|8|||
131706100|NCT00849667|474205529|FG001|Overall Study|Lost to Follow-up|8|||
131590338|NCT03460236|473789923|FG000|Overall Study|failed radiographic screening|16|||
131590339|NCT03460236|473789923|FG000|Overall Study|Withdrawal by Subject|11|||
131590340|NCT00979576|473789926|FG000|Combination Treatment Phase|Progressive disease|3|||
131590341|NCT00979576|473789927|FG001|Combination Treatment Phase|Progressive disease|1|||
131590342|NCT00979576|473789928|FG002|Combination Treatment Phase|Progressive disease|5|||
131590343|NCT00979576|473789926|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
131590344|NCT00979576|473789927|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
131590345|NCT00979576|473789928|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
131590346|NCT00979576|473789926|FG000|Combination Treatment Phase|Adverse Event|0|||
131590347|NCT00979576|473789927|FG001|Combination Treatment Phase|Adverse Event|2|||
131590348|NCT00979576|473789928|FG002|Combination Treatment Phase|Adverse Event|2|||
131590349|NCT00979576|473789926|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
131590350|NCT00979576|473789927|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
131590351|NCT00979576|473789928|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
131590352|NCT04855760|473789929|FG000|Overall Study|Adverse Event|21|||
131590353|NCT04855760|473789929|FG000|Overall Study|Withdrawal by Subject|116|||
131590354|NCT04855760|473789929|FG000|Overall Study|Lack of Efficacy|21|||
131590355|NCT04855760|473789929|FG000|Overall Study|Lost to Follow-up|49|||
131590356|NCT04855760|473789929|FG000|Overall Study|Protocol Violation|2|||
131590357|NCT04855760|473789929|FG000|Overall Study|Physician Decision|5|||
131590358|NCT04855760|473789929|FG000|Overall Study|Pregnancy|1|||
131590359|NCT04855760|473789929|FG000|Overall Study|Non-Compliance with Study Drug|11|||
131590360|NCT04855760|473789929|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
131590361|NCT04855760|473789929|FG000|Overall Study|Study Completed by Sponsor|202|||
131590362|NCT04855760|473789929|FG000|Overall Study|Other|13|||
131590363|NCT04868110|473789934|FG000|Overall Study|Withdrawal by Subject|3|||
131590364|NCT04868110|473789935|FG001|Overall Study|Withdrawal by Subject|4|||
131590365|NCT04823611|473789936|FG000|Overall Study|Adverse Event|2|||
131590366|NCT04823611|473789937|FG001|Overall Study|Adverse Event|0|||
131590367|NCT04823611|473789938|FG002|Overall Study|Adverse Event|1|||
131590368|NCT04823611|473789939|FG003|Overall Study|Adverse Event|0|||
131590369|NCT04823611|473789940|FG004|Overall Study|Adverse Event|0|||
131590370|NCT04823611|473789941|FG005|Overall Study|Adverse Event|0|||
131590371|NCT04823611|473789942|FG006|Overall Study|Adverse Event|0|||
131590372|NCT01894061|473789946|FG000|Overall Study|Screen failure|1|||
131590373|NCT01894061|473789946|FG000|Overall Study|Withdrawal by Subject|1|||
131590374|NCT01673984|473789947|FG000|Overall Study|Adverse Event|1|||
131590375|NCT01673984|473789948|FG001|Overall Study|Adverse Event|0|||
131590376|NCT01673984|473789947|FG000|Overall Study|Study termination|9|||
131590377|NCT01673984|473789948|FG001|Overall Study|Study termination|6|||
131590378|NCT05384730|473789952|FG000|Overall Study|Adverse Event|1|||
131590379|NCT05384730|473789953|FG001|Overall Study|Adverse Event|0|||
131590380|NCT05384730|473789952|FG000|Overall Study|Lack of social support|2|||
131590381|NCT05384730|473789953|FG001|Overall Study|Lack of social support|0|||
131590382|NCT05384730|473789952|FG000|Overall Study|Hospital readmission|2|||
131590383|NCT05384730|473789953|FG001|Overall Study|Hospital readmission|0|||
131590384|NCT05384730|473789952|FG000|Overall Study|Disease progression|5|||
131590385|NCT05384730|473789953|FG001|Overall Study|Disease progression|0|||
131590386|NCT05384730|473789952|FG000|Overall Study|Overwhelmed with College commitments|0|||
131590387|NCT05384730|473789953|FG001|Overall Study|Overwhelmed with College commitments|2|||
131590388|NCT04436107|473789957|FG000|Overall Study|Sponsor Ended Study|2|||
131590389|NCT04436107|473789958|FG001|Overall Study|Sponsor Ended Study|4|||
131590390|NCT04436107|473789959|FG002|Overall Study|Sponsor Ended Study|8|||
131590391|NCT04436107|473789960|FG003|Overall Study|Sponsor Ended Study|20|||
131590392|NCT04436107|473789957|FG000|Overall Study|Death|3|||
131590393|NCT04436107|473789958|FG001|Overall Study|Death|5|||
131590394|NCT04436107|473789959|FG002|Overall Study|Death|3|||
131590395|NCT04436107|473789960|FG003|Overall Study|Death|18|||
131590396|NCT04436107|473789957|FG000|Overall Study|Withdrawal by Subject|1|||
131590397|NCT04436107|473789958|FG001|Overall Study|Withdrawal by Subject|1|||
131590398|NCT04436107|473789959|FG002|Overall Study|Withdrawal by Subject|0|||
131590399|NCT04436107|473789960|FG003|Overall Study|Withdrawal by Subject|1|||
131590400|NCT04854096|473789961|FG000|Overall Study|Adverse Event|1|||
131590401|NCT04854096|473789962|FG001|Overall Study|Adverse Event|0|||
131590402|NCT04854096|473789961|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
131590403|NCT04854096|473789962|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
131590404|NCT04854096|473789961|FG000|Overall Study|Withdrawal by Subject|1|||
131590405|NCT04854096|473789962|FG001|Overall Study|Withdrawal by Subject|0|||
131590406|NCT04854096|473789961|FG000|Overall Study|Other reasons|1|||
131590407|NCT04854096|473789962|FG001|Overall Study|Other reasons|0|||
131590408|NCT04757610|473789963|FG000|Overall Study|Adverse Event|13|||
131590409|NCT04757610|473789964|FG001|Overall Study|Adverse Event|10|||
131590410|NCT04757610|473789965|FG002|Overall Study|Adverse Event|5|||
131590411|NCT04757610|473789963|FG000|Overall Study|Death|5|||
131590412|NCT04757610|473789964|FG001|Overall Study|Death|13|||
131590413|NCT04757610|473789965|FG002|Overall Study|Death|8|||
131590414|NCT04757610|473789963|FG000|Overall Study|Lack of Efficacy|1|||
131590415|NCT04757610|473789964|FG001|Overall Study|Lack of Efficacy|2|||
131706101|NCT00849667|474205530|FG002|Overall Study|Lost to Follow-up|8|||
131590416|NCT04757610|473789965|FG002|Overall Study|Lack of Efficacy|3|||
131590417|NCT04757610|473789963|FG000|Overall Study|Lost to Follow-up|7|||
131590418|NCT04757610|473789964|FG001|Overall Study|Lost to Follow-up|2|||
131590419|NCT04757610|473789965|FG002|Overall Study|Lost to Follow-up|7|||
131590420|NCT04757610|473789963|FG000|Overall Study|Physician Decision|4|||
131590421|NCT04757610|473789964|FG001|Overall Study|Physician Decision|1|||
131590422|NCT04757610|473789965|FG002|Overall Study|Physician Decision|2|||
131590423|NCT04757610|473789963|FG000|Overall Study|Withdrawal by Subject|26|||
131590424|NCT04757610|473789964|FG001|Overall Study|Withdrawal by Subject|25|||
131590425|NCT04757610|473789965|FG002|Overall Study|Withdrawal by Subject|25|||
131590426|NCT04757610|473789963|FG000|Overall Study|Study Terminated by Sponsor|105|||
131590427|NCT04757610|473789964|FG001|Overall Study|Study Terminated by Sponsor|105|||
131590428|NCT04757610|473789965|FG002|Overall Study|Study Terminated by Sponsor|110|||
131590429|NCT04757610|473789963|FG000|Overall Study|Randomized in Error|1|||
131590430|NCT04757610|473789964|FG001|Overall Study|Randomized in Error|0|||
131590431|NCT04757610|473789965|FG002|Overall Study|Randomized in Error|0|||
131590432|NCT02965846|473789966|FG000|Overall Study|Lost to Follow-up|1|||
131590433|NCT02965846|473789967|FG001|Overall Study|Lost to Follow-up|0|||
131590434|NCT02965846|473789968|FG002|Overall Study|Lost to Follow-up|0|||
131590435|NCT02965846|473789966|FG000|Overall Study|Withdrawal by Subject|0|||
131590436|NCT02965846|473789967|FG001|Overall Study|Withdrawal by Subject|1|||
131590437|NCT02965846|473789968|FG002|Overall Study|Withdrawal by Subject|0|||
131590438|NCT02965846|473789966|FG000|Overall Study|Study Terminated By Sponsor|4|||
131590439|NCT02965846|473789967|FG001|Overall Study|Study Terminated By Sponsor|4|||
131590440|NCT02965846|473789968|FG002|Overall Study|Study Terminated By Sponsor|0|||
131590441|NCT02965846|473789966|FG000|Overall Study|Participants not randomized|0|||
131590442|NCT02965846|473789967|FG001|Overall Study|Participants not randomized|0|||
131439023|NCT00395746|473233385|FG000|Overall Study|Subject decision|0|||
131590443|NCT02965846|473789968|FG002|Overall Study|Participants not randomized|33|||
131590444|NCT05048186|473789973|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
131590445|NCT05048186|473789974|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
131590446|NCT05048186|473789973|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
131590447|NCT05048186|473789974|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
131590448|NCT01091168|473789977|FG000|Overall Study|Progressive disease|250|||
131590449|NCT01091168|473789978|FG001|Overall Study|Progressive disease|234|||
131590450|NCT01091168|473789977|FG000|Overall Study|Adverse Event|21|||
131590451|NCT01091168|473789978|FG001|Overall Study|Adverse Event|24|||
131590452|NCT01091168|473789977|FG000|Overall Study|Lost to Follow-up|0|||
131590453|NCT01091168|473789978|FG001|Overall Study|Lost to Follow-up|1|||
131590454|NCT01091168|473789977|FG000|Overall Study|Physician, patient's decision, other|27|||
131590455|NCT01091168|473789978|FG001|Overall Study|Physician, patient's decision, other|37|||
131590456|NCT04567615|473789983|FG000|Randomization|Participant withdrew consent|1|||
131590457|NCT04567615|473789984|FG001|Randomization|Participant withdrew consent|0|||
131590458|NCT04567615|473789985|FG002|Randomization|Participant withdrew consent|0|||
131590459|NCT04567615|473789983|FG000|Randomization|Adverse event unrelated to study drug|0|||
131590460|NCT04567615|473789984|FG001|Randomization|Adverse event unrelated to study drug|1|||
131590461|NCT04567615|473789985|FG002|Randomization|Adverse event unrelated to study drug|0|||
131590462|NCT04567615|473789983|FG000|Treatment Period|Participant Withdrew Consent|2|||
131590463|NCT04567615|473789984|FG001|Treatment Period|Participant Withdrew Consent|5|||
131590464|NCT04567615|473789985|FG002|Treatment Period|Participant Withdrew Consent|1|||
131590465|NCT04567615|473789983|FG000|Treatment Period|Death|1|||
131590466|NCT04567615|473789984|FG001|Treatment Period|Death|2|||
131590467|NCT04567615|473789985|FG002|Treatment Period|Death|0|||
131590468|NCT04567615|473789983|FG000|Treatment Period|Lost to Follow-up|0|||
131590469|NCT04567615|473789984|FG001|Treatment Period|Lost to Follow-up|1|||
131590470|NCT04567615|473789985|FG002|Treatment Period|Lost to Follow-up|0|||
131590471|NCT04567615|473789983|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
131590472|NCT04567615|473789984|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
131590473|NCT04567615|473789985|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
131590474|NCT04567615|473789983|FG000|Treatment Period|Disease Progression|85|||
131590475|NCT04567615|473789984|FG001|Treatment Period|Disease Progression|63|||
131590476|NCT04567615|473789985|FG002|Treatment Period|Disease Progression|16|||
131590477|NCT04567615|473789983|FG000|Treatment Period|Study Drug Toxicity|3|||
131590478|NCT04567615|473789984|FG001|Treatment Period|Study Drug Toxicity|10|||
131590479|NCT04567615|473789985|FG002|Treatment Period|Study Drug Toxicity|4|||
131590480|NCT04567615|473789983|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
131590481|NCT04567615|473789984|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
131590482|NCT04567615|473789985|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
131439024|NCT00395746|473233386|FG001|Overall Study|Subject decision|0|||
131590483|NCT04567615|473789983|FG000|Treatment Period|Other Reasons|1|||
131590484|NCT04567615|473789984|FG001|Treatment Period|Other Reasons|2|||
131590485|NCT04567615|473789985|FG002|Treatment Period|Other Reasons|0|||
131590486|NCT04567615|473789983|FG000|Treatment Period|Still On-going Treatment|21|||
131590487|NCT04567615|473789984|FG001|Treatment Period|Still On-going Treatment|22|||
131590488|NCT04567615|473789985|FG002|Treatment Period|Still On-going Treatment|2|||
131590489|NCT05134337|473791261|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
131590490|NCT05134337|473791262|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
131590491|NCT04059354|473791265|FG000|Overall Study|COVID-19 pandemic|3|||
131590492|NCT03424811|473791267|FG000|Overall Study|Lost to Follow-up|9|||
131590493|NCT03424811|473791268|FG001|Overall Study|Lost to Follow-up|0|||
131590494|NCT05215847|473791269|FG000|Overall Study|Lost to Follow-up|1|||
131590495|NCT02819843|473791276|FG000|Overall Study|Disease progression before RT|0|||
131590496|NCT02819843|473791277|FG001|Overall Study|Disease progression before RT|1|||
131590497|NCT03055858|473791279|FG000|Overall Study|Death|9|||
131590498|NCT03055858|473791279|FG000|Overall Study|Withdrawal by Subject|11|||
131590499|NCT03055858|473791279|FG000|Overall Study|Lost to Follow-up|6|||
131590500|NCT03055858|473791279|FG000|Overall Study|Missed Follow-Up Visits|18|||
131590501|NCT04586920|473791280|FG000|Overall Study|Lost to Follow-up|0|||
131590502|NCT04586920|473791281|FG001|Overall Study|Lost to Follow-up|0|||
131590503|NCT04586920|473791282|FG002|Overall Study|Lost to Follow-up|0|||
131590504|NCT04586920|473791283|FG003|Overall Study|Lost to Follow-up|0|||
131590505|NCT04586920|473791284|FG004|Overall Study|Lost to Follow-up|0|||
131590506|NCT04586920|473791285|FG005|Overall Study|Lost to Follow-up|0|||
131590507|NCT04586920|473791286|FG006|Overall Study|Lost to Follow-up|1|||
131590508|NCT04586920|473791287|FG007|Overall Study|Lost to Follow-up|1|||
131590509|NCT04586920|473791288|FG008|Overall Study|Lost to Follow-up|0|||
131590510|NCT04586920|473791289|FG009|Overall Study|Lost to Follow-up|1|||
131590511|NCT04586920|473791290|FG010|Overall Study|Lost to Follow-up|0|||
131590512|NCT04586920|473791291|FG011|Overall Study|Lost to Follow-up|0|||
131590513|NCT04586920|473791292|FG012|Overall Study|Lost to Follow-up|0|||
131590514|NCT04586920|473791293|FG013|Overall Study|Lost to Follow-up|1|||
131590515|NCT04586920|473791294|FG014|Overall Study|Lost to Follow-up|0|||
131590516|NCT04586920|473791295|FG015|Overall Study|Lost to Follow-up|0|||
131590517|NCT04586920|473791296|FG016|Overall Study|Lost to Follow-up|0|||
131590518|NCT04586920|473791297|FG017|Overall Study|Lost to Follow-up|0|||
131590519|NCT04586920|473791280|FG000|Overall Study|Withdrawal by Subject|0|||
131590520|NCT04586920|473791281|FG001|Overall Study|Withdrawal by Subject|0|||
131590521|NCT04586920|473791282|FG002|Overall Study|Withdrawal by Subject|0|||
131590522|NCT04586920|473791283|FG003|Overall Study|Withdrawal by Subject|0|||
131590523|NCT04586920|473791284|FG004|Overall Study|Withdrawal by Subject|0|||
131590524|NCT04586920|473791285|FG005|Overall Study|Withdrawal by Subject|0|||
131590525|NCT04586920|473791286|FG006|Overall Study|Withdrawal by Subject|0|||
131590526|NCT04586920|473791287|FG007|Overall Study|Withdrawal by Subject|1|||
131590527|NCT04586920|473791288|FG008|Overall Study|Withdrawal by Subject|0|||
131590528|NCT04586920|473791289|FG009|Overall Study|Withdrawal by Subject|1|||
131590529|NCT04586920|473791290|FG010|Overall Study|Withdrawal by Subject|0|||
131590530|NCT04586920|473791291|FG011|Overall Study|Withdrawal by Subject|1|||
131590531|NCT04586920|473791292|FG012|Overall Study|Withdrawal by Subject|0|||
131590532|NCT04586920|473791293|FG013|Overall Study|Withdrawal by Subject|0|||
131590533|NCT04586920|473791294|FG014|Overall Study|Withdrawal by Subject|0|||
131590534|NCT04586920|473791295|FG015|Overall Study|Withdrawal by Subject|0|||
131590535|NCT04586920|473791296|FG016|Overall Study|Withdrawal by Subject|0|||
131590536|NCT04586920|473791297|FG017|Overall Study|Withdrawal by Subject|0|||
131590537|NCT02728557|473791302|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
131590538|NCT02728557|473791303|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
131590539|NCT02728557|473791302|FG000|Overall Study|Dissatisfaction with research tasks|0|||
131590540|NCT02728557|473791303|FG001|Overall Study|Dissatisfaction with research tasks|1|||
131590541|NCT02728557|473791302|FG000|Overall Study|Scheduling or change in availability|1|||
131590542|NCT02728557|473791303|FG001|Overall Study|Scheduling or change in availability|1|||
131590543|NCT03897686|473791304|FG000|Overall Study|Protocol Violation|1|||
131590544|NCT03897686|473791305|FG001|Overall Study|Protocol Violation|1|||
131590545|NCT03897686|473791304|FG000|Overall Study|Withdrawal by Subject|1|||
131590546|NCT03897686|473791305|FG001|Overall Study|Withdrawal by Subject|1|||
131590547|NCT03416010|473791306|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
131791232|NCT01405820|474518637|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
131791233|NCT01405820|474518638|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
131590548|NCT03416010|473791307|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
131590549|NCT03416010|473791306|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
131590550|NCT03416010|473791307|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
131590551|NCT03416010|473791306|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
131590552|NCT03416010|473791307|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
131590553|NCT03416010|473791306|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
131590554|NCT03416010|473791307|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
131439025|NCT00395746|473233387|FG002|Overall Study|Subject decision|1|||
131590555|NCT03416010|473791306|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
131590556|NCT03416010|473791307|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
131590557|NCT03416010|473791306|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
131590558|NCT03416010|473791307|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
131590559|NCT03416010|473791306|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
131590560|NCT03416010|473791307|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
131590561|NCT05415436|473791311|FG000|Overall Study|Surgeon cancelled procedure|1|||
131590562|NCT05415436|473791312|FG001|Overall Study|Surgeon cancelled procedure|0|||
131590563|NCT05415436|473791311|FG000|Overall Study|Death|1|||
131590564|NCT05415436|473791312|FG001|Overall Study|Death|0|||
131590565|NCT03819686|473791319|FG000|Overall Study|Lost to Follow-up|2|||
131590566|NCT03819686|473791320|FG001|Overall Study|Lost to Follow-up|3|||
131590567|NCT03157167|473791331|FG000|Overall Study|Withdrawal by Subject|1|||
131590568|NCT03157167|473791332|FG001|Overall Study|Withdrawal by Subject|0|||
131590569|NCT03157167|473791333|FG002|Overall Study|Withdrawal by Subject|0|||
131590570|NCT04905407|473791335|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
131590571|NCT04905407|473791336|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
131590572|NCT04905407|473791337|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
131590573|NCT04905407|473791338|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
131590574|NCT04905407|473791335|FG000|Part 1 and Part 2|Death|7|||
131590575|NCT04905407|473791336|FG001|Part 1 and Part 2|Death|7|||
131590576|NCT04905407|473791337|FG002|Part 1 and Part 2|Death|7|||
131590577|NCT04905407|473791338|FG003|Part 1 and Part 2|Death|0|||
131590578|NCT04905407|473791335|FG000|Part 1 and Part 2|Other than specified|0|||
131590579|NCT04905407|473791336|FG001|Part 1 and Part 2|Other than specified|0|||
131590580|NCT04905407|473791337|FG002|Part 1 and Part 2|Other than specified|1|||
131590581|NCT04905407|473791338|FG003|Part 1 and Part 2|Other than specified|0|||
131590582|NCT04905407|473791335|FG000|Part 3|Death|0|||
131590583|NCT04905407|473791336|FG001|Part 3|Death|0|||
131590584|NCT04905407|473791337|FG002|Part 3|Death|0|||
131590585|NCT04905407|473791338|FG003|Part 3|Death|2|||
131590586|NCT02840474|473791341|FG000|Overall Study|Lost to Follow-up|1|||
131590587|NCT02840474|473791342|FG001|Overall Study|Lost to Follow-up|0|||
131590588|NCT04437433|473791343|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
131590589|NCT04437433|473791344|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
131590590|NCT04437433|473791343|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
131590591|NCT04437433|473791344|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
131590592|NCT04437433|473791343|FG000|Overall Study|Adverse Event|9|||
131590593|NCT04437433|473791344|FG001|Overall Study|Adverse Event|0|||
131590594|NCT04437433|473791343|FG000|Overall Study|Lack of Efficacy|4|||
131590595|NCT04437433|473791344|FG001|Overall Study|Lack of Efficacy|0|||
131590596|NCT04437433|473791343|FG000|Overall Study|Withdrawal by Subject|4|||
131590597|NCT04437433|473791344|FG001|Overall Study|Withdrawal by Subject|1|||
131590598|NCT04437433|473791343|FG000|Overall Study|Protocol Deviation|0|||
131590599|NCT04437433|473791344|FG001|Overall Study|Protocol Deviation|1|||
131590600|NCT04437433|473791343|FG000|Overall Study|Other, not specified|0|||
131590601|NCT04437433|473791344|FG001|Overall Study|Other, not specified|1|||
131590602|NCT04048681|473791345|FG000|Overall Study|family emergency|0|||
131590603|NCT04048681|473791346|FG001|Overall Study|family emergency|0|||
131590604|NCT04048681|473791347|FG002|Overall Study|family emergency|0|||
131590605|NCT04048681|473791348|FG003|Overall Study|family emergency|1|||
131590606|NCT04048681|473791349|FG004|Overall Study|family emergency|0|||
131590607|NCT01376700|473791350|FG000|Overall Study|Sponsor terminated study early|8|||
131590608|NCT01376700|473791350|FG000|Overall Study|Low or high titer inhibitor|8|||
131590609|NCT00593489|473791354|FG000|Allocation|did not attend workshop; allocation not|2|||
131590610|NCT00593489|473791355|FG001|Allocation|did not attend workshop; allocation not|1|||
131590611|NCT00879333|473791356|FG000|Overall Study|Adverse Event|94|||
131590612|NCT00879333|473791357|FG001|Overall Study|Adverse Event|34|||
131590613|NCT00879333|473791356|FG000|Overall Study|Abnormal Laboratory Value|1|||
131590614|NCT00879333|473791357|FG001|Overall Study|Abnormal Laboratory Value|0|||
131590615|NCT00879333|473791356|FG000|Overall Study|Withdrawal by Subject|20|||
131590616|NCT00879333|473791357|FG001|Overall Study|Withdrawal by Subject|7|||
131590617|NCT00879333|473791356|FG000|Overall Study|Lost to Follow-up|2|||
131590618|NCT00879333|473791357|FG001|Overall Study|Lost to Follow-up|1|||
131590619|NCT00879333|473791356|FG000|Overall Study|Administrative Problems|2|||
131590620|NCT00879333|473791357|FG001|Overall Study|Administrative Problems|0|||
131590621|NCT00879333|473791356|FG000|Overall Study|Death|16|||
131590622|NCT00879333|473791357|FG001|Overall Study|Death|5|||
131590623|NCT00879333|473791356|FG000|Overall Study|Disease Progression|292|||
131590624|NCT00879333|473791357|FG001|Overall Study|Disease Progression|169|||
131590625|NCT00879333|473791356|FG000|Overall Study|Protocol Violation|1|||
131590626|NCT00879333|473791357|FG001|Overall Study|Protocol Violation|1|||
131590627|NCT04154384|473791358|FG000|Overall Study|Lost to Follow-up|24|||
131590628|NCT04154384|473791359|FG001|Overall Study|Lost to Follow-up|33|||
131590629|NCT04154384|473791360|FG002|Overall Study|Lost to Follow-up|0|||
131590630|NCT04154384|473791358|FG000|Overall Study|Withdrawal by Subject|7|||
131590631|NCT04154384|473791359|FG001|Overall Study|Withdrawal by Subject|18|||
131590632|NCT04154384|473791360|FG002|Overall Study|Withdrawal by Subject|0|||
131590633|NCT04154384|473791358|FG000|Overall Study|Missing outcome data|1|||
131590634|NCT04154384|473791359|FG001|Overall Study|Missing outcome data|0|||
131590635|NCT04154384|473791360|FG002|Overall Study|Missing outcome data|0|||
131590636|NCT00951379|473791361|FG000|Overall Study|Adverse Event|4|||
131590637|NCT00951379|473791362|FG001|Overall Study|Adverse Event|1|||
131590638|NCT00951379|473791361|FG000|Overall Study|Withdrawal by Subject|1|||
131590639|NCT00951379|473791362|FG001|Overall Study|Withdrawal by Subject|0|||
131590640|NCT00951379|473791361|FG000|Overall Study|Noncompliance|1|||
131590641|NCT00951379|473791362|FG001|Overall Study|Noncompliance|0|||
131590642|NCT00951379|473791361|FG000|Overall Study|Disease Progression|0|||
131590643|NCT00951379|473791362|FG001|Overall Study|Disease Progression|1|||
131590644|NCT04218266|473791363|FG000|Overall Study|Death|1|||
131590645|NCT04218266|473791364|FG001|Overall Study|Death|2|||
131590646|NCT04218266|473791365|FG002|Overall Study|Death|3|||
131590647|NCT04218266|473791363|FG000|Overall Study|Adverse Event|13|||
131590648|NCT04218266|473791364|FG001|Overall Study|Adverse Event|14|||
131590649|NCT04218266|473791365|FG002|Overall Study|Adverse Event|11|||
131590650|NCT04218266|473791363|FG000|Overall Study|Other|7|||
131590651|NCT04218266|473791364|FG001|Overall Study|Other|5|||
131590652|NCT04218266|473791365|FG002|Overall Study|Other|14|||
131590653|NCT04218266|473791363|FG000|Overall Study|Physician Decision|1|||
131590654|NCT04218266|473791364|FG001|Overall Study|Physician Decision|3|||
131590655|NCT04218266|473791365|FG002|Overall Study|Physician Decision|2|||
131590656|NCT04218266|473791363|FG000|Overall Study|Non-compliance with study drug|0|||
131590657|NCT04218266|473791364|FG001|Overall Study|Non-compliance with study drug|0|||
131590658|NCT04218266|473791365|FG002|Overall Study|Non-compliance with study drug|1|||
131590659|NCT04218266|473791363|FG000|Overall Study|Withdrawal by Subject|1|||
131590660|NCT04218266|473791364|FG001|Overall Study|Withdrawal by Subject|3|||
131590661|NCT04218266|473791365|FG002|Overall Study|Withdrawal by Subject|1|||
131590662|NCT04218266|473791363|FG000|Overall Study|Study drug never administered|2|||
131590663|NCT04218266|473791364|FG001|Overall Study|Study drug never administered|0|||
131590664|NCT04218266|473791365|FG002|Overall Study|Study drug never administered|0|||
131590665|NCT04377308|473791367|FG000|Overall Study|Withdrawal by Subject|0|||
131590666|NCT04377308|473791368|FG001|Overall Study|Withdrawal by Subject|1|||
131590667|NCT02759016|473791369|FG000|Overall Study|Not treated with BI 836826|1|||
131590668|NCT02759016|473791370|FG001|Overall Study|Not treated with BI 836826|0|||
131590669|NCT02759016|473791369|FG000|Overall Study|Progressive disease|1|||
131590670|NCT02759016|473791370|FG001|Overall Study|Progressive disease|0|||
131590671|NCT02759016|473791369|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
131590672|NCT02759016|473791370|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
131590673|NCT02759016|473791369|FG000|Overall Study|Other not defined above|2|||
131590674|NCT02759016|473791370|FG001|Overall Study|Other not defined above|1|||
131590675|NCT01494922|473791371|FG000|Overall Study|Adverse Event|1|||
131590676|NCT03580369|473791372|FG000|Overall Study|No treatment due to mis-randomization|1|||
131590677|NCT03580369|473791373|FG001|Overall Study|No treatment due to mis-randomization|0|||
131590678|NCT03580369|473791374|FG002|Overall Study|No treatment due to mis-randomization|0|||
131590679|NCT03580369|473791375|FG003|Overall Study|No treatment due to mis-randomization|0|||
131590680|NCT03580369|473791376|FG004|Overall Study|No treatment due to mis-randomization|3|||
131590681|NCT03580369|473791377|FG005|Overall Study|No treatment due to mis-randomization|0|||
131590682|NCT03580369|473791378|FG006|Overall Study|No treatment due to mis-randomization|0|||
131590683|NCT03580369|473791379|FG007|Overall Study|No treatment due to mis-randomization|0|||
131590684|NCT03580369|473791372|FG000|Overall Study|Reason unknown|0|||
131590685|NCT03580369|473791373|FG001|Overall Study|Reason unknown|0|||
131590686|NCT03580369|473791374|FG002|Overall Study|Reason unknown|1|||
131590687|NCT03580369|473791375|FG003|Overall Study|Reason unknown|0|||
131590688|NCT03580369|473791376|FG004|Overall Study|Reason unknown|0|||
131590689|NCT03580369|473791377|FG005|Overall Study|Reason unknown|0|||
131590690|NCT03580369|473791378|FG006|Overall Study|Reason unknown|0|||
131590691|NCT03580369|473791379|FG007|Overall Study|Reason unknown|0|||
131590692|NCT03580369|473791372|FG000|Overall Study|Technical problems|0|||
131590693|NCT03580369|473791373|FG001|Overall Study|Technical problems|0|||
131791234|NCT01405820|474518639|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
131791235|NCT01405820|474518640|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
131791236|NCT01405820|474518641|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
131791237|NCT01405820|474518642|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
131590694|NCT03580369|473791374|FG002|Overall Study|Technical problems|0|||
131590695|NCT03580369|473791375|FG003|Overall Study|Technical problems|0|||
131590696|NCT03580369|473791376|FG004|Overall Study|Technical problems|1|||
131590697|NCT03580369|473791377|FG005|Overall Study|Technical problems|0|||
131590698|NCT03580369|473791378|FG006|Overall Study|Technical problems|2|||
131590699|NCT03580369|473791379|FG007|Overall Study|Technical problems|0|||
131590700|NCT03580369|473791372|FG000|Overall Study|Pregnancy|2|||
131590701|NCT03580369|473791373|FG001|Overall Study|Pregnancy|0|||
131590702|NCT03580369|473791374|FG002|Overall Study|Pregnancy|3|||
131590703|NCT03580369|473791375|FG003|Overall Study|Pregnancy|0|||
131590704|NCT03580369|473791376|FG004|Overall Study|Pregnancy|2|||
131590705|NCT03580369|473791377|FG005|Overall Study|Pregnancy|0|||
131590706|NCT03580369|473791378|FG006|Overall Study|Pregnancy|0|||
131590707|NCT03580369|473791379|FG007|Overall Study|Pregnancy|0|||
131590708|NCT03580369|473791372|FG000|Overall Study|Lost to Follow-up|2|||
131590709|NCT03580369|473791373|FG001|Overall Study|Lost to Follow-up|0|||
131590710|NCT03580369|473791374|FG002|Overall Study|Lost to Follow-up|2|||
131590711|NCT03580369|473791375|FG003|Overall Study|Lost to Follow-up|0|||
131590712|NCT03580369|473791376|FG004|Overall Study|Lost to Follow-up|3|||
131590713|NCT03580369|473791377|FG005|Overall Study|Lost to Follow-up|0|||
131590714|NCT03580369|473791378|FG006|Overall Study|Lost to Follow-up|1|||
131590715|NCT03580369|473791379|FG007|Overall Study|Lost to Follow-up|0|||
131590716|NCT03580369|473791372|FG000|Overall Study|Physician Decision|4|||
131590717|NCT03580369|473791373|FG001|Overall Study|Physician Decision|0|||
131590718|NCT03580369|473791374|FG002|Overall Study|Physician Decision|4|||
131590719|NCT03580369|473791375|FG003|Overall Study|Physician Decision|1|||
131590720|NCT03580369|473791376|FG004|Overall Study|Physician Decision|1|||
131590721|NCT03580369|473791377|FG005|Overall Study|Physician Decision|0|||
131590722|NCT03580369|473791378|FG006|Overall Study|Physician Decision|0|||
131590723|NCT03580369|473791379|FG007|Overall Study|Physician Decision|0|||
131590724|NCT03580369|473791372|FG000|Overall Study|Lack of Efficacy|3|||
131590725|NCT03580369|473791373|FG001|Overall Study|Lack of Efficacy|0|||
131590726|NCT03580369|473791374|FG002|Overall Study|Lack of Efficacy|7|||
131590727|NCT03580369|473791375|FG003|Overall Study|Lack of Efficacy|0|||
131590728|NCT03580369|473791376|FG004|Overall Study|Lack of Efficacy|2|||
131590729|NCT03580369|473791377|FG005|Overall Study|Lack of Efficacy|0|||
131590730|NCT03580369|473791378|FG006|Overall Study|Lack of Efficacy|3|||
131590731|NCT03580369|473791379|FG007|Overall Study|Lack of Efficacy|0|||
131590732|NCT03580369|473791372|FG000|Overall Study|Protocol Violation|6|||
131590733|NCT03580369|473791373|FG001|Overall Study|Protocol Violation|0|||
131590734|NCT03580369|473791374|FG002|Overall Study|Protocol Violation|6|||
131590735|NCT03580369|473791375|FG003|Overall Study|Protocol Violation|1|||
131590736|NCT03580369|473791376|FG004|Overall Study|Protocol Violation|8|||
131590737|NCT03580369|473791377|FG005|Overall Study|Protocol Violation|2|||
131590738|NCT03580369|473791378|FG006|Overall Study|Protocol Violation|1|||
131590739|NCT03580369|473791379|FG007|Overall Study|Protocol Violation|0|||
131590740|NCT03580369|473791372|FG000|Overall Study|Adverse Event|7|||
131590741|NCT03580369|473791373|FG001|Overall Study|Adverse Event|0|||
131590742|NCT03580369|473791374|FG002|Overall Study|Adverse Event|14|||
131590743|NCT03580369|473791375|FG003|Overall Study|Adverse Event|1|||
131590744|NCT03580369|473791376|FG004|Overall Study|Adverse Event|6|||
131590745|NCT03580369|473791377|FG005|Overall Study|Adverse Event|0|||
131590746|NCT03580369|473791378|FG006|Overall Study|Adverse Event|1|||
131590747|NCT03580369|473791379|FG007|Overall Study|Adverse Event|0|||
131590748|NCT03580369|473791372|FG000|Overall Study|Withdrawal by Subject|19|||
131590749|NCT03580369|473791373|FG001|Overall Study|Withdrawal by Subject|0|||
131590750|NCT03580369|473791374|FG002|Overall Study|Withdrawal by Subject|17|||
131590751|NCT03580369|473791375|FG003|Overall Study|Withdrawal by Subject|0|||
131590752|NCT03580369|473791376|FG004|Overall Study|Withdrawal by Subject|16|||
131590753|NCT03580369|473791377|FG005|Overall Study|Withdrawal by Subject|1|||
131590754|NCT03580369|473791378|FG006|Overall Study|Withdrawal by Subject|7|||
131590755|NCT03580369|473791379|FG007|Overall Study|Withdrawal by Subject|0|||
131590756|NCT02891915|473791382|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
131590757|NCT02891915|473791383|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
131590758|NCT02891915|473791382|FG000|Overall Study|Withdrawal by Subject|3|||
131590759|NCT02891915|473791383|FG001|Overall Study|Withdrawal by Subject|3|||
131590760|NCT02891915|473791382|FG000|Overall Study|Became Ineligible After Enrollment|2|||
131590761|NCT02891915|473791383|FG001|Overall Study|Became Ineligible After Enrollment|1|||
131590762|NCT02891915|473791382|FG000|Overall Study|Lost to Follow-up|1|||
131590763|NCT02891915|473791383|FG001|Overall Study|Lost to Follow-up|4|||
131590764|NCT02891915|473791382|FG000|Overall Study|Physician Decision|1|||
131590765|NCT02891915|473791383|FG001|Overall Study|Physician Decision|0|||
131590766|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
131590767|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
131590768|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
131590769|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
131590770|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
131590771|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
131706102|NCT00849667|474205528|FG000|Overall Study|Adverse Event|1|||
131706103|NCT00849667|474205529|FG001|Overall Study|Adverse Event|2|||
131706104|NCT00849667|474205530|FG002|Overall Study|Adverse Event|0|||
131706105|NCT00849667|474205528|FG000|Overall Study|Other|18|||
131706106|NCT00849667|474205529|FG001|Overall Study|Other|19|||
131706107|NCT00849667|474205530|FG002|Overall Study|Other|18|||
131706108|NCT00849667|474205528|FG000|Overall Study|Progressive disease|119|||
131706109|NCT00849667|474205529|FG001|Overall Study|Progressive disease|100|||
131590772|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
131590773|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
131590774|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
131706110|NCT00849667|474205530|FG002|Overall Study|Progressive disease|112|||
131706111|NCT00849667|474205528|FG000|Overall Study|Sponsor decision|208|||
131590775|NCT03939312|473791384|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
131590776|NCT03939312|473791384|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
131590777|NCT03939312|473791384|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
131590778|NCT02119650|473791386|FG000|Overall Study|Adverse Event|3|||
131590779|NCT02119650|473791387|FG001|Overall Study|Adverse Event|4|||
131590780|NCT02119650|473791386|FG000|Overall Study|Subject decision|2|||
131590781|NCT02119650|473791387|FG001|Overall Study|Subject decision|3|||
131590782|NCT02119650|473791386|FG000|Overall Study|Disease progression|11|||
131590783|NCT02119650|473791387|FG001|Overall Study|Disease progression|14|||
131590784|NCT02119650|473791386|FG000|Overall Study|Death|5|||
131590785|NCT02119650|473791387|FG001|Overall Study|Death|1|||
131590786|NCT02119650|473791386|FG000|Overall Study|Noncompliance with study treatment|1|||
131590787|NCT02119650|473791387|FG001|Overall Study|Noncompliance with study treatment|1|||
131590788|NCT02119650|473791386|FG000|Overall Study|Study terminated by the sponsor|1|||
131590789|NCT02119650|473791387|FG001|Overall Study|Study terminated by the sponsor|0|||
131590790|NCT02119650|473791386|FG000|Overall Study|Physician Decision|0|||
131590791|NCT02119650|473791387|FG001|Overall Study|Physician Decision|2|||
131590792|NCT02119650|473791386|FG000|Overall Study|Multiple reasons for termination|2|||
131590793|NCT02119650|473791387|FG001|Overall Study|Multiple reasons for termination|1|||
131590794|NCT01721291|473791389|FG000|Overall Study|Withdrawal by Subject|1|||
131590795|NCT01721291|473791390|FG001|Overall Study|Withdrawal by Subject|0|||
131590796|NCT01721291|473791389|FG000|Overall Study|did not like the treatment|1|||
131590797|NCT01721291|473791390|FG001|Overall Study|did not like the treatment|0|||
131590798|NCT04442126|473791401|FG000|Overall Study|Withdrawal by Subject|0|||
131590799|NCT04442126|473791402|FG001|Overall Study|Withdrawal by Subject|0|||
131590800|NCT04442126|473791403|FG002|Overall Study|Withdrawal by Subject|0|||
131590801|NCT04442126|473791404|FG003|Overall Study|Withdrawal by Subject|2|||
131590802|NCT04442126|473791405|FG004|Overall Study|Withdrawal by Subject|1|||
131590803|NCT04442126|473791406|FG005|Overall Study|Withdrawal by Subject|0|||
131590804|NCT04442126|473791407|FG006|Overall Study|Withdrawal by Subject|1|||
131590805|NCT04442126|473791408|FG007|Overall Study|Withdrawal by Subject|1|||
131590806|NCT04442126|473791409|FG008|Overall Study|Withdrawal by Subject|3|||
131590807|NCT04442126|473791401|FG000|Overall Study|Death|1|||
131590808|NCT04442126|473791402|FG001|Overall Study|Death|0|||
131590809|NCT04442126|473791403|FG002|Overall Study|Death|0|||
131590810|NCT04442126|473791404|FG003|Overall Study|Death|1|||
131590811|NCT04442126|473791405|FG004|Overall Study|Death|2|||
131590812|NCT04442126|473791406|FG005|Overall Study|Death|2|||
131590813|NCT04442126|473791407|FG006|Overall Study|Death|4|||
131590814|NCT04442126|473791408|FG007|Overall Study|Death|1|||
131791238|NCT01405820|474518637|FG000|Randomized Treatment Period|Other|2|||
131791239|NCT01405820|474518638|FG001|Randomized Treatment Period|Other|2|||
131791240|NCT01405820|474518639|FG002|Randomized Treatment Period|Other|1|||
131791241|NCT01405820|474518640|FG003|Randomized Treatment Period|Other|1|||
131791242|NCT01405820|474518641|FG004|Randomized Treatment Period|Other|0|||
131791243|NCT01405820|474518642|FG005|Randomized Treatment Period|Other|0|||
131791244|NCT01405820|474518637|FG000|Randomized Treatment Period|Physician Decision|0|||
131791245|NCT01405820|474518638|FG001|Randomized Treatment Period|Physician Decision|2|||
131791246|NCT01405820|474518639|FG002|Randomized Treatment Period|Physician Decision|1|||
131791247|NCT01405820|474518640|FG003|Randomized Treatment Period|Physician Decision|0|||
131791248|NCT01405820|474518641|FG004|Randomized Treatment Period|Physician Decision|0|||
131791249|NCT01405820|474518642|FG005|Randomized Treatment Period|Physician Decision|0|||
131791250|NCT01405820|474518637|FG000|Randomized Treatment Period|Rescue|0|||
131791251|NCT01405820|474518638|FG001|Randomized Treatment Period|Rescue|1|||
131791252|NCT01405820|474518639|FG002|Randomized Treatment Period|Rescue|13|||
131791253|NCT01405820|474518640|FG003|Randomized Treatment Period|Rescue|10|||
131791254|NCT01405820|474518641|FG004|Randomized Treatment Period|Rescue|8|||
131791255|NCT01405820|474518642|FG005|Randomized Treatment Period|Rescue|8|||
131791256|NCT01405820|474518637|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
131791257|NCT01405820|474518638|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
131590815|NCT04442126|473791409|FG008|Overall Study|Death|5|||
131791258|NCT01405820|474518639|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
131791259|NCT01405820|474518640|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
131791260|NCT01405820|474518641|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
131791261|NCT01405820|474518642|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
131590816|NCT04442126|473791401|FG000|Overall Study|Study Terminated by Sponsor|0|||
131590817|NCT04442126|473791402|FG001|Overall Study|Study Terminated by Sponsor|0|||
131590818|NCT04442126|473791403|FG002|Overall Study|Study Terminated by Sponsor|0|||
131791262|NCT01405820|474518637|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
131899079|NCT03569098|474917492|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
131590819|NCT04442126|473791404|FG003|Overall Study|Study Terminated by Sponsor|0|||
131590820|NCT04442126|473791405|FG004|Overall Study|Study Terminated by Sponsor|0|||
131590821|NCT04442126|473791406|FG005|Overall Study|Study Terminated by Sponsor|1|||
131590822|NCT04442126|473791407|FG006|Overall Study|Study Terminated by Sponsor|4|||
131590823|NCT04442126|473791408|FG007|Overall Study|Study Terminated by Sponsor|2|||
131590824|NCT04442126|473791409|FG008|Overall Study|Study Terminated by Sponsor|10|||
131590825|NCT04442126|473791401|FG000|Overall Study|Lost to Follow-up|0|||
131590826|NCT04442126|473791402|FG001|Overall Study|Lost to Follow-up|0|||
131590827|NCT04442126|473791403|FG002|Overall Study|Lost to Follow-up|0|||
131590828|NCT04442126|473791404|FG003|Overall Study|Lost to Follow-up|0|||
131590829|NCT04442126|473791405|FG004|Overall Study|Lost to Follow-up|0|||
131590830|NCT04442126|473791406|FG005|Overall Study|Lost to Follow-up|0|||
131590831|NCT04442126|473791407|FG006|Overall Study|Lost to Follow-up|0|||
131590832|NCT04442126|473791408|FG007|Overall Study|Lost to Follow-up|1|||
131590833|NCT04442126|473791409|FG008|Overall Study|Lost to Follow-up|2|||
131590834|NCT04442126|473791401|FG000|Overall Study|Progressive Disease|0|||
131590835|NCT04442126|473791402|FG001|Overall Study|Progressive Disease|1|||
131590836|NCT04442126|473791403|FG002|Overall Study|Progressive Disease|3|||
131590837|NCT04442126|473791404|FG003|Overall Study|Progressive Disease|0|||
131590838|NCT04442126|473791405|FG004|Overall Study|Progressive Disease|3|||
131590839|NCT04442126|473791406|FG005|Overall Study|Progressive Disease|0|||
131590840|NCT04442126|473791407|FG006|Overall Study|Progressive Disease|0|||
131590841|NCT04442126|473791408|FG007|Overall Study|Progressive Disease|0|||
131590842|NCT04442126|473791409|FG008|Overall Study|Progressive Disease|0|||
131590843|NCT04442126|473791401|FG000|Overall Study|Other|0|||
131590844|NCT04442126|473791402|FG001|Overall Study|Other|0|||
131590845|NCT04442126|473791403|FG002|Overall Study|Other|0|||
131590846|NCT04442126|473791404|FG003|Overall Study|Other|0|||
131590847|NCT04442126|473791405|FG004|Overall Study|Other|0|||
131590848|NCT04442126|473791406|FG005|Overall Study|Other|0|||
131590849|NCT04442126|473791407|FG006|Overall Study|Other|0|||
131590850|NCT04442126|473791408|FG007|Overall Study|Other|0|||
131590851|NCT04442126|473791409|FG008|Overall Study|Other|1|||
131590852|NCT06450405|473791410|FG000|Overall Study|Study funding terminated.|0|||
131590853|NCT06450405|473791411|FG001|Overall Study|Study funding terminated.|2|||
131590854|NCT03948763|473792650|FG000|Overall Study|Sponsor's decision|0|||
131590855|NCT03948763|473792651|FG001|Overall Study|Sponsor's decision|2|||
131590856|NCT03948763|473792652|FG002|Overall Study|Sponsor's decision|6|||
131590857|NCT03948763|473792653|FG003|Overall Study|Sponsor's decision|4|||
131590858|NCT03948763|473792654|FG004|Overall Study|Sponsor's decision|0|||
131590859|NCT03948763|473792650|FG000|Overall Study|Physician Decision|0|||
131590860|NCT03948763|473792651|FG001|Overall Study|Physician Decision|0|||
131590861|NCT03948763|473792652|FG002|Overall Study|Physician Decision|1|||
131590862|NCT03948763|473792653|FG003|Overall Study|Physician Decision|0|||
131590863|NCT03948763|473792654|FG004|Overall Study|Physician Decision|0|||
131590864|NCT03948763|473792650|FG000|Overall Study|Lost to Follow-up|0|||
131590865|NCT03948763|473792651|FG001|Overall Study|Lost to Follow-up|0|||
131590866|NCT03948763|473792652|FG002|Overall Study|Lost to Follow-up|0|||
131590867|NCT03948763|473792653|FG003|Overall Study|Lost to Follow-up|0|||
131590868|NCT03948763|473792654|FG004|Overall Study|Lost to Follow-up|1|||
131590869|NCT03948763|473792650|FG000|Overall Study|Death|2|||
131590870|NCT03948763|473792651|FG001|Overall Study|Death|12|||
131899080|NCT03569098|474917493|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
131590871|NCT03948763|473792652|FG002|Overall Study|Death|13|||
131899081|NCT03569098|474917494|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
131590872|NCT03948763|473792653|FG003|Overall Study|Death|10|||
131590873|NCT03948763|473792654|FG004|Overall Study|Death|11|||
131590874|NCT03948763|473792650|FG000|Overall Study|Withdrawal by Subject|1|||
131590875|NCT03948763|473792651|FG001|Overall Study|Withdrawal by Subject|1|||
131590876|NCT03948763|473792652|FG002|Overall Study|Withdrawal by Subject|0|||
131590877|NCT03948763|473792653|FG003|Overall Study|Withdrawal by Subject|2|||
131590878|NCT03948763|473792654|FG004|Overall Study|Withdrawal by Subject|4|||
131590879|NCT05038566|473792656|FG000|Overall Study|Technical Difficulties with the Device|0|||
131590880|NCT05038566|473792657|FG001|Overall Study|Technical Difficulties with the Device|1|||
131590881|NCT03192891|473792660|FG000|Overall Study|Lost to Follow-up|55|||
131590882|NCT04716634|473792662|FG000|Overall Study|Death|24|||
131590883|NCT04716634|473792663|FG001|Overall Study|Death|24|||
131590884|NCT04716634|473792664|FG002|Overall Study|Death|8|||
131590885|NCT04716634|473792662|FG000|Overall Study|Closed by Sponsor|4|||
131590886|NCT04716634|473792663|FG001|Overall Study|Closed by Sponsor|4|||
131590887|NCT04716634|473792664|FG002|Overall Study|Closed by Sponsor|5|||
131590888|NCT04716634|473792662|FG000|Overall Study|Lost to Follow-up|1|||
131590889|NCT04716634|473792663|FG001|Overall Study|Lost to Follow-up|0|||
131590890|NCT04716634|473792664|FG002|Overall Study|Lost to Follow-up|1|||
131590891|NCT04716634|473792662|FG000|Overall Study|Withdrawal by Subject|0|||
131590892|NCT04716634|473792663|FG001|Overall Study|Withdrawal by Subject|0|||
131590893|NCT04716634|473792664|FG002|Overall Study|Withdrawal by Subject|1|||
131590894|NCT02630823|473792673|FG000|Overall Study|Withdrawal by Subject|1|||
131590895|NCT02630823|473792673|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
131590896|NCT05387447|473792674|FG000|Overall Study|Participants changed their minds about study participation.|3|||
131590897|NCT05387447|473792675|FG001|Overall Study|Participants changed their minds about study participation.|5|||
131590898|NCT03391466|473792678|FG000|Overall Study|Death|82|||
131590899|NCT03391466|473792679|FG001|Overall Study|Death|85|||
131590900|NCT03391466|473792678|FG000|Overall Study|Still on study|93|||
131590901|NCT03391466|473792679|FG001|Overall Study|Still on study|74|||
131590902|NCT03391466|473792678|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
131590903|NCT03391466|473792679|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
131590904|NCT03391466|473792678|FG000|Overall Study|Lost to Follow-up|5|||
131590905|NCT03391466|473792679|FG001|Overall Study|Lost to Follow-up|5|||
131590906|NCT03391466|473792678|FG000|Overall Study|Investigator decision|0|||
131590907|NCT03391466|473792679|FG001|Overall Study|Investigator decision|1|||
131590908|NCT03391466|473792678|FG000|Overall Study|Other|0|||
131590909|NCT03391466|473792679|FG001|Overall Study|Other|1|||
131590910|NCT03655132|473792682|FG000|Overall Study|Lost to Follow-up|2|||
131590911|NCT03655132|473792683|FG001|Overall Study|Lost to Follow-up|1|||
131590912|NCT03655132|473792682|FG000|Overall Study|Withdrawal by Subject|0|||
131590913|NCT03655132|473792683|FG001|Overall Study|Withdrawal by Subject|1|||
131590914|NCT03655132|473792682|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
131590915|NCT03655132|473792683|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
131590916|NCT05919082|473792685|FG000|Overall Study|Adverse Event|3|||
131590917|NCT05919082|473792686|FG001|Overall Study|Adverse Event|0|||
131590918|NCT05919082|473792685|FG000|Overall Study|Lost to Follow-up|0|||
131590919|NCT05919082|473792686|FG001|Overall Study|Lost to Follow-up|1|||
131590920|NCT05919082|473792685|FG000|Overall Study|Withdrawal by Subject|8|||
131590921|NCT05919082|473792686|FG001|Overall Study|Withdrawal by Subject|9|||
131590922|NCT05919082|473792685|FG000|Overall Study|Lack of Efficacy|0|||
131590923|NCT05919082|473792686|FG001|Overall Study|Lack of Efficacy|1|||
131590924|NCT05919082|473792685|FG000|Overall Study|Investigator Decision|1|||
131590925|NCT05919082|473792686|FG001|Overall Study|Investigator Decision|0|||
131590926|NCT05461131|473792688|FG000|Overall Study|Lost to Follow-up|0|||
131590927|NCT05461131|473792689|FG001|Overall Study|Lost to Follow-up|2|||
131590928|NCT02682316|473792695|FG000|Overall Study|Benign Final Pathology|27|||
131590929|NCT02682316|473792696|FG001|Overall Study|Benign Final Pathology|26|||
131590930|NCT02682316|473792695|FG000|Overall Study|Reoperation before 30 days|7|||
131590931|NCT02682316|473792696|FG001|Overall Study|Reoperation before 30 days|6|||
131590932|NCT02682316|473792695|FG000|Overall Study|Ineligible|1|||
131590933|NCT02682316|473792696|FG001|Overall Study|Ineligible|0|||
131590934|NCT02682316|473792695|FG000|Overall Study|Death|1|||
131590935|NCT02682316|473792696|FG001|Overall Study|Death|0|||
131590936|NCT02682316|473792695|FG000|Overall Study|Lost to Follow-up|7|||
131590937|NCT02682316|473792696|FG001|Overall Study|Lost to Follow-up|3|||
131590938|NCT03101904|473792697|FG000|Wash Out (10 Days)|Adverse Event|1|||
131590939|NCT03101904|473792698|FG001|Wash Out (10 Days)|Adverse Event|0|||
131590940|NCT03101904|473792697|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
131590941|NCT03101904|473792698|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
131590942|NCT04538417|473792699|FG000|Overall Study|Withdrawal by Subject|2|||
131590943|NCT00150813|473792701|FG000|Overall Study|Adverse Event|1|||
131590944|NCT00150813|473792701|FG000|Overall Study|Lack of Efficacy|1|||
131590945|NCT00150813|473792701|FG000|Overall Study|Lost to Follow-up|5|||
131590946|NCT00150813|473792701|FG000|Overall Study|Withdrawal by Subject|5|||
131590947|NCT00150813|473792701|FG000|Overall Study|Remission|3|||
131590948|NCT00150813|473792701|FG000|Overall Study|Planned pregancy|1|||
131590949|NCT00150813|473792701|FG000|Overall Study|Switch to commercially available LEV|2|||
131590950|NCT01707030|473792704|FG000|Overall Study|Death|1|||
131590951|NCT01707030|473792705|FG001|Overall Study|Death|1|||
131590952|NCT01707030|473792704|FG000|Overall Study|Withdrawal by Subject|2|||
131590953|NCT01707030|473792705|FG001|Overall Study|Withdrawal by Subject|3|||
131590954|NCT01707030|473792704|FG000|Overall Study|Lost to Follow-up|8|||
131590955|NCT01707030|473792705|FG001|Overall Study|Lost to Follow-up|13|||
131590956|NCT04820855|473792706|FG000|Overall Study|Lost to Follow-up|6|||
131590957|NCT04820855|473792707|FG001|Overall Study|Lost to Follow-up|9|||
131590958|NCT00650104|473792709|FG000|Overall Study|Adverse Event|17|||
131590959|NCT00650104|473792709|FG000|Overall Study|Death|2|||
131590960|NCT00650104|473792709|FG000|Overall Study|Withdrawal by Subject|11|||
131590961|NCT00650104|473792709|FG000|Overall Study|Physician Decision|7|||
131590962|NCT00650104|473792709|FG000|Overall Study|Lost to Follow-up|1|||
131590963|NCT00650104|473792709|FG000|Overall Study|Non-compliance|2|||
131590964|NCT00650104|473792709|FG000|Overall Study|Sponsor Terminated Dosing|1|||
131590965|NCT00601900|473792721|FG000|Overall Study|Withdrawal by Subject|0|||
131590966|NCT00601900|473792722|FG001|Overall Study|Withdrawal by Subject|3|||
131590967|NCT02500758|473792731|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
131590968|NCT02500758|473792732|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
131590969|NCT02500758|473792731|FG000|Washout (1 Week)|Lost to Follow-up|2|||
131590970|NCT02500758|473792732|FG001|Washout (1 Week)|Lost to Follow-up|2|||
131590971|NCT02500758|473792731|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
131590972|NCT02500758|473792732|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
131590973|NCT02500758|473792731|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
131590974|NCT02500758|473792732|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
131590975|NCT02500758|473792731|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
131590976|NCT02500758|473792732|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
131590977|NCT00274469|473792734|FG000|Overall Study|Death|63|||
131590978|NCT00274469|473792735|FG001|Overall Study|Death|74|||
131590979|NCT00274469|473792734|FG000|Overall Study|Did not consent to OS follow-up|16|||
131590980|NCT00274469|473792735|FG001|Overall Study|Did not consent to OS follow-up|19|||
131590981|NCT04093752|473792739|FG000|Overall Study|Adverse Event|7|||
131590982|NCT04093752|473792740|FG001|Overall Study|Adverse Event|19|||
131590983|NCT04093752|473792741|FG002|Overall Study|Adverse Event|18|||
131590984|NCT04093752|473792742|FG003|Overall Study|Adverse Event|4|||
131590985|NCT04093752|473792739|FG000|Overall Study|Withdrawal by Subject|6|||
131590986|NCT04093752|473792740|FG001|Overall Study|Withdrawal by Subject|6|||
131590987|NCT04093752|473792741|FG002|Overall Study|Withdrawal by Subject|8|||
131590988|NCT04093752|473792742|FG003|Overall Study|Withdrawal by Subject|20|||
131590989|NCT04093752|473792739|FG000|Overall Study|Lost to Follow-up|2|||
131590990|NCT04093752|473792740|FG001|Overall Study|Lost to Follow-up|1|||
131590991|NCT04093752|473792741|FG002|Overall Study|Lost to Follow-up|1|||
131590992|NCT04093752|473792742|FG003|Overall Study|Lost to Follow-up|1|||
131590993|NCT04093752|473792739|FG000|Overall Study|Death|0|||
131590994|NCT04093752|473792740|FG001|Overall Study|Death|0|||
131590995|NCT04093752|473792741|FG002|Overall Study|Death|1|||
131590996|NCT04093752|473792742|FG003|Overall Study|Death|2|||
131590997|NCT04093752|473792739|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
131590998|NCT04093752|473792740|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
131590999|NCT04093752|473792741|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
131591000|NCT04093752|473792742|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
131591001|NCT04093752|473792739|FG000|Overall Study|Covid 19|0|||
131791263|NCT01405820|474518638|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
131791264|NCT01405820|474518639|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
131791265|NCT01405820|474518640|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
131791266|NCT01405820|474518641|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
131791267|NCT01405820|474518642|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
131791268|NCT01405820|474518637|FG000|Randomized Treatment Period|Death|0|||
131791269|NCT01405820|474518638|FG001|Randomized Treatment Period|Death|0|||
131791270|NCT01405820|474518639|FG002|Randomized Treatment Period|Death|0|||
131791271|NCT01405820|474518640|FG003|Randomized Treatment Period|Death|1|||
131591002|NCT04093752|473792740|FG001|Overall Study|Covid 19|0|||
131591003|NCT04093752|473792741|FG002|Overall Study|Covid 19|0|||
131591004|NCT04093752|473792742|FG003|Overall Study|Covid 19|1|||
131591005|NCT04093752|473792739|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
131591006|NCT04093752|473792740|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
131591007|NCT04093752|473792741|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
131591008|NCT04093752|473792742|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
131591009|NCT04093752|473792739|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
131591010|NCT04093752|473792740|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
131791272|NCT01405820|474518641|FG004|Randomized Treatment Period|Death|0|||
131791273|NCT01405820|474518642|FG005|Randomized Treatment Period|Death|0|||
131791274|NCT01405820|474518637|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131591011|NCT04093752|473792741|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
131591012|NCT04093752|473792742|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
131591013|NCT04093752|473792739|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
131591014|NCT04093752|473792740|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
131591015|NCT04093752|473792741|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
131591016|NCT04093752|473792742|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
131591017|NCT02140645|473792744|FG000|Overall Study|Not linked|5489|||
131591018|NCT02140645|473792745|FG001|Overall Study|Not linked|61654|||
131591019|NCT02140645|473792746|FG002|Overall Study|Not linked|4236|||
131591020|NCT02140645|473792747|FG003|Overall Study|Not linked|13833|||
131591021|NCT02140645|473792748|FG004|Overall Study|Not linked|3286|||
131591022|NCT02140645|473792749|FG005|Overall Study|Not linked|70896|||
131591023|NCT01101451|473792750|FG000|Overall Study|Eligible and never treated|0|||
131591024|NCT01101451|473792751|FG001|Overall Study|Eligible and never treated|5|||
131591025|NCT01101451|473792750|FG000|Overall Study|Ineligible and treated|12|||
131591026|NCT01101451|473792751|FG001|Overall Study|Ineligible and treated|8|||
131591027|NCT01101451|473792750|FG000|Overall Study|Ineligible and never treated|2|||
131591028|NCT01101451|473792751|FG001|Overall Study|Ineligible and never treated|2|||
131591029|NCT00073749|473792757|FG000|Overall Study|Disease Progression|2|||
131591030|NCT00073749|473792758|FG001|Overall Study|Disease Progression|0|||
131591031|NCT00073749|473792759|FG002|Overall Study|Disease Progression|3|||
131591032|NCT00073749|473792760|FG003|Overall Study|Disease Progression|2|||
131591033|NCT00073749|473792761|FG004|Overall Study|Disease Progression|3|||
131591034|NCT00073749|473792762|FG005|Overall Study|Disease Progression|1|||
131591035|NCT00073749|473792763|FG006|Overall Study|Disease Progression|3|||
131591036|NCT00073749|473792757|FG000|Overall Study|Death|0|||
131591037|NCT00073749|473792758|FG001|Overall Study|Death|1|||
131591038|NCT00073749|473792759|FG002|Overall Study|Death|1|||
131591039|NCT00073749|473792760|FG003|Overall Study|Death|0|||
131591040|NCT00073749|473792761|FG004|Overall Study|Death|0|||
131591041|NCT00073749|473792762|FG005|Overall Study|Death|0|||
131591042|NCT00073749|473792763|FG006|Overall Study|Death|29|||
131591043|NCT00073749|473792757|FG000|Overall Study|Adverse Event|0|||
131591044|NCT00073749|473792758|FG001|Overall Study|Adverse Event|3|||
131591045|NCT00073749|473792759|FG002|Overall Study|Adverse Event|6|||
131591046|NCT00073749|473792760|FG003|Overall Study|Adverse Event|4|||
131591047|NCT00073749|473792761|FG004|Overall Study|Adverse Event|2|||
131591048|NCT00073749|473792762|FG005|Overall Study|Adverse Event|1|||
131591049|NCT00073749|473792763|FG006|Overall Study|Adverse Event|0|||
131591050|NCT00073749|473792757|FG000|Overall Study|Physician Decision|0|||
131591051|NCT00073749|473792758|FG001|Overall Study|Physician Decision|0|||
131591052|NCT00073749|473792759|FG002|Overall Study|Physician Decision|1|||
131591053|NCT00073749|473792760|FG003|Overall Study|Physician Decision|0|||
131591054|NCT00073749|473792761|FG004|Overall Study|Physician Decision|0|||
131591055|NCT00073749|473792762|FG005|Overall Study|Physician Decision|2|||
131591056|NCT00073749|473792763|FG006|Overall Study|Physician Decision|0|||
131591057|NCT00073749|473792757|FG000|Overall Study|Withdrawal by Subject|0|||
131591058|NCT00073749|473792758|FG001|Overall Study|Withdrawal by Subject|1|||
131591059|NCT00073749|473792759|FG002|Overall Study|Withdrawal by Subject|0|||
131591060|NCT00073749|473792760|FG003|Overall Study|Withdrawal by Subject|0|||
131591061|NCT00073749|473792761|FG004|Overall Study|Withdrawal by Subject|1|||
131706112|NCT00849667|474205529|FG001|Overall Study|Sponsor decision|204|||
131591062|NCT00073749|473792762|FG005|Overall Study|Withdrawal by Subject|0|||
131591063|NCT00073749|473792763|FG006|Overall Study|Withdrawal by Subject|2|||
131591064|NCT00073749|473792757|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
131591065|NCT00073749|473792758|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131591066|NCT00073749|473792759|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
131591067|NCT00073749|473792760|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
131591068|NCT00073749|473792761|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
131591069|NCT00073749|473792762|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
131591070|NCT00073749|473792763|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
131591071|NCT00073749|473792757|FG000|Overall Study|Lost to Follow-up|0|||
131591072|NCT00073749|473792758|FG001|Overall Study|Lost to Follow-up|0|||
131591073|NCT00073749|473792759|FG002|Overall Study|Lost to Follow-up|0|||
131591074|NCT00073749|473792760|FG003|Overall Study|Lost to Follow-up|0|||
131591075|NCT00073749|473792761|FG004|Overall Study|Lost to Follow-up|0|||
131591076|NCT00073749|473792762|FG005|Overall Study|Lost to Follow-up|0|||
131591077|NCT00073749|473792763|FG006|Overall Study|Lost to Follow-up|2|||
131591078|NCT00073749|473792757|FG000|Overall Study|Other|0|||
131591079|NCT00073749|473792758|FG001|Overall Study|Other|0|||
131591080|NCT00073749|473792759|FG002|Overall Study|Other|0|||
131591081|NCT00073749|473792760|FG003|Overall Study|Other|0|||
131591082|NCT00073749|473792761|FG004|Overall Study|Other|0|||
131591083|NCT00073749|473792762|FG005|Overall Study|Other|2|||
131591084|NCT00073749|473792763|FG006|Overall Study|Other|0|||
131591085|NCT00611559|473792764|FG000|Overall Study|Lost to Follow-up|0|||
131591086|NCT00611559|473792765|FG001|Overall Study|Lost to Follow-up|1|||
131591087|NCT00611559|473792766|FG002|Overall Study|Lost to Follow-up|0|||
131591088|NCT00611559|473792764|FG000|Overall Study|Protocol Violation|1|||
131591089|NCT00611559|473792765|FG001|Overall Study|Protocol Violation|0|||
131591090|NCT00611559|473792766|FG002|Overall Study|Protocol Violation|1|||
131591091|NCT04999592|473792767|FG000|Overall Study|Withdrawal by Subject|1|||
131591092|NCT04999592|473792768|FG001|Overall Study|Withdrawal by Subject|0|||
131591093|NCT04095104|473792769|FG000|Overall Study|Withdrawal by Subject|0|||
131591094|NCT04095104|473792770|FG001|Overall Study|Withdrawal by Subject|1|||
131591095|NCT02742519|473792771|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
131591096|NCT02742519|473792772|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
131591097|NCT02742519|473792773|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
131591098|NCT02742519|473792771|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
131591099|NCT02742519|473792772|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
131591100|NCT02742519|473792773|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
131591101|NCT02742519|473792771|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
131591102|NCT02742519|473792772|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
131591103|NCT02742519|473792773|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
131591104|NCT04774237|473792776|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
131591105|NCT04774237|473792777|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
131591106|NCT04774237|473792778|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
131591107|NCT04774237|473792779|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
131591108|NCT04774237|473792780|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
131591109|NCT04774237|473792781|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
131591110|NCT03152786|473794122|FG000|Overall Study|Withdrawal by Subject|2|||
131591111|NCT03152786|473794123|FG001|Overall Study|Withdrawal by Subject|1|||
131591112|NCT04923347|473794124|FG000|Overall Study|Withdrawal by Subject|14|||
131591113|NCT00753090|473794136|FG000|Overall Study|Withdrawal by Subject|10|||
131591114|NCT00753090|473794137|FG001|Overall Study|Withdrawal by Subject|10|||
131591115|NCT00753090|473794136|FG000|Overall Study|Death|17|||
131591116|NCT00753090|473794137|FG001|Overall Study|Death|6|||
131591117|NCT00753090|473794136|FG000|Overall Study|Study Prosthesis Removed|12|||
131591118|NCT00753090|473794137|FG001|Overall Study|Study Prosthesis Removed|3|||
131591119|NCT00753090|473794136|FG000|Overall Study|Lost to Follow-up|2|||
131591120|NCT00753090|473794137|FG001|Overall Study|Lost to Follow-up|2|||
131591121|NCT00753090|473794136|FG000|Overall Study|Other|127|||
131591122|NCT00753090|473794137|FG001|Overall Study|Other|75|||
131591123|NCT06066541|473794138|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
131591124|NCT06066541|473794139|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
131591125|NCT06066541|473794140|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
131591126|NCT06066541|473794141|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
131591127|NCT06066541|473794142|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
131591128|NCT06066541|473794143|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
131591129|NCT06066541|473794144|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
131591130|NCT06066541|473794138|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
131591131|NCT06066541|473794139|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
131591132|NCT06066541|473794140|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
131791275|NCT01405820|474518638|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131791276|NCT01405820|474518639|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131791277|NCT01405820|474518640|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
131791278|NCT01405820|474518641|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131791279|NCT01405820|474518642|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131791280|NCT01405820|474518637|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
131591133|NCT06066541|473794141|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
131591134|NCT06066541|473794142|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
131591135|NCT06066541|473794143|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
131591136|NCT06066541|473794144|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
131791281|NCT01405820|474518638|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
131791282|NCT01405820|474518639|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
131791283|NCT01405820|474518640|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
131791284|NCT01405820|474518641|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
131791285|NCT01405820|474518642|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
131791286|NCT01405820|474518637|FG000|Open-Label Treatment Period|Other|1|||
131791287|NCT01405820|474518638|FG001|Open-Label Treatment Period|Other|1|||
131791288|NCT01405820|474518639|FG002|Open-Label Treatment Period|Other|1|||
131791289|NCT01405820|474518640|FG003|Open-Label Treatment Period|Other|1|||
131791290|NCT01405820|474518641|FG004|Open-Label Treatment Period|Other|1|||
131791291|NCT01405820|474518642|FG005|Open-Label Treatment Period|Other|1|||
131791292|NCT01405820|474518637|FG000|Open-Label Treatment Period|Physician Decision|0|||
131791293|NCT01405820|474518638|FG001|Open-Label Treatment Period|Physician Decision|0|||
131791294|NCT01405820|474518639|FG002|Open-Label Treatment Period|Physician Decision|1|||
131791295|NCT01405820|474518640|FG003|Open-Label Treatment Period|Physician Decision|2|||
131791296|NCT01405820|474518641|FG004|Open-Label Treatment Period|Physician Decision|1|||
131791297|NCT01405820|474518642|FG005|Open-Label Treatment Period|Physician Decision|0|||
131791298|NCT01405820|474518637|FG000|Open-Label Treatment Period|Adverse Event|0|||
131791299|NCT01405820|474518638|FG001|Open-Label Treatment Period|Adverse Event|0|||
131791300|NCT01405820|474518639|FG002|Open-Label Treatment Period|Adverse Event|0|||
131791301|NCT01405820|474518640|FG003|Open-Label Treatment Period|Adverse Event|1|||
131791302|NCT01405820|474518641|FG004|Open-Label Treatment Period|Adverse Event|0|||
131791303|NCT01405820|474518642|FG005|Open-Label Treatment Period|Adverse Event|0|||
131791304|NCT03263819|474518646|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
131791305|NCT03263819|474518647|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
131791306|NCT01271933|474518659|FG000|Single-Blind Phase|Lack of Efficacy|37|||
131791307|NCT01271933|474518660|FG001|Single-Blind Phase|Lack of Efficacy|0|||
131791308|NCT01271933|474518661|FG002|Single-Blind Phase|Lack of Efficacy|0|||
131791309|NCT01271933|474518659|FG000|Single-Blind Phase|Lost to Follow-up|10|||
131791310|NCT01271933|474518660|FG001|Single-Blind Phase|Lost to Follow-up|0|||
131791311|NCT01271933|474518661|FG002|Single-Blind Phase|Lost to Follow-up|0|||
131791312|NCT01271933|474518659|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
131791313|NCT01271933|474518660|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
131791314|NCT01271933|474518661|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
131791315|NCT01271933|474518659|FG000|Single-Blind Phase|Protocol Violation|3|||
131791316|NCT01271933|474518660|FG001|Single-Blind Phase|Protocol Violation|0|||
131791317|NCT01271933|474518661|FG002|Single-Blind Phase|Protocol Violation|0|||
131791318|NCT01271933|474518659|FG000|Single-Blind Phase|Adverse Event|52|||
131791319|NCT01271933|474518660|FG001|Single-Blind Phase|Adverse Event|0|||
131791320|NCT01271933|474518661|FG002|Single-Blind Phase|Adverse Event|0|||
131791321|NCT01271933|474518659|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
131791322|NCT01271933|474518660|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
131791323|NCT01271933|474518661|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
131791324|NCT01271933|474518659|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
131791325|NCT01271933|474518660|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
131791326|NCT01271933|474518661|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
131791327|NCT01271933|474518659|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
131791328|NCT01271933|474518660|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
131791329|NCT01271933|474518661|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
131791330|NCT01271933|474518659|FG000|Double-Blind Phase|Randomized but not treated|0|||
131791331|NCT01271933|474518660|FG001|Double-Blind Phase|Randomized but not treated|0|||
131791332|NCT01271933|474518661|FG002|Double-Blind Phase|Randomized but not treated|1|||
131791333|NCT01271933|474518659|FG000|Double-Blind Phase|Lack of Efficacy|0|||
131591137|NCT04533022|473794145|FG000|Overall Study|Withdrawal by Subject|15|||
131591138|NCT04533022|473794145|FG000|Overall Study|Adverse Event|6|||
131591139|NCT04533022|473794145|FG000|Overall Study|Death|1|||
131591140|NCT04533022|473794145|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
131591141|NCT04533022|473794145|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
131591142|NCT02163447|473794146|FG000|Overall Study|Withdrawal by Subject|2|||
131591143|NCT02163447|473794147|FG001|Overall Study|Withdrawal by Subject|0|||
131591144|NCT02163447|473794148|FG002|Overall Study|Withdrawal by Subject|1|||
131591145|NCT02163447|473794146|FG000|Overall Study|Lost to Follow-up|1|||
131591146|NCT02163447|473794147|FG001|Overall Study|Lost to Follow-up|3|||
131791334|NCT01271933|474518660|FG001|Double-Blind Phase|Lack of Efficacy|6|||
131791335|NCT01271933|474518661|FG002|Double-Blind Phase|Lack of Efficacy|9|||
131791336|NCT01271933|474518659|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131791337|NCT01271933|474518660|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131791338|NCT01271933|474518661|FG002|Double-Blind Phase|Lost to Follow-up|1|||
131791339|NCT01271933|474518659|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131591147|NCT02163447|473794148|FG002|Overall Study|Lost to Follow-up|0|||
131591148|NCT02163447|473794146|FG000|Overall Study|Moved out of study area|2|||
131899082|NCT00758498|474917497|FG000|Overall Study|Adverse Event|2|||
131591149|NCT02163447|473794147|FG001|Overall Study|Moved out of study area|3|||
131591150|NCT02163447|473794148|FG002|Overall Study|Moved out of study area|2|||
131591151|NCT02163447|473794146|FG000|Overall Study|Became HIV infected at time of delivery|1|||
131591152|NCT02163447|473794147|FG001|Overall Study|Became HIV infected at time of delivery|0|||
131591153|NCT02163447|473794148|FG002|Overall Study|Became HIV infected at time of delivery|0|||
131591154|NCT04052516|473794150|FG000|Overall Study|Withdrawal by Subject|4|||
131791340|NCT01271933|474518660|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
131791341|NCT01271933|474518661|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
131791342|NCT01271933|474518659|FG000|Double-Blind Phase|Adverse Event|0|||
131791343|NCT01271933|474518660|FG001|Double-Blind Phase|Adverse Event|3|||
131791344|NCT01271933|474518661|FG002|Double-Blind Phase|Adverse Event|0|||
131791345|NCT01271933|474518659|FG000|Double-Blind Phase|Participant request-personal reason|0|||
131791346|NCT01271933|474518660|FG001|Double-Blind Phase|Participant request-personal reason|1|||
131791347|NCT01271933|474518661|FG002|Double-Blind Phase|Participant request-personal reason|0|||
131791348|NCT01138150|474518662|FG000|Overall Study|blood unable to be processed|0|||
131791349|NCT01138150|474518663|FG001|Overall Study|blood unable to be processed|1|||
131791350|NCT01138150|474518662|FG000|Overall Study|Physician Decision|1|||
131791351|NCT01138150|474518663|FG001|Overall Study|Physician Decision|0|||
131791352|NCT01620983|474518664|FG000|Overall Study|Lost to Follow-up|8|||
131791353|NCT01620983|474518665|FG001|Overall Study|Lost to Follow-up|4|||
131791354|NCT01620983|474518666|FG002|Overall Study|Lost to Follow-up|9|||
131791355|NCT01620983|474518664|FG000|Overall Study|Withdrawal by Subject|6|||
131791356|NCT01620983|474518665|FG001|Overall Study|Withdrawal by Subject|8|||
131591155|NCT04052516|473794151|FG001|Overall Study|Withdrawal by Subject|5|||
131591156|NCT04052516|473794152|FG002|Overall Study|Withdrawal by Subject|6|||
131591157|NCT04052516|473794150|FG000|Overall Study|Adverse Event|3|||
131591158|NCT04052516|473794151|FG001|Overall Study|Adverse Event|2|||
131591159|NCT04052516|473794152|FG002|Overall Study|Adverse Event|8|||
131591160|NCT04052516|473794150|FG000|Overall Study|Lost to Follow-up|2|||
131591161|NCT04052516|473794151|FG001|Overall Study|Lost to Follow-up|5|||
131591162|NCT04052516|473794152|FG002|Overall Study|Lost to Follow-up|3|||
131791357|NCT01620983|474518666|FG002|Overall Study|Withdrawal by Subject|1|||
131791358|NCT01620983|474518664|FG000|Overall Study|Death|2|||
131791359|NCT01620983|474518665|FG001|Overall Study|Death|0|||
131791360|NCT01620983|474518666|FG002|Overall Study|Death|0|||
131591163|NCT04052516|473794150|FG000|Overall Study|Protocol Violation|1|||
131591164|NCT04052516|473794151|FG001|Overall Study|Protocol Violation|1|||
131591165|NCT04052516|473794152|FG002|Overall Study|Protocol Violation|0|||
131591166|NCT04052516|473794150|FG000|Overall Study|Death|1|||
131591167|NCT04052516|473794151|FG001|Overall Study|Death|0|||
131591168|NCT04052516|473794152|FG002|Overall Study|Death|0|||
131591169|NCT04052516|473794150|FG000|Overall Study|Physician Decision|0|||
131591170|NCT04052516|473794151|FG001|Overall Study|Physician Decision|1|||
131591171|NCT04052516|473794152|FG002|Overall Study|Physician Decision|0|||
131591172|NCT04052516|473794150|FG000|Overall Study|Pregnancy|1|||
131591173|NCT04052516|473794151|FG001|Overall Study|Pregnancy|0|||
131591174|NCT04052516|473794152|FG002|Overall Study|Pregnancy|0|||
131591175|NCT04052516|473794150|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
131591176|NCT04052516|473794151|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
131591177|NCT04052516|473794152|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
131591178|NCT04052516|473794150|FG000|Overall Study|Reason not recorded|0|||
131591179|NCT04052516|473794151|FG001|Overall Study|Reason not recorded|1|||
131591180|NCT04052516|473794152|FG002|Overall Study|Reason not recorded|0|||
131591181|NCT05113966|473794153|FG000|Overall Study|Death|21|||
131591182|NCT05113966|473794153|FG000|Overall Study|Study Terminated by Sponsor|9|||
131591183|NCT03747484|473794154|FG000|Overall Study|Lack of Efficacy|0|||
131591184|NCT03747484|473794155|FG001|Overall Study|Lack of Efficacy|1|||
131591185|NCT03747484|473794156|FG002|Overall Study|Lack of Efficacy|1|||
131591186|NCT03747484|473794157|FG003|Overall Study|Lack of Efficacy|2|||
131591187|NCT03747484|473794158|FG004|Overall Study|Lack of Efficacy|2|||
131591188|NCT02597946|473794161|FG000|Overall Study|Withdrawal by Subject|1|||
131591189|NCT02597946|473794161|FG000|Overall Study|Progressive disease|16|||
131591190|NCT02597946|473794161|FG000|Overall Study|Other than above|1|||
131591191|NCT04521478|473794165|FG000|Overall Study|Protocol Violation|2|||
131591192|NCT04521478|473794166|FG001|Overall Study|Protocol Violation|0|||
131591193|NCT04521478|473794167|FG002|Overall Study|Protocol Violation|1|||
131791361|NCT01620983|474518664|FG000|Overall Study|Physician Decision|3|||
131899083|NCT00758498|474917498|FG001|Overall Study|Adverse Event|2|||
131591194|NCT04521478|473794168|FG003|Overall Study|Protocol Violation|0|||
131591195|NCT04521478|473794169|FG004|Overall Study|Protocol Violation|0|||
131591196|NCT04521478|473794170|FG005|Overall Study|Protocol Violation|0|||
131591197|NCT04521478|473794165|FG000|Overall Study|Technical Problems|0|||
131591198|NCT04521478|473794166|FG001|Overall Study|Technical Problems|0|||
131591199|NCT04521478|473794167|FG002|Overall Study|Technical Problems|0|||
131591200|NCT04521478|473794168|FG003|Overall Study|Technical Problems|1|||
131591201|NCT04521478|473794169|FG004|Overall Study|Technical Problems|0|||
131591202|NCT04521478|473794170|FG005|Overall Study|Technical Problems|0|||
131791362|NCT01620983|474518665|FG001|Overall Study|Physician Decision|10|||
131591203|NCT04521478|473794165|FG000|Overall Study|Burden of Study Procedures|1|||
131591204|NCT04521478|473794166|FG001|Overall Study|Burden of Study Procedures|0|||
131591205|NCT04521478|473794167|FG002|Overall Study|Burden of Study Procedures|0|||
131591206|NCT04521478|473794168|FG003|Overall Study|Burden of Study Procedures|1|||
131591207|NCT04521478|473794169|FG004|Overall Study|Burden of Study Procedures|0|||
131591208|NCT04521478|473794170|FG005|Overall Study|Burden of Study Procedures|1|||
131591209|NCT04521478|473794165|FG000|Overall Study|Lack of Efficacy|0|||
131591210|NCT04521478|473794166|FG001|Overall Study|Lack of Efficacy|0|||
131591211|NCT04521478|473794167|FG002|Overall Study|Lack of Efficacy|0|||
131591212|NCT04521478|473794168|FG003|Overall Study|Lack of Efficacy|0|||
131591213|NCT04521478|473794169|FG004|Overall Study|Lack of Efficacy|1|||
131591214|NCT04521478|473794170|FG005|Overall Study|Lack of Efficacy|1|||
131591215|NCT04521478|473794165|FG000|Overall Study|Adverse Event|7|||
131591216|NCT04521478|473794166|FG001|Overall Study|Adverse Event|0|||
131591217|NCT04521478|473794167|FG002|Overall Study|Adverse Event|2|||
131591218|NCT04521478|473794168|FG003|Overall Study|Adverse Event|1|||
131591219|NCT04521478|473794169|FG004|Overall Study|Adverse Event|2|||
131591220|NCT04521478|473794170|FG005|Overall Study|Adverse Event|7|||
131591221|NCT04521478|473794165|FG000|Overall Study|No Reason Available|0|||
131591222|NCT04521478|473794166|FG001|Overall Study|No Reason Available|2|||
131591223|NCT04521478|473794167|FG002|Overall Study|No Reason Available|0|||
131591224|NCT04521478|473794168|FG003|Overall Study|No Reason Available|0|||
131591225|NCT04521478|473794169|FG004|Overall Study|No Reason Available|1|||
131591226|NCT04521478|473794170|FG005|Overall Study|No Reason Available|0|||
131591227|NCT04521478|473794165|FG000|Overall Study|Other than listed|3|||
131591228|NCT04521478|473794166|FG001|Overall Study|Other than listed|3|||
131591229|NCT04521478|473794167|FG002|Overall Study|Other than listed|3|||
131591230|NCT04521478|473794168|FG003|Overall Study|Other than listed|2|||
131591231|NCT04521478|473794169|FG004|Overall Study|Other than listed|3|||
131591232|NCT04521478|473794170|FG005|Overall Study|Other than listed|3|||
131591233|NCT04521478|473794165|FG000|Overall Study|Not treated|0|||
131591234|NCT04521478|473794166|FG001|Overall Study|Not treated|0|||
131591235|NCT04521478|473794167|FG002|Overall Study|Not treated|0|||
131591236|NCT04521478|473794168|FG003|Overall Study|Not treated|0|||
131591237|NCT04521478|473794169|FG004|Overall Study|Not treated|0|||
131706113|NCT00849667|474205530|FG002|Overall Study|Sponsor decision|190|||
131591238|NCT04521478|473794170|FG005|Overall Study|Not treated|1|||
131591239|NCT03625882|473794171|FG000|Overall Study|Protocol Violation|3|||
131591240|NCT05058391|473794176|FG000|Overall Study|Adverse Event|1|||
131706114|NCT00849667|474205528|FG000|Overall Study|Investigator discretion|0|||
131706115|NCT00849667|474205529|FG001|Overall Study|Investigator discretion|0|||
131706116|NCT00849667|474205530|FG002|Overall Study|Investigator discretion|1|||
131706117|NCT01731678|474205540|FG000|Overall Study|Withdrawal by Subject|3|||
131706118|NCT01731678|474205540|FG000|Overall Study|Did not meet inclusion criteria|1|||
131706119|NCT01731678|474205540|FG000|Overall Study|RMT too high, making TMS difficult|3|||
131706120|NCT01551693|474205542|FG000|Overall Study|Disease Progression|1|||
131706121|NCT01551693|474205543|FG001|Overall Study|Disease Progression|0|||
131706122|NCT01551693|474205542|FG000|Overall Study|Adverse Event|0|||
131706123|NCT01551693|474205543|FG001|Overall Study|Adverse Event|1|||
131706124|NCT01551693|474205542|FG000|Overall Study|Withdrawal by Subject|0|||
131706125|NCT01551693|474205543|FG001|Overall Study|Withdrawal by Subject|1|||
131706126|NCT00130286|474205548|FG000|Overall Study|Withdrawal by Subject|0|||
131706127|NCT00130286|474205549|FG001|Overall Study|Withdrawal by Subject|1|||
131706128|NCT00130286|474205550|FG002|Overall Study|Withdrawal by Subject|2|||
131591241|NCT01938547|473794179|FG000|Overall Study|Physician Decision|1|||
131591242|NCT05320432|473794182|FG000|Overall Study|Withdrawal by Subject|0|||
131591243|NCT05320432|473794183|FG001|Overall Study|Withdrawal by Subject|2|||
131591244|NCT00739648|473794184|FG000|Overall Study|Adverse Event|3|||
131591245|NCT00739648|473794185|FG001|Overall Study|Adverse Event|15|||
131591246|NCT00739648|473794184|FG000|Overall Study|Withdrawal by Subject|13|||
131591247|NCT00739648|473794185|FG001|Overall Study|Withdrawal by Subject|25|||
131706129|NCT00130286|474205551|FG003|Overall Study|Withdrawal by Subject|2|||
131591248|NCT00739648|473794184|FG000|Overall Study|Lost to Follow-up|4|||
131591249|NCT00739648|473794185|FG001|Overall Study|Lost to Follow-up|7|||
131591250|NCT00739648|473794184|FG000|Overall Study|Death|2|||
131591251|NCT00739648|473794185|FG001|Overall Study|Death|0|||
131591252|NCT00739648|473794184|FG000|Overall Study|Do not know|4|||
131591253|NCT00739648|473794185|FG001|Overall Study|Do not know|6|||
131591254|NCT05110495|473794186|FG000|Overall Study|Lost to Follow-up|1|||
131591255|NCT05110495|473794186|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
131591256|NCT05141903|473794187|FG000|Overall Study|Withdrawal by Subject|0|||
131591257|NCT05141903|473794188|FG001|Overall Study|Withdrawal by Subject|1|||
131591258|NCT05141903|473794189|FG002|Overall Study|Withdrawal by Subject|1|||
131591259|NCT05141903|473794190|FG003|Overall Study|Withdrawal by Subject|0|||
131591260|NCT05141903|473794191|FG004|Overall Study|Withdrawal by Subject|0|||
131591261|NCT05141903|473794187|FG000|Overall Study|Other|1|||
131591262|NCT05141903|473794188|FG001|Overall Study|Other|1|||
131591263|NCT05141903|473794189|FG002|Overall Study|Other|0|||
131591264|NCT05141903|473794190|FG003|Overall Study|Other|0|||
131591265|NCT05141903|473794191|FG004|Overall Study|Other|0|||
131591266|NCT03089398|473794199|FG000|Overall Study|Death|4|||
131591267|NCT03089398|473794200|FG001|Overall Study|Death|9|||
131591268|NCT03089398|473794199|FG000|Overall Study|Lost to Follow-up|21|||
131591269|NCT03089398|473794200|FG001|Overall Study|Lost to Follow-up|30|||
131591270|NCT03089398|473794199|FG000|Overall Study|Withdrawal by Subject|2|||
131591271|NCT03089398|473794200|FG001|Overall Study|Withdrawal by Subject|2|||
131591272|NCT05062265|473794201|FG000|Overall Study|Withdrawal by Subject|1|||
131591273|NCT05062265|473794202|FG001|Overall Study|Withdrawal by Subject|0|||
131591274|NCT05439603|473794203|FG000|Overall Study|met withdrawal criteria|2|||
131591275|NCT03052608|473794207|FG000|Treatment Phase|Adverse Event|10|||
131591276|NCT03052608|473794208|FG001|Treatment Phase|Adverse Event|12|||
131591277|NCT03052608|473794207|FG000|Treatment Phase|Death|6|||
131591278|NCT03052608|473794208|FG001|Treatment Phase|Death|4|||
131591279|NCT03052608|473794207|FG000|Treatment Phase|Withdrawal by Subject|4|||
131591280|NCT03052608|473794208|FG001|Treatment Phase|Withdrawal by Subject|12|||
131591281|NCT03052608|473794207|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
131591282|NCT03052608|473794208|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
131591283|NCT03052608|473794207|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
131591284|NCT03052608|473794208|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
131591285|NCT03052608|473794207|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
131591286|NCT03052608|473794208|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
131591287|NCT03052608|473794207|FG000|Treatment Phase|Ongoing|103|||
131706130|NCT00130286|474205548|FG000|Overall Study|Adverse Event|0|||
131706131|NCT00130286|474205549|FG001|Overall Study|Adverse Event|0|||
131706132|NCT00130286|474205550|FG002|Overall Study|Adverse Event|2|||
131706133|NCT00130286|474205551|FG003|Overall Study|Adverse Event|0|||
131706134|NCT00130286|474205548|FG000|Overall Study|Missing lab specimens|0|||
131591288|NCT03052608|473794208|FG001|Treatment Phase|Ongoing|31|||
131591289|NCT03052608|473794207|FG000|Long-Term Follow-up Phase|Death|23|||
131591290|NCT03052608|473794208|FG001|Long-Term Follow-up Phase|Death|28|||
131591291|NCT03052608|473794207|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
131591292|NCT03052608|473794208|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
131591293|NCT03052608|473794207|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
131591294|NCT03052608|473794208|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
131591295|NCT03052608|473794207|FG000|Long-Term Follow-up Phase|Ongoing|122|||
131591296|NCT03052608|473794208|FG001|Long-Term Follow-up Phase|Ongoing|99|||
131591297|NCT03113500|473794209|FG000|Overall Study|Withdrawal by Subject|1|||
131591298|NCT05249439|473794211|FG000|Overall Study|Withdrawal by Subject|2|||
131706135|NCT00130286|474205549|FG001|Overall Study|Missing lab specimens|2|||
131706136|NCT00130286|474205550|FG002|Overall Study|Missing lab specimens|0|||
131706137|NCT00130286|474205551|FG003|Overall Study|Missing lab specimens|0|||
131591299|NCT05249439|473794212|FG001|Overall Study|Withdrawal by Subject|5|||
131591300|NCT05249439|473794211|FG000|Overall Study|Physician Decision|3|||
131591301|NCT05249439|473794212|FG001|Overall Study|Physician Decision|1|||
131591302|NCT03526861|473794217|FG000|Initial Treatment Period|Not dosed|1|||
131591303|NCT03526861|473794218|FG001|Initial Treatment Period|Not dosed|1|||
131591304|NCT03526861|473794219|FG002|Initial Treatment Period|Not dosed|1|||
131591305|NCT03526861|473794220|FG003|Initial Treatment Period|Not dosed|0|||
131591306|NCT03526861|473794221|FG004|Initial Treatment Period|Not dosed|0|||
131591307|NCT03526861|473794222|FG005|Initial Treatment Period|Not dosed|0|||
131591308|NCT03526861|473794223|FG006|Initial Treatment Period|Not dosed|0|||
131591309|NCT03526861|473794224|FG007|Initial Treatment Period|Not dosed|0|||
131591310|NCT03526861|473794225|FG008|Initial Treatment Period|Not dosed|0|||
131591311|NCT03526861|473794217|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
131591312|NCT03526861|473794218|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
131591313|NCT03526861|473794219|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
131591314|NCT03526861|473794220|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591315|NCT03526861|473794221|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591316|NCT03526861|473794222|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591317|NCT03526861|473794223|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591318|NCT03526861|473794224|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591319|NCT03526861|473794225|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591320|NCT03526861|473794217|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
131591321|NCT03526861|473794218|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
131591322|NCT03526861|473794219|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
131591323|NCT03526861|473794220|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131591324|NCT03526861|473794221|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131591325|NCT03526861|473794222|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131591326|NCT03526861|473794223|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131591327|NCT03526861|473794224|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131591328|NCT03526861|473794225|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131591329|NCT03526861|473794217|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591330|NCT03526861|473794218|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591331|NCT03526861|473794219|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591332|NCT03526861|473794220|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
131591333|NCT03526861|473794221|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
131591334|NCT03526861|473794222|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591335|NCT03526861|473794223|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
131591336|NCT03526861|473794224|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591337|NCT03526861|473794225|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591338|NCT03526861|473794217|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131591339|NCT03526861|473794218|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131591340|NCT03526861|473794219|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131591341|NCT03526861|473794220|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
131591342|NCT03526861|473794221|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
131591343|NCT03526861|473794222|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
131591344|NCT03526861|473794223|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
131591345|NCT03526861|473794224|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
131591346|NCT03526861|473794225|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131653621|NCT03842228|474018427|FG006|Overall Study|Withdrawal by Subject|2|||
131791363|NCT01620983|474518666|FG002|Overall Study|Physician Decision|5|||
131591347|NCT03526861|473794217|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591348|NCT03526861|473794218|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591349|NCT03526861|473794219|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591350|NCT03526861|473794220|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
131591351|NCT03526861|473794221|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591352|NCT03526861|473794222|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131439026|NCT00395746|473233385|FG000|Overall Study|Withdrawal of consent|0|||
131591353|NCT03526861|473794223|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591354|NCT03526861|473794224|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591355|NCT03526861|473794225|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131439027|NCT00395746|473233386|FG001|Overall Study|Withdrawal of consent|0|||
131439028|NCT00395746|473233387|FG002|Overall Study|Withdrawal of consent|1|||
131439029|NCT00395746|473233385|FG000|Overall Study|Difficultulty in use of device|0|||
131439030|NCT00395746|473233386|FG001|Overall Study|Difficultulty in use of device|0|||
131439031|NCT00395746|473233387|FG002|Overall Study|Difficultulty in use of device|1|||
131439032|NCT00395746|473233385|FG000|Overall Study|Unable to visit site on schedule|1|||
131439033|NCT00395746|473233386|FG001|Overall Study|Unable to visit site on schedule|0|||
131439034|NCT00395746|473233387|FG002|Overall Study|Unable to visit site on schedule|0|||
131439035|NCT03137992|473233392|FG000|Washout Period 1|Adverse Event|1|||
131439036|NCT03137992|473233393|FG001|Washout Period 1|Adverse Event|1|||
131439037|NCT03137992|473233394|FG002|Washout Period 1|Adverse Event|0|||
131439038|NCT03137992|473233395|FG003|Washout Period 1|Adverse Event|0|||
131439039|NCT03137992|473233396|FG004|Washout Period 1|Adverse Event|0|||
131439040|NCT03137992|473233397|FG005|Washout Period 1|Adverse Event|1|||
131439041|NCT03137992|473233392|FG000|Washout Period 1|Withdrawal by Subject|0|||
131439042|NCT03137992|473233393|FG001|Washout Period 1|Withdrawal by Subject|1|||
131439043|NCT03137992|473233394|FG002|Washout Period 1|Withdrawal by Subject|1|||
131439044|NCT03137992|473233395|FG003|Washout Period 1|Withdrawal by Subject|0|||
131439045|NCT03137992|473233396|FG004|Washout Period 1|Withdrawal by Subject|0|||
131439046|NCT03137992|473233397|FG005|Washout Period 1|Withdrawal by Subject|0|||
131439047|NCT03137992|473233392|FG000|Washout Period 1|Principal Investigator Discretion|0|||
131439048|NCT03137992|473233393|FG001|Washout Period 1|Principal Investigator Discretion|1|||
131439049|NCT03137992|473233394|FG002|Washout Period 1|Principal Investigator Discretion|0|||
131439050|NCT03137992|473233395|FG003|Washout Period 1|Principal Investigator Discretion|0|||
131439051|NCT03137992|473233396|FG004|Washout Period 1|Principal Investigator Discretion|0|||
131439052|NCT03137992|473233397|FG005|Washout Period 1|Principal Investigator Discretion|0|||
131439053|NCT03137992|473233392|FG000|Washout Period 1|COPD Exacerbation|1|||
131439054|NCT03137992|473233393|FG001|Washout Period 1|COPD Exacerbation|1|||
131439055|NCT03137992|473233394|FG002|Washout Period 1|COPD Exacerbation|1|||
131439056|NCT03137992|473233395|FG003|Washout Period 1|COPD Exacerbation|0|||
131439057|NCT03137992|473233396|FG004|Washout Period 1|COPD Exacerbation|1|||
131439058|NCT03137992|473233397|FG005|Washout Period 1|COPD Exacerbation|1|||
131439059|NCT03137992|473233392|FG000|Washout Period 1|Subject Noncompliance|1|||
131439060|NCT03137992|473233393|FG001|Washout Period 1|Subject Noncompliance|0|||
131439061|NCT03137992|473233394|FG002|Washout Period 1|Subject Noncompliance|0|||
131439062|NCT03137992|473233395|FG003|Washout Period 1|Subject Noncompliance|0|||
131439063|NCT03137992|473233396|FG004|Washout Period 1|Subject Noncompliance|1|||
131439064|NCT03137992|473233397|FG005|Washout Period 1|Subject Noncompliance|0|||
131439065|NCT03137992|473233392|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
131439066|NCT03137992|473233393|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
131439067|NCT03137992|473233394|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
131439068|NCT03137992|473233395|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
131439069|NCT03137992|473233396|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
131439070|NCT03137992|473233397|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
131439071|NCT03137992|473233392|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
131439072|NCT03137992|473233393|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
131439073|NCT03137992|473233394|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
131439074|NCT03137992|473233395|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
131439075|NCT03137992|473233396|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
131439076|NCT03137992|473233397|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
131439077|NCT03137992|473233392|FG000|Period 2 (Visit 3)|Adverse Event|0|||
131439078|NCT03137992|473233393|FG001|Period 2 (Visit 3)|Adverse Event|1|||
131439079|NCT03137992|473233394|FG002|Period 2 (Visit 3)|Adverse Event|0|||
131439080|NCT03137992|473233395|FG003|Period 2 (Visit 3)|Adverse Event|0|||
131439081|NCT03137992|473233396|FG004|Period 2 (Visit 3)|Adverse Event|0|||
131439082|NCT03137992|473233397|FG005|Period 2 (Visit 3)|Adverse Event|0|||
131439083|NCT03137992|473233392|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
131591356|NCT03526861|473794217|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131439084|NCT03137992|473233393|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
131439085|NCT03137992|473233394|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
131439086|NCT03137992|473233395|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
131439087|NCT03137992|473233396|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
131439088|NCT03137992|473233397|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
131439089|NCT03137992|473233392|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
131439090|NCT03137992|473233393|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
131439091|NCT03137992|473233394|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
131439092|NCT03137992|473233395|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
131439093|NCT03137992|473233396|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
131439094|NCT03137992|473233397|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
131439095|NCT03137992|473233392|FG000|Washout Period 2|COPD Exacerbation|1|||
131439096|NCT03137992|473233393|FG001|Washout Period 2|COPD Exacerbation|1|||
131439097|NCT03137992|473233394|FG002|Washout Period 2|COPD Exacerbation|0|||
131439098|NCT03137992|473233395|FG003|Washout Period 2|COPD Exacerbation|0|||
131439099|NCT03137992|473233396|FG004|Washout Period 2|COPD Exacerbation|1|||
131439100|NCT03137992|473233397|FG005|Washout Period 2|COPD Exacerbation|0|||
131439101|NCT03137992|473233392|FG000|Washout Period 2|Subject Non-compliance|0|||
131439102|NCT03137992|473233393|FG001|Washout Period 2|Subject Non-compliance|1|||
131439103|NCT03137992|473233394|FG002|Washout Period 2|Subject Non-compliance|0|||
131439104|NCT03137992|473233395|FG003|Washout Period 2|Subject Non-compliance|0|||
131439105|NCT03137992|473233396|FG004|Washout Period 2|Subject Non-compliance|0|||
131439106|NCT03137992|473233397|FG005|Washout Period 2|Subject Non-compliance|0|||
131439107|NCT03137992|473233392|FG000|Washout Period 2|Adverse Event|0|||
131439108|NCT03137992|473233393|FG001|Washout Period 2|Adverse Event|0|||
131439109|NCT03137992|473233394|FG002|Washout Period 2|Adverse Event|0|||
131439110|NCT03137992|473233395|FG003|Washout Period 2|Adverse Event|1|||
131439111|NCT03137992|473233396|FG004|Washout Period 2|Adverse Event|1|||
131439112|NCT03137992|473233397|FG005|Washout Period 2|Adverse Event|0|||
131439113|NCT03137992|473233392|FG000|Washout Period 2|Withdrawal by Subject|1|||
131439114|NCT03137992|473233393|FG001|Washout Period 2|Withdrawal by Subject|0|||
131439115|NCT03137992|473233394|FG002|Washout Period 2|Withdrawal by Subject|0|||
131439116|NCT03137992|473233395|FG003|Washout Period 2|Withdrawal by Subject|0|||
131439117|NCT03137992|473233396|FG004|Washout Period 2|Withdrawal by Subject|1|||
131439118|NCT03137992|473233397|FG005|Washout Period 2|Withdrawal by Subject|0|||
131439119|NCT03137992|473233392|FG000|Washout Period 2|Sponsor Decision|0|||
131439120|NCT03137992|473233393|FG001|Washout Period 2|Sponsor Decision|0|||
131439121|NCT03137992|473233394|FG002|Washout Period 2|Sponsor Decision|0|||
131439122|NCT03137992|473233395|FG003|Washout Period 2|Sponsor Decision|0|||
131591357|NCT03526861|473794218|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591358|NCT03526861|473794219|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591359|NCT03526861|473794220|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591360|NCT03526861|473794221|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591361|NCT03526861|473794222|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591362|NCT03526861|473794223|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591363|NCT03526861|473794224|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131591364|NCT03526861|473794225|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
131591365|NCT03526861|473794217|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591366|NCT03526861|473794218|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591367|NCT03526861|473794219|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591368|NCT03526861|473794220|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591369|NCT03526861|473794221|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591370|NCT03526861|473794222|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591371|NCT03526861|473794223|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131591372|NCT03526861|473794224|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131706138|NCT02154425|474205552|FG000|Screening Period|Adverse Event|1|||
131706139|NCT02211261|474205559|FG000|Overall Study|Withdrawal by Subject|0|||
131439123|NCT03137992|473233396|FG004|Washout Period 2|Sponsor Decision|0|||
131439124|NCT03137992|473233397|FG005|Washout Period 2|Sponsor Decision|1|||
131439125|NCT03137992|473233392|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
131439126|NCT03137992|473233393|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
131439127|NCT03137992|473233394|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
131439128|NCT03137992|473233395|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
131439129|NCT03137992|473233396|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
131439130|NCT03137992|473233397|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
131439131|NCT03137992|473233392|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
131591373|NCT03526861|473794225|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
131591374|NCT03526861|473794217|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591375|NCT03526861|473794218|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591376|NCT03526861|473794219|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591377|NCT03526861|473794220|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591378|NCT03526861|473794221|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591379|NCT03526861|473794222|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591380|NCT03526861|473794223|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591381|NCT03526861|473794224|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131591382|NCT03526861|473794225|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
131591383|NCT02814838|473794234|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
131591384|NCT02814838|473794235|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
131591385|NCT02814838|473794234|FG000|Overall Study|Consent withdrawal|1|||
131591386|NCT02814838|473794235|FG001|Overall Study|Consent withdrawal|1|||
131591387|NCT03912831|473794237|FG000|Overall Study|Death|1|||
131591388|NCT03912831|473794238|FG001|Overall Study|Death|1|||
131591389|NCT03912831|473794239|FG002|Overall Study|Death|1|||
131591390|NCT03912831|473794240|FG003|Overall Study|Death|1|||
131591391|NCT03912831|473794241|FG004|Overall Study|Death|1|||
131591392|NCT03912831|473794242|FG005|Overall Study|Death|1|||
131591393|NCT03912831|473794237|FG000|Overall Study|Reason not Specified|0|||
131591394|NCT03912831|473794238|FG001|Overall Study|Reason not Specified|0|||
131591395|NCT03912831|473794239|FG002|Overall Study|Reason not Specified|0|||
131591396|NCT03912831|473794240|FG003|Overall Study|Reason not Specified|0|||
131591397|NCT03912831|473794241|FG004|Overall Study|Reason not Specified|1|||
131591398|NCT03912831|473794242|FG005|Overall Study|Reason not Specified|0|||
131591399|NCT03912831|473794237|FG000|Overall Study|Withdrawal by Participant|0|||
131591400|NCT03912831|473794238|FG001|Overall Study|Withdrawal by Participant|0|||
131591401|NCT03912831|473794239|FG002|Overall Study|Withdrawal by Participant|0|||
131591402|NCT03912831|473794240|FG003|Overall Study|Withdrawal by Participant|0|||
131591403|NCT03912831|473794241|FG004|Overall Study|Withdrawal by Participant|1|||
131591404|NCT03912831|473794242|FG005|Overall Study|Withdrawal by Participant|0|||
131591405|NCT03527160|473794243|FG000|Overall Study|No urine collected|13|||
131591406|NCT03527160|473794243|FG000|Overall Study|No clinical serum creatinine collected|6|||
131591407|NCT03527160|473794243|FG000|Overall Study|Did not meet inclusion|2|||
131591408|NCT02910713|473794244|FG000|Overall Study|Protocol Violation|2|||
131591409|NCT02910713|473794244|FG000|Overall Study|Subject Choice|4|||
131591410|NCT02910713|473794244|FG000|Overall Study|Received One Application|10|||
131591411|NCT02910713|473794244|FG000|Overall Study|Received Neither Application|18|||
131591412|NCT02910713|473794244|FG000|Overall Study|Enrollment cap|7|||
131591413|NCT02910713|473794244|FG000|Overall Study|Investigator Discretion|1|||
131591414|NCT03767517|473794246|FG000|Overall Study|Lost to Follow-up|16|||
131591415|NCT03767517|473794247|FG001|Overall Study|Lost to Follow-up|10|||
131591416|NCT03767517|473794246|FG000|Overall Study|Death|2|||
131591417|NCT03767517|473794247|FG001|Overall Study|Death|3|||
131591418|NCT05338086|473795598|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
131591419|NCT05338086|473795599|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131591420|NCT05338086|473795600|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131591421|NCT05338086|473795601|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131591422|NCT05338086|473795602|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131591423|NCT05338086|473795598|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
131591424|NCT05338086|473795599|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
131591425|NCT05338086|473795600|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
131591426|NCT05338086|473795601|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
131591427|NCT05338086|473795602|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
131591428|NCT05338086|473795598|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
131591429|NCT05338086|473795599|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
131591430|NCT05338086|473795600|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
131591431|NCT05338086|473795601|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
131653622|NCT03842228|474018421|FG000|Overall Study|Progression|8|||
131591432|NCT05338086|473795602|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
131591433|NCT05338086|473795598|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
131591434|NCT05338086|473795599|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131591435|NCT05338086|473795600|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131591436|NCT05338086|473795601|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131591437|NCT05338086|473795602|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131591438|NCT05338086|473795598|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
131591439|NCT05338086|473795599|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
131591440|NCT05338086|473795600|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
131591441|NCT05338086|473795601|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
131591442|NCT05338086|473795602|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
131591443|NCT05338086|473795598|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
131591444|NCT05338086|473795599|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
131591445|NCT05338086|473795600|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
131591446|NCT05338086|473795601|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
131591447|NCT05338086|473795602|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
131591448|NCT05338086|473795598|FG000|Transition Period (M12 to M18)|Death|0|||
131591449|NCT05338086|473795599|FG001|Transition Period (M12 to M18)|Death|0|||
131591450|NCT05338086|473795600|FG002|Transition Period (M12 to M18)|Death|1|||
131591451|NCT05338086|473795601|FG003|Transition Period (M12 to M18)|Death|0|||
131591452|NCT05338086|473795602|FG004|Transition Period (M12 to M18)|Death|0|||
131591453|NCT05338086|473795598|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
131591454|NCT05338086|473795599|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
131591455|NCT05338086|473795600|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
131591456|NCT05338086|473795601|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
131591457|NCT05338086|473795602|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
131591458|NCT05338086|473795598|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
131591459|NCT05338086|473795599|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
131591460|NCT05338086|473795600|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
131591461|NCT05338086|473795601|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
131591462|NCT05338086|473795602|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
131591463|NCT05338086|473795598|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
131591464|NCT05338086|473795599|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
131591465|NCT05338086|473795600|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
131591466|NCT05338086|473795601|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
131591467|NCT05338086|473795602|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
131591468|NCT03940703|473795603|FG000|Overall Study|Still under treatment|31|||
131591469|NCT03940703|473795604|FG001|Overall Study|Still under treatment|0|||
131591470|NCT05386355|473795605|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131591471|NCT05386355|473795606|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131591472|NCT05386355|473795607|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131591473|NCT05386355|473795608|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131591474|NCT06143670|473795609|FG000|Overall Study|Lost to Follow-up|0|||
131591475|NCT06143670|473795610|FG001|Overall Study|Lost to Follow-up|1|||
131591476|NCT06143670|473795609|FG000|Overall Study|Withdrawal by Subject|3|||
131591477|NCT06143670|473795610|FG001|Overall Study|Withdrawal by Subject|0|||
131591478|NCT03833245|473795616|FG000|Overall Study|Death|0|||
131591479|NCT03833245|473795617|FG001|Overall Study|Death|1|||
131591480|NCT03775109|473795618|FG000|Overall Study|Adverse Event|1|||
131591481|NCT03775109|473795619|FG001|Overall Study|Adverse Event|0|||
131591482|NCT03775109|473795618|FG000|Overall Study|COVID-19 outbreak|2|||
131591483|NCT03775109|473795619|FG001|Overall Study|COVID-19 outbreak|0|||
131591484|NCT03775109|473795618|FG000|Overall Study|Lost to Follow-up|0|||
131591485|NCT03775109|473795619|FG001|Overall Study|Lost to Follow-up|2|||
131591486|NCT03775109|473795618|FG000|Overall Study|Withdrawal by Subject|1|||
131591487|NCT03775109|473795619|FG001|Overall Study|Withdrawal by Subject|1|||
131591488|NCT03775109|473795618|FG000|Overall Study|Death|0|||
131591489|NCT03775109|473795619|FG001|Overall Study|Death|1|||
131591490|NCT03775109|473795618|FG000|Overall Study|Lack of Efficacy|1|||
131591491|NCT03775109|473795619|FG001|Overall Study|Lack of Efficacy|0|||
131591492|NCT03347383|473795620|FG000|Overall Study|Death|39|||
131591493|NCT03347383|473795620|FG000|Overall Study|Withdrawal by Subject|3|||
131591494|NCT03347383|473795620|FG000|Overall Study|Lost to Follow-up|9|||
131591495|NCT05691452|473795628|FG000|Overall Study|Withdrawal by Subject|1|||
131591496|NCT05691452|473795629|FG001|Overall Study|Withdrawal by Subject|1|||
131591497|NCT05691452|473795630|FG002|Overall Study|Withdrawal by Subject|0|||
131706140|NCT02211261|474205560|FG001|Overall Study|Withdrawal by Subject|0|||
131591498|NCT05691452|473795628|FG000|Overall Study|Physician Decision|1|||
131591499|NCT05691452|473795629|FG001|Overall Study|Physician Decision|0|||
131591500|NCT05691452|473795630|FG002|Overall Study|Physician Decision|0|||
131591501|NCT05691452|473795628|FG000|Overall Study|Lost to Follow-up|0|||
131591502|NCT05691452|473795629|FG001|Overall Study|Lost to Follow-up|0|||
131591503|NCT05691452|473795630|FG002|Overall Study|Lost to Follow-up|1|||
131591504|NCT05691452|473795628|FG000|Overall Study|Adverse Event|0|||
131591505|NCT05691452|473795629|FG001|Overall Study|Adverse Event|0|||
131591506|NCT05691452|473795630|FG002|Overall Study|Adverse Event|1|||
131591507|NCT04173663|473795636|FG000|Overall Study|Withdrawal by Subject|1|||
131591508|NCT04173663|473795637|FG001|Overall Study|Withdrawal by Subject|6|||
131591509|NCT04173663|473795636|FG000|Overall Study|Lost to Follow-up|17|||
131591510|NCT04173663|473795637|FG001|Overall Study|Lost to Follow-up|24|||
131591511|NCT01757665|473795640|FG000|Overall Study|Still on Study - Visit Completed|240|||
131591512|NCT01757665|473795641|FG001|Overall Study|Still on Study - Visit Completed|30|||
131591513|NCT01757665|473795640|FG000|Overall Study|Still on Study - Visit Pending|398|||
131591514|NCT01757665|473795641|FG001|Overall Study|Still on Study - Visit Pending|40|||
131591515|NCT01757665|473795640|FG000|Overall Study|Still on Study - Missed Visit|14|||
131591516|NCT01757665|473795641|FG001|Overall Study|Still on Study - Missed Visit|1|||
131591517|NCT01757665|473795640|FG000|Overall Study|Death|25|||
131591518|NCT01757665|473795641|FG001|Overall Study|Death|8|||
131591519|NCT01757665|473795640|FG000|Overall Study|Explant|1|||
131591520|NCT01757665|473795641|FG001|Overall Study|Explant|2|||
131591521|NCT01757665|473795640|FG000|Overall Study|Withdrawal by Subject|10|||
131591522|NCT01757665|473795641|FG001|Overall Study|Withdrawal by Subject|0|||
131591523|NCT01757665|473795640|FG000|Overall Study|Lost to Follow-up|1|||
131591524|NCT01757665|473795641|FG001|Overall Study|Lost to Follow-up|1|||
131591525|NCT01757665|473795640|FG000|Overall Study|Not Implanted with Device|5|||
131591526|NCT01757665|473795641|FG001|Overall Study|Not Implanted with Device|1|||
131591527|NCT05816551|473795644|FG000|Overall Study|Withdrawal by Subject|0|||
131591528|NCT05816551|473795645|FG001|Overall Study|Withdrawal by Subject|1|||
131591529|NCT05816551|473795644|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
131591530|NCT05816551|473795645|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
131591531|NCT04549168|473795652|FG000|Randomization Phase|Adverse Event|0|||
131591532|NCT04549168|473795653|FG001|Randomization Phase|Adverse Event|0|||
131591533|NCT04549168|473795654|FG002|Randomization Phase|Adverse Event|1|||
131591534|NCT04549168|473795652|FG000|Randomization Phase|Other|0|||
131591535|NCT04549168|473795653|FG001|Randomization Phase|Other|2|||
131591536|NCT04549168|473795654|FG002|Randomization Phase|Other|0|||
131591537|NCT04549168|473795652|FG000|Randomization Phase|Withdrawal by Subject|0|||
131591538|NCT04549168|473795653|FG001|Randomization Phase|Withdrawal by Subject|2|||
131591539|NCT04549168|473795654|FG002|Randomization Phase|Withdrawal by Subject|1|||
131591540|NCT02662062|473795658|FG000|Overall Study|Withdrawal by Subject|1|||
131591541|NCT06311084|473795659|FG000|Overall Study|Lost to Follow-up|14|||
131591542|NCT03988634|473795660|FG000|Double-Blind|Adverse Event|4|||
131591543|NCT03988634|473795661|FG001|Double-Blind|Adverse Event|0|||
131591544|NCT03988634|473795662|FG002|Double-Blind|Adverse Event|0|||
131791364|NCT00871169|474518670|FG000|Overall Study|Protocol Violation|1|||
131791365|NCT00871169|474518670|FG000|Overall Study|Patient did not receive study treatment|2|||
131791366|NCT00252187|474518671|FG000|Overall Study|Adverse Event|3|||
131791367|NCT00252187|474518672|FG001|Overall Study|Adverse Event|1|||
131791368|NCT00252187|474518671|FG000|Overall Study|Withdrawal by Subject|1|||
131591545|NCT03988634|473795660|FG000|Double-Blind|Death|18|||
131591546|NCT03988634|473795661|FG001|Double-Blind|Death|26|||
131591547|NCT03988634|473795662|FG002|Double-Blind|Death|0|||
131591548|NCT03988634|473795660|FG000|Double-Blind|Lost to Follow-up|6|||
131791369|NCT00252187|474518672|FG001|Overall Study|Withdrawal by Subject|0|||
131791370|NCT01875445|474518673|FG000|Overall Study|Lost to Follow-up|5|||
131791371|NCT01875445|474518674|FG001|Overall Study|Lost to Follow-up|0|||
131791372|NCT01875445|474518673|FG000|Overall Study|Withdrawal by Subject|2|||
131791373|NCT01875445|474518674|FG001|Overall Study|Withdrawal by Subject|0|||
131899084|NCT00758498|474917499|FG002|Overall Study|Adverse Event|3|||
131791374|NCT00210626|474518675|FG000|Overall Study|Adverse Event|1|||
131899085|NCT00758498|474917497|FG000|Overall Study|Subject legally detained out of state|1|||
131899086|NCT00758498|474917498|FG001|Overall Study|Subject legally detained out of state|0|||
131791375|NCT00210626|474518676|FG001|Overall Study|Adverse Event|2|||
131591549|NCT03988634|473795661|FG001|Double-Blind|Lost to Follow-up|7|||
131591550|NCT03988634|473795662|FG002|Double-Blind|Lost to Follow-up|0|||
131591551|NCT03988634|473795660|FG000|Double-Blind|Physician Decision|9|||
131591552|NCT03988634|473795661|FG001|Double-Blind|Physician Decision|5|||
131591553|NCT03988634|473795662|FG002|Double-Blind|Physician Decision|0|||
131591554|NCT03988634|473795660|FG000|Double-Blind|Subject decision|24|||
131591555|NCT03988634|473795661|FG001|Double-Blind|Subject decision|13|||
131591556|NCT03988634|473795662|FG002|Double-Blind|Subject decision|0|||
131591557|NCT03988634|473795660|FG000|Open-Label|Adverse Event|0|||
131591558|NCT03988634|473795661|FG001|Open-Label|Adverse Event|0|||
131591559|NCT03988634|473795662|FG002|Open-Label|Adverse Event|7|||
131591560|NCT03988634|473795660|FG000|Open-Label|Physician Decision|0|||
131591561|NCT03988634|473795661|FG001|Open-Label|Physician Decision|0|||
131591562|NCT03988634|473795662|FG002|Open-Label|Physician Decision|1|||
131591563|NCT03988634|473795660|FG000|Open-Label|Technical problems|0|||
131591564|NCT03988634|473795661|FG001|Open-Label|Technical problems|0|||
131591565|NCT03988634|473795662|FG002|Open-Label|Technical problems|1|||
131591566|NCT04725240|473795663|FG000|Overall Study|Adverse Event|2|||
131591567|NCT00676715|473795669|FG000|Treatment Period (TP)|Adverse Event|0|||
131591568|NCT00676715|473795670|FG001|Treatment Period (TP)|Adverse Event|3|||
131591569|NCT00676715|473795671|FG002|Treatment Period (TP)|Adverse Event|2|||
131591570|NCT00676715|473795672|FG003|Treatment Period (TP)|Adverse Event|2|||
131591571|NCT00676715|473795669|FG000|Treatment Period (TP)|Death|0|||
131591572|NCT00676715|473795670|FG001|Treatment Period (TP)|Death|0|||
131591573|NCT00676715|473795671|FG002|Treatment Period (TP)|Death|1|||
131591574|NCT00676715|473795672|FG003|Treatment Period (TP)|Death|0|||
131591575|NCT00676715|473795669|FG000|Treatment Period (TP)|Failure to return|1|||
131591576|NCT00676715|473795670|FG001|Treatment Period (TP)|Failure to return|0|||
131591577|NCT00676715|473795671|FG002|Treatment Period (TP)|Failure to return|0|||
131591578|NCT00676715|473795672|FG003|Treatment Period (TP)|Failure to return|0|||
131591579|NCT00676715|473795669|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
131591580|NCT00676715|473795670|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
131591581|NCT00676715|473795671|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
131591582|NCT00676715|473795672|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
131591583|NCT00676715|473795669|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
131591584|NCT00676715|473795670|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
131591585|NCT00676715|473795671|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
131591586|NCT00676715|473795672|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
131591587|NCT00676715|473795669|FG000|Treatment Period (TP)|Withdrew consent|3|||
131591588|NCT00676715|473795670|FG001|Treatment Period (TP)|Withdrew consent|3|||
131591589|NCT00676715|473795671|FG002|Treatment Period (TP)|Withdrew consent|3|||
131591590|NCT00676715|473795672|FG003|Treatment Period (TP)|Withdrew consent|3|||
131591591|NCT00676715|473795669|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
131591592|NCT00676715|473795670|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
131591593|NCT00676715|473795671|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
131591594|NCT00676715|473795672|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
131591595|NCT00676715|473795669|FG000|Treatment Period (TP)|Administrative|0|||
131591596|NCT00676715|473795670|FG001|Treatment Period (TP)|Administrative|0|||
131591597|NCT00676715|473795671|FG002|Treatment Period (TP)|Administrative|0|||
131591598|NCT00676715|473795672|FG003|Treatment Period (TP)|Administrative|1|||
131591599|NCT00676715|473795669|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
131591600|NCT00676715|473795670|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
131591601|NCT00676715|473795671|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
131591602|NCT00676715|473795672|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
131591603|NCT00676715|473795669|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
131591604|NCT00676715|473795670|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
131591605|NCT00676715|473795671|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
131591606|NCT00676715|473795672|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
131591607|NCT00676715|473795669|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
131591608|NCT00676715|473795670|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
131591609|NCT00676715|473795671|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
131591610|NCT00676715|473795672|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
131791376|NCT00210626|474518675|FG000|Overall Study|Protocol Violation|1|||
131591611|NCT00676715|473795669|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
131591612|NCT00676715|473795670|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
131591613|NCT00676715|473795671|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
131591614|NCT00676715|473795672|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
131591615|NCT00676715|473795669|FG000|Treatment-free Period (TFP)|Death|1|||
131591616|NCT00676715|473795670|FG001|Treatment-free Period (TFP)|Death|1|||
131591617|NCT00676715|473795671|FG002|Treatment-free Period (TFP)|Death|1|||
131591618|NCT00676715|473795672|FG003|Treatment-free Period (TFP)|Death|0|||
131591619|NCT00676715|473795669|FG000|Open Label Extension (OLE)|Reason not provided|3|||
131591620|NCT00676715|473795670|FG001|Open Label Extension (OLE)|Reason not provided|4|||
131591621|NCT00676715|473795671|FG002|Open Label Extension (OLE)|Reason not provided|1|||
131591622|NCT00676715|473795672|FG003|Open Label Extension (OLE)|Reason not provided|4|||
131591623|NCT00676715|473795669|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
131591624|NCT00676715|473795670|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
131591625|NCT00676715|473795671|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
131591626|NCT00676715|473795672|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
131591627|NCT00676715|473795669|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
131591628|NCT00676715|473795670|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
131591629|NCT00676715|473795671|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
131591630|NCT00676715|473795672|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
131591631|NCT00676715|473795669|FG000|Open Label Extension (OLE)|Adverse Event|0|||
131591632|NCT00676715|473795670|FG001|Open Label Extension (OLE)|Adverse Event|3|||
131591633|NCT00676715|473795671|FG002|Open Label Extension (OLE)|Adverse Event|1|||
131591634|NCT00676715|473795672|FG003|Open Label Extension (OLE)|Adverse Event|0|||
131591635|NCT00676715|473795669|FG000|Open Label Extension (OLE)|Death|2|||
131591636|NCT00676715|473795670|FG001|Open Label Extension (OLE)|Death|0|||
131591637|NCT00676715|473795671|FG002|Open Label Extension (OLE)|Death|2|||
131591638|NCT00676715|473795672|FG003|Open Label Extension (OLE)|Death|2|||
131591639|NCT01820260|473795673|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591640|NCT01820260|473795674|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591641|NCT01820260|473795675|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591642|NCT01820260|473795676|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591643|NCT01820260|473795677|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591644|NCT01820260|473795678|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591645|NCT01820260|473795679|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
131591646|NCT01820260|473795680|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591647|NCT01820260|473795681|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591648|NCT01820260|473795682|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591649|NCT01820260|473795683|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591650|NCT01820260|473795684|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591651|NCT01820260|473795685|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591652|NCT01820260|473795686|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131591653|NCT01820260|473795673|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591654|NCT01820260|473795674|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591655|NCT01820260|473795675|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591656|NCT01820260|473795676|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591657|NCT01820260|473795677|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591658|NCT01820260|473795678|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591659|NCT01820260|473795679|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591660|NCT01820260|473795680|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591661|NCT01820260|473795681|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591662|NCT01820260|473795682|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
131591663|NCT01820260|473795683|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591664|NCT01820260|473795684|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591665|NCT01820260|473795685|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591666|NCT01820260|473795686|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131591667|NCT04831281|473795688|FG000|Overall Study|Adverse Event|1|||
131591668|NCT04831281|473795689|FG001|Overall Study|Adverse Event|0|||
131591669|NCT04831281|473795690|FG002|Overall Study|Adverse Event|3|||
131591670|NCT04831281|473795688|FG000|Overall Study|Withdrawal by Subject|0|||
131591671|NCT04831281|473795689|FG001|Overall Study|Withdrawal by Subject|1|||
131591672|NCT04831281|473795690|FG002|Overall Study|Withdrawal by Subject|2|||
131591673|NCT04831281|473795688|FG000|Overall Study|Undetermined|1|||
131591674|NCT04831281|473795689|FG001|Overall Study|Undetermined|1|||
131591675|NCT04831281|473795690|FG002|Overall Study|Undetermined|0|||
131591676|NCT05458011|473795691|FG000|DB Period (12 Weeks)|Adverse Event|2|||
131591677|NCT05458011|473795692|FG001|DB Period (12 Weeks)|Adverse Event|1|||
131591678|NCT05458011|473795693|FG002|DB Period (12 Weeks)|Adverse Event|1|||
131591679|NCT05458011|473795691|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
131591680|NCT05458011|473795692|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
131591681|NCT05458011|473795693|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
131591682|NCT05458011|473795691|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
131591683|NCT05458011|473795692|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
131591684|NCT05458011|473795693|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
131591685|NCT05458011|473795691|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
131706141|NCT02211261|474205561|FG002|Overall Study|Withdrawal by Subject|1|||
131706142|NCT02211261|474205562|FG003|Overall Study|Withdrawal by Subject|0|||
131706143|NCT02211261|474205563|FG004|Overall Study|Withdrawal by Subject|2|||
131706144|NCT02211261|474205564|FG005|Overall Study|Withdrawal by Subject|0|||
131706145|NCT02211261|474205565|FG006|Overall Study|Withdrawal by Subject|0|||
131706146|NCT02211261|474205566|FG007|Overall Study|Withdrawal by Subject|0|||
131706147|NCT02211261|474205567|FG008|Overall Study|Withdrawal by Subject|0|||
131706148|NCT02211261|474205568|FG009|Overall Study|Withdrawal by Subject|0|||
131591686|NCT05458011|473795692|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
131591687|NCT05458011|473795693|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
131591688|NCT05458011|473795691|FG000|OL Period (12 Weeks)|Adverse Event|1|||
131591689|NCT05458011|473795692|FG001|OL Period (12 Weeks)|Adverse Event|2|||
131591690|NCT05458011|473795693|FG002|OL Period (12 Weeks)|Adverse Event|1|||
131591691|NCT05458011|473795691|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
131591692|NCT05458011|473795692|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
131591693|NCT05458011|473795693|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
131591694|NCT05229120|473795694|FG000|Overall Study|Withdrawal by Subject|8|||
131591695|NCT05862870|473795697|FG000|Overall Study|Lost to Follow-up|3|||
131591696|NCT03385629|473795698|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
131591697|NCT03385629|473795699|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
131591698|NCT03385629|473795698|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
131591699|NCT03385629|473795699|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
131591700|NCT03385629|473795698|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
131591701|NCT03385629|473795699|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
131591702|NCT05633407|473795703|FG000|Overall Study|Physician Decision|2|||
131591703|NCT05633407|473795704|FG001|Overall Study|Physician Decision|0|||
131591704|NCT05633407|473795703|FG000|Overall Study|Adverse Event|1|||
131591705|NCT05633407|473795704|FG001|Overall Study|Adverse Event|0|||
131591706|NCT05633407|473795703|FG000|Overall Study|Withdrawal by Subject|1|||
131591707|NCT05633407|473795704|FG001|Overall Study|Withdrawal by Subject|0|||
131591708|NCT05633407|473795703|FG000|Overall Study|Other|1|||
131591709|NCT05633407|473795704|FG001|Overall Study|Other|1|||
131591710|NCT04842643|473796921|FG000|Overall Study|Physician Decision|1|||
131591711|NCT04842643|473796921|FG000|Overall Study|Other|1|||
131591712|NCT03484702|473796922|FG000|Treatment Period|Death|3|||
131591713|NCT03484702|473796923|FG001|Treatment Period|Death|1|||
131591714|NCT03484702|473796924|FG002|Treatment Period|Death|0|||
131591715|NCT03484702|473796925|FG003|Treatment Period|Death|0|||
131591716|NCT03484702|473796926|FG004|Treatment Period|Death|0|||
131591717|NCT03484702|473796927|FG005|Treatment Period|Death|0|||
131591718|NCT03484702|473796922|FG000|Treatment Period|Adverse Event|1|||
131591719|NCT03484702|473796923|FG001|Treatment Period|Adverse Event|0|||
131591720|NCT03484702|473796924|FG002|Treatment Period|Adverse Event|0|||
131591721|NCT03484702|473796925|FG003|Treatment Period|Adverse Event|0|||
131591722|NCT03484702|473796926|FG004|Treatment Period|Adverse Event|0|||
131591723|NCT03484702|473796927|FG005|Treatment Period|Adverse Event|0|||
131591724|NCT03484702|473796922|FG000|Treatment Period|Participant Withdrew from Study|0|||
131591725|NCT03484702|473796923|FG001|Treatment Period|Participant Withdrew from Study|1|||
131591726|NCT03484702|473796924|FG002|Treatment Period|Participant Withdrew from Study|0|||
131591727|NCT03484702|473796925|FG003|Treatment Period|Participant Withdrew from Study|0|||
131591728|NCT03484702|473796926|FG004|Treatment Period|Participant Withdrew from Study|0|||
131591729|NCT03484702|473796927|FG005|Treatment Period|Participant Withdrew from Study|0|||
131591730|NCT03484702|473796922|FG000|Treatment Period|Physician Decision|0|||
131591731|NCT03484702|473796923|FG001|Treatment Period|Physician Decision|1|||
131591732|NCT03484702|473796924|FG002|Treatment Period|Physician Decision|0|||
131591733|NCT03484702|473796925|FG003|Treatment Period|Physician Decision|0|||
131591734|NCT03484702|473796926|FG004|Treatment Period|Physician Decision|0|||
131591735|NCT03484702|473796927|FG005|Treatment Period|Physician Decision|1|||
131591736|NCT04850807|473796934|FG000|Overall Study|Death|50|||
131591737|NCT04850807|473796935|FG001|Overall Study|Death|55|||
131591738|NCT04850807|473796934|FG000|Overall Study|Discharged|17|||
131591739|NCT04850807|473796935|FG001|Overall Study|Discharged|13|||
131591740|NCT04850807|473796934|FG000|Overall Study|Incomplete baseline data|3|||
131591741|NCT04850807|473796935|FG001|Overall Study|Incomplete baseline data|2|||
131591742|NCT04178733|473796936|FG000|Overall Study|Investigator Decision|0|||
131591743|NCT04178733|473796937|FG001|Overall Study|Investigator Decision|0|||
131591744|NCT04178733|473796938|FG002|Overall Study|Investigator Decision|0|||
131591745|NCT04178733|473796939|FG003|Overall Study|Investigator Decision|1|||
131591746|NCT04178733|473796940|FG004|Overall Study|Investigator Decision|2|||
131591747|NCT02651324|473796943|FG000|Overall Study|drug not administered, due dispensing issue|1|||
131591748|NCT02651324|473796944|FG001|Overall Study|drug not administered, due dispensing issue|0|||
131591749|NCT02287311|473796948|FG000|Cohort 1: Dose Level 1|Death|2|||
131591750|NCT02287311|473796949|FG001|Cohort 1: Dose Level 1|Death|0|||
131591751|NCT02287311|473796950|FG002|Cohort 1: Dose Level 1|Death|0|||
131591752|NCT02287311|473796951|FG003|Cohort 1: Dose Level 1|Death|3|||
131591753|NCT02287311|473796952|FG004|Cohort 1: Dose Level 1|Death|0|||
131591754|NCT02287311|473796953|FG005|Cohort 1: Dose Level 1|Death|0|||
131591755|NCT02287311|473796954|FG006|Cohort 1: Dose Level 1|Death|1|||
131591756|NCT02287311|473796955|FG007|Cohort 1: Dose Level 1|Death|0|||
131591757|NCT02287311|473796956|FG008|Cohort 1: Dose Level 1|Death|0|||
131591758|NCT02287311|473796948|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131706149|NCT02211261|474205569|FG010|Overall Study|Withdrawal by Subject|0|||
131706150|NCT02211261|474205559|FG000|Overall Study|Other|0|||
131706151|NCT02211261|474205560|FG001|Overall Study|Other|0|||
131706152|NCT02211261|474205561|FG002|Overall Study|Other|0|||
131706153|NCT02211261|474205562|FG003|Overall Study|Other|0|||
131706154|NCT02211261|474205563|FG004|Overall Study|Other|0|||
131706155|NCT02211261|474205564|FG005|Overall Study|Other|1|||
131706156|NCT02211261|474205565|FG006|Overall Study|Other|0|||
131706157|NCT02211261|474205566|FG007|Overall Study|Other|0|||
131706158|NCT02211261|474205567|FG008|Overall Study|Other|0|||
131706159|NCT02211261|474205568|FG009|Overall Study|Other|2|||
131706160|NCT02211261|474205569|FG010|Overall Study|Other|0|||
131706161|NCT02211261|474205559|FG000|Overall Study|Lost to Follow-up|0|||
131706162|NCT02211261|474205560|FG001|Overall Study|Lost to Follow-up|0|||
131706163|NCT02211261|474205561|FG002|Overall Study|Lost to Follow-up|0|||
131706164|NCT02211261|474205562|FG003|Overall Study|Lost to Follow-up|0|||
131706165|NCT02211261|474205563|FG004|Overall Study|Lost to Follow-up|0|||
131706166|NCT02211261|474205564|FG005|Overall Study|Lost to Follow-up|0|||
131706167|NCT02211261|474205565|FG006|Overall Study|Lost to Follow-up|0|||
131706168|NCT02211261|474205566|FG007|Overall Study|Lost to Follow-up|1|||
131706169|NCT02211261|474205567|FG008|Overall Study|Lost to Follow-up|0|||
131706170|NCT02211261|474205568|FG009|Overall Study|Lost to Follow-up|0|||
131706171|NCT02211261|474205569|FG010|Overall Study|Lost to Follow-up|0|||
131706172|NCT04897867|474205573|FG000|Overall Study|Withdrawal of Consent|1|||
131706173|NCT04897867|474205573|FG000|Overall Study|Pregnancy|1|||
131706174|NCT04897867|474205573|FG000|Overall Study|Lost to Follow-up|7|||
131706175|NCT04897867|474205573|FG000|Overall Study|Reason not Specified|2|||
131706176|NCT02908516|474205574|FG000|Overall Study|Study Terminated|3|||
131706177|NCT02908516|474205575|FG001|Overall Study|Study Terminated|3|||
131706178|NCT00565617|474205578|FG000|Overall Study|Withdrawal by Subject|1|||
131706179|NCT01078805|474205581|FG000|Overall Study|Clinically significant abnormal lab|5|||
131706180|NCT01078805|474205581|FG000|Overall Study|Death|134|||
131706181|NCT01078805|474205581|FG000|Overall Study|Lost to Follow-up|676|||
131706182|NCT01078805|474205581|FG000|Overall Study|Physician Decision|169|||
131706183|NCT01078805|474205581|FG000|Overall Study|Serious adverse event|26|||
131706184|NCT01078805|474205581|FG000|Overall Study|Sponsor decision|46|||
131706185|NCT01078805|474205581|FG000|Overall Study|Withdrawal by Subject|739|||
131706186|NCT01078805|474205581|FG000|Overall Study|Other|173|||
131706187|NCT01078805|474205581|FG000|Overall Study|Didn't take study drug|82|||
131706188|NCT01609842|474205582|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
131706189|NCT01609842|474205583|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
131706190|NCT02474329|474205591|FG000|Overall Study|Withdraw or did not contribute data.|13|||
131706191|NCT00376961|474207305|FG000|Initial Registration|Adverse Event|1|||
131706192|NCT00376961|474207306|FG001|Initial Registration|Adverse Event|0|||
131706193|NCT00376961|474207305|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
131591759|NCT02287311|473796949|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131591760|NCT02287311|473796950|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131591761|NCT02287311|473796951|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
131706194|NCT00376961|474207306|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131706195|NCT00376961|474207305|FG000|Initial Registration|Progression/relapse|1|||
131591762|NCT02287311|473796952|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131591763|NCT02287311|473796953|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131591764|NCT02287311|473796954|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
131591765|NCT02287311|473796955|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131591766|NCT02287311|473796956|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131591767|NCT02287311|473796948|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
131591768|NCT02287311|473796949|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
131591769|NCT02287311|473796950|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
131591770|NCT02287311|473796951|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
131591771|NCT02287311|473796952|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
131591772|NCT02287311|473796953|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
131591773|NCT02287311|473796954|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
131591774|NCT02287311|473796955|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
131591775|NCT02287311|473796956|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
131591776|NCT02287311|473796948|FG000|Cohort 2: Dose Level 2|Death|0|||
131591777|NCT02287311|473796949|FG001|Cohort 2: Dose Level 2|Death|2|||
131591778|NCT02287311|473796950|FG002|Cohort 2: Dose Level 2|Death|0|||
131591779|NCT02287311|473796951|FG003|Cohort 2: Dose Level 2|Death|0|||
131591780|NCT02287311|473796952|FG004|Cohort 2: Dose Level 2|Death|2|||
131591781|NCT02287311|473796953|FG005|Cohort 2: Dose Level 2|Death|0|||
131591782|NCT02287311|473796954|FG006|Cohort 2: Dose Level 2|Death|0|||
131591783|NCT02287311|473796955|FG007|Cohort 2: Dose Level 2|Death|2|||
131591784|NCT02287311|473796956|FG008|Cohort 2: Dose Level 2|Death|0|||
131591785|NCT02287311|473796948|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591786|NCT02287311|473796949|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591787|NCT02287311|473796950|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591788|NCT02287311|473796951|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591789|NCT02287311|473796952|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
131591790|NCT02287311|473796953|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591791|NCT02287311|473796954|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591792|NCT02287311|473796955|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591793|NCT02287311|473796956|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131591794|NCT02287311|473796948|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591795|NCT02287311|473796949|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
131591796|NCT02287311|473796950|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591797|NCT02287311|473796951|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591798|NCT02287311|473796952|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591799|NCT02287311|473796953|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591800|NCT02287311|473796954|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591801|NCT02287311|473796955|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591802|NCT02287311|473796956|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
131591803|NCT02287311|473796948|FG000|Cohort 3: Dose Level 3|Death|0|||
131591804|NCT02287311|473796949|FG001|Cohort 3: Dose Level 3|Death|0|||
131591805|NCT02287311|473796950|FG002|Cohort 3: Dose Level 3|Death|4|||
131591806|NCT02287311|473796951|FG003|Cohort 3: Dose Level 3|Death|0|||
131591807|NCT02287311|473796952|FG004|Cohort 3: Dose Level 3|Death|0|||
131591808|NCT02287311|473796953|FG005|Cohort 3: Dose Level 3|Death|4|||
131591809|NCT02287311|473796954|FG006|Cohort 3: Dose Level 3|Death|0|||
131591810|NCT02287311|473796955|FG007|Cohort 3: Dose Level 3|Death|0|||
131591811|NCT02287311|473796956|FG008|Cohort 3: Dose Level 3|Death|2|||
131591812|NCT02287311|473796948|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131591813|NCT02287311|473796949|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131791377|NCT00210626|474518676|FG001|Overall Study|Protocol Violation|5|||
131591814|NCT02287311|473796950|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
131591815|NCT02287311|473796951|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131591816|NCT02287311|473796952|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131653623|NCT03842228|474018422|FG001|Overall Study|Progression|1|||
131653624|NCT03842228|474018423|FG002|Overall Study|Progression|7|||
131591817|NCT02287311|473796953|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
131591818|NCT02287311|473796954|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131591819|NCT02287311|473796955|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131591820|NCT02287311|473796956|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131591821|NCT02287311|473796948|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591822|NCT02287311|473796949|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591823|NCT02287311|473796950|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591824|NCT02287311|473796951|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591825|NCT02287311|473796952|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591826|NCT02287311|473796953|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
131591827|NCT02287311|473796954|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591828|NCT02287311|473796955|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131591829|NCT02287311|473796956|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
131591830|NCT03896516|473796957|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
131439132|NCT03137992|473233393|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
131591831|NCT03896516|473796958|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
131591832|NCT03896516|473796957|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
131591833|NCT03896516|473796958|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
131591834|NCT03896516|473796957|FG000|Washout Period|Physician Decision|3|||
131591835|NCT03896516|473796958|FG001|Washout Period|Physician Decision|1|||
131591836|NCT03896516|473796957|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
131591837|NCT03896516|473796958|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
131591838|NCT03713086|473796963|FG000|Overall Study|Withdrawal by Subject|0|||
131591839|NCT03713086|473796964|FG001|Overall Study|Withdrawal by Subject|2|||
131591840|NCT03713086|473796965|FG002|Overall Study|Withdrawal by Subject|1|||
131591841|NCT03713086|473796966|FG003|Overall Study|Withdrawal by Subject|0|||
131591842|NCT03713086|473796963|FG000|Overall Study|Lost to Follow-up|0|||
131591843|NCT03713086|473796964|FG001|Overall Study|Lost to Follow-up|1|||
131591844|NCT03713086|473796965|FG002|Overall Study|Lost to Follow-up|0|||
131591845|NCT03713086|473796966|FG003|Overall Study|Lost to Follow-up|1|||
131591846|NCT02249949|473796968|FG000|Overall Study|Cancelled prior to treatment|2|||
131591847|NCT02097420|473796969|FG000|Overall Study|Death|6|||
131591848|NCT02097420|473796969|FG000|Overall Study|Valve explanted|13|||
131591849|NCT02097420|473796969|FG000|Overall Study|Other Reason|1|||
131591850|NCT03161379|473796977|FG000|Overall Study|Withdrawal by Subject|4|||
131591851|NCT03161379|473796977|FG000|Overall Study|disease progression during chemotherapy|5|||
131591852|NCT03161379|473796977|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
131591853|NCT03161379|473796977|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
131591854|NCT02728076|473796982|FG000|Overall Study|Physician Decision|4|||
131591855|NCT05054374|473796983|FG000|Overall Study|Withdrawal by Subject|1|||
131591856|NCT05054374|473796984|FG001|Overall Study|Withdrawal by Subject|0|||
131591857|NCT05054374|473796985|FG002|Overall Study|Withdrawal by Subject|0|||
131591858|NCT05054374|473796986|FG003|Overall Study|Withdrawal by Subject|0|||
131591859|NCT05054374|473796983|FG000|Overall Study|Progressive Disease|5|||
131591860|NCT05054374|473796984|FG001|Overall Study|Progressive Disease|0|||
131591861|NCT05054374|473796985|FG002|Overall Study|Progressive Disease|0|||
131591862|NCT05054374|473796986|FG003|Overall Study|Progressive Disease|0|||
131591863|NCT03453619|473796988|FG000|Core Study (Part A)|Physician Decision|0|||
131591864|NCT03453619|473796989|FG001|Core Study (Part A)|Physician Decision|0|||
131591865|NCT03453619|473796990|FG002|Core Study (Part A)|Physician Decision|2|||
131591866|NCT03453619|473796991|FG003|Core Study (Part A)|Physician Decision|0|||
131591867|NCT03453619|473796988|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
131591868|NCT03453619|473796989|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
131591869|NCT03453619|473796990|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
131591870|NCT03453619|473796991|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
131591871|NCT03453619|473796988|FG000|Core Study (Part A)|Other|0|||
131591872|NCT03453619|473796989|FG001|Core Study (Part A)|Other|1|||
131591873|NCT03453619|473796990|FG002|Core Study (Part A)|Other|0|||
131439133|NCT03137992|473233394|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
131591874|NCT03453619|473796991|FG003|Core Study (Part A)|Other|0|||
131591875|NCT03453619|473796988|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
131591876|NCT03453619|473796989|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
131591877|NCT03453619|473796990|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
131591878|NCT03453619|473796991|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
131591879|NCT03453619|473796988|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
131591880|NCT03453619|473796989|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
131591881|NCT03453619|473796990|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
131591882|NCT03453619|473796991|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
131591883|NCT03453619|473796988|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
131591884|NCT03453619|473796989|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
131591885|NCT03453619|473796990|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
131653625|NCT03842228|474018424|FG003|Overall Study|Progression|5|||
131791378|NCT00210626|474518675|FG000|Overall Study|Lost to Follow-up|11|||
131439134|NCT03137992|473233395|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
131591886|NCT03453619|473796991|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
131591887|NCT03453619|473796988|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
131591888|NCT03453619|473796989|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
131591889|NCT03453619|473796990|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
131591890|NCT03453619|473796991|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
131591891|NCT02900924|473796992|FG000|Overall Study|Death|52|||
131591892|NCT02900924|473796992|FG000|Overall Study|Lost to Follow-up|4|||
131591893|NCT02900924|473796992|FG000|Overall Study|Withdrawal by Subject|20|||
131591894|NCT02900924|473796992|FG000|Overall Study|Missed Visit|33|||
131591895|NCT02365766|473797012|FG000|Overall Study|Withdrawal by Subject|0|||
131591896|NCT02365766|473797013|FG001|Overall Study|Withdrawal by Subject|0|||
131591897|NCT02365766|473797014|FG002|Overall Study|Withdrawal by Subject|1|||
131591898|NCT02365766|473797012|FG000|Overall Study|Eligibility Criteria Not Met|0|||
131591899|NCT02365766|473797013|FG001|Overall Study|Eligibility Criteria Not Met|0|||
131591900|NCT02365766|473797014|FG002|Overall Study|Eligibility Criteria Not Met|1|||
131591901|NCT03763708|473797018|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
131591902|NCT03763708|473797019|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591903|NCT03763708|473797020|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591904|NCT03763708|473797021|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591905|NCT03763708|473797022|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591906|NCT03763708|473797023|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591907|NCT03763708|473797024|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591908|NCT03763708|473797025|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591909|NCT03763708|473797026|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131591910|NCT03763708|473797018|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591911|NCT03763708|473797019|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591912|NCT03763708|473797020|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
131591913|NCT03763708|473797021|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591914|NCT03763708|473797022|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591915|NCT03763708|473797023|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591916|NCT03763708|473797024|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591917|NCT03763708|473797025|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591918|NCT03763708|473797026|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131591919|NCT03763708|473797018|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591920|NCT03763708|473797019|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591921|NCT03763708|473797020|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591922|NCT03763708|473797021|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
131591923|NCT03763708|473797022|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591924|NCT03763708|473797023|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591925|NCT03763708|473797024|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591926|NCT03763708|473797025|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591927|NCT03763708|473797026|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131591928|NCT03763708|473797018|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591929|NCT03763708|473797019|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591930|NCT03763708|473797020|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591931|NCT03763708|473797021|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591932|NCT03763708|473797022|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
131591933|NCT03763708|473797023|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591934|NCT03763708|473797024|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591935|NCT03763708|473797025|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591936|NCT03763708|473797026|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131591937|NCT03763708|473797018|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591938|NCT03763708|473797019|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591939|NCT03763708|473797020|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591940|NCT03763708|473797021|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591941|NCT03763708|473797022|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591942|NCT03763708|473797023|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
131591943|NCT03763708|473797024|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591944|NCT03763708|473797025|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591945|NCT03763708|473797026|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131591946|NCT03763708|473797018|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591947|NCT03763708|473797019|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591948|NCT03763708|473797020|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131439135|NCT03137992|473233396|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
131591949|NCT03763708|473797021|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591950|NCT03763708|473797022|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591951|NCT03763708|473797023|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591952|NCT03763708|473797024|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
131591953|NCT03763708|473797025|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591954|NCT03763708|473797026|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131591955|NCT03763708|473797018|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
131591956|NCT03763708|473797019|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
131591957|NCT03763708|473797020|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
131591958|NCT03763708|473797021|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
131591959|NCT03763708|473797022|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
131591960|NCT03763708|473797023|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
131591961|NCT03763708|473797024|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
131591962|NCT03763708|473797025|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
131591963|NCT03763708|473797026|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
131591964|NCT03763708|473797018|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
131591965|NCT03763708|473797019|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
131706196|NCT00376961|474207306|FG001|Initial Registration|Progression/relapse|0|||
131706197|NCT00376961|474207305|FG000|Initial Registration|Ineligible|3|||
131706198|NCT00376961|474207306|FG001|Initial Registration|Ineligible|0|||
131706199|NCT00376961|474207305|FG000|Maintenance|Adverse Event|0|||
131706200|NCT00376961|474207306|FG001|Maintenance|Adverse Event|1|||
131706201|NCT00376961|474207305|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
131706202|NCT00376961|474207306|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
131591966|NCT03763708|473797020|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
131591967|NCT03763708|473797021|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
131591968|NCT03763708|473797022|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
131591969|NCT03763708|473797023|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
131591970|NCT03763708|473797024|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
131591971|NCT03763708|473797025|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
131591972|NCT03763708|473797026|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
131591973|NCT03763708|473797018|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
131591974|NCT03763708|473797019|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
131591975|NCT03763708|473797020|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
131591976|NCT03763708|473797021|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
131591977|NCT03763708|473797022|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
131591978|NCT03763708|473797023|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
131591979|NCT03763708|473797024|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
131591980|NCT03763708|473797025|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
131591981|NCT03763708|473797026|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
131591982|NCT00931710|473797029|FG000|Overall Study|Adverse Event|16|||
131591983|NCT00931710|473797030|FG001|Overall Study|Adverse Event|10|||
131591984|NCT00931710|473797029|FG000|Overall Study|Abnormal test procedure results|2|||
131591985|NCT00931710|473797030|FG001|Overall Study|Abnormal test procedure results|0|||
131591986|NCT00931710|473797029|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
131591987|NCT00931710|473797030|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
131591988|NCT00931710|473797029|FG000|Overall Study|Patient withdrew consent|4|||
131591989|NCT00931710|473797030|FG001|Overall Study|Patient withdrew consent|9|||
131591990|NCT00931710|473797029|FG000|Overall Study|Lost to Follow-up|6|||
131591991|NCT00931710|473797030|FG001|Overall Study|Lost to Follow-up|5|||
131591992|NCT00931710|473797029|FG000|Overall Study|Protocol deviation|1|||
131591993|NCT00931710|473797030|FG001|Overall Study|Protocol deviation|2|||
131591994|NCT02913872|473797031|FG000|Overall Study|Withdrawal by Subject|1|||
131591995|NCT02323321|473797032|FG000|Overall Study|Re-Transplant|1|||
131591996|NCT02323321|473797032|FG000|Overall Study|Death|12|||
131591997|NCT00446225|473797033|FG000|Overall Study|Protocol Violation|1|||
131591998|NCT00446225|473797034|FG001|Overall Study|Protocol Violation|0|||
131591999|NCT04450342|473797035|FG000|Overall Study|Adverse Event|1|||
131592000|NCT04450342|473797036|FG001|Overall Study|Adverse Event|1|||
131592001|NCT04450342|473797037|FG002|Overall Study|Adverse Event|0|||
131592002|NCT04450342|473797035|FG000|Overall Study|Device not used|1|||
131592003|NCT04450342|473797036|FG001|Overall Study|Device not used|0|||
131592004|NCT04450342|473797037|FG002|Overall Study|Device not used|0|||
131592005|NCT04450342|473797035|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
131592006|NCT04450342|473797036|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
131592007|NCT04450342|473797037|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
131592008|NCT04450342|473797035|FG000|Overall Study|Physician Decision|1|||
131592009|NCT04450342|473797036|FG001|Overall Study|Physician Decision|0|||
131592010|NCT04450342|473797037|FG002|Overall Study|Physician Decision|1|||
131592011|NCT04450342|473797035|FG000|Overall Study|Protocol Deviation|0|||
131592012|NCT04450342|473797036|FG001|Overall Study|Protocol Deviation|1|||
131592013|NCT04450342|473797037|FG002|Overall Study|Protocol Deviation|0|||
131592014|NCT04450342|473797035|FG000|Overall Study|Reoperation|1|||
131592015|NCT04450342|473797036|FG001|Overall Study|Reoperation|1|||
131592016|NCT04450342|473797037|FG002|Overall Study|Reoperation|0|||
131592017|NCT04450342|473797035|FG000|Overall Study|Screen Failures|0|||
131592018|NCT04450342|473797036|FG001|Overall Study|Screen Failures|0|||
131592019|NCT04450342|473797037|FG002|Overall Study|Screen Failures|2|||
131592020|NCT04450342|473797035|FG000|Overall Study|Site Terminated by Sponsor|1|||
131592021|NCT04450342|473797036|FG001|Overall Study|Site Terminated by Sponsor|1|||
131592022|NCT04450342|473797037|FG002|Overall Study|Site Terminated by Sponsor|1|||
131592023|NCT04450342|473797035|FG000|Overall Study|Study Terminated by Sponsor|31|||
131706203|NCT00376961|474207305|FG000|Maintenance|Progression/relapse|0|||
131706204|NCT00376961|474207306|FG001|Maintenance|Progression/relapse|18|||
131706205|NCT00376961|474207305|FG000|Maintenance|Ineligible|0|||
131706206|NCT00376961|474207306|FG001|Maintenance|Ineligible|3|||
131706207|NCT02911688|474207311|FG000|Washout|Lost to Follow-up|1|||
131706208|NCT02911688|474207312|FG001|Washout|Lost to Follow-up|1|||
131706209|NCT02911688|474207311|FG000|Washout|Withdrawal by Subject|0|||
131592024|NCT04450342|473797036|FG001|Overall Study|Study Terminated by Sponsor|29|||
131592025|NCT04450342|473797037|FG002|Overall Study|Study Terminated by Sponsor|6|||
131592026|NCT04450342|473797035|FG000|Overall Study|Withdrawal by Subject|0|||
131592027|NCT04450342|473797036|FG001|Overall Study|Withdrawal by Subject|1|||
131592028|NCT04450342|473797037|FG002|Overall Study|Withdrawal by Subject|2|||
131592029|NCT03361748|473797045|FG000|Overall Study|Death|77|||
131592030|NCT03361748|473797045|FG000|Overall Study|Lost to Follow-up|4|||
131592031|NCT03361748|473797045|FG000|Overall Study|Withdrawal by Subject|20|||
131592032|NCT05792423|473797046|FG000|Overall Study|Withdrawal by Subject|2|||
131706210|NCT02911688|474207312|FG001|Washout|Withdrawal by Subject|1|||
131706211|NCT00809328|474207313|FG000|Overall Study|Lack of Efficacy|18|||
131592033|NCT02471638|473797047|FG000|Overall Study|Early Term Withdrawal|10|||
131592034|NCT02187003|473798263|FG000|Overall Study|Adverse Event|2|||
131706212|NCT00809328|474207313|FG000|Overall Study|Adverse Event|6|||
131899087|NCT00758498|474917499|FG002|Overall Study|Subject legally detained out of state|0|||
131899088|NCT00758498|474917497|FG000|Overall Study|Withdrawal by Subject|0|||
131899089|NCT00758498|474917498|FG001|Overall Study|Withdrawal by Subject|0|||
131899090|NCT00758498|474917499|FG002|Overall Study|Withdrawal by Subject|1|||
131899091|NCT00758498|474917497|FG000|Overall Study|Noncompliance to study procedures|0|||
131899092|NCT00758498|474917498|FG001|Overall Study|Noncompliance to study procedures|0|||
131899093|NCT00758498|474917499|FG002|Overall Study|Noncompliance to study procedures|1|||
131899094|NCT01697800|474917502|FG000|Overall Study|Death|0|||
131899095|NCT01697800|474917503|FG001|Overall Study|Death|1|||
131899096|NCT00522548|474917507|FG000|Overall Study|Adverse Event|2|||
131899097|NCT00522548|474917508|FG001|Overall Study|Adverse Event|2|||
131899098|NCT00522548|474917507|FG000|Overall Study|Withdrawal by Subject|0|||
131899099|NCT00522548|474917508|FG001|Overall Study|Withdrawal by Subject|2|||
131899100|NCT04147247|474917509|FG000|Overall Study|Progressive disease|3|||
131899101|NCT04147247|474917510|FG001|Overall Study|Progressive disease|3|||
131899102|NCT04147247|474917511|FG002|Overall Study|Progressive disease|4|||
131899103|NCT04147247|474917512|FG003|Overall Study|Progressive disease|4|||
131899104|NCT04147247|474917513|FG004|Overall Study|Progressive disease|3|||
131899105|NCT04147247|474917509|FG000|Overall Study|Physician Decision|0|||
131899106|NCT04147247|474917510|FG001|Overall Study|Physician Decision|1|||
131899107|NCT04147247|474917511|FG002|Overall Study|Physician Decision|0|||
131899108|NCT04147247|474917512|FG003|Overall Study|Physician Decision|0|||
131899109|NCT04147247|474917513|FG004|Overall Study|Physician Decision|0|||
131899110|NCT04147247|474917509|FG000|Overall Study|Clinical Disease Progression|0|||
131899111|NCT04147247|474917510|FG001|Overall Study|Clinical Disease Progression|0|||
131899112|NCT04147247|474917511|FG002|Overall Study|Clinical Disease Progression|0|||
131899113|NCT04147247|474917512|FG003|Overall Study|Clinical Disease Progression|0|||
131899114|NCT04147247|474917513|FG004|Overall Study|Clinical Disease Progression|1|||
131899115|NCT04147247|474917509|FG000|Overall Study|Adverse Event|0|||
131899116|NCT04147247|474917510|FG001|Overall Study|Adverse Event|0|||
131899117|NCT04147247|474917511|FG002|Overall Study|Adverse Event|1|||
131899118|NCT04147247|474917512|FG003|Overall Study|Adverse Event|0|||
131899119|NCT04147247|474917513|FG004|Overall Study|Adverse Event|1|||
131899120|NCT02683239|474917514|FG000|Overall Study|Protocol Violation|35|||
131899121|NCT02683239|474917515|FG001|Overall Study|Protocol Violation|23|||
131899122|NCT02683239|474917516|FG002|Overall Study|Protocol Violation|26|||
131899123|NCT02683239|474917517|FG003|Overall Study|Protocol Violation|4|||
131899124|NCT02683239|474917518|FG004|Overall Study|Protocol Violation|35|||
131899125|NCT02683239|474917519|FG005|Overall Study|Protocol Violation|4|||
131899126|NCT02683239|474917520|FG006|Overall Study|Protocol Violation|5|||
131899127|NCT02683239|474917514|FG000|Overall Study|Adverse Event|64|||
131899128|NCT02683239|474917515|FG001|Overall Study|Adverse Event|39|||
131899129|NCT02683239|474917516|FG002|Overall Study|Adverse Event|42|||
131899130|NCT02683239|474917517|FG003|Overall Study|Adverse Event|16|||
131899131|NCT02683239|474917518|FG004|Overall Study|Adverse Event|189|||
131899132|NCT02683239|474917519|FG005|Overall Study|Adverse Event|9|||
131899133|NCT02683239|474917520|FG006|Overall Study|Adverse Event|9|||
131899134|NCT02683239|474917514|FG000|Overall Study|Physician Decision|38|||
131899135|NCT02683239|474917515|FG001|Overall Study|Physician Decision|19|||
131899136|NCT02683239|474917516|FG002|Overall Study|Physician Decision|14|||
131899137|NCT02683239|474917517|FG003|Overall Study|Physician Decision|73|||
131899138|NCT02683239|474917518|FG004|Overall Study|Physician Decision|143|||
131899139|NCT02683239|474917519|FG005|Overall Study|Physician Decision|14|||
131899140|NCT02683239|474917520|FG006|Overall Study|Physician Decision|15|||
131899141|NCT02683239|474917514|FG000|Overall Study|Withdrawal by Subject|187|||
131899142|NCT02683239|474917515|FG001|Overall Study|Withdrawal by Subject|99|||
131899143|NCT02683239|474917516|FG002|Overall Study|Withdrawal by Subject|91|||
131899144|NCT02683239|474917517|FG003|Overall Study|Withdrawal by Subject|18|||
131899145|NCT02683239|474917518|FG004|Overall Study|Withdrawal by Subject|248|||
131899146|NCT02683239|474917519|FG005|Overall Study|Withdrawal by Subject|22|||
131592035|NCT02187003|473798264|FG001|Overall Study|Adverse Event|0|||
131592036|NCT02187003|473798263|FG000|Overall Study|Lost to Follow-up|14|||
131899147|NCT02683239|474917520|FG006|Overall Study|Withdrawal by Subject|28|||
131899148|NCT02683239|474917514|FG000|Overall Study|Lost to Follow-up|77|||
131899149|NCT02683239|474917515|FG001|Overall Study|Lost to Follow-up|24|||
131592037|NCT02187003|473798264|FG001|Overall Study|Lost to Follow-up|10|||
131592038|NCT02187003|473798263|FG000|Overall Study|Withdrawal by Subject|3|||
131899150|NCT02683239|474917516|FG002|Overall Study|Lost to Follow-up|25|||
131899151|NCT02683239|474917517|FG003|Overall Study|Lost to Follow-up|7|||
131899152|NCT02683239|474917518|FG004|Overall Study|Lost to Follow-up|88|||
131899153|NCT02683239|474917519|FG005|Overall Study|Lost to Follow-up|8|||
131899154|NCT02683239|474917520|FG006|Overall Study|Lost to Follow-up|11|||
131899155|NCT02683239|474917514|FG000|Overall Study|Death|9|||
131899156|NCT02683239|474917515|FG001|Overall Study|Death|5|||
131899157|NCT02683239|474917516|FG002|Overall Study|Death|8|||
131899158|NCT02683239|474917517|FG003|Overall Study|Death|0|||
131899159|NCT02683239|474917518|FG004|Overall Study|Death|12|||
131899160|NCT02683239|474917519|FG005|Overall Study|Death|1|||
131899161|NCT02683239|474917520|FG006|Overall Study|Death|0|||
131592039|NCT02187003|473798264|FG001|Overall Study|Withdrawal by Subject|7|||
131592040|NCT02187003|473798263|FG000|Overall Study|Protocol Violation|2|||
131592041|NCT02187003|473798264|FG001|Overall Study|Protocol Violation|4|||
131592042|NCT02187003|473798263|FG000|Overall Study|Other|5|||
131592043|NCT02187003|473798264|FG001|Overall Study|Other|5|||
131592044|NCT02187003|473798263|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131899162|NCT02683239|474917514|FG000|Overall Study|Lack of Efficacy|50|||
131899163|NCT02683239|474917515|FG001|Overall Study|Lack of Efficacy|23|||
131899164|NCT02683239|474917516|FG002|Overall Study|Lack of Efficacy|12|||
131899165|NCT02683239|474917517|FG003|Overall Study|Lack of Efficacy|2|||
131899166|NCT02683239|474917518|FG004|Overall Study|Lack of Efficacy|29|||
131899167|NCT02683239|474917519|FG005|Overall Study|Lack of Efficacy|2|||
131899168|NCT02683239|474917520|FG006|Overall Study|Lack of Efficacy|3|||
131899169|NCT02683239|474917514|FG000|Overall Study|Missing data|0|||
131899170|NCT02683239|474917515|FG001|Overall Study|Missing data|1|||
131899171|NCT02683239|474917516|FG002|Overall Study|Missing data|1|||
131899172|NCT02683239|474917517|FG003|Overall Study|Missing data|0|||
131899173|NCT02683239|474917518|FG004|Overall Study|Missing data|1|||
131899174|NCT02683239|474917519|FG005|Overall Study|Missing data|0|||
131899175|NCT02683239|474917520|FG006|Overall Study|Missing data|0|||
131899176|NCT01254656|474917523|FG000|Overall Study|Discontinued due to termination of study|40|||
131899177|NCT01254656|474917524|FG001|Overall Study|Discontinued due to termination of study|39|||
131899178|NCT01254656|474917525|FG002|Overall Study|Discontinued due to termination of study|13|||
131899179|NCT01254656|474917523|FG000|Overall Study|Lack of Efficacy|3|||
131899180|NCT01254656|474917524|FG001|Overall Study|Lack of Efficacy|0|||
131899181|NCT01254656|474917525|FG002|Overall Study|Lack of Efficacy|0|||
131899182|NCT01254656|474917523|FG000|Overall Study|Lost to Follow-up|1|||
131899183|NCT01254656|474917524|FG001|Overall Study|Lost to Follow-up|0|||
131899184|NCT01254656|474917525|FG002|Overall Study|Lost to Follow-up|2|||
131899185|NCT01254656|474917523|FG000|Overall Study|Withdrawal by Subject|2|||
131899186|NCT01254656|474917524|FG001|Overall Study|Withdrawal by Subject|2|||
131899187|NCT01254656|474917525|FG002|Overall Study|Withdrawal by Subject|1|||
131899188|NCT01254656|474917523|FG000|Overall Study|Pregnancy|0|||
131899189|NCT01254656|474917524|FG001|Overall Study|Pregnancy|0|||
131899190|NCT01254656|474917525|FG002|Overall Study|Pregnancy|2|||
131899191|NCT01254656|474917523|FG000|Overall Study|Adverse Event|1|||
131899192|NCT01254656|474917524|FG001|Overall Study|Adverse Event|1|||
131899193|NCT01254656|474917525|FG002|Overall Study|Adverse Event|0|||
131899194|NCT01254656|474917523|FG000|Overall Study|Death|0|||
131899195|NCT01254656|474917524|FG001|Overall Study|Death|1|||
131899196|NCT01254656|474917525|FG002|Overall Study|Death|0|||
131899197|NCT02762084|474917526|FG000|Overall Study|Withdrawal by Subject|1|||
131899198|NCT02762084|474917527|FG001|Overall Study|Withdrawal by Subject|0|||
131899199|NCT02762084|474917528|FG002|Overall Study|Withdrawal by Subject|0|||
131899200|NCT02762084|474917526|FG000|Overall Study|Adverse Event|0|||
131899201|NCT02762084|474917527|FG001|Overall Study|Adverse Event|0|||
131899202|NCT02762084|474917528|FG002|Overall Study|Adverse Event|1|||
131899203|NCT01781962|474917531|FG000|Overall Study|Other Miscellaneous Reasons|5|||
131899204|NCT03200548|474917532|FG000|Overall Study|Withdrawal by Subject|5|||
131592045|NCT02187003|473798264|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
131592046|NCT04593472|473798265|FG000|Overall Study|Death|31|||
131592047|NCT04593472|473798266|FG001|Overall Study|Death|27|||
131592048|NCT04593472|473798265|FG000|Overall Study|Withdrawal by Subject|12|||
131592049|NCT04593472|473798266|FG001|Overall Study|Withdrawal by Subject|12|||
131653626|NCT03842228|474018425|FG004|Overall Study|Progression|4|||
131899205|NCT03200548|474917533|FG001|Overall Study|Withdrawal by Subject|11|||
131899206|NCT03200548|474917534|FG002|Overall Study|Withdrawal by Subject|7|||
131899207|NCT03200548|474917535|FG003|Overall Study|Withdrawal by Subject|6|||
131899208|NCT01765296|474917540|FG000|Overall Study|Protocol Violation|0|||
131899209|NCT01765296|474917541|FG001|Overall Study|Protocol Violation|5|||
131899210|NCT01765296|474917542|FG002|Overall Study|Protocol Violation|4|||
131899211|NCT01765296|474917540|FG000|Overall Study|Withdrawal by Subject|4|||
131653627|NCT03842228|474018426|FG005|Overall Study|Progression|2|||
131899212|NCT01765296|474917541|FG001|Overall Study|Withdrawal by Subject|2|||
131899213|NCT01765296|474917542|FG002|Overall Study|Withdrawal by Subject|2|||
131899214|NCT01765296|474917540|FG000|Overall Study|Adverse Event|1|||
131899215|NCT01765296|474917541|FG001|Overall Study|Adverse Event|13|||
131592050|NCT04593472|473798265|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
131592051|NCT04593472|473798266|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
131592052|NCT04593472|473798265|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
131592053|NCT04593472|473798266|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
131592054|NCT04593472|473798265|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
131592055|NCT04593472|473798266|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
131592056|NCT04593472|473798265|FG000|Overall Study|Lost to Follow-up|0|||
131592057|NCT04593472|473798266|FG001|Overall Study|Lost to Follow-up|2|||
131592058|NCT04593472|473798265|FG000|Overall Study|Still collecting 24-month assessment|17|||
131592059|NCT04593472|473798266|FG001|Overall Study|Still collecting 24-month assessment|10|||
131592060|NCT05418296|473798271|FG000|Overall Study|Withdrawal by Subject|4|||
131592061|NCT05418296|473798272|FG001|Overall Study|Withdrawal by Subject|1|||
131592062|NCT05382936|473798273|FG000|Overall Study|Progressive Disease|3|||
131592063|NCT05382936|473798274|FG001|Overall Study|Progressive Disease|5|||
131592064|NCT05382936|473798275|FG002|Overall Study|Progressive Disease|2|||
131592065|NCT05382936|473798276|FG003|Overall Study|Progressive Disease|5|||
131592066|NCT05382936|473798273|FG000|Overall Study|Adverse Event|0|||
131592067|NCT05382936|473798274|FG001|Overall Study|Adverse Event|1|||
131592068|NCT05382936|473798275|FG002|Overall Study|Adverse Event|1|||
131592069|NCT05382936|473798276|FG003|Overall Study|Adverse Event|0|||
131592070|NCT05382936|473798273|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
131592071|NCT05382936|473798274|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
131592072|NCT05382936|473798275|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
131592073|NCT05382936|473798276|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
131592074|NCT05382936|473798273|FG000|Overall Study|Withdrawal by Subject|0|||
131592075|NCT05382936|473798274|FG001|Overall Study|Withdrawal by Subject|0|||
131592076|NCT05382936|473798275|FG002|Overall Study|Withdrawal by Subject|1|||
131592077|NCT05382936|473798276|FG003|Overall Study|Withdrawal by Subject|1|||
131592078|NCT01195831|473798281|FG000|Overall Study|Lost to Follow-up|2|||
131592079|NCT01195831|473798282|FG001|Overall Study|Lost to Follow-up|4|||
131592080|NCT01195831|473798281|FG000|Overall Study|Withdrawal by Subject|2|||
131592081|NCT01195831|473798282|FG001|Overall Study|Withdrawal by Subject|2|||
131592082|NCT01195831|473798281|FG000|Overall Study|Adverse Event|4|||
131592083|NCT01195831|473798282|FG001|Overall Study|Adverse Event|2|||
131592084|NCT01195831|473798281|FG000|Overall Study|Protocol Violation|0|||
131592085|NCT01195831|473798282|FG001|Overall Study|Protocol Violation|2|||
131592086|NCT04703322|473798283|FG000|Overall Study|Ongoing|8|||
131592087|NCT04703322|473798283|FG000|Overall Study|Withdrawal by Subject|1|||
131592088|NCT03692611|473798285|FG000|Overall Study|Found to be ineligible postrandomization|3|||
131592089|NCT03692611|473798286|FG001|Overall Study|Found to be ineligible postrandomization|0|||
131592090|NCT05374837|473798293|FG000|Overall Study|Lost to Follow-up|17|||
131592091|NCT05374837|473798294|FG001|Overall Study|Lost to Follow-up|18|||
131592092|NCT05406921|473798298|FG000|Overall Study|Withdrawal by Subject|25|||
131592093|NCT05406921|473798299|FG001|Overall Study|Withdrawal by Subject|0|||
131592094|NCT05406921|473798300|FG002|Overall Study|Withdrawal by Subject|25|||
131592095|NCT05406921|473798298|FG000|Overall Study|Protocol Violation|0|||
131592096|NCT05406921|473798299|FG001|Overall Study|Protocol Violation|12|||
131592097|NCT05406921|473798300|FG002|Overall Study|Protocol Violation|0|||
131592098|NCT02312960|473798303|FG000|Overall Study|Death|24|||
131592099|NCT02312960|473798304|FG001|Overall Study|Death|32|||
131592100|NCT02312960|473798305|FG002|Overall Study|Death|25|||
131592101|NCT02312960|473798306|FG003|Overall Study|Death|11|||
131592102|NCT02312960|473798307|FG004|Overall Study|Death|5|||
131592103|NCT02312960|473798308|FG005|Overall Study|Death|5|||
131592104|NCT02312960|473798309|FG006|Overall Study|Death|8|||
131592105|NCT02312960|473798310|FG007|Overall Study|Death|5|||
131592106|NCT02312960|473798311|FG008|Overall Study|Death|7|||
131592107|NCT02312960|473798312|FG009|Overall Study|Death|3|||
131592108|NCT02312960|473798313|FG010|Overall Study|Death|3|||
131592109|NCT02312960|473798314|FG011|Overall Study|Death|1|||
131592110|NCT02312960|473798315|FG012|Overall Study|Death|25|||
131592111|NCT02312960|473798316|FG013|Overall Study|Death|19|||
131592112|NCT02312960|473798303|FG000|Overall Study|Missing|0|||
131592113|NCT02312960|473798304|FG001|Overall Study|Missing|0|||
131592114|NCT02312960|473798305|FG002|Overall Study|Missing|2|||
131592115|NCT02312960|473798306|FG003|Overall Study|Missing|0|||
131592116|NCT02312960|473798307|FG004|Overall Study|Missing|0|||
131592117|NCT02312960|473798308|FG005|Overall Study|Missing|0|||
131592118|NCT02312960|473798309|FG006|Overall Study|Missing|0|||
131592119|NCT02312960|473798310|FG007|Overall Study|Missing|0|||
131592120|NCT02312960|473798311|FG008|Overall Study|Missing|0|||
131592121|NCT02312960|473798312|FG009|Overall Study|Missing|0|||
131592122|NCT02312960|473798313|FG010|Overall Study|Missing|0|||
131592123|NCT02312960|473798314|FG011|Overall Study|Missing|0|||
131592124|NCT02312960|473798315|FG012|Overall Study|Missing|0|||
131592125|NCT02312960|473798316|FG013|Overall Study|Missing|0|||
131592126|NCT02312960|473798303|FG000|Overall Study|Lost to Follow-up|0|||
131592127|NCT02312960|473798304|FG001|Overall Study|Lost to Follow-up|0|||
131592128|NCT02312960|473798305|FG002|Overall Study|Lost to Follow-up|1|||
131592129|NCT02312960|473798306|FG003|Overall Study|Lost to Follow-up|0|||
131592130|NCT02312960|473798307|FG004|Overall Study|Lost to Follow-up|0|||
131592131|NCT02312960|473798308|FG005|Overall Study|Lost to Follow-up|0|||
131592132|NCT02312960|473798309|FG006|Overall Study|Lost to Follow-up|1|||
131592133|NCT02312960|473798310|FG007|Overall Study|Lost to Follow-up|1|||
131592134|NCT02312960|473798311|FG008|Overall Study|Lost to Follow-up|0|||
131592135|NCT02312960|473798312|FG009|Overall Study|Lost to Follow-up|1|||
131592136|NCT02312960|473798313|FG010|Overall Study|Lost to Follow-up|0|||
131592137|NCT02312960|473798314|FG011|Overall Study|Lost to Follow-up|0|||
131592138|NCT02312960|473798315|FG012|Overall Study|Lost to Follow-up|1|||
131592139|NCT02312960|473798316|FG013|Overall Study|Lost to Follow-up|0|||
131592140|NCT02312960|473798303|FG000|Overall Study|Withdrawal by Subject|1|||
131592141|NCT02312960|473798304|FG001|Overall Study|Withdrawal by Subject|2|||
131592142|NCT02312960|473798305|FG002|Overall Study|Withdrawal by Subject|0|||
131592143|NCT02312960|473798306|FG003|Overall Study|Withdrawal by Subject|0|||
131592144|NCT02312960|473798307|FG004|Overall Study|Withdrawal by Subject|1|||
131592145|NCT02312960|473798308|FG005|Overall Study|Withdrawal by Subject|0|||
131592146|NCT02312960|473798309|FG006|Overall Study|Withdrawal by Subject|1|||
131592147|NCT02312960|473798310|FG007|Overall Study|Withdrawal by Subject|2|||
131592148|NCT02312960|473798311|FG008|Overall Study|Withdrawal by Subject|2|||
131592149|NCT02312960|473798312|FG009|Overall Study|Withdrawal by Subject|3|||
131592150|NCT02312960|473798313|FG010|Overall Study|Withdrawal by Subject|0|||
131592151|NCT02312960|473798314|FG011|Overall Study|Withdrawal by Subject|0|||
131592152|NCT02312960|473798315|FG012|Overall Study|Withdrawal by Subject|2|||
131592153|NCT02312960|473798316|FG013|Overall Study|Withdrawal by Subject|0|||
131592154|NCT03958955|473798317|FG000|Overall Study|Adverse Event|1|||
131592155|NCT04838262|473798318|FG000|Overall Study|Withdrawal by Subject|9|||
131592156|NCT04838262|473798319|FG001|Overall Study|Withdrawal by Subject|4|||
131592157|NCT04089371|473798328|FG000|Overall Study|Withdrawal by Subject|0|||
131592158|NCT04089371|473798329|FG001|Overall Study|Withdrawal by Subject|1|||
131592159|NCT04089371|473798328|FG000|Overall Study|Study terminated early|0|||
131592160|NCT04089371|473798329|FG001|Overall Study|Study terminated early|9|||
131592161|NCT04382898|473798330|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
131592162|NCT04382898|473798331|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
131592163|NCT04382898|473798332|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
131592164|NCT04382898|473798333|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
131592165|NCT04382898|473798334|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
131592166|NCT04382898|473798330|FG000|Part 1: Dose Titration|Death|6|||
131592167|NCT04382898|473798331|FG001|Part 1: Dose Titration|Death|0|||
131592168|NCT04382898|473798332|FG002|Part 1: Dose Titration|Death|0|||
131592169|NCT04382898|473798333|FG003|Part 1: Dose Titration|Death|0|||
131592170|NCT04382898|473798334|FG004|Part 1: Dose Titration|Death|0|||
131592171|NCT04382898|473798330|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131592172|NCT04382898|473798331|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131592173|NCT04382898|473798332|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131592174|NCT04382898|473798333|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131592175|NCT04382898|473798334|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131592176|NCT04382898|473798330|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
131592177|NCT04382898|473798331|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
131592178|NCT04382898|473798332|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
131592179|NCT04382898|473798333|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
131592180|NCT04382898|473798334|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
131592181|NCT04382898|473798330|FG000|Part 2: Dose Expansion|Death|0|||
131592182|NCT04382898|473798331|FG001|Part 2: Dose Expansion|Death|17|||
131592183|NCT04382898|473798332|FG002|Part 2: Dose Expansion|Death|13|||
131592184|NCT04382898|473798333|FG003|Part 2: Dose Expansion|Death|1|||
131592185|NCT04382898|473798334|FG004|Part 2: Dose Expansion|Death|0|||
131592186|NCT04382898|473798330|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
131592187|NCT04382898|473798331|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
131592188|NCT04382898|473798332|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
131592189|NCT04382898|473798333|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
131592190|NCT04382898|473798334|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
131592191|NCT04382898|473798330|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
131899216|NCT01765296|474917542|FG002|Overall Study|Adverse Event|5|||
131899217|NCT01765296|474917540|FG000|Overall Study|Lack of Efficacy|0|||
131899218|NCT01765296|474917541|FG001|Overall Study|Lack of Efficacy|0|||
131899219|NCT01765296|474917542|FG002|Overall Study|Lack of Efficacy|2|||
131899220|NCT03257436|474917543|FG000|Overall Study|Withdrawal by Subject|76|||
131899221|NCT03257436|474917543|FG000|Overall Study|Death|19|||
131899222|NCT05417412|474917544|FG000|Overall Study|Lost to Follow-up|2|||
131899223|NCT03478371|474917547|FG000|Overall Study|non-compliance|1|||
131899224|NCT03478371|474917547|FG000|Overall Study|Lost to Follow-up|4|||
131899225|NCT02849743|474917548|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
131899226|NCT02849743|474917549|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
131899227|NCT02849743|474917548|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
131899228|NCT02849743|474917549|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
131899229|NCT03874013|474917554|FG000|Overall Study|Adverse Event|0|||
131899230|NCT03874013|474917555|FG001|Overall Study|Adverse Event|1|||
131899231|NCT01096160|474917557|FG000|Overall Study|Adverse Event|0|||
131899232|NCT01096160|474917558|FG001|Overall Study|Adverse Event|0|||
131899233|NCT01096160|474917559|FG002|Overall Study|Adverse Event|1|||
131899234|NCT01096160|474917560|FG003|Overall Study|Adverse Event|0|||
131899235|NCT01096160|474917561|FG004|Overall Study|Adverse Event|0|||
131899236|NCT01096160|474917562|FG005|Overall Study|Adverse Event|0|||
131899237|NCT01096160|474917563|FG006|Overall Study|Adverse Event|0|||
131899238|NCT01096160|474917564|FG007|Overall Study|Adverse Event|0|||
131592192|NCT04382898|473798331|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
131592193|NCT04382898|473798332|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
131592194|NCT04382898|473798333|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
131592195|NCT04382898|473798334|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
131592196|NCT04382898|473798330|FG000|Part 2: Dose Expansion|Other|0|||
131592197|NCT04382898|473798331|FG001|Part 2: Dose Expansion|Other|0|||
131592198|NCT04382898|473798332|FG002|Part 2: Dose Expansion|Other|1|||
131592199|NCT04382898|473798333|FG003|Part 2: Dose Expansion|Other|0|||
131592200|NCT04382898|473798334|FG004|Part 2: Dose Expansion|Other|0|||
131592201|NCT03932682|473798335|FG000|Overall Study|Death|1|||
131592202|NCT03932682|473798336|FG001|Overall Study|Death|2|||
131592203|NCT03932682|473798335|FG000|Overall Study|Withdrawal by Subject|37|||
131592204|NCT03932682|473798336|FG001|Overall Study|Withdrawal by Subject|45|||
131592205|NCT03932682|473798335|FG000|Overall Study|Lost to Follow-up|19|||
131592206|NCT03932682|473798336|FG001|Overall Study|Lost to Follow-up|25|||
131592207|NCT03932682|473798335|FG000|Overall Study|Protocol Violation|0|||
131592208|NCT03932682|473798336|FG001|Overall Study|Protocol Violation|2|||
131592209|NCT03932682|473798335|FG000|Overall Study|Other|9|||
131592210|NCT03932682|473798336|FG001|Overall Study|Other|23|||
131592211|NCT02307565|473798338|FG000|Overall Study|Adverse Event|3|||
131592212|NCT02307565|473798339|FG001|Overall Study|Adverse Event|2|||
131592213|NCT02307565|473798338|FG000|Overall Study|Withdrawal by Subject|2|||
131592214|NCT02307565|473798339|FG001|Overall Study|Withdrawal by Subject|2|||
131592215|NCT04936035|473798346|FG000|Overall Study|Adverse Event|0|||
131592216|NCT04936035|473798347|FG001|Overall Study|Adverse Event|1|||
131592217|NCT04936035|473798348|FG002|Overall Study|Adverse Event|0|||
131592218|NCT04936035|473798349|FG003|Overall Study|Adverse Event|0|||
131592219|NCT04936035|473798350|FG004|Overall Study|Adverse Event|0|||
131592220|NCT04936035|473798346|FG000|Overall Study|Death|0|||
131592221|NCT04936035|473798347|FG001|Overall Study|Death|0|||
131592222|NCT04936035|473798348|FG002|Overall Study|Death|0|||
131592223|NCT04936035|473798349|FG003|Overall Study|Death|1|||
131592224|NCT04936035|473798350|FG004|Overall Study|Death|0|||
131592225|NCT04936035|473798346|FG000|Overall Study|Lost to Follow-up|0|||
131592226|NCT04936035|473798347|FG001|Overall Study|Lost to Follow-up|1|||
131592227|NCT04936035|473798348|FG002|Overall Study|Lost to Follow-up|1|||
131592228|NCT04936035|473798349|FG003|Overall Study|Lost to Follow-up|2|||
131592229|NCT04936035|473798350|FG004|Overall Study|Lost to Follow-up|1|||
131592230|NCT04936035|473798346|FG000|Overall Study|Physician Decision|0|||
131592231|NCT04936035|473798347|FG001|Overall Study|Physician Decision|1|||
131592232|NCT04936035|473798348|FG002|Overall Study|Physician Decision|0|||
131592233|NCT04936035|473798349|FG003|Overall Study|Physician Decision|0|||
131592234|NCT04936035|473798350|FG004|Overall Study|Physician Decision|0|||
131592235|NCT04936035|473798346|FG000|Overall Study|Protocol Deviation|0|||
131592236|NCT04936035|473798347|FG001|Overall Study|Protocol Deviation|0|||
131592237|NCT04936035|473798348|FG002|Overall Study|Protocol Deviation|1|||
131592238|NCT04936035|473798349|FG003|Overall Study|Protocol Deviation|0|||
131592239|NCT04936035|473798350|FG004|Overall Study|Protocol Deviation|0|||
131592240|NCT04936035|473798346|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
131899239|NCT01096160|474917565|FG008|Overall Study|Adverse Event|0|||
131899240|NCT01096160|474917566|FG009|Overall Study|Adverse Event|1|||
131899241|NCT01096160|474917557|FG000|Overall Study|Met stopping criteria per protocol|0|||
131592241|NCT04936035|473798347|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
131899242|NCT01096160|474917558|FG001|Overall Study|Met stopping criteria per protocol|0|||
131899243|NCT01096160|474917559|FG002|Overall Study|Met stopping criteria per protocol|0|||
131899244|NCT01096160|474917560|FG003|Overall Study|Met stopping criteria per protocol|0|||
131592242|NCT04936035|473798348|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
131592243|NCT04936035|473798349|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
131592244|NCT04936035|473798350|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
131592245|NCT04936035|473798346|FG000|Overall Study|Reason Unknown|0|||
131592246|NCT04936035|473798347|FG001|Overall Study|Reason Unknown|0|||
131592247|NCT04936035|473798348|FG002|Overall Study|Reason Unknown|0|||
131592248|NCT04936035|473798349|FG003|Overall Study|Reason Unknown|0|||
131592249|NCT04936035|473798350|FG004|Overall Study|Reason Unknown|1|||
131592250|NCT04936035|473798346|FG000|Overall Study|Withdrawal by Subject|1|||
131592251|NCT04936035|473798347|FG001|Overall Study|Withdrawal by Subject|0|||
131592252|NCT04936035|473798348|FG002|Overall Study|Withdrawal by Subject|0|||
131592253|NCT04936035|473798349|FG003|Overall Study|Withdrawal by Subject|0|||
131592254|NCT04936035|473798350|FG004|Overall Study|Withdrawal by Subject|0|||
131592255|NCT04936035|473798346|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131592256|NCT04936035|473798347|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131592257|NCT04936035|473798348|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131592258|NCT04936035|473798349|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
131592259|NCT04936035|473798350|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131592260|NCT04936035|473798346|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131592261|NCT04936035|473798347|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131439136|NCT03137992|473233397|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
131439137|NCT03137992|473233392|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
131439138|NCT03137992|473233393|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
131439139|NCT03137992|473233394|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
131439140|NCT03137992|473233395|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
131439141|NCT03137992|473233396|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
131439142|NCT03137992|473233397|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
131439143|NCT03137992|473233392|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
131439144|NCT03137992|473233393|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
131439145|NCT03137992|473233394|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
131439146|NCT03137992|473233395|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
131439147|NCT03137992|473233396|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
131439148|NCT03137992|473233397|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
131439149|NCT03137992|473233392|FG000|Part 2 (Open-label Extension)|Per study team|1|||
131439150|NCT03137992|473233393|FG001|Part 2 (Open-label Extension)|Per study team|0|||
131439151|NCT03137992|473233394|FG002|Part 2 (Open-label Extension)|Per study team|0|||
131439152|NCT03137992|473233395|FG003|Part 2 (Open-label Extension)|Per study team|0|||
131439153|NCT03137992|473233396|FG004|Part 2 (Open-label Extension)|Per study team|0|||
131439154|NCT03137992|473233397|FG005|Part 2 (Open-label Extension)|Per study team|0|||
131439155|NCT03137992|473233392|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
131439156|NCT03137992|473233393|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
131439157|NCT03137992|473233394|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
131439158|NCT03137992|473233395|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
131439159|NCT03137992|473233396|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
131439160|NCT03137992|473233397|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
131439161|NCT02370420|473233398|FG000|Overall Study|Physician Decision|3|||
131439162|NCT02370420|473233399|FG001|Overall Study|Physician Decision|3|||
131439163|NCT02370420|473233398|FG000|Overall Study|Lost to Follow-up|11|||
131439164|NCT02370420|473233399|FG001|Overall Study|Lost to Follow-up|9|||
131439165|NCT03077542|473233400|FG000|Overall Study|Death|4|||
131439166|NCT03077542|473233401|FG001|Overall Study|Death|0|||
131439167|NCT03077542|473233400|FG000|Overall Study|Physician Decision|6|||
131439168|NCT03077542|473233401|FG001|Overall Study|Physician Decision|1|||
131439169|NCT03077542|473233400|FG000|Overall Study|Withdrawal by Subject|0|||
131439170|NCT03077542|473233401|FG001|Overall Study|Withdrawal by Subject|1|||
131439171|NCT00795704|473233402|FG000|Overall Study|Withdrawal by Subject|3|||
131439172|NCT00795704|473233403|FG001|Overall Study|Withdrawal by Subject|2|||
131439173|NCT00795704|473233402|FG000|Overall Study|Adverse Event|1|||
131439174|NCT00795704|473233403|FG001|Overall Study|Adverse Event|1|||
131592262|NCT04936035|473798348|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131592263|NCT04936035|473798349|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131592264|NCT04936035|473798350|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
131592265|NCT04936035|473798346|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131592266|NCT04936035|473798347|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131592267|NCT04936035|473798348|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131439175|NCT03980730|473233404|FG000|Overall Study|Study Terminated by Sponsor|0|||
131592268|NCT04936035|473798349|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131592269|NCT04936035|473798350|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
131592270|NCT02811679|473798361|FG000|Overall Study|Adverse Event|1|||
131592271|NCT02811679|473798361|FG000|Overall Study|Lack of Efficacy|6|||
131592272|NCT02811679|473798361|FG000|Overall Study|Early study closure due to slow accrual|3|||
131592273|NCT05319860|473798363|FG000|Overall Study|Death|1|||
131592274|NCT05319860|473798364|FG001|Overall Study|Death|1|||
131592275|NCT05319860|473798363|FG000|Overall Study|Lost to Follow-up|3|||
131592276|NCT05319860|473798364|FG001|Overall Study|Lost to Follow-up|1|||
131592277|NCT05319860|473798363|FG000|Overall Study|Withdrawal by Subject|1|||
131592278|NCT05319860|473798364|FG001|Overall Study|Withdrawal by Subject|7|||
131592279|NCT04314895|473798365|FG000|Overall Study|Lost to Follow-up|1|||
131592280|NCT04314895|473798365|FG000|Overall Study|Death|10|||
131592281|NCT04314895|473798365|FG000|Overall Study|Physician Decision|2|||
131592282|NCT03941860|473798366|FG000|Overall Study|Withdrawal by Subject|0|||
131592283|NCT03941860|473798367|FG001|Overall Study|Withdrawal by Subject|1|||
131592284|NCT01361711|473798368|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
131592285|NCT01361711|473798368|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
131592286|NCT01361711|473798368|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
131592287|NCT01361711|473798368|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
131592288|NCT01361711|473798368|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
131592289|NCT01361711|473798368|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
131592290|NCT01361711|473798368|FG000|Completed Week 18 of Treatment|Other|9|||
131592291|NCT01361711|473798368|FG000|10 Year Follow-up|Still in follow-up|22|||
131592292|NCT01361711|473798368|FG000|10 Year Follow-up|Death|7|||
131592293|NCT01361711|473798368|FG000|10 Year Follow-up|Developed new cancer|1|||
131592294|NCT01361711|473798368|FG000|10 Year Follow-up|Lost to Follow-up|2|||
131592295|NCT01361711|473798368|FG000|10 Year Follow-up|New treatment started|6|||
131592296|NCT01361711|473798368|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
131592297|NCT01361711|473798368|FG000|10 Year Follow-up|Progressive Disease|1|||
131592298|NCT02596126|473798369|FG000|Overall Study|Lost to Follow-up|12|||
131592299|NCT02596126|473798370|FG001|Overall Study|Lost to Follow-up|21|||
131592300|NCT02596126|473798369|FG000|Overall Study|Protocol Violation|7|||
131592301|NCT02596126|473798370|FG001|Overall Study|Protocol Violation|9|||
131592302|NCT03396588|473798371|FG000|Overall Study|Physician Decision|2|||
131592303|NCT03396588|473798372|FG001|Overall Study|Physician Decision|3|||
131592304|NCT05179395|473798373|FG000|Overall Study|Lack of Efficacy|1|||
131592305|NCT00812461|473798374|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
131592306|NCT00812461|473798375|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
131592307|NCT00812461|473798374|FG000|All Treated Patients|Adverse Event|8|||
131592308|NCT00812461|473798375|FG001|All Treated Patients|Adverse Event|15|||
131592309|NCT00812461|473798374|FG000|All Treated Patients|Lack of Efficacy|13|||
131592310|NCT00812461|473798375|FG001|All Treated Patients|Lack of Efficacy|7|||
131592311|NCT00812461|473798374|FG000|All Treated Patients|Non-compliance|6|||
131592312|NCT00812461|473798375|FG001|All Treated Patients|Non-compliance|9|||
131592313|NCT00812461|473798374|FG000|All Treated Patients|Protocol Violation|36|||
131592314|NCT00812461|473798375|FG001|All Treated Patients|Protocol Violation|27|||
131592315|NCT00812461|473798374|FG000|All Treated Patients|Withdrawal by Subject|45|||
131592316|NCT00812461|473798375|FG001|All Treated Patients|Withdrawal by Subject|54|||
131592317|NCT00812461|473798374|FG000|All Treated Patients|Lost to Follow-up|11|||
131592318|NCT00812461|473798375|FG001|All Treated Patients|Lost to Follow-up|14|||
131592319|NCT00812461|473798374|FG000|All Treated Patients|Other Reason|13|||
131592320|NCT00812461|473798375|FG001|All Treated Patients|Other Reason|21|||
131592321|NCT04402489|473800826|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131592322|NCT04402489|473800827|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
131592323|NCT04402489|473800828|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131592324|NCT04402489|473800829|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131592325|NCT04402489|473800830|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131592326|NCT04402489|473800826|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
131592327|NCT04402489|473800827|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131592328|NCT04402489|473800828|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131592329|NCT04402489|473800829|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131592330|NCT04402489|473800830|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131592331|NCT04402489|473800826|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
131592332|NCT04402489|473800827|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
131592333|NCT04402489|473800828|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
131592334|NCT04402489|473800829|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
131592335|NCT04402489|473800830|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
131592336|NCT04402489|473800826|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131592337|NCT04402489|473800827|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131592338|NCT04402489|473800828|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
131592339|NCT04402489|473800829|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131592340|NCT04402489|473800830|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131592341|NCT04402489|473800826|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131592342|NCT04402489|473800827|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131592343|NCT04402489|473800828|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131592344|NCT04402489|473800829|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
131592345|NCT04402489|473800830|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131592346|NCT04402489|473800826|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
131592347|NCT04402489|473800827|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
131592348|NCT04402489|473800828|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
131592349|NCT04402489|473800829|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
131592350|NCT04402489|473800830|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
131592351|NCT04833777|473800836|FG000|Overall Study|Lost to Follow-up|1|||
131592352|NCT04833777|473800837|FG001|Overall Study|Lost to Follow-up|0|||
131706213|NCT00809328|474207313|FG000|Overall Study|Protocol Violation|3|||
131706214|NCT00809328|474207313|FG000|Overall Study|Withdrawal by Subject|2|||
131706215|NCT03706365|474207317|FG000|Overall Study|Lost to Follow-up|7|||
131706216|NCT03706365|474207318|FG001|Overall Study|Lost to Follow-up|0|||
131706217|NCT03706365|474207317|FG000|Overall Study|Withdrawal by Subject|17|||
131706218|NCT03706365|474207318|FG001|Overall Study|Withdrawal by Subject|15|||
131706219|NCT03706365|474207317|FG000|Overall Study|On Study Treatment|51|||
131706220|NCT03706365|474207318|FG001|Overall Study|On Study Treatment|51|||
131706221|NCT03116113|474207319|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706222|NCT03116113|474207320|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706223|NCT03116113|474207321|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706224|NCT03116113|474207322|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706225|NCT03116113|474207323|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706226|NCT03116113|474207324|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706227|NCT03116113|474207325|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131706228|NCT03116113|474207326|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
131706229|NCT03116113|474207327|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
131706230|NCT02159807|474207328|FG000|Overall Study|Adverse Event|0|||
131706231|NCT02159807|474207329|FG001|Overall Study|Adverse Event|0|||
131706232|NCT02159807|474207330|FG002|Overall Study|Adverse Event|1|||
131592373|NCT03648840|473800850|FG000|First IV Infusion Session|Adverse Event|0|||
131592374|NCT03648840|473800851|FG001|First IV Infusion Session|Adverse Event|2|||
131592375|NCT03648840|473800850|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
131592376|NCT03648840|473800851|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
131592377|NCT03648840|473800850|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
131592378|NCT03648840|473800851|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
131706233|NCT02159807|474207328|FG000|Overall Study|No CSF|1|||
131706234|NCT02159807|474207329|FG001|Overall Study|No CSF|1|||
131706235|NCT02159807|474207330|FG002|Overall Study|No CSF|1|||
131706236|NCT02159807|474207328|FG000|Overall Study|elevated blood pressure|0|||
131706237|NCT02159807|474207329|FG001|Overall Study|elevated blood pressure|0|||
131706238|NCT02159807|474207330|FG002|Overall Study|elevated blood pressure|1|||
131706239|NCT01552902|474207332|FG000|Overall Study|Adverse Event|1|||
131706240|NCT01552902|474207333|FG001|Overall Study|Adverse Event|15|||
131706241|NCT01552902|474207334|FG002|Overall Study|Adverse Event|14|||
131706242|NCT01552902|474207332|FG000|Overall Study|Protocol Violation|3|||
131706243|NCT01552902|474207333|FG001|Overall Study|Protocol Violation|3|||
131706244|NCT01552902|474207334|FG002|Overall Study|Protocol Violation|3|||
131706245|NCT01552902|474207332|FG000|Overall Study|Lack of Efficacy|4|||
131592379|NCT03648840|473800850|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
131592380|NCT03648840|473800851|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
131592381|NCT05063994|473800855|FG000|Cortef Run-In|Withdrawal of Consent|1|||
131592382|NCT05063994|473800856|FG001|Cortef Run-In|Withdrawal of Consent|0|||
131592383|NCT05063994|473800857|FG002|Cortef Run-In|Withdrawal of Consent|0|||
131592384|NCT05063994|473800855|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
131592385|NCT05063994|473800856|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
131592386|NCT05063994|473800857|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
131592387|NCT05063994|473800855|FG000|Treatment|Physician Decision|0|||
131592388|NCT05063994|473800856|FG001|Treatment|Physician Decision|0|||
131592389|NCT05063994|473800857|FG002|Treatment|Physician Decision|1|||
131592390|NCT05063994|473800855|FG000|Treatment|Withdrawal by Subject|0|||
131592391|NCT05063994|473800856|FG001|Treatment|Withdrawal by Subject|0|||
131592392|NCT05063994|473800857|FG002|Treatment|Withdrawal by Subject|1|||
131592393|NCT05063994|473800855|FG000|Treatment|Withdrawal of Consent|0|||
131706246|NCT01552902|474207333|FG001|Overall Study|Lack of Efficacy|3|||
131706247|NCT01552902|474207334|FG002|Overall Study|Lack of Efficacy|1|||
131706248|NCT01552902|474207332|FG000|Overall Study|Withdrawal by Subject|1|||
131439176|NCT03980730|473233405|FG001|Overall Study|Study Terminated by Sponsor|3|||
131439177|NCT03980730|473233404|FG000|Overall Study|Adverse Event|2|||
131592394|NCT05063994|473800856|FG001|Treatment|Withdrawal of Consent|0|||
131592395|NCT05063994|473800857|FG002|Treatment|Withdrawal of Consent|1|||
131592396|NCT04630262|473800859|FG000|Overall Study|Intraoperative Screen Failure|5|||
131592397|NCT04630262|473800859|FG000|Overall Study|Study terminated prematurely|71|||
131592398|NCT04630262|473800859|FG000|Overall Study|Withdrawal by Subject|2|||
131592399|NCT04630262|473800859|FG000|Overall Study|Physician Decision|2|||
131592400|NCT01857934|473800861|FG000|Overall Study|Relapse or progression|2|||
131592401|NCT01857934|473800861|FG000|Overall Study|Unacceptable toxicity|3|||
131592402|NCT01857934|473800861|FG000|Overall Study|Unwillingness or inability to comply|2|||
131592403|NCT01857934|473800861|FG000|Overall Study|Physician Decision|3|||
131592404|NCT04638998|473800866|FG000|Overall Study|Withdrawal by Subject|1|||
131592405|NCT04638998|473800867|FG001|Overall Study|Withdrawal by Subject|3|||
131592406|NCT03692676|473800868|FG000|Overall Study|exclude patients with prior use|4424|||
131592407|NCT03692676|473800869|FG001|Overall Study|exclude patients with prior use|24726|||
131592408|NCT03692676|473800870|FG002|Overall Study|exclude patients with prior use|0|||
131592409|NCT03692676|473800871|FG003|Overall Study|exclude patients with prior use|0|||
131592410|NCT03692676|473800868|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
131592411|NCT03692676|473800869|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
131592412|NCT03692676|473800870|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
131592413|NCT03692676|473800871|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
131592414|NCT03692676|473800868|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
131592415|NCT03692676|473800869|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
131592416|NCT03692676|473800870|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
131592417|NCT03692676|473800871|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
131592418|NCT03692676|473800868|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
131592419|NCT03692676|473800869|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
131592420|NCT03692676|473800870|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
131592421|NCT03692676|473800871|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
131592422|NCT03692676|473800868|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
131592423|NCT03692676|473800869|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
131592424|NCT03692676|473800870|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
131592425|NCT03692676|473800871|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
131592426|NCT03692676|473800868|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
131592427|NCT03692676|473800869|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
131592428|NCT03692676|473800870|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
131592429|NCT03692676|473800871|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
131592430|NCT03692676|473800868|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
131592431|NCT03692676|473800869|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
131592432|NCT03692676|473800870|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
131592433|NCT03692676|473800871|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
131592434|NCT03692676|473800868|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
131592435|NCT03692676|473800869|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
131592436|NCT03692676|473800870|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
131592437|NCT03692676|473800871|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
131653628|NCT03842228|474018427|FG006|Overall Study|Progression|3|||
131653629|NCT01263509|474018428|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
131653630|NCT01263509|474018429|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
131653631|NCT01263509|474018430|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
131653632|NCT01263509|474018431|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
131653633|NCT01263509|474018428|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131653634|NCT01263509|474018429|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
131653635|NCT01263509|474018430|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131653636|NCT01263509|474018431|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131653637|NCT01263509|474018428|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131653638|NCT01263509|474018429|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131653639|NCT01263509|474018430|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131653640|NCT01263509|474018431|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131653641|NCT01263509|474018428|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
131653642|NCT01263509|474018429|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
131653643|NCT01263509|474018430|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131653644|NCT01263509|474018431|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131653645|NCT01263509|474018428|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
131653646|NCT01263509|474018429|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
131653647|NCT01263509|474018430|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
131653648|NCT01263509|474018431|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
131653649|NCT01572740|474018432|FG000|Overall Study|Adverse Event|1|||
131653650|NCT01572740|474018433|FG001|Overall Study|Adverse Event|1|||
131653651|NCT01572740|474018432|FG000|Overall Study|Withdrawal by Subject|1|||
131653652|NCT01572740|474018433|FG001|Overall Study|Withdrawal by Subject|1|||
131653653|NCT01572740|474018432|FG000|Overall Study|unclassified|4|||
131653654|NCT01572740|474018433|FG001|Overall Study|unclassified|3|||
131653655|NCT01711853|474018438|FG000|Overall Study|Not treated|3|||
131653656|NCT01427725|474018439|FG000|Overall Study|Lost to Follow-up|17|||
131653657|NCT01427725|474018439|FG000|Overall Study|Protocol Violation|1|||
131653658|NCT01427725|474018439|FG000|Overall Study|Drug not administered|1|||
131653659|NCT01427725|474018439|FG000|Overall Study|Failure to visit|7|||
131653660|NCT01427725|474018439|FG000|Overall Study|Adverse Event|46|||
131653661|NCT01427725|474018439|FG000|Overall Study|Failure to visit after administration|40|||
131653662|NCT01427725|474018439|FG000|Overall Study|Patient's rejection|27|||
131653663|NCT01427725|474018439|FG000|Overall Study|Transfer to a different hospital|17|||
131653664|NCT01427725|474018439|FG000|Overall Study|Lack of Efficacy|8|||
131653665|NCT01427725|474018439|FG000|Overall Study|Death|7|||
131653666|NCT01427725|474018439|FG000|Overall Study|Symptom improvement|6|||
131653667|NCT01427725|474018439|FG000|Overall Study|AE and Patient's rejection|5|||
131592438|NCT03692676|473800868|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
131592439|NCT03692676|473800869|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
131592440|NCT03692676|473800870|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
131592441|NCT03692676|473800871|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
131592442|NCT03692676|473800868|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
131592443|NCT03692676|473800869|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
131592444|NCT03692676|473800870|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
131592445|NCT03692676|473800871|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
131592446|NCT03692676|473800868|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
131592447|NCT03692676|473800869|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
131592448|NCT03692676|473800870|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
131592449|NCT03692676|473800871|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
131592450|NCT03692676|473800868|FG000|Overall Study|Other|0|||
131592451|NCT03692676|473800869|FG001|Overall Study|Other|805|||
131592452|NCT03692676|473800870|FG002|Overall Study|Other|758|||
131592453|NCT03692676|473800871|FG003|Overall Study|Other|277|||
131592454|NCT03692676|473800868|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
131592455|NCT03692676|473800869|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
131592456|NCT03692676|473800870|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
131592457|NCT03692676|473800871|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
131592458|NCT01180634|473800872|FG000|Overall Study|Adverse Event|4|||
131592459|NCT01180634|473800873|FG001|Overall Study|Adverse Event|1|||
131592460|NCT01180634|473800872|FG000|Overall Study|Miscellaneous|2|||
131592461|NCT01180634|473800873|FG001|Overall Study|Miscellaneous|0|||
131592462|NCT01180634|473800872|FG000|Overall Study|Withdrawal by Subject|4|||
131592463|NCT01180634|473800873|FG001|Overall Study|Withdrawal by Subject|0|||
131706249|NCT01552902|474207333|FG001|Overall Study|Withdrawal by Subject|9|||
131706250|NCT01552902|474207334|FG002|Overall Study|Withdrawal by Subject|6|||
131706251|NCT01552902|474207332|FG000|Overall Study|Lost to Follow-up|1|||
131706252|NCT01552902|474207333|FG001|Overall Study|Lost to Follow-up|3|||
131706253|NCT01552902|474207334|FG002|Overall Study|Lost to Follow-up|6|||
131706254|NCT01552902|474207332|FG000|Overall Study|Other|3|||
131706255|NCT01552902|474207333|FG001|Overall Study|Other|4|||
131706256|NCT01552902|474207334|FG002|Overall Study|Other|3|||
131706257|NCT02720757|474207338|FG000|Overall Study|Other reason|5|||
131706258|NCT02720757|474207338|FG000|Overall Study|Loss of contact|4|||
131706259|NCT02720757|474207338|FG000|Overall Study|Informed consent withdrawal|1|||
131706260|NCT02720757|474207338|FG000|Overall Study|Patients wish to withdraw|2|||
131706261|NCT02720757|474207338|FG000|Overall Study|Missing|3|||
131706262|NCT02720757|474207338|FG000|Overall Study|General exclusion|3|||
131706263|NCT02649634|474207342|FG000|Overall Study|Withdrawal by Subject|3|||
131706264|NCT02649634|474207343|FG001|Overall Study|Withdrawal by Subject|5|||
131706265|NCT02649634|474207342|FG000|Overall Study|Lost to Follow-up|0|||
131706266|NCT02649634|474207343|FG001|Overall Study|Lost to Follow-up|1|||
131706267|NCT01318122|474207344|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131706268|NCT01318122|474207345|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131706269|NCT01318122|474207346|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
131706270|NCT01318122|474207347|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
131706271|NCT01318122|474207344|FG000|Enrolled - Long-Term Extension Study|Other|1|||
131706272|NCT01318122|474207345|FG001|Enrolled - Long-Term Extension Study|Other|0|||
131706273|NCT01318122|474207346|FG002|Enrolled - Long-Term Extension Study|Other|0|||
131706274|NCT01318122|474207347|FG003|Enrolled - Long-Term Extension Study|Other|0|||
131706275|NCT01318122|474207344|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
131706276|NCT01318122|474207345|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
131706277|NCT01318122|474207346|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
131706278|NCT01318122|474207347|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
131706279|NCT01318122|474207344|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
131706280|NCT01318122|474207345|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131706281|NCT01318122|474207346|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131706282|NCT01318122|474207347|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131706283|NCT01318122|474207344|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131706284|NCT01318122|474207345|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
131706285|NCT01318122|474207346|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131706286|NCT01318122|474207347|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131706287|NCT01318122|474207344|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131592464|NCT04419168|473800874|FG000|Overall Study|Protocol Violation|1|||
131592465|NCT04419168|473800875|FG001|Overall Study|Protocol Violation|1|||
131592466|NCT04419168|473800874|FG000|Overall Study|Lost to Follow-up|7|||
131592467|NCT04419168|473800875|FG001|Overall Study|Lost to Follow-up|7|||
131592468|NCT04419168|473800874|FG000|Overall Study|Missed 6-month Visit|48|||
131592469|NCT04419168|473800875|FG001|Overall Study|Missed 6-month Visit|45|||
131592470|NCT04490915|473800876|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131592471|NCT04490915|473800877|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131592472|NCT04490915|473800876|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131592473|NCT04490915|473800877|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131592474|NCT04490915|473800876|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131592475|NCT04490915|473800877|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
131592476|NCT04490915|473800876|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
131592477|NCT04490915|473800877|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
131592478|NCT04490915|473800876|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
131592479|NCT04490915|473800877|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
131592480|NCT04490915|473800876|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
131592481|NCT04490915|473800877|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
131592482|NCT04490915|473800876|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
131592483|NCT04490915|473800877|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
131592484|NCT05009251|473800878|FG000|Overall Study|Protocol Violation|100|||
131592485|NCT05009251|473800879|FG001|Overall Study|Protocol Violation|105|||
131592486|NCT05009251|473800880|FG002|Overall Study|Protocol Violation|119|||
131592487|NCT05009251|473800881|FG003|Overall Study|Protocol Violation|120|||
131592488|NCT05009251|473800882|FG004|Overall Study|Protocol Violation|119|||
131592489|NCT05009251|473800878|FG000|Overall Study|Death|25|||
131592490|NCT05009251|473800879|FG001|Overall Study|Death|22|||
131592491|NCT05009251|473800880|FG002|Overall Study|Death|24|||
131592492|NCT05009251|473800881|FG003|Overall Study|Death|19|||
131592493|NCT05009251|473800882|FG004|Overall Study|Death|15|||
131592494|NCT00616967|473800889|FG000|Overall Study|Withdrawal by Subject|0|||
131592495|NCT00616967|473800890|FG001|Overall Study|Withdrawal by Subject|0|||
131592496|NCT00616967|473800891|FG002|Overall Study|Withdrawal by Subject|1|||
131592497|NCT02910583|473800892|FG000|Overall Study|Death|7|||
131592498|NCT02910583|473800893|FG001|Overall Study|Death|3|||
131592499|NCT02910583|473800892|FG000|Overall Study|Lost to Follow-up|1|||
131592500|NCT02910583|473800893|FG001|Overall Study|Lost to Follow-up|0|||
131592501|NCT02910583|473800892|FG000|Overall Study|Withdrawal by Subject|12|||
131592502|NCT02910583|473800893|FG001|Overall Study|Withdrawal by Subject|8|||
131592503|NCT02910583|473800892|FG000|Overall Study|Other, Not Specified|6|||
131592504|NCT02910583|473800893|FG001|Overall Study|Other, Not Specified|3|||
131592505|NCT05059262|473800894|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
131592506|NCT05059262|473800895|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
131592507|NCT05059262|473800894|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
131592508|NCT05059262|473800895|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
131592509|NCT05059262|473800894|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
131592510|NCT05059262|473800895|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
131592511|NCT05059262|473800894|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
131592512|NCT05059262|473800895|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
131592513|NCT05059262|473800894|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
131592514|NCT05059262|473800895|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
131592515|NCT05059262|473800894|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
131592516|NCT05059262|473800895|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
131592517|NCT05059262|473800894|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
131592518|NCT05059262|473800895|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
131592519|NCT05059262|473800894|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
131592520|NCT05059262|473800895|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
131592521|NCT05059262|473800894|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
131592522|NCT05059262|473800895|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
131592523|NCT02029443|473800907|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
131706288|NCT01318122|474207345|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
131706289|NCT01318122|474207346|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
131706290|NCT01318122|474207347|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131706291|NCT01486199|474207348|FG000|Two Year Period Between Study Days|Physician Decision|1|||
131706292|NCT01486199|474207349|FG001|Two Year Period Between Study Days|Physician Decision|0|||
131706293|NCT02471716|474207351|FG000|Overall Study|Withdrawal by Subject|0|||
131706294|NCT02471716|474207352|FG001|Overall Study|Withdrawal by Subject|1|||
131706295|NCT02471716|474207353|FG002|Overall Study|Withdrawal by Subject|0|||
131706296|NCT02471716|474207354|FG003|Overall Study|Withdrawal by Subject|2|||
131592524|NCT02029443|473800908|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
131592525|NCT02029443|473800909|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
131592526|NCT02029443|473800910|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
131706297|NCT02471716|474207355|FG004|Overall Study|Withdrawal by Subject|5|||
131592527|NCT02029443|473800911|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
131592528|NCT02029443|473800907|FG000|Overall Study|Death|13|||
131592529|NCT02029443|473800908|FG001|Overall Study|Death|2|||
131592530|NCT02029443|473800909|FG002|Overall Study|Death|2|||
131592531|NCT02029443|473800910|FG003|Overall Study|Death|11|||
131592532|NCT02029443|473800911|FG004|Overall Study|Death|2|||
131592533|NCT02029443|473800907|FG000|Overall Study|Lost to Follow-up|1|||
131592534|NCT02029443|473800908|FG001|Overall Study|Lost to Follow-up|0|||
131592535|NCT02029443|473800909|FG002|Overall Study|Lost to Follow-up|1|||
131592536|NCT02029443|473800910|FG003|Overall Study|Lost to Follow-up|1|||
131592537|NCT02029443|473800911|FG004|Overall Study|Lost to Follow-up|0|||
131592538|NCT02029443|473800907|FG000|Overall Study|Started other anti-cancer therapy|17|||
131592539|NCT02029443|473800908|FG001|Overall Study|Started other anti-cancer therapy|4|||
131592540|NCT02029443|473800909|FG002|Overall Study|Started other anti-cancer therapy|7|||
131592541|NCT02029443|473800910|FG003|Overall Study|Started other anti-cancer therapy|9|||
131592542|NCT02029443|473800911|FG004|Overall Study|Started other anti-cancer therapy|3|||
131592543|NCT02029443|473800907|FG000|Overall Study|Withdrawal by Subject|3|||
131592544|NCT02029443|473800908|FG001|Overall Study|Withdrawal by Subject|1|||
131592545|NCT02029443|473800909|FG002|Overall Study|Withdrawal by Subject|1|||
131592546|NCT02029443|473800910|FG003|Overall Study|Withdrawal by Subject|1|||
131592547|NCT02029443|473800911|FG004|Overall Study|Withdrawal by Subject|0|||
131592548|NCT02029443|473800907|FG000|Overall Study|Other|6|||
131592549|NCT02029443|473800908|FG001|Overall Study|Other|6|||
131592550|NCT02029443|473800909|FG002|Overall Study|Other|4|||
131592551|NCT02029443|473800910|FG003|Overall Study|Other|2|||
131592552|NCT02029443|473800911|FG004|Overall Study|Other|0|||
131592553|NCT02549339|473800917|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
131592554|NCT02549339|473800918|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
131592555|NCT02549339|473800917|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
131592556|NCT02549339|473800918|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
131592557|NCT02549339|473800917|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
131592558|NCT02549339|473800918|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
131592559|NCT02549339|473800917|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
131592560|NCT02549339|473800918|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
131592561|NCT02549339|473800917|FG000|12-month Follow-up|Lack of Efficacy|0|||
131592562|NCT02549339|473800918|FG001|12-month Follow-up|Lack of Efficacy|2|||
131592563|NCT02549339|473800917|FG000|12-month Follow-up|Withdrawal by Subject|8|||
131592564|NCT02549339|473800918|FG001|12-month Follow-up|Withdrawal by Subject|3|||
131592565|NCT02549339|473800917|FG000|12-month Follow-up|Lost to Follow-up|1|||
131592566|NCT02549339|473800918|FG001|12-month Follow-up|Lost to Follow-up|3|||
131592567|NCT02549339|473800917|FG000|12-month Follow-up|Other|0|||
131592568|NCT02549339|473800918|FG001|12-month Follow-up|Other|3|||
131592569|NCT03016169|473800919|FG000|Overall Study|Lost to Follow-up|4|||
131592570|NCT03016169|473800919|FG000|Overall Study|Death|54|||
131592571|NCT03016169|473800919|FG000|Overall Study|Device Explant|11|||
131592572|NCT03016169|473800919|FG000|Overall Study|Withdrawal by Subject|19|||
131592573|NCT03016169|473800919|FG000|Overall Study|Other Reasons|1|||
131592574|NCT05524233|473800936|FG000|Overall Study|Lost to Follow-up|2|||
131592575|NCT05524233|473800936|FG000|Overall Study|Adverse Event|2|||
131592576|NCT05524233|473800936|FG000|Overall Study|Withdrawal by Subject|1|||
131592577|NCT03126019|473800942|FG000|Overall Study|Death|5|||
131592578|NCT03126019|473800943|FG001|Overall Study|Death|27|||
131592579|NCT03126019|473800942|FG000|Overall Study|Lost to Follow-up|2|||
131592580|NCT03126019|473800943|FG001|Overall Study|Lost to Follow-up|4|||
131592581|NCT03126019|473800942|FG000|Overall Study|Withdrawal by Subject|1|||
131592582|NCT03126019|473800943|FG001|Overall Study|Withdrawal by Subject|9|||
131592583|NCT03126019|473800942|FG000|Overall Study|Physician Decision|1|||
131592584|NCT03126019|473800943|FG001|Overall Study|Physician Decision|0|||
131592585|NCT03126019|473800942|FG000|Overall Study|Transitioned to Rollover Study|0|||
131592586|NCT03126019|473800943|FG001|Overall Study|Transitioned to Rollover Study|11|||
131592587|NCT03126019|473800942|FG000|Overall Study|Did Not Return to Site for Care|0|||
131592588|NCT03126019|473800943|FG001|Overall Study|Did Not Return to Site for Care|1|||
131592589|NCT03126019|473800942|FG000|Overall Study|Site Closed|0|||
131592590|NCT03126019|473800943|FG001|Overall Study|Site Closed|1|||
131592591|NCT01566695|473800952|FG000|Overall Study|Lack of Efficacy|1|||
131592592|NCT01566695|473800953|FG001|Overall Study|Lack of Efficacy|0|||
131592593|NCT01566695|473800952|FG000|Overall Study|Adverse Event|3|||
131592594|NCT01566695|473800953|FG001|Overall Study|Adverse Event|0|||
131592595|NCT01566695|473800952|FG000|Overall Study|Death|79|||
131592596|NCT01566695|473800953|FG001|Overall Study|Death|86|||
131592597|NCT01566695|473800952|FG000|Overall Study|Withdrawal by Subject|13|||
131592598|NCT01566695|473800953|FG001|Overall Study|Withdrawal by Subject|12|||
131592599|NCT01566695|473800952|FG000|Overall Study|Lost to Follow-up|0|||
131592600|NCT01566695|473800953|FG001|Overall Study|Lost to Follow-up|3|||
131592601|NCT01566695|473800952|FG000|Overall Study|Other reasons|11|||
131592602|NCT01566695|473800953|FG001|Overall Study|Other reasons|8|||
131592603|NCT05956002|473800954|FG000|Treatment Period 3|Adverse Event|0|||
131592604|NCT05956002|473800955|FG001|Treatment Period 3|Adverse Event|0|||
131592605|NCT05956002|473800956|FG002|Treatment Period 3|Adverse Event|1|||
131592606|NCT05956002|473800957|FG003|Treatment Period 3|Adverse Event|0|||
131592607|NCT02281955|473800963|FG000|Overall Study|Death|1|||
131592608|NCT02783300|473800964|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592609|NCT02783300|473800965|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592610|NCT02783300|473800966|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592611|NCT02783300|473800967|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592612|NCT02783300|473800968|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592613|NCT02783300|473800969|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592614|NCT02783300|473800970|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
131592615|NCT02783300|473800971|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592616|NCT02783300|473800972|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592617|NCT02783300|473800973|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592618|NCT02783300|473800974|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592619|NCT02783300|473800975|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592620|NCT02783300|473800976|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592621|NCT02783300|473800977|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592622|NCT02783300|473800978|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592623|NCT02783300|473800979|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592624|NCT02783300|473800980|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592625|NCT02783300|473800981|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592626|NCT02783300|473800982|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592627|NCT02783300|473800983|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592628|NCT02783300|473800984|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592629|NCT02783300|473800985|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592630|NCT02783300|473800986|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592631|NCT02783300|473800987|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592632|NCT02783300|473800988|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592633|NCT02783300|473800989|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592634|NCT02783300|473800990|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131592635|NCT02783300|473800964|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592636|NCT02783300|473800965|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592637|NCT02783300|473800966|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592638|NCT02783300|473800967|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
131592639|NCT02783300|473800968|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592640|NCT02783300|473800969|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592641|NCT02783300|473800970|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592642|NCT02783300|473800971|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592643|NCT02783300|473800972|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592644|NCT02783300|473800973|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592645|NCT02783300|473800974|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592646|NCT02783300|473800975|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592647|NCT02783300|473800976|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592648|NCT02783300|473800977|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592649|NCT02783300|473800978|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592650|NCT02783300|473800979|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592651|NCT02783300|473800980|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592652|NCT02783300|473800981|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592653|NCT02783300|473800982|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592654|NCT02783300|473800983|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592655|NCT02783300|473800984|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592656|NCT02783300|473800985|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592657|NCT02783300|473800986|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592658|NCT02783300|473800987|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592659|NCT02783300|473800988|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592660|NCT02783300|473800989|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592661|NCT02783300|473800990|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131592662|NCT02783300|473800964|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
131592663|NCT02783300|473800965|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
131592664|NCT02783300|473800966|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
131592665|NCT02783300|473800967|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
131592666|NCT02783300|473800968|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
131592667|NCT02783300|473800969|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
131592668|NCT02783300|473800970|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
131592669|NCT02783300|473800971|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
131592670|NCT02783300|473800972|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
131592671|NCT02783300|473800973|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
131592672|NCT02783300|473800974|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
131592673|NCT02783300|473800975|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
131592674|NCT02783300|473800976|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
131592675|NCT02783300|473800977|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
131592676|NCT02783300|473800978|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
131592677|NCT02783300|473800979|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
131592678|NCT02783300|473800980|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
131592679|NCT02783300|473800981|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
131592680|NCT02783300|473800982|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
131592681|NCT02783300|473800983|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
131592682|NCT02783300|473800984|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
131592683|NCT02783300|473800985|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
131592684|NCT02783300|473800986|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
131592685|NCT02783300|473800987|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
131592686|NCT02783300|473800988|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
131592687|NCT02783300|473800989|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
131592688|NCT02783300|473800990|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
131592689|NCT02783300|473800964|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592690|NCT02783300|473800965|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131653668|NCT01427725|474018439|FG000|Overall Study|Physician Decision|5|||
131592691|NCT02783300|473800966|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592692|NCT02783300|473800967|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592693|NCT02783300|473800968|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592694|NCT02783300|473800969|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592695|NCT02783300|473800970|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
131592696|NCT02783300|473800971|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592697|NCT02783300|473800972|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592698|NCT02783300|473800973|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592699|NCT02783300|473800974|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592700|NCT02783300|473800975|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592701|NCT02783300|473800976|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
131592702|NCT02783300|473800977|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592703|NCT02783300|473800978|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592704|NCT02783300|473800979|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592705|NCT02783300|473800980|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592706|NCT02783300|473800981|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592707|NCT02783300|473800982|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592708|NCT02783300|473800983|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592709|NCT02783300|473800984|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592710|NCT02783300|473800985|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592711|NCT02783300|473800986|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592712|NCT02783300|473800987|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592713|NCT02783300|473800988|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592714|NCT02783300|473800989|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592715|NCT02783300|473800990|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131592716|NCT02783300|473800964|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592717|NCT02783300|473800965|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592718|NCT02783300|473800966|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592719|NCT02783300|473800967|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592720|NCT02783300|473800968|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
131592721|NCT02783300|473800969|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592722|NCT02783300|473800970|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
131592723|NCT02783300|473800971|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592724|NCT02783300|473800972|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592725|NCT02783300|473800973|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
131592726|NCT02783300|473800974|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592727|NCT02783300|473800975|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592728|NCT02783300|473800976|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
131592729|NCT02783300|473800977|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592730|NCT02783300|473800978|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131439178|NCT03980730|473233405|FG001|Overall Study|Adverse Event|0|||
131439179|NCT03980730|473233404|FG000|Overall Study|Sponsor Request|0|||
131439180|NCT03980730|473233405|FG001|Overall Study|Sponsor Request|1|||
131439181|NCT01300728|473233406|FG000|Overall Study|Withdrawal by Subject|1|||
131439182|NCT01300728|473233407|FG001|Overall Study|Withdrawal by Subject|1|||
131439183|NCT01300728|473233406|FG000|Overall Study|Physician Decision|1|||
131439184|NCT01300728|473233407|FG001|Overall Study|Physician Decision|0|||
131439185|NCT00880620|473233410|FG000|Overall Study|Adverse Event|4|||
131439186|NCT00880620|473233411|FG001|Overall Study|Adverse Event|5|||
131439187|NCT00880620|473233412|FG002|Overall Study|Adverse Event|15|||
131439188|NCT00880620|473233413|FG003|Overall Study|Adverse Event|15|||
131439189|NCT00880620|473233410|FG000|Overall Study|Death|0|||
131592731|NCT02783300|473800979|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592732|NCT02783300|473800980|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592733|NCT02783300|473800981|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592734|NCT02783300|473800982|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592735|NCT02783300|473800983|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592736|NCT02783300|473800984|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592737|NCT02783300|473800985|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592738|NCT02783300|473800986|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592739|NCT02783300|473800987|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592740|NCT02783300|473800988|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592741|NCT02783300|473800989|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592742|NCT02783300|473800990|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131592743|NCT02783300|473800964|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592744|NCT02783300|473800965|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131791379|NCT00210626|474518676|FG001|Overall Study|Lost to Follow-up|11|||
131439190|NCT00880620|473233411|FG001|Overall Study|Death|0|||
131592745|NCT02783300|473800966|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592746|NCT02783300|473800967|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592747|NCT02783300|473800968|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592748|NCT02783300|473800969|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592749|NCT02783300|473800970|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592750|NCT02783300|473800971|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592751|NCT02783300|473800972|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592752|NCT02783300|473800973|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592753|NCT02783300|473800974|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592754|NCT02783300|473800975|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592755|NCT02783300|473800976|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592756|NCT02783300|473800977|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592757|NCT02783300|473800978|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592758|NCT02783300|473800979|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
131592759|NCT02783300|473800980|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592760|NCT02783300|473800981|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
131592761|NCT02783300|473800982|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
131592762|NCT02783300|473800983|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
131592763|NCT02783300|473800984|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592764|NCT02783300|473800985|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592765|NCT02783300|473800986|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592766|NCT02783300|473800987|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592767|NCT02783300|473800988|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
131592768|NCT02783300|473800989|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592769|NCT02783300|473800990|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131592770|NCT02783300|473800964|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592771|NCT02783300|473800965|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592772|NCT02783300|473800966|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592773|NCT02783300|473800967|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592774|NCT02783300|473800968|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592775|NCT02783300|473800969|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592776|NCT02783300|473800970|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592777|NCT02783300|473800971|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592778|NCT02783300|473800972|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592779|NCT02783300|473800973|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592780|NCT02783300|473800974|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592781|NCT02783300|473800975|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592782|NCT02783300|473800976|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592783|NCT02783300|473800977|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592784|NCT02783300|473800978|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592785|NCT02783300|473800979|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592786|NCT02783300|473800980|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
131592787|NCT02783300|473800981|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592788|NCT02783300|473800982|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
131592789|NCT02783300|473800983|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
131592790|NCT02783300|473800984|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592791|NCT02783300|473800985|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592792|NCT02783300|473800986|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592793|NCT02783300|473800987|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592794|NCT02783300|473800988|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592795|NCT02783300|473800989|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592796|NCT02783300|473800990|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131592797|NCT02783300|473800964|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592798|NCT02783300|473800965|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592799|NCT02783300|473800966|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592800|NCT02783300|473800967|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592801|NCT02783300|473800968|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592802|NCT02783300|473800969|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131706298|NCT02471716|474207351|FG000|Overall Study|Study Terminiated by sponsor|0|||
131706299|NCT02471716|474207352|FG001|Overall Study|Study Terminiated by sponsor|0|||
131791380|NCT00210626|474518675|FG000|Overall Study|Death|1|||
131592803|NCT02783300|473800970|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592804|NCT02783300|473800971|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592805|NCT02783300|473800972|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592806|NCT02783300|473800973|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592807|NCT02783300|473800974|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592808|NCT02783300|473800975|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592809|NCT02783300|473800976|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592810|NCT02783300|473800977|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592811|NCT02783300|473800978|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592812|NCT02783300|473800979|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592813|NCT02783300|473800980|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
131592814|NCT02783300|473800981|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592815|NCT02783300|473800982|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
131592816|NCT02783300|473800983|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
131592817|NCT02783300|473800984|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
131592818|NCT02783300|473800985|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592819|NCT02783300|473800986|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592820|NCT02783300|473800987|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592821|NCT02783300|473800988|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592822|NCT02783300|473800989|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592823|NCT02783300|473800990|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131592824|NCT02783300|473800964|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592825|NCT02783300|473800965|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592826|NCT02783300|473800966|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592827|NCT02783300|473800967|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592828|NCT02783300|473800968|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592829|NCT02783300|473800969|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592830|NCT02783300|473800970|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592831|NCT02783300|473800971|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592832|NCT02783300|473800972|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592833|NCT02783300|473800973|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592834|NCT02783300|473800974|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592835|NCT02783300|473800975|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592836|NCT02783300|473800976|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592837|NCT02783300|473800977|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592838|NCT02783300|473800978|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592839|NCT02783300|473800979|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
131592840|NCT02783300|473800980|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592841|NCT02783300|473800981|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592842|NCT02783300|473800982|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592843|NCT02783300|473800983|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592844|NCT02783300|473800984|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592845|NCT02783300|473800985|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592846|NCT02783300|473800986|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
131592847|NCT02783300|473800987|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592848|NCT02783300|473800988|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592849|NCT02783300|473800989|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592850|NCT02783300|473800990|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131592851|NCT02783300|473800964|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592852|NCT02783300|473800965|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592853|NCT02783300|473800966|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592854|NCT02783300|473800967|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592855|NCT02783300|473800968|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592856|NCT02783300|473800969|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592857|NCT02783300|473800970|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592858|NCT02783300|473800971|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592859|NCT02783300|473800972|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592860|NCT02783300|473800973|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592861|NCT02783300|473800974|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592862|NCT02783300|473800975|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592863|NCT02783300|473800976|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592864|NCT02783300|473800977|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
131592865|NCT02783300|473800978|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
131592866|NCT02783300|473800979|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
131592867|NCT02783300|473800980|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
131592868|NCT02783300|473800981|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592869|NCT02783300|473800982|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
131592870|NCT02783300|473800983|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
131592871|NCT02783300|473800984|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592872|NCT02783300|473800985|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592873|NCT02783300|473800986|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592874|NCT02783300|473800987|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592875|NCT02783300|473800988|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592876|NCT02783300|473800989|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131899245|NCT01096160|474917561|FG004|Overall Study|Met stopping criteria per protocol|1|||
131899246|NCT01096160|474917562|FG005|Overall Study|Met stopping criteria per protocol|0|||
131899247|NCT01096160|474917563|FG006|Overall Study|Met stopping criteria per protocol|2|||
131899248|NCT01096160|474917564|FG007|Overall Study|Met stopping criteria per protocol|0|||
131899249|NCT01096160|474917565|FG008|Overall Study|Met stopping criteria per protocol|2|||
131899250|NCT01096160|474917566|FG009|Overall Study|Met stopping criteria per protocol|0|||
131899251|NCT00922116|474917568|FG000|Overall Study|Adverse Event|4|||
131899252|NCT00922116|474917568|FG000|Overall Study|Death|1|||
131899253|NCT00922116|474917568|FG000|Overall Study|Lost to Follow-up|1|||
131899254|NCT00922116|474917568|FG000|Overall Study|Withdrawal by Subject|4|||
131899255|NCT00922116|474917568|FG000|Overall Study|Other|5|||
131899256|NCT04607135|474917569|FG000|Overall Study|Physician Decision|1|||
131899257|NCT04607135|474917569|FG000|Overall Study|Withdrawal by Subject|1|||
131899258|NCT04607135|474917569|FG000|Overall Study|Equipment not working|3|||
131899259|NCT06060496|474917570|FG000|Overall Study|Withdrawal by Subject|2|||
131899260|NCT06060496|474917570|FG000|Overall Study|Lost to Follow-up|2|||
131899261|NCT03990051|474917571|FG000|Masked Period|Lost to Follow-up|1|||
131899262|NCT03990051|474917572|FG001|Masked Period|Lost to Follow-up|0|||
131899263|NCT03990051|474917571|FG000|Long Term Period|Death|1|||
131592877|NCT02783300|473800990|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131592878|NCT02783300|473800964|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592879|NCT02783300|473800965|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592880|NCT02783300|473800966|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131899264|NCT03990051|474917572|FG001|Long Term Period|Death|1|||
131899265|NCT03990051|474917571|FG000|Long Term Period|Lost to Follow-up|7|||
131899266|NCT03990051|474917572|FG001|Long Term Period|Lost to Follow-up|2|||
131899267|NCT00618826|474917573|FG000|Overall Study|Adverse Event|1|||
131899268|NCT03193047|474917575|FG000|Overall Study|Physician Decision|1|||
131899269|NCT03193047|474917576|FG001|Overall Study|Physician Decision|0|||
131592881|NCT02783300|473800967|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592882|NCT02783300|473800968|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592883|NCT02783300|473800969|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592884|NCT02783300|473800970|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592885|NCT02783300|473800971|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592886|NCT02783300|473800972|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592887|NCT02783300|473800973|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592888|NCT02783300|473800974|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592889|NCT02783300|473800975|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592890|NCT02783300|473800976|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592891|NCT02783300|473800977|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
131592892|NCT02783300|473800978|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131592893|NCT02783300|473800979|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131592894|NCT02783300|473800980|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131592895|NCT02783300|473800981|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
131592896|NCT02783300|473800982|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131592897|NCT02783300|473800983|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
131592898|NCT02783300|473800984|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
131592899|NCT02783300|473800985|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
131592900|NCT02783300|473800986|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
131592901|NCT02783300|473800987|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
131592902|NCT02783300|473800988|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131592903|NCT02783300|473800989|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
131592904|NCT02783300|473800990|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131592905|NCT02783300|473800964|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592906|NCT02783300|473800965|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592907|NCT02783300|473800966|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592908|NCT02783300|473800967|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592909|NCT02783300|473800968|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592910|NCT02783300|473800969|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592911|NCT02783300|473800970|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592912|NCT02783300|473800971|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592913|NCT02783300|473800972|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592914|NCT02783300|473800973|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592915|NCT02783300|473800974|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592916|NCT02783300|473800975|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592917|NCT02783300|473800976|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592918|NCT02783300|473800977|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592919|NCT02783300|473800978|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592920|NCT02783300|473800979|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592921|NCT02783300|473800980|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592922|NCT02783300|473800981|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592923|NCT02783300|473800982|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592924|NCT02783300|473800983|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592925|NCT02783300|473800984|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592926|NCT02783300|473800985|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592927|NCT02783300|473800986|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592928|NCT02783300|473800987|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592929|NCT02783300|473800988|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131899270|NCT03193047|474917575|FG000|Overall Study|Participant Left State|1|||
131899271|NCT03193047|474917576|FG001|Overall Study|Participant Left State|0|||
131439191|NCT00880620|473233412|FG002|Overall Study|Death|1|||
131592930|NCT02783300|473800989|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131592931|NCT02783300|473800990|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
131592932|NCT02783300|473800964|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592933|NCT02783300|473800965|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592934|NCT02783300|473800966|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592935|NCT02783300|473800967|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592936|NCT02783300|473800968|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592937|NCT02783300|473800969|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592938|NCT02783300|473800970|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592939|NCT02783300|473800971|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592940|NCT02783300|473800972|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592941|NCT02783300|473800973|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592942|NCT02783300|473800974|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592943|NCT02783300|473800975|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592944|NCT02783300|473800976|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592945|NCT02783300|473800977|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592946|NCT02783300|473800978|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592947|NCT02783300|473800979|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592948|NCT02783300|473800980|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592949|NCT02783300|473800981|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592950|NCT02783300|473800982|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592951|NCT02783300|473800983|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592952|NCT02783300|473800984|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592953|NCT02783300|473800985|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592954|NCT02783300|473800986|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592955|NCT02783300|473800987|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592956|NCT02783300|473800988|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592957|NCT02783300|473800989|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
131592958|NCT02783300|473800990|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
131592959|NCT05192200|473800993|FG000|Treatment Period|Other|1|||
131592960|NCT05192200|473800993|FG000|Treatment Period|Lack of Efficacy|1|||
131592961|NCT05192200|473800993|FG000|Treatment Period|Withdrawal by Subject|1|||
131592962|NCT05192200|473800993|FG000|Follow-up|Withdrawal by Subject|1|||
131592963|NCT03978871|473800997|FG000|Overall Study|Lost to Follow-up|11|||
131592964|NCT03978871|473800998|FG001|Overall Study|Lost to Follow-up|12|||
131592965|NCT04072822|473800999|FG000|Treatment|Adverse Event|9|||
131592966|NCT04072822|473801000|FG001|Treatment|Adverse Event|5|||
131592967|NCT04072822|473800999|FG000|Treatment|Met Stopping Criteria|13|||
131592968|NCT04072822|473801000|FG001|Treatment|Met Stopping Criteria|24|||
131592969|NCT04072822|473800999|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
131592970|NCT04072822|473801000|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
131592971|NCT04072822|473800999|FG000|Treatment|Withdrawal by Subject|0|||
131592972|NCT04072822|473801000|FG001|Treatment|Withdrawal by Subject|2|||
131592973|NCT04072822|473800999|FG000|Treatment|Death|0|||
131592974|NCT04072822|473801000|FG001|Treatment|Death|2|||
131592975|NCT04072822|473800999|FG000|Treatment|Lost to Follow-up|11|||
131592976|NCT04072822|473801000|FG001|Treatment|Lost to Follow-up|3|||
131592977|NCT04072822|473800999|FG000|Treatment|Physician Decision|1|||
131592978|NCT04072822|473801000|FG001|Treatment|Physician Decision|0|||
131592979|NCT04072822|473800999|FG000|Treatment|Other|7|||
131592980|NCT04072822|473801000|FG001|Treatment|Other|9|||
131592981|NCT04072822|473800999|FG000|Follow-up|Withdrawal by Subject|1|||
131592982|NCT04072822|473801000|FG001|Follow-up|Withdrawal by Subject|0|||
131592983|NCT04072822|473800999|FG000|Follow-up|Lost to Follow-up|5|||
131592984|NCT04072822|473801000|FG001|Follow-up|Lost to Follow-up|4|||
131592985|NCT04391894|473801002|FG000|Overall Study|Adverse Event|1|||
131592986|NCT04391894|473801003|FG001|Overall Study|Adverse Event|1|||
131592987|NCT04391894|473801004|FG002|Overall Study|Adverse Event|1|||
131592988|NCT04391894|473801005|FG003|Overall Study|Adverse Event|1|||
131592989|NCT04391894|473801006|FG004|Overall Study|Adverse Event|1|||
131592990|NCT04391894|473801002|FG000|Overall Study|Lost to Follow-up|1|||
131592991|NCT04391894|473801003|FG001|Overall Study|Lost to Follow-up|0|||
131592992|NCT04391894|473801004|FG002|Overall Study|Lost to Follow-up|0|||
131592993|NCT04391894|473801005|FG003|Overall Study|Lost to Follow-up|0|||
131592994|NCT04391894|473801006|FG004|Overall Study|Lost to Follow-up|0|||
131592995|NCT04391894|473801002|FG000|Overall Study|Protocol Violation|0|||
131592996|NCT04391894|473801003|FG001|Overall Study|Protocol Violation|0|||
131592997|NCT04391894|473801004|FG002|Overall Study|Protocol Violation|0|||
131592998|NCT04391894|473801005|FG003|Overall Study|Protocol Violation|1|||
131592999|NCT04391894|473801006|FG004|Overall Study|Protocol Violation|0|||
131593000|NCT04391894|473801002|FG000|Overall Study|Withdrawal by Subject|2|||
131593001|NCT04391894|473801003|FG001|Overall Study|Withdrawal by Subject|0|||
131593002|NCT04391894|473801004|FG002|Overall Study|Withdrawal by Subject|3|||
131593003|NCT04391894|473801005|FG003|Overall Study|Withdrawal by Subject|0|||
131593004|NCT04391894|473801006|FG004|Overall Study|Withdrawal by Subject|1|||
131593005|NCT04391894|473801002|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
131593006|NCT04391894|473801003|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
131593007|NCT04391894|473801004|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
131593008|NCT04391894|473801005|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
131593009|NCT04391894|473801006|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
131593010|NCT00220740|473801012|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
131593011|NCT00220740|473801013|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
131593012|NCT00220740|473801012|FG000|Efficacy Period|Adverse Event|1|||
131593013|NCT00220740|473801013|FG001|Efficacy Period|Adverse Event|1|||
131593014|NCT00220740|473801012|FG000|Efficacy Period|Withdrawal by Subject|1|||
131593015|NCT00220740|473801013|FG001|Efficacy Period|Withdrawal by Subject|0|||
131593016|NCT00220740|473801012|FG000|Efficacy Period|Protocol Violation|1|||
131593017|NCT00220740|473801013|FG001|Efficacy Period|Protocol Violation|0|||
131593018|NCT00220740|473801012|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
131593019|NCT00220740|473801013|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
131593020|NCT01057433|473801014|FG000|Overall Study|Adverse Event|1|||
131593021|NCT05268302|473801015|FG000|Overall Study|Death|0|||
131593022|NCT05268302|473801016|FG001|Overall Study|Death|1|||
131593023|NCT01331005|473802526|FG000|Overall Study|Lost to Follow-up|2|||
131593024|NCT01331005|473802527|FG001|Overall Study|Lost to Follow-up|1|||
131593025|NCT01331005|473802526|FG000|Overall Study|Withdrawal by Subject|2|||
131593026|NCT01331005|473802527|FG001|Overall Study|Withdrawal by Subject|3|||
131593027|NCT03393975|473802529|FG000|Urgent Treatment Period|Physician Decision|0|||
131593028|NCT03393975|473802530|FG001|Urgent Treatment Period|Physician Decision|0|||
131593029|NCT03393975|473802531|FG002|Urgent Treatment Period|Physician Decision|0|||
131593030|NCT03393975|473802532|FG003|Urgent Treatment Period|Physician Decision|1|||
131593031|NCT03393975|473802529|FG000|Prophylaxis Period 1|Reason not Specified|0|||
131593032|NCT03393975|473802530|FG001|Prophylaxis Period 1|Reason not Specified|1|||
131593033|NCT03393975|473802531|FG002|Prophylaxis Period 1|Reason not Specified|0|||
131593034|NCT03393975|473802532|FG003|Prophylaxis Period 1|Reason not Specified|0|||
131593035|NCT03393975|473802529|FG000|Prophylaxis Period 2|Reason not Specified|0|||
131593036|NCT03393975|473802530|FG001|Prophylaxis Period 2|Reason not Specified|1|||
131593037|NCT03393975|473802531|FG002|Prophylaxis Period 2|Reason not Specified|0|||
131593038|NCT03393975|473802532|FG003|Prophylaxis Period 2|Reason not Specified|0|||
131593039|NCT04083235|473802536|FG000|Overall Study|Death|252|||
131593040|NCT04083235|473802537|FG001|Overall Study|Death|277|||
131593041|NCT04083235|473802536|FG000|Overall Study|Withdrawal by Subject|13|||
131593042|NCT04083235|473802537|FG001|Overall Study|Withdrawal by Subject|17|||
131593043|NCT04083235|473802536|FG000|Overall Study|Lost to Follow-up|1|||
131593044|NCT04083235|473802537|FG001|Overall Study|Lost to Follow-up|1|||
131593045|NCT04083235|473802536|FG000|Overall Study|Does not meet entry criteria|1|||
131593046|NCT04083235|473802537|FG001|Overall Study|Does not meet entry criteria|0|||
131593047|NCT04083235|473802536|FG000|Overall Study|Did not receive treatment|13|||
131593048|NCT04083235|473802537|FG001|Overall Study|Did not receive treatment|8|||
131593049|NCT04083235|473802536|FG000|Overall Study|Ongoing at the time of DCO|44|||
131593050|NCT04083235|473802537|FG001|Overall Study|Ongoing at the time of DCO|7|||
131593051|NCT05691309|473802540|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
131593052|NCT05691309|473802540|FG000|Overall Study|vancomycin levels not evaluable|2|||
131593053|NCT02724878|473802541|FG000|Overall Study|Still on Active Therapy|15|||
131593054|NCT02724878|473802541|FG000|Overall Study|Disease Progression|31|||
131593055|NCT02724878|473802541|FG000|Overall Study|Toxicity|5|||
131593056|NCT02724878|473802541|FG000|Overall Study|Death|1|||
131593057|NCT02724878|473802541|FG000|Overall Study|Withdrawal by Subject|4|||
131593058|NCT02724878|473802541|FG000|Overall Study|Lost to Follow-up|2|||
131593059|NCT02724878|473802541|FG000|Overall Study|Protocol Violation|1|||
131593060|NCT02724878|473802541|FG000|Overall Study|Ineligible for Study Drug|5|||
131593061|NCT02724878|473802541|FG000|Overall Study|not started|1|||
131593062|NCT01804816|473802542|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
131593063|NCT01804816|473802542|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
131593064|NCT04421378|473802548|FG000|Overall Study|Adverse Event|2|||
131593065|NCT04421378|473802549|FG001|Overall Study|Adverse Event|7|||
131593066|NCT04421378|473802550|FG002|Overall Study|Adverse Event|0|||
131593067|NCT04421378|473802551|FG003|Overall Study|Adverse Event|1|||
131593068|NCT04421378|473802552|FG004|Overall Study|Adverse Event|0|||
131593069|NCT04421378|473802548|FG000|Overall Study|Physician Decision|1|||
131706300|NCT02471716|474207353|FG002|Overall Study|Study Terminiated by sponsor|0|||
131706301|NCT02471716|474207354|FG003|Overall Study|Study Terminiated by sponsor|1|||
131706302|NCT02471716|474207355|FG004|Overall Study|Study Terminiated by sponsor|0|||
131593070|NCT04421378|473802549|FG001|Overall Study|Physician Decision|2|||
131593071|NCT04421378|473802550|FG002|Overall Study|Physician Decision|0|||
131593072|NCT04421378|473802551|FG003|Overall Study|Physician Decision|0|||
131706303|NCT02471716|474207351|FG000|Overall Study|Lost to Follow-up|0|||
131593073|NCT04421378|473802552|FG004|Overall Study|Physician Decision|0|||
131593074|NCT04421378|473802548|FG000|Overall Study|Progressive Disease|16|||
131593075|NCT04421378|473802549|FG001|Overall Study|Progressive Disease|4|||
131593076|NCT04421378|473802550|FG002|Overall Study|Progressive Disease|18|||
131593077|NCT04421378|473802551|FG003|Overall Study|Progressive Disease|11|||
131593078|NCT04421378|473802552|FG004|Overall Study|Progressive Disease|3|||
131593079|NCT04421378|473802548|FG000|Overall Study|Study Terminated by Sponsor|0|||
131593080|NCT04421378|473802549|FG001|Overall Study|Study Terminated by Sponsor|1|||
131593081|NCT04421378|473802550|FG002|Overall Study|Study Terminated by Sponsor|1|||
131593082|NCT04421378|473802551|FG003|Overall Study|Study Terminated by Sponsor|0|||
131593083|NCT04421378|473802552|FG004|Overall Study|Study Terminated by Sponsor|0|||
131593084|NCT04421378|473802548|FG000|Overall Study|Withdrawal by Subject|3|||
131593085|NCT04421378|473802549|FG001|Overall Study|Withdrawal by Subject|1|||
131593086|NCT04421378|473802550|FG002|Overall Study|Withdrawal by Subject|0|||
131593087|NCT04421378|473802551|FG003|Overall Study|Withdrawal by Subject|2|||
131593088|NCT04421378|473802552|FG004|Overall Study|Withdrawal by Subject|0|||
131593089|NCT04421378|473802548|FG000|Overall Study|Other|1|||
131593090|NCT04421378|473802549|FG001|Overall Study|Other|0|||
131593091|NCT04421378|473802550|FG002|Overall Study|Other|0|||
131593092|NCT04421378|473802551|FG003|Overall Study|Other|0|||
131593093|NCT04421378|473802552|FG004|Overall Study|Other|0|||
131593094|NCT04263311|473802553|FG000|Overall Study|Lost to Follow-up|1|||
131593095|NCT04263311|473802554|FG001|Overall Study|Lost to Follow-up|2|||
131593096|NCT04263311|473802555|FG002|Overall Study|Lost to Follow-up|0|||
131593097|NCT04263311|473802553|FG000|Overall Study|Health Issues|1|||
131593098|NCT04263311|473802554|FG001|Overall Study|Health Issues|0|||
131593099|NCT04263311|473802555|FG002|Overall Study|Health Issues|0|||
131593100|NCT04263311|473802553|FG000|Overall Study|Left the country|1|||
131593101|NCT04263311|473802554|FG001|Overall Study|Left the country|0|||
131593102|NCT04263311|473802555|FG002|Overall Study|Left the country|0|||
131593103|NCT04263311|473802553|FG000|Overall Study|Unable to maintain time commitment|1|||
131593104|NCT04263311|473802554|FG001|Overall Study|Unable to maintain time commitment|0|||
131593105|NCT04263311|473802555|FG002|Overall Study|Unable to maintain time commitment|0|||
131593106|NCT04263311|473802553|FG000|Overall Study|No longer interested|1|||
131593107|NCT04263311|473802554|FG001|Overall Study|No longer interested|0|||
131593108|NCT04263311|473802555|FG002|Overall Study|No longer interested|0|||
131593109|NCT04263311|473802553|FG000|Overall Study|Ineligible post consent|0|||
131593110|NCT04263311|473802554|FG001|Overall Study|Ineligible post consent|0|||
131593111|NCT04263311|473802555|FG002|Overall Study|Ineligible post consent|5|||
131593112|NCT02592330|473802556|FG000|Overall Study|Withdrawal by Subject|1|||
131593113|NCT02592330|473802557|FG001|Overall Study|Withdrawal by Subject|0|||
131593114|NCT02592330|473802556|FG000|Overall Study|Failed Biopsy|1|||
131593115|NCT02592330|473802557|FG001|Overall Study|Failed Biopsy|0|||
131593116|NCT04673929|473802558|FG000|Overall Study|Death|73|||
131593117|NCT04673929|473802558|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
131593118|NCT02807636|473802562|FG000|Overall Study|Lost to Follow-up|10|||
131593119|NCT02807636|473802563|FG001|Overall Study|Lost to Follow-up|13|||
131593120|NCT02807636|473802564|FG002|Overall Study|Lost to Follow-up|6|||
131593121|NCT02807636|473802562|FG000|Overall Study|Protocol Deviation|1|||
131593122|NCT02807636|473802563|FG001|Overall Study|Protocol Deviation|0|||
131593123|NCT02807636|473802564|FG002|Overall Study|Protocol Deviation|0|||
131593124|NCT02807636|473802562|FG000|Overall Study|Symptomatic Deterioration|0|||
131593125|NCT02807636|473802563|FG001|Overall Study|Symptomatic Deterioration|1|||
131593126|NCT02807636|473802564|FG002|Overall Study|Symptomatic Deterioration|0|||
131593127|NCT02807636|473802562|FG000|Overall Study|Withdrawal by Subject|39|||
131593128|NCT02807636|473802563|FG001|Overall Study|Withdrawal by Subject|28|||
131593129|NCT02807636|473802564|FG002|Overall Study|Withdrawal by Subject|24|||
131593130|NCT02807636|473802562|FG000|Overall Study|Death|303|||
131593131|NCT02807636|473802563|FG001|Overall Study|Death|332|||
131593132|NCT02807636|473802564|FG002|Overall Study|Death|272|||
131593133|NCT02807636|473802562|FG000|Overall Study|Study Terminated By Sponsor|47|||
131593134|NCT02807636|473802563|FG001|Overall Study|Study Terminated By Sponsor|76|||
131593135|NCT02807636|473802564|FG002|Overall Study|Study Terminated By Sponsor|60|||
131593136|NCT02807636|473802562|FG000|Overall Study|Physician Decision|0|||
131593137|NCT02807636|473802563|FG001|Overall Study|Physician Decision|1|||
131593138|NCT02807636|473802564|FG002|Overall Study|Physician Decision|0|||
131593139|NCT05082909|473802565|FG000|Overall Study|Protocol Violation|0|||
131593140|NCT05082909|473802566|FG001|Overall Study|Protocol Violation|0|||
131593141|NCT05082909|473802567|FG002|Overall Study|Protocol Violation|1|||
131593142|NCT05082909|473802568|FG003|Overall Study|Protocol Violation|0|||
131593143|NCT05082909|473802569|FG004|Overall Study|Protocol Violation|0|||
131593144|NCT05082909|473802570|FG005|Overall Study|Protocol Violation|0|||
131593145|NCT04088630|473802571|FG000|Overall Study|Lost to Follow-up|3|||
131593146|NCT04088630|473802572|FG001|Overall Study|Lost to Follow-up|2|||
131593147|NCT04088630|473802573|FG002|Overall Study|Lost to Follow-up|6|||
131593148|NCT04088630|473802571|FG000|Overall Study|Death|3|||
131593149|NCT04088630|473802572|FG001|Overall Study|Death|1|||
131593150|NCT04088630|473802573|FG002|Overall Study|Death|1|||
131593151|NCT04088630|473802571|FG000|Overall Study|Physician Decision|0|||
131593152|NCT04088630|473802572|FG001|Overall Study|Physician Decision|1|||
131593153|NCT04088630|473802573|FG002|Overall Study|Physician Decision|1|||
131593154|NCT03175029|473802574|FG000|Overall Study|Withdrawal by Subject|2|||
131593155|NCT03175029|473802575|FG001|Overall Study|Withdrawal by Subject|1|||
131593156|NCT03175029|473802574|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
131593157|NCT03175029|473802575|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
131593158|NCT03315754|473802578|FG000|Overall Study|COVID-19 complications leading to death|1|||
131593159|NCT03315754|473802578|FG000|Overall Study|insurance coverage issue|1|||
131593160|NCT05227209|473802580|FG000|Overall Study|Adverse Event|11|||
131593161|NCT05227209|473802580|FG000|Overall Study|Lost to Follow-up|1|||
131593162|NCT05227209|473802580|FG000|Overall Study|Withdrawal by Subject|7|||
131593163|NCT05227209|473802580|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
131593164|NCT04245501|473802581|FG000|Overall Study|Adverse Event|2|||
131593165|NCT04245501|473802582|FG001|Overall Study|Adverse Event|0|||
131593166|NCT04245501|473802581|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
131593167|NCT04245501|473802582|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
131593168|NCT01426425|473802583|FG000|Overall Study|Exited prior to EP study|22|||
131593169|NCT01426425|473802583|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
131593170|NCT01426425|473802583|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
131593171|NCT03281291|473802589|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
131593172|NCT03281291|473802590|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
131593173|NCT03281291|473802591|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
131593174|NCT03281291|473802592|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
131593175|NCT03281291|473802593|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
131593176|NCT03281291|473802589|FG000|Overall Study|Protocol Deviation|2|||
131593177|NCT03281291|473802590|FG001|Overall Study|Protocol Deviation|0|||
131593178|NCT03281291|473802591|FG002|Overall Study|Protocol Deviation|1|||
131593179|NCT03281291|473802592|FG003|Overall Study|Protocol Deviation|2|||
131593180|NCT03281291|473802593|FG004|Overall Study|Protocol Deviation|1|||
131593181|NCT03281291|473802589|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
131593182|NCT03281291|473802590|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131593183|NCT03281291|473802591|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
131593184|NCT03281291|473802592|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131593185|NCT03281291|473802593|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
131593186|NCT03281291|473802589|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
131593187|NCT03281291|473802590|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
131593188|NCT03281291|473802591|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
131593189|NCT03281291|473802592|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
131593190|NCT03281291|473802593|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
131593191|NCT03281291|473802589|FG000|Overall Study|Lost to Follow-up|10|||
131593192|NCT03281291|473802590|FG001|Overall Study|Lost to Follow-up|10|||
131593193|NCT03281291|473802591|FG002|Overall Study|Lost to Follow-up|4|||
131593194|NCT03281291|473802592|FG003|Overall Study|Lost to Follow-up|6|||
131593195|NCT03281291|473802593|FG004|Overall Study|Lost to Follow-up|10|||
131593196|NCT03281291|473802589|FG000|Overall Study|Other|0|||
131593197|NCT03281291|473802590|FG001|Overall Study|Other|2|||
131593198|NCT03281291|473802591|FG002|Overall Study|Other|0|||
131593199|NCT03281291|473802592|FG003|Overall Study|Other|2|||
131899272|NCT01509664|474917579|FG000|Overall Study|Lost to Follow-up|15|||
131439192|NCT00880620|473233413|FG003|Overall Study|Death|0|||
131439193|NCT00880620|473233410|FG000|Overall Study|Lack of Efficacy|12|||
131439194|NCT00880620|473233411|FG001|Overall Study|Lack of Efficacy|4|||
131439195|NCT00880620|473233412|FG002|Overall Study|Lack of Efficacy|0|||
131593200|NCT03281291|473802593|FG004|Overall Study|Other|1|||
131593201|NCT00512070|473802596|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
131593202|NCT00512070|473802597|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
131593203|NCT00512070|473802598|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
131593204|NCT00512070|473802596|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
131593205|NCT00512070|473802597|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
131593206|NCT00512070|473802598|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
131593207|NCT00961571|473802599|FG000|Overall Study|Physician Decision|39|||
131439196|NCT00880620|473233413|FG003|Overall Study|Lack of Efficacy|1|||
131593208|NCT02506959|473802601|FG000|Overall Study|Physician Decision|2|||
131593209|NCT02506959|473802602|FG001|Overall Study|Physician Decision|1|||
131593210|NCT02312557|473802603|FG000|Overall Study|Survival follow-up|4|||
131593211|NCT04237298|473802604|FG000|Overall Study|Lost to Follow-up|4|||
131593212|NCT04237298|473802605|FG001|Overall Study|Lost to Follow-up|5|||
131593213|NCT04390048|473802606|FG000|Overall Study|Withdrawal by Subject|1|||
131593214|NCT04390048|473802607|FG001|Overall Study|Withdrawal by Subject|3|||
131593215|NCT00170573|473802609|FG000|Overall Study|Violation of inclusion criteria|13|||
131593216|NCT04556656|473802610|FG000|Overall Study|Withdrawal by Subject|14|||
131593217|NCT04556656|473802611|FG001|Overall Study|Withdrawal by Subject|12|||
131593218|NCT04556656|473802610|FG000|Overall Study|Physician Decision|1|||
131593219|NCT04556656|473802611|FG001|Overall Study|Physician Decision|0|||
131593220|NCT04556656|473802610|FG000|Overall Study|Adverse Event|4|||
131593221|NCT04556656|473802611|FG001|Overall Study|Adverse Event|7|||
131593222|NCT04556656|473802610|FG000|Overall Study|Death|4|||
131593223|NCT04556656|473802611|FG001|Overall Study|Death|0|||
131593224|NCT04556656|473802610|FG000|Overall Study|Lost to Follow-up|3|||
131593225|NCT04556656|473802611|FG001|Overall Study|Lost to Follow-up|2|||
131593226|NCT04556656|473802610|FG000|Overall Study|Not further specified|2|||
131593227|NCT04556656|473802611|FG001|Overall Study|Not further specified|1|||
131593228|NCT04588298|473802614|FG000|Overall Study|Adverse Event|0|||
131593229|NCT04588298|473802615|FG001|Overall Study|Adverse Event|0|||
131593230|NCT04588298|473802616|FG002|Overall Study|Adverse Event|1|||
131593231|NCT04588298|473802617|FG003|Overall Study|Adverse Event|0|||
131593232|NCT04588298|473802618|FG004|Overall Study|Adverse Event|2|||
131593233|NCT04588298|473802614|FG000|Overall Study|Withdrawal by Subject|1|||
131593234|NCT04588298|473802615|FG001|Overall Study|Withdrawal by Subject|0|||
131593235|NCT04588298|473802616|FG002|Overall Study|Withdrawal by Subject|0|||
131593236|NCT04588298|473802617|FG003|Overall Study|Withdrawal by Subject|1|||
131593237|NCT04588298|473802618|FG004|Overall Study|Withdrawal by Subject|0|||
131593238|NCT03846505|473802620|FG000|Treatment Phase|Withdrawal by Subject|9|||
131593239|NCT03846505|473802621|FG001|Treatment Phase|Withdrawal by Subject|11|||
131593240|NCT03846505|473802620|FG000|Treatment Phase|Lost to Follow-up|6|||
131593241|NCT03846505|473802621|FG001|Treatment Phase|Lost to Follow-up|2|||
131593242|NCT03846505|473802620|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
131593243|NCT03846505|473802621|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
131593244|NCT03846505|473802620|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
131593245|NCT03846505|473802621|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
131593246|NCT03535272|473802624|FG000|Overall Study|Lost to Follow-up|71|||
131593247|NCT03535272|473802625|FG001|Overall Study|Lost to Follow-up|73|||
131706304|NCT02471716|474207352|FG001|Overall Study|Lost to Follow-up|0|||
131706305|NCT02471716|474207353|FG002|Overall Study|Lost to Follow-up|0|||
131706306|NCT02471716|474207354|FG003|Overall Study|Lost to Follow-up|3|||
131706307|NCT02471716|474207355|FG004|Overall Study|Lost to Follow-up|2|||
131706308|NCT02471716|474207351|FG000|Overall Study|Death|0|||
131706309|NCT02471716|474207352|FG001|Overall Study|Death|0|||
131706310|NCT02471716|474207353|FG002|Overall Study|Death|0|||
131706311|NCT02471716|474207354|FG003|Overall Study|Death|1|||
131706312|NCT02471716|474207355|FG004|Overall Study|Death|0|||
131706313|NCT02471716|474207351|FG000|Overall Study|Other|0|||
131706314|NCT02471716|474207352|FG001|Overall Study|Other|0|||
131706315|NCT02471716|474207353|FG002|Overall Study|Other|0|||
131706316|NCT02471716|474207354|FG003|Overall Study|Other|8|||
131706317|NCT02471716|474207355|FG004|Overall Study|Other|9|||
131706318|NCT01737931|474207358|FG000|Overall Study|Withdrawal by Subject|0|||
131706319|NCT01737931|474207359|FG001|Overall Study|Withdrawal by Subject|1|||
131706320|NCT01737931|474207360|FG002|Overall Study|Withdrawal by Subject|1|||
131706321|NCT01737931|474207358|FG000|Overall Study|Physician Decision|0|||
131706322|NCT01737931|474207359|FG001|Overall Study|Physician Decision|1|||
131706323|NCT01737931|474207360|FG002|Overall Study|Physician Decision|0|||
131706324|NCT03183128|474207363|FG000|Overall Study|Adverse Event|1|||
131706325|NCT03183128|474207364|FG001|Overall Study|Adverse Event|2|||
131706326|NCT03183128|474207363|FG000|Overall Study|Withdrawal by Subject|1|||
131706327|NCT03183128|474207364|FG001|Overall Study|Withdrawal by Subject|8|||
131706328|NCT03183128|474207363|FG000|Overall Study|Protocol Violation|2|||
131593248|NCT03892616|473802626|FG000|Washout Period 2|Met discontinuation criterion|0|||
131593249|NCT03892616|473802627|FG001|Washout Period 2|Met discontinuation criterion|0|||
131593250|NCT03892616|473802628|FG002|Washout Period 2|Met discontinuation criterion|0|||
131593251|NCT03892616|473802629|FG003|Washout Period 2|Met discontinuation criterion|0|||
131593252|NCT03892616|473802630|FG004|Washout Period 2|Met discontinuation criterion|0|||
131593253|NCT03892616|473802631|FG005|Washout Period 2|Met discontinuation criterion|0|||
131593254|NCT03892616|473802632|FG006|Washout Period 2|Met discontinuation criterion|0|||
131593255|NCT03892616|473802633|FG007|Washout Period 2|Met discontinuation criterion|0|||
131706329|NCT03183128|474207364|FG001|Overall Study|Protocol Violation|0|||
131706330|NCT03183128|474207363|FG000|Overall Study|Lack of Efficacy|4|||
131706331|NCT03183128|474207364|FG001|Overall Study|Lack of Efficacy|27|||
131706332|NCT03183128|474207363|FG000|Overall Study|Lost to Follow-up|1|||
131706333|NCT03183128|474207364|FG001|Overall Study|Lost to Follow-up|0|||
131593256|NCT03892616|473802634|FG008|Washout Period 2|Met discontinuation criterion|1|||
131593257|NCT03892616|473802635|FG009|Washout Period 2|Met discontinuation criterion|0|||
131593258|NCT03892616|473802636|FG010|Washout Period 2|Met discontinuation criterion|0|||
131593259|NCT03892616|473802637|FG011|Washout Period 2|Met discontinuation criterion|0|||
131593260|NCT00378105|473802638|FG000|Overall Study|Adverse Event|3|||
131593261|NCT00378105|473802639|FG001|Overall Study|Adverse Event|1|||
131593262|NCT00378105|473802638|FG000|Overall Study|Withdrawal by Subject|3|||
131593263|NCT00378105|473802639|FG001|Overall Study|Withdrawal by Subject|3|||
131593264|NCT00378105|473802638|FG000|Overall Study|Death|1|||
131593265|NCT00378105|473802639|FG001|Overall Study|Death|0|||
131593266|NCT00378105|473802638|FG000|Overall Study|Going to transplant|7|||
131593267|NCT00378105|473802639|FG001|Overall Study|Going to transplant|8|||
131593268|NCT00378105|473802638|FG000|Overall Study|Progressive disease|3|||
131593269|NCT00378105|473802639|FG001|Overall Study|Progressive disease|3|||
131593270|NCT00378105|473802638|FG000|Overall Study|remain on study|3|||
131593271|NCT00378105|473802639|FG001|Overall Study|remain on study|11|||
131593272|NCT00378105|473802638|FG000|Overall Study|Physician Decision|0|||
131593273|NCT00378105|473802639|FG001|Overall Study|Physician Decision|2|||
131593274|NCT00378105|473802638|FG000|Overall Study|Going non-protocol therapy|0|||
131593275|NCT00378105|473802639|FG001|Overall Study|Going non-protocol therapy|1|||
131593276|NCT00378105|473802638|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
131593277|NCT00378105|473802639|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
131593278|NCT04533347|473802643|FG000|Overall Study|Adverse Event|1|||
131593279|NCT04533347|473802644|FG001|Overall Study|Adverse Event|2|||
131593280|NCT04533347|473802643|FG000|Overall Study|Lost to Follow-up|2|||
131593281|NCT04533347|473802644|FG001|Overall Study|Lost to Follow-up|0|||
131593282|NCT04533347|473802643|FG000|Overall Study|Withdrawal by Subject|1|||
131593283|NCT04533347|473802644|FG001|Overall Study|Withdrawal by Subject|0|||
131593284|NCT03907397|473802645|FG000|Overall Study|Lost to Follow-up|0|||
131593285|NCT03907397|473802646|FG001|Overall Study|Lost to Follow-up|1|||
131593286|NCT03907397|473802645|FG000|Overall Study|Physician Decision|2|||
131593287|NCT03907397|473802646|FG001|Overall Study|Physician Decision|1|||
131593288|NCT03907397|473802645|FG000|Overall Study|Withdrawal by Subject|5|||
131593289|NCT03907397|473802646|FG001|Overall Study|Withdrawal by Subject|4|||
131593290|NCT03907397|473802645|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
131593291|NCT03907397|473802646|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
131593292|NCT05592418|473802652|FG000|Overall Study|Adverse Event|1|||
131593293|NCT05592418|473802653|FG001|Overall Study|Adverse Event|0|||
131593294|NCT05592418|473802652|FG000|Overall Study|Lost to Follow-up|1|||
131593295|NCT05592418|473802653|FG001|Overall Study|Lost to Follow-up|3|||
131593296|NCT05592418|473802652|FG000|Overall Study|Withdrawal by Subject|2|||
131593297|NCT05592418|473802653|FG001|Overall Study|Withdrawal by Subject|7|||
131593298|NCT05569252|473802657|FG000|Overall Study|Adverse event (central vision loss)|1|||
131593299|NCT05569252|473802658|FG001|Overall Study|Adverse event (central vision loss)|0|||
131593300|NCT05569252|473802659|FG002|Overall Study|Adverse event (central vision loss)|0|||
131593301|NCT05569252|473802660|FG003|Overall Study|Adverse event (central vision loss)|0|||
131593302|NCT03665597|473802661|FG000|Period 1|Adverse Event|1|||
131593303|NCT03665597|473802662|FG001|Period 1|Adverse Event|0|||
131593304|NCT03665597|473802663|FG002|Period 1|Adverse Event|0|||
131593305|NCT03665597|473802664|FG003|Period 1|Adverse Event|1|||
131593306|NCT03665597|473802665|FG004|Period 1|Adverse Event|0|||
131593307|NCT03665597|473802666|FG005|Period 1|Adverse Event|0|||
131593308|NCT03665597|473802667|FG006|Period 1|Adverse Event|0|||
131593309|NCT03665597|473802661|FG000|Period 1|Screen Failure|0|||
131593310|NCT03665597|473802662|FG001|Period 1|Screen Failure|0|||
131593311|NCT03665597|473802663|FG002|Period 1|Screen Failure|0|||
131593312|NCT03665597|473802664|FG003|Period 1|Screen Failure|1|||
131593313|NCT03665597|473802665|FG004|Period 1|Screen Failure|0|||
131593314|NCT03665597|473802666|FG005|Period 1|Screen Failure|0|||
131593315|NCT03665597|473802667|FG006|Period 1|Screen Failure|0|||
131593316|NCT03665597|473802661|FG000|Period 1|Death|0|||
131593317|NCT03665597|473802662|FG001|Period 1|Death|0|||
131593318|NCT03665597|473802663|FG002|Period 1|Death|0|||
131593319|NCT03665597|473802664|FG003|Period 1|Death|0|||
131593320|NCT03665597|473802665|FG004|Period 1|Death|0|||
131593321|NCT03665597|473802666|FG005|Period 1|Death|0|||
131593322|NCT03665597|473802667|FG006|Period 1|Death|45|||
131593323|NCT03665597|473802661|FG000|Period 1|Withdrawal by Subject|0|||
131593324|NCT03665597|473802662|FG001|Period 1|Withdrawal by Subject|0|||
131593325|NCT03665597|473802663|FG002|Period 1|Withdrawal by Subject|0|||
131593326|NCT03665597|473802664|FG003|Period 1|Withdrawal by Subject|0|||
131593327|NCT03665597|473802665|FG004|Period 1|Withdrawal by Subject|0|||
131593328|NCT03665597|473802666|FG005|Period 1|Withdrawal by Subject|0|||
131593329|NCT03665597|473802667|FG006|Period 1|Withdrawal by Subject|5|||
131593330|NCT03665597|473802661|FG000|Period 2|Adverse Event|0|||
131593331|NCT03665597|473802662|FG001|Period 2|Adverse Event|0|||
131593332|NCT03665597|473802663|FG002|Period 2|Adverse Event|0|||
131593333|NCT03665597|473802664|FG003|Period 2|Adverse Event|0|||
131593334|NCT03665597|473802665|FG004|Period 2|Adverse Event|0|||
131593335|NCT03665597|473802666|FG005|Period 2|Adverse Event|1|||
131593336|NCT03665597|473802667|FG006|Period 2|Adverse Event|0|||
131593337|NCT03665597|473802661|FG000|Period 3|Adverse Event|0|||
131593338|NCT03665597|473802662|FG001|Period 3|Adverse Event|1|||
131593339|NCT03665597|473802663|FG002|Period 3|Adverse Event|0|||
131593340|NCT03665597|473802664|FG003|Period 3|Adverse Event|0|||
131593341|NCT03665597|473802665|FG004|Period 3|Adverse Event|0|||
131593342|NCT03665597|473802666|FG005|Period 3|Adverse Event|0|||
131593343|NCT03665597|473802667|FG006|Period 3|Adverse Event|0|||
131593344|NCT03665597|473802661|FG000|Period 3|Death|0|||
131593345|NCT03665597|473802662|FG001|Period 3|Death|0|||
131593346|NCT03665597|473802663|FG002|Period 3|Death|0|||
131593347|NCT03665597|473802664|FG003|Period 3|Death|0|||
131593348|NCT03665597|473802665|FG004|Period 3|Death|1|||
131593349|NCT03665597|473802666|FG005|Period 3|Death|0|||
131593350|NCT03665597|473802667|FG006|Period 3|Death|0|||
131593351|NCT03665597|473802661|FG000|Period 4|Adverse Event|2|||
131593352|NCT03665597|473802662|FG001|Period 4|Adverse Event|2|||
131593353|NCT03665597|473802663|FG002|Period 4|Adverse Event|2|||
131593354|NCT03665597|473802664|FG003|Period 4|Adverse Event|2|||
131593355|NCT03665597|473802665|FG004|Period 4|Adverse Event|1|||
131593356|NCT03665597|473802666|FG005|Period 4|Adverse Event|0|||
131593357|NCT03665597|473802667|FG006|Period 4|Adverse Event|0|||
131593358|NCT03665597|473802661|FG000|Period 4|Death|0|||
131593359|NCT03665597|473802662|FG001|Period 4|Death|0|||
131593360|NCT03665597|473802663|FG002|Period 4|Death|2|||
131593361|NCT03665597|473802664|FG003|Period 4|Death|0|||
131593362|NCT03665597|473802665|FG004|Period 4|Death|0|||
131593363|NCT03665597|473802666|FG005|Period 4|Death|0|||
131593364|NCT03665597|473802667|FG006|Period 4|Death|0|||
131593365|NCT03665597|473802661|FG000|Period 4|Physician Decision|1|||
131593366|NCT03665597|473802662|FG001|Period 4|Physician Decision|2|||
131593367|NCT03665597|473802663|FG002|Period 4|Physician Decision|0|||
131593368|NCT03665597|473802664|FG003|Period 4|Physician Decision|0|||
131593369|NCT03665597|473802665|FG004|Period 4|Physician Decision|0|||
131593370|NCT03665597|473802666|FG005|Period 4|Physician Decision|0|||
131593371|NCT03665597|473802667|FG006|Period 4|Physician Decision|0|||
131593372|NCT04831216|473802670|FG000|Overall Study|Lost to Follow-up|32|||
131706334|NCT03183128|474207363|FG000|Overall Study|Death|2|||
131706335|NCT03183128|474207364|FG001|Overall Study|Death|0|||
131706336|NCT03183128|474207363|FG000|Overall Study|Physician Decision|1|||
131593373|NCT05021640|473803926|FG000|Overall Study|Lost to Follow-up|0|||
131593374|NCT05021640|473803927|FG001|Overall Study|Lost to Follow-up|0|||
131593375|NCT05021640|473803928|FG002|Overall Study|Lost to Follow-up|0|||
131593376|NCT05021640|473803929|FG003|Overall Study|Lost to Follow-up|0|||
131593377|NCT05021640|473803930|FG004|Overall Study|Lost to Follow-up|1|||
131593378|NCT04737772|473803931|FG000|Phase 2 Study|Lost to Follow-up|15|||
131593379|NCT04737772|473803932|FG001|Phase 2 Study|Lost to Follow-up|15|||
131593380|NCT04737772|473803931|FG000|Phase 2 Study|Withdrawal by Subject|0|||
131593381|NCT04737772|473803932|FG001|Phase 2 Study|Withdrawal by Subject|1|||
131593382|NCT04737772|473803931|FG000|Phase 2 Study|Did not take any coaching calls|4|||
131593383|NCT04737772|473803932|FG001|Phase 2 Study|Did not take any coaching calls|0|||
131593384|NCT04737772|473803931|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
131593385|NCT04737772|473803932|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
131593386|NCT04737772|473803931|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
131593387|NCT04737772|473803932|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
131593388|NCT04060355|473803935|FG000|Overall Study|Lost to Follow-up|41|||
131593389|NCT01140880|473803936|FG000|Overall Study|Death|0|||
131593390|NCT01140880|473803937|FG001|Overall Study|Death|1|||
131593391|NCT01140880|473803936|FG000|Overall Study|Withdrawal by Subject|6|||
131593392|NCT01140880|473803937|FG001|Overall Study|Withdrawal by Subject|3|||
131593393|NCT01140880|473803936|FG000|Overall Study|Lost to Follow-up|8|||
131593394|NCT01140880|473803937|FG001|Overall Study|Lost to Follow-up|10|||
131593395|NCT01140880|473803936|FG000|Overall Study|Protocol Violation|0|||
131593396|NCT01140880|473803937|FG001|Overall Study|Protocol Violation|30|||
131593397|NCT03090152|473803939|FG000|Overall Study|Withdrawal by Subject|0|||
131593398|NCT03090152|473803940|FG001|Overall Study|Withdrawal by Subject|2|||
131593399|NCT03090152|473803941|FG002|Overall Study|Withdrawal by Subject|1|||
131593400|NCT03090152|473803939|FG000|Overall Study|Surgery Canceled|1|||
131593401|NCT03090152|473803940|FG001|Overall Study|Surgery Canceled|0|||
131593402|NCT03090152|473803941|FG002|Overall Study|Surgery Canceled|0|||
131593403|NCT03090152|473803939|FG000|Overall Study|Epidural catheter could not be placed|0|||
131593404|NCT03090152|473803940|FG001|Overall Study|Epidural catheter could not be placed|2|||
131593405|NCT03090152|473803941|FG002|Overall Study|Epidural catheter could not be placed|0|||
131593406|NCT02927769|473803942|FG000|Induction Phase|Study drug toxicity|1|||
131593407|NCT02927769|473803943|FG001|Induction Phase|Study drug toxicity|1|||
131593408|NCT02927769|473803942|FG000|Induction Phase|Disease progression|0|||
131593409|NCT02927769|473803943|FG001|Induction Phase|Disease progression|1|||
131593410|NCT02927769|473803942|FG000|Intensification Phase|Study drug toxicity|1|||
131593411|NCT02927769|473803943|FG001|Intensification Phase|Study drug toxicity|0|||
131593412|NCT02954341|473803944|FG000|Overall Study|Attempted Implant unsuccessful|5|||
131593413|NCT02954341|473803944|FG000|Overall Study|Death|90|||
131593414|NCT02954341|473803944|FG000|Overall Study|Withdrawal by Subject|4|||
131593415|NCT02954341|473803944|FG000|Overall Study|Physician Decision|13|||
131593416|NCT02954341|473803944|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
131593417|NCT02954341|473803944|FG000|Overall Study|Not implanted due to physician's decision|1|||
131593418|NCT02954341|473803944|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
131593419|NCT04024813|473803947|FG000|Overall Study|Study terminated by Sponsor|1|||
131593420|NCT02729311|473803948|FG000|Overall Study|Withdrawal by Subject|8|||
131593421|NCT02729311|473803949|FG001|Overall Study|Withdrawal by Subject|2|||
131593422|NCT04321031|473803954|FG000|Overall Study|Adverse Event|0|||
131593423|NCT04321031|473803955|FG001|Overall Study|Adverse Event|2|||
131593424|NCT04321031|473803956|FG002|Overall Study|Adverse Event|2|||
131593425|NCT04321031|473803957|FG003|Overall Study|Adverse Event|2|||
131593426|NCT04321031|473803958|FG004|Overall Study|Adverse Event|2|||
131593427|NCT04321031|473803959|FG005|Overall Study|Adverse Event|2|||
131593428|NCT04321031|473803960|FG006|Overall Study|Adverse Event|0|||
131593429|NCT04321031|473803954|FG000|Overall Study|Lost to Follow-up|0|||
131593430|NCT04321031|473803955|FG001|Overall Study|Lost to Follow-up|0|||
131593431|NCT04321031|473803956|FG002|Overall Study|Lost to Follow-up|0|||
131593432|NCT04321031|473803957|FG003|Overall Study|Lost to Follow-up|1|||
131593433|NCT04321031|473803958|FG004|Overall Study|Lost to Follow-up|0|||
131593434|NCT04321031|473803959|FG005|Overall Study|Lost to Follow-up|2|||
131593435|NCT04321031|473803960|FG006|Overall Study|Lost to Follow-up|1|||
131593436|NCT04321031|473803954|FG000|Overall Study|Withdrawal by Subject|2|||
131593437|NCT04321031|473803955|FG001|Overall Study|Withdrawal by Subject|2|||
131593438|NCT04321031|473803956|FG002|Overall Study|Withdrawal by Subject|1|||
131593439|NCT04321031|473803957|FG003|Overall Study|Withdrawal by Subject|3|||
131593440|NCT04321031|473803958|FG004|Overall Study|Withdrawal by Subject|1|||
131593441|NCT04321031|473803959|FG005|Overall Study|Withdrawal by Subject|0|||
131593442|NCT04321031|473803960|FG006|Overall Study|Withdrawal by Subject|1|||
131593443|NCT04321031|473803954|FG000|Overall Study|Non-compliance with study drug|0|||
131593444|NCT04321031|473803955|FG001|Overall Study|Non-compliance with study drug|0|||
131593445|NCT04321031|473803956|FG002|Overall Study|Non-compliance with study drug|0|||
131593446|NCT04321031|473803957|FG003|Overall Study|Non-compliance with study drug|0|||
131593447|NCT04321031|473803958|FG004|Overall Study|Non-compliance with study drug|0|||
131593448|NCT04321031|473803959|FG005|Overall Study|Non-compliance with study drug|1|||
131593449|NCT04321031|473803960|FG006|Overall Study|Non-compliance with study drug|0|||
131593450|NCT04321031|473803954|FG000|Overall Study|Other|0|||
131593451|NCT04321031|473803955|FG001|Overall Study|Other|0|||
131593452|NCT04321031|473803956|FG002|Overall Study|Other|0|||
131593453|NCT04321031|473803957|FG003|Overall Study|Other|1|||
131593454|NCT04321031|473803958|FG004|Overall Study|Other|0|||
131593455|NCT04321031|473803959|FG005|Overall Study|Other|0|||
131593456|NCT04321031|473803960|FG006|Overall Study|Other|0|||
131593457|NCT03143153|473803963|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
131593458|NCT03143153|473803964|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
131593459|NCT03143153|473803965|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
131593460|NCT03143153|473803963|FG000|Pre-Treatment|Participant withdrew consent|0|||
131593461|NCT03143153|473803964|FG001|Pre-Treatment|Participant withdrew consent|1|||
131593462|NCT03143153|473803965|FG002|Pre-Treatment|Participant withdrew consent|12|||
131593463|NCT03143153|473803963|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
131593464|NCT03143153|473803964|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
131593465|NCT03143153|473803965|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
131593466|NCT03143153|473803963|FG000|Pre-Treatment|Other Reasons|1|||
131593467|NCT03143153|473803964|FG001|Pre-Treatment|Other Reasons|2|||
131593468|NCT03143153|473803965|FG002|Pre-Treatment|Other Reasons|1|||
131593469|NCT03143153|473803963|FG000|Pre-Treatment|Disease Progression|1|||
131593470|NCT03143153|473803964|FG001|Pre-Treatment|Disease Progression|1|||
131593471|NCT03143153|473803965|FG002|Pre-Treatment|Disease Progression|2|||
131593472|NCT03143153|473803963|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
131593473|NCT03143153|473803964|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
131593474|NCT03143153|473803965|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
131593475|NCT03143153|473803963|FG000|Treatment|Disease progression|174|||
131593476|NCT03143153|473803964|FG001|Treatment|Disease progression|184|||
131593477|NCT03143153|473803965|FG002|Treatment|Disease progression|193|||
131593478|NCT03143153|473803963|FG000|Treatment|Study drug toxicity|59|||
131593479|NCT03143153|473803964|FG001|Treatment|Study drug toxicity|33|||
131593480|NCT03143153|473803965|FG002|Treatment|Study drug toxicity|40|||
131593481|NCT03143153|473803963|FG000|Treatment|Death|5|||
131593482|NCT03143153|473803964|FG001|Treatment|Death|3|||
131593483|NCT03143153|473803965|FG002|Treatment|Death|4|||
131593484|NCT03143153|473803963|FG000|Treatment|Adverse event unrelated to study drug|19|||
131593485|NCT03143153|473803964|FG001|Treatment|Adverse event unrelated to study drug|28|||
131593486|NCT03143153|473803965|FG002|Treatment|Adverse event unrelated to study drug|12|||
131593487|NCT03143153|473803963|FG000|Treatment|Participant request to discontinue study treatment|13|||
131593488|NCT03143153|473803964|FG001|Treatment|Participant request to discontinue study treatment|15|||
131593489|NCT03143153|473803965|FG002|Treatment|Participant request to discontinue study treatment|20|||
131593490|NCT03143153|473803963|FG000|Treatment|Participant withdrew consent|3|||
131593491|NCT03143153|473803964|FG001|Treatment|Participant withdrew consent|4|||
131593492|NCT03143153|473803965|FG002|Treatment|Participant withdrew consent|12|||
131593493|NCT03143153|473803963|FG000|Treatment|Pregnancy|1|||
131593494|NCT03143153|473803964|FG001|Treatment|Pregnancy|0|||
131593495|NCT03143153|473803965|FG002|Treatment|Pregnancy|0|||
131593496|NCT03143153|473803963|FG000|Treatment|Maximum clinical benefit|1|||
131593497|NCT03143153|473803964|FG001|Treatment|Maximum clinical benefit|3|||
131593498|NCT03143153|473803965|FG002|Treatment|Maximum clinical benefit|4|||
131593499|NCT03143153|473803963|FG000|Treatment|Completed treatment as per Protocol|13|||
131593500|NCT03143153|473803964|FG001|Treatment|Completed treatment as per Protocol|8|||
131593501|NCT03143153|473803965|FG002|Treatment|Completed treatment as per Protocol|0|||
131593502|NCT03143153|473803963|FG000|Treatment|Other reasons|12|||
131593503|NCT03143153|473803964|FG001|Treatment|Other reasons|7|||
131593504|NCT03143153|473803965|FG002|Treatment|Other reasons|15|||
131593505|NCT03143153|473803963|FG000|Treatment|Not reported|1|||
131593506|NCT03143153|473803964|FG001|Treatment|Not reported|0|||
131593507|NCT03143153|473803965|FG002|Treatment|Not reported|0|||
131593508|NCT02530671|473803966|FG000|Overall Study|Lost to Follow-up|2|||
131593509|NCT02530671|473803967|FG001|Overall Study|Lost to Follow-up|0|||
131593510|NCT02530671|473803966|FG000|Overall Study|Withdrawal by Subject|1|||
131593511|NCT02530671|473803967|FG001|Overall Study|Withdrawal by Subject|0|||
131593512|NCT01415154|473803968|FG000|Overall Study|Lack of Efficacy|4|||
131593513|NCT01415154|473803969|FG001|Overall Study|Lack of Efficacy|5|||
131593514|NCT01415154|473803968|FG000|Overall Study|Withdrawal by Subject|7|||
131593515|NCT01415154|473803969|FG001|Overall Study|Withdrawal by Subject|8|||
131593516|NCT01415154|473803968|FG000|Overall Study|Lost to Follow-up|1|||
131593517|NCT01415154|473803969|FG001|Overall Study|Lost to Follow-up|4|||
131593518|NCT01415154|473803968|FG000|Overall Study|Protocol Violation|0|||
131593519|NCT01415154|473803969|FG001|Overall Study|Protocol Violation|1|||
131593520|NCT01415154|473803968|FG000|Overall Study|Satisfactory Response|0|||
131593521|NCT01415154|473803969|FG001|Overall Study|Satisfactory Response|1|||
131593522|NCT01415154|473803968|FG000|Overall Study|Adverse Event|1|||
131593523|NCT01415154|473803969|FG001|Overall Study|Adverse Event|1|||
131593524|NCT06283173|473803985|FG000|Overall Study|Did not show for first visit|10|||
131593525|NCT06283173|473803985|FG000|Overall Study|Lost to Follow-up|12|||
131593526|NCT06283173|473803985|FG000|Overall Study|Physician Decision|7|||
131593527|NCT05470400|473803990|FG000|Overall Study|Lost to Follow-up|0|||
131899273|NCT01509664|474917580|FG001|Overall Study|Lost to Follow-up|21|||
131899274|NCT00149396|474917587|FG000|Overall Study|Death|15|||
131593528|NCT05470400|473803991|FG001|Overall Study|Lost to Follow-up|0|||
131593529|NCT05470400|473803992|FG002|Overall Study|Lost to Follow-up|0|||
131593530|NCT05470400|473803993|FG003|Overall Study|Lost to Follow-up|0|||
131593531|NCT05470400|473803994|FG004|Overall Study|Lost to Follow-up|0|||
131593532|NCT05470400|473803995|FG005|Overall Study|Lost to Follow-up|0|||
131593533|NCT05470400|473803996|FG006|Overall Study|Lost to Follow-up|0|||
131593534|NCT05470400|473803997|FG007|Overall Study|Lost to Follow-up|1|||
131899275|NCT00149396|474917587|FG000|Overall Study|Withdrawal by Subject|1|||
131899276|NCT00149396|474917587|FG000|Overall Study|Subject noncompliance|2|||
131439197|NCT00880620|473233410|FG000|Overall Study|Lost to Follow-up|0|||
131593535|NCT05470400|473803990|FG000|Overall Study|Withdrawal by Subject|1|||
131593536|NCT05470400|473803991|FG001|Overall Study|Withdrawal by Subject|0|||
131593537|NCT05470400|473803992|FG002|Overall Study|Withdrawal by Subject|0|||
131593538|NCT05470400|473803993|FG003|Overall Study|Withdrawal by Subject|0|||
131593539|NCT05470400|473803994|FG004|Overall Study|Withdrawal by Subject|0|||
131593540|NCT05470400|473803995|FG005|Overall Study|Withdrawal by Subject|1|||
131593541|NCT05470400|473803996|FG006|Overall Study|Withdrawal by Subject|0|||
131593542|NCT05470400|473803997|FG007|Overall Study|Withdrawal by Subject|2|||
131593543|NCT03138512|473803998|FG000|Randomization|Participants withdrew consent|0|||
131593544|NCT03138512|473803999|FG001|Randomization|Participants withdrew consent|1|||
131593545|NCT03138512|473804000|FG002|Randomization|Participants withdrew consent|1|||
131593546|NCT03138512|473804001|FG003|Randomization|Participants withdrew consent|0|||
131593547|NCT03138512|473804002|FG004|Randomization|Participants withdrew consent|0|||
131593548|NCT03138512|473803998|FG000|Randomization|Participant no longer meets study criteria|0|||
131593549|NCT03138512|473803999|FG001|Randomization|Participant no longer meets study criteria|3|||
131593550|NCT03138512|473804000|FG002|Randomization|Participant no longer meets study criteria|1|||
131593551|NCT03138512|473804001|FG003|Randomization|Participant no longer meets study criteria|1|||
131593552|NCT03138512|473804002|FG004|Randomization|Participant no longer meets study criteria|3|||
131593553|NCT03138512|473803998|FG000|Randomization|Other reasons|1|||
131593554|NCT03138512|473803999|FG001|Randomization|Other reasons|0|||
131593555|NCT03138512|473804000|FG002|Randomization|Other reasons|0|||
131593556|NCT03138512|473804001|FG003|Randomization|Other reasons|0|||
131593557|NCT03138512|473804002|FG004|Randomization|Other reasons|0|||
131593558|NCT03138512|473803998|FG000|Treatment Part A|Disease recurrence|10|||
131593559|NCT03138512|473803999|FG001|Treatment Part A|Disease recurrence|20|||
131593560|NCT03138512|473804000|FG002|Treatment Part A|Disease recurrence|0|||
131593561|NCT03138512|473804001|FG003|Treatment Part A|Disease recurrence|0|||
131593562|NCT03138512|473804002|FG004|Treatment Part A|Disease recurrence|0|||
131593563|NCT03138512|473803998|FG000|Treatment Part A|Study Drug Toxicity|132|||
131593564|NCT03138512|473803999|FG001|Treatment Part A|Study Drug Toxicity|5|||
131593565|NCT03138512|473804000|FG002|Treatment Part A|Study Drug Toxicity|0|||
131593566|NCT03138512|473804001|FG003|Treatment Part A|Study Drug Toxicity|0|||
131593567|NCT03138512|473804002|FG004|Treatment Part A|Study Drug Toxicity|0|||
131593568|NCT03138512|473803998|FG000|Treatment Part A|Death|1|||
131593569|NCT03138512|473803999|FG001|Treatment Part A|Death|0|||
131593570|NCT03138512|473804000|FG002|Treatment Part A|Death|0|||
131593571|NCT03138512|473804001|FG003|Treatment Part A|Death|0|||
131593572|NCT03138512|473804002|FG004|Treatment Part A|Death|0|||
131593573|NCT03138512|473803998|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
131593574|NCT03138512|473803999|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
131593575|NCT03138512|473804000|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
131593576|NCT03138512|473804001|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
131593577|NCT03138512|473804002|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
131593578|NCT03138512|473803998|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
131593579|NCT03138512|473803999|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
131593580|NCT03138512|473804000|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
131593581|NCT03138512|473804001|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
131593582|NCT03138512|473804002|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
131593583|NCT03138512|473803998|FG000|Treatment Part A|Participant withdrew consent|2|||
131593584|NCT03138512|473803999|FG001|Treatment Part A|Participant withdrew consent|4|||
131593585|NCT03138512|473804000|FG002|Treatment Part A|Participant withdrew consent|0|||
131593586|NCT03138512|473804001|FG003|Treatment Part A|Participant withdrew consent|0|||
131593587|NCT03138512|473804002|FG004|Treatment Part A|Participant withdrew consent|0|||
131593588|NCT03138512|473803998|FG000|Treatment Part A|Lost to Follow-up|0|||
131593589|NCT03138512|473803999|FG001|Treatment Part A|Lost to Follow-up|1|||
131593590|NCT03138512|473804000|FG002|Treatment Part A|Lost to Follow-up|0|||
131593591|NCT03138512|473804001|FG003|Treatment Part A|Lost to Follow-up|0|||
131593592|NCT03138512|473804002|FG004|Treatment Part A|Lost to Follow-up|0|||
131593593|NCT03138512|473803998|FG000|Treatment Part A|Poor/non-compliance|1|||
131593594|NCT03138512|473803999|FG001|Treatment Part A|Poor/non-compliance|0|||
131899277|NCT00149396|474917587|FG000|Overall Study|other treatment|5|||
131439198|NCT00880620|473233411|FG001|Overall Study|Lost to Follow-up|1|||
131439199|NCT00880620|473233412|FG002|Overall Study|Lost to Follow-up|1|||
131593595|NCT03138512|473804000|FG002|Treatment Part A|Poor/non-compliance|0|||
131899278|NCT02364388|474917588|FG000|Overall Study|Protocol Violation|1|||
131593596|NCT03138512|473804001|FG003|Treatment Part A|Poor/non-compliance|0|||
131593597|NCT03138512|473804002|FG004|Treatment Part A|Poor/non-compliance|0|||
131593598|NCT03138512|473803998|FG000|Treatment Part A|Pregnancy|0|||
131593599|NCT03138512|473803999|FG001|Treatment Part A|Pregnancy|1|||
131593600|NCT03138512|473804000|FG002|Treatment Part A|Pregnancy|0|||
131593601|NCT03138512|473804001|FG003|Treatment Part A|Pregnancy|0|||
131593602|NCT03138512|473804002|FG004|Treatment Part A|Pregnancy|0|||
131593603|NCT03138512|473803998|FG000|Treatment Part A|Other reasons|11|||
131593604|NCT03138512|473803999|FG001|Treatment Part A|Other reasons|8|||
131593605|NCT03138512|473804000|FG002|Treatment Part A|Other reasons|0|||
131593606|NCT03138512|473804001|FG003|Treatment Part A|Other reasons|0|||
131593607|NCT03138512|473804002|FG004|Treatment Part A|Other reasons|0|||
131593608|NCT03138512|473803998|FG000|Treatment Part B|Disease recurrence|0|||
131593609|NCT03138512|473803999|FG001|Treatment Part B|Disease recurrence|0|||
131593610|NCT03138512|473804000|FG002|Treatment Part B|Disease recurrence|6|||
131593611|NCT03138512|473804001|FG003|Treatment Part B|Disease recurrence|12|||
131593612|NCT03138512|473804002|FG004|Treatment Part B|Disease recurrence|10|||
131593613|NCT03138512|473803998|FG000|Treatment Part B|Study drug toxicity|0|||
131593614|NCT03138512|473803999|FG001|Treatment Part B|Study drug toxicity|0|||
131593615|NCT03138512|473804000|FG002|Treatment Part B|Study drug toxicity|63|||
131593616|NCT03138512|473804001|FG003|Treatment Part B|Study drug toxicity|3|||
131593617|NCT03138512|473804002|FG004|Treatment Part B|Study drug toxicity|45|||
131593618|NCT03138512|473803998|FG000|Treatment Part B|Death|0|||
131593619|NCT03138512|473803999|FG001|Treatment Part B|Death|0|||
131593620|NCT03138512|473804000|FG002|Treatment Part B|Death|1|||
131593621|NCT03138512|473804001|FG003|Treatment Part B|Death|0|||
131593622|NCT03138512|473804002|FG004|Treatment Part B|Death|0|||
131593623|NCT03138512|473803998|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
131593624|NCT03138512|473803999|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
131593625|NCT03138512|473804000|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
131593626|NCT03138512|473804001|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
131593627|NCT03138512|473804002|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
131593628|NCT03138512|473803998|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
131593629|NCT03138512|473803999|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
131593630|NCT03138512|473804000|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
131593631|NCT03138512|473804001|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
131593632|NCT03138512|473804002|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
131593633|NCT03138512|473803998|FG000|Treatment Part B|Participant withdrew consent|0|||
131593634|NCT03138512|473803999|FG001|Treatment Part B|Participant withdrew consent|0|||
131593635|NCT03138512|473804000|FG002|Treatment Part B|Participant withdrew consent|1|||
131593636|NCT03138512|473804001|FG003|Treatment Part B|Participant withdrew consent|1|||
131593637|NCT03138512|473804002|FG004|Treatment Part B|Participant withdrew consent|2|||
131593638|NCT03138512|473803998|FG000|Treatment Part B|Lost to Follow-up|0|||
131593639|NCT03138512|473803999|FG001|Treatment Part B|Lost to Follow-up|0|||
131593640|NCT03138512|473804000|FG002|Treatment Part B|Lost to Follow-up|0|||
131593641|NCT03138512|473804001|FG003|Treatment Part B|Lost to Follow-up|1|||
131593642|NCT03138512|473804002|FG004|Treatment Part B|Lost to Follow-up|0|||
131593643|NCT03138512|473803998|FG000|Treatment Part B|Poor/non-compliance|0|||
131593644|NCT03138512|473803999|FG001|Treatment Part B|Poor/non-compliance|0|||
131593645|NCT03138512|473804000|FG002|Treatment Part B|Poor/non-compliance|1|||
131593646|NCT03138512|473804001|FG003|Treatment Part B|Poor/non-compliance|1|||
131593647|NCT03138512|473804002|FG004|Treatment Part B|Poor/non-compliance|1|||
131593648|NCT03138512|473803998|FG000|Treatment Part B|Other reasons|0|||
131593649|NCT03138512|473803999|FG001|Treatment Part B|Other reasons|0|||
131593650|NCT03138512|473804000|FG002|Treatment Part B|Other reasons|3|||
131593651|NCT03138512|473804001|FG003|Treatment Part B|Other reasons|1|||
131593652|NCT03138512|473804002|FG004|Treatment Part B|Other reasons|5|||
131593653|NCT05687916|473804005|FG000|Overall Study|Adverse Event|1|||
131593654|NCT05687916|473804006|FG001|Overall Study|Adverse Event|2|||
131593655|NCT05687916|473804007|FG002|Overall Study|Adverse Event|0|||
131593656|NCT05687916|473804005|FG000|Overall Study|Withdrawal by Subject|1|||
131593657|NCT05687916|473804006|FG001|Overall Study|Withdrawal by Subject|0|||
131593658|NCT05687916|473804007|FG002|Overall Study|Withdrawal by Subject|1|||
131593659|NCT05687916|473804005|FG000|Overall Study|Protocol Violation|0|||
131593660|NCT05687916|473804006|FG001|Overall Study|Protocol Violation|2|||
131593661|NCT05687916|473804007|FG002|Overall Study|Protocol Violation|1|||
131593662|NCT05687916|473804005|FG000|Overall Study|Reason not Specified|1|||
131593663|NCT05687916|473804006|FG001|Overall Study|Reason not Specified|0|||
131593664|NCT05687916|473804007|FG002|Overall Study|Reason not Specified|0|||
131593665|NCT03332017|473804008|FG000|Overall Study|Lost to Follow-up|1|||
131593666|NCT03332017|473804009|FG001|Overall Study|Lost to Follow-up|2|||
131593667|NCT03332017|473804008|FG000|Overall Study|Death|17|||
131593668|NCT03332017|473804009|FG001|Overall Study|Death|16|||
131593669|NCT03332017|473804008|FG000|Overall Study|Withdrawal by Subject|6|||
131593670|NCT03332017|473804009|FG001|Overall Study|Withdrawal by Subject|14|||
131593671|NCT03332017|473804008|FG000|Overall Study|Other|1|||
131593672|NCT03332017|473804009|FG001|Overall Study|Other|3|||
131593673|NCT03332017|473804008|FG000|Overall Study|Remained in Study (Ongoing)|47|||
131593674|NCT03332017|473804009|FG001|Overall Study|Remained in Study (Ongoing)|110|||
131593675|NCT03436745|473804010|FG000|Overall Study|Ineligible|0|||
131593676|NCT03436745|473804011|FG001|Overall Study|Ineligible|0|||
131593677|NCT03436745|473804012|FG002|Overall Study|Ineligible|1|||
131593678|NCT01809691|473804013|FG000|Overall Study|Currently on Treatment|192|||
131593679|NCT01809691|473804014|FG001|Overall Study|Currently on Treatment|100|||
131593680|NCT01809691|473804013|FG000|Overall Study|No Protocol Treatment|10|||
131593681|NCT01809691|473804014|FG001|Overall Study|No Protocol Treatment|11|||
131593682|NCT01809691|473804013|FG000|Overall Study|Adverse Event|80|||
131593683|NCT01809691|473804014|FG001|Overall Study|Adverse Event|21|||
131593684|NCT01809691|473804013|FG000|Overall Study|Disease Progression|226|||
131593685|NCT01809691|473804014|FG001|Overall Study|Disease Progression|372|||
131593686|NCT01809691|473804013|FG000|Overall Study|Death|26|||
131593687|NCT01809691|473804014|FG001|Overall Study|Death|13|||
131593688|NCT01809691|473804013|FG000|Overall Study|Participant Refusal|70|||
131593689|NCT01809691|473804014|FG001|Overall Study|Participant Refusal|72|||
131593690|NCT01809691|473804013|FG000|Overall Study|Other, Not Specified|34|||
131593691|NCT01809691|473804014|FG001|Overall Study|Other, Not Specified|52|||
131593692|NCT01580488|473804017|FG000|Overall Study|Withdrawal by Subject|1|||
131593693|NCT04401800|473804020|FG000|Overall Study|Death|17|||
131593694|NCT04401800|473804020|FG000|Overall Study|Lost to Follow-up|5|||
131593695|NCT04401800|473804020|FG000|Overall Study|Withdrawal by Subject|4|||
131593696|NCT03338790|473804027|FG000|Overall Study|Disease Progression|65|||
131593697|NCT03338790|473804028|FG001|Overall Study|Disease Progression|43|||
131593698|NCT03338790|473804029|FG002|Overall Study|Disease Progression|50|||
131593699|NCT03338790|473804030|FG003|Overall Study|Disease Progression|37|||
131593700|NCT03338790|473804027|FG000|Overall Study|Study Drug Toxicity|9|||
131593701|NCT03338790|473804028|FG001|Overall Study|Study Drug Toxicity|8|||
131593702|NCT03338790|473804029|FG002|Overall Study|Study Drug Toxicity|15|||
131593703|NCT03338790|473804030|FG003|Overall Study|Study Drug Toxicity|0|||
131593704|NCT03338790|473804027|FG000|Overall Study|Death|1|||
131593705|NCT03338790|473804028|FG001|Overall Study|Death|1|||
131593706|NCT03338790|473804029|FG002|Overall Study|Death|1|||
131593707|NCT03338790|473804030|FG003|Overall Study|Death|0|||
131593708|NCT03338790|473804027|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
131593709|NCT03338790|473804028|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
131593710|NCT03338790|473804029|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
131593711|NCT03338790|473804030|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
131593712|NCT03338790|473804027|FG000|Overall Study|Participant request to discontinue study treatment|3|||
131593713|NCT03338790|473804028|FG001|Overall Study|Participant request to discontinue study treatment|3|||
131593714|NCT03338790|473804029|FG002|Overall Study|Participant request to discontinue study treatment|2|||
131593715|NCT03338790|473804030|FG003|Overall Study|Participant request to discontinue study treatment|1|||
131593716|NCT03338790|473804027|FG000|Overall Study|Poor/non-compliance|0|||
131593717|NCT03338790|473804028|FG001|Overall Study|Poor/non-compliance|1|||
131593718|NCT03338790|473804029|FG002|Overall Study|Poor/non-compliance|0|||
131593719|NCT03338790|473804030|FG003|Overall Study|Poor/non-compliance|0|||
131593720|NCT03338790|473804027|FG000|Overall Study|Participant withdrew consent|1|||
131593721|NCT03338790|473804028|FG001|Overall Study|Participant withdrew consent|0|||
131593722|NCT03338790|473804029|FG002|Overall Study|Participant withdrew consent|1|||
131593723|NCT03338790|473804030|FG003|Overall Study|Participant withdrew consent|1|||
131593724|NCT03338790|473804027|FG000|Overall Study|Other reasons|0|||
131593725|NCT03338790|473804028|FG001|Overall Study|Other reasons|5|||
131593726|NCT03338790|473804029|FG002|Overall Study|Other reasons|0|||
131593727|NCT03338790|473804030|FG003|Overall Study|Other reasons|2|||
131593728|NCT03338790|473804027|FG000|Overall Study|Not reported|0|||
131593729|NCT03338790|473804028|FG001|Overall Study|Not reported|0|||
131593730|NCT03338790|473804029|FG002|Overall Study|Not reported|1|||
131593731|NCT03338790|473804030|FG003|Overall Study|Not reported|0|||
131593732|NCT03338790|473804027|FG000|Overall Study|Completed treatment period|1|||
131593733|NCT03338790|473804028|FG001|Overall Study|Completed treatment period|2|||
131593734|NCT03338790|473804029|FG002|Overall Study|Completed treatment period|0|||
131593735|NCT03338790|473804030|FG003|Overall Study|Completed treatment period|0|||
131593736|NCT03110315|473804035|FG000|Overall Study|Withdrawal by Subject|1|||
131593737|NCT03110315|473804036|FG001|Overall Study|Withdrawal by Subject|0|||
131593738|NCT04727554|473804038|FG000|Overall Study|Lost to Follow-up|0|||
131593739|NCT04727554|473804039|FG001|Overall Study|Lost to Follow-up|1|||
131593740|NCT04727554|473804038|FG000|Overall Study|Death|2|||
131593741|NCT04727554|473804039|FG001|Overall Study|Death|6|||
131593742|NCT04727554|473804038|FG000|Overall Study|Withdrawal by Subject|1|||
131593743|NCT04727554|473804039|FG001|Overall Study|Withdrawal by Subject|0|||
131593744|NCT03930342|473804040|FG000|Overall Study|Lost to Follow-up|70|||
131593745|NCT03930342|473804041|FG001|Overall Study|Lost to Follow-up|77|||
131593746|NCT05034952|473805736|FG000|Overall Study|Adverse Event|1|||
131593747|NCT05034952|473805737|FG001|Overall Study|Adverse Event|0|||
131593748|NCT05034952|473805738|FG002|Overall Study|Adverse Event|0|||
131593749|NCT05034952|473805739|FG003|Overall Study|Adverse Event|0|||
131593750|NCT05034952|473805736|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131593751|NCT05034952|473805737|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
131593752|NCT05034952|473805738|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
131593753|NCT05034952|473805739|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
131593754|NCT05034952|473805736|FG000|Overall Study|Lost to Follow-up|1|||
131593755|NCT05034952|473805737|FG001|Overall Study|Lost to Follow-up|4|||
131593756|NCT05034952|473805738|FG002|Overall Study|Lost to Follow-up|3|||
131593757|NCT05034952|473805739|FG003|Overall Study|Lost to Follow-up|3|||
131593758|NCT05034952|473805736|FG000|Overall Study|Other|0|||
131593759|NCT05034952|473805737|FG001|Overall Study|Other|0|||
131593760|NCT05034952|473805738|FG002|Overall Study|Other|0|||
131593761|NCT05034952|473805739|FG003|Overall Study|Other|1|||
131593762|NCT04950660|473805744|FG000|Overall Study|Protocol Violation|4|||
131593763|NCT04950660|473805745|FG001|Overall Study|Protocol Violation|2|||
131593764|NCT04950660|473805744|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
131593765|NCT04950660|473805745|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
131593766|NCT04950660|473805744|FG000|Overall Study|Withdrawal by Subject|0|||
131593767|NCT04950660|473805745|FG001|Overall Study|Withdrawal by Subject|1|||
131593768|NCT04950660|473805744|FG000|Overall Study|Hypotension|1|||
131593769|NCT04950660|473805745|FG001|Overall Study|Hypotension|0|||
131593770|NCT02437318|473805748|FG000|Overall Study|Progressive disease|207|||
131593771|NCT02437318|473805749|FG001|Overall Study|Progressive disease|240|||
131593772|NCT02437318|473805748|FG000|Overall Study|Subject/guardian decision|24|||
131593773|NCT02437318|473805749|FG001|Overall Study|Subject/guardian decision|11|||
131593774|NCT02437318|473805748|FG000|Overall Study|Physician Decision|29|||
131593775|NCT02437318|473805749|FG001|Overall Study|Physician Decision|22|||
131593776|NCT02437318|473805748|FG000|Overall Study|Adverse Event|14|||
131593777|NCT02437318|473805749|FG001|Overall Study|Adverse Event|4|||
131593778|NCT02437318|473805748|FG000|Overall Study|Death|4|||
131593779|NCT02437318|473805749|FG001|Overall Study|Death|4|||
131593780|NCT02437318|473805748|FG000|Overall Study|Protocol deviation|5|||
131593781|NCT02437318|473805749|FG001|Overall Study|Protocol deviation|7|||
131593782|NCT02437318|473805748|FG000|Overall Study|Sponsor decision|1|||
131593783|NCT02437318|473805749|FG001|Overall Study|Sponsor decision|0|||
131593784|NCT00920621|473805751|FG000|Overall Study|Lost to Follow-up|16|||
131593785|NCT00920621|473805752|FG001|Overall Study|Lost to Follow-up|17|||
131593786|NCT00920621|473805753|FG002|Overall Study|Lost to Follow-up|19|||
131593787|NCT00920621|473805754|FG003|Overall Study|Lost to Follow-up|21|||
131593788|NCT00920621|473805751|FG000|Overall Study|Fetal/neonatal deaths|16|||
131593789|NCT00920621|473805752|FG001|Overall Study|Fetal/neonatal deaths|14|||
131593790|NCT00920621|473805753|FG002|Overall Study|Fetal/neonatal deaths|16|||
131593791|NCT00920621|473805754|FG003|Overall Study|Fetal/neonatal deaths|14|||
131593792|NCT00920621|473805751|FG000|Overall Study|Blood sample not collected|22|||
131593793|NCT00920621|473805752|FG001|Overall Study|Blood sample not collected|14|||
131593794|NCT00920621|473805753|FG002|Overall Study|Blood sample not collected|0|||
131593795|NCT00920621|473805754|FG003|Overall Study|Blood sample not collected|0|||
131593796|NCT02736409|473805755|FG000|Overall Study|Withdrawal by Subject|4|||
131593797|NCT02736409|473805756|FG001|Overall Study|Withdrawal by Subject|2|||
131593798|NCT02736409|473805757|FG002|Overall Study|Withdrawal by Subject|17|||
131593799|NCT02736409|473805758|FG003|Overall Study|Withdrawal by Subject|3|||
131593800|NCT02736409|473805755|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131593801|NCT02736409|473805756|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131593802|NCT02736409|473805757|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131593803|NCT02736409|473805758|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131593804|NCT02736409|473805755|FG000|Overall Study|Adverse Event|0|||
131593805|NCT02736409|473805756|FG001|Overall Study|Adverse Event|1|||
131593806|NCT02736409|473805757|FG002|Overall Study|Adverse Event|5|||
131593807|NCT02736409|473805758|FG003|Overall Study|Adverse Event|4|||
131593808|NCT02736409|473805755|FG000|Overall Study|Other|0|||
131593809|NCT02736409|473805756|FG001|Overall Study|Other|0|||
131593810|NCT02736409|473805757|FG002|Overall Study|Other|1|||
131593811|NCT02736409|473805758|FG003|Overall Study|Other|1|||
131593812|NCT02736409|473805755|FG000|Overall Study|Pregnancy|0|||
131593813|NCT02736409|473805756|FG001|Overall Study|Pregnancy|0|||
131593814|NCT02736409|473805757|FG002|Overall Study|Pregnancy|1|||
131593815|NCT02736409|473805758|FG003|Overall Study|Pregnancy|0|||
131593816|NCT02736409|473805755|FG000|Overall Study|Lost to Follow-up|0|||
131593817|NCT02736409|473805756|FG001|Overall Study|Lost to Follow-up|0|||
131593818|NCT02736409|473805757|FG002|Overall Study|Lost to Follow-up|2|||
131593819|NCT02736409|473805758|FG003|Overall Study|Lost to Follow-up|1|||
131593820|NCT02736409|473805755|FG000|Overall Study|Physician Decision|0|||
131593821|NCT02736409|473805756|FG001|Overall Study|Physician Decision|0|||
131593822|NCT02736409|473805757|FG002|Overall Study|Physician Decision|0|||
131593823|NCT02736409|473805758|FG003|Overall Study|Physician Decision|2|||
131593824|NCT05536440|473805762|FG000|Overall Study|Adverse Event|0|||
131593825|NCT05536440|473805763|FG001|Overall Study|Adverse Event|0|||
131593826|NCT05536440|473805764|FG002|Overall Study|Adverse Event|0|||
131593827|NCT05536440|473805765|FG003|Overall Study|Adverse Event|0|||
131593828|NCT05536440|473805766|FG004|Overall Study|Adverse Event|0|||
131593829|NCT05536440|473805767|FG005|Overall Study|Adverse Event|0|||
131593830|NCT05536440|473805768|FG006|Overall Study|Adverse Event|0|||
131593831|NCT05536440|473805769|FG007|Overall Study|Adverse Event|0|||
131593832|NCT05536440|473805770|FG008|Overall Study|Adverse Event|1|||
131593833|NCT05323084|473805771|FG000|Period 2 - Washout|Lost to Follow-up|0|||
131593834|NCT05323084|473805772|FG001|Period 2 - Washout|Lost to Follow-up|1|||
131593835|NCT04382404|473805773|FG000|Overall Study|Adverse Event|1|||
131593836|NCT04382404|473805773|FG000|Overall Study|Lost to Follow-up|2|||
131593837|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
131593838|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
131593839|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
131593840|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593841|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593842|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593843|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593844|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593845|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593846|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593847|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593848|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593849|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131593850|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
131593851|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
131593852|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593853|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593854|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593855|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593856|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593857|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593858|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593859|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593860|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593861|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593862|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131593863|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
131593864|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
131593865|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593866|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593867|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593868|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593869|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593870|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593871|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593872|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593873|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593874|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593875|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131593876|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
131593877|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
131593878|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593879|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593880|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593881|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593882|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593883|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593884|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593885|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593886|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593887|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593888|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131593889|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
131593890|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
131593891|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
131593892|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593893|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593894|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593895|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593896|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593897|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593898|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131439200|NCT00880620|473233413|FG003|Overall Study|Lost to Follow-up|0|||
131593899|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593900|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593901|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131593902|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
131593903|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
131593904|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
131593905|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593906|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593907|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593908|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593909|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593910|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593911|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593912|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593913|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593914|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131593915|NCT01261312|473805775|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
131593916|NCT01261312|473805776|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593917|NCT01261312|473805777|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
131593918|NCT01261312|473805778|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593919|NCT01261312|473805779|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593920|NCT01261312|473805780|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593921|NCT01261312|473805781|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593922|NCT01261312|473805782|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593923|NCT01261312|473805783|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593924|NCT01261312|473805784|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593925|NCT01261312|473805785|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593926|NCT01261312|473805786|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593927|NCT01261312|473805787|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131593928|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593929|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593930|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593931|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
131593932|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
131593933|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
131593934|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593935|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593936|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593937|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593938|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593939|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593940|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131593941|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593942|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593943|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593944|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593945|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
131593946|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
131593947|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593948|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593949|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593950|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593951|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593952|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593953|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131593954|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593955|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593956|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131706337|NCT03183128|474207364|FG001|Overall Study|Physician Decision|0|||
131706338|NCT00364182|474207365|FG000|First Intervention|Secondary prophylaxis|1|||
131439201|NCT00880620|473233410|FG000|Overall Study|Protocol Violation|0|||
131439202|NCT00880620|473233411|FG001|Overall Study|Protocol Violation|1|||
131439203|NCT00880620|473233412|FG002|Overall Study|Protocol Violation|0|||
131439204|NCT00880620|473233413|FG003|Overall Study|Protocol Violation|2|||
131439205|NCT00880620|473233410|FG000|Overall Study|Withdrawal by Subject|4|||
131439206|NCT00880620|473233411|FG001|Overall Study|Withdrawal by Subject|3|||
131439207|NCT00880620|473233412|FG002|Overall Study|Withdrawal by Subject|1|||
131439208|NCT00880620|473233413|FG003|Overall Study|Withdrawal by Subject|3|||
131439209|NCT00880620|473233410|FG000|Overall Study|Noncompliance|0|||
131439210|NCT00880620|473233411|FG001|Overall Study|Noncompliance|0|||
131439211|NCT00880620|473233412|FG002|Overall Study|Noncompliance|1|||
131439212|NCT00880620|473233413|FG003|Overall Study|Noncompliance|1|||
131439213|NCT00880620|473233410|FG000|Overall Study|Other|1|||
131439214|NCT00880620|473233411|FG001|Overall Study|Other|1|||
131439215|NCT00880620|473233412|FG002|Overall Study|Other|2|||
131439216|NCT00880620|473233413|FG003|Overall Study|Other|2|||
131439217|NCT00301808|473233415|FG000|Overall Study|Adverse Event|5|||
131439218|NCT00301808|473233415|FG000|Overall Study|Death|3|||
131439219|NCT00301808|473233415|FG000|Overall Study|Lack of Efficacy|4|||
131439220|NCT05893862|473233422|FG000|Overall Study|Physician Decision|0|||
131439221|NCT05893862|473233423|FG001|Overall Study|Physician Decision|1|||
131439222|NCT05893862|473233424|FG002|Overall Study|Physician Decision|0|||
131439223|NCT05893862|473233425|FG003|Overall Study|Physician Decision|0|||
131439224|NCT05893862|473233426|FG004|Overall Study|Physician Decision|1|||
131439225|NCT05893862|473233427|FG005|Overall Study|Physician Decision|0|||
131439226|NCT05893862|473233422|FG000|Overall Study|Withdrawal by Subject|1|||
131439227|NCT05893862|473233423|FG001|Overall Study|Withdrawal by Subject|7|||
131439228|NCT05893862|473233424|FG002|Overall Study|Withdrawal by Subject|1|||
131439229|NCT05893862|473233425|FG003|Overall Study|Withdrawal by Subject|3|||
131439230|NCT05893862|473233426|FG004|Overall Study|Withdrawal by Subject|3|||
131439231|NCT05893862|473233427|FG005|Overall Study|Withdrawal by Subject|2|||
131593957|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593958|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
131593959|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
131593960|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593961|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593962|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593963|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593964|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593965|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593966|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131593967|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593968|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593969|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593970|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
131593971|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
131593972|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
131593973|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593974|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593975|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593976|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593977|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593978|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593979|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
131593980|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593981|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593982|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593983|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593984|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593985|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
131593986|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593987|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593988|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593989|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593990|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593991|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593992|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131593993|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131439232|NCT05893862|473233422|FG000|Overall Study|Adverse Event|1|||
131439233|NCT05893862|473233423|FG001|Overall Study|Adverse Event|4|||
131439234|NCT05893862|473233424|FG002|Overall Study|Adverse Event|2|||
131439235|NCT05893862|473233425|FG003|Overall Study|Adverse Event|2|||
131439236|NCT05893862|473233426|FG004|Overall Study|Adverse Event|1|||
131439237|NCT05893862|473233427|FG005|Overall Study|Adverse Event|0|||
131439238|NCT02919761|473233428|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
131439239|NCT02919761|473233429|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
131593994|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131593995|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131593996|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
131593997|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
131593998|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
131593999|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594000|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594001|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594002|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594003|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594004|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594005|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131594006|NCT01261312|473805775|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594007|NCT01261312|473805776|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594008|NCT01261312|473805777|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594009|NCT01261312|473805778|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
131594010|NCT01261312|473805779|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
131594011|NCT01261312|473805780|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
131594012|NCT01261312|473805781|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594013|NCT01261312|473805782|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594014|NCT01261312|473805783|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594015|NCT01261312|473805784|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594016|NCT01261312|473805785|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594017|NCT01261312|473805786|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594018|NCT01261312|473805787|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131594019|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594020|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594021|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594022|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594023|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594024|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594025|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
131594026|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
131594027|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
131594028|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594029|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594030|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594031|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131594032|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594033|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594034|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594035|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594036|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594037|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594038|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594039|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
131594040|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
131594041|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594042|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594043|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594044|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131594045|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594046|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594047|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594048|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594049|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594050|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594051|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
131594052|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
131594053|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
131594054|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594055|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594056|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594057|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131594058|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
131594059|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
131594060|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
131594061|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
131594062|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
131594063|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
131594064|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
131594065|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
131439240|NCT02919761|473233430|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
131594066|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
131594067|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
131594068|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
131439241|NCT02919761|473233428|FG000|Part 1: Open Label|Adverse Event|1|||
131439242|NCT02919761|473233429|FG001|Part 1: Open Label|Adverse Event|0|||
131594069|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
131594070|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
131594071|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594072|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594073|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594074|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594075|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594076|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594077|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
131594078|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
131594079|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
131594080|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594081|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594082|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594083|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131594084|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594085|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594086|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594087|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594088|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594089|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131791381|NCT00210626|474518676|FG001|Overall Study|Death|0|||
131439243|NCT02919761|473233430|FG002|Part 1: Open Label|Adverse Event|0|||
131439244|NCT02919761|473233428|FG000|Part 1: Open Label|Lost to Follow-up|1|||
131594090|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
131439245|NCT02919761|473233429|FG001|Part 1: Open Label|Lost to Follow-up|0|||
131439246|NCT02919761|473233430|FG002|Part 1: Open Label|Lost to Follow-up|0|||
131439247|NCT02919761|473233428|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
131439248|NCT02919761|473233429|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
131439249|NCT02919761|473233430|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
131439250|NCT02919761|473233428|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
131439251|NCT02919761|473233429|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
131439252|NCT02919761|473233430|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
131439253|NCT02919761|473233428|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
131439254|NCT02919761|473233429|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
131439255|NCT02919761|473233430|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
131439256|NCT02919761|473233428|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
131439257|NCT02919761|473233429|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
131439258|NCT02919761|473233430|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
131439259|NCT02919761|473233428|FG000|Part 1: Open Label|Termination by Sponsor|1|||
131439260|NCT02919761|473233429|FG001|Part 1: Open Label|Termination by Sponsor|0|||
131594091|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
131594092|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
131594093|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594094|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594095|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594096|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131594097|NCT01261312|473805775|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594098|NCT01261312|473805776|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594099|NCT01261312|473805777|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594100|NCT01261312|473805778|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594101|NCT01261312|473805779|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594102|NCT01261312|473805780|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594103|NCT01261312|473805781|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
131594104|NCT01261312|473805782|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
131594105|NCT01261312|473805783|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
131594106|NCT01261312|473805784|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594107|NCT01261312|473805785|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594108|NCT01261312|473805786|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594109|NCT01261312|473805787|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131594110|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594111|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594112|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594113|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594114|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594115|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594116|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594117|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594118|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131594119|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
131594120|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
131594121|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
131594122|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
131594123|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594124|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131706339|NCT00364182|474207366|FG001|First Intervention|Secondary prophylaxis|0|||
131439261|NCT02919761|473233430|FG002|Part 1: Open Label|Termination by Sponsor|0|||
131439262|NCT02919761|473233428|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
131439263|NCT02919761|473233429|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
131439264|NCT02919761|473233430|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
131439265|NCT02919761|473233428|FG000|Part 2: Double-blind|Adverse Event|0|||
131439266|NCT02919761|473233429|FG001|Part 2: Double-blind|Adverse Event|1|||
131439267|NCT02919761|473233430|FG002|Part 2: Double-blind|Adverse Event|0|||
131439268|NCT02919761|473233428|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
131439269|NCT02919761|473233429|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
131439270|NCT02919761|473233430|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
131439271|NCT02919761|473233428|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
131439272|NCT02919761|473233429|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
131439273|NCT02919761|473233430|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
131439274|NCT02919761|473233428|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
131594125|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594126|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594127|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594128|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594129|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594130|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594131|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594132|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
131594133|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131594134|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
131594135|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
131594136|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594137|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594138|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594139|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594140|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594141|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594142|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594143|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594144|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131594145|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
131594146|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
131594147|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
131594148|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
131594149|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594150|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594151|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594152|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594153|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594154|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594155|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594156|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594157|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131594158|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
131594159|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
131594160|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
131594161|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
131594162|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594163|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594164|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594165|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594166|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594167|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594168|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594169|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594170|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131594171|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
131594172|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
131594173|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
131594174|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
131439275|NCT02919761|473233429|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
131439276|NCT02919761|473233430|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
131439277|NCT02919761|473233428|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
131439278|NCT02919761|473233429|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
131439279|NCT02919761|473233430|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
131439280|NCT02919761|473233428|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
131439281|NCT02919761|473233429|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
131439282|NCT02919761|473233430|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
131439283|NCT02919761|473233428|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
131439284|NCT02919761|473233429|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
131439285|NCT02919761|473233430|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
131439286|NCT02429830|473233433|FG000|Overall Study|Lost to Follow-up|1|||
131706340|NCT00364182|474207367|FG002|First Intervention|Secondary prophylaxis|0|||
131439287|NCT02429830|473233433|FG000|Overall Study|Device Explant|2|||
131439288|NCT03346434|473235435|FG000|Overall Study|Randomized in Error|0|||
131439289|NCT03346434|473235436|FG001|Overall Study|Randomized in Error|0|||
131439290|NCT03346434|473235437|FG002|Overall Study|Randomized in Error|0|||
131594175|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594176|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594177|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594178|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594179|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594180|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594181|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594182|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594183|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131594184|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
131594185|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
131594186|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
131594187|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
131594188|NCT01261312|473805775|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594189|NCT01261312|473805776|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594190|NCT01261312|473805777|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594191|NCT01261312|473805778|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594192|NCT01261312|473805779|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594193|NCT01261312|473805780|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594194|NCT01261312|473805781|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594195|NCT01261312|473805782|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594196|NCT01261312|473805783|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131594197|NCT01261312|473805784|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
131594198|NCT01261312|473805785|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
131594199|NCT01261312|473805786|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
131594200|NCT01261312|473805787|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
131594201|NCT04812535|473805796|FG000|Overall Study|Withdrawal by Subject|0|||
131594202|NCT04812535|473805797|FG001|Overall Study|Withdrawal by Subject|0|||
131594203|NCT04812535|473805798|FG002|Overall Study|Withdrawal by Subject|0|||
131594204|NCT04812535|473805799|FG003|Overall Study|Withdrawal by Subject|1|||
131594205|NCT04812535|473805796|FG000|Overall Study|Death|7|||
131594206|NCT04812535|473805797|FG001|Overall Study|Death|2|||
131594207|NCT04812535|473805798|FG002|Overall Study|Death|4|||
131594208|NCT04812535|473805799|FG003|Overall Study|Death|1|||
131594209|NCT04812535|473805796|FG000|Overall Study|Due to premature study termination by sponsor|2|||
131594210|NCT04812535|473805797|FG001|Overall Study|Due to premature study termination by sponsor|0|||
131594211|NCT04812535|473805798|FG002|Overall Study|Due to premature study termination by sponsor|1|||
131594212|NCT04812535|473805799|FG003|Overall Study|Due to premature study termination by sponsor|3|||
131594213|NCT03336333|473805800|FG000|Overall Study|Remained on study at time of data cut-off|202|||
131594214|NCT03336333|473805801|FG001|Overall Study|Remained on study at time of data cut-off|219|||
131594215|NCT03336333|473805802|FG002|Overall Study|Remained on study at time of data cut-off|102|||
131594216|NCT03336333|473805800|FG000|Overall Study|Death|14|||
131594217|NCT03336333|473805801|FG001|Overall Study|Death|16|||
131594218|NCT03336333|473805802|FG002|Overall Study|Death|8|||
131594219|NCT03336333|473805800|FG000|Overall Study|Withdrawal by Subject|16|||
131594220|NCT03336333|473805801|FG001|Overall Study|Withdrawal by Subject|5|||
131594221|NCT03336333|473805802|FG002|Overall Study|Withdrawal by Subject|1|||
131594222|NCT03336333|473805800|FG000|Overall Study|Physician Decision|5|||
131594223|NCT03336333|473805801|FG001|Overall Study|Physician Decision|1|||
131594224|NCT03336333|473805802|FG002|Overall Study|Physician Decision|0|||
131594225|NCT03336333|473805800|FG000|Overall Study|Lost to Follow-up|1|||
131594226|NCT03336333|473805801|FG001|Overall Study|Lost to Follow-up|0|||
131594227|NCT03336333|473805802|FG002|Overall Study|Lost to Follow-up|0|||
131594228|NCT03792555|473805806|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
131594229|NCT03792555|473805807|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
131594230|NCT03792555|473805808|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
131439291|NCT03346434|473235438|FG003|Overall Study|Randomized in Error|0|||
131439292|NCT03346434|473235439|FG004|Overall Study|Randomized in Error|1|||
131594231|NCT03792555|473805806|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
131594232|NCT03792555|473805807|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
131594233|NCT03792555|473805808|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
131594234|NCT03792555|473805806|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
131594235|NCT03792555|473805807|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
131594236|NCT03792555|473805808|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
131594237|NCT04485039|473805809|FG000|TPOXX Only|Adverse Event|2|||
131594238|NCT04485039|473805809|FG000|TPOXX Only|Physician Decision|1|||
131594239|NCT04485039|473805809|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
131594240|NCT04485039|473805809|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
131594241|NCT04005716|473805813|FG000|Overall Study|Death|175|||
131594242|NCT04005716|473805814|FG001|Overall Study|Death|196|||
131594243|NCT04005716|473805813|FG000|Overall Study|Withdrawal by Subject|1|||
131594244|NCT04005716|473805814|FG001|Overall Study|Withdrawal by Subject|6|||
131594245|NCT04005716|473805813|FG000|Overall Study|Lost to Follow-up|2|||
131594246|NCT04005716|473805814|FG001|Overall Study|Lost to Follow-up|2|||
131594247|NCT04021602|473805815|FG000|Overall Study|Lost to Follow-up|3|||
131594248|NCT04021602|473805816|FG001|Overall Study|Lost to Follow-up|3|||
131594249|NCT04021602|473805817|FG002|Overall Study|Lost to Follow-up|1|||
131594250|NCT04021602|473805815|FG000|Overall Study|Adverse Event|1|||
131594251|NCT04021602|473805816|FG001|Overall Study|Adverse Event|0|||
131594252|NCT04021602|473805817|FG002|Overall Study|Adverse Event|1|||
131594253|NCT03623321|473805818|FG000|Overall Study|Adverse Event|32|||
131594254|NCT03623321|473805818|FG000|Overall Study|Death|9|||
131594255|NCT03623321|473805818|FG000|Overall Study|Lack of Efficacy|9|||
131594256|NCT03623321|473805818|FG000|Overall Study|Lost to Follow-up|6|||
131899279|NCT02364388|474917588|FG000|Overall Study|Technical Failure|3|||
131899280|NCT02364388|474917588|FG000|Overall Study|No OA/US data|2|||
131594257|NCT03623321|473805818|FG000|Overall Study|Noncompliance with study drug|6|||
131594258|NCT03623321|473805818|FG000|Overall Study|Use of prohibited medication|3|||
131594259|NCT03623321|473805818|FG000|Overall Study|Physician Decision|5|||
131594260|NCT03623321|473805818|FG000|Overall Study|Protocol Violation|1|||
131594261|NCT03623321|473805818|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
131594262|NCT03623321|473805818|FG000|Overall Study|Not further specified|43|||
131594263|NCT02243709|473805819|FG000|Phase 1|Lost to Follow-up|0|||
131594264|NCT02243709|473805820|FG001|Phase 1|Lost to Follow-up|1|||
131594265|NCT02243709|473805819|FG000|Phase 1|Withdrawal by Subject|1|||
131594266|NCT02243709|473805820|FG001|Phase 1|Withdrawal by Subject|0|||
131594267|NCT02243709|473805819|FG000|Phase 1|Protocol Violation|0|||
131594268|NCT02243709|473805820|FG001|Phase 1|Protocol Violation|1|||
131594269|NCT02243709|473805819|FG000|Phase 1|Adverse Event|0|||
131594270|NCT02243709|473805820|FG001|Phase 1|Adverse Event|1|||
131594271|NCT04347161|473805823|FG000|Overall Study|Death|0|||
131594272|NCT04347161|473805824|FG001|Overall Study|Death|2|||
131594273|NCT04347161|473805823|FG000|Overall Study|Withdrawal by Subject|1|||
131594274|NCT04347161|473805824|FG001|Overall Study|Withdrawal by Subject|0|||
131594275|NCT04347161|473805823|FG000|Overall Study|Lost to Follow-up|0|||
131594276|NCT04347161|473805824|FG001|Overall Study|Lost to Follow-up|1|||
131594277|NCT04347161|473805823|FG000|Overall Study|No longer on study medication|1|||
131594278|NCT04347161|473805824|FG001|Overall Study|No longer on study medication|1|||
131594279|NCT04169373|473805825|FG000|Week 1 to Week 14|Adverse Event|1|||
131594280|NCT04169373|473805826|FG001|Week 1 to Week 14|Adverse Event|0|||
131594281|NCT04169373|473805827|FG002|Week 1 to Week 14|Adverse Event|1|||
131594282|NCT04169373|473805828|FG003|Week 1 to Week 14|Adverse Event|2|||
131594283|NCT04169373|473805825|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
131594284|NCT04169373|473805826|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
131594285|NCT04169373|473805827|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
131594286|NCT04169373|473805828|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
131594287|NCT04169373|473805825|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
131594288|NCT04169373|473805826|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
131594289|NCT04169373|473805827|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
131594290|NCT04169373|473805828|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
131594291|NCT04169373|473805825|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
131594292|NCT04169373|473805826|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
131594293|NCT04169373|473805827|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
131594294|NCT04169373|473805828|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
131594295|NCT04169373|473805825|FG000|Week 1 to Week 14|Other|1|||
131594296|NCT04169373|473805826|FG001|Week 1 to Week 14|Other|3|||
131594297|NCT04169373|473805827|FG002|Week 1 to Week 14|Other|3|||
131594298|NCT04169373|473805828|FG003|Week 1 to Week 14|Other|5|||
131594299|NCT04169373|473805825|FG000|Week 14 to Week 52|Adverse Event|1|||
131594300|NCT04169373|473805826|FG001|Week 14 to Week 52|Adverse Event|0|||
131594301|NCT04169373|473805827|FG002|Week 14 to Week 52|Adverse Event|0|||
131594302|NCT04169373|473805828|FG003|Week 14 to Week 52|Adverse Event|1|||
131594303|NCT04169373|473805825|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
131594304|NCT04169373|473805826|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
131594305|NCT04169373|473805827|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
131594306|NCT04169373|473805828|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
131594307|NCT04169373|473805825|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
131594308|NCT04169373|473805826|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
131594309|NCT04169373|473805827|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
131594310|NCT04169373|473805828|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
131594311|NCT04169373|473805825|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
131594312|NCT04169373|473805826|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
131594313|NCT04169373|473805827|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
131594314|NCT04169373|473805828|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
131594315|NCT04169373|473805825|FG000|Week 14 to Week 52|Other|4|||
131594316|NCT04169373|473805826|FG001|Week 14 to Week 52|Other|5|||
131594317|NCT04169373|473805827|FG002|Week 14 to Week 52|Other|4|||
131594318|NCT04169373|473805828|FG003|Week 14 to Week 52|Other|5|||
131791382|NCT00210626|474518675|FG000|Overall Study|Withdrawal by Subject|29|||
131791383|NCT00210626|474518676|FG001|Overall Study|Withdrawal by Subject|20|||
131791384|NCT00210626|474518675|FG000|Overall Study|Physician Decision|0|||
131791385|NCT00210626|474518676|FG001|Overall Study|Physician Decision|2|||
131791386|NCT00210626|474518675|FG000|Overall Study|Sponser Request|1|||
131791387|NCT00210626|474518676|FG001|Overall Study|Sponser Request|0|||
131791388|NCT00210626|474518675|FG000|Overall Study|Other|4|||
131791389|NCT00210626|474518676|FG001|Overall Study|Other|5|||
131791390|NCT01086215|474518680|FG000|Overall Study|Death|14|||
131791391|NCT01086215|474518681|FG001|Overall Study|Death|8|||
131791392|NCT01086215|474518682|FG002|Overall Study|Death|8|||
131791393|NCT01086215|474518683|FG003|Overall Study|Death|1|||
131791394|NCT01086215|474518680|FG000|Overall Study|Lost to Follow-up|22|||
131791395|NCT01086215|474518681|FG001|Overall Study|Lost to Follow-up|39|||
131791396|NCT01086215|474518682|FG002|Overall Study|Lost to Follow-up|18|||
131791397|NCT01086215|474518683|FG003|Overall Study|Lost to Follow-up|2|||
131791398|NCT01965652|474518684|FG000|Overall Study|Adverse Event|40|||
131791399|NCT01965652|474518685|FG001|Overall Study|Adverse Event|37|||
131791400|NCT01965652|474518684|FG000|Overall Study|Withdrawal by Subject|62|||
131791401|NCT01965652|474518685|FG001|Overall Study|Withdrawal by Subject|69|||
131791402|NCT01965652|474518684|FG000|Overall Study|Lost to Follow-up|53|||
131791403|NCT01965652|474518685|FG001|Overall Study|Lost to Follow-up|40|||
131791404|NCT01965652|474518684|FG000|Overall Study|Protocol Violation|34|||
131791405|NCT01965652|474518685|FG001|Overall Study|Protocol Violation|38|||
131791406|NCT01965652|474518684|FG000|Overall Study|Death|3|||
131791407|NCT01965652|474518685|FG001|Overall Study|Death|4|||
131791408|NCT01965652|474518684|FG000|Overall Study|Other - Miscellaneous|18|||
131791409|NCT01965652|474518685|FG001|Overall Study|Other - Miscellaneous|21|||
131791410|NCT01965652|474518684|FG000|Overall Study|Pregnancy|0|||
131791411|NCT01965652|474518685|FG001|Overall Study|Pregnancy|1|||
131791412|NCT01121900|474518688|FG000|First Intervention Period|Adverse Event|1|||
131791413|NCT01121900|474518689|FG001|First Intervention Period|Adverse Event|1|||
131791414|NCT01121900|474518688|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131791415|NCT01121900|474518689|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131791416|NCT03469271|474518690|FG000|Overall Study|Withdrawal by Subject|2|||
131791417|NCT03469271|474518691|FG001|Overall Study|Withdrawal by Subject|0|||
131791418|NCT03469271|474518692|FG002|Overall Study|Withdrawal by Subject|0|||
131791419|NCT03469271|474518693|FG003|Overall Study|Withdrawal by Subject|1|||
131791420|NCT01328054|474518694|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
131791421|NCT01328054|474518695|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
131791422|NCT01328054|474518694|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
131791423|NCT01328054|474518695|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
131791424|NCT01328054|474518694|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
131791425|NCT01328054|474518695|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
131791426|NCT03493698|474518696|FG000|Treatment Period C|Adverse Event|1|||
131791427|NCT03493698|474518696|FG000|Treatment Period C|Withdrawal by Subject|1|||
131791428|NCT02006147|474518697|FG000|Overall Study|Protocol Violation|1|||
131791429|NCT02006147|474518698|FG001|Overall Study|Protocol Violation|1|||
131791430|NCT02006147|474518699|FG002|Overall Study|Protocol Violation|0|||
131791431|NCT02006147|474518700|FG003|Overall Study|Protocol Violation|0|||
131791432|NCT02006147|474518697|FG000|Overall Study|Withdrawal by Subject|0|||
131791433|NCT02006147|474518698|FG001|Overall Study|Withdrawal by Subject|1|||
131791434|NCT02006147|474518699|FG002|Overall Study|Withdrawal by Subject|0|||
131791435|NCT02006147|474518700|FG003|Overall Study|Withdrawal by Subject|0|||
131791436|NCT02006147|474518697|FG000|Overall Study|Withdrawal by Sponsor|1|||
131791437|NCT02006147|474518698|FG001|Overall Study|Withdrawal by Sponsor|0|||
131791438|NCT02006147|474518699|FG002|Overall Study|Withdrawal by Sponsor|0|||
131791439|NCT02006147|474518700|FG003|Overall Study|Withdrawal by Sponsor|0|||
131791440|NCT00408876|474518701|FG000|Overall Study|Adverse Event|9|||
131791441|NCT00408876|474518702|FG001|Overall Study|Adverse Event|17|||
131791442|NCT00408876|474518703|FG002|Overall Study|Adverse Event|27|||
131791443|NCT00408876|474518704|FG003|Overall Study|Adverse Event|10|||
131791444|NCT00408876|474518701|FG000|Overall Study|Withdrawal by Subject|3|||
131791445|NCT00408876|474518702|FG001|Overall Study|Withdrawal by Subject|6|||
131791446|NCT00408876|474518703|FG002|Overall Study|Withdrawal by Subject|6|||
131791447|NCT00408876|474518704|FG003|Overall Study|Withdrawal by Subject|14|||
131791448|NCT00408876|474518701|FG000|Overall Study|Lack of Efficacy|2|||
131791449|NCT00408876|474518702|FG001|Overall Study|Lack of Efficacy|4|||
131791450|NCT00408876|474518703|FG002|Overall Study|Lack of Efficacy|5|||
131791451|NCT00408876|474518704|FG003|Overall Study|Lack of Efficacy|6|||
131594319|NCT04169373|473805825|FG000|Week 14 to Week 52|Ongoing|0|||
131594320|NCT04169373|473805826|FG001|Week 14 to Week 52|Ongoing|1|||
131594321|NCT04169373|473805827|FG002|Week 14 to Week 52|Ongoing|0|||
131594322|NCT04169373|473805828|FG003|Week 14 to Week 52|Ongoing|0|||
131594323|NCT03445988|473805834|FG000|Overall Study|Lost to Follow-up|14|||
131594324|NCT03445988|473805835|FG001|Overall Study|Lost to Follow-up|26|||
131594325|NCT03445988|473805836|FG002|Overall Study|Lost to Follow-up|27|||
131594326|NCT03445988|473805837|FG003|Overall Study|Lost to Follow-up|66|||
131594327|NCT03445988|473805834|FG000|Overall Study|Withdrawal by Subject|7|||
131594328|NCT03445988|473805835|FG001|Overall Study|Withdrawal by Subject|4|||
131594329|NCT03445988|473805836|FG002|Overall Study|Withdrawal by Subject|3|||
131594330|NCT03445988|473805837|FG003|Overall Study|Withdrawal by Subject|5|||
131594331|NCT03445988|473805834|FG000|Overall Study|Death (unrelated to study)|5|||
131594332|NCT03445988|473805835|FG001|Overall Study|Death (unrelated to study)|1|||
131594333|NCT03445988|473805836|FG002|Overall Study|Death (unrelated to study)|2|||
131594334|NCT03445988|473805837|FG003|Overall Study|Death (unrelated to study)|4|||
131594335|NCT03988608|473805841|FG000|Overall Study|Adverse Event|1|||
131594336|NCT03988608|473805841|FG000|Overall Study|Lost to Follow-up|1|||
131594337|NCT03988608|473805841|FG000|Overall Study|Withdrawal by Subject|3|||
131594338|NCT03988608|473805841|FG000|Overall Study|Death|1|||
131594339|NCT02689284|473805848|FG000|Overall Study|Adverse Event|1|||
131594340|NCT02689284|473805849|FG001|Overall Study|Adverse Event|8|||
131594341|NCT02689284|473805848|FG000|Overall Study|Death|0|||
131594342|NCT02689284|473805849|FG001|Overall Study|Death|1|||
131594343|NCT02689284|473805848|FG000|Overall Study|Physician Decision|1|||
131594344|NCT02689284|473805849|FG001|Overall Study|Physician Decision|2|||
131594345|NCT02689284|473805848|FG000|Overall Study|Withdrawal by Subject|0|||
131594346|NCT02689284|473805849|FG001|Overall Study|Withdrawal by Subject|1|||
131594347|NCT02689284|473805848|FG000|Overall Study|progression of cancer|1|||
131594348|NCT02689284|473805849|FG001|Overall Study|progression of cancer|72|||
131594349|NCT02689284|473805848|FG000|Overall Study|decreased heart function|0|||
131594350|NCT02689284|473805849|FG001|Overall Study|decreased heart function|1|||
131594351|NCT02689284|473805848|FG000|Overall Study|concern for anemia|0|||
131594352|NCT02689284|473805849|FG001|Overall Study|concern for anemia|1|||
131594353|NCT02689284|473805848|FG000|Overall Study|no measurable cancer for evaluation|0|||
131594354|NCT02689284|473805849|FG001|Overall Study|no measurable cancer for evaluation|1|||
131594355|NCT03519581|473805852|FG000|Overall Study|Lost to Follow-up|3|||
131594356|NCT03519581|473805853|FG001|Overall Study|Lost to Follow-up|2|||
131594357|NCT03519581|473805852|FG000|Overall Study|Adverse Event|5|||
131594358|NCT03519581|473805853|FG001|Overall Study|Adverse Event|2|||
131594359|NCT03519581|473805852|FG000|Overall Study|Withdrawal by Subject|2|||
131594360|NCT03519581|473805853|FG001|Overall Study|Withdrawal by Subject|0|||
131594361|NCT03519581|473805852|FG000|Overall Study|Change to insurance|2|||
131594362|NCT03519581|473805853|FG001|Overall Study|Change to insurance|1|||
131594363|NCT03519581|473805852|FG000|Overall Study|Other|2|||
131594364|NCT03519581|473805853|FG001|Overall Study|Other|4|||
131594365|NCT05268393|473805854|FG000|Overall Study|Withdrawal by Subject|2|||
131594366|NCT05268393|473805855|FG001|Overall Study|Withdrawal by Subject|1|||
131594367|NCT03396926|473805856|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
131594368|NCT03396926|473805857|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
131594369|NCT00450658|473805858|FG000|Overall Study|Adverse Event|24|||
131439293|NCT03346434|473235440|FG005|Overall Study|Randomized in Error|0|||
131439294|NCT03346434|473235435|FG000|Overall Study|Withdrawal by Subject|0|||
131594370|NCT00450658|473805859|FG001|Overall Study|Adverse Event|15|||
131594371|NCT00450658|473805858|FG000|Overall Study|Withdrawal by Subject|43|||
131594372|NCT00450658|473805859|FG001|Overall Study|Withdrawal by Subject|26|||
131594373|NCT00450658|473805858|FG000|Overall Study|Lost to Follow-up|22|||
131594374|NCT00450658|473805859|FG001|Overall Study|Lost to Follow-up|5|||
131594375|NCT00450658|473805858|FG000|Overall Study|UGI ulcer|33|||
131594376|NCT00450658|473805859|FG001|Overall Study|UGI ulcer|34|||
131594377|NCT00450658|473805858|FG000|Overall Study|misc|21|||
131594378|NCT00450658|473805859|FG001|Overall Study|misc|10|||
131439295|NCT03346434|473235436|FG001|Overall Study|Withdrawal by Subject|0|||
131439296|NCT03346434|473235437|FG002|Overall Study|Withdrawal by Subject|1|||
131594379|NCT05763823|473805860|FG000|Overall Study|Death|6|||
131594380|NCT05763823|473805860|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131594381|NCT05763823|473805860|FG000|Overall Study|Withdrawal by Subject|6|||
131439297|NCT03346434|473235438|FG003|Overall Study|Withdrawal by Subject|0|||
131594382|NCT05371652|473805861|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
131594383|NCT05371652|473805861|FG000|Overall Study|Withdrawal by Subject|12|||
131899281|NCT02364388|474917588|FG000|Overall Study|No Biopsy|2|||
131594384|NCT05371652|473805861|FG000|Overall Study|Adverse Event|1|||
131594385|NCT05371652|473805861|FG000|Overall Study|Other|11|||
131594386|NCT04410042|473805867|FG000|Overall Study|Not Eligible|1|||
131594387|NCT04410042|473805868|FG001|Overall Study|Not Eligible|1|||
131594388|NCT03720795|473805871|FG000|Phase 1|Lost to Follow-up|4|||
131594389|NCT03720795|473805871|FG000|Phase 1|Withdrawal by Subject|6|||
131594390|NCT03720795|473805871|FG000|Phase 1|Protocol Violation|1|||
131594391|NCT03720795|473805871|FG000|Phase 1|Other|1|||
131594392|NCT03720795|473805871|FG000|Phase 2|Lost to Follow-up|5|||
131594393|NCT03720795|473805871|FG000|Phase 2|Withdrawal by Subject|10|||
131594394|NCT03720795|473805871|FG000|Phase 2|Protocol Violation|2|||
131594395|NCT03720795|473805871|FG000|3 Month Follow Up|Lost to Follow-up|2|||
131594396|NCT01494662|473805873|FG000|Overall Study|Withdrawal by Subject|0|||
131594397|NCT01494662|473805874|FG001|Overall Study|Withdrawal by Subject|0|||
131594398|NCT01494662|473805875|FG002|Overall Study|Withdrawal by Subject|1|||
131594399|NCT01494662|473805876|FG003|Overall Study|Withdrawal by Subject|0|||
131594400|NCT01494662|473805877|FG004|Overall Study|Withdrawal by Subject|0|||
131594401|NCT01494662|473805878|FG005|Overall Study|Withdrawal by Subject|0|||
131594402|NCT01494662|473805879|FG006|Overall Study|Withdrawal by Subject|0|||
131594403|NCT01494662|473805873|FG000|Overall Study|Physician Decision|0|||
131594404|NCT01494662|473805874|FG001|Overall Study|Physician Decision|0|||
131594405|NCT01494662|473805875|FG002|Overall Study|Physician Decision|1|||
131594406|NCT01494662|473805876|FG003|Overall Study|Physician Decision|0|||
131594407|NCT01494662|473805877|FG004|Overall Study|Physician Decision|0|||
131594408|NCT01494662|473805878|FG005|Overall Study|Physician Decision|0|||
131594409|NCT01494662|473805879|FG006|Overall Study|Physician Decision|0|||
131594410|NCT05311384|473805880|FG000|Overall Study|Uncontrolled health conditions|2|||
131594411|NCT05311384|473805880|FG000|Overall Study|Withdrawal by Subject|1|||
131594412|NCT03302494|473805881|FG000|Overall Study|Other|7|||
131594413|NCT03302494|473805882|FG001|Overall Study|Other|4|||
131594414|NCT03302494|473805883|FG002|Overall Study|Other|6|||
131594415|NCT03302494|473805881|FG000|Overall Study|Withdrawal by Subject|10|||
131594416|NCT03302494|473805882|FG001|Overall Study|Withdrawal by Subject|2|||
131594417|NCT03302494|473805883|FG002|Overall Study|Withdrawal by Subject|9|||
131594418|NCT03302494|473805881|FG000|Overall Study|Study Terminated by Sponsor|32|||
131594419|NCT03302494|473805882|FG001|Overall Study|Study Terminated by Sponsor|29|||
131594420|NCT03302494|473805883|FG002|Overall Study|Study Terminated by Sponsor|30|||
131594421|NCT03302494|473805881|FG000|Overall Study|Physician Decision|1|||
131594422|NCT03302494|473805882|FG001|Overall Study|Physician Decision|0|||
131594423|NCT03302494|473805883|FG002|Overall Study|Physician Decision|1|||
131594424|NCT03302494|473805881|FG000|Overall Study|Lost to Follow-up|1|||
131594425|NCT03302494|473805882|FG001|Overall Study|Lost to Follow-up|3|||
131594426|NCT03302494|473805883|FG002|Overall Study|Lost to Follow-up|3|||
131594427|NCT03302494|473805881|FG000|Overall Study|Death|13|||
131594428|NCT03302494|473805882|FG001|Overall Study|Death|11|||
131594429|NCT03302494|473805883|FG002|Overall Study|Death|4|||
131594430|NCT03302494|473805881|FG000|Overall Study|Adverse Event|1|||
131594431|NCT03302494|473805882|FG001|Overall Study|Adverse Event|2|||
131594432|NCT03302494|473805883|FG002|Overall Study|Adverse Event|0|||
131594433|NCT03302494|473805881|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
131594434|NCT03302494|473805882|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
131594435|NCT03302494|473805883|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
131594436|NCT05134233|473805884|FG000|Overall Study|Pregnancy|1|||
131594437|NCT05134233|473805884|FG000|Overall Study|MEP value too low|2|||
131594438|NCT05134233|473805884|FG000|Overall Study|Lost to Follow-up|1|||
131594439|NCT02724631|473805887|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
131594440|NCT04763265|473805891|FG000|Overall Study|Adverse Event|1|||
131594441|NCT04763265|473805892|FG001|Overall Study|Adverse Event|0|||
131594442|NCT04763265|473805891|FG000|Overall Study|Lost to Follow-up|2|||
131594443|NCT04763265|473805892|FG001|Overall Study|Lost to Follow-up|4|||
131594444|NCT04763265|473805891|FG000|Overall Study|Withdrawal by Subject|0|||
131594445|NCT04763265|473805892|FG001|Overall Study|Withdrawal by Subject|1|||
131594446|NCT05609760|473805902|FG000|Overall Study|Lost to Follow-up|0|||
131594447|NCT05609760|473805903|FG001|Overall Study|Lost to Follow-up|1|||
131594448|NCT05609760|473805902|FG000|Overall Study|Withdrawal by Subject|1|||
131594449|NCT05609760|473805903|FG001|Overall Study|Withdrawal by Subject|0|||
131594450|NCT05089734|473805905|FG000|Overall Study|Still on study|122|||
131594451|NCT05089734|473805906|FG001|Overall Study|Still on study|101|||
131594452|NCT05089734|473805905|FG000|Overall Study|Death|161|||
131594453|NCT05089734|473805906|FG001|Overall Study|Death|179|||
131594454|NCT05089734|473805905|FG000|Overall Study|Withdrew consent|11|||
131594455|NCT05089734|473805906|FG001|Overall Study|Withdrew consent|24|||
131594456|NCT05089734|473805905|FG000|Overall Study|Lost to Follow-up|5|||
131594457|NCT05089734|473805906|FG001|Overall Study|Lost to Follow-up|0|||
131594458|NCT02992925|473807525|FG000|Cohort 2|Physician Decision|0|||
131594459|NCT02992925|473807526|FG001|Cohort 2|Physician Decision|0|||
131594460|NCT02992925|473807527|FG002|Cohort 2|Physician Decision|1|||
131594461|NCT02992925|473807528|FG003|Cohort 2|Physician Decision|0|||
131594462|NCT02992925|473807525|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
131594463|NCT02992925|473807526|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
131594464|NCT02992925|473807527|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
131594465|NCT02992925|473807528|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
131594466|NCT03779204|473807529|FG000|Overall Study|Lost to Follow-up|2|||
131594467|NCT03779204|473807530|FG001|Overall Study|Lost to Follow-up|0|||
131899282|NCT00186485|474917591|FG000|Overall Study|Lost to Follow-up|3|||
131899283|NCT02080364|474917592|FG000|Baseline Period|Protocol Violation|2|||
131899284|NCT02080364|474917593|FG001|Baseline Period|Protocol Violation|1|||
131899285|NCT02080364|474917594|FG002|Baseline Period|Protocol Violation|0|||
131594468|NCT04150718|473807531|FG000|Overall Study|Withdrawal by Subject|2|||
131899286|NCT02080364|474917595|FG003|Baseline Period|Protocol Violation|0|||
131594469|NCT04150718|473807532|FG001|Overall Study|Withdrawal by Subject|7|||
131594470|NCT04150718|473807533|FG002|Overall Study|Withdrawal by Subject|1|||
131594471|NCT04150718|473807531|FG000|Overall Study|Lost to Follow-up|1|||
131594472|NCT04150718|473807532|FG001|Overall Study|Lost to Follow-up|2|||
131594473|NCT04150718|473807533|FG002|Overall Study|Lost to Follow-up|0|||
131594474|NCT04150718|473807531|FG000|Overall Study|Ineligible|1|||
131594475|NCT04150718|473807532|FG001|Overall Study|Ineligible|0|||
131594476|NCT04150718|473807533|FG002|Overall Study|Ineligible|10|||
131594477|NCT05633953|473807534|FG000|Overall Study|Adverse Event|7|||
131594478|NCT05633953|473807534|FG000|Overall Study|Death|30|||
131899287|NCT02080364|474917592|FG000|Baseline Period|Other|0|||
131899288|NCT02080364|474917593|FG001|Baseline Period|Other|1|||
131899289|NCT02080364|474917594|FG002|Baseline Period|Other|1|||
131899290|NCT02080364|474917595|FG003|Baseline Period|Other|0|||
131899291|NCT02080364|474917592|FG000|Treatment Period|Adverse Event|10|||
131899292|NCT02080364|474917593|FG001|Treatment Period|Adverse Event|15|||
131899293|NCT02080364|474917594|FG002|Treatment Period|Adverse Event|11|||
131899294|NCT02080364|474917595|FG003|Treatment Period|Adverse Event|14|||
131899295|NCT02080364|474917592|FG000|Treatment Period|Lost to Follow-up|2|||
131899296|NCT02080364|474917593|FG001|Treatment Period|Lost to Follow-up|3|||
131899297|NCT02080364|474917594|FG002|Treatment Period|Lost to Follow-up|5|||
131899298|NCT02080364|474917595|FG003|Treatment Period|Lost to Follow-up|0|||
131899299|NCT02080364|474917592|FG000|Treatment Period|Protocol Violation|5|||
131899300|NCT02080364|474917593|FG001|Treatment Period|Protocol Violation|3|||
131899301|NCT02080364|474917594|FG002|Treatment Period|Protocol Violation|5|||
131899302|NCT02080364|474917595|FG003|Treatment Period|Protocol Violation|1|||
131899303|NCT02080364|474917592|FG000|Treatment Period|Withdrawal by Subject|16|||
131899304|NCT02080364|474917593|FG001|Treatment Period|Withdrawal by Subject|16|||
131899305|NCT02080364|474917594|FG002|Treatment Period|Withdrawal by Subject|15|||
131899306|NCT02080364|474917595|FG003|Treatment Period|Withdrawal by Subject|10|||
131899307|NCT02080364|474917592|FG000|Treatment Period|Study Terminated by Sponsor|0|||
131899308|NCT02080364|474917593|FG001|Treatment Period|Study Terminated by Sponsor|0|||
131899309|NCT02080364|474917594|FG002|Treatment Period|Study Terminated by Sponsor|180|||
131594479|NCT05633953|473807534|FG000|Overall Study|Lost to Follow-up|1|||
131594480|NCT05633953|473807534|FG000|Overall Study|Osilodrostat discontinued|4|||
131594481|NCT05633953|473807534|FG000|Overall Study|Physician Decision|1|||
131594482|NCT05633953|473807534|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
131594483|NCT05633953|473807534|FG000|Overall Study|Progressive disease|2|||
131594484|NCT04034251|473807535|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
131594485|NCT04034251|473807536|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
131594486|NCT04034251|473807537|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
131594487|NCT04783935|473807550|FG000|Overall Study|Withdrawal by Subject|6|||
131899310|NCT02080364|474917595|FG003|Treatment Period|Study Terminated by Sponsor|183|||
131899311|NCT02080364|474917592|FG000|Treatment Period|Other|14|||
131594488|NCT04783935|473807550|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
131594489|NCT04783935|473807550|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
131899312|NCT02080364|474917593|FG001|Treatment Period|Other|12|||
131899313|NCT02080364|474917594|FG002|Treatment Period|Other|21|||
131899314|NCT02080364|474917595|FG003|Treatment Period|Other|16|||
131899315|NCT00905424|474917596|FG000|Overall Study|Lost to Follow-up|3|||
131899316|NCT00905424|474917597|FG001|Overall Study|Lost to Follow-up|3|||
131899317|NCT00905424|474917596|FG000|Overall Study|Withdrawal by Subject|1|||
131899318|NCT00905424|474917597|FG001|Overall Study|Withdrawal by Subject|2|||
131899319|NCT00905424|474917596|FG000|Overall Study|Adverse Event|4|||
131899320|NCT00905424|474917597|FG001|Overall Study|Adverse Event|2|||
131899321|NCT00905424|474917596|FG000|Overall Study|Non-compliance with study medication|2|||
131594490|NCT04783935|473807550|FG000|Overall Study|Lost to Follow-up|3|||
131594491|NCT04783935|473807550|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
131706341|NCT00364182|474207365|FG000|First Intervention|Withdrawal by Subject|2|||
131899322|NCT00905424|474917597|FG001|Overall Study|Non-compliance with study medication|0|||
131899323|NCT00905424|474917596|FG000|Overall Study|Sponsor decision|1|||
131594492|NCT06074523|473807554|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
131594493|NCT06074523|473807554|FG000|Overall Study|Withdrawal by Subject|1|||
131594494|NCT04956861|473807559|FG000|Overall Study|Withdrawal by Subject|4|||
131594495|NCT04956861|473807560|FG001|Overall Study|Withdrawal by Subject|4|||
131594496|NCT04956861|473807561|FG002|Overall Study|Withdrawal by Subject|2|||
131594497|NCT04956861|473807559|FG000|Overall Study|Physician Decision|4|||
131594498|NCT04956861|473807560|FG001|Overall Study|Physician Decision|5|||
131594499|NCT04956861|473807561|FG002|Overall Study|Physician Decision|1|||
131594500|NCT05337748|473807565|FG000|Overall Study|Withdrawal by Subject|1|||
131594501|NCT05337748|473807566|FG001|Overall Study|Withdrawal by Subject|0|||
131594502|NCT05337748|473807565|FG000|Overall Study|Death|1|||
131594503|NCT05337748|473807566|FG001|Overall Study|Death|0|||
131594504|NCT02543281|473807572|FG000|Overall Study|Lost to Follow-up|0|||
131594505|NCT02543281|473807573|FG001|Overall Study|Lost to Follow-up|0|||
131594506|NCT02543281|473807574|FG002|Overall Study|Lost to Follow-up|1|||
131594507|NCT05247489|473807575|FG000|Overall Study|Lost to Follow-up|5|||
131594508|NCT05247489|473807576|FG001|Overall Study|Lost to Follow-up|1|||
131594509|NCT05247489|473807575|FG000|Overall Study|Withdrawal by Subject|6|||
131594510|NCT05247489|473807576|FG001|Overall Study|Withdrawal by Subject|7|||
131594511|NCT05247489|473807575|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
131594512|NCT05247489|473807576|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
131594513|NCT05247489|473807575|FG000|Overall Study|Left Country|1|||
131594514|NCT05247489|473807576|FG001|Overall Study|Left Country|0|||
131594515|NCT05247489|473807575|FG000|Overall Study|Noncompliance with Investigational Product|1|||
131594516|NCT05247489|473807576|FG001|Overall Study|Noncompliance with Investigational Product|0|||
131594517|NCT05247489|473807575|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
131594518|NCT05247489|473807576|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
131594519|NCT04541706|473807577|FG000|Overall Study|Withdrawal by Subject|3|||
131594520|NCT04541706|473807577|FG000|Overall Study|Progressive disease|33|||
131594521|NCT04541706|473807577|FG000|Overall Study|Physician Decision|1|||
131594522|NCT04541706|473807577|FG000|Overall Study|Lost to Follow-up|2|||
131594523|NCT04541706|473807577|FG000|Overall Study|Death|5|||
131594524|NCT04541706|473807577|FG000|Overall Study|Adverse Event|1|||
131594525|NCT05563246|473807578|FG000|Overall Study|Withdrawal by Subject|1|||
131594526|NCT05563246|473807579|FG001|Overall Study|Withdrawal by Subject|2|||
131594527|NCT05563246|473807580|FG002|Overall Study|Withdrawal by Subject|0|||
131594528|NCT05563246|473807581|FG003|Overall Study|Withdrawal by Subject|0|||
131594529|NCT05563246|473807578|FG000|Overall Study|Protocol Deviation|0|||
131594530|NCT05563246|473807579|FG001|Overall Study|Protocol Deviation|1|||
131594531|NCT05563246|473807580|FG002|Overall Study|Protocol Deviation|0|||
131594532|NCT05563246|473807581|FG003|Overall Study|Protocol Deviation|0|||
131594533|NCT05563246|473807578|FG000|Overall Study|Physician Decision|0|||
131594534|NCT05563246|473807579|FG001|Overall Study|Physician Decision|1|||
131594535|NCT05563246|473807580|FG002|Overall Study|Physician Decision|0|||
131594536|NCT05563246|473807581|FG003|Overall Study|Physician Decision|0|||
131594537|NCT05563246|473807578|FG000|Overall Study|Adverse Event|0|||
131594538|NCT05563246|473807579|FG001|Overall Study|Adverse Event|0|||
131594539|NCT05563246|473807580|FG002|Overall Study|Adverse Event|2|||
131594540|NCT05563246|473807581|FG003|Overall Study|Adverse Event|0|||
131594541|NCT05563246|473807578|FG000|Overall Study|Lost to Follow-up|0|||
131594542|NCT05563246|473807579|FG001|Overall Study|Lost to Follow-up|0|||
131594543|NCT05563246|473807580|FG002|Overall Study|Lost to Follow-up|1|||
131594544|NCT05563246|473807581|FG003|Overall Study|Lost to Follow-up|0|||
131594545|NCT04294225|473807588|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
131594546|NCT04294225|473807588|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
131594547|NCT04294225|473807588|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
131594548|NCT04294225|473807588|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
131594549|NCT04294225|473807588|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
131594550|NCT04927065|473807590|FG000|First Booster|Adverse Event|1|||
131594551|NCT04927065|473807591|FG001|First Booster|Adverse Event|0|||
131594552|NCT04927065|473807592|FG002|First Booster|Adverse Event|0|||
131594553|NCT04927065|473807593|FG003|First Booster|Adverse Event|0|||
131594554|NCT04927065|473807594|FG004|First Booster|Adverse Event|0|||
131594555|NCT04927065|473807595|FG005|First Booster|Adverse Event|0|||
131594556|NCT04927065|473807596|FG006|First Booster|Adverse Event|0|||
131594557|NCT04927065|473807597|FG007|First Booster|Adverse Event|1|||
131594558|NCT04927065|473807598|FG008|First Booster|Adverse Event|0|||
131594559|NCT04927065|473807599|FG009|First Booster|Adverse Event|0|||
131594560|NCT04927065|473807600|FG010|First Booster|Adverse Event|0|||
131594561|NCT04927065|473807601|FG011|First Booster|Adverse Event|0|||
131594562|NCT04927065|473807602|FG012|First Booster|Adverse Event|0|||
131594563|NCT04927065|473807603|FG013|First Booster|Adverse Event|0|||
131594564|NCT04927065|473807604|FG014|First Booster|Adverse Event|0|||
131594565|NCT04927065|473807605|FG015|First Booster|Adverse Event|0|||
131594566|NCT04927065|473807590|FG000|First Booster|Death|1|||
131594567|NCT04927065|473807591|FG001|First Booster|Death|0|||
131594568|NCT04927065|473807592|FG002|First Booster|Death|0|||
131594569|NCT04927065|473807593|FG003|First Booster|Death|1|||
131594570|NCT04927065|473807594|FG004|First Booster|Death|0|||
131594571|NCT04927065|473807595|FG005|First Booster|Death|1|||
131594572|NCT04927065|473807596|FG006|First Booster|Death|0|||
131594573|NCT04927065|473807597|FG007|First Booster|Death|0|||
131594574|NCT04927065|473807598|FG008|First Booster|Death|0|||
131594575|NCT04927065|473807599|FG009|First Booster|Death|0|||
131594576|NCT04927065|473807600|FG010|First Booster|Death|0|||
131594577|NCT04927065|473807601|FG011|First Booster|Death|0|||
131594578|NCT04927065|473807602|FG012|First Booster|Death|0|||
131594579|NCT04927065|473807603|FG013|First Booster|Death|0|||
131594580|NCT04927065|473807604|FG014|First Booster|Death|0|||
131594581|NCT04927065|473807605|FG015|First Booster|Death|0|||
131594582|NCT04927065|473807590|FG000|First Booster|Lost to Follow-up|8|||
131594583|NCT04927065|473807591|FG001|First Booster|Lost to Follow-up|20|||
131594584|NCT04927065|473807592|FG002|First Booster|Lost to Follow-up|0|||
131594585|NCT04927065|473807593|FG003|First Booster|Lost to Follow-up|11|||
131594586|NCT04927065|473807594|FG004|First Booster|Lost to Follow-up|43|||
131594587|NCT04927065|473807595|FG005|First Booster|Lost to Follow-up|30|||
131594588|NCT04927065|473807596|FG006|First Booster|Lost to Follow-up|28|||
131594589|NCT04927065|473807597|FG007|First Booster|Lost to Follow-up|23|||
131594590|NCT04927065|473807598|FG008|First Booster|Lost to Follow-up|4|||
131594591|NCT04927065|473807599|FG009|First Booster|Lost to Follow-up|15|||
131594592|NCT04927065|473807600|FG010|First Booster|Lost to Follow-up|0|||
131594593|NCT04927065|473807601|FG011|First Booster|Lost to Follow-up|0|||
131594594|NCT04927065|473807602|FG012|First Booster|Lost to Follow-up|0|||
131594595|NCT04927065|473807603|FG013|First Booster|Lost to Follow-up|0|||
131594596|NCT04927065|473807604|FG014|First Booster|Lost to Follow-up|0|||
131594597|NCT04927065|473807605|FG015|First Booster|Lost to Follow-up|0|||
131594598|NCT04927065|473807590|FG000|First Booster|Physician Decision|1|||
131594599|NCT04927065|473807591|FG001|First Booster|Physician Decision|0|||
131594600|NCT04927065|473807592|FG002|First Booster|Physician Decision|0|||
131594601|NCT04927065|473807593|FG003|First Booster|Physician Decision|3|||
131594602|NCT04927065|473807594|FG004|First Booster|Physician Decision|1|||
131594603|NCT04927065|473807595|FG005|First Booster|Physician Decision|1|||
131594604|NCT04927065|473807596|FG006|First Booster|Physician Decision|0|||
131594605|NCT04927065|473807597|FG007|First Booster|Physician Decision|3|||
131594606|NCT04927065|473807598|FG008|First Booster|Physician Decision|0|||
131594607|NCT04927065|473807599|FG009|First Booster|Physician Decision|0|||
131594608|NCT04927065|473807600|FG010|First Booster|Physician Decision|0|||
131594609|NCT04927065|473807601|FG011|First Booster|Physician Decision|0|||
131594610|NCT04927065|473807602|FG012|First Booster|Physician Decision|0|||
131594611|NCT04927065|473807603|FG013|First Booster|Physician Decision|0|||
131594612|NCT04927065|473807604|FG014|First Booster|Physician Decision|0|||
131594613|NCT04927065|473807605|FG015|First Booster|Physician Decision|0|||
131594614|NCT04927065|473807590|FG000|First Booster|Protocol Violation|4|||
131594615|NCT04927065|473807591|FG001|First Booster|Protocol Violation|4|||
131594616|NCT04927065|473807592|FG002|First Booster|Protocol Violation|0|||
131594617|NCT04927065|473807593|FG003|First Booster|Protocol Violation|3|||
131594618|NCT04927065|473807594|FG004|First Booster|Protocol Violation|0|||
131594619|NCT04927065|473807595|FG005|First Booster|Protocol Violation|0|||
131594620|NCT04927065|473807596|FG006|First Booster|Protocol Violation|0|||
131594621|NCT04927065|473807597|FG007|First Booster|Protocol Violation|2|||
131594622|NCT04927065|473807598|FG008|First Booster|Protocol Violation|0|||
131594623|NCT04927065|473807599|FG009|First Booster|Protocol Violation|0|||
131594624|NCT04927065|473807600|FG010|First Booster|Protocol Violation|0|||
131594625|NCT04927065|473807601|FG011|First Booster|Protocol Violation|0|||
131594626|NCT04927065|473807602|FG012|First Booster|Protocol Violation|0|||
131594627|NCT04927065|473807603|FG013|First Booster|Protocol Violation|0|||
131594628|NCT04927065|473807604|FG014|First Booster|Protocol Violation|0|||
131594629|NCT04927065|473807605|FG015|First Booster|Protocol Violation|0|||
131594630|NCT04927065|473807590|FG000|First Booster|Withdrawal by Subject|8|||
131594631|NCT04927065|473807591|FG001|First Booster|Withdrawal by Subject|23|||
131594632|NCT04927065|473807592|FG002|First Booster|Withdrawal by Subject|0|||
131594633|NCT04927065|473807593|FG003|First Booster|Withdrawal by Subject|19|||
131594634|NCT04927065|473807594|FG004|First Booster|Withdrawal by Subject|20|||
131594635|NCT04927065|473807595|FG005|First Booster|Withdrawal by Subject|15|||
131594636|NCT04927065|473807596|FG006|First Booster|Withdrawal by Subject|6|||
131594637|NCT04927065|473807597|FG007|First Booster|Withdrawal by Subject|24|||
131594638|NCT04927065|473807598|FG008|First Booster|Withdrawal by Subject|0|||
131594639|NCT04927065|473807599|FG009|First Booster|Withdrawal by Subject|4|||
131594640|NCT04927065|473807600|FG010|First Booster|Withdrawal by Subject|0|||
131594641|NCT04927065|473807601|FG011|First Booster|Withdrawal by Subject|0|||
131594642|NCT04927065|473807602|FG012|First Booster|Withdrawal by Subject|0|||
131594643|NCT04927065|473807603|FG013|First Booster|Withdrawal by Subject|0|||
131594644|NCT04927065|473807604|FG014|First Booster|Withdrawal by Subject|0|||
131594645|NCT04927065|473807605|FG015|First Booster|Withdrawal by Subject|0|||
131594646|NCT04927065|473807590|FG000|First Booster|Other Than Specified|1|||
131594647|NCT04927065|473807591|FG001|First Booster|Other Than Specified|1|||
131594648|NCT04927065|473807592|FG002|First Booster|Other Than Specified|0|||
131594649|NCT04927065|473807593|FG003|First Booster|Other Than Specified|1|||
131791452|NCT00408876|474518701|FG000|Overall Study|Lost to Follow-up|1|||
131594650|NCT04927065|473807594|FG004|First Booster|Other Than Specified|2|||
131594651|NCT04927065|473807595|FG005|First Booster|Other Than Specified|3|||
131594652|NCT04927065|473807596|FG006|First Booster|Other Than Specified|2|||
131594653|NCT04927065|473807597|FG007|First Booster|Other Than Specified|6|||
131594654|NCT04927065|473807598|FG008|First Booster|Other Than Specified|0|||
131594655|NCT04927065|473807599|FG009|First Booster|Other Than Specified|4|||
131594656|NCT04927065|473807600|FG010|First Booster|Other Than Specified|0|||
131594657|NCT04927065|473807601|FG011|First Booster|Other Than Specified|0|||
131594658|NCT04927065|473807602|FG012|First Booster|Other Than Specified|0|||
131594659|NCT04927065|473807603|FG013|First Booster|Other Than Specified|0|||
131594660|NCT04927065|473807604|FG014|First Booster|Other Than Specified|0|||
131594661|NCT04927065|473807605|FG015|First Booster|Other Than Specified|0|||
131594662|NCT04927065|473807590|FG000|Second Booster|Death|0|||
131594663|NCT04927065|473807591|FG001|Second Booster|Death|0|||
131594664|NCT04927065|473807592|FG002|Second Booster|Death|0|||
131594665|NCT04927065|473807593|FG003|Second Booster|Death|0|||
131594666|NCT04927065|473807594|FG004|Second Booster|Death|0|||
131594667|NCT04927065|473807595|FG005|Second Booster|Death|0|||
131594668|NCT04927065|473807596|FG006|Second Booster|Death|0|||
131594669|NCT04927065|473807597|FG007|Second Booster|Death|0|||
131594670|NCT04927065|473807598|FG008|Second Booster|Death|0|||
131594671|NCT04927065|473807599|FG009|Second Booster|Death|0|||
131594672|NCT04927065|473807600|FG010|Second Booster|Death|2|||
131594673|NCT04927065|473807601|FG011|Second Booster|Death|0|||
131594674|NCT04927065|473807602|FG012|Second Booster|Death|2|||
131594675|NCT04927065|473807603|FG013|Second Booster|Death|2|||
131594676|NCT04927065|473807604|FG014|Second Booster|Death|0|||
131594677|NCT04927065|473807605|FG015|Second Booster|Death|0|||
131594678|NCT04927065|473807590|FG000|Second Booster|Lost to Follow-up|0|||
131594679|NCT04927065|473807591|FG001|Second Booster|Lost to Follow-up|0|||
131594680|NCT04927065|473807592|FG002|Second Booster|Lost to Follow-up|3|||
131594681|NCT04927065|473807593|FG003|Second Booster|Lost to Follow-up|0|||
131594682|NCT04927065|473807594|FG004|Second Booster|Lost to Follow-up|0|||
131594683|NCT04927065|473807595|FG005|Second Booster|Lost to Follow-up|0|||
131594684|NCT04927065|473807596|FG006|Second Booster|Lost to Follow-up|0|||
131594685|NCT04927065|473807597|FG007|Second Booster|Lost to Follow-up|0|||
131594686|NCT04927065|473807598|FG008|Second Booster|Lost to Follow-up|0|||
131594687|NCT04927065|473807599|FG009|Second Booster|Lost to Follow-up|0|||
131594688|NCT04927065|473807600|FG010|Second Booster|Lost to Follow-up|14|||
131594689|NCT04927065|473807601|FG011|Second Booster|Lost to Follow-up|10|||
131594690|NCT04927065|473807602|FG012|Second Booster|Lost to Follow-up|13|||
131594691|NCT04927065|473807603|FG013|Second Booster|Lost to Follow-up|16|||
131594692|NCT04927065|473807604|FG014|Second Booster|Lost to Follow-up|0|||
131594693|NCT04927065|473807605|FG015|Second Booster|Lost to Follow-up|0|||
131594694|NCT04927065|473807590|FG000|Second Booster|Physician Decision|0|||
131594695|NCT04927065|473807591|FG001|Second Booster|Physician Decision|0|||
131594696|NCT04927065|473807592|FG002|Second Booster|Physician Decision|0|||
131594697|NCT04927065|473807593|FG003|Second Booster|Physician Decision|0|||
131594698|NCT04927065|473807594|FG004|Second Booster|Physician Decision|0|||
131594699|NCT04927065|473807595|FG005|Second Booster|Physician Decision|0|||
131594700|NCT04927065|473807596|FG006|Second Booster|Physician Decision|0|||
131439298|NCT03346434|473235439|FG004|Overall Study|Withdrawal by Subject|1|||
131439299|NCT03346434|473235440|FG005|Overall Study|Withdrawal by Subject|0|||
131439300|NCT03346434|473235435|FG000|Overall Study|Lost to Follow-up|0|||
131439301|NCT03346434|473235436|FG001|Overall Study|Lost to Follow-up|0|||
131439302|NCT03346434|473235437|FG002|Overall Study|Lost to Follow-up|0|||
131439303|NCT03346434|473235438|FG003|Overall Study|Lost to Follow-up|0|||
131439304|NCT03346434|473235439|FG004|Overall Study|Lost to Follow-up|1|||
131439305|NCT03346434|473235440|FG005|Overall Study|Lost to Follow-up|1|||
131439306|NCT03346434|473235435|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
131439307|NCT03346434|473235436|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
131439308|NCT03346434|473235437|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
131439309|NCT03346434|473235438|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
131439310|NCT03346434|473235439|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
131439311|NCT03346434|473235440|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
131439312|NCT01959503|473235443|FG000|Overall Study|Death|2|||
131439313|NCT01959503|473235444|FG001|Overall Study|Death|1|||
131439314|NCT01959503|473235443|FG000|Overall Study|Randomized but not treated|1|||
131439315|NCT01959503|473235444|FG001|Overall Study|Randomized but not treated|1|||
131594701|NCT04927065|473807597|FG007|Second Booster|Physician Decision|0|||
131594702|NCT04927065|473807598|FG008|Second Booster|Physician Decision|0|||
131594703|NCT04927065|473807599|FG009|Second Booster|Physician Decision|0|||
131594704|NCT04927065|473807600|FG010|Second Booster|Physician Decision|0|||
131594705|NCT04927065|473807601|FG011|Second Booster|Physician Decision|3|||
131594706|NCT04927065|473807602|FG012|Second Booster|Physician Decision|0|||
131899324|NCT00905424|474917597|FG001|Overall Study|Sponsor decision|0|||
131594707|NCT04927065|473807603|FG013|Second Booster|Physician Decision|1|||
131594708|NCT04927065|473807604|FG014|Second Booster|Physician Decision|0|||
131594709|NCT04927065|473807605|FG015|Second Booster|Physician Decision|0|||
131594710|NCT04927065|473807590|FG000|Second Booster|Withdrawal by Subject|0|||
131594711|NCT04927065|473807591|FG001|Second Booster|Withdrawal by Subject|0|||
131594712|NCT04927065|473807592|FG002|Second Booster|Withdrawal by Subject|4|||
131594713|NCT04927065|473807593|FG003|Second Booster|Withdrawal by Subject|0|||
131594714|NCT04927065|473807594|FG004|Second Booster|Withdrawal by Subject|0|||
131594715|NCT04927065|473807595|FG005|Second Booster|Withdrawal by Subject|0|||
131594716|NCT04927065|473807596|FG006|Second Booster|Withdrawal by Subject|0|||
131594717|NCT04927065|473807597|FG007|Second Booster|Withdrawal by Subject|0|||
131594718|NCT04927065|473807598|FG008|Second Booster|Withdrawal by Subject|0|||
131594719|NCT04927065|473807599|FG009|Second Booster|Withdrawal by Subject|0|||
131594720|NCT04927065|473807600|FG010|Second Booster|Withdrawal by Subject|3|||
131594721|NCT04927065|473807601|FG011|Second Booster|Withdrawal by Subject|16|||
131594722|NCT04927065|473807602|FG012|Second Booster|Withdrawal by Subject|13|||
131594723|NCT04927065|473807603|FG013|Second Booster|Withdrawal by Subject|9|||
131594724|NCT04927065|473807604|FG014|Second Booster|Withdrawal by Subject|0|||
131594725|NCT04927065|473807605|FG015|Second Booster|Withdrawal by Subject|0|||
131594726|NCT04927065|473807590|FG000|Second Booster|Other Than Specified|0|||
131594727|NCT04927065|473807591|FG001|Second Booster|Other Than Specified|0|||
131594728|NCT04927065|473807592|FG002|Second Booster|Other Than Specified|0|||
131594729|NCT04927065|473807593|FG003|Second Booster|Other Than Specified|0|||
131594730|NCT04927065|473807594|FG004|Second Booster|Other Than Specified|0|||
131594731|NCT04927065|473807595|FG005|Second Booster|Other Than Specified|0|||
131594732|NCT04927065|473807596|FG006|Second Booster|Other Than Specified|0|||
131594733|NCT04927065|473807597|FG007|Second Booster|Other Than Specified|0|||
131594734|NCT04927065|473807598|FG008|Second Booster|Other Than Specified|0|||
131594735|NCT04927065|473807599|FG009|Second Booster|Other Than Specified|0|||
131594736|NCT04927065|473807600|FG010|Second Booster|Other Than Specified|1|||
131594737|NCT04927065|473807601|FG011|Second Booster|Other Than Specified|1|||
131594738|NCT04927065|473807602|FG012|Second Booster|Other Than Specified|4|||
131594739|NCT04927065|473807603|FG013|Second Booster|Other Than Specified|0|||
131594740|NCT04927065|473807604|FG014|Second Booster|Other Than Specified|0|||
131594741|NCT04927065|473807605|FG015|Second Booster|Other Than Specified|0|||
131439316|NCT01600326|473235445|FG000|Overall Study|Lost to Follow-up|1|||
131439317|NCT01600326|473235446|FG001|Overall Study|Lost to Follow-up|1|||
131439318|NCT02587520|473235452|FG000|Overall Study|Protocol Violation|2|||
131439319|NCT02587520|473235453|FG001|Overall Study|Protocol Violation|0|||
131439320|NCT02587520|473235454|FG002|Overall Study|Protocol Violation|0|||
131439321|NCT02587520|473235455|FG003|Overall Study|Protocol Violation|2|||
131439322|NCT02587520|473235456|FG004|Overall Study|Protocol Violation|0|||
131439323|NCT02587520|473235457|FG005|Overall Study|Protocol Violation|1|||
131439324|NCT02587520|473235458|FG006|Overall Study|Protocol Violation|1|||
131439325|NCT02587520|473235459|FG007|Overall Study|Protocol Violation|1|||
131439326|NCT02587520|473235460|FG008|Overall Study|Protocol Violation|3|||
131439327|NCT02587520|473235461|FG009|Overall Study|Protocol Violation|3|||
131439328|NCT02587520|473235462|FG010|Overall Study|Protocol Violation|1|||
131439329|NCT02587520|473235463|FG011|Overall Study|Protocol Violation|2|||
131439330|NCT02587520|473235464|FG012|Overall Study|Protocol Violation|0|||
131439331|NCT02587520|473235465|FG013|Overall Study|Protocol Violation|0|||
131439332|NCT02587520|473235466|FG014|Overall Study|Protocol Violation|0|||
131439333|NCT02587520|473235467|FG015|Overall Study|Protocol Violation|0|||
131439334|NCT02587520|473235468|FG016|Overall Study|Protocol Violation|0|||
131439335|NCT02587520|473235469|FG017|Overall Study|Protocol Violation|0|||
131439336|NCT02587520|473235452|FG000|Overall Study|Adverse Event|0|||
131439337|NCT02587520|473235453|FG001|Overall Study|Adverse Event|0|||
131439338|NCT02587520|473235454|FG002|Overall Study|Adverse Event|0|||
131439339|NCT02587520|473235455|FG003|Overall Study|Adverse Event|0|||
131594742|NCT04927065|473807590|FG000|Third Booster|Lost to Follow-up|0|||
131594743|NCT04927065|473807591|FG001|Third Booster|Lost to Follow-up|0|||
131594744|NCT04927065|473807592|FG002|Third Booster|Lost to Follow-up|0|||
131594745|NCT04927065|473807593|FG003|Third Booster|Lost to Follow-up|0|||
131706342|NCT00364182|474207366|FG001|First Intervention|Withdrawal by Subject|0|||
131706343|NCT00364182|474207367|FG002|First Intervention|Withdrawal by Subject|0|||
131439340|NCT02587520|473235456|FG004|Overall Study|Adverse Event|0|||
131439341|NCT02587520|473235457|FG005|Overall Study|Adverse Event|0|||
131439342|NCT02587520|473235458|FG006|Overall Study|Adverse Event|0|||
131439343|NCT02587520|473235459|FG007|Overall Study|Adverse Event|0|||
131439344|NCT02587520|473235460|FG008|Overall Study|Adverse Event|0|||
131594746|NCT04927065|473807594|FG004|Third Booster|Lost to Follow-up|0|||
131594747|NCT04927065|473807595|FG005|Third Booster|Lost to Follow-up|0|||
131594748|NCT04927065|473807596|FG006|Third Booster|Lost to Follow-up|0|||
131594749|NCT04927065|473807597|FG007|Third Booster|Lost to Follow-up|0|||
131594750|NCT04927065|473807598|FG008|Third Booster|Lost to Follow-up|0|||
131706344|NCT00364182|474207365|FG000|Second Intervention|non-compliance|0|||
131594751|NCT04927065|473807599|FG009|Third Booster|Lost to Follow-up|0|||
131439345|NCT02587520|473235461|FG009|Overall Study|Adverse Event|0|||
131439346|NCT02587520|473235462|FG010|Overall Study|Adverse Event|0|||
131439347|NCT02587520|473235463|FG011|Overall Study|Adverse Event|1|||
131439348|NCT02587520|473235464|FG012|Overall Study|Adverse Event|0|||
131594752|NCT04927065|473807600|FG010|Third Booster|Lost to Follow-up|0|||
131594753|NCT04927065|473807601|FG011|Third Booster|Lost to Follow-up|0|||
131594754|NCT04927065|473807602|FG012|Third Booster|Lost to Follow-up|0|||
131594755|NCT04927065|473807603|FG013|Third Booster|Lost to Follow-up|0|||
131594756|NCT04927065|473807604|FG014|Third Booster|Lost to Follow-up|0|||
131594757|NCT04927065|473807605|FG015|Third Booster|Lost to Follow-up|1|||
131594758|NCT04927065|473807590|FG000|Third Booster|Withdrawal by Subject|0|||
131594759|NCT04927065|473807591|FG001|Third Booster|Withdrawal by Subject|0|||
131594760|NCT04927065|473807592|FG002|Third Booster|Withdrawal by Subject|0|||
131594761|NCT04927065|473807593|FG003|Third Booster|Withdrawal by Subject|0|||
131594762|NCT04927065|473807594|FG004|Third Booster|Withdrawal by Subject|0|||
131594763|NCT04927065|473807595|FG005|Third Booster|Withdrawal by Subject|0|||
131594764|NCT04927065|473807596|FG006|Third Booster|Withdrawal by Subject|0|||
131594765|NCT04927065|473807597|FG007|Third Booster|Withdrawal by Subject|0|||
131594766|NCT04927065|473807598|FG008|Third Booster|Withdrawal by Subject|0|||
131594767|NCT04927065|473807599|FG009|Third Booster|Withdrawal by Subject|0|||
131594768|NCT04927065|473807600|FG010|Third Booster|Withdrawal by Subject|0|||
131594769|NCT04927065|473807601|FG011|Third Booster|Withdrawal by Subject|0|||
131594770|NCT04927065|473807602|FG012|Third Booster|Withdrawal by Subject|0|||
131594771|NCT04927065|473807603|FG013|Third Booster|Withdrawal by Subject|0|||
131594772|NCT04927065|473807604|FG014|Third Booster|Withdrawal by Subject|0|||
131594773|NCT04927065|473807605|FG015|Third Booster|Withdrawal by Subject|1|||
131594774|NCT03366649|473807612|FG000|Overall Study|Failed preoperative screening|4|||
131594775|NCT03366649|473807613|FG001|Overall Study|Failed preoperative screening|0|||
131594776|NCT03366649|473807614|FG002|Overall Study|Failed preoperative screening|0|||
131594777|NCT03366649|473807612|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
131594778|NCT03366649|473807613|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
131594779|NCT03366649|473807614|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
131594780|NCT03673111|473807615|FG000|Overall Study|Protocol Violation|0|||
131594781|NCT03673111|473807616|FG001|Overall Study|Protocol Violation|0|||
131594782|NCT03673111|473807617|FG002|Overall Study|Protocol Violation|0|||
131594783|NCT03673111|473807618|FG003|Overall Study|Protocol Violation|0|||
131594784|NCT03673111|473807619|FG004|Overall Study|Protocol Violation|0|||
131594785|NCT03673111|473807620|FG005|Overall Study|Protocol Violation|0|||
131594786|NCT03673111|473807621|FG006|Overall Study|Protocol Violation|0|||
131594787|NCT03673111|473807622|FG007|Overall Study|Protocol Violation|0|||
131594788|NCT03673111|473807623|FG008|Overall Study|Protocol Violation|0|||
131594789|NCT03673111|473807624|FG009|Overall Study|Protocol Violation|0|||
131594790|NCT03673111|473807625|FG010|Overall Study|Protocol Violation|1|||
131594791|NCT03673111|473807626|FG011|Overall Study|Protocol Violation|0|||
131594792|NCT03673111|473807627|FG012|Overall Study|Protocol Violation|0|||
131594793|NCT03673111|473807628|FG013|Overall Study|Protocol Violation|0|||
131594794|NCT03673111|473807615|FG000|Overall Study|Adverse Event|1|||
131594795|NCT03673111|473807616|FG001|Overall Study|Adverse Event|0|||
131594796|NCT03673111|473807617|FG002|Overall Study|Adverse Event|0|||
131594797|NCT03673111|473807618|FG003|Overall Study|Adverse Event|0|||
131594798|NCT03673111|473807619|FG004|Overall Study|Adverse Event|0|||
131594799|NCT03673111|473807620|FG005|Overall Study|Adverse Event|0|||
131594800|NCT03673111|473807621|FG006|Overall Study|Adverse Event|0|||
131594801|NCT03673111|473807622|FG007|Overall Study|Adverse Event|0|||
131594802|NCT03673111|473807623|FG008|Overall Study|Adverse Event|0|||
131594803|NCT03673111|473807624|FG009|Overall Study|Adverse Event|0|||
131594804|NCT03673111|473807625|FG010|Overall Study|Adverse Event|0|||
131594805|NCT03673111|473807626|FG011|Overall Study|Adverse Event|0|||
131594806|NCT03673111|473807627|FG012|Overall Study|Adverse Event|0|||
131594807|NCT03673111|473807628|FG013|Overall Study|Adverse Event|0|||
131594808|NCT01744782|473807632|FG000|Overall Study|Death|1|||
131594809|NCT02120456|473807633|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594810|NCT02120456|473807634|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594811|NCT02120456|473807635|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594812|NCT02120456|473807636|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594813|NCT02120456|473807637|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594814|NCT02120456|473807638|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594815|NCT02120456|473807639|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
131594816|NCT02120456|473807640|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594817|NCT02120456|473807641|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131594818|NCT02120456|473807633|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594819|NCT02120456|473807634|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594820|NCT02120456|473807635|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594821|NCT02120456|473807636|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594822|NCT02120456|473807637|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594823|NCT02120456|473807638|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594824|NCT02120456|473807639|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
131594825|NCT02120456|473807640|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594826|NCT02120456|473807641|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131594827|NCT02120456|473807633|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594828|NCT02120456|473807634|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594829|NCT02120456|473807635|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594830|NCT02120456|473807636|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594831|NCT02120456|473807637|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594832|NCT02120456|473807638|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594833|NCT02120456|473807639|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594834|NCT02120456|473807640|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131594835|NCT02120456|473807641|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
131594836|NCT01785719|473807643|FG000|4-week Baseline Evaluation|Physician Decision|1|||
131594837|NCT01785719|473807644|FG001|4-week Baseline Evaluation|Physician Decision|0|||
131594838|NCT01785719|473807643|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
131594839|NCT01785719|473807644|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
131594840|NCT01785719|473807643|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
131594841|NCT01785719|473807644|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
131594842|NCT01785719|473807643|FG000|4-week Baseline Evaluation|Pregnancy|0|||
131594843|NCT01785719|473807644|FG001|4-week Baseline Evaluation|Pregnancy|2|||
131594844|NCT01785719|473807643|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
131594845|NCT01785719|473807644|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
131594846|NCT01785719|473807643|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
131594847|NCT01785719|473807644|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
131594848|NCT01785719|473807643|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
131594849|NCT01785719|473807644|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
131594850|NCT01785719|473807643|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
131594851|NCT01785719|473807644|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
131594852|NCT01785719|473807643|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
131594853|NCT01785719|473807644|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
131594854|NCT01785719|473807643|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
131594855|NCT01785719|473807644|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
131594856|NCT01785719|473807643|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
131594857|NCT01785719|473807644|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
131594858|NCT01785719|473807643|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
131594859|NCT01785719|473807644|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
131594860|NCT01785719|473807643|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
131594861|NCT01785719|473807644|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
131594862|NCT01785719|473807643|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
131594863|NCT01785719|473807644|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
131594864|NCT01785719|473807643|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
131594865|NCT01785719|473807644|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
131594866|NCT03443323|473807645|FG000|Overall Study|Lost to Follow-up|2|||
131594867|NCT03443323|473807646|FG001|Overall Study|Lost to Follow-up|2|||
131594868|NCT03443323|473807645|FG000|Overall Study|PI withdrawal|1|||
131594869|NCT03443323|473807646|FG001|Overall Study|PI withdrawal|0|||
131594870|NCT04610892|473807654|FG000|Overall Study|Adverse Event|1|||
131594871|NCT04610892|473807655|FG001|Overall Study|Adverse Event|0|||
131594872|NCT04610892|473807656|FG002|Overall Study|Adverse Event|0|||
131594873|NCT04610892|473807657|FG003|Overall Study|Adverse Event|1|||
131594874|NCT04610892|473807658|FG004|Overall Study|Adverse Event|3|||
131594875|NCT04610892|473807654|FG000|Overall Study|Death|0|||
131594876|NCT04610892|473807655|FG001|Overall Study|Death|1|||
131594877|NCT04610892|473807656|FG002|Overall Study|Death|0|||
131594878|NCT04610892|473807657|FG003|Overall Study|Death|1|||
131594879|NCT04610892|473807658|FG004|Overall Study|Death|0|||
131594880|NCT04610892|473807654|FG000|Overall Study|Withdrawal by Subject|3|||
131594881|NCT04610892|473807655|FG001|Overall Study|Withdrawal by Subject|2|||
131594882|NCT04610892|473807656|FG002|Overall Study|Withdrawal by Subject|0|||
131594883|NCT04610892|473807657|FG003|Overall Study|Withdrawal by Subject|6|||
131594884|NCT04610892|473807658|FG004|Overall Study|Withdrawal by Subject|6|||
131594885|NCT04610892|473807654|FG000|Overall Study|Subjects who did not receive treatment|1|||
131594886|NCT04610892|473807655|FG001|Overall Study|Subjects who did not receive treatment|0|||
131594887|NCT04610892|473807656|FG002|Overall Study|Subjects who did not receive treatment|0|||
131594888|NCT04610892|473807657|FG003|Overall Study|Subjects who did not receive treatment|0|||
131594889|NCT04610892|473807658|FG004|Overall Study|Subjects who did not receive treatment|2|||
131594890|NCT05520190|473807659|FG000|Overall Study|Lost to Follow-up|7|||
131594891|NCT05520190|473807659|FG000|Overall Study|Withdrawal by Subject|2|||
131594892|NCT01999075|473807660|FG000|Overall Study|Lost to Follow-up|0|||
131594893|NCT01999075|473807661|FG001|Overall Study|Lost to Follow-up|2|||
131594894|NCT01999075|473807660|FG000|Overall Study|Withdrawal by Subject|2|||
131594895|NCT01999075|473807661|FG001|Overall Study|Withdrawal by Subject|7|||
131594896|NCT01999075|473807660|FG000|Overall Study|Enrolled in drug trial|3|||
131594897|NCT01999075|473807661|FG001|Overall Study|Enrolled in drug trial|1|||
131594898|NCT01999075|473807660|FG000|Overall Study|Became ineligible|0|||
131594899|NCT01999075|473807661|FG001|Overall Study|Became ineligible|2|||
131594900|NCT03683719|473807662|FG000|Overall Study|Lack of Efficacy|1|||
131594901|NCT03683719|473807663|FG001|Overall Study|Lack of Efficacy|3|||
131594902|NCT03683719|473807664|FG002|Overall Study|Lack of Efficacy|4|||
131594903|NCT03683719|473807665|FG003|Overall Study|Lack of Efficacy|0|||
131594904|NCT03683719|473807666|FG004|Overall Study|Lack of Efficacy|4|||
131594905|NCT03683719|473807662|FG000|Overall Study|Adverse Event|6|||
131594906|NCT03683719|473807663|FG001|Overall Study|Adverse Event|6|||
131594907|NCT03683719|473807664|FG002|Overall Study|Adverse Event|0|||
131594908|NCT03683719|473807665|FG003|Overall Study|Adverse Event|1|||
131594909|NCT03683719|473807666|FG004|Overall Study|Adverse Event|3|||
131594910|NCT03683719|473807662|FG000|Overall Study|Withdrawal by Subject|4|||
131594911|NCT03683719|473807663|FG001|Overall Study|Withdrawal by Subject|4|||
131594912|NCT03683719|473807664|FG002|Overall Study|Withdrawal by Subject|3|||
131594913|NCT03683719|473807665|FG003|Overall Study|Withdrawal by Subject|5|||
131594914|NCT03683719|473807666|FG004|Overall Study|Withdrawal by Subject|5|||
131594915|NCT03683719|473807662|FG000|Overall Study|Lost to Follow-up|1|||
131594916|NCT03683719|473807663|FG001|Overall Study|Lost to Follow-up|0|||
131594917|NCT03683719|473807664|FG002|Overall Study|Lost to Follow-up|0|||
131594918|NCT03683719|473807665|FG003|Overall Study|Lost to Follow-up|1|||
131594919|NCT03683719|473807666|FG004|Overall Study|Lost to Follow-up|1|||
131594920|NCT03683719|473807662|FG000|Overall Study|Other personal reasons|0|||
131594921|NCT03683719|473807663|FG001|Overall Study|Other personal reasons|0|||
131594922|NCT03683719|473807664|FG002|Overall Study|Other personal reasons|1|||
131594923|NCT03683719|473807665|FG003|Overall Study|Other personal reasons|0|||
131594924|NCT03683719|473807666|FG004|Overall Study|Other personal reasons|1|||
131594925|NCT03699709|473807671|FG000|Overall Study|Death|1|||
131594926|NCT03699709|473807672|FG001|Overall Study|Death|2|||
131594927|NCT03699709|473807671|FG000|Overall Study|Lost to Follow-up|10|||
131594928|NCT03699709|473807672|FG001|Overall Study|Lost to Follow-up|3|||
131594929|NCT03699709|473807671|FG000|Overall Study|Withdrawal by Subject|5|||
131594930|NCT03699709|473807672|FG001|Overall Study|Withdrawal by Subject|0|||
131594931|NCT03699709|473807671|FG000|Overall Study|incarcerated|1|||
131594932|NCT03699709|473807672|FG001|Overall Study|incarcerated|0|||
131594933|NCT03699709|473807671|FG000|Overall Study|scheduled, but no show|0|||
131594934|NCT03699709|473807672|FG001|Overall Study|scheduled, but no show|1|||
131594935|NCT04562649|473807673|FG000|Overall Study|Withdrawal by Subject|11|||
131594936|NCT04562649|473807674|FG001|Overall Study|Withdrawal by Subject|8|||
131594937|NCT04562649|473807673|FG000|Overall Study|Lost to Follow-up|26|||
131594938|NCT04562649|473807674|FG001|Overall Study|Lost to Follow-up|20|||
131594939|NCT03056040|473807680|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
131594940|NCT03056040|473807681|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
131594941|NCT03056040|473807680|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
131594942|NCT03056040|473807681|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
131594943|NCT03056040|473807680|FG000|Primary Evaluation Period|Pregnancy|0|||
131594944|NCT03056040|473807681|FG001|Primary Evaluation Period|Pregnancy|1|||
131594945|NCT03056040|473807680|FG000|Primary Evaluation Period|Randomized, not treated|1|||
131594946|NCT03056040|473807681|FG001|Primary Evaluation Period|Randomized, not treated|1|||
131594947|NCT03056040|473807680|FG000|Extension Period|Physician Decision|3|||
131594948|NCT03056040|473807681|FG001|Extension Period|Physician Decision|3|||
131594949|NCT03056040|473807680|FG000|Extension Period|Lost to Follow-up|0|||
131594950|NCT03056040|473807681|FG001|Extension Period|Lost to Follow-up|1|||
131594951|NCT03056040|473807680|FG000|Extension Period|Death|0|||
131594952|NCT03056040|473807681|FG001|Extension Period|Death|3|||
131594953|NCT03056040|473807680|FG000|Extension Period|Withdrawal by Subject|1|||
131439349|NCT02587520|473235465|FG013|Overall Study|Adverse Event|0|||
131594954|NCT03056040|473807681|FG001|Extension Period|Withdrawal by Subject|0|||
131594955|NCT01997840|473807682|FG000|Overall Study|Lost to Follow-up|0|||
131594956|NCT01997840|473807683|FG001|Overall Study|Lost to Follow-up|0|||
131594957|NCT01997840|473807684|FG002|Overall Study|Lost to Follow-up|1|||
131594958|NCT01997840|473807685|FG003|Overall Study|Lost to Follow-up|0|||
131899325|NCT00905424|474917596|FG000|Overall Study|Positive urine drug screen|0|||
131594959|NCT01997840|473807682|FG000|Overall Study|Withdrawal by participant|0|||
131594960|NCT01997840|473807683|FG001|Overall Study|Withdrawal by participant|0|||
131594961|NCT01997840|473807684|FG002|Overall Study|Withdrawal by participant|8|||
131594962|NCT01997840|473807685|FG003|Overall Study|Withdrawal by participant|1|||
131594963|NCT01997840|473807682|FG000|Overall Study|Physician Decision|0|||
131594964|NCT01997840|473807683|FG001|Overall Study|Physician Decision|0|||
131594965|NCT01997840|473807684|FG002|Overall Study|Physician Decision|3|||
131594966|NCT01997840|473807685|FG003|Overall Study|Physician Decision|0|||
131594967|NCT01997840|473807682|FG000|Overall Study|Progressive disease|3|||
131594968|NCT01997840|473807683|FG001|Overall Study|Progressive disease|4|||
131594969|NCT01997840|473807684|FG002|Overall Study|Progressive disease|57|||
131594970|NCT01997840|473807685|FG003|Overall Study|Progressive disease|8|||
131594971|NCT01997840|473807682|FG000|Overall Study|Other reasons|0|||
131594972|NCT01997840|473807683|FG001|Overall Study|Other reasons|0|||
131594973|NCT01997840|473807684|FG002|Overall Study|Other reasons|1|||
131594974|NCT01997840|473807685|FG003|Overall Study|Other reasons|0|||
131594975|NCT01997840|473807682|FG000|Overall Study|Adverse Event|0|||
131594976|NCT01997840|473807683|FG001|Overall Study|Adverse Event|0|||
131594977|NCT01997840|473807684|FG002|Overall Study|Adverse Event|15|||
131594978|NCT01997840|473807685|FG003|Overall Study|Adverse Event|2|||
131594979|NCT01573442|473807686|FG000|Overall Study|Cancels|9|||
131594980|NCT01573442|473807687|FG001|Overall Study|Cancels|10|||
131594981|NCT05710107|473807688|FG000|Overall Study|Withdrawal by Subject|1|||
131594982|NCT05710107|473807689|FG001|Overall Study|Withdrawal by Subject|1|||
131594983|NCT05710107|473807688|FG000|Overall Study|Lost to Follow-up|8|||
131594984|NCT05710107|473807689|FG001|Overall Study|Lost to Follow-up|9|||
131594985|NCT05710107|473807688|FG000|Overall Study|Unable to place assigned block|2|||
131594986|NCT05710107|473807689|FG001|Overall Study|Unable to place assigned block|0|||
131594987|NCT05710107|473807688|FG000|Overall Study|Withdrawn by study team|0|||
131594988|NCT05710107|473807689|FG001|Overall Study|Withdrawn by study team|1|||
131594989|NCT04166773|473807690|FG000|Overall Study|Adverse Event|2|||
131594990|NCT04166773|473807691|FG001|Overall Study|Adverse Event|0|||
131594991|NCT04166773|473807692|FG002|Overall Study|Adverse Event|2|||
131594992|NCT04166773|473807693|FG003|Overall Study|Adverse Event|1|||
131594993|NCT04166773|473807690|FG000|Overall Study|Lost to Follow-up|4|||
131594994|NCT04166773|473807691|FG001|Overall Study|Lost to Follow-up|2|||
131594995|NCT04166773|473807692|FG002|Overall Study|Lost to Follow-up|1|||
131594996|NCT04166773|473807693|FG003|Overall Study|Lost to Follow-up|3|||
131594997|NCT04166773|473807690|FG000|Overall Study|Physician Decision|0|||
131594998|NCT04166773|473807691|FG001|Overall Study|Physician Decision|0|||
131594999|NCT04166773|473807692|FG002|Overall Study|Physician Decision|0|||
131595000|NCT04166773|473807693|FG003|Overall Study|Physician Decision|1|||
131595001|NCT04166773|473807690|FG000|Overall Study|Withdrawal by Subject|1|||
131595002|NCT04166773|473807691|FG001|Overall Study|Withdrawal by Subject|1|||
131595003|NCT04166773|473807692|FG002|Overall Study|Withdrawal by Subject|2|||
131595004|NCT04166773|473807693|FG003|Overall Study|Withdrawal by Subject|5|||
131595005|NCT04456517|473807694|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
131595006|NCT04456517|473807695|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
131595007|NCT05071807|473807696|FG000|Overall Study|Withdrawal by Subject|4|||
131595008|NCT05071807|473807697|FG001|Overall Study|Withdrawal by Subject|0|||
131595009|NCT05071807|473807696|FG000|Overall Study|Unrelated medical issues|3|||
131595010|NCT05071807|473807697|FG001|Overall Study|Unrelated medical issues|0|||
131595011|NCT05071807|473807696|FG000|Overall Study|Relocated|0|||
131595012|NCT05071807|473807697|FG001|Overall Study|Relocated|1|||
131595013|NCT05302596|473807700|FG000|Overall Study|Withdrawal by Subject|1|||
131595014|NCT05302596|473807701|FG001|Overall Study|Withdrawal by Subject|1|||
131595015|NCT03131648|473809719|FG000|Initial Treatment Period|Not dosed|2|||
131595016|NCT03131648|473809720|FG001|Initial Treatment Period|Not dosed|2|||
131595017|NCT03131648|473809721|FG002|Initial Treatment Period|Not dosed|0|||
131595018|NCT03131648|473809722|FG003|Initial Treatment Period|Not dosed|0|||
131595019|NCT03131648|473809723|FG004|Initial Treatment Period|Not dosed|0|||
131595020|NCT03131648|473809724|FG005|Initial Treatment Period|Not dosed|0|||
131595021|NCT03131648|473809725|FG006|Initial Treatment Period|Not dosed|0|||
131595022|NCT03131648|473809726|FG007|Initial Treatment Period|Not dosed|0|||
131595023|NCT03131648|473809719|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
131595024|NCT03131648|473809720|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
131706345|NCT00364182|474207366|FG001|Second Intervention|non-compliance|1|||
131706346|NCT00364182|474207367|FG002|Second Intervention|non-compliance|1|||
131706347|NCT00364182|474207365|FG000|Second Intervention|Protocol Violation|0|||
131706348|NCT00364182|474207366|FG001|Second Intervention|Protocol Violation|1|||
131706349|NCT00364182|474207367|FG002|Second Intervention|Protocol Violation|0|||
131706350|NCT00364182|474207365|FG000|Second Intervention|Adverse Event|0|||
131706351|NCT00364182|474207366|FG001|Second Intervention|Adverse Event|0|||
131791453|NCT00408876|474518702|FG001|Overall Study|Lost to Follow-up|6|||
131791454|NCT00408876|474518703|FG002|Overall Study|Lost to Follow-up|5|||
131791455|NCT00408876|474518704|FG003|Overall Study|Lost to Follow-up|2|||
131595025|NCT03131648|473809721|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131595026|NCT03131648|473809722|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131595027|NCT03131648|473809723|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131595028|NCT03131648|473809724|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131595029|NCT03131648|473809725|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131595030|NCT03131648|473809726|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131595031|NCT03131648|473809719|FG000|Open-label Treatment|Discontinued IMP|0|||
131595032|NCT03131648|473809720|FG001|Open-label Treatment|Discontinued IMP|0|||
131595033|NCT03131648|473809721|FG002|Open-label Treatment|Discontinued IMP|0|||
131595034|NCT03131648|473809722|FG003|Open-label Treatment|Discontinued IMP|0|||
131595035|NCT03131648|473809723|FG004|Open-label Treatment|Discontinued IMP|0|||
131706352|NCT00364182|474207367|FG002|Second Intervention|Adverse Event|1|||
131595036|NCT03131648|473809724|FG005|Open-label Treatment|Discontinued IMP|0|||
131595037|NCT03131648|473809725|FG006|Open-label Treatment|Discontinued IMP|112|||
131595038|NCT03131648|473809726|FG007|Open-label Treatment|Discontinued IMP|0|||
131595039|NCT03131648|473809719|FG000|Open-label Treatment|Completed Week 50|0|||
131595040|NCT03131648|473809720|FG001|Open-label Treatment|Completed Week 50|0|||
131595041|NCT03131648|473809721|FG002|Open-label Treatment|Completed Week 50|0|||
131595042|NCT03131648|473809722|FG003|Open-label Treatment|Completed Week 50|0|||
131595043|NCT03131648|473809723|FG004|Open-label Treatment|Completed Week 50|0|||
131595044|NCT03131648|473809724|FG005|Open-label Treatment|Completed Week 50|0|||
131595045|NCT03131648|473809725|FG006|Open-label Treatment|Completed Week 50|6|||
131595046|NCT03131648|473809726|FG007|Open-label Treatment|Completed Week 50|0|||
131595047|NCT03131648|473809719|FG000|Maintenance Treatment Period|Not dosed|0|||
131595048|NCT03131648|473809720|FG001|Maintenance Treatment Period|Not dosed|0|||
131595049|NCT03131648|473809721|FG002|Maintenance Treatment Period|Not dosed|3|||
131595050|NCT03131648|473809722|FG003|Maintenance Treatment Period|Not dosed|2|||
131595051|NCT03131648|473809723|FG004|Maintenance Treatment Period|Not dosed|1|||
131595052|NCT03131648|473809724|FG005|Maintenance Treatment Period|Not dosed|0|||
131595053|NCT03131648|473809725|FG006|Maintenance Treatment Period|Not dosed|0|||
131595054|NCT03131648|473809726|FG007|Maintenance Treatment Period|Not dosed|0|||
131595055|NCT03131648|473809719|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
131595056|NCT03131648|473809720|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
131595057|NCT03131648|473809721|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
131595058|NCT03131648|473809722|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
131595059|NCT03131648|473809723|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
131595060|NCT03131648|473809724|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
131595061|NCT03131648|473809725|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
131595062|NCT03131648|473809726|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
131595063|NCT03131648|473809719|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131595064|NCT03131648|473809720|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131595065|NCT03131648|473809721|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
131595066|NCT03131648|473809722|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
131595067|NCT03131648|473809723|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
131595068|NCT03131648|473809724|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
131595069|NCT03131648|473809725|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131595070|NCT03131648|473809726|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131595071|NCT03131648|473809719|FG000|Maintenance Treatment Period|Completed Week 50|0|||
131595072|NCT03131648|473809720|FG001|Maintenance Treatment Period|Completed Week 50|0|||
131595073|NCT03131648|473809721|FG002|Maintenance Treatment Period|Completed Week 50|0|||
131595074|NCT03131648|473809722|FG003|Maintenance Treatment Period|Completed Week 50|0|||
131595075|NCT03131648|473809723|FG004|Maintenance Treatment Period|Completed Week 50|1|||
131595076|NCT03131648|473809724|FG005|Maintenance Treatment Period|Completed Week 50|0|||
131595077|NCT03131648|473809725|FG006|Maintenance Treatment Period|Completed Week 50|0|||
131595078|NCT03131648|473809726|FG007|Maintenance Treatment Period|Completed Week 50|0|||
131595079|NCT03131648|473809719|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595080|NCT03131648|473809720|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595081|NCT03131648|473809721|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595082|NCT03131648|473809722|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595083|NCT03131648|473809723|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595084|NCT03131648|473809724|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595085|NCT03131648|473809725|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
131595086|NCT03131648|473809726|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
131595087|NCT02671903|473809728|FG000|Period 0 (Run-In)|Death|0|||
131595088|NCT02671903|473809729|FG001|Period 0 (Run-In)|Death|0|||
131595089|NCT02671903|473809730|FG002|Period 0 (Run-In)|Death|3|||
131595090|NCT02671903|473809728|FG000|Period 0 (Run-In)|Physician Decision|0|||
131595091|NCT02671903|473809729|FG001|Period 0 (Run-In)|Physician Decision|0|||
131595092|NCT02671903|473809730|FG002|Period 0 (Run-In)|Physician Decision|4|||
131595093|NCT02671903|473809728|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
131595094|NCT02671903|473809729|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
131595095|NCT02671903|473809730|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
131595096|NCT02671903|473809728|FG000|Period 0 (Run-In)|Protocol Violation|0|||
131595097|NCT02671903|473809729|FG001|Period 0 (Run-In)|Protocol Violation|0|||
131595098|NCT02671903|473809730|FG002|Period 0 (Run-In)|Protocol Violation|1|||
131595099|NCT02671903|473809728|FG000|Period 0 (Run-In)|Adverse Event|0|||
131595100|NCT02671903|473809729|FG001|Period 0 (Run-In)|Adverse Event|0|||
131595101|NCT02671903|473809730|FG002|Period 0 (Run-In)|Adverse Event|1|||
131595102|NCT02671903|473809728|FG000|Period 0 (Run-In)|Implantation Failure|0|||
131595103|NCT02671903|473809729|FG001|Period 0 (Run-In)|Implantation Failure|0|||
131595104|NCT02671903|473809730|FG002|Period 0 (Run-In)|Implantation Failure|2|||
131595105|NCT02671903|473809728|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
131595106|NCT02671903|473809729|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
131595107|NCT02671903|473809730|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
131595108|NCT03376321|473809731|FG000|Overall Study|Other|5|||
131595109|NCT03376321|473809732|FG001|Overall Study|Other|1|||
131595110|NCT03376321|473809731|FG000|Overall Study|Withdrawal by Subject|8|||
131595111|NCT03376321|473809732|FG001|Overall Study|Withdrawal by Subject|14|||
131595112|NCT03376321|473809731|FG000|Overall Study|Lost to Follow-up|1|||
131595113|NCT03376321|473809732|FG001|Overall Study|Lost to Follow-up|7|||
131595114|NCT03376321|473809731|FG000|Overall Study|Death|4|||
131595115|NCT03376321|473809732|FG001|Overall Study|Death|0|||
131595116|NCT03376321|473809731|FG000|Overall Study|Randomized, not treated|5|||
131595117|NCT03376321|473809732|FG001|Overall Study|Randomized, not treated|3|||
131595118|NCT04258709|473809733|FG000|Overall Study|Lost to Follow-up|10|||
131595119|NCT04258709|473809734|FG001|Overall Study|Lost to Follow-up|4|||
131595120|NCT04258709|473809733|FG000|Overall Study|Withdrawal by Subject|1|||
131595121|NCT04258709|473809734|FG001|Overall Study|Withdrawal by Subject|0|||
131595122|NCT04258709|473809733|FG000|Overall Study|Fetal demise|0|||
131595123|NCT04258709|473809734|FG001|Overall Study|Fetal demise|1|||
131595124|NCT04258709|473809733|FG000|Overall Study|Protocol Violation|1|||
131595125|NCT04258709|473809734|FG001|Overall Study|Protocol Violation|1|||
131595126|NCT05324124|473809735|FG000|Period 1|Withdrawal by Subject|1|||
131595127|NCT05324124|473809736|FG001|Period 1|Withdrawal by Subject|0|||
131595128|NCT05324124|473809735|FG000|Period 1|Physician Decision|0|||
131595129|NCT05324124|473809736|FG001|Period 1|Physician Decision|1|||
131595130|NCT02287610|473809737|FG000|Overall Study|Lost to Follow-up|3|||
131595131|NCT02287610|473809737|FG000|Overall Study|Withdrawal by Subject|8|||
131595132|NCT02287610|473809737|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
131595133|NCT05273749|473809738|FG000|Overall Study|Adverse Event|14|||
131595134|NCT05273749|473809739|FG001|Overall Study|Adverse Event|8|||
131595135|NCT05273749|473809738|FG000|Overall Study|Lack of Efficacy|2|||
131595136|NCT05273749|473809739|FG001|Overall Study|Lack of Efficacy|8|||
131595137|NCT05273749|473809738|FG000|Overall Study|Physician Decision|0|||
131595138|NCT05273749|473809739|FG001|Overall Study|Physician Decision|2|||
131595139|NCT05273749|473809738|FG000|Overall Study|Withdrawal by Subject|14|||
131595140|NCT05273749|473809739|FG001|Overall Study|Withdrawal by Subject|16|||
131595141|NCT05273749|473809738|FG000|Overall Study|Lost to Follow-up|10|||
131595142|NCT05273749|473809739|FG001|Overall Study|Lost to Follow-up|10|||
131595143|NCT05273749|473809738|FG000|Overall Study|Pregnancy|1|||
131595144|NCT05273749|473809739|FG001|Overall Study|Pregnancy|0|||
131595145|NCT05273749|473809738|FG000|Overall Study|Non-Compliance|3|||
131595146|NCT05273749|473809739|FG001|Overall Study|Non-Compliance|2|||
131595147|NCT05273749|473809738|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
131595148|NCT05273749|473809739|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
131595149|NCT04806594|473809740|FG000|Overall Study|Withdrawal by Subject|2|||
131595150|NCT04806594|473809740|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
131595151|NCT04318548|473809743|FG000|Overall Study|Adverse Event|0|||
131595152|NCT04318548|473809744|FG001|Overall Study|Adverse Event|0|||
131595153|NCT04318548|473809745|FG002|Overall Study|Adverse Event|1|||
131595154|NCT04318548|473809743|FG000|Overall Study|Lost to Follow-up|6|||
131595155|NCT04318548|473809744|FG001|Overall Study|Lost to Follow-up|13|||
131595156|NCT04318548|473809745|FG002|Overall Study|Lost to Follow-up|9|||
131595157|NCT04318548|473809743|FG000|Overall Study|Protocol Violation|1|||
131595158|NCT04318548|473809744|FG001|Overall Study|Protocol Violation|0|||
131595159|NCT04318548|473809745|FG002|Overall Study|Protocol Violation|2|||
131595160|NCT04318548|473809743|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
131595161|NCT04318548|473809744|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
131595162|NCT04318548|473809745|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
131595163|NCT04318548|473809743|FG000|Overall Study|Migrated / moved from the study area|0|||
131595164|NCT04318548|473809744|FG001|Overall Study|Migrated / moved from the study area|0|||
131595165|NCT04318548|473809745|FG002|Overall Study|Migrated / moved from the study area|1|||
131595166|NCT04318548|473809743|FG000|Overall Study|Other|1|||
131595167|NCT04318548|473809744|FG001|Overall Study|Other|2|||
131595168|NCT04318548|473809745|FG002|Overall Study|Other|3|||
131595169|NCT01416831|473809747|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
131595170|NCT01416831|473809748|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
131595171|NCT05215314|473809749|FG000|Overall Study|Lost to Follow-up|2|||
131595172|NCT05215314|473809750|FG001|Overall Study|Lost to Follow-up|2|||
131595173|NCT05215314|473809749|FG000|Overall Study|Withdrawal by Subject|2|||
131595174|NCT05215314|473809750|FG001|Overall Study|Withdrawal by Subject|0|||
131595175|NCT05215314|473809749|FG000|Overall Study|Physician Decision|1|||
131595176|NCT05215314|473809750|FG001|Overall Study|Physician Decision|0|||
131595177|NCT04784559|473809751|FG000|Overall Study|Withdrawal by Subject|3|||
131595178|NCT04784559|473809752|FG001|Overall Study|Withdrawal by Subject|2|||
131595179|NCT04784559|473809753|FG002|Overall Study|Withdrawal by Subject|1|||
131595180|NCT04784559|473809751|FG000|Overall Study|Death|2|||
131595181|NCT04784559|473809752|FG001|Overall Study|Death|1|||
131595182|NCT04784559|473809753|FG002|Overall Study|Death|2|||
131595183|NCT04784559|473809751|FG000|Overall Study|Lost to Follow-up|0|||
131595184|NCT04784559|473809752|FG001|Overall Study|Lost to Follow-up|0|||
131595185|NCT04784559|473809753|FG002|Overall Study|Lost to Follow-up|2|||
131595186|NCT04784559|473809751|FG000|Overall Study|Participant worsened, PI decision|1|||
131595187|NCT04784559|473809752|FG001|Overall Study|Participant worsened, PI decision|0|||
131595188|NCT04784559|473809753|FG002|Overall Study|Participant worsened, PI decision|0|||
131595189|NCT04784559|473809751|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
131595190|NCT04784559|473809752|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
131899326|NCT00905424|474917597|FG001|Overall Study|Positive urine drug screen|1|||
131899327|NCT00905424|474917596|FG000|Overall Study|Non-adherence to visit schedule|0|||
131899328|NCT00905424|474917597|FG001|Overall Study|Non-adherence to visit schedule|1|||
131899329|NCT00379899|474917598|FG000|Overall Study|Adverse Event|7|||
131595191|NCT04784559|473809753|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
131595192|NCT04784559|473809751|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
131595193|NCT04784559|473809752|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
131595194|NCT04784559|473809753|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
131595195|NCT04784559|473809751|FG000|Overall Study|Did not meet all inclusion criteria|0|||
131595196|NCT04784559|473809752|FG001|Overall Study|Did not meet all inclusion criteria|1|||
131595197|NCT04784559|473809753|FG002|Overall Study|Did not meet all inclusion criteria|0|||
131595198|NCT04784559|473809751|FG000|Overall Study|The participant was transferred to IRCU|0|||
131595199|NCT04784559|473809752|FG001|Overall Study|The participant was transferred to IRCU|1|||
131595200|NCT04784559|473809753|FG002|Overall Study|The participant was transferred to IRCU|0|||
131595201|NCT04784559|473809751|FG000|Overall Study|SAE|0|||
131595202|NCT04784559|473809752|FG001|Overall Study|SAE|1|||
131595203|NCT04784559|473809753|FG002|Overall Study|SAE|0|||
131595204|NCT04784559|473809751|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
131595205|NCT04784559|473809752|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
131595206|NCT04784559|473809753|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
131595207|NCT03406871|473809754|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
131595208|NCT03406871|473809755|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
131595209|NCT03406871|473809756|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
131595210|NCT03406871|473809754|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
131595211|NCT03406871|473809755|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
131595212|NCT03406871|473809756|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
131595213|NCT03406871|473809754|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
131595214|NCT03406871|473809755|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
131595215|NCT03406871|473809756|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
131595216|NCT03406871|473809754|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
131595217|NCT03406871|473809755|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
131595218|NCT03406871|473809756|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
131595219|NCT03406871|473809754|FG000|Expansion Cohort(Final Analysis)|Death|0|||
131595220|NCT03406871|473809755|FG001|Expansion Cohort(Final Analysis)|Death|1|||
131595221|NCT03406871|473809756|FG002|Expansion Cohort(Final Analysis)|Death|0|||
131595222|NCT03406871|473809754|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
131595223|NCT03406871|473809755|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
131595224|NCT03406871|473809756|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
131595225|NCT04241068|473809762|FG000|Core Treatment Period|Adverse Event|91|||
131595226|NCT04241068|473809762|FG000|Core Treatment Period|Change of Treatment|4|||
131595227|NCT04241068|473809762|FG000|Core Treatment Period|Consent Withdrawn|143|||
131595228|NCT04241068|473809762|FG000|Core Treatment Period|Death|26|||
131595229|NCT04241068|473809762|FG000|Core Treatment Period|Disease Progression|67|||
131595230|NCT04241068|473809762|FG000|Core Treatment Period|Investigator Decision|40|||
131595231|NCT04241068|473809762|FG000|Core Treatment Period|Loss of Capacity|9|||
131595232|NCT04241068|473809762|FG000|Core Treatment Period|Lost to Follow-up|11|||
131899330|NCT00379899|474917599|FG001|Overall Study|Adverse Event|3|||
131899331|NCT00379899|474917598|FG000|Overall Study|Death|10|||
131899332|NCT00379899|474917599|FG001|Overall Study|Death|10|||
131899333|NCT00379899|474917598|FG000|Overall Study|Lost to Follow-up|2|||
131899334|NCT00379899|474917599|FG001|Overall Study|Lost to Follow-up|4|||
131899335|NCT00379899|474917598|FG000|Overall Study|Physician Decision|3|||
131899336|NCT00379899|474917599|FG001|Overall Study|Physician Decision|4|||
131595233|NCT04241068|473809762|FG000|Core Treatment Period|Relocation|4|||
131595234|NCT04241068|473809762|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
131595235|NCT04241068|473809762|FG000|Core Treatment Period|Study Visit Burden|40|||
131595236|NCT04241068|473809762|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
131595237|NCT04241068|473809762|FG000|Core Treatment Period|Missing|2|||
131595238|NCT04241068|473809762|FG000|Core Treatment Period|Reason Not Specified|41|||
131595239|NCT04241068|473809762|FG000|LTE Period|Adverse Event|19|||
131595240|NCT04241068|473809762|FG000|LTE Period|Change of Treatment|1|||
131595241|NCT04241068|473809762|FG000|LTE Period|Consent Withdrawn|71|||
131595242|NCT04241068|473809762|FG000|LTE Period|Death|8|||
131595243|NCT04241068|473809762|FG000|LTE Period|Disease Progression|11|||
131595244|NCT04241068|473809762|FG000|LTE Period|Investigator Decision|12|||
131595245|NCT04241068|473809762|FG000|LTE Period|Loss of Capacity|2|||
131595246|NCT04241068|473809762|FG000|LTE Period|Lost to Follow-up|7|||
131595247|NCT04241068|473809762|FG000|LTE Period|Relocation|6|||
131595248|NCT04241068|473809762|FG000|LTE Period|Site Terminated by Sponsor|26|||
131595249|NCT04241068|473809762|FG000|LTE Period|Study Terminated by Sponsor|276|||
131595250|NCT04241068|473809762|FG000|LTE Period|Study Visit Burden|10|||
131595251|NCT04241068|473809762|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
131595252|NCT04241068|473809762|FG000|LTE Period|Reason Not Specified|65|||
131595253|NCT01413100|473809763|FG000|Overall Study|Withdrawal by Subject|1|||
131595254|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
131595255|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
131595256|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
131595257|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
131595258|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
131595259|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
131595260|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
131595261|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
131595262|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
131899337|NCT00379899|474917598|FG000|Overall Study|Withdrawal by Subject|5|||
131899338|NCT00379899|474917599|FG001|Overall Study|Withdrawal by Subject|5|||
131899339|NCT00379899|474917598|FG000|Overall Study|Ineligibility determined|0|||
131899340|NCT00379899|474917599|FG001|Overall Study|Ineligibility determined|1|||
131899341|NCT00379899|474917598|FG000|Overall Study|Noncompliance|1|||
131899342|NCT00379899|474917599|FG001|Overall Study|Noncompliance|1|||
131899343|NCT00379899|474917598|FG000|Overall Study|Parathyroidectomy|0|||
131899344|NCT00379899|474917599|FG001|Overall Study|Parathyroidectomy|2|||
131899345|NCT00379899|474917598|FG000|Overall Study|Renal transplantation|5|||
131899346|NCT00379899|474917599|FG001|Overall Study|Renal transplantation|4|||
131899347|NCT00379899|474917598|FG000|Overall Study|Coronary artery bypass graft|1|||
131899348|NCT00379899|474917599|FG001|Overall Study|Coronary artery bypass graft|1|||
131899349|NCT00379899|474917598|FG000|Overall Study|Other protocol-specified criteria|3|||
131439350|NCT02587520|473235466|FG014|Overall Study|Adverse Event|0|||
131439351|NCT02587520|473235467|FG015|Overall Study|Adverse Event|0|||
131439352|NCT02587520|473235468|FG016|Overall Study|Adverse Event|0|||
131439353|NCT02587520|473235469|FG017|Overall Study|Adverse Event|0|||
131439354|NCT02587520|473235452|FG000|Overall Study|Withdrawal by Subject|0|||
131595263|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
131595264|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
131595265|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
131595266|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
131595267|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
131595268|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
131595269|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
131595270|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
131595271|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
131595272|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
131595273|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
131595274|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
131595275|NCT05369403|473809764|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
131595276|NCT05369403|473809765|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
131595277|NCT05369403|473809766|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
131595278|NCT05369403|473809764|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
131595279|NCT05369403|473809765|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
131595280|NCT05369403|473809766|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
131595281|NCT05369403|473809764|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
131595282|NCT05369403|473809765|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
131595283|NCT05369403|473809766|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
131595284|NCT05369403|473809764|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
131595285|NCT05369403|473809765|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
131595286|NCT05369403|473809766|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
131595287|NCT04760678|473809776|FG000|Overall Study|Death|13|||
131595288|NCT04760678|473809776|FG000|Overall Study|Lost to Follow-up|48|||
131595289|NCT04760678|473809776|FG000|Overall Study|Withdrawal by Subject|1|||
131595290|NCT04896476|473809781|FG000|Overall Study|Withdrawal by Subject|1|||
131595291|NCT04896476|473809781|FG000|Overall Study|Lost to Follow-up|2|||
131595292|NCT03476187|473809782|FG000|Overall Study|Protocol Violation|7|||
131595293|NCT03476187|473809782|FG000|Overall Study|Physician Decision|5|||
131595294|NCT01748448|473809783|FG000|Treatment Period|Consent withdrawn by subject|1|||
131595295|NCT01748448|473809784|FG001|Treatment Period|Consent withdrawn by subject|0|||
131595296|NCT01748448|473809783|FG000|Treatment Period|Adverse Event|1|||
131595297|NCT01748448|473809784|FG001|Treatment Period|Adverse Event|0|||
131595298|NCT01748448|473809783|FG000|Treatment Period|Personal|0|||
131595299|NCT01748448|473809784|FG001|Treatment Period|Personal|1|||
131595300|NCT03924986|473809785|FG000|Overall Study|Death|57|||
131595301|NCT03924986|473809786|FG001|Overall Study|Death|66|||
131595302|NCT03924986|473809785|FG000|Overall Study|Study Concluded by Sponsor|51|||
131595303|NCT03924986|473809786|FG001|Overall Study|Study Concluded by Sponsor|41|||
131595304|NCT03924986|473809785|FG000|Overall Study|Withdrawal by Subject|15|||
131595305|NCT03924986|473809786|FG001|Overall Study|Withdrawal by Subject|20|||
131595306|NCT03924986|473809785|FG000|Overall Study|Lost to Follow-up|7|||
131595307|NCT03924986|473809786|FG001|Overall Study|Lost to Follow-up|5|||
131595308|NCT03924986|473809785|FG000|Overall Study|Miscellaneous|1|||
131595309|NCT03924986|473809786|FG001|Overall Study|Miscellaneous|0|||
131595310|NCT05948670|473809788|FG000|Overall Study|Protocol Violation|6|||
131595311|NCT05948670|473809789|FG001|Overall Study|Protocol Violation|8|||
131595312|NCT05948670|473809788|FG000|Overall Study|Withdrawal by Subject|0|||
131595313|NCT05948670|473809789|FG001|Overall Study|Withdrawal by Subject|1|||
131899350|NCT00379899|474917599|FG001|Overall Study|Other protocol-specified criteria|4|||
131899351|NCT00379899|474917598|FG000|Overall Study|Other|3|||
131595314|NCT02907099|473809790|FG000|Overall Study|Adverse Event|1|||
131595315|NCT02907099|473809790|FG000|Overall Study|Withdrawal by Subject|2|||
131595316|NCT02907099|473809790|FG000|Overall Study|Screen Fail|2|||
131595317|NCT04029688|473809792|FG000|Overall Study|Death|8|||
131595318|NCT04029688|473809793|FG001|Overall Study|Death|3|||
131595319|NCT04029688|473809794|FG002|Overall Study|Death|6|||
131595320|NCT04029688|473809795|FG003|Overall Study|Death|2|||
131439355|NCT02587520|473235453|FG001|Overall Study|Withdrawal by Subject|0|||
131439356|NCT02587520|473235454|FG002|Overall Study|Withdrawal by Subject|1|||
131439357|NCT02587520|473235455|FG003|Overall Study|Withdrawal by Subject|1|||
131439358|NCT02587520|473235456|FG004|Overall Study|Withdrawal by Subject|0|||
131439359|NCT02587520|473235457|FG005|Overall Study|Withdrawal by Subject|1|||
131439360|NCT02587520|473235458|FG006|Overall Study|Withdrawal by Subject|1|||
131439361|NCT02587520|473235459|FG007|Overall Study|Withdrawal by Subject|0|||
131439362|NCT02587520|473235460|FG008|Overall Study|Withdrawal by Subject|0|||
131439363|NCT02587520|473235461|FG009|Overall Study|Withdrawal by Subject|0|||
131595321|NCT04029688|473809796|FG004|Overall Study|Death|5|||
131595322|NCT04029688|473809797|FG005|Overall Study|Death|0|||
131595323|NCT04029688|473809798|FG006|Overall Study|Death|2|||
131595324|NCT04029688|473809799|FG007|Overall Study|Death|3|||
131595325|NCT04029688|473809792|FG000|Overall Study|Study Terminated by Sponsor|0|||
131595326|NCT04029688|473809793|FG001|Overall Study|Study Terminated by Sponsor|0|||
131595327|NCT04029688|473809794|FG002|Overall Study|Study Terminated by Sponsor|0|||
131595328|NCT04029688|473809795|FG003|Overall Study|Study Terminated by Sponsor|0|||
131595329|NCT04029688|473809796|FG004|Overall Study|Study Terminated by Sponsor|1|||
131595330|NCT04029688|473809797|FG005|Overall Study|Study Terminated by Sponsor|3|||
131595331|NCT04029688|473809798|FG006|Overall Study|Study Terminated by Sponsor|1|||
131595332|NCT04029688|473809799|FG007|Overall Study|Study Terminated by Sponsor|3|||
131595333|NCT04029688|473809792|FG000|Overall Study|Withdrawal by Subject|0|||
131595334|NCT04029688|473809793|FG001|Overall Study|Withdrawal by Subject|0|||
131595335|NCT04029688|473809794|FG002|Overall Study|Withdrawal by Subject|0|||
131595336|NCT04029688|473809795|FG003|Overall Study|Withdrawal by Subject|1|||
131595337|NCT04029688|473809796|FG004|Overall Study|Withdrawal by Subject|0|||
131595338|NCT04029688|473809797|FG005|Overall Study|Withdrawal by Subject|0|||
131595339|NCT04029688|473809798|FG006|Overall Study|Withdrawal by Subject|0|||
131595340|NCT04029688|473809799|FG007|Overall Study|Withdrawal by Subject|0|||
131595341|NCT05784662|473809800|FG000|Overall Study|Lost to Follow-up|21|||
131595342|NCT05784662|473809801|FG001|Overall Study|Lost to Follow-up|17|||
131595343|NCT04739956|473809809|FG000|Overall Study|Withdrawal by Subject|1|||
131595344|NCT04739956|473809810|FG001|Overall Study|Withdrawal by Subject|1|||
131595345|NCT03920111|473809811|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
131595346|NCT03920111|473809812|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
131595347|NCT03920111|473809813|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
131595348|NCT03853746|473809817|FG000|Overall Study|Withdrawal by Subject|1|||
131595349|NCT00999804|473809818|FG000|Overall Study|Lack of Efficacy|9|||
131595350|NCT00999804|473809819|FG001|Overall Study|Lack of Efficacy|2|||
131595351|NCT00999804|473809818|FG000|Overall Study|Adverse Event|4|||
131595352|NCT00999804|473809819|FG001|Overall Study|Adverse Event|3|||
131595353|NCT00999804|473809818|FG000|Overall Study|Withdrawal by Subject|4|||
131595354|NCT00999804|473809819|FG001|Overall Study|Withdrawal by Subject|0|||
131595355|NCT00999804|473809818|FG000|Overall Study|Death|1|||
131595356|NCT00999804|473809819|FG001|Overall Study|Death|0|||
131595357|NCT00999804|473809818|FG000|Overall Study|Ineligible|3|||
131595358|NCT00999804|473809819|FG001|Overall Study|Ineligible|0|||
131595359|NCT05256706|473809821|FG000|Overall Study|Lost to Follow-up|9|||
131595360|NCT05256706|473809822|FG001|Overall Study|Lost to Follow-up|3|||
131595361|NCT05256706|473809821|FG000|Overall Study|Withdrawal by Subject|7|||
131595362|NCT05256706|473809822|FG001|Overall Study|Withdrawal by Subject|11|||
131595363|NCT05256706|473809821|FG000|Overall Study|Screen Failures|3|||
131595364|NCT05256706|473809822|FG001|Overall Study|Screen Failures|0|||
131595365|NCT03850678|473809823|FG000|Overall Study|Withdrawal by Subject|3|||
131595366|NCT03850678|473809824|FG001|Overall Study|Withdrawal by Subject|0|||
131595367|NCT03850678|473809823|FG000|Overall Study|Experimenter Error|1|||
131595368|NCT03850678|473809824|FG001|Overall Study|Experimenter Error|1|||
131595369|NCT03850678|473809823|FG000|Overall Study|Did Not Condition To Experiment|7|||
131595370|NCT03850678|473809824|FG001|Overall Study|Did Not Condition To Experiment|2|||
131595371|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Other|0|||
131439364|NCT02587520|473235462|FG010|Overall Study|Withdrawal by Subject|0|||
131439365|NCT02587520|473235463|FG011|Overall Study|Withdrawal by Subject|0|||
131595372|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Other|0|||
131595373|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Other|0|||
131595374|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Other|0|||
131595375|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Other|0|||
131595376|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Other|0|||
131595377|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Other|0|||
131595378|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Other|0|||
131595379|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Other|0|||
131595380|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Other|0|||
131595381|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Other|1|||
131595382|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Other|1|||
131595383|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Other|1|||
131595384|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Other|0|||
131595385|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Other|3|||
131595386|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Other|1|||
131595387|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Other|1|||
131595388|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Other|0|||
131595389|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595390|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595391|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595392|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595393|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595394|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595395|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
131595396|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595397|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
131595398|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595399|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595400|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595401|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
131595402|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595403|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
131899352|NCT00379899|474917599|FG001|Overall Study|Other|1|||
131899353|NCT05225389|474917600|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
131899354|NCT03311841|474917601|FG000|14-day Wash-out|Adverse Event|0|||
131899355|NCT03311841|474917602|FG001|14-day Wash-out|Adverse Event|1|||
131899356|NCT03311841|474917603|FG002|14-day Wash-out|Adverse Event|0|||
131899357|NCT03311841|474917604|FG003|14-day Wash-out|Adverse Event|0|||
131899358|NCT03311841|474917605|FG004|14-day Wash-out|Adverse Event|0|||
131899359|NCT03311841|474917601|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
131899360|NCT03311841|474917602|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
131899361|NCT03311841|474917603|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
131899362|NCT03311841|474917604|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
131899363|NCT03311841|474917605|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
131899364|NCT01026948|474917607|FG000|Overall Study|Physician Decision|8|||
131899365|NCT00627926|474917608|FG000|Overall Study|Adverse Event|26|||
131899366|NCT00627926|474917609|FG001|Overall Study|Adverse Event|37|||
131899367|NCT00627926|474917610|FG002|Overall Study|Adverse Event|36|||
131899368|NCT00627926|474917608|FG000|Overall Study|Death|1|||
131899369|NCT00627926|474917609|FG001|Overall Study|Death|0|||
131899370|NCT00627926|474917610|FG002|Overall Study|Death|0|||
131899371|NCT00627926|474917608|FG000|Overall Study|Lost to Follow-up|4|||
131899372|NCT00627926|474917609|FG001|Overall Study|Lost to Follow-up|3|||
131595404|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
131899373|NCT00627926|474917610|FG002|Overall Study|Lost to Follow-up|4|||
131899374|NCT00627926|474917608|FG000|Overall Study|Withdrawal by Subject|2|||
131899375|NCT00627926|474917609|FG001|Overall Study|Withdrawal by Subject|1|||
131899376|NCT00627926|474917610|FG002|Overall Study|Withdrawal by Subject|0|||
131899377|NCT00627926|474917608|FG000|Overall Study|Lack of Efficacy|118|||
131706353|NCT00364182|474207365|FG000|Third Intervention|non-compliance|0|||
131706354|NCT00364182|474207366|FG001|Third Intervention|non-compliance|1|||
131706355|NCT00364182|474207367|FG002|Third Intervention|non-compliance|0|||
131706356|NCT00364182|474207365|FG000|Third Intervention|Lost to Follow-up|0|||
131706357|NCT00364182|474207366|FG001|Third Intervention|Lost to Follow-up|0|||
131706358|NCT00364182|474207367|FG002|Third Intervention|Lost to Follow-up|1|||
131706359|NCT02601573|474207375|FG000|Overall Study|Lost to Follow-up|0|||
131706360|NCT02601573|474207376|FG001|Overall Study|Lost to Follow-up|3|||
131706361|NCT02601573|474207377|FG002|Overall Study|Lost to Follow-up|1|||
131706362|NCT02601573|474207378|FG003|Overall Study|Lost to Follow-up|0|||
131706363|NCT02601573|474207379|FG004|Overall Study|Lost to Follow-up|2|||
131706364|NCT02601573|474207375|FG000|Overall Study|Withdrawal by Subject|0|||
131706365|NCT02601573|474207376|FG001|Overall Study|Withdrawal by Subject|1|||
131706366|NCT02601573|474207377|FG002|Overall Study|Withdrawal by Subject|0|||
131706367|NCT02601573|474207378|FG003|Overall Study|Withdrawal by Subject|1|||
131706368|NCT02601573|474207379|FG004|Overall Study|Withdrawal by Subject|0|||
131706369|NCT00974220|474207380|FG000|Treatment Period 1|Adverse Event|2|||
131706370|NCT00974220|474207381|FG001|Treatment Period 1|Adverse Event|1|||
131706371|NCT00974220|474207380|FG000|Treatment Period 1|noncompliant subjects|0|||
131706372|NCT00974220|474207381|FG001|Treatment Period 1|noncompliant subjects|1|||
131706373|NCT02921425|474207382|FG000|Overall Study|Protocol Violation|9|||
131595405|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595406|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
131595407|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595408|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595409|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595410|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595411|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595412|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595413|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595414|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
131899378|NCT00627926|474917609|FG001|Overall Study|Lack of Efficacy|40|||
131899379|NCT00627926|474917610|FG002|Overall Study|Lack of Efficacy|38|||
131899380|NCT00627926|474917608|FG000|Overall Study|Noncompliance/unspecified|8|||
131595415|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131899381|NCT00627926|474917609|FG001|Overall Study|Noncompliance/unspecified|23|||
131439366|NCT02587520|473235464|FG012|Overall Study|Withdrawal by Subject|0|||
131439367|NCT02587520|473235465|FG013|Overall Study|Withdrawal by Subject|1|||
131439368|NCT02587520|473235466|FG014|Overall Study|Withdrawal by Subject|0|||
131439369|NCT02587520|473235467|FG015|Overall Study|Withdrawal by Subject|0|||
131439370|NCT02587520|473235468|FG016|Overall Study|Withdrawal by Subject|0|||
131439371|NCT02587520|473235469|FG017|Overall Study|Withdrawal by Subject|0|||
131439372|NCT02587520|473235452|FG000|Overall Study|Lost to Follow-up|0|||
131439373|NCT02587520|473235453|FG001|Overall Study|Lost to Follow-up|2|||
131439374|NCT02587520|473235454|FG002|Overall Study|Lost to Follow-up|0|||
131439375|NCT02587520|473235455|FG003|Overall Study|Lost to Follow-up|2|||
131439376|NCT02587520|473235456|FG004|Overall Study|Lost to Follow-up|0|||
131439377|NCT02587520|473235457|FG005|Overall Study|Lost to Follow-up|1|||
131439378|NCT02587520|473235458|FG006|Overall Study|Lost to Follow-up|1|||
131439379|NCT02587520|473235459|FG007|Overall Study|Lost to Follow-up|1|||
131439380|NCT02587520|473235460|FG008|Overall Study|Lost to Follow-up|0|||
131439381|NCT02587520|473235461|FG009|Overall Study|Lost to Follow-up|2|||
131439382|NCT02587520|473235462|FG010|Overall Study|Lost to Follow-up|2|||
131439383|NCT02587520|473235463|FG011|Overall Study|Lost to Follow-up|1|||
131439384|NCT02587520|473235464|FG012|Overall Study|Lost to Follow-up|0|||
131439385|NCT02587520|473235465|FG013|Overall Study|Lost to Follow-up|0|||
131439386|NCT02587520|473235466|FG014|Overall Study|Lost to Follow-up|0|||
131439387|NCT02587520|473235467|FG015|Overall Study|Lost to Follow-up|0|||
131439388|NCT02587520|473235468|FG016|Overall Study|Lost to Follow-up|0|||
131439389|NCT02587520|473235469|FG017|Overall Study|Lost to Follow-up|0|||
131439390|NCT03924622|473235470|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
131439391|NCT03924622|473235471|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
131439392|NCT03924622|473235472|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
131439393|NCT03924622|473235473|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
131439394|NCT03924622|473235474|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
131439395|NCT03924622|473235475|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
131439396|NCT00866177|473235479|FG000|Overall Study|Withdrawal by Subject|1|||
131439397|NCT00866177|473235479|FG000|Overall Study|Not Treated|151|||
131439398|NCT05316597|473235482|FG000|First Session|Withdrawal by Subject|0|||
131439399|NCT05316597|473235483|FG001|First Session|Withdrawal by Subject|1|||
131439400|NCT05316597|473235482|FG000|Washout Period|Lost to Follow-up|1|||
131439401|NCT05316597|473235483|FG001|Washout Period|Lost to Follow-up|2|||
131439402|NCT05316597|473235482|FG000|Washout Period|Physician Decision|1|||
131439403|NCT05316597|473235483|FG001|Washout Period|Physician Decision|1|||
131439404|NCT05316597|473235482|FG000|Washout Period|Excluded before second session|1|||
131439405|NCT05316597|473235483|FG001|Washout Period|Excluded before second session|1|||
131439406|NCT05316597|473235482|FG000|Washout Period|Withdrawal by Subject|0|||
131439407|NCT05316597|473235483|FG001|Washout Period|Withdrawal by Subject|4|||
131439408|NCT05526716|473235484|FG000|Overall Study|Death|1|||
131439409|NCT05526716|473235485|FG001|Overall Study|Death|2|||
131439410|NCT05526716|473235484|FG000|Overall Study|Lost to Follow-up|17|||
131439411|NCT05526716|473235485|FG001|Overall Study|Lost to Follow-up|15|||
131439412|NCT05526716|473235484|FG000|Overall Study|Physician Decision|0|||
131439413|NCT05526716|473235485|FG001|Overall Study|Physician Decision|1|||
131439414|NCT05526716|473235484|FG000|Overall Study|Randomized by mistake without study treatment|0|||
131439415|NCT05526716|473235485|FG001|Overall Study|Randomized by mistake without study treatment|1|||
131439416|NCT05526716|473235484|FG000|Overall Study|Withdrawal by Subject|12|||
131439417|NCT05526716|473235485|FG001|Overall Study|Withdrawal by Subject|12|||
131439418|NCT05526716|473235484|FG000|Overall Study|Not reported|0|||
131439419|NCT05526716|473235485|FG001|Overall Study|Not reported|2|||
131439420|NCT04750824|473235489|FG000|Overall Study|Toxicity/intolerability|3|||
131439421|NCT04750824|473235490|FG001|Overall Study|Toxicity/intolerability|1|||
131439422|NCT04750824|473235489|FG000|Overall Study|Death|1|||
131439423|NCT04750824|473235490|FG001|Overall Study|Death|3|||
131439424|NCT04750824|473235489|FG000|Overall Study|Scheduled duration of therapy complete|1|||
131595416|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131439425|NCT04750824|473235490|FG001|Overall Study|Scheduled duration of therapy complete|9|||
131595417|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595418|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595419|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595420|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595421|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595422|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595423|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131706374|NCT01227967|474207383|FG000|Overall Study|Protocol Violation|3|||
131706375|NCT01227967|474207384|FG001|Overall Study|Protocol Violation|1|||
131706376|NCT01227967|474207383|FG000|Overall Study|Death|0|||
131706377|NCT01227967|474207384|FG001|Overall Study|Death|1|||
131706378|NCT01227967|474207383|FG000|Overall Study|Lost to Follow-up|8|||
131706379|NCT01227967|474207384|FG001|Overall Study|Lost to Follow-up|3|||
131706380|NCT01227967|474207383|FG000|Overall Study|Withdrawal by Subject|4|||
131706381|NCT01227967|474207384|FG001|Overall Study|Withdrawal by Subject|3|||
131706382|NCT01227967|474207383|FG000|Overall Study|Physician Decision|0|||
131706383|NCT01227967|474207384|FG001|Overall Study|Physician Decision|1|||
131706384|NCT01227967|474207383|FG000|Overall Study|Never Started Treatment|0|||
131706385|NCT01227967|474207384|FG001|Overall Study|Never Started Treatment|4|||
131706386|NCT01227967|474207383|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
131706387|NCT01227967|474207384|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
131706388|NCT03403400|474207385|FG000|Overall Study|Lost to Follow-up|1|||
131706389|NCT03403400|474207386|FG001|Overall Study|Lost to Follow-up|0|||
131706390|NCT03403400|474207387|FG002|Overall Study|Lost to Follow-up|1|||
131706391|NCT03403400|474207385|FG000|Overall Study|Hospitalization|1|||
131706392|NCT03403400|474207386|FG001|Overall Study|Hospitalization|0|||
131706393|NCT03403400|474207387|FG002|Overall Study|Hospitalization|0|||
131706394|NCT03403400|474207385|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
131706395|NCT03403400|474207386|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
131706396|NCT03403400|474207387|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
131706397|NCT01763164|474207388|FG000|Treatment Phase|Participant/Guardian decision|26|||
131706398|NCT01763164|474207389|FG001|Treatment Phase|Participant/Guardian decision|14|||
131706399|NCT01763164|474207388|FG000|Treatment Phase|Protocol Violation|1|||
131706400|NCT01763164|474207389|FG001|Treatment Phase|Protocol Violation|1|||
131706401|NCT01763164|474207388|FG000|Treatment Phase|Progressive Disease|142|||
131706402|NCT01763164|474207389|FG001|Treatment Phase|Progressive Disease|76|||
131706403|NCT01763164|474207388|FG000|Treatment Phase|Physician Decision|24|||
131706404|NCT01763164|474207389|FG001|Treatment Phase|Physician Decision|13|||
131706405|NCT01763164|474207388|FG000|Treatment Phase|Death|10|||
131706406|NCT01763164|474207389|FG001|Treatment Phase|Death|1|||
131706407|NCT01763164|474207388|FG000|Treatment Phase|Adverse Event|66|||
131706408|NCT01763164|474207389|FG001|Treatment Phase|Adverse Event|8|||
131706409|NCT01763164|474207388|FG000|Treatment Phase|Randomized but not Treated|0|||
131706410|NCT01763164|474207389|FG001|Treatment Phase|Randomized but not Treated|19|||
131706411|NCT01763164|474207388|FG000|Treatment Phase|Other|0|||
131706412|NCT01763164|474207389|FG001|Treatment Phase|Other|1|||
131706413|NCT01763164|474207388|FG000|Follow up Phase|New therapy for study indication|12|||
131706414|NCT01763164|474207389|FG001|Follow up Phase|New therapy for study indication|3|||
131706415|NCT01763164|474207388|FG000|Follow up Phase|Death|21|||
131706416|NCT01763164|474207389|FG001|Follow up Phase|Death|4|||
131706417|NCT01763164|474207388|FG000|Follow up Phase|Subject/guardian decision|9|||
131706418|NCT01763164|474207389|FG001|Follow up Phase|Subject/guardian decision|2|||
131706419|NCT01763164|474207388|FG000|Follow up Phase|Progressive disease|127|||
131706420|NCT01763164|474207389|FG001|Follow up Phase|Progressive disease|62|||
131706421|NCT01763164|474207388|FG000|Follow up Phase|Physician Decision|10|||
131706422|NCT01763164|474207389|FG001|Follow up Phase|Physician Decision|3|||
131706423|NCT01763164|474207388|FG000|Follow up Phase|Lost to Follow-up|1|||
131706424|NCT01763164|474207389|FG001|Follow up Phase|Lost to Follow-up|0|||
131706425|NCT01763164|474207388|FG000|Follow up Phase|Adverse Event|17|||
131706426|NCT01763164|474207389|FG001|Follow up Phase|Adverse Event|1|||
131706427|NCT01384292|474207393|FG000|Part B|Severe non-compliance to protocol|1|||
131706428|NCT01384292|474207394|FG001|Part B|Severe non-compliance to protocol|0|||
131706429|NCT01384292|474207395|FG002|Part B|Severe non-compliance to protocol|0|||
131706430|NCT01171612|474207396|FG000|Overall Study|Lost to Follow-up|51|||
131706431|NCT00243659|474207399|FG000|Overall Study|Withdrawal by Subject|1|||
131706432|NCT00243659|474207400|FG001|Overall Study|Withdrawal by Subject|1|||
131706433|NCT00243659|474207399|FG000|Overall Study|Protocol Violation|1|||
131706434|NCT00243659|474207400|FG001|Overall Study|Protocol Violation|2|||
131706435|NCT03310970|474207401|FG000|Overall Study|Withdrawal by Subject|0|||
131706436|NCT03310970|474207402|FG001|Overall Study|Withdrawal by Subject|1|||
131706437|NCT01273064|474207403|FG000|Overall Study|Adverse Event|5|||
131706438|NCT01273064|474207404|FG001|Overall Study|Adverse Event|1|||
131706439|NCT01273064|474207405|FG002|Overall Study|Adverse Event|3|||
131706440|NCT01273064|474207406|FG003|Overall Study|Adverse Event|2|||
131706441|NCT01273064|474207407|FG004|Overall Study|Adverse Event|1|||
131706442|NCT01273064|474207403|FG000|Overall Study|Withdrawal by Subject|4|||
131439426|NCT04750824|473235489|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
131439427|NCT04750824|473235490|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
131439428|NCT00807911|473235491|FG000|Overall Study|Withdrawal by Subject|12|||
131439429|NCT00807911|473235492|FG001|Overall Study|Withdrawal by Subject|10|||
131439430|NCT00807911|473235491|FG000|Overall Study|Ineligible|0|||
131439431|NCT00807911|473235492|FG001|Overall Study|Ineligible|4|||
131439432|NCT03547518|473235495|FG000|Overall Study|Lost to Follow-up|2|||
131439433|NCT03547518|473235496|FG001|Overall Study|Lost to Follow-up|0|||
131439434|NCT02927301|473235497|FG000|Overall Study|Death|39|||
131439435|NCT02927301|473235497|FG000|Overall Study|Lost to Follow-up|8|||
131439436|NCT02927301|473235497|FG000|Overall Study|Physician Decision|2|||
131439437|NCT02927301|473235497|FG000|Overall Study|Withdrawal by Subject|12|||
131439438|NCT02927301|473235497|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
131439439|NCT04247347|473235500|FG000|Overall Study|Withdrawal by Subject|2|||
131439440|NCT04247347|473235501|FG001|Overall Study|Withdrawal by Subject|3|||
131439441|NCT04247347|473235502|FG002|Overall Study|Withdrawal by Subject|3|||
131439442|NCT04247347|473235500|FG000|Overall Study|Lost to Follow-up|1|||
131439443|NCT04247347|473235501|FG001|Overall Study|Lost to Follow-up|1|||
131439444|NCT04247347|473235502|FG002|Overall Study|Lost to Follow-up|1|||
131439445|NCT03562195|473235503|FG000|Overall Study|Adverse Event|0|||
131439446|NCT03562195|473235504|FG001|Overall Study|Adverse Event|6|||
131439447|NCT03562195|473235503|FG000|Overall Study|Lack of Efficacy|0|||
131439448|NCT03562195|473235504|FG001|Overall Study|Lack of Efficacy|5|||
131439449|NCT03562195|473235503|FG000|Overall Study|Protocol Violation|0|||
131439450|NCT03562195|473235504|FG001|Overall Study|Protocol Violation|1|||
131439451|NCT03562195|473235503|FG000|Overall Study|Lost to Follow-up|0|||
131439452|NCT03562195|473235504|FG001|Overall Study|Lost to Follow-up|1|||
131439453|NCT03562195|473235503|FG000|Overall Study|Physician Decision|1|||
131439454|NCT03562195|473235504|FG001|Overall Study|Physician Decision|0|||
131439455|NCT03562195|473235503|FG000|Overall Study|Withdrawal by Subject|3|||
131439456|NCT03562195|473235504|FG001|Overall Study|Withdrawal by Subject|0|||
131439457|NCT02529852|473235505|FG000|Overall Study|Withdrawal by Subject|2|||
131439458|NCT02201524|473235506|FG000|Overall Study|Adverse Event|0|||
131439459|NCT02201524|473235507|FG001|Overall Study|Adverse Event|2|||
131439460|NCT02201524|473235508|FG002|Overall Study|Adverse Event|1|||
131439461|NCT02201524|473235509|FG003|Overall Study|Adverse Event|0|||
131439462|NCT02201524|473235506|FG000|Overall Study|Insufficient clinical response|1|||
131439463|NCT02201524|473235507|FG001|Overall Study|Insufficient clinical response|0|||
131439464|NCT02201524|473235508|FG002|Overall Study|Insufficient clinical response|0|||
131439465|NCT02201524|473235509|FG003|Overall Study|Insufficient clinical response|0|||
131439466|NCT02201524|473235506|FG000|Overall Study|Lost to Follow-up|0|||
131439467|NCT02201524|473235507|FG001|Overall Study|Lost to Follow-up|0|||
131439468|NCT02201524|473235508|FG002|Overall Study|Lost to Follow-up|2|||
131439469|NCT02201524|473235509|FG003|Overall Study|Lost to Follow-up|0|||
131439470|NCT02201524|473235506|FG000|Overall Study|No longer meets eligibility criteria|0|||
131439471|NCT02201524|473235507|FG001|Overall Study|No longer meets eligibility criteria|0|||
131439472|NCT02201524|473235508|FG002|Overall Study|No longer meets eligibility criteria|0|||
131439473|NCT02201524|473235509|FG003|Overall Study|No longer meets eligibility criteria|2|||
131439474|NCT02201524|473235506|FG000|Overall Study|Protocol Violation|0|||
131439475|NCT02201524|473235507|FG001|Overall Study|Protocol Violation|0|||
131439476|NCT02201524|473235508|FG002|Overall Study|Protocol Violation|0|||
131439477|NCT02201524|473235509|FG003|Overall Study|Protocol Violation|1|||
131439478|NCT02201524|473235506|FG000|Overall Study|Withdrawal by Subject|0|||
131439479|NCT02201524|473235507|FG001|Overall Study|Withdrawal by Subject|0|||
131439480|NCT02201524|473235508|FG002|Overall Study|Withdrawal by Subject|1|||
131595424|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131595425|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595426|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595427|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595428|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595429|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595430|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595431|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
131439481|NCT02201524|473235509|FG003|Overall Study|Withdrawal by Subject|1|||
131439482|NCT02201524|473235506|FG000|Overall Study|Other|1|||
131439483|NCT02201524|473235507|FG001|Overall Study|Other|1|||
131595432|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
131439484|NCT02201524|473235508|FG002|Overall Study|Other|0|||
131439485|NCT02201524|473235509|FG003|Overall Study|Other|0|||
131439486|NCT00642356|473235516|FG000|Overall Study|Adverse Event|1|||
131439487|NCT00642356|473235517|FG001|Overall Study|Adverse Event|0|||
131439488|NCT00642356|473235516|FG000|Overall Study|Protocol Violation|0|||
131439489|NCT00642356|473235517|FG001|Overall Study|Protocol Violation|3|||
131439490|NCT00642356|473235516|FG000|Overall Study|Lack of Efficacy|1|||
131439491|NCT00642356|473235517|FG001|Overall Study|Lack of Efficacy|0|||
131439492|NCT05106959|473235524|FG000|Overall Study|Lost to Follow-up|1|||
131595433|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595434|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
131595435|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595436|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595437|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595438|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595439|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595440|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595441|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595442|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
131595443|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Death|0|||
131595444|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Death|0|||
131595445|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Death|0|||
131595446|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Death|0|||
131595447|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Death|0|||
131595448|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Death|0|||
131595449|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Death|0|||
131595450|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Death|0|||
131595451|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Death|0|||
131595452|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Death|1|||
131595453|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Death|0|||
131595454|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Death|1|||
131595455|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Death|0|||
131595456|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Death|1|||
131595457|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Death|0|||
131595458|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Death|0|||
131595459|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Death|2|||
131595460|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Death|0|||
131595461|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
131595462|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
131595463|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
131595464|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
131595465|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
131595466|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
131595467|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
131595468|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
131595469|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
131595470|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
131595471|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
131595472|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
131595473|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
131595474|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
131595475|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
131595476|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
131595477|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
131595478|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
131595479|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Adverse Event|0|||
131595480|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Adverse Event|0|||
131595481|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Adverse Event|0|||
131595482|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Adverse Event|0|||
131595483|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Adverse Event|0|||
131595484|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Adverse Event|0|||
131595485|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Adverse Event|2|||
131595486|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Adverse Event|0|||
131595487|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Adverse Event|0|||
131595488|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Adverse Event|0|||
131595489|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Adverse Event|1|||
131595490|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Adverse Event|2|||
131595491|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Adverse Event|0|||
131595492|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Adverse Event|1|||
131595493|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Adverse Event|0|||
131595494|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Adverse Event|0|||
131706443|NCT01273064|474207404|FG001|Overall Study|Withdrawal by Subject|2|||
131595495|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Adverse Event|1|||
131595496|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Adverse Event|0|||
131595497|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
131595498|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
131595499|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
131595500|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
131595501|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
131595502|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
131595503|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
131706444|NCT01273064|474207405|FG002|Overall Study|Withdrawal by Subject|2|||
131595504|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
131595505|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
131595506|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
131595507|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
131595508|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
131595509|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
131595510|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
131595511|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
131595512|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
131595513|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
131439493|NCT00286442|473235529|FG000|Overall Study|Hyperglycemic Rescue|19|||
131595514|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
131706445|NCT01273064|474207406|FG003|Overall Study|Withdrawal by Subject|2|||
131706446|NCT01273064|474207407|FG004|Overall Study|Withdrawal by Subject|0|||
131706447|NCT01273064|474207403|FG000|Overall Study|Study Termination|13|||
131706448|NCT01273064|474207404|FG001|Overall Study|Study Termination|27|||
131706449|NCT01273064|474207405|FG002|Overall Study|Study Termination|26|||
131706450|NCT01273064|474207406|FG003|Overall Study|Study Termination|16|||
131706451|NCT01273064|474207407|FG004|Overall Study|Study Termination|8|||
131706452|NCT01273064|474207403|FG000|Overall Study|Lost to Follow-up|1|||
131706453|NCT01273064|474207404|FG001|Overall Study|Lost to Follow-up|0|||
131706454|NCT01273064|474207405|FG002|Overall Study|Lost to Follow-up|0|||
131706455|NCT01273064|474207406|FG003|Overall Study|Lost to Follow-up|0|||
131706456|NCT01273064|474207407|FG004|Overall Study|Lost to Follow-up|0|||
131706457|NCT01273064|474207403|FG000|Overall Study|Physician Decision|0|||
131706458|NCT01273064|474207404|FG001|Overall Study|Physician Decision|0|||
131706459|NCT01273064|474207405|FG002|Overall Study|Physician Decision|0|||
131439494|NCT00286442|473235530|FG001|Overall Study|Hyperglycemic Rescue|17|||
131439495|NCT00286442|473235531|FG002|Overall Study|Hyperglycemic Rescue|25|||
131595515|NCT03269136|473809831|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595516|NCT03269136|473809832|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595517|NCT03269136|473809833|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595518|NCT03269136|473809834|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595519|NCT03269136|473809835|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595520|NCT03269136|473809836|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595521|NCT03269136|473809837|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595522|NCT03269136|473809838|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595523|NCT03269136|473809839|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595524|NCT03269136|473809840|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595525|NCT03269136|473809841|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595526|NCT03269136|473809842|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595527|NCT03269136|473809843|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
131595528|NCT03269136|473809844|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131595529|NCT03269136|473809845|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131595530|NCT03269136|473809846|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595531|NCT03269136|473809847|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
131595532|NCT03269136|473809848|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131595533|NCT03269136|473809831|FG000|Part 2A: Dose Expansion|Other|0|||
131595534|NCT03269136|473809832|FG001|Part 2A: Dose Expansion|Other|0|||
131595535|NCT03269136|473809833|FG002|Part 2A: Dose Expansion|Other|0|||
131595536|NCT03269136|473809834|FG003|Part 2A: Dose Expansion|Other|0|||
131595537|NCT03269136|473809835|FG004|Part 2A: Dose Expansion|Other|0|||
131595538|NCT03269136|473809836|FG005|Part 2A: Dose Expansion|Other|0|||
131595539|NCT03269136|473809837|FG006|Part 2A: Dose Expansion|Other|0|||
131595540|NCT03269136|473809838|FG007|Part 2A: Dose Expansion|Other|0|||
131595541|NCT03269136|473809839|FG008|Part 2A: Dose Expansion|Other|0|||
131595542|NCT03269136|473809840|FG009|Part 2A: Dose Expansion|Other|0|||
131595543|NCT03269136|473809841|FG010|Part 2A: Dose Expansion|Other|0|||
131595544|NCT03269136|473809842|FG011|Part 2A: Dose Expansion|Other|0|||
131595545|NCT03269136|473809843|FG012|Part 2A: Dose Expansion|Other|0|||
131595546|NCT03269136|473809844|FG013|Part 2A: Dose Expansion|Other|0|||
131595547|NCT03269136|473809845|FG014|Part 2A: Dose Expansion|Other|0|||
131595548|NCT03269136|473809846|FG015|Part 2A: Dose Expansion|Other|0|||
131595549|NCT03269136|473809847|FG016|Part 2A: Dose Expansion|Other|0|||
131595550|NCT03269136|473809848|FG017|Part 2A: Dose Expansion|Other|1|||
131595551|NCT03269136|473809831|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595552|NCT03269136|473809832|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595553|NCT03269136|473809833|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595554|NCT03269136|473809834|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595555|NCT03269136|473809835|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595556|NCT03269136|473809836|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595557|NCT03269136|473809837|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595558|NCT03269136|473809838|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595559|NCT03269136|473809839|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595560|NCT03269136|473809840|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595561|NCT03269136|473809841|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595562|NCT03269136|473809842|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595563|NCT03269136|473809843|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595564|NCT03269136|473809844|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595565|NCT03269136|473809845|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595566|NCT03269136|473809846|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595567|NCT03269136|473809847|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131595568|NCT03269136|473809848|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
131595569|NCT03269136|473809831|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
131595570|NCT03269136|473809832|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
131595571|NCT03269136|473809833|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
131595572|NCT03269136|473809834|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
131595573|NCT03269136|473809835|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
131595574|NCT03269136|473809836|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
131595575|NCT03269136|473809837|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
131595576|NCT03269136|473809838|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
131595577|NCT03269136|473809839|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
131791456|NCT00408876|474518701|FG000|Overall Study|Protocol Violation|0|||
131595578|NCT03269136|473809840|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
131595579|NCT03269136|473809841|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
131595580|NCT03269136|473809842|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
131595581|NCT03269136|473809843|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
131595582|NCT03269136|473809844|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
131595583|NCT03269136|473809845|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
131595584|NCT03269136|473809846|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
131595585|NCT03269136|473809847|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
131595586|NCT03269136|473809848|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
131595587|NCT03269136|473809831|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
131595588|NCT03269136|473809832|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
131595589|NCT03269136|473809833|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
131595590|NCT03269136|473809834|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
131595591|NCT03269136|473809835|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
131595592|NCT03269136|473809836|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
131595593|NCT03269136|473809837|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
131595594|NCT03269136|473809838|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
131595595|NCT03269136|473809839|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
131595596|NCT03269136|473809840|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
131595597|NCT03269136|473809841|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
131595598|NCT03269136|473809842|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
131595599|NCT03269136|473809843|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
131595600|NCT03269136|473809844|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
131595601|NCT03269136|473809845|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
131595602|NCT03269136|473809846|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
131595603|NCT03269136|473809847|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
131595604|NCT03269136|473809848|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
131595605|NCT03269136|473809831|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
131595606|NCT03269136|473809832|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
131595607|NCT03269136|473809833|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
131595608|NCT03269136|473809834|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
131595609|NCT03269136|473809835|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
131595610|NCT03269136|473809836|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
131595611|NCT03269136|473809837|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
131595612|NCT03269136|473809838|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
131595613|NCT03269136|473809839|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
131595614|NCT03269136|473809840|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
131595615|NCT03269136|473809841|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
131595616|NCT03269136|473809842|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
131595617|NCT03269136|473809843|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
131595618|NCT03269136|473809844|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
131595619|NCT03269136|473809845|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
131595620|NCT03269136|473809846|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
131595621|NCT03269136|473809847|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
131595622|NCT03269136|473809848|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
131595623|NCT04717492|473809849|FG000|Overall Study|Withdrawal by Subject|2|||
131595624|NCT04717492|473809850|FG001|Overall Study|Withdrawal by Subject|13|||
131595625|NCT04717492|473809849|FG000|Overall Study|Lost to Follow-up|2|||
131595626|NCT04717492|473809850|FG001|Overall Study|Lost to Follow-up|9|||
131595627|NCT03150810|473809852|FG000|Overall Study|Death|4|||
131595628|NCT03150810|473809853|FG001|Overall Study|Death|8|||
131595629|NCT03150810|473809854|FG002|Overall Study|Death|7|||
131899382|NCT00627926|474917610|FG002|Overall Study|Noncompliance/unspecified|17|||
131899383|NCT03360019|474917618|FG000|Overall Study|Withdrawal by Subject|2|||
131899384|NCT03360019|474917619|FG001|Overall Study|Withdrawal by Subject|0|||
131899385|NCT03360019|474917620|FG002|Overall Study|Withdrawal by Subject|0|||
131899386|NCT03360019|474917618|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
131899387|NCT03360019|474917619|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
131899388|NCT03360019|474917620|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
131899389|NCT01462110|474917621|FG000|Overall Study|Adverse Event|1|||
131899390|NCT01462110|474917622|FG001|Overall Study|Adverse Event|0|||
131899391|NCT00753675|474917623|FG000|Overall Study|other reason|11|||
131899392|NCT00753675|474917624|FG001|Overall Study|other reason|12|||
131899393|NCT00753675|474917625|FG002|Overall Study|other reason|13|||
131899394|NCT00753675|474917623|FG000|Overall Study|Death|1|||
131899395|NCT00753675|474917624|FG001|Overall Study|Death|2|||
131439496|NCT00286442|473235529|FG000|Overall Study|Adverse Event|7|||
131595630|NCT03150810|473809855|FG003|Overall Study|Death|2|||
131595631|NCT03150810|473809856|FG004|Overall Study|Death|2|||
131595632|NCT03150810|473809857|FG005|Overall Study|Death|10|||
131595633|NCT03150810|473809858|FG006|Overall Study|Death|8|||
131595634|NCT03150810|473809859|FG007|Overall Study|Death|6|||
131595635|NCT03150810|473809860|FG008|Overall Study|Death|18|||
131595636|NCT03150810|473809861|FG009|Overall Study|Death|3|||
131595637|NCT03150810|473809862|FG010|Overall Study|Death|19|||
131595638|NCT03150810|473809863|FG011|Overall Study|Death|1|||
131595639|NCT03150810|473809864|FG012|Overall Study|Death|19|||
131595640|NCT03150810|473809852|FG000|Overall Study|Withdrawal by Subject|0|||
131595641|NCT03150810|473809853|FG001|Overall Study|Withdrawal by Subject|1|||
131595642|NCT03150810|473809854|FG002|Overall Study|Withdrawal by Subject|1|||
131595643|NCT03150810|473809855|FG003|Overall Study|Withdrawal by Subject|1|||
131595644|NCT03150810|473809856|FG004|Overall Study|Withdrawal by Subject|0|||
131899396|NCT00753675|474917625|FG002|Overall Study|Death|4|||
131899397|NCT00753675|474917623|FG000|Overall Study|Adverse Event|11|||
131899398|NCT00753675|474917624|FG001|Overall Study|Adverse Event|9|||
131899399|NCT00753675|474917625|FG002|Overall Study|Adverse Event|4|||
131439497|NCT00286442|473235530|FG001|Overall Study|Adverse Event|6|||
131595645|NCT03150810|473809857|FG005|Overall Study|Withdrawal by Subject|0|||
131595646|NCT03150810|473809858|FG006|Overall Study|Withdrawal by Subject|2|||
131595647|NCT03150810|473809859|FG007|Overall Study|Withdrawal by Subject|0|||
131595648|NCT03150810|473809860|FG008|Overall Study|Withdrawal by Subject|2|||
131595649|NCT03150810|473809861|FG009|Overall Study|Withdrawal by Subject|0|||
131899400|NCT00753675|474917623|FG000|Overall Study|Objective progression of disease|35|||
131595650|NCT03150810|473809862|FG010|Overall Study|Withdrawal by Subject|1|||
131595651|NCT03150810|473809863|FG011|Overall Study|Withdrawal by Subject|0|||
131595652|NCT03150810|473809864|FG012|Overall Study|Withdrawal by Subject|1|||
131595653|NCT03150810|473809852|FG000|Overall Study|Sponsor Decision|0|||
131595654|NCT03150810|473809853|FG001|Overall Study|Sponsor Decision|2|||
131595655|NCT03150810|473809854|FG002|Overall Study|Sponsor Decision|0|||
131595656|NCT03150810|473809855|FG003|Overall Study|Sponsor Decision|0|||
131595657|NCT03150810|473809856|FG004|Overall Study|Sponsor Decision|1|||
131595658|NCT03150810|473809857|FG005|Overall Study|Sponsor Decision|1|||
131595659|NCT03150810|473809858|FG006|Overall Study|Sponsor Decision|0|||
131595660|NCT03150810|473809859|FG007|Overall Study|Sponsor Decision|0|||
131595661|NCT03150810|473809860|FG008|Overall Study|Sponsor Decision|1|||
131595662|NCT03150810|473809861|FG009|Overall Study|Sponsor Decision|0|||
131595663|NCT03150810|473809862|FG010|Overall Study|Sponsor Decision|0|||
131595664|NCT03150810|473809863|FG011|Overall Study|Sponsor Decision|0|||
131595665|NCT03150810|473809864|FG012|Overall Study|Sponsor Decision|5|||
131439498|NCT00286442|473235531|FG002|Overall Study|Adverse Event|1|||
131595666|NCT03150810|473809852|FG000|Overall Study|Lost to Follow-up|0|||
131595667|NCT03150810|473809853|FG001|Overall Study|Lost to Follow-up|1|||
131595668|NCT03150810|473809854|FG002|Overall Study|Lost to Follow-up|1|||
131595669|NCT03150810|473809855|FG003|Overall Study|Lost to Follow-up|0|||
131595670|NCT03150810|473809856|FG004|Overall Study|Lost to Follow-up|0|||
131595671|NCT03150810|473809857|FG005|Overall Study|Lost to Follow-up|0|||
131595672|NCT03150810|473809858|FG006|Overall Study|Lost to Follow-up|1|||
131595673|NCT03150810|473809859|FG007|Overall Study|Lost to Follow-up|0|||
131595674|NCT03150810|473809860|FG008|Overall Study|Lost to Follow-up|0|||
131595675|NCT03150810|473809861|FG009|Overall Study|Lost to Follow-up|0|||
131595676|NCT03150810|473809862|FG010|Overall Study|Lost to Follow-up|1|||
131595677|NCT03150810|473809863|FG011|Overall Study|Lost to Follow-up|0|||
131595678|NCT03150810|473809864|FG012|Overall Study|Lost to Follow-up|0|||
131595679|NCT03150810|473809852|FG000|Overall Study|Physician Decision|0|||
131595680|NCT03150810|473809853|FG001|Overall Study|Physician Decision|0|||
131595681|NCT03150810|473809854|FG002|Overall Study|Physician Decision|0|||
131595682|NCT03150810|473809855|FG003|Overall Study|Physician Decision|0|||
131595683|NCT03150810|473809856|FG004|Overall Study|Physician Decision|0|||
131595684|NCT03150810|473809857|FG005|Overall Study|Physician Decision|1|||
131595685|NCT03150810|473809858|FG006|Overall Study|Physician Decision|1|||
131595686|NCT03150810|473809859|FG007|Overall Study|Physician Decision|0|||
131595687|NCT03150810|473809860|FG008|Overall Study|Physician Decision|0|||
131595688|NCT03150810|473809861|FG009|Overall Study|Physician Decision|0|||
131595689|NCT03150810|473809862|FG010|Overall Study|Physician Decision|0|||
131595690|NCT03150810|473809863|FG011|Overall Study|Physician Decision|0|||
131595691|NCT03150810|473809864|FG012|Overall Study|Physician Decision|0|||
131595692|NCT03150810|473809852|FG000|Overall Study|Site withdrawal from study|0|||
131595693|NCT03150810|473809853|FG001|Overall Study|Site withdrawal from study|1|||
131595694|NCT03150810|473809854|FG002|Overall Study|Site withdrawal from study|0|||
131595695|NCT03150810|473809855|FG003|Overall Study|Site withdrawal from study|0|||
131595696|NCT03150810|473809856|FG004|Overall Study|Site withdrawal from study|0|||
131595697|NCT03150810|473809857|FG005|Overall Study|Site withdrawal from study|0|||
131595698|NCT03150810|473809858|FG006|Overall Study|Site withdrawal from study|0|||
131595699|NCT03150810|473809859|FG007|Overall Study|Site withdrawal from study|0|||
131595700|NCT03150810|473809860|FG008|Overall Study|Site withdrawal from study|0|||
131595701|NCT03150810|473809861|FG009|Overall Study|Site withdrawal from study|1|||
131595702|NCT03150810|473809862|FG010|Overall Study|Site withdrawal from study|1|||
131595703|NCT03150810|473809863|FG011|Overall Study|Site withdrawal from study|0|||
131595704|NCT03150810|473809864|FG012|Overall Study|Site withdrawal from study|0|||
131595705|NCT03150810|473809852|FG000|Overall Study|Hospice|0|||
131595706|NCT03150810|473809853|FG001|Overall Study|Hospice|0|||
131595707|NCT03150810|473809854|FG002|Overall Study|Hospice|0|||
131595708|NCT03150810|473809855|FG003|Overall Study|Hospice|0|||
131595709|NCT03150810|473809856|FG004|Overall Study|Hospice|0|||
131595710|NCT03150810|473809857|FG005|Overall Study|Hospice|1|||
131595711|NCT03150810|473809858|FG006|Overall Study|Hospice|0|||
131595712|NCT03150810|473809859|FG007|Overall Study|Hospice|0|||
131595713|NCT03150810|473809860|FG008|Overall Study|Hospice|0|||
131595714|NCT03150810|473809861|FG009|Overall Study|Hospice|0|||
131595715|NCT03150810|473809862|FG010|Overall Study|Hospice|0|||
131595716|NCT03150810|473809863|FG011|Overall Study|Hospice|0|||
131595717|NCT03150810|473809864|FG012|Overall Study|Hospice|0|||
131595718|NCT03150810|473809852|FG000|Overall Study|Participant relocated abroad.|0|||
131595719|NCT03150810|473809853|FG001|Overall Study|Participant relocated abroad.|0|||
131595720|NCT03150810|473809854|FG002|Overall Study|Participant relocated abroad.|0|||
131595721|NCT03150810|473809855|FG003|Overall Study|Participant relocated abroad.|0|||
131595722|NCT03150810|473809856|FG004|Overall Study|Participant relocated abroad.|0|||
131595723|NCT03150810|473809857|FG005|Overall Study|Participant relocated abroad.|1|||
131595724|NCT03150810|473809858|FG006|Overall Study|Participant relocated abroad.|0|||
131595725|NCT03150810|473809859|FG007|Overall Study|Participant relocated abroad.|0|||
131595726|NCT03150810|473809860|FG008|Overall Study|Participant relocated abroad.|0|||
131595727|NCT03150810|473809861|FG009|Overall Study|Participant relocated abroad.|0|||
131595728|NCT03150810|473809862|FG010|Overall Study|Participant relocated abroad.|0|||
131595729|NCT03150810|473809863|FG011|Overall Study|Participant relocated abroad.|0|||
131595730|NCT03150810|473809864|FG012|Overall Study|Participant relocated abroad.|0|||
131595731|NCT03150810|473809852|FG000|Overall Study|Transferred care to oncologist|0|||
131595732|NCT03150810|473809853|FG001|Overall Study|Transferred care to oncologist|0|||
131595733|NCT03150810|473809854|FG002|Overall Study|Transferred care to oncologist|0|||
131595734|NCT03150810|473809855|FG003|Overall Study|Transferred care to oncologist|0|||
131595735|NCT03150810|473809856|FG004|Overall Study|Transferred care to oncologist|0|||
131595736|NCT03150810|473809857|FG005|Overall Study|Transferred care to oncologist|0|||
131595737|NCT03150810|473809858|FG006|Overall Study|Transferred care to oncologist|2|||
131595738|NCT03150810|473809859|FG007|Overall Study|Transferred care to oncologist|0|||
131595739|NCT03150810|473809860|FG008|Overall Study|Transferred care to oncologist|0|||
131595740|NCT03150810|473809861|FG009|Overall Study|Transferred care to oncologist|0|||
131595741|NCT03150810|473809862|FG010|Overall Study|Transferred care to oncologist|0|||
131595742|NCT03150810|473809863|FG011|Overall Study|Transferred care to oncologist|0|||
131595743|NCT03150810|473809864|FG012|Overall Study|Transferred care to oncologist|0|||
131595744|NCT05116787|473809865|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
131595745|NCT05116787|473809866|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
131595746|NCT05116787|473809865|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
131595747|NCT05116787|473809866|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
131595748|NCT05116787|473809865|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
131595749|NCT05116787|473809866|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
131595750|NCT05116787|473809865|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
131595751|NCT05116787|473809866|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
131595752|NCT04359108|473809867|FG000|Overall Study|Withdrawal by Subject|1|||
131595753|NCT04359108|473809868|FG001|Overall Study|Withdrawal by Subject|0|||
131595754|NCT04359108|473809867|FG000|Overall Study|Unable or too feeble to walk independently|0|||
131595755|NCT04359108|473809868|FG001|Overall Study|Unable or too feeble to walk independently|2|||
131595756|NCT04359108|473809867|FG000|Overall Study|Argus II system stopped functioning|0|||
131595757|NCT04359108|473809868|FG001|Overall Study|Argus II system stopped functioning|1|||
131595758|NCT04359108|473809867|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
131595759|NCT04359108|473809868|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
131595760|NCT06393088|473809870|FG000|Overall Study|Withdrawal by Subject|0|||
131595761|NCT06393088|473809871|FG001|Overall Study|Withdrawal by Subject|2|||
131595762|NCT02515773|473809872|FG000|Overall Study|Withdrawal by Subject|12|||
131595763|NCT02515773|473809873|FG001|Overall Study|Withdrawal by Subject|2|||
131595764|NCT02515773|473809872|FG000|Overall Study|Lost to Follow-up|119|||
131595765|NCT02515773|473809873|FG001|Overall Study|Lost to Follow-up|126|||
131595766|NCT02515773|473809872|FG000|Overall Study|Discharged from Clinic Services|53|||
131595767|NCT02515773|473809873|FG001|Overall Study|Discharged from Clinic Services|84|||
131595768|NCT02515773|473809872|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
131595769|NCT02515773|473809873|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
131595770|NCT02515773|473809872|FG000|Overall Study|Follow-up at non-study site|8|||
131595771|NCT02515773|473809873|FG001|Overall Study|Follow-up at non-study site|16|||
131595772|NCT02515773|473809872|FG000|Overall Study|Moved from area|9|||
131595773|NCT02515773|473809873|FG001|Overall Study|Moved from area|14|||
131595774|NCT04176965|473809874|FG000|Overall Study|Death|1|||
131595775|NCT04176965|473809875|FG001|Overall Study|Death|2|||
131595776|NCT04176965|473809874|FG000|Overall Study|Lost to Follow-up|10|||
131595777|NCT04176965|473809875|FG001|Overall Study|Lost to Follow-up|2|||
131595778|NCT04176965|473809874|FG000|Overall Study|Withdrawal by Subject|6|||
131595779|NCT04176965|473809875|FG001|Overall Study|Withdrawal by Subject|1|||
131595780|NCT03903146|473809876|FG000|Overall Study|Lost to Follow-up|6|||
131595781|NCT03903146|473809877|FG001|Overall Study|Lost to Follow-up|4|||
131595782|NCT03903146|473809876|FG000|Overall Study|Withdrawal by Subject|0|||
131595783|NCT03903146|473809877|FG001|Overall Study|Withdrawal by Subject|1|||
131595784|NCT02919683|473809878|FG000|Post-Surgery Follow-Up|Death|2|||
131595785|NCT02919683|473809879|FG001|Post-Surgery Follow-Up|Death|2|||
131595786|NCT02919683|473809878|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
131595787|NCT02919683|473809879|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
131595788|NCT04072380|473809881|FG000|Overall Study|Adverse Event|4|||
131595789|NCT04072380|473809882|FG001|Overall Study|Adverse Event|6|||
131595790|NCT04072380|473809883|FG002|Overall Study|Adverse Event|0|||
131595791|NCT04072380|473809881|FG000|Overall Study|Withdrawal by Subject|3|||
131595792|NCT04072380|473809882|FG001|Overall Study|Withdrawal by Subject|1|||
131595793|NCT04072380|473809883|FG002|Overall Study|Withdrawal by Subject|1|||
131595794|NCT04072380|473809881|FG000|Overall Study|Physician Decision|2|||
131595795|NCT04072380|473809882|FG001|Overall Study|Physician Decision|0|||
131595796|NCT04072380|473809883|FG002|Overall Study|Physician Decision|0|||
131595797|NCT04072380|473809881|FG000|Overall Study|Protocol Violation|0|||
131595798|NCT04072380|473809882|FG001|Overall Study|Protocol Violation|2|||
131595799|NCT04072380|473809883|FG002|Overall Study|Protocol Violation|3|||
131595800|NCT04072380|473809881|FG000|Overall Study|Intercurrent Illness and Others|3|||
131595801|NCT04072380|473809882|FG001|Overall Study|Intercurrent Illness and Others|5|||
131595802|NCT04072380|473809883|FG002|Overall Study|Intercurrent Illness and Others|6|||
131595803|NCT04049643|473809884|FG000|Overall Study|Lack of Efficacy|1|||
131595804|NCT04049643|473809885|FG001|Overall Study|Lack of Efficacy|1|||
131595805|NCT04049643|473809886|FG002|Overall Study|Lack of Efficacy|0|||
131899401|NCT00753675|474917624|FG001|Overall Study|Objective progression of disease|35|||
131439499|NCT00286442|473235529|FG000|Overall Study|Protocol Violation|2|||
131595806|NCT04049643|473809884|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
131595807|NCT04049643|473809885|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
131595808|NCT04049643|473809886|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
131595809|NCT03792256|473811586|FG000|Overall Study|Death|0|||
131899402|NCT00753675|474917625|FG002|Overall Study|Objective progression of disease|35|||
131899403|NCT00753675|474917623|FG000|Overall Study|Withdrawal by Subject|0|||
131899404|NCT00753675|474917624|FG001|Overall Study|Withdrawal by Subject|1|||
131899405|NCT00753675|474917625|FG002|Overall Study|Withdrawal by Subject|0|||
131899406|NCT00753675|474917623|FG000|Overall Study|Lost to Follow-up|1|||
131899407|NCT00753675|474917624|FG001|Overall Study|Lost to Follow-up|0|||
131899408|NCT00753675|474917625|FG002|Overall Study|Lost to Follow-up|0|||
131899409|NCT02149264|474917631|FG000|Overall Study|Withdrawal by Subject|9|||
131899410|NCT02149264|474917631|FG000|Overall Study|Adverse Event|7|||
131899411|NCT02149264|474917631|FG000|Overall Study|Physician Decision|3|||
131899412|NCT02149264|474917631|FG000|Overall Study|Protocol Violation|1|||
131899413|NCT03283930|474917632|FG000|Overall Study|Scheduling conflict|8|||
131899414|NCT03283930|474917633|FG001|Overall Study|Scheduling conflict|10|||
131899415|NCT03283930|474917632|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
131899416|NCT03283930|474917633|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
131899417|NCT03283930|474917632|FG000|Overall Study|Technical software issue|2|||
131899418|NCT03283930|474917633|FG001|Overall Study|Technical software issue|2|||
131899419|NCT00805129|474917634|FG000|Overall Study|Not treated|1|||
131899420|NCT02499120|474917635|FG000|Overall Study|Death|52|||
131899421|NCT02499120|474917636|FG001|Overall Study|Death|43|||
131899422|NCT02499120|474917635|FG000|Overall Study|Lost to Follow-up|1|||
131899423|NCT02499120|474917636|FG001|Overall Study|Lost to Follow-up|2|||
131899424|NCT02499120|474917635|FG000|Overall Study|Participant refused further follow-up|1|||
131899425|NCT02499120|474917636|FG001|Overall Study|Participant refused further follow-up|0|||
131899426|NCT02499120|474917635|FG000|Overall Study|Withdrawal by Subject|2|||
131899427|NCT02499120|474917636|FG001|Overall Study|Withdrawal by Subject|5|||
131899428|NCT02499120|474917635|FG000|Overall Study|Other|9|||
131899429|NCT02499120|474917636|FG001|Overall Study|Other|10|||
131899430|NCT01839916|474917645|FG000|Overall Study|Death|9|||
131899431|NCT01839916|474917645|FG000|Overall Study|Physician Decision|17|||
131899432|NCT01839916|474917645|FG000|Overall Study|Relapse|12|||
131899433|NCT01839916|474917645|FG000|Overall Study|GVHD|2|||
131899434|NCT01839916|474917645|FG000|Overall Study|Graft Failure|1|||
131899435|NCT00964028|474917646|FG000|Overall Study|Withdrawal by Subject|0|||
131899436|NCT00964028|474917647|FG001|Overall Study|Withdrawal by Subject|1|||
131899437|NCT02385110|474917650|FG000|Overall Study|Early Death|1|||
131899438|NCT02385110|474917651|FG001|Overall Study|Early Death|0|||
131899439|NCT00069823|474917652|FG000|Overall Study|Did not have follow-up diary cards|6|||
131899440|NCT00069823|474917653|FG001|Overall Study|Did not have follow-up diary cards|3|||
131899441|NCT00520039|474917654|FG000|Overall Study|Exclusion criteria met at first visit|7|||
131899442|NCT00520039|474917655|FG001|Overall Study|Exclusion criteria met at first visit|5|||
131899443|NCT03560869|474917656|FG000|Overall Study|Withdrawal by Subject|3|||
131899444|NCT03560869|474917657|FG001|Overall Study|Withdrawal by Subject|4|||
131899445|NCT03560869|474917656|FG000|Overall Study|Screening failure|4|||
131899446|NCT03560869|474917657|FG001|Overall Study|Screening failure|4|||
131899447|NCT03560869|474917656|FG000|Overall Study|Withdrawal by PI|0|||
131899448|NCT03560869|474917657|FG001|Overall Study|Withdrawal by PI|1|||
131899449|NCT01223937|474917658|FG000|Overall Study|Withdrawal by Subject|3|||
131899450|NCT01223937|474917659|FG001|Overall Study|Withdrawal by Subject|2|||
131899451|NCT01223937|474917658|FG000|Overall Study|Lost to Follow-up|1|||
131899452|NCT01223937|474917659|FG001|Overall Study|Lost to Follow-up|4|||
131899453|NCT01223937|474917658|FG000|Overall Study|Adverse Event|1|||
131899454|NCT01223937|474917659|FG001|Overall Study|Adverse Event|4|||
131899455|NCT01223937|474917658|FG000|Overall Study|Protocol Violation|8|||
131899456|NCT01223937|474917659|FG001|Overall Study|Protocol Violation|7|||
131899457|NCT01223937|474917658|FG000|Overall Study|Other|4|||
131899458|NCT01223937|474917659|FG001|Overall Study|Other|1|||
131899459|NCT03999749|474917664|FG000|Overall Study|Toxicity|16|||
131899460|NCT03999749|474917664|FG000|Overall Study|Withdrawal by Subject|3|||
131899461|NCT03999749|474917664|FG000|Overall Study|Disease progression|26|||
131899462|NCT03999749|474917664|FG000|Overall Study|Physician Decision|4|||
131899463|NCT03999749|474917664|FG000|Overall Study|Death|5|||
131899464|NCT03999749|474917664|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
131899465|NCT00255164|474917665|FG000|Overall Study|Adverse Event|10|||
131899466|NCT00255164|474917666|FG001|Overall Study|Adverse Event|6|||
131899467|NCT00255164|474917667|FG002|Overall Study|Adverse Event|9|||
131899468|NCT00255164|474917665|FG000|Overall Study|Lost to Follow-up|4|||
131899469|NCT00255164|474917666|FG001|Overall Study|Lost to Follow-up|3|||
131899470|NCT00255164|474917667|FG002|Overall Study|Lost to Follow-up|4|||
131899471|NCT00255164|474917665|FG000|Overall Study|Withdrawal by Subject|18|||
131899472|NCT00255164|474917666|FG001|Overall Study|Withdrawal by Subject|17|||
131899473|NCT00255164|474917667|FG002|Overall Study|Withdrawal by Subject|8|||
131899474|NCT00255164|474917665|FG000|Overall Study|Noncompliance|0|||
131899475|NCT00255164|474917666|FG001|Overall Study|Noncompliance|1|||
131595810|NCT03792256|473811587|FG001|Overall Study|Death|1|||
131595811|NCT03792256|473811586|FG000|Overall Study|Lack of Efficacy|0|||
131595812|NCT03792256|473811587|FG001|Overall Study|Lack of Efficacy|1|||
131595813|NCT03792256|473811586|FG000|Overall Study|Withdrawal by Subject|0|||
131595814|NCT03792256|473811587|FG001|Overall Study|Withdrawal by Subject|1|||
131595815|NCT05368103|473811590|FG000|Overall Study|Withdrawal by Subject|4|||
131595816|NCT05368103|473811590|FG000|Overall Study|Lost to Follow-up|1|||
131595817|NCT05368103|473811590|FG000|Overall Study|Lack of Efficacy|3|||
131595818|NCT03675282|473811591|FG000|Overall Study|Lost to Follow-up|4|||
131595819|NCT03675282|473811592|FG001|Overall Study|Lost to Follow-up|8|||
131595820|NCT03675282|473811593|FG002|Overall Study|Lost to Follow-up|1|||
131595821|NCT03675282|473811594|FG003|Overall Study|Lost to Follow-up|0|||
131595822|NCT03675282|473811595|FG004|Overall Study|Lost to Follow-up|2|||
131595823|NCT03675282|473811596|FG005|Overall Study|Lost to Follow-up|7|||
131595824|NCT03675282|473811591|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
131595825|NCT03675282|473811592|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
131595826|NCT03675282|473811593|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
131595827|NCT03675282|473811594|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
131595828|NCT03675282|473811595|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
131595829|NCT03675282|473811596|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
131595830|NCT03675282|473811591|FG000|Overall Study|Physician Decision|1|||
131899476|NCT00255164|474917667|FG002|Overall Study|Noncompliance|2|||
131899477|NCT00255164|474917665|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
131899478|NCT00255164|474917666|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
131899479|NCT00255164|474917667|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
131899480|NCT00255164|474917665|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
131899481|NCT00255164|474917666|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
131899482|NCT00255164|474917667|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
131899483|NCT00255164|474917665|FG000|Overall Study|Possible Barrett's Esophagus|1|||
131595831|NCT03675282|473811592|FG001|Overall Study|Physician Decision|0|||
131595832|NCT03675282|473811593|FG002|Overall Study|Physician Decision|0|||
131595833|NCT03675282|473811594|FG003|Overall Study|Physician Decision|0|||
131595834|NCT03675282|473811595|FG004|Overall Study|Physician Decision|0|||
131595835|NCT03675282|473811596|FG005|Overall Study|Physician Decision|0|||
131595836|NCT05875142|473811597|FG000|Overall Study|Lost to Follow-up|0|||
131595837|NCT05875142|473811598|FG001|Overall Study|Lost to Follow-up|1|||
131595838|NCT05875142|473811599|FG002|Overall Study|Lost to Follow-up|1|||
131595839|NCT03232138|473811601|FG000|Overall Study|Physician Decision|1|||
131595840|NCT03232138|473811602|FG001|Overall Study|Physician Decision|0|||
131595841|NCT03232138|473811601|FG000|Overall Study|Adverse Event|2|||
131595842|NCT03232138|473811602|FG001|Overall Study|Adverse Event|0|||
131595843|NCT03232138|473811601|FG000|Overall Study|Withdrawal by Subject|1|||
131595844|NCT03232138|473811602|FG001|Overall Study|Withdrawal by Subject|2|||
131595845|NCT05076708|473811604|FG000|Overall Study|Withdrawal by Subject|4|||
131595846|NCT05076708|473811604|FG000|Overall Study|Lost to study during switch phase|8|||
131595847|NCT04952909|473811605|FG000|Overall Study|Death|3|||
131595848|NCT05308004|473811606|FG000|Overall Study|Not seen by Palliative Care NP|0|||
131595849|NCT05308004|473811607|FG001|Overall Study|Not seen by Palliative Care NP|1|||
131595850|NCT03575897|473811608|FG000|Overall Study|Lost to Follow-up|12|||
131595851|NCT03575897|473811609|FG001|Overall Study|Lost to Follow-up|13|||
131595852|NCT03652688|473811616|FG000|Baseline|Withdrawal by Subject|0|||
131595853|NCT03652688|473811617|FG001|Baseline|Withdrawal by Subject|3|||
131595854|NCT03652688|473811616|FG000|Follow-up|Lost to Follow-up|56|||
131595855|NCT03652688|473811617|FG001|Follow-up|Lost to Follow-up|54|||
131595856|NCT05551637|473811618|FG000|Overall Study|Lack of Efficacy|0|||
131595857|NCT05551637|473811619|FG001|Overall Study|Lack of Efficacy|6|||
131595858|NCT05551637|473811618|FG000|Overall Study|Lost to Follow-up|1|||
131899484|NCT00255164|474917666|FG001|Overall Study|Possible Barrett's Esophagus|3|||
131595859|NCT05551637|473811619|FG001|Overall Study|Lost to Follow-up|1|||
131595860|NCT03468218|473811622|FG000|Overall Study|Adverse Event|5|||
131595861|NCT03468218|473811622|FG000|Overall Study|Progressive Disease|16|||
131595862|NCT03468218|473811622|FG000|Overall Study|Death|1|||
131595863|NCT03468218|473811622|FG000|Overall Study|Alternate therapy|1|||
131595864|NCT03468218|473811622|FG000|Overall Study|Withdrawal by Subject|2|||
131595865|NCT03033576|473811623|FG000|Overall Study|Ineligible|1|||
131439500|NCT00286442|473235530|FG001|Overall Study|Protocol Violation|4|||
131439501|NCT00286442|473235531|FG002|Overall Study|Protocol Violation|2|||
131439502|NCT00286442|473235529|FG000|Overall Study|Lost to Follow-up|5|||
131439503|NCT00286442|473235530|FG001|Overall Study|Lost to Follow-up|2|||
131439504|NCT00286442|473235531|FG002|Overall Study|Lost to Follow-up|1|||
131439505|NCT00286442|473235529|FG000|Overall Study|Physician Decision|1|||
131439506|NCT00286442|473235530|FG001|Overall Study|Physician Decision|1|||
131439507|NCT00286442|473235531|FG002|Overall Study|Physician Decision|1|||
131439508|NCT00286442|473235529|FG000|Overall Study|Administrative Error|1|||
131439509|NCT00286442|473235530|FG001|Overall Study|Administrative Error|1|||
131439510|NCT00286442|473235531|FG002|Overall Study|Administrative Error|0|||
131439511|NCT00286442|473235529|FG000|Overall Study|Withdrawal by Subject|2|||
131439512|NCT00286442|473235530|FG001|Overall Study|Withdrawal by Subject|14|||
131439513|NCT00286442|473235531|FG002|Overall Study|Withdrawal by Subject|2|||
131439514|NCT04571944|473235532|FG000|Overall Study|Death|1|||
131439515|NCT04571944|473235533|FG001|Overall Study|Death|0|||
131439516|NCT04571944|473235532|FG000|Overall Study|Withdrawal by Subject|3|||
131439517|NCT04571944|473235533|FG001|Overall Study|Withdrawal by Subject|0|||
131439518|NCT04571944|473235532|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
131439519|NCT04571944|473235533|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
131439520|NCT03740048|473235536|FG000|Overall Study|Withdrawal by Subject|1|||
131439521|NCT03740048|473235537|FG001|Overall Study|Withdrawal by Subject|1|||
131439522|NCT03740048|473235536|FG000|Overall Study|Death|1|||
131439523|NCT03740048|473235537|FG001|Overall Study|Death|6|||
131439524|NCT03740048|473235536|FG000|Overall Study|Switched to thrice-weekly HD|2|||
131439525|NCT03740048|473235537|FG001|Overall Study|Switched to thrice-weekly HD|0|||
131439526|NCT03740048|473235536|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
131439527|NCT03740048|473235537|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
131439528|NCT03740048|473235536|FG000|Overall Study|Lost to Follow-up|0|||
131439529|NCT03740048|473235537|FG001|Overall Study|Lost to Follow-up|1|||
131439530|NCT03740048|473235536|FG000|Overall Study|Non-compliance with HD|0|||
131439531|NCT03740048|473235537|FG001|Overall Study|Non-compliance with HD|1|||
131439532|NCT03261336|473235538|FG000|Overall Study|Adverse Event|1|||
131439533|NCT00292942|473235539|FG000|Overall Study|Withdrawal by Subject|0|||
131439534|NCT00292942|473235540|FG001|Overall Study|Withdrawal by Subject|0|||
131439535|NCT00292942|473235541|FG002|Overall Study|Withdrawal by Subject|1|||
131439536|NCT00292942|473235542|FG003|Overall Study|Withdrawal by Subject|0|||
131439537|NCT00292942|473235539|FG000|Overall Study|Adverse Event|0|||
131439538|NCT00292942|473235540|FG001|Overall Study|Adverse Event|0|||
131439539|NCT00292942|473235541|FG002|Overall Study|Adverse Event|0|||
131439540|NCT00292942|473235542|FG003|Overall Study|Adverse Event|1|||
131439541|NCT00528957|473235543|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
131439542|NCT00528957|473235544|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
131439543|NCT00528957|473235543|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
131439544|NCT00528957|473235544|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
131439545|NCT00528957|473235543|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
131439546|NCT00528957|473235544|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
131439547|NCT00528957|473235543|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
131439548|NCT00528957|473235544|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
131439549|NCT00528957|473235543|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
131595866|NCT03033576|473811624|FG001|Overall Study|Ineligible|1|||
131595867|NCT03033576|473811623|FG000|Overall Study|Adverse Event|4|||
131439550|NCT00528957|473235544|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
131439551|NCT00528957|473235543|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
131439552|NCT00528957|473235544|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
131439553|NCT00528957|473235543|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
131439554|NCT00528957|473235544|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
131439555|NCT00528957|473235543|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
131439556|NCT00528957|473235544|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
131439557|NCT00528957|473235543|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
131439558|NCT00528957|473235544|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
131595868|NCT03033576|473811624|FG001|Overall Study|Adverse Event|20|||
131595869|NCT03033576|473811623|FG000|Overall Study|Progression/relapse|9|||
131595870|NCT03033576|473811624|FG001|Overall Study|Progression/relapse|36|||
131791457|NCT00408876|474518702|FG001|Overall Study|Protocol Violation|3|||
131595871|NCT03033576|473811623|FG000|Overall Study|Death|1|||
131595872|NCT03033576|473811624|FG001|Overall Study|Death|1|||
131595873|NCT03033576|473811623|FG000|Overall Study|Patient refusal|1|||
131595874|NCT03033576|473811624|FG001|Overall Study|Patient refusal|6|||
131595875|NCT03033576|473811623|FG000|Overall Study|Other, unspecified reasons|0|||
131595876|NCT03033576|473811624|FG001|Overall Study|Other, unspecified reasons|4|||
131595877|NCT03033576|473811623|FG000|Overall Study|Currently on protocol therapy|0|||
131595878|NCT03033576|473811624|FG001|Overall Study|Currently on protocol therapy|2|||
131595879|NCT05179837|473811625|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
131595880|NCT05179837|473811625|FG000|Overall Study|Device malfunctioned|1|||
131595881|NCT05179837|473811625|FG000|Overall Study|Image quality too low|2|||
131595882|NCT03719443|473811626|FG000|Overall Study|Lost to Follow-up|0|||
131595883|NCT03719443|473811627|FG001|Overall Study|Lost to Follow-up|0|||
131595884|NCT03719443|473811628|FG002|Overall Study|Lost to Follow-up|1|||
131595885|NCT03719443|473811629|FG003|Overall Study|Lost to Follow-up|0|||
131595886|NCT03719443|473811630|FG004|Overall Study|Lost to Follow-up|1|||
131595887|NCT03719443|473811631|FG005|Overall Study|Lost to Follow-up|0|||
131595888|NCT03719443|473811632|FG006|Overall Study|Lost to Follow-up|1|||
131595889|NCT03719443|473811626|FG000|Overall Study|Withdrawal by Subject|0|||
131595890|NCT03719443|473811627|FG001|Overall Study|Withdrawal by Subject|0|||
131595891|NCT03719443|473811628|FG002|Overall Study|Withdrawal by Subject|1|||
131595892|NCT03719443|473811629|FG003|Overall Study|Withdrawal by Subject|0|||
131595893|NCT03719443|473811630|FG004|Overall Study|Withdrawal by Subject|0|||
131595894|NCT03719443|473811631|FG005|Overall Study|Withdrawal by Subject|0|||
131448273|NCT02079246|473272632|FG001|OLEX|Other: Insufficient compliance|0|||
131595895|NCT03719443|473811632|FG006|Overall Study|Withdrawal by Subject|0|||
131595896|NCT05051124|473811633|FG000|Overall Study|Lost to Follow-up|2|||
131595897|NCT05051124|473811633|FG000|Overall Study|Withdrawal by Subject|1|||
131595898|NCT05051124|473811633|FG000|Overall Study|Residential relocation|2|||
131595899|NCT05051124|473811633|FG000|Overall Study|Death|1|||
131595900|NCT04782973|473811634|FG000|Overall Study|Withdrawal by Subject|5|||
131595901|NCT04782973|473811634|FG000|Overall Study|Protocol Violation|6|||
131595902|NCT04782973|473811634|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
131706460|NCT01273064|474207406|FG003|Overall Study|Physician Decision|0|||
131706461|NCT01273064|474207407|FG004|Overall Study|Physician Decision|1|||
131706462|NCT04062214|474207408|FG000|Week 12|Death|1|||
131706463|NCT04062214|474207409|FG001|Week 12|Death|1|||
131595903|NCT03557697|473811635|FG000|Overall Study|Withdrawal by Subject|2|||
131706464|NCT04062214|474207408|FG000|Week 12|Withdrawal by Subject|14|||
131706465|NCT04062214|474207409|FG001|Week 12|Withdrawal by Subject|13|||
131706466|NCT04062214|474207408|FG000|Week 12|Lost to Follow-up|55|||
131595904|NCT03557697|473811636|FG001|Overall Study|Withdrawal by Subject|4|||
131595905|NCT06491433|473811637|FG000|Overall Study|Protocol Violation|51|||
131595906|NCT06491433|473811637|FG000|Overall Study|consent withdrawal|2|||
131595907|NCT06491433|473811637|FG000|Overall Study|screen failure|1|||
131595908|NCT04749615|473811638|FG000|Overall Study|Lost to Follow-up|6|||
131595909|NCT04749615|473811639|FG001|Overall Study|Lost to Follow-up|10|||
131595910|NCT03611491|473811640|FG000|Overall Study|Lost to Follow-up|1|||
131595911|NCT05478499|473811659|FG000|Overall Study|Adverse Event|4|||
131595912|NCT05478499|473811660|FG001|Overall Study|Adverse Event|2|||
131595913|NCT05478499|473811659|FG000|Overall Study|Withdrawal by Subject|3|||
131595914|NCT05478499|473811660|FG001|Overall Study|Withdrawal by Subject|2|||
131595915|NCT05478499|473811659|FG000|Overall Study|Lack of Efficacy|1|||
131595916|NCT05478499|473811660|FG001|Overall Study|Lack of Efficacy|0|||
131595917|NCT05478499|473811659|FG000|Overall Study|Lost to Follow-up|1|||
131595918|NCT05478499|473811660|FG001|Overall Study|Lost to Follow-up|0|||
131595919|NCT05478499|473811659|FG000|Overall Study|Other reasons|0|||
131595920|NCT05478499|473811660|FG001|Overall Study|Other reasons|1|||
131595921|NCT02962895|473811661|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
131595922|NCT02962895|473811662|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
131595923|NCT02962895|473811663|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
131595924|NCT02962895|473811664|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131595925|NCT02962895|473811665|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131595926|NCT02962895|473811666|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131706467|NCT04062214|474207409|FG001|Week 12|Lost to Follow-up|68|||
131706468|NCT04062214|474207408|FG000|Week 12|Intermittent missing|31|||
131706469|NCT04062214|474207409|FG001|Week 12|Intermittent missing|29|||
131706470|NCT04062214|474207408|FG000|Week 36|Withdrawal by Subject|4|||
131706471|NCT04062214|474207409|FG001|Week 36|Withdrawal by Subject|5|||
131706472|NCT04062214|474207408|FG000|Week 36|Lost to Follow-up|50|||
131595927|NCT02962895|473811667|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131595928|NCT02962895|473811661|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131595929|NCT02962895|473811662|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
131595930|NCT02962895|473811663|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131595931|NCT02962895|473811664|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131595932|NCT02962895|473811665|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131595933|NCT02962895|473811666|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131595934|NCT02962895|473811667|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131595935|NCT02962895|473811661|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131595936|NCT02962895|473811662|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
131595937|NCT02962895|473811663|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
131595938|NCT02962895|473811664|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131595939|NCT02962895|473811665|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131595940|NCT02962895|473811666|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131595941|NCT02962895|473811667|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131595942|NCT02962895|473811661|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
131595943|NCT02962895|473811662|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131595944|NCT02962895|473811663|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131595945|NCT02962895|473811664|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131595946|NCT02962895|473811665|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131595947|NCT02962895|473811666|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131595948|NCT02962895|473811667|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131595949|NCT02962895|473811661|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131595950|NCT02962895|473811662|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
131595951|NCT02962895|473811663|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131595952|NCT02962895|473811664|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131595953|NCT02962895|473811665|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131595954|NCT02962895|473811666|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131595955|NCT02962895|473811667|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131595956|NCT02962895|473811661|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131595957|NCT02962895|473811662|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131595958|NCT02962895|473811663|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131595959|NCT02962895|473811664|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
131595960|NCT02962895|473811665|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131595961|NCT02962895|473811666|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131595962|NCT02962895|473811667|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131595963|NCT02962895|473811661|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131595964|NCT02962895|473811662|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131595965|NCT02962895|473811663|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131595966|NCT02962895|473811664|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131595967|NCT02962895|473811665|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131595968|NCT02962895|473811666|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131595969|NCT02962895|473811667|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
131595970|NCT02962895|473811661|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131595971|NCT02962895|473811662|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131595972|NCT02962895|473811663|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131595973|NCT02962895|473811664|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131595974|NCT02962895|473811665|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
131595975|NCT02962895|473811666|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131595976|NCT02962895|473811667|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
131595977|NCT02962895|473811661|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131595978|NCT02962895|473811662|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131595979|NCT02962895|473811663|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131595980|NCT02962895|473811664|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131595981|NCT02962895|473811665|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131595982|NCT02962895|473811666|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131595983|NCT02962895|473811667|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
131595984|NCT02962895|473811661|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131595985|NCT02962895|473811662|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
131595986|NCT02962895|473811663|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131595987|NCT02962895|473811664|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131595988|NCT02962895|473811665|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131595989|NCT02962895|473811666|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131595990|NCT02962895|473811667|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131595991|NCT02962895|473811661|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131595992|NCT02962895|473811662|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131595993|NCT02962895|473811663|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131595994|NCT02962895|473811664|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131595995|NCT02962895|473811665|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
131595996|NCT02962895|473811666|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131595997|NCT02962895|473811667|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131595998|NCT02962895|473811661|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131595999|NCT02962895|473811662|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131596000|NCT02962895|473811663|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131596001|NCT02962895|473811664|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131596002|NCT02962895|473811665|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
131596003|NCT02962895|473811666|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131596004|NCT02962895|473811667|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131596005|NCT02962895|473811661|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131596006|NCT02962895|473811662|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
131596007|NCT02962895|473811663|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
131596008|NCT02962895|473811664|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
131596009|NCT02962895|473811665|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131596010|NCT02962895|473811666|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131596011|NCT02962895|473811667|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131596012|NCT02962895|473811661|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
131596013|NCT02962895|473811662|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
131596014|NCT02962895|473811663|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
131596015|NCT02962895|473811664|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
131596016|NCT02962895|473811665|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
131596017|NCT02962895|473811666|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
131596018|NCT02962895|473811667|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
131596019|NCT05481320|473811668|FG000|Overall Study|Withdrawal by Subject|1|||
131596020|NCT05481320|473811669|FG001|Overall Study|Withdrawal by Subject|1|||
131596021|NCT05481320|473811668|FG000|Overall Study|Care recipent passed away|0|||
131596022|NCT05481320|473811669|FG001|Overall Study|Care recipent passed away|1|||
131596023|NCT05481320|473811668|FG000|Overall Study|Out-of-window assessment|0|||
131596024|NCT05481320|473811669|FG001|Overall Study|Out-of-window assessment|1|||
131596025|NCT05481320|473811668|FG000|Overall Study|No longer a primary caregiver|3|||
131596026|NCT05481320|473811669|FG001|Overall Study|No longer a primary caregiver|0|||
131596027|NCT05481320|473811668|FG000|Overall Study|Unable to contact|1|||
131596028|NCT05481320|473811669|FG001|Overall Study|Unable to contact|0|||
131596029|NCT05894577|473811670|FG000|Overall Study|No receipt of study drug|14|||
131596030|NCT05894577|473811671|FG001|Overall Study|No receipt of study drug|13|||
131596031|NCT05894577|473811670|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
131596032|NCT05894577|473811671|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
131596033|NCT05894577|473811670|FG000|Overall Study|Screen Fail|2|||
131596034|NCT05894577|473811671|FG001|Overall Study|Screen Fail|0|||
131596035|NCT05894577|473811670|FG000|Overall Study|Study drug recall|86|||
131596036|NCT05894577|473811671|FG001|Overall Study|Study drug recall|63|||
131596037|NCT05282173|473811674|FG000|Overall Study|Missed|3|||
131596038|NCT05282173|473811675|FG001|Overall Study|Missed|2|||
131596039|NCT05282173|473811676|FG002|Overall Study|Missed|4|||
131596040|NCT03364647|473811678|FG000|Overall Study|Withdrawal by Subject|3|||
131596041|NCT03364647|473811679|FG001|Overall Study|Withdrawal by Subject|1|||
131596042|NCT03476460|473811682|FG000|Overall Study|Withdrawal by Subject|3|||
131596043|NCT03476460|473811683|FG001|Overall Study|Withdrawal by Subject|2|||
131596044|NCT03476460|473811682|FG000|Overall Study|Non-compliance with treatment|3|||
131596045|NCT03476460|473811683|FG001|Overall Study|Non-compliance with treatment|0|||
131596046|NCT03476460|473811682|FG000|Overall Study|Missing laboratory tests|5|||
131596047|NCT03476460|473811683|FG001|Overall Study|Missing laboratory tests|5|||
131596048|NCT03476460|473811682|FG000|Overall Study|Adverse Event|0|||
131596049|NCT03476460|473811683|FG001|Overall Study|Adverse Event|1|||
131596050|NCT01606215|473811688|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
131596051|NCT01606215|473811689|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
131596052|NCT04592549|473811690|FG000|Overall Study|Withdrawal by Subject|0|||
131596053|NCT04592549|473811691|FG001|Overall Study|Withdrawal by Subject|1|||
131596054|NCT04592549|473811692|FG002|Overall Study|Withdrawal by Subject|0|||
131596055|NCT04592549|473811693|FG003|Overall Study|Withdrawal by Subject|1|||
131596056|NCT04592549|473811694|FG004|Overall Study|Withdrawal by Subject|1|||
131596057|NCT04592549|473811695|FG005|Overall Study|Withdrawal by Subject|0|||
131596058|NCT04592549|473811690|FG000|Overall Study|Lost to Follow-up|2|||
131596059|NCT04592549|473811691|FG001|Overall Study|Lost to Follow-up|0|||
131596060|NCT04592549|473811692|FG002|Overall Study|Lost to Follow-up|0|||
131596061|NCT04592549|473811693|FG003|Overall Study|Lost to Follow-up|1|||
131596062|NCT04592549|473811694|FG004|Overall Study|Lost to Follow-up|1|||
131596063|NCT04592549|473811695|FG005|Overall Study|Lost to Follow-up|1|||
131596064|NCT05184192|473811696|FG000|Overall Study|Lost to Follow-up|4|||
131596065|NCT05184192|473811697|FG001|Overall Study|Lost to Follow-up|7|||
131439559|NCT00528957|473235543|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
131439560|NCT00528957|473235544|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
131439561|NCT00528957|473235543|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
131439562|NCT00528957|473235544|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
131439563|NCT00528957|473235543|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
131439564|NCT00528957|473235544|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
131439565|NCT00528957|473235543|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
131439566|NCT00528957|473235544|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
131439567|NCT00528957|473235543|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
131439568|NCT00528957|473235544|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
131439569|NCT00528957|473235543|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
131439570|NCT00528957|473235544|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
131596066|NCT05184192|473811696|FG000|Overall Study|Adverse Event|1|||
131596067|NCT05184192|473811697|FG001|Overall Study|Adverse Event|4|||
131596068|NCT05184192|473811696|FG000|Overall Study|PI withdrawal|1|||
131439571|NCT00528957|473235543|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
131596069|NCT05184192|473811697|FG001|Overall Study|PI withdrawal|2|||
131596070|NCT05184192|473811696|FG000|Overall Study|Withdrew due to adverse effect|1|||
131596071|NCT05184192|473811697|FG001|Overall Study|Withdrew due to adverse effect|0|||
131596072|NCT05184192|473811696|FG000|Overall Study|Medication schedule|1|||
131596073|NCT05184192|473811697|FG001|Overall Study|Medication schedule|0|||
131439572|NCT00528957|473235544|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
131439573|NCT05083351|473235548|FG000|Overall Study|Adverse Event|3|||
131439574|NCT05083351|473235548|FG000|Overall Study|Did not meet data inclusion criteria|8|||
131439575|NCT05083351|473235548|FG000|Overall Study|Did not meet eligibility criteria|19|||
131439576|NCT05083351|473235548|FG000|Overall Study|Study Staff Decision|19|||
131439577|NCT01759420|473235551|FG000|Overall Study|Screen failure|5|||
131439578|NCT01759420|473235551|FG000|Overall Study|Inaccurate EKG machine readings|1|||
131439579|NCT02051764|473235556|FG000|Overall Study|Study terminated by sponsor|0|||
131439580|NCT02051764|473235557|FG001|Overall Study|Study terminated by sponsor|7|||
131439581|NCT03624881|473235558|FG000|Overall Study|Screen Failure|14|||
131439582|NCT03624881|473235559|FG001|Overall Study|Screen Failure|0|||
131439583|NCT03624881|473235558|FG000|Overall Study|No Catheter Inserted|6|||
131439584|NCT03624881|473235559|FG001|Overall Study|No Catheter Inserted|1|||
131439585|NCT03624881|473235558|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
131439586|NCT03624881|473235559|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
131439587|NCT03624881|473235558|FG000|Overall Study|Death|2|||
131439588|NCT03624881|473235559|FG001|Overall Study|Death|0|||
131439589|NCT03624881|473235558|FG000|Overall Study|Lost to Follow-up|10|||
131439590|NCT03624881|473235559|FG001|Overall Study|Lost to Follow-up|4|||
131596074|NCT05184192|473811696|FG000|Overall Study|Concern for adverse effects|0|||
131596075|NCT05184192|473811697|FG001|Overall Study|Concern for adverse effects|4|||
131439591|NCT03624881|473235558|FG000|Overall Study|Withdrawal by Subject|12|||
131439592|NCT03624881|473235559|FG001|Overall Study|Withdrawal by Subject|1|||
131439593|NCT05435339|473235560|FG000|Overall Study|Death|1|||
131596076|NCT04015167|473811711|FG000|Overall Study|Lost to Follow-up|40|||
131596077|NCT04015167|473811711|FG000|Overall Study|Adverse Event|5|||
131596078|NCT04015167|473811711|FG000|Overall Study|Withdrawal by Subject|2|||
131596079|NCT04015167|473811711|FG000|Overall Study|Subject went to jail|1|||
131596080|NCT03640312|473811712|FG000|Overall Study|Lost to Follow-up|3|||
131596081|NCT03640312|473811713|FG001|Overall Study|Lost to Follow-up|6|||
131596082|NCT06037369|473811722|FG000|Overall Study|Lost to Follow-up|0|||
131596083|NCT06037369|473811723|FG001|Overall Study|Lost to Follow-up|1|||
131596084|NCT04876118|473811728|FG000|Overall Study|Pregnancy|1|||
131596085|NCT04876118|473811728|FG000|Overall Study|Withdrawal by Subject|14|||
131596086|NCT05351554|473811731|FG000|Overall Study|Study terminated by sponsor|1|||
131596087|NCT03774082|473811732|FG000|Overall Study|Death|6|||
131596088|NCT03774082|473811733|FG001|Overall Study|Death|3|||
131596089|NCT03774082|473811734|FG002|Overall Study|Death|2|||
131596090|NCT03774082|473811732|FG000|Overall Study|Subject decision|0|||
131596091|NCT03774082|473811733|FG001|Overall Study|Subject decision|3|||
131596092|NCT03774082|473811734|FG002|Overall Study|Subject decision|0|||
131596093|NCT03774082|473811732|FG000|Overall Study|Lost to Follow-up|2|||
131596094|NCT03774082|473811733|FG001|Overall Study|Lost to Follow-up|0|||
131596095|NCT03774082|473811734|FG002|Overall Study|Lost to Follow-up|0|||
131596096|NCT03774082|473811732|FG000|Overall Study|Guardian decision|0|||
131596097|NCT03774082|473811733|FG001|Overall Study|Guardian decision|0|||
131596098|NCT03774082|473811734|FG002|Overall Study|Guardian decision|1|||
131596099|NCT03774082|473811732|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
131596100|NCT03774082|473811733|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
131596101|NCT03774082|473811734|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
131596102|NCT05093829|473811735|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131596103|NCT05093829|473811736|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131596104|NCT05093829|473811737|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
131596105|NCT05093829|473811738|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131596106|NCT05093829|473811739|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131596107|NCT04353661|473813499|FG000|Overall Study|Protocol Violation|0|||
131596108|NCT04353661|473813500|FG001|Overall Study|Protocol Violation|0|||
131596109|NCT04353661|473813501|FG002|Overall Study|Protocol Violation|1|||
131596110|NCT04353661|473813499|FG000|Overall Study|Study termination by the Sponsor|1|||
131596111|NCT04353661|473813500|FG001|Overall Study|Study termination by the Sponsor|1|||
131596112|NCT04353661|473813501|FG002|Overall Study|Study termination by the Sponsor|1|||
131596113|NCT00667251|473813502|FG000|Overall Study|Disease progression|232|||
131596114|NCT00667251|473813503|FG001|Overall Study|Disease progression|203|||
131596115|NCT00667251|473813502|FG000|Overall Study|Toxicity|44|||
131596116|NCT00667251|473813503|FG001|Overall Study|Toxicity|23|||
131596117|NCT00667251|473813502|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
131596118|NCT00667251|473813503|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
131596119|NCT00667251|473813502|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
131596120|NCT00667251|473813503|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
131596121|NCT00667251|473813502|FG000|Overall Study|Symptomatic progression|8|||
131596122|NCT00667251|473813503|FG001|Overall Study|Symptomatic progression|4|||
131596123|NCT00667251|473813502|FG000|Overall Study|Death|6|||
131596124|NCT00667251|473813503|FG001|Overall Study|Death|11|||
131596125|NCT00667251|473813502|FG000|Overall Study|Intercurrent illness|5|||
131439594|NCT05435339|473235561|FG001|Overall Study|Death|0|||
131439595|NCT05435339|473235562|FG002|Overall Study|Death|3|||
131439596|NCT05435339|473235563|FG003|Overall Study|Death|1|||
131439597|NCT05435339|473235564|FG004|Overall Study|Death|3|||
131439598|NCT05435339|473235565|FG005|Overall Study|Death|2|||
131439599|NCT05435339|473235566|FG006|Overall Study|Death|4|||
131439600|NCT05435339|473235567|FG007|Overall Study|Death|6|||
131439601|NCT05435339|473235560|FG000|Overall Study|Sponsor Decision|0|||
131439602|NCT05435339|473235561|FG001|Overall Study|Sponsor Decision|1|||
131439603|NCT05435339|473235562|FG002|Overall Study|Sponsor Decision|0|||
131439604|NCT05435339|473235563|FG003|Overall Study|Sponsor Decision|0|||
131439605|NCT05435339|473235564|FG004|Overall Study|Sponsor Decision|2|||
131439606|NCT05435339|473235565|FG005|Overall Study|Sponsor Decision|1|||
131439607|NCT05435339|473235566|FG006|Overall Study|Sponsor Decision|2|||
131439608|NCT05435339|473235567|FG007|Overall Study|Sponsor Decision|2|||
131439609|NCT05435339|473235560|FG000|Overall Study|Withdrawal by Subject|0|||
131439610|NCT05435339|473235561|FG001|Overall Study|Withdrawal by Subject|0|||
131439611|NCT05435339|473235562|FG002|Overall Study|Withdrawal by Subject|0|||
131439612|NCT05435339|473235563|FG003|Overall Study|Withdrawal by Subject|0|||
131439613|NCT05435339|473235564|FG004|Overall Study|Withdrawal by Subject|1|||
131439614|NCT05435339|473235565|FG005|Overall Study|Withdrawal by Subject|0|||
131439615|NCT05435339|473235566|FG006|Overall Study|Withdrawal by Subject|1|||
131596126|NCT00667251|473813503|FG001|Overall Study|Intercurrent illness|6|||
131596127|NCT00667251|473813502|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
131596128|NCT00667251|473813503|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
131596129|NCT00667251|473813502|FG000|Overall Study|Randomized not Treated|4|||
131596130|NCT00667251|473813503|FG001|Overall Study|Randomized not Treated|1|||
131596131|NCT02727699|473813504|FG000|Overall Study|Adverse Event|2|||
131596132|NCT02727699|473813505|FG001|Overall Study|Adverse Event|0|||
131596133|NCT02727699|473813504|FG000|Overall Study|Withdrawal by Subject|5|||
131596134|NCT02727699|473813505|FG001|Overall Study|Withdrawal by Subject|3|||
131596135|NCT02727699|473813504|FG000|Overall Study|Protocol Violation|0|||
131596136|NCT02727699|473813505|FG001|Overall Study|Protocol Violation|1|||
131596137|NCT02727699|473813504|FG000|Overall Study|Physician Decision|0|||
131596138|NCT02727699|473813505|FG001|Overall Study|Physician Decision|1|||
131596139|NCT02727699|473813504|FG000|Overall Study|Lost to Follow-up|1|||
131596140|NCT02727699|473813505|FG001|Overall Study|Lost to Follow-up|0|||
131596141|NCT02727699|473813504|FG000|Overall Study|Sponsor Decision|1|||
131596142|NCT02727699|473813505|FG001|Overall Study|Sponsor Decision|0|||
131596143|NCT02995434|473813510|FG000|Overall Study|Adverse Event|1|||
131596144|NCT02995434|473813511|FG001|Overall Study|Adverse Event|0|||
131596145|NCT02995434|473813510|FG000|Overall Study|Withdrawal by Subject|6|||
131596146|NCT02995434|473813511|FG001|Overall Study|Withdrawal by Subject|3|||
131596147|NCT03047928|473813512|FG000|Overall Study|Adverse Event|0|||
131596148|NCT03047928|473813513|FG001|Overall Study|Adverse Event|2|||
131596149|NCT03047928|473813514|FG002|Overall Study|Adverse Event|0|||
131596150|NCT03047928|473813512|FG000|Overall Study|Protocol Violation|0|||
131596151|NCT03047928|473813513|FG001|Overall Study|Protocol Violation|1|||
131596152|NCT03047928|473813514|FG002|Overall Study|Protocol Violation|0|||
131596153|NCT03047928|473813512|FG000|Overall Study|included in another protocol|0|||
131596154|NCT03047928|473813513|FG001|Overall Study|included in another protocol|1|||
131596155|NCT03047928|473813514|FG002|Overall Study|included in another protocol|0|||
131596156|NCT04179500|473813521|FG000|Treatment|Withdrawal by Subject|1|||
131596157|NCT04179500|473813521|FG000|Treatment|Adverse Event|2|||
131596158|NCT04179500|473813521|FG000|Treatment|pyrazinamide resistance|1|||
131596159|NCT04492007|473813522|FG000|Overall Study|Lost to Follow-up|1|||
131596160|NCT04492007|473813523|FG001|Overall Study|Lost to Follow-up|1|||
131596161|NCT04492007|473813524|FG002|Overall Study|Lost to Follow-up|2|||
131596162|NCT04492007|473813525|FG003|Overall Study|Lost to Follow-up|2|||
131596163|NCT04492007|473813522|FG000|Overall Study|Protocol Violation|1|||
131596164|NCT04492007|473813523|FG001|Overall Study|Protocol Violation|1|||
131439616|NCT05435339|473235567|FG007|Overall Study|Withdrawal by Subject|1|||
131439617|NCT03473236|473235574|FG000|Overall Study|Withdrawal by Subject|0|||
131439618|NCT03473236|473235575|FG001|Overall Study|Withdrawal by Subject|0|||
131439619|NCT03473236|473235576|FG002|Overall Study|Withdrawal by Subject|0|||
131439620|NCT03473236|473235577|FG003|Overall Study|Withdrawal by Subject|0|||
131596165|NCT04492007|473813524|FG002|Overall Study|Protocol Violation|1|||
131596166|NCT04492007|473813525|FG003|Overall Study|Protocol Violation|1|||
131596167|NCT04492007|473813522|FG000|Overall Study|Withdrawal by Subject|0|||
131596168|NCT04492007|473813523|FG001|Overall Study|Withdrawal by Subject|0|||
131596169|NCT04492007|473813524|FG002|Overall Study|Withdrawal by Subject|1|||
131596170|NCT04492007|473813525|FG003|Overall Study|Withdrawal by Subject|1|||
131596171|NCT04177823|473813528|FG000|Overall Study|Physician Decision|1|||
131596172|NCT04177823|473813528|FG000|Overall Study|Withdrawal by Subject|1|||
131596173|NCT04229992|473813529|FG000|Overall Study|Withdrawal by Subject|0|||
131596174|NCT04229992|473813530|FG001|Overall Study|Withdrawal by Subject|2|||
131596175|NCT04229992|473813531|FG002|Overall Study|Withdrawal by Subject|1|||
131439621|NCT03473236|473235578|FG004|Overall Study|Withdrawal by Subject|0|||
131439622|NCT03473236|473235579|FG005|Overall Study|Withdrawal by Subject|1|||
131596176|NCT04229992|473813532|FG003|Overall Study|Withdrawal by Subject|1|||
131596177|NCT04229992|473813529|FG000|Overall Study|Adverse Event|1|||
131596178|NCT04229992|473813530|FG001|Overall Study|Adverse Event|1|||
131596179|NCT04229992|473813531|FG002|Overall Study|Adverse Event|3|||
131596180|NCT04229992|473813532|FG003|Overall Study|Adverse Event|1|||
131596181|NCT04229992|473813529|FG000|Overall Study|Lost to Follow-up|0|||
131596182|NCT04229992|473813530|FG001|Overall Study|Lost to Follow-up|0|||
131596183|NCT04229992|473813531|FG002|Overall Study|Lost to Follow-up|0|||
131596184|NCT04229992|473813532|FG003|Overall Study|Lost to Follow-up|1|||
131596185|NCT05178316|473813535|FG000|Overall Study|Adverse Event|5|||
131596186|NCT05178316|473813536|FG001|Overall Study|Adverse Event|4|||
131596187|NCT05178316|473813537|FG002|Overall Study|Adverse Event|9|||
131596188|NCT05178316|473813535|FG000|Overall Study|Enrolled in Error|1|||
131596189|NCT05178316|473813536|FG001|Overall Study|Enrolled in Error|2|||
131596190|NCT05178316|473813537|FG002|Overall Study|Enrolled in Error|1|||
131596191|NCT05178316|473813535|FG000|Overall Study|Lost to Follow-up|3|||
131596192|NCT05178316|473813536|FG001|Overall Study|Lost to Follow-up|15|||
131596193|NCT05178316|473813537|FG002|Overall Study|Lost to Follow-up|11|||
131596194|NCT05178316|473813535|FG000|Overall Study|Noncompliance|1|||
131596195|NCT05178316|473813536|FG001|Overall Study|Noncompliance|3|||
131596196|NCT05178316|473813537|FG002|Overall Study|Noncompliance|1|||
131596197|NCT05178316|473813535|FG000|Overall Study|Other|0|||
131596198|NCT05178316|473813536|FG001|Overall Study|Other|1|||
131596199|NCT05178316|473813537|FG002|Overall Study|Other|0|||
131596200|NCT05178316|473813535|FG000|Overall Study|Physician Decision|0|||
131596201|NCT05178316|473813536|FG001|Overall Study|Physician Decision|3|||
131596202|NCT05178316|473813537|FG002|Overall Study|Physician Decision|2|||
131596203|NCT05178316|473813535|FG000|Overall Study|Protocol deviation|1|||
131596204|NCT05178316|473813536|FG001|Overall Study|Protocol deviation|0|||
131596205|NCT05178316|473813537|FG002|Overall Study|Protocol deviation|1|||
131596206|NCT05178316|473813535|FG000|Overall Study|Sponsor decision|1|||
131596207|NCT05178316|473813536|FG001|Overall Study|Sponsor decision|0|||
131596208|NCT05178316|473813537|FG002|Overall Study|Sponsor decision|1|||
131596209|NCT05178316|473813535|FG000|Overall Study|Withdrawal by Subject|5|||
131596210|NCT05178316|473813536|FG001|Overall Study|Withdrawal by Subject|11|||
131596211|NCT05178316|473813537|FG002|Overall Study|Withdrawal by Subject|5|||
131596212|NCT03457142|473813538|FG000|Overall Study|Death|1|||
131596213|NCT03770273|473813539|FG000|Overall Study|Adverse Event|2|||
131596214|NCT03770273|473813540|FG001|Overall Study|Adverse Event|0|||
131596215|NCT03770273|473813539|FG000|Overall Study|Lost to Follow-up|1|||
131596216|NCT03770273|473813540|FG001|Overall Study|Lost to Follow-up|1|||
131596217|NCT00418886|473813541|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
131596218|NCT00418886|473813542|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
131596219|NCT00418886|473813541|FG000|Randomized Period|Death|122|||
131596220|NCT00418886|473813542|FG001|Randomized Period|Death|147|||
131596221|NCT00418886|473813541|FG000|Randomized Period|Withdrawal by Subject|9|||
131596222|NCT00418886|473813542|FG001|Randomized Period|Withdrawal by Subject|10|||
131596223|NCT00418886|473813541|FG000|Randomized Period|Lost to Follow-up|4|||
131596224|NCT00418886|473813542|FG001|Randomized Period|Lost to Follow-up|6|||
131596225|NCT00418886|473813541|FG000|Randomized Period|withdrawn due to other reason|1|||
131439623|NCT03473236|473235580|FG006|Overall Study|Withdrawal by Subject|0|||
131439624|NCT03473236|473235581|FG007|Overall Study|Withdrawal by Subject|0|||
131439625|NCT03473236|473235582|FG008|Overall Study|Withdrawal by Subject|1|||
131439626|NCT03473236|473235583|FG009|Overall Study|Withdrawal by Subject|0|||
131439627|NCT03155724|473235584|FG000|Overall Study|Death|3|||
131439628|NCT03155724|473235584|FG000|Overall Study|Physician Decision|1|||
131439629|NCT03155724|473235584|FG000|Overall Study|Study closure|7|||
131439630|NCT04258423|473235588|FG000|Overall Study|Study Closure|2|||
131439631|NCT04258423|473235589|FG001|Overall Study|Study Closure|2|||
131596226|NCT00418886|473813542|FG001|Randomized Period|withdrawn due to other reason|0|||
131596227|NCT00418886|473813541|FG000|Randomized Period|randomised but no treatment received|0|||
131596228|NCT00418886|473813542|FG001|Randomized Period|randomised but no treatment received|1|||
131596229|NCT04060654|473813543|FG000|Overall Study|Withdrawal by Subject|1|||
131596230|NCT04060654|473813543|FG000|Overall Study|Lost to Follow-up|5|||
131596231|NCT03707951|473813544|FG000|Overall Study|Lost to Follow-up|8|||
131596232|NCT03707951|473813545|FG001|Overall Study|Lost to Follow-up|17|||
131596233|NCT03707951|473813544|FG000|Overall Study|Withdrawal by Subject|6|||
131596234|NCT03707951|473813545|FG001|Overall Study|Withdrawal by Subject|6|||
131596235|NCT04887129|473813546|FG000|Overall Study|Lost to Follow-up|0|||
131596236|NCT04887129|473813547|FG001|Overall Study|Lost to Follow-up|24|||
131596237|NCT04887129|473813546|FG000|Overall Study|Withdrawal by Subject|9|||
131596238|NCT04887129|473813547|FG001|Overall Study|Withdrawal by Subject|57|||
131596239|NCT04887129|473813546|FG000|Overall Study|Other|2|||
131596240|NCT04887129|473813547|FG001|Overall Study|Other|9|||
131596241|NCT04977947|473813550|FG000|Overall Study|Lost to Follow-up|1|||
131596242|NCT04977947|473813551|FG001|Overall Study|Lost to Follow-up|1|||
131596243|NCT03436290|473813552|FG000|Overall Study|Post-randomization Exclusion|1|||
131596244|NCT03436290|473813553|FG001|Overall Study|Post-randomization Exclusion|0|||
131596245|NCT03436290|473813552|FG000|Overall Study|Death|6|||
131899485|NCT00255164|474917667|FG002|Overall Study|Possible Barrett's Esophagus|8|||
131899486|NCT00255164|474917665|FG000|Overall Study|Esophageal Stricture|0|||
131899487|NCT00255164|474917666|FG001|Overall Study|Esophageal Stricture|0|||
131899488|NCT00255164|474917667|FG002|Overall Study|Esophageal Stricture|1|||
131899489|NCT00255164|474917665|FG000|Overall Study|Therapeutic Failure|11|||
131899490|NCT00255164|474917666|FG001|Overall Study|Therapeutic Failure|2|||
131899491|NCT00255164|474917667|FG002|Overall Study|Therapeutic Failure|3|||
131899492|NCT05219968|474917668|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
131899493|NCT05219968|474917669|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
131899494|NCT05219968|474917670|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
131899495|NCT05219968|474917671|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
131899496|NCT05219968|474917672|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
131899497|NCT05219968|474917668|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
131899498|NCT05219968|474917669|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
131899499|NCT05219968|474917670|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
131899500|NCT05219968|474917671|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
131899501|NCT05219968|474917672|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
131439632|NCT00321789|473235590|FG000|Overall Study|Lost to Follow-up|4|||
131439633|NCT00321789|473235591|FG001|Overall Study|Lost to Follow-up|7|||
131439634|NCT00321789|473235590|FG000|Overall Study|Withdrawal by Subject|6|||
131439635|NCT00321789|473235591|FG001|Overall Study|Withdrawal by Subject|6|||
131439636|NCT00321789|473235590|FG000|Overall Study|Protocol Violation|5|||
131439637|NCT00321789|473235591|FG001|Overall Study|Protocol Violation|3|||
131439638|NCT03309020|473235594|FG000|Overall Study|Death|1|||
131439639|NCT03309020|473235595|FG001|Overall Study|Death|0|||
131439640|NCT03309020|473235594|FG000|Overall Study|Did not undergo surgery|2|||
131439641|NCT03309020|473235595|FG001|Overall Study|Did not undergo surgery|1|||
131596246|NCT03436290|473813553|FG001|Overall Study|Death|0|||
131596247|NCT03436290|473813552|FG000|Overall Study|Withdrawal by Subject|4|||
131596248|NCT03436290|473813553|FG001|Overall Study|Withdrawal by Subject|0|||
131596249|NCT03436290|473813552|FG000|Overall Study|Protocol Violation|30|||
131899502|NCT05219968|474917668|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
131899503|NCT05219968|474917669|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
131439642|NCT02362724|473235596|FG000|Overall Study|Withdrawal by Subject|3|||
131439643|NCT02362724|473235597|FG001|Overall Study|Withdrawal by Subject|1|||
131439644|NCT02362724|473235596|FG000|Overall Study|Adverse Event|3|||
131439645|NCT02362724|473235597|FG001|Overall Study|Adverse Event|0|||
131439646|NCT02025179|473235598|FG000|Overall Study|Lost to Follow-up|0|||
131596250|NCT03436290|473813553|FG001|Overall Study|Protocol Violation|0|||
131596251|NCT04274764|473813554|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
131596252|NCT04274764|473813555|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
131596253|NCT02677298|473813560|FG000|Double Blind Phase|Adverse Event|2|||
131899504|NCT05219968|474917670|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
131899505|NCT05219968|474917671|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
131439647|NCT02025179|473235599|FG001|Overall Study|Lost to Follow-up|0|||
131596254|NCT02677298|473813561|FG001|Double Blind Phase|Adverse Event|1|||
131596255|NCT02677298|473813562|FG002|Double Blind Phase|Adverse Event|0|||
131596256|NCT02677298|473813560|FG000|Double Blind Phase|Physician Decision|5|||
131596257|NCT02677298|473813561|FG001|Double Blind Phase|Physician Decision|0|||
131596258|NCT02677298|473813562|FG002|Double Blind Phase|Physician Decision|0|||
131596259|NCT02677298|473813560|FG000|Double Blind Phase|Lost to Follow-up|11|||
131596260|NCT02677298|473813561|FG001|Double Blind Phase|Lost to Follow-up|7|||
131596261|NCT02677298|473813562|FG002|Double Blind Phase|Lost to Follow-up|0|||
131596262|NCT02677298|473813560|FG000|Double Blind Phase|Withdrawal by Subject|11|||
131596263|NCT02677298|473813561|FG001|Double Blind Phase|Withdrawal by Subject|8|||
131596264|NCT02677298|473813562|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131596265|NCT02677298|473813560|FG000|Double Blind Phase|No study drug available at site|0|||
131596266|NCT02677298|473813561|FG001|Double Blind Phase|No study drug available at site|1|||
131596267|NCT02677298|473813562|FG002|Double Blind Phase|No study drug available at site|0|||
131596268|NCT02677298|473813560|FG000|Open Label Phase|Adverse Event|0|||
131596269|NCT02677298|473813561|FG001|Open Label Phase|Adverse Event|0|||
131596270|NCT02677298|473813562|FG002|Open Label Phase|Adverse Event|4|||
131596271|NCT02677298|473813560|FG000|Open Label Phase|Physician Decision|0|||
131596272|NCT02677298|473813561|FG001|Open Label Phase|Physician Decision|0|||
131596273|NCT02677298|473813562|FG002|Open Label Phase|Physician Decision|1|||
131596274|NCT02677298|473813560|FG000|Open Label Phase|Lost to Follow-up|0|||
131596275|NCT02677298|473813561|FG001|Open Label Phase|Lost to Follow-up|0|||
131596276|NCT02677298|473813562|FG002|Open Label Phase|Lost to Follow-up|17|||
131596277|NCT02677298|473813560|FG000|Open Label Phase|Withdrawal by Subject|0|||
131596278|NCT02677298|473813561|FG001|Open Label Phase|Withdrawal by Subject|0|||
131596279|NCT02677298|473813562|FG002|Open Label Phase|Withdrawal by Subject|38|||
131596280|NCT03611621|473813563|FG000|Overall Study|Graft loss|3|||
131596281|NCT03611621|473813563|FG000|Overall Study|Death|3|||
131596282|NCT03611621|473813563|FG000|Overall Study|Lost to Follow-up|1|||
131596283|NCT03039023|473813577|FG000|Overall Study|Withdrawal by Subject|1|||
131596284|NCT03039023|473813578|FG001|Overall Study|Withdrawal by Subject|0|||
131596285|NCT03039023|473813579|FG002|Overall Study|Withdrawal by Subject|1|||
131596286|NCT03039023|473813580|FG003|Overall Study|Withdrawal by Subject|1|||
131596287|NCT03039023|473813581|FG004|Overall Study|Withdrawal by Subject|0|||
131596288|NCT03039023|473813577|FG000|Overall Study|Physician Decision|0|||
131596289|NCT03039023|473813578|FG001|Overall Study|Physician Decision|0|||
131596290|NCT03039023|473813579|FG002|Overall Study|Physician Decision|0|||
131596291|NCT03039023|473813580|FG003|Overall Study|Physician Decision|1|||
131596292|NCT03039023|473813581|FG004|Overall Study|Physician Decision|0|||
131596293|NCT04130438|473813582|FG000|Overall Study|Lost to Follow-up|0|||
131596294|NCT04130438|473813583|FG001|Overall Study|Lost to Follow-up|0|||
131439648|NCT02025179|473235600|FG002|Overall Study|Lost to Follow-up|1|||
131596295|NCT04130438|473813584|FG002|Overall Study|Lost to Follow-up|1|||
131596296|NCT04142788|473813586|FG000|Overall Study|Trial terminated prematurely|2|||
131596297|NCT04142788|473813587|FG001|Overall Study|Trial terminated prematurely|2|||
131596298|NCT05177848|473813593|FG000|Overall Study|Lost to Follow-up|1|||
131596299|NCT05177848|473813594|FG001|Overall Study|Lost to Follow-up|4|||
131596300|NCT05177848|473813593|FG000|Overall Study|Discontinued|2|||
131596301|NCT05177848|473813594|FG001|Overall Study|Discontinued|1|||
131596302|NCT05516147|473813595|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
131596303|NCT02035787|473813597|FG000|Overall Study- 12 Months|Adverse Event|3|||
131596304|NCT02035787|473813598|FG001|Overall Study- 12 Months|Adverse Event|0|||
131596305|NCT02035787|473813597|FG000|Overall Study- 12 Months|Complete response|4|||
131439649|NCT00402168|473235601|FG000|Randomized|Lost to Follow-up|1|||
131596306|NCT02035787|473813598|FG001|Overall Study- 12 Months|Complete response|1|||
131596307|NCT02035787|473813597|FG000|Overall Study- 12 Months|Protocol Violation|1|||
131596308|NCT02035787|473813598|FG001|Overall Study- 12 Months|Protocol Violation|1|||
131596309|NCT06414213|473813599|FG000|Overall Study|Lost to Follow-up|1|||
131596310|NCT06414213|473813600|FG001|Overall Study|Lost to Follow-up|1|||
131596311|NCT06414213|473813601|FG002|Overall Study|Lost to Follow-up|3|||
131596312|NCT03338933|473813602|FG000|Screening Visit|Lost to Follow-up|1|||
131596313|NCT03338933|473813603|FG001|Screening Visit|Lost to Follow-up|3|||
131596314|NCT03338933|473813604|FG002|Screening Visit|Lost to Follow-up|1|||
131596315|NCT03338933|473813605|FG003|Screening Visit|Lost to Follow-up|4|||
131596316|NCT03338933|473813602|FG000|Screening Visit|Screen fail after consent|2|||
131439650|NCT00402168|473235602|FG001|Randomized|Lost to Follow-up|0|||
131596317|NCT03338933|473813603|FG001|Screening Visit|Screen fail after consent|7|||
131596318|NCT03338933|473813604|FG002|Screening Visit|Screen fail after consent|1|||
131596319|NCT03338933|473813605|FG003|Screening Visit|Screen fail after consent|4|||
131596320|NCT03338933|473813602|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
131596321|NCT03338933|473813603|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
131596322|NCT03338933|473813604|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
131596323|NCT03338933|473813605|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
131596324|NCT03338933|473813602|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
131596325|NCT03338933|473813603|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
131596326|NCT03338933|473813604|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
131596327|NCT03338933|473813605|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
131596328|NCT03338933|473813602|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
131596329|NCT03338933|473813603|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
131596330|NCT03338933|473813604|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
131596331|NCT03338933|473813605|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
131596332|NCT04764448|473813607|FG000|Overall Study|Study terminated by sponsor|2|||
131596333|NCT04764448|473813608|FG001|Overall Study|Study terminated by sponsor|2|||
131596334|NCT04764448|473813609|FG002|Overall Study|Study terminated by sponsor|5|||
131596335|NCT04764448|473813607|FG000|Overall Study|Withdrawal by Subject|3|||
131596336|NCT04764448|473813608|FG001|Overall Study|Withdrawal by Subject|3|||
131596337|NCT04764448|473813609|FG002|Overall Study|Withdrawal by Subject|1|||
131596338|NCT01084876|473813610|FG000|Main Study Treatment Period|Adverse Event|12|||
131596339|NCT01084876|473813611|FG001|Main Study Treatment Period|Adverse Event|7|||
131596340|NCT01084876|473813610|FG000|Main Study Treatment Period|Disease Progression|41|||
131596341|NCT01084876|473813611|FG001|Main Study Treatment Period|Disease Progression|24|||
131596342|NCT01084876|473813610|FG000|Main Study Treatment Period|Physician Decision|2|||
131596343|NCT01084876|473813611|FG001|Main Study Treatment Period|Physician Decision|0|||
131596344|NCT01084876|473813610|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
131596345|NCT01084876|473813611|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
131596346|NCT01084876|473813610|FG000|Main Study Treatment Period|Other Reason|0|||
131596347|NCT01084876|473813611|FG001|Main Study Treatment Period|Other Reason|1|||
131596348|NCT01084876|473813610|FG000|Main Study Treatment Period|Other|0|||
131596349|NCT01084876|473813611|FG001|Main Study Treatment Period|Other|1|||
131596350|NCT01084876|473813610|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
131596351|NCT01084876|473813611|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
131596352|NCT01084876|473813610|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
131596353|NCT01084876|473813611|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
131596354|NCT01084876|473813610|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
131596355|NCT01084876|473813611|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
131596356|NCT01084876|473813610|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
131596357|NCT01084876|473813611|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
131439651|NCT00402168|473235601|FG000|Randomized|Withdrawal by Subject|0|||
131439652|NCT00402168|473235602|FG001|Randomized|Withdrawal by Subject|1|||
131596358|NCT01084876|473813610|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
131706473|NCT04062214|474207409|FG001|Week 36|Lost to Follow-up|46|||
131706474|NCT04062214|474207408|FG000|Week 36|Death|0|||
131706475|NCT04062214|474207409|FG001|Week 36|Death|1|||
131596359|NCT01084876|473813611|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
131706476|NCT00291551|474207410|FG000|Overall Study|Death|7|||
131596360|NCT01084876|473813610|FG000|Treatment Period Beyond Cycle 8|Other|6|||
131596361|NCT01084876|473813611|FG001|Treatment Period Beyond Cycle 8|Other|9|||
131596362|NCT04322643|473813621|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
131596363|NCT03891667|473813628|FG000|Overall Study|Physician Decision|1|||
131596364|NCT03891667|473813629|FG001|Overall Study|Physician Decision|1|||
131596365|NCT03891667|473813628|FG000|Overall Study|COVID related pause|1|||
131596366|NCT03891667|473813629|FG001|Overall Study|COVID related pause|0|||
131596367|NCT03891667|473813628|FG000|Overall Study|Withdrawal by Subject|0|||
131596368|NCT03891667|473813629|FG001|Overall Study|Withdrawal by Subject|1|||
131596369|NCT03891667|473813628|FG000|Overall Study|Adverse Event|0|||
131596370|NCT03891667|473813629|FG001|Overall Study|Adverse Event|1|||
131596371|NCT02924272|473813642|FG000|Overall Study|Site Terminated by Sponsor|4|||
131596372|NCT02924272|473813643|FG001|Overall Study|Site Terminated by Sponsor|1|||
131596373|NCT02924272|473813642|FG000|Overall Study|Withdrawal by Subject|2|||
131596374|NCT02924272|473813643|FG001|Overall Study|Withdrawal by Subject|0|||
131596375|NCT02924272|473813642|FG000|Overall Study|Adverse Event|3|||
131596376|NCT02924272|473813643|FG001|Overall Study|Adverse Event|0|||
131596377|NCT02924272|473813642|FG000|Overall Study|Progressive Disease|11|||
131596378|NCT02924272|473813643|FG001|Overall Study|Progressive Disease|8|||
131596379|NCT02924272|473813642|FG000|Overall Study|Clinical Deterioration|1|||
131596380|NCT02924272|473813643|FG001|Overall Study|Clinical Deterioration|0|||
131596381|NCT02924272|473813642|FG000|Overall Study|Death|1|||
131596382|NCT02924272|473813643|FG001|Overall Study|Death|0|||
131596383|NCT02924272|473813642|FG000|Overall Study|Reason Not Specified|1|||
131596384|NCT02924272|473813643|FG001|Overall Study|Reason Not Specified|0|||
131596385|NCT05434078|473813652|FG000|Overall Study|Lost to Follow-up|2|||
131596386|NCT05434078|473813653|FG001|Overall Study|Lost to Follow-up|1|||
131596387|NCT05434078|473813652|FG000|Overall Study|Withdrawal by Subject|1|||
131596388|NCT05434078|473813653|FG001|Overall Study|Withdrawal by Subject|0|||
131596389|NCT03829410|473813658|FG000|Overall Study|Adverse Event|1|||
131596390|NCT03829410|473813659|FG001|Overall Study|Adverse Event|0|||
131596391|NCT03829410|473813660|FG002|Overall Study|Adverse Event|1|||
131596392|NCT03829410|473813661|FG003|Overall Study|Adverse Event|4|||
131596393|NCT03829410|473813658|FG000|Overall Study|Physician Decision|0|||
131596394|NCT03829410|473813659|FG001|Overall Study|Physician Decision|0|||
131596395|NCT03829410|473813660|FG002|Overall Study|Physician Decision|0|||
131596396|NCT03829410|473813661|FG003|Overall Study|Physician Decision|2|||
131596397|NCT03829410|473813658|FG000|Overall Study|Disease Progressing|3|||
131596398|NCT03829410|473813659|FG001|Overall Study|Disease Progressing|4|||
131596399|NCT03829410|473813660|FG002|Overall Study|Disease Progressing|2|||
131596400|NCT03829410|473813661|FG003|Overall Study|Disease Progressing|31|||
131596401|NCT03829410|473813658|FG000|Overall Study|Miscellaneous|2|||
131596402|NCT03829410|473813659|FG001|Overall Study|Miscellaneous|4|||
131596403|NCT03829410|473813660|FG002|Overall Study|Miscellaneous|3|||
131596404|NCT03829410|473813661|FG003|Overall Study|Miscellaneous|10|||
131596405|NCT04924660|473813662|FG000|United States|Death|29|||
131596406|NCT04924660|473813663|FG001|United States|Death|32|||
131596407|NCT04924660|473813664|FG002|United States|Death|34|||
131596408|NCT04924660|473813665|FG003|United States|Death|25|||
131596409|NCT04924660|473813666|FG004|United States|Death|26|||
131596410|NCT04924660|473813667|FG005|United States|Death|23|||
131596411|NCT04924660|473813662|FG000|United States|Lost to Follow-up|15|||
131596412|NCT04924660|473813663|FG001|United States|Lost to Follow-up|10|||
131596413|NCT04924660|473813664|FG002|United States|Lost to Follow-up|13|||
131596414|NCT04924660|473813665|FG003|United States|Lost to Follow-up|5|||
131596415|NCT04924660|473813666|FG004|United States|Lost to Follow-up|19|||
131596416|NCT04924660|473813667|FG005|United States|Lost to Follow-up|20|||
131596417|NCT04924660|473813662|FG000|United States|Withdrawal by Subject|8|||
131596418|NCT04924660|473813663|FG001|United States|Withdrawal by Subject|3|||
131596419|NCT04924660|473813664|FG002|United States|Withdrawal by Subject|3|||
131596420|NCT04924660|473813665|FG003|United States|Withdrawal by Subject|3|||
131596421|NCT04924660|473813666|FG004|United States|Withdrawal by Subject|8|||
131596422|NCT04924660|473813667|FG005|United States|Withdrawal by Subject|4|||
131596423|NCT04924660|473813662|FG000|Spain|Death|0|||
131596424|NCT04924660|473813663|FG001|Spain|Death|0|||
131596425|NCT04924660|473813664|FG002|Spain|Death|0|||
131596426|NCT04924660|473813665|FG003|Spain|Death|0|||
131596427|NCT04924660|473813666|FG004|Spain|Death|0|||
131596428|NCT04924660|473813667|FG005|Spain|Death|2|||
131596429|NCT04924660|473813662|FG000|Spain|Lost to Follow-up|0|||
131596430|NCT04924660|473813663|FG001|Spain|Lost to Follow-up|0|||
131596431|NCT04924660|473813664|FG002|Spain|Lost to Follow-up|0|||
131596432|NCT04924660|473813665|FG003|Spain|Lost to Follow-up|0|||
131596433|NCT04924660|473813666|FG004|Spain|Lost to Follow-up|1|||
131596434|NCT04924660|473813667|FG005|Spain|Lost to Follow-up|0|||
131596435|NCT04924660|473813662|FG000|Brazil|Death|0|||
131596436|NCT04924660|473813663|FG001|Brazil|Death|0|||
131596437|NCT04924660|473813664|FG002|Brazil|Death|0|||
131596438|NCT04924660|473813665|FG003|Brazil|Death|0|||
131596439|NCT04924660|473813666|FG004|Brazil|Death|1|||
131596440|NCT04924660|473813667|FG005|Brazil|Death|0|||
131596441|NCT04924660|473813662|FG000|Italy|Lost to Follow-up|0|||
131596442|NCT04924660|473813663|FG001|Italy|Lost to Follow-up|0|||
131596443|NCT04924660|473813664|FG002|Italy|Lost to Follow-up|0|||
131596444|NCT04924660|473813665|FG003|Italy|Lost to Follow-up|0|||
131596445|NCT04924660|473813666|FG004|Italy|Lost to Follow-up|0|||
131596446|NCT04924660|473813667|FG005|Italy|Lost to Follow-up|1|||
131596447|NCT04924660|473813662|FG000|South Africa|Death|0|||
131596448|NCT04924660|473813663|FG001|South Africa|Death|0|||
131596449|NCT04924660|473813664|FG002|South Africa|Death|0|||
131596450|NCT04924660|473813665|FG003|South Africa|Death|0|||
131596451|NCT04924660|473813666|FG004|South Africa|Death|0|||
131596452|NCT04924660|473813667|FG005|South Africa|Death|1|||
131596453|NCT04924660|473813662|FG000|South Africa|Lost to Follow-up|0|||
131596454|NCT04924660|473813663|FG001|South Africa|Lost to Follow-up|0|||
131596455|NCT04924660|473813664|FG002|South Africa|Lost to Follow-up|0|||
131596456|NCT04924660|473813665|FG003|South Africa|Lost to Follow-up|0|||
131596457|NCT04924660|473813666|FG004|South Africa|Lost to Follow-up|0|||
131596458|NCT04924660|473813667|FG005|South Africa|Lost to Follow-up|1|||
131596459|NCT06205407|473813668|FG000|Period 2|Withdrawal by Subject|0|||
131596460|NCT06205407|473813669|FG001|Period 2|Withdrawal by Subject|1|||
131596461|NCT06205407|473813668|FG000|Period 2|Adverse Event|2|||
131596462|NCT06205407|473813669|FG001|Period 2|Adverse Event|1|||
131596463|NCT02577835|473813671|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
131596464|NCT04676022|473815378|FG000|Overall Study|Screen Failure/|1|||
131596465|NCT04676022|473815379|FG001|Overall Study|Screen Failure/|1|||
131596466|NCT04676022|473815380|FG002|Overall Study|Screen Failure/|85|||
131596467|NCT04676022|473815378|FG000|Overall Study|Lost to Follow-up|1|||
131596468|NCT04676022|473815379|FG001|Overall Study|Lost to Follow-up|1|||
131596469|NCT04676022|473815380|FG002|Overall Study|Lost to Follow-up|0|||
131596470|NCT04676022|473815378|FG000|Overall Study|Adverse Event|2|||
131596471|NCT04676022|473815379|FG001|Overall Study|Adverse Event|0|||
131596472|NCT04676022|473815380|FG002|Overall Study|Adverse Event|1|||
131596473|NCT04676022|473815378|FG000|Overall Study|Physician Decision|2|||
131596474|NCT04676022|473815379|FG001|Overall Study|Physician Decision|0|||
131596475|NCT04676022|473815380|FG002|Overall Study|Physician Decision|1|||
131596476|NCT04676022|473815378|FG000|Overall Study|Withdrawal by Subject|3|||
131596477|NCT04676022|473815379|FG001|Overall Study|Withdrawal by Subject|1|||
131596478|NCT04676022|473815380|FG002|Overall Study|Withdrawal by Subject|6|||
131596479|NCT04676022|473815378|FG000|Overall Study|Will not move forward with permanent implant|6|||
131596480|NCT04676022|473815379|FG001|Overall Study|Will not move forward with permanent implant|0|||
131596481|NCT04676022|473815380|FG002|Overall Study|Will not move forward with permanent implant|0|||
131439653|NCT00402168|473235601|FG000|Treatment (up to 12 Months)|Death|0|||
131596482|NCT04676022|473815378|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
131596483|NCT04676022|473815379|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
131596484|NCT04676022|473815380|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
131596485|NCT05409183|473815384|FG000|Complete Study|Adverse Event|1|||
131596486|NCT05409183|473815385|FG001|Complete Study|Adverse Event|2|||
131596487|NCT05409183|473815384|FG000|Complete Study|Withdrawal by Subject|3|||
131596488|NCT05409183|473815385|FG001|Complete Study|Withdrawal by Subject|0|||
131596489|NCT02274662|473815386|FG000|Overall Study|Death|1|||
131596490|NCT02274662|473815386|FG000|Overall Study|Lost to Follow-up|3|||
131596491|NCT03194217|473815387|FG000|Overall Study|Adverse Event|0|||
131596492|NCT03194217|473815388|FG001|Overall Study|Adverse Event|2|||
131596493|NCT03194217|473815389|FG002|Overall Study|Adverse Event|3|||
131596494|NCT03194217|473815390|FG003|Overall Study|Adverse Event|3|||
131596495|NCT03194217|473815387|FG000|Overall Study|Failure to meet randomisation criteria|0|||
131596496|NCT03194217|473815388|FG001|Overall Study|Failure to meet randomisation criteria|0|||
131596497|NCT03194217|473815389|FG002|Overall Study|Failure to meet randomisation criteria|0|||
131596498|NCT03194217|473815390|FG003|Overall Study|Failure to meet randomisation criteria|1|||
131596499|NCT03194217|473815387|FG000|Overall Study|Other|0|||
131596500|NCT03194217|473815388|FG001|Overall Study|Other|1|||
131596501|NCT03194217|473815389|FG002|Overall Study|Other|1|||
131596502|NCT03194217|473815390|FG003|Overall Study|Other|0|||
131596503|NCT02936752|473815391|FG000|Overall Study|Death|2|||
131596504|NCT02936752|473815392|FG001|Overall Study|Death|1|||
131596505|NCT02936752|473815391|FG000|Overall Study|Physician Decision|4|||
131899506|NCT05219968|474917672|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
131899507|NCT05219968|474917668|FG000|Week 24 Treatment Period|Adverse Event|3|||
131899508|NCT05219968|474917669|FG001|Week 24 Treatment Period|Adverse Event|0|||
131899509|NCT05219968|474917670|FG002|Week 24 Treatment Period|Adverse Event|0|||
131596506|NCT02936752|473815392|FG001|Overall Study|Physician Decision|0|||
131596507|NCT02936752|473815391|FG000|Overall Study|Withdrawal by Subject|0|||
131596508|NCT02936752|473815392|FG001|Overall Study|Withdrawal by Subject|2|||
131899510|NCT05219968|474917671|FG003|Week 24 Treatment Period|Adverse Event|0|||
131899511|NCT05219968|474917672|FG004|Week 24 Treatment Period|Adverse Event|0|||
131899512|NCT05219968|474917668|FG000|Week 24 Treatment Period|Physician Decision|0|||
131899513|NCT05219968|474917669|FG001|Week 24 Treatment Period|Physician Decision|1|||
131899514|NCT05219968|474917670|FG002|Week 24 Treatment Period|Physician Decision|0|||
131899515|NCT05219968|474917671|FG003|Week 24 Treatment Period|Physician Decision|0|||
131899516|NCT05219968|474917672|FG004|Week 24 Treatment Period|Physician Decision|0|||
131899517|NCT05219968|474917668|FG000|Week 24 Treatment Period|Other, not specified|3|||
131899518|NCT05219968|474917669|FG001|Week 24 Treatment Period|Other, not specified|0|||
131899519|NCT05219968|474917670|FG002|Week 24 Treatment Period|Other, not specified|0|||
131899520|NCT05219968|474917671|FG003|Week 24 Treatment Period|Other, not specified|0|||
131899521|NCT05219968|474917672|FG004|Week 24 Treatment Period|Other, not specified|0|||
131899522|NCT05219968|474917668|FG000|Safety Extension Period|Treatment administration failure|0|||
131899523|NCT05219968|474917669|FG001|Safety Extension Period|Treatment administration failure|0|||
131899524|NCT05219968|474917670|FG002|Safety Extension Period|Treatment administration failure|0|||
131899525|NCT05219968|474917671|FG003|Safety Extension Period|Treatment administration failure|1|||
131899526|NCT05219968|474917672|FG004|Safety Extension Period|Treatment administration failure|4|||
131439654|NCT00402168|473235602|FG001|Treatment (up to 12 Months)|Death|1|||
131596509|NCT04489771|473815395|FG000|Overall Study|Death|27|||
131596510|NCT04489771|473815396|FG001|Overall Study|Death|25|||
131899527|NCT05219968|474917668|FG000|Safety Extension Period|Bilateral dislodgement|0|||
131899528|NCT05219968|474917669|FG001|Safety Extension Period|Bilateral dislodgement|0|||
131439655|NCT00402168|473235601|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
131448274|NCT02079246|473272631|FG000|OLEX|Other: Caregiver unavailable|3|||
131596511|NCT04489771|473815395|FG000|Overall Study|Withdrawal by Subject|1|||
131899529|NCT05219968|474917670|FG002|Safety Extension Period|Bilateral dislodgement|4|||
131596512|NCT04489771|473815396|FG001|Overall Study|Withdrawal by Subject|0|||
131596513|NCT04489771|473815395|FG000|Overall Study|Participants Ongoing in Study|50|||
131596514|NCT04489771|473815396|FG001|Overall Study|Participants Ongoing in Study|51|||
131596515|NCT02979522|473815401|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
131596516|NCT02979522|473815402|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
131596517|NCT02979522|473815401|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
131596518|NCT02979522|473815402|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
131791458|NCT00408876|474518703|FG002|Overall Study|Protocol Violation|4|||
131791459|NCT00408876|474518704|FG003|Overall Study|Protocol Violation|3|||
131791460|NCT00408876|474518701|FG000|Overall Study|Physician Decision|1|||
131791461|NCT00408876|474518702|FG001|Overall Study|Physician Decision|0|||
131791462|NCT00408876|474518703|FG002|Overall Study|Physician Decision|3|||
131596519|NCT04509674|473815403|FG000|Overall Study|Not treated|33|||
131596520|NCT04509674|473815404|FG001|Overall Study|Not treated|26|||
131596521|NCT04509674|473815403|FG000|Overall Study|Protocol Violation|9|||
131596522|NCT04509674|473815404|FG001|Overall Study|Protocol Violation|10|||
131596523|NCT04509674|473815403|FG000|Overall Study|Lost to Follow-up|31|||
131596524|NCT04509674|473815404|FG001|Overall Study|Lost to Follow-up|39|||
131596525|NCT04509674|473815403|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
131596526|NCT04509674|473815404|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
131596527|NCT04509674|473815403|FG000|Overall Study|Adverse event, serious fatal event|11|||
131899530|NCT05219968|474917671|FG003|Safety Extension Period|Bilateral dislodgement|0|||
131899531|NCT05219968|474917672|FG004|Safety Extension Period|Bilateral dislodgement|1|||
131899532|NCT05219968|474917668|FG000|Safety Extension Period|Withdrawal by Subject|0|||
131899533|NCT05219968|474917669|FG001|Safety Extension Period|Withdrawal by Subject|0|||
131596528|NCT04509674|473815404|FG001|Overall Study|Adverse event, serious fatal event|4|||
131596529|NCT04509674|473815403|FG000|Overall Study|Adverse event, non-fatal event|107|||
131596530|NCT04509674|473815404|FG001|Overall Study|Adverse event, non-fatal event|118|||
131596531|NCT04509674|473815403|FG000|Overall Study|Other reason than listed|106|||
131596532|NCT04509674|473815404|FG001|Overall Study|Other reason than listed|95|||
131596533|NCT03197662|473815405|FG000|Overall Study|Withdrawn by family|0|||
131596534|NCT03197662|473815406|FG001|Overall Study|Withdrawn by family|2|||
131596535|NCT01214616|473815407|FG000|Overall Study|Progressive disease|2|||
131899534|NCT05219968|474917670|FG002|Safety Extension Period|Withdrawal by Subject|2|||
131899535|NCT05219968|474917671|FG003|Safety Extension Period|Withdrawal by Subject|0|||
131899536|NCT05219968|474917672|FG004|Safety Extension Period|Withdrawal by Subject|4|||
131899537|NCT05219968|474917668|FG000|Safety Extension Period|Adverse Event|0|||
131596536|NCT01214616|473815408|FG001|Overall Study|Progressive disease|2|||
131596537|NCT01214616|473815409|FG002|Overall Study|Progressive disease|2|||
131596538|NCT01214616|473815410|FG003|Overall Study|Progressive disease|4|||
131596539|NCT01214616|473815407|FG000|Overall Study|Dose limiting toxicity|0|||
131596540|NCT01214616|473815408|FG001|Overall Study|Dose limiting toxicity|2|||
131596541|NCT01214616|473815409|FG002|Overall Study|Dose limiting toxicity|0|||
131596542|NCT01214616|473815410|FG003|Overall Study|Dose limiting toxicity|0|||
131596543|NCT01214616|473815407|FG000|Overall Study|Other adverse events|0|||
131596544|NCT01214616|473815408|FG001|Overall Study|Other adverse events|1|||
131596545|NCT01214616|473815409|FG002|Overall Study|Other adverse events|1|||
131596546|NCT01214616|473815410|FG003|Overall Study|Other adverse events|1|||
131596547|NCT01214616|473815407|FG000|Overall Study|Withdrawal by Subject|1|||
131596548|NCT01214616|473815408|FG001|Overall Study|Withdrawal by Subject|0|||
131596549|NCT01214616|473815409|FG002|Overall Study|Withdrawal by Subject|0|||
131596550|NCT01214616|473815410|FG003|Overall Study|Withdrawal by Subject|1|||
131596551|NCT03721952|473815411|FG000|Overall Study|Lost to Follow-up|0|||
131596552|NCT03721952|473815412|FG001|Overall Study|Lost to Follow-up|0|||
131596553|NCT03721952|473815413|FG002|Overall Study|Lost to Follow-up|2|||
131596554|NCT03721952|473815414|FG003|Overall Study|Lost to Follow-up|0|||
131596555|NCT03721952|473815415|FG004|Overall Study|Lost to Follow-up|0|||
131596556|NCT03721952|473815411|FG000|Overall Study|Protocol Violation|0|||
131596557|NCT03721952|473815412|FG001|Overall Study|Protocol Violation|1|||
131596558|NCT03721952|473815413|FG002|Overall Study|Protocol Violation|0|||
131596559|NCT03721952|473815414|FG003|Overall Study|Protocol Violation|0|||
131596560|NCT03721952|473815415|FG004|Overall Study|Protocol Violation|0|||
131596561|NCT03721952|473815411|FG000|Overall Study|Withdrawal by Subject|1|||
131596562|NCT03721952|473815412|FG001|Overall Study|Withdrawal by Subject|0|||
131596563|NCT03721952|473815413|FG002|Overall Study|Withdrawal by Subject|40|||
131899538|NCT05219968|474917669|FG001|Safety Extension Period|Adverse Event|0|||
131596564|NCT03721952|473815414|FG003|Overall Study|Withdrawal by Subject|28|||
131596565|NCT03721952|473815415|FG004|Overall Study|Withdrawal by Subject|0|||
131596566|NCT05292365|473815418|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
131596567|NCT05292365|473815419|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
131706477|NCT00291551|474207410|FG000|Overall Study|Withdrawal by Subject|6|||
131706478|NCT04666038|474207411|FG000|Overall Study|Progressive Disease|2|||
131596568|NCT05292365|473815420|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
131596569|NCT05292365|473815421|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
131596570|NCT04495894|473815430|FG000|Overall Study|Withdrawal by Subject|2|||
131596571|NCT04495894|473815431|FG001|Overall Study|Withdrawal by Subject|0|||
131596572|NCT04495894|473815432|FG002|Overall Study|Withdrawal by Subject|2|||
131706479|NCT04666038|474207412|FG001|Overall Study|Progressive Disease|0|||
131448275|NCT02079246|473272632|FG001|OLEX|Other: Caregiver unavailable|0|||
131596573|NCT04495894|473815433|FG003|Overall Study|Withdrawal by Subject|3|||
131596574|NCT04495894|473815430|FG000|Overall Study|Early termination|0|||
131596575|NCT04495894|473815431|FG001|Overall Study|Early termination|0|||
131596576|NCT04495894|473815432|FG002|Overall Study|Early termination|3|||
131596577|NCT04495894|473815433|FG003|Overall Study|Early termination|0|||
131596578|NCT05579899|473815435|FG000|Overall Study|Lost to Follow-up|3|||
131596579|NCT05579899|473815436|FG001|Overall Study|Lost to Follow-up|1|||
131596580|NCT05579899|473815435|FG000|Overall Study|Adverse Event|0|||
131596581|NCT05579899|473815436|FG001|Overall Study|Adverse Event|3|||
131596582|NCT05579899|473815435|FG000|Overall Study|Pregnancy|0|||
131596583|NCT05579899|473815436|FG001|Overall Study|Pregnancy|1|||
131596584|NCT05579899|473815435|FG000|Overall Study|Withdrawal by Subject|0|||
131596585|NCT05579899|473815436|FG001|Overall Study|Withdrawal by Subject|3|||
131596586|NCT04064164|473815439|FG000|Overall Study|Withdrawal by Subject|8|||
131596587|NCT04064164|473815440|FG001|Overall Study|Withdrawal by Subject|8|||
131596588|NCT04059484|473815442|FG000|Overall Study|Adverse Event|2|||
131596589|NCT04059484|473815443|FG001|Overall Study|Adverse Event|5|||
131596590|NCT04059484|473815442|FG000|Overall Study|Withdrawal by Subject|5|||
131706480|NCT04666038|474207411|FG000|Overall Study|Death|38|||
131706481|NCT04666038|474207412|FG001|Overall Study|Death|32|||
131706482|NCT04666038|474207411|FG000|Overall Study|Withdrawal by Subject|10|||
131706483|NCT04666038|474207412|FG001|Overall Study|Withdrawal by Subject|19|||
131706484|NCT04666038|474207411|FG000|Overall Study|Lost to Follow-up|0|||
131706485|NCT04666038|474207412|FG001|Overall Study|Lost to Follow-up|2|||
131706486|NCT04666038|474207411|FG000|Overall Study|On Study Treatment|46|||
131706487|NCT04666038|474207412|FG001|Overall Study|On Study Treatment|5|||
131706488|NCT04666038|474207411|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
131706489|NCT04666038|474207412|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
131706490|NCT01512264|474207415|FG000|Overall Study|Lost to Follow-up|0|||
131706491|NCT01512264|474207416|FG001|Overall Study|Lost to Follow-up|0|||
131706492|NCT01512264|474207417|FG002|Overall Study|Lost to Follow-up|0|||
131706493|NCT01512264|474207418|FG003|Overall Study|Lost to Follow-up|1|||
131706494|NCT00705263|474207419|FG000|Overall Study|Withdrawal by Subject|2|||
131706495|NCT01752023|474207420|FG000|Overall Study|Physician Decision|2|||
131706496|NCT01752023|474207421|FG001|Overall Study|Physician Decision|1|||
131706497|NCT02440581|474207422|FG000|Overall Study|Death|0|||
131706498|NCT02440581|474207423|FG001|Overall Study|Death|0|||
131706499|NCT02440581|474207424|FG002|Overall Study|Death|7|||
131706500|NCT02440581|474207425|FG003|Overall Study|Death|5|||
131706501|NCT02440581|474207422|FG000|Overall Study|Transplanted|1|||
131706502|NCT02440581|474207423|FG001|Overall Study|Transplanted|0|||
131706503|NCT02440581|474207424|FG002|Overall Study|Transplanted|3|||
131706504|NCT02440581|474207425|FG003|Overall Study|Transplanted|2|||
131791463|NCT00408876|474518704|FG003|Overall Study|Physician Decision|0|||
131791464|NCT03760510|474518705|FG000|Overall Study|Not ventilated for 24 hours|105|||
131791465|NCT03760510|474518706|FG001|Overall Study|Not ventilated for 24 hours|97|||
131791466|NCT03361956|474518711|FG000|Overall Study|Adverse Event|1|||
131791467|NCT03361956|474518712|FG001|Overall Study|Adverse Event|0|||
131791468|NCT03361956|474518713|FG002|Overall Study|Adverse Event|1|||
131791469|NCT03361956|474518714|FG003|Overall Study|Adverse Event|1|||
131791470|NCT03361956|474518715|FG004|Overall Study|Adverse Event|0|||
131791471|NCT03361956|474518711|FG000|Overall Study|Other|0|||
131791472|NCT03361956|474518712|FG001|Overall Study|Other|0|||
131791473|NCT03361956|474518713|FG002|Overall Study|Other|0|||
131791474|NCT03361956|474518714|FG003|Overall Study|Other|1|||
131791475|NCT03361956|474518715|FG004|Overall Study|Other|0|||
131596591|NCT04059484|473815443|FG001|Overall Study|Withdrawal by Subject|3|||
131596592|NCT04059484|473815442|FG000|Overall Study|Progressive disease|112|||
131596593|NCT04059484|473815443|FG001|Overall Study|Progressive disease|112|||
131596594|NCT04059484|473815442|FG000|Overall Study|Other|8|||
131596595|NCT04059484|473815443|FG001|Overall Study|Other|3|||
131596596|NCT04059484|473815442|FG000|Overall Study|Ongoing|20|||
131596597|NCT04059484|473815443|FG001|Overall Study|Ongoing|20|||
131596598|NCT01000961|473815444|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131596599|NCT01000961|473815445|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131596600|NCT01000961|473815444|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
131596601|NCT01000961|473815445|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
131596602|NCT02949362|473815446|FG000|Retrospective Period|Inform consent not signed by participant|4|||
131596603|NCT02949362|473815447|FG001|Retrospective Period|Inform consent not signed by participant|1|||
131596604|NCT02949362|473815448|FG002|Retrospective Period|Inform consent not signed by participant|0|||
131596605|NCT02949362|473815449|FG003|Retrospective Period|Inform consent not signed by participant|0|||
131596606|NCT02949362|473815446|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
131596607|NCT02949362|473815447|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
131596608|NCT02949362|473815448|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
131596609|NCT02949362|473815449|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
131596610|NCT02949362|473815446|FG000|Prospective Period|Other|0|||
131596611|NCT02949362|473815447|FG001|Prospective Period|Other|0|||
131596612|NCT02949362|473815448|FG002|Prospective Period|Other|0|||
131596613|NCT02949362|473815449|FG003|Prospective Period|Other|4|||
131439656|NCT00402168|473235602|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
131439657|NCT00402168|473235601|FG000|Treatment (up to 12 Months)|non-specified|0|||
131439658|NCT00402168|473235602|FG001|Treatment (up to 12 Months)|non-specified|1|||
131439659|NCT00402168|473235601|FG000|Long Term (LT)|Adverse Event|1|||
131439660|NCT00402168|473235602|FG001|Long Term (LT)|Adverse Event|5|||
131439661|NCT00402168|473235601|FG000|Long Term (LT)|Withdrawal by Subject|4|||
131439662|NCT00402168|473235602|FG001|Long Term (LT)|Withdrawal by Subject|7|||
131439663|NCT00402168|473235601|FG000|Long Term (LT)|Pregnancy|0|||
131439664|NCT00402168|473235602|FG001|Long Term (LT)|Pregnancy|1|||
131439665|NCT00402168|473235601|FG000|Long Term (LT)|Lost to Follow-up|1|||
131439666|NCT00402168|473235602|FG001|Long Term (LT)|Lost to Follow-up|0|||
131439667|NCT00402168|473235601|FG000|Long Term (LT)|Death|4|||
131439668|NCT00402168|473235602|FG001|Long Term (LT)|Death|0|||
131439669|NCT00402168|473235601|FG000|Long Term (LT)|Lack of Efficacy|0|||
131439670|NCT00402168|473235602|FG001|Long Term (LT)|Lack of Efficacy|2|||
131439671|NCT00402168|473235601|FG000|Long Term (LT)|non-specified|1|||
131439672|NCT00402168|473235602|FG001|Long Term (LT)|non-specified|2|||
131439673|NCT00402168|473235601|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
131439674|NCT00402168|473235602|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
131596614|NCT04633122|473815456|FG000|Overall Study|Remained on treatment|19|||
131439675|NCT00402168|473235601|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
131596615|NCT04633122|473815457|FG001|Overall Study|Remained on treatment|14|||
131439676|NCT00402168|473235602|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
131596616|NCT04633122|473815456|FG000|Overall Study|Survival follow-up stopped|22|||
131596617|NCT04633122|473815457|FG001|Overall Study|Survival follow-up stopped|25|||
131596618|NCT03307343|473815458|FG000|Overall Study|Withdrawal by Subject|1|||
131596619|NCT03307343|473815459|FG001|Overall Study|Withdrawal by Subject|2|||
131706505|NCT02440581|474207422|FG000|Overall Study|Withdrawal by Subject|4|||
131706506|NCT02440581|474207423|FG001|Overall Study|Withdrawal by Subject|11|||
131706507|NCT02440581|474207424|FG002|Overall Study|Withdrawal by Subject|3|||
131706508|NCT02440581|474207425|FG003|Overall Study|Withdrawal by Subject|7|||
131706509|NCT03430986|474207426|FG000|24-week Control Period|Adverse Event|1|||
131706510|NCT03430986|474207427|FG001|24-week Control Period|Adverse Event|0|||
131439677|NCT00601835|473235608|FG000|Overall Study|Withdrawal by Subject|9|||
131439678|NCT00601835|473235609|FG001|Overall Study|Withdrawal by Subject|6|||
131706511|NCT03430986|474207426|FG000|24-week Control Period|Lost to Follow-up|2|||
131596620|NCT03307343|473815458|FG000|Overall Study|Pregnancy|0|||
131596621|NCT03307343|473815459|FG001|Overall Study|Pregnancy|2|||
131596622|NCT03307343|473815458|FG000|Overall Study|Physician Decision|1|||
131596623|NCT03307343|473815459|FG001|Overall Study|Physician Decision|0|||
131596624|NCT03307343|473815458|FG000|Overall Study|Lost to Follow-up|0|||
131596625|NCT03307343|473815459|FG001|Overall Study|Lost to Follow-up|2|||
131596626|NCT03382652|473815462|FG000|Overall Study|Lost to Follow-up|6|||
131596627|NCT03382652|473815462|FG000|Overall Study|Death|4|||
131596628|NCT03382652|473815462|FG000|Overall Study|Revision|5|||
131596629|NCT03382652|473815462|FG000|Overall Study|Patient withdrew|3|||
131596630|NCT03382652|473815462|FG000|Overall Study|Other reasons|21|||
131596631|NCT05794243|473815465|FG000|Overall Study|Withdrawal by Subject|1|||
131596632|NCT05794243|473815466|FG001|Overall Study|Withdrawal by Subject|0|||
131596633|NCT05794243|473815467|FG002|Overall Study|Withdrawal by Subject|1|||
131596634|NCT05794243|473815465|FG000|Overall Study|Physician Decision|0|||
131596635|NCT05794243|473815466|FG001|Overall Study|Physician Decision|3|||
131596636|NCT05794243|473815467|FG002|Overall Study|Physician Decision|1|||
131596637|NCT02761057|473815468|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
131596638|NCT02761057|473815469|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
131596639|NCT02761057|473815470|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
131596640|NCT02761057|473815471|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
131596641|NCT02761057|473815468|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
131596642|NCT02761057|473815469|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
131596643|NCT02761057|473815470|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
131596644|NCT02761057|473815471|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
131596645|NCT02761057|473815468|FG000|Overall Study|Currently On Study Treatment|0|||
131439679|NCT00601835|473235608|FG000|Overall Study|Physician Decision|1|||
131596646|NCT02761057|473815469|FG001|Overall Study|Currently On Study Treatment|3|||
131596647|NCT02761057|473815470|FG002|Overall Study|Currently On Study Treatment|0|||
131596648|NCT02761057|473815471|FG003|Overall Study|Currently On Study Treatment|0|||
131596649|NCT02761057|473815468|FG000|Overall Study|Adverse Event|11|||
131596650|NCT02761057|473815469|FG001|Overall Study|Adverse Event|9|||
131596651|NCT02761057|473815470|FG002|Overall Study|Adverse Event|5|||
131596652|NCT02761057|473815471|FG003|Overall Study|Adverse Event|3|||
131596653|NCT02761057|473815468|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
131596654|NCT02761057|473815469|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
131596655|NCT02761057|473815470|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
131596656|NCT02761057|473815471|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
131596657|NCT02761057|473815468|FG000|Overall Study|Progression/Relapse|29|||
131596658|NCT02761057|473815469|FG001|Overall Study|Progression/Relapse|27|||
131596659|NCT02761057|473815470|FG002|Overall Study|Progression/Relapse|20|||
131596660|NCT02761057|473815471|FG003|Overall Study|Progression/Relapse|23|||
131596661|NCT02761057|473815468|FG000|Overall Study|Death|2|||
131596662|NCT02761057|473815469|FG001|Overall Study|Death|2|||
131596663|NCT02761057|473815470|FG002|Overall Study|Death|1|||
131596664|NCT02761057|473815471|FG003|Overall Study|Death|1|||
131596665|NCT02761057|473815468|FG000|Overall Study|Other - Not Protocol Specified|2|||
131596666|NCT02761057|473815469|FG001|Overall Study|Other - Not Protocol Specified|1|||
131596667|NCT02761057|473815470|FG002|Overall Study|Other - Not Protocol Specified|2|||
131596668|NCT02761057|473815471|FG003|Overall Study|Other - Not Protocol Specified|0|||
131596669|NCT04209465|473815472|FG000|Overall Study|Adverse Event|0|||
131596670|NCT04209465|473815473|FG001|Overall Study|Adverse Event|0|||
131596671|NCT04209465|473815474|FG002|Overall Study|Adverse Event|0|||
131596672|NCT04209465|473815475|FG003|Overall Study|Adverse Event|0|||
131596673|NCT04209465|473815476|FG004|Overall Study|Adverse Event|0|||
131596674|NCT04209465|473815477|FG005|Overall Study|Adverse Event|1|||
131596675|NCT04209465|473815478|FG006|Overall Study|Adverse Event|0|||
131596676|NCT04209465|473815479|FG007|Overall Study|Adverse Event|0|||
131596677|NCT04209465|473815480|FG008|Overall Study|Adverse Event|1|||
131596678|NCT04209465|473815481|FG009|Overall Study|Adverse Event|0|||
131596679|NCT04209465|473815482|FG010|Overall Study|Adverse Event|2|||
131596680|NCT04209465|473815483|FG011|Overall Study|Adverse Event|1|||
131596681|NCT04209465|473815484|FG012|Overall Study|Adverse Event|1|||
131596682|NCT04209465|473815472|FG000|Overall Study|Death|1|||
131596683|NCT04209465|473815473|FG001|Overall Study|Death|0|||
131596684|NCT04209465|473815474|FG002|Overall Study|Death|0|||
131596685|NCT04209465|473815475|FG003|Overall Study|Death|0|||
131596686|NCT04209465|473815476|FG004|Overall Study|Death|2|||
131596687|NCT04209465|473815477|FG005|Overall Study|Death|7|||
131596688|NCT04209465|473815478|FG006|Overall Study|Death|2|||
131596689|NCT04209465|473815479|FG007|Overall Study|Death|2|||
131596690|NCT04209465|473815480|FG008|Overall Study|Death|1|||
131596691|NCT04209465|473815481|FG009|Overall Study|Death|1|||
131596692|NCT04209465|473815482|FG010|Overall Study|Death|1|||
131596693|NCT04209465|473815483|FG011|Overall Study|Death|0|||
131596694|NCT04209465|473815484|FG012|Overall Study|Death|10|||
131596695|NCT04209465|473815472|FG000|Overall Study|Physician Decision|0|||
131596696|NCT04209465|473815473|FG001|Overall Study|Physician Decision|1|||
131596697|NCT04209465|473815474|FG002|Overall Study|Physician Decision|0|||
131596698|NCT04209465|473815475|FG003|Overall Study|Physician Decision|0|||
131596699|NCT04209465|473815476|FG004|Overall Study|Physician Decision|0|||
131596700|NCT04209465|473815477|FG005|Overall Study|Physician Decision|0|||
131596701|NCT04209465|473815478|FG006|Overall Study|Physician Decision|0|||
131596702|NCT04209465|473815479|FG007|Overall Study|Physician Decision|0|||
131596703|NCT04209465|473815480|FG008|Overall Study|Physician Decision|0|||
131596704|NCT04209465|473815481|FG009|Overall Study|Physician Decision|0|||
131596705|NCT04209465|473815482|FG010|Overall Study|Physician Decision|0|||
131596706|NCT04209465|473815483|FG011|Overall Study|Physician Decision|0|||
131596707|NCT04209465|473815484|FG012|Overall Study|Physician Decision|0|||
131596708|NCT04209465|473815472|FG000|Overall Study|Progressive Disease|0|||
131596709|NCT04209465|473815473|FG001|Overall Study|Progressive Disease|0|||
131596710|NCT04209465|473815474|FG002|Overall Study|Progressive Disease|1|||
131596711|NCT04209465|473815475|FG003|Overall Study|Progressive Disease|2|||
131596712|NCT04209465|473815476|FG004|Overall Study|Progressive Disease|8|||
131596713|NCT04209465|473815477|FG005|Overall Study|Progressive Disease|5|||
131596714|NCT04209465|473815478|FG006|Overall Study|Progressive Disease|3|||
131596715|NCT04209465|473815479|FG007|Overall Study|Progressive Disease|4|||
131596716|NCT04209465|473815480|FG008|Overall Study|Progressive Disease|1|||
131596717|NCT04209465|473815481|FG009|Overall Study|Progressive Disease|3|||
131596718|NCT04209465|473815482|FG010|Overall Study|Progressive Disease|2|||
131596719|NCT04209465|473815483|FG011|Overall Study|Progressive Disease|1|||
131596720|NCT04209465|473815484|FG012|Overall Study|Progressive Disease|0|||
131596721|NCT04209465|473815472|FG000|Overall Study|Withdrawal by Subject|0|||
131596722|NCT04209465|473815473|FG001|Overall Study|Withdrawal by Subject|0|||
131596723|NCT04209465|473815474|FG002|Overall Study|Withdrawal by Subject|0|||
131596724|NCT04209465|473815475|FG003|Overall Study|Withdrawal by Subject|0|||
131596725|NCT04209465|473815476|FG004|Overall Study|Withdrawal by Subject|0|||
131596726|NCT04209465|473815477|FG005|Overall Study|Withdrawal by Subject|1|||
131596727|NCT04209465|473815478|FG006|Overall Study|Withdrawal by Subject|2|||
131596728|NCT04209465|473815479|FG007|Overall Study|Withdrawal by Subject|0|||
131596729|NCT04209465|473815480|FG008|Overall Study|Withdrawal by Subject|1|||
131596730|NCT04209465|473815481|FG009|Overall Study|Withdrawal by Subject|0|||
131596731|NCT04209465|473815482|FG010|Overall Study|Withdrawal by Subject|0|||
131596732|NCT04209465|473815483|FG011|Overall Study|Withdrawal by Subject|2|||
131596733|NCT04209465|473815484|FG012|Overall Study|Withdrawal by Subject|2|||
131596734|NCT04209465|473815472|FG000|Overall Study|Lost to Follow-up|0|||
131596735|NCT04209465|473815473|FG001|Overall Study|Lost to Follow-up|0|||
131596736|NCT04209465|473815474|FG002|Overall Study|Lost to Follow-up|0|||
131596737|NCT04209465|473815475|FG003|Overall Study|Lost to Follow-up|0|||
131596738|NCT04209465|473815476|FG004|Overall Study|Lost to Follow-up|0|||
131596739|NCT04209465|473815477|FG005|Overall Study|Lost to Follow-up|1|||
131596740|NCT04209465|473815478|FG006|Overall Study|Lost to Follow-up|0|||
131596741|NCT04209465|473815479|FG007|Overall Study|Lost to Follow-up|0|||
131596742|NCT04209465|473815480|FG008|Overall Study|Lost to Follow-up|1|||
131596743|NCT04209465|473815481|FG009|Overall Study|Lost to Follow-up|0|||
131596744|NCT04209465|473815482|FG010|Overall Study|Lost to Follow-up|0|||
131596745|NCT04209465|473815483|FG011|Overall Study|Lost to Follow-up|1|||
131596746|NCT04209465|473815484|FG012|Overall Study|Lost to Follow-up|0|||
131596747|NCT04209465|473815472|FG000|Overall Study|Started new therapy|0|||
131596748|NCT04209465|473815473|FG001|Overall Study|Started new therapy|0|||
131596749|NCT04209465|473815474|FG002|Overall Study|Started new therapy|0|||
131596750|NCT04209465|473815475|FG003|Overall Study|Started new therapy|0|||
131596751|NCT04209465|473815476|FG004|Overall Study|Started new therapy|0|||
131596752|NCT04209465|473815477|FG005|Overall Study|Started new therapy|1|||
131596753|NCT04209465|473815478|FG006|Overall Study|Started new therapy|0|||
131596754|NCT04209465|473815479|FG007|Overall Study|Started new therapy|0|||
131596755|NCT04209465|473815480|FG008|Overall Study|Started new therapy|0|||
131596756|NCT04209465|473815481|FG009|Overall Study|Started new therapy|0|||
131596757|NCT04209465|473815482|FG010|Overall Study|Started new therapy|0|||
131596758|NCT04209465|473815483|FG011|Overall Study|Started new therapy|0|||
131596759|NCT04209465|473815484|FG012|Overall Study|Started new therapy|0|||
131596760|NCT04209465|473815472|FG000|Overall Study|Study terminated early by sponsor|0|||
131596761|NCT04209465|473815473|FG001|Overall Study|Study terminated early by sponsor|0|||
131596762|NCT04209465|473815474|FG002|Overall Study|Study terminated early by sponsor|0|||
131596763|NCT04209465|473815475|FG003|Overall Study|Study terminated early by sponsor|0|||
131596764|NCT04209465|473815476|FG004|Overall Study|Study terminated early by sponsor|0|||
131596765|NCT04209465|473815477|FG005|Overall Study|Study terminated early by sponsor|0|||
131596766|NCT04209465|473815478|FG006|Overall Study|Study terminated early by sponsor|3|||
131596767|NCT04209465|473815479|FG007|Overall Study|Study terminated early by sponsor|0|||
131596768|NCT04209465|473815480|FG008|Overall Study|Study terminated early by sponsor|0|||
131596769|NCT04209465|473815481|FG009|Overall Study|Study terminated early by sponsor|0|||
131596770|NCT04209465|473815482|FG010|Overall Study|Study terminated early by sponsor|0|||
131899539|NCT05219968|474917670|FG002|Safety Extension Period|Adverse Event|2|||
131899540|NCT05219968|474917671|FG003|Safety Extension Period|Adverse Event|1|||
131899541|NCT05219968|474917672|FG004|Safety Extension Period|Adverse Event|1|||
131899542|NCT05219968|474917668|FG000|Safety Extension Period|Lost to Follow-up|0|||
131899543|NCT05219968|474917669|FG001|Safety Extension Period|Lost to Follow-up|0|||
131439680|NCT00601835|473235609|FG001|Overall Study|Physician Decision|0|||
131439681|NCT00601835|473235608|FG000|Overall Study|Lost to Follow-up|37|||
131439682|NCT00601835|473235609|FG001|Overall Study|Lost to Follow-up|5|||
131439683|NCT00601835|473235608|FG000|Overall Study|Adverse Event|1|||
131596771|NCT04209465|473815483|FG011|Overall Study|Study terminated early by sponsor|0|||
131596772|NCT04209465|473815484|FG012|Overall Study|Study terminated early by sponsor|3|||
131596773|NCT04209465|473815472|FG000|Overall Study|Other|0|||
131596774|NCT04209465|473815473|FG001|Overall Study|Other|0|||
131596775|NCT04209465|473815474|FG002|Overall Study|Other|0|||
131596776|NCT04209465|473815475|FG003|Overall Study|Other|0|||
131596777|NCT04209465|473815476|FG004|Overall Study|Other|0|||
131596778|NCT04209465|473815477|FG005|Overall Study|Other|0|||
131596779|NCT04209465|473815478|FG006|Overall Study|Other|0|||
131596780|NCT04209465|473815479|FG007|Overall Study|Other|0|||
131596781|NCT04209465|473815480|FG008|Overall Study|Other|1|||
131596782|NCT04209465|473815481|FG009|Overall Study|Other|0|||
131596783|NCT04209465|473815482|FG010|Overall Study|Other|0|||
131596784|NCT04209465|473815483|FG011|Overall Study|Other|0|||
131596785|NCT04209465|473815484|FG012|Overall Study|Other|0|||
131596786|NCT03097549|473815485|FG000|Overall Study|Withdrawal by Subject|1|||
131596787|NCT03097549|473815486|FG001|Overall Study|Withdrawal by Subject|0|||
131596788|NCT03097549|473815485|FG000|Overall Study|Lost to Follow-up|1|||
131596789|NCT03097549|473815486|FG001|Overall Study|Lost to Follow-up|0|||
131596790|NCT05783102|473815487|FG000|Overall Study|Lost to Follow-up|1|||
131596791|NCT05783102|473815487|FG000|Overall Study|Withdrawal by Subject|2|||
131596792|NCT04505904|473815488|FG000|Overall Study|Withdrawal by Subject|1|||
131899544|NCT05219968|474917670|FG002|Safety Extension Period|Lost to Follow-up|0|||
131596793|NCT04505904|473815489|FG001|Overall Study|Withdrawal by Subject|2|||
131596794|NCT04505904|473815490|FG002|Overall Study|Withdrawal by Subject|0|||
131596795|NCT04505904|473815491|FG003|Overall Study|Withdrawal by Subject|0|||
131899545|NCT05219968|474917671|FG003|Safety Extension Period|Lost to Follow-up|1|||
131899546|NCT05219968|474917672|FG004|Safety Extension Period|Lost to Follow-up|0|||
131596796|NCT04505904|473815488|FG000|Overall Study|Physician Decision|1|||
131596797|NCT04505904|473815489|FG001|Overall Study|Physician Decision|0|||
131596798|NCT04505904|473815490|FG002|Overall Study|Physician Decision|0|||
131439684|NCT00601835|473235609|FG001|Overall Study|Adverse Event|1|||
131596799|NCT04505904|473815491|FG003|Overall Study|Physician Decision|0|||
131596800|NCT04505904|473815488|FG000|Overall Study|Adverse Event|0|||
131596801|NCT04505904|473815489|FG001|Overall Study|Adverse Event|1|||
131439685|NCT00601835|473235608|FG000|Overall Study|Relocate|12|||
131439686|NCT00601835|473235609|FG001|Overall Study|Relocate|2|||
131899547|NCT04587336|474917673|FG000|Overall Study|Lost to Follow-up|1|||
131899548|NCT04587336|474917674|FG001|Overall Study|Lost to Follow-up|0|||
131899549|NCT00452439|474919321|FG000|Overall Study|Lost to Follow-up|1|||
131596802|NCT04505904|473815490|FG002|Overall Study|Adverse Event|0|||
131596803|NCT04505904|473815491|FG003|Overall Study|Adverse Event|0|||
131596804|NCT02547987|473815492|FG000|Overall Study|Withdrawal by Subject|1|||
131596805|NCT02547987|473815492|FG000|Overall Study|Adverse Event|2|||
131596806|NCT04282148|473815493|FG000|Overall Study|Death|7|||
131596807|NCT04282148|473815493|FG000|Overall Study|Withdrawal by Subject|1|||
131596808|NCT04282148|473815493|FG000|Overall Study|Physician Decision|1|||
131596809|NCT04925986|473815494|FG000|Overall Study|Death|0|||
131596810|NCT04925986|473815495|FG001|Overall Study|Death|0|||
131596811|NCT04925986|473815496|FG002|Overall Study|Death|2|||
131596812|NCT04925986|473815497|FG003|Overall Study|Death|0|||
131596813|NCT04925986|473815494|FG000|Overall Study|Lack of Efficacy|1|||
131596814|NCT04925986|473815495|FG001|Overall Study|Lack of Efficacy|2|||
131596815|NCT04925986|473815496|FG002|Overall Study|Lack of Efficacy|0|||
131596816|NCT04925986|473815497|FG003|Overall Study|Lack of Efficacy|1|||
131596817|NCT04925986|473815494|FG000|Overall Study|Withdrawal by Subject|0|||
131706512|NCT03430986|474207427|FG001|24-week Control Period|Lost to Follow-up|2|||
131596818|NCT04925986|473815495|FG001|Overall Study|Withdrawal by Subject|0|||
131596819|NCT04925986|473815496|FG002|Overall Study|Withdrawal by Subject|1|||
131596820|NCT04925986|473815497|FG003|Overall Study|Withdrawal by Subject|2|||
131596821|NCT06181760|473815498|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
131596822|NCT06181760|473815499|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
131596823|NCT06181760|473815500|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
131596824|NCT06181760|473815501|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
131596825|NCT03524612|473815502|FG000|Overall Study|Lack of Efficacy|10|||
131596826|NCT03524612|473815502|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
131596827|NCT03524612|473815502|FG000|Overall Study|Adverse Event|10|||
131596828|NCT03524612|473815502|FG000|Overall Study|Withdrawal by Subject|7|||
131596829|NCT03524612|473815502|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
131596830|NCT03524612|473815502|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
131596831|NCT03524612|473815502|FG000|Overall Study|New therapy for study indication|6|||
131596832|NCT03524612|473815502|FG000|Overall Study|Death|3|||
131596833|NCT03524612|473815502|FG000|Overall Study|Lost to Follow-up|2|||
131596834|NCT03524612|473815502|FG000|Overall Study|Protocol Violation|1|||
131596835|NCT04938492|473815504|FG000|Overall Study|Lost to Follow-up|17|||
131596836|NCT04938492|473815505|FG001|Overall Study|Lost to Follow-up|18|||
131596837|NCT02683447|473815506|FG000|Overall Study|Lost to Follow-up|2|||
131596838|NCT03448107|473815507|FG000|Overall Study|Lost to Follow-up|229|||
131596839|NCT03448107|473815508|FG001|Overall Study|Lost to Follow-up|258|||
131596840|NCT04025554|473815509|FG000|Overall Study|Adverse Event|3|||
131706513|NCT03430986|474207426|FG000|24-week Control Period|Withdrawal by Participant|5|||
131596841|NCT03115476|473815510|FG000|LP0084-1369|Death|1|||
131596842|NCT03115476|473815511|FG001|LP0084-1369|Death|0|||
131596843|NCT03115476|473815512|FG002|LP0084-1369|Death|2|||
131596844|NCT03115476|473815510|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
131596845|NCT03115476|473815511|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
131596846|NCT03115476|473815512|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
131596847|NCT05257486|473815516|FG000|Overall Study|Protocol Violation|3|||
131596848|NCT00613106|473815517|FG000|Overall Study|Adverse Event|3|||
131596849|NCT00613106|473815518|FG001|Overall Study|Adverse Event|1|||
131596850|NCT00613106|473815517|FG000|Overall Study|Withdrawal by Subject|6|||
131596851|NCT00613106|473815518|FG001|Overall Study|Withdrawal by Subject|3|||
131596852|NCT00613106|473815517|FG000|Overall Study|Lost to Follow-up|7|||
131596853|NCT00613106|473815518|FG001|Overall Study|Lost to Follow-up|2|||
131596854|NCT00613106|473815517|FG000|Overall Study|misc|4|||
131596855|NCT00613106|473815518|FG001|Overall Study|misc|3|||
131596856|NCT05296525|473815527|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
131596857|NCT05296525|473815528|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
131596858|NCT05296525|473815529|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
131596859|NCT05296525|473815530|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
131596860|NCT04065841|473815535|FG000|Overall Study|Adverse Event|4|||
131596861|NCT04065841|473815536|FG001|Overall Study|Adverse Event|2|||
131596862|NCT04065841|473815537|FG002|Overall Study|Adverse Event|10|||
131596863|NCT04065841|473815538|FG003|Overall Study|Adverse Event|1|||
131596864|NCT04065841|473815535|FG000|Overall Study|Lost to Follow-up|1|||
131596865|NCT04065841|473815536|FG001|Overall Study|Lost to Follow-up|2|||
131596866|NCT04065841|473815537|FG002|Overall Study|Lost to Follow-up|2|||
131596867|NCT04065841|473815538|FG003|Overall Study|Lost to Follow-up|2|||
131596868|NCT04065841|473815535|FG000|Overall Study|Physician Decision|1|||
131596869|NCT04065841|473815536|FG001|Overall Study|Physician Decision|0|||
131596870|NCT04065841|473815537|FG002|Overall Study|Physician Decision|0|||
131596871|NCT04065841|473815538|FG003|Overall Study|Physician Decision|0|||
131596872|NCT04065841|473815535|FG000|Overall Study|Protocol Violation|0|||
131596873|NCT04065841|473815536|FG001|Overall Study|Protocol Violation|1|||
131596874|NCT04065841|473815537|FG002|Overall Study|Protocol Violation|0|||
131596875|NCT04065841|473815538|FG003|Overall Study|Protocol Violation|0|||
131596876|NCT04065841|473815535|FG000|Overall Study|Study terminated by Sponsor|22|||
131596877|NCT04065841|473815536|FG001|Overall Study|Study terminated by Sponsor|16|||
131596878|NCT04065841|473815537|FG002|Overall Study|Study terminated by Sponsor|28|||
131596879|NCT04065841|473815538|FG003|Overall Study|Study terminated by Sponsor|17|||
131596880|NCT04065841|473815535|FG000|Overall Study|Withdrawal by Subject|1|||
131596881|NCT04065841|473815536|FG001|Overall Study|Withdrawal by Subject|1|||
131596882|NCT04065841|473815537|FG002|Overall Study|Withdrawal by Subject|2|||
131596883|NCT04065841|473815538|FG003|Overall Study|Withdrawal by Subject|0|||
131596884|NCT01420237|473815539|FG000|Overall Study|Death|13|||
131596885|NCT01420237|473815539|FG000|Overall Study|Withdrawal by Subject|41|||
131596886|NCT01420237|473815539|FG000|Overall Study|Lost to Follow-up|32|||
131596887|NCT01420237|473815539|FG000|Overall Study|Adverse Event|10|||
131596888|NCT01420237|473815539|FG000|Overall Study|Investigative Site Termination|43|||
131596889|NCT01420237|473815539|FG000|Overall Study|Censored because study device not implanted|21|||
131596890|NCT01420237|473815539|FG000|Overall Study|Censored because surgery not performed|2|||
131596891|NCT01420237|473815539|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
131596892|NCT01420237|473815539|FG000|Overall Study|Sponsor terminated study early|127|||
131439687|NCT03409796|473236864|FG000|Overall Study|Adverse Event|2|||
131596893|NCT04948697|473815540|FG000|Overall Study|Progressive disease|27|||
131596894|NCT04948697|473815541|FG001|Overall Study|Progressive disease|18|||
131596895|NCT04948697|473815540|FG000|Overall Study|Adverse Event|14|||
131596896|NCT04948697|473815541|FG001|Overall Study|Adverse Event|4|||
131596897|NCT04948697|473815540|FG000|Overall Study|Participant moved to long term extension study|7|||
131596898|NCT04948697|473815541|FG001|Overall Study|Participant moved to long term extension study|4|||
131596899|NCT04948697|473815540|FG000|Overall Study|Withdrawal by Subject|10|||
131596900|NCT04948697|473815541|FG001|Overall Study|Withdrawal by Subject|0|||
131596901|NCT04948697|473815540|FG000|Overall Study|Closed by Sponsor|3|||
131439688|NCT03409796|473236865|FG001|Overall Study|Adverse Event|0|||
131596902|NCT04948697|473815541|FG001|Overall Study|Closed by Sponsor|2|||
131596903|NCT04948697|473815540|FG000|Overall Study|Physician Decision|0|||
131596904|NCT04948697|473815541|FG001|Overall Study|Physician Decision|2|||
131596905|NCT04948697|473815540|FG000|Overall Study|Lost to Follow-up|0|||
131596906|NCT04948697|473815541|FG001|Overall Study|Lost to Follow-up|1|||
131596907|NCT04948697|473815540|FG000|Overall Study|Other-Miscellaneous|1|||
131596908|NCT04948697|473815541|FG001|Overall Study|Other-Miscellaneous|0|||
131439689|NCT03409796|473236864|FG000|Overall Study|Other|0|||
131596909|NCT04948697|473815540|FG000|Overall Study|Randomized but not treated|0|||
131596910|NCT04948697|473815541|FG001|Overall Study|Randomized but not treated|1|||
131596911|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
131596912|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
131596913|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
131596914|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
131596915|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
131596916|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
131596917|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
131596918|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
131596919|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
131596920|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
131596921|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
131596922|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
131596923|NCT04338061|473815542|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
131596924|NCT04338061|473815543|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
131596925|NCT04338061|473815542|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
131596926|NCT04338061|473815543|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
131596927|NCT04338061|473815542|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
131596928|NCT04338061|473815543|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
131596929|NCT04338061|473815542|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
131596930|NCT04338061|473815543|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
131596931|NCT04338061|473815542|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
131596932|NCT04338061|473815543|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
131596933|NCT04338061|473815542|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
131596934|NCT04338061|473815543|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
131596935|NCT04492722|473815544|FG000|Overall Study|Adverse Event|7|||
131596936|NCT04492722|473815545|FG001|Overall Study|Adverse Event|2|||
131596937|NCT04492722|473815546|FG002|Overall Study|Adverse Event|3|||
131596938|NCT04492722|473815547|FG003|Overall Study|Adverse Event|0|||
131596939|NCT04492722|473815544|FG000|Overall Study|Death|0|||
131596940|NCT04492722|473815545|FG001|Overall Study|Death|0|||
131596941|NCT04492722|473815546|FG002|Overall Study|Death|0|||
131596942|NCT04492722|473815547|FG003|Overall Study|Death|1|||
131596943|NCT04492722|473815544|FG000|Overall Study|Lost to Follow-up|0|||
131596944|NCT04492722|473815545|FG001|Overall Study|Lost to Follow-up|1|||
131596945|NCT04492722|473815546|FG002|Overall Study|Lost to Follow-up|0|||
131596946|NCT04492722|473815547|FG003|Overall Study|Lost to Follow-up|1|||
131596947|NCT04492722|473815544|FG000|Overall Study|Physician Decision|0|||
131596948|NCT04492722|473815545|FG001|Overall Study|Physician Decision|3|||
131596949|NCT04492722|473815546|FG002|Overall Study|Physician Decision|1|||
131596950|NCT04492722|473815547|FG003|Overall Study|Physician Decision|1|||
131596951|NCT04492722|473815544|FG000|Overall Study|Withdrawal by Subject|6|||
131596952|NCT04492722|473815545|FG001|Overall Study|Withdrawal by Subject|6|||
131596953|NCT04492722|473815546|FG002|Overall Study|Withdrawal by Subject|0|||
131596954|NCT04492722|473815547|FG003|Overall Study|Withdrawal by Subject|3|||
131596955|NCT04492722|473815544|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
131596956|NCT04492722|473815545|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
131596957|NCT04492722|473815546|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
131596958|NCT04492722|473815547|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
131596959|NCT04492722|473815544|FG000|Overall Study|Due to Covid-19 pandemic|7|||
131596960|NCT04492722|473815545|FG001|Overall Study|Due to Covid-19 pandemic|3|||
131596961|NCT04492722|473815546|FG002|Overall Study|Due to Covid-19 pandemic|7|||
131596962|NCT04492722|473815547|FG003|Overall Study|Due to Covid-19 pandemic|6|||
131596963|NCT04492722|473815544|FG000|Overall Study|Failure to meet randomisation criteria|2|||
131596964|NCT04492722|473815545|FG001|Overall Study|Failure to meet randomisation criteria|3|||
131596965|NCT04492722|473815546|FG002|Overall Study|Failure to meet randomisation criteria|4|||
131596966|NCT04492722|473815547|FG003|Overall Study|Failure to meet randomisation criteria|2|||
131596967|NCT04492722|473815544|FG000|Overall Study|Early termination from the study|54|||
131596968|NCT04492722|473815545|FG001|Overall Study|Early termination from the study|51|||
131596969|NCT04492722|473815546|FG002|Overall Study|Early termination from the study|50|||
131596970|NCT04492722|473815547|FG003|Overall Study|Early termination from the study|50|||
131596971|NCT04492722|473815544|FG000|Overall Study|Missing|3|||
131596972|NCT04492722|473815545|FG001|Overall Study|Missing|0|||
131596973|NCT04492722|473815546|FG002|Overall Study|Missing|0|||
131596974|NCT04492722|473815547|FG003|Overall Study|Missing|5|||
131596975|NCT04492722|473815544|FG000|Overall Study|Participants who did not receive treatment|0|||
131596976|NCT04492722|473815545|FG001|Overall Study|Participants who did not receive treatment|1|||
131596977|NCT04492722|473815546|FG002|Overall Study|Participants who did not receive treatment|4|||
131596978|NCT04492722|473815547|FG003|Overall Study|Participants who did not receive treatment|0|||
131596979|NCT03631784|473815549|FG000|Overall Study|Participants Ongoing|1|||
131596980|NCT03631784|473815550|FG001|Overall Study|Participants Ongoing|0|||
131596981|NCT03631784|473815549|FG000|Overall Study|Withdrawal by Subject|3|||
131596982|NCT03631784|473815550|FG001|Overall Study|Withdrawal by Subject|3|||
131596983|NCT03631784|473815549|FG000|Overall Study|Sponsor's Decision|36|||
131596984|NCT03631784|473815550|FG001|Overall Study|Sponsor's Decision|52|||
131596985|NCT03631784|473815549|FG000|Overall Study|Lost to Follow-up|1|||
131596986|NCT03631784|473815550|FG001|Overall Study|Lost to Follow-up|0|||
131596987|NCT03631784|473815549|FG000|Overall Study|Death|71|||
131596988|NCT03631784|473815550|FG001|Overall Study|Death|49|||
131596989|NCT05030233|473815551|FG000|Overall Study|withdrawn for transfer|1|||
131596990|NCT05030233|473815552|FG001|Overall Study|withdrawn for transfer|0|||
131596991|NCT03365882|473815553|FG000|Randomization|Still Receiving Protocol Treatment|2|||
131596992|NCT03365882|473815554|FG001|Randomization|Still Receiving Protocol Treatment|0|||
131596993|NCT03365882|473815553|FG000|Randomization|Adverse Event|1|||
131596994|NCT03365882|473815554|FG001|Randomization|Adverse Event|2|||
131596995|NCT03365882|473815553|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
131596996|NCT03365882|473815554|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
131596997|NCT03365882|473815553|FG000|Randomization|Progression/Relapse|21|||
131596998|NCT03365882|473815554|FG001|Randomization|Progression/Relapse|3|||
131596999|NCT03365882|473815553|FG000|Randomization|Death|1|||
131597000|NCT03365882|473815554|FG001|Randomization|Death|0|||
131597001|NCT03365882|473815553|FG000|Randomization|Other - Not Protocol Specified|1|||
131597002|NCT03365882|473815554|FG001|Randomization|Other - Not Protocol Specified|1|||
131597003|NCT03365882|473815553|FG000|Randomization|Major Protocol Deviation|0|||
131597004|NCT03365882|473815554|FG001|Randomization|Major Protocol Deviation|1|||
131597005|NCT03365882|473815553|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
131597006|NCT03365882|473815554|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
131597007|NCT03365882|473815553|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
131597008|NCT03365882|473815554|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
131597009|NCT03365882|473815553|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
131597010|NCT03365882|473815554|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
131597011|NCT03365882|473815553|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
131597012|NCT03365882|473815554|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
131597013|NCT04437615|473815555|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
131597014|NCT02921230|473817855|FG000|Overall Study|Withdrawal by Subject|20|||
131597015|NCT02921230|473817856|FG001|Overall Study|Withdrawal by Subject|8|||
131597016|NCT02921230|473817855|FG000|Overall Study|Death|12|||
131597017|NCT02921230|473817856|FG001|Overall Study|Death|3|||
131597018|NCT02921230|473817855|FG000|Overall Study|Protocol Violation|17|||
131597019|NCT02921230|473817856|FG001|Overall Study|Protocol Violation|6|||
131597020|NCT02921230|473817855|FG000|Overall Study|Early completion|5|||
131597021|NCT02921230|473817856|FG001|Overall Study|Early completion|1|||
131597022|NCT02921230|473817855|FG000|Overall Study|Pending data entry|1|||
131597023|NCT02921230|473817856|FG001|Overall Study|Pending data entry|0|||
131597024|NCT04971395|473817859|FG000|Overall Study|Withdrawal by Subject|0|||
131597025|NCT04971395|473817860|FG001|Overall Study|Withdrawal by Subject|1|||
131597026|NCT04971395|473817861|FG002|Overall Study|Withdrawal by Subject|0|||
131597027|NCT03953508|473817862|FG000|Baseline|Lost to Follow-up|3|||
131597028|NCT03953508|473817863|FG001|Baseline|Lost to Follow-up|2|||
131597029|NCT03953508|473817862|FG000|6-month Follow-up|Lost to Follow-up|62|||
131597030|NCT03953508|473817863|FG001|6-month Follow-up|Lost to Follow-up|70|||
131597031|NCT03771417|473817864|FG000|Overall Study|Withdrawal by Subject|1|||
131597032|NCT03771417|473817865|FG001|Overall Study|Withdrawal by Subject|0|||
131597033|NCT03771417|473817866|FG002|Overall Study|Withdrawal by Subject|0|||
131597034|NCT03771417|473817864|FG000|Overall Study|Covid-19 Shutdown|0|||
131597035|NCT03771417|473817865|FG001|Overall Study|Covid-19 Shutdown|1|||
131597036|NCT03771417|473817866|FG002|Overall Study|Covid-19 Shutdown|0|||
131597037|NCT02100813|473817867|FG000|Overall Study|Adverse Event|0|||
131597038|NCT02100813|473817868|FG001|Overall Study|Adverse Event|0|||
131597039|NCT02100813|473817869|FG002|Overall Study|Adverse Event|0|||
131597040|NCT02100813|473817870|FG003|Overall Study|Adverse Event|0|||
131597041|NCT02100813|473817871|FG004|Overall Study|Adverse Event|0|||
131597042|NCT02100813|473817872|FG005|Overall Study|Adverse Event|0|||
131597043|NCT02100813|473817873|FG006|Overall Study|Adverse Event|0|||
131597044|NCT02100813|473817874|FG007|Overall Study|Adverse Event|1|||
131597045|NCT04552223|473817875|FG000|Overall Study|Withdrawal by Subject|1|||
131597046|NCT04856163|473817876|FG000|Overall Study|Lost to Follow-up|97|||
131597047|NCT04856163|473817877|FG001|Overall Study|Lost to Follow-up|100|||
131597048|NCT00881621|473817881|FG000|Overall Study|Physician Decision|34|||
131597049|NCT03936322|473817886|FG000|Overall Study|Lost to Follow-up|1|||
131597050|NCT03936322|473817886|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
131597051|NCT02734290|473817888|FG000|Overall Study|Adverse Event|1|||
131597052|NCT02734290|473817889|FG001|Overall Study|Adverse Event|0|||
131597053|NCT02734290|473817888|FG000|Overall Study|Death|1|||
131597054|NCT02734290|473817889|FG001|Overall Study|Death|0|||
131597055|NCT03158129|473817890|FG000|Overall Study|Adverse Event|0|||
131597056|NCT03158129|473817891|FG001|Overall Study|Adverse Event|1|||
131706514|NCT03430986|474207427|FG001|24-week Control Period|Withdrawal by Participant|0|||
131706515|NCT03430986|474207426|FG000|24-week Control Period|Protocol Deviation|0|||
131706516|NCT03430986|474207427|FG001|24-week Control Period|Protocol Deviation|2|||
131706517|NCT03430986|474207426|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
131706518|NCT03430986|474207427|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
131706519|NCT03430986|474207426|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
131706520|NCT03430986|474207427|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
131706521|NCT03186989|474207428|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706522|NCT03186989|474207429|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706523|NCT03186989|474207430|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
131706524|NCT03186989|474207431|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
131706525|NCT03186989|474207432|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
131706526|NCT03186989|474207433|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706527|NCT03186989|474207434|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706528|NCT03186989|474207435|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706529|NCT03186989|474207436|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706530|NCT03186989|474207437|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706531|NCT03186989|474207438|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131706532|NCT03186989|474207428|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706533|NCT03186989|474207429|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706534|NCT03186989|474207430|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131597057|NCT03158129|473817892|FG002|Overall Study|Adverse Event|0|||
131597058|NCT03158129|473817893|FG003|Overall Study|Adverse Event|0|||
131597059|NCT03158129|473817890|FG000|Overall Study|Death|0|||
131597060|NCT03158129|473817891|FG001|Overall Study|Death|0|||
131597061|NCT03158129|473817892|FG002|Overall Study|Death|0|||
131597062|NCT03158129|473817893|FG003|Overall Study|Death|1|||
131597063|NCT03158129|473817890|FG000|Overall Study|High surgical risk|1|||
131706535|NCT03186989|474207431|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131597064|NCT03158129|473817891|FG001|Overall Study|High surgical risk|1|||
131597065|NCT03158129|473817892|FG002|Overall Study|High surgical risk|0|||
131597066|NCT03158129|473817893|FG003|Overall Study|High surgical risk|0|||
131597067|NCT03158129|473817890|FG000|Overall Study|Progression|1|||
131597068|NCT03158129|473817891|FG001|Overall Study|Progression|1|||
131597069|NCT03158129|473817892|FG002|Overall Study|Progression|0|||
131597070|NCT03158129|473817893|FG003|Overall Study|Progression|0|||
131597071|NCT03158129|473817890|FG000|Overall Study|Lack of resectability|0|||
131597072|NCT03158129|473817891|FG001|Overall Study|Lack of resectability|1|||
131597073|NCT03158129|473817892|FG002|Overall Study|Lack of resectability|0|||
131597074|NCT03158129|473817893|FG003|Overall Study|Lack of resectability|0|||
131597075|NCT03158129|473817890|FG000|Overall Study|Declined surgery|0|||
131597076|NCT03158129|473817891|FG001|Overall Study|Declined surgery|1|||
131597077|NCT03158129|473817892|FG002|Overall Study|Declined surgery|0|||
131597078|NCT03158129|473817893|FG003|Overall Study|Declined surgery|0|||
131597079|NCT03158129|473817890|FG000|Overall Study|No longer surgical candidate|0|||
131597080|NCT03158129|473817891|FG001|Overall Study|No longer surgical candidate|0|||
131597081|NCT03158129|473817892|FG002|Overall Study|No longer surgical candidate|0|||
131597082|NCT03158129|473817893|FG003|Overall Study|No longer surgical candidate|1|||
131597083|NCT04719390|473817907|FG000|Overall Study|Withdrawal by Subject|1|||
131597084|NCT04292223|473817908|FG000|Overall Study|Adverse Event|1|||
131597085|NCT04292223|473817908|FG000|Overall Study|Lost to Follow-up|1|||
131597086|NCT04292223|473817908|FG000|Overall Study|Noncompliance with study drug|2|||
131597087|NCT04292223|473817908|FG000|Overall Study|Patient moved out of the state|1|||
131597088|NCT00753545|473817909|FG000|Overall Study|Death|98|||
131597089|NCT00753545|473817910|FG001|Overall Study|Death|112|||
131597090|NCT00753545|473817909|FG000|Overall Study|Lost to Follow-up|2|||
131597091|NCT00753545|473817910|FG001|Overall Study|Lost to Follow-up|3|||
131706536|NCT03186989|474207432|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131597092|NCT00753545|473817909|FG000|Overall Study|Protocol Violation|1|||
131597093|NCT00753545|473817910|FG001|Overall Study|Protocol Violation|0|||
131706537|NCT03186989|474207433|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
131706538|NCT03186989|474207434|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706539|NCT03186989|474207435|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706540|NCT03186989|474207436|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706541|NCT03186989|474207437|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706542|NCT03186989|474207438|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131706543|NCT03186989|474207428|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706544|NCT03186989|474207429|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706545|NCT03186989|474207430|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706546|NCT03186989|474207431|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706547|NCT03186989|474207432|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706548|NCT03186989|474207433|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706549|NCT03186989|474207434|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
131706550|NCT03186989|474207435|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706551|NCT03186989|474207436|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706552|NCT03186989|474207437|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706553|NCT03186989|474207438|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131706554|NCT03186989|474207428|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706555|NCT03186989|474207429|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706556|NCT03186989|474207430|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706557|NCT03186989|474207431|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706558|NCT03186989|474207432|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706559|NCT03186989|474207433|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
131706560|NCT03186989|474207434|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
131706561|NCT03186989|474207435|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706562|NCT03186989|474207436|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
131706563|NCT03186989|474207437|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131706564|NCT03186989|474207438|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131899550|NCT00452439|474919322|FG001|Overall Study|Lost to Follow-up|1|||
131899551|NCT00452439|474919321|FG000|Overall Study|Refused Treatment|4|||
131597094|NCT00753545|473817909|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
131597095|NCT00753545|473817910|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
131597096|NCT04799899|473817912|FG000|Overall Study|Lost to Follow-up|2|||
131597097|NCT04799899|473817913|FG001|Overall Study|Lost to Follow-up|4|||
131597098|NCT04185298|473817915|FG000|Overall Study|Lost to Follow-up|1|||
131597099|NCT04185298|473817916|FG001|Overall Study|Lost to Follow-up|3|||
131597100|NCT04185298|473817915|FG000|Overall Study|Withdrawal by Subject|0|||
131597101|NCT04185298|473817916|FG001|Overall Study|Withdrawal by Subject|3|||
131597102|NCT01798498|473817917|FG000|Overall Study|Lost to Follow-up|1|||
131597103|NCT04963270|473817918|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
131597104|NCT04963270|473817919|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
131597105|NCT04963270|473817920|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
131597106|NCT04963270|473817921|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
131597107|NCT04963270|473817918|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131597108|NCT04963270|473817919|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
131597109|NCT04963270|473817920|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131597110|NCT04963270|473817921|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131597111|NCT04963270|473817918|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
131597112|NCT04963270|473817919|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131597113|NCT04963270|473817920|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131597114|NCT04963270|473817921|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131597115|NCT04963270|473817918|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
131597116|NCT04963270|473817919|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
131597117|NCT04963270|473817920|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
131597118|NCT04963270|473817921|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
131597119|NCT04963270|473817918|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
131597120|NCT04963270|473817919|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
131597121|NCT04963270|473817920|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
131597122|NCT04963270|473817921|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
131597123|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
131597124|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
131597125|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
131597126|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
131597127|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
131597128|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
131597129|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
131597130|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
131597131|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
131597132|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
131597133|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
131597134|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
131597135|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
131597136|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
131597137|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
131597138|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
131597139|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
131597140|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
131597141|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
131597142|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
131597143|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
131597144|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
131597145|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
131597146|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
131597147|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
131597148|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
131597149|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
131597150|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
131597151|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
131597152|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
131597153|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
131597154|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
131597155|NCT04963270|473817918|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
131597156|NCT04963270|473817919|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
131597157|NCT04963270|473817920|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
131597158|NCT04963270|473817921|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
131597159|NCT03896789|473817923|FG000|Baseline|Lost to Follow-up|1|||
131597160|NCT03896789|473817924|FG001|Baseline|Lost to Follow-up|2|||
131597161|NCT03896789|473817923|FG000|Baseline|Death|3|||
131597162|NCT03896789|473817924|FG001|Baseline|Death|6|||
131597163|NCT03896789|473817923|FG000|Post-Randomization|Lost to Follow-up|12|||
131597164|NCT03896789|473817924|FG001|Post-Randomization|Lost to Follow-up|11|||
131597165|NCT03896789|473817923|FG000|Post-Randomization|Death|12|||
131597166|NCT03896789|473817924|FG001|Post-Randomization|Death|13|||
131597167|NCT03447470|473817928|FG000|Overall Study|Death|0|||
131597168|NCT03447470|473817929|FG001|Overall Study|Death|1|||
131597169|NCT03447470|473817930|FG002|Overall Study|Death|3|||
131597170|NCT03447470|473817931|FG003|Overall Study|Death|0|||
131597171|NCT03447470|473817932|FG004|Overall Study|Death|1|||
131597172|NCT03447470|473817933|FG005|Overall Study|Death|0|||
131597173|NCT03447470|473817934|FG006|Overall Study|Death|3|||
131597174|NCT03447470|473817935|FG007|Overall Study|Death|3|||
131597175|NCT03447470|473817936|FG008|Overall Study|Death|1|||
131597176|NCT03447470|473817928|FG000|Overall Study|Withdrawal by Subject|1|||
131597177|NCT03447470|473817929|FG001|Overall Study|Withdrawal by Subject|0|||
131597178|NCT03447470|473817930|FG002|Overall Study|Withdrawal by Subject|0|||
131597179|NCT03447470|473817931|FG003|Overall Study|Withdrawal by Subject|0|||
131597180|NCT03447470|473817932|FG004|Overall Study|Withdrawal by Subject|1|||
131597181|NCT03447470|473817933|FG005|Overall Study|Withdrawal by Subject|0|||
131597182|NCT03447470|473817934|FG006|Overall Study|Withdrawal by Subject|1|||
131597183|NCT03447470|473817935|FG007|Overall Study|Withdrawal by Subject|1|||
131597184|NCT03447470|473817936|FG008|Overall Study|Withdrawal by Subject|3|||
131597185|NCT03447470|473817928|FG000|Overall Study|Treatment discontinued|3|||
131597186|NCT03447470|473817929|FG001|Overall Study|Treatment discontinued|2|||
131597187|NCT03447470|473817930|FG002|Overall Study|Treatment discontinued|4|||
131597188|NCT03447470|473817931|FG003|Overall Study|Treatment discontinued|6|||
131597189|NCT03447470|473817932|FG004|Overall Study|Treatment discontinued|2|||
131597190|NCT03447470|473817933|FG005|Overall Study|Treatment discontinued|1|||
131597191|NCT03447470|473817934|FG006|Overall Study|Treatment discontinued|2|||
131597192|NCT03447470|473817935|FG007|Overall Study|Treatment discontinued|4|||
131597193|NCT03447470|473817936|FG008|Overall Study|Treatment discontinued|3|||
131597194|NCT04295798|473817943|FG000|Overall Study|Lost to Follow-up|1|||
131597195|NCT04927364|473817944|FG000|Overall Study|Withdrawal by Subject|3|||
131597196|NCT04927364|473817944|FG000|Overall Study|Unable to complete preassessment MRI|1|||
131597197|NCT04624633|473817952|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
131597198|NCT04624633|473817953|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
131439690|NCT03409796|473236865|FG001|Overall Study|Other|1|||
131597199|NCT04624633|473817952|FG000|Overall Study|Death|1|||
131899552|NCT00452439|474919322|FG001|Overall Study|Refused Treatment|3|||
131899553|NCT00452439|474919321|FG000|Overall Study|Death|3|||
131899554|NCT00452439|474919322|FG001|Overall Study|Death|1|||
131899555|NCT00452439|474919321|FG000|Overall Study|Bone Marrow Transplant|0|||
131899556|NCT00452439|474919322|FG001|Overall Study|Bone Marrow Transplant|1|||
131899557|NCT00452439|474919321|FG000|Overall Study|Too Ill to Continue|0|||
131899558|NCT00452439|474919322|FG001|Overall Study|Too Ill to Continue|1|||
131899559|NCT00452439|474919321|FG000|Overall Study|Failed to achieve complete response|2|||
131899560|NCT00452439|474919322|FG001|Overall Study|Failed to achieve complete response|0|||
131899561|NCT00452439|474919321|FG000|Overall Study|Relapse|3|||
131899562|NCT00452439|474919322|FG001|Overall Study|Relapse|0|||
131899563|NCT00452439|474919321|FG000|Overall Study|Fracture|1|||
131899564|NCT00452439|474919322|FG001|Overall Study|Fracture|0|||
131899565|NCT03512353|474919323|FG000|Overall Study|Sponsor Decision|3|||
131899566|NCT03512353|474919323|FG000|Overall Study|Death|1|||
131899567|NCT01845597|474919324|FG000|Overall Study|Death|8|||
131899568|NCT01845597|474919324|FG000|Overall Study|Lost to Follow-up|22|||
131899569|NCT01302418|474919328|FG000|Overall Study|Protocol Violation|9|||
131899570|NCT01302418|474919328|FG000|Overall Study|Non-evaluable|9|||
131899571|NCT04194489|474919329|FG000|Overall Study|Withdrawal by Subject|5|||
131899572|NCT04194489|474919329|FG000|Overall Study|Lost to Follow-up|48|||
131899573|NCT00377637|474919330|FG000|Induction Phase|Adverse Event|12|||
131899574|NCT00377637|474919331|FG001|Induction Phase|Adverse Event|21|||
131899575|NCT00377637|474919332|FG002|Induction Phase|Adverse Event|0|||
131899576|NCT00377637|474919333|FG003|Induction Phase|Adverse Event|0|||
131899577|NCT00377637|474919330|FG000|Induction Phase|Deterioration/serum creatinine|2|||
131899578|NCT00377637|474919331|FG001|Induction Phase|Deterioration/serum creatinine|0|||
131899579|NCT00377637|474919332|FG002|Induction Phase|Deterioration/serum creatinine|0|||
131899580|NCT00377637|474919333|FG003|Induction Phase|Deterioration/serum creatinine|0|||
131899581|NCT00377637|474919330|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
131899582|NCT00377637|474919331|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
131899583|NCT00377637|474919332|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
131899584|NCT00377637|474919333|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
131899585|NCT00377637|474919330|FG000|Induction Phase|Lost to Follow-up|2|||
131899586|NCT00377637|474919331|FG001|Induction Phase|Lost to Follow-up|1|||
131899587|NCT00377637|474919332|FG002|Induction Phase|Lost to Follow-up|0|||
131899588|NCT00377637|474919333|FG003|Induction Phase|Lost to Follow-up|0|||
131899589|NCT00377637|474919330|FG000|Induction Phase|Death|1|||
131899590|NCT00377637|474919331|FG001|Induction Phase|Death|3|||
131899591|NCT00377637|474919332|FG002|Induction Phase|Death|0|||
131899592|NCT00377637|474919333|FG003|Induction Phase|Death|0|||
131899593|NCT00377637|474919330|FG000|Induction Phase|Withdrawal by Subject|5|||
131899594|NCT00377637|474919331|FG001|Induction Phase|Withdrawal by Subject|6|||
131899595|NCT00377637|474919332|FG002|Induction Phase|Withdrawal by Subject|0|||
131899596|NCT00377637|474919333|FG003|Induction Phase|Withdrawal by Subject|0|||
131899597|NCT00377637|474919330|FG000|Induction Phase|Physician Decision|3|||
131899598|NCT00377637|474919331|FG001|Induction Phase|Physician Decision|1|||
131899599|NCT00377637|474919332|FG002|Induction Phase|Physician Decision|0|||
131899600|NCT00377637|474919333|FG003|Induction Phase|Physician Decision|0|||
131899601|NCT00377637|474919330|FG000|Induction Phase|Sponsor decision|1|||
131899602|NCT00377637|474919331|FG001|Induction Phase|Sponsor decision|2|||
131899603|NCT00377637|474919332|FG002|Induction Phase|Sponsor decision|0|||
131899604|NCT00377637|474919333|FG003|Induction Phase|Sponsor decision|0|||
131899605|NCT00377637|474919330|FG000|Induction Phase|Non-Compliance|1|||
131899606|NCT00377637|474919331|FG001|Induction Phase|Non-Compliance|0|||
131899607|NCT00377637|474919332|FG002|Induction Phase|Non-Compliance|0|||
131899608|NCT00377637|474919333|FG003|Induction Phase|Non-Compliance|0|||
131899609|NCT00377637|474919330|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
131899610|NCT00377637|474919331|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
131899611|NCT00377637|474919332|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
131899612|NCT00377637|474919333|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
131899613|NCT00377637|474919330|FG000|Maintenance Phase|Adverse Event|0|||
131706565|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
131706566|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
131706567|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
131706568|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131706569|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131706570|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131706571|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131706572|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131899614|NCT00377637|474919331|FG001|Maintenance Phase|Adverse Event|0|||
131899615|NCT00377637|474919332|FG002|Maintenance Phase|Adverse Event|29|||
131597200|NCT04624633|473817953|FG001|Overall Study|Death|0|||
131597201|NCT04316871|473817954|FG000|Overall Study|Protocol Violation|2|||
131597202|NCT04316871|473817955|FG001|Overall Study|Protocol Violation|2|||
131597203|NCT04316871|473817956|FG002|Overall Study|Protocol Violation|2|||
131597204|NCT04316871|473817957|FG003|Overall Study|Protocol Violation|2|||
131597205|NCT04650269|473817958|FG000|Overall Study|Death|3|||
131597206|NCT04650269|473817958|FG000|Overall Study|Lost to Follow-up|6|||
131597207|NCT01437709|473817959|FG000|Overall Study|Adverse Event|0|||
131597208|NCT01437709|473817960|FG001|Overall Study|Adverse Event|1|||
131597209|NCT01437709|473817961|FG002|Overall Study|Adverse Event|0|||
131597210|NCT01437709|473817959|FG000|Overall Study|Pt trasnferred care|0|||
131597211|NCT01437709|473817960|FG001|Overall Study|Pt trasnferred care|1|||
131597212|NCT01437709|473817961|FG002|Overall Study|Pt trasnferred care|0|||
131597213|NCT05087992|473817962|FG000|Overall Study|Adverse Event|0|||
131597214|NCT05087992|473817963|FG001|Overall Study|Adverse Event|1|||
131597215|NCT05087992|473817964|FG002|Overall Study|Adverse Event|0|||
131597216|NCT05087992|473817962|FG000|Overall Study|Withdrawal by Subject|2|||
131597217|NCT05087992|473817963|FG001|Overall Study|Withdrawal by Subject|0|||
131597218|NCT05087992|473817964|FG002|Overall Study|Withdrawal by Subject|0|||
131597219|NCT05087992|473817962|FG000|Overall Study|clinical disease progression|3|||
131597220|NCT05087992|473817963|FG001|Overall Study|clinical disease progression|1|||
131597221|NCT05087992|473817964|FG002|Overall Study|clinical disease progression|0|||
131597222|NCT05087992|473817962|FG000|Overall Study|objective disease progression|4|||
131597223|NCT05087992|473817963|FG001|Overall Study|objective disease progression|1|||
131597224|NCT05087992|473817964|FG002|Overall Study|objective disease progression|0|||
131597225|NCT04091750|473817965|FG000|Overall Study|Adverse Event|4|||
131597226|NCT04091750|473817965|FG000|Overall Study|Withdrawal by Subject|1|||
131597227|NCT01842542|473817966|FG000|Overall Study|Withdrawal by Subject|2|||
131597228|NCT01842542|473817966|FG000|Overall Study|Lack of Efficacy|1|||
131597229|NCT01842542|473817966|FG000|Overall Study|Protocol Non-compliance|2|||
131597230|NCT01842542|473817966|FG000|Overall Study|Lost to Follow-up|1|||
131597231|NCT01824394|473817972|FG000|Overall Study|Early Termination|1|||
131597232|NCT01824394|473817973|FG001|Overall Study|Early Termination|1|||
131597233|NCT01824394|473817974|FG002|Overall Study|Early Termination|3|||
131597234|NCT01824394|473817972|FG000|Overall Study|Withdrawn due to Study Termination|91|||
131597235|NCT01824394|473817973|FG001|Overall Study|Withdrawn due to Study Termination|83|||
131597236|NCT01824394|473817974|FG002|Overall Study|Withdrawn due to Study Termination|41|||
131597237|NCT01824394|473817972|FG000|Overall Study|Lost to Follow-up|0|||
131597238|NCT01824394|473817973|FG001|Overall Study|Lost to Follow-up|9|||
131597239|NCT01824394|473817974|FG002|Overall Study|Lost to Follow-up|3|||
131597240|NCT01824394|473817972|FG000|Overall Study|Death|3|||
131597241|NCT01824394|473817973|FG001|Overall Study|Death|2|||
131597242|NCT01824394|473817974|FG002|Overall Study|Death|4|||
131597243|NCT01824394|473817972|FG000|Overall Study|Discontinued Subjects|1|||
131597244|NCT01824394|473817973|FG001|Overall Study|Discontinued Subjects|1|||
131597245|NCT01824394|473817974|FG002|Overall Study|Discontinued Subjects|2|||
131597246|NCT01824394|473817972|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
131597247|NCT01824394|473817973|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
131597248|NCT01824394|473817974|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
131597249|NCT05780437|473817975|FG000|Overall Study|Withdrawal by Subject|22|||
131597250|NCT05780437|473817976|FG001|Overall Study|Withdrawal by Subject|16|||
131597251|NCT03452579|473817977|FG000|Overall Study|Death|0|||
131597252|NCT03452579|473817978|FG001|Overall Study|Death|1|||
131597253|NCT03452579|473817977|FG000|Overall Study|Withdrawal by Subject|2|||
131597254|NCT03452579|473817978|FG001|Overall Study|Withdrawal by Subject|0|||
131597255|NCT03452579|473817977|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
131597256|NCT03452579|473817978|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
131597257|NCT03452579|473817977|FG000|Overall Study|Physician Decision|1|||
131597258|NCT03452579|473817978|FG001|Overall Study|Physician Decision|1|||
131597259|NCT03452579|473817977|FG000|Overall Study|Adverse Event|1|||
131597260|NCT03452579|473817978|FG001|Overall Study|Adverse Event|4|||
131597261|NCT04810650|473817981|FG000|Overall Study|Disenrolled in error|0|||
131597262|NCT04810650|473817982|FG001|Overall Study|Disenrolled in error|0|||
131597263|NCT04810650|473817983|FG002|Overall Study|Disenrolled in error|0|||
131597264|NCT04810650|473817984|FG003|Overall Study|Disenrolled in error|0|||
131597265|NCT04810650|473817985|FG004|Overall Study|Disenrolled in error|0|||
131597266|NCT04810650|473817986|FG005|Overall Study|Disenrolled in error|0|||
131597267|NCT04810650|473817987|FG006|Overall Study|Disenrolled in error|0|||
131597268|NCT04810650|473817988|FG007|Overall Study|Disenrolled in error|0|||
131597269|NCT04810650|473817989|FG008|Overall Study|Disenrolled in error|1|||
131597270|NCT04810650|473817990|FG009|Overall Study|Disenrolled in error|0|||
131597271|NCT04810650|473817991|FG010|Overall Study|Disenrolled in error|0|||
131597272|NCT04810650|473817992|FG011|Overall Study|Disenrolled in error|0|||
131597273|NCT04810650|473817993|FG012|Overall Study|Disenrolled in error|0|||
131597274|NCT04810650|473817994|FG013|Overall Study|Disenrolled in error|0|||
131597275|NCT04810650|473817981|FG000|Overall Study|Death|0|||
131597276|NCT04810650|473817982|FG001|Overall Study|Death|0|||
131597277|NCT04810650|473817983|FG002|Overall Study|Death|0|||
131597278|NCT04810650|473817984|FG003|Overall Study|Death|0|||
131597279|NCT04810650|473817985|FG004|Overall Study|Death|0|||
131597280|NCT04810650|473817986|FG005|Overall Study|Death|0|||
131597281|NCT04810650|473817987|FG006|Overall Study|Death|2|||
131597282|NCT04810650|473817988|FG007|Overall Study|Death|2|||
131899616|NCT00377637|474919333|FG003|Maintenance Phase|Adverse Event|43|||
131899617|NCT00377637|474919330|FG000|Maintenance Phase|Physician Decision|0|||
131899618|NCT00377637|474919331|FG001|Maintenance Phase|Physician Decision|0|||
131899619|NCT00377637|474919332|FG002|Maintenance Phase|Physician Decision|5|||
131899620|NCT00377637|474919333|FG003|Maintenance Phase|Physician Decision|4|||
131899621|NCT00377637|474919330|FG000|Maintenance Phase|Lost to Follow-up|0|||
131899622|NCT00377637|474919331|FG001|Maintenance Phase|Lost to Follow-up|0|||
131899623|NCT00377637|474919332|FG002|Maintenance Phase|Lost to Follow-up|3|||
131899624|NCT00377637|474919333|FG003|Maintenance Phase|Lost to Follow-up|1|||
131899625|NCT00377637|474919330|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131899626|NCT00377637|474919331|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131899627|NCT00377637|474919332|FG002|Maintenance Phase|Withdrawal by Subject|3|||
131899628|NCT00377637|474919333|FG003|Maintenance Phase|Withdrawal by Subject|3|||
131899629|NCT00377637|474919330|FG000|Maintenance Phase|Sponsor decision|0|||
131899630|NCT00377637|474919331|FG001|Maintenance Phase|Sponsor decision|0|||
131899631|NCT00377637|474919332|FG002|Maintenance Phase|Sponsor decision|2|||
131899632|NCT00377637|474919333|FG003|Maintenance Phase|Sponsor decision|3|||
131899633|NCT00377637|474919330|FG000|Maintenance Phase|Non-compliance|0|||
131899634|NCT00377637|474919331|FG001|Maintenance Phase|Non-compliance|0|||
131899635|NCT00377637|474919332|FG002|Maintenance Phase|Non-compliance|1|||
131899636|NCT00377637|474919333|FG003|Maintenance Phase|Non-compliance|1|||
131899637|NCT00377637|474919330|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
131899638|NCT00377637|474919331|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
131899639|NCT00377637|474919332|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
131899640|NCT00377637|474919333|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
131899641|NCT00377637|474919330|FG000|Maintenance Phase|Death|0|||
131899642|NCT00377637|474919331|FG001|Maintenance Phase|Death|0|||
131899643|NCT00377637|474919332|FG002|Maintenance Phase|Death|0|||
131899644|NCT00377637|474919333|FG003|Maintenance Phase|Death|1|||
131899645|NCT00994110|474919335|FG000|Overall Study|Withdrawal by Subject|9|||
131899646|NCT00994110|474919336|FG001|Overall Study|Withdrawal by Subject|9|||
131597283|NCT04810650|473817989|FG008|Overall Study|Death|0|||
131899647|NCT00994110|474919335|FG000|Overall Study|Not Treated|4|||
131597284|NCT04810650|473817990|FG009|Overall Study|Death|1|||
131597285|NCT04810650|473817991|FG010|Overall Study|Death|0|||
131597286|NCT04810650|473817992|FG011|Overall Study|Death|0|||
131899648|NCT00994110|474919336|FG001|Overall Study|Not Treated|8|||
131899649|NCT00994110|474919335|FG000|Overall Study|Adverse Event|1|||
131899650|NCT00994110|474919336|FG001|Overall Study|Adverse Event|0|||
131899651|NCT00994110|474919335|FG000|Overall Study|Patient not resected|41|||
131597287|NCT04810650|473817993|FG012|Overall Study|Death|2|||
131597288|NCT04810650|473817994|FG013|Overall Study|Death|1|||
131597289|NCT04810650|473817981|FG000|Overall Study|Moved/transferred care|0|||
131597290|NCT04810650|473817982|FG001|Overall Study|Moved/transferred care|0|||
131899652|NCT00994110|474919336|FG001|Overall Study|Patient not resected|52|||
131597291|NCT04810650|473817983|FG002|Overall Study|Moved/transferred care|0|||
131597292|NCT04810650|473817984|FG003|Overall Study|Moved/transferred care|0|||
131597293|NCT04810650|473817985|FG004|Overall Study|Moved/transferred care|0|||
131597294|NCT04810650|473817986|FG005|Overall Study|Moved/transferred care|0|||
131597295|NCT04810650|473817987|FG006|Overall Study|Moved/transferred care|0|||
131597296|NCT04810650|473817988|FG007|Overall Study|Moved/transferred care|1|||
131597297|NCT04810650|473817989|FG008|Overall Study|Moved/transferred care|12|||
131597298|NCT04810650|473817990|FG009|Overall Study|Moved/transferred care|10|||
131597299|NCT04810650|473817991|FG010|Overall Study|Moved/transferred care|0|||
131597300|NCT04810650|473817992|FG011|Overall Study|Moved/transferred care|0|||
131597301|NCT04810650|473817993|FG012|Overall Study|Moved/transferred care|0|||
131597302|NCT04810650|473817994|FG013|Overall Study|Moved/transferred care|0|||
131597303|NCT04810650|473817981|FG000|Overall Study|Lost to Follow-up|15|||
131597304|NCT04810650|473817982|FG001|Overall Study|Lost to Follow-up|12|||
131597305|NCT04810650|473817983|FG002|Overall Study|Lost to Follow-up|7|||
131597306|NCT04810650|473817984|FG003|Overall Study|Lost to Follow-up|9|||
131597307|NCT04810650|473817985|FG004|Overall Study|Lost to Follow-up|10|||
131597308|NCT04810650|473817986|FG005|Overall Study|Lost to Follow-up|6|||
131597309|NCT04810650|473817987|FG006|Overall Study|Lost to Follow-up|0|||
131597310|NCT04810650|473817988|FG007|Overall Study|Lost to Follow-up|0|||
131597311|NCT04810650|473817989|FG008|Overall Study|Lost to Follow-up|0|||
131597312|NCT04810650|473817990|FG009|Overall Study|Lost to Follow-up|0|||
131597313|NCT04810650|473817991|FG010|Overall Study|Lost to Follow-up|1|||
131597314|NCT04810650|473817992|FG011|Overall Study|Lost to Follow-up|0|||
131597315|NCT04810650|473817993|FG012|Overall Study|Lost to Follow-up|3|||
131597316|NCT04810650|473817994|FG013|Overall Study|Lost to Follow-up|9|||
131597317|NCT04810650|473817981|FG000|Overall Study|Participant declined|0|||
131597318|NCT04810650|473817982|FG001|Overall Study|Participant declined|0|||
131597319|NCT04810650|473817983|FG002|Overall Study|Participant declined|0|||
131597320|NCT04810650|473817984|FG003|Overall Study|Participant declined|0|||
131597321|NCT04810650|473817985|FG004|Overall Study|Participant declined|0|||
131597322|NCT04810650|473817986|FG005|Overall Study|Participant declined|0|||
131597323|NCT04810650|473817987|FG006|Overall Study|Participant declined|0|||
131597324|NCT04810650|473817988|FG007|Overall Study|Participant declined|0|||
131597325|NCT04810650|473817989|FG008|Overall Study|Participant declined|0|||
131597326|NCT04810650|473817990|FG009|Overall Study|Participant declined|0|||
131597327|NCT04810650|473817991|FG010|Overall Study|Participant declined|2|||
131597328|NCT04810650|473817992|FG011|Overall Study|Participant declined|0|||
131597329|NCT04810650|473817993|FG012|Overall Study|Participant declined|0|||
131597330|NCT04810650|473817994|FG013|Overall Study|Participant declined|0|||
131597331|NCT04788511|473817995|FG000|Overall Study|Withdrawal by Subject|2|||
131597332|NCT04788511|473817996|FG001|Overall Study|Withdrawal by Subject|1|||
131597333|NCT04788511|473817995|FG000|Overall Study|Lost to Follow-up|2|||
131597334|NCT04788511|473817996|FG001|Overall Study|Lost to Follow-up|7|||
131597335|NCT04788511|473817995|FG000|Overall Study|Death|3|||
131597336|NCT04788511|473817996|FG001|Overall Study|Death|4|||
131597337|NCT04652700|473817999|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
131597338|NCT04652700|473818000|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
131597339|NCT04652700|473817999|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
131597340|NCT04652700|473818000|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
131597341|NCT04652700|473817999|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
131597342|NCT04652700|473818000|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
131597343|NCT04652700|473817999|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
131597344|NCT04652700|473818000|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
131597345|NCT04652700|473817999|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
131597346|NCT04652700|473818000|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
131597347|NCT04652700|473817999|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
131597348|NCT04652700|473818000|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
131597349|NCT04652700|473817999|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
131597350|NCT04652700|473818000|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
131597351|NCT04652700|473817999|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
131597352|NCT04652700|473818000|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
131597353|NCT04652700|473817999|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
131597354|NCT04652700|473818000|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
131597355|NCT04187833|473818001|FG000|Overall Study|Withdrawal by Subject|1|||
131597356|NCT05603143|473818002|FG000|Overall Study|Withdrew consent|6|||
131597357|NCT05603143|473818003|FG001|Overall Study|Withdrew consent|2|||
131597358|NCT05603143|473818002|FG000|Overall Study|Randomized but never treated|0|||
131597359|NCT05603143|473818003|FG001|Overall Study|Randomized but never treated|3|||
131597360|NCT05603143|473818002|FG000|Overall Study|Adverse Event|2|||
131597361|NCT05603143|473818003|FG001|Overall Study|Adverse Event|0|||
131597362|NCT05603143|473818002|FG000|Overall Study|Death|0|||
131597363|NCT05603143|473818003|FG001|Overall Study|Death|1|||
131597364|NCT05603143|473818002|FG000|Overall Study|Investigator's discretion|1|||
131597365|NCT05603143|473818003|FG001|Overall Study|Investigator's discretion|0|||
131597366|NCT05603143|473818002|FG000|Overall Study|Lost to Follow-up|0|||
131597367|NCT05603143|473818003|FG001|Overall Study|Lost to Follow-up|1|||
131597368|NCT05603143|473818002|FG000|Overall Study|Protocol Violation|0|||
131597369|NCT05603143|473818003|FG001|Overall Study|Protocol Violation|1|||
131597370|NCT05008835|473818005|FG000|Overall Study|Adverse Event|5|||
131597371|NCT05008835|473818006|FG001|Overall Study|Adverse Event|2|||
131597372|NCT05008835|473818007|FG002|Overall Study|Adverse Event|1|||
131597373|NCT05008835|473818005|FG000|Overall Study|Lack of Efficacy|0|||
131597374|NCT05008835|473818006|FG001|Overall Study|Lack of Efficacy|0|||
131597375|NCT05008835|473818007|FG002|Overall Study|Lack of Efficacy|1|||
131597376|NCT05008835|473818005|FG000|Overall Study|Study terminated by sponsor|0|||
131597377|NCT05008835|473818006|FG001|Overall Study|Study terminated by sponsor|0|||
131597378|NCT05008835|473818007|FG002|Overall Study|Study terminated by sponsor|1|||
131597379|NCT05008835|473818005|FG000|Overall Study|Not further specified|3|||
131597380|NCT05008835|473818006|FG001|Overall Study|Not further specified|2|||
131597381|NCT05008835|473818007|FG002|Overall Study|Not further specified|1|||
131597382|NCT04171999|473818008|FG000|Overall Study|deemed ineligible after randomization|2|||
131597383|NCT04171999|473818009|FG001|Overall Study|deemed ineligible after randomization|1|||
131597384|NCT04277442|473818012|FG000|Overall Study|Death|1|||
131597385|NCT03544281|473818013|FG000|Main Study Phase|Death|3|||
131597386|NCT03544281|473818014|FG001|Main Study Phase|Death|2|||
131597387|NCT03544281|473818015|FG002|Main Study Phase|Death|6|||
131597388|NCT03544281|473818016|FG003|Main Study Phase|Death|8|||
131597389|NCT03544281|473818017|FG004|Main Study Phase|Death|4|||
131597390|NCT03544281|473818018|FG005|Main Study Phase|Death|2|||
131597391|NCT03544281|473818019|FG006|Main Study Phase|Death|4|||
131597392|NCT03544281|473818020|FG007|Main Study Phase|Death|5|||
131597393|NCT03544281|473818021|FG008|Main Study Phase|Death|5|||
131597394|NCT03544281|473818022|FG009|Main Study Phase|Death|8|||
131597395|NCT03544281|473818023|FG010|Main Study Phase|Death|6|||
131597396|NCT03544281|473818024|FG011|Main Study Phase|Death|4|||
131597397|NCT03544281|473818025|FG012|Main Study Phase|Death|0|||
131597398|NCT03544281|473818026|FG013|Main Study Phase|Death|0|||
131597399|NCT03544281|473818027|FG014|Main Study Phase|Death|0|||
131597400|NCT03544281|473818028|FG015|Main Study Phase|Death|0|||
131597401|NCT03544281|473818029|FG016|Main Study Phase|Death|0|||
131597402|NCT03544281|473818030|FG017|Main Study Phase|Death|0|||
131597403|NCT03544281|473818031|FG018|Main Study Phase|Death|0|||
131597404|NCT03544281|473818032|FG019|Main Study Phase|Death|0|||
131597405|NCT03544281|473818033|FG020|Main Study Phase|Death|0|||
131597406|NCT03544281|473818034|FG021|Main Study Phase|Death|0|||
131597407|NCT03544281|473818013|FG000|Main Study Phase|Lost to Follow-up|0|||
131597408|NCT03544281|473818014|FG001|Main Study Phase|Lost to Follow-up|0|||
131597409|NCT03544281|473818015|FG002|Main Study Phase|Lost to Follow-up|0|||
131597410|NCT03544281|473818016|FG003|Main Study Phase|Lost to Follow-up|0|||
131597411|NCT03544281|473818017|FG004|Main Study Phase|Lost to Follow-up|0|||
131597412|NCT03544281|473818018|FG005|Main Study Phase|Lost to Follow-up|0|||
131597413|NCT03544281|473818019|FG006|Main Study Phase|Lost to Follow-up|0|||
131597414|NCT03544281|473818020|FG007|Main Study Phase|Lost to Follow-up|0|||
131597415|NCT03544281|473818021|FG008|Main Study Phase|Lost to Follow-up|0|||
131597416|NCT03544281|473818022|FG009|Main Study Phase|Lost to Follow-up|0|||
131597417|NCT03544281|473818023|FG010|Main Study Phase|Lost to Follow-up|1|||
131597418|NCT03544281|473818024|FG011|Main Study Phase|Lost to Follow-up|0|||
131597419|NCT03544281|473818025|FG012|Main Study Phase|Lost to Follow-up|0|||
131597420|NCT03544281|473818026|FG013|Main Study Phase|Lost to Follow-up|0|||
131597421|NCT03544281|473818027|FG014|Main Study Phase|Lost to Follow-up|0|||
131597422|NCT03544281|473818028|FG015|Main Study Phase|Lost to Follow-up|0|||
131597423|NCT03544281|473818029|FG016|Main Study Phase|Lost to Follow-up|0|||
131597424|NCT03544281|473818030|FG017|Main Study Phase|Lost to Follow-up|0|||
131597425|NCT03544281|473818031|FG018|Main Study Phase|Lost to Follow-up|0|||
131597426|NCT03544281|473818032|FG019|Main Study Phase|Lost to Follow-up|0|||
131597427|NCT03544281|473818033|FG020|Main Study Phase|Lost to Follow-up|0|||
131597428|NCT03544281|473818034|FG021|Main Study Phase|Lost to Follow-up|0|||
131597429|NCT03544281|473818013|FG000|Main Study Phase|Physician Decision|0|||
131597430|NCT03544281|473818014|FG001|Main Study Phase|Physician Decision|0|||
131597431|NCT03544281|473818015|FG002|Main Study Phase|Physician Decision|0|||
131597432|NCT03544281|473818016|FG003|Main Study Phase|Physician Decision|0|||
131597433|NCT03544281|473818017|FG004|Main Study Phase|Physician Decision|0|||
131597434|NCT03544281|473818018|FG005|Main Study Phase|Physician Decision|0|||
131597435|NCT03544281|473818019|FG006|Main Study Phase|Physician Decision|0|||
131597436|NCT03544281|473818020|FG007|Main Study Phase|Physician Decision|1|||
131597437|NCT03544281|473818021|FG008|Main Study Phase|Physician Decision|0|||
131597438|NCT03544281|473818022|FG009|Main Study Phase|Physician Decision|0|||
131597439|NCT03544281|473818023|FG010|Main Study Phase|Physician Decision|0|||
131597440|NCT03544281|473818024|FG011|Main Study Phase|Physician Decision|0|||
131597441|NCT03544281|473818025|FG012|Main Study Phase|Physician Decision|0|||
131597442|NCT03544281|473818026|FG013|Main Study Phase|Physician Decision|0|||
131597443|NCT03544281|473818027|FG014|Main Study Phase|Physician Decision|0|||
131597444|NCT03544281|473818028|FG015|Main Study Phase|Physician Decision|0|||
131597445|NCT03544281|473818029|FG016|Main Study Phase|Physician Decision|0|||
131597446|NCT03544281|473818030|FG017|Main Study Phase|Physician Decision|0|||
131597447|NCT03544281|473818031|FG018|Main Study Phase|Physician Decision|0|||
131597448|NCT03544281|473818032|FG019|Main Study Phase|Physician Decision|0|||
131597449|NCT03544281|473818033|FG020|Main Study Phase|Physician Decision|0|||
131597450|NCT03544281|473818034|FG021|Main Study Phase|Physician Decision|0|||
131597451|NCT03544281|473818013|FG000|Main Study Phase|Withdrawal by Subject|2|||
131597452|NCT03544281|473818014|FG001|Main Study Phase|Withdrawal by Subject|0|||
131597453|NCT03544281|473818015|FG002|Main Study Phase|Withdrawal by Subject|1|||
131597454|NCT03544281|473818016|FG003|Main Study Phase|Withdrawal by Subject|2|||
131597455|NCT03544281|473818017|FG004|Main Study Phase|Withdrawal by Subject|0|||
131597456|NCT03544281|473818018|FG005|Main Study Phase|Withdrawal by Subject|0|||
131597457|NCT03544281|473818019|FG006|Main Study Phase|Withdrawal by Subject|0|||
131597458|NCT03544281|473818020|FG007|Main Study Phase|Withdrawal by Subject|0|||
131597459|NCT03544281|473818021|FG008|Main Study Phase|Withdrawal by Subject|2|||
131597460|NCT03544281|473818022|FG009|Main Study Phase|Withdrawal by Subject|3|||
131597461|NCT03544281|473818023|FG010|Main Study Phase|Withdrawal by Subject|0|||
131597462|NCT03544281|473818024|FG011|Main Study Phase|Withdrawal by Subject|4|||
131597463|NCT03544281|473818025|FG012|Main Study Phase|Withdrawal by Subject|0|||
131597464|NCT03544281|473818026|FG013|Main Study Phase|Withdrawal by Subject|0|||
131597465|NCT03544281|473818027|FG014|Main Study Phase|Withdrawal by Subject|0|||
131597466|NCT03544281|473818028|FG015|Main Study Phase|Withdrawal by Subject|0|||
131597467|NCT03544281|473818029|FG016|Main Study Phase|Withdrawal by Subject|0|||
131597468|NCT03544281|473818030|FG017|Main Study Phase|Withdrawal by Subject|0|||
131597469|NCT03544281|473818031|FG018|Main Study Phase|Withdrawal by Subject|0|||
131597470|NCT03544281|473818032|FG019|Main Study Phase|Withdrawal by Subject|0|||
131597471|NCT03544281|473818033|FG020|Main Study Phase|Withdrawal by Subject|0|||
131597472|NCT03544281|473818034|FG021|Main Study Phase|Withdrawal by Subject|0|||
131597473|NCT03544281|473818013|FG000|Main Study Phase|Ongoing|3|||
131597474|NCT03544281|473818014|FG001|Main Study Phase|Ongoing|1|||
131597475|NCT03544281|473818015|FG002|Main Study Phase|Ongoing|2|||
131597476|NCT03544281|473818016|FG003|Main Study Phase|Ongoing|4|||
131597477|NCT03544281|473818017|FG004|Main Study Phase|Ongoing|2|||
131597478|NCT03544281|473818018|FG005|Main Study Phase|Ongoing|4|||
131597479|NCT03544281|473818019|FG006|Main Study Phase|Ongoing|4|||
131597480|NCT03544281|473818020|FG007|Main Study Phase|Ongoing|0|||
131597481|NCT03544281|473818021|FG008|Main Study Phase|Ongoing|2|||
131597482|NCT03544281|473818022|FG009|Main Study Phase|Ongoing|2|||
131597483|NCT03544281|473818023|FG010|Main Study Phase|Ongoing|1|||
131597484|NCT03544281|473818024|FG011|Main Study Phase|Ongoing|0|||
131597485|NCT03544281|473818025|FG012|Main Study Phase|Ongoing|0|||
131597486|NCT03544281|473818026|FG013|Main Study Phase|Ongoing|0|||
131597487|NCT03544281|473818027|FG014|Main Study Phase|Ongoing|0|||
131597488|NCT03544281|473818028|FG015|Main Study Phase|Ongoing|0|||
131597489|NCT03544281|473818029|FG016|Main Study Phase|Ongoing|0|||
131597490|NCT03544281|473818030|FG017|Main Study Phase|Ongoing|0|||
131597491|NCT03544281|473818031|FG018|Main Study Phase|Ongoing|0|||
131597492|NCT03544281|473818032|FG019|Main Study Phase|Ongoing|0|||
131597493|NCT03544281|473818033|FG020|Main Study Phase|Ongoing|0|||
131597494|NCT03544281|473818034|FG021|Main Study Phase|Ongoing|0|||
131597495|NCT03544281|473818013|FG000|Main Study Phase|Investigator Site Closed|0|||
131597496|NCT03544281|473818014|FG001|Main Study Phase|Investigator Site Closed|0|||
131597497|NCT03544281|473818015|FG002|Main Study Phase|Investigator Site Closed|0|||
131597498|NCT03544281|473818016|FG003|Main Study Phase|Investigator Site Closed|0|||
131439691|NCT02412306|473236868|FG000|Overall Study|Lost to Follow-up|0|||
131597499|NCT03544281|473818017|FG004|Main Study Phase|Investigator Site Closed|0|||
131597500|NCT03544281|473818018|FG005|Main Study Phase|Investigator Site Closed|0|||
131597501|NCT03544281|473818019|FG006|Main Study Phase|Investigator Site Closed|0|||
131597502|NCT03544281|473818020|FG007|Main Study Phase|Investigator Site Closed|0|||
131597503|NCT03544281|473818021|FG008|Main Study Phase|Investigator Site Closed|0|||
131597504|NCT03544281|473818022|FG009|Main Study Phase|Investigator Site Closed|1|||
131597505|NCT03544281|473818023|FG010|Main Study Phase|Investigator Site Closed|0|||
131597506|NCT03544281|473818024|FG011|Main Study Phase|Investigator Site Closed|0|||
131597507|NCT03544281|473818025|FG012|Main Study Phase|Investigator Site Closed|0|||
131597508|NCT03544281|473818026|FG013|Main Study Phase|Investigator Site Closed|0|||
131597509|NCT03544281|473818027|FG014|Main Study Phase|Investigator Site Closed|0|||
131597510|NCT03544281|473818028|FG015|Main Study Phase|Investigator Site Closed|0|||
131597511|NCT03544281|473818029|FG016|Main Study Phase|Investigator Site Closed|0|||
131597512|NCT03544281|473818030|FG017|Main Study Phase|Investigator Site Closed|0|||
131597513|NCT03544281|473818031|FG018|Main Study Phase|Investigator Site Closed|0|||
131597514|NCT03544281|473818032|FG019|Main Study Phase|Investigator Site Closed|0|||
131597515|NCT03544281|473818033|FG020|Main Study Phase|Investigator Site Closed|0|||
131597516|NCT03544281|473818034|FG021|Main Study Phase|Investigator Site Closed|0|||
131597517|NCT03544281|473818013|FG000|Main Study Phase|Did not receive study treatment|0|||
131597518|NCT03544281|473818014|FG001|Main Study Phase|Did not receive study treatment|0|||
131597519|NCT03544281|473818015|FG002|Main Study Phase|Did not receive study treatment|0|||
131597520|NCT03544281|473818016|FG003|Main Study Phase|Did not receive study treatment|0|||
131597521|NCT03544281|473818017|FG004|Main Study Phase|Did not receive study treatment|0|||
131597522|NCT03544281|473818018|FG005|Main Study Phase|Did not receive study treatment|0|||
131597523|NCT03544281|473818019|FG006|Main Study Phase|Did not receive study treatment|1|||
131597524|NCT03544281|473818020|FG007|Main Study Phase|Did not receive study treatment|0|||
131597525|NCT03544281|473818021|FG008|Main Study Phase|Did not receive study treatment|0|||
131597526|NCT03544281|473818022|FG009|Main Study Phase|Did not receive study treatment|0|||
131597527|NCT03544281|473818023|FG010|Main Study Phase|Did not receive study treatment|0|||
131597528|NCT03544281|473818024|FG011|Main Study Phase|Did not receive study treatment|0|||
131597529|NCT03544281|473818025|FG012|Main Study Phase|Did not receive study treatment|0|||
131597530|NCT03544281|473818026|FG013|Main Study Phase|Did not receive study treatment|0|||
131597531|NCT03544281|473818027|FG014|Main Study Phase|Did not receive study treatment|0|||
131597532|NCT03544281|473818028|FG015|Main Study Phase|Did not receive study treatment|0|||
131597533|NCT03544281|473818029|FG016|Main Study Phase|Did not receive study treatment|0|||
131597534|NCT03544281|473818030|FG017|Main Study Phase|Did not receive study treatment|0|||
131597535|NCT03544281|473818031|FG018|Main Study Phase|Did not receive study treatment|0|||
131597536|NCT03544281|473818032|FG019|Main Study Phase|Did not receive study treatment|0|||
131597537|NCT03544281|473818033|FG020|Main Study Phase|Did not receive study treatment|0|||
131597538|NCT03544281|473818034|FG021|Main Study Phase|Did not receive study treatment|0|||
131706573|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131706574|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
131706575|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
131706576|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
131706577|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131706578|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131706579|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131706580|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131706581|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131706582|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131706583|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
131706584|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
131597539|NCT03544281|473818013|FG000|PACT Phase|Adverse Event|0|||
131706585|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131706586|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131706587|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131706588|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131597540|NCT03544281|473818014|FG001|PACT Phase|Adverse Event|0|||
131597541|NCT03544281|473818015|FG002|PACT Phase|Adverse Event|0|||
131597542|NCT03544281|473818016|FG003|PACT Phase|Adverse Event|0|||
131597543|NCT03544281|473818017|FG004|PACT Phase|Adverse Event|0|||
131597544|NCT03544281|473818018|FG005|PACT Phase|Adverse Event|0|||
131597545|NCT03544281|473818019|FG006|PACT Phase|Adverse Event|0|||
131597546|NCT03544281|473818020|FG007|PACT Phase|Adverse Event|0|||
131597547|NCT03544281|473818021|FG008|PACT Phase|Adverse Event|0|||
131597548|NCT03544281|473818022|FG009|PACT Phase|Adverse Event|0|||
131597549|NCT03544281|473818023|FG010|PACT Phase|Adverse Event|0|||
131597550|NCT03544281|473818024|FG011|PACT Phase|Adverse Event|0|||
131597551|NCT03544281|473818025|FG012|PACT Phase|Adverse Event|1|||
131597552|NCT03544281|473818026|FG013|PACT Phase|Adverse Event|0|||
131597553|NCT03544281|473818027|FG014|PACT Phase|Adverse Event|0|||
131597554|NCT03544281|473818028|FG015|PACT Phase|Adverse Event|0|||
131597555|NCT03544281|473818029|FG016|PACT Phase|Adverse Event|0|||
131597556|NCT03544281|473818030|FG017|PACT Phase|Adverse Event|1|||
131597557|NCT03544281|473818031|FG018|PACT Phase|Adverse Event|1|||
131597558|NCT03544281|473818032|FG019|PACT Phase|Adverse Event|0|||
131597559|NCT03544281|473818033|FG020|PACT Phase|Adverse Event|0|||
131597560|NCT03544281|473818034|FG021|PACT Phase|Adverse Event|0|||
131597561|NCT02146378|473818035|FG000|Overall Study|No information of administration|2|||
131597562|NCT04770532|473818036|FG000|Overall Study|Withdrawal by Subject|0|||
131597563|NCT04770532|473818037|FG001|Overall Study|Withdrawal by Subject|3|||
131597564|NCT04770532|473818036|FG000|Overall Study|Physician Decision|1|||
131597565|NCT04770532|473818037|FG001|Overall Study|Physician Decision|0|||
131597566|NCT04770532|473818036|FG000|Overall Study|Death|2|||
131597567|NCT04770532|473818037|FG001|Overall Study|Death|2|||
131597568|NCT05457647|473818038|FG000|Overall Study|Lost to Follow-up|3|||
131597569|NCT01396278|473820051|FG000|Overall Study|Adverse Event|0|||
131597570|NCT01396278|473820052|FG001|Overall Study|Adverse Event|0|||
131597571|NCT01396278|473820053|FG002|Overall Study|Adverse Event|0|||
131597572|NCT01396278|473820054|FG003|Overall Study|Adverse Event|2|||
131597573|NCT01396278|473820055|FG004|Overall Study|Adverse Event|0|||
131597574|NCT01396278|473820051|FG000|Overall Study|Withdraw due to trial termination|2|||
131597575|NCT01396278|473820052|FG001|Overall Study|Withdraw due to trial termination|1|||
131597576|NCT01396278|473820053|FG002|Overall Study|Withdraw due to trial termination|1|||
131597577|NCT01396278|473820054|FG003|Overall Study|Withdraw due to trial termination|0|||
131597578|NCT01396278|473820055|FG004|Overall Study|Withdraw due to trial termination|2|||
131597579|NCT04515576|473820058|FG000|Overall Study|Withdrawal by Subject|0|||
131597580|NCT04515576|473820059|FG001|Overall Study|Withdrawal by Subject|0|||
131597581|NCT04515576|473820060|FG002|Overall Study|Withdrawal by Subject|0|||
131597582|NCT04515576|473820061|FG003|Overall Study|Withdrawal by Subject|0|||
131597583|NCT04515576|473820062|FG004|Overall Study|Withdrawal by Subject|0|||
131597584|NCT04515576|473820063|FG005|Overall Study|Withdrawal by Subject|1|||
131597585|NCT05486078|473820069|FG000|Overall Study|4 drop out and one withdrawn|5|||
131597586|NCT04256941|473820070|FG000|Overall Study|Withdrawal by Subject|0|||
131597587|NCT04256941|473820071|FG001|Overall Study|Withdrawal by Subject|1|||
131597588|NCT04256941|473820070|FG000|Overall Study|Death|1|||
131597589|NCT04256941|473820071|FG001|Overall Study|Death|0|||
131597590|NCT04256941|473820070|FG000|Overall Study|Disease Progession|0|||
131597591|NCT04256941|473820071|FG001|Overall Study|Disease Progession|2|||
131597592|NCT02908477|473820078|FG000|Overall Study|Withdrawal by Subject|8|||
131597593|NCT02908477|473820079|FG001|Overall Study|Withdrawal by Subject|28|||
131597594|NCT02140554|473820080|FG000|Overall Study|Withdrawal of consent|1|||
131597595|NCT02140554|473820081|FG001|Overall Study|Withdrawal of consent|0|||
131597596|NCT02140554|473820082|FG002|Overall Study|Withdrawal of consent|4|||
131597597|NCT02140554|473820080|FG000|Overall Study|Physician Decision|1|||
131597598|NCT02140554|473820081|FG001|Overall Study|Physician Decision|0|||
131597599|NCT02140554|473820082|FG002|Overall Study|Physician Decision|2|||
131597600|NCT02140554|473820080|FG000|Overall Study|Death|0|||
131597601|NCT02140554|473820081|FG001|Overall Study|Death|0|||
131597602|NCT02140554|473820082|FG002|Overall Study|Death|1|||
131597603|NCT02140554|473820080|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
131899653|NCT00994110|474919335|FG000|Overall Study|Pt not eligible|10|||
131899654|NCT00994110|474919336|FG001|Overall Study|Pt not eligible|5|||
131899655|NCT00368108|474919337|FG000|Overall Study|Adverse Event|38|||
131597604|NCT02140554|473820081|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
131597605|NCT02140554|473820082|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
131597606|NCT05590403|473820083|FG000|Overall Study|Lost to Follow-up|13|||
131597607|NCT05590403|473820084|FG001|Overall Study|Lost to Follow-up|1|||
131597608|NCT05590403|473820085|FG002|Overall Study|Lost to Follow-up|7|||
131597609|NCT05590403|473820086|FG003|Overall Study|Lost to Follow-up|3|||
131597610|NCT05590403|473820087|FG004|Overall Study|Lost to Follow-up|4|||
131597611|NCT05590403|473820083|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
131597612|NCT05590403|473820084|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
131597613|NCT05590403|473820085|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
131597614|NCT05590403|473820086|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
131597615|NCT05590403|473820087|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
131597616|NCT05590403|473820083|FG000|Overall Study|Other|2|||
131597617|NCT05590403|473820084|FG001|Overall Study|Other|0|||
131597618|NCT05590403|473820085|FG002|Overall Study|Other|2|||
131597619|NCT05590403|473820086|FG003|Overall Study|Other|2|||
131597620|NCT05590403|473820087|FG004|Overall Study|Other|0|||
131597621|NCT05590403|473820083|FG000|Overall Study|Migrated / moved from the study area|1|||
131597622|NCT05590403|473820084|FG001|Overall Study|Migrated / moved from the study area|1|||
131597623|NCT05590403|473820085|FG002|Overall Study|Migrated / moved from the study area|0|||
131597624|NCT05590403|473820086|FG003|Overall Study|Migrated / moved from the study area|3|||
131597625|NCT05590403|473820087|FG004|Overall Study|Migrated / moved from the study area|1|||
131597626|NCT05590403|473820083|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
131597627|NCT05590403|473820084|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
131597628|NCT05590403|473820085|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
131597629|NCT05590403|473820086|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
131597630|NCT05590403|473820087|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
131597631|NCT05659537|473820088|FG000|Overall Study|Adverse Event|5|||
131597632|NCT05659537|473820088|FG000|Overall Study|Lost to Follow-up|4|||
131597633|NCT05659537|473820088|FG000|Overall Study|Withdrawal by Subject|13|||
131597634|NCT05659537|473820088|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
131597635|NCT05659537|473820088|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
131597636|NCT05659537|473820088|FG000|Overall Study|Participant was suffering from anaemia|1|||
131597637|NCT04526704|473820091|FG000|Overall Study|Adverse Event|1|||
131597638|NCT04526704|473820092|FG001|Overall Study|Adverse Event|0|||
131597639|NCT04526704|473820091|FG000|Overall Study|Physician Decision|1|||
131597640|NCT04526704|473820092|FG001|Overall Study|Physician Decision|0|||
131597641|NCT04526704|473820091|FG000|Overall Study|Withdrawal by Subject|2|||
131899656|NCT00368108|474919338|FG001|Overall Study|Adverse Event|26|||
131597642|NCT04526704|473820092|FG001|Overall Study|Withdrawal by Subject|0|||
131597643|NCT02737436|473820093|FG000|Washout Period|Lost to Follow-up|5|||
131597644|NCT02737436|473820094|FG001|Washout Period|Lost to Follow-up|11|||
131597645|NCT02737436|473820093|FG000|Data Analysis|Scanning data problems|5|||
131597646|NCT02737436|473820094|FG001|Data Analysis|Scanning data problems|8|||
131597647|NCT01160211|473820095|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
131597648|NCT01160211|473820096|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
131597649|NCT01160211|473820097|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
131597650|NCT01160211|473820095|FG000|Overall Study|Lost to Follow-up|4|||
131597651|NCT01160211|473820096|FG001|Overall Study|Lost to Follow-up|8|||
131597652|NCT01160211|473820097|FG002|Overall Study|Lost to Follow-up|4|||
131597653|NCT01160211|473820095|FG000|Overall Study|Physician Decision|1|||
131597654|NCT01160211|473820096|FG001|Overall Study|Physician Decision|0|||
131597655|NCT01160211|473820097|FG002|Overall Study|Physician Decision|0|||
131597656|NCT01160211|473820095|FG000|Overall Study|Withdrawal by Subject|4|||
131597657|NCT01160211|473820096|FG001|Overall Study|Withdrawal by Subject|2|||
131597658|NCT01160211|473820097|FG002|Overall Study|Withdrawal by Subject|2|||
131597659|NCT01160211|473820095|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
131597660|NCT01160211|473820096|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
131597661|NCT01160211|473820097|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
131597662|NCT02105766|473820102|FG000|Overall Study|Physician Decision|1|||
131597663|NCT02105766|473820103|FG001|Overall Study|Physician Decision|1|||
131597664|NCT02105766|473820104|FG002|Overall Study|Physician Decision|0|||
131597665|NCT02105766|473820102|FG000|Overall Study|Lost to Follow-up|2|||
131597666|NCT02105766|473820103|FG001|Overall Study|Lost to Follow-up|0|||
131597667|NCT02105766|473820104|FG002|Overall Study|Lost to Follow-up|0|||
131597668|NCT02105766|473820102|FG000|Overall Study|Death|1|||
131597669|NCT02105766|473820103|FG001|Overall Study|Death|1|||
131597670|NCT02105766|473820104|FG002|Overall Study|Death|0|||
131597671|NCT03701399|473820105|FG000|Overall Study|Adverse Event|3|||
131597672|NCT03701399|473820106|FG001|Overall Study|Adverse Event|5|||
131597673|NCT03701399|473820105|FG000|Overall Study|Withdrawal by Subject|6|||
131597674|NCT03701399|473820106|FG001|Overall Study|Withdrawal by Subject|3|||
131597675|NCT03701399|473820105|FG000|Overall Study|Investigators decision|1|||
131597676|NCT03701399|473820106|FG001|Overall Study|Investigators decision|2|||
131597677|NCT03701399|473820105|FG000|Overall Study|Lost to Follow-up|1|||
131597678|NCT03701399|473820106|FG001|Overall Study|Lost to Follow-up|2|||
131597679|NCT03701399|473820105|FG000|Overall Study|Death|1|||
131597680|NCT03701399|473820106|FG001|Overall Study|Death|1|||
131597681|NCT03701399|473820105|FG000|Overall Study|Randomized but not treated|1|||
131597682|NCT03701399|473820106|FG001|Overall Study|Randomized but not treated|0|||
131597683|NCT05119023|473820107|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
131653669|NCT01427725|474018439|FG000|Overall Study|Exacerbation of underlying disease|5|||
131653670|NCT01427725|474018439|FG000|Overall Study|Oral feeding difficulty|5|||
131653671|NCT01427725|474018439|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
131653672|NCT01427725|474018439|FG000|Overall Study|Forgetting prescription|1|||
131653673|NCT01427725|474018439|FG000|Overall Study|Other|2|||
131653674|NCT01374568|474018440|FG000|Overall Study|Lab unable to analyze BTM|0|||
131653675|NCT01374568|474018441|FG001|Overall Study|Lab unable to analyze BTM|2|||
131653676|NCT01912404|474018442|FG000|Overall Study|Due to personal reasons|1|||
131653677|NCT01912404|474018443|FG001|Overall Study|Due to personal reasons|0|||
131653678|NCT03651700|474018447|FG000|Overall Study|Withdrawal by Subject|1|||
131653679|NCT03651700|474018448|FG001|Overall Study|Withdrawal by Subject|0|||
131653680|NCT04916730|474018451|FG000|Overall Study|Withdrawal by Subject|4|||
131653681|NCT04916730|474018452|FG001|Overall Study|Withdrawal by Subject|2|||
131653682|NCT04916730|474018451|FG000|Overall Study|Lost to Follow-up|0|||
131597684|NCT05119023|473820107|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
131597685|NCT05119023|473820107|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
131597686|NCT04806451|473820110|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
131597687|NCT04806451|473820111|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
131597688|NCT04806451|473820110|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
131597689|NCT04806451|473820111|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
131597690|NCT04806451|473820110|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
131597691|NCT04806451|473820111|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
131597692|NCT03134196|473820119|FG000|Overall Study|Death|2|||
131597693|NCT03134196|473820120|FG001|Overall Study|Death|1|||
131597694|NCT03134196|473820119|FG000|Overall Study|Lost to Follow-up|13|||
131597695|NCT03134196|473820120|FG001|Overall Study|Lost to Follow-up|15|||
131597696|NCT03134196|473820119|FG000|Overall Study|Physician Decision|0|||
131597697|NCT03134196|473820120|FG001|Overall Study|Physician Decision|1|||
131597698|NCT03134196|473820119|FG000|Overall Study|Withdrawal by Subject|19|||
131597699|NCT03134196|473820120|FG001|Overall Study|Withdrawal by Subject|12|||
131597700|NCT03134196|473820119|FG000|Overall Study|Site Unable to Contact Participant|2|||
131597701|NCT03134196|473820120|FG001|Overall Study|Site Unable to Contact Participant|0|||
131597702|NCT03134196|473820119|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
131597703|NCT03134196|473820120|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
131597704|NCT03134196|473820119|FG000|Overall Study|Scheduling Conflict|1|||
131597705|NCT03134196|473820120|FG001|Overall Study|Scheduling Conflict|0|||
131597706|NCT06516705|473820121|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
131597707|NCT06516705|473820122|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
131597708|NCT06516705|473820121|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
131597709|NCT06516705|473820122|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
131597710|NCT06516705|473820121|FG000|T3 ( 3 Month After Education)|covid-19|1|||
131597711|NCT06516705|473820122|FG001|T3 ( 3 Month After Education)|covid-19|2|||
131597712|NCT06516705|473820121|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
131597713|NCT06516705|473820122|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
131597714|NCT06516705|473820121|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
131597715|NCT06516705|473820122|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
131597716|NCT06516705|473820121|FG000|T4 ( 6 Month After Education)|covid-19|3|||
131597717|NCT06516705|473820122|FG001|T4 ( 6 Month After Education)|covid-19|2|||
131597718|NCT06516705|473820121|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
131597719|NCT06516705|473820122|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
131597720|NCT05746455|473820123|FG000|Overall Study|Discharged from Clinical Service|1|||
131597721|NCT05746455|473820123|FG000|Overall Study|Lost to Follow-up|1|||
131597722|NCT05453773|473820124|FG000|Overall Study|Withdrawal by Subject|3|||
131597723|NCT05453773|473820124|FG000|Overall Study|Lost to Follow-up|3|||
131597724|NCT05453773|473820124|FG000|Overall Study|Difficult Blood Draw|3|||
131597725|NCT02023866|473820127|FG000|Overall Study|Non-compliance|2|||
131597726|NCT02023866|473820127|FG000|Overall Study|Adverse Event|3|||
131597727|NCT02023866|473820127|FG000|Overall Study|Withdrawal by Subject|1|||
131597728|NCT03241745|473820128|FG000|Overall Study|Adverse Event|7|||
131597729|NCT03241745|473820128|FG000|Overall Study|Death|1|||
131597730|NCT03241745|473820128|FG000|Overall Study|Withdrawal by Subject|5|||
131597731|NCT03241745|473820128|FG000|Overall Study|Treatment delay >28 days|2|||
131597732|NCT03241745|473820128|FG000|Overall Study|Lack of Efficacy|14|||
131597733|NCT03023410|473820129|FG000|Overall Study|study termination|0|||
131597734|NCT03023410|473820130|FG001|Overall Study|study termination|1|||
131597735|NCT04683744|473820138|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
131597736|NCT04683744|473820139|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
131597737|NCT04683744|473820140|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
131597738|NCT03560609|473820144|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
131597739|NCT03560609|473820145|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
131597740|NCT04293055|473820146|FG000|Overall Study|Lost to Follow-up|1|||
131597741|NCT04293055|473820147|FG001|Overall Study|Lost to Follow-up|1|||
131597742|NCT04293055|473820146|FG000|Overall Study|Did not trigger randomization|6|||
131597743|NCT04293055|473820147|FG001|Overall Study|Did not trigger randomization|5|||
131597744|NCT01369355|473820159|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
131597745|NCT01369355|473820160|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
131597746|NCT01369355|473820161|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
131597747|NCT01369355|473820162|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
131597748|NCT01369355|473820163|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
131597749|NCT01369355|473820164|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
131597750|NCT01369355|473820165|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
131597751|NCT01369355|473820166|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
131597752|NCT01369355|473820167|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
131597753|NCT01369355|473820159|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
131597754|NCT01369355|473820160|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
131597755|NCT01369355|473820161|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
131597756|NCT01369355|473820162|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
131597757|NCT01369355|473820163|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
131597758|NCT01369355|473820164|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
131597759|NCT01369355|473820165|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
131597760|NCT01369355|473820166|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
131597761|NCT01369355|473820167|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
131597762|NCT01369355|473820159|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131706589|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131899657|NCT00368108|474919339|FG002|Overall Study|Adverse Event|44|||
131899658|NCT00368108|474919337|FG000|Overall Study|Abnormal Laboratory Value|0|||
131597763|NCT01369355|473820160|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
131706590|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131597764|NCT01369355|473820161|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
131597765|NCT01369355|473820162|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131597766|NCT01369355|473820163|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131597767|NCT01369355|473820164|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
131597768|NCT01369355|473820165|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131597769|NCT01369355|473820166|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131597770|NCT01369355|473820167|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131597771|NCT01369355|473820159|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
131597772|NCT01369355|473820160|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131597773|NCT01369355|473820161|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
131597774|NCT01369355|473820162|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
131597775|NCT01369355|473820163|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
131439692|NCT02412306|473236869|FG001|Overall Study|Lost to Follow-up|1|||
131597776|NCT01369355|473820164|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
131597777|NCT01369355|473820165|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131597778|NCT01369355|473820166|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131597779|NCT01369355|473820167|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131597780|NCT01369355|473820159|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
131597781|NCT01369355|473820160|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
131597782|NCT01369355|473820161|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
131597783|NCT01369355|473820162|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
131597784|NCT01369355|473820163|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
131597785|NCT01369355|473820164|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
131597786|NCT01369355|473820165|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
131597787|NCT01369355|473820166|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
131597788|NCT01369355|473820167|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
131597789|NCT01369355|473820159|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
131597790|NCT01369355|473820160|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
131597791|NCT01369355|473820161|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
131597792|NCT01369355|473820162|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
131597793|NCT01369355|473820163|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
131597794|NCT01369355|473820164|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
131597795|NCT01369355|473820165|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
131597796|NCT01369355|473820166|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
131597797|NCT01369355|473820167|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
131597798|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
131597799|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
131597800|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
131597801|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
131597802|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
131597803|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
131597804|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
131597805|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
131597806|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
131597807|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Death|0|||
131597808|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Death|0|||
131597809|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Death|0|||
131706591|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131706592|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
131706593|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
131439693|NCT02412306|473236870|FG002|Overall Study|Lost to Follow-up|0|||
131597810|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Death|0|||
131597811|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Death|0|||
131597812|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Death|0|||
131597813|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Death|0|||
131439694|NCT02412306|473236871|FG003|Overall Study|Lost to Follow-up|0|||
131439695|NCT02412306|473236872|FG004|Overall Study|Lost to Follow-up|0|||
131439696|NCT02412306|473236868|FG000|Overall Study|Withdrawal by Subject|0|||
131597814|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Death|1|||
131597815|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Death|3|||
131597816|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131597817|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131597818|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131597819|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131597820|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131597821|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131597822|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
131597823|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
131597824|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
131597825|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597826|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597827|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597828|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597829|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597830|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597831|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131597832|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
131597833|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
131597834|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
131597835|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
131597836|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
131597837|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
131597838|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
131597839|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
131597840|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
131597841|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
131597842|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
131439697|NCT02412306|473236869|FG001|Overall Study|Withdrawal by Subject|0|||
131439698|NCT02412306|473236870|FG002|Overall Study|Withdrawal by Subject|1|||
131439699|NCT02412306|473236871|FG003|Overall Study|Withdrawal by Subject|0|||
131448276|NCT02079246|473272631|FG000|OLEX|Other: Coordinator decision|1|||
131653683|NCT04916730|474018452|FG001|Overall Study|Lost to Follow-up|2|||
131653684|NCT04916730|474018451|FG000|Overall Study|Physician Decision|1|||
131653685|NCT04916730|474018452|FG001|Overall Study|Physician Decision|0|||
131653686|NCT03945825|474018455|FG000|Overall Study|Enrolled but treatment not administered|0|||
131653687|NCT03945825|474018456|FG001|Overall Study|Enrolled but treatment not administered|0|||
131653688|NCT03945825|474018457|FG002|Overall Study|Enrolled but treatment not administered|0|||
131653689|NCT03945825|474018458|FG003|Overall Study|Enrolled but treatment not administered|0|||
131653690|NCT03945825|474018459|FG004|Overall Study|Enrolled but treatment not administered|1|||
131653691|NCT03945825|474018460|FG005|Overall Study|Enrolled but treatment not administered|0|||
131653692|NCT03945825|474018455|FG000|Overall Study|Lost to Follow-up|1|||
131653693|NCT03945825|474018456|FG001|Overall Study|Lost to Follow-up|5|||
131653694|NCT03945825|474018457|FG002|Overall Study|Lost to Follow-up|0|||
131653695|NCT03945825|474018458|FG003|Overall Study|Lost to Follow-up|1|||
131653696|NCT03945825|474018459|FG004|Overall Study|Lost to Follow-up|2|||
131653697|NCT03945825|474018460|FG005|Overall Study|Lost to Follow-up|2|||
131653698|NCT03945825|474018455|FG000|Overall Study|Withdrawal by Subject|1|||
131653699|NCT03945825|474018456|FG001|Overall Study|Withdrawal by Subject|0|||
131597843|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131597844|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131597845|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131597846|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131597847|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131597848|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131597849|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
131597850|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
131597851|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
131597852|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131597853|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131597854|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131597855|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131597856|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131597857|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131597858|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
131597859|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
131597860|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
131597861|NCT01369355|473820159|FG000|Long-term Extension (Week 44-272)|Other|0|||
131597862|NCT01369355|473820160|FG001|Long-term Extension (Week 44-272)|Other|0|||
131597863|NCT01369355|473820161|FG002|Long-term Extension (Week 44-272)|Other|0|||
131597864|NCT01369355|473820162|FG003|Long-term Extension (Week 44-272)|Other|0|||
131597865|NCT01369355|473820163|FG004|Long-term Extension (Week 44-272)|Other|0|||
131597866|NCT01369355|473820164|FG005|Long-term Extension (Week 44-272)|Other|0|||
131597867|NCT01369355|473820165|FG006|Long-term Extension (Week 44-272)|Other|110|||
131597868|NCT01369355|473820166|FG007|Long-term Extension (Week 44-272)|Other|9|||
131597869|NCT01369355|473820167|FG008|Long-term Extension (Week 44-272)|Other|17|||
131597870|NCT01902173|473820168|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
131597871|NCT01902173|473820169|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131597872|NCT01902173|473820170|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131597873|NCT01902173|473820171|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131597874|NCT01902173|473820172|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131597875|NCT01902173|473820173|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131597876|NCT01902173|473820168|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
131597877|NCT01902173|473820169|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131597878|NCT01902173|473820170|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131597879|NCT01902173|473820171|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131597880|NCT01902173|473820172|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131597881|NCT01902173|473820173|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131597882|NCT01902173|473820168|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131597883|NCT01902173|473820169|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
131597884|NCT01902173|473820170|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131597885|NCT01902173|473820171|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131597886|NCT01902173|473820172|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131597887|NCT01902173|473820173|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131597888|NCT01902173|473820168|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131597889|NCT01902173|473820169|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
131597890|NCT01902173|473820170|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131597891|NCT01902173|473820171|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131597892|NCT01902173|473820172|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131597893|NCT01902173|473820173|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131597894|NCT01902173|473820168|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131597895|NCT01902173|473820169|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
131597896|NCT01902173|473820170|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131597897|NCT01902173|473820171|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131597898|NCT01902173|473820172|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131597899|NCT01902173|473820173|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131899659|NCT00368108|474919338|FG001|Overall Study|Abnormal Laboratory Value|0|||
131899660|NCT00368108|474919339|FG002|Overall Study|Abnormal Laboratory Value|3|||
131448277|NCT02079246|473272632|FG001|OLEX|Other: Coordinator decision|0|||
131597900|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131597901|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131597902|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
131597903|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131597904|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131597905|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131597906|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131597907|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131597908|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
131597909|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131597910|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131597911|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131597912|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131597913|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131597914|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131597915|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
131597916|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131597917|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131597918|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131597919|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131597920|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131706594|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
131439700|NCT02412306|473236872|FG004|Overall Study|Withdrawal by Subject|0|||
131439701|NCT02412306|473236868|FG000|Overall Study|Death|5|||
131439702|NCT02412306|473236869|FG001|Overall Study|Death|7|||
131439703|NCT02412306|473236870|FG002|Overall Study|Death|15|||
131439704|NCT02412306|473236871|FG003|Overall Study|Death|0|||
131439705|NCT02412306|473236872|FG004|Overall Study|Death|2|||
131439706|NCT05543265|473236878|FG000|Overall Study|Lost to Follow-up|3|||
131439707|NCT05543265|473236879|FG001|Overall Study|Lost to Follow-up|3|||
131439708|NCT05543265|473236878|FG000|Overall Study|Withdrawal by Subject|0|||
131439709|NCT05543265|473236879|FG001|Overall Study|Withdrawal by Subject|1|||
131439710|NCT01706458|473236880|FG000|Overall Study|Physician Decision|3|||
131439711|NCT01706458|473236881|FG001|Overall Study|Physician Decision|4|||
131439712|NCT04349891|473236888|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
131439713|NCT04349891|473236889|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
131439714|NCT04349891|473236888|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
131439715|NCT04349891|473236889|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
131706595|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131439716|NCT04349891|473236888|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
131439717|NCT04349891|473236889|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
131439718|NCT04349891|473236888|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
131439719|NCT04349891|473236889|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
131439720|NCT02914639|473236895|FG000|Overall Study|Withdrawal by Subject|0|||
131439721|NCT02914639|473236896|FG001|Overall Study|Withdrawal by Subject|2|||
131439722|NCT01018030|473236897|FG000|Overall Study|Adverse Event|10|||
131439723|NCT01018030|473236898|FG001|Overall Study|Adverse Event|5|||
131439724|NCT01018030|473236899|FG002|Overall Study|Adverse Event|5|||
131439725|NCT01018030|473236897|FG000|Overall Study|Withdrawal by Subject|2|||
131439726|NCT01018030|473236898|FG001|Overall Study|Withdrawal by Subject|2|||
131439727|NCT01018030|473236899|FG002|Overall Study|Withdrawal by Subject|4|||
131439728|NCT01018030|473236897|FG000|Overall Study|Lost to Follow-up|2|||
131439729|NCT01018030|473236898|FG001|Overall Study|Lost to Follow-up|0|||
131439730|NCT01018030|473236899|FG002|Overall Study|Lost to Follow-up|3|||
131439731|NCT01018030|473236897|FG000|Overall Study|Protocol Violation|2|||
131439732|NCT01018030|473236898|FG001|Overall Study|Protocol Violation|1|||
131439733|NCT01018030|473236899|FG002|Overall Study|Protocol Violation|0|||
131439734|NCT01018030|473236897|FG000|Overall Study|Physician Decision|1|||
131439735|NCT01018030|473236898|FG001|Overall Study|Physician Decision|0|||
131439736|NCT01018030|473236899|FG002|Overall Study|Physician Decision|1|||
131439737|NCT01018030|473236897|FG000|Overall Study|Lack of Efficacy|1|||
131439738|NCT01018030|473236898|FG001|Overall Study|Lack of Efficacy|0|||
131439739|NCT01018030|473236899|FG002|Overall Study|Lack of Efficacy|0|||
131439740|NCT01018030|473236897|FG000|Overall Study|Did Not Receive Study Drug|1|||
131439741|NCT01018030|473236898|FG001|Overall Study|Did Not Receive Study Drug|3|||
131439742|NCT01018030|473236899|FG002|Overall Study|Did Not Receive Study Drug|0|||
131439743|NCT03617172|473236900|FG000|Overall Study|Lost to Follow-up|1|||
131439744|NCT03617172|473236901|FG001|Overall Study|Lost to Follow-up|0|||
131439745|NCT00189540|473236902|FG000|Overall Study|Withdrawal by Subject|3|||
131439746|NCT00189540|473236903|FG001|Overall Study|Withdrawal by Subject|0|||
131439747|NCT00189540|473236902|FG000|Overall Study|Death|4|||
131439748|NCT00189540|473236903|FG001|Overall Study|Death|1|||
131439749|NCT01089504|473236904|FG000|Overall Study|Lost to Follow-up|1|||
131439750|NCT01089504|473236905|FG001|Overall Study|Lost to Follow-up|1|||
131439751|NCT01089504|473236904|FG000|Overall Study|Withdrawal by Subject|2|||
131439752|NCT01089504|473236905|FG001|Overall Study|Withdrawal by Subject|0|||
131439753|NCT01924845|473236906|FG000|Overall Study|Adverse Event|3|||
131439754|NCT01924845|473236906|FG000|Overall Study|Withdrawal by Subject|2|||
131439755|NCT01924845|473236906|FG000|Overall Study|Protocol Violation|1|||
131439756|NCT00062439|473236907|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
131439757|NCT00062439|473236907|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
131439758|NCT00062439|473236907|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
131439759|NCT00062439|473236907|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
131439760|NCT00062439|473236907|FG000|Post Chemoradiation Assessment|Death|1|||
131439761|NCT00062439|473236907|FG000|Post Chemoradiation Assessment|Disease progression|2|||
131439762|NCT00062439|473236907|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
131439763|NCT00062439|473236907|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
131439764|NCT00062439|473236907|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
131439765|NCT00062439|473236907|FG000|Surgery|Physician Decision|4|||
131439766|NCT00062439|473236907|FG000|Surgery|Death|1|||
131439767|NCT00062439|473236907|FG000|Surgery|Adverse Event|2|||
131439768|NCT00062439|473236907|FG000|Consolidation Chemotherapy|Adverse Event|2|||
131439769|NCT00001832|473236908|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
131439770|NCT00001832|473236909|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
131439771|NCT00001832|473236910|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
131439772|NCT00001832|473236911|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
131439773|NCT00001832|473236912|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
131439774|NCT00001832|473236913|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
131439775|NCT00001832|473236914|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
131439776|NCT00001832|473236915|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
131439777|NCT00001832|473236916|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
131439778|NCT00001832|473236917|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
131439779|NCT00001832|473236918|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
131439780|NCT00001832|473236919|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
131439781|NCT00001832|473236920|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
131439782|NCT00001832|473236921|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
131439783|NCT00001832|473236922|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
131439784|NCT00001832|473236908|FG000|Treatment Period|Death during treatment|0|||
131439785|NCT00001832|473236909|FG001|Treatment Period|Death during treatment|0|||
131439786|NCT00001832|473236910|FG002|Treatment Period|Death during treatment|0|||
131439787|NCT00001832|473236911|FG003|Treatment Period|Death during treatment|0|||
131439788|NCT00001832|473236912|FG004|Treatment Period|Death during treatment|0|||
131439789|NCT00001832|473236913|FG005|Treatment Period|Death during treatment|1|||
131439790|NCT00001832|473236914|FG006|Treatment Period|Death during treatment|0|||
131439791|NCT00001832|473236915|FG007|Treatment Period|Death during treatment|0|||
131439792|NCT00001832|473236916|FG008|Treatment Period|Death during treatment|0|||
131439793|NCT00001832|473236917|FG009|Treatment Period|Death during treatment|0|||
131439794|NCT00001832|473236918|FG010|Treatment Period|Death during treatment|0|||
131439795|NCT00001832|473236919|FG011|Treatment Period|Death during treatment|0|||
131439796|NCT00001832|473236920|FG012|Treatment Period|Death during treatment|0|||
131439797|NCT00001832|473236921|FG013|Treatment Period|Death during treatment|0|||
131439798|NCT00001832|473236922|FG014|Treatment Period|Death during treatment|0|||
131439799|NCT00001832|473236908|FG000|Treatment Period|Not treated|0|||
131439800|NCT00001832|473236909|FG001|Treatment Period|Not treated|0|||
131439801|NCT00001832|473236910|FG002|Treatment Period|Not treated|0|||
131439802|NCT00001832|473236911|FG003|Treatment Period|Not treated|0|||
131439803|NCT00001832|473236912|FG004|Treatment Period|Not treated|0|||
131439804|NCT00001832|473236913|FG005|Treatment Period|Not treated|0|||
131439805|NCT00001832|473236914|FG006|Treatment Period|Not treated|0|||
131439806|NCT00001832|473236915|FG007|Treatment Period|Not treated|1|||
131439807|NCT00001832|473236916|FG008|Treatment Period|Not treated|0|||
131439808|NCT00001832|473236917|FG009|Treatment Period|Not treated|0|||
131439809|NCT00001832|473236918|FG010|Treatment Period|Not treated|0|||
131439810|NCT00001832|473236919|FG011|Treatment Period|Not treated|0|||
131439811|NCT00001832|473236920|FG012|Treatment Period|Not treated|0|||
131439812|NCT00001832|473236921|FG013|Treatment Period|Not treated|0|||
131439813|NCT00001832|473236922|FG014|Treatment Period|Not treated|0|||
131439814|NCT04196686|473236923|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
131439815|NCT04196686|473236924|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
131439816|NCT02546609|473236925|FG000|Overall Study|Withdrawal by Subject|0|||
131439817|NCT02546609|473236926|FG001|Overall Study|Withdrawal by Subject|1|||
131439818|NCT02546609|473236927|FG002|Overall Study|Withdrawal by Subject|2|||
131439819|NCT02546609|473236925|FG000|Overall Study|Adverse Event|0|||
131439820|NCT02546609|473236926|FG001|Overall Study|Adverse Event|6|||
131439821|NCT02546609|473236927|FG002|Overall Study|Adverse Event|1|||
131439822|NCT02546609|473236925|FG000|Overall Study|Protocol Violation|0|||
131439823|NCT02546609|473236926|FG001|Overall Study|Protocol Violation|1|||
131439824|NCT02546609|473236927|FG002|Overall Study|Protocol Violation|1|||
131439825|NCT02546609|473236925|FG000|Overall Study|Lost to Follow-up|2|||
131439826|NCT02546609|473236926|FG001|Overall Study|Lost to Follow-up|3|||
131439827|NCT02546609|473236927|FG002|Overall Study|Lost to Follow-up|1|||
131439828|NCT02546609|473236925|FG000|Overall Study|travel or work schedule restriction|0|||
131439829|NCT02546609|473236926|FG001|Overall Study|travel or work schedule restriction|0|||
131439830|NCT02546609|473236927|FG002|Overall Study|travel or work schedule restriction|2|||
131439831|NCT00914849|473236929|FG000|Overall Study|Withdrawal by Subject|1|||
131439832|NCT00914849|473236930|FG001|Overall Study|Withdrawal by Subject|0|||
131439833|NCT00914849|473236929|FG000|Overall Study|Not eligible|0|||
131439834|NCT00914849|473236930|FG001|Overall Study|Not eligible|1|||
131439835|NCT03448406|473236931|FG000|Overall Study|Noncompliance of scheduled visits|1|||
131439836|NCT03448406|473236932|FG001|Overall Study|Noncompliance of scheduled visits|2|||
131439837|NCT03448406|473236931|FG000|Overall Study|Withdrawal by Subject|1|||
131439838|NCT03448406|473236932|FG001|Overall Study|Withdrawal by Subject|2|||
131439839|NCT03448406|473236931|FG000|Overall Study|Protocol Violation|1|||
131439840|NCT03448406|473236932|FG001|Overall Study|Protocol Violation|0|||
131439841|NCT03448406|473236931|FG000|Overall Study|Adverse Event|8|||
131439842|NCT03448406|473236932|FG001|Overall Study|Adverse Event|9|||
131439843|NCT01292486|473236933|FG000|Overall Study|Protocol Violation|2|||
131439844|NCT01292486|473236933|FG000|Overall Study|Did not meet screening criteria|2|||
131439845|NCT01292486|473236933|FG000|Overall Study|Adverse Event|1|||
131439846|NCT01292486|473236933|FG000|Overall Study|Physician Decision|1|||
131439847|NCT04602390|473236941|FG000|Overall Study|Withdrawal by Subject|0|||
131439848|NCT04602390|473236942|FG001|Overall Study|Withdrawal by Subject|0|||
131439849|NCT04602390|473236943|FG002|Overall Study|Withdrawal by Subject|0|||
131439850|NCT04602390|473236944|FG003|Overall Study|Withdrawal by Subject|0|||
131439851|NCT04602390|473236945|FG004|Overall Study|Withdrawal by Subject|1|||
131439852|NCT04602390|473236946|FG005|Overall Study|Withdrawal by Subject|0|||
131439853|NCT04602390|473236941|FG000|Overall Study|Adverse Event|0|||
131439854|NCT04602390|473236942|FG001|Overall Study|Adverse Event|0|||
131439855|NCT04602390|473236943|FG002|Overall Study|Adverse Event|0|||
131439856|NCT04602390|473236944|FG003|Overall Study|Adverse Event|0|||
131439857|NCT04602390|473236945|FG004|Overall Study|Adverse Event|0|||
131439858|NCT04602390|473236946|FG005|Overall Study|Adverse Event|1|||
131706596|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131439859|NCT01553084|473236947|FG000|Overall Study|Withdrawal by Subject|15|||
131706597|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131706598|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131439860|NCT01553084|473236948|FG001|Overall Study|Withdrawal by Subject|13|||
131439861|NCT01553084|473236949|FG002|Overall Study|Withdrawal by Subject|35|||
131439862|NCT03988400|473236950|FG000|Overall Study|Adverse Event|1|||
131439863|NCT03988400|473236951|FG001|Overall Study|Adverse Event|0|||
131439864|NCT03988400|473236950|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
131597921|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
131597922|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131597923|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131597924|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131597925|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131597926|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131597927|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131597928|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
131597929|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131597930|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131597931|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131597932|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131597933|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131597934|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
131597935|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131597936|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131597937|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131597938|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131597939|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131597940|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131597941|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
131597942|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131597943|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131597944|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131597945|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131597946|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131597947|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
131597948|NCT01902173|473820168|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131597949|NCT01902173|473820169|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131597950|NCT01902173|473820170|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131597951|NCT01902173|473820171|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131597952|NCT01902173|473820172|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131597953|NCT01902173|473820173|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
131597954|NCT02262728|473820174|FG000|Follow-up Phase (3 Years)|Death|0|||
131597955|NCT02262728|473820175|FG001|Follow-up Phase (3 Years)|Death|1|||
131597956|NCT02262728|473820174|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
131597957|NCT02262728|473820175|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
131597958|NCT02262728|473820174|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
131597959|NCT02262728|473820175|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
131597960|NCT00227344|473820176|FG000|Overall Study|study terminated early|12|||
131597961|NCT00227344|473820177|FG001|Overall Study|study terminated early|5|||
131597962|NCT01987895|473820178|FG000|Overall Study|Withdrawal by Subject|12|||
131597963|NCT01987895|473820179|FG001|Overall Study|Withdrawal by Subject|7|||
131597964|NCT01987895|473820178|FG000|Overall Study|Physician Decision|8|||
131597965|NCT01987895|473820179|FG001|Overall Study|Physician Decision|10|||
131597966|NCT01987895|473820178|FG000|Overall Study|Death|7|||
131597967|NCT01987895|473820179|FG001|Overall Study|Death|7|||
131597968|NCT01987895|473820178|FG000|Overall Study|Lost to Follow-up|3|||
131597969|NCT01987895|473820179|FG001|Overall Study|Lost to Follow-up|5|||
131597970|NCT01987895|473820178|FG000|Overall Study|randomized before giving IC|0|||
131597971|NCT01987895|473820179|FG001|Overall Study|randomized before giving IC|1|||
131597972|NCT05364671|473820180|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
131597973|NCT05364671|473820181|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
131597974|NCT05364671|473820180|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
131597975|NCT05364671|473820181|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
131597976|NCT05364671|473820180|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
131597977|NCT05364671|473820181|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
131597978|NCT05364671|473820180|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
131597979|NCT05364671|473820181|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
131597980|NCT05364671|473820180|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
131653700|NCT03945825|474018457|FG002|Overall Study|Withdrawal by Subject|1|||
131653701|NCT03945825|474018458|FG003|Overall Study|Withdrawal by Subject|1|||
131439865|NCT03988400|473236951|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
131439866|NCT03988400|473236950|FG000|Overall Study|Lost to Follow-up|0|||
131439867|NCT03988400|473236951|FG001|Overall Study|Lost to Follow-up|1|||
131597981|NCT05364671|473820181|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
131597982|NCT02359890|473820182|FG000|Overall Study|Not meeting eligibility|4|||
131597983|NCT02359890|473820182|FG000|Overall Study|Never treated with study catheter|6|||
131597984|NCT05256017|473820183|FG000|Treatment Period|Withdrawal by Subject|1|||
131597985|NCT05256017|473820184|FG001|Treatment Period|Withdrawal by Subject|1|||
131597986|NCT05256017|473820183|FG000|Follow-up|Lost to Follow-up|7|||
131597987|NCT05256017|473820184|FG001|Follow-up|Lost to Follow-up|1|||
131597988|NCT05256017|473820183|FG000|Follow-up|Withdrawal by Subject|1|||
131597989|NCT05256017|473820184|FG001|Follow-up|Withdrawal by Subject|0|||
131597990|NCT05256017|473820183|FG000|Follow-up|Death|0|||
131597991|NCT05256017|473820184|FG001|Follow-up|Death|1|||
131597992|NCT03536754|473820189|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
131597993|NCT03536754|473820190|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
131597994|NCT03536754|473820191|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
131597995|NCT03536754|473820192|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
131597996|NCT03536754|473820193|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
131597997|NCT03536754|473820189|FG000|Open Label Extension|Other|0|||
131597998|NCT03536754|473820190|FG001|Open Label Extension|Other|0|||
131597999|NCT03536754|473820191|FG002|Open Label Extension|Other|0|||
131598000|NCT03536754|473820192|FG003|Open Label Extension|Other|0|||
131598001|NCT03536754|473820193|FG004|Open Label Extension|Other|1|||
131598002|NCT04858321|473820194|FG000|Overall Study|Withdrawal by Subject|3|||
131598003|NCT05057247|473820195|FG000|Overall Study|Death|4|||
131598004|NCT05057247|473820195|FG000|Overall Study|Physician Decision|3|||
131598005|NCT05057247|473820195|FG000|Overall Study|Progressive Disease|7|||
131598006|NCT05057247|473820195|FG000|Overall Study|Withdrawal by Subject|3|||
131598007|NCT05057247|473820195|FG000|Overall Study|Adverse Event|6|||
131598008|NCT05057247|473820195|FG000|Overall Study|Subject Non-Compliance|1|||
131598009|NCT05057247|473820195|FG000|Overall Study|On treatment|2|||
131598010|NCT04632992|473820197|FG000|Overall Study|Adverse Event|0|||
131598011|NCT04632992|473820198|FG001|Overall Study|Adverse Event|0|||
131598012|NCT04632992|473820199|FG002|Overall Study|Adverse Event|0|||
131598013|NCT04632992|473820200|FG003|Overall Study|Adverse Event|0|||
131598014|NCT04632992|473820201|FG004|Overall Study|Adverse Event|0|||
131598015|NCT04632992|473820202|FG005|Overall Study|Adverse Event|0|||
131598016|NCT04632992|473820203|FG006|Overall Study|Adverse Event|0|||
131598017|NCT04632992|473820204|FG007|Overall Study|Adverse Event|0|||
131598018|NCT04632992|473820205|FG008|Overall Study|Adverse Event|0|||
131598019|NCT04632992|473820206|FG009|Overall Study|Adverse Event|0|||
131598020|NCT04632992|473820207|FG010|Overall Study|Adverse Event|0|||
131598021|NCT04632992|473820208|FG011|Overall Study|Adverse Event|0|||
131598022|NCT04632992|473820209|FG012|Overall Study|Adverse Event|1|||
131598023|NCT04632992|473820210|FG013|Overall Study|Adverse Event|0|||
131598024|NCT04632992|473820197|FG000|Overall Study|Death|17|||
131598025|NCT04632992|473820198|FG001|Overall Study|Death|1|||
131598026|NCT04632992|473820199|FG002|Overall Study|Death|14|||
131598027|NCT04632992|473820200|FG003|Overall Study|Death|14|||
131598028|NCT04632992|473820201|FG004|Overall Study|Death|13|||
131598029|NCT04632992|473820202|FG005|Overall Study|Death|6|||
131598030|NCT04632992|473820203|FG006|Overall Study|Death|7|||
131598031|NCT04632992|473820204|FG007|Overall Study|Death|12|||
131598032|NCT04632992|473820205|FG008|Overall Study|Death|15|||
131598033|NCT04632992|473820206|FG009|Overall Study|Death|20|||
131598034|NCT04632992|473820207|FG010|Overall Study|Death|8|||
131598035|NCT04632992|473820208|FG011|Overall Study|Death|2|||
131598036|NCT04632992|473820209|FG012|Overall Study|Death|10|||
131598037|NCT04632992|473820210|FG013|Overall Study|Death|1|||
131598038|NCT04632992|473820197|FG000|Overall Study|Lost to Follow-up|1|||
131598039|NCT04632992|473820198|FG001|Overall Study|Lost to Follow-up|0|||
131598040|NCT04632992|473820199|FG002|Overall Study|Lost to Follow-up|1|||
131598041|NCT04632992|473820200|FG003|Overall Study|Lost to Follow-up|0|||
131598042|NCT04632992|473820201|FG004|Overall Study|Lost to Follow-up|2|||
131598043|NCT04632992|473820202|FG005|Overall Study|Lost to Follow-up|0|||
131899661|NCT00368108|474919337|FG000|Overall Study|Protocol Violation|5|||
131598044|NCT04632992|473820203|FG006|Overall Study|Lost to Follow-up|1|||
131598045|NCT04632992|473820204|FG007|Overall Study|Lost to Follow-up|1|||
131598046|NCT04632992|473820205|FG008|Overall Study|Lost to Follow-up|1|||
131598047|NCT04632992|473820206|FG009|Overall Study|Lost to Follow-up|1|||
131598048|NCT04632992|473820207|FG010|Overall Study|Lost to Follow-up|2|||
131598049|NCT04632992|473820208|FG011|Overall Study|Lost to Follow-up|0|||
131598050|NCT04632992|473820209|FG012|Overall Study|Lost to Follow-up|0|||
131598051|NCT04632992|473820210|FG013|Overall Study|Lost to Follow-up|0|||
131598052|NCT04632992|473820197|FG000|Overall Study|Reason not Specified|2|||
131598053|NCT04632992|473820198|FG001|Overall Study|Reason not Specified|0|||
131598054|NCT04632992|473820199|FG002|Overall Study|Reason not Specified|1|||
131598055|NCT04632992|473820200|FG003|Overall Study|Reason not Specified|1|||
131598056|NCT04632992|473820201|FG004|Overall Study|Reason not Specified|0|||
131598057|NCT04632992|473820202|FG005|Overall Study|Reason not Specified|0|||
131598058|NCT04632992|473820203|FG006|Overall Study|Reason not Specified|0|||
131598059|NCT04632992|473820204|FG007|Overall Study|Reason not Specified|0|||
131598060|NCT04632992|473820205|FG008|Overall Study|Reason not Specified|0|||
131598061|NCT04632992|473820206|FG009|Overall Study|Reason not Specified|0|||
131598062|NCT04632992|473820207|FG010|Overall Study|Reason not Specified|1|||
131598063|NCT04632992|473820208|FG011|Overall Study|Reason not Specified|0|||
131598064|NCT04632992|473820209|FG012|Overall Study|Reason not Specified|0|||
131598065|NCT04632992|473820210|FG013|Overall Study|Reason not Specified|0|||
131598066|NCT04632992|473820197|FG000|Overall Study|Physician Decision|0|||
131598067|NCT04632992|473820198|FG001|Overall Study|Physician Decision|0|||
131598068|NCT04632992|473820199|FG002|Overall Study|Physician Decision|0|||
131598069|NCT04632992|473820200|FG003|Overall Study|Physician Decision|2|||
131598070|NCT04632992|473820201|FG004|Overall Study|Physician Decision|1|||
131598071|NCT04632992|473820202|FG005|Overall Study|Physician Decision|0|||
131598072|NCT04632992|473820203|FG006|Overall Study|Physician Decision|0|||
131598073|NCT04632992|473820204|FG007|Overall Study|Physician Decision|0|||
131598074|NCT04632992|473820205|FG008|Overall Study|Physician Decision|0|||
131598075|NCT04632992|473820206|FG009|Overall Study|Physician Decision|0|||
131598076|NCT04632992|473820207|FG010|Overall Study|Physician Decision|0|||
131598077|NCT04632992|473820208|FG011|Overall Study|Physician Decision|0|||
131598078|NCT04632992|473820209|FG012|Overall Study|Physician Decision|3|||
131598079|NCT04632992|473820210|FG013|Overall Study|Physician Decision|0|||
131598080|NCT04632992|473820197|FG000|Overall Study|Progressive Disease|0|||
131598081|NCT04632992|473820198|FG001|Overall Study|Progressive Disease|0|||
131598082|NCT04632992|473820199|FG002|Overall Study|Progressive Disease|0|||
131598083|NCT04632992|473820200|FG003|Overall Study|Progressive Disease|0|||
131598084|NCT04632992|473820201|FG004|Overall Study|Progressive Disease|1|||
131598085|NCT04632992|473820202|FG005|Overall Study|Progressive Disease|0|||
131598086|NCT04632992|473820203|FG006|Overall Study|Progressive Disease|0|||
131598087|NCT04632992|473820204|FG007|Overall Study|Progressive Disease|0|||
131598088|NCT04632992|473820205|FG008|Overall Study|Progressive Disease|0|||
131598089|NCT04632992|473820206|FG009|Overall Study|Progressive Disease|1|||
131598090|NCT04632992|473820207|FG010|Overall Study|Progressive Disease|1|||
131598091|NCT04632992|473820208|FG011|Overall Study|Progressive Disease|0|||
131598092|NCT04632992|473820209|FG012|Overall Study|Progressive Disease|2|||
131598093|NCT04632992|473820210|FG013|Overall Study|Progressive Disease|0|||
131598094|NCT04632992|473820197|FG000|Overall Study|Withdrawal by Subject|4|||
131598095|NCT04632992|473820198|FG001|Overall Study|Withdrawal by Subject|1|||
131706599|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131706600|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131706601|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
131706602|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
131706603|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706604|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706605|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706606|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706607|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706608|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706609|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131706610|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706611|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706612|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
131706613|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706614|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706615|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706616|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706617|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706618|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131706619|NCT01583374|474207444|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
131706620|NCT01583374|474207445|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
131706621|NCT01583374|474207446|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
131706622|NCT01583374|474207447|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
131706623|NCT01583374|474207448|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
131598096|NCT04632992|473820199|FG002|Overall Study|Withdrawal by Subject|5|||
131598097|NCT04632992|473820200|FG003|Overall Study|Withdrawal by Subject|4|||
131598098|NCT04632992|473820201|FG004|Overall Study|Withdrawal by Subject|3|||
131598099|NCT04632992|473820202|FG005|Overall Study|Withdrawal by Subject|3|||
131598100|NCT04632992|473820203|FG006|Overall Study|Withdrawal by Subject|0|||
131598101|NCT04632992|473820204|FG007|Overall Study|Withdrawal by Subject|5|||
131598102|NCT04632992|473820205|FG008|Overall Study|Withdrawal by Subject|0|||
131598103|NCT04632992|473820206|FG009|Overall Study|Withdrawal by Subject|2|||
131598104|NCT04632992|473820207|FG010|Overall Study|Withdrawal by Subject|8|||
131598105|NCT04632992|473820208|FG011|Overall Study|Withdrawal by Subject|0|||
131598106|NCT04632992|473820209|FG012|Overall Study|Withdrawal by Subject|1|||
131598107|NCT04632992|473820210|FG013|Overall Study|Withdrawal by Subject|1|||
131598108|NCT05647304|473820211|FG000|Overall Study|Withdrawal by Subject|1|||
131899662|NCT00368108|474919338|FG001|Overall Study|Protocol Violation|9|||
131899663|NCT00368108|474919339|FG002|Overall Study|Protocol Violation|9|||
131706624|NCT01583374|474207449|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
131598109|NCT05647304|473820212|FG001|Overall Study|Withdrawal by Subject|0|||
131598110|NCT03092518|473820214|FG000|Overall Study|Ineligible|2|||
131598111|NCT03603600|473820217|FG000|Overall Study|Withdrawal by Subject|5|||
131598112|NCT03603600|473820218|FG001|Overall Study|Withdrawal by Subject|7|||
131598113|NCT03603600|473820217|FG000|Overall Study|Lost to Follow-up|2|||
131598114|NCT03603600|473820218|FG001|Overall Study|Lost to Follow-up|3|||
131598115|NCT03603600|473820217|FG000|Overall Study|Death|3|||
131598116|NCT03603600|473820218|FG001|Overall Study|Death|1|||
131598117|NCT03603600|473820217|FG000|Overall Study|Physician Decision|2|||
131598118|NCT03603600|473820218|FG001|Overall Study|Physician Decision|1|||
131598119|NCT03603600|473820217|FG000|Overall Study|Other reason|1|||
131598120|NCT03603600|473820218|FG001|Overall Study|Other reason|0|||
131598121|NCT05084508|473820219|FG000|Overall Study|Lost to Follow-up|6|||
131598122|NCT05084508|473820220|FG001|Overall Study|Lost to Follow-up|3|||
131598123|NCT05084508|473820221|FG002|Overall Study|Lost to Follow-up|7|||
131598124|NCT05084508|473820222|FG003|Overall Study|Lost to Follow-up|3|||
131598125|NCT05084508|473820219|FG000|Overall Study|Withdrawal by Subject|0|||
131598126|NCT05084508|473820220|FG001|Overall Study|Withdrawal by Subject|2|||
131598127|NCT05084508|473820221|FG002|Overall Study|Withdrawal by Subject|3|||
131598128|NCT05084508|473820222|FG003|Overall Study|Withdrawal by Subject|1|||
131598129|NCT05084508|473820219|FG000|Overall Study|Other|0|||
131598130|NCT05084508|473820220|FG001|Overall Study|Other|0|||
131598131|NCT05084508|473820221|FG002|Overall Study|Other|0|||
131598132|NCT05084508|473820222|FG003|Overall Study|Other|1|||
131598133|NCT03931174|473820224|FG000|Providers|Staff left organization|26|||
131598134|NCT03931174|473820225|FG001|Providers|Staff left organization|25|||
131598135|NCT03931174|473820224|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
131598136|NCT03931174|473820225|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
131598137|NCT03931174|473820224|FG000|Providers|Lost to Follow-up|4|||
131598138|NCT03931174|473820225|FG001|Providers|Lost to Follow-up|4|||
131598139|NCT03931174|473820224|FG000|Patients|Post-consent screening failure|1|||
131598140|NCT03931174|473820225|FG001|Patients|Post-consent screening failure|1|||
131598141|NCT03931174|473820224|FG000|Patients|Death|1|||
131598142|NCT03931174|473820225|FG001|Patients|Death|1|||
131598143|NCT03931174|473820224|FG000|Patients|Lost to Follow-up|60|||
131598144|NCT03931174|473820225|FG001|Patients|Lost to Follow-up|89|||
131598145|NCT03492216|473820226|FG000|Overall Study|Death|1|||
131598146|NCT03492216|473820227|FG001|Overall Study|Death|0|||
131598147|NCT03492216|473820228|FG002|Overall Study|Death|4|||
131598148|NCT03492216|473820229|FG003|Overall Study|Death|0|||
131598149|NCT03492216|473820226|FG000|Overall Study|Withdrawal by Subject|5|||
131598150|NCT03492216|473820227|FG001|Overall Study|Withdrawal by Subject|3|||
131598151|NCT03492216|473820228|FG002|Overall Study|Withdrawal by Subject|1|||
131598152|NCT03492216|473820229|FG003|Overall Study|Withdrawal by Subject|1|||
131598153|NCT03492216|473820226|FG000|Overall Study|Lost to Follow-up|9|||
131598154|NCT03492216|473820227|FG001|Overall Study|Lost to Follow-up|2|||
131439868|NCT04201431|473236953|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
131439869|NCT04201431|473236954|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
131439870|NCT04201431|473236955|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
131598155|NCT03492216|473820228|FG002|Overall Study|Lost to Follow-up|7|||
131598156|NCT03492216|473820229|FG003|Overall Study|Lost to Follow-up|8|||
131598157|NCT03492216|473820226|FG000|Overall Study|Moved|5|||
131598158|NCT03492216|473820227|FG001|Overall Study|Moved|3|||
131598159|NCT03492216|473820228|FG002|Overall Study|Moved|3|||
131598160|NCT03492216|473820229|FG003|Overall Study|Moved|5|||
131598161|NCT03492216|473820226|FG000|Overall Study|Too ill|0|||
131899664|NCT00368108|474919337|FG000|Overall Study|Withdrawal by Subject|9|||
131598162|NCT03492216|473820227|FG001|Overall Study|Too ill|1|||
131598163|NCT03492216|473820228|FG002|Overall Study|Too ill|0|||
131598164|NCT03492216|473820229|FG003|Overall Study|Too ill|0|||
131598165|NCT03492216|473820226|FG000|Overall Study|Incarcerated|0|||
131598166|NCT03492216|473820227|FG001|Overall Study|Incarcerated|0|||
131598167|NCT03492216|473820228|FG002|Overall Study|Incarcerated|2|||
131598168|NCT03492216|473820229|FG003|Overall Study|Incarcerated|0|||
131598169|NCT03812679|473822354|FG000|Overall Study|Adverse Event|2|||
131598170|NCT03812679|473822354|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
131598171|NCT03812679|473822354|FG000|Overall Study|Renal transplant|1|||
131598172|NCT03812679|473822354|FG000|Overall Study|Withdrawal by Subject|1|||
131598173|NCT03812679|473822354|FG000|Overall Study|Termination of study|2|||
131598174|NCT03812679|473822354|FG000|Overall Study|Water device replacement|1|||
131598175|NCT05653427|473822355|FG000|Overall Study|Study Terminated by Sponsor|13|||
131598176|NCT04728347|473822359|FG000|Overall Study|Sponsor decision|0|||
131598177|NCT04728347|473822360|FG001|Overall Study|Sponsor decision|0|||
131598178|NCT04728347|473822361|FG002|Overall Study|Sponsor decision|1|||
131598179|NCT04728347|473822362|FG003|Overall Study|Sponsor decision|0|||
131598180|NCT03766009|473822364|FG000|Usual Care|Death|0|||
131598181|NCT03766009|473822365|FG001|Usual Care|Death|0|||
131598182|NCT03766009|473822366|FG002|Usual Care|Death|0|||
131598183|NCT03766009|473822367|FG003|Usual Care|Death|1|||
131598184|NCT03766009|473822368|FG004|Usual Care|Death|0|||
131598185|NCT03766009|473822369|FG005|Usual Care|Death|0|||
131598186|NCT03766009|473822364|FG000|Usual Care|Lost to Follow-up|0|||
131598187|NCT03766009|473822365|FG001|Usual Care|Lost to Follow-up|0|||
131598188|NCT03766009|473822366|FG002|Usual Care|Lost to Follow-up|0|||
131598189|NCT03766009|473822367|FG003|Usual Care|Lost to Follow-up|1|||
131598190|NCT03766009|473822368|FG004|Usual Care|Lost to Follow-up|0|||
131598191|NCT03766009|473822369|FG005|Usual Care|Lost to Follow-up|0|||
131598192|NCT03766009|473822364|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
131598193|NCT03766009|473822365|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
131598194|NCT03766009|473822366|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
131598195|NCT03766009|473822367|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
131598196|NCT03766009|473822368|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
131598197|NCT03766009|473822369|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
131598198|NCT03766009|473822364|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131598199|NCT03766009|473822365|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
131598200|NCT03766009|473822366|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131598201|NCT03766009|473822367|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
131598202|NCT03766009|473822368|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131598203|NCT03766009|473822369|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131598204|NCT03766009|473822364|FG000|Usual Care|No treatment or declined surgery|0|||
131598205|NCT03766009|473822365|FG001|Usual Care|No treatment or declined surgery|0|||
131598206|NCT03766009|473822366|FG002|Usual Care|No treatment or declined surgery|0|||
131598207|NCT03766009|473822367|FG003|Usual Care|No treatment or declined surgery|2|||
131598208|NCT03766009|473822368|FG004|Usual Care|No treatment or declined surgery|0|||
131598209|NCT03766009|473822369|FG005|Usual Care|No treatment or declined surgery|0|||
131598210|NCT03766009|473822364|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
131598211|NCT03766009|473822365|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
131598212|NCT03766009|473822366|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
131598213|NCT03766009|473822367|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
131598214|NCT03766009|473822368|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
131598215|NCT03766009|473822369|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
131598216|NCT03766009|473822364|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131598217|NCT03766009|473822365|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
131598218|NCT03766009|473822366|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131598219|NCT03766009|473822367|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131598220|NCT03766009|473822368|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131598221|NCT03766009|473822369|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131598222|NCT03766009|473822364|FG000|Usual Care|Ineligible|0|||
131598223|NCT03766009|473822365|FG001|Usual Care|Ineligible|1|||
131598224|NCT03766009|473822366|FG002|Usual Care|Ineligible|0|||
131598225|NCT03766009|473822367|FG003|Usual Care|Ineligible|0|||
131598226|NCT03766009|473822368|FG004|Usual Care|Ineligible|0|||
131598227|NCT03766009|473822369|FG005|Usual Care|Ineligible|0|||
131598228|NCT03766009|473822364|FG000|Usual Care|Other: Staff turnover|0|||
131598229|NCT03766009|473822365|FG001|Usual Care|Other: Staff turnover|0|||
131598230|NCT03766009|473822366|FG002|Usual Care|Other: Staff turnover|0|||
131598231|NCT03766009|473822367|FG003|Usual Care|Other: Staff turnover|0|||
131598232|NCT03766009|473822368|FG004|Usual Care|Other: Staff turnover|0|||
131899665|NCT00368108|474919338|FG001|Overall Study|Withdrawal by Subject|3|||
131598233|NCT03766009|473822369|FG005|Usual Care|Other: Staff turnover|2|||
131598234|NCT00554788|473822374|FG000|Overall Study|Adverse Event|0|||
131598235|NCT00554788|473822375|FG001|Overall Study|Adverse Event|1|||
131598236|NCT00554788|473822376|FG002|Overall Study|Adverse Event|2|||
131598237|NCT00554788|473822374|FG000|Overall Study|Lost to Follow-up|4|||
131598238|NCT00554788|473822375|FG001|Overall Study|Lost to Follow-up|3|||
131598239|NCT00554788|473822376|FG002|Overall Study|Lost to Follow-up|3|||
131598240|NCT00554788|473822374|FG000|Overall Study|Physician Decision|1|||
131598241|NCT00554788|473822375|FG001|Overall Study|Physician Decision|1|||
131598242|NCT00554788|473822376|FG002|Overall Study|Physician Decision|3|||
131598243|NCT00554788|473822374|FG000|Overall Study|Withdrawal by Subject|0|||
131598244|NCT00554788|473822375|FG001|Overall Study|Withdrawal by Subject|0|||
131598245|NCT00554788|473822376|FG002|Overall Study|Withdrawal by Subject|1|||
131598246|NCT00554788|473822374|FG000|Overall Study|Refusal of further protocol therapy|0|||
131598247|NCT00554788|473822375|FG001|Overall Study|Refusal of further protocol therapy|1|||
131598248|NCT00554788|473822376|FG002|Overall Study|Refusal of further protocol therapy|1|||
131598249|NCT00554788|473822374|FG000|Overall Study|Progressive disease|0|||
131598250|NCT00554788|473822375|FG001|Overall Study|Progressive disease|0|||
131598251|NCT00554788|473822376|FG002|Overall Study|Progressive disease|3|||
131598252|NCT00554788|473822374|FG000|Overall Study|Ineligible|2|||
131598253|NCT00554788|473822375|FG001|Overall Study|Ineligible|0|||
131598254|NCT00554788|473822376|FG002|Overall Study|Ineligible|1|||
131598255|NCT03897465|473822377|FG000|Overall Study|Lost to Follow-up|2|||
131598256|NCT03897465|473822378|FG001|Overall Study|Lost to Follow-up|1|||
131598257|NCT03897465|473822377|FG000|Overall Study|Adverse Event|2|||
131598258|NCT03897465|473822378|FG001|Overall Study|Adverse Event|0|||
131598259|NCT03897465|473822377|FG000|Overall Study|complete healing by V2|1|||
131598260|NCT03897465|473822378|FG001|Overall Study|complete healing by V2|0|||
131598261|NCT03897465|473822377|FG000|Overall Study|occurence of exclusion criterion|1|||
131598262|NCT03897465|473822378|FG001|Overall Study|occurence of exclusion criterion|1|||
131598263|NCT03897465|473822377|FG000|Overall Study|Other|1|||
131598264|NCT03897465|473822378|FG001|Overall Study|Other|0|||
131598265|NCT02985957|473822380|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131598266|NCT02985957|473822381|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131598267|NCT02985957|473822382|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131598268|NCT02985957|473822383|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131598269|NCT02985957|473822384|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131598270|NCT02985957|473822385|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131598271|NCT02985957|473822386|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131598272|NCT02985957|473822380|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
131598273|NCT02985957|473822381|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131598274|NCT02985957|473822382|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
131598275|NCT02985957|473822383|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
131598276|NCT02985957|473822384|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
131598277|NCT02985957|473822385|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
131598278|NCT02985957|473822386|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
131598279|NCT02985957|473822380|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131598280|NCT02985957|473822381|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131598281|NCT02985957|473822382|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131598282|NCT02985957|473822383|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131598283|NCT02985957|473822384|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131598284|NCT02985957|473822385|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131598285|NCT02985957|473822386|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
131598286|NCT02985957|473822380|FG000|Treatment Period|Death|0|||
131598287|NCT02985957|473822381|FG001|Treatment Period|Death|0|||
131598288|NCT02985957|473822382|FG002|Treatment Period|Death|0|||
131598289|NCT02985957|473822383|FG003|Treatment Period|Death|0|||
131598290|NCT02985957|473822384|FG004|Treatment Period|Death|1|||
131598291|NCT02985957|473822385|FG005|Treatment Period|Death|0|||
131598292|NCT02985957|473822386|FG006|Treatment Period|Death|0|||
131598293|NCT02985957|473822380|FG000|Treatment Period|Participant withdrew consent|0|||
131598294|NCT02985957|473822381|FG001|Treatment Period|Participant withdrew consent|0|||
131598295|NCT02985957|473822382|FG002|Treatment Period|Participant withdrew consent|0|||
131598296|NCT02985957|473822383|FG003|Treatment Period|Participant withdrew consent|1|||
131598297|NCT02985957|473822384|FG004|Treatment Period|Participant withdrew consent|3|||
131598298|NCT02985957|473822385|FG005|Treatment Period|Participant withdrew consent|0|||
131598299|NCT02985957|473822386|FG006|Treatment Period|Participant withdrew consent|1|||
131598300|NCT02985957|473822380|FG000|Treatment Period|Lost to Follow-up|0|||
131598301|NCT02985957|473822381|FG001|Treatment Period|Lost to Follow-up|0|||
131598302|NCT02985957|473822382|FG002|Treatment Period|Lost to Follow-up|0|||
131598303|NCT02985957|473822383|FG003|Treatment Period|Lost to Follow-up|0|||
131598304|NCT02985957|473822384|FG004|Treatment Period|Lost to Follow-up|1|||
131598305|NCT02985957|473822385|FG005|Treatment Period|Lost to Follow-up|0|||
131598306|NCT02985957|473822386|FG006|Treatment Period|Lost to Follow-up|0|||
131598307|NCT02985957|473822380|FG000|Treatment Period|Other reasons|0|||
131598308|NCT02985957|473822381|FG001|Treatment Period|Other reasons|0|||
131598309|NCT02985957|473822382|FG002|Treatment Period|Other reasons|1|||
131598310|NCT02985957|473822383|FG003|Treatment Period|Other reasons|3|||
131598311|NCT02985957|473822384|FG004|Treatment Period|Other reasons|6|||
131598312|NCT02985957|473822385|FG005|Treatment Period|Other reasons|0|||
131598313|NCT02985957|473822386|FG006|Treatment Period|Other reasons|1|||
131598314|NCT02985957|473822380|FG000|Treatment Period|Not reported|0|||
131598315|NCT02985957|473822381|FG001|Treatment Period|Not reported|1|||
131598316|NCT02985957|473822382|FG002|Treatment Period|Not reported|2|||
131598317|NCT02985957|473822383|FG003|Treatment Period|Not reported|5|||
131598318|NCT02985957|473822384|FG004|Treatment Period|Not reported|0|||
131598319|NCT02985957|473822385|FG005|Treatment Period|Not reported|0|||
131598320|NCT02985957|473822386|FG006|Treatment Period|Not reported|0|||
131598321|NCT02985957|473822380|FG000|Treatment Period|Maximum clinical benefit|0|||
131598322|NCT02985957|473822381|FG001|Treatment Period|Maximum clinical benefit|0|||
131598323|NCT02985957|473822382|FG002|Treatment Period|Maximum clinical benefit|1|||
131598324|NCT02985957|473822383|FG003|Treatment Period|Maximum clinical benefit|1|||
131598325|NCT02985957|473822384|FG004|Treatment Period|Maximum clinical benefit|0|||
131598326|NCT02985957|473822385|FG005|Treatment Period|Maximum clinical benefit|0|||
131598327|NCT02985957|473822386|FG006|Treatment Period|Maximum clinical benefit|2|||
131598328|NCT02985957|473822380|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
131598329|NCT02985957|473822381|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
131598330|NCT02985957|473822382|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
131598331|NCT02985957|473822383|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
131598332|NCT02985957|473822384|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
131598333|NCT02985957|473822385|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
131598334|NCT02985957|473822386|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
131598335|NCT02985957|473822380|FG000|Treatment Period|Study drug toxicity|1|||
131598336|NCT02985957|473822381|FG001|Treatment Period|Study drug toxicity|23|||
131598337|NCT02985957|473822382|FG002|Treatment Period|Study drug toxicity|20|||
131598338|NCT02985957|473822383|FG003|Treatment Period|Study drug toxicity|11|||
131598339|NCT02985957|473822384|FG004|Treatment Period|Study drug toxicity|19|||
131598340|NCT02985957|473822385|FG005|Treatment Period|Study drug toxicity|3|||
131598341|NCT02985957|473822386|FG006|Treatment Period|Study drug toxicity|5|||
131598342|NCT02985957|473822380|FG000|Treatment Period|Disease progression|0|||
131598343|NCT02985957|473822381|FG001|Treatment Period|Disease progression|16|||
131598344|NCT02985957|473822382|FG002|Treatment Period|Disease progression|20|||
131598345|NCT02985957|473822383|FG003|Treatment Period|Disease progression|39|||
131598346|NCT02985957|473822384|FG004|Treatment Period|Disease progression|29|||
131598347|NCT02985957|473822385|FG005|Treatment Period|Disease progression|11|||
131598348|NCT02985957|473822386|FG006|Treatment Period|Disease progression|28|||
131598349|NCT02985957|473822380|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
131598350|NCT02985957|473822381|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
131598351|NCT02985957|473822382|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
131598352|NCT02985957|473822383|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
131598353|NCT02985957|473822384|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
131598354|NCT02985957|473822385|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
131598355|NCT02985957|473822386|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
131598356|NCT02985957|473822380|FG000|Treatment Period|Poor/Non-Compliance|0|||
131598357|NCT02985957|473822381|FG001|Treatment Period|Poor/Non-Compliance|0|||
131598358|NCT02985957|473822382|FG002|Treatment Period|Poor/Non-Compliance|0|||
131598359|NCT02985957|473822383|FG003|Treatment Period|Poor/Non-Compliance|0|||
131598360|NCT02985957|473822384|FG004|Treatment Period|Poor/Non-Compliance|1|||
131598361|NCT02985957|473822385|FG005|Treatment Period|Poor/Non-Compliance|1|||
131439871|NCT04913610|473236956|FG000|Randomized Participants|Did Not Receive Treatment|0|||
131439872|NCT04913610|473236957|FG001|Randomized Participants|Did Not Receive Treatment|0|||
131439873|NCT04913610|473236958|FG002|Randomized Participants|Did Not Receive Treatment|1|||
131439874|NCT04913610|473236959|FG003|Randomized Participants|Did Not Receive Treatment|1|||
131598362|NCT02985957|473822386|FG006|Treatment Period|Poor/Non-Compliance|0|||
131598363|NCT02985957|473822380|FG000|Treatment Period|Continuing in Treatment Period|0|||
131598364|NCT02985957|473822381|FG001|Treatment Period|Continuing in Treatment Period|1|||
131598365|NCT02985957|473822382|FG002|Treatment Period|Continuing in Treatment Period|0|||
131598366|NCT02985957|473822383|FG003|Treatment Period|Continuing in Treatment Period|4|||
131598367|NCT02985957|473822384|FG004|Treatment Period|Continuing in Treatment Period|4|||
131598368|NCT02985957|473822385|FG005|Treatment Period|Continuing in Treatment Period|0|||
131598369|NCT02985957|473822386|FG006|Treatment Period|Continuing in Treatment Period|0|||
131598370|NCT04342494|473822387|FG000|Overall Study|Questionnaire partially completed|1|||
131598371|NCT04342494|473822388|FG001|Overall Study|Questionnaire partially completed|0|||
131598372|NCT04342494|473822389|FG002|Overall Study|Questionnaire partially completed|2|||
131598373|NCT04342494|473822390|FG003|Overall Study|Questionnaire partially completed|0|||
131598374|NCT04342494|473822391|FG004|Overall Study|Questionnaire partially completed|1|||
131598375|NCT04342494|473822387|FG000|Overall Study|Lost to Follow-up|49|||
131598376|NCT04342494|473822388|FG001|Overall Study|Lost to Follow-up|38|||
131598377|NCT04342494|473822389|FG002|Overall Study|Lost to Follow-up|34|||
131598378|NCT04342494|473822390|FG003|Overall Study|Lost to Follow-up|34|||
131598379|NCT04342494|473822391|FG004|Overall Study|Lost to Follow-up|35|||
131598380|NCT05835336|473822393|FG000|Overall Study|Withdrawal by Subject|5|||
131598381|NCT05835336|473822393|FG000|Overall Study|Did not complete the personalization process|3|||
131598382|NCT03016754|473822396|FG000|Overall Study|Death|5|||
131598383|NCT03016754|473822397|FG001|Overall Study|Death|4|||
131598384|NCT03016754|473822398|FG002|Overall Study|Death|5|||
131598385|NCT03016754|473822399|FG003|Overall Study|Death|1|||
131598386|NCT03016754|473822396|FG000|Overall Study|Lost to Follow-up|23|||
131598387|NCT03016754|473822397|FG001|Overall Study|Lost to Follow-up|17|||
131598388|NCT03016754|473822398|FG002|Overall Study|Lost to Follow-up|4|||
131598389|NCT03016754|473822399|FG003|Overall Study|Lost to Follow-up|2|||
131598390|NCT03016754|473822396|FG000|Overall Study|Withdrawal by Subject|6|||
131598391|NCT03016754|473822397|FG001|Overall Study|Withdrawal by Subject|6|||
131598392|NCT03016754|473822398|FG002|Overall Study|Withdrawal by Subject|2|||
131598393|NCT03016754|473822399|FG003|Overall Study|Withdrawal by Subject|2|||
131598394|NCT03016754|473822396|FG000|Overall Study|Other/Unknown|2|||
131598395|NCT03016754|473822397|FG001|Overall Study|Other/Unknown|4|||
131598396|NCT03016754|473822398|FG002|Overall Study|Other/Unknown|2|||
131598397|NCT03016754|473822399|FG003|Overall Study|Other/Unknown|1|||
131598398|NCT03016754|473822396|FG000|Overall Study|Protocol Violation|0|||
131598399|NCT03016754|473822397|FG001|Overall Study|Protocol Violation|0|||
131598400|NCT03016754|473822398|FG002|Overall Study|Protocol Violation|0|||
131598401|NCT03016754|473822399|FG003|Overall Study|Protocol Violation|4|||
131598402|NCT03839940|473822400|FG000|Overall Study|Withdrawal by Subject|3|||
131598403|NCT03839940|473822401|FG001|Overall Study|Withdrawal by Subject|0|||
131598404|NCT03839940|473822400|FG000|Overall Study|Protocol Violation|0|||
131598405|NCT03839940|473822401|FG001|Overall Study|Protocol Violation|1|||
131598406|NCT03839940|473822400|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
131598407|NCT03839940|473822401|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
131598408|NCT00470704|473822402|FG000|Overall Study|Withdrawal by Subject|4|||
131598409|NCT00470704|473822403|FG001|Overall Study|Withdrawal by Subject|3|||
131598410|NCT00470704|473822402|FG000|Overall Study|Relapse/Progression|37|||
131598411|NCT00470704|473822403|FG001|Overall Study|Relapse/Progression|42|||
131598412|NCT00470704|473822402|FG000|Overall Study|toxicity|0|||
131598413|NCT00470704|473822403|FG001|Overall Study|toxicity|1|||
131598414|NCT04019873|473822404|FG000|Overall Study|Discontinued from the treatment|1|||
131598415|NCT04019873|473822405|FG001|Overall Study|Discontinued from the treatment|39|||
131598416|NCT04019873|473822406|FG002|Overall Study|Discontinued from the treatment|2|||
131598417|NCT00085735|473822407|FG000|Overall Study|Adverse Event|1|||
131598418|NCT00085735|473822408|FG001|Overall Study|Adverse Event|0|||
131598419|NCT00085735|473822409|FG002|Overall Study|Adverse Event|0|||
131598420|NCT00085735|473822410|FG003|Overall Study|Adverse Event|0|||
131598421|NCT00085735|473822411|FG004|Overall Study|Adverse Event|0|||
131598422|NCT00085735|473822412|FG005|Overall Study|Adverse Event|0|||
131706625|NCT01583374|474207450|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
131598423|NCT00085735|473822407|FG000|Overall Study|Lack of Efficacy|2|||
131598424|NCT00085735|473822408|FG001|Overall Study|Lack of Efficacy|4|||
131598425|NCT00085735|473822409|FG002|Overall Study|Lack of Efficacy|6|||
131598426|NCT00085735|473822410|FG003|Overall Study|Lack of Efficacy|3|||
131598427|NCT00085735|473822411|FG004|Overall Study|Lack of Efficacy|4|||
131598428|NCT00085735|473822412|FG005|Overall Study|Lack of Efficacy|3|||
131598429|NCT00085735|473822407|FG000|Overall Study|Lost to Follow-up|0|||
131598430|NCT00085735|473822408|FG001|Overall Study|Lost to Follow-up|1|||
131598431|NCT00085735|473822409|FG002|Overall Study|Lost to Follow-up|0|||
131598432|NCT00085735|473822410|FG003|Overall Study|Lost to Follow-up|0|||
131598433|NCT00085735|473822411|FG004|Overall Study|Lost to Follow-up|1|||
131598434|NCT00085735|473822412|FG005|Overall Study|Lost to Follow-up|0|||
131598435|NCT00085735|473822407|FG000|Overall Study|Physician Decision|2|||
131598436|NCT00085735|473822408|FG001|Overall Study|Physician Decision|3|||
131598437|NCT00085735|473822409|FG002|Overall Study|Physician Decision|2|||
131598438|NCT00085735|473822410|FG003|Overall Study|Physician Decision|3|||
131598439|NCT00085735|473822411|FG004|Overall Study|Physician Decision|11|||
131598440|NCT00085735|473822412|FG005|Overall Study|Physician Decision|8|||
131598441|NCT00085735|473822407|FG000|Overall Study|Protocol Violation|1|||
131598442|NCT00085735|473822408|FG001|Overall Study|Protocol Violation|0|||
131598443|NCT00085735|473822409|FG002|Overall Study|Protocol Violation|0|||
131598444|NCT00085735|473822410|FG003|Overall Study|Protocol Violation|0|||
131598445|NCT00085735|473822411|FG004|Overall Study|Protocol Violation|0|||
131598446|NCT00085735|473822412|FG005|Overall Study|Protocol Violation|0|||
131598447|NCT00085735|473822407|FG000|Overall Study|Withdrawal by Subject|1|||
131598448|NCT00085735|473822408|FG001|Overall Study|Withdrawal by Subject|0|||
131598449|NCT00085735|473822409|FG002|Overall Study|Withdrawal by Subject|4|||
131598450|NCT00085735|473822410|FG003|Overall Study|Withdrawal by Subject|5|||
131598451|NCT00085735|473822411|FG004|Overall Study|Withdrawal by Subject|7|||
131598452|NCT00085735|473822412|FG005|Overall Study|Withdrawal by Subject|8|||
131598453|NCT00085735|473822407|FG000|Overall Study|Patient ineligible|1|||
131598454|NCT00085735|473822408|FG001|Overall Study|Patient ineligible|0|||
131598455|NCT00085735|473822409|FG002|Overall Study|Patient ineligible|3|||
131598456|NCT00085735|473822410|FG003|Overall Study|Patient ineligible|7|||
131598457|NCT00085735|473822411|FG004|Overall Study|Patient ineligible|17|||
131598458|NCT00085735|473822412|FG005|Overall Study|Patient ineligible|8|||
131598459|NCT00085735|473822407|FG000|Overall Study|Excess residual disease|2|||
131598460|NCT00085735|473822408|FG001|Overall Study|Excess residual disease|2|||
131598461|NCT00085735|473822409|FG002|Overall Study|Excess residual disease|1|||
131598462|NCT00085735|473822410|FG003|Overall Study|Excess residual disease|1|||
131598463|NCT00085735|473822411|FG004|Overall Study|Excess residual disease|1|||
131598464|NCT00085735|473822412|FG005|Overall Study|Excess residual disease|4|||
131598465|NCT00085735|473822407|FG000|Overall Study|Reason not documented|1|||
131598466|NCT00085735|473822408|FG001|Overall Study|Reason not documented|0|||
131598467|NCT00085735|473822409|FG002|Overall Study|Reason not documented|1|||
131598468|NCT00085735|473822410|FG003|Overall Study|Reason not documented|0|||
131598469|NCT00085735|473822411|FG004|Overall Study|Reason not documented|1|||
131598470|NCT00085735|473822412|FG005|Overall Study|Reason not documented|0|||
131598471|NCT00085735|473822407|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
131598472|NCT00085735|473822408|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
131598473|NCT00085735|473822409|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
131598474|NCT00085735|473822410|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
131598475|NCT00085735|473822411|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
131598476|NCT00085735|473822412|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
131598477|NCT04473222|473822413|FG000|Overall Study|Lost to Follow-up|13|||
131598478|NCT04473222|473822414|FG001|Overall Study|Lost to Follow-up|13|||
131598479|NCT04473222|473822413|FG000|Overall Study|Withdrawal by Subject|0|||
131598480|NCT04473222|473822414|FG001|Overall Study|Withdrawal by Subject|1|||
131598481|NCT04473222|473822413|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
131598482|NCT04473222|473822414|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
131598483|NCT02919306|473822415|FG000|Overall Study|Withdrawal by Subject|1|||
131598484|NCT02919306|473822416|FG001|Overall Study|Withdrawal by Subject|0|||
131598485|NCT02919306|473822415|FG000|Overall Study|Protocol Violation|1|||
131598486|NCT02919306|473822416|FG001|Overall Study|Protocol Violation|0|||
131598487|NCT04195698|473822417|FG000|Overall Study|Adverse Event|4|||
131598488|NCT04195698|473822418|FG001|Overall Study|Adverse Event|11|||
131598489|NCT04195698|473822417|FG000|Overall Study|Withdrawal by Subject|9|||
131598490|NCT04195698|473822418|FG001|Overall Study|Withdrawal by Subject|10|||
131598491|NCT04195698|473822417|FG000|Overall Study|Lost to Follow-up|5|||
131598492|NCT04195698|473822418|FG001|Overall Study|Lost to Follow-up|4|||
131598493|NCT04195698|473822417|FG000|Overall Study|Lack of Efficacy|2|||
131598494|NCT04195698|473822418|FG001|Overall Study|Lack of Efficacy|10|||
131598495|NCT04195698|473822417|FG000|Overall Study|Other|5|||
131598496|NCT04195698|473822418|FG001|Overall Study|Other|4|||
131598497|NCT05459688|473822419|FG000|Overall Study|Lost to Follow-up|6|||
131598498|NCT05459688|473822419|FG000|Overall Study|Physician Decision|1|||
131598499|NCT05459688|473822419|FG000|Overall Study|Withdrawal by Subject|19|||
131598500|NCT05459688|473822419|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
131598501|NCT04908722|473822420|FG000|Overall Study|Protocol deviation|1|||
131598502|NCT04908722|473822421|FG001|Overall Study|Protocol deviation|0|||
131598503|NCT04908722|473822422|FG002|Overall Study|Protocol deviation|0|||
131598504|NCT04908722|473822423|FG003|Overall Study|Protocol deviation|0|||
131598505|NCT04908722|473822424|FG004|Overall Study|Protocol deviation|0|||
131598506|NCT04908722|473822425|FG005|Overall Study|Protocol deviation|1|||
131598507|NCT04908722|473822420|FG000|Overall Study|Lost to Follow-up|33|||
131598508|NCT04908722|473822421|FG001|Overall Study|Lost to Follow-up|33|||
131598509|NCT04908722|473822422|FG002|Overall Study|Lost to Follow-up|36|||
131598510|NCT04908722|473822423|FG003|Overall Study|Lost to Follow-up|30|||
131598511|NCT04908722|473822424|FG004|Overall Study|Lost to Follow-up|32|||
131598512|NCT04908722|473822425|FG005|Overall Study|Lost to Follow-up|34|||
131598513|NCT04908722|473822420|FG000|Overall Study|Physician Decision|1|||
131598514|NCT04908722|473822421|FG001|Overall Study|Physician Decision|1|||
131598515|NCT04908722|473822422|FG002|Overall Study|Physician Decision|1|||
131598516|NCT04908722|473822423|FG003|Overall Study|Physician Decision|2|||
131598517|NCT04908722|473822424|FG004|Overall Study|Physician Decision|0|||
131598518|NCT04908722|473822425|FG005|Overall Study|Physician Decision|0|||
131598519|NCT04908722|473822420|FG000|Overall Study|Death|1|||
131598520|NCT04908722|473822421|FG001|Overall Study|Death|0|||
131598521|NCT04908722|473822422|FG002|Overall Study|Death|0|||
131598522|NCT04908722|473822423|FG003|Overall Study|Death|0|||
131598523|NCT04908722|473822424|FG004|Overall Study|Death|0|||
131598524|NCT04908722|473822425|FG005|Overall Study|Death|1|||
131598525|NCT04908722|473822420|FG000|Overall Study|Withdrawal by Subject|12|||
131598526|NCT04908722|473822421|FG001|Overall Study|Withdrawal by Subject|8|||
131598527|NCT04908722|473822422|FG002|Overall Study|Withdrawal by Subject|7|||
131598528|NCT04908722|473822423|FG003|Overall Study|Withdrawal by Subject|6|||
131598529|NCT04908722|473822424|FG004|Overall Study|Withdrawal by Subject|12|||
131598530|NCT04908722|473822425|FG005|Overall Study|Withdrawal by Subject|14|||
131598531|NCT04908722|473822420|FG000|Overall Study|Other|3|||
131598532|NCT04908722|473822421|FG001|Overall Study|Other|1|||
131598533|NCT04908722|473822422|FG002|Overall Study|Other|3|||
131598534|NCT04908722|473822423|FG003|Overall Study|Other|2|||
131598535|NCT04908722|473822424|FG004|Overall Study|Other|4|||
131598536|NCT04908722|473822425|FG005|Overall Study|Other|1|||
131598537|NCT04908722|473822420|FG000|Overall Study|Initiated prohibited medication|0|||
131598538|NCT04908722|473822421|FG001|Overall Study|Initiated prohibited medication|0|||
131598539|NCT04908722|473822422|FG002|Overall Study|Initiated prohibited medication|0|||
131598540|NCT04908722|473822423|FG003|Overall Study|Initiated prohibited medication|1|||
131598541|NCT04908722|473822424|FG004|Overall Study|Initiated prohibited medication|0|||
131598542|NCT04908722|473822425|FG005|Overall Study|Initiated prohibited medication|1|||
131598543|NCT04908722|473822420|FG000|Overall Study|Randomized but not vaccinated|3|||
131598544|NCT04908722|473822421|FG001|Overall Study|Randomized but not vaccinated|1|||
131598545|NCT04908722|473822422|FG002|Overall Study|Randomized but not vaccinated|2|||
131598546|NCT04908722|473822423|FG003|Overall Study|Randomized but not vaccinated|2|||
131598547|NCT04908722|473822424|FG004|Overall Study|Randomized but not vaccinated|3|||
131598548|NCT04908722|473822425|FG005|Overall Study|Randomized but not vaccinated|4|||
131598549|NCT02319759|473822426|FG000|Week 0 - 16|Lack of Efficacy|1|||
131598550|NCT02319759|473822427|FG001|Week 0 - 16|Lack of Efficacy|0|||
131598551|NCT02319759|473822428|FG002|Week 0 - 16|Lack of Efficacy|0|||
131598552|NCT02319759|473822429|FG003|Week 0 - 16|Lack of Efficacy|0|||
131598553|NCT02319759|473822430|FG004|Week 0 - 16|Lack of Efficacy|0|||
131598554|NCT02319759|473822426|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
131598555|NCT02319759|473822427|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
131598556|NCT02319759|473822428|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
131598557|NCT02319759|473822429|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
131598558|NCT02319759|473822430|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
131598559|NCT02319759|473822426|FG000|Week 16 - 24|Lack of Efficacy|1|||
131706626|NCT01583374|474207451|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
131706627|NCT01583374|474207452|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
131706628|NCT01583374|474207444|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131706629|NCT01583374|474207445|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131598560|NCT02319759|473822427|FG001|Week 16 - 24|Lack of Efficacy|0|||
131598561|NCT02319759|473822428|FG002|Week 16 - 24|Lack of Efficacy|1|||
131598562|NCT02319759|473822429|FG003|Week 16 - 24|Lack of Efficacy|0|||
131598563|NCT02319759|473822430|FG004|Week 16 - 24|Lack of Efficacy|0|||
131598564|NCT02319759|473822426|FG000|Week 16 - 24|Lost to Follow-up|1|||
131598565|NCT02319759|473822427|FG001|Week 16 - 24|Lost to Follow-up|0|||
131598566|NCT02319759|473822428|FG002|Week 16 - 24|Lost to Follow-up|0|||
131598567|NCT02319759|473822429|FG003|Week 16 - 24|Lost to Follow-up|0|||
131598568|NCT02319759|473822430|FG004|Week 16 - 24|Lost to Follow-up|0|||
131598569|NCT02319759|473822426|FG000|Week 16 - 24|Withdrawal by Subject|0|||
131598570|NCT02319759|473822427|FG001|Week 16 - 24|Withdrawal by Subject|0|||
131598571|NCT02319759|473822428|FG002|Week 16 - 24|Withdrawal by Subject|2|||
131598572|NCT02319759|473822429|FG003|Week 16 - 24|Withdrawal by Subject|0|||
131598573|NCT02319759|473822430|FG004|Week 16 - 24|Withdrawal by Subject|0|||
131598574|NCT02319759|473822426|FG000|Week 24 - 56|Adverse Event|0|||
131598575|NCT02319759|473822427|FG001|Week 24 - 56|Adverse Event|0|||
131598576|NCT02319759|473822428|FG002|Week 24 - 56|Adverse Event|2|||
131598577|NCT02319759|473822429|FG003|Week 24 - 56|Adverse Event|0|||
131598578|NCT02319759|473822430|FG004|Week 24 - 56|Adverse Event|0|||
131598579|NCT02319759|473822426|FG000|Week 24 - 56|Lack of Efficacy|0|||
131598580|NCT02319759|473822427|FG001|Week 24 - 56|Lack of Efficacy|0|||
131598581|NCT02319759|473822428|FG002|Week 24 - 56|Lack of Efficacy|0|||
131598582|NCT02319759|473822429|FG003|Week 24 - 56|Lack of Efficacy|2|||
131598583|NCT02319759|473822430|FG004|Week 24 - 56|Lack of Efficacy|1|||
131598584|NCT02319759|473822426|FG000|Week 24 - 56|Withdrawal by Subject|0|||
131598585|NCT02319759|473822427|FG001|Week 24 - 56|Withdrawal by Subject|1|||
131598586|NCT02319759|473822428|FG002|Week 24 - 56|Withdrawal by Subject|0|||
131598587|NCT02319759|473822429|FG003|Week 24 - 56|Withdrawal by Subject|0|||
131598588|NCT02319759|473822430|FG004|Week 24 - 56|Withdrawal by Subject|0|||
131598589|NCT02319759|473822426|FG000|Week 24 - 56|Lost to Follow-up|0|||
131598590|NCT02319759|473822427|FG001|Week 24 - 56|Lost to Follow-up|0|||
131598591|NCT02319759|473822428|FG002|Week 24 - 56|Lost to Follow-up|0|||
131598592|NCT02319759|473822429|FG003|Week 24 - 56|Lost to Follow-up|0|||
131598593|NCT02319759|473822430|FG004|Week 24 - 56|Lost to Follow-up|1|||
131598594|NCT03339713|473822432|FG000|Overall Study|Lost to Follow-up|2|||
131598595|NCT03339713|473822433|FG001|Overall Study|Lost to Follow-up|1|||
131598596|NCT03339713|473822432|FG000|Overall Study|Protocol Violation|1|||
131598597|NCT03339713|473822433|FG001|Overall Study|Protocol Violation|0|||
131598598|NCT03339713|473822432|FG000|Overall Study|Withdrawal by Subject|1|||
131598599|NCT03339713|473822433|FG001|Overall Study|Withdrawal by Subject|1|||
131598600|NCT01959425|473822434|FG000|Overall Study|Withdrawal by Subject|5|||
131598601|NCT01959425|473822435|FG001|Overall Study|Withdrawal by Subject|4|||
131598602|NCT01959425|473822434|FG000|Overall Study|Lost to Follow-up|1|||
131598603|NCT01959425|473822435|FG001|Overall Study|Lost to Follow-up|0|||
131598604|NCT01959425|473822434|FG000|Overall Study|Discontinued Subjects|6|||
131598605|NCT01959425|473822435|FG001|Overall Study|Discontinued Subjects|4|||
131598606|NCT05540665|473822437|FG000|Overall Study|Study terminated by sponsor|6|||
131598607|NCT05540665|473822438|FG001|Overall Study|Study terminated by sponsor|6|||
131598608|NCT05540665|473822439|FG002|Overall Study|Study terminated by sponsor|7|||
131598609|NCT02619838|473822442|FG000|Overall Study|Lost to Follow-up|9|||
131598610|NCT02619838|473822442|FG000|Overall Study|Withdrawal by Subject|15|||
131598611|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
131598612|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
131598613|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
131598614|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
131598615|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
131598616|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
131598617|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
131598618|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
131598619|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
131598620|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
131598621|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
131598622|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
131598623|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
131598624|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
131598625|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
131598626|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
131598627|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
131598628|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
131598629|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
131598630|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
131598631|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
131598632|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
131598633|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
131598634|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
131598635|NCT01715285|473822443|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
131598636|NCT01715285|473822444|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
131598637|NCT01715285|473822445|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
131598638|NCT01715285|473822443|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
131598639|NCT01715285|473822444|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
131598640|NCT01715285|473822445|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
131598641|NCT01715285|473822443|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
131598642|NCT01715285|473822444|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
131598643|NCT01715285|473822445|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
131598644|NCT01715285|473822443|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
131598645|NCT01715285|473822444|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
131598646|NCT01715285|473822445|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
131598647|NCT01715285|473822443|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
131598648|NCT01715285|473822444|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
131598649|NCT01715285|473822445|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
131598650|NCT01715285|473822443|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
131598651|NCT01715285|473822444|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
131598652|NCT01715285|473822445|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
131598653|NCT05020249|473822446|FG000|Overall Study|Protocol Violation|1|||
131598654|NCT05020249|473822447|FG001|Overall Study|Protocol Violation|0|||
131598655|NCT02677805|473822471|FG000|Double Blind Phase|Lost to Follow-up|8|||
131598656|NCT02677805|473822472|FG001|Double Blind Phase|Lost to Follow-up|3|||
131598657|NCT02677805|473822473|FG002|Double Blind Phase|Lost to Follow-up|0|||
131598658|NCT02677805|473822471|FG000|Double Blind Phase|Withdrawal by Subject|5|||
131598659|NCT02677805|473822472|FG001|Double Blind Phase|Withdrawal by Subject|2|||
131598660|NCT02677805|473822473|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131598661|NCT02677805|473822471|FG000|Open Label Phase|Lost to Follow-up|0|||
131598662|NCT02677805|473822472|FG001|Open Label Phase|Lost to Follow-up|0|||
131598663|NCT02677805|473822473|FG002|Open Label Phase|Lost to Follow-up|10|||
131598664|NCT02677805|473822471|FG000|Open Label Phase|Withdrawal by Subject|0|||
131598665|NCT02677805|473822472|FG001|Open Label Phase|Withdrawal by Subject|0|||
131598666|NCT02677805|473822473|FG002|Open Label Phase|Withdrawal by Subject|6|||
131598667|NCT04111536|473822478|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131598668|NCT04111536|473822479|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
131598669|NCT04111536|473822478|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
131598670|NCT04111536|473822479|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
131598671|NCT04111536|473822478|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
131598672|NCT04111536|473822479|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
131598673|NCT04111536|473822478|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
131598674|NCT04111536|473822479|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
131598675|NCT04350463|473822480|FG000|Overall Study|Other reason|0|||
131598676|NCT04350463|473822481|FG001|Overall Study|Other reason|0|||
131598677|NCT04350463|473822482|FG002|Overall Study|Other reason|0|||
131598678|NCT04350463|473822483|FG003|Overall Study|Other reason|1|||
131598679|NCT04350463|473822480|FG000|Overall Study|Lost to Follow-up|0|||
131598680|NCT04350463|473822481|FG001|Overall Study|Lost to Follow-up|0|||
131598681|NCT04350463|473822482|FG002|Overall Study|Lost to Follow-up|0|||
131598682|NCT04350463|473822483|FG003|Overall Study|Lost to Follow-up|2|||
131598683|NCT04350463|473822480|FG000|Overall Study|Withdrawal by Subject|4|||
131598684|NCT04350463|473822481|FG001|Overall Study|Withdrawal by Subject|0|||
131598685|NCT04350463|473822482|FG002|Overall Study|Withdrawal by Subject|1|||
131598686|NCT04350463|473822483|FG003|Overall Study|Withdrawal by Subject|4|||
131598687|NCT04350463|473822480|FG000|Overall Study|Adverse Event|0|||
131598688|NCT04350463|473822481|FG001|Overall Study|Adverse Event|0|||
131598689|NCT04350463|473822482|FG002|Overall Study|Adverse Event|0|||
131598690|NCT04350463|473822483|FG003|Overall Study|Adverse Event|2|||
131598691|NCT04350463|473822480|FG000|Overall Study|Death|27|||
131598692|NCT04350463|473822481|FG001|Overall Study|Death|2|||
131598693|NCT04350463|473822482|FG002|Overall Study|Death|13|||
131598694|NCT04350463|473822483|FG003|Overall Study|Death|26|||
131598695|NCT05672069|473822485|FG000|Overall Study|Implant removal|1|||
131598696|NCT05672069|473822485|FG000|Overall Study|Lost to Follow-up|2|||
131598697|NCT02547233|473822486|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
131598698|NCT02547233|473822487|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
131598699|NCT02547233|473822486|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
131598700|NCT02547233|473822487|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
131598701|NCT02547233|473822486|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
131598702|NCT02547233|473822487|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
131598703|NCT02547233|473822486|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
131598704|NCT02547233|473822487|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
131598705|NCT02547233|473822486|FG000|12-month Follow-up|Withdrawal by Subject|10|||
131899666|NCT00368108|474919339|FG002|Overall Study|Withdrawal by Subject|5|||
131598706|NCT02547233|473822487|FG001|12-month Follow-up|Withdrawal by Subject|10|||
131598707|NCT02547233|473822486|FG000|12-month Follow-up|Lost to Follow-up|3|||
131598708|NCT02547233|473822487|FG001|12-month Follow-up|Lost to Follow-up|3|||
131598709|NCT02547233|473822486|FG000|12-month Follow-up|Lack of Efficacy|1|||
131598710|NCT02547233|473822487|FG001|12-month Follow-up|Lack of Efficacy|2|||
131598711|NCT02547233|473822486|FG000|12-month Follow-up|Protocol Violation|0|||
131598712|NCT02547233|473822487|FG001|12-month Follow-up|Protocol Violation|1|||
131598713|NCT02547233|473822486|FG000|12-month Follow-up|Other|0|||
131598714|NCT02547233|473822487|FG001|12-month Follow-up|Other|1|||
131598715|NCT04096040|473822488|FG000|Overall Study|Protocol Violation|12|||
131598716|NCT04096040|473822488|FG000|Overall Study|Non-compliant site|4|||
131598717|NCT04537715|473822493|FG000|Overall Study|Death|3|||
131598718|NCT04537715|473822494|FG001|Overall Study|Death|1|||
131598719|NCT04537715|473822493|FG000|Overall Study|Withdrawal by Subject|3|||
131598720|NCT04537715|473822494|FG001|Overall Study|Withdrawal by Subject|1|||
131598721|NCT04537715|473822493|FG000|Overall Study|Other|4|||
131598722|NCT04537715|473822494|FG001|Overall Study|Other|3|||
131598723|NCT04537715|473822493|FG000|Overall Study|Progressive disease|1|||
131598724|NCT04537715|473822494|FG001|Overall Study|Progressive disease|0|||
131598725|NCT02191618|473822495|FG000|Overall Study|Withdrawal by Subject|3|||
131598726|NCT02191618|473822495|FG000|Overall Study|Missed Visit|4|||
131598727|NCT02489903|473822496|FG000|Screening|Screen Failure|24|||
131598728|NCT02489903|473822497|FG001|Screening|Screen Failure|0|||
131598729|NCT02489903|473822498|FG002|Screening|Screen Failure|0|||
131598730|NCT02489903|473822499|FG003|Screening|Screen Failure|8|||
131598731|NCT02489903|473822496|FG000|Randomized and Received Treatment|Protocol Violation|0|||
131598732|NCT02489903|473822497|FG001|Randomized and Received Treatment|Protocol Violation|1|||
131598733|NCT02489903|473822498|FG002|Randomized and Received Treatment|Protocol Violation|0|||
131598734|NCT02489903|473822499|FG003|Randomized and Received Treatment|Protocol Violation|0|||
131598735|NCT02489903|473822496|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
131598736|NCT02489903|473822497|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
131598737|NCT02489903|473822498|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
131598738|NCT02489903|473822499|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
131598739|NCT02489903|473822496|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
131598740|NCT02489903|473822497|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
131598741|NCT02489903|473822498|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
131598742|NCT02489903|473822499|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
131598743|NCT02489903|473822496|FG000|Randomized and Received Treatment|Death|10|||
131598744|NCT02489903|473822497|FG001|Randomized and Received Treatment|Death|1|||
131598745|NCT02489903|473822498|FG002|Randomized and Received Treatment|Death|0|||
131598746|NCT02489903|473822499|FG003|Randomized and Received Treatment|Death|0|||
131598747|NCT04542317|473822500|FG000|Overall Study|Care recipients passed away|18|||
131598748|NCT04542317|473822501|FG001|Overall Study|Care recipients passed away|13|||
131598749|NCT04542317|473822500|FG000|Overall Study|No longer a primary caregiver|5|||
131598750|NCT04542317|473822501|FG001|Overall Study|No longer a primary caregiver|1|||
131598751|NCT04542317|473822500|FG000|Overall Study|Withdrawal by Subject|4|||
131598752|NCT04542317|473822501|FG001|Overall Study|Withdrawal by Subject|2|||
131598753|NCT04542317|473822500|FG000|Overall Study|Caregivers passed away|0|||
131598754|NCT04542317|473822501|FG001|Overall Study|Caregivers passed away|2|||
131598755|NCT05126433|473822504|FG000|Overall Study|Withdrawal by Subject|3|||
131598756|NCT05126433|473822505|FG001|Overall Study|Withdrawal by Subject|0|||
131598757|NCT05126433|473822506|FG002|Overall Study|Withdrawal by Subject|4|||
131598758|NCT05126433|473822504|FG000|Overall Study|Death|9|||
131598759|NCT05126433|473822505|FG001|Overall Study|Death|3|||
131598760|NCT05126433|473822506|FG002|Overall Study|Death|5|||
131598761|NCT05126433|473822504|FG000|Overall Study|Study Terminated by sponsor|0|||
131598762|NCT05126433|473822505|FG001|Overall Study|Study Terminated by sponsor|1|||
131598763|NCT05126433|473822506|FG002|Overall Study|Study Terminated by sponsor|2|||
131598764|NCT05126433|473822504|FG000|Overall Study|Progressive Disease|1|||
131598765|NCT05126433|473822505|FG001|Overall Study|Progressive Disease|4|||
131598766|NCT05126433|473822506|FG002|Overall Study|Progressive Disease|3|||
131598767|NCT05126433|473822504|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
131598768|NCT05126433|473822505|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
131598769|NCT05126433|473822506|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
131598770|NCT04137289|473822507|FG000|Overall Study|Death|0|||
131598771|NCT04137289|473822508|FG001|Overall Study|Death|0|||
131598772|NCT04137289|473822509|FG002|Overall Study|Death|0|||
131598773|NCT04137289|473822510|FG003|Overall Study|Death|0|||
131598774|NCT04137289|473822511|FG004|Overall Study|Death|0|||
131598775|NCT04137289|473822512|FG005|Overall Study|Death|0|||
131598776|NCT04137289|473822513|FG006|Overall Study|Death|1|||
131598777|NCT04137289|473822514|FG007|Overall Study|Death|0|||
131598778|NCT04137289|473822515|FG008|Overall Study|Death|0|||
131598779|NCT04137289|473822507|FG000|Overall Study|Clinical disease progression|0|||
131706630|NCT01583374|474207446|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131598780|NCT04137289|473822508|FG001|Overall Study|Clinical disease progression|0|||
131598781|NCT04137289|473822509|FG002|Overall Study|Clinical disease progression|0|||
131598782|NCT04137289|473822510|FG003|Overall Study|Clinical disease progression|4|||
131598783|NCT04137289|473822511|FG004|Overall Study|Clinical disease progression|4|||
131598784|NCT04137289|473822512|FG005|Overall Study|Clinical disease progression|2|||
131598785|NCT04137289|473822513|FG006|Overall Study|Clinical disease progression|5|||
131598786|NCT04137289|473822514|FG007|Overall Study|Clinical disease progression|1|||
131598787|NCT04137289|473822515|FG008|Overall Study|Clinical disease progression|0|||
131598788|NCT04137289|473822507|FG000|Overall Study|Lost to Follow-up|0|||
131598789|NCT04137289|473822508|FG001|Overall Study|Lost to Follow-up|0|||
131598790|NCT04137289|473822509|FG002|Overall Study|Lost to Follow-up|0|||
131598791|NCT04137289|473822510|FG003|Overall Study|Lost to Follow-up|1|||
131598792|NCT04137289|473822511|FG004|Overall Study|Lost to Follow-up|0|||
131598793|NCT04137289|473822512|FG005|Overall Study|Lost to Follow-up|0|||
131598794|NCT04137289|473822513|FG006|Overall Study|Lost to Follow-up|0|||
131598795|NCT04137289|473822514|FG007|Overall Study|Lost to Follow-up|0|||
131598796|NCT04137289|473822515|FG008|Overall Study|Lost to Follow-up|0|||
131598797|NCT04137289|473822507|FG000|Overall Study|Adverse Event|0|||
131598798|NCT04137289|473822508|FG001|Overall Study|Adverse Event|0|||
131598799|NCT04137289|473822509|FG002|Overall Study|Adverse Event|1|||
131598800|NCT04137289|473822510|FG003|Overall Study|Adverse Event|0|||
131598801|NCT04137289|473822511|FG004|Overall Study|Adverse Event|0|||
131598802|NCT04137289|473822512|FG005|Overall Study|Adverse Event|1|||
131598803|NCT04137289|473822513|FG006|Overall Study|Adverse Event|0|||
131598804|NCT04137289|473822514|FG007|Overall Study|Adverse Event|0|||
131598805|NCT04137289|473822515|FG008|Overall Study|Adverse Event|0|||
131598806|NCT04137289|473822507|FG000|Overall Study|Lack of clinical benefit|0|||
131598807|NCT04137289|473822508|FG001|Overall Study|Lack of clinical benefit|0|||
131598808|NCT04137289|473822509|FG002|Overall Study|Lack of clinical benefit|0|||
131598809|NCT04137289|473822510|FG003|Overall Study|Lack of clinical benefit|0|||
131598810|NCT04137289|473822511|FG004|Overall Study|Lack of clinical benefit|0|||
131598811|NCT04137289|473822512|FG005|Overall Study|Lack of clinical benefit|0|||
131598812|NCT04137289|473822513|FG006|Overall Study|Lack of clinical benefit|0|||
131598813|NCT04137289|473822514|FG007|Overall Study|Lack of clinical benefit|0|||
131598814|NCT04137289|473822515|FG008|Overall Study|Lack of clinical benefit|1|||
131598815|NCT04137289|473822507|FG000|Overall Study|Objective disease progression|1|||
131598816|NCT04137289|473822508|FG001|Overall Study|Objective disease progression|1|||
131598817|NCT04137289|473822509|FG002|Overall Study|Objective disease progression|6|||
131598818|NCT04137289|473822510|FG003|Overall Study|Objective disease progression|18|||
131598819|NCT04137289|473822511|FG004|Overall Study|Objective disease progression|12|||
131598820|NCT04137289|473822512|FG005|Overall Study|Objective disease progression|20|||
131598821|NCT04137289|473822513|FG006|Overall Study|Objective disease progression|18|||
131598822|NCT04137289|473822514|FG007|Overall Study|Objective disease progression|7|||
131598823|NCT04137289|473822515|FG008|Overall Study|Objective disease progression|6|||
131598824|NCT04599062|473822517|FG000|Overall Study|Physician Decision|1|||
131598825|NCT04599062|473822518|FG001|Overall Study|Physician Decision|0|||
131598826|NCT04828005|473822522|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
131598827|NCT04828005|473822523|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
131598828|NCT04828005|473822524|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
131598829|NCT04828005|473822525|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
131598830|NCT04828005|473822522|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
131598831|NCT04828005|473822523|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
131598832|NCT04828005|473822524|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
131598833|NCT04828005|473822525|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
131598834|NCT04828005|473822522|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
131598835|NCT04828005|473822523|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
131598836|NCT04828005|473822524|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
131598837|NCT04828005|473822525|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
131598838|NCT04828005|473822522|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
131598839|NCT04828005|473822523|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
131598840|NCT04828005|473822524|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
131598841|NCT04828005|473822525|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
131598842|NCT04828005|473822522|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
131598843|NCT04828005|473822523|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
131598844|NCT04828005|473822524|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
131598845|NCT04828005|473822525|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
131598846|NCT04828005|473822522|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
131598847|NCT04828005|473822523|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
131598848|NCT04828005|473822524|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
131706631|NCT01583374|474207447|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131598849|NCT04828005|473822525|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
131598850|NCT04828005|473822522|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
131598851|NCT04828005|473822523|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
131598852|NCT04828005|473822524|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
131598853|NCT04828005|473822525|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
131598854|NCT04828005|473822522|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
131598855|NCT04828005|473822523|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
131598856|NCT04828005|473822524|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
131598857|NCT04828005|473822525|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
131598858|NCT04828005|473822522|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
131598859|NCT04828005|473822523|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
131598860|NCT04828005|473822524|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
131598861|NCT04828005|473822525|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
131598862|NCT05028634|473824655|FG000|Overall Study|Withdrawal by Subject|0|||
131598863|NCT05028634|473824656|FG001|Overall Study|Withdrawal by Subject|1|||
131598864|NCT03869866|473824657|FG000|Overall Study|Protocol Violation|1|||
131598865|NCT03869866|473824657|FG000|Overall Study|Withdrawal by Subject|3|||
131598866|NCT02975882|473824658|FG000|Overall Study|Adverse Event|1|||
131598867|NCT02975882|473824659|FG001|Overall Study|Adverse Event|2|||
131598868|NCT02975882|473824660|FG002|Overall Study|Adverse Event|1|||
131598869|NCT02975882|473824661|FG003|Overall Study|Adverse Event|1|||
131598870|NCT02975882|473824658|FG000|Overall Study|Death|0|||
131598871|NCT02975882|473824659|FG001|Overall Study|Death|1|||
131598872|NCT02975882|473824660|FG002|Overall Study|Death|0|||
131598873|NCT02975882|473824661|FG003|Overall Study|Death|0|||
131598874|NCT02975882|473824658|FG000|Overall Study|Lack of Efficacy|3|||
131598875|NCT02975882|473824659|FG001|Overall Study|Lack of Efficacy|7|||
131598876|NCT02975882|473824660|FG002|Overall Study|Lack of Efficacy|4|||
131598877|NCT02975882|473824661|FG003|Overall Study|Lack of Efficacy|3|||
131598878|NCT02975882|473824658|FG000|Overall Study|Physician Decision|0|||
131598879|NCT02975882|473824659|FG001|Overall Study|Physician Decision|2|||
131598880|NCT02975882|473824660|FG002|Overall Study|Physician Decision|4|||
131598881|NCT02975882|473824661|FG003|Overall Study|Physician Decision|2|||
131598882|NCT02975882|473824658|FG000|Overall Study|Ineligible|0|||
131598883|NCT02975882|473824659|FG001|Overall Study|Ineligible|1|||
131598884|NCT02975882|473824660|FG002|Overall Study|Ineligible|0|||
131598885|NCT02975882|473824661|FG003|Overall Study|Ineligible|0|||
131598886|NCT03867500|473824662|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
131598887|NCT06190691|473824672|FG000|Overall Study|Adverse Event|2|||
131598888|NCT06190691|473824673|FG001|Overall Study|Adverse Event|0|||
131598889|NCT06190691|473824674|FG002|Overall Study|Adverse Event|0|||
131598890|NCT06190691|473824675|FG003|Overall Study|Adverse Event|0|||
131598891|NCT02485938|473824676|FG000|Overall Study|Withdrawal of consent|2|||
131598892|NCT02485938|473824677|FG001|Overall Study|Withdrawal of consent|0|||
131598893|NCT01824875|473824681|FG000|Overall Study|Disease progression|22|||
131598894|NCT01824875|473824682|FG001|Overall Study|Disease progression|15|||
131598895|NCT01824875|473824681|FG000|Overall Study|Withdrawal by Subject|5|||
131598896|NCT01824875|473824682|FG001|Overall Study|Withdrawal by Subject|4|||
131598897|NCT01824875|473824681|FG000|Overall Study|Adverse Event|4|||
131598898|NCT01824875|473824682|FG001|Overall Study|Adverse Event|10|||
131598899|NCT01824875|473824681|FG000|Overall Study|Alternative therapy|3|||
131598900|NCT01824875|473824682|FG001|Overall Study|Alternative therapy|0|||
131598901|NCT01824875|473824681|FG000|Overall Study|Complicating disease|1|||
131598902|NCT01824875|473824682|FG001|Overall Study|Complicating disease|0|||
131598903|NCT01824875|473824681|FG000|Overall Study|Physician Decision|0|||
131598904|NCT01824875|473824682|FG001|Overall Study|Physician Decision|1|||
131598905|NCT01824875|473824681|FG000|Overall Study|Non-compliance|1|||
131598906|NCT01824875|473824682|FG001|Overall Study|Non-compliance|1|||
131598907|NCT01824875|473824681|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
131598908|NCT01824875|473824682|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
131598909|NCT01824875|473824681|FG000|Overall Study|Administrative issues|0|||
131598910|NCT01824875|473824682|FG001|Overall Study|Administrative issues|2|||
131598911|NCT01824875|473824681|FG000|Overall Study|Ineligible or never started treatment|9|||
131598912|NCT01824875|473824682|FG001|Overall Study|Ineligible or never started treatment|5|||
131598913|NCT01824875|473824681|FG000|Overall Study|Other|0|||
131598914|NCT01824875|473824682|FG001|Overall Study|Other|2|||
131598915|NCT06424236|473824685|FG000|Overall Study|Adverse Event|0|||
131598916|NCT06424236|473824686|FG001|Overall Study|Adverse Event|1|||
131598917|NCT06424236|473824687|FG002|Overall Study|Adverse Event|0|||
131598918|NCT06424236|473824685|FG000|Overall Study|Withdrawal by Subject|3|||
131598919|NCT06424236|473824686|FG001|Overall Study|Withdrawal by Subject|1|||
131598920|NCT06424236|473824687|FG002|Overall Study|Withdrawal by Subject|2|||
131598921|NCT06424236|473824685|FG000|Overall Study|Physician Decision|0|||
131598922|NCT06424236|473824686|FG001|Overall Study|Physician Decision|1|||
131598923|NCT06424236|473824687|FG002|Overall Study|Physician Decision|0|||
131598924|NCT06424236|473824685|FG000|Overall Study|Study Terminated by Sponsor|11|||
131598925|NCT06424236|473824686|FG001|Overall Study|Study Terminated by Sponsor|20|||
131598926|NCT06424236|473824687|FG002|Overall Study|Study Terminated by Sponsor|16|||
131598927|NCT06424236|473824685|FG000|Overall Study|Lost to Follow-up|0|||
131598928|NCT06424236|473824686|FG001|Overall Study|Lost to Follow-up|1|||
131598929|NCT06424236|473824687|FG002|Overall Study|Lost to Follow-up|0|||
131598930|NCT06424236|473824685|FG000|Overall Study|Disease Progression|0|||
131598931|NCT06424236|473824686|FG001|Overall Study|Disease Progression|1|||
131598932|NCT06424236|473824687|FG002|Overall Study|Disease Progression|2|||
131598933|NCT06424236|473824685|FG000|Overall Study|Other|0|||
131598934|NCT06424236|473824686|FG001|Overall Study|Other|0|||
131598935|NCT06424236|473824687|FG002|Overall Study|Other|1|||
131598936|NCT04625283|473824688|FG000|Overall Study|post randomization exclusion|28|||
131598937|NCT04625283|473824689|FG001|Overall Study|post randomization exclusion|20|||
131598938|NCT03462030|473824692|FG000|Overall Study|Withdrawal by Subject|1|||
131598939|NCT03462030|473824693|FG001|Overall Study|Withdrawal by Subject|1|||
131598940|NCT01073566|473824694|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
131598941|NCT01073566|473824695|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
131598942|NCT05006872|473824706|FG000|Overall Study|Lost to Follow-up|37|||
131598943|NCT05006872|473824707|FG001|Overall Study|Lost to Follow-up|31|||
131598944|NCT05499377|473824713|FG000|Overall Study|Withdrawal by Subject|2|||
131598945|NCT05499377|473824714|FG001|Overall Study|Withdrawal by Subject|0|||
131598946|NCT05499377|473824713|FG000|Overall Study|Physician Decision|1|||
131598947|NCT05499377|473824714|FG001|Overall Study|Physician Decision|0|||
131598948|NCT04971681|473824716|FG000|Followup|Lost to Follow-up|1|||
131598949|NCT04971681|473824717|FG001|Followup|Lost to Follow-up|0|||
131598950|NCT00686335|473824718|FG000|Run-in Period|Adverse Event|1|||
131598951|NCT00686335|473824718|FG000|Run-in Period|asthma exacerbation|1|||
131598952|NCT00686335|473824718|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
131598953|NCT02268253|473824719|FG000|Stage 1|Withdrawal by Subject|1|||
131598954|NCT02268253|473824720|FG001|Stage 1|Withdrawal by Subject|0|||
131598955|NCT02268253|473824721|FG002|Stage 1|Withdrawal by Subject|0|||
131598956|NCT02268253|473824722|FG003|Stage 1|Withdrawal by Subject|0|||
131598957|NCT02268253|473824723|FG004|Stage 1|Withdrawal by Subject|0|||
131598958|NCT02268253|473824724|FG005|Stage 1|Withdrawal by Subject|0|||
131598959|NCT02268253|473824725|FG006|Stage 1|Withdrawal by Subject|0|||
131598960|NCT02268253|473824719|FG000|Stage 1|Death|0|||
131598961|NCT02268253|473824720|FG001|Stage 1|Death|2|||
131598962|NCT02268253|473824721|FG002|Stage 1|Death|2|||
131598963|NCT02268253|473824722|FG003|Stage 1|Death|2|||
131598964|NCT02268253|473824723|FG004|Stage 1|Death|1|||
131598965|NCT02268253|473824724|FG005|Stage 1|Death|1|||
131598966|NCT02268253|473824725|FG006|Stage 1|Death|0|||
131598967|NCT02268253|473824719|FG000|Stage 2|Disease Recurrence/ Progression|0|||
131598968|NCT02268253|473824720|FG001|Stage 2|Disease Recurrence/ Progression|0|||
131598969|NCT02268253|473824721|FG002|Stage 2|Disease Recurrence/ Progression|1|||
131598970|NCT02268253|473824722|FG003|Stage 2|Disease Recurrence/ Progression|0|||
131899667|NCT00368108|474919337|FG000|Overall Study|Lack of Efficacy|7|||
131598971|NCT02268253|473824723|FG004|Stage 2|Disease Recurrence/ Progression|0|||
131598972|NCT02268253|473824724|FG005|Stage 2|Disease Recurrence/ Progression|0|||
131598973|NCT02268253|473824725|FG006|Stage 2|Disease Recurrence/ Progression|0|||
131598974|NCT02268253|473824719|FG000|Stage 2|Withdrawal by Subject|0|||
131598975|NCT02268253|473824720|FG001|Stage 2|Withdrawal by Subject|0|||
131598976|NCT02268253|473824721|FG002|Stage 2|Withdrawal by Subject|2|||
131598977|NCT02268253|473824722|FG003|Stage 2|Withdrawal by Subject|0|||
131598978|NCT02268253|473824723|FG004|Stage 2|Withdrawal by Subject|0|||
131598979|NCT02268253|473824724|FG005|Stage 2|Withdrawal by Subject|2|||
131598980|NCT02268253|473824725|FG006|Stage 2|Withdrawal by Subject|0|||
131598981|NCT02268253|473824719|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131598982|NCT02268253|473824720|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131598983|NCT02268253|473824721|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
131598984|NCT02268253|473824722|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131598985|NCT02268253|473824723|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131598986|NCT02268253|473824724|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
131598987|NCT02268253|473824725|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131598988|NCT02268253|473824719|FG000|Stage 2|Death|0|||
131598989|NCT02268253|473824720|FG001|Stage 2|Death|0|||
131598990|NCT02268253|473824721|FG002|Stage 2|Death|19|||
131598991|NCT02268253|473824722|FG003|Stage 2|Death|0|||
131598992|NCT02268253|473824723|FG004|Stage 2|Death|0|||
131598993|NCT02268253|473824724|FG005|Stage 2|Death|20|||
131598994|NCT02268253|473824725|FG006|Stage 2|Death|1|||
131598995|NCT02268253|473824719|FG000|Stage 2|Lost to Follow-up|0|||
131598996|NCT02268253|473824720|FG001|Stage 2|Lost to Follow-up|0|||
131598997|NCT02268253|473824721|FG002|Stage 2|Lost to Follow-up|0|||
131598998|NCT02268253|473824722|FG003|Stage 2|Lost to Follow-up|0|||
131598999|NCT02268253|473824723|FG004|Stage 2|Lost to Follow-up|0|||
131899668|NCT00368108|474919338|FG001|Overall Study|Lack of Efficacy|8|||
131599000|NCT02268253|473824724|FG005|Stage 2|Lost to Follow-up|4|||
131599001|NCT02268253|473824725|FG006|Stage 2|Lost to Follow-up|0|||
131599002|NCT02268253|473824719|FG000|Stage 2|Transferred to Hospice|0|||
131599003|NCT02268253|473824720|FG001|Stage 2|Transferred to Hospice|0|||
131599004|NCT02268253|473824721|FG002|Stage 2|Transferred to Hospice|0|||
131599005|NCT02268253|473824722|FG003|Stage 2|Transferred to Hospice|0|||
131599006|NCT02268253|473824723|FG004|Stage 2|Transferred to Hospice|0|||
131599007|NCT02268253|473824724|FG005|Stage 2|Transferred to Hospice|2|||
131599008|NCT02268253|473824725|FG006|Stage 2|Transferred to Hospice|0|||
131599009|NCT02268253|473824719|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
131599010|NCT02268253|473824720|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
131599011|NCT02268253|473824721|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
131599012|NCT02268253|473824722|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
131599013|NCT02268253|473824723|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
131599014|NCT02268253|473824724|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
131599015|NCT02268253|473824725|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
131599016|NCT02268253|473824719|FG000|Stage 3A|Withdrawal by Subject|0|||
131599017|NCT02268253|473824720|FG001|Stage 3A|Withdrawal by Subject|0|||
131599018|NCT02268253|473824721|FG002|Stage 3A|Withdrawal by Subject|2|||
131599019|NCT02268253|473824722|FG003|Stage 3A|Withdrawal by Subject|0|||
131599020|NCT02268253|473824723|FG004|Stage 3A|Withdrawal by Subject|0|||
131599021|NCT02268253|473824724|FG005|Stage 3A|Withdrawal by Subject|0|||
131599022|NCT02268253|473824725|FG006|Stage 3A|Withdrawal by Subject|0|||
131599023|NCT02268253|473824719|FG000|Stage 3A|Physician Decision|0|||
131599024|NCT02268253|473824720|FG001|Stage 3A|Physician Decision|0|||
131599025|NCT02268253|473824721|FG002|Stage 3A|Physician Decision|2|||
131599026|NCT02268253|473824722|FG003|Stage 3A|Physician Decision|0|||
131599027|NCT02268253|473824723|FG004|Stage 3A|Physician Decision|0|||
131599028|NCT02268253|473824724|FG005|Stage 3A|Physician Decision|0|||
131599029|NCT02268253|473824725|FG006|Stage 3A|Physician Decision|0|||
131599030|NCT02268253|473824719|FG000|Stage 3A|Study Terminated by Sponsor|0|||
131599031|NCT02268253|473824720|FG001|Stage 3A|Study Terminated by Sponsor|0|||
131599032|NCT02268253|473824721|FG002|Stage 3A|Study Terminated by Sponsor|2|||
131599033|NCT02268253|473824722|FG003|Stage 3A|Study Terminated by Sponsor|0|||
131599034|NCT02268253|473824723|FG004|Stage 3A|Study Terminated by Sponsor|0|||
131599035|NCT02268253|473824724|FG005|Stage 3A|Study Terminated by Sponsor|0|||
131599036|NCT02268253|473824725|FG006|Stage 3A|Study Terminated by Sponsor|0|||
131599037|NCT02268253|473824719|FG000|Stage 3A|Lost to Follow-up|0|||
131599038|NCT02268253|473824720|FG001|Stage 3A|Lost to Follow-up|0|||
131599039|NCT02268253|473824721|FG002|Stage 3A|Lost to Follow-up|1|||
131599040|NCT02268253|473824722|FG003|Stage 3A|Lost to Follow-up|0|||
131599041|NCT02268253|473824723|FG004|Stage 3A|Lost to Follow-up|0|||
131599042|NCT02268253|473824724|FG005|Stage 3A|Lost to Follow-up|0|||
131599043|NCT02268253|473824725|FG006|Stage 3A|Lost to Follow-up|0|||
131599044|NCT02268253|473824719|FG000|Stage 3A|Death|0|||
131599045|NCT02268253|473824720|FG001|Stage 3A|Death|0|||
131599046|NCT02268253|473824721|FG002|Stage 3A|Death|5|||
131599047|NCT02268253|473824722|FG003|Stage 3A|Death|0|||
131599048|NCT02268253|473824723|FG004|Stage 3A|Death|0|||
131599049|NCT02268253|473824724|FG005|Stage 3A|Death|0|||
131599050|NCT02268253|473824725|FG006|Stage 3A|Death|0|||
131599051|NCT05714761|473824726|FG000|Overall Study|Lost to Follow-up|3|||
131599052|NCT05714761|473824726|FG000|Overall Study|Withdrawal by Subject|3|||
131599053|NCT05714761|473824726|FG000|Overall Study|unblinding of sensor data|1|||
131599054|NCT05714761|473824726|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
131599055|NCT05714761|473824726|FG000|Overall Study|did not return second CGM sensor|4|||
131599056|NCT05949788|473824727|FG000|Overall Study|severe birth deformity|2|||
131599057|NCT05949788|473824728|FG001|Overall Study|severe birth deformity|7|||
131599058|NCT05949788|473824727|FG000|Overall Study|twin-twin transfusion syndrome|2|||
131599059|NCT05949788|473824728|FG001|Overall Study|twin-twin transfusion syndrome|7|||
131599060|NCT05949788|473824727|FG000|Overall Study|neonatal hemolytic disease|3|||
131599061|NCT05949788|473824728|FG001|Overall Study|neonatal hemolytic disease|8|||
131599062|NCT05949788|473824727|FG000|Overall Study|death within 14 days after birth|2|||
131599063|NCT05949788|473824728|FG001|Overall Study|death within 14 days after birth|6|||
131599064|NCT05949788|473824727|FG000|Overall Study|transfer to another hospital|2|||
131599065|NCT05949788|473824728|FG001|Overall Study|transfer to another hospital|6|||
131599066|NCT01824537|473824729|FG000|Overall Study|Lost to Follow-up|78|||
131599067|NCT01824537|473824730|FG001|Overall Study|Lost to Follow-up|87|||
131599068|NCT04973254|473824733|FG000|Overall Study|Not adherent|0|||
131599069|NCT04973254|473824734|FG001|Overall Study|Not adherent|1|||
131599070|NCT04973254|473824735|FG002|Overall Study|Not adherent|0|||
131599071|NCT05170009|473824736|FG000|Overall Study|Physician Decision|0|||
131599072|NCT05170009|473824737|FG001|Overall Study|Physician Decision|1|||
131599073|NCT03808818|473824742|FG000|Overall Study|Death|6|||
131599074|NCT03808818|473824743|FG001|Overall Study|Death|6|||
131599075|NCT03808818|473824742|FG000|Overall Study|Withdrawal by Subject|7|||
131599076|NCT03808818|473824743|FG001|Overall Study|Withdrawal by Subject|18|||
131599077|NCT03808818|473824742|FG000|Overall Study|Lost to Follow-up|31|||
131599078|NCT03808818|473824743|FG001|Overall Study|Lost to Follow-up|33|||
131599079|NCT04629716|473824746|FG000|Overall Study|Lost to Follow-up|7|||
131599080|NCT04629716|473824747|FG001|Overall Study|Lost to Follow-up|3|||
131599081|NCT03031470|473824756|FG000|Overall Study|Adverse Event|3|||
131599082|NCT03031470|473824757|FG001|Overall Study|Adverse Event|0|||
131599083|NCT03031470|473824756|FG000|Overall Study|Death|3|||
131599084|NCT03031470|473824757|FG001|Overall Study|Death|1|||
131599085|NCT03031470|473824756|FG000|Overall Study|Lost to Follow-up|1|||
131599086|NCT03031470|473824757|FG001|Overall Study|Lost to Follow-up|1|||
131599087|NCT03031470|473824756|FG000|Overall Study|Withdrawal by Subject|1|||
131599088|NCT03031470|473824757|FG001|Overall Study|Withdrawal by Subject|0|||
131599089|NCT03031470|473824756|FG000|Overall Study|Protocol entry criteria not met|0|||
131599090|NCT03031470|473824757|FG001|Overall Study|Protocol entry criteria not met|1|||
131599091|NCT03031470|473824756|FG000|Overall Study|Cancel the operation|0|||
131599092|NCT03031470|473824757|FG001|Overall Study|Cancel the operation|1|||
131599093|NCT03461276|473824758|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
131599094|NCT03461276|473824759|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
131599095|NCT03461276|473824758|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
131599096|NCT03461276|473824759|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
131599097|NCT03461276|473824758|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
131599098|NCT03461276|473824759|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
131599099|NCT03461276|473824758|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
131599100|NCT03461276|473824759|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
131599101|NCT03461276|473824758|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
131599102|NCT03461276|473824759|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
131599103|NCT03461276|473824758|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
131599104|NCT03461276|473824759|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
131599105|NCT03461276|473824758|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
131599106|NCT03461276|473824759|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
131599107|NCT03461276|473824758|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
131599108|NCT03461276|473824759|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
131599109|NCT03461276|473824758|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
131599110|NCT03461276|473824759|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
131599111|NCT03461276|473824758|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
131599112|NCT03461276|473824759|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
131599113|NCT04623671|473824760|FG000|Overall Study|Adverse Event|0|||
131599114|NCT04623671|473824761|FG001|Overall Study|Adverse Event|1|||
131599115|NCT04623671|473824760|FG000|Overall Study|Lost to Follow-up|2|||
131599116|NCT04623671|473824761|FG001|Overall Study|Lost to Follow-up|1|||
131599117|NCT04623671|473824760|FG000|Overall Study|Death|5|||
131599118|NCT04623671|473824761|FG001|Overall Study|Death|5|||
131599119|NCT01943409|473824765|FG000|Overall Study|resumed oral/entral|24|||
131599120|NCT01943409|473824766|FG001|Overall Study|resumed oral/entral|20|||
131599121|NCT01943409|473824765|FG000|Overall Study|Protocol Violation|14|||
131599122|NCT01943409|473824766|FG001|Overall Study|Protocol Violation|24|||
131599123|NCT01943409|473824765|FG000|Overall Study|Death|3|||
131599124|NCT01943409|473824766|FG001|Overall Study|Death|1|||
131599125|NCT01943409|473824765|FG000|Overall Study|Withdrawal by Subject|4|||
131599126|NCT01943409|473824766|FG001|Overall Study|Withdrawal by Subject|3|||
131599127|NCT03496168|473824767|FG000|Overall Study|Other Reasons|1|||
131599128|NCT03496168|473824767|FG000|Overall Study|Adverse Event|1|||
131599129|NCT04074759|473824771|FG000|Overall Study|Withdrawal by Subject|0|||
131599130|NCT04074759|473824772|FG001|Overall Study|Withdrawal by Subject|0|||
131599131|NCT04074759|473824773|FG002|Overall Study|Withdrawal by Subject|0|||
131599132|NCT04074759|473824774|FG003|Overall Study|Withdrawal by Subject|0|||
131599133|NCT04074759|473824775|FG004|Overall Study|Withdrawal by Subject|0|||
131599134|NCT04074759|473824776|FG005|Overall Study|Withdrawal by Subject|2|||
131599135|NCT04074759|473824777|FG006|Overall Study|Withdrawal by Subject|0|||
131599136|NCT04074759|473824778|FG007|Overall Study|Withdrawal by Subject|2|||
131599137|NCT04074759|473824779|FG008|Overall Study|Withdrawal by Subject|1|||
131599138|NCT04074759|473824780|FG009|Overall Study|Withdrawal by Subject|2|||
131599139|NCT04074759|473824781|FG010|Overall Study|Withdrawal by Subject|9|||
131599140|NCT04074759|473824782|FG011|Overall Study|Withdrawal by Subject|2|||
131599141|NCT04074759|473824783|FG012|Overall Study|Withdrawal by Subject|1|||
131599142|NCT04074759|473824784|FG013|Overall Study|Withdrawal by Subject|3|||
131599143|NCT04074759|473824785|FG014|Overall Study|Withdrawal by Subject|2|||
131599144|NCT04074759|473824786|FG015|Overall Study|Withdrawal by Subject|0|||
131599145|NCT04074759|473824787|FG016|Overall Study|Withdrawal by Subject|0|||
131599146|NCT04074759|473824788|FG017|Overall Study|Withdrawal by Subject|3|||
131599147|NCT04074759|473824789|FG018|Overall Study|Withdrawal by Subject|1|||
131599148|NCT04074759|473824771|FG000|Overall Study|Death|1|||
131599149|NCT04074759|473824772|FG001|Overall Study|Death|0|||
131599150|NCT04074759|473824773|FG002|Overall Study|Death|1|||
131599151|NCT04074759|473824774|FG003|Overall Study|Death|1|||
131599152|NCT04074759|473824775|FG004|Overall Study|Death|2|||
131439875|NCT04913610|473236960|FG004|Randomized Participants|Did Not Receive Treatment|0|||
131439876|NCT04913610|473236956|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
131439877|NCT04913610|473236957|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
131439878|NCT04913610|473236958|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
131599153|NCT04074759|473824776|FG005|Overall Study|Death|0|||
131599154|NCT04074759|473824777|FG006|Overall Study|Death|1|||
131599155|NCT04074759|473824778|FG007|Overall Study|Death|0|||
131599156|NCT04074759|473824779|FG008|Overall Study|Death|3|||
131599157|NCT04074759|473824780|FG009|Overall Study|Death|2|||
131599158|NCT04074759|473824781|FG010|Overall Study|Death|4|||
131599159|NCT04074759|473824782|FG011|Overall Study|Death|1|||
131599160|NCT04074759|473824783|FG012|Overall Study|Death|0|||
131599161|NCT04074759|473824784|FG013|Overall Study|Death|2|||
131599162|NCT04074759|473824785|FG014|Overall Study|Death|1|||
131599163|NCT04074759|473824786|FG015|Overall Study|Death|0|||
131599164|NCT04074759|473824787|FG016|Overall Study|Death|1|||
131599165|NCT04074759|473824788|FG017|Overall Study|Death|0|||
131599166|NCT04074759|473824789|FG018|Overall Study|Death|1|||
131599167|NCT04074759|473824771|FG000|Overall Study|Lost to Follow-up|0|||
131599168|NCT04074759|473824772|FG001|Overall Study|Lost to Follow-up|0|||
131599169|NCT04074759|473824773|FG002|Overall Study|Lost to Follow-up|0|||
131599170|NCT04074759|473824774|FG003|Overall Study|Lost to Follow-up|0|||
131599171|NCT04074759|473824775|FG004|Overall Study|Lost to Follow-up|0|||
131599172|NCT04074759|473824776|FG005|Overall Study|Lost to Follow-up|0|||
131599173|NCT04074759|473824777|FG006|Overall Study|Lost to Follow-up|0|||
131599174|NCT04074759|473824778|FG007|Overall Study|Lost to Follow-up|0|||
131599175|NCT04074759|473824779|FG008|Overall Study|Lost to Follow-up|0|||
131599176|NCT04074759|473824780|FG009|Overall Study|Lost to Follow-up|0|||
131599177|NCT04074759|473824781|FG010|Overall Study|Lost to Follow-up|1|||
131599178|NCT04074759|473824782|FG011|Overall Study|Lost to Follow-up|0|||
131599179|NCT04074759|473824783|FG012|Overall Study|Lost to Follow-up|0|||
131599180|NCT04074759|473824784|FG013|Overall Study|Lost to Follow-up|0|||
131599181|NCT04074759|473824785|FG014|Overall Study|Lost to Follow-up|0|||
131599182|NCT04074759|473824786|FG015|Overall Study|Lost to Follow-up|0|||
131439879|NCT04913610|473236959|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
131439880|NCT04913610|473236960|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
131439881|NCT00659061|473236961|FG000|Overall Study|Migration due to political unrest|21|||
131439882|NCT00659061|473236962|FG001|Overall Study|Migration due to political unrest|15|||
131439883|NCT01277744|473236965|FG000|Overall Study|Physician Decision|2|||
131439884|NCT01650558|473236968|FG000|Overall Study|Migration out of study area|61|||
131439885|NCT01650558|473236969|FG001|Overall Study|Migration out of study area|71|||
131439886|NCT01650558|473236970|FG002|Overall Study|Migration out of study area|56|||
131439887|NCT01650558|473236968|FG000|Overall Study|Lost to Follow-up|10|||
131599183|NCT04074759|473824787|FG016|Overall Study|Lost to Follow-up|1|||
131599184|NCT04074759|473824788|FG017|Overall Study|Lost to Follow-up|0|||
131599185|NCT04074759|473824789|FG018|Overall Study|Lost to Follow-up|1|||
131599186|NCT04074759|473824771|FG000|Overall Study|Other|0|||
131599187|NCT04074759|473824772|FG001|Overall Study|Other|1|||
131599188|NCT04074759|473824773|FG002|Overall Study|Other|1|||
131599189|NCT04074759|473824774|FG003|Overall Study|Other|0|||
131599190|NCT04074759|473824775|FG004|Overall Study|Other|2|||
131599191|NCT04074759|473824776|FG005|Overall Study|Other|1|||
131599192|NCT04074759|473824777|FG006|Overall Study|Other|2|||
131439888|NCT01650558|473236969|FG001|Overall Study|Lost to Follow-up|13|||
131599193|NCT04074759|473824778|FG007|Overall Study|Other|1|||
131599194|NCT04074759|473824779|FG008|Overall Study|Other|1|||
131599195|NCT04074759|473824780|FG009|Overall Study|Other|4|||
131599196|NCT04074759|473824781|FG010|Overall Study|Other|4|||
131599197|NCT04074759|473824782|FG011|Overall Study|Other|2|||
131599198|NCT04074759|473824783|FG012|Overall Study|Other|0|||
131599199|NCT04074759|473824784|FG013|Overall Study|Other|0|||
131599200|NCT04074759|473824785|FG014|Overall Study|Other|0|||
131599201|NCT04074759|473824786|FG015|Overall Study|Other|1|||
131599202|NCT04074759|473824787|FG016|Overall Study|Other|0|||
131599203|NCT04074759|473824788|FG017|Overall Study|Other|0|||
131706632|NCT01583374|474207448|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131706633|NCT01583374|474207449|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131706634|NCT01583374|474207450|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131706635|NCT01583374|474207451|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
131706636|NCT01583374|474207452|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131706637|NCT01583374|474207444|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131706638|NCT01583374|474207445|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131706639|NCT01583374|474207446|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
131706640|NCT01583374|474207447|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131706641|NCT01583374|474207448|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131706642|NCT01583374|474207449|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131706643|NCT01583374|474207450|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131706644|NCT01583374|474207451|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131706645|NCT01583374|474207452|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131706646|NCT01583374|474207444|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
131706647|NCT01583374|474207445|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
131706648|NCT01583374|474207446|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
131706649|NCT01583374|474207447|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
131706650|NCT01583374|474207448|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
131706651|NCT01583374|474207449|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
131706652|NCT01583374|474207450|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
131899669|NCT00368108|474919339|FG002|Overall Study|Lack of Efficacy|5|||
131439889|NCT01650558|473236970|FG002|Overall Study|Lost to Follow-up|6|||
131599204|NCT04074759|473824789|FG018|Overall Study|Other|0|||
131599205|NCT04074759|473824771|FG000|Overall Study|Missing end of study status|0|||
131599206|NCT04074759|473824772|FG001|Overall Study|Missing end of study status|0|||
131599207|NCT04074759|473824773|FG002|Overall Study|Missing end of study status|0|||
131599208|NCT04074759|473824774|FG003|Overall Study|Missing end of study status|0|||
131599209|NCT04074759|473824775|FG004|Overall Study|Missing end of study status|0|||
131599210|NCT04074759|473824776|FG005|Overall Study|Missing end of study status|0|||
131599211|NCT04074759|473824777|FG006|Overall Study|Missing end of study status|0|||
131599212|NCT04074759|473824778|FG007|Overall Study|Missing end of study status|0|||
131599213|NCT04074759|473824779|FG008|Overall Study|Missing end of study status|0|||
131599214|NCT04074759|473824780|FG009|Overall Study|Missing end of study status|0|||
131599215|NCT04074759|473824781|FG010|Overall Study|Missing end of study status|2|||
131599216|NCT04074759|473824782|FG011|Overall Study|Missing end of study status|0|||
131599217|NCT04074759|473824783|FG012|Overall Study|Missing end of study status|0|||
131599218|NCT04074759|473824784|FG013|Overall Study|Missing end of study status|0|||
131706653|NCT01583374|474207451|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
131706654|NCT01583374|474207452|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
131706655|NCT01583374|474207444|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131706656|NCT01583374|474207445|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
131706657|NCT01583374|474207446|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
131706658|NCT01583374|474207447|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131706659|NCT01583374|474207448|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
131706660|NCT01583374|474207449|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131706661|NCT01583374|474207450|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131706662|NCT01583374|474207451|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131706663|NCT01583374|474207452|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131706664|NCT01583374|474207444|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131706665|NCT01583374|474207445|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131706666|NCT01583374|474207446|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
131706667|NCT01583374|474207447|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131706668|NCT01583374|474207448|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
131706669|NCT01583374|474207449|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
131706670|NCT01583374|474207450|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131706671|NCT01583374|474207451|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131706672|NCT01583374|474207452|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131706673|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
131706674|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
131706675|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131706676|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131706677|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
131706678|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131706679|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131706680|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
131706681|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
131706682|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
131706683|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
131706684|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
131706685|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
131706686|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
131706687|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
131706688|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
131706689|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
131706690|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
131706691|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131706692|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131706693|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131706694|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131706695|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
131899670|NCT00368108|474919337|FG000|Overall Study|Physician Decision|2|||
131599219|NCT04074759|473824785|FG014|Overall Study|Missing end of study status|0|||
131599220|NCT04074759|473824786|FG015|Overall Study|Missing end of study status|0|||
131599221|NCT04074759|473824787|FG016|Overall Study|Missing end of study status|1|||
131599222|NCT04074759|473824788|FG017|Overall Study|Missing end of study status|0|||
131599223|NCT04074759|473824789|FG018|Overall Study|Missing end of study status|0|||
131599224|NCT05329220|473824790|FG000|Active Trial Period|Adverse Event|0|||
131599225|NCT05329220|473824791|FG001|Active Trial Period|Adverse Event|0|||
131599226|NCT05329220|473824792|FG002|Active Trial Period|Adverse Event|0|||
131599227|NCT05329220|473824793|FG003|Active Trial Period|Adverse Event|0|||
131599228|NCT05329220|473824794|FG004|Active Trial Period|Adverse Event|1|||
131599229|NCT05329220|473824795|FG005|Active Trial Period|Adverse Event|0|||
131599230|NCT05329220|473824790|FG000|Active Trial Period|Lost to Follow-up|0|||
131599231|NCT05329220|473824791|FG001|Active Trial Period|Lost to Follow-up|0|||
131599232|NCT05329220|473824792|FG002|Active Trial Period|Lost to Follow-up|0|||
131599233|NCT05329220|473824793|FG003|Active Trial Period|Lost to Follow-up|0|||
131599234|NCT05329220|473824794|FG004|Active Trial Period|Lost to Follow-up|32|||
131599235|NCT05329220|473824795|FG005|Active Trial Period|Lost to Follow-up|28|||
131599236|NCT05329220|473824790|FG000|Active Trial Period|Physician Decision|0|||
131599237|NCT05329220|473824791|FG001|Active Trial Period|Physician Decision|0|||
131599238|NCT05329220|473824792|FG002|Active Trial Period|Physician Decision|0|||
131599239|NCT05329220|473824793|FG003|Active Trial Period|Physician Decision|0|||
131599240|NCT05329220|473824794|FG004|Active Trial Period|Physician Decision|2|||
131599241|NCT05329220|473824795|FG005|Active Trial Period|Physician Decision|0|||
131599242|NCT05329220|473824790|FG000|Active Trial Period|Protocol Violation|0|||
131599243|NCT05329220|473824791|FG001|Active Trial Period|Protocol Violation|0|||
131599244|NCT05329220|473824792|FG002|Active Trial Period|Protocol Violation|0|||
131599245|NCT05329220|473824793|FG003|Active Trial Period|Protocol Violation|0|||
131599246|NCT05329220|473824794|FG004|Active Trial Period|Protocol Violation|1|||
131599247|NCT05329220|473824795|FG005|Active Trial Period|Protocol Violation|3|||
131599248|NCT05329220|473824790|FG000|Active Trial Period|Withdrawal by Subject|0|||
131599249|NCT05329220|473824791|FG001|Active Trial Period|Withdrawal by Subject|0|||
131599250|NCT05329220|473824792|FG002|Active Trial Period|Withdrawal by Subject|0|||
131599251|NCT05329220|473824793|FG003|Active Trial Period|Withdrawal by Subject|1|||
131599252|NCT05329220|473824794|FG004|Active Trial Period|Withdrawal by Subject|12|||
131599253|NCT05329220|473824795|FG005|Active Trial Period|Withdrawal by Subject|13|||
131599254|NCT05329220|473824790|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131599255|NCT05329220|473824791|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131599256|NCT05329220|473824792|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131599257|NCT05329220|473824793|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131599258|NCT05329220|473824794|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131599259|NCT05329220|473824795|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
131599260|NCT05329220|473824790|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131599261|NCT05329220|473824791|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131599262|NCT05329220|473824792|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131599263|NCT05329220|473824793|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131599264|NCT05329220|473824794|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131599265|NCT05329220|473824795|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
131599266|NCT05329220|473824790|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
131599267|NCT05329220|473824791|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
131599268|NCT05329220|473824792|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
131599269|NCT05329220|473824793|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
131599270|NCT05329220|473824794|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
131599271|NCT05329220|473824795|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
131599272|NCT05329220|473824790|FG000|Follow-up Period|Adverse Event|0|||
131599273|NCT05329220|473824791|FG001|Follow-up Period|Adverse Event|0|||
131599274|NCT05329220|473824792|FG002|Follow-up Period|Adverse Event|0|||
131599275|NCT05329220|473824793|FG003|Follow-up Period|Adverse Event|0|||
131599276|NCT05329220|473824794|FG004|Follow-up Period|Adverse Event|2|||
131599277|NCT05329220|473824795|FG005|Follow-up Period|Adverse Event|1|||
131599278|NCT05329220|473824790|FG000|Follow-up Period|Death|0|||
131599279|NCT05329220|473824791|FG001|Follow-up Period|Death|0|||
131599280|NCT05329220|473824792|FG002|Follow-up Period|Death|1|||
131599281|NCT05329220|473824793|FG003|Follow-up Period|Death|1|||
131599282|NCT05329220|473824794|FG004|Follow-up Period|Death|0|||
131599283|NCT05329220|473824795|FG005|Follow-up Period|Death|1|||
131599284|NCT05329220|473824790|FG000|Follow-up Period|Lost to Follow-up|0|||
131439890|NCT01650558|473236968|FG000|Overall Study|Death|10|||
131599285|NCT05329220|473824791|FG001|Follow-up Period|Lost to Follow-up|1|||
131599286|NCT05329220|473824792|FG002|Follow-up Period|Lost to Follow-up|2|||
131599287|NCT05329220|473824793|FG003|Follow-up Period|Lost to Follow-up|2|||
131599288|NCT05329220|473824794|FG004|Follow-up Period|Lost to Follow-up|113|||
131599289|NCT05329220|473824795|FG005|Follow-up Period|Lost to Follow-up|89|||
131599290|NCT05329220|473824790|FG000|Follow-up Period|Physician Decision|0|||
131599291|NCT05329220|473824791|FG001|Follow-up Period|Physician Decision|0|||
131599292|NCT05329220|473824792|FG002|Follow-up Period|Physician Decision|0|||
131599293|NCT05329220|473824793|FG003|Follow-up Period|Physician Decision|0|||
131599294|NCT05329220|473824794|FG004|Follow-up Period|Physician Decision|2|||
131599295|NCT05329220|473824795|FG005|Follow-up Period|Physician Decision|2|||
131599296|NCT05329220|473824790|FG000|Follow-up Period|Protocol Violation|0|||
131599297|NCT05329220|473824791|FG001|Follow-up Period|Protocol Violation|0|||
131599298|NCT05329220|473824792|FG002|Follow-up Period|Protocol Violation|0|||
131599299|NCT05329220|473824793|FG003|Follow-up Period|Protocol Violation|0|||
131599300|NCT05329220|473824794|FG004|Follow-up Period|Protocol Violation|0|||
131599301|NCT05329220|473824795|FG005|Follow-up Period|Protocol Violation|1|||
131599302|NCT05329220|473824790|FG000|Follow-up Period|Withdrawal by Subject|0|||
131599303|NCT05329220|473824791|FG001|Follow-up Period|Withdrawal by Subject|0|||
131599304|NCT05329220|473824792|FG002|Follow-up Period|Withdrawal by Subject|1|||
131599305|NCT05329220|473824793|FG003|Follow-up Period|Withdrawal by Subject|1|||
131599306|NCT05329220|473824794|FG004|Follow-up Period|Withdrawal by Subject|34|||
131599307|NCT05329220|473824795|FG005|Follow-up Period|Withdrawal by Subject|35|||
131599308|NCT05329220|473824790|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131599309|NCT05329220|473824791|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131599310|NCT05329220|473824792|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
131599311|NCT05329220|473824793|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131599312|NCT05329220|473824794|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131599313|NCT05329220|473824795|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131599314|NCT05329220|473824790|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131599315|NCT05329220|473824791|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131599316|NCT05329220|473824792|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131599317|NCT05329220|473824793|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131599318|NCT05329220|473824794|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
131599319|NCT05329220|473824795|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131599320|NCT05329220|473824790|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131599321|NCT05329220|473824791|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131599322|NCT05329220|473824792|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131599323|NCT05329220|473824793|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131599324|NCT05329220|473824794|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
131599325|NCT05329220|473824795|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131599326|NCT05329220|473824790|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131599327|NCT05329220|473824791|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131599328|NCT05329220|473824792|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131599329|NCT05329220|473824793|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131599330|NCT05329220|473824794|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131599331|NCT05329220|473824795|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
131599332|NCT05329220|473824790|FG000|Follow-up Period|EARLY TERMINATION|0|||
131599333|NCT05329220|473824791|FG001|Follow-up Period|EARLY TERMINATION|0|||
131599334|NCT05329220|473824792|FG002|Follow-up Period|EARLY TERMINATION|0|||
131599335|NCT05329220|473824793|FG003|Follow-up Period|EARLY TERMINATION|0|||
131599336|NCT05329220|473824794|FG004|Follow-up Period|EARLY TERMINATION|0|||
131599337|NCT05329220|473824795|FG005|Follow-up Period|EARLY TERMINATION|1|||
131599338|NCT05329220|473824790|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131599339|NCT05329220|473824791|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131599340|NCT05329220|473824792|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131599341|NCT05329220|473824793|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131599342|NCT05329220|473824794|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131599343|NCT05329220|473824795|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
131599344|NCT05329220|473824790|FG000|Follow-up Period|DROPPED|0|||
131599345|NCT05329220|473824791|FG001|Follow-up Period|DROPPED|0|||
131599346|NCT05329220|473824792|FG002|Follow-up Period|DROPPED|0|||
131599347|NCT05329220|473824793|FG003|Follow-up Period|DROPPED|0|||
131599348|NCT05329220|473824794|FG004|Follow-up Period|DROPPED|0|||
131599349|NCT05329220|473824795|FG005|Follow-up Period|DROPPED|1|||
131599350|NCT05329220|473824790|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131599351|NCT05329220|473824791|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131599352|NCT05329220|473824792|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131599353|NCT05329220|473824793|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131599354|NCT05329220|473824794|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131599355|NCT05329220|473824795|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
131599356|NCT02231164|473824796|FG000|Overall Study|Adverse Event|1|||
131599357|NCT02231164|473824797|FG001|Overall Study|Adverse Event|1|||
131599358|NCT02231164|473824796|FG000|Overall Study|Lack of Efficacy|4|||
131599359|NCT02231164|473824797|FG001|Overall Study|Lack of Efficacy|3|||
131599360|NCT02231164|473824796|FG000|Overall Study|Withdrawal by Subject|1|||
131599361|NCT02231164|473824797|FG001|Overall Study|Withdrawal by Subject|2|||
131599362|NCT02547363|473824798|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
131599363|NCT02547363|473824799|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
131599364|NCT02547363|473824798|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
131599365|NCT02547363|473824799|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
131599366|NCT02547363|473824798|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
131599367|NCT02547363|473824799|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
131599368|NCT02547363|473824798|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
131599369|NCT02547363|473824799|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
131599370|NCT02547363|473824798|FG000|12-month Follow-up|Withdrawal by Subject|4|||
131599371|NCT02547363|473824799|FG001|12-month Follow-up|Withdrawal by Subject|3|||
131599372|NCT02547363|473824798|FG000|12-month Follow-up|Lost to Follow-up|4|||
131599373|NCT02547363|473824799|FG001|12-month Follow-up|Lost to Follow-up|1|||
131599374|NCT02547363|473824798|FG000|12-month Follow-up|Lack of Efficacy|1|||
131599375|NCT02547363|473824799|FG001|12-month Follow-up|Lack of Efficacy|1|||
131599376|NCT02547363|473824798|FG000|12-month Follow-up|Other|1|||
131599377|NCT02547363|473824799|FG001|12-month Follow-up|Other|0|||
131599378|NCT04436276|473824802|FG000|Overall Study|Adverse Event|0|||
131599379|NCT04436276|473824803|FG001|Overall Study|Adverse Event|0|||
131599380|NCT04436276|473824804|FG002|Overall Study|Adverse Event|0|||
131599381|NCT04436276|473824805|FG003|Overall Study|Adverse Event|0|||
131599382|NCT04436276|473824806|FG004|Overall Study|Adverse Event|0|||
131599383|NCT04436276|473824807|FG005|Overall Study|Adverse Event|0|||
131599384|NCT04436276|473824808|FG006|Overall Study|Adverse Event|0|||
131599385|NCT04436276|473824809|FG007|Overall Study|Adverse Event|0|||
131599386|NCT04436276|473824810|FG008|Overall Study|Adverse Event|0|||
131599387|NCT04436276|473824811|FG009|Overall Study|Adverse Event|0|||
131599388|NCT04436276|473824812|FG010|Overall Study|Adverse Event|0|||
131599389|NCT04436276|473824813|FG011|Overall Study|Adverse Event|0|||
131599390|NCT04436276|473824814|FG012|Overall Study|Adverse Event|0|||
131599391|NCT04436276|473824815|FG013|Overall Study|Adverse Event|0|||
131599392|NCT04436276|473824816|FG014|Overall Study|Adverse Event|0|||
131599393|NCT04436276|473824817|FG015|Overall Study|Adverse Event|0|||
131599394|NCT04436276|473824818|FG016|Overall Study|Adverse Event|1|||
131599395|NCT04436276|473824819|FG017|Overall Study|Adverse Event|0|||
131599396|NCT04436276|473824820|FG018|Overall Study|Adverse Event|0|||
131599397|NCT04436276|473824821|FG019|Overall Study|Adverse Event|0|||
131599398|NCT04436276|473824822|FG020|Overall Study|Adverse Event|0|||
131599399|NCT04436276|473824823|FG021|Overall Study|Adverse Event|0|||
131599400|NCT04436276|473824824|FG022|Overall Study|Adverse Event|0|||
131599401|NCT04436276|473824802|FG000|Overall Study|Death|0|||
131599402|NCT04436276|473824803|FG001|Overall Study|Death|0|||
131599403|NCT04436276|473824804|FG002|Overall Study|Death|0|||
131599404|NCT04436276|473824805|FG003|Overall Study|Death|0|||
131599405|NCT04436276|473824806|FG004|Overall Study|Death|0|||
131599406|NCT04436276|473824807|FG005|Overall Study|Death|0|||
131599407|NCT04436276|473824808|FG006|Overall Study|Death|0|||
131599408|NCT04436276|473824809|FG007|Overall Study|Death|0|||
131599409|NCT04436276|473824810|FG008|Overall Study|Death|0|||
131599410|NCT04436276|473824811|FG009|Overall Study|Death|0|||
131599411|NCT04436276|473824812|FG010|Overall Study|Death|0|||
131599412|NCT04436276|473824813|FG011|Overall Study|Death|0|||
131599413|NCT04436276|473824814|FG012|Overall Study|Death|1|||
131599414|NCT04436276|473824815|FG013|Overall Study|Death|0|||
131599415|NCT04436276|473824816|FG014|Overall Study|Death|1|||
131599416|NCT04436276|473824817|FG015|Overall Study|Death|0|||
131599417|NCT04436276|473824818|FG016|Overall Study|Death|0|||
131599418|NCT04436276|473824819|FG017|Overall Study|Death|0|||
131599419|NCT04436276|473824820|FG018|Overall Study|Death|0|||
131599420|NCT04436276|473824821|FG019|Overall Study|Death|2|||
131599421|NCT04436276|473824822|FG020|Overall Study|Death|0|||
131599422|NCT04436276|473824823|FG021|Overall Study|Death|1|||
131599423|NCT04436276|473824824|FG022|Overall Study|Death|0|||
131599424|NCT04436276|473824802|FG000|Overall Study|Lost to Follow-up|0|||
131599425|NCT04436276|473824803|FG001|Overall Study|Lost to Follow-up|2|||
131706696|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131599426|NCT04436276|473824804|FG002|Overall Study|Lost to Follow-up|2|||
131599427|NCT04436276|473824805|FG003|Overall Study|Lost to Follow-up|1|||
131599428|NCT04436276|473824806|FG004|Overall Study|Lost to Follow-up|4|||
131599429|NCT04436276|473824807|FG005|Overall Study|Lost to Follow-up|1|||
131599430|NCT04436276|473824808|FG006|Overall Study|Lost to Follow-up|0|||
131599431|NCT04436276|473824809|FG007|Overall Study|Lost to Follow-up|0|||
131599432|NCT04436276|473824810|FG008|Overall Study|Lost to Follow-up|1|||
131599433|NCT04436276|473824811|FG009|Overall Study|Lost to Follow-up|0|||
131599434|NCT04436276|473824812|FG010|Overall Study|Lost to Follow-up|5|||
131599435|NCT04436276|473824813|FG011|Overall Study|Lost to Follow-up|5|||
131439891|NCT01650558|473236969|FG001|Overall Study|Death|6|||
131439892|NCT01650558|473236970|FG002|Overall Study|Death|8|||
131439893|NCT01650558|473236968|FG000|Overall Study|Withdrawal by Subject|1|||
131439894|NCT01650558|473236969|FG001|Overall Study|Withdrawal by Subject|1|||
131439895|NCT01650558|473236970|FG002|Overall Study|Withdrawal by Subject|3|||
131599436|NCT04436276|473824814|FG012|Overall Study|Lost to Follow-up|4|||
131599437|NCT04436276|473824815|FG013|Overall Study|Lost to Follow-up|1|||
131599438|NCT04436276|473824816|FG014|Overall Study|Lost to Follow-up|7|||
131599439|NCT04436276|473824817|FG015|Overall Study|Lost to Follow-up|7|||
131599440|NCT04436276|473824818|FG016|Overall Study|Lost to Follow-up|1|||
131599441|NCT04436276|473824819|FG017|Overall Study|Lost to Follow-up|0|||
131599442|NCT04436276|473824820|FG018|Overall Study|Lost to Follow-up|1|||
131599443|NCT04436276|473824821|FG019|Overall Study|Lost to Follow-up|1|||
131599444|NCT04436276|473824822|FG020|Overall Study|Lost to Follow-up|2|||
131599445|NCT04436276|473824823|FG021|Overall Study|Lost to Follow-up|1|||
131599446|NCT04436276|473824824|FG022|Overall Study|Lost to Follow-up|1|||
131599447|NCT04436276|473824802|FG000|Overall Study|Physician Decision|1|||
131599448|NCT04436276|473824803|FG001|Overall Study|Physician Decision|0|||
131599449|NCT04436276|473824804|FG002|Overall Study|Physician Decision|2|||
131599450|NCT04436276|473824805|FG003|Overall Study|Physician Decision|1|||
131599451|NCT04436276|473824806|FG004|Overall Study|Physician Decision|0|||
131599452|NCT04436276|473824807|FG005|Overall Study|Physician Decision|0|||
131599453|NCT04436276|473824808|FG006|Overall Study|Physician Decision|0|||
131599454|NCT04436276|473824809|FG007|Overall Study|Physician Decision|0|||
131599455|NCT04436276|473824810|FG008|Overall Study|Physician Decision|0|||
131599456|NCT04436276|473824811|FG009|Overall Study|Physician Decision|0|||
131599457|NCT04436276|473824812|FG010|Overall Study|Physician Decision|0|||
131599458|NCT04436276|473824813|FG011|Overall Study|Physician Decision|1|||
131599459|NCT04436276|473824814|FG012|Overall Study|Physician Decision|2|||
131599460|NCT04436276|473824815|FG013|Overall Study|Physician Decision|0|||
131599461|NCT04436276|473824816|FG014|Overall Study|Physician Decision|0|||
131599462|NCT04436276|473824817|FG015|Overall Study|Physician Decision|0|||
131599463|NCT04436276|473824818|FG016|Overall Study|Physician Decision|0|||
131439896|NCT01650558|473236968|FG000|Overall Study|Non-compliant participant|1|||
131439897|NCT01650558|473236969|FG001|Overall Study|Non-compliant participant|0|||
131439898|NCT01650558|473236970|FG002|Overall Study|Non-compliant participant|2|||
131439899|NCT01650558|473236968|FG000|Overall Study|Physician Decision|0|||
131599464|NCT04436276|473824819|FG017|Overall Study|Physician Decision|0|||
131439900|NCT01650558|473236969|FG001|Overall Study|Physician Decision|1|||
131439901|NCT01650558|473236970|FG002|Overall Study|Physician Decision|0|||
131599465|NCT04436276|473824820|FG018|Overall Study|Physician Decision|0|||
131599466|NCT04436276|473824821|FG019|Overall Study|Physician Decision|0|||
131899671|NCT00368108|474919338|FG001|Overall Study|Physician Decision|0|||
131899672|NCT00368108|474919339|FG002|Overall Study|Physician Decision|1|||
131599467|NCT04436276|473824822|FG020|Overall Study|Physician Decision|1|||
131599468|NCT04436276|473824823|FG021|Overall Study|Physician Decision|2|||
131439902|NCT01069484|473236974|FG000|Overall Study|Death-in-near-family|1|||
131599469|NCT04436276|473824824|FG022|Overall Study|Physician Decision|0|||
131599470|NCT04436276|473824802|FG000|Overall Study|Protocol Violation|0|||
131599471|NCT04436276|473824803|FG001|Overall Study|Protocol Violation|0|||
131599472|NCT04436276|473824804|FG002|Overall Study|Protocol Violation|0|||
131599473|NCT04436276|473824805|FG003|Overall Study|Protocol Violation|0|||
131599474|NCT04436276|473824806|FG004|Overall Study|Protocol Violation|0|||
131599475|NCT04436276|473824807|FG005|Overall Study|Protocol Violation|0|||
131599476|NCT04436276|473824808|FG006|Overall Study|Protocol Violation|0|||
131599477|NCT04436276|473824809|FG007|Overall Study|Protocol Violation|0|||
131599478|NCT04436276|473824810|FG008|Overall Study|Protocol Violation|0|||
131599479|NCT04436276|473824811|FG009|Overall Study|Protocol Violation|0|||
131599480|NCT04436276|473824812|FG010|Overall Study|Protocol Violation|0|||
131599481|NCT04436276|473824813|FG011|Overall Study|Protocol Violation|0|||
131599482|NCT04436276|473824814|FG012|Overall Study|Protocol Violation|0|||
131599483|NCT04436276|473824815|FG013|Overall Study|Protocol Violation|1|||
131599484|NCT04436276|473824816|FG014|Overall Study|Protocol Violation|0|||
131599485|NCT04436276|473824817|FG015|Overall Study|Protocol Violation|1|||
131599486|NCT04436276|473824818|FG016|Overall Study|Protocol Violation|0|||
131599487|NCT04436276|473824819|FG017|Overall Study|Protocol Violation|0|||
131599488|NCT04436276|473824820|FG018|Overall Study|Protocol Violation|0|||
131599489|NCT04436276|473824821|FG019|Overall Study|Protocol Violation|0|||
131599490|NCT04436276|473824822|FG020|Overall Study|Protocol Violation|0|||
131599491|NCT04436276|473824823|FG021|Overall Study|Protocol Violation|0|||
131599492|NCT04436276|473824824|FG022|Overall Study|Protocol Violation|0|||
131599493|NCT04436276|473824802|FG000|Overall Study|Withdrawal by Subject|25|||
131599494|NCT04436276|473824803|FG001|Overall Study|Withdrawal by Subject|22|||
131599495|NCT04436276|473824804|FG002|Overall Study|Withdrawal by Subject|24|||
131599496|NCT04436276|473824805|FG003|Overall Study|Withdrawal by Subject|23|||
131599497|NCT04436276|473824806|FG004|Overall Study|Withdrawal by Subject|14|||
131599498|NCT04436276|473824807|FG005|Overall Study|Withdrawal by Subject|0|||
131599499|NCT04436276|473824808|FG006|Overall Study|Withdrawal by Subject|0|||
131599500|NCT04436276|473824809|FG007|Overall Study|Withdrawal by Subject|1|||
131599501|NCT04436276|473824810|FG008|Overall Study|Withdrawal by Subject|0|||
131599502|NCT04436276|473824811|FG009|Overall Study|Withdrawal by Subject|1|||
131599503|NCT04436276|473824812|FG010|Overall Study|Withdrawal by Subject|17|||
131599504|NCT04436276|473824813|FG011|Overall Study|Withdrawal by Subject|7|||
131599505|NCT04436276|473824814|FG012|Overall Study|Withdrawal by Subject|10|||
131599506|NCT04436276|473824815|FG013|Overall Study|Withdrawal by Subject|6|||
131599507|NCT04436276|473824816|FG014|Overall Study|Withdrawal by Subject|20|||
131599508|NCT04436276|473824817|FG015|Overall Study|Withdrawal by Subject|6|||
131599509|NCT04436276|473824818|FG016|Overall Study|Withdrawal by Subject|11|||
131599510|NCT04436276|473824819|FG017|Overall Study|Withdrawal by Subject|4|||
131599511|NCT04436276|473824820|FG018|Overall Study|Withdrawal by Subject|14|||
131599512|NCT04436276|473824821|FG019|Overall Study|Withdrawal by Subject|24|||
131599513|NCT04436276|473824822|FG020|Overall Study|Withdrawal by Subject|24|||
131599514|NCT04436276|473824823|FG021|Overall Study|Withdrawal by Subject|16|||
131599515|NCT04436276|473824824|FG022|Overall Study|Withdrawal by Subject|14|||
131599516|NCT04436276|473824802|FG000|Overall Study|Other|3|||
131599517|NCT04436276|473824803|FG001|Overall Study|Other|2|||
131599518|NCT04436276|473824804|FG002|Overall Study|Other|5|||
131599519|NCT04436276|473824805|FG003|Overall Study|Other|9|||
131599520|NCT04436276|473824806|FG004|Overall Study|Other|23|||
131599521|NCT04436276|473824807|FG005|Overall Study|Other|1|||
131599522|NCT04436276|473824808|FG006|Overall Study|Other|0|||
131599523|NCT04436276|473824809|FG007|Overall Study|Other|0|||
131599524|NCT04436276|473824810|FG008|Overall Study|Other|0|||
131599525|NCT04436276|473824811|FG009|Overall Study|Other|0|||
131599526|NCT04436276|473824812|FG010|Overall Study|Other|3|||
131599527|NCT04436276|473824813|FG011|Overall Study|Other|1|||
131599528|NCT04436276|473824814|FG012|Overall Study|Other|1|||
131599529|NCT04436276|473824815|FG013|Overall Study|Other|2|||
131599530|NCT04436276|473824816|FG014|Overall Study|Other|3|||
131599531|NCT04436276|473824817|FG015|Overall Study|Other|0|||
131599532|NCT04436276|473824818|FG016|Overall Study|Other|0|||
131599533|NCT04436276|473824819|FG017|Overall Study|Other|6|||
131599534|NCT04436276|473824820|FG018|Overall Study|Other|1|||
131599535|NCT04436276|473824821|FG019|Overall Study|Other|0|||
131599536|NCT04436276|473824822|FG020|Overall Study|Other|2|||
131599537|NCT04436276|473824823|FG021|Overall Study|Other|2|||
131599538|NCT04436276|473824824|FG022|Overall Study|Other|60|||
131599539|NCT05281562|473824825|FG000|Overall Study|Ineligible patient|1|||
131599540|NCT05281562|473824826|FG001|Overall Study|Ineligible patient|0|||
131599541|NCT03322267|473824827|FG000|Overall Study|Lack of Efficacy|11|||
131599542|NCT03322267|473824827|FG000|Overall Study|Adverse Event|1|||
131599543|NCT03322267|473824827|FG000|Overall Study|Withdrawal by Subject|2|||
131599544|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
131599545|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
131599546|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
131599547|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
131599548|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
131599549|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
131599550|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
131599551|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
131599552|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
131599553|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
131599554|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
131599555|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
131599556|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
131599557|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
131599558|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
131599559|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
131599560|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
131599561|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
131599562|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
131599563|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
131599564|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131599565|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
131599566|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131599567|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131599568|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131599569|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
131599570|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
131599571|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
131599572|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
131599573|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
131599574|NCT03852472|473824838|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
131599575|NCT03852472|473824839|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
131599576|NCT03852472|473824840|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
131599577|NCT03852472|473824841|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
131599578|NCT03852472|473824842|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
131599579|NCT03852472|473824838|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
131599580|NCT03852472|473824839|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
131599581|NCT03852472|473824840|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
131599582|NCT03852472|473824841|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
131599583|NCT03852472|473824842|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
131599584|NCT03852472|473824838|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
131599585|NCT03852472|473824839|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
131599586|NCT03852472|473824840|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
131599587|NCT03852472|473824841|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
131599588|NCT03852472|473824842|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
131599589|NCT03852472|473824838|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
131599590|NCT03852472|473824839|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
131599591|NCT03852472|473824840|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
131599592|NCT03852472|473824841|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
131599593|NCT03852472|473824842|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
131599594|NCT03852472|473824838|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
131599595|NCT03852472|473824839|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
131599596|NCT03852472|473824840|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
131599597|NCT03852472|473824841|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
131599598|NCT03852472|473824842|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
131599599|NCT03852472|473824838|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
131599600|NCT03852472|473824839|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
131599601|NCT03852472|473824840|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
131599602|NCT03852472|473824841|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
131599603|NCT03852472|473824842|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
131599604|NCT03852472|473824838|FG000|Period 2 - Week 44|Adverse Event|0|||
131599605|NCT03852472|473824839|FG001|Period 2 - Week 44|Adverse Event|3|||
131599606|NCT03852472|473824840|FG002|Period 2 - Week 44|Adverse Event|1|||
131599607|NCT03852472|473824841|FG003|Period 2 - Week 44|Adverse Event|2|||
131599608|NCT03852472|473824842|FG004|Period 2 - Week 44|Adverse Event|2|||
131599609|NCT03852472|473824838|FG000|Period 2 - Week 44|COVID-19 Related|0|||
131599610|NCT03852472|473824839|FG001|Period 2 - Week 44|COVID-19 Related|0|||
131599611|NCT03852472|473824840|FG002|Period 2 - Week 44|COVID-19 Related|0|||
131599612|NCT03852472|473824841|FG003|Period 2 - Week 44|COVID-19 Related|1|||
131599613|NCT03852472|473824842|FG004|Period 2 - Week 44|COVID-19 Related|0|||
131599614|NCT03852472|473824838|FG000|Period 2 - Week 44|Reason not stated|0|||
131599615|NCT03852472|473824839|FG001|Period 2 - Week 44|Reason not stated|0|||
131599616|NCT03852472|473824840|FG002|Period 2 - Week 44|Reason not stated|0|||
131599617|NCT03852472|473824841|FG003|Period 2 - Week 44|Reason not stated|0|||
131599618|NCT03852472|473824842|FG004|Period 2 - Week 44|Reason not stated|1|||
131599619|NCT05977530|473824843|FG000|Overall Study|Withdrawal by Subject|1|||
131599620|NCT05977530|473824843|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
131599621|NCT06457802|473824844|FG000|Overall Study|Early termination of study prior to participant completion|2|||
131791476|NCT03361956|474518711|FG000|Overall Study|Withdrawal by Subject|2|||
131791477|NCT03361956|474518712|FG001|Overall Study|Withdrawal by Subject|2|||
131791478|NCT03361956|474518713|FG002|Overall Study|Withdrawal by Subject|2|||
131791479|NCT03361956|474518714|FG003|Overall Study|Withdrawal by Subject|0|||
131599622|NCT06457802|473824845|FG001|Overall Study|Early termination of study prior to participant completion|2|||
131599623|NCT03161028|473824846|FG000|Overall Study|Withdrawal by Subject|6|||
131599624|NCT03161028|473824847|FG001|Overall Study|Withdrawal by Subject|4|||
131599625|NCT03161028|473824846|FG000|Overall Study|Adverse Event|5|||
131599626|NCT03161028|473824847|FG001|Overall Study|Adverse Event|1|||
131599627|NCT03161028|473824846|FG000|Overall Study|Study drug side effects|2|||
131599628|NCT03161028|473824847|FG001|Overall Study|Study drug side effects|2|||
131599629|NCT03161028|473824846|FG000|Overall Study|Administrative PD/UP|4|||
131599630|NCT03161028|473824847|FG001|Overall Study|Administrative PD/UP|2|||
131599631|NCT03161028|473824846|FG000|Overall Study|Lost to Follow-up|2|||
131599632|NCT03161028|473824847|FG001|Overall Study|Lost to Follow-up|0|||
131599633|NCT03161028|473824846|FG000|Overall Study|Unable to comply with procedures|1|||
131599634|NCT03161028|473824847|FG001|Overall Study|Unable to comply with procedures|1|||
131599635|NCT00736723|473824848|FG000|Overall Study|Withdrawal by Subject|4|||
131599636|NCT00736723|473824849|FG001|Overall Study|Withdrawal by Subject|3|||
131599637|NCT04797897|473824850|FG000|Overall Study|Study Termination by Sponsor|1|||
131599638|NCT04797897|473824851|FG001|Overall Study|Study Termination by Sponsor|1|||
131599639|NCT03024437|473824857|FG000|Overall Study|Adverse Event|0|||
131599640|NCT03024437|473824858|FG001|Overall Study|Adverse Event|1|||
131599641|NCT03024437|473824859|FG002|Overall Study|Adverse Event|3|||
131599642|NCT03024437|473824860|FG003|Overall Study|Adverse Event|5|||
131599643|NCT03024437|473824861|FG004|Overall Study|Adverse Event|0|||
131599644|NCT03024437|473824857|FG000|Overall Study|Physician Decision|1|||
131599645|NCT03024437|473824858|FG001|Overall Study|Physician Decision|0|||
131599646|NCT03024437|473824859|FG002|Overall Study|Physician Decision|0|||
131599647|NCT03024437|473824860|FG003|Overall Study|Physician Decision|1|||
131599648|NCT03024437|473824861|FG004|Overall Study|Physician Decision|0|||
131599649|NCT03024437|473824857|FG000|Overall Study|Disease progression, relapse|1|||
131599650|NCT03024437|473824858|FG001|Overall Study|Disease progression, relapse|0|||
131599651|NCT03024437|473824859|FG002|Overall Study|Disease progression, relapse|0|||
131599652|NCT03024437|473824860|FG003|Overall Study|Disease progression, relapse|3|||
131599653|NCT03024437|473824861|FG004|Overall Study|Disease progression, relapse|0|||
131599654|NCT03024437|473824857|FG000|Overall Study|Disease progression, refractory disease|4|||
131599655|NCT03024437|473824858|FG001|Overall Study|Disease progression, refractory disease|4|||
131599656|NCT03024437|473824859|FG002|Overall Study|Disease progression, refractory disease|2|||
131599657|NCT03024437|473824860|FG003|Overall Study|Disease progression, refractory disease|2|||
131599658|NCT03024437|473824861|FG004|Overall Study|Disease progression, refractory disease|1|||
131599659|NCT03024437|473824857|FG000|Overall Study|Newly diagnosed cancer|0|||
131599660|NCT03024437|473824858|FG001|Overall Study|Newly diagnosed cancer|0|||
131599661|NCT03024437|473824859|FG002|Overall Study|Newly diagnosed cancer|0|||
131599662|NCT03024437|473824860|FG003|Overall Study|Newly diagnosed cancer|1|||
131599663|NCT03024437|473824861|FG004|Overall Study|Newly diagnosed cancer|0|||
131599664|NCT03024437|473824857|FG000|Overall Study|Moved out of state|0|||
131599665|NCT03024437|473824858|FG001|Overall Study|Moved out of state|1|||
131599666|NCT03024437|473824859|FG002|Overall Study|Moved out of state|0|||
131599667|NCT03024437|473824860|FG003|Overall Study|Moved out of state|0|||
131599668|NCT03024437|473824861|FG004|Overall Study|Moved out of state|0|||
131599669|NCT03024437|473824857|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131599670|NCT03024437|473824858|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131599671|NCT03024437|473824859|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
131599672|NCT03024437|473824860|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131599673|NCT03024437|473824861|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131599674|NCT02601313|473824862|FG000|Overall Study|Death|2|||
131599675|NCT02601313|473824863|FG001|Overall Study|Death|41|||
131599676|NCT02601313|473824864|FG002|Overall Study|Death|6|||
131599677|NCT02601313|473824862|FG000|Overall Study|Enrolled but never treated|0|||
131599678|NCT02601313|473824863|FG001|Overall Study|Enrolled but never treated|6|||
131599679|NCT02601313|473824864|FG002|Overall Study|Enrolled but never treated|3|||
131599680|NCT02601313|473824862|FG000|Overall Study|Enrolled, did not initiate AC|4|||
131599681|NCT02601313|473824863|FG001|Overall Study|Enrolled, did not initiate AC|0|||
131791480|NCT03361956|474518715|FG004|Overall Study|Withdrawal by Subject|3|||
131599682|NCT02601313|473824864|FG002|Overall Study|Enrolled, did not initiate AC|0|||
131599683|NCT02601313|473824862|FG000|Overall Study|Full consent withdrawal|0|||
131599684|NCT02601313|473824863|FG001|Overall Study|Full consent withdrawal|3|||
131599685|NCT02601313|473824864|FG002|Overall Study|Full consent withdrawal|2|||
131599686|NCT02601313|473824862|FG000|Overall Study|Lost to Follow-up|0|||
131599687|NCT02601313|473824863|FG001|Overall Study|Lost to Follow-up|1|||
131599688|NCT02601313|473824864|FG002|Overall Study|Lost to Follow-up|1|||
131599689|NCT04802967|473826608|FG000|Part B|Withdrawal by Subject|0|||
131599690|NCT04802967|473826609|FG001|Part B|Withdrawal by Subject|0|||
131599691|NCT04802967|473826610|FG002|Part B|Withdrawal by Subject|0|||
131599692|NCT04802967|473826611|FG003|Part B|Withdrawal by Subject|0|||
131599693|NCT04802967|473826612|FG004|Part B|Withdrawal by Subject|0|||
131599694|NCT04802967|473826613|FG005|Part B|Withdrawal by Subject|1|||
131599695|NCT04802967|473826614|FG006|Part B|Withdrawal by Subject|0|||
131599696|NCT04802967|473826615|FG007|Part B|Withdrawal by Subject|0|||
131599697|NCT04802967|473826616|FG008|Part B|Withdrawal by Subject|0|||
131599698|NCT04802967|473826617|FG009|Part B|Withdrawal by Subject|0|||
131599699|NCT01098812|473826620|FG000|Overall Study|Death|2|||
131599700|NCT01098812|473826621|FG001|Overall Study|Death|0|||
131599701|NCT01098812|473826622|FG002|Overall Study|Death|1|||
131599702|NCT01098812|473826620|FG000|Overall Study|Lost to Follow-up|0|||
131599703|NCT01098812|473826621|FG001|Overall Study|Lost to Follow-up|1|||
131599704|NCT01098812|473826622|FG002|Overall Study|Lost to Follow-up|0|||
131599705|NCT03379675|473826625|FG000|Overall Study|Lost to Follow-up|0|||
131599706|NCT03379675|473826626|FG001|Overall Study|Lost to Follow-up|1|||
131599707|NCT03379675|473826627|FG002|Overall Study|Lost to Follow-up|0|||
131599708|NCT03379675|473826625|FG000|Overall Study|Adverse Event|2|||
131599709|NCT03379675|473826626|FG001|Overall Study|Adverse Event|0|||
131599710|NCT03379675|473826627|FG002|Overall Study|Adverse Event|0|||
131599711|NCT03379675|473826625|FG000|Overall Study|Withdrawal by Subject|2|||
131599712|NCT03379675|473826626|FG001|Overall Study|Withdrawal by Subject|1|||
131706697|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131791481|NCT03361956|474518711|FG000|Overall Study|Disease Relapse|0|||
131599713|NCT03379675|473826627|FG002|Overall Study|Withdrawal by Subject|2|||
131599714|NCT02817776|473826629|FG000|Overall Study|Excluded|33|||
131599715|NCT02817776|473826629|FG000|Overall Study|Lost to Follow-up|20|||
131599716|NCT02817776|473826629|FG000|Overall Study|Withdrawal by Subject|33|||
131599717|NCT02817776|473826629|FG000|Overall Study|Death|2|||
131599718|NCT02598388|473826630|FG000|Overall Study|Lost to Follow-up|1|||
131599719|NCT02598388|473826631|FG001|Overall Study|Lost to Follow-up|0|||
131599720|NCT02598388|473826632|FG002|Overall Study|Lost to Follow-up|1|||
131599721|NCT02598388|473826633|FG003|Overall Study|Lost to Follow-up|0|||
131599722|NCT02598388|473826634|FG004|Overall Study|Lost to Follow-up|5|||
131599723|NCT02598388|473826635|FG005|Overall Study|Lost to Follow-up|1|||
131599724|NCT02598388|473826636|FG006|Overall Study|Lost to Follow-up|2|||
131599725|NCT02598388|473826637|FG007|Overall Study|Lost to Follow-up|1|||
131599726|NCT02598388|473826638|FG008|Overall Study|Lost to Follow-up|0|||
131599727|NCT02598388|473826639|FG009|Overall Study|Lost to Follow-up|0|||
131599728|NCT02598388|473826640|FG010|Overall Study|Lost to Follow-up|1|||
131599729|NCT02598388|473826641|FG011|Overall Study|Lost to Follow-up|0|||
131599730|NCT02598388|473826630|FG000|Overall Study|Withdrawal by Subject|0|||
131599731|NCT02598388|473826631|FG001|Overall Study|Withdrawal by Subject|0|||
131599732|NCT02598388|473826632|FG002|Overall Study|Withdrawal by Subject|0|||
131599733|NCT02598388|473826633|FG003|Overall Study|Withdrawal by Subject|0|||
131599734|NCT02598388|473826634|FG004|Overall Study|Withdrawal by Subject|2|||
131599735|NCT02598388|473826635|FG005|Overall Study|Withdrawal by Subject|0|||
131599736|NCT02598388|473826636|FG006|Overall Study|Withdrawal by Subject|2|||
131599737|NCT02598388|473826637|FG007|Overall Study|Withdrawal by Subject|0|||
131599738|NCT02598388|473826638|FG008|Overall Study|Withdrawal by Subject|0|||
131599739|NCT02598388|473826639|FG009|Overall Study|Withdrawal by Subject|1|||
131599740|NCT02598388|473826640|FG010|Overall Study|Withdrawal by Subject|0|||
131599741|NCT02598388|473826641|FG011|Overall Study|Withdrawal by Subject|0|||
131599742|NCT02598388|473826630|FG000|Overall Study|Other|0|||
131599743|NCT02598388|473826631|FG001|Overall Study|Other|0|||
131599744|NCT02598388|473826632|FG002|Overall Study|Other|1|||
131599745|NCT02598388|473826633|FG003|Overall Study|Other|0|||
131599746|NCT02598388|473826634|FG004|Overall Study|Other|3|||
131599747|NCT02598388|473826635|FG005|Overall Study|Other|0|||
131599748|NCT02598388|473826636|FG006|Overall Study|Other|1|||
131599749|NCT02598388|473826637|FG007|Overall Study|Other|0|||
131599750|NCT02598388|473826638|FG008|Overall Study|Other|0|||
131599751|NCT02598388|473826639|FG009|Overall Study|Other|0|||
131599752|NCT02598388|473826640|FG010|Overall Study|Other|0|||
131599753|NCT02598388|473826641|FG011|Overall Study|Other|0|||
131599754|NCT02979327|473826642|FG000|First Intervention|Protocol Violation|1|||
131599755|NCT02979327|473826643|FG001|First Intervention|Protocol Violation|0|||
131599756|NCT03474679|473826652|FG000|Overall Study|Death|7|||
131599757|NCT03474679|473826652|FG000|Overall Study|Withdrawal by Subject|1|||
131599758|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
131599759|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
131599760|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
131599761|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
131599762|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
131599763|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
131599764|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Death|6|||
131599765|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Death|0|||
131599766|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Death|0|||
131599767|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
131599768|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
131599769|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
131599770|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
131599771|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
131599772|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
131599773|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
131599774|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
131599775|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
131599776|NCT01539083|473826655|FG000|Before Randomization (VCD Induction)|Other|5|||
131599777|NCT01539083|473826656|FG001|Before Randomization (VCD Induction)|Other|0|||
131599778|NCT01539083|473826657|FG002|Before Randomization (VCD Induction)|Other|0|||
131599779|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
131599780|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
131599781|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
131599782|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Other|0|||
131599783|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Other|1|||
131599784|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Other|1|||
131599785|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
131599786|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
131599787|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
131599788|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
131599789|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
131599790|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
131599791|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
131599792|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
131599793|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
131599794|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
131599795|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
131599796|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
131599797|NCT01539083|473826655|FG000|After Randomization (TP and VTP)|Death|0|||
131599798|NCT01539083|473826656|FG001|After Randomization (TP and VTP)|Death|6|||
131599799|NCT01539083|473826657|FG002|After Randomization (TP and VTP)|Death|11|||
131599800|NCT02573493|473826666|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
131599801|NCT02573493|473826667|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
131599802|NCT02573493|473826668|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
131599803|NCT02573493|473826669|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
131599804|NCT04149704|473826670|FG000|Three Month Follow-up|Death|2|||
131599805|NCT04149704|473826671|FG001|Three Month Follow-up|Death|0|||
131599806|NCT04149704|473826672|FG002|Three Month Follow-up|Death|0|||
131599807|NCT04149704|473826673|FG003|Three Month Follow-up|Death|0|||
131599808|NCT04149704|473826670|FG000|Three Month Follow-up|Lost to Follow-up|1|||
131599809|NCT04149704|473826671|FG001|Three Month Follow-up|Lost to Follow-up|4|||
131599810|NCT04149704|473826672|FG002|Three Month Follow-up|Lost to Follow-up|5|||
131599811|NCT04149704|473826673|FG003|Three Month Follow-up|Lost to Follow-up|5|||
131599812|NCT04149704|473826670|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
131599813|NCT04149704|473826671|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
131599814|NCT04149704|473826672|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
131599815|NCT04149704|473826673|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
131599816|NCT04149704|473826670|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
131599817|NCT04149704|473826671|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
131653702|NCT03945825|474018459|FG004|Overall Study|Withdrawal by Subject|0|||
131599818|NCT04149704|473826672|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
131599819|NCT04149704|473826673|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
131599820|NCT04332926|473826674|FG000|Overall Study|Withdrawal by Subject|6|||
131599821|NCT04332926|473826674|FG000|Overall Study|Physician Decision|6|||
131599822|NCT05213390|473826682|FG000|Overall Study|Withdrawal by Subject|2|||
131599823|NCT05213390|473826682|FG000|Overall Study|Lost to Follow-up|12|||
131599824|NCT05213390|473826682|FG000|Overall Study|Protocol Violation|9|||
131599825|NCT05362487|473826683|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
131599826|NCT05415722|473826692|FG000|Overall Study|Lost to Follow-up|0|||
131599827|NCT05415722|473826693|FG001|Overall Study|Lost to Follow-up|2|||
131599828|NCT05415722|473826694|FG002|Overall Study|Lost to Follow-up|0|||
131599829|NCT05415722|473826695|FG003|Overall Study|Lost to Follow-up|1|||
131599830|NCT05415722|473826696|FG004|Overall Study|Lost to Follow-up|0|||
131599831|NCT05415722|473826697|FG005|Overall Study|Lost to Follow-up|0|||
131599832|NCT05415722|473826698|FG006|Overall Study|Lost to Follow-up|1|||
131599833|NCT05415722|473826692|FG000|Overall Study|Physician Decision|0|||
131599834|NCT05415722|473826693|FG001|Overall Study|Physician Decision|0|||
131599835|NCT05415722|473826694|FG002|Overall Study|Physician Decision|0|||
131599836|NCT05415722|473826695|FG003|Overall Study|Physician Decision|1|||
131599837|NCT05415722|473826696|FG004|Overall Study|Physician Decision|0|||
131599838|NCT05415722|473826697|FG005|Overall Study|Physician Decision|0|||
131599839|NCT05415722|473826698|FG006|Overall Study|Physician Decision|1|||
131599840|NCT05415722|473826692|FG000|Overall Study|Protocol Violation|0|||
131439903|NCT01069484|473236975|FG001|Overall Study|Death-in-near-family|0|||
131439904|NCT01069484|473236974|FG000|Overall Study|No specific reason|8|||
131439905|NCT01069484|473236975|FG001|Overall Study|No specific reason|2|||
131439906|NCT01069484|473236974|FG000|Overall Study|Illness mother or child|3|||
131439907|NCT01069484|473236975|FG001|Overall Study|Illness mother or child|1|||
131439908|NCT00644358|473236976|FG000|Overall Study|Adverse Event|124|||
131439909|NCT00644358|473236976|FG000|Overall Study|Lost to Follow-up|105|||
131439910|NCT00644358|473236976|FG000|Overall Study|Consent Withdrawal|64|||
131439911|NCT00644358|473236976|FG000|Overall Study|Lack of Effectiveness|39|||
131439912|NCT00644358|473236976|FG000|Overall Study|Protocol Violation|5|||
131439913|NCT00644358|473236976|FG000|Overall Study|Noncompliance|14|||
131439914|NCT00644358|473236976|FG000|Overall Study|Other Unspecified|11|||
131439915|NCT00758771|473236984|FG000|Overall Study|Withdrawal by Subject|1|||
131439916|NCT00758771|473236985|FG001|Overall Study|Withdrawal by Subject|1|||
131439917|NCT00758771|473236984|FG000|Overall Study|Did not meet eligibility criteria|2|||
131439918|NCT00758771|473236985|FG001|Overall Study|Did not meet eligibility criteria|4|||
131439919|NCT02978417|473236988|FG000|Overall Study|Lost to Follow-up|2|||
131439920|NCT02978417|473236989|FG001|Overall Study|Lost to Follow-up|2|||
131439921|NCT01323582|473236995|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
131439922|NCT01323582|473236996|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
131439923|NCT01323582|473236995|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
131439924|NCT01323582|473236996|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
131439925|NCT01323582|473236995|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
131599841|NCT05415722|473826693|FG001|Overall Study|Protocol Violation|0|||
131599842|NCT05415722|473826694|FG002|Overall Study|Protocol Violation|0|||
131599843|NCT05415722|473826695|FG003|Overall Study|Protocol Violation|1|||
131599844|NCT05415722|473826696|FG004|Overall Study|Protocol Violation|0|||
131599845|NCT05415722|473826697|FG005|Overall Study|Protocol Violation|0|||
131439926|NCT01323582|473236996|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
131599846|NCT05415722|473826698|FG006|Overall Study|Protocol Violation|0|||
131599847|NCT05415722|473826692|FG000|Overall Study|Sponsor Discretion|0|||
131599848|NCT05415722|473826693|FG001|Overall Study|Sponsor Discretion|0|||
131439927|NCT03416868|473236997|FG000|Overall Study|Withdrawal by Subject|2|||
131439928|NCT03416868|473236997|FG000|Overall Study|Lost to Follow-up|1|||
131439929|NCT00960375|473237000|FG000|Overall Study|Lost to Follow-up|20|||
131439930|NCT00960375|473237001|FG001|Overall Study|Lost to Follow-up|22|||
131599849|NCT05415722|473826694|FG002|Overall Study|Sponsor Discretion|0|||
131599850|NCT05415722|473826695|FG003|Overall Study|Sponsor Discretion|0|||
131599851|NCT05415722|473826696|FG004|Overall Study|Sponsor Discretion|1|||
131599852|NCT05415722|473826697|FG005|Overall Study|Sponsor Discretion|1|||
131599853|NCT05415722|473826698|FG006|Overall Study|Sponsor Discretion|0|||
131599854|NCT05415722|473826692|FG000|Overall Study|Withdrawal by Subject|0|||
131599855|NCT05415722|473826693|FG001|Overall Study|Withdrawal by Subject|1|||
131599856|NCT05415722|473826694|FG002|Overall Study|Withdrawal by Subject|0|||
131599857|NCT05415722|473826695|FG003|Overall Study|Withdrawal by Subject|1|||
131599858|NCT05415722|473826696|FG004|Overall Study|Withdrawal by Subject|1|||
131599859|NCT05415722|473826697|FG005|Overall Study|Withdrawal by Subject|0|||
131599860|NCT05415722|473826698|FG006|Overall Study|Withdrawal by Subject|1|||
131599861|NCT04663737|473826702|FG000|Overall Study|Withdrawal by Subject|2|||
131599862|NCT04663737|473826703|FG001|Overall Study|Withdrawal by Subject|0|||
131599863|NCT02310646|473826704|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
131599864|NCT02310646|473826705|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
131439931|NCT00083889|473237002|FG000|Overall Study|Adverse Event|76|||
131439932|NCT00083889|473237003|FG001|Overall Study|Adverse Event|86|||
131439933|NCT00083889|473237002|FG000|Overall Study|Protocol Violation|2|||
131439934|NCT00083889|473237003|FG001|Overall Study|Protocol Violation|2|||
131439935|NCT00083889|473237002|FG000|Overall Study|Withdrawal by Subject|22|||
131439936|NCT00083889|473237003|FG001|Overall Study|Withdrawal by Subject|24|||
131439937|NCT00083889|473237002|FG000|Overall Study|Lack of Efficacy|240|||
131439938|NCT00083889|473237003|FG001|Overall Study|Lack of Efficacy|219|||
131439939|NCT00083889|473237002|FG000|Overall Study|Decision of sponsor|32|||
131439940|NCT00083889|473237003|FG001|Overall Study|Decision of sponsor|4|||
131439941|NCT00083889|473237002|FG000|Overall Study|Randomized: did not take study drug|0|||
131439942|NCT00083889|473237003|FG001|Overall Study|Randomized: did not take study drug|15|||
131439943|NCT00083889|473237002|FG000|Overall Study|Completed on marketed sunitinub|3|||
131439944|NCT00083889|473237003|FG001|Overall Study|Completed on marketed sunitinub|0|||
131439945|NCT00083889|473237002|FG000|Overall Study|Crossover to SU011248|0|||
131439946|NCT00083889|473237003|FG001|Overall Study|Crossover to SU011248|25|||
131439947|NCT03557970|473237004|FG000|Overall Study|Study closure|1|||
131439948|NCT03557970|473237005|FG001|Overall Study|Study closure|0|||
131439949|NCT03557970|473237004|FG000|Overall Study|Physician Decision|0|||
131439950|NCT03557970|473237005|FG001|Overall Study|Physician Decision|1|||
131439951|NCT03557970|473237004|FG000|Overall Study|Death|0|||
131439952|NCT03557970|473237005|FG001|Overall Study|Death|1|||
131439953|NCT00112736|473237006|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
131439954|NCT00112736|473237007|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
131439955|NCT00849940|473237008|FG000|Overall Study|Physician Decision|4|||
131439956|NCT01927497|473237009|FG000|Overall Study|Death|0|||
131439957|NCT01927497|473237010|FG001|Overall Study|Death|1|||
131439958|NCT01927497|473237009|FG000|Overall Study|Protocol Violation|2|||
131439959|NCT01927497|473237010|FG001|Overall Study|Protocol Violation|0|||
131439960|NCT03914417|473237011|FG000|Overall Study|Withdrawal by Subject|2|||
131439961|NCT03836625|473237014|FG000|Overall Study|Lost to Follow-up|9|||
131439962|NCT03836625|473237015|FG001|Overall Study|Lost to Follow-up|9|||
131439963|NCT03836625|473237014|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
131439964|NCT03836625|473237015|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
131439965|NCT03836625|473237014|FG000|Overall Study|Death|0|||
131439966|NCT03836625|473237015|FG001|Overall Study|Death|1|||
131439967|NCT03836625|473237014|FG000|Overall Study|Refused follow-up|0|||
131439968|NCT03836625|473237015|FG001|Overall Study|Refused follow-up|1|||
131439969|NCT01400698|473237018|FG000|Overall Study|Lost to Follow-up|2|||
131439970|NCT01400698|473237019|FG001|Overall Study|Lost to Follow-up|5|||
131439971|NCT01400698|473237020|FG002|Overall Study|Lost to Follow-up|2|||
131439972|NCT01400698|473237021|FG003|Overall Study|Lost to Follow-up|1|||
131439973|NCT01400698|473237022|FG004|Overall Study|Lost to Follow-up|4|||
131439974|NCT01400698|473237023|FG005|Overall Study|Lost to Follow-up|3|||
131599865|NCT02310646|473826704|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
131599866|NCT02310646|473826705|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
131599867|NCT04700163|473826706|FG000|Overall Study|Lost to Follow-up|0|||
131599868|NCT04700163|473826707|FG001|Overall Study|Lost to Follow-up|0|||
131599869|NCT04700163|473826708|FG002|Overall Study|Lost to Follow-up|0|||
131706698|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
131439975|NCT01400698|473237018|FG000|Overall Study|Withdrawal by Subject|8|||
131439976|NCT01400698|473237019|FG001|Overall Study|Withdrawal by Subject|2|||
131439977|NCT01400698|473237020|FG002|Overall Study|Withdrawal by Subject|0|||
131439978|NCT01400698|473237021|FG003|Overall Study|Withdrawal by Subject|4|||
131439979|NCT01400698|473237022|FG004|Overall Study|Withdrawal by Subject|1|||
131439980|NCT01400698|473237023|FG005|Overall Study|Withdrawal by Subject|3|||
131439981|NCT01400698|473237018|FG000|Overall Study|Protocol Violation|0|||
131439982|NCT01400698|473237019|FG001|Overall Study|Protocol Violation|1|||
131439983|NCT01400698|473237020|FG002|Overall Study|Protocol Violation|0|||
131439984|NCT01400698|473237021|FG003|Overall Study|Protocol Violation|0|||
131439985|NCT01400698|473237022|FG004|Overall Study|Protocol Violation|1|||
131439986|NCT01400698|473237023|FG005|Overall Study|Protocol Violation|0|||
131439987|NCT01400698|473237018|FG000|Overall Study|Non-compliance|0|||
131439988|NCT01400698|473237019|FG001|Overall Study|Non-compliance|1|||
131439989|NCT01400698|473237020|FG002|Overall Study|Non-compliance|0|||
131439990|NCT01400698|473237021|FG003|Overall Study|Non-compliance|1|||
131439991|NCT01400698|473237022|FG004|Overall Study|Non-compliance|0|||
131439992|NCT01400698|473237023|FG005|Overall Study|Non-compliance|0|||
131439993|NCT01400698|473237018|FG000|Overall Study|Adverse Event|1|||
131439994|NCT01400698|473237019|FG001|Overall Study|Adverse Event|0|||
131439995|NCT01400698|473237020|FG002|Overall Study|Adverse Event|0|||
131439996|NCT01400698|473237021|FG003|Overall Study|Adverse Event|0|||
131439997|NCT01400698|473237022|FG004|Overall Study|Adverse Event|0|||
131439998|NCT01400698|473237023|FG005|Overall Study|Adverse Event|0|||
131439999|NCT01400698|473237018|FG000|Overall Study|Other|4|||
131440000|NCT01400698|473237019|FG001|Overall Study|Other|2|||
131440001|NCT01400698|473237020|FG002|Overall Study|Other|0|||
131440002|NCT01400698|473237021|FG003|Overall Study|Other|2|||
131440003|NCT01400698|473237022|FG004|Overall Study|Other|1|||
131440004|NCT01400698|473237023|FG005|Overall Study|Other|0|||
131440005|NCT00740220|473239191|FG000|Overall Study|screen failures (non-COPD patients)|9|||
131440006|NCT01602224|473239192|FG000|Overall Study|Adverse Event|0|||
131440007|NCT01602224|473239193|FG001|Overall Study|Adverse Event|1|||
131440008|NCT01602224|473239194|FG002|Overall Study|Adverse Event|0|||
131440009|NCT01602224|473239192|FG000|Overall Study|Investigator Decison|1|||
131440010|NCT01602224|473239193|FG001|Overall Study|Investigator Decison|0|||
131440011|NCT01602224|473239194|FG002|Overall Study|Investigator Decison|0|||
131440012|NCT01602224|473239192|FG000|Overall Study|Lost to Follow-up|0|||
131440013|NCT01602224|473239193|FG001|Overall Study|Lost to Follow-up|0|||
131440014|NCT01602224|473239194|FG002|Overall Study|Lost to Follow-up|1|||
131440015|NCT01602224|473239192|FG000|Overall Study|Protocol Violation|0|||
131440016|NCT01602224|473239193|FG001|Overall Study|Protocol Violation|1|||
131440017|NCT01602224|473239194|FG002|Overall Study|Protocol Violation|0|||
131440018|NCT01602224|473239192|FG000|Overall Study|Sponsor Decision|2|||
131440019|NCT01602224|473239193|FG001|Overall Study|Sponsor Decision|3|||
131440020|NCT01602224|473239194|FG002|Overall Study|Sponsor Decision|2|||
131440021|NCT01602224|473239192|FG000|Overall Study|Withdrawal by Subject|5|||
131440022|NCT01602224|473239193|FG001|Overall Study|Withdrawal by Subject|3|||
131440023|NCT01602224|473239194|FG002|Overall Study|Withdrawal by Subject|3|||
131440024|NCT01352117|473239195|FG000|Overall Study|Death|15|||
131440025|NCT01352117|473239196|FG001|Overall Study|Death|16|||
131440026|NCT01352117|473239195|FG000|Overall Study|Withdrawal by Subject|1|||
131440027|NCT01352117|473239196|FG001|Overall Study|Withdrawal by Subject|0|||
131440028|NCT01352117|473239195|FG000|Overall Study|Lost to Follow-up|2|||
131440029|NCT01352117|473239196|FG001|Overall Study|Lost to Follow-up|7|||
131440030|NCT01352117|473239195|FG000|Overall Study|Non-adherent to study requirements|1|||
131599870|NCT04700163|473826709|FG003|Overall Study|Lost to Follow-up|0|||
131599871|NCT04700163|473826710|FG004|Overall Study|Lost to Follow-up|0|||
131599872|NCT04700163|473826711|FG005|Overall Study|Lost to Follow-up|1|||
131599873|NCT03848065|473826712|FG000|Overall Study|Death|0|||
131599874|NCT03848065|473826713|FG001|Overall Study|Death|1|||
131599875|NCT03848065|473826714|FG002|Overall Study|Death|0|||
131599876|NCT03848065|473826712|FG000|Overall Study|Lost to Follow-up|0|||
131599877|NCT03848065|473826713|FG001|Overall Study|Lost to Follow-up|0|||
131599878|NCT03848065|473826714|FG002|Overall Study|Lost to Follow-up|1|||
131599879|NCT03848065|473826712|FG000|Overall Study|Physician Decision|0|||
131599880|NCT03848065|473826713|FG001|Overall Study|Physician Decision|0|||
131599881|NCT03848065|473826714|FG002|Overall Study|Physician Decision|1|||
131599882|NCT03865498|473826721|FG000|Overall Study|Lack of Efficacy|12|||
131599883|NCT03865498|473826722|FG001|Overall Study|Lack of Efficacy|11|||
131599884|NCT03865498|473826721|FG000|Overall Study|Lost to Follow-up|125|||
131599885|NCT03865498|473826722|FG001|Overall Study|Lost to Follow-up|133|||
131599886|NCT03865498|473826721|FG000|Overall Study|Withdrawal by Subject|2|||
131599887|NCT03865498|473826722|FG001|Overall Study|Withdrawal by Subject|4|||
131599888|NCT05869383|473826725|FG000|Overall Study|Withdrawal by Subject|2|||
131440031|NCT01352117|473239196|FG001|Overall Study|Non-adherent to study requirements|1|||
131440032|NCT01352117|473239195|FG000|Overall Study|Did not initiate study treatment|1|||
131440033|NCT01352117|473239196|FG001|Overall Study|Did not initiate study treatment|0|||
131440034|NCT01352117|473239195|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
131440035|NCT01352117|473239196|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
131440036|NCT00770653|473239200|FG000|Overall Study|Adverse Event|13|||
131440037|NCT00770653|473239201|FG001|Overall Study|Adverse Event|5|||
131599889|NCT05869383|473826726|FG001|Overall Study|Withdrawal by Subject|0|||
131440038|NCT00770653|473239200|FG000|Overall Study|Protocol Violation|8|||
131440039|NCT00770653|473239201|FG001|Overall Study|Protocol Violation|6|||
131440040|NCT00770653|473239200|FG000|Overall Study|Withdrawal by Subject|4|||
131599890|NCT04137367|473826729|FG000|Overall Study|Lost to Follow-up|8|||
131599891|NCT04137367|473826730|FG001|Overall Study|Lost to Follow-up|6|||
131440041|NCT00770653|473239201|FG001|Overall Study|Withdrawal by Subject|7|||
131599892|NCT04137367|473826731|FG002|Overall Study|Lost to Follow-up|4|||
131599893|NCT03907878|473826732|FG000|Treatment Period|Withdrawal by Subject|5|||
131440042|NCT00770653|473239200|FG000|Overall Study|Lack of Compliance|1|||
131440043|NCT00770653|473239201|FG001|Overall Study|Lack of Compliance|4|||
131440044|NCT00770653|473239200|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
131599894|NCT03907878|473826732|FG000|Treatment Period|Adverse Event|4|||
131599895|NCT03907878|473826732|FG000|Treatment Period|Lack of Efficacy|1|||
131599896|NCT03907878|473826732|FG000|Treatment Period|Protocol Violation|1|||
131599897|NCT03907878|473826732|FG000|Follow-up Period|Adverse Event|3|||
131599898|NCT03907878|473826732|FG000|Follow-up Period|Withdrawal by Subject|3|||
131599899|NCT05144009|473826733|FG000|Overall Study|Lost to Follow-up|0|||
131599900|NCT05144009|473826734|FG001|Overall Study|Lost to Follow-up|1|||
131599901|NCT05144009|473826733|FG000|Overall Study|Study Termination by the Sponsor|11|||
131599902|NCT05144009|473826734|FG001|Overall Study|Study Termination by the Sponsor|11|||
131599903|NCT05144009|473826733|FG000|Overall Study|Disease Progression|1|||
131599904|NCT05144009|473826734|FG001|Overall Study|Disease Progression|0|||
131599905|NCT05144009|473826733|FG000|Overall Study|Participant Decision|0|||
131599906|NCT05144009|473826734|FG001|Overall Study|Participant Decision|2|||
131599907|NCT05144009|473826733|FG000|Overall Study|Death|5|||
131599908|NCT05144009|473826734|FG001|Overall Study|Death|10|||
131599909|NCT04499924|473826735|FG000|Overall Study|Study termination by sponsor|4|||
131599910|NCT04499924|473826736|FG001|Overall Study|Study termination by sponsor|6|||
131599911|NCT04499924|473826735|FG000|Overall Study|Withdrawal by Subject|1|||
131599912|NCT04499924|473826736|FG001|Overall Study|Withdrawal by Subject|3|||
131599913|NCT03270501|473826741|FG000|Overall Study|Screen failure|6|||
131599914|NCT03270501|473826741|FG000|Overall Study|Lost to Follow-up|2|||
131599915|NCT03270501|473826741|FG000|Overall Study|Adverse Event|1|||
131599916|NCT01648023|473826742|FG000|Overall Study|Screen Fail Post Randomization|1|||
131599917|NCT01648023|473826743|FG001|Overall Study|Screen Fail Post Randomization|2|||
131599918|NCT03020199|473826751|FG000|Treatment Period|Adverse Event|0|||
131599919|NCT03020199|473826752|FG001|Treatment Period|Adverse Event|2|||
131599920|NCT03020199|473826751|FG000|Treatment Period|Lack of Efficacy|1|||
131899673|NCT00368108|474919337|FG000|Overall Study|Other|3|||
131599921|NCT03020199|473826752|FG001|Treatment Period|Lack of Efficacy|6|||
131599922|NCT03020199|473826751|FG000|Treatment Period|Lost to Follow-up|1|||
131899674|NCT00368108|474919338|FG001|Overall Study|Other|7|||
131599923|NCT03020199|473826752|FG001|Treatment Period|Lost to Follow-up|6|||
131599924|NCT03020199|473826751|FG000|Treatment Period|Physician Decision|0|||
131599925|NCT03020199|473826752|FG001|Treatment Period|Physician Decision|1|||
131599926|NCT03020199|473826751|FG000|Treatment Period|Subject/guardian decision|8|||
131599927|NCT03020199|473826752|FG001|Treatment Period|Subject/guardian decision|15|||
131599928|NCT03020199|473826751|FG000|Treatment Period|Subjects not treated|3|||
131599929|NCT03020199|473826752|FG001|Treatment Period|Subjects not treated|4|||
131599930|NCT03020199|473826751|FG000|Follow-up Period|Disease relapse|32|||
131599931|NCT03020199|473826752|FG001|Follow-up Period|Disease relapse|7|||
131599932|NCT03020199|473826751|FG000|Follow-up Period|Lack of Efficacy|1|||
131599933|NCT03020199|473826752|FG001|Follow-up Period|Lack of Efficacy|2|||
131599934|NCT03020199|473826751|FG000|Follow-up Period|Lost to Follow-up|4|||
131599935|NCT03020199|473826752|FG001|Follow-up Period|Lost to Follow-up|6|||
131599936|NCT03020199|473826751|FG000|Follow-up Period|Physician Decision|2|||
131599937|NCT03020199|473826752|FG001|Follow-up Period|Physician Decision|2|||
131599938|NCT03020199|473826751|FG000|Follow-up Period|Protocol Violation|1|||
131599939|NCT03020199|473826752|FG001|Follow-up Period|Protocol Violation|2|||
131599940|NCT03020199|473826751|FG000|Follow-up Period|Study terminated by Sponsor|6|||
131599941|NCT03020199|473826752|FG001|Follow-up Period|Study terminated by Sponsor|3|||
131599942|NCT03020199|473826751|FG000|Follow-up Period|Subject/guardian decision|14|||
131599943|NCT03020199|473826752|FG001|Follow-up Period|Subject/guardian decision|9|||
131599944|NCT05386030|473826755|FG000|Overall Study|Death|1|||
131599945|NCT05386030|473826756|FG001|Overall Study|Death|0|||
131599946|NCT05386030|473826755|FG000|Overall Study|Physician Decision|2|||
131599947|NCT05386030|473826756|FG001|Overall Study|Physician Decision|1|||
131599948|NCT05386030|473826755|FG000|Overall Study|Lost to Follow-up|19|||
131599949|NCT05386030|473826756|FG001|Overall Study|Lost to Follow-up|7|||
131599950|NCT05386030|473826755|FG000|Overall Study|Withdrawal by Subject|20|||
131599951|NCT05386030|473826756|FG001|Overall Study|Withdrawal by Subject|10|||
131599952|NCT05386030|473826755|FG000|Overall Study|Eligibility criteria violation|1|||
131599953|NCT05386030|473826756|FG001|Overall Study|Eligibility criteria violation|1|||
131599954|NCT05386030|473826755|FG000|Overall Study|Personal Reasons|1|||
131599955|NCT05386030|473826756|FG001|Overall Study|Personal Reasons|0|||
131599956|NCT04719832|473826757|FG000|Overall Study|Adverse Event|2|||
131599957|NCT04719832|473826758|FG001|Overall Study|Adverse Event|0|||
131599958|NCT04719832|473826757|FG000|Overall Study|Lack of Efficacy|2|||
131791482|NCT03361956|474518712|FG001|Overall Study|Disease Relapse|0|||
131599959|NCT04719832|473826758|FG001|Overall Study|Lack of Efficacy|4|||
131599960|NCT04719832|473826757|FG000|Overall Study|Lost to Follow-up|0|||
131599961|NCT04719832|473826758|FG001|Overall Study|Lost to Follow-up|2|||
131599962|NCT04719832|473826757|FG000|Overall Study|Physician Decision|0|||
131599963|NCT04719832|473826758|FG001|Overall Study|Physician Decision|1|||
131599964|NCT04719832|473826757|FG000|Overall Study|Pregnancy|1|||
131599965|NCT04719832|473826758|FG001|Overall Study|Pregnancy|1|||
131599966|NCT04719832|473826757|FG000|Overall Study|Withdrawal by Subject|5|||
131599967|NCT04719832|473826758|FG001|Overall Study|Withdrawal by Subject|5|||
131599968|NCT04719832|473826757|FG000|Overall Study|Randomized, not treated|0|||
131599969|NCT04719832|473826758|FG001|Overall Study|Randomized, not treated|2|||
131599970|NCT04719832|473826757|FG000|Overall Study|GCP violations|4|||
131599971|NCT04719832|473826758|FG001|Overall Study|GCP violations|7|||
131599972|NCT05228457|473826759|FG000|Overall Study|Withdrawal by Subject|1|||
131599973|NCT05228457|473826760|FG001|Overall Study|Withdrawal by Subject|1|||
131599974|NCT04880863|473826763|FG000|Overall Study|Adverse Event|1|||
131599975|NCT04880863|473826763|FG000|Overall Study|Patient decision|2|||
131599976|NCT04880863|473826763|FG000|Overall Study|Confirmed Disease Progression|15|||
131599977|NCT04880863|473826763|FG000|Overall Study|Death|3|||
131599978|NCT04880863|473826763|FG000|Overall Study|Physician Decision|4|||
131599979|NCT04880863|473826763|FG000|Overall Study|Unconfirmed Disease Progression|4|||
131599980|NCT04880863|473826763|FG000|Overall Study|Withdrawal by Subject|2|||
131599981|NCT04880863|473826763|FG000|Overall Study|Study discontinuation by the sponsor|4|||
131599982|NCT04880863|473826763|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
131599983|NCT04880863|473826763|FG000|Overall Study|Not received study drug NAP|2|||
131599984|NCT03213691|473826766|FG000|Overall Study|Adverse Event|2|||
131599985|NCT03213691|473826766|FG000|Overall Study|Death|3|||
131599986|NCT03213691|473826766|FG000|Overall Study|Physician Decision|1|||
131599987|NCT03213691|473826766|FG000|Overall Study|Progressive Disease|14|||
131599988|NCT03213691|473826766|FG000|Overall Study|Ineligible|1|||
131599989|NCT04898673|473826767|FG000|Overall Study|Screenfail|1|||
131599990|NCT04898673|473826768|FG001|Overall Study|Screenfail|0|||
131599991|NCT01152450|473826773|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
131599992|NCT01152450|473826774|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
131599993|NCT01152450|473826775|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
131599994|NCT01152450|473826776|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
131599995|NCT01152450|473826777|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
131599996|NCT01152450|473826778|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
131599997|NCT01152450|473826773|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
131599998|NCT01152450|473826774|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
131599999|NCT01152450|473826775|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
131600000|NCT01152450|473826776|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
131600001|NCT01152450|473826777|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
131600002|NCT01152450|473826778|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
131600003|NCT01152450|473826773|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131600004|NCT01152450|473826774|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
131600005|NCT01152450|473826775|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
131600006|NCT01152450|473826776|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131600007|NCT01152450|473826777|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131600008|NCT01152450|473826778|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131600009|NCT01544114|473826782|FG000|Overall Study|Withdrawal by Subject|0|||
131600010|NCT01544114|473826783|FG001|Overall Study|Withdrawal by Subject|0|||
131600011|NCT01544114|473826784|FG002|Overall Study|Withdrawal by Subject|3|||
131600012|NCT01544114|473826782|FG000|Overall Study|Lost to Follow-up|0|||
131600013|NCT01544114|473826783|FG001|Overall Study|Lost to Follow-up|2|||
131600014|NCT01544114|473826784|FG002|Overall Study|Lost to Follow-up|0|||
131600015|NCT01544114|473826782|FG000|Overall Study|Adverse Event|1|||
131600016|NCT01544114|473826783|FG001|Overall Study|Adverse Event|1|||
131600017|NCT01544114|473826784|FG002|Overall Study|Adverse Event|2|||
131600018|NCT01544114|473826782|FG000|Overall Study|Protocol Violation|0|||
131600019|NCT01544114|473826783|FG001|Overall Study|Protocol Violation|1|||
131600020|NCT01544114|473826784|FG002|Overall Study|Protocol Violation|0|||
131600021|NCT01733316|473826789|FG000|RP103 Phase|Non-compliance|1|||
131600022|NCT01733316|473826789|FG000|Long Term Extension Phase|Adverse Event|1|||
131600023|NCT01733316|473826789|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
131600024|NCT01733316|473826789|FG000|Long Term Extension Phase|Sponsor Decision|2|||
131600025|NCT05239455|473826797|FG000|Overall Study|Adverse Event|1|||
131600026|NCT05239455|473826797|FG000|Overall Study|Sponsor Decision|5|||
131600027|NCT05239455|473826797|FG000|Overall Study|Incomplete Blood Collection|1|||
131600028|NCT01799265|473826798|FG000|Overall Study|Lost to Follow-up|1|||
131600029|NCT01799265|473826799|FG001|Overall Study|Lost to Follow-up|0|||
131899675|NCT00368108|474919339|FG002|Overall Study|Other|1|||
131899676|NCT02532374|474919364|FG000|Overall Study|Withdrawal by Subject|1|||
131600030|NCT01799265|473826798|FG000|Overall Study|Protocol Violation|2|||
131600031|NCT01799265|473826799|FG001|Overall Study|Protocol Violation|1|||
131600032|NCT01799265|473826798|FG000|Overall Study|inadequate sleep study|0|||
131600033|NCT01799265|473826799|FG001|Overall Study|inadequate sleep study|2|||
131600034|NCT03459729|473826800|FG000|Overall Study|Physician Decision|2|||
131600035|NCT04200456|473826805|FG000|Overall Study|Physician Decision|0|||
131600036|NCT04200456|473826806|FG001|Overall Study|Physician Decision|1|||
131600037|NCT04200456|473826805|FG000|Overall Study|Withdrawal by Subject|2|||
131600038|NCT04200456|473826806|FG001|Overall Study|Withdrawal by Subject|2|||
131600039|NCT04200456|473826805|FG000|Overall Study|Lack of Efficacy|1|||
131899677|NCT02532374|474919364|FG000|Overall Study|Physician Decision|1|||
131600040|NCT04200456|473826806|FG001|Overall Study|Lack of Efficacy|1|||
131600041|NCT04200456|473826805|FG000|Overall Study|Adverse event, non-fatal|0|||
131600042|NCT04200456|473826806|FG001|Overall Study|Adverse event, non-fatal|1|||
131600043|NCT04200456|473826805|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
131600044|NCT04200456|473826806|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
131600045|NCT00506519|473828983|FG000|Overall Study|Death|4|||
131600046|NCT00506519|473828984|FG001|Overall Study|Death|6|||
131600047|NCT00506519|473828985|FG002|Overall Study|Death|0|||
131600048|NCT00506519|473828983|FG000|Overall Study|Adverse Event|1|||
131600049|NCT00506519|473828984|FG001|Overall Study|Adverse Event|0|||
131600050|NCT00506519|473828985|FG002|Overall Study|Adverse Event|0|||
131600051|NCT01186367|473828986|FG000|Overall Study|Lost to Follow-up|7|||
131600052|NCT01186367|473828987|FG001|Overall Study|Lost to Follow-up|4|||
131600053|NCT01186367|473828988|FG002|Overall Study|Lost to Follow-up|7|||
131600054|NCT01186367|473828986|FG000|Overall Study|Did not receive study treatment|0|||
131600055|NCT01186367|473828987|FG001|Overall Study|Did not receive study treatment|1|||
131600056|NCT01186367|473828988|FG002|Overall Study|Did not receive study treatment|0|||
131600057|NCT03945292|473828993|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
131600058|NCT03945292|473828994|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131600059|NCT03945292|473828995|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
131600060|NCT03945292|473828996|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131600061|NCT03945292|473828997|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131600062|NCT03945292|473828998|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131600063|NCT03945292|473828999|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131600064|NCT03945292|473829000|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131600065|NCT03945292|473828993|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131440045|NCT00770653|473239201|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
131600066|NCT03945292|473828994|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131600067|NCT03945292|473828995|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
131600068|NCT03945292|473828996|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131600069|NCT03945292|473828997|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131600070|NCT03945292|473828998|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131791483|NCT03361956|474518713|FG002|Overall Study|Disease Relapse|1|||
131791484|NCT03361956|474518714|FG003|Overall Study|Disease Relapse|0|||
131791485|NCT03361956|474518715|FG004|Overall Study|Disease Relapse|0|||
131791486|NCT03361956|474518711|FG000|Overall Study|Physician Decision|0|||
131791487|NCT03361956|474518712|FG001|Overall Study|Physician Decision|2|||
131791488|NCT03361956|474518713|FG002|Overall Study|Physician Decision|0|||
131791489|NCT03361956|474518714|FG003|Overall Study|Physician Decision|1|||
131791490|NCT03361956|474518715|FG004|Overall Study|Physician Decision|0|||
131600071|NCT03945292|473828999|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131600072|NCT03945292|473829000|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131600073|NCT03945292|473828993|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131600074|NCT03945292|473828994|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131600075|NCT03945292|473828995|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131791491|NCT03361956|474518711|FG000|Overall Study|Lost to Follow-up|0|||
131791492|NCT03361956|474518712|FG001|Overall Study|Lost to Follow-up|0|||
131791493|NCT03361956|474518713|FG002|Overall Study|Lost to Follow-up|1|||
131791494|NCT03361956|474518714|FG003|Overall Study|Lost to Follow-up|1|||
131600076|NCT03945292|473828996|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131600077|NCT03945292|473828997|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131600078|NCT03945292|473828998|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131600079|NCT03945292|473828999|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131600080|NCT03945292|473829000|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
131600081|NCT03524118|473829004|FG000|Overall Study|Lost to Follow-up|0|||
131600082|NCT03524118|473829005|FG001|Overall Study|Lost to Follow-up|0|||
131600083|NCT03524118|473829006|FG002|Overall Study|Lost to Follow-up|0|||
131440046|NCT00770653|473239200|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
131440047|NCT00770653|473239201|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
131440048|NCT00770653|473239200|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
131440049|NCT00770653|473239201|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
131440050|NCT00770653|473239200|FG000|Overall Study|Lost to Follow-up|1|||
131440051|NCT00770653|473239201|FG001|Overall Study|Lost to Follow-up|2|||
131440052|NCT00770653|473239200|FG000|Overall Study|Physician Decision|1|||
131440053|NCT00770653|473239201|FG001|Overall Study|Physician Decision|0|||
131440054|NCT04906499|473239206|FG000|Overall Study|Lack of time|1|||
131440055|NCT00262860|473239211|FG000|Overall Study|Adverse Event|2|||
131440056|NCT02891174|473239221|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
131440057|NCT02891174|473239222|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
131440058|NCT02891174|473239221|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
131440059|NCT02891174|473239222|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
131440060|NCT02891174|473239221|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
131440061|NCT02891174|473239222|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
131440062|NCT02891174|473239221|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
131440063|NCT02891174|473239222|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
131440064|NCT02891174|473239221|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
131440065|NCT02891174|473239222|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
131440066|NCT02891174|473239221|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
131440067|NCT02891174|473239222|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
131440068|NCT02891174|473239221|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
131440069|NCT02891174|473239222|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
131440070|NCT04124939|473239223|FG000|Overall Study|Lost to Follow-up|1|||
131440071|NCT04124939|473239224|FG001|Overall Study|Lost to Follow-up|3|||
131440072|NCT04516746|473239226|FG000|Overall Study|Randomized but not Treated|51|||
131440073|NCT04516746|473239227|FG001|Overall Study|Randomized but not Treated|19|||
131440074|NCT04516746|473239226|FG000|Overall Study|Adverse Event|0|||
131440075|NCT04516746|473239227|FG001|Overall Study|Adverse Event|1|||
131440076|NCT04516746|473239226|FG000|Overall Study|Death|62|||
131440077|NCT04516746|473239227|FG001|Overall Study|Death|32|||
131440078|NCT04516746|473239226|FG000|Overall Study|Lost to Follow-up|3431|||
131440079|NCT04516746|473239227|FG001|Overall Study|Lost to Follow-up|1831|||
131440080|NCT04516746|473239226|FG000|Overall Study|Withdrawal by Subject|1946|||
131440081|NCT04516746|473239227|FG001|Overall Study|Withdrawal by Subject|1696|||
131440082|NCT04516746|473239226|FG000|Overall Study|Physician Decision|10|||
131440083|NCT04516746|473239227|FG001|Overall Study|Physician Decision|8|||
131440084|NCT04516746|473239226|FG000|Overall Study|Other|35|||
131440085|NCT04516746|473239227|FG001|Overall Study|Other|16|||
131440086|NCT03115359|473239230|FG000|Overall Study|Withdrawal by Subject|29|||
131440087|NCT03115359|473239231|FG001|Overall Study|Withdrawal by Subject|39|||
131440088|NCT03115359|473239230|FG000|Overall Study|Scheduling conflict|25|||
131440089|NCT03115359|473239231|FG001|Overall Study|Scheduling conflict|23|||
131440090|NCT03115359|473239230|FG000|Overall Study|Personal reasons including health|12|||
131440091|NCT03115359|473239231|FG001|Overall Study|Personal reasons including health|9|||
131440092|NCT03115359|473239230|FG000|Overall Study|Transportation barriers|3|||
131440093|NCT03115359|473239231|FG001|Overall Study|Transportation barriers|0|||
131440094|NCT03115359|473239230|FG000|Overall Study|No longer interested|5|||
131440095|NCT03115359|473239231|FG001|Overall Study|No longer interested|4|||
131440096|NCT03115359|473239230|FG000|Overall Study|No reason provided|45|||
131440097|NCT03115359|473239231|FG001|Overall Study|No reason provided|47|||
131440098|NCT02814916|473239238|FG000|Overall Study|Withdrawal of consent|0|||
131440099|NCT02814916|473239239|FG001|Overall Study|Withdrawal of consent|2|||
131440100|NCT02814916|473239240|FG002|Overall Study|Withdrawal of consent|0|||
131440101|NCT02814916|473239238|FG000|Overall Study|Lost to Follow-up|0|||
131440102|NCT02814916|473239239|FG001|Overall Study|Lost to Follow-up|1|||
131440103|NCT02814916|473239240|FG002|Overall Study|Lost to Follow-up|0|||
131440104|NCT02814916|473239238|FG000|Overall Study|Other, not specified|0|||
131706699|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
131440105|NCT02814916|473239239|FG001|Overall Study|Other, not specified|1|||
131440106|NCT02814916|473239240|FG002|Overall Study|Other, not specified|0|||
131440107|NCT02384551|473239251|FG000|Overall Study|Lost to Follow-up|13|||
131440108|NCT02384551|473239252|FG001|Overall Study|Lost to Follow-up|14|||
131440109|NCT02384551|473239253|FG002|Overall Study|Lost to Follow-up|14|||
131600084|NCT03524118|473829007|FG003|Overall Study|Lost to Follow-up|0|||
131600085|NCT03524118|473829008|FG004|Overall Study|Lost to Follow-up|1|||
131600086|NCT03524118|473829009|FG005|Overall Study|Lost to Follow-up|0|||
131600087|NCT03524118|473829004|FG000|Overall Study|Other|0|||
131600088|NCT03524118|473829005|FG001|Overall Study|Other|1|||
131600089|NCT03524118|473829006|FG002|Overall Study|Other|0|||
131600090|NCT03524118|473829007|FG003|Overall Study|Other|0|||
131600091|NCT03524118|473829008|FG004|Overall Study|Other|1|||
131600092|NCT03524118|473829009|FG005|Overall Study|Other|1|||
131600093|NCT03524118|473829004|FG000|Overall Study|Physician Decision|0|||
131706700|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
131706701|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
131706702|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
131706703|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
131706704|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
131706705|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
131706706|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
131706707|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
131706708|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
131706709|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706710|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706711|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706712|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706713|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
131706714|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706715|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
131706716|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706717|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
131706718|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131706719|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131706720|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131706721|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131706722|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131706723|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131706724|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131706725|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131600094|NCT03524118|473829005|FG001|Overall Study|Physician Decision|0|||
131600095|NCT03524118|473829006|FG002|Overall Study|Physician Decision|0|||
131600096|NCT03524118|473829007|FG003|Overall Study|Physician Decision|0|||
131600097|NCT03524118|473829008|FG004|Overall Study|Physician Decision|1|||
131600098|NCT03524118|473829009|FG005|Overall Study|Physician Decision|0|||
131600099|NCT03524118|473829004|FG000|Overall Study|Protocol Violation|0|||
131600100|NCT03524118|473829005|FG001|Overall Study|Protocol Violation|0|||
131600101|NCT03524118|473829006|FG002|Overall Study|Protocol Violation|1|||
131600102|NCT03524118|473829007|FG003|Overall Study|Protocol Violation|0|||
131600103|NCT03524118|473829008|FG004|Overall Study|Protocol Violation|1|||
131600104|NCT03524118|473829009|FG005|Overall Study|Protocol Violation|0|||
131600105|NCT03524118|473829004|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131600106|NCT03524118|473829005|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131600107|NCT03524118|473829006|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131600108|NCT03524118|473829007|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
131600109|NCT03524118|473829008|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
131600110|NCT03524118|473829009|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131600111|NCT04987320|473829010|FG000|Overall Study|Withdrawal by Subject|0|||
131600112|NCT04987320|473829011|FG001|Overall Study|Withdrawal by Subject|1|||
131600113|NCT01129102|473829012|FG000|Overall Study|No study drug treatment|2|||
131600114|NCT01129102|473829013|FG001|Overall Study|No study drug treatment|3|||
131600115|NCT01129102|473829014|FG002|Overall Study|No study drug treatment|1|||
131600116|NCT01129102|473829012|FG000|Overall Study|Withdrawal by Subject|2|||
131600117|NCT01129102|473829013|FG001|Overall Study|Withdrawal by Subject|0|||
131600118|NCT01129102|473829014|FG002|Overall Study|Withdrawal by Subject|3|||
131600119|NCT01129102|473829012|FG000|Overall Study|Protocol Violation|0|||
131600120|NCT01129102|473829013|FG001|Overall Study|Protocol Violation|1|||
131600121|NCT01129102|473829014|FG002|Overall Study|Protocol Violation|1|||
131600122|NCT01129102|473829012|FG000|Overall Study|Pregnancy|0|||
131600123|NCT01129102|473829013|FG001|Overall Study|Pregnancy|0|||
131600124|NCT01129102|473829014|FG002|Overall Study|Pregnancy|1|||
131600125|NCT01129102|473829012|FG000|Overall Study|Adverse Event|2|||
131600126|NCT01129102|473829013|FG001|Overall Study|Adverse Event|2|||
131600127|NCT01129102|473829014|FG002|Overall Study|Adverse Event|1|||
131600128|NCT01129102|473829012|FG000|Overall Study|Lost to Follow-up|2|||
131600129|NCT01129102|473829013|FG001|Overall Study|Lost to Follow-up|0|||
131600130|NCT01129102|473829014|FG002|Overall Study|Lost to Follow-up|0|||
131600131|NCT02675751|473829017|FG000|Overall Study|Lost to Follow-up|16|||
131600132|NCT03628924|473829018|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
131600133|NCT03628924|473829019|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131600134|NCT03628924|473829020|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131440110|NCT02384551|473239254|FG003|Overall Study|Lost to Follow-up|14|||
131440111|NCT04742556|473239257|FG000|Overall Study|Withdrawal by Subject|0|||
131440112|NCT04742556|473239258|FG001|Overall Study|Withdrawal by Subject|1|||
131440113|NCT04742556|473239259|FG002|Overall Study|Withdrawal by Subject|0|||
131600135|NCT03628924|473829021|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131600136|NCT03628924|473829022|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131600137|NCT03628924|473829023|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131600138|NCT03628924|473829024|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131600139|NCT03628924|473829018|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131600140|NCT03628924|473829019|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131600141|NCT03628924|473829020|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
131791495|NCT03361956|474518715|FG004|Overall Study|Lost to Follow-up|2|||
131600142|NCT03628924|473829021|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131600143|NCT03628924|473829022|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131600144|NCT03628924|473829023|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131600145|NCT03628924|473829024|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131600146|NCT03628924|473829018|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
131600147|NCT03628924|473829019|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
131600148|NCT03628924|473829020|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
131600149|NCT03628924|473829021|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131600150|NCT03628924|473829022|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131600151|NCT03628924|473829023|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131600152|NCT03628924|473829024|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131600153|NCT03628924|473829018|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131600154|NCT03628924|473829019|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
131600155|NCT03628924|473829020|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131600156|NCT03628924|473829021|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131600157|NCT03628924|473829022|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131600158|NCT03628924|473829023|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131600159|NCT03628924|473829024|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131600160|NCT03628924|473829018|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
131600161|NCT03628924|473829019|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131706726|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131706727|NCT01583374|474207444|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
131706728|NCT01583374|474207445|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
131706729|NCT01583374|474207446|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
131706730|NCT01583374|474207447|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
131706731|NCT01583374|474207448|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
131706732|NCT01583374|474207449|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
131706733|NCT01583374|474207450|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
131706734|NCT01583374|474207451|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
131791496|NCT00871728|474518717|FG000|Overall Study|Adverse Event|1|||
131600162|NCT03628924|473829020|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
131600163|NCT03628924|473829021|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131600164|NCT03628924|473829022|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131600165|NCT03628924|473829023|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131600166|NCT03628924|473829024|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131600167|NCT03628924|473829018|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
131600168|NCT03628924|473829019|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
131600169|NCT03628924|473829020|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
131600170|NCT03628924|473829021|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
131600171|NCT03628924|473829022|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
131600172|NCT03628924|473829023|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
131600173|NCT03628924|473829024|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
131600174|NCT03628924|473829018|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131600175|NCT03628924|473829019|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131600176|NCT03628924|473829020|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131600177|NCT03628924|473829021|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
131600178|NCT03628924|473829022|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131600179|NCT03628924|473829023|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
131600180|NCT03628924|473829024|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
131600181|NCT03628924|473829018|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131600182|NCT03628924|473829019|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131600183|NCT03628924|473829020|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131600184|NCT03628924|473829021|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
131600185|NCT03628924|473829022|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
131600186|NCT03628924|473829023|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131600187|NCT03628924|473829024|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
131600188|NCT03628924|473829018|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
131600189|NCT03628924|473829019|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
131600190|NCT03628924|473829020|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
131600191|NCT03628924|473829021|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
131600192|NCT03628924|473829022|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
131600193|NCT03628924|473829023|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
131600194|NCT03628924|473829024|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
131600195|NCT03628924|473829018|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131600196|NCT03628924|473829019|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131600197|NCT03628924|473829020|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131600198|NCT03628924|473829021|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131600199|NCT03628924|473829022|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
131600200|NCT03628924|473829023|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
131791497|NCT00871728|474518717|FG000|Overall Study|Protocol Violation|7|||
131791498|NCT00871728|474518717|FG000|Overall Study|Lost to Follow-up|2|||
131440114|NCT04742556|473239257|FG000|Overall Study|Adverse Event|0|||
131600201|NCT03628924|473829024|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
131600202|NCT06019559|473829027|FG000|Overall Study|Withdrawal by Subject|7|||
131600203|NCT06019559|473829028|FG001|Overall Study|Withdrawal by Subject|6|||
131600204|NCT06019559|473829029|FG002|Overall Study|Withdrawal by Subject|5|||
131600205|NCT06019559|473829027|FG000|Overall Study|Lost to Follow-up|2|||
131600206|NCT06019559|473829028|FG001|Overall Study|Lost to Follow-up|0|||
131600207|NCT06019559|473829029|FG002|Overall Study|Lost to Follow-up|3|||
131600208|NCT06215521|473829031|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
131600209|NCT06215521|473829032|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
131600210|NCT06215521|473829033|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
131600211|NCT06215521|473829034|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
131600212|NCT06215521|473829035|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
131600213|NCT06215521|473829036|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
131600214|NCT04044768|473829037|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
131600215|NCT04044768|473829038|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
131600216|NCT05089019|473829042|FG000|Period 1|Withdrawal by Subject|0|||
131600217|NCT05089019|473829043|FG001|Period 1|Withdrawal by Subject|1|||
131600218|NCT05089019|473829042|FG000|Washout Period|Adverse Event|3|||
131600219|NCT05089019|473829043|FG001|Washout Period|Adverse Event|4|||
131600220|NCT05089019|473829042|FG000|Washout Period|Lost to Follow-up|1|||
131600221|NCT05089019|473829043|FG001|Washout Period|Lost to Follow-up|0|||
131600222|NCT05089019|473829042|FG000|Washout Period|Physician Decision|2|||
131600223|NCT05089019|473829043|FG001|Washout Period|Physician Decision|0|||
131600224|NCT05089019|473829042|FG000|Washout Period|Withdrawal by Subject|6|||
131600225|NCT05089019|473829043|FG001|Washout Period|Withdrawal by Subject|3|||
131600226|NCT05089019|473829042|FG000|Period 2|Adverse Event|4|||
131600227|NCT05089019|473829043|FG001|Period 2|Adverse Event|2|||
131600228|NCT05089019|473829042|FG000|Period 2|Lost to Follow-up|1|||
131600229|NCT05089019|473829043|FG001|Period 2|Lost to Follow-up|0|||
131600230|NCT05089019|473829042|FG000|Period 2|Withdrawal by Subject|0|||
131600231|NCT05089019|473829043|FG001|Period 2|Withdrawal by Subject|1|||
131600232|NCT03858634|473829044|FG000|Overall Study|Withdrawal by Subject|1|||
131600233|NCT03858634|473829045|FG001|Overall Study|Withdrawal by Subject|0|||
131600234|NCT03858634|473829044|FG000|Overall Study|Adverse Event|1|||
131600235|NCT03858634|473829045|FG001|Overall Study|Adverse Event|0|||
131600236|NCT03858634|473829044|FG000|Overall Study|Lost to Follow-up|0|||
131600237|NCT03858634|473829045|FG001|Overall Study|Lost to Follow-up|1|||
131600238|NCT03858634|473829044|FG000|Overall Study|Other, Not Specified|1|||
131600239|NCT03858634|473829045|FG001|Overall Study|Other, Not Specified|1|||
131600240|NCT03150173|473829046|FG000|Overall Study|Lost to Follow-up|13|||
131600241|NCT03150173|473829047|FG001|Overall Study|Lost to Follow-up|5|||
131600242|NCT01593917|473829048|FG000|Overall Study|Death|67|||
131600243|NCT01593917|473829048|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
131600244|NCT01593917|473829048|FG000|Overall Study|Withdrawal by Subject|23|||
131600245|NCT01593917|473829048|FG000|Overall Study|Lost to Follow-up|12|||
131600246|NCT01593917|473829048|FG000|Overall Study|Protocol Violation|5|||
131600247|NCT01593917|473829048|FG000|Overall Study|Physician Decision|3|||
131600248|NCT04016662|473829049|FG000|Run-In Phase|Death|1|||
131600249|NCT04016662|473829049|FG000|Run-In Phase|Withdrawal by Subject|11|||
131600250|NCT04016662|473829049|FG000|Run-In Phase|Not meeting screening eligibility|9|||
131600251|NCT04016662|473829049|FG000|Run-In Phase|Physician Decision|3|||
131600252|NCT04016662|473829049|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
131600253|NCT04016662|473829049|FG000|PLGS (12 Weeks)|Death|1|||
131600254|NCT04016662|473829049|FG000|SAP (12 Weeks)|Death|1|||
131600255|NCT01802788|473829050|FG000|Overall Study|Withdrawal by Subject|102|||
131600256|NCT01802788|473829051|FG001|Overall Study|Withdrawal by Subject|5|||
131600257|NCT01802788|473829050|FG000|Overall Study|Death|382|||
131600258|NCT01802788|473829051|FG001|Overall Study|Death|18|||
131600259|NCT01802788|473829050|FG000|Overall Study|Lost to Follow-up|31|||
131600260|NCT01802788|473829051|FG001|Overall Study|Lost to Follow-up|2|||
131600261|NCT01802788|473829050|FG000|Overall Study|Physician Decision|3|||
131600262|NCT01802788|473829051|FG001|Overall Study|Physician Decision|0|||
131600263|NCT01802788|473829050|FG000|Overall Study|Patient Non-Compliance|1|||
131600264|NCT01802788|473829051|FG001|Overall Study|Patient Non-Compliance|0|||
131600265|NCT01802788|473829050|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
131600266|NCT01802788|473829051|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
131600267|NCT01802788|473829050|FG000|Overall Study|Other Reasons|19|||
131600268|NCT01802788|473829051|FG001|Overall Study|Other Reasons|0|||
131600269|NCT03021096|473829054|FG000|Overall Study|Lost to Follow-up|4|||
131600270|NCT03021096|473829054|FG000|Overall Study|Protocol Violation|2|||
131600271|NCT02043678|473829057|FG000|Overall Study|Never treated|11|||
131600272|NCT02043678|473829058|FG001|Overall Study|Never treated|9|||
131600273|NCT02043678|473829057|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
131600274|NCT02043678|473829058|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
131600275|NCT02043678|473829057|FG000|Overall Study|AE without clinical PD|54|||
131600276|NCT02043678|473829058|FG001|Overall Study|AE without clinical PD|36|||
131600277|NCT02043678|473829057|FG000|Overall Study|Lost to Follow-up|1|||
131600278|NCT02043678|473829058|FG001|Overall Study|Lost to Follow-up|1|||
131600279|NCT02043678|473829057|FG000|Overall Study|Other|10|||
131600280|NCT02043678|473829058|FG001|Overall Study|Other|14|||
131600281|NCT02043678|473829057|FG000|Overall Study|Clinical PD|114|||
131600282|NCT02043678|473829058|FG001|Overall Study|Clinical PD|148|||
131600283|NCT02043678|473829057|FG000|Overall Study|Radiological PD|100|||
131600284|NCT02043678|473829058|FG001|Overall Study|Radiological PD|90|||
131600285|NCT02043678|473829057|FG000|Overall Study|Protocol-driven decision point|59|||
131600286|NCT02043678|473829058|FG001|Overall Study|Protocol-driven decision point|58|||
131600287|NCT02043678|473829057|FG000|Overall Study|Withdrawal by Subject|16|||
131600288|NCT02043678|473829058|FG001|Overall Study|Withdrawal by Subject|20|||
131600289|NCT02043678|473829057|FG000|Overall Study|Protocol Violation|1|||
131600290|NCT02043678|473829058|FG001|Overall Study|Protocol Violation|0|||
131791499|NCT00871728|474518717|FG000|Overall Study|Failed to Visit Hospital|4|||
131791500|NCT00871728|474518717|FG000|Overall Study|Participant Non-compliance|1|||
131791501|NCT00871728|474518717|FG000|Overall Study|Withdrawal of Informed Consent|5|||
131791502|NCT01829295|474518720|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
131791503|NCT01829295|474518721|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
131791504|NCT01829295|474518722|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
131791505|NCT01829295|474518723|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
131791506|NCT01829295|474518720|FG000|6-12 Months|Adverse Event|0|||
131791507|NCT01829295|474518721|FG001|6-12 Months|Adverse Event|0|||
131791508|NCT01829295|474518722|FG002|6-12 Months|Adverse Event|3|||
131791509|NCT01829295|474518723|FG003|6-12 Months|Adverse Event|2|||
131791510|NCT01829295|474518720|FG000|6-12 Months|Lost to Follow-up|2|||
131600291|NCT02043678|473829057|FG000|Overall Study|Deterioration of general conditions|1|||
131600292|NCT02043678|473829058|FG001|Overall Study|Deterioration of general conditions|1|||
131600293|NCT02043678|473829057|FG000|Overall Study|Logistical difficulties|2|||
131600294|NCT02043678|473829058|FG001|Overall Study|Logistical difficulties|0|||
131600295|NCT02043678|473829057|FG000|Overall Study|Non-compliance with study drug|3|||
131600296|NCT02043678|473829058|FG001|Overall Study|Non-compliance with study drug|1|||
131791511|NCT01829295|474518721|FG001|6-12 Months|Lost to Follow-up|0|||
131791512|NCT01829295|474518722|FG002|6-12 Months|Lost to Follow-up|0|||
131791513|NCT01829295|474518723|FG003|6-12 Months|Lost to Follow-up|0|||
131791514|NCT01829295|474518720|FG000|6-12 Months|Withdrawal by Subject|2|||
131600297|NCT02043678|473829057|FG000|Overall Study|Physician Decision|4|||
131600298|NCT02043678|473829058|FG001|Overall Study|Physician Decision|3|||
131600299|NCT02043678|473829057|FG000|Overall Study|Subject decision|0|||
131600300|NCT02043678|473829058|FG001|Overall Study|Subject decision|1|||
131600301|NCT02043678|473829057|FG000|Overall Study|Switching to other therapy|3|||
131600302|NCT02043678|473829058|FG001|Overall Study|Switching to other therapy|2|||
131600303|NCT02043678|473829057|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
131791515|NCT01829295|474518721|FG001|6-12 Months|Withdrawal by Subject|2|||
131600304|NCT02043678|473829058|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
131600305|NCT02043678|473829057|FG000|Overall Study|Missing|1|||
131600306|NCT02043678|473829058|FG001|Overall Study|Missing|0|||
131600307|NCT02043678|473829057|FG000|Overall Study|Adverse Event|0|||
131791516|NCT01829295|474518722|FG002|6-12 Months|Withdrawal by Subject|0|||
131791517|NCT01829295|474518723|FG003|6-12 Months|Withdrawal by Subject|0|||
131791518|NCT03558997|474518724|FG000|Overall Study|Adverse Event|0|||
131791519|NCT03558997|474518725|FG001|Overall Study|Adverse Event|2|||
131791520|NCT03558997|474518726|FG002|Overall Study|Adverse Event|5|||
131791521|NCT03558997|474518727|FG003|Overall Study|Adverse Event|1|||
131791522|NCT03558997|474518724|FG000|Overall Study|Physician Decision|0|||
131791523|NCT03558997|474518725|FG001|Overall Study|Physician Decision|0|||
131791524|NCT03558997|474518726|FG002|Overall Study|Physician Decision|1|||
131791525|NCT03558997|474518727|FG003|Overall Study|Physician Decision|0|||
131791526|NCT03558997|474518724|FG000|Overall Study|Withdrawal by Subject|1|||
131791527|NCT03558997|474518725|FG001|Overall Study|Withdrawal by Subject|0|||
131791528|NCT03558997|474518726|FG002|Overall Study|Withdrawal by Subject|1|||
131791529|NCT03558997|474518727|FG003|Overall Study|Withdrawal by Subject|1|||
131791530|NCT03558997|474518724|FG000|Overall Study|Lost to Follow-up|0|||
131791531|NCT03558997|474518725|FG001|Overall Study|Lost to Follow-up|0|||
131791532|NCT03558997|474518726|FG002|Overall Study|Lost to Follow-up|1|||
131791533|NCT03558997|474518727|FG003|Overall Study|Lost to Follow-up|0|||
131791534|NCT03572933|474520797|FG000|Overall Study|Adverse Event|4|||
131791535|NCT03572933|474520798|FG001|Overall Study|Adverse Event|1|||
131791536|NCT03572933|474520797|FG000|Overall Study|Withdrawal by Subject|0|||
131791537|NCT03572933|474520798|FG001|Overall Study|Withdrawal by Subject|1|||
131600308|NCT02043678|473829058|FG001|Overall Study|Adverse Event|1|||
131791538|NCT01405950|474520799|FG000|Overall Study|Withdrawal by Subject|1|||
131791539|NCT01405950|474520800|FG001|Overall Study|Withdrawal by Subject|0|||
131791540|NCT01405950|474520801|FG002|Overall Study|Withdrawal by Subject|0|||
131791541|NCT01405950|474520802|FG003|Overall Study|Withdrawal by Subject|0|||
131600309|NCT05543629|473829059|FG000|Overall Study|Death|1|||
131791542|NCT02410252|474520803|FG000|Overall Study|Withdrawal by Subject|4|||
131791543|NCT02410252|474520803|FG000|Overall Study|Physician Decision|2|||
131791544|NCT00387712|474520806|FG000|Overall Study|Physician Decision|6|||
131791545|NCT00387712|474520807|FG001|Overall Study|Physician Decision|4|||
131791546|NCT00387712|474520806|FG000|Overall Study|Lost to Follow-up|17|||
131791547|NCT00387712|474520807|FG001|Overall Study|Lost to Follow-up|20|||
131791548|NCT00387712|474520806|FG000|Overall Study|Withdrawal by Subject|6|||
131600310|NCT05543629|473829060|FG001|Overall Study|Death|0|||
131600311|NCT05543629|473829061|FG002|Overall Study|Death|1|||
131600312|NCT05543629|473829062|FG003|Overall Study|Death|0|||
131600313|NCT05543629|473829063|FG004|Overall Study|Death|0|||
131600314|NCT05543629|473829064|FG005|Overall Study|Death|1|||
131600315|NCT05543629|473829065|FG006|Overall Study|Death|2|||
131600316|NCT05543629|473829066|FG007|Overall Study|Death|2|||
131600317|NCT05543629|473829059|FG000|Overall Study|Other Reasons|0|||
131600318|NCT05543629|473829060|FG001|Overall Study|Other Reasons|0|||
131600319|NCT05543629|473829061|FG002|Overall Study|Other Reasons|0|||
131600320|NCT05543629|473829062|FG003|Overall Study|Other Reasons|0|||
131600321|NCT05543629|473829063|FG004|Overall Study|Other Reasons|1|||
131600322|NCT05543629|473829064|FG005|Overall Study|Other Reasons|0|||
131600323|NCT05543629|473829065|FG006|Overall Study|Other Reasons|0|||
131600324|NCT05543629|473829066|FG007|Overall Study|Other Reasons|0|||
131600325|NCT05543629|473829059|FG000|Overall Study|Physician Decision|0|||
131600326|NCT05543629|473829060|FG001|Overall Study|Physician Decision|0|||
131600327|NCT05543629|473829061|FG002|Overall Study|Physician Decision|3|||
131600328|NCT05543629|473829062|FG003|Overall Study|Physician Decision|0|||
131600329|NCT05543629|473829063|FG004|Overall Study|Physician Decision|0|||
131600330|NCT05543629|473829064|FG005|Overall Study|Physician Decision|0|||
131600331|NCT05543629|473829065|FG006|Overall Study|Physician Decision|1|||
131600332|NCT05543629|473829066|FG007|Overall Study|Physician Decision|0|||
131600333|NCT05543629|473829059|FG000|Overall Study|Study terminated by Sponsor|1|||
131600334|NCT05543629|473829060|FG001|Overall Study|Study terminated by Sponsor|0|||
131600335|NCT05543629|473829061|FG002|Overall Study|Study terminated by Sponsor|0|||
131600336|NCT05543629|473829062|FG003|Overall Study|Study terminated by Sponsor|1|||
131600337|NCT05543629|473829063|FG004|Overall Study|Study terminated by Sponsor|0|||
131600338|NCT05543629|473829064|FG005|Overall Study|Study terminated by Sponsor|4|||
131600339|NCT05543629|473829065|FG006|Overall Study|Study terminated by Sponsor|1|||
131600340|NCT05543629|473829066|FG007|Overall Study|Study terminated by Sponsor|0|||
131600341|NCT05543629|473829059|FG000|Overall Study|Withdrawal by Subject|1|||
131600342|NCT05543629|473829060|FG001|Overall Study|Withdrawal by Subject|1|||
131600343|NCT05543629|473829061|FG002|Overall Study|Withdrawal by Subject|0|||
131600344|NCT05543629|473829062|FG003|Overall Study|Withdrawal by Subject|2|||
131600345|NCT05543629|473829063|FG004|Overall Study|Withdrawal by Subject|1|||
131600346|NCT05543629|473829064|FG005|Overall Study|Withdrawal by Subject|1|||
131600347|NCT05543629|473829065|FG006|Overall Study|Withdrawal by Subject|1|||
131600348|NCT05543629|473829066|FG007|Overall Study|Withdrawal by Subject|1|||
131600349|NCT05543629|473829059|FG000|Overall Study|Not Reported|2|||
131600350|NCT05543629|473829060|FG001|Overall Study|Not Reported|2|||
131600351|NCT05543629|473829061|FG002|Overall Study|Not Reported|0|||
131600352|NCT05543629|473829062|FG003|Overall Study|Not Reported|0|||
131600353|NCT05543629|473829063|FG004|Overall Study|Not Reported|1|||
131600354|NCT05543629|473829064|FG005|Overall Study|Not Reported|1|||
131600355|NCT05543629|473829065|FG006|Overall Study|Not Reported|3|||
131600356|NCT05543629|473829066|FG007|Overall Study|Not Reported|0|||
131600357|NCT03216057|473829067|FG000|Overall Study|Lost to Follow-up|2|||
131600358|NCT03216057|473829068|FG001|Overall Study|Lost to Follow-up|2|||
131600359|NCT04568603|473829069|FG000|Overall Study|Physician Decision|1|||
131600360|NCT04564742|473829070|FG000|Overall Study|Lost to Follow-up|1|||
131600361|NCT04564742|473829071|FG001|Overall Study|Lost to Follow-up|0|||
131600362|NCT04564742|473829070|FG000|Overall Study|Consent Withdrawal|4|||
131600363|NCT04564742|473829071|FG001|Overall Study|Consent Withdrawal|4|||
131600364|NCT03313076|473829075|FG000|Overall Study|Withdrawal by Subject|2|||
131600365|NCT03313076|473829076|FG001|Overall Study|Withdrawal by Subject|0|||
131600366|NCT03313076|473829077|FG002|Overall Study|Withdrawal by Subject|0|||
131600367|NCT03313076|473829078|FG003|Overall Study|Withdrawal by Subject|0|||
131600368|NCT03313076|473829075|FG000|Overall Study|Lost to Follow-up|0|||
131600369|NCT03313076|473829076|FG001|Overall Study|Lost to Follow-up|2|||
131600370|NCT03313076|473829077|FG002|Overall Study|Lost to Follow-up|2|||
131600371|NCT03313076|473829078|FG003|Overall Study|Lost to Follow-up|2|||
131600372|NCT03904147|473829081|FG000|Overall Study|Death|15|||
131600373|NCT03904147|473829082|FG001|Overall Study|Death|13|||
131600374|NCT03904147|473829083|FG002|Overall Study|Death|15|||
131600375|NCT03904147|473829081|FG000|Overall Study|Withdrawal by Subject|7|||
131600376|NCT03904147|473829082|FG001|Overall Study|Withdrawal by Subject|12|||
131600377|NCT03904147|473829083|FG002|Overall Study|Withdrawal by Subject|1|||
131600378|NCT03904147|473829081|FG000|Overall Study|1Y visit completed after 365 days|1|||
131600379|NCT03904147|473829082|FG001|Overall Study|1Y visit completed after 365 days|1|||
131600380|NCT03904147|473829083|FG002|Overall Study|1Y visit completed after 365 days|0|||
131600381|NCT00764751|473829091|FG000|Overall Study|Adverse Event|1|||
131600382|NCT00764751|473829092|FG001|Overall Study|Adverse Event|1|||
131600383|NCT00764751|473829091|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
131600384|NCT00764751|473829092|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
131600385|NCT03011333|473829103|FG000|Overall Study|Lost to Follow-up|0|||
131600386|NCT03011333|473829104|FG001|Overall Study|Lost to Follow-up|1|||
131600387|NCT03011333|473829105|FG002|Overall Study|Lost to Follow-up|0|||
131600388|NCT03011333|473829106|FG003|Overall Study|Lost to Follow-up|1|||
131600389|NCT03011333|473829107|FG004|Overall Study|Lost to Follow-up|4|||
131600390|NCT03011333|473829108|FG005|Overall Study|Lost to Follow-up|4|||
131600391|NCT03011333|473829109|FG006|Overall Study|Lost to Follow-up|5|||
131600392|NCT04307355|473829110|FG000|Overall Study|Non-Compliance|3|||
131600393|NCT04307355|473829111|FG001|Overall Study|Non-Compliance|3|||
131600394|NCT04307355|473829112|FG002|Overall Study|Non-Compliance|0|||
131600395|NCT02998268|473829116|FG000|Overall Study|Adverse Event|0|||
131600396|NCT02998268|473829117|FG001|Overall Study|Adverse Event|2|||
131600397|NCT02998268|473829116|FG000|Overall Study|Withdrawal by Subject|0|||
131600398|NCT02998268|473829117|FG001|Overall Study|Withdrawal by Subject|1|||
131600399|NCT05269667|473829118|FG000|Overall Study|Study Terminated by Sponsor|4|||
131600400|NCT04413708|473829120|FG000|Overall Study|Lost to Follow-up|1|||
131600401|NCT04413708|473829121|FG001|Overall Study|Lost to Follow-up|2|||
131600402|NCT03768505|473829124|FG000|Overall Study|sponsor decision|76|||
131600403|NCT03768505|473829124|FG000|Overall Study|Death|35|||
131600404|NCT03768505|473829124|FG000|Overall Study|Other -Various|30|||
131600405|NCT03768505|473829124|FG000|Overall Study|Withdrawal by Subject|22|||
131600406|NCT03768505|473829124|FG000|Overall Study|Lost to Follow-up|6|||
131600407|NCT04032704|473829130|FG000|Part A|Withdrawal by Subject|0|||
131600408|NCT04032704|473829131|FG001|Part A|Withdrawal by Subject|0|||
131600409|NCT04032704|473829132|FG002|Part A|Withdrawal by Subject|3|||
131600410|NCT04032704|473829133|FG003|Part A|Withdrawal by Subject|0|||
131600411|NCT04032704|473829134|FG004|Part A|Withdrawal by Subject|1|||
131600412|NCT04032704|473829135|FG005|Part A|Withdrawal by Subject|7|||
131600413|NCT04032704|473829136|FG006|Part A|Withdrawal by Subject|0|||
131600414|NCT04032704|473829137|FG007|Part A|Withdrawal by Subject|0|||
131600415|NCT04032704|473829138|FG008|Part A|Withdrawal by Subject|0|||
131600416|NCT04032704|473829139|FG009|Part A|Withdrawal by Subject|0|||
131600417|NCT04032704|473829140|FG010|Part A|Withdrawal by Subject|0|||
131600418|NCT04032704|473829141|FG011|Part A|Withdrawal by Subject|0|||
131600419|NCT04032704|473829142|FG012|Part A|Withdrawal by Subject|0|||
131600420|NCT04032704|473829143|FG013|Part A|Withdrawal by Subject|0|||
131600421|NCT04032704|473829144|FG014|Part A|Withdrawal by Subject|0|||
131600422|NCT04032704|473829145|FG015|Part A|Withdrawal by Subject|0|||
131600423|NCT04032704|473829146|FG016|Part A|Withdrawal by Subject|0|||
131600424|NCT04032704|473829147|FG017|Part A|Withdrawal by Subject|0|||
131600425|NCT04032704|473829130|FG000|Part A|Lost to Follow-up|1|||
131600426|NCT04032704|473829131|FG001|Part A|Lost to Follow-up|0|||
131600427|NCT04032704|473829132|FG002|Part A|Lost to Follow-up|0|||
131600428|NCT04032704|473829133|FG003|Part A|Lost to Follow-up|0|||
131600429|NCT04032704|473829134|FG004|Part A|Lost to Follow-up|0|||
131600430|NCT04032704|473829135|FG005|Part A|Lost to Follow-up|0|||
131600431|NCT04032704|473829136|FG006|Part A|Lost to Follow-up|0|||
131600432|NCT04032704|473829137|FG007|Part A|Lost to Follow-up|0|||
131600433|NCT04032704|473829138|FG008|Part A|Lost to Follow-up|0|||
131600434|NCT04032704|473829139|FG009|Part A|Lost to Follow-up|0|||
131600435|NCT04032704|473829140|FG010|Part A|Lost to Follow-up|0|||
131600436|NCT04032704|473829141|FG011|Part A|Lost to Follow-up|0|||
131600437|NCT04032704|473829142|FG012|Part A|Lost to Follow-up|0|||
131600438|NCT04032704|473829143|FG013|Part A|Lost to Follow-up|0|||
131600439|NCT04032704|473829144|FG014|Part A|Lost to Follow-up|0|||
131600440|NCT04032704|473829145|FG015|Part A|Lost to Follow-up|0|||
131600441|NCT04032704|473829146|FG016|Part A|Lost to Follow-up|0|||
131600442|NCT04032704|473829147|FG017|Part A|Lost to Follow-up|0|||
131791549|NCT00387712|474520807|FG001|Overall Study|Withdrawal by Subject|12|||
131791550|NCT01907737|474520816|FG000|Overall Study|Withdrawal by Subject|1|||
131600443|NCT04032704|473829130|FG000|Part A|Death|9|||
131600444|NCT04032704|473829131|FG001|Part A|Death|2|||
131600445|NCT04032704|473829132|FG002|Part A|Death|10|||
131600446|NCT04032704|473829133|FG003|Part A|Death|7|||
131600447|NCT04032704|473829134|FG004|Part A|Death|4|||
131600448|NCT04032704|473829135|FG005|Part A|Death|5|||
131600449|NCT04032704|473829136|FG006|Part A|Death|0|||
131600450|NCT04032704|473829137|FG007|Part A|Death|0|||
131600451|NCT04032704|473829138|FG008|Part A|Death|0|||
131600452|NCT04032704|473829139|FG009|Part A|Death|0|||
131600453|NCT04032704|473829140|FG010|Part A|Death|0|||
131600454|NCT04032704|473829141|FG011|Part A|Death|0|||
131600455|NCT04032704|473829142|FG012|Part A|Death|0|||
131600456|NCT04032704|473829143|FG013|Part A|Death|0|||
131600457|NCT04032704|473829144|FG014|Part A|Death|0|||
131600458|NCT04032704|473829145|FG015|Part A|Death|0|||
131600459|NCT04032704|473829146|FG016|Part A|Death|0|||
131600460|NCT04032704|473829147|FG017|Part A|Death|0|||
131600461|NCT04032704|473829130|FG000|Part B|Other|0|||
131600462|NCT04032704|473829131|FG001|Part B|Other|0|||
131600463|NCT04032704|473829132|FG002|Part B|Other|0|||
131600464|NCT04032704|473829133|FG003|Part B|Other|0|||
131600465|NCT04032704|473829134|FG004|Part B|Other|0|||
131600466|NCT04032704|473829135|FG005|Part B|Other|0|||
131600467|NCT04032704|473829136|FG006|Part B|Other|0|||
131600468|NCT04032704|473829137|FG007|Part B|Other|1|||
131600469|NCT04032704|473829138|FG008|Part B|Other|2|||
131600470|NCT04032704|473829139|FG009|Part B|Other|1|||
131600471|NCT04032704|473829140|FG010|Part B|Other|1|||
131600472|NCT04032704|473829141|FG011|Part B|Other|1|||
131600473|NCT04032704|473829142|FG012|Part B|Other|5|||
131600474|NCT04032704|473829143|FG013|Part B|Other|13|||
131600475|NCT04032704|473829144|FG014|Part B|Other|0|||
131600476|NCT04032704|473829145|FG015|Part B|Other|0|||
131600477|NCT04032704|473829146|FG016|Part B|Other|0|||
131600478|NCT04032704|473829147|FG017|Part B|Other|0|||
131600479|NCT04032704|473829130|FG000|Part B|Study termination by Sponsor|0|||
131600480|NCT04032704|473829131|FG001|Part B|Study termination by Sponsor|0|||
131600481|NCT04032704|473829132|FG002|Part B|Study termination by Sponsor|0|||
131600482|NCT04032704|473829133|FG003|Part B|Study termination by Sponsor|0|||
131600483|NCT04032704|473829134|FG004|Part B|Study termination by Sponsor|0|||
131600484|NCT04032704|473829135|FG005|Part B|Study termination by Sponsor|0|||
131600485|NCT04032704|473829136|FG006|Part B|Study termination by Sponsor|0|||
131600486|NCT04032704|473829137|FG007|Part B|Study termination by Sponsor|0|||
131600487|NCT04032704|473829138|FG008|Part B|Study termination by Sponsor|1|||
131600488|NCT04032704|473829139|FG009|Part B|Study termination by Sponsor|0|||
131600489|NCT04032704|473829140|FG010|Part B|Study termination by Sponsor|0|||
131600490|NCT04032704|473829141|FG011|Part B|Study termination by Sponsor|0|||
131600491|NCT04032704|473829142|FG012|Part B|Study termination by Sponsor|0|||
131791551|NCT01772368|474520818|FG000|Overall Study|Adverse Event|1|||
131791552|NCT01772368|474520818|FG000|Overall Study|Withdrawal by Subject|3|||
131791553|NCT01772368|474520818|FG000|Overall Study|Protocol Violation|2|||
131600492|NCT04032704|473829143|FG013|Part B|Study termination by Sponsor|0|||
131600493|NCT04032704|473829144|FG014|Part B|Study termination by Sponsor|0|||
131600494|NCT04032704|473829145|FG015|Part B|Study termination by Sponsor|0|||
131600495|NCT04032704|473829146|FG016|Part B|Study termination by Sponsor|0|||
131600496|NCT04032704|473829147|FG017|Part B|Study termination by Sponsor|0|||
131600497|NCT04032704|473829130|FG000|Part B|Withdrawal by Subject|0|||
131600498|NCT04032704|473829131|FG001|Part B|Withdrawal by Subject|0|||
131600499|NCT04032704|473829132|FG002|Part B|Withdrawal by Subject|0|||
131600500|NCT04032704|473829133|FG003|Part B|Withdrawal by Subject|0|||
131600501|NCT04032704|473829134|FG004|Part B|Withdrawal by Subject|0|||
131600502|NCT04032704|473829135|FG005|Part B|Withdrawal by Subject|0|||
131600503|NCT04032704|473829136|FG006|Part B|Withdrawal by Subject|3|||
131600504|NCT04032704|473829137|FG007|Part B|Withdrawal by Subject|2|||
131600505|NCT04032704|473829138|FG008|Part B|Withdrawal by Subject|2|||
131600506|NCT04032704|473829139|FG009|Part B|Withdrawal by Subject|1|||
131600507|NCT04032704|473829140|FG010|Part B|Withdrawal by Subject|4|||
131600508|NCT04032704|473829141|FG011|Part B|Withdrawal by Subject|6|||
131600509|NCT04032704|473829142|FG012|Part B|Withdrawal by Subject|2|||
131600510|NCT04032704|473829143|FG013|Part B|Withdrawal by Subject|1|||
131600511|NCT04032704|473829144|FG014|Part B|Withdrawal by Subject|0|||
131600512|NCT04032704|473829145|FG015|Part B|Withdrawal by Subject|1|||
131600513|NCT04032704|473829146|FG016|Part B|Withdrawal by Subject|0|||
131600514|NCT04032704|473829147|FG017|Part B|Withdrawal by Subject|0|||
131600515|NCT04032704|473829130|FG000|Part B|Lost to Follow-up|0|||
131600516|NCT04032704|473829131|FG001|Part B|Lost to Follow-up|0|||
131600517|NCT04032704|473829132|FG002|Part B|Lost to Follow-up|0|||
131600518|NCT04032704|473829133|FG003|Part B|Lost to Follow-up|0|||
131600519|NCT04032704|473829134|FG004|Part B|Lost to Follow-up|0|||
131600520|NCT04032704|473829135|FG005|Part B|Lost to Follow-up|0|||
131600521|NCT04032704|473829136|FG006|Part B|Lost to Follow-up|0|||
131600522|NCT04032704|473829137|FG007|Part B|Lost to Follow-up|0|||
131600523|NCT04032704|473829138|FG008|Part B|Lost to Follow-up|0|||
131600524|NCT04032704|473829139|FG009|Part B|Lost to Follow-up|0|||
131600525|NCT04032704|473829140|FG010|Part B|Lost to Follow-up|0|||
131600526|NCT04032704|473829141|FG011|Part B|Lost to Follow-up|1|||
131600527|NCT04032704|473829142|FG012|Part B|Lost to Follow-up|0|||
131600528|NCT04032704|473829143|FG013|Part B|Lost to Follow-up|0|||
131600529|NCT04032704|473829144|FG014|Part B|Lost to Follow-up|0|||
131791554|NCT01772368|474520818|FG000|Overall Study|Other|1|||
131791555|NCT01452529|474520819|FG000|Run-in Period|Adverse Event|96|||
131791556|NCT01452529|474520820|FG001|Run-in Period|Adverse Event|0|||
131791557|NCT01452529|474520821|FG002|Run-in Period|Adverse Event|0|||
131791558|NCT01452529|474520819|FG000|Run-in Period|Withdrawal by Subject|49|||
131791559|NCT01452529|474520820|FG001|Run-in Period|Withdrawal by Subject|0|||
131791560|NCT01452529|474520821|FG002|Run-in Period|Withdrawal by Subject|0|||
131791561|NCT01452529|474520819|FG000|Run-in Period|Lost to Follow-up|19|||
131600530|NCT04032704|473829145|FG015|Part B|Lost to Follow-up|0|||
131600531|NCT04032704|473829146|FG016|Part B|Lost to Follow-up|0|||
131600532|NCT04032704|473829147|FG017|Part B|Lost to Follow-up|0|||
131600533|NCT04032704|473829130|FG000|Part B|Death|0|||
131600534|NCT04032704|473829131|FG001|Part B|Death|0|||
131600535|NCT04032704|473829132|FG002|Part B|Death|0|||
131600536|NCT04032704|473829133|FG003|Part B|Death|0|||
131600537|NCT04032704|473829134|FG004|Part B|Death|0|||
131600538|NCT04032704|473829135|FG005|Part B|Death|0|||
131600539|NCT04032704|473829136|FG006|Part B|Death|13|||
131600540|NCT04032704|473829137|FG007|Part B|Death|13|||
131600541|NCT04032704|473829138|FG008|Part B|Death|14|||
131600542|NCT04032704|473829139|FG009|Part B|Death|12|||
131600543|NCT04032704|473829140|FG010|Part B|Death|12|||
131600544|NCT04032704|473829141|FG011|Part B|Death|13|||
131600545|NCT04032704|473829142|FG012|Part B|Death|7|||
131600546|NCT04032704|473829143|FG013|Part B|Death|17|||
131600547|NCT04032704|473829144|FG014|Part B|Death|2|||
131600548|NCT04032704|473829145|FG015|Part B|Death|1|||
131600549|NCT04032704|473829146|FG016|Part B|Death|2|||
131600550|NCT04032704|473829147|FG017|Part B|Death|2|||
131706735|NCT01583374|474207452|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
131706736|NCT01292057|474207455|FG000|Overall Study|Protocol Violation|1|||
131706737|NCT01292057|474207456|FG001|Overall Study|Protocol Violation|1|||
131706738|NCT01292057|474207455|FG000|Overall Study|Lost to Follow-up|1|||
131706739|NCT01292057|474207456|FG001|Overall Study|Lost to Follow-up|1|||
131706740|NCT01506882|474207459|FG000|Overall Study|Lack of Efficacy|4|||
131706741|NCT01506882|474207460|FG001|Overall Study|Lack of Efficacy|3|||
131706742|NCT01506882|474207459|FG000|Overall Study|Lost to Follow-up|1|||
131706743|NCT01506882|474207460|FG001|Overall Study|Lost to Follow-up|0|||
131706744|NCT01506882|474207459|FG000|Overall Study|Withdrawal by Subject|9|||
131791562|NCT01452529|474520820|FG001|Run-in Period|Lost to Follow-up|0|||
131600551|NCT02861300|473829148|FG000|Overall Study|Death|0|||
131600552|NCT02861300|473829149|FG001|Overall Study|Death|0|||
131600553|NCT02861300|473829150|FG002|Overall Study|Death|0|||
131600554|NCT02861300|473829151|FG003|Overall Study|Death|0|||
131600555|NCT02861300|473829152|FG004|Overall Study|Death|0|||
131600556|NCT02861300|473829153|FG005|Overall Study|Death|0|||
131600557|NCT02861300|473829154|FG006|Overall Study|Death|24|||
131600558|NCT02861300|473829148|FG000|Overall Study|Delay in treatment|0|||
131600559|NCT02861300|473829149|FG001|Overall Study|Delay in treatment|0|||
131600560|NCT02861300|473829150|FG002|Overall Study|Delay in treatment|0|||
131600561|NCT02861300|473829151|FG003|Overall Study|Delay in treatment|0|||
131600562|NCT02861300|473829152|FG004|Overall Study|Delay in treatment|0|||
131600563|NCT02861300|473829153|FG005|Overall Study|Delay in treatment|1|||
131600564|NCT02861300|473829154|FG006|Overall Study|Delay in treatment|0|||
131600565|NCT02861300|473829148|FG000|Overall Study|Disease Progression|0|||
131600566|NCT02861300|473829149|FG001|Overall Study|Disease Progression|1|||
131600567|NCT02861300|473829150|FG002|Overall Study|Disease Progression|0|||
131600568|NCT02861300|473829151|FG003|Overall Study|Disease Progression|0|||
131600569|NCT02861300|473829152|FG004|Overall Study|Disease Progression|0|||
131600570|NCT02861300|473829153|FG005|Overall Study|Disease Progression|0|||
131600571|NCT02861300|473829154|FG006|Overall Study|Disease Progression|2|||
131600572|NCT02861300|473829148|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
131600573|NCT02861300|473829149|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
131600574|NCT02861300|473829150|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
131600575|NCT02861300|473829151|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
131600576|NCT02861300|473829152|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
131600577|NCT02861300|473829153|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
131600578|NCT02861300|473829154|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
131600579|NCT02861300|473829148|FG000|Overall Study|Clinical Complications|0|||
131791563|NCT01452529|474520821|FG002|Run-in Period|Lost to Follow-up|0|||
131791564|NCT01452529|474520819|FG000|Run-in Period|Lack of Efficacy|46|||
131791565|NCT01452529|474520820|FG001|Run-in Period|Lack of Efficacy|0|||
131791566|NCT01452529|474520821|FG002|Run-in Period|Lack of Efficacy|0|||
131791567|NCT01452529|474520819|FG000|Run-in Period|Confirmed or suspected diversion|23|||
131791568|NCT01452529|474520820|FG001|Run-in Period|Confirmed or suspected diversion|0|||
131791569|NCT01452529|474520821|FG002|Run-in Period|Confirmed or suspected diversion|0|||
131791570|NCT01452529|474520819|FG000|Run-in Period|Administrative|21|||
131791571|NCT01452529|474520820|FG001|Run-in Period|Administrative|0|||
131791572|NCT01452529|474520821|FG002|Run-in Period|Administrative|0|||
131791573|NCT01452529|474520819|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
131791574|NCT01452529|474520820|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
131791575|NCT01452529|474520821|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
131791576|NCT01452529|474520819|FG000|Double-blind (DB) Period|Adverse Event|0|||
131791577|NCT01452529|474520820|FG001|Double-blind (DB) Period|Adverse Event|18|||
131791578|NCT01452529|474520821|FG002|Double-blind (DB) Period|Adverse Event|11|||
131791579|NCT01452529|474520819|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
131791580|NCT01452529|474520820|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
131791581|NCT01452529|474520821|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
131791582|NCT01452529|474520819|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
131791583|NCT01452529|474520820|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
131791584|NCT01452529|474520821|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
131791585|NCT01452529|474520819|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
131791586|NCT01452529|474520820|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
131791587|NCT01452529|474520821|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
131791588|NCT01452529|474520819|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
131791589|NCT01452529|474520820|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
131791590|NCT01452529|474520821|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
131791591|NCT01452529|474520819|FG000|Double-blind (DB) Period|Administrative|0|||
131791592|NCT01452529|474520820|FG001|Double-blind (DB) Period|Administrative|11|||
131791593|NCT01452529|474520821|FG002|Double-blind (DB) Period|Administrative|7|||
131791594|NCT03347695|474520828|FG000|Overall Study|Death|0|||
131791595|NCT03347695|474520829|FG001|Overall Study|Death|4|||
131791596|NCT03347695|474520828|FG000|Overall Study|Lost to Follow-up|0|||
131791597|NCT03347695|474520829|FG001|Overall Study|Lost to Follow-up|1|||
131791598|NCT02884206|474520830|FG000|Valsartan Run-in Period|Death|1|||
131791599|NCT02884206|474520831|FG001|Valsartan Run-in Period|Death|0|||
131791600|NCT02884206|474520832|FG002|Valsartan Run-in Period|Death|0|||
131791601|NCT02884206|474520830|FG000|Valsartan Run-in Period|Adverse Event|31|||
131791602|NCT02884206|474520831|FG001|Valsartan Run-in Period|Adverse Event|0|||
131791603|NCT02884206|474520832|FG002|Valsartan Run-in Period|Adverse Event|0|||
131899678|NCT01619852|474919371|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
131600580|NCT02861300|473829149|FG001|Overall Study|Clinical Complications|0|||
131791604|NCT02884206|474520830|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
131791605|NCT02884206|474520831|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
131791606|NCT02884206|474520832|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
131899679|NCT01619852|474919372|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
131899680|NCT01619852|474919371|FG000|3 Month Follow up|Lost to Follow-up|31|||
131791607|NCT02884206|474520830|FG000|Valsartan Run-in Period|Protocol deviation|4|||
131791608|NCT02884206|474520831|FG001|Valsartan Run-in Period|Protocol deviation|0|||
131600581|NCT02861300|473829150|FG002|Overall Study|Clinical Complications|0|||
131600582|NCT02861300|473829151|FG003|Overall Study|Clinical Complications|0|||
131600583|NCT02861300|473829152|FG004|Overall Study|Clinical Complications|0|||
131600584|NCT02861300|473829153|FG005|Overall Study|Clinical Complications|0|||
131600585|NCT02861300|473829154|FG006|Overall Study|Clinical Complications|1|||
131600586|NCT02465268|473829155|FG000|Overall Study|Withdrawal by Subject|4|||
131600587|NCT02465268|473829156|FG001|Overall Study|Withdrawal by Subject|3|||
131600588|NCT02465268|473829157|FG002|Overall Study|Withdrawal by Subject|1|||
131600589|NCT02465268|473829155|FG000|Overall Study|Not evaluable per protocol criteria|3|||
131600590|NCT02465268|473829156|FG001|Overall Study|Not evaluable per protocol criteria|2|||
131600591|NCT02465268|473829157|FG002|Overall Study|Not evaluable per protocol criteria|1|||
131600592|NCT02465268|473829155|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
131600593|NCT02465268|473829156|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
131600594|NCT02465268|473829157|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
131600595|NCT02465268|473829155|FG000|Overall Study|Study drug did not pass QA/QC|1|||
131600596|NCT02465268|473829156|FG001|Overall Study|Study drug did not pass QA/QC|0|||
131600597|NCT02465268|473829157|FG002|Overall Study|Study drug did not pass QA/QC|0|||
131600598|NCT02465268|473829155|FG000|Overall Study|Adverse Event|0|||
131600599|NCT02465268|473829156|FG001|Overall Study|Adverse Event|1|||
131600600|NCT02465268|473829157|FG002|Overall Study|Adverse Event|0|||
131600601|NCT02465268|473829155|FG000|Overall Study|Physician Decision|0|||
131600602|NCT02465268|473829156|FG001|Overall Study|Physician Decision|1|||
131600603|NCT02465268|473829157|FG002|Overall Study|Physician Decision|0|||
131600604|NCT00324805|473829162|FG000|Overall Study|Adverse Event|62|||
131600605|NCT00324805|473829163|FG001|Overall Study|Adverse Event|203|||
131600606|NCT00324805|473829162|FG000|Overall Study|Progression|7|||
131600607|NCT00324805|473829163|FG001|Overall Study|Progression|35|||
131600608|NCT00324805|473829162|FG000|Overall Study|Withdrawal by Subject|51|||
131600609|NCT00324805|473829163|FG001|Overall Study|Withdrawal by Subject|174|||
131600610|NCT00324805|473829162|FG000|Overall Study|Death|6|||
131600611|NCT00324805|473829163|FG001|Overall Study|Death|9|||
131600612|NCT00324805|473829162|FG000|Overall Study|Alternative therapy|4|||
131600613|NCT00324805|473829163|FG001|Overall Study|Alternative therapy|8|||
131600614|NCT00324805|473829162|FG000|Overall Study|Other complicating disease|1|||
131600615|NCT00324805|473829163|FG001|Overall Study|Other complicating disease|9|||
131600616|NCT00324805|473829162|FG000|Overall Study|Other reasons|7|||
131600617|NCT00324805|473829163|FG001|Overall Study|Other reasons|26|||
131600618|NCT00324805|473829162|FG000|Overall Study|Other|0|||
131600619|NCT00324805|473829163|FG001|Overall Study|Other|2|||
131600620|NCT00324805|473829162|FG000|Overall Study|Did not start therapy|12|||
131600621|NCT00324805|473829163|FG001|Overall Study|Did not start therapy|17|||
131600622|NCT05792085|473829165|FG000|Overall Study|Death|0|||
131600623|NCT05792085|473829166|FG001|Overall Study|Death|0|||
131600624|NCT05792085|473829167|FG002|Overall Study|Death|0|||
131600625|NCT05792085|473829168|FG003|Overall Study|Death|0|||
131600626|NCT05792085|473829169|FG004|Overall Study|Death|1|||
131600627|NCT01919554|473829170|FG000|Overall Study|Withdrawal by Subject|0|||
131600628|NCT01919554|473829171|FG001|Overall Study|Withdrawal by Subject|0|||
131600629|NCT01919554|473829172|FG002|Overall Study|Withdrawal by Subject|1|||
131600630|NCT01919554|473829173|FG003|Overall Study|Withdrawal by Subject|1|||
131600631|NCT03058289|473829174|FG000|Overall Study|Radiographic Deterioration|0|||
131600632|NCT03058289|473829175|FG001|Overall Study|Radiographic Deterioration|3|||
131600633|NCT03058289|473829176|FG002|Overall Study|Radiographic Deterioration|1|||
131600634|NCT03058289|473829177|FG003|Overall Study|Radiographic Deterioration|2|||
131600635|NCT03058289|473829178|FG004|Overall Study|Radiographic Deterioration|6|||
131600636|NCT03058289|473829179|FG005|Overall Study|Radiographic Deterioration|3|||
131600637|NCT03058289|473829180|FG006|Overall Study|Radiographic Deterioration|0|||
131600638|NCT03058289|473829181|FG007|Overall Study|Radiographic Deterioration|4|||
131600639|NCT03058289|473829182|FG008|Overall Study|Radiographic Deterioration|2|||
131600640|NCT03058289|473829174|FG000|Overall Study|Adverse Event|2|||
131600641|NCT03058289|473829175|FG001|Overall Study|Adverse Event|0|||
131600642|NCT03058289|473829176|FG002|Overall Study|Adverse Event|1|||
131600643|NCT03058289|473829177|FG003|Overall Study|Adverse Event|3|||
131600644|NCT03058289|473829178|FG004|Overall Study|Adverse Event|1|||
131600645|NCT03058289|473829179|FG005|Overall Study|Adverse Event|0|||
131600646|NCT03058289|473829180|FG006|Overall Study|Adverse Event|1|||
131600647|NCT03058289|473829181|FG007|Overall Study|Adverse Event|3|||
131600648|NCT03058289|473829182|FG008|Overall Study|Adverse Event|0|||
131600649|NCT03058289|473829174|FG000|Overall Study|Withdrawal by Subject|0|||
131600650|NCT03058289|473829175|FG001|Overall Study|Withdrawal by Subject|0|||
131600651|NCT03058289|473829176|FG002|Overall Study|Withdrawal by Subject|0|||
131600652|NCT03058289|473829177|FG003|Overall Study|Withdrawal by Subject|2|||
131600653|NCT03058289|473829178|FG004|Overall Study|Withdrawal by Subject|0|||
131600654|NCT03058289|473829179|FG005|Overall Study|Withdrawal by Subject|2|||
131600655|NCT03058289|473829180|FG006|Overall Study|Withdrawal by Subject|0|||
131600656|NCT03058289|473829181|FG007|Overall Study|Withdrawal by Subject|4|||
131600657|NCT03058289|473829182|FG008|Overall Study|Withdrawal by Subject|1|||
131600658|NCT03058289|473829174|FG000|Overall Study|Physician Decision|1|||
131600659|NCT03058289|473829175|FG001|Overall Study|Physician Decision|0|||
131600660|NCT03058289|473829176|FG002|Overall Study|Physician Decision|0|||
131600661|NCT03058289|473829177|FG003|Overall Study|Physician Decision|2|||
131600662|NCT03058289|473829178|FG004|Overall Study|Physician Decision|1|||
131600663|NCT03058289|473829179|FG005|Overall Study|Physician Decision|0|||
131600664|NCT03058289|473829180|FG006|Overall Study|Physician Decision|2|||
131600665|NCT03058289|473829181|FG007|Overall Study|Physician Decision|3|||
131600666|NCT03058289|473829182|FG008|Overall Study|Physician Decision|0|||
131600667|NCT03058289|473829174|FG000|Overall Study|Clinical Deterioration|2|||
131600668|NCT03058289|473829175|FG001|Overall Study|Clinical Deterioration|0|||
131600669|NCT03058289|473829176|FG002|Overall Study|Clinical Deterioration|0|||
131600670|NCT03058289|473829177|FG003|Overall Study|Clinical Deterioration|2|||
131600671|NCT03058289|473829178|FG004|Overall Study|Clinical Deterioration|1|||
131600672|NCT03058289|473829179|FG005|Overall Study|Clinical Deterioration|1|||
131600673|NCT03058289|473829180|FG006|Overall Study|Clinical Deterioration|0|||
131600674|NCT03058289|473829181|FG007|Overall Study|Clinical Deterioration|3|||
131600675|NCT03058289|473829182|FG008|Overall Study|Clinical Deterioration|2|||
131600676|NCT03058289|473829174|FG000|Overall Study|Lost to Follow-up|0|||
131600677|NCT03058289|473829175|FG001|Overall Study|Lost to Follow-up|0|||
131600678|NCT03058289|473829176|FG002|Overall Study|Lost to Follow-up|0|||
131600679|NCT03058289|473829177|FG003|Overall Study|Lost to Follow-up|0|||
131600680|NCT03058289|473829178|FG004|Overall Study|Lost to Follow-up|1|||
131600681|NCT03058289|473829179|FG005|Overall Study|Lost to Follow-up|0|||
131600682|NCT03058289|473829180|FG006|Overall Study|Lost to Follow-up|0|||
131600683|NCT03058289|473829181|FG007|Overall Study|Lost to Follow-up|0|||
131600684|NCT03058289|473829182|FG008|Overall Study|Lost to Follow-up|0|||
131600685|NCT03058289|473829174|FG000|Overall Study|Refused Further Treatment|0|||
131600686|NCT03058289|473829175|FG001|Overall Study|Refused Further Treatment|0|||
131600687|NCT03058289|473829176|FG002|Overall Study|Refused Further Treatment|1|||
131600688|NCT03058289|473829177|FG003|Overall Study|Refused Further Treatment|0|||
131600689|NCT03058289|473829178|FG004|Overall Study|Refused Further Treatment|1|||
131600690|NCT03058289|473829179|FG005|Overall Study|Refused Further Treatment|0|||
131600691|NCT03058289|473829180|FG006|Overall Study|Refused Further Treatment|0|||
131600692|NCT03058289|473829181|FG007|Overall Study|Refused Further Treatment|0|||
131600693|NCT03058289|473829182|FG008|Overall Study|Refused Further Treatment|0|||
131600694|NCT03058289|473829174|FG000|Overall Study|Rapid Progression of Disease|0|||
131600695|NCT03058289|473829175|FG001|Overall Study|Rapid Progression of Disease|0|||
131600696|NCT03058289|473829176|FG002|Overall Study|Rapid Progression of Disease|0|||
131600697|NCT03058289|473829177|FG003|Overall Study|Rapid Progression of Disease|1|||
131600698|NCT03058289|473829178|FG004|Overall Study|Rapid Progression of Disease|0|||
131600699|NCT03058289|473829179|FG005|Overall Study|Rapid Progression of Disease|0|||
131600700|NCT03058289|473829180|FG006|Overall Study|Rapid Progression of Disease|0|||
131600701|NCT03058289|473829181|FG007|Overall Study|Rapid Progression of Disease|0|||
131600702|NCT03058289|473829182|FG008|Overall Study|Rapid Progression of Disease|0|||
131600703|NCT03371381|473830705|FG000|Overall Study|Death|5|||
131600704|NCT03371381|473830705|FG000|Overall Study|Study terminated by sponsor|3|||
131600705|NCT03371381|473830705|FG000|Overall Study|Other|4|||
131600706|NCT04225273|473830712|FG000|Overall Study|Lost to Follow-up|3|||
131600707|NCT05270408|473830713|FG000|Started Treatment|Withdrawal by Subject|0|||
131600708|NCT05270408|473830714|FG001|Started Treatment|Withdrawal by Subject|0|||
131600709|NCT05270408|473830715|FG002|Started Treatment|Withdrawal by Subject|3|||
131600710|NCT05270408|473830713|FG000|Started Treatment|Adverse Event|0|||
131600711|NCT05270408|473830714|FG001|Started Treatment|Adverse Event|0|||
131600712|NCT05270408|473830715|FG002|Started Treatment|Adverse Event|1|||
131600713|NCT05270408|473830713|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
131600714|NCT05270408|473830714|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
131600715|NCT05270408|473830715|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
131600716|NCT03133546|473830720|FG000|Overall Study|Death|46|||
131600717|NCT03133546|473830721|FG001|Overall Study|Death|43|||
131600718|NCT03133546|473830720|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
131600719|NCT03133546|473830721|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
131600720|NCT02993159|473830722|FG000|Overall Study|Withdrawal by Subject|1|||
131600721|NCT02993159|473830723|FG001|Overall Study|Withdrawal by Subject|3|||
131600722|NCT02993159|473830722|FG000|Overall Study|Protocol Violation|1|||
131600723|NCT02993159|473830723|FG001|Overall Study|Protocol Violation|0|||
131600724|NCT02993159|473830722|FG000|Overall Study|Opted out of surgery|2|||
131600725|NCT02993159|473830723|FG001|Overall Study|Opted out of surgery|0|||
131600726|NCT02993159|473830722|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
131600727|NCT02993159|473830723|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
131600728|NCT02993159|473830722|FG000|Overall Study|Physician Decision|0|||
131600729|NCT02993159|473830723|FG001|Overall Study|Physician Decision|1|||
131600730|NCT05399459|473830726|FG000|Overall Study|Randomized but not treated|29|||
131600731|NCT05399459|473830727|FG001|Overall Study|Randomized but not treated|30|||
131600732|NCT05399459|473830728|FG002|Overall Study|Randomized but not treated|38|||
131600733|NCT05399459|473830726|FG000|Overall Study|Lost to Follow-up|1|||
131600734|NCT05399459|473830727|FG001|Overall Study|Lost to Follow-up|0|||
131600735|NCT05399459|473830728|FG002|Overall Study|Lost to Follow-up|0|||
131600736|NCT04992520|473830729|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
131600737|NCT04992520|473830730|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
131600738|NCT04992520|473830731|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
131600739|NCT04992520|473830732|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
131600740|NCT04992520|473830733|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
131600741|NCT04992520|473830734|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
131600742|NCT04992520|473830729|FG000|Part A: First Challenge|Non-compliance|0|||
131600743|NCT04992520|473830730|FG001|Part A: First Challenge|Non-compliance|0|||
131600744|NCT04992520|473830731|FG002|Part A: First Challenge|Non-compliance|0|||
131600745|NCT04992520|473830732|FG003|Part A: First Challenge|Non-compliance|1|||
131600746|NCT04992520|473830733|FG004|Part A: First Challenge|Non-compliance|0|||
131600747|NCT04992520|473830734|FG005|Part A: First Challenge|Non-compliance|0|||
131600748|NCT04992520|473830729|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131600749|NCT04992520|473830730|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131600750|NCT04992520|473830731|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
131600751|NCT04992520|473830732|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131600752|NCT04992520|473830733|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131600753|NCT04992520|473830734|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
131600754|NCT04992520|473830729|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131600755|NCT04992520|473830730|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131600756|NCT04992520|473830731|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
131600757|NCT04992520|473830732|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131600758|NCT04992520|473830733|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131600759|NCT04992520|473830734|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131440115|NCT04742556|473239258|FG001|Overall Study|Adverse Event|0|||
131600760|NCT05583578|473830741|FG000|Overall Study|Withdrawal by Subject|2|||
131600761|NCT05583578|473830742|FG001|Overall Study|Withdrawal by Subject|0|||
131791609|NCT02884206|474520832|FG002|Valsartan Run-in Period|Protocol deviation|0|||
131600762|NCT04313972|473830743|FG000|Overall Study|Withdrawal by Subject|0|||
131600763|NCT04313972|473830744|FG001|Overall Study|Withdrawal by Subject|1|||
131600764|NCT05201079|473830746|FG000|Overall Study|Adverse Event|7|||
131600765|NCT05201079|473830747|FG001|Overall Study|Adverse Event|11|||
131600766|NCT05201079|473830746|FG000|Overall Study|Death|1|||
131600767|NCT05201079|473830747|FG001|Overall Study|Death|1|||
131600768|NCT05201079|473830746|FG000|Overall Study|Lack of Efficacy|0|||
131600769|NCT05201079|473830747|FG001|Overall Study|Lack of Efficacy|2|||
131600770|NCT05201079|473830746|FG000|Overall Study|Lost to Follow-up|0|||
131600771|NCT05201079|473830747|FG001|Overall Study|Lost to Follow-up|1|||
131600772|NCT05201079|473830746|FG000|Overall Study|Physician Decision|1|||
131600773|NCT05201079|473830747|FG001|Overall Study|Physician Decision|1|||
131600774|NCT05201079|473830746|FG000|Overall Study|Protocol Violation|1|||
131600775|NCT05201079|473830747|FG001|Overall Study|Protocol Violation|0|||
131600776|NCT05201079|473830746|FG000|Overall Study|Withdrawal by Subject|1|||
131600777|NCT05201079|473830747|FG001|Overall Study|Withdrawal by Subject|0|||
131600778|NCT05201079|473830746|FG000|Overall Study|Forbidden medication|9|||
131600779|NCT05201079|473830747|FG001|Overall Study|Forbidden medication|5|||
131600780|NCT05201079|473830746|FG000|Overall Study|Transfer to another hospital|0|||
131600781|NCT05201079|473830747|FG001|Overall Study|Transfer to another hospital|1|||
131600782|NCT05201079|473830746|FG000|Overall Study|Clinical condition|1|||
131600783|NCT05201079|473830747|FG001|Overall Study|Clinical condition|0|||
131600784|NCT05201079|473830746|FG000|Overall Study|SAE and sepsis|1|||
131600785|NCT05201079|473830747|FG001|Overall Study|SAE and sepsis|0|||
131600786|NCT04103580|473830750|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
131600787|NCT04103580|473830751|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
131600788|NCT04103580|473830750|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
131600789|NCT04103580|473830751|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
131600790|NCT04103580|473830750|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
131600791|NCT04103580|473830751|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
131600792|NCT04103580|473830750|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
131600793|NCT04103580|473830751|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
131600794|NCT04103580|473830750|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
131600795|NCT04103580|473830751|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
131600796|NCT04103580|473830750|FG000|Phase 1 Active Caregiving|Other|3|||
131600797|NCT04103580|473830751|FG001|Phase 1 Active Caregiving|Other|3|||
131600798|NCT04103580|473830750|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
131600799|NCT04103580|473830751|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
131600800|NCT04103580|473830750|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
131600801|NCT04103580|473830751|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
131600802|NCT04103580|473830750|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
131600803|NCT04103580|473830751|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
131600804|NCT04103580|473830750|FG000|Phase 2 Bereavement|Other|8|||
131600805|NCT04103580|473830751|FG001|Phase 2 Bereavement|Other|6|||
131600806|NCT04042233|473830752|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
131600807|NCT04042233|473830753|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
131600808|NCT04042233|473830752|FG000|Overall Study|Protocol Violation|0|||
131600809|NCT04042233|473830753|FG001|Overall Study|Protocol Violation|2|||
131600810|NCT04907851|473830756|FG000|Overall Study|Consent withdrawn|1|||
131600811|NCT04907851|473830757|FG001|Overall Study|Consent withdrawn|2|||
131600812|NCT04907851|473830758|FG002|Overall Study|Consent withdrawn|0|||
131600813|NCT04907851|473830756|FG000|Overall Study|Death|5|||
131600814|NCT04907851|473830757|FG001|Overall Study|Death|15|||
131600815|NCT04907851|473830758|FG002|Overall Study|Death|10|||
131600816|NCT01210807|473830763|FG000|Overall Study|Lost to Follow-up|1|||
131600817|NCT01210807|473830764|FG001|Overall Study|Lost to Follow-up|2|||
131600818|NCT01210807|473830763|FG000|Overall Study|Not implanted bilaterally|2|||
131600819|NCT01210807|473830764|FG001|Overall Study|Not implanted bilaterally|1|||
131600820|NCT05477186|473830767|FG000|Overall Study|Vaccine not administered|0|||
131600821|NCT05477186|473830768|FG001|Overall Study|Vaccine not administered|2|||
131600822|NCT05477186|473830769|FG002|Overall Study|Vaccine not administered|1|||
131600823|NCT05477186|473830770|FG003|Overall Study|Vaccine not administered|0|||
131600824|NCT05477186|473830771|FG004|Overall Study|Vaccine not administered|1|||
131600825|NCT05477186|473830772|FG005|Overall Study|Vaccine not administered|0|||
131600826|NCT05477186|473830773|FG006|Overall Study|Vaccine not administered|0|||
131600827|NCT05477186|473830767|FG000|Overall Study|Withdrawal by Subject|1|||
131899681|NCT01619852|474919372|FG001|3 Month Follow up|Lost to Follow-up|34|||
131600828|NCT05477186|473830768|FG001|Overall Study|Withdrawal by Subject|0|||
131600829|NCT05477186|473830769|FG002|Overall Study|Withdrawal by Subject|0|||
131600830|NCT05477186|473830770|FG003|Overall Study|Withdrawal by Subject|0|||
131600831|NCT05477186|473830771|FG004|Overall Study|Withdrawal by Subject|0|||
131899682|NCT02659943|474919373|FG000|Overall Study|Switched to alternative treatment|1|||
131600832|NCT05477186|473830772|FG005|Overall Study|Withdrawal by Subject|1|||
131600833|NCT05477186|473830773|FG006|Overall Study|Withdrawal by Subject|0|||
131600834|NCT05477186|473830767|FG000|Overall Study|Lost to Follow-up|1|||
131600835|NCT05477186|473830768|FG001|Overall Study|Lost to Follow-up|0|||
131600836|NCT05477186|473830769|FG002|Overall Study|Lost to Follow-up|2|||
131600837|NCT05477186|473830770|FG003|Overall Study|Lost to Follow-up|1|||
131600838|NCT05477186|473830771|FG004|Overall Study|Lost to Follow-up|1|||
131600839|NCT05477186|473830772|FG005|Overall Study|Lost to Follow-up|0|||
131600840|NCT05477186|473830773|FG006|Overall Study|Lost to Follow-up|2|||
131600841|NCT04524442|473830775|FG000|Overall Study|Subject Decision|1|||
131600842|NCT01197378|473830790|FG000|Overall Study|Adverse Event|3|||
131600843|NCT01197378|473830790|FG000|Overall Study|Withdrawal by Subject|1|||
131600844|NCT01197378|473830790|FG000|Overall Study|Physician Decision|1|||
131600845|NCT01197378|473830790|FG000|Overall Study|Other|2|||
131600846|NCT05546411|473830792|FG000|Overall Study|Progressive Disease|1|||
131600847|NCT05546411|473830793|FG001|Overall Study|Progressive Disease|0|||
131600848|NCT05546411|473830792|FG000|Overall Study|Adverse Event|0|||
131600849|NCT05546411|473830793|FG001|Overall Study|Adverse Event|1|||
131600850|NCT05546411|473830792|FG000|Overall Study|Metastatic disease|1|||
131600851|NCT05546411|473830793|FG001|Overall Study|Metastatic disease|0|||
131600852|NCT02606422|473830794|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
131600853|NCT02606422|473830795|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
131600854|NCT02606422|473830794|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
131600855|NCT02606422|473830795|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
131600856|NCT02606422|473830794|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
131600857|NCT02606422|473830795|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
131600858|NCT02606422|473830794|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
131600859|NCT02606422|473830795|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
131600860|NCT04625465|473830796|FG000|Overall Study|Lost to Follow-up|2|||
131600861|NCT04625465|473830797|FG001|Overall Study|Lost to Follow-up|2|||
131600862|NCT04625465|473830798|FG002|Overall Study|Lost to Follow-up|1|||
131600863|NCT04625465|473830799|FG003|Overall Study|Lost to Follow-up|0|||
131600864|NCT04625465|473830800|FG004|Overall Study|Lost to Follow-up|0|||
131600865|NCT04625465|473830801|FG005|Overall Study|Lost to Follow-up|2|||
131600866|NCT04625465|473830802|FG006|Overall Study|Lost to Follow-up|0|||
131600867|NCT04625465|473830803|FG007|Overall Study|Lost to Follow-up|0|||
131600868|NCT04625465|473830796|FG000|Overall Study|Death|1|||
131600869|NCT04625465|473830797|FG001|Overall Study|Death|0|||
131600870|NCT04625465|473830798|FG002|Overall Study|Death|0|||
131600871|NCT04625465|473830799|FG003|Overall Study|Death|0|||
131600872|NCT04625465|473830800|FG004|Overall Study|Death|0|||
131600873|NCT04625465|473830801|FG005|Overall Study|Death|0|||
131600874|NCT04625465|473830802|FG006|Overall Study|Death|0|||
131600875|NCT04625465|473830803|FG007|Overall Study|Death|0|||
131600876|NCT04625465|473830796|FG000|Overall Study|Withdrawal by Subject|1|||
131600877|NCT04625465|473830797|FG001|Overall Study|Withdrawal by Subject|0|||
131600878|NCT04625465|473830798|FG002|Overall Study|Withdrawal by Subject|4|||
131600879|NCT04625465|473830799|FG003|Overall Study|Withdrawal by Subject|4|||
131600880|NCT04625465|473830800|FG004|Overall Study|Withdrawal by Subject|4|||
131440116|NCT04742556|473239259|FG002|Overall Study|Adverse Event|2|||
131600881|NCT04625465|473830801|FG005|Overall Study|Withdrawal by Subject|0|||
131600882|NCT04625465|473830802|FG006|Overall Study|Withdrawal by Subject|0|||
131600883|NCT04625465|473830803|FG007|Overall Study|Withdrawal by Subject|0|||
131600884|NCT04159415|473830804|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131600885|NCT04159415|473830805|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131600886|NCT04159415|473830806|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131600887|NCT04159415|473830807|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131600888|NCT04159415|473830808|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131440117|NCT04742556|473239257|FG000|Overall Study|Clinical disease progression|0|||
131440118|NCT04742556|473239258|FG001|Overall Study|Clinical disease progression|1|||
131440119|NCT04742556|473239259|FG002|Overall Study|Clinical disease progression|2|||
131440120|NCT04742556|473239257|FG000|Overall Study|Objective disease progression|3|||
131440121|NCT04742556|473239258|FG001|Overall Study|Objective disease progression|2|||
131440122|NCT04742556|473239259|FG002|Overall Study|Objective disease progression|4|||
131440123|NCT02399215|473239285|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
131440124|NCT02399215|473239285|FG000|Overall Study|Withdrawal by Subject|1|||
131440125|NCT01903356|473239286|FG000|Overall Study|Lost to Follow-up|7|||
131440126|NCT01903356|473239286|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
131440127|NCT01903356|473239286|FG000|Overall Study|Violated the dosage and administration|3|||
131440128|NCT04529083|473239287|FG000|Overall Study|Withdrawal by Subject|3|||
131440129|NCT01546857|473239295|FG000|Overall Study|Withdrawal by Subject|2|||
131440130|NCT01546857|473239296|FG001|Overall Study|Withdrawal by Subject|3|||
131440131|NCT02542865|473239297|FG000|Overall Study|Identified as screen failure|1|||
131440132|NCT02542865|473239298|FG001|Overall Study|Identified as screen failure|0|||
131440133|NCT02542865|473239297|FG000|Overall Study|Withdrawal by Subject|16|||
131440134|NCT02542865|473239298|FG001|Overall Study|Withdrawal by Subject|0|||
131440135|NCT01176032|473239299|FG000|Overall Study|Adverse Event|1|||
131440136|NCT01176032|473239300|FG001|Overall Study|Adverse Event|0|||
131440137|NCT01176032|473239299|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131440138|NCT01176032|473239300|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131440139|NCT01176032|473239299|FG000|Overall Study|Protocol Violation|1|||
131440140|NCT01176032|473239300|FG001|Overall Study|Protocol Violation|0|||
131440141|NCT01176032|473239299|FG000|Overall Study|Informed consent withdrawn|3|||
131440142|NCT01176032|473239300|FG001|Overall Study|Informed consent withdrawn|0|||
131440143|NCT01176032|473239299|FG000|Overall Study|Other|1|||
131440144|NCT01176032|473239300|FG001|Overall Study|Other|0|||
131440145|NCT01469221|473239301|FG000|Double Blind Phase|Protocol Violation|1|||
131440146|NCT01469221|473239302|FG001|Double Blind Phase|Protocol Violation|0|||
131440147|NCT01469221|473239303|FG002|Double Blind Phase|Protocol Violation|0|||
131440148|NCT01469221|473239301|FG000|Double Blind Phase|Physician Decision|1|||
131440149|NCT01469221|473239302|FG001|Double Blind Phase|Physician Decision|1|||
131600889|NCT04159415|473830809|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131600890|NCT04159415|473830810|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
131600891|NCT04159415|473830811|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
131600892|NCT03800654|473830812|FG000|Overall Study|Time constraints|3|||
131600893|NCT03800654|473830813|FG001|Overall Study|Time constraints|3|||
131600894|NCT03800654|473830814|FG002|Overall Study|Time constraints|3|||
131600895|NCT03800654|473830812|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
131600896|NCT03800654|473830813|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
131600897|NCT03800654|473830814|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
131600898|NCT03800654|473830812|FG000|Overall Study|Lost to Follow-up|2|||
131600899|NCT03800654|473830813|FG001|Overall Study|Lost to Follow-up|1|||
131600900|NCT03800654|473830814|FG002|Overall Study|Lost to Follow-up|6|||
131440150|NCT01469221|473239303|FG002|Double Blind Phase|Physician Decision|0|||
131440151|NCT01469221|473239301|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
131440152|NCT01469221|473239302|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
131440153|NCT01469221|473239303|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
131440154|NCT03186209|473239313|FG000|Overall Study|Withdrawal by Subject|11|||
131440155|NCT03186209|473239314|FG001|Overall Study|Withdrawal by Subject|22|||
131600901|NCT03800654|473830812|FG000|Overall Study|Medical Health Issue|0|||
131440156|NCT03186209|473239313|FG000|Overall Study|Pregnancy|1|||
131440157|NCT03186209|473239314|FG001|Overall Study|Pregnancy|0|||
131440158|NCT03186209|473239313|FG000|Overall Study|Adverse Event|4|||
131440159|NCT03186209|473239314|FG001|Overall Study|Adverse Event|0|||
131600902|NCT03800654|473830813|FG001|Overall Study|Medical Health Issue|0|||
131600903|NCT03800654|473830814|FG002|Overall Study|Medical Health Issue|1|||
131600904|NCT03800654|473830812|FG000|Overall Study|Personal Issues|0|||
131600905|NCT03800654|473830813|FG001|Overall Study|Personal Issues|2|||
131600906|NCT03800654|473830814|FG002|Overall Study|Personal Issues|0|||
131600907|NCT03800654|473830812|FG000|Overall Study|Protocol Violation|0|||
131600908|NCT03800654|473830813|FG001|Overall Study|Protocol Violation|1|||
131600909|NCT03800654|473830814|FG002|Overall Study|Protocol Violation|0|||
131600910|NCT06182033|473830815|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
131600911|NCT06182033|473830816|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
131600912|NCT06182033|473830815|FG000|Overall Study|Target child relocation|1|||
131600913|NCT06182033|473830816|FG001|Overall Study|Target child relocation|1|||
131600914|NCT06182033|473830815|FG000|Overall Study|Withdrawal by Subject|1|||
131600915|NCT06182033|473830816|FG001|Overall Study|Withdrawal by Subject|0|||
131600916|NCT05704543|473830817|FG000|Overall Study|Withdrawal by Subject|1|||
131600917|NCT05704543|473830818|FG001|Overall Study|Withdrawal by Subject|1|||
131600918|NCT05704543|473830819|FG002|Overall Study|Withdrawal by Subject|0|||
131600919|NCT05704543|473830820|FG003|Overall Study|Withdrawal by Subject|2|||
131600920|NCT05704543|473830817|FG000|Overall Study|Lost to Follow-up|1|||
131600921|NCT05704543|473830818|FG001|Overall Study|Lost to Follow-up|2|||
131600922|NCT05704543|473830819|FG002|Overall Study|Lost to Follow-up|0|||
131600923|NCT05704543|473830820|FG003|Overall Study|Lost to Follow-up|0|||
131600924|NCT03710603|473830823|FG000|Overall Study|Adverse Event|1|||
131600925|NCT03710603|473830824|FG001|Overall Study|Adverse Event|0|||
131600926|NCT03710603|473830823|FG000|Overall Study|Death|44|||
131600927|NCT03710603|473830824|FG001|Overall Study|Death|34|||
131600928|NCT03710603|473830823|FG000|Overall Study|Lost to Follow-up|3|||
131600929|NCT03710603|473830824|FG001|Overall Study|Lost to Follow-up|5|||
131600930|NCT03710603|473830823|FG000|Overall Study|Withdrawal by Subject|11|||
131600931|NCT03710603|473830824|FG001|Overall Study|Withdrawal by Subject|10|||
131600932|NCT03691935|473830825|FG000|Overall Study|Physician Decision|2|||
131600933|NCT03691935|473830826|FG001|Overall Study|Physician Decision|1|||
131600934|NCT03691935|473830825|FG000|Overall Study|Adverse Event|3|||
131600935|NCT03691935|473830826|FG001|Overall Study|Adverse Event|0|||
131600936|NCT02151981|473830829|FG000|Overall Study|Death|184|||
131600937|NCT02151981|473830830|FG001|Overall Study|Death|88|||
131600938|NCT02151981|473830829|FG000|Overall Study|Lost to Follow-up|7|||
131600939|NCT02151981|473830830|FG001|Overall Study|Lost to Follow-up|1|||
131600940|NCT02151981|473830829|FG000|Overall Study|Withdrawal by Subject|27|||
131600941|NCT02151981|473830830|FG001|Overall Study|Withdrawal by Subject|21|||
131600942|NCT02151981|473830829|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131600943|NCT02151981|473830830|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131600944|NCT02151981|473830829|FG000|Overall Study|Other reasons|1|||
131600945|NCT02151981|473830830|FG001|Overall Study|Other reasons|2|||
131600946|NCT05446168|473830831|FG000|Overall Study|Physician Decision|0|||
131600947|NCT05446168|473830832|FG001|Overall Study|Physician Decision|1|||
131600948|NCT01946789|473830838|FG000|Overall Study|Death|0|||
131600949|NCT01946789|473830839|FG001|Overall Study|Death|2|||
131600950|NCT01946789|473830840|FG002|Overall Study|Death|1|||
131600951|NCT01946789|473830841|FG003|Overall Study|Death|1|||
131600952|NCT01946789|473830842|FG004|Overall Study|Death|1|||
131600953|NCT01946789|473830843|FG005|Overall Study|Death|1|||
131600954|NCT01946789|473830844|FG006|Overall Study|Death|3|||
131600955|NCT01946789|473830845|FG007|Overall Study|Death|1|||
131600956|NCT01946789|473830846|FG008|Overall Study|Death|2|||
131600957|NCT01946789|473830838|FG000|Overall Study|Progressive Disease|0|||
131600958|NCT01946789|473830839|FG001|Overall Study|Progressive Disease|0|||
131600959|NCT01946789|473830840|FG002|Overall Study|Progressive Disease|1|||
131600960|NCT01946789|473830841|FG003|Overall Study|Progressive Disease|0|||
131600961|NCT01946789|473830842|FG004|Overall Study|Progressive Disease|0|||
131600962|NCT01946789|473830843|FG005|Overall Study|Progressive Disease|2|||
131600963|NCT01946789|473830844|FG006|Overall Study|Progressive Disease|0|||
131600964|NCT01946789|473830845|FG007|Overall Study|Progressive Disease|0|||
131600965|NCT01946789|473830846|FG008|Overall Study|Progressive Disease|0|||
131600966|NCT01946789|473830838|FG000|Overall Study|Withdrawal by Subject|0|||
131600967|NCT01946789|473830839|FG001|Overall Study|Withdrawal by Subject|0|||
131600968|NCT01946789|473830840|FG002|Overall Study|Withdrawal by Subject|0|||
131600969|NCT01946789|473830841|FG003|Overall Study|Withdrawal by Subject|2|||
131600970|NCT01946789|473830842|FG004|Overall Study|Withdrawal by Subject|1|||
131600971|NCT01946789|473830843|FG005|Overall Study|Withdrawal by Subject|0|||
131600972|NCT01946789|473830844|FG006|Overall Study|Withdrawal by Subject|1|||
131600973|NCT01946789|473830845|FG007|Overall Study|Withdrawal by Subject|0|||
131600974|NCT01946789|473830846|FG008|Overall Study|Withdrawal by Subject|0|||
131600975|NCT05374798|473830847|FG000|Overall Study|Lost to Follow-up|2|||
131600976|NCT05374798|473830847|FG000|Overall Study|Withdrawal by Subject|2|||
131600977|NCT05374798|473830847|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
131600978|NCT05576155|473830848|FG000|Overall Study|Withdrawal by Subject|1|||
131600979|NCT05576155|473830849|FG001|Overall Study|Withdrawal by Subject|1|||
131600980|NCT01275677|473830850|FG000|Overall Study|Not at risk for recurrence.|1|||
131600981|NCT01275677|473830851|FG001|Overall Study|Not at risk for recurrence.|1|||
131600982|NCT01275677|473830850|FG000|Overall Study|No follow-up|26|||
131600983|NCT01275677|473830851|FG001|Overall Study|No follow-up|37|||
131600984|NCT01275677|473830850|FG000|Overall Study|No clinical follow up.|1|||
131600985|NCT01275677|473830851|FG001|Overall Study|No clinical follow up.|4|||
131600986|NCT04409353|473830855|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
131600987|NCT04409353|473830856|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
131600988|NCT04409353|473830857|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
131600989|NCT04409353|473830855|FG000|Overall Study|Lost to Follow-up|6|||
131600990|NCT04409353|473830856|FG001|Overall Study|Lost to Follow-up|8|||
131600991|NCT04409353|473830857|FG002|Overall Study|Lost to Follow-up|7|||
131600992|NCT04409353|473830855|FG000|Overall Study|Major surgery during participation window|4|||
131600993|NCT04409353|473830856|FG001|Overall Study|Major surgery during participation window|3|||
131440160|NCT03186209|473239313|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
131440161|NCT03186209|473239314|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
131440162|NCT03186209|473239313|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
131440163|NCT03186209|473239314|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
131440164|NCT03186209|473239313|FG000|Overall Study|Fail to meet randomization criteria|0|||
131440165|NCT03186209|473239314|FG001|Overall Study|Fail to meet randomization criteria|1|||
131440166|NCT03186209|473239313|FG000|Overall Study|Lost to Follow-up|0|||
131440167|NCT03186209|473239314|FG001|Overall Study|Lost to Follow-up|1|||
131440168|NCT02358473|473239316|FG000|Overall Study|Disease Progession|6|||
131440169|NCT02358473|473239316|FG000|Overall Study|Adverse Event|3|||
131440170|NCT02358473|473239316|FG000|Overall Study|Withdrawal by Subject|2|||
131440171|NCT02358473|473239316|FG000|Overall Study|Physician Decision|2|||
131440172|NCT04079296|473239317|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
131440173|NCT04079296|473239318|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
131440174|NCT04079296|473239319|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
131440175|NCT04079296|473239320|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
131440176|NCT04079296|473239321|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
131440177|NCT04079296|473239317|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
131440178|NCT04079296|473239318|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
131440179|NCT04079296|473239319|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
131440180|NCT04079296|473239320|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
131440181|NCT04079296|473239321|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
131440182|NCT04079296|473239317|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
131600994|NCT04409353|473830857|FG002|Overall Study|Major surgery during participation window|3|||
131440183|NCT04079296|473239318|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
131600995|NCT04409353|473830855|FG000|Overall Study|Life event occurred during participation window|3|||
131600996|NCT04409353|473830856|FG001|Overall Study|Life event occurred during participation window|2|||
131600997|NCT04409353|473830857|FG002|Overall Study|Life event occurred during participation window|4|||
131600998|NCT04409353|473830855|FG000|Overall Study|Lack of Efficacy|4|||
131600999|NCT04409353|473830856|FG001|Overall Study|Lack of Efficacy|1|||
131601000|NCT04409353|473830857|FG002|Overall Study|Lack of Efficacy|3|||
131601001|NCT04409353|473830855|FG000|Overall Study|Adverse Event|2|||
131601002|NCT04409353|473830856|FG001|Overall Study|Adverse Event|1|||
131601003|NCT04409353|473830857|FG002|Overall Study|Adverse Event|1|||
131601004|NCT04409353|473830855|FG000|Overall Study|Disease burden - unable to participate|0|||
131601005|NCT04409353|473830856|FG001|Overall Study|Disease burden - unable to participate|1|||
131601006|NCT04409353|473830857|FG002|Overall Study|Disease burden - unable to participate|1|||
131601007|NCT04409353|473830855|FG000|Overall Study|Intervention too complicated|1|||
131601008|NCT04409353|473830856|FG001|Overall Study|Intervention too complicated|0|||
131601009|NCT04409353|473830857|FG002|Overall Study|Intervention too complicated|1|||
131601010|NCT05309291|473830858|FG000|Overall Study|Adverse Event|0|||
131601011|NCT05309291|473830859|FG001|Overall Study|Adverse Event|1|||
131601012|NCT02696707|473832483|FG000|Per Protocol Population|Physician Decision|2|||
131601013|NCT02696707|473832484|FG001|Per Protocol Population|Physician Decision|1|||
131601014|NCT02696707|473832483|FG000|Per Protocol Population|Participant Decision|0|||
131601015|NCT02696707|473832484|FG001|Per Protocol Population|Participant Decision|2|||
131601016|NCT02696707|473832483|FG000|Completed Study as Planned|Reason = LVEF|2|||
131601017|NCT02696707|473832484|FG001|Completed Study as Planned|Reason = LVEF|2|||
131601018|NCT02696707|473832483|FG000|Completed Study as Planned|Protocol Violation|2|||
131601019|NCT02696707|473832484|FG001|Completed Study as Planned|Protocol Violation|6|||
131601020|NCT02696707|473832483|FG000|Completed Study as Planned|Metastatic disease|3|||
131601021|NCT02696707|473832484|FG001|Completed Study as Planned|Metastatic disease|0|||
131440184|NCT04079296|473239319|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
131601022|NCT02696707|473832483|FG000|Completed Study as Planned|Location|1|||
131601023|NCT02696707|473832484|FG001|Completed Study as Planned|Location|1|||
131601024|NCT05251909|473832485|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
131601025|NCT05251909|473832486|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
131601026|NCT06181227|473832487|FG000|Overall Study|Study terminated by sponsor|7|||
131601027|NCT06181227|473832488|FG001|Overall Study|Study terminated by sponsor|9|||
131601028|NCT05543915|473832489|FG000|Overall Study|Lost to Follow-up|0|||
131601029|NCT05543915|473832490|FG001|Overall Study|Lost to Follow-up|1|||
131601030|NCT03381196|473832491|FG000|Overall Study|Withdrawal by Subject|7|||
131601031|NCT03381196|473832492|FG001|Overall Study|Withdrawal by Subject|7|||
131601032|NCT03381196|473832491|FG000|Overall Study|Other|0|||
131601033|NCT03381196|473832492|FG001|Overall Study|Other|1|||
131601034|NCT03381196|473832491|FG000|Overall Study|Lost to Follow-up|5|||
131601035|NCT03381196|473832492|FG001|Overall Study|Lost to Follow-up|4|||
131601036|NCT03381196|473832491|FG000|Overall Study|Death|0|||
131706745|NCT01506882|474207460|FG001|Overall Study|Withdrawal by Subject|3|||
131601037|NCT03381196|473832492|FG001|Overall Study|Death|1|||
131601038|NCT03381196|473832491|FG000|Overall Study|Adverse Event|1|||
131601039|NCT03381196|473832492|FG001|Overall Study|Adverse Event|0|||
131601040|NCT03381196|473832491|FG000|Overall Study|Randomized, not treated|3|||
131601041|NCT03381196|473832492|FG001|Overall Study|Randomized, not treated|6|||
131601042|NCT01574274|473832495|FG000|Overall Study|Ineligible|0|||
131601043|NCT01574274|473832496|FG001|Overall Study|Ineligible|1|||
131601044|NCT01574274|473832495|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
131601045|NCT01574274|473832496|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
131601046|NCT01574274|473832495|FG000|Overall Study|Ph+ B-ALL|3|||
131601047|NCT01574274|473832496|FG001|Overall Study|Ph+ B-ALL|4|||
131601048|NCT01574274|473832495|FG000|Overall Study|Induction Death|2|||
131601049|NCT01574274|473832496|FG001|Overall Study|Induction Death|0|||
131601050|NCT01574274|473832495|FG000|Overall Study|Induction Failure|4|||
131601051|NCT01574274|473832496|FG001|Overall Study|Induction Failure|1|||
131601052|NCT01574274|473832495|FG000|Overall Study|Adverse Event|16|||
131601053|NCT01574274|473832496|FG001|Overall Study|Adverse Event|13|||
131601054|NCT01574274|473832495|FG000|Overall Study|Remission Death|1|||
131706746|NCT01506882|474207459|FG000|Overall Study|SAE, non-fatal|2|||
131706747|NCT01506882|474207460|FG001|Overall Study|SAE, non-fatal|0|||
131706748|NCT01506882|474207459|FG000|Overall Study|AE, non-serious non-fatal|3|||
131601055|NCT01574274|473832496|FG001|Overall Study|Remission Death|0|||
131601056|NCT01574274|473832495|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
131601057|NCT01574274|473832496|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
131601058|NCT01574274|473832495|FG000|Overall Study|Other, unknown|3|||
131601059|NCT01574274|473832496|FG001|Overall Study|Other, unknown|2|||
131440185|NCT04079296|473239320|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
131440186|NCT04079296|473239321|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
131440187|NCT04079296|473239317|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
131791610|NCT02884206|474520830|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
131791611|NCT02884206|474520831|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
131791612|NCT02884206|474520832|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
131440188|NCT04079296|473239318|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
131440189|NCT04079296|473239319|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
131440190|NCT04079296|473239320|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
131440191|NCT04079296|473239321|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
131440192|NCT04079296|473239317|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
131440193|NCT04079296|473239318|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
131440194|NCT04079296|473239319|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
131791613|NCT02884206|474520830|FG000|Valsartan Run-in Period|Physician Decision|1|||
131791614|NCT02884206|474520831|FG001|Valsartan Run-in Period|Physician Decision|0|||
131791615|NCT02884206|474520832|FG002|Valsartan Run-in Period|Physician Decision|0|||
131791616|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Adverse Event|38|||
131791617|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Adverse Event|0|||
131440195|NCT04079296|473239320|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
131601060|NCT04676763|473832497|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
131601061|NCT04676763|473832498|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
131601062|NCT04676763|473832499|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
131601063|NCT04676763|473832497|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
131601064|NCT04676763|473832498|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
131601065|NCT04676763|473832499|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
131601066|NCT04676763|473832497|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
131601067|NCT04676763|473832498|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
131601068|NCT04676763|473832499|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
131601069|NCT02815566|473832504|FG000|Overall Study|Adverse Event|1|||
131601070|NCT02815566|473832505|FG001|Overall Study|Adverse Event|1|||
131601071|NCT02815566|473832504|FG000|Overall Study|Withdrawal by Subject|1|||
131601072|NCT02815566|473832505|FG001|Overall Study|Withdrawal by Subject|0|||
131601073|NCT02815566|473832504|FG000|Overall Study|Lost to Follow-up|0|||
131601074|NCT02815566|473832505|FG001|Overall Study|Lost to Follow-up|1|||
131601075|NCT03252847|473832506|FG000|Overall Study|Withdrawal by Subject|0|||
131601076|NCT03252847|473832507|FG001|Overall Study|Withdrawal by Subject|0|||
131601077|NCT03252847|473832508|FG002|Overall Study|Withdrawal by Subject|1|||
131601078|NCT03252847|473832509|FG003|Overall Study|Withdrawal by Subject|0|||
131601079|NCT03252847|473832510|FG004|Overall Study|Withdrawal by Subject|0|||
131601080|NCT03252847|473832511|FG005|Overall Study|Withdrawal by Subject|0|||
131601081|NCT03252847|473832512|FG006|Overall Study|Withdrawal by Subject|0|||
131601082|NCT03252847|473832506|FG000|Overall Study|Other: Patient decision|0|||
131601083|NCT03252847|473832507|FG001|Overall Study|Other: Patient decision|0|||
131601084|NCT03252847|473832508|FG002|Overall Study|Other: Patient decision|0|||
131601085|NCT03252847|473832509|FG003|Overall Study|Other: Patient decision|0|||
131601086|NCT03252847|473832510|FG004|Overall Study|Other: Patient decision|1|||
131601087|NCT03252847|473832511|FG005|Overall Study|Other: Patient decision|0|||
131601088|NCT03252847|473832512|FG006|Overall Study|Other: Patient decision|0|||
131601089|NCT06103188|473832516|FG000|Overall Study|Lost to Follow-up|1|||
131601090|NCT06103188|473832517|FG001|Overall Study|Lost to Follow-up|6|||
131601091|NCT06103188|473832518|FG002|Overall Study|Lost to Follow-up|4|||
131601092|NCT04979442|473832521|FG000|Overall Study|Death|43|||
131601093|NCT04979442|473832522|FG001|Overall Study|Death|30|||
131601094|NCT04979442|473832521|FG000|Overall Study|Withdrawal by Subject|8|||
131601095|NCT04979442|473832522|FG001|Overall Study|Withdrawal by Subject|13|||
131601096|NCT04979442|473832521|FG000|Overall Study|Physician Decision|1|||
131601097|NCT04979442|473832522|FG001|Overall Study|Physician Decision|1|||
131601098|NCT04979442|473832521|FG000|Overall Study|Lost to Follow-up|0|||
131601099|NCT04979442|473832522|FG001|Overall Study|Lost to Follow-up|2|||
131440196|NCT04079296|473239321|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
131706749|NCT01506882|474207460|FG001|Overall Study|AE, non-serious non-fatal|1|||
131706750|NCT01506882|474207459|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
131706751|NCT01506882|474207460|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131706752|NCT01506882|474207459|FG000|Overall Study|Other Reason|2|||
131706753|NCT01506882|474207460|FG001|Overall Study|Other Reason|0|||
131706754|NCT00821678|474207465|FG000|Overall Study|Withdrawal by Subject|8|||
131706755|NCT00821678|474207466|FG001|Overall Study|Withdrawal by Subject|0|||
131706756|NCT00821678|474207465|FG000|Overall Study|Lost to Follow-up|13|||
131706757|NCT00821678|474207466|FG001|Overall Study|Lost to Follow-up|12|||
131706758|NCT00821678|474207465|FG000|Overall Study|Death|0|||
131706759|NCT00821678|474207466|FG001|Overall Study|Death|2|||
131706760|NCT06441877|474209232|FG000|Overall Study|Withdrawal by Subject|0|||
131706761|NCT06441877|474209233|FG001|Overall Study|Withdrawal by Subject|2|||
131706762|NCT06441877|474209234|FG002|Overall Study|Withdrawal by Subject|0|||
131706763|NCT06441877|474209235|FG003|Overall Study|Withdrawal by Subject|0|||
131706764|NCT00600171|474209236|FG000|Overall Study|Adverse Event|0|||
131706765|NCT00600171|474209237|FG001|Overall Study|Adverse Event|1|||
131601100|NCT04979442|473832521|FG000|Overall Study|do not want to continue|0|||
131601101|NCT04979442|473832522|FG001|Overall Study|do not want to continue|1|||
131601102|NCT01175356|473832523|FG000|Overall Study|Death|1|||
131601103|NCT01175356|473832523|FG000|Overall Study|Lack of Efficacy|12|||
131601104|NCT01175356|473832523|FG000|Overall Study|Lost to Follow-up|1|||
131601105|NCT01175356|473832523|FG000|Overall Study|Physician Decision|23|||
131601106|NCT01175356|473832523|FG000|Overall Study|Ineligible|1|||
131601107|NCT01175356|473832523|FG000|Overall Study|Treatment Slot Not Available|18|||
131601108|NCT01175356|473832523|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
131601109|NCT01175356|473832523|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
131601110|NCT01175356|473832523|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
131601111|NCT01175356|473832523|FG000|Overall Study|Inadequate stem cell for transplant|1|||
131601112|NCT01175356|473832523|FG000|Overall Study|Initiation other tx prior to completion|9|||
131601113|NCT04005794|473832528|FG000|Overall Study|Lost to Follow-up|0|||
131601114|NCT04005794|473832529|FG001|Overall Study|Lost to Follow-up|4|||
131601115|NCT04005794|473832530|FG002|Overall Study|Lost to Follow-up|0|||
131601116|NCT00248287|473832537|FG000|Overall Study|Adverse Event|11|||
131601117|NCT00248287|473832538|FG001|Overall Study|Adverse Event|10|||
131601118|NCT00248287|473832537|FG000|Overall Study|Death|1|||
131601119|NCT00248287|473832538|FG001|Overall Study|Death|0|||
131601120|NCT00248287|473832537|FG000|Overall Study|Lost to Follow-up|0|||
131601121|NCT00248287|473832538|FG001|Overall Study|Lost to Follow-up|1|||
131601122|NCT00248287|473832537|FG000|Overall Study|Investigator Request|4|||
131601123|NCT00248287|473832538|FG001|Overall Study|Investigator Request|3|||
131601124|NCT00248287|473832537|FG000|Overall Study|Patient Request|5|||
131601125|NCT00248287|473832538|FG001|Overall Study|Patient Request|3|||
131601126|NCT00248287|473832537|FG000|Overall Study|Other|3|||
131601127|NCT00248287|473832538|FG001|Overall Study|Other|2|||
131601128|NCT02714257|473832551|FG000|Overall Study|Withdrawal by Subject|6|||
131601129|NCT02714257|473832552|FG001|Overall Study|Withdrawal by Subject|11|||
131601130|NCT02714257|473832551|FG000|Overall Study|Death|3|||
131601131|NCT02714257|473832552|FG001|Overall Study|Death|4|||
131601132|NCT02714257|473832551|FG000|Overall Study|Lost to Follow-up|1|||
131601133|NCT02714257|473832552|FG001|Overall Study|Lost to Follow-up|6|||
131601134|NCT04145440|473832553|FG000|Overall Study|Physician Decision|3|||
131601135|NCT04145440|473832554|FG001|Overall Study|Physician Decision|0|||
131601136|NCT04145440|473832553|FG000|Overall Study|Use of prohibited therapy|2|||
131601137|NCT04145440|473832554|FG001|Overall Study|Use of prohibited therapy|3|||
131601138|NCT00104676|473832555|FG000|Overall Study|Death|3|||
131601139|NCT00104676|473832556|FG001|Overall Study|Death|2|||
131601140|NCT00104676|473832555|FG000|Overall Study|Withdrawal by Subject|0|||
131601141|NCT00104676|473832556|FG001|Overall Study|Withdrawal by Subject|2|||
131601142|NCT00104676|473832555|FG000|Overall Study|treatment interruption|4|||
131601143|NCT00104676|473832556|FG001|Overall Study|treatment interruption|10|||
131601144|NCT05808257|473832559|FG000|Overall Study|Lost to Follow-up|8|||
131601145|NCT05808257|473832560|FG001|Overall Study|Lost to Follow-up|8|||
131601146|NCT04568486|473832561|FG000|Overall Study|Withdrawal by Subject|26|||
131601147|NCT04568486|473832561|FG000|Overall Study|Lost to Follow-up|7|||
131601148|NCT05297565|473832568|FG000|Overall Study|Other Reasons|0|||
131601149|NCT05297565|473832569|FG001|Overall Study|Other Reasons|1|||
131601150|NCT05297565|473832568|FG000|Overall Study|Physician Decision|0|||
131601151|NCT05297565|473832569|FG001|Overall Study|Physician Decision|1|||
131601152|NCT05297565|473832568|FG000|Overall Study|Disease recurrence|1|||
131601153|NCT05297565|473832569|FG001|Overall Study|Disease recurrence|0|||
131601154|NCT03899259|473832572|FG000|Overall Study|Adverse Event|5|||
131601155|NCT03899259|473832573|FG001|Overall Study|Adverse Event|4|||
131601156|NCT03899259|473832574|FG002|Overall Study|Adverse Event|6|||
131601157|NCT03899259|473832572|FG000|Overall Study|Lack of Efficacy|5|||
131601158|NCT03899259|473832573|FG001|Overall Study|Lack of Efficacy|0|||
131601159|NCT03899259|473832574|FG002|Overall Study|Lack of Efficacy|2|||
131601160|NCT03899259|473832572|FG000|Overall Study|Pregnancy|3|||
131601161|NCT03899259|473832573|FG001|Overall Study|Pregnancy|0|||
131601162|NCT03899259|473832574|FG002|Overall Study|Pregnancy|1|||
131601163|NCT03899259|473832572|FG000|Overall Study|Physician Decision|0|||
131601164|NCT03899259|473832573|FG001|Overall Study|Physician Decision|1|||
131601165|NCT03899259|473832574|FG002|Overall Study|Physician Decision|0|||
131601166|NCT03899259|473832572|FG000|Overall Study|Protocol Deviation|1|||
131601167|NCT03899259|473832573|FG001|Overall Study|Protocol Deviation|1|||
131601168|NCT03899259|473832574|FG002|Overall Study|Protocol Deviation|1|||
131601169|NCT03899259|473832572|FG000|Overall Study|Withdrawal by Subject|8|||
131601170|NCT03899259|473832573|FG001|Overall Study|Withdrawal by Subject|10|||
131601171|NCT03899259|473832574|FG002|Overall Study|Withdrawal by Subject|12|||
131601172|NCT03899259|473832572|FG000|Overall Study|Lost to Follow-up|5|||
131601173|NCT03899259|473832573|FG001|Overall Study|Lost to Follow-up|6|||
131601174|NCT03899259|473832574|FG002|Overall Study|Lost to Follow-up|2|||
131601175|NCT03899259|473832572|FG000|Overall Study|Lack of Adherence|1|||
131601176|NCT03899259|473832573|FG001|Overall Study|Lack of Adherence|0|||
131601177|NCT03899259|473832574|FG002|Overall Study|Lack of Adherence|0|||
131601178|NCT03899259|473832572|FG000|Overall Study|Screen Failure|1|||
131601179|NCT03899259|473832573|FG001|Overall Study|Screen Failure|0|||
131601180|NCT03899259|473832574|FG002|Overall Study|Screen Failure|0|||
131601181|NCT03899259|473832572|FG000|Overall Study|Ongoing Study Participation|127|||
131601182|NCT03899259|473832573|FG001|Overall Study|Ongoing Study Participation|134|||
131601183|NCT03899259|473832574|FG002|Overall Study|Ongoing Study Participation|210|||
131601184|NCT05139810|473832575|FG000|Overall Study|Voluntary Withdrawal|2|||
131601185|NCT05139810|473832576|FG001|Overall Study|Voluntary Withdrawal|1|||
131601186|NCT05139810|473832577|FG002|Overall Study|Voluntary Withdrawal|0|||
131601187|NCT05139810|473832575|FG000|Overall Study|Pregnancy|1|||
131601188|NCT05139810|473832576|FG001|Overall Study|Pregnancy|0|||
131601189|NCT05139810|473832577|FG002|Overall Study|Pregnancy|0|||
131601190|NCT05139810|473832575|FG000|Overall Study|Roll Over to CS7|19|||
131601191|NCT05139810|473832576|FG001|Overall Study|Roll Over to CS7|44|||
131601192|NCT05139810|473832577|FG002|Overall Study|Roll Over to CS7|20|||
131601193|NCT05940194|473832578|FG000|Overall Study|Adverse Event|0|||
131601194|NCT05940194|473832579|FG001|Overall Study|Adverse Event|1|||
131601195|NCT05940194|473832580|FG002|Overall Study|Adverse Event|0|||
131601196|NCT05940194|473832578|FG000|Overall Study|Migrated/Moved from the study area|2|||
131601197|NCT05940194|473832579|FG001|Overall Study|Migrated/Moved from the study area|2|||
131601198|NCT05940194|473832580|FG002|Overall Study|Migrated/Moved from the study area|4|||
131601199|NCT05566639|473832587|FG000|Overall Study|Adverse Event|1|||
131601200|NCT05566639|473832588|FG001|Overall Study|Adverse Event|1|||
131601201|NCT05566639|473832587|FG000|Overall Study|Serious Adverse Event|1|||
131601202|NCT05566639|473832588|FG001|Overall Study|Serious Adverse Event|3|||
131601203|NCT05566639|473832587|FG000|Overall Study|Death|44|||
131601204|NCT05566639|473832588|FG001|Overall Study|Death|45|||
131601205|NCT05566639|473832587|FG000|Overall Study|Lost to Follow-up|467|||
131706766|NCT00600171|474209238|FG002|Overall Study|Adverse Event|0|||
131440197|NCT04079296|473239317|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
131440198|NCT04079296|473239318|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
131440199|NCT04079296|473239319|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
131440200|NCT04079296|473239320|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
131440201|NCT04079296|473239321|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
131440202|NCT04079296|473239317|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
131440203|NCT04079296|473239318|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
131440204|NCT04079296|473239319|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
131601206|NCT05566639|473832588|FG001|Overall Study|Lost to Follow-up|461|||
131601207|NCT05566639|473832587|FG000|Overall Study|Physician Decision|45|||
131601208|NCT05566639|473832588|FG001|Overall Study|Physician Decision|44|||
131706767|NCT00600171|474209239|FG003|Overall Study|Adverse Event|0|||
131706768|NCT00600171|474209240|FG004|Overall Study|Adverse Event|1|||
131601209|NCT05566639|473832587|FG000|Overall Study|Protocol Deviation|4|||
131601210|NCT05566639|473832588|FG001|Overall Study|Protocol Deviation|4|||
131601211|NCT05566639|473832587|FG000|Overall Study|Withdrawal by Subject|277|||
131601212|NCT05566639|473832588|FG001|Overall Study|Withdrawal by Subject|271|||
131601213|NCT05566639|473832587|FG000|Overall Study|Other Than Specified|52|||
131601214|NCT05566639|473832588|FG001|Overall Study|Other Than Specified|64|||
131601215|NCT04054193|473832597|FG000|Cycle 1|Physician Decision|1|||
131706769|NCT00600171|474209241|FG005|Overall Study|Adverse Event|0|||
131601216|NCT04054193|473832597|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
131601217|NCT04054193|473832597|FG000|Cycle 1|Allocated but not treated|3|||
131601218|NCT04054193|473832597|FG000|Cycles 2-3|Physician Decision|2|||
131601219|NCT04054193|473832597|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
131791618|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Adverse Event|0|||
131791619|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Death|2|||
131791620|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Death|0|||
131791621|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Death|0|||
131791622|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
131791623|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
131791624|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
131791625|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
131791626|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
131791627|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
131791628|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
131791629|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
131601220|NCT04054193|473832597|FG000|Cycles 2-3|Various reasons|17|||
131601221|NCT02966873|473832598|FG000|Overall Study|Lost to Follow-up|16|||
131601222|NCT02966873|473832599|FG001|Overall Study|Lost to Follow-up|15|||
131601223|NCT03084536|473832600|FG000|Overall Study|Determined to be ineligible|0|||
131601224|NCT03084536|473832601|FG001|Overall Study|Determined to be ineligible|0|||
131601225|NCT03084536|473832602|FG002|Overall Study|Determined to be ineligible|16|||
131601226|NCT03084536|473832600|FG000|Overall Study|Withdrawal by Subject|0|||
131601227|NCT03084536|473832601|FG001|Overall Study|Withdrawal by Subject|0|||
131601228|NCT03084536|473832602|FG002|Overall Study|Withdrawal by Subject|4|||
131601229|NCT03084536|473832600|FG000|Overall Study|Physician Decision|0|||
131601230|NCT03084536|473832601|FG001|Overall Study|Physician Decision|0|||
131601231|NCT03084536|473832602|FG002|Overall Study|Physician Decision|3|||
131601232|NCT03084536|473832600|FG000|Overall Study|Death|0|||
131601233|NCT03084536|473832601|FG001|Overall Study|Death|0|||
131601234|NCT03084536|473832602|FG002|Overall Study|Death|1|||
131601235|NCT03084536|473832600|FG000|Overall Study|Lost to Follow-up|0|||
131601236|NCT03084536|473832601|FG001|Overall Study|Lost to Follow-up|0|||
131601237|NCT03084536|473832602|FG002|Overall Study|Lost to Follow-up|1|||
131601238|NCT03084536|473832600|FG000|Overall Study|Protocol Violation|0|||
131601239|NCT03084536|473832601|FG001|Overall Study|Protocol Violation|0|||
131601240|NCT03084536|473832602|FG002|Overall Study|Protocol Violation|1|||
131601241|NCT03084536|473832600|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
131601242|NCT03084536|473832601|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
131601243|NCT03084536|473832602|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
131601244|NCT04830800|473832605|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
131601245|NCT04830800|473832606|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
131601246|NCT04830800|473832607|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
131601247|NCT04830800|473832608|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
131601248|NCT04830800|473832609|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
131601249|NCT01456949|473832612|FG000|Enrollment|PI death- incomplete data|6|||
131601250|NCT01456949|473832612|FG000|Enrollment|Death|1|||
131601251|NCT01456949|473832612|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
131601252|NCT01456949|473832612|FG000|Enrollment|Physician Decision|10|||
131601253|NCT01456949|473832612|FG000|Enrollment|Withdrawal by Subject|7|||
131601254|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
131601255|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
131601256|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
131601257|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
131601258|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
131601259|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
131601260|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
131601261|NCT01456949|473832612|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
131601262|NCT04753697|473832613|FG000|Induction Phase|Withdrawal by Subject|12|||
131601263|NCT04753697|473832614|FG001|Induction Phase|Withdrawal by Subject|5|||
131601264|NCT04753697|473832615|FG002|Induction Phase|Withdrawal by Subject|6|||
131601265|NCT04753697|473832613|FG000|Induction Phase|Physician Decision|1|||
131601266|NCT04753697|473832614|FG001|Induction Phase|Physician Decision|0|||
131601267|NCT04753697|473832615|FG002|Induction Phase|Physician Decision|0|||
131601268|NCT04753697|473832613|FG000|Induction Phase|Lost to Follow-up|2|||
131791630|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
131791631|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Physician Decision|1|||
131791632|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Physician Decision|0|||
131791633|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Physician Decision|0|||
131601269|NCT04753697|473832614|FG001|Induction Phase|Lost to Follow-up|2|||
131601270|NCT04753697|473832615|FG002|Induction Phase|Lost to Follow-up|1|||
131601271|NCT04753697|473832613|FG000|Induction Phase|Lack of Efficacy|1|||
131440205|NCT04079296|473239320|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
131440206|NCT04079296|473239321|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
131440207|NCT04079296|473239317|FG000|Dose Expansion Phase (168 Days)|Death|0|||
131440208|NCT04079296|473239318|FG001|Dose Expansion Phase (168 Days)|Death|0|||
131440209|NCT04079296|473239319|FG002|Dose Expansion Phase (168 Days)|Death|0|||
131440210|NCT04079296|473239320|FG003|Dose Expansion Phase (168 Days)|Death|1|||
131440211|NCT04079296|473239321|FG004|Dose Expansion Phase (168 Days)|Death|0|||
131440212|NCT02240485|473239336|FG000|3 Months Post-admission|Lost to Follow-up|1|||
131440213|NCT02240485|473239337|FG001|3 Months Post-admission|Lost to Follow-up|5|||
131440214|NCT02240485|473239336|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
131440215|NCT02240485|473239337|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
131440216|NCT02240485|473239336|FG000|9 Months Post-admission|Lost to Follow-up|3|||
131440217|NCT02240485|473239337|FG001|9 Months Post-admission|Lost to Follow-up|1|||
131440218|NCT02240485|473239336|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
131440219|NCT02240485|473239337|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
131440220|NCT02240485|473239336|FG000|18 Months Post-admission|Lost to Follow-up|1|||
131440221|NCT02240485|473239337|FG001|18 Months Post-admission|Lost to Follow-up|1|||
131440222|NCT02240485|473239336|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
131440223|NCT02240485|473239337|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
131440224|NCT00953667|473239338|FG000|Overall Study|Lost to Follow-up|11|||
131440225|NCT00953667|473239338|FG000|Overall Study|Physician Decision|35|||
131440226|NCT00953667|473239338|FG000|Overall Study|Withdrawal by Subject|63|||
131440227|NCT00953667|473239338|FG000|Overall Study|Adverse Event|10|||
131440228|NCT00953667|473239338|FG000|Overall Study|poor venous access,unable to draw blood|4|||
131706770|NCT00600171|474209236|FG000|Overall Study|Lack of Efficacy|9|||
131706771|NCT00600171|474209237|FG001|Overall Study|Lack of Efficacy|12|||
131706772|NCT00600171|474209238|FG002|Overall Study|Lack of Efficacy|3|||
131440229|NCT04819945|473239339|FG000|Overall Study|Lost to Follow-up|1|||
131440230|NCT00475670|473239340|FG000|Overall Study|Death|0|||
131440231|NCT00475670|473239341|FG001|Overall Study|Death|1|||
131440232|NCT00475670|473239340|FG000|Overall Study|Lack of Efficacy|3|||
131440233|NCT00475670|473239341|FG001|Overall Study|Lack of Efficacy|34|||
131440234|NCT00475670|473239340|FG000|Overall Study|Refused treatment|0|||
131440235|NCT00475670|473239341|FG001|Overall Study|Refused treatment|2|||
131440236|NCT00475670|473239340|FG000|Overall Study|Failure to Return|0|||
131440237|NCT00475670|473239341|FG001|Overall Study|Failure to Return|1|||
131440238|NCT00475670|473239340|FG000|Overall Study|Other|0|||
131440239|NCT00475670|473239341|FG001|Overall Study|Other|3|||
131706773|NCT00600171|474209239|FG003|Overall Study|Lack of Efficacy|5|||
131706774|NCT00600171|474209240|FG004|Overall Study|Lack of Efficacy|4|||
131706775|NCT00600171|474209241|FG005|Overall Study|Lack of Efficacy|0|||
131706776|NCT00600171|474209236|FG000|Overall Study|Protocol Violation|1|||
131706777|NCT00600171|474209237|FG001|Overall Study|Protocol Violation|2|||
131706778|NCT00600171|474209238|FG002|Overall Study|Protocol Violation|0|||
131706779|NCT00600171|474209239|FG003|Overall Study|Protocol Violation|1|||
131706780|NCT00600171|474209240|FG004|Overall Study|Protocol Violation|0|||
131706781|NCT00600171|474209241|FG005|Overall Study|Protocol Violation|0|||
131706782|NCT00600171|474209236|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
131706783|NCT00600171|474209237|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131706784|NCT00600171|474209238|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
131706785|NCT00600171|474209239|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
131706786|NCT00600171|474209240|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
131706787|NCT00600171|474209241|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
131706788|NCT00600171|474209236|FG000|Overall Study|Withdrawal by Subject|3|||
131706789|NCT00600171|474209237|FG001|Overall Study|Withdrawal by Subject|0|||
131706790|NCT00600171|474209238|FG002|Overall Study|Withdrawal by Subject|0|||
131706791|NCT00600171|474209239|FG003|Overall Study|Withdrawal by Subject|1|||
131706792|NCT00600171|474209240|FG004|Overall Study|Withdrawal by Subject|1|||
131706793|NCT00600171|474209241|FG005|Overall Study|Withdrawal by Subject|1|||
131706794|NCT00600171|474209236|FG000|Overall Study|Physician Decision|0|||
131706795|NCT00600171|474209237|FG001|Overall Study|Physician Decision|1|||
131791634|NCT02884206|474520830|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
131791635|NCT02884206|474520831|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
131440240|NCT04949191|473239342|FG000|Overall Study|Non-compliance with Study Drug|1|||
131440241|NCT04949191|473239343|FG001|Overall Study|Non-compliance with Study Drug|0|||
131440242|NCT04949191|473239344|FG002|Overall Study|Non-compliance with Study Drug|0|||
131440243|NCT04949191|473239345|FG003|Overall Study|Non-compliance with Study Drug|0|||
131440244|NCT04949191|473239342|FG000|Overall Study|Progressive Disease|0|||
131440245|NCT04949191|473239343|FG001|Overall Study|Progressive Disease|1|||
131440246|NCT04949191|473239344|FG002|Overall Study|Progressive Disease|0|||
131440247|NCT04949191|473239345|FG003|Overall Study|Progressive Disease|0|||
131440248|NCT04949191|473239342|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
131791636|NCT02884206|474520832|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
131706796|NCT00600171|474209238|FG002|Overall Study|Physician Decision|0|||
131706797|NCT00600171|474209239|FG003|Overall Study|Physician Decision|1|||
131706798|NCT00600171|474209240|FG004|Overall Study|Physician Decision|0|||
131440249|NCT04949191|473239343|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
131440250|NCT04949191|473239344|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
131440251|NCT04949191|473239345|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
131440252|NCT04949191|473239342|FG000|Overall Study|Sponsor Terminated Study|0|||
131440253|NCT04949191|473239343|FG001|Overall Study|Sponsor Terminated Study|0|||
131440254|NCT04949191|473239344|FG002|Overall Study|Sponsor Terminated Study|1|||
131440255|NCT04949191|473239345|FG003|Overall Study|Sponsor Terminated Study|1|||
131440256|NCT02913482|473239346|FG000|Overall Study|Death|0|||
131440257|NCT02913482|473239347|FG001|Overall Study|Death|2|||
131440258|NCT02913482|473239348|FG002|Overall Study|Death|2|||
131440259|NCT02913482|473239346|FG000|Overall Study|Progressive Disease|1|||
131440260|NCT02913482|473239347|FG001|Overall Study|Progressive Disease|1|||
131440261|NCT02913482|473239348|FG002|Overall Study|Progressive Disease|1|||
131440262|NCT02913482|473239346|FG000|Overall Study|Reason not specified|0|||
131440263|NCT02913482|473239347|FG001|Overall Study|Reason not specified|0|||
131440264|NCT02913482|473239348|FG002|Overall Study|Reason not specified|1|||
131440265|NCT02913482|473239346|FG000|Overall Study|Withdrawal by Subject|0|||
131440266|NCT02913482|473239347|FG001|Overall Study|Withdrawal by Subject|1|||
131440267|NCT02913482|473239348|FG002|Overall Study|Withdrawal by Subject|1|||
131440268|NCT01046565|473239353|FG000|Overall Study|Adverse Event|2|||
131440269|NCT01046565|473239353|FG000|Overall Study|Withdrawal by Subject|7|||
131440270|NCT00918385|473239354|FG000|Monotherapy|Adverse Event|1|||
131440271|NCT00918385|473239355|FG001|Monotherapy|Adverse Event|6|||
131440272|NCT00918385|473239354|FG000|Monotherapy|Complicating illness|1|||
131440273|NCT00918385|473239355|FG001|Monotherapy|Complicating illness|0|||
131440274|NCT00918385|473239354|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
131440275|NCT00918385|473239355|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
131440276|NCT00918385|473239354|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
131440277|NCT00918385|473239355|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
131440278|NCT00918385|473239354|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
131440279|NCT00918385|473239355|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
131440280|NCT00918385|473239354|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
131440281|NCT00918385|473239355|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
131440282|NCT00771914|473239358|FG000|Overall Study|Physician Decision|0|||
131440283|NCT00771914|473239359|FG001|Overall Study|Physician Decision|0|||
131440284|NCT00771914|473239360|FG002|Overall Study|Physician Decision|0|||
131440285|NCT00771914|473239361|FG003|Overall Study|Physician Decision|1|||
131440286|NCT00771914|473239358|FG000|Overall Study|Lost to Follow-up|0|||
131440287|NCT00771914|473239359|FG001|Overall Study|Lost to Follow-up|0|||
131440288|NCT00771914|473239360|FG002|Overall Study|Lost to Follow-up|0|||
131440289|NCT00771914|473239361|FG003|Overall Study|Lost to Follow-up|1|||
131440290|NCT05135871|473239365|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
131440291|NCT05135871|473239366|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
131440292|NCT05135871|473239367|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
131440293|NCT05135871|473239368|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
131440294|NCT00633477|473241456|FG000|Overall Study|Death|1|||
131440295|NCT00633477|473241457|FG001|Overall Study|Death|0|||
131440296|NCT00633477|473241456|FG000|Overall Study|Randomized but not treated|1|||
131440297|NCT00633477|473241457|FG001|Overall Study|Randomized but not treated|0|||
131440298|NCT00179621|473241459|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
131440299|NCT00179621|473241460|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
131440300|NCT00179621|473241461|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
131440301|NCT00179621|473241462|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
131440302|NCT00179621|473241459|FG000|Double-Blind Period|Adverse Event|2|||
131440303|NCT00179621|473241460|FG001|Double-Blind Period|Adverse Event|7|||
131440304|NCT00179621|473241461|FG002|Double-Blind Period|Adverse Event|4|||
131440305|NCT00179621|473241462|FG003|Double-Blind Period|Adverse Event|0|||
131440306|NCT00179621|473241459|FG000|Double-Blind Period|Withdrawal by Subject|2|||
131440307|NCT00179621|473241460|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131440308|NCT00179621|473241461|FG002|Double-Blind Period|Withdrawal by Subject|3|||
131440309|NCT00179621|473241462|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131440310|NCT00179621|473241459|FG000|Double-Blind Period|Death|0|||
131440311|NCT00179621|473241460|FG001|Double-Blind Period|Death|1|||
131601272|NCT04753697|473832614|FG001|Induction Phase|Lack of Efficacy|0|||
131601273|NCT04753697|473832615|FG002|Induction Phase|Lack of Efficacy|0|||
131601274|NCT04753697|473832613|FG000|Maintenance Phase|Physician Decision|0|||
131601275|NCT04753697|473832614|FG001|Maintenance Phase|Physician Decision|0|||
131601276|NCT04753697|473832615|FG002|Maintenance Phase|Physician Decision|1|||
131601277|NCT04753697|473832613|FG000|Maintenance Phase|Withdrawal by Subject|3|||
131601278|NCT04753697|473832614|FG001|Maintenance Phase|Withdrawal by Subject|4|||
131601279|NCT04753697|473832615|FG002|Maintenance Phase|Withdrawal by Subject|6|||
131601280|NCT04753697|473832613|FG000|Maintenance Phase|Lost to Follow-up|2|||
131601281|NCT04753697|473832614|FG001|Maintenance Phase|Lost to Follow-up|2|||
131601282|NCT04753697|473832615|FG002|Maintenance Phase|Lost to Follow-up|0|||
131601283|NCT04753697|473832613|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
131601284|NCT04753697|473832614|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
131601285|NCT04753697|473832615|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
131601286|NCT04753697|473832613|FG000|Maintenance Phase|Adverse Event|0|||
131601287|NCT04753697|473832614|FG001|Maintenance Phase|Adverse Event|1|||
131601288|NCT04753697|473832615|FG002|Maintenance Phase|Adverse Event|1|||
131601289|NCT04753697|473832613|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
131601290|NCT04753697|473832614|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
131601291|NCT04753697|473832615|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
131601292|NCT02626533|473832616|FG000|Overall Study|Protocol Violation|14|||
131601293|NCT02626533|473832616|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
131601294|NCT02626533|473832616|FG000|Overall Study|Withdrawal by Subject|1|||
131601295|NCT02723591|473832617|FG000|Overall Study|Adverse Event|48|||
131601296|NCT02723591|473832618|FG001|Overall Study|Adverse Event|40|||
131601297|NCT02723591|473832617|FG000|Overall Study|Death|2|||
131601298|NCT02723591|473832618|FG001|Overall Study|Death|2|||
131601299|NCT02723591|473832617|FG000|Overall Study|Lack of Efficacy|4|||
131601300|NCT02723591|473832618|FG001|Overall Study|Lack of Efficacy|3|||
131601301|NCT02723591|473832617|FG000|Overall Study|Lost to Follow-up|1|||
131440312|NCT00179621|473241461|FG002|Double-Blind Period|Death|2|||
131440313|NCT00179621|473241462|FG003|Double-Blind Period|Death|0|||
131440314|NCT00179621|473241459|FG000|Double-Blind Period|Protocol Violation|1|||
131440315|NCT00179621|473241460|FG001|Double-Blind Period|Protocol Violation|0|||
131440316|NCT00179621|473241461|FG002|Double-Blind Period|Protocol Violation|0|||
131601302|NCT02723591|473832618|FG001|Overall Study|Lost to Follow-up|7|||
131601303|NCT02723591|473832617|FG000|Overall Study|Protocol Violation|20|||
131601304|NCT02723591|473832618|FG001|Overall Study|Protocol Violation|23|||
131601305|NCT02723591|473832617|FG000|Overall Study|Withdrawal by Subject|4|||
131601306|NCT02723591|473832618|FG001|Overall Study|Withdrawal by Subject|8|||
131440317|NCT00179621|473241462|FG003|Double-Blind Period|Protocol Violation|0|||
131440318|NCT00179621|473241459|FG000|Double-Blind Period|Other|0|||
131440319|NCT00179621|473241460|FG001|Double-Blind Period|Other|2|||
131706799|NCT00600171|474209241|FG005|Overall Study|Physician Decision|2|||
131440320|NCT00179621|473241461|FG002|Double-Blind Period|Other|2|||
131440321|NCT00179621|473241462|FG003|Double-Blind Period|Other|0|||
131440322|NCT00179621|473241459|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
131440323|NCT00179621|473241460|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
131440324|NCT00179621|473241461|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
131440325|NCT00179621|473241462|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
131440326|NCT00179621|473241459|FG000|Open-Label Period|Adverse Event|0|||
131440327|NCT00179621|473241460|FG001|Open-Label Period|Adverse Event|6|||
131440328|NCT00179621|473241461|FG002|Open-Label Period|Adverse Event|5|||
131601307|NCT02723591|473832617|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
131601308|NCT02723591|473832618|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
131601309|NCT02723591|473832617|FG000|Overall Study|Miscellaneous|5|||
131601310|NCT02723591|473832618|FG001|Overall Study|Miscellaneous|6|||
131601311|NCT03511664|473832621|FG000|Overall Study|Death|457|||
131601312|NCT03511664|473832622|FG001|Overall Study|Death|201|||
131440329|NCT00179621|473241462|FG003|Open-Label Period|Adverse Event|6|||
131440330|NCT00179621|473241459|FG000|Open-Label Period|Withdrawal by Subject|0|||
131440331|NCT00179621|473241460|FG001|Open-Label Period|Withdrawal by Subject|2|||
131601313|NCT03511664|473832623|FG002|Overall Study|Death|21|||
131601314|NCT03511664|473832621|FG000|Overall Study|Withdrew consent|40|||
131601315|NCT03511664|473832622|FG001|Overall Study|Withdrew consent|63|||
131601316|NCT03511664|473832623|FG002|Overall Study|Withdrew consent|3|||
131601317|NCT03511664|473832621|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
131601318|NCT03511664|473832622|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
131601319|NCT03511664|473832623|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
131601320|NCT03511664|473832621|FG000|Overall Study|Lost to Follow-up|8|||
131601321|NCT03511664|473832622|FG001|Overall Study|Lost to Follow-up|5|||
131601322|NCT03511664|473832623|FG002|Overall Study|Lost to Follow-up|0|||
131601323|NCT03511664|473832621|FG000|Overall Study|Physician Decision|2|||
131601324|NCT03511664|473832622|FG001|Overall Study|Physician Decision|1|||
131601325|NCT03511664|473832623|FG002|Overall Study|Physician Decision|0|||
131601326|NCT03511664|473832621|FG000|Overall Study|Patient non-compliance|1|||
131601327|NCT03511664|473832622|FG001|Overall Study|Patient non-compliance|0|||
131601328|NCT03511664|473832623|FG002|Overall Study|Patient non-compliance|0|||
131601329|NCT04081103|473832628|FG000|Overall Study|Adverse Event|1|||
131601330|NCT04081103|473832629|FG001|Overall Study|Adverse Event|1|||
131601331|NCT04081103|473832630|FG002|Overall Study|Adverse Event|1|||
131601332|NCT04081103|473832628|FG000|Overall Study|Physician Decision|0|||
131601333|NCT04081103|473832629|FG001|Overall Study|Physician Decision|0|||
131601334|NCT04081103|473832630|FG002|Overall Study|Physician Decision|1|||
131601335|NCT05209152|473832633|FG000|Overall Study|Sponsor decision|1|||
131601336|NCT05209152|473832634|FG001|Overall Study|Sponsor decision|2|||
131601337|NCT05209152|473832633|FG000|Overall Study|Death|3|||
131601338|NCT05209152|473832634|FG001|Overall Study|Death|1|||
131601339|NCT03287817|473834254|FG000|Overall Study|Progressive disease|4|||
131601340|NCT03287817|473834255|FG001|Overall Study|Progressive disease|2|||
131601341|NCT03287817|473834256|FG002|Overall Study|Progressive disease|3|||
131601342|NCT03287817|473834257|FG003|Overall Study|Progressive disease|10|||
131601343|NCT03287817|473834258|FG004|Overall Study|Progressive disease|8|||
131601344|NCT03287817|473834254|FG000|Overall Study|Death|0|||
131601345|NCT03287817|473834255|FG001|Overall Study|Death|0|||
131440332|NCT00179621|473241461|FG002|Open-Label Period|Withdrawal by Subject|2|||
131440333|NCT00179621|473241462|FG003|Open-Label Period|Withdrawal by Subject|2|||
131440334|NCT00179621|473241459|FG000|Open-Label Period|Death|0|||
131440335|NCT00179621|473241460|FG001|Open-Label Period|Death|0|||
131440336|NCT00179621|473241461|FG002|Open-Label Period|Death|1|||
131440337|NCT00179621|473241462|FG003|Open-Label Period|Death|2|||
131440338|NCT00179621|473241459|FG000|Open-Label Period|Other|0|||
131440339|NCT00179621|473241460|FG001|Open-Label Period|Other|1|||
131601346|NCT03287817|473834256|FG002|Overall Study|Death|2|||
131706800|NCT00600171|474209236|FG000|Overall Study|Lost to Follow-up|0|||
131440340|NCT00179621|473241461|FG002|Open-Label Period|Other|1|||
131440341|NCT00179621|473241462|FG003|Open-Label Period|Other|2|||
131601347|NCT03287817|473834257|FG003|Overall Study|Death|3|||
131601348|NCT03287817|473834258|FG004|Overall Study|Death|4|||
131601349|NCT03287817|473834254|FG000|Overall Study|Physician Decision|0|||
131601350|NCT03287817|473834255|FG001|Overall Study|Physician Decision|0|||
131601351|NCT03287817|473834256|FG002|Overall Study|Physician Decision|0|||
131601352|NCT03287817|473834257|FG003|Overall Study|Physician Decision|1|||
131601353|NCT03287817|473834258|FG004|Overall Study|Physician Decision|0|||
131601354|NCT03287817|473834254|FG000|Overall Study|Withdrawal by Subject|0|||
131440342|NCT04235140|473241470|FG000|Overall Study|Adverse Event|2|||
131440343|NCT04235140|473241470|FG000|Overall Study|Lost to Follow-up|1|||
131440344|NCT04235140|473241470|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
131440345|NCT04235140|473241470|FG000|Overall Study|Commercial drug is available for participants|7|||
131440346|NCT00672555|473241471|FG000|Overall Study|Lost to Follow-up|4|||
131601355|NCT03287817|473834255|FG001|Overall Study|Withdrawal by Subject|0|||
131601356|NCT03287817|473834256|FG002|Overall Study|Withdrawal by Subject|0|||
131601357|NCT03287817|473834257|FG003|Overall Study|Withdrawal by Subject|0|||
131601358|NCT03287817|473834258|FG004|Overall Study|Withdrawal by Subject|4|||
131601359|NCT00433329|473834265|FG000|Overall Study|Adverse Event|9|||
131601360|NCT00433329|473834265|FG000|Overall Study|Death|4|||
131601361|NCT00433329|473834265|FG000|Overall Study|Withdrew consent|3|||
131601362|NCT00433329|473834265|FG000|Overall Study|Discontinued sildenafil|2|||
131601363|NCT00433329|473834265|FG000|Overall Study|Moved out of state|1|||
131601364|NCT00433329|473834265|FG000|Overall Study|Lost to Follow-up|1|||
131601365|NCT00433329|473834265|FG000|Overall Study|Physician Decision|1|||
131601366|NCT03854227|473834266|FG000|Overall Study|Adverse Event|0|||
131601367|NCT03854227|473834267|FG001|Overall Study|Adverse Event|0|||
131601368|NCT03854227|473834268|FG002|Overall Study|Adverse Event|0|||
131601369|NCT03854227|473834269|FG003|Overall Study|Adverse Event|1|||
131601370|NCT03854227|473834270|FG004|Overall Study|Adverse Event|0|||
131601371|NCT03854227|473834271|FG005|Overall Study|Adverse Event|0|||
131601372|NCT03854227|473834272|FG006|Overall Study|Adverse Event|1|||
131601373|NCT03854227|473834273|FG007|Overall Study|Adverse Event|0|||
131601374|NCT03854227|473834274|FG008|Overall Study|Adverse Event|0|||
131601375|NCT03854227|473834275|FG009|Overall Study|Adverse Event|3|||
131601376|NCT03854227|473834276|FG010|Overall Study|Adverse Event|0|||
131601377|NCT03854227|473834277|FG011|Overall Study|Adverse Event|1|||
131601378|NCT03854227|473834266|FG000|Overall Study|Death|0|||
131601379|NCT03854227|473834267|FG001|Overall Study|Death|0|||
131601380|NCT03854227|473834268|FG002|Overall Study|Death|0|||
131601381|NCT03854227|473834269|FG003|Overall Study|Death|0|||
131601382|NCT03854227|473834270|FG004|Overall Study|Death|0|||
131601383|NCT03854227|473834271|FG005|Overall Study|Death|1|||
131601384|NCT03854227|473834272|FG006|Overall Study|Death|0|||
131601385|NCT03854227|473834273|FG007|Overall Study|Death|0|||
131601386|NCT03854227|473834274|FG008|Overall Study|Death|0|||
131601387|NCT03854227|473834275|FG009|Overall Study|Death|1|||
131601388|NCT03854227|473834276|FG010|Overall Study|Death|0|||
131601389|NCT03854227|473834277|FG011|Overall Study|Death|1|||
131601390|NCT03854227|473834266|FG000|Overall Study|Physician Decision|0|||
131601391|NCT03854227|473834267|FG001|Overall Study|Physician Decision|0|||
131601392|NCT03854227|473834268|FG002|Overall Study|Physician Decision|0|||
131601393|NCT03854227|473834269|FG003|Overall Study|Physician Decision|0|||
131601394|NCT03854227|473834270|FG004|Overall Study|Physician Decision|0|||
131601395|NCT03854227|473834271|FG005|Overall Study|Physician Decision|1|||
131601396|NCT03854227|473834272|FG006|Overall Study|Physician Decision|0|||
131601397|NCT03854227|473834273|FG007|Overall Study|Physician Decision|0|||
131601398|NCT03854227|473834274|FG008|Overall Study|Physician Decision|1|||
131601399|NCT03854227|473834275|FG009|Overall Study|Physician Decision|1|||
131601400|NCT03854227|473834276|FG010|Overall Study|Physician Decision|0|||
131601401|NCT03854227|473834277|FG011|Overall Study|Physician Decision|1|||
131601402|NCT03854227|473834266|FG000|Overall Study|Progressive disease|1|||
131601403|NCT03854227|473834267|FG001|Overall Study|Progressive disease|1|||
131601404|NCT03854227|473834268|FG002|Overall Study|Progressive disease|1|||
131601405|NCT03854227|473834269|FG003|Overall Study|Progressive disease|2|||
131601406|NCT03854227|473834270|FG004|Overall Study|Progressive disease|3|||
131601407|NCT03854227|473834271|FG005|Overall Study|Progressive disease|1|||
131601408|NCT03854227|473834272|FG006|Overall Study|Progressive disease|2|||
131601409|NCT03854227|473834273|FG007|Overall Study|Progressive disease|5|||
131601410|NCT03854227|473834274|FG008|Overall Study|Progressive disease|2|||
131601411|NCT03854227|473834275|FG009|Overall Study|Progressive disease|5|||
131601412|NCT03854227|473834276|FG010|Overall Study|Progressive disease|1|||
131601413|NCT03854227|473834277|FG011|Overall Study|Progressive disease|6|||
131706801|NCT00600171|474209237|FG001|Overall Study|Lost to Follow-up|0|||
131601414|NCT03854227|473834266|FG000|Overall Study|Study terminated by sponsor|0|||
131601415|NCT03854227|473834267|FG001|Overall Study|Study terminated by sponsor|0|||
131601416|NCT03854227|473834268|FG002|Overall Study|Study terminated by sponsor|0|||
131601417|NCT03854227|473834269|FG003|Overall Study|Study terminated by sponsor|0|||
131601418|NCT03854227|473834270|FG004|Overall Study|Study terminated by sponsor|0|||
131601419|NCT03854227|473834271|FG005|Overall Study|Study terminated by sponsor|0|||
131601420|NCT03854227|473834272|FG006|Overall Study|Study terminated by sponsor|0|||
131601421|NCT03854227|473834273|FG007|Overall Study|Study terminated by sponsor|0|||
131601422|NCT03854227|473834274|FG008|Overall Study|Study terminated by sponsor|0|||
131601423|NCT03854227|473834275|FG009|Overall Study|Study terminated by sponsor|1|||
131601424|NCT03854227|473834276|FG010|Overall Study|Study terminated by sponsor|0|||
131601425|NCT03854227|473834277|FG011|Overall Study|Study terminated by sponsor|0|||
131601426|NCT03854227|473834266|FG000|Overall Study|Withdrawal by Subject|0|||
131601427|NCT03854227|473834267|FG001|Overall Study|Withdrawal by Subject|0|||
131601428|NCT03854227|473834268|FG002|Overall Study|Withdrawal by Subject|1|||
131601429|NCT03854227|473834269|FG003|Overall Study|Withdrawal by Subject|0|||
131601430|NCT03854227|473834270|FG004|Overall Study|Withdrawal by Subject|0|||
131601431|NCT03854227|473834271|FG005|Overall Study|Withdrawal by Subject|0|||
131601432|NCT03854227|473834272|FG006|Overall Study|Withdrawal by Subject|0|||
131601433|NCT03854227|473834273|FG007|Overall Study|Withdrawal by Subject|0|||
131601434|NCT03854227|473834274|FG008|Overall Study|Withdrawal by Subject|0|||
131601435|NCT03854227|473834275|FG009|Overall Study|Withdrawal by Subject|1|||
131601436|NCT03854227|473834276|FG010|Overall Study|Withdrawal by Subject|1|||
131601437|NCT03854227|473834277|FG011|Overall Study|Withdrawal by Subject|0|||
131601438|NCT03854227|473834266|FG000|Overall Study|Disease relapse|0|||
131601439|NCT03854227|473834267|FG001|Overall Study|Disease relapse|0|||
131601440|NCT03854227|473834268|FG002|Overall Study|Disease relapse|0|||
131601441|NCT03854227|473834269|FG003|Overall Study|Disease relapse|0|||
131601442|NCT03854227|473834270|FG004|Overall Study|Disease relapse|0|||
131601443|NCT03854227|473834271|FG005|Overall Study|Disease relapse|0|||
131601444|NCT03854227|473834272|FG006|Overall Study|Disease relapse|0|||
131601445|NCT03854227|473834273|FG007|Overall Study|Disease relapse|0|||
131601446|NCT03854227|473834274|FG008|Overall Study|Disease relapse|1|||
131601447|NCT03854227|473834275|FG009|Overall Study|Disease relapse|0|||
131601448|NCT03854227|473834276|FG010|Overall Study|Disease relapse|0|||
131601449|NCT03854227|473834277|FG011|Overall Study|Disease relapse|0|||
131601450|NCT03854227|473834266|FG000|Overall Study|Global deterioration of health status|0|||
131601451|NCT03854227|473834267|FG001|Overall Study|Global deterioration of health status|0|||
131601452|NCT03854227|473834268|FG002|Overall Study|Global deterioration of health status|0|||
131601453|NCT03854227|473834269|FG003|Overall Study|Global deterioration of health status|0|||
131601454|NCT03854227|473834270|FG004|Overall Study|Global deterioration of health status|0|||
131601455|NCT03854227|473834271|FG005|Overall Study|Global deterioration of health status|1|||
131601456|NCT03854227|473834272|FG006|Overall Study|Global deterioration of health status|0|||
131601457|NCT03854227|473834273|FG007|Overall Study|Global deterioration of health status|1|||
131601458|NCT03854227|473834274|FG008|Overall Study|Global deterioration of health status|0|||
131601459|NCT03854227|473834275|FG009|Overall Study|Global deterioration of health status|0|||
131601460|NCT03854227|473834276|FG010|Overall Study|Global deterioration of health status|0|||
131601461|NCT03854227|473834277|FG011|Overall Study|Global deterioration of health status|0|||
131601462|NCT03854227|473834266|FG000|Overall Study|Refused further treatment|0|||
131601463|NCT03854227|473834267|FG001|Overall Study|Refused further treatment|0|||
131601464|NCT03854227|473834268|FG002|Overall Study|Refused further treatment|0|||
131601465|NCT03854227|473834269|FG003|Overall Study|Refused further treatment|0|||
131601466|NCT03854227|473834270|FG004|Overall Study|Refused further treatment|0|||
131601467|NCT03854227|473834271|FG005|Overall Study|Refused further treatment|0|||
131601468|NCT03854227|473834272|FG006|Overall Study|Refused further treatment|0|||
131601469|NCT03854227|473834273|FG007|Overall Study|Refused further treatment|0|||
131601470|NCT03854227|473834274|FG008|Overall Study|Refused further treatment|0|||
131706802|NCT00600171|474209238|FG002|Overall Study|Lost to Follow-up|0|||
131706803|NCT00600171|474209239|FG003|Overall Study|Lost to Follow-up|1|||
131601471|NCT03854227|473834275|FG009|Overall Study|Refused further treatment|1|||
131706804|NCT00600171|474209240|FG004|Overall Study|Lost to Follow-up|0|||
131601472|NCT03854227|473834276|FG010|Overall Study|Refused further treatment|0|||
131601473|NCT03854227|473834277|FG011|Overall Study|Refused further treatment|1|||
131601474|NCT03854227|473834266|FG000|Overall Study|Other|0|||
131601475|NCT03854227|473834267|FG001|Overall Study|Other|0|||
131601476|NCT03854227|473834268|FG002|Overall Study|Other|0|||
131601477|NCT03854227|473834269|FG003|Overall Study|Other|0|||
131601478|NCT03854227|473834270|FG004|Overall Study|Other|0|||
131601479|NCT03854227|473834271|FG005|Overall Study|Other|0|||
131440347|NCT00672555|473241471|FG000|Overall Study|Did not want to answer questionnaire|2|||
131440348|NCT00419393|473241472|FG000|Overall Study|Adverse Event|5|||
131601480|NCT03854227|473834272|FG006|Overall Study|Other|0|||
131601481|NCT03854227|473834273|FG007|Overall Study|Other|0|||
131601482|NCT03854227|473834274|FG008|Overall Study|Other|1|||
131601483|NCT03854227|473834275|FG009|Overall Study|Other|1|||
131601484|NCT03854227|473834276|FG010|Overall Study|Other|0|||
131601485|NCT03854227|473834277|FG011|Overall Study|Other|0|||
131601486|NCT04376502|473834283|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
131601487|NCT03748953|473834284|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
131601488|NCT03748953|473834285|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
131601489|NCT03748953|473834284|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
131601490|NCT03748953|473834285|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
131601491|NCT03748953|473834284|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
131601492|NCT03748953|473834285|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
131601493|NCT03748953|473834284|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
131601494|NCT03748953|473834285|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
131601495|NCT03748953|473834284|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
131601496|NCT03748953|473834285|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
131601497|NCT02841579|473834286|FG000|Overall Study|Death|1|||
131601498|NCT02841579|473834286|FG000|Overall Study|Adverse Event|1|||
131601499|NCT02841579|473834286|FG000|Overall Study|Lack of Efficacy|9|||
131706805|NCT00600171|474209241|FG005|Overall Study|Lost to Follow-up|0|||
131601500|NCT04233216|473834287|FG000|Overall Study|Lost to Follow-up|1|||
131601501|NCT04233216|473834288|FG001|Overall Study|Lost to Follow-up|0|||
131601502|NCT04233216|473834289|FG002|Overall Study|Lost to Follow-up|2|||
131601503|NCT04233216|473834290|FG003|Overall Study|Lost to Follow-up|0|||
131601504|NCT04233216|473834287|FG000|Overall Study|Physician Decision|0|||
131601505|NCT04233216|473834288|FG001|Overall Study|Physician Decision|3|||
131601506|NCT04233216|473834289|FG002|Overall Study|Physician Decision|0|||
131601507|NCT04233216|473834290|FG003|Overall Study|Physician Decision|2|||
131601508|NCT04233216|473834287|FG000|Overall Study|Withdrawal by Subject|0|||
131601509|NCT04233216|473834288|FG001|Overall Study|Withdrawal by Subject|2|||
131601510|NCT04233216|473834289|FG002|Overall Study|Withdrawal by Subject|1|||
131601511|NCT04233216|473834290|FG003|Overall Study|Withdrawal by Subject|0|||
131601512|NCT01501955|473834291|FG000|Overall Study|Withdrawal by Subject|1|||
131601513|NCT01501955|473834292|FG001|Overall Study|Withdrawal by Subject|0|||
131601514|NCT01501955|473834291|FG000|Overall Study|Adverse Event|1|||
131601515|NCT01501955|473834292|FG001|Overall Study|Adverse Event|3|||
131601516|NCT04314713|473834295|FG000|Overall Study|Lost to Follow-up|0|||
131601517|NCT04314713|473834296|FG001|Overall Study|Lost to Follow-up|0|||
131601518|NCT04314713|473834297|FG002|Overall Study|Lost to Follow-up|0|||
131601519|NCT04314713|473834298|FG003|Overall Study|Lost to Follow-up|1|||
131601520|NCT04314713|473834299|FG004|Overall Study|Lost to Follow-up|0|||
131601521|NCT04314713|473834300|FG005|Overall Study|Lost to Follow-up|0|||
131601522|NCT05670587|473834303|FG000|Overall Study|Withdrawal by Subject|3|||
131601523|NCT05073458|473834305|FG000|24-week Double-blind Period|Adverse Event|1|||
131601524|NCT05073458|473834306|FG001|24-week Double-blind Period|Adverse Event|0|||
131601525|NCT05073458|473834305|FG000|24-week Double-blind Period|Physician Decision|1|||
131601526|NCT05073458|473834306|FG001|24-week Double-blind Period|Physician Decision|0|||
131601527|NCT05073458|473834305|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
131601528|NCT05073458|473834306|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
131601529|NCT05073458|473834305|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
131601530|NCT05073458|473834306|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
131601531|NCT05073458|473834305|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
131601532|NCT05073458|473834306|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
131601533|NCT05073458|473834305|FG000|24-week Open-label Period|Adverse Event|1|||
131601534|NCT05073458|473834306|FG001|24-week Open-label Period|Adverse Event|2|||
131601535|NCT03235544|473834315|FG000|Overall Study|Death|11|||
131601536|NCT03235544|473834316|FG001|Overall Study|Death|31|||
131601537|NCT03235544|473834317|FG002|Overall Study|Death|19|||
131601538|NCT03235544|473834318|FG003|Overall Study|Death|34|||
131601539|NCT03235544|473834315|FG000|Overall Study|Lost to Follow-up|0|||
131601540|NCT03235544|473834316|FG001|Overall Study|Lost to Follow-up|1|||
131601541|NCT03235544|473834317|FG002|Overall Study|Lost to Follow-up|1|||
131601542|NCT03235544|473834318|FG003|Overall Study|Lost to Follow-up|1|||
131601543|NCT03235544|473834315|FG000|Overall Study|Withdrawal by Subject|0|||
131601544|NCT03235544|473834316|FG001|Overall Study|Withdrawal by Subject|3|||
131601545|NCT03235544|473834317|FG002|Overall Study|Withdrawal by Subject|1|||
131601546|NCT03235544|473834318|FG003|Overall Study|Withdrawal by Subject|5|||
131601547|NCT03235544|473834315|FG000|Overall Study|Disease Progression|0|||
131601548|NCT03235544|473834316|FG001|Overall Study|Disease Progression|1|||
131601549|NCT03235544|473834317|FG002|Overall Study|Disease Progression|0|||
131601550|NCT03235544|473834318|FG003|Overall Study|Disease Progression|2|||
131601551|NCT03235544|473834315|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
131601552|NCT03235544|473834316|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
131601553|NCT03235544|473834317|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
131601554|NCT03235544|473834318|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
131601555|NCT03235544|473834315|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
131601556|NCT03235544|473834316|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
131601557|NCT03235544|473834317|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
131601558|NCT03235544|473834318|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
131601559|NCT04850898|473834321|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
131601560|NCT04850898|473834322|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
131601561|NCT03701763|473834323|FG000|Placebo-controlled Phase|Adverse Event|1|||
131601562|NCT03701763|473834324|FG001|Placebo-controlled Phase|Adverse Event|5|||
131601563|NCT03701763|473834325|FG002|Placebo-controlled Phase|Adverse Event|0|||
131601564|NCT03701763|473834326|FG003|Placebo-controlled Phase|Adverse Event|0|||
131601565|NCT03701763|473834323|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
131601566|NCT03701763|473834324|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
131601567|NCT03701763|473834325|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
131601568|NCT03701763|473834326|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
131899683|NCT02659943|474919374|FG001|Overall Study|Switched to alternative treatment|1|||
131601569|NCT03701763|473834323|FG000|Placebo-controlled Phase|Miscellaneous|2|||
131899684|NCT02659943|474919375|FG002|Overall Study|Switched to alternative treatment|0|||
131899685|NCT02659943|474919376|FG003|Overall Study|Switched to alternative treatment|2|||
131601570|NCT03701763|473834324|FG001|Placebo-controlled Phase|Miscellaneous|0|||
131601571|NCT03701763|473834325|FG002|Placebo-controlled Phase|Miscellaneous|0|||
131601572|NCT03701763|473834326|FG003|Placebo-controlled Phase|Miscellaneous|0|||
131601573|NCT03701763|473834323|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
131601574|NCT03701763|473834324|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
131601575|NCT03701763|473834325|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
131601576|NCT03701763|473834326|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
131601577|NCT03701763|473834323|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
131601578|NCT03701763|473834324|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
131601579|NCT03701763|473834325|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
131601580|NCT03701763|473834326|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
131601581|NCT03701763|473834323|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
131601582|NCT03701763|473834324|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
131601583|NCT03701763|473834325|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
131601584|NCT03701763|473834326|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
131601585|NCT03701763|473834323|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
131601586|NCT03701763|473834324|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
131601587|NCT03701763|473834325|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
131601588|NCT03701763|473834326|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
131601589|NCT03701763|473834323|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
131601590|NCT03701763|473834324|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
131601591|NCT03701763|473834325|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
131601592|NCT03701763|473834326|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
131601593|NCT03701763|473834323|FG000|Apremilast Extension Phase|Adverse Event|0|||
131601594|NCT03701763|473834324|FG001|Apremilast Extension Phase|Adverse Event|0|||
131601595|NCT03701763|473834325|FG002|Apremilast Extension Phase|Adverse Event|3|||
131601596|NCT03701763|473834326|FG003|Apremilast Extension Phase|Adverse Event|1|||
131601597|NCT03701763|473834323|FG000|Apremilast Extension Phase|Miscellaneous|0|||
131601598|NCT03701763|473834324|FG001|Apremilast Extension Phase|Miscellaneous|0|||
131601599|NCT03701763|473834325|FG002|Apremilast Extension Phase|Miscellaneous|2|||
131601600|NCT03701763|473834326|FG003|Apremilast Extension Phase|Miscellaneous|1|||
131601601|NCT03701763|473834323|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
131601602|NCT03701763|473834324|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
131601603|NCT03701763|473834325|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
131601604|NCT03701763|473834326|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
131601605|NCT03701763|473834323|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
131601606|NCT03701763|473834324|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
131601607|NCT03701763|473834325|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
131601608|NCT03701763|473834326|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
131601609|NCT03701763|473834323|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
131601610|NCT03701763|473834324|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
131601611|NCT03701763|473834325|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
131601612|NCT03701763|473834326|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
131601613|NCT03701763|473834323|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
131601614|NCT03701763|473834324|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
131601615|NCT03701763|473834325|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
131601616|NCT03701763|473834326|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
131601617|NCT03701763|473834323|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
131601618|NCT03701763|473834324|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
131601619|NCT03701763|473834325|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
131601620|NCT03701763|473834326|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
131601621|NCT03701763|473834323|FG000|14-Week Observational Follow-up Phase|Other|0|||
131601622|NCT03701763|473834324|FG001|14-Week Observational Follow-up Phase|Other|0|||
131601623|NCT03701763|473834325|FG002|14-Week Observational Follow-up Phase|Other|1|||
131601624|NCT03701763|473834326|FG003|14-Week Observational Follow-up Phase|Other|0|||
131601625|NCT03701763|473834323|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
131601626|NCT03701763|473834324|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
131601627|NCT03701763|473834325|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
131601628|NCT03701763|473834326|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
131601629|NCT03701763|473834323|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
131601630|NCT03701763|473834324|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
131601631|NCT03701763|473834325|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
131601632|NCT03701763|473834326|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
131601633|NCT06473662|473834334|FG000|Overall Study|Withdrawal by Subject|1|||
131601634|NCT06473662|473834335|FG001|Overall Study|Withdrawal by Subject|6|||
131601635|NCT06473662|473834336|FG002|Overall Study|Withdrawal by Subject|5|||
131601636|NCT06473662|473834334|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
131601637|NCT06473662|473834335|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
131899686|NCT02659943|474919377|FG004|Overall Study|Switched to alternative treatment|1|||
131899687|NCT02659943|474919378|FG005|Overall Study|Switched to alternative treatment|0|||
131601638|NCT06473662|473834336|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
131601639|NCT06473662|473834334|FG000|Overall Study|Starting HbA1c below 7%|0|||
131601640|NCT06473662|473834335|FG001|Overall Study|Starting HbA1c below 7%|1|||
131601641|NCT06473662|473834336|FG002|Overall Study|Starting HbA1c below 7%|1|||
131601642|NCT06473662|473834334|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
131601643|NCT06473662|473834335|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
131601644|NCT06473662|473834336|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
131601645|NCT06473662|473834334|FG000|Overall Study|Did not take medication|2|||
131601646|NCT06473662|473834335|FG001|Overall Study|Did not take medication|3|||
131601647|NCT06473662|473834336|FG002|Overall Study|Did not take medication|2|||
131601648|NCT03463044|473834339|FG000|Overall Study|Lost to Follow-up|0|||
131601649|NCT03463044|473834340|FG001|Overall Study|Lost to Follow-up|0|||
131601650|NCT03463044|473834341|FG002|Overall Study|Lost to Follow-up|0|||
131601651|NCT03463044|473834342|FG003|Overall Study|Lost to Follow-up|0|||
131601652|NCT03463044|473834343|FG004|Overall Study|Lost to Follow-up|0|||
131601653|NCT03463044|473834344|FG005|Overall Study|Lost to Follow-up|0|||
131601654|NCT03463044|473834345|FG006|Overall Study|Lost to Follow-up|0|||
131601655|NCT03463044|473834346|FG007|Overall Study|Lost to Follow-up|1|||
131601656|NCT03463044|473834347|FG008|Overall Study|Lost to Follow-up|0|||
131601657|NCT05192109|473834348|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
131601658|NCT05192109|473834349|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
131601659|NCT05192109|473834350|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131601660|NCT05192109|473834351|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131601661|NCT05192109|473834348|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
131601662|NCT05192109|473834349|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
131601663|NCT05192109|473834350|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131601664|NCT05192109|473834351|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131601665|NCT04498390|473834352|FG000|Overall Study|Adverse Event|0|||
131601666|NCT04498390|473834353|FG001|Overall Study|Adverse Event|0|||
131601667|NCT04498390|473834354|FG002|Overall Study|Adverse Event|1|||
131601668|NCT04498390|473834355|FG003|Overall Study|Adverse Event|0|||
131601669|NCT04498390|473834356|FG004|Overall Study|Adverse Event|0|||
131601670|NCT04498390|473834352|FG000|Overall Study|Withdrawal by Subject|0|||
131601671|NCT04498390|473834353|FG001|Overall Study|Withdrawal by Subject|0|||
131601672|NCT04498390|473834354|FG002|Overall Study|Withdrawal by Subject|0|||
131601673|NCT04498390|473834355|FG003|Overall Study|Withdrawal by Subject|1|||
131601674|NCT04498390|473834356|FG004|Overall Study|Withdrawal by Subject|0|||
131440349|NCT00419393|473241472|FG000|Overall Study|Protocol Violation|5|||
131440350|NCT00419393|473241472|FG000|Overall Study|Withdrawal by Subject|7|||
131440351|NCT00419393|473241472|FG000|Overall Study|Other: Sponsor request|3|||
131440352|NCT00419393|473241472|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
131601675|NCT04515849|473834357|FG000|Overall Study|Adverse Event|0|||
131601676|NCT04515849|473834358|FG001|Overall Study|Adverse Event|0|||
131601677|NCT04515849|473834359|FG002|Overall Study|Adverse Event|0|||
131601678|NCT04515849|473834360|FG003|Overall Study|Adverse Event|1|||
131601679|NCT04515849|473834361|FG004|Overall Study|Adverse Event|2|||
131601680|NCT04515849|473834357|FG000|Overall Study|Death|2|||
131601681|NCT04515849|473834358|FG001|Overall Study|Death|0|||
131601682|NCT04515849|473834359|FG002|Overall Study|Death|0|||
131601683|NCT04515849|473834360|FG003|Overall Study|Death|0|||
131601684|NCT04515849|473834361|FG004|Overall Study|Death|0|||
131601685|NCT04515849|473834357|FG000|Overall Study|Other:family emergency|0|||
131601686|NCT04515849|473834358|FG001|Overall Study|Other:family emergency|0|||
131601687|NCT04515849|473834359|FG002|Overall Study|Other:family emergency|0|||
131601688|NCT04515849|473834360|FG003|Overall Study|Other:family emergency|1|||
131601689|NCT04515849|473834361|FG004|Overall Study|Other:family emergency|0|||
131601690|NCT04515849|473834357|FG000|Overall Study|Other:randomised by error|0|||
131601691|NCT04515849|473834358|FG001|Overall Study|Other:randomised by error|1|||
131601692|NCT04515849|473834359|FG002|Overall Study|Other:randomised by error|0|||
131601693|NCT04515849|473834360|FG003|Overall Study|Other:randomised by error|0|||
131601694|NCT04515849|473834361|FG004|Overall Study|Other:randomised by error|0|||
131601695|NCT04515849|473834357|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131601696|NCT04515849|473834358|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131601697|NCT04515849|473834359|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131601698|NCT04515849|473834360|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
131601699|NCT04515849|473834361|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131601700|NCT04515849|473834357|FG000|Overall Study|Physician Decision|0|||
131440353|NCT00419393|473241472|FG000|Overall Study|Other: Site closure|1|||
131440354|NCT00419393|473241472|FG000|Overall Study|Other: Other health problems|1|||
131601701|NCT04515849|473834358|FG001|Overall Study|Physician Decision|1|||
131601702|NCT04515849|473834359|FG002|Overall Study|Physician Decision|0|||
131601703|NCT04515849|473834360|FG003|Overall Study|Physician Decision|0|||
131601704|NCT04515849|473834361|FG004|Overall Study|Physician Decision|0|||
131601705|NCT04515849|473834357|FG000|Overall Study|Withdrawal by Subject|1|||
131601706|NCT04515849|473834358|FG001|Overall Study|Withdrawal by Subject|2|||
131601707|NCT04515849|473834359|FG002|Overall Study|Withdrawal by Subject|1|||
131601708|NCT04515849|473834360|FG003|Overall Study|Withdrawal by Subject|0|||
131601709|NCT04515849|473834361|FG004|Overall Study|Withdrawal by Subject|0|||
131601710|NCT03478956|473834375|FG000|Randomized Treatment Period|Adverse Event|1|||
131601711|NCT03478956|473834376|FG001|Randomized Treatment Period|Adverse Event|0|||
131601712|NCT03478956|473834377|FG002|Randomized Treatment Period|Adverse Event|0|||
131601713|NCT03478956|473834378|FG003|Randomized Treatment Period|Adverse Event|0|||
131601714|NCT03478956|473834375|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
131601715|NCT03478956|473834376|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
131601716|NCT03478956|473834377|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
131601717|NCT03478956|473834378|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
131601718|NCT03478956|473834375|FG000|Open Label Extension Period|Adverse Event|0|||
131601719|NCT03478956|473834376|FG001|Open Label Extension Period|Adverse Event|0|||
131601720|NCT03478956|473834377|FG002|Open Label Extension Period|Adverse Event|4|||
131601721|NCT03478956|473834378|FG003|Open Label Extension Period|Adverse Event|0|||
131601722|NCT03478956|473834375|FG000|Open Label Extension Period|Lack of Efficacy|0|||
131601723|NCT03478956|473834376|FG001|Open Label Extension Period|Lack of Efficacy|0|||
131601724|NCT03478956|473834377|FG002|Open Label Extension Period|Lack of Efficacy|8|||
131601725|NCT03478956|473834378|FG003|Open Label Extension Period|Lack of Efficacy|0|||
131601726|NCT03478956|473834375|FG000|Open Label Extension Period|Reason Not Provided|0|||
131601727|NCT03478956|473834376|FG001|Open Label Extension Period|Reason Not Provided|0|||
131601728|NCT03478956|473834377|FG002|Open Label Extension Period|Reason Not Provided|1|||
131601729|NCT03478956|473834378|FG003|Open Label Extension Period|Reason Not Provided|0|||
131601730|NCT03478956|473834375|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
131601731|NCT03478956|473834376|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
131601732|NCT03478956|473834377|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
131601733|NCT03478956|473834378|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
131601734|NCT03478956|473834375|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
131601735|NCT03478956|473834376|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
131601736|NCT03478956|473834377|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
131601737|NCT03478956|473834378|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
131601738|NCT03478956|473834375|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131601739|NCT03478956|473834376|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131601740|NCT03478956|473834377|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131601741|NCT03478956|473834378|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
131601742|NCT04865289|473834379|FG000|Overall Study|Participant ongoing in study|47|||
131601743|NCT04865289|473834380|FG001|Overall Study|Participant ongoing in study|35|||
131601744|NCT04865289|473834379|FG000|Overall Study|Death|27|||
131601745|NCT04865289|473834380|FG001|Overall Study|Death|21|||
131601746|NCT04577963|473834383|FG000|Part 2|Death|0|||
131601747|NCT04577963|473834384|FG001|Part 2|Death|1|||
131601748|NCT04577963|473834385|FG002|Part 2|Death|8|||
131601749|NCT04577963|473834386|FG003|Part 2|Death|0|||
131601750|NCT04577963|473834387|FG004|Part 2|Death|20|||
131601751|NCT04577963|473834383|FG000|Part 2|Lost to Follow-up|0|||
131601752|NCT04577963|473834384|FG001|Part 2|Lost to Follow-up|0|||
131601753|NCT04577963|473834385|FG002|Part 2|Lost to Follow-up|0|||
131601754|NCT04577963|473834386|FG003|Part 2|Lost to Follow-up|0|||
131601755|NCT04577963|473834387|FG004|Part 2|Lost to Follow-up|2|||
131601756|NCT04577963|473834383|FG000|Part 2|Withdrawal by Subject|0|||
131601757|NCT04577963|473834384|FG001|Part 2|Withdrawal by Subject|0|||
131601758|NCT04577963|473834385|FG002|Part 2|Withdrawal by Subject|0|||
131601759|NCT04577963|473834386|FG003|Part 2|Withdrawal by Subject|0|||
131601760|NCT04577963|473834387|FG004|Part 2|Withdrawal by Subject|10|||
131601761|NCT04577963|473834383|FG000|Part 2|Progressive disease|0|||
131601762|NCT04577963|473834384|FG001|Part 2|Progressive disease|0|||
131601763|NCT04577963|473834385|FG002|Part 2|Progressive disease|0|||
131601764|NCT04577963|473834386|FG003|Part 2|Progressive disease|0|||
131601765|NCT04577963|473834387|FG004|Part 2|Progressive disease|2|||
131601766|NCT04577963|473834383|FG000|Part 2|Investigator decision|0|||
131706806|NCT02367521|474209242|FG000|Overall Study|severe headache after intervention|2|||
131706807|NCT02367521|474209243|FG001|Overall Study|severe headache after intervention|0|||
131706808|NCT02367521|474209242|FG000|Overall Study|unable to find transportation|2|||
131706809|NCT02367521|474209243|FG001|Overall Study|unable to find transportation|0|||
131899688|NCT02659943|474919379|FG006|Overall Study|Switched to alternative treatment|1|||
131601767|NCT04577963|473834384|FG001|Part 2|Investigator decision|0|||
131601768|NCT04577963|473834385|FG002|Part 2|Investigator decision|0|||
131601769|NCT04577963|473834386|FG003|Part 2|Investigator decision|0|||
131601770|NCT04577963|473834387|FG004|Part 2|Investigator decision|1|||
131601771|NCT04577963|473834383|FG000|Part 2|Sponsor terminated study|0|||
131601772|NCT04577963|473834384|FG001|Part 2|Sponsor terminated study|0|||
131601773|NCT04577963|473834385|FG002|Part 2|Sponsor terminated study|3|||
131601774|NCT04577963|473834386|FG003|Part 2|Sponsor terminated study|1|||
131601775|NCT04577963|473834387|FG004|Part 2|Sponsor terminated study|4|||
131601776|NCT03034356|473834388|FG000|Baseline|Lost to Follow-up|2|||
131601777|NCT03034356|473834389|FG001|Baseline|Lost to Follow-up|4|||
131601778|NCT03034356|473834388|FG000|Baseline|Withdrawal by Subject|2|||
131601779|NCT03034356|473834389|FG001|Baseline|Withdrawal by Subject|0|||
131601780|NCT03034356|473834388|FG000|Baseline|Physician Decision|0|||
131601781|NCT03034356|473834389|FG001|Baseline|Physician Decision|1|||
131601782|NCT03034356|473834388|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
131601783|NCT03034356|473834389|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
131601784|NCT03034356|473834388|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
131601785|NCT03034356|473834389|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
131601786|NCT03034356|473834388|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
131601787|NCT03034356|473834389|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
131601788|NCT03034356|473834388|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
131899689|NCT02659943|474919373|FG000|Overall Study|Disease progression on study|0|||
131601789|NCT03034356|473834389|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
131601790|NCT02823145|473834390|FG000|Enrollment|Other|1|||
131601791|NCT02823145|473834391|FG001|Enrollment|Other|0|||
131601792|NCT02823145|473834390|FG000|Treatment|Adverse Event|0|||
131601793|NCT02823145|473834391|FG001|Treatment|Adverse Event|11|||
131601794|NCT02823145|473834390|FG000|Treatment|Death|0|||
131601795|NCT02823145|473834391|FG001|Treatment|Death|3|||
131601796|NCT02823145|473834390|FG000|Treatment|Family Decision|0|||
131601797|NCT02823145|473834391|FG001|Treatment|Family Decision|1|||
131601798|NCT02823145|473834390|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
131601799|NCT02823145|473834391|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
131601800|NCT02823145|473834390|FG000|Treatment|Lack of Efficacy|0|||
131601801|NCT02823145|473834391|FG001|Treatment|Lack of Efficacy|48|||
131601802|NCT02823145|473834390|FG000|Treatment|Non-Compliance With E-Diary|0|||
131601803|NCT02823145|473834391|FG001|Treatment|Non-Compliance With E-Diary|1|||
131601804|NCT02823145|473834390|FG000|Treatment|Physician Decision|0|||
131601805|NCT02823145|473834391|FG001|Treatment|Physician Decision|2|||
131601806|NCT02823145|473834390|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
131601807|NCT02823145|473834391|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
131601808|NCT02823145|473834390|FG000|Treatment|Subject needed to take prohibited medication|0|||
131601809|NCT02823145|473834391|FG001|Treatment|Subject needed to take prohibited medication|1|||
131601810|NCT02823145|473834390|FG000|Treatment|Subject transferred to direct access programme|0|||
131601811|NCT02823145|473834391|FG001|Treatment|Subject transferred to direct access programme|1|||
131601812|NCT02823145|473834390|FG000|Treatment|Switching to commercially available drug|0|||
131601813|NCT02823145|473834391|FG001|Treatment|Switching to commercially available drug|11|||
131601814|NCT02823145|473834390|FG000|Treatment|Transitioned to commercial supply of medication|0|||
131601815|NCT02823145|473834391|FG001|Treatment|Transitioned to commercial supply of medication|1|||
131601816|NCT02823145|473834390|FG000|Treatment|Withdrawal By Caregiver|0|||
131601817|NCT02823145|473834391|FG001|Treatment|Withdrawal By Caregiver|1|||
131601818|NCT02823145|473834390|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
131601819|NCT02823145|473834391|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
131601820|NCT02823145|473834390|FG000|Treatment|Withdrawal by Subject|0|||
131601821|NCT02823145|473834391|FG001|Treatment|Withdrawal by Subject|16|||
131601822|NCT02823145|473834390|FG000|Treatment|Reason unknown|0|||
131601823|NCT02823145|473834391|FG001|Treatment|Reason unknown|1|||
131601824|NCT05292391|473834392|FG000|Overall Study|Lost to Follow-up|0|||
131601825|NCT05292391|473834393|FG001|Overall Study|Lost to Follow-up|0|||
131601826|NCT05292391|473834394|FG002|Overall Study|Lost to Follow-up|0|||
131601827|NCT05292391|473834395|FG003|Overall Study|Lost to Follow-up|1|||
131601828|NCT05292391|473834396|FG004|Overall Study|Lost to Follow-up|0|||
131601829|NCT04857723|473834398|FG000|Overall Study|Withdrawal by Subject|2|||
131601830|NCT05809453|473836005|FG000|Overall Study|Withdrawal by Subject|1|||
131601831|NCT05809453|473836006|FG001|Overall Study|Withdrawal by Subject|0|||
131706810|NCT00542191|474209247|FG000|Overall Study|Death|3|||
131601832|NCT05809453|473836007|FG002|Overall Study|Withdrawal by Subject|0|||
131601833|NCT05809453|473836008|FG003|Overall Study|Withdrawal by Subject|0|||
131601834|NCT03257410|473836009|FG000|Overall Study|Adverse Event|2|||
131601835|NCT03257410|473836010|FG001|Overall Study|Adverse Event|3|||
131601836|NCT03257410|473836009|FG000|Overall Study|Protocol Violation|1|||
131601837|NCT03257410|473836010|FG001|Overall Study|Protocol Violation|2|||
131601838|NCT03257410|473836009|FG000|Overall Study|Lost to Follow-up|1|||
131601839|NCT03257410|473836010|FG001|Overall Study|Lost to Follow-up|0|||
131601840|NCT03257410|473836009|FG000|Overall Study|Withdrawal by Subject|1|||
131601841|NCT03257410|473836010|FG001|Overall Study|Withdrawal by Subject|2|||
131601842|NCT03257410|473836009|FG000|Overall Study|Physician Decision|1|||
131601843|NCT03257410|473836010|FG001|Overall Study|Physician Decision|1|||
131601844|NCT03257410|473836009|FG000|Overall Study|Renal transplantation|2|||
131601845|NCT03257410|473836010|FG001|Overall Study|Renal transplantation|0|||
131601846|NCT03257410|473836009|FG000|Overall Study|Switch to peritoneal dialysis|1|||
131601847|NCT03257410|473836010|FG001|Overall Study|Switch to peritoneal dialysis|0|||
131601848|NCT03257410|473836009|FG000|Overall Study|Death|3|||
131601849|NCT03257410|473836010|FG001|Overall Study|Death|2|||
131601850|NCT03257410|473836009|FG000|Overall Study|Change to another dialysis center|2|||
131601851|NCT03257410|473836010|FG001|Overall Study|Change to another dialysis center|2|||
131601852|NCT03257410|473836009|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
131601853|NCT03257410|473836010|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
131601854|NCT03257410|473836009|FG000|Overall Study|Miscellaneous|2|||
131601855|NCT03257410|473836010|FG001|Overall Study|Miscellaneous|2|||
131601856|NCT03257410|473836009|FG000|Overall Study|Other|0|||
131601857|NCT03257410|473836010|FG001|Overall Study|Other|1|||
131601858|NCT03668236|473836011|FG000|90-day Follow-up|Withdrawal by Subject|3|||
131601859|NCT03668236|473836012|FG001|90-day Follow-up|Withdrawal by Subject|2|||
131601860|NCT03668236|473836011|FG000|90-day Follow-up|Lost to Follow-up|3|||
131601861|NCT03668236|473836012|FG001|90-day Follow-up|Lost to Follow-up|1|||
131601862|NCT03668236|473836011|FG000|Baseline Characteristics|Lost to Follow-up|9|||
131601863|NCT03668236|473836012|FG001|Baseline Characteristics|Lost to Follow-up|5|||
131601864|NCT03668236|473836011|FG000|1-year Follow-up|Withdrawal by Subject|17|||
131601865|NCT03668236|473836012|FG001|1-year Follow-up|Withdrawal by Subject|15|||
131601866|NCT06132282|473836013|FG000|Overall Study|Lost to Follow-up|31|||
131601867|NCT02276885|473836017|FG000|Overall Study|Withdrawal by Subject|2|||
131601868|NCT02276885|473836018|FG001|Overall Study|Withdrawal by Subject|0|||
131601869|NCT02276885|473836017|FG000|Overall Study|Lost to Follow-up|5|||
131601870|NCT02276885|473836018|FG001|Overall Study|Lost to Follow-up|2|||
131601871|NCT04171141|473836022|FG000|Overall Study|Adverse Event|0|||
131601872|NCT04171141|473836023|FG001|Overall Study|Adverse Event|0|||
131601873|NCT04171141|473836024|FG002|Overall Study|Adverse Event|2|||
131601874|NCT04171141|473836025|FG003|Overall Study|Adverse Event|0|||
131601875|NCT04171141|473836026|FG004|Overall Study|Adverse Event|0|||
131601876|NCT04171141|473836027|FG005|Overall Study|Adverse Event|0|||
131601877|NCT04171141|473836028|FG006|Overall Study|Adverse Event|0|||
131601878|NCT04171141|473836029|FG007|Overall Study|Adverse Event|0|||
131601879|NCT04171141|473836030|FG008|Overall Study|Adverse Event|0|||
131601880|NCT04171141|473836031|FG009|Overall Study|Adverse Event|0|||
131601881|NCT04171141|473836032|FG010|Overall Study|Adverse Event|0|||
131601882|NCT04171141|473836033|FG011|Overall Study|Adverse Event|0|||
131601883|NCT04171141|473836034|FG012|Overall Study|Adverse Event|0|||
131601884|NCT04171141|473836035|FG013|Overall Study|Adverse Event|2|||
131601885|NCT04171141|473836036|FG014|Overall Study|Adverse Event|0|||
131601886|NCT04171141|473836037|FG015|Overall Study|Adverse Event|0|||
131601887|NCT04171141|473836022|FG000|Overall Study|Physician Decision|0|||
131601888|NCT04171141|473836023|FG001|Overall Study|Physician Decision|0|||
131601889|NCT04171141|473836024|FG002|Overall Study|Physician Decision|0|||
131601890|NCT04171141|473836025|FG003|Overall Study|Physician Decision|0|||
131601891|NCT04171141|473836026|FG004|Overall Study|Physician Decision|1|||
131601892|NCT04171141|473836027|FG005|Overall Study|Physician Decision|0|||
131601893|NCT04171141|473836028|FG006|Overall Study|Physician Decision|0|||
131601894|NCT04171141|473836029|FG007|Overall Study|Physician Decision|0|||
131601895|NCT04171141|473836030|FG008|Overall Study|Physician Decision|0|||
131899690|NCT02659943|474919374|FG001|Overall Study|Disease progression on study|1|||
131601896|NCT04171141|473836031|FG009|Overall Study|Physician Decision|0|||
131601897|NCT04171141|473836032|FG010|Overall Study|Physician Decision|0|||
131601898|NCT04171141|473836033|FG011|Overall Study|Physician Decision|0|||
131601899|NCT04171141|473836034|FG012|Overall Study|Physician Decision|0|||
131601900|NCT04171141|473836035|FG013|Overall Study|Physician Decision|0|||
131601901|NCT04171141|473836036|FG014|Overall Study|Physician Decision|0|||
131601902|NCT04171141|473836037|FG015|Overall Study|Physician Decision|1|||
131601903|NCT04171141|473836022|FG000|Overall Study|Progressive disease|2|||
131601904|NCT04171141|473836023|FG001|Overall Study|Progressive disease|3|||
131601905|NCT04171141|473836024|FG002|Overall Study|Progressive disease|4|||
131601906|NCT04171141|473836025|FG003|Overall Study|Progressive disease|7|||
131601907|NCT04171141|473836026|FG004|Overall Study|Progressive disease|1|||
131601908|NCT04171141|473836027|FG005|Overall Study|Progressive disease|8|||
131601909|NCT04171141|473836028|FG006|Overall Study|Progressive disease|4|||
131601910|NCT04171141|473836029|FG007|Overall Study|Progressive disease|6|||
131601911|NCT04171141|473836030|FG008|Overall Study|Progressive disease|7|||
131601912|NCT04171141|473836031|FG009|Overall Study|Progressive disease|3|||
131601913|NCT04171141|473836032|FG010|Overall Study|Progressive disease|4|||
131601914|NCT04171141|473836033|FG011|Overall Study|Progressive disease|3|||
131601915|NCT04171141|473836034|FG012|Overall Study|Progressive disease|4|||
131601916|NCT04171141|473836035|FG013|Overall Study|Progressive disease|2|||
131601917|NCT04171141|473836036|FG014|Overall Study|Progressive disease|4|||
131601918|NCT04171141|473836037|FG015|Overall Study|Progressive disease|1|||
131601919|NCT04171141|473836022|FG000|Overall Study|Withdrawal by Subject|0|||
131601920|NCT04171141|473836023|FG001|Overall Study|Withdrawal by Subject|0|||
131601921|NCT04171141|473836024|FG002|Overall Study|Withdrawal by Subject|0|||
131601922|NCT04171141|473836025|FG003|Overall Study|Withdrawal by Subject|1|||
131601923|NCT04171141|473836026|FG004|Overall Study|Withdrawal by Subject|0|||
131601924|NCT04171141|473836027|FG005|Overall Study|Withdrawal by Subject|0|||
131601925|NCT04171141|473836028|FG006|Overall Study|Withdrawal by Subject|1|||
131601926|NCT04171141|473836029|FG007|Overall Study|Withdrawal by Subject|0|||
131601927|NCT04171141|473836030|FG008|Overall Study|Withdrawal by Subject|0|||
131601928|NCT04171141|473836031|FG009|Overall Study|Withdrawal by Subject|1|||
131601929|NCT04171141|473836032|FG010|Overall Study|Withdrawal by Subject|0|||
131601930|NCT04171141|473836033|FG011|Overall Study|Withdrawal by Subject|0|||
131601931|NCT04171141|473836034|FG012|Overall Study|Withdrawal by Subject|0|||
131601932|NCT04171141|473836035|FG013|Overall Study|Withdrawal by Subject|0|||
131601933|NCT04171141|473836036|FG014|Overall Study|Withdrawal by Subject|0|||
131601934|NCT04171141|473836037|FG015|Overall Study|Withdrawal by Subject|0|||
131601935|NCT04171141|473836022|FG000|Overall Study|Global deterioration of health status|0|||
131601936|NCT04171141|473836023|FG001|Overall Study|Global deterioration of health status|0|||
131601937|NCT04171141|473836024|FG002|Overall Study|Global deterioration of health status|0|||
131601938|NCT04171141|473836025|FG003|Overall Study|Global deterioration of health status|1|||
131601939|NCT04171141|473836026|FG004|Overall Study|Global deterioration of health status|0|||
131601940|NCT04171141|473836027|FG005|Overall Study|Global deterioration of health status|2|||
131601941|NCT04171141|473836028|FG006|Overall Study|Global deterioration of health status|1|||
131601942|NCT04171141|473836029|FG007|Overall Study|Global deterioration of health status|0|||
131601943|NCT04171141|473836030|FG008|Overall Study|Global deterioration of health status|1|||
131601944|NCT04171141|473836031|FG009|Overall Study|Global deterioration of health status|0|||
131601945|NCT04171141|473836032|FG010|Overall Study|Global deterioration of health status|0|||
131601946|NCT04171141|473836033|FG011|Overall Study|Global deterioration of health status|0|||
131601947|NCT04171141|473836034|FG012|Overall Study|Global deterioration of health status|0|||
131601948|NCT04171141|473836035|FG013|Overall Study|Global deterioration of health status|0|||
131601949|NCT04171141|473836036|FG014|Overall Study|Global deterioration of health status|1|||
131601950|NCT04171141|473836037|FG015|Overall Study|Global deterioration of health status|1|||
131601951|NCT03314454|473836040|FG000|Overall Study|Protocol Violation|1|||
131601952|NCT04119843|473836041|FG000|Overall Study|Adverse Event|3|||
131601953|NCT04119843|473836041|FG000|Overall Study|Death|1|||
131601954|NCT03652389|473836042|FG000|Overall Study|Lost to Follow-up|1|||
131601955|NCT03652389|473836043|FG001|Overall Study|Lost to Follow-up|5|||
131601956|NCT03652389|473836042|FG000|Overall Study|Withdrawal by Subject|5|||
131601957|NCT03652389|473836043|FG001|Overall Study|Withdrawal by Subject|1|||
131601958|NCT03652389|473836042|FG000|Overall Study|New diagnosis|2|||
131601959|NCT03652389|473836043|FG001|Overall Study|New diagnosis|0|||
131601960|NCT03663569|473836044|FG000|Overall Study|Discontinuation of study|11|||
131601961|NCT03663569|473836044|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
131601962|NCT03663569|473836044|FG000|Overall Study|Deceased patient|6|||
131601963|NCT03663569|473836044|FG000|Overall Study|Lost to Follow-up|18|||
131601964|NCT03663569|473836044|FG000|Overall Study|Withdrawal of consent|5|||
131601965|NCT03663569|473836044|FG000|Overall Study|Patient's request|11|||
131601966|NCT03663569|473836044|FG000|Overall Study|Adverse Event|4|||
131601967|NCT03663569|473836044|FG000|Overall Study|Not come to second visit|3|||
131601968|NCT03663569|473836044|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
131601969|NCT03663569|473836044|FG000|Overall Study|Serious adverse event|1|||
131706811|NCT00469612|474209248|FG000|Overall Study|Study terminated before data collected|2|||
131601970|NCT05034328|473836049|FG000|Overall Study|Protocol Violation|1|||
131601971|NCT05034328|473836050|FG001|Overall Study|Protocol Violation|0|||
131601972|NCT05034328|473836049|FG000|Overall Study|Lost to Follow-up|0|||
131601973|NCT05034328|473836050|FG001|Overall Study|Lost to Follow-up|10|||
131601974|NCT03625167|473836055|FG000|Overall Study|Protocol Violation|5|||
131601975|NCT02969707|473836056|FG000|Overall Study|Withdrawal by Subject|6|||
131601976|NCT02969707|473836057|FG001|Overall Study|Withdrawal by Subject|5|||
131601977|NCT02969707|473836056|FG000|Overall Study|Severe anxiety|0|||
131601978|NCT02969707|473836057|FG001|Overall Study|Severe anxiety|1|||
131601979|NCT02969707|473836056|FG000|Overall Study|Positive toxicology screen|0|||
131601980|NCT02969707|473836057|FG001|Overall Study|Positive toxicology screen|2|||
131601981|NCT02969707|473836056|FG000|Overall Study|Claustrophobia|2|||
131601982|NCT02969707|473836057|FG001|Overall Study|Claustrophobia|2|||
131601983|NCT02969707|473836056|FG000|Overall Study|Non-compliance|1|||
131601984|NCT02969707|473836057|FG001|Overall Study|Non-compliance|2|||
131601985|NCT04298983|473836059|FG000|Overall Study|Adverse Event|4|||
131601986|NCT04298983|473836059|FG000|Overall Study|Lack of Efficacy|3|||
131601987|NCT04248725|473836069|FG000|Post-Treatment|Lost to Follow-up|6|||
131601988|NCT04248725|473836070|FG001|Post-Treatment|Lost to Follow-up|5|||
131601989|NCT04248725|473836069|FG000|6-Month Follow Up|Lost to Follow-up|9|||
131601990|NCT04248725|473836070|FG001|6-Month Follow Up|Lost to Follow-up|8|||
131601991|NCT03766685|473836075|FG000|Overall Study|Lost to Follow-up|1|||
131601992|NCT03766685|473836076|FG001|Overall Study|Lost to Follow-up|1|||
131601993|NCT03766685|473836077|FG002|Overall Study|Lost to Follow-up|0|||
131601994|NCT03766685|473836078|FG003|Overall Study|Lost to Follow-up|0|||
131601995|NCT03766685|473836075|FG000|Overall Study|Adverse Event, not fatal|0|||
131601996|NCT03766685|473836076|FG001|Overall Study|Adverse Event, not fatal|1|||
131601997|NCT03766685|473836077|FG002|Overall Study|Adverse Event, not fatal|0|||
131601998|NCT03766685|473836078|FG003|Overall Study|Adverse Event, not fatal|1|||
131601999|NCT03766685|473836075|FG000|Overall Study|Withdrawal by Subject|0|||
131602000|NCT03766685|473836076|FG001|Overall Study|Withdrawal by Subject|2|||
131602001|NCT03766685|473836077|FG002|Overall Study|Withdrawal by Subject|0|||
131602002|NCT03766685|473836078|FG003|Overall Study|Withdrawal by Subject|0|||
131602003|NCT03766685|473836075|FG000|Overall Study|Protocol Violation|0|||
131602004|NCT03766685|473836076|FG001|Overall Study|Protocol Violation|1|||
131602005|NCT03766685|473836077|FG002|Overall Study|Protocol Violation|0|||
131602006|NCT03766685|473836078|FG003|Overall Study|Protocol Violation|0|||
131602007|NCT03766685|473836075|FG000|Overall Study|Non-compliance|0|||
131602008|NCT03766685|473836076|FG001|Overall Study|Non-compliance|2|||
131602009|NCT03766685|473836077|FG002|Overall Study|Non-compliance|0|||
131602010|NCT03766685|473836078|FG003|Overall Study|Non-compliance|0|||
131602011|NCT02116530|473836079|FG000|Overall Study|Withdrawal by Subject|1|||
131602012|NCT02116530|473836080|FG001|Overall Study|Withdrawal by Subject|2|||
131602013|NCT02116530|473836079|FG000|Overall Study|Adverse Event|4|||
131602014|NCT02116530|473836080|FG001|Overall Study|Adverse Event|0|||
131602015|NCT02116530|473836079|FG000|Overall Study|Physician Decision|1|||
131602016|NCT02116530|473836080|FG001|Overall Study|Physician Decision|0|||
131602017|NCT02116530|473836079|FG000|Overall Study|Lost to Follow-up|1|||
131602018|NCT02116530|473836080|FG001|Overall Study|Lost to Follow-up|0|||
131602019|NCT02116530|473836079|FG000|Overall Study|Other Medical Problems|2|||
131602020|NCT02116530|473836080|FG001|Overall Study|Other Medical Problems|2|||
131602021|NCT02927236|473836085|FG000|Characterization Phase|Physician Decision|0|||
131602022|NCT02927236|473836086|FG001|Characterization Phase|Physician Decision|3|||
131602023|NCT02927236|473836087|FG002|Characterization Phase|Physician Decision|0|||
131602024|NCT02927236|473836088|FG003|Characterization Phase|Physician Decision|2|||
131602025|NCT02927236|473836085|FG000|Characterization Phase|Lost to Follow-up|0|||
131602026|NCT02927236|473836086|FG001|Characterization Phase|Lost to Follow-up|0|||
131602027|NCT02927236|473836087|FG002|Characterization Phase|Lost to Follow-up|0|||
131602028|NCT02927236|473836088|FG003|Characterization Phase|Lost to Follow-up|3|||
131602029|NCT02927236|473836085|FG000|Characterization Phase|Withdrawal by Subject|1|||
131602030|NCT02927236|473836086|FG001|Characterization Phase|Withdrawal by Subject|0|||
131602031|NCT02927236|473836087|FG002|Characterization Phase|Withdrawal by Subject|0|||
131602032|NCT02927236|473836088|FG003|Characterization Phase|Withdrawal by Subject|1|||
131602033|NCT02927236|473836085|FG000|Treatment Phase|Adverse Event|1|||
131602034|NCT02927236|473836086|FG001|Treatment Phase|Adverse Event|0|||
131602035|NCT02927236|473836087|FG002|Treatment Phase|Adverse Event|1|||
131602036|NCT02927236|473836088|FG003|Treatment Phase|Adverse Event|1|||
131602037|NCT02927236|473836085|FG000|Treatment Phase|Protocol Violation|3|||
131602038|NCT02927236|473836086|FG001|Treatment Phase|Protocol Violation|0|||
131602039|NCT02927236|473836087|FG002|Treatment Phase|Protocol Violation|0|||
131602040|NCT02927236|473836088|FG003|Treatment Phase|Protocol Violation|1|||
131602041|NCT02927236|473836085|FG000|Treatment Phase|Lost to Follow-up|1|||
131602042|NCT02927236|473836086|FG001|Treatment Phase|Lost to Follow-up|0|||
131602043|NCT02927236|473836087|FG002|Treatment Phase|Lost to Follow-up|0|||
131602044|NCT02927236|473836088|FG003|Treatment Phase|Lost to Follow-up|0|||
131602045|NCT02927236|473836085|FG000|Follow-up Phase|Lost to Follow-up|1|||
131602046|NCT02927236|473836086|FG001|Follow-up Phase|Lost to Follow-up|0|||
131602047|NCT02927236|473836087|FG002|Follow-up Phase|Lost to Follow-up|1|||
131602048|NCT02927236|473836088|FG003|Follow-up Phase|Lost to Follow-up|0|||
131602049|NCT05496231|473836094|FG000|Overall Study|Adverse Event|1|||
131602050|NCT05496231|473836095|FG001|Overall Study|Adverse Event|1|||
131602051|NCT05496231|473836096|FG002|Overall Study|Adverse Event|0|||
131602052|NCT05496231|473836097|FG003|Overall Study|Adverse Event|4|||
131602053|NCT05496231|473836094|FG000|Overall Study|Withdrawal by Subject|5|||
131602054|NCT05496231|473836095|FG001|Overall Study|Withdrawal by Subject|5|||
131602055|NCT05496231|473836096|FG002|Overall Study|Withdrawal by Subject|4|||
131602056|NCT05496231|473836097|FG003|Overall Study|Withdrawal by Subject|11|||
131602057|NCT05496231|473836094|FG000|Overall Study|Migrated/moved from the study area|3|||
131602058|NCT05496231|473836095|FG001|Overall Study|Migrated/moved from the study area|5|||
131602059|NCT05496231|473836096|FG002|Overall Study|Migrated/moved from the study area|3|||
131602060|NCT05496231|473836097|FG003|Overall Study|Migrated/moved from the study area|3|||
131602061|NCT05496231|473836094|FG000|Overall Study|Lost to Follow-up|13|||
131602062|NCT05496231|473836095|FG001|Overall Study|Lost to Follow-up|6|||
131602063|NCT05496231|473836096|FG002|Overall Study|Lost to Follow-up|11|||
131602064|NCT05496231|473836097|FG003|Overall Study|Lost to Follow-up|6|||
131602065|NCT05496231|473836094|FG000|Overall Study|Other|9|||
131602066|NCT05496231|473836095|FG001|Overall Study|Other|7|||
131602067|NCT05496231|473836096|FG002|Overall Study|Other|7|||
131602068|NCT05496231|473836097|FG003|Overall Study|Other|8|||
131602069|NCT05029622|473836102|FG000|Overall Study|Lost to Follow-up|1|||
131602070|NCT03785964|473836112|FG000|Overall Study|Adverse Event|14|||
131602071|NCT03785964|473836113|FG001|Overall Study|Adverse Event|1|||
131602072|NCT03785964|473836112|FG000|Overall Study|Unqualified Clinical Progression|1|||
131602073|NCT03785964|473836113|FG001|Overall Study|Unqualified Clinical Progression|1|||
131602074|NCT03785964|473836112|FG000|Overall Study|Participant non-compliance|1|||
131602075|NCT03785964|473836113|FG001|Overall Study|Participant non-compliance|1|||
131602076|NCT03785964|473836112|FG000|Overall Study|Not treated|1|||
131602077|NCT03785964|473836113|FG001|Overall Study|Not treated|0|||
131602078|NCT03785964|473836112|FG000|Overall Study|Other reason|5|||
131602079|NCT03785964|473836113|FG001|Overall Study|Other reason|11|||
131602080|NCT03785964|473836112|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
131602081|NCT03785964|473836113|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
131602082|NCT04433208|473836131|FG000|Overall Study|Withdrawal by Subject|0|||
131602083|NCT04433208|473836132|FG001|Overall Study|Withdrawal by Subject|1|||
131602084|NCT04433208|473836133|FG002|Overall Study|Withdrawal by Subject|1|||
131602085|NCT04433208|473836134|FG003|Overall Study|Withdrawal by Subject|0|||
131602086|NCT04433208|473836135|FG004|Overall Study|Withdrawal by Subject|2|||
131602087|NCT04433208|473836136|FG005|Overall Study|Withdrawal by Subject|1|||
131602088|NCT04433208|473836131|FG000|Overall Study|Lost to Follow-up|0|||
131602089|NCT04433208|473836132|FG001|Overall Study|Lost to Follow-up|0|||
131602090|NCT04433208|473836133|FG002|Overall Study|Lost to Follow-up|0|||
131602091|NCT04433208|473836134|FG003|Overall Study|Lost to Follow-up|0|||
131602092|NCT04433208|473836135|FG004|Overall Study|Lost to Follow-up|0|||
131602093|NCT04433208|473836136|FG005|Overall Study|Lost to Follow-up|1|||
131602094|NCT02733159|473836137|FG000|Overall Study|Adverse Event|1|||
131602095|NCT02733159|473836137|FG000|Overall Study|Lack of disease progression|1|||
131602096|NCT02709161|473836138|FG000|Overall Study|Withdrawal by Subject|1|||
131602097|NCT02709161|473836139|FG001|Overall Study|Withdrawal by Subject|0|||
131602098|NCT03221426|473836141|FG000|Overall Study|Ongoing in study|212|||
131602099|NCT03221426|473836142|FG001|Overall Study|Ongoing in study|193|||
131440355|NCT00419393|473241472|FG000|Overall Study|Other: Investigator decision|1|||
131440356|NCT01751061|473241475|FG000|Overall Study|Death|1|||
131440357|NCT01751061|473241476|FG001|Overall Study|Death|0|||
131440358|NCT01751061|473241475|FG000|Overall Study|patient death|5|||
131440359|NCT01751061|473241476|FG001|Overall Study|patient death|0|||
131440360|NCT01751061|473241475|FG000|Overall Study|Lost to Follow-up|40|||
131440361|NCT01751061|473241476|FG001|Overall Study|Lost to Follow-up|25|||
131440362|NCT01751061|473241475|FG000|Overall Study|patient regained decisional capacity|4|||
131440363|NCT01751061|473241476|FG001|Overall Study|patient regained decisional capacity|8|||
131440364|NCT01751061|473241475|FG000|Overall Study|Withdrawal by Subject|4|||
131440365|NCT01751061|473241476|FG001|Overall Study|Withdrawal by Subject|1|||
131440366|NCT01751061|473241475|FG000|Overall Study|Physician Decision|2|||
131440367|NCT01751061|473241476|FG001|Overall Study|Physician Decision|0|||
131440368|NCT02153086|473241480|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
131440369|NCT02153086|473241480|FG000|Overall Study|Other|2|||
131440370|NCT00446849|473241481|FG000|Acute Phase|Lack of Efficacy|64|||
131440371|NCT00446849|473241481|FG000|Acute Phase|Protocol Violation|10|||
131440372|NCT00446849|473241481|FG000|Acute Phase|Consent withdrawn|4|||
131440373|NCT00446849|473241481|FG000|Acute Phase|Lost to Follow-up|2|||
131440374|NCT00446849|473241481|FG000|Acute Phase|Physician Decision|1|||
131440375|NCT00446849|473241481|FG000|Acute Phase|noncompliance|1|||
131440376|NCT00446849|473241481|FG000|Maintenance Phase|Lack of Efficacy|40|||
131440377|NCT00446849|473241481|FG000|Maintenance Phase|Protocol Violation|7|||
131602100|NCT03221426|473836143|FG002|Overall Study|Ongoing in study|61|||
131440378|NCT00446849|473241481|FG000|Maintenance Phase|Adverse Event|6|||
131440379|NCT00446849|473241481|FG000|Maintenance Phase|Consent withdrawn|5|||
131440380|NCT00446849|473241481|FG000|Maintenance Phase|Lost to Follow-up|3|||
131602101|NCT03221426|473836144|FG003|Overall Study|Ongoing in study|55|||
131440381|NCT00446849|473241481|FG000|Maintenance Phase|Pregnancy|1|||
131602102|NCT03221426|473836141|FG000|Overall Study|Withdrawal by Subject|12|||
131602103|NCT03221426|473836142|FG001|Overall Study|Withdrawal by Subject|4|||
131602104|NCT03221426|473836143|FG002|Overall Study|Withdrawal by Subject|2|||
131602105|NCT03221426|473836144|FG003|Overall Study|Withdrawal by Subject|3|||
131602106|NCT03221426|473836141|FG000|Overall Study|Lost to Follow-up|4|||
131602107|NCT03221426|473836142|FG001|Overall Study|Lost to Follow-up|1|||
131602108|NCT03221426|473836143|FG002|Overall Study|Lost to Follow-up|1|||
131602109|NCT03221426|473836144|FG003|Overall Study|Lost to Follow-up|0|||
131602110|NCT03221426|473836141|FG000|Overall Study|Death|174|||
131602111|NCT03221426|473836142|FG001|Overall Study|Death|204|||
131602112|NCT03221426|473836143|FG002|Overall Study|Death|36|||
131602113|NCT03221426|473836144|FG003|Overall Study|Death|45|||
131602114|NCT02561247|473837901|FG000|Overall Study|Protocol Violation|1|||
131602115|NCT02561247|473837901|FG000|Overall Study|Withdrawal by Subject|1|||
131602116|NCT02561247|473837901|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
131602117|NCT04858451|473837902|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
131602118|NCT04858451|473837903|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602119|NCT04858451|473837904|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602120|NCT04858451|473837905|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602121|NCT04858451|473837906|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602122|NCT04858451|473837907|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602123|NCT04858451|473837908|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602124|NCT04858451|473837909|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602125|NCT04858451|473837910|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131602126|NCT04858451|473837902|FG000|Part 2|Discontinued|0|||
131602127|NCT04858451|473837903|FG001|Part 2|Discontinued|0|||
131602128|NCT04858451|473837904|FG002|Part 2|Discontinued|0|||
131602129|NCT04858451|473837905|FG003|Part 2|Discontinued|0|||
131602130|NCT04858451|473837906|FG004|Part 2|Discontinued|0|||
131602131|NCT04858451|473837907|FG005|Part 2|Discontinued|0|||
131602132|NCT04858451|473837908|FG006|Part 2|Discontinued|0|||
131602133|NCT04858451|473837909|FG007|Part 2|Discontinued|0|||
131602134|NCT04858451|473837910|FG008|Part 2|Discontinued|63|||
131602135|NCT03656510|473837913|FG000|Overall Study|Lost to Follow-up|1|||
131602136|NCT03656510|473837914|FG001|Overall Study|Lost to Follow-up|0|||
131602137|NCT03656510|473837915|FG002|Overall Study|Lost to Follow-up|0|||
131602138|NCT03656510|473837916|FG003|Overall Study|Lost to Follow-up|0|||
131602139|NCT03656510|473837917|FG004|Overall Study|Lost to Follow-up|0|||
131602140|NCT03656510|473837918|FG005|Overall Study|Lost to Follow-up|0|||
131602141|NCT03656510|473837913|FG000|Overall Study|Withdrawal by Subject|1|||
131602142|NCT03656510|473837914|FG001|Overall Study|Withdrawal by Subject|1|||
131602143|NCT03656510|473837915|FG002|Overall Study|Withdrawal by Subject|0|||
131602144|NCT03656510|473837916|FG003|Overall Study|Withdrawal by Subject|1|||
131602145|NCT03656510|473837917|FG004|Overall Study|Withdrawal by Subject|0|||
131602146|NCT03656510|473837918|FG005|Overall Study|Withdrawal by Subject|0|||
131602147|NCT03819153|473837919|FG000|Overall Study|Withdrawal by Subject|20|||
131602148|NCT03819153|473837920|FG001|Overall Study|Withdrawal by Subject|28|||
131602149|NCT03819153|473837919|FG000|Overall Study|Lost to Follow-up|23|||
131602150|NCT03819153|473837920|FG001|Overall Study|Lost to Follow-up|30|||
131602151|NCT03974178|473837922|FG000|Overall Study|Death|0|||
131602152|NCT03974178|473837923|FG001|Overall Study|Death|1|||
131602153|NCT04508309|473837929|FG000|Overall Study|Death|0|||
131602154|NCT04508309|473837930|FG001|Overall Study|Death|0|||
131602155|NCT04508309|473837931|FG002|Overall Study|Death|0|||
131602156|NCT04508309|473837932|FG003|Overall Study|Death|0|||
131602157|NCT04508309|473837933|FG004|Overall Study|Death|1|||
131602158|NCT04508309|473837929|FG000|Overall Study|Lost to Follow-up|0|||
131602159|NCT04508309|473837930|FG001|Overall Study|Lost to Follow-up|0|||
131602160|NCT04508309|473837931|FG002|Overall Study|Lost to Follow-up|1|||
131602161|NCT04508309|473837932|FG003|Overall Study|Lost to Follow-up|1|||
131602162|NCT04508309|473837933|FG004|Overall Study|Lost to Follow-up|0|||
131602163|NCT04508309|473837929|FG000|Overall Study|Withdrawal by Subject|0|||
131602164|NCT04508309|473837930|FG001|Overall Study|Withdrawal by Subject|0|||
131602165|NCT04508309|473837931|FG002|Overall Study|Withdrawal by Subject|0|||
131602166|NCT04508309|473837932|FG003|Overall Study|Withdrawal by Subject|0|||
131602167|NCT04508309|473837933|FG004|Overall Study|Withdrawal by Subject|1|||
131602168|NCT05526430|473837934|FG000|Overall Study|Withdrawal by Subject|0|||
131602169|NCT05526430|473837935|FG001|Overall Study|Withdrawal by Subject|2|||
131602170|NCT05526430|473837936|FG002|Overall Study|Withdrawal by Subject|0|||
131602171|NCT05526430|473837937|FG003|Overall Study|Withdrawal by Subject|0|||
131602172|NCT02305888|473837938|FG000|Overall Study|Lost to Follow-up|0|||
131602173|NCT02305888|473837939|FG001|Overall Study|Lost to Follow-up|0|||
131602174|NCT02305888|473837940|FG002|Overall Study|Lost to Follow-up|1|||
131602175|NCT02305888|473837938|FG000|Overall Study|Adverse Event|0|||
131602176|NCT02305888|473837939|FG001|Overall Study|Adverse Event|1|||
131602177|NCT02305888|473837940|FG002|Overall Study|Adverse Event|0|||
131602178|NCT06232590|473837941|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
131602179|NCT06232590|473837942|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
131602180|NCT04914676|473837943|FG000|Overall Study|Study termination|3|||
131602181|NCT04914676|473837944|FG001|Overall Study|Study termination|0|||
131602182|NCT03085810|473837945|FG000|Main Study|Withdrawal by Subject|77|||
131602183|NCT03085810|473837946|FG001|Main Study|Withdrawal by Subject|0|||
131602184|NCT03085810|473837947|FG002|Main Study|Withdrawal by Subject|0|||
131602185|NCT03085810|473837945|FG000|Main Study|Terminated By Sponsor|14|||
131602186|NCT03085810|473837946|FG001|Main Study|Terminated By Sponsor|0|||
131602187|NCT03085810|473837947|FG002|Main Study|Terminated By Sponsor|0|||
131602188|NCT03085810|473837945|FG000|Main Study|Protocol Violation|15|||
131602189|NCT03085810|473837946|FG001|Main Study|Protocol Violation|0|||
131602190|NCT03085810|473837947|FG002|Main Study|Protocol Violation|0|||
131602191|NCT03085810|473837945|FG000|Main Study|Physician Decision|13|||
131602192|NCT03085810|473837946|FG001|Main Study|Physician Decision|0|||
131602193|NCT03085810|473837947|FG002|Main Study|Physician Decision|0|||
131602194|NCT03085810|473837945|FG000|Main Study|Lost to Follow-up|17|||
131602195|NCT03085810|473837946|FG001|Main Study|Lost to Follow-up|0|||
131602196|NCT03085810|473837947|FG002|Main Study|Lost to Follow-up|0|||
131602197|NCT03085810|473837945|FG000|Main Study|Adverse Event|25|||
131602198|NCT03085810|473837946|FG001|Main Study|Adverse Event|0|||
131602199|NCT03085810|473837947|FG002|Main Study|Adverse Event|0|||
131602200|NCT03085810|473837945|FG000|Main Study|Pregnancy|7|||
131602201|NCT03085810|473837946|FG001|Main Study|Pregnancy|0|||
131602202|NCT03085810|473837947|FG002|Main Study|Pregnancy|0|||
131602203|NCT03085810|473837945|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
131602204|NCT03085810|473837946|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
131602205|NCT03085810|473837947|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
131602206|NCT03085810|473837945|FG000|Main Study|Lack of Efficacy|10|||
131602207|NCT03085810|473837946|FG001|Main Study|Lack of Efficacy|0|||
131602208|NCT03085810|473837947|FG002|Main Study|Lack of Efficacy|0|||
131602209|NCT03085810|473837945|FG000|Main Study|Death|12|||
131602210|NCT03085810|473837946|FG001|Main Study|Death|0|||
131602211|NCT03085810|473837947|FG002|Main Study|Death|0|||
131602212|NCT03085810|473837945|FG000|Main Study|Disease progression|1|||
131602213|NCT03085810|473837946|FG001|Main Study|Disease progression|0|||
131602214|NCT03085810|473837947|FG002|Main Study|Disease progression|0|||
131602215|NCT03085810|473837945|FG000|Main Study|Site Closure|3|||
131602216|NCT03085810|473837946|FG001|Main Study|Site Closure|0|||
131602217|NCT03085810|473837947|FG002|Main Study|Site Closure|0|||
131602218|NCT03085810|473837945|FG000|Main Study|Planned pregnancy|17|||
131602219|NCT03085810|473837946|FG001|Main Study|Planned pregnancy|0|||
131602220|NCT03085810|473837947|FG002|Main Study|Planned pregnancy|0|||
131602221|NCT03085810|473837945|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
131602222|NCT03085810|473837946|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
131602223|NCT03085810|473837947|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
131602224|NCT03085810|473837945|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
131602225|NCT03085810|473837946|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
131602226|NCT03085810|473837947|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
131602227|NCT03085810|473837945|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
131602228|NCT03085810|473837946|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
131602229|NCT03085810|473837947|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
131602230|NCT03085810|473837945|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
131602231|NCT03085810|473837946|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
131602232|NCT03085810|473837947|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
131602233|NCT03240016|473837948|FG000|Overall Study|Adverse Event|9|||
131602234|NCT03240016|473837948|FG000|Overall Study|Withdrawal by Subject|7|||
131602235|NCT03240016|473837948|FG000|Overall Study|Death|1|||
131602236|NCT03240016|473837948|FG000|Overall Study|Physician Decision|2|||
131602237|NCT05200403|473837949|FG000|Overall Study|Withdrawal by Subject|4|||
131602238|NCT05200403|473837950|FG001|Overall Study|Withdrawal by Subject|2|||
131602239|NCT05200403|473837951|FG002|Overall Study|Withdrawal by Subject|6|||
131602240|NCT01959607|473837952|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
131602241|NCT01959607|473837953|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
131602242|NCT01959607|473837954|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131602243|NCT01959607|473837955|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
131602244|NCT03913442|473837956|FG000|Overall Study|Adverse Event|0|||
131602245|NCT03913442|473837957|FG001|Overall Study|Adverse Event|3|||
131602246|NCT03913442|473837956|FG000|Overall Study|Withdrawal by Subject|5|||
131602247|NCT03913442|473837957|FG001|Overall Study|Withdrawal by Subject|5|||
131602248|NCT03913442|473837956|FG000|Overall Study|Terminations|2|||
131602249|NCT03913442|473837957|FG001|Overall Study|Terminations|1|||
131602250|NCT03913442|473837956|FG000|Overall Study|Lost to Follow-up|2|||
131602251|NCT03913442|473837957|FG001|Overall Study|Lost to Follow-up|2|||
131602252|NCT00950742|473837958|FG000|Overall Study|Other Adverse Event|1|||
131602253|NCT00950742|473837959|FG001|Overall Study|Other Adverse Event|0|||
131602254|NCT00950742|473837958|FG000|Overall Study|Withdrawal by Subject|3|||
131602255|NCT00950742|473837959|FG001|Overall Study|Withdrawal by Subject|0|||
131602256|NCT00950742|473837958|FG000|Overall Study|Progressive Disease|6|||
131602257|NCT00950742|473837959|FG001|Overall Study|Progressive Disease|2|||
131706812|NCT00469612|474209249|FG001|Overall Study|Study terminated before data collected|0|||
131602258|NCT00950742|473837958|FG000|Overall Study|Dose limiting toxicity|6|||
131602259|NCT00950742|473837959|FG001|Overall Study|Dose limiting toxicity|0|||
131602260|NCT05436262|473837961|FG000|Pre-Randomization|Withdrawal by Subject|1|||
131602261|NCT05436262|473837962|FG001|Pre-Randomization|Withdrawal by Subject|0|||
131602262|NCT05436262|473837963|FG002|Pre-Randomization|Withdrawal by Subject|0|||
131602263|NCT05436262|473837961|FG000|Randomization|Withdrawal by Subject|0|||
131602264|NCT05436262|473837962|FG001|Randomization|Withdrawal by Subject|1|||
131602265|NCT05436262|473837963|FG002|Randomization|Withdrawal by Subject|0|||
131602266|NCT00592852|473837964|FG000|Overall Study|Non-compliance|1|||
131602267|NCT00592852|473837964|FG000|Overall Study|Adverse Event|3|||
131602268|NCT00592852|473837964|FG000|Overall Study|Found ineligible|1|||
131602269|NCT00592852|473837964|FG000|Overall Study|Withdrawal by Subject|1|||
131602270|NCT05002088|473837966|FG000|Overall Study|Withdrawal by Subject|9|||
131602271|NCT05002088|473837967|FG001|Overall Study|Withdrawal by Subject|0|||
131602272|NCT05002088|473837966|FG000|Overall Study|Lost to Follow-up|0|||
131602273|NCT05002088|473837967|FG001|Overall Study|Lost to Follow-up|1|||
131602274|NCT05002088|473837966|FG000|Overall Study|Death|16|||
131602275|NCT05002088|473837967|FG001|Overall Study|Death|2|||
131602276|NCT05002088|473837966|FG000|Overall Study|Protocol Violation|25|||
131602277|NCT05002088|473837967|FG001|Overall Study|Protocol Violation|7|||
131602278|NCT04068181|473837968|FG000|Overall Study|Death|17|||
131602279|NCT04068181|473837969|FG001|Overall Study|Death|12|||
131602280|NCT04068181|473837970|FG002|Overall Study|Death|4|||
131602281|NCT04068181|473837971|FG003|Overall Study|Death|7|||
131602282|NCT04068181|473837968|FG000|Overall Study|Lost to Follow-up|1|||
131602283|NCT04068181|473837969|FG001|Overall Study|Lost to Follow-up|0|||
131602284|NCT04068181|473837970|FG002|Overall Study|Lost to Follow-up|0|||
131602285|NCT04068181|473837971|FG003|Overall Study|Lost to Follow-up|0|||
131602286|NCT04068181|473837968|FG000|Overall Study|Withdrawal of consent from study|3|||
131602287|NCT04068181|473837969|FG001|Overall Study|Withdrawal of consent from study|0|||
131602288|NCT04068181|473837970|FG002|Overall Study|Withdrawal of consent from study|0|||
131602289|NCT04068181|473837971|FG003|Overall Study|Withdrawal of consent from study|0|||
131602290|NCT05070728|473837976|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
131602291|NCT05070728|473837977|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
131602292|NCT04770402|473837990|FG000|Overall Study|Lost to Follow-up|1|||
131602293|NCT04770402|473837991|FG001|Overall Study|Lost to Follow-up|2|||
131602294|NCT04770402|473837990|FG000|Overall Study|Non-compliance|1|||
131602295|NCT04770402|473837991|FG001|Overall Study|Non-compliance|0|||
131602296|NCT04770402|473837990|FG000|Overall Study|Withdrawal by Subject|0|||
131602297|NCT04770402|473837991|FG001|Overall Study|Withdrawal by Subject|1|||
131602298|NCT02589795|473837993|FG000|Overall Study|Lost to Follow-up|1|||
131602299|NCT02589795|473837994|FG001|Overall Study|Lost to Follow-up|0|||
131602300|NCT02589795|473837995|FG002|Overall Study|Lost to Follow-up|0|||
131602301|NCT02589795|473837993|FG000|Overall Study|Withdrawal by Subject|0|||
131602302|NCT02589795|473837994|FG001|Overall Study|Withdrawal by Subject|0|||
131602303|NCT02589795|473837995|FG002|Overall Study|Withdrawal by Subject|2|||
131602304|NCT02589795|473837993|FG000|Overall Study|Protocol Violation|0|||
131602305|NCT02589795|473837994|FG001|Overall Study|Protocol Violation|0|||
131602306|NCT02589795|473837995|FG002|Overall Study|Protocol Violation|1|||
131602307|NCT03599661|473837997|FG000|Overall Study|Lost to Follow-up|9|||
131602308|NCT04117347|473838002|FG000|Overall Study|Adverse Event|0|||
131602309|NCT04117347|473838003|FG001|Overall Study|Adverse Event|0|||
131602310|NCT04117347|473838004|FG002|Overall Study|Adverse Event|1|||
131602311|NCT04117347|473838002|FG000|Overall Study|No time for study|0|||
131602312|NCT04117347|473838003|FG001|Overall Study|No time for study|2|||
131602313|NCT04117347|473838004|FG002|Overall Study|No time for study|0|||
131602314|NCT04117347|473838002|FG000|Overall Study|Family emergency|1|||
131602315|NCT04117347|473838003|FG001|Overall Study|Family emergency|0|||
131602316|NCT04117347|473838004|FG002|Overall Study|Family emergency|0|||
131602317|NCT03687086|473838005|FG000|Overall Study|Withdrawal by Subject|3|||
131602318|NCT03687086|473838006|FG001|Overall Study|Withdrawal by Subject|4|||
131602319|NCT03687086|473838005|FG000|Overall Study|Lost to Follow-up|1|||
131602320|NCT03687086|473838006|FG001|Overall Study|Lost to Follow-up|1|||
131602321|NCT03687086|473838005|FG000|Overall Study|Death|1|||
131602322|NCT03687086|473838006|FG001|Overall Study|Death|0|||
131602323|NCT03687086|473838005|FG000|Overall Study|Incomplete assessment|0|||
131602324|NCT03687086|473838006|FG001|Overall Study|Incomplete assessment|2|||
131602325|NCT02505984|473838007|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
131602326|NCT02505984|473838008|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
131602327|NCT02505984|473838007|FG000|Overall Study|Unreliable self-report data|1|||
131602328|NCT02505984|473838008|FG001|Overall Study|Unreliable self-report data|0|||
131602329|NCT02505984|473838007|FG000|Overall Study|Study blind opened during assessment|0|||
131602330|NCT02505984|473838008|FG001|Overall Study|Study blind opened during assessment|1|||
131602331|NCT02505984|473838007|FG000|Overall Study|Noncompliance with study protocol|0|||
131602332|NCT02505984|473838008|FG001|Overall Study|Noncompliance with study protocol|1|||
131602333|NCT03905798|473838020|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
131602334|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
131602335|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
131602336|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
131602337|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
131602338|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
131602339|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
131602340|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
131602341|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
131602342|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
131602343|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
131602344|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
131602345|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
131602346|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
131602347|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
131602348|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
131602349|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
131602350|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
131602351|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
131602352|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
131602353|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
131602354|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
131602355|NCT04800211|473838023|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
131602356|NCT04800211|473838024|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
131602357|NCT04800211|473838025|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
131602358|NCT04800211|473838023|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
131602359|NCT04800211|473838024|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
131602360|NCT04800211|473838025|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
131602361|NCT04800211|473838023|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
131602362|NCT04800211|473838024|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
131602363|NCT04800211|473838025|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
131602364|NCT04800211|473838023|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
131602365|NCT04800211|473838024|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
131602366|NCT04800211|473838025|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
131602367|NCT05170841|473838026|FG000|Single Dose Phase|Adverse Event|1|||
131602368|NCT05170841|473838027|FG001|Single Dose Phase|Adverse Event|2|||
131602369|NCT05170841|473838028|FG002|Single Dose Phase|Adverse Event|0|||
131602370|NCT05170841|473838029|FG003|Single Dose Phase|Adverse Event|2|||
131602371|NCT05170841|473838026|FG000|Multiple Dose Phase|Adverse Event|1|||
131602372|NCT05170841|473838027|FG001|Multiple Dose Phase|Adverse Event|2|||
131602373|NCT05170841|473838028|FG002|Multiple Dose Phase|Adverse Event|1|||
131602374|NCT05170841|473838029|FG003|Multiple Dose Phase|Adverse Event|4|||
131602375|NCT05170841|473838026|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
131602376|NCT05170841|473838027|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
131602377|NCT05170841|473838028|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
131602378|NCT05170841|473838029|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
131602379|NCT05123586|473838032|FG000|Overall Study|Physician Decision|1|||
131602380|NCT05123586|473838033|FG001|Overall Study|Physician Decision|1|||
131602381|NCT05123586|473838032|FG000|Overall Study|Withdrawal by Subject|0|||
131602382|NCT05123586|473838033|FG001|Overall Study|Withdrawal by Subject|3|||
131602383|NCT03734679|473838039|FG000|Overall Study|Missed Visit|1|||
131602384|NCT06122194|473838041|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
131602385|NCT06122194|473838042|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
131602386|NCT06122194|473838043|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
131602387|NCT06122194|473838044|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
131602388|NCT02887521|473838053|FG000|Overall Study|Withdrawal by Subject|0|||
131602389|NCT02887521|473838054|FG001|Overall Study|Withdrawal by Subject|3|||
131602390|NCT03626220|473838057|FG000|Overall Study|Withdrawal by Subject|2|||
131602391|NCT03626220|473838058|FG001|Overall Study|Withdrawal by Subject|0|||
131602392|NCT03916185|473839334|FG000|Overall Study|Lost to Follow-up|0|||
131602393|NCT03916185|473839335|FG001|Overall Study|Lost to Follow-up|1|||
131602394|NCT03916185|473839336|FG002|Overall Study|Lost to Follow-up|0|||
131602395|NCT03916185|473839337|FG003|Overall Study|Lost to Follow-up|0|||
131602396|NCT03916185|473839334|FG000|Overall Study|Moved|1|||
131706813|NCT01084551|474209252|FG000|Overall Study|Adverse Event|2|||
131899691|NCT02659943|474919375|FG002|Overall Study|Disease progression on study|1|||
131602397|NCT03916185|473839335|FG001|Overall Study|Moved|0|||
131602398|NCT03916185|473839336|FG002|Overall Study|Moved|0|||
131602399|NCT03916185|473839337|FG003|Overall Study|Moved|1|||
131602400|NCT03916185|473839334|FG000|Overall Study|Not Able to Get to Clinic|1|||
131602401|NCT03916185|473839335|FG001|Overall Study|Not Able to Get to Clinic|0|||
131602402|NCT03916185|473839336|FG002|Overall Study|Not Able to Get to Clinic|0|||
131602403|NCT03916185|473839337|FG003|Overall Study|Not Able to Get to Clinic|0|||
131899692|NCT02659943|474919376|FG003|Overall Study|Disease progression on study|1|||
131602404|NCT02844465|473839339|FG000|Overall Study|Screen Failure|36|||
131602405|NCT02844465|473839339|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
131602406|NCT02844465|473839339|FG000|Overall Study|Withdrawal by Subject|5|||
131602407|NCT02844465|473839339|FG000|Overall Study|Lost to Follow-up|1|||
131602408|NCT02844465|473839339|FG000|Overall Study|Retreatment|1|||
131602409|NCT03220035|473839340|FG000|Overall Study|Adverse Event|1|||
131602410|NCT03220035|473839340|FG000|Overall Study|Protocol Violation|1|||
131602411|NCT03220035|473839340|FG000|Overall Study|Progressive Disease|2|||
131602412|NCT02433379|473839344|FG000|Overall Study|Screen Failures|55|||
131602413|NCT02433379|473839344|FG000|Overall Study|Death|57|||
131602414|NCT02433379|473839344|FG000|Overall Study|Total Withdrawals|209|||
131602415|NCT05299073|473839345|FG000|Overall Study|Withdrawal by Subject|0|||
131602416|NCT05299073|473839346|FG001|Overall Study|Withdrawal by Subject|0|||
131602417|NCT05299073|473839347|FG002|Overall Study|Withdrawal by Subject|1|||
131602418|NCT05299073|473839345|FG000|Overall Study|Adverse Event|0|||
131602419|NCT05299073|473839346|FG001|Overall Study|Adverse Event|1|||
131602420|NCT05299073|473839347|FG002|Overall Study|Adverse Event|0|||
131602421|NCT05299073|473839345|FG000|Overall Study|Lost to Follow-up|0|||
131602422|NCT05299073|473839346|FG001|Overall Study|Lost to Follow-up|1|||
131602423|NCT05299073|473839347|FG002|Overall Study|Lost to Follow-up|0|||
131602424|NCT04909801|473839348|FG000|Overall Study|Lack of Efficacy|2|||
131602425|NCT04909801|473839349|FG001|Overall Study|Lack of Efficacy|1|||
131602426|NCT04909801|473839348|FG000|Overall Study|Adverse Event|1|||
131602427|NCT04909801|473839349|FG001|Overall Study|Adverse Event|2|||
131602428|NCT04909801|473839348|FG000|Overall Study|Participant request to discontinue study treatment|1|||
131602429|NCT04909801|473839349|FG001|Overall Study|Participant request to discontinue study treatment|2|||
131602430|NCT04909801|473839348|FG000|Overall Study|Withdrawal by Subject|2|||
131602431|NCT04909801|473839349|FG001|Overall Study|Withdrawal by Subject|1|||
131602432|NCT04909801|473839348|FG000|Overall Study|other reasons|1|||
131602433|NCT04909801|473839349|FG001|Overall Study|other reasons|1|||
131602434|NCT04550221|473839350|FG000|Overall Study|Lost to Follow-up|0|||
131602435|NCT04550221|473839351|FG001|Overall Study|Lost to Follow-up|4|||
131602436|NCT04550221|473839350|FG000|Overall Study|Withdrawn|3|||
131602437|NCT04550221|473839351|FG001|Overall Study|Withdrawn|0|||
131602438|NCT04550221|473839350|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
131602439|NCT04550221|473839351|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
131602440|NCT04811040|473839352|FG000|Overall Study|Lost to Follow-up|2|||
131602441|NCT04811040|473839353|FG001|Overall Study|Lost to Follow-up|0|||
131602442|NCT04811040|473839354|FG002|Overall Study|Lost to Follow-up|0|||
131602443|NCT04811040|473839355|FG003|Overall Study|Lost to Follow-up|0|||
131602444|NCT04811040|473839352|FG000|Overall Study|Withdrew consent|1|||
131602445|NCT04811040|473839353|FG001|Overall Study|Withdrew consent|1|||
131602446|NCT04811040|473839354|FG002|Overall Study|Withdrew consent|0|||
131602447|NCT04811040|473839355|FG003|Overall Study|Withdrew consent|0|||
131602448|NCT05274074|473839356|FG000|Overall Study|Lost to Follow-up|2|||
131602449|NCT05274074|473839357|FG001|Overall Study|Lost to Follow-up|3|||
131602450|NCT05274074|473839356|FG000|Overall Study|Withdrawal by Subject|1|||
131602451|NCT05274074|473839357|FG001|Overall Study|Withdrawal by Subject|2|||
131602452|NCT05194956|473839358|FG000|Washout Period|Withdrawal by Subject|0|||
131602453|NCT05194956|473839359|FG001|Washout Period|Withdrawal by Subject|2|||
131899693|NCT02659943|474919377|FG004|Overall Study|Disease progression on study|1|||
131602454|NCT01828099|473839363|FG000|Treatment Period|Adverse Event|24|||
131602455|NCT01828099|473839364|FG001|Treatment Period|Adverse Event|23|||
131602456|NCT01828099|473839363|FG000|Treatment Period|Death|10|||
131602457|NCT01828099|473839364|FG001|Treatment Period|Death|12|||
131602458|NCT01828099|473839363|FG000|Treatment Period|Lost to Follow-up|2|||
131602459|NCT01828099|473839364|FG001|Treatment Period|Lost to Follow-up|1|||
131602460|NCT01828099|473839363|FG000|Treatment Period|Non-compliance with study treatment|1|||
131602461|NCT01828099|473839364|FG001|Treatment Period|Non-compliance with study treatment|0|||
131602462|NCT01828099|473839363|FG000|Treatment Period|Physician Decision|17|||
131602463|NCT01828099|473839364|FG001|Treatment Period|Physician Decision|16|||
131602464|NCT01828099|473839363|FG000|Treatment Period|Progressive disease|99|||
131602465|NCT01828099|473839364|FG001|Treatment Period|Progressive disease|107|||
131602466|NCT01828099|473839363|FG000|Treatment Period|Subject/guardian decision|22|||
131602467|NCT01828099|473839364|FG001|Treatment Period|Subject/guardian decision|26|||
131602468|NCT01828099|473839363|FG000|Treatment Period|Study terminated by Sponsor|13|||
131602469|NCT01828099|473839364|FG001|Treatment Period|Study terminated by Sponsor|1|||
131602470|NCT01828099|473839363|FG000|Treatment Period|Protocol deviation|1|||
131602471|NCT01828099|473839364|FG001|Treatment Period|Protocol deviation|0|||
131602472|NCT01828099|473839363|FG000|Treatment Period|No longer requires treatment|0|||
131602473|NCT01828099|473839364|FG001|Treatment Period|No longer requires treatment|1|||
131602474|NCT01828099|473839363|FG000|Extension-treatment Phase|Adverse Event|0|||
131602475|NCT01828099|473839364|FG001|Extension-treatment Phase|Adverse Event|17|||
131602476|NCT01828099|473839363|FG000|Extension-treatment Phase|Death|0|||
131602477|NCT01828099|473839364|FG001|Extension-treatment Phase|Death|11|||
131602478|NCT01828099|473839363|FG000|Extension-treatment Phase|Physician Decision|0|||
131602479|NCT01828099|473839364|FG001|Extension-treatment Phase|Physician Decision|5|||
131602480|NCT01828099|473839363|FG000|Extension-treatment Phase|Progressive disease|0|||
131602481|NCT01828099|473839364|FG001|Extension-treatment Phase|Progressive disease|54|||
131602482|NCT01828099|473839363|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
131602483|NCT01828099|473839364|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
131602484|NCT01828099|473839363|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
131602485|NCT01828099|473839364|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
131602486|NCT05934942|473839368|FG000|Run-in Period|Not treated|1|||
131602487|NCT05934942|473839368|FG000|Run-in Period|Withdrawal by Subject|1|||
131602488|NCT04362254|473839369|FG000|Overall Study|Adverse Event|1|||
131602489|NCT04362254|473839369|FG000|Overall Study|Protocol Violation|1|||
131602490|NCT04362254|473839369|FG000|Overall Study|Due to early termination of the trial|10|||
131602491|NCT01928394|473839370|FG000|Treatment Period|Disease progression|17|||
131602492|NCT01928394|473839371|FG001|Treatment Period|Disease progression|2|||
131602493|NCT01928394|473839372|FG002|Treatment Period|Disease progression|12|||
131602494|NCT01928394|473839373|FG003|Treatment Period|Disease progression|48|||
131602495|NCT01928394|473839374|FG004|Treatment Period|Disease progression|3|||
131602496|NCT01928394|473839375|FG005|Treatment Period|Disease progression|25|||
131602497|NCT01928394|473839376|FG006|Treatment Period|Disease progression|38|||
131602498|NCT01928394|473839377|FG007|Treatment Period|Disease progression|16|||
131602499|NCT01928394|473839378|FG008|Treatment Period|Disease progression|3|||
131602500|NCT01928394|473839379|FG009|Treatment Period|Disease progression|11|||
131602501|NCT01928394|473839380|FG010|Treatment Period|Disease progression|22|||
131602502|NCT01928394|473839381|FG011|Treatment Period|Disease progression|73|||
131602503|NCT01928394|473839382|FG012|Treatment Period|Disease progression|38|||
131602504|NCT01928394|473839383|FG013|Treatment Period|Disease progression|118|||
131602505|NCT01928394|473839384|FG014|Treatment Period|Disease progression|59|||
131602506|NCT01928394|473839385|FG015|Treatment Period|Disease progression|1|||
131602507|NCT01928394|473839386|FG016|Treatment Period|Disease progression|43|||
131602508|NCT01928394|473839387|FG017|Treatment Period|Disease progression|56|||
131706814|NCT01084551|474209253|FG001|Overall Study|Adverse Event|9|||
131706815|NCT01084551|474209254|FG002|Overall Study|Adverse Event|4|||
131706816|NCT01084551|474209252|FG000|Overall Study|Lack of Efficacy|2|||
131706817|NCT01084551|474209253|FG001|Overall Study|Lack of Efficacy|0|||
131706818|NCT01084551|474209254|FG002|Overall Study|Lack of Efficacy|1|||
131706819|NCT01084551|474209252|FG000|Overall Study|Withdrawal by Subject|2|||
131706820|NCT01084551|474209253|FG001|Overall Study|Withdrawal by Subject|1|||
131706821|NCT01084551|474209254|FG002|Overall Study|Withdrawal by Subject|0|||
131706822|NCT01084551|474209252|FG000|Overall Study|Protocol Violation|2|||
131706823|NCT01084551|474209253|FG001|Overall Study|Protocol Violation|4|||
131706824|NCT01084551|474209254|FG002|Overall Study|Protocol Violation|0|||
131706825|NCT01084551|474209252|FG000|Overall Study|Lost to Follow-up|0|||
131706826|NCT01084551|474209253|FG001|Overall Study|Lost to Follow-up|0|||
131706827|NCT01084551|474209254|FG002|Overall Study|Lost to Follow-up|3|||
131706828|NCT01084551|474209252|FG000|Overall Study|Physician Decision|1|||
131706829|NCT01084551|474209253|FG001|Overall Study|Physician Decision|0|||
131706830|NCT01084551|474209254|FG002|Overall Study|Physician Decision|0|||
131791637|NCT02884206|474520830|FG000|Double-Blind Period|Death|0|||
131791638|NCT02884206|474520831|FG001|Double-Blind Period|Death|28|||
131706831|NCT00463476|474209255|FG000|Overall Study|Withdrawal by Subject|1|||
131706832|NCT00463476|474209256|FG001|Overall Study|Withdrawal by Subject|2|||
131791639|NCT02884206|474520832|FG002|Double-Blind Period|Death|39|||
131706833|NCT00463476|474209255|FG000|Overall Study|Lost to Follow-up|1|||
131706834|NCT00463476|474209256|FG001|Overall Study|Lost to Follow-up|1|||
131706835|NCT00988247|474209257|FG000|Overall Study|Adverse Event|17|||
131706836|NCT00988247|474209258|FG001|Overall Study|Adverse Event|3|||
131791640|NCT02884206|474520830|FG000|Double-Blind Period|Patient/guardian decision|0|||
131791641|NCT02884206|474520831|FG001|Double-Blind Period|Patient/guardian decision|10|||
131602509|NCT01928394|473839388|FG018|Treatment Period|Disease progression|50|||
131602510|NCT01928394|473839389|FG019|Treatment Period|Disease progression|71|||
131602511|NCT01928394|473839390|FG020|Treatment Period|Disease progression|30|||
131602512|NCT01928394|473839391|FG021|Treatment Period|Disease progression|31|||
131602513|NCT01928394|473839392|FG022|Treatment Period|Disease progression|31|||
131602514|NCT01928394|473839370|FG000|Treatment Period|Study drug toxicity|1|||
131602515|NCT01928394|473839371|FG001|Treatment Period|Study drug toxicity|1|||
131602516|NCT01928394|473839372|FG002|Treatment Period|Study drug toxicity|3|||
131602517|NCT01928394|473839373|FG003|Treatment Period|Study drug toxicity|3|||
131602518|NCT01928394|473839374|FG004|Treatment Period|Study drug toxicity|0|||
131602519|NCT01928394|473839375|FG005|Treatment Period|Study drug toxicity|9|||
131602520|NCT01928394|473839376|FG006|Treatment Period|Study drug toxicity|7|||
131602521|NCT01928394|473839377|FG007|Treatment Period|Study drug toxicity|1|||
131602522|NCT01928394|473839378|FG008|Treatment Period|Study drug toxicity|0|||
131602523|NCT01928394|473839379|FG009|Treatment Period|Study drug toxicity|5|||
131602524|NCT01928394|473839380|FG010|Treatment Period|Study drug toxicity|2|||
131602525|NCT01928394|473839381|FG011|Treatment Period|Study drug toxicity|3|||
131602526|NCT01928394|473839382|FG012|Treatment Period|Study drug toxicity|7|||
131602527|NCT01928394|473839383|FG013|Treatment Period|Study drug toxicity|5|||
131602528|NCT01928394|473839384|FG014|Treatment Period|Study drug toxicity|12|||
131602529|NCT01928394|473839385|FG015|Treatment Period|Study drug toxicity|0|||
131602530|NCT01928394|473839386|FG016|Treatment Period|Study drug toxicity|3|||
131602531|NCT01928394|473839387|FG017|Treatment Period|Study drug toxicity|3|||
131602532|NCT01928394|473839388|FG018|Treatment Period|Study drug toxicity|12|||
131602533|NCT01928394|473839389|FG019|Treatment Period|Study drug toxicity|15|||
131602534|NCT01928394|473839390|FG020|Treatment Period|Study drug toxicity|4|||
131602535|NCT01928394|473839391|FG021|Treatment Period|Study drug toxicity|7|||
131602536|NCT01928394|473839392|FG022|Treatment Period|Study drug toxicity|4|||
131602537|NCT01928394|473839370|FG000|Treatment Period|AE unrelated to study drug|0|||
131602538|NCT01928394|473839371|FG001|Treatment Period|AE unrelated to study drug|0|||
131602539|NCT01928394|473839372|FG002|Treatment Period|AE unrelated to study drug|2|||
131602540|NCT01928394|473839373|FG003|Treatment Period|AE unrelated to study drug|3|||
131602541|NCT01928394|473839374|FG004|Treatment Period|AE unrelated to study drug|0|||
131602542|NCT01928394|473839375|FG005|Treatment Period|AE unrelated to study drug|5|||
131602543|NCT01928394|473839376|FG006|Treatment Period|AE unrelated to study drug|1|||
131602544|NCT01928394|473839377|FG007|Treatment Period|AE unrelated to study drug|0|||
131602545|NCT01928394|473839378|FG008|Treatment Period|AE unrelated to study drug|0|||
131602546|NCT01928394|473839379|FG009|Treatment Period|AE unrelated to study drug|2|||
131602547|NCT01928394|473839380|FG010|Treatment Period|AE unrelated to study drug|0|||
131602548|NCT01928394|473839381|FG011|Treatment Period|AE unrelated to study drug|12|||
131602549|NCT01928394|473839382|FG012|Treatment Period|AE unrelated to study drug|6|||
131602550|NCT01928394|473839383|FG013|Treatment Period|AE unrelated to study drug|13|||
131602551|NCT01928394|473839384|FG014|Treatment Period|AE unrelated to study drug|6|||
131602552|NCT01928394|473839385|FG015|Treatment Period|AE unrelated to study drug|1|||
131602553|NCT01928394|473839386|FG016|Treatment Period|AE unrelated to study drug|1|||
131602554|NCT01928394|473839387|FG017|Treatment Period|AE unrelated to study drug|6|||
131602555|NCT01928394|473839388|FG018|Treatment Period|AE unrelated to study drug|3|||
131602556|NCT01928394|473839389|FG019|Treatment Period|AE unrelated to study drug|5|||
131602557|NCT01928394|473839390|FG020|Treatment Period|AE unrelated to study drug|1|||
131602558|NCT01928394|473839391|FG021|Treatment Period|AE unrelated to study drug|1|||
131602559|NCT01928394|473839392|FG022|Treatment Period|AE unrelated to study drug|0|||
131602560|NCT01928394|473839370|FG000|Treatment Period|Participant request to stop therapy|0|||
131602561|NCT01928394|473839371|FG001|Treatment Period|Participant request to stop therapy|0|||
131602562|NCT01928394|473839372|FG002|Treatment Period|Participant request to stop therapy|0|||
131602563|NCT01928394|473839373|FG003|Treatment Period|Participant request to stop therapy|0|||
131602564|NCT01928394|473839374|FG004|Treatment Period|Participant request to stop therapy|0|||
131602565|NCT01928394|473839375|FG005|Treatment Period|Participant request to stop therapy|3|||
131602566|NCT01928394|473839376|FG006|Treatment Period|Participant request to stop therapy|3|||
131602567|NCT01928394|473839377|FG007|Treatment Period|Participant request to stop therapy|0|||
131602568|NCT01928394|473839378|FG008|Treatment Period|Participant request to stop therapy|0|||
131602569|NCT01928394|473839379|FG009|Treatment Period|Participant request to stop therapy|0|||
131602570|NCT01928394|473839380|FG010|Treatment Period|Participant request to stop therapy|3|||
131602571|NCT01928394|473839381|FG011|Treatment Period|Participant request to stop therapy|2|||
131791642|NCT02884206|474520832|FG002|Double-Blind Period|Patient/guardian decision|13|||
131791643|NCT02884206|474520830|FG000|Double-Blind Period|Lost to Follow-up|0|||
131791644|NCT02884206|474520831|FG001|Double-Blind Period|Lost to Follow-up|4|||
131791645|NCT02884206|474520832|FG002|Double-Blind Period|Lost to Follow-up|4|||
131791646|NCT02884206|474520830|FG000|Double-Blind Period|Physician Decision|0|||
131602572|NCT01928394|473839382|FG012|Treatment Period|Participant request to stop therapy|1|||
131602573|NCT01928394|473839383|FG013|Treatment Period|Participant request to stop therapy|2|||
131602574|NCT01928394|473839384|FG014|Treatment Period|Participant request to stop therapy|4|||
131602575|NCT01928394|473839385|FG015|Treatment Period|Participant request to stop therapy|0|||
131602576|NCT01928394|473839386|FG016|Treatment Period|Participant request to stop therapy|1|||
131602577|NCT01928394|473839387|FG017|Treatment Period|Participant request to stop therapy|3|||
131602578|NCT01928394|473839388|FG018|Treatment Period|Participant request to stop therapy|1|||
131602579|NCT01928394|473839389|FG019|Treatment Period|Participant request to stop therapy|1|||
131602580|NCT01928394|473839390|FG020|Treatment Period|Participant request to stop therapy|3|||
131602581|NCT01928394|473839391|FG021|Treatment Period|Participant request to stop therapy|1|||
131602582|NCT01928394|473839392|FG022|Treatment Period|Participant request to stop therapy|3|||
131602583|NCT01928394|473839370|FG000|Treatment Period|Participant withdrew consent|0|||
131602584|NCT01928394|473839371|FG001|Treatment Period|Participant withdrew consent|0|||
131602585|NCT01928394|473839372|FG002|Treatment Period|Participant withdrew consent|1|||
131602586|NCT01928394|473839373|FG003|Treatment Period|Participant withdrew consent|1|||
131602587|NCT01928394|473839374|FG004|Treatment Period|Participant withdrew consent|0|||
131602588|NCT01928394|473839375|FG005|Treatment Period|Participant withdrew consent|1|||
131602589|NCT01928394|473839376|FG006|Treatment Period|Participant withdrew consent|0|||
131602590|NCT01928394|473839377|FG007|Treatment Period|Participant withdrew consent|1|||
131602591|NCT01928394|473839378|FG008|Treatment Period|Participant withdrew consent|0|||
131602592|NCT01928394|473839379|FG009|Treatment Period|Participant withdrew consent|0|||
131602593|NCT01928394|473839380|FG010|Treatment Period|Participant withdrew consent|1|||
131602594|NCT01928394|473839381|FG011|Treatment Period|Participant withdrew consent|1|||
131602595|NCT01928394|473839382|FG012|Treatment Period|Participant withdrew consent|1|||
131602596|NCT01928394|473839383|FG013|Treatment Period|Participant withdrew consent|0|||
131602597|NCT01928394|473839384|FG014|Treatment Period|Participant withdrew consent|2|||
131602598|NCT01928394|473839385|FG015|Treatment Period|Participant withdrew consent|0|||
131602599|NCT01928394|473839386|FG016|Treatment Period|Participant withdrew consent|2|||
131602600|NCT01928394|473839387|FG017|Treatment Period|Participant withdrew consent|1|||
131602601|NCT01928394|473839388|FG018|Treatment Period|Participant withdrew consent|1|||
131602602|NCT01928394|473839389|FG019|Treatment Period|Participant withdrew consent|1|||
131602603|NCT01928394|473839390|FG020|Treatment Period|Participant withdrew consent|0|||
131602604|NCT01928394|473839391|FG021|Treatment Period|Participant withdrew consent|2|||
131602605|NCT01928394|473839392|FG022|Treatment Period|Participant withdrew consent|0|||
131602606|NCT01928394|473839370|FG000|Treatment Period|Poor/non-compliance|0|||
131602607|NCT01928394|473839371|FG001|Treatment Period|Poor/non-compliance|0|||
131602608|NCT01928394|473839372|FG002|Treatment Period|Poor/non-compliance|0|||
131602609|NCT01928394|473839373|FG003|Treatment Period|Poor/non-compliance|1|||
131602610|NCT01928394|473839374|FG004|Treatment Period|Poor/non-compliance|0|||
131602611|NCT01928394|473839375|FG005|Treatment Period|Poor/non-compliance|0|||
131706837|NCT00988247|474209257|FG000|Overall Study|Withdrawal by Subject|44|||
131706838|NCT00988247|474209258|FG001|Overall Study|Withdrawal by Subject|13|||
131706839|NCT00988247|474209257|FG000|Overall Study|Pregnancy|1|||
131602612|NCT01928394|473839376|FG006|Treatment Period|Poor/non-compliance|0|||
131602613|NCT01928394|473839377|FG007|Treatment Period|Poor/non-compliance|0|||
131602614|NCT01928394|473839378|FG008|Treatment Period|Poor/non-compliance|0|||
131602615|NCT01928394|473839379|FG009|Treatment Period|Poor/non-compliance|0|||
131602616|NCT01928394|473839380|FG010|Treatment Period|Poor/non-compliance|0|||
131602617|NCT01928394|473839381|FG011|Treatment Period|Poor/non-compliance|0|||
131602618|NCT01928394|473839382|FG012|Treatment Period|Poor/non-compliance|1|||
131602619|NCT01928394|473839383|FG013|Treatment Period|Poor/non-compliance|0|||
131602620|NCT01928394|473839384|FG014|Treatment Period|Poor/non-compliance|1|||
131602621|NCT01928394|473839385|FG015|Treatment Period|Poor/non-compliance|0|||
131602622|NCT01928394|473839386|FG016|Treatment Period|Poor/non-compliance|0|||
131602623|NCT01928394|473839387|FG017|Treatment Period|Poor/non-compliance|1|||
131602624|NCT01928394|473839388|FG018|Treatment Period|Poor/non-compliance|0|||
131602625|NCT01928394|473839389|FG019|Treatment Period|Poor/non-compliance|1|||
131602626|NCT01928394|473839390|FG020|Treatment Period|Poor/non-compliance|0|||
131602627|NCT01928394|473839391|FG021|Treatment Period|Poor/non-compliance|0|||
131602628|NCT01928394|473839392|FG022|Treatment Period|Poor/non-compliance|0|||
131602629|NCT01928394|473839370|FG000|Treatment Period|other reason|0|||
131602630|NCT01928394|473839371|FG001|Treatment Period|other reason|0|||
131602631|NCT01928394|473839372|FG002|Treatment Period|other reason|0|||
131602632|NCT01928394|473839373|FG003|Treatment Period|other reason|0|||
131602633|NCT01928394|473839374|FG004|Treatment Period|other reason|0|||
131602634|NCT01928394|473839375|FG005|Treatment Period|other reason|0|||
131602635|NCT01928394|473839376|FG006|Treatment Period|other reason|0|||
131706840|NCT00988247|474209258|FG001|Overall Study|Pregnancy|2|||
131706841|NCT00988247|474209257|FG000|Overall Study|Lost to Follow-up|11|||
131706842|NCT00988247|474209258|FG001|Overall Study|Lost to Follow-up|2|||
131706843|NCT00988247|474209257|FG000|Overall Study|Protocol Violation|4|||
131706844|NCT00988247|474209258|FG001|Overall Study|Protocol Violation|5|||
131706845|NCT00988247|474209257|FG000|Overall Study|Sponsor requested withdrawal|3|||
131706846|NCT00988247|474209258|FG001|Overall Study|Sponsor requested withdrawal|1|||
131706847|NCT00988247|474209257|FG000|Overall Study|Other|3|||
131706848|NCT00988247|474209258|FG001|Overall Study|Other|0|||
131706849|NCT02661594|474209259|FG000|Overall Study|Protocol Violation|1|||
131706850|NCT02661594|474209260|FG001|Overall Study|Protocol Violation|0|||
131706851|NCT02661594|474209261|FG002|Overall Study|Protocol Violation|1|||
131706852|NCT02661594|474209262|FG003|Overall Study|Protocol Violation|0|||
131706853|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706854|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
131706855|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706856|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706857|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706858|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
131791647|NCT02884206|474520831|FG001|Double-Blind Period|Physician Decision|2|||
131602636|NCT01928394|473839377|FG007|Treatment Period|other reason|0|||
131602637|NCT01928394|473839378|FG008|Treatment Period|other reason|0|||
131602638|NCT01928394|473839379|FG009|Treatment Period|other reason|0|||
131602639|NCT01928394|473839380|FG010|Treatment Period|other reason|1|||
131602640|NCT01928394|473839381|FG011|Treatment Period|other reason|1|||
131602641|NCT01928394|473839382|FG012|Treatment Period|other reason|1|||
131602642|NCT01928394|473839383|FG013|Treatment Period|other reason|0|||
131602643|NCT01928394|473839384|FG014|Treatment Period|other reason|1|||
131602644|NCT01928394|473839385|FG015|Treatment Period|other reason|0|||
131602645|NCT01928394|473839386|FG016|Treatment Period|other reason|0|||
131602646|NCT01928394|473839387|FG017|Treatment Period|other reason|0|||
131602647|NCT01928394|473839388|FG018|Treatment Period|other reason|2|||
131602648|NCT01928394|473839389|FG019|Treatment Period|other reason|2|||
131602649|NCT01928394|473839390|FG020|Treatment Period|other reason|0|||
131602650|NCT01928394|473839391|FG021|Treatment Period|other reason|0|||
131602651|NCT01928394|473839392|FG022|Treatment Period|other reason|0|||
131602652|NCT01928394|473839370|FG000|Treatment Period|Maximum clinical benefit|0|||
131602653|NCT01928394|473839371|FG001|Treatment Period|Maximum clinical benefit|0|||
131602654|NCT01928394|473839372|FG002|Treatment Period|Maximum clinical benefit|0|||
131602655|NCT01928394|473839373|FG003|Treatment Period|Maximum clinical benefit|0|||
131602656|NCT01928394|473839374|FG004|Treatment Period|Maximum clinical benefit|0|||
131602657|NCT01928394|473839375|FG005|Treatment Period|Maximum clinical benefit|0|||
131602658|NCT01928394|473839376|FG006|Treatment Period|Maximum clinical benefit|0|||
131602659|NCT01928394|473839377|FG007|Treatment Period|Maximum clinical benefit|0|||
131602660|NCT01928394|473839378|FG008|Treatment Period|Maximum clinical benefit|0|||
131602661|NCT01928394|473839379|FG009|Treatment Period|Maximum clinical benefit|0|||
131602662|NCT01928394|473839380|FG010|Treatment Period|Maximum clinical benefit|1|||
131602663|NCT01928394|473839381|FG011|Treatment Period|Maximum clinical benefit|1|||
131602664|NCT01928394|473839382|FG012|Treatment Period|Maximum clinical benefit|0|||
131602665|NCT01928394|473839383|FG013|Treatment Period|Maximum clinical benefit|0|||
131602666|NCT01928394|473839384|FG014|Treatment Period|Maximum clinical benefit|1|||
131602667|NCT01928394|473839385|FG015|Treatment Period|Maximum clinical benefit|0|||
131602668|NCT01928394|473839386|FG016|Treatment Period|Maximum clinical benefit|0|||
131602669|NCT01928394|473839387|FG017|Treatment Period|Maximum clinical benefit|1|||
131602670|NCT01928394|473839388|FG018|Treatment Period|Maximum clinical benefit|1|||
131602671|NCT01928394|473839389|FG019|Treatment Period|Maximum clinical benefit|0|||
131602672|NCT01928394|473839390|FG020|Treatment Period|Maximum clinical benefit|2|||
131602673|NCT01928394|473839391|FG021|Treatment Period|Maximum clinical benefit|0|||
131602674|NCT01928394|473839392|FG022|Treatment Period|Maximum clinical benefit|0|||
131602675|NCT01928394|473839370|FG000|Treatment Period|Lost to Follow-up|0|||
131602676|NCT01928394|473839371|FG001|Treatment Period|Lost to Follow-up|0|||
131602677|NCT01928394|473839372|FG002|Treatment Period|Lost to Follow-up|0|||
131602678|NCT01928394|473839373|FG003|Treatment Period|Lost to Follow-up|0|||
131602679|NCT01928394|473839374|FG004|Treatment Period|Lost to Follow-up|0|||
131602680|NCT01928394|473839375|FG005|Treatment Period|Lost to Follow-up|0|||
131602681|NCT01928394|473839376|FG006|Treatment Period|Lost to Follow-up|0|||
131602682|NCT01928394|473839377|FG007|Treatment Period|Lost to Follow-up|0|||
131602683|NCT01928394|473839378|FG008|Treatment Period|Lost to Follow-up|0|||
131602684|NCT01928394|473839379|FG009|Treatment Period|Lost to Follow-up|0|||
131602685|NCT01928394|473839380|FG010|Treatment Period|Lost to Follow-up|0|||
131602686|NCT01928394|473839381|FG011|Treatment Period|Lost to Follow-up|0|||
131602687|NCT01928394|473839382|FG012|Treatment Period|Lost to Follow-up|0|||
131602688|NCT01928394|473839383|FG013|Treatment Period|Lost to Follow-up|0|||
131602689|NCT01928394|473839384|FG014|Treatment Period|Lost to Follow-up|0|||
131602690|NCT01928394|473839385|FG015|Treatment Period|Lost to Follow-up|0|||
131602691|NCT01928394|473839386|FG016|Treatment Period|Lost to Follow-up|0|||
131602692|NCT01928394|473839387|FG017|Treatment Period|Lost to Follow-up|0|||
131602693|NCT01928394|473839388|FG018|Treatment Period|Lost to Follow-up|0|||
131602694|NCT01928394|473839389|FG019|Treatment Period|Lost to Follow-up|0|||
131602695|NCT01928394|473839390|FG020|Treatment Period|Lost to Follow-up|0|||
131602696|NCT01928394|473839391|FG021|Treatment Period|Lost to Follow-up|0|||
131602697|NCT01928394|473839392|FG022|Treatment Period|Lost to Follow-up|1|||
131602698|NCT01928394|473839370|FG000|Treatment Period|Death|0|||
131602699|NCT01928394|473839371|FG001|Treatment Period|Death|0|||
131602700|NCT01928394|473839372|FG002|Treatment Period|Death|0|||
131602701|NCT01928394|473839373|FG003|Treatment Period|Death|0|||
131602702|NCT01928394|473839374|FG004|Treatment Period|Death|0|||
131602703|NCT01928394|473839375|FG005|Treatment Period|Death|0|||
131602704|NCT01928394|473839376|FG006|Treatment Period|Death|0|||
131602705|NCT01928394|473839377|FG007|Treatment Period|Death|0|||
131602706|NCT01928394|473839378|FG008|Treatment Period|Death|0|||
131602707|NCT01928394|473839379|FG009|Treatment Period|Death|0|||
131602708|NCT01928394|473839380|FG010|Treatment Period|Death|0|||
131602709|NCT01928394|473839381|FG011|Treatment Period|Death|0|||
131602710|NCT01928394|473839382|FG012|Treatment Period|Death|0|||
131602711|NCT01928394|473839383|FG013|Treatment Period|Death|1|||
131602712|NCT01928394|473839384|FG014|Treatment Period|Death|2|||
131602713|NCT01928394|473839385|FG015|Treatment Period|Death|0|||
131602714|NCT01928394|473839386|FG016|Treatment Period|Death|0|||
131602715|NCT01928394|473839387|FG017|Treatment Period|Death|0|||
131602716|NCT01928394|473839388|FG018|Treatment Period|Death|0|||
131602717|NCT01928394|473839389|FG019|Treatment Period|Death|0|||
131602718|NCT01928394|473839390|FG020|Treatment Period|Death|0|||
131602719|NCT01928394|473839391|FG021|Treatment Period|Death|0|||
131602720|NCT01928394|473839392|FG022|Treatment Period|Death|0|||
131602721|NCT01928394|473839370|FG000|Follow-up Period|Participant withdrew consent|3|||
131602722|NCT01928394|473839371|FG001|Follow-up Period|Participant withdrew consent|0|||
131602723|NCT01928394|473839372|FG002|Follow-up Period|Participant withdrew consent|1|||
131602724|NCT01928394|473839373|FG003|Follow-up Period|Participant withdrew consent|4|||
131602725|NCT01928394|473839374|FG004|Follow-up Period|Participant withdrew consent|0|||
131602726|NCT01928394|473839375|FG005|Follow-up Period|Participant withdrew consent|2|||
131602727|NCT01928394|473839376|FG006|Follow-up Period|Participant withdrew consent|5|||
131602728|NCT01928394|473839377|FG007|Follow-up Period|Participant withdrew consent|1|||
131602729|NCT01928394|473839378|FG008|Follow-up Period|Participant withdrew consent|0|||
131602730|NCT01928394|473839379|FG009|Follow-up Period|Participant withdrew consent|0|||
131602731|NCT01928394|473839380|FG010|Follow-up Period|Participant withdrew consent|5|||
131602732|NCT01928394|473839381|FG011|Follow-up Period|Participant withdrew consent|8|||
131602733|NCT01928394|473839382|FG012|Follow-up Period|Participant withdrew consent|2|||
131602734|NCT01928394|473839383|FG013|Follow-up Period|Participant withdrew consent|12|||
131602735|NCT01928394|473839384|FG014|Follow-up Period|Participant withdrew consent|7|||
131602736|NCT01928394|473839385|FG015|Follow-up Period|Participant withdrew consent|0|||
131602737|NCT01928394|473839386|FG016|Follow-up Period|Participant withdrew consent|5|||
131602738|NCT01928394|473839387|FG017|Follow-up Period|Participant withdrew consent|3|||
131602739|NCT01928394|473839388|FG018|Follow-up Period|Participant withdrew consent|2|||
131602740|NCT01928394|473839389|FG019|Follow-up Period|Participant withdrew consent|7|||
131602741|NCT01928394|473839390|FG020|Follow-up Period|Participant withdrew consent|4|||
131706859|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
131706860|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
131706861|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
131602742|NCT01928394|473839391|FG021|Follow-up Period|Participant withdrew consent|6|||
131602743|NCT01928394|473839392|FG022|Follow-up Period|Participant withdrew consent|2|||
131602744|NCT01928394|473839370|FG000|Follow-up Period|Death|0|||
131602745|NCT01928394|473839371|FG001|Follow-up Period|Death|0|||
131602746|NCT01928394|473839372|FG002|Follow-up Period|Death|2|||
131602747|NCT01928394|473839373|FG003|Follow-up Period|Death|6|||
131602748|NCT01928394|473839374|FG004|Follow-up Period|Death|0|||
131602749|NCT01928394|473839375|FG005|Follow-up Period|Death|6|||
131602750|NCT01928394|473839376|FG006|Follow-up Period|Death|6|||
131602751|NCT01928394|473839377|FG007|Follow-up Period|Death|2|||
131602752|NCT01928394|473839378|FG008|Follow-up Period|Death|1|||
131602753|NCT01928394|473839379|FG009|Follow-up Period|Death|2|||
131602754|NCT01928394|473839380|FG010|Follow-up Period|Death|4|||
131602755|NCT01928394|473839381|FG011|Follow-up Period|Death|12|||
131602756|NCT01928394|473839382|FG012|Follow-up Period|Death|11|||
131602757|NCT01928394|473839383|FG013|Follow-up Period|Death|25|||
131602758|NCT01928394|473839384|FG014|Follow-up Period|Death|18|||
131602759|NCT01928394|473839385|FG015|Follow-up Period|Death|0|||
131602760|NCT01928394|473839386|FG016|Follow-up Period|Death|6|||
131602761|NCT01928394|473839387|FG017|Follow-up Period|Death|5|||
131602762|NCT01928394|473839388|FG018|Follow-up Period|Death|13|||
131602763|NCT01928394|473839389|FG019|Follow-up Period|Death|13|||
131602764|NCT01928394|473839390|FG020|Follow-up Period|Death|5|||
131602765|NCT01928394|473839391|FG021|Follow-up Period|Death|3|||
131602766|NCT01928394|473839392|FG022|Follow-up Period|Death|2|||
131602767|NCT01928394|473839370|FG000|Follow-up Period|other reason|0|||
131602768|NCT01928394|473839371|FG001|Follow-up Period|other reason|0|||
131602769|NCT01928394|473839372|FG002|Follow-up Period|other reason|0|||
131602770|NCT01928394|473839373|FG003|Follow-up Period|other reason|0|||
131602771|NCT01928394|473839374|FG004|Follow-up Period|other reason|0|||
131602772|NCT01928394|473839375|FG005|Follow-up Period|other reason|0|||
131602773|NCT01928394|473839376|FG006|Follow-up Period|other reason|1|||
131602774|NCT01928394|473839377|FG007|Follow-up Period|other reason|3|||
131602775|NCT01928394|473839378|FG008|Follow-up Period|other reason|0|||
131602776|NCT01928394|473839379|FG009|Follow-up Period|other reason|0|||
131602777|NCT01928394|473839380|FG010|Follow-up Period|other reason|2|||
131602778|NCT01928394|473839381|FG011|Follow-up Period|other reason|1|||
131602779|NCT01928394|473839382|FG012|Follow-up Period|other reason|0|||
131602780|NCT01928394|473839383|FG013|Follow-up Period|other reason|1|||
131602781|NCT01928394|473839384|FG014|Follow-up Period|other reason|4|||
131602782|NCT01928394|473839385|FG015|Follow-up Period|other reason|0|||
131602783|NCT01928394|473839386|FG016|Follow-up Period|other reason|2|||
131602784|NCT01928394|473839387|FG017|Follow-up Period|other reason|0|||
131602785|NCT01928394|473839388|FG018|Follow-up Period|other reason|1|||
131602786|NCT01928394|473839389|FG019|Follow-up Period|other reason|1|||
131602787|NCT01928394|473839390|FG020|Follow-up Period|other reason|0|||
131602788|NCT01928394|473839391|FG021|Follow-up Period|other reason|0|||
131602789|NCT01928394|473839392|FG022|Follow-up Period|other reason|1|||
131602790|NCT01928394|473839370|FG000|Follow-up Period|Lost to Follow-up|0|||
131602791|NCT01928394|473839371|FG001|Follow-up Period|Lost to Follow-up|0|||
131602792|NCT01928394|473839372|FG002|Follow-up Period|Lost to Follow-up|0|||
131602793|NCT01928394|473839373|FG003|Follow-up Period|Lost to Follow-up|0|||
131602794|NCT01928394|473839374|FG004|Follow-up Period|Lost to Follow-up|0|||
131602795|NCT01928394|473839375|FG005|Follow-up Period|Lost to Follow-up|0|||
131602796|NCT01928394|473839376|FG006|Follow-up Period|Lost to Follow-up|0|||
131602797|NCT01928394|473839377|FG007|Follow-up Period|Lost to Follow-up|0|||
131602798|NCT01928394|473839378|FG008|Follow-up Period|Lost to Follow-up|0|||
131602799|NCT01928394|473839379|FG009|Follow-up Period|Lost to Follow-up|0|||
131602800|NCT01928394|473839380|FG010|Follow-up Period|Lost to Follow-up|0|||
131602801|NCT01928394|473839381|FG011|Follow-up Period|Lost to Follow-up|1|||
131602802|NCT01928394|473839382|FG012|Follow-up Period|Lost to Follow-up|1|||
131602803|NCT01928394|473839383|FG013|Follow-up Period|Lost to Follow-up|0|||
131602804|NCT01928394|473839384|FG014|Follow-up Period|Lost to Follow-up|1|||
131602805|NCT01928394|473839385|FG015|Follow-up Period|Lost to Follow-up|0|||
131602806|NCT01928394|473839386|FG016|Follow-up Period|Lost to Follow-up|1|||
131602807|NCT01928394|473839387|FG017|Follow-up Period|Lost to Follow-up|0|||
131602808|NCT01928394|473839388|FG018|Follow-up Period|Lost to Follow-up|0|||
131602809|NCT01928394|473839389|FG019|Follow-up Period|Lost to Follow-up|0|||
131602810|NCT01928394|473839390|FG020|Follow-up Period|Lost to Follow-up|0|||
131602811|NCT01928394|473839391|FG021|Follow-up Period|Lost to Follow-up|0|||
131602812|NCT01928394|473839392|FG022|Follow-up Period|Lost to Follow-up|1|||
131602813|NCT04707625|473839393|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
131602814|NCT00321048|473839394|FG000|Overall Study|Withdrawal by Subject|6|||
131602815|NCT00321048|473839395|FG001|Overall Study|Withdrawal by Subject|8|||
131602816|NCT04971109|473839398|FG000|Overall Study|Adverse Event|4|||
131602817|NCT04971109|473839399|FG001|Overall Study|Adverse Event|3|||
131602818|NCT04971109|473839398|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
131602819|NCT04971109|473839399|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
131602820|NCT04971109|473839398|FG000|Overall Study|Lost to Follow-up|8|||
131602821|NCT04971109|473839399|FG001|Overall Study|Lost to Follow-up|2|||
131602822|NCT04971109|473839398|FG000|Overall Study|Physician Decision|5|||
131602823|NCT04971109|473839399|FG001|Overall Study|Physician Decision|0|||
131602824|NCT04971109|473839398|FG000|Overall Study|Protocol Violation|0|||
131602825|NCT04971109|473839399|FG001|Overall Study|Protocol Violation|1|||
131602826|NCT04971109|473839398|FG000|Overall Study|Withdrawal by Subject|18|||
131602827|NCT04971109|473839399|FG001|Overall Study|Withdrawal by Subject|3|||
131602828|NCT04971109|473839398|FG000|Overall Study|Subject was randomized in error|1|||
131602829|NCT04971109|473839399|FG001|Overall Study|Subject was randomized in error|0|||
131602830|NCT05293171|473839401|FG000|Washout 5 to 7 Days|Adverse Event|1|||
131602831|NCT05293171|473839402|FG001|Washout 5 to 7 Days|Adverse Event|1|||
131602832|NCT05293171|473839403|FG002|Washout 5 to 7 Days|Adverse Event|0|||
131602833|NCT05293171|473839404|FG003|Washout 5 to 7 Days|Adverse Event|0|||
131602834|NCT05293171|473839405|FG004|Washout 5 to 7 Days|Adverse Event|0|||
131602835|NCT05293171|473839406|FG005|Washout 5 to 7 Days|Adverse Event|0|||
131602836|NCT05293171|473839407|FG006|Washout 5 to 7 Days|Adverse Event|0|||
131602837|NCT05293171|473839408|FG007|Washout 5 to 7 Days|Adverse Event|0|||
131602838|NCT05293171|473839409|FG008|Washout 5 to 7 Days|Adverse Event|0|||
131602839|NCT05293171|473839410|FG009|Washout 5 to 7 Days|Adverse Event|0|||
131602840|NCT05293171|473839411|FG010|Washout 5 to 7 Days|Adverse Event|0|||
131602841|NCT05293171|473839412|FG011|Washout 5 to 7 Days|Adverse Event|0|||
131602842|NCT05293171|473839401|FG000|Washout 5 to 7 Days|Adverse Event|0|||
131602843|NCT05293171|473839402|FG001|Washout 5 to 7 Days|Adverse Event|0|||
131602844|NCT05293171|473839403|FG002|Washout 5 to 7 Days|Adverse Event|0|||
131602845|NCT05293171|473839404|FG003|Washout 5 to 7 Days|Adverse Event|0|||
131602846|NCT05293171|473839405|FG004|Washout 5 to 7 Days|Adverse Event|0|||
131602847|NCT05293171|473839406|FG005|Washout 5 to 7 Days|Adverse Event|1|||
131602848|NCT05293171|473839407|FG006|Washout 5 to 7 Days|Adverse Event|0|||
131602849|NCT05293171|473839408|FG007|Washout 5 to 7 Days|Adverse Event|0|||
131602850|NCT05293171|473839409|FG008|Washout 5 to 7 Days|Adverse Event|0|||
131602851|NCT05293171|473839410|FG009|Washout 5 to 7 Days|Adverse Event|0|||
131602852|NCT05293171|473839411|FG010|Washout 5 to 7 Days|Adverse Event|0|||
131602853|NCT05293171|473839412|FG011|Washout 5 to 7 Days|Adverse Event|0|||
131602854|NCT01712490|473839418|FG000|Overall Study|Ongoing|601|||
131602855|NCT01712490|473839419|FG001|Overall Study|Ongoing|586|||
131602856|NCT01712490|473839418|FG000|Overall Study|Other|11|||
131602857|NCT01712490|473839419|FG001|Overall Study|Other|11|||
131602858|NCT01712490|473839418|FG000|Overall Study|Withdrawal by Subject|36|||
131602859|NCT01712490|473839419|FG001|Overall Study|Withdrawal by Subject|44|||
131602860|NCT01712490|473839418|FG000|Overall Study|Lost to Follow-up|16|||
131602861|NCT01712490|473839419|FG001|Overall Study|Lost to Follow-up|29|||
131602862|NCT03987022|473839420|FG000|Overall Study|Lost to Follow-up|2|||
131602863|NCT03987022|473839421|FG001|Overall Study|Lost to Follow-up|2|||
131602864|NCT03987022|473839420|FG000|Overall Study|Withdrawal by Subject|1|||
131602865|NCT03987022|473839421|FG001|Overall Study|Withdrawal by Subject|0|||
131602866|NCT02724969|473839439|FG000|Overall Study|Lost to Follow-up|12|||
131602867|NCT02724969|473839440|FG001|Overall Study|Lost to Follow-up|6|||
131602868|NCT02724969|473839439|FG000|Overall Study|Withdrawal by Subject|3|||
131602869|NCT02724969|473839440|FG001|Overall Study|Withdrawal by Subject|3|||
131602870|NCT02724969|473839439|FG000|Overall Study|Infant demise|0|||
131602871|NCT02724969|473839440|FG001|Overall Study|Infant demise|2|||
131602872|NCT01346540|473839441|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
131602873|NCT01346540|473839442|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
131602874|NCT01346540|473839441|FG000|Overall Study|Adverse Event|0|||
131602875|NCT01346540|473839442|FG001|Overall Study|Adverse Event|4|||
131602876|NCT03362476|473839447|FG000|Overall Study|Withdrawal by Subject|0|||
131602877|NCT03362476|473839448|FG001|Overall Study|Withdrawal by Subject|1|||
131602878|NCT03672916|473839450|FG000|Overall Study|Death|6|||
131602879|NCT03672916|473839450|FG000|Overall Study|Lost to Follow-up|29|||
131602880|NCT03672916|473839450|FG000|Overall Study|Adverse Event|6|||
131602881|NCT03672916|473839450|FG000|Overall Study|Withdrawal by Subject|11|||
131602882|NCT00746096|473839451|FG000|Overall Study|Adverse Event|1|||
131602883|NCT00746096|473839452|FG001|Overall Study|Adverse Event|0|||
131602884|NCT00746096|473839451|FG000|Overall Study|Withdrawal by Subject|5|||
131602885|NCT00746096|473839452|FG001|Overall Study|Withdrawal by Subject|1|||
131602886|NCT00746096|473839451|FG000|Overall Study|Lost to Follow-up|2|||
131602887|NCT00746096|473839452|FG001|Overall Study|Lost to Follow-up|1|||
131602888|NCT00746096|473839451|FG000|Overall Study|Protocol Violation|1|||
131602889|NCT00746096|473839452|FG001|Overall Study|Protocol Violation|0|||
131602890|NCT00746096|473839451|FG000|Overall Study|No study drug treatment|1|||
131602891|NCT00746096|473839452|FG001|Overall Study|No study drug treatment|1|||
131602892|NCT05623228|473839456|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
131602893|NCT05623228|473839457|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131602894|NCT05623228|473839458|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131602895|NCT05623228|473839459|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131602896|NCT05623228|473839460|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131440382|NCT00446849|473241481|FG000|Maintenance Phase|noncompliance|2|||
131602897|NCT05623228|473839461|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131602898|NCT05623228|473839462|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131602899|NCT05623228|473839463|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131440383|NCT00446849|473241481|FG000|Maintenance Phase|prohibited medication use|2|||
131602900|NCT05623228|473839456|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
131602901|NCT05623228|473839457|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131602902|NCT05623228|473839458|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
131602903|NCT05623228|473839459|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
131602904|NCT05623228|473839460|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131602905|NCT05623228|473839461|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131602906|NCT05623228|473839462|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131602907|NCT05623228|473839463|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131602908|NCT04141891|473839464|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
131602909|NCT04141891|473839465|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
131602910|NCT04141891|473839464|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
131602911|NCT04141891|473839465|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
131602912|NCT04141891|473839464|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
131602913|NCT04141891|473839465|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
131602914|NCT04141891|473839464|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
131602915|NCT04141891|473839465|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
131602916|NCT04141891|473839464|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
131602917|NCT04141891|473839465|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
131602918|NCT04141891|473839464|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
131602919|NCT04141891|473839465|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
131602920|NCT04141891|473839464|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
131602921|NCT04141891|473839465|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
131602922|NCT04141891|473839464|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
131602923|NCT04141891|473839465|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
131602924|NCT04141891|473839464|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
131602925|NCT04141891|473839465|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
131602926|NCT04141891|473839464|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
131602927|NCT04141891|473839465|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
131602928|NCT04141891|473839464|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
131602929|NCT04141891|473839465|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
131602930|NCT04141891|473839464|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
131602931|NCT04141891|473839465|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
131602932|NCT04141891|473839464|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
131602933|NCT04141891|473839465|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
131602934|NCT04141891|473839464|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
131602935|NCT04141891|473839465|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
131602936|NCT04737330|473839466|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
131602937|NCT04737330|473839467|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
131602938|NCT04737330|473839466|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
131602939|NCT04737330|473839467|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
131602940|NCT04737330|473839466|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
131602941|NCT04737330|473839467|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
131602942|NCT04737330|473839466|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
131602943|NCT04737330|473839467|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
131602944|NCT04737330|473839466|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
131602945|NCT04737330|473839467|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
131602946|NCT04737330|473839466|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
131602947|NCT04737330|473839467|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
131602948|NCT04625725|473839468|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
131602949|NCT04625725|473839469|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131602950|NCT04625725|473839470|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131602951|NCT04625725|473839471|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131602952|NCT04625725|473839472|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131602953|NCT04625725|473839473|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131602954|NCT04625725|473839468|FG000|Provent Main Study|Withdrawal by Subject|242|||
131602955|NCT04625725|473839469|FG001|Provent Main Study|Withdrawal by Subject|144|||
131791648|NCT02884206|474520832|FG002|Double-Blind Period|Physician Decision|0|||
131791649|NCT02884206|474520830|FG000|Double-Blind Period|Adverse Event|0|||
131791650|NCT02884206|474520831|FG001|Double-Blind Period|Adverse Event|0|||
131791651|NCT02884206|474520832|FG002|Double-Blind Period|Adverse Event|3|||
131791652|NCT02884206|474520830|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
131791653|NCT02884206|474520831|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
131791654|NCT02884206|474520832|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
131791655|NCT04467697|474520833|FG000|Overall Study|Adverse Event|2|||
131602956|NCT04625725|473839470|FG002|Provent Main Study|Withdrawal by Subject|0|||
131791656|NCT04467697|474520833|FG000|Overall Study|Lost to Follow-up|6|||
131791657|NCT04467697|474520833|FG000|Overall Study|Withdrawal by Subject|9|||
131602957|NCT04625725|473839471|FG003|Provent Main Study|Withdrawal by Subject|0|||
131602958|NCT04625725|473839472|FG004|Provent Main Study|Withdrawal by Subject|0|||
131791658|NCT04467697|474520833|FG000|Overall Study|Protocol Violation|3|||
131602959|NCT04625725|473839473|FG005|Provent Main Study|Withdrawal by Subject|0|||
131602960|NCT04625725|473839468|FG000|Provent Main Study|Physician Decision|5|||
131602961|NCT04625725|473839469|FG001|Provent Main Study|Physician Decision|0|||
131602962|NCT04625725|473839470|FG002|Provent Main Study|Physician Decision|0|||
131602963|NCT04625725|473839471|FG003|Provent Main Study|Physician Decision|0|||
131602964|NCT04625725|473839472|FG004|Provent Main Study|Physician Decision|0|||
131602965|NCT04625725|473839473|FG005|Provent Main Study|Physician Decision|0|||
131602966|NCT04625725|473839468|FG000|Provent Main Study|Protocol Violation|1|||
131602967|NCT04625725|473839469|FG001|Provent Main Study|Protocol Violation|0|||
131602968|NCT04625725|473839470|FG002|Provent Main Study|Protocol Violation|0|||
131706862|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
131706863|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131706864|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131706865|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131602969|NCT04625725|473839471|FG003|Provent Main Study|Protocol Violation|0|||
131602970|NCT04625725|473839472|FG004|Provent Main Study|Protocol Violation|0|||
131602971|NCT04625725|473839473|FG005|Provent Main Study|Protocol Violation|0|||
131602972|NCT04625725|473839468|FG000|Provent Main Study|Lost to Follow-up|357|||
131602973|NCT04625725|473839469|FG001|Provent Main Study|Lost to Follow-up|200|||
131602974|NCT04625725|473839470|FG002|Provent Main Study|Lost to Follow-up|0|||
131602975|NCT04625725|473839471|FG003|Provent Main Study|Lost to Follow-up|0|||
131602976|NCT04625725|473839472|FG004|Provent Main Study|Lost to Follow-up|0|||
131602977|NCT04625725|473839473|FG005|Provent Main Study|Lost to Follow-up|0|||
131602978|NCT04625725|473839468|FG000|Provent Main Study|Death|22|||
131602979|NCT04625725|473839469|FG001|Provent Main Study|Death|10|||
131602980|NCT04625725|473839470|FG002|Provent Main Study|Death|0|||
131602981|NCT04625725|473839471|FG003|Provent Main Study|Death|0|||
131602982|NCT04625725|473839472|FG004|Provent Main Study|Death|0|||
131602983|NCT04625725|473839473|FG005|Provent Main Study|Death|0|||
131602984|NCT04625725|473839468|FG000|Provent Main Study|Adverse Event|2|||
131602985|NCT04625725|473839469|FG001|Provent Main Study|Adverse Event|1|||
131602986|NCT04625725|473839470|FG002|Provent Main Study|Adverse Event|0|||
131602987|NCT04625725|473839471|FG003|Provent Main Study|Adverse Event|0|||
131602988|NCT04625725|473839472|FG004|Provent Main Study|Adverse Event|0|||
131602989|NCT04625725|473839473|FG005|Provent Main Study|Adverse Event|0|||
131602990|NCT04625725|473839468|FG000|Provent Main Study|Participants dosed in sub-study|310|||
131602991|NCT04625725|473839469|FG001|Provent Main Study|Participants dosed in sub-study|193|||
131602992|NCT04625725|473839470|FG002|Provent Main Study|Participants dosed in sub-study|0|||
131602993|NCT04625725|473839471|FG003|Provent Main Study|Participants dosed in sub-study|0|||
131602994|NCT04625725|473839472|FG004|Provent Main Study|Participants dosed in sub-study|0|||
131602995|NCT04625725|473839473|FG005|Provent Main Study|Participants dosed in sub-study|0|||
131602996|NCT04625725|473839468|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
131602997|NCT04625725|473839469|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
131602998|NCT04625725|473839470|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131602999|NCT04625725|473839471|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131603000|NCT04625725|473839472|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131603001|NCT04625725|473839473|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131603002|NCT04625725|473839468|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
131603003|NCT04625725|473839469|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
131603004|NCT04625725|473839470|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131603005|NCT04625725|473839471|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131603006|NCT04625725|473839472|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131706866|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131706867|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131706868|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131706869|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131706870|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131603007|NCT04625725|473839473|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131603008|NCT04625725|473839468|FG000|Provent Main Study|INCARCERATION|3|||
131706871|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131706872|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
131706873|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706874|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131603009|NCT04625725|473839469|FG001|Provent Main Study|INCARCERATION|0|||
131603010|NCT04625725|473839470|FG002|Provent Main Study|INCARCERATION|0|||
131603011|NCT04625725|473839471|FG003|Provent Main Study|INCARCERATION|0|||
131603012|NCT04625725|473839472|FG004|Provent Main Study|INCARCERATION|0|||
131603013|NCT04625725|473839473|FG005|Provent Main Study|INCARCERATION|0|||
131603014|NCT04625725|473839468|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
131603015|NCT04625725|473839469|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
131603016|NCT04625725|473839470|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131603017|NCT04625725|473839471|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131603018|NCT04625725|473839472|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131603019|NCT04625725|473839473|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131603020|NCT04625725|473839468|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
131603021|NCT04625725|473839469|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
131603022|NCT04625725|473839470|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131603023|NCT04625725|473839471|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131603024|NCT04625725|473839472|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131603025|NCT04625725|473839473|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131603026|NCT04625725|473839468|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
131603027|NCT04625725|473839469|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
131603028|NCT04625725|473839470|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131603029|NCT04625725|473839471|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131603030|NCT04625725|473839472|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131603031|NCT04625725|473839473|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131603032|NCT04625725|473839468|FG000|Provent Main Study|MISSING REASON|0|||
131603033|NCT04625725|473839469|FG001|Provent Main Study|MISSING REASON|1|||
131603034|NCT04625725|473839470|FG002|Provent Main Study|MISSING REASON|0|||
131603035|NCT04625725|473839471|FG003|Provent Main Study|MISSING REASON|0|||
131603036|NCT04625725|473839472|FG004|Provent Main Study|MISSING REASON|0|||
131603037|NCT04625725|473839473|FG005|Provent Main Study|MISSING REASON|0|||
131603038|NCT04625725|473839468|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131603039|NCT04625725|473839469|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131603040|NCT04625725|473839470|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131603041|NCT04625725|473839471|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
131603042|NCT04625725|473839472|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131603043|NCT04625725|473839473|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131603044|NCT04625725|473839468|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131603045|NCT04625725|473839469|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131603046|NCT04625725|473839470|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
131603047|NCT04625725|473839471|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131603048|NCT04625725|473839472|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131603049|NCT04625725|473839473|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131603050|NCT04625725|473839468|FG000|Provent Sub Study|Lost to Follow-up|0|||
131603051|NCT04625725|473839469|FG001|Provent Sub Study|Lost to Follow-up|0|||
131603052|NCT04625725|473839470|FG002|Provent Sub Study|Lost to Follow-up|20|||
131603053|NCT04625725|473839471|FG003|Provent Sub Study|Lost to Follow-up|10|||
131603054|NCT04625725|473839472|FG004|Provent Sub Study|Lost to Follow-up|6|||
131603055|NCT04625725|473839473|FG005|Provent Sub Study|Lost to Follow-up|4|||
131603056|NCT04625725|473839468|FG000|Provent Sub Study|Death|0|||
131603057|NCT04625725|473839469|FG001|Provent Sub Study|Death|0|||
131603058|NCT04625725|473839470|FG002|Provent Sub Study|Death|8|||
131603059|NCT04625725|473839471|FG003|Provent Sub Study|Death|5|||
131603060|NCT04625725|473839472|FG004|Provent Sub Study|Death|0|||
131603061|NCT04625725|473839473|FG005|Provent Sub Study|Death|1|||
131603062|NCT04625725|473839468|FG000|Provent Sub Study|Adverse Event|0|||
131603063|NCT04625725|473839469|FG001|Provent Sub Study|Adverse Event|0|||
131603064|NCT04625725|473839470|FG002|Provent Sub Study|Adverse Event|0|||
131603065|NCT04625725|473839471|FG003|Provent Sub Study|Adverse Event|0|||
131603066|NCT04625725|473839472|FG004|Provent Sub Study|Adverse Event|0|||
131603067|NCT04625725|473839473|FG005|Provent Sub Study|Adverse Event|1|||
131603068|NCT04625725|473839468|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131603069|NCT04625725|473839469|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131603070|NCT04625725|473839470|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131706875|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131603071|NCT04625725|473839471|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131603072|NCT04625725|473839472|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
131706876|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131603073|NCT04625725|473839473|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131603074|NCT04625725|473839468|FG000|Provent Sub Study|Withdrawal by Subject|0|||
131791659|NCT02231710|474520836|FG000|Overall Study|Physician Decision|1|||
131603075|NCT04625725|473839469|FG001|Provent Sub Study|Withdrawal by Subject|0|||
131603076|NCT04625725|473839470|FG002|Provent Sub Study|Withdrawal by Subject|11|||
131603077|NCT04625725|473839471|FG003|Provent Sub Study|Withdrawal by Subject|13|||
131603078|NCT04625725|473839472|FG004|Provent Sub Study|Withdrawal by Subject|5|||
131603079|NCT04625725|473839473|FG005|Provent Sub Study|Withdrawal by Subject|6|||
131603080|NCT04625725|473839468|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131603081|NCT04625725|473839469|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131603082|NCT04625725|473839470|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131603083|NCT04625725|473839471|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131603084|NCT04625725|473839472|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131603085|NCT04625725|473839473|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
131603086|NCT01651403|473839479|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
131603087|NCT01651403|473839480|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
131603088|NCT01651403|473839479|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
131603089|NCT01651403|473839480|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
131603090|NCT01651403|473839479|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
131603091|NCT01651403|473839480|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
131603092|NCT01651403|473839479|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
131603093|NCT01651403|473839480|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
131603094|NCT01651403|473839479|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
131603095|NCT01651403|473839480|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
131603096|NCT01651403|473839479|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
131603097|NCT01651403|473839480|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
131603098|NCT04231149|473841239|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131603099|NCT04231149|473841240|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
131603100|NCT04231149|473841241|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131603101|NCT04231149|473841242|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131603102|NCT04231149|473841243|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131603103|NCT05877976|473841244|FG000|Overall Study|Lost to Follow-up|31|||
131603104|NCT05622812|473841245|FG000|Overall Study|Withdrawal by Subject|1|||
131603105|NCT05622812|473841246|FG001|Overall Study|Withdrawal by Subject|4|||
131603106|NCT05622812|473841245|FG000|Overall Study|Lost to Follow-up|2|||
131603107|NCT05622812|473841246|FG001|Overall Study|Lost to Follow-up|1|||
131603108|NCT05671653|473841247|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
131603109|NCT05671653|473841248|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
131603110|NCT05671653|473841249|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
131603111|NCT05671653|473841250|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
131603112|NCT05671653|473841251|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
131603113|NCT05671653|473841252|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
131603114|NCT05671653|473841253|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
131603115|NCT05671653|473841254|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
131603116|NCT05671653|473841255|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
131603117|NCT05671653|473841256|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
131706877|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706878|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
131706879|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
131706880|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131603118|NCT05671653|473841257|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
131603119|NCT05671653|473841258|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
131603120|NCT05671653|473841259|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
131603121|NCT05671653|473841247|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603122|NCT05671653|473841248|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603123|NCT05671653|473841249|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603124|NCT05671653|473841250|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603125|NCT05671653|473841251|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603126|NCT05671653|473841252|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
131603127|NCT05671653|473841253|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603128|NCT05671653|473841254|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603129|NCT05671653|473841255|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603130|NCT05671653|473841256|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603131|NCT05671653|473841257|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603132|NCT05671653|473841258|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603133|NCT05671653|473841259|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131603134|NCT05671653|473841247|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603135|NCT05671653|473841248|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603136|NCT05671653|473841249|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603137|NCT05671653|473841250|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603138|NCT05671653|473841251|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603139|NCT05671653|473841252|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
131603140|NCT05671653|473841253|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603141|NCT05671653|473841254|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603142|NCT05671653|473841255|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603143|NCT05671653|473841256|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603144|NCT05671653|473841257|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131440384|NCT00446849|473241481|FG000|Maintenance Phase|antibiotic use|1|||
131440385|NCT00446849|473241481|FG000|Maintenance Phase|study closure|1|||
131440386|NCT00446849|473241481|FG000|Maintenance Phase|hydrocodone use|1|||
131603145|NCT05671653|473841258|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603146|NCT05671653|473841259|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131603147|NCT05671653|473841247|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131440387|NCT00446849|473241481|FG000|Maintenance Phase|concomitant medication use|1|||
131440388|NCT01194830|473241482|FG000|Overall Study|Adverse Event|3|||
131440389|NCT01194830|473241483|FG001|Overall Study|Adverse Event|2|||
131603148|NCT05671653|473841248|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603149|NCT05671653|473841249|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603150|NCT05671653|473841250|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603151|NCT05671653|473841251|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603152|NCT05671653|473841252|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603153|NCT05671653|473841253|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603154|NCT05671653|473841254|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603155|NCT05671653|473841255|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
131603156|NCT05671653|473841256|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603157|NCT05671653|473841257|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603158|NCT05671653|473841258|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603159|NCT05671653|473841259|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131603160|NCT05671653|473841247|FG000|Cohort 2 Period 2|Adverse Event|0|||
131603161|NCT05671653|473841248|FG001|Cohort 2 Period 2|Adverse Event|0|||
131603162|NCT05671653|473841249|FG002|Cohort 2 Period 2|Adverse Event|0|||
131603163|NCT05671653|473841250|FG003|Cohort 2 Period 2|Adverse Event|0|||
131603164|NCT05671653|473841251|FG004|Cohort 2 Period 2|Adverse Event|0|||
131603165|NCT05671653|473841252|FG005|Cohort 2 Period 2|Adverse Event|0|||
131603166|NCT05671653|473841253|FG006|Cohort 2 Period 2|Adverse Event|0|||
131603167|NCT05671653|473841254|FG007|Cohort 2 Period 2|Adverse Event|0|||
131603168|NCT05671653|473841255|FG008|Cohort 2 Period 2|Adverse Event|0|||
131603169|NCT05671653|473841256|FG009|Cohort 2 Period 2|Adverse Event|0|||
131603170|NCT05671653|473841257|FG010|Cohort 2 Period 2|Adverse Event|1|||
131603171|NCT05671653|473841258|FG011|Cohort 2 Period 2|Adverse Event|0|||
131603172|NCT05671653|473841259|FG012|Cohort 2 Period 2|Adverse Event|0|||
131603173|NCT05671653|473841247|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
131603174|NCT05671653|473841248|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
131603175|NCT05671653|473841249|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
131603176|NCT05671653|473841250|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
131603177|NCT05671653|473841251|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
131603178|NCT05671653|473841252|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
131603179|NCT05671653|473841253|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
131603180|NCT05671653|473841254|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
131603181|NCT05671653|473841255|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
131603182|NCT05671653|473841256|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
131603183|NCT05671653|473841257|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
131603184|NCT05671653|473841258|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
131603185|NCT05671653|473841259|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
131603186|NCT05671653|473841247|FG000|Cohort 2 Period 2|Pregnancy|0|||
131603187|NCT05671653|473841248|FG001|Cohort 2 Period 2|Pregnancy|0|||
131603188|NCT05671653|473841249|FG002|Cohort 2 Period 2|Pregnancy|0|||
131603189|NCT05671653|473841250|FG003|Cohort 2 Period 2|Pregnancy|0|||
131603190|NCT05671653|473841251|FG004|Cohort 2 Period 2|Pregnancy|0|||
131603191|NCT05671653|473841252|FG005|Cohort 2 Period 2|Pregnancy|0|||
131603192|NCT05671653|473841253|FG006|Cohort 2 Period 2|Pregnancy|0|||
131603193|NCT05671653|473841254|FG007|Cohort 2 Period 2|Pregnancy|0|||
131603194|NCT05671653|473841255|FG008|Cohort 2 Period 2|Pregnancy|0|||
131603195|NCT05671653|473841256|FG009|Cohort 2 Period 2|Pregnancy|0|||
131603196|NCT05671653|473841257|FG010|Cohort 2 Period 2|Pregnancy|1|||
131603197|NCT05671653|473841258|FG011|Cohort 2 Period 2|Pregnancy|0|||
131603198|NCT05671653|473841259|FG012|Cohort 2 Period 2|Pregnancy|0|||
131603199|NCT05671653|473841247|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603200|NCT05671653|473841248|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603201|NCT05671653|473841249|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603202|NCT05671653|473841250|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603203|NCT05671653|473841251|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603204|NCT05671653|473841252|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603205|NCT05671653|473841253|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603206|NCT05671653|473841254|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603207|NCT05671653|473841255|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603208|NCT05671653|473841256|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603209|NCT05671653|473841257|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
131603210|NCT05671653|473841258|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603211|NCT05671653|473841259|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
131603212|NCT05671653|473841247|FG000|Cohort 2 Period 2|Other|0|||
131603213|NCT05671653|473841248|FG001|Cohort 2 Period 2|Other|0|||
131603214|NCT05671653|473841249|FG002|Cohort 2 Period 2|Other|0|||
131603215|NCT05671653|473841250|FG003|Cohort 2 Period 2|Other|0|||
131603216|NCT05671653|473841251|FG004|Cohort 2 Period 2|Other|0|||
131603217|NCT05671653|473841252|FG005|Cohort 2 Period 2|Other|0|||
131603218|NCT05671653|473841253|FG006|Cohort 2 Period 2|Other|0|||
131603219|NCT05671653|473841254|FG007|Cohort 2 Period 2|Other|0|||
131603220|NCT05671653|473841255|FG008|Cohort 2 Period 2|Other|0|||
131603221|NCT05671653|473841256|FG009|Cohort 2 Period 2|Other|0|||
131603222|NCT05671653|473841257|FG010|Cohort 2 Period 2|Other|1|||
131603223|NCT05671653|473841258|FG011|Cohort 2 Period 2|Other|0|||
131603224|NCT05671653|473841259|FG012|Cohort 2 Period 2|Other|0|||
131440390|NCT01194830|473241482|FG000|Overall Study|Protocol Violation|5|||
131603225|NCT05671653|473841247|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603226|NCT05671653|473841248|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603227|NCT05671653|473841249|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603228|NCT05671653|473841250|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603229|NCT05671653|473841251|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603230|NCT05671653|473841252|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603231|NCT05671653|473841253|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603232|NCT05671653|473841254|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603233|NCT05671653|473841255|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131791660|NCT00829413|474520839|FG000|Overall Study|No study drug admimnistered|13|||
131603234|NCT05671653|473841256|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603235|NCT05671653|473841257|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603236|NCT05671653|473841258|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
131603237|NCT05671653|473841259|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131603238|NCT05299723|473841260|FG000|Overall Study|Withdrawal by Subject|0|||
131603239|NCT05299723|473841261|FG001|Overall Study|Withdrawal by Subject|2|||
131603240|NCT05299723|473841262|FG002|Overall Study|Withdrawal by Subject|0|||
131603241|NCT02460458|473841263|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
131603242|NCT02460458|473841263|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
131603243|NCT02460458|473841263|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
131603244|NCT02460458|473841263|FG000|First Prospective Phase|Lost to Follow-up|84|||
131603245|NCT02460458|473841263|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
131603246|NCT03952338|473841264|FG000|Overall Study|Lost to Follow-up|11|||
131603247|NCT03952338|473841265|FG001|Overall Study|Lost to Follow-up|17|||
131603248|NCT03952338|473841264|FG000|Overall Study|Withdrawal by Subject|1|||
131603249|NCT03952338|473841265|FG001|Overall Study|Withdrawal by Subject|1|||
131603250|NCT03952338|473841264|FG000|Overall Study|Protocol Violation|1|||
131603251|NCT03952338|473841265|FG001|Overall Study|Protocol Violation|0|||
131603252|NCT04568434|473841266|FG000|Overall Study|Voluntary Withdrawal|0|||
131603253|NCT04568434|473841267|FG001|Overall Study|Voluntary Withdrawal|1|||
131603254|NCT04568434|473841268|FG002|Overall Study|Voluntary Withdrawal|1|||
131603255|NCT04568434|473841266|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
131603256|NCT04568434|473841267|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
131603257|NCT04568434|473841268|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
131603258|NCT04568434|473841266|FG000|Overall Study|Investigator Judgement|1|||
131603259|NCT04568434|473841267|FG001|Overall Study|Investigator Judgement|0|||
131603260|NCT04568434|473841268|FG002|Overall Study|Investigator Judgement|0|||
131603261|NCT05469464|473841269|FG000|Overall Study|Withdrawal by Subject|8|||
131603262|NCT05469464|473841270|FG001|Overall Study|Withdrawal by Subject|7|||
131603263|NCT05469464|473841271|FG002|Overall Study|Withdrawal by Subject|4|||
131603264|NCT05469464|473841272|FG003|Overall Study|Withdrawal by Subject|5|||
131603265|NCT05469464|473841269|FG000|Overall Study|Adverse Event|8|||
131603266|NCT05469464|473841270|FG001|Overall Study|Adverse Event|14|||
131603267|NCT05469464|473841271|FG002|Overall Study|Adverse Event|13|||
131603268|NCT05469464|473841272|FG003|Overall Study|Adverse Event|2|||
131603269|NCT05469464|473841269|FG000|Overall Study|Lost to Follow-up|2|||
131603270|NCT05469464|473841270|FG001|Overall Study|Lost to Follow-up|5|||
131603271|NCT05469464|473841271|FG002|Overall Study|Lost to Follow-up|3|||
131603272|NCT05469464|473841272|FG003|Overall Study|Lost to Follow-up|3|||
131603273|NCT05469464|473841269|FG000|Overall Study|Lack of Efficacy|4|||
131603274|NCT05469464|473841270|FG001|Overall Study|Lack of Efficacy|1|||
131603275|NCT05469464|473841271|FG002|Overall Study|Lack of Efficacy|2|||
131603276|NCT05469464|473841272|FG003|Overall Study|Lack of Efficacy|2|||
131603277|NCT05469464|473841269|FG000|Overall Study|Physician Decision|0|||
131603278|NCT05469464|473841270|FG001|Overall Study|Physician Decision|0|||
131603279|NCT05469464|473841271|FG002|Overall Study|Physician Decision|0|||
131603280|NCT05469464|473841272|FG003|Overall Study|Physician Decision|1|||
131603281|NCT04076618|473841273|FG000|Overall Study|Lost to Follow-up|2|||
131603282|NCT04076618|473841274|FG001|Overall Study|Lost to Follow-up|1|||
131603283|NCT04076618|473841275|FG002|Overall Study|Lost to Follow-up|3|||
131603284|NCT04076618|473841273|FG000|Overall Study|Withdrawal by Subject|3|||
131603285|NCT04076618|473841274|FG001|Overall Study|Withdrawal by Subject|1|||
131603286|NCT04076618|473841275|FG002|Overall Study|Withdrawal by Subject|2|||
131603287|NCT04076618|473841273|FG000|Overall Study|Relocated out of state|0|||
131603288|NCT04076618|473841274|FG001|Overall Study|Relocated out of state|2|||
131603289|NCT04076618|473841275|FG002|Overall Study|Relocated out of state|0|||
131603290|NCT04076618|473841273|FG000|Overall Study|COVID concerns|0|||
131603291|NCT04076618|473841274|FG001|Overall Study|COVID concerns|1|||
131603292|NCT04076618|473841275|FG002|Overall Study|COVID concerns|0|||
131603293|NCT04076618|473841273|FG000|Overall Study|Adverse Event|0|||
131603294|NCT04076618|473841274|FG001|Overall Study|Adverse Event|0|||
131603295|NCT04076618|473841275|FG002|Overall Study|Adverse Event|2|||
131603296|NCT05485779|473841276|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603297|NCT05485779|473841277|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603298|NCT05485779|473841278|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603299|NCT05485779|473841279|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603300|NCT05485779|473841280|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603301|NCT05485779|473841281|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
131440391|NCT01194830|473241483|FG001|Overall Study|Protocol Violation|4|||
131603302|NCT05485779|473841282|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603303|NCT05485779|473841283|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
131440392|NCT01194830|473241482|FG000|Overall Study|Lost to Follow-up|9|||
131603304|NCT05485779|473841284|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
131440393|NCT01194830|473241483|FG001|Overall Study|Lost to Follow-up|7|||
131440394|NCT01194830|473241482|FG000|Overall Study|Withdrawal by Subject|2|||
131440395|NCT01194830|473241483|FG001|Overall Study|Withdrawal by Subject|1|||
131440396|NCT01194830|473241482|FG000|Overall Study|Lack of Efficacy|1|||
131603305|NCT05485779|473841285|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603306|NCT05485779|473841286|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
131603307|NCT05485779|473841276|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603308|NCT05485779|473841277|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603309|NCT05485779|473841278|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603310|NCT05485779|473841279|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603311|NCT05485779|473841280|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603312|NCT05485779|473841281|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603313|NCT05485779|473841282|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603314|NCT05485779|473841283|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603315|NCT05485779|473841284|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603316|NCT05485779|473841285|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
131603317|NCT05485779|473841286|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
131603318|NCT05485779|473841276|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603319|NCT05485779|473841277|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603320|NCT05485779|473841278|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603321|NCT05485779|473841279|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
131603322|NCT05485779|473841280|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603323|NCT05485779|473841281|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603324|NCT05485779|473841282|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603325|NCT05485779|473841283|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603326|NCT05485779|473841284|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603327|NCT05485779|473841285|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603328|NCT05485779|473841286|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131603329|NCT04471246|473841289|FG000|Overall Study|Lost to Follow-up|2|||
131603330|NCT04471246|473841290|FG001|Overall Study|Lost to Follow-up|2|||
131603331|NCT05764525|473841291|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
131603332|NCT05764525|473841292|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
131603333|NCT05764525|473841291|FG000|Overall Study|Withdrawal by Subject|4|||
131603334|NCT05764525|473841292|FG001|Overall Study|Withdrawal by Subject|8|||
131603335|NCT05764525|473841291|FG000|Overall Study|Physician Decision|1|||
131603336|NCT05764525|473841292|FG001|Overall Study|Physician Decision|0|||
131603337|NCT03334630|473841293|FG000|Overall Study|Withdrawal by Subject|7|||
131603338|NCT03334630|473841294|FG001|Overall Study|Withdrawal by Subject|7|||
131603339|NCT03334630|473841293|FG000|Overall Study|Lost to Follow-up|3|||
131603340|NCT03334630|473841294|FG001|Overall Study|Lost to Follow-up|1|||
131603341|NCT03334630|473841293|FG000|Overall Study|Adverse Event|0|||
131603342|NCT03334630|473841294|FG001|Overall Study|Adverse Event|1|||
131603343|NCT03334630|473841293|FG000|Overall Study|Physician Decision|1|||
131603344|NCT03334630|473841294|FG001|Overall Study|Physician Decision|1|||
131603345|NCT03334630|473841293|FG000|Overall Study|Enrollment closed|2|||
131603346|NCT03334630|473841294|FG001|Overall Study|Enrollment closed|1|||
131603347|NCT03334630|473841293|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
131603348|NCT03334630|473841294|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
131603349|NCT03334630|473841293|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
131603350|NCT03334630|473841294|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
131603351|NCT03030261|473841296|FG000|Overall Study|Still receiving continuation therapy|5|||
131603352|NCT03386578|473841300|FG000|PK Component|Lost to Follow-up|0|||
131603353|NCT03386578|473841301|FG001|PK Component|Lost to Follow-up|1|||
131603354|NCT03386578|473841302|FG002|PK Component|Lost to Follow-up|0|||
131603355|NCT03386578|473841303|FG003|PK Component|Lost to Follow-up|0|||
131603356|NCT03386578|473841304|FG004|PK Component|Lost to Follow-up|0|||
131603357|NCT03386578|473841305|FG005|PK Component|Lost to Follow-up|0|||
131603358|NCT03386578|473841306|FG006|PK Component|Lost to Follow-up|1|||
131603359|NCT03386578|473841307|FG007|PK Component|Lost to Follow-up|0|||
131603360|NCT03386578|473841308|FG008|PK Component|Lost to Follow-up|0|||
131603361|NCT03386578|473841309|FG009|PK Component|Lost to Follow-up|0|||
131603362|NCT03386578|473841300|FG000|PK Component|Stillbirth/Abortion|0|||
131603363|NCT03386578|473841301|FG001|PK Component|Stillbirth/Abortion|0|||
131603364|NCT03386578|473841302|FG002|PK Component|Stillbirth/Abortion|0|||
131899694|NCT02659943|474919378|FG005|Overall Study|Disease progression on study|4|||
131899695|NCT02659943|474919379|FG006|Overall Study|Disease progression on study|0|||
131440397|NCT01194830|473241483|FG001|Overall Study|Lack of Efficacy|1|||
131440398|NCT01194830|473241482|FG000|Overall Study|Non-compliance issues|4|||
131603365|NCT03386578|473841303|FG003|PK Component|Stillbirth/Abortion|0|||
131603366|NCT03386578|473841304|FG004|PK Component|Stillbirth/Abortion|0|||
131603367|NCT03386578|473841305|FG005|PK Component|Stillbirth/Abortion|2|||
131603368|NCT03386578|473841306|FG006|PK Component|Stillbirth/Abortion|0|||
131603369|NCT03386578|473841307|FG007|PK Component|Stillbirth/Abortion|0|||
131603370|NCT03386578|473841308|FG008|PK Component|Stillbirth/Abortion|0|||
131603371|NCT03386578|473841309|FG009|PK Component|Stillbirth/Abortion|0|||
131603372|NCT03386578|473841300|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131603373|NCT03386578|473841301|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131603374|NCT03386578|473841302|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
131603375|NCT03386578|473841303|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
131603376|NCT03386578|473841304|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131603377|NCT03386578|473841305|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131603378|NCT03386578|473841306|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131603379|NCT03386578|473841307|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
131603380|NCT03386578|473841308|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
131603381|NCT03386578|473841309|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131603382|NCT03386578|473841300|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131603383|NCT03386578|473841301|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131603384|NCT03386578|473841302|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
131603385|NCT03386578|473841303|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
131603386|NCT03386578|473841304|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131603387|NCT03386578|473841305|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131603388|NCT03386578|473841306|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131603389|NCT03386578|473841307|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
131603390|NCT03386578|473841308|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
131603391|NCT03386578|473841309|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131603392|NCT03386578|473841300|FG000|PrEP Comparison Component Step 1|Death|0|||
131603393|NCT03386578|473841301|FG001|PrEP Comparison Component Step 1|Death|0|||
131603394|NCT03386578|473841302|FG002|PrEP Comparison Component Step 1|Death|1|||
131603395|NCT03386578|473841303|FG003|PrEP Comparison Component Step 1|Death|0|||
131603396|NCT03386578|473841304|FG004|PrEP Comparison Component Step 1|Death|0|||
131603397|NCT03386578|473841305|FG005|PrEP Comparison Component Step 1|Death|0|||
131603398|NCT03386578|473841306|FG006|PrEP Comparison Component Step 1|Death|0|||
131603399|NCT03386578|473841307|FG007|PrEP Comparison Component Step 1|Death|9|||
131603400|NCT03386578|473841308|FG008|PrEP Comparison Component Step 1|Death|5|||
131603401|NCT03386578|473841309|FG009|PrEP Comparison Component Step 1|Death|0|||
131603402|NCT03386578|473841300|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603403|NCT03386578|473841301|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603404|NCT03386578|473841302|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603405|NCT03386578|473841303|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
131603406|NCT03386578|473841304|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603407|NCT03386578|473841305|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603408|NCT03386578|473841306|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603409|NCT03386578|473841307|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603410|NCT03386578|473841308|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
131603411|NCT03386578|473841309|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131603412|NCT03386578|473841300|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603413|NCT03386578|473841301|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603414|NCT03386578|473841302|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603415|NCT03386578|473841303|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603416|NCT03386578|473841304|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603417|NCT03386578|473841305|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603418|NCT03386578|473841306|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603419|NCT03386578|473841307|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
131603420|NCT03386578|473841308|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
131603421|NCT03386578|473841309|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131603422|NCT03386578|473841300|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603423|NCT03386578|473841301|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603424|NCT03386578|473841302|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603425|NCT03386578|473841303|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603426|NCT03386578|473841304|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603427|NCT03386578|473841305|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603428|NCT03386578|473841306|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603429|NCT03386578|473841307|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
131603430|NCT03386578|473841308|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
131603431|NCT03386578|473841309|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131603432|NCT05907174|473841312|FG000|3-Month Assessment|Withdrawal by Subject|0|||
131603433|NCT05907174|473841313|FG001|3-Month Assessment|Withdrawal by Subject|0|||
131440399|NCT01194830|473241483|FG001|Overall Study|Non-compliance issues|4|||
131440400|NCT01194830|473241482|FG000|Overall Study|Other Reason|12|||
131440401|NCT01194830|473241483|FG001|Overall Study|Other Reason|8|||
131440402|NCT01317472|473241486|FG000|Overall Study|Withdrawal by Subject|1|||
131603434|NCT05907174|473841314|FG002|3-Month Assessment|Withdrawal by Subject|0|||
131603435|NCT05907174|473841315|FG003|3-Month Assessment|Withdrawal by Subject|1|||
131603436|NCT05907174|473841312|FG000|3-Month Assessment|Lost to Follow-up|1|||
131603437|NCT05907174|473841313|FG001|3-Month Assessment|Lost to Follow-up|1|||
131603438|NCT05907174|473841314|FG002|3-Month Assessment|Lost to Follow-up|1|||
131603439|NCT05907174|473841315|FG003|3-Month Assessment|Lost to Follow-up|1|||
131603440|NCT05907174|473841312|FG000|6-Month Assessment|Death|0|||
131603441|NCT05907174|473841313|FG001|6-Month Assessment|Death|0|||
131603442|NCT05907174|473841314|FG002|6-Month Assessment|Death|3|||
131603443|NCT05907174|473841315|FG003|6-Month Assessment|Death|0|||
131603444|NCT05907174|473841312|FG000|6-Month Assessment|Withdrawal by Subject|0|||
131603445|NCT05907174|473841313|FG001|6-Month Assessment|Withdrawal by Subject|0|||
131603446|NCT05907174|473841314|FG002|6-Month Assessment|Withdrawal by Subject|1|||
131603447|NCT05907174|473841315|FG003|6-Month Assessment|Withdrawal by Subject|1|||
131603448|NCT05907174|473841312|FG000|6-Month Assessment|Lost to Follow-up|0|||
131603449|NCT05907174|473841313|FG001|6-Month Assessment|Lost to Follow-up|1|||
131603450|NCT05907174|473841314|FG002|6-Month Assessment|Lost to Follow-up|1|||
131603451|NCT05907174|473841315|FG003|6-Month Assessment|Lost to Follow-up|1|||
131603452|NCT05370040|473841320|FG000|Overall Study|Lost to Follow-up|0|||
131603453|NCT05370040|473841321|FG001|Overall Study|Lost to Follow-up|0|||
131603454|NCT05370040|473841322|FG002|Overall Study|Lost to Follow-up|1|||
131603455|NCT05370040|473841323|FG003|Overall Study|Lost to Follow-up|0|||
131603456|NCT05370040|473841324|FG004|Overall Study|Lost to Follow-up|1|||
131603457|NCT05370040|473841325|FG005|Overall Study|Lost to Follow-up|0|||
131603458|NCT05093842|473841328|FG000|Overall Study|Pregnancy loss|1|||
131603459|NCT05093842|473841329|FG001|Overall Study|Pregnancy loss|1|||
131603460|NCT05093842|473841328|FG000|Overall Study|Lost to Follow-up|6|||
131603461|NCT05093842|473841329|FG001|Overall Study|Lost to Follow-up|0|||
131603462|NCT05093842|473841328|FG000|Overall Study|Physician Decision|0|||
131603463|NCT05093842|473841329|FG001|Overall Study|Physician Decision|1|||
131603464|NCT03910478|473841330|FG000|Overall Study|Death|13|||
131603465|NCT03910478|473841331|FG001|Overall Study|Death|6|||
131603466|NCT03910478|473841330|FG000|Overall Study|Withdrawal by Subject|23|||
131603467|NCT03910478|473841331|FG001|Overall Study|Withdrawal by Subject|2|||
131603468|NCT03910478|473841330|FG000|Overall Study|Physician Decision|5|||
131603469|NCT03910478|473841331|FG001|Overall Study|Physician Decision|0|||
131603470|NCT03910478|473841330|FG000|Overall Study|Protocol Violation|1|||
131603471|NCT03910478|473841331|FG001|Overall Study|Protocol Violation|0|||
131603472|NCT03910478|473841330|FG000|Overall Study|Failure to meet continuation criteria|2|||
131603473|NCT03910478|473841331|FG001|Overall Study|Failure to meet continuation criteria|0|||
131603474|NCT03910478|473841330|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
131603475|NCT03910478|473841331|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
131603476|NCT05147116|473841337|FG000|Overall Study|Withdrawal by Subject|0|||
131603477|NCT05147116|473841338|FG001|Overall Study|Withdrawal by Subject|1|||
131603478|NCT04197336|473841339|FG000|Overall Study|Withdrawal by Subject|1|||
131603479|NCT05868382|473841340|FG000|Overall Study|Lost to Follow-up|5|||
131603480|NCT05868382|473841341|FG001|Overall Study|Lost to Follow-up|0|||
131603481|NCT05868382|473841342|FG002|Overall Study|Lost to Follow-up|6|||
131603482|NCT05868382|473841343|FG003|Overall Study|Lost to Follow-up|4|||
131603483|NCT05868382|473841344|FG004|Overall Study|Lost to Follow-up|2|||
131603484|NCT05868382|473841345|FG005|Overall Study|Lost to Follow-up|6|||
131603485|NCT05868382|473841340|FG000|Overall Study|Withdrawal by Subject|1|||
131603486|NCT05868382|473841341|FG001|Overall Study|Withdrawal by Subject|0|||
131603487|NCT05868382|473841342|FG002|Overall Study|Withdrawal by Subject|0|||
131603488|NCT05868382|473841343|FG003|Overall Study|Withdrawal by Subject|0|||
131603489|NCT05868382|473841344|FG004|Overall Study|Withdrawal by Subject|1|||
131603490|NCT05868382|473841345|FG005|Overall Study|Withdrawal by Subject|0|||
131603491|NCT04585815|473841346|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
131603492|NCT04585815|473841347|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
131603493|NCT04585815|473841348|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
131603494|NCT04585815|473841349|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
131603495|NCT04585815|473841350|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
131603496|NCT04585815|473841351|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
131603497|NCT04585815|473841352|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
131603498|NCT04585815|473841346|FG000|Sub-study A- Treatment Phase|Death|0|||
131603499|NCT04585815|473841347|FG001|Sub-study A- Treatment Phase|Death|1|||
131603500|NCT04585815|473841348|FG002|Sub-study A- Treatment Phase|Death|0|||
131603501|NCT04585815|473841349|FG003|Sub-study A- Treatment Phase|Death|0|||
131603502|NCT04585815|473841350|FG004|Sub-study A- Treatment Phase|Death|0|||
131603503|NCT04585815|473841351|FG005|Sub-study A- Treatment Phase|Death|0|||
131603504|NCT04585815|473841352|FG006|Sub-study A- Treatment Phase|Death|0|||
131603505|NCT04585815|473841346|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
131603506|NCT04585815|473841347|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131603507|NCT04585815|473841348|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131603508|NCT04585815|473841349|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131603509|NCT04585815|473841350|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131603510|NCT04585815|473841351|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131603511|NCT04585815|473841352|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131603512|NCT04585815|473841346|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131603513|NCT04585815|473841347|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
131603514|NCT04585815|473841348|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131603515|NCT04585815|473841349|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131603516|NCT04585815|473841350|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131603517|NCT04585815|473841351|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131603518|NCT04585815|473841352|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131603519|NCT04585815|473841346|FG000|Sub-study A- Treatment Phase|Other|1|||
131603520|NCT04585815|473841347|FG001|Sub-study A- Treatment Phase|Other|0|||
131603521|NCT04585815|473841348|FG002|Sub-study A- Treatment Phase|Other|0|||
131603522|NCT04585815|473841349|FG003|Sub-study A- Treatment Phase|Other|0|||
131603523|NCT04585815|473841350|FG004|Sub-study A- Treatment Phase|Other|0|||
131603524|NCT04585815|473841351|FG005|Sub-study A- Treatment Phase|Other|0|||
131603525|NCT04585815|473841352|FG006|Sub-study A- Treatment Phase|Other|0|||
131603526|NCT04585815|473841346|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
131603527|NCT04585815|473841347|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
131603528|NCT04585815|473841348|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131603529|NCT04585815|473841349|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131603530|NCT04585815|473841350|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131603531|NCT04585815|473841351|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131603532|NCT04585815|473841352|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131603533|NCT04585815|473841346|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131603534|NCT04585815|473841347|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
131603535|NCT04585815|473841348|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131603536|NCT04585815|473841349|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131603537|NCT04585815|473841350|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131603538|NCT04585815|473841351|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131791661|NCT00829413|474520839|FG000|Overall Study|Training Patients|67|||
131791662|NCT00829413|474520839|FG000|Overall Study|No truth standard procedure available|9|||
131791663|NCT00829413|474520839|FG000|Overall Study|Technically inadequate truth standard|2|||
131603539|NCT04585815|473841352|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131603540|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
131603541|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
131603542|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
131603543|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
131603544|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
131603545|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
131603546|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
131603547|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Death|0|||
131603548|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Death|0|||
131603549|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Death|0|||
131603550|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Death|1|||
131603551|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Death|0|||
131603552|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Death|0|||
131603553|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Death|0|||
131603554|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131603555|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131603556|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131603557|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
131603558|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131603559|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
131603560|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131603561|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131603562|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131603563|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131603564|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
131603565|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131603566|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131603567|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131603568|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131603569|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131603570|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131603571|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131603572|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131603573|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131603574|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
131603575|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
131603576|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
131603577|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
131603578|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
131603579|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
131603580|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
131603581|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
131603582|NCT04585815|473841346|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
131603583|NCT04585815|473841347|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
131603584|NCT04585815|473841348|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
131603585|NCT04585815|473841349|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
131603586|NCT04585815|473841350|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
131603587|NCT04585815|473841351|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
131603588|NCT04585815|473841352|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
131603589|NCT04585815|473841346|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131603590|NCT04585815|473841347|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131603591|NCT04585815|473841348|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131603592|NCT04585815|473841349|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131706881|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131706882|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131706883|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
131603593|NCT04585815|473841350|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
131603594|NCT04585815|473841351|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
131603595|NCT04585815|473841352|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
131603596|NCT04585815|473841346|FG000|Sub-study B- Follow-up Phase|Death|0|||
131706884|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
131706885|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
131440403|NCT01317472|473241487|FG001|Overall Study|Withdrawal by Subject|0|||
131440404|NCT01317472|473241486|FG000|Overall Study|Unrelated hospitalization|1|||
131440405|NCT01317472|473241487|FG001|Overall Study|Unrelated hospitalization|0|||
131706886|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
131706887|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
131706888|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131706889|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
131440406|NCT01815918|473241488|FG000|Overall Study|Patient samples not analyzable|3|||
131440407|NCT01815918|473241489|FG001|Overall Study|Patient samples not analyzable|4|||
131440408|NCT01815918|473241488|FG000|Overall Study|Lack of Efficacy|15|||
131440409|NCT01815918|473241489|FG001|Overall Study|Lack of Efficacy|15|||
131440410|NCT03284710|473241492|FG000|Overall Study|Withdrawal by Subject|1|||
131440411|NCT03284710|473241493|FG001|Overall Study|Withdrawal by Subject|0|||
131440412|NCT03284710|473241494|FG002|Overall Study|Withdrawal by Subject|1|||
131440413|NCT03284710|473241495|FG003|Overall Study|Withdrawal by Subject|6|||
131440414|NCT03284710|473241492|FG000|Overall Study|Lost to Follow-up|3|||
131603597|NCT04585815|473841347|FG001|Sub-study B- Follow-up Phase|Death|0|||
131603598|NCT04585815|473841348|FG002|Sub-study B- Follow-up Phase|Death|1|||
131603599|NCT04585815|473841349|FG003|Sub-study B- Follow-up Phase|Death|3|||
131603600|NCT04585815|473841350|FG004|Sub-study B- Follow-up Phase|Death|0|||
131603601|NCT04585815|473841351|FG005|Sub-study B- Follow-up Phase|Death|0|||
131603602|NCT04585815|473841352|FG006|Sub-study B- Follow-up Phase|Death|1|||
131603603|NCT01236781|473841353|FG000|Overall Study|Ineligible|2|||
131603604|NCT01236781|473841354|FG001|Overall Study|Ineligible|1|||
131603605|NCT01236781|473841353|FG000|Overall Study|Did not complete study imaging|5|||
131603606|NCT01236781|473841354|FG001|Overall Study|Did not complete study imaging|0|||
131603607|NCT01221948|473841362|FG000|Overall Study|Physician Decision|5|||
131603608|NCT01221948|473841362|FG000|Overall Study|Withdrawal by Subject|2|||
131603609|NCT01221948|473841362|FG000|Overall Study|not disclosed|2|||
131603610|NCT01221948|473841362|FG000|Overall Study|Death|1|||
131706890|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
131706891|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
131706892|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131603611|NCT01221948|473841362|FG000|Overall Study|Protocol Violation|4|||
131603612|NCT04295512|473841363|FG000|Overall Study|Lack of family response to schedule assessment|0|||
131603613|NCT04295512|473841364|FG001|Overall Study|Lack of family response to schedule assessment|0|||
131603614|NCT04295512|473841365|FG002|Overall Study|Lack of family response to schedule assessment|0|||
131603615|NCT04295512|473841366|FG003|Overall Study|Lack of family response to schedule assessment|2|||
131603616|NCT04295512|473841363|FG000|Overall Study|Therapist did not refer eligible family|7|||
131603617|NCT04295512|473841364|FG001|Overall Study|Therapist did not refer eligible family|7|||
131603618|NCT04295512|473841365|FG002|Overall Study|Therapist did not refer eligible family|0|||
131603619|NCT04295512|473841366|FG003|Overall Study|Therapist did not refer eligible family|0|||
131603620|NCT03571581|473841371|FG000|Overall Study|Death|2|||
131603621|NCT03571581|473841371|FG000|Overall Study|Withdrawal by Subject|2|||
131706893|NCT00289913|474209263|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
131899696|NCT02659943|474919373|FG000|Overall Study|Patient's condition per principal investigator|0|||
131603622|NCT01309672|473841373|FG000|Overall Study|Lack of Efficacy|20|||
131603623|NCT01309672|473841373|FG000|Overall Study|Other|9|||
131603624|NCT01309672|473841373|FG000|Overall Study|Adverse Event|5|||
131603625|NCT01309672|473841373|FG000|Overall Study|Withdrawal by Subject|3|||
131603626|NCT05090683|473841374|FG000|Overall Study|Lost to Follow-up|10|||
131603627|NCT05090683|473841375|FG001|Overall Study|Lost to Follow-up|2|||
131603628|NCT05090683|473841374|FG000|Overall Study|Withdrawal by Subject|15|||
131603629|NCT05090683|473841375|FG001|Overall Study|Withdrawal by Subject|0|||
131603630|NCT04032847|473841376|FG000|Overall Study|Study termination by sponsor|8|||
131603631|NCT04032847|473841377|FG001|Overall Study|Study termination by sponsor|0|||
131603632|NCT04032847|473841378|FG002|Overall Study|Study termination by sponsor|4|||
131603633|NCT04032847|473841376|FG000|Overall Study|Death|12|||
131603634|NCT04032847|473841377|FG001|Overall Study|Death|0|||
131603635|NCT04032847|473841378|FG002|Overall Study|Death|0|||
131603636|NCT04032847|473841376|FG000|Overall Study|Progressive disease|2|||
131603637|NCT04032847|473841377|FG001|Overall Study|Progressive disease|0|||
131603638|NCT04032847|473841378|FG002|Overall Study|Progressive disease|1|||
131603639|NCT03213665|473841379|FG000|Overall Study|Adverse Event|1|||
131603640|NCT03213665|473841379|FG000|Overall Study|Physician Decision|2|||
131603641|NCT03213665|473841379|FG000|Overall Study|Withdrawal by Subject|3|||
131603642|NCT03213665|473841379|FG000|Overall Study|Progressive Disease|13|||
131603643|NCT03056573|473841380|FG000|Overall Study|Death|2|||
131603644|NCT03056573|473841381|FG001|Overall Study|Death|4|||
131603645|NCT03056573|473841380|FG000|Overall Study|Withdrawal by Subject|2|||
131603646|NCT03056573|473841381|FG001|Overall Study|Withdrawal by Subject|0|||
131603647|NCT03056573|473841380|FG000|Overall Study|Lost to Follow-up|1|||
131440415|NCT03284710|473241493|FG001|Overall Study|Lost to Follow-up|3|||
131440416|NCT03284710|473241494|FG002|Overall Study|Lost to Follow-up|1|||
131603648|NCT03056573|473841381|FG001|Overall Study|Lost to Follow-up|1|||
131603649|NCT03606408|473841383|FG000|Overall Study|Adverse Event|13|||
131603650|NCT03606408|473841383|FG000|Overall Study|Withdrawal by Subject|7|||
131603651|NCT03606408|473841383|FG000|Overall Study|Physician Decision|4|||
131603652|NCT03606408|473841383|FG000|Overall Study|Lack of Efficacy|2|||
131603653|NCT03606408|473841383|FG000|Overall Study|Death|1|||
131603654|NCT03606408|473841383|FG000|Overall Study|new therapy for study indication|1|||
131603655|NCT04689256|473841384|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
131603656|NCT04689256|473841385|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
131603657|NCT05104463|473841386|FG000|Overall Study|Adverse Event|1|||
131603658|NCT05104463|473841387|FG001|Overall Study|Adverse Event|1|||
131603659|NCT05104463|473841386|FG000|Overall Study|Lost to Follow-up|1|||
131603660|NCT05104463|473841387|FG001|Overall Study|Lost to Follow-up|1|||
131603661|NCT05104463|473841386|FG000|Overall Study|Physician Decision|1|||
131603662|NCT05104463|473841387|FG001|Overall Study|Physician Decision|0|||
131603663|NCT05104463|473841386|FG000|Overall Study|Protocol Violation|0|||
131603664|NCT05104463|473841387|FG001|Overall Study|Protocol Violation|2|||
131603665|NCT05104463|473841386|FG000|Overall Study|Withdrawal by Subject|1|||
131603666|NCT05104463|473841387|FG001|Overall Study|Withdrawal by Subject|1|||
131603667|NCT02593773|473842571|FG000|Overall Study|Voluntary Withdrawal|3|||
131603668|NCT02593773|473842571|FG000|Overall Study|Study Terminated by Sponsor|31|||
131603669|NCT02593773|473842571|FG000|Overall Study|Death|1|||
131603670|NCT01208662|473842574|FG000|Induction and Consolidation|Disease Progression|23|||
131603671|NCT01208662|473842575|FG001|Induction and Consolidation|Disease Progression|13|||
131603672|NCT01208662|473842576|FG002|Induction and Consolidation|Disease Progression|0|||
131603673|NCT01208662|473842574|FG000|Induction and Consolidation|Adverse Event|16|||
131603674|NCT01208662|473842575|FG001|Induction and Consolidation|Adverse Event|18|||
131603675|NCT01208662|473842576|FG002|Induction and Consolidation|Adverse Event|2|||
131603676|NCT01208662|473842574|FG000|Induction and Consolidation|MD or Participant Decision|16|||
131603677|NCT01208662|473842575|FG001|Induction and Consolidation|MD or Participant Decision|34|||
131603678|NCT01208662|473842576|FG002|Induction and Consolidation|MD or Participant Decision|4|||
131603679|NCT01208662|473842574|FG000|Induction and Consolidation|Death|1|||
131603680|NCT01208662|473842575|FG001|Induction and Consolidation|Death|3|||
131603681|NCT01208662|473842576|FG002|Induction and Consolidation|Death|1|||
131603682|NCT01208662|473842574|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
131603683|NCT01208662|473842575|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
131603684|NCT01208662|473842576|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
131603685|NCT01208662|473842574|FG000|Maintenance|Disease Progression|156|||
131603686|NCT01208662|473842575|FG001|Maintenance|Disease Progression|102|||
131603687|NCT01208662|473842576|FG002|Maintenance|Disease Progression|0|||
131603688|NCT01208662|473842574|FG000|Maintenance|Adverse Event|12|||
131603689|NCT01208662|473842575|FG001|Maintenance|Adverse Event|28|||
131603690|NCT01208662|473842576|FG002|Maintenance|Adverse Event|0|||
131603691|NCT01208662|473842574|FG000|Maintenance|MD or Participant Decision|24|||
131603692|NCT01208662|473842575|FG001|Maintenance|MD or Participant Decision|36|||
131603693|NCT01208662|473842576|FG002|Maintenance|MD or Participant Decision|0|||
131603694|NCT01208662|473842574|FG000|Maintenance|Death|0|||
131603695|NCT01208662|473842575|FG001|Maintenance|Death|3|||
131603696|NCT01208662|473842576|FG002|Maintenance|Death|0|||
131603697|NCT01208662|473842574|FG000|Maintenance|Discontinued for other reasons|21|||
131603698|NCT01208662|473842575|FG001|Maintenance|Discontinued for other reasons|31|||
131603699|NCT01208662|473842576|FG002|Maintenance|Discontinued for other reasons|0|||
131603700|NCT01208662|473842574|FG000|Maintenance|Still on Treatment|78|||
131603701|NCT01208662|473842575|FG001|Maintenance|Still on Treatment|89|||
131603702|NCT01208662|473842576|FG002|Maintenance|Still on Treatment|0|||
131603703|NCT04079218|473842581|FG000|Overall Study|Death|1|||
131603704|NCT04079218|473842582|FG001|Overall Study|Death|0|||
131603705|NCT04079218|473842581|FG000|Overall Study|Withdrawal by Subject|3|||
131603706|NCT04079218|473842582|FG001|Overall Study|Withdrawal by Subject|0|||
131603707|NCT04079218|473842581|FG000|Overall Study|Physician Decision|4|||
131603708|NCT04079218|473842582|FG001|Overall Study|Physician Decision|0|||
131603709|NCT04079218|473842581|FG000|Overall Study|Lost to Follow-up|0|||
131603710|NCT04079218|473842582|FG001|Overall Study|Lost to Follow-up|1|||
131603711|NCT04066205|473842593|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
131603712|NCT04066205|473842594|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
131603713|NCT04066205|473842593|FG000|T2 Immediate Post-Intervention|did not respond|5|||
131706894|NCT00289913|474209264|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131706895|NCT00289913|474209265|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
131603714|NCT04066205|473842594|FG001|T2 Immediate Post-Intervention|did not respond|3|||
131603715|NCT02052882|473842595|FG000|Overall Study|Not treated|11|||
131603716|NCT02052882|473842595|FG000|Overall Study|Protocol Violation|1|||
131603717|NCT02052882|473842595|FG000|Overall Study|Inadequate testing|1|||
131603718|NCT04314778|473842602|FG000|Overall Study|Lost to Follow-up|5|||
131603719|NCT04314778|473842603|FG001|Overall Study|Lost to Follow-up|3|||
131603720|NCT04024020|473842606|FG000|Overall Study|Withdrawal by Subject|2|||
131603721|NCT04024020|473842607|FG001|Overall Study|Withdrawal by Subject|2|||
131603722|NCT05646355|473842608|FG000|Overall Study|Lost to Follow-up|1|||
131603723|NCT05646355|473842609|FG001|Overall Study|Lost to Follow-up|0|||
131603724|NCT05646355|473842608|FG000|Overall Study|translated materials not available for pilot|2|||
131603725|NCT05646355|473842609|FG001|Overall Study|translated materials not available for pilot|0|||
131603726|NCT05646355|473842608|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
131603727|NCT05646355|473842609|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
131603728|NCT04685135|473842610|FG000|Overall Study|Death|126|||
131603729|NCT04685135|473842611|FG001|Overall Study|Death|53|||
131603730|NCT04685135|473842610|FG000|Overall Study|Withdrawal by Subject|12|||
131603731|NCT04685135|473842611|FG001|Overall Study|Withdrawal by Subject|16|||
131603732|NCT05216406|473842614|FG000|Overall Study|Lost to Follow-up|8|||
131603733|NCT05216406|473842615|FG001|Overall Study|Lost to Follow-up|9|||
131603734|NCT03711474|473842616|FG000|Overall Study|Physician Decision|2|||
131603735|NCT03711474|473842617|FG001|Overall Study|Physician Decision|0|||
131603736|NCT03625115|473842622|FG000|Overall Study|Withdrawal by Subject|4|||
131603737|NCT03625115|473842623|FG001|Overall Study|Withdrawal by Subject|7|||
131603738|NCT03625115|473842622|FG000|Overall Study|Lost to Follow-up|17|||
131603739|NCT03625115|473842623|FG001|Overall Study|Lost to Follow-up|24|||
131603740|NCT04797195|473842624|FG000|Overall Study|Death|8|||
131603741|NCT04797195|473842625|FG001|Overall Study|Death|15|||
131603742|NCT04797195|473842624|FG000|Overall Study|Change from PD|15|||
131603743|NCT04797195|473842625|FG001|Overall Study|Change from PD|15|||
131603744|NCT04797195|473842624|FG000|Overall Study|Withdrawal by Subject|3|||
131603745|NCT04797195|473842625|FG001|Overall Study|Withdrawal by Subject|2|||
131603746|NCT04101357|473842627|FG000|Overall Study|Death|1|||
131603747|NCT04101357|473842628|FG001|Overall Study|Death|1|||
131603748|NCT04101357|473842629|FG002|Overall Study|Death|1|||
131603749|NCT04101357|473842630|FG003|Overall Study|Death|2|||
131603750|NCT04101357|473842631|FG004|Overall Study|Death|4|||
131603751|NCT04101357|473842632|FG005|Overall Study|Death|11|||
131603752|NCT04101357|473842633|FG006|Overall Study|Death|4|||
131603753|NCT04101357|473842634|FG007|Overall Study|Death|4|||
131603754|NCT04101357|473842635|FG008|Overall Study|Death|5|||
131603755|NCT04101357|473842636|FG009|Overall Study|Death|2|||
131603756|NCT04101357|473842637|FG010|Overall Study|Death|3|||
131603757|NCT04101357|473842627|FG000|Overall Study|Trial closure|0|||
131603758|NCT04101357|473842628|FG001|Overall Study|Trial closure|0|||
131603759|NCT04101357|473842629|FG002|Overall Study|Trial closure|0|||
131603760|NCT04101357|473842630|FG003|Overall Study|Trial closure|0|||
131603761|NCT04101357|473842631|FG004|Overall Study|Trial closure|0|||
131603762|NCT04101357|473842632|FG005|Overall Study|Trial closure|2|||
131603763|NCT04101357|473842633|FG006|Overall Study|Trial closure|2|||
131603764|NCT04101357|473842634|FG007|Overall Study|Trial closure|0|||
131603765|NCT04101357|473842635|FG008|Overall Study|Trial closure|0|||
131603766|NCT04101357|473842636|FG009|Overall Study|Trial closure|0|||
131603767|NCT04101357|473842637|FG010|Overall Study|Trial closure|1|||
131603768|NCT04101357|473842627|FG000|Overall Study|Lost to Follow-up|0|||
131603769|NCT04101357|473842628|FG001|Overall Study|Lost to Follow-up|0|||
131603770|NCT04101357|473842629|FG002|Overall Study|Lost to Follow-up|0|||
131603771|NCT04101357|473842630|FG003|Overall Study|Lost to Follow-up|1|||
131603772|NCT04101357|473842631|FG004|Overall Study|Lost to Follow-up|0|||
131603773|NCT04101357|473842632|FG005|Overall Study|Lost to Follow-up|0|||
131603774|NCT04101357|473842633|FG006|Overall Study|Lost to Follow-up|0|||
131603775|NCT04101357|473842634|FG007|Overall Study|Lost to Follow-up|1|||
131603776|NCT04101357|473842635|FG008|Overall Study|Lost to Follow-up|0|||
131603777|NCT04101357|473842636|FG009|Overall Study|Lost to Follow-up|0|||
131603778|NCT04101357|473842637|FG010|Overall Study|Lost to Follow-up|0|||
131603779|NCT04101357|473842627|FG000|Overall Study|Withdrawal by Subject|1|||
131603780|NCT04101357|473842628|FG001|Overall Study|Withdrawal by Subject|0|||
131603781|NCT04101357|473842629|FG002|Overall Study|Withdrawal by Subject|0|||
131603782|NCT04101357|473842630|FG003|Overall Study|Withdrawal by Subject|0|||
131603783|NCT04101357|473842631|FG004|Overall Study|Withdrawal by Subject|0|||
131603784|NCT04101357|473842632|FG005|Overall Study|Withdrawal by Subject|0|||
131603785|NCT04101357|473842633|FG006|Overall Study|Withdrawal by Subject|0|||
131603786|NCT04101357|473842634|FG007|Overall Study|Withdrawal by Subject|0|||
131603787|NCT04101357|473842635|FG008|Overall Study|Withdrawal by Subject|1|||
131603788|NCT04101357|473842636|FG009|Overall Study|Withdrawal by Subject|1|||
131603789|NCT04101357|473842637|FG010|Overall Study|Withdrawal by Subject|0|||
131603790|NCT04101357|473842627|FG000|Overall Study|Other|0|||
131603791|NCT04101357|473842628|FG001|Overall Study|Other|0|||
131603792|NCT04101357|473842629|FG002|Overall Study|Other|0|||
131791664|NCT00829413|474520839|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
131603793|NCT04101357|473842630|FG003|Overall Study|Other|0|||
131603794|NCT04101357|473842631|FG004|Overall Study|Other|0|||
131603795|NCT04101357|473842632|FG005|Overall Study|Other|1|||
131603796|NCT04101357|473842633|FG006|Overall Study|Other|2|||
131603797|NCT04101357|473842634|FG007|Overall Study|Other|1|||
131603798|NCT04101357|473842635|FG008|Overall Study|Other|0|||
131791665|NCT02043366|474520843|FG000|Overall Study|Lost to Follow-up|2|||
131603799|NCT04101357|473842636|FG009|Overall Study|Other|0|||
131603800|NCT04101357|473842637|FG010|Overall Study|Other|0|||
131603801|NCT04101357|473842627|FG000|Overall Study|Enrolled but not treated|0|||
131603802|NCT04101357|473842628|FG001|Overall Study|Enrolled but not treated|0|||
131603803|NCT04101357|473842629|FG002|Overall Study|Enrolled but not treated|0|||
131603804|NCT04101357|473842630|FG003|Overall Study|Enrolled but not treated|0|||
131603805|NCT04101357|473842631|FG004|Overall Study|Enrolled but not treated|0|||
131603806|NCT04101357|473842632|FG005|Overall Study|Enrolled but not treated|1|||
131603807|NCT04101357|473842633|FG006|Overall Study|Enrolled but not treated|1|||
131603808|NCT04101357|473842634|FG007|Overall Study|Enrolled but not treated|0|||
131603809|NCT04101357|473842635|FG008|Overall Study|Enrolled but not treated|0|||
131603810|NCT04101357|473842636|FG009|Overall Study|Enrolled but not treated|0|||
131603811|NCT04101357|473842637|FG010|Overall Study|Enrolled but not treated|0|||
131603812|NCT04059185|473842640|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
131603813|NCT04059185|473842641|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
131603814|NCT04059185|473842642|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
131603815|NCT04059185|473842640|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
131603816|NCT04059185|473842641|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
131603817|NCT04059185|473842642|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
131603818|NCT04059185|473842640|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
131603819|NCT04059185|473842641|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
131603820|NCT04059185|473842642|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
131603821|NCT04059185|473842640|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
131603822|NCT04059185|473842641|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
131603823|NCT04059185|473842642|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
131603824|NCT04059185|473842640|FG000|Longitudinal Assessment-Adults Only|Death|4|||
131603825|NCT04059185|473842641|FG001|Longitudinal Assessment-Adults Only|Death|4|||
131603826|NCT04059185|473842642|FG002|Longitudinal Assessment-Adults Only|Death|3|||
131603827|NCT03756662|473842643|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
131603828|NCT04587453|473842644|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
131603829|NCT04587453|473842645|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
131603830|NCT04786119|473842658|FG000|Overall Study|Withdrawal by Subject|2|||
131603831|NCT03325985|473842659|FG000|Overall Study|Lost to Follow-up|122|||
131603832|NCT03325985|473842660|FG001|Overall Study|Lost to Follow-up|26|||
131603833|NCT03325985|473842661|FG002|Overall Study|Lost to Follow-up|141|||
131603834|NCT03325985|473842662|FG003|Overall Study|Lost to Follow-up|28|||
131603835|NCT03325985|473842659|FG000|Overall Study|Death|99|||
131603836|NCT03325985|473842660|FG001|Overall Study|Death|36|||
131603837|NCT03325985|473842661|FG002|Overall Study|Death|94|||
131603838|NCT03325985|473842662|FG003|Overall Study|Death|32|||
131603839|NCT05873556|473842663|FG000|Overall Study|Lost to Follow-up|4|||
131603840|NCT05873556|473842664|FG001|Overall Study|Lost to Follow-up|1|||
131603841|NCT02684227|473842665|FG000|Overall Study|Adverse Event|1|||
131603842|NCT02684227|473842666|FG001|Overall Study|Adverse Event|7|||
131603843|NCT02684227|473842665|FG000|Overall Study|Death|0|||
131603844|NCT02684227|473842666|FG001|Overall Study|Death|2|||
131603845|NCT02684227|473842665|FG000|Overall Study|Withdrawal by Subject|0|||
131603846|NCT02684227|473842666|FG001|Overall Study|Withdrawal by Subject|1|||
131603847|NCT02684227|473842665|FG000|Overall Study|Progressive Disease|0|||
131603848|NCT02684227|473842666|FG001|Overall Study|Progressive Disease|2|||
131603849|NCT05267470|473842670|FG000|Overall Study|Decision by sponsor|0|||
131603850|NCT05267470|473842671|FG001|Overall Study|Decision by sponsor|3|||
131603851|NCT05267470|473842672|FG002|Overall Study|Decision by sponsor|19|||
131603852|NCT05267470|473842673|FG003|Overall Study|Decision by sponsor|7|||
131603853|NCT05267470|473842674|FG004|Overall Study|Decision by sponsor|3|||
131603854|NCT05267470|473842670|FG000|Overall Study|Withdrawal by Subject|1|||
131603855|NCT05267470|473842671|FG001|Overall Study|Withdrawal by Subject|1|||
131603856|NCT05267470|473842672|FG002|Overall Study|Withdrawal by Subject|2|||
131603857|NCT05267470|473842673|FG003|Overall Study|Withdrawal by Subject|2|||
131791666|NCT02043366|474520844|FG001|Overall Study|Lost to Follow-up|2|||
131603858|NCT05267470|473842674|FG004|Overall Study|Withdrawal by Subject|0|||
131603859|NCT05267470|473842670|FG000|Overall Study|Death|3|||
131603860|NCT05267470|473842671|FG001|Overall Study|Death|5|||
131603861|NCT05267470|473842672|FG002|Overall Study|Death|8|||
131603862|NCT05267470|473842673|FG003|Overall Study|Death|18|||
131791667|NCT02043366|474520845|FG002|Overall Study|Lost to Follow-up|2|||
131791668|NCT02043366|474520846|FG003|Overall Study|Lost to Follow-up|2|||
131603863|NCT05267470|473842674|FG004|Overall Study|Death|1|||
131603864|NCT05267470|473842670|FG000|Overall Study|Lost to Follow-up|0|||
131603865|NCT05267470|473842671|FG001|Overall Study|Lost to Follow-up|0|||
131603866|NCT05267470|473842672|FG002|Overall Study|Lost to Follow-up|0|||
131603867|NCT05267470|473842673|FG003|Overall Study|Lost to Follow-up|1|||
131603868|NCT05267470|473842674|FG004|Overall Study|Lost to Follow-up|0|||
131791669|NCT02043366|474520847|FG004|Overall Study|Lost to Follow-up|2|||
131603869|NCT05828017|473842677|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
131603870|NCT03381586|473842678|FG000|Overall Study|Adverse Event|1|||
131603871|NCT03381586|473842679|FG001|Overall Study|Adverse Event|1|||
131603872|NCT03381586|473842678|FG000|Overall Study|Protocol Violation|1|||
131603873|NCT03381586|473842679|FG001|Overall Study|Protocol Violation|0|||
131603874|NCT03381586|473842678|FG000|Overall Study|Withdrawal by Subject|1|||
131603875|NCT03381586|473842679|FG001|Overall Study|Withdrawal by Subject|2|||
131603876|NCT02852655|473842680|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
131603877|NCT02852655|473842681|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
131603878|NCT02852655|473842682|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
131603879|NCT02852655|473842680|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
131603880|NCT02852655|473842681|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
131603881|NCT02852655|473842682|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
131603882|NCT02852655|473842680|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
131603883|NCT02852655|473842681|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
131603884|NCT02852655|473842682|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
131603885|NCT02852655|473842680|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
131603886|NCT02852655|473842681|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
131603887|NCT02852655|473842682|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
131603888|NCT02852655|473842680|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
131603889|NCT02852655|473842681|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
131603890|NCT02852655|473842682|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
131603891|NCT02852655|473842680|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
131603892|NCT02852655|473842681|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
131603893|NCT02852655|473842682|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
131603894|NCT02852655|473842680|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
131603895|NCT02852655|473842681|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
131603896|NCT02852655|473842682|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
131603897|NCT02852655|473842680|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
131603898|NCT02852655|473842681|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
131603899|NCT02852655|473842682|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
131603900|NCT02852655|473842680|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
131603901|NCT02852655|473842681|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
131603902|NCT02852655|473842682|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
131603903|NCT04230681|473842687|FG000|Overall Study|Physician Decision|2|||
131603904|NCT04230681|473842688|FG001|Overall Study|Physician Decision|3|||
131603905|NCT04230681|473842687|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
131603906|NCT04230681|473842688|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
131603907|NCT04230681|473842687|FG000|Overall Study|IV inadvertently removed|0|||
131603908|NCT04230681|473842688|FG001|Overall Study|IV inadvertently removed|1|||
131653703|NCT03945825|474018460|FG005|Overall Study|Withdrawal by Subject|1|||
131653704|NCT03083665|474018461|FG000|Double-Blind Period|Adverse Event|5|||
131653705|NCT03083665|474018462|FG001|Double-Blind Period|Adverse Event|4|||
131653706|NCT03083665|474018463|FG002|Double-Blind Period|Adverse Event|5|||
131653707|NCT03083665|474018464|FG003|Double-Blind Period|Adverse Event|0|||
131653708|NCT03083665|474018465|FG004|Double-Blind Period|Adverse Event|0|||
131653709|NCT03083665|474018466|FG005|Double-Blind Period|Adverse Event|0|||
131653710|NCT03083665|474018461|FG000|Double-Blind Period|Lack of Efficacy|0|||
131653711|NCT03083665|474018462|FG001|Double-Blind Period|Lack of Efficacy|0|||
131653712|NCT03083665|474018463|FG002|Double-Blind Period|Lack of Efficacy|1|||
131653713|NCT03083665|474018464|FG003|Double-Blind Period|Lack of Efficacy|0|||
131653714|NCT03083665|474018465|FG004|Double-Blind Period|Lack of Efficacy|0|||
131653715|NCT03083665|474018466|FG005|Double-Blind Period|Lack of Efficacy|0|||
131653716|NCT03083665|474018461|FG000|Double-Blind Period|Protocol Violation|1|||
131653717|NCT03083665|474018462|FG001|Double-Blind Period|Protocol Violation|0|||
131653718|NCT03083665|474018463|FG002|Double-Blind Period|Protocol Violation|1|||
131653719|NCT03083665|474018464|FG003|Double-Blind Period|Protocol Violation|0|||
131653720|NCT03083665|474018465|FG004|Double-Blind Period|Protocol Violation|0|||
131653721|NCT03083665|474018466|FG005|Double-Blind Period|Protocol Violation|0|||
131653722|NCT03083665|474018461|FG000|Double-Blind Period|Lost to Follow-up|1|||
131653723|NCT03083665|474018462|FG001|Double-Blind Period|Lost to Follow-up|0|||
131653724|NCT03083665|474018463|FG002|Double-Blind Period|Lost to Follow-up|1|||
131653725|NCT03083665|474018464|FG003|Double-Blind Period|Lost to Follow-up|0|||
131653726|NCT03083665|474018465|FG004|Double-Blind Period|Lost to Follow-up|0|||
131653727|NCT03083665|474018466|FG005|Double-Blind Period|Lost to Follow-up|0|||
131653728|NCT03083665|474018461|FG000|Double-Blind Period|Withdrawal by Subject|3|||
131653729|NCT03083665|474018462|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131653730|NCT03083665|474018463|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131653731|NCT03083665|474018464|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131653732|NCT03083665|474018465|FG004|Double-Blind Period|Withdrawal by Subject|0|||
131899697|NCT02659943|474919374|FG001|Overall Study|Patient's condition per principal investigator|0|||
131603909|NCT00696111|473845160|FG000|Overall Study|Withdrawal by Subject|17|||
131706896|NCT00289913|474209266|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131603910|NCT05452460|473845162|FG000|Overall Study|Lost to Follow-up|3|||
131603911|NCT05452460|473845163|FG001|Overall Study|Lost to Follow-up|3|||
131603912|NCT05452460|473845162|FG000|Overall Study|Did not receive intervention|1|||
131603913|NCT05452460|473845163|FG001|Overall Study|Did not receive intervention|0|||
131603914|NCT05645757|473845164|FG000|Overall Study|Enrolled but treatment not administered|0|||
131603915|NCT05645757|473845165|FG001|Overall Study|Enrolled but treatment not administered|0|||
131603916|NCT05645757|473845166|FG002|Overall Study|Enrolled but treatment not administered|0|||
131603917|NCT05645757|473845167|FG003|Overall Study|Enrolled but treatment not administered|0|||
131603918|NCT05645757|473845168|FG004|Overall Study|Enrolled but treatment not administered|1|||
131603919|NCT05645757|473845169|FG005|Overall Study|Enrolled but treatment not administered|1|||
131603920|NCT05645757|473845170|FG006|Overall Study|Enrolled but treatment not administered|0|||
131603921|NCT05645757|473845171|FG007|Overall Study|Enrolled but treatment not administered|0|||
131603922|NCT03924635|473845172|FG000|Overall Study|Withdrawal by Subject|2|||
131603923|NCT03924635|473845173|FG001|Overall Study|Withdrawal by Subject|4|||
131603924|NCT00539591|473845174|FG000|Overall Study|Toxicity|3|||
131603925|NCT00539591|473845175|FG001|Overall Study|Toxicity|0|||
131603926|NCT00539591|473845176|FG002|Overall Study|Toxicity|0|||
131603927|NCT00539591|473845174|FG000|Overall Study|Disease progression|2|||
131603928|NCT00539591|473845175|FG001|Overall Study|Disease progression|2|||
131603929|NCT00539591|473845176|FG002|Overall Study|Disease progression|3|||
131603930|NCT04447040|473845177|FG000|Overall Study|Lost to Follow-up|2|||
131603931|NCT04447040|473845178|FG001|Overall Study|Lost to Follow-up|1|||
131603932|NCT04447040|473845179|FG002|Overall Study|Lost to Follow-up|3|||
131603933|NCT04447040|473845180|FG003|Overall Study|Lost to Follow-up|3|||
131603934|NCT04447040|473845181|FG004|Overall Study|Lost to Follow-up|1|||
131603935|NCT04447040|473845182|FG005|Overall Study|Lost to Follow-up|3|||
131603936|NCT04447040|473845177|FG000|Overall Study|Withdrawal by Subject|0|||
131603937|NCT04447040|473845178|FG001|Overall Study|Withdrawal by Subject|1|||
131603938|NCT04447040|473845179|FG002|Overall Study|Withdrawal by Subject|1|||
131603939|NCT04447040|473845180|FG003|Overall Study|Withdrawal by Subject|1|||
131603940|NCT04447040|473845181|FG004|Overall Study|Withdrawal by Subject|0|||
131603941|NCT04447040|473845182|FG005|Overall Study|Withdrawal by Subject|0|||
131603942|NCT02038777|473845185|FG000|Overall Study|Death|0|||
131603943|NCT02038777|473845186|FG001|Overall Study|Death|2|||
131603944|NCT02038777|473845187|FG002|Overall Study|Death|0|||
131603945|NCT02038777|473845188|FG003|Overall Study|Death|1|||
131603946|NCT02038777|473845189|FG004|Overall Study|Death|2|||
131603947|NCT02038777|473845190|FG005|Overall Study|Death|4|||
131603948|NCT02038777|473845191|FG006|Overall Study|Death|0|||
131603949|NCT02038777|473845192|FG007|Overall Study|Death|11|||
131603950|NCT02038777|473845185|FG000|Overall Study|Lost to Follow-up|0|||
131603951|NCT02038777|473845186|FG001|Overall Study|Lost to Follow-up|0|||
131706897|NCT00289913|474209267|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131603952|NCT02038777|473845187|FG002|Overall Study|Lost to Follow-up|0|||
131603953|NCT02038777|473845188|FG003|Overall Study|Lost to Follow-up|1|||
131603954|NCT02038777|473845189|FG004|Overall Study|Lost to Follow-up|0|||
131603955|NCT02038777|473845190|FG005|Overall Study|Lost to Follow-up|0|||
131603956|NCT02038777|473845191|FG006|Overall Study|Lost to Follow-up|0|||
131603957|NCT02038777|473845192|FG007|Overall Study|Lost to Follow-up|0|||
131603958|NCT02038777|473845185|FG000|Overall Study|Other|0|||
131603959|NCT02038777|473845186|FG001|Overall Study|Other|1|||
131603960|NCT02038777|473845187|FG002|Overall Study|Other|0|||
131440417|NCT03284710|473241495|FG003|Overall Study|Lost to Follow-up|0|||
131603961|NCT02038777|473845188|FG003|Overall Study|Other|2|||
131603962|NCT02038777|473845189|FG004|Overall Study|Other|1|||
131603963|NCT02038777|473845190|FG005|Overall Study|Other|0|||
131603964|NCT02038777|473845191|FG006|Overall Study|Other|0|||
131603965|NCT02038777|473845192|FG007|Overall Study|Other|0|||
131603966|NCT02038777|473845185|FG000|Overall Study|Randomized but not treated|0|||
131603967|NCT02038777|473845186|FG001|Overall Study|Randomized but not treated|1|||
131706898|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706899|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131603968|NCT02038777|473845187|FG002|Overall Study|Randomized but not treated|0|||
131603969|NCT02038777|473845188|FG003|Overall Study|Randomized but not treated|0|||
131899698|NCT02659943|474919375|FG002|Overall Study|Patient's condition per principal investigator|0|||
131899699|NCT02659943|474919376|FG003|Overall Study|Patient's condition per principal investigator|0|||
131603970|NCT02038777|473845189|FG004|Overall Study|Randomized but not treated|0|||
131603971|NCT02038777|473845190|FG005|Overall Study|Randomized but not treated|0|||
131603972|NCT02038777|473845191|FG006|Overall Study|Randomized but not treated|0|||
131603973|NCT02038777|473845192|FG007|Overall Study|Randomized but not treated|0|||
131440418|NCT03284710|473241492|FG000|Overall Study|Physician Decision|1|||
131603974|NCT02038777|473845185|FG000|Overall Study|Started Chemotherapy|1|||
131603975|NCT02038777|473845186|FG001|Overall Study|Started Chemotherapy|0|||
131603976|NCT02038777|473845187|FG002|Overall Study|Started Chemotherapy|3|||
131603977|NCT02038777|473845188|FG003|Overall Study|Started Chemotherapy|0|||
131603978|NCT02038777|473845189|FG004|Overall Study|Started Chemotherapy|0|||
131603979|NCT02038777|473845190|FG005|Overall Study|Started Chemotherapy|0|||
131603980|NCT02038777|473845191|FG006|Overall Study|Started Chemotherapy|0|||
131603981|NCT02038777|473845192|FG007|Overall Study|Started Chemotherapy|0|||
131603982|NCT02038777|473845185|FG000|Overall Study|participation terminated by sponsor|0|||
131603983|NCT02038777|473845186|FG001|Overall Study|participation terminated by sponsor|0|||
131603984|NCT02038777|473845187|FG002|Overall Study|participation terminated by sponsor|0|||
131603985|NCT02038777|473845188|FG003|Overall Study|participation terminated by sponsor|0|||
131603986|NCT02038777|473845189|FG004|Overall Study|participation terminated by sponsor|0|||
131603987|NCT02038777|473845190|FG005|Overall Study|participation terminated by sponsor|0|||
131603988|NCT02038777|473845191|FG006|Overall Study|participation terminated by sponsor|1|||
131603989|NCT02038777|473845192|FG007|Overall Study|participation terminated by sponsor|1|||
131603990|NCT04299464|473845193|FG000|Overall Study|Adverse Event|1|||
131440419|NCT03284710|473241493|FG001|Overall Study|Physician Decision|0|||
131440420|NCT03284710|473241494|FG002|Overall Study|Physician Decision|0|||
131440421|NCT03284710|473241495|FG003|Overall Study|Physician Decision|0|||
131440422|NCT03284710|473241492|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
131603991|NCT04299464|473845194|FG001|Overall Study|Adverse Event|0|||
131603992|NCT04299464|473845195|FG002|Overall Study|Adverse Event|2|||
131603993|NCT04299464|473845193|FG000|Overall Study|Non-compliance with Study Drug|1|||
131603994|NCT04299464|473845194|FG001|Overall Study|Non-compliance with Study Drug|0|||
131603995|NCT04299464|473845195|FG002|Overall Study|Non-compliance with Study Drug|0|||
131603996|NCT04299464|473845193|FG000|Overall Study|Reason not Specified|0|||
131603997|NCT04299464|473845194|FG001|Overall Study|Reason not Specified|1|||
131603998|NCT04299464|473845195|FG002|Overall Study|Reason not Specified|3|||
131603999|NCT04299464|473845193|FG000|Overall Study|Physician Decision|0|||
131604000|NCT04299464|473845194|FG001|Overall Study|Physician Decision|1|||
131604001|NCT04299464|473845195|FG002|Overall Study|Physician Decision|1|||
131604002|NCT04299464|473845193|FG000|Overall Study|Withdrawal by Subject|0|||
131604003|NCT04299464|473845194|FG001|Overall Study|Withdrawal by Subject|2|||
131604004|NCT04299464|473845195|FG002|Overall Study|Withdrawal by Subject|1|||
131604005|NCT03676192|473845196|FG000|Induction Study Period|Adverse Event|21|||
131604006|NCT03676192|473845197|FG001|Induction Study Period|Adverse Event|20|||
131604007|NCT03676192|473845196|FG000|Induction Study Period|Death|23|||
131604008|NCT03676192|473845197|FG001|Induction Study Period|Death|20|||
131604009|NCT03676192|473845196|FG000|Induction Study Period|Lost to Follow-up|3|||
131604010|NCT03676192|473845197|FG001|Induction Study Period|Lost to Follow-up|3|||
131604011|NCT03676192|473845196|FG000|Induction Study Period|Physician Decision|6|||
131604012|NCT03676192|473845197|FG001|Induction Study Period|Physician Decision|3|||
131604013|NCT03676192|473845196|FG000|Induction Study Period|Progressive Disease|32|||
131604014|NCT03676192|473845197|FG001|Induction Study Period|Progressive Disease|21|||
131604015|NCT03676192|473845196|FG000|Induction Study Period|Protocol Violation|1|||
131604016|NCT03676192|473845197|FG001|Induction Study Period|Protocol Violation|2|||
131604017|NCT03676192|473845196|FG000|Induction Study Period|Withdrawal by Subject|20|||
131604018|NCT03676192|473845197|FG001|Induction Study Period|Withdrawal by Subject|15|||
131604019|NCT02694822|473845198|FG000|Phase 1|Death|2|||
131604020|NCT02694822|473845199|FG001|Phase 1|Death|1|||
131604021|NCT02694822|473845200|FG002|Phase 1|Death|6|||
131604022|NCT02694822|473845201|FG003|Phase 1|Death|6|||
131604023|NCT02694822|473845202|FG004|Phase 1|Death|3|||
131604024|NCT02694822|473845203|FG005|Phase 1|Death|0|||
131604025|NCT02694822|473845198|FG000|Phase 1|Withdrawal by Subject|2|||
131604026|NCT02694822|473845199|FG001|Phase 1|Withdrawal by Subject|2|||
131604027|NCT02694822|473845200|FG002|Phase 1|Withdrawal by Subject|4|||
131604028|NCT02694822|473845201|FG003|Phase 1|Withdrawal by Subject|8|||
131604029|NCT02694822|473845202|FG004|Phase 1|Withdrawal by Subject|1|||
131604030|NCT02694822|473845203|FG005|Phase 1|Withdrawal by Subject|0|||
131706900|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
131706901|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706902|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131604031|NCT02694822|473845198|FG000|Phase 2|Death|0|||
131706903|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
131706904|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
131604032|NCT02694822|473845199|FG001|Phase 2|Death|0|||
131604033|NCT02694822|473845200|FG002|Phase 2|Death|0|||
131604034|NCT02694822|473845201|FG003|Phase 2|Death|0|||
131604035|NCT02694822|473845202|FG004|Phase 2|Death|0|||
131604036|NCT02694822|473845203|FG005|Phase 2|Death|26|||
131706905|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
131604037|NCT02694822|473845198|FG000|Phase 2|Withdrawal by Subject|0|||
131604038|NCT02694822|473845199|FG001|Phase 2|Withdrawal by Subject|0|||
131604039|NCT02694822|473845200|FG002|Phase 2|Withdrawal by Subject|0|||
131604040|NCT02694822|473845201|FG003|Phase 2|Withdrawal by Subject|0|||
131604041|NCT02694822|473845202|FG004|Phase 2|Withdrawal by Subject|0|||
131604042|NCT02694822|473845203|FG005|Phase 2|Withdrawal by Subject|13|||
131604043|NCT02694822|473845198|FG000|Phase 2|Administrative Study Closure|0|||
131604044|NCT02694822|473845199|FG001|Phase 2|Administrative Study Closure|0|||
131440423|NCT03284710|473241493|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131440424|NCT03284710|473241494|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131440425|NCT03284710|473241495|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
131440426|NCT03284710|473241492|FG000|Overall Study|HIV Infection|0|||
131440427|NCT03284710|473241493|FG001|Overall Study|HIV Infection|2|||
131440428|NCT03284710|473241494|FG002|Overall Study|HIV Infection|2|||
131440429|NCT03284710|473241495|FG003|Overall Study|HIV Infection|1|||
131440430|NCT05546476|473241496|FG000|Period 1: Part A|Adverse Event|2|||
131440431|NCT05546476|473241497|FG001|Period 1: Part A|Adverse Event|0|||
131440432|NCT05546476|473241498|FG002|Period 1: Part A|Adverse Event|0|||
131440433|NCT05546476|473241499|FG003|Period 1: Part A|Adverse Event|1|||
131440434|NCT05546476|473241496|FG000|Period 1: Part A|Death|4|||
131440435|NCT05546476|473241497|FG001|Period 1: Part A|Death|4|||
131440436|NCT05546476|473241498|FG002|Period 1: Part A|Death|5|||
131440437|NCT05546476|473241499|FG003|Period 1: Part A|Death|6|||
131440438|NCT05546476|473241496|FG000|Period 1: Part A|Lack of Efficacy|0|||
131440439|NCT05546476|473241497|FG001|Period 1: Part A|Lack of Efficacy|0|||
131440440|NCT05546476|473241498|FG002|Period 1: Part A|Lack of Efficacy|0|||
131440441|NCT05546476|473241499|FG003|Period 1: Part A|Lack of Efficacy|1|||
131440442|NCT05546476|473241496|FG000|Period 1: Part A|Lost to Follow-up|0|||
131440443|NCT05546476|473241497|FG001|Period 1: Part A|Lost to Follow-up|0|||
131440444|NCT05546476|473241498|FG002|Period 1: Part A|Lost to Follow-up|0|||
131440445|NCT05546476|473241499|FG003|Period 1: Part A|Lost to Follow-up|1|||
131440446|NCT05546476|473241496|FG000|Period 1: Part A|Physician Decision|1|||
131440447|NCT05546476|473241497|FG001|Period 1: Part A|Physician Decision|0|||
131440448|NCT05546476|473241498|FG002|Period 1: Part A|Physician Decision|0|||
131440449|NCT05546476|473241499|FG003|Period 1: Part A|Physician Decision|0|||
131440450|NCT05546476|473241496|FG000|Period 1: Part A|Progressive disease|3|||
131440451|NCT05546476|473241497|FG001|Period 1: Part A|Progressive disease|5|||
131440452|NCT05546476|473241498|FG002|Period 1: Part A|Progressive disease|0|||
131440453|NCT05546476|473241499|FG003|Period 1: Part A|Progressive disease|1|||
131440454|NCT05546476|473241496|FG000|Period 1: Part A|Withdrawal by Subject|1|||
131440455|NCT05546476|473241497|FG001|Period 1: Part A|Withdrawal by Subject|1|||
131440456|NCT05546476|473241498|FG002|Period 1: Part A|Withdrawal by Subject|1|||
131440457|NCT05546476|473241499|FG003|Period 1: Part A|Withdrawal by Subject|2|||
131440458|NCT05546476|473241496|FG000|Period 1: Part A|Global deterioration of health status|2|||
131440459|NCT05546476|473241497|FG001|Period 1: Part A|Global deterioration of health status|2|||
131440460|NCT05546476|473241498|FG002|Period 1: Part A|Global deterioration of health status|1|||
131440461|NCT05546476|473241499|FG003|Period 1: Part A|Global deterioration of health status|4|||
131440462|NCT05546476|473241496|FG000|Period 1: Part A|Other: Unspecified|0|||
131440463|NCT05546476|473241497|FG001|Period 1: Part A|Other: Unspecified|2|||
131440464|NCT05546476|473241498|FG002|Period 1: Part A|Other: Unspecified|0|||
131440465|NCT05546476|473241499|FG003|Period 1: Part A|Other: Unspecified|0|||
131440466|NCT05546476|473241496|FG000|Period 2: Part B|Ongoing|26|||
131440467|NCT05546476|473241497|FG001|Period 2: Part B|Ongoing|27|||
131440468|NCT05546476|473241498|FG002|Period 2: Part B|Ongoing|35|||
131440469|NCT05546476|473241499|FG003|Period 2: Part B|Ongoing|29|||
131604045|NCT02694822|473845200|FG002|Phase 2|Administrative Study Closure|0|||
131604046|NCT02694822|473845201|FG003|Phase 2|Administrative Study Closure|0|||
131604047|NCT02694822|473845202|FG004|Phase 2|Administrative Study Closure|0|||
131604048|NCT02694822|473845203|FG005|Phase 2|Administrative Study Closure|2|||
131604049|NCT02694822|473845198|FG000|Phase 2|Lost to Follow-up|0|||
131604050|NCT02694822|473845199|FG001|Phase 2|Lost to Follow-up|0|||
131604051|NCT02694822|473845200|FG002|Phase 2|Lost to Follow-up|0|||
131604052|NCT02694822|473845201|FG003|Phase 2|Lost to Follow-up|0|||
131604053|NCT02694822|473845202|FG004|Phase 2|Lost to Follow-up|0|||
131604054|NCT02694822|473845203|FG005|Phase 2|Lost to Follow-up|1|||
131604055|NCT02694822|473845198|FG000|Phase 2|Participant Transferred to Another Site|0|||
131604056|NCT02694822|473845199|FG001|Phase 2|Participant Transferred to Another Site|0|||
131706906|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
131706907|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
131706908|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131440470|NCT02953652|473241500|FG000|Overall Study|Adverse Event|18|||
131440471|NCT02953652|473241500|FG000|Overall Study|Withdrawal by Subject|6|||
131440472|NCT02953652|473241500|FG000|Overall Study|Protocol Violation|1|||
131440473|NCT02953652|473241500|FG000|Overall Study|Disease Progression|27|||
131440474|NCT03035032|473241501|FG000|Overall Study|Adverse Event|2|||
131440475|NCT03035032|473241501|FG000|Overall Study|Death|9|||
131440476|NCT03035032|473241501|FG000|Overall Study|Lost to Follow-up|1|||
131440477|NCT03035032|473241501|FG000|Overall Study|Progressive Disease|22|||
131440478|NCT03035032|473241501|FG000|Overall Study|Protocol Violation|2|||
131604057|NCT02694822|473845200|FG002|Phase 2|Participant Transferred to Another Site|0|||
131604058|NCT02694822|473845201|FG003|Phase 2|Participant Transferred to Another Site|0|||
131440479|NCT03035032|473241501|FG000|Overall Study|Withdrawal by Subject|2|||
131440480|NCT03035032|473241501|FG000|Overall Study|Physician Decision|5|||
131604059|NCT02694822|473845202|FG004|Phase 2|Participant Transferred to Another Site|0|||
131604060|NCT02694822|473845203|FG005|Phase 2|Participant Transferred to Another Site|1|||
131604061|NCT02424617|473845206|FG000|Overall Study|Adverse Event|0|||
131604062|NCT02424617|473845207|FG001|Overall Study|Adverse Event|1|||
131604063|NCT02424617|473845208|FG002|Overall Study|Adverse Event|0|||
131604064|NCT02424617|473845209|FG003|Overall Study|Adverse Event|0|||
131604065|NCT02424617|473845206|FG000|Overall Study|Investigator Decision|0|||
131604066|NCT02424617|473845207|FG001|Overall Study|Investigator Decision|0|||
131604067|NCT02424617|473845208|FG002|Overall Study|Investigator Decision|0|||
131604068|NCT02424617|473845209|FG003|Overall Study|Investigator Decision|1|||
131604069|NCT02424617|473845206|FG000|Overall Study|Withdrawal by Subject|1|||
131604070|NCT02424617|473845207|FG001|Overall Study|Withdrawal by Subject|1|||
131706909|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
131706910|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131706911|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131706912|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131706913|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
131706914|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131706915|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
131706916|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131706917|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131706918|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131706919|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706920|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131706921|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706922|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706923|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131706924|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
131791670|NCT02043366|474520848|FG005|Overall Study|Lost to Follow-up|2|||
131791671|NCT00891774|474520851|FG000|Overall Study|Lost to Follow-up|5|||
131791672|NCT00891774|474520851|FG000|Overall Study|Illness (Self/Mother)|3|||
131791673|NCT00891774|474520851|FG000|Overall Study|Withdrawal by Subject|2|||
131791674|NCT00891774|474520851|FG000|Overall Study|Protocol Violation|4|||
131791675|NCT01418352|474520858|FG000|Overall Study|Lost to Follow-up|2|||
131791676|NCT01418352|474520859|FG001|Overall Study|Lost to Follow-up|0|||
131791677|NCT01418352|474520860|FG002|Overall Study|Lost to Follow-up|0|||
131791678|NCT01418352|474520861|FG003|Overall Study|Lost to Follow-up|0|||
131791679|NCT01418352|474520858|FG000|Overall Study|Adverse Event|0|||
131791680|NCT01418352|474520859|FG001|Overall Study|Adverse Event|1|||
131791681|NCT01418352|474520860|FG002|Overall Study|Adverse Event|0|||
131791682|NCT01418352|474520861|FG003|Overall Study|Adverse Event|0|||
131791683|NCT01418352|474520858|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
131604071|NCT02424617|473845208|FG002|Overall Study|Withdrawal by Subject|0|||
131604072|NCT02424617|473845209|FG003|Overall Study|Withdrawal by Subject|1|||
131604073|NCT02424617|473845206|FG000|Overall Study|Progressive Disease|7|||
131604074|NCT02424617|473845207|FG001|Overall Study|Progressive Disease|6|||
131604075|NCT02424617|473845208|FG002|Overall Study|Progressive Disease|11|||
131604076|NCT02424617|473845209|FG003|Overall Study|Progressive Disease|10|||
131604077|NCT02424617|473845206|FG000|Overall Study|Other|0|||
131604078|NCT02424617|473845207|FG001|Overall Study|Other|0|||
131604079|NCT02424617|473845208|FG002|Overall Study|Other|0|||
131604080|NCT02424617|473845209|FG003|Overall Study|Other|1|||
131604081|NCT01868997|473845210|FG000|Overall Study|Adverse Event|2|||
131604082|NCT01868997|473845211|FG001|Overall Study|Adverse Event|5|||
131604083|NCT01868997|473845210|FG000|Overall Study|Lack of Efficacy|2|||
131604084|NCT01868997|473845211|FG001|Overall Study|Lack of Efficacy|0|||
131604085|NCT01868997|473845210|FG000|Overall Study|Other|3|||
131604086|NCT01868997|473845211|FG001|Overall Study|Other|1|||
131604087|NCT01960452|473845212|FG000|Overall Study|Withdrawal by Subject|2|||
131604088|NCT01960452|473845213|FG001|Overall Study|Withdrawal by Subject|1|||
131604089|NCT01960452|473845212|FG000|Overall Study|Sleep apnea in Night 1|1|||
131604090|NCT01960452|473845213|FG001|Overall Study|Sleep apnea in Night 1|0|||
131604091|NCT01960452|473845212|FG000|Overall Study|Poor Sleep in Night 1|0|||
131604092|NCT01960452|473845213|FG001|Overall Study|Poor Sleep in Night 1|2|||
131604093|NCT01960452|473845212|FG000|Overall Study|No Sex/Age Match Night 1|1|||
131604094|NCT01960452|473845213|FG001|Overall Study|No Sex/Age Match Night 1|0|||
131604095|NCT01960452|473845212|FG000|Overall Study|No Sex/Age Match Night 2|0|||
131604096|NCT01960452|473845213|FG001|Overall Study|No Sex/Age Match Night 2|2|||
131791684|NCT01418352|474520859|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
131791685|NCT01418352|474520860|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
131604097|NCT01960452|473845212|FG000|Overall Study|Technical Difficulties Night 2|2|||
131604098|NCT01960452|473845213|FG001|Overall Study|Technical Difficulties Night 2|0|||
131604099|NCT03209973|473845216|FG000|Overall Study|Withdrawal by Subject|7|||
131604100|NCT03209973|473845216|FG000|Overall Study|Lost to Follow-up|2|||
131604101|NCT03209973|473845216|FG000|Overall Study|Death|8|||
131604102|NCT03209973|473845216|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
131604103|NCT03209973|473845216|FG000|Overall Study|Sponsor Decision|18|||
131604104|NCT03209973|473845216|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
131604105|NCT03209973|473845216|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
131604106|NCT04766892|473845217|FG000|Overall Study|Withdrawal by Subject|1|||
131604107|NCT04766892|473845217|FG000|Overall Study|Lost to Follow-up|1|||
131604108|NCT04766892|473845217|FG000|Overall Study|Adverse Event|3|||
131604109|NCT04766892|473845217|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
131604110|NCT04778397|473845218|FG000|Overall Study|Death|59|||
131604111|NCT04778397|473845219|FG001|Overall Study|Death|54|||
131604112|NCT04778397|473845220|FG002|Overall Study|Death|11|||
131604113|NCT04778397|473845221|FG003|Overall Study|Death|9|||
131604114|NCT04778397|473845218|FG000|Overall Study|Study Terminated by Sponsor|34|||
131604115|NCT04778397|473845219|FG001|Overall Study|Study Terminated by Sponsor|42|||
131604116|NCT04778397|473845220|FG002|Overall Study|Study Terminated by Sponsor|15|||
131604117|NCT04778397|473845221|FG003|Overall Study|Study Terminated by Sponsor|12|||
131604118|NCT04778397|473845218|FG000|Overall Study|Withdrew Consent|5|||
131604119|NCT04778397|473845219|FG001|Overall Study|Withdrew Consent|4|||
131604120|NCT04778397|473845220|FG002|Overall Study|Withdrew Consent|1|||
131604121|NCT04778397|473845221|FG003|Overall Study|Withdrew Consent|1|||
131604122|NCT04778397|473845218|FG000|Overall Study|Reason Not Specified|1|||
131604123|NCT04778397|473845219|FG001|Overall Study|Reason Not Specified|3|||
131604124|NCT04778397|473845220|FG002|Overall Study|Reason Not Specified|0|||
131604125|NCT04778397|473845221|FG003|Overall Study|Reason Not Specified|2|||
131604126|NCT04778397|473845218|FG000|Overall Study|Lost to Follow-up|2|||
131604127|NCT04778397|473845219|FG001|Overall Study|Lost to Follow-up|1|||
131604128|NCT04778397|473845220|FG002|Overall Study|Lost to Follow-up|0|||
131604129|NCT04778397|473845221|FG003|Overall Study|Lost to Follow-up|1|||
131604130|NCT01627574|473845222|FG000|Overall Study|Withdrawal by Subject|8|||
131604131|NCT01627574|473845223|FG001|Overall Study|Withdrawal by Subject|5|||
131604132|NCT01627574|473845222|FG000|Overall Study|Lost to Follow-up|13|||
131604133|NCT01627574|473845223|FG001|Overall Study|Lost to Follow-up|13|||
131604134|NCT04730739|473845224|FG000|Overall Study|Death|1|||
131604135|NCT03249090|473845226|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
131604136|NCT03249090|473845227|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
131604137|NCT03249090|473845226|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
131604138|NCT03249090|473845227|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
131604139|NCT03249090|473845226|FG000|3 Month Time Point|Voluntary withdrawal|6|||
131604140|NCT03249090|473845227|FG001|3 Month Time Point|Voluntary withdrawal|3|||
131604141|NCT03249090|473845226|FG000|3 Month Time Point|Changed oncology practice|4|||
131604142|NCT03249090|473845227|FG001|3 Month Time Point|Changed oncology practice|2|||
131604143|NCT03249090|473845226|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
131604144|NCT03249090|473845227|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
131604145|NCT03249090|473845226|FG000|12 Month Time Point|Voluntary withdrawal|35|||
131604146|NCT03249090|473845227|FG001|12 Month Time Point|Voluntary withdrawal|4|||
131604147|NCT03249090|473845226|FG000|12 Month Time Point|Changed oncology practice|20|||
131604148|NCT03249090|473845227|FG001|12 Month Time Point|Changed oncology practice|9|||
131604149|NCT04359654|473845230|FG000|Overall Study|Withdrawal by Subject|1|||
131604150|NCT04359654|473845231|FG001|Overall Study|Withdrawal by Subject|0|||
131604151|NCT04359654|473845230|FG000|Overall Study|Adverse Event|0|||
131604152|NCT04359654|473845231|FG001|Overall Study|Adverse Event|1|||
131604153|NCT03523572|473845233|FG000|Dose Escalation|Progressive disease|1|||
131604154|NCT03523572|473845234|FG001|Dose Escalation|Progressive disease|0|||
131604155|NCT03523572|473845235|FG002|Dose Escalation|Progressive disease|0|||
131604156|NCT03523572|473845236|FG003|Dose Escalation|Progressive disease|0|||
131604157|NCT03523572|473845237|FG004|Dose Escalation|Progressive disease|0|||
131604158|NCT03523572|473845238|FG005|Dose Escalation|Progressive disease|0|||
131604159|NCT03523572|473845233|FG000|Dose Escalation|Clinical Progression|0|||
131706925|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
131706926|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
131706927|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131706928|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
131604160|NCT03523572|473845234|FG001|Dose Escalation|Clinical Progression|1|||
131604161|NCT03523572|473845235|FG002|Dose Escalation|Clinical Progression|0|||
131604162|NCT03523572|473845236|FG003|Dose Escalation|Clinical Progression|0|||
131604163|NCT03523572|473845237|FG004|Dose Escalation|Clinical Progression|0|||
131706929|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
131706930|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
131604164|NCT03523572|473845238|FG005|Dose Escalation|Clinical Progression|0|||
131604165|NCT03523572|473845233|FG000|Dose Escalation|Adverse Event|2|||
131604166|NCT03523572|473845234|FG001|Dose Escalation|Adverse Event|0|||
131706931|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
131706932|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
131706933|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
131604167|NCT03523572|473845235|FG002|Dose Escalation|Adverse Event|0|||
131604168|NCT03523572|473845236|FG003|Dose Escalation|Adverse Event|0|||
131604169|NCT03523572|473845237|FG004|Dose Escalation|Adverse Event|0|||
131604170|NCT03523572|473845238|FG005|Dose Escalation|Adverse Event|0|||
131604171|NCT03523572|473845233|FG000|Dose Escalation|Physician Decision|1|||
131604172|NCT03523572|473845234|FG001|Dose Escalation|Physician Decision|1|||
131604173|NCT03523572|473845235|FG002|Dose Escalation|Physician Decision|0|||
131604174|NCT03523572|473845236|FG003|Dose Escalation|Physician Decision|0|||
131604175|NCT03523572|473845237|FG004|Dose Escalation|Physician Decision|0|||
131604176|NCT03523572|473845238|FG005|Dose Escalation|Physician Decision|0|||
131604177|NCT03523572|473845233|FG000|Dose Expansion|Progressive Disease|0|||
131604178|NCT03523572|473845234|FG001|Dose Expansion|Progressive Disease|0|||
131604179|NCT03523572|473845235|FG002|Dose Expansion|Progressive Disease|9|||
131604180|NCT03523572|473845236|FG003|Dose Expansion|Progressive Disease|11|||
131604181|NCT03523572|473845237|FG004|Dose Expansion|Progressive Disease|15|||
131604182|NCT03523572|473845238|FG005|Dose Expansion|Progressive Disease|2|||
131604183|NCT03523572|473845233|FG000|Dose Expansion|Clinical Progression|0|||
131604184|NCT03523572|473845234|FG001|Dose Expansion|Clinical Progression|0|||
131604185|NCT03523572|473845235|FG002|Dose Expansion|Clinical Progression|2|||
131604186|NCT03523572|473845236|FG003|Dose Expansion|Clinical Progression|2|||
131604187|NCT03523572|473845237|FG004|Dose Expansion|Clinical Progression|2|||
131604188|NCT03523572|473845238|FG005|Dose Expansion|Clinical Progression|0|||
131604189|NCT03523572|473845233|FG000|Dose Expansion|Adverse Event|0|||
131604190|NCT03523572|473845234|FG001|Dose Expansion|Adverse Event|0|||
131604191|NCT03523572|473845235|FG002|Dose Expansion|Adverse Event|10|||
131604192|NCT03523572|473845236|FG003|Dose Expansion|Adverse Event|1|||
131604193|NCT03523572|473845237|FG004|Dose Expansion|Adverse Event|5|||
131604194|NCT03523572|473845238|FG005|Dose Expansion|Adverse Event|2|||
131604195|NCT03523572|473845233|FG000|Dose Expansion|Withdrawal by Subject|0|||
131604196|NCT03523572|473845234|FG001|Dose Expansion|Withdrawal by Subject|0|||
131604197|NCT03523572|473845235|FG002|Dose Expansion|Withdrawal by Subject|1|||
131604198|NCT03523572|473845236|FG003|Dose Expansion|Withdrawal by Subject|1|||
131604199|NCT03523572|473845237|FG004|Dose Expansion|Withdrawal by Subject|0|||
131604200|NCT03523572|473845238|FG005|Dose Expansion|Withdrawal by Subject|0|||
131604201|NCT03523572|473845233|FG000|Dose Expansion|Physician Decision|0|||
131604202|NCT03523572|473845234|FG001|Dose Expansion|Physician Decision|0|||
131604203|NCT03523572|473845235|FG002|Dose Expansion|Physician Decision|1|||
131604204|NCT03523572|473845236|FG003|Dose Expansion|Physician Decision|0|||
131604205|NCT03523572|473845237|FG004|Dose Expansion|Physician Decision|1|||
131604206|NCT03523572|473845238|FG005|Dose Expansion|Physician Decision|0|||
131604207|NCT03523572|473845233|FG000|Dose Expansion|Miscellaneous|0|||
131604208|NCT03523572|473845234|FG001|Dose Expansion|Miscellaneous|0|||
131604209|NCT03523572|473845235|FG002|Dose Expansion|Miscellaneous|0|||
131604210|NCT03523572|473845236|FG003|Dose Expansion|Miscellaneous|0|||
131604211|NCT03523572|473845237|FG004|Dose Expansion|Miscellaneous|3|||
131604212|NCT03523572|473845238|FG005|Dose Expansion|Miscellaneous|0|||
131604213|NCT02240238|473845254|FG000|Phase 1|Adverse Event|0|||
131604214|NCT02240238|473845255|FG001|Phase 1|Adverse Event|0|||
131604215|NCT02240238|473845256|FG002|Phase 1|Adverse Event|0|||
131604216|NCT02240238|473845257|FG003|Phase 1|Adverse Event|0|||
131604217|NCT02240238|473845258|FG004|Phase 1|Adverse Event|0|||
131604218|NCT02240238|473845259|FG005|Phase 1|Adverse Event|0|||
131604219|NCT02240238|473845260|FG006|Phase 1|Adverse Event|3|||
131604220|NCT02240238|473845261|FG007|Phase 1|Adverse Event|1|||
131604221|NCT02240238|473845262|FG008|Phase 1|Adverse Event|0|||
131604222|NCT02240238|473845263|FG009|Phase 1|Adverse Event|0|||
131604223|NCT02240238|473845264|FG010|Phase 1|Adverse Event|0|||
131604224|NCT02240238|473845265|FG011|Phase 1|Adverse Event|0|||
131604225|NCT02240238|473845254|FG000|Phase 1|Death|0|||
131899700|NCT02659943|474919377|FG004|Overall Study|Patient's condition per principal investigator|0|||
131899701|NCT02659943|474919378|FG005|Overall Study|Patient's condition per principal investigator|1|||
131899702|NCT02659943|474919379|FG006|Overall Study|Patient's condition per principal investigator|0|||
131604226|NCT02240238|473845255|FG001|Phase 1|Death|0|||
131604227|NCT02240238|473845256|FG002|Phase 1|Death|0|||
131604228|NCT02240238|473845257|FG003|Phase 1|Death|0|||
131604229|NCT02240238|473845258|FG004|Phase 1|Death|0|||
131604230|NCT02240238|473845259|FG005|Phase 1|Death|1|||
131604231|NCT02240238|473845260|FG006|Phase 1|Death|0|||
131604232|NCT02240238|473845261|FG007|Phase 1|Death|0|||
131604233|NCT02240238|473845262|FG008|Phase 1|Death|0|||
131604234|NCT02240238|473845263|FG009|Phase 1|Death|0|||
131604235|NCT02240238|473845264|FG010|Phase 1|Death|0|||
131604236|NCT02240238|473845265|FG011|Phase 1|Death|0|||
131604237|NCT02240238|473845254|FG000|Phase 1|Sponsor termination|0|||
131604238|NCT02240238|473845255|FG001|Phase 1|Sponsor termination|0|||
131604239|NCT02240238|473845256|FG002|Phase 1|Sponsor termination|0|||
131604240|NCT02240238|473845257|FG003|Phase 1|Sponsor termination|0|||
131706934|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
131604241|NCT02240238|473845258|FG004|Phase 1|Sponsor termination|0|||
131604242|NCT02240238|473845259|FG005|Phase 1|Sponsor termination|1|||
131604243|NCT02240238|473845260|FG006|Phase 1|Sponsor termination|0|||
131604244|NCT02240238|473845261|FG007|Phase 1|Sponsor termination|0|||
131604245|NCT02240238|473845262|FG008|Phase 1|Sponsor termination|0|||
131604246|NCT02240238|473845263|FG009|Phase 1|Sponsor termination|0|||
131604247|NCT02240238|473845264|FG010|Phase 1|Sponsor termination|0|||
131604248|NCT02240238|473845265|FG011|Phase 1|Sponsor termination|0|||
131604249|NCT02240238|473845254|FG000|Phase 1|Withdrawal by Subject|0|||
131604250|NCT02240238|473845255|FG001|Phase 1|Withdrawal by Subject|0|||
131604251|NCT02240238|473845256|FG002|Phase 1|Withdrawal by Subject|0|||
131604252|NCT02240238|473845257|FG003|Phase 1|Withdrawal by Subject|0|||
131604253|NCT02240238|473845258|FG004|Phase 1|Withdrawal by Subject|0|||
131604254|NCT02240238|473845259|FG005|Phase 1|Withdrawal by Subject|2|||
131604255|NCT02240238|473845260|FG006|Phase 1|Withdrawal by Subject|0|||
131604256|NCT02240238|473845261|FG007|Phase 1|Withdrawal by Subject|0|||
131604257|NCT02240238|473845262|FG008|Phase 1|Withdrawal by Subject|0|||
131604258|NCT02240238|473845263|FG009|Phase 1|Withdrawal by Subject|0|||
131604259|NCT02240238|473845264|FG010|Phase 1|Withdrawal by Subject|0|||
131604260|NCT02240238|473845265|FG011|Phase 1|Withdrawal by Subject|0|||
131604261|NCT02240238|473845254|FG000|Phase 1|Physician Decision|0|||
131604262|NCT02240238|473845255|FG001|Phase 1|Physician Decision|0|||
131604263|NCT02240238|473845256|FG002|Phase 1|Physician Decision|0|||
131604264|NCT02240238|473845257|FG003|Phase 1|Physician Decision|0|||
131604265|NCT02240238|473845258|FG004|Phase 1|Physician Decision|0|||
131604266|NCT02240238|473845259|FG005|Phase 1|Physician Decision|2|||
131604267|NCT02240238|473845260|FG006|Phase 1|Physician Decision|0|||
131604268|NCT02240238|473845261|FG007|Phase 1|Physician Decision|0|||
131604269|NCT02240238|473845262|FG008|Phase 1|Physician Decision|0|||
131604270|NCT02240238|473845263|FG009|Phase 1|Physician Decision|0|||
131604271|NCT02240238|473845264|FG010|Phase 1|Physician Decision|0|||
131604272|NCT02240238|473845265|FG011|Phase 1|Physician Decision|0|||
131604273|NCT02240238|473845254|FG000|Phase 2|Adverse Event|0|||
131604274|NCT02240238|473845255|FG001|Phase 2|Adverse Event|0|||
131604275|NCT02240238|473845256|FG002|Phase 2|Adverse Event|0|||
131604276|NCT02240238|473845257|FG003|Phase 2|Adverse Event|0|||
131604277|NCT02240238|473845258|FG004|Phase 2|Adverse Event|0|||
131604278|NCT02240238|473845259|FG005|Phase 2|Adverse Event|0|||
131604279|NCT02240238|473845260|FG006|Phase 2|Adverse Event|0|||
131604280|NCT02240238|473845261|FG007|Phase 2|Adverse Event|0|||
131604281|NCT02240238|473845262|FG008|Phase 2|Adverse Event|0|||
131604282|NCT02240238|473845263|FG009|Phase 2|Adverse Event|7|||
131604283|NCT02240238|473845264|FG010|Phase 2|Adverse Event|14|||
131604284|NCT02240238|473845265|FG011|Phase 2|Adverse Event|2|||
131604285|NCT02240238|473845254|FG000|Phase 2|Death|0|||
131604286|NCT02240238|473845255|FG001|Phase 2|Death|0|||
131604287|NCT02240238|473845256|FG002|Phase 2|Death|0|||
131604288|NCT02240238|473845257|FG003|Phase 2|Death|0|||
131604289|NCT02240238|473845258|FG004|Phase 2|Death|0|||
131604290|NCT02240238|473845259|FG005|Phase 2|Death|0|||
131604291|NCT02240238|473845260|FG006|Phase 2|Death|0|||
131604292|NCT02240238|473845261|FG007|Phase 2|Death|0|||
131604293|NCT02240238|473845262|FG008|Phase 2|Death|0|||
131604294|NCT02240238|473845263|FG009|Phase 2|Death|3|||
131604295|NCT02240238|473845264|FG010|Phase 2|Death|2|||
131604296|NCT02240238|473845265|FG011|Phase 2|Death|1|||
131604297|NCT02240238|473845254|FG000|Phase 2|Disease progression|0|||
131604298|NCT02240238|473845255|FG001|Phase 2|Disease progression|0|||
131604299|NCT02240238|473845256|FG002|Phase 2|Disease progression|0|||
131604300|NCT02240238|473845257|FG003|Phase 2|Disease progression|0|||
131604301|NCT02240238|473845258|FG004|Phase 2|Disease progression|0|||
131604302|NCT02240238|473845259|FG005|Phase 2|Disease progression|0|||
131604303|NCT02240238|473845260|FG006|Phase 2|Disease progression|0|||
131604304|NCT02240238|473845261|FG007|Phase 2|Disease progression|0|||
131604305|NCT02240238|473845262|FG008|Phase 2|Disease progression|0|||
131604306|NCT02240238|473845263|FG009|Phase 2|Disease progression|5|||
131604307|NCT02240238|473845264|FG010|Phase 2|Disease progression|11|||
131604308|NCT02240238|473845265|FG011|Phase 2|Disease progression|1|||
131604309|NCT02240238|473845254|FG000|Phase 2|Withdrawal by Subject|0|||
131604310|NCT02240238|473845255|FG001|Phase 2|Withdrawal by Subject|0|||
131604311|NCT02240238|473845256|FG002|Phase 2|Withdrawal by Subject|0|||
131604312|NCT02240238|473845257|FG003|Phase 2|Withdrawal by Subject|0|||
131604313|NCT02240238|473845258|FG004|Phase 2|Withdrawal by Subject|0|||
131604314|NCT02240238|473845259|FG005|Phase 2|Withdrawal by Subject|0|||
131604315|NCT02240238|473845260|FG006|Phase 2|Withdrawal by Subject|0|||
131604316|NCT02240238|473845261|FG007|Phase 2|Withdrawal by Subject|0|||
131604317|NCT02240238|473845262|FG008|Phase 2|Withdrawal by Subject|0|||
131604318|NCT02240238|473845263|FG009|Phase 2|Withdrawal by Subject|1|||
131604319|NCT02240238|473845264|FG010|Phase 2|Withdrawal by Subject|1|||
131604320|NCT02240238|473845265|FG011|Phase 2|Withdrawal by Subject|0|||
131604321|NCT02240238|473845254|FG000|Phase 2|Physician Decision|0|||
131604322|NCT02240238|473845255|FG001|Phase 2|Physician Decision|0|||
131604323|NCT02240238|473845256|FG002|Phase 2|Physician Decision|0|||
131604324|NCT02240238|473845257|FG003|Phase 2|Physician Decision|0|||
131604325|NCT02240238|473845258|FG004|Phase 2|Physician Decision|0|||
131604326|NCT02240238|473845259|FG005|Phase 2|Physician Decision|0|||
131604327|NCT02240238|473845260|FG006|Phase 2|Physician Decision|0|||
131604328|NCT02240238|473845261|FG007|Phase 2|Physician Decision|0|||
131604329|NCT02240238|473845262|FG008|Phase 2|Physician Decision|0|||
131604330|NCT02240238|473845263|FG009|Phase 2|Physician Decision|1|||
131604331|NCT02240238|473845264|FG010|Phase 2|Physician Decision|3|||
131604332|NCT02240238|473845265|FG011|Phase 2|Physician Decision|0|||
131604333|NCT02240238|473845254|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604334|NCT02240238|473845255|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604335|NCT02240238|473845256|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604336|NCT02240238|473845257|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604337|NCT02240238|473845258|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604338|NCT02240238|473845259|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604339|NCT02240238|473845260|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604340|NCT02240238|473845261|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604341|NCT02240238|473845262|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604342|NCT02240238|473845263|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
131604343|NCT02240238|473845264|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604344|NCT02240238|473845265|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131604345|NCT02240238|473845254|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604346|NCT02240238|473845255|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131440481|NCT00836589|473241502|FG000|Overall Study|Lost to Follow-up|246|||
131604347|NCT02240238|473845256|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604348|NCT02240238|473845257|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604349|NCT02240238|473845258|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604350|NCT02240238|473845259|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604351|NCT02240238|473845260|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604352|NCT02240238|473845261|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604353|NCT02240238|473845262|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604354|NCT02240238|473845263|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
131604355|NCT02240238|473845264|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604356|NCT02240238|473845265|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131604357|NCT02240238|473845254|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604358|NCT02240238|473845255|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604359|NCT02240238|473845256|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604360|NCT02240238|473845257|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604361|NCT02240238|473845258|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604362|NCT02240238|473845259|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604363|NCT02240238|473845260|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604364|NCT02240238|473845261|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604365|NCT02240238|473845262|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604366|NCT02240238|473845263|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604367|NCT02240238|473845264|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
131440482|NCT00836589|473241502|FG000|Overall Study|Death|429|||
131440483|NCT00836589|473241502|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
131440484|NCT00772538|473241503|FG000|Overall Study|Adverse Event|6|||
131604368|NCT02240238|473845265|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131604369|NCT02240238|473845254|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131791686|NCT01418352|474520861|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
131791687|NCT01418352|474520858|FG000|Overall Study|Subject Withdrew Consent|0|||
131791688|NCT01418352|474520859|FG001|Overall Study|Subject Withdrew Consent|1|||
131791689|NCT01418352|474520860|FG002|Overall Study|Subject Withdrew Consent|2|||
131791690|NCT01418352|474520861|FG003|Overall Study|Subject Withdrew Consent|1|||
131791691|NCT01418352|474520858|FG000|Overall Study|Protocol Deviation|0|||
131791692|NCT01418352|474520859|FG001|Overall Study|Protocol Deviation|0|||
131791693|NCT01418352|474520860|FG002|Overall Study|Protocol Deviation|1|||
131791694|NCT01418352|474520861|FG003|Overall Study|Protocol Deviation|0|||
131791695|NCT01418352|474520858|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
131791696|NCT01418352|474520859|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
131791697|NCT01418352|474520860|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
131791698|NCT01418352|474520861|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
131791699|NCT00619619|474520862|FG000|Overall Study|Physician Decision|0|||
131440485|NCT00772538|473241504|FG001|Overall Study|Adverse Event|6|||
131604370|NCT02240238|473845255|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604371|NCT02240238|473845256|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604372|NCT02240238|473845257|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604373|NCT02240238|473845258|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604374|NCT02240238|473845259|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604375|NCT02240238|473845260|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604376|NCT02240238|473845261|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604377|NCT02240238|473845262|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604378|NCT02240238|473845263|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604379|NCT02240238|473845264|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
131604380|NCT02240238|473845265|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131604381|NCT02240238|473845254|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604382|NCT02240238|473845255|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604383|NCT02240238|473845256|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604384|NCT02240238|473845257|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604385|NCT02240238|473845258|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604386|NCT02240238|473845259|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604387|NCT02240238|473845260|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604388|NCT02240238|473845261|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604389|NCT02240238|473845262|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604390|NCT02240238|473845263|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604391|NCT02240238|473845264|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
131604392|NCT02240238|473845265|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131604393|NCT02240238|473845254|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604394|NCT02240238|473845255|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604395|NCT02240238|473845256|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604396|NCT02240238|473845257|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604397|NCT02240238|473845258|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604398|NCT02240238|473845259|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604399|NCT02240238|473845260|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604400|NCT02240238|473845261|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604401|NCT02240238|473845262|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604402|NCT02240238|473845263|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604403|NCT02240238|473845264|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
131604404|NCT02240238|473845265|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131604405|NCT02240238|473845254|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604406|NCT02240238|473845255|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604407|NCT02240238|473845256|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604408|NCT02240238|473845257|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604409|NCT02240238|473845258|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604410|NCT02240238|473845259|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604411|NCT02240238|473845260|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604412|NCT02240238|473845261|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604413|NCT02240238|473845262|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604414|NCT02240238|473845263|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604415|NCT02240238|473845264|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
131604416|NCT02240238|473845265|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131604417|NCT02240238|473845254|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604418|NCT02240238|473845255|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604419|NCT02240238|473845256|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604420|NCT02240238|473845257|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604421|NCT02240238|473845258|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604422|NCT02240238|473845259|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604423|NCT02240238|473845260|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604424|NCT02240238|473845261|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604425|NCT02240238|473845262|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604426|NCT02240238|473845263|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604427|NCT02240238|473845264|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131604428|NCT02240238|473845265|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
131604429|NCT03519178|473845266|FG000|PF-06873600 Treatment|Adverse Event|0|||
131604430|NCT03519178|473845267|FG001|PF-06873600 Treatment|Adverse Event|0|||
131604431|NCT03519178|473845268|FG002|PF-06873600 Treatment|Adverse Event|0|||
131791700|NCT00619619|474520863|FG001|Overall Study|Physician Decision|0|||
131440486|NCT00772538|473241503|FG000|Overall Study|Protocol Violation|3|||
131604432|NCT03519178|473845269|FG003|PF-06873600 Treatment|Adverse Event|0|||
131604433|NCT03519178|473845270|FG004|PF-06873600 Treatment|Adverse Event|0|||
131604434|NCT03519178|473845271|FG005|PF-06873600 Treatment|Adverse Event|0|||
131604435|NCT03519178|473845272|FG006|PF-06873600 Treatment|Adverse Event|0|||
131604436|NCT03519178|473845273|FG007|PF-06873600 Treatment|Adverse Event|2|||
131604437|NCT03519178|473845274|FG008|PF-06873600 Treatment|Adverse Event|1|||
131604438|NCT03519178|473845275|FG009|PF-06873600 Treatment|Adverse Event|0|||
131604439|NCT03519178|473845276|FG010|PF-06873600 Treatment|Adverse Event|0|||
131604440|NCT03519178|473845277|FG011|PF-06873600 Treatment|Adverse Event|0|||
131604441|NCT03519178|473845278|FG012|PF-06873600 Treatment|Adverse Event|1|||
131604442|NCT03519178|473845279|FG013|PF-06873600 Treatment|Adverse Event|3|||
131604443|NCT03519178|473845280|FG014|PF-06873600 Treatment|Adverse Event|2|||
131604444|NCT03519178|473845266|FG000|PF-06873600 Treatment|Death|0|||
131604445|NCT03519178|473845267|FG001|PF-06873600 Treatment|Death|0|||
131604446|NCT03519178|473845268|FG002|PF-06873600 Treatment|Death|0|||
131604447|NCT03519178|473845269|FG003|PF-06873600 Treatment|Death|0|||
131604448|NCT03519178|473845270|FG004|PF-06873600 Treatment|Death|0|||
131604449|NCT03519178|473845271|FG005|PF-06873600 Treatment|Death|0|||
131604450|NCT03519178|473845272|FG006|PF-06873600 Treatment|Death|0|||
131604451|NCT03519178|473845273|FG007|PF-06873600 Treatment|Death|0|||
131604452|NCT03519178|473845274|FG008|PF-06873600 Treatment|Death|1|||
131604453|NCT03519178|473845275|FG009|PF-06873600 Treatment|Death|1|||
131604454|NCT03519178|473845276|FG010|PF-06873600 Treatment|Death|0|||
131604455|NCT03519178|473845277|FG011|PF-06873600 Treatment|Death|0|||
131604456|NCT03519178|473845278|FG012|PF-06873600 Treatment|Death|0|||
131604457|NCT03519178|473845279|FG013|PF-06873600 Treatment|Death|0|||
131604458|NCT03519178|473845280|FG014|PF-06873600 Treatment|Death|1|||
131604459|NCT03519178|473845266|FG000|PF-06873600 Treatment|Physician Decision|0|||
131604460|NCT03519178|473845267|FG001|PF-06873600 Treatment|Physician Decision|0|||
131604461|NCT03519178|473845268|FG002|PF-06873600 Treatment|Physician Decision|0|||
131604462|NCT03519178|473845269|FG003|PF-06873600 Treatment|Physician Decision|0|||
131604463|NCT03519178|473845270|FG004|PF-06873600 Treatment|Physician Decision|0|||
131604464|NCT03519178|473845271|FG005|PF-06873600 Treatment|Physician Decision|0|||
131604465|NCT03519178|473845272|FG006|PF-06873600 Treatment|Physician Decision|0|||
131604466|NCT03519178|473845273|FG007|PF-06873600 Treatment|Physician Decision|1|||
131604467|NCT03519178|473845274|FG008|PF-06873600 Treatment|Physician Decision|0|||
131604468|NCT03519178|473845275|FG009|PF-06873600 Treatment|Physician Decision|0|||
131604469|NCT03519178|473845276|FG010|PF-06873600 Treatment|Physician Decision|1|||
131604470|NCT03519178|473845277|FG011|PF-06873600 Treatment|Physician Decision|0|||
131604471|NCT03519178|473845278|FG012|PF-06873600 Treatment|Physician Decision|0|||
131604472|NCT03519178|473845279|FG013|PF-06873600 Treatment|Physician Decision|4|||
131604473|NCT03519178|473845280|FG014|PF-06873600 Treatment|Physician Decision|1|||
131604474|NCT03519178|473845266|FG000|PF-06873600 Treatment|Progressive disease|1|||
131604475|NCT03519178|473845267|FG001|PF-06873600 Treatment|Progressive disease|1|||
131604476|NCT03519178|473845268|FG002|PF-06873600 Treatment|Progressive disease|1|||
131604477|NCT03519178|473845269|FG003|PF-06873600 Treatment|Progressive disease|1|||
131604478|NCT03519178|473845270|FG004|PF-06873600 Treatment|Progressive disease|6|||
131604479|NCT03519178|473845271|FG005|PF-06873600 Treatment|Progressive disease|7|||
131604480|NCT03519178|473845272|FG006|PF-06873600 Treatment|Progressive disease|3|||
131604481|NCT03519178|473845273|FG007|PF-06873600 Treatment|Progressive disease|7|||
131604482|NCT03519178|473845274|FG008|PF-06873600 Treatment|Progressive disease|3|||
131604483|NCT03519178|473845275|FG009|PF-06873600 Treatment|Progressive disease|5|||
131604484|NCT03519178|473845276|FG010|PF-06873600 Treatment|Progressive disease|4|||
131604485|NCT03519178|473845277|FG011|PF-06873600 Treatment|Progressive disease|3|||
131604486|NCT03519178|473845278|FG012|PF-06873600 Treatment|Progressive disease|4|||
131604487|NCT03519178|473845279|FG013|PF-06873600 Treatment|Progressive disease|28|||
131604488|NCT03519178|473845280|FG014|PF-06873600 Treatment|Progressive disease|7|||
131604489|NCT03519178|473845266|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
131604490|NCT03519178|473845267|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
131604491|NCT03519178|473845268|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
131604492|NCT03519178|473845269|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
131604493|NCT03519178|473845270|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
131604494|NCT03519178|473845271|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
131604495|NCT03519178|473845272|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
131604496|NCT03519178|473845273|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
131604497|NCT03519178|473845274|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
131604498|NCT03519178|473845275|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
131604499|NCT03519178|473845276|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
131706935|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
131899703|NCT02659943|474919373|FG000|Overall Study|Ineligible|0|||
131706936|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
131706937|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
131899704|NCT02659943|474919374|FG001|Overall Study|Ineligible|0|||
131604500|NCT03519178|473845277|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
131604501|NCT03519178|473845278|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
131604502|NCT03519178|473845279|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
131604503|NCT03519178|473845280|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
131604504|NCT03519178|473845266|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
131604505|NCT03519178|473845267|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
131604506|NCT03519178|473845268|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
131604507|NCT03519178|473845269|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
131604508|NCT03519178|473845270|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
131604509|NCT03519178|473845271|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
131604510|NCT03519178|473845272|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
131604511|NCT03519178|473845273|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
131604512|NCT03519178|473845274|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
131604513|NCT03519178|473845275|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
131604514|NCT03519178|473845276|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
131604515|NCT03519178|473845277|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
131604516|NCT03519178|473845278|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
131604517|NCT03519178|473845279|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
131604518|NCT03519178|473845280|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
131604519|NCT03519178|473845266|FG000|PF-06873600 Treatment|Refused further treatment|0|||
131604520|NCT03519178|473845267|FG001|PF-06873600 Treatment|Refused further treatment|1|||
131604521|NCT03519178|473845268|FG002|PF-06873600 Treatment|Refused further treatment|0|||
131604522|NCT03519178|473845269|FG003|PF-06873600 Treatment|Refused further treatment|0|||
131604523|NCT03519178|473845270|FG004|PF-06873600 Treatment|Refused further treatment|1|||
131604524|NCT03519178|473845271|FG005|PF-06873600 Treatment|Refused further treatment|0|||
131604525|NCT03519178|473845272|FG006|PF-06873600 Treatment|Refused further treatment|0|||
131604526|NCT03519178|473845273|FG007|PF-06873600 Treatment|Refused further treatment|0|||
131604527|NCT03519178|473845274|FG008|PF-06873600 Treatment|Refused further treatment|0|||
131604528|NCT03519178|473845275|FG009|PF-06873600 Treatment|Refused further treatment|0|||
131604529|NCT03519178|473845276|FG010|PF-06873600 Treatment|Refused further treatment|0|||
131604530|NCT03519178|473845277|FG011|PF-06873600 Treatment|Refused further treatment|0|||
131604531|NCT03519178|473845278|FG012|PF-06873600 Treatment|Refused further treatment|0|||
131604532|NCT03519178|473845279|FG013|PF-06873600 Treatment|Refused further treatment|0|||
131604533|NCT03519178|473845280|FG014|PF-06873600 Treatment|Refused further treatment|1|||
131604534|NCT03519178|473845266|FG000|PF-06873600 Treatment|Other|0|||
131604535|NCT03519178|473845267|FG001|PF-06873600 Treatment|Other|0|||
131604536|NCT03519178|473845268|FG002|PF-06873600 Treatment|Other|0|||
131604537|NCT03519178|473845269|FG003|PF-06873600 Treatment|Other|0|||
131604538|NCT03519178|473845270|FG004|PF-06873600 Treatment|Other|0|||
131604539|NCT03519178|473845271|FG005|PF-06873600 Treatment|Other|0|||
131604540|NCT03519178|473845272|FG006|PF-06873600 Treatment|Other|0|||
131604541|NCT03519178|473845273|FG007|PF-06873600 Treatment|Other|0|||
131604542|NCT03519178|473845274|FG008|PF-06873600 Treatment|Other|1|||
131604543|NCT03519178|473845275|FG009|PF-06873600 Treatment|Other|0|||
131604544|NCT03519178|473845276|FG010|PF-06873600 Treatment|Other|0|||
131604545|NCT03519178|473845277|FG011|PF-06873600 Treatment|Other|0|||
131604546|NCT03519178|473845278|FG012|PF-06873600 Treatment|Other|0|||
131604547|NCT03519178|473845279|FG013|PF-06873600 Treatment|Other|1|||
131604548|NCT03519178|473845280|FG014|PF-06873600 Treatment|Other|3|||
131604549|NCT03519178|473845266|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
131604550|NCT03519178|473845267|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
131604551|NCT03519178|473845268|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
131604552|NCT03519178|473845269|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
131604553|NCT03519178|473845270|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
131604554|NCT03519178|473845271|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
131604555|NCT03519178|473845272|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
131604556|NCT03519178|473845273|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
131604557|NCT03519178|473845274|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
131604558|NCT03519178|473845275|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
131604559|NCT03519178|473845276|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
131440487|NCT00772538|473241504|FG001|Overall Study|Protocol Violation|3|||
131440488|NCT00772538|473241503|FG000|Overall Study|Lost to Follow-up|1|||
131440489|NCT00772538|473241504|FG001|Overall Study|Lost to Follow-up|1|||
131604560|NCT03519178|473845277|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
131604561|NCT03519178|473845278|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
131604562|NCT03519178|473845279|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
131604563|NCT03519178|473845280|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
131604564|NCT03519178|473845266|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604565|NCT03519178|473845267|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604566|NCT03519178|473845268|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604567|NCT03519178|473845269|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604568|NCT03519178|473845270|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
131706938|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
131440490|NCT00772538|473241503|FG000|Overall Study|Withdrawal by Subject|3|||
131440491|NCT00772538|473241504|FG001|Overall Study|Withdrawal by Subject|8|||
131440492|NCT00772538|473241503|FG000|Overall Study|Lack of Efficacy|0|||
131440493|NCT00772538|473241504|FG001|Overall Study|Lack of Efficacy|1|||
131440494|NCT00772538|473241503|FG000|Overall Study|Other|7|||
131440495|NCT00772538|473241504|FG001|Overall Study|Other|7|||
131440496|NCT00713609|473241507|FG000|Overall Study|Adverse Event|2|||
131440497|NCT00713609|473241508|FG001|Overall Study|Adverse Event|0|||
131440498|NCT00713609|473241509|FG002|Overall Study|Adverse Event|2|||
131440499|NCT00713609|473241510|FG003|Overall Study|Adverse Event|2|||
131604569|NCT03519178|473845271|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604570|NCT03519178|473845272|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604571|NCT03519178|473845273|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604572|NCT03519178|473845274|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604573|NCT03519178|473845275|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604574|NCT03519178|473845276|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604575|NCT03519178|473845277|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604576|NCT03519178|473845278|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
131604577|NCT03519178|473845279|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
131604578|NCT03519178|473845280|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
131440500|NCT00713609|473241511|FG004|Overall Study|Adverse Event|3|||
131440501|NCT00713609|473241512|FG005|Overall Study|Adverse Event|1|||
131440502|NCT00713609|473241507|FG000|Overall Study|Lost to Follow-up|5|||
131440503|NCT00713609|473241508|FG001|Overall Study|Lost to Follow-up|7|||
131440504|NCT00713609|473241509|FG002|Overall Study|Lost to Follow-up|5|||
131440505|NCT00713609|473241510|FG003|Overall Study|Lost to Follow-up|5|||
131440506|NCT00713609|473241511|FG004|Overall Study|Lost to Follow-up|7|||
131440507|NCT00713609|473241512|FG005|Overall Study|Lost to Follow-up|0|||
131440508|NCT00713609|473241507|FG000|Overall Study|Lack of Efficacy|1|||
131440509|NCT00713609|473241508|FG001|Overall Study|Lack of Efficacy|3|||
131440510|NCT00713609|473241509|FG002|Overall Study|Lack of Efficacy|0|||
131440511|NCT00713609|473241510|FG003|Overall Study|Lack of Efficacy|0|||
131440512|NCT00713609|473241511|FG004|Overall Study|Lack of Efficacy|1|||
131440513|NCT00713609|473241512|FG005|Overall Study|Lack of Efficacy|0|||
131440514|NCT00713609|473241507|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
131440515|NCT00713609|473241508|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
131440516|NCT00713609|473241509|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
131706939|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131706940|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131706941|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131604579|NCT03519178|473845266|FG000|PF-06873600 Treatment|Ongoing|0|||
131604580|NCT03519178|473845267|FG001|PF-06873600 Treatment|Ongoing|0|||
131604581|NCT03519178|473845268|FG002|PF-06873600 Treatment|Ongoing|0|||
131604582|NCT03519178|473845269|FG003|PF-06873600 Treatment|Ongoing|0|||
131604583|NCT03519178|473845270|FG004|PF-06873600 Treatment|Ongoing|0|||
131706942|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131706943|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131706944|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131706945|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131706946|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131440517|NCT00713609|473241510|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
131440518|NCT00713609|473241511|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
131440519|NCT00713609|473241512|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
131604584|NCT03519178|473845271|FG005|PF-06873600 Treatment|Ongoing|0|||
131706947|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
131706948|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131899705|NCT02659943|474919375|FG002|Overall Study|Ineligible|0|||
131604585|NCT03519178|473845272|FG006|PF-06873600 Treatment|Ongoing|0|||
131604586|NCT03519178|473845273|FG007|PF-06873600 Treatment|Ongoing|0|||
131604587|NCT03519178|473845274|FG008|PF-06873600 Treatment|Ongoing|0|||
131604588|NCT03519178|473845275|FG009|PF-06873600 Treatment|Ongoing|0|||
131604589|NCT03519178|473845276|FG010|PF-06873600 Treatment|Ongoing|0|||
131604590|NCT03519178|473845277|FG011|PF-06873600 Treatment|Ongoing|0|||
131604591|NCT03519178|473845278|FG012|PF-06873600 Treatment|Ongoing|0|||
131604592|NCT03519178|473845279|FG013|PF-06873600 Treatment|Ongoing|1|||
131604593|NCT03519178|473845280|FG014|PF-06873600 Treatment|Ongoing|6|||
131899706|NCT02659943|474919376|FG003|Overall Study|Ineligible|0|||
131440520|NCT00713609|473241507|FG000|Overall Study|Withdrawal by Subject|6|||
131440521|NCT00713609|473241508|FG001|Overall Study|Withdrawal by Subject|1|||
131440522|NCT00713609|473241509|FG002|Overall Study|Withdrawal by Subject|5|||
131440523|NCT00713609|473241510|FG003|Overall Study|Withdrawal by Subject|1|||
131604594|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604595|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131440524|NCT00713609|473241511|FG004|Overall Study|Withdrawal by Subject|5|||
131440525|NCT00713609|473241512|FG005|Overall Study|Withdrawal by Subject|7|||
131604596|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604597|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604598|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604599|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604600|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604601|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604602|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604603|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604604|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604605|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604606|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604607|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
131604608|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131604609|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Death|0|||
131604610|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Death|0|||
131604611|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Death|0|||
131604612|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Death|0|||
131604613|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Death|0|||
131604614|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Death|0|||
131604615|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Death|0|||
131604616|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Death|0|||
131604617|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Death|0|||
131604618|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Death|1|||
131604619|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Death|0|||
131604620|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Death|0|||
131604621|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Death|0|||
131604622|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Death|0|||
131604623|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Death|1|||
131604624|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604625|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604626|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604627|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604628|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604629|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604630|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604631|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604632|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604633|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604634|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604635|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604636|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604637|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131604638|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
131604639|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604640|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604641|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604642|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604643|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604644|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604645|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604646|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604647|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604648|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604649|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604650|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604651|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131604652|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
131604653|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
131604654|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604655|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604656|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604657|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604658|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604659|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604660|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604661|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131791701|NCT00619619|474520864|FG002|Overall Study|Physician Decision|1|||
131604662|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604663|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
131604664|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604665|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604666|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131604667|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
131604668|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
131604669|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604670|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604671|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604672|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604673|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604674|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604675|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604676|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604677|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604678|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604679|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604680|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604681|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131604682|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
131604683|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
131604684|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604685|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604686|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604687|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604688|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604689|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604690|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604691|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604692|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604693|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
131604694|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604695|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131440526|NCT00713609|473241507|FG000|Overall Study|Protocol Violation|6|||
131440527|NCT00713609|473241508|FG001|Overall Study|Protocol Violation|3|||
131440528|NCT00713609|473241509|FG002|Overall Study|Protocol Violation|1|||
131440529|NCT00713609|473241510|FG003|Overall Study|Protocol Violation|1|||
131604696|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131604697|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
131604698|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
131604699|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604700|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604701|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604702|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604703|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604704|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604705|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604706|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604707|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604708|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
131604709|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604710|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604711|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131604712|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
131604713|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131440530|NCT00713609|473241511|FG004|Overall Study|Protocol Violation|2|||
131604714|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604715|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131706949|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131440531|NCT00713609|473241512|FG005|Overall Study|Protocol Violation|0|||
131440532|NCT03780452|473241516|FG000|Overall Study|Screening failure|2|||
131440533|NCT01001221|473241517|FG000|Overall Study|Adverse Event|1|||
131440534|NCT01001221|473241518|FG001|Overall Study|Adverse Event|2|||
131440535|NCT01001221|473241519|FG002|Overall Study|Adverse Event|0|||
131440536|NCT01001221|473241520|FG003|Overall Study|Adverse Event|2|||
131440537|NCT01001221|473241521|FG004|Overall Study|Adverse Event|0|||
131440538|NCT01001221|473241517|FG000|Overall Study|Disease progression|3|||
131706950|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131706951|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131706952|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
131440539|NCT01001221|473241518|FG001|Overall Study|Disease progression|2|||
131440540|NCT01001221|473241519|FG002|Overall Study|Disease progression|2|||
131440541|NCT01001221|473241520|FG003|Overall Study|Disease progression|4|||
131440542|NCT01001221|473241521|FG004|Overall Study|Disease progression|0|||
131440543|NCT01001221|473241517|FG000|Overall Study|Other|1|||
131440544|NCT01001221|473241518|FG001|Overall Study|Other|1|||
131440545|NCT01001221|473241519|FG002|Overall Study|Other|0|||
131440546|NCT01001221|473241520|FG003|Overall Study|Other|0|||
131604716|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604717|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604718|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604719|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604720|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604721|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604722|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604723|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604724|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604725|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604726|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604727|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131604728|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
131604729|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Other|0|||
131604730|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Other|0|||
131604731|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Other|0|||
131604732|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Other|0|||
131604733|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Other|0|||
131604734|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Other|0|||
131604735|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Other|0|||
131604736|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Other|0|||
131604737|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Other|0|||
131604738|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Other|0|||
131604739|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Other|0|||
131604740|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Other|0|||
131604741|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Other|0|||
131604742|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Other|1|||
131440547|NCT01001221|473241521|FG004|Overall Study|Other|0|||
131440548|NCT01001221|473241517|FG000|Overall Study|Not treated; protocol exclusion|0|||
131440549|NCT01001221|473241518|FG001|Overall Study|Not treated; protocol exclusion|0|||
131440550|NCT01001221|473241519|FG002|Overall Study|Not treated; protocol exclusion|1|||
131604743|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Other|3|||
131604744|NCT03519178|473845266|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604745|NCT03519178|473845267|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604746|NCT03519178|473845268|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604747|NCT03519178|473845269|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604748|NCT03519178|473845270|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604749|NCT03519178|473845271|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604750|NCT03519178|473845272|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604751|NCT03519178|473845273|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604752|NCT03519178|473845274|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604753|NCT03519178|473845275|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604754|NCT03519178|473845276|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604755|NCT03519178|473845277|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604756|NCT03519178|473845278|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
131604757|NCT03519178|473845279|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
131706953|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131706954|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131440551|NCT01001221|473241520|FG003|Overall Study|Not treated; protocol exclusion|0|||
131440552|NCT01001221|473241521|FG004|Overall Study|Not treated; protocol exclusion|0|||
131440553|NCT02388269|473241522|FG000|Overall Study|Adverse Event|2|||
131440554|NCT02388269|473241523|FG001|Overall Study|Adverse Event|0|||
131440555|NCT02388269|473241524|FG002|Overall Study|Adverse Event|0|||
131440556|NCT02388269|473241522|FG000|Overall Study|Withdrawal by Subject|1|||
131440557|NCT02388269|473241523|FG001|Overall Study|Withdrawal by Subject|2|||
131440558|NCT02388269|473241524|FG002|Overall Study|Withdrawal by Subject|0|||
131440559|NCT02388269|473241522|FG000|Overall Study|less than 50% stimulations|1|||
131440560|NCT02388269|473241523|FG001|Overall Study|less than 50% stimulations|0|||
131440561|NCT02388269|473241524|FG002|Overall Study|less than 50% stimulations|0|||
131440562|NCT02388269|473241522|FG000|Overall Study|no diary data|3|||
131440563|NCT02388269|473241523|FG001|Overall Study|no diary data|0|||
131440564|NCT02388269|473241524|FG002|Overall Study|no diary data|0|||
131440565|NCT02388269|473241522|FG000|Overall Study|Protocol Violation|2|||
131440566|NCT02388269|473241523|FG001|Overall Study|Protocol Violation|0|||
131440567|NCT02388269|473241524|FG002|Overall Study|Protocol Violation|0|||
131440568|NCT02388269|473241522|FG000|Overall Study|Screen Failure|0|||
131440569|NCT02388269|473241523|FG001|Overall Study|Screen Failure|0|||
131440570|NCT02388269|473241524|FG002|Overall Study|Screen Failure|10|||
131440571|NCT04739982|473241525|FG000|Overall Study|Lost to Follow-up|176|||
131440572|NCT04739982|473241526|FG001|Overall Study|Lost to Follow-up|65|||
131440573|NCT04739982|473241525|FG000|Overall Study|Withdrawal by Subject|19|||
131440574|NCT04739982|473241526|FG001|Overall Study|Withdrawal by Subject|0|||
131440575|NCT04739982|473241525|FG000|Overall Study|Protocol Violation|0|||
131440576|NCT04739982|473241526|FG001|Overall Study|Protocol Violation|5|||
131440577|NCT01346358|473241527|FG000|Overall Study|Withdrawal by Subject|1|||
131440578|NCT01346358|473241528|FG001|Overall Study|Withdrawal by Subject|0|||
131440579|NCT01346358|473241529|FG002|Overall Study|Withdrawal by Subject|1|||
131440580|NCT01346358|473241530|FG003|Overall Study|Withdrawal by Subject|1|||
131440581|NCT01346358|473241531|FG004|Overall Study|Withdrawal by Subject|0|||
131440582|NCT01346358|473241532|FG005|Overall Study|Withdrawal by Subject|2|||
131440583|NCT01346358|473241533|FG006|Overall Study|Withdrawal by Subject|1|||
131440584|NCT01346358|473241534|FG007|Overall Study|Withdrawal by Subject|1|||
131604758|NCT03519178|473845280|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
131604759|NCT03519178|473845266|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
131604760|NCT03519178|473845267|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
131604761|NCT03519178|473845268|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
131604762|NCT03519178|473845269|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
131604763|NCT03519178|473845270|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
131604764|NCT03519178|473845271|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
131604765|NCT03519178|473845272|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
131604766|NCT03519178|473845273|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
131604767|NCT03519178|473845274|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
131604768|NCT03519178|473845275|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
131604769|NCT03519178|473845276|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
131604770|NCT03519178|473845277|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
131604771|NCT03519178|473845278|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
131604772|NCT03519178|473845279|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
131604773|NCT03519178|473845280|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
131604774|NCT03519178|473845266|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
131604775|NCT03519178|473845267|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
131604776|NCT03519178|473845268|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
131604777|NCT03519178|473845269|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
131604778|NCT03519178|473845270|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
131604779|NCT03519178|473845271|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
131604780|NCT03519178|473845272|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
131604781|NCT03519178|473845273|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
131604782|NCT03519178|473845274|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
131604783|NCT03519178|473845275|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
131604784|NCT03519178|473845276|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
131604785|NCT03519178|473845277|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
131604786|NCT03519178|473845278|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
131604787|NCT03519178|473845279|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
131604788|NCT03519178|473845280|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
131899707|NCT02659943|474919377|FG004|Overall Study|Ineligible|0|||
131899708|NCT02659943|474919378|FG005|Overall Study|Ineligible|0|||
131440585|NCT01346358|473241535|FG008|Overall Study|Withdrawal by Subject|1|||
131440586|NCT01346358|473241527|FG000|Overall Study|Adverse Event|1|||
131440587|NCT01346358|473241528|FG001|Overall Study|Adverse Event|0|||
131440588|NCT01346358|473241529|FG002|Overall Study|Adverse Event|0|||
131440589|NCT01346358|473241530|FG003|Overall Study|Adverse Event|0|||
131440590|NCT01346358|473241531|FG004|Overall Study|Adverse Event|1|||
131440591|NCT01346358|473241532|FG005|Overall Study|Adverse Event|0|||
131440592|NCT01346358|473241533|FG006|Overall Study|Adverse Event|0|||
131440593|NCT01346358|473241534|FG007|Overall Study|Adverse Event|0|||
131440594|NCT01346358|473241535|FG008|Overall Study|Adverse Event|1|||
131899709|NCT02659943|474919379|FG006|Overall Study|Ineligible|1|||
131440595|NCT01346358|473241527|FG000|Overall Study|Non-Compliance|0|||
131440596|NCT01346358|473241528|FG001|Overall Study|Non-Compliance|0|||
131440597|NCT01346358|473241529|FG002|Overall Study|Non-Compliance|0|||
131440598|NCT01346358|473241530|FG003|Overall Study|Non-Compliance|0|||
131440599|NCT01346358|473241531|FG004|Overall Study|Non-Compliance|0|||
131440600|NCT01346358|473241532|FG005|Overall Study|Non-Compliance|0|||
131440601|NCT01346358|473241533|FG006|Overall Study|Non-Compliance|0|||
131440602|NCT01346358|473241534|FG007|Overall Study|Non-Compliance|2|||
131440603|NCT01346358|473241535|FG008|Overall Study|Non-Compliance|0|||
131440604|NCT01346358|473241527|FG000|Overall Study|Physician Decision|0|||
131440605|NCT01346358|473241528|FG001|Overall Study|Physician Decision|1|||
131440606|NCT01346358|473241529|FG002|Overall Study|Physician Decision|0|||
131440607|NCT01346358|473241530|FG003|Overall Study|Physician Decision|0|||
131440608|NCT01346358|473241531|FG004|Overall Study|Physician Decision|0|||
131440609|NCT01346358|473241532|FG005|Overall Study|Physician Decision|0|||
131440610|NCT01346358|473241533|FG006|Overall Study|Physician Decision|0|||
131440611|NCT01346358|473241534|FG007|Overall Study|Physician Decision|1|||
131440612|NCT01346358|473241535|FG008|Overall Study|Physician Decision|1|||
131440613|NCT05058365|473241536|FG000|Overall Study|Migration|1|||
131440614|NCT05058365|473241537|FG001|Overall Study|Migration|1|||
131440615|NCT00702702|473241538|FG000|Overall Study|Study prematurely terminated|56|||
131440616|NCT04038359|473241539|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
131440617|NCT04038359|473241540|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
131440618|NCT04038359|473241539|FG000|Overall Study|Death|8|||
131440619|NCT04038359|473241540|FG001|Overall Study|Death|7|||
131440620|NCT04038359|473241539|FG000|Overall Study|Lost to Follow-up|3|||
131440621|NCT04038359|473241540|FG001|Overall Study|Lost to Follow-up|0|||
131440622|NCT04038359|473241539|FG000|Overall Study|Participant Moved|1|||
131440623|NCT04038359|473241540|FG001|Overall Study|Participant Moved|0|||
131440624|NCT04038359|473241539|FG000|Overall Study|Withdrawal by Subject|4|||
131440625|NCT04038359|473241540|FG001|Overall Study|Withdrawal by Subject|3|||
131440626|NCT04038359|473241539|FG000|Overall Study|Physician Decision|3|||
131440627|NCT04038359|473241540|FG001|Overall Study|Physician Decision|2|||
131440628|NCT04038359|473241539|FG000|Overall Study|Adverse Event|0|||
131440629|NCT04038359|473241540|FG001|Overall Study|Adverse Event|2|||
131440630|NCT04038359|473241539|FG000|Overall Study|Progressive Disease|0|||
131440631|NCT04038359|473241540|FG001|Overall Study|Progressive Disease|1|||
131440632|NCT02004236|473241541|FG000|Overall Study|Lack of Efficacy|0|||
131440633|NCT02004236|473241542|FG001|Overall Study|Lack of Efficacy|0|||
131440634|NCT02004236|473241543|FG002|Overall Study|Lack of Efficacy|16|||
131440635|NCT05121766|473241544|FG000|Overall Study|Covid reinfection|3|||
131440636|NCT05121766|473241545|FG001|Overall Study|Covid reinfection|0|||
131440637|NCT05121766|473241544|FG000|Overall Study|Withdrawal by Subject|3|||
131440638|NCT05121766|473241545|FG001|Overall Study|Withdrawal by Subject|1|||
131440639|NCT05121766|473241544|FG000|Overall Study|Adverse Event|2|||
131440640|NCT05121766|473241545|FG001|Overall Study|Adverse Event|4|||
131440641|NCT05121766|473241544|FG000|Overall Study|Lost to Follow-up|0|||
131440642|NCT05121766|473241545|FG001|Overall Study|Lost to Follow-up|1|||
131440643|NCT03259230|473241547|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
131440644|NCT03259230|473241548|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
131440645|NCT01033240|473241549|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
131440646|NCT01033240|473241550|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
131440647|NCT01033240|473241551|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
131440648|NCT01033240|473241549|FG000|Overall Study|Death|2|||
131440649|NCT01033240|473241550|FG001|Overall Study|Death|0|||
131440650|NCT01033240|473241551|FG002|Overall Study|Death|0|||
131440651|NCT01033240|473241549|FG000|Overall Study|Withdrew Consent|2|||
131440652|NCT01033240|473241550|FG001|Overall Study|Withdrew Consent|9|||
131440653|NCT01033240|473241551|FG002|Overall Study|Withdrew Consent|2|||
131440654|NCT01033240|473241549|FG000|Overall Study|Disease Progression|35|||
131440655|NCT01033240|473241550|FG001|Overall Study|Disease Progression|32|||
131440656|NCT01033240|473241551|FG002|Overall Study|Disease Progression|41|||
131440657|NCT01033240|473241549|FG000|Overall Study|Investigator Discretion|0|||
131899710|NCT02659943|474919373|FG000|Overall Study|No longer meets eligibility|0|||
131440658|NCT01033240|473241550|FG001|Overall Study|Investigator Discretion|0|||
131440659|NCT01033240|473241551|FG002|Overall Study|Investigator Discretion|2|||
131440660|NCT01033240|473241549|FG000|Overall Study|Other|0|||
131440661|NCT01033240|473241550|FG001|Overall Study|Other|1|||
131440662|NCT01033240|473241551|FG002|Overall Study|Other|2|||
131440663|NCT02960217|473241553|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
131440664|NCT02960217|473241554|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
131440665|NCT02960217|473241553|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
131440666|NCT02960217|473241554|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
131440667|NCT02960217|473241553|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
131440668|NCT02960217|473241554|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
131440669|NCT02960217|473241553|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
131440670|NCT02960217|473241554|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
131604789|NCT03519178|473845266|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604790|NCT03519178|473845267|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604791|NCT03519178|473845268|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604792|NCT03519178|473845269|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604793|NCT03519178|473845270|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604794|NCT03519178|473845271|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604795|NCT03519178|473845272|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604796|NCT03519178|473845273|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604797|NCT03519178|473845274|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604798|NCT03519178|473845275|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604799|NCT03519178|473845276|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
131604800|NCT03519178|473845277|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604801|NCT03519178|473845278|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604802|NCT03519178|473845279|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604803|NCT03519178|473845280|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131604804|NCT03519178|473845266|FG000|Follow-Up|Death|0|||
131604805|NCT03519178|473845267|FG001|Follow-Up|Death|0|||
131604806|NCT03519178|473845268|FG002|Follow-Up|Death|1|||
131604807|NCT03519178|473845269|FG003|Follow-Up|Death|0|||
131604808|NCT03519178|473845270|FG004|Follow-Up|Death|0|||
131604809|NCT03519178|473845271|FG005|Follow-Up|Death|0|||
131604810|NCT03519178|473845272|FG006|Follow-Up|Death|0|||
131604811|NCT03519178|473845273|FG007|Follow-Up|Death|0|||
131604812|NCT03519178|473845274|FG008|Follow-Up|Death|3|||
131604813|NCT03519178|473845275|FG009|Follow-Up|Death|1|||
131604814|NCT03519178|473845276|FG010|Follow-Up|Death|0|||
131604815|NCT03519178|473845277|FG011|Follow-Up|Death|0|||
131604816|NCT03519178|473845278|FG012|Follow-Up|Death|2|||
131604817|NCT03519178|473845279|FG013|Follow-Up|Death|0|||
131604818|NCT03519178|473845280|FG014|Follow-Up|Death|0|||
131604819|NCT03519178|473845266|FG000|Follow-Up|Lost to Follow-up|0|||
131604820|NCT03519178|473845267|FG001|Follow-Up|Lost to Follow-up|0|||
131604821|NCT03519178|473845268|FG002|Follow-Up|Lost to Follow-up|0|||
131604822|NCT03519178|473845269|FG003|Follow-Up|Lost to Follow-up|0|||
131604823|NCT03519178|473845270|FG004|Follow-Up|Lost to Follow-up|0|||
131604824|NCT03519178|473845271|FG005|Follow-Up|Lost to Follow-up|3|||
131604825|NCT03519178|473845272|FG006|Follow-Up|Lost to Follow-up|1|||
131604826|NCT03519178|473845273|FG007|Follow-Up|Lost to Follow-up|4|||
131604827|NCT03519178|473845274|FG008|Follow-Up|Lost to Follow-up|1|||
131604828|NCT03519178|473845275|FG009|Follow-Up|Lost to Follow-up|0|||
131604829|NCT03519178|473845276|FG010|Follow-Up|Lost to Follow-up|0|||
131604830|NCT03519178|473845277|FG011|Follow-Up|Lost to Follow-up|0|||
131604831|NCT03519178|473845278|FG012|Follow-Up|Lost to Follow-up|0|||
131604832|NCT03519178|473845279|FG013|Follow-Up|Lost to Follow-up|0|||
131604833|NCT03519178|473845280|FG014|Follow-Up|Lost to Follow-up|0|||
131604834|NCT03519178|473845266|FG000|Follow-Up|Withdrawal by Subject|1|||
131604835|NCT03519178|473845267|FG001|Follow-Up|Withdrawal by Subject|2|||
131604836|NCT03519178|473845268|FG002|Follow-Up|Withdrawal by Subject|2|||
131604837|NCT03519178|473845269|FG003|Follow-Up|Withdrawal by Subject|3|||
131604838|NCT03519178|473845270|FG004|Follow-Up|Withdrawal by Subject|5|||
131604839|NCT03519178|473845271|FG005|Follow-Up|Withdrawal by Subject|1|||
131604840|NCT03519178|473845272|FG006|Follow-Up|Withdrawal by Subject|2|||
131604841|NCT03519178|473845273|FG007|Follow-Up|Withdrawal by Subject|6|||
131791702|NCT00619619|474520865|FG003|Overall Study|Physician Decision|0|||
131791703|NCT00619619|474520866|FG004|Overall Study|Physician Decision|0|||
131791704|NCT00619619|474520867|FG005|Overall Study|Physician Decision|0|||
131791705|NCT00619619|474520868|FG006|Overall Study|Physician Decision|0|||
131791706|NCT00619619|474520869|FG007|Overall Study|Physician Decision|0|||
131791707|NCT00619619|474520862|FG000|Overall Study|Protocol Violation|0|||
131791708|NCT00619619|474520863|FG001|Overall Study|Protocol Violation|0|||
131791709|NCT00619619|474520864|FG002|Overall Study|Protocol Violation|0|||
131791710|NCT00619619|474520865|FG003|Overall Study|Protocol Violation|1|||
131791711|NCT00619619|474520866|FG004|Overall Study|Protocol Violation|0|||
131791712|NCT00619619|474520867|FG005|Overall Study|Protocol Violation|0|||
131791713|NCT00619619|474520868|FG006|Overall Study|Protocol Violation|1|||
131604842|NCT03519178|473845274|FG008|Follow-Up|Withdrawal by Subject|5|||
131604843|NCT03519178|473845275|FG009|Follow-Up|Withdrawal by Subject|2|||
131604844|NCT03519178|473845276|FG010|Follow-Up|Withdrawal by Subject|3|||
131604845|NCT03519178|473845277|FG011|Follow-Up|Withdrawal by Subject|5|||
131604846|NCT03519178|473845278|FG012|Follow-Up|Withdrawal by Subject|2|||
131604847|NCT03519178|473845279|FG013|Follow-Up|Withdrawal by Subject|0|||
131440671|NCT02960217|473241553|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
131604848|NCT03519178|473845280|FG014|Follow-Up|Withdrawal by Subject|0|||
131604849|NCT03519178|473845266|FG000|Follow-Up|Other|0|||
131604850|NCT03519178|473845267|FG001|Follow-Up|Other|0|||
131604851|NCT03519178|473845268|FG002|Follow-Up|Other|0|||
131604852|NCT03519178|473845269|FG003|Follow-Up|Other|0|||
131791714|NCT00619619|474520869|FG007|Overall Study|Protocol Violation|1|||
131604853|NCT03519178|473845270|FG004|Follow-Up|Other|0|||
131604854|NCT03519178|473845271|FG005|Follow-Up|Other|0|||
131604855|NCT03519178|473845272|FG006|Follow-Up|Other|0|||
131604856|NCT03519178|473845273|FG007|Follow-Up|Other|1|||
131604857|NCT03519178|473845274|FG008|Follow-Up|Other|0|||
131604858|NCT03519178|473845275|FG009|Follow-Up|Other|0|||
131604859|NCT03519178|473845276|FG010|Follow-Up|Other|0|||
131604860|NCT03519178|473845277|FG011|Follow-Up|Other|0|||
131604861|NCT03519178|473845278|FG012|Follow-Up|Other|0|||
131604862|NCT03519178|473845279|FG013|Follow-Up|Other|0|||
131604863|NCT03519178|473845280|FG014|Follow-Up|Other|0|||
131604864|NCT03519178|473845266|FG000|Long-term Follow-up|Death|0|||
131604865|NCT03519178|473845267|FG001|Long-term Follow-up|Death|0|||
131604866|NCT03519178|473845268|FG002|Long-term Follow-up|Death|0|||
131604867|NCT03519178|473845269|FG003|Long-term Follow-up|Death|0|||
131604868|NCT03519178|473845270|FG004|Long-term Follow-up|Death|0|||
131604869|NCT03519178|473845271|FG005|Long-term Follow-up|Death|0|||
131604870|NCT03519178|473845272|FG006|Long-term Follow-up|Death|0|||
131604871|NCT03519178|473845273|FG007|Long-term Follow-up|Death|0|||
131604872|NCT03519178|473845274|FG008|Long-term Follow-up|Death|0|||
131604873|NCT03519178|473845275|FG009|Long-term Follow-up|Death|0|||
131604874|NCT03519178|473845276|FG010|Long-term Follow-up|Death|0|||
131604875|NCT03519178|473845277|FG011|Long-term Follow-up|Death|0|||
131604876|NCT03519178|473845278|FG012|Long-term Follow-up|Death|0|||
131604877|NCT03519178|473845279|FG013|Long-term Follow-up|Death|4|||
131604878|NCT03519178|473845280|FG014|Long-term Follow-up|Death|4|||
131604879|NCT03519178|473845266|FG000|Long-term Follow-up|Lost to Follow-up|0|||
131604880|NCT03519178|473845267|FG001|Long-term Follow-up|Lost to Follow-up|0|||
131604881|NCT03519178|473845268|FG002|Long-term Follow-up|Lost to Follow-up|0|||
131604882|NCT03519178|473845269|FG003|Long-term Follow-up|Lost to Follow-up|0|||
131604883|NCT03519178|473845270|FG004|Long-term Follow-up|Lost to Follow-up|0|||
131604884|NCT03519178|473845271|FG005|Long-term Follow-up|Lost to Follow-up|0|||
131604885|NCT03519178|473845272|FG006|Long-term Follow-up|Lost to Follow-up|0|||
131604886|NCT03519178|473845273|FG007|Long-term Follow-up|Lost to Follow-up|0|||
131604887|NCT03519178|473845274|FG008|Long-term Follow-up|Lost to Follow-up|0|||
131604888|NCT03519178|473845275|FG009|Long-term Follow-up|Lost to Follow-up|0|||
131604889|NCT03519178|473845276|FG010|Long-term Follow-up|Lost to Follow-up|0|||
131604890|NCT03519178|473845277|FG011|Long-term Follow-up|Lost to Follow-up|0|||
131604891|NCT03519178|473845278|FG012|Long-term Follow-up|Lost to Follow-up|0|||
131604892|NCT03519178|473845279|FG013|Long-term Follow-up|Lost to Follow-up|1|||
131604893|NCT03519178|473845280|FG014|Long-term Follow-up|Lost to Follow-up|1|||
131604894|NCT03519178|473845266|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
131604895|NCT03519178|473845267|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
131604896|NCT03519178|473845268|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
131604897|NCT03519178|473845269|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
131604898|NCT03519178|473845270|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
131604899|NCT03519178|473845271|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
131604900|NCT03519178|473845272|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
131604901|NCT03519178|473845273|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
131604902|NCT03519178|473845274|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
131604903|NCT03519178|473845275|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
131604904|NCT03519178|473845276|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
131604905|NCT03519178|473845277|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
131604906|NCT03519178|473845278|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
131604907|NCT03519178|473845279|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
131604908|NCT03519178|473845280|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
131604909|NCT03519178|473845266|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
131604910|NCT03519178|473845267|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
131604911|NCT03519178|473845268|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
131604912|NCT03519178|473845269|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
131604913|NCT03519178|473845270|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
131604914|NCT03519178|473845271|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
131604915|NCT03519178|473845272|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
131604916|NCT03519178|473845273|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
131604917|NCT03519178|473845274|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
131791715|NCT00619619|474520862|FG000|Overall Study|Adverse Event|0|||
131604918|NCT03519178|473845275|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
131604919|NCT03519178|473845276|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
131604920|NCT03519178|473845277|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
131604921|NCT03519178|473845278|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
131604922|NCT03519178|473845279|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
131791716|NCT00619619|474520863|FG001|Overall Study|Adverse Event|0|||
131604923|NCT03519178|473845280|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
131604924|NCT03519178|473845266|FG000|Long-term Follow-up|Other|0|||
131604925|NCT03519178|473845267|FG001|Long-term Follow-up|Other|0|||
131604926|NCT03519178|473845268|FG002|Long-term Follow-up|Other|0|||
131604927|NCT03519178|473845269|FG003|Long-term Follow-up|Other|0|||
131604928|NCT03519178|473845270|FG004|Long-term Follow-up|Other|0|||
131604929|NCT03519178|473845271|FG005|Long-term Follow-up|Other|0|||
131604930|NCT03519178|473845272|FG006|Long-term Follow-up|Other|0|||
131604931|NCT03519178|473845273|FG007|Long-term Follow-up|Other|0|||
131604932|NCT03519178|473845274|FG008|Long-term Follow-up|Other|0|||
131604933|NCT03519178|473845275|FG009|Long-term Follow-up|Other|0|||
131604934|NCT03519178|473845276|FG010|Long-term Follow-up|Other|0|||
131604935|NCT03519178|473845277|FG011|Long-term Follow-up|Other|0|||
131604936|NCT03519178|473845278|FG012|Long-term Follow-up|Other|0|||
131604937|NCT03519178|473845279|FG013|Long-term Follow-up|Other|0|||
131604938|NCT03519178|473845280|FG014|Long-term Follow-up|Other|1|||
131604939|NCT03519178|473845266|FG000|Long-term Follow-up|Ongoing|0|||
131604940|NCT03519178|473845267|FG001|Long-term Follow-up|Ongoing|0|||
131604941|NCT03519178|473845268|FG002|Long-term Follow-up|Ongoing|0|||
131604942|NCT03519178|473845269|FG003|Long-term Follow-up|Ongoing|0|||
131604943|NCT03519178|473845270|FG004|Long-term Follow-up|Ongoing|0|||
131604944|NCT03519178|473845271|FG005|Long-term Follow-up|Ongoing|0|||
131604945|NCT03519178|473845272|FG006|Long-term Follow-up|Ongoing|0|||
131604946|NCT03519178|473845273|FG007|Long-term Follow-up|Ongoing|0|||
131604947|NCT03519178|473845274|FG008|Long-term Follow-up|Ongoing|0|||
131604948|NCT03519178|473845275|FG009|Long-term Follow-up|Ongoing|0|||
131604949|NCT03519178|473845276|FG010|Long-term Follow-up|Ongoing|0|||
131604950|NCT03519178|473845277|FG011|Long-term Follow-up|Ongoing|0|||
131604951|NCT03519178|473845278|FG012|Long-term Follow-up|Ongoing|0|||
131604952|NCT03519178|473845279|FG013|Long-term Follow-up|Ongoing|1|||
131604953|NCT03519178|473845280|FG014|Long-term Follow-up|Ongoing|0|||
131604954|NCT02315703|473845281|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131604955|NCT02315703|473845282|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131604956|NCT02315703|473845283|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131604957|NCT02315703|473845284|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
131604958|NCT02315703|473845285|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
131604959|NCT02315703|473845286|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131604960|NCT02315703|473845287|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
131604961|NCT02315703|473845288|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131604962|NCT02315703|473845281|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
131604963|NCT02315703|473845282|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
131604964|NCT02315703|473845283|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
131604965|NCT02315703|473845284|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
131604966|NCT02315703|473845285|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
131604967|NCT02315703|473845286|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
131604968|NCT02315703|473845287|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
131604969|NCT02315703|473845288|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
131604970|NCT02315703|473845281|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131604971|NCT02315703|473845282|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131604972|NCT02315703|473845283|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131604973|NCT02315703|473845284|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131604974|NCT02315703|473845285|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131604975|NCT02315703|473845286|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
131604976|NCT02315703|473845287|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
131604977|NCT02315703|473845288|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131604978|NCT02315703|473845281|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604979|NCT02315703|473845282|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604980|NCT02315703|473845283|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604981|NCT02315703|473845284|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604982|NCT02315703|473845285|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604983|NCT02315703|473845286|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604984|NCT02315703|473845287|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131604985|NCT02315703|473845288|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
131604986|NCT02315703|473845281|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
131791717|NCT00619619|474520864|FG002|Overall Study|Adverse Event|0|||
131604987|NCT02315703|473845282|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
131604988|NCT02315703|473845283|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
131604989|NCT02315703|473845284|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
131604990|NCT02315703|473845285|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
131791718|NCT00619619|474520865|FG003|Overall Study|Adverse Event|0|||
131604991|NCT02315703|473845286|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
131604992|NCT02315703|473845287|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
131791719|NCT00619619|474520866|FG004|Overall Study|Adverse Event|2|||
131604993|NCT02315703|473845288|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
131604994|NCT02315703|473845281|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
131604995|NCT02315703|473845282|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
131604996|NCT02315703|473845283|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
131604997|NCT02315703|473845284|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
131604998|NCT02315703|473845285|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
131604999|NCT02315703|473845286|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
131605000|NCT02315703|473845287|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
131605001|NCT02315703|473845288|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
131605002|NCT02315703|473845281|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
131605003|NCT02315703|473845282|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
131605004|NCT02315703|473845283|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131605005|NCT02315703|473845284|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131605006|NCT02315703|473845285|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131605007|NCT02315703|473845286|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131605008|NCT02315703|473845287|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131605009|NCT02315703|473845288|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131605010|NCT02315703|473845281|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605011|NCT02315703|473845282|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
131605012|NCT02315703|473845283|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605013|NCT02315703|473845284|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605014|NCT02315703|473845285|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605015|NCT02315703|473845286|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605016|NCT02315703|473845287|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605017|NCT02315703|473845288|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131605018|NCT02315703|473845281|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
131605019|NCT02315703|473845282|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
131605020|NCT02315703|473845283|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
131605021|NCT02315703|473845284|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
131605022|NCT02315703|473845285|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
131605023|NCT02315703|473845286|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
131605024|NCT02315703|473845287|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
131605025|NCT02315703|473845288|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
131605026|NCT03476343|473845299|FG000|Overall Study|Clinical exam moved to another scanner|7|||
131605027|NCT03476343|473845299|FG000|Overall Study|Clinical order cancelled|4|||
131605028|NCT03476343|473845299|FG000|Overall Study|Neonate did not settle down for the scan|1|||
131605029|NCT03088878|473845302|FG000|Overall Study|Adverse Event|0|||
131605030|NCT03088878|473845303|FG001|Overall Study|Adverse Event|0|||
131605031|NCT03088878|473845304|FG002|Overall Study|Adverse Event|0|||
131605032|NCT03088878|473845305|FG003|Overall Study|Adverse Event|0|||
131605033|NCT03088878|473845306|FG004|Overall Study|Adverse Event|4|||
131605034|NCT03088878|473845307|FG005|Overall Study|Adverse Event|2|||
131605035|NCT03088878|473845308|FG006|Overall Study|Adverse Event|1|||
131605036|NCT03088878|473845309|FG007|Overall Study|Adverse Event|0|||
131605037|NCT03088878|473845310|FG008|Overall Study|Adverse Event|0|||
131605038|NCT03088878|473845311|FG009|Overall Study|Adverse Event|0|||
131605039|NCT03088878|473845312|FG010|Overall Study|Adverse Event|0|||
131605040|NCT03088878|473845313|FG011|Overall Study|Adverse Event|0|||
131605041|NCT03088878|473845314|FG012|Overall Study|Adverse Event|5|||
131605042|NCT03088878|473845315|FG013|Overall Study|Adverse Event|3|||
131605043|NCT03088878|473845302|FG000|Overall Study|Clinical Progression|0|||
131605044|NCT03088878|473845303|FG001|Overall Study|Clinical Progression|0|||
131605045|NCT03088878|473845304|FG002|Overall Study|Clinical Progression|0|||
131605046|NCT03088878|473845305|FG003|Overall Study|Clinical Progression|0|||
131605047|NCT03088878|473845306|FG004|Overall Study|Clinical Progression|2|||
131605048|NCT03088878|473845307|FG005|Overall Study|Clinical Progression|0|||
131605049|NCT03088878|473845308|FG006|Overall Study|Clinical Progression|0|||
131605050|NCT03088878|473845309|FG007|Overall Study|Clinical Progression|0|||
131605051|NCT03088878|473845310|FG008|Overall Study|Clinical Progression|0|||
131605052|NCT03088878|473845311|FG009|Overall Study|Clinical Progression|0|||
131605053|NCT03088878|473845312|FG010|Overall Study|Clinical Progression|0|||
131605054|NCT03088878|473845313|FG011|Overall Study|Clinical Progression|0|||
131605055|NCT03088878|473845314|FG012|Overall Study|Clinical Progression|0|||
131605056|NCT03088878|473845315|FG013|Overall Study|Clinical Progression|0|||
131605057|NCT03088878|473845302|FG000|Overall Study|Death|0|||
131605058|NCT03088878|473845303|FG001|Overall Study|Death|0|||
131706955|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131706956|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131899711|NCT02659943|474919374|FG001|Overall Study|No longer meets eligibility|0|||
131605059|NCT03088878|473845304|FG002|Overall Study|Death|0|||
131605060|NCT03088878|473845305|FG003|Overall Study|Death|0|||
131605061|NCT03088878|473845306|FG004|Overall Study|Death|2|||
131605062|NCT03088878|473845307|FG005|Overall Study|Death|0|||
131605063|NCT03088878|473845308|FG006|Overall Study|Death|0|||
131605064|NCT03088878|473845309|FG007|Overall Study|Death|0|||
131605065|NCT03088878|473845310|FG008|Overall Study|Death|0|||
131605066|NCT03088878|473845311|FG009|Overall Study|Death|0|||
131605067|NCT03088878|473845312|FG010|Overall Study|Death|0|||
131605068|NCT03088878|473845313|FG011|Overall Study|Death|1|||
131605069|NCT03088878|473845314|FG012|Overall Study|Death|0|||
131605070|NCT03088878|473845315|FG013|Overall Study|Death|0|||
131605071|NCT03088878|473845302|FG000|Overall Study|Disease Progression|1|||
131605072|NCT03088878|473845303|FG001|Overall Study|Disease Progression|2|||
131605073|NCT03088878|473845304|FG002|Overall Study|Disease Progression|3|||
131605074|NCT03088878|473845305|FG003|Overall Study|Disease Progression|0|||
131605075|NCT03088878|473845306|FG004|Overall Study|Disease Progression|3|||
131605076|NCT03088878|473845307|FG005|Overall Study|Disease Progression|0|||
131605077|NCT03088878|473845308|FG006|Overall Study|Disease Progression|0|||
131605078|NCT03088878|473845309|FG007|Overall Study|Disease Progression|0|||
131605079|NCT03088878|473845310|FG008|Overall Study|Disease Progression|0|||
131605080|NCT03088878|473845311|FG009|Overall Study|Disease Progression|0|||
131605081|NCT03088878|473845312|FG010|Overall Study|Disease Progression|0|||
131605082|NCT03088878|473845313|FG011|Overall Study|Disease Progression|0|||
131605083|NCT03088878|473845314|FG012|Overall Study|Disease Progression|1|||
131605084|NCT03088878|473845315|FG013|Overall Study|Disease Progression|1|||
131605085|NCT03088878|473845302|FG000|Overall Study|Initiation of Alternative Treatment|0|||
131605086|NCT03088878|473845303|FG001|Overall Study|Initiation of Alternative Treatment|0|||
131605087|NCT03088878|473845304|FG002|Overall Study|Initiation of Alternative Treatment|0|||
131605088|NCT03088878|473845305|FG003|Overall Study|Initiation of Alternative Treatment|1|||
131605089|NCT03088878|473845306|FG004|Overall Study|Initiation of Alternative Treatment|0|||
131605090|NCT03088878|473845307|FG005|Overall Study|Initiation of Alternative Treatment|0|||
131605091|NCT03088878|473845308|FG006|Overall Study|Initiation of Alternative Treatment|0|||
131605092|NCT03088878|473845309|FG007|Overall Study|Initiation of Alternative Treatment|1|||
131605093|NCT03088878|473845310|FG008|Overall Study|Initiation of Alternative Treatment|1|||
131605094|NCT03088878|473845311|FG009|Overall Study|Initiation of Alternative Treatment|0|||
131605095|NCT03088878|473845312|FG010|Overall Study|Initiation of Alternative Treatment|0|||
131605096|NCT03088878|473845313|FG011|Overall Study|Initiation of Alternative Treatment|0|||
131605097|NCT03088878|473845314|FG012|Overall Study|Initiation of Alternative Treatment|0|||
131605098|NCT03088878|473845315|FG013|Overall Study|Initiation of Alternative Treatment|0|||
131605099|NCT03088878|473845302|FG000|Overall Study|Withdrawal by Subject|0|||
131605100|NCT03088878|473845303|FG001|Overall Study|Withdrawal by Subject|0|||
131605101|NCT03088878|473845304|FG002|Overall Study|Withdrawal by Subject|0|||
131605102|NCT03088878|473845305|FG003|Overall Study|Withdrawal by Subject|1|||
131605103|NCT03088878|473845306|FG004|Overall Study|Withdrawal by Subject|4|||
131605104|NCT03088878|473845307|FG005|Overall Study|Withdrawal by Subject|1|||
131605105|NCT03088878|473845308|FG006|Overall Study|Withdrawal by Subject|1|||
131605106|NCT03088878|473845309|FG007|Overall Study|Withdrawal by Subject|0|||
131605107|NCT03088878|473845310|FG008|Overall Study|Withdrawal by Subject|1|||
131605108|NCT03088878|473845311|FG009|Overall Study|Withdrawal by Subject|2|||
131605109|NCT03088878|473845312|FG010|Overall Study|Withdrawal by Subject|0|||
131605110|NCT03088878|473845313|FG011|Overall Study|Withdrawal by Subject|2|||
131605111|NCT03088878|473845314|FG012|Overall Study|Withdrawal by Subject|1|||
131605112|NCT03088878|473845315|FG013|Overall Study|Withdrawal by Subject|0|||
131605113|NCT03088878|473845302|FG000|Overall Study|Terminated by Sponsor|2|||
131605114|NCT03088878|473845303|FG001|Overall Study|Terminated by Sponsor|1|||
131605115|NCT03088878|473845304|FG002|Overall Study|Terminated by Sponsor|0|||
131605116|NCT03088878|473845305|FG003|Overall Study|Terminated by Sponsor|1|||
131605117|NCT03088878|473845306|FG004|Overall Study|Terminated by Sponsor|6|||
131605118|NCT03088878|473845307|FG005|Overall Study|Terminated by Sponsor|0|||
131605119|NCT03088878|473845308|FG006|Overall Study|Terminated by Sponsor|0|||
131605120|NCT03088878|473845309|FG007|Overall Study|Terminated by Sponsor|0|||
131605121|NCT03088878|473845310|FG008|Overall Study|Terminated by Sponsor|0|||
131605122|NCT03088878|473845311|FG009|Overall Study|Terminated by Sponsor|0|||
131605123|NCT03088878|473845312|FG010|Overall Study|Terminated by Sponsor|3|||
131605124|NCT03088878|473845313|FG011|Overall Study|Terminated by Sponsor|13|||
131605125|NCT03088878|473845314|FG012|Overall Study|Terminated by Sponsor|2|||
131605126|NCT03088878|473845315|FG013|Overall Study|Terminated by Sponsor|1|||
131605127|NCT03088878|473845302|FG000|Overall Study|Completed 2 years of Treatment|0|||
131605128|NCT03088878|473845303|FG001|Overall Study|Completed 2 years of Treatment|0|||
131605129|NCT03088878|473845304|FG002|Overall Study|Completed 2 years of Treatment|0|||
131605130|NCT03088878|473845305|FG003|Overall Study|Completed 2 years of Treatment|0|||
131605131|NCT03088878|473845306|FG004|Overall Study|Completed 2 years of Treatment|0|||
131605132|NCT03088878|473845307|FG005|Overall Study|Completed 2 years of Treatment|0|||
131605133|NCT03088878|473845308|FG006|Overall Study|Completed 2 years of Treatment|1|||
131605134|NCT03088878|473845309|FG007|Overall Study|Completed 2 years of Treatment|0|||
131605135|NCT03088878|473845310|FG008|Overall Study|Completed 2 years of Treatment|0|||
131605136|NCT03088878|473845311|FG009|Overall Study|Completed 2 years of Treatment|1|||
131605137|NCT03088878|473845312|FG010|Overall Study|Completed 2 years of Treatment|0|||
131605138|NCT03088878|473845313|FG011|Overall Study|Completed 2 years of Treatment|0|||
131605139|NCT03088878|473845314|FG012|Overall Study|Completed 2 years of Treatment|8|||
131605140|NCT03088878|473845315|FG013|Overall Study|Completed 2 years of Treatment|3|||
131605141|NCT03088878|473845302|FG000|Overall Study|Physician Decision|0|||
131605142|NCT03088878|473845303|FG001|Overall Study|Physician Decision|0|||
131605143|NCT03088878|473845304|FG002|Overall Study|Physician Decision|0|||
131605144|NCT03088878|473845305|FG003|Overall Study|Physician Decision|0|||
131605145|NCT03088878|473845306|FG004|Overall Study|Physician Decision|0|||
131605146|NCT03088878|473845307|FG005|Overall Study|Physician Decision|0|||
131605147|NCT03088878|473845308|FG006|Overall Study|Physician Decision|0|||
131605148|NCT03088878|473845309|FG007|Overall Study|Physician Decision|2|||
131605149|NCT03088878|473845310|FG008|Overall Study|Physician Decision|1|||
131605150|NCT03088878|473845311|FG009|Overall Study|Physician Decision|0|||
131605151|NCT03088878|473845312|FG010|Overall Study|Physician Decision|0|||
131605152|NCT03088878|473845313|FG011|Overall Study|Physician Decision|0|||
131605153|NCT03088878|473845314|FG012|Overall Study|Physician Decision|0|||
131791720|NCT00619619|474520867|FG005|Overall Study|Adverse Event|0|||
131791721|NCT00619619|474520868|FG006|Overall Study|Adverse Event|0|||
131791722|NCT00619619|474520869|FG007|Overall Study|Adverse Event|2|||
131791723|NCT01092702|474520870|FG000|Overall Study|Withdrawal by Subject|7|||
131791724|NCT01092702|474520870|FG000|Overall Study|Lost to Follow-up|2|||
131605154|NCT03088878|473845315|FG013|Overall Study|Physician Decision|1|||
131605155|NCT03088878|473845302|FG000|Overall Study|COVID Related noncompliance|0|||
131440672|NCT02960217|473241554|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
131605156|NCT03088878|473845303|FG001|Overall Study|COVID Related noncompliance|0|||
131605157|NCT03088878|473845304|FG002|Overall Study|COVID Related noncompliance|0|||
131605158|NCT03088878|473845305|FG003|Overall Study|COVID Related noncompliance|0|||
131605159|NCT03088878|473845306|FG004|Overall Study|COVID Related noncompliance|0|||
131605160|NCT03088878|473845307|FG005|Overall Study|COVID Related noncompliance|0|||
131605161|NCT03088878|473845308|FG006|Overall Study|COVID Related noncompliance|0|||
131605162|NCT03088878|473845309|FG007|Overall Study|COVID Related noncompliance|0|||
131440673|NCT02960217|473241553|FG000|Open-Label Extension Phase|Adverse Event|1|||
131605163|NCT03088878|473845310|FG008|Overall Study|COVID Related noncompliance|0|||
131605164|NCT03088878|473845311|FG009|Overall Study|COVID Related noncompliance|0|||
131605165|NCT03088878|473845312|FG010|Overall Study|COVID Related noncompliance|0|||
131605166|NCT03088878|473845313|FG011|Overall Study|COVID Related noncompliance|0|||
131605167|NCT03088878|473845314|FG012|Overall Study|COVID Related noncompliance|0|||
131605168|NCT03088878|473845315|FG013|Overall Study|COVID Related noncompliance|1|||
131605169|NCT03088878|473845302|FG000|Overall Study|Drug or Study Noncompliance|0|||
131605170|NCT03088878|473845303|FG001|Overall Study|Drug or Study Noncompliance|0|||
131605171|NCT03088878|473845304|FG002|Overall Study|Drug or Study Noncompliance|0|||
131605172|NCT03088878|473845305|FG003|Overall Study|Drug or Study Noncompliance|0|||
131605173|NCT03088878|473845306|FG004|Overall Study|Drug or Study Noncompliance|0|||
131605174|NCT03088878|473845307|FG005|Overall Study|Drug or Study Noncompliance|0|||
131605175|NCT03088878|473845308|FG006|Overall Study|Drug or Study Noncompliance|0|||
131605176|NCT03088878|473845309|FG007|Overall Study|Drug or Study Noncompliance|0|||
131605177|NCT03088878|473845310|FG008|Overall Study|Drug or Study Noncompliance|0|||
131605178|NCT03088878|473845311|FG009|Overall Study|Drug or Study Noncompliance|0|||
131605179|NCT03088878|473845312|FG010|Overall Study|Drug or Study Noncompliance|0|||
131605180|NCT03088878|473845313|FG011|Overall Study|Drug or Study Noncompliance|0|||
131605181|NCT03088878|473845314|FG012|Overall Study|Drug or Study Noncompliance|1|||
131605182|NCT03088878|473845315|FG013|Overall Study|Drug or Study Noncompliance|0|||
131605183|NCT04690582|473845316|FG000|Overall Study|Withdrawal by Subject|6|||
131605184|NCT04690582|473845317|FG001|Overall Study|Withdrawal by Subject|4|||
131605185|NCT05974501|473845318|FG000|Overall Study|Physician Decision|0|||
131605186|NCT05974501|473845319|FG001|Overall Study|Physician Decision|1|||
131605187|NCT04270942|473845322|FG000|Overall Study|Death|1|||
131605188|NCT02497950|473845324|FG000|Overall Study|Death|209|||
131605189|NCT02497950|473845324|FG000|Overall Study|Transplanted|85|||
131605190|NCT02497950|473845324|FG000|Overall Study|Explanted|8|||
131605191|NCT02497950|473845324|FG000|Overall Study|Device Permanently Deactivated|4|||
131605192|NCT02497950|473845324|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
131605193|NCT02497950|473845324|FG000|Overall Study|Lost to Follow-up|6|||
131605194|NCT02497950|473845324|FG000|Overall Study|Withdrawal by Subject|2|||
131605195|NCT02497950|473845324|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
131605196|NCT02497950|473845324|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
131605197|NCT01009788|473845332|FG000|Overall Study|Withdrawal by Subject|1|||
131605198|NCT01009788|473845333|FG001|Overall Study|Withdrawal by Subject|0|||
131605199|NCT04308681|473845334|FG000|Pre-Treatment|Not reported|1|||
131605200|NCT04308681|473845335|FG001|Pre-Treatment|Not reported|1|||
131605201|NCT04308681|473845336|FG002|Pre-Treatment|Not reported|0|||
131605202|NCT04308681|473845337|FG003|Pre-Treatment|Not reported|0|||
131605203|NCT04308681|473845338|FG004|Pre-Treatment|Not reported|0|||
131605204|NCT04308681|473845339|FG005|Pre-Treatment|Not reported|2|||
131605205|NCT04308681|473845340|FG006|Pre-Treatment|Not reported|0|||
131605206|NCT04308681|473845341|FG007|Pre-Treatment|Not reported|0|||
131605207|NCT04308681|473845334|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
131605208|NCT04308681|473845335|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
131605209|NCT04308681|473845336|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
131605210|NCT04308681|473845337|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
131605211|NCT04308681|473845338|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
131605212|NCT04308681|473845339|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
131605213|NCT04308681|473845340|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
131605214|NCT04308681|473845341|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
131605215|NCT04308681|473845334|FG000|Treatment up to Week 26|Other reasons|2|||
131605216|NCT04308681|473845335|FG001|Treatment up to Week 26|Other reasons|0|||
131605217|NCT04308681|473845336|FG002|Treatment up to Week 26|Other reasons|0|||
131605218|NCT04308681|473845337|FG003|Treatment up to Week 26|Other reasons|0|||
131791725|NCT00415532|474520874|FG000|Treatment Period|Adverse Event|2|||
131440674|NCT02960217|473241554|FG001|Open-Label Extension Phase|Adverse Event|0|||
131440675|NCT02960217|473241553|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
131605219|NCT04308681|473845338|FG004|Treatment up to Week 26|Other reasons|1|||
131605220|NCT04308681|473845339|FG005|Treatment up to Week 26|Other reasons|1|||
131605221|NCT04308681|473845340|FG006|Treatment up to Week 26|Other reasons|0|||
131605222|NCT04308681|473845341|FG007|Treatment up to Week 26|Other reasons|0|||
131605223|NCT04308681|473845334|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131605224|NCT04308681|473845335|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
131605225|NCT04308681|473845336|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
131791726|NCT00415532|474520875|FG001|Treatment Period|Adverse Event|3|||
131791727|NCT00415532|474520874|FG000|Treatment Period|Death|2|||
131605226|NCT04308681|473845337|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131791728|NCT00415532|474520875|FG001|Treatment Period|Death|1|||
131791729|NCT00415532|474520874|FG000|Treatment Period|Lost to Follow-up|1|||
131605227|NCT04308681|473845338|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
131605228|NCT04308681|473845339|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131605229|NCT04308681|473845340|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
131605230|NCT04308681|473845341|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131605231|NCT04308681|473845334|FG000|Treatment up to Week 26|Adverse Event|6|||
131605232|NCT04308681|473845335|FG001|Treatment up to Week 26|Adverse Event|5|||
131605233|NCT04308681|473845336|FG002|Treatment up to Week 26|Adverse Event|5|||
131605234|NCT04308681|473845337|FG003|Treatment up to Week 26|Adverse Event|0|||
131605235|NCT04308681|473845338|FG004|Treatment up to Week 26|Adverse Event|6|||
131605236|NCT04308681|473845339|FG005|Treatment up to Week 26|Adverse Event|1|||
131605237|NCT04308681|473845340|FG006|Treatment up to Week 26|Adverse Event|0|||
131605238|NCT04308681|473845341|FG007|Treatment up to Week 26|Adverse Event|0|||
131605239|NCT04308681|473845334|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131605240|NCT04308681|473845335|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
131605241|NCT04308681|473845336|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
131605242|NCT04308681|473845337|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131605243|NCT04308681|473845338|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131605244|NCT04308681|473845339|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131605245|NCT04308681|473845340|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131605246|NCT04308681|473845341|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131605247|NCT04308681|473845334|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
131605248|NCT04308681|473845335|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
131605249|NCT04308681|473845336|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
131605250|NCT04308681|473845337|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
131605251|NCT04308681|473845338|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
131605252|NCT04308681|473845339|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
131605253|NCT04308681|473845340|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
131605254|NCT04308681|473845341|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
131605255|NCT04308681|473845334|FG000|OTE - 26 Weeks|Death|0|||
131605256|NCT04308681|473845335|FG001|OTE - 26 Weeks|Death|1|||
131605257|NCT04308681|473845336|FG002|OTE - 26 Weeks|Death|0|||
131605258|NCT04308681|473845337|FG003|OTE - 26 Weeks|Death|0|||
131605259|NCT04308681|473845338|FG004|OTE - 26 Weeks|Death|0|||
131605260|NCT04308681|473845339|FG005|OTE - 26 Weeks|Death|0|||
131605261|NCT04308681|473845340|FG006|OTE - 26 Weeks|Death|1|||
131605262|NCT04308681|473845341|FG007|OTE - 26 Weeks|Death|0|||
131605263|NCT04308681|473845334|FG000|OTE - 26 Weeks|Adverse Event|0|||
131605264|NCT04308681|473845335|FG001|OTE - 26 Weeks|Adverse Event|2|||
131605265|NCT04308681|473845336|FG002|OTE - 26 Weeks|Adverse Event|8|||
131605266|NCT04308681|473845337|FG003|OTE - 26 Weeks|Adverse Event|3|||
131605267|NCT04308681|473845338|FG004|OTE - 26 Weeks|Adverse Event|0|||
131605268|NCT04308681|473845339|FG005|OTE - 26 Weeks|Adverse Event|1|||
131605269|NCT04308681|473845340|FG006|OTE - 26 Weeks|Adverse Event|2|||
131605270|NCT04308681|473845341|FG007|OTE - 26 Weeks|Adverse Event|0|||
131605271|NCT04308681|473845334|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131605272|NCT04308681|473845335|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
131605273|NCT04308681|473845336|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
131605274|NCT04308681|473845337|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131605275|NCT04308681|473845338|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131605276|NCT04308681|473845339|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
131605277|NCT04308681|473845340|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131605278|NCT04308681|473845341|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131605279|NCT05565820|473845342|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
131605280|NCT05565820|473845343|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
131605281|NCT05565820|473845342|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
131605282|NCT05565820|473845343|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
131605283|NCT03295721|473845346|FG000|Overall Study|Adverse Event|1|||
131605284|NCT03295721|473845347|FG001|Overall Study|Adverse Event|0|||
131605285|NCT03295721|473845348|FG002|Overall Study|Adverse Event|0|||
131605286|NCT03295721|473845346|FG000|Overall Study|Lost to Follow-up|1|||
131791730|NCT00415532|474520875|FG001|Treatment Period|Lost to Follow-up|1|||
131791731|NCT00415532|474520874|FG000|Treatment Period|Protocol Violation|1|||
131791732|NCT00415532|474520875|FG001|Treatment Period|Protocol Violation|0|||
131791733|NCT00415532|474520874|FG000|Treatment Period|Withdrawal by Subject|6|||
131791734|NCT00415532|474520875|FG001|Treatment Period|Withdrawal by Subject|6|||
131791735|NCT00415532|474520874|FG000|Treatment Period|Other|2|||
131791736|NCT00415532|474520875|FG001|Treatment Period|Other|2|||
131605287|NCT03295721|473845347|FG001|Overall Study|Lost to Follow-up|1|||
131605288|NCT03295721|473845348|FG002|Overall Study|Lost to Follow-up|1|||
131605289|NCT03295721|473845346|FG000|Overall Study|Withdrawal by Subject|1|||
131605290|NCT03295721|473845347|FG001|Overall Study|Withdrawal by Subject|0|||
131605291|NCT03295721|473845348|FG002|Overall Study|Withdrawal by Subject|1|||
131791737|NCT00415532|474520874|FG000|Treatment Period|Ineligibility determined|1|||
131791738|NCT00415532|474520875|FG001|Treatment Period|Ineligibility determined|1|||
131791739|NCT00415532|474520874|FG000|Treatment Period|Noncompliance|1|||
131605292|NCT03295721|473845346|FG000|Overall Study|Death|0|||
131605293|NCT03295721|473845347|FG001|Overall Study|Death|0|||
131605294|NCT03295721|473845348|FG002|Overall Study|Death|1|||
131605295|NCT04132518|473845356|FG000|Overall Study|Prematurely withdrawn from the study|0|||
131605296|NCT04132518|473845357|FG001|Overall Study|Prematurely withdrawn from the study|9|||
131605297|NCT04132518|473845358|FG002|Overall Study|Prematurely withdrawn from the study|1|||
131605298|NCT02988661|473845360|FG000|Overall Study|Death|2|||
131605299|NCT02988661|473845361|FG001|Overall Study|Death|18|||
131605300|NCT02988661|473845360|FG000|Overall Study|Lost to Follow-up|0|||
131605301|NCT02988661|473845361|FG001|Overall Study|Lost to Follow-up|33|||
131605302|NCT02988661|473845360|FG000|Overall Study|Withdrawal by Subject|0|||
131605303|NCT02988661|473845361|FG001|Overall Study|Withdrawal by Subject|6|||
131605304|NCT02988661|473845360|FG000|Overall Study|Unable to complete the 18-month survey|1|||
131605305|NCT02988661|473845361|FG001|Overall Study|Unable to complete the 18-month survey|27|||
131605306|NCT02413489|473845376|FG000|Overall Study|Death|11|||
131605307|NCT02413489|473845377|FG001|Overall Study|Death|3|||
131605308|NCT02413489|473845378|FG002|Overall Study|Death|4|||
131605309|NCT02413489|473845376|FG000|Overall Study|Withdrawal by Subject|2|||
131605310|NCT02413489|473845377|FG001|Overall Study|Withdrawal by Subject|0|||
131605311|NCT02413489|473845378|FG002|Overall Study|Withdrawal by Subject|0|||
131605312|NCT02413489|473845376|FG000|Overall Study|Study Terminated By Sponsor|2|||
131605313|NCT02413489|473845377|FG001|Overall Study|Study Terminated By Sponsor|13|||
131605314|NCT02413489|473845378|FG002|Overall Study|Study Terminated By Sponsor|1|||
131605315|NCT04294641|473846671|FG000|Overall Study|Screen failure|4|||
131605316|NCT05906784|473846673|FG000|Overall Study|Lost to Follow-up|2|||
131605317|NCT05906784|473846674|FG001|Overall Study|Lost to Follow-up|1|||
131605318|NCT05906784|473846675|FG002|Overall Study|Lost to Follow-up|1|||
131605319|NCT05906784|473846676|FG003|Overall Study|Lost to Follow-up|1|||
131605320|NCT02668692|473846677|FG000|Overall Study|Adverse Event|1|||
131605321|NCT02668692|473846678|FG001|Overall Study|Adverse Event|0|||
131605322|NCT02296684|473846682|FG000|Overall Study|Withdrawal by Subject|0|||
131605323|NCT02296684|473846683|FG001|Overall Study|Withdrawal by Subject|1|||
131605324|NCT02296684|473846684|FG002|Overall Study|Withdrawal by Subject|1|||
131605325|NCT02296684|473846682|FG000|Overall Study|Death|2|||
131605326|NCT02296684|473846683|FG001|Overall Study|Death|0|||
131605327|NCT02296684|473846684|FG002|Overall Study|Death|0|||
131605328|NCT01254864|473846685|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
131605329|NCT01254864|473846686|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
131605330|NCT01254864|473846687|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
131605331|NCT01254864|473846685|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
131605332|NCT01254864|473846686|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
131605333|NCT01254864|473846687|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
131605334|NCT01254864|473846685|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
131605335|NCT01254864|473846686|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
131605336|NCT01254864|473846687|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
131605337|NCT01254864|473846685|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
131605338|NCT01254864|473846686|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
131605339|NCT01254864|473846687|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
131605340|NCT01254864|473846685|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
131605341|NCT01254864|473846686|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
131605342|NCT01254864|473846687|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
131605343|NCT01254864|473846685|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
131605344|NCT01254864|473846686|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
131605345|NCT01254864|473846687|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
131605346|NCT01254864|473846685|FG000|Randomization Phase|Adverse Event|0|||
131605347|NCT01254864|473846686|FG001|Randomization Phase|Adverse Event|5|||
131605348|NCT01254864|473846687|FG002|Randomization Phase|Adverse Event|17|||
131605349|NCT01254864|473846685|FG000|Randomization Phase|Death|0|||
131605350|NCT01254864|473846686|FG001|Randomization Phase|Death|1|||
131605351|NCT01254864|473846687|FG002|Randomization Phase|Death|0|||
131605352|NCT01254864|473846685|FG000|Randomization Phase|Lost to Follow-up|0|||
131605353|NCT01254864|473846686|FG001|Randomization Phase|Lost to Follow-up|0|||
131605354|NCT01254864|473846687|FG002|Randomization Phase|Lost to Follow-up|1|||
131605355|NCT01254864|473846685|FG000|Randomization Phase|Physician Decision|0|||
131605356|NCT01254864|473846686|FG001|Randomization Phase|Physician Decision|20|||
131605357|NCT01254864|473846687|FG002|Randomization Phase|Physician Decision|25|||
131605358|NCT01254864|473846685|FG000|Randomization Phase|Withdrawal by Subject|0|||
131605359|NCT01254864|473846686|FG001|Randomization Phase|Withdrawal by Subject|4|||
131605360|NCT01254864|473846687|FG002|Randomization Phase|Withdrawal by Subject|2|||
131605361|NCT01254864|473846685|FG000|Randomization Phase|Non-Compliance|0|||
131605362|NCT01254864|473846686|FG001|Randomization Phase|Non-Compliance|1|||
131605363|NCT01254864|473846687|FG002|Randomization Phase|Non-Compliance|0|||
131605364|NCT01254864|473846685|FG000|Randomization Phase|Comorbidities|0|||
131605365|NCT01254864|473846686|FG001|Randomization Phase|Comorbidities|2|||
131440676|NCT02960217|473241554|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
131440677|NCT02960217|473241553|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
131440678|NCT02960217|473241554|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
131440679|NCT02960217|473241553|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
131440680|NCT02960217|473241554|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
131440681|NCT04764162|473241558|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
131440682|NCT04764162|473241559|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
131440683|NCT03361137|473241560|FG000|Overall Study|Reason not specified|1|||
131605366|NCT01254864|473846687|FG002|Randomization Phase|Comorbidities|1|||
131605367|NCT01828112|473846692|FG000|Treatment Phase|Adverse Event|7|||
131605368|NCT01828112|473846693|FG001|Treatment Phase|Adverse Event|8|||
131440684|NCT03361137|473241561|FG001|Overall Study|Reason not specified|0|||
131605369|NCT01828112|473846694|FG002|Treatment Phase|Adverse Event|0|||
131605370|NCT01828112|473846692|FG000|Treatment Phase|Death|9|||
131605371|NCT01828112|473846693|FG001|Treatment Phase|Death|5|||
131605372|NCT01828112|473846694|FG002|Treatment Phase|Death|0|||
131605373|NCT01828112|473846692|FG000|Treatment Phase|No longer required treatment|0|||
131605374|NCT01828112|473846693|FG001|Treatment Phase|No longer required treatment|1|||
131605375|NCT01828112|473846694|FG002|Treatment Phase|No longer required treatment|0|||
131605376|NCT01828112|473846692|FG000|Treatment Phase|Physician Decision|6|||
131605377|NCT01828112|473846693|FG001|Treatment Phase|Physician Decision|7|||
131605378|NCT01828112|473846694|FG002|Treatment Phase|Physician Decision|0|||
131605379|NCT01828112|473846692|FG000|Treatment Phase|Pregnancy|1|||
131605380|NCT01828112|473846693|FG001|Treatment Phase|Pregnancy|0|||
131605381|NCT01828112|473846694|FG002|Treatment Phase|Pregnancy|0|||
131605382|NCT01828112|473846692|FG000|Treatment Phase|Progressive disease|79|||
131605383|NCT01828112|473846693|FG001|Treatment Phase|Progressive disease|87|||
131605384|NCT01828112|473846694|FG002|Treatment Phase|Progressive disease|0|||
131605385|NCT01828112|473846692|FG000|Treatment Phase|Study terminated by sponsor|1|||
131605386|NCT01828112|473846693|FG001|Treatment Phase|Study terminated by sponsor|0|||
131605387|NCT01828112|473846694|FG002|Treatment Phase|Study terminated by sponsor|0|||
131605388|NCT01828112|473846692|FG000|Treatment Phase|Subject/guardian decision|12|||
131605389|NCT01828112|473846693|FG001|Treatment Phase|Subject/guardian decision|8|||
131605390|NCT01828112|473846694|FG002|Treatment Phase|Subject/guardian decision|0|||
131605391|NCT01828112|473846692|FG000|Extension Treatment Phase|Adverse Event|0|||
131605392|NCT01828112|473846693|FG001|Extension Treatment Phase|Adverse Event|0|||
131605393|NCT01828112|473846694|FG002|Extension Treatment Phase|Adverse Event|6|||
131605394|NCT01828112|473846692|FG000|Extension Treatment Phase|Death|0|||
131605395|NCT01828112|473846693|FG001|Extension Treatment Phase|Death|0|||
131605396|NCT01828112|473846694|FG002|Extension Treatment Phase|Death|17|||
131605397|NCT01828112|473846692|FG000|Extension Treatment Phase|Physician Decision|0|||
131605398|NCT01828112|473846693|FG001|Extension Treatment Phase|Physician Decision|0|||
131605399|NCT01828112|473846694|FG002|Extension Treatment Phase|Physician Decision|5|||
131605400|NCT01828112|473846692|FG000|Extension Treatment Phase|Progressive disease|0|||
131605401|NCT01828112|473846693|FG001|Extension Treatment Phase|Progressive disease|0|||
131605402|NCT01828112|473846694|FG002|Extension Treatment Phase|Progressive disease|46|||
131605403|NCT01828112|473846692|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
131605404|NCT01828112|473846693|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
131605405|NCT01828112|473846694|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
131605406|NCT01828112|473846692|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
131605407|NCT01828112|473846693|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
131605408|NCT01828112|473846694|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
131605409|NCT05586490|473846703|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131605410|NCT05586490|473846704|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131605411|NCT05586490|473846705|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
131605412|NCT05586490|473846706|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131605413|NCT05586490|473846707|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131605414|NCT05586490|473846703|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
131605415|NCT05586490|473846704|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131605416|NCT05586490|473846705|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131605417|NCT05586490|473846706|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131605418|NCT05586490|473846707|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131605419|NCT05586490|473846703|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
131605420|NCT05586490|473846704|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131605421|NCT05586490|473846705|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131605422|NCT05586490|473846706|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131605423|NCT05586490|473846707|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131605424|NCT03556293|473846708|FG000|Overall Study|Ineligible for analysis|1904|||
131605425|NCT03556293|473846709|FG001|Overall Study|Ineligible for analysis|1471|||
131791740|NCT00415532|474520875|FG001|Treatment Period|Noncompliance|1|||
131706957|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
131706958|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131706959|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131706960|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131706961|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131706962|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
131706963|NCT00289913|474209263|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131706964|NCT00289913|474209264|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131706965|NCT00289913|474209265|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131706966|NCT00289913|474209266|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131706967|NCT00289913|474209267|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
131706968|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706969|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
131706970|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706971|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706972|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131706973|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
131706974|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
131706975|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
131706976|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
131706977|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
131706978|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131706979|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131706980|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131706981|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
131706982|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131706983|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706984|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706985|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706986|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131706987|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131706988|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
131706989|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
131706990|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
131706991|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
131706992|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
131706993|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131706994|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
131706995|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
131706996|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131706997|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131706998|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131706999|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131707000|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131707001|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131707002|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
131707003|NCT00289913|474209263|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131707004|NCT00289913|474209264|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
131707005|NCT00289913|474209265|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131707006|NCT00289913|474209266|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131707007|NCT00289913|474209267|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131707008|NCT01169779|474209272|FG000|Overall Study|Adverse Event|3|||
131707009|NCT01169779|474209273|FG001|Overall Study|Adverse Event|11|||
131707010|NCT01169779|474209272|FG000|Overall Study|Lack of Efficacy|1|||
131707011|NCT01169779|474209273|FG001|Overall Study|Lack of Efficacy|0|||
131707012|NCT01169779|474209272|FG000|Overall Study|Protocol Violation|1|||
131707013|NCT01169779|474209273|FG001|Overall Study|Protocol Violation|1|||
131707014|NCT01169779|474209272|FG000|Overall Study|Withdrawal by Subject|3|||
131707015|NCT01169779|474209273|FG001|Overall Study|Withdrawal by Subject|2|||
131707016|NCT01169779|474209272|FG000|Overall Study|Familial and personal reasons|3|||
131899712|NCT02659943|474919375|FG002|Overall Study|No longer meets eligibility|0|||
131605426|NCT03556293|473846710|FG002|Overall Study|Ineligible for analysis|1091|||
131605427|NCT03556293|473846711|FG003|Overall Study|Ineligible for analysis|1269|||
131605428|NCT05012163|473846712|FG000|Overall Study|Protocol Violation|0|||
131605429|NCT05012163|473846713|FG001|Overall Study|Protocol Violation|0|||
131605430|NCT05012163|473846714|FG002|Overall Study|Protocol Violation|1|||
131605431|NCT05012163|473846715|FG003|Overall Study|Protocol Violation|1|||
131605432|NCT05076266|473846716|FG000|Overall Study|Survey not complete - Participant refusal|2|||
131605433|NCT05076266|473846717|FG001|Overall Study|Survey not complete - Participant refusal|0|||
131605434|NCT04003246|473846720|FG000|Overall Study|Death|9|||
131605435|NCT05524402|473846726|FG000|Overall Study|Withdrawal by Subject|3|||
131605436|NCT05524402|473846727|FG001|Overall Study|Withdrawal by Subject|1|||
131605437|NCT05524402|473846726|FG000|Overall Study|Lost to Follow-up|2|||
131605438|NCT05524402|473846727|FG001|Overall Study|Lost to Follow-up|1|||
131605439|NCT04428203|473846728|FG000|Overall Study|Adverse Event|1|||
131605440|NCT04428203|473846729|FG001|Overall Study|Adverse Event|0|||
131605441|NCT04428203|473846730|FG002|Overall Study|Adverse Event|0|||
131605442|NCT04428203|473846728|FG000|Overall Study|Withdrawal by Subject|1|||
131605443|NCT04428203|473846729|FG001|Overall Study|Withdrawal by Subject|0|||
131605444|NCT04428203|473846730|FG002|Overall Study|Withdrawal by Subject|1|||
131605445|NCT05280574|473846732|FG000|Overall Study|Withdrawal by Subject|0|||
131605446|NCT05280574|473846733|FG001|Overall Study|Withdrawal by Subject|2|||
131605447|NCT05280574|473846734|FG002|Overall Study|Withdrawal by Subject|0|||
131605448|NCT05237284|473846739|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
131605449|NCT05237284|473846740|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
131605450|NCT05237284|473846741|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
131605451|NCT05237284|473846742|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
131605452|NCT05237284|473846739|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
131605453|NCT05237284|473846740|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
131605454|NCT05237284|473846741|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
131605455|NCT05237284|473846742|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
131605456|NCT05237284|473846739|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
131605457|NCT05237284|473846740|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
131605458|NCT05237284|473846741|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
131605459|NCT05237284|473846742|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
131605460|NCT05237284|473846739|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
131605461|NCT05237284|473846740|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
131605462|NCT05237284|473846741|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
131605463|NCT05237284|473846742|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
131605464|NCT05237284|473846739|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
131605465|NCT05237284|473846740|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
131605466|NCT05237284|473846741|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
131605467|NCT05237284|473846742|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
131605468|NCT05237284|473846739|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
131605469|NCT05237284|473846740|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
131605470|NCT05237284|473846741|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
131605471|NCT05237284|473846742|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
131605472|NCT05237284|473846739|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
131605473|NCT05237284|473846740|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
131605474|NCT05237284|473846741|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
131605475|NCT05237284|473846742|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
131605476|NCT05237284|473846739|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
131605477|NCT05237284|473846740|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
131605478|NCT05237284|473846741|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
131605479|NCT05237284|473846742|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
131605480|NCT05237284|473846739|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
131605481|NCT05237284|473846740|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
131605482|NCT05237284|473846741|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
131605483|NCT05237284|473846742|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
131605484|NCT04056611|473846746|FG000|Overall Study|Physician Decision|1|||
131605485|NCT03733925|473846749|FG000|Overall Study|Lost to Follow-up|1|||
131605486|NCT03733925|473846749|FG000|Overall Study|Withdrawal by Subject|2|||
131605487|NCT03733925|473846749|FG000|Overall Study|Adverse Event|2|||
131899713|NCT02659943|474919376|FG003|Overall Study|No longer meets eligibility|0|||
131605488|NCT03733925|473846749|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131605489|NCT03213873|473846750|FG000|Overall Study|Withdrawal by Subject|8|||
131605490|NCT03213873|473846751|FG001|Overall Study|Withdrawal by Subject|9|||
131605491|NCT03213873|473846750|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
131605492|NCT03213873|473846751|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
131605493|NCT03213873|473846750|FG000|Overall Study|Lost to Follow-up|0|||
131605494|NCT03213873|473846751|FG001|Overall Study|Lost to Follow-up|2|||
131605495|NCT02631746|473846757|FG000|Overall Study|Lack of Efficacy|3|||
131605496|NCT04571619|473846758|FG000|Phase 1|Death|22|||
131605497|NCT04571619|473846759|FG001|Phase 1|Death|18|||
131605498|NCT04571619|473846758|FG000|Phase 1|Withdrawal by Subject|7|||
131605499|NCT04571619|473846759|FG001|Phase 1|Withdrawal by Subject|2|||
131605500|NCT04571619|473846758|FG000|Phase 2|Death|13|||
131605501|NCT04571619|473846759|FG001|Phase 2|Death|16|||
131605502|NCT04571619|473846758|FG000|Phase 2|Withdrawal by Subject|6|||
131605503|NCT04571619|473846759|FG001|Phase 2|Withdrawal by Subject|4|||
131605504|NCT02361216|473846760|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
131605505|NCT02361216|473846761|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
131605506|NCT02361216|473846760|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
131605507|NCT02361216|473846761|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
131605508|NCT02361216|473846760|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
131605509|NCT02361216|473846761|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
131605510|NCT02361216|473846760|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
131605511|NCT02361216|473846761|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
131605512|NCT02361216|473846760|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
131605513|NCT02361216|473846761|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
131605514|NCT02361216|473846760|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
131605515|NCT02361216|473846761|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
131605516|NCT02224144|473846762|FG000|Overall Study|Lost to Follow-up|3|||
131605517|NCT02224144|473846763|FG001|Overall Study|Lost to Follow-up|1|||
131605518|NCT02224144|473846762|FG000|Overall Study|Death|2|||
131605519|NCT02224144|473846763|FG001|Overall Study|Death|0|||
131605520|NCT02224144|473846762|FG000|Overall Study|Withdrawal by Subject|0|||
131605521|NCT02224144|473846763|FG001|Overall Study|Withdrawal by Subject|1|||
131605522|NCT02780700|473846773|FG000|Overall Study|Progressive disease|1|||
131605523|NCT04544007|473846784|FG000|Overall Study|Withdrawal by Subject|1|||
131605524|NCT04544007|473846784|FG000|Overall Study|Confirmed Progressive Disease|1|||
131605525|NCT05660434|473846785|FG000|Overall Study|Never obtained study materials|2|||
131605526|NCT05660434|473846786|FG001|Overall Study|Never obtained study materials|1|||
131605527|NCT03484819|473846790|FG000|Overall Study|Death|2|||
131605528|NCT03484819|473846790|FG000|Overall Study|Adverse Event|2|||
131605529|NCT03484819|473846790|FG000|Overall Study|Physician Decision|1|||
131605530|NCT03484819|473846790|FG000|Overall Study|Withdrawal by Subject|2|||
131605531|NCT03484819|473846790|FG000|Overall Study|Disease Progression|4|||
131605532|NCT03484819|473846790|FG000|Overall Study|Complicating Condition|1|||
131605533|NCT02575950|473846791|FG000|Overall Study|Withdrawal by Subject|0|||
131605534|NCT02575950|473846792|FG001|Overall Study|Withdrawal by Subject|0|||
131605535|NCT02575950|473846793|FG002|Overall Study|Withdrawal by Subject|0|||
131605536|NCT02575950|473846794|FG003|Overall Study|Withdrawal by Subject|2|||
131605537|NCT02575950|473846791|FG000|Overall Study|Lost to Follow-up|0|||
131605538|NCT02575950|473846792|FG001|Overall Study|Lost to Follow-up|1|||
131605539|NCT02575950|473846793|FG002|Overall Study|Lost to Follow-up|0|||
131605540|NCT02575950|473846794|FG003|Overall Study|Lost to Follow-up|3|||
131605541|NCT04271046|473846795|FG000|Overall Study|Death|0|||
131605542|NCT04271046|473846796|FG001|Overall Study|Death|2|||
131605543|NCT04271046|473846797|FG002|Overall Study|Death|0|||
131605544|NCT04271046|473846798|FG003|Overall Study|Death|2|||
131605545|NCT04271046|473846795|FG000|Overall Study|Lost to Follow-up|12|||
131605546|NCT04271046|473846796|FG001|Overall Study|Lost to Follow-up|12|||
131605547|NCT04271046|473846797|FG002|Overall Study|Lost to Follow-up|11|||
131605548|NCT04271046|473846798|FG003|Overall Study|Lost to Follow-up|11|||
131605549|NCT04271046|473846795|FG000|Overall Study|Patient with Dementia Died|2|||
131605550|NCT04271046|473846796|FG001|Overall Study|Patient with Dementia Died|0|||
131605551|NCT04271046|473846797|FG002|Overall Study|Patient with Dementia Died|2|||
131605552|NCT04271046|473846798|FG003|Overall Study|Patient with Dementia Died|0|||
131605553|NCT04271046|473846795|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
131605554|NCT04271046|473846796|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
131899714|NCT02659943|474919377|FG004|Overall Study|No longer meets eligibility|0|||
131605555|NCT04271046|473846797|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
131605556|NCT04271046|473846798|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
131605557|NCT03106740|473848905|FG000|Overall Study|Lost to Follow-up|2|||
131605558|NCT03106740|473848906|FG001|Overall Study|Lost to Follow-up|2|||
131605559|NCT03106740|473848905|FG000|Overall Study|Withdrawal by Subject|2|||
131605560|NCT03106740|473848906|FG001|Overall Study|Withdrawal by Subject|4|||
131605561|NCT03106740|473848905|FG000|Overall Study|Physician Decision|0|||
131605562|NCT03106740|473848906|FG001|Overall Study|Physician Decision|1|||
131605563|NCT03106740|473848905|FG000|Overall Study|Partial data|1|||
131605564|NCT03106740|473848906|FG001|Overall Study|Partial data|0|||
131605565|NCT03308877|473848907|FG000|Overall Study|Lost to Follow-up|32|||
131605566|NCT03308877|473848908|FG001|Overall Study|Lost to Follow-up|28|||
131707017|NCT01169779|474209273|FG001|Overall Study|Familial and personal reasons|3|||
131707018|NCT01279057|474209275|FG000|Overall Study|Adverse Event|1|||
131707019|NCT01279057|474209276|FG001|Overall Study|Adverse Event|0|||
131707020|NCT01279057|474209277|FG002|Overall Study|Adverse Event|1|||
131707021|NCT01279057|474209275|FG000|Overall Study|Insufficient therapeutic response|0|||
131707022|NCT01279057|474209276|FG001|Overall Study|Insufficient therapeutic response|0|||
131707023|NCT01279057|474209277|FG002|Overall Study|Insufficient therapeutic response|1|||
131707024|NCT01279057|474209275|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131707025|NCT01279057|474209276|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
131707026|NCT01279057|474209277|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131707027|NCT01279057|474209275|FG000|Overall Study|Withdrew consent|2|||
131707028|NCT01279057|474209276|FG001|Overall Study|Withdrew consent|0|||
131707029|NCT01279057|474209277|FG002|Overall Study|Withdrew consent|1|||
131605582|NCT05218096|473848933|FG000|Primary Evaluation|Withdrawal by Subject|0|||
131605583|NCT05218096|473848934|FG001|Primary Evaluation|Withdrawal by Subject|0|||
131605584|NCT05218096|473848935|FG002|Primary Evaluation|Withdrawal by Subject|2|||
131605585|NCT05218096|473848936|FG003|Primary Evaluation|Withdrawal by Subject|0|||
131605586|NCT05218096|473848937|FG004|Primary Evaluation|Withdrawal by Subject|0|||
131605587|NCT05218096|473848933|FG000|Primary Evaluation|Physician Decision|1|||
131605588|NCT05218096|473848934|FG001|Primary Evaluation|Physician Decision|0|||
131605589|NCT05218096|473848935|FG002|Primary Evaluation|Physician Decision|0|||
131605590|NCT05218096|473848936|FG003|Primary Evaluation|Physician Decision|0|||
131605591|NCT05218096|473848937|FG004|Primary Evaluation|Physician Decision|0|||
131605592|NCT05218096|473848933|FG000|Extended Treatment|Clinical Deterioration|1|||
131605593|NCT05218096|473848934|FG001|Extended Treatment|Clinical Deterioration|1|||
131605594|NCT05218096|473848935|FG002|Extended Treatment|Clinical Deterioration|0|||
131605595|NCT05218096|473848936|FG003|Extended Treatment|Clinical Deterioration|0|||
131605596|NCT05218096|473848937|FG004|Extended Treatment|Clinical Deterioration|0|||
131605597|NCT05218096|473848933|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
131605598|NCT05218096|473848934|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
131605599|NCT05218096|473848935|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
131605600|NCT05218096|473848936|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
131605601|NCT05218096|473848937|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
131605602|NCT05218096|473848933|FG000|Extended Treatment|Withdrawal by Subject|1|||
131605603|NCT05218096|473848934|FG001|Extended Treatment|Withdrawal by Subject|3|||
131605604|NCT05218096|473848935|FG002|Extended Treatment|Withdrawal by Subject|0|||
131605605|NCT05218096|473848936|FG003|Extended Treatment|Withdrawal by Subject|2|||
131605606|NCT05218096|473848937|FG004|Extended Treatment|Withdrawal by Subject|2|||
131605607|NCT05218096|473848933|FG000|Extended Treatment|Lack of Efficacy|3|||
131605608|NCT05218096|473848934|FG001|Extended Treatment|Lack of Efficacy|0|||
131605609|NCT05218096|473848935|FG002|Extended Treatment|Lack of Efficacy|0|||
131605610|NCT05218096|473848936|FG003|Extended Treatment|Lack of Efficacy|0|||
131605611|NCT05218096|473848937|FG004|Extended Treatment|Lack of Efficacy|0|||
131605612|NCT05218096|473848933|FG000|Extended Treatment|Physician Decision|0|||
131605613|NCT05218096|473848934|FG001|Extended Treatment|Physician Decision|1|||
131605614|NCT05218096|473848935|FG002|Extended Treatment|Physician Decision|0|||
131605615|NCT05218096|473848936|FG003|Extended Treatment|Physician Decision|0|||
131605616|NCT05218096|473848937|FG004|Extended Treatment|Physician Decision|0|||
131605617|NCT05218096|473848933|FG000|Open-label Extension|Adverse Event|1|||
131605618|NCT05218096|473848934|FG001|Open-label Extension|Adverse Event|0|||
131605619|NCT05218096|473848935|FG002|Open-label Extension|Adverse Event|0|||
131605620|NCT05218096|473848936|FG003|Open-label Extension|Adverse Event|0|||
131605621|NCT05218096|473848937|FG004|Open-label Extension|Adverse Event|1|||
131605622|NCT05218096|473848933|FG000|Open-label Extension|Pregnancy|0|||
131605623|NCT05218096|473848934|FG001|Open-label Extension|Pregnancy|0|||
131605624|NCT05218096|473848935|FG002|Open-label Extension|Pregnancy|0|||
131605625|NCT05218096|473848936|FG003|Open-label Extension|Pregnancy|0|||
131605626|NCT05218096|473848937|FG004|Open-label Extension|Pregnancy|1|||
131605627|NCT05218096|473848933|FG000|Open-label Extension|Lack of Efficacy|1|||
131605628|NCT05218096|473848934|FG001|Open-label Extension|Lack of Efficacy|2|||
131605629|NCT05218096|473848935|FG002|Open-label Extension|Lack of Efficacy|0|||
131605630|NCT05218096|473848936|FG003|Open-label Extension|Lack of Efficacy|0|||
131605631|NCT05218096|473848937|FG004|Open-label Extension|Lack of Efficacy|0|||
131605632|NCT05218096|473848933|FG000|Open-label Extension|Lost to Follow-up|1|||
131605633|NCT05218096|473848934|FG001|Open-label Extension|Lost to Follow-up|0|||
131605634|NCT05218096|473848935|FG002|Open-label Extension|Lost to Follow-up|0|||
131605635|NCT05218096|473848936|FG003|Open-label Extension|Lost to Follow-up|0|||
131605636|NCT05218096|473848937|FG004|Open-label Extension|Lost to Follow-up|0|||
131605637|NCT05218096|473848933|FG000|Open-label Extension|Death|0|||
131605638|NCT05218096|473848934|FG001|Open-label Extension|Death|0|||
131605639|NCT05218096|473848935|FG002|Open-label Extension|Death|0|||
131605640|NCT05218096|473848936|FG003|Open-label Extension|Death|1|||
131605641|NCT05218096|473848937|FG004|Open-label Extension|Death|0|||
131605642|NCT05218096|473848933|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
131605643|NCT05218096|473848934|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
131605644|NCT05218096|473848935|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
131605645|NCT05218096|473848936|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
131605646|NCT05218096|473848937|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
131605647|NCT05269966|473848940|FG000|Overall Study|Adverse Event|4|||
131605648|NCT05269966|473848940|FG000|Overall Study|Withdrawal by Subject|1|||
131605649|NCT05269966|473848940|FG000|Overall Study|Lost to Follow-up|4|||
131605650|NCT05269966|473848940|FG000|Overall Study|Physician Decision|1|||
131605651|NCT05863156|473848949|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
131605652|NCT05863156|473848950|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
131605653|NCT05863156|473848951|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
131605654|NCT04660539|473848954|FG000|Overall Study|Adverse Event|10|||
131605655|NCT04660539|473848954|FG000|Overall Study|Lack of Efficacy|4|||
131605656|NCT04660539|473848954|FG000|Overall Study|Lost to Follow-up|5|||
131605657|NCT04660539|473848954|FG000|Overall Study|Non-Compliance With Study Drug|3|||
131605658|NCT04660539|473848954|FG000|Overall Study|Reason not Specified|12|||
131605659|NCT04660539|473848954|FG000|Overall Study|Pregnancy|2|||
131605660|NCT04660539|473848954|FG000|Overall Study|Protocol Violation|2|||
131605661|NCT04660539|473848954|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
131605662|NCT04660539|473848954|FG000|Overall Study|Withdrawal by Subject|21|||
131605663|NCT03655028|473848957|FG000|12-weeks Follow up|Death|1|||
131605664|NCT03655028|473848958|FG001|12-weeks Follow up|Death|0|||
131605665|NCT03655028|473848957|FG000|12-weeks Follow up|Physician Decision|3|||
131605666|NCT03655028|473848958|FG001|12-weeks Follow up|Physician Decision|3|||
131605667|NCT03655028|473848957|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
131605668|NCT03655028|473848958|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
131605669|NCT03655028|473848957|FG000|12-weeks Follow up|Lost to Follow-up|4|||
131605670|NCT03655028|473848958|FG001|12-weeks Follow up|Lost to Follow-up|4|||
131605671|NCT03655028|473848957|FG000|24-weeks|Lost to Follow-up|1|||
131605672|NCT03655028|473848958|FG001|24-weeks|Lost to Follow-up|1|||
131605673|NCT03655028|473848957|FG000|24-weeks|Death|0|||
131605674|NCT03655028|473848958|FG001|24-weeks|Death|1|||
131605675|NCT03513302|473848959|FG000|First Intervention (14 Days)|Screen failure|15|||
131605676|NCT03513302|473848960|FG001|First Intervention (14 Days)|Screen failure|16|||
131605677|NCT05618587|473848961|FG000|Overall Study|Lost to Follow-up|2|||
131605678|NCT05618587|473848962|FG001|Overall Study|Lost to Follow-up|0|||
131605679|NCT05167864|473848963|FG000|Overall Study|Lost to Follow-up|7|||
131605680|NCT05167864|473848964|FG001|Overall Study|Lost to Follow-up|6|||
131605681|NCT05167864|473848965|FG002|Overall Study|Lost to Follow-up|7|||
131605682|NCT05167864|473848966|FG003|Overall Study|Lost to Follow-up|9|||
131605683|NCT03442309|473848969|FG000|Overall Study|Lost to Follow-up|1676|||
131605684|NCT03442309|473848970|FG001|Overall Study|Lost to Follow-up|1642|||
131605685|NCT04862416|473848971|FG000|Overall Study|Withdrawal by Subject|0|||
131605686|NCT04862416|473848972|FG001|Overall Study|Withdrawal by Subject|1|||
131605687|NCT04862416|473848973|FG002|Overall Study|Withdrawal by Subject|0|||
131605688|NCT04862416|473848974|FG003|Overall Study|Withdrawal by Subject|1|||
131605689|NCT04862416|473848975|FG004|Overall Study|Withdrawal by Subject|0|||
131605690|NCT04862416|473848976|FG005|Overall Study|Withdrawal by Subject|0|||
131605691|NCT04862416|473848977|FG006|Overall Study|Withdrawal by Subject|0|||
131605692|NCT04862416|473848978|FG007|Overall Study|Withdrawal by Subject|0|||
131605693|NCT03852550|473848979|FG000|Overall Study|Lost to Follow-up|4|||
131605694|NCT03852550|473848980|FG001|Overall Study|Lost to Follow-up|3|||
131605695|NCT03852550|473848979|FG000|Overall Study|Only parent outcomes completed|0|||
131605696|NCT03852550|473848980|FG001|Overall Study|Only parent outcomes completed|1|||
131605697|NCT03852550|473848979|FG000|Overall Study|Withdrawal by Subject|1|||
131605698|NCT03852550|473848980|FG001|Overall Study|Withdrawal by Subject|0|||
131605699|NCT05204654|473848981|FG000|Overall Study|Study terminated due to time restraint|2|||
131605700|NCT05204654|473848982|FG001|Overall Study|Study terminated due to time restraint|2|||
131605701|NCT05207956|473849002|FG000|Overall Study|Lost to follow up|1|||
131605702|NCT05207956|473849003|FG001|Overall Study|Lost to follow up|2|||
131605703|NCT02446236|473849005|FG000|Overall Study|Screen Failure|1|||
131605704|NCT02446236|473849006|FG001|Overall Study|Screen Failure|0|||
131605705|NCT02446236|473849007|FG002|Overall Study|Screen Failure|1|||
131605706|NCT02446236|473849005|FG000|Overall Study|Actively Receiving Therapy|0|||
131605707|NCT02446236|473849006|FG001|Overall Study|Actively Receiving Therapy|0|||
131605708|NCT02446236|473849007|FG002|Overall Study|Actively Receiving Therapy|1|||
131605709|NCT00429364|473849008|FG000|Overall Study|Withdrawal by Subject|11|||
131605710|NCT00429364|473849009|FG001|Overall Study|Withdrawal by Subject|5|||
131605711|NCT00429364|473849008|FG000|Overall Study|Physician Decision|4|||
131605712|NCT00429364|473849009|FG001|Overall Study|Physician Decision|2|||
131605713|NCT00429364|473849008|FG000|Overall Study|Lost to Follow-up|7|||
131605714|NCT00429364|473849009|FG001|Overall Study|Lost to Follow-up|6|||
131605715|NCT00429364|473849008|FG000|Overall Study|Death|0|||
131605716|NCT00429364|473849009|FG001|Overall Study|Death|1|||
131605717|NCT00429364|473849008|FG000|Overall Study|Underwent aortic root surgery|10|||
131605718|NCT00429364|473849009|FG001|Overall Study|Underwent aortic root surgery|18|||
131605719|NCT00429364|473849008|FG000|Overall Study|Pregnancy|0|||
131605720|NCT00429364|473849009|FG001|Overall Study|Pregnancy|1|||
131605721|NCT04871529|473849010|FG000|Overall Study|Withdrawal by Subject|0|||
131605722|NCT04871529|473849011|FG001|Overall Study|Withdrawal by Subject|1|||
131605723|NCT04871529|473849010|FG000|Overall Study|Death|0|||
131605724|NCT04871529|473849011|FG001|Overall Study|Death|1|||
131605725|NCT04871529|473849010|FG000|Overall Study|Not protocol specified|0|||
131605726|NCT04871529|473849011|FG001|Overall Study|Not protocol specified|1|||
131605727|NCT05184452|473849012|FG000|Overall Study|Lost to Follow-up|0|||
131605728|NCT05184452|473849013|FG001|Overall Study|Lost to Follow-up|0|||
131605729|NCT05184452|473849014|FG002|Overall Study|Lost to Follow-up|0|||
131605730|NCT05184452|473849015|FG003|Overall Study|Lost to Follow-up|0|||
131605731|NCT05184452|473849016|FG004|Overall Study|Lost to Follow-up|0|||
131605732|NCT05184452|473849017|FG005|Overall Study|Lost to Follow-up|2|||
131605733|NCT05184452|473849018|FG006|Overall Study|Lost to Follow-up|0|||
131605734|NCT05184452|473849019|FG007|Overall Study|Lost to Follow-up|0|||
131605735|NCT05184452|473849020|FG008|Overall Study|Lost to Follow-up|0|||
131605736|NCT05184452|473849021|FG009|Overall Study|Lost to Follow-up|1|||
131605737|NCT05184452|473849012|FG000|Overall Study|Withdrawal by Subject|0|||
131605738|NCT05184452|473849013|FG001|Overall Study|Withdrawal by Subject|0|||
131605739|NCT05184452|473849014|FG002|Overall Study|Withdrawal by Subject|0|||
131605740|NCT05184452|473849015|FG003|Overall Study|Withdrawal by Subject|0|||
131605741|NCT05184452|473849016|FG004|Overall Study|Withdrawal by Subject|0|||
131605742|NCT05184452|473849017|FG005|Overall Study|Withdrawal by Subject|1|||
131605743|NCT05184452|473849018|FG006|Overall Study|Withdrawal by Subject|0|||
131605744|NCT05184452|473849019|FG007|Overall Study|Withdrawal by Subject|0|||
131605745|NCT05184452|473849020|FG008|Overall Study|Withdrawal by Subject|0|||
131605746|NCT05184452|473849021|FG009|Overall Study|Withdrawal by Subject|1|||
131605747|NCT04862234|473849022|FG000|Overall Study|Surgery cancellation|1|||
131605748|NCT04862234|473849023|FG001|Overall Study|Surgery cancellation|2|||
131605749|NCT04862234|473849022|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
131605750|NCT04862234|473849023|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
131605751|NCT04862234|473849022|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
131605752|NCT04862234|473849023|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
131605753|NCT03292484|473849029|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
131605754|NCT03292484|473849029|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
131605755|NCT03292484|473849029|FG000|Overall Study|Protocol Violation|2|||
131605756|NCT03292484|473849029|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
131605757|NCT03292484|473849029|FG000|Overall Study|Sponsor decision|349|||
131605758|NCT03292484|473849029|FG000|Overall Study|Lost to Follow-up|7|||
131605759|NCT03292484|473849029|FG000|Overall Study|Coronavirus Disease 2019|1|||
131605760|NCT03292484|473849029|FG000|Overall Study|Other|20|||
131605761|NCT05425420|473849040|FG000|Overall Study|Physician Decision|1|||
131605762|NCT05425420|473849040|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
131605763|NCT03714815|473849041|FG000|Overall Study|Physician Decision|2|||
131605764|NCT03714815|473849041|FG000|Overall Study|Withdrawal by Subject|2|||
131605765|NCT03714815|473849041|FG000|Overall Study|Death|11|||
131605766|NCT03505008|473849042|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
131605767|NCT03505008|473849043|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
131605768|NCT03505008|473849044|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
131605769|NCT03505008|473849045|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
131605770|NCT03505008|473849042|FG000|Before Week 24 Randomization|Adverse Event|10|||
131605771|NCT03505008|473849043|FG001|Before Week 24 Randomization|Adverse Event|0|||
131605772|NCT03505008|473849044|FG002|Before Week 24 Randomization|Adverse Event|0|||
131605773|NCT03505008|473849045|FG003|Before Week 24 Randomization|Adverse Event|0|||
131605774|NCT03505008|473849042|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
131605775|NCT03505008|473849043|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
131605776|NCT03505008|473849044|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
131605777|NCT03505008|473849045|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
131605778|NCT03505008|473849042|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
131605779|NCT03505008|473849043|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
131605780|NCT03505008|473849044|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
131605781|NCT03505008|473849045|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
131605782|NCT03505008|473849042|FG000|Before Week 24 Randomization|Physician Decision|2|||
131605783|NCT03505008|473849043|FG001|Before Week 24 Randomization|Physician Decision|0|||
131605784|NCT03505008|473849044|FG002|Before Week 24 Randomization|Physician Decision|0|||
131605785|NCT03505008|473849045|FG003|Before Week 24 Randomization|Physician Decision|0|||
131605786|NCT03505008|473849042|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
131605787|NCT03505008|473849043|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
131605788|NCT03505008|473849044|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
131605789|NCT03505008|473849045|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
131605790|NCT03505008|473849042|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
131605791|NCT03505008|473849043|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
131605792|NCT03505008|473849044|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
131605793|NCT03505008|473849045|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
131605794|NCT03505008|473849042|FG000|Before Week 24 Randomization|Complication|1|||
131605795|NCT03505008|473849043|FG001|Before Week 24 Randomization|Complication|0|||
131605796|NCT03505008|473849044|FG002|Before Week 24 Randomization|Complication|0|||
131605797|NCT03505008|473849045|FG003|Before Week 24 Randomization|Complication|0|||
131605798|NCT03505008|473849042|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
131605799|NCT03505008|473849043|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
131605800|NCT03505008|473849044|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
131605801|NCT03505008|473849045|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
131605802|NCT03505008|473849042|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
131605803|NCT03505008|473849043|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
131605804|NCT03505008|473849044|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
131605805|NCT03505008|473849045|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
131605806|NCT03505008|473849042|FG000|After Week 24 Randomization|Adverse Event|0|||
131605807|NCT03505008|473849043|FG001|After Week 24 Randomization|Adverse Event|1|||
131605808|NCT03505008|473849044|FG002|After Week 24 Randomization|Adverse Event|2|||
131605809|NCT03505008|473849045|FG003|After Week 24 Randomization|Adverse Event|2|||
131605810|NCT03505008|473849042|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
131605811|NCT03505008|473849043|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
131605812|NCT03505008|473849044|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
131605813|NCT03505008|473849045|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
131605814|NCT03505008|473849042|FG000|After Week 24 Randomization|Protocol Violation|0|||
131605815|NCT03505008|473849043|FG001|After Week 24 Randomization|Protocol Violation|0|||
131605816|NCT03505008|473849044|FG002|After Week 24 Randomization|Protocol Violation|1|||
131605817|NCT03505008|473849045|FG003|After Week 24 Randomization|Protocol Violation|0|||
131605818|NCT03276676|473849049|FG000|Overall Study|Withdrawal by Subject|2|||
131605819|NCT03276676|473849050|FG001|Overall Study|Withdrawal by Subject|1|||
131605820|NCT04741776|473849052|FG000|Overall Study|Withdrawal by Subject|7|||
131605821|NCT04741776|473849053|FG001|Overall Study|Withdrawal by Subject|10|||
131605822|NCT04741776|473849054|FG002|Overall Study|Withdrawal by Subject|10|||
131605823|NCT04741776|473849055|FG003|Overall Study|Withdrawal by Subject|17|||
131605824|NCT04741776|473849052|FG000|Overall Study|Death|0|||
131605825|NCT04741776|473849053|FG001|Overall Study|Death|0|||
131605826|NCT04741776|473849054|FG002|Overall Study|Death|1|||
131605827|NCT04741776|473849055|FG003|Overall Study|Death|0|||
131605828|NCT04089865|473849056|FG000|Overall Study|Withdrawal by Subject|2|||
131605829|NCT04089865|473849057|FG001|Overall Study|Withdrawal by Subject|2|||
131605830|NCT04089865|473849058|FG002|Overall Study|Withdrawal by Subject|7|||
131605831|NCT04089865|473849059|FG003|Overall Study|Withdrawal by Subject|2|||
131605832|NCT03583333|473849060|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
131605833|NCT03583333|473849061|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
131605834|NCT03583333|473849060|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
131605835|NCT03583333|473849061|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
131605836|NCT03583333|473849060|FG000|Overall Study|Withdrawal by Subject|9|||
131605837|NCT03583333|473849061|FG001|Overall Study|Withdrawal by Subject|5|||
131605838|NCT03583333|473849060|FG000|Overall Study|Physician Decision|3|||
131605839|NCT03583333|473849061|FG001|Overall Study|Physician Decision|2|||
131605840|NCT03583333|473849060|FG000|Overall Study|Death|12|||
131605841|NCT03583333|473849061|FG001|Overall Study|Death|7|||
131605842|NCT03926130|473849062|FG000|Overall Study|Adverse Event|9|||
131605843|NCT03926130|473849063|FG001|Overall Study|Adverse Event|11|||
131605844|NCT03926130|473849064|FG002|Overall Study|Adverse Event|2|||
131605845|NCT03926130|473849065|FG003|Overall Study|Adverse Event|0|||
131605846|NCT03926130|473849062|FG000|Overall Study|Death|2|||
131605847|NCT03926130|473849063|FG001|Overall Study|Death|0|||
131605848|NCT03926130|473849064|FG002|Overall Study|Death|1|||
131605849|NCT03926130|473849065|FG003|Overall Study|Death|0|||
131605850|NCT03926130|473849062|FG000|Overall Study|Lack of Efficacy|14|||
131605851|NCT03926130|473849063|FG001|Overall Study|Lack of Efficacy|11|||
131605852|NCT03926130|473849064|FG002|Overall Study|Lack of Efficacy|7|||
131605853|NCT03926130|473849065|FG003|Overall Study|Lack of Efficacy|1|||
131605854|NCT03926130|473849062|FG000|Overall Study|Lost to Follow-up|0|||
131605855|NCT03926130|473849063|FG001|Overall Study|Lost to Follow-up|7|||
131605856|NCT03926130|473849064|FG002|Overall Study|Lost to Follow-up|1|||
131605857|NCT03926130|473849065|FG003|Overall Study|Lost to Follow-up|0|||
131605858|NCT03926130|473849062|FG000|Overall Study|As Reported by Investigator|2|||
131605859|NCT03926130|473849063|FG001|Overall Study|As Reported by Investigator|6|||
131605860|NCT03926130|473849064|FG002|Overall Study|As Reported by Investigator|6|||
131605861|NCT03926130|473849065|FG003|Overall Study|As Reported by Investigator|0|||
131605862|NCT03926130|473849062|FG000|Overall Study|Physician Decision|3|||
131605863|NCT03926130|473849063|FG001|Overall Study|Physician Decision|2|||
131605864|NCT03926130|473849064|FG002|Overall Study|Physician Decision|1|||
131605865|NCT03926130|473849065|FG003|Overall Study|Physician Decision|0|||
131605866|NCT03926130|473849062|FG000|Overall Study|Pregnancy|2|||
131605867|NCT03926130|473849063|FG001|Overall Study|Pregnancy|2|||
131605868|NCT03926130|473849064|FG002|Overall Study|Pregnancy|1|||
131605869|NCT03926130|473849065|FG003|Overall Study|Pregnancy|0|||
131605870|NCT03926130|473849062|FG000|Overall Study|Withdrawal by Subject|20|||
131605871|NCT03926130|473849063|FG001|Overall Study|Withdrawal by Subject|28|||
131605872|NCT03926130|473849064|FG002|Overall Study|Withdrawal by Subject|18|||
131605873|NCT03926130|473849065|FG003|Overall Study|Withdrawal by Subject|1|||
131605874|NCT03926130|473849062|FG000|Overall Study|Non-Compliance|1|||
131605875|NCT03926130|473849063|FG001|Overall Study|Non-Compliance|1|||
131605876|NCT03926130|473849064|FG002|Overall Study|Non-Compliance|0|||
131605877|NCT03926130|473849065|FG003|Overall Study|Non-Compliance|0|||
131605878|NCT03926130|473849062|FG000|Overall Study|Disposition Not Captured|0|||
131605879|NCT03926130|473849063|FG001|Overall Study|Disposition Not Captured|2|||
131605880|NCT03926130|473849064|FG002|Overall Study|Disposition Not Captured|1|||
131605881|NCT03926130|473849065|FG003|Overall Study|Disposition Not Captured|0|||
131605882|NCT04218851|473849079|FG000|Overall Study|Death|1|||
131605883|NCT04218851|473849080|FG001|Overall Study|Death|3|||
131605884|NCT05285137|473849081|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
131605885|NCT05285137|473849082|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
131605886|NCT05285137|473849083|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
131605887|NCT05285137|473849084|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
131605888|NCT05285137|473849085|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
131605889|NCT05285137|473849086|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
131605890|NCT05285137|473849087|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
131605891|NCT05285137|473849088|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
131605892|NCT05285137|473849089|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
131605893|NCT05285137|473849081|FG000|Overall Study|Lost to Follow-up|0|||
131605894|NCT05285137|473849082|FG001|Overall Study|Lost to Follow-up|0|||
131605895|NCT05285137|473849083|FG002|Overall Study|Lost to Follow-up|1|||
131605896|NCT05285137|473849084|FG003|Overall Study|Lost to Follow-up|3|||
131605897|NCT05285137|473849085|FG004|Overall Study|Lost to Follow-up|0|||
131605898|NCT05285137|473849086|FG005|Overall Study|Lost to Follow-up|0|||
131605899|NCT05285137|473849087|FG006|Overall Study|Lost to Follow-up|1|||
131605900|NCT05285137|473849088|FG007|Overall Study|Lost to Follow-up|0|||
131605901|NCT05285137|473849089|FG008|Overall Study|Lost to Follow-up|0|||
131605902|NCT05285137|473849081|FG000|Overall Study|Physician Decision|0|||
131605903|NCT05285137|473849082|FG001|Overall Study|Physician Decision|1|||
131605904|NCT05285137|473849083|FG002|Overall Study|Physician Decision|0|||
131605905|NCT05285137|473849084|FG003|Overall Study|Physician Decision|0|||
131605906|NCT05285137|473849085|FG004|Overall Study|Physician Decision|0|||
131605907|NCT05285137|473849086|FG005|Overall Study|Physician Decision|0|||
131605908|NCT05285137|473849087|FG006|Overall Study|Physician Decision|0|||
131605909|NCT05285137|473849088|FG007|Overall Study|Physician Decision|0|||
131605910|NCT05285137|473849089|FG008|Overall Study|Physician Decision|0|||
131605911|NCT05285137|473849081|FG000|Overall Study|Pregnancy|0|||
131605912|NCT05285137|473849082|FG001|Overall Study|Pregnancy|0|||
131605913|NCT05285137|473849083|FG002|Overall Study|Pregnancy|0|||
131605914|NCT05285137|473849084|FG003|Overall Study|Pregnancy|0|||
131605915|NCT05285137|473849085|FG004|Overall Study|Pregnancy|0|||
131605916|NCT05285137|473849086|FG005|Overall Study|Pregnancy|0|||
131605917|NCT05285137|473849087|FG006|Overall Study|Pregnancy|1|||
131605918|NCT05285137|473849088|FG007|Overall Study|Pregnancy|0|||
131605919|NCT05285137|473849089|FG008|Overall Study|Pregnancy|0|||
131605920|NCT05285137|473849081|FG000|Overall Study|Withdrawal by Subject|0|||
131605921|NCT05285137|473849082|FG001|Overall Study|Withdrawal by Subject|1|||
131605922|NCT05285137|473849083|FG002|Overall Study|Withdrawal by Subject|2|||
131605923|NCT05285137|473849084|FG003|Overall Study|Withdrawal by Subject|1|||
131791741|NCT00415532|474520874|FG000|Treatment Period|Requirement for alternative therapy|1|||
131605924|NCT05285137|473849085|FG004|Overall Study|Withdrawal by Subject|0|||
131605925|NCT05285137|473849086|FG005|Overall Study|Withdrawal by Subject|0|||
131605926|NCT05285137|473849087|FG006|Overall Study|Withdrawal by Subject|0|||
131605927|NCT05285137|473849088|FG007|Overall Study|Withdrawal by Subject|0|||
131605928|NCT05285137|473849089|FG008|Overall Study|Withdrawal by Subject|1|||
131605929|NCT04565990|473850642|FG000|Overall Study|Death|5|||
131605930|NCT04565990|473850642|FG000|Overall Study|Lost to Follow-up|1|||
131605931|NCT04565990|473850642|FG000|Overall Study|Withdrawal by Subject|1|||
131605932|NCT04797858|473850643|FG000|Overall Study|Withdrawal by Subject|0|||
131605933|NCT04797858|473850644|FG001|Overall Study|Withdrawal by Subject|1|||
131605934|NCT04797858|473850643|FG000|Overall Study|Excluded due to administrative error|7|||
131791742|NCT00415532|474520875|FG001|Treatment Period|Requirement for alternative therapy|0|||
131791743|NCT00415532|474520874|FG000|Safety Follow Up Period|Adverse Event|1|||
131791744|NCT00415532|474520875|FG001|Safety Follow Up Period|Adverse Event|3|||
131791745|NCT00415532|474520874|FG000|Safety Follow Up Period|Death|3|||
131791746|NCT00415532|474520875|FG001|Safety Follow Up Period|Death|0|||
131791747|NCT00415532|474520874|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
131791748|NCT00415532|474520875|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
131791749|NCT00415532|474520874|FG000|Safety Follow Up Period|Other|1|||
131791750|NCT00415532|474520875|FG001|Safety Follow Up Period|Other|4|||
131791751|NCT00415532|474520874|FG000|Safety Follow Up Period|Ineligibility determined|1|||
131791752|NCT00415532|474520875|FG001|Safety Follow Up Period|Ineligibility determined|1|||
131791753|NCT00415532|474520874|FG000|Safety Follow Up Period|Noncompliance|1|||
131791754|NCT00415532|474520875|FG001|Safety Follow Up Period|Noncompliance|0|||
131791755|NCT00415532|474520874|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
131791756|NCT00415532|474520875|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
131605935|NCT04797858|473850644|FG001|Overall Study|Excluded due to administrative error|8|||
131605936|NCT04826471|473850645|FG000|Overall Study|Lost to Follow-up|2|||
131605937|NCT04826471|473850645|FG000|Overall Study|Protocol Violation|3|||
131605938|NCT04826471|473850645|FG000|Overall Study|Withdrawal by Subject|1|||
131605939|NCT04414722|473850646|FG000|Overall Study|Lost to Follow-up|3|||
131605940|NCT04414722|473850647|FG001|Overall Study|Lost to Follow-up|4|||
131605941|NCT04414722|473850648|FG002|Overall Study|Lost to Follow-up|3|||
131605942|NCT04414722|473850649|FG003|Overall Study|Lost to Follow-up|2|||
131605943|NCT04414722|473850650|FG004|Overall Study|Lost to Follow-up|3|||
131605944|NCT04414722|473850646|FG000|Overall Study|Withdrawal by Subject|6|||
131605945|NCT04414722|473850647|FG001|Overall Study|Withdrawal by Subject|3|||
131605946|NCT04414722|473850648|FG002|Overall Study|Withdrawal by Subject|1|||
131605947|NCT04414722|473850649|FG003|Overall Study|Withdrawal by Subject|5|||
131605948|NCT04414722|473850650|FG004|Overall Study|Withdrawal by Subject|1|||
131605949|NCT04414722|473850646|FG000|Overall Study|Physician Decision|0|||
131605950|NCT04414722|473850647|FG001|Overall Study|Physician Decision|1|||
131605951|NCT04414722|473850648|FG002|Overall Study|Physician Decision|2|||
131605952|NCT04414722|473850649|FG003|Overall Study|Physician Decision|0|||
131605953|NCT04414722|473850650|FG004|Overall Study|Physician Decision|0|||
131605954|NCT04414722|473850646|FG000|Overall Study|Non-participatory|0|||
131605955|NCT04414722|473850647|FG001|Overall Study|Non-participatory|1|||
131605956|NCT04414722|473850648|FG002|Overall Study|Non-participatory|1|||
131605957|NCT04414722|473850649|FG003|Overall Study|Non-participatory|0|||
131605958|NCT04414722|473850650|FG004|Overall Study|Non-participatory|0|||
131605959|NCT04304144|473850651|FG000|DLT Observation Period|Physician Decision|0|||
131605960|NCT04304144|473850652|FG001|DLT Observation Period|Physician Decision|1|||
131605961|NCT04304144|473850653|FG002|DLT Observation Period|Physician Decision|0|||
131605962|NCT04304144|473850654|FG003|DLT Observation Period|Physician Decision|0|||
131605963|NCT04304144|473850651|FG000|Continued Treatment Period|Adverse Event|0|||
131605964|NCT04304144|473850652|FG001|Continued Treatment Period|Adverse Event|1|||
131605965|NCT04304144|473850653|FG002|Continued Treatment Period|Adverse Event|0|||
131605966|NCT04304144|473850654|FG003|Continued Treatment Period|Adverse Event|0|||
131605967|NCT04304144|473850651|FG000|Continued Treatment Period|Death|0|||
131605968|NCT04304144|473850652|FG001|Continued Treatment Period|Death|0|||
131605969|NCT04304144|473850653|FG002|Continued Treatment Period|Death|1|||
131605970|NCT04304144|473850654|FG003|Continued Treatment Period|Death|2|||
131605971|NCT04304144|473850651|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
131605972|NCT04304144|473850652|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
131605973|NCT04304144|473850653|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
131605974|NCT04304144|473850654|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
131605975|NCT04304144|473850651|FG000|Continued Treatment Period|Other than specified|2|||
131605976|NCT04304144|473850652|FG001|Continued Treatment Period|Other than specified|0|||
131605977|NCT04304144|473850653|FG002|Continued Treatment Period|Other than specified|1|||
131605978|NCT04304144|473850654|FG003|Continued Treatment Period|Other than specified|1|||
131605979|NCT05256654|473850655|FG000|Overall Study|Adverse Event|0|||
131605980|NCT05256654|473850656|FG001|Overall Study|Adverse Event|0|||
131605981|NCT05256654|473850657|FG002|Overall Study|Adverse Event|1|||
131605982|NCT05256654|473850658|FG003|Overall Study|Adverse Event|0|||
131605983|NCT05256654|473850655|FG000|Overall Study|Lost to Follow-up|0|||
131605984|NCT05256654|473850656|FG001|Overall Study|Lost to Follow-up|0|||
131605985|NCT05256654|473850657|FG002|Overall Study|Lost to Follow-up|0|||
131791757|NCT01698320|474520876|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
131791758|NCT01698320|474520877|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
131791759|NCT01698320|474520878|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
131791760|NCT01698320|474520876|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
131605986|NCT05256654|473850658|FG003|Overall Study|Lost to Follow-up|1|||
131605987|NCT05256654|473850655|FG000|Overall Study|Withdrawal by Subject|1|||
131605988|NCT05256654|473850656|FG001|Overall Study|Withdrawal by Subject|2|||
131605989|NCT05256654|473850657|FG002|Overall Study|Withdrawal by Subject|1|||
131605990|NCT05256654|473850658|FG003|Overall Study|Withdrawal by Subject|3|||
131605991|NCT05256654|473850655|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
131605992|NCT05256654|473850656|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
131605993|NCT05256654|473850657|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
131605994|NCT05256654|473850658|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
131605995|NCT05256654|473850655|FG000|Overall Study|Other|0|||
131605996|NCT05256654|473850656|FG001|Overall Study|Other|0|||
131605997|NCT05256654|473850657|FG002|Overall Study|Other|0|||
131605998|NCT05256654|473850658|FG003|Overall Study|Other|1|||
131605999|NCT05290493|473850663|FG000|Overall Study|Withdrawal by Subject|2|||
131606000|NCT05290493|473850664|FG001|Overall Study|Withdrawal by Subject|2|||
131606001|NCT05290493|473850663|FG000|Overall Study|Adverse Event|1|||
131606002|NCT05290493|473850664|FG001|Overall Study|Adverse Event|0|||
131606003|NCT04615273|473850668|FG000|Overall Study|Withdrawal by Subject|3|||
131606004|NCT04615273|473850669|FG001|Overall Study|Withdrawal by Subject|1|||
131606005|NCT04615273|473850670|FG002|Overall Study|Withdrawal by Subject|2|||
131606006|NCT04615273|473850668|FG000|Overall Study|Adverse Event|1|||
131606007|NCT04615273|473850669|FG001|Overall Study|Adverse Event|0|||
131606008|NCT04615273|473850670|FG002|Overall Study|Adverse Event|1|||
131606009|NCT04615273|473850668|FG000|Overall Study|Lost to Follow-up|0|||
131606010|NCT04615273|473850669|FG001|Overall Study|Lost to Follow-up|1|||
131606011|NCT04615273|473850670|FG002|Overall Study|Lost to Follow-up|0|||
131606012|NCT04615273|473850668|FG000|Overall Study|Physician Decision|0|||
131791761|NCT01698320|474520877|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
131791762|NCT01698320|474520878|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
131791763|NCT01698320|474520876|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
131791764|NCT01698320|474520877|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
131791765|NCT01698320|474520878|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
131606013|NCT04615273|473850669|FG001|Overall Study|Physician Decision|0|||
131606014|NCT04615273|473850670|FG002|Overall Study|Physician Decision|1|||
131606015|NCT04615273|473850668|FG000|Overall Study|Other|0|||
131606016|NCT04615273|473850669|FG001|Overall Study|Other|1|||
131606017|NCT04615273|473850670|FG002|Overall Study|Other|0|||
131606018|NCT04615273|473850668|FG000|Overall Study|Randomized but not treated|1|||
131606019|NCT04615273|473850669|FG001|Overall Study|Randomized but not treated|3|||
131606020|NCT04615273|473850670|FG002|Overall Study|Randomized but not treated|1|||
131606021|NCT03824366|473850674|FG000|Overall Study|Death|1|||
131606022|NCT03824366|473850674|FG000|Overall Study|Previously unidentified metal artifact|1|||
131606023|NCT03824366|473850674|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
131606024|NCT03824366|473850674|FG000|Overall Study|Withdrawal by Subject|1|||
131606025|NCT05069896|473850675|FG000|Overall Study|Adverse Event|0|||
131606026|NCT05069896|473850676|FG001|Overall Study|Adverse Event|1|||
131606027|NCT05069896|473850677|FG002|Overall Study|Adverse Event|1|||
131606028|NCT05069896|473850678|FG003|Overall Study|Adverse Event|0|||
131606029|NCT05069896|473850679|FG004|Overall Study|Adverse Event|0|||
131606030|NCT05069896|473850680|FG005|Overall Study|Adverse Event|0|||
131606031|NCT05069896|473850675|FG000|Overall Study|Lost to Follow-up|0|||
131606032|NCT05069896|473850676|FG001|Overall Study|Lost to Follow-up|0|||
131606033|NCT05069896|473850677|FG002|Overall Study|Lost to Follow-up|1|||
131606034|NCT05069896|473850678|FG003|Overall Study|Lost to Follow-up|0|||
131606035|NCT05069896|473850679|FG004|Overall Study|Lost to Follow-up|1|||
131606036|NCT05069896|473850680|FG005|Overall Study|Lost to Follow-up|2|||
131606037|NCT04068831|473850681|FG000|Overall Study|Disease Progression|10|||
131606038|NCT04068831|473850682|FG001|Overall Study|Disease Progression|8|||
131606039|NCT04820322|473850683|FG000|Overall Study|Adverse Event|1|||
131606040|NCT04820322|473850684|FG001|Overall Study|Adverse Event|0|||
131606041|NCT00323856|473850688|FG000|Overall Study|Withdrawal by Subject|1|||
131606042|NCT00323856|473850688|FG000|Overall Study|Was uncooperative and noncompliant|1|||
131606043|NCT00323856|473850688|FG000|Overall Study|Reason not specified|1|||
131606044|NCT00323856|473850688|FG000|Overall Study|Missing|2|||
131606045|NCT03156465|473850689|FG000|Overall Study|Withdrawal by Subject|2|||
131606046|NCT04086121|473850699|FG000|Overall Study|Other than listed|8|||
131606047|NCT04086121|473850699|FG000|Overall Study|Withdrawal by Subject|3|||
131606048|NCT04086121|473850699|FG000|Overall Study|Lost to Follow-up|2|||
131606049|NCT04086121|473850699|FG000|Overall Study|Adverse Event|1|||
131606050|NCT04580914|473850702|FG000|Overall Study|Withdrawal by Subject|6|||
131606051|NCT04580914|473850702|FG000|Overall Study|Lost to Follow-up|2|||
131606052|NCT03580356|473850703|FG000|Treatment Period|Withdrawal by Subject|13|||
131606053|NCT03580356|473850704|FG001|Treatment Period|Withdrawal by Subject|0|||
131606054|NCT03580356|473850705|FG002|Treatment Period|Withdrawal by Subject|13|||
131606055|NCT03580356|473850706|FG003|Treatment Period|Withdrawal by Subject|1|||
131606056|NCT03580356|473850707|FG004|Treatment Period|Withdrawal by Subject|17|||
131791766|NCT01698320|474520876|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
131791767|NCT01698320|474520877|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
131791768|NCT01698320|474520878|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
131791769|NCT01698320|474520876|FG000|12-Week Double-Blind Period|Adverse Event|0|||
131791770|NCT01698320|474520877|FG001|12-Week Double-Blind Period|Adverse Event|1|||
131791771|NCT01698320|474520878|FG002|12-Week Double-Blind Period|Adverse Event|1|||
131606057|NCT03580356|473850708|FG005|Treatment Period|Withdrawal by Subject|0|||
131606058|NCT03580356|473850709|FG006|Treatment Period|Withdrawal by Subject|5|||
131606059|NCT03580356|473850710|FG007|Treatment Period|Withdrawal by Subject|0|||
131606060|NCT03580356|473850703|FG000|Treatment Period|Adverse Event|10|||
131606061|NCT03580356|473850704|FG001|Treatment Period|Adverse Event|0|||
131606062|NCT03580356|473850705|FG002|Treatment Period|Adverse Event|13|||
131606063|NCT03580356|473850706|FG003|Treatment Period|Adverse Event|0|||
131606064|NCT03580356|473850707|FG004|Treatment Period|Adverse Event|5|||
131606065|NCT03580356|473850708|FG005|Treatment Period|Adverse Event|0|||
131606066|NCT03580356|473850709|FG006|Treatment Period|Adverse Event|8|||
131606067|NCT03580356|473850710|FG007|Treatment Period|Adverse Event|0|||
131606068|NCT03580356|473850703|FG000|Treatment Period|Protocol Violation|5|||
131606069|NCT03580356|473850704|FG001|Treatment Period|Protocol Violation|0|||
131606070|NCT03580356|473850705|FG002|Treatment Period|Protocol Violation|6|||
131606071|NCT03580356|473850706|FG003|Treatment Period|Protocol Violation|1|||
131606072|NCT03580356|473850707|FG004|Treatment Period|Protocol Violation|9|||
131606073|NCT03580356|473850708|FG005|Treatment Period|Protocol Violation|1|||
131606074|NCT03580356|473850709|FG006|Treatment Period|Protocol Violation|1|||
131606075|NCT03580356|473850710|FG007|Treatment Period|Protocol Violation|0|||
131606076|NCT03580356|473850703|FG000|Treatment Period|Lack of Efficacy|6|||
131606077|NCT03580356|473850704|FG001|Treatment Period|Lack of Efficacy|0|||
131606078|NCT03580356|473850705|FG002|Treatment Period|Lack of Efficacy|2|||
131606079|NCT03580356|473850706|FG003|Treatment Period|Lack of Efficacy|0|||
131606080|NCT03580356|473850707|FG004|Treatment Period|Lack of Efficacy|3|||
131606081|NCT03580356|473850708|FG005|Treatment Period|Lack of Efficacy|0|||
131606082|NCT03580356|473850709|FG006|Treatment Period|Lack of Efficacy|3|||
131606083|NCT03580356|473850710|FG007|Treatment Period|Lack of Efficacy|0|||
131606084|NCT03580356|473850703|FG000|Treatment Period|Pregnancy|1|||
131606085|NCT03580356|473850704|FG001|Treatment Period|Pregnancy|0|||
131606086|NCT03580356|473850705|FG002|Treatment Period|Pregnancy|7|||
131606087|NCT03580356|473850706|FG003|Treatment Period|Pregnancy|0|||
131606088|NCT03580356|473850707|FG004|Treatment Period|Pregnancy|2|||
131606089|NCT03580356|473850708|FG005|Treatment Period|Pregnancy|0|||
131606090|NCT03580356|473850709|FG006|Treatment Period|Pregnancy|1|||
131606091|NCT03580356|473850710|FG007|Treatment Period|Pregnancy|0|||
131606092|NCT03580356|473850703|FG000|Treatment Period|Physician Decision|2|||
131606093|NCT03580356|473850704|FG001|Treatment Period|Physician Decision|0|||
131606094|NCT03580356|473850705|FG002|Treatment Period|Physician Decision|1|||
131606095|NCT03580356|473850706|FG003|Treatment Period|Physician Decision|0|||
131606096|NCT03580356|473850707|FG004|Treatment Period|Physician Decision|4|||
131606097|NCT03580356|473850708|FG005|Treatment Period|Physician Decision|0|||
131606098|NCT03580356|473850709|FG006|Treatment Period|Physician Decision|2|||
131606099|NCT03580356|473850710|FG007|Treatment Period|Physician Decision|0|||
131606100|NCT03580356|473850703|FG000|Treatment Period|Lost to Follow-up|1|||
131606101|NCT03580356|473850704|FG001|Treatment Period|Lost to Follow-up|1|||
131606102|NCT03580356|473850705|FG002|Treatment Period|Lost to Follow-up|1|||
131606103|NCT03580356|473850706|FG003|Treatment Period|Lost to Follow-up|0|||
131606104|NCT03580356|473850707|FG004|Treatment Period|Lost to Follow-up|3|||
131606105|NCT03580356|473850708|FG005|Treatment Period|Lost to Follow-up|0|||
131606106|NCT03580356|473850709|FG006|Treatment Period|Lost to Follow-up|1|||
131606107|NCT03580356|473850710|FG007|Treatment Period|Lost to Follow-up|0|||
131606108|NCT03580356|473850703|FG000|Treatment Period|Death|0|||
131606109|NCT03580356|473850704|FG001|Treatment Period|Death|0|||
131606110|NCT03580356|473850705|FG002|Treatment Period|Death|1|||
131606111|NCT03580356|473850706|FG003|Treatment Period|Death|0|||
131606112|NCT03580356|473850707|FG004|Treatment Period|Death|0|||
131606113|NCT03580356|473850708|FG005|Treatment Period|Death|0|||
131606114|NCT03580356|473850709|FG006|Treatment Period|Death|0|||
131606115|NCT03580356|473850710|FG007|Treatment Period|Death|0|||
131606116|NCT03580356|473850703|FG000|Treatment Period|Technical problems|0|||
131606117|NCT03580356|473850704|FG001|Treatment Period|Technical problems|0|||
131606118|NCT03580356|473850705|FG002|Treatment Period|Technical problems|0|||
131606119|NCT03580356|473850706|FG003|Treatment Period|Technical problems|0|||
131606120|NCT03580356|473850707|FG004|Treatment Period|Technical problems|1|||
131606121|NCT03580356|473850708|FG005|Treatment Period|Technical problems|0|||
131606122|NCT03580356|473850709|FG006|Treatment Period|Technical problems|0|||
131606123|NCT03580356|473850710|FG007|Treatment Period|Technical problems|0|||
131606124|NCT03580356|473850703|FG000|Treatment Period|Misrandomized, no treatment|0|||
131606125|NCT03580356|473850704|FG001|Treatment Period|Misrandomized, no treatment|0|||
131606126|NCT03580356|473850705|FG002|Treatment Period|Misrandomized, no treatment|1|||
131606127|NCT03580356|473850706|FG003|Treatment Period|Misrandomized, no treatment|0|||
131791772|NCT01698320|474520876|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
131606128|NCT03580356|473850707|FG004|Treatment Period|Misrandomized, no treatment|2|||
131606129|NCT03580356|473850708|FG005|Treatment Period|Misrandomized, no treatment|0|||
131606130|NCT03580356|473850709|FG006|Treatment Period|Misrandomized, no treatment|0|||
131606131|NCT03580356|473850710|FG007|Treatment Period|Misrandomized, no treatment|0|||
131606132|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
131606133|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
131606134|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
131606135|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
131606136|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
131606137|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
131606138|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
131606139|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
131606140|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
131606141|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131606142|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
131606143|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131606144|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
131606145|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131606146|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131606147|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131606148|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
131606149|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
131606150|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
131606151|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
131606152|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
131606153|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
131606154|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
131606155|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
131606156|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131606157|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131606158|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
131606159|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131606160|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
131606161|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131606162|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131606163|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131606164|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
131606165|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
131606166|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
131606167|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
131606168|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
131606169|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
131606170|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
131606171|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
131606172|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
131606173|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
131606174|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
131606175|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
131606176|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
131791773|NCT01698320|474520877|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
131791774|NCT01698320|474520878|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
131791775|NCT01698320|474520876|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
131791776|NCT01698320|474520877|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
131791777|NCT01698320|474520878|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
131791778|NCT01698320|474520876|FG000|12-Week Double-Blind Period|Pregnancy|0|||
131791779|NCT01698320|474520877|FG001|12-Week Double-Blind Period|Pregnancy|1|||
131791780|NCT01698320|474520878|FG002|12-Week Double-Blind Period|Pregnancy|1|||
131791781|NCT01698320|474520876|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
131791782|NCT01698320|474520877|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
131791783|NCT01698320|474520878|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
131791784|NCT01698320|474520876|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
131791785|NCT01698320|474520877|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
131791786|NCT01698320|474520878|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
131791787|NCT01698320|474520876|FG000|40-Week Open-Label Period|Adverse Event|0|||
131791788|NCT01698320|474520877|FG001|40-Week Open-Label Period|Adverse Event|3|||
131791789|NCT01698320|474520878|FG002|40-Week Open-Label Period|Adverse Event|2|||
131606177|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
131606178|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
131606179|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
131606180|NCT03580356|473850703|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
131606181|NCT03580356|473850704|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
131606182|NCT03580356|473850705|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
131606183|NCT03580356|473850706|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
131606184|NCT03580356|473850707|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
131606185|NCT03580356|473850708|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
131606186|NCT03580356|473850709|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
131606187|NCT03580356|473850710|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
131606188|NCT05715528|473850712|FG000|Overall Study|Randomized but never treated|11|||
131606189|NCT05715528|473850713|FG001|Overall Study|Randomized but never treated|13|||
131606190|NCT05715528|473850712|FG000|Overall Study|Withdrew consent|7|||
131606191|NCT05715528|473850713|FG001|Overall Study|Withdrew consent|15|||
131606192|NCT05715528|473850712|FG000|Overall Study|Lost to Follow-up|5|||
131606193|NCT05715528|473850713|FG001|Overall Study|Lost to Follow-up|13|||
131606194|NCT05715528|473850712|FG000|Overall Study|Investigator's discretion|3|||
131606195|NCT05715528|473850713|FG001|Overall Study|Investigator's discretion|1|||
131606196|NCT05715528|473850712|FG000|Overall Study|Protocol Violation|2|||
131606197|NCT05715528|473850713|FG001|Overall Study|Protocol Violation|0|||
131606198|NCT05715528|473850712|FG000|Overall Study|Non-compliance with study drug|0|||
131606199|NCT05715528|473850713|FG001|Overall Study|Non-compliance with study drug|1|||
131606200|NCT02834390|473850714|FG000|Induction Phase|Progressive disease|0|||
131606201|NCT02834390|473850715|FG001|Induction Phase|Progressive disease|1|||
131606202|NCT02834390|473850714|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
131606203|NCT02834390|473850715|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
131606204|NCT02834390|473850714|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
131606205|NCT02834390|473850715|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
131606206|NCT02834390|473850714|FG000|Consolidation Phase|Physician Decision|1|||
131606207|NCT02834390|473850715|FG001|Consolidation Phase|Physician Decision|1|||
131606208|NCT03118518|473850716|FG000|Overall Study|Early Exit after treatment|2|||
131606209|NCT03118518|473850717|FG001|Overall Study|Early Exit after treatment|8|||
131606210|NCT03118518|473850716|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
131606211|NCT03118518|473850717|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
131606212|NCT02998528|473850723|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
131606213|NCT02998528|473850724|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
131606214|NCT02998528|473850725|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
131606215|NCT02998528|473850723|FG000|Randomization Period|Participant withdrew consent|0|||
131606216|NCT02998528|473850724|FG001|Randomization Period|Participant withdrew consent|3|||
131606217|NCT02998528|473850725|FG002|Randomization Period|Participant withdrew consent|0|||
131606218|NCT02998528|473850723|FG000|Randomization Period|Participant no longer meets study criteria|1|||
131606219|NCT02998528|473850724|FG001|Randomization Period|Participant no longer meets study criteria|3|||
131606220|NCT02998528|473850725|FG002|Randomization Period|Participant no longer meets study criteria|2|||
131606221|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
131606222|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
131606223|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
131606224|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
131606225|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
131606226|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
131606227|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
131606228|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
131606229|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
131606230|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
131606231|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
131606232|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
131606233|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
131606234|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
131707030|NCT01279057|474209275|FG000|Overall Study|Pregnancy|0|||
131707031|NCT01279057|474209276|FG001|Overall Study|Pregnancy|1|||
131707032|NCT01279057|474209277|FG002|Overall Study|Pregnancy|0|||
131707033|NCT01279057|474209275|FG000|Overall Study|Other|3|||
131707034|NCT01279057|474209276|FG001|Overall Study|Other|3|||
131606235|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
131606236|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Death|1|||
131606237|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Death|0|||
131606238|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Death|0|||
131606239|NCT02998528|473850723|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
131606240|NCT02998528|473850724|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
131606241|NCT02998528|473850725|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
131606242|NCT02998528|473850723|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
131606243|NCT02998528|473850724|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
131606244|NCT02998528|473850725|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
131606245|NCT02998528|473850723|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
131606246|NCT02998528|473850724|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
131606247|NCT02998528|473850725|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
131606248|NCT02998528|473850723|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
131606249|NCT02998528|473850724|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
131606250|NCT02998528|473850725|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
131606251|NCT02998528|473850723|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
131606252|NCT02998528|473850724|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
131606253|NCT02998528|473850725|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
131606254|NCT02998528|473850723|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
131606255|NCT02998528|473850724|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
131606256|NCT02998528|473850725|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
131606257|NCT05035654|473850727|FG000|Overall Study|Physician Decision|0|||
131606258|NCT05035654|473850728|FG001|Overall Study|Physician Decision|1|||
131606259|NCT05035654|473850729|FG002|Overall Study|Physician Decision|0|||
131606260|NCT05035654|473850727|FG000|Overall Study|Adverse Event|0|||
131606261|NCT05035654|473850728|FG001|Overall Study|Adverse Event|1|||
131606262|NCT05035654|473850729|FG002|Overall Study|Adverse Event|0|||
131606263|NCT05035654|473850727|FG000|Overall Study|Withdrawal by Subject|0|||
131606264|NCT05035654|473850728|FG001|Overall Study|Withdrawal by Subject|0|||
131606265|NCT05035654|473850729|FG002|Overall Study|Withdrawal by Subject|4|||
131606266|NCT05035654|473850727|FG000|Overall Study|Bilateral Dislodgement|1|||
131606267|NCT05035654|473850728|FG001|Overall Study|Bilateral Dislodgement|0|||
131606268|NCT05035654|473850729|FG002|Overall Study|Bilateral Dislodgement|0|||
131707035|NCT01279057|474209277|FG002|Overall Study|Other|0|||
131707036|NCT01427309|474209279|FG000|Overall Study|Lost to Follow-up|130|||
131707037|NCT01427309|474209280|FG001|Overall Study|Lost to Follow-up|145|||
131606272|NCT04934072|473850738|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
131606273|NCT04934072|473850739|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
131606274|NCT04934072|473850740|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
131606275|NCT04934072|473850741|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
131606276|NCT04934072|473850742|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
131606277|NCT04934072|473850738|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
131606278|NCT04934072|473850739|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
131606279|NCT04934072|473850740|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
131606280|NCT04934072|473850741|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
131606281|NCT04934072|473850742|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
131606282|NCT04934072|473850738|FG000|Day 0 to Week 52|Other|3|||
131606283|NCT04934072|473850739|FG001|Day 0 to Week 52|Other|1|||
131606284|NCT04934072|473850740|FG002|Day 0 to Week 52|Other|0|||
131606285|NCT04934072|473850741|FG003|Day 0 to Week 52|Other|0|||
131606286|NCT04934072|473850742|FG004|Day 0 to Week 52|Other|0|||
131606287|NCT04934072|473850738|FG000|Day 0 to Week 52|Adverse Event|1|||
131606288|NCT04934072|473850739|FG001|Day 0 to Week 52|Adverse Event|3|||
131606289|NCT04934072|473850740|FG002|Day 0 to Week 52|Adverse Event|0|||
131606290|NCT04934072|473850741|FG003|Day 0 to Week 52|Adverse Event|0|||
131606291|NCT04934072|473850742|FG004|Day 0 to Week 52|Adverse Event|0|||
131440685|NCT03361137|473241562|FG002|Overall Study|Reason not specified|0|||
131606292|NCT04934072|473850738|FG000|Week 52 to Week 78|Adverse Event|0|||
131606293|NCT04934072|473850739|FG001|Week 52 to Week 78|Adverse Event|0|||
131606294|NCT04934072|473850740|FG002|Week 52 to Week 78|Adverse Event|0|||
131606295|NCT04934072|473850741|FG003|Week 52 to Week 78|Adverse Event|1|||
131606296|NCT04934072|473850742|FG004|Week 52 to Week 78|Adverse Event|1|||
131606297|NCT04934072|473850738|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
131606298|NCT04934072|473850739|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
131707038|NCT01427309|474209281|FG002|Overall Study|Lost to Follow-up|122|||
131707039|NCT01427309|474209282|FG003|Overall Study|Lost to Follow-up|135|||
131707040|NCT01427309|474209279|FG000|Overall Study|Protocol Violation|42|||
131707041|NCT01427309|474209280|FG001|Overall Study|Protocol Violation|69|||
131707042|NCT01427309|474209281|FG002|Overall Study|Protocol Violation|125|||
131707043|NCT01427309|474209282|FG003|Overall Study|Protocol Violation|124|||
131707044|NCT01427309|474209279|FG000|Overall Study|Adverse Event|0|||
131707045|NCT01427309|474209280|FG001|Overall Study|Adverse Event|0|||
131606299|NCT04934072|473850740|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
131606300|NCT04934072|473850741|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
131606301|NCT04934072|473850742|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
131606302|NCT04934072|473850738|FG000|Week 52 to Week 78|Other|0|||
131606303|NCT04934072|473850739|FG001|Week 52 to Week 78|Other|0|||
131606304|NCT04934072|473850740|FG002|Week 52 to Week 78|Other|1|||
131606305|NCT04934072|473850741|FG003|Week 52 to Week 78|Other|0|||
131606306|NCT04934072|473850742|FG004|Week 52 to Week 78|Other|0|||
131606307|NCT03213678|473850745|FG000|Overall Study|Death|1|||
131606308|NCT03213678|473850745|FG000|Overall Study|Physician Decision|1|||
131606309|NCT03213678|473850745|FG000|Overall Study|Progressive disease|16|||
131606310|NCT03174275|473850748|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
131606311|NCT03174275|473850748|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
131606312|NCT03174275|473850748|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
131606313|NCT03174275|473850748|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
131606314|NCT03174275|473850748|FG000|Adjuvant Chemotherapy|Progression|1|||
131606315|NCT03174275|473850748|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
131606316|NCT03174275|473850748|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
131606317|NCT03174275|473850748|FG000|Adjuvant Durvalumab|Progression|1|||
131606318|NCT03174275|473850748|FG000|Adjuvant Durvalumab|Adverse Event|3|||
131606319|NCT03174275|473850748|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
131606320|NCT03174275|473850748|FG000|Adjuvant Radiotherapy|Progression|1|||
131606321|NCT03174275|473850748|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
131606322|NCT01820611|473850749|FG000|Overall Study|Death|8|||
131606323|NCT01820611|473850749|FG000|Overall Study|Adverse Event|1|||
131606324|NCT01820611|473850749|FG000|Overall Study|Withdrawal by Subject|9|||
131606325|NCT04456296|473850750|FG000|Overall Study|Withdrawal by Subject|14|||
131606326|NCT04456296|473850751|FG001|Overall Study|Withdrawal by Subject|21|||
131606327|NCT04456296|473850752|FG002|Overall Study|Withdrawal by Subject|21|||
131606328|NCT04456296|473850750|FG000|Overall Study|Adverse Event|2|||
131606329|NCT04456296|473850751|FG001|Overall Study|Adverse Event|2|||
131606330|NCT04456296|473850752|FG002|Overall Study|Adverse Event|2|||
131606331|NCT04456296|473850750|FG000|Overall Study|Death|1|||
131606332|NCT04456296|473850751|FG001|Overall Study|Death|0|||
131606333|NCT04456296|473850752|FG002|Overall Study|Death|0|||
131606334|NCT04456296|473850750|FG000|Overall Study|Lost to Follow-up|3|||
131606335|NCT04456296|473850751|FG001|Overall Study|Lost to Follow-up|5|||
131606336|NCT04456296|473850752|FG002|Overall Study|Lost to Follow-up|6|||
131606337|NCT04456296|473850750|FG000|Overall Study|Other than specified|0|||
131606338|NCT04456296|473850751|FG001|Overall Study|Other than specified|1|||
131606339|NCT04456296|473850752|FG002|Overall Study|Other than specified|4|||
131606340|NCT04456296|473850750|FG000|Overall Study|Randomized, not treated|2|||
131606341|NCT04456296|473850751|FG001|Overall Study|Randomized, not treated|1|||
131606342|NCT04456296|473850752|FG002|Overall Study|Randomized, not treated|0|||
131606343|NCT05736458|473850753|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
131606344|NCT05736458|473850754|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
131606345|NCT05736458|473850755|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
131606346|NCT05736458|473850753|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
131606347|NCT05736458|473850754|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
131606348|NCT05736458|473850755|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
131606349|NCT05736458|473850753|FG000|TMS/fMRI #1|Physician Decision|0|||
131606350|NCT05736458|473850754|FG001|TMS/fMRI #1|Physician Decision|0|||
131606351|NCT05736458|473850755|FG002|TMS/fMRI #1|Physician Decision|2|||
131606352|NCT05736458|473850753|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
131606353|NCT05736458|473850754|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
131606354|NCT05736458|473850755|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
131606355|NCT05013385|473850759|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
131606356|NCT04247802|473850760|FG000|Overall Study|Withdrawal by Subject|1|||
131606357|NCT04247802|473850761|FG001|Overall Study|Withdrawal by Subject|3|||
131606358|NCT04247802|473850760|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
131606359|NCT04247802|473850761|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
131606360|NCT03993392|473850768|FG000|Overall Study|Withdrawal by Subject|3|||
131606361|NCT03993392|473850768|FG000|Overall Study|Lost to Follow-up|2|||
131606362|NCT03993392|473850768|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
131606363|NCT02518048|473850771|FG000|Overall Study|Withdrawal by Subject|1|||
131606364|NCT05962814|473850772|FG000|Overall Study|failed eligibility|1|||
131606365|NCT02865538|473850774|FG000|Overall Study|Withdrawal by Subject|0|||
131606366|NCT02865538|473850775|FG001|Overall Study|Withdrawal by Subject|0|||
131606367|NCT02865538|473850776|FG002|Overall Study|Withdrawal by Subject|1|||
131606368|NCT02865538|473850777|FG003|Overall Study|Withdrawal by Subject|0|||
131606369|NCT02865538|473850778|FG004|Overall Study|Withdrawal by Subject|0|||
131606370|NCT02865538|473850774|FG000|Overall Study|Lost to Follow-up|1|||
131606371|NCT02865538|473850775|FG001|Overall Study|Lost to Follow-up|0|||
131606372|NCT02865538|473850776|FG002|Overall Study|Lost to Follow-up|0|||
131606373|NCT02865538|473850777|FG003|Overall Study|Lost to Follow-up|0|||
131606374|NCT02865538|473850778|FG004|Overall Study|Lost to Follow-up|0|||
131606375|NCT03677141|473852093|FG000|Overall Study|Death|2|||
131606376|NCT03677141|473852094|FG001|Overall Study|Death|1|||
131606377|NCT03677141|473852095|FG002|Overall Study|Death|6|||
131606378|NCT03677141|473852096|FG003|Overall Study|Death|9|||
131606379|NCT03677141|473852097|FG004|Overall Study|Death|5|||
131606380|NCT03677141|473852098|FG005|Overall Study|Death|3|||
131606381|NCT03677141|473852093|FG000|Overall Study|Lost to Follow-up|0|||
131606382|NCT03677141|473852094|FG001|Overall Study|Lost to Follow-up|0|||
131606383|NCT03677141|473852095|FG002|Overall Study|Lost to Follow-up|0|||
131606384|NCT03677141|473852096|FG003|Overall Study|Lost to Follow-up|2|||
131606385|NCT03677141|473852097|FG004|Overall Study|Lost to Follow-up|0|||
131606386|NCT03677141|473852098|FG005|Overall Study|Lost to Follow-up|0|||
131606387|NCT03677141|473852093|FG000|Overall Study|Screen failure or enrolled in error|0|||
131606388|NCT03677141|473852094|FG001|Overall Study|Screen failure or enrolled in error|0|||
131606389|NCT03677141|473852095|FG002|Overall Study|Screen failure or enrolled in error|0|||
131606390|NCT03677141|473852096|FG003|Overall Study|Screen failure or enrolled in error|0|||
131606391|NCT03677141|473852097|FG004|Overall Study|Screen failure or enrolled in error|2|||
131606392|NCT03677141|473852098|FG005|Overall Study|Screen failure or enrolled in error|0|||
131606393|NCT03677141|473852093|FG000|Overall Study|Physician Decision|0|||
131606394|NCT03677141|473852094|FG001|Overall Study|Physician Decision|0|||
131606395|NCT03677141|473852095|FG002|Overall Study|Physician Decision|0|||
131606396|NCT03677141|473852096|FG003|Overall Study|Physician Decision|0|||
131606397|NCT03677141|473852097|FG004|Overall Study|Physician Decision|1|||
131606398|NCT03677141|473852098|FG005|Overall Study|Physician Decision|0|||
131606399|NCT03677141|473852093|FG000|Overall Study|Withdrawal by Subject|0|||
131606400|NCT03677141|473852094|FG001|Overall Study|Withdrawal by Subject|0|||
131606401|NCT03677141|473852095|FG002|Overall Study|Withdrawal by Subject|1|||
131606402|NCT03677141|473852096|FG003|Overall Study|Withdrawal by Subject|1|||
131606403|NCT03677141|473852097|FG004|Overall Study|Withdrawal by Subject|1|||
131606404|NCT03677141|473852098|FG005|Overall Study|Withdrawal by Subject|0|||
131606405|NCT03673501|473852106|FG000|Overall Study|Participants ongoing.|36|||
131606406|NCT03673501|473852107|FG001|Overall Study|Participants ongoing.|24|||
131606407|NCT05838027|473852108|FG000|Overall Study|Lost to Follow-up|5|||
131606408|NCT05838027|473852109|FG001|Overall Study|Lost to Follow-up|1|||
131606409|NCT05838027|473852108|FG000|Overall Study|Withdrawal by Subject|1|||
131606410|NCT05838027|473852109|FG001|Overall Study|Withdrawal by Subject|0|||
131606411|NCT04599634|473852110|FG000|Overall Study|Dose limiting toxicity|0|||
131606412|NCT04599634|473852111|FG001|Overall Study|Dose limiting toxicity|0|||
131606413|NCT04599634|473852112|FG002|Overall Study|Dose limiting toxicity|2|||
131606414|NCT04599634|473852113|FG003|Overall Study|Dose limiting toxicity|0|||
131606415|NCT02962076|473852116|FG000|Overall Study|MHED tracer not available|5|||
131606416|NCT02962076|473852116|FG000|Overall Study|Protocol Violation|1|||
131606417|NCT02962076|473852116|FG000|Overall Study|Physician Decision|1|||
131606418|NCT03536884|473852117|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
131606419|NCT03536884|473852118|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
131606420|NCT03536884|473852119|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606421|NCT03536884|473852120|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606422|NCT03536884|473852121|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606423|NCT03536884|473852122|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606424|NCT03536884|473852123|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606425|NCT03536884|473852124|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131899715|NCT02659943|474919378|FG005|Overall Study|No longer meets eligibility|0|||
131606426|NCT03536884|473852125|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606427|NCT03536884|473852126|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606428|NCT03536884|473852127|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606429|NCT03536884|473852128|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131606430|NCT03536884|473852117|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606431|NCT03536884|473852118|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
131606432|NCT03536884|473852119|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606433|NCT03536884|473852120|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606434|NCT03536884|473852121|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606435|NCT03536884|473852122|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606436|NCT03536884|473852123|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606437|NCT03536884|473852124|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606438|NCT03536884|473852125|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606439|NCT03536884|473852126|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606440|NCT03536884|473852127|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606441|NCT03536884|473852128|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131606442|NCT03536884|473852117|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
131606443|NCT03536884|473852118|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
131606444|NCT03536884|473852119|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606445|NCT03536884|473852120|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606446|NCT03536884|473852121|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606447|NCT03536884|473852122|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606448|NCT03536884|473852123|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606449|NCT03536884|473852124|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606450|NCT03536884|473852125|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606451|NCT03536884|473852126|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606452|NCT03536884|473852127|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606453|NCT03536884|473852128|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131606454|NCT03536884|473852117|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606455|NCT03536884|473852118|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
131606456|NCT03536884|473852119|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606457|NCT03536884|473852120|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606458|NCT03536884|473852121|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606459|NCT03536884|473852122|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606460|NCT03536884|473852123|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606461|NCT03536884|473852124|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606462|NCT03536884|473852125|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606463|NCT03536884|473852126|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606464|NCT03536884|473852127|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606465|NCT03536884|473852128|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131606466|NCT03536884|473852117|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606467|NCT03536884|473852118|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
131606468|NCT03536884|473852119|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606469|NCT03536884|473852120|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606470|NCT03536884|473852121|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606471|NCT03536884|473852122|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606472|NCT03536884|473852123|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606473|NCT03536884|473852124|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606474|NCT03536884|473852125|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606475|NCT03536884|473852126|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606476|NCT03536884|473852127|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606477|NCT03536884|473852128|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131606478|NCT03536884|473852117|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606479|NCT03536884|473852118|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
131606480|NCT03536884|473852119|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606481|NCT03536884|473852120|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606482|NCT03536884|473852121|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606483|NCT03536884|473852122|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606484|NCT03536884|473852123|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606485|NCT03536884|473852124|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606486|NCT03536884|473852125|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606487|NCT03536884|473852126|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606488|NCT03536884|473852127|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606489|NCT03536884|473852128|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131606490|NCT03536884|473852117|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606491|NCT03536884|473852118|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606492|NCT03536884|473852119|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
131606493|NCT03536884|473852120|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606494|NCT03536884|473852121|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
131606495|NCT03536884|473852122|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606496|NCT03536884|473852123|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606497|NCT03536884|473852124|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606498|NCT03536884|473852125|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
131707046|NCT01427309|474209281|FG002|Overall Study|Adverse Event|3|||
131606499|NCT03536884|473852126|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606500|NCT03536884|473852127|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606501|NCT03536884|473852128|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
131606502|NCT03536884|473852117|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606503|NCT03536884|473852118|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606504|NCT03536884|473852119|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
131606505|NCT03536884|473852120|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
131606506|NCT03536884|473852121|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
131606507|NCT03536884|473852122|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606508|NCT03536884|473852123|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606509|NCT03536884|473852124|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606510|NCT03536884|473852125|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606511|NCT03536884|473852126|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606512|NCT03536884|473852127|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606513|NCT03536884|473852128|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131606514|NCT03536884|473852117|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131707047|NCT01427309|474209282|FG003|Overall Study|Adverse Event|1|||
131707048|NCT01427309|474209279|FG000|Overall Study|Serious adverse event|52|||
131707049|NCT01427309|474209280|FG001|Overall Study|Serious adverse event|45|||
131707050|NCT01427309|474209281|FG002|Overall Study|Serious adverse event|50|||
131707051|NCT01427309|474209282|FG003|Overall Study|Serious adverse event|61|||
131707052|NCT01427309|474209279|FG000|Overall Study|Withdrawal by Subject|148|||
131707053|NCT01427309|474209280|FG001|Overall Study|Withdrawal by Subject|148|||
131707054|NCT01427309|474209281|FG002|Overall Study|Withdrawal by Subject|61|||
131707055|NCT01427309|474209282|FG003|Overall Study|Withdrawal by Subject|55|||
131707056|NCT00214461|474209285|FG000|Overall Study|Adverse Event|0|||
131707057|NCT00214461|474209286|FG001|Overall Study|Adverse Event|0|||
131707058|NCT00214461|474209287|FG002|Overall Study|Adverse Event|1|||
131707059|NCT00214461|474209288|FG003|Overall Study|Adverse Event|1|||
131707060|NCT00214461|474209285|FG000|Overall Study|Withdrawal by Subject|0|||
131707061|NCT00214461|474209286|FG001|Overall Study|Withdrawal by Subject|0|||
131707062|NCT00214461|474209287|FG002|Overall Study|Withdrawal by Subject|1|||
131707063|NCT00214461|474209288|FG003|Overall Study|Withdrawal by Subject|0|||
131707064|NCT03502187|474209289|FG000|Overall Study|Withdrawal by Subject|4|||
131707065|NCT03502187|474209290|FG001|Overall Study|Withdrawal by Subject|3|||
131707066|NCT03502187|474209291|FG002|Overall Study|Withdrawal by Subject|3|||
131707067|NCT03502187|474209289|FG000|Overall Study|Lost to Follow-up|5|||
131707068|NCT03502187|474209290|FG001|Overall Study|Lost to Follow-up|4|||
131707069|NCT03502187|474209291|FG002|Overall Study|Lost to Follow-up|5|||
131707070|NCT01061008|474209292|FG000|Overall Study|Badiocephalic fistula failed|3|||
131707071|NCT01061008|474209293|FG001|Overall Study|Badiocephalic fistula failed|2|||
131707072|NCT01061008|474209292|FG000|Overall Study|Death|1|||
131707073|NCT01061008|474209293|FG001|Overall Study|Death|0|||
131707074|NCT01061008|474209292|FG000|Overall Study|Withdrawal by Subject|1|||
131707075|NCT01061008|474209293|FG001|Overall Study|Withdrawal by Subject|3|||
131707076|NCT01061008|474209292|FG000|Overall Study|Unable to exercise following surgery|1|||
131707077|NCT01061008|474209293|FG001|Overall Study|Unable to exercise following surgery|0|||
131707078|NCT01061008|474209292|FG000|Overall Study|Adverse Event|0|||
131707079|NCT01061008|474209293|FG001|Overall Study|Adverse Event|1|||
131707080|NCT02908100|474209295|FG000|Overall Study|Adverse Event|7|||
131707081|NCT02908100|474209296|FG001|Overall Study|Adverse Event|6|||
131707082|NCT02908100|474209297|FG002|Overall Study|Adverse Event|9|||
131707083|NCT02908100|474209295|FG000|Overall Study|Death|2|||
131707084|NCT02908100|474209296|FG001|Overall Study|Death|0|||
131707085|NCT02908100|474209297|FG002|Overall Study|Death|0|||
131707086|NCT02908100|474209295|FG000|Overall Study|Lack of Efficacy|2|||
131707087|NCT02908100|474209296|FG001|Overall Study|Lack of Efficacy|3|||
131707088|NCT02908100|474209297|FG002|Overall Study|Lack of Efficacy|3|||
131707089|NCT02908100|474209295|FG000|Overall Study|Lost to Follow-up|0|||
131707090|NCT02908100|474209296|FG001|Overall Study|Lost to Follow-up|1|||
131707091|NCT02908100|474209297|FG002|Overall Study|Lost to Follow-up|2|||
131707092|NCT02908100|474209295|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131707093|NCT02908100|474209296|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131707094|NCT02908100|474209297|FG002|Overall Study|Non-Compliance With Study Drug|2|||
131707095|NCT02908100|474209295|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
131707096|NCT02908100|474209296|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
131707097|NCT02908100|474209297|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
131707098|NCT02908100|474209295|FG000|Overall Study|Physician Decision|0|||
131707099|NCT02908100|474209296|FG001|Overall Study|Physician Decision|1|||
131707100|NCT02908100|474209297|FG002|Overall Study|Physician Decision|0|||
131707101|NCT02908100|474209295|FG000|Overall Study|Pregnancy|1|||
131707102|NCT02908100|474209296|FG001|Overall Study|Pregnancy|2|||
131606515|NCT03536884|473852118|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606516|NCT03536884|473852119|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606517|NCT03536884|473852120|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
131606518|NCT03536884|473852121|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
131606519|NCT03536884|473852122|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606520|NCT03536884|473852123|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606521|NCT03536884|473852124|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606522|NCT03536884|473852125|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606523|NCT03536884|473852126|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606524|NCT03536884|473852127|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606525|NCT03536884|473852128|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131606526|NCT03536884|473852117|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606527|NCT03536884|473852118|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606528|NCT03536884|473852119|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
131606529|NCT03536884|473852120|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
131606530|NCT03536884|473852121|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
131606531|NCT03536884|473852122|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606532|NCT03536884|473852123|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606533|NCT03536884|473852124|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606534|NCT03536884|473852125|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606535|NCT03536884|473852126|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606536|NCT03536884|473852127|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606537|NCT03536884|473852128|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131606538|NCT03536884|473852117|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606539|NCT03536884|473852118|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606540|NCT03536884|473852119|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
131707103|NCT02908100|474209297|FG002|Overall Study|Pregnancy|0|||
131707104|NCT02908100|474209295|FG000|Overall Study|Withdrawal by Subject|8|||
131707105|NCT02908100|474209296|FG001|Overall Study|Withdrawal by Subject|7|||
131707106|NCT02908100|474209297|FG002|Overall Study|Withdrawal by Subject|5|||
131707107|NCT02908100|474209295|FG000|Overall Study|Randomised in Error|1|||
131707108|NCT02908100|474209296|FG001|Overall Study|Randomised in Error|0|||
131707109|NCT02908100|474209297|FG002|Overall Study|Randomised in Error|0|||
131707110|NCT02024971|474209298|FG000|Overall Study|Data Not Available|30|||
131707111|NCT02024971|474209298|FG000|Overall Study|Lost to Follow-up|6|||
131707112|NCT00400400|474209299|FG000|Overall Study|Adverse Event|9|||
131707113|NCT00400400|474209300|FG001|Overall Study|Adverse Event|8|||
131707114|NCT00400400|474209299|FG000|Overall Study|Protocol Violation|2|||
131707115|NCT00400400|474209300|FG001|Overall Study|Protocol Violation|0|||
131707116|NCT00400400|474209299|FG000|Overall Study|Withdrawal by Subject|1|||
131707117|NCT00400400|474209300|FG001|Overall Study|Withdrawal by Subject|3|||
131707118|NCT00400400|474209299|FG000|Overall Study|Administrative Problem|1|||
131707119|NCT00400400|474209300|FG001|Overall Study|Administrative Problem|0|||
131707120|NCT00400400|474209299|FG000|Overall Study|Lost to Follow-up|0|||
131707121|NCT00400400|474209300|FG001|Overall Study|Lost to Follow-up|1|||
131707122|NCT00400400|474209299|FG000|Overall Study|Did not receive study drug|1|||
131707123|NCT00400400|474209300|FG001|Overall Study|Did not receive study drug|3|||
131707124|NCT01688050|474209301|FG000|Overall Study|Death|7|||
131707125|NCT01688050|474209301|FG000|Overall Study|Conversion to open repair|1|||
131707126|NCT01688050|474209301|FG000|Overall Study|Lost to Follow-up|13|||
131707127|NCT01688050|474209301|FG000|Overall Study|Withdrawal by Subject|10|||
131707128|NCT05655377|474209302|FG000|Overall Study|Withdrawal by Subject|2|||
131707129|NCT01869348|474209316|FG000|Overall Study|Withdrawal by Subject|1|||
131707130|NCT01869348|474209317|FG001|Overall Study|Withdrawal by Subject|1|||
131707131|NCT00110994|474209318|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
131707132|NCT00110994|474209319|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
131707133|NCT00110994|474209318|FG000|Double-blind (DB) Treatment|Death|1|||
131707134|NCT00110994|474209319|FG001|Double-blind (DB) Treatment|Death|0|||
131707135|NCT00110994|474209318|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
131707136|NCT00110994|474209319|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
131707137|NCT00110994|474209318|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
131707138|NCT00110994|474209319|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
131707139|NCT00110994|474209318|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
131707140|NCT00110994|474209319|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
131707141|NCT00110994|474209318|FG000|Double-blind (DB) Treatment|other reasons|2|||
131606541|NCT03536884|473852120|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
131707142|NCT00110994|474209319|FG001|Double-blind (DB) Treatment|other reasons|3|||
131707143|NCT00110994|474209318|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
131707144|NCT00110994|474209319|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
131707145|NCT00110994|474209318|FG000|Active Follow-up|Other reasons|0|||
131707146|NCT00110994|474209319|FG001|Active Follow-up|Other reasons|2|||
131606542|NCT03536884|473852121|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
131606543|NCT03536884|473852122|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606544|NCT03536884|473852123|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606545|NCT03536884|473852124|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606546|NCT03536884|473852125|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606547|NCT03536884|473852126|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606548|NCT03536884|473852127|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606549|NCT03536884|473852128|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131606550|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606551|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
131707147|NCT00110994|474209318|FG000|Long Term Follow-up|Death|19|||
131707148|NCT00110994|474209319|FG001|Long Term Follow-up|Death|17|||
131707149|NCT01299727|474209320|FG000|Overall Study|Withdrawal by Subject|1|||
131707150|NCT01299727|474209321|FG001|Overall Study|Withdrawal by Subject|0|||
131707151|NCT01299727|474209322|FG002|Overall Study|Withdrawal by Subject|0|||
131707152|NCT01299727|474209320|FG000|Overall Study|Adverse Event|0|||
131707153|NCT01299727|474209321|FG001|Overall Study|Adverse Event|0|||
131707154|NCT01299727|474209322|FG002|Overall Study|Adverse Event|1|||
131707155|NCT01299727|474209320|FG000|Overall Study|Completed the Treatment Period|3|||
131707156|NCT01299727|474209321|FG001|Overall Study|Completed the Treatment Period|4|||
131707157|NCT01299727|474209322|FG002|Overall Study|Completed the Treatment Period|3|||
131707158|NCT00944034|474209326|FG000|Overall Study|Inappropriate enrollment|0|||
131707159|NCT00944034|474209327|FG001|Overall Study|Inappropriate enrollment|1|||
131707160|NCT00944034|474209328|FG002|Overall Study|Inappropriate enrollment|0|||
131707161|NCT00944034|474209329|FG003|Overall Study|Inappropriate enrollment|1|||
131707162|NCT00944034|474209330|FG004|Overall Study|Inappropriate enrollment|2|||
131707163|NCT00944034|474209331|FG005|Overall Study|Inappropriate enrollment|1|||
131707164|NCT00944034|474209332|FG006|Overall Study|Inappropriate enrollment|0|||
131707165|NCT00944034|474209333|FG007|Overall Study|Inappropriate enrollment|0|||
131707166|NCT00944034|474209334|FG008|Overall Study|Inappropriate enrollment|1|||
131707167|NCT00944034|474209335|FG009|Overall Study|Inappropriate enrollment|1|||
131707168|NCT00944034|474209336|FG010|Overall Study|Inappropriate enrollment|0|||
131707169|NCT00944034|474209337|FG011|Overall Study|Inappropriate enrollment|0|||
131707170|NCT00944034|474209326|FG000|Overall Study|Withdrawal by Subject|3|||
131707171|NCT00944034|474209327|FG001|Overall Study|Withdrawal by Subject|2|||
131707172|NCT00944034|474209328|FG002|Overall Study|Withdrawal by Subject|6|||
131707173|NCT00944034|474209329|FG003|Overall Study|Withdrawal by Subject|2|||
131707174|NCT00944034|474209330|FG004|Overall Study|Withdrawal by Subject|5|||
131707175|NCT00944034|474209331|FG005|Overall Study|Withdrawal by Subject|8|||
131707176|NCT00944034|474209332|FG006|Overall Study|Withdrawal by Subject|2|||
131707177|NCT00944034|474209333|FG007|Overall Study|Withdrawal by Subject|2|||
131707178|NCT00944034|474209334|FG008|Overall Study|Withdrawal by Subject|3|||
131707179|NCT00944034|474209335|FG009|Overall Study|Withdrawal by Subject|4|||
131707180|NCT00944034|474209336|FG010|Overall Study|Withdrawal by Subject|0|||
131707181|NCT00944034|474209337|FG011|Overall Study|Withdrawal by Subject|4|||
131707182|NCT00944034|474209326|FG000|Overall Study|Lost to Follow-up|0|||
131707183|NCT00944034|474209327|FG001|Overall Study|Lost to Follow-up|4|||
131707184|NCT00944034|474209328|FG002|Overall Study|Lost to Follow-up|2|||
131707185|NCT00944034|474209329|FG003|Overall Study|Lost to Follow-up|0|||
131707186|NCT00944034|474209330|FG004|Overall Study|Lost to Follow-up|5|||
131707187|NCT00944034|474209331|FG005|Overall Study|Lost to Follow-up|7|||
131707188|NCT00944034|474209332|FG006|Overall Study|Lost to Follow-up|0|||
131707189|NCT00944034|474209333|FG007|Overall Study|Lost to Follow-up|1|||
131707190|NCT00944034|474209334|FG008|Overall Study|Lost to Follow-up|5|||
131707191|NCT00944034|474209335|FG009|Overall Study|Lost to Follow-up|1|||
131707192|NCT00944034|474209336|FG010|Overall Study|Lost to Follow-up|1|||
131707193|NCT00944034|474209337|FG011|Overall Study|Lost to Follow-up|0|||
131707194|NCT00944034|474209326|FG000|Overall Study|Death|0|||
131707195|NCT00944034|474209327|FG001|Overall Study|Death|0|||
131707196|NCT00944034|474209328|FG002|Overall Study|Death|1|||
131707197|NCT00944034|474209329|FG003|Overall Study|Death|0|||
131707198|NCT00944034|474209330|FG004|Overall Study|Death|0|||
131707199|NCT00944034|474209331|FG005|Overall Study|Death|0|||
131707200|NCT00944034|474209332|FG006|Overall Study|Death|0|||
131707201|NCT00944034|474209333|FG007|Overall Study|Death|0|||
131707202|NCT00944034|474209334|FG008|Overall Study|Death|0|||
131707203|NCT00944034|474209335|FG009|Overall Study|Death|0|||
131707204|NCT00944034|474209336|FG010|Overall Study|Death|0|||
131707205|NCT00944034|474209337|FG011|Overall Study|Death|0|||
131707206|NCT00944034|474209326|FG000|Overall Study|Protocol Violation|2|||
131707207|NCT00944034|474209327|FG001|Overall Study|Protocol Violation|0|||
131791790|NCT01698320|474520876|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
131791791|NCT01698320|474520877|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
131791792|NCT01698320|474520878|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
131791793|NCT01698320|474520876|FG000|40-Week Open-Label Period|Pregnancy|0|||
131791794|NCT01698320|474520877|FG001|40-Week Open-Label Period|Pregnancy|2|||
131791795|NCT01698320|474520878|FG002|40-Week Open-Label Period|Pregnancy|1|||
131791796|NCT01698320|474520876|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
131791797|NCT01698320|474520877|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
131606552|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606553|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606554|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606555|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
131606556|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
131606557|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
131606558|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
131606559|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606560|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606561|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
131606562|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606563|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606564|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606565|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606566|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606567|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
131606568|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
131606569|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
131606570|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
131606571|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606572|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606573|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131606574|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606575|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606576|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606577|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606578|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606579|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
131606580|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606581|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
131606582|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606583|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606584|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131606585|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131791798|NCT01698320|474520878|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
131606586|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606587|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606588|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606589|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606590|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606591|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
131606592|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606593|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
131606594|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
131606595|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606596|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606597|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131606598|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606599|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606600|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606601|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606602|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606603|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
131606604|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
131606605|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
131606606|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
131606607|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606608|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606609|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131606610|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606611|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606612|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131707208|NCT00944034|474209328|FG002|Overall Study|Protocol Violation|0|||
131707209|NCT00944034|474209329|FG003|Overall Study|Protocol Violation|1|||
131707210|NCT00944034|474209330|FG004|Overall Study|Protocol Violation|2|||
131707211|NCT00944034|474209331|FG005|Overall Study|Protocol Violation|3|||
131707212|NCT00944034|474209332|FG006|Overall Study|Protocol Violation|0|||
131707213|NCT00944034|474209333|FG007|Overall Study|Protocol Violation|1|||
131707214|NCT00944034|474209334|FG008|Overall Study|Protocol Violation|1|||
131707215|NCT00944034|474209335|FG009|Overall Study|Protocol Violation|4|||
131707216|NCT00944034|474209336|FG010|Overall Study|Protocol Violation|0|||
131707217|NCT00944034|474209337|FG011|Overall Study|Protocol Violation|0|||
131707218|NCT00944034|474209326|FG000|Overall Study|Unable to classify|0|||
131606613|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606614|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606615|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
131606616|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606617|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606618|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606619|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606620|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606621|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131606622|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606623|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606624|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606625|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606626|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606627|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606628|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
131606629|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606630|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606631|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606632|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606633|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131606634|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606635|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606636|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606637|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606638|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606639|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606640|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
131606641|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606642|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606643|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606644|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131606645|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131791799|NCT01698320|474520876|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
131791800|NCT01698320|474520877|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
131791801|NCT01698320|474520878|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
131791802|NCT01952574|474520879|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
131791803|NCT01952574|474520880|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
131791804|NCT01952574|474520881|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
131791805|NCT01952574|474520882|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
131791806|NCT01952574|474520883|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131791807|NCT01952574|474520884|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131791808|NCT01952574|474520885|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131791809|NCT01952574|474520879|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
131791810|NCT01952574|474520880|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
131791811|NCT01952574|474520881|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
131791812|NCT01952574|474520882|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
131791813|NCT01952574|474520883|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
131791814|NCT01952574|474520884|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
131791815|NCT01952574|474520885|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
131791816|NCT01952574|474520879|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
131791817|NCT01952574|474520880|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
131791818|NCT01952574|474520881|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
131791819|NCT01952574|474520882|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
131791820|NCT01952574|474520883|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
131791821|NCT01952574|474520884|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
131791822|NCT01952574|474520885|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
131791823|NCT01952574|474520879|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
131791824|NCT01952574|474520880|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
131791825|NCT01952574|474520881|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
131606646|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606647|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606648|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606649|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606650|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606651|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
131606652|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606653|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606654|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606655|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606656|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606657|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
131606658|NCT03536884|473852117|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606659|NCT03536884|473852118|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606660|NCT03536884|473852119|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606661|NCT03536884|473852120|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606662|NCT03536884|473852121|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606663|NCT03536884|473852122|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606664|NCT03536884|473852123|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606665|NCT03536884|473852124|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606666|NCT03536884|473852125|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
131606667|NCT03536884|473852126|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606668|NCT03536884|473852127|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606669|NCT03536884|473852128|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131606670|NCT03536884|473852117|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606671|NCT03536884|473852118|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606672|NCT03536884|473852119|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606673|NCT03536884|473852120|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606674|NCT03536884|473852121|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606675|NCT03536884|473852122|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606676|NCT03536884|473852123|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606677|NCT03536884|473852124|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606678|NCT03536884|473852125|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131606679|NCT03536884|473852126|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
131606680|NCT03536884|473852127|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
131606681|NCT03536884|473852128|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
131606682|NCT03536884|473852117|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606683|NCT03536884|473852118|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606684|NCT03536884|473852119|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606685|NCT03536884|473852120|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131707219|NCT00944034|474209327|FG001|Overall Study|Unable to classify|0|||
131707220|NCT00944034|474209328|FG002|Overall Study|Unable to classify|0|||
131707221|NCT00944034|474209329|FG003|Overall Study|Unable to classify|0|||
131707222|NCT00944034|474209330|FG004|Overall Study|Unable to classify|0|||
131707223|NCT00944034|474209331|FG005|Overall Study|Unable to classify|1|||
131707224|NCT00944034|474209332|FG006|Overall Study|Unable to classify|1|||
131707225|NCT00944034|474209333|FG007|Overall Study|Unable to classify|1|||
131707226|NCT00944034|474209334|FG008|Overall Study|Unable to classify|0|||
131707227|NCT00944034|474209335|FG009|Overall Study|Unable to classify|0|||
131707228|NCT00944034|474209336|FG010|Overall Study|Unable to classify|0|||
131707229|NCT00944034|474209337|FG011|Overall Study|Unable to classify|0|||
131707230|NCT00944034|474209326|FG000|Overall Study|Administrative reason|0|||
131707231|NCT00944034|474209327|FG001|Overall Study|Administrative reason|0|||
131707232|NCT00944034|474209328|FG002|Overall Study|Administrative reason|0|||
131707233|NCT00944034|474209329|FG003|Overall Study|Administrative reason|0|||
131707234|NCT00944034|474209330|FG004|Overall Study|Administrative reason|0|||
131707235|NCT00944034|474209331|FG005|Overall Study|Administrative reason|0|||
131707236|NCT00944034|474209332|FG006|Overall Study|Administrative reason|1|||
131707237|NCT00944034|474209333|FG007|Overall Study|Administrative reason|0|||
131707238|NCT00944034|474209334|FG008|Overall Study|Administrative reason|0|||
131707239|NCT00944034|474209335|FG009|Overall Study|Administrative reason|0|||
131707240|NCT00944034|474209336|FG010|Overall Study|Administrative reason|0|||
131707241|NCT00944034|474209337|FG011|Overall Study|Administrative reason|0|||
131707242|NCT01500057|474209338|FG000|Overall Study|Lost to Follow-up|6|||
131707243|NCT01500057|474209339|FG001|Overall Study|Lost to Follow-up|4|||
131707244|NCT00330187|474209344|FG000|Overall Study|Lost to Follow-up|12|||
131707245|NCT00330187|474209345|FG001|Overall Study|Lost to Follow-up|13|||
131707246|NCT00330187|474209346|FG002|Overall Study|Lost to Follow-up|14|||
131707247|NCT00330187|474209347|FG003|Overall Study|Lost to Follow-up|10|||
131707248|NCT00330187|474209344|FG000|Overall Study|Withdrawal by Subject|8|||
131707249|NCT00330187|474209345|FG001|Overall Study|Withdrawal by Subject|5|||
131707250|NCT00330187|474209346|FG002|Overall Study|Withdrawal by Subject|4|||
131606686|NCT03536884|473852121|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606687|NCT03536884|473852122|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606688|NCT03536884|473852123|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606689|NCT03536884|473852124|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606690|NCT03536884|473852125|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131606691|NCT03536884|473852126|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
131606692|NCT03536884|473852127|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
131606693|NCT03536884|473852128|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
131606694|NCT03536884|473852117|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606695|NCT03536884|473852118|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606696|NCT03536884|473852119|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606697|NCT03536884|473852120|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606698|NCT03536884|473852121|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606699|NCT03536884|473852122|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606700|NCT03536884|473852123|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606701|NCT03536884|473852124|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606702|NCT03536884|473852125|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606703|NCT03536884|473852126|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606704|NCT03536884|473852127|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
131606705|NCT03536884|473852128|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131606706|NCT03536884|473852117|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606707|NCT03536884|473852118|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606708|NCT03536884|473852119|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606709|NCT03536884|473852120|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606710|NCT03536884|473852121|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606711|NCT03536884|473852122|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606712|NCT03536884|473852123|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606713|NCT03536884|473852124|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606714|NCT03536884|473852125|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606715|NCT03536884|473852126|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606716|NCT03536884|473852127|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131606717|NCT03536884|473852128|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
131606718|NCT03536884|473852117|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606719|NCT03536884|473852118|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606720|NCT03536884|473852119|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606721|NCT03536884|473852120|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606722|NCT03536884|473852121|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606723|NCT03536884|473852122|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606724|NCT03536884|473852123|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606725|NCT03536884|473852124|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606726|NCT03536884|473852125|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606727|NCT03536884|473852126|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606728|NCT03536884|473852127|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131606729|NCT03536884|473852128|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
131606730|NCT03485729|473852143|FG000|Overall Study|Withdrawal by Subject|0|||
131606731|NCT03485729|473852144|FG001|Overall Study|Withdrawal by Subject|0|||
131606732|NCT03485729|473852145|FG002|Overall Study|Withdrawal by Subject|1|||
131606733|NCT03485729|473852143|FG000|Overall Study|Disease progression|8|||
131606734|NCT03485729|473852144|FG001|Overall Study|Disease progression|13|||
131606735|NCT03485729|473852145|FG002|Overall Study|Disease progression|1|||
131606736|NCT03485729|473852143|FG000|Overall Study|Hospice care|1|||
131606737|NCT03485729|473852144|FG001|Overall Study|Hospice care|0|||
131606738|NCT03485729|473852145|FG002|Overall Study|Hospice care|0|||
131606739|NCT03485729|473852143|FG000|Overall Study|Poor performance status|1|||
131606740|NCT03485729|473852144|FG001|Overall Study|Poor performance status|0|||
131606741|NCT03485729|473852145|FG002|Overall Study|Poor performance status|0|||
131606742|NCT03485729|473852143|FG000|Overall Study|Illness|0|||
131606743|NCT03485729|473852144|FG001|Overall Study|Illness|1|||
131606744|NCT03485729|473852145|FG002|Overall Study|Illness|0|||
131606745|NCT02839265|473852146|FG000|Overall Study|Screen Failure|2|||
131606746|NCT02839265|473852146|FG000|Overall Study|Death|1|||
131606747|NCT02839265|473852146|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
131606748|NCT05533190|473852149|FG000|Overall Study|Lost to Follow-up|19|||
131606749|NCT05533190|473852150|FG001|Overall Study|Lost to Follow-up|7|||
131606750|NCT05533190|473852149|FG000|Overall Study|Failed to download app|1|||
131606751|NCT05533190|473852150|FG001|Overall Study|Failed to download app|0|||
131606752|NCT05533190|473852149|FG000|Overall Study|Thought app was a scam|1|||
131606753|NCT05533190|473852150|FG001|Overall Study|Thought app was a scam|0|||
131606754|NCT05533190|473852149|FG000|Overall Study|Withdrawal by Subject|2|||
131606755|NCT05533190|473852150|FG001|Overall Study|Withdrawal by Subject|0|||
131606756|NCT05856435|473852166|FG000|Overall Study|Lost to Follow-up|6|||
131606757|NCT02323880|473852167|FG000|Overall Study|Adverse Event|2|||
131606758|NCT02323880|473852168|FG001|Overall Study|Adverse Event|0|||
131606759|NCT02323880|473852169|FG002|Overall Study|Adverse Event|1|||
131606760|NCT02323880|473852170|FG003|Overall Study|Adverse Event|1|||
131606761|NCT02323880|473852171|FG004|Overall Study|Adverse Event|1|||
131606762|NCT02323880|473852172|FG005|Overall Study|Adverse Event|0|||
131606763|NCT02323880|473852173|FG006|Overall Study|Adverse Event|1|||
131606764|NCT02323880|473852174|FG007|Overall Study|Adverse Event|0|||
131606765|NCT02323880|473852167|FG000|Overall Study|Death|0|||
131606766|NCT02323880|473852168|FG001|Overall Study|Death|0|||
131606767|NCT02323880|473852169|FG002|Overall Study|Death|0|||
131606768|NCT02323880|473852170|FG003|Overall Study|Death|0|||
131606769|NCT02323880|473852171|FG004|Overall Study|Death|0|||
131606770|NCT02323880|473852172|FG005|Overall Study|Death|1|||
131606771|NCT02323880|473852173|FG006|Overall Study|Death|0|||
131606772|NCT02323880|473852174|FG007|Overall Study|Death|0|||
131606773|NCT02323880|473852167|FG000|Overall Study|Lack of Efficacy|4|||
131606774|NCT02323880|473852168|FG001|Overall Study|Lack of Efficacy|11|||
131606775|NCT02323880|473852169|FG002|Overall Study|Lack of Efficacy|5|||
131606776|NCT02323880|473852170|FG003|Overall Study|Lack of Efficacy|5|||
131606777|NCT02323880|473852171|FG004|Overall Study|Lack of Efficacy|4|||
131606778|NCT02323880|473852172|FG005|Overall Study|Lack of Efficacy|8|||
131606779|NCT02323880|473852173|FG006|Overall Study|Lack of Efficacy|4|||
131606780|NCT02323880|473852174|FG007|Overall Study|Lack of Efficacy|6|||
131606781|NCT02323880|473852167|FG000|Overall Study|Physician Decision|0|||
131606782|NCT02323880|473852168|FG001|Overall Study|Physician Decision|0|||
131606783|NCT02323880|473852169|FG002|Overall Study|Physician Decision|0|||
131606784|NCT02323880|473852170|FG003|Overall Study|Physician Decision|0|||
131606785|NCT02323880|473852171|FG004|Overall Study|Physician Decision|1|||
131606786|NCT02323880|473852172|FG005|Overall Study|Physician Decision|1|||
131606787|NCT02323880|473852173|FG006|Overall Study|Physician Decision|1|||
131606788|NCT02323880|473852174|FG007|Overall Study|Physician Decision|0|||
131606789|NCT02323880|473852167|FG000|Overall Study|Withdrawal by Subject|0|||
131606790|NCT02323880|473852168|FG001|Overall Study|Withdrawal by Subject|2|||
131606791|NCT02323880|473852169|FG002|Overall Study|Withdrawal by Subject|0|||
131606792|NCT02323880|473852170|FG003|Overall Study|Withdrawal by Subject|0|||
131606793|NCT02323880|473852171|FG004|Overall Study|Withdrawal by Subject|0|||
131606794|NCT02323880|473852172|FG005|Overall Study|Withdrawal by Subject|0|||
131606795|NCT02323880|473852173|FG006|Overall Study|Withdrawal by Subject|0|||
131606796|NCT02323880|473852174|FG007|Overall Study|Withdrawal by Subject|0|||
131606797|NCT04167553|473852175|FG000|Overall Study|Withdrawal by Subject|1|||
131606798|NCT04167553|473852176|FG001|Overall Study|Withdrawal by Subject|0|||
131606799|NCT04167553|473852177|FG002|Overall Study|Withdrawal by Subject|1|||
131606800|NCT04167553|473852178|FG003|Overall Study|Withdrawal by Subject|2|||
131606801|NCT04167553|473852179|FG004|Overall Study|Withdrawal by Subject|1|||
131606802|NCT04167553|473852180|FG005|Overall Study|Withdrawal by Subject|0|||
131606803|NCT04167553|473852181|FG006|Overall Study|Withdrawal by Subject|0|||
131606804|NCT04167553|473852175|FG000|Overall Study|Physician Decision|0|||
131707251|NCT00330187|474209347|FG003|Overall Study|Withdrawal by Subject|4|||
131707252|NCT03258814|474209348|FG000|Overall Study|Early Termination|4|||
131707253|NCT03258814|474209349|FG001|Overall Study|Early Termination|3|||
131606805|NCT04167553|473852176|FG001|Overall Study|Physician Decision|0|||
131606806|NCT04167553|473852177|FG002|Overall Study|Physician Decision|0|||
131606807|NCT04167553|473852178|FG003|Overall Study|Physician Decision|0|||
131606808|NCT04167553|473852179|FG004|Overall Study|Physician Decision|2|||
131606809|NCT04167553|473852180|FG005|Overall Study|Physician Decision|2|||
131606810|NCT04167553|473852181|FG006|Overall Study|Physician Decision|0|||
131707254|NCT03258814|474209350|FG002|Overall Study|Early Termination|10|||
131606811|NCT04167553|473852175|FG000|Overall Study|Lost to Follow-up|0|||
131606812|NCT04167553|473852176|FG001|Overall Study|Lost to Follow-up|0|||
131606813|NCT04167553|473852177|FG002|Overall Study|Lost to Follow-up|2|||
131606814|NCT04167553|473852178|FG003|Overall Study|Lost to Follow-up|0|||
131606815|NCT04167553|473852179|FG004|Overall Study|Lost to Follow-up|0|||
131606816|NCT04167553|473852180|FG005|Overall Study|Lost to Follow-up|0|||
131606817|NCT04167553|473852181|FG006|Overall Study|Lost to Follow-up|0|||
131707255|NCT01413958|474209351|FG000|Overall Study|Lost to Follow-up|0|||
131707256|NCT01413958|474209352|FG001|Overall Study|Lost to Follow-up|1|||
131707257|NCT01900002|474209353|FG000|Overall Study|Withdrawal by Subject|2|||
131707258|NCT01900002|474209353|FG000|Overall Study|ineligible for Y-90|4|||
131707259|NCT01573910|474209360|FG000|Overall Study|Adverse Event|4|||
131707260|NCT01573910|474209361|FG001|Overall Study|Adverse Event|4|||
131707261|NCT01573910|474209360|FG000|Overall Study|Lost to Follow-up|2|||
131707262|NCT01573910|474209361|FG001|Overall Study|Lost to Follow-up|1|||
131707263|NCT01573910|474209360|FG000|Overall Study|Withdrawal by Subject|0|||
131707264|NCT01573910|474209361|FG001|Overall Study|Withdrawal by Subject|1|||
131707265|NCT01573910|474209360|FG000|Overall Study|Protocol Violation|3|||
131707266|NCT01573910|474209361|FG001|Overall Study|Protocol Violation|0|||
131707267|NCT01573910|474209360|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
131707268|NCT01573910|474209361|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
131707269|NCT01282229|474209372|FG000|Overall Study|Protocol Violation|2|||
131707270|NCT00996203|474209373|FG000|Overall Study|Adverse Event|3|||
131707271|NCT00996203|474209373|FG000|Overall Study|Lost to Follow-up|1|||
131707272|NCT00996203|474209373|FG000|Overall Study|Lack of Efficacy|1|||
131707273|NCT00996203|474209373|FG000|Overall Study|Protocol Violation|2|||
131791826|NCT01952574|474520882|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
131791827|NCT01952574|474520883|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
131791828|NCT01952574|474520884|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
131791829|NCT01952574|474520885|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
131791830|NCT01952574|474520879|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
131791831|NCT01952574|474520880|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
131791832|NCT01952574|474520881|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
131791833|NCT01952574|474520882|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
131791834|NCT01952574|474520883|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
131791835|NCT01952574|474520884|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
131791836|NCT01952574|474520885|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
131791837|NCT01952574|474520879|FG000|Open-label Treatment Phase|Missing|0|||
131791838|NCT01952574|474520880|FG001|Open-label Treatment Phase|Missing|0|||
131791839|NCT01952574|474520881|FG002|Open-label Treatment Phase|Missing|0|||
131791840|NCT01952574|474520882|FG003|Open-label Treatment Phase|Missing|0|||
131791841|NCT01952574|474520883|FG004|Open-label Treatment Phase|Missing|4|||
131791842|NCT01952574|474520884|FG005|Open-label Treatment Phase|Missing|0|||
131791843|NCT01952574|474520885|FG006|Open-label Treatment Phase|Missing|0|||
131791844|NCT01952574|474520879|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
131791845|NCT01952574|474520880|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
131791846|NCT01952574|474520881|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
131791847|NCT01952574|474520882|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
131791848|NCT01952574|474520883|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
131606818|NCT02828358|473852189|FG000|Overall Study|Physician Decision|7|||
131606819|NCT02828358|473852190|FG001|Overall Study|Physician Decision|1|||
131606820|NCT02828358|473852189|FG000|Overall Study|Treatment Failure|6|||
131606821|NCT02828358|473852190|FG001|Overall Study|Treatment Failure|0|||
131606822|NCT02828358|473852189|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
131606823|NCT02828358|473852190|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
131606824|NCT02828358|473852189|FG000|Overall Study|Refusal of further protocol therapy|2|||
131606825|NCT02828358|473852190|FG001|Overall Study|Refusal of further protocol therapy|0|||
131606826|NCT02828358|473852189|FG000|Overall Study|Relapse|25|||
131606827|NCT02828358|473852190|FG001|Overall Study|Relapse|0|||
131606828|NCT02828358|473852189|FG000|Overall Study|Still on therapy|5|||
131606829|NCT02828358|473852190|FG001|Overall Study|Still on therapy|0|||
131606830|NCT03717935|473852195|FG000|Overall Study|Withdrawal by Subject|0|||
131606831|NCT03717935|473852196|FG001|Overall Study|Withdrawal by Subject|2|||
131606832|NCT04186819|473852198|FG000|Overall Study|Adverse Event|1|||
131606833|NCT04186819|473852198|FG000|Overall Study|Lost to Follow-up|1|||
131606834|NCT04186819|473852198|FG000|Overall Study|Opted for EBRT|1|||
131606835|NCT04186819|473852198|FG000|Overall Study|Opted SBRT|1|||
131606836|NCT04186819|473852198|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
131606837|NCT04186819|473852198|FG000|Overall Study|Physician Decision|1|||
131606838|NCT04186819|473852198|FG000|Overall Study|RP Delayed|1|||
131606839|NCT04186819|473852198|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
131606840|NCT04186819|473852198|FG000|Overall Study|Subject declined for financial reasons|1|||
131606841|NCT04186819|473852198|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
131606842|NCT04186819|473852198|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
131707274|NCT03686969|474209374|FG000|Overall Study|Study terminated|1|||
131707275|NCT03686969|474209375|FG001|Overall Study|Study terminated|0|||
131791849|NCT01952574|474520884|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
131791850|NCT01952574|474520885|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
131791851|NCT01952574|474520879|FG000|Open-label Treatment Phase|Death|0|||
131707276|NCT01988090|474209383|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
131791852|NCT01952574|474520880|FG001|Open-label Treatment Phase|Death|0|||
131707277|NCT01988090|474209384|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
131606843|NCT04186819|473852198|FG000|Overall Study|The subject opted for other treatment option|2|||
131606844|NCT04186819|473852198|FG000|Overall Study|The subject opted for other treatment options|1|||
131606845|NCT04186819|473852198|FG000|Overall Study|Withdrawal by Subject|3|||
131606846|NCT04186819|473852198|FG000|Overall Study|Reason not specified|1|||
131606847|NCT01447719|473852202|FG000|Overall Study|Image acquisition failure|2|||
131606848|NCT01447719|473852202|FG000|Overall Study|Invalid image or not imaged|3|||
131606849|NCT01447719|473852202|FG000|Overall Study|Subject still living at end of study|79|||
131606850|NCT01447719|473852202|FG000|Overall Study|Withdrawal by Subject|2|||
131606851|NCT01447719|473852202|FG000|Overall Study|Family withdrew autopsy consent|7|||
131606852|NCT05100628|473852203|FG000|Overall Study|Progressive Disease|1|||
131606853|NCT05100628|473852204|FG001|Overall Study|Progressive Disease|0|||
131606854|NCT05100628|473852205|FG002|Overall Study|Progressive Disease|0|||
131606855|NCT05100628|473852206|FG003|Overall Study|Progressive Disease|0|||
131606856|NCT05100628|473852203|FG000|Overall Study|Study Terminated by Sponsor|0|||
131606857|NCT05100628|473852204|FG001|Overall Study|Study Terminated by Sponsor|0|||
131606858|NCT05100628|473852205|FG002|Overall Study|Study Terminated by Sponsor|3|||
131606859|NCT05100628|473852206|FG003|Overall Study|Study Terminated by Sponsor|0|||
131606860|NCT05100628|473852203|FG000|Overall Study|unkown|0|||
131606861|NCT05100628|473852204|FG001|Overall Study|unkown|1|||
131606862|NCT05100628|473852205|FG002|Overall Study|unkown|0|||
131606863|NCT05100628|473852206|FG003|Overall Study|unkown|0|||
131606864|NCT03252288|473852209|FG000|Overall Study|Death|1|||
131606865|NCT03252288|473852210|FG001|Overall Study|Death|0|||
131606866|NCT03252288|473852211|FG002|Overall Study|Death|0|||
131606867|NCT03252288|473852209|FG000|Overall Study|Death|11|||
131606868|NCT03252288|473852210|FG001|Overall Study|Death|0|||
131606869|NCT03252288|473852211|FG002|Overall Study|Death|0|||
131606870|NCT03252288|473852209|FG000|Overall Study|Withdrawal by Subject|2|||
131606871|NCT03252288|473852210|FG001|Overall Study|Withdrawal by Subject|0|||
131606872|NCT03252288|473852211|FG002|Overall Study|Withdrawal by Subject|0|||
131606873|NCT03252288|473852209|FG000|Overall Study|Lost to Follow-up|79|||
131606874|NCT03252288|473852210|FG001|Overall Study|Lost to Follow-up|0|||
131606875|NCT03252288|473852211|FG002|Overall Study|Lost to Follow-up|0|||
131606876|NCT03252288|473852209|FG000|Overall Study|Loss of baseline data on tablets|6|||
131606877|NCT03252288|473852210|FG001|Overall Study|Loss of baseline data on tablets|0|||
131606878|NCT03252288|473852211|FG002|Overall Study|Loss of baseline data on tablets|0|||
131606879|NCT05900154|473852215|FG000|Follow-Up Period|Lost to Follow-up|1|||
131606880|NCT05900154|473852216|FG001|Follow-Up Period|Lost to Follow-up|2|||
131606881|NCT05900154|473852217|FG002|Follow-Up Period|Lost to Follow-up|1|||
131606882|NCT05900154|473852218|FG003|Follow-Up Period|Lost to Follow-up|0|||
131606883|NCT05900154|473852219|FG004|Follow-Up Period|Lost to Follow-up|1|||
131606884|NCT05900154|473852220|FG005|Follow-Up Period|Lost to Follow-up|1|||
131606885|NCT02938923|473852222|FG000|Overall Study|Death|1|||
131606886|NCT02938923|473852223|FG001|Overall Study|Death|0|||
131606887|NCT02938923|473852224|FG002|Overall Study|Death|0|||
131606888|NCT02938923|473852222|FG000|Overall Study|Physician Decision|0|||
131606889|NCT02938923|473852223|FG001|Overall Study|Physician Decision|2|||
131606890|NCT02938923|473852224|FG002|Overall Study|Physician Decision|0|||
131606891|NCT02938923|473852222|FG000|Overall Study|Withdrawal by Subject|0|||
131606892|NCT02938923|473852223|FG001|Overall Study|Withdrawal by Subject|1|||
131606893|NCT02938923|473852224|FG002|Overall Study|Withdrawal by Subject|1|||
131707278|NCT01988090|474209383|FG000|Start Treament After Randomization|Protocol Violation|0|||
131707279|NCT01988090|474209384|FG001|Start Treament After Randomization|Protocol Violation|1|||
131707280|NCT01988090|474209383|FG000|Complete Study After Start|Withdrawal by Subject|2|||
131707281|NCT01988090|474209384|FG001|Complete Study After Start|Withdrawal by Subject|0|||
131707282|NCT01988090|474209383|FG000|Complete Study After Start|Protocol Violation|1|||
131707283|NCT01988090|474209384|FG001|Complete Study After Start|Protocol Violation|1|||
131707284|NCT03094195|474209385|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
131707285|NCT03094195|474209386|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
131707286|NCT03094195|474209387|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
131707287|NCT03094195|474209388|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131707288|NCT03094195|474209389|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131707289|NCT03094195|474209390|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131707290|NCT03094195|474209391|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131707291|NCT03094195|474209392|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131707292|NCT03094195|474209385|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
131707293|NCT03094195|474209386|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
131707294|NCT03094195|474209387|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
131707295|NCT03094195|474209388|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131707296|NCT03094195|474209389|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131707297|NCT03094195|474209390|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131707298|NCT03094195|474209391|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131707299|NCT03094195|474209392|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131899716|NCT02659943|474919379|FG006|Overall Study|No longer meets eligibility|1|||
131707300|NCT03094195|474209385|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707301|NCT03094195|474209386|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707302|NCT03094195|474209387|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
131707303|NCT03094195|474209388|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707304|NCT03094195|474209389|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707305|NCT03094195|474209390|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707306|NCT03094195|474209391|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707307|NCT03094195|474209392|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131707308|NCT03094195|474209385|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131707309|NCT03094195|474209386|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
131707310|NCT03094195|474209387|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
131707311|NCT03094195|474209388|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131707312|NCT03094195|474209389|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131707313|NCT03094195|474209390|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131707314|NCT03094195|474209391|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131707315|NCT03094195|474209392|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131707316|NCT03887130|474209399|FG000|Overall Study|Progressive disease|23|||
131707317|NCT03887130|474209400|FG001|Overall Study|Progressive disease|14|||
131707318|NCT03887130|474209401|FG002|Overall Study|Progressive disease|7|||
131707319|NCT03887130|474209399|FG000|Overall Study|Protocol Violation|3|||
131707320|NCT03887130|474209400|FG001|Overall Study|Protocol Violation|1|||
131707321|NCT03887130|474209401|FG002|Overall Study|Protocol Violation|2|||
131707322|NCT03887130|474209399|FG000|Overall Study|Drug related toxicity|7|||
131707323|NCT03887130|474209400|FG001|Overall Study|Drug related toxicity|7|||
131707324|NCT03887130|474209401|FG002|Overall Study|Drug related toxicity|13|||
131707325|NCT03887130|474209399|FG000|Overall Study|Non drug related toxicity|3|||
131707326|NCT03887130|474209400|FG001|Overall Study|Non drug related toxicity|0|||
131707327|NCT03887130|474209401|FG002|Overall Study|Non drug related toxicity|0|||
131707328|NCT03887130|474209399|FG000|Overall Study|Death|2|||
131707329|NCT03887130|474209400|FG001|Overall Study|Death|2|||
131707330|NCT03887130|474209401|FG002|Overall Study|Death|1|||
131707331|NCT03887130|474209399|FG000|Overall Study|Withdrawal by Subject|7|||
131707332|NCT03887130|474209400|FG001|Overall Study|Withdrawal by Subject|6|||
131791853|NCT01952574|474520881|FG002|Open-label Treatment Phase|Death|0|||
131791854|NCT01952574|474520882|FG003|Open-label Treatment Phase|Death|0|||
131791855|NCT01952574|474520883|FG004|Open-label Treatment Phase|Death|1|||
131791856|NCT01952574|474520884|FG005|Open-label Treatment Phase|Death|0|||
131791857|NCT01952574|474520885|FG006|Open-label Treatment Phase|Death|0|||
131791858|NCT01952574|474520879|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131791859|NCT01952574|474520880|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131791860|NCT01952574|474520881|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131791861|NCT01952574|474520882|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131791862|NCT01952574|474520883|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131791863|NCT01952574|474520884|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
131791864|NCT01952574|474520885|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131791865|NCT01952574|474520879|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
131791866|NCT01952574|474520880|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
131791867|NCT01952574|474520881|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
131791868|NCT01952574|474520882|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
131791869|NCT01952574|474520883|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
131791870|NCT01952574|474520884|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
131791871|NCT01952574|474520885|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
131791872|NCT02974114|474520890|FG000|Overall Study|Other (Not specified)|0|||
131791873|NCT02974114|474520891|FG001|Overall Study|Other (Not specified)|1|||
131791874|NCT02974114|474520892|FG002|Overall Study|Other (Not specified)|2|||
131791875|NCT05085964|474520893|FG000|Overall Study|Premature termination of study|21|||
131791876|NCT05085964|474520894|FG001|Overall Study|Premature termination of study|0|||
131791877|NCT00545233|474520899|FG000|Overall Study|Adverse Event|10|||
131791878|NCT00545233|474520900|FG001|Overall Study|Adverse Event|5|||
131707333|NCT03887130|474209401|FG002|Overall Study|Withdrawal by Subject|11|||
131707334|NCT03887130|474209399|FG000|Overall Study|other reason|6|||
131707335|NCT03887130|474209400|FG001|Overall Study|other reason|20|||
131791879|NCT00545233|474520899|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
131707336|NCT03887130|474209401|FG002|Overall Study|other reason|17|||
131707337|NCT01439945|474209405|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
131791880|NCT00545233|474520900|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131791881|NCT00545233|474520899|FG000|Overall Study|Protocol Violation|2|||
131791882|NCT00545233|474520900|FG001|Overall Study|Protocol Violation|0|||
131791883|NCT00545233|474520899|FG000|Overall Study|Refused Treatment|9|||
131791884|NCT00545233|474520900|FG001|Overall Study|Refused Treatment|7|||
131791885|NCT00545233|474520899|FG000|Overall Study|Failure to Return|4|||
131707338|NCT01439945|474209406|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
131707339|NCT01439945|474209407|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
131606894|NCT04583280|473852229|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
131606895|NCT04583280|473852230|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
131606896|NCT00631475|473852231|FG000|Overall Study|Death|18|||
131606897|NCT00631475|473852231|FG000|Overall Study|Adverse Event|14|||
131606898|NCT00631475|473852231|FG000|Overall Study|Withdrew consent|5|||
131606899|NCT00631475|473852231|FG000|Overall Study|Preparation for lung transplant|8|||
131606900|NCT00303459|473852232|FG000|Overall Study|Death|33|||
131606901|NCT00303459|473852233|FG001|Overall Study|Death|44|||
131606902|NCT00303459|473852232|FG000|Overall Study|Withdrawal of consent|32|||
131606903|NCT00303459|473852233|FG001|Overall Study|Withdrawal of consent|26|||
131791886|NCT00545233|474520900|FG001|Overall Study|Failure to Return|6|||
131791887|NCT00545233|474520899|FG000|Overall Study|Insufficient response|14|||
131791888|NCT00545233|474520900|FG001|Overall Study|Insufficient response|15|||
131791889|NCT00545233|474520899|FG000|Overall Study|Physician Decision|2|||
131791890|NCT00545233|474520900|FG001|Overall Study|Physician Decision|1|||
131791891|NCT01208402|474520901|FG000|Overall Study|Withdrawal by Subject|1|||
131791892|NCT01208402|474520902|FG001|Overall Study|Withdrawal by Subject|0|||
131791893|NCT01335464|474520905|FG000|Overall Study|Adverse Event|15|||
131791894|NCT01335464|474520906|FG001|Overall Study|Adverse Event|25|||
131791895|NCT01335464|474520905|FG000|Overall Study|Non compliant with protocol|2|||
131791896|NCT01335464|474520906|FG001|Overall Study|Non compliant with protocol|0|||
131791897|NCT01335464|474520905|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
131791898|NCT01335464|474520906|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
131791899|NCT01335464|474520905|FG000|Overall Study|Not treated|2|||
131791900|NCT01335464|474520906|FG001|Overall Study|Not treated|0|||
131791901|NCT01335464|474520905|FG000|Overall Study|Reason other than those stated above|1|||
131791902|NCT01335464|474520906|FG001|Overall Study|Reason other than those stated above|1|||
131791903|NCT03156270|474520907|FG000|Overall Study|Failed pre-treatment screening|1|||
131791904|NCT03156270|474520907|FG000|Overall Study|Lost to Follow-up|1|||
131791905|NCT00446654|474520908|FG000|Overall Study|Withdrawal by Subject|1|||
131791906|NCT00446654|474520909|FG001|Overall Study|Withdrawal by Subject|0|||
131791907|NCT00446654|474520908|FG000|Overall Study|Adverse Event|1|||
131791908|NCT00446654|474520909|FG001|Overall Study|Adverse Event|0|||
131791909|NCT02110706|474520916|FG000|Overall Study|Adverse Event|2|||
131791910|NCT02110706|474520917|FG001|Overall Study|Adverse Event|3|||
131791911|NCT02110706|474520916|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
131791912|NCT02110706|474520917|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
131791913|NCT02087059|474520918|FG000|Overall Study|Disease Progression|1|||
131791914|NCT02087059|474520918|FG000|Overall Study|Adverse Event|5|||
131791915|NCT02087059|474520918|FG000|Overall Study|Lost to Follow-up|1|||
131791916|NCT02175966|474520919|FG000|Follow-up Period|Lack of Efficacy|10|||
131791917|NCT02175966|474520920|FG001|Follow-up Period|Lack of Efficacy|6|||
131791918|NCT01306253|474520921|FG000|Overall Study|Lost to Follow-up|1|||
131791919|NCT01306253|474520922|FG001|Overall Study|Lost to Follow-up|1|||
131791920|NCT01261325|474520923|FG000|Overall Study|Lack of Efficacy|1|||
131791921|NCT01261325|474520924|FG001|Overall Study|Lack of Efficacy|1|||
131791922|NCT01261325|474520925|FG002|Overall Study|Lack of Efficacy|0|||
131791923|NCT01261325|474520923|FG000|Overall Study|Withdrawal by Subject|2|||
131791924|NCT01261325|474520924|FG001|Overall Study|Withdrawal by Subject|2|||
131791925|NCT01261325|474520925|FG002|Overall Study|Withdrawal by Subject|4|||
131791926|NCT01261325|474520923|FG000|Overall Study|SAE, non-fatal|1|||
131791927|NCT01261325|474520924|FG001|Overall Study|SAE, non-fatal|5|||
131791928|NCT01261325|474520925|FG002|Overall Study|SAE, non-fatal|1|||
131791929|NCT01261325|474520923|FG000|Overall Study|AE, non-serious non-fatal|9|||
131791930|NCT01261325|474520924|FG001|Overall Study|AE, non-serious non-fatal|15|||
131791931|NCT01261325|474520925|FG002|Overall Study|AE, non-serious non-fatal|13|||
131791932|NCT01261325|474520923|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131791933|NCT01261325|474520924|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131791934|NCT01261325|474520925|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131791935|NCT01261325|474520923|FG000|Overall Study|Non Compliance|2|||
131791936|NCT01261325|474520924|FG001|Overall Study|Non Compliance|0|||
131791937|NCT01261325|474520925|FG002|Overall Study|Non Compliance|0|||
131791938|NCT01261325|474520923|FG000|Overall Study|Patient Randomized by Mistake|0|||
131606904|NCT00303459|473852232|FG000|Overall Study|Lost to Follow-up|5|||
131606905|NCT00303459|473852233|FG001|Overall Study|Lost to Follow-up|4|||
131606906|NCT00303459|473852232|FG000|Overall Study|Administrative reason|7|||
131606907|NCT00303459|473852233|FG001|Overall Study|Administrative reason|7|||
131606908|NCT00303459|473852232|FG000|Overall Study|Decision by the investigator|5|||
131606909|NCT00303459|473852233|FG001|Overall Study|Decision by the investigator|7|||
131606910|NCT00303459|473852232|FG000|Overall Study|Lung transplantation|1|||
131606911|NCT00303459|473852233|FG001|Overall Study|Lung transplantation|1|||
131791939|NCT01261325|474520924|FG001|Overall Study|Patient Randomized by Mistake|1|||
131606912|NCT01570361|473852234|FG000|Overall Study|Subject discontinued|1|||
131606913|NCT01570361|473852235|FG001|Overall Study|Subject discontinued|2|||
131606914|NCT01570361|473852234|FG000|Overall Study|Sponsor closing the study|51|||
131791940|NCT01261325|474520925|FG002|Overall Study|Patient Randomized by Mistake|0|||
131791941|NCT01261325|474520923|FG000|Overall Study|Erroneously Randomized|1|||
131791942|NCT01261325|474520924|FG001|Overall Study|Erroneously Randomized|0|||
131791943|NCT01261325|474520925|FG002|Overall Study|Erroneously Randomized|0|||
131791944|NCT01261325|474520923|FG000|Overall Study|Screen Failure|1|||
131791945|NCT01261325|474520924|FG001|Overall Study|Screen Failure|0|||
131791946|NCT01261325|474520925|FG002|Overall Study|Screen Failure|0|||
131791947|NCT01261325|474520923|FG000|Overall Study|Randomized in Error|0|||
131606915|NCT01570361|473852235|FG001|Overall Study|Sponsor closing the study|50|||
131606916|NCT01570361|473852234|FG000|Overall Study|Subject excluded|5|||
131606917|NCT01570361|473852235|FG001|Overall Study|Subject excluded|3|||
131606918|NCT01570361|473852234|FG000|Overall Study|Subject withdrew consent|14|||
131606919|NCT01570361|473852235|FG001|Overall Study|Subject withdrew consent|9|||
131606920|NCT01570361|473852234|FG000|Overall Study|Adverse Event|2|||
131606921|NCT01570361|473852235|FG001|Overall Study|Adverse Event|1|||
131606922|NCT01570361|473852234|FG000|Overall Study|Lost to Follow-up|4|||
131606923|NCT01570361|473852235|FG001|Overall Study|Lost to Follow-up|4|||
131606924|NCT01570361|473852234|FG000|Overall Study|Death|5|||
131606925|NCT01570361|473852235|FG001|Overall Study|Death|4|||
131606926|NCT01570361|473852234|FG000|Overall Study|Other|0|||
131606927|NCT01570361|473852235|FG001|Overall Study|Other|2|||
131606928|NCT04129554|473852236|FG000|Overall Study|Withdrawal by Subject|4|||
131606929|NCT04129554|473852237|FG001|Overall Study|Withdrawal by Subject|3|||
131606930|NCT04129554|473852236|FG000|Overall Study|Other|0|||
131606931|NCT04129554|473852237|FG001|Overall Study|Other|2|||
131606932|NCT02846545|473852242|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
131606933|NCT02846545|473852243|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
131606934|NCT02846545|473852242|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
131606935|NCT02846545|473852243|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
131606936|NCT02846545|473852242|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
131606937|NCT02846545|473852243|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
131606938|NCT02846545|473852242|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
131606939|NCT02846545|473852243|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
131606940|NCT02846545|473852242|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
131606941|NCT02846545|473852243|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
131606942|NCT04183283|473853361|FG000|Period 1|Withdrawal by Subject|0|||
131606943|NCT04183283|473853362|FG001|Period 1|Withdrawal by Subject|1|||
131606944|NCT04183283|473853363|FG002|Period 1|Withdrawal by Subject|0|||
131606945|NCT04183283|473853364|FG003|Period 1|Withdrawal by Subject|0|||
131606946|NCT04183283|473853361|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
131606947|NCT04183283|473853362|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
131606948|NCT04183283|473853363|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
131606949|NCT04183283|473853364|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
131606950|NCT04709419|473853375|FG000|Overall Study|Physician Decision|1|||
131606951|NCT04709419|473853376|FG001|Overall Study|Physician Decision|0|||
131606952|NCT05683340|473853377|FG000|Overall Study|Adverse Event|1|||
131606953|NCT05683340|473853378|FG001|Overall Study|Adverse Event|1|||
131606954|NCT05683340|473853377|FG000|Overall Study|Protocol Violation|1|||
131606955|NCT05683340|473853378|FG001|Overall Study|Protocol Violation|0|||
131606956|NCT05683340|473853377|FG000|Overall Study|Withdrawal by Subject|0|||
131606957|NCT05683340|473853378|FG001|Overall Study|Withdrawal by Subject|2|||
131606958|NCT01314105|473853382|FG000|Overall Study|Progressive Disease|6|||
131606959|NCT01314105|473853383|FG001|Overall Study|Progressive Disease|10|||
131606960|NCT01314105|473853382|FG000|Overall Study|Refused to continue taking medication|0|||
131606961|NCT01314105|473853383|FG001|Overall Study|Refused to continue taking medication|1|||
131606962|NCT01314105|473853382|FG000|Overall Study|Other Adverse Event|1|||
131606963|NCT01314105|473853383|FG001|Overall Study|Other Adverse Event|1|||
131606964|NCT02056834|473853384|FG000|Overall Study|Lost to Follow-up|7|||
131606965|NCT06106022|473853387|FG000|Overall Study|Lost to Follow-up|1|||
131606966|NCT06106022|473853388|FG001|Overall Study|Lost to Follow-up|0|||
131606967|NCT06106022|473853387|FG000|Overall Study|Voluntary Withdrawal|0|||
131606968|NCT06106022|473853388|FG001|Overall Study|Voluntary Withdrawal|2|||
131606969|NCT04451772|473853411|FG000|Overall Study|Adverse Event|1|||
131606970|NCT04451772|473853412|FG001|Overall Study|Adverse Event|0|||
131606971|NCT04451772|473853413|FG002|Overall Study|Adverse Event|1|||
131606972|NCT04451772|473853414|FG003|Overall Study|Adverse Event|1|||
131606973|NCT04451772|473853415|FG004|Overall Study|Adverse Event|0|||
131606974|NCT04451772|473853416|FG005|Overall Study|Adverse Event|3|||
131606975|NCT04451772|473853411|FG000|Overall Study|Withdrawal by Subject|2|||
131606976|NCT04451772|473853412|FG001|Overall Study|Withdrawal by Subject|7|||
131606977|NCT04451772|473853413|FG002|Overall Study|Withdrawal by Subject|2|||
131606978|NCT04451772|473853414|FG003|Overall Study|Withdrawal by Subject|1|||
131606979|NCT04451772|473853415|FG004|Overall Study|Withdrawal by Subject|1|||
131606980|NCT04451772|473853416|FG005|Overall Study|Withdrawal by Subject|0|||
131606981|NCT04451772|473853411|FG000|Overall Study|Other, not specified|1|||
131606982|NCT04451772|473853412|FG001|Overall Study|Other, not specified|2|||
131606983|NCT04451772|473853413|FG002|Overall Study|Other, not specified|1|||
131606984|NCT04451772|473853414|FG003|Overall Study|Other, not specified|0|||
131606985|NCT04451772|473853415|FG004|Overall Study|Other, not specified|0|||
131606986|NCT04451772|473853416|FG005|Overall Study|Other, not specified|1|||
131791948|NCT01261325|474520924|FG001|Overall Study|Randomized in Error|0|||
131791949|NCT01261325|474520925|FG002|Overall Study|Randomized in Error|1|||
131791950|NCT01261325|474520923|FG000|Overall Study|Protocol Violation|0|||
131791951|NCT01261325|474520924|FG001|Overall Study|Protocol Violation|3|||
131791952|NCT01261325|474520925|FG002|Overall Study|Protocol Violation|1|||
131791953|NCT01261325|474520923|FG000|Overall Study|Lost to Follow-up|0|||
131791954|NCT01261325|474520924|FG001|Overall Study|Lost to Follow-up|1|||
131791955|NCT01261325|474520925|FG002|Overall Study|Lost to Follow-up|3|||
131791956|NCT01261325|474520923|FG000|Overall Study|AE, serious fatal|0|||
131791957|NCT01261325|474520924|FG001|Overall Study|AE, serious fatal|0|||
131791958|NCT01261325|474520925|FG002|Overall Study|AE, serious fatal|2|||
131791959|NCT04147715|474520928|FG000|Overall Study|Adverse Event|0|||
131791960|NCT04147715|474520929|FG001|Overall Study|Adverse Event|0|||
131791961|NCT04147715|474520930|FG002|Overall Study|Adverse Event|0|||
131791962|NCT04147715|474520931|FG003|Overall Study|Adverse Event|0|||
131791963|NCT04147715|474520932|FG004|Overall Study|Adverse Event|0|||
131791964|NCT04147715|474520933|FG005|Overall Study|Adverse Event|0|||
131791965|NCT04147715|474520934|FG006|Overall Study|Adverse Event|0|||
131791966|NCT04147715|474520935|FG007|Overall Study|Adverse Event|2|||
131791967|NCT04147715|474520936|FG008|Overall Study|Adverse Event|1|||
131791968|NCT04147715|474520937|FG009|Overall Study|Adverse Event|0|||
131791969|NCT04147715|474520938|FG010|Overall Study|Adverse Event|0|||
131791970|NCT04147715|474520939|FG011|Overall Study|Adverse Event|0|||
131791971|NCT03404206|474520940|FG000|Overall Study|Withdrawal by Subject|1|||
131791972|NCT03404206|474520941|FG001|Overall Study|Withdrawal by Subject|1|||
131791973|NCT03404206|474520942|FG002|Overall Study|Withdrawal by Subject|0|||
131791974|NCT03404206|474520940|FG000|Overall Study|Lost to Follow-up|3|||
131791975|NCT03404206|474520941|FG001|Overall Study|Lost to Follow-up|1|||
131791976|NCT03404206|474520942|FG002|Overall Study|Lost to Follow-up|0|||
131791977|NCT02629965|474520951|FG000|Period 1|Adverse Event|1|||
131791978|NCT02629965|474520952|FG001|Period 1|Adverse Event|0|||
131791979|NCT02629965|474520951|FG000|Period 1|Unexpected worsening of disease|2|||
131791980|NCT02629965|474520952|FG001|Period 1|Unexpected worsening of disease|0|||
131791981|NCT02629965|474520951|FG000|Period 1|Other than listed above|1|||
131791982|NCT02629965|474520952|FG001|Period 1|Other than listed above|2|||
131791983|NCT02629965|474520951|FG000|Period 2|Adverse Event|1|||
131791984|NCT02629965|474520952|FG001|Period 2|Adverse Event|0|||
131791985|NCT01337050|474520956|FG000|Overall Study|Death|0|||
131791986|NCT01337050|474520957|FG001|Overall Study|Death|0|||
131791987|NCT01337050|474520958|FG002|Overall Study|Death|4|||
131791988|NCT01337050|474520956|FG000|Overall Study|Other|4|||
131791989|NCT01337050|474520957|FG001|Overall Study|Other|6|||
131791990|NCT01337050|474520958|FG002|Overall Study|Other|8|||
131791991|NCT01337050|474520956|FG000|Overall Study|Participants refused further follow-up|0|||
131791992|NCT01337050|474520957|FG001|Overall Study|Participants refused further follow-up|7|||
131791993|NCT01337050|474520958|FG002|Overall Study|Participants refused further follow-up|7|||
131791994|NCT00003102|474520959|FG000|Overall Study|Physician Decision|1|||
131791995|NCT00003102|474520960|FG001|Overall Study|Physician Decision|1|||
131791996|NCT00003102|474520961|FG002|Overall Study|Physician Decision|0|||
131606987|NCT04451772|473853411|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
131606988|NCT04451772|473853412|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
131606989|NCT04451772|473853413|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
131606990|NCT04451772|473853414|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
131606991|NCT04451772|473853415|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
131606992|NCT04451772|473853416|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
131606993|NCT03858517|473853418|FG000|Overall Study|Adverse Event|1|||
131606994|NCT03858517|473853418|FG000|Overall Study|Lost to Follow-up|1|||
131606995|NCT03858517|473853418|FG000|Overall Study|removed for being incarcerated|1|||
131606996|NCT03858517|473853418|FG000|Overall Study|Sponsor Closure|48|||
131606997|NCT02473445|473853419|FG000|Overall Study|Withdrawal by Subject|2|||
131606998|NCT02473445|473853419|FG000|Overall Study|Sponsor Decision|20|||
131606999|NCT02990338|473853420|FG000|Overall Study|Randomized and not treated|4|||
131607000|NCT02990338|473853421|FG001|Overall Study|Randomized and not treated|2|||
131791997|NCT00003102|474520959|FG000|Overall Study|Progressive Disease|0|||
131607001|NCT02990338|473853420|FG000|Overall Study|Adverse Event|23|||
131791998|NCT00003102|474520960|FG001|Overall Study|Progressive Disease|1|||
131791999|NCT00003102|474520961|FG002|Overall Study|Progressive Disease|0|||
131792000|NCT00003102|474520959|FG000|Overall Study|Adverse Event|0|||
131792001|NCT00003102|474520960|FG001|Overall Study|Adverse Event|1|||
131792002|NCT00003102|474520961|FG002|Overall Study|Adverse Event|1|||
131792003|NCT00003102|474520959|FG000|Overall Study|Death|0|||
131792004|NCT00003102|474520960|FG001|Overall Study|Death|0|||
131792005|NCT00003102|474520961|FG002|Overall Study|Death|1|||
131792006|NCT01512979|474520962|FG000|Overall Study|Adverse Event|2|||
131707340|NCT01439945|474209408|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
131707341|NCT01439945|474209405|FG000|Double-Blind Treatment Phase|Ineligible|1|||
131707342|NCT01439945|474209406|FG001|Double-Blind Treatment Phase|Ineligible|2|||
131707343|NCT01439945|474209407|FG002|Double-Blind Treatment Phase|Ineligible|0|||
131707344|NCT01439945|474209408|FG003|Double-Blind Treatment Phase|Ineligible|1|||
131707345|NCT04082663|474209409|FG000|Overall Study|Adverse Event|6|||
131707346|NCT04082663|474209409|FG000|Overall Study|Lost to Follow-up|1|||
131707347|NCT04343651|474209410|FG000|Overall Study|Physician Decision|2|||
131707348|NCT04343651|474209411|FG001|Overall Study|Physician Decision|1|||
131707349|NCT04343651|474209410|FG000|Overall Study|Lost to Follow-up|2|||
131707350|NCT04343651|474209411|FG001|Overall Study|Lost to Follow-up|1|||
131707351|NCT04343651|474209410|FG000|Overall Study|Protocol Violation|4|||
131707352|NCT04343651|474209411|FG001|Overall Study|Protocol Violation|6|||
131707353|NCT04343651|474209410|FG000|Overall Study|Missing|3|||
131707354|NCT04343651|474209411|FG001|Overall Study|Missing|9|||
131707355|NCT04343651|474209410|FG000|Overall Study|Withdrawal by Subject|0|||
131707356|NCT04343651|474209411|FG001|Overall Study|Withdrawal by Subject|4|||
131707357|NCT04343651|474209410|FG000|Overall Study|Death|0|||
131707358|NCT04343651|474209411|FG001|Overall Study|Death|1|||
131707359|NCT04343651|474209410|FG000|Overall Study|Did not start treatment|1|||
131707360|NCT04343651|474209411|FG001|Overall Study|Did not start treatment|1|||
131707361|NCT04343651|474209410|FG000|Overall Study|Patient did not complete visits 3-6|0|||
131707362|NCT04343651|474209411|FG001|Overall Study|Patient did not complete visits 3-6|1|||
131707363|NCT02246621|474209412|FG000|Overall Study|Withdrawal by Subject|28|||
131707364|NCT02246621|474209413|FG001|Overall Study|Withdrawal by Subject|16|||
131707365|NCT02246621|474209412|FG000|Overall Study|Lost to Follow-up|1|||
131707366|NCT02246621|474209413|FG001|Overall Study|Lost to Follow-up|0|||
131707367|NCT02246621|474209412|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
131707368|NCT02246621|474209413|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
131707369|NCT01459614|474209414|FG000|Overall Study|Adverse Event|1|||
131707370|NCT01459614|474209415|FG001|Overall Study|Adverse Event|0|||
131707371|NCT03136107|474209425|FG000|Overall Study|Other (Not specified)|1|||
131707372|NCT03283085|474209426|FG000|Overall Study|Adverse Event|18|||
131707373|NCT03283085|474209427|FG001|Overall Study|Adverse Event|3|||
131707374|NCT03283085|474209428|FG002|Overall Study|Adverse Event|13|||
131707375|NCT03283085|474209429|FG003|Overall Study|Adverse Event|0|||
131707376|NCT03283085|474209430|FG004|Overall Study|Adverse Event|0|||
131707377|NCT03283085|474209431|FG005|Overall Study|Adverse Event|5|||
131707378|NCT03283085|474209426|FG000|Overall Study|Death|0|||
131707379|NCT03283085|474209427|FG001|Overall Study|Death|0|||
131707380|NCT03283085|474209428|FG002|Overall Study|Death|3|||
131707381|NCT03283085|474209429|FG003|Overall Study|Death|1|||
131707382|NCT03283085|474209430|FG004|Overall Study|Death|0|||
131707383|NCT03283085|474209431|FG005|Overall Study|Death|0|||
131792007|NCT01512979|474520963|FG001|Overall Study|Adverse Event|2|||
131792008|NCT01512979|474520962|FG000|Overall Study|Protocol Violation|1|||
131792009|NCT01512979|474520963|FG001|Overall Study|Protocol Violation|4|||
131792010|NCT01512979|474520962|FG000|Overall Study|Lost to Follow-up|2|||
131792011|NCT01512979|474520963|FG001|Overall Study|Lost to Follow-up|5|||
131792012|NCT01512979|474520962|FG000|Overall Study|Withdrawal by Subject|1|||
131792013|NCT01512979|474520963|FG001|Overall Study|Withdrawal by Subject|2|||
131792014|NCT01512979|474520962|FG000|Overall Study|Reason other than stated above|13|||
131792015|NCT01512979|474520963|FG001|Overall Study|Reason other than stated above|9|||
131792016|NCT02230085|474520964|FG000|Overall Study|Physician Decision|1|||
131792017|NCT02230085|474520964|FG000|Overall Study|Withdrawal by Subject|3|||
131792018|NCT02173301|474520965|FG000|Overall Study|Adverse Event|7|||
131792019|NCT02173301|474520966|FG001|Overall Study|Adverse Event|8|||
131792020|NCT02173301|474520967|FG002|Overall Study|Adverse Event|13|||
131792021|NCT02173301|474520968|FG003|Overall Study|Adverse Event|5|||
131792022|NCT02173301|474520965|FG000|Overall Study|Withdrawal by Subject|8|||
131792023|NCT02173301|474520966|FG001|Overall Study|Withdrawal by Subject|10|||
131792024|NCT02173301|474520967|FG002|Overall Study|Withdrawal by Subject|4|||
131792025|NCT02173301|474520968|FG003|Overall Study|Withdrawal by Subject|8|||
131707384|NCT03283085|474209426|FG000|Overall Study|Withdrawal by Subject|42|||
131792026|NCT02173301|474520965|FG000|Overall Study|Lost to Follow-up|4|||
131792027|NCT02173301|474520966|FG001|Overall Study|Lost to Follow-up|4|||
131707385|NCT03283085|474209427|FG001|Overall Study|Withdrawal by Subject|21|||
131707386|NCT03283085|474209428|FG002|Overall Study|Withdrawal by Subject|66|||
131707387|NCT03283085|474209429|FG003|Overall Study|Withdrawal by Subject|3|||
131707388|NCT03283085|474209430|FG004|Overall Study|Withdrawal by Subject|3|||
131707389|NCT03283085|474209431|FG005|Overall Study|Withdrawal by Subject|5|||
131707390|NCT03283085|474209426|FG000|Overall Study|Physician Decision|14|||
131707391|NCT03283085|474209427|FG001|Overall Study|Physician Decision|8|||
131792028|NCT02173301|474520967|FG002|Overall Study|Lost to Follow-up|2|||
131440686|NCT03361137|473241563|FG003|Overall Study|Reason not specified|0|||
131607002|NCT02990338|473853421|FG001|Overall Study|Adverse Event|22|||
131607003|NCT02990338|473853420|FG000|Overall Study|Progressive disease|118|||
131607004|NCT02990338|473853421|FG001|Overall Study|Progressive disease|107|||
131607005|NCT02990338|473853420|FG000|Overall Study|Poor compliance to protocol|0|||
131607006|NCT02990338|473853421|FG001|Overall Study|Poor compliance to protocol|1|||
131607007|NCT02990338|473853420|FG000|Overall Study|Withdrawal by Subject|6|||
131607008|NCT02990338|473853421|FG001|Overall Study|Withdrawal by Subject|8|||
131607009|NCT02990338|473853420|FG000|Overall Study|Physician's decision|2|||
131792029|NCT02173301|474520968|FG003|Overall Study|Lost to Follow-up|2|||
131792030|NCT02173301|474520965|FG000|Overall Study|Protocol Violation|0|||
131792031|NCT02173301|474520966|FG001|Overall Study|Protocol Violation|1|||
131792032|NCT02173301|474520967|FG002|Overall Study|Protocol Violation|0|||
131792033|NCT02173301|474520968|FG003|Overall Study|Protocol Violation|0|||
131792034|NCT02173301|474520965|FG000|Overall Study|Physician Decision|0|||
131792035|NCT02173301|474520966|FG001|Overall Study|Physician Decision|0|||
131792036|NCT02173301|474520967|FG002|Overall Study|Physician Decision|1|||
131792037|NCT02173301|474520968|FG003|Overall Study|Physician Decision|0|||
131792038|NCT02173301|474520965|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
131792039|NCT02173301|474520966|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
131792040|NCT02173301|474520967|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
131792041|NCT02173301|474520968|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
131792042|NCT03016078|474520969|FG000|Overall Study|Protocol Violation|1|||
131792043|NCT03016078|474520969|FG000|Overall Study|Protocol Violation|1|||
131792044|NCT02196506|474520972|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
131792045|NCT02196506|474520973|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
131792046|NCT02196506|474520974|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
131792047|NCT02196506|474520975|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
131792048|NCT02196506|474520972|FG000|Phase A|Withdrawal by Subject|34|||
131792049|NCT02196506|474520973|FG001|Phase A|Withdrawal by Subject|0|||
131792050|NCT02196506|474520974|FG002|Phase A|Withdrawal by Subject|0|||
131792051|NCT02196506|474520975|FG003|Phase A|Withdrawal by Subject|0|||
131792052|NCT02196506|474520972|FG000|Phase A|Adverse Event|22|||
131792053|NCT02196506|474520973|FG001|Phase A|Adverse Event|0|||
131792054|NCT02196506|474520974|FG002|Phase A|Adverse Event|0|||
131792055|NCT02196506|474520975|FG003|Phase A|Adverse Event|0|||
131792056|NCT02196506|474520972|FG000|Phase A|Lost to Follow-up|9|||
131792057|NCT02196506|474520973|FG001|Phase A|Lost to Follow-up|0|||
131792058|NCT02196506|474520974|FG002|Phase A|Lost to Follow-up|0|||
131792059|NCT02196506|474520975|FG003|Phase A|Lost to Follow-up|0|||
131792060|NCT02196506|474520972|FG000|Phase A|Protocol deviation|12|||
131792061|NCT02196506|474520973|FG001|Phase A|Protocol deviation|0|||
131792062|NCT02196506|474520974|FG002|Phase A|Protocol deviation|0|||
131792063|NCT02196506|474520975|FG003|Phase A|Protocol deviation|0|||
131792064|NCT02196506|474520972|FG000|Phase A|Participant withdrawn by investigator|10|||
131792065|NCT02196506|474520973|FG001|Phase A|Participant withdrawn by investigator|0|||
131792066|NCT02196506|474520974|FG002|Phase A|Participant withdrawn by investigator|0|||
131792067|NCT02196506|474520975|FG003|Phase A|Participant withdrawn by investigator|0|||
131792068|NCT02196506|474520972|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
131792069|NCT02196506|474520973|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
131792070|NCT02196506|474520974|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
131792071|NCT02196506|474520975|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
131792072|NCT02196506|474520972|FG000|Phase B|Lack of Efficacy|0|||
131792073|NCT02196506|474520973|FG001|Phase B|Lack of Efficacy|1|||
131792074|NCT02196506|474520974|FG002|Phase B|Lack of Efficacy|2|||
131792075|NCT02196506|474520975|FG003|Phase B|Lack of Efficacy|0|||
131792076|NCT02196506|474520972|FG000|Phase B|Withdrawal by Participant|0|||
131792077|NCT02196506|474520973|FG001|Phase B|Withdrawal by Participant|8|||
131792078|NCT02196506|474520974|FG002|Phase B|Withdrawal by Participant|1|||
131792079|NCT02196506|474520975|FG003|Phase B|Withdrawal by Participant|0|||
131792080|NCT02196506|474520972|FG000|Phase B|Adverse Event|0|||
131792081|NCT02196506|474520973|FG001|Phase B|Adverse Event|4|||
131440687|NCT03361137|473241564|FG004|Overall Study|Reason not specified|0|||
131792082|NCT02196506|474520974|FG002|Phase B|Adverse Event|1|||
131607010|NCT02990338|473853421|FG001|Overall Study|Physician's decision|6|||
131607011|NCT02990338|473853420|FG000|Overall Study|Treatment extension study|0|||
131607012|NCT02990338|473853421|FG001|Overall Study|Treatment extension study|6|||
131707392|NCT03283085|474209428|FG002|Overall Study|Physician Decision|19|||
131707393|NCT03283085|474209429|FG003|Overall Study|Physician Decision|0|||
131707394|NCT03283085|474209430|FG004|Overall Study|Physician Decision|0|||
131707395|NCT03283085|474209431|FG005|Overall Study|Physician Decision|2|||
131707396|NCT03283085|474209426|FG000|Overall Study|Site Terminated by Sponsor|1|||
131707397|NCT03283085|474209427|FG001|Overall Study|Site Terminated by Sponsor|0|||
131707398|NCT03283085|474209428|FG002|Overall Study|Site Terminated by Sponsor|3|||
131707399|NCT03283085|474209429|FG003|Overall Study|Site Terminated by Sponsor|0|||
131707400|NCT03283085|474209430|FG004|Overall Study|Site Terminated by Sponsor|0|||
131899717|NCT02659943|474919373|FG000|Overall Study|No treatment, per protocol|0|||
131899718|NCT02659943|474919374|FG001|Overall Study|No treatment, per protocol|0|||
131899719|NCT02659943|474919375|FG002|Overall Study|No treatment, per protocol|0|||
131899720|NCT02659943|474919376|FG003|Overall Study|No treatment, per protocol|0|||
131899721|NCT02659943|474919377|FG004|Overall Study|No treatment, per protocol|0|||
131899722|NCT02659943|474919378|FG005|Overall Study|No treatment, per protocol|0|||
131899723|NCT02659943|474919379|FG006|Overall Study|No treatment, per protocol|3|||
131899724|NCT01576575|474919380|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
131899725|NCT01576575|474919380|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
131899726|NCT01576575|474919380|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
131899727|NCT01723072|474919381|FG000|Overall Study|Withdrawal by Subject|7|||
131899728|NCT01723072|474919382|FG001|Overall Study|Withdrawal by Subject|13|||
131899729|NCT01723072|474919381|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
131899730|NCT01723072|474919382|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
131899731|NCT01723072|474919381|FG000|Overall Study|Other|4|||
131899732|NCT01723072|474919382|FG001|Overall Study|Other|3|||
131899733|NCT03428100|474919383|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
131899734|NCT03428100|474919384|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899735|NCT03428100|474919385|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
131899736|NCT03428100|474919386|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
131899737|NCT03428100|474919387|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899738|NCT03428100|474919388|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899739|NCT03428100|474919389|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899740|NCT03428100|474919390|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899741|NCT03428100|474919391|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899742|NCT03428100|474919392|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899743|NCT03428100|474919393|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899744|NCT03428100|474919394|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899745|NCT03428100|474919395|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899746|NCT03428100|474919396|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899747|NCT03428100|474919397|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899748|NCT03428100|474919398|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899749|NCT03428100|474919399|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899750|NCT03428100|474919400|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899751|NCT03428100|474919401|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131899752|NCT03428100|474919383|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
131899753|NCT03428100|474919384|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
131899754|NCT03428100|474919385|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
131899755|NCT03428100|474919386|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
131899756|NCT03428100|474919387|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899757|NCT03428100|474919388|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899758|NCT03428100|474919389|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899759|NCT03428100|474919390|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899760|NCT03428100|474919391|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131607013|NCT02990338|473853420|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
131607014|NCT02990338|473853421|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
131607015|NCT02990338|473853420|FG000|Overall Study|Continue with therapy available commercially|0|||
131607016|NCT02990338|473853421|FG001|Overall Study|Continue with therapy available commercially|1|||
131607017|NCT04479761|473853422|FG000|Overall Study|could not perform the balance tasks|1|||
131607018|NCT04479761|473853423|FG001|Overall Study|could not perform the balance tasks|0|||
131607019|NCT04479761|473853424|FG002|Overall Study|could not perform the balance tasks|0|||
131607020|NCT04479761|473853422|FG000|Overall Study|Adverse Event|1|||
131607021|NCT04479761|473853423|FG001|Overall Study|Adverse Event|0|||
131607022|NCT04479761|473853424|FG002|Overall Study|Adverse Event|0|||
131607023|NCT04479761|473853422|FG000|Overall Study|one control did not meet screening criteria|0|||
131607024|NCT04479761|473853423|FG001|Overall Study|one control did not meet screening criteria|0|||
131607025|NCT04479761|473853424|FG002|Overall Study|one control did not meet screening criteria|1|||
131607026|NCT04479761|473853422|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
131607027|NCT04479761|473853423|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
131607028|NCT04479761|473853424|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
131607029|NCT02997202|473853426|FG000|Overall Study|Miscellaneous|2|||
131607030|NCT02997202|473853427|FG001|Overall Study|Miscellaneous|2|||
131899761|NCT03428100|474919392|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899762|NCT03428100|474919393|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131607031|NCT02997202|473853426|FG000|Overall Study|Withdrawal by Subject|8|||
131899763|NCT03428100|474919394|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899764|NCT03428100|474919395|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131707401|NCT03283085|474209431|FG005|Overall Study|Site Terminated by Sponsor|0|||
131707402|NCT03283085|474209426|FG000|Overall Study|Lost to Follow-up|2|||
131707403|NCT03283085|474209427|FG001|Overall Study|Lost to Follow-up|0|||
131707404|NCT03283085|474209428|FG002|Overall Study|Lost to Follow-up|2|||
131707405|NCT03283085|474209429|FG003|Overall Study|Lost to Follow-up|0|||
131707406|NCT03283085|474209430|FG004|Overall Study|Lost to Follow-up|0|||
131707407|NCT03283085|474209431|FG005|Overall Study|Lost to Follow-up|1|||
131707408|NCT03283085|474209426|FG000|Overall Study|Pregnancy|0|||
131707409|NCT03283085|474209427|FG001|Overall Study|Pregnancy|0|||
131707410|NCT03283085|474209428|FG002|Overall Study|Pregnancy|1|||
131707411|NCT03283085|474209429|FG003|Overall Study|Pregnancy|0|||
131707412|NCT03283085|474209430|FG004|Overall Study|Pregnancy|0|||
131707413|NCT03283085|474209431|FG005|Overall Study|Pregnancy|0|||
131707414|NCT03283085|474209426|FG000|Overall Study|Lack of Efficacy|12|||
131707415|NCT03283085|474209427|FG001|Overall Study|Lack of Efficacy|6|||
131707416|NCT03283085|474209428|FG002|Overall Study|Lack of Efficacy|24|||
131707417|NCT03283085|474209429|FG003|Overall Study|Lack of Efficacy|1|||
131707418|NCT03283085|474209430|FG004|Overall Study|Lack of Efficacy|1|||
131707419|NCT03283085|474209431|FG005|Overall Study|Lack of Efficacy|0|||
131707420|NCT03283085|474209426|FG000|Overall Study|Reason not Specified|0|||
131707421|NCT03283085|474209427|FG001|Overall Study|Reason not Specified|4|||
131707422|NCT03283085|474209428|FG002|Overall Study|Reason not Specified|8|||
131707423|NCT03283085|474209429|FG003|Overall Study|Reason not Specified|0|||
131707424|NCT03283085|474209430|FG004|Overall Study|Reason not Specified|0|||
131707425|NCT03283085|474209431|FG005|Overall Study|Reason not Specified|1|||
131707426|NCT02292771|474209435|FG000|Overall Study|Withdrawal by Subject|2|||
131707427|NCT02292771|474209436|FG001|Overall Study|Withdrawal by Subject|1|||
131707428|NCT02292771|474209435|FG000|Overall Study|Lost to Follow-up|2|||
131707429|NCT02292771|474209436|FG001|Overall Study|Lost to Follow-up|1|||
131707430|NCT04574999|474211212|FG000|Overall Study|Adverse Event|1|||
131707431|NCT04574999|474211213|FG001|Overall Study|Adverse Event|0|||
131707432|NCT04574999|474211212|FG000|Overall Study|Lack of Efficacy|2|||
131707433|NCT04574999|474211213|FG001|Overall Study|Lack of Efficacy|3|||
131707434|NCT04574999|474211212|FG000|Overall Study|Protocol Violation|1|||
131707435|NCT04574999|474211213|FG001|Overall Study|Protocol Violation|0|||
131707436|NCT04574999|474211212|FG000|Overall Study|Withdrawal by Subject|2|||
131707437|NCT04574999|474211213|FG001|Overall Study|Withdrawal by Subject|2|||
131707438|NCT04574999|474211212|FG000|Overall Study|Lost to Follow-up|1|||
131707439|NCT04574999|474211213|FG001|Overall Study|Lost to Follow-up|0|||
131792083|NCT02196506|474520975|FG003|Phase B|Adverse Event|0|||
131792084|NCT02196506|474520972|FG000|Phase B|Lost to Follow-up|0|||
131792085|NCT02196506|474520973|FG001|Phase B|Lost to Follow-up|2|||
131792086|NCT02196506|474520974|FG002|Phase B|Lost to Follow-up|1|||
131792087|NCT02196506|474520975|FG003|Phase B|Lost to Follow-up|0|||
131792088|NCT02196506|474520972|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
131792089|NCT02196506|474520973|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
131792090|NCT02196506|474520974|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
131792091|NCT02196506|474520975|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
131792092|NCT02196506|474520972|FG000|Phase A+|Withdrawal by Participant|0|||
131792093|NCT02196506|474520973|FG001|Phase A+|Withdrawal by Participant|0|||
131792094|NCT02196506|474520974|FG002|Phase A+|Withdrawal by Participant|0|||
131792095|NCT02196506|474520975|FG003|Phase A+|Withdrawal by Participant|5|||
131792096|NCT02196506|474520972|FG000|Phase A+|Adverse Event|0|||
131792097|NCT02196506|474520973|FG001|Phase A+|Adverse Event|0|||
131707440|NCT04574999|474211212|FG000|Overall Study|Personal problems|1|||
131707441|NCT04574999|474211213|FG001|Overall Study|Personal problems|0|||
131707442|NCT04574999|474211212|FG000|Overall Study|Previous planned surgery|1|||
131707443|NCT04574999|474211213|FG001|Overall Study|Previous planned surgery|0|||
131707444|NCT00317044|474211216|FG000|Overall Study|Protocol Violation|28|||
131707445|NCT00317044|474211217|FG001|Overall Study|Protocol Violation|22|||
131707446|NCT00317044|474211218|FG002|Overall Study|Protocol Violation|20|||
131707447|NCT00317044|474211216|FG000|Overall Study|Adverse Event|4|||
131792098|NCT02196506|474520974|FG002|Phase A+|Adverse Event|0|||
131792099|NCT02196506|474520975|FG003|Phase A+|Adverse Event|1|||
131707448|NCT00317044|474211217|FG001|Overall Study|Adverse Event|7|||
131707449|NCT00317044|474211218|FG002|Overall Study|Adverse Event|4|||
131707450|NCT00317044|474211216|FG000|Overall Study|Withdrawal by Subject|10|||
131707451|NCT00317044|474211217|FG001|Overall Study|Withdrawal by Subject|7|||
131707452|NCT00317044|474211218|FG002|Overall Study|Withdrawal by Subject|12|||
131707453|NCT00317044|474211216|FG000|Overall Study|Lost to Follow-up|0|||
131707454|NCT00317044|474211217|FG001|Overall Study|Lost to Follow-up|2|||
131707455|NCT00317044|474211218|FG002|Overall Study|Lost to Follow-up|3|||
131792100|NCT02196506|474520972|FG000|Phase A+|Lost to Follow-up|0|||
131607032|NCT02997202|473853427|FG001|Overall Study|Withdrawal by Subject|12|||
131607033|NCT02997202|473853426|FG000|Overall Study|Lost to Follow-up|5|||
131607034|NCT02997202|473853427|FG001|Overall Study|Lost to Follow-up|3|||
131607035|NCT02997202|473853426|FG000|Overall Study|Death|41|||
131607036|NCT02997202|473853427|FG001|Overall Study|Death|45|||
131607037|NCT01199133|473853428|FG000|Year 1|Adverse Event|16|||
131607038|NCT01199133|473853429|FG001|Year 1|Adverse Event|4|||
131607039|NCT01199133|473853428|FG000|Year 1|Withdrawal by Subject|8|||
131607040|NCT01199133|473853429|FG001|Year 1|Withdrawal by Subject|4|||
131607041|NCT01199133|473853428|FG000|Year 1|Any other reason not above-mentioned|6|||
131607042|NCT01199133|473853429|FG001|Year 1|Any other reason not above-mentioned|7|||
131607043|NCT01199133|473853428|FG000|Year 2|Adverse Event|1|||
131607044|NCT01199133|473853429|FG001|Year 2|Adverse Event|0|||
131607045|NCT01199133|473853428|FG000|Year 2|Withdrawal by Subject|1|||
131607046|NCT01199133|473853429|FG001|Year 2|Withdrawal by Subject|1|||
131607047|NCT01199133|473853428|FG000|Year 2|Any other reason not above-mentioned|1|||
131607048|NCT01199133|473853429|FG001|Year 2|Any other reason not above-mentioned|2|||
131607049|NCT03988621|473853430|FG000|Overall Study|Lost to Follow-up|16|||
131607050|NCT03988621|473853431|FG001|Overall Study|Lost to Follow-up|17|||
131607051|NCT03988621|473853430|FG000|Overall Study|Withdrawal by Subject|14|||
131792101|NCT02196506|474520973|FG001|Phase A+|Lost to Follow-up|0|||
131792102|NCT02196506|474520974|FG002|Phase A+|Lost to Follow-up|0|||
131792103|NCT02196506|474520975|FG003|Phase A+|Lost to Follow-up|6|||
131792104|NCT02196506|474520972|FG000|Phase A+|Participant withdrawn by investigator|0|||
131792105|NCT02196506|474520973|FG001|Phase A+|Participant withdrawn by investigator|0|||
131792106|NCT02196506|474520974|FG002|Phase A+|Participant withdrawn by investigator|0|||
131792107|NCT02196506|474520975|FG003|Phase A+|Participant withdrawn by investigator|1|||
131792108|NCT00066807|474520986|FG000|Overall Study|Study was terminated early|14|||
131792109|NCT00066807|474520987|FG001|Overall Study|Study was terminated early|15|||
131792110|NCT05028751|474520988|FG000|Overall Study|Study Terminated by Sponsor|3|||
131792111|NCT05028751|474520989|FG001|Overall Study|Study Terminated by Sponsor|0|||
131792112|NCT05028751|474520990|FG002|Overall Study|Study Terminated by Sponsor|0|||
131792113|NCT05028751|474520991|FG003|Overall Study|Study Terminated by Sponsor|0|||
131792114|NCT05028751|474520988|FG000|Overall Study|Death|9|||
131792115|NCT05028751|474520989|FG001|Overall Study|Death|3|||
131792116|NCT05028751|474520990|FG002|Overall Study|Death|2|||
131792117|NCT05028751|474520991|FG003|Overall Study|Death|4|||
131792118|NCT05028751|474520988|FG000|Overall Study|Withdrawal by Subject|0|||
131792119|NCT05028751|474520989|FG001|Overall Study|Withdrawal by Subject|0|||
131792120|NCT05028751|474520990|FG002|Overall Study|Withdrawal by Subject|1|||
131792121|NCT05028751|474520991|FG003|Overall Study|Withdrawal by Subject|0|||
131792122|NCT05028751|474520988|FG000|Overall Study|Miscellaneous|2|||
131792123|NCT05028751|474520989|FG001|Overall Study|Miscellaneous|0|||
131792124|NCT05028751|474520990|FG002|Overall Study|Miscellaneous|0|||
131792125|NCT05028751|474520991|FG003|Overall Study|Miscellaneous|0|||
131792126|NCT03586830|474520992|FG000|Overall Study|Site terminated by Sponsor|1|||
131792127|NCT03586830|474520993|FG001|Overall Study|Site terminated by Sponsor|4|||
131792128|NCT03586830|474520994|FG002|Overall Study|Site terminated by Sponsor|3|||
131792129|NCT03586830|474520995|FG003|Overall Study|Site terminated by Sponsor|3|||
131792130|NCT03586830|474520992|FG000|Overall Study|Lost to Follow-up|0|||
131792131|NCT03586830|474520993|FG001|Overall Study|Lost to Follow-up|2|||
131792132|NCT03586830|474520994|FG002|Overall Study|Lost to Follow-up|2|||
131792133|NCT03586830|474520995|FG003|Overall Study|Lost to Follow-up|1|||
131792134|NCT03586830|474520992|FG000|Overall Study|Withdrawal by Subject|1|||
131792135|NCT03586830|474520993|FG001|Overall Study|Withdrawal by Subject|0|||
131792136|NCT03586830|474520994|FG002|Overall Study|Withdrawal by Subject|3|||
131792137|NCT03586830|474520995|FG003|Overall Study|Withdrawal by Subject|1|||
131607052|NCT03988621|473853431|FG001|Overall Study|Withdrawal by Subject|7|||
131607053|NCT03988621|473853430|FG000|Overall Study|Patient Lost to Follow Up|15|||
131607054|NCT03988621|473853431|FG001|Overall Study|Patient Lost to Follow Up|15|||
131607055|NCT03988621|473853430|FG000|Overall Study|Patient death|1|||
131607056|NCT03988621|473853431|FG001|Overall Study|Patient death|5|||
131607057|NCT02542631|473853443|FG000|Overall Study|Adverse Event|1|||
131607058|NCT02542631|473853444|FG001|Overall Study|Adverse Event|1|||
131607059|NCT02542631|473853443|FG000|Overall Study|Sponsor Termination|1|||
131792138|NCT04578548|474520996|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131792139|NCT04578548|474520997|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131792140|NCT04578548|474520996|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
131792141|NCT04578548|474520997|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
131792142|NCT04578548|474520996|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
131607060|NCT02542631|473853444|FG001|Overall Study|Sponsor Termination|0|||
131607061|NCT02542631|473853443|FG000|Overall Study|Withdrawal by Subject|11|||
131607062|NCT02542631|473853444|FG001|Overall Study|Withdrawal by Subject|16|||
131607063|NCT02542631|473853443|FG000|Overall Study|Protocol Violation|1|||
131607064|NCT02542631|473853444|FG001|Overall Study|Protocol Violation|1|||
131607065|NCT02542631|473853443|FG000|Overall Study|Physician Decision|6|||
131607066|NCT02542631|473853444|FG001|Overall Study|Physician Decision|4|||
131607067|NCT02542631|473853443|FG000|Overall Study|Lost to Follow-up|6|||
131607068|NCT02542631|473853444|FG001|Overall Study|Lost to Follow-up|5|||
131607069|NCT02542631|473853443|FG000|Overall Study|Death|1|||
131607070|NCT02542631|473853444|FG001|Overall Study|Death|2|||
131607071|NCT02542631|473853443|FG000|Overall Study|Other|2|||
131607072|NCT02542631|473853444|FG001|Overall Study|Other|1|||
131607073|NCT02542631|473853443|FG000|Overall Study|Used Prohibited Medication|2|||
131607074|NCT02542631|473853444|FG001|Overall Study|Used Prohibited Medication|1|||
131607075|NCT05158504|473853445|FG000|Overall Study|Lost to Follow-up|2|||
131607076|NCT05158504|473853446|FG001|Overall Study|Lost to Follow-up|3|||
131607077|NCT03606512|473853447|FG000|Overall Study|Lost to Follow-up|0|||
131607078|NCT03606512|473853448|FG001|Overall Study|Lost to Follow-up|1|||
131607079|NCT03606512|473853447|FG000|Overall Study|'moved from study area|0|||
131607080|NCT03606512|473853448|FG001|Overall Study|'moved from study area|1|||
131607081|NCT05513937|473853449|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
131607082|NCT05513937|473853450|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
131607083|NCT05513937|473853451|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
131607084|NCT05513937|473853452|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
131607085|NCT05513937|473853449|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
131607086|NCT05513937|473853450|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
131607087|NCT05513937|473853451|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
131607088|NCT05513937|473853452|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
131607089|NCT05513937|473853449|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
131607090|NCT05513937|473853450|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
131607091|NCT05513937|473853451|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
131607092|NCT05513937|473853452|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
131607093|NCT05513937|473853449|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
131607094|NCT05513937|473853450|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
131607095|NCT05513937|473853451|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
131607096|NCT05513937|473853452|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
131607097|NCT05513937|473853449|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
131607098|NCT05513937|473853450|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
131607099|NCT05513937|473853451|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
131607100|NCT05513937|473853452|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
131607101|NCT05513937|473853449|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
131607102|NCT05513937|473853450|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
131607103|NCT05513937|473853451|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
131607104|NCT05513937|473853452|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
131607105|NCT03691298|473853455|FG000|Overall Study|Lost to Follow-up|8|||
131607106|NCT03691298|473853455|FG000|Overall Study|Sponsor terminated study|2|||
131792143|NCT04578548|474520997|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
131792144|NCT04578548|474520996|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
131792145|NCT04578548|474520997|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
131792146|NCT04578548|474520996|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
131792147|NCT04578548|474520997|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
131792148|NCT04578548|474520996|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
131792149|NCT04578548|474520997|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
131792150|NCT00395083|474520998|FG000|Overall Study|Withdrawal by Subject|6|||
131792151|NCT00395083|474520999|FG001|Overall Study|Withdrawal by Subject|5|||
131792152|NCT00395083|474520998|FG000|Overall Study|Developed another disease|4|||
131792153|NCT00395083|474520999|FG001|Overall Study|Developed another disease|3|||
131792154|NCT04136626|474521000|FG000|Treatment Phase|Withdrawal by Subject|1|||
131792155|NCT04136626|474521001|FG001|Treatment Phase|Withdrawal by Subject|9|||
131792156|NCT04136626|474521000|FG000|Treatment Phase|Adverse Event|1|||
131792157|NCT04136626|474521001|FG001|Treatment Phase|Adverse Event|0|||
131792158|NCT04136626|474521000|FG000|Treatment Phase|Lost to Follow-up|1|||
131792159|NCT04136626|474521001|FG001|Treatment Phase|Lost to Follow-up|5|||
131792160|NCT04136626|474521000|FG000|12-month Follow-up|Lost to Follow-up|8|||
131792161|NCT04136626|474521001|FG001|12-month Follow-up|Lost to Follow-up|7|||
131792162|NCT00628745|474521002|FG000|Overall Study|Withdrawal by Subject|63|||
131792163|NCT00628745|474521003|FG001|Overall Study|Withdrawal by Subject|3|||
131792164|NCT00628745|474521004|FG002|Overall Study|Withdrawal by Subject|9|||
131792165|NCT00628745|474521005|FG003|Overall Study|Withdrawal by Subject|2|||
131792166|NCT00628745|474521006|FG004|Overall Study|Withdrawal by Subject|69|||
131792167|NCT00628745|474521002|FG000|Overall Study|Does not meet inclusion criteria|0|||
131607107|NCT02492711|473853459|FG000|Overall Study|Adverse Event|9|||
131607108|NCT02492711|473853460|FG001|Overall Study|Adverse Event|9|||
131792168|NCT00628745|474521003|FG001|Overall Study|Does not meet inclusion criteria|12|||
131707456|NCT00317044|474211216|FG000|Overall Study|Multiple Reasons|6|||
131707457|NCT00317044|474211217|FG001|Overall Study|Multiple Reasons|2|||
131707458|NCT00317044|474211218|FG002|Overall Study|Multiple Reasons|6|||
131707459|NCT00432237|474211225|FG000|Overall Study|Adverse Event|0|||
131707460|NCT00432237|474211226|FG001|Overall Study|Adverse Event|0|||
131707461|NCT00432237|474211227|FG002|Overall Study|Adverse Event|0|||
131707462|NCT00432237|474211228|FG003|Overall Study|Adverse Event|1|||
131707463|NCT00432237|474211225|FG000|Overall Study|Lack of Efficacy|0|||
131707464|NCT00432237|474211226|FG001|Overall Study|Lack of Efficacy|0|||
131707465|NCT00432237|474211227|FG002|Overall Study|Lack of Efficacy|0|||
131707466|NCT00432237|474211228|FG003|Overall Study|Lack of Efficacy|1|||
131707467|NCT00432237|474211225|FG000|Overall Study|Lost to Follow-up|10|||
131707468|NCT00432237|474211226|FG001|Overall Study|Lost to Follow-up|10|||
131707469|NCT00432237|474211227|FG002|Overall Study|Lost to Follow-up|18|||
131707470|NCT00432237|474211228|FG003|Overall Study|Lost to Follow-up|18|||
131707471|NCT00432237|474211225|FG000|Overall Study|Physician Decision|1|||
131707472|NCT00432237|474211226|FG001|Overall Study|Physician Decision|3|||
131707473|NCT00432237|474211227|FG002|Overall Study|Physician Decision|2|||
131707474|NCT00432237|474211228|FG003|Overall Study|Physician Decision|1|||
131707475|NCT00432237|474211225|FG000|Overall Study|Pregnancy|0|||
131707476|NCT00432237|474211226|FG001|Overall Study|Pregnancy|1|||
131707477|NCT00432237|474211227|FG002|Overall Study|Pregnancy|0|||
131707478|NCT00432237|474211228|FG003|Overall Study|Pregnancy|0|||
131707479|NCT00432237|474211225|FG000|Overall Study|Protocol Violation|13|||
131707480|NCT00432237|474211226|FG001|Overall Study|Protocol Violation|10|||
131707481|NCT00432237|474211227|FG002|Overall Study|Protocol Violation|11|||
131707482|NCT00432237|474211228|FG003|Overall Study|Protocol Violation|8|||
131792169|NCT00628745|474521004|FG002|Overall Study|Does not meet inclusion criteria|0|||
131792170|NCT00628745|474521005|FG003|Overall Study|Does not meet inclusion criteria|0|||
131792171|NCT00628745|474521006|FG004|Overall Study|Does not meet inclusion criteria|18|||
131792172|NCT00628745|474521002|FG000|Overall Study|Participation in an interventional clinical trial|81|||
131792173|NCT00628745|474521003|FG001|Overall Study|Participation in an interventional clinical trial|4|||
131792174|NCT00628745|474521004|FG002|Overall Study|Participation in an interventional clinical trial|7|||
131792175|NCT00628745|474521005|FG003|Overall Study|Participation in an interventional clinical trial|0|||
131792176|NCT00628745|474521006|FG004|Overall Study|Participation in an interventional clinical trial|63|||
131792177|NCT00628745|474521002|FG000|Overall Study|Physician Decision|8|||
131792178|NCT00628745|474521003|FG001|Overall Study|Physician Decision|4|||
131792179|NCT00628745|474521004|FG002|Overall Study|Physician Decision|3|||
131792180|NCT00628745|474521005|FG003|Overall Study|Physician Decision|0|||
131792181|NCT00628745|474521006|FG004|Overall Study|Physician Decision|30|||
131792182|NCT00628745|474521002|FG000|Overall Study|Lost to Follow-up|109|||
131792183|NCT00628745|474521003|FG001|Overall Study|Lost to Follow-up|7|||
131792184|NCT00628745|474521004|FG002|Overall Study|Lost to Follow-up|7|||
131792185|NCT00628745|474521005|FG003|Overall Study|Lost to Follow-up|0|||
131792186|NCT00628745|474521006|FG004|Overall Study|Lost to Follow-up|498|||
131792187|NCT00628745|474521002|FG000|Overall Study|Death|197|||
131792188|NCT00628745|474521003|FG001|Overall Study|Death|81|||
131792189|NCT00628745|474521004|FG002|Overall Study|Death|12|||
131792190|NCT00628745|474521005|FG003|Overall Study|Death|4|||
131792191|NCT00628745|474521006|FG004|Overall Study|Death|939|||
131792192|NCT00628745|474521002|FG000|Overall Study|Participant transferred to another THAOS site|6|||
131792193|NCT00628745|474521003|FG001|Overall Study|Participant transferred to another THAOS site|0|||
131792194|NCT00628745|474521004|FG002|Overall Study|Participant transferred to another THAOS site|0|||
131792195|NCT00628745|474521005|FG003|Overall Study|Participant transferred to another THAOS site|0|||
131792196|NCT00628745|474521006|FG004|Overall Study|Participant transferred to another THAOS site|7|||
131792197|NCT00628745|474521002|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
131792198|NCT00628745|474521003|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
131792199|NCT00628745|474521004|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
131792200|NCT00628745|474521005|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
131792201|NCT00628745|474521006|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
131792202|NCT00628745|474521002|FG000|Overall Study|Site closure|152|||
131792203|NCT00628745|474521003|FG001|Overall Study|Site closure|146|||
131792204|NCT00628745|474521004|FG002|Overall Study|Site closure|6|||
131792205|NCT00628745|474521005|FG003|Overall Study|Site closure|8|||
131792206|NCT00628745|474521006|FG004|Overall Study|Site closure|691|||
131792207|NCT00628745|474521002|FG000|Overall Study|Duplicate participant|0|||
131707483|NCT00432237|474211225|FG000|Overall Study|Withdrawal by Subject|5|||
131707484|NCT00432237|474211226|FG001|Overall Study|Withdrawal by Subject|6|||
131707485|NCT00432237|474211227|FG002|Overall Study|Withdrawal by Subject|9|||
131707486|NCT00432237|474211228|FG003|Overall Study|Withdrawal by Subject|11|||
131707487|NCT00432237|474211225|FG000|Overall Study|Lack of Qualifying Event|38|||
131792208|NCT00628745|474521003|FG001|Overall Study|Duplicate participant|0|||
131707488|NCT00432237|474211226|FG001|Overall Study|Lack of Qualifying Event|71|||
131707489|NCT00432237|474211227|FG002|Overall Study|Lack of Qualifying Event|69|||
131792209|NCT00628745|474521004|FG002|Overall Study|Duplicate participant|0|||
131792210|NCT00628745|474521005|FG003|Overall Study|Duplicate participant|0|||
131792211|NCT00628745|474521006|FG004|Overall Study|Duplicate participant|1|||
131792212|NCT00628745|474521002|FG000|Overall Study|Missing|4|||
131792213|NCT00628745|474521003|FG001|Overall Study|Missing|3|||
131899765|NCT03428100|474919396|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899766|NCT03428100|474919397|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899767|NCT03428100|474919398|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899768|NCT03428100|474919399|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899769|NCT03428100|474919400|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899770|NCT03428100|474919401|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131899771|NCT03428100|474919383|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899772|NCT03428100|474919384|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
131899773|NCT03428100|474919385|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
131899774|NCT03428100|474919386|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899775|NCT03428100|474919387|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899776|NCT03428100|474919388|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899777|NCT03428100|474919389|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899778|NCT03428100|474919390|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899779|NCT03428100|474919391|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899780|NCT03428100|474919392|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899781|NCT03428100|474919393|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899782|NCT03428100|474919394|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899783|NCT03428100|474919395|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899784|NCT03428100|474919396|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899785|NCT03428100|474919397|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899786|NCT03428100|474919398|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899787|NCT03428100|474919399|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899788|NCT03428100|474919400|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899789|NCT03428100|474919401|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
131899790|NCT03428100|474919383|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
131899791|NCT03428100|474919384|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899792|NCT03428100|474919385|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899793|NCT03428100|474919386|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899794|NCT03428100|474919387|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899795|NCT03428100|474919388|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899796|NCT03428100|474919389|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899797|NCT03428100|474919390|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899798|NCT03428100|474919391|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131607109|NCT02492711|473853461|FG002|Overall Study|Adverse Event|2|||
131607110|NCT02492711|473853459|FG000|Overall Study|Death|3|||
131607111|NCT02492711|473853460|FG001|Overall Study|Death|3|||
131792214|NCT00628745|474521004|FG002|Overall Study|Missing|0|||
131792215|NCT00628745|474521005|FG003|Overall Study|Missing|0|||
131792216|NCT00628745|474521006|FG004|Overall Study|Missing|10|||
131792217|NCT00628745|474521002|FG000|Overall Study|Othe reasons|987|||
131792218|NCT00628745|474521003|FG001|Overall Study|Othe reasons|373|||
131792219|NCT00628745|474521004|FG002|Overall Study|Othe reasons|105|||
131792220|NCT00628745|474521005|FG003|Overall Study|Othe reasons|1|||
131792221|NCT00628745|474521006|FG004|Overall Study|Othe reasons|1772|||
131792222|NCT01003886|474522728|FG000|Overall Study|Lack of Efficacy|5|||
131792223|NCT01003886|474522728|FG000|Overall Study|Lost to Follow-up|169|||
131792224|NCT01003886|474522728|FG000|Overall Study|Withdrawal by Subject|39|||
131792225|NCT01003886|474522728|FG000|Overall Study|Other|14|||
131792226|NCT01003886|474522728|FG000|Overall Study|Adverse Event|3|||
131792227|NCT03487796|474522729|FG000|Overall Study|Lost to Follow-up|18|||
131792228|NCT03487796|474522730|FG001|Overall Study|Lost to Follow-up|6|||
131607112|NCT02492711|473853461|FG002|Overall Study|Death|0|||
131607113|NCT02492711|473853459|FG000|Overall Study|Withdrawal by Subject|10|||
131607114|NCT02492711|473853460|FG001|Overall Study|Withdrawal by Subject|16|||
131607115|NCT02492711|473853461|FG002|Overall Study|Withdrawal by Subject|5|||
131607116|NCT02492711|473853459|FG000|Overall Study|Physician Decision|10|||
131792229|NCT00124020|474522731|FG000|Overall Study|Death|67|||
131792230|NCT00124020|474522732|FG001|Overall Study|Death|71|||
131792231|NCT00124020|474522731|FG000|Overall Study|Withdrawal by Subject|13|||
131607117|NCT02492711|473853460|FG001|Overall Study|Physician Decision|6|||
131607118|NCT02492711|473853461|FG002|Overall Study|Physician Decision|4|||
131607119|NCT02492711|473853459|FG000|Overall Study|Lost to Follow-up|0|||
131792232|NCT00124020|474522732|FG001|Overall Study|Withdrawal by Subject|11|||
131792233|NCT00124020|474522731|FG000|Overall Study|Lost to Follow-up|5|||
131899799|NCT03428100|474919392|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899800|NCT03428100|474919393|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899801|NCT03428100|474919394|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899802|NCT03428100|474919395|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899803|NCT03428100|474919396|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899804|NCT03428100|474919397|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899805|NCT03428100|474919398|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899806|NCT03428100|474919399|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899807|NCT03428100|474919400|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131899808|NCT03428100|474919401|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131607120|NCT02492711|473853460|FG001|Overall Study|Lost to Follow-up|0|||
131607121|NCT02492711|473853461|FG002|Overall Study|Lost to Follow-up|1|||
131607122|NCT02492711|473853459|FG000|Overall Study|study treatment delay|2|||
131607123|NCT02492711|473853460|FG001|Overall Study|study treatment delay|1|||
131792234|NCT00124020|474522732|FG001|Overall Study|Lost to Follow-up|8|||
131792235|NCT00124020|474522731|FG000|Overall Study|Other|1|||
131792236|NCT00124020|474522732|FG001|Overall Study|Other|1|||
131792237|NCT00124020|474522731|FG000|Overall Study|Transfer to another hospital|2|||
131792238|NCT00124020|474522732|FG001|Overall Study|Transfer to another hospital|0|||
131792239|NCT03175120|474522733|FG000|Overall Study|Adverse Event|2|||
131792240|NCT03175120|474522734|FG001|Overall Study|Adverse Event|2|||
131792241|NCT03175120|474522733|FG000|Overall Study|Protocol Violation|5|||
131792242|NCT03175120|474522734|FG001|Overall Study|Protocol Violation|2|||
131792243|NCT03175120|474522733|FG000|Overall Study|Lost to Follow-up|1|||
131792244|NCT03175120|474522734|FG001|Overall Study|Lost to Follow-up|0|||
131792245|NCT03175120|474522733|FG000|Overall Study|Withdrawal by Subject|2|||
131792246|NCT03175120|474522734|FG001|Overall Study|Withdrawal by Subject|5|||
131792247|NCT03175120|474522733|FG000|Overall Study|Other|2|||
131792248|NCT03175120|474522734|FG001|Overall Study|Other|3|||
131792249|NCT01977092|474522735|FG000|Overall Study|Death|3|||
131792250|NCT01977092|474522736|FG001|Overall Study|Death|4|||
131792251|NCT01977092|474522735|FG000|Overall Study|Lost to Follow-up|23|||
131899809|NCT03428100|474919383|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899810|NCT03428100|474919384|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
131899811|NCT03428100|474919385|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899812|NCT03428100|474919386|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899813|NCT03428100|474919387|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899814|NCT03428100|474919388|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899815|NCT03428100|474919389|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899816|NCT03428100|474919390|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899817|NCT03428100|474919391|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899818|NCT03428100|474919392|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899819|NCT03428100|474919393|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899820|NCT03428100|474919394|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131792252|NCT01977092|474522736|FG001|Overall Study|Lost to Follow-up|14|||
131792253|NCT01977092|474522735|FG000|Overall Study|Withdrawal by Subject|2|||
131792254|NCT01977092|474522736|FG001|Overall Study|Withdrawal by Subject|1|||
131792255|NCT01977092|474522735|FG000|Overall Study|In prison|3|||
131792256|NCT01977092|474522736|FG001|Overall Study|In prison|11|||
131792257|NCT03038113|474522737|FG000|Overall Study|Withdrawal by Subject|0|||
131792258|NCT03038113|474522738|FG001|Overall Study|Withdrawal by Subject|0|||
131792259|NCT03038113|474522739|FG002|Overall Study|Withdrawal by Subject|1|||
131792260|NCT03038113|474522740|FG003|Overall Study|Withdrawal by Subject|0|||
131792261|NCT03038113|474522741|FG004|Overall Study|Withdrawal by Subject|0|||
131792262|NCT03038113|474522742|FG005|Overall Study|Withdrawal by Subject|0|||
131440688|NCT03413891|473241565|FG000|Overall Study|Lost to Follow-up|2|||
131440689|NCT03413891|473241566|FG001|Overall Study|Lost to Follow-up|1|||
131440690|NCT03413891|473241565|FG000|Overall Study|Protocol Violation|0|||
131607124|NCT02492711|473853461|FG002|Overall Study|study treatment delay|0|||
131792263|NCT03038113|474522743|FG006|Overall Study|Withdrawal by Subject|0|||
131792264|NCT03038113|474522744|FG007|Overall Study|Withdrawal by Subject|0|||
131707490|NCT00432237|474211228|FG003|Overall Study|Lack of Qualifying Event|84|||
131707491|NCT01354132|474211231|FG000|Randomization|Physician Decision|1|||
131707492|NCT01354132|474211232|FG001|Randomization|Physician Decision|0|||
131707493|NCT01354132|474211231|FG000|Randomization|Withdrawal by Subject|0|||
131707494|NCT01354132|474211232|FG001|Randomization|Withdrawal by Subject|1|||
131707495|NCT01354132|474211231|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
131707496|NCT01354132|474211232|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
131707497|NCT01354132|474211231|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
131707498|NCT01354132|474211232|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
131707499|NCT01354132|474211231|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
131707500|NCT01354132|474211232|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
131707501|NCT02357420|474211233|FG000|Overall Study|Adverse Event|3|||
131707502|NCT02357420|474211234|FG001|Overall Study|Adverse Event|3|||
131707503|NCT02357420|474211235|FG002|Overall Study|Adverse Event|8|||
131707504|NCT02357420|474211236|FG003|Overall Study|Adverse Event|9|||
131707505|NCT02357420|474211233|FG000|Overall Study|Investigator Decision|1|||
131707506|NCT02357420|474211234|FG001|Overall Study|Investigator Decision|0|||
131707507|NCT02357420|474211235|FG002|Overall Study|Investigator Decision|0|||
131707508|NCT02357420|474211236|FG003|Overall Study|Investigator Decision|0|||
131707509|NCT02357420|474211233|FG000|Overall Study|Prohibited Medication|1|||
131707510|NCT02357420|474211234|FG001|Overall Study|Prohibited Medication|1|||
131707511|NCT02357420|474211235|FG002|Overall Study|Prohibited Medication|0|||
131707512|NCT02357420|474211236|FG003|Overall Study|Prohibited Medication|0|||
131707513|NCT02357420|474211233|FG000|Overall Study|Protocol Non-compliance|0|||
131707514|NCT02357420|474211234|FG001|Overall Study|Protocol Non-compliance|0|||
131707515|NCT02357420|474211235|FG002|Overall Study|Protocol Non-compliance|0|||
131707516|NCT02357420|474211236|FG003|Overall Study|Protocol Non-compliance|1|||
131707517|NCT02357420|474211233|FG000|Overall Study|Withdrawn Consent|4|||
131707518|NCT02357420|474211234|FG001|Overall Study|Withdrawn Consent|8|||
131707519|NCT02357420|474211235|FG002|Overall Study|Withdrawn Consent|6|||
131707520|NCT02357420|474211236|FG003|Overall Study|Withdrawn Consent|6|||
131707521|NCT02357420|474211233|FG000|Overall Study|Lost to Follow-up|3|||
131707522|NCT02357420|474211234|FG001|Overall Study|Lost to Follow-up|0|||
131707523|NCT02357420|474211235|FG002|Overall Study|Lost to Follow-up|2|||
131707524|NCT02357420|474211236|FG003|Overall Study|Lost to Follow-up|3|||
131707525|NCT03617705|474211237|FG000|Overall Study|Withdrawal by Subject|2|||
131707526|NCT03617705|474211237|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
131707527|NCT03617705|474211237|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
131707528|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
131707529|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
131707530|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
131707531|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
131707532|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
131707533|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
131707534|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
131707535|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
131707536|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
131440691|NCT03413891|473241566|FG001|Overall Study|Protocol Violation|1|||
131440692|NCT04905134|473241569|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
131440693|NCT04905134|473241569|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
131440694|NCT03009058|473241570|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
131440695|NCT05556265|473241571|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
131440696|NCT05556265|473241572|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
131440697|NCT05556265|473241573|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
131440698|NCT05556265|473241574|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
131440699|NCT05556265|473241575|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
131440700|NCT05556265|473241571|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
131440701|NCT05556265|473241572|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
131440702|NCT05556265|473241573|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
131440703|NCT05556265|473241574|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
131440704|NCT05556265|473241575|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
131707537|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
131707538|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
131707539|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
131707540|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
131707541|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
131707542|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
131707543|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
131707544|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
131607125|NCT02492711|473853459|FG000|Overall Study|change in chemotherapy|0|||
131607126|NCT02492711|473853460|FG001|Overall Study|change in chemotherapy|1|||
131607127|NCT02492711|473853461|FG002|Overall Study|change in chemotherapy|0|||
131607128|NCT02492711|473853459|FG000|Overall Study|never treated|2|||
131607129|NCT02492711|473853460|FG001|Overall Study|never treated|4|||
131607130|NCT02492711|473853461|FG002|Overall Study|never treated|0|||
131607131|NCT02492711|473853459|FG000|Overall Study|Other|0|||
131607132|NCT02492711|473853460|FG001|Overall Study|Other|0|||
131607133|NCT02492711|473853461|FG002|Overall Study|Other|1|||
131607134|NCT03245840|473853467|FG000|Overall Study|Adverse Event|6|||
131607135|NCT03245840|473853468|FG001|Overall Study|Adverse Event|0|||
131607136|NCT03245840|473853467|FG000|Overall Study|Death|2|||
131607137|NCT03245840|473853468|FG001|Overall Study|Death|0|||
131607138|NCT03245840|473853467|FG000|Overall Study|Withdrawal by Subject|31|||
131607139|NCT03245840|473853468|FG001|Overall Study|Withdrawal by Subject|1|||
131607140|NCT03245840|473853467|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131607141|NCT03245840|473853468|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131607142|NCT03245840|473853467|FG000|Overall Study|Physician Decision|4|||
131607143|NCT03245840|473853468|FG001|Overall Study|Physician Decision|1|||
131607144|NCT03245840|473853467|FG000|Overall Study|Study Terminated by Sponsor|56|||
131607145|NCT03245840|473853468|FG001|Overall Study|Study Terminated by Sponsor|6|||
131607146|NCT03245840|473853467|FG000|Overall Study|Site Terminated by Sponsor|4|||
131607147|NCT03245840|473853468|FG001|Overall Study|Site Terminated by Sponsor|0|||
131607148|NCT03245840|473853467|FG000|Overall Study|Lost to Follow-up|12|||
131607149|NCT03245840|473853468|FG001|Overall Study|Lost to Follow-up|2|||
131607150|NCT03245840|473853467|FG000|Overall Study|Pregnancy|2|||
131607151|NCT03245840|473853468|FG001|Overall Study|Pregnancy|0|||
131607152|NCT03245840|473853467|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131607153|NCT03245840|473853468|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131607154|NCT03245840|473853467|FG000|Overall Study|Not treated|1|||
131607155|NCT03245840|473853468|FG001|Overall Study|Not treated|1|||
131607156|NCT04109066|473853473|FG000|Pre-treatment|Participant withdrew consent|2|||
131607157|NCT04109066|473853474|FG001|Pre-treatment|Participant withdrew consent|0|||
131607158|NCT04109066|473853473|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
131607159|NCT04109066|473853474|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
131607160|NCT04109066|473853473|FG000|Treatment|Lack of Efficacy|2|||
131607161|NCT04109066|473853474|FG001|Treatment|Lack of Efficacy|4|||
131607162|NCT04109066|473853473|FG000|Treatment|Adverse Event|23|||
131607163|NCT04109066|473853474|FG001|Treatment|Adverse Event|7|||
131607164|NCT04109066|473853473|FG000|Treatment|Participant request to discontinue Study treatment|15|||
131607165|NCT04109066|473853474|FG001|Treatment|Participant request to discontinue Study treatment|14|||
131607166|NCT04109066|473853473|FG000|Treatment|Withdrawal by Subject|8|||
131607167|NCT04109066|473853474|FG001|Treatment|Withdrawal by Subject|8|||
131607168|NCT04109066|473853473|FG000|Treatment|Death|3|||
131607169|NCT04109066|473853474|FG001|Treatment|Death|0|||
131607170|NCT04109066|473853473|FG000|Treatment|Participant no longer meets study criteria|2|||
131607171|NCT04109066|473853474|FG001|Treatment|Participant no longer meets study criteria|2|||
131607172|NCT04109066|473853473|FG000|Treatment|Administrative reasons by sponsor|2|||
131607173|NCT04109066|473853474|FG001|Treatment|Administrative reasons by sponsor|3|||
131607174|NCT04109066|473853473|FG000|Treatment|Other reasons|17|||
131607175|NCT04109066|473853474|FG001|Treatment|Other reasons|23|||
131607176|NCT04109066|473853473|FG000|Treatment|Disease Progression|4|||
131607177|NCT04109066|473853474|FG001|Treatment|Disease Progression|7|||
131607178|NCT04109066|473853473|FG000|Treatment|Study drug toxicity|12|||
131607179|NCT04109066|473853474|FG001|Treatment|Study drug toxicity|5|||
131607180|NCT04109066|473853473|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
131607181|NCT04109066|473853474|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
131607182|NCT04109066|473853473|FG000|Treatment|Disease Recurrence|0|||
131607183|NCT04109066|473853474|FG001|Treatment|Disease Recurrence|2|||
131607184|NCT04109066|473853473|FG000|Treatment|Not reported|4|||
131607185|NCT04109066|473853474|FG001|Treatment|Not reported|8|||
131607186|NCT05890105|473853476|FG000|Overall Study|Adverse Event|1|||
131707545|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
131607187|NCT05890105|473853477|FG001|Overall Study|Adverse Event|0|||
131607188|NCT05890105|473853478|FG002|Overall Study|Adverse Event|0|||
131607189|NCT05890105|473853476|FG000|Overall Study|Other|1|||
131607190|NCT05890105|473853477|FG001|Overall Study|Other|2|||
131607191|NCT05890105|473853478|FG002|Overall Study|Other|0|||
131607192|NCT04505410|473853479|FG000|Overall Study|Adverse Event|2|||
131607193|NCT04505410|473853480|FG001|Overall Study|Adverse Event|0|||
131607194|NCT04505410|473853479|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
131607195|NCT04505410|473853480|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
131607196|NCT04505410|473853479|FG000|Overall Study|did not want to follow diet|1|||
131607197|NCT04505410|473853480|FG001|Overall Study|did not want to follow diet|0|||
131607198|NCT04505410|473853479|FG000|Overall Study|flare up of ulcerative colitis|0|||
131607199|NCT04505410|473853480|FG001|Overall Study|flare up of ulcerative colitis|1|||
131607200|NCT04505410|473853479|FG000|Overall Study|Lost to Follow-up|0|||
131792265|NCT03038113|474522745|FG008|Overall Study|Withdrawal by Subject|0|||
131792266|NCT03038113|474522746|FG009|Overall Study|Withdrawal by Subject|0|||
131792267|NCT03038113|474522747|FG010|Overall Study|Withdrawal by Subject|0|||
131792268|NCT03038113|474522748|FG011|Overall Study|Withdrawal by Subject|0|||
131792269|NCT03038113|474522749|FG012|Overall Study|Withdrawal by Subject|0|||
131792270|NCT03038113|474522750|FG013|Overall Study|Withdrawal by Subject|1|||
131792271|NCT03038113|474522737|FG000|Overall Study|Lost to Follow-up|0|||
131792272|NCT03038113|474522738|FG001|Overall Study|Lost to Follow-up|0|||
131792273|NCT03038113|474522739|FG002|Overall Study|Lost to Follow-up|0|||
131792274|NCT03038113|474522740|FG003|Overall Study|Lost to Follow-up|0|||
131792275|NCT03038113|474522741|FG004|Overall Study|Lost to Follow-up|0|||
131792276|NCT03038113|474522742|FG005|Overall Study|Lost to Follow-up|0|||
131792277|NCT03038113|474522743|FG006|Overall Study|Lost to Follow-up|1|||
131792278|NCT03038113|474522744|FG007|Overall Study|Lost to Follow-up|0|||
131792279|NCT03038113|474522745|FG008|Overall Study|Lost to Follow-up|0|||
131792280|NCT03038113|474522746|FG009|Overall Study|Lost to Follow-up|0|||
131792281|NCT03038113|474522747|FG010|Overall Study|Lost to Follow-up|0|||
131792282|NCT03038113|474522748|FG011|Overall Study|Lost to Follow-up|0|||
131792283|NCT03038113|474522749|FG012|Overall Study|Lost to Follow-up|0|||
131792284|NCT03038113|474522750|FG013|Overall Study|Lost to Follow-up|0|||
131792285|NCT00723554|474522752|FG000|Overall Study|Adverse Event|12|||
131792286|NCT00723554|474522752|FG000|Overall Study|Investigator's judgement|5|||
131792287|NCT00723554|474522752|FG000|Overall Study|Inhaled medication other than iloprost|4|||
131792288|NCT00723554|474522752|FG000|Overall Study|Withdrawal of consent|3|||
131792289|NCT00723554|474522752|FG000|Overall Study|Other|3|||
131792290|NCT00723554|474522752|FG000|Overall Study|Lost to Follow-up|1|||
131792291|NCT00723554|474522752|FG000|Overall Study|Non-compliance|1|||
131792292|NCT03255031|474522753|FG000|Overall Study|Adverse Event|5|||
131792293|NCT03255031|474522754|FG001|Overall Study|Adverse Event|3|||
131792294|NCT03255031|474522753|FG000|Overall Study|Physician Decision|2|||
131792295|NCT03255031|474522754|FG001|Overall Study|Physician Decision|1|||
131792296|NCT03255031|474522753|FG000|Overall Study|Withdrawal by Subject|9|||
131792297|NCT03255031|474522754|FG001|Overall Study|Withdrawal by Subject|3|||
131792298|NCT01689974|474522756|FG000|Overall Study|Termination of Study|5|||
131792299|NCT01689974|474522757|FG001|Overall Study|Termination of Study|5|||
131792300|NCT00770991|474522761|FG000|Overall Study|Physician Decision|2|||
131792301|NCT00770991|474522762|FG001|Overall Study|Physician Decision|0|||
131792302|NCT00770991|474522761|FG000|Overall Study|Withdrawal by Subject|1|||
131792303|NCT00770991|474522762|FG001|Overall Study|Withdrawal by Subject|0|||
131792304|NCT00770991|474522761|FG000|Overall Study|Adverse Event|1|||
131792305|NCT00770991|474522762|FG001|Overall Study|Adverse Event|5|||
131792306|NCT00770991|474522761|FG000|Overall Study|Pregnancy|1|||
131792307|NCT00770991|474522762|FG001|Overall Study|Pregnancy|0|||
131792308|NCT01107535|474522765|FG000|Overall Study|Death|5|||
131792309|NCT01214603|474522766|FG000|Overall Study|Adverse Event|0|||
131792310|NCT01214603|474522767|FG001|Overall Study|Adverse Event|0|||
131792311|NCT01214603|474522768|FG002|Overall Study|Adverse Event|1|||
131792312|NCT01214603|474522766|FG000|Overall Study|Death|1|||
131792313|NCT01214603|474522767|FG001|Overall Study|Death|0|||
131792314|NCT01214603|474522768|FG002|Overall Study|Death|0|||
131792315|NCT01214603|474522766|FG000|Overall Study|Progressive Disease|4|||
131792316|NCT01214603|474522767|FG001|Overall Study|Progressive Disease|1|||
131792317|NCT01214603|474522768|FG002|Overall Study|Progressive Disease|3|||
131792318|NCT02444533|474522769|FG000|Overall Study|Not able to complete forms|0|||
131792319|NCT02444533|474522770|FG001|Overall Study|Not able to complete forms|2|||
131792320|NCT02444533|474522769|FG000|Overall Study|Only gave post-procedure complications|2|||
131792321|NCT02444533|474522770|FG001|Overall Study|Only gave post-procedure complications|2|||
131792322|NCT01388647|474522771|FG000|Overall Study|Adverse Event|1|||
131792323|NCT01388647|474522772|FG001|Overall Study|Adverse Event|2|||
131792324|NCT03567057|474522773|FG000|Overall Study|Adverse Event|56|||
131792325|NCT03567057|474522774|FG001|Overall Study|Adverse Event|53|||
131792326|NCT03567057|474522775|FG002|Overall Study|Adverse Event|28|||
131792327|NCT03567057|474522773|FG000|Overall Study|Withdrawal by Subject|22|||
131792328|NCT03567057|474522774|FG001|Overall Study|Withdrawal by Subject|24|||
131792329|NCT03567057|474522775|FG002|Overall Study|Withdrawal by Subject|13|||
131792330|NCT03567057|474522773|FG000|Overall Study|Lost to Follow-up|3|||
131607201|NCT04505410|473853480|FG001|Overall Study|Lost to Follow-up|2|||
131792331|NCT03567057|474522774|FG001|Overall Study|Lost to Follow-up|5|||
131792332|NCT03567057|474522775|FG002|Overall Study|Lost to Follow-up|2|||
131792333|NCT03567057|474522773|FG000|Overall Study|COVID-19 pandemic|4|||
131792334|NCT03567057|474522774|FG001|Overall Study|COVID-19 pandemic|3|||
131792335|NCT03567057|474522775|FG002|Overall Study|COVID-19 pandemic|0|||
131792336|NCT03567057|474522773|FG000|Overall Study|Non-compliance with study drug|4|||
131792337|NCT03567057|474522774|FG001|Overall Study|Non-compliance with study drug|2|||
131707546|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
131707547|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
131707548|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
131707549|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
131707550|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
131707551|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
131707552|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
131707553|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
131707554|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
131707555|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
131707556|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
131707557|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
131707558|NCT00849017|474211240|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
131707559|NCT00849017|474211241|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
131707560|NCT00849017|474211242|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
131707561|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
131707562|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
131792338|NCT03567057|474522775|FG002|Overall Study|Non-compliance with study drug|0|||
131792339|NCT03567057|474522773|FG000|Overall Study|Lack of Efficacy|3|||
131792340|NCT03567057|474522774|FG001|Overall Study|Lack of Efficacy|0|||
131792341|NCT03567057|474522775|FG002|Overall Study|Lack of Efficacy|1|||
131792342|NCT03567057|474522773|FG000|Overall Study|Death|1|||
131792343|NCT03567057|474522774|FG001|Overall Study|Death|0|||
131792344|NCT03567057|474522775|FG002|Overall Study|Death|0|||
131792345|NCT03567057|474522773|FG000|Overall Study|Physician Decision|1|||
131792346|NCT03567057|474522774|FG001|Overall Study|Physician Decision|0|||
131792347|NCT03567057|474522775|FG002|Overall Study|Physician Decision|0|||
131792348|NCT03567057|474522773|FG000|Overall Study|Unstable medical condition|1|||
131792349|NCT03567057|474522774|FG001|Overall Study|Unstable medical condition|0|||
131792350|NCT03567057|474522775|FG002|Overall Study|Unstable medical condition|0|||
131792351|NCT03567057|474522773|FG000|Overall Study|Medical history event|0|||
131792352|NCT03567057|474522774|FG001|Overall Study|Medical history event|0|||
131792353|NCT03567057|474522775|FG002|Overall Study|Medical history event|1|||
131792354|NCT03567057|474522773|FG000|Overall Study|Other|0|||
131792355|NCT03567057|474522774|FG001|Overall Study|Other|0|||
131792356|NCT03567057|474522775|FG002|Overall Study|Other|1|||
131792357|NCT00490061|474522776|FG000|Overall Study|Physician Decision|1|||
131792358|NCT00886483|474522785|FG000|Overall Study|Lost to Follow-up|0|||
131792359|NCT00886483|474522786|FG001|Overall Study|Lost to Follow-up|1|||
131792360|NCT00886483|474522785|FG000|Overall Study|Pursue medications|1|||
131792361|NCT00886483|474522786|FG001|Overall Study|Pursue medications|2|||
131792362|NCT00886483|474522785|FG000|Overall Study|Distance to center, poor grades|1|||
131792363|NCT00886483|474522786|FG001|Overall Study|Distance to center, poor grades|0|||
131792364|NCT02040766|474522787|FG000|Overall Study|Adverse Event|1|||
131792365|NCT02040766|474522788|FG001|Overall Study|Adverse Event|1|||
131792366|NCT02040766|474522789|FG002|Overall Study|Adverse Event|1|||
131792367|NCT02040766|474522790|FG003|Overall Study|Adverse Event|0|||
131792368|NCT02040766|474522791|FG004|Overall Study|Adverse Event|2|||
131792369|NCT02040766|474522787|FG000|Overall Study|Withdrawal by Subject|4|||
131792370|NCT02040766|474522788|FG001|Overall Study|Withdrawal by Subject|3|||
131792371|NCT02040766|474522789|FG002|Overall Study|Withdrawal by Subject|2|||
131792372|NCT02040766|474522790|FG003|Overall Study|Withdrawal by Subject|3|||
131792373|NCT02040766|474522791|FG004|Overall Study|Withdrawal by Subject|2|||
131792374|NCT02040766|474522787|FG000|Overall Study|Non-compliance|0|||
131792375|NCT02040766|474522788|FG001|Overall Study|Non-compliance|1|||
131792376|NCT02040766|474522789|FG002|Overall Study|Non-compliance|0|||
131792377|NCT02040766|474522790|FG003|Overall Study|Non-compliance|0|||
131792378|NCT02040766|474522791|FG004|Overall Study|Non-compliance|0|||
131792379|NCT02040766|474522787|FG000|Overall Study|Protocol Violation|2|||
131792380|NCT02040766|474522788|FG001|Overall Study|Protocol Violation|1|||
131792381|NCT02040766|474522789|FG002|Overall Study|Protocol Violation|2|||
131792382|NCT02040766|474522790|FG003|Overall Study|Protocol Violation|3|||
131792383|NCT02040766|474522791|FG004|Overall Study|Protocol Violation|0|||
131792384|NCT02040766|474522787|FG000|Overall Study|Lost to Follow-up|4|||
131792385|NCT02040766|474522788|FG001|Overall Study|Lost to Follow-up|1|||
131792386|NCT02040766|474522789|FG002|Overall Study|Lost to Follow-up|3|||
131792387|NCT02040766|474522790|FG003|Overall Study|Lost to Follow-up|1|||
131792388|NCT02040766|474522791|FG004|Overall Study|Lost to Follow-up|4|||
131792389|NCT02040766|474522787|FG000|Overall Study|Not reported|1|||
131792390|NCT02040766|474522788|FG001|Overall Study|Not reported|0|||
131792391|NCT02040766|474522789|FG002|Overall Study|Not reported|0|||
131792392|NCT02040766|474522790|FG003|Overall Study|Not reported|0|||
131792393|NCT02040766|474522791|FG004|Overall Study|Not reported|0|||
131792394|NCT02040766|474522787|FG000|Overall Study|Lack of Efficacy|6|||
131792395|NCT02040766|474522788|FG001|Overall Study|Lack of Efficacy|3|||
131792396|NCT02040766|474522789|FG002|Overall Study|Lack of Efficacy|4|||
131792397|NCT02040766|474522790|FG003|Overall Study|Lack of Efficacy|6|||
131792398|NCT02040766|474522791|FG004|Overall Study|Lack of Efficacy|5|||
131792399|NCT01580020|474522792|FG000|Overall Study|Lack of Efficacy|0|||
131792400|NCT01580020|474522793|FG001|Overall Study|Lack of Efficacy|5|||
131792401|NCT01580020|474522794|FG002|Overall Study|Lack of Efficacy|0|||
131792402|NCT01580020|474522795|FG003|Overall Study|Lack of Efficacy|1|||
131792403|NCT01580020|474522792|FG000|Overall Study|Withdrawal by Subject|0|||
131792404|NCT01580020|474522793|FG001|Overall Study|Withdrawal by Subject|1|||
131792405|NCT01580020|474522794|FG002|Overall Study|Withdrawal by Subject|1|||
131792406|NCT01580020|474522795|FG003|Overall Study|Withdrawal by Subject|0|||
131792407|NCT01580020|474522792|FG000|Overall Study|Adverse Event|1|||
131792408|NCT01580020|474522793|FG001|Overall Study|Adverse Event|1|||
131792409|NCT01580020|474522794|FG002|Overall Study|Adverse Event|1|||
131607202|NCT04505410|473853479|FG000|Overall Study|Lost to Follow-up|1|||
131792410|NCT01580020|474522795|FG003|Overall Study|Adverse Event|1|||
131792411|NCT01580020|474522792|FG000|Overall Study|Administrative Problems|0|||
131792412|NCT01580020|474522793|FG001|Overall Study|Administrative Problems|0|||
131792413|NCT01580020|474522794|FG002|Overall Study|Administrative Problems|1|||
131792414|NCT01580020|474522795|FG003|Overall Study|Administrative Problems|0|||
131792415|NCT01580020|474522792|FG000|Overall Study|Lost to Follow-up|0|||
131792416|NCT01580020|474522793|FG001|Overall Study|Lost to Follow-up|0|||
131607203|NCT04505410|473853480|FG001|Overall Study|Lost to Follow-up|0|||
131607204|NCT04505410|473853479|FG000|Overall Study|initiated another diet on their own|0|||
131607205|NCT04505410|473853480|FG001|Overall Study|initiated another diet on their own|2|||
131607206|NCT06262477|473854731|FG000|Overall Study|Withdrawal by Subject|1|||
131607207|NCT06262477|473854732|FG001|Overall Study|Withdrawal by Subject|0|||
131607208|NCT06262477|473854731|FG000|Overall Study|Adverse Event|0|||
131792417|NCT01580020|474522794|FG002|Overall Study|Lost to Follow-up|1|||
131792418|NCT01580020|474522795|FG003|Overall Study|Lost to Follow-up|0|||
131792419|NCT01724359|474522796|FG000|Overall Study|Adverse Event|10|||
131607209|NCT06262477|473854732|FG001|Overall Study|Adverse Event|1|||
131607210|NCT06262477|473854731|FG000|Overall Study|Lost to Follow-up|0|||
131607211|NCT06262477|473854732|FG001|Overall Study|Lost to Follow-up|1|||
131607212|NCT05363163|473854739|FG000|Overall Study|Withdrawal by Subject|13|||
131607213|NCT04999111|473854745|FG000|Overall Study|Lost to Follow-up|21|||
131607214|NCT04999111|473854746|FG001|Overall Study|Lost to Follow-up|16|||
131607215|NCT04999111|473854747|FG002|Overall Study|Lost to Follow-up|2|||
131607216|NCT04999111|473854748|FG003|Overall Study|Lost to Follow-up|26|||
131607217|NCT04999111|473854749|FG004|Overall Study|Lost to Follow-up|30|||
131607218|NCT04999111|473854750|FG005|Overall Study|Lost to Follow-up|6|||
131607219|NCT04999111|473854745|FG000|Overall Study|Physician Decision|1|||
131607220|NCT04999111|473854746|FG001|Overall Study|Physician Decision|3|||
131607221|NCT04999111|473854747|FG002|Overall Study|Physician Decision|0|||
131607222|NCT04999111|473854748|FG003|Overall Study|Physician Decision|1|||
131607223|NCT04999111|473854749|FG004|Overall Study|Physician Decision|2|||
131607224|NCT04999111|473854750|FG005|Overall Study|Physician Decision|0|||
131607225|NCT04999111|473854745|FG000|Overall Study|Withdrawal by Subject|23|||
131792420|NCT01724359|474522796|FG000|Overall Study|Death|1|||
131792421|NCT01724359|474522796|FG000|Overall Study|Other|20|||
131792422|NCT00593333|474522798|FG000|Overall Study|Lost to Follow-up|10|||
131792423|NCT00593333|474522799|FG001|Overall Study|Lost to Follow-up|11|||
131792424|NCT01752920|474522800|FG000|Overall Study|Adverse Event|1|||
131792425|NCT01752920|474522801|FG001|Overall Study|Adverse Event|0|||
131792426|NCT01752920|474522802|FG002|Overall Study|Adverse Event|5|||
131792427|NCT01752920|474522803|FG003|Overall Study|Adverse Event|10|||
131792428|NCT01752920|474522800|FG000|Overall Study|Clinical Disease Progression|6|||
131792429|NCT01752920|474522801|FG001|Overall Study|Clinical Disease Progression|4|||
131792430|NCT01752920|474522802|FG002|Overall Study|Clinical Disease Progression|1|||
131792431|NCT01752920|474522803|FG003|Overall Study|Clinical Disease Progression|13|||
131792432|NCT01752920|474522800|FG000|Overall Study|Physician Decision|1|||
131792433|NCT01752920|474522801|FG001|Overall Study|Physician Decision|0|||
131792434|NCT01752920|474522802|FG002|Overall Study|Physician Decision|0|||
131792435|NCT01752920|474522803|FG003|Overall Study|Physician Decision|3|||
131792436|NCT01752920|474522800|FG000|Overall Study|Radiographic Disease Progression|20|||
131792437|NCT01752920|474522801|FG001|Overall Study|Radiographic Disease Progression|7|||
131792438|NCT01752920|474522802|FG002|Overall Study|Radiographic Disease Progression|12|||
131792439|NCT01752920|474522803|FG003|Overall Study|Radiographic Disease Progression|29|||
131792440|NCT01752920|474522800|FG000|Overall Study|Study Terminated by Sponsor|0|||
131792441|NCT01752920|474522801|FG001|Overall Study|Study Terminated by Sponsor|0|||
131792442|NCT01752920|474522802|FG002|Overall Study|Study Terminated by Sponsor|0|||
131792443|NCT01752920|474522803|FG003|Overall Study|Study Terminated by Sponsor|1|||
131792444|NCT01752920|474522800|FG000|Overall Study|Withdrawal by Subject|0|||
131792445|NCT01752920|474522801|FG001|Overall Study|Withdrawal by Subject|1|||
131792446|NCT01752920|474522802|FG002|Overall Study|Withdrawal by Subject|0|||
131792447|NCT01752920|474522803|FG003|Overall Study|Withdrawal by Subject|1|||
131792448|NCT01752920|474522800|FG000|Overall Study|Lack of clinical benefit|1|||
131792449|NCT01752920|474522801|FG001|Overall Study|Lack of clinical benefit|1|||
131792450|NCT01752920|474522802|FG002|Overall Study|Lack of clinical benefit|1|||
131607226|NCT04999111|473854746|FG001|Overall Study|Withdrawal by Subject|29|||
131792451|NCT01752920|474522803|FG003|Overall Study|Lack of clinical benefit|1|||
131792452|NCT01738581|474522804|FG000|Overall Study|Lost to Follow-up|1|||
131792453|NCT01738581|474522805|FG001|Overall Study|Lost to Follow-up|0|||
131607227|NCT04999111|473854747|FG002|Overall Study|Withdrawal by Subject|15|||
131792454|NCT00696709|474522806|FG000|Overall Study|Withdrawal by Subject|1|||
131792455|NCT00696709|474522807|FG001|Overall Study|Withdrawal by Subject|2|||
131607228|NCT04999111|473854748|FG003|Overall Study|Withdrawal by Subject|30|||
131607229|NCT04999111|473854749|FG004|Overall Study|Withdrawal by Subject|35|||
131607230|NCT04999111|473854750|FG005|Overall Study|Withdrawal by Subject|10|||
131607231|NCT04999111|473854745|FG000|Overall Study|Other|6|||
131607232|NCT04999111|473854746|FG001|Overall Study|Other|6|||
131792456|NCT00696709|474522808|FG002|Overall Study|Withdrawal by Subject|1|||
131792457|NCT00696709|474522809|FG003|Overall Study|Withdrawal by Subject|4|||
131792458|NCT00696709|474522810|FG004|Overall Study|Withdrawal by Subject|3|||
131792459|NCT00696709|474522806|FG000|Overall Study|Protocol Violation|1|||
131792460|NCT00696709|474522807|FG001|Overall Study|Protocol Violation|0|||
131792461|NCT00696709|474522808|FG002|Overall Study|Protocol Violation|0|||
131792462|NCT00696709|474522809|FG003|Overall Study|Protocol Violation|0|||
131792463|NCT00696709|474522810|FG004|Overall Study|Protocol Violation|0|||
131792464|NCT00696709|474522806|FG000|Overall Study|Lost to Follow-up|1|||
131792465|NCT00696709|474522807|FG001|Overall Study|Lost to Follow-up|1|||
131792466|NCT00696709|474522808|FG002|Overall Study|Lost to Follow-up|0|||
131792467|NCT00696709|474522809|FG003|Overall Study|Lost to Follow-up|0|||
131792468|NCT00696709|474522810|FG004|Overall Study|Lost to Follow-up|0|||
131792469|NCT00696709|474522806|FG000|Overall Study|Adverse Event|0|||
131792470|NCT00696709|474522807|FG001|Overall Study|Adverse Event|0|||
131792471|NCT00696709|474522808|FG002|Overall Study|Adverse Event|0|||
131899821|NCT03428100|474919395|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131607233|NCT04999111|473854747|FG002|Overall Study|Other|3|||
131607234|NCT04999111|473854748|FG003|Overall Study|Other|8|||
131607235|NCT04999111|473854749|FG004|Overall Study|Other|8|||
131607236|NCT04999111|473854750|FG005|Overall Study|Other|5|||
131792472|NCT00696709|474522809|FG003|Overall Study|Adverse Event|1|||
131792473|NCT00696709|474522810|FG004|Overall Study|Adverse Event|0|||
131899822|NCT03428100|474919396|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899823|NCT03428100|474919397|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899824|NCT03428100|474919398|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899825|NCT03428100|474919399|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899826|NCT03428100|474919400|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899827|NCT03428100|474919401|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131899828|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899829|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899830|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899831|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899832|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899833|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
131899834|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
131899835|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
131607237|NCT04999111|473854745|FG000|Overall Study|Non-compliance with study schedule|1|||
131607238|NCT04999111|473854746|FG001|Overall Study|Non-compliance with study schedule|0|||
131607239|NCT04999111|473854747|FG002|Overall Study|Non-compliance with study schedule|0|||
131607240|NCT04999111|473854748|FG003|Overall Study|Non-compliance with study schedule|1|||
131607241|NCT04999111|473854749|FG004|Overall Study|Non-compliance with study schedule|1|||
131607242|NCT04999111|473854750|FG005|Overall Study|Non-compliance with study schedule|1|||
131607243|NCT04999111|473854745|FG000|Overall Study|Randomized but not vaccinated|1|||
131607244|NCT04999111|473854746|FG001|Overall Study|Randomized but not vaccinated|2|||
131607245|NCT04999111|473854747|FG002|Overall Study|Randomized but not vaccinated|0|||
131607246|NCT04999111|473854748|FG003|Overall Study|Randomized but not vaccinated|3|||
131607247|NCT04999111|473854749|FG004|Overall Study|Randomized but not vaccinated|3|||
131607248|NCT04999111|473854750|FG005|Overall Study|Randomized but not vaccinated|0|||
131607249|NCT04999111|473854745|FG000|Overall Study|Adverse Event|1|||
131607250|NCT04999111|473854746|FG001|Overall Study|Adverse Event|1|||
131607251|NCT04999111|473854747|FG002|Overall Study|Adverse Event|0|||
131607252|NCT04999111|473854748|FG003|Overall Study|Adverse Event|0|||
131607253|NCT04999111|473854749|FG004|Overall Study|Adverse Event|0|||
131607254|NCT04999111|473854750|FG005|Overall Study|Adverse Event|0|||
131607255|NCT04999111|473854745|FG000|Overall Study|Initiated prohibited medication|0|||
131607256|NCT04999111|473854746|FG001|Overall Study|Initiated prohibited medication|0|||
131607257|NCT04999111|473854747|FG002|Overall Study|Initiated prohibited medication|0|||
131607258|NCT04999111|473854748|FG003|Overall Study|Initiated prohibited medication|0|||
131607259|NCT04999111|473854749|FG004|Overall Study|Initiated prohibited medication|1|||
131607260|NCT04999111|473854750|FG005|Overall Study|Initiated prohibited medication|0|||
131607261|NCT03640286|473854753|FG000|Overall Study|Adverse Event|6|||
131607262|NCT03640286|473854754|FG001|Overall Study|Adverse Event|6|||
131607263|NCT03640286|473854753|FG000|Overall Study|Lost to Follow-up|3|||
131607264|NCT03640286|473854754|FG001|Overall Study|Lost to Follow-up|6|||
131607265|NCT03640286|473854753|FG000|Overall Study|Pregnancy|1|||
131607266|NCT03640286|473854754|FG001|Overall Study|Pregnancy|0|||
131607267|NCT03640286|473854753|FG000|Overall Study|Withdrawal by Subject|10|||
131899836|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
131899837|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899838|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
131899839|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131440705|NCT05556265|473241571|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
131440706|NCT05556265|473241572|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
131440707|NCT05556265|473241573|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
131440708|NCT05556265|473241574|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
131607268|NCT03640286|473854754|FG001|Overall Study|Withdrawal by Subject|10|||
131607269|NCT03640286|473854753|FG000|Overall Study|Non-compliance|4|||
131607270|NCT03640286|473854754|FG001|Overall Study|Non-compliance|10|||
131607271|NCT03640286|473854753|FG000|Overall Study|Medication change|1|||
131607272|NCT03640286|473854754|FG001|Overall Study|Medication change|0|||
131607273|NCT03640286|473854753|FG000|Overall Study|Other|1|||
131607274|NCT03640286|473854754|FG001|Overall Study|Other|2|||
131607275|NCT03640286|473854753|FG000|Overall Study|Joined another lifestyle program|0|||
131607276|NCT03640286|473854754|FG001|Overall Study|Joined another lifestyle program|1|||
131607277|NCT03181516|473854755|FG000|Overall Study|Withdrawal by Subject|14|||
131607278|NCT03181516|473854756|FG001|Overall Study|Withdrawal by Subject|7|||
131607279|NCT03181516|473854755|FG000|Overall Study|Lost to Follow-up|2|||
131607280|NCT03181516|473854756|FG001|Overall Study|Lost to Follow-up|2|||
131607281|NCT04880733|473854757|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
131607282|NCT04880733|473854758|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
131607283|NCT04880733|473854759|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
131607284|NCT04880733|473854757|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
131607285|NCT04880733|473854758|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
131607286|NCT04880733|473854759|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
131607287|NCT04880733|473854757|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
131607288|NCT04880733|473854758|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
131607289|NCT04880733|473854759|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
131607290|NCT04880733|473854757|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
131607291|NCT04880733|473854758|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
131607292|NCT04880733|473854759|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
131607293|NCT04880733|473854757|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
131607294|NCT04880733|473854758|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
131607295|NCT04880733|473854759|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
131607296|NCT05552508|473854760|FG000|Overall Study|Adverse Event|3|||
131607297|NCT05424380|473854761|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
131607298|NCT05424380|473854762|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131607299|NCT05424380|473854763|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131607300|NCT05424380|473854764|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131607301|NCT05424380|473854765|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131607302|NCT05424380|473854766|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131607303|NCT05424380|473854761|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
131607304|NCT05424380|473854762|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131607305|NCT05424380|473854763|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131607306|NCT05424380|473854764|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131607307|NCT05424380|473854765|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131607308|NCT05424380|473854766|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131607309|NCT05424380|473854761|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
131607310|NCT05424380|473854762|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131607311|NCT05424380|473854763|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131607312|NCT05424380|473854764|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131707563|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
131707564|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
131707565|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
131707566|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
131707567|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
131707568|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
131707569|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
131707570|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
131707571|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
131707572|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
131707573|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
131707574|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
131707575|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
131707576|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
131707577|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
131707578|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
131707579|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
131707580|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
131707581|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
131707582|NCT00849017|474211240|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
131707583|NCT00849017|474211241|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
131707584|NCT00849017|474211242|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
131707585|NCT05254418|474211244|FG000|Overall Study|Adverse Event|2|||
131707586|NCT01323478|474211249|FG000|Overall Study|Adverse Event|7|||
131707587|NCT01323478|474211249|FG000|Overall Study|Lack of Efficacy|4|||
131707588|NCT01323478|474211249|FG000|Overall Study|Non-compliance With Study Product|3|||
131707589|NCT01323478|474211249|FG000|Overall Study|Protocol Violation|1|||
131707590|NCT01323478|474211249|FG000|Overall Study|Withdrawal of Consent|1|||
131899840|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
131899841|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
131899842|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
131899843|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
131899844|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
131899845|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899846|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131899847|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
131899848|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
131899849|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
131899850|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
131899851|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
131899852|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
131899853|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
131899854|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
131899855|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
131899856|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
131899857|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
131899858|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
131899859|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
131899860|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
131899861|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
131899862|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
131899863|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
131899864|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
131607313|NCT05424380|473854765|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131607314|NCT05424380|473854766|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131607315|NCT05424380|473854761|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131607316|NCT05424380|473854762|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
131607317|NCT05424380|473854763|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131607318|NCT05424380|473854764|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131607319|NCT05424380|473854765|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131607320|NCT05424380|473854766|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131707591|NCT01323478|474211249|FG000|Overall Study|Administrative or Other Reasons|8|||
131707592|NCT02411448|474211250|FG000|Overall Study|Withdrawal by Subject|1|||
131707593|NCT02411448|474211251|FG001|Overall Study|Withdrawal by Subject|14|||
131707594|NCT02411448|474211252|FG002|Overall Study|Withdrawal by Subject|9|||
131707595|NCT02411448|474211250|FG000|Overall Study|Other|0|||
131707596|NCT02411448|474211251|FG001|Overall Study|Other|2|||
131707597|NCT02411448|474211252|FG002|Overall Study|Other|0|||
131707598|NCT02411448|474211250|FG000|Overall Study|Did not receive study treatment|0|||
131707599|NCT02411448|474211251|FG001|Overall Study|Did not receive study treatment|3|||
131707600|NCT02411448|474211252|FG002|Overall Study|Did not receive study treatment|0|||
131707601|NCT02411448|474211250|FG000|Overall Study|Alive on study treatment|3|||
131707602|NCT02411448|474211251|FG001|Overall Study|Alive on study treatment|64|||
131707603|NCT02411448|474211252|FG002|Overall Study|Alive on study treatment|43|||
131707604|NCT02771522|474211255|FG000|Overall Study|Lost to Follow-up|3|||
131707605|NCT02771522|474211255|FG000|Overall Study|Withdrawal by Subject|2|||
131707606|NCT02771522|474211255|FG000|Overall Study|No white spot lesions|3|||
131707607|NCT01256177|474211258|FG000|Overall Study|Withdrawal by Subject|23|||
131707608|NCT01256177|474211259|FG001|Overall Study|Withdrawal by Subject|22|||
131707609|NCT01256177|474211258|FG000|Overall Study|Lost to Follow-up|2|||
131707610|NCT01256177|474211259|FG001|Overall Study|Lost to Follow-up|2|||
131707611|NCT01256177|474211258|FG000|Overall Study|Adverse Event|8|||
131707612|NCT01256177|474211259|FG001|Overall Study|Adverse Event|9|||
131707613|NCT01256177|474211258|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
131707614|NCT01256177|474211259|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
131707615|NCT01256177|474211258|FG000|Overall Study|Condition under Investigation Worsened|1|||
131707616|NCT01256177|474211259|FG001|Overall Study|Condition under Investigation Worsened|0|||
131707617|NCT01256177|474211258|FG000|Overall Study|Lack of Efficacy|11|||
131899865|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
131607321|NCT05424380|473854761|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131607322|NCT05424380|473854762|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
131707618|NCT01256177|474211259|FG001|Overall Study|Lack of Efficacy|2|||
131707619|NCT01256177|474211258|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
131707620|NCT01256177|474211259|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
131707621|NCT03624946|474211260|FG000|Overall Study|Lost to Follow-up|0|||
131707622|NCT03624946|474211261|FG001|Overall Study|Lost to Follow-up|1|||
131707623|NCT00553462|474211262|FG000|Overall Study|Adverse Event|4|||
131607323|NCT05424380|473854763|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131707624|NCT00553462|474211262|FG000|Overall Study|Progression|4|||
131707625|NCT00553462|474211262|FG000|Overall Study|Withdrawal by Subject|5|||
131707626|NCT00553462|474211262|FG000|Overall Study|Physician Decision|1|||
131707627|NCT03075163|474211264|FG000|Overall Study|not eligible for treatment limb|138|||
131707628|NCT03075163|474211265|FG001|Overall Study|not eligible for treatment limb|138|||
131707629|NCT01570244|474211270|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
131707630|NCT00531960|474211275|FG000|Overall Study|Adverse Event|5|||
131707631|NCT00531960|474211276|FG001|Overall Study|Adverse Event|4|||
131707632|NCT00531960|474211275|FG000|Overall Study|Death|3|||
131707633|NCT00531960|474211276|FG001|Overall Study|Death|2|||
131707634|NCT00531960|474211275|FG000|Overall Study|Lack of Efficacy|42|||
131707635|NCT00531960|474211276|FG001|Overall Study|Lack of Efficacy|41|||
131707636|NCT00531960|474211275|FG000|Overall Study|Violation of Selection Criteria|2|||
131707637|NCT00531960|474211276|FG001|Overall Study|Violation of Selection Criteria|0|||
131707638|NCT00531960|474211275|FG000|Overall Study|Refused Treatment|5|||
131707639|NCT00531960|474211276|FG001|Overall Study|Refused Treatment|6|||
131707640|NCT00531960|474211275|FG000|Overall Study|Other|4|||
131707641|NCT00531960|474211276|FG001|Overall Study|Other|10|||
131707642|NCT04134494|474211281|FG000|Overall Study|Lost to Follow-up|2|||
131707643|NCT00781365|474211282|FG000|Overall Study|Withdrawal by Subject|13|||
131707644|NCT00781365|474211283|FG001|Overall Study|Withdrawal by Subject|8|||
131707645|NCT00781365|474211282|FG000|Overall Study|Did Not Attend Visit|20|||
131707646|NCT00781365|474211283|FG001|Overall Study|Did Not Attend Visit|28|||
131707647|NCT00781365|474211282|FG000|Overall Study|Language barrier|1|||
131707648|NCT00781365|474211283|FG001|Overall Study|Language barrier|0|||
131707649|NCT01879410|474211284|FG000|Overall Study|Adverse Event|9|||
131707650|NCT01879410|474211285|FG001|Overall Study|Adverse Event|14|||
131707651|NCT01879410|474211284|FG000|Overall Study|Lack of Efficacy|4|||
131707652|NCT01879410|474211285|FG001|Overall Study|Lack of Efficacy|6|||
131707653|NCT01879410|474211284|FG000|Overall Study|Protocol Violation|1|||
131707654|NCT01879410|474211285|FG001|Overall Study|Protocol Violation|7|||
131707655|NCT01879410|474211284|FG000|Overall Study|Lost to Follow-up|2|||
131707656|NCT01879410|474211285|FG001|Overall Study|Lost to Follow-up|1|||
131707657|NCT01879410|474211284|FG000|Overall Study|Withdrawal by Subject|7|||
131707658|NCT01879410|474211285|FG001|Overall Study|Withdrawal by Subject|8|||
131707659|NCT01879410|474211284|FG000|Overall Study|Randomised in Error|1|||
131707660|NCT01879410|474211285|FG001|Overall Study|Randomised in Error|2|||
131707661|NCT01756456|474211293|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
131707662|NCT01756456|474211294|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
131707663|NCT01756456|474211295|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
131707664|NCT01756456|474211296|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
131707665|NCT01756456|474211297|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
131707666|NCT01756456|474211298|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
131707667|NCT01756456|474211293|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131707668|NCT01756456|474211294|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131707669|NCT01756456|474211295|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131707670|NCT01756456|474211296|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
131707671|NCT01756456|474211297|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
131707672|NCT01756456|474211298|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131707673|NCT01756456|474211293|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131707674|NCT01756456|474211294|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
131707675|NCT01756456|474211295|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131707676|NCT01756456|474211296|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131707677|NCT01756456|474211297|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131707678|NCT01756456|474211298|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131707679|NCT01756456|474211293|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
131792474|NCT00321711|474522811|FG000|Part A|Adverse Event|3|||
131792475|NCT00321711|474522812|FG001|Part A|Adverse Event|3|||
131792476|NCT00321711|474522813|FG002|Part A|Adverse Event|2|||
131792477|NCT00321711|474522814|FG003|Part A|Adverse Event|0|||
131792478|NCT00321711|474522815|FG004|Part A|Adverse Event|0|||
131792479|NCT00321711|474522811|FG000|Part A|Withdrawal by Subject|1|||
131792480|NCT00321711|474522812|FG001|Part A|Withdrawal by Subject|1|||
131707680|NCT01756456|474211294|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
131707681|NCT01756456|474211295|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
131707682|NCT01756456|474211296|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
131707683|NCT01756456|474211297|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
131707684|NCT01756456|474211298|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
131707685|NCT01756456|474211293|FG000|Treatment Period: Phase I/II|Other causes|0|||
131707686|NCT01756456|474211294|FG001|Treatment Period: Phase I/II|Other causes|0|||
131707687|NCT01756456|474211295|FG002|Treatment Period: Phase I/II|Other causes|0|||
131707688|NCT01756456|474211296|FG003|Treatment Period: Phase I/II|Other causes|1|||
131707689|NCT01756456|474211297|FG004|Treatment Period: Phase I/II|Other causes|2|||
131707690|NCT01756456|474211298|FG005|Treatment Period: Phase I/II|Other causes|2|||
131792481|NCT00321711|474522813|FG002|Part A|Withdrawal by Subject|1|||
131707691|NCT01756456|474211293|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
131707692|NCT01756456|474211294|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
131707693|NCT01756456|474211295|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
131707694|NCT01756456|474211296|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
131707695|NCT01756456|474211297|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
131707696|NCT01756456|474211298|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
131707697|NCT01756456|474211293|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131707698|NCT01756456|474211294|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
131707699|NCT01756456|474211295|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131707700|NCT01756456|474211296|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131707701|NCT01756456|474211297|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131707702|NCT01756456|474211298|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131707703|NCT01756456|474211293|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131707704|NCT01756456|474211294|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131707705|NCT01756456|474211295|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131707706|NCT01756456|474211296|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131707707|NCT01756456|474211297|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131707708|NCT01756456|474211298|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
131707709|NCT01756456|474211293|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
131707710|NCT01756456|474211294|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
131707711|NCT01756456|474211295|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
131707712|NCT01756456|474211296|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
131707713|NCT01756456|474211297|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
131707714|NCT01756456|474211298|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
131707715|NCT01756456|474211293|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
131707716|NCT01756456|474211294|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
131707717|NCT01756456|474211295|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
131707718|NCT01756456|474211296|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
131707719|NCT01756456|474211297|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
131792482|NCT00321711|474522814|FG003|Part A|Withdrawal by Subject|0|||
131792483|NCT00321711|474522815|FG004|Part A|Withdrawal by Subject|0|||
131792484|NCT00321711|474522811|FG000|Part A|Disease progression|0|||
131440709|NCT05556265|473241575|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
131440710|NCT05556265|473241571|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
131440711|NCT05556265|473241572|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
131440712|NCT05556265|473241573|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
131440713|NCT05556265|473241574|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
131440714|NCT05556265|473241575|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
131440715|NCT05556265|473241571|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
131440716|NCT05556265|473241572|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
131440717|NCT05556265|473241573|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
131440718|NCT05556265|473241574|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
131440719|NCT05556265|473241575|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
131440720|NCT05556265|473241571|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
131440721|NCT05556265|473241572|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
131440722|NCT05556265|473241573|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
131440723|NCT05556265|473241574|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
131440724|NCT05556265|473241575|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
131440725|NCT05556265|473241571|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
131440726|NCT05556265|473241572|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
131440727|NCT05556265|473241573|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
131440728|NCT05556265|473241574|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
131440729|NCT05556265|473241575|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
131440730|NCT05556265|473241571|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
131440731|NCT05556265|473241572|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
131440732|NCT05556265|473241573|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
131440733|NCT05556265|473241574|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
131440734|NCT05556265|473241575|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
131440735|NCT05556265|473241571|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
131440736|NCT05556265|473241572|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
131440737|NCT05556265|473241573|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
131440738|NCT05556265|473241574|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
131707720|NCT01756456|474211298|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
131707721|NCT01756456|474211293|FG000|Follow Up Period Phase I/II|Other causes|0|||
131707722|NCT01756456|474211294|FG001|Follow Up Period Phase I/II|Other causes|0|||
131607324|NCT05424380|473854764|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131607325|NCT05424380|473854765|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131607326|NCT05424380|473854766|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131607327|NCT05424380|473854761|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131607328|NCT05424380|473854762|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131607329|NCT05424380|473854763|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
131607330|NCT05424380|473854764|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131607331|NCT05424380|473854765|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131607332|NCT05424380|473854766|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131607333|NCT05424380|473854761|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131607334|NCT05424380|473854762|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131607335|NCT05424380|473854763|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
131607336|NCT05424380|473854764|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131607337|NCT05424380|473854765|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131607338|NCT05424380|473854766|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131607339|NCT05424380|473854761|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131607340|NCT05424380|473854762|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131607341|NCT05424380|473854763|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
131607342|NCT05424380|473854764|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131607343|NCT05424380|473854765|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131607344|NCT05424380|473854766|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131607345|NCT05424380|473854761|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607346|NCT05424380|473854762|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607347|NCT05424380|473854763|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607348|NCT05424380|473854764|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
131607349|NCT05424380|473854765|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607350|NCT05424380|473854766|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607351|NCT05424380|473854761|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131607352|NCT05424380|473854762|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131607353|NCT05424380|473854763|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131607354|NCT05424380|473854764|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
131607355|NCT05424380|473854765|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131607356|NCT05424380|473854766|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131607357|NCT05424380|473854761|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131607358|NCT05424380|473854762|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131607359|NCT05424380|473854763|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131607360|NCT05424380|473854764|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
131792485|NCT00321711|474522812|FG001|Part A|Disease progression|1|||
131792486|NCT00321711|474522813|FG002|Part A|Disease progression|0|||
131792487|NCT00321711|474522814|FG003|Part A|Disease progression|0|||
131792488|NCT00321711|474522815|FG004|Part A|Disease progression|0|||
131792489|NCT00321711|474522811|FG000|Part A|Requirement for alternative therapy|0|||
131792490|NCT00321711|474522812|FG001|Part A|Requirement for alternative therapy|2|||
131792491|NCT00321711|474522813|FG002|Part A|Requirement for alternative therapy|1|||
131792492|NCT00321711|474522814|FG003|Part A|Requirement for alternative therapy|0|||
131607361|NCT05424380|473854765|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131607362|NCT05424380|473854766|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131607363|NCT05424380|473854761|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131607364|NCT05424380|473854762|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131607365|NCT05424380|473854763|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131607366|NCT05424380|473854764|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131607367|NCT05424380|473854765|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
131607368|NCT05424380|473854766|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131607369|NCT05424380|473854761|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131792493|NCT00321711|474522815|FG004|Part A|Requirement for alternative therapy|0|||
131792494|NCT00321711|474522811|FG000|Part A|Physician Decision|0|||
131792495|NCT00321711|474522812|FG001|Part A|Physician Decision|1|||
131440739|NCT05556265|473241575|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
131792496|NCT00321711|474522813|FG002|Part A|Physician Decision|3|||
131792497|NCT00321711|474522814|FG003|Part A|Physician Decision|0|||
131792498|NCT00321711|474522815|FG004|Part A|Physician Decision|0|||
131607370|NCT05424380|473854762|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607371|NCT05424380|473854763|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607372|NCT05424380|473854764|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607373|NCT05424380|473854765|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
131607374|NCT05424380|473854766|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131607375|NCT05424380|473854761|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131607376|NCT05424380|473854762|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131607377|NCT05424380|473854763|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131607378|NCT05424380|473854764|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131607379|NCT05424380|473854765|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
131440740|NCT01247324|473241580|FG000|Overall Study|Death|6|||
131607380|NCT05424380|473854766|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131607381|NCT02909686|473854771|FG000|Overall Study|Physician Decision|3|||
131607382|NCT02909686|473854771|FG000|Overall Study|Withdrawal by Subject|2|||
131607383|NCT06037668|473854774|FG000|Overall Study|Lost to Follow-up|1|||
131607384|NCT06037668|473854775|FG001|Overall Study|Lost to Follow-up|1|||
131607385|NCT06037668|473854774|FG000|Overall Study|Protocol Violation|1|||
131607386|NCT06037668|473854775|FG001|Overall Study|Protocol Violation|0|||
131607387|NCT06037668|473854774|FG000|Overall Study|Withdrawal by Subject|1|||
131607388|NCT06037668|473854775|FG001|Overall Study|Withdrawal by Subject|0|||
131607389|NCT06037668|473854774|FG000|Overall Study|Other Study Discontinuation Reason|1|||
131607390|NCT06037668|473854775|FG001|Overall Study|Other Study Discontinuation Reason|0|||
131607391|NCT05224544|473854776|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
131607392|NCT05224544|473854777|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
131607393|NCT04804540|473854778|FG000|Overall Study|Adverse Event|26|||
131607394|NCT04804540|473854779|FG001|Overall Study|Adverse Event|13|||
131607395|NCT05172232|473854780|FG000|Overall Study|Lost to Follow-up|3|||
131607396|NCT01828021|473854781|FG000|Overall Study|Adverse Event|5|||
131607397|NCT01828021|473854781|FG000|Overall Study|Lack of Efficacy|17|||
131607398|NCT01828021|473854781|FG000|Overall Study|Withdrawal by Subject|2|||
131607399|NCT01828021|473854781|FG000|Overall Study|Ileal obstruction, unrelated|1|||
131607400|NCT00844415|473854782|FG000|Overall Study|Withdrawal by Subject|1|||
131607401|NCT03015532|473854784|FG000|Overall Study|Adverse Event|0|||
131607402|NCT03015532|473854785|FG001|Overall Study|Adverse Event|0|||
131607403|NCT03015532|473854786|FG002|Overall Study|Adverse Event|0|||
131440741|NCT01247324|473241581|FG001|Overall Study|Death|10|||
131607404|NCT03015532|473854787|FG003|Overall Study|Adverse Event|0|||
131607405|NCT03015532|473854788|FG004|Overall Study|Adverse Event|0|||
131607406|NCT03015532|473854789|FG005|Overall Study|Adverse Event|2|||
131607407|NCT03015532|473854790|FG006|Overall Study|Adverse Event|1|||
131607408|NCT03015532|473854791|FG007|Overall Study|Adverse Event|0|||
131607409|NCT03015532|473854784|FG000|Overall Study|Withdrawal by Subject|0|||
131607410|NCT03015532|473854785|FG001|Overall Study|Withdrawal by Subject|0|||
131607411|NCT03015532|473854786|FG002|Overall Study|Withdrawal by Subject|0|||
131607412|NCT03015532|473854787|FG003|Overall Study|Withdrawal by Subject|0|||
131607413|NCT03015532|473854788|FG004|Overall Study|Withdrawal by Subject|0|||
131607414|NCT03015532|473854789|FG005|Overall Study|Withdrawal by Subject|0|||
131607415|NCT03015532|473854790|FG006|Overall Study|Withdrawal by Subject|1|||
131607416|NCT03015532|473854791|FG007|Overall Study|Withdrawal by Subject|0|||
131607417|NCT05970861|473854792|FG000|Overall Study|Physician Decision|4|||
131607418|NCT05970861|473854793|FG001|Overall Study|Physician Decision|4|||
131607419|NCT05970861|473854792|FG000|Overall Study|Lost to Follow-up|4|||
131607420|NCT05970861|473854793|FG001|Overall Study|Lost to Follow-up|3|||
131607421|NCT04629339|473854797|FG000|Overall Study|Death|1|||
131607422|NCT04629339|473854798|FG001|Overall Study|Death|0|||
131607423|NCT04629339|473854799|FG002|Overall Study|Death|2|||
131607424|NCT04629339|473854800|FG003|Overall Study|Death|2|||
131607425|NCT04629339|473854801|FG004|Overall Study|Death|0|||
131607426|NCT04629339|473854797|FG000|Overall Study|Disease Progression|0|||
131607427|NCT04629339|473854798|FG001|Overall Study|Disease Progression|0|||
131607428|NCT04629339|473854799|FG002|Overall Study|Disease Progression|1|||
131607429|NCT04629339|473854800|FG003|Overall Study|Disease Progression|1|||
131607430|NCT04629339|473854801|FG004|Overall Study|Disease Progression|0|||
131607431|NCT04629339|473854797|FG000|Overall Study|Lost to Follow-up|0|||
131607432|NCT04629339|473854798|FG001|Overall Study|Lost to Follow-up|0|||
131607433|NCT04629339|473854799|FG002|Overall Study|Lost to Follow-up|0|||
131440742|NCT01247324|473241580|FG000|Overall Study|Physician Decision|2|||
131607434|NCT04629339|473854800|FG003|Overall Study|Lost to Follow-up|1|||
131607435|NCT04629339|473854801|FG004|Overall Study|Lost to Follow-up|0|||
131607436|NCT04629339|473854797|FG000|Overall Study|Physician Decision|0|||
131607437|NCT04629339|473854798|FG001|Overall Study|Physician Decision|1|||
131607438|NCT04629339|473854799|FG002|Overall Study|Physician Decision|0|||
131607439|NCT04629339|473854800|FG003|Overall Study|Physician Decision|0|||
131607440|NCT04629339|473854801|FG004|Overall Study|Physician Decision|0|||
131607441|NCT04629339|473854797|FG000|Overall Study|Study Terminated by Sponsor|0|||
131792499|NCT00321711|474522811|FG000|Part A|Other|1|||
131607442|NCT04629339|473854798|FG001|Overall Study|Study Terminated by Sponsor|0|||
131607443|NCT04629339|473854799|FG002|Overall Study|Study Terminated by Sponsor|0|||
131607444|NCT04629339|473854800|FG003|Overall Study|Study Terminated by Sponsor|1|||
131607445|NCT04629339|473854801|FG004|Overall Study|Study Terminated by Sponsor|0|||
131607446|NCT04629339|473854797|FG000|Overall Study|Withdrawal by Subject|0|||
131607447|NCT04629339|473854798|FG001|Overall Study|Withdrawal by Subject|0|||
131607448|NCT04629339|473854799|FG002|Overall Study|Withdrawal by Subject|2|||
131607449|NCT04629339|473854800|FG003|Overall Study|Withdrawal by Subject|2|||
131607450|NCT04629339|473854801|FG004|Overall Study|Withdrawal by Subject|0|||
131607451|NCT04158739|473854804|FG000|Overall Study|Adverse Event|1|||
131607452|NCT04158739|473854805|FG001|Overall Study|Adverse Event|0|||
131707723|NCT01756456|474211295|FG002|Follow Up Period Phase I/II|Other causes|0|||
131707724|NCT01756456|474211296|FG003|Follow Up Period Phase I/II|Other causes|1|||
131792500|NCT00321711|474522812|FG001|Part A|Other|2|||
131792501|NCT00321711|474522813|FG002|Part A|Other|3|||
131792502|NCT00321711|474522814|FG003|Part A|Other|0|||
131792503|NCT00321711|474522815|FG004|Part A|Other|0|||
131792504|NCT00321711|474522811|FG000|Part A|Protocol deviation|0|||
131792505|NCT00321711|474522812|FG001|Part A|Protocol deviation|0|||
131792506|NCT00321711|474522813|FG002|Part A|Protocol deviation|1|||
131792507|NCT00321711|474522814|FG003|Part A|Protocol deviation|0|||
131792508|NCT00321711|474522815|FG004|Part A|Protocol deviation|0|||
131792509|NCT00321711|474522811|FG000|Part B|Noncompliance|0|||
131792510|NCT00321711|474522812|FG001|Part B|Noncompliance|0|||
131792511|NCT00321711|474522813|FG002|Part B|Noncompliance|0|||
131792512|NCT00321711|474522814|FG003|Part B|Noncompliance|0|||
131792513|NCT00321711|474522815|FG004|Part B|Noncompliance|1|||
131792514|NCT00321711|474522811|FG000|Part B|Adverse Event|0|||
131792515|NCT00321711|474522812|FG001|Part B|Adverse Event|0|||
131792516|NCT00321711|474522813|FG002|Part B|Adverse Event|0|||
131792517|NCT00321711|474522814|FG003|Part B|Adverse Event|2|||
131792518|NCT00321711|474522815|FG004|Part B|Adverse Event|1|||
131792519|NCT00321711|474522811|FG000|Part B|Disease progression|0|||
131792520|NCT00321711|474522812|FG001|Part B|Disease progression|0|||
131792521|NCT00321711|474522813|FG002|Part B|Disease progression|0|||
131792522|NCT00321711|474522814|FG003|Part B|Disease progression|1|||
131792523|NCT00321711|474522815|FG004|Part B|Disease progression|0|||
131792524|NCT00321711|474522811|FG000|Part B|Physician Decision|0|||
131792525|NCT00321711|474522812|FG001|Part B|Physician Decision|0|||
131792526|NCT00321711|474522813|FG002|Part B|Physician Decision|0|||
131792527|NCT00321711|474522814|FG003|Part B|Physician Decision|1|||
131792528|NCT00321711|474522815|FG004|Part B|Physician Decision|2|||
131792529|NCT00321711|474522811|FG000|Part B|Death|0|||
131792530|NCT00321711|474522812|FG001|Part B|Death|0|||
131792531|NCT00321711|474522813|FG002|Part B|Death|0|||
131792532|NCT00321711|474522814|FG003|Part B|Death|2|||
131707725|NCT01756456|474211297|FG004|Follow Up Period Phase I/II|Other causes|3|||
131707726|NCT01756456|474211298|FG005|Follow Up Period Phase I/II|Other causes|5|||
131707727|NCT01375764|474211305|FG000|Overall Study|Lost to Follow-up|0|||
131707728|NCT01375764|474211306|FG001|Overall Study|Lost to Follow-up|1|||
131707729|NCT01375764|474211307|FG002|Overall Study|Lost to Follow-up|0|||
131707730|NCT01375764|474211308|FG003|Overall Study|Lost to Follow-up|0|||
131707731|NCT01375764|474211309|FG004|Overall Study|Lost to Follow-up|0|||
131707732|NCT01375764|474211305|FG000|Overall Study|Withdrawal by Subject|2|||
131707733|NCT01375764|474211306|FG001|Overall Study|Withdrawal by Subject|0|||
131707734|NCT01375764|474211307|FG002|Overall Study|Withdrawal by Subject|0|||
131707735|NCT01375764|474211308|FG003|Overall Study|Withdrawal by Subject|0|||
131707736|NCT01375764|474211309|FG004|Overall Study|Withdrawal by Subject|1|||
131707737|NCT01375764|474211305|FG000|Overall Study|Other|0|||
131707738|NCT01375764|474211306|FG001|Overall Study|Other|0|||
131707739|NCT01375764|474211307|FG002|Overall Study|Other|0|||
131707740|NCT01375764|474211308|FG003|Overall Study|Other|1|||
131707741|NCT01375764|474211309|FG004|Overall Study|Other|0|||
131707742|NCT03595280|474211311|FG000|Overall Study|Lost to Follow-up|6|||
131707743|NCT03595280|474211312|FG001|Overall Study|Lost to Follow-up|9|||
131792533|NCT00321711|474522815|FG004|Part B|Death|1|||
131792534|NCT01186978|474522816|FG000|Overall Study|Withdrawal by Subject|1|||
131792535|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
131792536|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
131792537|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
131607453|NCT04158739|473854804|FG000|Overall Study|Death|0|||
131707744|NCT03595280|474211313|FG002|Overall Study|Lost to Follow-up|15|||
131707745|NCT02658812|474211314|FG000|Overall Study|Disease Progression|7|||
131707746|NCT02658812|474211314|FG000|Overall Study|Unrelated to study treatment|1|||
131707747|NCT02658812|474211314|FG000|Overall Study|Adverse Event|1|||
131707748|NCT01194440|474211315|FG000|Baseline (First Dose)|Reason not specified|4|||
131707749|NCT01194440|474211315|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
131792538|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
131792539|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
131792540|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
131792541|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
131792542|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
131607454|NCT04158739|473854805|FG001|Overall Study|Death|1|||
131792543|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
131792544|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
131792545|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
131792546|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
131792547|NCT01227668|474522817|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
131792548|NCT01227668|474522818|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
131792549|NCT01227668|474522817|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
131792550|NCT01227668|474522818|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
131792551|NCT01227668|474522817|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
131792552|NCT01227668|474522818|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
131792553|NCT01227668|474522817|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
131792554|NCT01227668|474522818|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
131792555|NCT01227668|474522817|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
131792556|NCT01227668|474522818|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
131792557|NCT01227668|474522817|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
131792558|NCT01227668|474522818|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
131792559|NCT01709383|474522828|FG000|Overall Study|Lost to Follow-up|1|||
131792560|NCT01709383|474522829|FG001|Overall Study|Lost to Follow-up|0|||
131792561|NCT03264066|474522830|FG000|Overall Study|Adverse Event|1|||
131792562|NCT03264066|474522831|FG001|Overall Study|Adverse Event|1|||
131792563|NCT03264066|474522832|FG002|Overall Study|Adverse Event|0|||
131792564|NCT03264066|474522833|FG003|Overall Study|Adverse Event|0|||
131792565|NCT03264066|474522834|FG004|Overall Study|Adverse Event|0|||
131792566|NCT03264066|474522835|FG005|Overall Study|Adverse Event|0|||
131792567|NCT03264066|474522830|FG000|Overall Study|Death|12|||
131792568|NCT03264066|474522831|FG001|Overall Study|Death|12|||
131792569|NCT03264066|474522832|FG002|Overall Study|Death|8|||
131792570|NCT03264066|474522833|FG003|Overall Study|Death|10|||
131792571|NCT03264066|474522834|FG004|Overall Study|Death|6|||
131792572|NCT03264066|474522835|FG005|Overall Study|Death|1|||
131792573|NCT03264066|474522830|FG000|Overall Study|Lost to Follow-up|1|||
131607455|NCT04158739|473854804|FG000|Overall Study|Lack of Efficacy|3|||
131792574|NCT03264066|474522831|FG001|Overall Study|Lost to Follow-up|0|||
131792575|NCT03264066|474522832|FG002|Overall Study|Lost to Follow-up|0|||
131792576|NCT03264066|474522833|FG003|Overall Study|Lost to Follow-up|0|||
131792577|NCT03264066|474522834|FG004|Overall Study|Lost to Follow-up|0|||
131792578|NCT03264066|474522835|FG005|Overall Study|Lost to Follow-up|0|||
131792579|NCT03264066|474522830|FG000|Overall Study|Progressive Disease|0|||
131792580|NCT03264066|474522831|FG001|Overall Study|Progressive Disease|2|||
131792581|NCT03264066|474522832|FG002|Overall Study|Progressive Disease|1|||
131792582|NCT03264066|474522833|FG003|Overall Study|Progressive Disease|0|||
131792583|NCT03264066|474522834|FG004|Overall Study|Progressive Disease|0|||
131792584|NCT03264066|474522835|FG005|Overall Study|Progressive Disease|0|||
131792585|NCT03264066|474522830|FG000|Overall Study|Study Terminated by Sponsor|5|||
131792586|NCT03264066|474522831|FG001|Overall Study|Study Terminated by Sponsor|5|||
131792587|NCT03264066|474522832|FG002|Overall Study|Study Terminated by Sponsor|8|||
131792588|NCT03264066|474522833|FG003|Overall Study|Study Terminated by Sponsor|5|||
131792589|NCT03264066|474522834|FG004|Overall Study|Study Terminated by Sponsor|1|||
131792590|NCT03264066|474522835|FG005|Overall Study|Study Terminated by Sponsor|2|||
131607456|NCT04158739|473854805|FG001|Overall Study|Lack of Efficacy|7|||
131607457|NCT04158739|473854804|FG000|Overall Study|Physician Decision|0|||
131607458|NCT04158739|473854805|FG001|Overall Study|Physician Decision|1|||
131607459|NCT04158739|473854804|FG000|Overall Study|Withdrawal by Subject|3|||
131607460|NCT04158739|473854805|FG001|Overall Study|Withdrawal by Subject|0|||
131607461|NCT03914469|473854806|FG000|Overall Study|Lost to Follow-up|1|||
131607462|NCT03914469|473854807|FG001|Overall Study|Lost to Follow-up|4|||
131607463|NCT04778410|473854808|FG000|Safety Run-in Period|Death|5|||
131607464|NCT04778410|473854809|FG001|Safety Run-in Period|Death|6|||
131607465|NCT04778410|473854810|FG002|Safety Run-in Period|Death|0|||
131792591|NCT03264066|474522830|FG000|Overall Study|Withdrawal by Subject|1|||
131792592|NCT03264066|474522831|FG001|Overall Study|Withdrawal by Subject|0|||
131792593|NCT03264066|474522832|FG002|Overall Study|Withdrawal by Subject|0|||
131607466|NCT04778410|473854811|FG003|Safety Run-in Period|Death|0|||
131607467|NCT04778410|473854812|FG004|Safety Run-in Period|Death|0|||
131607468|NCT04778410|473854813|FG005|Safety Run-in Period|Death|0|||
131792594|NCT03264066|474522833|FG003|Overall Study|Withdrawal by Subject|5|||
131792595|NCT03264066|474522834|FG004|Overall Study|Withdrawal by Subject|0|||
131607469|NCT04778410|473854808|FG000|Phase 2 Period|Death|0|||
131607470|NCT04778410|473854809|FG001|Phase 2 Period|Death|0|||
131607471|NCT04778410|473854810|FG002|Phase 2 Period|Death|0|||
131607472|NCT04778410|473854811|FG003|Phase 2 Period|Death|5|||
131607473|NCT04778410|473854812|FG004|Phase 2 Period|Death|18|||
131607474|NCT04778410|473854813|FG005|Phase 2 Period|Death|0|||
131607475|NCT04778410|473854808|FG000|Phase 2 Period|Lost to Follow-up|0|||
131792596|NCT03264066|474522835|FG005|Overall Study|Withdrawal by Subject|0|||
131440743|NCT01247324|473241581|FG001|Overall Study|Physician Decision|3|||
131440744|NCT01247324|473241580|FG000|Overall Study|Non-compliance with study drug|3|||
131440745|NCT01247324|473241581|FG001|Overall Study|Non-compliance with study drug|0|||
131792597|NCT01484028|474522836|FG000|Period 1|Lost to Follow-up|0|||
131792598|NCT01484028|474522837|FG001|Period 1|Lost to Follow-up|1|||
131792599|NCT01484028|474522838|FG002|Period 1|Lost to Follow-up|0|||
131792600|NCT01484028|474522839|FG003|Period 1|Lost to Follow-up|0|||
131792601|NCT01484028|474522836|FG000|Period 1|Non-Compliance to Protocol|0|||
131792602|NCT01484028|474522837|FG001|Period 1|Non-Compliance to Protocol|1|||
131792603|NCT01484028|474522838|FG002|Period 1|Non-Compliance to Protocol|0|||
131792604|NCT01484028|474522839|FG003|Period 1|Non-Compliance to Protocol|1|||
131792605|NCT01484028|474522836|FG000|Period 1|Lens Discomfort|0|||
131792606|NCT01484028|474522837|FG001|Period 1|Lens Discomfort|1|||
131792607|NCT01484028|474522838|FG002|Period 1|Lens Discomfort|0|||
131792608|NCT01484028|474522839|FG003|Period 1|Lens Discomfort|0|||
131792609|NCT01193517|474522847|FG000|Overall Study|Early Progression|1|||
131792610|NCT01193517|474522848|FG001|Overall Study|Early Progression|0|||
131792611|NCT01193517|474522849|FG002|Overall Study|Early Progression|0|||
131792612|NCT02115256|474522852|FG000|Overall Study|Withdrawal by Subject|0|||
131792613|NCT02115256|474522853|FG001|Overall Study|Withdrawal by Subject|1|||
131792614|NCT01626859|474522856|FG000|Overall Study|Adverse Event|1|||
131792615|NCT01626859|474522857|FG001|Overall Study|Adverse Event|3|||
131792616|NCT01626859|474522858|FG002|Overall Study|Adverse Event|2|||
131792617|NCT01626859|474522856|FG000|Overall Study|Physician Decision|0|||
131792618|NCT01626859|474522857|FG001|Overall Study|Physician Decision|1|||
131792619|NCT01626859|474522858|FG002|Overall Study|Physician Decision|0|||
131792620|NCT01626859|474522856|FG000|Overall Study|Withdrawal by Subject|1|||
131792621|NCT01626859|474522857|FG001|Overall Study|Withdrawal by Subject|4|||
131792622|NCT01626859|474522858|FG002|Overall Study|Withdrawal by Subject|2|||
131792623|NCT02330081|474522859|FG000|Overall Study|Adverse Event|1|||
131792624|NCT02330081|474522859|FG000|Overall Study|Donation did not meet criteria|1|||
131792625|NCT02330081|474522859|FG000|Overall Study|Protocol Violation|6|||
131792626|NCT02826603|474522862|FG000|Overall Study|Adverse Event|17|||
131792627|NCT02826603|474522863|FG001|Overall Study|Adverse Event|9|||
131792628|NCT02826603|474522862|FG000|Overall Study|Lack of Efficacy|4|||
131792629|NCT02826603|474522863|FG001|Overall Study|Lack of Efficacy|9|||
131792630|NCT02826603|474522862|FG000|Overall Study|Lost to Follow-up|13|||
131792631|NCT02826603|474522863|FG001|Overall Study|Lost to Follow-up|12|||
131792632|NCT02826603|474522862|FG000|Overall Study|Noncompliance with treatment|0|||
131792633|NCT02826603|474522863|FG001|Overall Study|Noncompliance with treatment|2|||
131792634|NCT02826603|474522862|FG000|Overall Study|Physician Decision|1|||
131792635|NCT02826603|474522863|FG001|Overall Study|Physician Decision|7|||
131792636|NCT02826603|474522862|FG000|Overall Study|Pregnancy|1|||
131792637|NCT02826603|474522863|FG001|Overall Study|Pregnancy|2|||
131792638|NCT02826603|474522862|FG000|Overall Study|Protocol Violation|3|||
131792639|NCT02826603|474522863|FG001|Overall Study|Protocol Violation|3|||
131792640|NCT02826603|474522862|FG000|Overall Study|Withdrawal by Subject|20|||
131792641|NCT02826603|474522863|FG001|Overall Study|Withdrawal by Subject|19|||
131792642|NCT02826603|474522862|FG000|Overall Study|Death|2|||
131792643|NCT02826603|474522863|FG001|Overall Study|Death|0|||
131792644|NCT02826603|474522862|FG000|Overall Study|New therapy for study indication|0|||
131440746|NCT01247324|473241580|FG000|Overall Study|Lack of Efficacy|24|||
131440747|NCT01247324|473241581|FG001|Overall Study|Lack of Efficacy|14|||
131792645|NCT02826603|474522863|FG001|Overall Study|New therapy for study indication|1|||
131792646|NCT00583596|474522866|FG000|Overall Study|Lost to Follow-up|110|||
131792647|NCT00583596|474522866|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
131792648|NCT00583596|474522866|FG000|Overall Study|Death|2|||
131440748|NCT01247324|473241580|FG000|Overall Study|Non-compliance|3|||
131792649|NCT00583596|474522866|FG000|Overall Study|Withdrawal by Subject|6|||
131792650|NCT00583596|474522866|FG000|Overall Study|Lost to Follow-up|94|||
131440749|NCT01247324|473241581|FG001|Overall Study|Non-compliance|2|||
131440750|NCT01247324|473241580|FG000|Overall Study|Pregnancy|5|||
131440751|NCT01247324|473241581|FG001|Overall Study|Pregnancy|10|||
131607476|NCT04778410|473854809|FG001|Phase 2 Period|Lost to Follow-up|0|||
131792651|NCT00583596|474522866|FG000|Overall Study|Data not complete|1|||
131792652|NCT00583596|474522866|FG000|Overall Study|Not consented|15|||
131792653|NCT00583596|474522866|FG000|Overall Study|Outside f-up window|26|||
131792654|NCT00656019|474522867|FG000|Overall Study|Not Eligible|10|||
131792655|NCT00656019|474522868|FG001|Overall Study|Not Eligible|0|||
131792656|NCT00656019|474522869|FG002|Overall Study|Not Eligible|0|||
131607477|NCT04778410|473854810|FG002|Phase 2 Period|Lost to Follow-up|0|||
131792657|NCT00656019|474522870|FG003|Overall Study|Not Eligible|0|||
131440752|NCT01247324|473241580|FG000|Overall Study|Protocol Violation|1|||
131440753|NCT01247324|473241581|FG001|Overall Study|Protocol Violation|1|||
131440754|NCT01247324|473241580|FG000|Overall Study|Reason not specified|42|||
131440755|NCT01247324|473241581|FG001|Overall Study|Reason not specified|32|||
131440756|NCT01247324|473241580|FG000|Overall Study|Consent withdrawn by participant|41|||
131440757|NCT01247324|473241581|FG001|Overall Study|Consent withdrawn by participant|56|||
131440758|NCT01247324|473241580|FG000|Overall Study|Adverse Event|49|||
131440759|NCT01247324|473241581|FG001|Overall Study|Adverse Event|35|||
131792658|NCT00656019|474522867|FG000|Overall Study|Withdrawal by Subject|2|||
131792659|NCT00656019|474522868|FG001|Overall Study|Withdrawal by Subject|0|||
131792660|NCT00656019|474522869|FG002|Overall Study|Withdrawal by Subject|0|||
131792661|NCT00656019|474522870|FG003|Overall Study|Withdrawal by Subject|0|||
131792662|NCT00656019|474522867|FG000|Overall Study|Lost to Follow-up|2|||
131792663|NCT00656019|474522868|FG001|Overall Study|Lost to Follow-up|1|||
131792664|NCT00656019|474522869|FG002|Overall Study|Lost to Follow-up|0|||
131792665|NCT00656019|474522870|FG003|Overall Study|Lost to Follow-up|0|||
131792666|NCT00096486|474522875|FG000|Overall Study|Withdrawal by Subject|0|||
131792667|NCT00096486|474522876|FG001|Overall Study|Withdrawal by Subject|0|||
131792668|NCT00096486|474522877|FG002|Overall Study|Withdrawal by Subject|1|||
131792669|NCT00096486|474522878|FG003|Overall Study|Withdrawal by Subject|1|||
131792670|NCT00096486|474522875|FG000|Overall Study|Not Treated|0|||
131792671|NCT00096486|474522876|FG001|Overall Study|Not Treated|0|||
131792672|NCT00096486|474522877|FG002|Overall Study|Not Treated|1|||
131792673|NCT00096486|474522878|FG003|Overall Study|Not Treated|1|||
131792674|NCT00895583|474522879|FG000|Overall Study|Adverse Event|28|||
131792675|NCT00895583|474522880|FG001|Overall Study|Adverse Event|4|||
131792676|NCT00895583|474522879|FG000|Overall Study|Death|2|||
131792677|NCT00895583|474522880|FG001|Overall Study|Death|1|||
131792678|NCT00895583|474522879|FG000|Overall Study|Physician Decision|3|||
131792679|NCT00895583|474522880|FG001|Overall Study|Physician Decision|1|||
131792680|NCT00895583|474522879|FG000|Overall Study|Lost to Follow-up|1|||
131792681|NCT00895583|474522880|FG001|Overall Study|Lost to Follow-up|3|||
131792682|NCT00895583|474522879|FG000|Overall Study|Protocol Violation|1|||
131792683|NCT00895583|474522880|FG001|Overall Study|Protocol Violation|0|||
131792684|NCT00895583|474522879|FG000|Overall Study|Withdrawal by Subject|4|||
131792685|NCT00895583|474522880|FG001|Overall Study|Withdrawal by Subject|2|||
131792686|NCT00895583|474522879|FG000|Overall Study|Lack of Efficacy|5|||
131792687|NCT00895583|474522880|FG001|Overall Study|Lack of Efficacy|0|||
131792688|NCT00895583|474522879|FG000|Overall Study|Other|0|||
131792689|NCT00895583|474522880|FG001|Overall Study|Other|1|||
131792690|NCT01078090|474522884|FG000|Overall Study|Lost to Follow-up|2363|||
131792691|NCT01078090|474522884|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
131792692|NCT01078090|474522884|FG000|Overall Study|Lack of Efficacy|1193|||
131792693|NCT01078090|474522884|FG000|Overall Study|ADR and lack of efficacy|61|||
131792694|NCT01078090|474522884|FG000|Overall Study|Other|523|||
131792695|NCT04535583|474522885|FG000|Overall Study|Lost to Follow-up|1|||
131792696|NCT04535583|474522885|FG000|Overall Study|Physician Decision|1|||
131440760|NCT01247324|473241580|FG000|Overall Study|Lost to Follow-up|3|||
131440761|NCT01247324|473241581|FG001|Overall Study|Lost to Follow-up|6|||
131792697|NCT04535583|474522885|FG000|Overall Study|Withdrawal by Subject|1|||
131792698|NCT00526890|474522887|FG000|Overall Study|Adverse Event|2|||
131792699|NCT04049552|474522888|FG000|Overall Study|Lost to Follow-up|1|||
131792700|NCT01360632|474522892|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
131792701|NCT01360632|474522893|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
131792702|NCT01360632|474522894|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
131792703|NCT01360632|474522895|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
131440762|NCT01247324|473241580|FG000|Overall Study|Study Terminated by Sponsor|4|||
131440763|NCT01247324|473241581|FG001|Overall Study|Study Terminated by Sponsor|1|||
131440764|NCT01247324|473241580|FG000|Overall Study|Missing|2|||
131440765|NCT01247324|473241581|FG001|Overall Study|Missing|1|||
131440766|NCT01486966|473241582|FG000|Overall Study|Adverse Event|0|||
131440767|NCT01486966|473241583|FG001|Overall Study|Adverse Event|1|||
131440768|NCT01486966|473241582|FG000|Overall Study|Withdrawal by Subject|0|||
131440769|NCT01486966|473241583|FG001|Overall Study|Withdrawal by Subject|1|||
131440770|NCT04972786|473241584|FG000|First Intervention (1 Day)|Adverse Event|1|||
131440771|NCT04972786|473241585|FG001|First Intervention (1 Day)|Adverse Event|0|||
131440772|NCT00844844|473241586|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
131440773|NCT00844844|473241586|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
131440774|NCT00844844|473241586|FG000|Extension Treatment Period|Adverse Event|2|||
131440775|NCT00844844|473241586|FG000|Post Treatment Period|Withdrawal by Subject|1|||
131607478|NCT04778410|473854811|FG003|Phase 2 Period|Lost to Follow-up|1|||
131607479|NCT04778410|473854812|FG004|Phase 2 Period|Lost to Follow-up|1|||
131607480|NCT04778410|473854813|FG005|Phase 2 Period|Lost to Follow-up|0|||
131607481|NCT04778410|473854808|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
131607482|NCT04778410|473854809|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
131607483|NCT04778410|473854810|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
131607484|NCT04778410|473854811|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
131607485|NCT04778410|473854812|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
131440776|NCT03905096|473241587|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
131440777|NCT03905096|473241588|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
131440778|NCT02016781|473241590|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
131440779|NCT02016781|473241591|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
131440780|NCT02016781|473241590|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
131440781|NCT02016781|473241591|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
131440782|NCT02016781|473241590|FG000|Final Database Lock|Withdrawal by Subject|2|||
131440783|NCT02016781|473241591|FG001|Final Database Lock|Withdrawal by Subject|1|||
131440784|NCT02016781|473241590|FG000|Final Database Lock|Lost to Follow-up|11|||
131440785|NCT02016781|473241591|FG001|Final Database Lock|Lost to Follow-up|4|||
131440786|NCT02016781|473241590|FG000|Final Database Lock|Missing data|0|||
131440787|NCT02016781|473241591|FG001|Final Database Lock|Missing data|3|||
131440788|NCT04886154|473241592|FG000|Overall Study|Adverse Event|0|||
131440789|NCT04886154|473241593|FG001|Overall Study|Adverse Event|0|||
131440790|NCT04886154|473241594|FG002|Overall Study|Adverse Event|0|||
131440791|NCT04886154|473241595|FG003|Overall Study|Adverse Event|0|||
131440792|NCT04886154|473241596|FG004|Overall Study|Adverse Event|1|||
131440793|NCT04886154|473241597|FG005|Overall Study|Adverse Event|0|||
131440794|NCT04886154|473241598|FG006|Overall Study|Adverse Event|0|||
131440795|NCT04886154|473241599|FG007|Overall Study|Adverse Event|1|||
131440796|NCT04886154|473241600|FG008|Overall Study|Adverse Event|1|||
131440797|NCT04886154|473241601|FG009|Overall Study|Adverse Event|0|||
131440798|NCT04886154|473241602|FG010|Overall Study|Adverse Event|0|||
131440799|NCT04886154|473241603|FG011|Overall Study|Adverse Event|1|||
131440800|NCT04886154|473241604|FG012|Overall Study|Adverse Event|0|||
131440801|NCT04886154|473241605|FG013|Overall Study|Adverse Event|0|||
131440802|NCT04886154|473241606|FG014|Overall Study|Adverse Event|3|||
131440803|NCT04886154|473241592|FG000|Overall Study|Lost to Follow-up|1|||
131440804|NCT04886154|473241593|FG001|Overall Study|Lost to Follow-up|0|||
131440805|NCT04886154|473241594|FG002|Overall Study|Lost to Follow-up|2|||
131440806|NCT04886154|473241595|FG003|Overall Study|Lost to Follow-up|0|||
131440807|NCT04886154|473241596|FG004|Overall Study|Lost to Follow-up|17|||
131440808|NCT04886154|473241597|FG005|Overall Study|Lost to Follow-up|7|||
131440809|NCT04886154|473241598|FG006|Overall Study|Lost to Follow-up|8|||
131440810|NCT04886154|473241599|FG007|Overall Study|Lost to Follow-up|7|||
131440811|NCT04886154|473241600|FG008|Overall Study|Lost to Follow-up|8|||
131440812|NCT04886154|473241601|FG009|Overall Study|Lost to Follow-up|0|||
131440813|NCT04886154|473241602|FG010|Overall Study|Lost to Follow-up|2|||
131440814|NCT04886154|473241603|FG011|Overall Study|Lost to Follow-up|0|||
131440815|NCT04886154|473241604|FG012|Overall Study|Lost to Follow-up|0|||
131440816|NCT04886154|473241605|FG013|Overall Study|Lost to Follow-up|0|||
131440817|NCT04886154|473241606|FG014|Overall Study|Lost to Follow-up|0|||
131440818|NCT04886154|473241592|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440819|NCT04886154|473241593|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440820|NCT04886154|473241594|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440821|NCT04886154|473241595|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440822|NCT04886154|473241596|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440823|NCT04886154|473241597|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440824|NCT04886154|473241598|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
131440825|NCT04886154|473241599|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440826|NCT04886154|473241600|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440827|NCT04886154|473241601|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131607486|NCT04778410|473854813|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
131707750|NCT01194440|474211315|FG000|Baseline (First Dose)|Change in therapy|1|||
131707751|NCT01194440|474211315|FG000|Baseline (First Dose)|Adverse Event|1|||
131707752|NCT01194440|474211315|FG000|6-months (2nd Dose)|Change in therapy|4|||
131707753|NCT00854828|474211316|FG000|Overall Study|Death|1|||
131707754|NCT00854828|474211317|FG001|Overall Study|Death|0|||
131707755|NCT00854828|474211318|FG002|Overall Study|Death|0|||
131707756|NCT00854828|474211319|FG003|Overall Study|Death|0|||
131707757|NCT00854828|474211316|FG000|Overall Study|Withdrawal by Subject|1|||
131707758|NCT00854828|474211317|FG001|Overall Study|Withdrawal by Subject|1|||
131707759|NCT00854828|474211318|FG002|Overall Study|Withdrawal by Subject|0|||
131707760|NCT00854828|474211319|FG003|Overall Study|Withdrawal by Subject|9|||
131792704|NCT01360632|474522896|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
131792705|NCT01360632|474522892|FG000|Phase A (8 Weeks)|Adverse Event|60|||
131440828|NCT04886154|473241602|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440829|NCT04886154|473241603|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440830|NCT04886154|473241604|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440831|NCT04886154|473241605|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440832|NCT04886154|473241606|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
131440833|NCT04886154|473241592|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440834|NCT04886154|473241593|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440835|NCT04886154|473241594|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440836|NCT04886154|473241595|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440837|NCT04886154|473241596|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131607487|NCT04778410|473854808|FG000|Phase 2 Period|Withdrew Consent|0|||
131607488|NCT04778410|473854809|FG001|Phase 2 Period|Withdrew Consent|0|||
131607489|NCT04778410|473854810|FG002|Phase 2 Period|Withdrew Consent|0|||
131607490|NCT04778410|473854811|FG003|Phase 2 Period|Withdrew Consent|0|||
131607491|NCT04778410|473854812|FG004|Phase 2 Period|Withdrew Consent|2|||
131607492|NCT04778410|473854813|FG005|Phase 2 Period|Withdrew Consent|0|||
131607493|NCT00677365|473854814|FG000|Overall Study|Adverse Event|2|||
131792706|NCT01360632|474522893|FG001|Phase A (8 Weeks)|Adverse Event|0|||
131792707|NCT01360632|474522894|FG002|Phase A (8 Weeks)|Adverse Event|0|||
131792708|NCT01360632|474522895|FG003|Phase A (8 Weeks)|Adverse Event|0|||
131792709|NCT01360632|474522896|FG004|Phase A (8 Weeks)|Adverse Event|0|||
131792710|NCT01360632|474522892|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
131792711|NCT01360632|474522893|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131792712|NCT01360632|474522894|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131792713|NCT01360632|474522895|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131792714|NCT01360632|474522896|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131792715|NCT01360632|474522892|FG000|Phase A (8 Weeks)|Physician Decision|10|||
131792716|NCT01360632|474522893|FG001|Phase A (8 Weeks)|Physician Decision|0|||
131792717|NCT01360632|474522894|FG002|Phase A (8 Weeks)|Physician Decision|0|||
131792718|NCT01360632|474522895|FG003|Phase A (8 Weeks)|Physician Decision|0|||
131792719|NCT01360632|474522896|FG004|Phase A (8 Weeks)|Physician Decision|0|||
131792720|NCT01360632|474522892|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
131792721|NCT01360632|474522893|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131440838|NCT04886154|473241597|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440839|NCT04886154|473241598|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131440840|NCT04886154|473241599|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131440841|NCT04886154|473241600|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131607494|NCT00677365|473854815|FG001|Overall Study|Adverse Event|1|||
131440842|NCT04886154|473241601|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440843|NCT04886154|473241602|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440844|NCT04886154|473241603|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440845|NCT04886154|473241604|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440846|NCT04886154|473241605|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131440847|NCT04886154|473241606|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131440848|NCT04886154|473241592|FG000|Overall Study|Other, Not Specified|0|||
131440849|NCT04886154|473241593|FG001|Overall Study|Other, Not Specified|0|||
131607495|NCT00677365|473854816|FG002|Overall Study|Adverse Event|1|||
131607496|NCT00677365|473854817|FG003|Overall Study|Adverse Event|2|||
131607497|NCT00677365|473854814|FG000|Overall Study|Withdrawal by Subject|0|||
131607498|NCT00677365|473854815|FG001|Overall Study|Withdrawal by Subject|0|||
131607499|NCT00677365|473854816|FG002|Overall Study|Withdrawal by Subject|1|||
131607500|NCT00677365|473854817|FG003|Overall Study|Withdrawal by Subject|0|||
131607501|NCT00677365|473854814|FG000|Overall Study|Other reason|0|||
131607502|NCT00677365|473854815|FG001|Overall Study|Other reason|0|||
131440850|NCT04886154|473241594|FG002|Overall Study|Other, Not Specified|0|||
131440851|NCT04886154|473241595|FG003|Overall Study|Other, Not Specified|0|||
131440852|NCT04886154|473241596|FG004|Overall Study|Other, Not Specified|11|||
131440853|NCT04886154|473241597|FG005|Overall Study|Other, Not Specified|8|||
131440854|NCT04886154|473241598|FG006|Overall Study|Other, Not Specified|9|||
131440855|NCT04886154|473241599|FG007|Overall Study|Other, Not Specified|10|||
131440856|NCT04886154|473241600|FG008|Overall Study|Other, Not Specified|6|||
131440857|NCT04886154|473241601|FG009|Overall Study|Other, Not Specified|1|||
131440858|NCT04886154|473241602|FG010|Overall Study|Other, Not Specified|1|||
131440859|NCT04886154|473241603|FG011|Overall Study|Other, Not Specified|2|||
131440860|NCT04886154|473241604|FG012|Overall Study|Other, Not Specified|1|||
131440861|NCT04886154|473241605|FG013|Overall Study|Other, Not Specified|2|||
131440862|NCT04886154|473241606|FG014|Overall Study|Other, Not Specified|3|||
131440863|NCT03305666|473243091|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
131440864|NCT03305666|473243092|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
131440865|NCT02230410|473243094|FG000|Overall Study|Screen Failure|3|||
131607503|NCT00677365|473854816|FG002|Overall Study|Other reason|0|||
131792722|NCT01360632|474522894|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131440866|NCT02587221|473243099|FG000|Overall Study|Adverse Event|3|||
131440867|NCT02587221|473243100|FG001|Overall Study|Adverse Event|3|||
131440868|NCT02587221|473243099|FG000|Overall Study|Death|33|||
131440869|NCT02587221|473243100|FG001|Overall Study|Death|34|||
131440870|NCT02587221|473243099|FG000|Overall Study|Withdrawal by Subject|66|||
131440871|NCT02587221|473243100|FG001|Overall Study|Withdrawal by Subject|61|||
131440872|NCT02587221|473243099|FG000|Overall Study|Lost to Follow-up|21|||
131440873|NCT02587221|473243100|FG001|Overall Study|Lost to Follow-up|19|||
131440874|NCT02587221|473243099|FG000|Overall Study|Protocol Violation|6|||
131440875|NCT02587221|473243100|FG001|Overall Study|Protocol Violation|5|||
131440876|NCT02587221|473243099|FG000|Overall Study|Other Reason or Unspecified|2|||
131440877|NCT02587221|473243100|FG001|Overall Study|Other Reason or Unspecified|1|||
131440878|NCT01791244|473243104|FG000|Overall Study|Adverse Event|5|||
131440879|NCT01791244|473243105|FG001|Overall Study|Adverse Event|7|||
131440880|NCT01791244|473243104|FG000|Overall Study|Insufficient clinical response|10|||
131440881|NCT01791244|473243105|FG001|Overall Study|Insufficient clinical response|10|||
131440882|NCT01791244|473243104|FG000|Overall Study|Laboratory Abnormality|0|||
131440883|NCT01791244|473243105|FG001|Overall Study|Laboratory Abnormality|1|||
131440884|NCT01149096|473243106|FG000|Overall Study|Lost to Follow-up|0|||
131440885|NCT01149096|473243107|FG001|Overall Study|Lost to Follow-up|1|||
131440886|NCT00703014|473243112|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
131440887|NCT00703014|473243113|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
131440888|NCT00703014|473243114|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
131440889|NCT00703014|473243115|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
131440890|NCT00703014|473243112|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
131440891|NCT00703014|473243113|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
131440892|NCT00703014|473243114|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
131440893|NCT00703014|473243115|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
131440894|NCT05468814|473243116|FG000|Overall Study|Lost to Follow-up|5|||
131440895|NCT05468814|473243117|FG001|Overall Study|Lost to Follow-up|6|||
131440896|NCT00625131|473243118|FG000|Overall Study|Lost to Follow-up|3|||
131607504|NCT00677365|473854817|FG003|Overall Study|Other reason|1|||
131607505|NCT01121588|473854818|FG000|Overall Study|Death|5|||
131607506|NCT01121588|473854819|FG001|Overall Study|Death|3|||
131607507|NCT01121588|473854820|FG002|Overall Study|Death|13|||
131607508|NCT01121588|473854818|FG000|Overall Study|Study Terminated by Sponsor|1|||
131607509|NCT01121588|473854819|FG001|Overall Study|Study Terminated by Sponsor|1|||
131607510|NCT01121588|473854820|FG002|Overall Study|Study Terminated by Sponsor|0|||
131607511|NCT01121588|473854818|FG000|Overall Study|Participant Refused Further Followup|2|||
131607512|NCT01121588|473854819|FG001|Overall Study|Participant Refused Further Followup|0|||
131607513|NCT01121588|473854820|FG002|Overall Study|Participant Refused Further Followup|2|||
131607514|NCT01121588|473854818|FG000|Overall Study|Lost to Follow-up|0|||
131607515|NCT01121588|473854819|FG001|Overall Study|Lost to Follow-up|1|||
131607516|NCT01121588|473854820|FG002|Overall Study|Lost to Follow-up|1|||
131607517|NCT01121588|473854818|FG000|Overall Study|Non-Specified Reasons|9|||
131607518|NCT01121588|473854819|FG001|Overall Study|Non-Specified Reasons|4|||
131607519|NCT01121588|473854820|FG002|Overall Study|Non-Specified Reasons|2|||
131607520|NCT00721149|473854822|FG000|Overall Study|Physician Decision|1|||
131607521|NCT04206787|473854823|FG000|Overall Study|Other than listed|2|||
131607522|NCT04206787|473854823|FG000|Overall Study|Investigator decision|1|||
131607523|NCT04206787|473854823|FG000|Overall Study|Death|25|||
131607524|NCT04206787|473854823|FG000|Overall Study|Lost to Follow-up|9|||
131607525|NCT04206787|473854823|FG000|Overall Study|Withdrawal of consent|9|||
131607526|NCT02039401|473854824|FG000|Overall Study|Adverse Event|0|||
131607527|NCT02039401|473854825|FG001|Overall Study|Adverse Event|1|||
131607528|NCT03057054|473854826|FG000|Overall Study|Death|4|||
131607529|NCT03057054|473854827|FG001|Overall Study|Death|4|||
131607530|NCT03057054|473854826|FG000|Overall Study|Withdrawal by Subject|6|||
131707761|NCT00854828|474211316|FG000|Overall Study|Missed 24mo visit|1|||
131707762|NCT00854828|474211317|FG001|Overall Study|Missed 24mo visit|1|||
131440897|NCT00625131|473243119|FG001|Overall Study|Lost to Follow-up|2|||
131440898|NCT00625131|473243120|FG002|Overall Study|Lost to Follow-up|0|||
131440899|NCT00625131|473243118|FG000|Overall Study|Withdrawal by Subject|1|||
131440900|NCT00625131|473243119|FG001|Overall Study|Withdrawal by Subject|0|||
131607531|NCT03057054|473854827|FG001|Overall Study|Withdrawal by Subject|3|||
131440901|NCT00625131|473243120|FG002|Overall Study|Withdrawal by Subject|5|||
131440902|NCT00918281|473243123|FG000|Overall Study|Physician Decision|29|||
131440903|NCT01743469|473243124|FG000|Active Treatment Phase|Adverse Event|10|||
131440904|NCT01743469|473243125|FG001|Active Treatment Phase|Adverse Event|5|||
131440905|NCT01743469|473243126|FG002|Active Treatment Phase|Adverse Event|8|||
131440906|NCT01743469|473243127|FG003|Active Treatment Phase|Adverse Event|1|||
131440907|NCT01743469|473243124|FG000|Active Treatment Phase|Disease Progression|40|||
131440908|NCT01743469|473243125|FG001|Active Treatment Phase|Disease Progression|47|||
131440909|NCT01743469|473243126|FG002|Active Treatment Phase|Disease Progression|30|||
131440910|NCT01743469|473243127|FG003|Active Treatment Phase|Disease Progression|20|||
131440911|NCT01743469|473243124|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
131440912|NCT01743469|473243125|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
131440913|NCT01743469|473243126|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
131440914|NCT01743469|473243127|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
131792723|NCT01360632|474522895|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131792724|NCT01360632|474522896|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131792725|NCT01360632|474522892|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
131792726|NCT01360632|474522893|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
131792727|NCT01360632|474522894|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
131792728|NCT01360632|474522895|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
131792729|NCT01360632|474522896|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
131792730|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
131792731|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
131792732|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
131792733|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
131792734|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
131792735|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Adverse Event|0|||
131792736|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Adverse Event|3|||
131792737|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Adverse Event|9|||
131792738|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Adverse Event|3|||
131792739|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Adverse Event|0|||
131792740|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131792741|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131792742|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
131792743|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
131792744|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131792745|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Physician Decision|0|||
131440915|NCT01743469|473243124|FG000|Active Treatment Phase|Missing|1|||
131440916|NCT01743469|473243125|FG001|Active Treatment Phase|Missing|0|||
131440917|NCT01743469|473243126|FG002|Active Treatment Phase|Missing|0|||
131607532|NCT03057054|473854826|FG000|Overall Study|Ineligible|1|||
131607533|NCT03057054|473854827|FG001|Overall Study|Ineligible|1|||
131440918|NCT01743469|473243127|FG003|Active Treatment Phase|Missing|0|||
131440919|NCT01743469|473243124|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
131607534|NCT01064440|473855766|FG000|Overall Study|Lost to Follow-up|1|||
131607535|NCT01064440|473855767|FG001|Overall Study|Lost to Follow-up|1|||
131607536|NCT01064440|473855768|FG002|Overall Study|Lost to Follow-up|1|||
131607537|NCT01064440|473855766|FG000|Overall Study|Non-compliance|0|||
131607538|NCT01064440|473855767|FG001|Overall Study|Non-compliance|1|||
131607539|NCT01064440|473855768|FG002|Overall Study|Non-compliance|0|||
131607540|NCT01064440|473855766|FG000|Overall Study|Death|1|||
131440920|NCT01743469|473243125|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
131440921|NCT01743469|473243126|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
131440922|NCT01743469|473243127|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
131440923|NCT01743469|473243124|FG000|Follow-up Period - Post-Treatment|Death|43|||
131607541|NCT01064440|473855767|FG001|Overall Study|Death|0|||
131607542|NCT01064440|473855768|FG002|Overall Study|Death|1|||
131607543|NCT01064440|473855766|FG000|Overall Study|Withdrawal by Subject|0|||
131607544|NCT01064440|473855767|FG001|Overall Study|Withdrawal by Subject|1|||
131607545|NCT01064440|473855768|FG002|Overall Study|Withdrawal by Subject|1|||
131607546|NCT01064440|473855766|FG000|Overall Study|Other: amputation|1|||
131440924|NCT01743469|473243125|FG001|Follow-up Period - Post-Treatment|Death|47|||
131440925|NCT01743469|473243126|FG002|Follow-up Period - Post-Treatment|Death|22|||
131440926|NCT01743469|473243127|FG003|Follow-up Period - Post-Treatment|Death|16|||
131440927|NCT01743469|473243124|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
131607547|NCT01064440|473855767|FG001|Overall Study|Other: amputation|0|||
131707763|NCT00854828|474211318|FG002|Overall Study|Missed 24mo visit|8|||
131607548|NCT01064440|473855768|FG002|Overall Study|Other: amputation|0|||
131607549|NCT04108130|473855769|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
131440928|NCT01743469|473243125|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
131607550|NCT04108130|473855770|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
131607551|NCT04108130|473855769|FG000|Overall Study|Consent Withdrawn|9|||
131607552|NCT04108130|473855770|FG001|Overall Study|Consent Withdrawn|6|||
131792746|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Physician Decision|0|||
131792747|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Physician Decision|0|||
131792748|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Physician Decision|1|||
131792749|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Physician Decision|0|||
131792750|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131792751|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
131792752|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
131792753|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
131792754|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131792755|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
131792756|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
131792757|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
131792758|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
131792759|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
131792760|NCT01360632|474522892|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
131792761|NCT01360632|474522893|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
131792762|NCT01360632|474522894|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
131792763|NCT01360632|474522895|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
131792764|NCT01360632|474522896|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
131792765|NCT01360632|474522892|FG000|Phase A+|Lost to Follow-up|0|||
131792766|NCT01360632|474522893|FG001|Phase A+|Lost to Follow-up|0|||
131792767|NCT01360632|474522894|FG002|Phase A+|Lost to Follow-up|0|||
131792768|NCT01360632|474522895|FG003|Phase A+|Lost to Follow-up|0|||
131792769|NCT01360632|474522896|FG004|Phase A+|Lost to Follow-up|2|||
131792770|NCT01360632|474522892|FG000|Phase A+|Adverse Event|0|||
131792771|NCT01360632|474522893|FG001|Phase A+|Adverse Event|0|||
131792772|NCT01360632|474522894|FG002|Phase A+|Adverse Event|0|||
131792773|NCT01360632|474522895|FG003|Phase A+|Adverse Event|0|||
131792774|NCT01360632|474522896|FG004|Phase A+|Adverse Event|2|||
131792775|NCT01360632|474522892|FG000|Phase A+|Met Withdrawal Criteria|0|||
131792776|NCT01360632|474522893|FG001|Phase A+|Met Withdrawal Criteria|0|||
131792777|NCT01360632|474522894|FG002|Phase A+|Met Withdrawal Criteria|0|||
131792778|NCT01360632|474522895|FG003|Phase A+|Met Withdrawal Criteria|0|||
131792779|NCT01360632|474522896|FG004|Phase A+|Met Withdrawal Criteria|7|||
131792780|NCT01360632|474522892|FG000|Phase A+|Physician Decision|0|||
131707764|NCT00854828|474211319|FG003|Overall Study|Missed 24mo visit|8|||
131707765|NCT04957290|474211321|FG000|Overall Study|Progressive disease|3|||
131707766|NCT04957290|474211322|FG001|Overall Study|Progressive disease|3|||
131707767|NCT04957290|474211323|FG002|Overall Study|Progressive disease|2|||
131707768|NCT04957290|474211324|FG003|Overall Study|Progressive disease|0|||
131707769|NCT04957290|474211325|FG004|Overall Study|Progressive disease|0|||
131707770|NCT04957290|474211326|FG005|Overall Study|Progressive disease|0|||
131707771|NCT04957290|474211321|FG000|Overall Study|Withdrawal by Subject|1|||
131707772|NCT04957290|474211322|FG001|Overall Study|Withdrawal by Subject|0|||
131707773|NCT04957290|474211323|FG002|Overall Study|Withdrawal by Subject|1|||
131707774|NCT04957290|474211324|FG003|Overall Study|Withdrawal by Subject|0|||
131707775|NCT04957290|474211325|FG004|Overall Study|Withdrawal by Subject|0|||
131707776|NCT04957290|474211326|FG005|Overall Study|Withdrawal by Subject|0|||
131707777|NCT04957290|474211321|FG000|Overall Study|Death|0|||
131707778|NCT04957290|474211322|FG001|Overall Study|Death|2|||
131707779|NCT04957290|474211323|FG002|Overall Study|Death|1|||
131707780|NCT04957290|474211324|FG003|Overall Study|Death|0|||
131707781|NCT04957290|474211325|FG004|Overall Study|Death|0|||
131707782|NCT04957290|474211326|FG005|Overall Study|Death|0|||
131707783|NCT04957290|474211321|FG000|Overall Study|non compliance with study drug|0|||
131707784|NCT04957290|474211322|FG001|Overall Study|non compliance with study drug|1|||
131707785|NCT04957290|474211323|FG002|Overall Study|non compliance with study drug|0|||
131707786|NCT04957290|474211324|FG003|Overall Study|non compliance with study drug|0|||
131707787|NCT04957290|474211325|FG004|Overall Study|non compliance with study drug|0|||
131792781|NCT01360632|474522893|FG001|Phase A+|Physician Decision|0|||
131792782|NCT01360632|474522894|FG002|Phase A+|Physician Decision|0|||
131707788|NCT04957290|474211326|FG005|Overall Study|non compliance with study drug|0|||
131792783|NCT01360632|474522895|FG003|Phase A+|Physician Decision|0|||
131792784|NCT01360632|474522896|FG004|Phase A+|Physician Decision|3|||
131792785|NCT01360632|474522892|FG000|Phase A+|Withdrawal by Subject|0|||
131707789|NCT04957290|474211321|FG000|Overall Study|none specified.|0|||
131707790|NCT04957290|474211322|FG001|Overall Study|none specified.|1|||
131707791|NCT04957290|474211323|FG002|Overall Study|none specified.|2|||
131707792|NCT04957290|474211324|FG003|Overall Study|none specified.|0|||
131792786|NCT01360632|474522893|FG001|Phase A+|Withdrawal by Subject|0|||
131792787|NCT01360632|474522894|FG002|Phase A+|Withdrawal by Subject|0|||
131440929|NCT01743469|473243126|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
131440930|NCT01743469|473243127|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
131792788|NCT01360632|474522895|FG003|Phase A+|Withdrawal by Subject|0|||
131792789|NCT01360632|474522896|FG004|Phase A+|Withdrawal by Subject|8|||
131792790|NCT01360632|474522892|FG000|Phase A+|Protocol Deviation|0|||
131792791|NCT01360632|474522893|FG001|Phase A+|Protocol Deviation|0|||
131792792|NCT01360632|474522894|FG002|Phase A+|Protocol Deviation|0|||
131792793|NCT01360632|474522895|FG003|Phase A+|Protocol Deviation|0|||
131792794|NCT01360632|474522896|FG004|Phase A+|Protocol Deviation|3|||
131792795|NCT02123459|474522899|FG000|Washout Period (1 Day)|Adverse Event|1|||
131792796|NCT02123459|474522900|FG001|Washout Period (1 Day)|Adverse Event|0|||
131792797|NCT00254397|474522905|FG000|Overall Study|Disease Progression|4|||
131792798|NCT00254397|474522906|FG001|Overall Study|Disease Progression|1|||
131792799|NCT00254397|474522907|FG002|Overall Study|Disease Progression|16|||
131792800|NCT00254397|474522908|FG003|Overall Study|Disease Progression|23|||
131792801|NCT00254397|474522905|FG000|Overall Study|Non-Compliant|0|||
131792802|NCT00254397|474522906|FG001|Overall Study|Non-Compliant|0|||
131792803|NCT00254397|474522907|FG002|Overall Study|Non-Compliant|0|||
131792804|NCT00254397|474522908|FG003|Overall Study|Non-Compliant|1|||
131792805|NCT00254397|474522905|FG000|Overall Study|Adverse Event|2|||
131792806|NCT00254397|474522906|FG001|Overall Study|Adverse Event|0|||
131792807|NCT00254397|474522907|FG002|Overall Study|Adverse Event|3|||
131792808|NCT00254397|474522908|FG003|Overall Study|Adverse Event|1|||
131792809|NCT01715415|474522910|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
131792810|NCT01715415|474522911|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
131792811|NCT01715415|474522910|FG000|Double-blind Treatment|Adverse Event|3|||
131792812|NCT01715415|474522911|FG001|Double-blind Treatment|Adverse Event|0|||
131792813|NCT01715415|474522910|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
131792814|NCT01715415|474522911|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
131792815|NCT01715415|474522910|FG000|Double-blind Treatment|Other|1|||
131792816|NCT01715415|474522911|FG001|Double-blind Treatment|Other|0|||
131792817|NCT01715415|474522910|FG000|Open-label Treatment|Adverse Event|0|||
131792818|NCT01715415|474522911|FG001|Open-label Treatment|Adverse Event|1|||
131792819|NCT01715415|474522910|FG000|Open-label Treatment|Subject Noncompliant|0|||
131792820|NCT01715415|474522911|FG001|Open-label Treatment|Subject Noncompliant|1|||
131792821|NCT01015612|474522912|FG000|Overall Study|Death|113|||
131792822|NCT01015612|474522912|FG000|Overall Study|Withdrawal by Subject|40|||
131792823|NCT00972153|474522916|FG000|Overall Study|Equipment malfunction during case|0|||
131792824|NCT00972153|474522917|FG001|Overall Study|Equipment malfunction during case|1|||
131792825|NCT00972153|474522918|FG002|Overall Study|Equipment malfunction during case|0|||
131792826|NCT00982410|474524547|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
131792827|NCT00982410|474524548|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
131792828|NCT00982410|474524547|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
131792829|NCT00982410|474524548|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
131792830|NCT00982410|474524547|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
131792831|NCT00982410|474524548|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
131792832|NCT00982410|474524547|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
131792833|NCT00982410|474524548|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
131792834|NCT00982410|474524547|FG000|6-month Follow-up Assessment|participant no transportation|1|||
131792835|NCT00982410|474524548|FG001|6-month Follow-up Assessment|participant no transportation|0|||
131792836|NCT00982410|474524547|FG000|6-month Follow-up Assessment|incarceration|0|||
131792837|NCT00982410|474524548|FG001|6-month Follow-up Assessment|incarceration|2|||
131792838|NCT00982410|474524547|FG000|6-month Follow-up Assessment|patent surgery|0|||
131440931|NCT00317473|473243128|FG000|Overall Study|Withdrawal by Subject|2|||
131607553|NCT04108130|473855769|FG000|Overall Study|Surgery Cancelled|4|||
131792839|NCT00982410|474524548|FG001|6-month Follow-up Assessment|patent surgery|1|||
131792840|NCT00982410|474524547|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
131792841|NCT00982410|474524548|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
131792842|NCT00982410|474524547|FG000|12-month Follow-up Assessment|Death|0|||
131792843|NCT00982410|474524548|FG001|12-month Follow-up Assessment|Death|2|||
131792844|NCT00982410|474524547|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
131792845|NCT00982410|474524548|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
131792846|NCT00982410|474524547|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
131792847|NCT00982410|474524548|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
131440932|NCT00317473|473243129|FG001|Overall Study|Withdrawal by Subject|1|||
131440933|NCT00317473|473243130|FG002|Overall Study|Withdrawal by Subject|2|||
131440934|NCT00317473|473243131|FG003|Overall Study|Withdrawal by Subject|1|||
131440935|NCT00317473|473243132|FG004|Overall Study|Withdrawal by Subject|3|||
131440936|NCT00317473|473243133|FG005|Overall Study|Withdrawal by Subject|1|||
131440937|NCT00317473|473243128|FG000|Overall Study|Relocation|1|||
131440938|NCT00317473|473243129|FG001|Overall Study|Relocation|0|||
131440939|NCT00317473|473243130|FG002|Overall Study|Relocation|1|||
131440940|NCT00317473|473243131|FG003|Overall Study|Relocation|1|||
131440941|NCT00317473|473243132|FG004|Overall Study|Relocation|5|||
131440942|NCT00317473|473243133|FG005|Overall Study|Relocation|2|||
131440943|NCT00317473|473243128|FG000|Overall Study|Death|1|||
131440944|NCT00317473|473243129|FG001|Overall Study|Death|0|||
131440945|NCT00317473|473243130|FG002|Overall Study|Death|0|||
131440946|NCT00317473|473243131|FG003|Overall Study|Death|0|||
131440947|NCT00317473|473243132|FG004|Overall Study|Death|0|||
131440948|NCT00317473|473243133|FG005|Overall Study|Death|0|||
131440949|NCT00317473|473243128|FG000|Overall Study|Other|0|||
131440950|NCT00317473|473243129|FG001|Overall Study|Other|2|||
131440951|NCT00317473|473243130|FG002|Overall Study|Other|0|||
131440952|NCT00317473|473243131|FG003|Overall Study|Other|0|||
131440953|NCT00317473|473243132|FG004|Overall Study|Other|0|||
131440954|NCT00317473|473243133|FG005|Overall Study|Other|0|||
131440955|NCT00388349|473243134|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
131440956|NCT00388349|473243135|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
131440957|NCT00168844|473243136|FG000|Overall Study|Adverse Event|31|||
131440958|NCT00168844|473243137|FG001|Overall Study|Adverse Event|32|||
131440959|NCT00168844|473243138|FG002|Overall Study|Adverse Event|48|||
131440960|NCT00168844|473243136|FG000|Overall Study|Lost to Follow-up|4|||
131440961|NCT00168844|473243137|FG001|Overall Study|Lost to Follow-up|5|||
131440962|NCT00168844|473243138|FG002|Overall Study|Lost to Follow-up|11|||
131440963|NCT00168844|473243136|FG000|Overall Study|Withdrawal by Subject|12|||
131440964|NCT00168844|473243137|FG001|Overall Study|Withdrawal by Subject|9|||
131440965|NCT00168844|473243138|FG002|Overall Study|Withdrawal by Subject|19|||
131440966|NCT00168844|473243136|FG000|Overall Study|Protocol Violation|2|||
131440967|NCT00168844|473243137|FG001|Overall Study|Protocol Violation|2|||
131440968|NCT00168844|473243138|FG002|Overall Study|Protocol Violation|4|||
131792848|NCT00982410|474524547|FG000|12-month Follow-up Assessment|incarceration|2|||
131792849|NCT00982410|474524548|FG001|12-month Follow-up Assessment|incarceration|1|||
131899866|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
131899867|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
131899868|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
131899869|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
131899870|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
131899871|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
131899872|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
131899873|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
131899874|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
131899875|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
131899876|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
131899877|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
131899878|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
131899879|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
131899880|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
131899881|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
131440969|NCT00168844|473243136|FG000|Overall Study|Other|6|||
131792850|NCT00982410|474524547|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
131792851|NCT00982410|474524548|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
131792852|NCT03322462|474524549|FG000|Overall Study|Technical difficulties|2|||
131792853|NCT03322462|474524549|FG000|Overall Study|Other|1|||
131792854|NCT02004847|474524550|FG000|Overall Study|Protocol Violation|1|||
131792855|NCT02004847|474524551|FG001|Overall Study|Protocol Violation|1|||
131792856|NCT02034799|474524552|FG000|Overall Study|Withdrawal by Subject|0|||
131440970|NCT00168844|473243137|FG001|Overall Study|Other|7|||
131440971|NCT00168844|473243138|FG002|Overall Study|Other|9|||
131440972|NCT02138890|473243147|FG000|Overall Study|Adverse Event|1|||
131440973|NCT02138890|473243148|FG001|Overall Study|Adverse Event|0|||
131440974|NCT01446159|473243149|FG000|Overall Study|Withdrawal by Subject|1|||
131440975|NCT01446159|473243150|FG001|Overall Study|Withdrawal by Subject|0|||
131792857|NCT02034799|474524553|FG001|Overall Study|Withdrawal by Subject|2|||
131792858|NCT02034799|474524552|FG000|Overall Study|Lost to Follow-up|0|||
131440976|NCT01446159|473243151|FG002|Overall Study|Withdrawal by Subject|14|||
131440977|NCT01446159|473243152|FG003|Overall Study|Withdrawal by Subject|11|||
131440978|NCT01446159|473243149|FG000|Overall Study|Lost to Follow-up|0|||
131440979|NCT01446159|473243150|FG001|Overall Study|Lost to Follow-up|0|||
131440980|NCT01446159|473243151|FG002|Overall Study|Lost to Follow-up|1|||
131792859|NCT02034799|474524553|FG001|Overall Study|Lost to Follow-up|1|||
131792860|NCT02034799|474524552|FG000|Overall Study|Death|2|||
131792861|NCT02034799|474524553|FG001|Overall Study|Death|1|||
131792862|NCT01133821|474524562|FG000|Overall Study|Lost to Follow-up|8|||
131440981|NCT01446159|473243152|FG003|Overall Study|Lost to Follow-up|2|||
131792863|NCT01133821|474524563|FG001|Overall Study|Lost to Follow-up|11|||
131792864|NCT01133821|474524562|FG000|Overall Study|Withdrawal by Subject|8|||
131792865|NCT01133821|474524563|FG001|Overall Study|Withdrawal by Subject|3|||
131792866|NCT01133821|474524562|FG000|Overall Study|preferred other treatment|1|||
131792867|NCT01133821|474524563|FG001|Overall Study|preferred other treatment|1|||
131792868|NCT01133821|474524562|FG000|Overall Study|Protocol Violation|0|||
131792869|NCT01133821|474524563|FG001|Overall Study|Protocol Violation|1|||
131899882|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
131440982|NCT01446159|473243149|FG000|Overall Study|Death|2|||
131440983|NCT01446159|473243150|FG001|Overall Study|Death|3|||
131440984|NCT01446159|473243151|FG002|Overall Study|Death|43|||
131440985|NCT01446159|473243152|FG003|Overall Study|Death|36|||
131440986|NCT01446159|473243149|FG000|Overall Study|Other|0|||
131440987|NCT01446159|473243150|FG001|Overall Study|Other|0|||
131440988|NCT01446159|473243151|FG002|Overall Study|Other|13|||
131440989|NCT01446159|473243152|FG003|Overall Study|Other|13|||
131440990|NCT00537394|473243155|FG000|First Year of Follow-up|Death|7|||
131440991|NCT00537394|473243156|FG001|First Year of Follow-up|Death|0|||
131440992|NCT00537394|473243157|FG002|First Year of Follow-up|Death|0|||
131440993|NCT00537394|473243155|FG000|First Year of Follow-up|Severe debilitation|1|||
131440994|NCT00537394|473243156|FG001|First Year of Follow-up|Severe debilitation|0|||
131440995|NCT00537394|473243157|FG002|First Year of Follow-up|Severe debilitation|1|||
131440996|NCT00537394|473243155|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
131440997|NCT00537394|473243156|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
131440998|NCT00537394|473243157|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
131440999|NCT00537394|473243155|FG000|First Year of Follow-up|Lost to Follow-up|1|||
131441000|NCT00537394|473243156|FG001|First Year of Follow-up|Lost to Follow-up|5|||
131441001|NCT00537394|473243157|FG002|First Year of Follow-up|Lost to Follow-up|1|||
131441002|NCT00537394|473243155|FG000|2nd Year of Follow-up|Death|4|||
131441003|NCT00537394|473243156|FG001|2nd Year of Follow-up|Death|1|||
131441004|NCT00537394|473243157|FG002|2nd Year of Follow-up|Death|2|||
131441005|NCT00537394|473243155|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
131441006|NCT00537394|473243156|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
131441007|NCT00537394|473243157|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
131441008|NCT00537394|473243155|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
131441009|NCT00537394|473243156|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
131441010|NCT00537394|473243157|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
131441011|NCT00537394|473243155|FG000|2nd Year of Follow-up|Clinic site closure|1|||
131899883|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
131899884|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
131899885|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131441012|NCT00537394|473243156|FG001|2nd Year of Follow-up|Clinic site closure|0|||
131441013|NCT00537394|473243157|FG002|2nd Year of Follow-up|Clinic site closure|0|||
131441014|NCT01283139|473243158|FG000|Overall Study|Lost to Follow-up|5|||
131792870|NCT01133821|474524562|FG000|Overall Study|Refused participation|1|||
131792871|NCT01133821|474524563|FG001|Overall Study|Refused participation|3|||
131899886|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131441015|NCT01283139|473243159|FG001|Overall Study|Lost to Follow-up|2|||
131441016|NCT01283139|473243160|FG002|Overall Study|Lost to Follow-up|3|||
131441017|NCT01283139|473243161|FG003|Overall Study|Lost to Follow-up|1|||
131441018|NCT01283139|473243158|FG000|Overall Study|Withdrawal by Subject|8|||
131441019|NCT01283139|473243159|FG001|Overall Study|Withdrawal by Subject|8|||
131441020|NCT01283139|473243160|FG002|Overall Study|Withdrawal by Subject|6|||
131441021|NCT01283139|473243161|FG003|Overall Study|Withdrawal by Subject|8|||
131441022|NCT01283139|473243158|FG000|Overall Study|Death|2|||
131792872|NCT00434161|474524564|FG000|Overall Study|Adverse Event|5|||
131792873|NCT00434161|474524565|FG001|Overall Study|Adverse Event|1|||
131792874|NCT00434161|474524566|FG002|Overall Study|Adverse Event|4|||
131441023|NCT01283139|473243159|FG001|Overall Study|Death|0|||
131441024|NCT01283139|473243160|FG002|Overall Study|Death|2|||
131441025|NCT01283139|473243161|FG003|Overall Study|Death|2|||
131441026|NCT01283139|473243158|FG000|Overall Study|Lack of Efficacy|1|||
131441027|NCT01283139|473243159|FG001|Overall Study|Lack of Efficacy|2|||
131792875|NCT00434161|474524564|FG000|Overall Study|Lost to Follow-up|0|||
131792876|NCT00434161|474524565|FG001|Overall Study|Lost to Follow-up|1|||
131792877|NCT00434161|474524566|FG002|Overall Study|Lost to Follow-up|0|||
131792878|NCT00434161|474524564|FG000|Overall Study|Death|1|||
131792879|NCT00434161|474524565|FG001|Overall Study|Death|0|||
131792880|NCT00434161|474524566|FG002|Overall Study|Death|1|||
131792881|NCT00434161|474524564|FG000|Overall Study|Non-Compliance|1|||
131792882|NCT00434161|474524565|FG001|Overall Study|Non-Compliance|1|||
131792883|NCT00434161|474524566|FG002|Overall Study|Non-Compliance|0|||
131792884|NCT00434161|474524564|FG000|Overall Study|Withdrawal by Subject|2|||
131792885|NCT00434161|474524565|FG001|Overall Study|Withdrawal by Subject|0|||
131792886|NCT00434161|474524566|FG002|Overall Study|Withdrawal by Subject|3|||
131792887|NCT00434161|474524564|FG000|Overall Study|Logistical error study assessments|1|||
131792888|NCT00434161|474524565|FG001|Overall Study|Logistical error study assessments|0|||
131792889|NCT00434161|474524566|FG002|Overall Study|Logistical error study assessments|3|||
131792890|NCT03342898|474524567|FG000|Overall Study|Adverse Event|3|||
131792891|NCT03342898|474524568|FG001|Overall Study|Adverse Event|1|||
131792892|NCT03342898|474524569|FG002|Overall Study|Adverse Event|0|||
131792893|NCT03342898|474524567|FG000|Overall Study|Lost to Follow-up|44|||
131792894|NCT03342898|474524568|FG001|Overall Study|Lost to Follow-up|40|||
131792895|NCT03342898|474524569|FG002|Overall Study|Lost to Follow-up|42|||
131792896|NCT03342898|474524567|FG000|Overall Study|Withdrawal of Consent|5|||
131792897|NCT03342898|474524568|FG001|Overall Study|Withdrawal of Consent|9|||
131792898|NCT03342898|474524569|FG002|Overall Study|Withdrawal of Consent|11|||
131792899|NCT03342898|474524567|FG000|Overall Study|Death|0|||
131792900|NCT03342898|474524568|FG001|Overall Study|Death|1|||
131792901|NCT03342898|474524569|FG002|Overall Study|Death|1|||
131792902|NCT03342898|474524567|FG000|Overall Study|Reason not Specified|2|||
131792903|NCT03342898|474524568|FG001|Overall Study|Reason not Specified|2|||
131792904|NCT03342898|474524569|FG002|Overall Study|Reason not Specified|0|||
131792905|NCT01267266|474524570|FG000|Enrollment Phase|Withdrawal by Subject|2|||
131792906|NCT01267266|474524571|FG001|Enrollment Phase|Withdrawal by Subject|0|||
131792907|NCT01267266|474524570|FG000|Lead-in Phase|Lack of Efficacy|20|||
131792908|NCT01267266|474524571|FG001|Lead-in Phase|Lack of Efficacy|0|||
131792909|NCT01267266|474524570|FG000|Lead-in Phase|Adverse Event|2|||
131792910|NCT01267266|474524571|FG001|Lead-in Phase|Adverse Event|0|||
131792911|NCT01267266|474524570|FG000|Lead-in Phase|Withdrawal by Subject|1|||
131792912|NCT01267266|474524571|FG001|Lead-in Phase|Withdrawal by Subject|0|||
131792913|NCT01466686|474524581|FG000|Overall Study|Withdrawal by Subject|1|||
131792914|NCT02049359|474524586|FG000|Overall Study|Lost to Follow-up|26|||
131792915|NCT02049359|474524587|FG001|Overall Study|Lost to Follow-up|19|||
131792916|NCT01907087|474524588|FG000|Overall Study|Withdrawal by Subject|1|||
131792917|NCT05216978|474524589|FG000|Overall Study|Withdrawal by Subject|3|||
131792918|NCT05216978|474524589|FG000|Overall Study|Lost to Follow-up|5|||
131792919|NCT00658320|474524591|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
131792920|NCT00658320|474524592|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
131792921|NCT00658320|474524591|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
131792922|NCT00658320|474524592|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
131792923|NCT00658320|474524591|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
131792924|NCT00658320|474524592|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
131792925|NCT00658320|474524591|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
131792926|NCT00658320|474524592|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
131792927|NCT02040428|474524610|FG000|Overall Study|Death|4|||
131792928|NCT02040428|474524611|FG001|Overall Study|Death|3|||
131792929|NCT02040428|474524610|FG000|Overall Study|Withdrawal by Subject|1|||
131792930|NCT02040428|474524611|FG001|Overall Study|Withdrawal by Subject|1|||
131792931|NCT03551730|474524612|FG000|Overall Study|Adverse Event|1|||
131792932|NCT03551730|474524613|FG001|Overall Study|Adverse Event|0|||
131441028|NCT01283139|473243160|FG002|Overall Study|Lack of Efficacy|2|||
131792933|NCT03551730|474524614|FG002|Overall Study|Adverse Event|0|||
131792934|NCT03551730|474524615|FG003|Overall Study|Adverse Event|0|||
131792935|NCT02668783|474524629|FG000|Overall Study|Pregnancy|0|||
131792936|NCT02668783|474524630|FG001|Overall Study|Pregnancy|1|||
131792937|NCT02668783|474524629|FG000|Overall Study|Protocol Violation|2|||
131441029|NCT01283139|473243161|FG003|Overall Study|Lack of Efficacy|1|||
131792938|NCT02668783|474524630|FG001|Overall Study|Protocol Violation|1|||
131792939|NCT02668783|474524629|FG000|Overall Study|Study terminated by sponsor|9|||
131441030|NCT01283139|473243158|FG000|Overall Study|Early termination due to AE/SAE|1|||
131607554|NCT04108130|473855770|FG001|Overall Study|Surgery Cancelled|4|||
131792940|NCT02668783|474524630|FG001|Overall Study|Study terminated by sponsor|10|||
131792941|NCT02668783|474524629|FG000|Overall Study|Subject moved|1|||
131792942|NCT02668783|474524630|FG001|Overall Study|Subject moved|0|||
131792943|NCT02668783|474524629|FG000|Overall Study|Withdrawal by Subject|1|||
131441031|NCT01283139|473243159|FG001|Overall Study|Early termination due to AE/SAE|1|||
131441032|NCT01283139|473243160|FG002|Overall Study|Early termination due to AE/SAE|0|||
131441033|NCT01283139|473243161|FG003|Overall Study|Early termination due to AE/SAE|0|||
131441034|NCT01283139|473243158|FG000|Overall Study|Participant's refusal to continue|0|||
131441035|NCT01283139|473243159|FG001|Overall Study|Participant's refusal to continue|3|||
131441036|NCT01283139|473243160|FG002|Overall Study|Participant's refusal to continue|1|||
131441037|NCT01283139|473243161|FG003|Overall Study|Participant's refusal to continue|1|||
131707793|NCT04957290|474211325|FG004|Overall Study|none specified.|0|||
131707794|NCT04957290|474211326|FG005|Overall Study|none specified.|0|||
131707795|NCT04957290|474211321|FG000|Overall Study|unacceptable toxicity|0|||
131707796|NCT04957290|474211322|FG001|Overall Study|unacceptable toxicity|0|||
131707797|NCT04957290|474211323|FG002|Overall Study|unacceptable toxicity|1|||
131707798|NCT04957290|474211324|FG003|Overall Study|unacceptable toxicity|0|||
131707799|NCT04957290|474211325|FG004|Overall Study|unacceptable toxicity|0|||
131707800|NCT04957290|474211326|FG005|Overall Study|unacceptable toxicity|0|||
131707801|NCT04957290|474211321|FG000|Overall Study|Adverse Event|0|||
131707802|NCT04957290|474211322|FG001|Overall Study|Adverse Event|0|||
131707803|NCT04957290|474211323|FG002|Overall Study|Adverse Event|1|||
131707804|NCT04957290|474211324|FG003|Overall Study|Adverse Event|0|||
131707805|NCT04957290|474211325|FG004|Overall Study|Adverse Event|0|||
131707806|NCT04957290|474211326|FG005|Overall Study|Adverse Event|0|||
131707807|NCT04957290|474211321|FG000|Overall Study|study terminated by sponsor|0|||
131707808|NCT04957290|474211322|FG001|Overall Study|study terminated by sponsor|0|||
131707809|NCT04957290|474211323|FG002|Overall Study|study terminated by sponsor|2|||
131707810|NCT04957290|474211324|FG003|Overall Study|study terminated by sponsor|0|||
131707811|NCT04957290|474211325|FG004|Overall Study|study terminated by sponsor|0|||
131707812|NCT04957290|474211326|FG005|Overall Study|study terminated by sponsor|0|||
131707813|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707814|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707815|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707816|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
131707817|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707818|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
131707819|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707820|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131441038|NCT01283139|473243158|FG000|Overall Study|Pregnancy|0|||
131707821|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707822|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131441039|NCT01283139|473243159|FG001|Overall Study|Pregnancy|1|||
131441040|NCT01283139|473243160|FG002|Overall Study|Pregnancy|1|||
131792944|NCT02668783|474524630|FG001|Overall Study|Withdrawal by Subject|0|||
131441041|NCT01283139|473243161|FG003|Overall Study|Pregnancy|0|||
131441042|NCT01283139|473243158|FG000|Overall Study|Missed follow-up visit|0|||
131441043|NCT01283139|473243159|FG001|Overall Study|Missed follow-up visit|1|||
131441044|NCT01283139|473243160|FG002|Overall Study|Missed follow-up visit|2|||
131441045|NCT01283139|473243161|FG003|Overall Study|Missed follow-up visit|2|||
131441046|NCT01283139|473243158|FG000|Overall Study|Participant randomized in error|0|||
131441047|NCT01283139|473243159|FG001|Overall Study|Participant randomized in error|0|||
131441048|NCT01283139|473243160|FG002|Overall Study|Participant randomized in error|1|||
131441049|NCT01283139|473243161|FG003|Overall Study|Participant randomized in error|0|||
131441050|NCT03668873|473243162|FG000|Overall Study|Lost to Follow-up|6|||
131441051|NCT03668873|473243163|FG001|Overall Study|Lost to Follow-up|3|||
131441052|NCT01521117|473243164|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
131441053|NCT01521117|473243165|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
131441054|NCT01521117|473243164|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
131441055|NCT01521117|473243165|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
131441056|NCT01521117|473243164|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
131441057|NCT01521117|473243165|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
131441058|NCT00784563|473243167|FG000|Years 1 & 2|Withdrawal by Subject|3|||
131441059|NCT00784563|473243168|FG001|Years 1 & 2|Withdrawal by Subject|2|||
131441060|NCT00784563|473243169|FG002|Years 1 & 2|Withdrawal by Subject|0|||
131441061|NCT00784563|473243167|FG000|Years 1 & 2|Adverse Event|0|||
131441062|NCT00784563|473243168|FG001|Years 1 & 2|Adverse Event|3|||
131441063|NCT00784563|473243169|FG002|Years 1 & 2|Adverse Event|0|||
131441064|NCT00784563|473243167|FG000|Year 3|Withdrawal by Subject|0|||
131441065|NCT00784563|473243168|FG001|Year 3|Withdrawal by Subject|0|||
131441066|NCT00784563|473243169|FG002|Year 3|Withdrawal by Subject|2|||
131441067|NCT00784563|473243167|FG000|Year 3|Adverse Event|0|||
131441068|NCT00784563|473243168|FG001|Year 3|Adverse Event|0|||
131441069|NCT00784563|473243169|FG002|Year 3|Adverse Event|1|||
131441070|NCT00762164|473243170|FG000|Overall Study|Lost to Follow-up|1|||
131441071|NCT00762164|473243171|FG001|Overall Study|Lost to Follow-up|1|||
131441072|NCT00762164|473243170|FG000|Overall Study|Discontinued medication|2|||
131441073|NCT00762164|473243171|FG001|Overall Study|Discontinued medication|0|||
131441074|NCT00762164|473243170|FG000|Overall Study|Withdrawal by Subject|0|||
131441075|NCT00762164|473243171|FG001|Overall Study|Withdrawal by Subject|1|||
131441076|NCT00685165|473243178|FG000|Washout Period of 14 Days|Adverse Event|1|||
131441077|NCT00685165|473243179|FG001|Washout Period of 14 Days|Adverse Event|0|||
131441078|NCT00795535|473243187|FG000|Overall Study|incomplete data and technical problems|20|||
131441079|NCT00374140|473243188|FG000|Overall Study|Lost to Follow-up|1|||
131441080|NCT00374140|473243188|FG000|Overall Study|Protocol Violation|1|||
131441081|NCT04576988|473243189|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
131441082|NCT04576988|473243190|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
131441083|NCT04576988|473243189|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
131441084|NCT04576988|473243190|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
131441085|NCT04576988|473243189|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
131441086|NCT04576988|473243190|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
131441087|NCT04576988|473243189|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
131441088|NCT04576988|473243190|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
131441089|NCT04576988|473243189|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
131441090|NCT04576988|473243190|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
131792945|NCT00112489|474524633|FG000|Overall Study|Refused further treatment|8|||
131441091|NCT04576988|473243189|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
131441092|NCT04576988|473243190|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
131441093|NCT04576988|473243189|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
131792946|NCT00112489|474524633|FG000|Overall Study|Adverse Event|12|||
131792947|NCT00112489|474524633|FG000|Overall Study|Death|2|||
131441094|NCT04576988|473243190|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
131441095|NCT04576988|473243189|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
131441096|NCT04576988|473243190|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
131441097|NCT04576988|473243189|FG000|Long Term Double Blind (LTDB)|Death|2|||
131441098|NCT04576988|473243190|FG001|Long Term Double Blind (LTDB)|Death|1|||
131792948|NCT00112489|474524633|FG000|Overall Study|Other, Not Specified|9|||
131792949|NCT00112489|474524633|FG000|Overall Study|Patient never treated|2|||
131792950|NCT00112489|474524633|FG000|Overall Study|Ineligible|7|||
131441099|NCT04576988|473243189|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
131441100|NCT04576988|473243190|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
131441101|NCT00617734|473243191|FG000|Overall Study|Withdrew Consent|2|||
131441102|NCT00617734|473243192|FG001|Overall Study|Withdrew Consent|0|||
131441103|NCT00617734|473243191|FG000|Overall Study|Adverse Event|4|||
131441104|NCT00617734|473243192|FG001|Overall Study|Adverse Event|1|||
131441105|NCT00617734|473243191|FG000|Overall Study|Protocol Violation|1|||
131441106|NCT00617734|473243192|FG001|Overall Study|Protocol Violation|0|||
131441107|NCT00617734|473243191|FG000|Overall Study|Found Ineligible After Randomization|1|||
131792951|NCT01165996|474524634|FG000|Overall Study|Death|1|||
131899887|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899888|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899889|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899890|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131441108|NCT00617734|473243192|FG001|Overall Study|Found Ineligible After Randomization|4|||
131441109|NCT00617734|473243191|FG000|Overall Study|Lost to Follow-up|0|||
131441110|NCT00617734|473243192|FG001|Overall Study|Lost to Follow-up|1|||
131441111|NCT00556075|473243193|FG000|Overall Study|Lost to Follow-up|3|||
131441112|NCT00556075|473243194|FG001|Overall Study|Lost to Follow-up|0|||
131441113|NCT00556075|473243195|FG002|Overall Study|Lost to Follow-up|3|||
131441114|NCT00556075|473243193|FG000|Overall Study|Withdrawal by Subject|3|||
131441115|NCT00556075|473243194|FG001|Overall Study|Withdrawal by Subject|3|||
131441116|NCT00556075|473243195|FG002|Overall Study|Withdrawal by Subject|0|||
131441117|NCT00556075|473243193|FG000|Overall Study|Protocol Violation|1|||
131441118|NCT00556075|473243194|FG001|Overall Study|Protocol Violation|1|||
131441119|NCT00556075|473243195|FG002|Overall Study|Protocol Violation|3|||
131441120|NCT00556075|473243193|FG000|Overall Study|Not eligible|1|||
131441121|NCT00556075|473243194|FG001|Overall Study|Not eligible|1|||
131441122|NCT00556075|473243195|FG002|Overall Study|Not eligible|2|||
131441123|NCT00556075|473243193|FG000|Overall Study|Adverse Event|1|||
131441124|NCT00556075|473243194|FG001|Overall Study|Adverse Event|2|||
131441125|NCT00556075|473243195|FG002|Overall Study|Adverse Event|0|||
131441126|NCT00556075|473243193|FG000|Overall Study|Personal issues|4|||
131607555|NCT04108130|473855769|FG000|Overall Study|Found Ineligible for Study|4|||
131607556|NCT04108130|473855770|FG001|Overall Study|Found Ineligible for Study|3|||
131607557|NCT04108130|473855769|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
131607558|NCT04108130|473855770|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
131607559|NCT04108130|473855769|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
131607560|NCT04108130|473855770|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
131607561|NCT01130883|473855771|FG000|Overall Study|Patient Noncompliance|6|||
131607562|NCT01130883|473855771|FG000|Overall Study|Reason Unknown|1|||
131607563|NCT01130883|473855771|FG000|Overall Study|Adverse Event|3|||
131607564|NCT02585323|473855772|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
131607565|NCT02585323|473855773|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
131607566|NCT02585323|473855772|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
131607567|NCT02585323|473855773|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
131607568|NCT02585323|473855772|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
131607569|NCT02585323|473855773|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
131607570|NCT02585323|473855772|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
131607571|NCT02585323|473855773|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
131607572|NCT03981926|473855779|FG000|Overall Study|Lost to Follow-up|5|||
131607573|NCT03981926|473855780|FG001|Overall Study|Lost to Follow-up|9|||
131607574|NCT05464069|473855781|FG000|Overall Study|Protocol Violation|3|||
131607575|NCT05464069|473855782|FG001|Overall Study|Protocol Violation|2|||
131607576|NCT04136912|473855783|FG000|Overall Study|Operational reasons|0|||
131899891|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131607577|NCT04136912|473855784|FG001|Overall Study|Operational reasons|0|||
131607578|NCT04136912|473855785|FG002|Overall Study|Operational reasons|2|||
131607579|NCT05976334|473855786|FG000|Part B|Death|0|||
131607580|NCT05976334|473855787|FG001|Part B|Death|1|||
131441127|NCT00556075|473243194|FG001|Overall Study|Personal issues|1|||
131441128|NCT00556075|473243195|FG002|Overall Study|Personal issues|0|||
131441129|NCT00556075|473243193|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
131441130|NCT00556075|473243194|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
131441131|NCT00556075|473243195|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
131607581|NCT05976334|473855786|FG000|Part B|Study Terminated by Sponsor|0|||
131607582|NCT05976334|473855787|FG001|Part B|Study Terminated by Sponsor|1|||
131607583|NCT05976334|473855786|FG000|Part B|Reason Not Specified|0|||
131607584|NCT05976334|473855787|FG001|Part B|Reason Not Specified|1|||
131607585|NCT02437136|473855790|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
131607586|NCT02437136|473855791|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131607587|NCT02437136|473855792|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131607588|NCT02437136|473855793|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131607589|NCT02437136|473855794|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131707823|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131441132|NCT02485691|473243196|FG000|Overall Study|Adverse Event|25|||
131792952|NCT01165996|474524634|FG000|Overall Study|Physician Decision|1|||
131792953|NCT03907280|474524651|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
131792954|NCT03907280|474524652|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
131792955|NCT03907280|474524653|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
131607590|NCT02437136|473855795|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131792956|NCT05751629|474524654|FG000|Overall Study|Withdrawal by Subject|6|||
131792957|NCT05751629|474524654|FG000|Overall Study|Death|25|||
131792958|NCT05751629|474524654|FG000|Overall Study|Study Site Closed|9|||
131792959|NCT05751629|474524654|FG000|Overall Study|Physician Decision|1|||
131792960|NCT01927757|474524655|FG000|Overall Study|Withdrawal by Subject|14|||
131792961|NCT01927757|474524655|FG000|Overall Study|Lost to Follow-up|2|||
131792962|NCT01927757|474524655|FG000|Overall Study|Decision by Sponsor|2|||
131792963|NCT01927757|474524655|FG000|Overall Study|Other|1|||
131792964|NCT01927757|474524655|FG000|Overall Study|Ethical Reasons|4|||
131792965|NCT01399723|474524656|FG000|Overall Study|Lost to Follow-up|0|||
131792966|NCT01399723|474524657|FG001|Overall Study|Lost to Follow-up|1|||
131792967|NCT04081337|474524658|FG000|Overall Study|Adverse Event|0|||
131792968|NCT04081337|474524659|FG001|Overall Study|Adverse Event|1|||
131792969|NCT04081337|474524658|FG000|Overall Study|Withdrawal by Subject|2|||
131792970|NCT04081337|474524659|FG001|Overall Study|Withdrawal by Subject|0|||
131792971|NCT04081337|474524658|FG000|Overall Study|Physician Decision|1|||
131792972|NCT04081337|474524659|FG001|Overall Study|Physician Decision|2|||
131792973|NCT04081337|474524658|FG000|Overall Study|Lost to Follow-up|1|||
131792974|NCT04081337|474524659|FG001|Overall Study|Lost to Follow-up|0|||
131792975|NCT00673361|474524665|FG000|Overall Study|Screen Failure|2|||
131792976|NCT01464827|474524666|FG000|Overall Study|Adverse Event|0|||
131792977|NCT01464827|474524667|FG001|Overall Study|Adverse Event|0|||
131792978|NCT01464827|474524668|FG002|Overall Study|Adverse Event|0|||
131792979|NCT01464827|474524669|FG003|Overall Study|Adverse Event|0|||
131792980|NCT01464827|474524670|FG004|Overall Study|Adverse Event|0|||
131792981|NCT01464827|474524671|FG005|Overall Study|Adverse Event|0|||
131792982|NCT01464827|474524672|FG006|Overall Study|Adverse Event|0|||
131792983|NCT01464827|474524673|FG007|Overall Study|Adverse Event|0|||
131792984|NCT01464827|474524674|FG008|Overall Study|Adverse Event|0|||
131792985|NCT01464827|474524675|FG009|Overall Study|Adverse Event|0|||
131792986|NCT01464827|474524676|FG010|Overall Study|Adverse Event|0|||
131792987|NCT01464827|474524677|FG011|Overall Study|Adverse Event|0|||
131792988|NCT01464827|474524678|FG012|Overall Study|Adverse Event|1|||
131792989|NCT01464827|474524679|FG013|Overall Study|Adverse Event|0|||
131792990|NCT01464827|474524666|FG000|Overall Study|Withdrawal by Subject|1|||
131792991|NCT01464827|474524667|FG001|Overall Study|Withdrawal by Subject|0|||
131792992|NCT01464827|474524668|FG002|Overall Study|Withdrawal by Subject|0|||
131792993|NCT01464827|474524669|FG003|Overall Study|Withdrawal by Subject|0|||
131792994|NCT01464827|474524670|FG004|Overall Study|Withdrawal by Subject|1|||
131792995|NCT01464827|474524671|FG005|Overall Study|Withdrawal by Subject|0|||
131792996|NCT01464827|474524672|FG006|Overall Study|Withdrawal by Subject|0|||
131792997|NCT01464827|474524673|FG007|Overall Study|Withdrawal by Subject|1|||
131792998|NCT01464827|474524674|FG008|Overall Study|Withdrawal by Subject|0|||
131792999|NCT01464827|474524675|FG009|Overall Study|Withdrawal by Subject|0|||
131793000|NCT01464827|474524676|FG010|Overall Study|Withdrawal by Subject|0|||
131793001|NCT01464827|474524677|FG011|Overall Study|Withdrawal by Subject|0|||
131793002|NCT01464827|474524678|FG012|Overall Study|Withdrawal by Subject|0|||
131793003|NCT01464827|474524679|FG013|Overall Study|Withdrawal by Subject|0|||
131441133|NCT02485691|473243197|FG001|Overall Study|Adverse Event|11|||
131441134|NCT02485691|473243196|FG000|Overall Study|Poor compliance to protocol|0|||
131441135|NCT02485691|473243197|FG001|Overall Study|Poor compliance to protocol|1|||
131441136|NCT02485691|473243196|FG000|Overall Study|Disease progression|57|||
131441137|NCT02485691|473243197|FG001|Overall Study|Disease progression|92|||
131441138|NCT02485691|473243196|FG000|Overall Study|Investigator's decision|23|||
131441139|NCT02485691|473243197|FG001|Overall Study|Investigator's decision|5|||
131441140|NCT02485691|473243196|FG000|Overall Study|Participant's request|13|||
131441141|NCT02485691|473243197|FG001|Overall Study|Participant's request|6|||
131441142|NCT02485691|473243196|FG000|Overall Study|Other reason|8|||
131441143|NCT02485691|473243197|FG001|Overall Study|Other reason|9|||
131441144|NCT02485691|473243196|FG000|Overall Study|Randomized and not treated|3|||
131441145|NCT02485691|473243197|FG001|Overall Study|Randomized and not treated|2|||
131441146|NCT01420861|473243198|FG000|Overall Study|Adverse Event|2|||
131441147|NCT01420861|473243198|FG000|Overall Study|Study terminated by Sponsor|7|||
131441148|NCT01420861|473243198|FG000|Overall Study|Screen failure|7|||
131441149|NCT01420861|473243198|FG000|Overall Study|Randomized not Treated|2|||
131441150|NCT02336282|473243202|FG000|Overall Study|Unrelated illness|1|||
131441151|NCT02336282|473243202|FG000|Overall Study|Uncomfortable with technology|1|||
131441152|NCT02336282|473243202|FG000|Overall Study|Lost to Follow-up|1|||
131441153|NCT02336282|473243202|FG000|Overall Study|Not enough time to complete sessions|2|||
131441154|NCT03724942|473243217|FG000|Overall Study|Adverse Event|20|||
131441155|NCT03724942|473243218|FG001|Overall Study|Adverse Event|14|||
131441156|NCT03724942|473243217|FG000|Overall Study|Lack of Efficacy|0|||
131793004|NCT01464827|474524666|FG000|Overall Study|Lost to Follow-up|0|||
131793005|NCT01464827|474524667|FG001|Overall Study|Lost to Follow-up|2|||
131793006|NCT01464827|474524668|FG002|Overall Study|Lost to Follow-up|0|||
131793007|NCT01464827|474524669|FG003|Overall Study|Lost to Follow-up|2|||
131793008|NCT01464827|474524670|FG004|Overall Study|Lost to Follow-up|3|||
131793009|NCT01464827|474524671|FG005|Overall Study|Lost to Follow-up|1|||
131793010|NCT01464827|474524672|FG006|Overall Study|Lost to Follow-up|2|||
131793011|NCT01464827|474524673|FG007|Overall Study|Lost to Follow-up|2|||
131793012|NCT01464827|474524674|FG008|Overall Study|Lost to Follow-up|0|||
131793013|NCT01464827|474524675|FG009|Overall Study|Lost to Follow-up|0|||
131793014|NCT01464827|474524676|FG010|Overall Study|Lost to Follow-up|0|||
131793015|NCT01464827|474524677|FG011|Overall Study|Lost to Follow-up|1|||
131793016|NCT01464827|474524678|FG012|Overall Study|Lost to Follow-up|0|||
131793017|NCT01464827|474524679|FG013|Overall Study|Lost to Follow-up|1|||
131793018|NCT01464827|474524666|FG000|Overall Study|Other|2|||
131793019|NCT01464827|474524667|FG001|Overall Study|Other|3|||
131793020|NCT01464827|474524668|FG002|Overall Study|Other|0|||
131793021|NCT01464827|474524669|FG003|Overall Study|Other|2|||
131793022|NCT01464827|474524670|FG004|Overall Study|Other|3|||
131793023|NCT01464827|474524671|FG005|Overall Study|Other|0|||
131793024|NCT01464827|474524672|FG006|Overall Study|Other|1|||
131793025|NCT01464827|474524673|FG007|Overall Study|Other|0|||
131793026|NCT01464827|474524674|FG008|Overall Study|Other|3|||
131793027|NCT01464827|474524675|FG009|Overall Study|Other|1|||
131793028|NCT01464827|474524676|FG010|Overall Study|Other|2|||
131793029|NCT01464827|474524677|FG011|Overall Study|Other|0|||
131793030|NCT01464827|474524678|FG012|Overall Study|Other|1|||
131793031|NCT01464827|474524679|FG013|Overall Study|Other|0|||
131793032|NCT01464827|474524666|FG000|Overall Study|Not Treated|0|||
131793033|NCT01464827|474524667|FG001|Overall Study|Not Treated|2|||
131793034|NCT01464827|474524668|FG002|Overall Study|Not Treated|0|||
131793035|NCT01464827|474524669|FG003|Overall Study|Not Treated|0|||
131793036|NCT01464827|474524670|FG004|Overall Study|Not Treated|1|||
131793037|NCT01464827|474524671|FG005|Overall Study|Not Treated|0|||
131441157|NCT03724942|473243218|FG001|Overall Study|Lack of Efficacy|1|||
131441158|NCT03724942|473243217|FG000|Overall Study|Physician Decision|5|||
131441159|NCT03724942|473243218|FG001|Overall Study|Physician Decision|2|||
131793038|NCT01464827|474524672|FG006|Overall Study|Not Treated|1|||
131793039|NCT01464827|474524673|FG007|Overall Study|Not Treated|0|||
131793040|NCT01464827|474524674|FG008|Overall Study|Not Treated|0|||
131793041|NCT01464827|474524675|FG009|Overall Study|Not Treated|2|||
131793042|NCT01464827|474524676|FG010|Overall Study|Not Treated|0|||
131441160|NCT03724942|473243217|FG000|Overall Study|Protocol Violation|1|||
131793043|NCT01464827|474524677|FG011|Overall Study|Not Treated|1|||
131793044|NCT01464827|474524678|FG012|Overall Study|Not Treated|0|||
131793045|NCT01464827|474524679|FG013|Overall Study|Not Treated|2|||
131793046|NCT00268346|474524680|FG000|Overall Study|Adverse Event|0|||
131793047|NCT00268346|474524681|FG001|Overall Study|Adverse Event|1|||
131441161|NCT03724942|473243218|FG001|Overall Study|Protocol Violation|0|||
131441162|NCT03724942|473243217|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
131441163|NCT03724942|473243218|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
131441164|NCT03724942|473243217|FG000|Overall Study|Withdrawal by Legal Representative|3|||
131441165|NCT03724942|473243218|FG001|Overall Study|Withdrawal by Legal Representative|0|||
131793048|NCT00268346|474524680|FG000|Overall Study|Death|0|||
131793049|NCT00268346|474524681|FG001|Overall Study|Death|1|||
131793050|NCT00268346|474524680|FG000|Overall Study|Withdrawal by Subject|0|||
131441166|NCT00668148|473243219|FG000|Overall Study|Adverse Event|5|||
131441167|NCT00668148|473243219|FG000|Overall Study|Subject Non-compliance|1|||
131441168|NCT00668148|473243219|FG000|Overall Study|Progressive Disease Before Treatment|2|||
131441169|NCT00668148|473243219|FG000|Overall Study|Withdrawal of Consent|2|||
131441170|NCT04875975|473243222|FG000|Overall Study|Adverse Event|1|||
131441171|NCT04875975|473243223|FG001|Overall Study|Adverse Event|2|||
131441172|NCT04875975|473243222|FG000|Overall Study|Lack of Efficacy|2|||
131441173|NCT04875975|473243223|FG001|Overall Study|Lack of Efficacy|2|||
131441174|NCT04875975|473243222|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
131441175|NCT04875975|473243223|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
131441176|NCT04875975|473243222|FG000|Overall Study|Relapse With Insults|0|||
131441177|NCT04875975|473243223|FG001|Overall Study|Relapse With Insults|1|||
131441178|NCT04875975|473243222|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
131441179|NCT04875975|473243223|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
131441180|NCT05472090|473243224|FG000|Overall Study|Adverse Event|2|||
131441181|NCT05472090|473243225|FG001|Overall Study|Adverse Event|3|||
131441182|NCT05472090|473243224|FG000|Overall Study|Lack of Efficacy|1|||
131441183|NCT05472090|473243225|FG001|Overall Study|Lack of Efficacy|0|||
131441184|NCT05472090|473243224|FG000|Overall Study|Physician Decision|1|||
131441185|NCT05472090|473243225|FG001|Overall Study|Physician Decision|0|||
131441186|NCT05472090|473243224|FG000|Overall Study|Withdrawal by Subject|2|||
131441187|NCT05472090|473243225|FG001|Overall Study|Withdrawal by Subject|0|||
131441188|NCT05472090|473243224|FG000|Overall Study|Lost to Follow-up|0|||
131441189|NCT05472090|473243225|FG001|Overall Study|Lost to Follow-up|3|||
131441190|NCT01350999|473243227|FG000|Overall Study|Adverse Event|4|||
131441191|NCT01350999|473243228|FG001|Overall Study|Adverse Event|9|||
131441192|NCT01350999|473243229|FG002|Overall Study|Adverse Event|10|||
131441193|NCT01350999|473243227|FG000|Overall Study|Voluntary withdrawal|3|||
131441194|NCT01350999|473243228|FG001|Overall Study|Voluntary withdrawal|4|||
131441195|NCT01350999|473243229|FG002|Overall Study|Voluntary withdrawal|6|||
131441196|NCT01350999|473243227|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
131441197|NCT01350999|473243228|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
131441198|NCT01350999|473243229|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
131441199|NCT01766050|473245158|FG000|Overall Study|Adverse Event|1|||
131441200|NCT01766050|473245158|FG000|Overall Study|Lost to Follow-up|1|||
131441201|NCT01766050|473245158|FG000|Overall Study|Withdrawal by Subject|2|||
131441202|NCT00089297|473245160|FG000|Overall Study|Adverse Event|9|||
131441203|NCT00089297|473245160|FG000|Overall Study|Death|1|||
131441204|NCT00089297|473245160|FG000|Overall Study|Withdrawal by Subject|12|||
131441205|NCT00089297|473245160|FG000|Overall Study|Disease progression|2|||
131441206|NCT00089297|473245160|FG000|Overall Study|Ineligible|11|||
131441207|NCT00089297|473245160|FG000|Overall Study|Secondary malignancy|1|||
131441208|NCT00089297|473245160|FG000|Overall Study|IRB approval not ready|1|||
131441209|NCT00089297|473245160|FG000|Overall Study|Non-compliance|1|||
131441210|NCT01910298|473245163|FG000|Overall Study|Adverse Event|1|||
131441211|NCT01910298|473245164|FG001|Overall Study|Adverse Event|0|||
131441212|NCT01910298|473245163|FG000|Overall Study|Withdrawal by Subject|2|||
131441213|NCT01910298|473245164|FG001|Overall Study|Withdrawal by Subject|7|||
131441214|NCT01910298|473245163|FG000|Overall Study|Protocol Deviation|0|||
131441215|NCT01910298|473245164|FG001|Overall Study|Protocol Deviation|5|||
131441216|NCT01910298|473245163|FG000|Overall Study|Lost to Follow-up|1|||
131441217|NCT01910298|473245164|FG001|Overall Study|Lost to Follow-up|1|||
131441218|NCT01910298|473245163|FG000|Overall Study|Study Terminated by Sponsor|1|||
131441219|NCT01910298|473245164|FG001|Overall Study|Study Terminated by Sponsor|17|||
131441220|NCT01910298|473245163|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131441221|NCT01910298|473245164|FG001|Overall Study|Other Miscellaneous Reasons|2|||
131441222|NCT03037385|473245167|FG000|Overall Study|Adverse Event|0|||
131441223|NCT03037385|473245168|FG001|Overall Study|Adverse Event|0|||
131441224|NCT03037385|473245169|FG002|Overall Study|Adverse Event|1|||
131441225|NCT03037385|473245170|FG003|Overall Study|Adverse Event|0|||
131441226|NCT03037385|473245171|FG004|Overall Study|Adverse Event|0|||
131441227|NCT03037385|473245172|FG005|Overall Study|Adverse Event|0|||
131441228|NCT03037385|473245173|FG006|Overall Study|Adverse Event|0|||
131441229|NCT03037385|473245174|FG007|Overall Study|Adverse Event|0|||
131441230|NCT03037385|473245175|FG008|Overall Study|Adverse Event|0|||
131441231|NCT03037385|473245176|FG009|Overall Study|Adverse Event|6|||
131607591|NCT02437136|473855796|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131441232|NCT03037385|473245167|FG000|Overall Study|Death|1|||
131441233|NCT03037385|473245168|FG001|Overall Study|Death|4|||
131441234|NCT03037385|473245169|FG002|Overall Study|Death|2|||
131441235|NCT03037385|473245170|FG003|Overall Study|Death|2|||
131441236|NCT03037385|473245171|FG004|Overall Study|Death|5|||
131441237|NCT03037385|473245172|FG005|Overall Study|Death|2|||
131441238|NCT03037385|473245173|FG006|Overall Study|Death|1|||
131441239|NCT03037385|473245174|FG007|Overall Study|Death|4|||
131441240|NCT03037385|473245175|FG008|Overall Study|Death|3|||
131441241|NCT03037385|473245176|FG009|Overall Study|Death|240|||
131441242|NCT03037385|473245167|FG000|Overall Study|Initiation of Another Therapy|1|||
131607592|NCT02437136|473855790|FG000|Expansion (Phase 2)|Death|0|||
131441243|NCT03037385|473245168|FG001|Overall Study|Initiation of Another Therapy|0|||
131441244|NCT03037385|473245169|FG002|Overall Study|Initiation of Another Therapy|0|||
131441245|NCT03037385|473245170|FG003|Overall Study|Initiation of Another Therapy|0|||
131441246|NCT03037385|473245171|FG004|Overall Study|Initiation of Another Therapy|0|||
131441247|NCT03037385|473245172|FG005|Overall Study|Initiation of Another Therapy|0|||
131441248|NCT03037385|473245173|FG006|Overall Study|Initiation of Another Therapy|0|||
131441249|NCT03037385|473245174|FG007|Overall Study|Initiation of Another Therapy|1|||
131441250|NCT03037385|473245175|FG008|Overall Study|Initiation of Another Therapy|0|||
131441251|NCT03037385|473245176|FG009|Overall Study|Initiation of Another Therapy|2|||
131441252|NCT03037385|473245167|FG000|Overall Study|Lost to Follow-up|0|||
131441253|NCT03037385|473245168|FG001|Overall Study|Lost to Follow-up|0|||
131441254|NCT03037385|473245169|FG002|Overall Study|Lost to Follow-up|0|||
131441255|NCT03037385|473245170|FG003|Overall Study|Lost to Follow-up|0|||
131441256|NCT03037385|473245171|FG004|Overall Study|Lost to Follow-up|0|||
131441257|NCT03037385|473245172|FG005|Overall Study|Lost to Follow-up|1|||
131441258|NCT03037385|473245173|FG006|Overall Study|Lost to Follow-up|0|||
131441259|NCT03037385|473245174|FG007|Overall Study|Lost to Follow-up|0|||
131441260|NCT03037385|473245175|FG008|Overall Study|Lost to Follow-up|0|||
131441261|NCT03037385|473245176|FG009|Overall Study|Lost to Follow-up|16|||
131441262|NCT03037385|473245167|FG000|Overall Study|Physician Decision|0|||
131441263|NCT03037385|473245168|FG001|Overall Study|Physician Decision|0|||
131441264|NCT03037385|473245169|FG002|Overall Study|Physician Decision|0|||
131441265|NCT03037385|473245170|FG003|Overall Study|Physician Decision|0|||
131441266|NCT03037385|473245171|FG004|Overall Study|Physician Decision|0|||
131607593|NCT02437136|473855791|FG001|Expansion (Phase 2)|Death|0|||
131607594|NCT02437136|473855792|FG002|Expansion (Phase 2)|Death|0|||
131707824|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707825|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707826|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707827|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707828|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707829|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707830|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707831|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707832|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131793051|NCT00268346|474524681|FG001|Overall Study|Withdrawal by Subject|1|||
131793052|NCT01799590|474524682|FG000|Overall Study|Adverse Event|13|||
131793053|NCT01799590|474524683|FG001|Overall Study|Adverse Event|7|||
131793054|NCT01799590|474524684|FG002|Overall Study|Adverse Event|5|||
131441267|NCT03037385|473245172|FG005|Overall Study|Physician Decision|0|||
131441268|NCT03037385|473245173|FG006|Overall Study|Physician Decision|0|||
131441269|NCT03037385|473245174|FG007|Overall Study|Physician Decision|0|||
131441270|NCT03037385|473245175|FG008|Overall Study|Physician Decision|0|||
131441271|NCT03037385|473245176|FG009|Overall Study|Physician Decision|1|||
131441272|NCT03037385|473245167|FG000|Overall Study|Progressive Disease|0|||
131607595|NCT02437136|473855793|FG003|Expansion (Phase 2)|Death|6|||
131607596|NCT02437136|473855794|FG004|Expansion (Phase 2)|Death|37|||
131607597|NCT02437136|473855795|FG005|Expansion (Phase 2)|Death|29|||
131607598|NCT02437136|473855796|FG006|Expansion (Phase 2)|Death|24|||
131607599|NCT02437136|473855790|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
131607600|NCT02437136|473855791|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
131607601|NCT02437136|473855792|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
131607602|NCT02437136|473855793|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
131607603|NCT02437136|473855794|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
131607604|NCT02437136|473855795|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
131607605|NCT02437136|473855796|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
131607606|NCT02437136|473855790|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
131607607|NCT02437136|473855791|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
131607608|NCT02437136|473855792|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
131607609|NCT02437136|473855793|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
131607610|NCT02437136|473855794|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
131607611|NCT02437136|473855795|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
131607612|NCT02437136|473855796|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
131607613|NCT04526886|473855797|FG000|Overall Study|Physician Decision|4|||
131607614|NCT05524116|473855802|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
131607615|NCT05524116|473855803|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
131793055|NCT01799590|474524682|FG000|Overall Study|Pregnancy|2|||
131441273|NCT03037385|473245168|FG001|Overall Study|Progressive Disease|1|||
131441274|NCT03037385|473245169|FG002|Overall Study|Progressive Disease|1|||
131441275|NCT03037385|473245170|FG003|Overall Study|Progressive Disease|5|||
131441276|NCT03037385|473245171|FG004|Overall Study|Progressive Disease|2|||
131441277|NCT03037385|473245172|FG005|Overall Study|Progressive Disease|0|||
131441278|NCT03037385|473245173|FG006|Overall Study|Progressive Disease|1|||
131607616|NCT05524116|473855802|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
131607617|NCT05524116|473855803|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
131793056|NCT01799590|474524683|FG001|Overall Study|Pregnancy|0|||
131441279|NCT03037385|473245174|FG007|Overall Study|Progressive Disease|0|||
131793057|NCT01799590|474524684|FG002|Overall Study|Pregnancy|0|||
131793058|NCT01799590|474524682|FG000|Overall Study|Lack of Efficacy|3|||
131441280|NCT03037385|473245175|FG008|Overall Study|Progressive Disease|0|||
131441281|NCT03037385|473245176|FG009|Overall Study|Progressive Disease|30|||
131441282|NCT03037385|473245167|FG000|Overall Study|Withdrawal by Subject|0|||
131441283|NCT03037385|473245168|FG001|Overall Study|Withdrawal by Subject|0|||
131441284|NCT03037385|473245169|FG002|Overall Study|Withdrawal by Subject|1|||
131441285|NCT03037385|473245170|FG003|Overall Study|Withdrawal by Subject|2|||
131441286|NCT03037385|473245171|FG004|Overall Study|Withdrawal by Subject|1|||
131441287|NCT03037385|473245172|FG005|Overall Study|Withdrawal by Subject|3|||
131441288|NCT03037385|473245173|FG006|Overall Study|Withdrawal by Subject|0|||
131441289|NCT03037385|473245174|FG007|Overall Study|Withdrawal by Subject|0|||
131441290|NCT03037385|473245175|FG008|Overall Study|Withdrawal by Subject|0|||
131441291|NCT03037385|473245176|FG009|Overall Study|Withdrawal by Subject|52|||
131441292|NCT03037385|473245167|FG000|Overall Study|Reason Not Specified|0|||
131441293|NCT03037385|473245168|FG001|Overall Study|Reason Not Specified|1|||
131441294|NCT03037385|473245169|FG002|Overall Study|Reason Not Specified|0|||
131441295|NCT03037385|473245170|FG003|Overall Study|Reason Not Specified|4|||
131441296|NCT03037385|473245171|FG004|Overall Study|Reason Not Specified|3|||
131441297|NCT03037385|473245172|FG005|Overall Study|Reason Not Specified|6|||
131707833|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707834|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131441298|NCT03037385|473245173|FG006|Overall Study|Reason Not Specified|2|||
131441299|NCT03037385|473245174|FG007|Overall Study|Reason Not Specified|0|||
131707835|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131707836|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131707837|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
131707838|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131707839|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
131707840|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131707841|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131707842|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131441300|NCT03037385|473245175|FG008|Overall Study|Reason Not Specified|1|||
131441301|NCT03037385|473245176|FG009|Overall Study|Reason Not Specified|181|||
131441302|NCT04515771|473245181|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
131441303|NCT04515771|473245182|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
131441304|NCT04515771|473245181|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
131441305|NCT04515771|473245182|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
131441306|NCT04515771|473245181|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
131607618|NCT05524116|473855802|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
131607619|NCT05524116|473855803|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
131607620|NCT05524116|473855802|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
131607621|NCT05524116|473855803|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
131607622|NCT05524116|473855802|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
131607623|NCT05524116|473855803|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
131607624|NCT05405985|473855807|FG000|Overall Study|Withdrawal by Subject|1|||
131607625|NCT05405985|473855808|FG001|Overall Study|Withdrawal by Subject|0|||
131607626|NCT04282980|473855810|FG000|Overall Study|Remained on treatment|6|||
131607627|NCT04282980|473855810|FG000|Overall Study|Survival follow-up|11|||
131607628|NCT04282980|473855810|FG000|Overall Study|Withdrawal of informed consent|1|||
131607629|NCT04282980|473855810|FG000|Overall Study|Lost to Follow-up|1|||
131607630|NCT01917084|473855811|FG000|Overall Study|Withdrawal by Subject|1|||
131607631|NCT03571386|473855812|FG000|Overall Study|scheduling conflict|4|||
131607632|NCT03571386|473855813|FG001|Overall Study|scheduling conflict|0|||
131607633|NCT03571386|473855812|FG000|Overall Study|Withdrawal by Subject|15|||
131607634|NCT03571386|473855813|FG001|Overall Study|Withdrawal by Subject|5|||
131441307|NCT04515771|473245182|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
131441308|NCT01021020|473245183|FG000|Period I|Protocol Violation|1|||
131607635|NCT04311632|473855820|FG000|Overall Study|Withdrawal by Subject|0|||
131607636|NCT04311632|473855821|FG001|Overall Study|Withdrawal by Subject|0|||
131793059|NCT01799590|474524683|FG001|Overall Study|Lack of Efficacy|1|||
131793060|NCT01799590|474524684|FG002|Overall Study|Lack of Efficacy|3|||
131793061|NCT01799590|474524682|FG000|Overall Study|Participants convenience|4|||
131793062|NCT01799590|474524683|FG001|Overall Study|Participants convenience|4|||
131441309|NCT01021020|473245183|FG000|Period I|Withdrawal by Subject|1|||
131441310|NCT01021020|473245183|FG000|14 Day Washout Period A|Physician Decision|1|||
131441311|NCT00948246|473245186|FG000|Overall Study|Lost to Follow-up|11|||
131441312|NCT00948246|473245186|FG000|Overall Study|Adverse Event|11|||
131441313|NCT00948246|473245186|FG000|Overall Study|Death|1|||
131441314|NCT00948246|473245186|FG000|Overall Study|Withdrawal by Subject|1|||
131441315|NCT03598036|473245189|FG000|Overall Study|Withdrawal by Subject|1|||
131441316|NCT03598036|473245190|FG001|Overall Study|Withdrawal by Subject|0|||
131441317|NCT04199351|473245191|FG000|Overall Study|Decision by sponsor|0|||
131441318|NCT04199351|473245192|FG001|Overall Study|Decision by sponsor|0|||
131441319|NCT04199351|473245193|FG002|Overall Study|Decision by sponsor|0|||
131441320|NCT04199351|473245194|FG003|Overall Study|Decision by sponsor|2|||
131441321|NCT04199351|473245195|FG004|Overall Study|Decision by sponsor|0|||
131441322|NCT04199351|473245196|FG005|Overall Study|Decision by sponsor|0|||
131441323|NCT04199351|473245197|FG006|Overall Study|Decision by sponsor|0|||
131441324|NCT04199351|473245198|FG007|Overall Study|Decision by sponsor|0|||
131441325|NCT04199351|473245199|FG008|Overall Study|Decision by sponsor|0|||
131441326|NCT04199351|473245200|FG009|Overall Study|Decision by sponsor|6|||
131441327|NCT04199351|473245191|FG000|Overall Study|Lost to Follow-up|0|||
131441328|NCT04199351|473245192|FG001|Overall Study|Lost to Follow-up|0|||
131441329|NCT04199351|473245193|FG002|Overall Study|Lost to Follow-up|1|||
131441330|NCT04199351|473245194|FG003|Overall Study|Lost to Follow-up|0|||
131441331|NCT04199351|473245195|FG004|Overall Study|Lost to Follow-up|0|||
131441332|NCT04199351|473245196|FG005|Overall Study|Lost to Follow-up|1|||
131441333|NCT04199351|473245197|FG006|Overall Study|Lost to Follow-up|0|||
131441334|NCT04199351|473245198|FG007|Overall Study|Lost to Follow-up|0|||
131441335|NCT04199351|473245199|FG008|Overall Study|Lost to Follow-up|0|||
131441336|NCT04199351|473245200|FG009|Overall Study|Lost to Follow-up|0|||
131441337|NCT04199351|473245191|FG000|Overall Study|Withdrawal by Subject|0|||
131441338|NCT04199351|473245192|FG001|Overall Study|Withdrawal by Subject|1|||
131793063|NCT01799590|474524684|FG002|Overall Study|Participants convenience|2|||
131441339|NCT04199351|473245193|FG002|Overall Study|Withdrawal by Subject|0|||
131441340|NCT04199351|473245194|FG003|Overall Study|Withdrawal by Subject|0|||
131441341|NCT04199351|473245195|FG004|Overall Study|Withdrawal by Subject|1|||
131441342|NCT04199351|473245196|FG005|Overall Study|Withdrawal by Subject|4|||
131441343|NCT04199351|473245197|FG006|Overall Study|Withdrawal by Subject|2|||
131441344|NCT04199351|473245198|FG007|Overall Study|Withdrawal by Subject|0|||
131441345|NCT04199351|473245199|FG008|Overall Study|Withdrawal by Subject|3|||
131441346|NCT04199351|473245200|FG009|Overall Study|Withdrawal by Subject|0|||
131441347|NCT01838694|473245201|FG000|Overall Study|Adverse Event|0|||
131441348|NCT01838694|473245202|FG001|Overall Study|Adverse Event|1|||
131441349|NCT03623243|473245203|FG000|Overall Study|Adverse Event|15|||
131441350|NCT03623243|473245203|FG000|Overall Study|Guardian Decision|1|||
131441351|NCT03623243|473245203|FG000|Overall Study|New Therapy for Study Indication|1|||
131441352|NCT03623243|473245203|FG000|Overall Study|Protocol Deviation|3|||
131441353|NCT03623243|473245203|FG000|Overall Study|Physician Decision|4|||
131441354|NCT03623243|473245203|FG000|Overall Study|Patient Decision|15|||
131441355|NCT02177695|473245207|FG000|ITT Analysis|Ineligible|5|||
131441356|NCT02177695|473245208|FG001|ITT Analysis|Ineligible|5|||
131441357|NCT02177695|473245207|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
131607637|NCT04311632|473855822|FG002|Overall Study|Withdrawal by Subject|1|||
131607638|NCT04632225|473855823|FG000|Overall Study|Withdrawal by Subject|2|||
131607639|NCT04632225|473855824|FG001|Overall Study|Withdrawal by Subject|2|||
131607640|NCT04605159|473855825|FG000|Overall Study|Adverse Event|6|||
131607641|NCT04605159|473855826|FG001|Overall Study|Adverse Event|3|||
131607642|NCT04605159|473855827|FG002|Overall Study|Adverse Event|21|||
131607643|NCT04605159|473855828|FG003|Overall Study|Adverse Event|4|||
131607644|NCT04605159|473855825|FG000|Overall Study|Lost to Follow-up|74|||
131607645|NCT04605159|473855826|FG001|Overall Study|Lost to Follow-up|45|||
131607646|NCT04605159|473855827|FG002|Overall Study|Lost to Follow-up|119|||
131607647|NCT04605159|473855828|FG003|Overall Study|Lost to Follow-up|80|||
131607648|NCT04605159|473855825|FG000|Overall Study|Protocol Violation|4|||
131607649|NCT04605159|473855826|FG001|Overall Study|Protocol Violation|5|||
131607650|NCT04605159|473855827|FG002|Overall Study|Protocol Violation|2|||
131607651|NCT04605159|473855828|FG003|Overall Study|Protocol Violation|0|||
131607652|NCT04605159|473855825|FG000|Overall Study|Withdrawal by Subject|66|||
131607653|NCT04605159|473855826|FG001|Overall Study|Withdrawal by Subject|37|||
131607654|NCT04605159|473855827|FG002|Overall Study|Withdrawal by Subject|68|||
131607655|NCT04605159|473855828|FG003|Overall Study|Withdrawal by Subject|50|||
131607656|NCT04605159|473855825|FG000|Overall Study|Migrated / moved from the study area|32|||
131607657|NCT04605159|473855826|FG001|Overall Study|Migrated / moved from the study area|22|||
131607658|NCT04605159|473855827|FG002|Overall Study|Migrated / moved from the study area|41|||
131607659|NCT04605159|473855828|FG003|Overall Study|Migrated / moved from the study area|21|||
131607660|NCT04605159|473855825|FG000|Overall Study|Other|1|||
131607661|NCT04605159|473855826|FG001|Overall Study|Other|2|||
131607662|NCT04605159|473855827|FG002|Overall Study|Other|7|||
131607663|NCT04605159|473855828|FG003|Overall Study|Other|3|||
131607664|NCT02278211|473855829|FG000|Overall Study|Unable to analyse PET scan|2|||
131607665|NCT04881461|473855833|FG000|Overall Study|Adverse Event|2|||
131607666|NCT04881461|473855834|FG001|Overall Study|Adverse Event|4|||
131607667|NCT04881461|473855833|FG000|Overall Study|Withdrawal by Subject|19|||
131707843|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131607668|NCT04881461|473855834|FG001|Overall Study|Withdrawal by Subject|19|||
131607669|NCT04881461|473855833|FG000|Overall Study|Lost to Follow-up|4|||
131441358|NCT02177695|473245208|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
131441359|NCT02177695|473245207|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
131441360|NCT02177695|473245208|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
131441361|NCT02177695|473245207|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
131441362|NCT02177695|473245208|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
131441363|NCT00979901|473245209|FG000|Overall Study|Adverse Event|1|||
131441364|NCT00979901|473245210|FG001|Overall Study|Adverse Event|3|||
131441365|NCT00979901|473245211|FG002|Overall Study|Adverse Event|9|||
131793064|NCT01799590|474524682|FG000|Overall Study|Aggravation of complications|0|||
131793065|NCT01799590|474524683|FG001|Overall Study|Aggravation of complications|1|||
131793066|NCT01799590|474524684|FG002|Overall Study|Aggravation of complications|1|||
131793067|NCT01799590|474524682|FG000|Overall Study|Using drugs with restricted days of use|0|||
131793068|NCT01799590|474524683|FG001|Overall Study|Using drugs with restricted days of use|3|||
131793069|NCT01799590|474524684|FG002|Overall Study|Using drugs with restricted days of use|2|||
131793070|NCT01799590|474524682|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
131793071|NCT01799590|474524683|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
131793072|NCT01799590|474524684|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
131793073|NCT01799590|474524682|FG000|Overall Study|Other|3|||
131793074|NCT01799590|474524683|FG001|Overall Study|Other|0|||
131793075|NCT01799590|474524684|FG002|Overall Study|Other|1|||
131793076|NCT05487456|474524685|FG000|Overall Study|Withdrawal by Subject|0|||
131793077|NCT05487456|474524686|FG001|Overall Study|Withdrawal by Subject|0|||
131793078|NCT05487456|474524687|FG002|Overall Study|Withdrawal by Subject|1|||
131793079|NCT05487456|474524688|FG003|Overall Study|Withdrawal by Subject|0|||
131793080|NCT00294723|474524691|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
131793081|NCT00294723|474524692|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
131793082|NCT00294723|474524693|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
131793083|NCT00294723|474524691|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
131793084|NCT00294723|474524692|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
131793085|NCT00294723|474524693|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
131793086|NCT00294723|474524691|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
131793087|NCT00294723|474524692|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
131793088|NCT00294723|474524693|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
131793089|NCT00294723|474524691|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
131793090|NCT00294723|474524692|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
131793091|NCT00294723|474524693|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
131793092|NCT00294723|474524691|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
131793093|NCT00294723|474524692|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
131793094|NCT00294723|474524693|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
131793095|NCT00294723|474524691|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
131793096|NCT00294723|474524692|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
131793097|NCT00294723|474524693|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
131793098|NCT00294723|474524691|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
131793099|NCT00294723|474524692|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
131793100|NCT00294723|474524693|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
131793101|NCT00294723|474524691|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
131793102|NCT00294723|474524692|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
131793103|NCT00294723|474524693|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
131793104|NCT00294723|474524691|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
131793105|NCT00294723|474524692|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
131793106|NCT00294723|474524693|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
131793107|NCT00294723|474524691|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
131793108|NCT00294723|474524692|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
131793109|NCT00294723|474524693|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
131793110|NCT00294723|474524691|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
131793111|NCT00294723|474524692|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
131793112|NCT00294723|474524693|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
131793113|NCT00294723|474524691|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
131793114|NCT00294723|474524692|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
131793115|NCT00294723|474524693|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
131793116|NCT00752791|474524694|FG000|Overall Study|Adverse Event|7|||
131793117|NCT00752791|474524694|FG000|Overall Study|Withdrawal by Subject|1|||
131793118|NCT00752791|474524694|FG000|Overall Study|Physician Decision|1|||
131793119|NCT00752791|474524694|FG000|Overall Study|Death|1|||
131793120|NCT00752791|474524694|FG000|Overall Study|Renal transplant|3|||
131793121|NCT00752791|474524694|FG000|Overall Study|Switched to hemodialysis|2|||
131793122|NCT00752791|474524694|FG000|Overall Study|Protocol deviation|1|||
131793123|NCT01489956|474524695|FG000|Overall Study|Lost to Follow-up|1|||
131793124|NCT01489956|474524696|FG001|Overall Study|Lost to Follow-up|0|||
131441366|NCT00979901|473245212|FG003|Overall Study|Adverse Event|2|||
131441367|NCT00979901|473245209|FG000|Overall Study|Lack of Efficacy|8|||
131441368|NCT00979901|473245210|FG001|Overall Study|Lack of Efficacy|4|||
131441369|NCT00979901|473245211|FG002|Overall Study|Lack of Efficacy|9|||
131441370|NCT00979901|473245212|FG003|Overall Study|Lack of Efficacy|0|||
131793125|NCT01489956|474524697|FG002|Overall Study|Lost to Follow-up|0|||
131441371|NCT00979901|473245209|FG000|Overall Study|Lost to Follow-up|1|||
131441372|NCT00979901|473245210|FG001|Overall Study|Lost to Follow-up|1|||
131441373|NCT00979901|473245211|FG002|Overall Study|Lost to Follow-up|2|||
131441374|NCT00979901|473245212|FG003|Overall Study|Lost to Follow-up|0|||
131607670|NCT04881461|473855834|FG001|Overall Study|Lost to Follow-up|4|||
131899892|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
131441375|NCT00979901|473245209|FG000|Overall Study|Protocol Violation|2|||
131441376|NCT00979901|473245210|FG001|Overall Study|Protocol Violation|2|||
131441377|NCT00979901|473245211|FG002|Overall Study|Protocol Violation|7|||
131441378|NCT00979901|473245212|FG003|Overall Study|Protocol Violation|1|||
131899893|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899894|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899895|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899896|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
131899897|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
131899898|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899899|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
131899900|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899901|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899902|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
131899903|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131899904|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
131899905|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
131899906|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
131899907|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
131899908|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
131899909|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
131899910|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
131899911|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
131899912|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
131899913|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
131899914|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
131899915|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
131899916|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
131441379|NCT00979901|473245209|FG000|Overall Study|Withdrawal by Subject|2|||
131441380|NCT00979901|473245210|FG001|Overall Study|Withdrawal by Subject|1|||
131441381|NCT00979901|473245211|FG002|Overall Study|Withdrawal by Subject|1|||
131441382|NCT00979901|473245212|FG003|Overall Study|Withdrawal by Subject|1|||
131441383|NCT00979901|473245209|FG000|Overall Study|Noncompliance|1|||
131441384|NCT00979901|473245210|FG001|Overall Study|Noncompliance|0|||
131441385|NCT00979901|473245211|FG002|Overall Study|Noncompliance|0|||
131899917|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
131899918|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
131899919|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
131441386|NCT00979901|473245212|FG003|Overall Study|Noncompliance|0|||
131441387|NCT00979901|473245209|FG000|Overall Study|out-of-state|1|||
131441388|NCT00979901|473245210|FG001|Overall Study|out-of-state|0|||
131441389|NCT00979901|473245211|FG002|Overall Study|out-of-state|0|||
131441390|NCT00979901|473245212|FG003|Overall Study|out-of-state|0|||
131441391|NCT00979901|473245209|FG000|Overall Study|vacation|1|||
131441392|NCT00979901|473245210|FG001|Overall Study|vacation|0|||
131441393|NCT00979901|473245211|FG002|Overall Study|vacation|0|||
131441394|NCT00979901|473245212|FG003|Overall Study|vacation|0|||
131441395|NCT00979901|473245209|FG000|Overall Study|elevated lab values pre-randomization|1|||
131441396|NCT00979901|473245210|FG001|Overall Study|elevated lab values pre-randomization|0|||
131441397|NCT00979901|473245211|FG002|Overall Study|elevated lab values pre-randomization|0|||
131441398|NCT00979901|473245212|FG003|Overall Study|elevated lab values pre-randomization|0|||
131441399|NCT00979901|473245209|FG000|Overall Study|Discontinued in Error|0|||
131607671|NCT04881461|473855833|FG000|Overall Study|Lack of Efficacy|1|||
131607672|NCT04881461|473855834|FG001|Overall Study|Lack of Efficacy|0|||
131607673|NCT04881461|473855833|FG000|Overall Study|"Reason stated as other in CRF"|1|||
131607674|NCT04881461|473855834|FG001|Overall Study|"Reason stated as other in CRF"|2|||
131607675|NCT03663205|473855837|FG000|Overall Study|Death|144|||
131607676|NCT03663205|473855838|FG001|Overall Study|Death|69|||
131441400|NCT00979901|473245210|FG001|Overall Study|Discontinued in Error|1|||
131441401|NCT00979901|473245211|FG002|Overall Study|Discontinued in Error|0|||
131441402|NCT00979901|473245212|FG003|Overall Study|Discontinued in Error|0|||
131441403|NCT00979901|473245209|FG000|Overall Study|Left Country|0|||
131441404|NCT00979901|473245210|FG001|Overall Study|Left Country|0|||
131441405|NCT00979901|473245211|FG002|Overall Study|Left Country|1|||
131441406|NCT00979901|473245212|FG003|Overall Study|Left Country|0|||
131441407|NCT00979901|473245209|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
131441408|NCT00979901|473245210|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
131441409|NCT00979901|473245211|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
131441410|NCT00979901|473245212|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
131441411|NCT02182895|473245223|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
131441412|NCT02182895|473245224|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
131441413|NCT00286468|473245225|FG000|Overall Study|Hyperglycemic Rescue|28|||
131441414|NCT00286468|473245226|FG001|Overall Study|Hyperglycemic Rescue|30|||
131441415|NCT00286468|473245227|FG002|Overall Study|Hyperglycemic Rescue|31|||
131441416|NCT00286468|473245225|FG000|Overall Study|Adverse Event|2|||
131441417|NCT00286468|473245226|FG001|Overall Study|Adverse Event|6|||
131441418|NCT00286468|473245227|FG002|Overall Study|Adverse Event|4|||
131441419|NCT00286468|473245225|FG000|Overall Study|Protocol Violation|0|||
131441420|NCT00286468|473245226|FG001|Overall Study|Protocol Violation|3|||
131441421|NCT00286468|473245227|FG002|Overall Study|Protocol Violation|1|||
131607677|NCT03663205|473855837|FG000|Overall Study|Sponsor decision|53|||
131707844|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707845|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131607678|NCT03663205|473855838|FG001|Overall Study|Sponsor decision|19|||
131607679|NCT03663205|473855837|FG000|Overall Study|Withdrawal by Subject|8|||
131607680|NCT03663205|473855838|FG001|Overall Study|Withdrawal by Subject|11|||
131607681|NCT03663205|473855837|FG000|Overall Study|Lost to Follow-up|7|||
131607682|NCT03663205|473855838|FG001|Overall Study|Lost to Follow-up|9|||
131707846|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131607683|NCT03663205|473855837|FG000|Overall Study|Transferred to long term extension study|11|||
131607684|NCT03663205|473855838|FG001|Overall Study|Transferred to long term extension study|3|||
131607685|NCT04707768|473855843|FG000|Overall Study|Adverse Event|9|||
131607686|NCT04707768|473855844|FG001|Overall Study|Adverse Event|18|||
131607687|NCT04707768|473855845|FG002|Overall Study|Adverse Event|3|||
131607688|NCT04707768|473855843|FG000|Overall Study|Investigator's Discretion|8|||
131607689|NCT04707768|473855844|FG001|Overall Study|Investigator's Discretion|4|||
131607690|NCT04707768|473855845|FG002|Overall Study|Investigator's Discretion|3|||
131793126|NCT01489956|474524695|FG000|Overall Study|Withdrawal by Subject|0|||
131793127|NCT01489956|474524696|FG001|Overall Study|Withdrawal by Subject|0|||
131793128|NCT01489956|474524697|FG002|Overall Study|Withdrawal by Subject|1|||
131793129|NCT03341507|474524698|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
131607691|NCT04707768|473855843|FG000|Overall Study|Withdrawal by Subject|6|||
131607692|NCT04707768|473855844|FG001|Overall Study|Withdrawal by Subject|8|||
131793130|NCT02927847|474524699|FG000|Overall Study|Lost to Follow-up|1|||
131441422|NCT00286468|473245225|FG000|Overall Study|Lost to Follow-up|1|||
131793131|NCT02927847|474524700|FG001|Overall Study|Lost to Follow-up|0|||
131793132|NCT02927847|474524699|FG000|Overall Study|Withdrawal by Subject|4|||
131793133|NCT02927847|474524700|FG001|Overall Study|Withdrawal by Subject|2|||
131793134|NCT02927847|474524699|FG000|Overall Study|PI withdrawn due to missed visits|1|||
131793135|NCT02927847|474524700|FG001|Overall Study|PI withdrawn due to missed visits|1|||
131793136|NCT03882047|474524701|FG000|Overall Study|Adverse Event|0|||
131793137|NCT03882047|474524702|FG001|Overall Study|Adverse Event|2|||
131793138|NCT03882047|474524703|FG002|Overall Study|Adverse Event|2|||
131793139|NCT03882047|474524701|FG000|Overall Study|Treatment Failure|3|||
131793140|NCT03882047|474524702|FG001|Overall Study|Treatment Failure|3|||
131793141|NCT03882047|474524703|FG002|Overall Study|Treatment Failure|12|||
131793142|NCT03882047|474524701|FG000|Overall Study|Lost to Follow-up|0|||
131793143|NCT03882047|474524702|FG001|Overall Study|Lost to Follow-up|1|||
131793144|NCT03882047|474524703|FG002|Overall Study|Lost to Follow-up|0|||
131793145|NCT03882047|474524701|FG000|Overall Study|Did Not Wish to Continue|1|||
131793146|NCT03882047|474524702|FG001|Overall Study|Did Not Wish to Continue|4|||
131793147|NCT03882047|474524703|FG002|Overall Study|Did Not Wish to Continue|1|||
131793148|NCT03882047|474524701|FG000|Overall Study|Noncompliance With Protocol|2|||
131793149|NCT03882047|474524702|FG001|Overall Study|Noncompliance With Protocol|0|||
131793150|NCT03882047|474524703|FG002|Overall Study|Noncompliance With Protocol|0|||
131793151|NCT03882047|474524701|FG000|Overall Study|Did Not Meet Eligibility|0|||
131793152|NCT03882047|474524702|FG001|Overall Study|Did Not Meet Eligibility|0|||
131793153|NCT03882047|474524703|FG002|Overall Study|Did Not Meet Eligibility|1|||
131793154|NCT00441584|474524704|FG000|Overall Study|Lack of Efficacy|79|||
131793155|NCT00441584|474524704|FG000|Overall Study|Withdrawal by Subject|8|||
131793156|NCT00441584|474524704|FG000|Overall Study|Adverse Event|6|||
131793157|NCT00441584|474524704|FG000|Overall Study|Protocol Violation|5|||
131793158|NCT00441584|474524704|FG000|Overall Study|Lost to Follow-up|4|||
131793159|NCT00441584|474524704|FG000|Overall Study|Failure to meet eligibility criteria|3|||
131793160|NCT01333033|474524707|FG000|Overall Study|Ineligible|0|||
131793161|NCT01333033|474524708|FG001|Overall Study|Ineligible|0|||
131793162|NCT01333033|474524709|FG002|Overall Study|Ineligible|0|||
131793163|NCT01333033|474524710|FG003|Overall Study|Ineligible|0|||
131793164|NCT01333033|474524711|FG004|Overall Study|Ineligible|6|||
131793165|NCT01333033|474524712|FG005|Overall Study|Ineligible|8|||
131793166|NCT01333033|474524707|FG000|Overall Study|Withdrawal by Subject|0|||
131793167|NCT01333033|474524708|FG001|Overall Study|Withdrawal by Subject|0|||
131793168|NCT01333033|474524709|FG002|Overall Study|Withdrawal by Subject|0|||
131793169|NCT01333033|474524710|FG003|Overall Study|Withdrawal by Subject|0|||
131793170|NCT01333033|474524711|FG004|Overall Study|Withdrawal by Subject|4|||
131793171|NCT01333033|474524712|FG005|Overall Study|Withdrawal by Subject|2|||
131793172|NCT01333033|474524707|FG000|Overall Study|PET inevaluable|0|||
131793173|NCT01333033|474524708|FG001|Overall Study|PET inevaluable|0|||
131793174|NCT01333033|474524709|FG002|Overall Study|PET inevaluable|0|||
131793175|NCT01333033|474524710|FG003|Overall Study|PET inevaluable|0|||
131793176|NCT01333033|474524711|FG004|Overall Study|PET inevaluable|2|||
131793177|NCT01333033|474524712|FG005|Overall Study|PET inevaluable|4|||
131793178|NCT01333033|474524707|FG000|Overall Study|Adverse Event|0|||
131793179|NCT01333033|474524708|FG001|Overall Study|Adverse Event|0|||
131793180|NCT01333033|474524709|FG002|Overall Study|Adverse Event|0|||
131793181|NCT01333033|474524710|FG003|Overall Study|Adverse Event|0|||
131793182|NCT01333033|474524711|FG004|Overall Study|Adverse Event|2|||
131793183|NCT01333033|474524712|FG005|Overall Study|Adverse Event|1|||
131793184|NCT01333033|474524707|FG000|Overall Study|Progression|0|||
131793185|NCT01333033|474524708|FG001|Overall Study|Progression|0|||
131793186|NCT01333033|474524709|FG002|Overall Study|Progression|0|||
131793187|NCT01333033|474524710|FG003|Overall Study|Progression|0|||
131793188|NCT01333033|474524711|FG004|Overall Study|Progression|0|||
131793189|NCT01333033|474524712|FG005|Overall Study|Progression|1|||
131793190|NCT01333033|474524707|FG000|Overall Study|MD Decision|0|||
131793191|NCT01333033|474524708|FG001|Overall Study|MD Decision|0|||
131793192|NCT01333033|474524709|FG002|Overall Study|MD Decision|0|||
131793193|NCT01333033|474524710|FG003|Overall Study|MD Decision|0|||
131793194|NCT01333033|474524711|FG004|Overall Study|MD Decision|0|||
131793195|NCT01333033|474524712|FG005|Overall Study|MD Decision|2|||
131793196|NCT03687125|474524713|FG000|Overall Study|Progressive Disease|2|||
131793197|NCT03687125|474524714|FG001|Overall Study|Progressive Disease|1|||
131793198|NCT03687125|474524713|FG000|Overall Study|Protocol Violation|1|||
131793199|NCT03687125|474524714|FG001|Overall Study|Protocol Violation|0|||
131793200|NCT01992107|474524715|FG000|Overall Study|Administrative reasons|2|||
131793201|NCT01992107|474524716|FG001|Overall Study|Administrative reasons|0|||
131793202|NCT01992107|474524717|FG002|Overall Study|Administrative reasons|0|||
131441423|NCT00286468|473245226|FG001|Overall Study|Lost to Follow-up|1|||
131793203|NCT01992107|474524715|FG000|Overall Study|Adverse Event|0|||
131793204|NCT01992107|474524716|FG001|Overall Study|Adverse Event|1|||
131793205|NCT01992107|474524717|FG002|Overall Study|Adverse Event|0|||
131793206|NCT01992107|474524715|FG000|Overall Study|Lost to Follow-up|46|||
131793207|NCT01992107|474524716|FG001|Overall Study|Lost to Follow-up|22|||
131793208|NCT01992107|474524717|FG002|Overall Study|Lost to Follow-up|26|||
131793209|NCT01992107|474524715|FG000|Overall Study|noncompliance and were unavailable|7|||
131607693|NCT04707768|473855845|FG002|Overall Study|Withdrawal by Subject|2|||
131607694|NCT04707768|473855843|FG000|Overall Study|Lack of Efficacy|1|||
131607695|NCT04707768|473855844|FG001|Overall Study|Lack of Efficacy|3|||
131607696|NCT04707768|473855845|FG002|Overall Study|Lack of Efficacy|0|||
131607697|NCT04707768|473855843|FG000|Overall Study|Lost to Follow-up|0|||
131607698|NCT04707768|473855844|FG001|Overall Study|Lost to Follow-up|0|||
131441424|NCT00286468|473245227|FG002|Overall Study|Lost to Follow-up|2|||
131441425|NCT00286468|473245225|FG000|Overall Study|Withdrawal by Subject|3|||
131441426|NCT00286468|473245226|FG001|Overall Study|Withdrawal by Subject|8|||
131441427|NCT00286468|473245227|FG002|Overall Study|Withdrawal by Subject|11|||
131441428|NCT00286468|473245225|FG000|Overall Study|Physician Decision|3|||
131441429|NCT00286468|473245226|FG001|Overall Study|Physician Decision|2|||
131441430|NCT00286468|473245227|FG002|Overall Study|Physician Decision|1|||
131441431|NCT01383928|473245228|FG000|Overall Study|Initiation of ASCT|2|||
131441432|NCT01383928|473245229|FG001|Overall Study|Initiation of ASCT|1|||
131441433|NCT01383928|473245230|FG002|Overall Study|Initiation of ASCT|18|||
131441434|NCT01383928|473245228|FG000|Overall Study|Adverse Event|1|||
131441435|NCT01383928|473245229|FG001|Overall Study|Adverse Event|2|||
131441436|NCT01383928|473245230|FG002|Overall Study|Adverse Event|8|||
131441437|NCT01383928|473245228|FG000|Overall Study|Other|1|||
131441438|NCT01383928|473245229|FG001|Overall Study|Other|3|||
131441439|NCT01383928|473245230|FG002|Overall Study|Other|4|||
131441440|NCT01383928|473245228|FG000|Overall Study|Progressive Disease|1|||
131441441|NCT01383928|473245229|FG001|Overall Study|Progressive Disease|1|||
131441442|NCT01383928|473245230|FG002|Overall Study|Progressive Disease|5|||
131793210|NCT01992107|474524716|FG001|Overall Study|noncompliance and were unavailable|3|||
131793211|NCT01992107|474524717|FG002|Overall Study|noncompliance and were unavailable|2|||
131793212|NCT01992107|474524715|FG000|Overall Study|Withdrawal by Subject|13|||
131793213|NCT01992107|474524716|FG001|Overall Study|Withdrawal by Subject|7|||
131793214|NCT01992107|474524717|FG002|Overall Study|Withdrawal by Subject|8|||
131793215|NCT02022007|474524718|FG000|Overall Study|Withdrawal by Subject|1|||
131793216|NCT02022007|474524719|FG001|Overall Study|Withdrawal by Subject|1|||
131793217|NCT02022007|474524720|FG002|Overall Study|Withdrawal by Subject|1|||
131793218|NCT02022007|474524718|FG000|Overall Study|Noncompliant|0|||
131793219|NCT02022007|474524719|FG001|Overall Study|Noncompliant|0|||
131793220|NCT02022007|474524720|FG002|Overall Study|Noncompliant|1|||
131793221|NCT02087046|474524721|FG000|Overall Study|Adverse Event|4|||
131793222|NCT02087046|474524721|FG000|Overall Study|Death|1|||
131793223|NCT02087046|474524721|FG000|Overall Study|Lost to Follow-up|3|||
131793224|NCT02087046|474524721|FG000|Overall Study|Withdrawal by Subject|2|||
131793225|NCT02087046|474524721|FG000|Overall Study|Physician Decision|1|||
131793226|NCT00905489|474524722|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
131793227|NCT00905489|474524722|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
131793228|NCT00905489|474524722|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
131793229|NCT02668302|474524726|FG000|Overall Study|Withdrawal by Subject|1|||
131793230|NCT02668302|474524727|FG001|Overall Study|Withdrawal by Subject|0|||
131793231|NCT03775681|474524728|FG000|Overall Study|Physician Decision|3|||
131793232|NCT00616928|474524729|FG000|Overall Study|Adverse Event|6|||
131793233|NCT00616928|474524730|FG001|Overall Study|Adverse Event|3|||
131793234|NCT00616928|474524731|FG002|Overall Study|Adverse Event|2|||
131793235|NCT00616928|474524732|FG003|Overall Study|Adverse Event|2|||
131793236|NCT00616928|474524729|FG000|Overall Study|Other|51|||
131793237|NCT00616928|474524730|FG001|Overall Study|Other|8|||
131793238|NCT00616928|474524731|FG002|Overall Study|Other|15|||
131793239|NCT00616928|474524732|FG003|Overall Study|Other|5|||
131793240|NCT00616928|474524729|FG000|Overall Study|Lost to Follow-up|5|||
131441443|NCT01383928|473245228|FG000|Overall Study|Withdrawal by Subject|0|||
131441444|NCT01383928|473245229|FG001|Overall Study|Withdrawal by Subject|0|||
131441445|NCT01383928|473245230|FG002|Overall Study|Withdrawal by Subject|4|||
131441446|NCT01383928|473245228|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
131441447|NCT01383928|473245229|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
131441448|NCT01383928|473245230|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
131441449|NCT03651765|473245233|FG000|Overall Study|Adverse Event|6|||
131441450|NCT03651765|473245233|FG000|Overall Study|Lack of Efficacy|18|||
131793241|NCT00616928|474524730|FG001|Overall Study|Lost to Follow-up|7|||
131793242|NCT00616928|474524731|FG002|Overall Study|Lost to Follow-up|0|||
131793243|NCT00616928|474524732|FG003|Overall Study|Lost to Follow-up|0|||
131793244|NCT03529955|474524737|FG000|Overall Study|Adverse Event|1|||
131441451|NCT03651765|473245233|FG000|Overall Study|Lost to Follow-up|5|||
131441452|NCT03651765|473245233|FG000|Overall Study|Non-Compliance with Study Drug|4|||
131441453|NCT03651765|473245233|FG000|Overall Study|Physician Decision|6|||
131441454|NCT03651765|473245233|FG000|Overall Study|Pregnancy|1|||
131793245|NCT03529955|474524737|FG000|Overall Study|Lack of Efficacy|1|||
131793246|NCT00580983|474524738|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
131793247|NCT02468557|474526631|FG000|Overall Study|Adverse Event|1|||
131793248|NCT02468557|474526631|FG000|Overall Study|Death|1|||
131793249|NCT02468557|474526631|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
131793250|NCT02468557|474526631|FG000|Overall Study|All Enrolled but Never Dosed|4|||
131441455|NCT03651765|473245233|FG000|Overall Study|Discontinued by Sponsor|40|||
131441456|NCT03651765|473245233|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
131441457|NCT03651765|473245233|FG000|Overall Study|Withdrawal by Subject|24|||
131441458|NCT03651765|473245233|FG000|Overall Study|Miscellaneous|6|||
131441459|NCT02242942|473245243|FG000|Overall Study|Death|17|||
131441460|NCT02242942|473245244|FG001|Overall Study|Death|20|||
131441461|NCT02242942|473245245|FG002|Overall Study|Death|2|||
131707847|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707848|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131899920|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
131899921|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
131899922|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
131899923|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899924|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899925|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899926|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899927|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899928|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899929|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
131441462|NCT02242942|473245243|FG000|Overall Study|Physician Decision|1|||
131707849|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707850|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707851|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707852|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707853|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707854|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707855|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707856|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707857|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707858|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131707859|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131441463|NCT02242942|473245244|FG001|Overall Study|Physician Decision|0|||
131441464|NCT02242942|473245245|FG002|Overall Study|Physician Decision|0|||
131607699|NCT04707768|473855845|FG002|Overall Study|Lost to Follow-up|3|||
131607700|NCT04707768|473855843|FG000|Overall Study|Death|13|||
131607701|NCT04707768|473855844|FG001|Overall Study|Death|11|||
131607702|NCT04707768|473855845|FG002|Overall Study|Death|13|||
131607703|NCT04707768|473855843|FG000|Overall Study|Protocol Violation|2|||
131607704|NCT04707768|473855844|FG001|Overall Study|Protocol Violation|1|||
131607705|NCT04707768|473855845|FG002|Overall Study|Protocol Violation|0|||
131607706|NCT04707768|473855843|FG000|Overall Study|Non Compliance with Study Drug|1|||
131607707|NCT04707768|473855844|FG001|Overall Study|Non Compliance with Study Drug|0|||
131607708|NCT04707768|473855845|FG002|Overall Study|Non Compliance with Study Drug|0|||
131441465|NCT02242942|473245243|FG000|Overall Study|Withdrawal by Subject|8|||
131441466|NCT02242942|473245244|FG001|Overall Study|Withdrawal by Subject|10|||
131441467|NCT02242942|473245245|FG002|Overall Study|Withdrawal by Subject|0|||
131441468|NCT02242942|473245243|FG000|Overall Study|On-going in Study|190|||
131441469|NCT02242942|473245244|FG001|Overall Study|On-going in Study|186|||
131441470|NCT02242942|473245245|FG002|Overall Study|On-going in Study|11|||
131441471|NCT04716426|473245246|FG000|Overall Study|Vaccination|1|||
131441472|NCT04716426|473245247|FG001|Overall Study|Vaccination|1|||
131441473|NCT04716426|473245246|FG000|Overall Study|Contamination|1|||
131441474|NCT04716426|473245247|FG001|Overall Study|Contamination|0|||
131441475|NCT00551759|473245248|FG000|Overall Study|Adverse Event|7|||
131441476|NCT00551759|473245248|FG000|Overall Study|Death|5|||
131441477|NCT00551759|473245248|FG000|Overall Study|Ineligible|1|||
131441478|NCT04842747|473245253|FG000|Overall Study|Withdrawal by Subject|6|||
131607709|NCT04707768|473855843|FG000|Overall Study|Transplant|4|||
131607710|NCT04707768|473855844|FG001|Overall Study|Transplant|4|||
131707860|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
131793251|NCT04014959|474526632|FG000|Baseline MRI and Assessments|Physician Decision|2|||
131793252|NCT04014959|474526632|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
131793253|NCT04014959|474526632|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
131793254|NCT03381248|474526641|FG000|0-6 Months|Withdrawal by Subject|4|||
131793255|NCT03381248|474526642|FG001|0-6 Months|Withdrawal by Subject|1|||
131793256|NCT03381248|474526641|FG000|0-6 Months|Lost to Follow-up|3|||
131793257|NCT03381248|474526642|FG001|0-6 Months|Lost to Follow-up|2|||
131793258|NCT03381248|474526641|FG000|0-6 Months|Lack of Efficacy|1|||
131793259|NCT03381248|474526642|FG001|0-6 Months|Lack of Efficacy|0|||
131793260|NCT03381248|474526641|FG000|0-6 Months|Adverse Event|1|||
131793261|NCT03381248|474526642|FG001|0-6 Months|Adverse Event|0|||
131793262|NCT03381248|474526641|FG000|0-6 Months|Protocol Violation|2|||
131793263|NCT03381248|474526642|FG001|0-6 Months|Protocol Violation|1|||
131793264|NCT03381248|474526641|FG000|0-6 Months|Physician Decision|1|||
131793265|NCT03381248|474526642|FG001|0-6 Months|Physician Decision|0|||
131793266|NCT03381248|474526641|FG000|0-6 Months|Planning another procedure|1|||
131793267|NCT03381248|474526642|FG001|0-6 Months|Planning another procedure|2|||
131793268|NCT03381248|474526641|FG000|6-12 Months|Withdrawal by Subject|1|||
131793269|NCT03381248|474526642|FG001|6-12 Months|Withdrawal by Subject|3|||
131793270|NCT03381248|474526641|FG000|6-12 Months|Lost to Follow-up|0|||
131793271|NCT03381248|474526642|FG001|6-12 Months|Lost to Follow-up|2|||
131793272|NCT03381248|474526641|FG000|6-12 Months|Protocol Violation|3|||
131793273|NCT03381248|474526642|FG001|6-12 Months|Protocol Violation|2|||
131793274|NCT03381248|474526641|FG000|6-12 Months|Planning another procedure|6|||
131793275|NCT03381248|474526642|FG001|6-12 Months|Planning another procedure|2|||
131793276|NCT03381248|474526641|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
131793277|NCT03381248|474526642|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
131793278|NCT03381248|474526641|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
131793279|NCT03381248|474526642|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
131793280|NCT03381248|474526641|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
131793281|NCT03381248|474526642|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
131793282|NCT00759148|474526643|FG000|Overall Study|Adverse Event|1|||
131793283|NCT00759148|474526644|FG001|Overall Study|Adverse Event|6|||
131793284|NCT00759148|474526643|FG000|Overall Study|Withdrawal by Subject|3|||
131793285|NCT00759148|474526644|FG001|Overall Study|Withdrawal by Subject|7|||
131793286|NCT00759148|474526643|FG000|Overall Study|Lost to Follow-up|3|||
131793287|NCT00759148|474526644|FG001|Overall Study|Lost to Follow-up|9|||
131793288|NCT00759148|474526643|FG000|Overall Study|Treatment Failure|6|||
131793289|NCT00759148|474526644|FG001|Overall Study|Treatment Failure|10|||
131793290|NCT00759148|474526643|FG000|Overall Study|Reason not given|1|||
131793291|NCT00759148|474526644|FG001|Overall Study|Reason not given|0|||
131793292|NCT01387282|474526649|FG000|Overall Study|Death|47|||
131793293|NCT01387282|474526650|FG001|Overall Study|Death|16|||
131793294|NCT01387282|474526649|FG000|Overall Study|Other|5|||
131793295|NCT01387282|474526650|FG001|Overall Study|Other|1|||
131793296|NCT01387282|474526649|FG000|Overall Study|Unrelated AE|6|||
131793297|NCT01387282|474526650|FG001|Overall Study|Unrelated AE|4|||
131793298|NCT01387282|474526649|FG000|Overall Study|Withdrawal by patient|33|||
131793299|NCT01387282|474526650|FG001|Overall Study|Withdrawal by patient|23|||
131793300|NCT01387282|474526649|FG000|Overall Study|Study drug-related AE|2|||
131793301|NCT01387282|474526650|FG001|Overall Study|Study drug-related AE|2|||
131793302|NCT01387282|474526649|FG000|Overall Study|Lost to Follow-up|4|||
131793303|NCT01387282|474526650|FG001|Overall Study|Lost to Follow-up|1|||
131607711|NCT04707768|473855845|FG002|Overall Study|Transplant|8|||
131607712|NCT04707768|473855843|FG000|Overall Study|Other|9|||
131607713|NCT04707768|473855844|FG001|Overall Study|Other|5|||
131607714|NCT04707768|473855845|FG002|Overall Study|Other|2|||
131607715|NCT02510235|473855846|FG000|Overall Study|Withdrawal by Subject|1|||
131607716|NCT02510235|473855847|FG001|Overall Study|Withdrawal by Subject|0|||
131607717|NCT00450216|473855848|FG000|Overall Study|Adverse Event|38|||
131607718|NCT00450216|473855849|FG001|Overall Study|Adverse Event|23|||
131607719|NCT00450216|473855848|FG000|Overall Study|Withdrawal by Subject|48|||
131607720|NCT00450216|473855849|FG001|Overall Study|Withdrawal by Subject|26|||
131607721|NCT00450216|473855848|FG000|Overall Study|Lost to Follow-up|16|||
131793304|NCT03997448|474526653|FG000|Study Treatment|Disease Progression|1|||
131793305|NCT03997448|474526653|FG000|Study Treatment|Symptomatic Deterioration|1|||
131793306|NCT03997448|474526653|FG000|Follow up|Death|2|||
131793307|NCT03997448|474526653|FG000|Follow up|study terminated|1|||
131793308|NCT00125359|474526654|FG000|Overall Study|Death|4|||
131793309|NCT00125359|474526654|FG000|Overall Study|Adverse Event|5|||
131793310|NCT00125359|474526654|FG000|Overall Study|Physician Decision|14|||
131793311|NCT01513551|474526655|FG000|Overall Study|Death|0|||
131441479|NCT04842747|473245254|FG001|Overall Study|Withdrawal by Subject|2|||
131607722|NCT00450216|473855849|FG001|Overall Study|Lost to Follow-up|9|||
131793312|NCT01513551|474526656|FG001|Overall Study|Death|1|||
131793313|NCT01513551|474526657|FG002|Overall Study|Death|0|||
131793314|NCT01513551|474526655|FG000|Overall Study|Lost to Follow-up|3|||
131793315|NCT01513551|474526656|FG001|Overall Study|Lost to Follow-up|5|||
131793316|NCT01513551|474526657|FG002|Overall Study|Lost to Follow-up|2|||
131793317|NCT01513551|474526655|FG000|Overall Study|Withdrawal by Subject|1|||
131793318|NCT01513551|474526656|FG001|Overall Study|Withdrawal by Subject|0|||
131793319|NCT01513551|474526657|FG002|Overall Study|Withdrawal by Subject|2|||
131793320|NCT01513551|474526655|FG000|Overall Study|Randomized but not vaccinated|0|||
131793321|NCT01513551|474526656|FG001|Overall Study|Randomized but not vaccinated|0|||
131793322|NCT01513551|474526657|FG002|Overall Study|Randomized but not vaccinated|1|||
131793323|NCT02482805|474526660|FG000|Overall Study|Lost to Follow-up|4|||
131793324|NCT02482805|474526661|FG001|Overall Study|Lost to Follow-up|4|||
131793325|NCT02482805|474526662|FG002|Overall Study|Lost to Follow-up|0|||
131793326|NCT01144663|474526663|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
131793327|NCT01144663|474526664|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
131793328|NCT01144663|474526665|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
131793329|NCT01144663|474526666|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
131793330|NCT01144663|474526663|FG000|Primary Vaccination Phase|Adverse Event|1|||
131793331|NCT01144663|474526664|FG001|Primary Vaccination Phase|Adverse Event|0|||
131793332|NCT01144663|474526665|FG002|Primary Vaccination Phase|Adverse Event|0|||
131793333|NCT01144663|474526666|FG003|Primary Vaccination Phase|Adverse Event|1|||
131793334|NCT01144663|474526663|FG000|Primary Vaccination Phase|Protocol Violation|2|||
131793335|NCT01144663|474526664|FG001|Primary Vaccination Phase|Protocol Violation|0|||
131441480|NCT04842747|473245253|FG000|Overall Study|Lost to Follow-up|1|||
131441481|NCT04842747|473245254|FG001|Overall Study|Lost to Follow-up|2|||
131441482|NCT04842747|473245253|FG000|Overall Study|Physician Decision|1|||
131441483|NCT04842747|473245254|FG001|Overall Study|Physician Decision|0|||
131441484|NCT04842747|473245253|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
131441485|NCT04842747|473245254|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
131441486|NCT01451606|473245257|FG000|Overall Study|Withdrawal by Subject|4|||
131441487|NCT01451606|473245258|FG001|Overall Study|Withdrawal by Subject|3|||
131441488|NCT02559622|473245262|FG000|Overall Study|Progressive disease|0|||
131441489|NCT02559622|473245263|FG001|Overall Study|Progressive disease|1|||
131441490|NCT02559622|473245264|FG002|Overall Study|Progressive disease|0|||
131441491|NCT02559622|473245265|FG003|Overall Study|Progressive disease|0|||
131441492|NCT02559622|473245262|FG000|Overall Study|Adverse Event|0|||
131441493|NCT02559622|473245263|FG001|Overall Study|Adverse Event|2|||
131441494|NCT02559622|473245264|FG002|Overall Study|Adverse Event|2|||
131607723|NCT00450216|473855848|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
131607724|NCT00450216|473855849|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
131607725|NCT00450216|473855848|FG000|Overall Study|misc|21|||
131607726|NCT00450216|473855849|FG001|Overall Study|misc|20|||
131607727|NCT03734029|473855851|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
131607728|NCT03734029|473855852|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
131607729|NCT03734029|473855851|FG000|Overall Study|Adverse Event|60|||
131607730|NCT03734029|473855852|FG001|Overall Study|Adverse Event|14|||
131607731|NCT03734029|473855851|FG000|Overall Study|Withdrawal by Subject|12|||
131607732|NCT03734029|473855852|FG001|Overall Study|Withdrawal by Subject|11|||
131607733|NCT03734029|473855851|FG000|Overall Study|Clinical progression by investigator|10|||
131607734|NCT03734029|473855852|FG001|Overall Study|Clinical progression by investigator|8|||
131607735|NCT03734029|473855851|FG000|Overall Study|Death|5|||
131607736|NCT03734029|473855852|FG001|Overall Study|Death|2|||
131607737|NCT03734029|473855851|FG000|Overall Study|Physician Decision|4|||
131607738|NCT03734029|473855852|FG001|Overall Study|Physician Decision|3|||
131607739|NCT03734029|473855851|FG000|Overall Study|Other|2|||
131607740|NCT03734029|473855852|FG001|Overall Study|Other|0|||
131607741|NCT03734029|473855851|FG000|Overall Study|Lost to Follow-up|0|||
131607742|NCT03734029|473855852|FG001|Overall Study|Lost to Follow-up|1|||
131607743|NCT03734029|473855851|FG000|Overall Study|Randomized, but not treated|2|||
131607744|NCT03734029|473855852|FG001|Overall Study|Randomized, but not treated|12|||
131607745|NCT03367156|473857085|FG000|Overall Study|Lack of interest|3|||
131607746|NCT03367156|473857086|FG001|Overall Study|Lack of interest|1|||
131607747|NCT03367156|473857085|FG000|Overall Study|Death|2|||
131793336|NCT01144663|474526665|FG002|Primary Vaccination Phase|Protocol Violation|1|||
131607748|NCT03367156|473857086|FG001|Overall Study|Death|0|||
131607749|NCT03367156|473857085|FG000|Overall Study|Lost to Follow-up|2|||
131607750|NCT03367156|473857086|FG001|Overall Study|Lost to Follow-up|1|||
131607751|NCT03367156|473857085|FG000|Overall Study|Became ineligible|1|||
131607752|NCT03367156|473857086|FG001|Overall Study|Became ineligible|2|||
131793337|NCT01144663|474526666|FG003|Primary Vaccination Phase|Protocol Violation|0|||
131899930|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131607753|NCT03367156|473857085|FG000|Overall Study|Hospitalization|1|||
131607754|NCT03367156|473857086|FG001|Overall Study|Hospitalization|0|||
131607755|NCT03367156|473857085|FG000|Overall Study|Concerned about Treatment|11|||
131607756|NCT03367156|473857086|FG001|Overall Study|Concerned about Treatment|3|||
131607757|NCT03367156|473857085|FG000|Overall Study|Started new treatment|4|||
131607758|NCT03367156|473857086|FG001|Overall Study|Started new treatment|1|||
131607759|NCT01586910|473857087|FG000|Overall Study|Death|4|||
131607760|NCT01586910|473857088|FG001|Overall Study|Death|4|||
131707861|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131707862|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
131707863|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
131707864|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
131707865|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131707866|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131707867|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707868|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707869|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707870|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707871|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707872|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707873|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707874|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707875|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707876|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707877|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707878|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707879|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707880|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707881|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131707882|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707883|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707884|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
131707885|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707886|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
131707887|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707888|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707889|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707890|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131793338|NCT01144663|474526663|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
131793339|NCT01144663|474526664|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
131793340|NCT01144663|474526665|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
131793341|NCT01144663|474526666|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
131793342|NCT01144663|474526663|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
131793343|NCT01144663|474526664|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
131793344|NCT01144663|474526665|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
131793345|NCT01144663|474526666|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
131793346|NCT01144663|474526663|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
131793347|NCT01144663|474526664|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
131793348|NCT01144663|474526665|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
131793349|NCT01144663|474526666|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
131793350|NCT01144663|474526663|FG000|Primary Vaccination Phase|Other|0|||
131793351|NCT01144663|474526664|FG001|Primary Vaccination Phase|Other|1|||
131793352|NCT01144663|474526665|FG002|Primary Vaccination Phase|Other|0|||
131793353|NCT01144663|474526666|FG003|Primary Vaccination Phase|Other|2|||
131793354|NCT01144663|474526663|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
131793355|NCT01144663|474526664|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
131793356|NCT01144663|474526665|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
131793357|NCT01144663|474526666|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
131793358|NCT01144663|474526663|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
131793359|NCT01144663|474526664|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
131793360|NCT01144663|474526665|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
131793361|NCT01144663|474526666|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
131793362|NCT01144663|474526663|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
131793363|NCT01144663|474526664|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
131793364|NCT01144663|474526665|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
131793365|NCT01144663|474526666|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
131793366|NCT01144663|474526663|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
131793367|NCT01144663|474526664|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
131793368|NCT01144663|474526665|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
131793369|NCT01144663|474526666|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
131793370|NCT01144663|474526663|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
131793371|NCT01144663|474526664|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
131793372|NCT01144663|474526665|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
131793373|NCT01144663|474526666|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
131793374|NCT01144663|474526663|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
131793375|NCT01144663|474526664|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
131793376|NCT01144663|474526665|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
131793377|NCT01144663|474526666|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
131793378|NCT01335477|474526668|FG000|Overall Study|Adverse Event|30|||
131793379|NCT01335477|474526669|FG001|Overall Study|Adverse Event|42|||
131793380|NCT01335477|474526668|FG000|Overall Study|Non compliant with protocol|0|||
131793381|NCT01335477|474526669|FG001|Overall Study|Non compliant with protocol|2|||
131793382|NCT01335477|474526668|FG000|Overall Study|Lost to Follow-up|1|||
131793383|NCT01335477|474526669|FG001|Overall Study|Lost to Follow-up|2|||
131793384|NCT01335477|474526668|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
131793385|NCT01335477|474526669|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
131793386|NCT01335477|474526668|FG000|Overall Study|Not treated|1|||
131793387|NCT01335477|474526669|FG001|Overall Study|Not treated|2|||
131793388|NCT01335477|474526668|FG000|Overall Study|Reason other than those stated above|2|||
131793389|NCT01335477|474526669|FG001|Overall Study|Reason other than those stated above|2|||
131793390|NCT02497391|474526674|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
131793391|NCT02497391|474526675|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
131793392|NCT02497391|474526676|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
131793393|NCT02497391|474526677|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
131793394|NCT02497391|474526678|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
131793395|NCT02497391|474526679|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
131793396|NCT02497391|474526674|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
131793397|NCT02497391|474526675|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
131793398|NCT02497391|474526676|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
131793399|NCT02497391|474526677|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
131793400|NCT02497391|474526678|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
131793401|NCT02497391|474526679|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
131793402|NCT02497391|474526674|FG000|Period 3 (14 Days)|Adverse Event|0|||
131793403|NCT02497391|474526675|FG001|Period 3 (14 Days)|Adverse Event|1|||
131793404|NCT02497391|474526676|FG002|Period 3 (14 Days)|Adverse Event|0|||
131793405|NCT02497391|474526677|FG003|Period 3 (14 Days)|Adverse Event|0|||
131793406|NCT02497391|474526678|FG004|Period 3 (14 Days)|Adverse Event|0|||
131793407|NCT02497391|474526679|FG005|Period 3 (14 Days)|Adverse Event|0|||
131793408|NCT02497391|474526674|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
131793409|NCT02497391|474526675|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
131793410|NCT02497391|474526676|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
131793411|NCT02497391|474526677|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
131793412|NCT02497391|474526678|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
131793413|NCT02497391|474526679|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
131793414|NCT02497391|474526674|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
131793415|NCT02497391|474526675|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
131793416|NCT02497391|474526676|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
131793417|NCT02497391|474526677|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
131793418|NCT02497391|474526678|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
131793419|NCT02497391|474526679|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
131793420|NCT00633152|474526692|FG000|Overall Study|Adverse Event|1|||
131793421|NCT00633152|474526693|FG001|Overall Study|Adverse Event|0|||
131793422|NCT00633152|474526692|FG000|Overall Study|Randomized, did not receive study drug|5|||
131793423|NCT00633152|474526693|FG001|Overall Study|Randomized, did not receive study drug|2|||
131793424|NCT00633152|474526692|FG000|Overall Study|Withdrawal by Subject|1|||
131793425|NCT00633152|474526693|FG001|Overall Study|Withdrawal by Subject|1|||
131793426|NCT00633152|474526692|FG000|Overall Study|Lost to Follow-up|4|||
131793427|NCT00633152|474526693|FG001|Overall Study|Lost to Follow-up|1|||
131793428|NCT00633152|474526692|FG000|Overall Study|Miscellaneous Other|3|||
131793429|NCT00633152|474526693|FG001|Overall Study|Miscellaneous Other|2|||
131793430|NCT03273387|474526694|FG000|Overall Study|Death|2|||
131793431|NCT03273387|474526695|FG001|Overall Study|Death|2|||
131793432|NCT03273387|474526694|FG000|Overall Study|Withdrawal by Subject|1|||
131793433|NCT03273387|474526695|FG001|Overall Study|Withdrawal by Subject|1|||
131793434|NCT02180061|474526696|FG000|Overall Study|Adverse Event|4|||
131793435|NCT02180061|474526697|FG001|Overall Study|Adverse Event|2|||
131793436|NCT02180061|474526696|FG000|Overall Study|Clinical Progression|5|||
131441495|NCT02559622|473245265|FG003|Overall Study|Adverse Event|2|||
131607761|NCT01586910|473857087|FG000|Overall Study|Withdrawal by Subject|6|||
131793437|NCT02180061|474526697|FG001|Overall Study|Clinical Progression|1|||
131793438|NCT02180061|474526696|FG000|Overall Study|Progressive Disease|15|||
131793439|NCT02180061|474526697|FG001|Overall Study|Progressive Disease|5|||
131793440|NCT02180061|474526696|FG000|Overall Study|Physician Decision|1|||
131793441|NCT02180061|474526697|FG001|Overall Study|Physician Decision|0|||
131793442|NCT01469364|474526700|FG000|Overall Study|Adverse Event|1|||
131607762|NCT01586910|473857088|FG001|Overall Study|Withdrawal by Subject|43|||
131607763|NCT01586910|473857087|FG000|Overall Study|Physician withdrew Subject|5|||
131607764|NCT01586910|473857088|FG001|Overall Study|Physician withdrew Subject|24|||
131607765|NCT05507437|473857089|FG000|Overall Study|Withdrawal by Subject|1|||
131607766|NCT05507437|473857090|FG001|Overall Study|Withdrawal by Subject|1|||
131607767|NCT05507437|473857089|FG000|Overall Study|Death|3|||
131607768|NCT05507437|473857090|FG001|Overall Study|Death|0|||
131607769|NCT05507333|473857091|FG000|Overall Study|Protocol Violation|1|||
131607770|NCT05247034|473857094|FG000|Overall Study|Lost to Follow-up|3|||
131607771|NCT05247034|473857095|FG001|Overall Study|Lost to Follow-up|2|||
131607772|NCT05247034|473857094|FG000|Overall Study|Organizational problems when attending appointments|1|||
131607773|NCT05247034|473857095|FG001|Overall Study|Organizational problems when attending appointments|0|||
131607774|NCT04464564|473857096|FG000|Period A (Placebo lead-in)|Other|5|||
131607775|NCT04464564|473857097|FG001|Period A (Placebo lead-in)|Other|0|||
131607776|NCT04464564|473857098|FG002|Period A (Placebo lead-in)|Other|0|||
131607777|NCT04464564|473857099|FG003|Period A (Placebo lead-in)|Other|0|||
131607778|NCT04464564|473857096|FG000|Period B (Randomization Period)|Adverse Event|0|||
131607779|NCT04464564|473857097|FG001|Period B (Randomization Period)|Adverse Event|1|||
131607780|NCT04464564|473857098|FG002|Period B (Randomization Period)|Adverse Event|2|||
131607781|NCT04464564|473857099|FG003|Period B (Randomization Period)|Adverse Event|8|||
131607782|NCT04464564|473857096|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
131607783|NCT04464564|473857097|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
131607784|NCT04464564|473857098|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
131607785|NCT04464564|473857099|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
131607786|NCT04464564|473857096|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
131607787|NCT04464564|473857097|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
131607788|NCT04464564|473857098|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
131607789|NCT04464564|473857099|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
131607790|NCT04464564|473857096|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
131607791|NCT04464564|473857097|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
131607792|NCT04464564|473857098|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
131607793|NCT04464564|473857099|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
131607794|NCT04464564|473857096|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
131607795|NCT04464564|473857097|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
131607796|NCT04464564|473857098|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
131607797|NCT04464564|473857099|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
131607798|NCT04464564|473857096|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
131607799|NCT04464564|473857097|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
131607800|NCT04464564|473857098|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
131607801|NCT04464564|473857099|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
131607802|NCT04464564|473857096|FG000|Period B (Randomization Period)|Reason not Specified|0|||
131607803|NCT04464564|473857097|FG001|Period B (Randomization Period)|Reason not Specified|3|||
131607804|NCT04464564|473857098|FG002|Period B (Randomization Period)|Reason not Specified|3|||
131607805|NCT04464564|473857099|FG003|Period B (Randomization Period)|Reason not Specified|3|||
131607806|NCT03972150|473857100|FG000|Overall Study|Adverse Event|0|||
131607807|NCT03972150|473857101|FG001|Overall Study|Adverse Event|1|||
131607808|NCT03972150|473857102|FG002|Overall Study|Adverse Event|1|||
131607809|NCT03972150|473857103|FG003|Overall Study|Adverse Event|0|||
131607810|NCT03972150|473857104|FG004|Overall Study|Adverse Event|0|||
131607811|NCT03972150|473857100|FG000|Overall Study|Progressive disease|3|||
131607812|NCT03972150|473857101|FG001|Overall Study|Progressive disease|5|||
131607813|NCT03972150|473857102|FG002|Overall Study|Progressive disease|2|||
131607814|NCT03972150|473857103|FG003|Overall Study|Progressive disease|2|||
131607815|NCT03972150|473857104|FG004|Overall Study|Progressive disease|3|||
131607816|NCT05422885|473857116|FG000|Overall Study|Lost to Follow-up|1|||
131607817|NCT05422885|473857116|FG000|Overall Study|Withdrawal by Subject|2|||
131607818|NCT04084574|473857117|FG000|Overall Study|Lost to Follow-up|1|||
131607819|NCT04084574|473857118|FG001|Overall Study|Lost to Follow-up|0|||
131607820|NCT04084574|473857117|FG000|Overall Study|Physician Decision|1|||
131607821|NCT04084574|473857118|FG001|Overall Study|Physician Decision|0|||
131607822|NCT04084574|473857117|FG000|Overall Study|Relocated out of state|1|||
131607823|NCT04084574|473857118|FG001|Overall Study|Relocated out of state|0|||
131607824|NCT02944968|473857121|FG000|Overall Study|Subject excluded before study procedure|1|||
131607825|NCT02944968|473857121|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
131607826|NCT02905331|473857122|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
131607827|NCT02905331|473857123|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
131607828|NCT02905331|473857124|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
131607829|NCT02905331|473857122|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
131607830|NCT02905331|473857123|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
131607831|NCT02905331|473857124|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
131441496|NCT02559622|473245262|FG000|Overall Study|Patient/guardian decision|1|||
131793443|NCT01469364|474526700|FG000|Overall Study|Withdrawal by Subject|1|||
131793444|NCT03433001|474526708|FG000|Overall Study|Lack of Efficacy|109|||
131441497|NCT02559622|473245263|FG001|Overall Study|Patient/guardian decision|2|||
131441498|NCT02559622|473245264|FG002|Overall Study|Patient/guardian decision|0|||
131607832|NCT02905331|473857122|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
131793445|NCT03433001|474526708|FG000|Overall Study|Adverse Event|69|||
131793446|NCT03433001|474526708|FG000|Overall Study|Withdrawal by Subject|10|||
131793447|NCT03433001|474526708|FG000|Overall Study|Death|12|||
131793448|NCT03433001|474526708|FG000|Overall Study|Lost to Follow-up|4|||
131793449|NCT03433001|474526708|FG000|Overall Study|Other|25|||
131793450|NCT01007916|474526711|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
131793451|NCT01007916|474526712|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
131793452|NCT01007916|474526711|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
131793453|NCT01007916|474526712|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
131793454|NCT01958281|474526713|FG000|Overall Study|Lack of Efficacy|5|||
131793455|NCT01958281|474526714|FG001|Overall Study|Lack of Efficacy|2|||
131793456|NCT01958281|474526715|FG002|Overall Study|Lack of Efficacy|0|||
131793457|NCT01958281|474526713|FG000|Overall Study|Adverse Event|0|||
131793458|NCT01958281|474526714|FG001|Overall Study|Adverse Event|2|||
131793459|NCT01958281|474526715|FG002|Overall Study|Adverse Event|0|||
131793460|NCT01958281|474526713|FG000|Overall Study|Withdrew Consent|1|||
131793461|NCT01958281|474526714|FG001|Overall Study|Withdrew Consent|0|||
131793462|NCT01958281|474526715|FG002|Overall Study|Withdrew Consent|0|||
131793463|NCT02784106|474526716|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
131793464|NCT02784106|474526717|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
131793465|NCT02784106|474526718|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131793466|NCT02784106|474526719|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131793467|NCT02784106|474526716|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
131793468|NCT02784106|474526717|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
131793469|NCT02784106|474526718|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131793470|NCT02784106|474526719|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131793471|NCT02784106|474526716|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
131793472|NCT02784106|474526717|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
131793473|NCT02784106|474526718|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
131793474|NCT02784106|474526719|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
131793475|NCT02784106|474526716|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
131793476|NCT02784106|474526717|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131793477|NCT02784106|474526718|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131793478|NCT02784106|474526719|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131793479|NCT02784106|474526716|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
131793480|NCT02784106|474526717|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
131793481|NCT02784106|474526718|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
131793482|NCT02784106|474526719|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
131793483|NCT02784106|474526716|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
131793484|NCT02784106|474526717|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
131793485|NCT02784106|474526718|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
131441499|NCT02559622|473245265|FG003|Overall Study|Patient/guardian decision|1|||
131607833|NCT02905331|473857123|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
131607834|NCT02905331|473857124|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
131607835|NCT02905331|473857122|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
131607836|NCT02905331|473857123|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
131607837|NCT02905331|473857124|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
131607838|NCT02905331|473857122|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
131607839|NCT02905331|473857123|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
131607840|NCT02905331|473857124|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
131607841|NCT01385202|473857125|FG000|Overall Study|Lost to Follow-up|6|||
131607842|NCT01385202|473857125|FG000|Overall Study|Not Eligible|11|||
131607843|NCT01385202|473857125|FG000|Overall Study|Withdrawn|1|||
131607844|NCT03681262|473857126|FG000|Overall Study|Continuing on study|3|||
131607845|NCT03681262|473857127|FG001|Overall Study|Continuing on study|3|||
131607846|NCT03681262|473857126|FG000|Overall Study|Lost to Follow-up|1|||
131607847|NCT03681262|473857127|FG001|Overall Study|Lost to Follow-up|0|||
131607848|NCT04102111|473857129|FG000|Overall Study|Withdrawal by Subject|2|||
131607849|NCT04102111|473857130|FG001|Overall Study|Withdrawal by Subject|3|||
131607850|NCT04102111|473857129|FG000|Overall Study|Adverse Event|1|||
131607851|NCT04102111|473857130|FG001|Overall Study|Adverse Event|1|||
131607852|NCT04102111|473857129|FG000|Overall Study|Study terminated by sponsor|1|||
131607853|NCT04102111|473857130|FG001|Overall Study|Study terminated by sponsor|3|||
131607854|NCT02782676|473857131|FG000|Overall Study|Lost to Follow-up|0|||
131607855|NCT02782676|473857132|FG001|Overall Study|Lost to Follow-up|1|||
131607856|NCT03334695|473857133|FG000|Overall Study|Lost to Follow-up|3|||
131607857|NCT03334695|473857134|FG001|Overall Study|Lost to Follow-up|3|||
131707891|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707892|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707893|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707894|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707895|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707896|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707897|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707898|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707899|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707900|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707901|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707902|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707903|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707904|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131707905|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
131793486|NCT02784106|474526719|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
131793487|NCT03222141|474526722|FG000|Overall Study|Death|15|||
131793488|NCT03222141|474526722|FG000|Overall Study|Lost to Follow-up|3|||
131793489|NCT01155583|474526728|FG000|Phase I|Screen failure - did not start treatment|0|||
131793490|NCT01155583|474526729|FG001|Phase I|Screen failure - did not start treatment|0|||
131793491|NCT01155583|474526730|FG002|Phase I|Screen failure - did not start treatment|0|||
131793492|NCT01155583|474526731|FG003|Phase I|Screen failure - did not start treatment|0|||
131793493|NCT01155583|474526732|FG004|Phase I|Screen failure - did not start treatment|1|||
131793494|NCT01155583|474526733|FG005|Phase I|Screen failure - did not start treatment|0|||
131793495|NCT01155583|474526734|FG006|Phase I|Screen failure - did not start treatment|0|||
131793496|NCT01155583|474526735|FG007|Phase I|Screen failure - did not start treatment|2|||
131793497|NCT01155583|474526736|FG008|Phase I|Screen failure - did not start treatment|0|||
131793498|NCT01155583|474526728|FG000|Phase I|Withdrawal by Subject|0|||
131793499|NCT01155583|474526729|FG001|Phase I|Withdrawal by Subject|0|||
131793500|NCT01155583|474526730|FG002|Phase I|Withdrawal by Subject|0|||
131793501|NCT01155583|474526731|FG003|Phase I|Withdrawal by Subject|0|||
131793502|NCT01155583|474526732|FG004|Phase I|Withdrawal by Subject|0|||
131793503|NCT01155583|474526733|FG005|Phase I|Withdrawal by Subject|0|||
131793504|NCT01155583|474526734|FG006|Phase I|Withdrawal by Subject|0|||
131793505|NCT01155583|474526735|FG007|Phase I|Withdrawal by Subject|1|||
131793506|NCT01155583|474526736|FG008|Phase I|Withdrawal by Subject|0|||
131793507|NCT00952484|474526737|FG000|Overall Study|Withdrawal by Subject|0|||
131793508|NCT00952484|474526738|FG001|Overall Study|Withdrawal by Subject|1|||
131793509|NCT00952484|474526739|FG002|Overall Study|Withdrawal by Subject|0|||
131793510|NCT00192296|474526744|FG000|Overall Study|Withdrawal by Subject|0|||
131793511|NCT00192296|474526745|FG001|Overall Study|Withdrawal by Subject|1|||
131793512|NCT00192296|474526746|FG002|Overall Study|Withdrawal by Subject|0|||
131793513|NCT00192296|474526747|FG003|Overall Study|Withdrawal by Subject|0|||
131793514|NCT03465891|474526748|FG000|Overall Study|Withdrawal by Subject|0|||
131793515|NCT03465891|474526749|FG001|Overall Study|Withdrawal by Subject|1|||
131793516|NCT03465891|474526748|FG000|Overall Study|Disease progression|1|||
131793517|NCT03465891|474526749|FG001|Overall Study|Disease progression|0|||
131793518|NCT01001169|474526750|FG000|Overall Study|Withdrawal by Subject|2|||
131793519|NCT01001169|474526751|FG001|Overall Study|Withdrawal by Subject|1|||
131793520|NCT02536378|474526756|FG000|Overall Study|Physician Decision|0|||
131793521|NCT02536378|474526757|FG001|Overall Study|Physician Decision|2|||
131793522|NCT02536378|474526756|FG000|Overall Study|Withdrawal by Subject|0|||
131793523|NCT02536378|474526757|FG001|Overall Study|Withdrawal by Subject|1|||
131793524|NCT02536378|474526756|FG000|Overall Study|Death|1|||
131793525|NCT02536378|474526757|FG001|Overall Study|Death|2|||
131793526|NCT02536378|474526756|FG000|Overall Study|Patient refused further follow up|6|||
131793527|NCT02536378|474526757|FG001|Overall Study|Patient refused further follow up|2|||
131793528|NCT00798889|474526758|FG000|Overall Study|Adverse Event|53|||
131793529|NCT00798889|474526758|FG000|Overall Study|Protocol Violation|2|||
131793530|NCT00798889|474526758|FG000|Overall Study|Withdrawal by Subject|31|||
131793531|NCT00798889|474526758|FG000|Overall Study|Lost to Follow-up|1|||
131441500|NCT02163538|473245266|FG000|Overall Study|Protocol Violation|1|||
131441501|NCT02163538|473245267|FG001|Overall Study|Protocol Violation|0|||
131607858|NCT03334695|473857133|FG000|Overall Study|Physician Decision|1|||
131607859|NCT03334695|473857134|FG001|Overall Study|Physician Decision|2|||
131607860|NCT03334695|473857133|FG000|Overall Study|Protocol Violation|0|||
131607861|NCT03334695|473857134|FG001|Overall Study|Protocol Violation|1|||
131607862|NCT02641730|473857135|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
131607863|NCT02641730|473857136|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131607864|NCT02641730|473857137|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131607865|NCT02641730|473857138|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
131607866|NCT02641730|473857139|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
131607867|NCT02641730|473857135|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131607868|NCT02641730|473857136|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
131607869|NCT02641730|473857137|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
131607870|NCT02641730|473857138|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
131607871|NCT02641730|473857139|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
131607872|NCT02641730|473857135|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
131607873|NCT02641730|473857136|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
131607874|NCT02641730|473857137|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
131607875|NCT02641730|473857138|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
131607876|NCT02641730|473857139|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
131607877|NCT02641730|473857135|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131607878|NCT02641730|473857136|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131607879|NCT02641730|473857137|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131607880|NCT02641730|473857138|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
131607881|NCT02641730|473857139|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
131607882|NCT02641730|473857135|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
131607883|NCT02641730|473857136|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
131607884|NCT02641730|473857137|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
131607885|NCT02641730|473857138|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
131607886|NCT02641730|473857139|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
131607887|NCT02641730|473857135|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
131607888|NCT02641730|473857136|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
131607889|NCT02641730|473857137|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
131607890|NCT02641730|473857138|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
131607891|NCT02641730|473857139|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
131607892|NCT02874742|473857140|FG000|Overall Study|Death|0|||
131607893|NCT02874742|473857141|FG001|Overall Study|Death|1|||
131607894|NCT02874742|473857142|FG002|Overall Study|Death|0|||
131607895|NCT02874742|473857140|FG000|Overall Study|Lost to Follow-up|5|||
131607896|NCT02874742|473857141|FG001|Overall Study|Lost to Follow-up|4|||
131607897|NCT02874742|473857142|FG002|Overall Study|Lost to Follow-up|1|||
131607898|NCT02874742|473857140|FG000|Overall Study|Withdrawal by Subject|17|||
131607899|NCT02874742|473857141|FG001|Overall Study|Withdrawal by Subject|8|||
131607900|NCT02874742|473857142|FG002|Overall Study|Withdrawal by Subject|0|||
131607901|NCT02874742|473857140|FG000|Overall Study|Other|4|||
131607902|NCT02874742|473857141|FG001|Overall Study|Other|1|||
131607903|NCT02874742|473857142|FG002|Overall Study|Other|0|||
131607904|NCT02874742|473857140|FG000|Overall Study|Progressive Disease|1|||
131607905|NCT02874742|473857141|FG001|Overall Study|Progressive Disease|0|||
131607906|NCT02874742|473857142|FG002|Overall Study|Progressive Disease|0|||
131607907|NCT02874742|473857140|FG000|Overall Study|Screen Failure|0|||
131607908|NCT02874742|473857141|FG001|Overall Study|Screen Failure|2|||
131607909|NCT02874742|473857142|FG002|Overall Study|Screen Failure|0|||
131607910|NCT02577354|473857145|FG000|Overall Study|Lack of Efficacy|4|||
131607911|NCT02577354|473857146|FG001|Overall Study|Lack of Efficacy|4|||
131607912|NCT02577354|473857145|FG000|Overall Study|Lost to Follow-up|3|||
131607913|NCT02577354|473857146|FG001|Overall Study|Lost to Follow-up|1|||
131607914|NCT02577354|473857145|FG000|Overall Study|Missed Visit|4|||
131607915|NCT02577354|473857146|FG001|Overall Study|Missed Visit|3|||
131607916|NCT02577354|473857145|FG000|Overall Study|Adverse Event|4|||
131607917|NCT02577354|473857146|FG001|Overall Study|Adverse Event|5|||
131607918|NCT04924400|473857147|FG000|Overall Study|Lost to Follow-up|3|||
131607919|NCT04924400|473857148|FG001|Overall Study|Lost to Follow-up|0|||
131899931|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899932|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899933|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131607920|NCT04424316|473857149|FG000|Overall Study|Adverse Event|0|||
131607921|NCT04424316|473857150|FG001|Overall Study|Adverse Event|1|||
131607922|NCT04424316|473857151|FG002|Overall Study|Adverse Event|0|||
131607923|NCT04424316|473857152|FG003|Overall Study|Adverse Event|0|||
131607924|NCT04424316|473857149|FG000|Overall Study|Death|1|||
131607925|NCT04424316|473857150|FG001|Overall Study|Death|0|||
131607926|NCT04424316|473857151|FG002|Overall Study|Death|8|||
131607927|NCT04424316|473857152|FG003|Overall Study|Death|14|||
131607928|NCT04424316|473857149|FG000|Overall Study|Lost to Follow-up|93|||
131607929|NCT04424316|473857150|FG001|Overall Study|Lost to Follow-up|88|||
131607930|NCT04424316|473857151|FG002|Overall Study|Lost to Follow-up|224|||
131607931|NCT04424316|473857152|FG003|Overall Study|Lost to Follow-up|211|||
131607932|NCT04424316|473857149|FG000|Overall Study|No longer met eligibility criteria|1|||
131607933|NCT04424316|473857150|FG001|Overall Study|No longer met eligibility criteria|0|||
131607934|NCT04424316|473857151|FG002|Overall Study|No longer met eligibility criteria|0|||
131607935|NCT04424316|473857152|FG003|Overall Study|No longer met eligibility criteria|0|||
131607936|NCT04424316|473857149|FG000|Overall Study|Other|15|||
131607937|NCT04424316|473857150|FG001|Overall Study|Other|11|||
131607938|NCT04424316|473857151|FG002|Overall Study|Other|34|||
131607939|NCT04424316|473857152|FG003|Overall Study|Other|45|||
131607940|NCT04424316|473857149|FG000|Overall Study|Physician Decision|1|||
131607941|NCT04424316|473857150|FG001|Overall Study|Physician Decision|0|||
131607942|NCT04424316|473857151|FG002|Overall Study|Physician Decision|1|||
131607943|NCT04424316|473857152|FG003|Overall Study|Physician Decision|1|||
131707906|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707907|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707908|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
131707909|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707910|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707911|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707912|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707913|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707914|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707915|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707916|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707917|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707918|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707919|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707920|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707921|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707922|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707923|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707924|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707925|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707926|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707927|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131707928|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707929|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707930|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
131707931|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707932|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707933|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707934|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707935|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707936|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707937|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707938|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707939|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707940|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707941|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707942|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707943|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707944|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707945|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707946|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707947|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707948|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707949|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707950|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131707951|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707952|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707953|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
131707954|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131607944|NCT04424316|473857149|FG000|Overall Study|Protocol Violation|0|||
131607945|NCT04424316|473857150|FG001|Overall Study|Protocol Violation|1|||
131607946|NCT04424316|473857151|FG002|Overall Study|Protocol Violation|0|||
131607947|NCT04424316|473857152|FG003|Overall Study|Protocol Violation|0|||
131607948|NCT04424316|473857149|FG000|Overall Study|Withdrawal by Subject|71|||
131607949|NCT04424316|473857150|FG001|Overall Study|Withdrawal by Subject|77|||
131607950|NCT04424316|473857151|FG002|Overall Study|Withdrawal by Subject|0|||
131607951|NCT04424316|473857152|FG003|Overall Study|Withdrawal by Subject|0|||
131607952|NCT04424316|473857149|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131607953|NCT04424316|473857150|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131607954|NCT04424316|473857151|FG002|Overall Study|Withdrawal by parent/guardian|74|||
131607955|NCT04424316|473857152|FG003|Overall Study|Withdrawal by parent/guardian|81|||
131607956|NCT04424316|473857149|FG000|Overall Study|Randomized but not vaccinated|13|||
131607957|NCT04424316|473857150|FG001|Overall Study|Randomized but not vaccinated|21|||
131607958|NCT04424316|473857151|FG002|Overall Study|Randomized but not vaccinated|0|||
131607959|NCT04424316|473857152|FG003|Overall Study|Randomized but not vaccinated|0|||
131607960|NCT04424316|473857149|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
131607961|NCT04424316|473857150|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
131607962|NCT04424316|473857151|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
131607963|NCT04424316|473857152|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
131607964|NCT05070741|473857153|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
131607965|NCT03582033|473857155|FG000|Part A|Other|0|||
131607966|NCT03582033|473857156|FG001|Part A|Other|0|||
131607967|NCT03582033|473857157|FG002|Part A|Other|0|||
131607968|NCT03582033|473857158|FG003|Part A|Other|0|||
131607969|NCT03582033|473857159|FG004|Part A|Other|2|||
131607970|NCT03582033|473857160|FG005|Part A|Other|0|||
131607971|NCT03582033|473857161|FG006|Part A|Other|0|||
131607972|NCT03582033|473857162|FG007|Part A|Other|0|||
131607973|NCT03582033|473857163|FG008|Part A|Other|0|||
131607974|NCT03582033|473857164|FG009|Part A|Other|0|||
131607975|NCT03582033|473857155|FG000|Part A|Death|1|||
131607976|NCT03582033|473857156|FG001|Part A|Death|1|||
131607977|NCT03582033|473857157|FG002|Part A|Death|2|||
131607978|NCT03582033|473857158|FG003|Part A|Death|4|||
131607979|NCT03582033|473857159|FG004|Part A|Death|11|||
131607980|NCT03582033|473857160|FG005|Part A|Death|0|||
131607981|NCT03582033|473857161|FG006|Part A|Death|0|||
131607982|NCT03582033|473857162|FG007|Part A|Death|0|||
131607983|NCT03582033|473857163|FG008|Part A|Death|0|||
131607984|NCT03582033|473857164|FG009|Part A|Death|0|||
131607985|NCT03582033|473857155|FG000|Part A|Lost to Follow-up|0|||
131607986|NCT03582033|473857156|FG001|Part A|Lost to Follow-up|0|||
131607987|NCT03582033|473857157|FG002|Part A|Lost to Follow-up|0|||
131607988|NCT03582033|473857158|FG003|Part A|Lost to Follow-up|0|||
131607989|NCT03582033|473857159|FG004|Part A|Lost to Follow-up|1|||
131607990|NCT03582033|473857160|FG005|Part A|Lost to Follow-up|0|||
131607991|NCT03582033|473857161|FG006|Part A|Lost to Follow-up|0|||
131607992|NCT03582033|473857162|FG007|Part A|Lost to Follow-up|0|||
131607993|NCT03582033|473857163|FG008|Part A|Lost to Follow-up|0|||
131607994|NCT03582033|473857164|FG009|Part A|Lost to Follow-up|0|||
131607995|NCT03582033|473857155|FG000|Part A|Study terminated by sponsor|0|||
131607996|NCT03582033|473857156|FG001|Part A|Study terminated by sponsor|0|||
131607997|NCT03582033|473857157|FG002|Part A|Study terminated by sponsor|0|||
131607998|NCT03582033|473857158|FG003|Part A|Study terminated by sponsor|2|||
131607999|NCT03582033|473857159|FG004|Part A|Study terminated by sponsor|1|||
131608000|NCT03582033|473857160|FG005|Part A|Study terminated by sponsor|0|||
131608001|NCT03582033|473857161|FG006|Part A|Study terminated by sponsor|0|||
131608002|NCT03582033|473857162|FG007|Part A|Study terminated by sponsor|0|||
131608003|NCT03582033|473857163|FG008|Part A|Study terminated by sponsor|0|||
131608004|NCT03582033|473857164|FG009|Part A|Study terminated by sponsor|0|||
131608005|NCT03582033|473857155|FG000|Part A|Withdrawal by Subject|1|||
131608006|NCT03582033|473857156|FG001|Part A|Withdrawal by Subject|1|||
131608007|NCT03582033|473857157|FG002|Part A|Withdrawal by Subject|0|||
131608008|NCT03582033|473857158|FG003|Part A|Withdrawal by Subject|1|||
131608009|NCT03582033|473857159|FG004|Part A|Withdrawal by Subject|7|||
131608010|NCT03582033|473857160|FG005|Part A|Withdrawal by Subject|0|||
131608011|NCT03582033|473857161|FG006|Part A|Withdrawal by Subject|0|||
131608012|NCT03582033|473857162|FG007|Part A|Withdrawal by Subject|0|||
131608013|NCT03582033|473857163|FG008|Part A|Withdrawal by Subject|0|||
131608014|NCT03582033|473857164|FG009|Part A|Withdrawal by Subject|0|||
131608015|NCT03582033|473857155|FG000|Part B|Death|0|||
131608016|NCT03582033|473857156|FG001|Part B|Death|0|||
131608017|NCT03582033|473857157|FG002|Part B|Death|0|||
131608018|NCT03582033|473857158|FG003|Part B|Death|0|||
131608019|NCT03582033|473857159|FG004|Part B|Death|0|||
131608020|NCT03582033|473857160|FG005|Part B|Death|2|||
131608021|NCT03582033|473857161|FG006|Part B|Death|0|||
131608022|NCT03582033|473857162|FG007|Part B|Death|0|||
131608023|NCT03582033|473857163|FG008|Part B|Death|0|||
131608024|NCT03582033|473857164|FG009|Part B|Death|0|||
131608025|NCT03582033|473857155|FG000|Part B|Study terminated by sponsor|0|||
131608026|NCT03582033|473857156|FG001|Part B|Study terminated by sponsor|0|||
131608027|NCT03582033|473857157|FG002|Part B|Study terminated by sponsor|0|||
131608028|NCT03582033|473857158|FG003|Part B|Study terminated by sponsor|0|||
131608029|NCT03582033|473857159|FG004|Part B|Study terminated by sponsor|0|||
131608030|NCT03582033|473857160|FG005|Part B|Study terminated by sponsor|12|||
131608031|NCT03582033|473857161|FG006|Part B|Study terminated by sponsor|0|||
131608032|NCT03582033|473857162|FG007|Part B|Study terminated by sponsor|0|||
131608033|NCT03582033|473857163|FG008|Part B|Study terminated by sponsor|0|||
131608034|NCT03582033|473857164|FG009|Part B|Study terminated by sponsor|0|||
131608035|NCT03582033|473857155|FG000|Part B|Withdrawal by Subject|0|||
131608036|NCT03582033|473857156|FG001|Part B|Withdrawal by Subject|0|||
131608037|NCT03582033|473857157|FG002|Part B|Withdrawal by Subject|0|||
131608038|NCT03582033|473857158|FG003|Part B|Withdrawal by Subject|0|||
131608039|NCT03582033|473857159|FG004|Part B|Withdrawal by Subject|0|||
131608040|NCT03582033|473857160|FG005|Part B|Withdrawal by Subject|6|||
131608041|NCT03582033|473857161|FG006|Part B|Withdrawal by Subject|0|||
131608042|NCT03582033|473857162|FG007|Part B|Withdrawal by Subject|0|||
131608043|NCT03582033|473857163|FG008|Part B|Withdrawal by Subject|0|||
131608044|NCT03582033|473857164|FG009|Part B|Withdrawal by Subject|0|||
131608045|NCT03582033|473857155|FG000|Part C|Other|0|||
131608046|NCT03582033|473857156|FG001|Part C|Other|0|||
131608047|NCT03582033|473857157|FG002|Part C|Other|0|||
131608048|NCT03582033|473857158|FG003|Part C|Other|0|||
131608049|NCT03582033|473857159|FG004|Part C|Other|0|||
131608050|NCT03582033|473857160|FG005|Part C|Other|0|||
131608051|NCT03582033|473857161|FG006|Part C|Other|2|||
131608052|NCT03582033|473857162|FG007|Part C|Other|0|||
131608053|NCT03582033|473857163|FG008|Part C|Other|0|||
131608054|NCT03582033|473857164|FG009|Part C|Other|0|||
131608055|NCT03582033|473857155|FG000|Part C|Death|0|||
131608056|NCT03582033|473857156|FG001|Part C|Death|0|||
131608057|NCT03582033|473857157|FG002|Part C|Death|0|||
131608058|NCT03582033|473857158|FG003|Part C|Death|0|||
131608059|NCT03582033|473857159|FG004|Part C|Death|0|||
131608060|NCT03582033|473857160|FG005|Part C|Death|0|||
131608061|NCT03582033|473857161|FG006|Part C|Death|6|||
131608062|NCT03582033|473857162|FG007|Part C|Death|1|||
131608063|NCT03582033|473857163|FG008|Part C|Death|2|||
131608064|NCT03582033|473857164|FG009|Part C|Death|0|||
131608065|NCT03582033|473857155|FG000|Part C|Study terminated by sponsor|0|||
131608066|NCT03582033|473857156|FG001|Part C|Study terminated by sponsor|0|||
131608067|NCT03582033|473857157|FG002|Part C|Study terminated by sponsor|0|||
131608068|NCT03582033|473857158|FG003|Part C|Study terminated by sponsor|0|||
131608069|NCT03582033|473857159|FG004|Part C|Study terminated by sponsor|0|||
131608070|NCT03582033|473857160|FG005|Part C|Study terminated by sponsor|0|||
131608071|NCT03582033|473857161|FG006|Part C|Study terminated by sponsor|3|||
131608072|NCT03582033|473857162|FG007|Part C|Study terminated by sponsor|3|||
131608073|NCT03582033|473857163|FG008|Part C|Study terminated by sponsor|2|||
131608074|NCT03582033|473857164|FG009|Part C|Study terminated by sponsor|0|||
131608075|NCT03582033|473857155|FG000|Part C|Withdrawal by Subject|0|||
131608076|NCT03582033|473857156|FG001|Part C|Withdrawal by Subject|0|||
131608077|NCT03582033|473857157|FG002|Part C|Withdrawal by Subject|0|||
131608078|NCT03582033|473857158|FG003|Part C|Withdrawal by Subject|0|||
131608079|NCT03582033|473857159|FG004|Part C|Withdrawal by Subject|0|||
131608080|NCT03582033|473857160|FG005|Part C|Withdrawal by Subject|0|||
131608081|NCT03582033|473857161|FG006|Part C|Withdrawal by Subject|1|||
131608082|NCT03582033|473857162|FG007|Part C|Withdrawal by Subject|2|||
131608083|NCT03582033|473857163|FG008|Part C|Withdrawal by Subject|1|||
131608084|NCT03582033|473857164|FG009|Part C|Withdrawal by Subject|0|||
131608085|NCT03582033|473857155|FG000|Part D|Death|0|||
131608086|NCT03582033|473857156|FG001|Part D|Death|0|||
131608087|NCT03582033|473857157|FG002|Part D|Death|0|||
131608088|NCT03582033|473857158|FG003|Part D|Death|0|||
131608089|NCT03582033|473857159|FG004|Part D|Death|0|||
131608090|NCT03582033|473857160|FG005|Part D|Death|0|||
131608091|NCT03582033|473857161|FG006|Part D|Death|0|||
131608092|NCT03582033|473857162|FG007|Part D|Death|0|||
131608093|NCT03582033|473857163|FG008|Part D|Death|0|||
131608094|NCT03582033|473857164|FG009|Part D|Death|1|||
131608095|NCT03582033|473857155|FG000|Part D|Study terminated by sponsor|0|||
131608096|NCT03582033|473857156|FG001|Part D|Study terminated by sponsor|0|||
131608097|NCT03582033|473857157|FG002|Part D|Study terminated by sponsor|0|||
131608098|NCT03582033|473857158|FG003|Part D|Study terminated by sponsor|0|||
131608099|NCT03582033|473857159|FG004|Part D|Study terminated by sponsor|0|||
131608100|NCT03582033|473857160|FG005|Part D|Study terminated by sponsor|0|||
131608101|NCT03582033|473857161|FG006|Part D|Study terminated by sponsor|0|||
131608102|NCT03582033|473857162|FG007|Part D|Study terminated by sponsor|0|||
131608103|NCT03582033|473857163|FG008|Part D|Study terminated by sponsor|0|||
131608104|NCT03582033|473857164|FG009|Part D|Study terminated by sponsor|4|||
131608105|NCT04631016|473857167|FG000|Overall Study|Adverse Event|3|||
131608106|NCT04631016|473857168|FG001|Overall Study|Adverse Event|0|||
131608107|NCT04631016|473857167|FG000|Overall Study|Withdrawal by Subject|5|||
131608108|NCT04631016|473857168|FG001|Overall Study|Withdrawal by Subject|4|||
131899934|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899935|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131608109|NCT04631016|473857167|FG000|Overall Study|Reason unspecified|1|||
131608110|NCT04631016|473857168|FG001|Overall Study|Reason unspecified|0|||
131608111|NCT04631016|473857167|FG000|Overall Study|Failure to meet randomization criteria|2|||
131608112|NCT04631016|473857168|FG001|Overall Study|Failure to meet randomization criteria|1|||
131608113|NCT04078152|473857171|FG000|Overall Study|Other|83|||
131608114|NCT04078152|473857172|FG001|Overall Study|Other|22|||
131608115|NCT04078152|473857173|FG002|Overall Study|Other|25|||
131608116|NCT04078152|473857171|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
131608117|NCT04078152|473857172|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
131608118|NCT04078152|473857173|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
131608119|NCT04078152|473857171|FG000|Overall Study|Withdrawal by Subject|5|||
131608120|NCT04078152|473857172|FG001|Overall Study|Withdrawal by Subject|0|||
131608121|NCT04078152|473857173|FG002|Overall Study|Withdrawal by Subject|1|||
131608122|NCT04078152|473857171|FG000|Overall Study|Death|10|||
131608123|NCT04078152|473857172|FG001|Overall Study|Death|2|||
131608124|NCT04078152|473857173|FG002|Overall Study|Death|12|||
131608125|NCT04078152|473857171|FG000|Overall Study|Adverse Event|1|||
131608126|NCT04078152|473857172|FG001|Overall Study|Adverse Event|0|||
131608127|NCT04078152|473857173|FG002|Overall Study|Adverse Event|0|||
131608128|NCT03735979|473857174|FG000|Overall Study|Lost to Follow-up|1|||
131608129|NCT03735979|473857175|FG001|Overall Study|Lost to Follow-up|12|||
131608130|NCT03735979|473857176|FG002|Overall Study|Lost to Follow-up|14|||
131608131|NCT03735979|473857174|FG000|Overall Study|Withdrawal by Subject|1|||
131608132|NCT03735979|473857175|FG001|Overall Study|Withdrawal by Subject|5|||
131608133|NCT03735979|473857176|FG002|Overall Study|Withdrawal by Subject|2|||
131608134|NCT03735979|473857174|FG000|Overall Study|Not due to the above reasons|1|||
131608135|NCT03735979|473857175|FG001|Overall Study|Not due to the above reasons|0|||
131608136|NCT03735979|473857176|FG002|Overall Study|Not due to the above reasons|0|||
131608137|NCT05112900|473857177|FG000|Overall Study|Withdrawal by Subject|960|||
131608138|NCT05112900|473857178|FG001|Overall Study|Withdrawal by Subject|921|||
131608139|NCT05112900|473857179|FG002|Overall Study|Withdrawal by Subject|968|||
131608140|NCT03505710|473858370|FG000|Overall Study|Progressive Disease|24|||
131608141|NCT03505710|473858371|FG001|Overall Study|Progressive Disease|17|||
131608142|NCT03505710|473858372|FG002|Overall Study|Progressive Disease|43|||
131608143|NCT03505710|473858370|FG000|Overall Study|Clinical Progression|6|||
131608144|NCT03505710|473858371|FG001|Overall Study|Clinical Progression|8|||
131608145|NCT03505710|473858372|FG002|Overall Study|Clinical Progression|3|||
131608146|NCT03505710|473858370|FG000|Overall Study|Adverse Event|12|||
131608147|NCT03505710|473858371|FG001|Overall Study|Adverse Event|6|||
131608148|NCT03505710|473858372|FG002|Overall Study|Adverse Event|28|||
131608149|NCT03505710|473858370|FG000|Overall Study|Withdrawal by Subject|1|||
131608150|NCT03505710|473858371|FG001|Overall Study|Withdrawal by Subject|3|||
131608151|NCT03505710|473858372|FG002|Overall Study|Withdrawal by Subject|7|||
131608152|NCT03505710|473858370|FG000|Overall Study|Physician Decision|1|||
131608153|NCT03505710|473858371|FG001|Overall Study|Physician Decision|1|||
131608154|NCT03505710|473858372|FG002|Overall Study|Physician Decision|2|||
131608155|NCT03505710|473858370|FG000|Overall Study|Death|4|||
131608156|NCT03505710|473858371|FG001|Overall Study|Death|5|||
131608157|NCT03505710|473858372|FG002|Overall Study|Death|6|||
131441502|NCT02163538|473245266|FG000|Overall Study|Physician Decision|0|||
131608158|NCT03505710|473858370|FG000|Overall Study|Other Reasons|1|||
131608159|NCT03505710|473858371|FG001|Overall Study|Other Reasons|1|||
131608160|NCT03505710|473858372|FG002|Overall Study|Other Reasons|1|||
131608161|NCT03505710|473858370|FG000|Overall Study|Study Terminated by Sponsor|0|||
131608162|NCT03505710|473858371|FG001|Overall Study|Study Terminated by Sponsor|0|||
131608163|NCT03505710|473858372|FG002|Overall Study|Study Terminated by Sponsor|1|||
131608164|NCT00942877|473858376|FG000|Overall Study|Refused further treatment|1|||
131608165|NCT00942877|473858377|FG001|Overall Study|Refused further treatment|1|||
131608166|NCT00942877|473858376|FG000|Overall Study|Patient was not treated|1|||
131899936|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899937|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131608167|NCT00942877|473858377|FG001|Overall Study|Patient was not treated|0|||
131608168|NCT00942877|473858376|FG000|Overall Study|Adverse Event|1|||
131608169|NCT00942877|473858377|FG001|Overall Study|Adverse Event|0|||
131608170|NCT00942877|473858376|FG000|Overall Study|Progressive disease|42|||
131608171|NCT00942877|473858377|FG001|Overall Study|Progressive disease|3|||
131608172|NCT02326974|473858380|FG000|Overall Study|Withdrawal by Subject|2|||
131608173|NCT02326974|473858380|FG000|Overall Study|failed heterogenity evaluation|5|||
131608174|NCT04173247|473858381|FG000|Overall Study|Withdrawal by Subject|0|||
131608175|NCT04173247|473858382|FG001|Overall Study|Withdrawal by Subject|2|||
131608176|NCT04173247|473858381|FG000|Overall Study|Death|1|||
131608177|NCT04173247|473858382|FG001|Overall Study|Death|0|||
131608178|NCT04173247|473858381|FG000|Overall Study|Physician Decision|1|||
131608179|NCT04173247|473858382|FG001|Overall Study|Physician Decision|0|||
131608180|NCT00412607|473858390|FG000|Overall Study|Withdrawal by Subject|9|||
131608181|NCT00412607|473858390|FG000|Overall Study|Lost to Follow-up|19|||
131608182|NCT00412607|473858390|FG000|Overall Study|Death|61|||
131608183|NCT00412607|473858390|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
131608184|NCT03812614|473858391|FG000|Intervention|Withdrawal by Subject|7|||
131608185|NCT03812614|473858392|FG001|Intervention|Withdrawal by Subject|2|||
131608186|NCT03812614|473858393|FG002|Intervention|Withdrawal by Subject|7|||
131608187|NCT03812614|473858394|FG003|Intervention|Withdrawal by Subject|2|||
131608188|NCT03812614|473858391|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
131608189|NCT03812614|473858392|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
131608190|NCT03812614|473858393|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
131608191|NCT03812614|473858394|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
131608192|NCT03812614|473858391|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
131608193|NCT03812614|473858392|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
131608194|NCT03812614|473858393|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
131608195|NCT03812614|473858394|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
131608196|NCT03812614|473858391|FG000|6-month Follow-up|Lost to Follow-up|0|||
131608197|NCT03812614|473858392|FG001|6-month Follow-up|Lost to Follow-up|0|||
131608198|NCT03812614|473858393|FG002|6-month Follow-up|Lost to Follow-up|12|||
131608199|NCT03812614|473858394|FG003|6-month Follow-up|Lost to Follow-up|8|||
131608200|NCT03812614|473858391|FG000|12-month Follow-up|Lost to Follow-up|18|||
131608201|NCT03812614|473858392|FG001|12-month Follow-up|Lost to Follow-up|17|||
131608202|NCT03812614|473858393|FG002|12-month Follow-up|Lost to Follow-up|5|||
131608203|NCT03812614|473858394|FG003|12-month Follow-up|Lost to Follow-up|2|||
131608204|NCT05205161|473858395|FG000|Overall Study|Study terminated by sponsor|3|||
131441503|NCT02163538|473245267|FG001|Overall Study|Physician Decision|1|||
131608205|NCT05205161|473858396|FG001|Overall Study|Study terminated by sponsor|3|||
131899938|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131899939|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131608206|NCT05205161|473858397|FG002|Overall Study|Study terminated by sponsor|1|||
131608207|NCT05652010|473858398|FG000|First Intervention|Withdrawal by Subject|0|||
131608208|NCT05652010|473858399|FG001|First Intervention|Withdrawal by Subject|1|||
131608209|NCT05652010|473858398|FG000|Second Intervention|Withdrawal by Subject|1|||
131608210|NCT05652010|473858399|FG001|Second Intervention|Withdrawal by Subject|0|||
131608211|NCT04163991|473858401|FG000|Overall Study|Adverse Event|0|||
131608212|NCT04163991|473858402|FG001|Overall Study|Adverse Event|0|||
131608213|NCT04163991|473858403|FG002|Overall Study|Adverse Event|0|||
131608214|NCT04163991|473858404|FG003|Overall Study|Adverse Event|1|||
131608215|NCT04163991|473858405|FG004|Overall Study|Adverse Event|0|||
131899940|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
131608216|NCT04163991|473858401|FG000|Overall Study|Death|0|||
131608217|NCT04163991|473858402|FG001|Overall Study|Death|0|||
131899941|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
131899942|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
131899943|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
131707955|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707956|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707957|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707958|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707959|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707960|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707961|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707962|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707963|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707964|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707965|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707966|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707967|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707968|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707969|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707970|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707971|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707972|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707973|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131707974|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707975|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707976|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707977|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
131707978|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707979|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707980|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707981|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131608218|NCT04163991|473858403|FG002|Overall Study|Death|1|||
131608219|NCT04163991|473858404|FG003|Overall Study|Death|0|||
131608220|NCT04163991|473858405|FG004|Overall Study|Death|0|||
131608221|NCT04163991|473858401|FG000|Overall Study|Lost to Follow-up|0|||
131608222|NCT04163991|473858402|FG001|Overall Study|Lost to Follow-up|1|||
131608223|NCT04163991|473858403|FG002|Overall Study|Lost to Follow-up|0|||
131608224|NCT04163991|473858404|FG003|Overall Study|Lost to Follow-up|0|||
131608225|NCT04163991|473858405|FG004|Overall Study|Lost to Follow-up|0|||
131608226|NCT04163991|473858401|FG000|Overall Study|Withdrawal by Subject|1|||
131608227|NCT04163991|473858402|FG001|Overall Study|Withdrawal by Subject|1|||
131608228|NCT04163991|473858403|FG002|Overall Study|Withdrawal by Subject|3|||
131608229|NCT04163991|473858404|FG003|Overall Study|Withdrawal by Subject|1|||
131608230|NCT04163991|473858405|FG004|Overall Study|Withdrawal by Subject|1|||
131899944|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
131899945|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
131608231|NCT04163991|473858401|FG000|Overall Study|Other, Not Specified|0|||
131608232|NCT04163991|473858402|FG001|Overall Study|Other, Not Specified|1|||
131608233|NCT04163991|473858403|FG002|Overall Study|Other, Not Specified|1|||
131608234|NCT04163991|473858404|FG003|Overall Study|Other, Not Specified|1|||
131608235|NCT04163991|473858405|FG004|Overall Study|Other, Not Specified|0|||
131608236|NCT03372057|473858406|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
131608237|NCT03372057|473858407|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
131707982|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707983|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707984|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707985|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707986|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707987|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707988|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707989|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707990|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707991|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707992|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707993|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707994|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707995|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707996|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131707997|NCT00896532|474211327|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131707998|NCT00896532|474211328|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
131707999|NCT00896532|474211329|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708000|NCT00896532|474211330|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
131708001|NCT00896532|474211331|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
131708002|NCT00896532|474211332|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708003|NCT00896532|474211333|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708004|NCT00896532|474211334|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708005|NCT00896532|474211335|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708006|NCT00896532|474211336|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708007|NCT00896532|474211337|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708008|NCT00896532|474211338|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708009|NCT00896532|474211339|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708010|NCT00896532|474211340|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708011|NCT00896532|474211341|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708012|NCT00896532|474211342|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708013|NCT00896532|474211343|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708014|NCT00896532|474211344|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708015|NCT00896532|474211345|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708016|NCT00896532|474211346|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708017|NCT00896532|474211347|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708018|NCT00896532|474211348|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708019|NCT00896532|474211349|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131708020|NCT00896532|474211327|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708021|NCT00896532|474211328|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708022|NCT00896532|474211329|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708023|NCT00896532|474211330|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708024|NCT00896532|474211331|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708025|NCT00896532|474211332|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708026|NCT00896532|474211333|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708027|NCT00896532|474211334|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708028|NCT00896532|474211335|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
131708029|NCT00896532|474211336|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708030|NCT00896532|474211337|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708031|NCT00896532|474211338|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708032|NCT00896532|474211339|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708033|NCT00896532|474211340|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708034|NCT00896532|474211341|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708035|NCT00896532|474211342|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708036|NCT00896532|474211343|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131608238|NCT03372057|473858408|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
131608239|NCT03372057|473858406|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
131608240|NCT03372057|473858407|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
131608241|NCT03372057|473858408|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
131899946|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
131899947|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
131899948|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
131899949|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
131899950|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
131608242|NCT03372057|473858406|FG000|Dose Optimization Phase|Death|16|||
131608243|NCT03372057|473858407|FG001|Dose Optimization Phase|Death|11|||
131608244|NCT03372057|473858408|FG002|Dose Optimization Phase|Death|0|||
131608245|NCT03372057|473858406|FG000|Expansion Phase|Withdrawal by Subject|0|||
131608246|NCT03372057|473858407|FG001|Expansion Phase|Withdrawal by Subject|0|||
131899951|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
131899952|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
131608247|NCT03372057|473858408|FG002|Expansion Phase|Withdrawal by Subject|4|||
131904617|NCT01930539|474937037|FG001|Overall Study|Withdrawal by Subject|2|||
131608248|NCT03372057|473858406|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
131608249|NCT03372057|473858407|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
131608250|NCT03372057|473858408|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
131608251|NCT03372057|473858406|FG000|Expansion Phase|Death|0|||
131608252|NCT03372057|473858407|FG001|Expansion Phase|Death|0|||
131608253|NCT03372057|473858408|FG002|Expansion Phase|Death|78|||
131608254|NCT03372057|473858406|FG000|Expansion Phase|Progressive Disease|0|||
131608255|NCT03372057|473858407|FG001|Expansion Phase|Progressive Disease|0|||
131608256|NCT03372057|473858408|FG002|Expansion Phase|Progressive Disease|1|||
131608257|NCT03372057|473858406|FG000|Expansion Phase|Adverse Event|0|||
131608258|NCT03372057|473858407|FG001|Expansion Phase|Adverse Event|0|||
131608259|NCT03372057|473858408|FG002|Expansion Phase|Adverse Event|1|||
131608260|NCT05953740|473858409|FG000|Period 1|Physician Decision|0|||
131608261|NCT05953740|473858410|FG001|Period 1|Physician Decision|1|||
131608262|NCT05953740|473858411|FG002|Period 1|Physician Decision|0|||
131608263|NCT05953740|473858412|FG003|Period 1|Physician Decision|0|||
131608264|NCT05953740|473858413|FG004|Period 1|Physician Decision|0|||
131608265|NCT05953740|473858414|FG005|Period 1|Physician Decision|0|||
131608266|NCT05953740|473858415|FG006|Period 1|Physician Decision|0|||
131708037|NCT00896532|474211344|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708038|NCT00896532|474211345|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708039|NCT00896532|474211346|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708040|NCT00896532|474211347|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708041|NCT00896532|474211348|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708042|NCT00896532|474211349|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131708043|NCT00896532|474211327|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708044|NCT00896532|474211328|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708045|NCT00896532|474211329|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708046|NCT00896532|474211330|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708047|NCT00896532|474211331|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708048|NCT00896532|474211332|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708049|NCT00896532|474211333|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708050|NCT00896532|474211334|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708051|NCT00896532|474211335|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708052|NCT00896532|474211336|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708053|NCT00896532|474211337|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708054|NCT00896532|474211338|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708055|NCT00896532|474211339|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
131708056|NCT00896532|474211340|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708057|NCT00896532|474211341|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708058|NCT00896532|474211342|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708059|NCT00896532|474211343|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708060|NCT00896532|474211344|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708061|NCT00896532|474211345|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708062|NCT00896532|474211346|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708063|NCT00896532|474211347|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708064|NCT00896532|474211348|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708065|NCT00896532|474211349|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131708066|NCT00896532|474211327|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708067|NCT00896532|474211328|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708068|NCT00896532|474211329|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708069|NCT00896532|474211330|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708070|NCT00896532|474211331|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708071|NCT00896532|474211332|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708072|NCT00896532|474211333|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708073|NCT00896532|474211334|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708074|NCT00896532|474211335|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708075|NCT00896532|474211336|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708076|NCT00896532|474211337|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
131708077|NCT00896532|474211338|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131608267|NCT05953740|473858416|FG007|Period 1|Physician Decision|0|||
131608268|NCT05953740|473858409|FG000|Period 2|Withdrawal by Subject|0|||
131608269|NCT05953740|473858410|FG001|Period 2|Withdrawal by Subject|1|||
131608270|NCT05953740|473858411|FG002|Period 2|Withdrawal by Subject|1|||
131608271|NCT05953740|473858412|FG003|Period 2|Withdrawal by Subject|0|||
131608272|NCT05953740|473858413|FG004|Period 2|Withdrawal by Subject|0|||
131608273|NCT05953740|473858414|FG005|Period 2|Withdrawal by Subject|0|||
131608274|NCT05953740|473858415|FG006|Period 2|Withdrawal by Subject|0|||
131608275|NCT05953740|473858416|FG007|Period 2|Withdrawal by Subject|0|||
131608276|NCT03248479|473858417|FG000|Overall Study|Death|12|||
131608277|NCT03248479|473858418|FG001|Overall Study|Death|44|||
131608278|NCT03248479|473858419|FG002|Overall Study|Death|1|||
131608279|NCT03248479|473858420|FG003|Overall Study|Death|72|||
131608280|NCT03248479|473858421|FG004|Overall Study|Death|17|||
131608281|NCT03248479|473858422|FG005|Overall Study|Death|6|||
131608282|NCT03248479|473858423|FG006|Overall Study|Death|1|||
131608283|NCT03248479|473858424|FG007|Overall Study|Death|14|||
131608284|NCT03248479|473858425|FG008|Overall Study|Death|3|||
131608285|NCT03248479|473858426|FG009|Overall Study|Death|7|||
131608286|NCT03248479|473858427|FG010|Overall Study|Death|3|||
131608287|NCT03248479|473858428|FG011|Overall Study|Death|1|||
131608288|NCT03248479|473858429|FG012|Overall Study|Death|1|||
131608289|NCT03248479|473858417|FG000|Overall Study|Study terminated by sponsor|12|||
131608290|NCT03248479|473858418|FG001|Overall Study|Study terminated by sponsor|15|||
131608291|NCT03248479|473858419|FG002|Overall Study|Study terminated by sponsor|0|||
131608292|NCT03248479|473858420|FG003|Overall Study|Study terminated by sponsor|5|||
131608293|NCT03248479|473858421|FG004|Overall Study|Study terminated by sponsor|0|||
131608294|NCT03248479|473858422|FG005|Overall Study|Study terminated by sponsor|0|||
131608295|NCT03248479|473858423|FG006|Overall Study|Study terminated by sponsor|0|||
131608296|NCT03248479|473858424|FG007|Overall Study|Study terminated by sponsor|1|||
131608297|NCT03248479|473858425|FG008|Overall Study|Study terminated by sponsor|1|||
131608298|NCT03248479|473858426|FG009|Overall Study|Study terminated by sponsor|0|||
131608299|NCT03248479|473858427|FG010|Overall Study|Study terminated by sponsor|5|||
131608300|NCT03248479|473858428|FG011|Overall Study|Study terminated by sponsor|4|||
131608301|NCT03248479|473858429|FG012|Overall Study|Study terminated by sponsor|0|||
131608302|NCT03248479|473858417|FG000|Overall Study|Consent withdrawn|6|||
131608303|NCT03248479|473858418|FG001|Overall Study|Consent withdrawn|3|||
131608304|NCT03248479|473858419|FG002|Overall Study|Consent withdrawn|0|||
131608305|NCT03248479|473858420|FG003|Overall Study|Consent withdrawn|9|||
131608306|NCT03248479|473858421|FG004|Overall Study|Consent withdrawn|1|||
131608307|NCT03248479|473858422|FG005|Overall Study|Consent withdrawn|0|||
131608308|NCT03248479|473858423|FG006|Overall Study|Consent withdrawn|0|||
131608309|NCT03248479|473858424|FG007|Overall Study|Consent withdrawn|1|||
131608310|NCT03248479|473858425|FG008|Overall Study|Consent withdrawn|0|||
131608311|NCT03248479|473858426|FG009|Overall Study|Consent withdrawn|3|||
131608312|NCT03248479|473858427|FG010|Overall Study|Consent withdrawn|1|||
131608313|NCT03248479|473858428|FG011|Overall Study|Consent withdrawn|0|||
131608314|NCT03248479|473858429|FG012|Overall Study|Consent withdrawn|1|||
131608315|NCT03248479|473858417|FG000|Overall Study|Lost to Follow-up|2|||
131608316|NCT03248479|473858418|FG001|Overall Study|Lost to Follow-up|1|||
131608317|NCT03248479|473858419|FG002|Overall Study|Lost to Follow-up|0|||
131608318|NCT03248479|473858420|FG003|Overall Study|Lost to Follow-up|0|||
131608319|NCT03248479|473858421|FG004|Overall Study|Lost to Follow-up|0|||
131608320|NCT03248479|473858422|FG005|Overall Study|Lost to Follow-up|0|||
131608321|NCT03248479|473858423|FG006|Overall Study|Lost to Follow-up|0|||
131608322|NCT03248479|473858424|FG007|Overall Study|Lost to Follow-up|0|||
131608323|NCT03248479|473858425|FG008|Overall Study|Lost to Follow-up|0|||
131608324|NCT03248479|473858426|FG009|Overall Study|Lost to Follow-up|0|||
131608325|NCT03248479|473858427|FG010|Overall Study|Lost to Follow-up|0|||
131608326|NCT03248479|473858428|FG011|Overall Study|Lost to Follow-up|0|||
131608327|NCT03248479|473858429|FG012|Overall Study|Lost to Follow-up|1|||
131608328|NCT03248479|473858417|FG000|Overall Study|Not reported|0|||
131608329|NCT03248479|473858418|FG001|Overall Study|Not reported|0|||
131608330|NCT03248479|473858419|FG002|Overall Study|Not reported|0|||
131608331|NCT03248479|473858420|FG003|Overall Study|Not reported|1|||
131608332|NCT03248479|473858421|FG004|Overall Study|Not reported|1|||
131608333|NCT03248479|473858422|FG005|Overall Study|Not reported|0|||
131608334|NCT03248479|473858423|FG006|Overall Study|Not reported|0|||
131608335|NCT03248479|473858424|FG007|Overall Study|Not reported|1|||
131608336|NCT03248479|473858425|FG008|Overall Study|Not reported|1|||
131608337|NCT03248479|473858426|FG009|Overall Study|Not reported|0|||
131608338|NCT03248479|473858427|FG010|Overall Study|Not reported|0|||
131608339|NCT03248479|473858428|FG011|Overall Study|Not reported|0|||
131608340|NCT03248479|473858429|FG012|Overall Study|Not reported|0|||
131608341|NCT03011034|473858430|FG000|Overall Study|Adverse Event|1|||
131608342|NCT03011034|473858431|FG001|Overall Study|Adverse Event|0|||
131608343|NCT05123027|473858439|FG000|Overall Study|Lost to Follow-up|17|||
131608344|NCT05123027|473858440|FG001|Overall Study|Lost to Follow-up|22|||
131708078|NCT00896532|474211339|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
131708079|NCT00896532|474211340|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131608345|NCT05123027|473858439|FG000|Overall Study|Incarceration|3|||
131608346|NCT05123027|473858440|FG001|Overall Study|Incarceration|4|||
131608347|NCT05123027|473858439|FG000|Overall Study|Death|2|||
131793532|NCT00798889|474526758|FG000|Overall Study|Lack of Efficacy|213|||
131608348|NCT05123027|473858440|FG001|Overall Study|Death|2|||
131608349|NCT05123027|473858439|FG000|Overall Study|Other|2|||
131608350|NCT05123027|473858440|FG001|Overall Study|Other|0|||
131608351|NCT00319111|473858441|FG000|Overall Study|Adverse Event|20|||
131608352|NCT00319111|473858441|FG000|Overall Study|Withdrawal of consent|11|||
131608353|NCT00319111|473858441|FG000|Overall Study|Death|9|||
131608354|NCT00319111|473858441|FG000|Overall Study|Lack of clinical improvement|4|||
131608355|NCT00319111|473858441|FG000|Overall Study|Administrative|2|||
131608356|NCT00319111|473858441|FG000|Overall Study|Treatment failure|1|||
131608357|NCT02624050|473858446|FG000|Overall Study|Physician Decision|4|||
131608358|NCT02624050|473858447|FG001|Overall Study|Physician Decision|0|||
131608359|NCT02624050|473858446|FG000|Overall Study|Protocol Violation|2|||
131608360|NCT02624050|473858447|FG001|Overall Study|Protocol Violation|0|||
131608361|NCT03904576|473858448|FG000|Washout Period|Protocol Violation|1|||
131608362|NCT03904576|473858449|FG001|Washout Period|Protocol Violation|1|||
131608363|NCT04743973|473858451|FG000|Overall Study|Withdrawal by Subject|5|||
131608364|NCT01475786|473858452|FG000|Overall Study|Adverse Event|0|||
131608365|NCT01475786|473858453|FG001|Overall Study|Adverse Event|1|||
131608366|NCT01475786|473858454|FG002|Overall Study|Adverse Event|0|||
131608367|NCT01475786|473858452|FG000|Overall Study|Lost to Follow-up|1|||
131608368|NCT01475786|473858453|FG001|Overall Study|Lost to Follow-up|2|||
131608369|NCT01475786|473858454|FG002|Overall Study|Lost to Follow-up|1|||
131608370|NCT01475786|473858452|FG000|Overall Study|Withdrawal by Subject|0|||
131608371|NCT01475786|473858453|FG001|Overall Study|Withdrawal by Subject|1|||
131608372|NCT01475786|473858454|FG002|Overall Study|Withdrawal by Subject|1|||
131608373|NCT01475786|473858452|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
131608374|NCT01475786|473858453|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
131608375|NCT01475786|473858454|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
131608376|NCT05654662|473858455|FG000|Overall Study|Withdrawal by Subject|1|||
131608377|NCT05654662|473858456|FG001|Overall Study|Withdrawal by Subject|0|||
131608378|NCT05654662|473858455|FG000|Overall Study|A death in the family|1|||
131608379|NCT05654662|473858456|FG001|Overall Study|A death in the family|0|||
131608380|NCT03165955|473858457|FG000|Treatment|Withdrawal by Subject|3|||
131608381|NCT03165955|473858457|FG000|Treatment|Death|1|||
131608382|NCT03165955|473858457|FG000|Treatment|Adverse Event|1|||
131608383|NCT03165955|473858457|FG000|Treatment|Progressive disease|3|||
131608384|NCT04499521|473858458|FG000|Overall Study|Disease Progression|1|||
131608385|NCT04499521|473858459|FG001|Overall Study|Disease Progression|0|||
131608386|NCT05525104|473858460|FG000|Overall Study|Failed caudal analgesia|1|||
131608387|NCT05525104|473858461|FG001|Overall Study|Failed caudal analgesia|3|||
131793533|NCT00798889|474526758|FG000|Overall Study|Decision of Sponsor|11|||
131793534|NCT00798889|474526758|FG000|Overall Study|Enrolled, Not treated|3|||
131793535|NCT00617461|474526759|FG000|First Treatment Intervention Period|Adverse Event|2|||
131793536|NCT00617461|474526760|FG001|First Treatment Intervention Period|Adverse Event|0|||
131793537|NCT00617461|474526759|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
131793538|NCT00617461|474526760|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
131608388|NCT05525104|473858460|FG000|Overall Study|Premedication needed|0|||
131608389|NCT05525104|473858461|FG001|Overall Study|Premedication needed|1|||
131608390|NCT05525104|473858460|FG000|Overall Study|Protocol Violation|10|||
131608391|NCT05525104|473858461|FG001|Overall Study|Protocol Violation|0|||
131608392|NCT05525104|473858460|FG000|Overall Study|Cancelled operation|1|||
131608393|NCT05525104|473858461|FG001|Overall Study|Cancelled operation|0|||
131608394|NCT04678856|473858462|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
131608395|NCT04678856|473858463|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
131608396|NCT04678856|473858462|FG000|Overall Study|Withdrawal by Subject|5|||
131899953|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
131899954|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
131899955|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
131899956|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
131899957|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
131899958|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
131899959|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
131899960|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
131899961|NCT03428100|474919383|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899962|NCT03428100|474919384|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899963|NCT03428100|474919385|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899964|NCT03428100|474919386|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899965|NCT03428100|474919387|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
131899966|NCT03428100|474919388|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899967|NCT03428100|474919389|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
131899968|NCT03428100|474919390|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
131899969|NCT03428100|474919391|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899970|NCT03428100|474919392|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
131899971|NCT03428100|474919393|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
131899972|NCT03428100|474919394|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
131899973|NCT03428100|474919395|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
131899974|NCT03428100|474919396|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
131899975|NCT03428100|474919397|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
131899976|NCT03428100|474919398|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899977|NCT03428100|474919399|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
131899978|NCT03428100|474919400|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
131899979|NCT03428100|474919401|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
131899980|NCT04556760|474919402|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
131899981|NCT04556760|474919403|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
131899982|NCT04556760|474919404|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
131899983|NCT04556760|474919405|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
131441504|NCT04011540|473245273|FG000|Overall Study|Lost to Follow-up|9|||
131441505|NCT04011540|473245274|FG001|Overall Study|Lost to Follow-up|6|||
131441506|NCT03019406|473245275|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
131441507|NCT03019406|473245276|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
131441508|NCT03019406|473245277|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
131441509|NCT03019406|473245278|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
131793539|NCT00617461|474526759|FG000|First Treatment Intervention Period|Protocol Violation|2|||
131793540|NCT00617461|474526760|FG001|First Treatment Intervention Period|Protocol Violation|1|||
131608397|NCT04678856|473858463|FG001|Overall Study|Withdrawal by Subject|1|||
131608398|NCT04427007|473859725|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
131608399|NCT04427007|473859726|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
131608400|NCT06262347|473859731|FG000|Overall Study|Lost to Follow-up|4|||
131608401|NCT06262347|473859732|FG001|Overall Study|Lost to Follow-up|3|||
131608402|NCT06262347|473859731|FG000|Overall Study|Withdrawal by Subject|0|||
131608403|NCT06262347|473859732|FG001|Overall Study|Withdrawal by Subject|1|||
131608404|NCT04389957|473859735|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
131608405|NCT04389957|473859736|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
131608406|NCT04389957|473859737|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
131608407|NCT04389957|473859738|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
131608408|NCT04389957|473859739|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
131608409|NCT05460871|473859743|FG000|Overall Study|Withdrawal by Subject|1|||
131608410|NCT05460871|473859744|FG001|Overall Study|Withdrawal by Subject|2|||
131608411|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
131608412|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
131608413|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
131608414|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
131608415|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
131608416|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
131608417|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
131608418|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
131608419|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
131608420|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
131608421|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
131608422|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
131608423|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
131608424|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
131608425|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
131608426|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
131608427|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
131608428|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
131608429|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
131608430|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
131608431|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
131608432|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
131793541|NCT00617461|474526759|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
131793542|NCT00617461|474526760|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
131793543|NCT00617461|474526759|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
131793544|NCT00617461|474526760|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
131793545|NCT00617461|474526759|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
131793546|NCT00617461|474526760|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
131793547|NCT00617461|474526759|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
131793548|NCT00617461|474526760|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
131793549|NCT00617461|474526759|FG000|Second Treatment Intervention Period|Adverse Event|0|||
131899984|NCT04556760|474919406|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
131441510|NCT02954536|473245281|FG000|Overall Study|Adverse Event|2|||
131441511|NCT02954536|473245281|FG000|Overall Study|Death|12|||
131441512|NCT01844765|473245285|FG000|Overall Study|Adverse Event|6|||
131441513|NCT01844765|473245286|FG001|Overall Study|Adverse Event|8|||
131441514|NCT01844765|473245285|FG000|Overall Study|Withdrawal by Subject|2|||
131608433|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
131608434|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
131608435|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
131608436|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
131608437|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
131608438|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
131441515|NCT01844765|473245286|FG001|Overall Study|Withdrawal by Subject|3|||
131441516|NCT01844765|473245285|FG000|Overall Study|Disease progression|1|||
131608439|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
131608440|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
131608441|NCT04614948|473859745|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
131441517|NCT01844765|473245286|FG001|Overall Study|Disease progression|0|||
131441518|NCT01844765|473245285|FG000|Overall Study|Administrative problems|3|||
131608442|NCT04614948|473859746|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
131608443|NCT04614948|473859747|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
131608444|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
131608445|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
131608446|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
131608447|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
131608448|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
131608449|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
131608450|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
131608451|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
131608452|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
131608453|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
131608454|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
131608455|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
131608456|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
131608457|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
131608458|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
131608459|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
131441519|NCT01844765|473245286|FG001|Overall Study|Administrative problems|4|||
131441520|NCT01844765|473245285|FG000|Overall Study|Protocol deviation|2|||
131441521|NCT01844765|473245286|FG001|Overall Study|Protocol deviation|0|||
131441522|NCT01844765|473245285|FG000|Overall Study|Untreated|1|||
131441523|NCT01844765|473245286|FG001|Overall Study|Untreated|0|||
131441524|NCT03221556|473245288|FG000|Allocation|post-randomization exclusion|0|||
131441525|NCT03221556|473245289|FG001|Allocation|post-randomization exclusion|1|||
131441526|NCT03221556|473245288|FG000|Follow-Up|Withdrawal by Subject|0|||
131441527|NCT03221556|473245289|FG001|Follow-Up|Withdrawal by Subject|1|||
131441528|NCT02234843|473245293|FG000|Overall Study|Death|1|||
131441529|NCT02234843|473245294|FG001|Overall Study|Death|0|||
131441530|NCT02234843|473245295|FG002|Overall Study|Death|0|||
131441531|NCT02234843|473245296|FG003|Overall Study|Death|0|||
131441532|NCT02234843|473245297|FG004|Overall Study|Death|0|||
131441533|NCT02234843|473245298|FG005|Overall Study|Death|0|||
131441534|NCT02234843|473245299|FG006|Overall Study|Death|0|||
131441535|NCT02234843|473245300|FG007|Overall Study|Death|0|||
131441536|NCT02234843|473245301|FG008|Overall Study|Death|0|||
131441537|NCT02234843|473245302|FG009|Overall Study|Death|0|||
131441538|NCT02234843|473245293|FG000|Overall Study|Protocol Violation|1|||
131441539|NCT02234843|473245294|FG001|Overall Study|Protocol Violation|0|||
131441540|NCT02234843|473245295|FG002|Overall Study|Protocol Violation|1|||
131441541|NCT02234843|473245296|FG003|Overall Study|Protocol Violation|0|||
131441542|NCT02234843|473245297|FG004|Overall Study|Protocol Violation|0|||
131441543|NCT02234843|473245298|FG005|Overall Study|Protocol Violation|0|||
131441544|NCT02234843|473245299|FG006|Overall Study|Protocol Violation|0|||
131441545|NCT02234843|473245300|FG007|Overall Study|Protocol Violation|0|||
131441546|NCT02234843|473245301|FG008|Overall Study|Protocol Violation|0|||
131441547|NCT02234843|473245302|FG009|Overall Study|Protocol Violation|0|||
131441548|NCT02234843|473245293|FG000|Overall Study|Efficacy outcome reached|2|||
131441549|NCT02234843|473245294|FG001|Overall Study|Efficacy outcome reached|0|||
131441550|NCT02234843|473245295|FG002|Overall Study|Efficacy outcome reached|0|||
131441551|NCT02234843|473245296|FG003|Overall Study|Efficacy outcome reached|0|||
131441552|NCT02234843|473245297|FG004|Overall Study|Efficacy outcome reached|0|||
131441553|NCT02234843|473245298|FG005|Overall Study|Efficacy outcome reached|2|||
131441554|NCT02234843|473245299|FG006|Overall Study|Efficacy outcome reached|0|||
131441555|NCT02234843|473245300|FG007|Overall Study|Efficacy outcome reached|0|||
131441556|NCT02234843|473245301|FG008|Overall Study|Efficacy outcome reached|0|||
131441557|NCT02234843|473245302|FG009|Overall Study|Efficacy outcome reached|0|||
131441558|NCT02234843|473245293|FG000|Overall Study|Patient convenience|2|||
131441559|NCT02234843|473245294|FG001|Overall Study|Patient convenience|0|||
131441560|NCT02234843|473245295|FG002|Overall Study|Patient convenience|0|||
131441561|NCT02234843|473245296|FG003|Overall Study|Patient convenience|0|||
131441562|NCT02234843|473245297|FG004|Overall Study|Patient convenience|0|||
131441563|NCT02234843|473245298|FG005|Overall Study|Patient convenience|1|||
131441564|NCT02234843|473245299|FG006|Overall Study|Patient convenience|0|||
131608460|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
131608461|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
131608462|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
131441565|NCT02234843|473245300|FG007|Overall Study|Patient convenience|0|||
131441566|NCT02234843|473245301|FG008|Overall Study|Patient convenience|0|||
131441567|NCT02234843|473245302|FG009|Overall Study|Patient convenience|0|||
131793550|NCT00617461|474526760|FG001|Second Treatment Intervention Period|Adverse Event|1|||
131793551|NCT00617461|474526759|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
131793552|NCT00617461|474526760|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
131793553|NCT00617461|474526759|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
131793554|NCT00617461|474526760|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
131793555|NCT00617461|474526759|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
131793556|NCT00617461|474526760|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
131793557|NCT00358826|474526761|FG000|Core Study|Adverse Event|1|||
131793558|NCT00358826|474526762|FG001|Core Study|Adverse Event|3|||
131793559|NCT00358826|474526763|FG002|Core Study|Adverse Event|1|||
131793560|NCT00358826|474526764|FG003|Core Study|Adverse Event|1|||
131793561|NCT00358826|474526765|FG004|Core Study|Adverse Event|0|||
131793562|NCT00358826|474526766|FG005|Core Study|Adverse Event|0|||
131793563|NCT00358826|474526767|FG006|Core Study|Adverse Event|0|||
131793564|NCT00358826|474526768|FG007|Core Study|Adverse Event|0|||
131793565|NCT00358826|474526761|FG000|Core Study|Withdrawal by Subject|2|||
131793566|NCT00358826|474526762|FG001|Core Study|Withdrawal by Subject|2|||
131793567|NCT00358826|474526763|FG002|Core Study|Withdrawal by Subject|0|||
131793568|NCT00358826|474526764|FG003|Core Study|Withdrawal by Subject|0|||
131608463|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
131608464|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
131608465|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
131608466|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
131608467|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
131608468|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
131608469|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
131608470|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
131608471|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
131608472|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
131608473|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
131608474|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
131608475|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
131608476|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
131608477|NCT04614948|473859745|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
131608478|NCT04614948|473859746|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
131608479|NCT04614948|473859747|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
131608480|NCT00964392|473859748|FG000|Overall Study|Withdrawal by Subject|4|||
131608481|NCT00964392|473859749|FG001|Overall Study|Withdrawal by Subject|6|||
131608482|NCT00964392|473859748|FG000|Overall Study|Lost to Follow-up|4|||
131608483|NCT00964392|473859749|FG001|Overall Study|Lost to Follow-up|10|||
131608484|NCT00964392|473859748|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
131608485|NCT00964392|473859749|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
131608486|NCT00964392|473859748|FG000|Overall Study|Not completed|44|||
131608487|NCT00964392|473859749|FG001|Overall Study|Not completed|168|||
131608488|NCT03498521|473859750|FG000|Overall Study|Death|191|||
131608489|NCT03498521|473859751|FG001|Overall Study|Death|64|||
131608490|NCT03498521|473859752|FG002|Overall Study|Death|72|||
131608491|NCT03498521|473859750|FG000|Overall Study|Exclusion criteria|1|||
131608492|NCT03498521|473859751|FG001|Overall Study|Exclusion criteria|0|||
131608493|NCT03498521|473859752|FG002|Overall Study|Exclusion criteria|0|||
131608494|NCT03498521|473859750|FG000|Overall Study|Lost to Follow-up|3|||
131608495|NCT03498521|473859751|FG001|Overall Study|Lost to Follow-up|3|||
131608496|NCT03498521|473859752|FG002|Overall Study|Lost to Follow-up|3|||
131608497|NCT03498521|473859750|FG000|Overall Study|No profile due to technical failure|1|||
131608498|NCT03498521|473859751|FG001|Overall Study|No profile due to technical failure|0|||
131608499|NCT03498521|473859752|FG002|Overall Study|No profile due to technical failure|0|||
131608500|NCT03498521|473859750|FG000|Overall Study|Physician Decision|0|||
131608501|NCT03498521|473859751|FG001|Overall Study|Physician Decision|1|||
131608502|NCT03498521|473859752|FG002|Overall Study|Physician Decision|0|||
131793569|NCT00358826|474526765|FG004|Core Study|Withdrawal by Subject|0|||
131608503|NCT03498521|473859750|FG000|Overall Study|Withdrawal by Subject|9|||
131793570|NCT00358826|474526766|FG005|Core Study|Withdrawal by Subject|0|||
131793571|NCT00358826|474526767|FG006|Core Study|Withdrawal by Subject|0|||
131608504|NCT03498521|473859751|FG001|Overall Study|Withdrawal by Subject|6|||
131608505|NCT03498521|473859752|FG002|Overall Study|Withdrawal by Subject|2|||
131608506|NCT03498521|473859750|FG000|Overall Study|Study ongoing|121|||
131793572|NCT00358826|474526768|FG007|Core Study|Withdrawal by Subject|0|||
131793573|NCT00358826|474526761|FG000|Core Study|Lost to Follow-up|0|||
131793574|NCT00358826|474526762|FG001|Core Study|Lost to Follow-up|0|||
131608507|NCT03498521|473859751|FG001|Overall Study|Study ongoing|36|||
131793575|NCT00358826|474526763|FG002|Core Study|Lost to Follow-up|0|||
131793576|NCT00358826|474526764|FG003|Core Study|Lost to Follow-up|1|||
131793577|NCT00358826|474526765|FG004|Core Study|Lost to Follow-up|0|||
131793578|NCT00358826|474526766|FG005|Core Study|Lost to Follow-up|0|||
131793579|NCT00358826|474526767|FG006|Core Study|Lost to Follow-up|0|||
131793580|NCT00358826|474526768|FG007|Core Study|Lost to Follow-up|0|||
131793581|NCT00358826|474526761|FG000|Core Study|Physician Decision|0|||
131793582|NCT00358826|474526762|FG001|Core Study|Physician Decision|0|||
131793583|NCT00358826|474526763|FG002|Core Study|Physician Decision|1|||
131793584|NCT00358826|474526764|FG003|Core Study|Physician Decision|0|||
131793585|NCT00358826|474526765|FG004|Core Study|Physician Decision|0|||
131793586|NCT00358826|474526766|FG005|Core Study|Physician Decision|0|||
131793587|NCT00358826|474526767|FG006|Core Study|Physician Decision|0|||
131793588|NCT00358826|474526768|FG007|Core Study|Physician Decision|0|||
131793589|NCT00358826|474526761|FG000|MDCT Substudy|Adverse Event|0|||
131793590|NCT00358826|474526762|FG001|MDCT Substudy|Adverse Event|0|||
131793591|NCT00358826|474526763|FG002|MDCT Substudy|Adverse Event|0|||
131793592|NCT00358826|474526764|FG003|MDCT Substudy|Adverse Event|0|||
131793593|NCT00358826|474526765|FG004|MDCT Substudy|Adverse Event|1|||
131793594|NCT00358826|474526766|FG005|MDCT Substudy|Adverse Event|0|||
131793595|NCT00358826|474526767|FG006|MDCT Substudy|Adverse Event|0|||
131793596|NCT00358826|474526768|FG007|MDCT Substudy|Adverse Event|0|||
131899985|NCT04556760|474919407|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
131899986|NCT04556760|474919402|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
131899987|NCT04556760|474919403|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
131899988|NCT04556760|474919404|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
131899989|NCT04556760|474919405|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
131899990|NCT04556760|474919406|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
131899991|NCT04556760|474919407|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
131899992|NCT02168491|474919409|FG000|Overall Study|Withdrawal by Subject|1|||
131793597|NCT00358826|474526761|FG000|MDCT Substudy|Lost to Follow-up|0|||
131793598|NCT00358826|474526762|FG001|MDCT Substudy|Lost to Follow-up|0|||
131793599|NCT00358826|474526763|FG002|MDCT Substudy|Lost to Follow-up|0|||
131793600|NCT00358826|474526764|FG003|MDCT Substudy|Lost to Follow-up|0|||
131793601|NCT00358826|474526765|FG004|MDCT Substudy|Lost to Follow-up|0|||
131793602|NCT00358826|474526766|FG005|MDCT Substudy|Lost to Follow-up|1|||
131793603|NCT00358826|474526767|FG006|MDCT Substudy|Lost to Follow-up|0|||
131793604|NCT00358826|474526768|FG007|MDCT Substudy|Lost to Follow-up|0|||
131793605|NCT00358826|474526761|FG000|MDCT Substudy|Withdrawal by Subject|0|||
131793606|NCT00358826|474526762|FG001|MDCT Substudy|Withdrawal by Subject|0|||
131793607|NCT00358826|474526763|FG002|MDCT Substudy|Withdrawal by Subject|0|||
131793608|NCT00358826|474526764|FG003|MDCT Substudy|Withdrawal by Subject|0|||
131793609|NCT00358826|474526765|FG004|MDCT Substudy|Withdrawal by Subject|0|||
131793610|NCT00358826|474526766|FG005|MDCT Substudy|Withdrawal by Subject|1|||
131793611|NCT00358826|474526767|FG006|MDCT Substudy|Withdrawal by Subject|0|||
131793612|NCT00358826|474526768|FG007|MDCT Substudy|Withdrawal by Subject|0|||
131793613|NCT00903383|474526772|FG000|Overall Study|Adverse Event|1|||
131793614|NCT00903383|474526773|FG001|Overall Study|Adverse Event|2|||
131793615|NCT00903383|474526774|FG002|Overall Study|Adverse Event|3|||
131793616|NCT00903383|474526775|FG003|Overall Study|Adverse Event|1|||
131793617|NCT00903383|474526772|FG000|Overall Study|Physician Decision|1|||
131793618|NCT00903383|474526773|FG001|Overall Study|Physician Decision|2|||
131608508|NCT03498521|473859752|FG002|Overall Study|Study ongoing|15|||
131608509|NCT04055012|473859753|FG000|Overall Study|Withdrawal by Subject|1|||
131608510|NCT04055012|473859754|FG001|Overall Study|Withdrawal by Subject|3|||
131793619|NCT00903383|474526774|FG002|Overall Study|Physician Decision|0|||
131608511|NCT04055012|473859755|FG002|Overall Study|Withdrawal by Subject|1|||
131608512|NCT04055012|473859756|FG003|Overall Study|Withdrawal by Subject|0|||
131608513|NCT04055012|473859753|FG000|Overall Study|Metformin Recall|1|||
131608514|NCT04055012|473859754|FG001|Overall Study|Metformin Recall|1|||
131608515|NCT04055012|473859755|FG002|Overall Study|Metformin Recall|1|||
131608516|NCT04055012|473859756|FG003|Overall Study|Metformin Recall|0|||
131608517|NCT05830799|473859762|FG000|Overall Study|Withdrawal by Subject|1|||
131608518|NCT03652272|473859763|FG000|3 Month|Withdrawal by Subject|1|||
131608519|NCT03652272|473859764|FG001|3 Month|Withdrawal by Subject|1|||
131608520|NCT03652272|473859763|FG000|3 Month|Lost to Follow-up|16|||
131608521|NCT03652272|473859764|FG001|3 Month|Lost to Follow-up|14|||
131608522|NCT04214834|473859767|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
131608523|NCT04214834|473859768|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
131608524|NCT03884101|473859771|FG000|Overall Study|Participant Ongoing in Study|202|||
131608525|NCT03884101|473859772|FG001|Overall Study|Participant Ongoing in Study|186|||
131608526|NCT03884101|473859771|FG000|Overall Study|Death|212|||
131608527|NCT03884101|473859772|FG001|Overall Study|Death|224|||
131608528|NCT03884101|473859771|FG000|Overall Study|Lost to Follow-up|0|||
131608529|NCT03884101|473859772|FG001|Overall Study|Lost to Follow-up|1|||
131608530|NCT03884101|473859771|FG000|Overall Study|Withdrawal by Subject|6|||
131608531|NCT03884101|473859772|FG001|Overall Study|Withdrawal by Subject|11|||
131608532|NCT03370913|473859773|FG000|Overall Study|Death|1|||
131793620|NCT00903383|474526775|FG003|Overall Study|Physician Decision|0|||
131793621|NCT00903383|474526772|FG000|Overall Study|Lost to Follow-up|0|||
131793622|NCT00903383|474526773|FG001|Overall Study|Lost to Follow-up|0|||
131793623|NCT00903383|474526774|FG002|Overall Study|Lost to Follow-up|0|||
131793624|NCT00903383|474526775|FG003|Overall Study|Lost to Follow-up|1|||
131793625|NCT00903383|474526772|FG000|Overall Study|Decision of Sponsor|1|||
131793626|NCT00903383|474526773|FG001|Overall Study|Decision of Sponsor|0|||
131793627|NCT00903383|474526774|FG002|Overall Study|Decision of Sponsor|0|||
131793628|NCT00903383|474526775|FG003|Overall Study|Decision of Sponsor|0|||
131793629|NCT00903383|474526772|FG000|Overall Study|Withdrawal by Subject|4|||
131793630|NCT00903383|474526773|FG001|Overall Study|Withdrawal by Subject|1|||
131793631|NCT00903383|474526774|FG002|Overall Study|Withdrawal by Subject|0|||
131793632|NCT00903383|474526775|FG003|Overall Study|Withdrawal by Subject|2|||
131793633|NCT00903383|474526772|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
131793634|NCT00903383|474526773|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
131793635|NCT00903383|474526774|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
131793636|NCT00903383|474526775|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
131793637|NCT00903383|474526772|FG000|Overall Study|Patient Decision|0|||
131793638|NCT00903383|474526773|FG001|Overall Study|Patient Decision|0|||
131793639|NCT00903383|474526774|FG002|Overall Study|Patient Decision|0|||
131793640|NCT00903383|474526775|FG003|Overall Study|Patient Decision|1|||
131793641|NCT01821625|474526778|FG000|Overall Study|Withdrawal by Subject|2|||
131793642|NCT01821625|474526778|FG000|Overall Study|Lack of Efficacy|2|||
131793643|NCT01821625|474526778|FG000|Overall Study|Adverse Event|1|||
131793644|NCT01821625|474526778|FG000|Overall Study|Medical contraindication|1|||
131793645|NCT00320593|474526781|FG000|Overall Study|Lost to Follow-up|3|||
131793646|NCT00320593|474526782|FG001|Overall Study|Lost to Follow-up|0|||
131793647|NCT00320593|474526781|FG000|Overall Study|Moved to another state|1|||
131793648|NCT00320593|474526782|FG001|Overall Study|Moved to another state|0|||
131793649|NCT00320593|474526781|FG000|Overall Study|Withdrawal by Subject|2|||
131793650|NCT00320593|474526782|FG001|Overall Study|Withdrawal by Subject|1|||
131793651|NCT00320593|474526781|FG000|Overall Study|Withdrawal by clinical center|1|||
131793652|NCT00320593|474526782|FG001|Overall Study|Withdrawal by clinical center|0|||
131793653|NCT00457665|474526785|FG000|12 Months|Drug allergy|1|||
131793654|NCT00457665|474526786|FG001|12 Months|Drug allergy|1|||
131793655|NCT00457665|474526785|FG000|12 Months|High HIV viral load|5|||
131793656|NCT00457665|474526786|FG001|12 Months|High HIV viral load|1|||
131793657|NCT00457665|474526785|FG000|12 Months|Lipodystrophy|2|||
131793658|NCT00457665|474526786|FG001|12 Months|Lipodystrophy|0|||
131793659|NCT00457665|474526785|FG000|12 Months|Withdrawal by Subject|0|||
131793660|NCT00457665|474526786|FG001|12 Months|Withdrawal by Subject|2|||
131793661|NCT00457665|474526785|FG000|12 Months|Abnormal Liver function tests|0|||
131793662|NCT00457665|474526786|FG001|12 Months|Abnormal Liver function tests|5|||
131793663|NCT00457665|474526785|FG000|24 Months|Withdrawal by Subject|3|||
131793664|NCT00457665|474526786|FG001|24 Months|Withdrawal by Subject|2|||
131793665|NCT00457665|474526785|FG000|24 Months|Lipodystrophy|1|||
131793666|NCT00457665|474526786|FG001|24 Months|Lipodystrophy|1|||
131793667|NCT00457665|474526785|FG000|24 Months|Abnormal liver function tests|1|||
131793668|NCT00457665|474526786|FG001|24 Months|Abnormal liver function tests|5|||
131793669|NCT00481247|474526789|FG000|Overall Study|Death|0|||
131793670|NCT00481247|474526790|FG001|Overall Study|Death|1|||
131608533|NCT03370913|473859773|FG000|Overall Study|Lost to Follow-up|1|||
131608534|NCT04633538|473859774|FG000|Overall Study|Death|1|||
131608535|NCT04633538|473859774|FG000|Overall Study|Lost to Follow-up|3|||
131608536|NCT04633538|473859774|FG000|Overall Study|Withdrawal by Subject|1|||
131608537|NCT02938520|473859777|FG000|Overall Study|On-going at the time of analysis|258|||
131608538|NCT02938520|473859778|FG001|Overall Study|On-going at the time of analysis|261|||
131608539|NCT02938520|473859777|FG000|Overall Study|Physician Decision|2|||
131608540|NCT02938520|473859778|FG001|Overall Study|Physician Decision|5|||
131608541|NCT02938520|473859777|FG000|Overall Study|Lost to Follow-up|2|||
131608542|NCT02938520|473859778|FG001|Overall Study|Lost to Follow-up|2|||
131608543|NCT02938520|473859777|FG000|Overall Study|Withdrawal by Subject|7|||
131608544|NCT02938520|473859778|FG001|Overall Study|Withdrawal by Subject|7|||
131793671|NCT00481247|474526789|FG000|Overall Study|Disease progression|18|||
131793672|NCT00481247|474526790|FG001|Overall Study|Disease progression|22|||
131793673|NCT00481247|474526789|FG000|Overall Study|Intolerance|42|||
131793674|NCT00481247|474526790|FG001|Overall Study|Intolerance|17|||
131793675|NCT00481247|474526789|FG000|Overall Study|Treatment failure|10|||
131793676|NCT00481247|474526790|FG001|Overall Study|Treatment failure|14|||
131793677|NCT00481247|474526789|FG000|Overall Study|AE unrelated to study drug|13|||
131793678|NCT00481247|474526790|FG001|Overall Study|AE unrelated to study drug|4|||
131793679|NCT00481247|474526789|FG000|Overall Study|Withdrawal by Subject|8|||
131793680|NCT00481247|474526790|FG001|Overall Study|Withdrawal by Subject|13|||
131793681|NCT00481247|474526789|FG000|Overall Study|Pregnancy|2|||
131793682|NCT00481247|474526790|FG001|Overall Study|Pregnancy|1|||
131793683|NCT00481247|474526789|FG000|Overall Study|Lost to Follow-up|1|||
131793684|NCT00481247|474526790|FG001|Overall Study|Lost to Follow-up|2|||
131793685|NCT00481247|474526789|FG000|Overall Study|Poor compliance/noncompliance|1|||
131608545|NCT02938520|473859777|FG000|Overall Study|Protocol Violation|0|||
131608546|NCT02938520|473859778|FG001|Overall Study|Protocol Violation|1|||
131608547|NCT02938520|473859777|FG000|Overall Study|Lack of Efficacy|5|||
131608548|NCT02938520|473859778|FG001|Overall Study|Lack of Efficacy|3|||
131608549|NCT02938520|473859777|FG000|Overall Study|Adverse Event|9|||
131608550|NCT02938520|473859778|FG001|Overall Study|Adverse Event|4|||
131608551|NCT05741294|473859782|FG000|Overall Study|Lost to Follow-up|3|||
131608552|NCT05741294|473859782|FG000|Overall Study|Protocol deviation|3|||
131608553|NCT05741294|473859782|FG000|Overall Study|Withdrawal by Subject|1|||
131608554|NCT05451693|473859783|FG000|Overall Study|Withdrawal by Subject|1|||
131608555|NCT05451693|473859784|FG001|Overall Study|Withdrawal by Subject|1|||
131608556|NCT04675034|473859785|FG000|Overall Study|Lost to Follow-up|1|||
131608557|NCT04675034|473859786|FG001|Overall Study|Lost to Follow-up|1|||
131608558|NCT04675034|473859787|FG002|Overall Study|Lost to Follow-up|0|||
131608559|NCT04675034|473859788|FG003|Overall Study|Lost to Follow-up|2|||
131608560|NCT04675034|473859789|FG004|Overall Study|Lost to Follow-up|0|||
131608561|NCT04675034|473859785|FG000|Overall Study|Protocol Violation|1|||
131608562|NCT04675034|473859786|FG001|Overall Study|Protocol Violation|0|||
131608563|NCT04675034|473859787|FG002|Overall Study|Protocol Violation|0|||
131608564|NCT04675034|473859788|FG003|Overall Study|Protocol Violation|1|||
131608565|NCT04675034|473859789|FG004|Overall Study|Protocol Violation|3|||
131608566|NCT04675034|473859785|FG000|Overall Study|Withdrawal by Subject|9|||
131608567|NCT04675034|473859786|FG001|Overall Study|Withdrawal by Subject|3|||
131608568|NCT04675034|473859787|FG002|Overall Study|Withdrawal by Subject|4|||
131608569|NCT04675034|473859788|FG003|Overall Study|Withdrawal by Subject|8|||
131608570|NCT04675034|473859789|FG004|Overall Study|Withdrawal by Subject|6|||
131608571|NCT03880955|473859792|FG000|Overall Study|Adverse Event|1|||
131608572|NCT03880955|473859792|FG000|Overall Study|Death|1|||
131608573|NCT03880955|473859792|FG000|Overall Study|Lost to Follow-up|12|||
131608574|NCT03880955|473859792|FG000|Overall Study|Withdrawal by Subject|4|||
131608575|NCT03880955|473859792|FG000|Overall Study|Missing- Study Site Closed|27|||
131608576|NCT04214418|473859795|FG000|Overall Study|Withdrawal by Subject|1|||
131608577|NCT04214418|473859796|FG001|Overall Study|Withdrawal by Subject|0|||
131608578|NCT04214418|473859797|FG002|Overall Study|Withdrawal by Subject|0|||
131608579|NCT04214418|473859798|FG003|Overall Study|Withdrawal by Subject|0|||
131608580|NCT04214418|473859799|FG004|Overall Study|Withdrawal by Subject|0|||
131608581|NCT04214418|473859800|FG005|Overall Study|Withdrawal by Subject|0|||
131608582|NCT04214418|473859795|FG000|Overall Study|Adverse Event|0|||
131608583|NCT04214418|473859796|FG001|Overall Study|Adverse Event|2|||
131608584|NCT04214418|473859797|FG002|Overall Study|Adverse Event|0|||
131608585|NCT04214418|473859798|FG003|Overall Study|Adverse Event|0|||
131608586|NCT04214418|473859799|FG004|Overall Study|Adverse Event|0|||
131608587|NCT04214418|473859800|FG005|Overall Study|Adverse Event|0|||
131608588|NCT04214418|473859795|FG000|Overall Study|Death|1|||
131608589|NCT04214418|473859796|FG001|Overall Study|Death|0|||
131608590|NCT04214418|473859797|FG002|Overall Study|Death|0|||
131608591|NCT04214418|473859798|FG003|Overall Study|Death|0|||
131608592|NCT04214418|473859799|FG004|Overall Study|Death|0|||
131608593|NCT04214418|473859800|FG005|Overall Study|Death|0|||
131608594|NCT05008055|473859804|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
131608595|NCT05008055|473859805|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
131608596|NCT05008055|473859806|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
131608597|NCT04635059|473859807|FG000|Overall Study|Study terminated early.|4|||
131608598|NCT04679389|473859811|FG000|Overall Study|Adverse Event|1|||
131608599|NCT04679389|473859812|FG001|Overall Study|Adverse Event|0|||
131608600|NCT04679389|473859811|FG000|Overall Study|Protocol Violation|2|||
131608601|NCT04679389|473859812|FG001|Overall Study|Protocol Violation|0|||
131608602|NCT04679389|473859811|FG000|Overall Study|Physician Decision|3|||
131608603|NCT04679389|473859812|FG001|Overall Study|Physician Decision|5|||
131608604|NCT04679389|473859811|FG000|Overall Study|Withdrawal by Subject|5|||
131608605|NCT04679389|473859812|FG001|Overall Study|Withdrawal by Subject|7|||
131608606|NCT01438853|473859813|FG000|Overall Study|Death|0|||
131608607|NCT01438853|473859814|FG001|Overall Study|Death|0|||
131608608|NCT01438853|473859815|FG002|Overall Study|Death|0|||
131608609|NCT01438853|473859816|FG003|Overall Study|Death|1|||
131608610|NCT01438853|473859813|FG000|Overall Study|Withdrawal by Subject|0|||
131608611|NCT01438853|473859814|FG001|Overall Study|Withdrawal by Subject|0|||
131608612|NCT01438853|473859815|FG002|Overall Study|Withdrawal by Subject|1|||
131608613|NCT01438853|473859816|FG003|Overall Study|Withdrawal by Subject|0|||
131608614|NCT03279978|473859817|FG000|Overall Study|Withdrawal by Subject|0|||
131608615|NCT03279978|473859818|FG001|Overall Study|Withdrawal by Subject|1|||
131608616|NCT03279978|473859819|FG002|Overall Study|Withdrawal by Subject|0|||
131608617|NCT03279978|473859820|FG003|Overall Study|Withdrawal by Subject|0|||
131608618|NCT03279978|473859821|FG004|Overall Study|Withdrawal by Subject|0|||
131608619|NCT03279978|473859822|FG005|Overall Study|Withdrawal by Subject|0|||
131608620|NCT03279978|473859823|FG006|Overall Study|Withdrawal by Subject|0|||
131608621|NCT03279978|473859824|FG007|Overall Study|Withdrawal by Subject|0|||
131608622|NCT03279978|473859825|FG008|Overall Study|Withdrawal by Subject|0|||
131608623|NCT03279978|473859826|FG009|Overall Study|Withdrawal by Subject|1|||
131608624|NCT03279978|473859817|FG000|Overall Study|Lost to Follow-up|1|||
131608625|NCT03279978|473859818|FG001|Overall Study|Lost to Follow-up|0|||
131608626|NCT03279978|473859819|FG002|Overall Study|Lost to Follow-up|1|||
131608627|NCT03279978|473859820|FG003|Overall Study|Lost to Follow-up|0|||
131608628|NCT03279978|473859821|FG004|Overall Study|Lost to Follow-up|0|||
131608629|NCT03279978|473859822|FG005|Overall Study|Lost to Follow-up|0|||
131608630|NCT03279978|473859823|FG006|Overall Study|Lost to Follow-up|0|||
131608631|NCT03279978|473859824|FG007|Overall Study|Lost to Follow-up|0|||
131608632|NCT03279978|473859825|FG008|Overall Study|Lost to Follow-up|0|||
131608633|NCT03279978|473859826|FG009|Overall Study|Lost to Follow-up|0|||
131608634|NCT03279978|473859817|FG000|Overall Study|Other than stated above|0|||
131608635|NCT03279978|473859818|FG001|Overall Study|Other than stated above|0|||
131608636|NCT03279978|473859819|FG002|Overall Study|Other than stated above|0|||
131608637|NCT03279978|473859820|FG003|Overall Study|Other than stated above|0|||
131608638|NCT03279978|473859821|FG004|Overall Study|Other than stated above|0|||
131608639|NCT03279978|473859822|FG005|Overall Study|Other than stated above|0|||
131608640|NCT03279978|473859823|FG006|Overall Study|Other than stated above|1|||
131608641|NCT03279978|473859824|FG007|Overall Study|Other than stated above|0|||
131608642|NCT03279978|473859825|FG008|Overall Study|Other than stated above|0|||
131608643|NCT03279978|473859826|FG009|Overall Study|Other than stated above|0|||
131608644|NCT04330040|473859827|FG000|Overall Study|Other: Adverse event|5|||
131608645|NCT04330040|473859828|FG001|Overall Study|Other: Adverse event|0|||
131608646|NCT04330040|473859829|FG002|Overall Study|Other: Adverse event|0|||
131608647|NCT04330040|473859827|FG000|Overall Study|Disease progression|38|||
131608648|NCT04330040|473859828|FG001|Overall Study|Disease progression|10|||
131608649|NCT04330040|473859829|FG002|Overall Study|Disease progression|0|||
131608650|NCT04330040|473859827|FG000|Overall Study|Physician Decision|5|||
131608651|NCT04330040|473859828|FG001|Overall Study|Physician Decision|3|||
131608652|NCT04330040|473859829|FG002|Overall Study|Physician Decision|0|||
131608653|NCT04330040|473859827|FG000|Overall Study|Lost to Follow-up|1|||
131608654|NCT04330040|473859828|FG001|Overall Study|Lost to Follow-up|1|||
131608655|NCT04330040|473859829|FG002|Overall Study|Lost to Follow-up|0|||
131608656|NCT04330040|473859827|FG000|Overall Study|Death|2|||
131608657|NCT04330040|473859828|FG001|Overall Study|Death|1|||
131608658|NCT04330040|473859829|FG002|Overall Study|Death|0|||
131608659|NCT04330040|473859827|FG000|Overall Study|Withdrawal by Subject|3|||
131899993|NCT03743025|474919410|FG000|Overall Study|Surgery was cancelled|2|||
131899994|NCT03743025|474919411|FG001|Overall Study|Surgery was cancelled|1|||
131899995|NCT02420119|474919412|FG000|Overall Study|insufficient laboratory data|5|||
131899996|NCT00991289|474919413|FG000|Overall Study|Adverse Event|1|||
131899997|NCT00991289|474919413|FG000|Overall Study|Physician Decision|2|||
131899998|NCT00991289|474919413|FG000|Overall Study|Withdrawal by Subject|3|||
131899999|NCT00991289|474919413|FG000|Overall Study|Lost to Follow-up|4|||
131900000|NCT00991289|474919413|FG000|Overall Study|Protocol Violation|2|||
131900001|NCT01051817|474919425|FG000|Overall Study|Adverse Event|0|||
131608660|NCT04330040|473859828|FG001|Overall Study|Withdrawal by Subject|3|||
131608661|NCT04330040|473859829|FG002|Overall Study|Withdrawal by Subject|0|||
131608662|NCT04330040|473859827|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
131608663|NCT04330040|473859828|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
131608664|NCT04330040|473859829|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
131608665|NCT04330040|473859827|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
131608666|NCT04330040|473859828|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
131608667|NCT04330040|473859829|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
131608668|NCT04330040|473859827|FG000|Overall Study|Other: Disease progression|1|||
131608669|NCT04330040|473859828|FG001|Overall Study|Other: Disease progression|0|||
131608670|NCT04330040|473859829|FG002|Overall Study|Other: Disease progression|0|||
131608671|NCT04330040|473859827|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
131608672|NCT04330040|473859828|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
131608673|NCT04330040|473859829|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
131900002|NCT01051817|474919426|FG001|Overall Study|Adverse Event|2|||
131900003|NCT01051817|474919425|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
131608674|NCT04330040|473859827|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
131608675|NCT04330040|473859828|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
131608676|NCT04330040|473859829|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
131608677|NCT04330040|473859827|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
131608678|NCT04330040|473859828|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
131608679|NCT04330040|473859829|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
131608680|NCT00626795|473859832|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
131608681|NCT00626795|473859833|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
131608682|NCT00626795|473859834|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
131608683|NCT00626795|473859832|FG000|Blinded Treatment|Lack of Efficacy|2|||
131608684|NCT00626795|473859833|FG001|Blinded Treatment|Lack of Efficacy|0|||
131608685|NCT00626795|473859834|FG002|Blinded Treatment|Lack of Efficacy|0|||
131608686|NCT00626795|473859832|FG000|Blinded Treatment|Unacceptable adverse event|0|||
131608687|NCT00626795|473859833|FG001|Blinded Treatment|Unacceptable adverse event|0|||
131608688|NCT00626795|473859834|FG002|Blinded Treatment|Unacceptable adverse event|1|||
131608689|NCT00626795|473859832|FG000|Blinded Treatment|Protocol Violation|0|||
131608690|NCT00626795|473859833|FG001|Blinded Treatment|Protocol Violation|1|||
131608691|NCT00626795|473859834|FG002|Blinded Treatment|Protocol Violation|1|||
131608692|NCT00626795|473859832|FG000|Blinded Treatment|Withdrawal by Subject|1|||
131608693|NCT00626795|473859833|FG001|Blinded Treatment|Withdrawal by Subject|1|||
131608694|NCT00626795|473859834|FG002|Blinded Treatment|Withdrawal by Subject|0|||
131608695|NCT00626795|473859832|FG000|Blinded Treatment|Other reasons|2|||
131608696|NCT00626795|473859833|FG001|Blinded Treatment|Other reasons|0|||
131608697|NCT00626795|473859834|FG002|Blinded Treatment|Other reasons|2|||
131608698|NCT00626795|473859832|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
131608699|NCT00626795|473859833|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
131608700|NCT00626795|473859834|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
131608701|NCT01756300|473859840|FG000|Overall Study|Death|1|||
131608702|NCT01756300|473859840|FG000|Overall Study|Withdrawal by Subject|1|||
131608703|NCT03990883|473859841|FG000|Blinded Treatment Phase|Adverse Event|1|||
131608704|NCT03990883|473859842|FG001|Blinded Treatment Phase|Adverse Event|1|||
131608705|NCT03990883|473859843|FG002|Blinded Treatment Phase|Adverse Event|0|||
131608706|NCT03990883|473859841|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
131608707|NCT03990883|473859842|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
131608708|NCT03990883|473859843|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
131608709|NCT03990883|473859841|FG000|Blinded Treatment Phase|Physician Decision|1|||
131608710|NCT03990883|473859842|FG001|Blinded Treatment Phase|Physician Decision|0|||
131608711|NCT03990883|473859843|FG002|Blinded Treatment Phase|Physician Decision|0|||
131608712|NCT03990883|473859841|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
131608713|NCT03990883|473859842|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
131608714|NCT03990883|473859843|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
131608715|NCT03990883|473859841|FG000|Blinded Treatment Phase|COVID-19|3|||
131608716|NCT03990883|473859842|FG001|Blinded Treatment Phase|COVID-19|2|||
131608717|NCT03990883|473859843|FG002|Blinded Treatment Phase|COVID-19|0|||
131608718|NCT03990883|473859841|FG000|Blinded Treatment Phase|Personal Reasons|6|||
131608719|NCT03990883|473859842|FG001|Blinded Treatment Phase|Personal Reasons|3|||
131608720|NCT03990883|473859843|FG002|Blinded Treatment Phase|Personal Reasons|0|||
131608721|NCT03990883|473859841|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
131608722|NCT03990883|473859842|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
131608723|NCT03990883|473859843|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
131608724|NCT03990883|473859841|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
131608725|NCT03990883|473859842|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
131608726|NCT03990883|473859843|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
131608727|NCT03990883|473859841|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
131608728|NCT03990883|473859842|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
131608729|NCT03990883|473859843|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
131608730|NCT02095691|473860589|FG000|Overall Study|Physician Decision|1|||
131608731|NCT00887198|473860590|FG000|Randomized Period|Ongoing|42|||
131608732|NCT00887198|473860591|FG001|Randomized Period|Ongoing|0|||
131608733|NCT00887198|473860592|FG002|Randomized Period|Ongoing|0|||
131608734|NCT00887198|473860590|FG000|Randomized Period|Adverse Event|50|||
131608735|NCT00887198|473860591|FG001|Randomized Period|Adverse Event|33|||
131608736|NCT00887198|473860592|FG002|Randomized Period|Adverse Event|0|||
131900004|NCT01051817|474919426|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
131608737|NCT00887198|473860590|FG000|Randomized Period|Lost to Follow-up|1|||
131608738|NCT00887198|473860591|FG001|Randomized Period|Lost to Follow-up|0|||
131900005|NCT01051817|474919425|FG000|Overall Study|Withdrawal by Subject|3|||
131900006|NCT01051817|474919426|FG001|Overall Study|Withdrawal by Subject|5|||
131900007|NCT01051817|474919425|FG000|Overall Study|Protocol Violation|0|||
131608739|NCT00887198|473860592|FG002|Randomized Period|Lost to Follow-up|0|||
131608740|NCT00887198|473860590|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
131608741|NCT00887198|473860591|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
131608742|NCT00887198|473860592|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
131608743|NCT00887198|473860590|FG000|Randomized Period|Withdrawal by Subject|41|||
131608744|NCT00887198|473860591|FG001|Randomized Period|Withdrawal by Subject|56|||
131608745|NCT00887198|473860592|FG002|Randomized Period|Withdrawal by Subject|0|||
131608746|NCT00887198|473860590|FG000|Randomized Period|Progressive disease|366|||
131608747|NCT00887198|473860591|FG001|Randomized Period|Progressive disease|370|||
131608748|NCT00887198|473860592|FG002|Randomized Period|Progressive disease|0|||
131608749|NCT00887198|473860590|FG000|Randomized Period|Other|42|||
131608750|NCT00887198|473860591|FG001|Randomized Period|Other|30|||
131608751|NCT00887198|473860592|FG002|Randomized Period|Other|0|||
131608752|NCT00887198|473860590|FG000|Randomized Period|Randomized, Not treated|4|||
131608753|NCT00887198|473860591|FG001|Randomized Period|Randomized, Not treated|2|||
131608754|NCT00887198|473860592|FG002|Randomized Period|Randomized, Not treated|0|||
131608755|NCT00887198|473860590|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
131608756|NCT00887198|473860591|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
131608757|NCT00887198|473860592|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
131608758|NCT00887198|473860590|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
131608759|NCT00887198|473860591|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
131608760|NCT00887198|473860592|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
131608761|NCT00887198|473860590|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
131608762|NCT00887198|473860591|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
131608763|NCT00887198|473860592|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
131608764|NCT00887198|473860590|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
131608765|NCT00887198|473860591|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
131608766|NCT00887198|473860592|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
131608767|NCT00887198|473860590|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
131608768|NCT00887198|473860591|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
131900008|NCT01051817|474919426|FG001|Overall Study|Protocol Violation|1|||
131608769|NCT00887198|473860592|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
131608770|NCT00887198|473860590|FG000|Cross Over (Placebo to AA)|Other|0|||
131608771|NCT00887198|473860591|FG001|Cross Over (Placebo to AA)|Other|0|||
131793686|NCT00481247|474526790|FG001|Overall Study|Poor compliance/noncompliance|7|||
131793687|NCT00481247|474526789|FG000|Overall Study|Administrative reason by sponsor|157|||
131793688|NCT00481247|474526790|FG001|Overall Study|Administrative reason by sponsor|162|||
131608772|NCT00887198|473860592|FG002|Cross Over (Placebo to AA)|Other|19|||
131608773|NCT05007080|473860593|FG000|Overall Study|Lost to Follow-up|0|||
131608774|NCT05007080|473860594|FG001|Overall Study|Lost to Follow-up|1|||
131608775|NCT05007080|473860595|FG002|Overall Study|Lost to Follow-up|0|||
131608776|NCT05007080|473860596|FG003|Overall Study|Lost to Follow-up|1|||
131608777|NCT05007080|473860597|FG004|Overall Study|Lost to Follow-up|1|||
131608778|NCT05007080|473860598|FG005|Overall Study|Lost to Follow-up|1|||
131608779|NCT05007080|473860593|FG000|Overall Study|Death|0|||
131608780|NCT05007080|473860594|FG001|Overall Study|Death|1|||
131608781|NCT05007080|473860595|FG002|Overall Study|Death|0|||
131608782|NCT05007080|473860596|FG003|Overall Study|Death|0|||
131608783|NCT05007080|473860597|FG004|Overall Study|Death|0|||
131608784|NCT05007080|473860598|FG005|Overall Study|Death|0|||
131608785|NCT05007080|473860593|FG000|Overall Study|Withdrawal by Subject|1|||
131608786|NCT05007080|473860594|FG001|Overall Study|Withdrawal by Subject|2|||
131608787|NCT05007080|473860595|FG002|Overall Study|Withdrawal by Subject|0|||
131608788|NCT05007080|473860596|FG003|Overall Study|Withdrawal by Subject|2|||
131608789|NCT05007080|473860597|FG004|Overall Study|Withdrawal by Subject|1|||
131608790|NCT05007080|473860598|FG005|Overall Study|Withdrawal by Subject|1|||
131793689|NCT00481247|474526789|FG000|Overall Study|Varied|6|||
131793690|NCT00481247|474526790|FG001|Overall Study|Varied|15|||
131793691|NCT00481247|474526789|FG000|Overall Study|Did not receive treatment|1|||
131793692|NCT00481247|474526790|FG001|Overall Study|Did not receive treatment|2|||
131793693|NCT01716754|474526791|FG000|Overall Study|Death|0|||
131793694|NCT01716754|474526792|FG001|Overall Study|Death|0|||
131793695|NCT01716754|474526793|FG002|Overall Study|Death|0|||
131793696|NCT01716754|474526794|FG003|Overall Study|Death|1|||
131793697|NCT01716754|474526791|FG000|Overall Study|Protocol deviation|0|||
131793698|NCT01716754|474526792|FG001|Overall Study|Protocol deviation|2|||
131793699|NCT01716754|474526793|FG002|Overall Study|Protocol deviation|7|||
131793700|NCT01716754|474526794|FG003|Overall Study|Protocol deviation|2|||
131793701|NCT01716754|474526791|FG000|Overall Study|Non-compliance with study treatment|0|||
131608791|NCT05007080|473860593|FG000|Overall Study|Other|1|||
131608792|NCT05007080|473860594|FG001|Overall Study|Other|0|||
131608793|NCT05007080|473860595|FG002|Overall Study|Other|1|||
131608794|NCT05007080|473860596|FG003|Overall Study|Other|1|||
131608795|NCT05007080|473860597|FG004|Overall Study|Other|0|||
131608796|NCT05007080|473860598|FG005|Overall Study|Other|2|||
131608797|NCT05007080|473860593|FG000|Overall Study|Randomized not vaccinated|0|||
131608798|NCT05007080|473860594|FG001|Overall Study|Randomized not vaccinated|0|||
131608799|NCT05007080|473860595|FG002|Overall Study|Randomized not vaccinated|0|||
131608800|NCT05007080|473860596|FG003|Overall Study|Randomized not vaccinated|0|||
131608801|NCT05007080|473860597|FG004|Overall Study|Randomized not vaccinated|0|||
131608802|NCT05007080|473860598|FG005|Overall Study|Randomized not vaccinated|1|||
131608803|NCT00319046|473860599|FG000|Overall Study|withdrawal of subject's consent|7|||
131608804|NCT00319046|473860599|FG000|Overall Study|administrative reason|1|||
131608805|NCT05147584|473860600|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
131608806|NCT04560179|473860610|FG000|Overall Study|Physician Decision|1|||
131608807|NCT04560179|473860611|FG001|Overall Study|Physician Decision|0|||
131608808|NCT04560179|473860612|FG002|Overall Study|Physician Decision|0|||
131608809|NCT04560179|473860613|FG003|Overall Study|Physician Decision|0|||
131608810|NCT04560179|473860614|FG004|Overall Study|Physician Decision|0|||
131608811|NCT04560179|473860610|FG000|Overall Study|Adverse Event|0|||
131608812|NCT04560179|473860611|FG001|Overall Study|Adverse Event|0|||
131608813|NCT04560179|473860612|FG002|Overall Study|Adverse Event|0|||
131608814|NCT04560179|473860613|FG003|Overall Study|Adverse Event|1|||
131793702|NCT01716754|474526792|FG001|Overall Study|Non-compliance with study treatment|0|||
131793703|NCT01716754|474526793|FG002|Overall Study|Non-compliance with study treatment|1|||
131793704|NCT01716754|474526794|FG003|Overall Study|Non-compliance with study treatment|0|||
131608815|NCT04560179|473860614|FG004|Overall Study|Adverse Event|0|||
131608816|NCT04369911|473860617|FG000|Overall Study|Lost to Follow-up|3|||
131608817|NCT04369911|473860618|FG001|Overall Study|Lost to Follow-up|3|||
131608818|NCT04369911|473860617|FG000|Overall Study|Withdrawal by Subject|1|||
131608819|NCT04369911|473860618|FG001|Overall Study|Withdrawal by Subject|2|||
131608820|NCT03547271|473860627|FG000|Overall Study|Adverse Event|1|||
131608821|NCT03547271|473860628|FG001|Overall Study|Adverse Event|1|||
131608822|NCT03547271|473860629|FG002|Overall Study|Adverse Event|0|||
131608823|NCT03547271|473860630|FG003|Overall Study|Adverse Event|0|||
131608824|NCT03547271|473860627|FG000|Overall Study|Protocol deviation|5|||
131608825|NCT03547271|473860628|FG001|Overall Study|Protocol deviation|7|||
131608826|NCT03547271|473860629|FG002|Overall Study|Protocol deviation|3|||
131793705|NCT01716754|474526791|FG000|Overall Study|Physician Decision|1|||
131793706|NCT01716754|474526792|FG001|Overall Study|Physician Decision|0|||
131793707|NCT01716754|474526793|FG002|Overall Study|Physician Decision|0|||
131793708|NCT01716754|474526794|FG003|Overall Study|Physician Decision|0|||
131608827|NCT03547271|473860630|FG003|Overall Study|Protocol deviation|0|||
131608828|NCT03547271|473860627|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
131608829|NCT03547271|473860628|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
131608830|NCT03547271|473860629|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
131608831|NCT03547271|473860630|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
131608832|NCT03547271|473860627|FG000|Overall Study|Lost to Follow-up|3|||
131608833|NCT03547271|473860628|FG001|Overall Study|Lost to Follow-up|3|||
131608834|NCT03547271|473860629|FG002|Overall Study|Lost to Follow-up|1|||
131608835|NCT03547271|473860630|FG003|Overall Study|Lost to Follow-up|0|||
131608836|NCT02919917|473860636|FG000|Overall Study|Withdrawal by Subject|4|||
131793709|NCT01716754|474526791|FG000|Overall Study|Lost to Follow-up|1|||
131793710|NCT01716754|474526792|FG001|Overall Study|Lost to Follow-up|0|||
131793711|NCT01716754|474526793|FG002|Overall Study|Lost to Follow-up|0|||
131793712|NCT01716754|474526794|FG003|Overall Study|Lost to Follow-up|1|||
131793713|NCT01716754|474526791|FG000|Overall Study|Adverse Event|4|||
131793714|NCT01716754|474526792|FG001|Overall Study|Adverse Event|2|||
131793715|NCT01716754|474526793|FG002|Overall Study|Adverse Event|2|||
131793716|NCT01716754|474526794|FG003|Overall Study|Adverse Event|1|||
131793717|NCT01716754|474526791|FG000|Overall Study|Withdrawal by Subject|5|||
131793718|NCT01716754|474526792|FG001|Overall Study|Withdrawal by Subject|0|||
131608837|NCT02919917|473860637|FG001|Overall Study|Withdrawal by Subject|8|||
131608838|NCT05215054|473860638|FG000|Overall Study|Lost to Follow-up|1|||
131608839|NCT05215054|473860639|FG001|Overall Study|Lost to Follow-up|1|||
131608840|NCT05215054|473860638|FG000|Overall Study|Protocol Violation|1|||
131608841|NCT05215054|473860639|FG001|Overall Study|Protocol Violation|1|||
131608842|NCT05215054|473860638|FG000|Overall Study|Withdrawal by Subject|4|||
131608843|NCT05215054|473860639|FG001|Overall Study|Withdrawal by Subject|4|||
131608844|NCT04159519|473860643|FG000|Overall Study|Adverse Event|1|||
131608845|NCT04159519|473860644|FG001|Overall Study|Adverse Event|1|||
131608846|NCT04159519|473860643|FG000|Overall Study|Lack of Efficacy|1|||
131608847|NCT04159519|473860644|FG001|Overall Study|Lack of Efficacy|0|||
131608848|NCT04159519|473860643|FG000|Overall Study|Discontinued from study|1|||
131608849|NCT04159519|473860644|FG001|Overall Study|Discontinued from study|0|||
131608850|NCT04159519|473860643|FG000|Overall Study|Protocol Violation|1|||
131608851|NCT04159519|473860644|FG001|Overall Study|Protocol Violation|1|||
131608852|NCT04159519|473860643|FG000|Overall Study|Withdrawal by Subject|4|||
131608853|NCT04159519|473860644|FG001|Overall Study|Withdrawal by Subject|4|||
131608854|NCT01651000|473860645|FG000|Overall Study|Adverse Event|2|||
131608855|NCT01651000|473860646|FG001|Overall Study|Adverse Event|8|||
131608856|NCT01651000|473860645|FG000|Overall Study|Lost to Follow-up|3|||
131608857|NCT01651000|473860646|FG001|Overall Study|Lost to Follow-up|2|||
131608858|NCT01651000|473860645|FG000|Overall Study|Protocol Violation|0|||
131608859|NCT01651000|473860646|FG001|Overall Study|Protocol Violation|3|||
131793719|NCT01716754|474526793|FG002|Overall Study|Withdrawal by Subject|4|||
131793720|NCT01716754|474526794|FG003|Overall Study|Withdrawal by Subject|3|||
131793721|NCT02535000|474526796|FG000|Overall Study|Cancellation of surgery.|1|||
131793722|NCT02535000|474526797|FG001|Overall Study|Cancellation of surgery.|2|||
131793723|NCT04317781|474526798|FG000|Overall Study|Adverse Event|1|||
131793724|NCT04317781|474526798|FG000|Overall Study|Disease relapse|1|||
131793725|NCT04317781|474526798|FG000|Overall Study|Withdrawal by Subject|1|||
131793726|NCT01620489|474526800|FG000|Overall Study|Adverse Event|17|||
131793727|NCT01620489|474526801|FG001|Overall Study|Adverse Event|4|||
131793728|NCT01620489|474526800|FG000|Overall Study|Protocol Violation|0|||
131793729|NCT01620489|474526801|FG001|Overall Study|Protocol Violation|3|||
131793730|NCT01620489|474526800|FG000|Overall Study|Withdrawal Criteria|17|||
131793731|NCT01620489|474526801|FG001|Overall Study|Withdrawal Criteria|25|||
131793732|NCT01620489|474526800|FG000|Overall Study|Unclassified|1|||
131793733|NCT01620489|474526801|FG001|Overall Study|Unclassified|2|||
131793734|NCT02649231|474526802|FG000|Overall Study|Adverse Event|0|||
131793735|NCT02649231|474526803|FG001|Overall Study|Adverse Event|0|||
131793736|NCT02649231|474526804|FG002|Overall Study|Adverse Event|0|||
131793737|NCT02649231|474526805|FG003|Overall Study|Adverse Event|1|||
131793738|NCT02649231|474526802|FG000|Overall Study|Lost to Follow-up|2|||
131793739|NCT02649231|474526803|FG001|Overall Study|Lost to Follow-up|1|||
131441568|NCT02234843|473245293|FG000|Overall Study|Withdrawal by Subject|5|||
131608860|NCT01651000|473860645|FG000|Overall Study|Withdrawal by Subject|2|||
131608861|NCT01651000|473860646|FG001|Overall Study|Withdrawal by Subject|10|||
131608862|NCT01651000|473860645|FG000|Overall Study|Subject noncompliance|0|||
131608863|NCT01651000|473860646|FG001|Overall Study|Subject noncompliance|3|||
131608864|NCT01651000|473860645|FG000|Overall Study|Lack of Efficacy|1|||
131608865|NCT01651000|473860646|FG001|Overall Study|Lack of Efficacy|1|||
131608866|NCT01651000|473860645|FG000|Overall Study|Physician Decision|1|||
131608867|NCT01651000|473860646|FG001|Overall Study|Physician Decision|0|||
131608868|NCT01651000|473860645|FG000|Overall Study|Administrative reason|1|||
131608869|NCT01651000|473860646|FG001|Overall Study|Administrative reason|0|||
131793740|NCT02649231|474526804|FG002|Overall Study|Lost to Follow-up|1|||
131793741|NCT02649231|474526805|FG003|Overall Study|Lost to Follow-up|0|||
131608870|NCT01651000|473860645|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
131608871|NCT01651000|473860646|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
131608872|NCT02765412|473860647|FG000|Overall Study|Death|482|||
131608873|NCT02765412|473860648|FG001|Overall Study|Death|855|||
131608874|NCT04633278|473861411|FG000|Overall Study|Adverse Event|1|||
131608875|NCT04633278|473861412|FG001|Overall Study|Adverse Event|0|||
131608876|NCT04633278|473861411|FG000|Overall Study|Withdrawal by Subject|1|||
131608877|NCT04633278|473861412|FG001|Overall Study|Withdrawal by Subject|0|||
131608878|NCT04633278|473861411|FG000|Overall Study|Death|11|||
131608879|NCT04633278|473861412|FG001|Overall Study|Death|7|||
131608880|NCT04633278|473861411|FG000|Overall Study|Sponsor Decision|3|||
131608881|NCT04633278|473861412|FG001|Overall Study|Sponsor Decision|0|||
131608882|NCT04633278|473861411|FG000|Overall Study|Not Listed|1|||
131608883|NCT04633278|473861412|FG001|Overall Study|Not Listed|0|||
131608884|NCT03636490|473861413|FG000|Overall Study|Dropped out or incomplete data|141|||
131608885|NCT02246127|473861414|FG000|First Course Treatment|Adverse Event|9|||
131608886|NCT02246127|473861415|FG001|First Course Treatment|Adverse Event|7|||
131608887|NCT02246127|473861414|FG000|First Course Treatment|Withdrawal by Subject|6|||
131608888|NCT02246127|473861415|FG001|First Course Treatment|Withdrawal by Subject|7|||
131608889|NCT02246127|473861414|FG000|First Course Treatment|Physician Decision|9|||
131608890|NCT02246127|473861415|FG001|First Course Treatment|Physician Decision|9|||
131608891|NCT02246127|473861414|FG000|First Course Treatment|Death|3|||
131608892|NCT02246127|473861415|FG001|First Course Treatment|Death|3|||
131608893|NCT02246127|473861414|FG000|First Course Treatment|Not reported reasons|6|||
131608894|NCT02246127|473861415|FG001|First Course Treatment|Not reported reasons|7|||
131608895|NCT02246127|473861414|FG000|First Course Treatment|Not treated|3|||
131608896|NCT02246127|473861415|FG001|First Course Treatment|Not treated|3|||
131608897|NCT06010836|473861433|FG000|Overall Study|Lost to Follow-up|2|||
131608898|NCT06010836|473861434|FG001|Overall Study|Lost to Follow-up|2|||
131608899|NCT06010836|473861433|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
131608900|NCT06010836|473861434|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
131608901|NCT06010836|473861433|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
131608902|NCT06010836|473861434|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
131608903|NCT06010836|473861433|FG000|Overall Study|Did not receive intervention discussion|0|||
131608904|NCT06010836|473861434|FG001|Overall Study|Did not receive intervention discussion|4|||
131608905|NCT04496752|473861435|FG000|Second Assessment|Lost to Follow-up|3|||
131608906|NCT04496752|473861436|FG001|Second Assessment|Lost to Follow-up|3|||
131608907|NCT04496752|473861435|FG000|Second Assessment|Adverse Event|2|||
131608908|NCT04496752|473861436|FG001|Second Assessment|Adverse Event|0|||
131608909|NCT04524689|473861439|FG000|Overall Study|Withdrawal by Subject|1|||
131608910|NCT04524689|473861440|FG001|Overall Study|Withdrawal by Subject|1|||
131608911|NCT04524689|473861441|FG002|Overall Study|Withdrawal by Subject|0|||
131608912|NCT04524689|473861442|FG003|Overall Study|Withdrawal by Subject|0|||
131608913|NCT04524689|473861443|FG004|Overall Study|Withdrawal by Subject|1|||
131608914|NCT04524689|473861444|FG005|Overall Study|Withdrawal by Subject|0|||
131608915|NCT04524689|473861439|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
131608916|NCT04524689|473861440|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
131608917|NCT04524689|473861441|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
131608918|NCT04524689|473861442|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
131608919|NCT04524689|473861443|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
131608920|NCT04524689|473861444|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
131608921|NCT04524689|473861439|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
131608922|NCT04524689|473861440|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
131608923|NCT04524689|473861441|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
131608924|NCT04524689|473861442|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
131608925|NCT04524689|473861443|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
131608926|NCT04524689|473861444|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
131608927|NCT04967599|473861445|FG000|Overall Study|Lost to Follow-up|35|||
131608928|NCT04967599|473861446|FG001|Overall Study|Lost to Follow-up|19|||
131608929|NCT04967599|473861447|FG002|Overall Study|Lost to Follow-up|23|||
131608930|NCT03662022|473861450|FG000|Year 1 2019|prevalent case|83|||
131608931|NCT03662022|473861451|FG001|Year 1 2019|prevalent case|116|||
131608932|NCT03662022|473861452|FG002|Year 1 2019|prevalent case|158|||
131608933|NCT03662022|473861453|FG003|Year 1 2019|prevalent case|99|||
131608934|NCT03662022|473861450|FG000|Year 2 2020|incident case|18|||
131608935|NCT03662022|473861451|FG001|Year 2 2020|incident case|18|||
131608936|NCT03662022|473861452|FG002|Year 2 2020|incident case|16|||
131608937|NCT03662022|473861453|FG003|Year 2 2020|incident case|26|||
131608938|NCT03662022|473861450|FG000|Year 2 2020|other case|18|||
131608939|NCT03662022|473861451|FG001|Year 2 2020|other case|16|||
131441569|NCT02234843|473245294|FG001|Overall Study|Withdrawal by Subject|1|||
131441570|NCT02234843|473245295|FG002|Overall Study|Withdrawal by Subject|1|||
131441571|NCT02234843|473245296|FG003|Overall Study|Withdrawal by Subject|0|||
131441572|NCT02234843|473245297|FG004|Overall Study|Withdrawal by Subject|0|||
131441573|NCT02234843|473245298|FG005|Overall Study|Withdrawal by Subject|7|||
131441574|NCT02234843|473245299|FG006|Overall Study|Withdrawal by Subject|0|||
131441575|NCT02234843|473245300|FG007|Overall Study|Withdrawal by Subject|0|||
131441576|NCT02234843|473245301|FG008|Overall Study|Withdrawal by Subject|0|||
131441577|NCT02234843|473245302|FG009|Overall Study|Withdrawal by Subject|0|||
131441578|NCT02234843|473245293|FG000|Overall Study|Recovery|1|||
131441579|NCT02234843|473245294|FG001|Overall Study|Recovery|0|||
131441580|NCT02234843|473245295|FG002|Overall Study|Recovery|0|||
131441581|NCT02234843|473245296|FG003|Overall Study|Recovery|0|||
131441582|NCT02234843|473245297|FG004|Overall Study|Recovery|0|||
131441583|NCT02234843|473245298|FG005|Overall Study|Recovery|0|||
131441584|NCT02234843|473245299|FG006|Overall Study|Recovery|0|||
131441585|NCT02234843|473245300|FG007|Overall Study|Recovery|0|||
131441586|NCT02234843|473245301|FG008|Overall Study|Recovery|0|||
131441587|NCT02234843|473245302|FG009|Overall Study|Recovery|0|||
131441588|NCT02234843|473245293|FG000|Overall Study|Other|0|||
131441589|NCT02234843|473245294|FG001|Overall Study|Other|2|||
131441590|NCT02234843|473245295|FG002|Overall Study|Other|0|||
131441591|NCT02234843|473245296|FG003|Overall Study|Other|1|||
131441592|NCT02234843|473245297|FG004|Overall Study|Other|0|||
131608940|NCT03662022|473861452|FG002|Year 2 2020|other case|16|||
131608941|NCT03662022|473861453|FG003|Year 2 2020|other case|24|||
131608942|NCT03662022|473861450|FG000|Year 2 2020|Lost to Follow-up|1633|||
131608943|NCT03662022|473861451|FG001|Year 2 2020|Lost to Follow-up|1183|||
131608944|NCT03662022|473861452|FG002|Year 2 2020|Lost to Follow-up|1381|||
131608945|NCT03662022|473861453|FG003|Year 2 2020|Lost to Follow-up|2858|||
131608946|NCT03662022|473861450|FG000|Year 3 2021|incident case|24|||
131608947|NCT03662022|473861451|FG001|Year 3 2021|incident case|27|||
131608948|NCT03662022|473861452|FG002|Year 3 2021|incident case|24|||
131441593|NCT02234843|473245298|FG005|Overall Study|Other|1|||
131441594|NCT02234843|473245299|FG006|Overall Study|Other|0|||
131441595|NCT02234843|473245300|FG007|Overall Study|Other|1|||
131608949|NCT03662022|473861453|FG003|Year 3 2021|incident case|11|||
131608950|NCT03662022|473861450|FG000|Year 3 2021|other case|4|||
131608951|NCT03662022|473861451|FG001|Year 3 2021|other case|15|||
131608952|NCT03662022|473861452|FG002|Year 3 2021|other case|10|||
131608953|NCT03662022|473861453|FG003|Year 3 2021|other case|14|||
131608954|NCT03662022|473861450|FG000|Year 3 2021|Lost to Follow-up|179|||
131608955|NCT03662022|473861451|FG001|Year 3 2021|Lost to Follow-up|244|||
131608956|NCT03662022|473861452|FG002|Year 3 2021|Lost to Follow-up|480|||
131608957|NCT03662022|473861453|FG003|Year 3 2021|Lost to Follow-up|477|||
131608958|NCT03662022|473861450|FG000|Year 4 2022|incident case|25|||
131608959|NCT03662022|473861451|FG001|Year 4 2022|incident case|41|||
131608960|NCT03662022|473861452|FG002|Year 4 2022|incident case|28|||
131608961|NCT03662022|473861453|FG003|Year 4 2022|incident case|7|||
131608962|NCT03662022|473861450|FG000|Year 4 2022|other case|8|||
131608963|NCT03662022|473861451|FG001|Year 4 2022|other case|19|||
131608964|NCT03662022|473861452|FG002|Year 4 2022|other case|13|||
131608965|NCT03662022|473861453|FG003|Year 4 2022|other case|7|||
131608966|NCT03662022|473861450|FG000|Year 4 2022|Lost to Follow-up|986|||
131608967|NCT03662022|473861451|FG001|Year 4 2022|Lost to Follow-up|1079|||
131608968|NCT03662022|473861452|FG002|Year 4 2022|Lost to Follow-up|1236|||
131608969|NCT03662022|473861453|FG003|Year 4 2022|Lost to Follow-up|1826|||
131608970|NCT04490109|473861464|FG000|Overall Study|Lost to Follow-up|3|||
131608971|NCT04490109|473861465|FG001|Overall Study|Lost to Follow-up|10|||
131608972|NCT04490109|473861466|FG002|Overall Study|Lost to Follow-up|4|||
131608973|NCT04490109|473861464|FG000|Overall Study|Withdrawal by Subject|8|||
131608974|NCT04490109|473861465|FG001|Overall Study|Withdrawal by Subject|6|||
131608975|NCT04490109|473861466|FG002|Overall Study|Withdrawal by Subject|9|||
131608976|NCT04490109|473861464|FG000|Overall Study|Physician Decision|0|||
131608977|NCT04490109|473861465|FG001|Overall Study|Physician Decision|2|||
131608978|NCT04490109|473861466|FG002|Overall Study|Physician Decision|3|||
131608979|NCT04490109|473861464|FG000|Overall Study|Adverse Event|2|||
131608980|NCT04490109|473861465|FG001|Overall Study|Adverse Event|1|||
131608981|NCT04490109|473861466|FG002|Overall Study|Adverse Event|0|||
131608982|NCT04490109|473861464|FG000|Overall Study|Significant Non-Compliance|2|||
131608983|NCT04490109|473861465|FG001|Overall Study|Significant Non-Compliance|4|||
131608984|NCT04490109|473861466|FG002|Overall Study|Significant Non-Compliance|4|||
131608985|NCT04490109|473861464|FG000|Overall Study|Significant Clinical Event|0|||
131608986|NCT04490109|473861465|FG001|Overall Study|Significant Clinical Event|1|||
131608987|NCT04490109|473861466|FG002|Overall Study|Significant Clinical Event|0|||
131608988|NCT04490109|473861464|FG000|Overall Study|Other Reason|4|||
131608989|NCT04490109|473861465|FG001|Overall Study|Other Reason|1|||
131608990|NCT04490109|473861466|FG002|Overall Study|Other Reason|1|||
131608991|NCT03817983|473861469|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
131608992|NCT03817983|473861470|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
131608993|NCT03817983|473861471|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
131608994|NCT03744676|473861472|FG000|Pre-Treatment Phase|Disease related complications|2|||
131608995|NCT03744676|473861472|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
131608996|NCT03744676|473861472|FG000|Pre-Treatment Phase|Death|7|||
131608997|NCT03744676|473861472|FG000|Pre-Treatment Phase|Other Reasons|7|||
131608998|NCT03744676|473861472|FG000|Treatment Phase|Participant withdrew consent|8|||
131608999|NCT03744676|473861472|FG000|Treatment Phase|Death|33|||
131609000|NCT03744676|473861472|FG000|Treatment Phase|other reasons|6|||
131609001|NCT05541484|473861485|FG000|Overall Study|Withdrawal by Subject|1|||
131609002|NCT05541484|473861486|FG001|Overall Study|Withdrawal by Subject|0|||
131609003|NCT03884439|473861492|FG000|Overall Study|No informed consent for publication of study results|38|||
131609004|NCT03884439|473861492|FG000|Overall Study|Contract violation/deficiency|7|||
131793742|NCT02649231|474526802|FG000|Overall Study|Withdrawal by Subject|0|||
131793743|NCT02649231|474526803|FG001|Overall Study|Withdrawal by Subject|1|||
131441596|NCT02234843|473245301|FG008|Overall Study|Other|0|||
131609005|NCT04780581|473861493|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
131609006|NCT04780581|473861494|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
131609007|NCT04780581|473861493|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
131609008|NCT04780581|473861494|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
131609009|NCT05267639|473862356|FG000|Overall Study|Withdrawal by Subject|1|||
131609010|NCT05267639|473862357|FG001|Overall Study|Withdrawal by Subject|0|||
131609011|NCT04244175|473862361|FG000|Overall Study|Adverse Event|3|||
131609012|NCT04244175|473862362|FG001|Overall Study|Adverse Event|2|||
131609013|NCT04244175|473862363|FG002|Overall Study|Adverse Event|5|||
131609014|NCT04244175|473862361|FG000|Overall Study|Lack of Efficacy|1|||
131609015|NCT04244175|473862362|FG001|Overall Study|Lack of Efficacy|0|||
131609016|NCT04244175|473862363|FG002|Overall Study|Lack of Efficacy|1|||
131609017|NCT04244175|473862361|FG000|Overall Study|Lost to Follow-up|1|||
131609018|NCT04244175|473862362|FG001|Overall Study|Lost to Follow-up|0|||
131609019|NCT04244175|473862363|FG002|Overall Study|Lost to Follow-up|0|||
131609020|NCT04244175|473862361|FG000|Overall Study|Non-compliance with study drug|1|||
131609021|NCT04244175|473862362|FG001|Overall Study|Non-compliance with study drug|0|||
131609022|NCT04244175|473862363|FG002|Overall Study|Non-compliance with study drug|1|||
131609023|NCT04244175|473862361|FG000|Overall Study|Protocol deviation|0|||
131609024|NCT04244175|473862362|FG001|Overall Study|Protocol deviation|1|||
131609025|NCT04244175|473862363|FG002|Overall Study|Protocol deviation|0|||
131609026|NCT04244175|473862361|FG000|Overall Study|Withdrawal by Subject|1|||
131609027|NCT04244175|473862362|FG001|Overall Study|Withdrawal by Subject|3|||
131609028|NCT04244175|473862363|FG002|Overall Study|Withdrawal by Subject|1|||
131609029|NCT04244175|473862361|FG000|Overall Study|Other, not specified|0|||
131609030|NCT04244175|473862362|FG001|Overall Study|Other, not specified|1|||
131609031|NCT04244175|473862363|FG002|Overall Study|Other, not specified|2|||
131609032|NCT04595331|473862364|FG000|Overall Study|Withdrawal by Subject|0|||
131609033|NCT04595331|473862365|FG001|Overall Study|Withdrawal by Subject|1|||
131609034|NCT04595331|473862364|FG000|Overall Study|Lost to Follow-up|0|||
131609035|NCT04595331|473862365|FG001|Overall Study|Lost to Follow-up|5|||
131609036|NCT04595331|473862364|FG000|Overall Study|Medical reason|0|||
131609037|NCT04595331|473862365|FG001|Overall Study|Medical reason|1|||
131609038|NCT03781089|473862366|FG000|Overall Study|Constipation|1|||
131609039|NCT03781089|473862367|FG001|Overall Study|Constipation|0|||
131609040|NCT03781089|473862366|FG000|Overall Study|Positive pregnancy test|0|||
131609041|NCT03781089|473862367|FG001|Overall Study|Positive pregnancy test|1|||
131609042|NCT03417284|473862368|FG000|Overall Study|Inadequate supply on study drug|1|||
131609043|NCT03417284|473862369|FG001|Overall Study|Inadequate supply on study drug|0|||
131609044|NCT03417284|473862370|FG002|Overall Study|Inadequate supply on study drug|0|||
131609045|NCT03417284|473862371|FG003|Overall Study|Inadequate supply on study drug|0|||
131609046|NCT03417284|473862368|FG000|Overall Study|Disease Progression|0|||
131609047|NCT03417284|473862369|FG001|Overall Study|Disease Progression|0|||
131609048|NCT03417284|473862370|FG002|Overall Study|Disease Progression|1|||
131609049|NCT03417284|473862371|FG003|Overall Study|Disease Progression|0|||
131609050|NCT05132400|473862372|FG000|Overall Study|Withdrawal by Subject|14|||
131609051|NCT05132400|473862373|FG001|Overall Study|Withdrawal by Subject|8|||
131793744|NCT02649231|474526804|FG002|Overall Study|Withdrawal by Subject|0|||
131793745|NCT02649231|474526805|FG003|Overall Study|Withdrawal by Subject|1|||
131441597|NCT02234843|473245302|FG009|Overall Study|Other|0|||
131609052|NCT05132400|473862372|FG000|Overall Study|Lost to Follow-up|132|||
131609053|NCT05132400|473862373|FG001|Overall Study|Lost to Follow-up|121|||
131609054|NCT05311176|473862374|FG000|Overall Study|Death|6|||
131609055|NCT05311176|473862374|FG000|Overall Study|Sponsor discontinued the study|1|||
131609056|NCT06655818|473862394|FG000|Overall Study|Withdrawal by Subject|1|||
131609057|NCT02163694|473862395|FG000|Overall Study|Adverse event- related to progression|4|||
131609058|NCT02163694|473862396|FG001|Overall Study|Adverse event- related to progression|10|||
131793746|NCT02649231|474526802|FG000|Overall Study|Protocol Violation|2|||
131793747|NCT02649231|474526803|FG001|Overall Study|Protocol Violation|1|||
131609059|NCT02163694|473862395|FG000|Overall Study|Adverse event- not related to progression|7|||
131793748|NCT02649231|474526804|FG002|Overall Study|Protocol Violation|1|||
131793749|NCT02649231|474526805|FG003|Overall Study|Protocol Violation|0|||
131793750|NCT02995837|474526814|FG000|Overall Study|Lost to Follow-up|9|||
131609060|NCT02163694|473862396|FG001|Overall Study|Adverse event- not related to progression|22|||
131609061|NCT02163694|473862395|FG000|Overall Study|Withdrew consent|13|||
131609062|NCT02163694|473862396|FG001|Overall Study|Withdrew consent|28|||
131609063|NCT02163694|473862395|FG000|Overall Study|Lost to Follow-up|2|||
131609064|NCT02163694|473862396|FG001|Overall Study|Lost to Follow-up|2|||
131609065|NCT02163694|473862395|FG000|Overall Study|Sponsor discontinued study|3|||
131609066|NCT02163694|473862396|FG001|Overall Study|Sponsor discontinued study|29|||
131609067|NCT02163694|473862395|FG000|Overall Study|Progressive disease per protocol|125|||
131609068|NCT02163694|473862396|FG001|Overall Study|Progressive disease per protocol|224|||
131609069|NCT02163694|473862395|FG000|Overall Study|Other, not specified|17|||
131609070|NCT02163694|473862396|FG001|Overall Study|Other, not specified|22|||
131609071|NCT02163694|473862395|FG000|Overall Study|Randomized but Not Treated|1|||
131609072|NCT02163694|473862396|FG001|Overall Study|Randomized but Not Treated|0|||
131609073|NCT02163694|473862395|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
131609074|NCT02163694|473862396|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
131609075|NCT05836012|473862409|FG000|Overall Study|Lost to Follow-up|1|||
131609076|NCT05836012|473862410|FG001|Overall Study|Lost to Follow-up|0|||
131609077|NCT05836012|473862409|FG000|Overall Study|Withdrawal by Subject|1|||
131609078|NCT05836012|473862410|FG001|Overall Study|Withdrawal by Subject|3|||
131609079|NCT05836012|473862409|FG000|Overall Study|Reason not included in pre-specified categories|2|||
131609080|NCT05836012|473862410|FG001|Overall Study|Reason not included in pre-specified categories|1|||
131609081|NCT02461134|473862413|FG000|Overall Study|Adverse Event|1|||
131609082|NCT04761198|473862414|FG000|Overall Study|Progressive Disease|1|||
131609083|NCT04761198|473862415|FG001|Overall Study|Progressive Disease|0|||
131609084|NCT04761198|473862416|FG002|Overall Study|Progressive Disease|0|||
131609085|NCT04761198|473862417|FG003|Overall Study|Progressive Disease|1|||
131609086|NCT04761198|473862418|FG004|Overall Study|Progressive Disease|4|||
131609087|NCT04761198|473862419|FG005|Overall Study|Progressive Disease|1|||
131609088|NCT04761198|473862420|FG006|Overall Study|Progressive Disease|2|||
131609089|NCT04761198|473862414|FG000|Overall Study|Protocol Violation|0|||
131609090|NCT04761198|473862415|FG001|Overall Study|Protocol Violation|0|||
131609091|NCT04761198|473862416|FG002|Overall Study|Protocol Violation|0|||
131609092|NCT04761198|473862417|FG003|Overall Study|Protocol Violation|0|||
131609093|NCT04761198|473862418|FG004|Overall Study|Protocol Violation|1|||
131609094|NCT04761198|473862419|FG005|Overall Study|Protocol Violation|0|||
131609095|NCT04761198|473862420|FG006|Overall Study|Protocol Violation|0|||
131609096|NCT04761198|473862414|FG000|Overall Study|Death|2|||
131609097|NCT04761198|473862415|FG001|Overall Study|Death|1|||
131609098|NCT04761198|473862416|FG002|Overall Study|Death|2|||
131609099|NCT04761198|473862417|FG003|Overall Study|Death|5|||
131609100|NCT04761198|473862418|FG004|Overall Study|Death|14|||
131609101|NCT04761198|473862419|FG005|Overall Study|Death|2|||
131793751|NCT02995837|474526815|FG001|Overall Study|Lost to Follow-up|8|||
131793752|NCT01859702|474526816|FG000|Overall Study|Protocol deviation|3|||
131793753|NCT01859702|474526816|FG000|Overall Study|Adverse Event|2|||
131793754|NCT01077713|474526821|FG000|Overall Study|Withdrawal by Subject|1|||
131793755|NCT01077713|474526822|FG001|Overall Study|Withdrawal by Subject|2|||
131793756|NCT01077713|474526821|FG000|Overall Study|Progressive Disease (PD)|0|||
131793757|NCT01077713|474526822|FG001|Overall Study|Progressive Disease (PD)|1|||
131793758|NCT01077713|474526821|FG000|Overall Study|Death|28|||
131793759|NCT01077713|474526822|FG001|Overall Study|Death|29|||
131793760|NCT01077713|474526821|FG000|Overall Study|Lost to Follow-up|1|||
131793761|NCT01077713|474526822|FG001|Overall Study|Lost to Follow-up|1|||
131793762|NCT01077713|474526821|FG000|Overall Study|Adverse Event|2|||
131793763|NCT01077713|474526822|FG001|Overall Study|Adverse Event|1|||
131793764|NCT01077713|474526821|FG000|Overall Study|Other|4|||
131793765|NCT01077713|474526822|FG001|Overall Study|Other|2|||
131441598|NCT02234843|473245293|FG000|Overall Study|Physician Decision|4|||
131441599|NCT02234843|473245294|FG001|Overall Study|Physician Decision|1|||
131441600|NCT02234843|473245295|FG002|Overall Study|Physician Decision|0|||
131609102|NCT04761198|473862420|FG006|Overall Study|Death|5|||
131609103|NCT04761198|473862414|FG000|Overall Study|Lost to Follow-up|0|||
131609104|NCT04761198|473862415|FG001|Overall Study|Lost to Follow-up|0|||
131609105|NCT04761198|473862416|FG002|Overall Study|Lost to Follow-up|0|||
131609106|NCT04761198|473862417|FG003|Overall Study|Lost to Follow-up|0|||
131609107|NCT04761198|473862418|FG004|Overall Study|Lost to Follow-up|1|||
131609108|NCT04761198|473862419|FG005|Overall Study|Lost to Follow-up|0|||
131609109|NCT04761198|473862420|FG006|Overall Study|Lost to Follow-up|0|||
131609110|NCT04761198|473862414|FG000|Overall Study|Withdrawal by Subject|2|||
131793766|NCT00289458|474526823|FG000|Overall Study|Death|1|||
131793767|NCT00289458|474526824|FG001|Overall Study|Death|0|||
131793768|NCT00289458|474526825|FG002|Overall Study|Death|0|||
131793769|NCT00289458|474526823|FG000|Overall Study|Physician Decision|3|||
131793770|NCT00289458|474526824|FG001|Overall Study|Physician Decision|4|||
131793771|NCT00289458|474526825|FG002|Overall Study|Physician Decision|2|||
131793772|NCT00289458|474526823|FG000|Overall Study|Withdrawal by Subject|2|||
131609111|NCT04761198|473862415|FG001|Overall Study|Withdrawal by Subject|0|||
131609112|NCT04761198|473862416|FG002|Overall Study|Withdrawal by Subject|1|||
131793773|NCT00289458|474526824|FG001|Overall Study|Withdrawal by Subject|2|||
131793774|NCT00289458|474526825|FG002|Overall Study|Withdrawal by Subject|4|||
131793775|NCT00874757|474526826|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
131793776|NCT02806232|474528667|FG000|Overall Study|Lost to Follow-up|1|||
131793777|NCT02806232|474528668|FG001|Overall Study|Lost to Follow-up|2|||
131793778|NCT02806232|474528669|FG002|Overall Study|Lost to Follow-up|1|||
131793779|NCT02806232|474528670|FG003|Overall Study|Lost to Follow-up|0|||
131793780|NCT02806232|474528671|FG004|Overall Study|Lost to Follow-up|0|||
131793781|NCT02806232|474528672|FG005|Overall Study|Lost to Follow-up|1|||
131793782|NCT02806232|474528673|FG006|Overall Study|Lost to Follow-up|0|||
131793783|NCT02806232|474528674|FG007|Overall Study|Lost to Follow-up|0|||
131793784|NCT02806232|474528675|FG008|Overall Study|Lost to Follow-up|0|||
131793785|NCT02806232|474528667|FG000|Overall Study|Withdrawal by Subject|0|||
131793786|NCT02806232|474528668|FG001|Overall Study|Withdrawal by Subject|2|||
131793787|NCT02806232|474528669|FG002|Overall Study|Withdrawal by Subject|0|||
131793788|NCT02806232|474528670|FG003|Overall Study|Withdrawal by Subject|0|||
131793789|NCT02806232|474528671|FG004|Overall Study|Withdrawal by Subject|2|||
131793790|NCT02806232|474528672|FG005|Overall Study|Withdrawal by Subject|1|||
131793791|NCT02806232|474528673|FG006|Overall Study|Withdrawal by Subject|0|||
131793792|NCT02806232|474528674|FG007|Overall Study|Withdrawal by Subject|0|||
131793793|NCT02806232|474528675|FG008|Overall Study|Withdrawal by Subject|0|||
131793794|NCT01621490|474528676|FG000|Overall Study|Subject no longer meets study criteria|0|||
131793795|NCT01621490|474528677|FG001|Overall Study|Subject no longer meets study criteria|0|||
131793796|NCT01621490|474528678|FG002|Overall Study|Subject no longer meets study criteria|0|||
131793797|NCT01621490|474528679|FG003|Overall Study|Subject no longer meets study criteria|0|||
131793798|NCT01621490|474528680|FG004|Overall Study|Subject no longer meets study criteria|1|||
131793799|NCT01621490|474528681|FG005|Overall Study|Subject no longer meets study criteria|0|||
131793800|NCT01621490|474528682|FG006|Overall Study|Subject no longer meets study criteria|0|||
131609113|NCT04761198|473862417|FG003|Overall Study|Withdrawal by Subject|0|||
131609114|NCT04761198|473862418|FG004|Overall Study|Withdrawal by Subject|2|||
131609115|NCT04761198|473862419|FG005|Overall Study|Withdrawal by Subject|0|||
131609116|NCT04761198|473862420|FG006|Overall Study|Withdrawal by Subject|1|||
131609117|NCT04761198|473862414|FG000|Overall Study|Study Terminated by Sponsor|6|||
131609118|NCT04761198|473862415|FG001|Overall Study|Study Terminated by Sponsor|0|||
131609119|NCT04761198|473862416|FG002|Overall Study|Study Terminated by Sponsor|5|||
131609120|NCT04761198|473862417|FG003|Overall Study|Study Terminated by Sponsor|3|||
131609121|NCT04761198|473862418|FG004|Overall Study|Study Terminated by Sponsor|10|||
131609122|NCT04761198|473862419|FG005|Overall Study|Study Terminated by Sponsor|1|||
131609123|NCT04761198|473862420|FG006|Overall Study|Study Terminated by Sponsor|2|||
131609124|NCT02994927|473862421|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131609125|NCT02994927|473862422|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131609126|NCT02994927|473862421|FG000|Overall Study|Did not meet eligibility criteria|0|||
131609127|NCT02994927|473862422|FG001|Overall Study|Did not meet eligibility criteria|1|||
131609128|NCT02994927|473862421|FG000|Overall Study|Physician Decision|4|||
131609129|NCT02994927|473862422|FG001|Overall Study|Physician Decision|3|||
131609130|NCT02994927|473862421|FG000|Overall Study|Death|4|||
131609131|NCT02994927|473862422|FG001|Overall Study|Death|2|||
131609132|NCT02994927|473862421|FG000|Overall Study|Adverse Event|2|||
131609133|NCT02994927|473862422|FG001|Overall Study|Adverse Event|1|||
131609134|NCT02994927|473862421|FG000|Overall Study|Withdrawal by Subject|3|||
131609135|NCT02994927|473862422|FG001|Overall Study|Withdrawal by Subject|6|||
131609136|NCT02994927|473862421|FG000|Overall Study|Lost to Follow-up|2|||
131609137|NCT02994927|473862422|FG001|Overall Study|Lost to Follow-up|1|||
131609138|NCT03533257|473862430|FG000|Overall Study|Adverse Event|4|||
131609139|NCT03533257|473862431|FG001|Overall Study|Adverse Event|2|||
131609140|NCT03533257|473862430|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
131609141|NCT03533257|473862431|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
131609142|NCT03493542|473862432|FG000|Base Study|Withdrawal by Subject|0|||
131609143|NCT03493542|473862433|FG001|Base Study|Withdrawal by Subject|4|||
131609144|NCT03493542|473862434|FG002|Base Study|Withdrawal by Subject|0|||
131609145|NCT03493542|473862432|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
131609146|NCT03493542|473862433|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
131609147|NCT03493542|473862434|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
131609148|NCT03493542|473862432|FG000|Extension Study|Withdrawal by Subject|0|||
131609149|NCT03493542|473862433|FG001|Extension Study|Withdrawal by Subject|0|||
131609150|NCT03493542|473862434|FG002|Extension Study|Withdrawal by Subject|25|||
131793801|NCT01621490|474528683|FG007|Overall Study|Subject no longer meets study criteria|0|||
131441601|NCT02234843|473245296|FG003|Overall Study|Physician Decision|1|||
131441602|NCT02234843|473245297|FG004|Overall Study|Physician Decision|0|||
131441603|NCT02234843|473245298|FG005|Overall Study|Physician Decision|0|||
131441604|NCT02234843|473245299|FG006|Overall Study|Physician Decision|0|||
131441605|NCT02234843|473245300|FG007|Overall Study|Physician Decision|1|||
131441606|NCT02234843|473245301|FG008|Overall Study|Physician Decision|0|||
131441607|NCT02234843|473245302|FG009|Overall Study|Physician Decision|0|||
131441608|NCT02234843|473245293|FG000|Overall Study|Adverse Event|5|||
131441609|NCT02234843|473245294|FG001|Overall Study|Adverse Event|1|||
131441610|NCT02234843|473245295|FG002|Overall Study|Adverse Event|1|||
131441611|NCT02234843|473245296|FG003|Overall Study|Adverse Event|3|||
131441612|NCT02234843|473245297|FG004|Overall Study|Adverse Event|2|||
131441613|NCT02234843|473245298|FG005|Overall Study|Adverse Event|1|||
131441614|NCT02234843|473245299|FG006|Overall Study|Adverse Event|0|||
131441615|NCT02234843|473245300|FG007|Overall Study|Adverse Event|0|||
131441616|NCT02234843|473245301|FG008|Overall Study|Adverse Event|1|||
131441617|NCT02234843|473245302|FG009|Overall Study|Adverse Event|0|||
131708080|NCT00896532|474211341|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131441618|NCT02234843|473245293|FG000|Overall Study|Non-compliance with study drug|1|||
131441619|NCT02234843|473245294|FG001|Overall Study|Non-compliance with study drug|0|||
131441620|NCT02234843|473245295|FG002|Overall Study|Non-compliance with study drug|0|||
131609151|NCT04093869|473862435|FG000|Overall Study|Death|0|||
131609152|NCT04093869|473862436|FG001|Overall Study|Death|1|||
131609153|NCT04093869|473862435|FG000|Overall Study|Withdrawal by Subject|1|||
131609154|NCT04093869|473862436|FG001|Overall Study|Withdrawal by Subject|0|||
131609155|NCT03250676|473862437|FG000|Overall Study|Adverse Event|0|||
131609156|NCT03250676|473862438|FG001|Overall Study|Adverse Event|0|||
131609157|NCT03250676|473862439|FG002|Overall Study|Adverse Event|0|||
131609158|NCT03250676|473862440|FG003|Overall Study|Adverse Event|1|||
131609159|NCT03250676|473862441|FG004|Overall Study|Adverse Event|2|||
131609160|NCT03250676|473862442|FG005|Overall Study|Adverse Event|9|||
131609161|NCT03250676|473862437|FG000|Overall Study|Withdrawal by Subject|1|||
131609162|NCT03250676|473862438|FG001|Overall Study|Withdrawal by Subject|0|||
131609163|NCT03250676|473862439|FG002|Overall Study|Withdrawal by Subject|0|||
131609164|NCT03250676|473862440|FG003|Overall Study|Withdrawal by Subject|1|||
131609165|NCT03250676|473862441|FG004|Overall Study|Withdrawal by Subject|1|||
131609166|NCT03250676|473862442|FG005|Overall Study|Withdrawal by Subject|2|||
131609167|NCT03250676|473862437|FG000|Overall Study|Physician Decision|0|||
131609168|NCT03250676|473862438|FG001|Overall Study|Physician Decision|0|||
131609169|NCT03250676|473862439|FG002|Overall Study|Physician Decision|0|||
131609170|NCT03250676|473862440|FG003|Overall Study|Physician Decision|2|||
131609171|NCT03250676|473862441|FG004|Overall Study|Physician Decision|0|||
131609172|NCT03250676|473862442|FG005|Overall Study|Physician Decision|3|||
131609173|NCT03250676|473862437|FG000|Overall Study|Withdrawal of consent|0|||
131609174|NCT03250676|473862438|FG001|Overall Study|Withdrawal of consent|0|||
131609175|NCT03250676|473862439|FG002|Overall Study|Withdrawal of consent|2|||
131609176|NCT03250676|473862440|FG003|Overall Study|Withdrawal of consent|0|||
131609177|NCT03250676|473862441|FG004|Overall Study|Withdrawal of consent|0|||
131609178|NCT03250676|473862442|FG005|Overall Study|Withdrawal of consent|2|||
131609179|NCT03250676|473862437|FG000|Overall Study|Other|1|||
131609180|NCT03250676|473862438|FG001|Overall Study|Other|0|||
131609181|NCT03250676|473862439|FG002|Overall Study|Other|0|||
131609182|NCT03250676|473862440|FG003|Overall Study|Other|0|||
131609183|NCT03250676|473862441|FG004|Overall Study|Other|0|||
131609184|NCT03250676|473862442|FG005|Overall Study|Other|0|||
131609185|NCT03250676|473862437|FG000|Overall Study|Disease progression|4|||
131609186|NCT03250676|473862438|FG001|Overall Study|Disease progression|12|||
131609187|NCT03250676|473862439|FG002|Overall Study|Disease progression|9|||
131609188|NCT03250676|473862440|FG003|Overall Study|Disease progression|7|||
131609189|NCT03250676|473862441|FG004|Overall Study|Disease progression|4|||
131708081|NCT00896532|474211342|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708082|NCT00896532|474211343|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708083|NCT00896532|474211344|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708084|NCT00896532|474211345|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708085|NCT00896532|474211346|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708086|NCT00896532|474211347|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708087|NCT00896532|474211348|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708088|NCT00896532|474211349|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131708089|NCT00896532|474211327|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708090|NCT00896532|474211328|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708091|NCT00896532|474211329|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708092|NCT00896532|474211330|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708093|NCT00896532|474211331|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708094|NCT00896532|474211332|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708095|NCT00896532|474211333|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708096|NCT00896532|474211334|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708097|NCT00896532|474211335|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708098|NCT00896532|474211336|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708099|NCT00896532|474211337|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708100|NCT00896532|474211338|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708101|NCT00896532|474211339|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
131708102|NCT00896532|474211340|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
131793802|NCT01621490|474528684|FG008|Overall Study|Subject no longer meets study criteria|0|||
131793803|NCT01621490|474528685|FG009|Overall Study|Subject no longer meets study criteria|0|||
131708103|NCT00896532|474211341|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708104|NCT00896532|474211342|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708105|NCT00896532|474211343|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708106|NCT00896532|474211344|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708107|NCT00896532|474211345|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708108|NCT00896532|474211346|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708109|NCT00896532|474211347|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708110|NCT00896532|474211348|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131708111|NCT00896532|474211349|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131793804|NCT01621490|474528686|FG010|Overall Study|Subject no longer meets study criteria|0|||
131793805|NCT01621490|474528676|FG000|Overall Study|Maximum clinical benefit|3|||
131793806|NCT01621490|474528677|FG001|Overall Study|Maximum clinical benefit|2|||
131793807|NCT01621490|474528678|FG002|Overall Study|Maximum clinical benefit|0|||
131793808|NCT01621490|474528679|FG003|Overall Study|Maximum clinical benefit|0|||
131793809|NCT01621490|474528680|FG004|Overall Study|Maximum clinical benefit|0|||
131793810|NCT01621490|474528681|FG005|Overall Study|Maximum clinical benefit|0|||
131793811|NCT01621490|474528682|FG006|Overall Study|Maximum clinical benefit|1|||
131793812|NCT01621490|474528683|FG007|Overall Study|Maximum clinical benefit|2|||
131793813|NCT01621490|474528684|FG008|Overall Study|Maximum clinical benefit|2|||
131793814|NCT01621490|474528685|FG009|Overall Study|Maximum clinical benefit|0|||
131793815|NCT01621490|474528686|FG010|Overall Study|Maximum clinical benefit|0|||
131793816|NCT01621490|474528676|FG000|Overall Study|Withdrawal by Subject|1|||
131793817|NCT01621490|474528677|FG001|Overall Study|Withdrawal by Subject|0|||
131793818|NCT01621490|474528678|FG002|Overall Study|Withdrawal by Subject|0|||
131793819|NCT01621490|474528679|FG003|Overall Study|Withdrawal by Subject|0|||
131793820|NCT01621490|474528680|FG004|Overall Study|Withdrawal by Subject|0|||
131793821|NCT01621490|474528681|FG005|Overall Study|Withdrawal by Subject|1|||
131793822|NCT01621490|474528682|FG006|Overall Study|Withdrawal by Subject|0|||
131793823|NCT01621490|474528683|FG007|Overall Study|Withdrawal by Subject|0|||
131793824|NCT01621490|474528684|FG008|Overall Study|Withdrawal by Subject|0|||
131793825|NCT01621490|474528685|FG009|Overall Study|Withdrawal by Subject|0|||
131793826|NCT01621490|474528686|FG010|Overall Study|Withdrawal by Subject|0|||
131708112|NCT00896532|474211327|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
131708113|NCT00896532|474211328|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
131708114|NCT00896532|474211329|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
131708115|NCT00896532|474211330|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
131708116|NCT00896532|474211331|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
131441621|NCT02234843|473245296|FG003|Overall Study|Non-compliance with study drug|0|||
131793827|NCT01621490|474528676|FG000|Overall Study|Subject request to discontinue study|1|||
131793828|NCT01621490|474528677|FG001|Overall Study|Subject request to discontinue study|3|||
131793829|NCT01621490|474528678|FG002|Overall Study|Subject request to discontinue study|1|||
131793830|NCT01621490|474528679|FG003|Overall Study|Subject request to discontinue study|1|||
131441622|NCT02234843|473245297|FG004|Overall Study|Non-compliance with study drug|0|||
131609190|NCT03250676|473862442|FG005|Overall Study|Disease progression|88|||
131609191|NCT05454514|473862955|FG000|Overall Study|Withdrawal by Subject|4|||
131609192|NCT05785130|473862956|FG000|Overall Study|Withdrawal by Subject|1|||
131609193|NCT05785130|473862957|FG001|Overall Study|Withdrawal by Subject|0|||
131609194|NCT05785130|473862956|FG000|Overall Study|Lack of Efficacy|0|||
131609195|NCT05785130|473862957|FG001|Overall Study|Lack of Efficacy|1|||
131609196|NCT06065735|473862961|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
131900009|NCT02989402|474919427|FG000|Overall Study|Adverse event, or serious adverse event|4|||
131900010|NCT02989402|474919427|FG000|Overall Study|Death|2|||
131609197|NCT06065735|473862962|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
131609198|NCT06065735|473862963|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
131609199|NCT06065735|473862961|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
131609200|NCT06065735|473862962|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
131609201|NCT06065735|473862963|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
131609202|NCT06065735|473862961|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
131609203|NCT06065735|473862962|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
131609204|NCT06065735|473862963|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
131609205|NCT06065735|473862961|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
131609206|NCT06065735|473862962|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
131609207|NCT06065735|473862963|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
131609208|NCT06065735|473862961|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
131609209|NCT06065735|473862962|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
131609210|NCT06065735|473862963|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
131609211|NCT02532621|473862964|FG000|Overall Study|Death|3|||
131609212|NCT02532621|473862964|FG000|Overall Study|Lost to Follow-up|3|||
131609213|NCT02532621|473862964|FG000|Overall Study|Withdrawal by Subject|6|||
131609214|NCT02532621|473862964|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
131609215|NCT02532621|473862964|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
131609216|NCT04795245|473862967|FG000|Overall Study|Unkown reason|7|||
131609217|NCT04795245|473862967|FG000|Overall Study|Death|17|||
131609218|NCT04795245|473862967|FG000|Overall Study|Other than listed|19|||
131609219|NCT04795245|473862967|FG000|Overall Study|Adverse Event|143|||
131609220|NCT04795245|473862967|FG000|Overall Study|Progressive disease|512|||
131609221|NCT04795245|473862967|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
131609222|NCT03418740|473862968|FG000|Overall Study|Lost to Follow-up|13|||
131609223|NCT03418740|473862968|FG000|Overall Study|Scheduling Issues|7|||
131609224|NCT03418740|473862968|FG000|Overall Study|Withdrawal by Subject|2|||
131609225|NCT03418740|473862968|FG000|Overall Study|Unable to Continue Consent|1|||
131609226|NCT01897441|473862973|FG000|Overall Study|Lost to Follow-up|0|||
131609227|NCT01897441|473862974|FG001|Overall Study|Lost to Follow-up|0|||
131609228|NCT01897441|473862975|FG002|Overall Study|Lost to Follow-up|1|||
131609229|NCT01897441|473862976|FG003|Overall Study|Lost to Follow-up|0|||
131609230|NCT01897441|473862977|FG004|Overall Study|Lost to Follow-up|0|||
131609231|NCT01897441|473862978|FG005|Overall Study|Lost to Follow-up|0|||
131609232|NCT01897441|473862973|FG000|Overall Study|Withdrawal by Subject|0|||
131609233|NCT01897441|473862974|FG001|Overall Study|Withdrawal by Subject|0|||
131609234|NCT01897441|473862975|FG002|Overall Study|Withdrawal by Subject|0|||
131609235|NCT01897441|473862976|FG003|Overall Study|Withdrawal by Subject|0|||
131609236|NCT01897441|473862977|FG004|Overall Study|Withdrawal by Subject|1|||
131609237|NCT01897441|473862978|FG005|Overall Study|Withdrawal by Subject|0|||
131609238|NCT01897441|473862973|FG000|Overall Study|Withdrawn by Provider|0|||
131609239|NCT01897441|473862974|FG001|Overall Study|Withdrawn by Provider|2|||
131609240|NCT01897441|473862975|FG002|Overall Study|Withdrawn by Provider|0|||
131609241|NCT01897441|473862976|FG003|Overall Study|Withdrawn by Provider|0|||
131609242|NCT01897441|473862977|FG004|Overall Study|Withdrawn by Provider|0|||
131609243|NCT01897441|473862978|FG005|Overall Study|Withdrawn by Provider|0|||
131609244|NCT04157517|473862979|FG000|Overall Study|Death|1|||
131609245|NCT04157517|473862980|FG001|Overall Study|Death|2|||
131609246|NCT04157517|473862981|FG002|Overall Study|Death|2|||
131609247|NCT04157517|473862982|FG003|Overall Study|Death|3|||
131609248|NCT04157517|473862983|FG004|Overall Study|Death|3|||
131609249|NCT04157517|473862984|FG005|Overall Study|Death|4|||
131609250|NCT04157517|473862985|FG006|Overall Study|Death|1|||
131609251|NCT04157517|473862986|FG007|Overall Study|Death|2|||
131609252|NCT04157517|473862987|FG008|Overall Study|Death|4|||
131609253|NCT04157517|473862988|FG009|Overall Study|Death|0|||
131900011|NCT02989402|474919427|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
131609254|NCT04157517|473862979|FG000|Overall Study|Withdrawal by Subject|1|||
131609255|NCT04157517|473862980|FG001|Overall Study|Withdrawal by Subject|1|||
131609256|NCT04157517|473862981|FG002|Overall Study|Withdrawal by Subject|1|||
131609257|NCT04157517|473862982|FG003|Overall Study|Withdrawal by Subject|0|||
131609258|NCT04157517|473862983|FG004|Overall Study|Withdrawal by Subject|0|||
131609259|NCT04157517|473862984|FG005|Overall Study|Withdrawal by Subject|1|||
131609260|NCT04157517|473862985|FG006|Overall Study|Withdrawal by Subject|0|||
131609261|NCT04157517|473862986|FG007|Overall Study|Withdrawal by Subject|0|||
131900012|NCT02989402|474919427|FG000|Overall Study|Lost to Follow-up|8|||
131609262|NCT04157517|473862987|FG008|Overall Study|Withdrawal by Subject|1|||
131609263|NCT04157517|473862988|FG009|Overall Study|Withdrawal by Subject|0|||
131609264|NCT04157517|473862979|FG000|Overall Study|Other|1|||
131609265|NCT04157517|473862980|FG001|Overall Study|Other|0|||
131609266|NCT04157517|473862981|FG002|Overall Study|Other|0|||
131609267|NCT04157517|473862982|FG003|Overall Study|Other|0|||
131609268|NCT04157517|473862983|FG004|Overall Study|Other|0|||
131609269|NCT04157517|473862984|FG005|Overall Study|Other|1|||
131609270|NCT04157517|473862985|FG006|Overall Study|Other|2|||
131609271|NCT04157517|473862986|FG007|Overall Study|Other|7|||
131609272|NCT04157517|473862987|FG008|Overall Study|Other|7|||
131609273|NCT04157517|473862988|FG009|Overall Study|Other|0|||
131609274|NCT02933489|473862989|FG000|Overall Study|Ineligible|3|||
131609275|NCT02933489|473862990|FG001|Overall Study|Ineligible|3|||
131609276|NCT02933489|473862989|FG000|Overall Study|Withdrawal by Subject|27|||
131609277|NCT02933489|473862990|FG001|Overall Study|Withdrawal by Subject|18|||
131609278|NCT02933489|473862989|FG000|Overall Study|Unable to complete exams (other)|14|||
131609279|NCT02933489|473862990|FG001|Overall Study|Unable to complete exams (other)|7|||
131609280|NCT04626427|473862998|FG000|Overall Study|Death|1|||
131609281|NCT04626427|473862998|FG000|Overall Study|Withdrawal by Subject|1|||
131609282|NCT04626427|473862998|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
131609283|NCT04626427|473862998|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
131609284|NCT01265537|473862999|FG000|Overall Study|Adverse Event|2|||
131609285|NCT01265537|473863000|FG001|Overall Study|Adverse Event|1|||
131609286|NCT01265537|473862999|FG000|Overall Study|Physician Decision|0|||
131609287|NCT01265537|473863000|FG001|Overall Study|Physician Decision|1|||
131609288|NCT05020353|473863799|FG000|Overall Study|Protocol Violation|7|||
131609289|NCT05020353|473863799|FG000|Overall Study|Withdrawal by Subject|33|||
131609290|NCT03635567|473863807|FG000|Overall Study|Lost to Follow-up|4|||
131609291|NCT03635567|473863808|FG001|Overall Study|Lost to Follow-up|1|||
131609292|NCT03635567|473863807|FG000|Overall Study|Withdrawal by Subject|11|||
131609293|NCT03635567|473863808|FG001|Overall Study|Withdrawal by Subject|16|||
131609294|NCT03635567|473863807|FG000|Overall Study|Sponsor Decision|99|||
131609295|NCT03635567|473863808|FG001|Overall Study|Sponsor Decision|57|||
131609296|NCT03635567|473863807|FG000|Overall Study|Death|194|||
131609297|NCT03635567|473863808|FG001|Overall Study|Death|235|||
131609298|NCT01880515|473863810|FG000|Overall Study|Lost to Follow-up|3|||
131609299|NCT01880515|473863811|FG001|Overall Study|Lost to Follow-up|2|||
131609300|NCT01880515|473863810|FG000|Overall Study|Disease Progression|5|||
131609301|NCT01880515|473863811|FG001|Overall Study|Disease Progression|7|||
131609302|NCT02076009|473863812|FG000|Overall Study|Death|172|||
131609303|NCT02076009|473863813|FG001|Overall Study|Death|153|||
131609304|NCT02076009|473863812|FG000|Overall Study|Withdrawal by Subject|16|||
131609305|NCT02076009|473863813|FG001|Overall Study|Withdrawal by Subject|12|||
131609306|NCT02076009|473863812|FG000|Overall Study|Lost to Follow-up|4|||
131609307|NCT02076009|473863813|FG001|Overall Study|Lost to Follow-up|2|||
131609308|NCT02076009|473863812|FG000|Overall Study|Progressive Disease|1|||
131609309|NCT02076009|473863813|FG001|Overall Study|Progressive Disease|0|||
131609310|NCT02076009|473863812|FG000|Overall Study|Physician Decision|0|||
131609311|NCT02076009|473863813|FG001|Overall Study|Physician Decision|1|||
131609312|NCT02076009|473863812|FG000|Overall Study|End of data collection|90|||
131609313|NCT02076009|473863813|FG001|Overall Study|End of data collection|118|||
131609314|NCT04165213|473863814|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
131609315|NCT04165213|473863815|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
131609316|NCT04165213|473863814|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
131609317|NCT04165213|473863815|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
131609318|NCT04165213|473863814|FG000|Clinician Enrollment|Termination from site|0|||
131609319|NCT04165213|473863815|FG001|Clinician Enrollment|Termination from site|1|||
131609320|NCT04165213|473863814|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
131609321|NCT04165213|473863815|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
131609322|NCT04165213|473863814|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
131609323|NCT04165213|473863815|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
131609324|NCT04165213|473863814|FG000|Caregiver Enrollment|Physician Decision|1|||
131609325|NCT04165213|473863815|FG001|Caregiver Enrollment|Physician Decision|0|||
131609326|NCT04165213|473863814|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
131609327|NCT04165213|473863815|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
131609328|NCT04165213|473863814|FG000|Caregiver Enrollment|PLWD death|2|||
131609329|NCT04165213|473863815|FG001|Caregiver Enrollment|PLWD death|0|||
131609330|NCT04165213|473863814|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
131609331|NCT04165213|473863815|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
131609332|NCT04165213|473863814|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
131609333|NCT04165213|473863815|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
131609334|NCT04165213|473863814|FG000|PLWD Enrollment|Lost to Follow-up|1|||
131609335|NCT04165213|473863815|FG001|PLWD Enrollment|Lost to Follow-up|1|||
131609336|NCT04165213|473863814|FG000|PLWD Enrollment|Physician Decision|1|||
131609337|NCT04165213|473863815|FG001|PLWD Enrollment|Physician Decision|0|||
131609338|NCT04165213|473863814|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
131793831|NCT01621490|474528680|FG004|Overall Study|Subject request to discontinue study|0|||
131793832|NCT01621490|474528681|FG005|Overall Study|Subject request to discontinue study|2|||
131793833|NCT01621490|474528682|FG006|Overall Study|Subject request to discontinue study|1|||
131793834|NCT01621490|474528683|FG007|Overall Study|Subject request to discontinue study|0|||
131793835|NCT01621490|474528684|FG008|Overall Study|Subject request to discontinue study|1|||
131793836|NCT01621490|474528685|FG009|Overall Study|Subject request to discontinue study|0|||
131793837|NCT01621490|474528686|FG010|Overall Study|Subject request to discontinue study|0|||
131793838|NCT01621490|474528676|FG000|Overall Study|Adverse event unrelated to study drug|1|||
131793839|NCT01621490|474528677|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131793840|NCT01621490|474528678|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131609339|NCT04165213|473863815|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
131609340|NCT04165213|473863814|FG000|PLWD Enrollment|Death|2|||
131609341|NCT04165213|473863815|FG001|PLWD Enrollment|Death|0|||
131609342|NCT04165213|473863814|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
131609343|NCT04165213|473863815|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
131609344|NCT04933474|473863816|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
131793841|NCT01621490|474528679|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131793842|NCT01621490|474528680|FG004|Overall Study|Adverse event unrelated to study drug|0|||
131793843|NCT01621490|474528681|FG005|Overall Study|Adverse event unrelated to study drug|0|||
131793844|NCT01621490|474528682|FG006|Overall Study|Adverse event unrelated to study drug|0|||
131793845|NCT01621490|474528683|FG007|Overall Study|Adverse event unrelated to study drug|2|||
131793846|NCT01621490|474528684|FG008|Overall Study|Adverse event unrelated to study drug|0|||
131793847|NCT01621490|474528685|FG009|Overall Study|Adverse event unrelated to study drug|0|||
131793848|NCT01621490|474528686|FG010|Overall Study|Adverse event unrelated to study drug|0|||
131793849|NCT01621490|474528676|FG000|Overall Study|Disease progression|27|||
131793850|NCT01621490|474528677|FG001|Overall Study|Disease progression|28|||
131793851|NCT01621490|474528678|FG002|Overall Study|Disease progression|1|||
131793852|NCT01621490|474528679|FG003|Overall Study|Disease progression|5|||
131793853|NCT01621490|474528680|FG004|Overall Study|Disease progression|3|||
131793854|NCT01621490|474528681|FG005|Overall Study|Disease progression|8|||
131793855|NCT01621490|474528682|FG006|Overall Study|Disease progression|7|||
131793856|NCT01621490|474528683|FG007|Overall Study|Disease progression|1|||
131793857|NCT01621490|474528684|FG008|Overall Study|Disease progression|4|||
131793858|NCT01621490|474528685|FG009|Overall Study|Disease progression|1|||
131793859|NCT01621490|474528686|FG010|Overall Study|Disease progression|1|||
131793860|NCT01621490|474528676|FG000|Overall Study|Study drug toxicity|1|||
131793861|NCT01621490|474528677|FG001|Overall Study|Study drug toxicity|4|||
131793862|NCT01621490|474528678|FG002|Overall Study|Study drug toxicity|5|||
131793863|NCT01621490|474528679|FG003|Overall Study|Study drug toxicity|3|||
131793864|NCT01621490|474528680|FG004|Overall Study|Study drug toxicity|1|||
131793865|NCT01621490|474528681|FG005|Overall Study|Study drug toxicity|10|||
131793866|NCT01621490|474528682|FG006|Overall Study|Study drug toxicity|1|||
131793867|NCT01621490|474528683|FG007|Overall Study|Study drug toxicity|4|||
131793868|NCT01621490|474528684|FG008|Overall Study|Study drug toxicity|1|||
131793869|NCT01621490|474528685|FG009|Overall Study|Study drug toxicity|0|||
131793870|NCT01621490|474528686|FG010|Overall Study|Study drug toxicity|0|||
131900013|NCT02989402|474919427|FG000|Overall Study|Patient no longer on monotherapy|1|||
131609345|NCT04933474|473863817|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
131793871|NCT01621490|474528676|FG000|Overall Study|Death|0|||
131793872|NCT01621490|474528677|FG001|Overall Study|Death|0|||
131793873|NCT01621490|474528678|FG002|Overall Study|Death|0|||
131609346|NCT04933474|473863816|FG000|Overall Study|Lost to Follow-up|19|||
131609347|NCT04933474|473863817|FG001|Overall Study|Lost to Follow-up|9|||
131609348|NCT04933474|473863816|FG000|Overall Study|Life Burden - unable to participate|6|||
131609349|NCT04933474|473863817|FG001|Overall Study|Life Burden - unable to participate|2|||
131609350|NCT04933474|473863816|FG000|Overall Study|Disease Burden - unable to participate|4|||
131609351|NCT04933474|473863817|FG001|Overall Study|Disease Burden - unable to participate|1|||
131609352|NCT04933474|473863816|FG000|Overall Study|Surgery/Hospitalization|1|||
131609353|NCT04933474|473863817|FG001|Overall Study|Surgery/Hospitalization|2|||
131609354|NCT04933474|473863816|FG000|Overall Study|Dissatisfied with Intervention|1|||
131609355|NCT04933474|473863817|FG001|Overall Study|Dissatisfied with Intervention|1|||
131609356|NCT04933474|473863816|FG000|Overall Study|Withdrew interest in participation|1|||
131609357|NCT04933474|473863817|FG001|Overall Study|Withdrew interest in participation|0|||
131609358|NCT04933474|473863816|FG000|Overall Study|Had previously enrolled in the study|0|||
131609359|NCT04933474|473863817|FG001|Overall Study|Had previously enrolled in the study|1|||
131609360|NCT05988398|473863833|FG000|Overall Study|Lack of time|21|||
131609361|NCT05988398|473863834|FG001|Overall Study|Lack of time|0|||
131609362|NCT05988398|473863833|FG000|Overall Study|Absent from school|0|||
131609363|NCT05988398|473863834|FG001|Overall Study|Absent from school|38|||
131609364|NCT05988398|473863833|FG000|Overall Study|Chose not to participate|0|||
131609365|NCT05988398|473863834|FG001|Overall Study|Chose not to participate|42|||
131609366|NCT05988398|473863833|FG000|Overall Study|Other commitments (e.g., sports)|0|||
131609367|NCT05988398|473863834|FG001|Overall Study|Other commitments (e.g., sports)|25|||
131609368|NCT00942734|473863839|FG000|Overall Study|Adverse Event|2|||
131609369|NCT00942734|473863839|FG000|Overall Study|Protocol Violation|3|||
131609370|NCT00942734|473863839|FG000|Overall Study|Disease Progression|2|||
131609371|NCT00942734|473863839|FG000|Overall Study|Physician Decision|1|||
131609372|NCT03816397|473863840|FG000|Overall Study|Censored at interim analysis date.|13|||
131609373|NCT03816397|473863841|FG001|Overall Study|Censored at interim analysis date.|6|||
131609374|NCT03816397|473863840|FG000|Overall Study|Withdrawal by Subject|1|||
131609375|NCT03816397|473863841|FG001|Overall Study|Withdrawal by Subject|1|||
131609376|NCT05985395|473863842|FG000|Overall Study|Physician Decision|2|||
131609377|NCT05985395|473863843|FG001|Overall Study|Physician Decision|1|||
131609378|NCT05985395|473863842|FG000|Overall Study|Withdrawal by Subject|1|||
131609379|NCT05985395|473863843|FG001|Overall Study|Withdrawal by Subject|0|||
131609380|NCT03333915|473863844|FG000|Overall Study|Lost to Follow-up|0|||
131609381|NCT03333915|473863845|FG001|Overall Study|Lost to Follow-up|0|||
131609382|NCT03333915|473863846|FG002|Overall Study|Lost to Follow-up|1|||
131609383|NCT03333915|473863847|FG003|Overall Study|Lost to Follow-up|0|||
131609384|NCT03333915|473863848|FG004|Overall Study|Lost to Follow-up|0|||
131609385|NCT03333915|473863844|FG000|Overall Study|Disease Progression|0|||
131609386|NCT03333915|473863845|FG001|Overall Study|Disease Progression|1|||
131609387|NCT03333915|473863846|FG002|Overall Study|Disease Progression|0|||
131609388|NCT03333915|473863847|FG003|Overall Study|Disease Progression|0|||
131609389|NCT03333915|473863848|FG004|Overall Study|Disease Progression|0|||
131609390|NCT03333915|473863844|FG000|Overall Study|Death|0|||
131609391|NCT03333915|473863845|FG001|Overall Study|Death|0|||
131793874|NCT01621490|474528679|FG003|Overall Study|Death|0|||
131609392|NCT03333915|473863846|FG002|Overall Study|Death|0|||
131609393|NCT03333915|473863847|FG003|Overall Study|Death|37|||
131609394|NCT03333915|473863848|FG004|Overall Study|Death|18|||
131609395|NCT03333915|473863844|FG000|Overall Study|Sponsor's Decision|0|||
131609396|NCT03333915|473863845|FG001|Overall Study|Sponsor's Decision|0|||
131609397|NCT03333915|473863846|FG002|Overall Study|Sponsor's Decision|0|||
131793875|NCT01621490|474528680|FG004|Overall Study|Death|0|||
131609398|NCT03333915|473863847|FG003|Overall Study|Sponsor's Decision|48|||
131609399|NCT03333915|473863848|FG004|Overall Study|Sponsor's Decision|4|||
131609400|NCT03333915|473863844|FG000|Overall Study|Withdrawal by Subject|0|||
131609401|NCT03333915|473863845|FG001|Overall Study|Withdrawal by Subject|0|||
131609402|NCT03333915|473863846|FG002|Overall Study|Withdrawal by Subject|0|||
131609403|NCT03333915|473863847|FG003|Overall Study|Withdrawal by Subject|5|||
131609404|NCT03333915|473863848|FG004|Overall Study|Withdrawal by Subject|1|||
131793876|NCT01621490|474528681|FG005|Overall Study|Death|0|||
131609405|NCT03522298|473863851|FG000|Overall Study|Adverse Event|1|||
131609406|NCT03522298|473863852|FG001|Overall Study|Adverse Event|0|||
131609407|NCT03522298|473863853|FG002|Overall Study|Adverse Event|0|||
131609408|NCT03522298|473863854|FG003|Overall Study|Adverse Event|1|||
131609409|NCT03522298|473863851|FG000|Overall Study|Death|2|||
131609410|NCT03522298|473863852|FG001|Overall Study|Death|4|||
131609411|NCT03522298|473863853|FG002|Overall Study|Death|8|||
131609412|NCT03522298|473863854|FG003|Overall Study|Death|8|||
131609413|NCT03522298|473863851|FG000|Overall Study|Patient decision|0|||
131609414|NCT03522298|473863852|FG001|Overall Study|Patient decision|2|||
131609415|NCT03522298|473863853|FG002|Overall Study|Patient decision|2|||
131609416|NCT03522298|473863854|FG003|Overall Study|Patient decision|2|||
131609417|NCT02806726|473863855|FG000|Overall Study|Lost to Follow-up|1|||
131609418|NCT04281498|473863856|FG000|Overall Study|Progression of disease|1|||
131609419|NCT04281498|473863856|FG000|Overall Study|Planned SCT|1|||
131609420|NCT04281498|473863856|FG000|Overall Study|Alternative Treatment|1|||
131609421|NCT03587805|473863857|FG000|Overall Study|Adverse Event|72|||
131609422|NCT03587805|473863857|FG000|Overall Study|Death|1|||
131609423|NCT03587805|473863857|FG000|Overall Study|Lost to Follow-up|78|||
131609424|NCT03587805|473863857|FG000|Overall Study|Withdrawal by Subject|105|||
131609425|NCT03587805|473863857|FG000|Overall Study|Lack of Efficacy|119|||
131609426|NCT03587805|473863857|FG000|Overall Study|Reason unknown|26|||
131609427|NCT03587805|473863857|FG000|Overall Study|COVID_19 pandemic|4|||
131609428|NCT03587805|473863857|FG000|Overall Study|Various reasons|121|||
131609429|NCT03587805|473863857|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131609430|NCT01527188|473863858|FG000|Overall Study|Adverse Event|5|||
131609431|NCT01527188|473863859|FG001|Overall Study|Adverse Event|5|||
131609432|NCT01527188|473863860|FG002|Overall Study|Adverse Event|11|||
131609433|NCT01527188|473863861|FG003|Overall Study|Adverse Event|0|||
131609434|NCT01527188|473863858|FG000|Overall Study|Withdrawal by Subject|3|||
131609435|NCT01527188|473863859|FG001|Overall Study|Withdrawal by Subject|6|||
131609436|NCT01527188|473863860|FG002|Overall Study|Withdrawal by Subject|4|||
131609437|NCT01527188|473863861|FG003|Overall Study|Withdrawal by Subject|4|||
131609438|NCT01527188|473863858|FG000|Overall Study|Any other reason not above-mentioned|6|||
131609439|NCT01527188|473863859|FG001|Overall Study|Any other reason not above-mentioned|7|||
131609440|NCT01527188|473863860|FG002|Overall Study|Any other reason not above-mentioned|8|||
131609441|NCT01527188|473863861|FG003|Overall Study|Any other reason not above-mentioned|8|||
131609442|NCT03982186|473863862|FG000|Overall Study|Lost to Follow-up|0|||
131609443|NCT03982186|473863863|FG001|Overall Study|Lost to Follow-up|1|||
131609444|NCT03982186|473863864|FG002|Overall Study|Lost to Follow-up|2|||
131609445|NCT03982186|473863865|FG003|Overall Study|Lost to Follow-up|1|||
131609446|NCT03982186|473863866|FG004|Overall Study|Lost to Follow-up|1|||
131609447|NCT03982186|473863867|FG005|Overall Study|Lost to Follow-up|0|||
131609448|NCT03982186|473863862|FG000|Overall Study|Physician Decision|0|||
131609449|NCT03982186|473863863|FG001|Overall Study|Physician Decision|1|||
131609450|NCT03982186|473863864|FG002|Overall Study|Physician Decision|0|||
131609451|NCT03982186|473863865|FG003|Overall Study|Physician Decision|0|||
131609452|NCT03982186|473863866|FG004|Overall Study|Physician Decision|0|||
131609453|NCT03982186|473863867|FG005|Overall Study|Physician Decision|0|||
131609454|NCT03982186|473863862|FG000|Overall Study|Withdrawal by Subject|3|||
131609455|NCT03982186|473863863|FG001|Overall Study|Withdrawal by Subject|4|||
131609456|NCT03982186|473863864|FG002|Overall Study|Withdrawal by Subject|1|||
131609457|NCT03982186|473863865|FG003|Overall Study|Withdrawal by Subject|7|||
131609458|NCT03982186|473863866|FG004|Overall Study|Withdrawal by Subject|2|||
131609459|NCT03982186|473863867|FG005|Overall Study|Withdrawal by Subject|0|||
131609460|NCT03982186|473863862|FG000|Overall Study|Randomized and not treated|0|||
131609461|NCT03982186|473863863|FG001|Overall Study|Randomized and not treated|0|||
131609462|NCT03982186|473863864|FG002|Overall Study|Randomized and not treated|0|||
131609463|NCT03982186|473863865|FG003|Overall Study|Randomized and not treated|1|||
131609464|NCT03982186|473863866|FG004|Overall Study|Randomized and not treated|0|||
131609465|NCT03982186|473863867|FG005|Overall Study|Randomized and not treated|0|||
131609466|NCT05866926|473863868|FG000|Overall Study|Death|16|||
131609467|NCT05866926|473863869|FG001|Overall Study|Death|9|||
131609468|NCT05866926|473863868|FG000|Overall Study|Lost to Follow-up|0|||
131609469|NCT05866926|473863869|FG001|Overall Study|Lost to Follow-up|1|||
131609470|NCT05866926|473863868|FG000|Overall Study|Adverse Event|1|||
131609471|NCT05866926|473863869|FG001|Overall Study|Adverse Event|0|||
131609472|NCT05866926|473863868|FG000|Overall Study|Withdrawal by Subject|5|||
131609473|NCT05866926|473863869|FG001|Overall Study|Withdrawal by Subject|1|||
131609474|NCT05866926|473863868|FG000|Overall Study|Disease progression|1|||
131609475|NCT05866926|473863869|FG001|Overall Study|Disease progression|0|||
131609476|NCT05866926|473863868|FG000|Overall Study|other causes|2|||
131609477|NCT05866926|473863869|FG001|Overall Study|other causes|1|||
131609478|NCT04908930|473864494|FG000|Overall Study|Lost to Follow-up|1|||
131609479|NCT04908930|473864495|FG001|Overall Study|Lost to Follow-up|1|||
131609480|NCT04908930|473864496|FG002|Overall Study|Lost to Follow-up|0|||
131609481|NCT04908930|473864497|FG003|Overall Study|Lost to Follow-up|0|||
131609482|NCT04908930|473864498|FG004|Overall Study|Lost to Follow-up|0|||
131609483|NCT04908930|473864494|FG000|Overall Study|hardware in mouth|1|||
131609484|NCT04908930|473864495|FG001|Overall Study|hardware in mouth|1|||
131609485|NCT04908930|473864496|FG002|Overall Study|hardware in mouth|0|||
131609486|NCT04908930|473864497|FG003|Overall Study|hardware in mouth|0|||
131609487|NCT04908930|473864498|FG004|Overall Study|hardware in mouth|0|||
131609488|NCT04908930|473864494|FG000|Overall Study|wrong team|1|||
131609489|NCT04908930|473864495|FG001|Overall Study|wrong team|0|||
131609490|NCT04908930|473864496|FG002|Overall Study|wrong team|0|||
131609491|NCT04908930|473864497|FG003|Overall Study|wrong team|0|||
131609492|NCT04908930|473864498|FG004|Overall Study|wrong team|0|||
131609493|NCT04908930|473864494|FG000|Overall Study|quit team|2|||
131609494|NCT04908930|473864495|FG001|Overall Study|quit team|4|||
131609495|NCT04908930|473864496|FG002|Overall Study|quit team|0|||
131609496|NCT04908930|473864497|FG003|Overall Study|quit team|0|||
131609497|NCT04908930|473864498|FG004|Overall Study|quit team|0|||
131609498|NCT04908930|473864494|FG000|Overall Study|Withdrawal by Subject|1|||
131609499|NCT04908930|473864495|FG001|Overall Study|Withdrawal by Subject|2|||
131609500|NCT04908930|473864496|FG002|Overall Study|Withdrawal by Subject|0|||
131609501|NCT04908930|473864497|FG003|Overall Study|Withdrawal by Subject|0|||
131609502|NCT04908930|473864498|FG004|Overall Study|Withdrawal by Subject|0|||
131609503|NCT04908930|473864494|FG000|Overall Study|parent not liking program|0|||
131609504|NCT04908930|473864495|FG001|Overall Study|parent not liking program|1|||
131609505|NCT04908930|473864496|FG002|Overall Study|parent not liking program|0|||
131609506|NCT04908930|473864497|FG003|Overall Study|parent not liking program|0|||
131609507|NCT04908930|473864498|FG004|Overall Study|parent not liking program|0|||
131609508|NCT02777593|473864499|FG000|Overall Study|Still in study|1|||
131609509|NCT02777593|473864500|FG001|Overall Study|Still in study|32|||
131609510|NCT02777593|473864501|FG002|Overall Study|Still in study|3|||
131609511|NCT02777593|473864502|FG003|Overall Study|Still in study|6|||
131609512|NCT02777593|473864503|FG004|Overall Study|Still in study|5|||
131609513|NCT02777593|473864499|FG000|Overall Study|Death|21|||
131609514|NCT02777593|473864500|FG001|Overall Study|Death|28|||
131609515|NCT02777593|473864501|FG002|Overall Study|Death|0|||
131609516|NCT02777593|473864502|FG003|Overall Study|Death|5|||
131609517|NCT02777593|473864503|FG004|Overall Study|Death|0|||
131609518|NCT02777593|473864499|FG000|Overall Study|Withdrawal by Subject|8|||
131609519|NCT02777593|473864500|FG001|Overall Study|Withdrawal by Subject|4|||
131609520|NCT02777593|473864501|FG002|Overall Study|Withdrawal by Subject|1|||
131609521|NCT02777593|473864502|FG003|Overall Study|Withdrawal by Subject|1|||
131609522|NCT02777593|473864503|FG004|Overall Study|Withdrawal by Subject|0|||
131609523|NCT02777593|473864499|FG000|Overall Study|Lost to Follow-up|8|||
131609524|NCT02777593|473864500|FG001|Overall Study|Lost to Follow-up|16|||
131609525|NCT02777593|473864501|FG002|Overall Study|Lost to Follow-up|5|||
131793877|NCT01621490|474528682|FG006|Overall Study|Death|0|||
131793878|NCT01621490|474528683|FG007|Overall Study|Death|0|||
131793879|NCT01621490|474528684|FG008|Overall Study|Death|1|||
131793880|NCT01621490|474528685|FG009|Overall Study|Death|0|||
131793881|NCT01621490|474528686|FG010|Overall Study|Death|0|||
131793882|NCT01621490|474528676|FG000|Overall Study|Other reasons|7|||
131793883|NCT01621490|474528677|FG001|Overall Study|Other reasons|6|||
131793884|NCT01621490|474528678|FG002|Overall Study|Other reasons|4|||
131793885|NCT01621490|474528679|FG003|Overall Study|Other reasons|1|||
131793886|NCT01621490|474528680|FG004|Overall Study|Other reasons|1|||
131793887|NCT01621490|474528681|FG005|Overall Study|Other reasons|3|||
131793888|NCT01621490|474528682|FG006|Overall Study|Other reasons|1|||
131793889|NCT01621490|474528683|FG007|Overall Study|Other reasons|1|||
131793890|NCT01621490|474528684|FG008|Overall Study|Other reasons|1|||
131609526|NCT02777593|473864502|FG003|Overall Study|Lost to Follow-up|0|||
131609527|NCT02777593|473864503|FG004|Overall Study|Lost to Follow-up|1|||
131609528|NCT02777593|473864499|FG000|Overall Study|Physician Decision|2|||
131609529|NCT02777593|473864500|FG001|Overall Study|Physician Decision|2|||
131609530|NCT02777593|473864501|FG002|Overall Study|Physician Decision|0|||
131609531|NCT02777593|473864502|FG003|Overall Study|Physician Decision|0|||
131609532|NCT02777593|473864503|FG004|Overall Study|Physician Decision|0|||
131609533|NCT02777593|473864499|FG000|Overall Study|Discontinued due to Other|1|||
131609534|NCT02777593|473864500|FG001|Overall Study|Discontinued due to Other|0|||
131609535|NCT02777593|473864501|FG002|Overall Study|Discontinued due to Other|0|||
131609536|NCT02777593|473864502|FG003|Overall Study|Discontinued due to Other|0|||
131609537|NCT02777593|473864503|FG004|Overall Study|Discontinued due to Other|0|||
131609538|NCT05718687|473864507|FG000|Overall Study|Withdrawal by Subject|3|||
131609539|NCT05485935|473864508|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
131609540|NCT05485935|473864509|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
131793891|NCT01621490|474528685|FG009|Overall Study|Other reasons|0|||
131793892|NCT01621490|474528686|FG010|Overall Study|Other reasons|0|||
131793893|NCT00506753|474528687|FG000|Overall Study|Lost to Follow-up|21|||
131793894|NCT00506753|474528688|FG001|Overall Study|Lost to Follow-up|15|||
131441623|NCT02234843|473245298|FG005|Overall Study|Non-compliance with study drug|1|||
131441624|NCT02234843|473245299|FG006|Overall Study|Non-compliance with study drug|1|||
131441625|NCT02234843|473245300|FG007|Overall Study|Non-compliance with study drug|0|||
131441626|NCT02234843|473245301|FG008|Overall Study|Non-compliance with study drug|0|||
131441627|NCT02234843|473245302|FG009|Overall Study|Non-compliance with study drug|0|||
131441628|NCT02234843|473245293|FG000|Overall Study|Lost to Follow-up|0|||
131441629|NCT02234843|473245294|FG001|Overall Study|Lost to Follow-up|1|||
131441630|NCT02234843|473245295|FG002|Overall Study|Lost to Follow-up|0|||
131441631|NCT02234843|473245296|FG003|Overall Study|Lost to Follow-up|0|||
131441632|NCT02234843|473245297|FG004|Overall Study|Lost to Follow-up|0|||
131441633|NCT02234843|473245298|FG005|Overall Study|Lost to Follow-up|0|||
131441634|NCT02234843|473245299|FG006|Overall Study|Lost to Follow-up|1|||
131441635|NCT02234843|473245300|FG007|Overall Study|Lost to Follow-up|0|||
131441636|NCT02234843|473245301|FG008|Overall Study|Lost to Follow-up|0|||
131441637|NCT02234843|473245302|FG009|Overall Study|Lost to Follow-up|0|||
131441638|NCT00506350|473245305|FG000|Overall Study|Serious Adverse Event|1|||
131441639|NCT00506350|473245306|FG001|Overall Study|Serious Adverse Event|0|||
131441640|NCT00506350|473245307|FG002|Overall Study|Serious Adverse Event|0|||
131441641|NCT00506350|473245308|FG003|Overall Study|Serious Adverse Event|0|||
131441642|NCT00506350|473245309|FG004|Overall Study|Serious Adverse Event|0|||
131441643|NCT00506350|473245310|FG005|Overall Study|Serious Adverse Event|0|||
131441644|NCT00506350|473245311|FG006|Overall Study|Serious Adverse Event|0|||
131609541|NCT05485935|473864508|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
131609542|NCT05485935|473864509|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
131609543|NCT05485935|473864508|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
131609544|NCT05485935|473864509|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
131609545|NCT05485935|473864508|FG000|Period 2 (T2 and V3)|loss of contact|0|||
131609546|NCT05485935|473864509|FG001|Period 2 (T2 and V3)|loss of contact|1|||
131609547|NCT05129501|473864513|FG000|Overall Study|Lost to Follow-up|54|||
131609548|NCT05129501|473864514|FG001|Overall Study|Lost to Follow-up|41|||
131609549|NCT03092674|473864515|FG000|Overall Study|Adverse Event or Side Effects|1|||
131609550|NCT03092674|473864516|FG001|Overall Study|Adverse Event or Side Effects|4|||
131609551|NCT03092674|473864517|FG002|Overall Study|Adverse Event or Side Effects|4|||
131609552|NCT03092674|473864515|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
131609553|NCT03092674|473864516|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
131609554|NCT03092674|473864517|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
131609555|NCT03092674|473864515|FG000|Overall Study|Progression/Relapse|5|||
131609556|NCT03092674|473864516|FG001|Overall Study|Progression/Relapse|4|||
131609557|NCT03092674|473864517|FG002|Overall Study|Progression/Relapse|8|||
131609558|NCT03092674|473864515|FG000|Overall Study|Death|4|||
131609559|NCT03092674|473864516|FG001|Overall Study|Death|8|||
131609560|NCT03092674|473864517|FG002|Overall Study|Death|2|||
131609561|NCT03092674|473864515|FG000|Overall Study|Other - Not Protocol Specified|11|||
131609562|NCT03092674|473864516|FG001|Overall Study|Other - Not Protocol Specified|8|||
131609563|NCT03092674|473864517|FG002|Overall Study|Other - Not Protocol Specified|8|||
131609564|NCT01220531|473864520|FG000|Overall Study|Death|7|||
131609565|NCT01220531|473864520|FG000|Overall Study|Lost to Follow-up|1|||
131609566|NCT02325154|473864521|FG000|Overall Study|Physician Decision|1|||
131609567|NCT02611687|473864859|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
131609568|NCT02611687|473864860|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
131609569|NCT00447980|473864864|FG000|Overall Study|Withdrawal by Subject|1|||
131609570|NCT00447980|473864865|FG001|Overall Study|Withdrawal by Subject|1|||
131609571|NCT00447980|473864866|FG002|Overall Study|Withdrawal by Subject|4|||
131609572|NCT00447980|473864867|FG003|Overall Study|Withdrawal by Subject|4|||
131609573|NCT00447980|473864864|FG000|Overall Study|Lost to Follow-up|1|||
131609574|NCT00447980|473864865|FG001|Overall Study|Lost to Follow-up|1|||
131793895|NCT02451670|474528689|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
131793896|NCT02451670|474528690|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
131793897|NCT00461500|474528691|FG000|Overall Study|Adverse Event|1|||
131793898|NCT00461500|474528692|FG001|Overall Study|Adverse Event|0|||
131793899|NCT00461500|474528691|FG000|Overall Study|Lack of Efficacy|0|||
131793900|NCT00461500|474528692|FG001|Overall Study|Lack of Efficacy|1|||
131793901|NCT00461500|474528691|FG000|Overall Study|Expired Drug Treatment|1|||
131441645|NCT00506350|473245312|FG007|Overall Study|Serious Adverse Event|0|||
131609575|NCT00447980|473864866|FG002|Overall Study|Lost to Follow-up|0|||
131609576|NCT00447980|473864867|FG003|Overall Study|Lost to Follow-up|0|||
131609577|NCT00447980|473864864|FG000|Overall Study|Did not proceed with surgery|3|||
131609578|NCT00447980|473864865|FG001|Overall Study|Did not proceed with surgery|3|||
131609579|NCT00447980|473864866|FG002|Overall Study|Did not proceed with surgery|2|||
131609580|NCT00447980|473864867|FG003|Overall Study|Did not proceed with surgery|2|||
131609581|NCT05157841|473864868|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
131441646|NCT00506350|473245313|FG008|Overall Study|Serious Adverse Event|0|||
131441647|NCT00506350|473245305|FG000|Overall Study|Adverse Event|0|||
131441648|NCT00506350|473245306|FG001|Overall Study|Adverse Event|0|||
131441649|NCT00506350|473245307|FG002|Overall Study|Adverse Event|0|||
131708117|NCT00896532|474211332|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
131441650|NCT00506350|473245308|FG003|Overall Study|Adverse Event|0|||
131708118|NCT00896532|474211333|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
131708119|NCT00896532|474211334|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
131708120|NCT00896532|474211335|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
131900014|NCT02989402|474919427|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
131609582|NCT05157841|473864869|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
131609583|NCT05157841|473864870|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
131609584|NCT05157841|473864868|FG000|Part A (14 Days)|Adverse Event|1|||
131609585|NCT05157841|473864869|FG001|Part A (14 Days)|Adverse Event|0|||
131609586|NCT05157841|473864870|FG002|Part A (14 Days)|Adverse Event|0|||
131609587|NCT05157841|473864868|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
131609588|NCT05157841|473864869|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
131609589|NCT05157841|473864870|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
131708121|NCT00896532|474211336|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
131609590|NCT03242915|473864877|FG000|Overall Study|Adverse Event|5|||
131609591|NCT03242915|473864878|FG001|Overall Study|Adverse Event|1|||
131609592|NCT03242915|473864877|FG000|Overall Study|Withdrawal by Subject|0|||
131609593|NCT03242915|473864878|FG001|Overall Study|Withdrawal by Subject|2|||
131609594|NCT03242915|473864877|FG000|Overall Study|Physician Decision|4|||
131609595|NCT03242915|473864878|FG001|Overall Study|Physician Decision|1|||
131609596|NCT04408755|473864879|FG000|Period A (Placebo lead-in)|Other|11|||
131609597|NCT04408755|473864880|FG001|Period A (Placebo lead-in)|Other|0|||
131609598|NCT04408755|473864881|FG002|Period A (Placebo lead-in)|Other|0|||
131609599|NCT04408755|473864882|FG003|Period A (Placebo lead-in)|Other|0|||
131609600|NCT04408755|473864879|FG000|Period B (Randomization Period)|Adverse Event|0|||
131609601|NCT04408755|473864880|FG001|Period B (Randomization Period)|Adverse Event|3|||
131609602|NCT04408755|473864881|FG002|Period B (Randomization Period)|Adverse Event|0|||
131609603|NCT04408755|473864882|FG003|Period B (Randomization Period)|Adverse Event|1|||
131609604|NCT04408755|473864879|FG000|Period B (Randomization Period)|Death|0|||
131609605|NCT04408755|473864880|FG001|Period B (Randomization Period)|Death|0|||
131609606|NCT04408755|473864881|FG002|Period B (Randomization Period)|Death|1|||
131609607|NCT04408755|473864882|FG003|Period B (Randomization Period)|Death|0|||
131609608|NCT04408755|473864879|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
131609609|NCT04408755|473864880|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
131609610|NCT04408755|473864881|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
131609611|NCT04408755|473864882|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
131609612|NCT04408755|473864879|FG000|Period B (Randomization Period)|Physician Decision|0|||
131609613|NCT04408755|473864880|FG001|Period B (Randomization Period)|Physician Decision|0|||
131609614|NCT04408755|473864881|FG002|Period B (Randomization Period)|Physician Decision|1|||
131609615|NCT04408755|473864882|FG003|Period B (Randomization Period)|Physician Decision|0|||
131609616|NCT04408755|473864879|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
131609617|NCT04408755|473864880|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
131609618|NCT04408755|473864881|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
131609619|NCT04408755|473864882|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
131609620|NCT04408755|473864879|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
131609621|NCT04408755|473864880|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
131609622|NCT04408755|473864881|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
131609623|NCT04408755|473864882|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
131609624|NCT04408755|473864879|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
131609625|NCT04408755|473864880|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
131609626|NCT04408755|473864881|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
131609627|NCT04408755|473864882|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
131609628|NCT04408755|473864879|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
131609629|NCT04408755|473864880|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
131609630|NCT04408755|473864881|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
131609631|NCT04408755|473864882|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
131609632|NCT04408755|473864879|FG000|Period B (Randomization Period)|Reason not Specified|0|||
131609633|NCT04408755|473864880|FG001|Period B (Randomization Period)|Reason not Specified|1|||
131609634|NCT04408755|473864881|FG002|Period B (Randomization Period)|Reason not Specified|0|||
131609635|NCT04408755|473864882|FG003|Period B (Randomization Period)|Reason not Specified|2|||
131708122|NCT00896532|474211337|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
131708123|NCT00896532|474211338|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
131708124|NCT00896532|474211339|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
131708125|NCT00896532|474211340|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
131708126|NCT00896532|474211341|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
131708127|NCT00896532|474211342|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
131708128|NCT00896532|474211343|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
131708129|NCT00896532|474211344|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
131708130|NCT00896532|474211345|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
131708131|NCT00896532|474211346|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
131708132|NCT00896532|474211347|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
131708133|NCT00896532|474211348|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
131609636|NCT00308997|473864883|FG000|Overall Study|Subject feigned clinical data|0|||
131609637|NCT00308997|473864884|FG001|Overall Study|Subject feigned clinical data|1|||
131609638|NCT00308997|473864883|FG000|Overall Study|Unable to tolerate intervention|1|||
131609639|NCT00308997|473864884|FG001|Overall Study|Unable to tolerate intervention|0|||
131609640|NCT04490356|473864885|FG000|Overall Study|Lost to Follow-up|1|||
131609641|NCT01499368|473864895|FG000|Overall Study|Did not meet I/E criteria|8|||
131609642|NCT01499368|473864896|FG001|Overall Study|Did not meet I/E criteria|4|||
131609643|NCT01499368|473864897|FG002|Overall Study|Did not meet I/E criteria|4|||
131609644|NCT01499368|473864895|FG000|Overall Study|Prohibited Concomitant medication|1|||
131609645|NCT01499368|473864896|FG001|Overall Study|Prohibited Concomitant medication|1|||
131609646|NCT01499368|473864897|FG002|Overall Study|Prohibited Concomitant medication|0|||
131609647|NCT01499368|473864895|FG000|Overall Study|Withdrawal by Subject|11|||
131609648|NCT01499368|473864896|FG001|Overall Study|Withdrawal by Subject|10|||
131609649|NCT01499368|473864897|FG002|Overall Study|Withdrawal by Subject|8|||
131609650|NCT01499368|473864895|FG000|Overall Study|Lost to Follow-up|3|||
131609651|NCT01499368|473864896|FG001|Overall Study|Lost to Follow-up|2|||
131609652|NCT01499368|473864897|FG002|Overall Study|Lost to Follow-up|5|||
131609653|NCT01499368|473864895|FG000|Overall Study|Adverse Event|4|||
131609654|NCT01499368|473864896|FG001|Overall Study|Adverse Event|0|||
131609655|NCT01499368|473864897|FG002|Overall Study|Adverse Event|2|||
131609656|NCT01499368|473864895|FG000|Overall Study|Physician Decision|0|||
131609657|NCT01499368|473864896|FG001|Overall Study|Physician Decision|1|||
131609658|NCT01499368|473864897|FG002|Overall Study|Physician Decision|0|||
131609659|NCT01499368|473864895|FG000|Overall Study|Deviation from visit window|0|||
131609660|NCT01499368|473864896|FG001|Overall Study|Deviation from visit window|0|||
131609661|NCT01499368|473864897|FG002|Overall Study|Deviation from visit window|1|||
131609662|NCT01499368|473864895|FG000|Overall Study|Error of Prescriptions|0|||
131609663|NCT01499368|473864896|FG001|Overall Study|Error of Prescriptions|0|||
131609664|NCT01499368|473864897|FG002|Overall Study|Error of Prescriptions|1|||
131609665|NCT06059443|473864898|FG000|Overall Study|Withdrawal by Subject|2|||
131609666|NCT06059443|473864899|FG001|Overall Study|Withdrawal by Subject|0|||
131609667|NCT06059443|473864898|FG000|Overall Study|Lost to Follow-up|2|||
131609668|NCT06059443|473864899|FG001|Overall Study|Lost to Follow-up|2|||
131609669|NCT00709956|473864902|FG000|Overall Study|Withdrawal by Subject|1|||
131609670|NCT00709956|473864903|FG001|Overall Study|Withdrawal by Subject|1|||
131609671|NCT00709956|473864902|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
131609672|NCT00709956|473864903|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
131609673|NCT03008382|473864904|FG000|Overall Study|Withdrawal by Subject|2|||
131609674|NCT03008382|473864905|FG001|Overall Study|Withdrawal by Subject|5|||
131609675|NCT03008382|473864906|FG002|Overall Study|Withdrawal by Subject|2|||
131609676|NCT03008382|473864907|FG003|Overall Study|Withdrawal by Subject|0|||
131609677|NCT03008382|473864904|FG000|Overall Study|Protocol Violation|1|||
131609678|NCT03008382|473864905|FG001|Overall Study|Protocol Violation|0|||
131609679|NCT03008382|473864906|FG002|Overall Study|Protocol Violation|0|||
131609680|NCT03008382|473864907|FG003|Overall Study|Protocol Violation|0|||
131609681|NCT03008382|473864904|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
131609682|NCT03008382|473864905|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
131609683|NCT03008382|473864906|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
131609684|NCT03008382|473864907|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
131609685|NCT03008382|473864904|FG000|Overall Study|Lost to Follow-up|0|||
131609686|NCT03008382|473864905|FG001|Overall Study|Lost to Follow-up|0|||
131609687|NCT03008382|473864906|FG002|Overall Study|Lost to Follow-up|1|||
131609688|NCT03008382|473864907|FG003|Overall Study|Lost to Follow-up|0|||
131609689|NCT03008382|473864904|FG000|Overall Study|Screenfail|0|||
131609690|NCT03008382|473864905|FG001|Overall Study|Screenfail|0|||
131609691|NCT03008382|473864906|FG002|Overall Study|Screenfail|2|||
131609692|NCT03008382|473864907|FG003|Overall Study|Screenfail|0|||
131609693|NCT03782116|473864908|FG000|Completed Intervetion|Lost to Follow-up|11|||
131609694|NCT03782116|473864909|FG001|Completed Intervetion|Lost to Follow-up|7|||
131609695|NCT03782116|473864908|FG000|Completed Intervetion|Withdrawal by Subject|6|||
131708134|NCT00896532|474211349|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
131609696|NCT03782116|473864909|FG001|Completed Intervetion|Withdrawal by Subject|5|||
131609697|NCT03782116|473864908|FG000|Included in Analysis|Protocol Violation|5|||
131609698|NCT03782116|473864909|FG001|Included in Analysis|Protocol Violation|5|||
131609699|NCT03215706|473864910|FG000|Randomization|Adverse Event unrelated to study drug|1|||
131609700|NCT03215706|473864911|FG001|Randomization|Adverse Event unrelated to study drug|0|||
131609701|NCT03215706|473864910|FG000|Randomization|participant withdrew consent|1|||
131609702|NCT03215706|473864911|FG001|Randomization|participant withdrew consent|3|||
131609703|NCT03215706|473864910|FG000|Randomization|no longer meets study criteria|1|||
131609704|NCT03215706|473864911|FG001|Randomization|no longer meets study criteria|4|||
131609705|NCT03215706|473864910|FG000|Randomization|other reasons|0|||
131609706|NCT03215706|473864911|FG001|Randomization|other reasons|2|||
131609707|NCT03215706|473864910|FG000|Treatment Period|Disease Progression|150|||
131609708|NCT03215706|473864911|FG001|Treatment Period|Disease Progression|142|||
131609709|NCT03215706|473864910|FG000|Treatment Period|Study Drug Toxicity|53|||
131609710|NCT03215706|473864911|FG001|Treatment Period|Study Drug Toxicity|21|||
131609711|NCT03215706|473864910|FG000|Treatment Period|Death|2|||
131609712|NCT03215706|473864911|FG001|Treatment Period|Death|1|||
131609713|NCT03215706|473864910|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
131609714|NCT03215706|473864911|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
131609715|NCT03215706|473864910|FG000|Treatment Period|Request to D/C treatment|1|||
131609716|NCT03215706|473864911|FG001|Treatment Period|Request to D/C treatment|6|||
131609717|NCT03215706|473864910|FG000|Treatment Period|Participant withdrew consent|3|||
131609718|NCT03215706|473864911|FG001|Treatment Period|Participant withdrew consent|4|||
131609719|NCT03215706|473864910|FG000|Treatment Period|Lost to Follow-up|0|||
131609720|NCT03215706|473864911|FG001|Treatment Period|Lost to Follow-up|1|||
131609721|NCT03215706|473864910|FG000|Treatment Period|Other Reasons|4|||
131609722|NCT03215706|473864911|FG001|Treatment Period|Other Reasons|5|||
131609723|NCT03215706|473864910|FG000|Treatment Period|Ongoing in the treatment period|105|||
131609724|NCT03215706|473864911|FG001|Treatment Period|Ongoing in the treatment period|43|||
131609725|NCT00945724|473864912|FG000|Overall Study|Withdrawal by Subject|2|||
131609726|NCT00945724|473864912|FG000|Overall Study|Physician Decision|1|||
131609727|NCT00945724|473864912|FG000|Overall Study|Adverse Event|5|||
131609728|NCT00945724|473864912|FG000|Overall Study|Second malignancy|1|||
131609729|NCT03512301|473865469|FG000|Overall Study|Protocol Violation|2|||
131609730|NCT03512301|473865469|FG000|Overall Study|Did Not Qualify|3|||
131609731|NCT03512301|473865469|FG000|Overall Study|Age-ineligible|1|||
131609732|NCT03512301|473865469|FG000|Overall Study|Inadequate fluency with the English language|3|||
131609733|NCT03983382|473865470|FG000|Overall Study|Death|1|||
131609734|NCT03983382|473865470|FG000|Overall Study|Lost to Follow-up|3|||
131609735|NCT03983382|473865470|FG000|Overall Study|Physician Decision|2|||
131609736|NCT03983382|473865470|FG000|Overall Study|Withdrawal by Subject|10|||
131609737|NCT03983382|473865470|FG000|Overall Study|Change in cancer treatment|2|||
131609738|NCT04174170|473865471|FG000|Placebo Run-in Period|Not Randomized|38|||
131609739|NCT04174170|473865472|FG001|Placebo Run-in Period|Not Randomized|0|||
131609740|NCT04174170|473865473|FG002|Placebo Run-in Period|Not Randomized|0|||
131609741|NCT04174170|473865474|FG003|Placebo Run-in Period|Not Randomized|0|||
131609742|NCT04174170|473865471|FG000|Double Blind Treatment Period|Adverse Event|0|||
131609743|NCT04174170|473865472|FG001|Double Blind Treatment Period|Adverse Event|9|||
131609744|NCT04174170|473865473|FG002|Double Blind Treatment Period|Adverse Event|9|||
131609745|NCT04174170|473865474|FG003|Double Blind Treatment Period|Adverse Event|8|||
131609746|NCT04174170|473865471|FG000|Double Blind Treatment Period|Death|0|||
131609747|NCT04174170|473865472|FG001|Double Blind Treatment Period|Death|1|||
131609748|NCT04174170|473865473|FG002|Double Blind Treatment Period|Death|0|||
131609749|NCT04174170|473865474|FG003|Double Blind Treatment Period|Death|0|||
131609750|NCT04174170|473865471|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
131609751|NCT04174170|473865472|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
131609752|NCT04174170|473865473|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
131609753|NCT04174170|473865474|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
131609754|NCT04174170|473865471|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
131609755|NCT04174170|473865472|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
131609756|NCT04174170|473865473|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
131609757|NCT04174170|473865474|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
131609758|NCT04174170|473865471|FG000|Double Blind Treatment Period|Physician Decision|0|||
131609759|NCT04174170|473865472|FG001|Double Blind Treatment Period|Physician Decision|1|||
131609760|NCT04174170|473865473|FG002|Double Blind Treatment Period|Physician Decision|0|||
131609761|NCT04174170|473865474|FG003|Double Blind Treatment Period|Physician Decision|1|||
131609762|NCT04174170|473865471|FG000|Double Blind Treatment Period|Pregnancy|0|||
131441651|NCT00506350|473245309|FG004|Overall Study|Adverse Event|0|||
131441652|NCT00506350|473245310|FG005|Overall Study|Adverse Event|0|||
131609763|NCT04174170|473865472|FG001|Double Blind Treatment Period|Pregnancy|1|||
131609764|NCT04174170|473865473|FG002|Double Blind Treatment Period|Pregnancy|0|||
131609765|NCT04174170|473865474|FG003|Double Blind Treatment Period|Pregnancy|1|||
131609766|NCT04174170|473865471|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
131609767|NCT04174170|473865472|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
131609768|NCT04174170|473865473|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
131609769|NCT04174170|473865474|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
131708135|NCT00896532|474211327|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131609770|NCT04174170|473865471|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131609771|NCT04174170|473865472|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
131609772|NCT04174170|473865473|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
131609773|NCT04174170|473865474|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
131609774|NCT04174170|473865471|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
131609775|NCT04174170|473865472|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
131609776|NCT04174170|473865473|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
131708136|NCT00896532|474211328|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708137|NCT00896532|474211329|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131441653|NCT00506350|473245311|FG006|Overall Study|Adverse Event|0|||
131609777|NCT04174170|473865474|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
131609778|NCT04772534|473865482|FG000|Overall Study|Physician Decision|1|||
131609779|NCT04772534|473865483|FG001|Overall Study|Physician Decision|0|||
131609780|NCT04772534|473865484|FG002|Overall Study|Physician Decision|0|||
131609781|NCT04772534|473865482|FG000|Overall Study|Withdrawal by Subject|3|||
131609782|NCT04772534|473865483|FG001|Overall Study|Withdrawal by Subject|0|||
131609783|NCT04772534|473865484|FG002|Overall Study|Withdrawal by Subject|1|||
131609784|NCT04194450|473865485|FG000|Overall Study|not eligible|1|||
131609785|NCT04194450|473865486|FG001|Overall Study|not eligible|0|||
131609786|NCT03786926|473865496|FG000|Overall Study|Adverse Event|0|||
131609787|NCT03786926|473865497|FG001|Overall Study|Adverse Event|0|||
131609788|NCT03786926|473865498|FG002|Overall Study|Adverse Event|0|||
131609789|NCT03786926|473865499|FG003|Overall Study|Adverse Event|0|||
131609790|NCT03786926|473865500|FG004|Overall Study|Adverse Event|0|||
131609791|NCT03786926|473865501|FG005|Overall Study|Adverse Event|0|||
131609792|NCT03786926|473865502|FG006|Overall Study|Adverse Event|0|||
131609793|NCT03786926|473865503|FG007|Overall Study|Adverse Event|1|||
131609794|NCT03786926|473865504|FG008|Overall Study|Adverse Event|1|||
131609795|NCT03786926|473865505|FG009|Overall Study|Adverse Event|0|||
131609796|NCT03786926|473865506|FG010|Overall Study|Adverse Event|1|||
131609797|NCT03786926|473865496|FG000|Overall Study|Progressive disease|3|||
131609798|NCT03786926|473865497|FG001|Overall Study|Progressive disease|0|||
131609799|NCT03786926|473865498|FG002|Overall Study|Progressive disease|3|||
131609800|NCT03786926|473865499|FG003|Overall Study|Progressive disease|1|||
131609801|NCT03786926|473865500|FG004|Overall Study|Progressive disease|2|||
131609802|NCT03786926|473865501|FG005|Overall Study|Progressive disease|2|||
131609803|NCT03786926|473865502|FG006|Overall Study|Progressive disease|1|||
131609804|NCT03786926|473865503|FG007|Overall Study|Progressive disease|6|||
131609805|NCT03786926|473865504|FG008|Overall Study|Progressive disease|1|||
131609806|NCT03786926|473865505|FG009|Overall Study|Progressive disease|1|||
131609807|NCT03786926|473865506|FG010|Overall Study|Progressive disease|1|||
131609808|NCT03786926|473865496|FG000|Overall Study|Death|0|||
131609809|NCT03786926|473865497|FG001|Overall Study|Death|1|||
131609810|NCT03786926|473865498|FG002|Overall Study|Death|1|||
131609811|NCT03786926|473865499|FG003|Overall Study|Death|0|||
131609812|NCT03786926|473865500|FG004|Overall Study|Death|0|||
131609813|NCT03786926|473865501|FG005|Overall Study|Death|0|||
131609814|NCT03786926|473865502|FG006|Overall Study|Death|0|||
131609815|NCT03786926|473865503|FG007|Overall Study|Death|0|||
131609816|NCT03786926|473865504|FG008|Overall Study|Death|0|||
131609817|NCT03786926|473865505|FG009|Overall Study|Death|1|||
131609818|NCT03786926|473865506|FG010|Overall Study|Death|2|||
131609819|NCT03786926|473865496|FG000|Overall Study|Physician Decision|0|||
131609820|NCT03786926|473865497|FG001|Overall Study|Physician Decision|1|||
131609821|NCT03786926|473865498|FG002|Overall Study|Physician Decision|0|||
131609822|NCT03786926|473865499|FG003|Overall Study|Physician Decision|1|||
131609823|NCT03786926|473865500|FG004|Overall Study|Physician Decision|2|||
131609824|NCT03786926|473865501|FG005|Overall Study|Physician Decision|0|||
131609825|NCT03786926|473865502|FG006|Overall Study|Physician Decision|0|||
131609826|NCT03786926|473865503|FG007|Overall Study|Physician Decision|2|||
131609827|NCT03786926|473865504|FG008|Overall Study|Physician Decision|1|||
131609828|NCT03786926|473865505|FG009|Overall Study|Physician Decision|1|||
131609829|NCT03786926|473865506|FG010|Overall Study|Physician Decision|0|||
131609830|NCT03786926|473865496|FG000|Overall Study|Withdrawal by Subject|0|||
131609831|NCT03786926|473865497|FG001|Overall Study|Withdrawal by Subject|1|||
131793902|NCT00461500|474528692|FG001|Overall Study|Expired Drug Treatment|1|||
131609832|NCT03786926|473865498|FG002|Overall Study|Withdrawal by Subject|1|||
131609833|NCT03786926|473865499|FG003|Overall Study|Withdrawal by Subject|0|||
131609834|NCT03786926|473865500|FG004|Overall Study|Withdrawal by Subject|0|||
131609835|NCT03786926|473865501|FG005|Overall Study|Withdrawal by Subject|0|||
131609836|NCT03786926|473865502|FG006|Overall Study|Withdrawal by Subject|1|||
131609837|NCT03786926|473865503|FG007|Overall Study|Withdrawal by Subject|0|||
131609838|NCT03786926|473865504|FG008|Overall Study|Withdrawal by Subject|1|||
131609839|NCT03786926|473865505|FG009|Overall Study|Withdrawal by Subject|0|||
131609840|NCT03786926|473865506|FG010|Overall Study|Withdrawal by Subject|1|||
131609841|NCT03786926|473865496|FG000|Overall Study|Study terminated by Sponsor|0|||
131793903|NCT00461500|474528691|FG000|Overall Study|Study Stopped|1|||
131793904|NCT00461500|474528692|FG001|Overall Study|Study Stopped|2|||
131609842|NCT03786926|473865497|FG001|Overall Study|Study terminated by Sponsor|0|||
131609843|NCT03786926|473865498|FG002|Overall Study|Study terminated by Sponsor|0|||
131609844|NCT03786926|473865499|FG003|Overall Study|Study terminated by Sponsor|0|||
131609845|NCT03786926|473865500|FG004|Overall Study|Study terminated by Sponsor|1|||
131609846|NCT03786926|473865501|FG005|Overall Study|Study terminated by Sponsor|0|||
131609847|NCT03786926|473865502|FG006|Overall Study|Study terminated by Sponsor|0|||
131609848|NCT03786926|473865503|FG007|Overall Study|Study terminated by Sponsor|4|||
131609849|NCT03786926|473865504|FG008|Overall Study|Study terminated by Sponsor|0|||
131609850|NCT03786926|473865505|FG009|Overall Study|Study terminated by Sponsor|0|||
131609851|NCT03786926|473865506|FG010|Overall Study|Study terminated by Sponsor|0|||
131609852|NCT03786926|473865496|FG000|Overall Study|Anti-neoplasm treatment|0|||
131609853|NCT03786926|473865497|FG001|Overall Study|Anti-neoplasm treatment|0|||
131609854|NCT03786926|473865498|FG002|Overall Study|Anti-neoplasm treatment|0|||
131441654|NCT00506350|473245312|FG007|Overall Study|Adverse Event|1|||
131441655|NCT00506350|473245313|FG008|Overall Study|Adverse Event|1|||
131441656|NCT00506350|473245305|FG000|Overall Study|Protocol Violation|0|||
131441657|NCT00506350|473245306|FG001|Overall Study|Protocol Violation|0|||
131441658|NCT00506350|473245307|FG002|Overall Study|Protocol Violation|1|||
131441659|NCT00506350|473245308|FG003|Overall Study|Protocol Violation|0|||
131441660|NCT00506350|473245309|FG004|Overall Study|Protocol Violation|0|||
131441661|NCT00506350|473245310|FG005|Overall Study|Protocol Violation|0|||
131441662|NCT00506350|473245311|FG006|Overall Study|Protocol Violation|1|||
131441663|NCT00506350|473245312|FG007|Overall Study|Protocol Violation|0|||
131441664|NCT00506350|473245313|FG008|Overall Study|Protocol Violation|0|||
131441665|NCT00506350|473245305|FG000|Overall Study|Withdrawal by Subject|0|||
131609855|NCT03786926|473865499|FG003|Overall Study|Anti-neoplasm treatment|0|||
131609856|NCT03786926|473865500|FG004|Overall Study|Anti-neoplasm treatment|1|||
131609857|NCT03786926|473865501|FG005|Overall Study|Anti-neoplasm treatment|0|||
131609858|NCT03786926|473865502|FG006|Overall Study|Anti-neoplasm treatment|1|||
131609859|NCT03786926|473865503|FG007|Overall Study|Anti-neoplasm treatment|0|||
131609860|NCT03786926|473865504|FG008|Overall Study|Anti-neoplasm treatment|0|||
131609861|NCT03786926|473865505|FG009|Overall Study|Anti-neoplasm treatment|0|||
131609862|NCT03786926|473865506|FG010|Overall Study|Anti-neoplasm treatment|0|||
131609863|NCT03786926|473865496|FG000|Overall Study|Other|0|||
131609864|NCT03786926|473865497|FG001|Overall Study|Other|0|||
131609865|NCT03786926|473865498|FG002|Overall Study|Other|0|||
131609866|NCT03786926|473865499|FG003|Overall Study|Other|1|||
131609867|NCT03786926|473865500|FG004|Overall Study|Other|0|||
131609868|NCT03786926|473865501|FG005|Overall Study|Other|1|||
131609869|NCT03786926|473865502|FG006|Overall Study|Other|0|||
131609870|NCT03786926|473865503|FG007|Overall Study|Other|0|||
131609871|NCT03786926|473865504|FG008|Overall Study|Other|2|||
131609872|NCT03786926|473865505|FG009|Overall Study|Other|0|||
131609873|NCT03786926|473865506|FG010|Overall Study|Other|0|||
131708138|NCT00896532|474211330|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708139|NCT00896532|474211331|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708140|NCT00896532|474211332|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708141|NCT00896532|474211333|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708142|NCT00896532|474211334|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708143|NCT00896532|474211335|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708144|NCT00896532|474211336|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131609874|NCT05875701|473865512|FG000|Overall Study|Lost to Follow-up|2|||
131609875|NCT05875701|473865513|FG001|Overall Study|Lost to Follow-up|0|||
131708145|NCT00896532|474211337|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708146|NCT00896532|474211338|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708147|NCT00896532|474211339|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708148|NCT00896532|474211340|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708149|NCT00896532|474211341|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708150|NCT00896532|474211342|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
131708151|NCT00896532|474211343|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
131609876|NCT05875701|473865512|FG000|Overall Study|Withdrawal by Subject|1|||
131609877|NCT05875701|473865513|FG001|Overall Study|Withdrawal by Subject|1|||
131609878|NCT03142009|473865514|FG000|Overall Study|Lost to Follow-up|45|||
131708152|NCT00896532|474211344|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131793905|NCT00461500|474528691|FG000|Overall Study|Drug Treatment Misuse|1|||
131793906|NCT00461500|474528692|FG001|Overall Study|Drug Treatment Misuse|0|||
131441666|NCT00506350|473245306|FG001|Overall Study|Withdrawal by Subject|1|||
131609879|NCT03142009|473865515|FG001|Overall Study|Lost to Follow-up|30|||
131441667|NCT00506350|473245307|FG002|Overall Study|Withdrawal by Subject|1|||
131441668|NCT00506350|473245308|FG003|Overall Study|Withdrawal by Subject|1|||
131441669|NCT00506350|473245309|FG004|Overall Study|Withdrawal by Subject|4|||
131441670|NCT00506350|473245310|FG005|Overall Study|Withdrawal by Subject|1|||
131441671|NCT00506350|473245311|FG006|Overall Study|Withdrawal by Subject|1|||
131441672|NCT00506350|473245312|FG007|Overall Study|Withdrawal by Subject|2|||
131441673|NCT00506350|473245313|FG008|Overall Study|Withdrawal by Subject|0|||
131441674|NCT00506350|473245305|FG000|Overall Study|Lost to Follow-up|1|||
131609880|NCT05771467|473865517|FG000|Overall Study|Lost to Follow-up|6|||
131609881|NCT05771467|473865518|FG001|Overall Study|Lost to Follow-up|3|||
131609882|NCT01553149|473865519|FG000|Overall Study|Adverse Event|0|||
131609883|NCT01553149|473865520|FG001|Overall Study|Adverse Event|9|||
131609884|NCT01553149|473865519|FG000|Overall Study|Physician Decision|5|||
131609885|NCT01553149|473865520|FG001|Overall Study|Physician Decision|10|||
131609886|NCT01553149|473865519|FG000|Overall Study|Ineligible|0|||
131609887|NCT01553149|473865520|FG001|Overall Study|Ineligible|1|||
131609888|NCT01105091|473865522|FG000|Overall Study|Death|2|||
131609889|NCT01105091|473865523|FG001|Overall Study|Death|0|||
131609890|NCT00994643|473866074|FG000|Overall Study|Withdrawal by Subject|1|||
131609891|NCT03934931|473866075|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
131609892|NCT03934931|473866076|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
131609893|NCT03934931|473866077|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
131609894|NCT03733626|473866079|FG000|Overall Study|Physician Decision|4|||
131609895|NCT03733626|473866080|FG001|Overall Study|Physician Decision|4|||
131609896|NCT03201939|473866081|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
131609897|NCT03201939|473866082|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
131441675|NCT00506350|473245306|FG001|Overall Study|Lost to Follow-up|1|||
131441676|NCT00506350|473245307|FG002|Overall Study|Lost to Follow-up|1|||
131441677|NCT00506350|473245308|FG003|Overall Study|Lost to Follow-up|1|||
131609898|NCT04586244|473866087|FG000|Overall Study|Lost to Follow-up|1|||
131609899|NCT04586244|473866088|FG001|Overall Study|Lost to Follow-up|0|||
131609900|NCT04586244|473866089|FG002|Overall Study|Lost to Follow-up|0|||
131609901|NCT04586244|473866090|FG003|Overall Study|Lost to Follow-up|1|||
131609902|NCT04586244|473866091|FG004|Overall Study|Lost to Follow-up|0|||
131609903|NCT04586244|473866087|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131609904|NCT04586244|473866088|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
131609905|NCT04586244|473866089|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131609906|NCT04586244|473866090|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131609907|NCT04586244|473866091|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131609908|NCT05707351|473866096|FG000|Overall Study|Withdrawal by Subject|2|||
131609909|NCT05707351|473866096|FG000|Overall Study|Reason Not Specified|1|||
131609910|NCT04174560|473866104|FG000|Overall Study|Lost to Follow-up|1|||
131441678|NCT00506350|473245309|FG004|Overall Study|Lost to Follow-up|2|||
131441679|NCT00506350|473245310|FG005|Overall Study|Lost to Follow-up|1|||
131441680|NCT00506350|473245311|FG006|Overall Study|Lost to Follow-up|0|||
131441681|NCT00506350|473245312|FG007|Overall Study|Lost to Follow-up|0|||
131441682|NCT00506350|473245313|FG008|Overall Study|Lost to Follow-up|2|||
131441683|NCT00506350|473245305|FG000|Overall Study|Medical Reason|0|||
131441684|NCT00506350|473245306|FG001|Overall Study|Medical Reason|0|||
131441685|NCT00506350|473245307|FG002|Overall Study|Medical Reason|0|||
131441686|NCT00506350|473245308|FG003|Overall Study|Medical Reason|0|||
131441687|NCT00506350|473245309|FG004|Overall Study|Medical Reason|1|||
131441688|NCT00506350|473245310|FG005|Overall Study|Medical Reason|0|||
131441689|NCT00506350|473245311|FG006|Overall Study|Medical Reason|0|||
131441690|NCT00506350|473245312|FG007|Overall Study|Medical Reason|0|||
131441691|NCT00506350|473245313|FG008|Overall Study|Medical Reason|0|||
131441692|NCT00506350|473245305|FG000|Overall Study|Other|1|||
131441693|NCT00506350|473245306|FG001|Overall Study|Other|1|||
131441694|NCT00506350|473245307|FG002|Overall Study|Other|3|||
131441695|NCT00506350|473245308|FG003|Overall Study|Other|0|||
131441696|NCT00506350|473245309|FG004|Overall Study|Other|3|||
131441697|NCT00506350|473245310|FG005|Overall Study|Other|0|||
131441698|NCT00506350|473245311|FG006|Overall Study|Other|0|||
131609911|NCT04174560|473866105|FG001|Overall Study|Lost to Follow-up|0|||
131609912|NCT04174560|473866106|FG002|Overall Study|Lost to Follow-up|0|||
131609913|NCT04174560|473866107|FG003|Overall Study|Lost to Follow-up|0|||
131708153|NCT00896532|474211345|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131441699|NCT00506350|473245312|FG007|Overall Study|Other|2|||
131609914|NCT04174560|473866104|FG000|Overall Study|Withdrawal by Subject|0|||
131609915|NCT04174560|473866105|FG001|Overall Study|Withdrawal by Subject|0|||
131609916|NCT04174560|473866106|FG002|Overall Study|Withdrawal by Subject|2|||
131609917|NCT04174560|473866107|FG003|Overall Study|Withdrawal by Subject|0|||
131609918|NCT05424718|473866109|FG000|Overall Study|Lost to Follow-up|5|||
131708154|NCT00896532|474211346|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131441700|NCT00506350|473245313|FG008|Overall Study|Other|2|||
131441701|NCT01607957|473245314|FG000|Overall Study|Not treated|1|||
131441702|NCT01607957|473245315|FG001|Overall Study|Not treated|1|||
131441703|NCT01607957|473245314|FG000|Overall Study|Death|367|||
131441704|NCT01607957|473245315|FG001|Overall Study|Death|211|||
131609919|NCT05424718|473866110|FG001|Overall Study|Lost to Follow-up|4|||
131609920|NCT04046549|473866111|FG000|Overall Study|Adverse Event|1|||
131609921|NCT04046549|473866111|FG000|Overall Study|Physician Decision|1|||
131609922|NCT04046549|473866111|FG000|Overall Study|Withdrawal by Subject|3|||
131609923|NCT04046549|473866111|FG000|Overall Study|Other, Not Specified|5|||
131609924|NCT03872466|473866112|FG000|Overall Study|Withdrawal by Subject|1|||
131609925|NCT03872466|473866113|FG001|Overall Study|Withdrawal by Subject|0|||
131609926|NCT03872466|473866112|FG000|Overall Study|Physician Decision|2|||
131609927|NCT03872466|473866113|FG001|Overall Study|Physician Decision|0|||
131609928|NCT01778686|473866114|FG000|Overall Study|Adverse Event|0|||
131609929|NCT01778686|473866115|FG001|Overall Study|Adverse Event|0|||
131609930|NCT01778686|473866116|FG002|Overall Study|Adverse Event|1|||
131609931|NCT05412004|473866871|FG000|Overall Study|Adverse Event|0|||
131609932|NCT05412004|473866872|FG001|Overall Study|Adverse Event|2|||
131609933|NCT05412004|473866873|FG002|Overall Study|Adverse Event|1|||
131609934|NCT05412004|473866874|FG003|Overall Study|Adverse Event|5|||
131609935|NCT05412004|473866871|FG000|Overall Study|Assigned Treatment by Mistake|5|||
131609936|NCT05412004|473866872|FG001|Overall Study|Assigned Treatment by Mistake|10|||
131609937|NCT05412004|473866873|FG002|Overall Study|Assigned Treatment by Mistake|2|||
131609938|NCT05412004|473866874|FG003|Overall Study|Assigned Treatment by Mistake|5|||
131609939|NCT05412004|473866871|FG000|Overall Study|Lost to Follow-up|3|||
131609940|NCT05412004|473866872|FG001|Overall Study|Lost to Follow-up|0|||
131609941|NCT05412004|473866873|FG002|Overall Study|Lost to Follow-up|0|||
131609942|NCT05412004|473866874|FG003|Overall Study|Lost to Follow-up|0|||
131609943|NCT05412004|473866871|FG000|Overall Study|Patient could not travel to site|0|||
131609944|NCT05412004|473866872|FG001|Overall Study|Patient could not travel to site|1|||
131609945|NCT05412004|473866873|FG002|Overall Study|Patient could not travel to site|0|||
131609946|NCT05412004|473866874|FG003|Overall Study|Patient could not travel to site|0|||
131609947|NCT05412004|473866871|FG000|Overall Study|Physician Decision|0|||
131609948|NCT05412004|473866872|FG001|Overall Study|Physician Decision|1|||
131609949|NCT05412004|473866873|FG002|Overall Study|Physician Decision|0|||
131609950|NCT05412004|473866874|FG003|Overall Study|Physician Decision|0|||
131609951|NCT05412004|473866871|FG000|Overall Study|Pregnancy|0|||
131609952|NCT05412004|473866872|FG001|Overall Study|Pregnancy|1|||
131609953|NCT05412004|473866873|FG002|Overall Study|Pregnancy|0|||
131609954|NCT05412004|473866874|FG003|Overall Study|Pregnancy|0|||
131609955|NCT05412004|473866871|FG000|Overall Study|Protocol Violation|1|||
131609956|NCT05412004|473866872|FG001|Overall Study|Protocol Violation|0|||
131609957|NCT05412004|473866873|FG002|Overall Study|Protocol Violation|0|||
131609958|NCT05412004|473866874|FG003|Overall Study|Protocol Violation|0|||
131609959|NCT05412004|473866871|FG000|Overall Study|Withdrawal by Subject|4|||
131609960|NCT05412004|473866872|FG001|Overall Study|Withdrawal by Subject|19|||
131609961|NCT05412004|473866873|FG002|Overall Study|Withdrawal by Subject|4|||
131609962|NCT05412004|473866874|FG003|Overall Study|Withdrawal by Subject|14|||
131609963|NCT05412004|473866871|FG000|Overall Study|Screen Failure|0|||
131609964|NCT05412004|473866872|FG001|Overall Study|Screen Failure|0|||
131609965|NCT05412004|473866873|FG002|Overall Study|Screen Failure|0|||
131609966|NCT05412004|473866874|FG003|Overall Study|Screen Failure|1|||
131609967|NCT05412004|473866871|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
131609968|NCT05412004|473866872|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
131609969|NCT05412004|473866873|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
131609970|NCT05412004|473866874|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
131609971|NCT04644029|473866875|FG000|Overall Study|Death|1|||
131609972|NCT04644029|473866876|FG001|Overall Study|Death|0|||
131609973|NCT04644029|473866875|FG000|Overall Study|Physician Decision|1|||
131609974|NCT04644029|473866876|FG001|Overall Study|Physician Decision|2|||
131609975|NCT04644029|473866875|FG000|Overall Study|Withdrawal by Subject|21|||
131609976|NCT04644029|473866876|FG001|Overall Study|Withdrawal by Subject|19|||
131609977|NCT04644029|473866875|FG000|Overall Study|Lost to Follow-up|31|||
131609978|NCT04644029|473866876|FG001|Overall Study|Lost to Follow-up|34|||
131609979|NCT04644029|473866875|FG000|Overall Study|Study Terminated by Sponsor|308|||
131609980|NCT04644029|473866876|FG001|Overall Study|Study Terminated by Sponsor|309|||
131609981|NCT04644029|473866875|FG000|Overall Study|Randomized in Error|2|||
131609982|NCT04644029|473866876|FG001|Overall Study|Randomized in Error|1|||
131609983|NCT04644029|473866875|FG000|Overall Study|Other|0|||
131609984|NCT04644029|473866876|FG001|Overall Study|Other|1|||
131609985|NCT00968149|473866877|FG000|Overall Study|Adverse Event|5|||
131609986|NCT00968149|473866878|FG001|Overall Study|Adverse Event|1|||
131609987|NCT00968149|473866877|FG000|Overall Study|Lack of Efficacy|0|||
131609988|NCT00968149|473866878|FG001|Overall Study|Lack of Efficacy|4|||
131609989|NCT00968149|473866877|FG000|Overall Study|Lost to Follow-up|0|||
131609990|NCT00968149|473866878|FG001|Overall Study|Lost to Follow-up|1|||
131609991|NCT00968149|473866877|FG000|Overall Study|Protocol Violation|4|||
131609992|NCT00968149|473866878|FG001|Overall Study|Protocol Violation|0|||
131609993|NCT00968149|473866877|FG000|Overall Study|Withdrawal by Subject|2|||
131609994|NCT00968149|473866878|FG001|Overall Study|Withdrawal by Subject|0|||
131609995|NCT02467270|473866881|FG000|Overall Study|Participants Never Treated|0|||
131609996|NCT02467270|473866882|FG001|Overall Study|Participants Never Treated|1|||
131609997|NCT02467270|473866883|FG002|Overall Study|Participants Never Treated|0|||
131609998|NCT02467270|473866881|FG000|Overall Study|Ongoing|50|||
131609999|NCT02467270|473866882|FG001|Overall Study|Ongoing|41|||
131610000|NCT02467270|473866883|FG002|Overall Study|Ongoing|43|||
131610001|NCT02467270|473866881|FG000|Overall Study|Adverse Event|16|||
131610002|NCT02467270|473866882|FG001|Overall Study|Adverse Event|15|||
131610003|NCT02467270|473866883|FG002|Overall Study|Adverse Event|14|||
131610004|NCT02467270|473866881|FG000|Overall Study|Progressive Disease|7|||
131610005|NCT02467270|473866882|FG001|Overall Study|Progressive Disease|7|||
131610006|NCT02467270|473866883|FG002|Overall Study|Progressive Disease|4|||
131610007|NCT02467270|473866881|FG000|Overall Study|Death|2|||
131610008|NCT02467270|473866882|FG001|Overall Study|Death|0|||
131610009|NCT02467270|473866883|FG002|Overall Study|Death|2|||
131610010|NCT02467270|473866881|FG000|Overall Study|Lack of Efficacy|12|||
131610011|NCT02467270|473866882|FG001|Overall Study|Lack of Efficacy|18|||
131610012|NCT02467270|473866883|FG002|Overall Study|Lack of Efficacy|23|||
131610013|NCT02467270|473866881|FG000|Overall Study|Non-compliance With Study Drug|0|||
131610014|NCT02467270|473866882|FG001|Overall Study|Non-compliance With Study Drug|2|||
131610015|NCT02467270|473866883|FG002|Overall Study|Non-compliance With Study Drug|1|||
131610016|NCT02467270|473866881|FG000|Overall Study|Lost to Follow-up|2|||
131610017|NCT02467270|473866882|FG001|Overall Study|Lost to Follow-up|1|||
131610018|NCT02467270|473866883|FG002|Overall Study|Lost to Follow-up|0|||
131610019|NCT02467270|473866881|FG000|Overall Study|Pregnancy|0|||
131610020|NCT02467270|473866882|FG001|Overall Study|Pregnancy|1|||
131610021|NCT02467270|473866883|FG002|Overall Study|Pregnancy|0|||
131610022|NCT02467270|473866881|FG000|Overall Study|Physician Decision|0|||
131610023|NCT02467270|473866882|FG001|Overall Study|Physician Decision|4|||
131610024|NCT02467270|473866883|FG002|Overall Study|Physician Decision|1|||
131610025|NCT02467270|473866881|FG000|Overall Study|Withdrawal by Subject|4|||
131610026|NCT02467270|473866882|FG001|Overall Study|Withdrawal by Subject|3|||
131610027|NCT02467270|473866883|FG002|Overall Study|Withdrawal by Subject|5|||
131610028|NCT02467270|473866881|FG000|Overall Study|Reason not Specified|1|||
131610029|NCT02467270|473866882|FG001|Overall Study|Reason not Specified|2|||
131610030|NCT02467270|473866883|FG002|Overall Study|Reason not Specified|1|||
131610031|NCT00495677|473866884|FG000|Stage 1 (25 Days)|Adverse Event|0|||
131610032|NCT00495677|473866885|FG001|Stage 1 (25 Days)|Adverse Event|0|||
131610033|NCT00495677|473866886|FG002|Stage 1 (25 Days)|Adverse Event|1|||
131610034|NCT00495677|473866887|FG003|Stage 1 (25 Days)|Adverse Event|0|||
131610035|NCT00495677|473866888|FG004|Stage 1 (25 Days)|Adverse Event|0|||
131610036|NCT00495677|473866889|FG005|Stage 1 (25 Days)|Adverse Event|0|||
131610037|NCT00495677|473866890|FG006|Stage 1 (25 Days)|Adverse Event|0|||
131610038|NCT04129164|473866893|FG000|Overall Study|Non-compliance with procedures|0|||
131610039|NCT04129164|473866894|FG001|Overall Study|Non-compliance with procedures|0|||
131610040|NCT04129164|473866895|FG002|Overall Study|Non-compliance with procedures|2|||
131610041|NCT04129164|473866896|FG003|Overall Study|Non-compliance with procedures|0|||
131610042|NCT04129164|473866893|FG000|Overall Study|Adverse Event|0|||
131610043|NCT04129164|473866894|FG001|Overall Study|Adverse Event|0|||
131610044|NCT04129164|473866895|FG002|Overall Study|Adverse Event|2|||
131610045|NCT04129164|473866896|FG003|Overall Study|Adverse Event|0|||
131610046|NCT04129164|473866893|FG000|Overall Study|Pregnancy|0|||
131610047|NCT04129164|473866894|FG001|Overall Study|Pregnancy|0|||
131610048|NCT04129164|473866895|FG002|Overall Study|Pregnancy|0|||
131610049|NCT04129164|473866896|FG003|Overall Study|Pregnancy|1|||
131610050|NCT04129164|473866893|FG000|Overall Study|Withdrawal by Subject|3|||
131610051|NCT04129164|473866894|FG001|Overall Study|Withdrawal by Subject|2|||
131793907|NCT00461500|474528691|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
131793908|NCT00461500|474528692|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
131793909|NCT00461500|474528691|FG000|Overall Study|Lost to Follow-up|2|||
131793910|NCT00461500|474528692|FG001|Overall Study|Lost to Follow-up|2|||
131793911|NCT01806597|474528697|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
131793912|NCT01806597|474528698|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
131610052|NCT04129164|473866895|FG002|Overall Study|Withdrawal by Subject|4|||
131610053|NCT04129164|473866896|FG003|Overall Study|Withdrawal by Subject|6|||
131610054|NCT04129164|473866893|FG000|Overall Study|Death|0|||
131793913|NCT01806597|474528699|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
131610055|NCT04129164|473866894|FG001|Overall Study|Death|1|||
131793914|NCT01806597|474528700|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
131900015|NCT02989402|474919427|FG000|Overall Study|Withdrawal by Subject|7|||
131610056|NCT04129164|473866895|FG002|Overall Study|Death|0|||
131610057|NCT04129164|473866896|FG003|Overall Study|Death|0|||
131610058|NCT04129164|473866893|FG000|Overall Study|Lost to Follow-up|0|||
131610059|NCT04129164|473866894|FG001|Overall Study|Lost to Follow-up|1|||
131610060|NCT04129164|473866895|FG002|Overall Study|Lost to Follow-up|0|||
131610061|NCT04129164|473866896|FG003|Overall Study|Lost to Follow-up|0|||
131610062|NCT02231749|473866899|FG000|Overall Study|Disease progression|229|||
131610063|NCT02231749|473866900|FG001|Overall Study|Disease progression|297|||
131441705|NCT01607957|473245314|FG000|Overall Study|Lost to Follow-up|3|||
131441706|NCT01607957|473245315|FG001|Overall Study|Lost to Follow-up|3|||
131441707|NCT01607957|473245314|FG000|Overall Study|Participant refusal|1|||
131441708|NCT01607957|473245315|FG001|Overall Study|Participant refusal|0|||
131441709|NCT01691794|473245318|FG000|Overall Study|Poor/Non-Compliance|1|||
131441710|NCT01691794|473245319|FG001|Overall Study|Poor/Non-Compliance|4|||
131441711|NCT01691794|473245320|FG002|Overall Study|Poor/Non-Compliance|1|||
131441712|NCT01691794|473245318|FG000|Overall Study|Death|0|||
131441713|NCT01691794|473245319|FG001|Overall Study|Death|0|||
131441714|NCT01691794|473245320|FG002|Overall Study|Death|1|||
131441715|NCT01691794|473245318|FG000|Overall Study|Lack of Efficacy|0|||
131441716|NCT01691794|473245319|FG001|Overall Study|Lack of Efficacy|7|||
131441717|NCT01691794|473245320|FG002|Overall Study|Lack of Efficacy|1|||
131441718|NCT01691794|473245318|FG000|Overall Study|Participant request to discontinue|0|||
131441719|NCT01691794|473245319|FG001|Overall Study|Participant request to discontinue|1|||
131441720|NCT01691794|473245320|FG002|Overall Study|Participant request to discontinue|0|||
131441721|NCT01691794|473245318|FG000|Overall Study|Adverse Event|0|||
131441722|NCT01691794|473245319|FG001|Overall Study|Adverse Event|1|||
131441723|NCT01691794|473245320|FG002|Overall Study|Adverse Event|1|||
131441724|NCT01691794|473245318|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
131441725|NCT01691794|473245319|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
131441726|NCT01691794|473245320|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
131441727|NCT01691794|473245318|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
131441728|NCT01691794|473245319|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
131441729|NCT01691794|473245320|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
131441730|NCT02994108|473247179|FG000|Intervention Messages|Withdrawal by Subject|2|||
131441731|NCT02994108|473247180|FG001|Intervention Messages|Withdrawal by Subject|0|||
131441732|NCT02994108|473247179|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
131441733|NCT02994108|473247180|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
131441734|NCT02994108|473247179|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
131441735|NCT02994108|473247180|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
131441736|NCT02994108|473247179|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
131441737|NCT02994108|473247180|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
131441738|NCT02081677|473247181|FG000|Overall Study|Adverse Event|0|||
131441739|NCT02081677|473247182|FG001|Overall Study|Adverse Event|0|||
131441740|NCT02081677|473247183|FG002|Overall Study|Adverse Event|1|||
131441741|NCT02081677|473247184|FG003|Overall Study|Adverse Event|0|||
131441742|NCT02081677|473247181|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131441743|NCT02081677|473247182|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131441744|NCT02081677|473247183|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
131441745|NCT02081677|473247184|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
131441746|NCT02081677|473247181|FG000|Overall Study|Not comfortable with lens care system|1|||
131441747|NCT02081677|473247182|FG001|Overall Study|Not comfortable with lens care system|0|||
131610064|NCT02231749|473866899|FG000|Overall Study|Study Drug Toxicity|134|||
131610065|NCT02231749|473866900|FG001|Overall Study|Study Drug Toxicity|63|||
131610066|NCT02231749|473866899|FG000|Overall Study|Death|1|||
131610067|NCT02231749|473866900|FG001|Overall Study|Death|1|||
131610068|NCT02231749|473866899|FG000|Overall Study|AE unrelated to Study drug|32|||
131610069|NCT02231749|473866900|FG001|Overall Study|AE unrelated to Study drug|31|||
131610070|NCT02231749|473866899|FG000|Overall Study|Participant's request to discontinue|10|||
131441748|NCT02081677|473247183|FG002|Overall Study|Not comfortable with lens care system|0|||
131610071|NCT02231749|473866900|FG001|Overall Study|Participant's request to discontinue|21|||
131610072|NCT02231749|473866899|FG000|Overall Study|Participant withdrew Consent|8|||
131610073|NCT02231749|473866900|FG001|Overall Study|Participant withdrew Consent|15|||
131610074|NCT02231749|473866899|FG000|Overall Study|Lost to Follow-up|1|||
131610075|NCT02231749|473866900|FG001|Overall Study|Lost to Follow-up|2|||
131610076|NCT02231749|473866899|FG000|Overall Study|Maximum Clinical Benefit|5|||
131610077|NCT02231749|473866900|FG001|Overall Study|Maximum Clinical Benefit|8|||
131610078|NCT02231749|473866899|FG000|Overall Study|Poor/Non-Compliance|0|||
131610079|NCT02231749|473866900|FG001|Overall Study|Poor/Non-Compliance|3|||
131610080|NCT02231749|473866899|FG000|Overall Study|Pregnancy|1|||
131610081|NCT02231749|473866900|FG001|Overall Study|Pregnancy|0|||
131610082|NCT02231749|473866899|FG000|Overall Study|other|0|||
131610083|NCT02231749|473866900|FG001|Overall Study|other|8|||
131610084|NCT02231749|473866899|FG000|Overall Study|No longer meets Study Criteria|1|||
131610085|NCT02231749|473866900|FG001|Overall Study|No longer meets Study Criteria|0|||
131610086|NCT02989662|473866906|FG000|Overall Study|Lost to Follow-up|0|||
131441749|NCT02081677|473247184|FG003|Overall Study|Not comfortable with lens care system|0|||
131441750|NCT02081677|473247181|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
131441751|NCT02081677|473247182|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
131610087|NCT02989662|473866907|FG001|Overall Study|Lost to Follow-up|0|||
131610088|NCT02989662|473866908|FG002|Overall Study|Lost to Follow-up|0|||
131610089|NCT02989662|473866909|FG003|Overall Study|Lost to Follow-up|2|||
131610090|NCT02989662|473866906|FG000|Overall Study|Physician Decision|3|||
131610091|NCT02989662|473866907|FG001|Overall Study|Physician Decision|0|||
131610092|NCT02989662|473866908|FG002|Overall Study|Physician Decision|0|||
131900016|NCT02989402|474919427|FG000|Overall Study|Other|2|||
131610093|NCT02989662|473866909|FG003|Overall Study|Physician Decision|0|||
131610094|NCT02989662|473866906|FG000|Overall Study|Withdrawal by Subject|1|||
131610095|NCT02989662|473866907|FG001|Overall Study|Withdrawal by Subject|0|||
131610096|NCT02989662|473866908|FG002|Overall Study|Withdrawal by Subject|0|||
131610097|NCT02989662|473866909|FG003|Overall Study|Withdrawal by Subject|0|||
131610098|NCT02726386|473866912|FG000|Overall Study|Adverse Event|17|||
131610099|NCT02726386|473866913|FG001|Overall Study|Adverse Event|20|||
131610100|NCT02726386|473866912|FG000|Overall Study|Withdrawal by Subject|14|||
131610101|NCT02726386|473866913|FG001|Overall Study|Withdrawal by Subject|28|||
131610102|NCT02726386|473866912|FG000|Overall Study|Other reasons|7|||
131610103|NCT02726386|473866913|FG001|Overall Study|Other reasons|8|||
131610104|NCT04012567|473866918|FG000|Overall Study|Lost to Follow-up|0|||
131610105|NCT04012567|473866919|FG001|Overall Study|Lost to Follow-up|1|||
131610106|NCT04012567|473866918|FG000|Overall Study|Withdrawal by Subject|1|||
131610107|NCT04012567|473866919|FG001|Overall Study|Withdrawal by Subject|0|||
131610108|NCT02951052|473866921|FG000|Overall Study|Adverse Event|13|||
131610109|NCT02951052|473866922|FG001|Overall Study|Adverse Event|5|||
131610110|NCT02951052|473866921|FG000|Overall Study|Withdrawal by Subject|1|||
131610111|NCT02951052|473866922|FG001|Overall Study|Withdrawal by Subject|5|||
131610112|NCT02951052|473866921|FG000|Overall Study|Physician Decision|2|||
131610113|NCT02951052|473866922|FG001|Overall Study|Physician Decision|0|||
131610114|NCT02951052|473866921|FG000|Overall Study|Lost to Follow-up|1|||
131610115|NCT02951052|473866922|FG001|Overall Study|Lost to Follow-up|1|||
131610116|NCT02951052|473866921|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
131610117|NCT02951052|473866922|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
131610118|NCT02951052|473866921|FG000|Overall Study|Protocol Violation|5|||
131610119|NCT02951052|473866922|FG001|Overall Study|Protocol Violation|3|||
131610120|NCT02951052|473866921|FG000|Overall Study|Lack of Efficacy|3|||
131610121|NCT02951052|473866922|FG001|Overall Study|Lack of Efficacy|4|||
131610122|NCT02951052|473866921|FG000|Overall Study|Ongoing|1|||
131610123|NCT02951052|473866922|FG001|Overall Study|Ongoing|0|||
131610124|NCT02206828|473866923|FG000|Overall Study|Lost to Follow-up|7|||
131610125|NCT04518943|473868161|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
131610126|NCT04518943|473868162|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
131610127|NCT04518943|473868163|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
131610128|NCT04518943|473868164|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
131610129|NCT04518943|473868165|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
131610130|NCT04518943|473868166|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
131610131|NCT04518943|473868167|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
131610132|NCT04518943|473868168|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
131610133|NCT04518943|473868169|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
131610134|NCT04518943|473868170|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
131610135|NCT04518943|473868171|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
131610136|NCT04518943|473868172|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
131610137|NCT04518943|473868173|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
131610138|NCT04518943|473868174|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
131610139|NCT04518943|473868175|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
131610140|NCT04518943|473868176|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
131610141|NCT03705793|473868177|FG000|Overall Study|Lost to Follow-up|3|||
131610142|NCT03705793|473868178|FG001|Overall Study|Lost to Follow-up|4|||
131610143|NCT03705793|473868177|FG000|Overall Study|Withdrawal by Subject|2|||
131610144|NCT03705793|473868178|FG001|Overall Study|Withdrawal by Subject|1|||
131610145|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|Other|0|||
131610146|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|Other|2|||
131610147|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|Other|1|||
131610148|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|Other|2|||
131610149|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|Other|2|||
131610150|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|Other|0|||
131610151|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|Other|0|||
131610152|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|Other|0|||
131610153|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|Other|0|||
131610154|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|Other|0|||
131610155|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|Other|0|||
131610156|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|Other|0|||
131610157|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|Other|0|||
131610158|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|Other|0|||
131610159|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|Other|0|||
131610160|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|Other|0|||
131610161|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|Other|0|||
131610162|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
131610163|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
131708155|NCT00896532|474211347|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708156|NCT00896532|474211348|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708157|NCT00896532|474211349|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131708158|NCT00896532|474211327|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708159|NCT00896532|474211328|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708160|NCT00896532|474211329|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708161|NCT00896532|474211330|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708162|NCT00896532|474211331|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708163|NCT00896532|474211332|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708164|NCT00896532|474211333|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708165|NCT00896532|474211334|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708166|NCT00896532|474211335|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131900017|NCT02686164|474919436|FG000|Overall Study|Adverse Event|1|||
131900018|NCT02686164|474919436|FG000|Overall Study|Withdrawal of consent|1|||
131610164|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
131610165|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
131610166|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
131610167|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
131610168|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610169|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610170|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610171|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610172|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610173|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610174|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610175|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610176|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610177|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610178|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131610179|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610180|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
131610181|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
131610182|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610183|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
131610184|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
131610185|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610186|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610187|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610188|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610189|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610190|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610191|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610192|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610193|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610194|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610195|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131610196|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|Death|2|||
131610197|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|Death|1|||
131610198|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|Death|1|||
131610199|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|Death|0|||
131610200|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|Death|0|||
131610201|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|Death|0|||
131610202|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|Death|0|||
131610203|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|Death|0|||
131610204|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|Death|0|||
131610205|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|Death|0|||
131610206|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|Death|0|||
131610207|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|Death|0|||
131610208|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|Death|0|||
131610209|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|Death|0|||
131610210|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|Death|0|||
131610211|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|Death|0|||
131610212|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|Death|0|||
131610213|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610214|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
131610215|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610216|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610217|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
131610218|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
131610219|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610220|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610221|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610222|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610223|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610224|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610225|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610226|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
131793915|NCT01806597|474528701|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
131793916|NCT01806597|474528702|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
131793917|NCT01806597|474528697|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
131793918|NCT01806597|474528698|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131793919|NCT01806597|474528699|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131793920|NCT01806597|474528700|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131793921|NCT01806597|474528701|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
131793922|NCT01806597|474528702|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131793923|NCT01806597|474528697|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131610227|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610228|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610229|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
131610230|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610231|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610232|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610233|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610234|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
131610235|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
131610236|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610237|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610238|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610239|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610240|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610241|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610242|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
131708167|NCT00896532|474211336|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708168|NCT00896532|474211337|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708169|NCT00896532|474211338|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708170|NCT00896532|474211339|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708171|NCT00896532|474211340|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708172|NCT00896532|474211341|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708173|NCT00896532|474211342|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
131708174|NCT00896532|474211343|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
131708175|NCT00896532|474211344|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
131708176|NCT00896532|474211345|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708177|NCT00896532|474211346|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708178|NCT00896532|474211347|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708179|NCT00896532|474211348|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708180|NCT00896532|474211349|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131708181|NCT00896532|474211327|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708182|NCT00896532|474211328|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708183|NCT00896532|474211329|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708184|NCT00896532|474211330|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708185|NCT00896532|474211331|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708186|NCT00896532|474211332|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708187|NCT00896532|474211333|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708188|NCT00896532|474211334|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708189|NCT00896532|474211335|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708190|NCT00896532|474211336|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131793924|NCT01806597|474528698|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
131793925|NCT01806597|474528699|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131610243|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610244|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610245|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610246|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
131610247|NCT02719574|473868179|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610248|NCT02719574|473868180|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610249|NCT02719574|473868181|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
131610250|NCT02719574|473868182|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610251|NCT02719574|473868183|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610252|NCT02719574|473868184|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610253|NCT02719574|473868185|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610254|NCT02719574|473868186|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610255|NCT02719574|473868187|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610256|NCT02719574|473868188|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610257|NCT02719574|473868189|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610258|NCT02719574|473868190|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610259|NCT02719574|473868191|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610260|NCT02719574|473868192|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610261|NCT02719574|473868193|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610262|NCT02719574|473868194|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610263|NCT02719574|473868195|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131610264|NCT02719574|473868179|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610265|NCT02719574|473868180|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610266|NCT02719574|473868181|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610267|NCT02719574|473868182|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610268|NCT02719574|473868183|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610269|NCT02719574|473868184|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610270|NCT02719574|473868185|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
131610271|NCT02719574|473868186|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
131610272|NCT02719574|473868187|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
131610273|NCT02719574|473868188|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610274|NCT02719574|473868189|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610275|NCT02719574|473868190|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610276|NCT02719574|473868191|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610277|NCT02719574|473868192|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610278|NCT02719574|473868193|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610279|NCT02719574|473868194|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610280|NCT02719574|473868195|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131610281|NCT02719574|473868179|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610282|NCT02719574|473868180|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610283|NCT02719574|473868181|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610284|NCT02719574|473868182|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610285|NCT02719574|473868183|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610286|NCT02719574|473868184|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610287|NCT02719574|473868185|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
131610288|NCT02719574|473868186|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
131793926|NCT01806597|474528700|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131793927|NCT01806597|474528701|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131793928|NCT01806597|474528702|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131793929|NCT01806597|474528697|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
131793930|NCT01806597|474528698|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
131793931|NCT01806597|474528699|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
131793932|NCT01806597|474528700|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
131793933|NCT01806597|474528701|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
131793934|NCT01806597|474528702|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
131793935|NCT01806597|474528697|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131793936|NCT01806597|474528698|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
131610289|NCT02719574|473868187|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610290|NCT02719574|473868188|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610291|NCT02719574|473868189|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610292|NCT02719574|473868190|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610293|NCT02719574|473868191|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610294|NCT02719574|473868192|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610295|NCT02719574|473868193|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610296|NCT02719574|473868194|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610297|NCT02719574|473868195|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131610298|NCT02719574|473868179|FG000|Phase 1 (Dose Expansion)|Death|0|||
131610299|NCT02719574|473868180|FG001|Phase 1 (Dose Expansion)|Death|0|||
131610300|NCT02719574|473868181|FG002|Phase 1 (Dose Expansion)|Death|0|||
131610301|NCT02719574|473868182|FG003|Phase 1 (Dose Expansion)|Death|0|||
131610302|NCT02719574|473868183|FG004|Phase 1 (Dose Expansion)|Death|0|||
131610303|NCT02719574|473868184|FG005|Phase 1 (Dose Expansion)|Death|0|||
131610304|NCT02719574|473868185|FG006|Phase 1 (Dose Expansion)|Death|1|||
131610305|NCT02719574|473868186|FG007|Phase 1 (Dose Expansion)|Death|6|||
131610306|NCT02719574|473868187|FG008|Phase 1 (Dose Expansion)|Death|0|||
131610307|NCT02719574|473868188|FG009|Phase 1 (Dose Expansion)|Death|0|||
131610308|NCT02719574|473868189|FG010|Phase 1 (Dose Expansion)|Death|0|||
131610309|NCT02719574|473868190|FG011|Phase 1 (Dose Expansion)|Death|0|||
131610310|NCT02719574|473868191|FG012|Phase 1 (Dose Expansion)|Death|0|||
131610311|NCT02719574|473868192|FG013|Phase 1 (Dose Expansion)|Death|0|||
131610312|NCT02719574|473868193|FG014|Phase 1 (Dose Expansion)|Death|0|||
131610313|NCT02719574|473868194|FG015|Phase 1 (Dose Expansion)|Death|0|||
131610314|NCT02719574|473868195|FG016|Phase 1 (Dose Expansion)|Death|0|||
131610315|NCT02719574|473868179|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610316|NCT02719574|473868180|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610317|NCT02719574|473868181|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610318|NCT02719574|473868182|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610319|NCT02719574|473868183|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610320|NCT02719574|473868184|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610321|NCT02719574|473868185|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
131610322|NCT02719574|473868186|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
131610323|NCT02719574|473868187|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610324|NCT02719574|473868188|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610325|NCT02719574|473868189|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610326|NCT02719574|473868190|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610327|NCT02719574|473868191|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610328|NCT02719574|473868192|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610329|NCT02719574|473868193|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610330|NCT02719574|473868194|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610331|NCT02719574|473868195|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
131610332|NCT02719574|473868179|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610333|NCT02719574|473868180|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610334|NCT02719574|473868181|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610335|NCT02719574|473868182|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610336|NCT02719574|473868183|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610337|NCT02719574|473868184|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610338|NCT02719574|473868185|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
131610339|NCT02719574|473868186|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
131610340|NCT02719574|473868187|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610341|NCT02719574|473868188|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
131793937|NCT01806597|474528699|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131610342|NCT02719574|473868189|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
131793938|NCT01806597|474528700|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131610343|NCT02719574|473868190|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610344|NCT02719574|473868191|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610345|NCT02719574|473868192|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610346|NCT02719574|473868193|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610347|NCT02719574|473868194|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
131610348|NCT02719574|473868195|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
131708191|NCT00896532|474211337|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708192|NCT00896532|474211338|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708193|NCT00896532|474211339|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708194|NCT00896532|474211340|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131900019|NCT02686164|474919436|FG000|Overall Study|Clinical progression|1|||
131900020|NCT02824627|474919439|FG000|Overall Study|Adverse Event|1|||
131900021|NCT02824627|474919440|FG001|Overall Study|Adverse Event|2|||
131900022|NCT02824627|474919439|FG000|Overall Study|Lost to Follow-up|2|||
131900023|NCT02824627|474919440|FG001|Overall Study|Lost to Follow-up|1|||
131900024|NCT00672633|474919441|FG000|Overall Study|Withdrawal by Subject|0|||
131900025|NCT00672633|474919442|FG001|Overall Study|Withdrawal by Subject|1|||
131900026|NCT01938846|474919443|FG000|Overall Study|Progressive disease|26|||
131900027|NCT01938846|474919444|FG001|Overall Study|Progressive disease|18|||
131900028|NCT01938846|474919445|FG002|Overall Study|Progressive disease|16|||
131900029|NCT01938846|474919443|FG000|Overall Study|Adverse Event|8|||
131900030|NCT01938846|474919444|FG001|Overall Study|Adverse Event|4|||
131900031|NCT01938846|474919445|FG002|Overall Study|Adverse Event|3|||
131900032|NCT01938846|474919443|FG000|Overall Study|Withdrawal by Subject|2|||
131900033|NCT01938846|474919444|FG001|Overall Study|Withdrawal by Subject|2|||
131900034|NCT01938846|474919445|FG002|Overall Study|Withdrawal by Subject|1|||
131793939|NCT01806597|474528701|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131793940|NCT01806597|474528702|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131793941|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
131793942|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
131793943|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
131793944|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
131900035|NCT01938846|474919443|FG000|Overall Study|Other than listed|5|||
131610349|NCT02719574|473868179|FG000|Phase 1 (Dose Expansion)|Other|0|||
131610350|NCT02719574|473868180|FG001|Phase 1 (Dose Expansion)|Other|0|||
131610351|NCT02719574|473868181|FG002|Phase 1 (Dose Expansion)|Other|0|||
131610352|NCT02719574|473868182|FG003|Phase 1 (Dose Expansion)|Other|0|||
131610353|NCT02719574|473868183|FG004|Phase 1 (Dose Expansion)|Other|0|||
131610354|NCT02719574|473868184|FG005|Phase 1 (Dose Expansion)|Other|0|||
131610355|NCT02719574|473868185|FG006|Phase 1 (Dose Expansion)|Other|1|||
131610356|NCT02719574|473868186|FG007|Phase 1 (Dose Expansion)|Other|7|||
131610357|NCT02719574|473868187|FG008|Phase 1 (Dose Expansion)|Other|0|||
131610358|NCT02719574|473868188|FG009|Phase 1 (Dose Expansion)|Other|0|||
131610359|NCT02719574|473868189|FG010|Phase 1 (Dose Expansion)|Other|0|||
131610360|NCT02719574|473868190|FG011|Phase 1 (Dose Expansion)|Other|0|||
131610361|NCT02719574|473868191|FG012|Phase 1 (Dose Expansion)|Other|0|||
131610362|NCT02719574|473868192|FG013|Phase 1 (Dose Expansion)|Other|0|||
131610363|NCT02719574|473868193|FG014|Phase 1 (Dose Expansion)|Other|0|||
131610364|NCT02719574|473868194|FG015|Phase 1 (Dose Expansion)|Other|0|||
131610365|NCT02719574|473868195|FG016|Phase 1 (Dose Expansion)|Other|0|||
131610366|NCT02719574|473868179|FG000|Phase 2|Protocol Defined Disease Progression|0|||
131610367|NCT02719574|473868180|FG001|Phase 2|Protocol Defined Disease Progression|0|||
131610368|NCT02719574|473868181|FG002|Phase 2|Protocol Defined Disease Progression|0|||
131610369|NCT02719574|473868182|FG003|Phase 2|Protocol Defined Disease Progression|0|||
131610370|NCT02719574|473868183|FG004|Phase 2|Protocol Defined Disease Progression|0|||
131610371|NCT02719574|473868184|FG005|Phase 2|Protocol Defined Disease Progression|0|||
131610372|NCT02719574|473868185|FG006|Phase 2|Protocol Defined Disease Progression|0|||
131610373|NCT02719574|473868186|FG007|Phase 2|Protocol Defined Disease Progression|0|||
131610374|NCT02719574|473868187|FG008|Phase 2|Protocol Defined Disease Progression|0|||
131610375|NCT02719574|473868188|FG009|Phase 2|Protocol Defined Disease Progression|65|||
131610376|NCT02719574|473868189|FG010|Phase 2|Protocol Defined Disease Progression|8|||
131610377|NCT02719574|473868190|FG011|Phase 2|Protocol Defined Disease Progression|2|||
131610378|NCT02719574|473868191|FG012|Phase 2|Protocol Defined Disease Progression|4|||
131610379|NCT02719574|473868192|FG013|Phase 2|Protocol Defined Disease Progression|9|||
131610380|NCT02719574|473868193|FG014|Phase 2|Protocol Defined Disease Progression|11|||
131610381|NCT02719574|473868194|FG015|Phase 2|Protocol Defined Disease Progression|3|||
131610382|NCT02719574|473868195|FG016|Phase 2|Protocol Defined Disease Progression|4|||
131610383|NCT02719574|473868179|FG000|Phase 2|Adverse Event|0|||
131610384|NCT02719574|473868180|FG001|Phase 2|Adverse Event|0|||
131610385|NCT02719574|473868181|FG002|Phase 2|Adverse Event|0|||
131610386|NCT02719574|473868182|FG003|Phase 2|Adverse Event|0|||
131610387|NCT02719574|473868183|FG004|Phase 2|Adverse Event|0|||
131610388|NCT02719574|473868184|FG005|Phase 2|Adverse Event|0|||
131610389|NCT02719574|473868185|FG006|Phase 2|Adverse Event|0|||
131610390|NCT02719574|473868186|FG007|Phase 2|Adverse Event|0|||
131610391|NCT02719574|473868187|FG008|Phase 2|Adverse Event|0|||
131900036|NCT01938846|474919444|FG001|Overall Study|Other than listed|1|||
131610392|NCT02719574|473868188|FG009|Phase 2|Adverse Event|27|||
131610393|NCT02719574|473868189|FG010|Phase 2|Adverse Event|0|||
131610394|NCT02719574|473868190|FG011|Phase 2|Adverse Event|1|||
131793945|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
131793946|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
131900037|NCT01938846|474919445|FG002|Overall Study|Other than listed|4|||
131900038|NCT02324361|474919451|FG000|Overall Study|Lost to Follow-up|5|||
131610395|NCT02719574|473868191|FG012|Phase 2|Adverse Event|1|||
131900039|NCT02324361|474919452|FG001|Overall Study|Lost to Follow-up|2|||
131900040|NCT04235504|474919457|FG000|Study Phase|Withdrawal by Subject|5|||
131610396|NCT02719574|473868192|FG013|Phase 2|Adverse Event|1|||
131610397|NCT02719574|473868193|FG014|Phase 2|Adverse Event|2|||
131610398|NCT02719574|473868194|FG015|Phase 2|Adverse Event|2|||
131610399|NCT02719574|473868195|FG016|Phase 2|Adverse Event|3|||
131610400|NCT02719574|473868179|FG000|Phase 2|Other|0|||
131610401|NCT02719574|473868180|FG001|Phase 2|Other|0|||
131610402|NCT02719574|473868181|FG002|Phase 2|Other|0|||
131610403|NCT02719574|473868182|FG003|Phase 2|Other|0|||
131610404|NCT02719574|473868183|FG004|Phase 2|Other|0|||
131610405|NCT02719574|473868184|FG005|Phase 2|Other|0|||
131610406|NCT02719574|473868185|FG006|Phase 2|Other|0|||
131610407|NCT02719574|473868186|FG007|Phase 2|Other|0|||
131610408|NCT02719574|473868187|FG008|Phase 2|Other|0|||
131610409|NCT02719574|473868188|FG009|Phase 2|Other|20|||
131610410|NCT02719574|473868189|FG010|Phase 2|Other|7|||
131610411|NCT02719574|473868190|FG011|Phase 2|Other|0|||
131610412|NCT02719574|473868191|FG012|Phase 2|Other|5|||
131610413|NCT02719574|473868192|FG013|Phase 2|Other|7|||
131610414|NCT02719574|473868193|FG014|Phase 2|Other|0|||
131610415|NCT02719574|473868194|FG015|Phase 2|Other|1|||
131610416|NCT02719574|473868195|FG016|Phase 2|Other|4|||
131610417|NCT02719574|473868179|FG000|Phase 2|Transplant|0|||
131610418|NCT02719574|473868180|FG001|Phase 2|Transplant|0|||
131610419|NCT02719574|473868181|FG002|Phase 2|Transplant|0|||
131610420|NCT02719574|473868182|FG003|Phase 2|Transplant|0|||
131610421|NCT02719574|473868183|FG004|Phase 2|Transplant|0|||
131610422|NCT02719574|473868184|FG005|Phase 2|Transplant|0|||
131610423|NCT02719574|473868185|FG006|Phase 2|Transplant|0|||
131610424|NCT02719574|473868186|FG007|Phase 2|Transplant|0|||
131610425|NCT02719574|473868187|FG008|Phase 2|Transplant|0|||
131610426|NCT02719574|473868188|FG009|Phase 2|Transplant|15|||
131610427|NCT02719574|473868189|FG010|Phase 2|Transplant|2|||
131610428|NCT02719574|473868190|FG011|Phase 2|Transplant|0|||
131610429|NCT02719574|473868191|FG012|Phase 2|Transplant|6|||
131610430|NCT02719574|473868192|FG013|Phase 2|Transplant|1|||
131610431|NCT02719574|473868193|FG014|Phase 2|Transplant|1|||
131610432|NCT02719574|473868194|FG015|Phase 2|Transplant|0|||
131610433|NCT02719574|473868195|FG016|Phase 2|Transplant|0|||
131610434|NCT02719574|473868179|FG000|Phase 2|Death|0|||
131610435|NCT02719574|473868180|FG001|Phase 2|Death|0|||
131610436|NCT02719574|473868181|FG002|Phase 2|Death|0|||
131610437|NCT02719574|473868182|FG003|Phase 2|Death|0|||
131610438|NCT02719574|473868183|FG004|Phase 2|Death|0|||
131610439|NCT02719574|473868184|FG005|Phase 2|Death|0|||
131610440|NCT02719574|473868185|FG006|Phase 2|Death|0|||
131610441|NCT02719574|473868186|FG007|Phase 2|Death|0|||
131610442|NCT02719574|473868187|FG008|Phase 2|Death|0|||
131610443|NCT02719574|473868188|FG009|Phase 2|Death|14|||
131610444|NCT02719574|473868189|FG010|Phase 2|Death|0|||
131610445|NCT02719574|473868190|FG011|Phase 2|Death|0|||
131610446|NCT02719574|473868191|FG012|Phase 2|Death|1|||
131610447|NCT02719574|473868192|FG013|Phase 2|Death|1|||
131610448|NCT02719574|473868193|FG014|Phase 2|Death|2|||
131610449|NCT02719574|473868194|FG015|Phase 2|Death|0|||
131610450|NCT02719574|473868195|FG016|Phase 2|Death|0|||
131610451|NCT02719574|473868179|FG000|Phase 2|Investigator Decision|0|||
131610452|NCT02719574|473868180|FG001|Phase 2|Investigator Decision|0|||
131610453|NCT02719574|473868181|FG002|Phase 2|Investigator Decision|0|||
131900041|NCT04235504|474919458|FG001|Study Phase|Withdrawal by Subject|2|||
131900042|NCT04235504|474919459|FG002|Study Phase|Withdrawal by Subject|0|||
131900043|NCT04235504|474919460|FG003|Study Phase|Withdrawal by Subject|0|||
131610454|NCT02719574|473868182|FG003|Phase 2|Investigator Decision|0|||
131610455|NCT02719574|473868183|FG004|Phase 2|Investigator Decision|0|||
131610456|NCT02719574|473868184|FG005|Phase 2|Investigator Decision|0|||
131610457|NCT02719574|473868185|FG006|Phase 2|Investigator Decision|0|||
131610458|NCT02719574|473868186|FG007|Phase 2|Investigator Decision|0|||
131610459|NCT02719574|473868187|FG008|Phase 2|Investigator Decision|0|||
131610460|NCT02719574|473868188|FG009|Phase 2|Investigator Decision|6|||
131610461|NCT02719574|473868189|FG010|Phase 2|Investigator Decision|1|||
131610462|NCT02719574|473868190|FG011|Phase 2|Investigator Decision|2|||
131610463|NCT02719574|473868191|FG012|Phase 2|Investigator Decision|3|||
131610464|NCT02719574|473868192|FG013|Phase 2|Investigator Decision|1|||
131610465|NCT02719574|473868193|FG014|Phase 2|Investigator Decision|3|||
131610466|NCT02719574|473868194|FG015|Phase 2|Investigator Decision|2|||
131610467|NCT02719574|473868195|FG016|Phase 2|Investigator Decision|0|||
131610468|NCT02719574|473868179|FG000|Phase 2|Withdrawal by Subject|0|||
131610469|NCT02719574|473868180|FG001|Phase 2|Withdrawal by Subject|0|||
131610470|NCT02719574|473868181|FG002|Phase 2|Withdrawal by Subject|0|||
131610471|NCT02719574|473868182|FG003|Phase 2|Withdrawal by Subject|0|||
131610472|NCT02719574|473868183|FG004|Phase 2|Withdrawal by Subject|0|||
131610473|NCT02719574|473868184|FG005|Phase 2|Withdrawal by Subject|0|||
131610474|NCT02719574|473868185|FG006|Phase 2|Withdrawal by Subject|0|||
131610475|NCT02719574|473868186|FG007|Phase 2|Withdrawal by Subject|0|||
131610476|NCT02719574|473868187|FG008|Phase 2|Withdrawal by Subject|0|||
131610477|NCT02719574|473868188|FG009|Phase 2|Withdrawal by Subject|5|||
131610478|NCT02719574|473868189|FG010|Phase 2|Withdrawal by Subject|0|||
131610479|NCT02719574|473868190|FG011|Phase 2|Withdrawal by Subject|0|||
131610480|NCT02719574|473868191|FG012|Phase 2|Withdrawal by Subject|0|||
131610481|NCT02719574|473868192|FG013|Phase 2|Withdrawal by Subject|1|||
131610482|NCT02719574|473868193|FG014|Phase 2|Withdrawal by Subject|1|||
131610483|NCT02719574|473868194|FG015|Phase 2|Withdrawal by Subject|2|||
131610484|NCT02719574|473868195|FG016|Phase 2|Withdrawal by Subject|0|||
131610485|NCT02719574|473868179|FG000|Phase 2|Protocol Violation|0|||
131610486|NCT02719574|473868180|FG001|Phase 2|Protocol Violation|0|||
131610487|NCT02719574|473868181|FG002|Phase 2|Protocol Violation|0|||
131610488|NCT02719574|473868182|FG003|Phase 2|Protocol Violation|0|||
131610489|NCT02719574|473868183|FG004|Phase 2|Protocol Violation|0|||
131610490|NCT02719574|473868184|FG005|Phase 2|Protocol Violation|0|||
131610491|NCT02719574|473868185|FG006|Phase 2|Protocol Violation|0|||
131610492|NCT02719574|473868186|FG007|Phase 2|Protocol Violation|0|||
131610493|NCT02719574|473868187|FG008|Phase 2|Protocol Violation|0|||
131610494|NCT02719574|473868188|FG009|Phase 2|Protocol Violation|1|||
131610495|NCT02719574|473868189|FG010|Phase 2|Protocol Violation|0|||
131610496|NCT02719574|473868190|FG011|Phase 2|Protocol Violation|0|||
131610497|NCT02719574|473868191|FG012|Phase 2|Protocol Violation|0|||
131610498|NCT02719574|473868192|FG013|Phase 2|Protocol Violation|0|||
131610499|NCT02719574|473868193|FG014|Phase 2|Protocol Violation|0|||
131610500|NCT02719574|473868194|FG015|Phase 2|Protocol Violation|0|||
131610501|NCT02719574|473868195|FG016|Phase 2|Protocol Violation|0|||
131610502|NCT02720068|473868197|FG000|Overall Study|Adverse Event|0|||
131610503|NCT02720068|473868198|FG001|Overall Study|Adverse Event|0|||
131610504|NCT02720068|473868199|FG002|Overall Study|Adverse Event|0|||
131610505|NCT02720068|473868200|FG003|Overall Study|Adverse Event|0|||
131793947|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
131793948|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
131793949|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
131793950|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
131793951|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
131793952|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
131610506|NCT02720068|473868201|FG004|Overall Study|Adverse Event|0|||
131610507|NCT02720068|473868202|FG005|Overall Study|Adverse Event|0|||
131610508|NCT02720068|473868203|FG006|Overall Study|Adverse Event|0|||
131610509|NCT02720068|473868204|FG007|Overall Study|Adverse Event|0|||
131610510|NCT02720068|473868205|FG008|Overall Study|Adverse Event|0|||
131610511|NCT02720068|473868206|FG009|Overall Study|Adverse Event|0|||
131610512|NCT02720068|473868207|FG010|Overall Study|Adverse Event|0|||
131610513|NCT02720068|473868208|FG011|Overall Study|Adverse Event|1|||
131610514|NCT02720068|473868209|FG012|Overall Study|Adverse Event|0|||
131610515|NCT02720068|473868210|FG013|Overall Study|Adverse Event|0|||
131610516|NCT02720068|473868211|FG014|Overall Study|Adverse Event|0|||
131610517|NCT02720068|473868212|FG015|Overall Study|Adverse Event|0|||
131610518|NCT02720068|473868213|FG016|Overall Study|Adverse Event|0|||
131610519|NCT02720068|473868214|FG017|Overall Study|Adverse Event|0|||
131610520|NCT02720068|473868197|FG000|Overall Study|Death|1|||
131610521|NCT02720068|473868198|FG001|Overall Study|Death|3|||
131610522|NCT02720068|473868199|FG002|Overall Study|Death|2|||
131610523|NCT02720068|473868200|FG003|Overall Study|Death|1|||
131610524|NCT02720068|473868201|FG004|Overall Study|Death|2|||
131610525|NCT02720068|473868202|FG005|Overall Study|Death|1|||
131610526|NCT02720068|473868203|FG006|Overall Study|Death|2|||
131610527|NCT02720068|473868204|FG007|Overall Study|Death|2|||
131610528|NCT02720068|473868205|FG008|Overall Study|Death|3|||
131610529|NCT02720068|473868206|FG009|Overall Study|Death|1|||
131610530|NCT02720068|473868207|FG010|Overall Study|Death|20|||
131610531|NCT02720068|473868208|FG011|Overall Study|Death|166|||
131610532|NCT02720068|473868209|FG012|Overall Study|Death|34|||
131610533|NCT02720068|473868210|FG013|Overall Study|Death|30|||
131610534|NCT02720068|473868211|FG014|Overall Study|Death|45|||
131610535|NCT02720068|473868212|FG015|Overall Study|Death|16|||
131610536|NCT02720068|473868213|FG016|Overall Study|Death|20|||
131610537|NCT02720068|473868214|FG017|Overall Study|Death|28|||
131610538|NCT02720068|473868197|FG000|Overall Study|Lost to Follow-up|0|||
131610539|NCT02720068|473868198|FG001|Overall Study|Lost to Follow-up|0|||
131610540|NCT02720068|473868199|FG002|Overall Study|Lost to Follow-up|0|||
131793953|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
131793954|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131610541|NCT02720068|473868200|FG003|Overall Study|Lost to Follow-up|0|||
131610542|NCT02720068|473868201|FG004|Overall Study|Lost to Follow-up|0|||
131610543|NCT02720068|473868202|FG005|Overall Study|Lost to Follow-up|0|||
131610544|NCT02720068|473868203|FG006|Overall Study|Lost to Follow-up|0|||
131610545|NCT02720068|473868204|FG007|Overall Study|Lost to Follow-up|0|||
131793955|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131610546|NCT02720068|473868205|FG008|Overall Study|Lost to Follow-up|0|||
131610547|NCT02720068|473868206|FG009|Overall Study|Lost to Follow-up|0|||
131610548|NCT02720068|473868207|FG010|Overall Study|Lost to Follow-up|0|||
131610549|NCT02720068|473868208|FG011|Overall Study|Lost to Follow-up|1|||
131610550|NCT02720068|473868209|FG012|Overall Study|Lost to Follow-up|0|||
131610551|NCT02720068|473868210|FG013|Overall Study|Lost to Follow-up|1|||
131610552|NCT02720068|473868211|FG014|Overall Study|Lost to Follow-up|2|||
131610553|NCT02720068|473868212|FG015|Overall Study|Lost to Follow-up|0|||
131610554|NCT02720068|473868213|FG016|Overall Study|Lost to Follow-up|0|||
131610555|NCT02720068|473868214|FG017|Overall Study|Lost to Follow-up|1|||
131610556|NCT02720068|473868197|FG000|Overall Study|Physician Decision|0|||
131610557|NCT02720068|473868198|FG001|Overall Study|Physician Decision|0|||
131610558|NCT02720068|473868199|FG002|Overall Study|Physician Decision|0|||
131610559|NCT02720068|473868200|FG003|Overall Study|Physician Decision|1|||
131610560|NCT02720068|473868201|FG004|Overall Study|Physician Decision|0|||
131610561|NCT02720068|473868202|FG005|Overall Study|Physician Decision|0|||
131610562|NCT02720068|473868203|FG006|Overall Study|Physician Decision|0|||
131610563|NCT02720068|473868204|FG007|Overall Study|Physician Decision|0|||
131610564|NCT02720068|473868205|FG008|Overall Study|Physician Decision|0|||
131610565|NCT02720068|473868206|FG009|Overall Study|Physician Decision|0|||
131610566|NCT02720068|473868207|FG010|Overall Study|Physician Decision|0|||
131610567|NCT02720068|473868208|FG011|Overall Study|Physician Decision|1|||
131610568|NCT02720068|473868209|FG012|Overall Study|Physician Decision|0|||
131610569|NCT02720068|473868210|FG013|Overall Study|Physician Decision|0|||
131610570|NCT02720068|473868211|FG014|Overall Study|Physician Decision|0|||
131610571|NCT02720068|473868212|FG015|Overall Study|Physician Decision|0|||
131610572|NCT02720068|473868213|FG016|Overall Study|Physician Decision|0|||
131610573|NCT02720068|473868214|FG017|Overall Study|Physician Decision|1|||
131610574|NCT02720068|473868197|FG000|Overall Study|Progressive Disease|2|||
131610575|NCT02720068|473868198|FG001|Overall Study|Progressive Disease|3|||
131610576|NCT02720068|473868199|FG002|Overall Study|Progressive Disease|1|||
131610577|NCT02720068|473868200|FG003|Overall Study|Progressive Disease|1|||
131610578|NCT02720068|473868201|FG004|Overall Study|Progressive Disease|1|||
131610579|NCT02720068|473868202|FG005|Overall Study|Progressive Disease|2|||
131610580|NCT02720068|473868203|FG006|Overall Study|Progressive Disease|1|||
131610581|NCT02720068|473868204|FG007|Overall Study|Progressive Disease|1|||
131610582|NCT02720068|473868205|FG008|Overall Study|Progressive Disease|0|||
131610583|NCT02720068|473868206|FG009|Overall Study|Progressive Disease|1|||
131610584|NCT02720068|473868207|FG010|Overall Study|Progressive Disease|0|||
131610585|NCT02720068|473868208|FG011|Overall Study|Progressive Disease|4|||
131610586|NCT02720068|473868209|FG012|Overall Study|Progressive Disease|1|||
131610587|NCT02720068|473868210|FG013|Overall Study|Progressive Disease|0|||
131610588|NCT02720068|473868211|FG014|Overall Study|Progressive Disease|0|||
131610589|NCT02720068|473868212|FG015|Overall Study|Progressive Disease|0|||
131610590|NCT02720068|473868213|FG016|Overall Study|Progressive Disease|0|||
131610591|NCT02720068|473868214|FG017|Overall Study|Progressive Disease|0|||
131610592|NCT02720068|473868197|FG000|Overall Study|Sponsor Decision|0|||
131610593|NCT02720068|473868198|FG001|Overall Study|Sponsor Decision|0|||
131610594|NCT02720068|473868199|FG002|Overall Study|Sponsor Decision|0|||
131610595|NCT02720068|473868200|FG003|Overall Study|Sponsor Decision|0|||
131610596|NCT02720068|473868201|FG004|Overall Study|Sponsor Decision|0|||
131610597|NCT02720068|473868202|FG005|Overall Study|Sponsor Decision|0|||
131610598|NCT02720068|473868203|FG006|Overall Study|Sponsor Decision|0|||
131610599|NCT02720068|473868204|FG007|Overall Study|Sponsor Decision|0|||
131610600|NCT02720068|473868205|FG008|Overall Study|Sponsor Decision|0|||
131610601|NCT02720068|473868206|FG009|Overall Study|Sponsor Decision|0|||
131610602|NCT02720068|473868207|FG010|Overall Study|Sponsor Decision|0|||
131610603|NCT02720068|473868208|FG011|Overall Study|Sponsor Decision|6|||
131610604|NCT02720068|473868209|FG012|Overall Study|Sponsor Decision|3|||
131610605|NCT02720068|473868210|FG013|Overall Study|Sponsor Decision|2|||
131610606|NCT02720068|473868211|FG014|Overall Study|Sponsor Decision|4|||
131610607|NCT02720068|473868212|FG015|Overall Study|Sponsor Decision|4|||
131610608|NCT02720068|473868213|FG016|Overall Study|Sponsor Decision|0|||
131610609|NCT02720068|473868214|FG017|Overall Study|Sponsor Decision|8|||
131610610|NCT02720068|473868197|FG000|Overall Study|Withdrawal by Subject|0|||
131610611|NCT02720068|473868198|FG001|Overall Study|Withdrawal by Subject|0|||
131610612|NCT02720068|473868199|FG002|Overall Study|Withdrawal by Subject|0|||
131610613|NCT02720068|473868200|FG003|Overall Study|Withdrawal by Subject|0|||
131610614|NCT02720068|473868201|FG004|Overall Study|Withdrawal by Subject|0|||
131610615|NCT02720068|473868202|FG005|Overall Study|Withdrawal by Subject|0|||
131610616|NCT02720068|473868203|FG006|Overall Study|Withdrawal by Subject|0|||
131441752|NCT02081677|473247183|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
131441753|NCT02081677|473247184|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
131610617|NCT02720068|473868204|FG007|Overall Study|Withdrawal by Subject|0|||
131610618|NCT02720068|473868205|FG008|Overall Study|Withdrawal by Subject|0|||
131610619|NCT02720068|473868206|FG009|Overall Study|Withdrawal by Subject|1|||
131610620|NCT02720068|473868207|FG010|Overall Study|Withdrawal by Subject|0|||
131610621|NCT02720068|473868208|FG011|Overall Study|Withdrawal by Subject|27|||
131610622|NCT02720068|473868209|FG012|Overall Study|Withdrawal by Subject|2|||
131610623|NCT02720068|473868210|FG013|Overall Study|Withdrawal by Subject|8|||
131610624|NCT02720068|473868211|FG014|Overall Study|Withdrawal by Subject|7|||
131610625|NCT02720068|473868212|FG015|Overall Study|Withdrawal by Subject|0|||
131610626|NCT02720068|473868213|FG016|Overall Study|Withdrawal by Subject|0|||
131610627|NCT02720068|473868214|FG017|Overall Study|Withdrawal by Subject|2|||
131610628|NCT02720068|473868197|FG000|Overall Study|Protocol Violation|0|||
131610629|NCT02720068|473868198|FG001|Overall Study|Protocol Violation|0|||
131900044|NCT04235504|474919457|FG000|Continuation Phase|Withdrawal by Subject|0|||
131900045|NCT04235504|474919458|FG001|Continuation Phase|Withdrawal by Subject|4|||
131441754|NCT01097668|473247185|FG000|Overall Study|Withdrawal by Subject|1|||
131441755|NCT01097668|473247186|FG001|Overall Study|Withdrawal by Subject|2|||
131441756|NCT01097668|473247185|FG000|Overall Study|Lost to Follow-up|1|||
131441757|NCT01097668|473247186|FG001|Overall Study|Lost to Follow-up|0|||
131441758|NCT02923726|473247193|FG000|Overall Study|Death|196|||
131441759|NCT02923726|473247194|FG001|Overall Study|Death|175|||
131441760|NCT02923726|473247193|FG000|Overall Study|Withdrawal by Subject|337|||
131441761|NCT02923726|473247194|FG001|Overall Study|Withdrawal by Subject|307|||
131441762|NCT03962491|473247197|FG000|Overall Study|Lost to Follow-up|4|||
131441763|NCT03962491|473247198|FG001|Overall Study|Lost to Follow-up|5|||
131441764|NCT03882021|473247201|FG000|Enrollment|Procedure aborted/cancelled|2|||
131441765|NCT03882021|473247201|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
131441766|NCT03882021|473247201|FG000|Enrollment to 3-Month|Death|1|||
131441767|NCT03882021|473247201|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
131441768|NCT03882021|473247201|FG000|Enrollment to 3-Month|Missed Visit|4|||
131441769|NCT03882021|473247201|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
131441770|NCT03882021|473247201|FG000|6-Month to 12-Month Visit|Death|1|||
131441771|NCT03882021|473247201|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
131441772|NCT03796728|473247205|FG000|Overall Study|Lost to Follow-up|8|||
131441773|NCT03796728|473247205|FG000|Overall Study|Reason not Specified|16|||
131441774|NCT00333775|473247206|FG000|Overall Study|Death|144|||
131441775|NCT00333775|473247207|FG001|Overall Study|Death|149|||
131441776|NCT00333775|473247208|FG002|Overall Study|Death|143|||
131441777|NCT00333775|473247206|FG000|Overall Study|In Follow-up When Study Stopped|87|||
131441778|NCT00333775|473247207|FG001|Overall Study|In Follow-up When Study Stopped|92|||
131441779|NCT00333775|473247208|FG002|Overall Study|In Follow-up When Study Stopped|96|||
131708195|NCT00896532|474211341|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708196|NCT00896532|474211342|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131441780|NCT00333775|473247206|FG000|Overall Study|Lost to Follow-up|10|||
131441781|NCT00333775|473247207|FG001|Overall Study|Lost to Follow-up|7|||
131441782|NCT00333775|473247208|FG002|Overall Study|Lost to Follow-up|8|||
131708197|NCT00896532|474211343|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
131708198|NCT00896532|474211344|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708199|NCT00896532|474211345|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708200|NCT00896532|474211346|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708201|NCT00896532|474211347|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708202|NCT00896532|474211348|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708203|NCT00896532|474211349|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131708204|NCT00896532|474211327|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
131708205|NCT00896532|474211328|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
131708206|NCT00896532|474211329|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
131708207|NCT00896532|474211330|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
131708208|NCT00896532|474211331|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
131708209|NCT00896532|474211332|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
131708210|NCT00896532|474211333|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
131793956|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131793957|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131793958|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131793959|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
131441783|NCT02476617|473247212|FG000|Overall Study|Adverse Event|1|||
131441784|NCT02476617|473247212|FG000|Overall Study|Lost to Follow-up|1|||
131441785|NCT03486912|473247213|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
131441786|NCT03486912|473247214|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
131441787|NCT03486912|473247215|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
131441788|NCT03486912|473247216|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
131793960|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
131793961|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131793962|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131793963|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131793964|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131793965|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
131900046|NCT04235504|474919459|FG002|Continuation Phase|Withdrawal by Subject|0|||
131900047|NCT04235504|474919460|FG003|Continuation Phase|Withdrawal by Subject|0|||
131900048|NCT04235504|474919457|FG000|Continuation Phase|Adverse Event|0|||
131441789|NCT03486912|473247213|FG000|Treatment Period|Withdrawal by Subject|3|||
131441790|NCT03486912|473247214|FG001|Treatment Period|Withdrawal by Subject|3|||
131441791|NCT03486912|473247215|FG002|Treatment Period|Withdrawal by Subject|3|||
131441792|NCT03486912|473247216|FG003|Treatment Period|Withdrawal by Subject|2|||
131441793|NCT03486912|473247213|FG000|Treatment Period|Other Reasons|0|||
131441794|NCT03486912|473247214|FG001|Treatment Period|Other Reasons|2|||
131610630|NCT02720068|473868199|FG002|Overall Study|Protocol Violation|0|||
131610631|NCT02720068|473868200|FG003|Overall Study|Protocol Violation|0|||
131610632|NCT02720068|473868201|FG004|Overall Study|Protocol Violation|0|||
131610633|NCT02720068|473868202|FG005|Overall Study|Protocol Violation|0|||
131610634|NCT02720068|473868203|FG006|Overall Study|Protocol Violation|0|||
131610635|NCT02720068|473868204|FG007|Overall Study|Protocol Violation|0|||
131610636|NCT02720068|473868205|FG008|Overall Study|Protocol Violation|0|||
131610637|NCT02720068|473868206|FG009|Overall Study|Protocol Violation|0|||
131610638|NCT02720068|473868207|FG010|Overall Study|Protocol Violation|1|||
131610639|NCT02720068|473868208|FG011|Overall Study|Protocol Violation|0|||
131610640|NCT02720068|473868209|FG012|Overall Study|Protocol Violation|0|||
131610641|NCT02720068|473868210|FG013|Overall Study|Protocol Violation|0|||
131610642|NCT02720068|473868211|FG014|Overall Study|Protocol Violation|1|||
131610643|NCT02720068|473868212|FG015|Overall Study|Protocol Violation|0|||
131610644|NCT02720068|473868213|FG016|Overall Study|Protocol Violation|1|||
131610645|NCT02720068|473868214|FG017|Overall Study|Protocol Violation|0|||
131610646|NCT00113360|473868215|FG000|Overall Study|Adverse Event|3|||
131610647|NCT00113360|473868215|FG000|Overall Study|Subject required surgery|1|||
131610648|NCT00113360|473868215|FG000|Overall Study|Did not meet eligibility criteria|3|||
131610649|NCT00739908|473868230|FG000|Overall Study|Adverse Event|5|||
131610650|NCT00739908|473868231|FG001|Overall Study|Adverse Event|6|||
131610651|NCT00739908|473868230|FG000|Overall Study|Withdrawal by Subject|4|||
131610652|NCT00739908|473868231|FG001|Overall Study|Withdrawal by Subject|2|||
131610653|NCT00739908|473868230|FG000|Overall Study|Lost to Follow-up|14|||
131610654|NCT00739908|473868231|FG001|Overall Study|Lost to Follow-up|9|||
131610655|NCT00739908|473868230|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
131610656|NCT00739908|473868231|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
131610657|NCT00739908|473868230|FG000|Overall Study|Non-Compliance With Study Medication|0|||
131610658|NCT00739908|473868231|FG001|Overall Study|Non-Compliance With Study Medication|3|||
131610659|NCT00739908|473868230|FG000|Overall Study|Lack of Efficacy|0|||
131610660|NCT00739908|473868231|FG001|Overall Study|Lack of Efficacy|1|||
131610661|NCT00739908|473868230|FG000|Overall Study|Relocation|0|||
131610662|NCT00739908|473868231|FG001|Overall Study|Relocation|1|||
131610663|NCT03875313|473868235|FG000|Overall Study|Withdrawal by Subject|1|||
131610664|NCT03875313|473868236|FG001|Overall Study|Withdrawal by Subject|3|||
131610665|NCT03875313|473868237|FG002|Overall Study|Withdrawal by Subject|0|||
131610666|NCT03875313|473868238|FG003|Overall Study|Withdrawal by Subject|0|||
131610667|NCT03875313|473868239|FG004|Overall Study|Withdrawal by Subject|0|||
131610668|NCT03875313|473868235|FG000|Overall Study|Death|0|||
131610669|NCT03875313|473868236|FG001|Overall Study|Death|0|||
131610670|NCT03875313|473868237|FG002|Overall Study|Death|0|||
131610671|NCT03875313|473868238|FG003|Overall Study|Death|0|||
131610672|NCT03875313|473868239|FG004|Overall Study|Death|1|||
131610673|NCT03875313|473868235|FG000|Overall Study|Lost to Follow-up|0|||
131610674|NCT03875313|473868236|FG001|Overall Study|Lost to Follow-up|0|||
131610675|NCT03875313|473868237|FG002|Overall Study|Lost to Follow-up|0|||
131610676|NCT03875313|473868238|FG003|Overall Study|Lost to Follow-up|0|||
131708211|NCT00896532|474211334|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
131708212|NCT00896532|474211335|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
131708213|NCT00896532|474211336|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
131708214|NCT00896532|474211337|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
131708215|NCT00896532|474211338|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
131708216|NCT00896532|474211339|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
131900049|NCT04235504|474919458|FG001|Continuation Phase|Adverse Event|1|||
131610677|NCT03875313|473868239|FG004|Overall Study|Lost to Follow-up|1|||
131610678|NCT03875313|473868235|FG000|Overall Study|Study Termination by Sponsor|0|||
131610679|NCT03875313|473868236|FG001|Overall Study|Study Termination by Sponsor|1|||
131610680|NCT03875313|473868237|FG002|Overall Study|Study Termination by Sponsor|1|||
131610681|NCT03875313|473868238|FG003|Overall Study|Study Termination by Sponsor|0|||
131610682|NCT03875313|473868239|FG004|Overall Study|Study Termination by Sponsor|1|||
131610683|NCT03875313|473868235|FG000|Overall Study|New Anticancer Treatment|0|||
131610684|NCT03875313|473868236|FG001|Overall Study|New Anticancer Treatment|1|||
131610685|NCT03875313|473868237|FG002|Overall Study|New Anticancer Treatment|2|||
131610686|NCT03875313|473868238|FG003|Overall Study|New Anticancer Treatment|1|||
131610687|NCT03875313|473868239|FG004|Overall Study|New Anticancer Treatment|0|||
131900050|NCT04235504|474919459|FG002|Continuation Phase|Adverse Event|0|||
131610688|NCT03875313|473868235|FG000|Overall Study|Other, Not Specified|2|||
131610689|NCT03875313|473868236|FG001|Overall Study|Other, Not Specified|11|||
131610690|NCT03875313|473868237|FG002|Overall Study|Other, Not Specified|3|||
131610691|NCT03875313|473868238|FG003|Overall Study|Other, Not Specified|3|||
131610692|NCT03875313|473868239|FG004|Overall Study|Other, Not Specified|1|||
131610693|NCT03868930|473868242|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
131610694|NCT03868930|473868243|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
131610695|NCT03868930|473868242|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
131610696|NCT03868930|473868243|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
131610697|NCT03868930|473868242|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
131610698|NCT03868930|473868243|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
131610699|NCT03868930|473868242|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
131610700|NCT03868930|473868243|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
131610701|NCT03868930|473868242|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
131610702|NCT03868930|473868243|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
131610703|NCT04227899|473868245|FG000|Overall Study|Withdrawal by Subject|6|||
131610704|NCT04227899|473868246|FG001|Overall Study|Withdrawal by Subject|3|||
131610705|NCT04227899|473868245|FG000|Overall Study|Death|12|||
131441795|NCT03486912|473247215|FG002|Treatment Period|Other Reasons|1|||
131441796|NCT03486912|473247216|FG003|Treatment Period|Other Reasons|1|||
131610706|NCT04227899|473868246|FG001|Overall Study|Death|6|||
131610707|NCT04227899|473868245|FG000|Overall Study|Lost to Follow-up|2|||
131610708|NCT04227899|473868246|FG001|Overall Study|Lost to Follow-up|1|||
131610709|NCT01046825|473868247|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131610710|NCT01046825|473868248|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
131610711|NCT01046825|473868249|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131610712|NCT01046825|473868250|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131610713|NCT01046825|473868251|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131610714|NCT01046825|473868247|FG000|Overall Study|Physician Decision|0|||
131610715|NCT01046825|473868248|FG001|Overall Study|Physician Decision|1|||
131610716|NCT01046825|473868249|FG002|Overall Study|Physician Decision|2|||
131610717|NCT01046825|473868250|FG003|Overall Study|Physician Decision|0|||
131610718|NCT01046825|473868251|FG004|Overall Study|Physician Decision|0|||
131610719|NCT01046825|473868247|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131610720|NCT01046825|473868248|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131610721|NCT01046825|473868249|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
131610722|NCT01046825|473868250|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131610723|NCT01046825|473868251|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131610724|NCT01046825|473868247|FG000|Overall Study|Found to be ineligible|0|||
131610725|NCT01046825|473868248|FG001|Overall Study|Found to be ineligible|1|||
131610726|NCT01046825|473868249|FG002|Overall Study|Found to be ineligible|0|||
131610727|NCT01046825|473868250|FG003|Overall Study|Found to be ineligible|0|||
131610728|NCT01046825|473868251|FG004|Overall Study|Found to be ineligible|0|||
131610729|NCT01046825|473868247|FG000|Overall Study|Death|0|||
131610730|NCT01046825|473868248|FG001|Overall Study|Death|0|||
131610731|NCT01046825|473868249|FG002|Overall Study|Death|0|||
131610732|NCT01046825|473868250|FG003|Overall Study|Death|1|||
131610733|NCT01046825|473868251|FG004|Overall Study|Death|0|||
131610734|NCT01046825|473868247|FG000|Overall Study|Did not submit biology samples|0|||
131610735|NCT01046825|473868248|FG001|Overall Study|Did not submit biology samples|0|||
131610736|NCT01046825|473868249|FG002|Overall Study|Did not submit biology samples|0|||
131610737|NCT01046825|473868250|FG003|Overall Study|Did not submit biology samples|0|||
131610738|NCT01046825|473868251|FG004|Overall Study|Did not submit biology samples|13|||
131610739|NCT02075554|473868253|FG000|Overall Study|Lost to Follow-up|7|||
131610740|NCT02075554|473868253|FG000|Overall Study|Withdrawal by Subject|5|||
131610741|NCT02075554|473868253|FG000|Overall Study|Physician Decision|3|||
131610742|NCT01773993|473868259|FG000|Overall Study|No Visit After Treatment|35|||
131610743|NCT04664881|473868260|FG000|Overall Study|Withdrawal by Subject|1|||
131610744|NCT04664881|473868261|FG001|Overall Study|Withdrawal by Subject|8|||
131610745|NCT04664881|473868260|FG000|Overall Study|Physician Decision|0|||
131610746|NCT04664881|473868261|FG001|Overall Study|Physician Decision|5|||
131441797|NCT03486912|473247213|FG000|Treatment Period|Adverse Event|0|||
131441798|NCT03486912|473247214|FG001|Treatment Period|Adverse Event|1|||
131441799|NCT03486912|473247215|FG002|Treatment Period|Adverse Event|1|||
131441800|NCT03486912|473247216|FG003|Treatment Period|Adverse Event|0|||
131610747|NCT04664881|473868260|FG000|Overall Study|Lost to Follow-up|1|||
131610748|NCT04664881|473868261|FG001|Overall Study|Lost to Follow-up|0|||
131610749|NCT00003222|473868268|FG000|Overall Study|Physician Decision|0|||
131610750|NCT00003222|473868269|FG001|Overall Study|Physician Decision|1|||
131610751|NCT03767335|473868270|FG000|Overall Study|Physician Decision|1|||
131610752|NCT03767335|473868271|FG001|Overall Study|Physician Decision|1|||
131610753|NCT03767335|473868272|FG002|Overall Study|Physician Decision|0|||
131610754|NCT03767335|473868270|FG000|Overall Study|Withdrawal by Subject|0|||
131610755|NCT03767335|473868271|FG001|Overall Study|Withdrawal by Subject|0|||
131610756|NCT03767335|473868272|FG002|Overall Study|Withdrawal by Subject|6|||
131610757|NCT03767335|473868270|FG000|Overall Study|Participant excluded from efficacy population|0|||
131610758|NCT03767335|473868271|FG001|Overall Study|Participant excluded from efficacy population|0|||
131610759|NCT03767335|473868272|FG002|Overall Study|Participant excluded from efficacy population|1|||
131610760|NCT03767335|473868270|FG000|Overall Study|Death|0|||
131610761|NCT03767335|473868271|FG001|Overall Study|Death|0|||
131610762|NCT03767335|473868272|FG002|Overall Study|Death|2|||
131610763|NCT03767335|473868270|FG000|Overall Study|Progressive Disease|2|||
131610764|NCT03767335|473868271|FG001|Overall Study|Progressive Disease|2|||
131610765|NCT03767335|473868272|FG002|Overall Study|Progressive Disease|2|||
131610766|NCT03767335|473868270|FG000|Overall Study|Disease progression needing additional medication|0|||
131610767|NCT03767335|473868271|FG001|Overall Study|Disease progression needing additional medication|0|||
131610768|NCT03767335|473868272|FG002|Overall Study|Disease progression needing additional medication|17|||
131610769|NCT03767335|473868270|FG000|Overall Study|Sponsor decision|0|||
131610770|NCT03767335|473868271|FG001|Overall Study|Sponsor decision|0|||
131610771|NCT03767335|473868272|FG002|Overall Study|Sponsor decision|2|||
131610772|NCT03767335|473868270|FG000|Overall Study|Other Medical Reasons|0|||
131441801|NCT03486912|473247213|FG000|Treatment Period|Lost to Follow-up|1|||
131793966|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131793967|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131793968|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131793969|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131793970|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131793971|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131793972|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
131793973|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131793974|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
131793975|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131793976|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131793977|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
131793978|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
131793979|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
131793980|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
131793981|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
131793982|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
131793983|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
131793984|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
131793985|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
131793986|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
131793987|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
131793988|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
131793989|NCT01806597|474528697|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
131793990|NCT01806597|474528698|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131793991|NCT01806597|474528699|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131793992|NCT01806597|474528700|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131900051|NCT04235504|474919460|FG003|Continuation Phase|Adverse Event|0|||
131900052|NCT04235504|474919457|FG000|Continuation Phase|Physician Decision|1|||
131900053|NCT04235504|474919458|FG001|Continuation Phase|Physician Decision|2|||
131900054|NCT04235504|474919459|FG002|Continuation Phase|Physician Decision|1|||
131900055|NCT04235504|474919460|FG003|Continuation Phase|Physician Decision|0|||
131900056|NCT02106351|474919467|FG000|Treatment Cycle 1|Adverse Event|2|||
131900057|NCT02106351|474919468|FG001|Treatment Cycle 1|Adverse Event|0|||
131900058|NCT02106351|474919469|FG002|Treatment Cycle 1|Adverse Event|0|||
131900059|NCT02106351|474919467|FG000|Treatment Cycle 1|Consent withdrawn|1|||
131900060|NCT02106351|474919468|FG001|Treatment Cycle 1|Consent withdrawn|0|||
131900061|NCT02106351|474919469|FG002|Treatment Cycle 1|Consent withdrawn|2|||
131900062|NCT02106351|474919467|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
131900063|NCT02106351|474919468|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
131900064|NCT02106351|474919469|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
131900065|NCT02106351|474919467|FG000|Treatment Cycle 1|Other|0|||
131900066|NCT02106351|474919468|FG001|Treatment Cycle 1|Other|3|||
131900067|NCT02106351|474919469|FG002|Treatment Cycle 1|Other|1|||
131900068|NCT02106351|474919467|FG000|Treatment Cycle 1|Randomised but not treated|1|||
131900069|NCT02106351|474919468|FG001|Treatment Cycle 1|Randomised but not treated|0|||
131900070|NCT02106351|474919469|FG002|Treatment Cycle 1|Randomised but not treated|1|||
131900071|NCT02106351|474919467|FG000|Treatment Cycle 2|Adverse Event|0|||
131900072|NCT02106351|474919468|FG001|Treatment Cycle 2|Adverse Event|2|||
131900073|NCT02106351|474919469|FG002|Treatment Cycle 2|Adverse Event|0|||
131900074|NCT02106351|474919467|FG000|Treatment Cycle 2|Consent withdrawn|0|||
131900075|NCT02106351|474919468|FG001|Treatment Cycle 2|Consent withdrawn|1|||
131900076|NCT02106351|474919469|FG002|Treatment Cycle 2|Consent withdrawn|1|||
131900077|NCT02106351|474919467|FG000|Treatment Cycle 2|Other|0|||
131900078|NCT02106351|474919468|FG001|Treatment Cycle 2|Other|2|||
131900079|NCT02106351|474919469|FG002|Treatment Cycle 2|Other|2|||
131900080|NCT02106351|474919467|FG000|Treatment Cycle 3|Adverse Event|0|||
131900081|NCT02106351|474919468|FG001|Treatment Cycle 3|Adverse Event|1|||
131900082|NCT02106351|474919469|FG002|Treatment Cycle 3|Adverse Event|0|||
131900083|NCT02106351|474919467|FG000|Treatment Cycle 3|Consent withdrawn|0|||
131900084|NCT02106351|474919468|FG001|Treatment Cycle 3|Consent withdrawn|0|||
131900085|NCT02106351|474919469|FG002|Treatment Cycle 3|Consent withdrawn|2|||
131900086|NCT02106351|474919467|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
131900087|NCT02106351|474919468|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
131610773|NCT03767335|473868271|FG001|Overall Study|Other Medical Reasons|0|||
131610774|NCT03767335|473868272|FG002|Overall Study|Other Medical Reasons|3|||
131610775|NCT04495621|473868274|FG000|Overall Study|Withdrawal by Subject|0|||
131610776|NCT04495621|473868275|FG001|Overall Study|Withdrawal by Subject|3|||
131610777|NCT04495621|473868274|FG000|Overall Study|Death|7|||
131610778|NCT04495621|473868275|FG001|Overall Study|Death|11|||
131610779|NCT04495621|473868274|FG000|Overall Study|Investigator Decision|0|||
131610780|NCT04495621|473868275|FG001|Overall Study|Investigator Decision|7|||
131610781|NCT04495621|473868274|FG000|Overall Study|Lost to Follow-up|0|||
131610782|NCT04495621|473868275|FG001|Overall Study|Lost to Follow-up|1|||
131610783|NCT04757753|473868281|FG000|Overall Study|Lost to Follow-up|7|||
131610784|NCT04757753|473868282|FG001|Overall Study|Lost to Follow-up|7|||
131610785|NCT04757753|473868281|FG000|Overall Study|Withdrawal by Subject|0|||
131610786|NCT04757753|473868282|FG001|Overall Study|Withdrawal by Subject|3|||
131610787|NCT04757753|473868281|FG000|Overall Study|Endodontic treatment failure|1|||
131610788|NCT04757753|473868282|FG001|Overall Study|Endodontic treatment failure|2|||
131610789|NCT04757753|473868281|FG000|Overall Study|Tooth fracture/extraction|3|||
131610790|NCT04757753|473868282|FG001|Overall Study|Tooth fracture/extraction|0|||
131610791|NCT01313559|473868283|FG000|Overall Study|Withdrawal by Subject|1|||
131610792|NCT01313559|473868284|FG001|Overall Study|Withdrawal by Subject|2|||
131610793|NCT01313559|473868283|FG000|Overall Study|Disease progression|1|||
131610794|NCT01313559|473868284|FG001|Overall Study|Disease progression|0|||
131610795|NCT01313559|473868283|FG000|Overall Study|Rising PSA|2|||
131610796|NCT01313559|473868284|FG001|Overall Study|Rising PSA|0|||
131900088|NCT02106351|474919469|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
131900089|NCT02106351|474919467|FG000|Treatment Cycle 3|Other|0|||
131900090|NCT02106351|474919468|FG001|Treatment Cycle 3|Other|2|||
131900091|NCT02106351|474919469|FG002|Treatment Cycle 3|Other|3|||
131900092|NCT02106351|474919467|FG000|Treatment Cycle 4|Consent withdrawn|0|||
131900093|NCT02106351|474919468|FG001|Treatment Cycle 4|Consent withdrawn|0|||
131610797|NCT00328783|473868285|FG000|Overall Study|Could not tolerate ABC|21|||
131610798|NCT00328783|473868285|FG000|Overall Study|No heart in RT field|4|||
131610799|NCT00328783|473868285|FG000|Overall Study|Withdrawal by Subject|1|||
131610800|NCT00357682|473868286|FG000|Overall Study|Did not receive allocated Treatment|10|||
131610801|NCT00357682|473868287|FG001|Overall Study|Did not receive allocated Treatment|9|||
131610802|NCT00357682|473868288|FG002|Overall Study|Did not receive allocated Treatment|9|||
131610803|NCT00357682|473868289|FG003|Overall Study|Did not receive allocated Treatment|10|||
131610804|NCT00357682|473868286|FG000|Overall Study|Withdrew consent|6|||
131610805|NCT00357682|473868287|FG001|Overall Study|Withdrew consent|6|||
131610806|NCT00357682|473868288|FG002|Overall Study|Withdrew consent|5|||
131610807|NCT00357682|473868289|FG003|Overall Study|Withdrew consent|5|||
131610808|NCT00357682|473868286|FG000|Overall Study|Lost to Follow-up|39|||
131610809|NCT00357682|473868287|FG001|Overall Study|Lost to Follow-up|33|||
131610810|NCT00357682|473868288|FG002|Overall Study|Lost to Follow-up|26|||
131610811|NCT00357682|473868289|FG003|Overall Study|Lost to Follow-up|35|||
131610812|NCT00357682|473868286|FG000|Overall Study|Adverse Event|24|||
131610813|NCT00357682|473868287|FG001|Overall Study|Adverse Event|32|||
131610814|NCT00357682|473868288|FG002|Overall Study|Adverse Event|22|||
131610815|NCT00357682|473868289|FG003|Overall Study|Adverse Event|27|||
131610816|NCT00357682|473868286|FG000|Overall Study|Physician Decision|32|||
131610817|NCT00357682|473868287|FG001|Overall Study|Physician Decision|20|||
131610818|NCT00357682|473868288|FG002|Overall Study|Physician Decision|24|||
131610819|NCT00357682|473868289|FG003|Overall Study|Physician Decision|30|||
131610820|NCT00357682|473868286|FG000|Overall Study|Patient decision|73|||
131610821|NCT00357682|473868287|FG001|Overall Study|Patient decision|80|||
131610822|NCT00357682|473868288|FG002|Overall Study|Patient decision|51|||
131610823|NCT00357682|473868289|FG003|Overall Study|Patient decision|59|||
131610824|NCT00357682|473868286|FG000|Overall Study|Other reason|157|||
131610825|NCT00357682|473868287|FG001|Overall Study|Other reason|130|||
131610826|NCT00357682|473868288|FG002|Overall Study|Other reason|114|||
131610827|NCT00357682|473868289|FG003|Overall Study|Other reason|99|||
131610828|NCT02656706|473868293|FG000|Overall Study|Insurance Denial|1|||
131708217|NCT00896532|474211340|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
131708218|NCT00896532|474211341|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
131708219|NCT00896532|474211342|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
131708220|NCT00896532|474211343|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
131708221|NCT00896532|474211344|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
131708222|NCT00896532|474211345|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
131708223|NCT00896532|474211346|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
131708224|NCT00896532|474211347|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
131708225|NCT00896532|474211348|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
131708226|NCT00896532|474211349|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
131708227|NCT00896532|474211327|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708228|NCT00896532|474211328|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708229|NCT00896532|474211329|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708230|NCT00896532|474211330|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131610844|NCT05180539|473868907|FG000|Overall Study|Lost to Follow-up|27|||
131610845|NCT05180539|473868908|FG001|Overall Study|Lost to Follow-up|30|||
131610846|NCT02566889|473868909|FG000|Overall Study|Withdrawal by Subject|3|||
131610847|NCT02566889|473868910|FG001|Overall Study|Withdrawal by Subject|1|||
131610848|NCT02566889|473868909|FG000|Overall Study|Adverse Event|4|||
131610849|NCT02566889|473868910|FG001|Overall Study|Adverse Event|2|||
131610850|NCT02566889|473868909|FG000|Overall Study|Other|6|||
131610851|NCT02566889|473868910|FG001|Overall Study|Other|2|||
131610852|NCT03699163|473868911|FG000|Overall Study|Physician Decision|12|||
131610853|NCT03699163|473868912|FG001|Overall Study|Physician Decision|0|||
131610854|NCT03699163|473868911|FG000|Overall Study|failed QC measures|205|||
131610855|NCT03699163|473868912|FG001|Overall Study|failed QC measures|206|||
131610856|NCT03286114|473868919|FG000|Overall Study|Adverse Event|6|||
131610857|NCT03286114|473868919|FG000|Overall Study|Death|3|||
131610858|NCT04993677|473868922|FG000|Overall Study|Lost to Follow-up|1|||
131610859|NCT04993677|473868923|FG001|Overall Study|Lost to Follow-up|0|||
131610860|NCT04993677|473868924|FG002|Overall Study|Lost to Follow-up|0|||
131610861|NCT04993677|473868925|FG003|Overall Study|Lost to Follow-up|0|||
131610862|NCT04993677|473868922|FG000|Overall Study|Death|11|||
131610863|NCT04993677|473868923|FG001|Overall Study|Death|8|||
131610864|NCT04993677|473868924|FG002|Overall Study|Death|3|||
131610865|NCT04993677|473868925|FG003|Overall Study|Death|1|||
131610866|NCT04993677|473868922|FG000|Overall Study|Subject withdrawal of consent|4|||
131610867|NCT04993677|473868923|FG001|Overall Study|Subject withdrawal of consent|3|||
131610868|NCT04993677|473868924|FG002|Overall Study|Subject withdrawal of consent|0|||
131441802|NCT03486912|473247214|FG001|Treatment Period|Lost to Follow-up|0|||
131441803|NCT03486912|473247215|FG002|Treatment Period|Lost to Follow-up|0|||
131441804|NCT03486912|473247216|FG003|Treatment Period|Lost to Follow-up|2|||
131441805|NCT02491684|473247217|FG000|Treatment Phase|Adverse Event|2|||
131441806|NCT02491684|473247218|FG001|Treatment Phase|Adverse Event|2|||
131610869|NCT04993677|473868925|FG003|Overall Study|Subject withdrawal of consent|2|||
131610870|NCT04993677|473868922|FG000|Overall Study|Study termination by sponsor|3|||
131900094|NCT02106351|474919469|FG002|Treatment Cycle 4|Consent withdrawn|2|||
131900095|NCT02106351|474919467|FG000|Treatment Cycle 4|Other|0|||
131900096|NCT02106351|474919468|FG001|Treatment Cycle 4|Other|1|||
131900097|NCT02106351|474919469|FG002|Treatment Cycle 4|Other|0|||
131900098|NCT00101868|474919470|FG000|Overall Study|Death|10|||
131900099|NCT00101868|474919471|FG001|Overall Study|Death|10|||
131900100|NCT00101868|474919470|FG000|Overall Study|Withdrawal by Subject|8|||
131900101|NCT00101868|474919471|FG001|Overall Study|Withdrawal by Subject|9|||
131610871|NCT04993677|473868923|FG001|Overall Study|Study termination by sponsor|25|||
131610872|NCT04993677|473868924|FG002|Overall Study|Study termination by sponsor|3|||
131610873|NCT04993677|473868925|FG003|Overall Study|Study termination by sponsor|3|||
131610874|NCT04993677|473868922|FG000|Overall Study|Other|2|||
131610875|NCT04993677|473868923|FG001|Overall Study|Other|3|||
131610876|NCT04993677|473868924|FG002|Overall Study|Other|3|||
131610877|NCT04993677|473868925|FG003|Overall Study|Other|2|||
131610878|NCT03725332|473868928|FG000|Overall Study|Adverse Event|5|||
131610879|NCT03725332|473868929|FG001|Overall Study|Adverse Event|10|||
131610880|NCT03725332|473868928|FG000|Overall Study|Death|1|||
131610881|NCT03725332|473868929|FG001|Overall Study|Death|3|||
131610882|NCT03725332|473868928|FG000|Overall Study|Lost to Follow-up|43|||
131610883|NCT03725332|473868929|FG001|Overall Study|Lost to Follow-up|122|||
131610884|NCT03725332|473868928|FG000|Overall Study|Withdrawal by Subject|0|||
131610885|NCT03725332|473868929|FG001|Overall Study|Withdrawal by Subject|1|||
131610886|NCT03725332|473868928|FG000|Overall Study|Duplicate enrollment|0|||
131441807|NCT02491684|473247217|FG000|Treatment Phase|Incorrect randomisation|1|||
131900102|NCT00101868|474919470|FG000|Overall Study|Protocol Violation|3|||
131900103|NCT00101868|474919471|FG001|Overall Study|Protocol Violation|0|||
131610887|NCT03725332|473868929|FG001|Overall Study|Duplicate enrollment|1|||
131610888|NCT03725332|473868928|FG000|Overall Study|Did not consent|0|||
131610889|NCT03725332|473868929|FG001|Overall Study|Did not consent|1|||
131610890|NCT04908514|473868937|FG000|Overall Study|Lost to Follow-up|2|||
131610891|NCT04908514|473868937|FG000|Overall Study|Withdrawal by Subject|1|||
131610892|NCT05116774|473868941|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
131610893|NCT05116774|473868942|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
131610894|NCT05116774|473868941|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
131610895|NCT05116774|473868942|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
131610896|NCT05116774|473868941|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
131610897|NCT05116774|473868942|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
131610898|NCT05116774|473868941|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
131610899|NCT05116774|473868942|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
131610900|NCT03150862|473868943|FG000|Overall Study|Death|2|||
131610901|NCT03150862|473868944|FG001|Overall Study|Death|7|||
131610902|NCT03150862|473868945|FG002|Overall Study|Death|8|||
131610903|NCT03150862|473868946|FG003|Overall Study|Death|27|||
131610904|NCT03150862|473868947|FG004|Overall Study|Death|4|||
131610905|NCT03150862|473868948|FG005|Overall Study|Death|8|||
131610906|NCT03150862|473868949|FG006|Overall Study|Death|6|||
131610907|NCT03150862|473868950|FG007|Overall Study|Death|21|||
131610908|NCT03150862|473868943|FG000|Overall Study|Withdrawal by Subject|1|||
131610909|NCT03150862|473868944|FG001|Overall Study|Withdrawal by Subject|1|||
131610910|NCT03150862|473868945|FG002|Overall Study|Withdrawal by Subject|0|||
131610911|NCT03150862|473868946|FG003|Overall Study|Withdrawal by Subject|3|||
131610912|NCT03150862|473868947|FG004|Overall Study|Withdrawal by Subject|1|||
131610913|NCT03150862|473868948|FG005|Overall Study|Withdrawal by Subject|1|||
131610914|NCT03150862|473868949|FG006|Overall Study|Withdrawal by Subject|1|||
131610915|NCT03150862|473868950|FG007|Overall Study|Withdrawal by Subject|3|||
131610916|NCT03150862|473868943|FG000|Overall Study|Lost to Follow-up|0|||
131610917|NCT03150862|473868944|FG001|Overall Study|Lost to Follow-up|0|||
131610918|NCT03150862|473868945|FG002|Overall Study|Lost to Follow-up|1|||
131610919|NCT03150862|473868946|FG003|Overall Study|Lost to Follow-up|0|||
131610920|NCT03150862|473868947|FG004|Overall Study|Lost to Follow-up|0|||
131610921|NCT03150862|473868948|FG005|Overall Study|Lost to Follow-up|0|||
131610922|NCT03150862|473868949|FG006|Overall Study|Lost to Follow-up|0|||
131610923|NCT03150862|473868950|FG007|Overall Study|Lost to Follow-up|2|||
131610924|NCT03150862|473868943|FG000|Overall Study|Sponsor's decision|0|||
131610925|NCT03150862|473868944|FG001|Overall Study|Sponsor's decision|0|||
131610926|NCT03150862|473868945|FG002|Overall Study|Sponsor's decision|0|||
131610927|NCT03150862|473868946|FG003|Overall Study|Sponsor's decision|10|||
131610928|NCT03150862|473868947|FG004|Overall Study|Sponsor's decision|3|||
131610929|NCT03150862|473868948|FG005|Overall Study|Sponsor's decision|0|||
131610930|NCT03150862|473868949|FG006|Overall Study|Sponsor's decision|1|||
131610931|NCT03150862|473868950|FG007|Overall Study|Sponsor's decision|1|||
131610932|NCT03150862|473868943|FG000|Overall Study|Change in Methylation status|0|||
131610933|NCT03150862|473868944|FG001|Overall Study|Change in Methylation status|0|||
131610934|NCT03150862|473868945|FG002|Overall Study|Change in Methylation status|0|||
131610935|NCT03150862|473868946|FG003|Overall Study|Change in Methylation status|0|||
131610936|NCT03150862|473868947|FG004|Overall Study|Change in Methylation status|1|||
131610937|NCT03150862|473868948|FG005|Overall Study|Change in Methylation status|0|||
131610938|NCT03150862|473868949|FG006|Overall Study|Change in Methylation status|0|||
131610939|NCT03150862|473868950|FG007|Overall Study|Change in Methylation status|0|||
131610940|NCT03150862|473868943|FG000|Overall Study|Roll over in to Long Term Extension|0|||
131441808|NCT02491684|473247218|FG001|Treatment Phase|Incorrect randomisation|0|||
131441809|NCT02491684|473247217|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
131610941|NCT03150862|473868944|FG001|Overall Study|Roll over in to Long Term Extension|0|||
131610942|NCT03150862|473868945|FG002|Overall Study|Roll over in to Long Term Extension|0|||
131610943|NCT03150862|473868946|FG003|Overall Study|Roll over in to Long Term Extension|0|||
131610944|NCT03150862|473868947|FG004|Overall Study|Roll over in to Long Term Extension|0|||
131610945|NCT03150862|473868948|FG005|Overall Study|Roll over in to Long Term Extension|0|||
131610946|NCT03150862|473868949|FG006|Overall Study|Roll over in to Long Term Extension|0|||
131610947|NCT03150862|473868950|FG007|Overall Study|Roll over in to Long Term Extension|1|||
131610948|NCT03150862|473868943|FG000|Overall Study|Progressive Disease|0|||
131610949|NCT03150862|473868944|FG001|Overall Study|Progressive Disease|0|||
131610950|NCT03150862|473868945|FG002|Overall Study|Progressive Disease|0|||
131610951|NCT03150862|473868946|FG003|Overall Study|Progressive Disease|0|||
131793993|NCT01806597|474528701|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131793994|NCT01806597|474528702|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131793995|NCT01806597|474528697|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131793996|NCT01806597|474528698|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131793997|NCT01806597|474528699|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131793998|NCT01806597|474528700|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131793999|NCT01806597|474528701|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131794000|NCT01806597|474528702|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
131794001|NCT01806597|474528697|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131794002|NCT01806597|474528698|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131794003|NCT01806597|474528699|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131794004|NCT01806597|474528700|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131794005|NCT01806597|474528701|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131794006|NCT01806597|474528702|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
131794007|NCT01806597|474528697|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131794008|NCT01806597|474528698|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131794009|NCT01806597|474528699|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131441810|NCT02491684|473247218|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
131441811|NCT01263769|473247221|FG000|Overall Study|Non-Compliant with treatment|1|||
131610952|NCT03150862|473868947|FG004|Overall Study|Progressive Disease|0|||
131610953|NCT03150862|473868948|FG005|Overall Study|Progressive Disease|0|||
131610954|NCT03150862|473868949|FG006|Overall Study|Progressive Disease|0|||
131610955|NCT03150862|473868950|FG007|Overall Study|Progressive Disease|2|||
131610956|NCT03248492|473869456|FG000|Overall Study|Progressive Disease|24|||
131610957|NCT03248492|473869457|FG001|Overall Study|Progressive Disease|23|||
131610958|NCT03248492|473869458|FG002|Overall Study|Progressive Disease|11|||
131610959|NCT03248492|473869459|FG003|Overall Study|Progressive Disease|66|||
131610960|NCT03248492|473869460|FG004|Overall Study|Progressive Disease|1|||
131610961|NCT03248492|473869456|FG000|Overall Study|Adverse Event|14|||
131610962|NCT03248492|473869457|FG001|Overall Study|Adverse Event|13|||
131610963|NCT03248492|473869458|FG002|Overall Study|Adverse Event|9|||
131610964|NCT03248492|473869459|FG003|Overall Study|Adverse Event|22|||
131610965|NCT03248492|473869460|FG004|Overall Study|Adverse Event|2|||
131610966|NCT03248492|473869456|FG000|Overall Study|Withdrawal by Subject|5|||
131610967|NCT03248492|473869457|FG001|Overall Study|Withdrawal by Subject|4|||
131610968|NCT03248492|473869458|FG002|Overall Study|Withdrawal by Subject|0|||
131610969|NCT03248492|473869459|FG003|Overall Study|Withdrawal by Subject|8|||
131610970|NCT03248492|473869460|FG004|Overall Study|Withdrawal by Subject|1|||
131610971|NCT03248492|473869456|FG000|Overall Study|Physician Decision|1|||
131610972|NCT03248492|473869457|FG001|Overall Study|Physician Decision|1|||
131610973|NCT03248492|473869458|FG002|Overall Study|Physician Decision|1|||
131610974|NCT03248492|473869459|FG003|Overall Study|Physician Decision|7|||
131610975|NCT03248492|473869460|FG004|Overall Study|Physician Decision|0|||
131610976|NCT03248492|473869456|FG000|Overall Study|Death|1|||
131610977|NCT03248492|473869457|FG001|Overall Study|Death|1|||
131610978|NCT03248492|473869458|FG002|Overall Study|Death|0|||
131794010|NCT01806597|474528700|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131610979|NCT03248492|473869459|FG003|Overall Study|Death|6|||
131610980|NCT03248492|473869460|FG004|Overall Study|Death|0|||
131610981|NCT03248492|473869456|FG000|Overall Study|Study Terminated by Sponsor|3|||
131610982|NCT03248492|473869457|FG001|Overall Study|Study Terminated by Sponsor|1|||
131610983|NCT03248492|473869458|FG002|Overall Study|Study Terminated by Sponsor|0|||
131610984|NCT03248492|473869459|FG003|Overall Study|Study Terminated by Sponsor|7|||
131610985|NCT03248492|473869460|FG004|Overall Study|Study Terminated by Sponsor|0|||
131610986|NCT03248492|473869456|FG000|Overall Study|Other|2|||
131610987|NCT03248492|473869457|FG001|Overall Study|Other|5|||
131610988|NCT03248492|473869458|FG002|Overall Study|Other|0|||
131610989|NCT03248492|473869459|FG003|Overall Study|Other|14|||
131610990|NCT03248492|473869460|FG004|Overall Study|Other|0|||
131610991|NCT03705390|473869461|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
131610992|NCT03705390|473869461|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
131610993|NCT03213457|473869463|FG000|Screening Period|Withdrawal by Subject|0|||
131610994|NCT03213457|473869464|FG001|Screening Period|Withdrawal by Subject|1|||
131610995|NCT03213457|473869465|FG002|Screening Period|Withdrawal by Subject|0|||
131610996|NCT03213457|473869463|FG000|Screening Period|Other|1|||
131610997|NCT03213457|473869464|FG001|Screening Period|Other|0|||
131610998|NCT03213457|473869465|FG002|Screening Period|Other|0|||
131610999|NCT03213457|473869463|FG000|Double-Blind Period|Adverse Event|3|||
131611000|NCT03213457|473869464|FG001|Double-Blind Period|Adverse Event|2|||
131611001|NCT03213457|473869465|FG002|Double-Blind Period|Adverse Event|7|||
131611002|NCT03213457|473869463|FG000|Double-Blind Period|Withdrawal by Subject|14|||
131611003|NCT03213457|473869464|FG001|Double-Blind Period|Withdrawal by Subject|2|||
131611004|NCT03213457|473869465|FG002|Double-Blind Period|Withdrawal by Subject|14|||
131611005|NCT03213457|473869463|FG000|Double-Blind Period|Lost to Follow-up|2|||
131611006|NCT03213457|473869464|FG001|Double-Blind Period|Lost to Follow-up|3|||
131611007|NCT03213457|473869465|FG002|Double-Blind Period|Lost to Follow-up|9|||
131611008|NCT03213457|473869463|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
131611009|NCT03213457|473869464|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
131611010|NCT03213457|473869465|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
131611011|NCT03213457|473869463|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
131611012|NCT03213457|473869464|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
131611013|NCT03213457|473869465|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
131611014|NCT03213457|473869463|FG000|Double-Blind Period|Pregnancy|5|||
131611015|NCT03213457|473869464|FG001|Double-Blind Period|Pregnancy|0|||
131611016|NCT03213457|473869465|FG002|Double-Blind Period|Pregnancy|0|||
131611017|NCT03213457|473869463|FG000|Double-Blind Period|Other|10|||
131611018|NCT03213457|473869464|FG001|Double-Blind Period|Other|3|||
131611019|NCT03213457|473869465|FG002|Double-Blind Period|Other|17|||
131611020|NCT03213457|473869463|FG000|Open-Label Period|Adverse Event|1|||
131611021|NCT03213457|473869464|FG001|Open-Label Period|Adverse Event|2|||
131611022|NCT03213457|473869465|FG002|Open-Label Period|Adverse Event|2|||
131611023|NCT03213457|473869463|FG000|Open-Label Period|Withdrawal by Subject|12|||
131611024|NCT03213457|473869464|FG001|Open-Label Period|Withdrawal by Subject|5|||
131611025|NCT03213457|473869465|FG002|Open-Label Period|Withdrawal by Subject|24|||
131611026|NCT03213457|473869463|FG000|Open-Label Period|Lost to Follow-up|1|||
131611027|NCT03213457|473869464|FG001|Open-Label Period|Lost to Follow-up|2|||
131611028|NCT03213457|473869465|FG002|Open-Label Period|Lost to Follow-up|8|||
131611029|NCT03213457|473869463|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
131611030|NCT03213457|473869464|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
131611031|NCT03213457|473869465|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
131611032|NCT03213457|473869463|FG000|Open-Label Period|Non-compliance with study procedures|1|||
131611033|NCT03213457|473869464|FG001|Open-Label Period|Non-compliance with study procedures|1|||
131611034|NCT03213457|473869465|FG002|Open-Label Period|Non-compliance with study procedures|2|||
131611035|NCT03213457|473869463|FG000|Open-Label Period|Exclusionary medications|0|||
131611036|NCT03213457|473869464|FG001|Open-Label Period|Exclusionary medications|0|||
131611037|NCT03213457|473869465|FG002|Open-Label Period|Exclusionary medications|1|||
131611038|NCT03213457|473869463|FG000|Open-Label Period|Other|1|||
131611039|NCT03213457|473869464|FG001|Open-Label Period|Other|1|||
131611040|NCT03213457|473869465|FG002|Open-Label Period|Other|6|||
131611041|NCT03213457|473869463|FG000|Follow-Up Period|Adverse Event|16|||
131611042|NCT03213457|473869464|FG001|Follow-Up Period|Adverse Event|8|||
131611043|NCT03213457|473869465|FG002|Follow-Up Period|Adverse Event|37|||
131611044|NCT03213457|473869463|FG000|Follow-Up Period|Withdrawal by Subject|18|||
131611045|NCT03213457|473869464|FG001|Follow-Up Period|Withdrawal by Subject|11|||
131611046|NCT03213457|473869465|FG002|Follow-Up Period|Withdrawal by Subject|55|||
131611047|NCT03213457|473869463|FG000|Follow-Up Period|Lost to Follow-up|28|||
131611048|NCT03213457|473869464|FG001|Follow-Up Period|Lost to Follow-up|15|||
131611049|NCT03213457|473869465|FG002|Follow-Up Period|Lost to Follow-up|50|||
131611050|NCT03213457|473869463|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
131708231|NCT00896532|474211331|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708232|NCT00896532|474211332|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708233|NCT00896532|474211333|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708234|NCT00896532|474211334|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708235|NCT00896532|474211335|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708236|NCT00896532|474211336|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708237|NCT00896532|474211337|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131441812|NCT02285855|473247222|FG000|Overall Study|Withdrawal by Subject|2|||
131441813|NCT02285855|473247223|FG001|Overall Study|Withdrawal by Subject|1|||
131441814|NCT02718898|473247224|FG000|Blinded Treatment Period|Adverse Event|5|||
131441815|NCT02718898|473247225|FG001|Blinded Treatment Period|Adverse Event|1|||
131441816|NCT02718898|473247226|FG002|Blinded Treatment Period|Adverse Event|0|||
131441817|NCT02718898|473247227|FG003|Blinded Treatment Period|Adverse Event|0|||
131441818|NCT02718898|473247228|FG004|Blinded Treatment Period|Adverse Event|0|||
131441819|NCT02718898|473247229|FG005|Blinded Treatment Period|Adverse Event|0|||
131441820|NCT02718898|473247230|FG006|Blinded Treatment Period|Adverse Event|0|||
131441821|NCT02718898|473247224|FG000|Blinded Treatment Period|Physician Decision|1|||
131441822|NCT02718898|473247225|FG001|Blinded Treatment Period|Physician Decision|0|||
131441823|NCT02718898|473247226|FG002|Blinded Treatment Period|Physician Decision|0|||
131441824|NCT02718898|473247227|FG003|Blinded Treatment Period|Physician Decision|0|||
131441825|NCT02718898|473247228|FG004|Blinded Treatment Period|Physician Decision|0|||
131441826|NCT02718898|473247229|FG005|Blinded Treatment Period|Physician Decision|0|||
131441827|NCT02718898|473247230|FG006|Blinded Treatment Period|Physician Decision|0|||
131441828|NCT02718898|473247224|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
131441829|NCT02718898|473247225|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
131441830|NCT02718898|473247226|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
131441831|NCT02718898|473247227|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
131441832|NCT02718898|473247228|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
131441833|NCT02718898|473247229|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
131441834|NCT02718898|473247230|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
131441835|NCT02718898|473247224|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
131441836|NCT02718898|473247225|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
131441837|NCT02718898|473247226|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
131441838|NCT02718898|473247227|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
131441839|NCT02718898|473247228|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
131441840|NCT02718898|473247229|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
131441841|NCT02718898|473247230|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
131794011|NCT01806597|474528701|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131794012|NCT01806597|474528702|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
131794013|NCT01806597|474528697|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131794014|NCT01806597|474528698|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131794015|NCT01806597|474528699|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131794016|NCT01806597|474528700|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131794017|NCT01806597|474528701|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131794018|NCT01806597|474528702|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
131794019|NCT01806597|474528697|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131794020|NCT01806597|474528698|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131794021|NCT01806597|474528699|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131441842|NCT02718898|473247224|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
131441843|NCT02718898|473247225|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
131441844|NCT02718898|473247226|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
131611051|NCT03213457|473869464|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
131611052|NCT03213457|473869465|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
131611053|NCT03213457|473869463|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
131611054|NCT03213457|473869464|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
131611055|NCT03213457|473869465|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
131611056|NCT03213457|473869463|FG000|Follow-Up Period|Pregnancy|7|||
131611057|NCT03213457|473869464|FG001|Follow-Up Period|Pregnancy|0|||
131611058|NCT03213457|473869465|FG002|Follow-Up Period|Pregnancy|18|||
131611059|NCT03213457|473869463|FG000|Follow-Up Period|Exclusionary medications|1|||
131611060|NCT03213457|473869464|FG001|Follow-Up Period|Exclusionary medications|1|||
131611061|NCT03213457|473869465|FG002|Follow-Up Period|Exclusionary medications|5|||
131611062|NCT03213457|473869463|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
131611063|NCT03213457|473869464|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
131611064|NCT03213457|473869465|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
131611065|NCT03213457|473869463|FG000|Follow-Up Period|Other|14|||
131611066|NCT03213457|473869464|FG001|Follow-Up Period|Other|10|||
131611067|NCT03213457|473869465|FG002|Follow-Up Period|Other|31|||
131611068|NCT01830595|473869466|FG000|First Period|Withdrawal by Subject|1|||
131611069|NCT01830595|473869467|FG001|First Period|Withdrawal by Subject|3|||
131611070|NCT01830595|473869466|FG000|Washout|Withdrawal by Subject|2|||
131611071|NCT01830595|473869467|FG001|Washout|Withdrawal by Subject|2|||
131611072|NCT04940624|473869468|FG000|Overall Study|Adverse Event|4|||
131611073|NCT04940624|473869469|FG001|Overall Study|Adverse Event|11|||
131611074|NCT04940624|473869468|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131611075|NCT04940624|473869469|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131611076|NCT04940624|473869468|FG000|Overall Study|Physician Decision|1|||
131611077|NCT04940624|473869469|FG001|Overall Study|Physician Decision|0|||
131611078|NCT04940624|473869468|FG000|Overall Study|Lost to Follow-up|1|||
131611079|NCT04940624|473869469|FG001|Overall Study|Lost to Follow-up|0|||
131611080|NCT04940624|473869468|FG000|Overall Study|Reason Not Specified|1|||
131611081|NCT04940624|473869469|FG001|Overall Study|Reason Not Specified|0|||
131611082|NCT04059406|473869474|FG000|Overall Study|Early Treatment Termination|5|||
131611083|NCT04059406|473869475|FG001|Overall Study|Early Treatment Termination|5|||
131611084|NCT04059406|473869476|FG002|Overall Study|Early Treatment Termination|15|||
131611085|NCT05155306|473869477|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
131611086|NCT05155306|473869478|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
131611087|NCT05155306|473869479|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
131611088|NCT05155306|473869480|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
131611089|NCT05155306|473869477|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
131611090|NCT05155306|473869478|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
131611091|NCT05155306|473869479|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
131611092|NCT05155306|473869480|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
131611093|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
131611094|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
131611095|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
131611096|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
131611097|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
131611098|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
131611099|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
131611100|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
131611101|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
131611102|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
131611103|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
131611104|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
131611105|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
131611106|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
131611107|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
131708238|NCT00896532|474211338|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131611108|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
131708239|NCT00896532|474211339|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708240|NCT00896532|474211340|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708241|NCT00896532|474211341|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708242|NCT00896532|474211342|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131611109|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
131611110|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
131611111|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
131611112|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
131719513|NCT00883753|474253338|FG000|Overall Study|Administrative/Other|8|||
131611113|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
131611114|NCT04505722|473869483|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
131611115|NCT04505722|473869484|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
131441845|NCT02718898|473247227|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
131441846|NCT02718898|473247228|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
131441847|NCT02718898|473247229|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
131441848|NCT02718898|473247230|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
131441849|NCT02718898|473247224|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
131441850|NCT02718898|473247225|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
131441851|NCT02718898|473247226|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
131441852|NCT02718898|473247227|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
131441853|NCT02718898|473247228|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
131441854|NCT02718898|473247229|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
131441855|NCT02718898|473247230|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
131708243|NCT00896532|474211343|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
131708244|NCT00896532|474211344|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708245|NCT00896532|474211345|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708246|NCT00896532|474211346|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708247|NCT00896532|474211347|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708248|NCT00896532|474211348|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131708249|NCT00896532|474211349|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131719514|NCT01480180|474253339|FG000|Main Phase|Withdrawal criteria|12|||
131719515|NCT01480180|474253340|FG001|Main Phase|Withdrawal criteria|1|||
131719516|NCT01480180|474253341|FG002|Main Phase|Withdrawal criteria|0|||
131441856|NCT02718898|473247224|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131441857|NCT02718898|473247225|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131719517|NCT01480180|474253342|FG003|Main Phase|Withdrawal criteria|0|||
131719518|NCT01480180|474253343|FG004|Main Phase|Withdrawal criteria|0|||
131719519|NCT01480180|474253344|FG005|Main Phase|Withdrawal criteria|0|||
131719520|NCT01480180|474253339|FG000|Main Phase|Lack of Efficacy|1|||
131719521|NCT01480180|474253340|FG001|Main Phase|Lack of Efficacy|0|||
131719522|NCT01480180|474253341|FG002|Main Phase|Lack of Efficacy|0|||
131719523|NCT01480180|474253342|FG003|Main Phase|Lack of Efficacy|0|||
131719524|NCT01480180|474253343|FG004|Main Phase|Lack of Efficacy|0|||
131719525|NCT01480180|474253344|FG005|Main Phase|Lack of Efficacy|0|||
131719526|NCT01480180|474253339|FG000|Main Phase|Non-compliance|3|||
131719527|NCT01480180|474253340|FG001|Main Phase|Non-compliance|0|||
131719528|NCT01480180|474253341|FG002|Main Phase|Non-compliance|0|||
131719529|NCT01480180|474253342|FG003|Main Phase|Non-compliance|0|||
131719530|NCT01480180|474253343|FG004|Main Phase|Non-compliance|0|||
131719531|NCT01480180|474253344|FG005|Main Phase|Non-compliance|0|||
131719532|NCT01480180|474253339|FG000|Main Phase|Unclassified|3|||
131719533|NCT01480180|474253340|FG001|Main Phase|Unclassified|0|||
131719534|NCT01480180|474253341|FG002|Main Phase|Unclassified|0|||
131719535|NCT01480180|474253342|FG003|Main Phase|Unclassified|0|||
131719536|NCT01480180|474253343|FG004|Main Phase|Unclassified|0|||
131719537|NCT01480180|474253344|FG005|Main Phase|Unclassified|0|||
131719538|NCT01480180|474253339|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
131719539|NCT01480180|474253340|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
131719540|NCT01480180|474253341|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
131719541|NCT01480180|474253342|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
131719542|NCT01480180|474253343|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
131719543|NCT01480180|474253344|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
131719544|NCT01480180|474253339|FG000|Extension Phase, Part 1|Unclassified|0|||
131719545|NCT01480180|474253340|FG001|Extension Phase, Part 1|Unclassified|0|||
131441858|NCT02718898|473247226|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
131441859|NCT02718898|473247227|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
131441860|NCT02718898|473247228|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131441861|NCT02718898|473247229|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131441862|NCT02718898|473247230|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131441863|NCT02718898|473247224|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
131441864|NCT02718898|473247225|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
131441865|NCT02718898|473247226|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
131441866|NCT02718898|473247227|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
131441867|NCT02718898|473247228|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
131441868|NCT02718898|473247229|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
131441869|NCT02718898|473247230|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
131441870|NCT02718898|473247224|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
131441871|NCT02718898|473247225|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
131441872|NCT02718898|473247226|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
131441873|NCT02718898|473247227|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
131611116|NCT04505722|473869485|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
131611117|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
131611118|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
131611119|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
131611120|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
131611121|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
131611122|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
131611123|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
131611124|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
131611125|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
131611126|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
131611127|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
131611128|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
131611129|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
131611130|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
131611131|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
131611132|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
131794022|NCT01806597|474528700|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131794023|NCT01806597|474528701|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131794024|NCT01806597|474528702|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
131794025|NCT02247479|474528705|FG000|Overall Study|Adverse Event|8|||
131794026|NCT02247479|474528706|FG001|Overall Study|Adverse Event|9|||
131794027|NCT02247479|474528707|FG002|Overall Study|Adverse Event|8|||
131794028|NCT02247479|474528705|FG000|Overall Study|Death|5|||
131794029|NCT02247479|474528706|FG001|Overall Study|Death|4|||
131794030|NCT02247479|474528707|FG002|Overall Study|Death|6|||
131794031|NCT02247479|474528705|FG000|Overall Study|Lost to Follow-up|3|||
131794032|NCT02247479|474528706|FG001|Overall Study|Lost to Follow-up|3|||
131794033|NCT02247479|474528707|FG002|Overall Study|Lost to Follow-up|1|||
131794034|NCT02247479|474528705|FG000|Overall Study|Non-compliance|0|||
131794035|NCT02247479|474528706|FG001|Overall Study|Non-compliance|0|||
131794036|NCT02247479|474528707|FG002|Overall Study|Non-compliance|1|||
131794037|NCT02247479|474528705|FG000|Overall Study|Withdrawal by Subject|25|||
131794038|NCT02247479|474528706|FG001|Overall Study|Withdrawal by Subject|29|||
131794039|NCT02247479|474528707|FG002|Overall Study|Withdrawal by Subject|24|||
131794040|NCT02247479|474528705|FG000|Overall Study|Study Terminated by Sponsor|98|||
131794041|NCT02247479|474528706|FG001|Overall Study|Study Terminated by Sponsor|88|||
131794042|NCT02247479|474528707|FG002|Overall Study|Study Terminated by Sponsor|94|||
131794043|NCT02247479|474528705|FG000|Overall Study|Physician Decision|1|||
131794044|NCT02247479|474528706|FG001|Overall Study|Physician Decision|0|||
131794045|NCT02247479|474528707|FG002|Overall Study|Physician Decision|2|||
131794046|NCT02247479|474528705|FG000|Overall Study|Unspecified Reason|2|||
131794047|NCT02247479|474528706|FG001|Overall Study|Unspecified Reason|5|||
131794048|NCT02247479|474528707|FG002|Overall Study|Unspecified Reason|2|||
131794049|NCT01073020|474528708|FG000|Overall Study|Withdrawal by Subject|6|||
131794050|NCT01073020|474528709|FG001|Overall Study|Withdrawal by Subject|4|||
131794051|NCT01073020|474528710|FG002|Overall Study|Withdrawal by Subject|1|||
131794052|NCT01073020|474528711|FG003|Overall Study|Withdrawal by Subject|2|||
131794053|NCT01073020|474528708|FG000|Overall Study|Physician Decision|1|||
131794054|NCT01073020|474528709|FG001|Overall Study|Physician Decision|0|||
131794055|NCT01073020|474528710|FG002|Overall Study|Physician Decision|2|||
131794056|NCT01073020|474528711|FG003|Overall Study|Physician Decision|0|||
131794057|NCT01073020|474528708|FG000|Overall Study|Death|0|||
131794058|NCT01073020|474528709|FG001|Overall Study|Death|1|||
131794059|NCT01073020|474528710|FG002|Overall Study|Death|0|||
131441874|NCT02718898|473247228|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
131441875|NCT02718898|473247229|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
131441876|NCT02718898|473247230|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
131441877|NCT02718898|473247224|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
131441878|NCT02718898|473247225|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
131611133|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
131611134|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
131611135|NCT04505722|473869483|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
131611136|NCT04505722|473869484|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
131611137|NCT04505722|473869485|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
131611138|NCT04755595|473869486|FG000|Overall Study|Lost to Follow-up|1|||
131611139|NCT00319696|473869487|FG000|Overall Study|Adverse Event|36|||
131611140|NCT00319696|473869487|FG000|Overall Study|withdrawal of consent|14|||
131611141|NCT00319696|473869487|FG000|Overall Study|administrative|7|||
131611142|NCT00319696|473869487|FG000|Overall Study|Lost to Follow-up|3|||
131611143|NCT03891758|473869489|FG000|Overall Study|Adverse Event|2|||
131611144|NCT03891758|473869490|FG001|Overall Study|Adverse Event|0|||
131611145|NCT03891758|473869489|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131611146|NCT03891758|473869490|FG001|Overall Study|Withdrawal by parent/guardian|2|||
131611147|NCT05039021|473870037|FG000|Overall Study|Death|1|||
131611148|NCT05039021|473870037|FG000|Overall Study|Lost to Follow-up|3|||
131611149|NCT04977583|473870038|FG000|Overall Study|Lost to Follow-up|8|||
131611150|NCT04977583|473870039|FG001|Overall Study|Lost to Follow-up|4|||
131611151|NCT04977583|473870040|FG002|Overall Study|Lost to Follow-up|13|||
131611152|NCT04977583|473870038|FG000|Overall Study|Withdrawal by Subject|3|||
131611153|NCT04977583|473870039|FG001|Overall Study|Withdrawal by Subject|2|||
131611154|NCT04977583|473870040|FG002|Overall Study|Withdrawal by Subject|1|||
131611155|NCT01596972|473870041|FG000|Overall Study|Physician Decision|1|||
131611156|NCT01596972|473870042|FG001|Overall Study|Physician Decision|9|||
131708250|NCT00896532|474211327|FG000|Months 48-72: Follow-on Phase|Death|0|||
131708251|NCT00896532|474211328|FG001|Months 48-72: Follow-on Phase|Death|0|||
131708252|NCT00896532|474211329|FG002|Months 48-72: Follow-on Phase|Death|0|||
131708253|NCT00896532|474211330|FG003|Months 48-72: Follow-on Phase|Death|0|||
131708254|NCT00896532|474211331|FG004|Months 48-72: Follow-on Phase|Death|0|||
131708255|NCT00896532|474211332|FG005|Months 48-72: Follow-on Phase|Death|0|||
131708256|NCT00896532|474211333|FG006|Months 48-72: Follow-on Phase|Death|0|||
131708257|NCT00896532|474211334|FG007|Months 48-72: Follow-on Phase|Death|0|||
131708258|NCT00896532|474211335|FG008|Months 48-72: Follow-on Phase|Death|0|||
131708259|NCT00896532|474211336|FG009|Months 48-72: Follow-on Phase|Death|0|||
131708260|NCT00896532|474211337|FG010|Months 48-72: Follow-on Phase|Death|0|||
131708261|NCT00896532|474211338|FG011|Months 48-72: Follow-on Phase|Death|0|||
131708262|NCT00896532|474211339|FG012|Months 48-72: Follow-on Phase|Death|0|||
131708263|NCT00896532|474211340|FG013|Months 48-72: Follow-on Phase|Death|0|||
131708264|NCT00896532|474211341|FG014|Months 48-72: Follow-on Phase|Death|0|||
131708265|NCT00896532|474211342|FG015|Months 48-72: Follow-on Phase|Death|0|||
131708266|NCT00896532|474211343|FG016|Months 48-72: Follow-on Phase|Death|0|||
131708267|NCT00896532|474211344|FG017|Months 48-72: Follow-on Phase|Death|0|||
131708268|NCT00896532|474211345|FG018|Months 48-72: Follow-on Phase|Death|1|||
131708269|NCT00896532|474211346|FG019|Months 48-72: Follow-on Phase|Death|0|||
131708270|NCT00896532|474211347|FG020|Months 48-72: Follow-on Phase|Death|0|||
131708271|NCT00896532|474211348|FG021|Months 48-72: Follow-on Phase|Death|0|||
131708272|NCT00896532|474211349|FG022|Months 48-72: Follow-on Phase|Death|0|||
131708273|NCT00896532|474211327|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708274|NCT00896532|474211328|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708275|NCT00896532|474211329|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708276|NCT00896532|474211330|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708277|NCT00896532|474211331|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708278|NCT00896532|474211332|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708279|NCT00896532|474211333|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708280|NCT00896532|474211334|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708281|NCT00896532|474211335|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708282|NCT00896532|474211336|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708283|NCT00896532|474211337|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708284|NCT00896532|474211338|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131794060|NCT01073020|474528711|FG003|Overall Study|Death|0|||
131794061|NCT03031899|474528712|FG000|Overall Study|Protocol Violation|1|||
131794062|NCT03031899|474528712|FG000|Overall Study|lesion disappeared after stopping habit|1|||
131794063|NCT03740698|474528713|FG000|Overall Study|Physician Decision|0|||
131794064|NCT03740698|474528714|FG001|Overall Study|Physician Decision|1|||
131708285|NCT00896532|474211339|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131794065|NCT03740698|474528715|FG002|Overall Study|Physician Decision|1|||
131611157|NCT01596972|473870041|FG000|Overall Study|Lost to Follow-up|0|||
131611158|NCT01596972|473870042|FG001|Overall Study|Lost to Follow-up|4|||
131611159|NCT01596972|473870041|FG000|Overall Study|Withdrawal by Subject|0|||
131900104|NCT00101868|474919470|FG000|Overall Study|Lost to Follow-up|8|||
131611160|NCT01596972|473870042|FG001|Overall Study|Withdrawal by Subject|1|||
131611161|NCT01639131|473870043|FG000|Overall Study|Disease Progression|6|||
131611162|NCT04121546|473870048|FG000|Overall Study|Lost to Follow-up|1|||
131611163|NCT04121546|473870049|FG001|Overall Study|Lost to Follow-up|3|||
131611164|NCT03653364|473870050|FG000|Overall Study|Withdrawal by Subject|1|||
131611165|NCT03653364|473870050|FG000|Overall Study|Enrolled in Error|1|||
131611166|NCT03653364|473870050|FG000|Overall Study|Death|1|||
131611167|NCT00686595|473870051|FG000|Overall Study|Adverse Event|3|||
131611168|NCT00686595|473870051|FG000|Overall Study|Protocol Violation|1|||
131611169|NCT00686595|473870051|FG000|Overall Study|Lost to Follow-up|1|||
131611170|NCT00686595|473870051|FG000|Overall Study|Lack of Efficacy|1|||
131611171|NCT00686595|473870051|FG000|Overall Study|Poor Compliance|1|||
131611172|NCT05934292|473870058|FG000|Overall Study|Lost to Follow-up|0|||
131611173|NCT05934292|473870059|FG001|Overall Study|Lost to Follow-up|0|||
131611174|NCT05934292|473870060|FG002|Overall Study|Lost to Follow-up|1|||
131611175|NCT05934292|473870061|FG003|Overall Study|Lost to Follow-up|0|||
131611176|NCT04479787|473870062|FG000|Through 6 Months|Withdrawal by Subject|16|||
131611177|NCT04479787|473870063|FG001|Through 6 Months|Withdrawal by Subject|14|||
131611178|NCT04479787|473870062|FG000|Through 6 Months|Unsuccessful Trial|17|||
131611179|NCT04479787|473870063|FG001|Through 6 Months|Unsuccessful Trial|0|||
131611180|NCT04479787|473870062|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
131611181|NCT04479787|473870063|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
131611182|NCT04479787|473870062|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
131611183|NCT04479787|473870063|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
131611184|NCT04479787|473870062|FG000|Through 6 Months|Lost to Follow-up|3|||
131611185|NCT04479787|473870063|FG001|Through 6 Months|Lost to Follow-up|2|||
131611186|NCT04479787|473870062|FG000|Through 6 Months|Death|3|||
131611187|NCT04479787|473870063|FG001|Through 6 Months|Death|0|||
131611188|NCT04479787|473870062|FG000|Through 6 Months|Inclusion/Exclusion|2|||
131611189|NCT04479787|473870063|FG001|Through 6 Months|Inclusion/Exclusion|1|||
131611190|NCT04479787|473870062|FG000|Through 6 Months|Subject Became Pregnant|1|||
131611191|NCT04479787|473870063|FG001|Through 6 Months|Subject Became Pregnant|1|||
131611192|NCT04479787|473870062|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
131611193|NCT04479787|473870063|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
131611194|NCT04479787|473870062|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
131611195|NCT04479787|473870063|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
131611196|NCT04479787|473870062|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
131611197|NCT04479787|473870063|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
131611198|NCT04479787|473870062|FG000|After 6 Months|Withdrawal by Subject|3|||
131611199|NCT04479787|473870063|FG001|After 6 Months|Withdrawal by Subject|13|||
131611200|NCT04479787|473870062|FG000|After 6 Months|Unsuccessful Trial|0|||
131611201|NCT04479787|473870063|FG001|After 6 Months|Unsuccessful Trial|7|||
131611202|NCT04479787|473870062|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
131708286|NCT00896532|474211340|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708287|NCT00896532|474211341|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708288|NCT00896532|474211342|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708289|NCT00896532|474211343|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708290|NCT00896532|474211344|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708291|NCT00896532|474211345|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708292|NCT00896532|474211346|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708293|NCT00896532|474211347|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708294|NCT00896532|474211348|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
131708295|NCT00896532|474211349|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131708296|NCT00896532|474211327|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708297|NCT00896532|474211328|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131900105|NCT00101868|474919471|FG001|Overall Study|Lost to Follow-up|13|||
131611203|NCT04479787|473870063|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
131611204|NCT04479787|473870062|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
131611205|NCT04479787|473870063|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
131611206|NCT04479787|473870062|FG000|After 6 Months|Death|2|||
131611207|NCT04479787|473870063|FG001|After 6 Months|Death|0|||
131611208|NCT04479787|473870062|FG000|After 6 Months|Lost to Follow-up|1|||
131611209|NCT04479787|473870063|FG001|After 6 Months|Lost to Follow-up|1|||
131611210|NCT04479787|473870062|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
131611211|NCT04479787|473870063|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
131611212|NCT04479787|473870062|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
131611213|NCT04479787|473870063|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
131611214|NCT04479787|473870062|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
131611215|NCT04479787|473870063|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
131611216|NCT04479787|473870062|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
131611217|NCT04479787|473870063|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
131611218|NCT05714059|473870064|FG000|Overall Study|Withdrawal by Subject|2|||
131611219|NCT05714059|473870065|FG001|Overall Study|Withdrawal by Subject|2|||
131611220|NCT05714059|473870064|FG000|Overall Study|Adverse Event|0|||
131611221|NCT05714059|473870065|FG001|Overall Study|Adverse Event|1|||
131611222|NCT05714059|473870064|FG000|Overall Study|Lost to Follow-up|0|||
131611223|NCT05714059|473870065|FG001|Overall Study|Lost to Follow-up|1|||
131611224|NCT05714059|473870064|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
131611225|NCT05714059|473870065|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
131611226|NCT05714059|473870064|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
131611227|NCT05714059|473870065|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
131611228|NCT04899674|473870066|FG000|Test|Adverse Event|1|||
131611229|NCT03774472|473870067|FG000|Overall Study|Physician Decision|1|||
131611230|NCT03774472|473870068|FG001|Overall Study|Physician Decision|0|||
131611231|NCT03774472|473870069|FG002|Overall Study|Physician Decision|0|||
131611232|NCT03774472|473870067|FG000|Overall Study|Progression prior to 4 weeks|0|||
131611233|NCT03774472|473870068|FG001|Overall Study|Progression prior to 4 weeks|1|||
131611234|NCT03774472|473870069|FG002|Overall Study|Progression prior to 4 weeks|0|||
131611235|NCT03774472|473870067|FG000|Overall Study|Withdrawal by Subject|0|||
131611236|NCT03774472|473870068|FG001|Overall Study|Withdrawal by Subject|1|||
131611237|NCT03774472|473870069|FG002|Overall Study|Withdrawal by Subject|0|||
131611238|NCT03473223|473870072|FG000|Overall Study|Lost to Follow-up|1|||
131611239|NCT03473223|473870073|FG001|Overall Study|Lost to Follow-up|1|||
131611240|NCT03473223|473870072|FG000|Overall Study|Withdrawal by Subject|47|||
131611241|NCT03473223|473870073|FG001|Overall Study|Withdrawal by Subject|42|||
131611242|NCT03473223|473870072|FG000|Overall Study|Indirect contact|32|||
131611243|NCT03473223|473870073|FG001|Overall Study|Indirect contact|29|||
131611244|NCT03473223|473870072|FG000|Overall Study|Other (Not specified)|32|||
131611245|NCT03473223|473870073|FG001|Overall Study|Other (Not specified)|20|||
131611246|NCT00115934|473870076|FG000|Overall Study|Lost to Follow-up|1|||
131611247|NCT00115934|473870077|FG001|Overall Study|Lost to Follow-up|0|||
131611248|NCT00115934|473870076|FG000|Overall Study|Did not receive intervention|3|||
131611249|NCT00115934|473870077|FG001|Overall Study|Did not receive intervention|2|||
131611250|NCT04039113|473870078|FG000|Overall Study|Withdrawal by Subject|8|||
131611251|NCT04039113|473870079|FG001|Overall Study|Withdrawal by Subject|11|||
131611252|NCT04039113|473870078|FG000|Overall Study|Lost to Follow-up|1|||
131611253|NCT04039113|473870079|FG001|Overall Study|Lost to Follow-up|1|||
131611254|NCT04039113|473870078|FG000|Overall Study|Adverse Event|2|||
131611255|NCT04039113|473870079|FG001|Overall Study|Adverse Event|2|||
131611256|NCT04039113|473870078|FG000|Overall Study|Death|2|||
131611257|NCT04039113|473870079|FG001|Overall Study|Death|4|||
131611258|NCT04039113|473870078|FG000|Overall Study|Site Closure|6|||
131611259|NCT04039113|473870079|FG001|Overall Study|Site Closure|0|||
131611260|NCT04039113|473870078|FG000|Overall Study|Failure to meet randomisation criteria|4|||
131611261|NCT04039113|473870079|FG001|Overall Study|Failure to meet randomisation criteria|0|||
131611262|NCT00353496|473870080|FG000|Overall Study|Adverse Event|1|||
131611263|NCT00353496|473870081|FG001|Overall Study|Adverse Event|0|||
131611264|NCT00353496|473870080|FG000|Overall Study|Protocol Violation|2|||
131611265|NCT00353496|473870081|FG001|Overall Study|Protocol Violation|2|||
131611266|NCT00353496|473870080|FG000|Overall Study|Withdrawal by Subject|3|||
131611267|NCT00353496|473870081|FG001|Overall Study|Withdrawal by Subject|4|||
131611268|NCT00353496|473870080|FG000|Overall Study|Physician Decision|6|||
131611269|NCT00353496|473870081|FG001|Overall Study|Physician Decision|9|||
131611270|NCT00353496|473870080|FG000|Overall Study|Not otherwise specified|4|||
131611271|NCT00353496|473870081|FG001|Overall Study|Not otherwise specified|2|||
131611272|NCT02422615|473870501|FG000|Treatment Period|Progressive disease|314|||
131611273|NCT02422615|473870502|FG001|Treatment Period|Progressive disease|200|||
131611274|NCT02422615|473870501|FG000|Treatment Period|Adverse Event|51|||
131611275|NCT02422615|473870502|FG001|Treatment Period|Adverse Event|9|||
131611276|NCT02422615|473870501|FG000|Treatment Period|Physician Decision|32|||
131611277|NCT02422615|473870502|FG001|Treatment Period|Physician Decision|8|||
131611278|NCT02422615|473870501|FG000|Treatment Period|Subject/guardian decision|38|||
131611279|NCT02422615|473870502|FG001|Treatment Period|Subject/guardian decision|8|||
131611280|NCT02422615|473870501|FG000|Treatment Period|Death|2|||
131611281|NCT02422615|473870502|FG001|Treatment Period|Death|1|||
131611282|NCT02422615|473870501|FG000|Treatment Period|Technical problems|0|||
131611283|NCT02422615|473870502|FG001|Treatment Period|Technical problems|1|||
131611284|NCT02422615|473870501|FG000|Treatment Period|Protocol deviation|1|||
131611285|NCT02422615|473870502|FG001|Treatment Period|Protocol deviation|1|||
131611286|NCT02422615|473870501|FG000|Treatment Period|Study terminated as per protocol|46|||
131611287|NCT02422615|473870502|FG001|Treatment Period|Study terminated as per protocol|14|||
131611288|NCT02422615|473870501|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131611289|NCT02422615|473870502|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131611290|NCT02422615|473870501|FG000|Post-treatment Efficacy Follow-up|Death|2|||
131611291|NCT02422615|473870502|FG001|Post-treatment Efficacy Follow-up|Death|1|||
131611292|NCT02422615|473870501|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
131611293|NCT02422615|473870502|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131611294|NCT02422615|473870501|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
131611295|NCT02422615|473870502|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
131611296|NCT02422615|473870501|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
131611297|NCT02422615|473870502|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
131611298|NCT02422615|473870501|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
131611299|NCT02422615|473870502|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
131611300|NCT01260896|473870511|FG000|First Intervention|Withdrawn Due to Emesis|2|||
131611301|NCT01260896|473870512|FG001|First Intervention|Withdrawn Due to Emesis|0|||
131611302|NCT01315132|473870519|FG000|Overall Study|not treated due to disease progression|1|||
131611303|NCT03660930|473870520|FG000|Overall Study|Adverse Event|0|||
131611304|NCT03660930|473870521|FG001|Overall Study|Adverse Event|0|||
131611305|NCT03660930|473870522|FG002|Overall Study|Adverse Event|0|||
131611306|NCT03660930|473870523|FG003|Overall Study|Adverse Event|2|||
131611307|NCT03660930|473870524|FG004|Overall Study|Adverse Event|0|||
131611308|NCT03660930|473870525|FG005|Overall Study|Adverse Event|1|||
131611309|NCT03660930|473870526|FG006|Overall Study|Adverse Event|0|||
131611310|NCT03660930|473870527|FG007|Overall Study|Adverse Event|0|||
131611311|NCT03660930|473870520|FG000|Overall Study|Withdrawal by Subject|0|||
131611312|NCT03660930|473870521|FG001|Overall Study|Withdrawal by Subject|0|||
131611313|NCT03660930|473870522|FG002|Overall Study|Withdrawal by Subject|0|||
131611314|NCT03660930|473870523|FG003|Overall Study|Withdrawal by Subject|0|||
131611315|NCT03660930|473870524|FG004|Overall Study|Withdrawal by Subject|0|||
131611316|NCT03660930|473870525|FG005|Overall Study|Withdrawal by Subject|1|||
131611317|NCT03660930|473870526|FG006|Overall Study|Withdrawal by Subject|0|||
131611318|NCT03660930|473870527|FG007|Overall Study|Withdrawal by Subject|0|||
131611319|NCT00087685|473870528|FG000|Overall Study|Adverse Event|5|||
131611320|NCT00087685|473870528|FG000|Overall Study|Non-Compliance|1|||
131611321|NCT00087685|473870528|FG000|Overall Study|Progressive Disease|5|||
131611322|NCT00087685|473870528|FG000|Overall Study|Withdrawal by Subject|3|||
131611323|NCT04018495|473870529|FG000|Overall Study|Physician Decision|1|||
131611324|NCT05601882|473870532|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
131611325|NCT05601882|473870533|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
131611326|NCT05601882|473870534|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
131611327|NCT05601882|473870535|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
131611328|NCT05601882|473870532|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
131611329|NCT05601882|473870533|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
131611330|NCT05601882|473870534|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
131611331|NCT05601882|473870535|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
131611332|NCT05601882|473870532|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
131611333|NCT05601882|473870533|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
131611334|NCT05601882|473870534|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
131611335|NCT05601882|473870535|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
131611336|NCT05601882|473870532|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
131611337|NCT05601882|473870533|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
131611338|NCT05601882|473870534|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
131611339|NCT05601882|473870535|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
131611340|NCT05601882|473870532|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
131611341|NCT05601882|473870533|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
131794066|NCT01507896|474528723|FG000|Overall Study|Withdrawal by Subject|1|||
131794067|NCT01507896|474528723|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
131794068|NCT00585351|474528725|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
131794069|NCT00585351|474528726|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
131611342|NCT05601882|473870534|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
131611343|NCT05601882|473870535|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
131611344|NCT05601882|473870532|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
131794070|NCT00585351|474528727|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
131611345|NCT05601882|473870533|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
131611346|NCT05601882|473870534|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
131611347|NCT05601882|473870535|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
131611348|NCT04158141|473870536|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
131611349|NCT04158141|473870537|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
131611350|NCT04158141|473870538|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
131611351|NCT04158141|473870536|FG000|Step 1: Registration|Adverse Event|1|||
131611352|NCT04158141|473870537|FG001|Step 1: Registration|Adverse Event|0|||
131611353|NCT04158141|473870538|FG002|Step 1: Registration|Adverse Event|0|||
131611354|NCT04158141|473870536|FG000|Step 1: Registration|Withdrawal by Subject|1|||
131611355|NCT04158141|473870537|FG001|Step 1: Registration|Withdrawal by Subject|0|||
131611356|NCT04158141|473870538|FG002|Step 1: Registration|Withdrawal by Subject|0|||
131611357|NCT04158141|473870536|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
131611358|NCT04158141|473870537|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
131611359|NCT04158141|473870538|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
131611360|NCT04121741|473870542|FG000|Overall Study|Protocol Violation|1|||
131611361|NCT04121741|473870543|FG001|Overall Study|Protocol Violation|0|||
131611362|NCT04121741|473870544|FG002|Overall Study|Protocol Violation|0|||
131611363|NCT04121741|473870545|FG003|Overall Study|Protocol Violation|0|||
131611364|NCT04121741|473870546|FG004|Overall Study|Protocol Violation|0|||
131611365|NCT04121741|473870547|FG005|Overall Study|Protocol Violation|0|||
131611366|NCT05827068|473870553|FG000|Overall Study|Lost to Follow-up|1|||
131611367|NCT05827068|473870554|FG001|Overall Study|Lost to Follow-up|4|||
131611368|NCT05827068|473870555|FG002|Overall Study|Lost to Follow-up|1|||
131611369|NCT05827068|473870556|FG003|Overall Study|Lost to Follow-up|1|||
131611370|NCT05827068|473870557|FG004|Overall Study|Lost to Follow-up|2|||
131611371|NCT05827068|473870558|FG005|Overall Study|Lost to Follow-up|4|||
131611372|NCT05827068|473870559|FG006|Overall Study|Lost to Follow-up|1|||
131611373|NCT05827068|473870553|FG000|Overall Study|Withdrawal by Subject|4|||
131611374|NCT05827068|473870554|FG001|Overall Study|Withdrawal by Subject|0|||
131611375|NCT05827068|473870555|FG002|Overall Study|Withdrawal by Subject|1|||
131611376|NCT05827068|473870556|FG003|Overall Study|Withdrawal by Subject|2|||
131611377|NCT05827068|473870557|FG004|Overall Study|Withdrawal by Subject|3|||
131611378|NCT05827068|473870558|FG005|Overall Study|Withdrawal by Subject|0|||
131611379|NCT05827068|473870559|FG006|Overall Study|Withdrawal by Subject|1|||
131611380|NCT05827068|473870553|FG000|Overall Study|Physician Decision|0|||
131611381|NCT05827068|473870554|FG001|Overall Study|Physician Decision|0|||
131611382|NCT05827068|473870555|FG002|Overall Study|Physician Decision|0|||
131611383|NCT05827068|473870556|FG003|Overall Study|Physician Decision|0|||
131611384|NCT05827068|473870557|FG004|Overall Study|Physician Decision|1|||
131611385|NCT05827068|473870558|FG005|Overall Study|Physician Decision|0|||
131611386|NCT05827068|473870559|FG006|Overall Study|Physician Decision|1|||
131611387|NCT05827068|473870553|FG000|Overall Study|Other Than Specified|0|||
131611388|NCT05827068|473870554|FG001|Overall Study|Other Than Specified|1|||
131611389|NCT05827068|473870555|FG002|Overall Study|Other Than Specified|0|||
131611390|NCT05827068|473870556|FG003|Overall Study|Other Than Specified|0|||
131611391|NCT05827068|473870557|FG004|Overall Study|Other Than Specified|0|||
131611392|NCT05827068|473870558|FG005|Overall Study|Other Than Specified|0|||
131611393|NCT05827068|473870559|FG006|Overall Study|Other Than Specified|0|||
131611394|NCT01470144|473870562|FG000|Overall Study|Adverse Event|2|||
131611395|NCT01470144|473870562|FG000|Overall Study|Death|1|||
131611396|NCT01470144|473870562|FG000|Overall Study|Lung transplant|6|||
131611397|NCT01470144|473870562|FG000|Overall Study|Patient's and investigator's decision|1|||
131611398|NCT01105975|473871516|FG000|Overall Study|Adverse Event|2|||
131611399|NCT01105975|473871517|FG001|Overall Study|Adverse Event|1|||
131611400|NCT01105975|473871518|FG002|Overall Study|Adverse Event|5|||
131611401|NCT01105975|473871519|FG003|Overall Study|Adverse Event|1|||
131794071|NCT00585351|474528728|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
131794072|NCT00585351|474528729|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
131794073|NCT00585351|474528730|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
131794074|NCT00585351|474528731|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
131441879|NCT02718898|473247226|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
131611402|NCT01105975|473871520|FG004|Overall Study|Adverse Event|0|||
131611403|NCT01105975|473871521|FG005|Overall Study|Adverse Event|1|||
131611404|NCT01105975|473871522|FG006|Overall Study|Adverse Event|2|||
131611405|NCT01105975|473871523|FG007|Overall Study|Adverse Event|4|||
131900106|NCT02329327|474919472|FG000|Overall Study|Death|78|||
131611406|NCT01105975|473871524|FG008|Overall Study|Adverse Event|1|||
131611407|NCT01105975|473871525|FG009|Overall Study|Adverse Event|4|||
131611408|NCT01105975|473871516|FG000|Overall Study|Withdrawal by Subject|2|||
131611409|NCT01105975|473871517|FG001|Overall Study|Withdrawal by Subject|2|||
131611410|NCT01105975|473871518|FG002|Overall Study|Withdrawal by Subject|2|||
131611411|NCT01105975|473871519|FG003|Overall Study|Withdrawal by Subject|0|||
131611412|NCT01105975|473871520|FG004|Overall Study|Withdrawal by Subject|4|||
131611413|NCT01105975|473871521|FG005|Overall Study|Withdrawal by Subject|1|||
131794075|NCT00585351|474528732|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
131794076|NCT00585351|474528725|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
131611414|NCT01105975|473871522|FG006|Overall Study|Withdrawal by Subject|2|||
131611415|NCT01105975|473871523|FG007|Overall Study|Withdrawal by Subject|1|||
131611416|NCT01105975|473871524|FG008|Overall Study|Withdrawal by Subject|0|||
131611417|NCT01105975|473871525|FG009|Overall Study|Withdrawal by Subject|3|||
131611418|NCT01105975|473871516|FG000|Overall Study|Lost to Follow-up|1|||
131611419|NCT01105975|473871517|FG001|Overall Study|Lost to Follow-up|0|||
131611420|NCT01105975|473871518|FG002|Overall Study|Lost to Follow-up|0|||
131611421|NCT01105975|473871519|FG003|Overall Study|Lost to Follow-up|1|||
131611422|NCT01105975|473871520|FG004|Overall Study|Lost to Follow-up|1|||
131611423|NCT01105975|473871521|FG005|Overall Study|Lost to Follow-up|0|||
131611424|NCT01105975|473871522|FG006|Overall Study|Lost to Follow-up|0|||
131611425|NCT01105975|473871523|FG007|Overall Study|Lost to Follow-up|0|||
131611426|NCT01105975|473871524|FG008|Overall Study|Lost to Follow-up|1|||
131611427|NCT01105975|473871525|FG009|Overall Study|Lost to Follow-up|0|||
131611428|NCT01105975|473871516|FG000|Overall Study|Physician Decision|0|||
131611429|NCT01105975|473871517|FG001|Overall Study|Physician Decision|0|||
131611430|NCT01105975|473871518|FG002|Overall Study|Physician Decision|0|||
131611431|NCT01105975|473871519|FG003|Overall Study|Physician Decision|0|||
131611432|NCT01105975|473871520|FG004|Overall Study|Physician Decision|0|||
131611433|NCT01105975|473871521|FG005|Overall Study|Physician Decision|0|||
131611434|NCT01105975|473871522|FG006|Overall Study|Physician Decision|2|||
131611435|NCT01105975|473871523|FG007|Overall Study|Physician Decision|0|||
131611436|NCT01105975|473871524|FG008|Overall Study|Physician Decision|0|||
131611437|NCT01105975|473871525|FG009|Overall Study|Physician Decision|0|||
131611438|NCT01105975|473871516|FG000|Overall Study|Protocol Violation|0|||
131611439|NCT01105975|473871517|FG001|Overall Study|Protocol Violation|2|||
131611440|NCT01105975|473871518|FG002|Overall Study|Protocol Violation|2|||
131611441|NCT01105975|473871519|FG003|Overall Study|Protocol Violation|0|||
131611442|NCT01105975|473871520|FG004|Overall Study|Protocol Violation|1|||
131611443|NCT01105975|473871521|FG005|Overall Study|Protocol Violation|1|||
131611444|NCT01105975|473871522|FG006|Overall Study|Protocol Violation|1|||
131611445|NCT01105975|473871523|FG007|Overall Study|Protocol Violation|1|||
131611446|NCT01105975|473871524|FG008|Overall Study|Protocol Violation|2|||
131611447|NCT01105975|473871525|FG009|Overall Study|Protocol Violation|2|||
131611448|NCT01105975|473871516|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131611449|NCT01105975|473871517|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131611450|NCT01105975|473871518|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131611451|NCT01105975|473871519|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131611452|NCT01105975|473871520|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131611453|NCT01105975|473871521|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
131611454|NCT01105975|473871522|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131611455|NCT01105975|473871523|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131611456|NCT01105975|473871524|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
131611457|NCT01105975|473871525|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131611458|NCT00312208|473871529|FG000|Overall Study|Adverse Event|97|||
131611459|NCT00312208|473871530|FG001|Overall Study|Adverse Event|61|||
131611460|NCT00312208|473871529|FG000|Overall Study|Protocol Violation|5|||
131611461|NCT00312208|473871530|FG001|Overall Study|Protocol Violation|3|||
131611462|NCT00312208|473871529|FG000|Overall Study|Death|2|||
131611463|NCT00312208|473871530|FG001|Overall Study|Death|1|||
131611464|NCT00312208|473871529|FG000|Overall Study|Lack of Efficacy|7|||
131611465|NCT00312208|473871530|FG001|Overall Study|Lack of Efficacy|4|||
131611466|NCT00312208|473871529|FG000|Overall Study|Lost to Follow-up|3|||
131611467|NCT00312208|473871530|FG001|Overall Study|Lost to Follow-up|5|||
131611468|NCT00312208|473871529|FG000|Overall Study|Withdrawal by Subject|53|||
131611469|NCT00312208|473871530|FG001|Overall Study|Withdrawal by Subject|42|||
131611470|NCT00312208|473871529|FG000|Overall Study|Other|5|||
131611471|NCT00312208|473871530|FG001|Overall Study|Other|7|||
131794077|NCT00585351|474528726|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
131794078|NCT00585351|474528727|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
131611472|NCT02284113|473871531|FG000|Overall Study|Adverse Event|1|||
131611473|NCT02284113|473871532|FG001|Overall Study|Adverse Event|0|||
131611474|NCT02284113|473871531|FG000|Overall Study|non-compliance|0|||
131611475|NCT02284113|473871532|FG001|Overall Study|non-compliance|1|||
131611476|NCT02284113|473871531|FG000|Overall Study|Withdrawal by Subject|0|||
131611477|NCT02284113|473871532|FG001|Overall Study|Withdrawal by Subject|1|||
131611478|NCT02284113|473871531|FG000|Overall Study|not provided|0|||
131611479|NCT02284113|473871532|FG001|Overall Study|not provided|1|||
131611480|NCT02284113|473871531|FG000|Overall Study|surgery cancelled|2|||
131611481|NCT02284113|473871532|FG001|Overall Study|surgery cancelled|0|||
131611482|NCT00982644|473871535|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
131611483|NCT00982644|473871536|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
131611484|NCT00982644|473871535|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
131611485|NCT00982644|473871536|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
131611486|NCT00982644|473871535|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
131611487|NCT00982644|473871536|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
131611488|NCT00982644|473871535|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
131611489|NCT00982644|473871536|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
131611490|NCT00982644|473871535|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
131611491|NCT00982644|473871536|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
131611492|NCT00982644|473871535|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
131611493|NCT00982644|473871536|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
131611494|NCT00982644|473871535|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
131611495|NCT00982644|473871536|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
131611496|NCT00982644|473871535|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
131611497|NCT00982644|473871536|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
131611498|NCT00982644|473871535|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
131611499|NCT00982644|473871536|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
131611500|NCT00982644|473871535|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
131611501|NCT00982644|473871536|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
131611502|NCT00943917|473871539|FG000|Stage I|Adverse Event|1|||
131611503|NCT00943917|473871540|FG001|Stage I|Adverse Event|2|||
131611504|NCT00943917|473871541|FG002|Stage I|Adverse Event|2|||
131611505|NCT00943917|473871542|FG003|Stage I|Adverse Event|0|||
131611506|NCT00943917|473871543|FG004|Stage I|Adverse Event|0|||
131611507|NCT00943917|473871544|FG005|Stage I|Adverse Event|0|||
131611508|NCT00943917|473871545|FG006|Stage I|Adverse Event|0|||
131611509|NCT00943917|473871546|FG007|Stage I|Adverse Event|0|||
131611510|NCT00943917|473871547|FG008|Stage I|Adverse Event|0|||
131611511|NCT00943917|473871548|FG009|Stage I|Adverse Event|0|||
131611512|NCT00943917|473871549|FG010|Stage I|Adverse Event|0|||
131611513|NCT00943917|473871550|FG011|Stage I|Adverse Event|0|||
131611514|NCT00943917|473871551|FG012|Stage I|Adverse Event|0|||
131611515|NCT00943917|473871552|FG013|Stage I|Adverse Event|0|||
131611516|NCT00943917|473871553|FG014|Stage I|Adverse Event|0|||
131611517|NCT00943917|473871539|FG000|Stage I|Lost to Follow-up|0|||
131611518|NCT00943917|473871540|FG001|Stage I|Lost to Follow-up|0|||
131611519|NCT00943917|473871541|FG002|Stage I|Lost to Follow-up|1|||
131611520|NCT00943917|473871542|FG003|Stage I|Lost to Follow-up|0|||
131611521|NCT00943917|473871543|FG004|Stage I|Lost to Follow-up|0|||
131611522|NCT00943917|473871544|FG005|Stage I|Lost to Follow-up|0|||
131611523|NCT00943917|473871545|FG006|Stage I|Lost to Follow-up|0|||
131611524|NCT00943917|473871546|FG007|Stage I|Lost to Follow-up|0|||
131611525|NCT00943917|473871547|FG008|Stage I|Lost to Follow-up|0|||
131611526|NCT00943917|473871548|FG009|Stage I|Lost to Follow-up|0|||
131611527|NCT00943917|473871549|FG010|Stage I|Lost to Follow-up|0|||
131611528|NCT00943917|473871550|FG011|Stage I|Lost to Follow-up|0|||
131611529|NCT00943917|473871551|FG012|Stage I|Lost to Follow-up|0|||
131611530|NCT00943917|473871552|FG013|Stage I|Lost to Follow-up|0|||
131611531|NCT00943917|473871553|FG014|Stage I|Lost to Follow-up|0|||
131611532|NCT00943917|473871539|FG000|Stage I|hyperglycemia|0|||
131611533|NCT00943917|473871540|FG001|Stage I|hyperglycemia|0|||
131611534|NCT00943917|473871541|FG002|Stage I|hyperglycemia|1|||
131611535|NCT00943917|473871542|FG003|Stage I|hyperglycemia|0|||
131611536|NCT00943917|473871543|FG004|Stage I|hyperglycemia|0|||
131611537|NCT00943917|473871544|FG005|Stage I|hyperglycemia|0|||
131611538|NCT00943917|473871545|FG006|Stage I|hyperglycemia|0|||
131611539|NCT00943917|473871546|FG007|Stage I|hyperglycemia|0|||
131611540|NCT00943917|473871547|FG008|Stage I|hyperglycemia|0|||
131611541|NCT00943917|473871548|FG009|Stage I|hyperglycemia|0|||
131611542|NCT00943917|473871549|FG010|Stage I|hyperglycemia|0|||
131611543|NCT00943917|473871550|FG011|Stage I|hyperglycemia|0|||
131611544|NCT00943917|473871551|FG012|Stage I|hyperglycemia|0|||
131611545|NCT00943917|473871552|FG013|Stage I|hyperglycemia|0|||
131611546|NCT00943917|473871553|FG014|Stage I|hyperglycemia|0|||
131611547|NCT00943917|473871539|FG000|Stage I|A1C elevation|1|||
131611548|NCT00943917|473871540|FG001|Stage I|A1C elevation|0|||
131611549|NCT00943917|473871541|FG002|Stage I|A1C elevation|0|||
131611550|NCT00943917|473871542|FG003|Stage I|A1C elevation|0|||
131611551|NCT00943917|473871543|FG004|Stage I|A1C elevation|0|||
131611552|NCT00943917|473871544|FG005|Stage I|A1C elevation|0|||
131611553|NCT00943917|473871545|FG006|Stage I|A1C elevation|0|||
131611554|NCT00943917|473871546|FG007|Stage I|A1C elevation|0|||
131611555|NCT00943917|473871547|FG008|Stage I|A1C elevation|0|||
131611556|NCT00943917|473871548|FG009|Stage I|A1C elevation|0|||
131611557|NCT00943917|473871549|FG010|Stage I|A1C elevation|0|||
131611558|NCT00943917|473871550|FG011|Stage I|A1C elevation|0|||
131611559|NCT00943917|473871551|FG012|Stage I|A1C elevation|0|||
131611560|NCT00943917|473871552|FG013|Stage I|A1C elevation|0|||
131611561|NCT00943917|473871553|FG014|Stage I|A1C elevation|0|||
131611562|NCT00943917|473871539|FG000|Stage I|Withdrawal by Subject|2|||
131611563|NCT00943917|473871540|FG001|Stage I|Withdrawal by Subject|1|||
131611564|NCT00943917|473871541|FG002|Stage I|Withdrawal by Subject|2|||
131611565|NCT00943917|473871542|FG003|Stage I|Withdrawal by Subject|0|||
131611566|NCT00943917|473871543|FG004|Stage I|Withdrawal by Subject|0|||
131611567|NCT00943917|473871544|FG005|Stage I|Withdrawal by Subject|0|||
131611568|NCT00943917|473871545|FG006|Stage I|Withdrawal by Subject|0|||
131611569|NCT00943917|473871546|FG007|Stage I|Withdrawal by Subject|0|||
131611570|NCT00943917|473871547|FG008|Stage I|Withdrawal by Subject|0|||
131611571|NCT00943917|473871548|FG009|Stage I|Withdrawal by Subject|0|||
131611572|NCT00943917|473871549|FG010|Stage I|Withdrawal by Subject|0|||
131611573|NCT00943917|473871550|FG011|Stage I|Withdrawal by Subject|0|||
131611574|NCT00943917|473871551|FG012|Stage I|Withdrawal by Subject|0|||
131611575|NCT00943917|473871552|FG013|Stage I|Withdrawal by Subject|0|||
131611576|NCT00943917|473871553|FG014|Stage I|Withdrawal by Subject|0|||
131611577|NCT00943917|473871539|FG000|Stage II|Adverse Event|0|||
131611578|NCT00943917|473871540|FG001|Stage II|Adverse Event|0|||
131611579|NCT00943917|473871541|FG002|Stage II|Adverse Event|0|||
131611580|NCT00943917|473871542|FG003|Stage II|Adverse Event|0|||
131611581|NCT00943917|473871543|FG004|Stage II|Adverse Event|0|||
131611582|NCT00943917|473871544|FG005|Stage II|Adverse Event|1|||
131611583|NCT00943917|473871545|FG006|Stage II|Adverse Event|3|||
131611584|NCT00943917|473871546|FG007|Stage II|Adverse Event|0|||
131611585|NCT00943917|473871547|FG008|Stage II|Adverse Event|1|||
131611586|NCT00943917|473871548|FG009|Stage II|Adverse Event|0|||
131611587|NCT00943917|473871549|FG010|Stage II|Adverse Event|0|||
131611588|NCT00943917|473871550|FG011|Stage II|Adverse Event|0|||
131611589|NCT00943917|473871551|FG012|Stage II|Adverse Event|0|||
131611590|NCT00943917|473871552|FG013|Stage II|Adverse Event|0|||
131611591|NCT00943917|473871553|FG014|Stage II|Adverse Event|0|||
131611592|NCT00943917|473871539|FG000|Stage II|Withdrawal by Subject|0|||
131611593|NCT00943917|473871540|FG001|Stage II|Withdrawal by Subject|0|||
131611594|NCT00943917|473871541|FG002|Stage II|Withdrawal by Subject|0|||
131611595|NCT00943917|473871542|FG003|Stage II|Withdrawal by Subject|0|||
131611596|NCT00943917|473871543|FG004|Stage II|Withdrawal by Subject|0|||
131611597|NCT00943917|473871544|FG005|Stage II|Withdrawal by Subject|1|||
131611598|NCT00943917|473871545|FG006|Stage II|Withdrawal by Subject|0|||
131611599|NCT00943917|473871546|FG007|Stage II|Withdrawal by Subject|0|||
131611600|NCT00943917|473871547|FG008|Stage II|Withdrawal by Subject|0|||
131611601|NCT00943917|473871548|FG009|Stage II|Withdrawal by Subject|0|||
131611602|NCT00943917|473871549|FG010|Stage II|Withdrawal by Subject|0|||
131611603|NCT00943917|473871550|FG011|Stage II|Withdrawal by Subject|0|||
131611604|NCT00943917|473871551|FG012|Stage II|Withdrawal by Subject|0|||
131611605|NCT00943917|473871552|FG013|Stage II|Withdrawal by Subject|0|||
131611606|NCT00943917|473871553|FG014|Stage II|Withdrawal by Subject|0|||
131611607|NCT00943917|473871539|FG000|Stage II|Pregnancy|0|||
131611608|NCT00943917|473871540|FG001|Stage II|Pregnancy|0|||
131611609|NCT00943917|473871541|FG002|Stage II|Pregnancy|0|||
131611610|NCT00943917|473871542|FG003|Stage II|Pregnancy|0|||
131611611|NCT00943917|473871543|FG004|Stage II|Pregnancy|0|||
131611612|NCT00943917|473871544|FG005|Stage II|Pregnancy|1|||
131611613|NCT00943917|473871545|FG006|Stage II|Pregnancy|0|||
131611614|NCT00943917|473871546|FG007|Stage II|Pregnancy|0|||
131611615|NCT00943917|473871547|FG008|Stage II|Pregnancy|0|||
131611616|NCT00943917|473871548|FG009|Stage II|Pregnancy|0|||
131611617|NCT00943917|473871549|FG010|Stage II|Pregnancy|0|||
131611618|NCT00943917|473871550|FG011|Stage II|Pregnancy|0|||
131611619|NCT00943917|473871551|FG012|Stage II|Pregnancy|0|||
131611620|NCT00943917|473871552|FG013|Stage II|Pregnancy|0|||
131611621|NCT00943917|473871553|FG014|Stage II|Pregnancy|0|||
131611622|NCT00943917|473871539|FG000|Stage II Continuation|Adverse Event|0|||
131611623|NCT00943917|473871540|FG001|Stage II Continuation|Adverse Event|0|||
131611624|NCT00943917|473871541|FG002|Stage II Continuation|Adverse Event|0|||
131611625|NCT00943917|473871542|FG003|Stage II Continuation|Adverse Event|0|||
131611626|NCT00943917|473871543|FG004|Stage II Continuation|Adverse Event|0|||
131611627|NCT00943917|473871544|FG005|Stage II Continuation|Adverse Event|0|||
131611628|NCT00943917|473871545|FG006|Stage II Continuation|Adverse Event|0|||
131611629|NCT00943917|473871546|FG007|Stage II Continuation|Adverse Event|0|||
131611630|NCT00943917|473871547|FG008|Stage II Continuation|Adverse Event|0|||
131611631|NCT00943917|473871548|FG009|Stage II Continuation|Adverse Event|0|||
131708298|NCT00896532|474211329|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708299|NCT00896532|474211330|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708300|NCT00896532|474211331|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708301|NCT00896532|474211332|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708302|NCT00896532|474211333|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708303|NCT00896532|474211334|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131611632|NCT00943917|473871549|FG010|Stage II Continuation|Adverse Event|0|||
131611633|NCT00943917|473871550|FG011|Stage II Continuation|Adverse Event|1|||
131611634|NCT00943917|473871551|FG012|Stage II Continuation|Adverse Event|2|||
131611635|NCT00943917|473871552|FG013|Stage II Continuation|Adverse Event|1|||
131611636|NCT00943917|473871553|FG014|Stage II Continuation|Adverse Event|1|||
131611637|NCT00943917|473871539|FG000|Stage II Continuation|Withdrawal by Subject|0|||
131611638|NCT00943917|473871540|FG001|Stage II Continuation|Withdrawal by Subject|0|||
131611639|NCT00943917|473871541|FG002|Stage II Continuation|Withdrawal by Subject|0|||
131611640|NCT00943917|473871542|FG003|Stage II Continuation|Withdrawal by Subject|0|||
131611641|NCT00943917|473871543|FG004|Stage II Continuation|Withdrawal by Subject|0|||
131611642|NCT00943917|473871544|FG005|Stage II Continuation|Withdrawal by Subject|0|||
131611643|NCT00943917|473871545|FG006|Stage II Continuation|Withdrawal by Subject|0|||
131611644|NCT00943917|473871546|FG007|Stage II Continuation|Withdrawal by Subject|0|||
131611645|NCT00943917|473871547|FG008|Stage II Continuation|Withdrawal by Subject|0|||
131611646|NCT00943917|473871548|FG009|Stage II Continuation|Withdrawal by Subject|0|||
131611647|NCT00943917|473871549|FG010|Stage II Continuation|Withdrawal by Subject|0|||
131611648|NCT00943917|473871550|FG011|Stage II Continuation|Withdrawal by Subject|0|||
131611649|NCT00943917|473871551|FG012|Stage II Continuation|Withdrawal by Subject|0|||
131611650|NCT00943917|473871552|FG013|Stage II Continuation|Withdrawal by Subject|1|||
131611651|NCT00943917|473871553|FG014|Stage II Continuation|Withdrawal by Subject|3|||
131611652|NCT00943917|473871539|FG000|Stage II Continuation|Protocol Violation|0|||
131611653|NCT00943917|473871540|FG001|Stage II Continuation|Protocol Violation|0|||
131611654|NCT00943917|473871541|FG002|Stage II Continuation|Protocol Violation|0|||
131611655|NCT00943917|473871542|FG003|Stage II Continuation|Protocol Violation|0|||
131611656|NCT00943917|473871543|FG004|Stage II Continuation|Protocol Violation|0|||
131611657|NCT00943917|473871544|FG005|Stage II Continuation|Protocol Violation|0|||
131611658|NCT00943917|473871545|FG006|Stage II Continuation|Protocol Violation|0|||
131611659|NCT00943917|473871546|FG007|Stage II Continuation|Protocol Violation|0|||
131611660|NCT00943917|473871547|FG008|Stage II Continuation|Protocol Violation|0|||
131611661|NCT00943917|473871548|FG009|Stage II Continuation|Protocol Violation|1|||
131611662|NCT00943917|473871549|FG010|Stage II Continuation|Protocol Violation|0|||
131611663|NCT00943917|473871550|FG011|Stage II Continuation|Protocol Violation|1|||
131611664|NCT00943917|473871551|FG012|Stage II Continuation|Protocol Violation|0|||
131611665|NCT00943917|473871552|FG013|Stage II Continuation|Protocol Violation|0|||
131611666|NCT00943917|473871553|FG014|Stage II Continuation|Protocol Violation|0|||
131611667|NCT00943917|473871539|FG000|Stage II Continuation|hypoglycemia|0|||
131611668|NCT00943917|473871540|FG001|Stage II Continuation|hypoglycemia|0|||
131611669|NCT00943917|473871541|FG002|Stage II Continuation|hypoglycemia|0|||
131611670|NCT00943917|473871542|FG003|Stage II Continuation|hypoglycemia|0|||
131611671|NCT00943917|473871543|FG004|Stage II Continuation|hypoglycemia|0|||
131611672|NCT00943917|473871544|FG005|Stage II Continuation|hypoglycemia|0|||
131611673|NCT00943917|473871545|FG006|Stage II Continuation|hypoglycemia|0|||
131611674|NCT00943917|473871546|FG007|Stage II Continuation|hypoglycemia|0|||
131611675|NCT00943917|473871547|FG008|Stage II Continuation|hypoglycemia|0|||
131611676|NCT00943917|473871548|FG009|Stage II Continuation|hypoglycemia|0|||
131611677|NCT00943917|473871549|FG010|Stage II Continuation|hypoglycemia|0|||
131611678|NCT00943917|473871550|FG011|Stage II Continuation|hypoglycemia|0|||
131611679|NCT00943917|473871551|FG012|Stage II Continuation|hypoglycemia|1|||
131611680|NCT00943917|473871552|FG013|Stage II Continuation|hypoglycemia|0|||
131611681|NCT00943917|473871553|FG014|Stage II Continuation|hypoglycemia|0|||
131611682|NCT00943917|473871539|FG000|Stage II Continuation|A1C elevation|0|||
131611683|NCT00943917|473871540|FG001|Stage II Continuation|A1C elevation|0|||
131611684|NCT00943917|473871541|FG002|Stage II Continuation|A1C elevation|0|||
131611685|NCT00943917|473871542|FG003|Stage II Continuation|A1C elevation|0|||
131611686|NCT00943917|473871543|FG004|Stage II Continuation|A1C elevation|0|||
131611687|NCT00943917|473871544|FG005|Stage II Continuation|A1C elevation|0|||
131611688|NCT00943917|473871545|FG006|Stage II Continuation|A1C elevation|0|||
131611689|NCT00943917|473871546|FG007|Stage II Continuation|A1C elevation|0|||
131611690|NCT00943917|473871547|FG008|Stage II Continuation|A1C elevation|0|||
131611691|NCT00943917|473871548|FG009|Stage II Continuation|A1C elevation|0|||
131611692|NCT00943917|473871549|FG010|Stage II Continuation|A1C elevation|0|||
131611693|NCT00943917|473871550|FG011|Stage II Continuation|A1C elevation|0|||
131611694|NCT00943917|473871551|FG012|Stage II Continuation|A1C elevation|0|||
131611695|NCT00943917|473871552|FG013|Stage II Continuation|A1C elevation|1|||
131611696|NCT00943917|473871553|FG014|Stage II Continuation|A1C elevation|0|||
131611697|NCT01171976|473871554|FG000|Overall Study|Protocol Violation|0|||
131611698|NCT01171976|473871555|FG001|Overall Study|Protocol Violation|0|||
131611699|NCT01171976|473871556|FG002|Overall Study|Protocol Violation|1|||
131611700|NCT01171976|473871554|FG000|Overall Study|Death|2|||
131611701|NCT01171976|473871555|FG001|Overall Study|Death|4|||
131611702|NCT01171976|473871556|FG002|Overall Study|Death|1|||
131611703|NCT01171976|473871554|FG000|Overall Study|Lost to Follow-up|4|||
131611704|NCT01171976|473871555|FG001|Overall Study|Lost to Follow-up|0|||
131611705|NCT01171976|473871556|FG002|Overall Study|Lost to Follow-up|2|||
131611706|NCT01171976|473871554|FG000|Overall Study|Withdrawal by Subject|1|||
131611707|NCT01171976|473871555|FG001|Overall Study|Withdrawal by Subject|5|||
131611708|NCT01171976|473871556|FG002|Overall Study|Withdrawal by Subject|6|||
131611709|NCT01171976|473871554|FG000|Overall Study|Abnormal test result|1|||
131900107|NCT02329327|474919473|FG001|Overall Study|Death|0|||
131611710|NCT01171976|473871555|FG001|Overall Study|Abnormal test result|0|||
131611711|NCT01171976|473871556|FG002|Overall Study|Abnormal test result|0|||
131611712|NCT01171976|473871554|FG000|Overall Study|Adverse Event|6|||
131611713|NCT01171976|473871555|FG001|Overall Study|Adverse Event|2|||
131611714|NCT01171976|473871556|FG002|Overall Study|Adverse Event|5|||
131611715|NCT03885232|473871557|FG000|Overall Study|Lost to Follow-up|74|||
131611716|NCT03885232|473871558|FG001|Overall Study|Lost to Follow-up|32|||
131611717|NCT03885232|473871557|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
131611718|NCT03885232|473871558|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
131611719|NCT03840902|473871561|FG000|Overall Study|Randomized but not treated|1|||
131611720|NCT03840902|473871562|FG001|Overall Study|Randomized but not treated|1|||
131611721|NCT02754596|473871566|FG000|Overall Study|Withdrawal by Subject|3|||
131611722|NCT02754596|473871567|FG001|Overall Study|Withdrawal by Subject|4|||
131611723|NCT02754596|473871568|FG002|Overall Study|Withdrawal by Subject|0|||
131611724|NCT02754596|473871566|FG000|Overall Study|Physician Decision|1|||
131611725|NCT02754596|473871567|FG001|Overall Study|Physician Decision|1|||
131611726|NCT02754596|473871568|FG002|Overall Study|Physician Decision|1|||
131611727|NCT02754596|473871566|FG000|Overall Study|Lost to Follow-up|1|||
131611728|NCT02754596|473871567|FG001|Overall Study|Lost to Follow-up|1|||
131611729|NCT02754596|473871568|FG002|Overall Study|Lost to Follow-up|2|||
131611730|NCT02754596|473871566|FG000|Overall Study|Death|0|||
131611731|NCT02754596|473871567|FG001|Overall Study|Death|2|||
131611732|NCT02754596|473871568|FG002|Overall Study|Death|0|||
131611733|NCT02754596|473871566|FG000|Overall Study|Adverse Event|1|||
131611734|NCT02754596|473871567|FG001|Overall Study|Adverse Event|0|||
131611735|NCT02754596|473871568|FG002|Overall Study|Adverse Event|1|||
131611736|NCT02754596|473871566|FG000|Overall Study|Other|1|||
131611737|NCT02754596|473871567|FG001|Overall Study|Other|0|||
131611738|NCT02754596|473871568|FG002|Overall Study|Other|0|||
131611739|NCT05018143|473871571|FG000|Overall Study|Lost to Follow-up|5|||
131611740|NCT05018143|473871572|FG001|Overall Study|Lost to Follow-up|4|||
131611741|NCT05018143|473871571|FG000|Overall Study|Withdrawal by Subject|0|||
131611742|NCT05018143|473871572|FG001|Overall Study|Withdrawal by Subject|1|||
131611743|NCT06688357|473871573|FG000|Overall Study|Adverse Event|0|||
131611744|NCT06688357|473871574|FG001|Overall Study|Adverse Event|1|||
131611745|NCT01084863|473871575|FG000|Main Study Treatment Period|Disease progression|11|||
131611746|NCT01084863|473871576|FG001|Main Study Treatment Period|Disease progression|7|||
131611747|NCT01084863|473871575|FG000|Main Study Treatment Period|Adverse Event|5|||
131611748|NCT01084863|473871576|FG001|Main Study Treatment Period|Adverse Event|3|||
131611749|NCT01084863|473871575|FG000|Main Study Treatment Period|Other Reason|0|||
131611750|NCT01084863|473871576|FG001|Main Study Treatment Period|Other Reason|1|||
131611751|NCT01084863|473871575|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
131611752|NCT01084863|473871576|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
131611753|NCT01084863|473871575|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
131611754|NCT01084863|473871576|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
131611755|NCT01084863|473871575|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
131611756|NCT01084863|473871576|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
131611757|NCT01084863|473871575|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
131611758|NCT01084863|473871576|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
131611759|NCT01084863|473871575|FG000|Treatment Period Beyond Cycle 8|Other|0|||
131611760|NCT01084863|473871576|FG001|Treatment Period Beyond Cycle 8|Other|1|||
131611761|NCT01084863|473871575|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
131611762|NCT01084863|473871576|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
131611763|NCT03834740|473871577|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
131611764|NCT03834740|473871578|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
131611765|NCT03834740|473871579|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
131611766|NCT03275285|473871580|FG000|Overall Study|Ongoing|45|||
131611767|NCT03275285|473871581|FG001|Overall Study|Ongoing|69|||
131611768|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
131611769|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
131611770|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
131611771|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
131611772|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
131611773|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
131611774|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
131611775|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
131611776|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
131611777|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
131611778|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
131611779|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
131611780|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
131611781|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
131441880|NCT02718898|473247227|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
131611782|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
131611783|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
131611784|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
131611785|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
131611786|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
131611787|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
131794079|NCT00585351|474528728|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
131794080|NCT00585351|474528729|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
131794081|NCT00585351|474528730|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
131794082|NCT00585351|474528731|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
131794083|NCT00585351|474528732|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
131794084|NCT00585351|474528725|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
131794085|NCT00585351|474528726|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
131794086|NCT00585351|474528727|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
131794087|NCT00585351|474528728|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
131794088|NCT00585351|474528729|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
131794089|NCT00585351|474528730|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
131794090|NCT00585351|474528731|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
131794091|NCT00585351|474528732|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
131794092|NCT00585351|474528725|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
131794093|NCT00585351|474528726|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
131794094|NCT00585351|474528727|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131794095|NCT00585351|474528728|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131794096|NCT00585351|474528729|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131794097|NCT00585351|474528730|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131794098|NCT00585351|474528731|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131804443|NCT02178722|474568533|FG004|Overall Study|Withdrawal by Subject|33|||
131708304|NCT00896532|474211335|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708305|NCT00896532|474211336|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708306|NCT00896532|474211337|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708307|NCT00896532|474211338|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708308|NCT00896532|474211339|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708309|NCT00896532|474211340|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708310|NCT00896532|474211341|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708311|NCT00896532|474211342|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708312|NCT00896532|474211343|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708313|NCT00896532|474211344|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708314|NCT00896532|474211345|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708315|NCT00896532|474211346|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708316|NCT00896532|474211347|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708317|NCT00896532|474211348|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
131708318|NCT00896532|474211349|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131708319|NCT02411747|474211350|FG000|Overall Study|Withdrawal by Subject|1|||
131708320|NCT02411747|474211351|FG001|Overall Study|Withdrawal by Subject|0|||
131708321|NCT02411747|474211350|FG000|Overall Study|Protocol Violation|2|||
131708322|NCT02411747|474211351|FG001|Overall Study|Protocol Violation|4|||
131708323|NCT02149810|474211352|FG000|Overall Study|Physician Decision|1|||
131708324|NCT02149810|474211353|FG001|Overall Study|Physician Decision|2|||
131708325|NCT02149810|474211352|FG000|Overall Study|Lost to Follow-up|2|||
131708326|NCT02149810|474211353|FG001|Overall Study|Lost to Follow-up|1|||
131708327|NCT02149810|474211352|FG000|Overall Study|Withdrawal by Subject|5|||
131708328|NCT02149810|474211353|FG001|Overall Study|Withdrawal by Subject|1|||
131708329|NCT01176916|474211354|FG000|Overall Study|Adverse Event|61|||
131708330|NCT01176916|474211354|FG000|Overall Study|Death|1|||
131708331|NCT01176916|474211354|FG000|Overall Study|Lost to Follow-up|15|||
131708332|NCT01176916|474211354|FG000|Overall Study|Objective progression or relapse|17|||
131708333|NCT01176916|474211354|FG000|Overall Study|Protocol Violation|24|||
131708334|NCT01176916|474211354|FG000|Overall Study|Withdrawal by Subject|37|||
131708335|NCT01176916|474211354|FG000|Overall Study|Other|6|||
131708336|NCT01176916|474211354|FG000|Overall Study|Withdrawal prior to Treatment|6|||
131708337|NCT03158220|474211355|FG000|Overall Study|Screen Failure|0|||
131708338|NCT03158220|474211356|FG001|Overall Study|Screen Failure|1|||
131708339|NCT03158220|474211355|FG000|Overall Study|Withdrawal by Subject|8|||
131708340|NCT03158220|474211356|FG001|Overall Study|Withdrawal by Subject|9|||
131708341|NCT03158220|474211355|FG000|Overall Study|Status unknown|0|||
131708342|NCT03158220|474211356|FG001|Overall Study|Status unknown|1|||
131708343|NCT03158220|474211355|FG000|Overall Study|Lost to Follow-up|8|||
131708344|NCT03158220|474211356|FG001|Overall Study|Lost to Follow-up|5|||
131708345|NCT03158220|474211355|FG000|Overall Study|Physician Decision|1|||
131794099|NCT00585351|474528732|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131794100|NCT00585351|474528725|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131794101|NCT00585351|474528726|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131794102|NCT00585351|474528727|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131794103|NCT00585351|474528728|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131794104|NCT00585351|474528729|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131794105|NCT00585351|474528730|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131611788|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
131611789|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131611790|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131611791|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131611792|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131611793|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131611794|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
131611795|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131611796|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
131611797|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131611798|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131611799|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131611800|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131611801|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131611802|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
131611803|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131611804|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131611805|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131611806|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131611807|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131611808|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
131611809|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
131611810|NCT03656718|473871582|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131611811|NCT03656718|473871583|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131611812|NCT03656718|473871584|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131611813|NCT03656718|473871585|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131611814|NCT03656718|473871586|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131611815|NCT03656718|473871587|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131611816|NCT03656718|473871588|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
131611817|NCT03656718|473871582|FG000|Treatment Period Part C|Disease progression|0|||
131611818|NCT03656718|473871583|FG001|Treatment Period Part C|Disease progression|0|||
131611819|NCT03656718|473871584|FG002|Treatment Period Part C|Disease progression|0|||
131611820|NCT03656718|473871585|FG003|Treatment Period Part C|Disease progression|0|||
131611821|NCT03656718|473871586|FG004|Treatment Period Part C|Disease progression|12|||
131611822|NCT03656718|473871587|FG005|Treatment Period Part C|Disease progression|0|||
131611823|NCT03656718|473871588|FG006|Treatment Period Part C|Disease progression|0|||
131611824|NCT03656718|473871582|FG000|Treatment Period Part C|Death|0|||
131611825|NCT03656718|473871583|FG001|Treatment Period Part C|Death|0|||
131611826|NCT03656718|473871584|FG002|Treatment Period Part C|Death|0|||
131611827|NCT03656718|473871585|FG003|Treatment Period Part C|Death|0|||
131611828|NCT03656718|473871586|FG004|Treatment Period Part C|Death|1|||
131611829|NCT03656718|473871587|FG005|Treatment Period Part C|Death|0|||
131611830|NCT03656718|473871588|FG006|Treatment Period Part C|Death|0|||
131611831|NCT03656718|473871582|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131611832|NCT03656718|473871583|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131611833|NCT03656718|473871584|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131611834|NCT03656718|473871585|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131611835|NCT03656718|473871586|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
131611836|NCT03656718|473871587|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131611837|NCT03656718|473871588|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131611838|NCT03656718|473871582|FG000|Treatment Period Part C|Other reasons|0|||
131611839|NCT03656718|473871583|FG001|Treatment Period Part C|Other reasons|0|||
131611840|NCT03656718|473871584|FG002|Treatment Period Part C|Other reasons|0|||
131611841|NCT03656718|473871585|FG003|Treatment Period Part C|Other reasons|0|||
131794106|NCT00585351|474528731|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
131708346|NCT03158220|474211356|FG001|Overall Study|Physician Decision|0|||
131708347|NCT01015833|474211357|FG000|Overall Study|Death|1|||
131708348|NCT01015833|474211358|FG001|Overall Study|Death|0|||
131708349|NCT01015833|474211357|FG000|Overall Study|Withdrawal by Subject|3|||
131708350|NCT01015833|474211358|FG001|Overall Study|Withdrawal by Subject|2|||
131708351|NCT01015833|474211357|FG000|Overall Study|Adverse Event|0|||
131708352|NCT01015833|474211358|FG001|Overall Study|Adverse Event|1|||
131708353|NCT01015833|474211357|FG000|Overall Study|Physician Decision|2|||
131708354|NCT01015833|474211358|FG001|Overall Study|Physician Decision|0|||
131708355|NCT01015833|474211357|FG000|Overall Study|Symptomatic deterioration|0|||
131708356|NCT01015833|474211358|FG001|Overall Study|Symptomatic deterioration|1|||
131708357|NCT01015833|474211357|FG000|Overall Study|Other|5|||
131708358|NCT01015833|474211358|FG001|Overall Study|Other|1|||
131708359|NCT01015833|474211357|FG000|Overall Study|Motor Vehicle Accidents|1|||
131611842|NCT03656718|473871586|FG004|Treatment Period Part C|Other reasons|1|||
131611843|NCT03656718|473871587|FG005|Treatment Period Part C|Other reasons|0|||
131611844|NCT03656718|473871588|FG006|Treatment Period Part C|Other reasons|0|||
131611845|NCT03656718|473871582|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
131611846|NCT03656718|473871583|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
131611847|NCT03656718|473871584|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
131611848|NCT03656718|473871585|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
131611849|NCT03656718|473871586|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
131611850|NCT03656718|473871587|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
131611851|NCT03656718|473871588|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
131611852|NCT06191679|473871589|FG000|Baseline|Lost to Follow-up|1|||
131611853|NCT06191679|473871590|FG001|Baseline|Lost to Follow-up|0|||
131611854|NCT06191679|473871591|FG002|Baseline|Lost to Follow-up|1|||
131611855|NCT06191679|473871592|FG003|Baseline|Lost to Follow-up|0|||
131611856|NCT06191679|473871589|FG000|Allocation to Group|Withdrawal by Subject|0|||
131611857|NCT06191679|473871590|FG001|Allocation to Group|Withdrawal by Subject|1|||
131611858|NCT06191679|473871591|FG002|Allocation to Group|Withdrawal by Subject|2|||
131611859|NCT06191679|473871592|FG003|Allocation to Group|Withdrawal by Subject|0|||
131611860|NCT06191679|473871589|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
131611861|NCT06191679|473871590|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
131611862|NCT06191679|473871591|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
131611863|NCT06191679|473871592|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
131611864|NCT06191679|473871589|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
131611865|NCT06191679|473871590|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
131611866|NCT06191679|473871591|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
131611867|NCT06191679|473871592|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
131611868|NCT06191679|473871589|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
131611869|NCT06191679|473871590|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
131611870|NCT06191679|473871591|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
131611871|NCT06191679|473871592|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
131611872|NCT03211247|473871593|FG000|Overall Study|Adverse Event|8|||
131611873|NCT03211247|473871594|FG001|Overall Study|Adverse Event|0|||
131611874|NCT03211247|473871595|FG002|Overall Study|Adverse Event|1|||
131611875|NCT03211247|473871596|FG003|Overall Study|Adverse Event|0|||
131611876|NCT03211247|473871597|FG004|Overall Study|Adverse Event|0|||
131611877|NCT03211247|473871593|FG000|Overall Study|Lost to Follow-up|2|||
131708360|NCT01015833|474211358|FG001|Overall Study|Motor Vehicle Accidents|0|||
131708361|NCT01015833|474211357|FG000|Overall Study|Did not start treatment|1|||
131708362|NCT01015833|474211358|FG001|Overall Study|Did not start treatment|0|||
131794107|NCT00585351|474528732|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
131794108|NCT00585351|474528725|FG000|Enrollment Period (Intervention)|Death|0|||
131794109|NCT00585351|474528726|FG001|Enrollment Period (Intervention)|Death|0|||
131794110|NCT00585351|474528727|FG002|Enrollment Period (Intervention)|Death|0|||
131611878|NCT03211247|473871594|FG001|Overall Study|Lost to Follow-up|1|||
131611879|NCT03211247|473871595|FG002|Overall Study|Lost to Follow-up|0|||
131611880|NCT03211247|473871596|FG003|Overall Study|Lost to Follow-up|0|||
131611881|NCT03211247|473871597|FG004|Overall Study|Lost to Follow-up|0|||
131611882|NCT03211247|473871593|FG000|Overall Study|Physician Decision|1|||
131611883|NCT03211247|473871594|FG001|Overall Study|Physician Decision|2|||
131611884|NCT03211247|473871595|FG002|Overall Study|Physician Decision|0|||
131611885|NCT03211247|473871596|FG003|Overall Study|Physician Decision|0|||
131611886|NCT03211247|473871597|FG004|Overall Study|Physician Decision|0|||
131611887|NCT03211247|473871593|FG000|Overall Study|Non-compliance with study drug|2|||
131611888|NCT03211247|473871594|FG001|Overall Study|Non-compliance with study drug|0|||
131611889|NCT03211247|473871595|FG002|Overall Study|Non-compliance with study drug|0|||
131708363|NCT01671280|474211359|FG000|Overall Study|Withdrawal by Subject|2|||
131708364|NCT01959165|474211360|FG000|Overall Study|Adverse Event|0|||
131708365|NCT01959165|474211361|FG001|Overall Study|Adverse Event|0|||
131708366|NCT01959165|474211362|FG002|Overall Study|Adverse Event|0|||
131794111|NCT00585351|474528728|FG003|Enrollment Period (Intervention)|Death|0|||
131708367|NCT01959165|474211363|FG003|Overall Study|Adverse Event|1|||
131708368|NCT01959165|474211360|FG000|Overall Study|Lack of Efficacy|1|||
131708369|NCT01959165|474211361|FG001|Overall Study|Lack of Efficacy|0|||
131708370|NCT01959165|474211362|FG002|Overall Study|Lack of Efficacy|0|||
131708371|NCT01959165|474211363|FG003|Overall Study|Lack of Efficacy|0|||
131708372|NCT01959165|474211360|FG000|Overall Study|overdose|0|||
131708373|NCT01959165|474211361|FG001|Overall Study|overdose|0|||
131708374|NCT01959165|474211362|FG002|Overall Study|overdose|0|||
131708375|NCT01959165|474211363|FG003|Overall Study|overdose|1|||
131708376|NCT01959165|474211360|FG000|Overall Study|Welfare recipient|0|||
131708377|NCT01959165|474211361|FG001|Overall Study|Welfare recipient|1|||
131708378|NCT01959165|474211362|FG002|Overall Study|Welfare recipient|0|||
131708379|NCT01959165|474211363|FG003|Overall Study|Welfare recipient|0|||
131708380|NCT00560755|474211365|FG000|Overall Study|Protocol Violation|15|||
131708381|NCT00560755|474211365|FG000|Overall Study|Withdrawal by Subject|26|||
131708382|NCT00560755|474211365|FG000|Overall Study|Lost to Follow-up|9|||
131708383|NCT00560755|474211365|FG000|Overall Study|Adverse Event|8|||
131708384|NCT00560755|474211365|FG000|Overall Study|Physician Decision|2|||
131708385|NCT00848120|474211366|FG000|Overall Study|Adverse Event|1|||
131708386|NCT00927563|474211382|FG000|Overall Study|Lost to Follow-up|1|||
131708387|NCT00927563|474211382|FG000|Overall Study|Withdrawal by Subject|1|||
131708388|NCT02899156|474211386|FG000|Overall Study|Death|1|||
131708389|NCT02899156|474211387|FG001|Overall Study|Death|0|||
131611890|NCT03211247|473871596|FG003|Overall Study|Non-compliance with study drug|0|||
131611891|NCT03211247|473871597|FG004|Overall Study|Non-compliance with study drug|0|||
131611892|NCT03211247|473871593|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
131611893|NCT03211247|473871594|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
131611894|NCT03211247|473871595|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
131611895|NCT03211247|473871596|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
131611896|NCT03211247|473871597|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
131611897|NCT03211247|473871593|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
131611898|NCT03211247|473871594|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
131611899|NCT03211247|473871595|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
131611900|NCT03211247|473871596|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
131611901|NCT03211247|473871597|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
131611902|NCT03211247|473871593|FG000|Overall Study|Protocol Violation|0|||
131611903|NCT03211247|473871594|FG001|Overall Study|Protocol Violation|1|||
131611904|NCT03211247|473871595|FG002|Overall Study|Protocol Violation|0|||
131611905|NCT03211247|473871596|FG003|Overall Study|Protocol Violation|0|||
131611906|NCT03211247|473871597|FG004|Overall Study|Protocol Violation|0|||
131611907|NCT02500576|473871600|FG000|Overall Study|Adverse Event|0|||
131611908|NCT02500576|473871601|FG001|Overall Study|Adverse Event|1|||
131611909|NCT02500576|473871600|FG000|Overall Study|Death|2|||
131611910|NCT02500576|473871601|FG001|Overall Study|Death|1|||
131611911|NCT02500576|473871600|FG000|Overall Study|Lack of Efficacy|5|||
131611912|NCT02500576|473871601|FG001|Overall Study|Lack of Efficacy|5|||
131611913|NCT02500576|473871600|FG000|Overall Study|Withdrawal by Subject|1|||
131611914|NCT02500576|473871601|FG001|Overall Study|Withdrawal by Subject|1|||
131611915|NCT04882917|473871604|FG000|Overall Study|Adverse Event|0|||
131611916|NCT04882917|473871605|FG001|Overall Study|Adverse Event|1|||
131611917|NCT04882917|473871606|FG002|Overall Study|Adverse Event|2|||
131611918|NCT04882917|473871607|FG003|Overall Study|Adverse Event|2|||
131611919|NCT04882917|473871604|FG000|Overall Study|Withdrawal by Subject|1|||
131611920|NCT04882917|473871605|FG001|Overall Study|Withdrawal by Subject|0|||
131611921|NCT04882917|473871606|FG002|Overall Study|Withdrawal by Subject|2|||
131611922|NCT04882917|473871607|FG003|Overall Study|Withdrawal by Subject|1|||
131611923|NCT04882917|473871604|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
131611924|NCT04882917|473871605|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
131611925|NCT04882917|473871606|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
131794112|NCT00585351|474528729|FG004|Enrollment Period (Intervention)|Death|1|||
131794113|NCT00585351|474528730|FG005|Enrollment Period (Intervention)|Death|0|||
131794114|NCT00585351|474528731|FG006|Enrollment Period (Intervention)|Death|1|||
131794115|NCT00585351|474528732|FG007|Enrollment Period (Intervention)|Death|0|||
131794116|NCT00585351|474528725|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131794117|NCT00585351|474528726|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131794118|NCT00585351|474528727|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131611926|NCT04882917|473871607|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
131611927|NCT00319020|473871609|FG000|Overall Study|Death|2|||
131611928|NCT00319020|473871610|FG001|Overall Study|Death|2|||
131708390|NCT02899156|474211386|FG000|Overall Study|Physician Decision|0|||
131708391|NCT02899156|474211387|FG001|Overall Study|Physician Decision|1|||
131708392|NCT01468987|474211390|FG000|Overall Study|Adverse Event|12|||
131708393|NCT01468987|474211391|FG001|Overall Study|Adverse Event|9|||
131708394|NCT01468987|474211390|FG000|Overall Study|Death|4|||
131708395|NCT01468987|474211391|FG001|Overall Study|Death|1|||
131611929|NCT00319020|473871609|FG000|Overall Study|Withdrawal by Subject|4|||
131611930|NCT00319020|473871610|FG001|Overall Study|Withdrawal by Subject|1|||
131611931|NCT00319020|473871609|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
131611932|NCT00319020|473871610|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
131611933|NCT00319020|473871609|FG000|Overall Study|Administrative reason|0|||
131611934|NCT00319020|473871610|FG001|Overall Study|Administrative reason|5|||
131611935|NCT00319020|473871609|FG000|Overall Study|Disease progression|0|||
131611936|NCT00319020|473871610|FG001|Overall Study|Disease progression|2|||
131611937|NCT00319020|473871609|FG000|Overall Study|Transplant|0|||
131611938|NCT00319020|473871610|FG001|Overall Study|Transplant|1|||
131611939|NCT00319020|473871609|FG000|Overall Study|Treatment failure|0|||
131611940|NCT00319020|473871610|FG001|Overall Study|Treatment failure|1|||
131611941|NCT00319020|473871609|FG000|Overall Study|Adverse Event|0|||
131611942|NCT00319020|473871610|FG001|Overall Study|Adverse Event|1|||
131611943|NCT03997474|473871614|FG000|Overall Study|Death|6|||
131611944|NCT03997474|473871615|FG001|Overall Study|Death|2|||
131611945|NCT03997474|473871616|FG002|Overall Study|Death|1|||
131611946|NCT03997474|473871614|FG000|Overall Study|Physician Decision|2|||
131611947|NCT03997474|473871615|FG001|Overall Study|Physician Decision|0|||
131611948|NCT03997474|473871616|FG002|Overall Study|Physician Decision|0|||
131611949|NCT03997474|473871614|FG000|Overall Study|study terminated by sponsor|1|||
131611950|NCT03997474|473871615|FG001|Overall Study|study terminated by sponsor|0|||
131611951|NCT03997474|473871616|FG002|Overall Study|study terminated by sponsor|1|||
131611952|NCT02549352|473871617|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
131611953|NCT02549352|473871618|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
131611954|NCT02549352|473871617|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
131611955|NCT02549352|473871618|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
131611956|NCT02549352|473871617|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
131611957|NCT02549352|473871618|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
131611958|NCT02549352|473871617|FG000|12-month Follow-up|Withdrawal by Subject|4|||
131611959|NCT02549352|473871618|FG001|12-month Follow-up|Withdrawal by Subject|5|||
131611960|NCT02549352|473871617|FG000|12-month Follow-up|Lost to Follow-up|3|||
131611961|NCT02549352|473871618|FG001|12-month Follow-up|Lost to Follow-up|2|||
131611962|NCT02549352|473871617|FG000|12-month Follow-up|Death|0|||
131611963|NCT02549352|473871618|FG001|12-month Follow-up|Death|1|||
131611964|NCT02549352|473871617|FG000|12-month Follow-up|Protocol Violation|0|||
131611965|NCT02549352|473871618|FG001|12-month Follow-up|Protocol Violation|1|||
131611966|NCT02549352|473871617|FG000|12-month Follow-up|Other|1|||
131611967|NCT02549352|473871618|FG001|12-month Follow-up|Other|3|||
131611968|NCT04980300|473871619|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
131611969|NCT04980300|473871620|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
131611970|NCT04980300|473871619|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
131611971|NCT04980300|473871620|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
131611972|NCT04980300|473871619|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
131611973|NCT04980300|473871620|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
131611974|NCT04980300|473871619|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
131611975|NCT04980300|473871620|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
131611976|NCT03140670|473872282|FG000|Overall Study|Withdrawal by Subject|2|||
131611977|NCT03140670|473872282|FG000|Overall Study|Lost to Follow-up|1|||
131611978|NCT03140670|473872282|FG000|Overall Study|Physician Decision|1|||
131611979|NCT00220805|473872283|FG000|Overall Study|Adverse Event|1|||
131611980|NCT00220805|473872284|FG001|Overall Study|Adverse Event|3|||
131794119|NCT00585351|474528728|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131794120|NCT00585351|474528729|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
131794121|NCT00585351|474528730|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
131794122|NCT00585351|474528731|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131794123|NCT00585351|474528732|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131794124|NCT01829477|474528734|FG000|Overall Study|Study Terminated by Sponsor|15|||
131794125|NCT01829477|474528735|FG001|Overall Study|Study Terminated by Sponsor|15|||
131611981|NCT00220805|473872283|FG000|Overall Study|Withdrawal by Subject|3|||
131611982|NCT00220805|473872284|FG001|Overall Study|Withdrawal by Subject|0|||
131794126|NCT01829477|474528734|FG000|Overall Study|Withdrawal by Subject|1|||
131611983|NCT00220805|473872283|FG000|Overall Study|Lack of Efficacy|1|||
131611984|NCT00220805|473872284|FG001|Overall Study|Lack of Efficacy|0|||
131611985|NCT00220805|473872283|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
131611986|NCT00220805|473872284|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
131611987|NCT02325466|473872285|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
131611988|NCT02325466|473872286|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
131611989|NCT02325466|473872287|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
131611990|NCT02325466|473872285|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
131611991|NCT02325466|473872286|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
131611992|NCT02325466|473872287|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
131611993|NCT02325466|473872285|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
131611994|NCT02325466|473872286|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
131611995|NCT02325466|473872287|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
131611996|NCT02325466|473872285|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
131611997|NCT02325466|473872286|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
131611998|NCT02325466|473872287|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
131611999|NCT02325466|473872285|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
131612000|NCT02325466|473872286|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
131612001|NCT02325466|473872287|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
131612002|NCT02325466|473872285|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
131612003|NCT02325466|473872286|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
131612004|NCT02325466|473872287|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
131612005|NCT02325466|473872285|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
131612006|NCT02325466|473872286|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
131612007|NCT02325466|473872287|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
131612008|NCT02325466|473872285|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
131612009|NCT02325466|473872286|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
131612010|NCT02325466|473872287|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
131612011|NCT02325466|473872285|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
131612012|NCT02325466|473872286|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
131612013|NCT02325466|473872287|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
131612014|NCT03357952|473872288|FG000|Overall Study|Withdrawal by Subject|0|||
131612015|NCT03357952|473872289|FG001|Overall Study|Withdrawal by Subject|1|||
131612016|NCT03357952|473872288|FG000|Overall Study|Sponsor Decision|9|||
131612017|NCT03357952|473872289|FG001|Overall Study|Sponsor Decision|0|||
131612018|NCT01371994|473872290|FG000|Overall Study|Adverse Event|3|||
131612019|NCT01371994|473872291|FG001|Overall Study|Adverse Event|6|||
131612020|NCT01371994|473872290|FG000|Overall Study|Lack of Efficacy|3|||
131612021|NCT01371994|473872291|FG001|Overall Study|Lack of Efficacy|0|||
131612022|NCT01371994|473872290|FG000|Overall Study|Withdrawal by Subject|13|||
131612023|NCT01371994|473872291|FG001|Overall Study|Withdrawal by Subject|7|||
131612024|NCT01371994|473872290|FG000|Overall Study|Lost to Follow-up|1|||
131612025|NCT01371994|473872291|FG001|Overall Study|Lost to Follow-up|1|||
131612026|NCT01371994|473872290|FG000|Overall Study|Protocol Violation|24|||
131612027|NCT01371994|473872291|FG001|Overall Study|Protocol Violation|17|||
131612028|NCT01371994|473872290|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
131612029|NCT01371994|473872291|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
131612030|NCT01371994|473872290|FG000|Overall Study|Physician Decision|1|||
131612031|NCT01371994|473872291|FG001|Overall Study|Physician Decision|1|||
131612032|NCT01371994|473872290|FG000|Overall Study|Miscellaneous Reasons|6|||
131612033|NCT01371994|473872291|FG001|Overall Study|Miscellaneous Reasons|4|||
131612034|NCT03280030|473872292|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
131612035|NCT03280030|473872293|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
131612036|NCT03280030|473872294|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
131612037|NCT03280030|473872292|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
131612038|NCT03280030|473872293|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
131612039|NCT03280030|473872294|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
131612040|NCT03280030|473872292|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
131612041|NCT03280030|473872293|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
131612042|NCT03280030|473872294|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
131612043|NCT03280030|473872292|FG000|Part 2 - Efficacy|Adverse Event|0|||
131612044|NCT03280030|473872293|FG001|Part 2 - Efficacy|Adverse Event|4|||
131612045|NCT03280030|473872294|FG002|Part 2 - Efficacy|Adverse Event|6|||
131612046|NCT03280030|473872292|FG000|Part 2 - Efficacy|Death|0|||
131612047|NCT03280030|473872293|FG001|Part 2 - Efficacy|Death|3|||
131612048|NCT03280030|473872294|FG002|Part 2 - Efficacy|Death|0|||
131612049|NCT03280030|473872292|FG000|Part 2 - Efficacy|Physician Decision|0|||
131612050|NCT03280030|473872293|FG001|Part 2 - Efficacy|Physician Decision|10|||
131612051|NCT03280030|473872294|FG002|Part 2 - Efficacy|Physician Decision|16|||
131612052|NCT03280030|473872292|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
131612053|NCT03280030|473872293|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
131612054|NCT03280030|473872294|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
131612055|NCT03280030|473872292|FG000|Part 2 - Efficacy|Progressive disease|0|||
131612056|NCT03280030|473872293|FG001|Part 2 - Efficacy|Progressive disease|7|||
131612057|NCT03280030|473872294|FG002|Part 2 - Efficacy|Progressive disease|5|||
131612058|NCT01208974|473872297|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
131612059|NCT01208974|473872298|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
131794127|NCT01829477|474528735|FG001|Overall Study|Withdrawal by Subject|0|||
131794128|NCT00818623|474528738|FG000|Overall Study|Adverse Event|1|||
131612060|NCT01208974|473872299|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
131612061|NCT01208974|473872300|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
131612062|NCT01208974|473872297|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
131612063|NCT01208974|473872298|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
131612064|NCT01208974|473872299|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
131612065|NCT01208974|473872300|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
131612066|NCT01208974|473872297|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
131612067|NCT01208974|473872298|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
131612068|NCT01208974|473872299|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
131612069|NCT01208974|473872300|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
131612070|NCT05521516|473872301|FG000|Overall Study|Withdrawal by Subject|1|||
131612071|NCT05521516|473872302|FG001|Overall Study|Withdrawal by Subject|1|||
131612072|NCT00747565|473872303|FG000|Overall Study|Withdrawal by Subject|10|||
131612073|NCT00747565|473872304|FG001|Overall Study|Withdrawal by Subject|6|||
131612074|NCT00747565|473872303|FG000|Overall Study|Lost to Follow-up|4|||
131612075|NCT00747565|473872304|FG001|Overall Study|Lost to Follow-up|1|||
131612076|NCT03777657|473872305|FG000|Overall Study|Death|397|||
131612077|NCT03777657|473872306|FG001|Overall Study|Death|431|||
131612078|NCT03777657|473872305|FG000|Overall Study|Study Closed by Sponsor|77|||
131612079|NCT03777657|473872306|FG001|Overall Study|Study Closed by Sponsor|38|||
131612080|NCT03777657|473872305|FG000|Overall Study|Withdrawal by Subject|20|||
131612081|NCT03777657|473872306|FG001|Overall Study|Withdrawal by Subject|17|||
131612082|NCT03777657|473872305|FG000|Overall Study|Lost to Follow-up|6|||
131612083|NCT03777657|473872306|FG001|Overall Study|Lost to Follow-up|10|||
131612084|NCT01983683|473872307|FG000|Overall Study|Withdrawal by Subject|14|||
131612085|NCT01983683|473872308|FG001|Overall Study|Withdrawal by Subject|18|||
131612086|NCT01983683|473872307|FG000|Overall Study|Death|11|||
131612087|NCT01983683|473872308|FG001|Overall Study|Death|15|||
131612088|NCT01983683|473872307|FG000|Overall Study|Physician Decision|8|||
131612089|NCT01983683|473872308|FG001|Overall Study|Physician Decision|9|||
131612090|NCT01983683|473872307|FG000|Overall Study|Lost to Follow-up|4|||
131612091|NCT01983683|473872308|FG001|Overall Study|Lost to Follow-up|8|||
131612092|NCT01983683|473872307|FG000|Overall Study|Sponsor Decision|1|||
131612093|NCT01983683|473872308|FG001|Overall Study|Sponsor Decision|1|||
131612094|NCT00227266|473872312|FG000|Overall Study|Withdrawal by Subject|0|||
131612095|NCT00227266|473872313|FG001|Overall Study|Withdrawal by Subject|0|||
131612096|NCT00227266|473872314|FG002|Overall Study|Withdrawal by Subject|1|||
131612097|NCT00227266|473872312|FG000|Overall Study|Protocol Violation|1|||
131612098|NCT00227266|473872313|FG001|Overall Study|Protocol Violation|0|||
131612099|NCT00227266|473872314|FG002|Overall Study|Protocol Violation|1|||
131612100|NCT00227266|473872312|FG000|Overall Study|Excessive weight gain|0|||
131612101|NCT00227266|473872313|FG001|Overall Study|Excessive weight gain|0|||
131612102|NCT00227266|473872314|FG002|Overall Study|Excessive weight gain|2|||
131612103|NCT02678689|473872315|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
131612104|NCT02678689|473872316|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
131612105|NCT04153890|473872320|FG000|Overall Study|Lost to Follow-up|9|||
131612106|NCT04153890|473872321|FG001|Overall Study|Lost to Follow-up|0|||
131612107|NCT04153890|473872322|FG002|Overall Study|Lost to Follow-up|9|||
131612108|NCT04153890|473872323|FG003|Overall Study|Lost to Follow-up|0|||
131612109|NCT04153890|473872320|FG000|Overall Study|Death|0|||
131612110|NCT04153890|473872321|FG001|Overall Study|Death|2|||
131612111|NCT04153890|473872322|FG002|Overall Study|Death|0|||
131612112|NCT04153890|473872323|FG003|Overall Study|Death|0|||
131612113|NCT04153890|473872320|FG000|Overall Study|Withdrawal by Subject|0|||
131612114|NCT04153890|473872321|FG001|Overall Study|Withdrawal by Subject|0|||
131612115|NCT04153890|473872322|FG002|Overall Study|Withdrawal by Subject|0|||
131612116|NCT04153890|473872323|FG003|Overall Study|Withdrawal by Subject|2|||
131612117|NCT03959423|473872324|FG000|Overall Study|Withdrawal by Subject|2|||
131612118|NCT03959423|473872325|FG001|Overall Study|Withdrawal by Subject|3|||
131612119|NCT03959423|473872324|FG000|Overall Study|Physician Decision|0|||
131612120|NCT03959423|473872325|FG001|Overall Study|Physician Decision|1|||
131612121|NCT03959423|473872324|FG000|Overall Study|Lost to Follow-up|1|||
131612122|NCT03959423|473872325|FG001|Overall Study|Lost to Follow-up|0|||
131612123|NCT03959423|473872324|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
131708396|NCT01468987|474211390|FG000|Overall Study|Lost to Follow-up|10|||
131708397|NCT01468987|474211391|FG001|Overall Study|Lost to Follow-up|5|||
131708398|NCT01468987|474211390|FG000|Overall Study|Protocol Violation|8|||
131708399|NCT01468987|474211391|FG001|Overall Study|Protocol Violation|2|||
131708400|NCT01468987|474211390|FG000|Overall Study|Withdrawal by Subject|28|||
131708401|NCT01468987|474211391|FG001|Overall Study|Withdrawal by Subject|28|||
131708402|NCT01468987|474211390|FG000|Overall Study|Physician Decision|8|||
131708403|NCT01468987|474211391|FG001|Overall Study|Physician Decision|15|||
131708404|NCT01468987|474211390|FG000|Overall Study|Sponsor Decision|1|||
131612124|NCT03959423|473872325|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131612125|NCT05786612|473872327|FG000|Overall Study|Adverse Event|1|||
131612126|NCT05786612|473872328|FG001|Overall Study|Adverse Event|2|||
131612127|NCT05786612|473872327|FG000|Overall Study|one screening failure|0|||
131612128|NCT05786612|473872328|FG001|Overall Study|one screening failure|2|||
131612129|NCT04926740|473872329|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
131612130|NCT04926740|473872330|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
131612131|NCT04926740|473872329|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
131612132|NCT04926740|473872330|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
131612133|NCT03459196|473873745|FG000|Overall Study|Subject didn't receive study catheter|2|||
131612134|NCT00655499|473873749|FG000|Overall Study|not eligible|4|||
131612135|NCT00146172|473873750|FG000|Overall Study|Adverse Event|0|||
131612136|NCT00146172|473873751|FG001|Overall Study|Adverse Event|0|||
131612137|NCT00146172|473873752|FG002|Overall Study|Adverse Event|1|||
131612138|NCT00146172|473873753|FG003|Overall Study|Adverse Event|1|||
131612139|NCT00146172|473873754|FG004|Overall Study|Adverse Event|0|||
131612140|NCT00146172|473873755|FG005|Overall Study|Adverse Event|2|||
131612141|NCT00146172|473873756|FG006|Overall Study|Adverse Event|3|||
131612142|NCT00146172|473873757|FG007|Overall Study|Adverse Event|10|||
131612143|NCT00146172|473873750|FG000|Overall Study|Lost to Follow-up|0|||
131612144|NCT00146172|473873751|FG001|Overall Study|Lost to Follow-up|0|||
131612145|NCT00146172|473873752|FG002|Overall Study|Lost to Follow-up|0|||
131612146|NCT00146172|473873753|FG003|Overall Study|Lost to Follow-up|0|||
131612147|NCT00146172|473873754|FG004|Overall Study|Lost to Follow-up|0|||
131612148|NCT00146172|473873755|FG005|Overall Study|Lost to Follow-up|0|||
131612149|NCT00146172|473873756|FG006|Overall Study|Lost to Follow-up|0|||
131612150|NCT00146172|473873757|FG007|Overall Study|Lost to Follow-up|1|||
131612151|NCT00146172|473873750|FG000|Overall Study|Disease Progression|2|||
131612152|NCT00146172|473873751|FG001|Overall Study|Disease Progression|4|||
131612153|NCT00146172|473873752|FG002|Overall Study|Disease Progression|2|||
131612154|NCT00146172|473873753|FG003|Overall Study|Disease Progression|5|||
131612155|NCT00146172|473873754|FG004|Overall Study|Disease Progression|2|||
131612156|NCT00146172|473873755|FG005|Overall Study|Disease Progression|2|||
131612157|NCT00146172|473873756|FG006|Overall Study|Disease Progression|1|||
131612158|NCT00146172|473873757|FG007|Overall Study|Disease Progression|22|||
131612159|NCT00146172|473873750|FG000|Overall Study|Death|0|||
131612160|NCT00146172|473873751|FG001|Overall Study|Death|0|||
131612161|NCT00146172|473873752|FG002|Overall Study|Death|0|||
131612162|NCT00146172|473873753|FG003|Overall Study|Death|0|||
131612163|NCT00146172|473873754|FG004|Overall Study|Death|0|||
131612164|NCT00146172|473873755|FG005|Overall Study|Death|0|||
131612165|NCT00146172|473873756|FG006|Overall Study|Death|1|||
131612166|NCT00146172|473873757|FG007|Overall Study|Death|0|||
131612167|NCT00146172|473873750|FG000|Overall Study|Physician Decision|0|||
131612168|NCT00146172|473873751|FG001|Overall Study|Physician Decision|0|||
131612169|NCT00146172|473873752|FG002|Overall Study|Physician Decision|0|||
131612170|NCT00146172|473873753|FG003|Overall Study|Physician Decision|0|||
131612171|NCT00146172|473873754|FG004|Overall Study|Physician Decision|0|||
131612172|NCT00146172|473873755|FG005|Overall Study|Physician Decision|0|||
131612173|NCT00146172|473873756|FG006|Overall Study|Physician Decision|0|||
131612174|NCT00146172|473873757|FG007|Overall Study|Physician Decision|1|||
131612175|NCT00146172|473873750|FG000|Overall Study|Withdrawal by Subject|0|||
131612176|NCT00146172|473873751|FG001|Overall Study|Withdrawal by Subject|0|||
131612177|NCT00146172|473873752|FG002|Overall Study|Withdrawal by Subject|0|||
131612178|NCT00146172|473873753|FG003|Overall Study|Withdrawal by Subject|0|||
131612179|NCT00146172|473873754|FG004|Overall Study|Withdrawal by Subject|0|||
131612180|NCT00146172|473873755|FG005|Overall Study|Withdrawal by Subject|1|||
131612181|NCT00146172|473873756|FG006|Overall Study|Withdrawal by Subject|1|||
131612182|NCT00146172|473873757|FG007|Overall Study|Withdrawal by Subject|4|||
131612183|NCT00146172|473873750|FG000|Overall Study|Symptomatic Deterioration|1|||
131612184|NCT00146172|473873751|FG001|Overall Study|Symptomatic Deterioration|0|||
131612185|NCT00146172|473873752|FG002|Overall Study|Symptomatic Deterioration|1|||
131612186|NCT00146172|473873753|FG003|Overall Study|Symptomatic Deterioration|0|||
131612187|NCT00146172|473873754|FG004|Overall Study|Symptomatic Deterioration|1|||
131612188|NCT00146172|473873755|FG005|Overall Study|Symptomatic Deterioration|2|||
131612189|NCT00146172|473873756|FG006|Overall Study|Symptomatic Deterioration|0|||
131612190|NCT00146172|473873757|FG007|Overall Study|Symptomatic Deterioration|2|||
131612191|NCT03876457|473873760|FG000|Overall Study|Lost to Follow-up|1|||
131612192|NCT03876457|473873761|FG001|Overall Study|Lost to Follow-up|3|||
131612193|NCT01184326|473873762|FG000|Overall Study|Adverse Event|1|||
131612194|NCT01184326|473873763|FG001|Overall Study|Adverse Event|2|||
131612195|NCT01184326|473873764|FG002|Overall Study|Adverse Event|0|||
131612196|NCT01184326|473873762|FG000|Overall Study|Death|0|||
131612197|NCT01184326|473873763|FG001|Overall Study|Death|0|||
131612198|NCT01184326|473873764|FG002|Overall Study|Death|1|||
131612199|NCT01184326|473873762|FG000|Overall Study|Withdrawal by Subject|0|||
131612200|NCT01184326|473873763|FG001|Overall Study|Withdrawal by Subject|0|||
131612201|NCT01184326|473873764|FG002|Overall Study|Withdrawal by Subject|1|||
131612202|NCT01184326|473873762|FG000|Overall Study|Physician Decision|1|||
131612203|NCT01184326|473873763|FG001|Overall Study|Physician Decision|1|||
131612204|NCT01184326|473873764|FG002|Overall Study|Physician Decision|0|||
131612205|NCT01184326|473873762|FG000|Overall Study|Disease Progression|1|||
131612206|NCT01184326|473873763|FG001|Overall Study|Disease Progression|3|||
131612207|NCT01184326|473873764|FG002|Overall Study|Disease Progression|12|||
131612208|NCT01288443|473873765|FG000|Overall Study|Adverse Event|0|||
131612209|NCT01288443|473873766|FG001|Overall Study|Adverse Event|0|||
131612210|NCT01288443|473873767|FG002|Overall Study|Adverse Event|1|||
131612211|NCT01288443|473873768|FG003|Overall Study|Adverse Event|1|||
131612212|NCT01288443|473873769|FG004|Overall Study|Adverse Event|3|||
131612213|NCT01288443|473873770|FG005|Overall Study|Adverse Event|1|||
131612214|NCT01288443|473873765|FG000|Overall Study|Poor compliance to protocol|0|||
131612215|NCT01288443|473873766|FG001|Overall Study|Poor compliance to protocol|0|||
131612216|NCT01288443|473873767|FG002|Overall Study|Poor compliance to protocol|0|||
131612217|NCT01288443|473873768|FG003|Overall Study|Poor compliance to protocol|0|||
131612218|NCT01288443|473873769|FG004|Overall Study|Poor compliance to protocol|0|||
131612219|NCT01288443|473873770|FG005|Overall Study|Poor compliance to protocol|1|||
131612220|NCT01288443|473873765|FG000|Overall Study|Participant Moved|0|||
131612221|NCT01288443|473873766|FG001|Overall Study|Participant Moved|0|||
131612222|NCT01288443|473873767|FG002|Overall Study|Participant Moved|0|||
131612223|NCT01288443|473873768|FG003|Overall Study|Participant Moved|1|||
131612224|NCT01288443|473873769|FG004|Overall Study|Participant Moved|2|||
131612225|NCT01288443|473873770|FG005|Overall Study|Participant Moved|1|||
131612226|NCT01288443|473873765|FG000|Overall Study|Consent withdrawn by Participant|0|||
131612227|NCT01288443|473873766|FG001|Overall Study|Consent withdrawn by Participant|0|||
131612228|NCT01288443|473873767|FG002|Overall Study|Consent withdrawn by Participant|0|||
131612229|NCT01288443|473873768|FG003|Overall Study|Consent withdrawn by Participant|0|||
131612230|NCT01288443|473873769|FG004|Overall Study|Consent withdrawn by Participant|0|||
131612231|NCT01288443|473873770|FG005|Overall Study|Consent withdrawn by Participant|1|||
131612232|NCT01288443|473873765|FG000|Overall Study|Lost to Follow-up|0|||
131612233|NCT01288443|473873766|FG001|Overall Study|Lost to Follow-up|1|||
131612234|NCT01288443|473873767|FG002|Overall Study|Lost to Follow-up|0|||
131612235|NCT01288443|473873768|FG003|Overall Study|Lost to Follow-up|0|||
131612236|NCT01288443|473873769|FG004|Overall Study|Lost to Follow-up|0|||
131612237|NCT01288443|473873770|FG005|Overall Study|Lost to Follow-up|0|||
131612238|NCT01288443|473873765|FG000|Overall Study|Study drug auto-injector administration|0|||
131612239|NCT01288443|473873766|FG001|Overall Study|Study drug auto-injector administration|0|||
131612240|NCT01288443|473873767|FG002|Overall Study|Study drug auto-injector administration|0|||
131612241|NCT01288443|473873768|FG003|Overall Study|Study drug auto-injector administration|0|||
131612242|NCT01288443|473873769|FG004|Overall Study|Study drug auto-injector administration|1|||
131612243|NCT01288443|473873770|FG005|Overall Study|Study drug auto-injector administration|1|||
131612244|NCT01288443|473873765|FG000|Overall Study|Other than above|0|||
131612245|NCT01288443|473873766|FG001|Overall Study|Other than above|0|||
131612246|NCT01288443|473873767|FG002|Overall Study|Other than above|0|||
131612247|NCT01288443|473873768|FG003|Overall Study|Other than above|2|||
131612248|NCT01288443|473873769|FG004|Overall Study|Other than above|1|||
131612249|NCT01288443|473873770|FG005|Overall Study|Other than above|0|||
131612250|NCT01964300|473873773|FG000|Overall Study|Ineligible after enrollment|0|||
131612251|NCT01964300|473873774|FG001|Overall Study|Ineligible after enrollment|1|||
131612252|NCT01964300|473873773|FG000|Overall Study|Adverse Event|1|||
131612253|NCT01964300|473873774|FG001|Overall Study|Adverse Event|1|||
131612254|NCT01964300|473873773|FG000|Overall Study|Lack of Efficacy|3|||
131612255|NCT01964300|473873774|FG001|Overall Study|Lack of Efficacy|5|||
131612256|NCT01964300|473873773|FG000|Overall Study|Withdrawal by Subject|0|||
131612257|NCT01964300|473873774|FG001|Overall Study|Withdrawal by Subject|1|||
131612258|NCT01964300|473873773|FG000|Overall Study|To receive alternative therapy|1|||
131612259|NCT01964300|473873774|FG001|Overall Study|To receive alternative therapy|2|||
131612260|NCT01964300|473873773|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
131612261|NCT01964300|473873774|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
131612262|NCT01964300|473873773|FG000|Overall Study|Weight criteria not met|0|||
131612263|NCT01964300|473873774|FG001|Overall Study|Weight criteria not met|1|||
131612264|NCT00557492|473873777|FG000|Overall Study|Change in health insurance|1|||
131612265|NCT01574716|473873778|FG000|Part 1|Death|3|||
131612266|NCT01574716|473873779|FG001|Part 1|Death|1|||
131612267|NCT01574716|473873780|FG002|Part 1|Death|8|||
131612268|NCT01574716|473873781|FG003|Part 1|Death|0|||
131612269|NCT01574716|473873782|FG004|Part 1|Death|0|||
131612270|NCT01574716|473873778|FG000|Part 1|Discontinuation of study by sponsor|0|||
131612271|NCT01574716|473873779|FG001|Part 1|Discontinuation of study by sponsor|0|||
131612272|NCT01574716|473873780|FG002|Part 1|Discontinuation of study by sponsor|1|||
131612273|NCT01574716|473873781|FG003|Part 1|Discontinuation of study by sponsor|0|||
131612274|NCT01574716|473873782|FG004|Part 1|Discontinuation of study by sponsor|0|||
131612275|NCT01574716|473873778|FG000|Part 1|Withdrawal by Subject|0|||
131612276|NCT01574716|473873779|FG001|Part 1|Withdrawal by Subject|2|||
131612277|NCT01574716|473873780|FG002|Part 1|Withdrawal by Subject|0|||
131612278|NCT01574716|473873781|FG003|Part 1|Withdrawal by Subject|0|||
131612279|NCT01574716|473873782|FG004|Part 1|Withdrawal by Subject|0|||
131708405|NCT01468987|474211391|FG001|Overall Study|Sponsor Decision|0|||
131612280|NCT01574716|473873778|FG000|Part 1|Lost to Follow-up|0|||
131612281|NCT01574716|473873779|FG001|Part 1|Lost to Follow-up|1|||
131612282|NCT01574716|473873780|FG002|Part 1|Lost to Follow-up|0|||
131612283|NCT01574716|473873781|FG003|Part 1|Lost to Follow-up|0|||
131612284|NCT01574716|473873782|FG004|Part 1|Lost to Follow-up|0|||
131612285|NCT01574716|473873778|FG000|Part 2|Progressive disease|0|||
131612286|NCT01574716|473873779|FG001|Part 2|Progressive disease|0|||
131612287|NCT01574716|473873780|FG002|Part 2|Progressive disease|0|||
131612288|NCT01574716|473873781|FG003|Part 2|Progressive disease|1|||
131612289|NCT01574716|473873782|FG004|Part 2|Progressive disease|0|||
131612290|NCT01574716|473873778|FG000|Part 2|Death|0|||
131612291|NCT01574716|473873779|FG001|Part 2|Death|0|||
131612292|NCT01574716|473873780|FG002|Part 2|Death|0|||
131612293|NCT01574716|473873781|FG003|Part 2|Death|76|||
131612294|NCT01574716|473873782|FG004|Part 2|Death|35|||
131612295|NCT01574716|473873778|FG000|Part 2|Discontinuation of study by sponsor|0|||
131612296|NCT01574716|473873779|FG001|Part 2|Discontinuation of study by sponsor|0|||
131612297|NCT01574716|473873780|FG002|Part 2|Discontinuation of study by sponsor|0|||
131612298|NCT01574716|473873781|FG003|Part 2|Discontinuation of study by sponsor|51|||
131612299|NCT01574716|473873782|FG004|Part 2|Discontinuation of study by sponsor|31|||
131612300|NCT01574716|473873778|FG000|Part 2|Withdrawal by Subject|0|||
131612301|NCT01574716|473873779|FG001|Part 2|Withdrawal by Subject|0|||
131612302|NCT01574716|473873780|FG002|Part 2|Withdrawal by Subject|0|||
131612303|NCT01574716|473873781|FG003|Part 2|Withdrawal by Subject|5|||
131612304|NCT01574716|473873782|FG004|Part 2|Withdrawal by Subject|4|||
131612305|NCT01574716|473873778|FG000|Part 2|Brain metastases|0|||
131612306|NCT01574716|473873779|FG001|Part 2|Brain metastases|0|||
131612307|NCT01574716|473873780|FG002|Part 2|Brain metastases|0|||
131612308|NCT01574716|473873781|FG003|Part 2|Brain metastases|1|||
131612309|NCT01574716|473873782|FG004|Part 2|Brain metastases|0|||
131612310|NCT01574716|473873778|FG000|Part 2|Lost to Follow-up|0|||
131612311|NCT01574716|473873779|FG001|Part 2|Lost to Follow-up|0|||
131612312|NCT01574716|473873780|FG002|Part 2|Lost to Follow-up|0|||
131612313|NCT01574716|473873781|FG003|Part 2|Lost to Follow-up|3|||
131612314|NCT01574716|473873782|FG004|Part 2|Lost to Follow-up|0|||
131612315|NCT02438137|473873783|FG000|Overall Study|Lost to Follow-up|3|||
131612316|NCT02438137|473873784|FG001|Overall Study|Lost to Follow-up|2|||
131612317|NCT02438137|473873783|FG000|Overall Study|Adverse Event|1|||
131612318|NCT02438137|473873784|FG001|Overall Study|Adverse Event|0|||
131612319|NCT02438137|473873783|FG000|Overall Study|Withdrawal by Subject|4|||
131612320|NCT02438137|473873784|FG001|Overall Study|Withdrawal by Subject|3|||
131612321|NCT02438137|473873783|FG000|Overall Study|Physician Decision|0|||
131612322|NCT02438137|473873784|FG001|Overall Study|Physician Decision|1|||
131612323|NCT02285270|473873785|FG000|Overall Study|Lost to Follow-up|1|||
131612324|NCT02285270|473873785|FG000|Overall Study|Physician Decision|3|||
131612325|NCT02285270|473873785|FG000|Overall Study|Determined to be ineligible|1|||
131612326|NCT02111096|473873786|FG000|Overall Study|Adverse Event|4|||
131612327|NCT02111096|473873787|FG001|Overall Study|Adverse Event|1|||
131612328|NCT02111096|473873788|FG002|Overall Study|Adverse Event|2|||
131612329|NCT02111096|473873786|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131612330|NCT02111096|473873787|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131612331|NCT02111096|473873788|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131612332|NCT02111096|473873786|FG000|Overall Study|Lost to Follow Up|1|||
131612333|NCT02111096|473873787|FG001|Overall Study|Lost to Follow Up|1|||
131612334|NCT02111096|473873788|FG002|Overall Study|Lost to Follow Up|1|||
131612335|NCT02111096|473873786|FG000|Overall Study|Physician Decision|0|||
131612336|NCT02111096|473873787|FG001|Overall Study|Physician Decision|1|||
131612337|NCT02111096|473873788|FG002|Overall Study|Physician Decision|0|||
131612338|NCT02111096|473873786|FG000|Overall Study|Protocol Violation|1|||
131612339|NCT02111096|473873787|FG001|Overall Study|Protocol Violation|0|||
131612340|NCT02111096|473873788|FG002|Overall Study|Protocol Violation|1|||
131612341|NCT02111096|473873786|FG000|Overall Study|Terminated by Sponsor|53|||
131612342|NCT02111096|473873787|FG001|Overall Study|Terminated by Sponsor|35|||
131612343|NCT02111096|473873788|FG002|Overall Study|Terminated by Sponsor|54|||
131612344|NCT02111096|473873786|FG000|Overall Study|Withdrawal by Subject|4|||
131612345|NCT02111096|473873787|FG001|Overall Study|Withdrawal by Subject|2|||
131612346|NCT02111096|473873788|FG002|Overall Study|Withdrawal by Subject|8|||
131612347|NCT03621735|473873789|FG000|Overall Study|Withdrawal by Subject|13|||
131612348|NCT03621735|473873790|FG001|Overall Study|Withdrawal by Subject|13|||
131612349|NCT03709706|473873796|FG000|Overall Study|Adverse Event|0|||
131612350|NCT03709706|473873797|FG001|Overall Study|Adverse Event|1|||
131612351|NCT03709706|473873796|FG000|Overall Study|Physician Decision|14|||
131612352|NCT03709706|473873797|FG001|Overall Study|Physician Decision|8|||
131612353|NCT03709706|473873796|FG000|Overall Study|Withdrawal by Subject|2|||
131612354|NCT03709706|473873797|FG001|Overall Study|Withdrawal by Subject|1|||
131612355|NCT03709706|473873796|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
131612356|NCT03709706|473873797|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
131612357|NCT04868617|473873798|FG000|Overall Study|Death|1|||
131612358|NCT04868617|473873799|FG001|Overall Study|Death|0|||
131612359|NCT04868617|473873798|FG000|Overall Study|Adverse Event|1|||
131612360|NCT04868617|473873799|FG001|Overall Study|Adverse Event|0|||
131612361|NCT04868617|473873798|FG000|Overall Study|Withdrawal by Subject|1|||
131612362|NCT04868617|473873799|FG001|Overall Study|Withdrawal by Subject|0|||
131612363|NCT04868617|473873798|FG000|Overall Study|Device deficiency|1|||
131612364|NCT04868617|473873799|FG001|Overall Study|Device deficiency|0|||
131612365|NCT03183050|473873800|FG000|Overall Study|Lost to Follow-up|23|||
131612366|NCT02797132|473873801|FG000|Part A (15 Days)|Adverse Event|1|||
131612367|NCT02797132|473873801|FG000|Part B (24 Weeks)|Adverse Event|3|||
131612368|NCT00754065|473873804|FG000|Overall Study|Never received treatment|12|||
131612369|NCT00754065|473873805|FG001|Overall Study|Never received treatment|2|||
131612370|NCT00754065|473873804|FG000|Overall Study|Adverse Event|19|||
131612371|NCT00754065|473873805|FG001|Overall Study|Adverse Event|25|||
131612372|NCT00754065|473873804|FG000|Overall Study|Lost to Follow-up|7|||
131612373|NCT00754065|473873805|FG001|Overall Study|Lost to Follow-up|11|||
131612374|NCT00754065|473873804|FG000|Overall Study|Protocol Violation|12|||
131612375|NCT00754065|473873805|FG001|Overall Study|Protocol Violation|10|||
131612376|NCT00754065|473873804|FG000|Overall Study|Withdrawal by Subject|4|||
131612377|NCT00754065|473873805|FG001|Overall Study|Withdrawal by Subject|5|||
131612378|NCT00754065|473873804|FG000|Overall Study|Pregnancy|6|||
131612379|NCT00754065|473873805|FG001|Overall Study|Pregnancy|0|||
131612380|NCT00754065|473873804|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
131612381|NCT00754065|473873805|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
131612382|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
131612383|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
131612384|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
131612385|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
131612386|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
131612387|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
131612388|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
131612389|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
131612390|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
131612391|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
131612392|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
131612393|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
131612394|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
131612395|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
131612396|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
131612397|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
131612398|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
131612399|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
131612400|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
131612401|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
131612402|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
131612403|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
131612404|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
131612405|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
131612406|NCT01074294|473873806|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
131612407|NCT01074294|473873807|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
131612408|NCT01074294|473873808|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
131612409|NCT01074294|473873809|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
131612410|NCT01074294|473873806|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
131612411|NCT01074294|473873807|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
131612412|NCT01074294|473873808|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
131612413|NCT01074294|473873809|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
131612414|NCT01074294|473873806|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
131612415|NCT01074294|473873807|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
131612416|NCT01074294|473873808|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
131612417|NCT01074294|473873809|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
131612418|NCT01074294|473873806|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
131612419|NCT01074294|473873807|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
131612420|NCT01074294|473873808|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
131612421|NCT01074294|473873809|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
131612422|NCT01074294|473873806|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
131612423|NCT01074294|473873807|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
131612424|NCT01074294|473873808|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
131794129|NCT00818623|474528739|FG001|Overall Study|Adverse Event|0|||
131794130|NCT00818623|474528740|FG002|Overall Study|Adverse Event|1|||
131794131|NCT00818623|474528741|FG003|Overall Study|Adverse Event|0|||
131794132|NCT00818623|474528742|FG004|Overall Study|Adverse Event|0|||
131794133|NCT00818623|474528743|FG005|Overall Study|Adverse Event|1|||
131441881|NCT02718898|473247228|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
131441882|NCT02718898|473247229|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
131612425|NCT01074294|473873809|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
131612426|NCT01074294|473873806|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
131612427|NCT01074294|473873807|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
131612428|NCT01074294|473873808|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
131612429|NCT01074294|473873809|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
131612430|NCT01074294|473873806|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
131612431|NCT01074294|473873807|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
131612432|NCT01074294|473873808|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
131612433|NCT01074294|473873809|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
131612434|NCT00112359|473873810|FG000|Overall Study|Unrelated adverse event|16|||
131612435|NCT00112359|473873811|FG001|Overall Study|Unrelated adverse event|8|||
131612436|NCT00112359|473873810|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
131612437|NCT00112359|473873811|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
131612438|NCT00112359|473873810|FG000|Overall Study|Related adverse event|5|||
131612439|NCT00112359|473873811|FG001|Overall Study|Related adverse event|3|||
131612440|NCT00112359|473873810|FG000|Overall Study|Lost to Follow-up|0|||
131612441|NCT00112359|473873811|FG001|Overall Study|Lost to Follow-up|1|||
131612442|NCT00112359|473873810|FG000|Overall Study|Personal/administrative|1|||
131612443|NCT00112359|473873811|FG001|Overall Study|Personal/administrative|1|||
131612444|NCT00112359|473873810|FG000|Overall Study|Other|3|||
131612445|NCT00112359|473873811|FG001|Overall Study|Other|0|||
131612446|NCT00623194|473873812|FG000|Overall Study|Lack of Efficacy|1|||
131612447|NCT00623194|473873812|FG000|Overall Study|Protocol Violation|3|||
131612448|NCT00623194|473873812|FG000|Overall Study|Unclassified|1|||
131612449|NCT01961609|473873813|FG000|Initiation|Missing|3|||
131612450|NCT01961609|473873814|FG001|Initiation|Missing|2|||
131612451|NCT01961609|473873815|FG002|Initiation|Missing|0|||
131612452|NCT01961609|473873816|FG003|Initiation|Missing|0|||
131612453|NCT01961609|473873813|FG000|Initiation|Protocol deviation|1|||
131612454|NCT01961609|473873814|FG001|Initiation|Protocol deviation|0|||
131612455|NCT01961609|473873815|FG002|Initiation|Protocol deviation|0|||
131612456|NCT01961609|473873816|FG003|Initiation|Protocol deviation|0|||
131612457|NCT01961609|473873813|FG000|Initiation|Death|0|||
131612458|NCT01961609|473873814|FG001|Initiation|Death|1|||
131612459|NCT01961609|473873815|FG002|Initiation|Death|0|||
131612460|NCT01961609|473873816|FG003|Initiation|Death|0|||
131612461|NCT01961609|473873813|FG000|Initiation|Administrative problems|1|||
131612462|NCT01961609|473873814|FG001|Initiation|Administrative problems|0|||
131612463|NCT01961609|473873815|FG002|Initiation|Administrative problems|0|||
131612464|NCT01961609|473873816|FG003|Initiation|Administrative problems|0|||
131612465|NCT01961609|473873813|FG000|Initiation|Withdrawal by Subject|1|||
131612466|NCT01961609|473873814|FG001|Initiation|Withdrawal by Subject|2|||
131612467|NCT01961609|473873815|FG002|Initiation|Withdrawal by Subject|0|||
131612468|NCT01961609|473873816|FG003|Initiation|Withdrawal by Subject|0|||
131612469|NCT01961609|473873813|FG000|Initiation|Lack of Efficacy|2|||
131612470|NCT01961609|473873814|FG001|Initiation|Lack of Efficacy|1|||
131612471|NCT01961609|473873815|FG002|Initiation|Lack of Efficacy|0|||
131612472|NCT01961609|473873816|FG003|Initiation|Lack of Efficacy|0|||
131612473|NCT01961609|473873813|FG000|Initiation|Abnormal lab values|0|||
131612474|NCT01961609|473873814|FG001|Initiation|Abnormal lab values|1|||
131612475|NCT01961609|473873815|FG002|Initiation|Abnormal lab values|0|||
131612476|NCT01961609|473873816|FG003|Initiation|Abnormal lab values|0|||
131612477|NCT01961609|473873813|FG000|Initiation|Adverse Event|3|||
131612478|NCT01961609|473873814|FG001|Initiation|Adverse Event|5|||
131612479|NCT01961609|473873815|FG002|Initiation|Adverse Event|0|||
131612480|NCT01961609|473873816|FG003|Initiation|Adverse Event|0|||
131612481|NCT01961609|473873813|FG000|Initiation|Randomized but not treated|1|||
131612482|NCT01961609|473873814|FG001|Initiation|Randomized but not treated|1|||
131612483|NCT01961609|473873815|FG002|Initiation|Randomized but not treated|0|||
131612484|NCT01961609|473873816|FG003|Initiation|Randomized but not treated|0|||
131612485|NCT01961609|473873813|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
131612486|NCT01961609|473873814|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
131612487|NCT01961609|473873815|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
131612488|NCT01961609|473873816|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
131612489|NCT01961609|473873813|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
131612490|NCT01961609|473873814|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
131612491|NCT01961609|473873815|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
131612492|NCT01961609|473873816|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
131441883|NCT02718898|473247230|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
131612493|NCT01961609|473873813|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
131612494|NCT01961609|473873814|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
131612495|NCT01961609|473873815|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
131612496|NCT01961609|473873816|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
131612497|NCT01961609|473873813|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
131612498|NCT01961609|473873814|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
131612499|NCT01961609|473873815|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
131612500|NCT01961609|473873816|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
131612501|NCT01961609|473873813|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
131612502|NCT01961609|473873814|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
131612503|NCT01961609|473873815|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
131612504|NCT01961609|473873816|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
131612505|NCT01961609|473873813|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
131612506|NCT01961609|473873814|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
131612507|NCT01961609|473873815|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
131612508|NCT01961609|473873816|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
131612509|NCT01961609|473873813|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
131612510|NCT01961609|473873814|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
131612511|NCT01961609|473873815|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
131612512|NCT01961609|473873816|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
131612513|NCT01961609|473873813|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
131612514|NCT01961609|473873814|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
131612515|NCT01961609|473873815|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
131612516|NCT01961609|473873816|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
131612517|NCT01961609|473873813|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
131612518|NCT01961609|473873814|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
131612519|NCT01961609|473873815|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
131612520|NCT01961609|473873816|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
131708406|NCT00787787|474211392|FG000|Overall Study|Lack of Efficacy|4|||
131708407|NCT00787787|474211392|FG000|Overall Study|Adverse Event|3|||
131708408|NCT02116621|474211394|FG000|Baseline|Withdrawal by Subject|0|||
131708409|NCT02116621|474211395|FG001|Baseline|Withdrawal by Subject|4|||
131441884|NCT02718898|473247224|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
131441885|NCT02718898|473247225|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
131441886|NCT02718898|473247226|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
131441887|NCT02718898|473247227|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
131441888|NCT02718898|473247228|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
131441889|NCT02718898|473247229|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
131441890|NCT02718898|473247230|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
131708410|NCT02116621|474211394|FG000|Three Month Follow-up|Death|1|||
131708411|NCT02116621|474211395|FG001|Three Month Follow-up|Death|1|||
131794134|NCT00818623|474528744|FG006|Overall Study|Adverse Event|0|||
131441891|NCT02718898|473247224|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
131708412|NCT02116621|474211394|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
131612521|NCT01961609|473873813|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
131612522|NCT01961609|473873814|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
131612523|NCT01961609|473873815|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
131612524|NCT01961609|473873816|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
131900108|NCT02329327|474919472|FG000|Overall Study|Withdrawal by Subject|3|||
131900109|NCT02329327|474919473|FG001|Overall Study|Withdrawal by Subject|0|||
131900110|NCT02329327|474919472|FG000|Overall Study|Lost to Follow-up|4|||
131900111|NCT02329327|474919473|FG001|Overall Study|Lost to Follow-up|0|||
131900112|NCT01801111|474919474|FG000|Overall Study|Adverse Event|12|||
131900113|NCT01801111|474919474|FG000|Overall Study|Death|8|||
131900114|NCT01801111|474919474|FG000|Overall Study|Physician Decision|5|||
131900115|NCT01801111|474919474|FG000|Overall Study|Other|1|||
131900116|NCT01801111|474919474|FG000|Overall Study|Withdrawal by Subject|4|||
131900117|NCT01801111|474919474|FG000|Overall Study|Study Terminated by Sponsor|27|||
131900118|NCT01801111|474919474|FG000|Overall Study|Progressive Disease|81|||
131900119|NCT01210482|474919475|FG000|Overall Study|Protocol Violation|1|||
131900120|NCT01210482|474919475|FG000|Overall Study|Case Report Forms were not collected|18|||
131900121|NCT01210482|474919475|FG000|Overall Study|Duplicated|2|||
131900122|NCT01210482|474919475|FG000|Overall Study|No Drug Administration|28|||
131900123|NCT05176717|474919476|FG000|Overall Study|Sponsor Decision|1|||
131900124|NCT05176717|474919477|FG001|Overall Study|Sponsor Decision|2|||
131900125|NCT05176717|474919478|FG002|Overall Study|Sponsor Decision|2|||
131612525|NCT01961609|473873813|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
131612526|NCT01961609|473873814|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
131612527|NCT01961609|473873815|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
131612528|NCT01961609|473873816|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
131612529|NCT01961609|473873813|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
131900126|NCT03284853|474919479|FG000|Overall Study|Adverse Event|40|||
131900127|NCT03284853|474919480|FG001|Overall Study|Adverse Event|4|||
131900128|NCT03284853|474919479|FG000|Overall Study|Withdrawal by Subject|5|||
131900129|NCT03284853|474919480|FG001|Overall Study|Withdrawal by Subject|1|||
131900130|NCT03284853|474919479|FG000|Overall Study|Lost to Follow-up|1|||
131794135|NCT00818623|474528745|FG007|Overall Study|Adverse Event|0|||
131794136|NCT00818623|474528738|FG000|Overall Study|Bad prostate specific antigen response|0|||
131794137|NCT00818623|474528739|FG001|Overall Study|Bad prostate specific antigen response|3|||
131794138|NCT00818623|474528740|FG002|Overall Study|Bad prostate specific antigen response|2|||
131794139|NCT00818623|474528741|FG003|Overall Study|Bad prostate specific antigen response|5|||
131794140|NCT00818623|474528742|FG004|Overall Study|Bad prostate specific antigen response|0|||
131794141|NCT00818623|474528743|FG005|Overall Study|Bad prostate specific antigen response|1|||
131794142|NCT00818623|474528744|FG006|Overall Study|Bad prostate specific antigen response|0|||
131794143|NCT00818623|474528745|FG007|Overall Study|Bad prostate specific antigen response|0|||
131794144|NCT00818623|474528738|FG000|Overall Study|Withdrawal by Subject|0|||
131794145|NCT00818623|474528739|FG001|Overall Study|Withdrawal by Subject|1|||
131794146|NCT00818623|474528740|FG002|Overall Study|Withdrawal by Subject|1|||
131794147|NCT00818623|474528741|FG003|Overall Study|Withdrawal by Subject|0|||
131794148|NCT00818623|474528742|FG004|Overall Study|Withdrawal by Subject|0|||
131794149|NCT00818623|474528743|FG005|Overall Study|Withdrawal by Subject|1|||
131794150|NCT00818623|474528744|FG006|Overall Study|Withdrawal by Subject|1|||
131794151|NCT00818623|474528745|FG007|Overall Study|Withdrawal by Subject|1|||
131794152|NCT00818623|474528738|FG000|Overall Study|Protocol Violation|1|||
131794153|NCT00818623|474528739|FG001|Overall Study|Protocol Violation|0|||
131794154|NCT00818623|474528740|FG002|Overall Study|Protocol Violation|0|||
131794155|NCT00818623|474528741|FG003|Overall Study|Protocol Violation|0|||
131794156|NCT00818623|474528742|FG004|Overall Study|Protocol Violation|1|||
131794157|NCT00818623|474528743|FG005|Overall Study|Protocol Violation|0|||
131794158|NCT00818623|474528744|FG006|Overall Study|Protocol Violation|1|||
131794159|NCT00818623|474528745|FG007|Overall Study|Protocol Violation|0|||
131794160|NCT00818623|474528738|FG000|Overall Study|Need of additional treatment|0|||
131794161|NCT00818623|474528739|FG001|Overall Study|Need of additional treatment|0|||
131794162|NCT00818623|474528740|FG002|Overall Study|Need of additional treatment|0|||
131794163|NCT00818623|474528741|FG003|Overall Study|Need of additional treatment|0|||
131794164|NCT00818623|474528742|FG004|Overall Study|Need of additional treatment|1|||
131794165|NCT00818623|474528743|FG005|Overall Study|Need of additional treatment|0|||
131794166|NCT00818623|474528744|FG006|Overall Study|Need of additional treatment|0|||
131794167|NCT00818623|474528745|FG007|Overall Study|Need of additional treatment|0|||
131794168|NCT00818623|474528738|FG000|Overall Study|Lack of trial drug at site|0|||
131794169|NCT00818623|474528739|FG001|Overall Study|Lack of trial drug at site|0|||
131794170|NCT00818623|474528740|FG002|Overall Study|Lack of trial drug at site|0|||
131794171|NCT00818623|474528741|FG003|Overall Study|Lack of trial drug at site|0|||
131794172|NCT00818623|474528742|FG004|Overall Study|Lack of trial drug at site|2|||
131794173|NCT00818623|474528743|FG005|Overall Study|Lack of trial drug at site|0|||
131794174|NCT00818623|474528744|FG006|Overall Study|Lack of trial drug at site|1|||
131794175|NCT00818623|474528745|FG007|Overall Study|Lack of trial drug at site|0|||
131794176|NCT00818623|474528738|FG000|Overall Study|Disease progression|0|||
131794177|NCT00818623|474528739|FG001|Overall Study|Disease progression|0|||
131794178|NCT00818623|474528740|FG002|Overall Study|Disease progression|0|||
131794179|NCT00818623|474528741|FG003|Overall Study|Disease progression|0|||
131794180|NCT00818623|474528742|FG004|Overall Study|Disease progression|0|||
131794181|NCT00818623|474528743|FG005|Overall Study|Disease progression|0|||
131794182|NCT00818623|474528744|FG006|Overall Study|Disease progression|1|||
131794183|NCT00818623|474528745|FG007|Overall Study|Disease progression|0|||
131900131|NCT03284853|474919480|FG001|Overall Study|Lost to Follow-up|0|||
131900132|NCT03284853|474919479|FG000|Overall Study|Lack of Efficacy|1|||
131900133|NCT03284853|474919480|FG001|Overall Study|Lack of Efficacy|0|||
131612530|NCT01961609|473873814|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
131612531|NCT01961609|473873815|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
131612532|NCT01961609|473873816|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
131794184|NCT00602030|474528746|FG000|Lead-in Phase|Disease Progression|2|||
131794185|NCT00602030|474528747|FG001|Lead-in Phase|Disease Progression|3|||
131794186|NCT00602030|474528748|FG002|Lead-in Phase|Disease Progression|0|||
131794187|NCT00602030|474528749|FG003|Lead-in Phase|Disease Progression|0|||
131794188|NCT00602030|474528750|FG004|Lead-in Phase|Disease Progression|0|||
131794189|NCT00602030|474528746|FG000|Lead-in Phase|Adverse Event|0|||
131794190|NCT00602030|474528747|FG001|Lead-in Phase|Adverse Event|2|||
131794191|NCT00602030|474528748|FG002|Lead-in Phase|Adverse Event|0|||
131794192|NCT00602030|474528749|FG003|Lead-in Phase|Adverse Event|0|||
131441892|NCT02718898|473247225|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
131441893|NCT02718898|473247226|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
131441894|NCT02718898|473247227|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
131441895|NCT02718898|473247228|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
131441896|NCT02718898|473247229|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
131441897|NCT02718898|473247230|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
131441898|NCT02718898|473247224|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131441899|NCT02718898|473247225|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131441900|NCT02718898|473247226|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131441901|NCT02718898|473247227|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131441902|NCT02718898|473247228|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131441903|NCT02718898|473247229|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
131441904|NCT02718898|473247230|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
131612533|NCT01988402|473873817|FG000|Overall Study|Adverse Event|1|||
131612534|NCT01988402|473873818|FG001|Overall Study|Adverse Event|2|||
131612535|NCT01988402|473873817|FG000|Overall Study|Withdrawal by Subject|1|||
131612536|NCT01988402|473873818|FG001|Overall Study|Withdrawal by Subject|0|||
131612537|NCT01211184|473873822|FG000|Overall Study|Withdrawal by Subject|0|||
131612538|NCT01211184|473873823|FG001|Overall Study|Withdrawal by Subject|2|||
131612539|NCT01211184|473873824|FG002|Overall Study|Withdrawal by Subject|1|||
131612540|NCT04060212|473873825|FG000|Overall Study|Withdrawal by Subject|7|||
131612541|NCT03170648|473873828|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
131612542|NCT03170648|473873828|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
131612543|NCT03509909|473873829|FG000|Overall Study|Withdrawal by Subject|16|||
131612544|NCT03509909|473873830|FG001|Overall Study|Withdrawal by Subject|9|||
131612545|NCT03509909|473873829|FG000|Overall Study|Lost to Follow-up|3|||
131612546|NCT03509909|473873830|FG001|Overall Study|Lost to Follow-up|4|||
131612547|NCT03509909|473873829|FG000|Overall Study|Adverse Event|2|||
131612548|NCT03509909|473873830|FG001|Overall Study|Adverse Event|0|||
131612549|NCT03500549|473873831|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
131612550|NCT03500549|473873832|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
131612551|NCT03500549|473873831|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
131612552|NCT03500549|473873832|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
131612553|NCT02107261|473873833|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
131612554|NCT02107261|473873834|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
131612555|NCT02107261|473873833|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
131612556|NCT02107261|473873834|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
131612557|NCT03222609|473873835|FG000|Overall Study|Withdrew consent|2|||
131612558|NCT03222609|473873836|FG001|Overall Study|Withdrew consent|3|||
131612559|NCT03222609|473873837|FG002|Overall Study|Withdrew consent|4|||
131612560|NCT03222609|473873838|FG003|Overall Study|Withdrew consent|2|||
131612561|NCT03222609|473873835|FG000|Overall Study|Lost to Follow-up|1|||
131612562|NCT03222609|473873836|FG001|Overall Study|Lost to Follow-up|0|||
131612563|NCT03222609|473873837|FG002|Overall Study|Lost to Follow-up|0|||
131612564|NCT03222609|473873838|FG003|Overall Study|Lost to Follow-up|0|||
131612565|NCT03222609|473873835|FG000|Overall Study|Death|16|||
131612566|NCT03222609|473873836|FG001|Overall Study|Death|13|||
131612567|NCT03222609|473873837|FG002|Overall Study|Death|9|||
131612568|NCT03222609|473873838|FG003|Overall Study|Death|6|||
131794193|NCT00602030|474528750|FG004|Lead-in Phase|Adverse Event|0|||
131794194|NCT00602030|474528746|FG000|Double-blind Phase|Disease progression|0|||
131794195|NCT00602030|474528747|FG001|Double-blind Phase|Disease progression|0|||
131794196|NCT00602030|474528748|FG002|Double-blind Phase|Disease progression|33|||
131794197|NCT00602030|474528749|FG003|Double-blind Phase|Disease progression|30|||
131794198|NCT00602030|474528750|FG004|Double-blind Phase|Disease progression|0|||
131794199|NCT00602030|474528746|FG000|Double-blind Phase|Adverse Event|0|||
131794200|NCT00602030|474528747|FG001|Double-blind Phase|Adverse Event|0|||
131794201|NCT00602030|474528748|FG002|Double-blind Phase|Adverse Event|9|||
131794202|NCT00602030|474528749|FG003|Double-blind Phase|Adverse Event|18|||
131794203|NCT00602030|474528750|FG004|Double-blind Phase|Adverse Event|0|||
131794204|NCT00602030|474528746|FG000|Double-blind Phase|Consent withdrawal|0|||
131794205|NCT00602030|474528747|FG001|Double-blind Phase|Consent withdrawal|0|||
131794206|NCT00602030|474528748|FG002|Double-blind Phase|Consent withdrawal|4|||
131794207|NCT00602030|474528749|FG003|Double-blind Phase|Consent withdrawal|3|||
131794208|NCT00602030|474528750|FG004|Double-blind Phase|Consent withdrawal|0|||
131794209|NCT00602030|474528746|FG000|Double-blind Phase|Death|0|||
131794210|NCT00602030|474528747|FG001|Double-blind Phase|Death|0|||
131794211|NCT00602030|474528748|FG002|Double-blind Phase|Death|3|||
131794212|NCT00602030|474528749|FG003|Double-blind Phase|Death|3|||
131794213|NCT00602030|474528750|FG004|Double-blind Phase|Death|0|||
131794214|NCT00602030|474528746|FG000|Double-blind Phase|Administrative decision|0|||
131794215|NCT00602030|474528747|FG001|Double-blind Phase|Administrative decision|0|||
131794216|NCT00602030|474528748|FG002|Double-blind Phase|Administrative decision|0|||
131794217|NCT00602030|474528749|FG003|Double-blind Phase|Administrative decision|2|||
131794218|NCT00602030|474528750|FG004|Double-blind Phase|Administrative decision|0|||
131794219|NCT00602030|474528746|FG000|Double-blind Phase|Ineligibility|0|||
131794220|NCT00602030|474528747|FG001|Double-blind Phase|Ineligibility|0|||
131794221|NCT00602030|474528748|FG002|Double-blind Phase|Ineligibility|0|||
131794222|NCT00602030|474528749|FG003|Double-blind Phase|Ineligibility|1|||
131794223|NCT00602030|474528750|FG004|Double-blind Phase|Ineligibility|0|||
131794224|NCT00602030|474528746|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
131794225|NCT00602030|474528747|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
131794226|NCT00602030|474528748|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
131708413|NCT02116621|474211395|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
131708414|NCT02116621|474211394|FG000|Three Month Follow-up|Lost to Follow-up|0|||
131708415|NCT02116621|474211395|FG001|Three Month Follow-up|Lost to Follow-up|1|||
131708416|NCT02116621|474211394|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
131708417|NCT02116621|474211395|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
131708418|NCT02116621|474211394|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
131708419|NCT02116621|474211395|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
131441905|NCT04484961|473247231|FG000|Overall Study|Lost to Follow-up|9|||
131708420|NCT02116621|474211394|FG000|Six Month Follow-up|Lost to Follow-up|2|||
131612569|NCT03222609|473873835|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
131900134|NCT03284853|474919479|FG000|Overall Study|Disallowed Concurrent Medication|1|||
131794227|NCT00602030|474528749|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
131794228|NCT00602030|474528750|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
131441906|NCT04484961|473247232|FG001|Overall Study|Lost to Follow-up|9|||
131441907|NCT01667900|473247233|FG000|Part B|Death|0|||
131441908|NCT01667900|473247234|FG001|Part B|Death|0|||
131441909|NCT01667900|473247235|FG002|Part B|Death|0|||
131441910|NCT01667900|473247236|FG003|Part B|Death|0|||
131441911|NCT01667900|473247237|FG004|Part B|Death|0|||
131441912|NCT01667900|473247238|FG005|Part B|Death|0|||
131441913|NCT01667900|473247239|FG006|Part B|Death|0|||
131441914|NCT01667900|473247240|FG007|Part B|Death|0|||
131441915|NCT01667900|473247241|FG008|Part B|Death|0|||
131441916|NCT01667900|473247242|FG009|Part B|Death|0|||
131441917|NCT01667900|473247243|FG010|Part B|Death|0|||
131441918|NCT01667900|473247244|FG011|Part B|Death|0|||
131441919|NCT01667900|473247245|FG012|Part B|Death|0|||
131441920|NCT01667900|473247246|FG013|Part B|Death|0|||
131441921|NCT01667900|473247247|FG014|Part B|Death|0|||
131441922|NCT01667900|473247248|FG015|Part B|Death|0|||
131441923|NCT01667900|473247249|FG016|Part B|Death|1|||
131441924|NCT01667900|473247250|FG017|Part B|Death|0|||
131441925|NCT01667900|473247251|FG018|Part B|Death|0|||
131441926|NCT01667900|473247252|FG019|Part B|Death|0|||
131441927|NCT01339832|473247256|FG000|Overall Study|Lost to Follow-up|3|||
131441928|NCT01339832|473247256|FG000|Overall Study|Death|11|||
131441929|NCT00468169|473247257|FG000|Overall Study|Withdrawal by Subject|1|||
131441930|NCT00468169|473247258|FG001|Overall Study|Withdrawal by Subject|0|||
131441931|NCT00231816|473247259|FG000|Overall Study|Adverse Event|1|||
131441932|NCT00231816|473247260|FG001|Overall Study|Adverse Event|0|||
131441933|NCT00231816|473247259|FG000|Overall Study|Lost to Follow-up|8|||
131441934|NCT00231816|473247260|FG001|Overall Study|Lost to Follow-up|5|||
131441935|NCT00231816|473247259|FG000|Overall Study|Protocol Violation|2|||
131441936|NCT00231816|473247260|FG001|Overall Study|Protocol Violation|3|||
131441937|NCT00231816|473247259|FG000|Overall Study|Withdrawal by Subject|3|||
131441938|NCT00231816|473247260|FG001|Overall Study|Withdrawal by Subject|3|||
131441939|NCT00231816|473247259|FG000|Overall Study|Other|2|||
131441940|NCT00231816|473247260|FG001|Overall Study|Other|1|||
131441941|NCT01614249|473247268|FG000|Overall Study|Lost to Follow-up|11|||
131441942|NCT01614249|473247269|FG001|Overall Study|Lost to Follow-up|23|||
131441943|NCT05498649|473247270|FG000|Overall Study|Lost to Follow-up|1|||
131441944|NCT02946580|473247271|FG000|Overall Study|Withdrawal by Subject|1|||
131441945|NCT02946580|473247272|FG001|Overall Study|Withdrawal by Subject|2|||
131441946|NCT02946580|473247271|FG000|Overall Study|Adverse Event|0|||
131441947|NCT02946580|473247272|FG001|Overall Study|Adverse Event|2|||
131441948|NCT02946580|473247271|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
131441949|NCT02946580|473247272|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
131441950|NCT02761330|473247273|FG000|Treatment Week 1|Withdrawal by Subject|0|||
131441951|NCT02761330|473247274|FG001|Treatment Week 1|Withdrawal by Subject|0|||
131441952|NCT02761330|473247275|FG002|Treatment Week 1|Withdrawal by Subject|0|||
131441953|NCT02761330|473247276|FG003|Treatment Week 1|Withdrawal by Subject|1|||
131441954|NCT02761330|473247277|FG004|Treatment Week 1|Withdrawal by Subject|0|||
131441955|NCT02761330|473247278|FG005|Treatment Week 1|Withdrawal by Subject|1|||
131441956|NCT03043313|473247281|FG000|Overall Study|Withdrawal by Subject|5|||
131441957|NCT03043313|473247282|FG001|Overall Study|Withdrawal by Subject|1|||
131441958|NCT03043313|473247283|FG002|Overall Study|Withdrawal by Subject|1|||
131441959|NCT03043313|473247281|FG000|Overall Study|Lost to Follow-up|1|||
131441960|NCT03043313|473247282|FG001|Overall Study|Lost to Follow-up|1|||
131441961|NCT03043313|473247283|FG002|Overall Study|Lost to Follow-up|0|||
131441962|NCT03043313|473247281|FG000|Overall Study|Death|28|||
131441963|NCT03043313|473247282|FG001|Overall Study|Death|26|||
131441964|NCT03043313|473247283|FG002|Overall Study|Death|17|||
131441965|NCT03043313|473247281|FG000|Overall Study|Participation terminated by sponsor|11|||
131441966|NCT03043313|473247282|FG001|Overall Study|Participation terminated by sponsor|13|||
131441967|NCT03043313|473247283|FG002|Overall Study|Participation terminated by sponsor|13|||
131441968|NCT02657889|473247284|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
131441969|NCT02657889|473247285|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
131441970|NCT02657889|473247286|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
131441971|NCT02657889|473247287|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
131441972|NCT02657889|473247284|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
131441973|NCT02657889|473247285|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
131441974|NCT02657889|473247286|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
131441975|NCT02657889|473247287|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
131441976|NCT02657889|473247284|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
131441977|NCT02657889|473247285|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
131441978|NCT02657889|473247286|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
131441979|NCT02657889|473247287|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
131441980|NCT02657889|473247284|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
131441981|NCT02657889|473247285|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
131441982|NCT02657889|473247286|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
131441983|NCT02657889|473247287|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
131804444|NCT02178722|474568529|FG000|Overall Study|Death|2|||
131794229|NCT00602030|474528746|FG000|Double-blind Phase|Reason not specified|0|||
131794230|NCT00602030|474528747|FG001|Double-blind Phase|Reason not specified|0|||
131794231|NCT00602030|474528748|FG002|Double-blind Phase|Reason not specified|4|||
131794232|NCT00602030|474528749|FG003|Double-blind Phase|Reason not specified|2|||
131794233|NCT00602030|474528750|FG004|Double-blind Phase|Reason not specified|0|||
131794234|NCT00602030|474528746|FG000|Crossover Phase|Disease Progression|0|||
131794235|NCT00602030|474528747|FG001|Crossover Phase|Disease Progression|0|||
131794236|NCT00602030|474528748|FG002|Crossover Phase|Disease Progression|0|||
131794237|NCT00602030|474528749|FG003|Crossover Phase|Disease Progression|0|||
131794238|NCT00602030|474528750|FG004|Crossover Phase|Disease Progression|11|||
131794239|NCT00602030|474528746|FG000|Crossover Phase|Adverse Event|0|||
131794240|NCT00602030|474528747|FG001|Crossover Phase|Adverse Event|0|||
131794241|NCT00602030|474528748|FG002|Crossover Phase|Adverse Event|0|||
131794242|NCT00602030|474528749|FG003|Crossover Phase|Adverse Event|0|||
131794243|NCT00602030|474528750|FG004|Crossover Phase|Adverse Event|3|||
131794244|NCT00602030|474528746|FG000|Crossover Phase|Consent withdrawal|0|||
131794245|NCT00602030|474528747|FG001|Crossover Phase|Consent withdrawal|0|||
131794246|NCT00602030|474528748|FG002|Crossover Phase|Consent withdrawal|0|||
131794247|NCT00602030|474528749|FG003|Crossover Phase|Consent withdrawal|0|||
131794248|NCT00602030|474528750|FG004|Crossover Phase|Consent withdrawal|2|||
131794249|NCT01851590|474528757|FG000|Overall Study|Withdrawal by Subject|0|||
131794250|NCT01851590|474528758|FG001|Overall Study|Withdrawal by Subject|0|||
131794251|NCT01851590|474528759|FG002|Overall Study|Withdrawal by Subject|1|||
131794252|NCT01851590|474528757|FG000|Overall Study|Adverse Event|0|||
131794253|NCT01851590|474528758|FG001|Overall Study|Adverse Event|0|||
131794254|NCT01851590|474528759|FG002|Overall Study|Adverse Event|2|||
131794255|NCT01851590|474528757|FG000|Overall Study|Lack of Efficacy|0|||
131794256|NCT01851590|474528758|FG001|Overall Study|Lack of Efficacy|1|||
131794257|NCT01851590|474528759|FG002|Overall Study|Lack of Efficacy|0|||
131794258|NCT00310856|474528762|FG000|Overall Study|Withdrawal by Subject|2|||
131794259|NCT00310856|474528763|FG001|Overall Study|Withdrawal by Subject|2|||
131794260|NCT00310856|474528764|FG002|Overall Study|Withdrawal by Subject|2|||
131794261|NCT00310856|474528762|FG000|Overall Study|Lost to Follow-up|1|||
131794262|NCT00310856|474528763|FG001|Overall Study|Lost to Follow-up|2|||
131794263|NCT00310856|474528764|FG002|Overall Study|Lost to Follow-up|6|||
131794264|NCT00310856|474528762|FG000|Overall Study|Inappropriate enrollment|1|||
131794265|NCT00310856|474528763|FG001|Overall Study|Inappropriate enrollment|1|||
131794266|NCT00310856|474528764|FG002|Overall Study|Inappropriate enrollment|0|||
131794267|NCT00310856|474528762|FG000|Overall Study|Unable to classify|1|||
131794268|NCT00310856|474528763|FG001|Overall Study|Unable to classify|0|||
131794269|NCT00310856|474528764|FG002|Overall Study|Unable to classify|0|||
131794270|NCT02611752|474528765|FG000|Overall Study|Adverse Event|0|||
131794271|NCT02611752|474528766|FG001|Overall Study|Adverse Event|1|||
131794272|NCT00947856|474528768|FG000|Treatment Period|Progressive Disease|33|||
131794273|NCT00947856|474528769|FG001|Treatment Period|Progressive Disease|12|||
131794274|NCT00947856|474528768|FG000|Treatment Period|Adverse Event|15|||
131794275|NCT00947856|474528769|FG001|Treatment Period|Adverse Event|9|||
131794276|NCT00947856|474528768|FG000|Treatment Period|Physician Decision|14|||
131794277|NCT00947856|474528769|FG001|Treatment Period|Physician Decision|6|||
131708421|NCT02116621|474211395|FG001|Six Month Follow-up|Lost to Follow-up|1|||
131900135|NCT03284853|474919480|FG001|Overall Study|Disallowed Concurrent Medication|1|||
131441984|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
131900136|NCT03284853|474919479|FG000|Overall Study|Protocol Violation|3|||
131900137|NCT03284853|474919480|FG001|Overall Study|Protocol Violation|3|||
131900138|NCT03284853|474919479|FG000|Overall Study|Death|0|||
131900139|NCT03284853|474919480|FG001|Overall Study|Death|1|||
131612570|NCT03222609|473873836|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
131612571|NCT03222609|473873837|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
131612572|NCT03222609|473873838|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
131612573|NCT02415127|473873839|FG000|Overall Study|Adverse Event|1|||
131612574|NCT02415127|473873840|FG001|Overall Study|Adverse Event|0|||
131612575|NCT00545545|473873841|FG000|Overall Study|Progressive Neoplastic Disease|1|||
131612576|NCT00545545|473873842|FG001|Overall Study|Progressive Neoplastic Disease|5|||
131612577|NCT00545545|473873843|FG002|Overall Study|Progressive Neoplastic Disease|0|||
131612578|NCT00545545|473873844|FG003|Overall Study|Progressive Neoplastic Disease|4|||
131612579|NCT00545545|473873845|FG004|Overall Study|Progressive Neoplastic Disease|8|||
131612580|NCT00545545|473873846|FG005|Overall Study|Progressive Neoplastic Disease|7|||
131612581|NCT00545545|473873841|FG000|Overall Study|Withdrawal by Subject|0|||
131612582|NCT00545545|473873842|FG001|Overall Study|Withdrawal by Subject|1|||
131612583|NCT00545545|473873843|FG002|Overall Study|Withdrawal by Subject|0|||
131612584|NCT00545545|473873844|FG003|Overall Study|Withdrawal by Subject|0|||
131794278|NCT00947856|474528768|FG000|Treatment Period|Study Stopped by Sponsor|4|||
131794279|NCT00947856|474528769|FG001|Treatment Period|Study Stopped by Sponsor|4|||
131794280|NCT00947856|474528768|FG000|Treatment Period|Withdrawal by Subject|12|||
131794281|NCT00947856|474528769|FG001|Treatment Period|Withdrawal by Subject|1|||
131794282|NCT00947856|474528768|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
131794283|NCT00947856|474528769|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
131794284|NCT00947856|474528768|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
131794285|NCT00947856|474528769|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
131794286|NCT00947856|474528768|FG000|Follow-up Period|Lost to Follow-up|7|||
131794287|NCT00947856|474528769|FG001|Follow-up Period|Lost to Follow-up|0|||
131794288|NCT00947856|474528768|FG000|Follow-up Period|Patient unavailable for site visits|1|||
131794289|NCT00947856|474528769|FG001|Follow-up Period|Patient unavailable for site visits|0|||
131794290|NCT00947856|474528768|FG000|Follow-up Period|Withdrawal by Subject|1|||
131794291|NCT00947856|474528769|FG001|Follow-up Period|Withdrawal by Subject|0|||
131794292|NCT00543439|474528770|FG000|Period 1|Adverse Event|0|||
131900140|NCT03284853|474919479|FG000|Overall Study|Other - Reason not reported in CSR|4|||
131900141|NCT03284853|474919480|FG001|Overall Study|Other - Reason not reported in CSR|3|||
131900142|NCT02308228|474919481|FG000|Overall Study|Adverse Event|3|||
131900143|NCT02308228|474919482|FG001|Overall Study|Adverse Event|4|||
131900144|NCT02308228|474919481|FG000|Overall Study|Withdrawal by Subject|5|||
131900145|NCT02308228|474919482|FG001|Overall Study|Withdrawal by Subject|3|||
131900146|NCT02581488|474921410|FG000|Overall Study|Adverse Event|6|||
131900147|NCT02581488|474921411|FG001|Overall Study|Adverse Event|7|||
131900148|NCT02581488|474921410|FG000|Overall Study|Lost to Follow-up|1|||
131900149|NCT02581488|474921411|FG001|Overall Study|Lost to Follow-up|0|||
131900150|NCT02581488|474921410|FG000|Overall Study|Withdrawal by Subject|1|||
131900151|NCT02581488|474921411|FG001|Overall Study|Withdrawal by Subject|0|||
131900152|NCT02581488|474921410|FG000|Overall Study|Non-Compliance|1|||
131900153|NCT02581488|474921411|FG001|Overall Study|Non-Compliance|0|||
131900154|NCT02581488|474921410|FG000|Overall Study|Protocol Violation|0|||
131900155|NCT02581488|474921411|FG001|Overall Study|Protocol Violation|4|||
131900156|NCT01877668|474921412|FG000|Overall Study|Death|0|||
131900157|NCT01877668|474921413|FG001|Overall Study|Death|0|||
131900158|NCT01877668|474921414|FG002|Overall Study|Death|0|||
131900159|NCT01877668|474921415|FG003|Overall Study|Death|1|||
131900160|NCT01877668|474921416|FG004|Overall Study|Death|0|||
131900161|NCT01877668|474921412|FG000|Overall Study|No longer met study criteria|1|||
131900162|NCT01877668|474921413|FG001|Overall Study|No longer met study criteria|0|||
131900163|NCT01877668|474921414|FG002|Overall Study|No longer met study criteria|1|||
131900164|NCT01877668|474921415|FG003|Overall Study|No longer met study criteria|0|||
131900165|NCT01877668|474921416|FG004|Overall Study|No longer met study criteria|0|||
131900166|NCT01877668|474921412|FG000|Overall Study|Insufficient clinical response|0|||
131900167|NCT01877668|474921413|FG001|Overall Study|Insufficient clinical response|1|||
131900168|NCT01877668|474921414|FG002|Overall Study|Insufficient clinical response|2|||
131900169|NCT01877668|474921415|FG003|Overall Study|Insufficient clinical response|2|||
131900170|NCT01877668|474921416|FG004|Overall Study|Insufficient clinical response|0|||
131900171|NCT01877668|474921412|FG000|Overall Study|Lost to Follow-up|0|||
131900172|NCT01877668|474921413|FG001|Overall Study|Lost to Follow-up|2|||
131900173|NCT01877668|474921414|FG002|Overall Study|Lost to Follow-up|1|||
131900174|NCT01877668|474921415|FG003|Overall Study|Lost to Follow-up|0|||
131900175|NCT01877668|474921416|FG004|Overall Study|Lost to Follow-up|0|||
131900176|NCT01877668|474921412|FG000|Overall Study|Withdrawal by Subject|2|||
131900177|NCT01877668|474921413|FG001|Overall Study|Withdrawal by Subject|0|||
131900178|NCT01877668|474921414|FG002|Overall Study|Withdrawal by Subject|3|||
131900179|NCT01877668|474921415|FG003|Overall Study|Withdrawal by Subject|2|||
131900180|NCT01877668|474921416|FG004|Overall Study|Withdrawal by Subject|2|||
131900181|NCT01877668|474921412|FG000|Overall Study|Other|1|||
131900182|NCT01877668|474921413|FG001|Overall Study|Other|1|||
131900183|NCT01877668|474921414|FG002|Overall Study|Other|1|||
131900184|NCT01877668|474921415|FG003|Overall Study|Other|1|||
131900185|NCT01877668|474921416|FG004|Overall Study|Other|3|||
131900186|NCT01877668|474921412|FG000|Overall Study|Protocol Violation|1|||
131900187|NCT01877668|474921413|FG001|Overall Study|Protocol Violation|1|||
131900188|NCT01877668|474921414|FG002|Overall Study|Protocol Violation|0|||
131900189|NCT01877668|474921415|FG003|Overall Study|Protocol Violation|0|||
131900190|NCT01877668|474921416|FG004|Overall Study|Protocol Violation|3|||
131900191|NCT01877668|474921412|FG000|Overall Study|Adverse event related to study drug|2|||
131900192|NCT01877668|474921413|FG001|Overall Study|Adverse event related to study drug|2|||
131900193|NCT01877668|474921414|FG002|Overall Study|Adverse event related to study drug|2|||
131900194|NCT01877668|474921415|FG003|Overall Study|Adverse event related to study drug|2|||
131441985|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
131900195|NCT01877668|474921416|FG004|Overall Study|Adverse event related to study drug|1|||
131900196|NCT01877668|474921412|FG000|Overall Study|Adverse event unrelated to study drug|4|||
131900197|NCT01877668|474921413|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131900198|NCT01877668|474921414|FG002|Overall Study|Adverse event unrelated to study drug|2|||
131900199|NCT01877668|474921415|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131900200|NCT01877668|474921416|FG004|Overall Study|Adverse event unrelated to study drug|1|||
131900201|NCT00823134|474921420|FG000|Overall Study|Invalid measurement|1|||
131900202|NCT02291029|474921421|FG000|Overall Study|Withdrawal by Subject|0|||
131900203|NCT02291029|474921422|FG001|Overall Study|Withdrawal by Subject|0|||
131900204|NCT02291029|474921423|FG002|Overall Study|Withdrawal by Subject|1|||
131900205|NCT02291029|474921424|FG003|Overall Study|Withdrawal by Subject|0|||
131900206|NCT02291029|474921425|FG004|Overall Study|Withdrawal by Subject|0|||
131900207|NCT02291029|474921426|FG005|Overall Study|Withdrawal by Subject|0|||
131900208|NCT02291029|474921421|FG000|Overall Study|Adverse Event|0|||
131900209|NCT02291029|474921422|FG001|Overall Study|Adverse Event|1|||
131900210|NCT02291029|474921423|FG002|Overall Study|Adverse Event|0|||
131900211|NCT02291029|474921424|FG003|Overall Study|Adverse Event|0|||
131900212|NCT02291029|474921425|FG004|Overall Study|Adverse Event|0|||
131900213|NCT02291029|474921426|FG005|Overall Study|Adverse Event|0|||
131900214|NCT00493012|474921430|FG000|Overall Study|Lost to Follow-up|18|||
131900215|NCT00493012|474921431|FG001|Overall Study|Lost to Follow-up|17|||
131612585|NCT00545545|473873845|FG004|Overall Study|Withdrawal by Subject|0|||
131794293|NCT00543439|474528771|FG001|Period 1|Adverse Event|2|||
131794294|NCT00543439|474528772|FG002|Period 1|Adverse Event|1|||
131794295|NCT00543439|474528770|FG000|Period 1|Withdrawal by Subject|1|||
131794296|NCT00543439|474528771|FG001|Period 1|Withdrawal by Subject|1|||
131794297|NCT00543439|474528772|FG002|Period 1|Withdrawal by Subject|0|||
131794298|NCT00543439|474528770|FG000|Period 1|Physician Decision|0|||
131794299|NCT00543439|474528771|FG001|Period 1|Physician Decision|0|||
131794300|NCT00543439|474528772|FG002|Period 1|Physician Decision|1|||
131794301|NCT00543439|474528770|FG000|Period 2|Protocol Violation|1|||
131794302|NCT00543439|474528771|FG001|Period 2|Protocol Violation|0|||
131794303|NCT00543439|474528772|FG002|Period 2|Protocol Violation|1|||
131794304|NCT00543439|474528770|FG000|Period 2|Adverse Event|0|||
131794305|NCT00543439|474528771|FG001|Period 2|Adverse Event|1|||
131794306|NCT00543439|474528772|FG002|Period 2|Adverse Event|1|||
131794307|NCT01211769|474528773|FG000|Overall Study|Lost to Follow-up|7|||
131794308|NCT01211769|474528774|FG001|Overall Study|Lost to Follow-up|9|||
131794309|NCT01211769|474528775|FG002|Overall Study|Lost to Follow-up|5|||
131441986|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
131900216|NCT02922153|474921432|FG000|Overall Study|Death|8|||
131794310|NCT01211769|474528776|FG003|Overall Study|Lost to Follow-up|9|||
131794311|NCT01211769|474528773|FG000|Overall Study|Physician Decision|2|||
131794312|NCT01211769|474528774|FG001|Overall Study|Physician Decision|0|||
131794313|NCT01211769|474528775|FG002|Overall Study|Physician Decision|2|||
131441987|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
131441988|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
131441989|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
131441990|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
131794314|NCT01211769|474528776|FG003|Overall Study|Physician Decision|1|||
131794315|NCT01211769|474528773|FG000|Overall Study|Adverse Event|0|||
131794316|NCT01211769|474528774|FG001|Overall Study|Adverse Event|1|||
131794317|NCT01211769|474528775|FG002|Overall Study|Adverse Event|1|||
131794318|NCT01211769|474528776|FG003|Overall Study|Adverse Event|1|||
131794319|NCT01214330|474528777|FG000|Overall Study|Withdrawal by Subject|2|||
131794320|NCT01214330|474528777|FG000|Overall Study|Withdrawal by Subject|2|||
131794321|NCT01348542|474528779|FG000|Overall Study|Withdrawal by Subject|3|||
131794322|NCT01348542|474528780|FG001|Overall Study|Withdrawal by Subject|0|||
131794323|NCT03402893|474528781|FG000|Overall Study|Withdrawal by Subject|1|||
131794324|NCT00686036|474528784|FG000|Overall Study|Adverse Event|3|||
131794325|NCT00686036|474528785|FG001|Overall Study|Adverse Event|0|||
131794326|NCT00686036|474528784|FG000|Overall Study|Withdrawal by Subject|3|||
131794327|NCT00686036|474528785|FG001|Overall Study|Withdrawal by Subject|1|||
131794328|NCT00686036|474528784|FG000|Overall Study|Study terminated by AstraZeneca|2|||
131794329|NCT00686036|474528785|FG001|Overall Study|Study terminated by AstraZeneca|1|||
131794330|NCT00686036|474528784|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
131794331|NCT00686036|474528785|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
131612586|NCT00545545|473873846|FG005|Overall Study|Withdrawal by Subject|0|||
131794332|NCT00686036|474528784|FG000|Overall Study|Other reasons not identified|0|||
131794333|NCT00686036|474528785|FG001|Overall Study|Other reasons not identified|4|||
131794334|NCT00926289|474528788|FG000|Overall Study|Adverse Event|9|||
131794335|NCT00926289|474528789|FG001|Overall Study|Adverse Event|11|||
131900217|NCT02922153|474921433|FG001|Overall Study|Death|1|||
131900218|NCT02922153|474921432|FG000|Overall Study|Lost to Follow-up|1|||
131900219|NCT02922153|474921433|FG001|Overall Study|Lost to Follow-up|0|||
131900220|NCT02922153|474921432|FG000|Overall Study|Physician Decision|1|||
131900221|NCT02922153|474921433|FG001|Overall Study|Physician Decision|1|||
131900222|NCT04155463|474921434|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
131900223|NCT04155463|474921435|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
131900224|NCT00130689|474921437|FG000|Overall Study|Progressive Disease|29|||
131900225|NCT00130689|474921437|FG000|Overall Study|Death|1|||
131900226|NCT00130689|474921437|FG000|Overall Study|Clinical Deterioration|4|||
131441991|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
131441992|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
131794336|NCT00926289|474528788|FG000|Overall Study|Protocol Violation|8|||
131794337|NCT00926289|474528789|FG001|Overall Study|Protocol Violation|12|||
131794338|NCT00926289|474528788|FG000|Overall Study|Lost to Follow-up|3|||
131794339|NCT00926289|474528789|FG001|Overall Study|Lost to Follow-up|6|||
131794340|NCT00926289|474528788|FG000|Overall Study|Withdrawal by Subject|4|||
131794341|NCT00926289|474528789|FG001|Overall Study|Withdrawal by Subject|4|||
131794342|NCT00926289|474528788|FG000|Overall Study|Other|1|||
131794343|NCT00926289|474528789|FG001|Overall Study|Other|3|||
131794344|NCT00146770|474528791|FG000|Overall Study|Adverse Event|2|||
131794345|NCT00146770|474528792|FG001|Overall Study|Adverse Event|0|||
131794346|NCT00146770|474528791|FG000|Overall Study|Pregnancy|1|||
131441993|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
131794347|NCT00146770|474528792|FG001|Overall Study|Pregnancy|0|||
131900227|NCT00130689|474921437|FG000|Overall Study|Withdrawal by Subject|3|||
131900228|NCT00130689|474921437|FG000|Overall Study|Ineligible|6|||
131794348|NCT00146770|474528791|FG000|Overall Study|Withdrawal by Subject|2|||
131794349|NCT00146770|474528792|FG001|Overall Study|Withdrawal by Subject|0|||
131794350|NCT01855126|474528796|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
131612587|NCT00545545|473873841|FG000|Overall Study|Physician Decision|1|||
131900229|NCT01178125|474921440|FG000|Overall Study|Lost to Follow-up|397|||
131900230|NCT01178125|474921440|FG000|Overall Study|Adverse Event|244|||
131900231|NCT01178125|474921440|FG000|Overall Study|Withdrawal by Subject|209|||
131900232|NCT01178125|474921440|FG000|Overall Study|Noncompliance|184|||
131900233|NCT01178125|474921440|FG000|Overall Study|Pregnancy|55|||
131900234|NCT01178125|474921440|FG000|Overall Study|Other Reason|39|||
131900235|NCT01178125|474921440|FG000|Overall Study|Sponsor Decision|28|||
131900236|NCT01178125|474921440|FG000|Overall Study|Protocol Violation|17|||
131900237|NCT01178125|474921440|FG000|Overall Study|Investigator Decision|5|||
131900238|NCT02948829|474921441|FG000|Overall Study|Lost to Follow-up|2|||
131900239|NCT02948829|474921441|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
131900240|NCT02948829|474921441|FG000|Overall Study|Pregnancy|1|||
131900241|NCT02948829|474921441|FG000|Overall Study|Other: Reason not Specified|8|||
131900242|NCT01004978|474921442|FG000|Overall Study|Disease progression|31|||
131900243|NCT01004978|474921443|FG001|Overall Study|Disease progression|48|||
131900244|NCT01004978|474921442|FG000|Overall Study|Adverse Event|42|||
131900245|NCT01004978|474921443|FG001|Overall Study|Adverse Event|22|||
131900246|NCT01004978|474921442|FG000|Overall Study|Death|3|||
131900247|NCT01004978|474921443|FG001|Overall Study|Death|2|||
131900248|NCT01004978|474921442|FG000|Overall Study|Withdrawal by Subject|16|||
131900249|NCT01004978|474921443|FG001|Overall Study|Withdrawal by Subject|16|||
131900250|NCT01004978|474921442|FG000|Overall Study|Alternative therapy|4|||
131900251|NCT01004978|474921443|FG001|Overall Study|Alternative therapy|8|||
131900252|NCT01004978|474921442|FG000|Overall Study|Physician Decision|6|||
131900253|NCT01004978|474921443|FG001|Overall Study|Physician Decision|3|||
131900254|NCT01004978|474921442|FG000|Overall Study|Other complicating disease|2|||
131900255|NCT01004978|474921443|FG001|Overall Study|Other complicating disease|2|||
131900256|NCT01004978|474921442|FG000|Overall Study|Protocol Violation|2|||
131900257|NCT01004978|474921443|FG001|Overall Study|Protocol Violation|3|||
131900258|NCT01004978|474921442|FG000|Overall Study|Non-compliance|3|||
131900259|NCT01004978|474921443|FG001|Overall Study|Non-compliance|2|||
131900260|NCT01004978|474921442|FG000|Overall Study|Ineligible|1|||
131900261|NCT01004978|474921443|FG001|Overall Study|Ineligible|0|||
131900262|NCT01004978|474921442|FG000|Overall Study|Unblinded|0|||
131900263|NCT01004978|474921443|FG001|Overall Study|Unblinded|1|||
131900264|NCT01004978|474921442|FG000|Overall Study|Performance status worsening|0|||
131794351|NCT01855126|474528797|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
131794352|NCT01855126|474528796|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
131794353|NCT01855126|474528797|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
131794354|NCT01748890|474528802|FG000|Overall Study|Insufficient recruitment for analysis|4|||
131794355|NCT02669264|474528803|FG000|Overall Study|Death|5|||
131794356|NCT02669264|474528804|FG001|Overall Study|Death|5|||
131794357|NCT02669264|474528805|FG002|Overall Study|Death|3|||
131794358|NCT02669264|474528806|FG003|Overall Study|Death|3|||
131794359|NCT02669264|474528807|FG004|Overall Study|Death|3|||
131794360|NCT02669264|474528808|FG005|Overall Study|Death|6|||
131794361|NCT02669264|474528809|FG006|Overall Study|Death|3|||
131794362|NCT02669264|474528803|FG000|Overall Study|Withdrawal by Subject|0|||
131794363|NCT02669264|474528804|FG001|Overall Study|Withdrawal by Subject|1|||
131794364|NCT02669264|474528805|FG002|Overall Study|Withdrawal by Subject|0|||
131794365|NCT02669264|474528806|FG003|Overall Study|Withdrawal by Subject|0|||
131794366|NCT02669264|474528807|FG004|Overall Study|Withdrawal by Subject|1|||
131794367|NCT02669264|474528808|FG005|Overall Study|Withdrawal by Subject|0|||
131794368|NCT02669264|474528809|FG006|Overall Study|Withdrawal by Subject|0|||
131794369|NCT02669264|474528803|FG000|Overall Study|Lost to Follow-up|0|||
131900265|NCT01004978|474921443|FG001|Overall Study|Performance status worsening|1|||
131900266|NCT01004978|474921442|FG000|Overall Study|Never started treatment|8|||
131794370|NCT02669264|474528804|FG001|Overall Study|Lost to Follow-up|0|||
131794371|NCT02669264|474528805|FG002|Overall Study|Lost to Follow-up|0|||
131794372|NCT02669264|474528806|FG003|Overall Study|Lost to Follow-up|0|||
131794373|NCT02669264|474528807|FG004|Overall Study|Lost to Follow-up|1|||
131900267|NCT01004978|474921443|FG001|Overall Study|Never started treatment|9|||
131900268|NCT00369915|474921444|FG000|Overall Study|expected side effects|2|||
131900269|NCT00369915|474921445|FG001|Overall Study|expected side effects|1|||
131794374|NCT02669264|474528808|FG005|Overall Study|Lost to Follow-up|0|||
131794375|NCT02669264|474528809|FG006|Overall Study|Lost to Follow-up|0|||
131900270|NCT00369915|474921444|FG000|Overall Study|Withdrawal by Subject|4|||
131900271|NCT00369915|474921445|FG001|Overall Study|Withdrawal by Subject|1|||
131900272|NCT00369915|474921444|FG000|Overall Study|W/drawl by investigators|0|||
131794376|NCT02669264|474528803|FG000|Overall Study|Miscellaneous|0|||
131794377|NCT02669264|474528804|FG001|Overall Study|Miscellaneous|0|||
131794378|NCT02669264|474528805|FG002|Overall Study|Miscellaneous|0|||
131794379|NCT02669264|474528806|FG003|Overall Study|Miscellaneous|0|||
131794380|NCT02669264|474528807|FG004|Overall Study|Miscellaneous|0|||
131794381|NCT02669264|474528808|FG005|Overall Study|Miscellaneous|0|||
131794382|NCT02669264|474528809|FG006|Overall Study|Miscellaneous|2|||
131794383|NCT01688037|474528810|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
131794384|NCT01688037|474528811|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
131794385|NCT01688037|474528812|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
131794386|NCT01688037|474528810|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
131794387|NCT01688037|474528811|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
131794388|NCT01688037|474528812|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
131794389|NCT01688037|474528810|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
131794390|NCT01688037|474528811|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
131794391|NCT01688037|474528812|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
131794392|NCT01688037|474528810|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
131794393|NCT01688037|474528811|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
131794394|NCT01688037|474528812|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
131794395|NCT01688037|474528810|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
131794396|NCT01688037|474528811|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
131794397|NCT01688037|474528812|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
131794398|NCT01688037|474528810|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
131794399|NCT01688037|474528811|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
131794400|NCT01688037|474528812|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
131794401|NCT01688037|474528810|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
131794402|NCT01688037|474528811|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
131794403|NCT01688037|474528812|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
131794404|NCT01688037|474528810|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
131794405|NCT01688037|474528811|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
131794406|NCT01688037|474528812|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
131794407|NCT01688037|474528810|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
131794408|NCT01688037|474528811|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
131794409|NCT01688037|474528812|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
131794410|NCT01688037|474528810|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
131794411|NCT01688037|474528811|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
131794412|NCT01688037|474528812|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
131794413|NCT02100956|474528813|FG000|At Least One Week Between Injections|Adverse Event|0|||
131794414|NCT02100956|474528814|FG001|At Least One Week Between Injections|Adverse Event|1|||
131794415|NCT00859469|474528816|FG000|Overall Study|Adverse Event|2|||
131794416|NCT00859469|474528816|FG000|Overall Study|Lack of Efficacy|9|||
131794417|NCT00859469|474528816|FG000|Overall Study|Withdrawal by Subject|1|||
131794418|NCT00859469|474528816|FG000|Overall Study|Death|16|||
131794419|NCT02220907|474528817|FG000|Overall Study|Adverse Event|7|||
131794420|NCT02220907|474528817|FG000|Overall Study|Physician Decision|1|||
131794421|NCT02220907|474528817|FG000|Overall Study|Withdrawal by Subject|2|||
131794422|NCT02220907|474528817|FG000|Overall Study|Conflict with the stopping criteria|1|||
131794423|NCT03740100|474528818|FG000|Overall Study|Adverse Event|1|||
131794424|NCT03740100|474528818|FG000|Overall Study|Death|1|||
131794425|NCT03387059|474528820|FG000|Overall Study|Study termination|5|||
131794426|NCT03387059|474528821|FG001|Overall Study|Study termination|4|||
131794427|NCT01070394|474528822|FG000|Overall Study|Adverse Event|6|||
131794428|NCT01070394|474528822|FG000|Overall Study|Withdrawal by Subject|1|||
131794429|NCT01098240|474528823|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
131794430|NCT01098240|474528824|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
131794431|NCT01098240|474528825|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
131794432|NCT01098240|474528823|FG000|Open-Label Phase|Protocol Violation|4|||
131794433|NCT01098240|474528824|FG001|Open-Label Phase|Protocol Violation|0|||
131794434|NCT01098240|474528825|FG002|Open-Label Phase|Protocol Violation|0|||
131794435|NCT01098240|474528823|FG000|Open-Label Phase|Lost to Follow-up|13|||
131794436|NCT01098240|474528824|FG001|Open-Label Phase|Lost to Follow-up|0|||
131794437|NCT01098240|474528825|FG002|Open-Label Phase|Lost to Follow-up|0|||
131794438|NCT01098240|474528823|FG000|Open-Label Phase|Other|19|||
131794439|NCT01098240|474528824|FG001|Open-Label Phase|Other|0|||
131794440|NCT01098240|474528825|FG002|Open-Label Phase|Other|0|||
131794441|NCT01098240|474528823|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
131794442|NCT01098240|474528824|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
131794443|NCT01098240|474528825|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
131794444|NCT01098240|474528823|FG000|Open-Label Phase|Pregnancy|1|||
131794445|NCT01098240|474528824|FG001|Open-Label Phase|Pregnancy|0|||
131794446|NCT01098240|474528825|FG002|Open-Label Phase|Pregnancy|0|||
131794447|NCT01098240|474528823|FG000|Open-Label Phase|Withdrawal by Subject|9|||
131794448|NCT01098240|474528824|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131794449|NCT01098240|474528825|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131794450|NCT01098240|474528823|FG000|Open-Label Phase|Adverse Event|12|||
131794451|NCT01098240|474528824|FG001|Open-Label Phase|Adverse Event|0|||
131794452|NCT01098240|474528825|FG002|Open-Label Phase|Adverse Event|0|||
131794453|NCT01098240|474528823|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
131794454|NCT01098240|474528824|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
131794455|NCT01098240|474528825|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
131794456|NCT01098240|474528823|FG000|Double-Blind Phase|Protocol Violation|0|||
131794457|NCT01098240|474528824|FG001|Double-Blind Phase|Protocol Violation|2|||
131794458|NCT01098240|474528825|FG002|Double-Blind Phase|Protocol Violation|4|||
131794459|NCT01098240|474528823|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131794460|NCT01098240|474528824|FG001|Double-Blind Phase|Lost to Follow-up|2|||
131794461|NCT01098240|474528825|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131794462|NCT01098240|474528823|FG000|Double-Blind Phase|Other|0|||
131794463|NCT01098240|474528824|FG001|Double-Blind Phase|Other|2|||
131441994|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
131794464|NCT01098240|474528825|FG002|Double-Blind Phase|Other|2|||
131794465|NCT01098240|474528823|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
131794466|NCT01098240|474528824|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
131794467|NCT01098240|474528825|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
131794468|NCT01098240|474528823|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
131794469|NCT01098240|474528824|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
131794470|NCT01098240|474528825|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
131794471|NCT01098240|474528823|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131794472|NCT01098240|474528824|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
131794473|NCT01098240|474528825|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
131794474|NCT01098240|474528823|FG000|Double-Blind Phase|Adverse Event|0|||
131794475|NCT01098240|474528824|FG001|Double-Blind Phase|Adverse Event|3|||
131794476|NCT01098240|474528825|FG002|Double-Blind Phase|Adverse Event|3|||
131794477|NCT03280537|474528826|FG000|Overall Study|Withdrawal by Subject|2|||
131794478|NCT03280537|474528827|FG001|Overall Study|Withdrawal by Subject|4|||
131794479|NCT03083132|474528828|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
131794480|NCT03083132|474528829|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
131794481|NCT03083132|474528828|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
131794482|NCT03083132|474528829|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
131794483|NCT03083132|474528828|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
131794484|NCT03083132|474528829|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
131794485|NCT01588106|474528830|FG000|Overall Study|Withdrawal by Subject|5|||
131794486|NCT01588106|474528831|FG001|Overall Study|Withdrawal by Subject|4|||
131794487|NCT03118739|474528832|FG000|Overall Study|Physician Decision|0|||
131794488|NCT03118739|474528833|FG001|Overall Study|Physician Decision|1|||
131794489|NCT03118739|474528832|FG000|Overall Study|Withdrawal by Subject|5|||
131794490|NCT03118739|474528833|FG001|Overall Study|Withdrawal by Subject|3|||
131794491|NCT03118739|474528832|FG000|Overall Study|Lost to Follow-up|2|||
131794492|NCT03118739|474528833|FG001|Overall Study|Lost to Follow-up|0|||
131794493|NCT00669955|474528834|FG000|Overall Study|Adverse Event|3|||
131794494|NCT00669955|474528835|FG001|Overall Study|Adverse Event|5|||
131794495|NCT00669955|474528834|FG000|Overall Study|Death|0|||
131794496|NCT00669955|474528835|FG001|Overall Study|Death|1|||
131794497|NCT00669955|474528834|FG000|Overall Study|Withdrawal by Subject|2|||
131794498|NCT00669955|474528835|FG001|Overall Study|Withdrawal by Subject|3|||
131794499|NCT00669955|474528834|FG000|Overall Study|Lost to Follow-up|5|||
131794500|NCT00669955|474528835|FG001|Overall Study|Lost to Follow-up|7|||
131794501|NCT00669955|474528834|FG000|Overall Study|Protocol Violation|2|||
131794502|NCT00669955|474528835|FG001|Overall Study|Protocol Violation|7|||
131794503|NCT00669955|474528834|FG000|Overall Study|Investigator Sponsor Judgement|0|||
131794504|NCT00669955|474528835|FG001|Overall Study|Investigator Sponsor Judgement|1|||
131794505|NCT00669955|474528834|FG000|Overall Study|not compliant with study drug/visit|2|||
131794506|NCT00669955|474528835|FG001|Overall Study|not compliant with study drug/visit|3|||
131794507|NCT03507439|474528839|FG000|Overall Study|Other|2|||
131794508|NCT03507439|474528840|FG001|Overall Study|Other|1|||
131794509|NCT03507439|474528839|FG000|Overall Study|Withdrawal by Subject|1|||
131794510|NCT03507439|474528840|FG001|Overall Study|Withdrawal by Subject|0|||
131794511|NCT03507439|474528839|FG000|Overall Study|Death|1|||
131794512|NCT03507439|474528840|FG001|Overall Study|Death|1|||
131794513|NCT04274192|474528841|FG000|Overall Study|Protocol Violation|1|||
131794514|NCT04274192|474528842|FG001|Overall Study|Protocol Violation|0|||
131794515|NCT00094302|474530424|FG000|Overall Study|Lost to Follow-up|43|||
131794516|NCT00094302|474530425|FG001|Overall Study|Lost to Follow-up|41|||
131794517|NCT00094302|474530424|FG000|Overall Study|Physician Decision|5|||
131794518|NCT00094302|474530425|FG001|Overall Study|Physician Decision|8|||
131794519|NCT00094302|474530424|FG000|Overall Study|Withdrawal by Subject|103|||
131794520|NCT00094302|474530425|FG001|Overall Study|Withdrawal by Subject|111|||
131794521|NCT00094302|474530424|FG000|Overall Study|Death|266|||
131794522|NCT00094302|474530425|FG001|Overall Study|Death|246|||
131794523|NCT01162499|474530430|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
131794524|NCT01162499|474530431|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
131794525|NCT01590433|474530432|FG000|Overall Study|Lost to Follow-up|20|||
131794526|NCT01590433|474530433|FG001|Overall Study|Lost to Follow-up|8|||
131794527|NCT01590433|474530432|FG000|Overall Study|Withdrawal by Subject|21|||
131794528|NCT01590433|474530433|FG001|Overall Study|Withdrawal by Subject|11|||
131794529|NCT01590433|474530432|FG000|Overall Study|Adverse Event|11|||
131794530|NCT01590433|474530433|FG001|Overall Study|Adverse Event|3|||
131794531|NCT00555009|474530434|FG000|Overall Study|Withdrawal by Subject|0|||
131794532|NCT00555009|474530435|FG001|Overall Study|Withdrawal by Subject|1|||
131900273|NCT00369915|474921445|FG001|Overall Study|W/drawl by investigators|1|||
131794533|NCT00555009|474530434|FG000|Overall Study|Terminated by Sponsor|2|||
131794534|NCT00555009|474530435|FG001|Overall Study|Terminated by Sponsor|5|||
131794535|NCT02058628|474530436|FG000|Overall Study|Adverse Event|1|||
131794536|NCT02058628|474530437|FG001|Overall Study|Adverse Event|0|||
131794537|NCT02058628|474530436|FG000|Overall Study|Withdrawal by Subject|2|||
131794538|NCT02058628|474530437|FG001|Overall Study|Withdrawal by Subject|2|||
131794539|NCT02058628|474530436|FG000|Overall Study|Lost to Follow-up|2|||
131794540|NCT02058628|474530437|FG001|Overall Study|Lost to Follow-up|4|||
131794541|NCT02058628|474530436|FG000|Overall Study|Not in time schedule|0|||
131794542|NCT02058628|474530437|FG001|Overall Study|Not in time schedule|1|||
131794543|NCT02058628|474530436|FG000|Overall Study|The visit date was not in timeline|0|||
131900274|NCT01447407|474921450|FG000|Overall Study|Withdrawal by Subject|2|||
131794544|NCT02058628|474530437|FG001|Overall Study|The visit date was not in timeline|1|||
131441995|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
131441996|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
131708422|NCT02116621|474211394|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
131441997|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
131708423|NCT02116621|474211395|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
131441998|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
131441999|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
131442000|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
131442001|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
131442002|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
131442003|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
131442004|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
131442005|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
131442006|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
131442007|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
131442008|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
131442009|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
131442010|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
131442011|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
131442012|NCT02657889|473247284|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
131442013|NCT02657889|473247285|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
131442014|NCT02657889|473247286|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
131442015|NCT02657889|473247287|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
131442016|NCT01576341|473247288|FG000|Overall Study|Withdrawal by Subject|24|||
131442017|NCT01576341|473247288|FG000|Overall Study|Adverse Event|10|||
131442018|NCT01576341|473247288|FG000|Overall Study|Death|21|||
131442019|NCT01576341|473247288|FG000|Overall Study|Physician Decision|2|||
131442020|NCT01576341|473247288|FG000|Overall Study|Lost to Follow-up|2|||
131442021|NCT01576341|473247288|FG000|Overall Study|Kidney transplantation|10|||
131442022|NCT01576341|473247288|FG000|Overall Study|Protocol Violation|12|||
131442023|NCT01576341|473247288|FG000|Overall Study|Other|12|||
131442024|NCT00604565|473247296|FG000|Overall Study|Study terminated|0|||
131442025|NCT00604565|473247297|FG001|Overall Study|Study terminated|3|||
131442026|NCT04292535|473247299|FG000|Overall Study|Withdrawal by Subject|0|||
131442027|NCT04292535|473247300|FG001|Overall Study|Withdrawal by Subject|0|||
131442028|NCT04292535|473247301|FG002|Overall Study|Withdrawal by Subject|0|||
131442029|NCT04292535|473247302|FG003|Overall Study|Withdrawal by Subject|0|||
131442030|NCT04292535|473247303|FG004|Overall Study|Withdrawal by Subject|0|||
131442031|NCT04292535|473247304|FG005|Overall Study|Withdrawal by Subject|0|||
131442032|NCT04292535|473247305|FG006|Overall Study|Withdrawal by Subject|0|||
131442033|NCT04292535|473247306|FG007|Overall Study|Withdrawal by Subject|1|||
131442034|NCT04292535|473247307|FG008|Overall Study|Withdrawal by Subject|0|||
131442035|NCT04292535|473247308|FG009|Overall Study|Withdrawal by Subject|0|||
131442036|NCT04292535|473247309|FG010|Overall Study|Withdrawal by Subject|0|||
131442037|NCT04292535|473247310|FG011|Overall Study|Withdrawal by Subject|0|||
131442038|NCT04292535|473247311|FG012|Overall Study|Withdrawal by Subject|0|||
131442039|NCT04292535|473247312|FG013|Overall Study|Withdrawal by Subject|0|||
131442040|NCT04292535|473247299|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442041|NCT04292535|473247300|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442042|NCT04292535|473247301|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442043|NCT04292535|473247302|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442044|NCT04292535|473247303|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442045|NCT04292535|473247304|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442046|NCT04292535|473247305|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442047|NCT04292535|473247306|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
131442048|NCT04292535|473247307|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442049|NCT04292535|473247308|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442050|NCT04292535|473247309|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442051|NCT04292535|473247310|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
131442052|NCT04292535|473247311|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
131442053|NCT04292535|473247312|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
131442054|NCT04292535|473247299|FG000|Overall Study|Report of Dizziness|0|||
131442055|NCT04292535|473247300|FG001|Overall Study|Report of Dizziness|0|||
131442056|NCT04292535|473247301|FG002|Overall Study|Report of Dizziness|0|||
131442057|NCT04292535|473247302|FG003|Overall Study|Report of Dizziness|0|||
131612588|NCT00545545|473873842|FG001|Overall Study|Physician Decision|0|||
131612589|NCT00545545|473873843|FG002|Overall Study|Physician Decision|0|||
131612590|NCT00545545|473873844|FG003|Overall Study|Physician Decision|0|||
131612591|NCT00545545|473873845|FG004|Overall Study|Physician Decision|0|||
131442058|NCT04292535|473247303|FG004|Overall Study|Report of Dizziness|0|||
131442059|NCT04292535|473247304|FG005|Overall Study|Report of Dizziness|0|||
131442060|NCT04292535|473247305|FG006|Overall Study|Report of Dizziness|0|||
131442061|NCT04292535|473247306|FG007|Overall Study|Report of Dizziness|0|||
131442062|NCT04292535|473247307|FG008|Overall Study|Report of Dizziness|0|||
131900275|NCT01447407|474921451|FG001|Overall Study|Withdrawal by Subject|0|||
131900276|NCT01447407|474921452|FG002|Overall Study|Withdrawal by Subject|0|||
131900277|NCT01447407|474921453|FG003|Overall Study|Withdrawal by Subject|1|||
131900278|NCT01447407|474921450|FG000|Overall Study|Physician Decision|0|||
131900279|NCT01447407|474921451|FG001|Overall Study|Physician Decision|0|||
131900280|NCT01447407|474921452|FG002|Overall Study|Physician Decision|1|||
131900281|NCT01447407|474921453|FG003|Overall Study|Physician Decision|1|||
131900282|NCT00249873|474921455|FG000|Overall Study|Not treated|7|||
131900283|NCT00249873|474921456|FG001|Overall Study|Not treated|8|||
131612592|NCT00545545|473873846|FG005|Overall Study|Physician Decision|1|||
131612593|NCT00545545|473873841|FG000|Overall Study|Irinotecan intolerance|1|||
131612594|NCT00545545|473873842|FG001|Overall Study|Irinotecan intolerance|1|||
131900284|NCT00249873|474921455|FG000|Overall Study|Significant thrombocytopenia|9|||
131900285|NCT00249873|474921456|FG001|Overall Study|Significant thrombocytopenia|8|||
131900286|NCT00249873|474921455|FG000|Overall Study|Severe allergic reaction|8|||
131900287|NCT00249873|474921456|FG001|Overall Study|Severe allergic reaction|1|||
131900288|NCT00249873|474921455|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
131900289|NCT00249873|474921456|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
131900290|NCT00249873|474921455|FG000|Overall Study|Other Serious Adverse Event|86|||
131900291|NCT00249873|474921456|FG001|Overall Study|Other Serious Adverse Event|97|||
131900292|NCT00249873|474921455|FG000|Overall Study|Qualifying condition not present|20|||
131900293|NCT00249873|474921456|FG001|Overall Study|Qualifying condition not present|23|||
131900294|NCT00249873|474921455|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
131900295|NCT00249873|474921456|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
131900296|NCT00249873|474921455|FG000|Overall Study|Withdrawal by Subject|504|||
131900297|NCT00249873|474921456|FG001|Overall Study|Withdrawal by Subject|466|||
131900298|NCT00249873|474921455|FG000|Overall Study|Lost to Follow-up|4|||
131900299|NCT00249873|474921456|FG001|Overall Study|Lost to Follow-up|7|||
131900300|NCT00249873|474921455|FG000|Overall Study|Minor bleeding|99|||
131900301|NCT00249873|474921456|FG001|Overall Study|Minor bleeding|37|||
131900302|NCT00249873|474921455|FG000|Overall Study|Non-compliance|41|||
131900303|NCT00249873|474921456|FG001|Overall Study|Non-compliance|46|||
131900304|NCT00249873|474921455|FG000|Overall Study|Other non serious Adverse Event|112|||
131900305|NCT00249873|474921456|FG001|Overall Study|Other non serious Adverse Event|108|||
131900306|NCT00249873|474921455|FG000|Overall Study|Other contraindicated medication|1|||
131442063|NCT04292535|473247308|FG009|Overall Study|Report of Dizziness|0|||
131442064|NCT04292535|473247309|FG010|Overall Study|Report of Dizziness|0|||
131612595|NCT00545545|473873843|FG002|Overall Study|Irinotecan intolerance|0|||
131900307|NCT00249873|474921456|FG001|Overall Study|Other contraindicated medication|0|||
131442065|NCT04292535|473247310|FG011|Overall Study|Report of Dizziness|0|||
131612596|NCT00545545|473873844|FG003|Overall Study|Irinotecan intolerance|0|||
131612597|NCT00545545|473873845|FG004|Overall Study|Irinotecan intolerance|0|||
131612598|NCT00545545|473873846|FG005|Overall Study|Irinotecan intolerance|0|||
131612599|NCT00545545|473873841|FG000|Overall Study|No target lesions to track post surgery|0|||
131612600|NCT00545545|473873842|FG001|Overall Study|No target lesions to track post surgery|0|||
131612601|NCT00545545|473873843|FG002|Overall Study|No target lesions to track post surgery|0|||
131612602|NCT00545545|473873844|FG003|Overall Study|No target lesions to track post surgery|0|||
131612603|NCT00545545|473873845|FG004|Overall Study|No target lesions to track post surgery|1|||
131612604|NCT00545545|473873846|FG005|Overall Study|No target lesions to track post surgery|1|||
131612605|NCT03691493|473873847|FG000|Overall Study|Withdrawal by Subject|1|||
131612606|NCT05630833|473873859|FG000|Overall Study|Adverse Event|3|||
131612607|NCT05630833|473873860|FG001|Overall Study|Adverse Event|0|||
131612608|NCT05630833|473873859|FG000|Overall Study|Lack of Efficacy|0|||
131612609|NCT05630833|473873860|FG001|Overall Study|Lack of Efficacy|1|||
131612610|NCT05630833|473873859|FG000|Overall Study|Lost to Follow-up|1|||
131612611|NCT05630833|473873860|FG001|Overall Study|Lost to Follow-up|0|||
131612612|NCT05630833|473873859|FG000|Overall Study|Withdrawal by Subject|3|||
131612613|NCT05630833|473873860|FG001|Overall Study|Withdrawal by Subject|1|||
131708424|NCT02116621|474211394|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
131612615|NCT00593840|473873865|FG000|Overall Study|Withdrawal by Subject|1|||
131612616|NCT00777049|473874825|FG000|Overall Study|Withdrawal by Subject|1|||
131612617|NCT00777049|473874826|FG001|Overall Study|Withdrawal by Subject|0|||
131612618|NCT00777049|473874825|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
131612619|NCT00777049|473874826|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
131612620|NCT01627561|473874827|FG000|Overall Study|Lost to Follow-up|1|||
131612621|NCT01627561|473874828|FG001|Overall Study|Lost to Follow-up|0|||
131612622|NCT01627561|473874827|FG000|Overall Study|Withdrawal by Subject|0|||
131612623|NCT01627561|473874828|FG001|Overall Study|Withdrawal by Subject|1|||
131708425|NCT02116621|474211395|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
131708426|NCT02116621|474211394|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
131708427|NCT02116621|474211395|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
131708428|NCT02116621|474211394|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
131708429|NCT02116621|474211395|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
131708430|NCT02116621|474211394|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
131708431|NCT02116621|474211395|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
131442066|NCT04292535|473247311|FG012|Overall Study|Report of Dizziness|0|||
131442067|NCT04292535|473247312|FG013|Overall Study|Report of Dizziness|1|||
131442068|NCT04292535|473247299|FG000|Overall Study|Equipment Failure|0|||
131442069|NCT04292535|473247300|FG001|Overall Study|Equipment Failure|0|||
131442070|NCT04292535|473247301|FG002|Overall Study|Equipment Failure|0|||
131442071|NCT04292535|473247302|FG003|Overall Study|Equipment Failure|0|||
131442072|NCT04292535|473247303|FG004|Overall Study|Equipment Failure|0|||
131442073|NCT04292535|473247304|FG005|Overall Study|Equipment Failure|0|||
131442074|NCT04292535|473247305|FG006|Overall Study|Equipment Failure|0|||
131442075|NCT04292535|473247306|FG007|Overall Study|Equipment Failure|0|||
131442076|NCT04292535|473247307|FG008|Overall Study|Equipment Failure|0|||
131442077|NCT04292535|473247308|FG009|Overall Study|Equipment Failure|0|||
131442078|NCT04292535|473247309|FG010|Overall Study|Equipment Failure|0|||
131442079|NCT04292535|473247310|FG011|Overall Study|Equipment Failure|1|||
131442080|NCT04292535|473247311|FG012|Overall Study|Equipment Failure|0|||
131442081|NCT04292535|473247312|FG013|Overall Study|Equipment Failure|0|||
131442082|NCT04528641|473247313|FG000|Overall Study|Withdrawal by Subject|0|||
131442083|NCT04528641|473247314|FG001|Overall Study|Withdrawal by Subject|0|||
131442084|NCT04528641|473247315|FG002|Overall Study|Withdrawal by Subject|0|||
131442085|NCT04528641|473247316|FG003|Overall Study|Withdrawal by Subject|1|||
131442086|NCT04528641|473247317|FG004|Overall Study|Withdrawal by Subject|0|||
131442087|NCT04528641|473247318|FG005|Overall Study|Withdrawal by Subject|1|||
131442088|NCT00517296|473247319|FG000|Overall Study|Withdrawal by Subject|1|||
131442089|NCT00517296|473247320|FG001|Overall Study|Withdrawal by Subject|0|||
131442090|NCT00791934|473247322|FG000|Overall Study|Withdrawal by Subject|2|||
131442091|NCT00791934|473247322|FG000|Overall Study|Did not consent for extended follow-up|13|||
131442092|NCT02018562|473247324|FG000|Overall Study|Withdrawal by Subject|2|||
131442093|NCT02018562|473247325|FG001|Overall Study|Withdrawal by Subject|0|||
131442094|NCT02018562|473247324|FG000|Overall Study|Discharged prior to study completion|1|||
131442095|NCT02018562|473247325|FG001|Overall Study|Discharged prior to study completion|0|||
131442096|NCT03642873|473247327|FG000|Third Intervention (1 Day)|Screen failure|0|||
131442097|NCT03642873|473247328|FG001|Third Intervention (1 Day)|Screen failure|0|||
131442098|NCT03642873|473247329|FG002|Third Intervention (1 Day)|Screen failure|0|||
131442099|NCT03642873|473247330|FG003|Third Intervention (1 Day)|Screen failure|0|||
131442100|NCT03642873|473247331|FG004|Third Intervention (1 Day)|Screen failure|1|||
131442101|NCT03642873|473247332|FG005|Third Intervention (1 Day)|Screen failure|0|||
131442102|NCT04609319|473247333|FG000|Overall Study|Death|64|||
131442103|NCT04609319|473247334|FG001|Overall Study|Death|49|||
131442104|NCT04609319|473247335|FG002|Overall Study|Death|1|||
131442105|NCT04609319|473247333|FG000|Overall Study|Withdrawal of consent|15|||
131442106|NCT04609319|473247334|FG001|Overall Study|Withdrawal of consent|3|||
131442107|NCT04609319|473247335|FG002|Overall Study|Withdrawal of consent|0|||
131442108|NCT04609319|473247333|FG000|Overall Study|Lost to Follow-up|20|||
131442109|NCT04609319|473247334|FG001|Overall Study|Lost to Follow-up|33|||
131442110|NCT04609319|473247335|FG002|Overall Study|Lost to Follow-up|0|||
131442111|NCT04609319|473247333|FG000|Overall Study|Alive until end of follow-up|60|||
131442112|NCT04609319|473247334|FG001|Overall Study|Alive until end of follow-up|53|||
131442113|NCT04609319|473247335|FG002|Overall Study|Alive until end of follow-up|1|||
131442114|NCT01253291|473247336|FG000|Overall Study|Withdrawal by Subject|1|||
131442115|NCT01253291|473247337|FG001|Overall Study|Withdrawal by Subject|1|||
131442116|NCT01253291|473247338|FG002|Overall Study|Withdrawal by Subject|0|||
131442117|NCT01253291|473247339|FG003|Overall Study|Withdrawal by Subject|0|||
131442118|NCT01253291|473247340|FG004|Overall Study|Withdrawal by Subject|0|||
131442119|NCT01253291|473247336|FG000|Overall Study|Adverse Event|0|||
131442120|NCT01253291|473247337|FG001|Overall Study|Adverse Event|1|||
131442121|NCT01253291|473247338|FG002|Overall Study|Adverse Event|0|||
131442122|NCT01253291|473247339|FG003|Overall Study|Adverse Event|0|||
131442123|NCT01253291|473247340|FG004|Overall Study|Adverse Event|0|||
131442124|NCT01253291|473247336|FG000|Overall Study|Lack of Efficacy|1|||
131442125|NCT01253291|473247337|FG001|Overall Study|Lack of Efficacy|0|||
131442126|NCT01253291|473247338|FG002|Overall Study|Lack of Efficacy|0|||
131442127|NCT01253291|473247339|FG003|Overall Study|Lack of Efficacy|0|||
131442128|NCT01253291|473247340|FG004|Overall Study|Lack of Efficacy|0|||
131794545|NCT02058628|474530436|FG000|Overall Study|A lot of time for study for participant|1|||
131794546|NCT02058628|474530437|FG001|Overall Study|A lot of time for study for participant|0|||
131794547|NCT02058628|474530436|FG000|Overall Study|Non compliance|1|||
131794548|NCT02058628|474530437|FG001|Overall Study|Non compliance|0|||
131794549|NCT00832078|474530438|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
131794550|NCT00832078|474530439|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
131442129|NCT01253291|473247336|FG000|Overall Study|Physician Decision|2|||
131442130|NCT01253291|473247337|FG001|Overall Study|Physician Decision|0|||
131442131|NCT01253291|473247338|FG002|Overall Study|Physician Decision|0|||
131794551|NCT00832078|474530438|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
131442132|NCT01253291|473247339|FG003|Overall Study|Physician Decision|0|||
131442133|NCT01253291|473247340|FG004|Overall Study|Physician Decision|2|||
131612624|NCT01627561|473874827|FG000|Overall Study|Migrated/moved from study area|0|||
131442134|NCT00945009|473247348|FG000|Overall Study|Lack of Efficacy|10|||
131442135|NCT00945009|473247349|FG001|Overall Study|Lack of Efficacy|0|||
131442136|NCT00945009|473247350|FG002|Overall Study|Lack of Efficacy|0|||
131442137|NCT00945009|473247348|FG000|Overall Study|Physician Decision|21|||
131442138|NCT00945009|473247349|FG001|Overall Study|Physician Decision|4|||
131442139|NCT00945009|473247350|FG002|Overall Study|Physician Decision|3|||
131442140|NCT00945009|473247348|FG000|Overall Study|Protocol Violation|6|||
131442141|NCT00945009|473247349|FG001|Overall Study|Protocol Violation|1|||
131442142|NCT00945009|473247350|FG002|Overall Study|Protocol Violation|0|||
131442143|NCT00945009|473247348|FG000|Overall Study|Withdrawal by Subject|1|||
131442144|NCT00945009|473247349|FG001|Overall Study|Withdrawal by Subject|0|||
131442145|NCT00945009|473247350|FG002|Overall Study|Withdrawal by Subject|0|||
131442146|NCT00945009|473247348|FG000|Overall Study|Ineligible|6|||
131442147|NCT00945009|473247349|FG001|Overall Study|Ineligible|1|||
131612625|NCT01627561|473874828|FG001|Overall Study|Migrated/moved from study area|2|||
131612626|NCT00890591|473874830|FG000|Overall Study|Lack of Efficacy|20|||
131612627|NCT00739934|473874833|FG000|Voriconazole IV|Adverse Event|6|||
131612628|NCT00739934|473874833|FG000|Voriconazole Oral|Other|3|||
131612629|NCT01579318|473874836|FG000|Overall Study|Disease Progression|1|||
131612630|NCT02347332|473874837|FG000|Overall Study|Not treated|5|||
131612631|NCT02347332|473874838|FG001|Overall Study|Not treated|2|||
131612632|NCT02347332|473874837|FG000|Overall Study|Progressive disease|141|||
131612633|NCT02347332|473874838|FG001|Overall Study|Progressive disease|159|||
131612634|NCT02347332|473874837|FG000|Overall Study|Adverse Event|50|||
131612635|NCT02347332|473874838|FG001|Overall Study|Adverse Event|41|||
131612636|NCT02347332|473874837|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
131612637|NCT02347332|473874838|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
131612638|NCT02347332|473874837|FG000|Overall Study|Protocol Violation|1|||
131612639|NCT02347332|473874838|FG001|Overall Study|Protocol Violation|1|||
131612640|NCT02347332|473874837|FG000|Overall Study|Lost to Follow-up|2|||
131612641|NCT02347332|473874838|FG001|Overall Study|Lost to Follow-up|1|||
131612642|NCT02347332|473874837|FG000|Overall Study|Physician Decision|4|||
131612643|NCT02347332|473874838|FG001|Overall Study|Physician Decision|3|||
131612644|NCT02347332|473874837|FG000|Overall Study|Withdrawal by Subject|20|||
131612645|NCT02347332|473874838|FG001|Overall Study|Withdrawal by Subject|14|||
131612646|NCT02347332|473874837|FG000|Overall Study|Protocol requirement|1|||
131612647|NCT02347332|473874838|FG001|Overall Study|Protocol requirement|1|||
131612648|NCT02347332|473874837|FG000|Overall Study|Switch Post-Trial program|0|||
131612649|NCT02347332|473874838|FG001|Overall Study|Switch Post-Trial program|1|||
131612650|NCT02502526|473874839|FG000|Overall Study|Lost to Follow-up|2|||
131612651|NCT02502526|473874840|FG001|Overall Study|Lost to Follow-up|2|||
131612652|NCT02502526|473874841|FG002|Overall Study|Lost to Follow-up|3|||
131612653|NCT02502526|473874839|FG000|Overall Study|Withdrawal by Subject|0|||
131612654|NCT02502526|473874840|FG001|Overall Study|Withdrawal by Subject|1|||
131612655|NCT02502526|473874841|FG002|Overall Study|Withdrawal by Subject|1|||
131612656|NCT02502526|473874839|FG000|Overall Study|Disqualified due to cataract grading|0|||
131612657|NCT02502526|473874840|FG001|Overall Study|Disqualified due to cataract grading|0|||
131612658|NCT02502526|473874841|FG002|Overall Study|Disqualified due to cataract grading|1|||
131612659|NCT02502526|473874839|FG000|Overall Study|Enrollment suspension|4|||
131612660|NCT02502526|473874840|FG001|Overall Study|Enrollment suspension|1|||
131612661|NCT02502526|473874841|FG002|Overall Study|Enrollment suspension|1|||
131612662|NCT01970007|473874842|FG000|Overall Study|Death|5|||
131612663|NCT01970007|473874842|FG000|Overall Study|Withdrawal by Subject|23|||
131612664|NCT01970007|473874842|FG000|Overall Study|Lost to Follow-up|24|||
131612665|NCT01970007|473874842|FG000|Overall Study|"Other endpoint"|3|||
131612666|NCT01342367|473874844|FG000|Overall Study|Death|1|||
131612667|NCT01342367|473874845|FG001|Overall Study|Death|0|||
131612668|NCT01342367|473874844|FG000|Overall Study|Withdrawal by Subject|1|||
131612669|NCT01342367|473874845|FG001|Overall Study|Withdrawal by Subject|2|||
131612670|NCT02844439|473874847|FG000|Overall Study|Withdrawal by Subject|1|||
131612671|NCT02844439|473874847|FG000|Overall Study|Lost to Follow-up|2|||
131612672|NCT02844439|473874847|FG000|Overall Study|Termination by Sponsor|4|||
131612673|NCT02844439|473874847|FG000|Overall Study|Death|28|||
131612674|NCT02844439|473874847|FG000|Overall Study|Other|5|||
131612675|NCT04337931|473874854|FG000|Overall Study|Death|4|||
131612676|NCT04337931|473874855|FG001|Overall Study|Death|1|||
131612677|NCT04337931|473874856|FG002|Overall Study|Death|7|||
131612678|NCT04337931|473874854|FG000|Overall Study|Withdrawal by Subject|0|||
131612679|NCT04337931|473874855|FG001|Overall Study|Withdrawal by Subject|1|||
131612680|NCT04337931|473874856|FG002|Overall Study|Withdrawal by Subject|0|||
131612681|NCT04337931|473874854|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
131612682|NCT04337931|473874855|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
131612683|NCT04337931|473874856|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
131794552|NCT00832078|474530439|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
131794553|NCT01767597|474530440|FG000|Overall Study|Incomplete intervention|3|||
131442148|NCT00945009|473247350|FG002|Overall Study|Ineligible|0|||
131442149|NCT00945009|473247348|FG000|Overall Study|Inevaluable|0|||
131442150|NCT00945009|473247349|FG001|Overall Study|Inevaluable|1|||
131442151|NCT00945009|473247350|FG002|Overall Study|Inevaluable|0|||
131612684|NCT04337931|473874854|FG000|Overall Study|Study terminated by sponsor|3|||
131612685|NCT04337931|473874855|FG001|Overall Study|Study terminated by sponsor|6|||
131612686|NCT04337931|473874856|FG002|Overall Study|Study terminated by sponsor|2|||
131612687|NCT04337931|473874854|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
131612688|NCT04337931|473874855|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
131612689|NCT04337931|473874856|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
131612690|NCT04337931|473874854|FG000|Overall Study|Colorectal cancer treatment|1|||
131612691|NCT04337931|473874855|FG001|Overall Study|Colorectal cancer treatment|0|||
131612692|NCT04337931|473874856|FG002|Overall Study|Colorectal cancer treatment|0|||
131612693|NCT04337931|473874854|FG000|Overall Study|Participant decision|0|||
131612694|NCT04337931|473874855|FG001|Overall Study|Participant decision|1|||
131612695|NCT04337931|473874856|FG002|Overall Study|Participant decision|0|||
131612696|NCT01738438|473874858|FG000|Overall Study|Disease Progression|32|||
131612697|NCT01738438|473874858|FG000|Overall Study|Adverse Event|3|||
131612698|NCT04436289|473874859|FG000|Overall Study|Death prior to hospital discharge|8|||
131612699|NCT04436289|473874860|FG001|Overall Study|Death prior to hospital discharge|5|||
131612700|NCT04436289|473874861|FG002|Overall Study|Death prior to hospital discharge|0|||
131612701|NCT04436289|473874862|FG003|Overall Study|Death prior to hospital discharge|1|||
131612702|NCT04436289|473874859|FG000|Overall Study|Withdrawal by Subject|0|||
131612703|NCT04436289|473874860|FG001|Overall Study|Withdrawal by Subject|1|||
131612704|NCT04436289|473874861|FG002|Overall Study|Withdrawal by Subject|4|||
131612705|NCT04436289|473874862|FG003|Overall Study|Withdrawal by Subject|0|||
131612706|NCT04436289|473874859|FG000|Overall Study|Extended hospital stay|0|||
131612707|NCT04436289|473874860|FG001|Overall Study|Extended hospital stay|1|||
131612708|NCT04436289|473874861|FG002|Overall Study|Extended hospital stay|0|||
131612709|NCT04436289|473874862|FG003|Overall Study|Extended hospital stay|0|||
131612710|NCT04436289|473874859|FG000|Overall Study|Lost to Follow-up|0|||
131612711|NCT04436289|473874860|FG001|Overall Study|Lost to Follow-up|4|||
131612712|NCT04436289|473874861|FG002|Overall Study|Lost to Follow-up|1|||
131612713|NCT04436289|473874862|FG003|Overall Study|Lost to Follow-up|3|||
131612714|NCT02928172|473874863|FG000|Overall Study|Device did not record data|1|||
131612715|NCT04066075|473874864|FG000|Overall Study|Lost to Follow-up|3|||
131612716|NCT04066075|473874865|FG001|Overall Study|Lost to Follow-up|3|||
131612717|NCT04066075|473874864|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
131612718|NCT04066075|473874865|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
131612719|NCT04066075|473874864|FG000|Overall Study|Withdrawal by Subject|2|||
131612720|NCT04066075|473874865|FG001|Overall Study|Withdrawal by Subject|2|||
131612721|NCT00309166|473874866|FG000|Overall Study|Adverse event, non-fatal|1|||
131612722|NCT00309166|473874867|FG001|Overall Study|Adverse event, non-fatal|0|||
131612723|NCT00309166|473874866|FG000|Overall Study|Withdrawal by Subject|4|||
131612724|NCT00309166|473874867|FG001|Overall Study|Withdrawal by Subject|3|||
131612725|NCT00701701|473874868|FG000|Overall Study|Withdrawal by Subject|0|||
131612726|NCT00701701|473874869|FG001|Overall Study|Withdrawal by Subject|1|||
131612727|NCT00701701|473874868|FG000|Overall Study|Adverse Event|0|||
131612728|NCT00701701|473874869|FG001|Overall Study|Adverse Event|1|||
131612729|NCT00589875|473874870|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
131612730|NCT00589875|473874870|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
131612731|NCT02016872|473874875|FG000|Overall Study|Withdrawal by Subject|10|||
131612732|NCT02016872|473874875|FG000|Overall Study|Death Progression|2|||
131612733|NCT02016872|473874875|FG000|Overall Study|No FMISO scan|1|||
131612734|NCT02016872|473874875|FG000|Overall Study|Ineligible|2|||
131612735|NCT05139992|473874878|FG000|Overall Study|Withdrawal by Subject|12|||
131612736|NCT05139992|473874878|FG000|Overall Study|Lost to Follow-up|6|||
131612737|NCT04305327|473874879|FG000|Overall Study|Study early termination|2|||
131612738|NCT04305327|473874880|FG001|Overall Study|Study early termination|5|||
131794554|NCT01767597|474530441|FG001|Overall Study|Incomplete intervention|1|||
131794555|NCT01767597|474530440|FG000|Overall Study|Withdrawal by Subject|1|||
131794556|NCT01767597|474530441|FG001|Overall Study|Withdrawal by Subject|0|||
131794557|NCT03355742|474530442|FG000|Overall Study|Lost to Follow-up|4|||
131794558|NCT03355742|474530442|FG000|Overall Study|Withdrawal by Subject|29|||
131794559|NCT03355742|474530442|FG000|Overall Study|Physician Decision|6|||
131612739|NCT04305327|473874881|FG002|Overall Study|Study early termination|2|||
131612740|NCT04305327|473874882|FG003|Overall Study|Study early termination|2|||
131612741|NCT04305327|473874879|FG000|Overall Study|Withdrawal by Subject|0|||
131612742|NCT04305327|473874880|FG001|Overall Study|Withdrawal by Subject|1|||
131612743|NCT04305327|473874881|FG002|Overall Study|Withdrawal by Subject|0|||
131612744|NCT04305327|473874882|FG003|Overall Study|Withdrawal by Subject|0|||
131612745|NCT03593226|473874883|FG000|Overall Study|Disease progression|6|||
131794560|NCT03355742|474530442|FG000|Overall Study|Death|55|||
131612746|NCT03593226|473874884|FG001|Overall Study|Disease progression|13|||
131612747|NCT03593226|473874885|FG002|Overall Study|Disease progression|5|||
131794561|NCT03355742|474530442|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
131612748|NCT03593226|473874886|FG003|Overall Study|Disease progression|6|||
131612749|NCT03593226|473874883|FG000|Overall Study|Adverse Event|0|||
131612750|NCT03593226|473874884|FG001|Overall Study|Adverse Event|1|||
131612751|NCT03593226|473874885|FG002|Overall Study|Adverse Event|0|||
131612752|NCT03593226|473874886|FG003|Overall Study|Adverse Event|0|||
131612753|NCT03593226|473874883|FG000|Overall Study|Withdrawal by Subject|0|||
131612754|NCT03593226|473874884|FG001|Overall Study|Withdrawal by Subject|4|||
131612755|NCT03593226|473874885|FG002|Overall Study|Withdrawal by Subject|1|||
131612756|NCT03593226|473874886|FG003|Overall Study|Withdrawal by Subject|0|||
131612757|NCT03593226|473874883|FG000|Overall Study|Physician Decision|0|||
131612758|NCT03593226|473874884|FG001|Overall Study|Physician Decision|1|||
131612759|NCT03593226|473874885|FG002|Overall Study|Physician Decision|0|||
131612760|NCT03593226|473874886|FG003|Overall Study|Physician Decision|0|||
131612761|NCT03593226|473874883|FG000|Overall Study|Clinical disease progression|0|||
131612762|NCT03593226|473874884|FG001|Overall Study|Clinical disease progression|0|||
131612763|NCT03593226|473874885|FG002|Overall Study|Clinical disease progression|1|||
131612764|NCT03593226|473874886|FG003|Overall Study|Clinical disease progression|0|||
131612765|NCT04517435|473874903|FG000|Overall Study|Withdrawal by Subject|0|||
131612766|NCT04517435|473874904|FG001|Overall Study|Withdrawal by Subject|0|||
131612767|NCT04517435|473874905|FG002|Overall Study|Withdrawal by Subject|1|||
131612768|NCT04517435|473874903|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
131612769|NCT04517435|473874904|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
131612770|NCT04517435|473874905|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
131612771|NCT03789110|473874906|FG000|Overall Study|Adverse Event|2|||
131612772|NCT03789110|473874906|FG000|Overall Study|Physician Decision|1|||
131612773|NCT03789110|473874906|FG000|Overall Study|Withdrawal by Subject|2|||
131612774|NCT03789110|473874906|FG000|Overall Study|Lack of Efficacy|22|||
131612775|NCT03789110|473874906|FG000|Overall Study|still on treatment|3|||
131612776|NCT05464732|473874907|FG000|Overall Study|Lost to Follow-up|0|||
131612777|NCT05464732|473874908|FG001|Overall Study|Lost to Follow-up|1|||
131612778|NCT05464732|473874907|FG000|Overall Study|Adverse Event|1|||
131612779|NCT05464732|473874908|FG001|Overall Study|Adverse Event|0|||
131612780|NCT02761187|473874909|FG000|Overall Study|Too ill to Participate|13|||
131612781|NCT02761187|473874910|FG001|Overall Study|Too ill to Participate|8|||
131612782|NCT02761187|473874909|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
131612783|NCT02761187|473874910|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
131612784|NCT02761187|473874909|FG000|Overall Study|Patient withdrew consent|64|||
131612785|NCT02761187|473874910|FG001|Overall Study|Patient withdrew consent|58|||
131612786|NCT02761187|473874909|FG000|Overall Study|Physician discretion|4|||
131612787|NCT02761187|473874910|FG001|Overall Study|Physician discretion|8|||
131612788|NCT02761187|473874909|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
131612789|NCT02761187|473874910|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
131612790|NCT02761187|473874909|FG000|Overall Study|On Hospice|20|||
131612791|NCT02761187|473874910|FG001|Overall Study|On Hospice|26|||
131612792|NCT02761187|473874909|FG000|Overall Study|Deceased|474|||
131612793|NCT02761187|473874910|FG001|Overall Study|Deceased|642|||
131612794|NCT02761187|473874909|FG000|Overall Study|Lost to Follow-up|73|||
131612795|NCT02761187|473874910|FG001|Overall Study|Lost to Follow-up|63|||
131612796|NCT02761187|473874909|FG000|Overall Study|Due to study discontinued at site|100|||
131612797|NCT02761187|473874910|FG001|Overall Study|Due to study discontinued at site|85|||
131612798|NCT02761187|473874909|FG000|Overall Study|Reason not Specified|1484|||
131612799|NCT02761187|473874910|FG001|Overall Study|Reason not Specified|937|||
131612800|NCT03170349|473874911|FG000|From Implant to the 30-Day Visit|Death|1|||
131612801|NCT03170349|473874911|FG000|From 30-Day to 6-Month Visit|Death|3|||
131612802|NCT03170349|473874911|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
131612803|NCT03170349|473874911|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
131612804|NCT03170349|473874911|FG000|From 6-Month to 1-Year Visit|Death|6|||
131612805|NCT03170349|473874911|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
131612806|NCT03170349|473874911|FG000|From 1-Year to 2-Year Visit|Death|13|||
131612807|NCT03170349|473874911|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
131612808|NCT03170349|473874911|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
131612809|NCT03170349|473874911|FG000|From 2-Year to 3-Year Visit|Death|10|||
131612810|NCT03170349|473874911|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
131612811|NCT03170349|473874911|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
131612812|NCT03170349|473874911|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
131612813|NCT05529992|473874912|FG000|Overall Study|Withdrawal by Subject|1|||
131612814|NCT04530487|473876512|FG000|Overall Study|Death|1|||
131612815|NCT01036724|473876516|FG000|Overall Study|Adverse Event|1|||
131612816|NCT01036724|473876517|FG001|Overall Study|Adverse Event|2|||
131612817|NCT01036724|473876516|FG000|Overall Study|Lack of Efficacy|1|||
131708432|NCT00961961|474211396|FG000|Phase I|Withdrawal by Subject|7|||
131612818|NCT01036724|473876517|FG001|Overall Study|Lack of Efficacy|1|||
131612819|NCT01036724|473876516|FG000|Overall Study|Protocol Violation|4|||
131612820|NCT01036724|473876517|FG001|Overall Study|Protocol Violation|5|||
131612821|NCT04213807|473876524|FG000|Overall Study|Physician Decision|0|||
131612822|NCT04213807|473876525|FG001|Overall Study|Physician Decision|0|||
131612823|NCT04213807|473876526|FG002|Overall Study|Physician Decision|1|||
131612824|NCT00945321|473876527|FG000|Period 1|Adverse Event|0|||
131612825|NCT00945321|473876528|FG001|Period 1|Adverse Event|0|||
131612826|NCT00945321|473876529|FG002|Period 1|Adverse Event|0|||
131612827|NCT00945321|473876530|FG003|Period 1|Adverse Event|0|||
131612828|NCT00945321|473876531|FG004|Period 1|Adverse Event|1|||
131612829|NCT00945321|473876532|FG005|Period 1|Adverse Event|0|||
131612830|NCT00945321|473876527|FG000|Period 4|Lost to Follow-up|0|||
131612831|NCT00945321|473876528|FG001|Period 4|Lost to Follow-up|0|||
131612832|NCT00945321|473876529|FG002|Period 4|Lost to Follow-up|0|||
131612833|NCT00945321|473876530|FG003|Period 4|Lost to Follow-up|0|||
131612834|NCT00945321|473876531|FG004|Period 4|Lost to Follow-up|0|||
131612835|NCT00945321|473876532|FG005|Period 4|Lost to Follow-up|1|||
131612836|NCT02633215|473876533|FG000|Overall Study|Lost to Follow-up|2|||
131612837|NCT02633215|473876534|FG001|Overall Study|Lost to Follow-up|3|||
131612838|NCT00692913|473876536|FG000|Overall Study|Adverse Event|8|||
131612839|NCT00692913|473876537|FG001|Overall Study|Adverse Event|4|||
131442152|NCT00945009|473247348|FG000|Overall Study|Refusal of further protocol|1|||
131442153|NCT00945009|473247349|FG001|Overall Study|Refusal of further protocol|0|||
131442154|NCT00945009|473247350|FG002|Overall Study|Refusal of further protocol|0|||
131442155|NCT03919773|473247351|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
131442156|NCT03919773|473247352|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
131442157|NCT03919773|473247351|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
131442158|NCT03919773|473247352|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
131442159|NCT04659044|473247353|FG000|Induction|Physician Decision|1|||
131442160|NCT04659044|473247353|FG000|Induction|Adverse Event|2|||
131442161|NCT03589859|473247354|FG000|Overall Study|Withdrawal by Subject|0|||
131442162|NCT03589859|473247355|FG001|Overall Study|Withdrawal by Subject|6|||
131442163|NCT04966013|473247356|FG000|Overall Study|Withdrawal by Subject|0|||
131442164|NCT04966013|473247357|FG001|Overall Study|Withdrawal by Subject|2|||
131442165|NCT04966013|473247358|FG002|Overall Study|Withdrawal by Subject|1|||
131442166|NCT04966013|473247356|FG000|Overall Study|Adverse Event|2|||
131442167|NCT04966013|473247357|FG001|Overall Study|Adverse Event|1|||
131442168|NCT04966013|473247358|FG002|Overall Study|Adverse Event|1|||
131442169|NCT03518086|473247362|FG000|Overall Study|Adverse Event|23|||
131442170|NCT03518086|473247363|FG001|Overall Study|Adverse Event|15|||
131442171|NCT03518086|473247364|FG002|Overall Study|Adverse Event|3|||
131442172|NCT03518086|473247365|FG003|Overall Study|Adverse Event|2|||
131442173|NCT03518086|473247362|FG000|Overall Study|Withdrawal by Subject|8|||
131442174|NCT03518086|473247363|FG001|Overall Study|Withdrawal by Subject|5|||
131442175|NCT03518086|473247364|FG002|Overall Study|Withdrawal by Subject|1|||
131442176|NCT03518086|473247365|FG003|Overall Study|Withdrawal by Subject|0|||
131442177|NCT03518086|473247362|FG000|Overall Study|Lack of Efficacy|5|||
131442178|NCT03518086|473247363|FG001|Overall Study|Lack of Efficacy|5|||
131442179|NCT03518086|473247364|FG002|Overall Study|Lack of Efficacy|0|||
131442180|NCT03518086|473247365|FG003|Overall Study|Lack of Efficacy|2|||
131442181|NCT03518086|473247362|FG000|Overall Study|Protocol Violation|1|||
131442182|NCT03518086|473247363|FG001|Overall Study|Protocol Violation|5|||
131442183|NCT03518086|473247364|FG002|Overall Study|Protocol Violation|1|||
131612840|NCT00692913|473876536|FG000|Overall Study|Lost to Follow-up|3|||
131612841|NCT00692913|473876537|FG001|Overall Study|Lost to Follow-up|5|||
131612842|NCT00692913|473876536|FG000|Overall Study|Physician Decision|2|||
131612843|NCT00692913|473876537|FG001|Overall Study|Physician Decision|0|||
131612844|NCT00692913|473876536|FG000|Overall Study|Protocol Violation|1|||
131612845|NCT00692913|473876537|FG001|Overall Study|Protocol Violation|1|||
131612846|NCT00692913|473876536|FG000|Overall Study|Withdrawal by Subject|15|||
131612847|NCT00692913|473876537|FG001|Overall Study|Withdrawal by Subject|20|||
131612848|NCT02291913|473876538|FG000|Overall Study|Progressive Disease|32|||
131612849|NCT02291913|473876538|FG000|Overall Study|Adverse Event|11|||
131612850|NCT02291913|473876538|FG000|Overall Study|Death|2|||
131612851|NCT02291913|473876538|FG000|Overall Study|Physician Decision|1|||
131708433|NCT00961961|474211397|FG001|Phase I|Withdrawal by Subject|0|||
131708434|NCT00961961|474211398|FG002|Phase I|Withdrawal by Subject|0|||
131708435|NCT00961961|474211399|FG003|Phase I|Withdrawal by Subject|0|||
131708436|NCT00961961|474211396|FG000|Phase I|Lost to Follow-up|10|||
131708437|NCT00961961|474211397|FG001|Phase I|Lost to Follow-up|0|||
131708438|NCT00961961|474211398|FG002|Phase I|Lost to Follow-up|0|||
131708439|NCT00961961|474211399|FG003|Phase I|Lost to Follow-up|0|||
131708440|NCT00961961|474211396|FG000|Phase I|Lack of Efficacy|94|||
131708441|NCT00961961|474211397|FG001|Phase I|Lack of Efficacy|0|||
131442184|NCT03518086|473247365|FG003|Overall Study|Protocol Violation|3|||
131442185|NCT03518086|473247362|FG000|Overall Study|Lost to Follow-up|0|||
131442186|NCT03518086|473247363|FG001|Overall Study|Lost to Follow-up|3|||
131442187|NCT03518086|473247364|FG002|Overall Study|Lost to Follow-up|0|||
131442188|NCT03518086|473247365|FG003|Overall Study|Lost to Follow-up|0|||
131442189|NCT03518086|473247362|FG000|Overall Study|Insufficient Diary Data|0|||
131442190|NCT03518086|473247363|FG001|Overall Study|Insufficient Diary Data|2|||
131612852|NCT02291913|473876538|FG000|Overall Study|Withdrawal by Subject|1|||
131612853|NCT02291913|473876538|FG000|Overall Study|Protocol Violation|1|||
131612854|NCT01637402|473876547|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
131612855|NCT01637402|473876548|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
131612856|NCT01637402|473876547|FG000|Standard Dose Regimen|Adverse Event|1|||
131612857|NCT01637402|473876548|FG001|Standard Dose Regimen|Adverse Event|0|||
131612858|NCT01637402|473876547|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
131612859|NCT01637402|473876548|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
131612860|NCT01637402|473876547|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
131612861|NCT01637402|473876548|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
131612862|NCT01637402|473876547|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
131612863|NCT01637402|473876548|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
131612864|NCT01637402|473876547|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
131612865|NCT01637402|473876548|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
131612866|NCT02866942|473876549|FG000|Overall Study|Invalid consent|1|||
131612867|NCT01268306|473876552|FG000|Overall Study|Lost to Follow-up|1|||
131612868|NCT04334317|473876553|FG000|Overall Study|Adverse Event|1|||
131612869|NCT04334317|473876554|FG001|Overall Study|Adverse Event|2|||
131612870|NCT04334317|473876555|FG002|Overall Study|Adverse Event|0|||
131612871|NCT04334317|473876556|FG003|Overall Study|Adverse Event|0|||
131612872|NCT04334317|473876553|FG000|Overall Study|Protocol Deviation|0|||
131612873|NCT04334317|473876554|FG001|Overall Study|Protocol Deviation|1|||
131612874|NCT04334317|473876555|FG002|Overall Study|Protocol Deviation|0|||
131612875|NCT04334317|473876556|FG003|Overall Study|Protocol Deviation|0|||
131612876|NCT04334317|473876553|FG000|Overall Study|Withdrawal by Subject|2|||
131612877|NCT04334317|473876554|FG001|Overall Study|Withdrawal by Subject|2|||
131612878|NCT04334317|473876555|FG002|Overall Study|Withdrawal by Subject|0|||
131612879|NCT04334317|473876556|FG003|Overall Study|Withdrawal by Subject|0|||
131612880|NCT01128595|473876559|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131612881|NCT01128595|473876560|FG001|Treatment Period 3|Withdrawal by Subject|1|||
131612882|NCT01128595|473876561|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131612883|NCT01128595|473876562|FG003|Treatment Period 3|Withdrawal by Subject|0|||
131612884|NCT00605306|473876563|FG000|Overall Study|Adverse Event|0|||
131612885|NCT00605306|473876564|FG001|Overall Study|Adverse Event|1|||
131612886|NCT00372775|473876565|FG000|Overall Study|Adverse Event|8|||
131612887|NCT00372775|473876565|FG000|Overall Study|Death|15|||
131612888|NCT00372775|473876565|FG000|Overall Study|Objective progression or relapse|30|||
131612889|NCT00372775|473876565|FG000|Overall Study|Global deterioration of health status|6|||
131612890|NCT00372775|473876565|FG000|Overall Study|Withdrawal by Subject|1|||
131612891|NCT00372775|473876565|FG000|Overall Study|Other|1|||
131612892|NCT00372775|473876565|FG000|Overall Study|Not Treated|2|||
131612893|NCT02185794|473876567|FG000|Overall Study|Enrolled but Never Dosed|1|||
131612894|NCT02185794|473876568|FG001|Overall Study|Enrolled but Never Dosed|6|||
131612895|NCT02185794|473876569|FG002|Overall Study|Enrolled but Never Dosed|3|||
131612896|NCT02185794|473876570|FG003|Overall Study|Enrolled but Never Dosed|1|||
131612897|NCT02185794|473876571|FG004|Overall Study|Enrolled but Never Dosed|1|||
131612898|NCT02185794|473876572|FG005|Overall Study|Enrolled but Never Dosed|0|||
131612899|NCT02185794|473876567|FG000|Overall Study|Investigator's Discretion|1|||
131612900|NCT02185794|473876568|FG001|Overall Study|Investigator's Discretion|0|||
131612901|NCT02185794|473876569|FG002|Overall Study|Investigator's Discretion|1|||
131794562|NCT04527471|474530445|FG000|Overall Study|Adverse Event|1|||
131794563|NCT04527471|474530446|FG001|Overall Study|Adverse Event|0|||
131794564|NCT04527471|474530445|FG000|Overall Study|Lost to Follow-up|1|||
131794565|NCT04527471|474530446|FG001|Overall Study|Lost to Follow-up|0|||
131794566|NCT00096265|474530454|FG000|Overall Study|Ineligible|1|||
131794567|NCT00096265|474530455|FG001|Overall Study|Ineligible|0|||
131794568|NCT00096265|474530456|FG002|Overall Study|Ineligible|0|||
131794569|NCT01506323|474530457|FG000|Overall Study|Lost to Follow-up|5|||
131794570|NCT01506323|474530458|FG001|Overall Study|Lost to Follow-up|4|||
131794571|NCT01506323|474530457|FG000|Overall Study|Withdrawal by Subject|4|||
131794572|NCT01506323|474530458|FG001|Overall Study|Withdrawal by Subject|4|||
131794573|NCT01506323|474530457|FG000|Overall Study|Lack of Efficacy|1|||
131794574|NCT01506323|474530458|FG001|Overall Study|Lack of Efficacy|3|||
131794575|NCT01506323|474530457|FG000|Overall Study|Moved out of area|5|||
131794576|NCT01506323|474530458|FG001|Overall Study|Moved out of area|2|||
131794577|NCT01506323|474530457|FG000|Overall Study|Schedule or Transportation conflict|8|||
131794578|NCT01506323|474530458|FG001|Overall Study|Schedule or Transportation conflict|0|||
131794579|NCT01506323|474530457|FG000|Overall Study|Started another treatment|1|||
131794580|NCT01506323|474530458|FG001|Overall Study|Started another treatment|0|||
131794581|NCT02891200|474530459|FG000|Overall Study|Lost to Follow-up|31|||
131794582|NCT02891200|474530460|FG001|Overall Study|Lost to Follow-up|36|||
131794583|NCT02891200|474530459|FG000|Overall Study|Death|10|||
131612902|NCT02185794|473876570|FG003|Overall Study|Investigator's Discretion|2|||
131794584|NCT02891200|474530460|FG001|Overall Study|Death|9|||
131794585|NCT02891200|474530459|FG000|Overall Study|Withdrawal by Subject|1|||
131794586|NCT02891200|474530460|FG001|Overall Study|Withdrawal by Subject|4|||
131612903|NCT02185794|473876571|FG004|Overall Study|Investigator's Discretion|2|||
131612904|NCT02185794|473876572|FG005|Overall Study|Investigator's Discretion|15|||
131612905|NCT02185794|473876567|FG000|Overall Study|Withdrew Consent|2|||
131612906|NCT02185794|473876568|FG001|Overall Study|Withdrew Consent|5|||
131612907|NCT02185794|473876569|FG002|Overall Study|Withdrew Consent|10|||
131612908|NCT02185794|473876570|FG003|Overall Study|Withdrew Consent|2|||
131612909|NCT02185794|473876571|FG004|Overall Study|Withdrew Consent|0|||
131612910|NCT02185794|473876572|FG005|Overall Study|Withdrew Consent|0|||
131612911|NCT02185794|473876567|FG000|Overall Study|Lost to Follow-up|1|||
131612912|NCT02185794|473876568|FG001|Overall Study|Lost to Follow-up|2|||
131612913|NCT02185794|473876569|FG002|Overall Study|Lost to Follow-up|2|||
131612914|NCT02185794|473876570|FG003|Overall Study|Lost to Follow-up|3|||
131612915|NCT02185794|473876571|FG004|Overall Study|Lost to Follow-up|0|||
131612916|NCT02185794|473876572|FG005|Overall Study|Lost to Follow-up|1|||
131612917|NCT00336505|473876573|FG000|Overall Study|Adverse Event|10|||
131612918|NCT00336505|473876574|FG001|Overall Study|Adverse Event|9|||
131612919|NCT00336505|473876573|FG000|Overall Study|Lack of Efficacy|8|||
131612920|NCT00336505|473876574|FG001|Overall Study|Lack of Efficacy|4|||
131612921|NCT00336505|473876573|FG000|Overall Study|Lost to Follow-up|7|||
131612922|NCT00336505|473876574|FG001|Overall Study|Lost to Follow-up|4|||
131612923|NCT00336505|473876573|FG000|Overall Study|Withdrawal by Subject|5|||
131612924|NCT00336505|473876574|FG001|Overall Study|Withdrawal by Subject|3|||
131612925|NCT00336505|473876573|FG000|Overall Study|Other|7|||
131612926|NCT00336505|473876574|FG001|Overall Study|Other|7|||
131612927|NCT01092416|473876575|FG000|Enrollment|Atherectomy device not inserted|3|||
131612928|NCT01092416|473876575|FG000|30-Day Follow-up|Death|2|||
131612929|NCT01092416|473876575|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
131612930|NCT01092416|473876575|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
131612931|NCT01092416|473876575|FG000|12-Month Follow-up|Death|16|||
131612932|NCT01092416|473876575|FG000|12-Month Follow-up|Lost to Follow-up|4|||
131612933|NCT01092416|473876575|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
131794587|NCT02232074|474530461|FG000|Overall Study|Withdrawal by Subject|5|||
131794588|NCT02232074|474530462|FG001|Overall Study|Withdrawal by Subject|3|||
131794589|NCT02232074|474530461|FG000|Overall Study|No legal concerns at baseline|36|||
131794590|NCT02232074|474530462|FG001|Overall Study|No legal concerns at baseline|41|||
131794591|NCT02232074|474530461|FG000|Overall Study|deemed ineligible|0|||
131794592|NCT02232074|474530462|FG001|Overall Study|deemed ineligible|1|||
131794593|NCT04480463|474530465|FG000|Overall Study|Death|0|||
131794594|NCT04480463|474530466|FG001|Overall Study|Death|1|||
131794595|NCT04480463|474530465|FG000|Overall Study|Adverse Event|6|||
131794596|NCT04480463|474530466|FG001|Overall Study|Adverse Event|8|||
131794597|NCT04480463|474530465|FG000|Overall Study|Lost to Follow-up|3|||
131794598|NCT04480463|474530466|FG001|Overall Study|Lost to Follow-up|2|||
131794599|NCT04480463|474530465|FG000|Overall Study|Physician Decision|2|||
131794600|NCT04480463|474530466|FG001|Overall Study|Physician Decision|5|||
131794601|NCT04480463|474530465|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
131794602|NCT04480463|474530466|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
131794603|NCT04480463|474530465|FG000|Overall Study|Protocol Violation|2|||
131794604|NCT04480463|474530466|FG001|Overall Study|Protocol Violation|1|||
131794605|NCT04480463|474530465|FG000|Overall Study|Withdrawal by Subject|6|||
131794606|NCT04480463|474530466|FG001|Overall Study|Withdrawal by Subject|7|||
131794607|NCT04480463|474530465|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
131794608|NCT04480463|474530466|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
131794609|NCT04480463|474530465|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
131794610|NCT04480463|474530466|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
131794611|NCT04480463|474530465|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
131794612|NCT04480463|474530466|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
131794613|NCT04480463|474530465|FG000|Overall Study|Other|6|||
131794614|NCT04480463|474530466|FG001|Overall Study|Other|4|||
131794615|NCT00988169|474530468|FG000|Overall Study|Withdrawal by Subject|1|||
131794616|NCT02637076|474530470|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
131794617|NCT02637076|474530471|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
131794618|NCT02637076|474530470|FG000|Overall Study|Withdrawal by Subject|0|||
131794619|NCT02637076|474530471|FG001|Overall Study|Withdrawal by Subject|4|||
131794620|NCT03083483|474530479|FG000|Overall Study|Adverse Event|1|||
131794621|NCT03083483|474530480|FG001|Overall Study|Adverse Event|1|||
131794622|NCT03083483|474530481|FG002|Overall Study|Adverse Event|1|||
131794623|NCT03083483|474530479|FG000|Overall Study|Lost to Follow-up|2|||
131612934|NCT01092416|473876575|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
131612935|NCT01092416|473876575|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
131612936|NCT01561300|473876576|FG000|Run in on Placebo|Adverse Event|1|||
131612937|NCT01561300|473876577|FG001|Run in on Placebo|Adverse Event|0|||
131612938|NCT00246805|473876578|FG000|Phase 1|Lost to Follow-up|1|||
131612939|NCT00246805|473876579|FG001|Phase 1|Lost to Follow-up|0|||
131612940|NCT00609869|473876580|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
131612941|NCT00609869|473876580|FG000|Overall Study|Severe hematologic toxicity|1|||
131612942|NCT00609869|473876580|FG000|Overall Study|Withdrawal by Subject|1|||
131612943|NCT00609869|473876580|FG000|Overall Study|Seizures|1|||
131612944|NCT00609869|473876580|FG000|Overall Study|Severe tumor flare reaction|1|||
131612945|NCT00609869|473876580|FG000|Overall Study|Hepatitis B infection|1|||
131612946|NCT00609869|473876580|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
131708442|NCT00961961|474211398|FG002|Phase I|Lack of Efficacy|0|||
131708443|NCT00961961|474211399|FG003|Phase I|Lack of Efficacy|0|||
131708444|NCT00961961|474211396|FG000|Phase I|Adverse Event|7|||
131708445|NCT00961961|474211397|FG001|Phase I|Adverse Event|0|||
131708446|NCT00961961|474211398|FG002|Phase I|Adverse Event|0|||
131708447|NCT00961961|474211399|FG003|Phase I|Adverse Event|0|||
131708448|NCT00961961|474211396|FG000|Phase I|Physician Decision|8|||
131708449|NCT00961961|474211397|FG001|Phase I|Physician Decision|0|||
131708450|NCT00961961|474211398|FG002|Phase I|Physician Decision|0|||
131708451|NCT00961961|474211399|FG003|Phase I|Physician Decision|0|||
131708452|NCT00961961|474211396|FG000|Phase II|Lost to Follow-up|0|||
131708453|NCT00961961|474211397|FG001|Phase II|Lost to Follow-up|0|||
131708454|NCT00961961|474211398|FG002|Phase II|Lost to Follow-up|10|||
131708455|NCT00961961|474211399|FG003|Phase II|Lost to Follow-up|7|||
131708456|NCT00961961|474211396|FG000|Phase II|Adverse Event|0|||
131708457|NCT00961961|474211397|FG001|Phase II|Adverse Event|0|||
131708458|NCT00961961|474211398|FG002|Phase II|Adverse Event|0|||
131708459|NCT00961961|474211399|FG003|Phase II|Adverse Event|1|||
131708460|NCT00961961|474211396|FG000|Phase II|Physician Decision|0|||
131708461|NCT00961961|474211397|FG001|Phase II|Physician Decision|0|||
131708462|NCT00961961|474211398|FG002|Phase II|Physician Decision|1|||
131708463|NCT00961961|474211399|FG003|Phase II|Physician Decision|0|||
131708464|NCT00961961|474211396|FG000|Phase II|Withdrawal by Subject|0|||
131708465|NCT00961961|474211397|FG001|Phase II|Withdrawal by Subject|0|||
131708466|NCT00961961|474211398|FG002|Phase II|Withdrawal by Subject|1|||
131708467|NCT00961961|474211399|FG003|Phase II|Withdrawal by Subject|0|||
131708468|NCT01412957|474211400|FG000|Overall Study|Withdrawal by Subject|6|||
131708469|NCT01412957|474211401|FG001|Overall Study|Withdrawal by Subject|22|||
131708470|NCT01412957|474211400|FG000|Overall Study|Lost to Follow-up|7|||
131708471|NCT01412957|474211401|FG001|Overall Study|Lost to Follow-up|2|||
131708472|NCT01412957|474211400|FG000|Overall Study|Death|136|||
131708473|NCT01412957|474211401|FG001|Overall Study|Death|133|||
131708474|NCT04722991|474211407|FG000|Overall Study|Adverse Event|12|||
131708475|NCT04722991|474211408|FG001|Overall Study|Adverse Event|4|||
131708476|NCT04722991|474211407|FG000|Overall Study|Death|2|||
131708477|NCT04722991|474211408|FG001|Overall Study|Death|0|||
131708478|NCT04722991|474211407|FG000|Overall Study|Lost to Follow-up|1|||
131708479|NCT04722991|474211408|FG001|Overall Study|Lost to Follow-up|1|||
131708480|NCT04722991|474211407|FG000|Overall Study|Withdrawal cirterion met|2|||
131708481|NCT04722991|474211408|FG001|Overall Study|Withdrawal cirterion met|2|||
131708482|NCT04722991|474211407|FG000|Overall Study|Other|1|||
131708483|NCT04722991|474211408|FG001|Overall Study|Other|0|||
131708484|NCT04722991|474211407|FG000|Overall Study|Non-compliance|0|||
131708485|NCT04722991|474211408|FG001|Overall Study|Non-compliance|1|||
131708486|NCT04722991|474211407|FG000|Overall Study|Withdrawal by Subject|0|||
131708487|NCT04722991|474211408|FG001|Overall Study|Withdrawal by Subject|1|||
131708488|NCT00413959|474211409|FG000|Overall Study|Pt had only one cycle.|1|||
131708489|NCT01929135|474211413|FG000|Overall Study|Lost to Follow-up|1|||
131708490|NCT01929135|474211414|FG001|Overall Study|Lost to Follow-up|1|||
131708491|NCT02425098|474211415|FG000|Overall Study|Lost to Follow-up|7|||
131794624|NCT03083483|474530480|FG001|Overall Study|Lost to Follow-up|1|||
131794625|NCT03083483|474530481|FG002|Overall Study|Lost to Follow-up|1|||
131794626|NCT03083483|474530479|FG000|Overall Study|technological issues|1|||
131794627|NCT03083483|474530480|FG001|Overall Study|technological issues|0|||
131794628|NCT03083483|474530481|FG002|Overall Study|technological issues|1|||
131794629|NCT02710071|474530485|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
131794630|NCT02710071|474530486|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
131708492|NCT02425098|474211416|FG001|Overall Study|Lost to Follow-up|7|||
131708493|NCT02425098|474211415|FG000|Overall Study|Withdrawal by Subject|4|||
131708494|NCT02425098|474211416|FG001|Overall Study|Withdrawal by Subject|8|||
131708495|NCT02425098|474211415|FG000|Overall Study|Pregnancy|2|||
131708496|NCT02425098|474211416|FG001|Overall Study|Pregnancy|0|||
131708497|NCT02425098|474211415|FG000|Overall Study|Reason not Specified|0|||
131708498|NCT02425098|474211416|FG001|Overall Study|Reason not Specified|1|||
131612947|NCT00609869|473876580|FG000|Overall Study|Mantle cell: not evaluable|4|||
131612948|NCT01436175|473876581|FG000|Overall Study|Adverse Event|111|||
131612949|NCT01436175|473876581|FG000|Overall Study|Protocol Violation|49|||
131612950|NCT01436175|473876581|FG000|Overall Study|Withdrawal by Subject|108|||
131612951|NCT01436175|473876581|FG000|Overall Study|Lost to Follow-up|89|||
131612952|NCT01436175|473876581|FG000|Overall Study|Lack of Efficacy|24|||
131612953|NCT01436175|473876581|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
131612954|NCT01436175|473876581|FG000|Overall Study|Other|826|||
131612955|NCT03418922|473876582|FG000|Overall Study|Withdrawal by Subject|0|||
131612956|NCT03418922|473876583|FG001|Overall Study|Withdrawal by Subject|2|||
131612957|NCT03418922|473876582|FG000|Overall Study|Adverse Event|2|||
131612958|NCT03418922|473876583|FG001|Overall Study|Adverse Event|2|||
131612959|NCT03418922|473876582|FG000|Overall Study|Death|0|||
131612960|NCT03418922|473876583|FG001|Overall Study|Death|1|||
131612961|NCT03418922|473876582|FG000|Overall Study|Physician Decision|0|||
131612962|NCT03418922|473876583|FG001|Overall Study|Physician Decision|1|||
131612963|NCT01952366|473876587|FG000|Overall Study|Death|22|||
131612964|NCT01952366|473876587|FG000|Overall Study|Withdrawal by Subject|9|||
131612965|NCT04860505|473876588|FG000|Overall Study|Lost to Follow-up|2|||
131612966|NCT00571649|473876591|FG000|Treatment Period|Adverse Event|438|||
131612967|NCT00571649|473876592|FG001|Treatment Period|Adverse Event|385|||
131612968|NCT00571649|473876591|FG000|Treatment Period|Clinical endpoint reached|50|||
131612969|NCT00571649|473876592|FG001|Treatment Period|Clinical endpoint reached|56|||
131612970|NCT00571649|473876591|FG000|Treatment Period|Withdrawal by Subject|285|||
131612971|NCT00571649|473876592|FG001|Treatment Period|Withdrawal by Subject|255|||
131612972|NCT00571649|473876591|FG000|Treatment Period|Death|76|||
131612973|NCT00571649|473876592|FG001|Treatment Period|Death|59|||
131612974|NCT00571649|473876591|FG000|Treatment Period|Physician Decision|8|||
131612975|NCT00571649|473876592|FG001|Treatment Period|Physician Decision|9|||
131612976|NCT00571649|473876591|FG000|Treatment Period|Lost to Follow-up|43|||
131612977|NCT00571649|473876592|FG001|Treatment Period|Lost to Follow-up|41|||
131612978|NCT00571649|473876591|FG000|Treatment Period|Non-compliant with study medication|88|||
131612979|NCT00571649|473876592|FG001|Treatment Period|Non-compliant with study medication|89|||
131612980|NCT00571649|473876591|FG000|Treatment Period|Patient convenience|11|||
131612981|NCT00571649|473876592|FG001|Treatment Period|Patient convenience|13|||
131612982|NCT00571649|473876591|FG000|Treatment Period|Protocol Violation|90|||
131612983|NCT00571649|473876592|FG001|Treatment Period|Protocol Violation|92|||
131612984|NCT00571649|473876591|FG000|Treatment Period|Technical problems|3|||
131612985|NCT00571649|473876592|FG001|Treatment Period|Technical problems|5|||
131612986|NCT00571649|473876591|FG000|Follow-up Period|Adverse Event|46|||
131612987|NCT00571649|473876592|FG001|Follow-up Period|Adverse Event|40|||
131612988|NCT00571649|473876591|FG000|Follow-up Period|Clinical endpoint reached|5|||
131612989|NCT00571649|473876592|FG001|Follow-up Period|Clinical endpoint reached|2|||
131794631|NCT02710071|474530485|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
131794632|NCT02710071|474530486|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
131794633|NCT02637557|474530493|FG000|Overall Study|Adverse Event|3|||
131794634|NCT02637557|474530494|FG001|Overall Study|Adverse Event|1|||
131794635|NCT02637557|474530495|FG002|Overall Study|Adverse Event|3|||
131794636|NCT02637557|474530496|FG003|Overall Study|Adverse Event|3|||
131794637|NCT02637557|474530493|FG000|Overall Study|Lost to Follow-up|1|||
131794638|NCT02637557|474530494|FG001|Overall Study|Lost to Follow-up|1|||
131794639|NCT02637557|474530495|FG002|Overall Study|Lost to Follow-up|0|||
131794640|NCT02637557|474530496|FG003|Overall Study|Lost to Follow-up|1|||
131794641|NCT02637557|474530493|FG000|Overall Study|Physician Decision|1|||
131794642|NCT02637557|474530494|FG001|Overall Study|Physician Decision|0|||
131794643|NCT02637557|474530495|FG002|Overall Study|Physician Decision|0|||
131794644|NCT02637557|474530496|FG003|Overall Study|Physician Decision|0|||
131794645|NCT02637557|474530493|FG000|Overall Study|Protocol Violation|2|||
131612990|NCT00571649|473876591|FG000|Follow-up Period|Withdrawal by Subject|119|||
131612991|NCT00571649|473876592|FG001|Follow-up Period|Withdrawal by Subject|115|||
131612992|NCT00571649|473876591|FG000|Follow-up Period|Death|132|||
131612993|NCT00571649|473876592|FG001|Follow-up Period|Death|133|||
131612994|NCT00571649|473876591|FG000|Follow-up Period|Physician Decision|7|||
131612995|NCT00571649|473876592|FG001|Follow-up Period|Physician Decision|13|||
131612996|NCT00571649|473876591|FG000|Follow-up Period|Lost to Follow-up|95|||
131612997|NCT00571649|473876592|FG001|Follow-up Period|Lost to Follow-up|92|||
131794646|NCT02637557|474530494|FG001|Overall Study|Protocol Violation|0|||
131794647|NCT02637557|474530495|FG002|Overall Study|Protocol Violation|2|||
131612998|NCT00571649|473876591|FG000|Follow-up Period|Patient convenience|136|||
131794648|NCT02637557|474530496|FG003|Overall Study|Protocol Violation|1|||
131794649|NCT02637557|474530493|FG000|Overall Study|Withdrawal by Subject|1|||
131612999|NCT00571649|473876592|FG001|Follow-up Period|Patient convenience|121|||
131613000|NCT00571649|473876591|FG000|Follow-up Period|Protocol Violation|5|||
131794650|NCT02637557|474530494|FG001|Overall Study|Withdrawal by Subject|3|||
131794651|NCT02637557|474530495|FG002|Overall Study|Withdrawal by Subject|4|||
131613001|NCT00571649|473876592|FG001|Follow-up Period|Protocol Violation|12|||
131613002|NCT00582972|473876593|FG000|Overall Study|Protocol Violation|2|||
131613003|NCT03066609|473876596|FG000|INDUCTION|Pregnancy|0|||
131613004|NCT03066609|473876597|FG001|INDUCTION|Pregnancy|0|||
131613005|NCT03066609|473876598|FG002|INDUCTION|Pregnancy|1|||
131613006|NCT03066609|473876599|FG003|INDUCTION|Pregnancy|0|||
131613007|NCT03066609|473876596|FG000|INDUCTION|Lack of Efficacy|0|||
131613008|NCT03066609|473876597|FG001|INDUCTION|Lack of Efficacy|0|||
131613009|NCT03066609|473876598|FG002|INDUCTION|Lack of Efficacy|1|||
131613010|NCT03066609|473876599|FG003|INDUCTION|Lack of Efficacy|0|||
131613011|NCT03066609|473876596|FG000|INDUCTION|Adverse Event|2|||
131613012|NCT03066609|473876597|FG001|INDUCTION|Adverse Event|2|||
131613013|NCT03066609|473876598|FG002|INDUCTION|Adverse Event|0|||
131613014|NCT03066609|473876599|FG003|INDUCTION|Adverse Event|0|||
131613015|NCT03066609|473876596|FG000|MAINTENANCE|Adverse Event|0|||
131613016|NCT03066609|473876597|FG001|MAINTENANCE|Adverse Event|0|||
131613017|NCT03066609|473876598|FG002|MAINTENANCE|Adverse Event|0|||
131613018|NCT03066609|473876599|FG003|MAINTENANCE|Adverse Event|1|||
131613019|NCT03066609|473876596|FG000|MAINTENANCE|Withdrawal by Subject|4|||
131613020|NCT03066609|473876597|FG001|MAINTENANCE|Withdrawal by Subject|2|||
131613021|NCT03066609|473876598|FG002|MAINTENANCE|Withdrawal by Subject|1|||
131613022|NCT03066609|473876599|FG003|MAINTENANCE|Withdrawal by Subject|1|||
131613023|NCT03066609|473876596|FG000|MAINTENANCE|Lost to Follow-up|0|||
131613024|NCT03066609|473876597|FG001|MAINTENANCE|Lost to Follow-up|1|||
131613025|NCT03066609|473876598|FG002|MAINTENANCE|Lost to Follow-up|1|||
131613026|NCT03066609|473876599|FG003|MAINTENANCE|Lost to Follow-up|0|||
131613027|NCT03066609|473876596|FG000|MAINTENANCE|Pregnancy|1|||
131613028|NCT03066609|473876597|FG001|MAINTENANCE|Pregnancy|0|||
131613029|NCT03066609|473876598|FG002|MAINTENANCE|Pregnancy|0|||
131613030|NCT03066609|473876599|FG003|MAINTENANCE|Pregnancy|0|||
131613031|NCT03066609|473876596|FG000|MAINTENANCE|Lack of Efficacy|2|||
131613032|NCT03066609|473876597|FG001|MAINTENANCE|Lack of Efficacy|1|||
131613033|NCT03066609|473876598|FG002|MAINTENANCE|Lack of Efficacy|0|||
131613034|NCT03066609|473876599|FG003|MAINTENANCE|Lack of Efficacy|1|||
131613035|NCT03066609|473876596|FG000|OVERALL STUDY|Adverse Event|2|||
131613036|NCT03066609|473876597|FG001|OVERALL STUDY|Adverse Event|2|||
131613037|NCT03066609|473876598|FG002|OVERALL STUDY|Adverse Event|0|||
131613038|NCT03066609|473876599|FG003|OVERALL STUDY|Adverse Event|1|||
131613039|NCT03066609|473876596|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
131613040|NCT03066609|473876597|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
131613041|NCT03066609|473876598|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
131613042|NCT03066609|473876599|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
131613043|NCT03066609|473876596|FG000|OVERALL STUDY|Lost to Follow-up|1|||
131613044|NCT03066609|473876597|FG001|OVERALL STUDY|Lost to Follow-up|1|||
131613045|NCT03066609|473876598|FG002|OVERALL STUDY|Lost to Follow-up|1|||
131613046|NCT03066609|473876599|FG003|OVERALL STUDY|Lost to Follow-up|1|||
131613047|NCT03066609|473876596|FG000|OVERALL STUDY|Pregnancy|1|||
131613048|NCT03066609|473876597|FG001|OVERALL STUDY|Pregnancy|0|||
131613049|NCT03066609|473876598|FG002|OVERALL STUDY|Pregnancy|1|||
131613050|NCT03066609|473876599|FG003|OVERALL STUDY|Pregnancy|0|||
131613051|NCT03066609|473876596|FG000|OVERALL STUDY|Lack of Efficacy|2|||
131613052|NCT03066609|473876597|FG001|OVERALL STUDY|Lack of Efficacy|1|||
131613053|NCT03066609|473876598|FG002|OVERALL STUDY|Lack of Efficacy|1|||
131613054|NCT03066609|473876599|FG003|OVERALL STUDY|Lack of Efficacy|1|||
131613055|NCT03066609|473876596|FG000|OVERALL STUDY|discontinued follow up|0|||
131613056|NCT03066609|473876597|FG001|OVERALL STUDY|discontinued follow up|2|||
131613057|NCT03066609|473876598|FG002|OVERALL STUDY|discontinued follow up|0|||
131794652|NCT02637557|474530496|FG003|Overall Study|Withdrawal by Subject|2|||
131442191|NCT03518086|473247364|FG002|Overall Study|Insufficient Diary Data|0|||
131442192|NCT03518086|473247365|FG003|Overall Study|Insufficient Diary Data|0|||
131442193|NCT03518086|473247362|FG000|Overall Study|Non- compliance to Protocol|0|||
131613058|NCT03066609|473876599|FG003|OVERALL STUDY|discontinued follow up|0|||
131613059|NCT01566890|473876600|FG000|Overall Study|Adverse Event|1|||
131613060|NCT01566890|473876601|FG001|Overall Study|Adverse Event|0|||
131613061|NCT01566890|473876602|FG002|Overall Study|Adverse Event|0|||
131613062|NCT01566890|473876603|FG003|Overall Study|Adverse Event|0|||
131613063|NCT01566890|473876604|FG004|Overall Study|Adverse Event|0|||
131613064|NCT01566890|473876600|FG000|Overall Study|Withdrawal by Subject|3|||
131613065|NCT01566890|473876601|FG001|Overall Study|Withdrawal by Subject|1|||
131794653|NCT00613574|474530497|FG000|Overall Study|Adverse Event|3|||
131613066|NCT01566890|473876602|FG002|Overall Study|Withdrawal by Subject|1|||
131613067|NCT01566890|473876603|FG003|Overall Study|Withdrawal by Subject|1|||
131613068|NCT01566890|473876604|FG004|Overall Study|Withdrawal by Subject|0|||
131613069|NCT01566890|473876600|FG000|Overall Study|Screen failure|6|||
131613070|NCT01566890|473876601|FG001|Overall Study|Screen failure|0|||
131613071|NCT01566890|473876602|FG002|Overall Study|Screen failure|1|||
131613072|NCT01566890|473876603|FG003|Overall Study|Screen failure|1|||
131613073|NCT01566890|473876604|FG004|Overall Study|Screen failure|0|||
131613074|NCT01566890|473876600|FG000|Overall Study|Incomplete CEU data|1|||
131613075|NCT01566890|473876601|FG001|Overall Study|Incomplete CEU data|3|||
131613076|NCT01566890|473876602|FG002|Overall Study|Incomplete CEU data|5|||
131613077|NCT01566890|473876603|FG003|Overall Study|Incomplete CEU data|8|||
131613078|NCT01566890|473876604|FG004|Overall Study|Incomplete CEU data|0|||
131613079|NCT01566890|473876600|FG000|Overall Study|Lost to Follow-up|0|||
131613080|NCT01566890|473876601|FG001|Overall Study|Lost to Follow-up|0|||
131613081|NCT01566890|473876602|FG002|Overall Study|Lost to Follow-up|4|||
131613082|NCT01566890|473876603|FG003|Overall Study|Lost to Follow-up|4|||
131613083|NCT01566890|473876604|FG004|Overall Study|Lost to Follow-up|0|||
131613084|NCT01566890|473876600|FG000|Overall Study|Other|0|||
131613085|NCT01566890|473876601|FG001|Overall Study|Other|0|||
131613086|NCT01566890|473876602|FG002|Overall Study|Other|0|||
131613087|NCT01566890|473876603|FG003|Overall Study|Other|0|||
131613088|NCT01566890|473876604|FG004|Overall Study|Other|7|||
131613089|NCT01421667|473876612|FG000|Overall Study|Withdrawal by Subject|0|||
131613090|NCT01421667|473876613|FG001|Overall Study|Withdrawal by Subject|1|||
131613091|NCT01421667|473876614|FG002|Overall Study|Withdrawal by Subject|2|||
131613092|NCT01421667|473876615|FG003|Overall Study|Withdrawal by Subject|1|||
131613093|NCT01421667|473876612|FG000|Overall Study|Lost to Follow-up|0|||
131442194|NCT03518086|473247363|FG001|Overall Study|Non- compliance to Protocol|1|||
131442195|NCT03518086|473247364|FG002|Overall Study|Non- compliance to Protocol|0|||
131442196|NCT03518086|473247365|FG003|Overall Study|Non- compliance to Protocol|0|||
131442197|NCT03518086|473247362|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
131442198|NCT03518086|473247363|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
131442199|NCT03518086|473247364|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
131613094|NCT01421667|473876613|FG001|Overall Study|Lost to Follow-up|1|||
131613095|NCT01421667|473876614|FG002|Overall Study|Lost to Follow-up|0|||
131613096|NCT01421667|473876615|FG003|Overall Study|Lost to Follow-up|0|||
131613097|NCT00822120|473876616|FG000|Initial Registration|Adverse Event|1|||
131613098|NCT00822120|473876617|FG001|Initial Registration|Adverse Event|0|||
131613099|NCT00822120|473876618|FG002|Initial Registration|Adverse Event|0|||
131613100|NCT00822120|473876619|FG003|Initial Registration|Adverse Event|0|||
131613101|NCT00822120|473876620|FG004|Initial Registration|Adverse Event|0|||
131613102|NCT00822120|473876621|FG005|Initial Registration|Adverse Event|0|||
131613103|NCT00822120|473876616|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
131613104|NCT00822120|473876617|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131613105|NCT00822120|473876618|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131613106|NCT00822120|473876619|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131613107|NCT00822120|473876620|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131613108|NCT00822120|473876621|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131613109|NCT00822120|473876616|FG000|Initial Registration|Reasons not Protocol Specified|2|||
131613110|NCT00822120|473876617|FG001|Initial Registration|Reasons not Protocol Specified|0|||
131613111|NCT00822120|473876618|FG002|Initial Registration|Reasons not Protocol Specified|0|||
131613112|NCT00822120|473876619|FG003|Initial Registration|Reasons not Protocol Specified|0|||
131613113|NCT00822120|473876620|FG004|Initial Registration|Reasons not Protocol Specified|0|||
131613114|NCT00822120|473876621|FG005|Initial Registration|Reasons not Protocol Specified|0|||
131613115|NCT00822120|473876616|FG000|Initial Registration|Ineligible|22|||
131613116|NCT00822120|473876617|FG001|Initial Registration|Ineligible|1|||
131613117|NCT00822120|473876618|FG002|Initial Registration|Ineligible|0|||
131613118|NCT00822120|473876619|FG003|Initial Registration|Ineligible|0|||
131613119|NCT00822120|473876620|FG004|Initial Registration|Ineligible|0|||
131613120|NCT00822120|473876621|FG005|Initial Registration|Ineligible|0|||
131613121|NCT00822120|473876616|FG000|PET-directed Therapy|Adverse Event|0|||
131613122|NCT00822120|473876617|FG001|PET-directed Therapy|Adverse Event|0|||
131613123|NCT00822120|473876618|FG002|PET-directed Therapy|Adverse Event|0|||
131613124|NCT00822120|473876619|FG003|PET-directed Therapy|Adverse Event|1|||
131613125|NCT00822120|473876620|FG004|PET-directed Therapy|Adverse Event|0|||
131613126|NCT00822120|473876621|FG005|PET-directed Therapy|Adverse Event|0|||
131613127|NCT00822120|473876616|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131613128|NCT00822120|473876617|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131613129|NCT00822120|473876618|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131613130|NCT00822120|473876619|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
131613131|NCT00822120|473876620|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131613132|NCT00822120|473876621|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131613133|NCT00822120|473876616|FG000|PET-directed Therapy|Death|0|||
131613134|NCT00822120|473876617|FG001|PET-directed Therapy|Death|0|||
131613135|NCT00822120|473876618|FG002|PET-directed Therapy|Death|0|||
131613136|NCT00822120|473876619|FG003|PET-directed Therapy|Death|2|||
131613137|NCT00822120|473876620|FG004|PET-directed Therapy|Death|0|||
131613138|NCT00822120|473876621|FG005|PET-directed Therapy|Death|0|||
131613139|NCT00822120|473876616|FG000|PET-directed Therapy|Protocol Violation|0|||
131613140|NCT00822120|473876617|FG001|PET-directed Therapy|Protocol Violation|0|||
131613141|NCT00822120|473876618|FG002|PET-directed Therapy|Protocol Violation|0|||
131613142|NCT00822120|473876619|FG003|PET-directed Therapy|Protocol Violation|6|||
131442200|NCT03518086|473247365|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
131613143|NCT00822120|473876620|FG004|PET-directed Therapy|Protocol Violation|0|||
131613144|NCT00822120|473876621|FG005|PET-directed Therapy|Protocol Violation|0|||
131613145|NCT01218009|473876622|FG000|Overall Study|Protocol Violation|2|||
131613146|NCT01218009|473876623|FG001|Overall Study|Protocol Violation|1|||
131613147|NCT01218009|473876622|FG000|Overall Study|Withdrawal by Subject|3|||
131613148|NCT01218009|473876623|FG001|Overall Study|Withdrawal by Subject|1|||
131613149|NCT01218009|473876622|FG000|Overall Study|Sponsor terminated study|161|||
131613150|NCT01218009|473876623|FG001|Overall Study|Sponsor terminated study|163|||
131613151|NCT00503906|473876624|FG000|Overall Study|Withdrawal by Subject|1|||
131613152|NCT01324310|473876625|FG000|Overall Study|Adverse Event|1|||
131613153|NCT01324310|473876625|FG000|Overall Study|Disease Progression|1|||
131613154|NCT03170882|473876627|FG000|Overall Study|Death|17|||
131613155|NCT03170882|473876628|FG001|Overall Study|Death|29|||
131613156|NCT03170882|473876627|FG000|Overall Study|Lost to Follow-up|0|||
131613157|NCT03170882|473876628|FG001|Overall Study|Lost to Follow-up|1|||
131613158|NCT03170882|473876627|FG000|Overall Study|Withdrawal by Subject|4|||
131613159|NCT03170882|473876628|FG001|Overall Study|Withdrawal by Subject|7|||
131613160|NCT03170882|473876627|FG000|Overall Study|Reason not Specified|28|||
131613161|NCT03170882|473876628|FG001|Overall Study|Reason not Specified|36|||
131613162|NCT02787005|473876648|FG000|Overall Study|Adverse Event|24|||
131613163|NCT02787005|473876649|FG001|Overall Study|Adverse Event|9|||
131613164|NCT02787005|473876650|FG002|Overall Study|Adverse Event|9|||
131613165|NCT02787005|473876651|FG003|Overall Study|Adverse Event|7|||
131613166|NCT02787005|473876652|FG004|Overall Study|Adverse Event|2|||
131613167|NCT02787005|473876648|FG000|Overall Study|Death|100|||
131613168|NCT02787005|473876649|FG001|Overall Study|Death|53|||
131613169|NCT02787005|473876650|FG002|Overall Study|Death|48|||
131613170|NCT02787005|473876651|FG003|Overall Study|Death|69|||
131613171|NCT02787005|473876652|FG004|Overall Study|Death|38|||
131613172|NCT02787005|473876648|FG000|Overall Study|Sponsor Decision|7|||
131613173|NCT02787005|473876649|FG001|Overall Study|Sponsor Decision|4|||
131613174|NCT02787005|473876650|FG002|Overall Study|Sponsor Decision|0|||
131613175|NCT02787005|473876651|FG003|Overall Study|Sponsor Decision|4|||
131613176|NCT02787005|473876652|FG004|Overall Study|Sponsor Decision|5|||
131613177|NCT02787005|473876648|FG000|Overall Study|Withdrawal by Subject|2|||
131613178|NCT02787005|473876649|FG001|Overall Study|Withdrawal by Subject|1|||
131613179|NCT02787005|473876650|FG002|Overall Study|Withdrawal by Subject|1|||
131613180|NCT02787005|473876651|FG003|Overall Study|Withdrawal by Subject|0|||
131613181|NCT02787005|473876652|FG004|Overall Study|Withdrawal by Subject|1|||
131613182|NCT02787005|473876648|FG000|Overall Study|Screen Failure|0|||
131613183|NCT02787005|473876649|FG001|Overall Study|Screen Failure|2|||
131613184|NCT02787005|473876650|FG002|Overall Study|Screen Failure|0|||
131613185|NCT02787005|473876651|FG003|Overall Study|Screen Failure|0|||
131613186|NCT02787005|473876652|FG004|Overall Study|Screen Failure|1|||
131613187|NCT02787005|473876648|FG000|Overall Study|Lost to Follow-up|0|||
131613188|NCT02787005|473876649|FG001|Overall Study|Lost to Follow-up|0|||
131613189|NCT02787005|473876650|FG002|Overall Study|Lost to Follow-up|0|||
131613190|NCT02787005|473876651|FG003|Overall Study|Lost to Follow-up|1|||
131613191|NCT02787005|473876652|FG004|Overall Study|Lost to Follow-up|0|||
131613192|NCT05580003|473876653|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613193|NCT05580003|473876654|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613194|NCT05580003|473876655|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613195|NCT05580003|473876656|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613196|NCT05580003|473876657|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613197|NCT05580003|473876658|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613198|NCT05580003|473876659|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
131613199|NCT05580003|473876660|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613200|NCT05580003|473876661|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613201|NCT05580003|473876662|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613202|NCT05580003|473876663|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613203|NCT05580003|473876664|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613204|NCT05580003|473876665|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613205|NCT05580003|473876666|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613206|NCT05580003|473876667|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613207|NCT05580003|473876668|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613208|NCT05580003|473876669|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613209|NCT05580003|473876670|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613210|NCT05580003|473876671|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613211|NCT05580003|473876672|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613212|NCT05580003|473876673|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613213|NCT05580003|473876674|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613214|NCT05580003|473876675|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613215|NCT05580003|473876676|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613216|NCT05580003|473876677|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613217|NCT05580003|473876678|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613218|NCT05580003|473876679|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613219|NCT05580003|473876680|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131613220|NCT05580003|473876653|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613221|NCT05580003|473876654|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613222|NCT05580003|473876655|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613223|NCT05580003|473876656|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613224|NCT05580003|473876657|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613225|NCT05580003|473876658|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
131613226|NCT05580003|473876659|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613227|NCT05580003|473876660|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613228|NCT05580003|473876661|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613229|NCT05580003|473876662|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613230|NCT05580003|473876663|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613231|NCT05580003|473876664|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613232|NCT05580003|473876665|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613233|NCT05580003|473876666|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613234|NCT05580003|473876667|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613235|NCT05580003|473876668|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613236|NCT05580003|473876669|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613237|NCT05580003|473876670|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613238|NCT05580003|473876671|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613239|NCT05580003|473876672|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613240|NCT05580003|473876673|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613241|NCT05580003|473876674|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613242|NCT05580003|473876675|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613243|NCT05580003|473876676|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613244|NCT05580003|473876677|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613245|NCT05580003|473876678|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613246|NCT05580003|473876679|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613247|NCT05580003|473876680|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131613248|NCT05580003|473876653|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613249|NCT05580003|473876654|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613250|NCT05580003|473876655|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613251|NCT05580003|473876656|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
131613252|NCT05580003|473876657|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613253|NCT05580003|473876658|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613254|NCT05580003|473876659|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613255|NCT05580003|473876660|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613256|NCT05580003|473876661|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613257|NCT05580003|473876662|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613258|NCT05580003|473876663|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613259|NCT05580003|473876664|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613260|NCT05580003|473876665|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613261|NCT05580003|473876666|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613262|NCT05580003|473876667|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613263|NCT05580003|473876668|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613264|NCT05580003|473876669|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613265|NCT05580003|473876670|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613266|NCT05580003|473876671|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613267|NCT05580003|473876672|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613268|NCT05580003|473876673|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131708499|NCT02078219|474211417|FG000|Overall Study|Other|2|||
131708500|NCT02078219|474211418|FG001|Overall Study|Other|2|||
131613269|NCT05580003|473876674|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613270|NCT05580003|473876675|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613271|NCT05580003|473876676|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613272|NCT05580003|473876677|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131708501|NCT02078219|474211419|FG002|Overall Study|Other|3|||
131708502|NCT02078219|474211420|FG003|Overall Study|Other|0|||
131708503|NCT02078219|474211421|FG004|Overall Study|Other|1|||
131442201|NCT03518086|473247362|FG000|Overall Study|Site Terminated by Sponsor|0|||
131442202|NCT03518086|473247363|FG001|Overall Study|Site Terminated by Sponsor|1|||
131442203|NCT03518086|473247364|FG002|Overall Study|Site Terminated by Sponsor|0|||
131442204|NCT03518086|473247365|FG003|Overall Study|Site Terminated by Sponsor|0|||
131442205|NCT03518086|473247362|FG000|Overall Study|Pregnancy|0|||
131442206|NCT03518086|473247363|FG001|Overall Study|Pregnancy|0|||
131442207|NCT03518086|473247364|FG002|Overall Study|Pregnancy|0|||
131442208|NCT03518086|473247365|FG003|Overall Study|Pregnancy|2|||
131442209|NCT05967260|473247366|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
131442210|NCT05967260|473247367|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
131442211|NCT03253393|473247369|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
131442212|NCT03253393|473247370|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
131442213|NCT03253393|473247371|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
131442214|NCT04607668|473248783|FG000|Overall Study|Death|49|||
131442215|NCT04607668|473248784|FG001|Overall Study|Death|26|||
131442216|NCT04607668|473248783|FG000|Overall Study|Lost to Follow-up|3|||
131442217|NCT04607668|473248784|FG001|Overall Study|Lost to Follow-up|4|||
131442218|NCT04607668|473248783|FG000|Overall Study|Study terminated by Sponsor|92|||
131442219|NCT04607668|473248784|FG001|Overall Study|Study terminated by Sponsor|114|||
131442220|NCT04607668|473248783|FG000|Overall Study|Withdrawal by Subject|12|||
131442221|NCT04607668|473248784|FG001|Overall Study|Withdrawal by Subject|11|||
131442222|NCT04607668|473248783|FG000|Overall Study|Other, unspecified|8|||
131442223|NCT04607668|473248784|FG001|Overall Study|Other, unspecified|7|||
131442224|NCT03007966|473248787|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
131442225|NCT03007966|473248788|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
131442226|NCT00474487|473248789|FG000|Overall Study|Withdrawal by Subject|6|||
131442227|NCT00474487|473248790|FG001|Overall Study|Withdrawal by Subject|0|||
131442228|NCT00474487|473248791|FG002|Overall Study|Withdrawal by Subject|0|||
131442229|NCT00474487|473248792|FG003|Overall Study|Withdrawal by Subject|0|||
131442230|NCT00474487|473248789|FG000|Overall Study|Lost to Follow-up|20|||
131442231|NCT00474487|473248790|FG001|Overall Study|Lost to Follow-up|1|||
131442232|NCT00474487|473248791|FG002|Overall Study|Lost to Follow-up|7|||
131442233|NCT00474487|473248792|FG003|Overall Study|Lost to Follow-up|0|||
131442234|NCT00474487|473248789|FG000|Overall Study|Inappropriate enrollment|4|||
131442235|NCT00474487|473248790|FG001|Overall Study|Inappropriate enrollment|0|||
131442236|NCT00474487|473248791|FG002|Overall Study|Inappropriate enrollment|7|||
131794654|NCT00613574|474530497|FG000|Overall Study|Lost to Follow-up|2|||
131794655|NCT00613574|474530497|FG000|Overall Study|Other|1|||
131794656|NCT04604184|474530504|FG000|Overall Study|Adverse Event|5|||
131794657|NCT04604184|474530505|FG001|Overall Study|Adverse Event|5|||
131794658|NCT04604184|474530504|FG000|Overall Study|Death|2|||
131794659|NCT04604184|474530505|FG001|Overall Study|Death|1|||
131442237|NCT00474487|473248792|FG003|Overall Study|Inappropriate enrollment|0|||
131442238|NCT00474487|473248789|FG000|Overall Study|Death|0|||
131442239|NCT00474487|473248790|FG001|Overall Study|Death|1|||
131442240|NCT00474487|473248791|FG002|Overall Study|Death|0|||
131442241|NCT00474487|473248792|FG003|Overall Study|Death|0|||
131442242|NCT01428258|473248793|FG000|Intervention 1|Withdrawal by Subject|2|||
131613273|NCT05580003|473876678|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613274|NCT05580003|473876679|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613275|NCT05580003|473876680|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131613276|NCT05580003|473876653|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613277|NCT05580003|473876654|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
131794660|NCT04604184|474530504|FG000|Overall Study|Withdrawal by Subject|1|||
131613278|NCT05580003|473876655|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613279|NCT05580003|473876656|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613280|NCT05580003|473876657|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613281|NCT05580003|473876658|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613282|NCT05580003|473876659|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613283|NCT05580003|473876660|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613284|NCT05580003|473876661|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613285|NCT05580003|473876662|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613286|NCT05580003|473876663|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613287|NCT05580003|473876664|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131794661|NCT04604184|474530505|FG001|Overall Study|Withdrawal by Subject|3|||
131442243|NCT01428258|473248794|FG001|Intervention 1|Withdrawal by Subject|0|||
131442244|NCT00248625|473248795|FG000|Overall Study|Withdrawal by Subject|0|||
131442245|NCT00248625|473248796|FG001|Overall Study|Withdrawal by Subject|2|||
131442246|NCT00616759|473248799|FG000|Overall Study|Physician Decision|2|||
131442247|NCT00616759|473248800|FG001|Overall Study|Physician Decision|0|||
131442248|NCT00616759|473248799|FG000|Overall Study|Withdrawal by Subject|1|||
131442249|NCT00616759|473248800|FG001|Overall Study|Withdrawal by Subject|2|||
131442250|NCT00726063|473248804|FG000|Overall Study|Adverse Event|9|||
131708504|NCT02078219|474211417|FG000|Overall Study|Withdrawal by Subject|0|||
131708505|NCT02078219|474211418|FG001|Overall Study|Withdrawal by Subject|1|||
131708506|NCT02078219|474211419|FG002|Overall Study|Withdrawal by Subject|0|||
131708507|NCT02078219|474211420|FG003|Overall Study|Withdrawal by Subject|1|||
131708508|NCT02078219|474211421|FG004|Overall Study|Withdrawal by Subject|1|||
131708509|NCT02078219|474211417|FG000|Overall Study|Protocol Violation|0|||
131708510|NCT02078219|474211418|FG001|Overall Study|Protocol Violation|0|||
131708511|NCT02078219|474211419|FG002|Overall Study|Protocol Violation|0|||
131708512|NCT02078219|474211420|FG003|Overall Study|Protocol Violation|1|||
131708513|NCT02078219|474211421|FG004|Overall Study|Protocol Violation|0|||
131708514|NCT02078219|474211417|FG000|Overall Study|Death|0|||
131708515|NCT02078219|474211418|FG001|Overall Study|Death|0|||
131708516|NCT02078219|474211419|FG002|Overall Study|Death|0|||
131708517|NCT02078219|474211420|FG003|Overall Study|Death|1|||
131708518|NCT02078219|474211421|FG004|Overall Study|Death|0|||
131708519|NCT02078219|474211417|FG000|Overall Study|Adverse Event|1|||
131708520|NCT02078219|474211418|FG001|Overall Study|Adverse Event|1|||
131708521|NCT02078219|474211419|FG002|Overall Study|Adverse Event|3|||
131708522|NCT02078219|474211420|FG003|Overall Study|Adverse Event|1|||
131708523|NCT02078219|474211421|FG004|Overall Study|Adverse Event|0|||
131708524|NCT00127127|474213286|FG000|Overall Study|Adverse Event|0|||
131708525|NCT00127127|474213287|FG001|Overall Study|Adverse Event|2|||
131708526|NCT00127127|474213288|FG002|Overall Study|Adverse Event|0|||
131708527|NCT00127127|474213289|FG003|Overall Study|Adverse Event|1|||
131708528|NCT00127127|474213286|FG000|Overall Study|Lack of Efficacy|1|||
131708529|NCT00127127|474213287|FG001|Overall Study|Lack of Efficacy|3|||
131708530|NCT00127127|474213288|FG002|Overall Study|Lack of Efficacy|0|||
131708531|NCT00127127|474213289|FG003|Overall Study|Lack of Efficacy|2|||
131708532|NCT01805180|474213292|FG000|Lead-in Donor Phase|screen failure|1|||
131708533|NCT01805180|474213293|FG001|Lead-in Donor Phase|screen failure|0|||
131708534|NCT01805180|474213294|FG002|Lead-in Donor Phase|screen failure|0|||
131708535|NCT00008385|474213312|FG000|Overall Study|Off treatment reasons not reported|79|||
131708536|NCT00008385|474213313|FG001|Overall Study|Off treatment reasons not reported|70|||
131708537|NCT00008385|474213312|FG000|Overall Study|Progressive disease|52|||
131708538|NCT00008385|474213313|FG001|Overall Study|Progressive disease|117|||
131708539|NCT00008385|474213312|FG000|Overall Study|Adverse Event|8|||
131708540|NCT00008385|474213313|FG001|Overall Study|Adverse Event|20|||
131708541|NCT00008385|474213312|FG000|Overall Study|Death|12|||
131708542|NCT00008385|474213313|FG001|Overall Study|Death|18|||
131708543|NCT00008385|474213312|FG000|Overall Study|Withdrawal by Subject|67|||
131708544|NCT00008385|474213313|FG001|Overall Study|Withdrawal by Subject|157|||
131708545|NCT00008385|474213312|FG000|Overall Study|Start non-protocol therapy|3|||
131708546|NCT00008385|474213313|FG001|Overall Study|Start non-protocol therapy|1|||
131708547|NCT00008385|474213312|FG000|Overall Study|Other complicating disease|17|||
131900308|NCT00249873|474921455|FG000|Overall Study|Patient not wish to continue after May08|3|||
131900309|NCT00249873|474921456|FG001|Overall Study|Patient not wish to continue after May08|4|||
131442251|NCT00726063|473248805|FG001|Overall Study|Adverse Event|7|||
131442252|NCT02007096|473248806|FG000|Overall Study|medication not available|2|||
131442253|NCT02007096|473248807|FG001|Overall Study|medication not available|0|||
131613288|NCT05580003|473876665|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613289|NCT05580003|473876666|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613290|NCT05580003|473876667|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613291|NCT05580003|473876668|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613292|NCT05580003|473876669|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613293|NCT05580003|473876670|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613294|NCT05580003|473876671|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613295|NCT05580003|473876672|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613296|NCT05580003|473876673|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613297|NCT05580003|473876674|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613298|NCT05580003|473876675|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613299|NCT05580003|473876676|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613300|NCT05580003|473876677|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613301|NCT05580003|473876678|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613302|NCT05580003|473876679|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613303|NCT05580003|473876680|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131613304|NCT05580003|473876653|FG000|Part 2 (up to 10 Days)|Other|0|||
131613305|NCT05580003|473876654|FG001|Part 2 (up to 10 Days)|Other|0|||
131613306|NCT05580003|473876655|FG002|Part 2 (up to 10 Days)|Other|0|||
131613307|NCT05580003|473876656|FG003|Part 2 (up to 10 Days)|Other|0|||
131613308|NCT05580003|473876657|FG004|Part 2 (up to 10 Days)|Other|0|||
131613309|NCT05580003|473876658|FG005|Part 2 (up to 10 Days)|Other|0|||
131613310|NCT05580003|473876659|FG006|Part 2 (up to 10 Days)|Other|0|||
131613311|NCT05580003|473876660|FG007|Part 2 (up to 10 Days)|Other|0|||
131613312|NCT05580003|473876661|FG008|Part 2 (up to 10 Days)|Other|0|||
131613313|NCT05580003|473876662|FG009|Part 2 (up to 10 Days)|Other|1|||
131613314|NCT05580003|473876663|FG010|Part 2 (up to 10 Days)|Other|0|||
131613315|NCT05580003|473876664|FG011|Part 2 (up to 10 Days)|Other|0|||
131613316|NCT05580003|473876665|FG012|Part 2 (up to 10 Days)|Other|0|||
131613317|NCT05580003|473876666|FG013|Part 2 (up to 10 Days)|Other|0|||
131613318|NCT05580003|473876667|FG014|Part 2 (up to 10 Days)|Other|0|||
131613319|NCT05580003|473876668|FG015|Part 2 (up to 10 Days)|Other|0|||
131613320|NCT05580003|473876669|FG016|Part 2 (up to 10 Days)|Other|0|||
131613321|NCT05580003|473876670|FG017|Part 2 (up to 10 Days)|Other|0|||
131613322|NCT05580003|473876671|FG018|Part 2 (up to 10 Days)|Other|0|||
131613323|NCT05580003|473876672|FG019|Part 2 (up to 10 Days)|Other|0|||
131613324|NCT05580003|473876673|FG020|Part 2 (up to 10 Days)|Other|0|||
131613325|NCT05580003|473876674|FG021|Part 2 (up to 10 Days)|Other|0|||
131613326|NCT05580003|473876675|FG022|Part 2 (up to 10 Days)|Other|0|||
131613327|NCT05580003|473876676|FG023|Part 2 (up to 10 Days)|Other|0|||
131613328|NCT05580003|473876677|FG024|Part 2 (up to 10 Days)|Other|0|||
131613329|NCT05580003|473876678|FG025|Part 2 (up to 10 Days)|Other|0|||
131613330|NCT05580003|473876679|FG026|Part 2 (up to 10 Days)|Other|0|||
131613331|NCT05580003|473876680|FG027|Part 2 (up to 10 Days)|Other|0|||
131613332|NCT05580003|473876653|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613333|NCT05580003|473876654|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613334|NCT05580003|473876655|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131708548|NCT00008385|474213313|FG001|Overall Study|Other complicating disease|30|||
131442254|NCT02007096|473248806|FG000|Overall Study|did not inject saline|0|||
131442255|NCT02007096|473248807|FG001|Overall Study|did not inject saline|3|||
131442256|NCT02007096|473248806|FG000|Overall Study|did not follow postoperative protocol|8|||
131613335|NCT05580003|473876656|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613336|NCT05580003|473876657|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613337|NCT05580003|473876658|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613338|NCT05580003|473876659|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613339|NCT05580003|473876660|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613340|NCT05580003|473876661|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131708549|NCT00008385|474213312|FG000|Overall Study|Maximum dose reached|0|||
131900310|NCT00249873|474921455|FG000|Overall Study|Physician withdrew consent|59|||
131613341|NCT05580003|473876662|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613342|NCT05580003|473876663|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613343|NCT05580003|473876664|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613344|NCT05580003|473876665|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613345|NCT05580003|473876666|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613346|NCT05580003|473876667|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613347|NCT05580003|473876668|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613348|NCT05580003|473876669|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613349|NCT05580003|473876670|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131708550|NCT00008385|474213313|FG001|Overall Study|Maximum dose reached|2|||
131613350|NCT05580003|473876671|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613351|NCT05580003|473876672|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
131613352|NCT05580003|473876673|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613353|NCT05580003|473876674|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613354|NCT05580003|473876675|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613355|NCT05580003|473876676|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613356|NCT05580003|473876677|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613357|NCT05580003|473876678|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613358|NCT05580003|473876679|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613359|NCT05580003|473876680|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131613360|NCT05580003|473876653|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613361|NCT05580003|473876654|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613362|NCT05580003|473876655|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613363|NCT05580003|473876656|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613364|NCT05580003|473876657|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613365|NCT05580003|473876658|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613366|NCT05580003|473876659|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613367|NCT05580003|473876660|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613368|NCT05580003|473876661|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613369|NCT05580003|473876662|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613370|NCT05580003|473876663|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613371|NCT05580003|473876664|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613372|NCT05580003|473876665|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613373|NCT05580003|473876666|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613374|NCT05580003|473876667|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613375|NCT05580003|473876668|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613376|NCT05580003|473876669|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613377|NCT05580003|473876670|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131708551|NCT00008385|474213312|FG000|Overall Study|Other|105|||
131900311|NCT00249873|474921456|FG001|Overall Study|Physician withdrew consent|60|||
131442257|NCT02007096|473248807|FG001|Overall Study|did not follow postoperative protocol|11|||
131442258|NCT02007096|473248806|FG000|Overall Study|converted to open surgery|1|||
131442259|NCT02007096|473248807|FG001|Overall Study|converted to open surgery|1|||
131442260|NCT02007096|473248806|FG000|Overall Study|no mesh placed|0|||
131613378|NCT05580003|473876671|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613379|NCT05580003|473876672|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131708552|NCT00008385|474213313|FG001|Overall Study|Other|212|||
131613380|NCT05580003|473876673|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
131613381|NCT05580003|473876674|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613382|NCT05580003|473876675|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613383|NCT05580003|473876676|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613384|NCT05580003|473876677|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613385|NCT05580003|473876678|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613386|NCT05580003|473876679|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613387|NCT05580003|473876680|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131613388|NCT05580003|473876653|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613389|NCT05580003|473876654|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613390|NCT05580003|473876655|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613391|NCT05580003|473876656|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613392|NCT05580003|473876657|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613393|NCT05580003|473876658|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613394|NCT05580003|473876659|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613395|NCT05580003|473876660|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613396|NCT05580003|473876661|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613397|NCT05580003|473876662|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613398|NCT05580003|473876663|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613399|NCT05580003|473876664|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613400|NCT05580003|473876665|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613401|NCT05580003|473876666|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613402|NCT05580003|473876667|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613403|NCT05580003|473876668|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613404|NCT05580003|473876669|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613405|NCT05580003|473876670|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613406|NCT05580003|473876671|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613407|NCT05580003|473876672|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613408|NCT05580003|473876673|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131442261|NCT02007096|473248807|FG001|Overall Study|no mesh placed|1|||
131442262|NCT05176314|473248809|FG000|Overall Study|Lost to Follow-up|2|||
131442263|NCT05176314|473248809|FG000|Overall Study|Physician Decision|1|||
131613409|NCT05580003|473876674|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
131613410|NCT05580003|473876675|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613411|NCT05580003|473876676|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613412|NCT05580003|473876677|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613413|NCT05580003|473876678|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613414|NCT05580003|473876679|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613415|NCT05580003|473876680|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131613416|NCT05580003|473876653|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613417|NCT05580003|473876654|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613418|NCT05580003|473876655|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613419|NCT05580003|473876656|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613420|NCT05580003|473876657|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613421|NCT05580003|473876658|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613422|NCT05580003|473876659|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613423|NCT05580003|473876660|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613424|NCT05580003|473876661|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613425|NCT05580003|473876662|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613426|NCT05580003|473876663|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613427|NCT05580003|473876664|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613428|NCT05580003|473876665|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613429|NCT05580003|473876666|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613430|NCT05580003|473876667|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613431|NCT05580003|473876668|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613432|NCT05580003|473876669|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613433|NCT05580003|473876670|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131708553|NCT00008385|474213312|FG000|Overall Study|Not start protocol therapy|44|||
131708554|NCT00008385|474213313|FG001|Overall Study|Not start protocol therapy|175|||
131708555|NCT00398112|474213314|FG000|Overall Study|Adverse Event|4|||
131708556|NCT00398112|474213314|FG000|Overall Study|Disease progression|9|||
131708557|NCT00398112|474213314|FG000|Overall Study|Alternative treatment|1|||
131708558|NCT00398112|474213314|FG000|Overall Study|Withdrawal by Subject|3|||
131708559|NCT00398112|474213314|FG000|Overall Study|Death|1|||
131708560|NCT05148884|474213315|FG000|Overall Study|Withdrawal by Subject|3|||
131708561|NCT05148884|474213316|FG001|Overall Study|Withdrawal by Subject|0|||
131708562|NCT05148884|474213315|FG000|Overall Study|Deep brain stimulation operation|0|||
131708563|NCT05148884|474213316|FG001|Overall Study|Deep brain stimulation operation|1|||
131708564|NCT00582556|474213317|FG000|Overall Study|Withdrawal by Subject|0|||
131708565|NCT00582556|474213318|FG001|Overall Study|Withdrawal by Subject|1|||
131708566|NCT00582556|474213319|FG002|Overall Study|Withdrawal by Subject|1|||
131613434|NCT05580003|473876671|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613435|NCT05580003|473876672|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613436|NCT05580003|473876673|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613437|NCT05580003|473876674|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613438|NCT05580003|473876675|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613439|NCT05580003|473876676|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613440|NCT05580003|473876677|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613441|NCT05580003|473876678|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613442|NCT05580003|473876679|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131613443|NCT05580003|473876680|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
131613444|NCT05580003|473876653|FG000|Part 6 Period 2 (Day 1)|Other|0|||
131613445|NCT05580003|473876654|FG001|Part 6 Period 2 (Day 1)|Other|0|||
131613446|NCT05580003|473876655|FG002|Part 6 Period 2 (Day 1)|Other|0|||
131613447|NCT05580003|473876656|FG003|Part 6 Period 2 (Day 1)|Other|0|||
131613448|NCT05580003|473876657|FG004|Part 6 Period 2 (Day 1)|Other|0|||
131442264|NCT05176314|473248809|FG000|Overall Study|Adverse Event|1|||
131442265|NCT01231984|473248810|FG000|Study Period 1|Withdrawal by Subject|0|||
131442266|NCT01231984|473248811|FG001|Study Period 1|Withdrawal by Subject|0|||
131708567|NCT00582556|474213317|FG000|Overall Study|Physician Decision|0|||
131900312|NCT00249873|474921455|FG000|Overall Study|Open label clopidogrel required|31|||
131900313|NCT00249873|474921456|FG001|Overall Study|Open label clopidogrel required|42|||
131900314|NCT00249873|474921455|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
131900315|NCT00249873|474921456|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
131900316|NCT00249873|474921455|FG000|Overall Study|Oral anticoagulant required|159|||
131900317|NCT00249873|474921456|FG001|Overall Study|Oral anticoagulant required|157|||
131900318|NCT00249873|474921455|FG000|Overall Study|Study drug intolerance|5|||
131900319|NCT00249873|474921456|FG001|Overall Study|Study drug intolerance|0|||
131900320|NCT00249873|474921455|FG000|Overall Study|Surgery/ procedure|9|||
131900321|NCT00249873|474921456|FG001|Overall Study|Surgery/ procedure|9|||
131900322|NCT00249873|474921455|FG000|Overall Study|Event related to cardiac condition|12|||
131900323|NCT00249873|474921456|FG001|Overall Study|Event related to cardiac condition|21|||
131900324|NCT00249873|474921455|FG000|Overall Study|Thromboembolic/outcome event|82|||
131900325|NCT00249873|474921456|FG001|Overall Study|Thromboembolic/outcome event|122|||
131900326|NCT03131167|474921457|FG000|Overall Study|Other (Unspecified)|0|||
131900327|NCT03131167|474921458|FG001|Overall Study|Other (Unspecified)|0|||
131900328|NCT03131167|474921459|FG002|Overall Study|Other (Unspecified)|0|||
131900329|NCT03131167|474921460|FG003|Overall Study|Other (Unspecified)|0|||
131900330|NCT03131167|474921461|FG004|Overall Study|Other (Unspecified)|0|||
131900331|NCT03131167|474921462|FG005|Overall Study|Other (Unspecified)|1|||
131900332|NCT03131167|474921463|FG006|Overall Study|Other (Unspecified)|0|||
131900333|NCT03131167|474921464|FG007|Overall Study|Other (Unspecified)|0|||
131900334|NCT03131167|474921465|FG008|Overall Study|Other (Unspecified)|0|||
131900335|NCT03131167|474921466|FG009|Overall Study|Other (Unspecified)|0|||
131900336|NCT03131167|474921467|FG010|Overall Study|Other (Unspecified)|0|||
131900337|NCT03131167|474921468|FG011|Overall Study|Other (Unspecified)|0|||
131900338|NCT03131167|474921469|FG012|Overall Study|Other (Unspecified)|0|||
131900339|NCT03286218|474921470|FG000|Qualification Phase Period 1|Adverse Event|1|||
131900340|NCT03286218|474921471|FG001|Qualification Phase Period 1|Adverse Event|0|||
131442267|NCT01231984|473248812|FG002|Study Period 1|Withdrawal by Subject|0|||
131442268|NCT01231984|473248813|FG003|Study Period 1|Withdrawal by Subject|1|||
131442269|NCT01231984|473248810|FG000|Study Period 1|Lost to Follow-up|1|||
131442270|NCT01231984|473248811|FG001|Study Period 1|Lost to Follow-up|1|||
131442271|NCT01231984|473248812|FG002|Study Period 1|Lost to Follow-up|1|||
131442272|NCT01231984|473248813|FG003|Study Period 1|Lost to Follow-up|0|||
131613449|NCT05580003|473876658|FG005|Part 6 Period 2 (Day 1)|Other|0|||
131613450|NCT05580003|473876659|FG006|Part 6 Period 2 (Day 1)|Other|0|||
131613451|NCT05580003|473876660|FG007|Part 6 Period 2 (Day 1)|Other|0|||
131613452|NCT05580003|473876661|FG008|Part 6 Period 2 (Day 1)|Other|0|||
131613453|NCT05580003|473876662|FG009|Part 6 Period 2 (Day 1)|Other|0|||
131613454|NCT05580003|473876663|FG010|Part 6 Period 2 (Day 1)|Other|0|||
131613455|NCT05580003|473876664|FG011|Part 6 Period 2 (Day 1)|Other|0|||
131613456|NCT05580003|473876665|FG012|Part 6 Period 2 (Day 1)|Other|0|||
131613457|NCT05580003|473876666|FG013|Part 6 Period 2 (Day 1)|Other|0|||
131613458|NCT05580003|473876667|FG014|Part 6 Period 2 (Day 1)|Other|0|||
131613459|NCT05580003|473876668|FG015|Part 6 Period 2 (Day 1)|Other|0|||
131613460|NCT05580003|473876669|FG016|Part 6 Period 2 (Day 1)|Other|0|||
131613461|NCT05580003|473876670|FG017|Part 6 Period 2 (Day 1)|Other|0|||
131613462|NCT05580003|473876671|FG018|Part 6 Period 2 (Day 1)|Other|0|||
131613463|NCT05580003|473876672|FG019|Part 6 Period 2 (Day 1)|Other|0|||
131613464|NCT05580003|473876673|FG020|Part 6 Period 2 (Day 1)|Other|0|||
131613465|NCT05580003|473876674|FG021|Part 6 Period 2 (Day 1)|Other|0|||
131613466|NCT05580003|473876675|FG022|Part 6 Period 2 (Day 1)|Other|0|||
131613467|NCT05580003|473876676|FG023|Part 6 Period 2 (Day 1)|Other|0|||
131613468|NCT05580003|473876677|FG024|Part 6 Period 2 (Day 1)|Other|1|||
131613469|NCT05580003|473876678|FG025|Part 6 Period 2 (Day 1)|Other|0|||
131613470|NCT05580003|473876679|FG026|Part 6 Period 2 (Day 1)|Other|0|||
131613471|NCT05580003|473876680|FG027|Part 6 Period 2 (Day 1)|Other|0|||
131613472|NCT02029235|473876681|FG000|Overall Study|Non-compliance with study meds or diary|4|||
131613473|NCT02029235|473876682|FG001|Overall Study|Non-compliance with study meds or diary|1|||
131613474|NCT01387516|473876683|FG000|Overall Study|Lost to Follow-up|4|||
131613475|NCT01387516|473876684|FG001|Overall Study|Lost to Follow-up|4|||
131613476|NCT01387516|473876685|FG002|Overall Study|Lost to Follow-up|2|||
131613477|NCT01387516|473876686|FG003|Overall Study|Lost to Follow-up|3|||
131613478|NCT01387516|473876683|FG000|Overall Study|Withdrawal by Subject|1|||
131613479|NCT01387516|473876684|FG001|Overall Study|Withdrawal by Subject|1|||
131613480|NCT01387516|473876685|FG002|Overall Study|Withdrawal by Subject|2|||
131613481|NCT01387516|473876686|FG003|Overall Study|Withdrawal by Subject|0|||
131613482|NCT01387516|473876683|FG000|Overall Study|Death|0|||
131613483|NCT01387516|473876684|FG001|Overall Study|Death|0|||
131613484|NCT01387516|473876685|FG002|Overall Study|Death|0|||
131613485|NCT01387516|473876686|FG003|Overall Study|Death|1|||
131613486|NCT04057131|473876687|FG000|Overall Study|Protocol Violation|24|||
131900341|NCT03286218|474921472|FG002|Qualification Phase Period 1|Adverse Event|0|||
131613487|NCT03160885|473876688|FG000|Initial Treatment Period|Not dosed|2|||
131613488|NCT03160885|473876689|FG001|Initial Treatment Period|Not dosed|0|||
131613489|NCT03160885|473876690|FG002|Initial Treatment Period|Not dosed|0|||
131613490|NCT03160885|473876691|FG003|Initial Treatment Period|Not dosed|0|||
131613491|NCT03160885|473876692|FG004|Initial Treatment Period|Not dosed|0|||
131613492|NCT03160885|473876693|FG005|Initial Treatment Period|Not dosed|0|||
131613493|NCT03160885|473876694|FG006|Initial Treatment Period|Not dosed|0|||
131794662|NCT04604184|474530504|FG000|Overall Study|Not treated|2|||
131794663|NCT04604184|474530505|FG001|Overall Study|Not treated|2|||
131613494|NCT03160885|473876688|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
131613495|NCT03160885|473876689|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
131613496|NCT03160885|473876690|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131613497|NCT03160885|473876691|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131794664|NCT04604184|474530504|FG000|Overall Study|Due to sponsor decision|9|||
131794665|NCT04604184|474530505|FG001|Overall Study|Due to sponsor decision|7|||
131794666|NCT04604184|474530504|FG000|Overall Study|Physician Decision|0|||
131613498|NCT03160885|473876692|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131613499|NCT03160885|473876693|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131613500|NCT03160885|473876694|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131613501|NCT03160885|473876688|FG000|Open-label Treatment|Not dosed|0|||
131613502|NCT03160885|473876689|FG001|Open-label Treatment|Not dosed|0|||
131613503|NCT03160885|473876690|FG002|Open-label Treatment|Not dosed|0|||
131613504|NCT03160885|473876691|FG003|Open-label Treatment|Not dosed|0|||
131613505|NCT03160885|473876692|FG004|Open-label Treatment|Not dosed|0|||
131613506|NCT03160885|473876693|FG005|Open-label Treatment|Not dosed|0|||
131613507|NCT03160885|473876694|FG006|Open-label Treatment|Not dosed|2|||
131613508|NCT03160885|473876688|FG000|Open-label Treatment|Discontinued IMP|0|||
131613509|NCT03160885|473876689|FG001|Open-label Treatment|Discontinued IMP|0|||
131613510|NCT03160885|473876690|FG002|Open-label Treatment|Discontinued IMP|0|||
131613511|NCT03160885|473876691|FG003|Open-label Treatment|Discontinued IMP|0|||
131613512|NCT03160885|473876692|FG004|Open-label Treatment|Discontinued IMP|0|||
131613513|NCT03160885|473876693|FG005|Open-label Treatment|Discontinued IMP|0|||
131613514|NCT03160885|473876694|FG006|Open-label Treatment|Discontinued IMP|131|||
131613515|NCT03160885|473876688|FG000|Open-label Treatment|Completed Week 50|0|||
131613516|NCT03160885|473876689|FG001|Open-label Treatment|Completed Week 50|0|||
131794667|NCT04604184|474530505|FG001|Overall Study|Physician Decision|1|||
131613517|NCT03160885|473876690|FG002|Open-label Treatment|Completed Week 50|0|||
131794668|NCT04604184|474530504|FG000|Overall Study|Transfer to healthcare|1|||
131794669|NCT04604184|474530505|FG001|Overall Study|Transfer to healthcare|0|||
131794670|NCT01751412|474530506|FG000|Overall Study|Disease Progression Before Treatment|1|||
131613518|NCT03160885|473876691|FG003|Open-label Treatment|Completed Week 50|0|||
131613519|NCT03160885|473876692|FG004|Open-label Treatment|Completed Week 50|0|||
131613520|NCT03160885|473876693|FG005|Open-label Treatment|Completed Week 50|0|||
131613521|NCT03160885|473876694|FG006|Open-label Treatment|Completed Week 50|4|||
131900342|NCT03286218|474921473|FG003|Qualification Phase Period 1|Adverse Event|0|||
131900343|NCT03286218|474921474|FG004|Qualification Phase Period 1|Adverse Event|0|||
131900344|NCT03286218|474921475|FG005|Qualification Phase Period 1|Adverse Event|0|||
131900345|NCT03286218|474921476|FG006|Qualification Phase Period 1|Adverse Event|0|||
131900346|NCT03286218|474921477|FG007|Qualification Phase Period 1|Adverse Event|0|||
131900347|NCT03286218|474921478|FG008|Qualification Phase Period 1|Adverse Event|0|||
131900348|NCT03286218|474921479|FG009|Qualification Phase Period 1|Adverse Event|0|||
131900349|NCT03286218|474921480|FG010|Qualification Phase Period 1|Adverse Event|0|||
131900350|NCT03286218|474921481|FG011|Qualification Phase Period 1|Adverse Event|0|||
131900351|NCT03286218|474921470|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900352|NCT03286218|474921471|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
131613522|NCT03160885|473876688|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131613523|NCT03160885|473876689|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131613524|NCT03160885|473876690|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131613525|NCT03160885|473876691|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
131613526|NCT03160885|473876692|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131613527|NCT03160885|473876693|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131613528|NCT03160885|473876694|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131613529|NCT03160885|473876688|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
131613530|NCT03160885|473876689|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
131613531|NCT03160885|473876690|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
131613532|NCT03160885|473876691|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
131613533|NCT03160885|473876692|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
131613534|NCT03160885|473876693|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
131708568|NCT00582556|474213318|FG001|Overall Study|Physician Decision|0|||
131900353|NCT03286218|474921472|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900354|NCT03286218|474921473|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900355|NCT03286218|474921474|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
131708569|NCT00582556|474213319|FG002|Overall Study|Physician Decision|1|||
131708570|NCT01993888|474213320|FG000|Overall Study|Death|1|||
131708571|NCT01993888|474213321|FG001|Overall Study|Death|1|||
131900356|NCT03286218|474921475|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900357|NCT03286218|474921476|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900358|NCT03286218|474921477|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900359|NCT03286218|474921478|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900360|NCT03286218|474921479|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900361|NCT03286218|474921480|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900362|NCT03286218|474921481|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
131900363|NCT03286218|474921470|FG000|Qualification Phase Period 2|Adverse Event|0|||
131613535|NCT03160885|473876694|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
131613536|NCT03160885|473876688|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131708572|NCT01993888|474213320|FG000|Overall Study|Lost to Follow-up|1|||
131708573|NCT01993888|474213321|FG001|Overall Study|Lost to Follow-up|1|||
131708574|NCT01993888|474213320|FG000|Overall Study|Withdrawal by Subject|0|||
131613537|NCT03160885|473876689|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131613538|NCT03160885|473876690|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
131613539|NCT03160885|473876691|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
131613540|NCT03160885|473876692|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
131613541|NCT03160885|473876693|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
131613542|NCT03160885|473876694|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131613543|NCT03160885|473876688|FG000|Maintenance Treatment Period|Completed Week 50|0|||
131613544|NCT03160885|473876689|FG001|Maintenance Treatment Period|Completed Week 50|0|||
131613545|NCT03160885|473876690|FG002|Maintenance Treatment Period|Completed Week 50|1|||
131613546|NCT03160885|473876691|FG003|Maintenance Treatment Period|Completed Week 50|0|||
131613547|NCT03160885|473876692|FG004|Maintenance Treatment Period|Completed Week 50|0|||
131613548|NCT03160885|473876693|FG005|Maintenance Treatment Period|Completed Week 50|0|||
131613549|NCT03160885|473876694|FG006|Maintenance Treatment Period|Completed Week 50|0|||
131613550|NCT05704725|473876698|FG000|Overall Study|Lost to Follow-up|0|||
131613551|NCT05704725|473876699|FG001|Overall Study|Lost to Follow-up|1|||
131613552|NCT05704725|473876698|FG000|Overall Study|Withdrawal by Subject|1|||
131613553|NCT05704725|473876699|FG001|Overall Study|Withdrawal by Subject|0|||
131613554|NCT00210106|473878273|FG000|Overall Study|Death|1|||
131613555|NCT00210106|473878273|FG000|Overall Study|Protocol Violation|13|||
131613556|NCT00065182|473878277|FG000|Overall Study|Adverse Event|24|||
131613557|NCT00065182|473878278|FG001|Overall Study|Adverse Event|17|||
131613558|NCT00065182|473878277|FG000|Overall Study|Lost to Follow-up|0|||
131613559|NCT00065182|473878278|FG001|Overall Study|Lost to Follow-up|4|||
131613560|NCT00065182|473878277|FG000|Overall Study|Protocol Violation|3|||
131613561|NCT00065182|473878278|FG001|Overall Study|Protocol Violation|4|||
131613562|NCT00065182|473878277|FG000|Overall Study|Serious adverse events (SAE)|1|||
131613563|NCT00065182|473878278|FG001|Overall Study|Serious adverse events (SAE)|0|||
131613564|NCT00065182|473878277|FG000|Overall Study|Sponsor Decision|11|||
131613565|NCT00065182|473878278|FG001|Overall Study|Sponsor Decision|7|||
131613566|NCT00065182|473878277|FG000|Overall Study|Withdrawal by Subject|8|||
131613567|NCT00065182|473878278|FG001|Overall Study|Withdrawal by Subject|3|||
131613568|NCT00065182|473878277|FG000|Overall Study|No clinical benefit|1|||
131613569|NCT00065182|473878278|FG001|Overall Study|No clinical benefit|0|||
131613570|NCT00065182|473878277|FG000|Overall Study|Death|0|||
131613571|NCT00065182|473878278|FG001|Overall Study|Death|1|||
131613572|NCT00065182|473878277|FG000|Overall Study|Decline in Status|0|||
131613573|NCT00065182|473878278|FG001|Overall Study|Decline in Status|1|||
131613574|NCT04017611|473878279|FG000|Overall Study|Withdrawn prior to completion|1|||
131613575|NCT04876417|473878282|FG000|Overall Study|Lost to Follow-up|5|||
131613576|NCT04876417|473878283|FG001|Overall Study|Lost to Follow-up|8|||
131613577|NCT04876417|473878284|FG002|Overall Study|Lost to Follow-up|0|||
131794671|NCT03734237|474530509|FG000|Overall Study|Lost to Follow-up|1|||
131794672|NCT03734237|474530510|FG001|Overall Study|Lost to Follow-up|3|||
131794673|NCT03734237|474530511|FG002|Overall Study|Lost to Follow-up|0|||
131794674|NCT03734237|474530509|FG000|Overall Study|Withdrawal by Subject|7|||
131794675|NCT03734237|474530510|FG001|Overall Study|Withdrawal by Subject|9|||
131794676|NCT03734237|474530511|FG002|Overall Study|Withdrawal by Subject|10|||
131794677|NCT02711956|474530512|FG000|Overall Study|Adverse Event|0|||
131613578|NCT04876417|473878285|FG003|Overall Study|Lost to Follow-up|0|||
131613579|NCT03801148|473878286|FG000|Period 1 (2 Days)|Adverse Event|1|||
131613580|NCT03801148|473878287|FG001|Period 1 (2 Days)|Adverse Event|1|||
131613581|NCT03801148|473878288|FG002|Period 1 (2 Days)|Adverse Event|0|||
131613582|NCT03801148|473878289|FG003|Period 1 (2 Days)|Adverse Event|0|||
131613583|NCT03801148|473878286|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131613584|NCT03801148|473878287|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131794678|NCT02711956|474530513|FG001|Overall Study|Adverse Event|0|||
131794679|NCT02711956|474530514|FG002|Overall Study|Adverse Event|0|||
131708575|NCT01993888|474213321|FG001|Overall Study|Withdrawal by Subject|1|||
131708576|NCT00365989|474213322|FG000|Overall Study|Withdrawal by Subject|1|||
131708577|NCT00365989|474213322|FG000|Overall Study|Non-compliance|1|||
131708578|NCT00832819|474213324|FG000|Overall Study|Adverse Event|0|||
131708579|NCT00832819|474213325|FG001|Overall Study|Adverse Event|1|||
131708580|NCT00832819|474213326|FG002|Overall Study|Adverse Event|0|||
131708581|NCT00832819|474213324|FG000|Overall Study|Protocol Violation|0|||
131708582|NCT00832819|474213325|FG001|Overall Study|Protocol Violation|0|||
131708583|NCT00832819|474213326|FG002|Overall Study|Protocol Violation|1|||
131794680|NCT02711956|474530515|FG003|Overall Study|Adverse Event|1|||
131794681|NCT02711956|474530516|FG004|Overall Study|Adverse Event|2|||
131794682|NCT02711956|474530517|FG005|Overall Study|Adverse Event|0|||
131442273|NCT01231984|473248810|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
131442274|NCT01231984|473248811|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
131442275|NCT01231984|473248812|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
131442276|NCT01231984|473248813|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
131442277|NCT01231984|473248810|FG000|Study Period 1|Screen Failure|0|||
131442278|NCT01231984|473248811|FG001|Study Period 1|Screen Failure|0|||
131442279|NCT01231984|473248812|FG002|Study Period 1|Screen Failure|0|||
131442280|NCT01231984|473248813|FG003|Study Period 1|Screen Failure|1|||
131442281|NCT01231984|473248810|FG000|Study Period 1|Non-compliance with study requirements|5|||
131442282|NCT01231984|473248811|FG001|Study Period 1|Non-compliance with study requirements|0|||
131442283|NCT01231984|473248812|FG002|Study Period 1|Non-compliance with study requirements|2|||
131442284|NCT01231984|473248813|FG003|Study Period 1|Non-compliance with study requirements|1|||
131442285|NCT01231984|473248810|FG000|Study Period 1|Protocol Violation|3|||
131442286|NCT01231984|473248811|FG001|Study Period 1|Protocol Violation|4|||
131442287|NCT01231984|473248812|FG002|Study Period 1|Protocol Violation|2|||
131442288|NCT01231984|473248813|FG003|Study Period 1|Protocol Violation|3|||
131442289|NCT01231984|473248810|FG000|Study Period 1|Adverse Event|1|||
131442290|NCT01231984|473248811|FG001|Study Period 1|Adverse Event|0|||
131442291|NCT01231984|473248812|FG002|Study Period 1|Adverse Event|0|||
131442292|NCT01231984|473248813|FG003|Study Period 1|Adverse Event|0|||
131442293|NCT01231984|473248810|FG000|Study Period 1|Other|0|||
131442294|NCT01231984|473248811|FG001|Study Period 1|Other|0|||
131442295|NCT01231984|473248812|FG002|Study Period 1|Other|0|||
131442296|NCT01231984|473248813|FG003|Study Period 1|Other|1|||
131442297|NCT01231984|473248810|FG000|Study Period 2|Withdrawal by Subject|1|||
131442298|NCT01231984|473248811|FG001|Study Period 2|Withdrawal by Subject|1|||
131442299|NCT01231984|473248812|FG002|Study Period 2|Withdrawal by Subject|0|||
131442300|NCT01231984|473248813|FG003|Study Period 2|Withdrawal by Subject|0|||
131442301|NCT01231984|473248810|FG000|Study Period 2|Lost to Follow-up|1|||
131442302|NCT01231984|473248811|FG001|Study Period 2|Lost to Follow-up|0|||
131442303|NCT01231984|473248812|FG002|Study Period 2|Lost to Follow-up|0|||
131442304|NCT01231984|473248813|FG003|Study Period 2|Lost to Follow-up|3|||
131442305|NCT01231984|473248810|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
131442306|NCT01231984|473248811|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
131442307|NCT01231984|473248812|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
131442308|NCT01231984|473248813|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
131442309|NCT02766023|473248816|FG000|Overall Study|Lost to Follow-up|23|||
131442310|NCT02766023|473248817|FG001|Overall Study|Lost to Follow-up|11|||
131442311|NCT02766023|473248816|FG000|Overall Study|Pregnancy|1|||
131442312|NCT02766023|473248817|FG001|Overall Study|Pregnancy|0|||
131442313|NCT02766023|473248816|FG000|Overall Study|Adverse Event|1|||
131442314|NCT02766023|473248817|FG001|Overall Study|Adverse Event|0|||
131442315|NCT02766023|473248816|FG000|Overall Study|Withdrawal by Subject|4|||
131794683|NCT02711956|474530518|FG006|Overall Study|Adverse Event|0|||
131794684|NCT02711956|474530519|FG007|Overall Study|Adverse Event|1|||
131794685|NCT02711956|474530520|FG008|Overall Study|Adverse Event|1|||
131794686|NCT02711956|474530521|FG009|Overall Study|Adverse Event|1|||
131794687|NCT02711956|474530522|FG010|Overall Study|Adverse Event|1|||
131794688|NCT02711956|474530523|FG011|Overall Study|Adverse Event|0|||
131442316|NCT02766023|473248817|FG001|Overall Study|Withdrawal by Subject|5|||
131442317|NCT02766023|473248816|FG000|Overall Study|Physician Decision|1|||
131442318|NCT02766023|473248817|FG001|Overall Study|Physician Decision|0|||
131708584|NCT00851903|474213327|FG000|Overall Study|Withdrawal by Subject|2|||
131708585|NCT02318095|474213328|FG000|Overall Study|Adverse Event|1|||
131708586|NCT00686127|474213329|FG000|Overall Study|Withdrawal by Subject|14|||
131794689|NCT02711956|474530524|FG012|Overall Study|Adverse Event|0|||
131442319|NCT02766023|473248816|FG000|Overall Study|Not Eligible at Enrollment|0|||
131442320|NCT02766023|473248817|FG001|Overall Study|Not Eligible at Enrollment|1|||
131442321|NCT01488045|473248818|FG000|Overall Study|Withdrawal by Subject|6|||
131442322|NCT01488045|473248819|FG001|Overall Study|Withdrawal by Subject|11|||
131900364|NCT03286218|474921471|FG001|Qualification Phase Period 2|Adverse Event|1|||
131442323|NCT01488045|473248818|FG000|Overall Study|Failure to present for colonoscopy|3|||
131708587|NCT00686127|474213330|FG001|Overall Study|Withdrawal by Subject|6|||
131708588|NCT02300129|474213331|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
131794690|NCT02711956|474530525|FG013|Overall Study|Adverse Event|0|||
131613585|NCT03801148|473878288|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131613586|NCT03801148|473878289|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
131613587|NCT03801148|473878286|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131613588|NCT03801148|473878287|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131613589|NCT03801148|473878288|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
131613590|NCT03801148|473878289|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131613591|NCT03801148|473878286|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
131613592|NCT03801148|473878287|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
131613593|NCT03801148|473878288|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
131613594|NCT03801148|473878289|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
131613595|NCT00366249|473878293|FG000|Overall Study|Adverse Event|53|||
131613596|NCT00366249|473878294|FG001|Overall Study|Adverse Event|28|||
131613597|NCT00366249|473878293|FG000|Overall Study|Death|0|||
131613598|NCT00366249|473878294|FG001|Overall Study|Death|1|||
131613599|NCT00366249|473878293|FG000|Overall Study|Physician Decision|5|||
131613600|NCT00366249|473878294|FG001|Overall Study|Physician Decision|2|||
131613601|NCT00366249|473878293|FG000|Overall Study|Lost to Follow-up|2|||
131613602|NCT00366249|473878294|FG001|Overall Study|Lost to Follow-up|0|||
131613603|NCT00366249|473878293|FG000|Overall Study|Protocol Violation|1|||
131613604|NCT00366249|473878294|FG001|Overall Study|Protocol Violation|2|||
131613605|NCT00366249|473878293|FG000|Overall Study|Withdrawal by Subject|18|||
131613606|NCT00366249|473878294|FG001|Overall Study|Withdrawal by Subject|4|||
131613607|NCT00366249|473878293|FG000|Overall Study|Lack of Efficacy|21|||
131613608|NCT00366249|473878294|FG001|Overall Study|Lack of Efficacy|21|||
131613609|NCT00366249|473878293|FG000|Overall Study|Most due to osteomylitis status|31|||
131613610|NCT00366249|473878294|FG001|Overall Study|Most due to osteomylitis status|20|||
131613611|NCT00724126|473878295|FG000|Overall Study|Adverse Event|2|||
131613612|NCT00724126|473878296|FG001|Overall Study|Adverse Event|0|||
131613613|NCT00724126|473878295|FG000|Overall Study|Withdrawal by Subject|8|||
131613614|NCT00724126|473878296|FG001|Overall Study|Withdrawal by Subject|6|||
131613615|NCT00724126|473878295|FG000|Overall Study|Lost to Follow-up|6|||
131613616|NCT00724126|473878296|FG001|Overall Study|Lost to Follow-up|6|||
131613617|NCT00724126|473878295|FG000|Overall Study|Noncompliance|2|||
131613618|NCT00724126|473878296|FG001|Overall Study|Noncompliance|1|||
131613619|NCT00724126|473878295|FG000|Overall Study|Subject randomized although ineligible|1|||
131613620|NCT00724126|473878296|FG001|Overall Study|Subject randomized although ineligible|1|||
131613621|NCT00724126|473878295|FG000|Overall Study|Subject had to leave vicinity of site|0|||
131613622|NCT00724126|473878296|FG001|Overall Study|Subject had to leave vicinity of site|1|||
131613623|NCT03577106|473878298|FG000|Overall Study|Withdrawal by Subject|3|||
131613624|NCT04191824|473878305|FG000|Overall Study|Death|13|||
131613625|NCT04191824|473878306|FG001|Overall Study|Death|12|||
131613626|NCT04191824|473878305|FG000|Overall Study|Lost to Follow-up|456|||
131613627|NCT04191824|473878306|FG001|Overall Study|Lost to Follow-up|435|||
131613628|NCT04191824|473878305|FG000|Overall Study|Physician Decision|2|||
131613629|NCT04191824|473878306|FG001|Overall Study|Physician Decision|1|||
131708589|NCT02300129|474213332|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
131708590|NCT02300129|474213333|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
131708591|NCT02300129|474213334|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
131708592|NCT02300129|474213331|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
131708593|NCT02300129|474213332|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
131708594|NCT02300129|474213333|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
131708595|NCT02300129|474213334|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
131708596|NCT02300129|474213331|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
131708597|NCT02300129|474213332|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
131708598|NCT02300129|474213333|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
131708599|NCT02300129|474213334|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
131708600|NCT05742984|474213335|FG000|Overall Study|Adverse Event|0|||
131708601|NCT05742984|474213336|FG001|Overall Study|Adverse Event|0|||
131708602|NCT05742984|474213337|FG002|Overall Study|Adverse Event|1|||
131708603|NCT05742984|474213338|FG003|Overall Study|Adverse Event|0|||
131708604|NCT05742984|474213339|FG004|Overall Study|Adverse Event|1|||
131708605|NCT05742984|474213340|FG005|Overall Study|Adverse Event|1|||
131708606|NCT05742984|474213335|FG000|Overall Study|Withdrawal by Subject|0|||
131708607|NCT05742984|474213336|FG001|Overall Study|Withdrawal by Subject|1|||
131708608|NCT05742984|474213337|FG002|Overall Study|Withdrawal by Subject|0|||
131708609|NCT05742984|474213338|FG003|Overall Study|Withdrawal by Subject|0|||
131708610|NCT05742984|474213339|FG004|Overall Study|Withdrawal by Subject|0|||
131708611|NCT05742984|474213340|FG005|Overall Study|Withdrawal by Subject|2|||
131708612|NCT00379340|474213341|FG000|Overall Study|Death|0|||
131708613|NCT00379340|474213342|FG001|Overall Study|Death|0|||
131708614|NCT00379340|474213343|FG002|Overall Study|Death|0|||
131708615|NCT00379340|474213344|FG003|Overall Study|Death|2|||
131613630|NCT04191824|473878305|FG000|Overall Study|Protocol Violation|0|||
131613631|NCT04191824|473878306|FG001|Overall Study|Protocol Violation|2|||
131613632|NCT04191824|473878305|FG000|Overall Study|Withdrawal by Subject|16|||
131613633|NCT04191824|473878306|FG001|Overall Study|Withdrawal by Subject|18|||
131613634|NCT04191824|473878305|FG000|Overall Study|Early site closure|24|||
131613635|NCT04191824|473878306|FG001|Overall Study|Early site closure|22|||
131613636|NCT00293397|473878309|FG000|Overall Study|Death|2|||
131613637|NCT00523419|473878310|FG000|Overall Study|Adverse Event|1|||
131613638|NCT00523419|473878310|FG000|Overall Study|Withdrawal by Subject|1|||
131613639|NCT00523419|473878310|FG000|Overall Study|Physician Decision|2|||
131613640|NCT00523419|473878310|FG000|Overall Study|Progressive Disease|22|||
131613641|NCT00523419|473878310|FG000|Overall Study|Death due to Study Disease|4|||
131613642|NCT00523419|473878310|FG000|Overall Study|Death due to Adverse Event|2|||
131613643|NCT01437319|473878314|FG000|Phase I|Lost to Follow-up|2|||
131613644|NCT01437319|473878315|FG001|Phase I|Lost to Follow-up|0|||
131613645|NCT01437319|473878316|FG002|Phase I|Lost to Follow-up|0|||
131613646|NCT01437319|473878314|FG000|Phase I|Protocol Violation|1|||
131613647|NCT01437319|473878315|FG001|Phase I|Protocol Violation|0|||
131613648|NCT01437319|473878316|FG002|Phase I|Protocol Violation|0|||
131613649|NCT01437319|473878314|FG000|Phase I|Study related symptoms/complaints|27|||
131613650|NCT01437319|473878315|FG001|Phase I|Study related symptoms/complaints|0|||
131613651|NCT01437319|473878316|FG002|Phase I|Study related symptoms/complaints|0|||
131613652|NCT01437319|473878314|FG000|Phase I|Withdrawal by Subject|25|||
131613653|NCT01437319|473878315|FG001|Phase I|Withdrawal by Subject|0|||
131613654|NCT01437319|473878316|FG002|Phase I|Withdrawal by Subject|0|||
131794691|NCT02711956|474530526|FG014|Overall Study|Adverse Event|2|||
131794692|NCT02711956|474530512|FG000|Overall Study|Physician Decision|0|||
131794693|NCT02711956|474530513|FG001|Overall Study|Physician Decision|0|||
131794694|NCT02711956|474530514|FG002|Overall Study|Physician Decision|0|||
131613655|NCT01437319|473878314|FG000|Phase II|Withdrawal by Subject|0|||
131794695|NCT02711956|474530515|FG003|Overall Study|Physician Decision|2|||
131613656|NCT01437319|473878315|FG001|Phase II|Withdrawal by Subject|8|||
131613657|NCT01437319|473878316|FG002|Phase II|Withdrawal by Subject|16|||
131613658|NCT01437319|473878314|FG000|Phase II|Lost to Follow-up|0|||
131613659|NCT01437319|473878315|FG001|Phase II|Lost to Follow-up|7|||
131613660|NCT01437319|473878316|FG002|Phase II|Lost to Follow-up|2|||
131708616|NCT00379340|474213345|FG004|Overall Study|Death|0|||
131708617|NCT00379340|474213341|FG000|Overall Study|Lack of Efficacy|6|||
131708618|NCT00379340|474213342|FG001|Overall Study|Lack of Efficacy|1|||
131708619|NCT00379340|474213343|FG002|Overall Study|Lack of Efficacy|0|||
131708620|NCT00379340|474213344|FG003|Overall Study|Lack of Efficacy|4|||
131708621|NCT00379340|474213345|FG004|Overall Study|Lack of Efficacy|3|||
131708622|NCT00379340|474213341|FG000|Overall Study|Physician Decision|6|||
131708623|NCT00379340|474213342|FG001|Overall Study|Physician Decision|2|||
131708624|NCT00379340|474213343|FG002|Overall Study|Physician Decision|1|||
131794696|NCT02711956|474530516|FG004|Overall Study|Physician Decision|0|||
131794697|NCT02711956|474530517|FG005|Overall Study|Physician Decision|0|||
131794698|NCT02711956|474530518|FG006|Overall Study|Physician Decision|0|||
131708625|NCT00379340|474213344|FG003|Overall Study|Physician Decision|2|||
131708626|NCT00379340|474213345|FG004|Overall Study|Physician Decision|3|||
131708627|NCT00379340|474213341|FG000|Overall Study|Withdrawal by Subject|0|||
131708628|NCT00379340|474213342|FG001|Overall Study|Withdrawal by Subject|0|||
131442324|NCT01488045|473248819|FG001|Overall Study|Failure to present for colonoscopy|6|||
131442325|NCT01488045|473248818|FG000|Overall Study|Failure to report exclusion criteria|0|||
131442326|NCT01488045|473248819|FG001|Overall Study|Failure to report exclusion criteria|1|||
131442327|NCT05365217|473248822|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131442328|NCT05365217|473248823|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131442329|NCT01527149|473248826|FG000|Overall Study|Death|2|||
131442330|NCT01680341|473248828|FG000|Overall Study|Adverse Event|3|||
131442331|NCT01680341|473248829|FG001|Overall Study|Adverse Event|2|||
131442332|NCT01680341|473248828|FG000|Overall Study|Unclassified|18|||
131442333|NCT01680341|473248829|FG001|Overall Study|Unclassified|15|||
131442334|NCT00481832|473248830|FG000|Enrollment|Physician Decision|8|||
131442335|NCT00481832|473248830|FG000|Enrollment|Unable to collect enough stem cells|2|||
131442336|NCT00481832|473248830|FG000|Inter-transplant Period|Adverse Event|4|||
131442337|NCT00481832|473248830|FG000|Inter-transplant Period|Death|3|||
131442338|NCT00481832|473248830|FG000|Inter-transplant Period|Physician Decision|4|||
131442339|NCT00481832|473248830|FG000|Inter-transplant Period|Disease relapse|11|||
131442340|NCT00481832|473248830|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
131442341|NCT02558894|473248833|FG000|Overall Study|Death; any cause, entire study duration|28|||
131442342|NCT02558894|473248834|FG001|Overall Study|Death; any cause, entire study duration|31|||
131442343|NCT02558894|473248833|FG000|Overall Study|Withdrawal by Subject|2|||
131442344|NCT02558894|473248834|FG001|Overall Study|Withdrawal by Subject|1|||
131442345|NCT02558894|473248833|FG000|Overall Study|Closure of Part A|2|||
131442346|NCT02558894|473248834|FG001|Overall Study|Closure of Part A|1|||
131442347|NCT02006472|473248838|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
131442348|NCT02006472|473248839|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
131442349|NCT02006472|473248840|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
131442350|NCT02006472|473248841|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
131442351|NCT02006472|473248842|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
131442352|NCT02006472|473248838|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
131442353|NCT02006472|473248839|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
131442354|NCT02006472|473248840|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
131442355|NCT02006472|473248841|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
131442356|NCT02006472|473248842|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
131442357|NCT02006472|473248838|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
131442358|NCT02006472|473248839|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
131442359|NCT02006472|473248840|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
131442360|NCT02006472|473248841|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
131442361|NCT02006472|473248842|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
131442362|NCT02006472|473248838|FG000|Period 1 (Through Week 26)|Other|1|||
131442363|NCT02006472|473248839|FG001|Period 1 (Through Week 26)|Other|5|||
131442364|NCT02006472|473248840|FG002|Period 1 (Through Week 26)|Other|0|||
131442365|NCT02006472|473248841|FG003|Period 1 (Through Week 26)|Other|2|||
131442366|NCT02006472|473248842|FG004|Period 1 (Through Week 26)|Other|3|||
131442367|NCT02006472|473248838|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
131442368|NCT02006472|473248839|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
131442369|NCT02006472|473248840|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
131442370|NCT02006472|473248841|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
131442371|NCT02006472|473248842|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
131442372|NCT02006472|473248838|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
131442373|NCT02006472|473248839|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
131442374|NCT02006472|473248840|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
131442375|NCT02006472|473248841|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
131442376|NCT02006472|473248842|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
131442377|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
131442378|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
131442379|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
131442380|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
131442381|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
131442382|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
131442383|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
131442384|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
131442385|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
131442386|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
131442387|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
131442388|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
131900365|NCT03286218|474921472|FG002|Qualification Phase Period 2|Adverse Event|0|||
131442389|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
131442390|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
131442391|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
131708629|NCT00379340|474213343|FG002|Overall Study|Withdrawal by Subject|0|||
131900366|NCT03286218|474921473|FG003|Qualification Phase Period 2|Adverse Event|0|||
131442392|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Other|0|||
131442393|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Other|1|||
131442394|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Other|0|||
131442395|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Other|1|||
131442396|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Other|0|||
131442397|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Not treated|0|||
131442398|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Not treated|0|||
131442399|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Not treated|2|||
131613661|NCT01437319|473878314|FG000|Phase II|Study related symptoms/complaints|0|||
131613662|NCT01437319|473878315|FG001|Phase II|Study related symptoms/complaints|28|||
131613663|NCT01437319|473878316|FG002|Phase II|Study related symptoms/complaints|19|||
131613664|NCT01437319|473878314|FG000|Phase II|Protocol Violation|0|||
131613665|NCT01437319|473878315|FG001|Phase II|Protocol Violation|1|||
131613666|NCT01437319|473878316|FG002|Phase II|Protocol Violation|0|||
131613667|NCT01499849|473878317|FG000|Overall Study|Adverse Event|28|||
131613668|NCT01499849|473878318|FG001|Overall Study|Adverse Event|32|||
131613669|NCT01499849|473878317|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
131613670|NCT01499849|473878318|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
131613671|NCT01499849|473878317|FG000|Overall Study|Withdrawal by Subject|43|||
131613672|NCT01499849|473878318|FG001|Overall Study|Withdrawal by Subject|43|||
131613673|NCT01499849|473878317|FG000|Overall Study|Death|5|||
131613674|NCT01499849|473878318|FG001|Overall Study|Death|7|||
131613675|NCT01499849|473878317|FG000|Overall Study|Disease Progression|11|||
131613676|NCT01499849|473878318|FG001|Overall Study|Disease Progression|10|||
131613677|NCT01499849|473878317|FG000|Overall Study|Protocol Violation|11|||
131613678|NCT01499849|473878318|FG001|Overall Study|Protocol Violation|11|||
131613679|NCT01499849|473878317|FG000|Overall Study|Physician Decision|20|||
131613680|NCT01499849|473878318|FG001|Overall Study|Physician Decision|19|||
131613681|NCT01499849|473878317|FG000|Overall Study|Lack of Efficacy|3|||
131613682|NCT01499849|473878318|FG001|Overall Study|Lack of Efficacy|4|||
131613683|NCT01499849|473878317|FG000|Overall Study|Lost to Follow-up|6|||
131613684|NCT01499849|473878318|FG001|Overall Study|Lost to Follow-up|3|||
131613685|NCT01499849|473878317|FG000|Overall Study|Other Reasons|27|||
131613686|NCT01499849|473878318|FG001|Overall Study|Other Reasons|30|||
131613687|NCT00174252|473878319|FG000|Overall Study|Protocol Violation|2|||
131613688|NCT00811941|473878320|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
131613689|NCT00811941|473878321|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
131613690|NCT00811941|473878320|FG000|All Treated Patients|Adverse Event|2|||
131613691|NCT00811941|473878321|FG001|All Treated Patients|Adverse Event|43|||
131613692|NCT00811941|473878320|FG000|All Treated Patients|Lack of Efficacy|2|||
131613693|NCT00811941|473878321|FG001|All Treated Patients|Lack of Efficacy|3|||
131613694|NCT00811941|473878320|FG000|All Treated Patients|Non-compliance|1|||
131613695|NCT00811941|473878321|FG001|All Treated Patients|Non-compliance|8|||
131613696|NCT00811941|473878320|FG000|All Treated Patients|Protocol Violation|5|||
131613697|NCT00811941|473878321|FG001|All Treated Patients|Protocol Violation|17|||
131613698|NCT00811941|473878320|FG000|All Treated Patients|Withdrawal by Subject|35|||
131613699|NCT00811941|473878321|FG001|All Treated Patients|Withdrawal by Subject|94|||
131613700|NCT00811941|473878320|FG000|All Treated Patients|Lost to Follow-up|3|||
131613701|NCT00811941|473878321|FG001|All Treated Patients|Lost to Follow-up|12|||
131613702|NCT00811941|473878320|FG000|All Treated Patients|Other Reason|4|||
131613703|NCT00811941|473878321|FG001|All Treated Patients|Other Reason|14|||
131613704|NCT03802994|473878322|FG000|Overall Study|Lost to Follow-up|0|||
131613705|NCT03802994|473878323|FG001|Overall Study|Lost to Follow-up|2|||
131613706|NCT03802994|473878324|FG002|Overall Study|Lost to Follow-up|3|||
131613707|NCT03802994|473878325|FG003|Overall Study|Lost to Follow-up|2|||
131613708|NCT03802994|473878326|FG004|Overall Study|Lost to Follow-up|2|||
131613709|NCT00622700|473878332|FG000|Core Treatment Period|Randomized but Not Treated|0|||
131613710|NCT00622700|473878333|FG001|Core Treatment Period|Randomized but Not Treated|2|||
131613711|NCT00622700|473878334|FG002|Core Treatment Period|Randomized but Not Treated|2|||
131613712|NCT00622700|473878335|FG003|Core Treatment Period|Randomized but Not Treated|0|||
131613713|NCT00622700|473878336|FG004|Core Treatment Period|Randomized but Not Treated|0|||
131613714|NCT00622700|473878337|FG005|Core Treatment Period|Randomized but Not Treated|0|||
131613715|NCT00622700|473878338|FG006|Core Treatment Period|Randomized but Not Treated|0|||
131613716|NCT00622700|473878332|FG000|Core Treatment Period|Adverse Event|18|||
131613717|NCT00622700|473878333|FG001|Core Treatment Period|Adverse Event|25|||
131613718|NCT00622700|473878334|FG002|Core Treatment Period|Adverse Event|18|||
131613719|NCT00622700|473878335|FG003|Core Treatment Period|Adverse Event|0|||
131613720|NCT00622700|473878336|FG004|Core Treatment Period|Adverse Event|0|||
131613721|NCT00622700|473878337|FG005|Core Treatment Period|Adverse Event|0|||
131613722|NCT00622700|473878338|FG006|Core Treatment Period|Adverse Event|0|||
131613723|NCT00622700|473878332|FG000|Core Treatment Period|Lack of Efficacy|19|||
131613724|NCT00622700|473878333|FG001|Core Treatment Period|Lack of Efficacy|6|||
131613725|NCT00622700|473878334|FG002|Core Treatment Period|Lack of Efficacy|12|||
131794699|NCT02711956|474530519|FG007|Overall Study|Physician Decision|0|||
131794700|NCT02711956|474530520|FG008|Overall Study|Physician Decision|0|||
131613726|NCT00622700|473878335|FG003|Core Treatment Period|Lack of Efficacy|0|||
131613727|NCT00622700|473878336|FG004|Core Treatment Period|Lack of Efficacy|0|||
131613728|NCT00622700|473878337|FG005|Core Treatment Period|Lack of Efficacy|0|||
131442400|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Not treated|0|||
131708630|NCT00379340|474213344|FG003|Overall Study|Withdrawal by Subject|1|||
131708631|NCT00379340|474213345|FG004|Overall Study|Withdrawal by Subject|0|||
131708632|NCT00379340|474213341|FG000|Overall Study|Refusal of further protocol therapy|1|||
131708633|NCT00379340|474213342|FG001|Overall Study|Refusal of further protocol therapy|0|||
131708634|NCT00379340|474213343|FG002|Overall Study|Refusal of further protocol therapy|1|||
131708635|NCT00379340|474213344|FG003|Overall Study|Refusal of further protocol therapy|1|||
131708636|NCT00379340|474213345|FG004|Overall Study|Refusal of further protocol therapy|7|||
131708637|NCT00379340|474213341|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
131708638|NCT00379340|474213342|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
131708639|NCT00379340|474213343|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
131708640|NCT00379340|474213344|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
131708641|NCT00379340|474213345|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
131708642|NCT00379340|474213341|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
131708643|NCT00379340|474213342|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
131708644|NCT00379340|474213343|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
131708645|NCT00379340|474213344|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
131708646|NCT00379340|474213345|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
131708647|NCT02162862|474213348|FG000|Overall Study|Lost to Follow-up|0|||
131708648|NCT02162862|474213349|FG001|Overall Study|Lost to Follow-up|11|||
131708649|NCT02162862|474213350|FG002|Overall Study|Lost to Follow-up|0|||
131708650|NCT02162862|474213348|FG000|Overall Study|Subject did not feel the med was needed|0|||
131708651|NCT02162862|474213349|FG001|Overall Study|Subject did not feel the med was needed|0|||
131708652|NCT02162862|474213350|FG002|Overall Study|Subject did not feel the med was needed|4|||
131708653|NCT00522392|474213351|FG000|Overall Study|Disease progression|0|||
131708654|NCT00522392|474213352|FG001|Overall Study|Disease progression|3|||
131708655|NCT00522392|474213351|FG000|Overall Study|Adverse Event|7|||
131708656|NCT00522392|474213352|FG001|Overall Study|Adverse Event|7|||
131708657|NCT00522392|474213351|FG000|Overall Study|Withdrawal by Subject|1|||
131708658|NCT00522392|474213352|FG001|Overall Study|Withdrawal by Subject|1|||
131708659|NCT00522392|474213351|FG000|Overall Study|Physician Decision|0|||
131708660|NCT00522392|474213352|FG001|Overall Study|Physician Decision|1|||
131708661|NCT00522392|474213351|FG000|Overall Study|Non-compliance|0|||
131708662|NCT00522392|474213352|FG001|Overall Study|Non-compliance|1|||
131708663|NCT00430755|474213357|FG000|Overall Study|Withdrawal by Subject|53|||
131708664|NCT00103012|474213358|FG000|Overall Study|Withdrawal by Subject|2|||
131708665|NCT00103012|474213359|FG001|Overall Study|Withdrawal by Subject|1|||
131794701|NCT02711956|474530521|FG009|Overall Study|Physician Decision|0|||
131708666|NCT00103012|474213360|FG002|Overall Study|Withdrawal by Subject|2|||
131708667|NCT00103012|474213358|FG000|Overall Study|Pregnancy|1|||
131708668|NCT00103012|474213359|FG001|Overall Study|Pregnancy|0|||
131708669|NCT00103012|474213360|FG002|Overall Study|Pregnancy|0|||
131708670|NCT00103012|474213358|FG000|Overall Study|Adverse Event|0|||
131442401|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Not treated|0|||
131442402|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
131442403|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
131442404|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
131442405|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
131442406|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
131442407|NCT02006472|473248838|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
131442408|NCT02006472|473248839|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
131442409|NCT02006472|473248840|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
131442410|NCT02006472|473248841|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
131442411|NCT02006472|473248842|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
131442412|NCT00499486|473248843|FG000|Overall Study|Withdrawal by Subject|16|||
131442413|NCT00656513|473248844|FG000|Overall Study|Protocol Violation|1|||
131442414|NCT00656513|473248845|FG001|Overall Study|Protocol Violation|0|||
131442415|NCT00656513|473248846|FG002|Overall Study|Protocol Violation|2|||
131442416|NCT00656513|473248844|FG000|Overall Study|Withdrawal by Subject|0|||
131442417|NCT00656513|473248845|FG001|Overall Study|Withdrawal by Subject|11|||
131442418|NCT00656513|473248846|FG002|Overall Study|Withdrawal by Subject|4|||
131442419|NCT00656513|473248844|FG000|Overall Study|Death|0|||
131442420|NCT00656513|473248845|FG001|Overall Study|Death|0|||
131442421|NCT00656513|473248846|FG002|Overall Study|Death|1|||
131442422|NCT00656513|473248844|FG000|Overall Study|Missing data|0|||
131442423|NCT00656513|473248845|FG001|Overall Study|Missing data|11|||
131442424|NCT00656513|473248846|FG002|Overall Study|Missing data|9|||
131442425|NCT00656513|473248844|FG000|Overall Study|Incomplete treatment|3|||
131442426|NCT00656513|473248845|FG001|Overall Study|Incomplete treatment|0|||
131442427|NCT00656513|473248846|FG002|Overall Study|Incomplete treatment|0|||
131442428|NCT00656513|473248844|FG000|Overall Study|Treatment completed outside of timeframe|0|||
131442429|NCT00656513|473248845|FG001|Overall Study|Treatment completed outside of timeframe|3|||
131442430|NCT00656513|473248846|FG002|Overall Study|Treatment completed outside of timeframe|1|||
131442431|NCT00656513|473248844|FG000|Overall Study|Missing baseline form|0|||
131442432|NCT00656513|473248845|FG001|Overall Study|Missing baseline form|5|||
131442433|NCT00656513|473248846|FG002|Overall Study|Missing baseline form|5|||
131442434|NCT00087152|473248847|FG000|Overall Study|Ineligible|6|||
131442435|NCT03405792|473248848|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
131442436|NCT03405792|473248849|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
131442437|NCT03405792|473248848|FG000|Overall Study|o Did not receive pembrolizumab|1|||
131442438|NCT03405792|473248849|FG001|Overall Study|o Did not receive pembrolizumab|0|||
131442439|NCT03125395|473248850|FG000|Overall Study|Adverse Event|2|||
131442440|NCT03125395|473248850|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
131442441|NCT03125395|473248850|FG000|Overall Study|Physician Decision|2|||
131442442|NCT03125395|473248850|FG000|Overall Study|Commercial drug is available|5|||
131442443|NCT01780506|473248851|FG000|Double-Blind Phase|Randomized but not Treated|3|||
131442444|NCT01780506|473248852|FG001|Double-Blind Phase|Randomized but not Treated|2|||
131442445|NCT01780506|473248851|FG000|Double-Blind Phase|Adverse Event|4|||
131442446|NCT01780506|473248852|FG001|Double-Blind Phase|Adverse Event|14|||
131442447|NCT01780506|473248851|FG000|Double-Blind Phase|Death|1|||
131442448|NCT01780506|473248852|FG001|Double-Blind Phase|Death|2|||
131442449|NCT01780506|473248851|FG000|Double-Blind Phase|Pregnancy|2|||
131442450|NCT01780506|473248852|FG001|Double-Blind Phase|Pregnancy|1|||
131442451|NCT01780506|473248851|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131442452|NCT01780506|473248852|FG001|Double-Blind Phase|Lack of Efficacy|1|||
131442453|NCT01780506|473248851|FG000|Double-Blind Phase|Investigator's Discretion|5|||
131613729|NCT00622700|473878338|FG006|Core Treatment Period|Lack of Efficacy|0|||
131613730|NCT00622700|473878332|FG000|Core Treatment Period|Lost to Follow-up|1|||
131613731|NCT00622700|473878333|FG001|Core Treatment Period|Lost to Follow-up|1|||
131613732|NCT00622700|473878334|FG002|Core Treatment Period|Lost to Follow-up|1|||
131613733|NCT00622700|473878335|FG003|Core Treatment Period|Lost to Follow-up|0|||
131613734|NCT00622700|473878336|FG004|Core Treatment Period|Lost to Follow-up|0|||
131613735|NCT00622700|473878337|FG005|Core Treatment Period|Lost to Follow-up|0|||
131613736|NCT00622700|473878338|FG006|Core Treatment Period|Lost to Follow-up|0|||
131613737|NCT00622700|473878332|FG000|Core Treatment Period|Death|1|||
131613738|NCT00622700|473878333|FG001|Core Treatment Period|Death|0|||
131794702|NCT02711956|474530522|FG010|Overall Study|Physician Decision|0|||
131794703|NCT02711956|474530523|FG011|Overall Study|Physician Decision|0|||
131794704|NCT02711956|474530524|FG012|Overall Study|Physician Decision|0|||
131442454|NCT01780506|473248852|FG001|Double-Blind Phase|Investigator's Discretion|2|||
131442455|NCT01780506|473248851|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
131442456|NCT01780506|473248852|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
131442457|NCT01780506|473248851|FG000|Double-Blind Phase|Protocol Violation|4|||
131442458|NCT01780506|473248852|FG001|Double-Blind Phase|Protocol Violation|3|||
131442459|NCT01780506|473248851|FG000|Double-Blind Phase|Withdrew Consent|23|||
131442460|NCT01780506|473248852|FG001|Double-Blind Phase|Withdrew Consent|24|||
131613739|NCT00622700|473878334|FG002|Core Treatment Period|Death|0|||
131794705|NCT02711956|474530525|FG013|Overall Study|Physician Decision|0|||
131613740|NCT00622700|473878335|FG003|Core Treatment Period|Death|0|||
131442461|NCT01780506|473248851|FG000|Double-Blind Phase|Lost to Follow-up|23|||
131442462|NCT01780506|473248852|FG001|Double-Blind Phase|Lost to Follow-up|26|||
131442463|NCT01780506|473248851|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
131442464|NCT01780506|473248852|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
131442465|NCT01499940|473248853|FG000|Overall Study|Study was withdrawn before completion.|9|||
131442466|NCT01436149|473248854|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
131442467|NCT01436149|473248855|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
131442468|NCT01436149|473248856|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
131442469|NCT01436149|473248854|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
131442470|NCT01436149|473248855|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
131442471|NCT01436149|473248856|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
131442472|NCT01436149|473248854|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
131442473|NCT01436149|473248855|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131442474|NCT01436149|473248856|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131442475|NCT01436149|473248854|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
131442476|NCT01436149|473248855|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131442477|NCT01436149|473248856|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131442478|NCT01436149|473248854|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
131442479|NCT01436149|473248855|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
131442480|NCT01436149|473248856|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
131442481|NCT01436149|473248854|FG000|Antidepressant Lead-in Phase|Other|119|||
131442482|NCT01436149|473248855|FG001|Antidepressant Lead-in Phase|Other|0|||
131442483|NCT01436149|473248856|FG002|Antidepressant Lead-in Phase|Other|0|||
131442484|NCT01436149|473248854|FG000|Randomized Phase|Adverse Event|9|||
131442485|NCT01436149|473248855|FG001|Randomized Phase|Adverse Event|10|||
131442486|NCT01436149|473248856|FG002|Randomized Phase|Adverse Event|11|||
131442487|NCT01436149|473248854|FG000|Randomized Phase|Protocol Violation|4|||
131442488|NCT01436149|473248855|FG001|Randomized Phase|Protocol Violation|5|||
131442489|NCT01436149|473248856|FG002|Randomized Phase|Protocol Violation|0|||
131442490|NCT01436149|473248854|FG000|Randomized Phase|Withdrawal by Subject|16|||
131442491|NCT01436149|473248855|FG001|Randomized Phase|Withdrawal by Subject|10|||
131442492|NCT01436149|473248856|FG002|Randomized Phase|Withdrawal by Subject|10|||
131442493|NCT01436149|473248854|FG000|Randomized Phase|Lost to Follow-up|34|||
131442494|NCT01436149|473248855|FG001|Randomized Phase|Lost to Follow-up|5|||
131442495|NCT01436149|473248856|FG002|Randomized Phase|Lost to Follow-up|6|||
131442496|NCT01436149|473248854|FG000|Randomized Phase|Lack of Efficacy|0|||
131442497|NCT01436149|473248855|FG001|Randomized Phase|Lack of Efficacy|0|||
131442498|NCT01436149|473248856|FG002|Randomized Phase|Lack of Efficacy|1|||
131442499|NCT01436149|473248854|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
131442500|NCT01436149|473248855|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
131442501|NCT01436149|473248856|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
131442502|NCT01436149|473248854|FG000|Randomized Phase|Other|12|||
131708671|NCT00103012|474213359|FG001|Overall Study|Adverse Event|0|||
131708672|NCT00103012|474213360|FG002|Overall Study|Adverse Event|1|||
131708673|NCT00103012|474213358|FG000|Overall Study|Subject non-compliant with medications|0|||
131708674|NCT00103012|474213359|FG001|Overall Study|Subject non-compliant with medications|0|||
131708675|NCT00103012|474213360|FG002|Overall Study|Subject non-compliant with medications|1|||
131708676|NCT05211336|474213365|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
131708677|NCT05211336|474213366|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
131708678|NCT05211336|474213365|FG000|Overall Study|Progressive disease|0|||
131708679|NCT05211336|474213366|FG001|Overall Study|Progressive disease|4|||
131708680|NCT05211336|474213365|FG000|Overall Study|Death due to myocardial infarction|0|||
131708681|NCT05211336|474213366|FG001|Overall Study|Death due to myocardial infarction|1|||
131708682|NCT05211336|474213365|FG000|Overall Study|Death due to unknown cause|0|||
131708683|NCT05211336|474213366|FG001|Overall Study|Death due to unknown cause|1|||
131708684|NCT05211336|474213365|FG000|Overall Study|Worsening kidney function and quality of response|0|||
131708685|NCT05211336|474213366|FG001|Overall Study|Worsening kidney function and quality of response|1|||
131708686|NCT05019131|474213375|FG000|Overall Study|Lost to Follow-up|0|||
131613741|NCT00622700|473878336|FG004|Core Treatment Period|Death|0|||
131613742|NCT00622700|473878337|FG005|Core Treatment Period|Death|0|||
131794706|NCT02711956|474530526|FG014|Overall Study|Physician Decision|0|||
131794707|NCT02711956|474530512|FG000|Overall Study|Withdrawal by Subject|0|||
131794708|NCT02711956|474530513|FG001|Overall Study|Withdrawal by Subject|0|||
131794709|NCT02711956|474530514|FG002|Overall Study|Withdrawal by Subject|0|||
131794710|NCT02711956|474530515|FG003|Overall Study|Withdrawal by Subject|0|||
131794711|NCT02711956|474530516|FG004|Overall Study|Withdrawal by Subject|0|||
131794712|NCT02711956|474530517|FG005|Overall Study|Withdrawal by Subject|0|||
131794713|NCT02711956|474530518|FG006|Overall Study|Withdrawal by Subject|1|||
131794714|NCT02711956|474530519|FG007|Overall Study|Withdrawal by Subject|0|||
131794715|NCT02711956|474530520|FG008|Overall Study|Withdrawal by Subject|0|||
131794716|NCT02711956|474530521|FG009|Overall Study|Withdrawal by Subject|0|||
131794717|NCT02711956|474530522|FG010|Overall Study|Withdrawal by Subject|0|||
131794718|NCT02711956|474530523|FG011|Overall Study|Withdrawal by Subject|1|||
131794719|NCT02711956|474530524|FG012|Overall Study|Withdrawal by Subject|6|||
131794720|NCT02711956|474530525|FG013|Overall Study|Withdrawal by Subject|0|||
131613743|NCT00622700|473878338|FG006|Core Treatment Period|Death|0|||
131794721|NCT02711956|474530526|FG014|Overall Study|Withdrawal by Subject|1|||
131794722|NCT02711956|474530512|FG000|Overall Study|Clinical progression|1|||
131794723|NCT02711956|474530513|FG001|Overall Study|Clinical progression|0|||
131794724|NCT02711956|474530514|FG002|Overall Study|Clinical progression|0|||
131794725|NCT02711956|474530515|FG003|Overall Study|Clinical progression|0|||
131794726|NCT02711956|474530516|FG004|Overall Study|Clinical progression|0|||
131794727|NCT02711956|474530517|FG005|Overall Study|Clinical progression|0|||
131794728|NCT02711956|474530518|FG006|Overall Study|Clinical progression|1|||
131794729|NCT02711956|474530519|FG007|Overall Study|Clinical progression|0|||
131794730|NCT02711956|474530520|FG008|Overall Study|Clinical progression|1|||
131794731|NCT02711956|474530521|FG009|Overall Study|Clinical progression|0|||
131794732|NCT02711956|474530522|FG010|Overall Study|Clinical progression|0|||
131794733|NCT02711956|474530523|FG011|Overall Study|Clinical progression|2|||
131794734|NCT02711956|474530524|FG012|Overall Study|Clinical progression|4|||
131794735|NCT02711956|474530525|FG013|Overall Study|Clinical progression|1|||
131794736|NCT02711956|474530526|FG014|Overall Study|Clinical progression|1|||
131794737|NCT02711956|474530512|FG000|Overall Study|Radiographic progression|1|||
131794738|NCT02711956|474530513|FG001|Overall Study|Radiographic progression|1|||
131794739|NCT02711956|474530514|FG002|Overall Study|Radiographic progression|2|||
131794740|NCT02711956|474530515|FG003|Overall Study|Radiographic progression|0|||
131794741|NCT02711956|474530516|FG004|Overall Study|Radiographic progression|1|||
131794742|NCT02711956|474530517|FG005|Overall Study|Radiographic progression|0|||
131794743|NCT02711956|474530518|FG006|Overall Study|Radiographic progression|0|||
131794744|NCT02711956|474530519|FG007|Overall Study|Radiographic progression|0|||
131794745|NCT02711956|474530520|FG008|Overall Study|Radiographic progression|2|||
131794746|NCT02711956|474530521|FG009|Overall Study|Radiographic progression|1|||
131794747|NCT02711956|474530522|FG010|Overall Study|Radiographic progression|0|||
131794748|NCT02711956|474530523|FG011|Overall Study|Radiographic progression|5|||
131794749|NCT02711956|474530524|FG012|Overall Study|Radiographic progression|3|||
131794750|NCT02711956|474530525|FG013|Overall Study|Radiographic progression|0|||
131794751|NCT02711956|474530526|FG014|Overall Study|Radiographic progression|1|||
131794752|NCT02711956|474530512|FG000|Overall Study|PSA progression with clinical progression|0|||
131794753|NCT02711956|474530513|FG001|Overall Study|PSA progression with clinical progression|0|||
131442503|NCT01436149|473248855|FG001|Randomized Phase|Other|5|||
131794754|NCT02711956|474530514|FG002|Overall Study|PSA progression with clinical progression|0|||
131794755|NCT02711956|474530515|FG003|Overall Study|PSA progression with clinical progression|0|||
131708687|NCT05019131|474213376|FG001|Overall Study|Lost to Follow-up|3|||
131708688|NCT00332709|474213377|FG000|Overall Study|Adverse Event|11|||
131708689|NCT00332709|474213378|FG001|Overall Study|Adverse Event|14|||
131708690|NCT00332709|474213377|FG000|Overall Study|Withdrawal by Subject|2|||
131708691|NCT00332709|474213378|FG001|Overall Study|Withdrawal by Subject|3|||
131708692|NCT00332709|474213377|FG000|Overall Study|Lost to Follow-up|2|||
131708693|NCT00332709|474213378|FG001|Overall Study|Lost to Follow-up|0|||
131708694|NCT00332709|474213377|FG000|Overall Study|Administrative Problems|0|||
131708695|NCT00332709|474213378|FG001|Overall Study|Administrative Problems|3|||
131708696|NCT00332709|474213377|FG000|Overall Study|Abnormal test procedure result|1|||
131708697|NCT00332709|474213378|FG001|Overall Study|Abnormal test procedure result|0|||
131708698|NCT03575104|474213379|FG000|Overall Study|Adverse Event|4|||
131708699|NCT03575104|474213380|FG001|Overall Study|Adverse Event|3|||
131708700|NCT03575104|474213381|FG002|Overall Study|Adverse Event|4|||
131708701|NCT03575104|474213379|FG000|Overall Study|Withdrawal by Subject|13|||
131708702|NCT03575104|474213380|FG001|Overall Study|Withdrawal by Subject|16|||
131708703|NCT03575104|474213381|FG002|Overall Study|Withdrawal by Subject|11|||
131708704|NCT03575104|474213379|FG000|Overall Study|Other reasons|6|||
131708705|NCT03575104|474213380|FG001|Overall Study|Other reasons|8|||
131708706|NCT03575104|474213381|FG002|Overall Study|Other reasons|6|||
131708707|NCT03575104|474213379|FG000|Overall Study|Lost to Follow-up|1|||
131708708|NCT03575104|474213380|FG001|Overall Study|Lost to Follow-up|2|||
131708709|NCT03575104|474213381|FG002|Overall Study|Lost to Follow-up|1|||
131708710|NCT04684420|474213382|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131708711|NCT04684420|474213383|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131708712|NCT04684420|474213384|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
131804445|NCT02178722|474568530|FG001|Overall Study|Death|13|||
131900367|NCT03286218|474921474|FG004|Qualification Phase Period 2|Adverse Event|0|||
131442504|NCT01436149|473248856|FG002|Randomized Phase|Other|11|||
131442505|NCT01643668|473248860|FG000|Overall Study|Death|1|||
131442506|NCT00322881|473248861|FG000|Overall Study|Death|2|||
131442507|NCT00322881|473248861|FG000|Overall Study|Adverse Event|1|||
131442508|NCT00322881|473248861|FG000|Overall Study|Disease Progression|2|||
131442509|NCT01126749|473248862|FG000|Phase 1b|Other|0|||
131442510|NCT01126749|473248863|FG001|Phase 1b|Other|1|||
131442511|NCT01126749|473248864|FG002|Phase 1b|Other|0|||
131442512|NCT01126749|473248865|FG003|Phase 1b|Other|0|||
131442513|NCT01126749|473248862|FG000|Phase 1b|Withdrawal by Subject|0|||
131442514|NCT01126749|473248863|FG001|Phase 1b|Withdrawal by Subject|1|||
131442515|NCT01126749|473248864|FG002|Phase 1b|Withdrawal by Subject|0|||
131442516|NCT01126749|473248865|FG003|Phase 1b|Withdrawal by Subject|0|||
131442517|NCT01126749|473248862|FG000|Phase 1b|Death|3|||
131442518|NCT01126749|473248863|FG001|Phase 1b|Death|4|||
131442519|NCT01126749|473248864|FG002|Phase 1b|Death|0|||
131442520|NCT01126749|473248865|FG003|Phase 1b|Death|0|||
131442521|NCT01126749|473248862|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
131442522|NCT01126749|473248863|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
131442523|NCT01126749|473248864|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
131442524|NCT01126749|473248865|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
131442525|NCT01126749|473248862|FG000|Phase 2|Study Termination by Sponsor|0|||
131442526|NCT01126749|473248863|FG001|Phase 2|Study Termination by Sponsor|0|||
131442527|NCT01126749|473248864|FG002|Phase 2|Study Termination by Sponsor|12|||
131442528|NCT01126749|473248865|FG003|Phase 2|Study Termination by Sponsor|6|||
131442529|NCT01126749|473248862|FG000|Phase 2|Other|0|||
131442530|NCT01126749|473248863|FG001|Phase 2|Other|0|||
131442531|NCT01126749|473248864|FG002|Phase 2|Other|4|||
131442532|NCT01126749|473248865|FG003|Phase 2|Other|2|||
131442533|NCT01126749|473248862|FG000|Phase 2|Withdrawal by Subject|0|||
131442534|NCT01126749|473248863|FG001|Phase 2|Withdrawal by Subject|0|||
131442535|NCT01126749|473248864|FG002|Phase 2|Withdrawal by Subject|0|||
131442536|NCT01126749|473248865|FG003|Phase 2|Withdrawal by Subject|2|||
131442537|NCT01126749|473248862|FG000|Phase 2|Lost to Follow-up|0|||
131442538|NCT01126749|473248863|FG001|Phase 2|Lost to Follow-up|0|||
131442539|NCT01126749|473248864|FG002|Phase 2|Lost to Follow-up|0|||
131442540|NCT01126749|473248865|FG003|Phase 2|Lost to Follow-up|1|||
131442541|NCT01126749|473248862|FG000|Phase 2|Death|0|||
131442542|NCT01126749|473248863|FG001|Phase 2|Death|0|||
131442543|NCT01126749|473248864|FG002|Phase 2|Death|22|||
131442544|NCT01126749|473248865|FG003|Phase 2|Death|22|||
131442545|NCT01126749|473248862|FG000|Phase 2|Adverse Event|0|||
131442546|NCT01126749|473248863|FG001|Phase 2|Adverse Event|0|||
131442547|NCT01126749|473248864|FG002|Phase 2|Adverse Event|0|||
131442548|NCT01126749|473248865|FG003|Phase 2|Adverse Event|1|||
131442549|NCT00976274|473248867|FG000|Overall Study|Lost to Follow-up|5|||
131442550|NCT00976274|473248868|FG001|Overall Study|Lost to Follow-up|5|||
131442551|NCT00976274|473248867|FG000|Overall Study|Withdrawal by Subject|1|||
131442552|NCT00976274|473248868|FG001|Overall Study|Withdrawal by Subject|1|||
131442553|NCT00976274|473248867|FG000|Overall Study|Physician Decision|1|||
131900368|NCT03286218|474921475|FG005|Qualification Phase Period 2|Adverse Event|0|||
131442554|NCT00976274|473248868|FG001|Overall Study|Physician Decision|2|||
131442555|NCT00627393|473248871|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
131708713|NCT04684420|474213385|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
131708714|NCT04684420|474213382|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
131708715|NCT04684420|474213383|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
131708716|NCT04684420|474213384|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
131708717|NCT04684420|474213385|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
131708718|NCT01703000|474213388|FG000|Overall Study|Death|1|||
131708719|NCT03822884|474213389|FG000|Overall Study|Withdrawal by Subject|0|||
131708720|NCT03822884|474213390|FG001|Overall Study|Withdrawal by Subject|0|||
131708721|NCT03822884|474213391|FG002|Overall Study|Withdrawal by Subject|0|||
131708722|NCT03822884|474213392|FG003|Overall Study|Withdrawal by Subject|0|||
131708723|NCT03822884|474213393|FG004|Overall Study|Withdrawal by Subject|1|||
131708724|NCT03822884|474213394|FG005|Overall Study|Withdrawal by Subject|0|||
131900369|NCT03286218|474921476|FG006|Qualification Phase Period 2|Adverse Event|0|||
131900370|NCT03286218|474921477|FG007|Qualification Phase Period 2|Adverse Event|0|||
131442556|NCT00627393|473248872|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
131442557|NCT00627393|473248871|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
131442558|NCT00627393|473248872|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
131442559|NCT00627393|473248871|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
131442560|NCT00627393|473248872|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
131442561|NCT00627393|473248871|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
131442562|NCT00627393|473248872|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
131442563|NCT02183675|473248873|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
131442564|NCT02183675|473248874|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
131442565|NCT02183675|473248875|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
131442566|NCT02183675|473248876|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
131613744|NCT00622700|473878332|FG000|Core Treatment Period|Progressive Disease|3|||
131613745|NCT00622700|473878333|FG001|Core Treatment Period|Progressive Disease|1|||
131613746|NCT00622700|473878334|FG002|Core Treatment Period|Progressive Disease|0|||
131613747|NCT00622700|473878335|FG003|Core Treatment Period|Progressive Disease|0|||
131613748|NCT00622700|473878336|FG004|Core Treatment Period|Progressive Disease|0|||
131613749|NCT00622700|473878337|FG005|Core Treatment Period|Progressive Disease|0|||
131613750|NCT00622700|473878338|FG006|Core Treatment Period|Progressive Disease|0|||
131613751|NCT00622700|473878332|FG000|Core Treatment Period|Withdrawal by Subject|12|||
131613752|NCT00622700|473878333|FG001|Core Treatment Period|Withdrawal by Subject|18|||
131708725|NCT00603239|474213397|FG000|Overall Study|Adverse Event|4|||
131794756|NCT02711956|474530516|FG004|Overall Study|PSA progression with clinical progression|1|||
131794757|NCT02711956|474530517|FG005|Overall Study|PSA progression with clinical progression|0|||
131794758|NCT02711956|474530518|FG006|Overall Study|PSA progression with clinical progression|0|||
131794759|NCT02711956|474530519|FG007|Overall Study|PSA progression with clinical progression|0|||
131794760|NCT02711956|474530520|FG008|Overall Study|PSA progression with clinical progression|0|||
131794761|NCT02711956|474530521|FG009|Overall Study|PSA progression with clinical progression|0|||
131794762|NCT02711956|474530522|FG010|Overall Study|PSA progression with clinical progression|0|||
131794763|NCT02711956|474530523|FG011|Overall Study|PSA progression with clinical progression|0|||
131794764|NCT02711956|474530524|FG012|Overall Study|PSA progression with clinical progression|1|||
131794765|NCT02711956|474530525|FG013|Overall Study|PSA progression with clinical progression|1|||
131794766|NCT02711956|474530526|FG014|Overall Study|PSA progression with clinical progression|0|||
131794767|NCT02711956|474530512|FG000|Overall Study|PSA progression with radiographic progression|0|||
131900371|NCT03286218|474921478|FG008|Qualification Phase Period 2|Adverse Event|0|||
131900372|NCT03286218|474921479|FG009|Qualification Phase Period 2|Adverse Event|0|||
131442567|NCT02183675|473248877|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
131442568|NCT02183675|473248878|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
131442569|NCT00004563|473248879|FG000|Overall Study|Withdrawal by Subject|20|||
131442570|NCT00004563|473248880|FG001|Overall Study|Withdrawal by Subject|16|||
131442571|NCT00004563|473248879|FG000|Overall Study|Lack of Efficacy|3|||
131442572|NCT00004563|473248880|FG001|Overall Study|Lack of Efficacy|5|||
131442573|NCT00004563|473248879|FG000|Overall Study|Death|2|||
131442574|NCT00004563|473248880|FG001|Overall Study|Death|3|||
131442575|NCT03337308|473248881|FG000|Overall Study|Adverse Event|2|||
131442576|NCT03337308|473248882|FG001|Overall Study|Adverse Event|3|||
131613753|NCT00622700|473878334|FG002|Core Treatment Period|Withdrawal by Subject|15|||
131613754|NCT00622700|473878335|FG003|Core Treatment Period|Withdrawal by Subject|0|||
131613755|NCT00622700|473878336|FG004|Core Treatment Period|Withdrawal by Subject|0|||
131613756|NCT00622700|473878337|FG005|Core Treatment Period|Withdrawal by Subject|0|||
131613757|NCT00622700|473878338|FG006|Core Treatment Period|Withdrawal by Subject|0|||
131613758|NCT00622700|473878332|FG000|Core Treatment Period|Other than specified above|2|||
131613759|NCT00622700|473878333|FG001|Core Treatment Period|Other than specified above|2|||
131613760|NCT00622700|473878334|FG002|Core Treatment Period|Other than specified above|5|||
131613761|NCT00622700|473878335|FG003|Core Treatment Period|Other than specified above|0|||
131613762|NCT00622700|473878336|FG004|Core Treatment Period|Other than specified above|0|||
131613763|NCT00622700|473878337|FG005|Core Treatment Period|Other than specified above|0|||
131613764|NCT00622700|473878338|FG006|Core Treatment Period|Other than specified above|0|||
131613765|NCT00622700|473878332|FG000|Extension Treatment Period|Adverse Event|0|||
131613766|NCT00622700|473878333|FG001|Extension Treatment Period|Adverse Event|0|||
131613767|NCT00622700|473878334|FG002|Extension Treatment Period|Adverse Event|0|||
131613768|NCT00622700|473878335|FG003|Extension Treatment Period|Adverse Event|5|||
131613769|NCT00622700|473878336|FG004|Extension Treatment Period|Adverse Event|9|||
131613770|NCT00622700|473878337|FG005|Extension Treatment Period|Adverse Event|6|||
131613771|NCT00622700|473878338|FG006|Extension Treatment Period|Adverse Event|8|||
131613772|NCT00622700|473878332|FG000|Extension Treatment Period|Lack of Efficacy|0|||
131613773|NCT00622700|473878333|FG001|Extension Treatment Period|Lack of Efficacy|0|||
131613774|NCT00622700|473878334|FG002|Extension Treatment Period|Lack of Efficacy|0|||
131613775|NCT00622700|473878335|FG003|Extension Treatment Period|Lack of Efficacy|2|||
131613776|NCT00622700|473878336|FG004|Extension Treatment Period|Lack of Efficacy|8|||
131613777|NCT00622700|473878337|FG005|Extension Treatment Period|Lack of Efficacy|1|||
131613778|NCT00622700|473878338|FG006|Extension Treatment Period|Lack of Efficacy|9|||
131613779|NCT00622700|473878332|FG000|Extension Treatment Period|Protocol Violation|0|||
131708726|NCT00603239|474213398|FG001|Overall Study|Adverse Event|1|||
131708727|NCT00603239|474213397|FG000|Overall Study|Entry criteria not met|0|||
131708728|NCT00603239|474213398|FG001|Overall Study|Entry criteria not met|1|||
131708729|NCT00603239|474213397|FG000|Overall Study|Loss of glucose control|3|||
131708730|NCT00603239|474213398|FG001|Overall Study|Loss of glucose control|0|||
131708731|NCT00603239|474213397|FG000|Overall Study|Lost to Follow-up|2|||
131708732|NCT00603239|474213398|FG001|Overall Study|Lost to Follow-up|1|||
131708733|NCT00603239|474213397|FG000|Overall Study|Physician Decision|2|||
131708734|NCT00603239|474213398|FG001|Overall Study|Physician Decision|0|||
131708735|NCT00603239|474213397|FG000|Overall Study|Protocol Violation|2|||
131708736|NCT00603239|474213398|FG001|Overall Study|Protocol Violation|0|||
131708737|NCT00603239|474213397|FG000|Overall Study|Subject decision|2|||
131708738|NCT00603239|474213398|FG001|Overall Study|Subject decision|1|||
131708739|NCT00928070|474213399|FG000|Overall Study|Lost to Follow-up|1|||
131708740|NCT00928070|474213400|FG001|Overall Study|Lost to Follow-up|2|||
131708741|NCT00928070|474213399|FG000|Overall Study|Withdrawal by Subject|10|||
131708742|NCT00928070|474213400|FG001|Overall Study|Withdrawal by Subject|3|||
131708743|NCT00928070|474213399|FG000|Overall Study|Adverse Event|14|||
131613780|NCT00622700|473878333|FG001|Extension Treatment Period|Protocol Violation|0|||
131708744|NCT00928070|474213400|FG001|Overall Study|Adverse Event|26|||
131708745|NCT00928070|474213399|FG000|Overall Study|Lack of Efficacy|9|||
131708746|NCT00928070|474213400|FG001|Overall Study|Lack of Efficacy|5|||
131708747|NCT00928070|474213399|FG000|Overall Study|Did not meet entrance criteria|16|||
131442577|NCT03337308|473248883|FG002|Overall Study|Adverse Event|3|||
131442578|NCT03337308|473248884|FG003|Overall Study|Adverse Event|1|||
131442579|NCT03337308|473248881|FG000|Overall Study|Lost to Follow-up|1|||
131442580|NCT03337308|473248882|FG001|Overall Study|Lost to Follow-up|2|||
131442581|NCT03337308|473248883|FG002|Overall Study|Lost to Follow-up|0|||
131442582|NCT03337308|473248884|FG003|Overall Study|Lost to Follow-up|0|||
131442583|NCT03337308|473248881|FG000|Overall Study|Withdrawal by Subject|2|||
131442584|NCT03337308|473248882|FG001|Overall Study|Withdrawal by Subject|1|||
131442585|NCT03337308|473248883|FG002|Overall Study|Withdrawal by Subject|2|||
131442586|NCT03337308|473248884|FG003|Overall Study|Withdrawal by Subject|1|||
131442587|NCT03337308|473248881|FG000|Overall Study|Protocol Violation|0|||
131442588|NCT03337308|473248882|FG001|Overall Study|Protocol Violation|1|||
131442589|NCT03337308|473248883|FG002|Overall Study|Protocol Violation|0|||
131442590|NCT03337308|473248884|FG003|Overall Study|Protocol Violation|0|||
131442591|NCT01056822|473248885|FG000|Overall Study|Adverse Event|0|||
131442592|NCT01056822|473248886|FG001|Overall Study|Adverse Event|1|||
131442593|NCT01056822|473248885|FG000|Overall Study|Protocol Violation|6|||
131442594|NCT01056822|473248886|FG001|Overall Study|Protocol Violation|5|||
131442595|NCT01056822|473248885|FG000|Overall Study|Withdrawal by Subject|1|||
131442596|NCT01056822|473248886|FG001|Overall Study|Withdrawal by Subject|1|||
131442597|NCT01056822|473248885|FG000|Overall Study|Lost to Follow-up|1|||
131442598|NCT01056822|473248886|FG001|Overall Study|Lost to Follow-up|0|||
131442599|NCT04366349|473248888|FG000|Overall Study|Withdrawal by Subject|1|||
131442600|NCT04366349|473248889|FG001|Overall Study|Withdrawal by Subject|0|||
131442601|NCT04366349|473248890|FG002|Overall Study|Withdrawal by Subject|0|||
131442602|NCT04366349|473248891|FG003|Overall Study|Withdrawal by Subject|0|||
131442603|NCT04366349|473248892|FG004|Overall Study|Withdrawal by Subject|0|||
131442604|NCT04366349|473248893|FG005|Overall Study|Withdrawal by Subject|0|||
131442605|NCT03341299|473248897|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
131442606|NCT03341299|473248898|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
131442607|NCT03341299|473248899|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
131442608|NCT03341299|473248900|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
131442609|NCT05194124|473248903|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442610|NCT05194124|473248904|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442611|NCT05194124|473248905|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442612|NCT05194124|473248906|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
131442613|NCT05194124|473248907|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442614|NCT05194124|473248908|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
131794768|NCT02711956|474530513|FG001|Overall Study|PSA progression with radiographic progression|1|||
131442615|NCT05194124|473248909|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131794769|NCT02711956|474530514|FG002|Overall Study|PSA progression with radiographic progression|0|||
131794770|NCT02711956|474530515|FG003|Overall Study|PSA progression with radiographic progression|0|||
131794771|NCT02711956|474530516|FG004|Overall Study|PSA progression with radiographic progression|0|||
131794772|NCT02711956|474530517|FG005|Overall Study|PSA progression with radiographic progression|2|||
131794773|NCT02711956|474530518|FG006|Overall Study|PSA progression with radiographic progression|2|||
131794774|NCT02711956|474530519|FG007|Overall Study|PSA progression with radiographic progression|1|||
131794775|NCT02711956|474530520|FG008|Overall Study|PSA progression with radiographic progression|0|||
131794776|NCT02711956|474530521|FG009|Overall Study|PSA progression with radiographic progression|1|||
131794777|NCT02711956|474530522|FG010|Overall Study|PSA progression with radiographic progression|0|||
131794778|NCT02711956|474530523|FG011|Overall Study|PSA progression with radiographic progression|1|||
131794779|NCT02711956|474530524|FG012|Overall Study|PSA progression with radiographic progression|2|||
131900373|NCT03286218|474921480|FG010|Qualification Phase Period 2|Adverse Event|0|||
131900374|NCT03286218|474921481|FG011|Qualification Phase Period 2|Adverse Event|0|||
131900375|NCT03286218|474921470|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
131442616|NCT05194124|473248910|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442617|NCT05194124|473248911|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442618|NCT05194124|473248912|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
131442619|NCT05194124|473248903|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442620|NCT05194124|473248904|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442621|NCT05194124|473248905|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442622|NCT05194124|473248906|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442623|NCT05194124|473248907|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442624|NCT05194124|473248908|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442625|NCT05194124|473248909|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442626|NCT05194124|473248910|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131900376|NCT03286218|474921471|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
131442627|NCT05194124|473248911|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
131442628|NCT05194124|473248912|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
131442629|NCT02783690|473248913|FG000|Overall Study|Withdrawal by Subject|3|||
131613781|NCT00622700|473878334|FG002|Extension Treatment Period|Protocol Violation|0|||
131613782|NCT00622700|473878335|FG003|Extension Treatment Period|Protocol Violation|0|||
131613783|NCT00622700|473878336|FG004|Extension Treatment Period|Protocol Violation|0|||
131794780|NCT02711956|474530525|FG013|Overall Study|PSA progression with radiographic progression|3|||
131613784|NCT00622700|473878337|FG005|Extension Treatment Period|Protocol Violation|2|||
131613785|NCT00622700|473878338|FG006|Extension Treatment Period|Protocol Violation|0|||
131613786|NCT00622700|473878332|FG000|Extension Treatment Period|Lost to Follow-up|0|||
131613787|NCT00622700|473878333|FG001|Extension Treatment Period|Lost to Follow-up|0|||
131613788|NCT00622700|473878334|FG002|Extension Treatment Period|Lost to Follow-up|0|||
131613789|NCT00622700|473878335|FG003|Extension Treatment Period|Lost to Follow-up|0|||
131613790|NCT00622700|473878336|FG004|Extension Treatment Period|Lost to Follow-up|1|||
131613791|NCT00622700|473878337|FG005|Extension Treatment Period|Lost to Follow-up|0|||
131613792|NCT00622700|473878338|FG006|Extension Treatment Period|Lost to Follow-up|0|||
131613793|NCT00622700|473878332|FG000|Extension Treatment Period|Progressive Disease|0|||
131613794|NCT00622700|473878333|FG001|Extension Treatment Period|Progressive Disease|0|||
131613795|NCT00622700|473878334|FG002|Extension Treatment Period|Progressive Disease|0|||
131613796|NCT00622700|473878335|FG003|Extension Treatment Period|Progressive Disease|1|||
131613797|NCT00622700|473878336|FG004|Extension Treatment Period|Progressive Disease|2|||
131613798|NCT00622700|473878337|FG005|Extension Treatment Period|Progressive Disease|0|||
131613799|NCT00622700|473878338|FG006|Extension Treatment Period|Progressive Disease|2|||
131613800|NCT00622700|473878332|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
131613801|NCT00622700|473878333|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131613802|NCT00622700|473878334|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
131613803|NCT00622700|473878335|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
131613804|NCT00622700|473878336|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
131613805|NCT00622700|473878337|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
131613806|NCT00622700|473878338|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
131613807|NCT00622700|473878332|FG000|Extension Treatment Period|Missing|0|||
131613808|NCT00622700|473878333|FG001|Extension Treatment Period|Missing|0|||
131613809|NCT00622700|473878334|FG002|Extension Treatment Period|Missing|0|||
131613810|NCT00622700|473878335|FG003|Extension Treatment Period|Missing|2|||
131613811|NCT00622700|473878336|FG004|Extension Treatment Period|Missing|3|||
131613812|NCT00622700|473878337|FG005|Extension Treatment Period|Missing|1|||
131613813|NCT00622700|473878338|FG006|Extension Treatment Period|Missing|0|||
131613814|NCT00622700|473878332|FG000|Extension Treatment Period|Other than specified above|0|||
131613815|NCT00622700|473878333|FG001|Extension Treatment Period|Other than specified above|0|||
131613816|NCT00622700|473878334|FG002|Extension Treatment Period|Other than specified above|0|||
131613817|NCT00622700|473878335|FG003|Extension Treatment Period|Other than specified above|0|||
131613818|NCT00622700|473878336|FG004|Extension Treatment Period|Other than specified above|0|||
131613819|NCT00622700|473878337|FG005|Extension Treatment Period|Other than specified above|1|||
131613820|NCT00622700|473878338|FG006|Extension Treatment Period|Other than specified above|1|||
131613821|NCT03611556|473878339|FG000|Overall Study|Death|7|||
131613822|NCT03611556|473878340|FG001|Overall Study|Death|7|||
131613823|NCT03611556|473878341|FG002|Overall Study|Death|3|||
131613824|NCT03611556|473878342|FG003|Overall Study|Death|8|||
131613825|NCT03611556|473878343|FG004|Overall Study|Death|47|||
131613826|NCT03611556|473878344|FG005|Overall Study|Death|32|||
131613827|NCT03611556|473878345|FG006|Overall Study|Death|53|||
131613828|NCT03611556|473878339|FG000|Overall Study|Withdrawal by Subject|0|||
131613829|NCT03611556|473878340|FG001|Overall Study|Withdrawal by Subject|0|||
131613830|NCT03611556|473878341|FG002|Overall Study|Withdrawal by Subject|0|||
131613831|NCT03611556|473878342|FG003|Overall Study|Withdrawal by Subject|0|||
131613832|NCT03611556|473878343|FG004|Overall Study|Withdrawal by Subject|4|||
131613833|NCT03611556|473878344|FG005|Overall Study|Withdrawal by Subject|2|||
131613834|NCT03611556|473878345|FG006|Overall Study|Withdrawal by Subject|4|||
131613835|NCT03611556|473878339|FG000|Overall Study|Sponsor decision|0|||
131613836|NCT03611556|473878340|FG001|Overall Study|Sponsor decision|0|||
131613837|NCT03611556|473878341|FG002|Overall Study|Sponsor decision|0|||
131613838|NCT03611556|473878342|FG003|Overall Study|Sponsor decision|0|||
131613839|NCT03611556|473878343|FG004|Overall Study|Sponsor decision|9|||
131613840|NCT03611556|473878344|FG005|Overall Study|Sponsor decision|4|||
131613841|NCT03611556|473878345|FG006|Overall Study|Sponsor decision|12|||
131613842|NCT03611556|473878339|FG000|Overall Study|Reasons|0|||
131613843|NCT03611556|473878340|FG001|Overall Study|Reasons|0|||
131613844|NCT03611556|473878341|FG002|Overall Study|Reasons|0|||
131613845|NCT03611556|473878342|FG003|Overall Study|Reasons|0|||
131613846|NCT03611556|473878343|FG004|Overall Study|Reasons|2|||
131613847|NCT03611556|473878344|FG005|Overall Study|Reasons|0|||
131613848|NCT03611556|473878345|FG006|Overall Study|Reasons|1|||
131613849|NCT02646618|473878346|FG000|Overall Study|Lost to Follow-up|10|||
131613850|NCT02646618|473878347|FG001|Overall Study|Lost to Follow-up|14|||
131613851|NCT00390884|473878348|FG000|Overall Study|Withdrawal by Subject|2|||
131613852|NCT00390884|473878349|FG001|Overall Study|Withdrawal by Subject|2|||
131613853|NCT04035447|473878350|FG000|Treatment Period|Lost to Follow-up|6|||
131613854|NCT04035447|473878351|FG001|Treatment Period|Lost to Follow-up|5|||
131613855|NCT04035447|473878350|FG000|Treatment Period|Physician Decision|0|||
131613856|NCT04035447|473878351|FG001|Treatment Period|Physician Decision|2|||
131442630|NCT02783690|473248914|FG001|Overall Study|Withdrawal by Subject|3|||
131613857|NCT01753999|473878352|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
131613858|NCT01753999|473878353|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
131613859|NCT01753999|473878352|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
131613860|NCT01753999|473878353|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
131442631|NCT03474588|473248915|FG000|Overall Study|Withdrawal by Subject|4|||
131613861|NCT01753999|473878352|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
131613862|NCT01753999|473878353|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
131613863|NCT01753999|473878352|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
131613864|NCT01753999|473878353|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
131613865|NCT01753999|473878352|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
131804446|NCT02178722|474568531|FG002|Overall Study|Death|12|||
131442632|NCT03474588|473248916|FG001|Overall Study|Withdrawal by Subject|3|||
131442633|NCT03474588|473248915|FG000|Overall Study|Death|0|||
131442634|NCT03474588|473248916|FG001|Overall Study|Death|1|||
131442635|NCT00626106|473248919|FG000|Overall Study|Withdrawal by Subject|2|||
131442636|NCT00626106|473248920|FG001|Overall Study|Withdrawal by Subject|1|||
131442637|NCT00626106|473248919|FG000|Overall Study|Lost to Follow-up|1|||
131442638|NCT00626106|473248920|FG001|Overall Study|Lost to Follow-up|4|||
131442639|NCT00626106|473248919|FG000|Overall Study|Death|64|||
131442640|NCT00626106|473248920|FG001|Overall Study|Death|19|||
131442641|NCT02702492|473248921|FG000|Overall Study|Disease progression|3|||
131442642|NCT02702492|473248922|FG001|Overall Study|Disease progression|3|||
131442643|NCT02702492|473248923|FG002|Overall Study|Disease progression|2|||
131442644|NCT02702492|473248924|FG003|Overall Study|Disease progression|4|||
131442645|NCT02702492|473248925|FG004|Overall Study|Disease progression|4|||
131442646|NCT02702492|473248926|FG005|Overall Study|Disease progression|1|||
131442647|NCT02702492|473248927|FG006|Overall Study|Disease progression|2|||
131442648|NCT02702492|473248928|FG007|Overall Study|Disease progression|8|||
131442649|NCT02702492|473248929|FG008|Overall Study|Disease progression|5|||
131442650|NCT02702492|473248930|FG009|Overall Study|Disease progression|1|||
131442651|NCT02702492|473248931|FG010|Overall Study|Disease progression|0|||
131442652|NCT02702492|473248932|FG011|Overall Study|Disease progression|3|||
131613866|NCT01753999|473878353|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
131613867|NCT01753999|473878352|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
131442653|NCT02702492|473248933|FG012|Overall Study|Disease progression|2|||
131442654|NCT02702492|473248921|FG000|Overall Study|Clinical progression|0|||
131442655|NCT02702492|473248922|FG001|Overall Study|Clinical progression|0|||
131442656|NCT02702492|473248923|FG002|Overall Study|Clinical progression|2|||
131442657|NCT02702492|473248924|FG003|Overall Study|Clinical progression|1|||
131442658|NCT02702492|473248925|FG004|Overall Study|Clinical progression|0|||
131442659|NCT02702492|473248926|FG005|Overall Study|Clinical progression|2|||
131442660|NCT02702492|473248927|FG006|Overall Study|Clinical progression|1|||
131442661|NCT02702492|473248928|FG007|Overall Study|Clinical progression|4|||
131442662|NCT02702492|473248929|FG008|Overall Study|Clinical progression|0|||
131442663|NCT02702492|473248930|FG009|Overall Study|Clinical progression|0|||
131442664|NCT02702492|473248931|FG010|Overall Study|Clinical progression|1|||
131442665|NCT02702492|473248932|FG011|Overall Study|Clinical progression|2|||
131442666|NCT02702492|473248933|FG012|Overall Study|Clinical progression|0|||
131442667|NCT02702492|473248921|FG000|Overall Study|Adverse Event|0|||
131613868|NCT01753999|473878353|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
131613869|NCT02130557|473878354|FG000|Overall Study|Withdrawal by Subject|12|||
131613870|NCT02130557|473878355|FG001|Overall Study|Withdrawal by Subject|12|||
131613871|NCT02130557|473878354|FG000|Overall Study|Investigator Request|0|||
131613872|NCT02130557|473878355|FG001|Overall Study|Investigator Request|2|||
131613873|NCT02130557|473878354|FG000|Overall Study|Deceased|14|||
131613874|NCT02130557|473878355|FG001|Overall Study|Deceased|14|||
131613875|NCT02130557|473878354|FG000|Overall Study|Lost to Follow-up|6|||
131708748|NCT00928070|474213400|FG001|Overall Study|Did not meet entrance criteria|9|||
131708749|NCT00928070|474213399|FG000|Overall Study|Protocol Violation|6|||
131708750|NCT00928070|474213400|FG001|Overall Study|Protocol Violation|5|||
131708751|NCT00928070|474213399|FG000|Overall Study|Randomized but not treated|2|||
131708752|NCT00928070|474213400|FG001|Overall Study|Randomized but not treated|2|||
131708753|NCT00928070|474213399|FG000|Overall Study|Other|5|||
131708754|NCT00928070|474213400|FG001|Overall Study|Other|5|||
131708755|NCT00191854|474213401|FG000|Overall Study|Death|26|||
131708756|NCT00191854|474213402|FG001|Overall Study|Death|23|||
131708757|NCT00191854|474213403|FG002|Overall Study|Death|29|||
131708758|NCT00191854|474213401|FG000|Overall Study|Lost to Follow-up|7|||
131708759|NCT00191854|474213402|FG001|Overall Study|Lost to Follow-up|5|||
131708760|NCT00191854|474213403|FG002|Overall Study|Lost to Follow-up|5|||
131708761|NCT00191854|474213401|FG000|Overall Study|Withdrawal by Subject|4|||
131442668|NCT02702492|473248922|FG001|Overall Study|Adverse Event|0|||
131442669|NCT02702492|473248923|FG002|Overall Study|Adverse Event|1|||
131442670|NCT02702492|473248924|FG003|Overall Study|Adverse Event|2|||
131442671|NCT02702492|473248925|FG004|Overall Study|Adverse Event|1|||
131442672|NCT02702492|473248926|FG005|Overall Study|Adverse Event|0|||
131442673|NCT02702492|473248927|FG006|Overall Study|Adverse Event|1|||
131442674|NCT02702492|473248928|FG007|Overall Study|Adverse Event|0|||
131442675|NCT02702492|473248929|FG008|Overall Study|Adverse Event|2|||
131442676|NCT02702492|473248930|FG009|Overall Study|Adverse Event|0|||
131442677|NCT02702492|473248931|FG010|Overall Study|Adverse Event|0|||
131708762|NCT00191854|474213402|FG001|Overall Study|Withdrawal by Subject|2|||
131708763|NCT00191854|474213403|FG002|Overall Study|Withdrawal by Subject|3|||
131613876|NCT02130557|473878355|FG001|Overall Study|Lost to Follow-up|7|||
131613877|NCT02130557|473878354|FG000|Overall Study|Other|2|||
131613878|NCT02130557|473878355|FG001|Overall Study|Other|1|||
131613879|NCT02130557|473878354|FG000|Overall Study|Missing|2|||
131613880|NCT02130557|473878355|FG001|Overall Study|Missing|1|||
131613881|NCT02408887|473878356|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
131613882|NCT02408887|473878357|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
131613883|NCT02408887|473878356|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
131613884|NCT02408887|473878357|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
131613885|NCT03333109|473878359|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
131613886|NCT03333109|473878360|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
131613887|NCT03333109|473878361|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
131613888|NCT03333109|473878359|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131613889|NCT03333109|473878360|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131613890|NCT03333109|473878361|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
131613891|NCT03333109|473878359|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
131613892|NCT03333109|473878360|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
131613893|NCT03333109|473878361|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
131613894|NCT03333109|473878359|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
131613895|NCT03333109|473878360|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
131613896|NCT03333109|473878361|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
131442678|NCT02702492|473248932|FG011|Overall Study|Adverse Event|0|||
131442679|NCT02702492|473248933|FG012|Overall Study|Adverse Event|1|||
131442680|NCT02702492|473248921|FG000|Overall Study|Other|0|||
131442681|NCT02702492|473248922|FG001|Overall Study|Other|0|||
131442682|NCT02702492|473248923|FG002|Overall Study|Other|0|||
131442683|NCT02702492|473248924|FG003|Overall Study|Other|0|||
131442684|NCT02702492|473248925|FG004|Overall Study|Other|0|||
131442685|NCT02702492|473248926|FG005|Overall Study|Other|0|||
131442686|NCT02702492|473248927|FG006|Overall Study|Other|0|||
131442687|NCT02702492|473248928|FG007|Overall Study|Other|0|||
131442688|NCT02702492|473248929|FG008|Overall Study|Other|0|||
131442689|NCT02702492|473248930|FG009|Overall Study|Other|0|||
131442690|NCT02702492|473248931|FG010|Overall Study|Other|0|||
131442691|NCT02702492|473248932|FG011|Overall Study|Other|0|||
131442692|NCT02702492|473248933|FG012|Overall Study|Other|1|||
131442693|NCT00781768|473250701|FG000|Overall Study|Not transplanted.|0|||
131442694|NCT00781768|473250702|FG001|Overall Study|Not transplanted.|2|||
131442695|NCT00079417|473250705|FG000|Overall Study|Physician Decision|2|||
131442696|NCT00079417|473250705|FG000|Overall Study|Ineligible|7|||
131442697|NCT02458313|473250706|FG000|Overall Study|Withdrawal by Subject|6|||
131442698|NCT02458313|473250707|FG001|Overall Study|Withdrawal by Subject|8|||
131442699|NCT02458313|473250706|FG000|Overall Study|Excluded for motion during MRI|1|||
131442700|NCT02458313|473250707|FG001|Overall Study|Excluded for motion during MRI|2|||
131442701|NCT00904969|473250708|FG000|Overall Study|Lost to Follow-up|4|||
131442702|NCT00904969|473250708|FG000|Overall Study|Withdrawal by Subject|3|||
131442703|NCT00904969|473250708|FG000|Overall Study|Additional Treatments|11|||
131442704|NCT00904969|473250708|FG000|Overall Study|Case Aborted; Subject Exited|1|||
131442705|NCT00199381|473250715|FG000|Overall Study|Withdrawal by Subject|38|||
131442706|NCT00199381|473250715|FG000|Overall Study|Adverse Event|73|||
131442707|NCT00199381|473250715|FG000|Overall Study|Protocol Violation|6|||
131442708|NCT00199381|473250715|FG000|Overall Study|Lack of Efficacy|27|||
131442709|NCT00199381|473250715|FG000|Overall Study|Not including due to early termination|37|||
131442710|NCT00199381|473250715|FG000|Overall Study|Study termination by Sponsor|323|||
131442711|NCT00385671|473250717|FG000|Overall Study|Adverse Event|14|||
131442712|NCT00385671|473250718|FG001|Overall Study|Adverse Event|27|||
131442713|NCT00385671|473250719|FG002|Overall Study|Adverse Event|18|||
131442714|NCT00385671|473250717|FG000|Overall Study|Lack of Efficacy|5|||
131442715|NCT00385671|473250718|FG001|Overall Study|Lack of Efficacy|9|||
131442716|NCT00385671|473250719|FG002|Overall Study|Lack of Efficacy|5|||
131442717|NCT00385671|473250717|FG000|Overall Study|Lost to Follow-up|6|||
131442718|NCT00385671|473250718|FG001|Overall Study|Lost to Follow-up|6|||
131442719|NCT00385671|473250719|FG002|Overall Study|Lost to Follow-up|5|||
131442720|NCT00385671|473250717|FG000|Overall Study|Physician Decision|2|||
131442721|NCT00385671|473250718|FG001|Overall Study|Physician Decision|1|||
131442722|NCT00385671|473250719|FG002|Overall Study|Physician Decision|2|||
131442723|NCT00385671|473250717|FG000|Overall Study|Protocol Violation|5|||
131442724|NCT00385671|473250718|FG001|Overall Study|Protocol Violation|2|||
131442725|NCT00385671|473250719|FG002|Overall Study|Protocol Violation|1|||
131442726|NCT00385671|473250717|FG000|Overall Study|Sponsor Decision|2|||
131442727|NCT00385671|473250718|FG001|Overall Study|Sponsor Decision|2|||
131442728|NCT00385671|473250719|FG002|Overall Study|Sponsor Decision|1|||
131442729|NCT00385671|473250717|FG000|Overall Study|Withdrawal by Subject|4|||
131794781|NCT02711956|474530526|FG014|Overall Study|PSA progression with radiographic progression|3|||
131442730|NCT00385671|473250718|FG001|Overall Study|Withdrawal by Subject|4|||
131442731|NCT00385671|473250719|FG002|Overall Study|Withdrawal by Subject|4|||
131442732|NCT00303069|473250720|FG000|Overall Study|Lost to Follow-up|1|||
131442733|NCT00303069|473250721|FG001|Overall Study|Lost to Follow-up|0|||
131442734|NCT00303069|473250722|FG002|Overall Study|Lost to Follow-up|0|||
131442735|NCT00303069|473250723|FG003|Overall Study|Lost to Follow-up|2|||
131442736|NCT00303069|473250720|FG000|Overall Study|subject moved|1|||
131442737|NCT00303069|473250721|FG001|Overall Study|subject moved|0|||
131442738|NCT00303069|473250722|FG002|Overall Study|subject moved|0|||
131442739|NCT00303069|473250723|FG003|Overall Study|subject moved|0|||
131794782|NCT01844583|474530527|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
131794783|NCT01844583|474530528|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
131794784|NCT01625377|474530529|FG000|Overall Study|Death|1|||
131794785|NCT01625377|474530530|FG001|Overall Study|Death|1|||
131794786|NCT01625377|474530529|FG000|Overall Study|Administrative Problem|1|||
131794787|NCT01625377|474530530|FG001|Overall Study|Administrative Problem|1|||
131794788|NCT01625377|474530529|FG000|Overall Study|Protocol Violation|0|||
131794789|NCT01625377|474530530|FG001|Overall Study|Protocol Violation|3|||
131794790|NCT01625377|474530529|FG000|Overall Study|Adverse Event|3|||
131794791|NCT01625377|474530530|FG001|Overall Study|Adverse Event|16|||
131794792|NCT01625377|474530529|FG000|Overall Study|Graft loss|1|||
131794793|NCT01625377|474530530|FG001|Overall Study|Graft loss|0|||
131794794|NCT01625377|474530529|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131613897|NCT03333109|473878359|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
131794795|NCT01625377|474530530|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131794796|NCT01625377|474530529|FG000|Overall Study|Abnormal laboratory values|1|||
131794797|NCT01625377|474530530|FG001|Overall Study|Abnormal laboratory values|0|||
131794798|NCT03294538|474530535|FG000|Overall Study|Adverse Event|0|||
131794799|NCT03294538|474530536|FG001|Overall Study|Adverse Event|1|||
131794800|NCT03294538|474530537|FG002|Overall Study|Adverse Event|1|||
131794801|NCT03294538|474530535|FG000|Overall Study|Lost to Follow-up|1|||
131794802|NCT03294538|474530536|FG001|Overall Study|Lost to Follow-up|0|||
131794803|NCT03294538|474530537|FG002|Overall Study|Lost to Follow-up|0|||
131794804|NCT03294538|474530535|FG000|Overall Study|Outside of Visit Window|4|||
131794805|NCT03294538|474530536|FG001|Overall Study|Outside of Visit Window|4|||
131794806|NCT03294538|474530537|FG002|Overall Study|Outside of Visit Window|1|||
131794807|NCT00449072|474530544|FG000|Overall Study|Adverse Event|3|||
131794808|NCT00449072|474530545|FG001|Overall Study|Adverse Event|1|||
131794809|NCT00449072|474530544|FG000|Overall Study|Protocol Violation|14|||
131794810|NCT00449072|474530545|FG001|Overall Study|Protocol Violation|12|||
131794811|NCT00449072|474530544|FG000|Overall Study|Lost to Follow-up|5|||
131794812|NCT00449072|474530545|FG001|Overall Study|Lost to Follow-up|7|||
131794813|NCT00449072|474530544|FG000|Overall Study|Withdrawal by Subject|11|||
131794814|NCT00449072|474530545|FG001|Overall Study|Withdrawal by Subject|8|||
131794815|NCT00449072|474530544|FG000|Overall Study|Lack of Efficacy|1|||
131794816|NCT00449072|474530545|FG001|Overall Study|Lack of Efficacy|1|||
131794817|NCT00449072|474530544|FG000|Overall Study|Physician Decision|1|||
131794818|NCT00449072|474530545|FG001|Overall Study|Physician Decision|0|||
131794819|NCT00449072|474530544|FG000|Overall Study|Not treated|0|||
131794820|NCT00449072|474530545|FG001|Overall Study|Not treated|1|||
131794821|NCT00449072|474530544|FG000|Overall Study|Excluded medication|0|||
131613898|NCT03333109|473878360|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
131613899|NCT03333109|473878361|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
131613900|NCT03333109|473878359|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
131613901|NCT03333109|473878360|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
131613902|NCT03333109|473878361|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
131613903|NCT03333109|473878359|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
131613904|NCT03333109|473878360|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
131613905|NCT03333109|473878361|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
131613906|NCT03333109|473878359|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
131613907|NCT03333109|473878360|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
131613908|NCT03333109|473878361|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
131708764|NCT00191854|474213401|FG000|Overall Study|Sponsor Decision|0|||
131708765|NCT00191854|474213402|FG001|Overall Study|Sponsor Decision|0|||
131708766|NCT00191854|474213403|FG002|Overall Study|Sponsor Decision|1|||
131708767|NCT00191854|474213401|FG000|Overall Study|Screen Failure|0|||
131708768|NCT00191854|474213402|FG001|Overall Study|Screen Failure|0|||
131708769|NCT00191854|474213403|FG002|Overall Study|Screen Failure|1|||
131708770|NCT06118385|474213407|FG000|Overall Study|Protocol Violation|0|||
131708771|NCT06118385|474213408|FG001|Overall Study|Protocol Violation|0|||
131708772|NCT06118385|474213409|FG002|Overall Study|Protocol Violation|0|||
131708773|NCT06118385|474213410|FG003|Overall Study|Protocol Violation|0|||
131794822|NCT00449072|474530545|FG001|Overall Study|Excluded medication|2|||
131794823|NCT00449072|474530544|FG000|Overall Study|Non-compliance|2|||
131794824|NCT00449072|474530545|FG001|Overall Study|Non-compliance|5|||
131442740|NCT00303069|473250720|FG000|Overall Study|Recruitment into Army Reserves|0|||
131442741|NCT00303069|473250721|FG001|Overall Study|Recruitment into Army Reserves|0|||
131442742|NCT00303069|473250722|FG002|Overall Study|Recruitment into Army Reserves|1|||
131442743|NCT00303069|473250723|FG003|Overall Study|Recruitment into Army Reserves|0|||
131442744|NCT00751296|473250724|FG000|Overall Study|Adverse Event|2|||
131442745|NCT01775501|473250725|FG000|Overall Study|Discontinued prior to treatment|1|||
131442746|NCT03780244|473250728|FG000|Overall Study|Lost to Follow-up|1|||
131442747|NCT03780244|473250729|FG001|Overall Study|Lost to Follow-up|0|||
131442748|NCT00804908|473250733|FG000|Overall Study|Other|115|||
131442749|NCT00804908|473250734|FG001|Overall Study|Other|116|||
131442750|NCT00804908|473250735|FG002|Overall Study|Other|114|||
131442751|NCT01280903|473250736|FG000|Overall Study|Lost to Follow-up|23|||
131442752|NCT01280903|473250737|FG001|Overall Study|Lost to Follow-up|16|||
131442753|NCT03453164|473250738|FG000|Overall Study|Lack of Efficacy|16|||
131442754|NCT03453164|473250738|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
131442755|NCT03181932|473250739|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
131442756|NCT03181932|473250740|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
131442757|NCT03181932|473250739|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
131442758|NCT03181932|473250740|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
131708774|NCT06118385|474213411|FG004|Overall Study|Protocol Violation|0|||
131708775|NCT06118385|474213412|FG005|Overall Study|Protocol Violation|0|||
131708776|NCT06118385|474213413|FG006|Overall Study|Protocol Violation|0|||
131708777|NCT06118385|474213414|FG007|Overall Study|Protocol Violation|0|||
131794825|NCT00449072|474530544|FG000|Overall Study|Sponsor decision|1|||
131794826|NCT00449072|474530545|FG001|Overall Study|Sponsor decision|3|||
131794827|NCT00449072|474530544|FG000|Overall Study|Relocation|3|||
131794828|NCT00449072|474530545|FG001|Overall Study|Relocation|2|||
131794829|NCT01769378|474530546|FG000|Overall Study|Adverse Event|10|||
131794830|NCT01769378|474530547|FG001|Overall Study|Adverse Event|0|||
131794831|NCT01769378|474530546|FG000|Overall Study|Entry criteria not met|1|||
131794832|NCT01769378|474530547|FG001|Overall Study|Entry criteria not met|0|||
131794833|NCT01769378|474530546|FG000|Overall Study|Protocol Violation|1|||
131794834|NCT01769378|474530547|FG001|Overall Study|Protocol Violation|1|||
131442759|NCT03181932|473250739|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
131442760|NCT03181932|473250740|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
131708778|NCT06118385|474213415|FG008|Overall Study|Protocol Violation|1|||
131708779|NCT06118385|474213416|FG009|Overall Study|Protocol Violation|0|||
131708780|NCT06118385|474213417|FG010|Overall Study|Protocol Violation|0|||
131708781|NCT06118385|474213418|FG011|Overall Study|Protocol Violation|0|||
131708782|NCT06118385|474213407|FG000|Overall Study|Out-of-range blood tests|0|||
131708783|NCT06118385|474213408|FG001|Overall Study|Out-of-range blood tests|0|||
131708784|NCT06118385|474213409|FG002|Overall Study|Out-of-range blood tests|0|||
131708785|NCT06118385|474213410|FG003|Overall Study|Out-of-range blood tests|0|||
131708786|NCT06118385|474213411|FG004|Overall Study|Out-of-range blood tests|0|||
131708787|NCT06118385|474213412|FG005|Overall Study|Out-of-range blood tests|0|||
131708788|NCT06118385|474213413|FG006|Overall Study|Out-of-range blood tests|0|||
131708789|NCT06118385|474213414|FG007|Overall Study|Out-of-range blood tests|0|||
131708790|NCT06118385|474213415|FG008|Overall Study|Out-of-range blood tests|1|||
131708791|NCT06118385|474213416|FG009|Overall Study|Out-of-range blood tests|0|||
131708792|NCT06118385|474213417|FG010|Overall Study|Out-of-range blood tests|0|||
131708793|NCT06118385|474213418|FG011|Overall Study|Out-of-range blood tests|0|||
131708794|NCT01925209|474213419|FG000|Treatment Epoch|Physician Decision|1|||
131708795|NCT01925209|474213420|FG001|Treatment Epoch|Physician Decision|0|||
131794835|NCT01769378|474530546|FG000|Overall Study|Withdrawal by Subject|10|||
131794836|NCT01769378|474530547|FG001|Overall Study|Withdrawal by Subject|3|||
131442761|NCT03181932|473250739|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
131794837|NCT01769378|474530546|FG000|Overall Study|Sponsor Decision|1|||
131442762|NCT03181932|473250740|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
131442763|NCT03181932|473250739|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
131708796|NCT01925209|474213421|FG002|Treatment Epoch|Physician Decision|0|||
131708797|NCT01925209|474213422|FG003|Treatment Epoch|Physician Decision|0|||
131794838|NCT01769378|474530547|FG001|Overall Study|Sponsor Decision|0|||
131794839|NCT01769378|474530546|FG000|Overall Study|Lost to Follow-up|2|||
131613909|NCT04300023|473878364|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
131613910|NCT04300023|473878365|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
131613911|NCT01855750|473878366|FG000|Overall Study|Death|78|||
131613912|NCT01855750|473878367|FG001|Overall Study|Death|78|||
131613913|NCT01855750|473878366|FG000|Overall Study|Lost to Follow-up|9|||
131613914|NCT01855750|473878367|FG001|Overall Study|Lost to Follow-up|23|||
131613915|NCT01855750|473878366|FG000|Overall Study|Withdrawal by Subject|35|||
131613916|NCT01855750|473878367|FG001|Overall Study|Withdrawal by Subject|28|||
131613917|NCT01855750|473878366|FG000|Overall Study|Sponsor ends the study|297|||
131613918|NCT01855750|473878367|FG001|Overall Study|Sponsor ends the study|290|||
131613919|NCT02307682|473878368|FG000|Overall Study|Adverse Event|9|||
131613920|NCT02307682|473878369|FG001|Overall Study|Adverse Event|8|||
131794840|NCT01769378|474530547|FG001|Overall Study|Lost to Follow-up|0|||
131613921|NCT02307682|473878370|FG002|Overall Study|Adverse Event|12|||
131794841|NCT01787825|474530548|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
131794842|NCT01787825|474530549|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
131708798|NCT01925209|474213419|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
131794843|NCT01787825|474530548|FG000|Overall Study|Data Not Analyzable|5|||
131794844|NCT01787825|474530549|FG001|Overall Study|Data Not Analyzable|1|||
131794845|NCT00989261|474530550|FG000|Overall Study|Still in follow up|12|||
131794846|NCT00989261|474530551|FG001|Overall Study|Still in follow up|21|||
131794847|NCT00989261|474530550|FG000|Overall Study|Withdrawal by Subject|0|||
131794848|NCT00989261|474530551|FG001|Overall Study|Withdrawal by Subject|1|||
131794849|NCT00989261|474530550|FG000|Overall Study|Lost to Follow-up|3|||
131794850|NCT00989261|474530551|FG001|Overall Study|Lost to Follow-up|0|||
131794851|NCT01842958|474530552|FG000|Overall Study|Lost to Follow-up|1|||
131794852|NCT01842958|474530553|FG001|Overall Study|Lost to Follow-up|1|||
131794853|NCT00876733|474530556|FG000|Overall Study|Adverse Event|34|||
131794854|NCT00876733|474530557|FG001|Overall Study|Adverse Event|20|||
131794855|NCT00876733|474530558|FG002|Overall Study|Adverse Event|10|||
131794856|NCT00876733|474530559|FG003|Overall Study|Adverse Event|3|||
131794857|NCT00876733|474530556|FG000|Overall Study|Lack of Efficacy|17|||
131794858|NCT00876733|474530557|FG001|Overall Study|Lack of Efficacy|9|||
131794859|NCT00876733|474530558|FG002|Overall Study|Lack of Efficacy|10|||
131794860|NCT00876733|474530559|FG003|Overall Study|Lack of Efficacy|1|||
131794861|NCT00876733|474530556|FG000|Overall Study|Lost to Follow-up|26|||
131794862|NCT00876733|474530557|FG001|Overall Study|Lost to Follow-up|10|||
131794863|NCT00876733|474530558|FG002|Overall Study|Lost to Follow-up|3|||
131794864|NCT00876733|474530559|FG003|Overall Study|Lost to Follow-up|2|||
131794865|NCT00876733|474530556|FG000|Overall Study|Data not available|14|||
131794866|NCT00876733|474530557|FG001|Overall Study|Data not available|3|||
131794867|NCT00876733|474530558|FG002|Overall Study|Data not available|7|||
131794868|NCT00876733|474530559|FG003|Overall Study|Data not available|1|||
131794869|NCT02843074|474530562|FG000|Overall Study|Withdrawal by Subject|5|||
131794870|NCT02843074|474530562|FG000|Overall Study|Progressive disease|1|||
131794871|NCT02843074|474530562|FG000|Overall Study|Physician Decision|1|||
131794872|NCT02843074|474530562|FG000|Overall Study|Lost to Follow-up|1|||
131794873|NCT02843074|474530562|FG000|Overall Study|Death|9|||
131794874|NCT03035227|474530565|FG000|Overall Study|study stopped due to PI leaving institut|1|||
131794875|NCT03035227|474530566|FG001|Overall Study|study stopped due to PI leaving institut|1|||
131794876|NCT00095199|474530567|FG000|Overall Study|Adverse Event|40|||
131794877|NCT00095199|474530568|FG001|Overall Study|Adverse Event|22|||
131794878|NCT00095199|474530569|FG002|Overall Study|Adverse Event|26|||
131794879|NCT00095199|474530570|FG003|Overall Study|Adverse Event|11|||
131794880|NCT00095199|474530567|FG000|Overall Study|Progressive disease|213|||
131794881|NCT00095199|474530568|FG001|Overall Study|Progressive disease|179|||
131794882|NCT00095199|474530569|FG002|Overall Study|Progressive disease|105|||
131794883|NCT00095199|474530570|FG003|Overall Study|Progressive disease|98|||
131794884|NCT00095199|474530567|FG000|Overall Study|Death|10|||
131442764|NCT03181932|473250740|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
131442765|NCT03181932|473250739|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
131442766|NCT03181932|473250740|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
131442767|NCT03181932|473250739|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
131442768|NCT03181932|473250740|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
131442769|NCT03181932|473250739|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
131442770|NCT03181932|473250740|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
131442771|NCT03181932|473250739|FG000|Period 2 (Open-label Period)|Reason missing|2|||
131442772|NCT03181932|473250740|FG001|Period 2 (Open-label Period)|Reason missing|0|||
131442773|NCT02443688|473250741|FG000|Overall Study|Adverse Event|2|||
131442774|NCT02443688|473250742|FG001|Overall Study|Adverse Event|3|||
131442775|NCT02443688|473250743|FG002|Overall Study|Adverse Event|2|||
131442776|NCT02443688|473250741|FG000|Overall Study|Lost to Follow-up|1|||
131442777|NCT02443688|473250742|FG001|Overall Study|Lost to Follow-up|0|||
131442778|NCT02443688|473250743|FG002|Overall Study|Lost to Follow-up|0|||
131442779|NCT02443688|473250741|FG000|Overall Study|Physician Decision|3|||
131442780|NCT02443688|473250742|FG001|Overall Study|Physician Decision|0|||
131442781|NCT02443688|473250743|FG002|Overall Study|Physician Decision|1|||
131442782|NCT02443688|473250741|FG000|Overall Study|Pregnancy|0|||
131442783|NCT02443688|473250742|FG001|Overall Study|Pregnancy|0|||
131442784|NCT02443688|473250743|FG002|Overall Study|Pregnancy|1|||
131442785|NCT02443688|473250741|FG000|Overall Study|Withdrawal by Subject|3|||
131442786|NCT02443688|473250742|FG001|Overall Study|Withdrawal by Subject|3|||
131442787|NCT02443688|473250743|FG002|Overall Study|Withdrawal by Subject|4|||
131442788|NCT02443688|473250741|FG000|Overall Study|Non-compliance with study drug|1|||
131442789|NCT02443688|473250742|FG001|Overall Study|Non-compliance with study drug|2|||
131442790|NCT02443688|473250743|FG002|Overall Study|Non-compliance with study drug|4|||
131442791|NCT02443688|473250741|FG000|Overall Study|Sponsor Request|2|||
131442792|NCT02443688|473250742|FG001|Overall Study|Sponsor Request|1|||
131442793|NCT02443688|473250743|FG002|Overall Study|Sponsor Request|0|||
131442794|NCT03182374|473250744|FG000|Overall Study|Lost to Follow-up|3|||
131442795|NCT03182374|473250745|FG001|Overall Study|Lost to Follow-up|2|||
131442796|NCT03182374|473250744|FG000|Overall Study|Lack of Efficacy|8|||
131442797|NCT03182374|473250745|FG001|Overall Study|Lack of Efficacy|14|||
131442798|NCT03182374|473250744|FG000|Overall Study|Withdrawal by Subject|1|||
131442799|NCT03182374|473250745|FG001|Overall Study|Withdrawal by Subject|1|||
131442800|NCT03182374|473250744|FG000|Overall Study|exit for non-compliance|1|||
131442801|NCT03182374|473250745|FG001|Overall Study|exit for non-compliance|1|||
131442802|NCT03182374|473250744|FG000|Overall Study|one subject was randomized but not treated|1|||
131442803|NCT03182374|473250745|FG001|Overall Study|one subject was randomized but not treated|0|||
131442804|NCT03182374|473250744|FG000|Overall Study|Other reasons|0|||
131442805|NCT03182374|473250745|FG001|Overall Study|Other reasons|3|||
131442806|NCT03085095|473250746|FG000|Overall Study|Adverse Event|23|||
131442807|NCT03085095|473250747|FG001|Overall Study|Adverse Event|8|||
131442808|NCT03085095|473250746|FG000|Overall Study|Protocol Violation|0|||
131442809|NCT03085095|473250747|FG001|Overall Study|Protocol Violation|1|||
131442810|NCT03085095|473250746|FG000|Overall Study|Lost to Follow-up|2|||
131442811|NCT03085095|473250747|FG001|Overall Study|Lost to Follow-up|1|||
131442812|NCT03085095|473250746|FG000|Overall Study|Withdrawal by Subject|17|||
131442813|NCT03085095|473250747|FG001|Overall Study|Withdrawal by Subject|6|||
131613922|NCT02307682|473878368|FG000|Overall Study|Lack of Efficacy|1|||
131613923|NCT02307682|473878369|FG001|Overall Study|Lack of Efficacy|0|||
131613924|NCT02307682|473878370|FG002|Overall Study|Lack of Efficacy|1|||
131613925|NCT02307682|473878368|FG000|Overall Study|Physician Decision|2|||
131613926|NCT02307682|473878369|FG001|Overall Study|Physician Decision|2|||
131613927|NCT02307682|473878370|FG002|Overall Study|Physician Decision|8|||
131613928|NCT02307682|473878368|FG000|Overall Study|Progressive Disease|1|||
131613929|NCT02307682|473878369|FG001|Overall Study|Progressive Disease|0|||
131613930|NCT02307682|473878370|FG002|Overall Study|Progressive Disease|0|||
131442814|NCT03085095|473250746|FG000|Overall Study|Physician Decision|9|||
131613931|NCT02307682|473878368|FG000|Overall Study|Withdrawal by Subject|26|||
131442815|NCT03085095|473250747|FG001|Overall Study|Physician Decision|3|||
131442816|NCT03085095|473250746|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
131442817|NCT03085095|473250747|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
131442818|NCT03085095|473250746|FG000|Overall Study|Did not Receive Study Drug|2|||
131442819|NCT03085095|473250747|FG001|Overall Study|Did not Receive Study Drug|2|||
131613932|NCT02307682|473878369|FG001|Overall Study|Withdrawal by Subject|34|||
131613933|NCT02307682|473878370|FG002|Overall Study|Withdrawal by Subject|23|||
131613934|NCT02307682|473878368|FG000|Overall Study|Death|9|||
131613935|NCT02307682|473878369|FG001|Overall Study|Death|7|||
131613936|NCT02307682|473878370|FG002|Overall Study|Death|12|||
131442820|NCT03085095|473250746|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
131613937|NCT02307682|473878368|FG000|Overall Study|Lost to Follow-up|1|||
131613938|NCT02307682|473878369|FG001|Overall Study|Lost to Follow-up|5|||
131613939|NCT02307682|473878370|FG002|Overall Study|Lost to Follow-up|6|||
131442821|NCT03085095|473250747|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
131613940|NCT02307682|473878368|FG000|Overall Study|Protocol Deviation|0|||
131613941|NCT02307682|473878369|FG001|Overall Study|Protocol Deviation|0|||
131613942|NCT02307682|473878370|FG002|Overall Study|Protocol Deviation|2|||
131613943|NCT02307682|473878368|FG000|Overall Study|Other|1|||
131613944|NCT02307682|473878369|FG001|Overall Study|Other|1|||
131613945|NCT02307682|473878370|FG002|Overall Study|Other|0|||
131708799|NCT01925209|474213420|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
131708800|NCT01925209|474213421|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
131613948|NCT03277989|473878372|FG000|Overall Study|Lost to Follow-up|6|||
131613949|NCT03277989|473878372|FG000|Overall Study|Adverse Event|6|||
131613950|NCT03277989|473878372|FG000|Overall Study|Withdrawal by Subject|3|||
131613951|NCT03277989|473878372|FG000|Overall Study|Didn't Receive Study Device|7|||
131613952|NCT03277989|473878372|FG000|Overall Study|Site Closure|26|||
131613953|NCT03277989|473878372|FG000|Overall Study|Sponsor Closure|107|||
131613954|NCT03227861|473878375|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
131613955|NCT03227861|473878375|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
131613956|NCT03227861|473878375|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
131613957|NCT03227861|473878375|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
131613958|NCT03227861|473878375|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
131613959|NCT03227861|473878375|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
131613960|NCT03227861|473878375|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
131613961|NCT03227861|473878375|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
131613962|NCT03227861|473878375|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
131900377|NCT03286218|474921472|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900378|NCT03286218|474921473|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900379|NCT03286218|474921474|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900380|NCT03286218|474921475|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900381|NCT03286218|474921476|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900382|NCT03286218|474921477|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900383|NCT03286218|474921478|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900384|NCT03286218|474921479|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900385|NCT03286218|474921480|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900386|NCT03286218|474921481|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
131900387|NCT03286218|474921470|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
131900388|NCT03286218|474921471|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
131900389|NCT03286218|474921472|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
131900390|NCT03286218|474921473|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
131900391|NCT03286218|474921474|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
131900392|NCT03286218|474921475|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
131900393|NCT03286218|474921476|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
131900394|NCT03286218|474921477|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
131900395|NCT03286218|474921478|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
131900396|NCT03286218|474921479|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
131900397|NCT03286218|474921480|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
131900398|NCT03286218|474921481|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
131900399|NCT03286218|474921470|FG000|Qualification Phase Period 2|Protocol Violation|2|||
131900400|NCT03286218|474921471|FG001|Qualification Phase Period 2|Protocol Violation|0|||
131900401|NCT03286218|474921472|FG002|Qualification Phase Period 2|Protocol Violation|0|||
131900402|NCT03286218|474921473|FG003|Qualification Phase Period 2|Protocol Violation|0|||
131900403|NCT03286218|474921474|FG004|Qualification Phase Period 2|Protocol Violation|0|||
131900404|NCT03286218|474921475|FG005|Qualification Phase Period 2|Protocol Violation|0|||
131900405|NCT03286218|474921476|FG006|Qualification Phase Period 2|Protocol Violation|0|||
131900406|NCT03286218|474921477|FG007|Qualification Phase Period 2|Protocol Violation|0|||
131900407|NCT03286218|474921478|FG008|Qualification Phase Period 2|Protocol Violation|0|||
131900408|NCT03286218|474921479|FG009|Qualification Phase Period 2|Protocol Violation|0|||
131900409|NCT03286218|474921480|FG010|Qualification Phase Period 2|Protocol Violation|0|||
131900410|NCT03286218|474921481|FG011|Qualification Phase Period 2|Protocol Violation|0|||
131900411|NCT03286218|474921470|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
131900412|NCT03286218|474921471|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
131900413|NCT03286218|474921472|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900414|NCT03286218|474921473|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900415|NCT03286218|474921474|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900416|NCT03286218|474921475|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900417|NCT03286218|474921476|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
131613963|NCT03227861|473878375|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
131613964|NCT03516942|473878376|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
131613965|NCT03516942|473878376|FG000|Registration Through Baseline Survey Com|Death|8|||
131613966|NCT03516942|473878376|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
131794885|NCT00095199|474530568|FG001|Overall Study|Death|6|||
131794886|NCT00095199|474530569|FG002|Overall Study|Death|11|||
131794887|NCT00095199|474530570|FG003|Overall Study|Death|9|||
131794888|NCT00095199|474530567|FG000|Overall Study|Withdrawal by Subject|21|||
131794889|NCT00095199|474530568|FG001|Overall Study|Withdrawal by Subject|16|||
131794890|NCT00095199|474530569|FG002|Overall Study|Withdrawal by Subject|13|||
131794891|NCT00095199|474530570|FG003|Overall Study|Withdrawal by Subject|22|||
131794892|NCT00095199|474530567|FG000|Overall Study|Protocol Violation|4|||
131794893|NCT00095199|474530568|FG001|Overall Study|Protocol Violation|4|||
131794894|NCT00095199|474530569|FG002|Overall Study|Protocol Violation|2|||
131794895|NCT00095199|474530570|FG003|Overall Study|Protocol Violation|0|||
131794896|NCT00095199|474530567|FG000|Overall Study|Liver function test results elevated|0|||
131900418|NCT03286218|474921477|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
131442822|NCT00408317|473250748|FG000|First Intervention Period|Adverse Event|0|||
131442823|NCT00408317|473250749|FG001|First Intervention Period|Adverse Event|1|||
131613967|NCT03516942|473878376|FG000|T0: Baseline|LOST|13|||
131613968|NCT03516942|473878376|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
131613969|NCT03516942|473878376|FG000|T1: 3 Months Survey|Death|10|||
131613970|NCT03516942|473878376|FG000|T1: 3 Months Survey|Lost|163|||
131613971|NCT03516942|473878376|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
131613972|NCT03516942|473878376|FG000|T2: 6 Month Survey|Death|14|||
131613973|NCT03516942|473878376|FG000|T2: 6 Month Survey|Lost|180|||
131613974|NCT03516942|473878376|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
131613975|NCT03516942|473878376|FG000|T3: 12 Month Survey|Death|19|||
131613976|NCT03516942|473878376|FG000|T3: 12 Month Survey|Lost|209|||
131613977|NCT02401815|473878377|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613978|NCT02401815|473878378|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613979|NCT02401815|473878379|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613980|NCT02401815|473878380|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
131613981|NCT02401815|473878381|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613982|NCT02401815|473878382|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613983|NCT02401815|473878383|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613984|NCT02401815|473878384|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613985|NCT02401815|473878385|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613986|NCT02401815|473878386|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131613987|NCT02401815|473878377|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
131613988|NCT02401815|473878378|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613989|NCT02401815|473878379|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613990|NCT02401815|473878380|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
131613991|NCT02401815|473878381|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613992|NCT02401815|473878382|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613993|NCT02401815|473878383|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613994|NCT02401815|473878384|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613995|NCT02401815|473878385|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613996|NCT02401815|473878386|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131613997|NCT02401815|473878377|FG000|Dose Escalation (up to 670 Days)|Death|1|||
131900419|NCT03286218|474921478|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900420|NCT03286218|474921479|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900421|NCT03286218|474921480|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900422|NCT03286218|474921481|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
131900423|NCT03286218|474921470|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900424|NCT03286218|474921471|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900425|NCT03286218|474921472|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
131900426|NCT03286218|474921473|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
131900427|NCT03286218|474921474|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900428|NCT03286218|474921475|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
131900429|NCT03286218|474921476|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900430|NCT03286218|474921477|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900431|NCT03286218|474921478|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900432|NCT03286218|474921479|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
131900433|NCT03286218|474921480|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
131442824|NCT00408317|473250748|FG000|Second Intervention Period|Adverse Event|2|||
131613998|NCT02401815|473878378|FG001|Dose Escalation (up to 670 Days)|Death|2|||
131613999|NCT02401815|473878379|FG002|Dose Escalation (up to 670 Days)|Death|3|||
131614000|NCT02401815|473878380|FG003|Dose Escalation (up to 670 Days)|Death|5|||
131614001|NCT02401815|473878381|FG004|Dose Escalation (up to 670 Days)|Death|4|||
131614002|NCT02401815|473878382|FG005|Dose Escalation (up to 670 Days)|Death|0|||
131794897|NCT00095199|474530568|FG001|Overall Study|Liver function test results elevated|0|||
131794898|NCT00095199|474530569|FG002|Overall Study|Liver function test results elevated|1|||
131794899|NCT00095199|474530570|FG003|Overall Study|Liver function test results elevated|1|||
131794900|NCT00095199|474530567|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
131614003|NCT02401815|473878383|FG006|Dose Escalation (up to 670 Days)|Death|0|||
131900434|NCT03286218|474921481|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
131900435|NCT03286218|474921470|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900436|NCT03286218|474921471|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900437|NCT03286218|474921472|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900438|NCT03286218|474921473|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900439|NCT03286218|474921474|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900440|NCT03286218|474921475|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900441|NCT03286218|474921476|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900442|NCT03286218|474921477|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900443|NCT03286218|474921478|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900444|NCT03286218|474921479|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900445|NCT03286218|474921480|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
131900446|NCT03286218|474921481|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
131900447|NCT01348139|474921482|FG000|Period 1|Adverse Event|1|||
131900448|NCT01348139|474921483|FG001|Period 1|Adverse Event|0|||
131900449|NCT01348139|474921484|FG002|Period 1|Adverse Event|0|||
131900450|NCT01348139|474921485|FG003|Period 1|Adverse Event|0|||
131900451|NCT01348139|474921486|FG004|Period 1|Adverse Event|0|||
131900452|NCT01348139|474921487|FG005|Period 1|Adverse Event|0|||
131900453|NCT00165503|474921490|FG000|Overall Study|Death|1|||
131900454|NCT00165503|474921490|FG000|Overall Study|Lost to Follow-up|12|||
131900455|NCT00165503|474921490|FG000|Overall Study|Unresectable|3|||
131900456|NCT02346708|474921491|FG000|Overall Study|Adverse Event|2|||
131900457|NCT02346708|474921492|FG001|Overall Study|Adverse Event|0|||
131900458|NCT02346708|474921491|FG000|Overall Study|Protocol Violation|0|||
131900459|NCT02346708|474921492|FG001|Overall Study|Protocol Violation|1|||
131900460|NCT02976519|474921493|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
131900461|NCT02976519|474921494|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
131900462|NCT02976519|474921495|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
131900463|NCT02976519|474921496|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
131900464|NCT02976519|474921497|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
131900465|NCT02976519|474921498|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
131900466|NCT02976519|474921499|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
131900467|NCT02976519|474921493|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131900468|NCT02976519|474921494|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131900469|NCT02976519|474921495|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131900470|NCT02976519|474921496|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
131900471|NCT02976519|474921497|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131900472|NCT02976519|474921498|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131900473|NCT02976519|474921499|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131900474|NCT02976519|474921493|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
131900475|NCT02976519|474921494|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
131900476|NCT02976519|474921495|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
131900477|NCT02976519|474921496|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
131900478|NCT02976519|474921497|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
131900479|NCT02976519|474921498|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
131900480|NCT02976519|474921499|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
131900481|NCT02976519|474921493|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
131900482|NCT02976519|474921494|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
131900483|NCT02976519|474921495|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
131900484|NCT02976519|474921496|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
131900485|NCT02976519|474921497|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
131614004|NCT02401815|473878384|FG007|Dose Escalation (up to 670 Days)|Death|0|||
131614005|NCT02401815|473878385|FG008|Dose Escalation (up to 670 Days)|Death|0|||
131614006|NCT02401815|473878386|FG009|Dose Escalation (up to 670 Days)|Death|0|||
131614007|NCT02401815|473878377|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131614008|NCT02401815|473878378|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
131614009|NCT02401815|473878379|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131614010|NCT02401815|473878380|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131614011|NCT02401815|473878381|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
131614012|NCT02401815|473878382|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131614013|NCT02401815|473878383|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131900486|NCT02976519|474921498|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
131900487|NCT02976519|474921499|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
131900488|NCT02976519|474921493|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131900489|NCT02976519|474921494|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131614014|NCT02401815|473878384|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131614015|NCT02401815|473878385|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131900490|NCT02976519|474921495|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131900491|NCT02976519|474921496|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131614016|NCT02401815|473878386|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131900492|NCT02976519|474921497|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131614017|NCT02401815|473878377|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
131614018|NCT02401815|473878378|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614019|NCT02401815|473878379|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614020|NCT02401815|473878380|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614021|NCT02401815|473878381|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
131614022|NCT02401815|473878382|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614023|NCT02401815|473878383|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614024|NCT02401815|473878384|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614025|NCT02401815|473878385|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614026|NCT02401815|473878386|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131614027|NCT02401815|473878377|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614028|NCT02401815|473878378|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614029|NCT02401815|473878379|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614030|NCT02401815|473878380|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614031|NCT02401815|473878381|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614032|NCT02401815|473878382|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
131614033|NCT02401815|473878383|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614034|NCT02401815|473878384|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614035|NCT02401815|473878385|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614036|NCT02401815|473878386|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131614037|NCT02401815|473878377|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614038|NCT02401815|473878378|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614039|NCT02401815|473878379|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614040|NCT02401815|473878380|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614041|NCT02401815|473878381|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614042|NCT02401815|473878382|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614043|NCT02401815|473878383|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
131614044|NCT02401815|473878384|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614045|NCT02401815|473878385|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614046|NCT02401815|473878386|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614047|NCT02401815|473878377|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614048|NCT02401815|473878378|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614049|NCT02401815|473878379|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614050|NCT02401815|473878380|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614051|NCT02401815|473878381|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614052|NCT02401815|473878382|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
131614053|NCT02401815|473878383|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
131614054|NCT02401815|473878384|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614055|NCT02401815|473878385|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614056|NCT02401815|473878386|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131614057|NCT02401815|473878377|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614058|NCT02401815|473878378|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614059|NCT02401815|473878379|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614060|NCT02401815|473878380|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614061|NCT02401815|473878381|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614062|NCT02401815|473878382|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
131614063|NCT02401815|473878383|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614064|NCT02401815|473878384|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614065|NCT02401815|473878385|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614066|NCT02401815|473878386|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131614067|NCT02401815|473878377|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131614068|NCT02401815|473878378|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131614069|NCT02401815|473878379|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131900493|NCT02976519|474921498|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131900494|NCT02976519|474921499|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
131900495|NCT00928434|474921500|FG000|Overall Study|Adverse Event|14|||
131900496|NCT00928434|474921501|FG001|Overall Study|Adverse Event|5|||
131900497|NCT00928434|474921502|FG002|Overall Study|Adverse Event|18|||
131900498|NCT00928434|474921500|FG000|Overall Study|Protocol Violation|5|||
131900499|NCT00928434|474921501|FG001|Overall Study|Protocol Violation|0|||
131900500|NCT00928434|474921502|FG002|Overall Study|Protocol Violation|8|||
131900501|NCT00928434|474921500|FG000|Overall Study|Physician Decision|2|||
131708801|NCT01925209|474213422|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
131708802|NCT01925209|474213419|FG000|Treatment Epoch|Death|1|||
131708803|NCT01925209|474213420|FG001|Treatment Epoch|Death|0|||
131900502|NCT00928434|474921501|FG001|Overall Study|Physician Decision|0|||
131442825|NCT00408317|473250749|FG001|Second Intervention Period|Adverse Event|0|||
131442826|NCT00408317|473250748|FG000|Second Intervention Period|Protocol Violation|0|||
131442827|NCT00408317|473250749|FG001|Second Intervention Period|Protocol Violation|1|||
131442828|NCT00408317|473250748|FG000|Second Intervention Period|Withdrawal of consent|0|||
131442829|NCT00408317|473250749|FG001|Second Intervention Period|Withdrawal of consent|1|||
131442830|NCT03822117|473250751|FG000|Overall Study|Death|18|||
131442831|NCT03822117|473250752|FG001|Overall Study|Death|17|||
131442832|NCT03822117|473250753|FG002|Overall Study|Death|12|||
131442833|NCT03822117|473250754|FG003|Overall Study|Death|4|||
131442834|NCT03822117|473250751|FG000|Overall Study|Lost to Follow-up|1|||
131442835|NCT03822117|473250752|FG001|Overall Study|Lost to Follow-up|2|||
131442836|NCT03822117|473250753|FG002|Overall Study|Lost to Follow-up|3|||
131442837|NCT03822117|473250754|FG003|Overall Study|Lost to Follow-up|0|||
131442838|NCT03822117|473250751|FG000|Overall Study|Study Terminated by Sponsor|25|||
131442839|NCT03822117|473250752|FG001|Overall Study|Study Terminated by Sponsor|11|||
131442840|NCT03822117|473250753|FG002|Overall Study|Study Terminated by Sponsor|6|||
131442841|NCT03822117|473250754|FG003|Overall Study|Study Terminated by Sponsor|0|||
131442842|NCT03822117|473250751|FG000|Overall Study|Withdrawal by Subject|4|||
131442843|NCT03822117|473250752|FG001|Overall Study|Withdrawal by Subject|0|||
131442844|NCT03822117|473250753|FG002|Overall Study|Withdrawal by Subject|3|||
131442845|NCT03822117|473250754|FG003|Overall Study|Withdrawal by Subject|0|||
131442846|NCT03822117|473250751|FG000|Overall Study|Disease Progression|1|||
131442847|NCT03822117|473250752|FG001|Overall Study|Disease Progression|2|||
131442848|NCT03822117|473250753|FG002|Overall Study|Disease Progression|1|||
131442849|NCT03822117|473250754|FG003|Overall Study|Disease Progression|0|||
131442850|NCT03822117|473250751|FG000|Overall Study|Never Returned to Hospital|0|||
131442851|NCT03822117|473250752|FG001|Overall Study|Never Returned to Hospital|0|||
131442852|NCT03822117|473250753|FG002|Overall Study|Never Returned to Hospital|1|||
131442853|NCT03822117|473250754|FG003|Overall Study|Never Returned to Hospital|0|||
131442854|NCT01074502|473250755|FG000|Overall Study|Withdrawal by Subject|1|||
131442855|NCT03459079|473250756|FG000|Overall Study|Adverse Event|4|||
131442856|NCT03459079|473250757|FG001|Overall Study|Adverse Event|2|||
131442857|NCT03459079|473250758|FG002|Overall Study|Adverse Event|0|||
131442858|NCT03459079|473250756|FG000|Overall Study|Withdrawal by Subject|2|||
131442859|NCT03459079|473250757|FG001|Overall Study|Withdrawal by Subject|2|||
131442860|NCT03459079|473250758|FG002|Overall Study|Withdrawal by Subject|0|||
131442861|NCT03198715|473250759|FG000|Overall Study|Death|0|||
131442862|NCT03198715|473250760|FG001|Overall Study|Death|0|||
131442863|NCT03198715|473250761|FG002|Overall Study|Death|1|||
131442864|NCT03198715|473250762|FG003|Overall Study|Death|0|||
131442865|NCT03198715|473250763|FG004|Overall Study|Death|2|||
131442866|NCT03198715|473250759|FG000|Overall Study|Other|0|||
131442867|NCT03198715|473250760|FG001|Overall Study|Other|1|||
131442868|NCT03198715|473250761|FG002|Overall Study|Other|1|||
131708804|NCT01925209|474213421|FG002|Treatment Epoch|Death|0|||
131708805|NCT01925209|474213422|FG003|Treatment Epoch|Death|0|||
131708806|NCT01925209|474213419|FG000|Treatment Epoch|Protocol deviation|0|||
131708807|NCT01925209|474213420|FG001|Treatment Epoch|Protocol deviation|0|||
131708808|NCT01925209|474213421|FG002|Treatment Epoch|Protocol deviation|1|||
131708809|NCT01925209|474213422|FG003|Treatment Epoch|Protocol deviation|1|||
131708810|NCT01925209|474213419|FG000|Treatment Epoch|Withdrawal by Subject|4|||
131708811|NCT01925209|474213420|FG001|Treatment Epoch|Withdrawal by Subject|3|||
131708812|NCT01925209|474213421|FG002|Treatment Epoch|Withdrawal by Subject|3|||
131900503|NCT00928434|474921502|FG002|Overall Study|Physician Decision|3|||
131900504|NCT00928434|474921500|FG000|Overall Study|Lost to Follow-up|1|||
131900505|NCT00928434|474921501|FG001|Overall Study|Lost to Follow-up|0|||
131900506|NCT00928434|474921502|FG002|Overall Study|Lost to Follow-up|3|||
131900507|NCT00928434|474921500|FG000|Overall Study|Withdrawal by Subject|5|||
131900508|NCT00928434|474921501|FG001|Overall Study|Withdrawal by Subject|3|||
131900509|NCT00928434|474921502|FG002|Overall Study|Withdrawal by Subject|2|||
131900510|NCT00928434|474921500|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
131900511|NCT00928434|474921501|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
131442869|NCT03198715|473250762|FG003|Overall Study|Other|0|||
131442870|NCT03198715|473250763|FG004|Overall Study|Other|0|||
131900512|NCT00928434|474921502|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
131442871|NCT02220920|473250764|FG000|Overall Study|Adverse Event|1|||
131442872|NCT02220920|473250765|FG001|Overall Study|Adverse Event|0|||
131442873|NCT02220920|473250764|FG000|Overall Study|Lack of Efficacy|0|||
131442874|NCT02220920|473250765|FG001|Overall Study|Lack of Efficacy|1|||
131442875|NCT02220920|473250764|FG000|Overall Study|Withdrawal by Subject|1|||
131442876|NCT02220920|473250765|FG001|Overall Study|Withdrawal by Subject|0|||
131442877|NCT02220920|473250764|FG000|Overall Study|Conflict with the stopping criteria|1|||
131442878|NCT02220920|473250765|FG001|Overall Study|Conflict with the stopping criteria|2|||
131442879|NCT02177123|473250766|FG000|Overall Study|Lost to Follow-up|6|||
131708813|NCT01925209|474213422|FG003|Treatment Epoch|Withdrawal by Subject|2|||
131614070|NCT02401815|473878380|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131614071|NCT02401815|473878381|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131900513|NCT00928434|474921500|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
131900514|NCT00928434|474921501|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
131900515|NCT00928434|474921502|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
131900516|NCT00928434|474921500|FG000|Overall Study|Other (not meeting above criteria)|5|||
131900517|NCT00928434|474921501|FG001|Overall Study|Other (not meeting above criteria)|1|||
131900518|NCT00928434|474921502|FG002|Overall Study|Other (not meeting above criteria)|2|||
131900519|NCT03933449|474921503|FG000|Overall Study|Adverse Event|6|||
131900520|NCT03933449|474921504|FG001|Overall Study|Adverse Event|4|||
131900521|NCT03933449|474921503|FG000|Overall Study|Death|55|||
131900522|NCT03933449|474921504|FG001|Overall Study|Death|57|||
131900523|NCT03933449|474921503|FG000|Overall Study|Sponsor Decision|1|||
131900524|NCT03933449|474921504|FG001|Overall Study|Sponsor Decision|0|||
131900525|NCT01610037|474921506|FG000|All Patients|Adverse Event|27|||
131900526|NCT01610037|474921507|FG001|All Patients|Adverse Event|22|||
131900527|NCT01610037|474921508|FG002|All Patients|Adverse Event|26|||
131900528|NCT01610037|474921506|FG000|All Patients|Withdrawal by Subject|12|||
131900529|NCT01610037|474921507|FG001|All Patients|Withdrawal by Subject|10|||
131900530|NCT01610037|474921508|FG002|All Patients|Withdrawal by Subject|20|||
131900531|NCT01610037|474921506|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
131900532|NCT01610037|474921507|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
131900533|NCT01610037|474921508|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
131900534|NCT01610037|474921506|FG000|All Patients|Death|4|||
131900535|NCT01610037|474921507|FG001|All Patients|Death|2|||
131900536|NCT01610037|474921508|FG002|All Patients|Death|1|||
131900537|NCT01610037|474921506|FG000|All Patients|Protocol deviation|4|||
131900538|NCT01610037|474921507|FG001|All Patients|Protocol deviation|3|||
131900539|NCT01610037|474921508|FG002|All Patients|Protocol deviation|3|||
131900540|NCT01610037|474921506|FG000|All Patients|Abnormal laboratory value|1|||
131900541|NCT01610037|474921507|FG001|All Patients|Abnormal laboratory value|1|||
131900542|NCT01610037|474921508|FG002|All Patients|Abnormal laboratory value|0|||
131900543|NCT01610037|474921506|FG000|All Patients|Administrative problems|1|||
131900544|NCT01610037|474921507|FG001|All Patients|Administrative problems|4|||
131900545|NCT01610037|474921508|FG002|All Patients|Administrative problems|4|||
131900546|NCT01610037|474921506|FG000|All Patients|Lost to Follow-up|1|||
131900547|NCT01610037|474921507|FG001|All Patients|Lost to Follow-up|0|||
131900548|NCT01610037|474921508|FG002|All Patients|Lost to Follow-up|0|||
131900549|NCT01610037|474921506|FG000|All Patients|Abnormal test procedure result(s)|0|||
131900550|NCT01610037|474921507|FG001|All Patients|Abnormal test procedure result(s)|1|||
131900551|NCT01610037|474921508|FG002|All Patients|Abnormal test procedure result(s)|3|||
131900552|NCT01610037|474921506|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
131900553|NCT01610037|474921507|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
131900554|NCT01610037|474921508|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
131900555|NCT01610037|474921506|FG000|Treatment and Follow up Period|Death|10|||
131900556|NCT01610037|474921507|FG001|Treatment and Follow up Period|Death|5|||
131900557|NCT01610037|474921508|FG002|Treatment and Follow up Period|Death|4|||
131900558|NCT01610037|474921506|FG000|Treatment and Follow up Period|Administrative problems|1|||
131900559|NCT01610037|474921507|FG001|Treatment and Follow up Period|Administrative problems|3|||
131900560|NCT01610037|474921508|FG002|Treatment and Follow up Period|Administrative problems|2|||
131900561|NCT01610037|474921506|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
131900562|NCT01610037|474921507|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
131900563|NCT01610037|474921508|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
131900564|NCT00705757|474921509|FG000|Overall Study|Lack of Efficacy|5|||
131900565|NCT00705757|474921510|FG001|Overall Study|Lack of Efficacy|1|||
131794901|NCT00095199|474530568|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
131794902|NCT00095199|474530569|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
131794903|NCT00095199|474530570|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
131794904|NCT00095199|474530567|FG000|Overall Study|Physician Decision|5|||
131794905|NCT00095199|474530568|FG001|Overall Study|Physician Decision|6|||
131794906|NCT00095199|474530569|FG002|Overall Study|Physician Decision|1|||
131794907|NCT00095199|474530570|FG003|Overall Study|Physician Decision|1|||
131794908|NCT00095199|474530567|FG000|Overall Study|Not eligible|1|||
131794909|NCT00095199|474530568|FG001|Overall Study|Not eligible|7|||
131794910|NCT00095199|474530569|FG002|Overall Study|Not eligible|0|||
131794911|NCT00095199|474530570|FG003|Overall Study|Not eligible|1|||
131794912|NCT00095199|474530567|FG000|Overall Study|Started Palliative Radiotherapy|1|||
131794913|NCT00095199|474530568|FG001|Overall Study|Started Palliative Radiotherapy|0|||
131794914|NCT00095199|474530569|FG002|Overall Study|Started Palliative Radiotherapy|0|||
131794915|NCT00095199|474530570|FG003|Overall Study|Started Palliative Radiotherapy|0|||
131794916|NCT00095199|474530567|FG000|Overall Study|Started radiotherapy regimen|0|||
131794917|NCT00095199|474530568|FG001|Overall Study|Started radiotherapy regimen|1|||
131794918|NCT00095199|474530569|FG002|Overall Study|Started radiotherapy regimen|0|||
131794919|NCT00095199|474530570|FG003|Overall Study|Started radiotherapy regimen|0|||
131794920|NCT00095199|474530567|FG000|Overall Study|Primary tumor removed in other surgery|0|||
131794921|NCT00095199|474530568|FG001|Overall Study|Primary tumor removed in other surgery|1|||
131794922|NCT00095199|474530569|FG002|Overall Study|Primary tumor removed in other surgery|0|||
131794923|NCT00095199|474530570|FG003|Overall Study|Primary tumor removed in other surgery|0|||
131794924|NCT00095199|474530567|FG000|Overall Study|Data inadvertently lost by site|1|||
131794925|NCT00095199|474530568|FG001|Overall Study|Data inadvertently lost by site|0|||
131794926|NCT00095199|474530569|FG002|Overall Study|Data inadvertently lost by site|0|||
131794927|NCT00095199|474530570|FG003|Overall Study|Data inadvertently lost by site|0|||
131794928|NCT05188521|474532010|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
131794929|NCT05188521|474532011|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
131794930|NCT04582266|474532012|FG000|Overall Study|Lost to Follow-up|7|||
131794931|NCT04582266|474532013|FG001|Overall Study|Lost to Follow-up|5|||
131794932|NCT04582266|474532012|FG000|Overall Study|Withdrawal by Subject|1|||
131794933|NCT04582266|474532013|FG001|Overall Study|Withdrawal by Subject|0|||
131794934|NCT04582266|474532012|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
131794935|NCT04582266|474532013|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
131794936|NCT01341639|474532014|FG000|Infant Series|Protocol Violation|1|||
131794937|NCT01341639|474532015|FG001|Infant Series|Protocol Violation|0|||
131794938|NCT01341639|474532014|FG000|Infant Series|Not Vaccinated|0|||
131794939|NCT01341639|474532015|FG001|Infant Series|Not Vaccinated|1|||
131794940|NCT01341639|474532014|FG000|Infant Series|Adverse Event|0|||
131614072|NCT02401815|473878382|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131614073|NCT02401815|473878383|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131614074|NCT02401815|473878384|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
131614075|NCT02401815|473878385|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
131614076|NCT02401815|473878386|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
131614077|NCT02401815|473878377|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614078|NCT02401815|473878378|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614079|NCT02401815|473878379|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614080|NCT02401815|473878380|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614081|NCT02401815|473878381|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614082|NCT02401815|473878382|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614083|NCT02401815|473878383|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614084|NCT02401815|473878384|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131614085|NCT02401815|473878385|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
131614086|NCT02401815|473878386|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
131614087|NCT02401815|473878377|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614088|NCT02401815|473878378|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614089|NCT02401815|473878379|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614090|NCT02401815|473878380|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614091|NCT02401815|473878381|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614092|NCT02401815|473878382|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614093|NCT02401815|473878383|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614094|NCT02401815|473878384|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614095|NCT02401815|473878385|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131614096|NCT02401815|473878386|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
131614097|NCT02401815|473878377|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614098|NCT02401815|473878378|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614099|NCT02401815|473878379|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614100|NCT02401815|473878380|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614101|NCT02401815|473878381|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614102|NCT02401815|473878382|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614103|NCT02401815|473878383|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614104|NCT02401815|473878384|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614105|NCT02401815|473878385|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
131614106|NCT02401815|473878386|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131614107|NCT02401815|473878377|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614108|NCT02401815|473878378|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614109|NCT02401815|473878379|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614110|NCT02401815|473878380|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614111|NCT02401815|473878381|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614112|NCT02401815|473878382|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614113|NCT02401815|473878383|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131614114|NCT02401815|473878384|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
131614115|NCT02401815|473878385|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131708814|NCT01925209|474213419|FG000|Treatment Epoch|Adverse Event|3|||
131708815|NCT01925209|474213420|FG001|Treatment Epoch|Adverse Event|5|||
131442880|NCT02177123|473250766|FG000|Overall Study|Withdrawal by Subject|4|||
131442881|NCT02177123|473250766|FG000|Overall Study|Adverse Event|4|||
131442882|NCT02177123|473250766|FG000|Overall Study|Physician Decision|3|||
131442883|NCT02177123|473250766|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
131442884|NCT02177123|473250766|FG000|Overall Study|Excluded for medical reasons|2|||
131442885|NCT02177123|473250766|FG000|Overall Study|Death|1|||
131442886|NCT02177123|473250766|FG000|Overall Study|Other|1|||
131442887|NCT02177123|473250766|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
131442888|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
131442889|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
131442890|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
131442891|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Death|9|||
131442892|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Death|0|||
131442893|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Death|0|||
131442894|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
131442895|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
131442896|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
131442897|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
131442898|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
131442899|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
131900566|NCT00705757|474921511|FG002|Overall Study|Lack of Efficacy|3|||
131900567|NCT00705757|474921509|FG000|Overall Study|Lost to Follow-up|7|||
131900568|NCT00705757|474921510|FG001|Overall Study|Lost to Follow-up|6|||
131442900|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Other|135|||
131442901|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Other|0|||
131442902|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Other|0|||
131442903|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
131442904|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
131442905|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
131442906|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
131442907|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
131442908|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
131442909|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
131442910|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
131442911|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
131442912|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Other|3|||
131442913|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Other|0|||
131442914|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Other|0|||
131614116|NCT02401815|473878386|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
131614117|NCT05613907|473878387|FG000|Overall Study|Lost to Follow-up|5|||
131614118|NCT05613907|473878387|FG000|Overall Study|Death|3|||
131614119|NCT05613907|473878387|FG000|Overall Study|Withdrawal by Subject|2|||
131614120|NCT02751528|473878388|FG000|Overall Study|Withdrawal by Subject|1|||
131614121|NCT02751528|473878388|FG000|Overall Study|Adverse Event|1|||
131614122|NCT05349838|473878389|FG000|Overall Study|Virological Failure|1|||
131614123|NCT05349838|473878390|FG001|Overall Study|Virological Failure|2|||
131614124|NCT05349838|473878389|FG000|Overall Study|Withdrawal by Subject|2|||
131614125|NCT05349838|473878390|FG001|Overall Study|Withdrawal by Subject|3|||
131614126|NCT05349838|473878389|FG000|Overall Study|Adverse Event|3|||
131614127|NCT05349838|473878390|FG001|Overall Study|Adverse Event|1|||
131614128|NCT05349838|473878389|FG000|Overall Study|Lost to Follow-up|1|||
131614129|NCT05349838|473878390|FG001|Overall Study|Lost to Follow-up|2|||
131614130|NCT05349838|473878389|FG000|Overall Study|Other reasons|5|||
131614131|NCT05349838|473878390|FG001|Overall Study|Other reasons|1|||
131614132|NCT05071430|473878392|FG000|Overall Study|Adverse Event|1|||
131614133|NCT05071430|473878393|FG001|Overall Study|Adverse Event|2|||
131614134|NCT05071430|473878392|FG000|Overall Study|Lost to Follow-up|4|||
131614135|NCT05071430|473878393|FG001|Overall Study|Lost to Follow-up|4|||
131614136|NCT05071430|473878392|FG000|Overall Study|Protocol Violation|1|||
131614137|NCT05071430|473878393|FG001|Overall Study|Protocol Violation|0|||
131614138|NCT05071430|473878392|FG000|Overall Study|Withdrawal by Subject|3|||
131614139|NCT05071430|473878393|FG001|Overall Study|Withdrawal by Subject|2|||
131614140|NCT05071430|473878392|FG000|Overall Study|Other|1|||
131614141|NCT05071430|473878393|FG001|Overall Study|Other|1|||
131614142|NCT01958021|473878394|FG000|Treatment|Progressive disease|206|||
131614143|NCT01958021|473878395|FG001|Treatment|Progressive disease|265|||
131614144|NCT01958021|473878394|FG000|Treatment|Adverse Event|38|||
131614145|NCT01958021|473878395|FG001|Treatment|Adverse Event|10|||
131900569|NCT00705757|474921511|FG002|Overall Study|Lost to Follow-up|6|||
131614146|NCT01958021|473878394|FG000|Treatment|Subject/guardian decision|29|||
131614147|NCT01958021|473878395|FG001|Treatment|Subject/guardian decision|25|||
131614148|NCT01958021|473878394|FG000|Treatment|Physician Decision|28|||
131614149|NCT01958021|473878395|FG001|Treatment|Physician Decision|21|||
131614150|NCT01958021|473878394|FG000|Treatment|Death|6|||
131900570|NCT00705757|474921509|FG000|Overall Study|Withdrawal by Subject|1|||
131442915|NCT02118584|473250768|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
131442916|NCT02118584|473250769|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
131442917|NCT02118584|473250770|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
131442918|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131442919|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
131442920|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131442921|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
131442922|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
131442923|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
131442924|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
131442925|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
131442926|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
131442927|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
131442928|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
131442929|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
131442930|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
131442931|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
131442932|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
131442933|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
131442934|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
131442935|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
131442936|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131442937|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
131442938|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131442939|NCT02118584|473250768|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
131442940|NCT02118584|473250769|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
131442941|NCT02118584|473250770|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
131442942|NCT06271993|473250771|FG000|Overall Study|Not reactive to histamine|5|||
131442943|NCT06271993|473250772|FG001|Overall Study|Not reactive to histamine|5|||
131442944|NCT06271993|473250773|FG002|Overall Study|Not reactive to histamine|5|||
131442945|NCT03103542|473250774|FG000|Overall Study|Physician Decision|2|||
131442946|NCT03103542|473250774|FG000|Overall Study|Adverse Event|2|||
131442947|NCT03103542|473250774|FG000|Overall Study|Other|2|||
131442948|NCT03103542|473250774|FG000|Overall Study|Withdrawal by Subject|1|||
131442949|NCT03566511|473250775|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
131442950|NCT03566511|473250776|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
131442951|NCT02939287|473250781|FG000|Overall Study|met exclusion criteria|1|||
131442952|NCT02939287|473250782|FG001|Overall Study|met exclusion criteria|1|||
131442953|NCT02939287|473250783|FG002|Overall Study|met exclusion criteria|1|||
131442954|NCT02939287|473250781|FG000|Overall Study|Did not complete survey|2|||
131442955|NCT02939287|473250782|FG001|Overall Study|Did not complete survey|2|||
131442956|NCT02939287|473250783|FG002|Overall Study|Did not complete survey|0|||
131442957|NCT02939287|473250781|FG000|Overall Study|Withdrawal by Subject|1|||
131442958|NCT02939287|473250782|FG001|Overall Study|Withdrawal by Subject|1|||
131442959|NCT02939287|473250783|FG002|Overall Study|Withdrawal by Subject|0|||
131442960|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
131442961|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
131442962|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131442963|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
131442964|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
131442965|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
131442966|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
131614151|NCT01958021|473878395|FG001|Treatment|Death|1|||
131614152|NCT01958021|473878394|FG000|Treatment|Protocol deviation|3|||
131614153|NCT01958021|473878395|FG001|Treatment|Protocol deviation|1|||
131614154|NCT01958021|473878394|FG000|Treatment|Sponsor decision|24|||
131614155|NCT01958021|473878395|FG001|Treatment|Sponsor decision|11|||
131614156|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131614157|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131614158|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Death|1|||
131614159|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Death|0|||
131614160|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
131614161|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131614162|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131614163|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131442967|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
131614164|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
131614165|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
131614166|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
131614167|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
131614168|NCT01958021|473878394|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
131614169|NCT01958021|473878395|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
131614170|NCT00490139|473878397|FG000|Overall Study|Lost to Follow-up|249|||
131614171|NCT00490139|473878398|FG001|Overall Study|Lost to Follow-up|216|||
131614172|NCT00490139|473878399|FG002|Overall Study|Lost to Follow-up|205|||
131614173|NCT00490139|473878400|FG003|Overall Study|Lost to Follow-up|229|||
131614174|NCT00490139|473878397|FG000|Overall Study|Withdrawal by Subject|333|||
131614175|NCT00490139|473878398|FG001|Overall Study|Withdrawal by Subject|322|||
131614176|NCT00490139|473878399|FG002|Overall Study|Withdrawal by Subject|396|||
131614177|NCT00490139|473878400|FG003|Overall Study|Withdrawal by Subject|295|||
131614178|NCT00490139|473878397|FG000|Overall Study|Patient did not sign ICF 12|169|||
131614179|NCT00490139|473878398|FG001|Overall Study|Patient did not sign ICF 12|176|||
131614180|NCT00490139|473878399|FG002|Overall Study|Patient did not sign ICF 12|139|||
131614181|NCT00490139|473878400|FG003|Overall Study|Patient did not sign ICF 12|167|||
131614182|NCT00490139|473878397|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
131614183|NCT00490139|473878398|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
131614184|NCT00490139|473878399|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
131614185|NCT00490139|473878400|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
131614186|NCT00490139|473878397|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
131614187|NCT00490139|473878398|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
131614188|NCT00490139|473878399|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
131614189|NCT00490139|473878400|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
131614190|NCT00490139|473878397|FG000|Overall Study|Other reasons as defined per protocol|98|||
131614191|NCT00490139|473878398|FG001|Overall Study|Other reasons as defined per protocol|84|||
131614192|NCT00490139|473878399|FG002|Overall Study|Other reasons as defined per protocol|82|||
131614193|NCT00490139|473878400|FG003|Overall Study|Other reasons as defined per protocol|105|||
131614194|NCT04484623|473878401|FG000|Overall Study|Lost to Follow-up|0|||
131614195|NCT04484623|473878402|FG001|Overall Study|Lost to Follow-up|1|||
131614196|NCT04484623|473878401|FG000|Overall Study|Protocol Deviation|1|||
131614197|NCT04484623|473878402|FG001|Overall Study|Protocol Deviation|0|||
131614198|NCT04484623|473878401|FG000|Overall Study|Physician Decision|1|||
131614199|NCT04484623|473878402|FG001|Overall Study|Physician Decision|0|||
131614200|NCT04484623|473878401|FG000|Overall Study|Withdrawal by Subject|11|||
131614201|NCT04484623|473878402|FG001|Overall Study|Withdrawal by Subject|8|||
131614202|NCT04484623|473878401|FG000|Overall Study|Ongoing|94|||
131614203|NCT04484623|473878402|FG001|Overall Study|Ongoing|84|||
131708816|NCT01925209|474213421|FG002|Treatment Epoch|Adverse Event|3|||
131708817|NCT01925209|474213422|FG003|Treatment Epoch|Adverse Event|1|||
131708818|NCT01925209|474213419|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
131708819|NCT01925209|474213420|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
131442968|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
131442969|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131442970|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131442971|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131442972|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
131442973|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
131442974|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
131442975|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
131442976|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
131442977|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
131442978|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
131442979|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
131442980|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
131442981|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
131442982|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131442983|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131442984|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
131442985|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
131708820|NCT01925209|474213421|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
131708821|NCT01925209|474213422|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
131708822|NCT01925209|474213419|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
131708823|NCT01925209|474213420|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
131708824|NCT01925209|474213421|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
131708825|NCT01925209|474213422|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
131708826|NCT01925209|474213419|FG000|Follow-up|Adverse Event|1|||
131708827|NCT01925209|474213420|FG001|Follow-up|Adverse Event|4|||
131708828|NCT01925209|474213421|FG002|Follow-up|Adverse Event|0|||
131708829|NCT01925209|474213422|FG003|Follow-up|Adverse Event|1|||
131708830|NCT01925209|474213419|FG000|Follow-up|Physician Decision|0|||
131708831|NCT01925209|474213420|FG001|Follow-up|Physician Decision|0|||
131708832|NCT01925209|474213421|FG002|Follow-up|Physician Decision|1|||
131708833|NCT01925209|474213422|FG003|Follow-up|Physician Decision|0|||
131708834|NCT01925209|474213419|FG000|Follow-up|Non-compliance with study treatment|0|||
131708835|NCT01925209|474213420|FG001|Follow-up|Non-compliance with study treatment|0|||
131708836|NCT01925209|474213421|FG002|Follow-up|Non-compliance with study treatment|0|||
131708837|NCT01925209|474213422|FG003|Follow-up|Non-compliance with study treatment|1|||
131614224|NCT02798471|473878406|FG000|Overall Study|Adverse Event|7|||
131442986|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
131442987|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
131442988|NCT04026113|473250784|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
131442989|NCT04026113|473250785|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
131442990|NCT04026113|473250786|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
131442991|NCT04026113|473250787|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
131442992|NCT04026113|473250784|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
131442993|NCT04026113|473250785|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
131442994|NCT04026113|473250786|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
131442995|NCT04026113|473250787|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
131442996|NCT04613362|473250788|FG000|3 Month Follow-up|Lost to Follow-up|1|||
131442997|NCT04613362|473250789|FG001|3 Month Follow-up|Lost to Follow-up|2|||
131442998|NCT04613362|473250788|FG000|6 Month Follow-up|Lost to Follow-up|0|||
131442999|NCT04613362|473250789|FG001|6 Month Follow-up|Lost to Follow-up|1|||
131443000|NCT02218372|473250790|FG000|Overall Study|Adverse Event|1|||
131443001|NCT02218372|473250791|FG001|Overall Study|Adverse Event|1|||
131443002|NCT02218372|473250790|FG000|Overall Study|Miscellaneous|2|||
131614225|NCT02798471|473878407|FG001|Overall Study|Adverse Event|2|||
131614226|NCT02798471|473878406|FG000|Overall Study|Physician Decision|3|||
131614227|NCT02798471|473878407|FG001|Overall Study|Physician Decision|7|||
131614228|NCT02798471|473878406|FG000|Overall Study|Death|2|||
131614229|NCT02798471|473878407|FG001|Overall Study|Death|3|||
131614230|NCT02798471|473878406|FG000|Overall Study|Lost to Follow-up|0|||
131614231|NCT02798471|473878407|FG001|Overall Study|Lost to Follow-up|1|||
131614232|NCT02798471|473878406|FG000|Overall Study|Other|5|||
131614233|NCT02798471|473878407|FG001|Overall Study|Other|3|||
131614234|NCT02798471|473878406|FG000|Overall Study|Subject withdrew consent|0|||
131614235|NCT02798471|473878407|FG001|Overall Study|Subject withdrew consent|6|||
131614236|NCT02798471|473878406|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
131614237|NCT02798471|473878407|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
131614238|NCT02798471|473878406|FG000|Overall Study|Randomized, but not treated|0|||
131614239|NCT02798471|473878407|FG001|Overall Study|Randomized, but not treated|2|||
131443003|NCT02218372|473250791|FG001|Overall Study|Miscellaneous|1|||
131443004|NCT02218372|473250790|FG000|Overall Study|Randomized but did not receive treatment|2|||
131443005|NCT02218372|473250791|FG001|Overall Study|Randomized but did not receive treatment|3|||
131443006|NCT02218372|473250790|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131443007|NCT02218372|473250791|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131443008|NCT03406780|473250799|FG000|Overall Study|Withdrawal by Subject|1|||
131443009|NCT03406780|473250800|FG001|Overall Study|Withdrawal by Subject|1|||
131443010|NCT03406780|473250799|FG000|Overall Study|Other|0|||
131443011|NCT03406780|473250800|FG001|Overall Study|Other|2|||
131443012|NCT00074711|473250802|FG000|Overall Study|Withdrawal by Subject|1|||
131443013|NCT00074711|473250803|FG001|Overall Study|Withdrawal by Subject|1|||
131443014|NCT00074711|473250802|FG000|Overall Study|Lost to Follow-up|10|||
131443015|NCT00074711|473250803|FG001|Overall Study|Lost to Follow-up|8|||
131443016|NCT00074711|473250802|FG000|Overall Study|Participant stopped study drug|4|||
131443017|NCT00074711|473250803|FG001|Overall Study|Participant stopped study drug|6|||
131443018|NCT00671658|473250804|FG000|Overall Study|Physician Decision|5|||
131443019|NCT01921205|473250805|FG000|Overall Study|Adverse Event|12|||
131443020|NCT01921205|473250806|FG001|Overall Study|Adverse Event|7|||
131443021|NCT01921205|473250805|FG000|Overall Study|Lack of Efficacy|1|||
131443022|NCT01921205|473250806|FG001|Overall Study|Lack of Efficacy|0|||
131443023|NCT01921205|473250805|FG000|Overall Study|Protocol Violation|1|||
131443024|NCT01921205|473250806|FG001|Overall Study|Protocol Violation|3|||
131443025|NCT01921205|473250805|FG000|Overall Study|Lost to Follow-up|1|||
131443026|NCT01921205|473250806|FG001|Overall Study|Lost to Follow-up|1|||
131443027|NCT01921205|473250805|FG000|Overall Study|Withdrawal by Subject|6|||
131708838|NCT01925209|474213419|FG000|Follow-up|Withdrawal by Subject|0|||
131443028|NCT01921205|473250806|FG001|Overall Study|Withdrawal by Subject|5|||
131614240|NCT04503681|473879479|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
131614241|NCT04503681|473879480|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
131614242|NCT03752684|473879481|FG000|Overall Study|Lost to Follow-up|4|||
131614243|NCT01812759|473879482|FG000|Overall Study|Physician Decision|0|||
131614244|NCT01812759|473879483|FG001|Overall Study|Physician Decision|0|||
131614245|NCT01812759|473879484|FG002|Overall Study|Physician Decision|1|||
131708839|NCT01925209|474213420|FG001|Follow-up|Withdrawal by Subject|2|||
131708840|NCT01925209|474213421|FG002|Follow-up|Withdrawal by Subject|0|||
131708841|NCT01925209|474213422|FG003|Follow-up|Withdrawal by Subject|2|||
131708842|NCT02388295|474213423|FG000|Dose Escalation Week 1|Adverse Event|1|||
131708843|NCT02388295|474213424|FG001|Dose Escalation Week 1|Adverse Event|2|||
131708844|NCT02388295|474213425|FG002|Dose Escalation Week 1|Adverse Event|1|||
131708845|NCT02388295|474213423|FG000|Dose Escalation Week 1|Determined not eligible|1|||
131614246|NCT00536120|473879485|FG000|Overall Study|Lost to Follow-up|1|||
131614247|NCT00536120|473879486|FG001|Overall Study|Lost to Follow-up|0|||
131614248|NCT00536120|473879485|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
131614249|NCT00536120|473879486|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
131614250|NCT00536120|473879485|FG000|Overall Study|Non-compliance|1|||
131614251|NCT00536120|473879486|FG001|Overall Study|Non-compliance|0|||
131614252|NCT00536120|473879485|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
131614253|NCT00536120|473879486|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
131614254|NCT00536120|473879485|FG000|Overall Study|Steroid Use|0|||
131614255|NCT00536120|473879486|FG001|Overall Study|Steroid Use|2|||
131614256|NCT00536120|473879485|FG000|Overall Study|Missed Study Visit|0|||
131614257|NCT00536120|473879486|FG001|Overall Study|Missed Study Visit|1|||
131614258|NCT02722434|473879487|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
131614259|NCT02722434|473879488|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
131614260|NCT02722434|473879487|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
131614261|NCT02722434|473879488|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
131614262|NCT04989816|473879491|FG000|Overall Study|Death|77|||
131614263|NCT04989816|473879491|FG000|Overall Study|Lost to Follow-up|3|||
131614264|NCT01982682|473879492|FG000|Overall Study|Physician Decision|1|||
131708846|NCT02388295|474213424|FG001|Dose Escalation Week 1|Determined not eligible|1|||
131708847|NCT02388295|474213425|FG002|Dose Escalation Week 1|Determined not eligible|1|||
131708848|NCT02388295|474213423|FG000|Dose Escalation Week 2|Protocol Violation|0|||
131708849|NCT02388295|474213424|FG001|Dose Escalation Week 2|Protocol Violation|1|||
131708850|NCT02388295|474213425|FG002|Dose Escalation Week 2|Protocol Violation|0|||
131708851|NCT02388295|474213423|FG000|Dose Escalation Week 2|Determined not eligible|1|||
131708852|NCT02388295|474213424|FG001|Dose Escalation Week 2|Determined not eligible|1|||
131708853|NCT02388295|474213425|FG002|Dose Escalation Week 2|Determined not eligible|1|||
131708854|NCT02388295|474213423|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
131900571|NCT00705757|474921510|FG001|Overall Study|Withdrawal by Subject|1|||
131900572|NCT00705757|474921511|FG002|Overall Study|Withdrawal by Subject|2|||
131900573|NCT01411852|474921512|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
131900574|NCT01411852|474921513|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
131900575|NCT01411852|474921512|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
131900576|NCT01411852|474921513|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
131900577|NCT01411852|474921512|FG000|Prehospital Intervention Phase|Found to be under age|0|||
131900578|NCT01411852|474921513|FG001|Prehospital Intervention Phase|Found to be under age|1|||
131900579|NCT01411852|474921512|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
131900580|NCT01411852|474921513|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
131900581|NCT01411852|474921512|FG000|Hospital Intervention Phase|Severe head injury|5|||
131900582|NCT01411852|474921513|FG001|Hospital Intervention Phase|Severe head injury|4|||
131900583|NCT01411852|474921512|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
131900584|NCT01411852|474921513|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
131900585|NCT01411852|474921512|FG000|Hospital Intervention Phase|Miscommunication error|1|||
131900586|NCT01411852|474921513|FG001|Hospital Intervention Phase|Miscommunication error|2|||
131900587|NCT01411852|474921512|FG000|Hospital Intervention Phase|CPR administered|3|||
131900588|NCT01411852|474921513|FG001|Hospital Intervention Phase|CPR administered|1|||
131900589|NCT01411852|474921512|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
131900590|NCT01411852|474921513|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
131900591|NCT01411852|474921512|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
131900592|NCT01411852|474921513|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
131900593|NCT01411852|474921512|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
131900594|NCT01411852|474921513|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
131614265|NCT02760654|473879493|FG000|Overall Study|Lost to Follow-up|3|||
131614266|NCT02760654|473879494|FG001|Overall Study|Lost to Follow-up|3|||
131614267|NCT02760654|473879493|FG000|Overall Study|Withdrawal by Subject|4|||
131708855|NCT02388295|474213424|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
131614268|NCT02760654|473879494|FG001|Overall Study|Withdrawal by Subject|3|||
131614269|NCT01084694|473879496|FG000|Overall Study|Withdrawal by Subject|2|||
131614270|NCT01084694|473879497|FG001|Overall Study|Withdrawal by Subject|1|||
131614271|NCT01084694|473879496|FG000|Overall Study|Death|2|||
131708856|NCT02388295|474213425|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
131708857|NCT04258579|474213426|FG000|Overall Study|Withdrawal by Subject|7|||
131708858|NCT04258579|474213426|FG000|Overall Study|Lost to Follow-up|3|||
131708859|NCT04258579|474213426|FG000|Overall Study|Protocol Violation|2|||
131900595|NCT01411852|474921512|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
131443029|NCT01921205|473250805|FG000|Overall Study|Use Of Prohibited Medication|0|||
131443030|NCT01921205|473250806|FG001|Overall Study|Use Of Prohibited Medication|1|||
131443031|NCT01921205|473250805|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
131443032|NCT01921205|473250806|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
131443033|NCT01921205|473250805|FG000|Overall Study|Non Compliance Of The Parent|0|||
131614272|NCT01084694|473879497|FG001|Overall Study|Death|12|||
131614273|NCT01084694|473879496|FG000|Overall Study|eligibility not maintained|2|||
131614274|NCT01084694|473879497|FG001|Overall Study|eligibility not maintained|7|||
131614275|NCT02568215|473879501|FG000|Overall Study|Death|1|||
131614276|NCT02568215|473879502|FG001|Overall Study|Death|2|||
131614277|NCT02568215|473879503|FG002|Overall Study|Death|0|||
131614278|NCT02568215|473879501|FG000|Overall Study|Physician Decision|2|||
131614279|NCT02568215|473879502|FG001|Overall Study|Physician Decision|2|||
131614280|NCT02568215|473879503|FG002|Overall Study|Physician Decision|2|||
131614281|NCT02568215|473879501|FG000|Overall Study|Lost to Follow-up|29|||
131614282|NCT02568215|473879502|FG001|Overall Study|Lost to Follow-up|32|||
131614283|NCT02568215|473879503|FG002|Overall Study|Lost to Follow-up|41|||
131614284|NCT02568215|473879501|FG000|Overall Study|Withdrawal by Subject|21|||
131614285|NCT02568215|473879502|FG001|Overall Study|Withdrawal by Subject|19|||
131614286|NCT02568215|473879503|FG002|Overall Study|Withdrawal by Subject|22|||
131614287|NCT02568215|473879501|FG000|Overall Study|Protocol Violation|1|||
131614288|NCT02568215|473879502|FG001|Overall Study|Protocol Violation|1|||
131614289|NCT02568215|473879503|FG002|Overall Study|Protocol Violation|0|||
131614290|NCT02568215|473879501|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
131614291|NCT02568215|473879502|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
131614292|NCT02568215|473879503|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
131614293|NCT02568215|473879501|FG000|Overall Study|Other|0|||
131614294|NCT02568215|473879502|FG001|Overall Study|Other|1|||
131614295|NCT02568215|473879503|FG002|Overall Study|Other|4|||
131614296|NCT03478969|473879504|FG000|Overall Study|Withdrawal by Subject|4|||
131614297|NCT03478969|473879505|FG001|Overall Study|Withdrawal by Subject|7|||
131614298|NCT03478969|473879506|FG002|Overall Study|Withdrawal by Subject|6|||
131614299|NCT03478969|473879504|FG000|Overall Study|Adverse Event|2|||
131614300|NCT03478969|473879505|FG001|Overall Study|Adverse Event|0|||
131614301|NCT03478969|473879506|FG002|Overall Study|Adverse Event|1|||
131614302|NCT03478969|473879504|FG000|Overall Study|Pregnancy|1|||
131614303|NCT03478969|473879505|FG001|Overall Study|Pregnancy|0|||
131614304|NCT03478969|473879506|FG002|Overall Study|Pregnancy|0|||
131614305|NCT03478969|473879504|FG000|Overall Study|Personal Reasons|1|||
131614306|NCT03478969|473879505|FG001|Overall Study|Personal Reasons|0|||
131614307|NCT03478969|473879506|FG002|Overall Study|Personal Reasons|1|||
131614308|NCT03478969|473879504|FG000|Overall Study|Covid-19|1|||
131614309|NCT03478969|473879505|FG001|Overall Study|Covid-19|4|||
131614310|NCT03478969|473879506|FG002|Overall Study|Covid-19|3|||
131614311|NCT03478969|473879504|FG000|Overall Study|Multiple Reasons|0|||
131614312|NCT03478969|473879505|FG001|Overall Study|Multiple Reasons|1|||
131614313|NCT03478969|473879506|FG002|Overall Study|Multiple Reasons|1|||
131614314|NCT03478969|473879504|FG000|Overall Study|Eligibility Criteria|0|||
131614315|NCT03478969|473879505|FG001|Overall Study|Eligibility Criteria|0|||
131614316|NCT03478969|473879506|FG002|Overall Study|Eligibility Criteria|5|||
131614317|NCT03478969|473879504|FG000|Overall Study|Lost to Follow-up|0|||
131614318|NCT03478969|473879505|FG001|Overall Study|Lost to Follow-up|0|||
131614319|NCT03478969|473879506|FG002|Overall Study|Lost to Follow-up|1|||
131614320|NCT01185600|473879507|FG000|Overall Study|Adverse Event|1|||
131614321|NCT01185600|473879508|FG001|Overall Study|Adverse Event|1|||
131614322|NCT01185600|473879507|FG000|Overall Study|Death|0|||
131614323|NCT01185600|473879508|FG001|Overall Study|Death|1|||
131614324|NCT01185600|473879507|FG000|Overall Study|Lost to Follow-up|0|||
131614325|NCT01185600|473879508|FG001|Overall Study|Lost to Follow-up|5|||
131614326|NCT01185600|473879507|FG000|Overall Study|Physician Decision|29|||
131443034|NCT01921205|473250806|FG001|Overall Study|Non Compliance Of The Parent|1|||
131443035|NCT01921205|473250805|FG000|Overall Study|Non Compliance Of Child|0|||
131443036|NCT01921205|473250806|FG001|Overall Study|Non Compliance Of Child|1|||
131614327|NCT01185600|473879508|FG001|Overall Study|Physician Decision|35|||
131614328|NCT01185600|473879507|FG000|Overall Study|Withdrawal by Subject|1|||
131614329|NCT01185600|473879508|FG001|Overall Study|Withdrawal by Subject|1|||
131614330|NCT01185600|473879507|FG000|Overall Study|Hold by DSMB|1|||
131614331|NCT01185600|473879508|FG001|Overall Study|Hold by DSMB|2|||
131614332|NCT05405244|473879509|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
131614333|NCT05405244|473879510|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
131614334|NCT05405244|473879509|FG000|Washout (2 Weeks)|Adverse Event|2|||
131614335|NCT05405244|473879510|FG001|Washout (2 Weeks)|Adverse Event|0|||
131614336|NCT05405244|473879509|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
131614337|NCT05405244|473879510|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
131614338|NCT02964741|473879511|FG000|Overall Study|Protocol Violation|1|||
131614339|NCT02964741|473879512|FG001|Overall Study|Protocol Violation|0|||
131614340|NCT02964741|473879513|FG002|Overall Study|Protocol Violation|0|||
131614341|NCT02964741|473879511|FG000|Overall Study|Withdrawal by Subject|0|||
131708860|NCT04258579|474213426|FG000|Overall Study|Adverse Event|1|||
131614342|NCT02964741|473879512|FG001|Overall Study|Withdrawal by Subject|1|||
131614343|NCT02964741|473879513|FG002|Overall Study|Withdrawal by Subject|0|||
131614344|NCT02964741|473879511|FG000|Overall Study|claustrophobia|1|||
131614345|NCT02964741|473879512|FG001|Overall Study|claustrophobia|0|||
131614346|NCT02964741|473879513|FG002|Overall Study|claustrophobia|0|||
131614347|NCT01500200|473879517|FG000|Stage 1|Adverse Event|1|||
131900596|NCT01411852|474921513|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
131900597|NCT01411852|474921512|FG000|Hospital Intervention Phase|Other ineligible|2|||
131900598|NCT01411852|474921513|FG001|Hospital Intervention Phase|Other ineligible|2|||
131900599|NCT01411852|474921512|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
131900600|NCT01411852|474921513|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
131900601|NCT01411852|474921512|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
131900602|NCT01411852|474921513|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
131900603|NCT01411852|474921512|FG000|Hospital Intervention Phase|Vascular access failed|1|||
131900604|NCT01411852|474921513|FG001|Hospital Intervention Phase|Vascular access failed|0|||
131900605|NCT00807885|474921514|FG000|Overall Study|Lost to Follow-up|0|||
131900606|NCT00807885|474921515|FG001|Overall Study|Lost to Follow-up|0|||
131900607|NCT00807885|474921516|FG002|Overall Study|Lost to Follow-up|0|||
131900608|NCT00807885|474921517|FG003|Overall Study|Lost to Follow-up|0|||
131900609|NCT00807885|474921518|FG004|Overall Study|Lost to Follow-up|0|||
131900610|NCT00807885|474921519|FG005|Overall Study|Lost to Follow-up|1|||
131900611|NCT00807885|474921520|FG006|Overall Study|Lost to Follow-up|0|||
131900612|NCT00807885|474921521|FG007|Overall Study|Lost to Follow-up|0|||
131900613|NCT00807885|474921522|FG008|Overall Study|Lost to Follow-up|0|||
131900614|NCT03126786|474921526|FG000|Overall Study|Adverse Event|3|||
131900615|NCT03126786|474921527|FG001|Overall Study|Adverse Event|0|||
131900616|NCT03126786|474921526|FG000|Overall Study|Lost to Follow-up|0|||
131900617|NCT03126786|474921527|FG001|Overall Study|Lost to Follow-up|1|||
131900618|NCT03126786|474921526|FG000|Overall Study|Withdrawal by Subject|3|||
131900619|NCT03126786|474921527|FG001|Overall Study|Withdrawal by Subject|1|||
131900620|NCT00227539|474921530|FG000|Overall Study|Protocol Violation|1|||
131900621|NCT00426764|474921531|FG000|Overall Study|Protocol Violation|1|||
131900622|NCT00426764|474921531|FG000|Overall Study|Withdrawal by Subject|4|||
131900623|NCT00426764|474921531|FG000|Overall Study|Physician Decision|6|||
131900624|NCT00426764|474921531|FG000|Overall Study|Compassionate Use|1|||
131900625|NCT00426764|474921531|FG000|Overall Study|Progressive Disease|83|||
131900626|NCT00426764|474921531|FG000|Overall Study|Adverse Event|24|||
131900627|NCT00426764|474921531|FG000|Overall Study|Other|1|||
131900628|NCT00426764|474921531|FG000|Overall Study|Death|1|||
131900629|NCT00426764|474921531|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
131900630|NCT04552132|474921532|FG000|Overall Study|Lost to Follow-up|4|||
131900631|NCT04552132|474921533|FG001|Overall Study|Lost to Follow-up|3|||
131900632|NCT04552132|474921532|FG000|Overall Study|Protocol Violation|1|||
131900633|NCT04552132|474921533|FG001|Overall Study|Protocol Violation|0|||
131900634|NCT03804268|474921534|FG000|Overall Study|Adverse Event|2|||
131900635|NCT03804268|474921535|FG001|Overall Study|Adverse Event|2|||
131900636|NCT03804268|474921534|FG000|Overall Study|Withdrawal by Subject|2|||
131900637|NCT03804268|474921535|FG001|Overall Study|Withdrawal by Subject|0|||
131900638|NCT03804268|474921534|FG000|Overall Study|Lost to Follow-up|1|||
131900639|NCT03804268|474921535|FG001|Overall Study|Lost to Follow-up|0|||
131900640|NCT03804268|474921534|FG000|Overall Study|Physician Decision|2|||
131900641|NCT03804268|474921535|FG001|Overall Study|Physician Decision|0|||
131900642|NCT02716779|474921536|FG000|Monotherapy|Adverse Event|0|||
131900643|NCT02716779|474921537|FG001|Monotherapy|Adverse Event|1|||
131900644|NCT02716779|474921538|FG002|Monotherapy|Adverse Event|1|||
131900645|NCT02716779|474921536|FG000|Combination Therapy|Adverse Event|0|||
131900646|NCT02716779|474921537|FG001|Combination Therapy|Adverse Event|2|||
131900647|NCT02716779|474921538|FG002|Combination Therapy|Adverse Event|1|||
131900648|NCT02256839|474921539|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
131900649|NCT02256839|474921540|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
131900650|NCT01843803|474921541|FG000|Overall Study|not a Veteran, did not see provider|1|||
131900651|NCT01843803|474921542|FG001|Overall Study|not a Veteran, did not see provider|3|||
131900652|NCT01951417|474921557|FG000|Overall Study|Withdrawal by Subject|1|||
131900653|NCT01951417|474921557|FG000|Overall Study|Protocol Violation|2|||
131900654|NCT01951417|474921557|FG000|Overall Study|Lost to Follow-up|6|||
131900655|NCT01598610|474921562|FG000|Overall Study|Adverse Event|1|||
131900656|NCT04346199|474921563|FG000|Overall Study|Death|8|||
131900657|NCT04346199|474921564|FG001|Overall Study|Death|9|||
131900658|NCT04346199|474921563|FG000|Overall Study|Lost to Follow-up|0|||
131900659|NCT04346199|474921564|FG001|Overall Study|Lost to Follow-up|1|||
131900660|NCT04346199|474921563|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
131900661|NCT04346199|474921564|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
131900662|NCT04346199|474921563|FG000|Overall Study|Withdrawal by Subject|5|||
131900663|NCT04346199|474921564|FG001|Overall Study|Withdrawal by Subject|1|||
131900664|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
131614348|NCT01500200|473879518|FG001|Stage 1|Adverse Event|4|||
131614349|NCT01500200|473879519|FG002|Stage 1|Adverse Event|5|||
131708861|NCT02076165|474213428|FG000|Overall Study|Lost to Follow-up|7|||
131443037|NCT00129402|473250807|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
131443038|NCT00129402|473250808|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
131443039|NCT00129402|473250809|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
131443040|NCT00129402|473250810|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
131443041|NCT00129402|473250811|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
131443042|NCT00129402|473250812|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
131443043|NCT00129402|473250813|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
131443044|NCT00129402|473250807|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
131443045|NCT00129402|473250808|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
131443046|NCT00129402|473250809|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
131443047|NCT00129402|473250810|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
131443048|NCT00129402|473250811|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
131443049|NCT00129402|473250812|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
131443050|NCT00129402|473250813|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
131443051|NCT00129402|473250807|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
131443052|NCT00129402|473250808|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
131443053|NCT00129402|473250809|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
131443054|NCT00129402|473250810|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
131443055|NCT00129402|473250811|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
131443056|NCT00129402|473250812|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
131443057|NCT00129402|473250813|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
131443058|NCT00129402|473250807|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
131443059|NCT00129402|473250808|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
131443060|NCT00129402|473250809|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
131443061|NCT00129402|473250810|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
131443062|NCT00129402|473250811|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
131443063|NCT00129402|473250812|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
131443064|NCT00129402|473250813|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
131443065|NCT00129402|473250807|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
131443066|NCT00129402|473250808|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
131443067|NCT00129402|473250809|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
131443068|NCT00129402|473250810|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
131443069|NCT00129402|473250811|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
131443070|NCT00129402|473250812|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
131708862|NCT02076165|474213429|FG001|Overall Study|Lost to Follow-up|5|||
131708863|NCT02076165|474213428|FG000|Overall Study|Refused follow-up assessment|1|||
131708864|NCT02076165|474213429|FG001|Overall Study|Refused follow-up assessment|1|||
131708865|NCT03157531|474213433|FG000|Overall Study|Death|2|||
131708866|NCT03157531|474213433|FG000|Overall Study|Lost to Follow-up|4|||
131708867|NCT00331006|474213434|FG000|Screening Phase|Withdrawal by Subject|1|||
131708868|NCT00331006|474213434|FG000|Screening Phase|enrollment halted|1|||
131708869|NCT00331006|474213434|FG000|Screening Phase|Lost to Follow-up|1|||
131708870|NCT00331006|474213434|FG000|Screening Phase|Ineligible for treatment phase|4|||
131708871|NCT00331006|474213434|FG000|Treatment Phase|Withdrawal by Subject|1|||
131443071|NCT00129402|473250813|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
131443072|NCT00129402|473250807|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
131443073|NCT00129402|473250808|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
131443074|NCT00129402|473250809|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
131443075|NCT00129402|473250810|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
131443076|NCT00129402|473250811|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
131443077|NCT00129402|473250812|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
131443078|NCT00129402|473250813|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
131443079|NCT00129402|473250807|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
131443080|NCT00129402|473250808|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
131443081|NCT00129402|473250809|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
131443082|NCT00129402|473250810|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
131443083|NCT00129402|473250811|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
131443084|NCT00129402|473250812|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
131443085|NCT00129402|473250813|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
131443086|NCT00129402|473250807|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
131708872|NCT00331006|474213434|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
131708873|NCT00331006|474213434|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
131708874|NCT01950819|474213435|FG000|Overall Study|Graft Loss|35|||
131708875|NCT01950819|474213436|FG001|Overall Study|Graft Loss|30|||
131708876|NCT01950819|474213435|FG000|Overall Study|Death|29|||
131614350|NCT01500200|473879520|FG003|Stage 1|Adverse Event|0|||
131614351|NCT01500200|473879521|FG004|Stage 1|Adverse Event|0|||
131614352|NCT01500200|473879522|FG005|Stage 1|Adverse Event|0|||
131708877|NCT01950819|474213436|FG001|Overall Study|Death|34|||
131708878|NCT01950819|474213435|FG000|Overall Study|Subject / Gardian decision|54|||
131900665|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
131900666|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Adverse Event|57|||
131614353|NCT01500200|473879517|FG000|Stage 1|Lost to Follow-up|2|||
131614354|NCT01500200|473879518|FG001|Stage 1|Lost to Follow-up|2|||
131614355|NCT01500200|473879519|FG002|Stage 1|Lost to Follow-up|1|||
131614356|NCT01500200|473879520|FG003|Stage 1|Lost to Follow-up|0|||
131614357|NCT01500200|473879521|FG004|Stage 1|Lost to Follow-up|0|||
131614358|NCT01500200|473879522|FG005|Stage 1|Lost to Follow-up|0|||
131614359|NCT01500200|473879517|FG000|Stage 1|Withdrawal by Subject|3|||
131614360|NCT01500200|473879518|FG001|Stage 1|Withdrawal by Subject|0|||
131614361|NCT01500200|473879519|FG002|Stage 1|Withdrawal by Subject|0|||
131614362|NCT01500200|473879520|FG003|Stage 1|Withdrawal by Subject|0|||
131614363|NCT01500200|473879521|FG004|Stage 1|Withdrawal by Subject|0|||
131614364|NCT01500200|473879522|FG005|Stage 1|Withdrawal by Subject|0|||
131614365|NCT01500200|473879517|FG000|Stage 1|Noncompliance with Study Drug|1|||
131614366|NCT01500200|473879518|FG001|Stage 1|Noncompliance with Study Drug|0|||
131614367|NCT01500200|473879519|FG002|Stage 1|Noncompliance with Study Drug|0|||
131614368|NCT01500200|473879520|FG003|Stage 1|Noncompliance with Study Drug|0|||
131614369|NCT01500200|473879521|FG004|Stage 1|Noncompliance with Study Drug|0|||
131614370|NCT01500200|473879522|FG005|Stage 1|Noncompliance with Study Drug|0|||
131614371|NCT01500200|473879517|FG000|Stage 1|Physician Decision|1|||
131614372|NCT01500200|473879518|FG001|Stage 1|Physician Decision|0|||
131614373|NCT01500200|473879519|FG002|Stage 1|Physician Decision|0|||
131614374|NCT01500200|473879520|FG003|Stage 1|Physician Decision|0|||
131614375|NCT01500200|473879521|FG004|Stage 1|Physician Decision|0|||
131614376|NCT01500200|473879522|FG005|Stage 1|Physician Decision|0|||
131614377|NCT01500200|473879517|FG000|Stage 2|Adverse Event|0|||
131614378|NCT01500200|473879518|FG001|Stage 2|Adverse Event|0|||
131614379|NCT01500200|473879519|FG002|Stage 2|Adverse Event|0|||
131614380|NCT01500200|473879520|FG003|Stage 2|Adverse Event|0|||
131614381|NCT01500200|473879521|FG004|Stage 2|Adverse Event|5|||
131614382|NCT01500200|473879522|FG005|Stage 2|Adverse Event|4|||
131614383|NCT01212744|473879523|FG000|Overall Study|Withdrawal by Subject|1|||
131614384|NCT02167451|473879524|FG000|Overall Study|Withdrawal by Subject|1|||
131614385|NCT01218659|473879525|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
131614386|NCT01218659|473879526|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
131614387|NCT01218659|473879527|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
131614388|NCT01218659|473879525|FG000|18-Month Randomized Period|Did not receive study drug|0|||
131614389|NCT01218659|473879526|FG001|18-Month Randomized Period|Did not receive study drug|3|||
131614390|NCT01218659|473879527|FG002|18-Month Randomized Period|Did not receive study drug|0|||
131614391|NCT01218659|473879525|FG000|12-Month OLE|Withdrawal by Subject|0|||
131614392|NCT01218659|473879526|FG001|12-Month OLE|Withdrawal by Subject|0|||
131614393|NCT01218659|473879527|FG002|12-Month OLE|Withdrawal by Subject|2|||
131614394|NCT01218659|473879525|FG000|12-Month OLE|Physician Decision|0|||
131900667|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Adverse Event|49|||
131900668|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
131900669|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
131900670|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Site closure|3|||
131900671|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Site closure|2|||
131900672|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
131900673|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
131900674|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Physician Decision|48|||
131900675|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Physician Decision|38|||
131900676|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
131900677|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
131900678|NCT01705977|474921567|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
131900679|NCT01705977|474921568|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
131900680|NCT01705977|474921567|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
131900681|NCT01705977|474921568|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
131614395|NCT01218659|473879526|FG001|12-Month OLE|Physician Decision|0|||
131614396|NCT01218659|473879527|FG002|12-Month OLE|Physician Decision|1|||
131614397|NCT01218659|473879525|FG000|12-Month OLE|Lost to Follow-up|0|||
131614398|NCT01218659|473879526|FG001|12-Month OLE|Lost to Follow-up|0|||
131614399|NCT01218659|473879527|FG002|12-Month OLE|Lost to Follow-up|1|||
131614400|NCT01218659|473879525|FG000|12-Month OLE|Pregnancy|0|||
131614401|NCT01218659|473879526|FG001|12-Month OLE|Pregnancy|0|||
131614402|NCT01218659|473879527|FG002|12-Month OLE|Pregnancy|1|||
131614403|NCT01218659|473879525|FG000|12-Month OLE|Lack of Efficacy|0|||
131614404|NCT01218659|473879526|FG001|12-Month OLE|Lack of Efficacy|0|||
131614405|NCT01218659|473879527|FG002|12-Month OLE|Lack of Efficacy|1|||
131614406|NCT01218659|473879525|FG000|12-Month OLE|Declined to participate in the OLE|0|||
131900682|NCT01705977|474921567|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
131900683|NCT01705977|474921568|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
131443087|NCT00129402|473250808|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
131443088|NCT00129402|473250809|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
131443089|NCT00129402|473250810|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
131443090|NCT00129402|473250811|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
131443091|NCT00129402|473250812|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
131443092|NCT00129402|473250813|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
131443093|NCT00129402|473250807|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
131443094|NCT00129402|473250808|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
131443095|NCT00129402|473250809|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
131443096|NCT00129402|473250810|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
131443097|NCT00129402|473250811|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
131443098|NCT00129402|473250812|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
131443099|NCT00129402|473250813|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
131443100|NCT00129402|473250807|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
131443101|NCT00129402|473250808|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
131443102|NCT00129402|473250809|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
131443103|NCT00129402|473250810|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
131443104|NCT00129402|473250811|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
131443105|NCT00129402|473250812|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
131443106|NCT00129402|473250813|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
131443107|NCT00129402|473250807|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
131443108|NCT00129402|473250808|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
131443109|NCT00129402|473250809|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
131443110|NCT00129402|473250810|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
131443111|NCT00129402|473250811|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
131443112|NCT00129402|473250812|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
131443113|NCT00129402|473250813|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
131443114|NCT00129402|473250807|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
131443115|NCT00129402|473250808|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
131443116|NCT00129402|473250809|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
131443117|NCT00129402|473250810|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
131443118|NCT00129402|473250811|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
131443119|NCT00129402|473250812|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
131443120|NCT00129402|473250813|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
131443121|NCT00129402|473250807|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
131443122|NCT00129402|473250808|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
131443123|NCT00129402|473250809|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
131443124|NCT00129402|473250810|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
131443125|NCT00129402|473250811|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
131443126|NCT00129402|473250812|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
131614407|NCT01218659|473879526|FG001|12-Month OLE|Declined to participate in the OLE|0|||
131614408|NCT01218659|473879527|FG002|12-Month OLE|Declined to participate in the OLE|4|||
131614409|NCT03355573|473879528|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
131614410|NCT03355573|473879528|FG000|Overall Study|Sponsor's decision|1|||
131614411|NCT03355573|473879528|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
131614412|NCT03355573|473879528|FG000|Overall Study|PI's decision|2|||
131614413|NCT03355573|473879528|FG000|Overall Study|Withdrawal by Subject|23|||
131614414|NCT03355573|473879528|FG000|Overall Study|Lost to Follow-up|4|||
131614415|NCT03355573|473879528|FG000|Overall Study|Lack of Efficacy|2|||
131614416|NCT03355573|473879528|FG000|Overall Study|Adverse Event, non-fatal|17|||
131614417|NCT03355573|473879528|FG000|Overall Study|Adverse Event, serious fatal|2|||
131614418|NCT01536093|473879531|FG000|Overall Study|Death|1|||
131614419|NCT01536093|473879532|FG001|Overall Study|Death|2|||
131614420|NCT01536093|473879531|FG000|Overall Study|absence of maternal colostrum|2|||
131614421|NCT01536093|473879532|FG001|Overall Study|absence of maternal colostrum|0|||
131614422|NCT01536093|473879531|FG000|Overall Study|Withdrawal by Subject|0|||
131614423|NCT01536093|473879532|FG001|Overall Study|Withdrawal by Subject|1|||
131614424|NCT00942266|473879533|FG000|Overall Study|Withdrawal by Subject|1|||
131614425|NCT00942266|473879534|FG001|Overall Study|Withdrawal by Subject|0|||
131614426|NCT00942266|473879533|FG000|Overall Study|Adverse Event|2|||
131614427|NCT00942266|473879534|FG001|Overall Study|Adverse Event|1|||
131614428|NCT00942266|473879533|FG000|Overall Study|Disease Progression|38|||
131614429|NCT00942266|473879534|FG001|Overall Study|Disease Progression|11|||
131614430|NCT00942266|473879533|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
131614431|NCT00942266|473879534|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
131614432|NCT00942266|473879533|FG000|Overall Study|Intercurrent illness|0|||
131614433|NCT00942266|473879534|FG001|Overall Study|Intercurrent illness|1|||
131614434|NCT00942266|473879533|FG000|Overall Study|Physician Decision|2|||
131614435|NCT00942266|473879534|FG001|Overall Study|Physician Decision|0|||
131614436|NCT00942266|473879533|FG000|Overall Study|medical deterioration (pneumonia)|0|||
131614437|NCT00942266|473879534|FG001|Overall Study|medical deterioration (pneumonia)|1|||
131614438|NCT03304587|473879535|FG000|Overall Study|Headache after intervention|0|||
131614439|NCT03304587|473879536|FG001|Overall Study|Headache after intervention|1|||
131900684|NCT01705977|474921567|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
131900685|NCT01705977|474921568|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
131900686|NCT01705977|474921567|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
131900687|NCT01705977|474921568|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
131900688|NCT03066830|474921569|FG000|Overall Study|At the Participant's own Request|16|||
131900689|NCT03066830|474921570|FG001|Overall Study|At the Participant's own Request|17|||
131900690|NCT03066830|474921569|FG000|Overall Study|Other|3|||
131900691|NCT03066830|474921570|FG001|Overall Study|Other|0|||
131900692|NCT03066830|474921569|FG000|Overall Study|Poor Compliance to Protocol|1|||
131900693|NCT03066830|474921570|FG001|Overall Study|Poor Compliance to Protocol|0|||
131900694|NCT03066830|474921569|FG000|Overall Study|Adverse Event|2|||
131900695|NCT03066830|474921570|FG001|Overall Study|Adverse Event|2|||
131900696|NCT03066830|474921569|FG000|Overall Study|Lost to Follow-up|11|||
131900697|NCT03066830|474921570|FG001|Overall Study|Lost to Follow-up|3|||
131900698|NCT02039778|474921572|FG000|Overall Study|Death|2|||
131900699|NCT02039778|474921572|FG000|Overall Study|Withdrawal by Subject|1|||
131900700|NCT02039778|474921572|FG000|Overall Study|Never started the protocol treatment|1|||
131900701|NCT00096538|474921575|FG000|Overall Study|Withdrawal by Subject|1|||
131900702|NCT01827592|474921577|FG000|Overall Study|Adverse Event|11|||
131900703|NCT01827592|474921578|FG001|Overall Study|Adverse Event|9|||
131900704|NCT01827592|474921579|FG002|Overall Study|Adverse Event|2|||
131900705|NCT01827592|474921577|FG000|Overall Study|Physician Decision|0|||
131900706|NCT01827592|474921578|FG001|Overall Study|Physician Decision|2|||
131900707|NCT01827592|474921579|FG002|Overall Study|Physician Decision|1|||
131900708|NCT01827592|474921577|FG000|Overall Study|Protocol Violation|2|||
131900709|NCT01827592|474921578|FG001|Overall Study|Protocol Violation|1|||
131900710|NCT01827592|474921579|FG002|Overall Study|Protocol Violation|0|||
131900711|NCT01827592|474921577|FG000|Overall Study|Lost to Follow-up|1|||
131900712|NCT01827592|474921578|FG001|Overall Study|Lost to Follow-up|2|||
131900713|NCT01827592|474921579|FG002|Overall Study|Lost to Follow-up|2|||
131900714|NCT01827592|474921577|FG000|Overall Study|Withdrawal by Subject|12|||
131900715|NCT01827592|474921578|FG001|Overall Study|Withdrawal by Subject|11|||
131900716|NCT01827592|474921579|FG002|Overall Study|Withdrawal by Subject|11|||
131900717|NCT01827592|474921577|FG000|Overall Study|Patient's substantial non-compliance|1|||
131900718|NCT01827592|474921578|FG001|Overall Study|Patient's substantial non-compliance|1|||
131900719|NCT01827592|474921579|FG002|Overall Study|Patient's substantial non-compliance|6|||
131900720|NCT01827592|474921577|FG000|Overall Study|Trial terminated by Sponsor|47|||
131900721|NCT01827592|474921578|FG001|Overall Study|Trial terminated by Sponsor|53|||
131900722|NCT01827592|474921579|FG002|Overall Study|Trial terminated by Sponsor|51|||
131900723|NCT01827592|474921577|FG000|Overall Study|Others|0|||
131900724|NCT01827592|474921578|FG001|Overall Study|Others|1|||
131900725|NCT01827592|474921579|FG002|Overall Study|Others|3|||
131900726|NCT01931397|474921588|FG000|Overall Study|Physician Decision|2|||
131900727|NCT01931397|474921588|FG000|Overall Study|Withdrawal by Subject|8|||
131900728|NCT01931397|474921588|FG000|Overall Study|moved out of state|1|||
131900729|NCT02058589|474921592|FG000|Overall Study|Serious Adverse Event|1|||
131900730|NCT02058589|474921593|FG001|Overall Study|Serious Adverse Event|1|||
131900731|NCT02058589|474921592|FG000|Overall Study|Non-Serious Adverse Event|1|||
131900732|NCT02058589|474921593|FG001|Overall Study|Non-Serious Adverse Event|0|||
131900733|NCT02058589|474921592|FG000|Overall Study|Withdrawal by Subject|0|||
131900734|NCT02058589|474921593|FG001|Overall Study|Withdrawal by Subject|1|||
131900735|NCT02143024|474921594|FG000|Overall Study|Lost to Follow-up|1|||
131900736|NCT02143024|474921595|FG001|Overall Study|Lost to Follow-up|1|||
131900737|NCT02143024|474921594|FG000|Overall Study|Withdrawal by Subject|1|||
131900738|NCT02143024|474921595|FG001|Overall Study|Withdrawal by Subject|0|||
131900739|NCT01945944|474921596|FG000|Overall Study|Adverse Event|0|||
131900740|NCT01945944|474921597|FG001|Overall Study|Adverse Event|2|||
131900741|NCT01945944|474921596|FG000|Overall Study|Physician Decision|1|||
131900742|NCT01945944|474921597|FG001|Overall Study|Physician Decision|0|||
131900743|NCT01945944|474921596|FG000|Overall Study|Withdrawal by Subject|0|||
131900744|NCT01945944|474921597|FG001|Overall Study|Withdrawal by Subject|1|||
131900745|NCT01212094|474923425|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
131900746|NCT01212094|474923426|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
131900747|NCT01212094|474923427|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
131900748|NCT01212094|474923425|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
131900749|NCT01212094|474923426|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
131614440|NCT03304587|473879535|FG000|Overall Study|Withdrawal by Subject|1|||
131900750|NCT01212094|474923427|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
131900751|NCT01212094|474923425|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
131900752|NCT01212094|474923426|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
131443127|NCT00129402|473250813|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
131443128|NCT02992288|473250814|FG000|Overall Study|Adverse Event|8|||
131443129|NCT02992288|473250815|FG001|Overall Study|Adverse Event|2|||
131443130|NCT02992288|473250816|FG002|Overall Study|Adverse Event|2|||
131443131|NCT02992288|473250817|FG003|Overall Study|Adverse Event|2|||
131443132|NCT02992288|473250818|FG004|Overall Study|Adverse Event|2|||
131443133|NCT02992288|473250819|FG005|Overall Study|Adverse Event|7|||
131443134|NCT02992288|473250814|FG000|Overall Study|Non-compliance with study drug|0|||
131443135|NCT02992288|473250815|FG001|Overall Study|Non-compliance with study drug|1|||
131443136|NCT02992288|473250816|FG002|Overall Study|Non-compliance with study drug|1|||
131443137|NCT02992288|473250817|FG003|Overall Study|Non-compliance with study drug|0|||
131443138|NCT02992288|473250818|FG004|Overall Study|Non-compliance with study drug|1|||
131443139|NCT02992288|473250819|FG005|Overall Study|Non-compliance with study drug|0|||
131443140|NCT02992288|473250814|FG000|Overall Study|Physician Decision|3|||
131443141|NCT02992288|473250815|FG001|Overall Study|Physician Decision|0|||
131443142|NCT02992288|473250816|FG002|Overall Study|Physician Decision|1|||
131443143|NCT02992288|473250817|FG003|Overall Study|Physician Decision|0|||
131443144|NCT02992288|473250818|FG004|Overall Study|Physician Decision|0|||
131443145|NCT02992288|473250819|FG005|Overall Study|Physician Decision|1|||
131443146|NCT02992288|473250814|FG000|Overall Study|Death|2|||
131443147|NCT02992288|473250815|FG001|Overall Study|Death|0|||
131443148|NCT02992288|473250816|FG002|Overall Study|Death|2|||
131443149|NCT02992288|473250817|FG003|Overall Study|Death|1|||
131443150|NCT02992288|473250818|FG004|Overall Study|Death|2|||
131443151|NCT02992288|473250819|FG005|Overall Study|Death|0|||
131443152|NCT02992288|473250814|FG000|Overall Study|Lost to Follow-up|0|||
131443153|NCT02992288|473250815|FG001|Overall Study|Lost to Follow-up|0|||
131443154|NCT02992288|473250816|FG002|Overall Study|Lost to Follow-up|0|||
131443155|NCT02992288|473250817|FG003|Overall Study|Lost to Follow-up|1|||
131443156|NCT02992288|473250818|FG004|Overall Study|Lost to Follow-up|0|||
131443157|NCT02992288|473250819|FG005|Overall Study|Lost to Follow-up|0|||
131443158|NCT02992288|473250814|FG000|Overall Study|Protocol Violation|0|||
131443159|NCT02992288|473250815|FG001|Overall Study|Protocol Violation|0|||
131443160|NCT02992288|473250816|FG002|Overall Study|Protocol Violation|0|||
131443161|NCT02992288|473250817|FG003|Overall Study|Protocol Violation|0|||
131443162|NCT02992288|473250818|FG004|Overall Study|Protocol Violation|0|||
131443163|NCT02992288|473250819|FG005|Overall Study|Protocol Violation|1|||
131443164|NCT02992288|473250814|FG000|Overall Study|Withdrawal by Subject|4|||
131443165|NCT02992288|473250815|FG001|Overall Study|Withdrawal by Subject|2|||
131443166|NCT02992288|473250816|FG002|Overall Study|Withdrawal by Subject|1|||
131443167|NCT02992288|473250817|FG003|Overall Study|Withdrawal by Subject|5|||
131443168|NCT02992288|473250818|FG004|Overall Study|Withdrawal by Subject|3|||
131443169|NCT02992288|473250819|FG005|Overall Study|Withdrawal by Subject|4|||
131443170|NCT03199976|473250822|FG000|Overall Study|Lack of Efficacy|3|||
131443171|NCT03199976|473250823|FG001|Overall Study|Lack of Efficacy|6|||
131443172|NCT03199976|473250824|FG002|Overall Study|Lack of Efficacy|13|||
131443173|NCT03199976|473250822|FG000|Overall Study|Withdrawal by Subject|1|||
131443174|NCT03199976|473250823|FG001|Overall Study|Withdrawal by Subject|0|||
131443175|NCT03199976|473250824|FG002|Overall Study|Withdrawal by Subject|0|||
131443176|NCT03199976|473250822|FG000|Overall Study|Lost to Follow-up|0|||
131443177|NCT03199976|473250823|FG001|Overall Study|Lost to Follow-up|1|||
131443178|NCT03199976|473250824|FG002|Overall Study|Lost to Follow-up|1|||
131443179|NCT05236270|473250825|FG000|Overall Study|Lost to Follow-up|3|||
131443180|NCT05236270|473250826|FG001|Overall Study|Lost to Follow-up|2|||
131443181|NCT05236270|473250827|FG002|Overall Study|Lost to Follow-up|0|||
131443182|NCT05236270|473250828|FG003|Overall Study|Lost to Follow-up|0|||
131443183|NCT05236270|473250829|FG004|Overall Study|Lost to Follow-up|2|||
131614441|NCT03304587|473879536|FG001|Overall Study|Withdrawal by Subject|0|||
131614442|NCT01458366|473879538|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
131614443|NCT01458366|473879539|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
131614444|NCT01458366|473879540|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
131614445|NCT01458366|473879541|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
131614446|NCT01458366|473879542|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
131614447|NCT01458366|473879538|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131614448|NCT01458366|473879539|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131443184|NCT05236270|473250830|FG005|Overall Study|Lost to Follow-up|0|||
131443185|NCT05236270|473250831|FG006|Overall Study|Lost to Follow-up|1|||
131443186|NCT05236270|473250832|FG007|Overall Study|Lost to Follow-up|3|||
131443187|NCT04030143|473250833|FG000|Overall Study|Adverse Event|5|||
131443188|NCT04030143|473250834|FG001|Overall Study|Adverse Event|10|||
131443189|NCT04030143|473250833|FG000|Overall Study|Lost to Follow-up|3|||
131443190|NCT04030143|473250834|FG001|Overall Study|Lost to Follow-up|7|||
131614449|NCT01458366|473879540|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131443191|NCT04030143|473250833|FG000|Overall Study|Protocol Deviation|2|||
131443192|NCT04030143|473250834|FG001|Overall Study|Protocol Deviation|2|||
131443193|NCT04030143|473250833|FG000|Overall Study|Withdrawal by Subject|16|||
131443194|NCT04030143|473250834|FG001|Overall Study|Withdrawal by Subject|18|||
131614450|NCT01458366|473879541|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131794941|NCT01341639|474532015|FG001|Infant Series|Adverse Event|5|||
131794942|NCT01341639|474532014|FG000|Infant Series|Withdrawal by Subject|11|||
131794943|NCT01341639|474532015|FG001|Infant Series|Withdrawal by Subject|8|||
131794944|NCT01341639|474532014|FG000|Infant Series|Lost to Follow-up|0|||
131614451|NCT01458366|473879542|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
131614452|NCT02397096|473879543|FG000|Day 1 to Week 24|Adverse Event|7|||
131614453|NCT02397096|473879544|FG001|Day 1 to Week 24|Adverse Event|1|||
131614454|NCT02397096|473879543|FG000|Day 1 to Week 24|Death|1|||
131614455|NCT02397096|473879544|FG001|Day 1 to Week 24|Death|0|||
131614456|NCT02397096|473879543|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
131614457|NCT02397096|473879544|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
131614458|NCT02397096|473879543|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
131794945|NCT01341639|474532015|FG001|Infant Series|Lost to Follow-up|2|||
131614459|NCT02397096|473879544|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
131614460|NCT02397096|473879543|FG000|Day 1 to Week 24|Physician Decision|2|||
131614461|NCT02397096|473879544|FG001|Day 1 to Week 24|Physician Decision|3|||
131614462|NCT02397096|473879543|FG000|Day 1 to Week 24|Protocol Violation|1|||
131614463|NCT02397096|473879544|FG001|Day 1 to Week 24|Protocol Violation|4|||
131614464|NCT02397096|473879543|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
131794946|NCT01341639|474532014|FG000|Infant Series|Site 0048 Participants|17|||
131794947|NCT01341639|474532015|FG001|Infant Series|Site 0048 Participants|16|||
131794948|NCT01341639|474532014|FG000|Interim Period|Withdrawal by Subject|6|||
131794949|NCT01341639|474532015|FG001|Interim Period|Withdrawal by Subject|7|||
131794950|NCT01341639|474532014|FG000|Interim Period|Lost to Follow-up|2|||
131794951|NCT01341639|474532015|FG001|Interim Period|Lost to Follow-up|0|||
131794952|NCT01341639|474532014|FG000|Interim Period|Physician Decision|0|||
131794953|NCT01341639|474532015|FG001|Interim Period|Physician Decision|1|||
131794954|NCT01341639|474532014|FG000|Interim Period|Protocol Violation|0|||
131794955|NCT01341639|474532015|FG001|Interim Period|Protocol Violation|1|||
131794956|NCT01341639|474532014|FG000|Post-Treatment|Withdrawal by Subject|0|||
131794957|NCT01341639|474532015|FG001|Post-Treatment|Withdrawal by Subject|1|||
131794958|NCT01341639|474532014|FG000|Post-Treatment|Adverse Event|0|||
131794959|NCT01341639|474532015|FG001|Post-Treatment|Adverse Event|2|||
131794960|NCT01241461|474532016|FG000|Overall Study|Progressive Disease|3|||
131794961|NCT01241461|474532017|FG001|Overall Study|Progressive Disease|6|||
131794962|NCT01132118|474532018|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
131794963|NCT01132118|474532019|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
131794964|NCT01132118|474532018|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
131794965|NCT01132118|474532019|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
131794966|NCT01132118|474532018|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
131794967|NCT01132118|474532019|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
131794968|NCT03705351|474532022|FG000|Overall Study|Study termination|3|||
131794969|NCT03705351|474532022|FG000|Overall Study|Death|1|||
131794970|NCT03705351|474532022|FG000|Overall Study|Lack of Efficacy|2|||
131794971|NCT03705351|474532022|FG000|Overall Study|Withdrawal by Subject|1|||
131794972|NCT01299038|474532030|FG000|Overall Study|Withdrawal by Subject|1|||
131794973|NCT01299038|474532031|FG001|Overall Study|Withdrawal by Subject|0|||
131794974|NCT00322556|474532032|FG000|Overall Study|Adverse Event|1|||
131794975|NCT00322556|474532032|FG000|Overall Study|Withdrawal by Subject|1|||
131794976|NCT00322556|474532032|FG000|Overall Study|Lost to Follow-up|3|||
131794977|NCT00322556|474532032|FG000|Overall Study|Other Reason|7|||
131794978|NCT02961920|474532033|FG000|Overall Study|did not achive stydy protocol schedule|1|||
131794979|NCT02961920|474532034|FG001|Overall Study|did not achive stydy protocol schedule|1|||
131794980|NCT00444795|474532035|FG000|Overall Study|Not Treated|1|||
131794981|NCT00444795|474532035|FG000|Overall Study|Treated Prior to the Contract Date|2|||
131794982|NCT00704418|474532036|FG000|Overall Study|Withdrawal by Subject|2|||
131794983|NCT00704418|474532037|FG001|Overall Study|Withdrawal by Subject|0|||
131794984|NCT00704418|474532036|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
131794985|NCT00704418|474532037|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
131794986|NCT02322879|474532038|FG000|First Intervention|Physician Decision|1|||
131794987|NCT02322879|474532039|FG001|First Intervention|Physician Decision|0|||
131794988|NCT01579474|474532040|FG000|Overall Study|Adverse Event|1|||
131794989|NCT01579474|474532041|FG001|Overall Study|Adverse Event|13|||
131794990|NCT01579474|474532042|FG002|Overall Study|Adverse Event|2|||
131794991|NCT01579474|474532043|FG003|Overall Study|Adverse Event|0|||
131794992|NCT01579474|474532044|FG004|Overall Study|Adverse Event|0|||
131794993|NCT01579474|474532045|FG005|Overall Study|Adverse Event|1|||
131794994|NCT01579474|474532040|FG000|Overall Study|Lack of Efficacy|1|||
131794995|NCT01579474|474532041|FG001|Overall Study|Lack of Efficacy|0|||
131794996|NCT01579474|474532042|FG002|Overall Study|Lack of Efficacy|0|||
131794997|NCT01579474|474532043|FG003|Overall Study|Lack of Efficacy|0|||
131794998|NCT01579474|474532044|FG004|Overall Study|Lack of Efficacy|1|||
131794999|NCT01579474|474532045|FG005|Overall Study|Lack of Efficacy|0|||
131614465|NCT02397096|473879544|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
131614466|NCT02397096|473879543|FG000|Day 1 to Week 24|Randomized, not treated|3|||
131795000|NCT01579474|474532040|FG000|Overall Study|Withdrawal by Subject|1|||
131614467|NCT02397096|473879544|FG001|Day 1 to Week 24|Randomized, not treated|0|||
131614468|NCT02397096|473879543|FG000|Week 24 to Week 48|Adverse Event|6|||
131614469|NCT02397096|473879544|FG001|Week 24 to Week 48|Adverse Event|2|||
131614470|NCT02397096|473879543|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
131614471|NCT02397096|473879544|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
131614472|NCT02397096|473879543|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
131614473|NCT02397096|473879544|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
131614474|NCT02397096|473879543|FG000|Week 24 to Week 48|Physician Decision|2|||
131614475|NCT02397096|473879544|FG001|Week 24 to Week 48|Physician Decision|1|||
131614476|NCT02397096|473879543|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
131614477|NCT02397096|473879544|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
131614478|NCT02397096|473879543|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
131614479|NCT02397096|473879544|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
131614480|NCT02397096|473879543|FG000|Study Extension 1|Adverse Event|7|||
131614481|NCT02397096|473879544|FG001|Study Extension 1|Adverse Event|5|||
131614482|NCT02397096|473879543|FG000|Study Extension 1|Death|1|||
131614483|NCT02397096|473879544|FG001|Study Extension 1|Death|0|||
131614484|NCT02397096|473879543|FG000|Study Extension 1|Lack of Efficacy|2|||
131614485|NCT02397096|473879544|FG001|Study Extension 1|Lack of Efficacy|5|||
131614486|NCT02397096|473879543|FG000|Study Extension 1|Lost to Follow-up|2|||
131614487|NCT02397096|473879544|FG001|Study Extension 1|Lost to Follow-up|3|||
131614488|NCT02397096|473879543|FG000|Study Extension 1|Non-compliance with study drug|3|||
131614489|NCT02397096|473879544|FG001|Study Extension 1|Non-compliance with study drug|0|||
131614490|NCT02397096|473879543|FG000|Study Extension 1|Physician Decision|4|||
131614491|NCT02397096|473879544|FG001|Study Extension 1|Physician Decision|2|||
131614492|NCT02397096|473879543|FG000|Study Extension 1|Pregnancy|1|||
131614493|NCT02397096|473879544|FG001|Study Extension 1|Pregnancy|0|||
131614494|NCT02397096|473879543|FG000|Study Extension 1|Protocol Violation|0|||
131614495|NCT02397096|473879544|FG001|Study Extension 1|Protocol Violation|1|||
131614496|NCT02397096|473879543|FG000|Study Extension 1|Withdrawal by Subject|21|||
131614497|NCT02397096|473879544|FG001|Study Extension 1|Withdrawal by Subject|7|||
131614498|NCT02397096|473879543|FG000|Study Extension 2|Adverse Event|3|||
131614499|NCT02397096|473879544|FG001|Study Extension 2|Adverse Event|3|||
131900753|NCT01212094|474923427|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
131900754|NCT01212094|474923425|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
131900755|NCT01212094|474923426|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
131900756|NCT01212094|474923427|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
131900757|NCT01212094|474923425|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
131900758|NCT01212094|474923426|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
131900759|NCT01212094|474923427|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
131900760|NCT01212094|474923425|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
131900761|NCT01212094|474923426|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
131900762|NCT01212094|474923427|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
131900763|NCT02019550|474923434|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
131614500|NCT02397096|473879543|FG000|Study Extension 2|Availability of study medication locally|152|||
131614501|NCT02397096|473879544|FG001|Study Extension 2|Availability of study medication locally|64|||
131614502|NCT02397096|473879543|FG000|Study Extension 2|Death|2|||
131614503|NCT02397096|473879544|FG001|Study Extension 2|Death|0|||
131614504|NCT02397096|473879543|FG000|Study Extension 2|Lack of Efficacy|1|||
131614505|NCT02397096|473879544|FG001|Study Extension 2|Lack of Efficacy|0|||
131614506|NCT02397096|473879543|FG000|Study Extension 2|Lost to Follow-up|2|||
131900764|NCT02019550|474923435|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
131900765|NCT04771013|474923439|FG000|Overall Study|Withdrawal by Subject|2|||
131900766|NCT04771013|474923440|FG001|Overall Study|Withdrawal by Subject|0|||
131900767|NCT04771013|474923439|FG000|Overall Study|Death|0|||
131900768|NCT04771013|474923440|FG001|Overall Study|Death|5|||
131900769|NCT04771013|474923439|FG000|Overall Study|Referred to another hospital before day 20|0|||
131900770|NCT04771013|474923440|FG001|Overall Study|Referred to another hospital before day 20|1|||
131614507|NCT02397096|473879544|FG001|Study Extension 2|Lost to Follow-up|1|||
131708879|NCT01950819|474213436|FG001|Overall Study|Subject / Gardian decision|51|||
131708880|NCT01950819|474213435|FG000|Overall Study|technical problems|2|||
131708881|NCT01950819|474213436|FG001|Overall Study|technical problems|0|||
131708882|NCT01950819|474213435|FG000|Overall Study|Pregnancy|0|||
131900771|NCT00419757|474923441|FG000|Overall Study|Adverse Event|1|||
131900772|NCT00419757|474923442|FG001|Overall Study|Adverse Event|4|||
131900773|NCT00419757|474923441|FG000|Overall Study|Lost to Follow-up|1|||
131614508|NCT02397096|473879543|FG000|Study Extension 2|Non-compliance with study drug|1|||
131614509|NCT02397096|473879544|FG001|Study Extension 2|Non-compliance with study drug|0|||
131614510|NCT02397096|473879543|FG000|Study Extension 2|Physician Decision|2|||
131614511|NCT02397096|473879544|FG001|Study Extension 2|Physician Decision|5|||
131614512|NCT02397096|473879543|FG000|Study Extension 2|Pregnancy|1|||
131614513|NCT02397096|473879544|FG001|Study Extension 2|Pregnancy|0|||
131614514|NCT02397096|473879543|FG000|Study Extension 2|Withdrawal by Subject|10|||
131614515|NCT02397096|473879544|FG001|Study Extension 2|Withdrawal by Subject|3|||
131708883|NCT01950819|474213436|FG001|Overall Study|Pregnancy|2|||
131614516|NCT02397096|473879543|FG000|Study Extension 3|Adverse Event|1|||
131614517|NCT02397096|473879544|FG001|Study Extension 3|Adverse Event|0|||
131614518|NCT02397096|473879543|FG000|Study Extension 3|Availability of study medication locally|11|||
131614519|NCT02397096|473879544|FG001|Study Extension 3|Availability of study medication locally|3|||
131614520|NCT02397096|473879543|FG000|Study Extension 3|Lost to Follow-up|1|||
131614521|NCT02397096|473879544|FG001|Study Extension 3|Lost to Follow-up|0|||
131614522|NCT02397096|473879543|FG000|Study Extension 3|Withdrawal by Subject|2|||
131614523|NCT02397096|473879544|FG001|Study Extension 3|Withdrawal by Subject|1|||
131614524|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131614525|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
131443195|NCT04030143|473250833|FG000|Overall Study|Physician Decision|1|||
131443196|NCT04030143|473250834|FG001|Overall Study|Physician Decision|1|||
131443197|NCT04030143|473250833|FG000|Overall Study|Due to Covid-19|2|||
131443198|NCT04030143|473250834|FG001|Overall Study|Due to Covid-19|3|||
131443199|NCT04030143|473250833|FG000|Overall Study|Not Due to Covid-19|1|||
131443200|NCT04030143|473250834|FG001|Overall Study|Not Due to Covid-19|1|||
131443201|NCT04914364|473250836|FG000|Overall Study|No longer eligible for study|1|||
131443202|NCT04914364|473250836|FG000|Overall Study|Lost to Follow-up|2|||
131443203|NCT04097678|473250837|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
131443204|NCT04097678|473250838|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
131443205|NCT02435212|473250839|FG000|Core Phase|Adverse Event|8|||
131443206|NCT02435212|473250840|FG001|Core Phase|Adverse Event|5|||
131443207|NCT02435212|473250839|FG000|Core Phase|Withdrawal by Subject|3|||
131443208|NCT02435212|473250840|FG001|Core Phase|Withdrawal by Subject|0|||
131443209|NCT02435212|473250839|FG000|Core Phase|Withdrawal by parent/guardian|9|||
131443210|NCT02435212|473250840|FG001|Core Phase|Withdrawal by parent/guardian|4|||
131443211|NCT02435212|473250839|FG000|Core Phase|Protocol Violation|1|||
131443212|NCT02435212|473250840|FG001|Core Phase|Protocol Violation|2|||
131443213|NCT02435212|473250839|FG000|Core Phase|Physician Decision|3|||
131443214|NCT02435212|473250840|FG001|Core Phase|Physician Decision|0|||
131443215|NCT02435212|473250839|FG000|Core Phase|Lost to Follow-up|0|||
131443216|NCT02435212|473250840|FG001|Core Phase|Lost to Follow-up|1|||
131443217|NCT02435212|473250839|FG000|Core Phase|Lack of Efficacy|0|||
131443218|NCT02435212|473250840|FG001|Core Phase|Lack of Efficacy|1|||
131443219|NCT02435212|473250839|FG000|Core Phase|Recovery|1|||
131443220|NCT02435212|473250840|FG001|Core Phase|Recovery|0|||
131443221|NCT02435212|473250839|FG000|Optional Extension Phase|Adverse Event|3|||
131443222|NCT02435212|473250840|FG001|Optional Extension Phase|Adverse Event|9|||
131443223|NCT02435212|473250839|FG000|Optional Extension Phase|Physician Decision|6|||
131443224|NCT02435212|473250840|FG001|Optional Extension Phase|Physician Decision|8|||
131443225|NCT02435212|473250839|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
131443226|NCT02435212|473250840|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
131443227|NCT02435212|473250839|FG000|Optional Extension Phase|Lack of Efficacy|2|||
131443228|NCT02435212|473250840|FG001|Optional Extension Phase|Lack of Efficacy|3|||
131614526|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131614527|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
131614528|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131614529|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131614530|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131614531|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131614532|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131614533|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131443229|NCT02435212|473250839|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
131443230|NCT02435212|473250840|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
131443231|NCT02435212|473250839|FG000|Optional Extension Phase|Protocol Violation|0|||
131443232|NCT02435212|473250840|FG001|Optional Extension Phase|Protocol Violation|1|||
131443233|NCT02435212|473250839|FG000|Optional Extension Phase|Recovery|1|||
131443234|NCT02435212|473250840|FG001|Optional Extension Phase|Recovery|1|||
131443235|NCT02435212|473250839|FG000|Optional Extension Phase|Death|1|||
131443236|NCT02435212|473250840|FG001|Optional Extension Phase|Death|0|||
131614534|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
131614535|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131443237|NCT02435212|473250839|FG000|Optional Extension Phase|Technical problems|2|||
131443238|NCT02435212|473250840|FG001|Optional Extension Phase|Technical problems|0|||
131443239|NCT04852302|473250846|FG000|Overall Study|Withdrawal by Subject|2|||
131443240|NCT04852302|473250846|FG000|Overall Study|Did not complete CALM therapy.|2|||
131443241|NCT04711850|473250847|FG000|Overall Study|Graft loss|2|||
131443242|NCT04711850|473250848|FG001|Overall Study|Graft loss|1|||
131443243|NCT04711850|473250847|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
131443244|NCT04711850|473250848|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
131443245|NCT04711850|473250847|FG000|Overall Study|Study terminated by sponsor|5|||
131614536|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131614537|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131614538|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131443246|NCT04711850|473250848|FG001|Overall Study|Study terminated by sponsor|3|||
131443247|NCT04711850|473250847|FG000|Overall Study|Sponsor decision|0|||
131443248|NCT04711850|473250848|FG001|Overall Study|Sponsor decision|2|||
131443249|NCT03267277|473250849|FG000|Overall Study|Withdrawal by Subject|1|||
131443250|NCT04849364|473250850|FG000|Overall Study|Eligibility criteria not meet|0|||
131443251|NCT04849364|473250851|FG001|Overall Study|Eligibility criteria not meet|1|||
131443252|NCT04849364|473250852|FG002|Overall Study|Eligibility criteria not meet|0|||
131443253|NCT00561652|473250858|FG000|Overall Study|Withdrawal by Subject|0|||
131443254|NCT00561652|473250859|FG001|Overall Study|Withdrawal by Subject|1|||
131443255|NCT05417438|473250865|FG000|Overall Study|Withdrawal by Subject|3|||
131443256|NCT04944992|473252585|FG000|Overall Study|Lost to Follow-up|1|||
131443257|NCT04944992|473252586|FG001|Overall Study|Lost to Follow-up|1|||
131443258|NCT04944992|473252585|FG000|Overall Study|Physician Decision|1|||
131443259|NCT04944992|473252586|FG001|Overall Study|Physician Decision|0|||
131443260|NCT04944992|473252585|FG000|Overall Study|Withdrawal by Subject|6|||
131443261|NCT04944992|473252586|FG001|Overall Study|Withdrawal by Subject|1|||
131614539|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131614540|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131614541|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
131614542|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
131614543|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131614544|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131614545|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
131614546|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131614547|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131614548|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131614549|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131614550|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131614551|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131614552|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131614553|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
131614554|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
131614555|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
131614556|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
131614557|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
131614558|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
131614559|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
131614560|NCT02392234|473879545|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131614561|NCT02392234|473879546|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131614562|NCT02392234|473879547|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
131614563|NCT02392234|473879548|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131614564|NCT02392234|473879549|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
131614565|NCT02392234|473879550|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131614566|NCT02392234|473879545|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
131614567|NCT02392234|473879546|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131614568|NCT02392234|473879547|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131614569|NCT02392234|473879548|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131443262|NCT01295814|473252587|FG000|Overall Study|Lack of Efficacy|0|||
131443263|NCT01295814|473252588|FG001|Overall Study|Lack of Efficacy|2|||
131443264|NCT01295814|473252587|FG000|Overall Study|Withdrawal by Subject|2|||
131614570|NCT02392234|473879549|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131614571|NCT02392234|473879550|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131614572|NCT02052440|473879555|FG000|Overall Study|Withdrawal by Subject|0|||
131614573|NCT02052440|473879556|FG001|Overall Study|Withdrawal by Subject|1|||
131614574|NCT02078648|473879557|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
131614575|NCT02078648|473879558|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
131614576|NCT02078648|473879557|FG000|Overall Study|Adverse Event|0|||
131614577|NCT02078648|473879558|FG001|Overall Study|Adverse Event|1|||
131614578|NCT02078648|473879557|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
131614579|NCT02078648|473879558|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
131443265|NCT01295814|473252588|FG001|Overall Study|Withdrawal by Subject|0|||
131614580|NCT02078648|473879557|FG000|Overall Study|Withdrawal by Subject|3|||
131614581|NCT02078648|473879558|FG001|Overall Study|Withdrawal by Subject|1|||
131614582|NCT02078648|473879557|FG000|Overall Study|Investigator Decision|5|||
131614583|NCT02078648|473879558|FG001|Overall Study|Investigator Decision|7|||
131614584|NCT02078648|473879557|FG000|Overall Study|Death|1|||
131614585|NCT02078648|473879558|FG001|Overall Study|Death|1|||
131614586|NCT02078648|473879557|FG000|Overall Study|Undefined|0|||
131708884|NCT01950819|474213435|FG000|Overall Study|Lost to Follow-up|9|||
131708885|NCT01950819|474213436|FG001|Overall Study|Lost to Follow-up|17|||
131708886|NCT01838044|474213440|FG000|Overall Study|Adverse Event|4|||
131708887|NCT01838044|474213441|FG001|Overall Study|Adverse Event|6|||
131708888|NCT01838044|474213440|FG000|Overall Study|Protocol Violation|3|||
131614587|NCT02078648|473879558|FG001|Overall Study|Undefined|1|||
131614588|NCT04088227|473879559|FG000|Overall Study|Withdrawal by Subject|1|||
131614589|NCT04088227|473879560|FG001|Overall Study|Withdrawal by Subject|0|||
131614590|NCT04088227|473879559|FG000|Overall Study|Surgery postponed >5weeks|1|||
131614591|NCT04088227|473879560|FG001|Overall Study|Surgery postponed >5weeks|0|||
131614592|NCT05525572|473879561|FG000|Overall Study|Lost to Follow-up|2|||
131614593|NCT03425682|473879562|FG000|Overall Study|Lost to Follow-up|2|||
131708889|NCT01838044|474213441|FG001|Overall Study|Protocol Violation|3|||
131708890|NCT01838044|474213440|FG000|Overall Study|Withdrawal by Subject|0|||
131708891|NCT01838044|474213441|FG001|Overall Study|Withdrawal by Subject|2|||
131708892|NCT01838044|474213440|FG000|Overall Study|Insufficient clinical response|1|||
131708893|NCT01838044|474213441|FG001|Overall Study|Insufficient clinical response|2|||
131708894|NCT01838044|474213440|FG000|Overall Study|Medication error without associated AE|0|||
131708895|NCT01838044|474213441|FG001|Overall Study|Medication error without associated AE|1|||
131708896|NCT01838044|474213440|FG000|Overall Study|Lost to Follow-up|0|||
131708897|NCT01838044|474213441|FG001|Overall Study|Lost to Follow-up|2|||
131708898|NCT02928952|474213445|FG000|Overall Study|Lost to Follow-up|5|||
131708899|NCT02928952|474213446|FG001|Overall Study|Lost to Follow-up|5|||
131708900|NCT02928952|474213445|FG000|Overall Study|Withdrawal by Subject|5|||
131708901|NCT02928952|474213446|FG001|Overall Study|Withdrawal by Subject|1|||
131708902|NCT02928952|474213445|FG000|Overall Study|Physician Decision|0|||
131708903|NCT02928952|474213446|FG001|Overall Study|Physician Decision|1|||
131708904|NCT00723957|474213447|FG000|Overall Study|Adverse event unrelated to study drug|1|||
131708905|NCT00723957|474213448|FG001|Overall Study|Adverse event unrelated to study drug|4|||
131708906|NCT00723957|474213447|FG000|Overall Study|Death|3|||
131708907|NCT00723957|474213448|FG001|Overall Study|Death|4|||
131708908|NCT00723957|474213447|FG000|Overall Study|Disease progression|27|||
131708909|NCT00723957|474213448|FG001|Overall Study|Disease progression|25|||
131708910|NCT00723957|474213447|FG000|Overall Study|Maximum clinical benefit|4|||
131708911|NCT00723957|474213448|FG001|Overall Study|Maximum clinical benefit|5|||
131708912|NCT00723957|474213447|FG000|Overall Study|Investigator decision|1|||
131708913|NCT00723957|474213448|FG001|Overall Study|Investigator decision|1|||
131708914|NCT00723957|474213447|FG000|Overall Study|Study drug toxicity|4|||
131708915|NCT00723957|474213448|FG001|Overall Study|Study drug toxicity|6|||
131708916|NCT00723957|474213447|FG000|Overall Study|Withdrawal by Subject|7|||
131708917|NCT00723957|474213448|FG001|Overall Study|Withdrawal by Subject|5|||
131708918|NCT00723957|474213447|FG000|Overall Study|Reason not analyzed|1|||
131708919|NCT00723957|474213448|FG001|Overall Study|Reason not analyzed|0|||
131708920|NCT00723957|474213447|FG000|Overall Study|Never received treatment|3|||
131708921|NCT00723957|474213448|FG001|Overall Study|Never received treatment|3|||
131708922|NCT01850615|474213450|FG000|Overall Study|Protocol Violation|4|||
131708923|NCT01850615|474213451|FG001|Overall Study|Protocol Violation|1|||
131708924|NCT01850615|474213450|FG000|Overall Study|Adverse Event|2|||
131708925|NCT01850615|474213451|FG001|Overall Study|Adverse Event|1|||
131708926|NCT01850615|474213450|FG000|Overall Study|Withdrawal by Subject|3|||
131708927|NCT01850615|474213451|FG001|Overall Study|Withdrawal by Subject|1|||
131708928|NCT01850615|474213450|FG000|Overall Study|Lost to Follow-up|0|||
131708929|NCT01850615|474213451|FG001|Overall Study|Lost to Follow-up|1|||
131708930|NCT01850615|474213450|FG000|Overall Study|Unclassified|0|||
131708931|NCT01850615|474213451|FG001|Overall Study|Unclassified|1|||
131708932|NCT00706628|474213452|FG000|Overall Study|Other Adverse Event|16|||
131708933|NCT00706628|474213453|FG001|Overall Study|Other Adverse Event|5|||
131708934|NCT00706628|474213454|FG002|Overall Study|Other Adverse Event|5|||
131708935|NCT00706628|474213455|FG003|Overall Study|Other Adverse Event|2|||
131708936|NCT00706628|474213452|FG000|Overall Study|Non compliant with protocol|0|||
131708937|NCT00706628|474213453|FG001|Overall Study|Non compliant with protocol|1|||
131708938|NCT00706628|474213454|FG002|Overall Study|Non compliant with protocol|0|||
131795001|NCT01579474|474532041|FG001|Overall Study|Withdrawal by Subject|0|||
131795002|NCT01579474|474532042|FG002|Overall Study|Withdrawal by Subject|0|||
131614594|NCT03425682|473879563|FG001|Overall Study|Lost to Follow-up|4|||
131614595|NCT03425682|473879562|FG000|Overall Study|Withdrawal by Subject|0|||
131614596|NCT03425682|473879563|FG001|Overall Study|Withdrawal by Subject|3|||
131614597|NCT03425682|473879562|FG000|Overall Study|Subject did not meet I/E|4|||
131614598|NCT03425682|473879563|FG001|Overall Study|Subject did not meet I/E|10|||
131614599|NCT05485805|473879568|FG000|Overall Study|Withdrawal by Subject|1|||
131614600|NCT05485805|473879569|FG001|Overall Study|Withdrawal by Subject|2|||
131614601|NCT05485805|473879570|FG002|Overall Study|Withdrawal by Subject|2|||
131614602|NCT05485805|473879571|FG003|Overall Study|Withdrawal by Subject|0|||
131614603|NCT05485805|473879572|FG004|Overall Study|Withdrawal by Subject|2|||
131614604|NCT05485805|473879568|FG000|Overall Study|Adverse Event|0|||
131614605|NCT05485805|473879569|FG001|Overall Study|Adverse Event|1|||
131614606|NCT05485805|473879570|FG002|Overall Study|Adverse Event|0|||
131614607|NCT05485805|473879571|FG003|Overall Study|Adverse Event|0|||
131614608|NCT05485805|473879572|FG004|Overall Study|Adverse Event|0|||
131614609|NCT05485805|473879568|FG000|Overall Study|Lost to Follow-up|1|||
131614610|NCT05485805|473879569|FG001|Overall Study|Lost to Follow-up|1|||
131614611|NCT05485805|473879570|FG002|Overall Study|Lost to Follow-up|3|||
131900774|NCT00419757|474923442|FG001|Overall Study|Lost to Follow-up|4|||
131900775|NCT00419757|474923441|FG000|Overall Study|Withdrawal by Subject|7|||
131900776|NCT00419757|474923442|FG001|Overall Study|Withdrawal by Subject|1|||
131900777|NCT00419757|474923441|FG000|Overall Study|Protocol Violation|2|||
131900778|NCT00419757|474923442|FG001|Overall Study|Protocol Violation|3|||
131900779|NCT00419757|474923441|FG000|Overall Study|Study specific discontinuation criteria|4|||
131900780|NCT00419757|474923442|FG001|Overall Study|Study specific discontinuation criteria|8|||
131900781|NCT00419757|474923441|FG000|Overall Study|Multiple reasons|3|||
131900782|NCT00419757|474923442|FG001|Overall Study|Multiple reasons|1|||
131900783|NCT01519817|474923444|FG000|Overall Study|Withdrawal by Subject|1|||
131900784|NCT01519817|474923445|FG001|Overall Study|Withdrawal by Subject|0|||
131900785|NCT01519817|474923446|FG002|Overall Study|Withdrawal by Subject|0|||
131900786|NCT01519817|474923447|FG003|Overall Study|Withdrawal by Subject|0|||
131900787|NCT01519817|474923444|FG000|Overall Study|Off study due to infection|0|||
131900788|NCT01519817|474923445|FG001|Overall Study|Off study due to infection|0|||
131900789|NCT01519817|474923446|FG002|Overall Study|Off study due to infection|0|||
131900790|NCT01519817|474923447|FG003|Overall Study|Off study due to infection|1|||
131900791|NCT02692586|474923452|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
131900792|NCT02692586|474923452|FG000|Overall Study|Received adjunctive thrombolytics|2|||
131900793|NCT01128296|474923454|FG000|Overall Study|Physician Decision|0|||
131900794|NCT01128296|474923455|FG001|Overall Study|Physician Decision|0|||
131900795|NCT01128296|474923456|FG002|Overall Study|Physician Decision|0|||
131900796|NCT01128296|474923457|FG003|Overall Study|Physician Decision|0|||
131900797|NCT01128296|474923458|FG004|Overall Study|Physician Decision|0|||
131900798|NCT01128296|474923459|FG005|Overall Study|Physician Decision|3|||
131900799|NCT01128296|474923454|FG000|Overall Study|Withdrawal by Subject|0|||
131900800|NCT01128296|474923455|FG001|Overall Study|Withdrawal by Subject|0|||
131900801|NCT01128296|474923456|FG002|Overall Study|Withdrawal by Subject|0|||
131900802|NCT01128296|474923457|FG003|Overall Study|Withdrawal by Subject|0|||
131900803|NCT01128296|474923458|FG004|Overall Study|Withdrawal by Subject|0|||
131900804|NCT01128296|474923459|FG005|Overall Study|Withdrawal by Subject|2|||
131900805|NCT01914393|474923460|FG000|Overall Study|Protocol Violation|11|||
131900806|NCT01914393|474923461|FG001|Overall Study|Protocol Violation|3|||
131900807|NCT01914393|474923462|FG002|Overall Study|Protocol Violation|19|||
131900808|NCT01914393|474923460|FG000|Overall Study|Lack of Efficacy|11|||
131900809|NCT01914393|474923461|FG001|Overall Study|Lack of Efficacy|16|||
131900810|NCT01914393|474923462|FG002|Overall Study|Lack of Efficacy|5|||
131900811|NCT01914393|474923460|FG000|Overall Study|no reason given|14|||
131900812|NCT01914393|474923461|FG001|Overall Study|no reason given|8|||
131900813|NCT01914393|474923462|FG002|Overall Study|no reason given|16|||
131900814|NCT01914393|474923460|FG000|Overall Study|Adverse Event|29|||
131900815|NCT01914393|474923461|FG001|Overall Study|Adverse Event|18|||
131900816|NCT01914393|474923462|FG002|Overall Study|Adverse Event|31|||
131900817|NCT01914393|474923460|FG000|Overall Study|Withdrawal by Subject|38|||
131900818|NCT01914393|474923461|FG001|Overall Study|Withdrawal by Subject|20|||
131900819|NCT01914393|474923462|FG002|Overall Study|Withdrawal by Subject|47|||
131900820|NCT01914393|474923460|FG000|Overall Study|Lost to Follow-up|12|||
131900821|NCT01914393|474923461|FG001|Overall Study|Lost to Follow-up|6|||
131900822|NCT01914393|474923462|FG002|Overall Study|Lost to Follow-up|19|||
131900823|NCT01914393|474923460|FG000|Overall Study|subject never dosed|0|||
131900824|NCT01914393|474923461|FG001|Overall Study|subject never dosed|0|||
131900825|NCT01914393|474923462|FG002|Overall Study|subject never dosed|1|||
131900826|NCT03234036|474923465|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
131900827|NCT03234036|474923466|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
131900828|NCT03234036|474923467|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
131900829|NCT03234036|474923468|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
131900830|NCT02999789|474923469|FG000|Overall Study|Withdrawal by Subject|0|||
131900831|NCT02999789|474923470|FG001|Overall Study|Withdrawal by Subject|1|||
131900832|NCT02999789|474923469|FG000|Overall Study|Became ineligible|1|||
131900833|NCT02999789|474923470|FG001|Overall Study|Became ineligible|2|||
131900834|NCT04613739|474923473|FG000|Overall Study|Lost to Follow-up|6|||
131900835|NCT04613739|474923474|FG001|Overall Study|Lost to Follow-up|9|||
131900836|NCT04613739|474923473|FG000|Overall Study|potentially duplicative/fraudulent|1|||
131900837|NCT04613739|474923474|FG001|Overall Study|potentially duplicative/fraudulent|3|||
131614612|NCT05485805|473879571|FG003|Overall Study|Lost to Follow-up|1|||
131614613|NCT05485805|473879572|FG004|Overall Study|Lost to Follow-up|0|||
131900838|NCT00003537|474923475|FG000|Overall Study|Not evalauable|1|||
131900839|NCT01051557|474923476|FG000|Overall Study|Physician Decision|1|||
131900840|NCT01051557|474923477|FG001|Overall Study|Physician Decision|0|||
131900841|NCT01051557|474923478|FG002|Overall Study|Physician Decision|0|||
131900842|NCT01051557|474923479|FG003|Overall Study|Physician Decision|0|||
131900843|NCT01051557|474923480|FG004|Overall Study|Physician Decision|0|||
131900844|NCT01051557|474923481|FG005|Overall Study|Physician Decision|0|||
131614614|NCT04218357|473879573|FG000|1st Allocation|Withdrawal by Subject|1|||
131900845|NCT01051557|474923482|FG006|Overall Study|Physician Decision|0|||
131900846|NCT01051557|474923476|FG000|Overall Study|disease progression|3|||
131614615|NCT04218357|473879574|FG001|1st Allocation|Withdrawal by Subject|0|||
131614616|NCT02488408|473879576|FG000|Part A|Adverse Event|2|||
131614617|NCT02488408|473879577|FG001|Part A|Adverse Event|0|||
131443266|NCT00092417|473252589|FG000|Overall Study|Lost to Follow-up|2|||
131443267|NCT00092417|473252590|FG001|Overall Study|Lost to Follow-up|0|||
131443268|NCT00092417|473252589|FG000|Overall Study|Withdrawal by Subject|2|||
131443269|NCT00092417|473252590|FG001|Overall Study|Withdrawal by Subject|1|||
131443270|NCT00092417|473252589|FG000|Overall Study|Other|1|||
131443271|NCT00092417|473252590|FG001|Overall Study|Other|0|||
131443272|NCT00755183|473252594|FG000|Overall Study|Adverse Event|5|||
131443273|NCT00755183|473252595|FG001|Overall Study|Adverse Event|2|||
131443274|NCT00755183|473252594|FG000|Overall Study|Protocol Violation|0|||
131443275|NCT00755183|473252595|FG001|Overall Study|Protocol Violation|1|||
131443276|NCT00755183|473252594|FG000|Overall Study|Withdrawal by Subject|0|||
131443277|NCT00755183|473252595|FG001|Overall Study|Withdrawal by Subject|2|||
131614618|NCT02488408|473879578|FG002|Part A|Adverse Event|0|||
131614619|NCT02488408|473879579|FG003|Part A|Adverse Event|0|||
131614620|NCT02488408|473879580|FG004|Part A|Adverse Event|0|||
131614621|NCT02488408|473879581|FG005|Part A|Adverse Event|0|||
131614622|NCT02488408|473879582|FG006|Part A|Adverse Event|0|||
131443278|NCT00755183|473252594|FG000|Overall Study|Administrative|2|||
131443279|NCT00755183|473252595|FG001|Overall Study|Administrative|1|||
131443280|NCT00148317|473252596|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
131443281|NCT00148317|473252596|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
131443282|NCT00148317|473252596|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
131443283|NCT00992108|473252604|FG000|Overall Study|Lost to Follow-up|0|||
131443284|NCT00992108|473252605|FG001|Overall Study|Lost to Follow-up|1|||
131443285|NCT04639245|473252606|FG000|Overall Study|Death|1|||
131443286|NCT01702311|473252607|FG000|Overall Study|Withdrawal by Subject|3|||
131443287|NCT01702311|473252608|FG001|Overall Study|Withdrawal by Subject|2|||
131443288|NCT01702311|473252607|FG000|Overall Study|Discharge less than 24 hours|10|||
131443289|NCT01702311|473252608|FG001|Overall Study|Discharge less than 24 hours|7|||
131443290|NCT01702311|473252607|FG000|Overall Study|Physician Decision|3|||
131443291|NCT01702311|473252608|FG001|Overall Study|Physician Decision|4|||
131443292|NCT04106557|473252617|FG000|Overall Study|Physician Decision|0|||
131443293|NCT04106557|473252618|FG001|Overall Study|Physician Decision|1|||
131443294|NCT04106557|473252619|FG002|Overall Study|Physician Decision|0|||
131443295|NCT04106557|473252617|FG000|Overall Study|Protocol Violation|0|||
131443296|NCT04106557|473252618|FG001|Overall Study|Protocol Violation|1|||
131443297|NCT04106557|473252619|FG002|Overall Study|Protocol Violation|0|||
131443298|NCT01209689|473252620|FG000|Overall Study|Insufficient Therapeutic Response|7|||
131443299|NCT01209689|473252621|FG001|Overall Study|Insufficient Therapeutic Response|2|||
131443300|NCT01209689|473252620|FG000|Overall Study|Refused Treatment|8|||
131443301|NCT01209689|473252621|FG001|Overall Study|Refused Treatment|3|||
131443302|NCT01209689|473252620|FG000|Overall Study|Adverse Event|4|||
131443303|NCT01209689|473252621|FG001|Overall Study|Adverse Event|0|||
131443304|NCT01209689|473252620|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131443305|NCT01209689|473252621|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
131443306|NCT01209689|473252620|FG000|Overall Study|Failure to Return|3|||
131443307|NCT01209689|473252621|FG001|Overall Study|Failure to Return|0|||
131614623|NCT02488408|473879583|FG007|Part A|Adverse Event|0|||
131614624|NCT02488408|473879584|FG008|Part A|Adverse Event|0|||
131614625|NCT02488408|473879585|FG009|Part A|Adverse Event|0|||
131614626|NCT02488408|473879576|FG000|Part A|Death|1|||
131708939|NCT00706628|474213455|FG003|Overall Study|Non compliant with protocol|0|||
131708940|NCT00706628|474213452|FG000|Overall Study|Consent withdrawn|6|||
131708941|NCT00706628|474213453|FG001|Overall Study|Consent withdrawn|1|||
131708942|NCT00706628|474213454|FG002|Overall Study|Consent withdrawn|3|||
131708943|NCT00706628|474213455|FG003|Overall Study|Consent withdrawn|0|||
131443308|NCT01209689|473252620|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
131443309|NCT01209689|473252621|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
131443310|NCT03175367|473252622|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
131708944|NCT00706628|474213452|FG000|Overall Study|Progressive disease|20|||
131708945|NCT00706628|474213453|FG001|Overall Study|Progressive disease|13|||
131708946|NCT00706628|474213454|FG002|Overall Study|Progressive disease|8|||
131708947|NCT00706628|474213455|FG003|Overall Study|Progressive disease|1|||
131708948|NCT00706628|474213452|FG000|Overall Study|Other than those stated above|4|||
131708949|NCT00706628|474213453|FG001|Overall Study|Other than those stated above|0|||
131708950|NCT00706628|474213454|FG002|Overall Study|Other than those stated above|0|||
131795003|NCT01579474|474532043|FG003|Overall Study|Withdrawal by Subject|0|||
131614627|NCT02488408|473879577|FG001|Part A|Death|5|||
131614628|NCT02488408|473879578|FG002|Part A|Death|0|||
131708951|NCT00706628|474213455|FG003|Overall Study|Other than those stated above|0|||
131708952|NCT00706628|474213452|FG000|Overall Study|Not treated|1|||
131443311|NCT03175367|473252623|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
131614629|NCT02488408|473879579|FG003|Part A|Death|0|||
131614630|NCT02488408|473879580|FG004|Part A|Death|3|||
131614631|NCT02488408|473879581|FG005|Part A|Death|0|||
131614632|NCT02488408|473879582|FG006|Part A|Death|0|||
131443312|NCT03175367|473252624|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
131443313|NCT03175367|473252625|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
131443314|NCT03175367|473252626|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
131443315|NCT03175367|473252627|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
131443316|NCT03175367|473252628|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
131443317|NCT03175367|473252622|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
131443318|NCT03175367|473252623|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
131443319|NCT03175367|473252624|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
131443320|NCT03175367|473252625|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
131443321|NCT03175367|473252626|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
131443322|NCT03175367|473252627|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
131443323|NCT03175367|473252628|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
131443324|NCT03175367|473252622|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131443325|NCT03175367|473252623|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131443326|NCT03175367|473252624|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
131443327|NCT03175367|473252625|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
131443328|NCT03175367|473252626|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131443329|NCT03175367|473252627|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131443330|NCT03175367|473252628|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131443331|NCT03175367|473252622|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
131443332|NCT03175367|473252623|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
131443333|NCT03175367|473252624|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
131443334|NCT03175367|473252625|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
131443335|NCT03175367|473252626|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
131443336|NCT03175367|473252627|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
131443337|NCT03175367|473252628|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
131443338|NCT03175367|473252622|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131443339|NCT03175367|473252623|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131443340|NCT03175367|473252624|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
131443341|NCT03175367|473252625|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131443342|NCT03175367|473252626|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
131443343|NCT03175367|473252627|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131443344|NCT03175367|473252628|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131443345|NCT03175367|473252622|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
131443346|NCT03175367|473252623|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
131443347|NCT03175367|473252624|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
131443348|NCT03175367|473252625|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
131443349|NCT03175367|473252626|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
131443350|NCT03175367|473252627|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
131443351|NCT03175367|473252628|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
131443352|NCT03175367|473252622|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131443353|NCT03175367|473252623|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131443354|NCT03175367|473252624|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131443355|NCT03175367|473252625|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131443356|NCT03175367|473252626|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131443357|NCT03175367|473252627|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
131443358|NCT03175367|473252628|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
131443359|NCT03466658|473252629|FG000|Overall Study|Withdrawal by Subject|3|||
131443360|NCT03044106|473252630|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
131443361|NCT03044106|473252631|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
131443362|NCT00412984|473252632|FG000|Overall Study|Death|331|||
131443363|NCT00412984|473252633|FG001|Overall Study|Death|349|||
131443364|NCT00412984|473252632|FG000|Overall Study|Adverse Event|679|||
131443365|NCT00412984|473252633|FG001|Overall Study|Adverse Event|738|||
131443366|NCT00412984|473252632|FG000|Overall Study|Withdrawal by Subject|921|||
131443367|NCT00412984|473252633|FG001|Overall Study|Withdrawal by Subject|989|||
131443368|NCT00412984|473252632|FG000|Overall Study|Lost to Follow-up|51|||
131443369|NCT00412984|473252633|FG001|Overall Study|Lost to Follow-up|39|||
131443370|NCT00412984|473252632|FG000|Overall Study|Poor/Noncompliance|57|||
131443371|NCT00412984|473252633|FG001|Overall Study|Poor/Noncompliance|77|||
131443372|NCT00412984|473252632|FG000|Overall Study|Pregnancy|1|||
131708953|NCT00706628|474213453|FG001|Overall Study|Not treated|1|||
131708954|NCT00706628|474213454|FG002|Overall Study|Not treated|0|||
131708955|NCT00706628|474213455|FG003|Overall Study|Not treated|0|||
131708956|NCT02266433|474213460|FG000|Overall Study|Lost to Follow-up|54|||
131708957|NCT02266433|474213461|FG001|Overall Study|Lost to Follow-up|46|||
131708958|NCT02266433|474213460|FG000|Overall Study|Withdrawal by Subject|5|||
131708959|NCT02266433|474213461|FG001|Overall Study|Withdrawal by Subject|7|||
131708960|NCT04525703|474213465|FG000|Overall Study|Lost to Follow-up|6|||
131614633|NCT02488408|473879583|FG007|Part A|Death|0|||
131614634|NCT02488408|473879584|FG008|Part A|Death|0|||
131614635|NCT02488408|473879585|FG009|Part A|Death|0|||
131614636|NCT02488408|473879576|FG000|Part A|Disease Progression|2|||
131614637|NCT02488408|473879577|FG001|Part A|Disease Progression|8|||
131614638|NCT02488408|473879578|FG002|Part A|Disease Progression|2|||
131614639|NCT02488408|473879579|FG003|Part A|Disease Progression|3|||
131614640|NCT02488408|473879580|FG004|Part A|Disease Progression|4|||
131614641|NCT02488408|473879581|FG005|Part A|Disease Progression|0|||
131614642|NCT02488408|473879582|FG006|Part A|Disease Progression|0|||
131614643|NCT02488408|473879583|FG007|Part A|Disease Progression|0|||
131614644|NCT02488408|473879584|FG008|Part A|Disease Progression|0|||
131614645|NCT02488408|473879585|FG009|Part A|Disease Progression|0|||
131614646|NCT02488408|473879576|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
131614647|NCT02488408|473879577|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
131614648|NCT02488408|473879578|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
131614649|NCT02488408|473879579|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
131708961|NCT04525703|474213466|FG001|Overall Study|Lost to Follow-up|15|||
131708962|NCT04525703|474213467|FG002|Overall Study|Lost to Follow-up|8|||
131708963|NCT01285349|474213468|FG000|Overall Study|Lost to Follow-up|27|||
131708964|NCT01285349|474213469|FG001|Overall Study|Lost to Follow-up|20|||
131708965|NCT01285349|474213470|FG002|Overall Study|Lost to Follow-up|27|||
131708966|NCT00712348|474213471|FG000|Overall Study|Withdrawal by Subject|1|||
131708967|NCT05032950|474213472|FG000|Overall Study|Adverse Event|0|||
131708968|NCT05032950|474213473|FG001|Overall Study|Adverse Event|0|||
131708969|NCT05032950|474213474|FG002|Overall Study|Adverse Event|1|||
131708970|NCT05032950|474213475|FG003|Overall Study|Adverse Event|1|||
131708971|NCT05032950|474213476|FG004|Overall Study|Adverse Event|0|||
131708972|NCT05032950|474213477|FG005|Overall Study|Adverse Event|0|||
131708973|NCT02959814|474213481|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
131708974|NCT02959814|474213481|FG000|Overall Study|Excluded based on anatomical criteria|2|||
131708975|NCT02959814|474213481|FG000|Overall Study|Protocol Violation|7|||
131708976|NCT02959814|474213481|FG000|Overall Study|FFR not measured|2|||
131708977|NCT02959814|474213481|FG000|Overall Study|In-procedure QFR not computed|6|||
131708978|NCT02959814|474213481|FG000|Overall Study|Excluded by FFR core-lab|24|||
131708979|NCT00484315|474213482|FG000|12-Month Clinical Follow-up|Death|6|||
131708980|NCT00484315|474213483|FG001|12-Month Clinical Follow-up|Death|2|||
131708981|NCT00484315|474213482|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
131708982|NCT00484315|474213483|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
131708983|NCT00484315|474213482|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
131708984|NCT00484315|474213483|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
131708985|NCT00484315|474213482|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
131708986|NCT00484315|474213483|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
131708987|NCT00484315|474213482|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
131708988|NCT00484315|474213483|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
131708989|NCT00484315|474213482|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
131708990|NCT00484315|474213483|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
131708991|NCT00484315|474213482|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
131708992|NCT00484315|474213483|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
131708993|NCT01245673|474213484|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
131708994|NCT01468311|474213491|FG000|Overall Study|mobilization failure|1|||
131708995|NCT01468311|474213491|FG000|Overall Study|Withdrawal by Subject|1|||
131708996|NCT02689492|474215530|FG000|Overall Study|Lost to Follow-up|61|||
131708997|NCT02689492|474215530|FG000|Overall Study|Withdrawal by Subject|11|||
131708998|NCT02689492|474215530|FG000|Overall Study|Death|9|||
131708999|NCT02689492|474215530|FG000|Overall Study|Physician Decision|2|||
131709000|NCT02689492|474215530|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
131709001|NCT02689492|474215530|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
131709002|NCT02689492|474215530|FG000|Overall Study|Other than listed|1|||
131709003|NCT02029976|474215531|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
131709004|NCT02029976|474215532|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
131709005|NCT02029976|474215531|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
131709006|NCT02029976|474215532|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
131709007|NCT02029976|474215531|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
131709008|NCT02029976|474215532|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
131709009|NCT02029976|474215531|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
131709010|NCT02029976|474215532|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
131709011|NCT04025632|474215533|FG000|Overall Study|Adverse Event|1|||
131709012|NCT04025632|474215534|FG001|Overall Study|Adverse Event|1|||
131709013|NCT04025632|474215533|FG000|Overall Study|Withdrawal by Subject|1|||
131795004|NCT01579474|474532044|FG004|Overall Study|Withdrawal by Subject|0|||
131795005|NCT01579474|474532045|FG005|Overall Study|Withdrawal by Subject|0|||
131795006|NCT00130520|474532046|FG000|Overall Study|Adverse Event|11|||
131443373|NCT00412984|473252633|FG001|Overall Study|Pregnancy|0|||
131443374|NCT00412984|473252632|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
131443375|NCT00412984|473252633|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
131443376|NCT00412984|473252632|FG000|Overall Study|Administrative Reason by Sponsor|11|||
131443377|NCT00412984|473252633|FG001|Overall Study|Administrative Reason by Sponsor|8|||
131443378|NCT00412984|473252632|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
131443379|NCT00412984|473252633|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
131443380|NCT00412984|473252632|FG000|Overall Study|Other Reason|80|||
131443381|NCT00412984|473252633|FG001|Overall Study|Other Reason|92|||
131443382|NCT00412984|473252632|FG000|Overall Study|Not Reported|11|||
131443383|NCT00412984|473252633|FG001|Overall Study|Not Reported|12|||
131443384|NCT02383576|473252634|FG000|Overall Study|Death|53|||
131443385|NCT02383576|473252635|FG001|Overall Study|Death|33|||
131443386|NCT02383576|473252634|FG000|Overall Study|Lost to Follow-up|7|||
131443387|NCT02383576|473252635|FG001|Overall Study|Lost to Follow-up|1|||
131443388|NCT02383576|473252634|FG000|Overall Study|Withdrew Consent|1|||
131443389|NCT02383576|473252635|FG001|Overall Study|Withdrew Consent|6|||
131443390|NCT02383576|473252634|FG000|Overall Study|Investigator's Decision|0|||
131443391|NCT02383576|473252635|FG001|Overall Study|Investigator's Decision|1|||
131443392|NCT02383576|473252634|FG000|Overall Study|Administrative/Other|2|||
131443393|NCT02383576|473252635|FG001|Overall Study|Administrative/Other|4|||
131443394|NCT04218240|473252636|FG000|Overall Study|Withdrawal by Subject|6|||
131443395|NCT04218240|473252637|FG001|Overall Study|Withdrawal by Subject|0|||
131443396|NCT04218240|473252636|FG000|Overall Study|Lack of Efficacy|24|||
131443397|NCT04218240|473252637|FG001|Overall Study|Lack of Efficacy|19|||
131443398|NCT04218240|473252636|FG000|Overall Study|Physician Decision|0|||
131443399|NCT04218240|473252637|FG001|Overall Study|Physician Decision|1|||
131443400|NCT04218240|473252636|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
131443401|NCT04218240|473252637|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
131443402|NCT03694678|473252638|FG000|Overall Study|Withdrawal by Subject|2|||
131443403|NCT03694678|473252639|FG001|Overall Study|Withdrawal by Subject|0|||
131443404|NCT03694678|473252638|FG000|Overall Study|Lost to Follow-up|2|||
131443405|NCT03694678|473252639|FG001|Overall Study|Lost to Follow-up|3|||
131443406|NCT02340026|473252640|FG000|Treatment Phase|Withdrawal by Subject|2|||
131443407|NCT02340026|473252641|FG001|Treatment Phase|Withdrawal by Subject|2|||
131443408|NCT02340026|473252640|FG000|Follow-up Phase|Lost to Follow-up|1|||
131443409|NCT02340026|473252641|FG001|Follow-up Phase|Lost to Follow-up|0|||
131443410|NCT03521570|473252648|FG000|Overall Study|Not eligible|11|||
131443411|NCT03279081|473252649|FG000|Overall Study|Withdrawal by Subject|12|||
131443412|NCT03279081|473252650|FG001|Overall Study|Withdrawal by Subject|20|||
131443413|NCT03279081|473252649|FG000|Overall Study|Physician Decision|4|||
131443414|NCT03279081|473252650|FG001|Overall Study|Physician Decision|1|||
131443415|NCT03279081|473252649|FG000|Overall Study|Lost to Follow-up|8|||
131443416|NCT03279081|473252650|FG001|Overall Study|Lost to Follow-up|8|||
131443417|NCT03279081|473252649|FG000|Overall Study|Death|0|||
131443418|NCT03279081|473252650|FG001|Overall Study|Death|1|||
131443419|NCT03279081|473252649|FG000|Overall Study|Adverse Event|1|||
131443420|NCT03279081|473252650|FG001|Overall Study|Adverse Event|0|||
131443421|NCT03279081|473252649|FG000|Overall Study|Reason not Specified|14|||
131443422|NCT03279081|473252650|FG001|Overall Study|Reason not Specified|4|||
131443423|NCT04531176|473252661|FG000|Overall Study|Study was stopped early|24|||
131443424|NCT04531176|473252662|FG001|Overall Study|Study was stopped early|26|||
131443425|NCT04531176|473252663|FG002|Overall Study|Study was stopped early|24|||
131614650|NCT02488408|473879580|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
131614651|NCT02488408|473879581|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
131614652|NCT02488408|473879582|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
131795007|NCT00130520|474532046|FG000|Overall Study|Death|1|||
131443426|NCT03253796|473252664|FG000|Period 1: Run-In|Adverse Event|4|||
131443427|NCT03253796|473252665|FG001|Period 1: Run-In|Adverse Event|0|||
131614653|NCT02488408|473879583|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
131443428|NCT03253796|473252666|FG002|Period 1: Run-In|Adverse Event|0|||
131443429|NCT03253796|473252667|FG003|Period 1: Run-In|Adverse Event|0|||
131443430|NCT03253796|473252668|FG004|Period 1: Run-In|Adverse Event|0|||
131443431|NCT03253796|473252664|FG000|Period 1: Run-In|Lack of Efficacy|1|||
131443432|NCT03253796|473252665|FG001|Period 1: Run-In|Lack of Efficacy|0|||
131443433|NCT03253796|473252666|FG002|Period 1: Run-In|Lack of Efficacy|0|||
131443434|NCT03253796|473252667|FG003|Period 1: Run-In|Lack of Efficacy|0|||
131443435|NCT03253796|473252668|FG004|Period 1: Run-In|Lack of Efficacy|0|||
131443436|NCT03253796|473252664|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
131443437|NCT03253796|473252665|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
131443438|NCT03253796|473252666|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
131443439|NCT03253796|473252667|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
131614654|NCT02488408|473879584|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
131795008|NCT00130520|474532046|FG000|Overall Study|Physician Decision|1|||
131443440|NCT03253796|473252668|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
131614655|NCT02488408|473879585|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
131614656|NCT02488408|473879576|FG000|Part A|Investigator Decision|0|||
131614657|NCT02488408|473879577|FG001|Part A|Investigator Decision|1|||
131614658|NCT02488408|473879578|FG002|Part A|Investigator Decision|1|||
131614659|NCT02488408|473879579|FG003|Part A|Investigator Decision|0|||
131614660|NCT02488408|473879580|FG004|Part A|Investigator Decision|0|||
131614661|NCT02488408|473879581|FG005|Part A|Investigator Decision|0|||
131614662|NCT02488408|473879582|FG006|Part A|Investigator Decision|0|||
131614663|NCT02488408|473879583|FG007|Part A|Investigator Decision|0|||
131614664|NCT02488408|473879584|FG008|Part A|Investigator Decision|0|||
131614665|NCT02488408|473879585|FG009|Part A|Investigator Decision|0|||
131614666|NCT02488408|473879576|FG000|Part A|Withdrawal by Subject|0|||
131614667|NCT02488408|473879577|FG001|Part A|Withdrawal by Subject|0|||
131614668|NCT02488408|473879578|FG002|Part A|Withdrawal by Subject|2|||
131614669|NCT02488408|473879579|FG003|Part A|Withdrawal by Subject|0|||
131614670|NCT02488408|473879580|FG004|Part A|Withdrawal by Subject|0|||
131614671|NCT02488408|473879581|FG005|Part A|Withdrawal by Subject|0|||
131614672|NCT02488408|473879582|FG006|Part A|Withdrawal by Subject|0|||
131614673|NCT02488408|473879583|FG007|Part A|Withdrawal by Subject|0|||
131614674|NCT02488408|473879584|FG008|Part A|Withdrawal by Subject|0|||
131614675|NCT02488408|473879585|FG009|Part A|Withdrawal by Subject|0|||
131614676|NCT02488408|473879576|FG000|Part A|Other|1|||
131795009|NCT00130520|474532046|FG000|Overall Study|Withdrawal by Subject|1|||
131795010|NCT00130520|474532046|FG000|Overall Study|Disease Progression|23|||
131795011|NCT00130520|474532046|FG000|Overall Study|Protocol non-compliance|1|||
131795012|NCT00130520|474532046|FG000|Overall Study|Did not meet re-treatment criteria|1|||
131795013|NCT02295774|474532047|FG000|Overall Study|Physician Decision|1|||
131795014|NCT02295774|474532047|FG000|Overall Study|Withdrawal by Subject|2|||
131795015|NCT00718159|474532050|FG000|Overall Study|Progressive Disease|3|||
131795016|NCT00718159|474532051|FG001|Overall Study|Progressive Disease|3|||
131795017|NCT00718159|474532052|FG002|Overall Study|Progressive Disease|2|||
131795018|NCT00718159|474532053|FG003|Overall Study|Progressive Disease|0|||
131900847|NCT01051557|474923477|FG001|Overall Study|disease progression|3|||
131614677|NCT02488408|473879577|FG001|Part A|Other|0|||
131614678|NCT02488408|473879578|FG002|Part A|Other|0|||
131614679|NCT02488408|473879579|FG003|Part A|Other|0|||
131614680|NCT02488408|473879580|FG004|Part A|Other|0|||
131614681|NCT02488408|473879581|FG005|Part A|Other|0|||
131614682|NCT02488408|473879582|FG006|Part A|Other|0|||
131614683|NCT02488408|473879583|FG007|Part A|Other|0|||
131614684|NCT02488408|473879584|FG008|Part A|Other|0|||
131795019|NCT00718159|474532054|FG004|Overall Study|Progressive Disease|6|||
131900848|NCT01051557|474923478|FG002|Overall Study|disease progression|5|||
131900849|NCT01051557|474923479|FG003|Overall Study|disease progression|2|||
131900850|NCT01051557|474923480|FG004|Overall Study|disease progression|4|||
131900851|NCT01051557|474923481|FG005|Overall Study|disease progression|3|||
131900852|NCT01051557|474923482|FG006|Overall Study|disease progression|1|||
131900853|NCT01051557|474923476|FG000|Overall Study|Withdrawal by Subject|0|||
131900854|NCT01051557|474923477|FG001|Overall Study|Withdrawal by Subject|0|||
131900855|NCT01051557|474923478|FG002|Overall Study|Withdrawal by Subject|1|||
131900856|NCT01051557|474923479|FG003|Overall Study|Withdrawal by Subject|0|||
131900857|NCT01051557|474923480|FG004|Overall Study|Withdrawal by Subject|2|||
131900858|NCT01051557|474923481|FG005|Overall Study|Withdrawal by Subject|0|||
131900859|NCT01051557|474923482|FG006|Overall Study|Withdrawal by Subject|1|||
131900860|NCT01051557|474923476|FG000|Overall Study|Adverse Event|0|||
131900861|NCT01051557|474923477|FG001|Overall Study|Adverse Event|0|||
131900862|NCT01051557|474923478|FG002|Overall Study|Adverse Event|0|||
131900863|NCT01051557|474923479|FG003|Overall Study|Adverse Event|1|||
131900864|NCT01051557|474923480|FG004|Overall Study|Adverse Event|1|||
131443441|NCT03253796|473252664|FG000|Period 1: Run-In|Protocol Violation|5|||
131443442|NCT03253796|473252665|FG001|Period 1: Run-In|Protocol Violation|0|||
131443443|NCT03253796|473252666|FG002|Period 1: Run-In|Protocol Violation|0|||
131614685|NCT02488408|473879585|FG009|Part A|Other|0|||
131614686|NCT02488408|473879576|FG000|Part B|Adverse Event|0|||
131900865|NCT01051557|474923481|FG005|Overall Study|Adverse Event|3|||
131614687|NCT02488408|473879577|FG001|Part B|Adverse Event|0|||
131900866|NCT01051557|474923482|FG006|Overall Study|Adverse Event|4|||
131900867|NCT04110314|474923484|FG000|Overall Study|Did not meet inclusion criteria|35255|||
131614688|NCT02488408|473879578|FG002|Part B|Adverse Event|0|||
131614689|NCT02488408|473879579|FG003|Part B|Adverse Event|0|||
131443444|NCT03253796|473252667|FG003|Period 1: Run-In|Protocol Violation|0|||
131614690|NCT02488408|473879580|FG004|Part B|Adverse Event|0|||
131614691|NCT02488408|473879581|FG005|Part B|Adverse Event|2|||
131614692|NCT02488408|473879582|FG006|Part B|Adverse Event|2|||
131614693|NCT02488408|473879583|FG007|Part B|Adverse Event|7|||
131614694|NCT02488408|473879584|FG008|Part B|Adverse Event|2|||
131614695|NCT02488408|473879585|FG009|Part B|Adverse Event|2|||
131614696|NCT02488408|473879576|FG000|Part B|Death|0|||
131795020|NCT00718159|474532055|FG005|Overall Study|Progressive Disease|0|||
131795021|NCT00718159|474532056|FG006|Overall Study|Progressive Disease|0|||
131795022|NCT00718159|474532050|FG000|Overall Study|Death due to Adverse Event|0|||
131795023|NCT00718159|474532051|FG001|Overall Study|Death due to Adverse Event|0|||
131795024|NCT00718159|474532052|FG002|Overall Study|Death due to Adverse Event|0|||
131795025|NCT00718159|474532053|FG003|Overall Study|Death due to Adverse Event|2|||
131795026|NCT00718159|474532054|FG004|Overall Study|Death due to Adverse Event|2|||
131795027|NCT00718159|474532055|FG005|Overall Study|Death due to Adverse Event|0|||
131795028|NCT00718159|474532056|FG006|Overall Study|Death due to Adverse Event|0|||
131795029|NCT00718159|474532050|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
131795030|NCT00718159|474532051|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
131795031|NCT00718159|474532052|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
131795032|NCT00718159|474532053|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
131795033|NCT00718159|474532054|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
131795034|NCT00718159|474532055|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
131795035|NCT00718159|474532056|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
131795036|NCT00718159|474532050|FG000|Overall Study|Investigator Decision|0|||
131795037|NCT00718159|474532051|FG001|Overall Study|Investigator Decision|0|||
131795038|NCT00718159|474532052|FG002|Overall Study|Investigator Decision|0|||
131795039|NCT00718159|474532053|FG003|Overall Study|Investigator Decision|0|||
131795040|NCT00718159|474532054|FG004|Overall Study|Investigator Decision|0|||
131795041|NCT00718159|474532055|FG005|Overall Study|Investigator Decision|1|||
131795042|NCT00718159|474532056|FG006|Overall Study|Investigator Decision|1|||
131795043|NCT01238848|474532058|FG000|Overall Study|Physician Decision|13|||
131795044|NCT01238848|474532059|FG001|Overall Study|Physician Decision|5|||
131795045|NCT00576901|474532060|FG000|Overall Study|Withdrawal by Subject|1|||
131795046|NCT00576901|474532060|FG000|Overall Study|Disease course|1|||
131795047|NCT00576901|474532060|FG000|Overall Study|Protocol Violation|1|||
131795048|NCT01755858|474532063|FG000|Overall Study|Adverse Event|1|||
131795049|NCT01755858|474532064|FG001|Overall Study|Adverse Event|1|||
131795050|NCT02398188|474532065|FG000|Overall Study|Adverse Event|2|||
131795051|NCT02398188|474532066|FG001|Overall Study|Adverse Event|3|||
131795052|NCT02398188|474532065|FG000|Overall Study|Lost to Follow-up|5|||
131795053|NCT02398188|474532066|FG001|Overall Study|Lost to Follow-up|0|||
131443445|NCT03253796|473252668|FG004|Period 1: Run-In|Protocol Violation|0|||
131795054|NCT02398188|474532065|FG000|Overall Study|Non-compliance|4|||
131795055|NCT02398188|474532066|FG001|Overall Study|Non-compliance|4|||
131795056|NCT02398188|474532065|FG000|Overall Study|Protocol Violation|6|||
131795057|NCT02398188|474532066|FG001|Overall Study|Protocol Violation|10|||
131795058|NCT02398188|474532065|FG000|Overall Study|Sponsor Decision|2|||
131795059|NCT02398188|474532066|FG001|Overall Study|Sponsor Decision|1|||
131795060|NCT02398188|474532065|FG000|Overall Study|Pregnancy|1|||
131795061|NCT02398188|474532066|FG001|Overall Study|Pregnancy|0|||
131804447|NCT02178722|474568532|FG003|Overall Study|Death|12|||
131804448|NCT02178722|474568533|FG004|Overall Study|Death|205|||
131804449|NCT02178722|474568529|FG000|Overall Study|Lost to Follow-up|0|||
131804450|NCT02178722|474568530|FG001|Overall Study|Lost to Follow-up|0|||
131804451|NCT02178722|474568531|FG002|Overall Study|Lost to Follow-up|0|||
131804452|NCT02178722|474568532|FG003|Overall Study|Lost to Follow-up|2|||
131804453|NCT02178722|474568533|FG004|Overall Study|Lost to Follow-up|11|||
131804454|NCT02178722|474568529|FG000|Overall Study|Study terminated by Sponsor|2|||
131804455|NCT02178722|474568530|FG001|Overall Study|Study terminated by Sponsor|7|||
131804456|NCT02178722|474568531|FG002|Overall Study|Study terminated by Sponsor|6|||
131804457|NCT02178722|474568532|FG003|Overall Study|Study terminated by Sponsor|4|||
131804458|NCT02178722|474568533|FG004|Overall Study|Study terminated by Sponsor|128|||
131804459|NCT02178722|474568529|FG000|Overall Study|Physician Decision|0|||
131804460|NCT02178722|474568530|FG001|Overall Study|Physician Decision|0|||
131804461|NCT02178722|474568531|FG002|Overall Study|Physician Decision|0|||
131804462|NCT02178722|474568532|FG003|Overall Study|Physician Decision|0|||
131804463|NCT02178722|474568533|FG004|Overall Study|Physician Decision|3|||
131804464|NCT02178722|474568529|FG000|Overall Study|Other|0|||
131804465|NCT02178722|474568530|FG001|Overall Study|Other|0|||
131804466|NCT02178722|474568531|FG002|Overall Study|Other|0|||
131804467|NCT02178722|474568532|FG003|Overall Study|Other|0|||
131804468|NCT02178722|474568533|FG004|Overall Study|Other|2|||
131804469|NCT01572948|474568534|FG000|Overall Study|Lost to Follow-up|1|||
131804470|NCT01572948|474568535|FG001|Overall Study|Lost to Follow-up|0|||
131804471|NCT01572948|474568534|FG000|Overall Study|unable to contact|0|||
131804472|NCT01572948|474568535|FG001|Overall Study|unable to contact|1|||
131804473|NCT03553823|474568536|FG000|Overall Study|Physician Decision|0|||
131804474|NCT03553823|474568537|FG001|Overall Study|Physician Decision|1|||
131804475|NCT03340727|474568538|FG000|Overall Study|Death|1|||
131804476|NCT03340727|474568539|FG001|Overall Study|Death|0|||
131804477|NCT03340727|474568538|FG000|Overall Study|Lost to Follow-up|31|||
131804478|NCT03340727|474568539|FG001|Overall Study|Lost to Follow-up|35|||
131804479|NCT03340727|474568538|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
131804480|NCT03340727|474568539|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
131804481|NCT03340727|474568538|FG000|Overall Study|Transferred to another facility|10|||
131804482|NCT03340727|474568539|FG001|Overall Study|Transferred to another facility|7|||
131804483|NCT03340727|474568538|FG000|Overall Study|Withdrawal by Subject|28|||
131795062|NCT02398188|474532065|FG000|Overall Study|Withdrawal by Subject|7|||
131795063|NCT02398188|474532066|FG001|Overall Study|Withdrawal by Subject|16|||
131795064|NCT00782509|474532067|FG000|Overall Study|Adverse Event|20|||
131795065|NCT00782509|474532068|FG001|Overall Study|Adverse Event|10|||
131795066|NCT00782509|474532069|FG002|Overall Study|Adverse Event|20|||
131795067|NCT00782509|474532067|FG000|Overall Study|Lost to Follow-up|1|||
131795068|NCT00782509|474532068|FG001|Overall Study|Lost to Follow-up|2|||
131795069|NCT00782509|474532069|FG002|Overall Study|Lost to Follow-up|3|||
131795070|NCT00782509|474532067|FG000|Overall Study|Withdrawal by Subject|3|||
131795071|NCT00782509|474532068|FG001|Overall Study|Withdrawal by Subject|5|||
131795072|NCT00782509|474532069|FG002|Overall Study|Withdrawal by Subject|8|||
131795073|NCT00782509|474532067|FG000|Overall Study|Non compliance with protocol|2|||
131795074|NCT00782509|474532068|FG001|Overall Study|Non compliance with protocol|0|||
131795075|NCT00782509|474532069|FG002|Overall Study|Non compliance with protocol|0|||
131795076|NCT00782509|474532067|FG000|Overall Study|Other reasons not stated above|5|||
131795077|NCT00782509|474532068|FG001|Overall Study|Other reasons not stated above|2|||
131795078|NCT00782509|474532069|FG002|Overall Study|Other reasons not stated above|3|||
131795079|NCT00782509|474532067|FG000|Overall Study|Lack of Efficacy|10|||
131795080|NCT00782509|474532068|FG001|Overall Study|Lack of Efficacy|5|||
131795081|NCT00782509|474532069|FG002|Overall Study|Lack of Efficacy|2|||
131795082|NCT01259869|474532071|FG000|Overall Study|Duplicated registration|1|||
131795083|NCT00175019|474532072|FG000|Overall Study|Adverse Event|54|||
131795084|NCT00175019|474532073|FG001|Overall Study|Adverse Event|22|||
131795085|NCT00175019|474532074|FG002|Overall Study|Adverse Event|2|||
131795086|NCT00175019|474532072|FG000|Overall Study|Protocol Violation|6|||
131795087|NCT00175019|474532073|FG001|Overall Study|Protocol Violation|3|||
131795088|NCT00175019|474532074|FG002|Overall Study|Protocol Violation|3|||
131795089|NCT00175019|474532072|FG000|Overall Study|Lost to Follow-up|42|||
131795090|NCT00175019|474532073|FG001|Overall Study|Lost to Follow-up|39|||
131795091|NCT00175019|474532074|FG002|Overall Study|Lost to Follow-up|9|||
131795092|NCT00175019|474532072|FG000|Overall Study|Did not continue under Amendment 4|1|||
131795093|NCT00175019|474532073|FG001|Overall Study|Did not continue under Amendment 4|1|||
131795094|NCT00175019|474532074|FG002|Overall Study|Did not continue under Amendment 4|2|||
131795095|NCT00175019|474532072|FG000|Overall Study|Personal Reason(s)|39|||
131795096|NCT00175019|474532073|FG001|Overall Study|Personal Reason(s)|31|||
131795097|NCT00175019|474532074|FG002|Overall Study|Personal Reason(s)|8|||
131795098|NCT00175019|474532072|FG000|Overall Study|Therapeutic Failure|10|||
131795099|NCT00175019|474532073|FG001|Overall Study|Therapeutic Failure|38|||
131795100|NCT00175019|474532074|FG002|Overall Study|Therapeutic Failure|22|||
131795101|NCT00175019|474532072|FG000|Overall Study|Gout Flare|2|||
131795102|NCT00175019|474532073|FG001|Overall Study|Gout Flare|3|||
131900868|NCT04110314|474923485|FG001|Overall Study|Did not meet inclusion criteria|35104|||
131900869|NCT04110314|474923486|FG002|Overall Study|Did not meet inclusion criteria|35636|||
131900870|NCT04110314|474923487|FG003|Overall Study|Did not meet inclusion criteria|35135|||
131900871|NCT04110314|474923488|FG004|Overall Study|Did not meet inclusion criteria|35247|||
131900872|NCT04110314|474923489|FG005|Overall Study|Did not meet inclusion criteria|35727|||
131900873|NCT01711983|474923496|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
131900874|NCT01711983|474923496|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
131900875|NCT01711983|474923496|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
131900876|NCT01711983|474923496|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
131900877|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131614697|NCT02488408|473879577|FG001|Part B|Death|0|||
131795103|NCT00175019|474532074|FG002|Overall Study|Gout Flare|0|||
131795104|NCT00175019|474532072|FG000|Overall Study|Reason Not Specified|40|||
131795105|NCT00175019|474532073|FG001|Overall Study|Reason Not Specified|34|||
131795106|NCT00175019|474532074|FG002|Overall Study|Reason Not Specified|11|||
131795107|NCT03209570|474532079|FG000|Overall Study|Death|1|||
131795108|NCT03209570|474532080|FG001|Overall Study|Death|0|||
131795109|NCT03209570|474532079|FG000|Overall Study|Incomplete Data|8|||
131795110|NCT03209570|474532080|FG001|Overall Study|Incomplete Data|10|||
131795111|NCT03209570|474532079|FG000|Overall Study|Protocol Violation|1|||
131795112|NCT03209570|474532080|FG001|Overall Study|Protocol Violation|0|||
131709014|NCT04025632|474215534|FG001|Overall Study|Withdrawal by Subject|1|||
131709015|NCT04025632|474215533|FG000|Overall Study|Study Terminated by Sponsor|10|||
131709016|NCT04025632|474215534|FG001|Overall Study|Study Terminated by Sponsor|9|||
131709017|NCT04025632|474215533|FG000|Overall Study|Physician Decision|3|||
131709018|NCT04025632|474215534|FG001|Overall Study|Physician Decision|1|||
131709019|NCT01793792|474215539|FG000|Overall Study|Death|5|||
131709020|NCT01793792|474215539|FG000|Overall Study|Lost to Follow-up|5|||
131709021|NCT01793792|474215539|FG000|Overall Study|Withdrawal by Subject|1|||
131709022|NCT01793792|474215539|FG000|Overall Study|Device Not Implanted|1|||
131795113|NCT03209570|474532079|FG000|Overall Study|Withdrawal by Subject|0|||
131795114|NCT03209570|474532080|FG001|Overall Study|Withdrawal by Subject|3|||
131709023|NCT01524991|474215540|FG000|Overall Study|Adverse Event|12|||
131709024|NCT01524991|474215540|FG000|Overall Study|Death|1|||
131709025|NCT01524991|474215540|FG000|Overall Study|Disease ProgressionDu|17|||
131709026|NCT01524991|474215540|FG000|Overall Study|Other complicating disease|1|||
131709027|NCT01524991|474215540|FG000|Overall Study|Withdrawal by Subject|2|||
131709028|NCT01524991|474215540|FG000|Overall Study|Symptomatic Deterioration|1|||
131795115|NCT00220701|474532091|FG000|Overall Study|Lost to Follow-up|5|||
131443446|NCT03253796|473252664|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
131443447|NCT03253796|473252665|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
131443448|NCT03253796|473252666|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
131443449|NCT03253796|473252667|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
131443450|NCT03253796|473252668|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
131443451|NCT03253796|473252664|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
131443452|NCT03253796|473252665|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
131443453|NCT03253796|473252666|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
131443454|NCT03253796|473252667|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
131443455|NCT03253796|473252668|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
131443456|NCT03253796|473252664|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
131443457|NCT03253796|473252665|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
131443458|NCT03253796|473252666|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
131443459|NCT03253796|473252667|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
131443460|NCT03253796|473252668|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
131443461|NCT03253796|473252664|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
131443462|NCT03253796|473252665|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
131443463|NCT03253796|473252666|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
131443464|NCT03253796|473252667|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
131900878|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
131900879|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
131900880|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900881|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900882|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900883|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900884|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900885|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131443465|NCT03253796|473252668|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
131443466|NCT03253796|473252664|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
131443467|NCT03253796|473252665|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
131443468|NCT03253796|473252666|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
131443469|NCT03253796|473252667|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
131443470|NCT03253796|473252668|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
131443471|NCT03253796|473252664|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
131443472|NCT03253796|473252665|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
131443473|NCT03253796|473252666|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
131443474|NCT03253796|473252667|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
131443475|NCT03253796|473252668|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
131443476|NCT03253796|473252664|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
131443477|NCT03253796|473252665|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
131443478|NCT03253796|473252666|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
131443479|NCT03253796|473252667|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
131443480|NCT03253796|473252668|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
131443481|NCT00528112|473252669|FG000|Treatment up to 3 Years|Adverse Event|313|||
131443482|NCT00528112|473252670|FG001|Treatment up to 3 Years|Adverse Event|278|||
131443483|NCT00528112|473252669|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
131443484|NCT00528112|473252670|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
131443485|NCT00528112|473252669|FG000|Treatment up to 3 Years|Protocol Violation|16|||
131900886|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900887|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900888|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131614698|NCT02488408|473879578|FG002|Part B|Death|0|||
131614699|NCT02488408|473879579|FG003|Part B|Death|0|||
131614700|NCT02488408|473879580|FG004|Part B|Death|0|||
131614701|NCT02488408|473879581|FG005|Part B|Death|3|||
131614702|NCT02488408|473879582|FG006|Part B|Death|1|||
131614703|NCT02488408|473879583|FG007|Part B|Death|2|||
131614704|NCT02488408|473879584|FG008|Part B|Death|2|||
131614705|NCT02488408|473879585|FG009|Part B|Death|2|||
131614706|NCT02488408|473879576|FG000|Part B|Death due to Disease Progression|0|||
131614707|NCT02488408|473879577|FG001|Part B|Death due to Disease Progression|0|||
131614708|NCT02488408|473879578|FG002|Part B|Death due to Disease Progression|0|||
131614709|NCT02488408|473879579|FG003|Part B|Death due to Disease Progression|0|||
131614710|NCT02488408|473879580|FG004|Part B|Death due to Disease Progression|0|||
131614711|NCT02488408|473879581|FG005|Part B|Death due to Disease Progression|2|||
131614712|NCT02488408|473879582|FG006|Part B|Death due to Disease Progression|2|||
131614713|NCT02488408|473879583|FG007|Part B|Death due to Disease Progression|1|||
131614714|NCT02488408|473879584|FG008|Part B|Death due to Disease Progression|1|||
131614715|NCT02488408|473879585|FG009|Part B|Death due to Disease Progression|1|||
131614716|NCT02488408|473879576|FG000|Part B|Disease Progression|0|||
131614717|NCT02488408|473879577|FG001|Part B|Disease Progression|0|||
131614718|NCT02488408|473879578|FG002|Part B|Disease Progression|0|||
131614719|NCT02488408|473879579|FG003|Part B|Disease Progression|0|||
131614720|NCT02488408|473879580|FG004|Part B|Disease Progression|0|||
131614721|NCT02488408|473879581|FG005|Part B|Disease Progression|6|||
131614722|NCT02488408|473879582|FG006|Part B|Disease Progression|9|||
131614723|NCT02488408|473879583|FG007|Part B|Disease Progression|7|||
131614724|NCT02488408|473879584|FG008|Part B|Disease Progression|9|||
131614725|NCT02488408|473879585|FG009|Part B|Disease Progression|11|||
131614726|NCT02488408|473879576|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
131614727|NCT02488408|473879577|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
131614728|NCT02488408|473879578|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
131614729|NCT02488408|473879579|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
131614730|NCT02488408|473879580|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
131614731|NCT02488408|473879581|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
131614732|NCT02488408|473879582|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
131614733|NCT02488408|473879583|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
131614734|NCT02488408|473879584|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
131614735|NCT02488408|473879585|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
131614736|NCT02488408|473879576|FG000|Part B|Investigator Decision|0|||
131614737|NCT02488408|473879577|FG001|Part B|Investigator Decision|0|||
131614738|NCT02488408|473879578|FG002|Part B|Investigator Decision|0|||
131614739|NCT02488408|473879579|FG003|Part B|Investigator Decision|0|||
131614740|NCT02488408|473879580|FG004|Part B|Investigator Decision|0|||
131614741|NCT02488408|473879581|FG005|Part B|Investigator Decision|0|||
131614742|NCT02488408|473879582|FG006|Part B|Investigator Decision|1|||
131614743|NCT02488408|473879583|FG007|Part B|Investigator Decision|0|||
131614744|NCT02488408|473879584|FG008|Part B|Investigator Decision|2|||
131614745|NCT02488408|473879585|FG009|Part B|Investigator Decision|1|||
131614746|NCT03664804|473879588|FG000|Overall Study|Withdrawal by Subject|7|||
131614747|NCT04701203|473879589|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
131614748|NCT04701203|473879590|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
131614749|NCT04701203|473879591|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
131614750|NCT04701203|473879589|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
131614751|NCT04701203|473879590|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
131614752|NCT04701203|473879591|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
131614753|NCT04701203|473879589|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
131614754|NCT04701203|473879590|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
131614755|NCT04701203|473879591|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
131614756|NCT04701203|473879589|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
131614757|NCT04701203|473879590|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
131614758|NCT04701203|473879591|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
131614759|NCT06140290|473879593|FG000|Period 1|Adverse Event|1|||
131614760|NCT06140290|473879594|FG001|Period 1|Adverse Event|0|||
131614761|NCT06140290|473879593|FG000|Period 2|Assigned but not treated|0|||
131614762|NCT06140290|473879594|FG001|Period 2|Assigned but not treated|1|||
131614763|NCT06140290|473879593|FG000|Period 2|Withdrawal by Subject|0|||
131614764|NCT06140290|473879594|FG001|Period 2|Withdrawal by Subject|1|||
131614765|NCT03352713|473880686|FG000|Overall Study|Lost to Follow-up|8|||
131614766|NCT03352713|473880686|FG000|Overall Study|Withdrawn by investigator|5|||
131614767|NCT03352713|473880686|FG000|Overall Study|Completed 0 EMAs|8|||
131614768|NCT03352713|473880686|FG000|Overall Study|Device incompatible/stolen|5|||
131614769|NCT00360269|473880687|FG000|Overall Study|Lost to Follow-up|7|||
131614770|NCT00360269|473880688|FG001|Overall Study|Lost to Follow-up|9|||
131614771|NCT00360269|473880687|FG000|Overall Study|Physician Decision|1|||
131614772|NCT00360269|473880688|FG001|Overall Study|Physician Decision|2|||
131614773|NCT00360269|473880687|FG000|Overall Study|Adverse Event|1|||
131614774|NCT00360269|473880688|FG001|Overall Study|Adverse Event|0|||
131614775|NCT00360269|473880687|FG000|Overall Study|Withdrawal by Subject|1|||
131614776|NCT00360269|473880688|FG001|Overall Study|Withdrawal by Subject|1|||
131614777|NCT03002194|473880689|FG000|Overall Study|Lost to Follow-up|6|||
131614778|NCT03002194|473880689|FG000|Overall Study|Adverse Event|1|||
131614779|NCT03002194|473880689|FG000|Overall Study|Lack of Efficacy|1|||
131614780|NCT03002194|473880689|FG000|Overall Study|Withdrawal by Subject|2|||
131614781|NCT00048932|473880692|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
131614782|NCT00048932|473880693|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
131614783|NCT00048932|473880694|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
131795116|NCT00220701|474532092|FG001|Overall Study|Lost to Follow-up|4|||
131614784|NCT00048932|473880692|FG000|Double Blind Period (DB)|Adverse Event|51|||
131614785|NCT00048932|473880693|FG001|Double Blind Period (DB)|Adverse Event|19|||
131614786|NCT00048932|473880694|FG002|Double Blind Period (DB)|Adverse Event|0|||
131614787|NCT00048932|473880692|FG000|Double Blind Period (DB)|Death|5|||
131614788|NCT00048932|473880693|FG001|Double Blind Period (DB)|Death|3|||
131614789|NCT00048932|473880694|FG002|Double Blind Period (DB)|Death|0|||
131614790|NCT00048932|473880692|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
131614791|NCT00048932|473880693|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
131614792|NCT00048932|473880694|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
131614793|NCT00048932|473880692|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
131614794|NCT00048932|473880693|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
131614795|NCT00048932|473880694|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
131614796|NCT00048932|473880692|FG000|Double Blind Period (DB)|Relocation|1|||
131614797|NCT00048932|473880693|FG001|Double Blind Period (DB)|Relocation|0|||
131614798|NCT00048932|473880694|FG002|Double Blind Period (DB)|Relocation|0|||
131614799|NCT00048932|473880692|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
131614800|NCT00048932|473880693|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
131614801|NCT00048932|473880694|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
131614802|NCT00048932|473880692|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
131614803|NCT00048932|473880693|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
131614804|NCT00048932|473880694|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
131614805|NCT00048932|473880692|FG000|Double Blind Period (DB)|Pregnancy|1|||
131614806|NCT00048932|473880693|FG001|Double Blind Period (DB)|Pregnancy|0|||
131614807|NCT00048932|473880694|FG002|Double Blind Period (DB)|Pregnancy|0|||
131614808|NCT00048932|473880692|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
131614809|NCT00048932|473880693|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
131614810|NCT00048932|473880694|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
131614811|NCT00048932|473880692|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
131614812|NCT00048932|473880693|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
131614813|NCT00048932|473880694|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
131614814|NCT00048932|473880692|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
131614815|NCT00048932|473880693|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
131614816|NCT00048932|473880694|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
131614817|NCT00048932|473880692|FG000|Open Label Period (OL)|Death|0|||
131614818|NCT00048932|473880693|FG001|Open Label Period (OL)|Death|0|||
131614819|NCT00048932|473880694|FG002|Open Label Period (OL)|Death|25|||
131614820|NCT00048932|473880692|FG000|Open Label Period (OL)|Adverse Event|0|||
131614821|NCT00048932|473880693|FG001|Open Label Period (OL)|Adverse Event|0|||
131614822|NCT00048932|473880694|FG002|Open Label Period (OL)|Adverse Event|103|||
131614823|NCT00048932|473880692|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
131614824|NCT00048932|473880693|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
131614825|NCT00048932|473880694|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
131614826|NCT00048932|473880692|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
131614827|NCT00048932|473880693|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
131614828|NCT00048932|473880694|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
131614829|NCT00048932|473880692|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
131614830|NCT00048932|473880693|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
131614831|NCT00048932|473880694|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
131614832|NCT00048932|473880692|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
131614833|NCT00048932|473880693|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
131614834|NCT00048932|473880694|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
131614835|NCT00048932|473880692|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
131614836|NCT00048932|473880693|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
131614837|NCT00048932|473880694|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
131614838|NCT00048932|473880692|FG000|Open Label Period (OL)|Pregnancy|0|||
131614839|NCT00048932|473880693|FG001|Open Label Period (OL)|Pregnancy|0|||
131614840|NCT00048932|473880694|FG002|Open Label Period (OL)|Pregnancy|6|||
131614841|NCT00048932|473880692|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
131614842|NCT00048932|473880693|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
131614843|NCT00048932|473880694|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
131614844|NCT00048932|473880692|FG000|Open Label Period (OL)|Investigator Retiring|0|||
131614845|NCT00048932|473880693|FG001|Open Label Period (OL)|Investigator Retiring|0|||
131614846|NCT00048932|473880694|FG002|Open Label Period (OL)|Investigator Retiring|2|||
131614847|NCT00048932|473880692|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
131614848|NCT00048932|473880693|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
131614849|NCT00048932|473880694|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
131614850|NCT00048932|473880692|FG000|Open Label Period (OL)|Participant Relocated|0|||
131614851|NCT00048932|473880693|FG001|Open Label Period (OL)|Participant Relocated|0|||
131614852|NCT00048932|473880694|FG002|Open Label Period (OL)|Participant Relocated|6|||
131614853|NCT00048932|473880692|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
131614854|NCT00048932|473880693|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
131614855|NCT00048932|473880694|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
131614856|NCT00048932|473880692|FG000|Open Label Period (OL)|Site Closure|0|||
131614857|NCT00048932|473880693|FG001|Open Label Period (OL)|Site Closure|0|||
131614858|NCT00048932|473880694|FG002|Open Label Period (OL)|Site Closure|3|||
131614859|NCT00048932|473880692|FG000|Open Label Period (OL)|Trial Terminated|0|||
131614860|NCT00048932|473880693|FG001|Open Label Period (OL)|Trial Terminated|0|||
131614861|NCT00048932|473880694|FG002|Open Label Period (OL)|Trial Terminated|1|||
131614862|NCT00048932|473880692|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
131614863|NCT00048932|473880693|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
131614864|NCT00048932|473880694|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
131614865|NCT00048932|473880692|FG000|Open Label Period (OL)|Patient Decision|0|||
131614866|NCT00048932|473880693|FG001|Open Label Period (OL)|Patient Decision|0|||
131614867|NCT00048932|473880694|FG002|Open Label Period (OL)|Patient Decision|4|||
131614868|NCT00048932|473880692|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
131614869|NCT00048932|473880693|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
131614870|NCT00048932|473880694|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
131614871|NCT00048932|473880692|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
131614872|NCT00048932|473880693|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
131614873|NCT00048932|473880694|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
131614874|NCT00048932|473880692|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
131614875|NCT00048932|473880693|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
131614876|NCT00048932|473880694|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
131614877|NCT00048932|473880692|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
131614878|NCT00048932|473880693|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
131614879|NCT00048932|473880694|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
131614880|NCT00048932|473880692|FG000|Open Label Period (OL)|Investigator Decision|0|||
131614881|NCT00048932|473880693|FG001|Open Label Period (OL)|Investigator Decision|0|||
131614882|NCT00048932|473880694|FG002|Open Label Period (OL)|Investigator Decision|4|||
131614883|NCT00048932|473880692|FG000|Open Label Period (OL)|Site Staff Issues|0|||
131614884|NCT00048932|473880693|FG001|Open Label Period (OL)|Site Staff Issues|0|||
131614885|NCT00048932|473880694|FG002|Open Label Period (OL)|Site Staff Issues|2|||
131614886|NCT00048932|473880692|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
131614887|NCT00048932|473880693|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
131614888|NCT00048932|473880694|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
131614889|NCT00048932|473880692|FG000|Open Label Period (OL)|Participant Surgery|0|||
131614890|NCT00048932|473880693|FG001|Open Label Period (OL)|Participant Surgery|0|||
131614891|NCT00048932|473880694|FG002|Open Label Period (OL)|Participant Surgery|1|||
131614892|NCT02232737|473880695|FG000|Overall Study|Lost to Follow-up|18|||
131614893|NCT02232737|473880696|FG001|Overall Study|Lost to Follow-up|28|||
131614894|NCT02232737|473880697|FG002|Overall Study|Lost to Follow-up|33|||
131614895|NCT02232737|473880695|FG000|Overall Study|Personal reasons|7|||
131614896|NCT02232737|473880696|FG001|Overall Study|Personal reasons|8|||
131614897|NCT02232737|473880697|FG002|Overall Study|Personal reasons|14|||
131614898|NCT02232737|473880695|FG000|Overall Study|Adverse Event|6|||
131614899|NCT02232737|473880696|FG001|Overall Study|Adverse Event|3|||
131443486|NCT00528112|473252670|FG001|Treatment up to 3 Years|Protocol Violation|16|||
131443487|NCT00528112|473252669|FG000|Treatment up to 3 Years|Death|0|||
131443488|NCT00528112|473252670|FG001|Treatment up to 3 Years|Death|1|||
131443489|NCT00528112|473252669|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
131443490|NCT00528112|473252670|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
131443491|NCT00528112|473252669|FG000|Treatment up to 3 Years|Pregnancy|9|||
131443492|NCT00528112|473252670|FG001|Treatment up to 3 Years|Pregnancy|10|||
131443493|NCT00528112|473252669|FG000|Treatment up to 3 Years|Other reasons|186|||
131614900|NCT02232737|473880697|FG002|Overall Study|Adverse Event|8|||
131443494|NCT00528112|473252670|FG001|Treatment up to 3 Years|Other reasons|186|||
131614901|NCT02232737|473880695|FG000|Overall Study|Incarcerated|2|||
131614902|NCT02232737|473880696|FG001|Overall Study|Incarcerated|1|||
131443495|NCT00528112|473252669|FG000|Extension Phase|Withdrawal by Subject|0|||
131614903|NCT02232737|473880697|FG002|Overall Study|Incarcerated|2|||
131614904|NCT02232737|473880695|FG000|Overall Study|Withdrawal by Subject|0|||
131614905|NCT02232737|473880696|FG001|Overall Study|Withdrawal by Subject|1|||
131614906|NCT02232737|473880697|FG002|Overall Study|Withdrawal by Subject|2|||
131614907|NCT02232737|473880695|FG000|Overall Study|Death|0|||
131614908|NCT02232737|473880696|FG001|Overall Study|Death|1|||
131614909|NCT02232737|473880697|FG002|Overall Study|Death|1|||
131614910|NCT02232737|473880695|FG000|Overall Study|Physician Decision|1|||
131614911|NCT02232737|473880696|FG001|Overall Study|Physician Decision|3|||
131614912|NCT02232737|473880697|FG002|Overall Study|Physician Decision|1|||
131614913|NCT02232737|473880695|FG000|Overall Study|Protocol Violation|1|||
131614914|NCT02232737|473880696|FG001|Overall Study|Protocol Violation|0|||
131614915|NCT02232737|473880697|FG002|Overall Study|Protocol Violation|1|||
131614916|NCT02232737|473880695|FG000|Overall Study|Reason unknown|1|||
131614917|NCT02232737|473880696|FG001|Overall Study|Reason unknown|0|||
131614918|NCT02232737|473880697|FG002|Overall Study|Reason unknown|0|||
131614919|NCT04559698|473880707|FG000|Overall Study|Lost to Follow-up|14|||
131614920|NCT04559698|473880708|FG001|Overall Study|Lost to Follow-up|15|||
131614921|NCT04559698|473880707|FG000|Overall Study|Withdrawal by Subject|0|||
131614922|NCT04559698|473880708|FG001|Overall Study|Withdrawal by Subject|1|||
131614923|NCT02200705|473880709|FG000|Overall Study|Excluded|12|||
131614924|NCT02200705|473880709|FG000|Overall Study|Death|21|||
131614925|NCT02200705|473880709|FG000|Overall Study|Withdrawal by Subject|22|||
131614926|NCT02200705|473880709|FG000|Overall Study|Lost to Follow-up|13|||
131614927|NCT02200705|473880709|FG000|Overall Study|Physician Decision|5|||
131614928|NCT02200705|473880709|FG000|Overall Study|Adverse Event|2|||
131614929|NCT03437733|473880710|FG000|Overall Study|Eligibility criteria not met|0|||
131614930|NCT03437733|473880711|FG001|Overall Study|Eligibility criteria not met|3|||
131614931|NCT00754325|473880712|FG000|Initial Treatment|Continuing Active Treatment|4|||
131614932|NCT00754325|473880713|FG001|Initial Treatment|Continuing Active Treatment|5|||
131614933|NCT00754325|473880712|FG000|Initial Treatment|Adverse Event|7|||
131614934|NCT00754325|473880713|FG001|Initial Treatment|Adverse Event|6|||
131614935|NCT00754325|473880712|FG000|Initial Treatment|Withdrawal by Subject|2|||
131614936|NCT00754325|473880713|FG001|Initial Treatment|Withdrawal by Subject|2|||
131614937|NCT00754325|473880712|FG000|Initial Treatment|Physician Decision|2|||
131614938|NCT00754325|473880713|FG001|Initial Treatment|Physician Decision|0|||
131614939|NCT00754325|473880712|FG000|Initial Treatment|Sponsor Request|0|||
131614940|NCT00754325|473880713|FG001|Initial Treatment|Sponsor Request|1|||
131614941|NCT00754325|473880712|FG000|Initial Treatment|Disease Progression|35|||
131614942|NCT00754325|473880713|FG001|Initial Treatment|Disease Progression|35|||
131614943|NCT03442777|473880714|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
131795117|NCT00755326|474532094|FG000|Overall Study|Lost to Follow-up|2|||
131614944|NCT03442777|473880715|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
131614945|NCT03442777|473880716|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
131614946|NCT00439270|473880717|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
131614947|NCT00439270|473880718|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
131614948|NCT00439270|473880719|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
131614949|NCT00439270|473880720|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
131614950|NCT00439270|473880721|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
131614951|NCT00439270|473880717|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131614952|NCT00439270|473880718|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
131614953|NCT00439270|473880719|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131614954|NCT00439270|473880720|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131614955|NCT00439270|473880721|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131614956|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
131614957|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
131614958|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
131614959|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
131614960|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
131614961|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131614962|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131614963|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131614964|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
131614965|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131614966|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131614967|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131614968|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131614969|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
131614970|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131614971|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131614972|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131614973|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131614974|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
131614975|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131614976|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131614977|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131614978|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131614979|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
131614980|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131614981|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131614982|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131614983|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131614984|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
131614985|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131614986|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131614987|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131614988|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131614989|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
131614990|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131614991|NCT00439270|473880717|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131614992|NCT00439270|473880718|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131614993|NCT00439270|473880719|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131614994|NCT00439270|473880720|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
131614995|NCT00439270|473880721|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131614996|NCT04162210|473880722|FG000|Overall Study|Lost to Follow-up|4|||
131614997|NCT04162210|473880723|FG001|Overall Study|Lost to Follow-up|1|||
131614998|NCT04162210|473880722|FG000|Overall Study|Withdrawal by Subject|17|||
131614999|NCT04162210|473880723|FG001|Overall Study|Withdrawal by Subject|9|||
131615000|NCT04162210|473880722|FG000|Overall Study|Ongoing|113|||
131615001|NCT04162210|473880723|FG001|Overall Study|Ongoing|59|||
131615002|NCT01750684|473880724|FG000|Overall Study|Death|1|||
131615003|NCT01750684|473880725|FG001|Overall Study|Death|0|||
131615004|NCT01750684|473880724|FG000|Overall Study|Non-compliance with Study Drug|0|||
131615005|NCT01750684|473880725|FG001|Overall Study|Non-compliance with Study Drug|1|||
131615006|NCT01750684|473880724|FG000|Overall Study|Withdrawn by Sponsor|0|||
131615007|NCT01750684|473880725|FG001|Overall Study|Withdrawn by Sponsor|1|||
131615008|NCT01750684|473880724|FG000|Overall Study|Protocol Violation|1|||
131615009|NCT01750684|473880725|FG001|Overall Study|Protocol Violation|0|||
131615010|NCT01641900|473880726|FG000|Overall Study|Withdrawal by Subject|2|||
131615011|NCT01641900|473880727|FG001|Overall Study|Withdrawal by Subject|2|||
131615012|NCT02941549|473880728|FG000|Overall Study|Adverse Event|1|||
131795118|NCT00755326|474532095|FG001|Overall Study|Lost to Follow-up|3|||
131615013|NCT02941549|473880729|FG001|Overall Study|Adverse Event|0|||
131615014|NCT02941549|473880730|FG002|Overall Study|Adverse Event|0|||
131615015|NCT02941549|473880728|FG000|Overall Study|Withdrawal by Subject|2|||
131795119|NCT01798485|474532101|FG000|Overall Study|Adverse Event|32|||
131795120|NCT01798485|474532102|FG001|Overall Study|Adverse Event|40|||
131795121|NCT01798485|474532101|FG000|Overall Study|Withdrawal by Subject|27|||
131795122|NCT01798485|474532102|FG001|Overall Study|Withdrawal by Subject|31|||
131795123|NCT01798485|474532101|FG000|Overall Study|Lost to Follow-up|0|||
131795124|NCT01798485|474532102|FG001|Overall Study|Lost to Follow-up|3|||
131615016|NCT02941549|473880729|FG001|Overall Study|Withdrawal by Subject|1|||
131615017|NCT02941549|473880730|FG002|Overall Study|Withdrawal by Subject|2|||
131615018|NCT03451422|473880733|FG000|Overall Study|Lost to Follow-up|0|||
131615019|NCT03451422|473880734|FG001|Overall Study|Lost to Follow-up|0|||
131615020|NCT03451422|473880735|FG002|Overall Study|Lost to Follow-up|0|||
131615021|NCT03451422|473880736|FG003|Overall Study|Lost to Follow-up|0|||
131615022|NCT03451422|473880737|FG004|Overall Study|Lost to Follow-up|0|||
131615023|NCT03451422|473880738|FG005|Overall Study|Lost to Follow-up|1|||
131615024|NCT03451422|473880733|FG000|Overall Study|Decision by sponsor|1|||
131615025|NCT03451422|473880734|FG001|Overall Study|Decision by sponsor|0|||
131615026|NCT03451422|473880735|FG002|Overall Study|Decision by sponsor|1|||
131615027|NCT03451422|473880736|FG003|Overall Study|Decision by sponsor|0|||
131615028|NCT03451422|473880737|FG004|Overall Study|Decision by sponsor|0|||
131615029|NCT03451422|473880738|FG005|Overall Study|Decision by sponsor|0|||
131615030|NCT03451422|473880733|FG000|Overall Study|Withdrawal by Subject|0|||
131615031|NCT03451422|473880734|FG001|Overall Study|Withdrawal by Subject|0|||
131615032|NCT03451422|473880735|FG002|Overall Study|Withdrawal by Subject|2|||
131615033|NCT03451422|473880736|FG003|Overall Study|Withdrawal by Subject|3|||
131615034|NCT03451422|473880737|FG004|Overall Study|Withdrawal by Subject|2|||
131615035|NCT03451422|473880738|FG005|Overall Study|Withdrawal by Subject|1|||
131615036|NCT03601715|473880739|FG000|Second Intervention|Lost to Follow-up|1|||
131615037|NCT03601715|473880740|FG001|Second Intervention|Lost to Follow-up|1|||
131615038|NCT03601715|473880741|FG002|Second Intervention|Lost to Follow-up|0|||
131615039|NCT00918333|473880744|FG000|Overall Study|Drug not taken per protocol|1|||
131615040|NCT00918333|473880745|FG001|Overall Study|Drug not taken per protocol|0|||
131615041|NCT00918333|473880744|FG000|Overall Study|Inadequate amount of drugs provided|1|||
131615042|NCT00918333|473880745|FG001|Overall Study|Inadequate amount of drugs provided|4|||
131615043|NCT00918333|473880744|FG000|Overall Study|Ineligible|1|||
131615044|NCT00918333|473880745|FG001|Overall Study|Ineligible|0|||
131615045|NCT00918333|473880744|FG000|Overall Study|Withdrawal by Subject|0|||
131615046|NCT00918333|473880745|FG001|Overall Study|Withdrawal by Subject|1|||
131615047|NCT01313884|473880747|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
131615048|NCT02463448|473880748|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
131615049|NCT02463448|473880748|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
131615050|NCT02463448|473880748|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
131615051|NCT02463448|473880748|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
131615052|NCT00640159|473880749|FG000|Overall Study|Lost to Follow-up|2|||
131615053|NCT00857766|473880756|FG000|Overall Study|Adverse Event|13|||
131615054|NCT00857766|473880757|FG001|Overall Study|Adverse Event|12|||
131615055|NCT00857766|473880756|FG000|Overall Study|Protocol Violation|11|||
131615056|NCT00857766|473880757|FG001|Overall Study|Protocol Violation|11|||
131615057|NCT00857766|473880756|FG000|Overall Study|Lost to Follow-up|1|||
131615058|NCT00857766|473880757|FG001|Overall Study|Lost to Follow-up|0|||
131615059|NCT00857766|473880756|FG000|Overall Study|Investigator Discretion|2|||
131615060|NCT00857766|473880757|FG001|Overall Study|Investigator Discretion|3|||
131615061|NCT00857766|473880756|FG000|Overall Study|Participant Withdrew Consent|4|||
131615062|NCT00857766|473880757|FG001|Overall Study|Participant Withdrew Consent|4|||
131615063|NCT03631407|473880764|FG000|Overall Study|Withdrawal by Subject|3|||
131615064|NCT03631407|473880765|FG001|Overall Study|Withdrawal by Subject|2|||
131615065|NCT03631407|473880764|FG000|Overall Study|Sponsor Decision|0|||
131615066|NCT03631407|473880765|FG001|Overall Study|Sponsor Decision|2|||
131615067|NCT03631407|473880764|FG000|Overall Study|Death|16|||
131615068|NCT03631407|473880765|FG001|Overall Study|Death|16|||
131615069|NCT03631407|473880764|FG000|Overall Study|Randomized by mistake without study treatment|1|||
131615070|NCT03631407|473880765|FG001|Overall Study|Randomized by mistake without study treatment|0|||
131615071|NCT00756574|473880771|FG000|Overall Study|Withdrawal by Subject|9|||
131615072|NCT00756574|473880772|FG001|Overall Study|Withdrawal by Subject|7|||
131615073|NCT00756574|473880771|FG000|Overall Study|Lost to Follow-up|4|||
131615074|NCT00756574|473880772|FG001|Overall Study|Lost to Follow-up|4|||
131615075|NCT04795167|473880773|FG000|Overall Study|Death|1|||
131615076|NCT04795167|473880774|FG001|Overall Study|Death|18|||
131615077|NCT04795167|473880775|FG002|Overall Study|Death|1|||
131795125|NCT01798485|474532101|FG000|Overall Study|Physician Decision|14|||
131615078|NCT04795167|473880773|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
131615079|NCT04795167|473880774|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
131615080|NCT04795167|473880775|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
131615081|NCT00918203|473880781|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
131615082|NCT00918203|473880782|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
131795126|NCT01798485|474532102|FG001|Overall Study|Physician Decision|10|||
131795127|NCT01798485|474532101|FG000|Overall Study|Objective Disease Progression|152|||
131615083|NCT00918203|473880783|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
131615084|NCT00918203|473880781|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
131615085|NCT00918203|473880782|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
131615086|NCT00918203|473880783|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
131615087|NCT00918203|473880781|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
131615088|NCT00918203|473880782|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
131615089|NCT00918203|473880783|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
131615090|NCT00918203|473880781|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
131615091|NCT00918203|473880782|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
131615092|NCT00918203|473880783|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
131615093|NCT03488719|473880790|FG000|Overall Study|Adverse Event|0|||
131615094|NCT03488719|473880791|FG001|Overall Study|Adverse Event|4|||
131615095|NCT03488719|473880792|FG002|Overall Study|Adverse Event|2|||
131615096|NCT03488719|473880790|FG000|Overall Study|Other|0|||
131615097|NCT03488719|473880791|FG001|Overall Study|Other|0|||
131615098|NCT03488719|473880792|FG002|Overall Study|Other|5|||
131615099|NCT03598907|473880797|FG000|Overall Study|Physician Decision|14|||
131615100|NCT03598907|473880798|FG001|Overall Study|Physician Decision|19|||
131615101|NCT03477175|473880801|FG000|Overall Study|Unable to travel due to COVID-19|0|||
131615102|NCT03477175|473880802|FG001|Overall Study|Unable to travel due to COVID-19|1|||
131615103|NCT03477175|473880801|FG000|Overall Study|Physician Decision|1|||
131615104|NCT03477175|473880802|FG001|Overall Study|Physician Decision|0|||
131615105|NCT03477175|473880801|FG000|Overall Study|Transitioned to commercial drug|6|||
131615106|NCT03477175|473880802|FG001|Overall Study|Transitioned to commercial drug|6|||
131615107|NCT03477175|473880801|FG000|Overall Study|Lost to Follow-up|1|||
131615108|NCT03477175|473880802|FG001|Overall Study|Lost to Follow-up|1|||
131615109|NCT03477175|473880801|FG000|Overall Study|Withdrawal by Subject|3|||
131615110|NCT03477175|473880802|FG001|Overall Study|Withdrawal by Subject|1|||
131615111|NCT03477175|473880801|FG000|Overall Study|Adverse Event|1|||
131615112|NCT03477175|473880802|FG001|Overall Study|Adverse Event|5|||
131615113|NCT03477175|473880801|FG000|Overall Study|Disease Progression|7|||
131615114|NCT03477175|473880802|FG001|Overall Study|Disease Progression|7|||
131615115|NCT01675492|473880803|FG000|Overall Study|study completed early - product approval|42|||
131615116|NCT05025384|473880804|FG000|Overall Study|Physician Decision|5|||
131615117|NCT05025384|473880805|FG001|Overall Study|Physician Decision|6|||
131615118|NCT03610581|473880806|FG000|Overall Study|Study terminated by sponsor|2|||
131615119|NCT03610581|473880807|FG001|Overall Study|Study terminated by sponsor|0|||
131615120|NCT03610581|473880806|FG000|Overall Study|Other|0|||
131615121|NCT03610581|473880807|FG001|Overall Study|Other|1|||
131615122|NCT03610581|473880806|FG000|Overall Study|Withdrawal by Subject|1|||
131615123|NCT03610581|473880807|FG001|Overall Study|Withdrawal by Subject|0|||
131615124|NCT04306367|473880812|FG000|Overall Study|Progression of Disease|9|||
131615125|NCT04306367|473880812|FG000|Overall Study|Adverse Event|3|||
131615126|NCT04306367|473880812|FG000|Overall Study|Withdrawal by Subject|1|||
131615127|NCT05886777|473880817|FG000|Overall Study|Lost to Follow-up|1|||
131615128|NCT05886777|473880818|FG001|Overall Study|Lost to Follow-up|0|||
131615129|NCT05886777|473880819|FG002|Overall Study|Lost to Follow-up|2|||
131615130|NCT05886777|473880820|FG003|Overall Study|Lost to Follow-up|1|||
131615131|NCT05886777|473880821|FG004|Overall Study|Lost to Follow-up|0|||
131615132|NCT05886777|473880822|FG005|Overall Study|Lost to Follow-up|2|||
131615133|NCT05886777|473880823|FG006|Overall Study|Lost to Follow-up|0|||
131615134|NCT05886777|473880817|FG000|Overall Study|Other|0|||
131615135|NCT05886777|473880818|FG001|Overall Study|Other|2|||
131795128|NCT01798485|474532102|FG001|Overall Study|Objective Disease Progression|106|||
131795129|NCT01798485|474532101|FG000|Overall Study|Death|25|||
131795130|NCT01798485|474532102|FG001|Overall Study|Death|22|||
131795131|NCT01798485|474532101|FG000|Overall Study|Sponsor Decision|61|||
131795132|NCT01798485|474532102|FG001|Overall Study|Sponsor Decision|54|||
131615136|NCT05886777|473880819|FG002|Overall Study|Other|1|||
131795133|NCT01798485|474532101|FG000|Overall Study|Clinical Progression|35|||
131615137|NCT05886777|473880820|FG003|Overall Study|Other|0|||
131615138|NCT05886777|473880821|FG004|Overall Study|Other|0|||
131615139|NCT05886777|473880822|FG005|Overall Study|Other|0|||
131615140|NCT05886777|473880823|FG006|Overall Study|Other|0|||
131615141|NCT05886777|473880817|FG000|Overall Study|Withdrawal by Subject|1|||
131615142|NCT05886777|473880818|FG001|Overall Study|Withdrawal by Subject|0|||
131615143|NCT05886777|473880819|FG002|Overall Study|Withdrawal by Subject|1|||
131615144|NCT05886777|473880820|FG003|Overall Study|Withdrawal by Subject|4|||
131615145|NCT05886777|473880821|FG004|Overall Study|Withdrawal by Subject|3|||
131615146|NCT05886777|473880822|FG005|Overall Study|Withdrawal by Subject|1|||
131615147|NCT05886777|473880823|FG006|Overall Study|Withdrawal by Subject|1|||
131615148|NCT05886777|473880817|FG000|Overall Study|Protocol Violation|0|||
131795134|NCT01798485|474532102|FG001|Overall Study|Clinical Progression|24|||
131795135|NCT00681863|474532103|FG000|Overall Study|Adverse Event|1|||
131615149|NCT05886777|473880818|FG001|Overall Study|Protocol Violation|0|||
131615150|NCT05886777|473880819|FG002|Overall Study|Protocol Violation|1|||
131615151|NCT05886777|473880820|FG003|Overall Study|Protocol Violation|0|||
131615152|NCT05886777|473880821|FG004|Overall Study|Protocol Violation|0|||
131615153|NCT05886777|473880822|FG005|Overall Study|Protocol Violation|0|||
131615154|NCT05886777|473880823|FG006|Overall Study|Protocol Violation|0|||
131615155|NCT05886777|473880817|FG000|Overall Study|No longer met eligibility criteria|0|||
131615156|NCT05886777|473880818|FG001|Overall Study|No longer met eligibility criteria|1|||
131615157|NCT05886777|473880819|FG002|Overall Study|No longer met eligibility criteria|0|||
131615158|NCT05886777|473880820|FG003|Overall Study|No longer met eligibility criteria|0|||
131615159|NCT05886777|473880821|FG004|Overall Study|No longer met eligibility criteria|0|||
131615160|NCT05886777|473880822|FG005|Overall Study|No longer met eligibility criteria|0|||
131615161|NCT05886777|473880823|FG006|Overall Study|No longer met eligibility criteria|0|||
131615162|NCT05293717|473880824|FG000|Overall Study|Physician Decision|1|||
131615163|NCT05864209|473882265|FG000|Overall Study|Lost to Follow-up|2|||
131615164|NCT05864209|473882266|FG001|Overall Study|Lost to Follow-up|3|||
131615165|NCT03762850|473882267|FG000|Overall Study|Death|0|||
131615166|NCT03762850|473882268|FG001|Overall Study|Death|1|||
131615167|NCT03762850|473882267|FG000|Overall Study|Lost to Follow-up|0|||
131615168|NCT03762850|473882268|FG001|Overall Study|Lost to Follow-up|1|||
131615169|NCT03762850|473882267|FG000|Overall Study|Physician Decision|0|||
131615170|NCT03762850|473882268|FG001|Overall Study|Physician Decision|1|||
131615171|NCT03762850|473882267|FG000|Overall Study|Withdrawal by Subject|4|||
131615172|NCT03762850|473882268|FG001|Overall Study|Withdrawal by Subject|9|||
131709029|NCT01341457|474215543|FG000|Overall Study|Adverse Event|2|||
131709030|NCT01341457|474215544|FG001|Overall Study|Adverse Event|0|||
131709031|NCT01717638|474215551|FG000|Overall Study|Lost to Follow-up|0|||
131709032|NCT01717638|474215552|FG001|Overall Study|Lost to Follow-up|0|||
131615177|NCT00092534|473882273|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
131615178|NCT00092534|473882274|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
131615179|NCT00092534|473882275|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131615180|NCT00092534|473882276|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131615181|NCT00092534|473882277|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131615182|NCT00092534|473882273|FG000|Base Study Vaccination Period|Adverse Event|3|||
131615183|NCT00092534|473882274|FG001|Base Study Vaccination Period|Adverse Event|1|||
131615184|NCT00092534|473882275|FG002|Base Study Vaccination Period|Adverse Event|0|||
131615185|NCT00092534|473882276|FG003|Base Study Vaccination Period|Adverse Event|0|||
131615186|NCT00092534|473882277|FG004|Base Study Vaccination Period|Adverse Event|0|||
131615187|NCT00092534|473882273|FG000|Base Study Vaccination Period|Death|5|||
131615188|NCT00092534|473882274|FG001|Base Study Vaccination Period|Death|4|||
131615189|NCT00092534|473882275|FG002|Base Study Vaccination Period|Death|0|||
131615190|NCT00092534|473882276|FG003|Base Study Vaccination Period|Death|0|||
131615191|NCT00092534|473882277|FG004|Base Study Vaccination Period|Death|0|||
131615192|NCT00092534|473882273|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
131615193|NCT00092534|473882274|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
131615194|NCT00092534|473882275|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
131615195|NCT00092534|473882276|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
131615196|NCT00092534|473882277|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131615197|NCT00092534|473882273|FG000|Base Study Vaccination Period|Physician Decision|1|||
131615198|NCT00092534|473882274|FG001|Base Study Vaccination Period|Physician Decision|0|||
131615199|NCT00092534|473882275|FG002|Base Study Vaccination Period|Physician Decision|0|||
131615200|NCT00092534|473882276|FG003|Base Study Vaccination Period|Physician Decision|0|||
131615201|NCT00092534|473882277|FG004|Base Study Vaccination Period|Physician Decision|0|||
131615202|NCT00092534|473882273|FG000|Base Study Vaccination Period|Pregnancy|9|||
131709033|NCT01717638|474215553|FG002|Overall Study|Lost to Follow-up|0|||
131709034|NCT01717638|474215554|FG003|Overall Study|Lost to Follow-up|0|||
131709035|NCT01717638|474215555|FG004|Overall Study|Lost to Follow-up|0|||
131709036|NCT01717638|474215556|FG005|Overall Study|Lost to Follow-up|1|||
131709037|NCT01717638|474215557|FG006|Overall Study|Lost to Follow-up|0|||
131709038|NCT01717638|474215558|FG007|Overall Study|Lost to Follow-up|0|||
131709039|NCT01717638|474215559|FG008|Overall Study|Lost to Follow-up|0|||
131709040|NCT01717638|474215560|FG009|Overall Study|Lost to Follow-up|0|||
131709041|NCT01717638|474215561|FG010|Overall Study|Lost to Follow-up|0|||
131709042|NCT01717638|474215562|FG011|Overall Study|Lost to Follow-up|0|||
131709043|NCT01717638|474215563|FG012|Overall Study|Lost to Follow-up|0|||
131709044|NCT01717638|474215551|FG000|Overall Study|Father in hospital|0|||
131615203|NCT00092534|473882274|FG001|Base Study Vaccination Period|Pregnancy|7|||
131615204|NCT00092534|473882275|FG002|Base Study Vaccination Period|Pregnancy|0|||
131615205|NCT00092534|473882276|FG003|Base Study Vaccination Period|Pregnancy|0|||
131615206|NCT00092534|473882277|FG004|Base Study Vaccination Period|Pregnancy|0|||
131615207|NCT00092534|473882273|FG000|Base Study Vaccination Period|Protocol Violation|2|||
131615208|NCT00092534|473882274|FG001|Base Study Vaccination Period|Protocol Violation|1|||
131615209|NCT00092534|473882275|FG002|Base Study Vaccination Period|Protocol Violation|0|||
131615210|NCT00092534|473882276|FG003|Base Study Vaccination Period|Protocol Violation|0|||
131709045|NCT01717638|474215552|FG001|Overall Study|Father in hospital|0|||
131795136|NCT00681863|474532103|FG000|Overall Study|Lost to Follow-up|2|||
131795137|NCT00681863|474532103|FG000|Overall Study|Lack of Efficacy|2|||
131795138|NCT00681863|474532103|FG000|Overall Study|Other|18|||
131795139|NCT01076166|474532104|FG000|Overall Study|Adverse Event|3|||
131795140|NCT01076166|474532104|FG000|Overall Study|Symptoms improved/resolved|6|||
131615211|NCT00092534|473882277|FG004|Base Study Vaccination Period|Protocol Violation|0|||
131615212|NCT00092534|473882273|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
131615213|NCT00092534|473882274|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
131795141|NCT00638157|474532124|FG000|Overall Study|Adverse Event|0|||
131795142|NCT00638157|474532125|FG001|Overall Study|Adverse Event|1|||
131795143|NCT00638157|474532124|FG000|Overall Study|Clinical (symptomatic) failure|1|||
131795144|NCT00638157|474532125|FG001|Overall Study|Clinical (symptomatic) failure|1|||
131795145|NCT00638157|474532124|FG000|Overall Study|Microbiological failure|1|||
131795146|NCT00638157|474532125|FG001|Overall Study|Microbiological failure|0|||
131795147|NCT00638157|474532124|FG000|Overall Study|Lost to Follow-up|1|||
131795148|NCT00638157|474532125|FG001|Overall Study|Lost to Follow-up|0|||
131795149|NCT00638157|474532124|FG000|Overall Study|Physician Decision|1|||
131795150|NCT00638157|474532125|FG001|Overall Study|Physician Decision|0|||
131615214|NCT00092534|473882275|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
131615215|NCT00092534|473882276|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
131615216|NCT00092534|473882277|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131615217|NCT00092534|473882273|FG000|Base Study Vaccination Period|Moved|14|||
131615218|NCT00092534|473882274|FG001|Base Study Vaccination Period|Moved|12|||
131615219|NCT00092534|473882275|FG002|Base Study Vaccination Period|Moved|0|||
131615220|NCT00092534|473882276|FG003|Base Study Vaccination Period|Moved|0|||
131615221|NCT00092534|473882277|FG004|Base Study Vaccination Period|Moved|0|||
131615222|NCT00092534|473882273|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
131615223|NCT00092534|473882274|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131615224|NCT00092534|473882275|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131615225|NCT00092534|473882276|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131615226|NCT00092534|473882277|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131615227|NCT00092534|473882273|FG000|Base Study Vaccination Period|Travel|1|||
131615228|NCT00092534|473882274|FG001|Base Study Vaccination Period|Travel|0|||
131615229|NCT00092534|473882275|FG002|Base Study Vaccination Period|Travel|0|||
131615230|NCT00092534|473882276|FG003|Base Study Vaccination Period|Travel|0|||
131615231|NCT00092534|473882277|FG004|Base Study Vaccination Period|Travel|0|||
131615232|NCT00092534|473882273|FG000|Base Study Vaccination Period|Site Closed|0|||
131615233|NCT00092534|473882274|FG001|Base Study Vaccination Period|Site Closed|1|||
131615234|NCT00092534|473882275|FG002|Base Study Vaccination Period|Site Closed|0|||
131615235|NCT00092534|473882276|FG003|Base Study Vaccination Period|Site Closed|0|||
131615236|NCT00092534|473882277|FG004|Base Study Vaccination Period|Site Closed|0|||
131615237|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Adverse Event|2|||
131615238|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Adverse Event|4|||
131615239|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Adverse Event|0|||
131615240|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Adverse Event|0|||
131615241|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Adverse Event|0|||
131615242|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Death|2|||
131615243|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Death|1|||
131615244|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Death|0|||
131615245|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Death|0|||
131615246|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Death|0|||
131615247|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
131615248|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
131615249|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
131615250|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
131615251|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
131615252|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Pregnancy|6|||
131615253|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Pregnancy|10|||
131615254|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Pregnancy|0|||
131615255|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Pregnancy|0|||
131795151|NCT00638157|474532124|FG000|Overall Study|Other|1|||
131795152|NCT00638157|474532125|FG001|Overall Study|Other|2|||
131795153|NCT00638157|474532124|FG000|Overall Study|Randomized, not treated|2|||
131795154|NCT00638157|474532125|FG001|Overall Study|Randomized, not treated|0|||
131795155|NCT05476679|474532130|FG000|Overall Study|Withdrawal by Subject|0|||
131795156|NCT05476679|474532131|FG001|Overall Study|Withdrawal by Subject|0|||
131795157|NCT05476679|474532132|FG002|Overall Study|Withdrawal by Subject|0|||
131615256|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Pregnancy|0|||
131615257|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
131615258|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
131795158|NCT05476679|474532133|FG003|Overall Study|Withdrawal by Subject|1|||
131795159|NCT05476679|474532134|FG004|Overall Study|Withdrawal by Subject|0|||
131615259|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
131795160|NCT05476679|474532130|FG000|Overall Study|Lost to Follow-up|0|||
131615260|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
131615261|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
131615262|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
131615263|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
131615264|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
131615265|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
131615266|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
131615267|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Moved|62|||
131615268|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Moved|58|||
131615269|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Moved|0|||
131615270|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Moved|0|||
131615271|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Moved|0|||
131615272|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Travel|10|||
131615273|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Travel|7|||
131615274|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Travel|0|||
131615275|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Travel|0|||
131615276|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Travel|0|||
131615277|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Site Closed|0|||
131615278|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Site Closed|2|||
131615279|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Site Closed|0|||
131615280|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Site Closed|0|||
131615281|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Site Closed|0|||
131615282|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
131615283|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
131615284|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
131615285|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
131615286|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
131615287|NCT00092534|473882273|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
131615288|NCT00092534|473882274|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
131615289|NCT00092534|473882275|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
131615290|NCT00092534|473882276|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
131615291|NCT00092534|473882277|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
131615292|NCT00092534|473882273|FG000|Base Study EXT|Lost to Follow-up|0|||
131615293|NCT00092534|473882274|FG001|Base Study EXT|Lost to Follow-up|0|||
131615294|NCT00092534|473882275|FG002|Base Study EXT|Lost to Follow-up|41|||
131615295|NCT00092534|473882276|FG003|Base Study EXT|Lost to Follow-up|0|||
131615296|NCT00092534|473882277|FG004|Base Study EXT|Lost to Follow-up|0|||
131615297|NCT00092534|473882273|FG000|Base Study EXT|Physician Decision|0|||
131615298|NCT00092534|473882274|FG001|Base Study EXT|Physician Decision|0|||
131615299|NCT00092534|473882275|FG002|Base Study EXT|Physician Decision|1|||
131615300|NCT00092534|473882276|FG003|Base Study EXT|Physician Decision|0|||
131615301|NCT00092534|473882277|FG004|Base Study EXT|Physician Decision|0|||
131615302|NCT00092534|473882273|FG000|Base Study EXT|Pregnancy|0|||
131615303|NCT00092534|473882274|FG001|Base Study EXT|Pregnancy|0|||
131615304|NCT00092534|473882275|FG002|Base Study EXT|Pregnancy|12|||
131615305|NCT00092534|473882276|FG003|Base Study EXT|Pregnancy|0|||
131615306|NCT00092534|473882277|FG004|Base Study EXT|Pregnancy|0|||
131615307|NCT00092534|473882273|FG000|Base Study EXT|Withdrawal by Subject|0|||
131615308|NCT00092534|473882274|FG001|Base Study EXT|Withdrawal by Subject|0|||
131615309|NCT00092534|473882275|FG002|Base Study EXT|Withdrawal by Subject|18|||
131615310|NCT00092534|473882276|FG003|Base Study EXT|Withdrawal by Subject|0|||
131615311|NCT00092534|473882277|FG004|Base Study EXT|Withdrawal by Subject|0|||
131615312|NCT00092534|473882273|FG000|Base Study EXT|Participant moved|0|||
131615313|NCT00092534|473882274|FG001|Base Study EXT|Participant moved|0|||
131615314|NCT00092534|473882275|FG002|Base Study EXT|Participant moved|6|||
131615315|NCT00092534|473882276|FG003|Base Study EXT|Participant moved|0|||
131615316|NCT00092534|473882277|FG004|Base Study EXT|Participant moved|0|||
131615317|NCT00092534|473882273|FG000|Base Study EXT|Travel|0|||
131615318|NCT00092534|473882274|FG001|Base Study EXT|Travel|0|||
131615319|NCT00092534|473882275|FG002|Base Study EXT|Travel|2|||
131615320|NCT00092534|473882276|FG003|Base Study EXT|Travel|0|||
131615321|NCT00092534|473882277|FG004|Base Study EXT|Travel|0|||
131615322|NCT00092534|473882273|FG000|Base Study EXT|Site closed|0|||
131615323|NCT00092534|473882274|FG001|Base Study EXT|Site closed|0|||
131615324|NCT00092534|473882275|FG002|Base Study EXT|Site closed|21|||
131615325|NCT00092534|473882276|FG003|Base Study EXT|Site closed|0|||
131615326|NCT00092534|473882277|FG004|Base Study EXT|Site closed|0|||
131615327|NCT00092534|473882273|FG000|Base Study EXT|Study ended|0|||
131615328|NCT00092534|473882274|FG001|Base Study EXT|Study ended|0|||
131615329|NCT00092534|473882275|FG002|Base Study EXT|Study ended|29|||
131615330|NCT00092534|473882276|FG003|Base Study EXT|Study ended|0|||
131615331|NCT00092534|473882277|FG004|Base Study EXT|Study ended|0|||
131615332|NCT00092534|473882273|FG000|Base Study EXT|Protocol Violation|0|||
131615333|NCT00092534|473882274|FG001|Base Study EXT|Protocol Violation|0|||
131615334|NCT00092534|473882275|FG002|Base Study EXT|Protocol Violation|15|||
131615335|NCT00092534|473882276|FG003|Base Study EXT|Protocol Violation|0|||
131615336|NCT00092534|473882277|FG004|Base Study EXT|Protocol Violation|0|||
131615337|NCT00092534|473882273|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131615338|NCT00092534|473882274|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131615339|NCT00092534|473882275|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131615340|NCT00092534|473882276|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
131615341|NCT00092534|473882277|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131615342|NCT03083366|473882278|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
131615343|NCT03083366|473882279|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
131615344|NCT03083366|473882278|FG000|Enrollment Period|Lack of Efficacy|1|||
131615345|NCT03083366|473882279|FG001|Enrollment Period|Lack of Efficacy|0|||
131615346|NCT02036970|473882284|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131615347|NCT02036970|473882285|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131615348|NCT02036970|473882286|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
131615349|NCT02036970|473882287|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
131615350|NCT02036970|473882288|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131615351|NCT02036970|473882289|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
131795161|NCT05476679|474532131|FG001|Overall Study|Lost to Follow-up|0|||
131795162|NCT05476679|474532132|FG002|Overall Study|Lost to Follow-up|0|||
131795163|NCT05476679|474532133|FG003|Overall Study|Lost to Follow-up|1|||
131795164|NCT05476679|474532134|FG004|Overall Study|Lost to Follow-up|0|||
131795165|NCT01199601|474532135|FG000|Overall Study|Lost to Follow-up|47|||
131795166|NCT01199601|474532136|FG001|Overall Study|Lost to Follow-up|66|||
131795167|NCT01199601|474532135|FG000|Overall Study|Withdrawal by Subject|15|||
131795168|NCT01199601|474532136|FG001|Overall Study|Withdrawal by Subject|3|||
131795169|NCT01199601|474532135|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
131795170|NCT01199601|474532136|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
131795171|NCT00753714|474532138|FG000|Overall Study|Lack of Efficacy|21|||
131795172|NCT00753714|474532139|FG001|Overall Study|Lack of Efficacy|34|||
131795173|NCT00753714|474532138|FG000|Overall Study|Adverse Event|26|||
131795174|NCT00753714|474532139|FG001|Overall Study|Adverse Event|18|||
131795175|NCT00753714|474532138|FG000|Overall Study|Protocol Violation|1|||
131795176|NCT00753714|474532139|FG001|Overall Study|Protocol Violation|0|||
131795177|NCT00753714|474532138|FG000|Overall Study|Lost to Follow-up|0|||
131795178|NCT00753714|474532139|FG001|Overall Study|Lost to Follow-up|1|||
131795179|NCT00753714|474532138|FG000|Overall Study|Withdrawal by Subject|2|||
131795180|NCT00753714|474532139|FG001|Overall Study|Withdrawal by Subject|1|||
131795181|NCT00753714|474532138|FG000|Overall Study|Death|3|||
131795182|NCT00753714|474532139|FG001|Overall Study|Death|3|||
131795183|NCT00753714|474532138|FG000|Overall Study|Other|7|||
131795184|NCT00753714|474532139|FG001|Overall Study|Other|5|||
131795185|NCT02486796|474532140|FG000|Overall Study|Withdrawal by Subject|1|||
131795186|NCT02486796|474532141|FG001|Overall Study|Withdrawal by Subject|1|||
131795187|NCT02486796|474532140|FG000|Overall Study|Physician Decision|1|||
131795188|NCT02486796|474532141|FG001|Overall Study|Physician Decision|0|||
131795189|NCT01185288|474532142|FG000|Overall Study|Adverse Event|7|||
131795190|NCT01185288|474532143|FG001|Overall Study|Adverse Event|6|||
131795191|NCT01185288|474532142|FG000|Overall Study|Withdrawal by Subject|6|||
131795192|NCT01185288|474532143|FG001|Overall Study|Withdrawal by Subject|4|||
131795193|NCT01185288|474532142|FG000|Overall Study|Lost to Follow-up|2|||
131795194|NCT01185288|474532143|FG001|Overall Study|Lost to Follow-up|5|||
131795195|NCT01185288|474532142|FG000|Overall Study|Lack of Efficacy|2|||
131795196|NCT01185288|474532143|FG001|Overall Study|Lack of Efficacy|0|||
131795197|NCT01185288|474532142|FG000|Overall Study|Investigator discretion|1|||
131795198|NCT01185288|474532143|FG001|Overall Study|Investigator discretion|0|||
131795199|NCT01185288|474532142|FG000|Overall Study|Did not meet inclusion criteria|1|||
131795200|NCT01185288|474532143|FG001|Overall Study|Did not meet inclusion criteria|0|||
131795201|NCT01185288|474532142|FG000|Overall Study|Noncompliance|0|||
131795202|NCT01185288|474532143|FG001|Overall Study|Noncompliance|1|||
131795203|NCT00278512|474532144|FG000|Overall Study|Death|1|||
131795204|NCT00278512|474532145|FG001|Overall Study|Death|0|||
131795205|NCT01202747|474532146|FG000|Overall Study|Withdrawal by Subject|1|||
131795206|NCT01620177|474532147|FG000|Overall Study|Failure at Screening Visit|43|||
131795207|NCT01620177|474532147|FG000|Overall Study|Withdrawal by Subject|26|||
131795208|NCT01620177|474532147|FG000|Overall Study|Lost to Follow-up|7|||
131795209|NCT01620177|474532147|FG000|Overall Study|Physician Decision|2|||
131795210|NCT01620177|474532147|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
131795211|NCT02292238|474532151|FG000|Overall Study|Protocol Violation|1|||
131615352|NCT02036970|473882290|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131795212|NCT02292238|474532152|FG001|Overall Study|Protocol Violation|2|||
131795213|NCT02292238|474532151|FG000|Overall Study|Withdrawal by Subject|2|||
131795214|NCT02292238|474532152|FG001|Overall Study|Withdrawal by Subject|1|||
131795215|NCT02292238|474532151|FG000|Overall Study|Lost to Follow-up|1|||
131795216|NCT02292238|474532152|FG001|Overall Study|Lost to Follow-up|0|||
131795217|NCT02292238|474532151|FG000|Overall Study|Physician Decision|0|||
131795218|NCT02292238|474532152|FG001|Overall Study|Physician Decision|1|||
131795219|NCT01789320|474532153|FG000|Overall Study|Re-enrolled into study|1|||
131795220|NCT01789320|474532153|FG000|Overall Study|Lost to Follow-up|1|||
131795221|NCT01626885|474532160|FG000|Overall Study|Adverse Event|8|||
131795222|NCT01626885|474532160|FG000|Overall Study|Withdrawal by Subject|4|||
131443496|NCT00528112|473252670|FG001|Extension Phase|Withdrawal by Subject|3|||
131443497|NCT00528112|473252669|FG000|Extension Phase|Other reasons|0|||
131443498|NCT00528112|473252670|FG001|Extension Phase|Other reasons|100|||
131443499|NCT00528112|473252669|FG000|Extension Phase|Pregnancy|0|||
131443500|NCT00528112|473252670|FG001|Extension Phase|Pregnancy|3|||
131443501|NCT00528112|473252669|FG000|Extension Phase|Lost to Follow-up|0|||
131443502|NCT00528112|473252670|FG001|Extension Phase|Lost to Follow-up|12|||
131443503|NCT00528112|473252669|FG000|Extension Phase|Death|0|||
131443504|NCT00528112|473252670|FG001|Extension Phase|Death|1|||
131443505|NCT00528112|473252669|FG000|Extension Phase|Adverse Event|0|||
131443506|NCT00528112|473252670|FG001|Extension Phase|Adverse Event|36|||
131443507|NCT00528112|473252669|FG000|Extension Phase|Protocol Violation|0|||
131443508|NCT00528112|473252670|FG001|Extension Phase|Protocol Violation|2|||
131443509|NCT00894803|473252671|FG000|Overall Study|Death|20|||
131443510|NCT00894803|473252672|FG001|Overall Study|Death|4|||
131443511|NCT00894803|473252671|FG000|Overall Study|Lost to Follow-up|0|||
131443512|NCT00894803|473252672|FG001|Overall Study|Lost to Follow-up|1|||
131795223|NCT01533428|474532163|FG000|Overall Study|Adverse Event|0|||
131795224|NCT01533428|474532164|FG001|Overall Study|Adverse Event|1|||
131795225|NCT01533428|474532163|FG000|Overall Study|Lost to Follow-up|2|||
131795226|NCT01533428|474532164|FG001|Overall Study|Lost to Follow-up|1|||
131795227|NCT01533428|474532163|FG000|Overall Study|Withdrawal by Subject|7|||
131795228|NCT01533428|474532164|FG001|Overall Study|Withdrawal by Subject|6|||
131795229|NCT01364870|474532165|FG000|Overall Study|Withdrawal by Subject|13|||
131795230|NCT01364870|474532166|FG001|Overall Study|Withdrawal by Subject|24|||
131795231|NCT01364870|474532167|FG002|Overall Study|Withdrawal by Subject|10|||
131795232|NCT01364870|474532165|FG000|Overall Study|Adverse Event|8|||
131795233|NCT01364870|474532166|FG001|Overall Study|Adverse Event|6|||
131795234|NCT01364870|474532167|FG002|Overall Study|Adverse Event|4|||
131795235|NCT01364870|474532165|FG000|Overall Study|Protocol Violation|1|||
131795236|NCT01364870|474532166|FG001|Overall Study|Protocol Violation|0|||
131795237|NCT01364870|474532167|FG002|Overall Study|Protocol Violation|0|||
131795238|NCT02666430|474532168|FG000|Period 1|Lost to Follow-up|1|||
131795239|NCT02666430|474532169|FG001|Period 1|Lost to Follow-up|0|||
131795240|NCT02666430|474532168|FG000|Period 1|Adverse Event|0|||
131795241|NCT02666430|474532169|FG001|Period 1|Adverse Event|1|||
131795242|NCT02666430|474532168|FG000|Period 2|Withdrawal by Subject|1|||
131900889|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131615353|NCT02036970|473882291|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
131615354|NCT02036970|473882292|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
131615355|NCT02036970|473882293|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
131615356|NCT02036970|473882284|FG000|Part 1: Day 1 Through Week 16|Death|0|||
131615357|NCT02036970|473882285|FG001|Part 1: Day 1 Through Week 16|Death|0|||
131615358|NCT02036970|473882286|FG002|Part 1: Day 1 Through Week 16|Death|0|||
131615359|NCT02036970|473882287|FG003|Part 1: Day 1 Through Week 16|Death|0|||
131615360|NCT02036970|473882288|FG004|Part 1: Day 1 Through Week 16|Death|0|||
131615361|NCT02036970|473882289|FG005|Part 1: Day 1 Through Week 16|Death|0|||
131615362|NCT02036970|473882290|FG006|Part 1: Day 1 Through Week 16|Death|0|||
131615363|NCT02036970|473882291|FG007|Part 1: Day 1 Through Week 16|Death|0|||
131615364|NCT02036970|473882292|FG008|Part 1: Day 1 Through Week 16|Death|1|||
131615365|NCT02036970|473882293|FG009|Part 1: Day 1 Through Week 16|Death|0|||
131615366|NCT02036970|473882284|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
131615367|NCT02036970|473882285|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615368|NCT02036970|473882286|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
131615369|NCT02036970|473882287|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615370|NCT02036970|473882288|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615371|NCT02036970|473882289|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615372|NCT02036970|473882290|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615373|NCT02036970|473882291|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615374|NCT02036970|473882292|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
131615375|NCT02036970|473882293|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131615376|NCT02036970|473882284|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131709046|NCT01717638|474215553|FG002|Overall Study|Father in hospital|0|||
131709047|NCT01717638|474215554|FG003|Overall Study|Father in hospital|0|||
131709048|NCT01717638|474215555|FG004|Overall Study|Father in hospital|0|||
131443513|NCT01345240|473252674|FG000|Overall Study|Adverse Event|3|||
131443514|NCT01345240|473252675|FG001|Overall Study|Adverse Event|5|||
131443515|NCT01345240|473252676|FG002|Overall Study|Adverse Event|4|||
131709049|NCT01717638|474215556|FG005|Overall Study|Father in hospital|0|||
131709050|NCT01717638|474215557|FG006|Overall Study|Father in hospital|0|||
131709051|NCT01717638|474215558|FG007|Overall Study|Father in hospital|0|||
131709052|NCT01717638|474215559|FG008|Overall Study|Father in hospital|0|||
131709053|NCT01717638|474215560|FG009|Overall Study|Father in hospital|0|||
131709054|NCT01717638|474215561|FG010|Overall Study|Father in hospital|0|||
131709055|NCT01717638|474215562|FG011|Overall Study|Father in hospital|0|||
131709056|NCT01717638|474215563|FG012|Overall Study|Father in hospital|1|||
131709057|NCT01717638|474215551|FG000|Overall Study|Withdrawal by Subject|0|||
131709058|NCT01717638|474215552|FG001|Overall Study|Withdrawal by Subject|1|||
131709059|NCT01717638|474215553|FG002|Overall Study|Withdrawal by Subject|1|||
131709060|NCT01717638|474215554|FG003|Overall Study|Withdrawal by Subject|0|||
131709061|NCT01717638|474215555|FG004|Overall Study|Withdrawal by Subject|1|||
131709062|NCT01717638|474215556|FG005|Overall Study|Withdrawal by Subject|0|||
131709063|NCT01717638|474215557|FG006|Overall Study|Withdrawal by Subject|2|||
131709064|NCT01717638|474215558|FG007|Overall Study|Withdrawal by Subject|1|||
131709065|NCT01717638|474215559|FG008|Overall Study|Withdrawal by Subject|2|||
131709066|NCT01717638|474215560|FG009|Overall Study|Withdrawal by Subject|1|||
131709067|NCT01717638|474215561|FG010|Overall Study|Withdrawal by Subject|0|||
131709068|NCT01717638|474215562|FG011|Overall Study|Withdrawal by Subject|0|||
131709069|NCT01717638|474215563|FG012|Overall Study|Withdrawal by Subject|18|||
131795243|NCT02666430|474532169|FG001|Period 2|Withdrawal by Subject|4|||
131795244|NCT02666430|474532168|FG000|Period 3|Lost to Follow-up|1|||
131795245|NCT02666430|474532169|FG001|Period 3|Lost to Follow-up|0|||
131795246|NCT03828461|474532170|FG000|Overall Study|Lost to Follow-up|1|||
131795247|NCT03828461|474532170|FG000|Overall Study|Withdrawal by Subject|3|||
131795248|NCT00576199|474532171|FG000|Overall Study|Adverse Event|12|||
131795249|NCT00576199|474532171|FG000|Overall Study|Insufficient Therapeutic Response|14|||
131795250|NCT00576199|474532171|FG000|Overall Study|Refused Treatment|2|||
131709070|NCT03480802|474215564|FG000|Overall Study|Lost to Follow-up|5|||
131709071|NCT03480802|474215565|FG001|Overall Study|Lost to Follow-up|1|||
131709072|NCT03480802|474215564|FG000|Overall Study|Withdrawal by Subject|2|||
131709073|NCT03480802|474215565|FG001|Overall Study|Withdrawal by Subject|1|||
131709074|NCT03480802|474215564|FG000|Overall Study|Relocated|0|||
131709075|NCT03480802|474215565|FG001|Overall Study|Relocated|1|||
131795251|NCT00576199|474532171|FG000|Overall Study|Reason Unspecified|2|||
131709076|NCT01409928|474215566|FG000|Overall Study|Physician Decision|12|||
131615377|NCT02036970|473882285|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131615378|NCT02036970|473882286|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131615379|NCT02036970|473882287|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131615380|NCT02036970|473882288|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
131615381|NCT02036970|473882289|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131615382|NCT02036970|473882290|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131615383|NCT02036970|473882291|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131615384|NCT02036970|473882292|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
131615385|NCT02036970|473882293|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
131615386|NCT02036970|473882284|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615387|NCT02036970|473882285|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615388|NCT02036970|473882286|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615389|NCT02036970|473882287|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
131615390|NCT02036970|473882288|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615391|NCT02036970|473882289|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615392|NCT02036970|473882290|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615393|NCT02036970|473882291|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615394|NCT02036970|473882292|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615395|NCT02036970|473882293|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131615396|NCT02036970|473882284|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
131615397|NCT02036970|473882285|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
131615398|NCT02036970|473882286|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
131615399|NCT02036970|473882287|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
131615400|NCT02036970|473882288|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
131615401|NCT02036970|473882289|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
131615402|NCT02036970|473882290|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
131615403|NCT02036970|473882291|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
131615404|NCT02036970|473882292|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
131615405|NCT02036970|473882293|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
131615406|NCT02036970|473882284|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615407|NCT02036970|473882285|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615408|NCT02036970|473882286|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615409|NCT02036970|473882287|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615410|NCT02036970|473882288|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615411|NCT02036970|473882289|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615412|NCT02036970|473882290|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615413|NCT02036970|473882291|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
131615414|NCT02036970|473882292|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615415|NCT02036970|473882293|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
131615416|NCT02036970|473882284|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615417|NCT02036970|473882285|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
131615418|NCT02036970|473882286|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
131615419|NCT02036970|473882287|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615420|NCT02036970|473882288|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615421|NCT02036970|473882289|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615422|NCT02036970|473882290|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615423|NCT02036970|473882291|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615424|NCT02036970|473882292|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
131615425|NCT02036970|473882293|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131615426|NCT02036970|473882284|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
131615427|NCT02036970|473882285|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
131615428|NCT02036970|473882286|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
131615429|NCT02036970|473882287|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
131615430|NCT02036970|473882288|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
131615431|NCT02036970|473882289|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
131615432|NCT02036970|473882290|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
131615433|NCT02036970|473882291|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
131795252|NCT03111147|474532172|FG000|Overall Study|Lost to Follow-up|2|||
131795253|NCT03111147|474532173|FG001|Overall Study|Lost to Follow-up|5|||
131615434|NCT02036970|473882292|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
131615435|NCT02036970|473882293|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
131615436|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
131615437|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
131615438|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
131615439|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
131615440|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
131615441|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
131615442|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
131795254|NCT03111147|474532172|FG000|Overall Study|Withdrawal by Subject|4|||
131615443|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
131615444|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
131615445|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
131615446|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
131615447|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
131615448|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
131615449|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
131615450|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
131615451|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131615452|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
131615453|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131615454|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131615455|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131615456|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
131615457|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
131615458|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
131615459|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
131615460|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
131615461|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Other|1|||
131615462|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Other|0|||
131615463|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Other|0|||
131615464|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Other|0|||
131615465|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Other|0|||
131615466|NCT02386098|473882294|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
131615467|NCT02386098|473882295|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
131615468|NCT02386098|473882296|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
131615469|NCT02386098|473882297|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
131615470|NCT02386098|473882298|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
131615471|NCT00786864|473882303|FG000|Overall Study|Lost to Follow-up|0|||
131615472|NCT00786864|473882304|FG001|Overall Study|Lost to Follow-up|1|||
131615473|NCT00786864|473882303|FG000|Overall Study|Sustained serious back injury|1|||
131615474|NCT00786864|473882304|FG001|Overall Study|Sustained serious back injury|0|||
131615475|NCT03220724|473882317|FG000|Overall Study|Lost to Follow-up|2|||
131615476|NCT03220724|473882318|FG001|Overall Study|Lost to Follow-up|2|||
131615477|NCT03220724|473882319|FG002|Overall Study|Lost to Follow-up|0|||
131615478|NCT03220724|473882320|FG003|Overall Study|Lost to Follow-up|3|||
131615479|NCT03220724|473882321|FG004|Overall Study|Lost to Follow-up|1|||
131615480|NCT03220724|473882322|FG005|Overall Study|Lost to Follow-up|0|||
131615481|NCT03220724|473882323|FG006|Overall Study|Lost to Follow-up|2|||
131615482|NCT03220724|473882324|FG007|Overall Study|Lost to Follow-up|1|||
131615483|NCT03220724|473882325|FG008|Overall Study|Lost to Follow-up|0|||
131615484|NCT03220724|473882317|FG000|Overall Study|Withdrawal by Subject|1|||
131615485|NCT03220724|473882318|FG001|Overall Study|Withdrawal by Subject|0|||
131615486|NCT03220724|473882319|FG002|Overall Study|Withdrawal by Subject|1|||
131615487|NCT03220724|473882320|FG003|Overall Study|Withdrawal by Subject|0|||
131615488|NCT03220724|473882321|FG004|Overall Study|Withdrawal by Subject|0|||
131615489|NCT03220724|473882322|FG005|Overall Study|Withdrawal by Subject|0|||
131615490|NCT03220724|473882323|FG006|Overall Study|Withdrawal by Subject|0|||
131615491|NCT03220724|473882324|FG007|Overall Study|Withdrawal by Subject|0|||
131615492|NCT03220724|473882325|FG008|Overall Study|Withdrawal by Subject|0|||
131615493|NCT00371345|473882326|FG000|Overall Study|Disease Progression|21|||
131615494|NCT00371345|473882327|FG001|Overall Study|Disease Progression|35|||
131615495|NCT00371345|473882326|FG000|Overall Study|Study Drug Toxicity|1|||
131615496|NCT00371345|473882327|FG001|Overall Study|Study Drug Toxicity|7|||
131615497|NCT00371345|473882326|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
131615498|NCT00371345|473882327|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
131615499|NCT00371345|473882326|FG000|Overall Study|Participant Request|1|||
131615500|NCT00371345|473882327|FG001|Overall Study|Participant Request|1|||
131615501|NCT00371345|473882326|FG000|Overall Study|Participant Withdrew Consent|0|||
131615502|NCT00371345|473882327|FG001|Overall Study|Participant Withdrew Consent|1|||
131615503|NCT00263757|473882328|FG000|Overall Study|Withdrawal by Subject|5|||
131795255|NCT03111147|474532173|FG001|Overall Study|Withdrawal by Subject|3|||
131795256|NCT03111147|474532172|FG000|Overall Study|Protocol Violation|2|||
131795257|NCT03111147|474532173|FG001|Overall Study|Protocol Violation|1|||
131615504|NCT00263757|473882329|FG001|Overall Study|Withdrawal by Subject|4|||
131615505|NCT00263757|473882328|FG000|Overall Study|Screen failure|0|||
131615506|NCT00263757|473882329|FG001|Overall Study|Screen failure|1|||
131615507|NCT00263757|473882328|FG000|Overall Study|Adverse Event|3|||
131615508|NCT00263757|473882329|FG001|Overall Study|Adverse Event|3|||
131615509|NCT00713596|473882330|FG000|Overall Study|Study was terminated|2|||
131615510|NCT00713596|473882331|FG001|Overall Study|Study was terminated|3|||
131615511|NCT00713596|473882332|FG002|Overall Study|Study was terminated|2|||
131615512|NCT04545619|473882333|FG000|Overall Study|due to equipment challenges|1|||
131615513|NCT01767467|473882336|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
131615514|NCT01767467|473882337|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
131615515|NCT01767467|473882336|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
131615516|NCT01767467|473882337|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
131615517|NCT01767467|473882336|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
131615518|NCT01767467|473882337|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
131615519|NCT01767467|473882336|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
131615520|NCT01767467|473882337|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
131615521|NCT01767467|473882336|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
131615522|NCT01767467|473882337|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
131615523|NCT01767467|473882336|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
131615524|NCT01767467|473882337|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
131615525|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
131615526|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
131615527|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
131615528|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
131615529|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
131615530|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
131615531|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
131615532|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
131615533|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
131615534|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
131615535|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
131615536|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
131615537|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
131615538|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
131615539|NCT01767467|473882336|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
131615540|NCT01767467|473882337|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
131615541|NCT03113409|473882338|FG000|Overall Study|Withdrawal by Subject|5|||
131615542|NCT03113409|473882339|FG001|Overall Study|Withdrawal by Subject|0|||
131615543|NCT03113409|473882340|FG002|Overall Study|Withdrawal by Subject|0|||
131615544|NCT00776009|473882343|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
131615545|NCT00776009|473882344|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
131615546|NCT00776009|473882345|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
131615547|NCT00776009|473882346|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
131615548|NCT00776009|473882347|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
131615549|NCT00776009|473882348|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
131615550|NCT00776009|473882343|FG000|Period 1: First Intervention|Protocol Violation|0|||
131615551|NCT00776009|473882344|FG001|Period 1: First Intervention|Protocol Violation|1|||
131615552|NCT00776009|473882345|FG002|Period 1: First Intervention|Protocol Violation|0|||
131615553|NCT00776009|473882346|FG003|Period 1: First Intervention|Protocol Violation|0|||
131615554|NCT00776009|473882347|FG004|Period 1: First Intervention|Protocol Violation|1|||
131615555|NCT00776009|473882348|FG005|Period 1: First Intervention|Protocol Violation|0|||
131615556|NCT00776009|473882343|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
131615557|NCT00776009|473882344|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
131615558|NCT00776009|473882345|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
131615559|NCT00776009|473882346|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
131615560|NCT00776009|473882347|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
131615561|NCT00776009|473882348|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
131615562|NCT00776009|473882343|FG000|Period 2: Second Intervention|Protocol Violation|1|||
131615563|NCT00776009|473882344|FG001|Period 2: Second Intervention|Protocol Violation|0|||
131615564|NCT00776009|473882345|FG002|Period 2: Second Intervention|Protocol Violation|1|||
131615565|NCT00776009|473882346|FG003|Period 2: Second Intervention|Protocol Violation|0|||
131615566|NCT00776009|473882347|FG004|Period 2: Second Intervention|Protocol Violation|0|||
131615567|NCT00776009|473882348|FG005|Period 2: Second Intervention|Protocol Violation|0|||
131615568|NCT00776009|473882343|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
131795258|NCT03111147|474532172|FG000|Overall Study|Death|1|||
131795259|NCT03111147|474532173|FG001|Overall Study|Death|1|||
131795260|NCT01896297|474532176|FG000|Overall Study|Died in post treatment phase|1|||
131795261|NCT01628120|474533913|FG000|Overall Study|Withdrawal by Subject|7|||
131795262|NCT01628120|474533913|FG000|Overall Study|Adverse Event|12|||
131615569|NCT00776009|473882344|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
131615570|NCT00776009|473882345|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
131615571|NCT00776009|473882346|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
131615572|NCT00776009|473882347|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
131615573|NCT00776009|473882348|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
131615574|NCT01640951|473882349|FG000|Overall Study|Adverse Event|8|||
131615575|NCT01640951|473882350|FG001|Overall Study|Adverse Event|3|||
131615576|NCT01640951|473882351|FG002|Overall Study|Adverse Event|10|||
131615577|NCT01640951|473882352|FG003|Overall Study|Adverse Event|6|||
131615578|NCT01640951|473882353|FG004|Overall Study|Adverse Event|1|||
131615579|NCT01640951|473882354|FG005|Overall Study|Adverse Event|11|||
131615580|NCT01640951|473882355|FG006|Overall Study|Adverse Event|1|||
131615581|NCT01640951|473882356|FG007|Overall Study|Adverse Event|3|||
131615582|NCT01640951|473882349|FG000|Overall Study|Lack of Efficacy|20|||
131615583|NCT01640951|473882350|FG001|Overall Study|Lack of Efficacy|1|||
131615584|NCT01640951|473882351|FG002|Overall Study|Lack of Efficacy|7|||
131615585|NCT01640951|473882352|FG003|Overall Study|Lack of Efficacy|14|||
131443516|NCT01345240|473252677|FG003|Overall Study|Adverse Event|2|||
131443517|NCT01345240|473252678|FG004|Overall Study|Adverse Event|1|||
131443518|NCT01345240|473252674|FG000|Overall Study|Lost to Follow-up|8|||
131615586|NCT01640951|473882353|FG004|Overall Study|Lack of Efficacy|0|||
131615587|NCT01640951|473882354|FG005|Overall Study|Lack of Efficacy|6|||
131615588|NCT01640951|473882355|FG006|Overall Study|Lack of Efficacy|5|||
131615589|NCT01640951|473882356|FG007|Overall Study|Lack of Efficacy|6|||
131615590|NCT01640951|473882349|FG000|Overall Study|Lost to Follow-up|1|||
131615591|NCT01640951|473882350|FG001|Overall Study|Lost to Follow-up|0|||
131615592|NCT01640951|473882351|FG002|Overall Study|Lost to Follow-up|6|||
131615593|NCT01640951|473882352|FG003|Overall Study|Lost to Follow-up|2|||
131615594|NCT01640951|473882353|FG004|Overall Study|Lost to Follow-up|2|||
131615595|NCT01640951|473882354|FG005|Overall Study|Lost to Follow-up|3|||
131615596|NCT01640951|473882355|FG006|Overall Study|Lost to Follow-up|1|||
131615597|NCT01640951|473882356|FG007|Overall Study|Lost to Follow-up|1|||
131615598|NCT01640951|473882349|FG000|Overall Study|Non-compliance with study treatment|0|||
131615599|NCT01640951|473882350|FG001|Overall Study|Non-compliance with study treatment|0|||
131615600|NCT01640951|473882351|FG002|Overall Study|Non-compliance with study treatment|1|||
131615601|NCT01640951|473882352|FG003|Overall Study|Non-compliance with study treatment|1|||
131615602|NCT01640951|473882353|FG004|Overall Study|Non-compliance with study treatment|1|||
131615603|NCT01640951|473882354|FG005|Overall Study|Non-compliance with study treatment|4|||
131615604|NCT01640951|473882355|FG006|Overall Study|Non-compliance with study treatment|1|||
131615605|NCT01640951|473882356|FG007|Overall Study|Non-compliance with study treatment|0|||
131615606|NCT01640951|473882349|FG000|Overall Study|Physician Decision|2|||
131615607|NCT01640951|473882350|FG001|Overall Study|Physician Decision|5|||
131615608|NCT01640951|473882351|FG002|Overall Study|Physician Decision|2|||
131615609|NCT01640951|473882352|FG003|Overall Study|Physician Decision|2|||
131615610|NCT01640951|473882353|FG004|Overall Study|Physician Decision|2|||
131615611|NCT01640951|473882354|FG005|Overall Study|Physician Decision|3|||
131615612|NCT01640951|473882355|FG006|Overall Study|Physician Decision|3|||
131615613|NCT01640951|473882356|FG007|Overall Study|Physician Decision|0|||
131615614|NCT01640951|473882349|FG000|Overall Study|Pregnancy|3|||
131615615|NCT01640951|473882350|FG001|Overall Study|Pregnancy|0|||
131615616|NCT01640951|473882351|FG002|Overall Study|Pregnancy|0|||
131615617|NCT01640951|473882352|FG003|Overall Study|Pregnancy|4|||
131615618|NCT01640951|473882353|FG004|Overall Study|Pregnancy|0|||
131615619|NCT01640951|473882354|FG005|Overall Study|Pregnancy|0|||
131615620|NCT01640951|473882355|FG006|Overall Study|Pregnancy|2|||
131615621|NCT01640951|473882356|FG007|Overall Study|Pregnancy|0|||
131615622|NCT01640951|473882349|FG000|Overall Study|Protocol Deviation|0|||
131615623|NCT01640951|473882350|FG001|Overall Study|Protocol Deviation|1|||
131615624|NCT01640951|473882351|FG002|Overall Study|Protocol Deviation|2|||
131615625|NCT01640951|473882352|FG003|Overall Study|Protocol Deviation|1|||
131615626|NCT01640951|473882353|FG004|Overall Study|Protocol Deviation|0|||
131615627|NCT01640951|473882354|FG005|Overall Study|Protocol Deviation|1|||
131615628|NCT01640951|473882355|FG006|Overall Study|Protocol Deviation|0|||
131615629|NCT01640951|473882356|FG007|Overall Study|Protocol Deviation|0|||
131615630|NCT01640951|473882349|FG000|Overall Study|Subject/Guardian decision|12|||
131615631|NCT01640951|473882350|FG001|Overall Study|Subject/Guardian decision|4|||
131615632|NCT01640951|473882351|FG002|Overall Study|Subject/Guardian decision|13|||
131709077|NCT00408005|474215569|FG000|Induction|Adverse Event|19|||
131443519|NCT01345240|473252675|FG001|Overall Study|Lost to Follow-up|9|||
131615633|NCT01640951|473882352|FG003|Overall Study|Subject/Guardian decision|15|||
131709078|NCT00408005|474215570|FG001|Induction|Adverse Event|3|||
131709079|NCT00408005|474215571|FG002|Induction|Adverse Event|0|||
131615634|NCT01640951|473882353|FG004|Overall Study|Subject/Guardian decision|7|||
131615635|NCT01640951|473882354|FG005|Overall Study|Subject/Guardian decision|19|||
131615636|NCT01640951|473882355|FG006|Overall Study|Subject/Guardian decision|5|||
131615637|NCT01640951|473882356|FG007|Overall Study|Subject/Guardian decision|4|||
131615638|NCT01640951|473882349|FG000|Overall Study|Death|0|||
131615639|NCT01640951|473882350|FG001|Overall Study|Death|1|||
131615640|NCT01640951|473882351|FG002|Overall Study|Death|1|||
131615641|NCT01640951|473882352|FG003|Overall Study|Death|0|||
131615642|NCT01640951|473882353|FG004|Overall Study|Death|0|||
131443520|NCT01345240|473252676|FG002|Overall Study|Lost to Follow-up|14|||
131615643|NCT01640951|473882354|FG005|Overall Study|Death|0|||
131615644|NCT01640951|473882355|FG006|Overall Study|Death|0|||
131615645|NCT01640951|473882356|FG007|Overall Study|Death|2|||
131615646|NCT02040870|473882357|FG000|Overall Study|Completed treatment phase|6|||
131709080|NCT00408005|474215572|FG003|Induction|Adverse Event|0|||
131615647|NCT02040870|473882357|FG000|Overall Study|Adverse Event|7|||
131615648|NCT02040870|473882357|FG000|Overall Study|Progressive disease|58|||
131615649|NCT02040870|473882357|FG000|Overall Study|Physician Decision|6|||
131615650|NCT02040870|473882357|FG000|Overall Study|Subject/guardian decision|10|||
131615651|NCT02040870|473882357|FG000|Overall Study|Lost to Follow-up|3|||
131615652|NCT02040870|473882357|FG000|Overall Study|Death|13|||
131615653|NCT04971733|473882358|FG000|Overall Study|Adverse Event|1|||
131615654|NCT04971733|473882359|FG001|Overall Study|Adverse Event|1|||
131615655|NCT04971733|473882358|FG000|Overall Study|Subject choice|2|||
131615656|NCT04971733|473882359|FG001|Overall Study|Subject choice|0|||
131615657|NCT04971733|473882358|FG000|Overall Study|Withdrawal by Subject|1|||
131615658|NCT04971733|473882359|FG001|Overall Study|Withdrawal by Subject|0|||
131615659|NCT04971733|473882358|FG000|Overall Study|Other|1|||
131615660|NCT04971733|473882359|FG001|Overall Study|Other|0|||
131615661|NCT02275611|473882362|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
131615662|NCT02275611|473882363|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
131615663|NCT02275611|473882364|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
131615664|NCT02275611|473882365|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
131615665|NCT02406092|473882369|FG000|Overall Study|Screen failure|10|||
131615666|NCT02406092|473882370|FG001|Overall Study|Screen failure|7|||
131615667|NCT02406092|473882369|FG000|Overall Study|Death|22|||
131615668|NCT02406092|473882370|FG001|Overall Study|Death|5|||
131615669|NCT02406092|473882369|FG000|Overall Study|Lost to Follow-up|4|||
131615670|NCT02406092|473882370|FG001|Overall Study|Lost to Follow-up|1|||
131615671|NCT02406092|473882369|FG000|Overall Study|Adverse Event|1|||
131615672|NCT02406092|473882370|FG001|Overall Study|Adverse Event|0|||
131615673|NCT02406092|473882369|FG000|Overall Study|Withdrawal by Subject|1|||
131615674|NCT02406092|473882370|FG001|Overall Study|Withdrawal by Subject|0|||
131615675|NCT01759862|473882373|FG000|Overall Study|Physician Decision|3|||
131615676|NCT01759862|473882374|FG001|Overall Study|Physician Decision|1|||
131615677|NCT01759862|473882373|FG000|Overall Study|Adverse Event|0|||
131615678|NCT01759862|473882374|FG001|Overall Study|Adverse Event|1|||
131615679|NCT01593020|473882377|FG000|Overall Study|Adverse Event|1|||
131615680|NCT01593020|473882378|FG001|Overall Study|Adverse Event|1|||
131615681|NCT01593020|473882377|FG000|Overall Study|Death|0|||
131615682|NCT01593020|473882378|FG001|Overall Study|Death|1|||
131615683|NCT01593020|473882377|FG000|Overall Study|Ineligible|1|||
131615684|NCT01593020|473882378|FG001|Overall Study|Ineligible|0|||
131615685|NCT01532999|473882382|FG000|Overall Study|Lost to Follow-up|14|||
131615686|NCT01532999|473882383|FG001|Overall Study|Lost to Follow-up|8|||
131615687|NCT01532999|473882382|FG000|Overall Study|Physician Decision|1|||
131615688|NCT01532999|473882383|FG001|Overall Study|Physician Decision|2|||
131615689|NCT01532999|473882382|FG000|Overall Study|Withdrawal by Subject|5|||
131615690|NCT01532999|473882383|FG001|Overall Study|Withdrawal by Subject|0|||
131615691|NCT01532999|473882382|FG000|Overall Study|Relocated|2|||
131615692|NCT01532999|473882383|FG001|Overall Study|Relocated|0|||
131615693|NCT01532999|473882382|FG000|Overall Study|should not have been randomized|1|||
131615694|NCT01532999|473882383|FG001|Overall Study|should not have been randomized|0|||
131615695|NCT01532999|473882382|FG000|Overall Study|substantial noncompliance|2|||
131615696|NCT01532999|473882383|FG001|Overall Study|substantial noncompliance|0|||
131615697|NCT01532999|473882382|FG000|Overall Study|no show for week 9 assessments|6|||
131615698|NCT01532999|473882383|FG001|Overall Study|no show for week 9 assessments|4|||
131615699|NCT01532999|473882382|FG000|Overall Study|Adverse Event|0|||
131615700|NCT01532999|473882383|FG001|Overall Study|Adverse Event|1|||
131615701|NCT01532999|473882382|FG000|Overall Study|incarcerated|0|||
131615702|NCT01532999|473882383|FG001|Overall Study|incarcerated|1|||
131615703|NCT01532999|473882382|FG000|Overall Study|New job|0|||
131615704|NCT01532999|473882383|FG001|Overall Study|New job|2|||
131615705|NCT05251363|473882384|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
131615706|NCT05251363|473882384|FG000|Overall Study After Implant Period|Death|9|||
131615707|NCT05251363|473882384|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
131615708|NCT05251363|473882384|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
131615709|NCT05251363|473882384|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
131615710|NCT05251363|473882384|FG000|Overall Study After Implant Period|Physician Decision|1|||
131615711|NCT05251363|473882384|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
131615712|NCT03835754|473882387|FG000|Overall Study|Death|4|||
131615713|NCT04686266|473882390|FG000|Overall Study|Withdrawal by Subject|0|||
131615714|NCT04686266|473882391|FG001|Overall Study|Withdrawal by Subject|1|||
131615715|NCT04445831|473882392|FG000|Overall Study|Withdrawal by Subject|2|||
131615716|NCT04445831|473882393|FG001|Overall Study|Withdrawal by Subject|1|||
131615717|NCT04445831|473882394|FG002|Overall Study|Withdrawal by Subject|1|||
131615718|NCT04445831|473882395|FG003|Overall Study|Withdrawal by Subject|0|||
131615719|NCT04445831|473882396|FG004|Overall Study|Withdrawal by Subject|0|||
131615720|NCT04445831|473882397|FG005|Overall Study|Withdrawal by Subject|0|||
131615721|NCT04445831|473882398|FG006|Overall Study|Withdrawal by Subject|0|||
131709081|NCT00408005|474215573|FG004|Induction|Adverse Event|0|||
131709082|NCT00408005|474215574|FG005|Induction|Adverse Event|0|||
131709083|NCT00408005|474215575|FG006|Induction|Adverse Event|0|||
131709084|NCT00408005|474215576|FG007|Induction|Adverse Event|0|||
131709085|NCT00408005|474215569|FG000|Induction|Death|6|||
131709086|NCT00408005|474215570|FG001|Induction|Death|0|||
131709087|NCT00408005|474215571|FG002|Induction|Death|0|||
131709088|NCT00408005|474215572|FG003|Induction|Death|0|||
131709089|NCT00408005|474215573|FG004|Induction|Death|0|||
131709090|NCT00408005|474215574|FG005|Induction|Death|0|||
131709091|NCT00408005|474215575|FG006|Induction|Death|0|||
131709092|NCT00408005|474215576|FG007|Induction|Death|0|||
131709093|NCT00408005|474215569|FG000|Induction|Physician Decision|83|||
131709094|NCT00408005|474215570|FG001|Induction|Physician Decision|9|||
131709095|NCT00408005|474215571|FG002|Induction|Physician Decision|0|||
131709096|NCT00408005|474215572|FG003|Induction|Physician Decision|0|||
131709097|NCT00408005|474215573|FG004|Induction|Physician Decision|0|||
131709098|NCT00408005|474215574|FG005|Induction|Physician Decision|0|||
131709099|NCT00408005|474215575|FG006|Induction|Physician Decision|0|||
131709100|NCT00408005|474215576|FG007|Induction|Physician Decision|0|||
131615722|NCT04445831|473882392|FG000|Overall Study|Subject withdrawal by caregiver|0|||
131615723|NCT04445831|473882393|FG001|Overall Study|Subject withdrawal by caregiver|1|||
131615724|NCT04445831|473882394|FG002|Overall Study|Subject withdrawal by caregiver|0|||
131615725|NCT04445831|473882395|FG003|Overall Study|Subject withdrawal by caregiver|0|||
131615726|NCT04445831|473882396|FG004|Overall Study|Subject withdrawal by caregiver|0|||
131615727|NCT04445831|473882397|FG005|Overall Study|Subject withdrawal by caregiver|0|||
131615728|NCT04445831|473882398|FG006|Overall Study|Subject withdrawal by caregiver|0|||
131615729|NCT04912856|473882404|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
131615730|NCT04912856|473882405|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
131615731|NCT04912856|473882404|FG000|Overall Study|Not reported in synoptic CSR.|0|||
131615732|NCT04912856|473882405|FG001|Overall Study|Not reported in synoptic CSR.|1|||
131615733|NCT00748709|473882406|FG000|Overall Study|Progressive disease|15|||
131615734|NCT00748709|473882406|FG000|Overall Study|Drug reducing Toxity|2|||
131615735|NCT00748709|473882406|FG000|Overall Study|Other Adverse Event|1|||
131615736|NCT00748709|473882406|FG000|Overall Study|Withdrawal by Subject|1|||
131615737|NCT00748709|473882406|FG000|Overall Study|Other Reasons|1|||
131615738|NCT06056310|473883574|FG000|Overall Study|Other Reasons|2|||
131615739|NCT06056310|473883574|FG000|Overall Study|Sponsor Request|16|||
131615740|NCT05029284|473883577|FG000|Overall Study|Lost to Follow-up|1|||
131615741|NCT01737398|473883578|FG000|Overall Study|Adverse event or SAE|16|||
131615742|NCT01737398|473883579|FG001|Overall Study|Adverse event or SAE|1|||
131615743|NCT01737398|473883578|FG000|Overall Study|Stopping rule met|2|||
131615744|NCT01737398|473883579|FG001|Overall Study|Stopping rule met|1|||
131615745|NCT01737398|473883578|FG000|Overall Study|Voluntary withdrawal|2|||
131615746|NCT01737398|473883579|FG001|Overall Study|Voluntary withdrawal|3|||
131615747|NCT01737398|473883578|FG000|Overall Study|Ineligibility|1|||
131615748|NCT01737398|473883579|FG001|Overall Study|Ineligibility|0|||
131615749|NCT01737398|473883578|FG000|Overall Study|Liver transplant|1|||
131615750|NCT01737398|473883579|FG001|Overall Study|Liver transplant|0|||
131615751|NCT01737398|473883578|FG000|Overall Study|Disease progression|2|||
131615752|NCT01737398|473883579|FG001|Overall Study|Disease progression|3|||
131615753|NCT01737398|473883578|FG000|Overall Study|Sponsor's decision|2|||
131615754|NCT01737398|473883579|FG001|Overall Study|Sponsor's decision|0|||
131615755|NCT05250115|473883580|FG000|Overall Study|Premature study end|40|||
131615756|NCT05250115|473883580|FG000|Overall Study|Adverse Event|8|||
131615757|NCT05250115|473883580|FG000|Overall Study|Lost to Follow-up|7|||
131615758|NCT05250115|473883580|FG000|Overall Study|Withdrawal by Subject|6|||
131615759|NCT05250115|473883580|FG000|Overall Study|Withdrawal of informed consent|1|||
131615760|NCT05250115|473883580|FG000|Overall Study|Other|7|||
131615761|NCT01478594|473883587|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
131615762|NCT01478594|473883588|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
131615763|NCT01478594|473883587|FG000|Overall Study|Death|45|||
131709101|NCT00408005|474215569|FG000|Induction|Withdrawal by Subject|2|||
131709102|NCT00408005|474215570|FG001|Induction|Withdrawal by Subject|4|||
131709103|NCT00408005|474215571|FG002|Induction|Withdrawal by Subject|0|||
131709104|NCT00408005|474215572|FG003|Induction|Withdrawal by Subject|0|||
131709105|NCT00408005|474215573|FG004|Induction|Withdrawal by Subject|0|||
131709106|NCT00408005|474215574|FG005|Induction|Withdrawal by Subject|0|||
131709107|NCT00408005|474215575|FG006|Induction|Withdrawal by Subject|0|||
131615764|NCT01478594|473883588|FG001|Overall Study|Death|18|||
131615765|NCT01478594|473883587|FG000|Overall Study|Lost to Follow-up|3|||
131615766|NCT01478594|473883588|FG001|Overall Study|Lost to Follow-up|1|||
131615767|NCT01478594|473883587|FG000|Overall Study|Withdrawal by Subject|9|||
131615768|NCT01478594|473883588|FG001|Overall Study|Withdrawal by Subject|3|||
131615769|NCT01478594|473883587|FG000|Overall Study|Study Closed by Sponsor|8|||
131615770|NCT01478594|473883588|FG001|Overall Study|Study Closed by Sponsor|5|||
131709108|NCT00408005|474215576|FG007|Induction|Withdrawal by Subject|0|||
131709109|NCT00408005|474215569|FG000|Induction|Ineligible|33|||
131709110|NCT00408005|474215570|FG001|Induction|Ineligible|14|||
131709111|NCT00408005|474215571|FG002|Induction|Ineligible|0|||
131709112|NCT00408005|474215572|FG003|Induction|Ineligible|0|||
131709113|NCT00408005|474215573|FG004|Induction|Ineligible|0|||
131709114|NCT00408005|474215574|FG005|Induction|Ineligible|0|||
131615771|NCT04885998|473883589|FG000|Overall Study|Withdrawal by Subject|0|||
131615772|NCT04885998|473883590|FG001|Overall Study|Withdrawal by Subject|2|||
131615773|NCT04885998|473883591|FG002|Overall Study|Withdrawal by Subject|0|||
131615774|NCT04885998|473883592|FG003|Overall Study|Withdrawal by Subject|3|||
131615775|NCT04885998|473883589|FG000|Overall Study|Lost to Follow-up|1|||
131615776|NCT04885998|473883590|FG001|Overall Study|Lost to Follow-up|1|||
131615777|NCT04885998|473883591|FG002|Overall Study|Lost to Follow-up|0|||
131615778|NCT04885998|473883592|FG003|Overall Study|Lost to Follow-up|0|||
131615779|NCT04885998|473883589|FG000|Overall Study|Death|2|||
131615780|NCT04885998|473883590|FG001|Overall Study|Death|1|||
131615781|NCT04885998|473883591|FG002|Overall Study|Death|2|||
131615782|NCT04885998|473883592|FG003|Overall Study|Death|2|||
131615783|NCT04885998|473883589|FG000|Overall Study|Decision by sponsor|1|||
131615784|NCT04885998|473883590|FG001|Overall Study|Decision by sponsor|1|||
131615785|NCT04885998|473883591|FG002|Overall Study|Decision by sponsor|0|||
131615786|NCT04885998|473883592|FG003|Overall Study|Decision by sponsor|0|||
131615787|NCT03712371|473883594|FG000|Overall Study|Lack of Efficacy|0|||
131615788|NCT03712371|473883595|FG001|Overall Study|Lack of Efficacy|0|||
131615789|NCT03712371|473883596|FG002|Overall Study|Lack of Efficacy|0|||
131615790|NCT03712371|473883597|FG003|Overall Study|Lack of Efficacy|1|||
131615791|NCT02788981|473883602|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
131615792|NCT02788981|473883603|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
131615793|NCT01953224|473883606|FG000|Overall Study|Lost to Follow-up|1|||
131615794|NCT01953224|473883607|FG001|Overall Study|Lost to Follow-up|1|||
131615795|NCT01953224|473883606|FG000|Overall Study|Withdrawal by Subject|1|||
131615796|NCT01953224|473883607|FG001|Overall Study|Withdrawal by Subject|2|||
131615797|NCT01359150|473883608|FG000|Overall Study|Lack of Efficacy|1|||
131615798|NCT01359150|473883609|FG001|Overall Study|Lack of Efficacy|1|||
131615799|NCT01359150|473883608|FG000|Overall Study|Withdrawal by Subject|1|||
131615800|NCT01359150|473883609|FG001|Overall Study|Withdrawal by Subject|1|||
131615801|NCT01359150|473883608|FG000|Overall Study|Adverse Event|4|||
131615802|NCT01359150|473883609|FG001|Overall Study|Adverse Event|3|||
131615803|NCT01359150|473883608|FG000|Overall Study|Other|1|||
131615804|NCT01359150|473883609|FG001|Overall Study|Other|0|||
131615805|NCT03890289|473883610|FG000|Overall Study|Adverse Event|1|||
131615806|NCT03890289|473883610|FG000|Overall Study|Physician Decision|1|||
131615807|NCT03890289|473883610|FG000|Overall Study|Lack of Efficacy|2|||
131615808|NCT02816398|473883613|FG000|Overall Study|Death|5|||
131615809|NCT02816398|473883613|FG000|Overall Study|Lack of Efficacy|8|||
131615810|NCT02816398|473883613|FG000|Overall Study|Lost to Follow-up|1|||
131615811|NCT03362190|473883617|FG000|Overall Study|Adverse Event|0|||
131615812|NCT03362190|473883618|FG001|Overall Study|Adverse Event|0|||
131615813|NCT03362190|473883619|FG002|Overall Study|Adverse Event|0|||
131615814|NCT03362190|473883620|FG003|Overall Study|Adverse Event|1|||
131615815|NCT03362190|473883617|FG000|Overall Study|Withdrawal by Subject|0|||
131615816|NCT03362190|473883618|FG001|Overall Study|Withdrawal by Subject|0|||
131615817|NCT03362190|473883619|FG002|Overall Study|Withdrawal by Subject|0|||
131615818|NCT03362190|473883620|FG003|Overall Study|Withdrawal by Subject|1|||
131615819|NCT00687219|473883621|FG000|Overall Study|Adverse Event|8|||
131615820|NCT00687219|473883621|FG000|Overall Study|Discontinuance criteria met|7|||
131615821|NCT00687219|473883621|FG000|Overall Study|HCV-RNA positive conversion|34|||
131615822|NCT00687219|473883621|FG000|Overall Study|Withdrawal by Subject|1|||
131615823|NCT00687219|473883621|FG000|Overall Study|Lack of Efficacy|1|||
131615824|NCT01588951|473883627|FG000|Overall Study|Ineligible in retrospect|0|||
131615825|NCT01588951|473883628|FG001|Overall Study|Ineligible in retrospect|0|||
131615826|NCT01588951|473883629|FG002|Overall Study|Ineligible in retrospect|1|||
131615827|NCT02628626|473883630|FG000|Overall Study|Withdrawal by Subject|2|||
131615828|NCT02628626|473883631|FG001|Overall Study|Withdrawal by Subject|2|||
131615829|NCT01400958|473883640|FG000|Overall Study|Physician Decision|0|||
131615830|NCT01400958|473883641|FG001|Overall Study|Physician Decision|1|||
131615831|NCT01400958|473883640|FG000|Overall Study|Withdrawal by Subject|0|||
131615832|NCT01400958|473883641|FG001|Overall Study|Withdrawal by Subject|1|||
131615833|NCT01400958|473883640|FG000|Overall Study|Adverse Event|1|||
131615834|NCT01400958|473883641|FG001|Overall Study|Adverse Event|0|||
131615835|NCT02063659|473883647|FG000|Double-Blind Treatment Period|Adverse Event|1|||
131615836|NCT02063659|473883648|FG001|Double-Blind Treatment Period|Adverse Event|2|||
131615837|NCT02063659|473883649|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131615838|NCT02063659|473883650|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131615839|NCT02063659|473883647|FG000|Double-Blind Treatment Period|Physician Decision|1|||
131615840|NCT02063659|473883648|FG001|Double-Blind Treatment Period|Physician Decision|0|||
131615841|NCT02063659|473883649|FG002|Double-Blind Treatment Period|Physician Decision|0|||
131615842|NCT02063659|473883650|FG003|Double-Blind Treatment Period|Physician Decision|0|||
131615843|NCT02063659|473883647|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
131615844|NCT02063659|473883648|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
131615845|NCT02063659|473883649|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
131615846|NCT02063659|473883650|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
131615847|NCT02063659|473883647|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
131615848|NCT02063659|473883648|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
131615849|NCT02063659|473883649|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
131615850|NCT02063659|473883650|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
131615851|NCT02063659|473883647|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131615852|NCT02063659|473883648|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131615853|NCT02063659|473883649|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131615854|NCT02063659|473883650|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
131615855|NCT02063659|473883647|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131615856|NCT02063659|473883648|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131615857|NCT02063659|473883649|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131615858|NCT02063659|473883650|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
131615859|NCT02063659|473883647|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
131615860|NCT02063659|473883648|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
131615861|NCT02063659|473883649|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
131615862|NCT02063659|473883650|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
131615863|NCT02063659|473883647|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131615864|NCT02063659|473883648|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131615865|NCT02063659|473883649|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131615866|NCT02063659|473883650|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
131615867|NCT02972359|473883651|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
131615868|NCT02972359|473883651|FG000|Overall Study|Lack of Efficacy|1|||
131615869|NCT02972359|473883651|FG000|Overall Study|Adverse Event|4|||
131615870|NCT02972359|473883651|FG000|Overall Study|Death|1|||
131615871|NCT02972359|473883651|FG000|Overall Study|Withdrawal by Subject|30|||
131615872|NCT02972359|473883651|FG000|Overall Study|Protocol Violation|1|||
131615873|NCT02972359|473883651|FG000|Overall Study|Lost to Follow-up|26|||
131615874|NCT02972359|473883651|FG000|Overall Study|Other reasons|5|||
131615875|NCT02972359|473883651|FG000|Overall Study|Missing|1|||
131709115|NCT00408005|474215575|FG006|Induction|Ineligible|0|||
131709116|NCT00408005|474215576|FG007|Induction|Ineligible|0|||
131709117|NCT00408005|474215569|FG000|Induction|Refusal of Further Protocol Therapy|225|||
131709118|NCT00408005|474215570|FG001|Induction|Refusal of Further Protocol Therapy|44|||
131709119|NCT00408005|474215571|FG002|Induction|Refusal of Further Protocol Therapy|0|||
131709120|NCT00408005|474215572|FG003|Induction|Refusal of Further Protocol Therapy|0|||
131709121|NCT00408005|474215573|FG004|Induction|Refusal of Further Protocol Therapy|0|||
131709122|NCT00408005|474215574|FG005|Induction|Refusal of Further Protocol Therapy|0|||
131709123|NCT00408005|474215575|FG006|Induction|Refusal of Further Protocol Therapy|0|||
131709124|NCT00408005|474215576|FG007|Induction|Refusal of Further Protocol Therapy|0|||
131709125|NCT00408005|474215569|FG000|Induction|Entered another COG therapeutic protocol|4|||
131709126|NCT00408005|474215570|FG001|Induction|Entered another COG therapeutic protocol|0|||
131709127|NCT00408005|474215571|FG002|Induction|Entered another COG therapeutic protocol|0|||
131709128|NCT00408005|474215572|FG003|Induction|Entered another COG therapeutic protocol|0|||
131709129|NCT00408005|474215573|FG004|Induction|Entered another COG therapeutic protocol|0|||
131709130|NCT00408005|474215574|FG005|Induction|Entered another COG therapeutic protocol|0|||
131709131|NCT00408005|474215575|FG006|Induction|Entered another COG therapeutic protocol|0|||
131709132|NCT00408005|474215576|FG007|Induction|Entered another COG therapeutic protocol|0|||
131709133|NCT00408005|474215569|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
131709134|NCT00408005|474215570|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
131709135|NCT00408005|474215571|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
131709136|NCT00408005|474215572|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
131709137|NCT00408005|474215573|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
131709138|NCT00408005|474215574|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
131709139|NCT00408005|474215575|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
131709140|NCT00408005|474215576|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
131709141|NCT00408005|474215569|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
131709142|NCT00408005|474215570|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
131709143|NCT00408005|474215571|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
131709144|NCT00408005|474215572|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
131709145|NCT00408005|474215573|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
131709146|NCT00408005|474215574|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
131709147|NCT00408005|474215575|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
131709148|NCT00408005|474215576|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
131709149|NCT00408005|474215569|FG000|Induction|Progressive Disease|0|||
131709150|NCT00408005|474215570|FG001|Induction|Progressive Disease|1|||
131709151|NCT00408005|474215571|FG002|Induction|Progressive Disease|0|||
131709152|NCT00408005|474215572|FG003|Induction|Progressive Disease|0|||
131709153|NCT00408005|474215573|FG004|Induction|Progressive Disease|0|||
131615876|NCT02830204|473883654|FG000|Overall Study|Death|9|||
131709154|NCT00408005|474215574|FG005|Induction|Progressive Disease|0|||
131709155|NCT00408005|474215575|FG006|Induction|Progressive Disease|0|||
131709156|NCT00408005|474215576|FG007|Induction|Progressive Disease|0|||
131709157|NCT00408005|474215569|FG000|Induction|Inevaluable|18|||
131709158|NCT00408005|474215570|FG001|Induction|Inevaluable|14|||
131709159|NCT00408005|474215571|FG002|Induction|Inevaluable|0|||
131709160|NCT00408005|474215572|FG003|Induction|Inevaluable|0|||
131709161|NCT00408005|474215573|FG004|Induction|Inevaluable|0|||
131709162|NCT00408005|474215574|FG005|Induction|Inevaluable|0|||
131709163|NCT00408005|474215575|FG006|Induction|Inevaluable|0|||
131709164|NCT00408005|474215576|FG007|Induction|Inevaluable|0|||
131709165|NCT00408005|474215569|FG000|Induction|Failed to Complete Randomization|3|||
131709166|NCT00408005|474215570|FG001|Induction|Failed to Complete Randomization|2|||
131709167|NCT00408005|474215571|FG002|Induction|Failed to Complete Randomization|0|||
131709168|NCT00408005|474215572|FG003|Induction|Failed to Complete Randomization|0|||
131709169|NCT00408005|474215573|FG004|Induction|Failed to Complete Randomization|0|||
131709170|NCT00408005|474215574|FG005|Induction|Failed to Complete Randomization|0|||
131709171|NCT00408005|474215575|FG006|Induction|Failed to Complete Randomization|0|||
131709172|NCT00408005|474215576|FG007|Induction|Failed to Complete Randomization|0|||
131615877|NCT02830204|473883654|FG000|Overall Study|Withdrawal by Subject|1|||
131615878|NCT02517268|473883659|FG000|Overall Study|Withdrawal by Subject|1|||
131615879|NCT02517268|473883660|FG001|Overall Study|Withdrawal by Subject|0|||
131615880|NCT05470114|473883673|FG000|Overall Study|Withdrawal by Subject|1|||
131615881|NCT05470114|473883674|FG001|Overall Study|Withdrawal by Subject|0|||
131615882|NCT05470114|473883673|FG000|Overall Study|Lost to Follow-up|1|||
131615883|NCT05470114|473883674|FG001|Overall Study|Lost to Follow-up|0|||
131615884|NCT05037513|473883675|FG000|Intervention Period|Lost to Follow-up|1|||
131615885|NCT05037513|473883676|FG001|Intervention Period|Lost to Follow-up|2|||
131615886|NCT05037513|473883675|FG000|Follow Up Period|Lost to Follow-up|16|||
131615887|NCT05037513|473883676|FG001|Follow Up Period|Lost to Follow-up|21|||
131615888|NCT05037513|473883675|FG000|Follow Up Period|Death|0|||
131615889|NCT05037513|473883676|FG001|Follow Up Period|Death|1|||
131615890|NCT05037513|473883675|FG000|Follow Up Period|Incarcerated|4|||
131615891|NCT05037513|473883676|FG001|Follow Up Period|Incarcerated|2|||
131615892|NCT01563185|473883680|FG000|Overall Study|Withdrawal by Subject|1|||
131615893|NCT01563185|473883680|FG000|Overall Study|Non-Compliance with study drug|1|||
131615894|NCT04577651|473883681|FG000|Overall Study|Screen Failure|7|||
131615895|NCT04577651|473883681|FG000|Overall Study|Adverse Event|1|||
131615896|NCT04577651|473883681|FG000|Overall Study|Death|1|||
131615897|NCT04577651|473883681|FG000|Overall Study|Physician Decision|1|||
131615898|NCT04577651|473883681|FG000|Overall Study|Withdrawal by Subject|3|||
131615899|NCT04001829|473885070|FG000|Overall Study|Never start protocol therapy|5|||
131615900|NCT04001829|473885071|FG001|Overall Study|Never start protocol therapy|5|||
131615901|NCT04001829|473885070|FG000|Overall Study|Adverse Event|11|||
131615902|NCT04001829|473885071|FG001|Overall Study|Adverse Event|7|||
131615903|NCT04001829|473885070|FG000|Overall Study|Alternative therapy|1|||
131615904|NCT04001829|473885071|FG001|Overall Study|Alternative therapy|2|||
131615905|NCT04001829|473885070|FG000|Overall Study|Disease progression/relapse|2|||
131615906|NCT04001829|473885071|FG001|Overall Study|Disease progression/relapse|1|||
131615907|NCT04001829|473885070|FG000|Overall Study|Other complicating disease|1|||
131615908|NCT04001829|473885071|FG001|Overall Study|Other complicating disease|0|||
131615909|NCT04001829|473885070|FG000|Overall Study|Withdrawal by Subject|1|||
131615910|NCT04001829|473885071|FG001|Overall Study|Withdrawal by Subject|4|||
131615911|NCT04001829|473885070|FG000|Overall Study|Ineligible|2|||
131615912|NCT04001829|473885071|FG001|Overall Study|Ineligible|2|||
131615913|NCT04001829|473885070|FG000|Overall Study|Reason missing due to delinquent data|1|||
131709173|NCT00408005|474215569|FG000|Induction|Protocol Deviation|3|||
131709174|NCT00408005|474215570|FG001|Induction|Protocol Deviation|1|||
131709175|NCT00408005|474215571|FG002|Induction|Protocol Deviation|0|||
131709176|NCT00408005|474215572|FG003|Induction|Protocol Deviation|0|||
131709177|NCT00408005|474215573|FG004|Induction|Protocol Deviation|0|||
131709178|NCT00408005|474215574|FG005|Induction|Protocol Deviation|0|||
131709179|NCT00408005|474215575|FG006|Induction|Protocol Deviation|0|||
131709180|NCT00408005|474215576|FG007|Induction|Protocol Deviation|0|||
131709181|NCT00408005|474215569|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
131795263|NCT01628120|474533913|FG000|Overall Study|Lost to Follow-up|1|||
131615914|NCT04001829|473885071|FG001|Overall Study|Reason missing due to delinquent data|0|||
131615915|NCT00985088|473885072|FG000|Overall Study|Serious Adverse Event|1|||
131615916|NCT00985088|473885073|FG001|Overall Study|Serious Adverse Event|1|||
131615917|NCT00985088|473885074|FG002|Overall Study|Serious Adverse Event|0|||
131709182|NCT00408005|474215570|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
131615918|NCT00985088|473885075|FG003|Overall Study|Serious Adverse Event|0|||
131615919|NCT00985088|473885076|FG004|Overall Study|Serious Adverse Event|0|||
131615920|NCT00985088|473885077|FG005|Overall Study|Serious Adverse Event|0|||
131615921|NCT00985088|473885078|FG006|Overall Study|Serious Adverse Event|0|||
131615922|NCT00985088|473885079|FG007|Overall Study|Serious Adverse Event|1|||
131615923|NCT00985088|473885072|FG000|Overall Study|Adverse Event|0|||
131709183|NCT00408005|474215571|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
131615924|NCT00985088|473885073|FG001|Overall Study|Adverse Event|0|||
131615925|NCT00985088|473885074|FG002|Overall Study|Adverse Event|1|||
131615926|NCT00985088|473885075|FG003|Overall Study|Adverse Event|0|||
131615927|NCT00985088|473885076|FG004|Overall Study|Adverse Event|0|||
131615928|NCT00985088|473885077|FG005|Overall Study|Adverse Event|0|||
131615929|NCT00985088|473885078|FG006|Overall Study|Adverse Event|0|||
131615930|NCT00985088|473885079|FG007|Overall Study|Adverse Event|0|||
131615931|NCT00985088|473885072|FG000|Overall Study|Withdrawal by Subject|4|||
131615932|NCT00985088|473885073|FG001|Overall Study|Withdrawal by Subject|0|||
131615933|NCT00985088|473885074|FG002|Overall Study|Withdrawal by Subject|0|||
131615934|NCT00985088|473885075|FG003|Overall Study|Withdrawal by Subject|1|||
131615935|NCT00985088|473885076|FG004|Overall Study|Withdrawal by Subject|3|||
131615936|NCT00985088|473885077|FG005|Overall Study|Withdrawal by Subject|2|||
131615937|NCT00985088|473885078|FG006|Overall Study|Withdrawal by Subject|1|||
131615938|NCT00985088|473885079|FG007|Overall Study|Withdrawal by Subject|2|||
131615939|NCT00985088|473885072|FG000|Overall Study|Migrated/moved from study area|0|||
131615940|NCT00985088|473885073|FG001|Overall Study|Migrated/moved from study area|0|||
131615941|NCT00985088|473885074|FG002|Overall Study|Migrated/moved from study area|1|||
131615942|NCT00985088|473885075|FG003|Overall Study|Migrated/moved from study area|0|||
131615943|NCT00985088|473885076|FG004|Overall Study|Migrated/moved from study area|0|||
131615944|NCT00985088|473885077|FG005|Overall Study|Migrated/moved from study area|0|||
131615945|NCT00985088|473885078|FG006|Overall Study|Migrated/moved from study area|0|||
131795264|NCT01628120|474533913|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
131795265|NCT01628120|474533913|FG000|Overall Study|Non-compliant with Study Procedures|1|||
131795266|NCT01628120|474533913|FG000|Overall Study|Not Treated|3|||
131795267|NCT01628120|474533913|FG000|Overall Study|Sponsor Decision|5|||
131795268|NCT01628120|474533913|FG000|Overall Study|Switched Dialysis Method|2|||
131795269|NCT01628120|474533913|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
131795270|NCT01628120|474533913|FG000|Overall Study|Moved or Relocated|5|||
131795271|NCT01628120|474533913|FG000|Overall Study|Kidney Transplant|2|||
131795272|NCT01628120|474533913|FG000|Overall Study|Use of Standard of Care|1|||
131615946|NCT00985088|473885079|FG007|Overall Study|Migrated/moved from study area|1|||
131615947|NCT00985088|473885072|FG000|Overall Study|Lost to Follow-up|6|||
131615948|NCT00985088|473885073|FG001|Overall Study|Lost to Follow-up|1|||
131615949|NCT00985088|473885074|FG002|Overall Study|Lost to Follow-up|2|||
131615950|NCT00985088|473885075|FG003|Overall Study|Lost to Follow-up|6|||
131615951|NCT00985088|473885076|FG004|Overall Study|Lost to Follow-up|6|||
131615952|NCT00985088|473885077|FG005|Overall Study|Lost to Follow-up|5|||
131615953|NCT00985088|473885078|FG006|Overall Study|Lost to Follow-up|3|||
131615954|NCT00985088|473885079|FG007|Overall Study|Lost to Follow-up|2|||
131615955|NCT00790569|473885084|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
131615956|NCT00790569|473885085|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
131615957|NCT00790569|473885086|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
131615958|NCT00790569|473885084|FG000|End of Treatment (6 Month Interview)|Death|0|||
131615959|NCT00790569|473885085|FG001|End of Treatment (6 Month Interview)|Death|2|||
131615960|NCT00790569|473885086|FG002|End of Treatment (6 Month Interview)|Death|1|||
131615961|NCT00790569|473885084|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
131615962|NCT00790569|473885085|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
131615963|NCT00790569|473885086|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
131615964|NCT00790569|473885084|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
131615965|NCT00790569|473885085|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
131615966|NCT00790569|473885086|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
131615967|NCT00790569|473885084|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
131615968|NCT00790569|473885085|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
131615969|NCT00790569|473885086|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
131615970|NCT00790569|473885084|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
131615971|NCT00790569|473885085|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
131615972|NCT00790569|473885086|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
131615973|NCT03244800|473885088|FG000|Overall Study|Adverse Event|0|||
131615974|NCT03244800|473885089|FG001|Overall Study|Adverse Event|1|||
131615975|NCT03244800|473885090|FG002|Overall Study|Adverse Event|0|||
131615976|NCT03244800|473885091|FG003|Overall Study|Adverse Event|1|||
131615977|NCT03244800|473885088|FG000|Overall Study|Withdrew treatment|0|||
131615978|NCT03244800|473885089|FG001|Overall Study|Withdrew treatment|0|||
131615979|NCT03244800|473885090|FG002|Overall Study|Withdrew treatment|0|||
131615980|NCT03244800|473885091|FG003|Overall Study|Withdrew treatment|1|||
131615981|NCT00442104|473885093|FG000|Overall Study|Adverse Event|5|||
131615982|NCT00442104|473885093|FG000|Overall Study|Death|2|||
131615983|NCT00442104|473885093|FG000|Overall Study|Lost to Follow-up|3|||
131443521|NCT01345240|473252677|FG003|Overall Study|Lost to Follow-up|7|||
131615984|NCT00442104|473885093|FG000|Overall Study|Withdrawal by Subject|5|||
131443522|NCT01345240|473252678|FG004|Overall Study|Lost to Follow-up|9|||
131615985|NCT00442104|473885093|FG000|Overall Study|Insufficient Clinical Response|10|||
131615986|NCT00442104|473885093|FG000|Overall Study|Other|21|||
131795273|NCT01075763|474533916|FG000|Overall Study|Lost to Follow-up|2|||
131709184|NCT00408005|474215572|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
131709185|NCT00408005|474215573|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
131709186|NCT00408005|474215574|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
131709187|NCT00408005|474215575|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
131709188|NCT00408005|474215576|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
131615987|NCT00442104|473885093|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
131615988|NCT02362035|473885096|FG000|Overall Study|Death|67|||
131615989|NCT02362035|473885096|FG000|Overall Study|Lost to Follow-up|3|||
131615990|NCT02362035|473885096|FG000|Overall Study|Adverse Event|1|||
131615991|NCT02362035|473885096|FG000|Overall Study|Physician Decision|1|||
131615992|NCT02362035|473885096|FG000|Overall Study|Subject started another cancer therapy|10|||
131615993|NCT02362035|473885096|FG000|Overall Study|Study terminated by sponsor|45|||
131615994|NCT02362035|473885096|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
131615995|NCT02362035|473885096|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
131615996|NCT02362035|473885096|FG000|Overall Study|Disease progression|11|||
131615997|NCT02362035|473885096|FG000|Overall Study|Withdrawal by Subject|20|||
131615998|NCT04250194|473885097|FG000|Overall Study|Declined to schedule biopsy|6|||
131615999|NCT04250194|473885098|FG001|Overall Study|Declined to schedule biopsy|10|||
131616000|NCT04250194|473885097|FG000|Overall Study|Medically Unfit for Biopsy|2|||
131616001|NCT04250194|473885098|FG001|Overall Study|Medically Unfit for Biopsy|1|||
131616002|NCT04250194|473885097|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
131616003|NCT04250194|473885098|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
131616004|NCT04250194|473885097|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
131616005|NCT04250194|473885098|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
131616006|NCT04250194|473885097|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
131616007|NCT04250194|473885098|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
131616008|NCT00229658|473885103|FG000|Overall Study|Administrative|2|||
131616009|NCT00229658|473885104|FG001|Overall Study|Administrative|1|||
131616010|NCT00229658|473885103|FG000|Overall Study|Investigator decision|13|||
131616011|NCT00229658|473885104|FG001|Overall Study|Investigator decision|10|||
131616012|NCT00229658|473885103|FG000|Overall Study|Other|80|||
131616013|NCT00229658|473885104|FG001|Overall Study|Other|60|||
131616014|NCT00229658|473885103|FG000|Overall Study|Lost to Follow-up|82|||
131616015|NCT00229658|473885104|FG001|Overall Study|Lost to Follow-up|55|||
131616016|NCT00229658|473885103|FG000|Overall Study|Serious Adverse Event|2|||
131616017|NCT00229658|473885104|FG001|Overall Study|Serious Adverse Event|2|||
131616018|NCT00229658|473885103|FG000|Overall Study|Withdrawal of consent|46|||
131616019|NCT00229658|473885104|FG001|Overall Study|Withdrawal of consent|39|||
131616020|NCT00249769|473885105|FG000|Overall Study|Withdrawal by Subject|1|||
131616021|NCT00249769|473885106|FG001|Overall Study|Withdrawal by Subject|10|||
131616022|NCT00249769|473885107|FG002|Overall Study|Withdrawal by Subject|6|||
131616023|NCT00249769|473885105|FG000|Overall Study|Migration from Study Area|1|||
131616024|NCT00249769|473885106|FG001|Overall Study|Migration from Study Area|3|||
131616025|NCT00249769|473885107|FG002|Overall Study|Migration from Study Area|14|||
131616026|NCT00249769|473885105|FG000|Overall Study|Miscellaneous|0|||
131616027|NCT00249769|473885106|FG001|Overall Study|Miscellaneous|2|||
131616028|NCT00249769|473885107|FG002|Overall Study|Miscellaneous|2|||
131616029|NCT00249769|473885105|FG000|Overall Study|Adverse Event|0|||
131616030|NCT00249769|473885106|FG001|Overall Study|Adverse Event|0|||
131616031|NCT00249769|473885107|FG002|Overall Study|Adverse Event|1|||
131616032|NCT00249769|473885105|FG000|Overall Study|Physician Decision|0|||
131616033|NCT00249769|473885106|FG001|Overall Study|Physician Decision|0|||
131616034|NCT00249769|473885107|FG002|Overall Study|Physician Decision|2|||
131616035|NCT00249769|473885105|FG000|Overall Study|Lost to Follow-up|0|||
131616036|NCT00249769|473885106|FG001|Overall Study|Lost to Follow-up|0|||
131616037|NCT00249769|473885107|FG002|Overall Study|Lost to Follow-up|3|||
131616038|NCT02157116|473885108|FG000|Overall Study|Withdrawal by Subject|4|||
131616039|NCT02157116|473885108|FG000|Overall Study|Physician Decision|3|||
131616040|NCT02157116|473885108|FG000|Overall Study|Failed Screening|2|||
131616041|NCT00463229|473885109|FG000|Overall Study|Lost to Follow-up|5|||
131709189|NCT00408005|474215569|FG000|Induction|Recurrent leukemia|1|||
131709190|NCT00408005|474215570|FG001|Induction|Recurrent leukemia|0|||
131709191|NCT00408005|474215571|FG002|Induction|Recurrent leukemia|0|||
131709192|NCT00408005|474215572|FG003|Induction|Recurrent leukemia|0|||
131709193|NCT00408005|474215573|FG004|Induction|Recurrent leukemia|0|||
131709194|NCT00408005|474215574|FG005|Induction|Recurrent leukemia|0|||
131709195|NCT00408005|474215575|FG006|Induction|Recurrent leukemia|0|||
131709196|NCT00408005|474215576|FG007|Induction|Recurrent leukemia|0|||
131709197|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131709198|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131795274|NCT01075763|474533917|FG001|Overall Study|Lost to Follow-up|1|||
131616042|NCT00463229|473885110|FG001|Overall Study|Lost to Follow-up|7|||
131616043|NCT00463229|473885109|FG000|Overall Study|Death|4|||
131616044|NCT00463229|473885110|FG001|Overall Study|Death|3|||
131443523|NCT01502293|473252679|FG000|Overall Study|Progressive Disease|20|||
131443524|NCT01502293|473252680|FG001|Overall Study|Progressive Disease|12|||
131443525|NCT01502293|473252681|FG002|Overall Study|Progressive Disease|2|||
131443526|NCT01502293|473252679|FG000|Overall Study|Withdrawal by Subject|3|||
131443527|NCT01502293|473252680|FG001|Overall Study|Withdrawal by Subject|3|||
131443528|NCT01502293|473252681|FG002|Overall Study|Withdrawal by Subject|1|||
131443529|NCT01502293|473252679|FG000|Overall Study|Adverse Event|0|||
131443530|NCT01502293|473252680|FG001|Overall Study|Adverse Event|2|||
131443531|NCT01502293|473252681|FG002|Overall Study|Adverse Event|0|||
131443532|NCT01502293|473252679|FG000|Overall Study|Reason Not Specified|2|||
131443533|NCT01502293|473252680|FG001|Overall Study|Reason Not Specified|0|||
131443534|NCT01502293|473252681|FG002|Overall Study|Reason Not Specified|0|||
131443535|NCT01502293|473252679|FG000|Overall Study|Physician Decision|0|||
131443536|NCT01502293|473252680|FG001|Overall Study|Physician Decision|0|||
131443537|NCT01502293|473252681|FG002|Overall Study|Physician Decision|1|||
131443538|NCT00774046|473252687|FG000|Screening|Not eligible|56|||
131443539|NCT00774046|473252687|FG000|Enrollment|Desired other therapy/refused|28|||
131443540|NCT00774046|473252687|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
131443541|NCT01075243|473252688|FG000|Overall Study|Lost to Follow-up|5|||
131443542|NCT01075243|473252689|FG001|Overall Study|Lost to Follow-up|2|||
131443543|NCT01075243|473252690|FG002|Overall Study|Lost to Follow-up|0|||
131616045|NCT01932970|473885111|FG000|Overall Study|Withdrawal by Subject|5|||
131616046|NCT01932970|473885111|FG000|Overall Study|Death|1|||
131616047|NCT01932970|473885111|FG000|Overall Study|Lost to Follow-up|2|||
131616048|NCT01932970|473885111|FG000|Overall Study|Protocol Specified Criteria|10|||
131616049|NCT01787032|473885122|FG000|Overall Study|Protocol Violation|0|||
131616050|NCT01787032|473885123|FG001|Overall Study|Protocol Violation|0|||
131616051|NCT01787032|473885124|FG002|Overall Study|Protocol Violation|0|||
131616052|NCT01787032|473885125|FG003|Overall Study|Protocol Violation|0|||
131616053|NCT01787032|473885126|FG004|Overall Study|Protocol Violation|1|||
131616054|NCT01787032|473885127|FG005|Overall Study|Protocol Violation|1|||
131616055|NCT03041233|473885128|FG000|Overall Study|Death|5|||
131616056|NCT03041233|473885128|FG000|Overall Study|Physician Decision|1|||
131616057|NCT03041233|473885128|FG000|Overall Study|Lost to Follow-up|16|||
131616058|NCT03041233|473885128|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
131616059|NCT03041233|473885128|FG000|Overall Study|Sponsor Request|1|||
131616060|NCT03041233|473885128|FG000|Overall Study|Duplicate subject|1|||
131616061|NCT03041233|473885128|FG000|Overall Study|Re-ablation|1|||
131616062|NCT03229408|473885129|FG000|Overall Study|Withdrawal by Subject|4|||
131616063|NCT03229408|473885130|FG001|Overall Study|Withdrawal by Subject|1|||
131616064|NCT03229408|473885129|FG000|Overall Study|Adverse Event|2|||
131616065|NCT03229408|473885130|FG001|Overall Study|Adverse Event|0|||
131616066|NCT03229408|473885129|FG000|Overall Study|Pregnancy|0|||
131616067|NCT03229408|473885130|FG001|Overall Study|Pregnancy|1|||
131616068|NCT03229408|473885129|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
131616069|NCT03229408|473885130|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
131616070|NCT04200664|473885131|FG000|Overall Study|Withdrawal by Subject|1|||
131616071|NCT04200664|473885132|FG001|Overall Study|Withdrawal by Subject|0|||
131616072|NCT04200664|473885133|FG002|Overall Study|Withdrawal by Subject|0|||
131616073|NCT03745313|473885136|FG000|At 30 Days Follow-up|Death|2|||
131616074|NCT03745313|473885136|FG000|At 6 Months Follow-up|Death|1|||
131616075|NCT03745313|473885136|FG000|At 6 Months Follow-up|Missed Visit|1|||
131616076|NCT03745313|473885136|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
131616077|NCT03745313|473885136|FG000|At 1 Year Follow-up|Death|2|||
131616078|NCT03745313|473885136|FG000|At 1 Year Follow-up|Missed Visit|2|||
131616079|NCT03745313|473885136|FG000|At 2 Year Follow-up|Missed Visit|1|||
131616080|NCT03516812|473885137|FG000|Overall Study|Adverse Event|4|||
131709199|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
131709200|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
131709201|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
131709202|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
131709203|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
131443544|NCT01075243|473252688|FG000|Overall Study|Withdrawal by Subject|1|||
131443545|NCT01075243|473252689|FG001|Overall Study|Withdrawal by Subject|1|||
131443546|NCT01075243|473252690|FG002|Overall Study|Withdrawal by Subject|0|||
131443547|NCT03094416|473252693|FG000|Run-in|Screening failure|8|||
131443548|NCT03094416|473252693|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
131443549|NCT03094416|473252693|FG000|Run-in|Withdrawal by Subject|3|||
131443550|NCT03094416|473252693|FG000|Treatment Period|Withdrawal by Subject|2|||
131616081|NCT03516812|473885137|FG000|Overall Study|Lack of Efficacy|2|||
131616082|NCT00274261|473885140|FG000|Overall Study|Adverse Event|19|||
131616083|NCT00274261|473885141|FG001|Overall Study|Adverse Event|11|||
131616084|NCT00274261|473885140|FG000|Overall Study|Pregnancy|114|||
131616085|NCT00274261|473885141|FG001|Overall Study|Pregnancy|83|||
131616086|NCT00274261|473885140|FG000|Overall Study|Withdrawal by Subject|179|||
131616087|NCT00274261|473885141|FG001|Overall Study|Withdrawal by Subject|126|||
131616088|NCT00274261|473885140|FG000|Overall Study|Protocol Violation|71|||
131616089|NCT00274261|473885141|FG001|Overall Study|Protocol Violation|42|||
131616090|NCT00274261|473885140|FG000|Overall Study|Lost to Follow-up|106|||
131616091|NCT00274261|473885141|FG001|Overall Study|Lost to Follow-up|75|||
131616092|NCT02350634|473885145|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
131616093|NCT04827732|473885148|FG000|Overall Study|Did not start treatment|0|||
131616094|NCT04827732|473885149|FG001|Overall Study|Did not start treatment|1|||
131616095|NCT04827732|473885150|FG002|Overall Study|Did not start treatment|0|||
131616096|NCT04827732|473885151|FG003|Overall Study|Did not start treatment|1|||
131616097|NCT03414684|473885153|FG000|First-course Treatment|Complete response|0|||
131616098|NCT03414684|473885154|FG001|First-course Treatment|Complete response|1|||
131616099|NCT03414684|473885153|FG000|First-course Treatment|Intercurrent illness|1|||
131616100|NCT03414684|473885154|FG001|First-course Treatment|Intercurrent illness|0|||
131616101|NCT03414684|473885153|FG000|First-course Treatment|Progressive Disease|31|||
131616102|NCT03414684|473885154|FG001|First-course Treatment|Progressive Disease|32|||
131616103|NCT03414684|473885153|FG000|First-course Treatment|Adverse Event|1|||
131616104|NCT03414684|473885154|FG001|First-course Treatment|Adverse Event|2|||
131616105|NCT03414684|473885153|FG000|First-course Treatment|Physician Decision|0|||
131616106|NCT03414684|473885154|FG001|First-course Treatment|Physician Decision|1|||
131616107|NCT03414684|473885153|FG000|First-course Treatment|Withdrawal by Subject|0|||
131616108|NCT03414684|473885154|FG001|First-course Treatment|Withdrawal by Subject|1|||
131616109|NCT03414684|473885153|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
131616110|NCT03414684|473885154|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
131616111|NCT03414684|473885153|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
131616112|NCT03414684|473885154|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
131616113|NCT03414684|473885153|FG000|First-course Treatment|Still on treatment|3|||
131616114|NCT03414684|473885154|FG001|First-course Treatment|Still on treatment|0|||
131616115|NCT03414684|473885153|FG000|First-course Treatment|Never started protocol therapy|2|||
131616116|NCT03414684|473885154|FG001|First-course Treatment|Never started protocol therapy|1|||
131616117|NCT03414684|473885153|FG000|Crossover Treatment|Progressive disease|0|||
131616118|NCT03414684|473885154|FG001|Crossover Treatment|Progressive disease|12|||
131616119|NCT03414684|473885153|FG000|Crossover Treatment|Adverse Event|0|||
131616120|NCT03414684|473885154|FG001|Crossover Treatment|Adverse Event|3|||
131616121|NCT03414684|473885153|FG000|Crossover Treatment|Physician Decision|0|||
131616122|NCT03414684|473885154|FG001|Crossover Treatment|Physician Decision|1|||
131616123|NCT03414684|473885153|FG000|Crossover Treatment|Still on treatment|0|||
131616124|NCT03414684|473885154|FG001|Crossover Treatment|Still on treatment|2|||
131616125|NCT04038580|473885155|FG000|Washout 1|Death|0|||
131616126|NCT04038580|473885156|FG001|Washout 1|Death|0|||
131616127|NCT04038580|473885157|FG002|Washout 1|Death|0|||
131616128|NCT04038580|473885158|FG003|Washout 1|Death|1|||
131616129|NCT04038580|473885159|FG004|Washout 1|Death|0|||
131616130|NCT04038580|473885160|FG005|Washout 1|Death|0|||
131616131|NCT04038580|473885155|FG000|Washout 1|Withdrawal by Subject|0|||
131616132|NCT04038580|473885156|FG001|Washout 1|Withdrawal by Subject|0|||
131616133|NCT04038580|473885157|FG002|Washout 1|Withdrawal by Subject|0|||
131616134|NCT04038580|473885158|FG003|Washout 1|Withdrawal by Subject|0|||
131616135|NCT04038580|473885159|FG004|Washout 1|Withdrawal by Subject|1|||
131616136|NCT04038580|473885160|FG005|Washout 1|Withdrawal by Subject|0|||
131616137|NCT04038580|473885155|FG000|Wash-out 2|Withdrawal by Subject|1|||
131616138|NCT04038580|473885156|FG001|Wash-out 2|Withdrawal by Subject|0|||
131616139|NCT04038580|473885157|FG002|Wash-out 2|Withdrawal by Subject|0|||
131616140|NCT04038580|473885158|FG003|Wash-out 2|Withdrawal by Subject|2|||
131616141|NCT04038580|473885159|FG004|Wash-out 2|Withdrawal by Subject|0|||
131616142|NCT04038580|473885160|FG005|Wash-out 2|Withdrawal by Subject|1|||
131616143|NCT04038580|473885155|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
131616144|NCT04038580|473885156|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
131616145|NCT04038580|473885157|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
131616146|NCT04038580|473885158|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
131616147|NCT04038580|473885159|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
131616148|NCT04038580|473885160|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
131616149|NCT04038580|473885155|FG000|Wash-out 3|Withdrawal by Subject|1|||
131616150|NCT04038580|473885156|FG001|Wash-out 3|Withdrawal by Subject|0|||
131616151|NCT04038580|473885157|FG002|Wash-out 3|Withdrawal by Subject|2|||
131616152|NCT04038580|473885158|FG003|Wash-out 3|Withdrawal by Subject|0|||
131616153|NCT04038580|473885159|FG004|Wash-out 3|Withdrawal by Subject|0|||
131616154|NCT04038580|473885160|FG005|Wash-out 3|Withdrawal by Subject|0|||
131616155|NCT04021862|473885161|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131616156|NCT04021862|473885162|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
131616157|NCT04021862|473885163|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131616158|NCT04021862|473885164|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131709204|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131709205|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
131709206|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
131616159|NCT04021862|473885165|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131616160|NCT04021862|473885166|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131616161|NCT04021862|473885161|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
131616162|NCT04021862|473885162|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131616163|NCT04021862|473885163|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131616164|NCT04021862|473885164|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131616165|NCT04021862|473885165|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131616166|NCT04021862|473885166|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131616167|NCT04021862|473885161|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131616168|NCT04021862|473885162|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131616169|NCT04021862|473885163|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
131616170|NCT04021862|473885164|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131616171|NCT04021862|473885165|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131616172|NCT04021862|473885166|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131616173|NCT04021862|473885161|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
131616174|NCT04021862|473885162|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
131616175|NCT04021862|473885163|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
131616176|NCT04021862|473885164|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
131795275|NCT01075763|474533916|FG000|Overall Study|Lack of Efficacy|0|||
131795276|NCT01075763|474533917|FG001|Overall Study|Lack of Efficacy|1|||
131795277|NCT01075763|474533916|FG000|Overall Study|Withdrawal by Subject|2|||
131616177|NCT04021862|473885165|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
131616178|NCT04021862|473885166|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
131616179|NCT04021862|473885161|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131616180|NCT04021862|473885162|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131616181|NCT04021862|473885163|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131616182|NCT04021862|473885164|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
131616183|NCT04021862|473885165|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131616184|NCT04021862|473885166|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131616185|NCT01690624|473885167|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
131616186|NCT01690624|473885168|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
131616187|NCT01690624|473885169|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
131616188|NCT01690624|473885170|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
131616189|NCT01690624|473885167|FG000|Overall Study|Adverse event (other than DLT)|3|||
131616190|NCT01690624|473885168|FG001|Overall Study|Adverse event (other than DLT)|1|||
131616191|NCT01690624|473885169|FG002|Overall Study|Adverse event (other than DLT)|1|||
131616192|NCT01690624|473885170|FG003|Overall Study|Adverse event (other than DLT)|1|||
131616193|NCT01690624|473885167|FG000|Overall Study|Withdrawal by Subject|0|||
131616194|NCT01690624|473885168|FG001|Overall Study|Withdrawal by Subject|0|||
131616195|NCT01690624|473885169|FG002|Overall Study|Withdrawal by Subject|1|||
131616196|NCT01690624|473885170|FG003|Overall Study|Withdrawal by Subject|0|||
131616197|NCT01690624|473885167|FG000|Overall Study|Sponsor is ending trial|0|||
131616198|NCT01690624|473885168|FG001|Overall Study|Sponsor is ending trial|0|||
131616199|NCT01690624|473885169|FG002|Overall Study|Sponsor is ending trial|0|||
131616200|NCT01690624|473885170|FG003|Overall Study|Sponsor is ending trial|1|||
131616201|NCT01690624|473885167|FG000|Overall Study|Physician Decision|0|||
131616202|NCT01690624|473885168|FG001|Overall Study|Physician Decision|0|||
131616203|NCT01690624|473885169|FG002|Overall Study|Physician Decision|0|||
131616204|NCT01690624|473885170|FG003|Overall Study|Physician Decision|1|||
131616205|NCT01690624|473885167|FG000|Overall Study|Withdrawal by Subject|0|||
131616206|NCT01690624|473885168|FG001|Overall Study|Withdrawal by Subject|1|||
131616207|NCT01690624|473885169|FG002|Overall Study|Withdrawal by Subject|0|||
131616208|NCT01690624|473885170|FG003|Overall Study|Withdrawal by Subject|0|||
131616209|NCT01690624|473885167|FG000|Overall Study|Lack of Efficacy|1|||
131616210|NCT01690624|473885168|FG001|Overall Study|Lack of Efficacy|1|||
131616211|NCT01690624|473885169|FG002|Overall Study|Lack of Efficacy|3|||
131616212|NCT01690624|473885170|FG003|Overall Study|Lack of Efficacy|0|||
131616213|NCT04649047|473885178|FG000|Overall Study|Withdrawal by Subject|3|||
131616214|NCT00719888|473885179|FG000|Overall Study|Death|24|||
131616215|NCT00719888|473885180|FG001|Overall Study|Death|9|||
131616216|NCT00719888|473885179|FG000|Overall Study|Relapse|8|||
131616217|NCT00719888|473885180|FG001|Overall Study|Relapse|3|||
131616218|NCT00719888|473885179|FG000|Overall Study|Physician Decision|1|||
131616219|NCT00719888|473885180|FG001|Overall Study|Physician Decision|0|||
131616220|NCT00719888|473885179|FG000|Overall Study|Withdrawal by Subject|1|||
131616221|NCT00719888|473885180|FG001|Overall Study|Withdrawal by Subject|0|||
131616222|NCT03773107|473885181|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
131616223|NCT03773107|473885182|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
131616224|NCT03773107|473885183|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
131795278|NCT01075763|474533917|FG001|Overall Study|Withdrawal by Subject|2|||
131795279|NCT00586521|474533918|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
131616225|NCT03773107|473885184|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
131616226|NCT02328014|473886442|FG000|Overall Study|Adverse Event|1|||
131616227|NCT02328014|473886443|FG001|Overall Study|Adverse Event|0|||
131616228|NCT02328014|473886444|FG002|Overall Study|Adverse Event|0|||
131616229|NCT02328014|473886445|FG003|Overall Study|Adverse Event|1|||
131616230|NCT02328014|473886442|FG000|Overall Study|Death|0|||
131616231|NCT02328014|473886443|FG001|Overall Study|Death|0|||
131616232|NCT02328014|473886444|FG002|Overall Study|Death|0|||
131616233|NCT02328014|473886445|FG003|Overall Study|Death|4|||
131616234|NCT02328014|473886442|FG000|Overall Study|Physician Decision|0|||
131616235|NCT02328014|473886443|FG001|Overall Study|Physician Decision|0|||
131616236|NCT02328014|473886444|FG002|Overall Study|Physician Decision|0|||
131616237|NCT02328014|473886445|FG003|Overall Study|Physician Decision|1|||
131616238|NCT02328014|473886442|FG000|Overall Study|Disease Progression|1|||
131616239|NCT02328014|473886443|FG001|Overall Study|Disease Progression|0|||
131616240|NCT02328014|473886444|FG002|Overall Study|Disease Progression|1|||
131616241|NCT02328014|473886445|FG003|Overall Study|Disease Progression|3|||
131616242|NCT02328014|473886442|FG000|Overall Study|Study Terminated by Sponsor|4|||
131616243|NCT02328014|473886443|FG001|Overall Study|Study Terminated by Sponsor|1|||
131616244|NCT02328014|473886444|FG002|Overall Study|Study Terminated by Sponsor|1|||
131616245|NCT02328014|473886445|FG003|Overall Study|Study Terminated by Sponsor|0|||
131616246|NCT02328014|473886442|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
131616247|NCT02328014|473886443|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
131616248|NCT02328014|473886444|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
131616249|NCT02328014|473886445|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
131616250|NCT02328014|473886442|FG000|Overall Study|Withdrawal by Subject|0|||
131616251|NCT02328014|473886443|FG001|Overall Study|Withdrawal by Subject|0|||
131616252|NCT02328014|473886444|FG002|Overall Study|Withdrawal by Subject|0|||
131616253|NCT02328014|473886445|FG003|Overall Study|Withdrawal by Subject|1|||
131616254|NCT01274338|473886446|FG000|Overall Study|Lack of Efficacy|72|||
131616255|NCT01274338|473886447|FG001|Overall Study|Lack of Efficacy|108|||
131616256|NCT01274338|473886448|FG002|Overall Study|Lack of Efficacy|116|||
131616257|NCT01274338|473886449|FG003|Overall Study|Lack of Efficacy|0|||
131616258|NCT01274338|473886450|FG004|Overall Study|Lack of Efficacy|0|||
131616259|NCT01274338|473886451|FG005|Overall Study|Lack of Efficacy|0|||
131616260|NCT01274338|473886446|FG000|Overall Study|Adverse Event|272|||
131616261|NCT01274338|473886447|FG001|Overall Study|Adverse Event|105|||
131616262|NCT01274338|473886448|FG002|Overall Study|Adverse Event|180|||
131616263|NCT01274338|473886449|FG003|Overall Study|Adverse Event|1|||
131616264|NCT01274338|473886450|FG004|Overall Study|Adverse Event|0|||
131616265|NCT01274338|473886451|FG005|Overall Study|Adverse Event|0|||
131616266|NCT01274338|473886446|FG000|Overall Study|Death|8|||
131616267|NCT01274338|473886447|FG001|Overall Study|Death|1|||
131616268|NCT01274338|473886448|FG002|Overall Study|Death|0|||
131616269|NCT01274338|473886449|FG003|Overall Study|Death|0|||
131616270|NCT01274338|473886450|FG004|Overall Study|Death|0|||
131616271|NCT01274338|473886451|FG005|Overall Study|Death|0|||
131616272|NCT01274338|473886446|FG000|Overall Study|Withdrawal by Subject|27|||
131616273|NCT01274338|473886447|FG001|Overall Study|Withdrawal by Subject|99|||
131616274|NCT01274338|473886448|FG002|Overall Study|Withdrawal by Subject|17|||
131616275|NCT01274338|473886449|FG003|Overall Study|Withdrawal by Subject|0|||
131616276|NCT01274338|473886450|FG004|Overall Study|Withdrawal by Subject|0|||
131616277|NCT01274338|473886451|FG005|Overall Study|Withdrawal by Subject|0|||
131616278|NCT01274338|473886446|FG000|Overall Study|Did not start treatment|8|||
131616279|NCT01274338|473886447|FG001|Overall Study|Did not start treatment|116|||
131616280|NCT01274338|473886448|FG002|Overall Study|Did not start treatment|7|||
131616281|NCT01274338|473886449|FG003|Overall Study|Did not start treatment|0|||
131616282|NCT01274338|473886450|FG004|Overall Study|Did not start treatment|0|||
131616283|NCT01274338|473886451|FG005|Overall Study|Did not start treatment|0|||
131616284|NCT01274338|473886446|FG000|Overall Study|Alternative therapy|0|||
131616285|NCT01274338|473886447|FG001|Overall Study|Alternative therapy|1|||
131616286|NCT01274338|473886448|FG002|Overall Study|Alternative therapy|0|||
131616287|NCT01274338|473886449|FG003|Overall Study|Alternative therapy|0|||
131616288|NCT01274338|473886450|FG004|Overall Study|Alternative therapy|0|||
131616289|NCT01274338|473886451|FG005|Overall Study|Alternative therapy|0|||
131616290|NCT01274338|473886446|FG000|Overall Study|Other complicating diseases|0|||
131616291|NCT01274338|473886447|FG001|Overall Study|Other complicating diseases|3|||
131616292|NCT01274338|473886448|FG002|Overall Study|Other complicating diseases|1|||
131616293|NCT01274338|473886449|FG003|Overall Study|Other complicating diseases|0|||
131616294|NCT01274338|473886450|FG004|Overall Study|Other complicating diseases|0|||
131616295|NCT01274338|473886451|FG005|Overall Study|Other complicating diseases|0|||
131616296|NCT01274338|473886446|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
131616297|NCT01274338|473886447|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
131616298|NCT01274338|473886448|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
131616299|NCT01274338|473886449|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
131616300|NCT01274338|473886450|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
131616301|NCT01274338|473886451|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
131616302|NCT01274338|473886446|FG000|Overall Study|Pregnancy|0|||
131616303|NCT01274338|473886447|FG001|Overall Study|Pregnancy|0|||
131616304|NCT01274338|473886448|FG002|Overall Study|Pregnancy|1|||
131616305|NCT01274338|473886449|FG003|Overall Study|Pregnancy|0|||
131616306|NCT01274338|473886450|FG004|Overall Study|Pregnancy|0|||
131616307|NCT01274338|473886451|FG005|Overall Study|Pregnancy|0|||
131616308|NCT01274338|473886446|FG000|Overall Study|Reason not reported|12|||
131616309|NCT01274338|473886447|FG001|Overall Study|Reason not reported|21|||
131616310|NCT01274338|473886448|FG002|Overall Study|Reason not reported|3|||
131616311|NCT01274338|473886449|FG003|Overall Study|Reason not reported|0|||
131616312|NCT01274338|473886450|FG004|Overall Study|Reason not reported|1|||
131616313|NCT01274338|473886451|FG005|Overall Study|Reason not reported|0|||
131616314|NCT05422339|473886452|FG000|Overall Study|Withdrawal by Subject|17|||
131900890|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131900891|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131443551|NCT01668784|473252694|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
131443552|NCT01668784|473252695|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
131616315|NCT05422339|473886453|FG001|Overall Study|Withdrawal by Subject|15|||
131616316|NCT03678688|473886460|FG000|Overall Study|Reason not Specified|0|||
131616317|NCT03678688|473886461|FG001|Overall Study|Reason not Specified|0|||
131616318|NCT03678688|473886462|FG002|Overall Study|Reason not Specified|3|||
131616319|NCT03678688|473886463|FG003|Overall Study|Reason not Specified|0|||
131616320|NCT03678688|473886464|FG004|Overall Study|Reason not Specified|1|||
131616321|NCT03678688|473886465|FG005|Overall Study|Reason not Specified|0|||
131616322|NCT03678688|473886466|FG006|Overall Study|Reason not Specified|0|||
131616323|NCT03678688|473886467|FG007|Overall Study|Reason not Specified|0|||
131616324|NCT03678688|473886468|FG008|Overall Study|Reason not Specified|0|||
131616325|NCT03678688|473886460|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
131616326|NCT03678688|473886461|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
131616327|NCT03678688|473886462|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
131616328|NCT03678688|473886463|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
131616329|NCT03678688|473886464|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
131616330|NCT03678688|473886465|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
131616331|NCT03678688|473886466|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
131616332|NCT03678688|473886467|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
131616333|NCT03678688|473886468|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
131616334|NCT03678688|473886460|FG000|Overall Study|Covid Related Adverse Event|0|||
131616335|NCT03678688|473886461|FG001|Overall Study|Covid Related Adverse Event|0|||
131616336|NCT03678688|473886462|FG002|Overall Study|Covid Related Adverse Event|0|||
131616337|NCT03678688|473886463|FG003|Overall Study|Covid Related Adverse Event|0|||
131616338|NCT03678688|473886464|FG004|Overall Study|Covid Related Adverse Event|0|||
131616339|NCT03678688|473886465|FG005|Overall Study|Covid Related Adverse Event|3|||
131616340|NCT03678688|473886466|FG006|Overall Study|Covid Related Adverse Event|1|||
131616341|NCT03678688|473886467|FG007|Overall Study|Covid Related Adverse Event|1|||
131616342|NCT03678688|473886468|FG008|Overall Study|Covid Related Adverse Event|0|||
131616343|NCT03678688|473886460|FG000|Overall Study|Physician Decision|0|||
131616344|NCT03678688|473886461|FG001|Overall Study|Physician Decision|0|||
131616345|NCT03678688|473886462|FG002|Overall Study|Physician Decision|0|||
131616346|NCT03678688|473886463|FG003|Overall Study|Physician Decision|0|||
131616347|NCT03678688|473886464|FG004|Overall Study|Physician Decision|0|||
131616348|NCT03678688|473886465|FG005|Overall Study|Physician Decision|1|||
131616349|NCT03678688|473886466|FG006|Overall Study|Physician Decision|0|||
131616350|NCT03678688|473886467|FG007|Overall Study|Physician Decision|0|||
131443553|NCT01668784|473252694|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
131443554|NCT01668784|473252695|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
131443555|NCT01668784|473252694|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
131443556|NCT01668784|473252695|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
131443557|NCT01668784|473252694|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
131443558|NCT01668784|473252695|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
131616351|NCT03678688|473886468|FG008|Overall Study|Physician Decision|0|||
131616352|NCT03678688|473886460|FG000|Overall Study|Withdrawal by Subject|0|||
131616353|NCT03678688|473886461|FG001|Overall Study|Withdrawal by Subject|0|||
131616354|NCT03678688|473886462|FG002|Overall Study|Withdrawal by Subject|0|||
131616355|NCT03678688|473886463|FG003|Overall Study|Withdrawal by Subject|0|||
131709207|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
131709208|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
131616356|NCT03678688|473886464|FG004|Overall Study|Withdrawal by Subject|0|||
131616357|NCT03678688|473886465|FG005|Overall Study|Withdrawal by Subject|0|||
131616358|NCT03678688|473886466|FG006|Overall Study|Withdrawal by Subject|2|||
131616359|NCT03678688|473886467|FG007|Overall Study|Withdrawal by Subject|1|||
131795280|NCT03731182|474533925|FG000|Overall Study|Lost to Follow-up|2|||
131795281|NCT03731182|474533926|FG001|Overall Study|Lost to Follow-up|0|||
131795282|NCT03731182|474533925|FG000|Overall Study|Physician Decision|1|||
131795283|NCT03731182|474533926|FG001|Overall Study|Physician Decision|0|||
131795284|NCT03731182|474533925|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
131795285|NCT03731182|474533926|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
131795286|NCT00582036|474533927|FG000|Overall Study|Withdrawal by Subject|0|||
131795287|NCT00582036|474533928|FG001|Overall Study|Withdrawal by Subject|1|||
131795288|NCT01673009|474533929|FG000|Overall Study|Physician Decision|5|||
131616360|NCT03678688|473886468|FG008|Overall Study|Withdrawal by Subject|0|||
131616361|NCT01278030|473886475|FG000|Overall Study|Withdrawal by Subject|8|||
131616362|NCT01278030|473886476|FG001|Overall Study|Withdrawal by Subject|4|||
131616363|NCT00458783|473886478|FG000|Overall Study|Protocol Violation|1228|||
131616364|NCT00458783|473886479|FG001|Overall Study|Protocol Violation|1220|||
131616365|NCT04401267|473886481|FG000|Overall Study|Death|0|||
131616366|NCT04401267|473886482|FG001|Overall Study|Death|1|||
131616367|NCT04401267|473886481|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
131616368|NCT04401267|473886482|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
131616369|NCT04401267|473886481|FG000|Overall Study|Found to be Ineligible|1|||
131616370|NCT04401267|473886482|FG001|Overall Study|Found to be Ineligible|0|||
131616371|NCT03214081|473886483|FG000|Overall Study|Case Report Forms Uncollected|9|||
131616372|NCT03214081|473886483|FG000|Overall Study|Protocol Deviation|54|||
131616373|NCT02962284|473886484|FG000|Overall Study|Death|2|||
131616374|NCT02962284|473886485|FG001|Overall Study|Death|0|||
131616375|NCT02962284|473886484|FG000|Overall Study|Progressive disease|2|||
131616376|NCT02962284|473886485|FG001|Overall Study|Progressive disease|3|||
131616377|NCT02962284|473886484|FG000|Overall Study|Withdrawal by Subject|1|||
131616378|NCT02962284|473886485|FG001|Overall Study|Withdrawal by Subject|0|||
131616379|NCT05815342|473886486|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
131616380|NCT05815342|473886486|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
131616381|NCT05815342|473886486|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
131616382|NCT05815342|473886486|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
131616383|NCT05815342|473886486|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
131616384|NCT00345046|473886489|FG000|Overall Study|Protocol Violation|1|||
131616385|NCT00345046|473886490|FG001|Overall Study|Protocol Violation|1|||
131616386|NCT00345046|473886491|FG002|Overall Study|Protocol Violation|2|||
131616387|NCT01613417|473886492|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
131709209|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
131709210|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
131709211|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
131709212|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
131709213|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131709214|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131709215|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
131709216|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131795289|NCT01673009|474533929|FG000|Overall Study|Withdrawal by Subject|8|||
131795290|NCT04161144|474533931|FG000|Overall Study|Withdrawal by Subject|0|||
131795291|NCT04161144|474533932|FG001|Overall Study|Withdrawal by Subject|1|||
131795292|NCT04161144|474533931|FG000|Overall Study|Protocol Violation|1|||
131795293|NCT04161144|474533932|FG001|Overall Study|Protocol Violation|0|||
131795294|NCT02207621|474533934|FG000|Overall Study|Adverse Event|71|||
131795295|NCT02207621|474533935|FG001|Overall Study|Adverse Event|15|||
131795296|NCT02207621|474533936|FG002|Overall Study|Adverse Event|132|||
131795297|NCT02207621|474533934|FG000|Overall Study|Withdrawal by Subject|9|||
131795298|NCT02207621|474533935|FG001|Overall Study|Withdrawal by Subject|9|||
131795299|NCT02207621|474533936|FG002|Overall Study|Withdrawal by Subject|13|||
131795300|NCT02207621|474533934|FG000|Overall Study|Non-Compliant|3|||
131795301|NCT02207621|474533935|FG001|Overall Study|Non-Compliant|3|||
131795302|NCT02207621|474533936|FG002|Overall Study|Non-Compliant|1|||
131795303|NCT02207621|474533934|FG000|Overall Study|Lost to Follow-up|1|||
131709217|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
131709218|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131709219|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131795304|NCT02207621|474533935|FG001|Overall Study|Lost to Follow-up|0|||
131795305|NCT02207621|474533936|FG002|Overall Study|Lost to Follow-up|3|||
131795306|NCT02207621|474533934|FG000|Overall Study|Lack of Efficacy|10|||
131795307|NCT02207621|474533935|FG001|Overall Study|Lack of Efficacy|2|||
131795308|NCT02207621|474533936|FG002|Overall Study|Lack of Efficacy|4|||
131709220|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131709221|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
131709222|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
131709223|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
131709224|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
131709225|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
131709226|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
131709227|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
131709228|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
131709229|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131709230|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131709231|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
131709232|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
131709233|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131709234|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
131709235|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131709236|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131709237|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
131709238|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
131709239|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
131709240|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
131709241|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
131709242|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
131709243|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
131709244|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
131709245|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709246|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709247|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709248|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709249|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
131709250|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709251|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709252|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131709253|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131709254|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131709255|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
131709256|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
131709257|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
131709258|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131709259|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
131709260|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131709261|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131709262|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131709263|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131709264|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131709265|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
131709266|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131709267|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
131709268|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
131709269|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709270|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709271|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709272|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709273|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709274|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
131709275|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709276|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131709277|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131709278|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131709279|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
131709280|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
131709281|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
131709282|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
131709283|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131709284|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131616388|NCT01613417|473886493|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
131616389|NCT00512252|473886494|FG000|Overall Study|Lost to Follow-up|0|||
131616390|NCT00512252|473886495|FG001|Overall Study|Lost to Follow-up|0|||
131616391|NCT00512252|473886496|FG002|Overall Study|Lost to Follow-up|1|||
131616392|NCT00512252|473886494|FG000|Overall Study|Protocol Violation|0|||
131616393|NCT00512252|473886495|FG001|Overall Study|Protocol Violation|0|||
131616394|NCT00512252|473886496|FG002|Overall Study|Protocol Violation|1|||
131616395|NCT00512252|473886494|FG000|Overall Study|Death|0|||
131616396|NCT00512252|473886495|FG001|Overall Study|Death|0|||
131616397|NCT00512252|473886496|FG002|Overall Study|Death|1|||
131616398|NCT02357966|473886497|FG000|Overall Study|Death|0|||
131616399|NCT02357966|473886498|FG001|Overall Study|Death|0|||
131616400|NCT02357966|473886499|FG002|Overall Study|Death|1|||
131616401|NCT02357966|473886500|FG003|Overall Study|Death|0|||
131616402|NCT02357966|473886501|FG004|Overall Study|Death|2|||
131616403|NCT02357966|473886502|FG005|Overall Study|Death|0|||
131616404|NCT02357966|473886497|FG000|Overall Study|Physician Decision|1|||
131616405|NCT02357966|473886498|FG001|Overall Study|Physician Decision|0|||
131616406|NCT02357966|473886499|FG002|Overall Study|Physician Decision|0|||
131616407|NCT02357966|473886500|FG003|Overall Study|Physician Decision|0|||
131616408|NCT02357966|473886501|FG004|Overall Study|Physician Decision|1|||
131616409|NCT02357966|473886502|FG005|Overall Study|Physician Decision|0|||
131709285|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131709286|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131709287|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131709288|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131709289|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
131709290|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
131443559|NCT01668784|473252694|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
131443560|NCT01668784|473252695|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
131443561|NCT01668784|473252694|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
131443562|NCT01668784|473252695|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
131709291|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131709292|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131709293|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
131709294|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
131709295|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
131709296|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
131709297|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
131709298|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
131709299|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
131709300|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
131709301|NCT00408005|474215569|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131709302|NCT00408005|474215570|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131616410|NCT00705406|473886503|FG000|Overall Study|Lost to Follow-up|3|||
131616411|NCT00705406|473886504|FG001|Overall Study|Lost to Follow-up|3|||
131616412|NCT00705406|473886503|FG000|Overall Study|Did not receive study drug|1|||
131616413|NCT00705406|473886504|FG001|Overall Study|Did not receive study drug|2|||
131616414|NCT00093496|473886509|FG000|Overall Study|Protocol Violation|1|||
131616415|NCT00093496|473886510|FG001|Overall Study|Protocol Violation|3|||
131616416|NCT02101775|473886511|FG000|Overall Study|Adverse Event|4|||
131616417|NCT02101775|473886512|FG001|Overall Study|Adverse Event|0|||
131709303|NCT00408005|474215571|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
131709304|NCT00408005|474215572|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
131709305|NCT00408005|474215573|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
131709306|NCT00408005|474215574|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
131709307|NCT00408005|474215575|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131709308|NCT00408005|474215576|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131709309|NCT03155997|474215577|FG000|Overall Study|Withdrawal by Subject|119|||
131709310|NCT03155997|474215578|FG001|Overall Study|Withdrawal by Subject|134|||
131709311|NCT03155997|474215577|FG000|Overall Study|Lost to Follow-up|12|||
131709312|NCT03155997|474215578|FG001|Overall Study|Lost to Follow-up|13|||
131616418|NCT02101775|473886513|FG002|Overall Study|Adverse Event|0|||
131616419|NCT02101775|473886511|FG000|Overall Study|Admission to Hospital|0|||
131616420|NCT02101775|473886512|FG001|Overall Study|Admission to Hospital|1|||
131616421|NCT02101775|473886513|FG002|Overall Study|Admission to Hospital|0|||
131616422|NCT04941482|473886516|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
131616423|NCT04941482|473886517|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
131616424|NCT03389802|473886518|FG000|Overall Study|Lack of Efficacy|3|||
131616425|NCT03389802|473886519|FG001|Overall Study|Lack of Efficacy|3|||
131616426|NCT03389802|473886520|FG002|Overall Study|Lack of Efficacy|13|||
131616427|NCT03389802|473886521|FG003|Overall Study|Lack of Efficacy|6|||
131616428|NCT03389802|473886522|FG004|Overall Study|Lack of Efficacy|1|||
131616429|NCT03389802|473886518|FG000|Overall Study|Adverse Event|0|||
131616430|NCT03389802|473886519|FG001|Overall Study|Adverse Event|0|||
131616431|NCT03389802|473886520|FG002|Overall Study|Adverse Event|1|||
131616432|NCT03389802|473886521|FG003|Overall Study|Adverse Event|0|||
131616433|NCT03389802|473886522|FG004|Overall Study|Adverse Event|4|||
131616434|NCT03389802|473886518|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
131616435|NCT03389802|473886519|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
131616436|NCT03389802|473886520|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
131616437|NCT03389802|473886521|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
131616438|NCT03389802|473886522|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
131616439|NCT02426138|473886523|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131616440|NCT02426138|473886524|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131616441|NCT01367236|473886536|FG000|Overall Study|Withdrawal by Subject|3|||
131616442|NCT01367236|473886537|FG001|Overall Study|Withdrawal by Subject|1|||
131616443|NCT02744066|473886540|FG000|Overall Study|Withdrawal by parent|0|||
131616444|NCT02744066|473886541|FG001|Overall Study|Withdrawal by parent|1|||
131616445|NCT02744066|473886540|FG000|Overall Study|Discharged from NICU prior to completion|0|||
131616446|NCT02744066|473886541|FG001|Overall Study|Discharged from NICU prior to completion|4|||
131616447|NCT02454959|473886542|FG000|Overall Study|Protocol-Specified Criteria|3|||
131616448|NCT02454959|473886542|FG000|Overall Study|Physician Decision|1|||
131616449|NCT02454959|473886542|FG000|Overall Study|Withdrawal by Subject|3|||
131616450|NCT02454959|473886542|FG000|Overall Study|Adverse Event|2|||
131616451|NCT04745676|473886543|FG000|Overall Study|Death|1|||
131616452|NCT04745676|473886544|FG001|Overall Study|Death|0|||
131616453|NCT04745676|473886545|FG002|Overall Study|Death|0|||
131616454|NCT03102034|473886548|FG000|Overall Study|Withdrawal by Subject|1|||
131616455|NCT03102034|473886549|FG001|Overall Study|Withdrawal by Subject|0|||
131616456|NCT00914966|473886552|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
131616457|NCT00914966|473886552|FG000|Step 1: 1500 Units|Physician Decision|1|||
131616458|NCT00914966|473886552|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
131616459|NCT05810285|473886560|FG000|Overall Study|Death|4|||
131616460|NCT05810285|473886561|FG001|Overall Study|Death|21|||
131616461|NCT05810285|473886560|FG000|Overall Study|Adverse Event|18|||
131616462|NCT05810285|473886561|FG001|Overall Study|Adverse Event|16|||
131616463|NCT02278796|473887739|FG000|Overall Study|Death|2|||
131616464|NCT02278796|473887740|FG001|Overall Study|Death|3|||
131616465|NCT00357994|473887741|FG000|Overall Study|Adverse Event|1|||
131616466|NCT00357994|473887742|FG001|Overall Study|Adverse Event|2|||
131616467|NCT00357994|473887741|FG000|Overall Study|Lack of Efficacy|0|||
131616468|NCT00357994|473887742|FG001|Overall Study|Lack of Efficacy|1|||
131616469|NCT00357994|473887741|FG000|Overall Study|Protocol Violation|1|||
131616470|NCT00357994|473887742|FG001|Overall Study|Protocol Violation|0|||
131616471|NCT01079806|473887749|FG000|Day 1 to Week 96|Adverse Event|0|||
131616472|NCT01079806|473887750|FG001|Day 1 to Week 96|Adverse Event|3|||
131616473|NCT01079806|473887749|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
131616474|NCT01079806|473887750|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
131616475|NCT01079806|473887749|FG000|Day 1 to Week 96|Pregnancy|0|||
131616476|NCT01079806|473887750|FG001|Day 1 to Week 96|Pregnancy|1|||
131616477|NCT01079806|473887749|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
131616478|NCT01079806|473887750|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
131616479|NCT01079806|473887749|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
131616480|NCT01079806|473887750|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
131616481|NCT01079806|473887749|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
131616482|NCT01079806|473887750|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
131616483|NCT01079806|473887749|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
131616484|NCT01079806|473887750|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
131709313|NCT03155997|474215577|FG000|Overall Study|Missing disposition data|0|||
131443563|NCT01668784|473252694|FG000|Treatment Period|Disease Progression|316|||
131616485|NCT01079806|473887749|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
131616486|NCT01079806|473887750|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
131616487|NCT01079806|473887749|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
131616488|NCT01079806|473887750|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
131616489|NCT01079806|473887749|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
131616490|NCT01079806|473887750|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
131616491|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
131616492|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
131616493|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
131616494|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
131616495|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
131616496|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
131616497|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
131616498|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
131616499|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131616500|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
131616501|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
131616502|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
131616503|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131616504|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131616505|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
131616506|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
131616507|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
131616508|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
131616509|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
131616510|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
131616511|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
131616512|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
131616513|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
131616514|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
131616515|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
131616516|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
131616517|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
131616518|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
131616519|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
131616520|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
131616521|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
131616522|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
131616523|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
131616524|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
131616525|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
131616526|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131616527|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131616528|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131616529|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131616530|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
131616531|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
131616532|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
131616533|NCT03732807|473887751|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131616534|NCT03732807|473887752|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131616535|NCT03732807|473887753|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131616536|NCT03732807|473887754|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131616537|NCT03732807|473887755|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131616538|NCT03732807|473887756|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
131616539|NCT03732807|473887757|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131616540|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
131616541|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
131616542|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
131616543|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
131616544|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
131616545|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
131616546|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
131616547|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
131616548|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
131443564|NCT01668784|473252695|FG001|Treatment Period|Disease Progression|293|||
131616549|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
131616550|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
131616551|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
131616552|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
131616553|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
131616554|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
131616555|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
131616556|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
131616557|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
131616558|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
131616559|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
131616560|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
131616561|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131616562|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
131616563|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131616564|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131616565|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131616566|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131616567|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131616568|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131616569|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
131616570|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131616571|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
131616572|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
131616573|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131616574|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131616575|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
131616576|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
131616577|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131616578|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131616579|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
131616580|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131616581|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131616582|NCT03732807|473887751|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
131616583|NCT03732807|473887752|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
131616584|NCT03732807|473887753|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
131616585|NCT03732807|473887754|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
131616586|NCT03732807|473887755|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
131616587|NCT03732807|473887756|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
131616588|NCT03732807|473887757|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
131616589|NCT01779700|473887758|FG000|Overall Study|Adverse Event|4|||
131616590|NCT01779700|473887759|FG001|Overall Study|Adverse Event|3|||
131616591|NCT01779700|473887758|FG000|Overall Study|Withdrawal by Subject|0|||
131616592|NCT01779700|473887759|FG001|Overall Study|Withdrawal by Subject|2|||
131616593|NCT00019604|473887760|FG000|Overall Study|Death|1|||
131616594|NCT00019604|473887760|FG000|Overall Study|Progressive disease|23|||
131616595|NCT00019604|473887760|FG000|Overall Study|Refused treatment|1|||
131616596|NCT00019604|473887760|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
131616597|NCT00019604|473887760|FG000|Overall Study|Going to have liver transplant|1|||
131616598|NCT00019604|473887760|FG000|Overall Study|Move to a different study|1|||
131616599|NCT00019604|473887760|FG000|Overall Study|Non compliant on systemic CH|1|||
131616600|NCT00019604|473887760|FG000|Overall Study|Non compliant|1|||
131616601|NCT00019604|473887760|FG000|Overall Study|Resectable disease|1|||
131616602|NCT00019604|473887760|FG000|Overall Study|Started new chemo regimen|1|||
131709314|NCT03155997|474215578|FG001|Overall Study|Missing disposition data|1|||
131709315|NCT03155997|474215577|FG000|Overall Study|On study treatment|2027|||
131709316|NCT03155997|474215578|FG001|Overall Study|On study treatment|2074|||
131709317|NCT01848145|474215579|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
131709318|NCT01848145|474215579|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
131709319|NCT01848145|474215579|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
131709320|NCT01848145|474215579|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
131709321|NCT01848145|474215579|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
131709322|NCT01848145|474215579|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
131616603|NCT00019604|473887760|FG000|Overall Study|Pt going to immunotherapy study|1|||
131616604|NCT00019604|473887760|FG000|Overall Study|Too much disease|1|||
131616605|NCT00019604|473887760|FG000|Overall Study|Unable to evaluate|1|||
131616606|NCT00019604|473887760|FG000|Overall Study|Details for other not available|4|||
131795309|NCT02207621|474533934|FG000|Overall Study|Disallowed Concurrent Medication|2|||
131616607|NCT04608409|473887761|FG000|Overall Study|Physician Decision|1|||
131616608|NCT04608409|473887762|FG001|Overall Study|Physician Decision|1|||
131616609|NCT04608409|473887763|FG002|Overall Study|Physician Decision|2|||
131616610|NCT00599196|473887764|FG000|Overall Study|Lack of Efficacy|22|||
131616611|NCT00599196|473887764|FG000|Overall Study|Adverse Event|93|||
131616612|NCT00599196|473887764|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
131616613|NCT00599196|473887764|FG000|Overall Study|Subject withdrew consent|43|||
131616614|NCT00599196|473887764|FG000|Overall Study|Study ended per sponsor|197|||
131616615|NCT00599196|473887764|FG000|Overall Study|Lost to Follow-up|17|||
131616616|NCT00599196|473887764|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
131616617|NCT00599196|473887764|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
131616618|NCT00599196|473887764|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
131616619|NCT00599196|473887764|FG000|Overall Study|Other: Pt Moved To Australia|1|||
131616620|NCT00599196|473887764|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
131616621|NCT00599196|473887764|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
131616622|NCT00734578|473887769|FG000|Overall Study|Adverse Event|4|||
131616623|NCT00734578|473887770|FG001|Overall Study|Adverse Event|6|||
131616624|NCT00734578|473887771|FG002|Overall Study|Adverse Event|1|||
131616625|NCT00734578|473887769|FG000|Overall Study|Protocol Violation|8|||
131616626|NCT00734578|473887770|FG001|Overall Study|Protocol Violation|6|||
131616627|NCT00734578|473887771|FG002|Overall Study|Protocol Violation|3|||
131616628|NCT00734578|473887769|FG000|Overall Study|Withdrawal by Subject|7|||
131616629|NCT00734578|473887770|FG001|Overall Study|Withdrawal by Subject|8|||
131616630|NCT00734578|473887771|FG002|Overall Study|Withdrawal by Subject|11|||
131616631|NCT00734578|473887769|FG000|Overall Study|Lost to Follow-up|9|||
131616632|NCT00734578|473887770|FG001|Overall Study|Lost to Follow-up|3|||
131616633|NCT00734578|473887771|FG002|Overall Study|Lost to Follow-up|5|||
131616634|NCT00734578|473887769|FG000|Overall Study|Lack of Efficacy|3|||
131616635|NCT00734578|473887770|FG001|Overall Study|Lack of Efficacy|2|||
131616636|NCT00734578|473887771|FG002|Overall Study|Lack of Efficacy|5|||
131616637|NCT00734578|473887769|FG000|Overall Study|Randomized in error|1|||
131616638|NCT00734578|473887770|FG001|Overall Study|Randomized in error|0|||
131616639|NCT00734578|473887771|FG002|Overall Study|Randomized in error|0|||
131616640|NCT00734578|473887769|FG000|Overall Study|Exclusion criteria|1|||
131616641|NCT00734578|473887770|FG001|Overall Study|Exclusion criteria|0|||
131616642|NCT00734578|473887771|FG002|Overall Study|Exclusion criteria|0|||
131616643|NCT02085941|473887772|FG000|Overall Study|Lack of Efficacy|1|||
131616644|NCT02085941|473887773|FG001|Overall Study|Lack of Efficacy|0|||
131616645|NCT02085941|473887772|FG000|Overall Study|Death|6|||
131616646|NCT02085941|473887773|FG001|Overall Study|Death|1|||
131616647|NCT02085941|473887772|FG000|Overall Study|Lost to Follow-up|1|||
131616648|NCT02085941|473887773|FG001|Overall Study|Lost to Follow-up|0|||
131616649|NCT02085941|473887772|FG000|Overall Study|Physician Decision|0|||
131616650|NCT02085941|473887773|FG001|Overall Study|Physician Decision|2|||
131616651|NCT03274076|473887775|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
131616652|NCT03274076|473887776|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
131616653|NCT03274076|473887777|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
131616654|NCT03274076|473887778|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
131616655|NCT03274076|473887775|FG000|24 Weeks Open Label|Adverse Event|0|||
131616656|NCT03274076|473887776|FG001|24 Weeks Open Label|Adverse Event|0|||
131616657|NCT03274076|473887777|FG002|24 Weeks Open Label|Adverse Event|2|||
131616658|NCT03274076|473887778|FG003|24 Weeks Open Label|Adverse Event|0|||
131616659|NCT03274076|473887775|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
131616660|NCT03274076|473887776|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
131616661|NCT03274076|473887777|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
131616662|NCT03274076|473887778|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
131616663|NCT00975585|473887779|FG000|Overall Study|Adverse Event|0|||
131616664|NCT00975585|473887780|FG001|Overall Study|Adverse Event|4|||
131616665|NCT00975585|473887779|FG000|Overall Study|Lost to Follow-up|3|||
131616666|NCT00975585|473887780|FG001|Overall Study|Lost to Follow-up|5|||
131616667|NCT00975585|473887779|FG000|Overall Study|Withdrawal by Subject|2|||
131616668|NCT00975585|473887780|FG001|Overall Study|Withdrawal by Subject|1|||
131616669|NCT00975585|473887779|FG000|Overall Study|Lens issue|2|||
131616670|NCT00975585|473887780|FG001|Overall Study|Lens issue|2|||
131616671|NCT00683800|473887781|FG000|Overall Study|Adverse Event|195|||
131616672|NCT00683800|473887782|FG001|Overall Study|Adverse Event|102|||
131616673|NCT00683800|473887781|FG000|Overall Study|Death|0|||
131616674|NCT00683800|473887782|FG001|Overall Study|Death|1|||
131616675|NCT00683800|473887781|FG000|Overall Study|Lost to Follow-up|57|||
131616676|NCT00683800|473887782|FG001|Overall Study|Lost to Follow-up|44|||
131616677|NCT00683800|473887781|FG000|Overall Study|Other|5|||
131616678|NCT00683800|473887782|FG001|Overall Study|Other|2|||
131616679|NCT00683800|473887781|FG000|Overall Study|Protocol Violation|13|||
131616680|NCT00683800|473887782|FG001|Overall Study|Protocol Violation|16|||
131616681|NCT00683800|473887781|FG000|Overall Study|Withdrawal by Subject|66|||
131616682|NCT00683800|473887782|FG001|Overall Study|Withdrawal by Subject|64|||
131616683|NCT00683800|473887781|FG000|Overall Study|Lack of Efficacy|61|||
131616684|NCT00683800|473887782|FG001|Overall Study|Lack of Efficacy|104|||
131616685|NCT00683800|473887781|FG000|Overall Study|Randomized, not treated|35|||
131616686|NCT00683800|473887782|FG001|Overall Study|Randomized, not treated|33|||
131616687|NCT00388726|473887787|FG000|Overall Study|Adverse Event|50|||
131616688|NCT00388726|473887788|FG001|Overall Study|Adverse Event|24|||
131616689|NCT00388726|473887787|FG000|Overall Study|Progressive Disease|336|||
131616690|NCT00388726|473887788|FG001|Overall Study|Progressive Disease|153|||
131616691|NCT00388726|473887787|FG000|Overall Study|Clinical Progression|61|||
131443565|NCT01668784|473252694|FG000|Treatment Period|Study Drug Toxicity|46|||
131443566|NCT01668784|473252695|FG001|Treatment Period|Study Drug Toxicity|53|||
131443567|NCT01668784|473252694|FG000|Treatment Period|Death|1|||
131443568|NCT01668784|473252695|FG001|Treatment Period|Death|1|||
131443569|NCT01668784|473252694|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
131443570|NCT01668784|473252695|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
131443571|NCT01668784|473252694|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
131443572|NCT01668784|473252695|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
131443573|NCT01668784|473252694|FG000|Treatment Period|Withdrawal by Subject|5|||
131443574|NCT01668784|473252695|FG001|Treatment Period|Withdrawal by Subject|3|||
131443575|NCT01668784|473252694|FG000|Treatment Period|Maximal Clinical Benefit|3|||
131443576|NCT01668784|473252695|FG001|Treatment Period|Maximal Clinical Benefit|3|||
131443577|NCT01668784|473252694|FG000|Treatment Period|Other|2|||
131443578|NCT01668784|473252695|FG001|Treatment Period|Other|8|||
131443579|NCT01668784|473252694|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
131443580|NCT01668784|473252695|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
131443581|NCT02246530|473252697|FG000|Overall Study|Lost to Follow-up|4|||
131443582|NCT02246530|473252698|FG001|Overall Study|Lost to Follow-up|0|||
131443583|NCT05135767|473252699|FG000|Baseline|Lost to Follow-up|1|||
131443584|NCT05135767|473252700|FG001|Baseline|Lost to Follow-up|1|||
131443585|NCT05135767|473252699|FG000|Baseline|Withdrawal by Subject|0|||
131709323|NCT01848145|474215579|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
131709324|NCT04067518|474215580|FG000|Overall Study|Adverse Event|1|||
131709325|NCT04067518|474215581|FG001|Overall Study|Adverse Event|3|||
131709326|NCT04067518|474215580|FG000|Overall Study|Screen failures|0|||
131709327|NCT04067518|474215581|FG001|Overall Study|Screen failures|1|||
131709328|NCT04067518|474215580|FG000|Overall Study|Enrolled but not treated|0|||
131709329|NCT04067518|474215581|FG001|Overall Study|Enrolled but not treated|1|||
131709330|NCT01728779|474215582|FG000|Overall Study|Withdrawal by Subject|1|||
131795310|NCT02207621|474533935|FG001|Overall Study|Disallowed Concurrent Medication|5|||
131795311|NCT02207621|474533936|FG002|Overall Study|Disallowed Concurrent Medication|2|||
131795312|NCT02207621|474533934|FG000|Overall Study|Physician Decision|1|||
131795313|NCT02207621|474533935|FG001|Overall Study|Physician Decision|2|||
131795314|NCT02207621|474533936|FG002|Overall Study|Physician Decision|2|||
131795315|NCT02207621|474533934|FG000|Overall Study|Protocol Violation|4|||
131443586|NCT05135767|473252700|FG001|Baseline|Withdrawal by Subject|2|||
131443587|NCT05135767|473252699|FG000|Active Study Phase|Lost to Follow-up|2|||
131443588|NCT05135767|473252700|FG001|Active Study Phase|Lost to Follow-up|0|||
131443589|NCT03597347|473252708|FG000|Overall Study|Withdrawal by Subject|1|||
131443590|NCT03597347|473252709|FG001|Overall Study|Withdrawal by Subject|1|||
131443591|NCT03597347|473252710|FG002|Overall Study|Withdrawal by Subject|0|||
131443592|NCT03597347|473252708|FG000|Overall Study|Withdrawal due to Covid-19|3|||
131443593|NCT03597347|473252709|FG001|Overall Study|Withdrawal due to Covid-19|0|||
131443594|NCT03597347|473252710|FG002|Overall Study|Withdrawal due to Covid-19|0|||
131616692|NCT00388726|473887788|FG001|Overall Study|Clinical Progression|36|||
131616693|NCT00388726|473887787|FG000|Overall Study|Withdrawal by Subject|10|||
131616694|NCT00388726|473887788|FG001|Overall Study|Withdrawal by Subject|7|||
131616695|NCT00388726|473887787|FG000|Overall Study|Administrative|6|||
131616696|NCT00388726|473887788|FG001|Overall Study|Administrative|9|||
131616697|NCT00388726|473887787|FG000|Overall Study|Physician Decision|18|||
131616698|NCT00388726|473887788|FG001|Overall Study|Physician Decision|13|||
131616699|NCT00388726|473887787|FG000|Overall Study|Death|3|||
131616700|NCT00388726|473887788|FG001|Overall Study|Death|2|||
131616701|NCT01953692|473887789|FG000|Overall Study|Adverse Event|5|||
131616702|NCT01953692|473887790|FG001|Overall Study|Adverse Event|2|||
131616703|NCT01953692|473887791|FG002|Overall Study|Adverse Event|4|||
131616704|NCT01953692|473887792|FG003|Overall Study|Adverse Event|2|||
131616705|NCT01953692|473887793|FG004|Overall Study|Adverse Event|1|||
131616706|NCT01953692|473887794|FG005|Overall Study|Adverse Event|2|||
131616707|NCT01953692|473887795|FG006|Overall Study|Adverse Event|0|||
131616708|NCT01953692|473887796|FG007|Overall Study|Adverse Event|0|||
131616709|NCT01953692|473887797|FG008|Overall Study|Adverse Event|0|||
131616710|NCT01953692|473887789|FG000|Overall Study|Clinical Progression|0|||
131616711|NCT01953692|473887790|FG001|Overall Study|Clinical Progression|15|||
131616712|NCT01953692|473887791|FG002|Overall Study|Clinical Progression|7|||
131616713|NCT01953692|473887792|FG003|Overall Study|Clinical Progression|5|||
131616714|NCT01953692|473887793|FG004|Overall Study|Clinical Progression|0|||
131709331|NCT00862251|474215583|FG000|Overall Study|Adverse Event|8|||
131709332|NCT00862251|474215584|FG001|Overall Study|Adverse Event|3|||
131443595|NCT03597347|473252708|FG000|Overall Study|Sponsor decision to terminate study|3|||
131709333|NCT00862251|474215585|FG002|Overall Study|Adverse Event|1|||
131795316|NCT02207621|474533935|FG001|Overall Study|Protocol Violation|10|||
131443596|NCT03597347|473252709|FG001|Overall Study|Sponsor decision to terminate study|2|||
131443597|NCT03597347|473252710|FG002|Overall Study|Sponsor decision to terminate study|4|||
131443598|NCT03804528|473252718|FG000|Overall Study|Time Commitment|18|||
131443599|NCT03804528|473252718|FG000|Overall Study|Health Reasons|5|||
131443600|NCT04607005|473252719|FG000|Overall Study|Adverse Event|0|||
131443601|NCT04607005|473252720|FG001|Overall Study|Adverse Event|1|||
131443602|NCT04607005|473252719|FG000|Overall Study|Lack of Efficacy|1|||
131443603|NCT04607005|473252720|FG001|Overall Study|Lack of Efficacy|6|||
131443604|NCT04607005|473252719|FG000|Overall Study|Withdrawal by Subject|4|||
131443605|NCT04607005|473252720|FG001|Overall Study|Withdrawal by Subject|9|||
131443606|NCT04607005|473252719|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
131443607|NCT04607005|473252720|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
131443608|NCT02331134|473252721|FG000|Overall Study|Withdrawal by Subject|1|||
131443609|NCT04825574|473252723|FG000|Overall Study|Commercial treatment became available|1|||
131443610|NCT04825574|473252723|FG000|Overall Study|Disease progression|1|||
131443611|NCT04272242|473252726|FG000|Overall Study|Withdrawal by Subject|3|||
131443612|NCT04272242|473252726|FG000|Overall Study|Lost to Follow-up|1|||
131443613|NCT04272242|473252726|FG000|Overall Study|Adverse Event|1|||
131443614|NCT03414983|473254860|FG000|Pre-Treatment|Other reasons|1|||
131443615|NCT03414983|473254861|FG001|Pre-Treatment|Other reasons|0|||
131443616|NCT03414983|473254860|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
131616715|NCT01953692|473887794|FG005|Overall Study|Clinical Progression|7|||
131616716|NCT01953692|473887795|FG006|Overall Study|Clinical Progression|20|||
131443617|NCT03414983|473254861|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
131443618|NCT03414983|473254860|FG000|Pre-Treatment|Participant withdrew consent|1|||
131443619|NCT03414983|473254861|FG001|Pre-Treatment|Participant withdrew consent|3|||
131443620|NCT03414983|473254860|FG000|Treatment|Participant withdrew consent|4|||
131443621|NCT03414983|473254861|FG001|Treatment|Participant withdrew consent|3|||
131443622|NCT03414983|473254860|FG000|Treatment|Participant request to discontinue study treatment|8|||
131443623|NCT03414983|473254861|FG001|Treatment|Participant request to discontinue study treatment|10|||
131443624|NCT03414983|473254860|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
131443625|NCT03414983|473254861|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
131443626|NCT03414983|473254860|FG000|Treatment|Death|0|||
131443627|NCT03414983|473254861|FG001|Treatment|Death|1|||
131443628|NCT03414983|473254860|FG000|Treatment|Study Drug Toxicity|10|||
131443629|NCT03414983|473254861|FG001|Treatment|Study Drug Toxicity|5|||
131443630|NCT03414983|473254860|FG000|Treatment|Disease Progression|75|||
131443631|NCT03414983|473254861|FG001|Treatment|Disease Progression|29|||
131616717|NCT01953692|473887796|FG007|Overall Study|Clinical Progression|3|||
131616718|NCT01953692|473887797|FG008|Overall Study|Clinical Progression|3|||
131616719|NCT01953692|473887789|FG000|Overall Study|Death|5|||
131616720|NCT01953692|473887790|FG001|Overall Study|Death|0|||
131616721|NCT01953692|473887791|FG002|Overall Study|Death|2|||
131616722|NCT01953692|473887792|FG003|Overall Study|Death|2|||
131616723|NCT01953692|473887793|FG004|Overall Study|Death|1|||
131616724|NCT01953692|473887794|FG005|Overall Study|Death|3|||
131616725|NCT01953692|473887795|FG006|Overall Study|Death|6|||
131616726|NCT01953692|473887796|FG007|Overall Study|Death|2|||
131616727|NCT01953692|473887797|FG008|Overall Study|Death|1|||
131616728|NCT01953692|473887789|FG000|Overall Study|Excluded Medication|1|||
131616729|NCT01953692|473887790|FG001|Overall Study|Excluded Medication|0|||
131616730|NCT01953692|473887791|FG002|Overall Study|Excluded Medication|0|||
131616731|NCT01953692|473887792|FG003|Overall Study|Excluded Medication|0|||
131616732|NCT01953692|473887793|FG004|Overall Study|Excluded Medication|0|||
131616733|NCT01953692|473887794|FG005|Overall Study|Excluded Medication|0|||
131616734|NCT01953692|473887795|FG006|Overall Study|Excluded Medication|0|||
131616735|NCT01953692|473887796|FG007|Overall Study|Excluded Medication|0|||
131616736|NCT01953692|473887797|FG008|Overall Study|Excluded Medication|0|||
131616737|NCT01953692|473887789|FG000|Overall Study|Lost to Follow-up|1|||
131616738|NCT01953692|473887790|FG001|Overall Study|Lost to Follow-up|0|||
131443632|NCT03414983|473254860|FG000|Treatment|Not reported|1|||
131443633|NCT03414983|473254861|FG001|Treatment|Not reported|0|||
131443634|NCT03414983|473254860|FG000|Treatment|Other reasons|3|||
131616739|NCT01953692|473887791|FG002|Overall Study|Lost to Follow-up|3|||
131616740|NCT01953692|473887792|FG003|Overall Study|Lost to Follow-up|1|||
131616741|NCT01953692|473887793|FG004|Overall Study|Lost to Follow-up|0|||
131616742|NCT01953692|473887794|FG005|Overall Study|Lost to Follow-up|1|||
131616743|NCT01953692|473887795|FG006|Overall Study|Lost to Follow-up|0|||
131616744|NCT01953692|473887796|FG007|Overall Study|Lost to Follow-up|0|||
131616745|NCT01953692|473887797|FG008|Overall Study|Lost to Follow-up|0|||
131616746|NCT01953692|473887789|FG000|Overall Study|Physician Decision|11|||
131616747|NCT01953692|473887790|FG001|Overall Study|Physician Decision|4|||
131616748|NCT01953692|473887791|FG002|Overall Study|Physician Decision|2|||
131616749|NCT01953692|473887792|FG003|Overall Study|Physician Decision|2|||
131616750|NCT01953692|473887793|FG004|Overall Study|Physician Decision|1|||
131616751|NCT01953692|473887794|FG005|Overall Study|Physician Decision|2|||
131616752|NCT01953692|473887795|FG006|Overall Study|Physician Decision|4|||
131616753|NCT01953692|473887796|FG007|Overall Study|Physician Decision|1|||
131616754|NCT01953692|473887797|FG008|Overall Study|Physician Decision|0|||
131616755|NCT01953692|473887789|FG000|Overall Study|Protocol Violation|0|||
131616756|NCT01953692|473887790|FG001|Overall Study|Protocol Violation|2|||
131616757|NCT01953692|473887791|FG002|Overall Study|Protocol Violation|1|||
131616758|NCT01953692|473887792|FG003|Overall Study|Protocol Violation|0|||
131616759|NCT01953692|473887793|FG004|Overall Study|Protocol Violation|0|||
131616760|NCT01953692|473887794|FG005|Overall Study|Protocol Violation|0|||
131616761|NCT01953692|473887795|FG006|Overall Study|Protocol Violation|0|||
131616762|NCT01953692|473887796|FG007|Overall Study|Protocol Violation|1|||
131616763|NCT01953692|473887797|FG008|Overall Study|Protocol Violation|0|||
131616764|NCT01953692|473887789|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616765|NCT01953692|473887790|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616766|NCT01953692|473887791|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131709334|NCT00862251|474215583|FG000|Overall Study|Lost to Follow-up|0|||
131709335|NCT00862251|474215584|FG001|Overall Study|Lost to Follow-up|0|||
131616767|NCT01953692|473887792|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616768|NCT01953692|473887793|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616769|NCT01953692|473887794|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616770|NCT01953692|473887795|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616771|NCT01953692|473887796|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
131616772|NCT01953692|473887797|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131616773|NCT01953692|473887789|FG000|Overall Study|Withdrawal by Subject|4|||
131616774|NCT01953692|473887790|FG001|Overall Study|Withdrawal by Subject|2|||
131616775|NCT01953692|473887791|FG002|Overall Study|Withdrawal by Subject|1|||
131616776|NCT01953692|473887792|FG003|Overall Study|Withdrawal by Subject|2|||
131616777|NCT01953692|473887793|FG004|Overall Study|Withdrawal by Subject|0|||
131616778|NCT01953692|473887794|FG005|Overall Study|Withdrawal by Subject|3|||
131616779|NCT01953692|473887795|FG006|Overall Study|Withdrawal by Subject|2|||
131616780|NCT01953692|473887796|FG007|Overall Study|Withdrawal by Subject|1|||
131616781|NCT01953692|473887797|FG008|Overall Study|Withdrawal by Subject|1|||
131616782|NCT01328496|473887806|FG000|Overall Study|Significant Change in Health Status|1|||
131616783|NCT01328496|473887807|FG001|Overall Study|Significant Change in Health Status|0|||
131616784|NCT00983294|473887808|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
131616785|NCT00983294|473887808|FG000|Colchicine With Azithromycin|Adverse Event|1|||
131616786|NCT00853593|473887809|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
131616787|NCT00853593|473887809|FG000|Overall Study|Model 4396 lead not attempted|29|||
131616788|NCT00853593|473887809|FG000|Overall Study|Implant not attempted|4|||
131616789|NCT00600353|473887814|FG000|Overall Study|history of malignancy within 5 years|1|||
131616790|NCT00600353|473887815|FG001|Overall Study|history of malignancy within 5 years|0|||
131616791|NCT00600353|473887814|FG000|Overall Study|History of prepartive regimen|0|||
131616792|NCT00600353|473887815|FG001|Overall Study|History of prepartive regimen|1|||
131616793|NCT01886872|473887816|FG000|Overall Study|Ineligible|7|||
131616794|NCT01886872|473887817|FG001|Overall Study|Ineligible|4|||
131616795|NCT01886872|473887818|FG002|Overall Study|Ineligible|12|||
131616796|NCT05966155|473887819|FG000|Overall Study|Death|1|||
131616797|NCT05966155|473887820|FG001|Overall Study|Death|2|||
131616798|NCT05966155|473887819|FG000|Overall Study|Lost to Follow-up|63|||
131616799|NCT05966155|473887820|FG001|Overall Study|Lost to Follow-up|67|||
131616800|NCT05966155|473887819|FG000|Overall Study|Protocol Violation|1|||
131616801|NCT05966155|473887820|FG001|Overall Study|Protocol Violation|0|||
131616802|NCT05966155|473887819|FG000|Overall Study|Withdrawal by Subject|8|||
131616803|NCT05966155|473887820|FG001|Overall Study|Withdrawal by Subject|9|||
131616804|NCT05966155|473887819|FG000|Overall Study|Enrolled Erroneously|0|||
131616805|NCT05966155|473887820|FG001|Overall Study|Enrolled Erroneously|1|||
131616806|NCT05966155|473887819|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
131616807|NCT05966155|473887820|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
131616808|NCT02743819|473887821|FG000|Overall Study|Lack of Efficacy|5|||
131616809|NCT02743819|473887821|FG000|Overall Study|Death|2|||
131616810|NCT02743819|473887821|FG000|Overall Study|Adverse Event|1|||
131616811|NCT03582475|473887832|FG000|Treatment Period|Withdrawal by Subject|0|||
131709336|NCT00862251|474215585|FG002|Overall Study|Lost to Follow-up|1|||
131709337|NCT00862251|474215583|FG000|Overall Study|Protocol Violation|2|||
131709338|NCT00862251|474215584|FG001|Overall Study|Protocol Violation|0|||
131709339|NCT00862251|474215585|FG002|Overall Study|Protocol Violation|1|||
131616812|NCT03582475|473887833|FG001|Treatment Period|Withdrawal by Subject|1|||
131616813|NCT03582475|473887832|FG000|Follow-up Period|Withdrawal by Subject|0|||
131616814|NCT03582475|473887833|FG001|Follow-up Period|Withdrawal by Subject|1|||
131443635|NCT03414983|473254861|FG001|Treatment|Other reasons|2|||
131443636|NCT03414983|473254860|FG000|Treatment|Poor/non-compliance|2|||
131443637|NCT03414983|473254861|FG001|Treatment|Poor/non-compliance|0|||
131443638|NCT03414983|473254860|FG000|Treatment|Maximum clinical benefit|5|||
131443639|NCT03414983|473254861|FG001|Treatment|Maximum clinical benefit|9|||
131443640|NCT03414983|473254860|FG000|Treatment|Lost to Follow-up|0|||
131443641|NCT03414983|473254861|FG001|Treatment|Lost to Follow-up|1|||
131443642|NCT03414983|473254860|FG000|Treatment|Administrative reasons by sponsor|1|||
131443643|NCT03414983|473254861|FG001|Treatment|Administrative reasons by sponsor|0|||
131443644|NCT02318706|473254864|FG000|Double-blind Phase|Adverse Event|7|||
131443645|NCT02318706|473254865|FG001|Double-blind Phase|Adverse Event|4|||
131443646|NCT02318706|473254866|FG002|Double-blind Phase|Adverse Event|3|||
131443647|NCT02318706|473254867|FG003|Double-blind Phase|Adverse Event|10|||
131443648|NCT02318706|473254868|FG004|Double-blind Phase|Adverse Event|0|||
131443649|NCT02318706|473254864|FG000|Double-blind Phase|Lost to Follow-up|1|||
131443650|NCT02318706|473254865|FG001|Double-blind Phase|Lost to Follow-up|0|||
131443651|NCT02318706|473254866|FG002|Double-blind Phase|Lost to Follow-up|0|||
131443652|NCT02318706|473254867|FG003|Double-blind Phase|Lost to Follow-up|0|||
131443653|NCT02318706|473254868|FG004|Double-blind Phase|Lost to Follow-up|0|||
131443654|NCT02318706|473254864|FG000|Double-blind Phase|Protocol Violation|4|||
131616815|NCT01706159|473887834|FG000|Overall Study|Withdrawal Criteria|2|||
131616816|NCT01706159|473887835|FG001|Overall Study|Withdrawal Criteria|1|||
131616817|NCT01706159|473887834|FG000|Overall Study|Unclassified|6|||
131616818|NCT01706159|473887835|FG001|Overall Study|Unclassified|1|||
131616819|NCT00553332|473887836|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
131709340|NCT00862251|474215583|FG000|Overall Study|Withdrawal by Subject|9|||
131709341|NCT00862251|474215584|FG001|Overall Study|Withdrawal by Subject|2|||
131709342|NCT00862251|474215585|FG002|Overall Study|Withdrawal by Subject|6|||
131709343|NCT00624520|474215586|FG000|Overall Study|Withdrawal by Subject|12|||
131709344|NCT00624520|474215587|FG001|Overall Study|Withdrawal by Subject|7|||
131709345|NCT00624520|474215586|FG000|Overall Study|Death|0|||
131709346|NCT00624520|474215587|FG001|Overall Study|Death|1|||
131709347|NCT02796755|474215588|FG000|Overall Study|Adverse Event|2|||
131709348|NCT02796755|474215589|FG001|Overall Study|Adverse Event|0|||
131709349|NCT00675025|474215590|FG000|Overall Study|Study Terminated by Sponsor|38|||
131709350|NCT00675025|474215591|FG001|Overall Study|Study Terminated by Sponsor|42|||
131709351|NCT00675025|474215590|FG000|Overall Study|Adverse Event|6|||
131709352|NCT00675025|474215591|FG001|Overall Study|Adverse Event|11|||
131709353|NCT00675025|474215590|FG000|Overall Study|Lost to Follow-up|6|||
131616834|NCT02235298|473887840|FG000|Overall Study|Lost to Follow-up|6|||
131616835|NCT02235298|473887841|FG001|Overall Study|Lost to Follow-up|5|||
131616836|NCT02235298|473887840|FG000|Overall Study|Adverse Event|2|||
131616837|NCT02235298|473887841|FG001|Overall Study|Adverse Event|2|||
131616838|NCT02235298|473887840|FG000|Overall Study|Withdrawal by Subject|0|||
131616839|NCT02235298|473887841|FG001|Overall Study|Withdrawal by Subject|1|||
131616840|NCT03683576|473887842|FG000|Overall Study|Withdrawal by Subject|2|||
131616841|NCT03683576|473887843|FG001|Overall Study|Withdrawal by Subject|0|||
131616842|NCT03683576|473887844|FG002|Overall Study|Withdrawal by Subject|8|||
131616843|NCT03683576|473887845|FG003|Overall Study|Withdrawal by Subject|3|||
131616844|NCT03683576|473887842|FG000|Overall Study|Adverse Event|3|||
131616845|NCT03683576|473887843|FG001|Overall Study|Adverse Event|0|||
131616846|NCT03683576|473887844|FG002|Overall Study|Adverse Event|0|||
131616847|NCT03683576|473887845|FG003|Overall Study|Adverse Event|4|||
131616848|NCT03683576|473887842|FG000|Overall Study|Lack of Efficacy|1|||
131616849|NCT03683576|473887843|FG001|Overall Study|Lack of Efficacy|0|||
131616850|NCT03683576|473887844|FG002|Overall Study|Lack of Efficacy|1|||
131616851|NCT03683576|473887845|FG003|Overall Study|Lack of Efficacy|1|||
131616852|NCT03683576|473887842|FG000|Overall Study|Lost to Follow-up|0|||
131616853|NCT03683576|473887843|FG001|Overall Study|Lost to Follow-up|1|||
131616854|NCT03683576|473887844|FG002|Overall Study|Lost to Follow-up|2|||
131616855|NCT03683576|473887845|FG003|Overall Study|Lost to Follow-up|0|||
131616856|NCT03683576|473887842|FG000|Overall Study|Other, Not Specified|0|||
131616857|NCT03683576|473887843|FG001|Overall Study|Other, Not Specified|2|||
131616858|NCT03683576|473887844|FG002|Overall Study|Other, Not Specified|0|||
131616859|NCT03683576|473887845|FG003|Overall Study|Other, Not Specified|0|||
131616860|NCT03683576|473887842|FG000|Overall Study|Protocol Violation|0|||
131616861|NCT03683576|473887843|FG001|Overall Study|Protocol Violation|1|||
131616862|NCT03683576|473887844|FG002|Overall Study|Protocol Violation|1|||
131616863|NCT03683576|473887845|FG003|Overall Study|Protocol Violation|0|||
131616864|NCT00647387|473887847|FG000|Overall Study|Lost to Follow-up|6|||
131616865|NCT00647387|473887847|FG000|Overall Study|Unsuccessful implant|5|||
131616866|NCT00647387|473887847|FG000|Overall Study|Device explanted|3|||
131616867|NCT00647387|473887847|FG000|Overall Study|Other Reason|3|||
131616868|NCT00647387|473887847|FG000|Overall Study|Death|2|||
131616869|NCT02969356|473887848|FG000|Overall Study|Adverse Event|7|||
131616870|NCT02969356|473887848|FG000|Overall Study|Consent withdrawn|2|||
131443655|NCT02318706|473254865|FG001|Double-blind Phase|Protocol Violation|2|||
131616871|NCT02969356|473887848|FG000|Overall Study|Lost to Follow-up|3|||
131709354|NCT00675025|474215591|FG001|Overall Study|Lost to Follow-up|4|||
131795317|NCT02207621|474533936|FG002|Overall Study|Protocol Violation|6|||
131795318|NCT02207621|474533934|FG000|Overall Study|Death|2|||
131795319|NCT02207621|474533935|FG001|Overall Study|Death|0|||
131795320|NCT02207621|474533936|FG002|Overall Study|Death|0|||
131795321|NCT02207621|474533934|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
131795322|NCT02207621|474533935|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
131795323|NCT02207621|474533936|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
131795324|NCT02623959|474533941|FG000|Overall Study|Progression|0|||
131795325|NCT02623959|474533942|FG001|Overall Study|Progression|1|||
131795326|NCT04041570|474533952|FG000|Overall Study|Moved from Area|0|||
131795327|NCT04041570|474533953|FG001|Overall Study|Moved from Area|2|||
131795328|NCT01338636|474533954|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
131795329|NCT02385526|474533955|FG000|Overall Study|Withdrawal by Subject|0|||
131795330|NCT02385526|474533956|FG001|Overall Study|Withdrawal by Subject|2|||
131795331|NCT02385526|474533957|FG002|Overall Study|Withdrawal by Subject|0|||
131795332|NCT02385526|474533955|FG000|Overall Study|Lost to Follow-up|0|||
131795333|NCT02385526|474533956|FG001|Overall Study|Lost to Follow-up|1|||
131795334|NCT02385526|474533957|FG002|Overall Study|Lost to Follow-up|0|||
131795335|NCT02385526|474533955|FG000|Overall Study|Physician Decision|1|||
131795336|NCT02385526|474533956|FG001|Overall Study|Physician Decision|0|||
131795337|NCT02385526|474533957|FG002|Overall Study|Physician Decision|0|||
131795338|NCT02385526|474533955|FG000|Overall Study|Protocol Violation|1|||
131795339|NCT02385526|474533956|FG001|Overall Study|Protocol Violation|0|||
131795340|NCT02385526|474533957|FG002|Overall Study|Protocol Violation|0|||
131795341|NCT03532009|474533958|FG000|Overall Study|Other|1|||
131795342|NCT03532009|474533959|FG001|Overall Study|Other|1|||
131795343|NCT03532009|474533958|FG000|Overall Study|Death|1|||
131795344|NCT03532009|474533959|FG001|Overall Study|Death|1|||
131795345|NCT03532009|474533958|FG000|Overall Study|Withdrawal by Patient|0|||
131795346|NCT03532009|474533959|FG001|Overall Study|Withdrawal by Patient|2|||
131795347|NCT02035137|474533961|FG000|Overall Study|Physician Decision|0|||
131795348|NCT02035137|474533962|FG001|Overall Study|Physician Decision|0|||
131795349|NCT02035137|474533963|FG002|Overall Study|Physician Decision|1|||
131795350|NCT02035137|474533961|FG000|Overall Study|Withdrawal by Subject|0|||
131795351|NCT02035137|474533962|FG001|Overall Study|Withdrawal by Subject|1|||
131795352|NCT02035137|474533963|FG002|Overall Study|Withdrawal by Subject|2|||
131795353|NCT02035137|474533961|FG000|Overall Study|Ineligible|0|||
131795354|NCT02035137|474533962|FG001|Overall Study|Ineligible|1|||
131795355|NCT02035137|474533963|FG002|Overall Study|Ineligible|2|||
131795356|NCT02035137|474533961|FG000|Overall Study|Disease progression prior to treatment start|2|||
131795357|NCT02035137|474533962|FG001|Overall Study|Disease progression prior to treatment start|0|||
131616872|NCT02969356|473887848|FG000|Overall Study|Did not need to be reinjected|6|||
131616873|NCT02969356|473887848|FG000|Overall Study|Personal reasons|5|||
131616874|NCT03147287|473887849|FG000|Overall Study|Randomized Not Treated|2|||
131616875|NCT03147287|473887850|FG001|Overall Study|Randomized Not Treated|1|||
131616876|NCT03147287|473887851|FG002|Overall Study|Randomized Not Treated|1|||
131616877|NCT03147287|473887849|FG000|Overall Study|Progressive Disease RECIST|31|||
131616878|NCT03147287|473887850|FG001|Overall Study|Progressive Disease RECIST|72|||
131616879|NCT03147287|473887851|FG002|Overall Study|Progressive Disease RECIST|32|||
131616880|NCT03147287|473887849|FG000|Overall Study|Progressive Disease not RECIST|13|||
131616881|NCT03147287|473887850|FG001|Overall Study|Progressive Disease not RECIST|21|||
131616882|NCT03147287|473887851|FG002|Overall Study|Progressive Disease not RECIST|13|||
131616883|NCT03147287|473887849|FG000|Overall Study|Physician Decision|1|||
131616884|NCT03147287|473887850|FG001|Overall Study|Physician Decision|2|||
131616885|NCT03147287|473887851|FG002|Overall Study|Physician Decision|1|||
131616886|NCT03147287|473887849|FG000|Overall Study|Intercurrent illness|0|||
131616887|NCT03147287|473887850|FG001|Overall Study|Intercurrent illness|1|||
131616888|NCT03147287|473887851|FG002|Overall Study|Intercurrent illness|0|||
131616889|NCT03147287|473887849|FG000|Overall Study|Withdrawal by Subject|2|||
131616890|NCT03147287|473887850|FG001|Overall Study|Withdrawal by Subject|3|||
131616891|NCT03147287|473887851|FG002|Overall Study|Withdrawal by Subject|2|||
131616892|NCT03147287|473887849|FG000|Overall Study|Patient Non-Compliance|0|||
131616893|NCT03147287|473887850|FG001|Overall Study|Patient Non-Compliance|2|||
131616894|NCT03147287|473887851|FG002|Overall Study|Patient Non-Compliance|0|||
131616895|NCT03147287|473887849|FG000|Overall Study|Patient moved|0|||
131616896|NCT03147287|473887850|FG001|Overall Study|Patient moved|1|||
131616897|NCT03147287|473887851|FG002|Overall Study|Patient moved|0|||
131795358|NCT02035137|474533963|FG002|Overall Study|Disease progression prior to treatment start|0|||
131795359|NCT00384033|474533979|FG000|Overall Study|Adverse Event|10|||
131795360|NCT00384033|474533980|FG001|Overall Study|Adverse Event|8|||
131616898|NCT03147287|473887849|FG000|Overall Study|Arm A crossover without PD|1|||
131795361|NCT00384033|474533981|FG002|Overall Study|Adverse Event|11|||
131795362|NCT00384033|474533982|FG003|Overall Study|Adverse Event|20|||
131795363|NCT00384033|474533979|FG000|Overall Study|Failed to return|1|||
131795364|NCT00384033|474533980|FG001|Overall Study|Failed to return|3|||
131795365|NCT00384033|474533981|FG002|Overall Study|Failed to return|2|||
131616899|NCT03147287|473887850|FG001|Overall Study|Arm A crossover without PD|0|||
131616900|NCT03147287|473887851|FG002|Overall Study|Arm A crossover without PD|0|||
131616901|NCT03147287|473887849|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
131616902|NCT03147287|473887850|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
131616903|NCT03147287|473887851|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
131616904|NCT03945773|473888895|FG000|Overall Study|Consent Withdrawn|1|||
131616905|NCT03945773|473888896|FG001|Overall Study|Consent Withdrawn|1|||
131616906|NCT03945773|473888895|FG000|Overall Study|Lost to Follow-up|1|||
131616907|NCT03945773|473888896|FG001|Overall Study|Lost to Follow-up|0|||
131616908|NCT03945773|473888895|FG000|Overall Study|Death|46|||
131616909|NCT03945773|473888896|FG001|Overall Study|Death|22|||
131616910|NCT03945773|473888895|FG000|Overall Study|Physician Decision|1|||
131616911|NCT03945773|473888896|FG001|Overall Study|Physician Decision|0|||
131616912|NCT03945773|473888895|FG000|Overall Study|Other|1|||
131616913|NCT03945773|473888896|FG001|Overall Study|Other|0|||
131616914|NCT03945773|473888895|FG000|Overall Study|Ongoing at the time of DCO|3|||
131616915|NCT03945773|473888896|FG001|Overall Study|Ongoing at the time of DCO|4|||
131616916|NCT01970878|473888898|FG000|Overall Study|Withdrawal by Subject|11|||
131616917|NCT01970878|473888899|FG001|Overall Study|Withdrawal by Subject|10|||
131616918|NCT01970878|473888900|FG002|Overall Study|Withdrawal by Subject|14|||
131616919|NCT01970878|473888901|FG003|Overall Study|Withdrawal by Subject|7|||
131616920|NCT01970878|473888898|FG000|Overall Study|Lost to Follow-up|1|||
131616921|NCT01970878|473888899|FG001|Overall Study|Lost to Follow-up|3|||
131616922|NCT01970878|473888900|FG002|Overall Study|Lost to Follow-up|2|||
131616923|NCT01970878|473888901|FG003|Overall Study|Lost to Follow-up|4|||
131616924|NCT01970878|473888898|FG000|Overall Study|Administrative Reasons|1|||
131616925|NCT01970878|473888899|FG001|Overall Study|Administrative Reasons|0|||
131616926|NCT01970878|473888900|FG002|Overall Study|Administrative Reasons|0|||
131616927|NCT01970878|473888901|FG003|Overall Study|Administrative Reasons|4|||
131616928|NCT01970878|473888898|FG000|Overall Study|Lack of Efficacy|2|||
131616929|NCT01970878|473888899|FG001|Overall Study|Lack of Efficacy|1|||
131616930|NCT01970878|473888900|FG002|Overall Study|Lack of Efficacy|2|||
131616931|NCT01970878|473888901|FG003|Overall Study|Lack of Efficacy|0|||
131616932|NCT01970878|473888898|FG000|Overall Study|Adverse Event|12|||
131616933|NCT01970878|473888899|FG001|Overall Study|Adverse Event|7|||
131443656|NCT02318706|473254866|FG002|Double-blind Phase|Protocol Violation|4|||
131443657|NCT02318706|473254867|FG003|Double-blind Phase|Protocol Violation|3|||
131616934|NCT01970878|473888900|FG002|Overall Study|Adverse Event|4|||
131616935|NCT01970878|473888901|FG003|Overall Study|Adverse Event|3|||
131616936|NCT01970878|473888898|FG000|Overall Study|Protocol Specified Criteria|10|||
131616937|NCT01970878|473888899|FG001|Overall Study|Protocol Specified Criteria|4|||
131616938|NCT01970878|473888900|FG002|Overall Study|Protocol Specified Criteria|3|||
131616939|NCT01970878|473888901|FG003|Overall Study|Protocol Specified Criteria|6|||
131616940|NCT01970878|473888898|FG000|Overall Study|Physician Decision|0|||
131616941|NCT01970878|473888899|FG001|Overall Study|Physician Decision|1|||
131616942|NCT01970878|473888900|FG002|Overall Study|Physician Decision|1|||
131616943|NCT01970878|473888901|FG003|Overall Study|Physician Decision|0|||
131616944|NCT01970878|473888898|FG000|Overall Study|No Completion Status|0|||
131616945|NCT01970878|473888899|FG001|Overall Study|No Completion Status|1|||
131616946|NCT01970878|473888900|FG002|Overall Study|No Completion Status|0|||
131616947|NCT01970878|473888901|FG003|Overall Study|No Completion Status|0|||
131616948|NCT00795184|473888910|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
131616949|NCT00795184|473888911|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
131616950|NCT00205179|473888913|FG000|Overall Study|Death|0|||
131616951|NCT00205179|473888914|FG001|Overall Study|Death|2|||
131616952|NCT00205179|473888913|FG000|Overall Study|Physician Decision|1|||
131616953|NCT00205179|473888914|FG001|Overall Study|Physician Decision|1|||
131616954|NCT00205179|473888913|FG000|Overall Study|Adverse Event|1|||
131616955|NCT00205179|473888914|FG001|Overall Study|Adverse Event|1|||
131616956|NCT00586313|473888915|FG000|Overall Study|Lack of Efficacy|2|||
131616957|NCT02079649|473888916|FG000|Overall Study|Lost to Follow-up|0|||
131443658|NCT02318706|473254868|FG004|Double-blind Phase|Protocol Violation|0|||
131616958|NCT02079649|473888917|FG001|Overall Study|Lost to Follow-up|0|||
131616959|NCT02079649|473888918|FG002|Overall Study|Lost to Follow-up|0|||
131616960|NCT02079649|473888919|FG003|Overall Study|Lost to Follow-up|1|||
131616961|NCT02079649|473888916|FG000|Overall Study|Withdrawal by Subject|0|||
131616962|NCT02079649|473888917|FG001|Overall Study|Withdrawal by Subject|0|||
131616963|NCT02079649|473888918|FG002|Overall Study|Withdrawal by Subject|0|||
131616964|NCT02079649|473888919|FG003|Overall Study|Withdrawal by Subject|1|||
131616965|NCT02079649|473888916|FG000|Overall Study|Randomization error (prior to treatment)|1|||
131616966|NCT02079649|473888917|FG001|Overall Study|Randomization error (prior to treatment)|0|||
131616967|NCT02079649|473888918|FG002|Overall Study|Randomization error (prior to treatment)|1|||
131616968|NCT02079649|473888919|FG003|Overall Study|Randomization error (prior to treatment)|0|||
131616969|NCT00853580|473888922|FG000|Overall Study|Lost to Follow-up|3|||
131616970|NCT00853580|473888923|FG001|Overall Study|Lost to Follow-up|5|||
131616971|NCT00853580|473888922|FG000|Overall Study|Protocol Violation|2|||
131616972|NCT00853580|473888923|FG001|Overall Study|Protocol Violation|1|||
131616973|NCT00853580|473888922|FG000|Overall Study|Withdrawal by Subject|2|||
131616974|NCT00853580|473888923|FG001|Overall Study|Withdrawal by Subject|8|||
131616975|NCT00853580|473888922|FG000|Overall Study|Commenced contraindicated therapy|0|||
131616976|NCT00853580|473888923|FG001|Overall Study|Commenced contraindicated therapy|2|||
131616977|NCT01728324|473888924|FG000|Termination of DBV|Adverse Event|14|||
131616978|NCT01728324|473888925|FG001|Termination of DBV|Adverse Event|13|||
131616979|NCT01728324|473888926|FG002|Termination of DBV|Adverse Event|4|||
131616980|NCT01728324|473888924|FG000|Termination of DBV|Lack of Efficacy|14|||
131616981|NCT01728324|473888925|FG001|Termination of DBV|Lack of Efficacy|12|||
131616982|NCT01728324|473888926|FG002|Termination of DBV|Lack of Efficacy|8|||
131616983|NCT01728324|473888924|FG000|Termination of DBV|Withdrawal by Subject|9|||
131616984|NCT01728324|473888925|FG001|Termination of DBV|Withdrawal by Subject|6|||
131616985|NCT01728324|473888926|FG002|Termination of DBV|Withdrawal by Subject|2|||
131616986|NCT01728324|473888924|FG000|Termination of DBV|Other than stated|1|||
131616987|NCT01728324|473888925|FG001|Termination of DBV|Other than stated|3|||
131616988|NCT01728324|473888926|FG002|Termination of DBV|Other than stated|0|||
131616989|NCT01728324|473888924|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
131443659|NCT02318706|473254864|FG000|Double-blind Phase|Withdrawal by Subject|9|||
131443660|NCT02318706|473254865|FG001|Double-blind Phase|Withdrawal by Subject|5|||
131443661|NCT02318706|473254866|FG002|Double-blind Phase|Withdrawal by Subject|7|||
131443662|NCT02318706|473254867|FG003|Double-blind Phase|Withdrawal by Subject|10|||
131443663|NCT02318706|473254868|FG004|Double-blind Phase|Withdrawal by Subject|0|||
131443664|NCT02318706|473254864|FG000|Double-blind Phase|Other|4|||
131443665|NCT02318706|473254865|FG001|Double-blind Phase|Other|1|||
131443666|NCT02318706|473254866|FG002|Double-blind Phase|Other|2|||
131443667|NCT02318706|473254867|FG003|Double-blind Phase|Other|1|||
131443668|NCT02318706|473254868|FG004|Double-blind Phase|Other|0|||
131443669|NCT02318706|473254864|FG000|Double-blind Phase|Death|0|||
131443670|NCT02318706|473254865|FG001|Double-blind Phase|Death|0|||
131443671|NCT02318706|473254866|FG002|Double-blind Phase|Death|2|||
131443672|NCT02318706|473254867|FG003|Double-blind Phase|Death|0|||
131443673|NCT02318706|473254868|FG004|Double-blind Phase|Death|0|||
131443674|NCT02318706|473254864|FG000|Open-label Extension Phase|Adverse Event|0|||
131616990|NCT01728324|473888925|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
131616991|NCT01728324|473888926|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
131616992|NCT01728324|473888924|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
131616993|NCT01728324|473888925|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
131616994|NCT01728324|473888926|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
131616995|NCT01728324|473888924|FG000|Termination of FDV|Adverse Event|14|||
131616996|NCT01728324|473888925|FG001|Termination of FDV|Adverse Event|13|||
131616997|NCT01728324|473888926|FG002|Termination of FDV|Adverse Event|4|||
131616998|NCT01728324|473888924|FG000|Termination of FDV|Lack of Efficacy|14|||
131616999|NCT01728324|473888925|FG001|Termination of FDV|Lack of Efficacy|12|||
131617000|NCT01728324|473888926|FG002|Termination of FDV|Lack of Efficacy|8|||
131617001|NCT01728324|473888924|FG000|Termination of FDV|Withdrawal by Subject|9|||
131617002|NCT01728324|473888925|FG001|Termination of FDV|Withdrawal by Subject|6|||
131443675|NCT02318706|473254865|FG001|Open-label Extension Phase|Adverse Event|0|||
131443676|NCT02318706|473254866|FG002|Open-label Extension Phase|Adverse Event|0|||
131617003|NCT01728324|473888926|FG002|Termination of FDV|Withdrawal by Subject|2|||
131617004|NCT01728324|473888924|FG000|Termination of FDV|Other than stated|1|||
131617005|NCT01728324|473888925|FG001|Termination of FDV|Other than stated|3|||
131617006|NCT01728324|473888926|FG002|Termination of FDV|Other than stated|0|||
131617007|NCT01728324|473888924|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
131617008|NCT01728324|473888925|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
131617009|NCT01728324|473888926|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
131617010|NCT01728324|473888924|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
131617011|NCT01728324|473888925|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
131617012|NCT01728324|473888926|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
131617013|NCT01728324|473888924|FG000|Termination of RBV|Adverse Event|15|||
131709355|NCT00675025|474215590|FG000|Overall Study|Withdrawal by Subject|4|||
131709356|NCT00675025|474215591|FG001|Overall Study|Withdrawal by Subject|6|||
131709357|NCT04398732|474215595|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
131709358|NCT00556426|474215596|FG000|Overall Study|Withdrawal by Subject|3|||
131709359|NCT00556426|474215596|FG000|Overall Study|Death|6|||
131709360|NCT01596257|474215598|FG000|Overall Study|Inadequate Collection|23|||
131617014|NCT01728324|473888925|FG001|Termination of RBV|Adverse Event|16|||
131617015|NCT01728324|473888926|FG002|Termination of RBV|Adverse Event|5|||
131617016|NCT01728324|473888924|FG000|Termination of RBV|Lack of Efficacy|14|||
131617017|NCT01728324|473888925|FG001|Termination of RBV|Lack of Efficacy|11|||
131617018|NCT01728324|473888926|FG002|Termination of RBV|Lack of Efficacy|7|||
131617019|NCT01728324|473888924|FG000|Termination of RBV|Withdrawal by Subject|9|||
131617020|NCT01728324|473888925|FG001|Termination of RBV|Withdrawal by Subject|5|||
131617021|NCT01728324|473888926|FG002|Termination of RBV|Withdrawal by Subject|2|||
131617022|NCT01728324|473888924|FG000|Termination of RBV|Other than stated|1|||
131617023|NCT01728324|473888925|FG001|Termination of RBV|Other than stated|3|||
131617024|NCT01728324|473888926|FG002|Termination of RBV|Other than stated|1|||
131617025|NCT01728324|473888924|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
131617026|NCT01728324|473888925|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
131617027|NCT01728324|473888926|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
131617028|NCT01728324|473888924|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
131617029|NCT01728324|473888925|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
131617030|NCT01728324|473888926|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
131617031|NCT01170208|473888927|FG000|Overall Study|Withdrawal by Subject|5|||
131617032|NCT01170208|473888928|FG001|Overall Study|Withdrawal by Subject|0|||
131617033|NCT01170208|473888929|FG002|Overall Study|Withdrawal by Subject|1|||
131617034|NCT01170208|473888927|FG000|Overall Study|Protocol Violation|1|||
131617035|NCT01170208|473888928|FG001|Overall Study|Protocol Violation|0|||
131617036|NCT01170208|473888929|FG002|Overall Study|Protocol Violation|1|||
131617037|NCT03335488|473888934|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
131617038|NCT03335488|473888935|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
131617039|NCT03335488|473888934|FG000|Safety Extension Period|Adverse Event|1|||
131617040|NCT03335488|473888935|FG001|Safety Extension Period|Adverse Event|0|||
131617041|NCT03335488|473888934|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
131617042|NCT03335488|473888935|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
131617043|NCT02022670|473888936|FG000|Overall Study|Adverse Event|1|||
131617044|NCT02022670|473888937|FG001|Overall Study|Adverse Event|0|||
131617045|NCT02022670|473888938|FG002|Overall Study|Adverse Event|1|||
131617046|NCT02113449|473888939|FG000|Overall Study|Adverse Event|4|||
131617047|NCT04638816|473888940|FG000|Overall Study|Withdrawal by Subject|0|||
131617048|NCT04638816|473888941|FG001|Overall Study|Withdrawal by Subject|1|||
131617049|NCT04638816|473888940|FG000|Overall Study|Lost to Follow-up|0|||
131617050|NCT04638816|473888941|FG001|Overall Study|Lost to Follow-up|1|||
131617051|NCT02251652|473888942|FG000|Overall Study|Withdrawal by Subject|1|||
131617052|NCT01160354|473888945|FG000|Overall Study|Death|0|||
131617053|NCT01160354|473888946|FG001|Overall Study|Death|1|||
131617054|NCT01160354|473888947|FG002|Overall Study|Death|1|||
131617055|NCT01822756|473888948|FG000|Overall Study|Adverse Event|0|||
131617056|NCT01822756|473888949|FG001|Overall Study|Adverse Event|0|||
131617057|NCT01822756|473888950|FG002|Overall Study|Adverse Event|0|||
131617058|NCT01822756|473888951|FG003|Overall Study|Adverse Event|2|||
131617059|NCT01822756|473888952|FG004|Overall Study|Adverse Event|0|||
131617060|NCT01822756|473888948|FG000|Overall Study|Disease progression|11|||
131617061|NCT01822756|473888949|FG001|Overall Study|Disease progression|1|||
131709361|NCT01596257|474215599|FG001|Overall Study|Inadequate Collection|19|||
131709362|NCT02054702|474215603|FG000|Overall Study|Lost to Follow-up|3|||
131709363|NCT02054702|474215604|FG001|Overall Study|Lost to Follow-up|5|||
131709364|NCT02054702|474215603|FG000|Overall Study|Adverse Event|3|||
131709365|NCT02054702|474215604|FG001|Overall Study|Adverse Event|1|||
131709366|NCT02054702|474215603|FG000|Overall Study|Met Withdrawal Criteria|4|||
131709367|NCT02054702|474215604|FG001|Overall Study|Met Withdrawal Criteria|1|||
131709368|NCT02054702|474215603|FG000|Overall Study|Physician Decision|0|||
131709369|NCT02054702|474215604|FG001|Overall Study|Physician Decision|1|||
131617062|NCT01822756|473888950|FG002|Overall Study|Disease progression|7|||
131617063|NCT01822756|473888951|FG003|Overall Study|Disease progression|2|||
131617064|NCT01822756|473888952|FG004|Overall Study|Disease progression|6|||
131709370|NCT02054702|474215603|FG000|Overall Study|Withdrawal by Subject|14|||
131617065|NCT01822756|473888948|FG000|Overall Study|Death|2|||
131617066|NCT01822756|473888949|FG001|Overall Study|Death|2|||
131617067|NCT01822756|473888950|FG002|Overall Study|Death|1|||
131617068|NCT01822756|473888951|FG003|Overall Study|Death|0|||
131617069|NCT01822756|473888952|FG004|Overall Study|Death|0|||
131617070|NCT01822756|473888948|FG000|Overall Study|Lost to Follow-up|1|||
131617071|NCT01822756|473888949|FG001|Overall Study|Lost to Follow-up|0|||
131617072|NCT01822756|473888950|FG002|Overall Study|Lost to Follow-up|1|||
131617073|NCT01822756|473888951|FG003|Overall Study|Lost to Follow-up|0|||
131617074|NCT01822756|473888952|FG004|Overall Study|Lost to Follow-up|1|||
131617075|NCT01822756|473888948|FG000|Overall Study|Physician Decision|0|||
131617076|NCT01822756|473888949|FG001|Overall Study|Physician Decision|1|||
131617077|NCT01822756|473888950|FG002|Overall Study|Physician Decision|0|||
131617078|NCT01822756|473888951|FG003|Overall Study|Physician Decision|0|||
131617079|NCT01822756|473888952|FG004|Overall Study|Physician Decision|0|||
131617080|NCT01822756|473888948|FG000|Overall Study|disease progression & patient preference|2|||
131617081|NCT01822756|473888949|FG001|Overall Study|disease progression & patient preference|0|||
131617082|NCT01822756|473888950|FG002|Overall Study|disease progression & patient preference|1|||
131795366|NCT00384033|474533982|FG003|Overall Study|Failed to return|2|||
131795367|NCT00384033|474533979|FG000|Overall Study|Physician Decision|1|||
131795368|NCT00384033|474533980|FG001|Overall Study|Physician Decision|0|||
131795369|NCT00384033|474533981|FG002|Overall Study|Physician Decision|0|||
131795370|NCT00384033|474533982|FG003|Overall Study|Physician Decision|0|||
131795371|NCT00384033|474533979|FG000|Overall Study|Lost to Follow-up|6|||
131795372|NCT00384033|474533980|FG001|Overall Study|Lost to Follow-up|12|||
131795373|NCT00384033|474533981|FG002|Overall Study|Lost to Follow-up|7|||
131795374|NCT00384033|474533982|FG003|Overall Study|Lost to Follow-up|7|||
131795375|NCT00384033|474533979|FG000|Overall Study|Other|2|||
131795376|NCT00384033|474533980|FG001|Overall Study|Other|0|||
131795377|NCT00384033|474533981|FG002|Overall Study|Other|0|||
131795378|NCT00384033|474533982|FG003|Overall Study|Other|0|||
131795379|NCT00384033|474533979|FG000|Overall Study|Protocol Violation|5|||
131617083|NCT01822756|473888951|FG003|Overall Study|disease progression & patient preference|0|||
131617084|NCT01822756|473888952|FG004|Overall Study|disease progression & patient preference|0|||
131617085|NCT03611075|473888957|FG000|Overall Study|Physician Decision|0|||
131617086|NCT03611075|473888958|FG001|Overall Study|Physician Decision|1|||
131617087|NCT03611075|473888959|FG002|Overall Study|Physician Decision|1|||
131617088|NCT03611075|473888960|FG003|Overall Study|Physician Decision|0|||
131617089|NCT03611075|473888961|FG004|Overall Study|Physician Decision|0|||
131617090|NCT03611075|473888962|FG005|Overall Study|Physician Decision|0|||
131617091|NCT03611075|473888963|FG006|Overall Study|Physician Decision|0|||
131617092|NCT03611075|473888964|FG007|Overall Study|Physician Decision|0|||
131617093|NCT03611075|473888965|FG008|Overall Study|Physician Decision|0|||
131617094|NCT03611075|473888957|FG000|Overall Study|Lost to Follow-up|1|||
131617095|NCT03611075|473888958|FG001|Overall Study|Lost to Follow-up|0|||
131617096|NCT03611075|473888959|FG002|Overall Study|Lost to Follow-up|0|||
131617097|NCT03611075|473888960|FG003|Overall Study|Lost to Follow-up|2|||
131617098|NCT03611075|473888961|FG004|Overall Study|Lost to Follow-up|0|||
131617099|NCT03611075|473888962|FG005|Overall Study|Lost to Follow-up|0|||
131617100|NCT03611075|473888963|FG006|Overall Study|Lost to Follow-up|0|||
131617101|NCT03611075|473888964|FG007|Overall Study|Lost to Follow-up|0|||
131617102|NCT03611075|473888965|FG008|Overall Study|Lost to Follow-up|0|||
131617103|NCT03611075|473888957|FG000|Overall Study|Withdrawal by Subject|0|||
131617104|NCT03611075|473888958|FG001|Overall Study|Withdrawal by Subject|1|||
131617105|NCT03611075|473888959|FG002|Overall Study|Withdrawal by Subject|1|||
131617106|NCT03611075|473888960|FG003|Overall Study|Withdrawal by Subject|1|||
131617107|NCT03611075|473888961|FG004|Overall Study|Withdrawal by Subject|0|||
131617108|NCT03611075|473888962|FG005|Overall Study|Withdrawal by Subject|0|||
131617109|NCT03611075|473888963|FG006|Overall Study|Withdrawal by Subject|1|||
131617110|NCT03611075|473888964|FG007|Overall Study|Withdrawal by Subject|0|||
131617111|NCT03611075|473888965|FG008|Overall Study|Withdrawal by Subject|0|||
131617112|NCT03611075|473888957|FG000|Overall Study|Reason unknown|0|||
131617113|NCT03611075|473888958|FG001|Overall Study|Reason unknown|0|||
131617114|NCT03611075|473888959|FG002|Overall Study|Reason unknown|0|||
131617115|NCT03611075|473888960|FG003|Overall Study|Reason unknown|1|||
131617116|NCT03611075|473888961|FG004|Overall Study|Reason unknown|0|||
131617117|NCT03611075|473888962|FG005|Overall Study|Reason unknown|0|||
131617118|NCT03611075|473888963|FG006|Overall Study|Reason unknown|1|||
131617119|NCT03611075|473888964|FG007|Overall Study|Reason unknown|0|||
131795380|NCT00384033|474533980|FG001|Overall Study|Protocol Violation|0|||
131617120|NCT03611075|473888965|FG008|Overall Study|Reason unknown|0|||
131617121|NCT00676091|473888966|FG000|Infant Series|Parent or legal guardian request|10|||
131617122|NCT00676091|473888967|FG001|Infant Series|Parent or legal guardian request|8|||
131795381|NCT00384033|474533981|FG002|Overall Study|Protocol Violation|5|||
131795382|NCT00384033|474533982|FG003|Overall Study|Protocol Violation|6|||
131617123|NCT00676091|473888966|FG000|Infant Series|Protocol Violation|6|||
131617124|NCT00676091|473888967|FG001|Infant Series|Protocol Violation|3|||
131617125|NCT00676091|473888966|FG000|Infant Series|Adverse Event|2|||
131795383|NCT00384033|474533979|FG000|Overall Study|Withdrawal by Subject|6|||
131795384|NCT00384033|474533980|FG001|Overall Study|Withdrawal by Subject|2|||
131443677|NCT02318706|473254867|FG003|Open-label Extension Phase|Adverse Event|0|||
131443678|NCT02318706|473254868|FG004|Open-label Extension Phase|Adverse Event|21|||
131443679|NCT02318706|473254864|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
131443680|NCT02318706|473254865|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
131443681|NCT02318706|473254866|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
131443682|NCT02318706|473254867|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
131443683|NCT02318706|473254868|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
131443684|NCT02318706|473254864|FG000|Open-label Extension Phase|Death|0|||
131443685|NCT02318706|473254865|FG001|Open-label Extension Phase|Death|0|||
131443686|NCT02318706|473254866|FG002|Open-label Extension Phase|Death|0|||
131443687|NCT02318706|473254867|FG003|Open-label Extension Phase|Death|0|||
131443688|NCT02318706|473254868|FG004|Open-label Extension Phase|Death|1|||
131443689|NCT02318706|473254864|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
131443690|NCT02318706|473254865|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
131443691|NCT02318706|473254866|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
131443692|NCT02318706|473254867|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
131443693|NCT02318706|473254868|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
131443694|NCT01456039|473254869|FG000|Phase 1 (First Step)|Disease Progression|1|||
131443695|NCT01456039|473254870|FG001|Phase 1 (First Step)|Disease Progression|1|||
131443696|NCT01456039|473254871|FG002|Phase 1 (First Step)|Disease Progression|0|||
131443697|NCT01456039|473254869|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
131617126|NCT00676091|473888967|FG001|Infant Series|Adverse Event|3|||
131617127|NCT00676091|473888966|FG000|Infant Series|Failed to return|1|||
131617128|NCT00676091|473888967|FG001|Infant Series|Failed to return|3|||
131617129|NCT00676091|473888966|FG000|Infant Series|Lost to Follow-up|1|||
131617130|NCT00676091|473888967|FG001|Infant Series|Lost to Follow-up|0|||
131617131|NCT00676091|473888966|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
131617132|NCT00676091|473888967|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
131617133|NCT00676091|473888966|FG000|After Infant Series|Adverse Event|0|||
131617134|NCT00676091|473888967|FG001|After Infant Series|Adverse Event|1|||
131617135|NCT00676091|473888966|FG000|After Infant Series|Protocol Violation|0|||
131617136|NCT00676091|473888967|FG001|After Infant Series|Protocol Violation|1|||
131617137|NCT00676091|473888966|FG000|After Infant Series|Failed to return|1|||
131617138|NCT00676091|473888967|FG001|After Infant Series|Failed to return|1|||
131617139|NCT00676091|473888966|FG000|Toddler Dose|Failed to return|2|||
131617140|NCT00676091|473888967|FG001|Toddler Dose|Failed to return|0|||
131617141|NCT00676091|473888966|FG000|Toddler Dose|Parent or legal guardian request|1|||
131617142|NCT00676091|473888967|FG001|Toddler Dose|Parent or legal guardian request|0|||
131617143|NCT01701401|473888971|FG000|Overall Study|Randomized But Not Treated|3|||
131617144|NCT01701401|473888972|FG001|Overall Study|Randomized But Not Treated|1|||
131617145|NCT01701401|473888973|FG002|Overall Study|Randomized But Not Treated|0|||
131617146|NCT01701401|473888974|FG003|Overall Study|Randomized But Not Treated|1|||
131617147|NCT01701401|473888971|FG000|Overall Study|Lost to Follow-up|5|||
131617148|NCT01701401|473888972|FG001|Overall Study|Lost to Follow-up|5|||
131617149|NCT01701401|473888973|FG002|Overall Study|Lost to Follow-up|1|||
131617150|NCT01701401|473888974|FG003|Overall Study|Lost to Follow-up|3|||
131617151|NCT01701401|473888971|FG000|Overall Study|Withdrew Consent|0|||
131617152|NCT01701401|473888972|FG001|Overall Study|Withdrew Consent|3|||
131617153|NCT01701401|473888973|FG002|Overall Study|Withdrew Consent|1|||
131617154|NCT01701401|473888974|FG003|Overall Study|Withdrew Consent|2|||
131900892|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
131443698|NCT01456039|473254870|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
131443699|NCT01456039|473254871|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
131443700|NCT01456039|473254869|FG000|Phase 1 (First Step)|Adverse Event|0|||
131443701|NCT01456039|473254870|FG001|Phase 1 (First Step)|Adverse Event|3|||
131443702|NCT01456039|473254871|FG002|Phase 1 (First Step)|Adverse Event|0|||
131443703|NCT01456039|473254869|FG000|Phase 1 (First Step)|Other|0|||
131443704|NCT01456039|473254870|FG001|Phase 1 (First Step)|Other|1|||
131443705|NCT01456039|473254871|FG002|Phase 1 (First Step)|Other|0|||
131443706|NCT01456039|473254869|FG000|Phase 2 (Second Step)|Disease Progression|0|||
131443707|NCT01456039|473254870|FG001|Phase 2 (Second Step)|Disease Progression|0|||
131443708|NCT01456039|473254871|FG002|Phase 2 (Second Step)|Disease Progression|17|||
131443709|NCT01456039|473254869|FG000|Phase 2 (Second Step)|Adverse Event|0|||
131617155|NCT01701401|473888971|FG000|Overall Study|Lack of Efficacy|1|||
131617156|NCT01701401|473888972|FG001|Overall Study|Lack of Efficacy|0|||
131617157|NCT01701401|473888973|FG002|Overall Study|Lack of Efficacy|2|||
131617158|NCT01701401|473888974|FG003|Overall Study|Lack of Efficacy|0|||
131617159|NCT01701401|473888971|FG000|Overall Study|Adverse Event|1|||
131617160|NCT01701401|473888972|FG001|Overall Study|Adverse Event|0|||
131617161|NCT01701401|473888973|FG002|Overall Study|Adverse Event|0|||
131617162|NCT01701401|473888974|FG003|Overall Study|Adverse Event|0|||
131617163|NCT01701401|473888971|FG000|Overall Study|Protocol Violation|0|||
131443710|NCT01456039|473254870|FG001|Phase 2 (Second Step)|Adverse Event|0|||
131443711|NCT01456039|473254871|FG002|Phase 2 (Second Step)|Adverse Event|10|||
131443712|NCT01456039|473254869|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
131617164|NCT01701401|473888972|FG001|Overall Study|Protocol Violation|0|||
131709371|NCT02054702|474215604|FG001|Overall Study|Withdrawal by Subject|4|||
131709372|NCT02347631|474215607|FG000|First Intervention (2 Months)|Adverse Event|1|||
131709373|NCT02347631|474215608|FG001|First Intervention (2 Months)|Adverse Event|1|||
131709374|NCT02347631|474215607|FG000|First Intervention (2 Months)|Pregnancy|1|||
131709375|NCT02347631|474215608|FG001|First Intervention (2 Months)|Pregnancy|0|||
131709376|NCT02347631|474215607|FG000|First Intervention (2 Months)|Moved out of area|0|||
131709377|NCT02347631|474215608|FG001|First Intervention (2 Months)|Moved out of area|2|||
131709378|NCT02347631|474215607|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
131709379|NCT02347631|474215608|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
131709380|NCT02347631|474215607|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
131709381|NCT02347631|474215608|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
131709382|NCT02347631|474215607|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
131709383|NCT02347631|474215608|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
131709384|NCT02347631|474215607|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
131709385|NCT02347631|474215608|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
131709386|NCT02347631|474215607|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
131795385|NCT00384033|474533981|FG002|Overall Study|Withdrawal by Subject|5|||
131795386|NCT00384033|474533982|FG003|Overall Study|Withdrawal by Subject|2|||
131795387|NCT00384033|474533979|FG000|Overall Study|Lack of Efficacy|7|||
131795388|NCT00384033|474533980|FG001|Overall Study|Lack of Efficacy|3|||
131795389|NCT00384033|474533981|FG002|Overall Study|Lack of Efficacy|3|||
131795390|NCT00384033|474533982|FG003|Overall Study|Lack of Efficacy|1|||
131795391|NCT00384033|474533979|FG000|Overall Study|Randomized but not treated|3|||
131795392|NCT00384033|474533980|FG001|Overall Study|Randomized but not treated|7|||
131795393|NCT00384033|474533981|FG002|Overall Study|Randomized but not treated|10|||
131795394|NCT00384033|474533982|FG003|Overall Study|Randomized but not treated|2|||
131795395|NCT01006707|474533983|FG000|Study Session 1|Lost to Follow-up|2|||
131795396|NCT01006707|474533984|FG001|Study Session 1|Lost to Follow-up|0|||
131795397|NCT01006707|474533985|FG002|Study Session 1|Lost to Follow-up|0|||
131795398|NCT01006707|474533983|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
131795399|NCT01006707|474533984|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
131795400|NCT01006707|474533985|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
131795401|NCT00290745|474533986|FG000|Overall Study|Withdrawal by Subject|4|||
131795402|NCT00290745|474533986|FG000|Overall Study|Physician Decision|2|||
131795403|NCT00290745|474533986|FG000|Overall Study|Surgery after 3 months for progression|3|||
131795404|NCT00290745|474533986|FG000|Overall Study|Baseline MRI not available|3|||
131795405|NCT02750306|474533987|FG000|Overall Study|Withdrawal by Subject|5|||
131795406|NCT02750306|474533988|FG001|Overall Study|Withdrawal by Subject|2|||
131795407|NCT02750306|474533987|FG000|Overall Study|Protocol Violation|1|||
131795408|NCT02750306|474533988|FG001|Overall Study|Protocol Violation|0|||
131795409|NCT02737306|474533989|FG000|Overall Study|Adverse Event|3|||
131795410|NCT02737306|474533990|FG001|Overall Study|Adverse Event|0|||
131795411|NCT02737306|474533989|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
131795412|NCT02737306|474533990|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
131795413|NCT03361423|474533991|FG000|Overall Study|Withdrawal by Subject|4|||
131795414|NCT03361423|474533992|FG001|Overall Study|Withdrawal by Subject|3|||
131795415|NCT03361423|474533991|FG000|Overall Study|Did not treat|19|||
131795416|NCT03361423|474533992|FG001|Overall Study|Did not treat|18|||
131795417|NCT03361423|474533991|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
131795418|NCT03361423|474533992|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
131795419|NCT03361423|474533991|FG000|Overall Study|Missing data|4|||
131795420|NCT03361423|474533992|FG001|Overall Study|Missing data|1|||
131709387|NCT02347631|474215608|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
131709388|NCT00934102|474215610|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
131709389|NCT00934102|474215611|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
131795421|NCT01336894|474533993|FG000|Follow-up|Study terminated prematurely|2|||
131795422|NCT01336894|474533994|FG001|Follow-up|Study terminated prematurely|7|||
131795423|NCT05034731|474533995|FG000|Overall Study|Screen fail|1|||
131709390|NCT00934102|474215612|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
131443713|NCT01456039|473254870|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
131443714|NCT01456039|473254871|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
131443715|NCT01456039|473254869|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
131443716|NCT01456039|473254870|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
131443717|NCT01456039|473254871|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
131443718|NCT01456039|473254869|FG000|Phase 2 (Second Step)|Other|0|||
131443719|NCT01456039|473254870|FG001|Phase 2 (Second Step)|Other|0|||
131443720|NCT01456039|473254871|FG002|Phase 2 (Second Step)|Other|1|||
131443721|NCT02151058|473254875|FG000|Overall Study|Withdrawal by Subject|1|||
131443722|NCT02151058|473254876|FG001|Overall Study|Withdrawal by Subject|1|||
131443723|NCT02151058|473254877|FG002|Overall Study|Withdrawal by Subject|3|||
131443724|NCT02151058|473254875|FG000|Overall Study|Lost to Follow-up|1|||
131443725|NCT02151058|473254876|FG001|Overall Study|Lost to Follow-up|0|||
131443726|NCT02151058|473254877|FG002|Overall Study|Lost to Follow-up|2|||
131443727|NCT00321620|473254878|FG000|Overall Study|Death|269|||
131443728|NCT00321620|473254879|FG001|Overall Study|Death|294|||
131443729|NCT00321620|473254878|FG000|Overall Study|Withdrawal by Subject|164|||
131443730|NCT00321620|473254879|FG001|Overall Study|Withdrawal by Subject|147|||
131443731|NCT00321620|473254878|FG000|Overall Study|Disease progression|113|||
131443732|NCT00321620|473254879|FG001|Overall Study|Disease progression|117|||
131443733|NCT00321620|473254878|FG000|Overall Study|Adverse Event|43|||
131443734|NCT00321620|473254879|FG001|Overall Study|Adverse Event|56|||
131443735|NCT00321620|473254878|FG000|Overall Study|Lost to Follow-up|13|||
131443736|NCT00321620|473254879|FG001|Overall Study|Lost to Follow-up|9|||
131443737|NCT00321620|473254878|FG000|Overall Study|Physician Decision|4|||
131443738|NCT00321620|473254879|FG001|Overall Study|Physician Decision|1|||
131443739|NCT00321620|473254878|FG000|Overall Study|Noncompliance|14|||
131443740|NCT00321620|473254879|FG001|Overall Study|Noncompliance|7|||
131443741|NCT00321620|473254878|FG000|Overall Study|Protocol deviation|4|||
131443742|NCT00321620|473254879|FG001|Overall Study|Protocol deviation|3|||
131443743|NCT00321620|473254878|FG000|Overall Study|Ineligibility determined|2|||
131443744|NCT00321620|473254879|FG001|Overall Study|Ineligibility determined|3|||
131443745|NCT00321620|473254878|FG000|Overall Study|Participant request|75|||
131443746|NCT00321620|473254879|FG001|Overall Study|Participant request|52|||
131443747|NCT00321620|473254878|FG000|Overall Study|Other|42|||
131443748|NCT00321620|473254879|FG001|Overall Study|Other|33|||
131443749|NCT03829228|473254880|FG000|Overall Study|Protocol Violation|1|||
131443750|NCT03337477|473254881|FG000|Overall Study|not categorized into the listed ones|11|||
131443751|NCT03337477|473254882|FG001|Overall Study|not categorized into the listed ones|9|||
131443752|NCT03337477|473254881|FG000|Overall Study|Withdrawal by Subject|0|||
131443753|NCT03337477|473254882|FG001|Overall Study|Withdrawal by Subject|1|||
131443754|NCT03337477|473254881|FG000|Overall Study|Death|0|||
131443755|NCT03337477|473254882|FG001|Overall Study|Death|1|||
131443756|NCT03337477|473254881|FG000|Overall Study|Lost to Follow-up|0|||
131443757|NCT03337477|473254882|FG001|Overall Study|Lost to Follow-up|2|||
131443758|NCT01462370|473254887|FG000|Overall Study|Lack of Qualifying Event|1|||
131443759|NCT01462370|473254888|FG001|Overall Study|Lack of Qualifying Event|1|||
131443760|NCT01462370|473254887|FG000|Overall Study|Physician Decision|0|||
131443761|NCT01462370|473254888|FG001|Overall Study|Physician Decision|1|||
131443762|NCT01462370|473254887|FG000|Overall Study|Withdrawal by Subject|0|||
131443763|NCT01462370|473254888|FG001|Overall Study|Withdrawal by Subject|3|||
131443764|NCT00853307|473254889|FG000|Overall Study|Adverse Event|1|||
131443765|NCT00853307|473254890|FG001|Overall Study|Adverse Event|2|||
131443766|NCT00853307|473254889|FG000|Overall Study|Withdrawal by Subject|1|||
131443767|NCT00853307|473254890|FG001|Overall Study|Withdrawal by Subject|2|||
131443768|NCT00853307|473254889|FG000|Overall Study|Reason Not Specified|0|||
131443769|NCT00853307|473254890|FG001|Overall Study|Reason Not Specified|1|||
131443770|NCT00674817|473254891|FG000|Period 1|Withdrawal by Subject|2|||
131443771|NCT00674817|473254891|FG000|Period 1|Protocol Violation|1|||
131443772|NCT00674817|473254891|FG000|Period 3|Adverse Event|1|||
131443773|NCT00674817|473254891|FG000|Period 3|Protocol Violation|1|||
131443774|NCT00674817|473254891|FG000|Period 4|Adverse Event|1|||
131443775|NCT00473564|473254892|FG000|Overall Study|robot surgery aborted in OR|23|||
131443776|NCT01112917|473254893|FG000|Overall Study|Death|2|||
131443777|NCT01112917|473254894|FG001|Overall Study|Death|11|||
131443778|NCT01112917|473254893|FG000|Overall Study|Lost to Follow-up|1|||
131443779|NCT01112917|473254894|FG001|Overall Study|Lost to Follow-up|1|||
131443780|NCT01112917|473254893|FG000|Overall Study|Withdrawal by Subject|1|||
131443781|NCT01112917|473254894|FG001|Overall Study|Withdrawal by Subject|3|||
131443782|NCT01112917|473254893|FG000|Overall Study|Unable to Convert Filter|3|||
131443783|NCT01112917|473254894|FG001|Overall Study|Unable to Convert Filter|0|||
131443784|NCT04385277|473254900|FG000|Overall Study|Physician Decision|2|||
131443785|NCT04385277|473254900|FG000|Overall Study|Ineligible|1|||
131443786|NCT04385277|473254900|FG000|Overall Study|Patient/Parent Refusal|2|||
131617165|NCT01701401|473888973|FG002|Overall Study|Protocol Violation|1|||
131617166|NCT01701401|473888974|FG003|Overall Study|Protocol Violation|0|||
131617167|NCT05366751|473888975|FG000|Overall Study|Adverse Event|25|||
131617168|NCT05366751|473888975|FG000|Overall Study|Physician Decision|3|||
131617169|NCT05366751|473888975|FG000|Overall Study|Lost to Follow-up|2|||
131617170|NCT05366751|473888975|FG000|Overall Study|Withdrawal by Subject|14|||
131617171|NCT05366751|473888975|FG000|Overall Study|Study Terminated by Sponsor|50|||
131617172|NCT05366751|473888975|FG000|Overall Study|Site Terminated by Sponsor|3|||
131617173|NCT05325294|473888985|FG000|Overall Study|Adverse Event|3|||
131617174|NCT05325294|473888986|FG001|Overall Study|Adverse Event|3|||
131617175|NCT05325294|473888985|FG000|Overall Study|Physician Decision|0|||
131617176|NCT05325294|473888986|FG001|Overall Study|Physician Decision|1|||
131617177|NCT05325294|473888985|FG000|Overall Study|Withdrawal by Subject|0|||
131617178|NCT05325294|473888986|FG001|Overall Study|Withdrawal by Subject|3|||
131617179|NCT05325294|473888985|FG000|Overall Study|Lost to Follow-up|1|||
131617180|NCT05325294|473888986|FG001|Overall Study|Lost to Follow-up|0|||
131617181|NCT05325294|473888985|FG000|Overall Study|Sponsor Request|0|||
131617182|NCT05325294|473888986|FG001|Overall Study|Sponsor Request|2|||
131617183|NCT00491894|473888987|FG000|Overall Study|Adverse Event|14|||
131617184|NCT00491894|473888987|FG000|Overall Study|Withdrawal by Subject|5|||
131617185|NCT00491894|473888987|FG000|Overall Study|Death|3|||
131443787|NCT00981656|473254907|FG000|Overall Study|Protocol Violation|1|||
131443788|NCT00981656|473254907|FG000|Overall Study|Did not start protocol treatment|2|||
131443789|NCT00687596|473254908|FG000|Overall Study|Adverse Event (AE)|10|||
131443790|NCT00687596|473254909|FG001|Overall Study|Adverse Event (AE)|3|||
131443791|NCT00687596|473254908|FG000|Overall Study|Radiological Disease Progression|6|||
131443792|NCT00687596|473254909|FG001|Overall Study|Radiological Disease Progression|2|||
131443793|NCT00687596|473254908|FG000|Overall Study|Clinical Disease Progression|1|||
131443794|NCT00687596|473254909|FG001|Overall Study|Clinical Disease Progression|3|||
131443795|NCT00687596|473254908|FG000|Overall Study|Investigator Discretion|3|||
131443796|NCT00687596|473254909|FG001|Overall Study|Investigator Discretion|1|||
131443797|NCT00687596|473254908|FG000|Overall Study|Sponsor Terminated Study|6|||
131443798|NCT00687596|473254909|FG001|Overall Study|Sponsor Terminated Study|17|||
131443799|NCT00837434|473254912|FG000|Overall Study|Physician Decision|3|||
131443800|NCT00837434|473254913|FG001|Overall Study|Physician Decision|0|||
131443801|NCT00837434|473254912|FG000|Overall Study|Lost to Follow-up|1|||
131443802|NCT00837434|473254913|FG001|Overall Study|Lost to Follow-up|1|||
131443803|NCT00837434|473254912|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
131443804|NCT00837434|473254913|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
131443805|NCT00837434|473254912|FG000|Overall Study|Noncompliant|2|||
131443806|NCT00837434|473254913|FG001|Overall Study|Noncompliant|0|||
131443807|NCT00837434|473254912|FG000|Overall Study|Baseline assessments not done in time|1|||
131443808|NCT00837434|473254913|FG001|Overall Study|Baseline assessments not done in time|0|||
131443809|NCT00837434|473254912|FG000|Overall Study|Unable to obtain study drug|1|||
131443810|NCT00837434|473254913|FG001|Overall Study|Unable to obtain study drug|0|||
131443811|NCT00456846|473254914|FG000|Overall Study|Adverse Event|2|||
131443812|NCT00456846|473254915|FG001|Overall Study|Adverse Event|15|||
131443813|NCT00456846|473254914|FG000|Overall Study|Physician Decision|11|||
131443814|NCT00456846|473254915|FG001|Overall Study|Physician Decision|6|||
131443815|NCT00456846|473254914|FG000|Overall Study|Protocol Deviation|2|||
131443816|NCT00456846|473254915|FG001|Overall Study|Protocol Deviation|0|||
131443817|NCT00456846|473254914|FG000|Overall Study|Participant Discretion|1|||
131443818|NCT00456846|473254915|FG001|Overall Study|Participant Discretion|5|||
131443819|NCT00456846|473254914|FG000|Overall Study|Other|0|||
131443820|NCT00456846|473254915|FG001|Overall Study|Other|2|||
131443821|NCT01207414|473254916|FG000|Overall Study|Adverse Event|25|||
131443822|NCT01207414|473254917|FG001|Overall Study|Adverse Event|39|||
131617186|NCT00491894|473888987|FG000|Overall Study|Lost to Follow-up|3|||
131617187|NCT00491894|473888987|FG000|Overall Study|Lack of Efficacy|2|||
131617188|NCT00491894|473888987|FG000|Overall Study|Other-Failed to meet any criteria|2|||
131617189|NCT00491894|473888987|FG000|Overall Study|Physician Decision|2|||
131617190|NCT00491894|473888987|FG000|Overall Study|Protocol Violation|2|||
131617191|NCT00491894|473888987|FG000|Overall Study|Other-Intake of prohibited medication|1|||
131617192|NCT02972034|473890680|FG000|Overall Study|Death|11|||
131617193|NCT02972034|473890681|FG001|Overall Study|Death|1|||
131617194|NCT02972034|473890682|FG002|Overall Study|Death|3|||
131617195|NCT02972034|473890683|FG003|Overall Study|Death|3|||
131617196|NCT02972034|473890684|FG004|Overall Study|Death|2|||
131617197|NCT02972034|473890685|FG005|Overall Study|Death|2|||
131617198|NCT02972034|473890686|FG006|Overall Study|Death|3|||
131617199|NCT02972034|473890687|FG007|Overall Study|Death|4|||
131617200|NCT02972034|473890688|FG008|Overall Study|Death|8|||
131709391|NCT02318784|474215613|FG000|Overall Study|Adverse Event|13|||
131709392|NCT02318784|474215613|FG000|Overall Study|Death|2|||
131709393|NCT02318784|474215613|FG000|Overall Study|Progressive Disease|37|||
131709394|NCT02318784|474215613|FG000|Overall Study|Withdrawal by Subject|10|||
131709395|NCT02304926|474215615|FG000|Overall Study|Lost to Follow-up|2|||
131709396|NCT02304926|474215616|FG001|Overall Study|Lost to Follow-up|1|||
131709397|NCT00792298|474215617|FG000|Treatment Period 1|Adverse Event|0|||
131709398|NCT00792298|474215618|FG001|Treatment Period 1|Adverse Event|1|||
131709399|NCT00792298|474215619|FG002|Treatment Period 1|Adverse Event|0|||
131709400|NCT00792298|474215620|FG003|Treatment Period 1|Adverse Event|1|||
131709401|NCT00792298|474215621|FG004|Treatment Period 1|Adverse Event|0|||
131709402|NCT00792298|474215622|FG005|Treatment Period 1|Adverse Event|1|||
131709403|NCT00792298|474215623|FG006|Treatment Period 1|Adverse Event|1|||
131709404|NCT00792298|474215624|FG007|Treatment Period 1|Adverse Event|0|||
131709405|NCT00792298|474215617|FG000|Treatment Period 1|Lack of Efficacy|0|||
131709406|NCT00792298|474215618|FG001|Treatment Period 1|Lack of Efficacy|0|||
131709407|NCT00792298|474215619|FG002|Treatment Period 1|Lack of Efficacy|1|||
131709408|NCT00792298|474215620|FG003|Treatment Period 1|Lack of Efficacy|0|||
131709409|NCT00792298|474215621|FG004|Treatment Period 1|Lack of Efficacy|0|||
131709410|NCT00792298|474215622|FG005|Treatment Period 1|Lack of Efficacy|0|||
131709411|NCT00792298|474215623|FG006|Treatment Period 1|Lack of Efficacy|0|||
131709412|NCT00792298|474215624|FG007|Treatment Period 1|Lack of Efficacy|0|||
131709413|NCT00792298|474215617|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131709414|NCT00792298|474215618|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131709415|NCT00792298|474215619|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131709416|NCT00792298|474215620|FG003|Treatment Period 1|Withdrawal by Subject|2|||
131709417|NCT00792298|474215621|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131709418|NCT00792298|474215622|FG005|Treatment Period 1|Withdrawal by Subject|2|||
131709419|NCT00792298|474215623|FG006|Treatment Period 1|Withdrawal by Subject|1|||
131709420|NCT00792298|474215624|FG007|Treatment Period 1|Withdrawal by Subject|0|||
131709421|NCT00792298|474215617|FG000|Treatment Period 1|Lost to Follow-up|0|||
131709422|NCT00792298|474215618|FG001|Treatment Period 1|Lost to Follow-up|0|||
131709423|NCT00792298|474215619|FG002|Treatment Period 1|Lost to Follow-up|0|||
131709424|NCT00792298|474215620|FG003|Treatment Period 1|Lost to Follow-up|0|||
131709425|NCT00792298|474215621|FG004|Treatment Period 1|Lost to Follow-up|0|||
131709426|NCT00792298|474215622|FG005|Treatment Period 1|Lost to Follow-up|0|||
131709427|NCT00792298|474215623|FG006|Treatment Period 1|Lost to Follow-up|1|||
131709428|NCT00792298|474215624|FG007|Treatment Period 1|Lost to Follow-up|0|||
131709429|NCT00792298|474215617|FG000|Treatment Period 1|Physician Decision|0|||
131709430|NCT00792298|474215618|FG001|Treatment Period 1|Physician Decision|0|||
131709431|NCT00792298|474215619|FG002|Treatment Period 1|Physician Decision|0|||
131709432|NCT00792298|474215620|FG003|Treatment Period 1|Physician Decision|1|||
131709433|NCT00792298|474215621|FG004|Treatment Period 1|Physician Decision|0|||
131709434|NCT00792298|474215622|FG005|Treatment Period 1|Physician Decision|0|||
131709435|NCT00792298|474215623|FG006|Treatment Period 1|Physician Decision|1|||
131709436|NCT00792298|474215624|FG007|Treatment Period 1|Physician Decision|0|||
131709437|NCT00792298|474215617|FG000|Treatment Period 1|Protocol Violation|0|||
131709438|NCT00792298|474215618|FG001|Treatment Period 1|Protocol Violation|0|||
131709439|NCT00792298|474215619|FG002|Treatment Period 1|Protocol Violation|0|||
131709440|NCT00792298|474215620|FG003|Treatment Period 1|Protocol Violation|0|||
131709441|NCT00792298|474215621|FG004|Treatment Period 1|Protocol Violation|0|||
131709442|NCT00792298|474215622|FG005|Treatment Period 1|Protocol Violation|0|||
131709443|NCT00792298|474215623|FG006|Treatment Period 1|Protocol Violation|0|||
131709444|NCT00792298|474215624|FG007|Treatment Period 1|Protocol Violation|1|||
131709445|NCT00792298|474215617|FG000|Washout|Adverse Event|0|||
131709446|NCT00792298|474215618|FG001|Washout|Adverse Event|0|||
131709447|NCT00792298|474215619|FG002|Washout|Adverse Event|0|||
131709448|NCT00792298|474215620|FG003|Washout|Adverse Event|0|||
131709449|NCT00792298|474215621|FG004|Washout|Adverse Event|0|||
131709450|NCT00792298|474215622|FG005|Washout|Adverse Event|1|||
131709451|NCT00792298|474215623|FG006|Washout|Adverse Event|0|||
131709452|NCT00792298|474215624|FG007|Washout|Adverse Event|0|||
131709453|NCT00792298|474215617|FG000|Washout|Withdrawal by Subject|0|||
131709454|NCT00792298|474215618|FG001|Washout|Withdrawal by Subject|0|||
131709455|NCT00792298|474215619|FG002|Washout|Withdrawal by Subject|1|||
131709456|NCT00792298|474215620|FG003|Washout|Withdrawal by Subject|0|||
131709457|NCT00792298|474215621|FG004|Washout|Withdrawal by Subject|0|||
131709458|NCT00792298|474215622|FG005|Washout|Withdrawal by Subject|1|||
131709459|NCT00792298|474215623|FG006|Washout|Withdrawal by Subject|0|||
131709460|NCT00792298|474215624|FG007|Washout|Withdrawal by Subject|0|||
131709461|NCT00792298|474215617|FG000|Treatment Period 2|Lack of Efficacy|0|||
131709462|NCT00792298|474215618|FG001|Treatment Period 2|Lack of Efficacy|0|||
131709463|NCT00792298|474215619|FG002|Treatment Period 2|Lack of Efficacy|0|||
131709464|NCT00792298|474215620|FG003|Treatment Period 2|Lack of Efficacy|0|||
131709465|NCT00792298|474215621|FG004|Treatment Period 2|Lack of Efficacy|1|||
131709466|NCT00792298|474215622|FG005|Treatment Period 2|Lack of Efficacy|0|||
131709467|NCT00792298|474215623|FG006|Treatment Period 2|Lack of Efficacy|0|||
131443823|NCT01207414|473254916|FG000|Overall Study|Abnormal test procedure results|0|||
131443824|NCT01207414|473254917|FG001|Overall Study|Abnormal test procedure results|1|||
131443825|NCT01207414|473254916|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131443826|NCT01207414|473254917|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131443827|NCT01207414|473254916|FG000|Overall Study|Patient withdrew consent|14|||
131443828|NCT01207414|473254917|FG001|Overall Study|Patient withdrew consent|11|||
131443829|NCT01207414|473254916|FG000|Overall Study|Lost to Follow-up|15|||
131443830|NCT01207414|473254917|FG001|Overall Study|Lost to Follow-up|17|||
131443831|NCT01207414|473254916|FG000|Overall Study|Administrative problems|1|||
131443832|NCT01207414|473254917|FG001|Overall Study|Administrative problems|1|||
131443833|NCT01207414|473254916|FG000|Overall Study|Protocol deviation|12|||
131443834|NCT01207414|473254917|FG001|Overall Study|Protocol deviation|9|||
131443835|NCT01207414|473254916|FG000|Overall Study|Randomized in error|1|||
131443836|NCT01207414|473254917|FG001|Overall Study|Randomized in error|0|||
131443837|NCT01748292|473254918|FG000|Overall Study|Adverse Event|2|||
131443838|NCT01748292|473254919|FG001|Overall Study|Adverse Event|4|||
131443839|NCT01748292|473254918|FG000|Overall Study|Lost to Follow-up|0|||
131443840|NCT01748292|473254919|FG001|Overall Study|Lost to Follow-up|3|||
131443841|NCT01748292|473254918|FG000|Overall Study|Death|0|||
131443842|NCT01748292|473254919|FG001|Overall Study|Death|3|||
131443843|NCT01748292|473254918|FG000|Overall Study|Withdrawal by Subject|0|||
131443844|NCT01748292|473254919|FG001|Overall Study|Withdrawal by Subject|2|||
131443845|NCT03379818|473254922|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
131443846|NCT03379818|473254923|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
131443847|NCT03379818|473254922|FG000|Overall Study|Withdrawal by Subject|2|||
131443848|NCT03379818|473254923|FG001|Overall Study|Withdrawal by Subject|3|||
131443849|NCT03379818|473254922|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
131443850|NCT03379818|473254923|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
131443851|NCT05966142|473254940|FG000|Overall Study|Death|3|||
131443852|NCT05966142|473254941|FG001|Overall Study|Death|3|||
131443853|NCT05966142|473254940|FG000|Overall Study|Lost to Follow-up|55|||
131443854|NCT05966142|473254941|FG001|Overall Study|Lost to Follow-up|52|||
131443855|NCT05966142|473254940|FG000|Overall Study|Physician Decision|1|||
131443856|NCT05966142|473254941|FG001|Overall Study|Physician Decision|0|||
131443857|NCT05966142|473254940|FG000|Overall Study|Withdrawal by Subject|9|||
131443858|NCT05966142|473254941|FG001|Overall Study|Withdrawal by Subject|8|||
131443859|NCT05966142|473254940|FG000|Overall Study|Duplicate Enrollment|1|||
131443860|NCT05966142|473254941|FG001|Overall Study|Duplicate Enrollment|0|||
131443861|NCT05966142|473254940|FG000|Overall Study|Study Logistical Reason|1|||
131617201|NCT02972034|473890689|FG009|Overall Study|Death|11|||
131617202|NCT02972034|473890690|FG010|Overall Study|Death|3|||
131617203|NCT02972034|473890691|FG011|Overall Study|Death|2|||
131617204|NCT02972034|473890692|FG012|Overall Study|Death|11|||
131617205|NCT02972034|473890693|FG013|Overall Study|Death|10|||
131617206|NCT02972034|473890694|FG014|Overall Study|Death|9|||
131617207|NCT02972034|473890680|FG000|Overall Study|Lost to Follow-up|0|||
131709468|NCT00792298|474215624|FG007|Treatment Period 2|Lack of Efficacy|0|||
131709469|NCT00792298|474215617|FG000|Treatment Period 2|Physician Decision|0|||
131709470|NCT00792298|474215618|FG001|Treatment Period 2|Physician Decision|0|||
131709471|NCT00792298|474215619|FG002|Treatment Period 2|Physician Decision|0|||
131709472|NCT00792298|474215620|FG003|Treatment Period 2|Physician Decision|0|||
131709473|NCT00792298|474215621|FG004|Treatment Period 2|Physician Decision|0|||
131709474|NCT00792298|474215622|FG005|Treatment Period 2|Physician Decision|0|||
131709475|NCT00792298|474215623|FG006|Treatment Period 2|Physician Decision|1|||
131709476|NCT00792298|474215624|FG007|Treatment Period 2|Physician Decision|0|||
131709477|NCT00792298|474215617|FG000|Treatment Period 2|Pregnancy|0|||
131709478|NCT00792298|474215618|FG001|Treatment Period 2|Pregnancy|0|||
131709479|NCT00792298|474215619|FG002|Treatment Period 2|Pregnancy|1|||
131709480|NCT00792298|474215620|FG003|Treatment Period 2|Pregnancy|0|||
131709481|NCT00792298|474215621|FG004|Treatment Period 2|Pregnancy|0|||
131709482|NCT00792298|474215622|FG005|Treatment Period 2|Pregnancy|0|||
131709483|NCT00792298|474215623|FG006|Treatment Period 2|Pregnancy|0|||
131709484|NCT00792298|474215624|FG007|Treatment Period 2|Pregnancy|0|||
131709485|NCT00792298|474215617|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131709486|NCT00792298|474215618|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131709487|NCT00792298|474215619|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131709488|NCT00792298|474215620|FG003|Treatment Period 2|Withdrawal by Subject|2|||
131709489|NCT00792298|474215621|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131709490|NCT00792298|474215622|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131709491|NCT00792298|474215623|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131709492|NCT00792298|474215624|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131709493|NCT04007159|474215630|FG000|Induction Phase|(missed study visits)|16|||
131709494|NCT04007159|474215630|FG000|Induction Phase|Withdrawal by Subject|4|||
131709495|NCT04007159|474215630|FG000|Induction Phase|Adverse Event|2|||
131709496|NCT04007159|474215630|FG000|Challenge Phase|missed study visits|3|||
131709497|NCT00619957|474215636|FG000|Month 24 Double-Blind|Adverse Event|9|||
131709498|NCT00619957|474215637|FG001|Month 24 Double-Blind|Adverse Event|7|||
131709499|NCT00619957|474215636|FG000|Month 24 Double-Blind|Protocol Violation|1|||
131709500|NCT00619957|474215637|FG001|Month 24 Double-Blind|Protocol Violation|0|||
131709501|NCT00619957|474215636|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
131709502|NCT00619957|474215637|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
131709503|NCT00619957|474215636|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
131709504|NCT00619957|474215637|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
131709505|NCT00619957|474215636|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
131709506|NCT00619957|474215637|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
131709507|NCT00619957|474215636|FG000|Month 48 Open-Label|Adverse Event|4|||
131709508|NCT00619957|474215637|FG001|Month 48 Open-Label|Adverse Event|4|||
131709509|NCT00619957|474215636|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
131709510|NCT00619957|474215637|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
131709511|NCT00619957|474215636|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
131709512|NCT00619957|474215637|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
131709513|NCT02292212|474215638|FG000|ViE Phase|Withdrawal by Subject|1|||
131709514|NCT02292212|474215638|FG000|ViE Phase|Protocol Violation|2|||
131709515|NCT00772447|474215639|FG000|Overall Study|Withdrawal by Subject|9|||
131709516|NCT00772447|474215640|FG001|Overall Study|Withdrawal by Subject|5|||
131709517|NCT00772447|474215639|FG000|Overall Study|Physician Decision|4|||
131709518|NCT00772447|474215640|FG001|Overall Study|Physician Decision|8|||
131709519|NCT00772447|474215639|FG000|Overall Study|Lost to Follow-up|2|||
131709520|NCT00772447|474215640|FG001|Overall Study|Lost to Follow-up|4|||
131709521|NCT00772447|474215639|FG000|Overall Study|incorrect enrolment|3|||
131709522|NCT00772447|474215640|FG001|Overall Study|incorrect enrolment|4|||
131709523|NCT00772447|474215639|FG000|Overall Study|Protocol Violation|0|||
131709524|NCT00772447|474215640|FG001|Overall Study|Protocol Violation|1|||
131709525|NCT00772447|474215639|FG000|Overall Study|all others|2|||
131709526|NCT00772447|474215640|FG001|Overall Study|all others|2|||
131709527|NCT01957137|474215641|FG000|Randomized Portion|Adverse Event|1|||
131709528|NCT01957137|474215641|FG000|Randomized Portion|Withdrawal by Subject|1|||
131709529|NCT03529409|474215642|FG000|Randomized|Lost to Follow-up|0|||
131709530|NCT03529409|474215643|FG001|Randomized|Lost to Follow-up|0|||
131709531|NCT03529409|474215644|FG002|Randomized|Lost to Follow-up|4|||
131709532|NCT03529409|474215642|FG000|Randomized|Excluded|0|||
131709533|NCT03529409|474215643|FG001|Randomized|Excluded|0|||
131709534|NCT03529409|474215644|FG002|Randomized|Excluded|1|||
131709535|NCT03529409|474215642|FG000|Post-treatment Assessment|Death|1|||
131709536|NCT03529409|474215643|FG001|Post-treatment Assessment|Death|0|||
131443862|NCT05966142|473254941|FG001|Overall Study|Study Logistical Reason|0|||
131443863|NCT05966142|473254940|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
131443864|NCT05966142|473254941|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
131443865|NCT02738801|473254953|FG000|Overall Study|Adverse Event|1|||
131443866|NCT02738801|473254954|FG001|Overall Study|Adverse Event|1|||
131443867|NCT02738801|473254953|FG000|Overall Study|Withdrawal by Subject|0|||
131443868|NCT02738801|473254954|FG001|Overall Study|Withdrawal by Subject|1|||
131443869|NCT00888134|473254969|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
131443870|NCT00888134|473254969|FG000|Follow-up|being followed for long-term survival|1|||
131443871|NCT01506596|473254972|FG000|Overall Study|ineligible pathology|1|||
131443872|NCT01488890|473254973|FG000|Overall Study|Serious adverse event|2|||
131443873|NCT01488890|473254974|FG001|Overall Study|Serious adverse event|0|||
131443874|NCT01488890|473254975|FG002|Overall Study|Serious adverse event|0|||
131443875|NCT01488890|473254976|FG003|Overall Study|Serious adverse event|0|||
131443876|NCT01488890|473254973|FG000|Overall Study|Protocol Violation|3|||
131443877|NCT01488890|473254974|FG001|Overall Study|Protocol Violation|0|||
131443878|NCT01488890|473254975|FG002|Overall Study|Protocol Violation|4|||
131443879|NCT01488890|473254976|FG003|Overall Study|Protocol Violation|0|||
131443880|NCT01488890|473254973|FG000|Overall Study|Lost to Follow-up|13|||
131443881|NCT01488890|473254974|FG001|Overall Study|Lost to Follow-up|10|||
131443882|NCT01488890|473254975|FG002|Overall Study|Lost to Follow-up|20|||
131443883|NCT01488890|473254976|FG003|Overall Study|Lost to Follow-up|3|||
131443884|NCT01488890|473254973|FG000|Overall Study|Withdrawal by Subject|14|||
131443885|NCT01488890|473254974|FG001|Overall Study|Withdrawal by Subject|10|||
131443886|NCT01488890|473254975|FG002|Overall Study|Withdrawal by Subject|11|||
131443887|NCT01488890|473254976|FG003|Overall Study|Withdrawal by Subject|2|||
131443888|NCT05712460|473254977|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443889|NCT05712460|473254978|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443890|NCT05712460|473254979|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443891|NCT05712460|473254980|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443892|NCT05712460|473254981|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443893|NCT05712460|473254982|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443894|NCT05712460|473254983|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443895|NCT05712460|473254984|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
131443896|NCT05712460|473254985|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443897|NCT05712460|473254986|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443898|NCT05712460|473254987|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443899|NCT05712460|473254988|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
131443900|NCT00829426|473254993|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131443901|NCT00829426|473254994|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
131443902|NCT02260934|473254997|FG000|Overall Study|Lost to Follow-up|2|||
131443903|NCT02260934|473254998|FG001|Overall Study|Lost to Follow-up|1|||
131443904|NCT02260934|473254997|FG000|Overall Study|Withdrawal by Subject|0|||
131443905|NCT02260934|473254998|FG001|Overall Study|Withdrawal by Subject|2|||
131443906|NCT02260934|473254997|FG000|Overall Study|Participant Relocated|1|||
131443907|NCT02260934|473254998|FG001|Overall Study|Participant Relocated|0|||
131443908|NCT02260934|473254997|FG000|Overall Study|Site error|0|||
131443909|NCT02260934|473254998|FG001|Overall Study|Site error|1|||
131443910|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
131443911|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
131443912|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
131443913|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
131443914|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
131443915|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
131443916|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
131443917|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
131443918|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
131443919|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
131443920|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
131443921|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
131443922|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
131709537|NCT03529409|474215644|FG002|Post-treatment Assessment|Death|0|||
131443923|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
131443924|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
131443925|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
131443926|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
131443927|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
131617208|NCT02972034|473890681|FG001|Overall Study|Lost to Follow-up|0|||
131617209|NCT02972034|473890682|FG002|Overall Study|Lost to Follow-up|0|||
131617210|NCT02972034|473890683|FG003|Overall Study|Lost to Follow-up|0|||
131617211|NCT02972034|473890684|FG004|Overall Study|Lost to Follow-up|1|||
131617212|NCT02972034|473890685|FG005|Overall Study|Lost to Follow-up|0|||
131617213|NCT02972034|473890686|FG006|Overall Study|Lost to Follow-up|0|||
131617214|NCT02972034|473890687|FG007|Overall Study|Lost to Follow-up|1|||
131617215|NCT02972034|473890688|FG008|Overall Study|Lost to Follow-up|0|||
131617216|NCT02972034|473890689|FG009|Overall Study|Lost to Follow-up|0|||
131617217|NCT02972034|473890690|FG010|Overall Study|Lost to Follow-up|0|||
131617218|NCT02972034|473890691|FG011|Overall Study|Lost to Follow-up|0|||
131617219|NCT02972034|473890692|FG012|Overall Study|Lost to Follow-up|0|||
131617220|NCT02972034|473890693|FG013|Overall Study|Lost to Follow-up|0|||
131617221|NCT02972034|473890694|FG014|Overall Study|Lost to Follow-up|1|||
131617222|NCT02972034|473890680|FG000|Overall Study|Physician Decision|0|||
131617223|NCT02972034|473890681|FG001|Overall Study|Physician Decision|0|||
131617224|NCT02972034|473890682|FG002|Overall Study|Physician Decision|0|||
131617225|NCT02972034|473890683|FG003|Overall Study|Physician Decision|0|||
131617226|NCT02972034|473890684|FG004|Overall Study|Physician Decision|0|||
131617227|NCT02972034|473890685|FG005|Overall Study|Physician Decision|0|||
131617228|NCT02972034|473890686|FG006|Overall Study|Physician Decision|0|||
131617229|NCT02972034|473890687|FG007|Overall Study|Physician Decision|1|||
131617230|NCT02972034|473890688|FG008|Overall Study|Physician Decision|0|||
131617231|NCT02972034|473890689|FG009|Overall Study|Physician Decision|0|||
131617232|NCT02972034|473890690|FG010|Overall Study|Physician Decision|1|||
131617233|NCT02972034|473890691|FG011|Overall Study|Physician Decision|0|||
131900893|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
131900894|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131617234|NCT02972034|473890692|FG012|Overall Study|Physician Decision|0|||
131617235|NCT02972034|473890693|FG013|Overall Study|Physician Decision|0|||
131617236|NCT02972034|473890694|FG014|Overall Study|Physician Decision|0|||
131617237|NCT02972034|473890680|FG000|Overall Study|Sponsor Decision|0|||
131617238|NCT02972034|473890681|FG001|Overall Study|Sponsor Decision|0|||
131900895|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131617239|NCT02972034|473890682|FG002|Overall Study|Sponsor Decision|0|||
131617240|NCT02972034|473890683|FG003|Overall Study|Sponsor Decision|1|||
131617241|NCT02972034|473890684|FG004|Overall Study|Sponsor Decision|0|||
131617242|NCT02972034|473890685|FG005|Overall Study|Sponsor Decision|0|||
131617243|NCT02972034|473890686|FG006|Overall Study|Sponsor Decision|1|||
131617244|NCT02972034|473890687|FG007|Overall Study|Sponsor Decision|1|||
131617245|NCT02972034|473890688|FG008|Overall Study|Sponsor Decision|1|||
131617246|NCT02972034|473890689|FG009|Overall Study|Sponsor Decision|2|||
131617247|NCT02972034|473890690|FG010|Overall Study|Sponsor Decision|2|||
131617248|NCT02972034|473890691|FG011|Overall Study|Sponsor Decision|0|||
131617249|NCT02972034|473890692|FG012|Overall Study|Sponsor Decision|1|||
131617250|NCT02972034|473890693|FG013|Overall Study|Sponsor Decision|0|||
131617251|NCT02972034|473890694|FG014|Overall Study|Sponsor Decision|1|||
131617252|NCT02972034|473890680|FG000|Overall Study|Withdrawal by Subject|3|||
131617253|NCT02972034|473890681|FG001|Overall Study|Withdrawal by Subject|0|||
131617254|NCT02972034|473890682|FG002|Overall Study|Withdrawal by Subject|0|||
131617255|NCT02972034|473890683|FG003|Overall Study|Withdrawal by Subject|0|||
131617256|NCT02972034|473890684|FG004|Overall Study|Withdrawal by Subject|1|||
131617257|NCT02972034|473890685|FG005|Overall Study|Withdrawal by Subject|1|||
131795424|NCT05034731|474533996|FG001|Overall Study|Screen fail|1|||
131795425|NCT01254409|474533997|FG000|Overall Study|Adverse Event|0|||
131795426|NCT01254409|474533998|FG001|Overall Study|Adverse Event|1|||
131795427|NCT01254409|474533999|FG002|Overall Study|Adverse Event|0|||
131795428|NCT01254409|474534000|FG003|Overall Study|Adverse Event|0|||
131795429|NCT00299156|474534003|FG000|Period 2 (Randomized)|Screen Failure|0|||
131617258|NCT02972034|473890686|FG006|Overall Study|Withdrawal by Subject|0|||
131617259|NCT02972034|473890687|FG007|Overall Study|Withdrawal by Subject|0|||
131617260|NCT02972034|473890688|FG008|Overall Study|Withdrawal by Subject|1|||
131617261|NCT02972034|473890689|FG009|Overall Study|Withdrawal by Subject|1|||
131617262|NCT02972034|473890690|FG010|Overall Study|Withdrawal by Subject|2|||
131617263|NCT02972034|473890691|FG011|Overall Study|Withdrawal by Subject|1|||
131617264|NCT02972034|473890692|FG012|Overall Study|Withdrawal by Subject|1|||
131617265|NCT02972034|473890693|FG013|Overall Study|Withdrawal by Subject|1|||
131617266|NCT02972034|473890694|FG014|Overall Study|Withdrawal by Subject|0|||
131617267|NCT02972034|473890680|FG000|Overall Study|Screen Failure|0|||
131617268|NCT02972034|473890681|FG001|Overall Study|Screen Failure|0|||
131617269|NCT02972034|473890682|FG002|Overall Study|Screen Failure|0|||
131617270|NCT02972034|473890683|FG003|Overall Study|Screen Failure|0|||
131617271|NCT02972034|473890684|FG004|Overall Study|Screen Failure|0|||
131617272|NCT02972034|473890685|FG005|Overall Study|Screen Failure|0|||
131617273|NCT02972034|473890686|FG006|Overall Study|Screen Failure|0|||
131617274|NCT02972034|473890687|FG007|Overall Study|Screen Failure|0|||
131617275|NCT02972034|473890688|FG008|Overall Study|Screen Failure|0|||
131617276|NCT02972034|473890689|FG009|Overall Study|Screen Failure|0|||
131617277|NCT02972034|473890690|FG010|Overall Study|Screen Failure|0|||
131617278|NCT02972034|473890691|FG011|Overall Study|Screen Failure|0|||
131617279|NCT02972034|473890692|FG012|Overall Study|Screen Failure|1|||
131617280|NCT02972034|473890693|FG013|Overall Study|Screen Failure|0|||
131617281|NCT02972034|473890694|FG014|Overall Study|Screen Failure|0|||
131617282|NCT03861052|473890695|FG000|Overall Study|Adverse Event|1|||
131617283|NCT03861052|473890696|FG001|Overall Study|Adverse Event|1|||
131617284|NCT03861052|473890697|FG002|Overall Study|Adverse Event|2|||
131617285|NCT03861052|473890698|FG003|Overall Study|Adverse Event|4|||
131617286|NCT03861052|473890695|FG000|Overall Study|Lost to Follow-up|0|||
131617287|NCT03861052|473890696|FG001|Overall Study|Lost to Follow-up|0|||
131617288|NCT03861052|473890697|FG002|Overall Study|Lost to Follow-up|0|||
131617289|NCT03861052|473890698|FG003|Overall Study|Lost to Follow-up|1|||
131617290|NCT03861052|473890695|FG000|Overall Study|Physician Decision|0|||
131617291|NCT03861052|473890696|FG001|Overall Study|Physician Decision|1|||
131617292|NCT03861052|473890697|FG002|Overall Study|Physician Decision|0|||
131617293|NCT03861052|473890698|FG003|Overall Study|Physician Decision|0|||
131617294|NCT03861052|473890695|FG000|Overall Study|Withdrawal by Subject|2|||
131617295|NCT03861052|473890696|FG001|Overall Study|Withdrawal by Subject|5|||
131617296|NCT03861052|473890697|FG002|Overall Study|Withdrawal by Subject|3|||
131617297|NCT03861052|473890698|FG003|Overall Study|Withdrawal by Subject|0|||
131617298|NCT03861052|473890695|FG000|Overall Study|Relocation to other city|1|||
131617299|NCT03861052|473890696|FG001|Overall Study|Relocation to other city|0|||
131617300|NCT03861052|473890697|FG002|Overall Study|Relocation to other city|0|||
131617301|NCT03861052|473890698|FG003|Overall Study|Relocation to other city|0|||
131617302|NCT00378898|473890699|FG000|Overall Study|Withdrawal by Subject|10|||
131617303|NCT00378898|473890700|FG001|Overall Study|Withdrawal by Subject|5|||
131617304|NCT00378898|473890699|FG000|Overall Study|Protocol Violation|1|||
131617305|NCT00378898|473890700|FG001|Overall Study|Protocol Violation|1|||
131617306|NCT03136159|473890701|FG000|Overall Study|chorioamnionitis|2|||
131617307|NCT03136159|473890702|FG001|Overall Study|chorioamnionitis|0|||
131617308|NCT03136159|473890701|FG000|Overall Study|vertical skin incision|1|||
131617309|NCT03136159|473890702|FG001|Overall Study|vertical skin incision|0|||
131617310|NCT03136159|473890701|FG000|Overall Study|additional dressing|1|||
131617311|NCT03136159|473890702|FG001|Overall Study|additional dressing|0|||
131617312|NCT03136159|473890701|FG000|Overall Study|never got dressing placed|1|||
131617313|NCT03136159|473890702|FG001|Overall Study|never got dressing placed|0|||
131617314|NCT03137459|473890703|FG000|2-month Assessment|Withdrawal by Subject|13|||
131617315|NCT03137459|473890704|FG001|2-month Assessment|Withdrawal by Subject|3|||
131617316|NCT03137459|473890703|FG000|2-month Assessment|Unable to reach|42|||
131617317|NCT03137459|473890704|FG001|2-month Assessment|Unable to reach|32|||
131709538|NCT03529409|474215642|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
131617318|NCT03137459|473890703|FG000|2-month Assessment|Refused assessment|7|||
131617319|NCT03137459|473890704|FG001|2-month Assessment|Refused assessment|5|||
131617320|NCT03137459|473890703|FG000|2-month Assessment|Acutely ill|6|||
131617321|NCT03137459|473890704|FG001|2-month Assessment|Acutely ill|2|||
131617322|NCT03137459|473890703|FG000|4-month Assessment|Death|4|||
131617323|NCT03137459|473890704|FG001|4-month Assessment|Death|2|||
131617324|NCT03137459|473890703|FG000|4-month Assessment|Withdrawal by Subject|4|||
131617325|NCT03137459|473890704|FG001|4-month Assessment|Withdrawal by Subject|2|||
131617326|NCT03137459|473890703|FG000|4-month Assessment|Unable to reach|44|||
131617327|NCT03137459|473890704|FG001|4-month Assessment|Unable to reach|29|||
131709539|NCT03529409|474215643|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
131617328|NCT03137459|473890703|FG000|4-month Assessment|Refused assessment|24|||
131617329|NCT03137459|473890704|FG001|4-month Assessment|Refused assessment|10|||
131617330|NCT03137459|473890703|FG000|4-month Assessment|Acutely ill|2|||
131617331|NCT03137459|473890704|FG001|4-month Assessment|Acutely ill|3|||
131617332|NCT03137459|473890703|FG000|6-months|Lost to Follow-up|14|||
131617333|NCT03137459|473890704|FG001|6-months|Lost to Follow-up|11|||
131617334|NCT03137459|473890703|FG000|6-months|Death|0|||
131617335|NCT03137459|473890704|FG001|6-months|Death|2|||
131617336|NCT03137459|473890703|FG000|6-months|Refused assessment|6|||
131617337|NCT03137459|473890704|FG001|6-months|Refused assessment|3|||
131617338|NCT03137459|473890703|FG000|6-months|Acutely ill|1|||
131617339|NCT03137459|473890704|FG001|6-months|Acutely ill|1|||
131617340|NCT04926857|473890705|FG000|Overall Study|Withdrawal by Subject|40|||
131617341|NCT04926857|473890705|FG000|Overall Study|Death|9|||
131617342|NCT04926857|473890705|FG000|Overall Study|Study product no longer in use|44|||
131617343|NCT04926857|473890705|FG000|Overall Study|Inadequate data to address primary objective|16|||
131617344|NCT00089609|473890708|FG000|Overall Study|Withdrawal by Subject|3|||
131617345|NCT00089609|473890709|FG001|Overall Study|Withdrawal by Subject|1|||
131617346|NCT00597376|473890711|FG000|Overall Study|Withdrawal by Subject|4|||
131617347|NCT00597376|473890712|FG001|Overall Study|Withdrawal by Subject|3|||
131617348|NCT00597376|473890711|FG000|Overall Study|Adverse Event|4|||
131617349|NCT00597376|473890712|FG001|Overall Study|Adverse Event|1|||
131617350|NCT00747006|473890713|FG000|Overall Study|Adverse Event|1|||
131617351|NCT00747006|473890714|FG001|Overall Study|Adverse Event|0|||
131617352|NCT00747006|473890715|FG002|Overall Study|Adverse Event|0|||
131617353|NCT00747006|473890713|FG000|Overall Study|Lost to Follow-up|0|||
131617354|NCT00747006|473890714|FG001|Overall Study|Lost to Follow-up|1|||
131617355|NCT00747006|473890715|FG002|Overall Study|Lost to Follow-up|0|||
131617356|NCT00747006|473890713|FG000|Overall Study|Physician Decision|2|||
131617357|NCT00747006|473890714|FG001|Overall Study|Physician Decision|0|||
131617358|NCT00747006|473890715|FG002|Overall Study|Physician Decision|1|||
131617359|NCT00745875|473890722|FG000|Overall Study|Continuing study treatment|4|||
131617360|NCT00745875|473890723|FG001|Overall Study|Continuing study treatment|4|||
131617361|NCT01532648|473890724|FG000|Overall Study|Lost to Follow-up|3|||
131617362|NCT01532648|473890725|FG001|Overall Study|Lost to Follow-up|4|||
131617363|NCT01532648|473890724|FG000|Overall Study|Lack of Efficacy|4|||
131617364|NCT01532648|473890725|FG001|Overall Study|Lack of Efficacy|1|||
131617365|NCT01532648|473890724|FG000|Overall Study|Protocol Violation|1|||
131617366|NCT01532648|473890725|FG001|Overall Study|Protocol Violation|1|||
131617367|NCT01532648|473890724|FG000|Overall Study|Adverse Event|12|||
131617368|NCT01532648|473890725|FG001|Overall Study|Adverse Event|9|||
131617369|NCT01532648|473890724|FG000|Overall Study|Withdrawal by Subject|16|||
131617370|NCT01532648|473890725|FG001|Overall Study|Withdrawal by Subject|2|||
131617371|NCT01583166|473890726|FG000|Overall Study|Withdrawal by Subject|4|||
131617372|NCT01583166|473890727|FG001|Overall Study|Withdrawal by Subject|6|||
131617373|NCT04652869|473890732|FG000|Overall Study|Withdrawal by Subject|0|||
131617374|NCT04652869|473890733|FG001|Overall Study|Withdrawal by Subject|2|||
131617375|NCT04652869|473890734|FG002|Overall Study|Withdrawal by Subject|0|||
131617376|NCT01372085|473890735|FG000|Washout Period 2|Physician Decision|0|||
131617377|NCT01372085|473890736|FG001|Washout Period 2|Physician Decision|0|||
131617378|NCT01372085|473890737|FG002|Washout Period 2|Physician Decision|0|||
131617379|NCT01372085|473890738|FG003|Washout Period 2|Physician Decision|0|||
131617380|NCT01372085|473890739|FG004|Washout Period 2|Physician Decision|1|||
131617381|NCT01372085|473890740|FG005|Washout Period 2|Physician Decision|0|||
131617382|NCT01372085|473890741|FG006|Washout Period 2|Physician Decision|0|||
131617383|NCT01372085|473890742|FG007|Washout Period 2|Physician Decision|0|||
131617384|NCT01372085|473890743|FG008|Washout Period 2|Physician Decision|0|||
131617385|NCT01372085|473890744|FG009|Washout Period 2|Physician Decision|0|||
131617386|NCT01372085|473890735|FG000|Washout Period 3|Withdrawal by Subject|0|||
131617387|NCT01372085|473890736|FG001|Washout Period 3|Withdrawal by Subject|0|||
131617388|NCT01372085|473890737|FG002|Washout Period 3|Withdrawal by Subject|0|||
131617389|NCT01372085|473890738|FG003|Washout Period 3|Withdrawal by Subject|0|||
131617390|NCT01372085|473890739|FG004|Washout Period 3|Withdrawal by Subject|0|||
131617391|NCT01372085|473890740|FG005|Washout Period 3|Withdrawal by Subject|2|||
131617392|NCT01372085|473890741|FG006|Washout Period 3|Withdrawal by Subject|0|||
131617393|NCT01372085|473890742|FG007|Washout Period 3|Withdrawal by Subject|0|||
131617394|NCT01372085|473890743|FG008|Washout Period 3|Withdrawal by Subject|0|||
131617395|NCT01372085|473890744|FG009|Washout Period 3|Withdrawal by Subject|0|||
131617396|NCT02824198|473890745|FG000|Overall Study|Non-compliance with the protocol|5|||
131617397|NCT02824198|473890746|FG001|Overall Study|Non-compliance with the protocol|1|||
131617398|NCT02824198|473890745|FG000|Overall Study|Lost to Follow-up|5|||
131617399|NCT02824198|473890746|FG001|Overall Study|Lost to Follow-up|2|||
131617400|NCT02824198|473890745|FG000|Overall Study|Withdrawal by Subject|5|||
131617401|NCT02824198|473890746|FG001|Overall Study|Withdrawal by Subject|0|||
131617402|NCT01833455|473890747|FG000|Overall Study|Withdrawal by Subject|1|||
131617403|NCT01833455|473890748|FG001|Overall Study|Withdrawal by Subject|0|||
131617404|NCT00562094|473890749|FG000|Overall Study|Lost to Follow-up|62|||
131617405|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
131617406|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
131617407|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
131617408|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
131617409|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
131617410|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
131443928|NCT03605667|473255001|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
131443929|NCT03605667|473255002|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
131617411|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
131617412|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
131617413|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
131617414|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
131617415|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
131617416|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
131617417|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Other|1|||
131617418|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Other|0|||
131617419|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Other|0|||
131617420|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
131617421|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
131617422|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
131617423|NCT00887224|473890750|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
131617424|NCT00887224|473890751|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
131617425|NCT00887224|473890752|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
131617426|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
131617427|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
131617428|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
131617429|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
131617430|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
131617431|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
131617432|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
131617433|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
131617434|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
131617435|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
131617436|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
131617437|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
131617438|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Other|1|||
131617439|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Other|0|||
131617440|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Other|0|||
131617441|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
131617442|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
131617443|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
131617444|NCT00887224|473890750|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
131617445|NCT00887224|473890751|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
131617446|NCT00887224|473890752|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
131617447|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
131617448|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
131617449|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
131617450|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
131709540|NCT03529409|474215644|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
131709541|NCT03529409|474215642|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
131709542|NCT03529409|474215643|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
131709543|NCT03529409|474215644|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
131709544|NCT03529409|474215642|FG000|Follow-up Assessment|Death|1|||
131709545|NCT03529409|474215643|FG001|Follow-up Assessment|Death|0|||
131709546|NCT03529409|474215644|FG002|Follow-up Assessment|Death|0|||
131709547|NCT03529409|474215642|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
131443930|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
131617451|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
131617452|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
131617453|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
131709548|NCT03529409|474215643|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
131709549|NCT03529409|474215644|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
131709550|NCT01497262|474215645|FG000|Overall Study|Abnormal Lab Values|4|||
131443931|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
131617454|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
131617455|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
131617456|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
131617457|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
131617458|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
131617459|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Other|30|||
131617460|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Other|0|||
131617461|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Other|0|||
131617462|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
131617463|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
131617464|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
131617465|NCT00887224|473890750|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
131617466|NCT00887224|473890751|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
131617467|NCT00887224|473890752|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
131617468|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Adverse Event|0|||
131617469|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Adverse Event|7|||
131617470|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Adverse Event|2|||
131617471|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Failed to return|0|||
131617472|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Failed to return|2|||
131617473|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Failed to return|2|||
131617474|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
131617475|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
131617476|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
131617477|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
131617478|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
131617479|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
131617480|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Other|0|||
131617481|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Other|2|||
131617482|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Other|0|||
131617483|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
131617484|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
131617485|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
131617486|NCT00887224|473890750|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
131617487|NCT00887224|473890751|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
131617488|NCT00887224|473890752|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
131617489|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
131617490|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
131617491|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
131617492|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
131617493|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
131617494|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
131617495|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
131617496|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
131617497|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
131617498|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
131617499|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
131617500|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
131617501|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
131617502|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
131617503|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
131617504|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
131617505|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
131617506|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
131617507|NCT00887224|473890750|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
131617508|NCT00887224|473890751|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
131617509|NCT00887224|473890752|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
131617510|NCT03689946|473890755|FG000|Overall Study|Withdrawal by Subject|3|||
131617511|NCT03689946|473890755|FG000|Overall Study|Lost to Follow-up|3|||
131617512|NCT03689946|473890755|FG000|Overall Study|Data corruption|2|||
131617513|NCT01555138|473890756|FG000|Overall Study|Death|0|||
131617514|NCT01555138|473890757|FG001|Overall Study|Death|1|||
131709551|NCT01497262|474215645|FG000|Overall Study|Abnormal Test Procedure Result|1|||
131709552|NCT01497262|474215645|FG000|Overall Study|Physician Decision|1|||
131709553|NCT01497262|474215645|FG000|Overall Study|Withdrawal by Subject|2|||
131709554|NCT01497262|474215645|FG000|Overall Study|Adverse Event|2|||
131709555|NCT01497262|474215645|FG000|Overall Study|Protocol Violation|1|||
131709556|NCT02497001|474215648|FG000|Overall Study|Lost to Follow-up|10|||
131709557|NCT02497001|474215649|FG001|Overall Study|Lost to Follow-up|2|||
131709558|NCT02497001|474215650|FG002|Overall Study|Lost to Follow-up|0|||
131709559|NCT02497001|474215651|FG003|Overall Study|Lost to Follow-up|2|||
131709560|NCT02497001|474215648|FG000|Overall Study|Adverse Event|28|||
131617515|NCT01555138|473890756|FG000|Overall Study|Lost to Follow-up|1|||
131617516|NCT01555138|473890757|FG001|Overall Study|Lost to Follow-up|0|||
131617517|NCT01555138|473890756|FG000|Overall Study|Abnormal Lab reults|1|||
131617518|NCT01555138|473890757|FG001|Overall Study|Abnormal Lab reults|3|||
131617519|NCT01555138|473890756|FG000|Overall Study|Lack of Efficacy|2|||
131617520|NCT01555138|473890757|FG001|Overall Study|Lack of Efficacy|2|||
131617521|NCT01555138|473890756|FG000|Overall Study|Protocol Violation|5|||
131617522|NCT01555138|473890757|FG001|Overall Study|Protocol Violation|3|||
131617523|NCT01555138|473890756|FG000|Overall Study|Administrative problems|8|||
131617524|NCT01555138|473890757|FG001|Overall Study|Administrative problems|0|||
131617525|NCT01555138|473890756|FG000|Overall Study|Withdrawal by Subject|16|||
131617526|NCT01555138|473890757|FG001|Overall Study|Withdrawal by Subject|15|||
131617527|NCT01555138|473890756|FG000|Overall Study|Adverse Event|14|||
131617528|NCT01555138|473890757|FG001|Overall Study|Adverse Event|14|||
131617529|NCT01256359|473890758|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
131617530|NCT01256359|473890759|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
131617531|NCT01256359|473890758|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
131617532|NCT01256359|473890759|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
131617533|NCT02000752|473890762|FG000|Overall Study|Dystocic delivery|19|||
131617534|NCT02000752|473890763|FG001|Overall Study|Dystocic delivery|8|||
131617535|NCT02000752|473890762|FG000|Overall Study|Shift Changes|12|||
131617536|NCT02000752|473890763|FG001|Overall Study|Shift Changes|5|||
131617537|NCT04938453|473890767|FG000|Washout Period 1|Adverse Event|1|||
131617538|NCT04938453|473890768|FG001|Washout Period 1|Adverse Event|0|||
131617539|NCT04938453|473890767|FG000|Washout Period 1|Physician Decision|0|||
131617540|NCT04938453|473890768|FG001|Washout Period 1|Physician Decision|1|||
131617541|NCT04497415|473890784|FG000|Overall Study|Lost to Follow-up|43|||
131617542|NCT04497415|473890785|FG001|Overall Study|Lost to Follow-up|27|||
131617543|NCT04237792|473890789|FG000|Treatment (Day 1)|Adverse Event|1|||
131617544|NCT04237792|473890790|FG001|Treatment (Day 1)|Adverse Event|0|||
131617545|NCT04237792|473890791|FG002|Treatment (Day 1)|Adverse Event|0|||
131617546|NCT04237792|473890792|FG003|Treatment (Day 1)|Adverse Event|0|||
131617547|NCT04237792|473890793|FG004|Treatment (Day 1)|Adverse Event|1|||
131617548|NCT04237792|473890794|FG005|Treatment (Day 1)|Adverse Event|1|||
131617549|NCT04237792|473890789|FG000|Treatment (Day 1)|Other|0|||
131617550|NCT04237792|473890790|FG001|Treatment (Day 1)|Other|0|||
131617551|NCT04237792|473890791|FG002|Treatment (Day 1)|Other|1|||
131617552|NCT04237792|473890792|FG003|Treatment (Day 1)|Other|0|||
131617553|NCT04237792|473890793|FG004|Treatment (Day 1)|Other|0|||
131617554|NCT04237792|473890794|FG005|Treatment (Day 1)|Other|1|||
131617555|NCT04237792|473890789|FG000|Treatment (Day 1)|Not treated|1|||
131617556|NCT04237792|473890790|FG001|Treatment (Day 1)|Not treated|1|||
131617557|NCT04237792|473890791|FG002|Treatment (Day 1)|Not treated|2|||
131617558|NCT04237792|473890792|FG003|Treatment (Day 1)|Not treated|1|||
131617559|NCT04237792|473890793|FG004|Treatment (Day 1)|Not treated|0|||
131617560|NCT04237792|473890794|FG005|Treatment (Day 1)|Not treated|1|||
131617561|NCT04693637|473890795|FG000|Overall Study|Death|4|||
131617562|NCT04693637|473890795|FG000|Overall Study|Withdrawal by Subject|3|||
131617563|NCT04693637|473890795|FG000|Overall Study|Physician Decision|2|||
131617564|NCT04693637|473890795|FG000|Overall Study|Lost to Follow-up|1|||
131617565|NCT05553366|473890796|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
131617566|NCT05553366|473890797|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
131617567|NCT05553366|473890798|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
131617568|NCT05553366|473890796|FG000|Overall Study|Lost to Follow-up|3|||
131617569|NCT05553366|473890797|FG001|Overall Study|Lost to Follow-up|3|||
131617570|NCT05553366|473890798|FG002|Overall Study|Lost to Follow-up|3|||
131617571|NCT05553366|473890796|FG000|Overall Study|Other non-compliance|1|||
131617572|NCT05553366|473890797|FG001|Overall Study|Other non-compliance|1|||
131617573|NCT05553366|473890798|FG002|Overall Study|Other non-compliance|0|||
131617574|NCT05553366|473890796|FG000|Overall Study|Randomized but not dosed|0|||
131617575|NCT05553366|473890797|FG001|Overall Study|Randomized but not dosed|0|||
131617576|NCT05553366|473890798|FG002|Overall Study|Randomized but not dosed|2|||
131617577|NCT02022657|473890802|FG000|Overall Study|Withdrawal by Subject|2|||
131617578|NCT02022657|473890803|FG001|Overall Study|Withdrawal by Subject|0|||
131709561|NCT02497001|474215649|FG001|Overall Study|Adverse Event|30|||
131709562|NCT02497001|474215650|FG002|Overall Study|Adverse Event|11|||
131709563|NCT02497001|474215651|FG003|Overall Study|Adverse Event|11|||
131709564|NCT02497001|474215648|FG000|Overall Study|Withdrawal by Subject|14|||
131617579|NCT02022657|473890804|FG002|Overall Study|Withdrawal by Subject|1|||
131617580|NCT02022657|473890805|FG003|Overall Study|Withdrawal by Subject|0|||
131617581|NCT02022657|473890806|FG004|Overall Study|Withdrawal by Subject|0|||
131617582|NCT02022657|473890807|FG005|Overall Study|Withdrawal by Subject|0|||
131443932|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Other|6|||
131617583|NCT02022657|473890802|FG000|Overall Study|Physician Decision|0|||
131617584|NCT02022657|473890803|FG001|Overall Study|Physician Decision|0|||
131617585|NCT02022657|473890804|FG002|Overall Study|Physician Decision|0|||
131617586|NCT02022657|473890805|FG003|Overall Study|Physician Decision|0|||
131617587|NCT02022657|473890806|FG004|Overall Study|Physician Decision|0|||
131617588|NCT02022657|473890807|FG005|Overall Study|Physician Decision|1|||
131617589|NCT03739866|473890831|FG000|Overall Study|Lost to Follow-up|0|||
131617590|NCT03739866|473890832|FG001|Overall Study|Lost to Follow-up|0|||
131617591|NCT03739866|473890833|FG002|Overall Study|Lost to Follow-up|0|||
131617592|NCT03739866|473890834|FG003|Overall Study|Lost to Follow-up|1|||
131617593|NCT03739866|473890835|FG004|Overall Study|Lost to Follow-up|0|||
131617594|NCT03739866|473890836|FG005|Overall Study|Lost to Follow-up|0|||
131617595|NCT03739866|473890837|FG006|Overall Study|Lost to Follow-up|0|||
131617596|NCT03739866|473890838|FG007|Overall Study|Lost to Follow-up|0|||
131617597|NCT03739866|473890831|FG000|Overall Study|Enrolled but not treated|0|||
131617598|NCT03739866|473890832|FG001|Overall Study|Enrolled but not treated|0|||
131617599|NCT03739866|473890833|FG002|Overall Study|Enrolled but not treated|1|||
131617600|NCT03739866|473890834|FG003|Overall Study|Enrolled but not treated|0|||
131617601|NCT03739866|473890835|FG004|Overall Study|Enrolled but not treated|1|||
131617602|NCT03739866|473890836|FG005|Overall Study|Enrolled but not treated|0|||
131617603|NCT03739866|473890837|FG006|Overall Study|Enrolled but not treated|0|||
131617604|NCT03739866|473890838|FG007|Overall Study|Enrolled but not treated|0|||
131617605|NCT01700205|473890839|FG000|Overall Study|Withdrawal by Subject|13|||
131617606|NCT01700205|473890840|FG001|Overall Study|Withdrawal by Subject|13|||
131617607|NCT01700205|473890839|FG000|Overall Study|Protocol Violation|2|||
131617608|NCT01700205|473890840|FG001|Overall Study|Protocol Violation|2|||
131617609|NCT01034306|473890841|FG000|Overall Study|Adverse Event|1|||
131617610|NCT01034306|473890842|FG001|Overall Study|Adverse Event|0|||
131617611|NCT01034306|473890841|FG000|Overall Study|Lost to Follow-up|0|||
131443933|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Other|8|||
131443934|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
131443935|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
131443936|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
131443937|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
131443938|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
131443939|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
131443940|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
131443941|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
131617612|NCT01034306|473890842|FG001|Overall Study|Lost to Follow-up|1|||
131617613|NCT01034306|473890841|FG000|Overall Study|Withdrawal by Subject|2|||
131617614|NCT01034306|473890842|FG001|Overall Study|Withdrawal by Subject|2|||
131617615|NCT01034306|473890841|FG000|Overall Study|hospitalized and decided to stop|1|||
131617616|NCT01034306|473890842|FG001|Overall Study|hospitalized and decided to stop|0|||
131617617|NCT01034306|473890841|FG000|Overall Study|Noncomplience|1|||
131617618|NCT01034306|473890842|FG001|Overall Study|Noncomplience|0|||
131617619|NCT01619059|473890845|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
131617620|NCT01619059|473890846|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
131617621|NCT01619059|473890845|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
131617622|NCT01619059|473890846|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
131617623|NCT01619059|473890845|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
131617624|NCT01619059|473890846|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
131617625|NCT01619059|473890845|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
131617626|NCT01619059|473890846|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
131617627|NCT01619059|473890845|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
131617628|NCT01619059|473890846|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
131617629|NCT01619059|473890845|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
131617630|NCT01619059|473890846|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
131617631|NCT01619059|473890845|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
131617632|NCT01619059|473890846|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
131617633|NCT01619059|473890845|FG000|Long-Term (LT) Treatment Period|Death|1|||
131617634|NCT01619059|473890846|FG001|Long-Term (LT) Treatment Period|Death|0|||
131617635|NCT01619059|473890845|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
131795430|NCT00299156|474534004|FG001|Period 2 (Randomized)|Screen Failure|1|||
131795431|NCT00299156|474534005|FG002|Period 2 (Randomized)|Screen Failure|0|||
131617636|NCT01619059|473890846|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
131617637|NCT01619059|473890845|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
131795432|NCT01166568|474534015|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
131795433|NCT01166568|474534016|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
131795434|NCT01166568|474534017|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
131443942|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
131443943|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
131617638|NCT01619059|473890846|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
131617639|NCT01968967|473890849|FG000|Treatment Period|Other|22|||
131617640|NCT01968967|473890850|FG001|Treatment Period|Other|22|||
131617641|NCT01968967|473890851|FG002|Treatment Period|Other|0|||
131617642|NCT01968967|473890852|FG003|Treatment Period|Other|0|||
131709565|NCT02497001|474215649|FG001|Overall Study|Withdrawal by Subject|37|||
131709566|NCT02497001|474215650|FG002|Overall Study|Withdrawal by Subject|19|||
131709567|NCT02497001|474215651|FG003|Overall Study|Withdrawal by Subject|15|||
131709568|NCT02497001|474215648|FG000|Overall Study|Physician Decision|5|||
131709569|NCT02497001|474215649|FG001|Overall Study|Physician Decision|11|||
131709570|NCT02497001|474215650|FG002|Overall Study|Physician Decision|5|||
131709571|NCT02497001|474215651|FG003|Overall Study|Physician Decision|1|||
131709572|NCT02497001|474215648|FG000|Overall Study|subjects that were not treated|1|||
131709573|NCT02497001|474215649|FG001|Overall Study|subjects that were not treated|2|||
131709574|NCT02497001|474215650|FG002|Overall Study|subjects that were not treated|2|||
131709575|NCT02497001|474215651|FG003|Overall Study|subjects that were not treated|1|||
131709576|NCT02497001|474215648|FG000|Overall Study|Major Protocol Deviation|3|||
131709577|NCT02497001|474215649|FG001|Overall Study|Major Protocol Deviation|4|||
131709578|NCT02497001|474215650|FG002|Overall Study|Major Protocol Deviation|4|||
131709579|NCT02497001|474215651|FG003|Overall Study|Major Protocol Deviation|4|||
131709580|NCT02497001|474215648|FG000|Overall Study|Lack of Efficacy|10|||
131709581|NCT02497001|474215649|FG001|Overall Study|Lack of Efficacy|16|||
131709582|NCT02497001|474215650|FG002|Overall Study|Lack of Efficacy|6|||
131709583|NCT02497001|474215651|FG003|Overall Study|Lack of Efficacy|6|||
131709584|NCT02497001|474215648|FG000|Overall Study|Protocol Violation|3|||
131709585|NCT02497001|474215649|FG001|Overall Study|Protocol Violation|1|||
131709586|NCT02497001|474215650|FG002|Overall Study|Protocol Violation|3|||
131709587|NCT02497001|474215651|FG003|Overall Study|Protocol Violation|1|||
131709588|NCT01795547|474215652|FG000|Overall Study|Adverse Event|16|||
131709589|NCT01795547|474215653|FG001|Overall Study|Adverse Event|27|||
131709590|NCT01795547|474215652|FG000|Overall Study|Lack of Efficacy|8|||
131709591|NCT01795547|474215653|FG001|Overall Study|Lack of Efficacy|3|||
131709592|NCT01795547|474215652|FG000|Overall Study|Protocol Violation|6|||
131709593|NCT01795547|474215653|FG001|Overall Study|Protocol Violation|4|||
131709594|NCT01795547|474215652|FG000|Overall Study|Lost to Follow-up|2|||
131709595|NCT01795547|474215653|FG001|Overall Study|Lost to Follow-up|5|||
131709596|NCT01795547|474215652|FG000|Overall Study|Withdrawal of consent|7|||
131709597|NCT01795547|474215653|FG001|Overall Study|Withdrawal of consent|12|||
131709598|NCT01795547|474215652|FG000|Overall Study|Not Treated|4|||
131709599|NCT01795547|474215653|FG001|Overall Study|Not Treated|10|||
131709600|NCT01795547|474215652|FG000|Overall Study|Non-compliance with IMP|1|||
131709601|NCT01795547|474215653|FG001|Overall Study|Non-compliance with IMP|1|||
131709602|NCT01795547|474215652|FG000|Overall Study|Others|4|||
131709603|NCT01795547|474215653|FG001|Overall Study|Others|1|||
131709604|NCT01795547|474215652|FG000|Overall Study|Not stated|0|||
131709605|NCT01795547|474215653|FG001|Overall Study|Not stated|1|||
131709606|NCT03437447|474215655|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131709607|NCT03437447|474215656|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131709608|NCT03437447|474215657|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131709609|NCT00943683|474215658|FG000|Overall Study|Adverse Event|3|||
131709610|NCT00943683|474215659|FG001|Overall Study|Adverse Event|3|||
131709611|NCT00943683|474215658|FG000|Overall Study|Lost to Follow-up|1|||
131709612|NCT00943683|474215659|FG001|Overall Study|Lost to Follow-up|1|||
131709613|NCT00943683|474215658|FG000|Overall Study|Protocol Violation|1|||
131709614|NCT00943683|474215659|FG001|Overall Study|Protocol Violation|2|||
131709615|NCT00943683|474215658|FG000|Overall Study|Withdrawal by Subject|1|||
131709616|NCT00943683|474215659|FG001|Overall Study|Withdrawal by Subject|0|||
131709617|NCT00943683|474215658|FG000|Overall Study|Patient Moved|1|||
131709618|NCT00943683|474215659|FG001|Overall Study|Patient Moved|0|||
131709619|NCT01551745|474215660|FG000|Overall Study|Withdrawal by Subject|1|||
131709620|NCT01551745|474215660|FG000|Overall Study|Disease Progression|2|||
131709621|NCT00749190|474215661|FG000|Overall Study|Adverse Event|0|||
131709622|NCT00749190|474215662|FG001|Overall Study|Adverse Event|2|||
131709623|NCT00749190|474215663|FG002|Overall Study|Adverse Event|0|||
131709624|NCT00749190|474215664|FG003|Overall Study|Adverse Event|4|||
131709625|NCT00749190|474215665|FG004|Overall Study|Adverse Event|0|||
131709626|NCT00749190|474215666|FG005|Overall Study|Adverse Event|3|||
131709627|NCT00749190|474215667|FG006|Overall Study|Adverse Event|0|||
131709628|NCT00749190|474215661|FG000|Overall Study|Lack of Efficacy|3|||
131709629|NCT00749190|474215662|FG001|Overall Study|Lack of Efficacy|1|||
131709630|NCT00749190|474215663|FG002|Overall Study|Lack of Efficacy|1|||
131709631|NCT00749190|474215664|FG003|Overall Study|Lack of Efficacy|0|||
131709632|NCT00749190|474215665|FG004|Overall Study|Lack of Efficacy|0|||
131709633|NCT00749190|474215666|FG005|Overall Study|Lack of Efficacy|1|||
131709634|NCT00749190|474215667|FG006|Overall Study|Lack of Efficacy|0|||
131709635|NCT00749190|474215661|FG000|Overall Study|Withdrawal by Subject|2|||
131709636|NCT00749190|474215662|FG001|Overall Study|Withdrawal by Subject|1|||
131709637|NCT00749190|474215663|FG002|Overall Study|Withdrawal by Subject|0|||
131709638|NCT00749190|474215664|FG003|Overall Study|Withdrawal by Subject|0|||
131709639|NCT00749190|474215665|FG004|Overall Study|Withdrawal by Subject|0|||
131709640|NCT00749190|474215666|FG005|Overall Study|Withdrawal by Subject|1|||
131617643|NCT01968967|473890853|FG004|Treatment Period|Other|0|||
131617644|NCT01968967|473890849|FG000|Treatment Period|Withdrawal by Subject|71|||
131617645|NCT01968967|473890850|FG001|Treatment Period|Withdrawal by Subject|61|||
131617646|NCT01968967|473890851|FG002|Treatment Period|Withdrawal by Subject|0|||
131617647|NCT01968967|473890852|FG003|Treatment Period|Withdrawal by Subject|0|||
131617648|NCT01968967|473890853|FG004|Treatment Period|Withdrawal by Subject|0|||
131617649|NCT01968967|473890849|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
131617650|NCT01968967|473890850|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
131617651|NCT01968967|473890851|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
131617652|NCT01968967|473890852|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
131617653|NCT01968967|473890853|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
131617654|NCT01968967|473890849|FG000|Treatment Period|Lost to Follow-up|26|||
131617655|NCT01968967|473890850|FG001|Treatment Period|Lost to Follow-up|31|||
131617656|NCT01968967|473890851|FG002|Treatment Period|Lost to Follow-up|0|||
131617657|NCT01968967|473890852|FG003|Treatment Period|Lost to Follow-up|0|||
131617658|NCT01968967|473890853|FG004|Treatment Period|Lost to Follow-up|0|||
131617659|NCT01968967|473890849|FG000|Treatment Period|Protocol Violation|1|||
131617660|NCT01968967|473890850|FG001|Treatment Period|Protocol Violation|2|||
131617661|NCT01968967|473890851|FG002|Treatment Period|Protocol Violation|0|||
131617662|NCT01968967|473890852|FG003|Treatment Period|Protocol Violation|0|||
131617663|NCT01968967|473890853|FG004|Treatment Period|Protocol Violation|0|||
131617664|NCT01968967|473890849|FG000|Treatment Period|Adverse Event|9|||
131617665|NCT01968967|473890850|FG001|Treatment Period|Adverse Event|8|||
131617666|NCT01968967|473890851|FG002|Treatment Period|Adverse Event|0|||
131617667|NCT01968967|473890852|FG003|Treatment Period|Adverse Event|0|||
131617668|NCT01968967|473890853|FG004|Treatment Period|Adverse Event|0|||
131617669|NCT01968967|473890849|FG000|Treatment Period|Death|9|||
131617670|NCT01968967|473890850|FG001|Treatment Period|Death|2|||
131617671|NCT01968967|473890851|FG002|Treatment Period|Death|0|||
131617672|NCT01968967|473890852|FG003|Treatment Period|Death|0|||
131617673|NCT01968967|473890853|FG004|Treatment Period|Death|0|||
131617674|NCT01968967|473890849|FG000|Treatment Period|Randomized Not Treated|6|||
131617675|NCT01968967|473890850|FG001|Treatment Period|Randomized Not Treated|5|||
131617676|NCT01968967|473890851|FG002|Treatment Period|Randomized Not Treated|0|||
131617677|NCT01968967|473890852|FG003|Treatment Period|Randomized Not Treated|0|||
131617678|NCT01968967|473890853|FG004|Treatment Period|Randomized Not Treated|0|||
131617679|NCT01968967|473890849|FG000|Extension Period|Withdrew Consent|0|||
131617680|NCT01968967|473890850|FG001|Extension Period|Withdrew Consent|0|||
131617681|NCT01968967|473890851|FG002|Extension Period|Withdrew Consent|2|||
131617682|NCT01968967|473890852|FG003|Extension Period|Withdrew Consent|0|||
131617683|NCT01968967|473890853|FG004|Extension Period|Withdrew Consent|5|||
131617684|NCT03489369|473890854|FG000|Overall Study|Documented Progressive Disease|3|||
131617685|NCT03489369|473890855|FG001|Overall Study|Documented Progressive Disease|2|||
131617686|NCT03489369|473890856|FG002|Overall Study|Documented Progressive Disease|3|||
131617687|NCT03489369|473890857|FG003|Overall Study|Documented Progressive Disease|6|||
131617688|NCT03489369|473890854|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
131617689|NCT03489369|473890855|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
131617690|NCT03489369|473890856|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
131617691|NCT03489369|473890857|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
131617692|NCT01827839|473890866|FG000|Overall Study|Adverse Event|1|||
131617693|NCT01827839|473890866|FG000|Overall Study|Consent Withdrawal|2|||
131617694|NCT05824559|473890875|FG000|Overall Study|Adverse Event|2|||
131617695|NCT05824559|473890875|FG000|Overall Study|Physician Decision|2|||
131617696|NCT05824559|473890875|FG000|Overall Study|Progressive Disease|16|||
131617697|NCT05824559|473890875|FG000|Overall Study|Study Terminated by Sponsor|1|||
131617698|NCT05824559|473890875|FG000|Overall Study|Withdrawal by Subject|2|||
131617699|NCT02409680|473890880|FG000|Overall Study|Lost to Follow-up|15|||
131617700|NCT02409680|473890881|FG001|Overall Study|Lost to Follow-up|30|||
131617701|NCT00302211|473890884|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
131709641|NCT00749190|474215667|FG006|Overall Study|Withdrawal by Subject|0|||
131709642|NCT00749190|474215661|FG000|Overall Study|Protocol Violation|0|||
131709643|NCT00749190|474215662|FG001|Overall Study|Protocol Violation|1|||
131709644|NCT00749190|474215663|FG002|Overall Study|Protocol Violation|0|||
131617702|NCT00302211|473890885|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
131617703|NCT00302211|473890886|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
131617704|NCT00302211|473890887|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
131617705|NCT00302211|473890888|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
131617706|NCT00302211|473890884|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
131709645|NCT00749190|474215664|FG003|Overall Study|Protocol Violation|0|||
131617707|NCT00302211|473890885|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
131617708|NCT00302211|473890886|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
131709646|NCT00749190|474215665|FG004|Overall Study|Protocol Violation|0|||
131709647|NCT00749190|474215666|FG005|Overall Study|Protocol Violation|0|||
131617709|NCT00302211|473890887|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
131709648|NCT00749190|474215667|FG006|Overall Study|Protocol Violation|1|||
131709649|NCT00749190|474215661|FG000|Overall Study|Other reason not defined above|0|||
131709650|NCT00749190|474215662|FG001|Overall Study|Other reason not defined above|0|||
131709651|NCT00749190|474215663|FG002|Overall Study|Other reason not defined above|0|||
131709652|NCT00749190|474215664|FG003|Overall Study|Other reason not defined above|1|||
131709653|NCT00749190|474215665|FG004|Overall Study|Other reason not defined above|0|||
131709654|NCT00749190|474215666|FG005|Overall Study|Other reason not defined above|0|||
131709655|NCT00749190|474215667|FG006|Overall Study|Other reason not defined above|0|||
131709656|NCT00355121|474215668|FG000|Overall Study|Did not receive study vaccine|1|||
131709657|NCT00355121|474215669|FG001|Overall Study|Did not receive study vaccine|0|||
131709658|NCT00355121|474215670|FG002|Overall Study|Did not receive study vaccine|1|||
131709659|NCT00355121|474215668|FG000|Overall Study|Adverse Event|0|||
131709660|NCT00355121|474215669|FG001|Overall Study|Adverse Event|1|||
131709661|NCT00355121|474215670|FG002|Overall Study|Adverse Event|0|||
131709662|NCT00355121|474215668|FG000|Overall Study|Protocol Violation|7|||
131709663|NCT00355121|474215669|FG001|Overall Study|Protocol Violation|9|||
131709664|NCT00355121|474215670|FG002|Overall Study|Protocol Violation|1|||
131709665|NCT00355121|474215668|FG000|Overall Study|Lost to Follow-up|4|||
131709666|NCT00355121|474215669|FG001|Overall Study|Lost to Follow-up|7|||
131709667|NCT00355121|474215670|FG002|Overall Study|Lost to Follow-up|1|||
131709668|NCT00355121|474215668|FG000|Overall Study|Withdrawal by Subject|9|||
131709669|NCT00355121|474215669|FG001|Overall Study|Withdrawal by Subject|10|||
131709670|NCT00355121|474215670|FG002|Overall Study|Withdrawal by Subject|2|||
131709671|NCT00355121|474215668|FG000|Overall Study|Serious adverse events|0|||
131709672|NCT00355121|474215669|FG001|Overall Study|Serious adverse events|2|||
131709673|NCT00355121|474215670|FG002|Overall Study|Serious adverse events|0|||
131709674|NCT00630331|474215672|FG000|Overall Study|Death|2|||
131709675|NCT00630331|474215673|FG001|Overall Study|Death|1|||
131709676|NCT00630331|474215674|FG002|Overall Study|Death|1|||
131709677|NCT00630331|474215672|FG000|Overall Study|Adverse Event|1|||
131709678|NCT00630331|474215673|FG001|Overall Study|Adverse Event|0|||
131709679|NCT00630331|474215674|FG002|Overall Study|Adverse Event|0|||
131709680|NCT00630331|474215672|FG000|Overall Study|Withdrawal by Subject|12|||
131709681|NCT00630331|474215673|FG001|Overall Study|Withdrawal by Subject|7|||
131709682|NCT00630331|474215674|FG002|Overall Study|Withdrawal by Subject|5|||
131709683|NCT00630331|474215672|FG000|Overall Study|Lost to Follow-up|175|||
131709684|NCT00630331|474215673|FG001|Overall Study|Lost to Follow-up|143|||
131709685|NCT00630331|474215674|FG002|Overall Study|Lost to Follow-up|170|||
131709686|NCT00630331|474215672|FG000|Overall Study|Inappropriate enrollment|3|||
131709687|NCT00630331|474215673|FG001|Overall Study|Inappropriate enrollment|6|||
131709688|NCT00630331|474215674|FG002|Overall Study|Inappropriate enrollment|3|||
131709689|NCT00630331|474215672|FG000|Overall Study|Unable to classify|9|||
131709690|NCT00630331|474215673|FG001|Overall Study|Unable to classify|4|||
131709691|NCT00630331|474215674|FG002|Overall Study|Unable to classify|3|||
131709692|NCT00630331|474215672|FG000|Overall Study|Protocol Violation|4|||
131709693|NCT00630331|474215673|FG001|Overall Study|Protocol Violation|5|||
131709694|NCT00630331|474215674|FG002|Overall Study|Protocol Violation|6|||
131709695|NCT01565980|474215675|FG000|Overall Study|Death|1|||
131709696|NCT01565980|474215676|FG001|Overall Study|Death|0|||
131709697|NCT01565980|474215675|FG000|Overall Study|Lost to Follow-up|1|||
131709698|NCT01565980|474215676|FG001|Overall Study|Lost to Follow-up|0|||
131709699|NCT01565980|474215675|FG000|Overall Study|health complications|1|||
131709700|NCT01565980|474215676|FG001|Overall Study|health complications|1|||
131709701|NCT01565980|474215675|FG000|Overall Study|stopped medical treatment|1|||
131709702|NCT01565980|474215676|FG001|Overall Study|stopped medical treatment|0|||
131709703|NCT01565980|474215675|FG000|Overall Study|Withdrawal by Subject|0|||
131709704|NCT01565980|474215676|FG001|Overall Study|Withdrawal by Subject|3|||
131709705|NCT01817790|474215689|FG000|Overall Study|Adverse Event|0|||
131709706|NCT01817790|474215690|FG001|Overall Study|Adverse Event|2|||
131709707|NCT01817790|474215689|FG000|Overall Study|Lost to Follow-up|0|||
131709708|NCT01817790|474215690|FG001|Overall Study|Lost to Follow-up|1|||
131709709|NCT01817790|474215689|FG000|Overall Study|Protocol Violation|2|||
131709710|NCT01817790|474215690|FG001|Overall Study|Protocol Violation|1|||
131709711|NCT01817790|474215689|FG000|Overall Study|Withdrawal by Subject|1|||
131709712|NCT01817790|474215690|FG001|Overall Study|Withdrawal by Subject|3|||
131709713|NCT01817790|474215689|FG000|Overall Study|Other: Could not attend appointment|1|||
131709714|NCT01817790|474215690|FG001|Overall Study|Other: Could not attend appointment|1|||
131709715|NCT01671345|474215691|FG000|Overall Study|Lost to Follow-up|10|||
131709716|NCT01671345|474215692|FG001|Overall Study|Lost to Follow-up|6|||
131709717|NCT01671345|474215691|FG000|Overall Study|visit with non-participating physician|3|||
131709718|NCT01671345|474215692|FG001|Overall Study|visit with non-participating physician|3|||
131617710|NCT00302211|473890888|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
131617711|NCT00302211|473890884|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
131617712|NCT00302211|473890885|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
131617713|NCT00302211|473890886|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
131617714|NCT00302211|473890887|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
131617715|NCT00302211|473890888|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
131617716|NCT00302211|473890884|FG000|Double Blind Period (New Patients)|Disease progression|0|||
131617717|NCT00302211|473890885|FG001|Double Blind Period (New Patients)|Disease progression|1|||
131617718|NCT00302211|473890886|FG002|Double Blind Period (New Patients)|Disease progression|1|||
131617719|NCT00302211|473890887|FG003|Double Blind Period (New Patients)|Disease progression|0|||
131617720|NCT00302211|473890888|FG004|Double Blind Period (New Patients)|Disease progression|0|||
131617721|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
131617722|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
131617723|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
131617724|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
131617725|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
131617726|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
131617727|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
131617728|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
131617729|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
131617730|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
131617731|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131617732|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131617733|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131617734|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
131617735|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131617736|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
131617737|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
131617738|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
131617739|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
131617740|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
131617741|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Death|0|||
131617742|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Death|0|||
131617743|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Death|0|||
131617744|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Death|1|||
131617745|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Death|1|||
131617746|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131617747|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131617748|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131617749|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131709719|NCT03636906|474215693|FG000|Overall Study|Adverse Event|0|||
131709720|NCT03636906|474215694|FG001|Overall Study|Adverse Event|0|||
131709721|NCT03636906|474215695|FG002|Overall Study|Adverse Event|1|||
131709722|NCT03636906|474215693|FG000|Overall Study|Lost to Follow-up|1|||
131709723|NCT03636906|474215694|FG001|Overall Study|Lost to Follow-up|0|||
131709724|NCT03636906|474215695|FG002|Overall Study|Lost to Follow-up|0|||
131709725|NCT03636906|474215693|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
131709726|NCT03636906|474215694|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
131709727|NCT03636906|474215695|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
131709728|NCT03636906|474215693|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
131709729|NCT03636906|474215694|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131709730|NCT03636906|474215695|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
131709731|NCT03636906|474215693|FG000|Overall Study|Other|0|||
131709732|NCT03636906|474215694|FG001|Overall Study|Other|0|||
131709733|NCT03636906|474215695|FG002|Overall Study|Other|1|||
131709734|NCT04280081|474215698|FG000|Overall Study|Adverse Event|4|||
131709735|NCT04280081|474215698|FG000|Overall Study|Death|2|||
131709736|NCT04280081|474215698|FG000|Overall Study|Progressive Disease|6|||
131709737|NCT03417440|474217720|FG000|Overall Study|Lost to Follow-up|0|||
131709738|NCT03417440|474217721|FG001|Overall Study|Lost to Follow-up|1|||
131709739|NCT03417440|474217722|FG002|Overall Study|Lost to Follow-up|0|||
131617750|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
131617751|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131709740|NCT03417440|474217723|FG003|Overall Study|Lost to Follow-up|0|||
131709741|NCT03417440|474217724|FG004|Overall Study|Lost to Follow-up|1|||
131709742|NCT03417440|474217725|FG005|Overall Study|Lost to Follow-up|0|||
131709743|NCT03417440|474217726|FG006|Overall Study|Lost to Follow-up|0|||
131709744|NCT03417440|474217727|FG007|Overall Study|Lost to Follow-up|0|||
131617752|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131617753|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131617754|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131617755|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
131617756|NCT00302211|473890884|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131617757|NCT00302211|473890885|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131617758|NCT00302211|473890886|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131617759|NCT00302211|473890887|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
131617760|NCT00302211|473890888|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131617761|NCT05432986|473890894|FG000|Overall Study|Withdrawal by Subject|2|||
131617762|NCT05432986|473890894|FG000|Overall Study|incomplete measurement|7|||
131617763|NCT04172675|473892483|FG000|Overall Study|Withdrawal by Subject|7|||
131617764|NCT04172675|473892484|FG001|Overall Study|Withdrawal by Subject|5|||
131617765|NCT04172675|473892485|FG002|Overall Study|Withdrawal by Subject|1|||
131617766|NCT04172675|473892486|FG003|Overall Study|Withdrawal by Subject|4|||
131617767|NCT05349721|473892487|FG000|Part A (24 Weeks)|Adverse Event|9|||
131617768|NCT05349721|473892488|FG001|Part A (24 Weeks)|Adverse Event|2|||
131617769|NCT05349721|473892487|FG000|Part A (24 Weeks)|Death|8|||
131617770|NCT05349721|473892488|FG001|Part A (24 Weeks)|Death|3|||
131617771|NCT05349721|473892487|FG000|Part A (24 Weeks)|Disease Progression|1|||
131617772|NCT05349721|473892488|FG001|Part A (24 Weeks)|Disease Progression|1|||
131617773|NCT05349721|473892487|FG000|Part A (24 Weeks)|Screen Failure|2|||
131617774|NCT05349721|473892488|FG001|Part A (24 Weeks)|Screen Failure|0|||
131617775|NCT05349721|473892487|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
131617776|NCT05349721|473892488|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
131617777|NCT05349721|473892487|FG000|Part A (24 Weeks)|Other Than Specified|5|||
131617778|NCT05349721|473892488|FG001|Part A (24 Weeks)|Other Than Specified|1|||
131617779|NCT05349721|473892487|FG000|Part B (28 Weeks)|Adverse Event|3|||
131617780|NCT05349721|473892488|FG001|Part B (28 Weeks)|Adverse Event|0|||
131617781|NCT05349721|473892487|FG000|Part B (28 Weeks)|Death|21|||
131617782|NCT05349721|473892488|FG001|Part B (28 Weeks)|Death|11|||
131617783|NCT05349721|473892487|FG000|Part B (28 Weeks)|Disease Progression|2|||
131617784|NCT05349721|473892488|FG001|Part B (28 Weeks)|Disease Progression|1|||
131617785|NCT05349721|473892487|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
131617786|NCT05349721|473892488|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
131617787|NCT05349721|473892487|FG000|Part B (28 Weeks)|Physician Decision|1|||
131617788|NCT05349721|473892488|FG001|Part B (28 Weeks)|Physician Decision|0|||
131617789|NCT05349721|473892487|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
131617790|NCT05349721|473892488|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
131617791|NCT05349721|473892487|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
131617792|NCT05349721|473892488|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
131617793|NCT05349721|473892487|FG000|Part B (28 Weeks)|Other Than Specified|4|||
131617794|NCT05349721|473892488|FG001|Part B (28 Weeks)|Other Than Specified|2|||
131617795|NCT05349721|473892487|FG000|Part C (108 Weeks)|Death|0|||
131617796|NCT05349721|473892488|FG001|Part C (108 Weeks)|Death|1|||
131617797|NCT05349721|473892487|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
131617798|NCT05349721|473892488|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
131617799|NCT05349721|473892487|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
131617800|NCT05349721|473892488|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
131617801|NCT05349721|473892487|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
131617802|NCT05349721|473892488|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
131617803|NCT03070392|473892489|FG000|Overall Study|Not Treated|7|||
131617804|NCT03070392|473892490|FG001|Overall Study|Not Treated|0|||
131617805|NCT03070392|473892491|FG002|Overall Study|Not Treated|3|||
131617806|NCT03070392|473892492|FG003|Overall Study|Not Treated|12|||
131617807|NCT03070392|473892489|FG000|Overall Study|Death|3|||
131617808|NCT03070392|473892490|FG001|Overall Study|Death|0|||
131617809|NCT03070392|473892491|FG002|Overall Study|Death|0|||
131617810|NCT03070392|473892492|FG003|Overall Study|Death|1|||
131617811|NCT03070392|473892489|FG000|Overall Study|Withdrawal by Subject|7|||
131709745|NCT03417440|474217720|FG000|Overall Study|Withdrawal by Subject|2|||
131709746|NCT03417440|474217721|FG001|Overall Study|Withdrawal by Subject|0|||
131709747|NCT03417440|474217722|FG002|Overall Study|Withdrawal by Subject|2|||
131709748|NCT03417440|474217723|FG003|Overall Study|Withdrawal by Subject|1|||
131617812|NCT03070392|473892490|FG001|Overall Study|Withdrawal by Subject|0|||
131617813|NCT03070392|473892491|FG002|Overall Study|Withdrawal by Subject|0|||
131617814|NCT03070392|473892492|FG003|Overall Study|Withdrawal by Subject|3|||
131617815|NCT03070392|473892489|FG000|Overall Study|Physician Decision|1|||
131617816|NCT03070392|473892490|FG001|Overall Study|Physician Decision|0|||
131617817|NCT03070392|473892491|FG002|Overall Study|Physician Decision|0|||
131617818|NCT03070392|473892492|FG003|Overall Study|Physician Decision|2|||
131617819|NCT03070392|473892489|FG000|Overall Study|Progressive Disease|154|||
131617820|NCT03070392|473892490|FG001|Overall Study|Progressive Disease|6|||
131617821|NCT03070392|473892491|FG002|Overall Study|Progressive Disease|2|||
131617822|NCT03070392|473892492|FG003|Overall Study|Progressive Disease|70|||
131617823|NCT03070392|473892489|FG000|Overall Study|Adverse Event|6|||
131617824|NCT03070392|473892490|FG001|Overall Study|Adverse Event|1|||
131617825|NCT03070392|473892491|FG002|Overall Study|Adverse Event|1|||
131617826|NCT03070392|473892492|FG003|Overall Study|Adverse Event|3|||
131617827|NCT03070392|473892489|FG000|Overall Study|Alternate anticancer treatment|1|||
131617828|NCT03070392|473892490|FG001|Overall Study|Alternate anticancer treatment|0|||
131617829|NCT03070392|473892491|FG002|Overall Study|Alternate anticancer treatment|0|||
131617830|NCT03070392|473892492|FG003|Overall Study|Alternate anticancer treatment|1|||
131617831|NCT03070392|473892489|FG000|Overall Study|Ongoing|73|||
131617832|NCT03070392|473892490|FG001|Overall Study|Ongoing|0|||
131617833|NCT03070392|473892491|FG002|Overall Study|Ongoing|0|||
131617834|NCT03070392|473892492|FG003|Overall Study|Ongoing|11|||
131617835|NCT03009344|473892494|FG000|Overall Study|Lack of Efficacy|5|||
131617836|NCT03009344|473892494|FG000|Overall Study|Withdrawal by Subject|1|||
131617837|NCT03009344|473892494|FG000|Overall Study|Adverse Event|1|||
131617838|NCT02534233|473892497|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
131617839|NCT03823703|473892498|FG000|Overall Study|Sponsor request|0|||
131617840|NCT03823703|473892499|FG001|Overall Study|Sponsor request|3|||
131617841|NCT03823703|473892500|FG002|Overall Study|Sponsor request|4|||
131617842|NCT03823703|473892498|FG000|Overall Study|Adverse Event|3|||
131617843|NCT03823703|473892499|FG001|Overall Study|Adverse Event|1|||
131617844|NCT03823703|473892500|FG002|Overall Study|Adverse Event|0|||
131617845|NCT03823703|473892498|FG000|Overall Study|Withdrawal by Subject|0|||
131617846|NCT03823703|473892499|FG001|Overall Study|Withdrawal by Subject|1|||
131617847|NCT03823703|473892500|FG002|Overall Study|Withdrawal by Subject|0|||
131617848|NCT01732757|473892501|FG000|Overall Study|Lost to Follow-up|1|||
131617849|NCT01732757|473892502|FG001|Overall Study|Lost to Follow-up|0|||
131617850|NCT01732757|473892503|FG002|Overall Study|Lost to Follow-up|0|||
131617851|NCT00925548|473892504|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
131617852|NCT00925548|473892505|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
131617853|NCT04921358|473892506|FG000|Overall Study|Withdrawal by Subject|6|||
131617854|NCT04921358|473892507|FG001|Overall Study|Withdrawal by Subject|13|||
131617855|NCT04921358|473892506|FG000|Overall Study|Lost to Follow-up|3|||
131617856|NCT04921358|473892507|FG001|Overall Study|Lost to Follow-up|6|||
131709749|NCT03417440|474217724|FG004|Overall Study|Withdrawal by Subject|1|||
131709750|NCT03417440|474217725|FG005|Overall Study|Withdrawal by Subject|0|||
131709751|NCT03417440|474217726|FG006|Overall Study|Withdrawal by Subject|0|||
131709752|NCT03417440|474217727|FG007|Overall Study|Withdrawal by Subject|1|||
131709753|NCT03304522|474217728|FG000|Overall Study|Adverse Event|0|||
131709754|NCT03304522|474217729|FG001|Overall Study|Adverse Event|4|||
131709755|NCT03304522|474217728|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
131709756|NCT03304522|474217729|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
131709757|NCT03304522|474217728|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
131795435|NCT01166568|474534015|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
131795436|NCT01166568|474534016|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
131795437|NCT01166568|474534017|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
131795438|NCT01166568|474534015|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
131795439|NCT01166568|474534016|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
131795440|NCT01166568|474534017|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
131795441|NCT03335371|474534018|FG000|Overall Study|Lost to Follow-up|0|||
131795442|NCT03335371|474534019|FG001|Overall Study|Lost to Follow-up|0|||
131795443|NCT03335371|474534020|FG002|Overall Study|Lost to Follow-up|0|||
131795444|NCT03335371|474534021|FG003|Overall Study|Lost to Follow-up|0|||
131795445|NCT03335371|474534022|FG004|Overall Study|Lost to Follow-up|1|||
131795446|NCT03335371|474534018|FG000|Overall Study|Withdrawal by Subject|0|||
131795447|NCT03335371|474534019|FG001|Overall Study|Withdrawal by Subject|0|||
131795448|NCT03335371|474534020|FG002|Overall Study|Withdrawal by Subject|0|||
131795449|NCT03335371|474534021|FG003|Overall Study|Withdrawal by Subject|0|||
131795450|NCT03335371|474534022|FG004|Overall Study|Withdrawal by Subject|1|||
131795451|NCT03335371|474534018|FG000|Overall Study|Randomization Error|0|||
131795452|NCT03335371|474534019|FG001|Overall Study|Randomization Error|0|||
131795453|NCT03335371|474534020|FG002|Overall Study|Randomization Error|1|||
131795454|NCT03335371|474534021|FG003|Overall Study|Randomization Error|0|||
131795455|NCT03335371|474534022|FG004|Overall Study|Randomization Error|0|||
131795456|NCT00684671|474534023|FG000|Overall Study|Adverse Event|1|||
131795457|NCT00684671|474534024|FG001|Overall Study|Adverse Event|0|||
131795458|NCT00684671|474534025|FG002|Overall Study|Adverse Event|0|||
131795459|NCT00684671|474534023|FG000|Overall Study|Lost to Follow-up|1|||
131795460|NCT00684671|474534024|FG001|Overall Study|Lost to Follow-up|0|||
131795461|NCT00684671|474534025|FG002|Overall Study|Lost to Follow-up|0|||
131795462|NCT00684671|474534023|FG000|Overall Study|Alcoholic dependance|1|||
131795463|NCT00684671|474534024|FG001|Overall Study|Alcoholic dependance|0|||
131795464|NCT00684671|474534025|FG002|Overall Study|Alcoholic dependance|0|||
131795465|NCT01725451|474534026|FG000|Period 1|Withdrawal by Subject|1|||
131795466|NCT01725451|474534027|FG001|Period 1|Withdrawal by Subject|0|||
131617857|NCT04921358|473892506|FG000|Overall Study|Study Terminated by Sponsor|86|||
131709758|NCT03304522|474217729|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
131709759|NCT03304522|474217728|FG000|Overall Study|Other|0|||
131709760|NCT03304522|474217729|FG001|Overall Study|Other|1|||
131709761|NCT02013544|474217732|FG000|Overall Study|Adverse Event|5|||
131709762|NCT02013544|474217733|FG001|Overall Study|Adverse Event|5|||
131709763|NCT02013544|474217732|FG000|Overall Study|Lost to Follow-up|2|||
131709764|NCT02013544|474217733|FG001|Overall Study|Lost to Follow-up|3|||
131709765|NCT02013544|474217732|FG000|Overall Study|Withdrawal by Subject|2|||
131709766|NCT02013544|474217733|FG001|Overall Study|Withdrawal by Subject|8|||
131709767|NCT02013544|474217732|FG000|Overall Study|Physician Decision|0|||
131709768|NCT02013544|474217733|FG001|Overall Study|Physician Decision|1|||
131795467|NCT01725451|474534028|FG002|Period 1|Withdrawal by Subject|0|||
131795468|NCT01725451|474534029|FG003|Period 1|Withdrawal by Subject|0|||
131795469|NCT01725451|474534026|FG000|Washout From Period 3|Protocol Violation|0|||
131795470|NCT01725451|474534027|FG001|Washout From Period 3|Protocol Violation|0|||
131795471|NCT01725451|474534028|FG002|Washout From Period 3|Protocol Violation|1|||
131617858|NCT04921358|473892507|FG001|Overall Study|Study Terminated by Sponsor|89|||
131617859|NCT04921358|473892506|FG000|Overall Study|Death|92|||
131617860|NCT04921358|473892507|FG001|Overall Study|Death|82|||
131617861|NCT02372799|473892508|FG000|Treatment Period|Adverse Event|3|||
131617862|NCT02372799|473892509|FG001|Treatment Period|Adverse Event|10|||
131617863|NCT02372799|473892510|FG002|Treatment Period|Adverse Event|6|||
131617864|NCT02372799|473892508|FG000|Treatment Period|Insufficient therapeutic response|2|||
131617865|NCT02372799|473892509|FG001|Treatment Period|Insufficient therapeutic response|2|||
131617866|NCT02372799|473892510|FG002|Treatment Period|Insufficient therapeutic response|0|||
131617867|NCT02372799|473892508|FG000|Treatment Period|Withdrawal by Subject|10|||
131617868|NCT02372799|473892509|FG001|Treatment Period|Withdrawal by Subject|10|||
131617869|NCT02372799|473892510|FG002|Treatment Period|Withdrawal by Subject|2|||
131617870|NCT02372799|473892508|FG000|Treatment Period|Lost to Follow-up|11|||
131617871|NCT02372799|473892509|FG001|Treatment Period|Lost to Follow-up|5|||
131617872|NCT02372799|473892510|FG002|Treatment Period|Lost to Follow-up|3|||
131617873|NCT02372799|473892508|FG000|Treatment Period|Protocol Violation|3|||
131617874|NCT02372799|473892509|FG001|Treatment Period|Protocol Violation|0|||
131617875|NCT02372799|473892510|FG002|Treatment Period|Protocol Violation|0|||
131617876|NCT02372799|473892508|FG000|Treatment Period|Non-compliance with study drug|4|||
131617877|NCT02372799|473892509|FG001|Treatment Period|Non-compliance with study drug|4|||
131617878|NCT02372799|473892510|FG002|Treatment Period|Non-compliance with study drug|4|||
131617879|NCT02372799|473892508|FG000|Treatment Period|Miscellaneous Reasons|1|||
131617880|NCT02372799|473892509|FG001|Treatment Period|Miscellaneous Reasons|1|||
131617881|NCT02372799|473892510|FG002|Treatment Period|Miscellaneous Reasons|0|||
131617882|NCT02372799|473892508|FG000|Down-taper Period|Lost to Follow-up|1|||
131617883|NCT02372799|473892509|FG001|Down-taper Period|Lost to Follow-up|2|||
131617884|NCT02372799|473892510|FG002|Down-taper Period|Lost to Follow-up|2|||
131617885|NCT03116464|473892511|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
131617886|NCT00491400|473892512|FG000|Overall Study|Withdrawal by Subject|5|||
131617887|NCT00491400|473892513|FG001|Overall Study|Withdrawal by Subject|4|||
131617888|NCT02310581|473892514|FG000|Overall Study|Adverse Event|1|||
131617889|NCT02310581|473892515|FG001|Overall Study|Adverse Event|1|||
131617890|NCT02310581|473892516|FG002|Overall Study|Adverse Event|1|||
131617891|NCT02310581|473892517|FG003|Overall Study|Adverse Event|0|||
131617892|NCT02310581|473892514|FG000|Overall Study|Withdrawal by Subject|2|||
131617893|NCT02310581|473892515|FG001|Overall Study|Withdrawal by Subject|1|||
131617894|NCT02310581|473892516|FG002|Overall Study|Withdrawal by Subject|0|||
131617895|NCT02310581|473892517|FG003|Overall Study|Withdrawal by Subject|1|||
131617896|NCT03883828|473892518|FG000|Overall Study|Did not start radiotherapy|1|||
131617897|NCT03883828|473892519|FG001|Overall Study|Did not start radiotherapy|2|||
131617898|NCT04658784|473892522|FG000|6-month Follow-up|Lost to Follow-up|2|||
131617899|NCT04658784|473892523|FG001|6-month Follow-up|Lost to Follow-up|5|||
131617900|NCT00454194|473892525|FG000|Overall Study|Adverse Event|7|||
131617901|NCT00454194|473892526|FG001|Overall Study|Adverse Event|2|||
131617902|NCT00454194|473892525|FG000|Overall Study|Withdrawal by Subject|12|||
131709769|NCT02013544|474217732|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
131795472|NCT01725451|474534029|FG003|Washout From Period 3|Protocol Violation|0|||
131795473|NCT01725451|474534026|FG000|Washout From Period 3|Adverse Event|0|||
131617903|NCT00454194|473892526|FG001|Overall Study|Withdrawal by Subject|8|||
131795474|NCT01725451|474534027|FG001|Washout From Period 3|Adverse Event|1|||
131709770|NCT02013544|474217733|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
131709771|NCT00238264|474217734|FG000|Overall Study|Death|7|||
131795475|NCT01725451|474534028|FG002|Washout From Period 3|Adverse Event|0|||
131795476|NCT01725451|474534029|FG003|Washout From Period 3|Adverse Event|0|||
131617904|NCT00454194|473892525|FG000|Overall Study|Other Medical Problems|1|||
131617905|NCT00454194|473892526|FG001|Overall Study|Other Medical Problems|2|||
131709772|NCT00238264|474217734|FG000|Overall Study|Lost to Follow-up|18|||
131617906|NCT00454194|473892525|FG000|Overall Study|Other Unspecified Reason|2|||
131617907|NCT00454194|473892526|FG001|Overall Study|Other Unspecified Reason|2|||
131617908|NCT02827201|473892527|FG000|Overall Study|Death|1|||
131617909|NCT02827201|473892528|FG001|Overall Study|Death|2|||
131617910|NCT02827201|473892527|FG000|Overall Study|Patients not treated|1|||
131617911|NCT02827201|473892528|FG001|Overall Study|Patients not treated|1|||
131617912|NCT00620854|473892529|FG000|Washout 1|Withdrawal by Subject|0|||
131617913|NCT00620854|473892530|FG001|Washout 1|Withdrawal by Subject|0|||
131617914|NCT00620854|473892531|FG002|Washout 1|Withdrawal by Subject|1|||
131617915|NCT00620854|473892532|FG003|Washout 1|Withdrawal by Subject|1|||
131617916|NCT00620854|473892533|FG004|Washout 1|Withdrawal by Subject|0|||
131617917|NCT00620854|473892534|FG005|Washout 1|Withdrawal by Subject|0|||
131617918|NCT03057600|473892537|FG000|Overall Study|Adverse Event|0|||
131617919|NCT03057600|473892538|FG001|Overall Study|Adverse Event|0|||
131617920|NCT03057600|473892539|FG002|Overall Study|Adverse Event|4|||
131617921|NCT03057600|473892540|FG003|Overall Study|Adverse Event|0|||
131617922|NCT03057600|473892537|FG000|Overall Study|Radiologic Disease Progression|8|||
131617923|NCT03057600|473892538|FG001|Overall Study|Radiologic Disease Progression|7|||
131617924|NCT03057600|473892539|FG002|Overall Study|Radiologic Disease Progression|13|||
131617925|NCT03057600|473892540|FG003|Overall Study|Radiologic Disease Progression|10|||
131617926|NCT03057600|473892537|FG000|Overall Study|Symptomatic Deterioration|0|||
131617927|NCT03057600|473892538|FG001|Overall Study|Symptomatic Deterioration|1|||
131617928|NCT03057600|473892539|FG002|Overall Study|Symptomatic Deterioration|1|||
131617929|NCT03057600|473892540|FG003|Overall Study|Symptomatic Deterioration|0|||
131617930|NCT03057600|473892537|FG000|Overall Study|Investigator Decision|0|||
131617931|NCT03057600|473892538|FG001|Overall Study|Investigator Decision|0|||
131617932|NCT03057600|473892539|FG002|Overall Study|Investigator Decision|1|||
131617933|NCT03057600|473892540|FG003|Overall Study|Investigator Decision|0|||
131617934|NCT03057600|473892537|FG000|Overall Study|Study Termination by Sponsor|0|||
131617935|NCT03057600|473892538|FG001|Overall Study|Study Termination by Sponsor|0|||
131617936|NCT03057600|473892539|FG002|Overall Study|Study Termination by Sponsor|0|||
131617937|NCT03057600|473892540|FG003|Overall Study|Study Termination by Sponsor|2|||
131617938|NCT03057600|473892537|FG000|Overall Study|Withdrawal by Subject|0|||
131617939|NCT03057600|473892538|FG001|Overall Study|Withdrawal by Subject|1|||
131617940|NCT03057600|473892539|FG002|Overall Study|Withdrawal by Subject|0|||
131617941|NCT03057600|473892540|FG003|Overall Study|Withdrawal by Subject|0|||
131617942|NCT03057600|473892537|FG000|Overall Study|Other, Not Specified|1|||
131617943|NCT03057600|473892538|FG001|Overall Study|Other, Not Specified|1|||
131617944|NCT03057600|473892539|FG002|Overall Study|Other, Not Specified|1|||
131617945|NCT03057600|473892540|FG003|Overall Study|Other, Not Specified|1|||
131617946|NCT01957163|473892547|FG000|Overall Study|Adverse Event|5|||
131617947|NCT01957163|473892548|FG001|Overall Study|Adverse Event|2|||
131617948|NCT01957163|473892549|FG002|Overall Study|Adverse Event|4|||
131617949|NCT01957163|473892547|FG000|Overall Study|Lack of Efficacy|5|||
131617950|NCT01957163|473892548|FG001|Overall Study|Lack of Efficacy|4|||
131795477|NCT01725451|474534026|FG000|Period 4|Adverse Event|0|||
131795478|NCT01725451|474534027|FG001|Period 4|Adverse Event|0|||
131795479|NCT01725451|474534028|FG002|Period 4|Adverse Event|1|||
131795480|NCT01725451|474534029|FG003|Period 4|Adverse Event|0|||
131795481|NCT00283686|474534031|FG000|Overall Study|Death|1|||
131795482|NCT00283686|474534032|FG001|Overall Study|Death|1|||
131795483|NCT00283686|474534033|FG002|Overall Study|Death|1|||
131795484|NCT00283686|474534034|FG003|Overall Study|Death|0|||
131795485|NCT00283686|474534031|FG000|Overall Study|Lost to Follow-up|21|||
131795486|NCT00283686|474534032|FG001|Overall Study|Lost to Follow-up|31|||
131795487|NCT00283686|474534033|FG002|Overall Study|Lost to Follow-up|26|||
131795488|NCT00283686|474534034|FG003|Overall Study|Lost to Follow-up|20|||
131795489|NCT00283686|474534031|FG000|Overall Study|Less than full participation|7|||
131795490|NCT00283686|474534032|FG001|Overall Study|Less than full participation|9|||
131795491|NCT00283686|474534033|FG002|Overall Study|Less than full participation|6|||
131795492|NCT00283686|474534034|FG003|Overall Study|Less than full participation|12|||
131795493|NCT02970669|474534035|FG000|Double-blind Period|Adverse Event|4|||
131795494|NCT02970669|474534036|FG001|Double-blind Period|Adverse Event|0|||
131795495|NCT02970669|474534035|FG000|Double-blind Period|Death|1|||
131617951|NCT01957163|473892549|FG002|Overall Study|Lack of Efficacy|9|||
131617952|NCT01957163|473892547|FG000|Overall Study|Protocol Violation|1|||
131617953|NCT01957163|473892548|FG001|Overall Study|Protocol Violation|2|||
131617954|NCT01957163|473892549|FG002|Overall Study|Protocol Violation|0|||
131617955|NCT01957163|473892547|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
131617956|NCT01957163|473892548|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
131617957|NCT01957163|473892549|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
131795496|NCT02970669|474534036|FG001|Double-blind Period|Death|0|||
131617958|NCT01957163|473892547|FG000|Overall Study|Lost to Follow-up|0|||
131795497|NCT02970669|474534035|FG000|Double-blind Period|Study terminated by sponsor|1|||
131795498|NCT02970669|474534036|FG001|Double-blind Period|Study terminated by sponsor|2|||
131795499|NCT02970669|474534035|FG000|Double-blind Period|Physician Decision|0|||
131617959|NCT01957163|473892548|FG001|Overall Study|Lost to Follow-up|1|||
131617960|NCT01957163|473892549|FG002|Overall Study|Lost to Follow-up|0|||
131617961|NCT01957163|473892547|FG000|Overall Study|Withdrawal by Subject|4|||
131617962|NCT01957163|473892548|FG001|Overall Study|Withdrawal by Subject|2|||
131617963|NCT01957163|473892549|FG002|Overall Study|Withdrawal by Subject|4|||
131617964|NCT01065779|473892550|FG000|Overall Study|Duplicate Investigation|1|||
131617965|NCT01065779|473892550|FG000|Overall Study|Investigation Before Contract Date|37|||
131617966|NCT01065779|473892550|FG000|Overall Study|Non-enrollment Period Administration|10|||
131617967|NCT01065779|473892550|FG000|Overall Study|Not Administered With Study Drug|17|||
131617968|NCT01065779|473892550|FG000|Overall Study|Failed to Follow-up|10|||
131617969|NCT01065779|473892550|FG000|Overall Study|Inclusion Criteria Violation|7|||
131617970|NCT00641537|473892551|FG000|96-week Period|Adverse Event|0|||
131617971|NCT00641537|473892552|FG001|96-week Period|Adverse Event|1|||
131617972|NCT00641537|473892553|FG002|96-week Period|Adverse Event|3|||
131617973|NCT00641537|473892554|FG003|96-week Period|Adverse Event|0|||
131617974|NCT00641537|473892555|FG004|96-week Period|Adverse Event|2|||
131617975|NCT00641537|473892556|FG005|96-week Period|Adverse Event|0|||
131617976|NCT00641537|473892557|FG006|96-week Period|Adverse Event|0|||
131617977|NCT00641537|473892558|FG007|96-week Period|Adverse Event|0|||
131617978|NCT00641537|473892551|FG000|96-week Period|Lost to Follow-up|3|||
131617979|NCT00641537|473892552|FG001|96-week Period|Lost to Follow-up|1|||
131617980|NCT00641537|473892553|FG002|96-week Period|Lost to Follow-up|2|||
131617981|NCT00641537|473892554|FG003|96-week Period|Lost to Follow-up|2|||
131617982|NCT00641537|473892555|FG004|96-week Period|Lost to Follow-up|4|||
131617983|NCT00641537|473892556|FG005|96-week Period|Lost to Follow-up|0|||
131617984|NCT00641537|473892557|FG006|96-week Period|Lost to Follow-up|1|||
131617985|NCT00641537|473892558|FG007|96-week Period|Lost to Follow-up|0|||
131617986|NCT00641537|473892551|FG000|96-week Period|Protocol Violation|0|||
131617987|NCT00641537|473892552|FG001|96-week Period|Protocol Violation|1|||
131617988|NCT00641537|473892553|FG002|96-week Period|Protocol Violation|0|||
131617989|NCT00641537|473892554|FG003|96-week Period|Protocol Violation|1|||
131617990|NCT00641537|473892555|FG004|96-week Period|Protocol Violation|0|||
131617991|NCT00641537|473892556|FG005|96-week Period|Protocol Violation|1|||
131617992|NCT00641537|473892557|FG006|96-week Period|Protocol Violation|0|||
131617993|NCT00641537|473892558|FG007|96-week Period|Protocol Violation|0|||
131617994|NCT00641537|473892551|FG000|96-week Period|Death|2|||
131617995|NCT00641537|473892552|FG001|96-week Period|Death|0|||
131617996|NCT00641537|473892553|FG002|96-week Period|Death|1|||
131617997|NCT00641537|473892554|FG003|96-week Period|Death|0|||
131617998|NCT00641537|473892555|FG004|96-week Period|Death|0|||
131617999|NCT00641537|473892556|FG005|96-week Period|Death|0|||
131618000|NCT00641537|473892557|FG006|96-week Period|Death|0|||
131618001|NCT00641537|473892558|FG007|96-week Period|Death|0|||
131618002|NCT00641537|473892551|FG000|96-week Period|Other|4|||
131618003|NCT00641537|473892552|FG001|96-week Period|Other|7|||
131618004|NCT00641537|473892553|FG002|96-week Period|Other|14|||
131618005|NCT00641537|473892554|FG003|96-week Period|Other|9|||
131618006|NCT00641537|473892555|FG004|96-week Period|Other|11|||
131618007|NCT00641537|473892556|FG005|96-week Period|Other|6|||
131618008|NCT00641537|473892557|FG006|96-week Period|Other|4|||
131618009|NCT00641537|473892558|FG007|96-week Period|Other|6|||
131618010|NCT00641537|473892551|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
131618011|NCT00641537|473892552|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
131618012|NCT00641537|473892553|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
131618013|NCT00641537|473892554|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
131618014|NCT00641537|473892555|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
131618015|NCT00641537|473892556|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
131618016|NCT00641537|473892557|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
131618017|NCT00641537|473892558|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
131618018|NCT00641537|473892551|FG000|24-Week Supplemental Follow-up Period|Other|0|||
131618019|NCT00641537|473892552|FG001|24-Week Supplemental Follow-up Period|Other|2|||
131618020|NCT00641537|473892553|FG002|24-Week Supplemental Follow-up Period|Other|2|||
131618021|NCT00641537|473892554|FG003|24-Week Supplemental Follow-up Period|Other|1|||
131618022|NCT00641537|473892555|FG004|24-Week Supplemental Follow-up Period|Other|3|||
131618023|NCT00641537|473892556|FG005|24-Week Supplemental Follow-up Period|Other|0|||
131618024|NCT00641537|473892557|FG006|24-Week Supplemental Follow-up Period|Other|1|||
131618025|NCT00641537|473892558|FG007|24-Week Supplemental Follow-up Period|Other|1|||
131618026|NCT01801007|473892559|FG000|Overall Study|Adverse Event|2|||
131618027|NCT01801007|473892559|FG000|Overall Study|Lost to Follow-up|4|||
131618028|NCT01801007|473892559|FG000|Overall Study|Withdrawal by Subject|5|||
131618029|NCT00665392|473892560|FG000|Overall Study|not treated|1|||
131709773|NCT00238264|474217734|FG000|Overall Study|Withdrawal by Subject|4|||
131618030|NCT01321073|473892566|FG000|Overall Study|Did not attempt implant|4|||
131618031|NCT01321073|473892566|FG000|Overall Study|Death|3|||
131618032|NCT05352230|473892575|FG000|First Intervention (3 Months)|study terminated|2|||
131618033|NCT05352230|473892576|FG001|First Intervention (3 Months)|study terminated|2|||
131618034|NCT03697603|473892577|FG000|Overall Study|Adverse Event|3|||
131618035|NCT03697603|473892578|FG001|Overall Study|Adverse Event|18|||
131618036|NCT03697603|473892579|FG002|Overall Study|Adverse Event|3|||
131618037|NCT03697603|473892577|FG000|Overall Study|Physician Decision|1|||
131618038|NCT03697603|473892578|FG001|Overall Study|Physician Decision|0|||
131618039|NCT03697603|473892579|FG002|Overall Study|Physician Decision|2|||
131709774|NCT00238264|474217734|FG000|Overall Study|Ineligible|7|||
131709775|NCT00885365|474217737|FG000|4 Weeks ON Treatment|Adverse Event|2|||
131709776|NCT00885365|474217738|FG001|4 Weeks ON Treatment|Adverse Event|4|||
131709777|NCT00885365|474217737|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
131709778|NCT00885365|474217738|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
131709779|NCT00885365|474217737|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
131709780|NCT00885365|474217738|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
131709781|NCT02978222|474217743|FG000|Overall Study|Withdrawal by Subject|2|||
131709782|NCT02978222|474217744|FG001|Overall Study|Withdrawal by Subject|2|||
131709783|NCT02978222|474217743|FG000|Overall Study|Physician Decision|2|||
131709784|NCT02978222|474217744|FG001|Overall Study|Physician Decision|0|||
131709785|NCT02978222|474217743|FG000|Overall Study|Adverse Event|0|||
131709786|NCT02978222|474217744|FG001|Overall Study|Adverse Event|1|||
131709787|NCT02978222|474217743|FG000|Overall Study|Death|1|||
131709788|NCT02978222|474217744|FG001|Overall Study|Death|0|||
131709789|NCT02978222|474217743|FG000|Overall Study|Disease Progression|32|||
131709790|NCT02978222|474217744|FG001|Overall Study|Disease Progression|32|||
131618040|NCT03697603|473892577|FG000|Overall Study|Protocol Violation|3|||
131618041|NCT03697603|473892578|FG001|Overall Study|Protocol Violation|8|||
131618042|NCT03697603|473892579|FG002|Overall Study|Protocol Violation|5|||
131618043|NCT03697603|473892577|FG000|Overall Study|Withdrawal by Subject|5|||
131618044|NCT03697603|473892578|FG001|Overall Study|Withdrawal by Subject|1|||
131618045|NCT03697603|473892579|FG002|Overall Study|Withdrawal by Subject|1|||
131618046|NCT03697603|473892577|FG000|Overall Study|Protocol Violation|0|||
131618047|NCT03697603|473892578|FG001|Overall Study|Protocol Violation|0|||
131618048|NCT03697603|473892579|FG002|Overall Study|Protocol Violation|1|||
131618049|NCT02686658|473892580|FG000|Overall Study|Adverse Event|0|||
131618050|NCT02686658|473892581|FG001|Overall Study|Adverse Event|0|||
131618051|NCT02686658|473892582|FG002|Overall Study|Adverse Event|1|||
131618052|NCT02686658|473892583|FG003|Overall Study|Adverse Event|1|||
131618053|NCT02686658|473892584|FG004|Overall Study|Adverse Event|2|||
131618054|NCT02686658|473892585|FG005|Overall Study|Adverse Event|1|||
131618055|NCT02686658|473892580|FG000|Overall Study|Investigator decision|0|||
131618056|NCT02686658|473892581|FG001|Overall Study|Investigator decision|0|||
131618057|NCT02686658|473892582|FG002|Overall Study|Investigator decision|0|||
131618058|NCT02686658|473892583|FG003|Overall Study|Investigator decision|1|||
131618059|NCT02686658|473892584|FG004|Overall Study|Investigator decision|2|||
131618060|NCT02686658|473892585|FG005|Overall Study|Investigator decision|1|||
131618061|NCT02686658|473892580|FG000|Overall Study|Sponsor decision|1|||
131618062|NCT02686658|473892581|FG001|Overall Study|Sponsor decision|2|||
131618063|NCT02686658|473892582|FG002|Overall Study|Sponsor decision|1|||
131618064|NCT02686658|473892583|FG003|Overall Study|Sponsor decision|5|||
131618065|NCT02686658|473892584|FG004|Overall Study|Sponsor decision|13|||
131618066|NCT02686658|473892585|FG005|Overall Study|Sponsor decision|2|||
131618067|NCT02686658|473892580|FG000|Overall Study|Lost to Follow-up|0|||
131618068|NCT02686658|473892581|FG001|Overall Study|Lost to Follow-up|0|||
131618069|NCT02686658|473892582|FG002|Overall Study|Lost to Follow-up|2|||
131618070|NCT02686658|473892583|FG003|Overall Study|Lost to Follow-up|0|||
131618071|NCT02686658|473892584|FG004|Overall Study|Lost to Follow-up|0|||
131618072|NCT02686658|473892585|FG005|Overall Study|Lost to Follow-up|1|||
131618073|NCT02686658|473892580|FG000|Overall Study|Death|1|||
131618074|NCT02686658|473892581|FG001|Overall Study|Death|0|||
131618075|NCT02686658|473892582|FG002|Overall Study|Death|0|||
131618076|NCT02686658|473892583|FG003|Overall Study|Death|1|||
131618077|NCT02686658|473892584|FG004|Overall Study|Death|1|||
131618078|NCT02686658|473892585|FG005|Overall Study|Death|1|||
131618079|NCT02686658|473892580|FG000|Overall Study|Withdrawal by Subject|2|||
131618080|NCT02686658|473892581|FG001|Overall Study|Withdrawal by Subject|5|||
131618081|NCT02686658|473892582|FG002|Overall Study|Withdrawal by Subject|4|||
131618082|NCT02686658|473892583|FG003|Overall Study|Withdrawal by Subject|4|||
131618083|NCT02686658|473892584|FG004|Overall Study|Withdrawal by Subject|17|||
131618084|NCT02686658|473892585|FG005|Overall Study|Withdrawal by Subject|8|||
131709791|NCT02978222|474217743|FG000|Overall Study|Early Study Termination|24|||
131709792|NCT02978222|474217744|FG001|Overall Study|Early Study Termination|21|||
131709793|NCT01686568|474217745|FG000|Main Study|Withdrawal by Subject|1|||
131618085|NCT02686658|473892580|FG000|Overall Study|Placed in hospice care|0|||
131618086|NCT02686658|473892581|FG001|Overall Study|Placed in hospice care|0|||
131618087|NCT02686658|473892582|FG002|Overall Study|Placed in hospice care|1|||
131618088|NCT02686658|473892583|FG003|Overall Study|Placed in hospice care|0|||
131618089|NCT02686658|473892584|FG004|Overall Study|Placed in hospice care|0|||
131618090|NCT02686658|473892585|FG005|Overall Study|Placed in hospice care|0|||
131618091|NCT02686658|473892580|FG000|Overall Study|Participant non-compliance|0|||
131443944|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
131443945|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
131618092|NCT02686658|473892581|FG001|Overall Study|Participant non-compliance|0|||
131618093|NCT02686658|473892582|FG002|Overall Study|Participant non-compliance|0|||
131618094|NCT02686658|473892583|FG003|Overall Study|Participant non-compliance|0|||
131618095|NCT02686658|473892584|FG004|Overall Study|Participant non-compliance|0|||
131618096|NCT02686658|473892585|FG005|Overall Study|Participant non-compliance|1|||
131618097|NCT02686658|473892580|FG000|Overall Study|Concern over coronavirus disease care|0|||
131618098|NCT02686658|473892581|FG001|Overall Study|Concern over coronavirus disease care|0|||
131618099|NCT02686658|473892582|FG002|Overall Study|Concern over coronavirus disease care|0|||
131618100|NCT02686658|473892583|FG003|Overall Study|Concern over coronavirus disease care|0|||
131618101|NCT02686658|473892584|FG004|Overall Study|Concern over coronavirus disease care|2|||
131618102|NCT02686658|473892585|FG005|Overall Study|Concern over coronavirus disease care|1|||
131618103|NCT02309294|473892588|FG000|Overall Study|Withdrawal by Subject|2|||
131618104|NCT03520036|473892589|FG000|Overall Study|Adverse Event|1|||
131618105|NCT03520036|473892590|FG001|Overall Study|Adverse Event|2|||
131618106|NCT03520036|473892591|FG002|Overall Study|Adverse Event|0|||
131618107|NCT03520036|473892589|FG000|Overall Study|Protocol Violation|1|||
131618108|NCT03520036|473892590|FG001|Overall Study|Protocol Violation|0|||
131618109|NCT03520036|473892591|FG002|Overall Study|Protocol Violation|0|||
131618110|NCT03520036|473892589|FG000|Overall Study|Withdrawal by Subject|0|||
131618111|NCT03520036|473892590|FG001|Overall Study|Withdrawal by Subject|1|||
131618112|NCT03520036|473892591|FG002|Overall Study|Withdrawal by Subject|4|||
131618113|NCT03520036|473892589|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
131618114|NCT03520036|473892590|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
131618115|NCT03520036|473892591|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
131618116|NCT00467272|473892594|FG000|Overall Study|Pneumonia|2|||
131618117|NCT00467272|473892594|FG000|Overall Study|Thrombophlebitis|1|||
131618118|NCT00570505|473892595|FG000|Overall Study|Adverse Event|7|||
131618119|NCT00570505|473892595|FG000|Overall Study|Withdrawal by Subject|7|||
131618120|NCT00570505|473892595|FG000|Overall Study|Lost to Follow-up|23|||
131618121|NCT00570505|473892595|FG000|Overall Study|Other loss to follow-up|4|||
131618122|NCT00614614|473892596|FG000|Primary Vaccination Phase|Adverse Event|6|||
131618123|NCT00614614|473892597|FG001|Primary Vaccination Phase|Adverse Event|0|||
131618124|NCT00614614|473892598|FG002|Primary Vaccination Phase|Adverse Event|0|||
131618125|NCT00614614|473892599|FG003|Primary Vaccination Phase|Adverse Event|0|||
131618126|NCT00614614|473892600|FG004|Primary Vaccination Phase|Adverse Event|0|||
131618127|NCT00614614|473892596|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
131618128|NCT00614614|473892597|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
131618129|NCT00614614|473892598|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
131618130|NCT00614614|473892599|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
131618131|NCT00614614|473892600|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
131618132|NCT00614614|473892596|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
131618133|NCT00614614|473892597|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
131618134|NCT00614614|473892598|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
131618135|NCT00614614|473892599|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
131618136|NCT00614614|473892600|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
131618137|NCT00614614|473892596|FG000|Primary Vaccination Phase|Protocol Violation|9|||
131618138|NCT00614614|473892597|FG001|Primary Vaccination Phase|Protocol Violation|3|||
131618139|NCT00614614|473892598|FG002|Primary Vaccination Phase|Protocol Violation|0|||
131618140|NCT00614614|473892599|FG003|Primary Vaccination Phase|Protocol Violation|0|||
131618141|NCT00614614|473892600|FG004|Primary Vaccination Phase|Protocol Violation|0|||
131618142|NCT00614614|473892596|FG000|Primary Vaccination Phase|Other|4|||
131618143|NCT00614614|473892597|FG001|Primary Vaccination Phase|Other|0|||
131618144|NCT00614614|473892598|FG002|Primary Vaccination Phase|Other|0|||
131618145|NCT00614614|473892599|FG003|Primary Vaccination Phase|Other|0|||
131618146|NCT00614614|473892600|FG004|Primary Vaccination Phase|Other|0|||
131618147|NCT00614614|473892596|FG000|Booster Vaccination Phase|Adverse Event|0|||
131618148|NCT00614614|473892597|FG001|Booster Vaccination Phase|Adverse Event|0|||
131618149|NCT00614614|473892598|FG002|Booster Vaccination Phase|Adverse Event|1|||
131618150|NCT00614614|473892599|FG003|Booster Vaccination Phase|Adverse Event|1|||
131618151|NCT00614614|473892600|FG004|Booster Vaccination Phase|Adverse Event|0|||
131618152|NCT00614614|473892596|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
131443946|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Death|0|||
131443947|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Death|2|||
131618153|NCT00614614|473892597|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
131618154|NCT00614614|473892598|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
131618155|NCT00614614|473892599|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
131618156|NCT00614614|473892600|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
131618157|NCT00614614|473892596|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
131618158|NCT00614614|473892597|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
131618159|NCT00614614|473892598|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
131618160|NCT00614614|473892599|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
131709794|NCT01686568|474217746|FG001|Main Study|Withdrawal by Subject|3|||
131709795|NCT01686568|474217745|FG000|Main Study|Noncompliance with protocol|0|||
131709796|NCT01686568|474217746|FG001|Main Study|Noncompliance with protocol|1|||
131709797|NCT01686568|474217745|FG000|Main Study|Liver enzymes above range of exclusion|1|||
131709798|NCT01686568|474217746|FG001|Main Study|Liver enzymes above range of exclusion|0|||
131709799|NCT01686568|474217745|FG000|Sub-Study|Not consented for sub-study|2|||
131709800|NCT01686568|474217746|FG001|Sub-Study|Not consented for sub-study|2|||
131709801|NCT02706938|474217747|FG000|First Period, 6 Weeks|Adverse Event|8|||
131709802|NCT02706938|474217748|FG001|First Period, 6 Weeks|Adverse Event|0|||
131709803|NCT02706938|474217747|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
131709804|NCT02706938|474217748|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
131709805|NCT02706938|474217747|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
131709806|NCT02706938|474217748|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
131709807|NCT02706938|474217747|FG000|Second Period, 6 Weeks|Adverse Event|0|||
131709808|NCT02706938|474217748|FG001|Second Period, 6 Weeks|Adverse Event|7|||
131709809|NCT02706938|474217747|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
131795500|NCT02970669|474534036|FG001|Double-blind Period|Physician Decision|2|||
131795501|NCT02970669|474534035|FG000|Double-blind Period|Withdrawal by Subject|2|||
131795502|NCT02970669|474534036|FG001|Double-blind Period|Withdrawal by Subject|2|||
131795503|NCT02970669|474534035|FG000|Open-label Period|Withdrawal by Subject|2|||
131618161|NCT00614614|473892600|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
131618162|NCT00614614|473892596|FG000|Booster Vaccination Phase|Protocol Violation|0|||
131618163|NCT00614614|473892597|FG001|Booster Vaccination Phase|Protocol Violation|0|||
131618164|NCT00614614|473892598|FG002|Booster Vaccination Phase|Protocol Violation|2|||
131618165|NCT00614614|473892599|FG003|Booster Vaccination Phase|Protocol Violation|3|||
131618166|NCT00614614|473892600|FG004|Booster Vaccination Phase|Protocol Violation|0|||
131618167|NCT00614614|473892596|FG000|Booster Vaccination Phase|Other|0|||
131618168|NCT00614614|473892597|FG001|Booster Vaccination Phase|Other|1|||
131618169|NCT00614614|473892598|FG002|Booster Vaccination Phase|Other|3|||
131618170|NCT00614614|473892599|FG003|Booster Vaccination Phase|Other|2|||
131618171|NCT00614614|473892600|FG004|Booster Vaccination Phase|Other|1|||
131618172|NCT05426109|473892601|FG000|Overall Study|Withdrawal by Subject|0|||
131618173|NCT05426109|473892602|FG001|Overall Study|Withdrawal by Subject|1|||
131618174|NCT05212285|473892603|FG000|Overall Study|Lack of Efficacy|12|||
131618175|NCT05212285|473892604|FG001|Overall Study|Lack of Efficacy|8|||
131618176|NCT05212285|473892603|FG000|Overall Study|Withdrawal by Subject|8|||
131618177|NCT05212285|473892604|FG001|Overall Study|Withdrawal by Subject|1|||
131618178|NCT05212285|473892603|FG000|Overall Study|Lost to Follow-up|13|||
131618179|NCT05212285|473892604|FG001|Overall Study|Lost to Follow-up|1|||
131618180|NCT05212285|473892603|FG000|Overall Study|miss data|21|||
131618181|NCT05212285|473892604|FG001|Overall Study|miss data|2|||
131618182|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
131618183|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
131618184|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
131618185|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
131618186|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
131618187|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
131618188|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
131618189|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
131618190|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
131618191|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
131618192|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
131618193|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
131618194|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
131618195|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
131618196|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
131618197|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
131618198|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
131618199|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
131618200|NCT02222493|473892605|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
131618201|NCT02222493|473892606|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
131795504|NCT02970669|474534036|FG001|Open-label Period|Withdrawal by Subject|2|||
131795505|NCT02970669|474534035|FG000|Open-label Period|Adverse Event|1|||
131709810|NCT02706938|474217748|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
131795506|NCT02970669|474534036|FG001|Open-label Period|Adverse Event|0|||
131709811|NCT03838484|474217751|FG000|Overall Study|Lost to Follow-up|0|||
131709812|NCT03838484|474217752|FG001|Overall Study|Lost to Follow-up|1|||
131709813|NCT03838484|474217753|FG002|Overall Study|Lost to Follow-up|0|||
131709814|NCT03838484|474217754|FG003|Overall Study|Lost to Follow-up|0|||
131709815|NCT02507349|474217755|FG000|Overall Study|Death|12|||
131795507|NCT02970669|474534035|FG000|Open-label Period|Physician Decision|1|||
131900896|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131618202|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
131618203|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
131618204|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
131618205|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
131618206|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
131618207|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
131618208|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
131618209|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
131618210|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
131618211|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
131618212|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
131618213|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
131618214|NCT02222493|473892605|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
131618215|NCT02222493|473892606|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
131618216|NCT02222493|473892605|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
131618217|NCT02222493|473892606|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
131618218|NCT02222493|473892605|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
131618219|NCT02222493|473892606|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
131618220|NCT02222493|473892605|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
131618221|NCT02222493|473892606|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
131618222|NCT02222493|473892605|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
131618223|NCT02222493|473892606|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
131618224|NCT02222493|473892605|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
131618225|NCT02222493|473892606|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
131618226|NCT00933270|473892607|FG000|Overall Study|Withdrawal by Subject|26|||
131618227|NCT00933270|473892607|FG000|Overall Study|Insufficient Follow-up|10|||
131618228|NCT00933270|473892607|FG000|Overall Study|Lost to Follow-up|14|||
131618229|NCT00933270|473892607|FG000|Overall Study|Adverse Event|1|||
131618230|NCT00933270|473892607|FG000|Overall Study|Missed Visit|2|||
131618231|NCT00933270|473892607|FG000|Overall Study|Death|24|||
131618232|NCT00933270|473892607|FG000|Overall Study|Moved or would not return|10|||
131618233|NCT01000805|473892608|FG000|Overall Study|Adverse Event|21|||
131618234|NCT01000805|473892609|FG001|Overall Study|Adverse Event|9|||
131618235|NCT01000805|473892608|FG000|Overall Study|Lack of Efficacy|5|||
131618236|NCT01000805|473892609|FG001|Overall Study|Lack of Efficacy|16|||
131618237|NCT01000805|473892608|FG000|Overall Study|Lost to Follow-up|16|||
131618238|NCT01000805|473892609|FG001|Overall Study|Lost to Follow-up|21|||
131618239|NCT01000805|473892608|FG000|Overall Study|Physician Decision|0|||
131618240|NCT01000805|473892609|FG001|Overall Study|Physician Decision|1|||
131618241|NCT01000805|473892608|FG000|Overall Study|Protocol Violation|12|||
131618242|NCT01000805|473892609|FG001|Overall Study|Protocol Violation|8|||
131618243|NCT01000805|473892608|FG000|Overall Study|Withdrawal by Subject|16|||
131618244|NCT01000805|473892609|FG001|Overall Study|Withdrawal by Subject|6|||
131618245|NCT01000805|473892608|FG000|Overall Study|Sponsor Decision|0|||
131618246|NCT01000805|473892609|FG001|Overall Study|Sponsor Decision|1|||
131618247|NCT00989196|473892610|FG000|Treatment Period|Lost to Follow-up|1|||
131618248|NCT00989196|473892611|FG001|Treatment Period|Lost to Follow-up|0|||
131618249|NCT03476798|473892612|FG000|Overall Study|Death|1|||
131618250|NCT03476798|473892612|FG000|Overall Study|Withdrawal by Subject|2|||
131618251|NCT03476798|473892612|FG000|Overall Study|Protocol Violation|2|||
131618252|NCT03343704|473892618|FG000|Overall Study|Refused to complete follow up|0|||
131618253|NCT03343704|473892619|FG001|Overall Study|Refused to complete follow up|1|||
131618254|NCT03343704|473892618|FG000|Overall Study|Death|0|||
131618255|NCT03343704|473892619|FG001|Overall Study|Death|1|||
131618256|NCT03343704|473892618|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
131618257|NCT03343704|473892619|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
131618258|NCT03789656|473892620|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
131618259|NCT03789656|473892621|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
131618260|NCT03789656|473892622|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
131709816|NCT02507349|474217756|FG001|Overall Study|Death|16|||
131618261|NCT03789656|473892623|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
131618262|NCT03789656|473892624|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
131618263|NCT03789656|473892620|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131618264|NCT03789656|473892621|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131618265|NCT03789656|473892622|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
131618266|NCT03789656|473892623|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131618267|NCT03789656|473892624|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131709817|NCT02507349|474217755|FG000|Overall Study|Withdrawal by Subject|1|||
131709818|NCT02507349|474217756|FG001|Overall Study|Withdrawal by Subject|1|||
131618268|NCT03789656|473892620|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
131618269|NCT03789656|473892621|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131618270|NCT03789656|473892622|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131618271|NCT03789656|473892623|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131618272|NCT03789656|473892624|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131618273|NCT03789656|473892620|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
131618274|NCT03789656|473892621|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131618275|NCT03789656|473892622|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131618276|NCT03789656|473892623|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131618277|NCT03789656|473892624|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131618278|NCT02132949|473893695|FG000|Overall Study|Death|7|||
131618279|NCT02132949|473893696|FG001|Overall Study|Death|13|||
131618280|NCT02132949|473893695|FG000|Overall Study|Lost to Follow-up|14|||
131618281|NCT02132949|473893696|FG001|Overall Study|Lost to Follow-up|4|||
131618282|NCT02132949|473893695|FG000|Overall Study|Withdrawal by Subject|6|||
131618283|NCT02132949|473893696|FG001|Overall Study|Withdrawal by Subject|5|||
131618284|NCT02132949|473893695|FG000|Overall Study|Noncompliance|5|||
131618285|NCT02132949|473893696|FG001|Overall Study|Noncompliance|1|||
131618286|NCT02132949|473893695|FG000|Overall Study|Physician Decision|3|||
131618287|NCT02132949|473893696|FG001|Overall Study|Physician Decision|1|||
131618288|NCT02132949|473893695|FG000|Overall Study|Disease Progression|3|||
131618289|NCT02132949|473893696|FG001|Overall Study|Disease Progression|0|||
131618290|NCT02132949|473893695|FG000|Overall Study|Adverse Event|2|||
131618291|NCT02132949|473893696|FG001|Overall Study|Adverse Event|1|||
131618292|NCT02132949|473893695|FG000|Overall Study|Withdrew Prior to Treatment|1|||
131618293|NCT02132949|473893696|FG001|Overall Study|Withdrew Prior to Treatment|2|||
131618294|NCT02132949|473893695|FG000|Overall Study|Reason Unspecified|0|||
131618295|NCT02132949|473893696|FG001|Overall Study|Reason Unspecified|1|||
131618296|NCT03392194|473893703|FG000|Overall Study|Withdrawal by Subject|1|||
131618297|NCT03392194|473893704|FG001|Overall Study|Withdrawal by Subject|2|||
131618298|NCT03392194|473893703|FG000|Overall Study|Conflicts with personal schedule|1|||
131618299|NCT03392194|473893704|FG001|Overall Study|Conflicts with personal schedule|0|||
131618300|NCT03345979|473893709|FG000|Overall Study|Withdrawal by Subject|20|||
131618301|NCT03345979|473893710|FG001|Overall Study|Withdrawal by Subject|31|||
131618302|NCT03345979|473893709|FG000|Overall Study|Adverse Event|10|||
131618303|NCT03345979|473893710|FG001|Overall Study|Adverse Event|11|||
131618304|NCT03345979|473893709|FG000|Overall Study|Lost to Follow-up|8|||
131618305|NCT03345979|473893710|FG001|Overall Study|Lost to Follow-up|9|||
131618306|NCT03345979|473893709|FG000|Overall Study|Lack of Efficacy|4|||
131618307|NCT03345979|473893710|FG001|Overall Study|Lack of Efficacy|2|||
131618308|NCT03345979|473893709|FG000|Overall Study|Protocol Violation|1|||
131618309|NCT03345979|473893710|FG001|Overall Study|Protocol Violation|3|||
131618310|NCT03345979|473893709|FG000|Overall Study|Physician Decision|0|||
131618311|NCT03345979|473893710|FG001|Overall Study|Physician Decision|2|||
131618312|NCT00487240|473893711|FG000|Overall Study|Withdrawal by Subject|12|||
131618313|NCT00487240|473893712|FG001|Overall Study|Withdrawal by Subject|6|||
131618314|NCT00487240|473893711|FG000|Overall Study|Lost to Follow-up|7|||
131618315|NCT00487240|473893712|FG001|Overall Study|Lost to Follow-up|6|||
131618316|NCT00487240|473893711|FG000|Overall Study|Adverse Event|0|||
131618317|NCT00487240|473893712|FG001|Overall Study|Adverse Event|4|||
131618318|NCT00487240|473893711|FG000|Overall Study|Protocol Violation|5|||
131618319|NCT00487240|473893712|FG001|Overall Study|Protocol Violation|5|||
131618320|NCT00487240|473893711|FG000|Overall Study|Entry Criteria Not Met|3|||
131618321|NCT00487240|473893712|FG001|Overall Study|Entry Criteria Not Met|4|||
131618322|NCT00487240|473893711|FG000|Overall Study|Sponsor Decision|2|||
131618323|NCT00487240|473893712|FG001|Overall Study|Sponsor Decision|1|||
131618324|NCT00487240|473893711|FG000|Overall Study|Physician Decision|2|||
131618325|NCT00487240|473893712|FG001|Overall Study|Physician Decision|0|||
131618326|NCT00999596|473893715|FG000|Overall Study|Statistical population not required|101|||
131618327|NCT02095145|473893716|FG000|Overall Study|Withdrawal by Subject|1|||
131618328|NCT02095145|473893717|FG001|Overall Study|Withdrawal by Subject|0|||
131618329|NCT01698918|473893718|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
131618330|NCT01698918|473893718|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
131618331|NCT01698918|473893718|FG000|First Line Treatment (Core+Extension)|Death|2|||
131618332|NCT01698918|473893718|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
131618333|NCT01698918|473893718|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
131618334|NCT01698918|473893718|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
131618335|NCT01698918|473893718|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
131618336|NCT01698918|473893718|FG000|Second Line Treatment (Core+Extension)|Death|1|||
131618337|NCT01698918|473893718|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
131618338|NCT01698918|473893718|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
131618339|NCT01019135|473893719|FG000|Overall Study|Did not receive allocated intervention|12|||
131618340|NCT01019135|473893720|FG001|Overall Study|Did not receive allocated intervention|6|||
131618341|NCT01019135|473893721|FG002|Overall Study|Did not receive allocated intervention|25|||
131618342|NCT01019135|473893719|FG000|Overall Study|Did not attend CR|8|||
131618343|NCT01019135|473893720|FG001|Overall Study|Did not attend CR|13|||
131618344|NCT01019135|473893721|FG002|Overall Study|Did not attend CR|6|||
131618345|NCT02630186|473893722|FG000|Overall Study|Withdrawal by Subject|1|||
131618346|NCT00439218|473893725|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
131618347|NCT01124045|473893730|FG000|Overall Study|Lost to Follow-up|0|||
131618348|NCT01124045|473893731|FG001|Overall Study|Lost to Follow-up|1|||
131618349|NCT01124045|473893730|FG000|Overall Study|Physician Decision|0|||
131618350|NCT01124045|473893731|FG001|Overall Study|Physician Decision|2|||
131618351|NCT03205566|473893735|FG000|Phase 1|Protocol Violation|1|||
131618352|NCT03205566|473893736|FG001|Phase 1|Protocol Violation|1|||
131618353|NCT02384382|473893743|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
131618354|NCT02384382|473893743|FG000|Overall Study|Death|1|||
131618355|NCT02384382|473893743|FG000|Overall Study|Adverse Event|1|||
131618356|NCT02384382|473893743|FG000|Overall Study|Disease progression|16|||
131618357|NCT01074242|473893752|FG000|Overall Study|Case report before date of contract|40|||
131618358|NCT01074242|473893752|FG000|Overall Study|Lost to Follow-up|1|||
131618359|NCT01074242|473893752|FG000|Overall Study|Case report unclear|6|||
131618360|NCT01074242|473893752|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
131618361|NCT01074242|473893752|FG000|Overall Study|Duplicate Case Report Form|5|||
131618362|NCT00109031|473893753|FG000|Overall Study|Adverse Event|0|||
131618363|NCT00109031|473893754|FG001|Overall Study|Adverse Event|0|||
131618364|NCT00109031|473893755|FG002|Overall Study|Adverse Event|1|||
131618365|NCT00109031|473893756|FG003|Overall Study|Adverse Event|0|||
131618366|NCT00109031|473893753|FG000|Overall Study|Withdrawal by Subject|0|||
131618367|NCT00109031|473893754|FG001|Overall Study|Withdrawal by Subject|1|||
131618368|NCT00109031|473893755|FG002|Overall Study|Withdrawal by Subject|0|||
131618369|NCT00109031|473893756|FG003|Overall Study|Withdrawal by Subject|0|||
131618370|NCT00109031|473893753|FG000|Overall Study|Physician Decision|0|||
131618371|NCT00109031|473893754|FG001|Overall Study|Physician Decision|1|||
131618372|NCT00109031|473893755|FG002|Overall Study|Physician Decision|0|||
131618373|NCT00109031|473893756|FG003|Overall Study|Physician Decision|0|||
131618374|NCT00109031|473893753|FG000|Overall Study|Protocol Violation|0|||
131618375|NCT00109031|473893754|FG001|Overall Study|Protocol Violation|0|||
131618376|NCT00109031|473893755|FG002|Overall Study|Protocol Violation|1|||
131618377|NCT00109031|473893756|FG003|Overall Study|Protocol Violation|0|||
131618378|NCT04218864|473893764|FG000|Overall Study|Lost to Follow-up|8|||
131618379|NCT04218864|473893765|FG001|Overall Study|Lost to Follow-up|4|||
131618380|NCT04218864|473893764|FG000|Overall Study|Withdrawal by Subject|1|||
131618381|NCT04218864|473893765|FG001|Overall Study|Withdrawal by Subject|3|||
131618382|NCT03924869|473893770|FG000|Overall Study|Death|66|||
131618383|NCT03924869|473893771|FG001|Overall Study|Death|53|||
131618384|NCT03924869|473893770|FG000|Overall Study|Lost to Follow-up|2|||
131618385|NCT03924869|473893771|FG001|Overall Study|Lost to Follow-up|0|||
131618386|NCT03924869|473893770|FG000|Overall Study|Physician Decision|0|||
131618387|NCT03924869|473893771|FG001|Overall Study|Physician Decision|3|||
131618388|NCT03924869|473893770|FG000|Overall Study|Withdrawal by Subject|5|||
131618389|NCT03924869|473893771|FG001|Overall Study|Withdrawal by Subject|1|||
131618390|NCT03924869|473893770|FG000|Overall Study|Participants Ongoing|154|||
131618391|NCT03924869|473893771|FG001|Overall Study|Participants Ongoing|164|||
131618392|NCT02542943|473893772|FG000|Overall Study|Lost to Follow-up|1|||
131618393|NCT02542943|473893773|FG001|Overall Study|Lost to Follow-up|0|||
131618394|NCT02542943|473893774|FG002|Overall Study|Lost to Follow-up|0|||
131618395|NCT02542943|473893772|FG000|Overall Study|Withdrawal by Subject|0|||
131618396|NCT02542943|473893773|FG001|Overall Study|Withdrawal by Subject|1|||
131618397|NCT02542943|473893774|FG002|Overall Study|Withdrawal by Subject|0|||
131618398|NCT05865392|473893783|FG000|Overall Study|Withdrawal by Subject|4|||
131618399|NCT05865392|473893784|FG001|Overall Study|Withdrawal by Subject|0|||
131618400|NCT05865392|473893783|FG000|Overall Study|Didn't meet inclusion criteria|4|||
131618401|NCT05865392|473893784|FG001|Overall Study|Didn't meet inclusion criteria|0|||
131618402|NCT02434328|473893787|FG000|Overall Study|Adverse Event|9|||
131618403|NCT02434328|473893788|FG001|Overall Study|Adverse Event|4|||
131618404|NCT02434328|473893787|FG000|Overall Study|Lack of Efficacy|0|||
131618405|NCT02434328|473893788|FG001|Overall Study|Lack of Efficacy|2|||
131618406|NCT02434328|473893787|FG000|Overall Study|Physician Decision|0|||
131618407|NCT02434328|473893788|FG001|Overall Study|Physician Decision|1|||
131618408|NCT02434328|473893787|FG000|Overall Study|Withdrawal by Subject|12|||
131618409|NCT02434328|473893788|FG001|Overall Study|Withdrawal by Subject|21|||
131618410|NCT02434328|473893787|FG000|Overall Study|Death|4|||
131618411|NCT02434328|473893788|FG001|Overall Study|Death|7|||
131618412|NCT02434328|473893787|FG000|Overall Study|Lost to Follow-up|1|||
131618413|NCT02434328|473893788|FG001|Overall Study|Lost to Follow-up|6|||
131618414|NCT02434328|473893787|FG000|Overall Study|Other|4|||
131618415|NCT02434328|473893788|FG001|Overall Study|Other|1|||
131618416|NCT02556918|473895334|FG000|Overall Study|Protocol Violation|5|||
131618417|NCT02556918|473895335|FG001|Overall Study|Protocol Violation|6|||
131618418|NCT02556918|473895334|FG000|Overall Study|Withdrawal by Subject|4|||
131618419|NCT02556918|473895335|FG001|Overall Study|Withdrawal by Subject|4|||
131618420|NCT02637063|473895346|FG000|Overall Study|Lost to Follow-up|3|||
131618421|NCT02637063|473895347|FG001|Overall Study|Lost to Follow-up|2|||
131618422|NCT02637063|473895348|FG002|Overall Study|Lost to Follow-up|3|||
131618423|NCT02637063|473895346|FG000|Overall Study|Withdrawal by Subject|2|||
131618424|NCT02637063|473895347|FG001|Overall Study|Withdrawal by Subject|2|||
131618425|NCT02637063|473895348|FG002|Overall Study|Withdrawal by Subject|3|||
131618426|NCT02634307|473895349|FG000|Overall Study|Adverse Event|50|||
131618427|NCT02634307|473895350|FG001|Overall Study|Adverse Event|24|||
131618428|NCT02634307|473895351|FG002|Overall Study|Adverse Event|14|||
131618429|NCT02634307|473895349|FG000|Overall Study|Lost to Follow-up|21|||
131618430|NCT02634307|473895350|FG001|Overall Study|Lost to Follow-up|5|||
131618431|NCT02634307|473895351|FG002|Overall Study|Lost to Follow-up|6|||
131618432|NCT02634307|473895349|FG000|Overall Study|Pregnancy|5|||
131618433|NCT02634307|473895350|FG001|Overall Study|Pregnancy|1|||
131618434|NCT02634307|473895351|FG002|Overall Study|Pregnancy|3|||
131618435|NCT02634307|473895349|FG000|Overall Study|Withdrawal by Subject|38|||
131618436|NCT02634307|473895350|FG001|Overall Study|Withdrawal by Subject|24|||
131618437|NCT02634307|473895351|FG002|Overall Study|Withdrawal by Subject|18|||
131618438|NCT02634307|473895349|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131618439|NCT02634307|473895350|FG001|Overall Study|Non-Compliance with Study Drug|2|||
131618440|NCT02634307|473895351|FG002|Overall Study|Non-Compliance with Study Drug|2|||
131618441|NCT02634307|473895349|FG000|Overall Study|Lack of Efficacy|1|||
131618442|NCT02634307|473895350|FG001|Overall Study|Lack of Efficacy|5|||
131618443|NCT02634307|473895351|FG002|Overall Study|Lack of Efficacy|3|||
131618444|NCT02634307|473895349|FG000|Overall Study|Physician Decision|7|||
131618445|NCT02634307|473895350|FG001|Overall Study|Physician Decision|5|||
131618446|NCT02634307|473895351|FG002|Overall Study|Physician Decision|5|||
131618447|NCT02634307|473895349|FG000|Overall Study|Reason not Specified|3|||
131618448|NCT02634307|473895350|FG001|Overall Study|Reason not Specified|5|||
131618449|NCT02634307|473895351|FG002|Overall Study|Reason not Specified|10|||
131618450|NCT02698475|473895352|FG000|Main Study Period|Lack of Efficacy|1|||
131618451|NCT02698475|473895352|FG000|Main Study Period|Protocol Violation|2|||
131618452|NCT02698475|473895352|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
131618453|NCT02698475|473895352|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
131618454|NCT02698475|473895352|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
131618455|NCT02698475|473895352|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
131618456|NCT02698475|473895352|FG000|Long-Term Extension Period|Other|1|||
131618457|NCT01673594|473895353|FG000|Overall Study|Adverse Event|3|||
131618458|NCT01673594|473895354|FG001|Overall Study|Adverse Event|1|||
131618459|NCT01673594|473895353|FG000|Overall Study|Lost to Follow-up|1|||
131618460|NCT01673594|473895354|FG001|Overall Study|Lost to Follow-up|0|||
131618461|NCT01673594|473895353|FG000|Overall Study|Physician Decision|2|||
131618462|NCT01673594|473895354|FG001|Overall Study|Physician Decision|4|||
131618463|NCT01673594|473895353|FG000|Overall Study|Withdrawal by Subject|0|||
131618464|NCT01673594|473895354|FG001|Overall Study|Withdrawal by Subject|1|||
131618465|NCT03865732|473895356|FG000|Overall Study|Adverse Event|0|||
131618466|NCT03865732|473895357|FG001|Overall Study|Adverse Event|1|||
131618467|NCT03176407|473895358|FG000|Overall Study|Protocol Violation|1|||
131618468|NCT03176407|473895358|FG000|Overall Study|human failure|1|||
131618469|NCT03176407|473895358|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
131618470|NCT01428583|473895360|FG000|Overall Study|Adverse Event|75|||
131618471|NCT01428583|473895360|FG000|Overall Study|Withdrawal by Subject|51|||
131618472|NCT01428583|473895360|FG000|Overall Study|Lack of Efficacy|37|||
131618473|NCT01428583|473895360|FG000|Overall Study|Lost to Follow-up|17|||
131618474|NCT01428583|473895360|FG000|Overall Study|Death|1|||
131618475|NCT01428583|473895360|FG000|Overall Study|Pregnancy|1|||
131618476|NCT01428583|473895360|FG000|Overall Study|Protocol Violation|1|||
131618477|NCT01428583|473895360|FG000|Overall Study|Physician Decision|12|||
131618478|NCT01428583|473895360|FG000|Overall Study|Non-compliant|25|||
131618479|NCT01428583|473895360|FG000|Overall Study|Confirmed positive urine drug test|8|||
131618480|NCT01428583|473895360|FG000|Overall Study|Sponsor's request|3|||
131618481|NCT01428583|473895360|FG000|Overall Study|Other|6|||
131618482|NCT00670488|473895361|FG000|Overall Study|Adverse Event|0|||
131618483|NCT00670488|473895362|FG001|Overall Study|Adverse Event|7|||
131618484|NCT00670488|473895363|FG002|Overall Study|Adverse Event|0|||
131795508|NCT02970669|474534036|FG001|Open-label Period|Physician Decision|0|||
131795509|NCT03521999|474534037|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
131795510|NCT03521999|474534038|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
131795511|NCT03521999|474534037|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
131795512|NCT03521999|474534038|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
131795513|NCT03521999|474534037|FG000|Completed 3 Month Follow up|Death|0|||
131618485|NCT00670488|473895364|FG003|Overall Study|Adverse Event|3|||
131618486|NCT00670488|473895365|FG004|Overall Study|Adverse Event|1|||
131618487|NCT00670488|473895366|FG005|Overall Study|Adverse Event|1|||
131618488|NCT00670488|473895367|FG006|Overall Study|Adverse Event|5|||
131618489|NCT00670488|473895368|FG007|Overall Study|Adverse Event|1|||
131618490|NCT00670488|473895369|FG008|Overall Study|Adverse Event|0|||
131618491|NCT00670488|473895370|FG009|Overall Study|Adverse Event|1|||
131618492|NCT00670488|473895361|FG000|Overall Study|Physician Decision|1|||
131709819|NCT02507349|474217755|FG000|Overall Study|Lost to Follow-up|174|||
131709820|NCT02507349|474217756|FG001|Overall Study|Lost to Follow-up|144|||
131709821|NCT00813995|474217757|FG000|Overall Study|Clinical adverse event|9|||
131709822|NCT00813995|474217758|FG001|Overall Study|Clinical adverse event|3|||
131709823|NCT00813995|474217757|FG000|Overall Study|Laboratory adverse event|0|||
131709824|NCT00813995|474217758|FG001|Overall Study|Laboratory adverse event|2|||
131709825|NCT00813995|474217757|FG000|Overall Study|Lack of Efficacy|1|||
131709826|NCT00813995|474217758|FG001|Overall Study|Lack of Efficacy|0|||
131709827|NCT00813995|474217757|FG000|Overall Study|Lost to Follow-up|4|||
131709828|NCT00813995|474217758|FG001|Overall Study|Lost to Follow-up|2|||
131709829|NCT00813995|474217757|FG000|Overall Study|Other reason|2|||
131709830|NCT00813995|474217758|FG001|Overall Study|Other reason|2|||
131709831|NCT00813995|474217757|FG000|Overall Study|Protocol Violation|3|||
131709832|NCT00813995|474217758|FG001|Overall Study|Protocol Violation|2|||
131709833|NCT00813995|474217757|FG000|Overall Study|Subject moved|4|||
131709834|NCT00813995|474217758|FG001|Overall Study|Subject moved|0|||
131709835|NCT00813995|474217757|FG000|Overall Study|Withdrawal by Subject|0|||
131709836|NCT00813995|474217758|FG001|Overall Study|Withdrawal by Subject|5|||
131709837|NCT01614964|474217759|FG000|Overall Study|Withdrawal by Subject|2|||
131709838|NCT01614964|474217760|FG001|Overall Study|Withdrawal by Subject|0|||
131709839|NCT01614964|474217759|FG000|Overall Study|Lost to Follow-up|3|||
131709840|NCT01614964|474217760|FG001|Overall Study|Lost to Follow-up|0|||
131709841|NCT00860470|474217769|FG000|Overall Study|Death|6|||
131709842|NCT00860470|474217770|FG001|Overall Study|Death|10|||
131709843|NCT00860470|474217769|FG000|Overall Study|Moved away|8|||
131709844|NCT00860470|474217770|FG001|Overall Study|Moved away|10|||
131709845|NCT00860470|474217769|FG000|Overall Study|Lost to Follow-up|34|||
131709846|NCT00860470|474217770|FG001|Overall Study|Lost to Follow-up|39|||
131709847|NCT00888238|474217772|FG000|Washout Period After Period 2|Adverse Event|0|||
131709848|NCT00888238|474217773|FG001|Washout Period After Period 2|Adverse Event|0|||
131709849|NCT00888238|474217774|FG002|Washout Period After Period 2|Adverse Event|1|||
131709850|NCT02700984|474217775|FG000|Overall Study|Death|2|||
131709851|NCT02700984|474217776|FG001|Overall Study|Death|1|||
131709852|NCT02700984|474217775|FG000|Overall Study|Lost to Follow-up|2|||
131709853|NCT02700984|474217776|FG001|Overall Study|Lost to Follow-up|1|||
131709854|NCT02700984|474217775|FG000|Overall Study|Physician Decision|0|||
131709855|NCT02700984|474217776|FG001|Overall Study|Physician Decision|1|||
131709856|NCT02700984|474217775|FG000|Overall Study|Withdrawal by Subject|8|||
131709857|NCT02700984|474217776|FG001|Overall Study|Withdrawal by Subject|9|||
131709858|NCT02700984|474217775|FG000|Overall Study|Reason not specified|3|||
131709859|NCT02700984|474217776|FG001|Overall Study|Reason not specified|2|||
131709860|NCT00473876|474217785|FG000|Overall Study|Lost to Follow-up|3|||
131709861|NCT00473876|474217786|FG001|Overall Study|Lost to Follow-up|1|||
131709862|NCT01032629|474217788|FG000|Overall Study|Closed Site|21|||
131709863|NCT01032629|474217789|FG001|Overall Study|Closed Site|18|||
131709864|NCT01032629|474217790|FG002|Overall Study|Closed Site|16|||
131709865|NCT01032629|474217788|FG000|Overall Study|Withdrawal by Subject|50|||
131709866|NCT01032629|474217789|FG001|Overall Study|Withdrawal by Subject|36|||
131709867|NCT01032629|474217790|FG002|Overall Study|Withdrawal by Subject|35|||
131709868|NCT01032629|474217788|FG000|Overall Study|Lost to Follow-up|74|||
131709869|NCT01032629|474217789|FG001|Overall Study|Lost to Follow-up|47|||
131618493|NCT00670488|473895362|FG001|Overall Study|Physician Decision|9|||
131618494|NCT00670488|473895363|FG002|Overall Study|Physician Decision|0|||
131618495|NCT00670488|473895364|FG003|Overall Study|Physician Decision|1|||
131618496|NCT00670488|473895365|FG004|Overall Study|Physician Decision|0|||
131618497|NCT00670488|473895366|FG005|Overall Study|Physician Decision|0|||
131618498|NCT00670488|473895367|FG006|Overall Study|Physician Decision|0|||
131618499|NCT00670488|473895368|FG007|Overall Study|Physician Decision|0|||
131618500|NCT00670488|473895369|FG008|Overall Study|Physician Decision|0|||
131709870|NCT01032629|474217790|FG002|Overall Study|Lost to Follow-up|37|||
131709871|NCT00348140|474217791|FG000|Overall Study|Adverse Event|46|||
131709872|NCT00348140|474217792|FG001|Overall Study|Adverse Event|49|||
131709873|NCT00348140|474217793|FG002|Overall Study|Adverse Event|78|||
131709874|NCT00348140|474217791|FG000|Overall Study|Lost to Follow-up|4|||
131709875|NCT00348140|474217792|FG001|Overall Study|Lost to Follow-up|4|||
131709876|NCT00348140|474217793|FG002|Overall Study|Lost to Follow-up|4|||
131709877|NCT00348140|474217791|FG000|Overall Study|Protocol Violation|12|||
131709878|NCT00348140|474217792|FG001|Overall Study|Protocol Violation|13|||
131709879|NCT00348140|474217793|FG002|Overall Study|Protocol Violation|14|||
131709880|NCT00348140|474217791|FG000|Overall Study|Withdrawal by Subject|32|||
131795514|NCT03521999|474534038|FG001|Completed 3 Month Follow up|Death|1|||
131709881|NCT00348140|474217792|FG001|Overall Study|Withdrawal by Subject|40|||
131709882|NCT00348140|474217793|FG002|Overall Study|Withdrawal by Subject|40|||
131618501|NCT00670488|473895370|FG009|Overall Study|Physician Decision|0|||
131618502|NCT00670488|473895361|FG000|Overall Study|Progressive Disease|2|||
131618503|NCT00670488|473895362|FG001|Overall Study|Progressive Disease|41|||
131618504|NCT00670488|473895363|FG002|Overall Study|Progressive Disease|3|||
131618505|NCT00670488|473895364|FG003|Overall Study|Progressive Disease|2|||
131618506|NCT00670488|473895365|FG004|Overall Study|Progressive Disease|2|||
131618507|NCT00670488|473895366|FG005|Overall Study|Progressive Disease|4|||
131618508|NCT00670488|473895367|FG006|Overall Study|Progressive Disease|11|||
131618509|NCT00670488|473895368|FG007|Overall Study|Progressive Disease|2|||
131618510|NCT00670488|473895369|FG008|Overall Study|Progressive Disease|2|||
131618511|NCT00670488|473895370|FG009|Overall Study|Progressive Disease|1|||
131618512|NCT00670488|473895361|FG000|Overall Study|Withdrawal by Subject|0|||
131618513|NCT00670488|473895362|FG001|Overall Study|Withdrawal by Subject|1|||
131618514|NCT00670488|473895363|FG002|Overall Study|Withdrawal by Subject|0|||
131618515|NCT00670488|473895364|FG003|Overall Study|Withdrawal by Subject|1|||
131618516|NCT00670488|473895365|FG004|Overall Study|Withdrawal by Subject|0|||
131618517|NCT00670488|473895366|FG005|Overall Study|Withdrawal by Subject|0|||
131618518|NCT00670488|473895367|FG006|Overall Study|Withdrawal by Subject|1|||
131618519|NCT00670488|473895368|FG007|Overall Study|Withdrawal by Subject|0|||
131618520|NCT00670488|473895369|FG008|Overall Study|Withdrawal by Subject|1|||
131618521|NCT00670488|473895370|FG009|Overall Study|Withdrawal by Subject|0|||
131618522|NCT03052517|473895371|FG000|Overall Study|Study Terminated By Sponsor|928|||
131618523|NCT03052517|473895372|FG001|Overall Study|Study Terminated By Sponsor|938|||
131618524|NCT03052517|473895373|FG002|Overall Study|Study Terminated By Sponsor|296|||
131618525|NCT03052517|473895371|FG000|Overall Study|Subject/Guardian Decision|50|||
131618526|NCT03052517|473895372|FG001|Overall Study|Subject/Guardian Decision|45|||
131618527|NCT03052517|473895373|FG002|Overall Study|Subject/Guardian Decision|22|||
131618528|NCT03052517|473895371|FG000|Overall Study|Lack of Efficacy|23|||
131618529|NCT03052517|473895372|FG001|Overall Study|Lack of Efficacy|14|||
131618530|NCT03052517|473895373|FG002|Overall Study|Lack of Efficacy|7|||
131618531|NCT03052517|473895371|FG000|Overall Study|Adverse Event|6|||
131618532|NCT03052517|473895372|FG001|Overall Study|Adverse Event|5|||
131618533|NCT03052517|473895373|FG002|Overall Study|Adverse Event|0|||
131618534|NCT03052517|473895371|FG000|Overall Study|Physician Decision|4|||
131618535|NCT03052517|473895372|FG001|Overall Study|Physician Decision|5|||
131618536|NCT03052517|473895373|FG002|Overall Study|Physician Decision|1|||
131618537|NCT03052517|473895371|FG000|Overall Study|Death|3|||
131618538|NCT03052517|473895372|FG001|Overall Study|Death|0|||
131618539|NCT03052517|473895373|FG002|Overall Study|Death|1|||
131618540|NCT03052517|473895371|FG000|Overall Study|Lost to Follow-up|2|||
131618541|NCT03052517|473895372|FG001|Overall Study|Lost to Follow-up|4|||
131618542|NCT03052517|473895373|FG002|Overall Study|Lost to Follow-up|0|||
131618543|NCT03052517|473895371|FG000|Overall Study|Pregnancy|1|||
131618544|NCT03052517|473895372|FG001|Overall Study|Pregnancy|0|||
131618545|NCT03052517|473895373|FG002|Overall Study|Pregnancy|1|||
131618546|NCT03052517|473895371|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
131618547|NCT03052517|473895372|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
131618548|NCT03052517|473895373|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
131618549|NCT03052517|473895371|FG000|Overall Study|Technical Problems|0|||
131618550|NCT03052517|473895372|FG001|Overall Study|Technical Problems|1|||
131618551|NCT03052517|473895373|FG002|Overall Study|Technical Problems|0|||
131618552|NCT03298087|473895376|FG000|Overall Study|Withdrawal by Subject|4|||
131618553|NCT03781375|473895382|FG000|Double-blind Phase|Adverse Event|0|||
131618554|NCT03781375|473895383|FG001|Double-blind Phase|Adverse Event|1|||
131618555|NCT03781375|473895382|FG000|Double-blind Phase|Lack of Response|6|||
131618556|NCT03781375|473895383|FG001|Double-blind Phase|Lack of Response|2|||
131618557|NCT03781375|473895382|FG000|Double-blind Phase|Other|1|||
131618558|NCT03781375|473895383|FG001|Double-blind Phase|Other|3|||
131618559|NCT03781375|473895382|FG000|Open-label Phase|Protocol Issues|0|||
131618560|NCT03781375|473895383|FG001|Open-label Phase|Protocol Issues|1|||
131618561|NCT03781375|473895382|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
131618562|NCT03781375|473895383|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
131618563|NCT03781375|473895382|FG000|Open-label Phase|Other|2|||
131618564|NCT03781375|473895383|FG001|Open-label Phase|Other|2|||
131618565|NCT01530334|473895384|FG000|Overall Study|Adverse Event|3|||
131618566|NCT01530334|473895384|FG000|Overall Study|unknown reason|1|||
131618567|NCT01530334|473895384|FG000|Overall Study|Progressive disease|47|||
131618568|NCT01485887|473895385|FG000|Overall Study|Withdrawal by Subject|2|||
131618569|NCT01485887|473895385|FG000|Overall Study|Adverse Event|8|||
131618570|NCT01485887|473895385|FG000|Overall Study|Deterioration of primary disease|1|||
131618571|NCT01485887|473895385|FG000|Overall Study|Primary disease markedly improved|1|||
131618572|NCT03184987|473895389|FG000|Overall Study|Withdrawal by Subject|0|||
131618573|NCT03184987|473895390|FG001|Overall Study|Withdrawal by Subject|1|||
131618574|NCT03184987|473895391|FG002|Overall Study|Withdrawal by Subject|2|||
131618575|NCT03184987|473895389|FG000|Overall Study|Physician Decision|0|||
131618576|NCT03184987|473895390|FG001|Overall Study|Physician Decision|0|||
131618577|NCT03184987|473895391|FG002|Overall Study|Physician Decision|1|||
131618578|NCT03184987|473895389|FG000|Overall Study|Adverse Event|1|||
131618579|NCT03184987|473895390|FG001|Overall Study|Adverse Event|0|||
131618580|NCT03184987|473895391|FG002|Overall Study|Adverse Event|1|||
131618581|NCT00836498|473895392|FG000|Overall Study|Adverse Event|1|||
131618582|NCT00836498|473895393|FG001|Overall Study|Adverse Event|0|||
131618583|NCT00836498|473895392|FG000|Overall Study|Lost to Follow-up|1|||
131618584|NCT00836498|473895393|FG001|Overall Study|Lost to Follow-up|0|||
131618585|NCT00836498|473895392|FG000|Overall Study|Withdrawal by Subject|2|||
131618586|NCT00836498|473895393|FG001|Overall Study|Withdrawal by Subject|1|||
131618587|NCT03418545|473895394|FG000|Overall Study|Withdrawal by Participant|2|||
131618588|NCT03418545|473895395|FG001|Overall Study|Withdrawal by Participant|4|||
131618589|NCT03418545|473895394|FG000|Overall Study|Lost to Follow-up|3|||
131618590|NCT03418545|473895395|FG001|Overall Study|Lost to Follow-up|5|||
131618591|NCT03418545|473895394|FG000|Overall Study|Reason Not Specified|0|||
131618592|NCT03418545|473895395|FG001|Overall Study|Reason Not Specified|1|||
131618593|NCT03418545|473895394|FG000|Overall Study|Missing Completion Status|0|||
131618594|NCT03418545|473895395|FG001|Overall Study|Missing Completion Status|1|||
131618595|NCT03567616|473895396|FG000|Overall Study|Disease progression|4|||
131618596|NCT03567616|473895396|FG000|Overall Study|Withdrawal by Subject|1|||
131618597|NCT03567616|473895396|FG000|Overall Study|Physician Decision|1|||
131618598|NCT03567616|473895396|FG000|Overall Study|Death|1|||
131618599|NCT03567616|473895396|FG000|Overall Study|Adverse Event|1|||
131618600|NCT02630966|473895399|FG000|Overall Study|Adverse Event|1|||
131618601|NCT02630966|473895400|FG001|Overall Study|Adverse Event|3|||
131618602|NCT02630966|473895399|FG000|Overall Study|Significant Protocol Deviation|0|||
131618603|NCT02630966|473895400|FG001|Overall Study|Significant Protocol Deviation|2|||
131618604|NCT02630966|473895399|FG000|Overall Study|Voluntary Withdrawal|1|||
131618605|NCT02630966|473895400|FG001|Overall Study|Voluntary Withdrawal|1|||
131618606|NCT02630966|473895399|FG000|Overall Study|Lack of Efficacy|0|||
131618607|NCT02630966|473895400|FG001|Overall Study|Lack of Efficacy|2|||
131618608|NCT01683409|473895401|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131618609|NCT01683409|473895402|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131618610|NCT01683409|473895403|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
131618611|NCT01683409|473895404|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131618612|NCT01683409|473895405|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131618613|NCT01683409|473895401|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
131618614|NCT01683409|473895402|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
131618615|NCT01683409|473895403|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
131618616|NCT01683409|473895404|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
131618617|NCT01683409|473895405|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
131618618|NCT01683409|473895401|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131618619|NCT01683409|473895402|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
131618620|NCT01683409|473895403|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131618621|NCT01683409|473895404|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131618622|NCT01683409|473895405|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131618623|NCT01683409|473895401|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
131618624|NCT01683409|473895402|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
131618625|NCT01683409|473895403|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
131618626|NCT01683409|473895404|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
131618627|NCT01683409|473895405|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
131618628|NCT01683409|473895401|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131618629|NCT01683409|473895402|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131618630|NCT01683409|473895403|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
131618631|NCT01683409|473895404|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131618632|NCT01683409|473895405|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131618633|NCT01683409|473895401|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
131618634|NCT01683409|473895402|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
131618635|NCT01683409|473895403|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
131618636|NCT01683409|473895404|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
131618637|NCT01683409|473895405|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
131618638|NCT01683409|473895401|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
131618639|NCT01683409|473895402|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
131618640|NCT01683409|473895403|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
131618641|NCT01683409|473895404|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
131618642|NCT01683409|473895405|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
131618643|NCT01683409|473895401|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
131618644|NCT01683409|473895402|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131618645|NCT01683409|473895403|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131618646|NCT01683409|473895404|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131618647|NCT01683409|473895405|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131618648|NCT01683409|473895401|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
131618649|NCT01683409|473895402|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
131709883|NCT00348140|474217791|FG000|Overall Study|Non-compliance|8|||
131709884|NCT00348140|474217792|FG001|Overall Study|Non-compliance|13|||
131618650|NCT01683409|473895403|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
131618651|NCT01683409|473895404|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
131618652|NCT01683409|473895405|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
131618653|NCT01683409|473895401|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131618654|NCT01683409|473895402|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131618655|NCT01683409|473895403|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131618656|NCT01683409|473895404|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131618657|NCT01683409|473895405|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
131618658|NCT01683409|473895401|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131618659|NCT01683409|473895402|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131618660|NCT01683409|473895403|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
131618661|NCT01683409|473895404|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131618662|NCT01683409|473895405|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131618663|NCT01227421|473895407|FG000|Overall Study|Lost to Follow-up|6|||
131618664|NCT01227421|473895408|FG001|Overall Study|Lost to Follow-up|7|||
131618665|NCT01227421|473895409|FG002|Overall Study|Lost to Follow-up|5|||
131618666|NCT01227421|473895407|FG000|Overall Study|Adverse Event|2|||
131618667|NCT01227421|473895408|FG001|Overall Study|Adverse Event|7|||
131618668|NCT01227421|473895409|FG002|Overall Study|Adverse Event|2|||
131618669|NCT01227421|473895407|FG000|Overall Study|Withdrawal by Subject|1|||
131618670|NCT01227421|473895408|FG001|Overall Study|Withdrawal by Subject|2|||
131618671|NCT01227421|473895409|FG002|Overall Study|Withdrawal by Subject|1|||
131618672|NCT01227421|473895407|FG000|Overall Study|Protocol Violation|1|||
131618673|NCT01227421|473895408|FG001|Overall Study|Protocol Violation|1|||
131618674|NCT01227421|473895409|FG002|Overall Study|Protocol Violation|2|||
131618675|NCT01227421|473895407|FG000|Overall Study|Randomized in error|1|||
131618676|NCT01227421|473895408|FG001|Overall Study|Randomized in error|1|||
131618677|NCT01227421|473895409|FG002|Overall Study|Randomized in error|0|||
131618678|NCT02499328|473895410|FG000|Overall Study|Withdrawal by Subject|1|||
131618679|NCT02499328|473895411|FG001|Overall Study|Withdrawal by Subject|1|||
131618680|NCT02499328|473895412|FG002|Overall Study|Withdrawal by Subject|5|||
131618681|NCT02499328|473895413|FG003|Overall Study|Withdrawal by Subject|3|||
131618682|NCT02499328|473895414|FG004|Overall Study|Withdrawal by Subject|5|||
131618683|NCT02499328|473895415|FG005|Overall Study|Withdrawal by Subject|0|||
131618684|NCT02499328|473895416|FG006|Overall Study|Withdrawal by Subject|0|||
131618685|NCT02499328|473895417|FG007|Overall Study|Withdrawal by Subject|0|||
131618686|NCT02499328|473895418|FG008|Overall Study|Withdrawal by Subject|2|||
131618687|NCT02499328|473895419|FG009|Overall Study|Withdrawal by Subject|2|||
131618688|NCT02499328|473895420|FG010|Overall Study|Withdrawal by Subject|0|||
131618689|NCT02499328|473895421|FG011|Overall Study|Withdrawal by Subject|3|||
131618690|NCT02499328|473895422|FG012|Overall Study|Withdrawal by Subject|7|||
131618691|NCT02499328|473895423|FG013|Overall Study|Withdrawal by Subject|3|||
131618692|NCT02499328|473895424|FG014|Overall Study|Withdrawal by Subject|1|||
131618693|NCT02499328|473895425|FG015|Overall Study|Withdrawal by Subject|0|||
131618694|NCT02499328|473895426|FG016|Overall Study|Withdrawal by Subject|0|||
131618695|NCT02499328|473895427|FG017|Overall Study|Withdrawal by Subject|3|||
131618696|NCT02499328|473895428|FG018|Overall Study|Withdrawal by Subject|0|||
131618697|NCT02499328|473895410|FG000|Overall Study|Lost to Follow-up|0|||
131618698|NCT02499328|473895411|FG001|Overall Study|Lost to Follow-up|1|||
131618699|NCT02499328|473895412|FG002|Overall Study|Lost to Follow-up|1|||
131618700|NCT02499328|473895413|FG003|Overall Study|Lost to Follow-up|2|||
131618701|NCT02499328|473895414|FG004|Overall Study|Lost to Follow-up|0|||
131618702|NCT02499328|473895415|FG005|Overall Study|Lost to Follow-up|0|||
131618703|NCT02499328|473895416|FG006|Overall Study|Lost to Follow-up|0|||
131618704|NCT02499328|473895417|FG007|Overall Study|Lost to Follow-up|2|||
131618705|NCT02499328|473895418|FG008|Overall Study|Lost to Follow-up|3|||
131618706|NCT02499328|473895419|FG009|Overall Study|Lost to Follow-up|0|||
131618707|NCT02499328|473895420|FG010|Overall Study|Lost to Follow-up|0|||
131618708|NCT02499328|473895421|FG011|Overall Study|Lost to Follow-up|0|||
131618709|NCT02499328|473895422|FG012|Overall Study|Lost to Follow-up|0|||
131618710|NCT02499328|473895423|FG013|Overall Study|Lost to Follow-up|0|||
131795515|NCT03521999|474534037|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
131618711|NCT02499328|473895424|FG014|Overall Study|Lost to Follow-up|0|||
131618712|NCT02499328|473895425|FG015|Overall Study|Lost to Follow-up|0|||
131618713|NCT02499328|473895426|FG016|Overall Study|Lost to Follow-up|0|||
131618714|NCT02499328|473895427|FG017|Overall Study|Lost to Follow-up|0|||
131618715|NCT02499328|473895428|FG018|Overall Study|Lost to Follow-up|1|||
131618716|NCT02499328|473895410|FG000|Overall Study|Death|0|||
131618717|NCT02499328|473895411|FG001|Overall Study|Death|3|||
131618718|NCT02499328|473895412|FG002|Overall Study|Death|3|||
131618719|NCT02499328|473895413|FG003|Overall Study|Death|2|||
131618720|NCT02499328|473895414|FG004|Overall Study|Death|4|||
131618721|NCT02499328|473895415|FG005|Overall Study|Death|7|||
131618722|NCT02499328|473895416|FG006|Overall Study|Death|3|||
131618723|NCT02499328|473895417|FG007|Overall Study|Death|0|||
131618724|NCT02499328|473895418|FG008|Overall Study|Death|2|||
131618725|NCT02499328|473895419|FG009|Overall Study|Death|6|||
131618726|NCT02499328|473895420|FG010|Overall Study|Death|6|||
131709885|NCT00348140|474217793|FG002|Overall Study|Non-compliance|5|||
131709886|NCT00348140|474217791|FG000|Overall Study|Participant at risk due to study drug|2|||
131709887|NCT00348140|474217792|FG001|Overall Study|Participant at risk due to study drug|0|||
131709888|NCT00348140|474217793|FG002|Overall Study|Participant at risk due to study drug|0|||
131709889|NCT00348140|474217791|FG000|Overall Study|Conditional medication increased dose|1|||
131709890|NCT00348140|474217792|FG001|Overall Study|Conditional medication increased dose|0|||
131709891|NCT00348140|474217793|FG002|Overall Study|Conditional medication increased dose|0|||
131709892|NCT00348140|474217791|FG000|Overall Study|Caregiver related|4|||
131709893|NCT00348140|474217792|FG001|Overall Study|Caregiver related|7|||
131709894|NCT00348140|474217793|FG002|Overall Study|Caregiver related|3|||
131709895|NCT00348140|474217791|FG000|Overall Study|Participant hospitalised|3|||
131709896|NCT00348140|474217792|FG001|Overall Study|Participant hospitalised|0|||
131709897|NCT00348140|474217793|FG002|Overall Study|Participant hospitalised|0|||
131709898|NCT00348140|474217791|FG000|Overall Study|Efficacy related|1|||
131709899|NCT00348140|474217792|FG001|Overall Study|Efficacy related|1|||
131709900|NCT00348140|474217793|FG002|Overall Study|Efficacy related|0|||
131709901|NCT00348140|474217791|FG000|Overall Study|Administration related|3|||
131709902|NCT00348140|474217792|FG001|Overall Study|Administration related|1|||
131709903|NCT00348140|474217793|FG002|Overall Study|Administration related|1|||
131709904|NCT00348140|474217791|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
131709905|NCT00348140|474217792|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
131709906|NCT00348140|474217793|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
131709907|NCT00348140|474217791|FG000|Overall Study|Participant unwell|1|||
131709908|NCT00348140|474217792|FG001|Overall Study|Participant unwell|0|||
131709909|NCT00348140|474217793|FG002|Overall Study|Participant unwell|0|||
131709910|NCT00348140|474217791|FG000|Overall Study|Screen failure|1|||
131709911|NCT00348140|474217792|FG001|Overall Study|Screen failure|0|||
131709912|NCT00348140|474217793|FG002|Overall Study|Screen failure|0|||
131709913|NCT00348140|474217791|FG000|Overall Study|Investigator decided to discontinue|4|||
131709914|NCT00348140|474217792|FG001|Overall Study|Investigator decided to discontinue|1|||
131709915|NCT00348140|474217793|FG002|Overall Study|Investigator decided to discontinue|4|||
131709916|NCT00348140|474217791|FG000|Overall Study|Decided to discontinue on their own|1|||
131709917|NCT00348140|474217792|FG001|Overall Study|Decided to discontinue on their own|4|||
131618727|NCT02499328|473895421|FG011|Overall Study|Death|20|||
131618728|NCT02499328|473895422|FG012|Overall Study|Death|9|||
131618729|NCT02499328|473895423|FG013|Overall Study|Death|7|||
131618730|NCT02499328|473895424|FG014|Overall Study|Death|3|||
131618731|NCT02499328|473895425|FG015|Overall Study|Death|1|||
131618732|NCT02499328|473895426|FG016|Overall Study|Death|1|||
131618733|NCT02499328|473895427|FG017|Overall Study|Death|16|||
131618734|NCT02499328|473895428|FG018|Overall Study|Death|5|||
131618735|NCT02499328|473895410|FG000|Overall Study|"Other"|2|||
131618736|NCT02499328|473895411|FG001|Overall Study|"Other"|2|||
131618737|NCT02499328|473895412|FG002|Overall Study|"Other"|1|||
131618738|NCT02499328|473895413|FG003|Overall Study|"Other"|3|||
131618739|NCT02499328|473895414|FG004|Overall Study|"Other"|6|||
131618740|NCT02499328|473895415|FG005|Overall Study|"Other"|2|||
131709918|NCT00348140|474217793|FG002|Overall Study|Decided to discontinue on their own|1|||
131709919|NCT00348140|474217791|FG000|Overall Study|Use of prohibited drug|1|||
131709920|NCT00348140|474217792|FG001|Overall Study|Use of prohibited drug|0|||
131709921|NCT00348140|474217793|FG002|Overall Study|Use of prohibited drug|2|||
131709922|NCT00348140|474217791|FG000|Overall Study|Disease progression|1|||
131709923|NCT00348140|474217792|FG001|Overall Study|Disease progression|2|||
131709924|NCT00348140|474217793|FG002|Overall Study|Disease progression|5|||
131709925|NCT00348140|474217791|FG000|Overall Study|Increased risk of cardiac infarction|0|||
131709926|NCT00348140|474217792|FG001|Overall Study|Increased risk of cardiac infarction|1|||
131709927|NCT00348140|474217793|FG002|Overall Study|Increased risk of cardiac infarction|0|||
131709928|NCT00348140|474217791|FG000|Overall Study|Serious adverse event|0|||
131709929|NCT00348140|474217792|FG001|Overall Study|Serious adverse event|1|||
131709930|NCT00348140|474217793|FG002|Overall Study|Serious adverse event|0|||
131709931|NCT00348140|474217791|FG000|Overall Study|Abnormal ECG|0|||
131709932|NCT00348140|474217792|FG001|Overall Study|Abnormal ECG|1|||
131709933|NCT00348140|474217793|FG002|Overall Study|Abnormal ECG|3|||
131709934|NCT00348140|474217791|FG000|Overall Study|Participant died|0|||
131709935|NCT00348140|474217792|FG001|Overall Study|Participant died|1|||
131709936|NCT00348140|474217793|FG002|Overall Study|Participant died|0|||
131709937|NCT00348140|474217791|FG000|Overall Study|Exclusion criteria met|0|||
131709938|NCT00348140|474217792|FG001|Overall Study|Exclusion criteria met|0|||
131618741|NCT02499328|473895416|FG006|Overall Study|"Other"|3|||
131618742|NCT02499328|473895417|FG007|Overall Study|"Other"|4|||
131618743|NCT02499328|473895418|FG008|Overall Study|"Other"|6|||
131618744|NCT02499328|473895419|FG009|Overall Study|"Other"|16|||
131709939|NCT00348140|474217793|FG002|Overall Study|Exclusion criteria met|1|||
131618745|NCT02499328|473895420|FG010|Overall Study|"Other"|13|||
131618746|NCT02499328|473895421|FG011|Overall Study|"Other"|31|||
131618747|NCT02499328|473895422|FG012|Overall Study|"Other"|8|||
131618748|NCT02499328|473895423|FG013|Overall Study|"Other"|7|||
131618749|NCT02499328|473895424|FG014|Overall Study|"Other"|6|||
131618750|NCT02499328|473895425|FG015|Overall Study|"Other"|0|||
131618751|NCT02499328|473895426|FG016|Overall Study|"Other"|0|||
131618752|NCT02499328|473895427|FG017|Overall Study|"Other"|34|||
131618753|NCT02499328|473895428|FG018|Overall Study|"Other"|43|||
131618754|NCT02499328|473895410|FG000|Overall Study|Disease Progression|0|||
131618755|NCT02499328|473895411|FG001|Overall Study|Disease Progression|0|||
131618756|NCT02499328|473895412|FG002|Overall Study|Disease Progression|0|||
131618757|NCT02499328|473895413|FG003|Overall Study|Disease Progression|0|||
131618758|NCT02499328|473895414|FG004|Overall Study|Disease Progression|0|||
131618759|NCT02499328|473895415|FG005|Overall Study|Disease Progression|0|||
131618760|NCT02499328|473895416|FG006|Overall Study|Disease Progression|1|||
131618761|NCT02499328|473895417|FG007|Overall Study|Disease Progression|0|||
131618762|NCT02499328|473895418|FG008|Overall Study|Disease Progression|1|||
131618763|NCT02499328|473895419|FG009|Overall Study|Disease Progression|0|||
131618764|NCT02499328|473895420|FG010|Overall Study|Disease Progression|1|||
131618765|NCT02499328|473895421|FG011|Overall Study|Disease Progression|0|||
131618766|NCT02499328|473895422|FG012|Overall Study|Disease Progression|0|||
131618767|NCT02499328|473895423|FG013|Overall Study|Disease Progression|0|||
131618768|NCT02499328|473895424|FG014|Overall Study|Disease Progression|0|||
131618769|NCT02499328|473895425|FG015|Overall Study|Disease Progression|0|||
131618770|NCT02499328|473895426|FG016|Overall Study|Disease Progression|0|||
131618771|NCT02499328|473895427|FG017|Overall Study|Disease Progression|2|||
131618772|NCT02499328|473895428|FG018|Overall Study|Disease Progression|0|||
131618773|NCT02499328|473895410|FG000|Overall Study|Adverse Event|1|||
131618774|NCT02499328|473895411|FG001|Overall Study|Adverse Event|0|||
131618775|NCT02499328|473895412|FG002|Overall Study|Adverse Event|0|||
131618776|NCT02499328|473895413|FG003|Overall Study|Adverse Event|1|||
131618777|NCT02499328|473895414|FG004|Overall Study|Adverse Event|0|||
131618778|NCT02499328|473895415|FG005|Overall Study|Adverse Event|0|||
131618779|NCT02499328|473895416|FG006|Overall Study|Adverse Event|0|||
131618780|NCT02499328|473895417|FG007|Overall Study|Adverse Event|0|||
131618781|NCT02499328|473895418|FG008|Overall Study|Adverse Event|0|||
131618782|NCT02499328|473895419|FG009|Overall Study|Adverse Event|0|||
131618783|NCT02499328|473895420|FG010|Overall Study|Adverse Event|0|||
131618784|NCT02499328|473895421|FG011|Overall Study|Adverse Event|0|||
131618785|NCT02499328|473895422|FG012|Overall Study|Adverse Event|1|||
131618786|NCT02499328|473895423|FG013|Overall Study|Adverse Event|0|||
131618787|NCT02499328|473895424|FG014|Overall Study|Adverse Event|0|||
131618788|NCT02499328|473895425|FG015|Overall Study|Adverse Event|0|||
131618789|NCT02499328|473895426|FG016|Overall Study|Adverse Event|0|||
131618790|NCT02499328|473895427|FG017|Overall Study|Adverse Event|0|||
131618791|NCT02499328|473895428|FG018|Overall Study|Adverse Event|0|||
131618792|NCT00145470|473895429|FG000|Overall Study|Adverse Event|19|||
131618793|NCT00145470|473895430|FG001|Overall Study|Adverse Event|25|||
131618794|NCT00145470|473895429|FG000|Overall Study|Lack of Efficacy|27|||
131618795|NCT00145470|473895430|FG001|Overall Study|Lack of Efficacy|13|||
131618796|NCT00145470|473895429|FG000|Overall Study|Withdrawal by Subject|36|||
131618797|NCT00145470|473895430|FG001|Overall Study|Withdrawal by Subject|34|||
131618798|NCT00145470|473895429|FG000|Overall Study|Lost to Follow-up|21|||
131618799|NCT00145470|473895430|FG001|Overall Study|Lost to Follow-up|17|||
131618800|NCT00145470|473895429|FG000|Overall Study|Reason Not Reported|9|||
131618801|NCT00145470|473895430|FG001|Overall Study|Reason Not Reported|9|||
131618802|NCT04224272|473895433|FG000|Part 1 - Dose Finding|Death|4|||
131618803|NCT04224272|473895433|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
131618804|NCT04224272|473895433|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
131618805|NCT04224272|473895433|FG000|Part 2 - Dose Expansion|Death|10|||
131618806|NCT04224272|473895433|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
131618807|NCT02609048|473895434|FG000|Overall Study|Adverse Event|3|||
131618808|NCT02609048|473895435|FG001|Overall Study|Adverse Event|0|||
131618809|NCT02609048|473895436|FG002|Overall Study|Adverse Event|0|||
131618810|NCT02609048|473895434|FG000|Overall Study|Randomized but never treated|1|||
131618811|NCT02609048|473895435|FG001|Overall Study|Randomized but never treated|1|||
131618812|NCT02609048|473895436|FG002|Overall Study|Randomized but never treated|1|||
131618813|NCT02609048|473895434|FG000|Overall Study|Withdrawal of informed consent|1|||
131618814|NCT02609048|473895435|FG001|Overall Study|Withdrawal of informed consent|0|||
131618815|NCT02609048|473895436|FG002|Overall Study|Withdrawal of informed consent|0|||
131618816|NCT02609048|473895434|FG000|Overall Study|Reason not specified|6|||
131618817|NCT02609048|473895435|FG001|Overall Study|Reason not specified|9|||
131618818|NCT02609048|473895436|FG002|Overall Study|Reason not specified|9|||
131618819|NCT02485925|473895437|FG000|Overall Study|Withdrawal by Subject|3|||
131618820|NCT02485925|473895437|FG000|Overall Study|Death|1|||
131618821|NCT02485925|473895437|FG000|Overall Study|Lost to Follow-up|11|||
131618822|NCT05995977|473895440|FG000|Overall Study|Withdrawal by Subject|1|||
131618823|NCT05995977|473895441|FG001|Overall Study|Withdrawal by Subject|4|||
131618824|NCT05995977|473895440|FG000|Overall Study|Lost to Follow-up|2|||
131618825|NCT05995977|473895441|FG001|Overall Study|Lost to Follow-up|0|||
131618826|NCT04181788|473895442|FG000|TREATMENT|Adverse Event|0|||
131618827|NCT04181788|473895443|FG001|TREATMENT|Adverse Event|2|||
131618828|NCT04181788|473895444|FG002|TREATMENT|Adverse Event|1|||
131618829|NCT04181788|473895445|FG003|TREATMENT|Adverse Event|0|||
131618830|NCT04181788|473895446|FG004|TREATMENT|Adverse Event|1|||
131618831|NCT04181788|473895447|FG005|TREATMENT|Adverse Event|3|||
131618832|NCT04181788|473895442|FG000|TREATMENT|Death|0|||
131618833|NCT04181788|473895443|FG001|TREATMENT|Death|0|||
131618834|NCT04181788|473895444|FG002|TREATMENT|Death|0|||
131618835|NCT04181788|473895445|FG003|TREATMENT|Death|0|||
131618836|NCT04181788|473895446|FG004|TREATMENT|Death|8|||
131618837|NCT04181788|473895447|FG005|TREATMENT|Death|8|||
131618838|NCT04181788|473895442|FG000|TREATMENT|Physician Decision|0|||
131618839|NCT04181788|473895443|FG001|TREATMENT|Physician Decision|0|||
131618840|NCT04181788|473895444|FG002|TREATMENT|Physician Decision|0|||
131618841|NCT04181788|473895445|FG003|TREATMENT|Physician Decision|0|||
131618842|NCT04181788|473895446|FG004|TREATMENT|Physician Decision|0|||
131618843|NCT04181788|473895447|FG005|TREATMENT|Physician Decision|1|||
131618844|NCT04181788|473895442|FG000|TREATMENT|Progressive disease|3|||
131618845|NCT04181788|473895443|FG001|TREATMENT|Progressive disease|3|||
131618846|NCT04181788|473895444|FG002|TREATMENT|Progressive disease|5|||
131618847|NCT04181788|473895445|FG003|TREATMENT|Progressive disease|7|||
131618848|NCT04181788|473895446|FG004|TREATMENT|Progressive disease|20|||
131618849|NCT04181788|473895447|FG005|TREATMENT|Progressive disease|38|||
131618850|NCT04181788|473895442|FG000|TREATMENT|Global deterioration of health status|0|||
131618851|NCT04181788|473895443|FG001|TREATMENT|Global deterioration of health status|2|||
131618852|NCT04181788|473895444|FG002|TREATMENT|Global deterioration of health status|0|||
131618853|NCT04181788|473895445|FG003|TREATMENT|Global deterioration of health status|0|||
131618854|NCT04181788|473895446|FG004|TREATMENT|Global deterioration of health status|2|||
131618855|NCT04181788|473895447|FG005|TREATMENT|Global deterioration of health status|8|||
131618856|NCT04181788|473895442|FG000|TREATMENT|Withdrawal by Subject|1|||
131618857|NCT04181788|473895443|FG001|TREATMENT|Withdrawal by Subject|2|||
131618858|NCT04181788|473895444|FG002|TREATMENT|Withdrawal by Subject|0|||
131618859|NCT04181788|473895445|FG003|TREATMENT|Withdrawal by Subject|0|||
131618860|NCT04181788|473895446|FG004|TREATMENT|Withdrawal by Subject|3|||
131618861|NCT04181788|473895447|FG005|TREATMENT|Withdrawal by Subject|5|||
131618862|NCT04181788|473895442|FG000|TREATMENT|Other unspecified|0|||
131618863|NCT04181788|473895443|FG001|TREATMENT|Other unspecified|0|||
131618864|NCT04181788|473895444|FG002|TREATMENT|Other unspecified|0|||
131618865|NCT04181788|473895445|FG003|TREATMENT|Other unspecified|0|||
131618866|NCT04181788|473895446|FG004|TREATMENT|Other unspecified|0|||
131618867|NCT04181788|473895447|FG005|TREATMENT|Other unspecified|2|||
131618868|NCT04181788|473895442|FG000|TREATMENT|Ongoing|0|||
131618869|NCT04181788|473895443|FG001|TREATMENT|Ongoing|3|||
131618870|NCT04181788|473895444|FG002|TREATMENT|Ongoing|0|||
131618871|NCT04181788|473895445|FG003|TREATMENT|Ongoing|5|||
131618872|NCT04181788|473895446|FG004|TREATMENT|Ongoing|7|||
131618873|NCT04181788|473895447|FG005|TREATMENT|Ongoing|15|||
131618874|NCT04181788|473895442|FG000|FOLLOW-UP|Death|0|||
131618875|NCT04181788|473895443|FG001|FOLLOW-UP|Death|0|||
131618876|NCT04181788|473895444|FG002|FOLLOW-UP|Death|1|||
131618877|NCT04181788|473895445|FG003|FOLLOW-UP|Death|2|||
131618878|NCT04181788|473895446|FG004|FOLLOW-UP|Death|8|||
131618879|NCT04181788|473895447|FG005|FOLLOW-UP|Death|20|||
131618880|NCT04181788|473895442|FG000|FOLLOW-UP|Lost to Follow-up|0|||
131618881|NCT04181788|473895443|FG001|FOLLOW-UP|Lost to Follow-up|0|||
131618882|NCT04181788|473895444|FG002|FOLLOW-UP|Lost to Follow-up|0|||
131618883|NCT04181788|473895445|FG003|FOLLOW-UP|Lost to Follow-up|0|||
131618884|NCT04181788|473895446|FG004|FOLLOW-UP|Lost to Follow-up|0|||
131618885|NCT04181788|473895447|FG005|FOLLOW-UP|Lost to Follow-up|2|||
131618886|NCT04181788|473895442|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
131618887|NCT04181788|473895443|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
131618888|NCT04181788|473895444|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
131618889|NCT04181788|473895445|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
131618890|NCT04181788|473895446|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
131618891|NCT04181788|473895447|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
131618892|NCT04181788|473895442|FG000|FOLLOW-UP|Other unspecified|0|||
131618893|NCT04181788|473895443|FG001|FOLLOW-UP|Other unspecified|1|||
131618894|NCT04181788|473895444|FG002|FOLLOW-UP|Other unspecified|0|||
131618895|NCT04181788|473895445|FG003|FOLLOW-UP|Other unspecified|0|||
131795516|NCT03521999|474534038|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
131795517|NCT01564758|474534039|FG000|Overall Study|Death|8|||
131618896|NCT04181788|473895446|FG004|FOLLOW-UP|Other unspecified|0|||
131618897|NCT04181788|473895447|FG005|FOLLOW-UP|Other unspecified|3|||
131618898|NCT04181788|473895442|FG000|FOLLOW-UP|Ongoing|0|||
131618899|NCT04181788|473895443|FG001|FOLLOW-UP|Ongoing|0|||
131618900|NCT04181788|473895444|FG002|FOLLOW-UP|Ongoing|1|||
131618901|NCT04181788|473895445|FG003|FOLLOW-UP|Ongoing|3|||
131618902|NCT04181788|473895446|FG004|FOLLOW-UP|Ongoing|2|||
131618903|NCT04181788|473895447|FG005|FOLLOW-UP|Ongoing|2|||
131618904|NCT04937504|473895448|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
131618905|NCT04937504|473895449|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
131618906|NCT04937504|473895448|FG000|9 Months Assessment|Lost to Follow-up|3|||
131618907|NCT04937504|473895449|FG001|9 Months Assessment|Lost to Follow-up|2|||
131618908|NCT04186247|473895450|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
131618909|NCT04186247|473895451|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131709940|NCT00348140|474217791|FG000|Overall Study|Memory declined|0|||
131709941|NCT00348140|474217792|FG001|Overall Study|Memory declined|0|||
131709942|NCT00348140|474217793|FG002|Overall Study|Memory declined|1|||
131709943|NCT03371355|474217796|FG000|Overall Study|Investigator judgment|0|||
131709944|NCT03371355|474217797|FG001|Overall Study|Investigator judgment|0|||
131709945|NCT03371355|474217798|FG002|Overall Study|Investigator judgment|1|||
131709946|NCT03371355|474217799|FG003|Overall Study|Investigator judgment|1|||
131709947|NCT03371355|474217796|FG000|Overall Study|Voluntary withdrawal|1|||
131709948|NCT03371355|474217797|FG001|Overall Study|Voluntary withdrawal|0|||
131709949|NCT03371355|474217798|FG002|Overall Study|Voluntary withdrawal|1|||
131709950|NCT03371355|474217799|FG003|Overall Study|Voluntary withdrawal|2|||
131709951|NCT03371355|474217796|FG000|Overall Study|Adverse Event|0|||
131709952|NCT03371355|474217797|FG001|Overall Study|Adverse Event|1|||
131709953|NCT03371355|474217798|FG002|Overall Study|Adverse Event|2|||
131709954|NCT03371355|474217799|FG003|Overall Study|Adverse Event|3|||
131709955|NCT03371355|474217796|FG000|Overall Study|Reason not Specified|0|||
131709956|NCT03371355|474217797|FG001|Overall Study|Reason not Specified|1|||
131709957|NCT03371355|474217798|FG002|Overall Study|Reason not Specified|0|||
131709958|NCT03371355|474217799|FG003|Overall Study|Reason not Specified|1|||
131709959|NCT02868892|474217800|FG000|Overall Study|Investigator left site and no follow-up|6|||
131709960|NCT01662648|474217801|FG000|Overall Study|Death|1|||
131709961|NCT01662648|474217802|FG001|Overall Study|Death|3|||
131709962|NCT01662648|474217801|FG000|Overall Study|Adverse Event|40|||
131709963|NCT01662648|474217802|FG001|Overall Study|Adverse Event|37|||
131709964|NCT01662648|474217801|FG000|Overall Study|Lack of Efficacy|17|||
131709965|NCT01662648|474217802|FG001|Overall Study|Lack of Efficacy|16|||
131709966|NCT01662648|474217801|FG000|Overall Study|Participant ineligible to continue trial|1|||
131709967|NCT01662648|474217802|FG001|Overall Study|Participant ineligible to continue trial|1|||
131709968|NCT01662648|474217801|FG000|Overall Study|Lost to Follow-up|24|||
131709969|NCT01662648|474217802|FG001|Overall Study|Lost to Follow-up|36|||
131709970|NCT01662648|474217801|FG000|Overall Study|Withdrawal by Subject|36|||
131709971|NCT01662648|474217802|FG001|Overall Study|Withdrawal by Subject|53|||
131709972|NCT01662648|474217801|FG000|Overall Study|Participant non-compliant|16|||
131709973|NCT01662648|474217802|FG001|Overall Study|Participant non-compliant|20|||
131709974|NCT01662648|474217801|FG000|Overall Study|Other|8|||
131709975|NCT01662648|474217802|FG001|Overall Study|Other|11|||
131709976|NCT01662648|474217801|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
131709977|NCT01662648|474217802|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
131709978|NCT01662648|474217801|FG000|Overall Study|LOE and other reason unspecified|1|||
131709979|NCT01662648|474217802|FG001|Overall Study|LOE and other reason unspecified|0|||
131709980|NCT01662648|474217801|FG000|Overall Study|LOE and Participant non-compliant|0|||
131709981|NCT01662648|474217802|FG001|Overall Study|LOE and Participant non-compliant|1|||
131709982|NCT03751111|474217807|FG000|Overall Study|Lack of Efficacy|9|||
131709983|NCT03751111|474217808|FG001|Overall Study|Lack of Efficacy|30|||
131709984|NCT03751111|474217807|FG000|Overall Study|Adverse Event|3|||
131709985|NCT03751111|474217808|FG001|Overall Study|Adverse Event|2|||
131709986|NCT00868790|474217810|FG000|Period 1|Adverse Event|1|||
131709987|NCT00868790|474217811|FG001|Period 1|Adverse Event|0|||
131709988|NCT00868790|474217812|FG002|Period 1|Adverse Event|0|||
131709989|NCT00868790|474217813|FG003|Period 1|Adverse Event|0|||
131709990|NCT00868790|474217814|FG004|Period 1|Adverse Event|0|||
131709991|NCT00868790|474217815|FG005|Period 1|Adverse Event|0|||
131709992|NCT00868790|474217816|FG006|Period 1|Adverse Event|0|||
131709993|NCT00868790|474217817|FG007|Period 1|Adverse Event|3|||
131709994|NCT00868790|474217818|FG008|Period 1|Adverse Event|1|||
131709995|NCT00868790|474217819|FG009|Period 1|Adverse Event|0|||
131709996|NCT00868790|474217820|FG010|Period 1|Adverse Event|0|||
131709997|NCT00868790|474217821|FG011|Period 1|Adverse Event|0|||
131709998|NCT00868790|474217822|FG012|Period 1|Adverse Event|0|||
131709999|NCT00868790|474217823|FG013|Period 1|Adverse Event|1|||
131710000|NCT00868790|474217810|FG000|Period 1|Protocol Violation|1|||
131710001|NCT00868790|474217811|FG001|Period 1|Protocol Violation|0|||
131710002|NCT00868790|474217812|FG002|Period 1|Protocol Violation|0|||
131710003|NCT00868790|474217813|FG003|Period 1|Protocol Violation|0|||
131710004|NCT00868790|474217814|FG004|Period 1|Protocol Violation|0|||
131710005|NCT00868790|474217815|FG005|Period 1|Protocol Violation|0|||
131710006|NCT00868790|474217816|FG006|Period 1|Protocol Violation|0|||
131710007|NCT00868790|474217817|FG007|Period 1|Protocol Violation|0|||
131710008|NCT00868790|474217818|FG008|Period 1|Protocol Violation|0|||
131710009|NCT00868790|474217819|FG009|Period 1|Protocol Violation|0|||
131710010|NCT00868790|474217820|FG010|Period 1|Protocol Violation|0|||
131710011|NCT00868790|474217821|FG011|Period 1|Protocol Violation|0|||
131710012|NCT00868790|474217822|FG012|Period 1|Protocol Violation|0|||
131710013|NCT00868790|474217823|FG013|Period 1|Protocol Violation|0|||
131710014|NCT00868790|474217810|FG000|Period 1|Withdrawal by Subject|0|||
131710015|NCT00868790|474217811|FG001|Period 1|Withdrawal by Subject|1|||
131710016|NCT00868790|474217812|FG002|Period 1|Withdrawal by Subject|0|||
131710017|NCT00868790|474217813|FG003|Period 1|Withdrawal by Subject|0|||
131710018|NCT00868790|474217814|FG004|Period 1|Withdrawal by Subject|0|||
131710019|NCT00868790|474217815|FG005|Period 1|Withdrawal by Subject|0|||
131710020|NCT00868790|474217816|FG006|Period 1|Withdrawal by Subject|0|||
131710021|NCT00868790|474217817|FG007|Period 1|Withdrawal by Subject|0|||
131710022|NCT00868790|474217818|FG008|Period 1|Withdrawal by Subject|0|||
131710023|NCT00868790|474217819|FG009|Period 1|Withdrawal by Subject|0|||
131710024|NCT00868790|474217820|FG010|Period 1|Withdrawal by Subject|0|||
131710025|NCT00868790|474217821|FG011|Period 1|Withdrawal by Subject|0|||
131710026|NCT00868790|474217822|FG012|Period 1|Withdrawal by Subject|0|||
131710027|NCT00868790|474217823|FG013|Period 1|Withdrawal by Subject|1|||
131710028|NCT00868790|474217810|FG000|Period 1|Abnormal Triglycerides|0|||
131710029|NCT00868790|474217811|FG001|Period 1|Abnormal Triglycerides|0|||
131710030|NCT00868790|474217812|FG002|Period 1|Abnormal Triglycerides|0|||
131710031|NCT00868790|474217813|FG003|Period 1|Abnormal Triglycerides|0|||
131710032|NCT00868790|474217814|FG004|Period 1|Abnormal Triglycerides|1|||
131710033|NCT00868790|474217815|FG005|Period 1|Abnormal Triglycerides|0|||
131710034|NCT00868790|474217816|FG006|Period 1|Abnormal Triglycerides|0|||
131710035|NCT00868790|474217817|FG007|Period 1|Abnormal Triglycerides|0|||
131710036|NCT00868790|474217818|FG008|Period 1|Abnormal Triglycerides|0|||
131710037|NCT00868790|474217819|FG009|Period 1|Abnormal Triglycerides|0|||
131710038|NCT00868790|474217820|FG010|Period 1|Abnormal Triglycerides|0|||
131710039|NCT00868790|474217821|FG011|Period 1|Abnormal Triglycerides|0|||
131710040|NCT00868790|474217822|FG012|Period 1|Abnormal Triglycerides|0|||
131710041|NCT00868790|474217823|FG013|Period 1|Abnormal Triglycerides|0|||
131710042|NCT00868790|474217810|FG000|Period 1|Lost to Follow-up|0|||
131710043|NCT00868790|474217811|FG001|Period 1|Lost to Follow-up|0|||
131710044|NCT00868790|474217812|FG002|Period 1|Lost to Follow-up|0|||
131710045|NCT00868790|474217813|FG003|Period 1|Lost to Follow-up|0|||
131710046|NCT00868790|474217814|FG004|Period 1|Lost to Follow-up|0|||
131710047|NCT00868790|474217815|FG005|Period 1|Lost to Follow-up|1|||
131710048|NCT00868790|474217816|FG006|Period 1|Lost to Follow-up|0|||
131710049|NCT00868790|474217817|FG007|Period 1|Lost to Follow-up|0|||
131710050|NCT00868790|474217818|FG008|Period 1|Lost to Follow-up|0|||
131710051|NCT00868790|474217819|FG009|Period 1|Lost to Follow-up|0|||
131710052|NCT00868790|474217820|FG010|Period 1|Lost to Follow-up|0|||
131710053|NCT00868790|474217821|FG011|Period 1|Lost to Follow-up|0|||
131710054|NCT00868790|474217822|FG012|Period 1|Lost to Follow-up|0|||
131710055|NCT00868790|474217823|FG013|Period 1|Lost to Follow-up|0|||
131710056|NCT00868790|474217810|FG000|Period 2|Adverse Event|0|||
131710057|NCT00868790|474217811|FG001|Period 2|Adverse Event|0|||
131710058|NCT00868790|474217812|FG002|Period 2|Adverse Event|0|||
131710059|NCT00868790|474217813|FG003|Period 2|Adverse Event|0|||
131710060|NCT00868790|474217814|FG004|Period 2|Adverse Event|0|||
131710061|NCT00868790|474217815|FG005|Period 2|Adverse Event|0|||
131710062|NCT00868790|474217816|FG006|Period 2|Adverse Event|0|||
131710063|NCT00868790|474217817|FG007|Period 2|Adverse Event|0|||
131710064|NCT00868790|474217818|FG008|Period 2|Adverse Event|1|||
131710065|NCT00868790|474217819|FG009|Period 2|Adverse Event|0|||
131710066|NCT00868790|474217820|FG010|Period 2|Adverse Event|0|||
131710067|NCT00868790|474217821|FG011|Period 2|Adverse Event|0|||
131710068|NCT00868790|474217822|FG012|Period 2|Adverse Event|0|||
131710069|NCT00868790|474217823|FG013|Period 2|Adverse Event|0|||
131710070|NCT00868790|474217810|FG000|Period 2|Lost to Follow-up|0|||
131710071|NCT00868790|474217811|FG001|Period 2|Lost to Follow-up|1|||
131710072|NCT00868790|474217812|FG002|Period 2|Lost to Follow-up|0|||
131710073|NCT00868790|474217813|FG003|Period 2|Lost to Follow-up|0|||
131710074|NCT00868790|474217814|FG004|Period 2|Lost to Follow-up|0|||
131795518|NCT01564758|474534039|FG000|Overall Study|Adverse Event|3|||
131795519|NCT01564758|474534039|FG000|Overall Study|Other|3|||
131795520|NCT00249821|474534040|FG000|Overall Study|Technical problem|0|||
131795521|NCT00249821|474534041|FG001|Overall Study|Technical problem|1|||
131710075|NCT00868790|474217815|FG005|Period 2|Lost to Follow-up|1|||
131795522|NCT00467584|474534046|FG000|Overall Study|Withdrawal by Subject|4|||
131795523|NCT00467584|474534047|FG001|Overall Study|Withdrawal by Subject|5|||
131795524|NCT00467584|474534048|FG002|Overall Study|Withdrawal by Subject|1|||
131795525|NCT02482571|474534049|FG000|Overall Study|Adverse Event|1|||
131795526|NCT02482571|474534049|FG000|Overall Study|Scanner or Respiract failure|3|||
131795527|NCT02482571|474534049|FG000|Overall Study|Withdrawal by Subject|4|||
131710076|NCT00868790|474217816|FG006|Period 2|Lost to Follow-up|0|||
131710077|NCT00868790|474217817|FG007|Period 2|Lost to Follow-up|0|||
131710078|NCT00868790|474217818|FG008|Period 2|Lost to Follow-up|0|||
131710079|NCT00868790|474217819|FG009|Period 2|Lost to Follow-up|0|||
131710080|NCT00868790|474217820|FG010|Period 2|Lost to Follow-up|0|||
131710081|NCT00868790|474217821|FG011|Period 2|Lost to Follow-up|0|||
131710082|NCT00868790|474217822|FG012|Period 2|Lost to Follow-up|0|||
131710083|NCT00868790|474217823|FG013|Period 2|Lost to Follow-up|0|||
131710084|NCT00868790|474217810|FG000|Period 2|Withdrawal by Subject|0|||
131710085|NCT00868790|474217811|FG001|Period 2|Withdrawal by Subject|0|||
131710086|NCT00868790|474217812|FG002|Period 2|Withdrawal by Subject|0|||
131710087|NCT00868790|474217813|FG003|Period 2|Withdrawal by Subject|0|||
131710088|NCT00868790|474217814|FG004|Period 2|Withdrawal by Subject|0|||
131710089|NCT00868790|474217815|FG005|Period 2|Withdrawal by Subject|0|||
131710090|NCT00868790|474217816|FG006|Period 2|Withdrawal by Subject|0|||
131710091|NCT00868790|474217817|FG007|Period 2|Withdrawal by Subject|0|||
131618910|NCT04186247|473895452|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131618911|NCT04186247|473895453|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131618912|NCT04186247|473895454|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131618913|NCT03662659|473895455|FG000|Pre-treatment|Participant no longer met study criteria|1|||
131618914|NCT03662659|473895456|FG001|Pre-treatment|Participant no longer met study criteria|1|||
131618915|NCT03662659|473895455|FG000|Pre-treatment|Other reasons|1|||
131618916|NCT03662659|473895456|FG001|Pre-treatment|Other reasons|0|||
131618917|NCT03662659|473895455|FG000|Treatment|Completed Treatment|0|||
131618918|NCT03662659|473895456|FG001|Treatment|Completed Treatment|2|||
131618919|NCT03662659|473895455|FG000|Treatment|Disease Progression|85|||
131618920|NCT03662659|473895456|FG001|Treatment|Disease Progression|97|||
131618921|NCT03662659|473895455|FG000|Treatment|Study Drug Toxicity|19|||
131618922|NCT03662659|473895456|FG001|Treatment|Study Drug Toxicity|9|||
131618923|NCT03662659|473895455|FG000|Treatment|Death|11|||
131618924|NCT03662659|473895456|FG001|Treatment|Death|9|||
131618925|NCT03662659|473895455|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
131618926|NCT03662659|473895456|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
131618927|NCT03662659|473895455|FG000|Treatment|Withdrawal by Subject|1|||
131618928|NCT03662659|473895456|FG001|Treatment|Withdrawal by Subject|1|||
131618929|NCT03662659|473895455|FG000|Treatment|Poor/Non-compliance|1|||
131618930|NCT03662659|473895456|FG001|Treatment|Poor/Non-compliance|0|||
131618931|NCT03662659|473895455|FG000|Treatment|Participant no longer meets study criteria|1|||
131618932|NCT03662659|473895456|FG001|Treatment|Participant no longer meets study criteria|0|||
131618933|NCT03662659|473895455|FG000|Treatment|Other reasons|10|||
131618934|NCT03662659|473895456|FG001|Treatment|Other reasons|8|||
131618935|NCT03662659|473895455|FG000|Treatment|Administrative reasons by sponsor|1|||
131618936|NCT03662659|473895456|FG001|Treatment|Administrative reasons by sponsor|0|||
131618937|NCT03662659|473895455|FG000|Treatment|maximum clinical benefit|0|||
131618938|NCT03662659|473895456|FG001|Treatment|maximum clinical benefit|2|||
131618939|NCT00551421|473896999|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
131618940|NCT04323800|473897002|FG000|Overall Study|Withdrawal by Subject|4|||
131618941|NCT04323800|473897003|FG001|Overall Study|Withdrawal by Subject|4|||
131618942|NCT04323800|473897002|FG000|Overall Study|Incomplete transfusion|1|||
131618943|NCT04323800|473897003|FG001|Overall Study|Incomplete transfusion|0|||
131618944|NCT04323800|473897002|FG000|Overall Study|Other|0|||
131618945|NCT04323800|473897003|FG001|Overall Study|Other|1|||
131618946|NCT04323800|473897002|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
131618947|NCT04323800|473897003|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
131618948|NCT00489554|473897004|FG000|Overall Study|Adverse Event|2|||
131618949|NCT00489554|473897004|FG000|Overall Study|Withdrawal by Subject|1|||
131618950|NCT00489554|473897004|FG000|Overall Study|Lost to Follow-up|1|||
131618951|NCT06571695|473897005|FG000|Overall Study|Lost to Follow-up|1|||
131618952|NCT06571695|473897006|FG001|Overall Study|Lost to Follow-up|6|||
131618953|NCT02713594|473897010|FG000|Overall Study|Withdrawal by Subject|32|||
131618954|NCT02713594|473897011|FG001|Overall Study|Withdrawal by Subject|22|||
131618955|NCT02713594|473897010|FG000|Overall Study|Lost to Follow-up|358|||
131618956|NCT02713594|473897011|FG001|Overall Study|Lost to Follow-up|374|||
131618957|NCT01380145|473897012|FG000|Overall Study|Progressive disease|4|||
131618958|NCT02038049|473897017|FG000|Overall Study|Lost to Follow-up|1|||
131618959|NCT02038049|473897018|FG001|Overall Study|Lost to Follow-up|0|||
131618960|NCT02771366|473897019|FG000|Period 1|Withdrawal by Subject|0|||
131618961|NCT02771366|473897020|FG001|Period 1|Withdrawal by Subject|2|||
131618962|NCT02771366|473897019|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
131618963|NCT02771366|473897020|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
131618964|NCT01808534|473897023|FG000|Overall Study|Disease progression|3|||
131618965|NCT01808534|473897023|FG000|Overall Study|Physician Decision|1|||
131618966|NCT01214200|473897024|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
131618967|NCT01214200|473897024|FG000|Overall Study|Withdrawal by Subject|2|||
131618968|NCT01823224|473897025|FG000|Overall Study|Lost to Follow-up|5|||
131618969|NCT01823224|473897026|FG001|Overall Study|Lost to Follow-up|6|||
131618970|NCT01823224|473897025|FG000|Overall Study|didn't qualify|1|||
131618971|NCT01823224|473897026|FG001|Overall Study|didn't qualify|2|||
131618972|NCT01823224|473897025|FG000|Overall Study|pharmacy error|0|||
131618973|NCT01823224|473897026|FG001|Overall Study|pharmacy error|1|||
131710092|NCT00868790|474217818|FG008|Period 2|Withdrawal by Subject|1|||
131618974|NCT01823224|473897025|FG000|Overall Study|missed med dose|0|||
131618975|NCT01823224|473897026|FG001|Overall Study|missed med dose|1|||
131618976|NCT01823224|473897025|FG000|Overall Study|Withdrawal by Subject|0|||
131618977|NCT01823224|473897026|FG001|Overall Study|Withdrawal by Subject|1|||
131618978|NCT02148705|473897032|FG000|Overall Study|Death|2|||
131618979|NCT02148705|473897033|FG001|Overall Study|Death|0|||
131618980|NCT02148705|473897034|FG002|Overall Study|Death|0|||
131618981|NCT02148705|473897032|FG000|Overall Study|Lost to Follow-up|13|||
131618982|NCT02148705|473897033|FG001|Overall Study|Lost to Follow-up|4|||
131618983|NCT02148705|473897034|FG002|Overall Study|Lost to Follow-up|10|||
131618984|NCT02148705|473897032|FG000|Overall Study|Withdrawal by Subject|3|||
131618985|NCT02148705|473897033|FG001|Overall Study|Withdrawal by Subject|0|||
131618986|NCT02148705|473897034|FG002|Overall Study|Withdrawal by Subject|2|||
131618987|NCT02148705|473897032|FG000|Overall Study|Not Treated|0|||
131618988|NCT02148705|473897033|FG001|Overall Study|Not Treated|1|||
131618989|NCT02148705|473897034|FG002|Overall Study|Not Treated|5|||
131618990|NCT01737021|473897037|FG000|Overall Study|Lost to Follow-up|5|||
131618991|NCT01737021|473897038|FG001|Overall Study|Lost to Follow-up|3|||
131618992|NCT03292406|473897041|FG000|Overall Study|Progressive Disease|6|||
131618993|NCT03292406|473897042|FG001|Overall Study|Progressive Disease|3|||
131618994|NCT03292406|473897043|FG002|Overall Study|Progressive Disease|4|||
131618995|NCT03292406|473897041|FG000|Overall Study|Adverse Event|7|||
131618996|NCT03292406|473897042|FG001|Overall Study|Adverse Event|1|||
131618997|NCT03292406|473897043|FG002|Overall Study|Adverse Event|4|||
131618998|NCT03292406|473897041|FG000|Overall Study|Withdrawal by Subject|0|||
131618999|NCT03292406|473897042|FG001|Overall Study|Withdrawal by Subject|7|||
131619000|NCT03292406|473897043|FG002|Overall Study|Withdrawal by Subject|2|||
131619001|NCT03292406|473897041|FG000|Overall Study|Protocol Violation|0|||
131619002|NCT03292406|473897042|FG001|Overall Study|Protocol Violation|1|||
131619003|NCT03292406|473897043|FG002|Overall Study|Protocol Violation|1|||
131619004|NCT03292406|473897041|FG000|Overall Study|Other|0|||
131619005|NCT03292406|473897042|FG001|Overall Study|Other|1|||
131619006|NCT03292406|473897043|FG002|Overall Study|Other|2|||
131619007|NCT03737110|473897044|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
131619008|NCT03737110|473897045|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
131619009|NCT03737110|473897046|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
131619010|NCT03737110|473897047|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
131619011|NCT03737110|473897048|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
131619012|NCT03737110|473897049|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
131619013|NCT03737110|473897044|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
131619014|NCT03737110|473897045|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131795528|NCT01498484|474534053|FG000|Overall Study|Death|6|||
131795529|NCT01498484|474534054|FG001|Overall Study|Death|3|||
131795530|NCT01498484|474534055|FG002|Overall Study|Death|1|||
131795531|NCT01498484|474534056|FG003|Overall Study|Death|1|||
131795532|NCT01498484|474534057|FG004|Overall Study|Death|0|||
131795533|NCT01498484|474534058|FG005|Overall Study|Death|0|||
131795534|NCT01498484|474534059|FG006|Overall Study|Death|10|||
131795535|NCT01498484|474534060|FG007|Overall Study|Death|1|||
131795536|NCT01498484|474534061|FG008|Overall Study|Death|0|||
131795537|NCT01498484|474534053|FG000|Overall Study|Physician Decision|3|||
131795538|NCT01498484|474534054|FG001|Overall Study|Physician Decision|2|||
131795539|NCT01498484|474534055|FG002|Overall Study|Physician Decision|1|||
131795540|NCT01498484|474534056|FG003|Overall Study|Physician Decision|1|||
131795541|NCT01498484|474534057|FG004|Overall Study|Physician Decision|0|||
131795542|NCT01498484|474534058|FG005|Overall Study|Physician Decision|0|||
131795543|NCT01498484|474534059|FG006|Overall Study|Physician Decision|8|||
131795544|NCT01498484|474534060|FG007|Overall Study|Physician Decision|13|||
131795545|NCT01498484|474534061|FG008|Overall Study|Physician Decision|1|||
131795546|NCT01498484|474534053|FG000|Overall Study|Adverse Event|0|||
131619015|NCT03737110|473897046|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131619016|NCT03737110|473897047|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131619017|NCT03737110|473897048|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131619018|NCT03737110|473897049|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131619019|NCT03737110|473897044|FG000|Run-in (RI) Period|Adverse Event|4|||
131619020|NCT03737110|473897045|FG001|Run-in (RI) Period|Adverse Event|0|||
131619021|NCT03737110|473897046|FG002|Run-in (RI) Period|Adverse Event|0|||
131619022|NCT03737110|473897047|FG003|Run-in (RI) Period|Adverse Event|0|||
131619023|NCT03737110|473897048|FG004|Run-in (RI) Period|Adverse Event|0|||
131619024|NCT03737110|473897049|FG005|Run-in (RI) Period|Adverse Event|0|||
131619025|NCT03737110|473897044|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131619026|NCT03737110|473897045|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
131619027|NCT03737110|473897046|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131619028|NCT03737110|473897047|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131619029|NCT03737110|473897048|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131619030|NCT03737110|473897049|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131619031|NCT03737110|473897044|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131619032|NCT03737110|473897045|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131619033|NCT03737110|473897046|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
131619034|NCT03737110|473897047|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131619035|NCT03737110|473897048|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131619036|NCT03737110|473897049|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131619037|NCT03737110|473897044|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131619038|NCT03737110|473897045|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131619039|NCT03737110|473897046|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131795547|NCT01498484|474534054|FG001|Overall Study|Adverse Event|0|||
131795548|NCT01498484|474534055|FG002|Overall Study|Adverse Event|0|||
131619040|NCT03737110|473897047|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
131619041|NCT03737110|473897048|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131619042|NCT03737110|473897049|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131619043|NCT03737110|473897044|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131619044|NCT03737110|473897045|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131619045|NCT03737110|473897046|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131619046|NCT03737110|473897047|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
131619047|NCT03737110|473897048|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131619048|NCT03737110|473897049|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
131619049|NCT03737110|473897044|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131619050|NCT03737110|473897045|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131619051|NCT03737110|473897046|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131619052|NCT03737110|473897047|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131619053|NCT03737110|473897048|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
131619054|NCT03737110|473897049|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131619055|NCT00047385|473897054|FG000|Overall Study|Death before any screening|2|||
131619056|NCT00047385|473897055|FG001|Overall Study|Death before any screening|5|||
131619057|NCT00047385|473897054|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
131619058|NCT00047385|473897055|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
131619059|NCT00047385|473897054|FG000|Overall Study|Eligible for screening but had no screen|260|||
131619060|NCT00047385|473897055|FG001|Overall Study|Eligible for screening but had no screen|492|||
131619061|NCT02575365|473897060|FG000|Overall Study|Lost to Follow-up|4|||
131619062|NCT01009645|473897067|FG000|Overall Study|Lost to Follow-up|2|||
131619063|NCT01009645|473897068|FG001|Overall Study|Lost to Follow-up|8|||
131619064|NCT01009645|473897069|FG002|Overall Study|Lost to Follow-up|4|||
131619065|NCT01009645|473897070|FG003|Overall Study|Lost to Follow-up|5|||
131619066|NCT05124210|473897071|FG000|Overall Study|Lost to Follow-up|1|||
131619067|NCT05124210|473897072|FG001|Overall Study|Lost to Follow-up|0|||
131619068|NCT05124210|473897071|FG000|Overall Study|Withdrawal by Subject|1|||
131619069|NCT05124210|473897072|FG001|Overall Study|Withdrawal by Subject|0|||
131619070|NCT00768755|473897075|FG000|Phase 1|Death|6|||
131619071|NCT00768755|473897076|FG001|Phase 1|Death|0|||
131619072|NCT00768755|473897077|FG002|Phase 1|Death|0|||
131619073|NCT00768755|473897078|FG003|Phase 1|Death|0|||
131619074|NCT00768755|473897075|FG000|Phase 1|Other|4|||
131619075|NCT00768755|473897076|FG001|Phase 1|Other|0|||
131619076|NCT00768755|473897077|FG002|Phase 1|Other|0|||
131619077|NCT00768755|473897078|FG003|Phase 1|Other|0|||
131619078|NCT00768755|473897075|FG000|Phase 2|Death|0|||
131619079|NCT00768755|473897076|FG001|Phase 2|Death|37|||
131619080|NCT00768755|473897077|FG002|Phase 2|Death|48|||
131619081|NCT00768755|473897078|FG003|Phase 2|Death|31|||
131619082|NCT00768755|473897075|FG000|Phase 2|Protocol Violation|0|||
131619083|NCT00768755|473897076|FG001|Phase 2|Protocol Violation|2|||
131619084|NCT00768755|473897077|FG002|Phase 2|Protocol Violation|0|||
131619085|NCT00768755|473897078|FG003|Phase 2|Protocol Violation|1|||
131619086|NCT00768755|473897075|FG000|Phase 2|Lost to Follow-up|0|||
131619087|NCT00768755|473897076|FG001|Phase 2|Lost to Follow-up|1|||
131619088|NCT00768755|473897077|FG002|Phase 2|Lost to Follow-up|1|||
131619089|NCT00768755|473897078|FG003|Phase 2|Lost to Follow-up|4|||
131619090|NCT00768755|473897075|FG000|Phase 2|Withdrawal by Subject|0|||
131619091|NCT00768755|473897076|FG001|Phase 2|Withdrawal by Subject|1|||
131619092|NCT00768755|473897077|FG002|Phase 2|Withdrawal by Subject|0|||
131619093|NCT00768755|473897078|FG003|Phase 2|Withdrawal by Subject|1|||
131619094|NCT00768755|473897075|FG000|Phase 2|Other|0|||
131619095|NCT00768755|473897076|FG001|Phase 2|Other|1|||
131619096|NCT00768755|473897077|FG002|Phase 2|Other|2|||
131619097|NCT00768755|473897078|FG003|Phase 2|Other|4|||
131619098|NCT00768755|473897075|FG000|Phase 2|Study Terminated by Sponsor|0|||
131619099|NCT00768755|473897076|FG001|Phase 2|Study Terminated by Sponsor|13|||
131619100|NCT00768755|473897077|FG002|Phase 2|Study Terminated by Sponsor|7|||
131619101|NCT00768755|473897078|FG003|Phase 2|Study Terminated by Sponsor|14|||
131619102|NCT00768755|473897075|FG000|Phase 2|Randomized but not treated|0|||
131619103|NCT00768755|473897076|FG001|Phase 2|Randomized but not treated|0|||
131619104|NCT00768755|473897077|FG002|Phase 2|Randomized but not treated|0|||
131619105|NCT00768755|473897078|FG003|Phase 2|Randomized but not treated|2|||
131619106|NCT00310037|473897079|FG000|Overall Study|Adverse Event|7|||
131619107|NCT00310037|473897080|FG001|Overall Study|Adverse Event|14|||
131619108|NCT00310037|473897079|FG000|Overall Study|Withdrawal by Subject|4|||
131619109|NCT00310037|473897080|FG001|Overall Study|Withdrawal by Subject|3|||
131619110|NCT00310037|473897079|FG000|Overall Study|Progression|6|||
131619111|NCT00310037|473897080|FG001|Overall Study|Progression|0|||
131619112|NCT00310037|473897079|FG000|Overall Study|Non-protocol treatment|1|||
131619113|NCT00310037|473897080|FG001|Overall Study|Non-protocol treatment|0|||
131619114|NCT02203799|473897081|FG000|Overall Study|Withdrawal by Subject|3|||
131619115|NCT02106884|473897082|FG000|Overall Study|Change of diagnosis/exclusion|0|||
131619116|NCT02106884|473897083|FG001|Overall Study|Change of diagnosis/exclusion|1|||
131619117|NCT00659373|473897084|FG000|Overall Study|Withdrawal by Subject|3|||
131619118|NCT00659373|473897085|FG001|Overall Study|Withdrawal by Subject|5|||
131619119|NCT00659373|473897084|FG000|Overall Study|Assessment Missed|2|||
131619120|NCT00659373|473897085|FG001|Overall Study|Assessment Missed|2|||
131619121|NCT02382640|473897086|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
131619122|NCT02382640|473897087|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
131619123|NCT02382640|473897088|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
131619124|NCT02382640|473897089|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
131619125|NCT01560429|473897092|FG000|Overall Study|Protocol Violation|3|||
131619126|NCT01560429|473897093|FG001|Overall Study|Protocol Violation|6|||
131619127|NCT03162614|473897094|FG000|Overall Study|Lost to Follow-up|2|||
131619128|NCT03162614|473897095|FG001|Overall Study|Lost to Follow-up|1|||
131619129|NCT03162614|473897096|FG002|Overall Study|Lost to Follow-up|1|||
131619130|NCT03162614|473897097|FG003|Overall Study|Lost to Follow-up|1|||
131619131|NCT03162614|473897098|FG004|Overall Study|Lost to Follow-up|2|||
131619132|NCT03162614|473897099|FG005|Overall Study|Lost to Follow-up|0|||
131619133|NCT03162614|473897094|FG000|Overall Study|Protocol Violation|0|||
131619134|NCT03162614|473897095|FG001|Overall Study|Protocol Violation|1|||
131619135|NCT03162614|473897096|FG002|Overall Study|Protocol Violation|0|||
131619136|NCT03162614|473897097|FG003|Overall Study|Protocol Violation|1|||
131619137|NCT03162614|473897098|FG004|Overall Study|Protocol Violation|0|||
131619138|NCT03162614|473897099|FG005|Overall Study|Protocol Violation|0|||
131619139|NCT03162614|473897094|FG000|Overall Study|Withdrawal by Subject|2|||
131619140|NCT03162614|473897095|FG001|Overall Study|Withdrawal by Subject|1|||
131619141|NCT03162614|473897096|FG002|Overall Study|Withdrawal by Subject|1|||
131619142|NCT03162614|473897097|FG003|Overall Study|Withdrawal by Subject|1|||
131619143|NCT03162614|473897098|FG004|Overall Study|Withdrawal by Subject|0|||
131619144|NCT03162614|473897099|FG005|Overall Study|Withdrawal by Subject|0|||
131619145|NCT03162614|473897094|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
131619146|NCT03162614|473897095|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
131619147|NCT03162614|473897096|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
131619148|NCT03162614|473897097|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
131619149|NCT03162614|473897098|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
131619150|NCT03162614|473897099|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
131619151|NCT00380250|473897110|FG000|Overall Study|Withdrawal by Subject|39|||
131619152|NCT00380250|473897111|FG001|Overall Study|Withdrawal by Subject|28|||
131619153|NCT00380250|473897110|FG000|Overall Study|Adverse Event|20|||
131619154|NCT00380250|473897111|FG001|Overall Study|Adverse Event|9|||
131619155|NCT00380250|473897110|FG000|Overall Study|Lack of Efficacy|10|||
131619156|NCT00380250|473897111|FG001|Overall Study|Lack of Efficacy|8|||
131619157|NCT00380250|473897110|FG000|Overall Study|Protocol Violation|15|||
131619158|NCT00380250|473897111|FG001|Overall Study|Protocol Violation|5|||
131619159|NCT00380250|473897110|FG000|Overall Study|Lost to Follow-up|14|||
131619160|NCT00380250|473897111|FG001|Overall Study|Lost to Follow-up|5|||
131619161|NCT00380250|473897110|FG000|Overall Study|Physician Decision|1|||
131619162|NCT00380250|473897111|FG001|Overall Study|Physician Decision|0|||
131619163|NCT04029090|473897112|FG000|Overall Study|Protocol Violation|1|||
131619164|NCT04029090|473897113|FG001|Overall Study|Protocol Violation|0|||
131619165|NCT04029090|473897114|FG002|Overall Study|Protocol Violation|0|||
131619166|NCT04029090|473897112|FG000|Overall Study|Withdrawal by Subject|0|||
131619167|NCT04029090|473897113|FG001|Overall Study|Withdrawal by Subject|1|||
131619168|NCT04029090|473897114|FG002|Overall Study|Withdrawal by Subject|0|||
131619169|NCT02157948|473897115|FG000|Overall Study|Withdrawal by Subject|4|||
131619170|NCT02157948|473897116|FG001|Overall Study|Withdrawal by Subject|5|||
131619171|NCT02157948|473897115|FG000|Overall Study|Lost to Follow-up|3|||
131619172|NCT02157948|473897116|FG001|Overall Study|Lost to Follow-up|2|||
131619173|NCT02157948|473897115|FG000|Overall Study|Protocol Specified Criteria|2|||
131619174|NCT02157948|473897116|FG001|Overall Study|Protocol Specified Criteria|1|||
131619175|NCT02157948|473897115|FG000|Overall Study|Decision by Sponsor|0|||
131619176|NCT02157948|473897116|FG001|Overall Study|Decision by Sponsor|1|||
131619177|NCT01604824|473897117|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131619178|NCT01604824|473897118|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131619179|NCT01604824|473897119|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131619180|NCT01604824|473897120|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131619181|NCT01604824|473897121|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
131619182|NCT01604824|473897122|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131619183|NCT01604824|473897117|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
131619184|NCT01604824|473897118|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
131619185|NCT01604824|473897119|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
131619186|NCT01604824|473897120|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
131619187|NCT01604824|473897121|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
131619188|NCT01604824|473897122|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
131619189|NCT00243867|473897123|FG000|Overall Study|Adverse Event|24|||
131619190|NCT00243867|473897124|FG001|Overall Study|Adverse Event|34|||
131619191|NCT00243867|473897123|FG000|Overall Study|Lack of Efficacy|115|||
131619192|NCT00243867|473897124|FG001|Overall Study|Lack of Efficacy|78|||
131619193|NCT00243867|473897123|FG000|Overall Study|Withdrawal by Subject|11|||
131619194|NCT00243867|473897124|FG001|Overall Study|Withdrawal by Subject|23|||
131619195|NCT00243867|473897123|FG000|Overall Study|Lost to Follow-up|2|||
131619196|NCT00243867|473897124|FG001|Overall Study|Lost to Follow-up|1|||
131619197|NCT00243867|473897123|FG000|Overall Study|Physician Decision|2|||
131619198|NCT00243867|473897124|FG001|Overall Study|Physician Decision|7|||
131619199|NCT00243867|473897123|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
131619200|NCT00243867|473897124|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
131619201|NCT06269003|473897136|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
131619202|NCT06269003|473897137|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
131619203|NCT06269003|473897138|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
131619204|NCT06269003|473897139|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
131619205|NCT04602728|473897140|FG000|Overall Study|Lost to Follow-up|4|||
131619206|NCT04602728|473897141|FG001|Overall Study|Lost to Follow-up|4|||
131619207|NCT04447027|473897144|FG000|Dose Escalation|Withdrawal by Subject|1|||
131619208|NCT04447027|473897145|FG001|Dose Escalation|Withdrawal by Subject|4|||
131619209|NCT04447027|473897146|FG002|Dose Escalation|Withdrawal by Subject|3|||
131619210|NCT04447027|473897147|FG003|Dose Escalation|Withdrawal by Subject|3|||
131619211|NCT04447027|473897148|FG004|Dose Escalation|Withdrawal by Subject|1|||
131619212|NCT04447027|473897149|FG005|Dose Escalation|Withdrawal by Subject|0|||
131619213|NCT04447027|473897150|FG006|Dose Escalation|Withdrawal by Subject|0|||
131619214|NCT04447027|473897151|FG007|Dose Escalation|Withdrawal by Subject|0|||
131619215|NCT04447027|473897152|FG008|Dose Escalation|Withdrawal by Subject|0|||
131619216|NCT04447027|473897144|FG000|Dose Escalation|Refused further treatment|0|||
131619217|NCT04447027|473897145|FG001|Dose Escalation|Refused further treatment|1|||
131619218|NCT04447027|473897146|FG002|Dose Escalation|Refused further treatment|1|||
131619219|NCT04447027|473897147|FG003|Dose Escalation|Refused further treatment|0|||
131619220|NCT04447027|473897148|FG004|Dose Escalation|Refused further treatment|0|||
131619221|NCT04447027|473897149|FG005|Dose Escalation|Refused further treatment|0|||
131619222|NCT04447027|473897150|FG006|Dose Escalation|Refused further treatment|0|||
131619223|NCT04447027|473897151|FG007|Dose Escalation|Refused further treatment|0|||
131619224|NCT04447027|473897152|FG008|Dose Escalation|Refused further treatment|0|||
131619225|NCT04447027|473897144|FG000|Dose Expansion|Withdrawal by Subject|0|||
131619226|NCT04447027|473897145|FG001|Dose Expansion|Withdrawal by Subject|0|||
131619227|NCT04447027|473897146|FG002|Dose Expansion|Withdrawal by Subject|0|||
131619228|NCT04447027|473897147|FG003|Dose Expansion|Withdrawal by Subject|0|||
131619229|NCT04447027|473897148|FG004|Dose Expansion|Withdrawal by Subject|0|||
131619230|NCT04447027|473897149|FG005|Dose Expansion|Withdrawal by Subject|2|||
131619231|NCT04447027|473897150|FG006|Dose Expansion|Withdrawal by Subject|0|||
131619232|NCT04447027|473897151|FG007|Dose Expansion|Withdrawal by Subject|2|||
131619233|NCT04447027|473897152|FG008|Dose Expansion|Withdrawal by Subject|0|||
131619234|NCT02831049|473897153|FG000|Overall Study|Lost to Follow-up|0|||
131619235|NCT02831049|473897154|FG001|Overall Study|Lost to Follow-up|0|||
131619236|NCT02831049|473897155|FG002|Overall Study|Lost to Follow-up|1|||
131619237|NCT02831049|473897153|FG000|Overall Study|Withdrawal by Subject|0|||
131619238|NCT02831049|473897154|FG001|Overall Study|Withdrawal by Subject|1|||
131619239|NCT02831049|473897155|FG002|Overall Study|Withdrawal by Subject|1|||
131619240|NCT02831049|473897153|FG000|Overall Study|Pandemic shutdown|1|||
131619241|NCT02831049|473897154|FG001|Overall Study|Pandemic shutdown|0|||
131619242|NCT02831049|473897155|FG002|Overall Study|Pandemic shutdown|0|||
131619243|NCT04118894|473897157|FG000|Overall Study|Lost to Follow-up|21|||
131619244|NCT04118894|473897157|FG000|Overall Study|Withdrawal by Subject|10|||
131619245|NCT04118894|473897157|FG000|Overall Study|Adverse Event|4|||
131619246|NCT00667017|473898516|FG000|Overall Study|Withdrawal by Subject|1|||
131619247|NCT03960645|473898520|FG000|Overall Study|Protocol Violation|1|||
131619248|NCT03960645|473898521|FG001|Overall Study|Protocol Violation|0|||
131619249|NCT00022672|473898522|FG000|Main Phase: 24 Months|Adverse Event|6|||
131619250|NCT00022672|473898523|FG001|Main Phase: 24 Months|Adverse Event|0|||
131619251|NCT00022672|473898522|FG000|Main Phase: 24 Months|Death|0|||
131619252|NCT00022672|473898523|FG001|Main Phase: 24 Months|Death|3|||
131619253|NCT00022672|473898522|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
131619254|NCT00022672|473898523|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
131619255|NCT00022672|473898522|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
131619256|NCT00022672|473898523|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
131619257|NCT00022672|473898522|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
131619258|NCT00022672|473898523|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
131619259|NCT00022672|473898522|FG000|Main Phase: 24 Months|Refused Treatment|3|||
131619260|NCT00022672|473898523|FG001|Main Phase: 24 Months|Refused Treatment|4|||
131619261|NCT00022672|473898522|FG000|Main Phase: 24 Months|Failure to Return|1|||
131619262|NCT00022672|473898523|FG001|Main Phase: 24 Months|Failure to Return|1|||
131619263|NCT00022672|473898522|FG000|Main Phase: 24 Months|Other|1|||
131619264|NCT00022672|473898523|FG001|Main Phase: 24 Months|Other|0|||
131619265|NCT00022672|473898522|FG000|Extension Phase|Adverse Event|1|||
131619266|NCT00022672|473898523|FG001|Extension Phase|Adverse Event|3|||
131619267|NCT00022672|473898522|FG000|Extension Phase|Death|0|||
131619268|NCT00022672|473898523|FG001|Extension Phase|Death|1|||
131619269|NCT00022672|473898522|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
131619270|NCT00022672|473898523|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
131619271|NCT00022672|473898522|FG000|Extension Phase|Refused Treatment|0|||
131619272|NCT00022672|473898523|FG001|Extension Phase|Refused Treatment|2|||
131619273|NCT00022672|473898522|FG000|Extension Phase|Other|1|||
131619274|NCT00022672|473898523|FG001|Extension Phase|Other|1|||
131619275|NCT00403494|473898524|FG000|Overall Study|Adverse Event|10|||
131619276|NCT00403494|473898525|FG001|Overall Study|Adverse Event|8|||
131619277|NCT00403494|473898524|FG000|Overall Study|Withdrew Consent|3|||
131619278|NCT00403494|473898525|FG001|Overall Study|Withdrew Consent|2|||
131619279|NCT00403494|473898524|FG000|Overall Study|Inappropriately enrolled|0|||
131619280|NCT00403494|473898525|FG001|Overall Study|Inappropriately enrolled|1|||
131619281|NCT00403494|473898524|FG000|Overall Study|Lost to Follow-up|0|||
131619282|NCT00403494|473898525|FG001|Overall Study|Lost to Follow-up|2|||
131619283|NCT00403494|473898524|FG000|Overall Study|Protocol noncompliance|0|||
131619284|NCT00403494|473898525|FG001|Overall Study|Protocol noncompliance|1|||
131619285|NCT00403494|473898524|FG000|Overall Study|Death|1|||
131619286|NCT00403494|473898525|FG001|Overall Study|Death|0|||
131619287|NCT00403494|473898524|FG000|Overall Study|Sponsor Request|1|||
131619288|NCT00403494|473898525|FG001|Overall Study|Sponsor Request|0|||
131619289|NCT00273052|473898530|FG000|Overall Study|Withdrawal by Subject|16|||
131619290|NCT00273052|473898531|FG001|Overall Study|Withdrawal by Subject|19|||
131619291|NCT00273052|473898530|FG000|Overall Study|Adverse Event|21|||
131619292|NCT00273052|473898531|FG001|Overall Study|Adverse Event|19|||
131619293|NCT00273052|473898530|FG000|Overall Study|Protocol Violation|14|||
131619294|NCT00273052|473898531|FG001|Overall Study|Protocol Violation|18|||
131619295|NCT00273052|473898530|FG000|Overall Study|Lost to Follow-up|7|||
131619296|NCT00273052|473898531|FG001|Overall Study|Lost to Follow-up|25|||
131619297|NCT00273052|473898530|FG000|Overall Study|Lack of Efficacy|6|||
131619298|NCT00273052|473898531|FG001|Overall Study|Lack of Efficacy|4|||
131619299|NCT00273052|473898530|FG000|Overall Study|Non-Compliance|3|||
131619300|NCT00273052|473898531|FG001|Overall Study|Non-Compliance|1|||
131619301|NCT00273052|473898530|FG000|Overall Study|Other|2|||
131619302|NCT00273052|473898531|FG001|Overall Study|Other|0|||
131619303|NCT00273052|473898530|FG000|Overall Study|Worsening serum lipid levels|0|||
131619304|NCT00273052|473898531|FG001|Overall Study|Worsening serum lipid levels|2|||
131619305|NCT02224755|473898532|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
131619306|NCT02224755|473898533|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
131619307|NCT02224755|473898532|FG000|Two Year Follow up Post-implant|Death|103|||
131619308|NCT02224755|473898533|FG001|Two Year Follow up Post-implant|Death|98|||
131619309|NCT02224755|473898532|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
131619310|NCT02224755|473898533|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
131619311|NCT02224755|473898532|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
131619312|NCT02224755|473898533|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
131710093|NCT00868790|474217819|FG009|Period 2|Withdrawal by Subject|0|||
131710094|NCT00868790|474217820|FG010|Period 2|Withdrawal by Subject|0|||
131619313|NCT02224755|473898532|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
131619314|NCT02224755|473898533|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
131619315|NCT01951703|473898536|FG000|First Intervention|Withdrawal by Subject|1|||
131619316|NCT01951703|473898537|FG001|First Intervention|Withdrawal by Subject|0|||
131619317|NCT01951703|473898536|FG000|First Intervention|Subject was not compliant|1|||
131619318|NCT01951703|473898537|FG001|First Intervention|Subject was not compliant|1|||
131619319|NCT01951703|473898536|FG000|First Intervention|Physician Decision|1|||
131619320|NCT01951703|473898537|FG001|First Intervention|Physician Decision|0|||
131619321|NCT01951703|473898536|FG000|Second Intervention|Protocol Violation|0|||
131619322|NCT01951703|473898537|FG001|Second Intervention|Protocol Violation|1|||
131619323|NCT01951703|473898536|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
131619324|NCT01951703|473898537|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
131619325|NCT02007070|473898539|FG000|Overall Study|Adverse Event|4|||
131619326|NCT02007070|473898539|FG000|Overall Study|Clinical Progression|4|||
131619327|NCT02007070|473898539|FG000|Overall Study|Death|1|||
131619328|NCT02007070|473898539|FG000|Overall Study|Protocol Violation|2|||
131619329|NCT02007070|473898539|FG000|Overall Study|Physician Decision|1|||
131619330|NCT02007070|473898539|FG000|Overall Study|Progressive Disease|21|||
131619331|NCT02708498|473898540|FG000|Overall Study|Death|20|||
131619332|NCT02708498|473898541|FG001|Overall Study|Death|19|||
131619333|NCT02708498|473898542|FG002|Overall Study|Death|0|||
131619334|NCT02708498|473898543|FG003|Overall Study|Death|0|||
131619335|NCT02708498|473898544|FG004|Overall Study|Death|1|||
131619336|NCT02708498|473898545|FG005|Overall Study|Death|0|||
131619337|NCT02708498|473898546|FG006|Overall Study|Death|0|||
131619338|NCT02708498|473898547|FG007|Overall Study|Death|0|||
131619339|NCT02708498|473898540|FG000|Overall Study|Unknown reason, missing data|0|||
131619340|NCT02708498|473898541|FG001|Overall Study|Unknown reason, missing data|0|||
131619341|NCT02708498|473898542|FG002|Overall Study|Unknown reason, missing data|62|||
131619342|NCT02708498|473898543|FG003|Overall Study|Unknown reason, missing data|51|||
131619343|NCT02708498|473898544|FG004|Overall Study|Unknown reason, missing data|195|||
131619344|NCT02708498|473898545|FG005|Overall Study|Unknown reason, missing data|132|||
131619345|NCT02708498|473898546|FG006|Overall Study|Unknown reason, missing data|0|||
131619346|NCT02708498|473898547|FG007|Overall Study|Unknown reason, missing data|0|||
131619347|NCT01640288|473898550|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
131619348|NCT01640288|473898551|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
131619349|NCT01640288|473898550|FG000|Overall Study|Screen Failure|20|||
131619350|NCT01640288|473898551|FG001|Overall Study|Screen Failure|18|||
131619351|NCT01640288|473898550|FG000|Overall Study|Withdrawn by PI|5|||
131619352|NCT01640288|473898551|FG001|Overall Study|Withdrawn by PI|0|||
131619353|NCT01640288|473898550|FG000|Overall Study|Withdrawal by Subject|1|||
131619354|NCT01640288|473898551|FG001|Overall Study|Withdrawal by Subject|0|||
131619355|NCT05260437|473898554|FG000|Overall Study|Lost to Follow-up|5|||
131619356|NCT05260437|473898555|FG001|Overall Study|Lost to Follow-up|2|||
131619357|NCT05260437|473898556|FG002|Overall Study|Lost to Follow-up|1|||
131619358|NCT05260437|473898557|FG003|Overall Study|Lost to Follow-up|2|||
131619359|NCT05260437|473898558|FG004|Overall Study|Lost to Follow-up|2|||
131619360|NCT05260437|473898554|FG000|Overall Study|Withdrawal by Subject|3|||
131619361|NCT05260437|473898555|FG001|Overall Study|Withdrawal by Subject|0|||
131619362|NCT05260437|473898556|FG002|Overall Study|Withdrawal by Subject|4|||
131619363|NCT05260437|473898557|FG003|Overall Study|Withdrawal by Subject|5|||
131619364|NCT05260437|473898558|FG004|Overall Study|Withdrawal by Subject|0|||
131619365|NCT05260437|473898554|FG000|Overall Study|Vaccine Not Administered|0|||
131619366|NCT05260437|473898555|FG001|Overall Study|Vaccine Not Administered|1|||
131619367|NCT05260437|473898556|FG002|Overall Study|Vaccine Not Administered|0|||
131619368|NCT05260437|473898557|FG003|Overall Study|Vaccine Not Administered|0|||
131619369|NCT05260437|473898558|FG004|Overall Study|Vaccine Not Administered|0|||
131619370|NCT00910962|473898559|FG000|Overall Study|Adverse Event|5|||
131619371|NCT00910962|473898560|FG001|Overall Study|Adverse Event|20|||
131619372|NCT00910962|473898561|FG002|Overall Study|Adverse Event|17|||
131619373|NCT00910962|473898559|FG000|Overall Study|Protocol Violation|1|||
131619374|NCT00910962|473898560|FG001|Overall Study|Protocol Violation|3|||
131619375|NCT00910962|473898561|FG002|Overall Study|Protocol Violation|3|||
131710095|NCT00868790|474217821|FG011|Period 2|Withdrawal by Subject|0|||
131619376|NCT00910962|473898559|FG000|Overall Study|Lost to Follow-up|0|||
131619377|NCT00910962|473898560|FG001|Overall Study|Lost to Follow-up|3|||
131710096|NCT00868790|474217822|FG012|Period 2|Withdrawal by Subject|0|||
131619378|NCT00910962|473898561|FG002|Overall Study|Lost to Follow-up|1|||
131619379|NCT00910962|473898559|FG000|Overall Study|Physician Decision|0|||
131619380|NCT00910962|473898560|FG001|Overall Study|Physician Decision|6|||
131619381|NCT00910962|473898561|FG002|Overall Study|Physician Decision|6|||
131619382|NCT00910962|473898559|FG000|Overall Study|Withdrawal by Subject|25|||
131619383|NCT00910962|473898560|FG001|Overall Study|Withdrawal by Subject|32|||
131619384|NCT00910962|473898561|FG002|Overall Study|Withdrawal by Subject|32|||
131619385|NCT00910962|473898559|FG000|Overall Study|Reached defined stopping criteria|12|||
131619386|NCT00910962|473898560|FG001|Overall Study|Reached defined stopping criteria|14|||
131619387|NCT00910962|473898561|FG002|Overall Study|Reached defined stopping criteria|17|||
131619388|NCT00195819|473898562|FG000|Double-Blind|Withdrawal by Subject|1|||
131619389|NCT00195819|473898563|FG001|Double-Blind|Withdrawal by Subject|0|||
131619390|NCT00195819|473898562|FG000|Double-Blind|Moved|1|||
131619391|NCT00195819|473898563|FG001|Double-Blind|Moved|0|||
131619392|NCT00195819|473898562|FG000|Open-label|Adverse Event|0|||
131619393|NCT00195819|473898563|FG001|Open-label|Adverse Event|9|||
131619394|NCT00195819|473898562|FG000|Open-label|Lack of Efficacy|0|||
131619395|NCT00195819|473898563|FG001|Open-label|Lack of Efficacy|2|||
131619396|NCT00195819|473898562|FG000|Open-label|Pregnancy|0|||
131619397|NCT00195819|473898563|FG001|Open-label|Pregnancy|1|||
131619398|NCT00195819|473898562|FG000|Open-label|Protocol Violation|0|||
131619399|NCT00195819|473898563|FG001|Open-label|Protocol Violation|2|||
131619400|NCT00195819|473898562|FG000|Open-label|Moved|0|||
131619401|NCT00195819|473898563|FG001|Open-label|Moved|1|||
131619402|NCT00195819|473898562|FG000|Open-label|Withdrawal by Subject|0|||
131619403|NCT00195819|473898563|FG001|Open-label|Withdrawal by Subject|5|||
131619404|NCT00787176|473898564|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
131619405|NCT00787176|473898565|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
131619406|NCT00787176|473898566|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
131619407|NCT00787176|473898567|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
131619408|NCT01629589|473898571|FG000|Overall Study|Protocol Violation|4|||
131619409|NCT01629589|473898572|FG001|Overall Study|Protocol Violation|2|||
131619410|NCT01629589|473898571|FG000|Overall Study|Lost to Follow-up|2|||
131619411|NCT01629589|473898572|FG001|Overall Study|Lost to Follow-up|1|||
131619412|NCT01629589|473898571|FG000|Overall Study|Withdrawal by Subject|2|||
131619413|NCT01629589|473898572|FG001|Overall Study|Withdrawal by Subject|3|||
131619414|NCT01629589|473898571|FG000|Overall Study|Did not receive study vaccine|0|||
131619415|NCT01629589|473898572|FG001|Overall Study|Did not receive study vaccine|1|||
131619416|NCT01303510|473898573|FG000|Overall Study|Lost to Follow-up|1|||
131619417|NCT01303510|473898574|FG001|Overall Study|Lost to Follow-up|0|||
131619418|NCT00822900|473898575|FG000|Overall Study|Withdrawal by Subject|14|||
131619419|NCT00822900|473898576|FG001|Overall Study|Withdrawal by Subject|14|||
131619420|NCT00822900|473898575|FG000|Overall Study|Lost to Follow-up|9|||
131619421|NCT00822900|473898576|FG001|Overall Study|Lost to Follow-up|9|||
131619422|NCT00822900|473898575|FG000|Overall Study|Death|83|||
131619423|NCT00822900|473898576|FG001|Overall Study|Death|69|||
131619424|NCT00822900|473898575|FG000|Overall Study|Became a ward of the state|2|||
131619425|NCT00822900|473898576|FG001|Overall Study|Became a ward of the state|1|||
131619426|NCT02095678|473898577|FG000|Overall Study|Withdrawal by Subject|0|||
131619427|NCT02095678|473898578|FG001|Overall Study|Withdrawal by Subject|1|||
131619428|NCT02095678|473898577|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
131619429|NCT02095678|473898578|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
131619430|NCT02095678|473898577|FG000|Overall Study|lesion impacted by previous treatment|1|||
131619431|NCT02095678|473898578|FG001|Overall Study|lesion impacted by previous treatment|1|||
131619432|NCT02095678|473898577|FG000|Overall Study|No Confirmed Diagnosis|0|||
131619433|NCT02095678|473898578|FG001|Overall Study|No Confirmed Diagnosis|3|||
131710097|NCT00868790|474217823|FG013|Period 2|Withdrawal by Subject|1|||
131710098|NCT00868790|474217810|FG000|Period 3|Adverse Event|0|||
131710099|NCT00868790|474217811|FG001|Period 3|Adverse Event|0|||
131710100|NCT00868790|474217812|FG002|Period 3|Adverse Event|0|||
131710101|NCT00868790|474217813|FG003|Period 3|Adverse Event|0|||
131710102|NCT00868790|474217814|FG004|Period 3|Adverse Event|0|||
131710103|NCT00868790|474217815|FG005|Period 3|Adverse Event|0|||
131710104|NCT00868790|474217816|FG006|Period 3|Adverse Event|0|||
131710105|NCT00868790|474217817|FG007|Period 3|Adverse Event|0|||
131710106|NCT00868790|474217818|FG008|Period 3|Adverse Event|0|||
131710107|NCT00868790|474217819|FG009|Period 3|Adverse Event|1|||
131710108|NCT00868790|474217820|FG010|Period 3|Adverse Event|0|||
131710109|NCT00868790|474217821|FG011|Period 3|Adverse Event|0|||
131710110|NCT00868790|474217822|FG012|Period 3|Adverse Event|0|||
131710111|NCT00868790|474217823|FG013|Period 3|Adverse Event|0|||
131710112|NCT00868790|474217810|FG000|Period 3|Protocol Violation|0|||
131710113|NCT00868790|474217811|FG001|Period 3|Protocol Violation|0|||
131710114|NCT00868790|474217812|FG002|Period 3|Protocol Violation|0|||
131710115|NCT00868790|474217813|FG003|Period 3|Protocol Violation|0|||
131795549|NCT01498484|474534056|FG003|Overall Study|Adverse Event|0|||
131710116|NCT00868790|474217814|FG004|Period 3|Protocol Violation|0|||
131710117|NCT00868790|474217815|FG005|Period 3|Protocol Violation|0|||
131619434|NCT02095678|473898577|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
131710118|NCT00868790|474217816|FG006|Period 3|Protocol Violation|0|||
131710119|NCT00868790|474217817|FG007|Period 3|Protocol Violation|0|||
131710120|NCT00868790|474217818|FG008|Period 3|Protocol Violation|0|||
131619435|NCT02095678|473898578|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
131619436|NCT02095678|473898577|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
131619437|NCT02095678|473898578|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
131619438|NCT00681109|473898579|FG000|Overall Study|Lost to Follow-up|2|||
131619439|NCT00681109|473898580|FG001|Overall Study|Lost to Follow-up|6|||
131619440|NCT00681109|473898581|FG002|Overall Study|Lost to Follow-up|0|||
131619441|NCT04660799|473898582|FG000|Overall Study|Progressive Disease|1|||
131619442|NCT04660799|473898583|FG001|Overall Study|Progressive Disease|1|||
131619443|NCT04660799|473898582|FG000|Overall Study|Death|2|||
131619444|NCT04660799|473898583|FG001|Overall Study|Death|1|||
131619445|NCT04660799|473898582|FG000|Overall Study|Adverse Event|2|||
131619446|NCT04660799|473898583|FG001|Overall Study|Adverse Event|1|||
131619447|NCT04660799|473898582|FG000|Overall Study|Withdrawal by Subject|2|||
131619448|NCT04660799|473898583|FG001|Overall Study|Withdrawal by Subject|5|||
131619449|NCT00701415|473898584|FG000|Overall Study|Adverse Event|0|||
131619450|NCT00701415|473898585|FG001|Overall Study|Adverse Event|1|||
131619451|NCT00701415|473898584|FG000|Overall Study|Social/family issues and needle phobia|1|||
131619452|NCT00701415|473898585|FG001|Overall Study|Social/family issues and needle phobia|0|||
131619453|NCT02161458|473898588|FG000|Overall Study|Withdrawal by Subject|0|||
131619454|NCT02161458|473898589|FG001|Overall Study|Withdrawal by Subject|4|||
131619455|NCT02161458|473898590|FG002|Overall Study|Withdrawal by Subject|4|||
131619456|NCT02161458|473898591|FG003|Overall Study|Withdrawal by Subject|0|||
131619457|NCT02161458|473898588|FG000|Overall Study|Lost to Follow-up|0|||
131619458|NCT02161458|473898589|FG001|Overall Study|Lost to Follow-up|2|||
131619459|NCT02161458|473898590|FG002|Overall Study|Lost to Follow-up|1|||
131619460|NCT02161458|473898591|FG003|Overall Study|Lost to Follow-up|0|||
131619461|NCT02066636|473898594|FG000|Overall Study|Disease progression|51|||
131619462|NCT02066636|473898595|FG001|Overall Study|Disease progression|60|||
131619463|NCT02066636|473898596|FG002|Overall Study|Disease progression|700|||
131619464|NCT02066636|473898594|FG000|Overall Study|Study drug toxicity|13|||
131619465|NCT02066636|473898595|FG001|Overall Study|Study drug toxicity|2|||
131619466|NCT02066636|473898596|FG002|Overall Study|Study drug toxicity|58|||
131619467|NCT02066636|473898594|FG000|Overall Study|Death|4|||
131619468|NCT02066636|473898595|FG001|Overall Study|Death|2|||
131710121|NCT00868790|474217819|FG009|Period 3|Protocol Violation|0|||
131710122|NCT00868790|474217820|FG010|Period 3|Protocol Violation|1|||
131619469|NCT02066636|473898596|FG002|Overall Study|Death|158|||
131619470|NCT02066636|473898594|FG000|Overall Study|Adverse event unrelated to study drug|6|||
131619471|NCT02066636|473898595|FG001|Overall Study|Adverse event unrelated to study drug|4|||
131619472|NCT02066636|473898596|FG002|Overall Study|Adverse event unrelated to study drug|45|||
131619473|NCT02066636|473898594|FG000|Overall Study|Participant request to discontinue treatment|12|||
131619474|NCT02066636|473898595|FG001|Overall Study|Participant request to discontinue treatment|12|||
131619475|NCT02066636|473898596|FG002|Overall Study|Participant request to discontinue treatment|70|||
131619476|NCT02066636|473898594|FG000|Overall Study|Participant withdrew consent|10|||
131619477|NCT02066636|473898595|FG001|Overall Study|Participant withdrew consent|18|||
131619478|NCT02066636|473898596|FG002|Overall Study|Participant withdrew consent|61|||
131619479|NCT02066636|473898594|FG000|Overall Study|Lost to Follow-up|0|||
131619480|NCT02066636|473898595|FG001|Overall Study|Lost to Follow-up|2|||
131619481|NCT02066636|473898596|FG002|Overall Study|Lost to Follow-up|2|||
131619482|NCT02066636|473898594|FG000|Overall Study|Maximum clinical benefit|2|||
131619483|NCT02066636|473898595|FG001|Overall Study|Maximum clinical benefit|2|||
131619484|NCT02066636|473898596|FG002|Overall Study|Maximum clinical benefit|3|||
131795550|NCT01498484|474534057|FG004|Overall Study|Adverse Event|0|||
131795551|NCT01498484|474534058|FG005|Overall Study|Adverse Event|1|||
131795552|NCT01498484|474534059|FG006|Overall Study|Adverse Event|0|||
131795553|NCT01498484|474534060|FG007|Overall Study|Adverse Event|0|||
131795554|NCT01498484|474534061|FG008|Overall Study|Adverse Event|0|||
131795555|NCT01498484|474534053|FG000|Overall Study|Withdrawal by Subject|0|||
131795556|NCT01498484|474534054|FG001|Overall Study|Withdrawal by Subject|0|||
131795557|NCT01498484|474534055|FG002|Overall Study|Withdrawal by Subject|0|||
131795558|NCT01498484|474534056|FG003|Overall Study|Withdrawal by Subject|1|||
131795559|NCT01498484|474534057|FG004|Overall Study|Withdrawal by Subject|0|||
131795560|NCT01498484|474534058|FG005|Overall Study|Withdrawal by Subject|0|||
131795561|NCT01498484|474534059|FG006|Overall Study|Withdrawal by Subject|1|||
131795562|NCT01498484|474534060|FG007|Overall Study|Withdrawal by Subject|0|||
131795563|NCT01498484|474534061|FG008|Overall Study|Withdrawal by Subject|0|||
131619485|NCT02066636|473898594|FG000|Overall Study|Poor/non-compliance|2|||
131619486|NCT02066636|473898595|FG001|Overall Study|Poor/non-compliance|1|||
131619487|NCT02066636|473898596|FG002|Overall Study|Poor/non-compliance|1|||
131619488|NCT02066636|473898594|FG000|Overall Study|Participant no loner meets study criteria|3|||
131619489|NCT02066636|473898595|FG001|Overall Study|Participant no loner meets study criteria|2|||
131619490|NCT02066636|473898596|FG002|Overall Study|Participant no loner meets study criteria|28|||
131619491|NCT02066636|473898594|FG000|Overall Study|Administrative reasons by sponsor|8|||
131443948|NCT03605667|473255001|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
131443949|NCT03605667|473255002|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
131443950|NCT00107653|473255003|FG000|Overall Study|Adverse Event|24|||
131443951|NCT00107653|473255004|FG001|Overall Study|Adverse Event|43|||
131619492|NCT02066636|473898595|FG001|Overall Study|Administrative reasons by sponsor|5|||
131619493|NCT02066636|473898596|FG002|Overall Study|Administrative reasons by sponsor|0|||
131619494|NCT02066636|473898594|FG000|Overall Study|Other reasons|16|||
131619495|NCT02066636|473898595|FG001|Overall Study|Other reasons|15|||
131619496|NCT02066636|473898596|FG002|Overall Study|Other reasons|50|||
131619497|NCT00391170|473898597|FG000|Overall Study|Withdrawal by Subject|1|||
131619498|NCT00391170|473898598|FG001|Overall Study|Withdrawal by Subject|0|||
131443952|NCT00107653|473255003|FG000|Overall Study|Insufficient Therapeutic Response|25|||
131619499|NCT00391170|473898597|FG000|Overall Study|Adverse Event|3|||
131619500|NCT00391170|473898598|FG001|Overall Study|Adverse Event|2|||
131619501|NCT00391170|473898597|FG000|Overall Study|Physician Decision|2|||
131619502|NCT00391170|473898598|FG001|Overall Study|Physician Decision|2|||
131443953|NCT00107653|473255004|FG001|Overall Study|Insufficient Therapeutic Response|11|||
131619503|NCT00705159|473898604|FG000|Overall Study|Withdrawal by Subject|0|||
131619504|NCT00705159|473898605|FG001|Overall Study|Withdrawal by Subject|1|||
131619505|NCT00705159|473898606|FG002|Overall Study|Withdrawal by Subject|1|||
131619506|NCT00705159|473898607|FG003|Overall Study|Withdrawal by Subject|1|||
131619507|NCT00705159|473898604|FG000|Overall Study|Protocol Violation|0|||
131443954|NCT00107653|473255003|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131443955|NCT00107653|473255004|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131443956|NCT00107653|473255003|FG000|Overall Study|Protocol Violation|1|||
131619508|NCT00705159|473898605|FG001|Overall Study|Protocol Violation|1|||
131619509|NCT00705159|473898606|FG002|Overall Study|Protocol Violation|0|||
131619510|NCT00705159|473898607|FG003|Overall Study|Protocol Violation|0|||
131619511|NCT00705159|473898604|FG000|Overall Study|Adverse Event|0|||
131619512|NCT00705159|473898605|FG001|Overall Study|Adverse Event|0|||
131619513|NCT00705159|473898606|FG002|Overall Study|Adverse Event|1|||
131619514|NCT00705159|473898607|FG003|Overall Study|Adverse Event|0|||
131619515|NCT00705159|473898604|FG000|Overall Study|Lost to Follow-up|0|||
131619516|NCT00705159|473898605|FG001|Overall Study|Lost to Follow-up|0|||
131619517|NCT00705159|473898606|FG002|Overall Study|Lost to Follow-up|3|||
131619518|NCT00705159|473898607|FG003|Overall Study|Lost to Follow-up|2|||
131619519|NCT00705159|473898604|FG000|Overall Study|Screen Failure|0|||
131619520|NCT00705159|473898605|FG001|Overall Study|Screen Failure|0|||
131619521|NCT00705159|473898606|FG002|Overall Study|Screen Failure|0|||
131619522|NCT00705159|473898607|FG003|Overall Study|Screen Failure|1|||
131619523|NCT03026166|473898608|FG000|Overall Study|Death|22|||
131619524|NCT03026166|473898609|FG001|Overall Study|Death|7|||
131619525|NCT03026166|473898608|FG000|Overall Study|Physician Decision|2|||
131619526|NCT03026166|473898609|FG001|Overall Study|Physician Decision|0|||
131619527|NCT03026166|473898608|FG000|Overall Study|Withdrawal by Subject|1|||
131619528|NCT03026166|473898609|FG001|Overall Study|Withdrawal by Subject|2|||
131619529|NCT03026166|473898608|FG000|Overall Study|Lost to Follow-up|1|||
131619530|NCT03026166|473898609|FG001|Overall Study|Lost to Follow-up|0|||
131619531|NCT03026166|473898608|FG000|Overall Study|Study Terminated by Sponsor|3|||
131619532|NCT03026166|473898609|FG001|Overall Study|Study Terminated by Sponsor|3|||
131619533|NCT03026166|473898608|FG000|Overall Study|Other|1|||
131619534|NCT03026166|473898609|FG001|Overall Study|Other|0|||
131619535|NCT03035942|473898612|FG000|Overall Study|Adverse Event|8|||
131619536|NCT03035942|473898613|FG001|Overall Study|Adverse Event|4|||
131619537|NCT03035942|473898614|FG002|Overall Study|Adverse Event|5|||
131619538|NCT05270460|473898615|FG000|Overall Study|Adverse Event|0|||
131619539|NCT05270460|473898616|FG001|Overall Study|Adverse Event|1|||
131619540|NCT05270460|473898617|FG002|Overall Study|Adverse Event|0|||
131619541|NCT05270460|473898615|FG000|Overall Study|Early Termination|0|||
131619542|NCT05270460|473898616|FG001|Overall Study|Early Termination|1|||
131619543|NCT05270460|473898617|FG002|Overall Study|Early Termination|0|||
131619544|NCT02091752|473898618|FG000|Overall Study|Study terminated by Sponsor|2|||
131619545|NCT02091752|473898618|FG000|Overall Study|Adverse Event|1|||
131619546|NCT01989104|473898619|FG000|Overall Study|Withdrawal by Subject|3|||
131619547|NCT01989104|473898620|FG001|Overall Study|Withdrawal by Subject|0|||
131619548|NCT01989104|473898621|FG002|Overall Study|Withdrawal by Subject|0|||
131619549|NCT01989104|473898622|FG003|Overall Study|Withdrawal by Subject|0|||
131619550|NCT01989104|473898623|FG004|Overall Study|Withdrawal by Subject|0|||
131619551|NCT02833948|473898626|FG000|Overall Study|Death|2|||
131619552|NCT02833948|473898627|FG001|Overall Study|Death|3|||
131619553|NCT02833948|473898626|FG000|Overall Study|were not scanned|8|||
131619554|NCT02833948|473898627|FG001|Overall Study|were not scanned|13|||
131619555|NCT02833948|473898626|FG000|Overall Study|scans could not be evaluated|5|||
131619556|NCT02833948|473898627|FG001|Overall Study|scans could not be evaluated|2|||
131619557|NCT03539055|473898635|FG000|Overall Study|Death|4|||
131619558|NCT03539055|473898635|FG000|Overall Study|Lost to Follow-up|1|||
131619559|NCT03539055|473898635|FG000|Overall Study|Withdrawal by Subject|2|||
131443957|NCT00107653|473255004|FG001|Overall Study|Protocol Violation|0|||
131619560|NCT03539055|473898635|FG000|Overall Study|Screen Fail|7|||
131619561|NCT03539055|473898635|FG000|Overall Study|Drug Intolerance|2|||
131619562|NCT01638000|473898636|FG000|Overall Study|Randomized but Never Received Drug|7|||
131619563|NCT01638000|473898637|FG001|Overall Study|Randomized but Never Received Drug|10|||
131619564|NCT01638000|473898636|FG000|Overall Study|Adverse Event|14|||
131619565|NCT01638000|473898637|FG001|Overall Study|Adverse Event|16|||
131619566|NCT01638000|473898636|FG000|Overall Study|Lack of Efficacy|5|||
131619567|NCT01638000|473898637|FG001|Overall Study|Lack of Efficacy|6|||
131619568|NCT01638000|473898636|FG000|Overall Study|Protocol Violation|11|||
131619569|NCT01638000|473898637|FG001|Overall Study|Protocol Violation|13|||
131619570|NCT01638000|473898636|FG000|Overall Study|Withdrawal by Subject|21|||
131619571|NCT01638000|473898637|FG001|Overall Study|Withdrawal by Subject|24|||
131619572|NCT01638000|473898636|FG000|Overall Study|Miscellaneous|2|||
131795564|NCT01498484|474534053|FG000|Overall Study|Other|5|||
131619573|NCT01638000|473898637|FG001|Overall Study|Miscellaneous|2|||
131619574|NCT04821271|473898638|FG000|Period 1|Withdrawal by Subject|2|||
131619575|NCT04821271|473898639|FG001|Period 1|Withdrawal by Subject|0|||
131619576|NCT04076059|473898640|FG000|Double Blind Phase|Progressive disease|22|||
131619577|NCT04076059|473898641|FG001|Double Blind Phase|Progressive disease|26|||
131619578|NCT04076059|473898642|FG002|Double Blind Phase|Progressive disease|0|||
131619579|NCT04076059|473898640|FG000|Double Blind Phase|Withdrawal by Subject|4|||
131619580|NCT04076059|473898641|FG001|Double Blind Phase|Withdrawal by Subject|11|||
131619581|NCT04076059|473898642|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131619582|NCT04076059|473898640|FG000|Double Blind Phase|Death|1|||
131619583|NCT04076059|473898641|FG001|Double Blind Phase|Death|1|||
131619584|NCT04076059|473898642|FG002|Double Blind Phase|Death|0|||
131619585|NCT04076059|473898640|FG000|Double Blind Phase|Lost to Follow-up|1|||
131619586|NCT04076059|473898641|FG001|Double Blind Phase|Lost to Follow-up|0|||
131795565|NCT01498484|474534054|FG001|Overall Study|Other|2|||
131619587|NCT04076059|473898642|FG002|Double Blind Phase|Lost to Follow-up|0|||
131619588|NCT04076059|473898640|FG000|Double Blind Phase|Adverse Event|5|||
131619589|NCT04076059|473898641|FG001|Double Blind Phase|Adverse Event|1|||
131710123|NCT00868790|474217821|FG011|Period 3|Protocol Violation|0|||
131710124|NCT00868790|474217822|FG012|Period 3|Protocol Violation|0|||
131710125|NCT00868790|474217823|FG013|Period 3|Protocol Violation|0|||
131710126|NCT00868790|474217810|FG000|Period 3|Study Terminated by Sponsor|0|||
131710127|NCT00868790|474217811|FG001|Period 3|Study Terminated by Sponsor|0|||
131710128|NCT00868790|474217812|FG002|Period 3|Study Terminated by Sponsor|0|||
131710129|NCT00868790|474217813|FG003|Period 3|Study Terminated by Sponsor|1|||
131710130|NCT00868790|474217814|FG004|Period 3|Study Terminated by Sponsor|0|||
131710131|NCT00868790|474217815|FG005|Period 3|Study Terminated by Sponsor|0|||
131710132|NCT00868790|474217816|FG006|Period 3|Study Terminated by Sponsor|0|||
131710133|NCT00868790|474217817|FG007|Period 3|Study Terminated by Sponsor|0|||
131710134|NCT00868790|474217818|FG008|Period 3|Study Terminated by Sponsor|0|||
131619590|NCT04076059|473898642|FG002|Double Blind Phase|Adverse Event|0|||
131619591|NCT04076059|473898640|FG000|Double Blind Phase|Ongoing Participants|82|||
131619592|NCT04076059|473898641|FG001|Double Blind Phase|Ongoing Participants|18|||
131619593|NCT04076059|473898642|FG002|Double Blind Phase|Ongoing Participants|0|||
131619594|NCT04076059|473898640|FG000|Double Blind Phase|Miscellaneous|3|||
131619595|NCT04076059|473898641|FG001|Double Blind Phase|Miscellaneous|1|||
131619596|NCT04076059|473898642|FG002|Double Blind Phase|Miscellaneous|0|||
131619597|NCT04076059|473898640|FG000|Double Blind Phase|Protocol Deviation|1|||
131619598|NCT04076059|473898641|FG001|Double Blind Phase|Protocol Deviation|1|||
131619599|NCT04076059|473898642|FG002|Double Blind Phase|Protocol Deviation|0|||
131619600|NCT04076059|473898640|FG000|Double Blind Phase|Did not take study drug|1|||
131619601|NCT04076059|473898641|FG001|Double Blind Phase|Did not take study drug|1|||
131619602|NCT04076059|473898642|FG002|Double Blind Phase|Did not take study drug|0|||
131619603|NCT04076059|473898640|FG000|Open Label Phase|Progressive disease|0|||
131619604|NCT04076059|473898641|FG001|Open Label Phase|Progressive disease|0|||
131619605|NCT04076059|473898642|FG002|Open Label Phase|Progressive disease|7|||
131619606|NCT04076059|473898640|FG000|Open Label Phase|Withdrawal by Subject|0|||
131619607|NCT04076059|473898641|FG001|Open Label Phase|Withdrawal by Subject|0|||
131619608|NCT04076059|473898642|FG002|Open Label Phase|Withdrawal by Subject|3|||
131619609|NCT04076059|473898640|FG000|Open Label Phase|Death|0|||
131619610|NCT04076059|473898641|FG001|Open Label Phase|Death|0|||
131619611|NCT04076059|473898642|FG002|Open Label Phase|Death|2|||
131619612|NCT04076059|473898640|FG000|Open Label Phase|Ongoing Participants|0|||
131619613|NCT04076059|473898641|FG001|Open Label Phase|Ongoing Participants|0|||
131619614|NCT04076059|473898642|FG002|Open Label Phase|Ongoing Participants|11|||
131619615|NCT02521493|473898644|FG000|Overall Study|Death|3|||
131619616|NCT02521493|473898645|FG001|Overall Study|Death|4|||
131619617|NCT02521493|473898646|FG002|Overall Study|Death|1|||
131619618|NCT02521493|473898644|FG000|Overall Study|Physician Decision|19|||
131619619|NCT02521493|473898645|FG001|Overall Study|Physician Decision|1|||
131619620|NCT02521493|473898646|FG002|Overall Study|Physician Decision|2|||
131619621|NCT02521493|473898644|FG000|Overall Study|Withdrawal by Subject|3|||
131619622|NCT02521493|473898645|FG001|Overall Study|Withdrawal by Subject|0|||
131619623|NCT02521493|473898646|FG002|Overall Study|Withdrawal by Subject|0|||
131619624|NCT02521493|473898644|FG000|Overall Study|Ineligible|0|||
131619625|NCT02521493|473898645|FG001|Overall Study|Ineligible|1|||
131619626|NCT02521493|473898646|FG002|Overall Study|Ineligible|0|||
131619627|NCT02521493|473898644|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
131619628|NCT02521493|473898645|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
131619629|NCT02521493|473898646|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
131619630|NCT02521493|473898644|FG000|Overall Study|No MRD result|0|||
131710135|NCT00868790|474217819|FG009|Period 3|Study Terminated by Sponsor|0|||
131619631|NCT02521493|473898645|FG001|Overall Study|No MRD result|0|||
131619632|NCT02521493|473898646|FG002|Overall Study|No MRD result|4|||
131619633|NCT04924608|473902712|FG000|Overall Study|Adverse Event|10|||
131619634|NCT04924608|473902713|FG001|Overall Study|Adverse Event|6|||
131619635|NCT04924608|473902712|FG000|Overall Study|Lost to Follow-up|1|||
131619636|NCT04924608|473902713|FG001|Overall Study|Lost to Follow-up|1|||
131619637|NCT04924608|473902712|FG000|Overall Study|Ongoing at the data cut-off date|54|||
131619638|NCT04924608|473902713|FG001|Overall Study|Ongoing at the data cut-off date|60|||
131710136|NCT00868790|474217820|FG010|Period 3|Study Terminated by Sponsor|0|||
131710137|NCT00868790|474217821|FG011|Period 3|Study Terminated by Sponsor|0|||
131619639|NCT04924608|473902712|FG000|Overall Study|Progressive Disease|2|||
131619640|NCT04924608|473902713|FG001|Overall Study|Progressive Disease|0|||
131619641|NCT04924608|473902712|FG000|Overall Study|Withdrawal by Subject|3|||
131619642|NCT04924608|473902713|FG001|Overall Study|Withdrawal by Subject|6|||
131619643|NCT04924608|473902712|FG000|Overall Study|Other reason|1|||
131619644|NCT04924608|473902713|FG001|Overall Study|Other reason|1|||
131619703|NCT02180724|473902734|FG000|Overall Study|Death|26|||
131619704|NCT02180724|473902735|FG001|Overall Study|Death|1|||
131619705|NCT02180724|473902734|FG000|Overall Study|Lost to Follow-up|3|||
131619706|NCT02180724|473902735|FG001|Overall Study|Lost to Follow-up|1|||
131619707|NCT02180724|473902734|FG000|Overall Study|Withdrawal by Subject|4|||
131619708|NCT02180724|473902735|FG001|Overall Study|Withdrawal by Subject|2|||
131619709|NCT02180724|473902734|FG000|Overall Study|PI Decision|5|||
131619710|NCT02180724|473902735|FG001|Overall Study|PI Decision|2|||
131619711|NCT02180724|473902734|FG000|Overall Study|Study terminated by sponsor|54|||
131619712|NCT02180724|473902735|FG001|Overall Study|Study terminated by sponsor|8|||
131443958|NCT00107653|473255003|FG000|Overall Study|Withdrawal by Subject|12|||
131443959|NCT00107653|473255004|FG001|Overall Study|Withdrawal by Subject|13|||
131443960|NCT00107653|473255003|FG000|Overall Study|Lost to Follow-up|13|||
131443961|NCT00107653|473255004|FG001|Overall Study|Lost to Follow-up|5|||
131443962|NCT00107653|473255003|FG000|Overall Study|Administrative Reasons|3|||
131443963|NCT00107653|473255004|FG001|Overall Study|Administrative Reasons|3|||
131710138|NCT00868790|474217822|FG012|Period 3|Study Terminated by Sponsor|0|||
131710139|NCT00868790|474217823|FG013|Period 3|Study Terminated by Sponsor|0|||
131443964|NCT02532517|473255008|FG000|Overall Study|Did not complete 24-Month visit|4|||
131795566|NCT01498484|474534055|FG002|Overall Study|Other|0|||
131710140|NCT00868790|474217810|FG000|Period 4|Adverse Event|0|||
131710141|NCT00868790|474217811|FG001|Period 4|Adverse Event|0|||
131710142|NCT00868790|474217812|FG002|Period 4|Adverse Event|0|||
131710143|NCT00868790|474217813|FG003|Period 4|Adverse Event|0|||
131710144|NCT00868790|474217814|FG004|Period 4|Adverse Event|0|||
131710145|NCT00868790|474217815|FG005|Period 4|Adverse Event|0|||
131710146|NCT00868790|474217816|FG006|Period 4|Adverse Event|0|||
131710147|NCT00868790|474217817|FG007|Period 4|Adverse Event|1|||
131710148|NCT00868790|474217818|FG008|Period 4|Adverse Event|0|||
131710149|NCT00868790|474217819|FG009|Period 4|Adverse Event|0|||
131710150|NCT00868790|474217820|FG010|Period 4|Adverse Event|1|||
131710151|NCT00868790|474217821|FG011|Period 4|Adverse Event|0|||
131710152|NCT00868790|474217822|FG012|Period 4|Adverse Event|1|||
131710153|NCT00868790|474217823|FG013|Period 4|Adverse Event|0|||
131710154|NCT00868790|474217810|FG000|Period 4|Lost to Follow-up|0|||
131710155|NCT00868790|474217811|FG001|Period 4|Lost to Follow-up|0|||
131710156|NCT00868790|474217812|FG002|Period 4|Lost to Follow-up|0|||
131710157|NCT00868790|474217813|FG003|Period 4|Lost to Follow-up|0|||
131710158|NCT00868790|474217814|FG004|Period 4|Lost to Follow-up|0|||
131710159|NCT00868790|474217815|FG005|Period 4|Lost to Follow-up|0|||
131710160|NCT00868790|474217816|FG006|Period 4|Lost to Follow-up|0|||
131710161|NCT00868790|474217817|FG007|Period 4|Lost to Follow-up|1|||
131710162|NCT00868790|474217818|FG008|Period 4|Lost to Follow-up|0|||
131710163|NCT00868790|474217819|FG009|Period 4|Lost to Follow-up|0|||
131710164|NCT00868790|474217820|FG010|Period 4|Lost to Follow-up|0|||
131710165|NCT00868790|474217821|FG011|Period 4|Lost to Follow-up|0|||
131710166|NCT00868790|474217822|FG012|Period 4|Lost to Follow-up|0|||
131710167|NCT00868790|474217823|FG013|Period 4|Lost to Follow-up|0|||
131710168|NCT00868790|474217810|FG000|Period 4|Study Terminated by Sponsor|2|||
131795567|NCT01498484|474534056|FG003|Overall Study|Other|0|||
131795568|NCT01498484|474534057|FG004|Overall Study|Other|1|||
131710169|NCT00868790|474217811|FG001|Period 4|Study Terminated by Sponsor|0|||
131710170|NCT00868790|474217812|FG002|Period 4|Study Terminated by Sponsor|0|||
131710171|NCT00868790|474217813|FG003|Period 4|Study Terminated by Sponsor|0|||
131710172|NCT00868790|474217814|FG004|Period 4|Study Terminated by Sponsor|0|||
131710173|NCT00868790|474217815|FG005|Period 4|Study Terminated by Sponsor|0|||
131710174|NCT00868790|474217816|FG006|Period 4|Study Terminated by Sponsor|0|||
131795569|NCT01498484|474534058|FG005|Overall Study|Other|0|||
131795570|NCT01498484|474534059|FG006|Overall Study|Other|3|||
131795571|NCT01498484|474534060|FG007|Overall Study|Other|0|||
131795572|NCT01498484|474534061|FG008|Overall Study|Other|1|||
131795573|NCT00319956|474534062|FG000|Overall Study|Death|20|||
131795574|NCT00319956|474534063|FG001|Overall Study|Death|24|||
131795575|NCT02607800|474534064|FG000|Overall Study|Lost to Follow-up|7|||
131795576|NCT02607800|474534065|FG001|Overall Study|Lost to Follow-up|10|||
131795577|NCT02607800|474534064|FG000|Overall Study|Withdrew Consent|2|||
131795578|NCT02607800|474534065|FG001|Overall Study|Withdrew Consent|0|||
131795579|NCT02607800|474534064|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
131795580|NCT02607800|474534065|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
131795581|NCT01446913|474534066|FG000|Overall Study|Significant illness|1|||
131795582|NCT01446913|474534067|FG001|Overall Study|Significant illness|1|||
131795583|NCT01446913|474534068|FG002|Overall Study|Significant illness|1|||
131795584|NCT01446913|474534066|FG000|Overall Study|Withdrawal by Subject|5|||
131795585|NCT01446913|474534067|FG001|Overall Study|Withdrawal by Subject|3|||
131795586|NCT01446913|474534068|FG002|Overall Study|Withdrawal by Subject|5|||
131795587|NCT01446913|474534066|FG000|Overall Study|Physician Decision|0|||
131795588|NCT01446913|474534067|FG001|Overall Study|Physician Decision|0|||
131795589|NCT01446913|474534068|FG002|Overall Study|Physician Decision|2|||
131795590|NCT01446913|474534066|FG000|Overall Study|Lost to Follow-up|3|||
131710175|NCT00868790|474217817|FG007|Period 4|Study Terminated by Sponsor|1|||
131710176|NCT00868790|474217818|FG008|Period 4|Study Terminated by Sponsor|2|||
131710177|NCT00868790|474217819|FG009|Period 4|Study Terminated by Sponsor|0|||
131710178|NCT00868790|474217820|FG010|Period 4|Study Terminated by Sponsor|2|||
131710179|NCT00868790|474217821|FG011|Period 4|Study Terminated by Sponsor|1|||
131710180|NCT00868790|474217822|FG012|Period 4|Study Terminated by Sponsor|0|||
131710181|NCT00868790|474217823|FG013|Period 4|Study Terminated by Sponsor|1|||
131710182|NCT00868790|474217810|FG000|Period 4|Abnormal ALT/AST|0|||
131710183|NCT00868790|474217811|FG001|Period 4|Abnormal ALT/AST|0|||
131710184|NCT00868790|474217812|FG002|Period 4|Abnormal ALT/AST|1|||
131710185|NCT00868790|474217813|FG003|Period 4|Abnormal ALT/AST|0|||
131710186|NCT00868790|474217814|FG004|Period 4|Abnormal ALT/AST|0|||
131710187|NCT00868790|474217815|FG005|Period 4|Abnormal ALT/AST|0|||
131710188|NCT00868790|474217816|FG006|Period 4|Abnormal ALT/AST|0|||
131710189|NCT00868790|474217817|FG007|Period 4|Abnormal ALT/AST|0|||
131710190|NCT00868790|474217818|FG008|Period 4|Abnormal ALT/AST|0|||
131710191|NCT00868790|474217819|FG009|Period 4|Abnormal ALT/AST|0|||
131710192|NCT00868790|474217820|FG010|Period 4|Abnormal ALT/AST|0|||
131710193|NCT00868790|474217821|FG011|Period 4|Abnormal ALT/AST|0|||
131710194|NCT00868790|474217822|FG012|Period 4|Abnormal ALT/AST|0|||
131710195|NCT00868790|474217823|FG013|Period 4|Abnormal ALT/AST|0|||
131710196|NCT00868790|474217810|FG000|Post-study|Withdrawal by Subject|0|||
131710197|NCT00868790|474217811|FG001|Post-study|Withdrawal by Subject|0|||
131710198|NCT00868790|474217812|FG002|Post-study|Withdrawal by Subject|0|||
131710199|NCT00868790|474217813|FG003|Post-study|Withdrawal by Subject|0|||
131710200|NCT00868790|474217814|FG004|Post-study|Withdrawal by Subject|1|||
131710201|NCT00868790|474217815|FG005|Post-study|Withdrawal by Subject|0|||
131710202|NCT00868790|474217816|FG006|Post-study|Withdrawal by Subject|0|||
131710203|NCT00868790|474217817|FG007|Post-study|Withdrawal by Subject|0|||
131710204|NCT00868790|474217818|FG008|Post-study|Withdrawal by Subject|0|||
131710205|NCT00868790|474217819|FG009|Post-study|Withdrawal by Subject|0|||
131710206|NCT00868790|474217820|FG010|Post-study|Withdrawal by Subject|0|||
131710207|NCT00868790|474217821|FG011|Post-study|Withdrawal by Subject|0|||
131710208|NCT00868790|474217822|FG012|Post-study|Withdrawal by Subject|0|||
131710209|NCT00868790|474217823|FG013|Post-study|Withdrawal by Subject|0|||
131710210|NCT00868790|474217810|FG000|Post-study|Excluded Medication|0|||
131710211|NCT00868790|474217811|FG001|Post-study|Excluded Medication|0|||
131710212|NCT00868790|474217812|FG002|Post-study|Excluded Medication|0|||
131710213|NCT00868790|474217813|FG003|Post-study|Excluded Medication|0|||
131710214|NCT00868790|474217814|FG004|Post-study|Excluded Medication|0|||
131710215|NCT00868790|474217815|FG005|Post-study|Excluded Medication|0|||
131710216|NCT00868790|474217816|FG006|Post-study|Excluded Medication|0|||
131710217|NCT00868790|474217817|FG007|Post-study|Excluded Medication|2|||
131795591|NCT01446913|474534067|FG001|Overall Study|Lost to Follow-up|5|||
131795592|NCT01446913|474534068|FG002|Overall Study|Lost to Follow-up|3|||
131795593|NCT02789111|474534071|FG000|Overall Study|Withdrawal by Subject|1|||
131795594|NCT02789111|474534072|FG001|Overall Study|Withdrawal by Subject|4|||
131443965|NCT02532517|473255008|FG000|Overall Study|Failed Angiographic eligibility|1|||
131443966|NCT02532517|473255008|FG000|Overall Study|Lost to Follow-up|4|||
131795595|NCT00717756|474534075|FG000|Overall Study|Withdrawal by Subject|1|||
131710218|NCT00868790|474217818|FG008|Post-study|Excluded Medication|0|||
131710219|NCT00868790|474217819|FG009|Post-study|Excluded Medication|1|||
131710220|NCT00868790|474217820|FG010|Post-study|Excluded Medication|0|||
131710221|NCT00868790|474217821|FG011|Post-study|Excluded Medication|0|||
131710222|NCT00868790|474217822|FG012|Post-study|Excluded Medication|0|||
131710223|NCT00868790|474217823|FG013|Post-study|Excluded Medication|0|||
131620077|NCT04511702|473902803|FG000|Overall Study|Lost to Follow-up|3|||
131620078|NCT04511702|473902804|FG001|Overall Study|Lost to Follow-up|0|||
131620079|NCT04511702|473902805|FG002|Overall Study|Lost to Follow-up|4|||
131620080|NCT04511702|473902803|FG000|Overall Study|Withdrawal by Subject|17|||
131620081|NCT04511702|473902804|FG001|Overall Study|Withdrawal by Subject|1|||
131620082|NCT04511702|473902805|FG002|Overall Study|Withdrawal by Subject|8|||
131710224|NCT03377634|474217827|FG000|Study Period|Adverse Event|1|||
131710225|NCT03377634|474217828|FG001|Study Period|Adverse Event|0|||
131710226|NCT03377634|474217827|FG000|Study Period|Withdrawal by Subject|1|||
131620092|NCT02489318|473902809|FG000|Randomized|Withdrawal by Subject|0|||
131620093|NCT02489318|473902810|FG001|Randomized|Withdrawal by Subject|1|||
131710227|NCT03377634|474217828|FG001|Study Period|Withdrawal by Subject|0|||
131443967|NCT02532517|473255008|FG000|Overall Study|Withdrawal by Subject|4|||
131443968|NCT02532517|473255008|FG000|Overall Study|Death|4|||
131620094|NCT02489318|473902809|FG000|Treated|Adverse Event|19|||
131620095|NCT02489318|473902810|FG001|Treated|Adverse Event|62|||
131620096|NCT02489318|473902809|FG000|Treated|Death|13|||
131620097|NCT02489318|473902810|FG001|Treated|Death|11|||
131620098|NCT02489318|473902809|FG000|Treated|Physician Decision|4|||
131620099|NCT02489318|473902810|FG001|Treated|Physician Decision|6|||
131620100|NCT02489318|473902809|FG000|Treated|Protocol Violation|1|||
131620101|NCT02489318|473902810|FG001|Treated|Protocol Violation|2|||
131620102|NCT02489318|473902809|FG000|Treated|Withdrawal by Subject|37|||
131620103|NCT02489318|473902810|FG001|Treated|Withdrawal by Subject|36|||
131620104|NCT02489318|473902809|FG000|Treated|Other: Progressive Disease|245|||
131620105|NCT02489318|473902810|FG001|Treated|Other: Progressive Disease|138|||
131620106|NCT02489318|473902809|FG000|Treated|Other|0|||
131620107|NCT02489318|473902810|FG001|Treated|Other|2|||
131620108|NCT02489318|473902809|FG000|Treated|Ongoing|0|||
131620109|NCT02489318|473902810|FG001|Treated|Ongoing|267|||
131620110|NCT04493424|473902811|FG000|Overall Study|Termination of the trial by the sponsor|89|||
131620111|NCT04493424|473902811|FG000|Overall Study|Withdrawal by Subject|9|||
131620112|NCT04493424|473902811|FG000|Overall Study|Lost to Follow-up|2|||
131620113|NCT04493424|473902811|FG000|Overall Study|Lack of Efficacy|3|||
131620114|NCT04493424|473902811|FG000|Overall Study|Adverse Event|5|||
131443969|NCT03312231|473255009|FG000|Overall Study|Lost to Follow-up|2|||
131443970|NCT03312231|473255010|FG001|Overall Study|Lost to Follow-up|6|||
131620135|NCT02932410|473902816|FG000|Overall Study|Death|7|||
131620136|NCT02932410|473902817|FG001|Overall Study|Death|6|||
131710228|NCT01264939|474217829|FG000|Overall Study|Adverse Event|1|||
131620137|NCT02932410|473902818|FG002|Overall Study|Death|0|||
131620138|NCT02932410|473902819|FG003|Overall Study|Death|0|||
131620139|NCT02932410|473902816|FG000|Overall Study|Lost to Follow-up|1|||
131620140|NCT02932410|473902817|FG001|Overall Study|Lost to Follow-up|2|||
131620141|NCT02932410|473902818|FG002|Overall Study|Lost to Follow-up|0|||
131620142|NCT02932410|473902819|FG003|Overall Study|Lost to Follow-up|0|||
131620143|NCT02932410|473902816|FG000|Overall Study|Parent/Subjects decision|6|||
131710229|NCT01264939|474217830|FG001|Overall Study|Adverse Event|3|||
131710230|NCT01264939|474217829|FG000|Overall Study|Lost to Follow-up|0|||
131620144|NCT02932410|473902817|FG001|Overall Study|Parent/Subjects decision|6|||
131620145|NCT02932410|473902818|FG002|Overall Study|Parent/Subjects decision|1|||
131620146|NCT02932410|473902819|FG003|Overall Study|Parent/Subjects decision|0|||
131620147|NCT02932410|473902816|FG000|Overall Study|Physician Decision|0|||
131620148|NCT02932410|473902817|FG001|Overall Study|Physician Decision|1|||
131620149|NCT02932410|473902818|FG002|Overall Study|Physician Decision|0|||
131620150|NCT02932410|473902819|FG003|Overall Study|Physician Decision|0|||
131710231|NCT01264939|474217830|FG001|Overall Study|Lost to Follow-up|3|||
131710232|NCT01264939|474217829|FG000|Overall Study|Physician Decision|1|||
131620167|NCT04992273|473902828|FG000|Overall Study|Lost to Follow-up|0|||
131620168|NCT04992273|473902829|FG001|Overall Study|Lost to Follow-up|1|||
131795596|NCT00601484|474534079|FG000|Overall Study|Adverse Event|0|||
131620187|NCT01364597|473902836|FG000|Overall Study|Adverse Event|4|||
131620188|NCT01364597|473902837|FG001|Overall Study|Adverse Event|5|||
131620189|NCT01364597|473902838|FG002|Overall Study|Adverse Event|16|||
131620190|NCT01364597|473902839|FG003|Overall Study|Adverse Event|7|||
131620191|NCT01364597|473902836|FG000|Overall Study|Lack of Efficacy|4|||
131620192|NCT01364597|473902837|FG001|Overall Study|Lack of Efficacy|4|||
131620193|NCT01364597|473902838|FG002|Overall Study|Lack of Efficacy|23|||
131620194|NCT01364597|473902839|FG003|Overall Study|Lack of Efficacy|8|||
131620195|NCT01364597|473902836|FG000|Overall Study|Protocol Violation|0|||
131620196|NCT01364597|473902837|FG001|Overall Study|Protocol Violation|0|||
131620197|NCT01364597|473902838|FG002|Overall Study|Protocol Violation|2|||
131620198|NCT01364597|473902839|FG003|Overall Study|Protocol Violation|0|||
131620199|NCT01364597|473902836|FG000|Overall Study|Lost to Follow-up|0|||
131620200|NCT01364597|473902837|FG001|Overall Study|Lost to Follow-up|0|||
131620201|NCT01364597|473902838|FG002|Overall Study|Lost to Follow-up|5|||
131620202|NCT01364597|473902839|FG003|Overall Study|Lost to Follow-up|3|||
131620203|NCT01364597|473902836|FG000|Overall Study|Withdrawal by Subject|4|||
131620204|NCT01364597|473902837|FG001|Overall Study|Withdrawal by Subject|1|||
131620205|NCT01364597|473902838|FG002|Overall Study|Withdrawal by Subject|18|||
131620206|NCT01364597|473902839|FG003|Overall Study|Withdrawal by Subject|6|||
131620207|NCT01364597|473902836|FG000|Overall Study|Non compliance|1|||
131620208|NCT01364597|473902837|FG001|Overall Study|Non compliance|0|||
131620209|NCT01364597|473902838|FG002|Overall Study|Non compliance|1|||
131620210|NCT01364597|473902839|FG003|Overall Study|Non compliance|0|||
131620211|NCT01364597|473902836|FG000|Overall Study|Lack of compliance|1|||
131620212|NCT01364597|473902837|FG001|Overall Study|Lack of compliance|0|||
131620213|NCT01364597|473902838|FG002|Overall Study|Lack of compliance|0|||
131620214|NCT01364597|473902839|FG003|Overall Study|Lack of compliance|0|||
131620215|NCT01364597|473902836|FG000|Overall Study|End of treatment epilepsy|1|||
131620216|NCT01364597|473902837|FG001|Overall Study|End of treatment epilepsy|0|||
131620217|NCT01364597|473902838|FG002|Overall Study|End of treatment epilepsy|0|||
131795597|NCT00601484|474534080|FG001|Overall Study|Adverse Event|1|||
131795598|NCT00601484|474534079|FG000|Overall Study|Lost to Follow-up|4|||
131795599|NCT00601484|474534080|FG001|Overall Study|Lost to Follow-up|3|||
131795600|NCT00601484|474534079|FG000|Overall Study|Lack of Efficacy|0|||
131795601|NCT00601484|474534080|FG001|Overall Study|Lack of Efficacy|2|||
131795602|NCT00601484|474534079|FG000|Overall Study|Withdrawal by Subject|1|||
131795603|NCT00601484|474534080|FG001|Overall Study|Withdrawal by Subject|1|||
131795604|NCT00601484|474534079|FG000|Overall Study|Randomized, but not treated|0|||
131795605|NCT00601484|474534080|FG001|Overall Study|Randomized, but not treated|1|||
131620218|NCT01364597|473902839|FG003|Overall Study|End of treatment epilepsy|0|||
131620219|NCT01364597|473902836|FG000|Overall Study|No Seizures|1|||
131795606|NCT00745251|474534081|FG000|Overall Study|Adverse Event|1|||
131795607|NCT00745251|474534082|FG001|Overall Study|Adverse Event|2|||
131795608|NCT00745251|474534081|FG000|Overall Study|Withdrawal by Subject|1|||
131795609|NCT00745251|474534082|FG001|Overall Study|Withdrawal by Subject|1|||
131795610|NCT02729896|474534083|FG000|Overall Study|Death|0|||
131795611|NCT02729896|474534084|FG001|Overall Study|Death|2|||
131795612|NCT02729896|474534085|FG002|Overall Study|Death|13|||
131795613|NCT02729896|474534083|FG000|Overall Study|Lost to Follow-up|0|||
131795614|NCT02729896|474534084|FG001|Overall Study|Lost to Follow-up|2|||
131795615|NCT02729896|474534085|FG002|Overall Study|Lost to Follow-up|3|||
131900897|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131900898|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131620220|NCT01364597|473902837|FG001|Overall Study|No Seizures|0|||
131620221|NCT01364597|473902838|FG002|Overall Study|No Seizures|0|||
131620222|NCT01364597|473902839|FG003|Overall Study|No Seizures|0|||
131620223|NCT01364597|473902836|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
131620224|NCT01364597|473902837|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
131795616|NCT02729896|474534083|FG000|Overall Study|Other|0|||
131620225|NCT01364597|473902838|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
131620226|NCT01364597|473902839|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
131620227|NCT01364597|473902836|FG000|Overall Study|Cure|1|||
131620228|NCT01364597|473902837|FG001|Overall Study|Cure|0|||
131620229|NCT01364597|473902838|FG002|Overall Study|Cure|0|||
131620230|NCT01364597|473902839|FG003|Overall Study|Cure|0|||
131620231|NCT01364597|473902836|FG000|Overall Study|Patient was moving|0|||
131620232|NCT01364597|473902837|FG001|Overall Study|Patient was moving|1|||
131620233|NCT01364597|473902838|FG002|Overall Study|Patient was moving|0|||
131620234|NCT01364597|473902839|FG003|Overall Study|Patient was moving|0|||
131620235|NCT01364597|473902836|FG000|Overall Study|Seizures resolved|0|||
131620236|NCT01364597|473902837|FG001|Overall Study|Seizures resolved|0|||
131620237|NCT01364597|473902838|FG002|Overall Study|Seizures resolved|1|||
131620238|NCT01364597|473902839|FG003|Overall Study|Seizures resolved|0|||
131620239|NCT01364597|473902836|FG000|Overall Study|Patient became seizure-free after surgery|0|||
131620240|NCT01364597|473902837|FG001|Overall Study|Patient became seizure-free after surgery|0|||
131620241|NCT01364597|473902838|FG002|Overall Study|Patient became seizure-free after surgery|1|||
131620242|NCT01364597|473902839|FG003|Overall Study|Patient became seizure-free after surgery|0|||
131620243|NCT01364597|473902836|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
131620244|NCT01364597|473902837|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
131620245|NCT01364597|473902838|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
131620246|NCT01364597|473902839|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
131620247|NCT01364597|473902836|FG000|Overall Study|Patient cured from Epilepsy|0|||
131620248|NCT01364597|473902837|FG001|Overall Study|Patient cured from Epilepsy|0|||
131620249|NCT01364597|473902838|FG002|Overall Study|Patient cured from Epilepsy|1|||
131620250|NCT01364597|473902839|FG003|Overall Study|Patient cured from Epilepsy|0|||
131620251|NCT01364597|473902836|FG000|Overall Study|Investigator decision|0|||
131620252|NCT01364597|473902837|FG001|Overall Study|Investigator decision|0|||
131620253|NCT01364597|473902838|FG002|Overall Study|Investigator decision|1|||
131620254|NCT01364597|473902839|FG003|Overall Study|Investigator decision|0|||
131620255|NCT01364597|473902836|FG000|Overall Study|Sponsor recommended discontinuation|0|||
131620256|NCT01364597|473902837|FG001|Overall Study|Sponsor recommended discontinuation|0|||
131620257|NCT01364597|473902838|FG002|Overall Study|Sponsor recommended discontinuation|0|||
131620258|NCT01364597|473902839|FG003|Overall Study|Sponsor recommended discontinuation|1|||
131620259|NCT01364597|473902836|FG000|Overall Study|Parents went abroad with the patient|0|||
131620260|NCT01364597|473902837|FG001|Overall Study|Parents went abroad with the patient|0|||
131620261|NCT01364597|473902838|FG002|Overall Study|Parents went abroad with the patient|1|||
131620262|NCT01364597|473902839|FG003|Overall Study|Parents went abroad with the patient|0|||
131620263|NCT01364597|473902836|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
131620264|NCT01364597|473902837|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
131620265|NCT01364597|473902838|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
131620266|NCT01364597|473902839|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
131620267|NCT01364597|473902836|FG000|Overall Study|BRV administration dropout|0|||
131620268|NCT01364597|473902837|FG001|Overall Study|BRV administration dropout|0|||
131620269|NCT01364597|473902838|FG002|Overall Study|BRV administration dropout|1|||
131620270|NCT01364597|473902839|FG003|Overall Study|BRV administration dropout|0|||
131620271|NCT01364597|473902836|FG000|Overall Study|Dropout|0|||
131620272|NCT01364597|473902837|FG001|Overall Study|Dropout|0|||
131620273|NCT01364597|473902838|FG002|Overall Study|Dropout|3|||
131620274|NCT01364597|473902839|FG003|Overall Study|Dropout|1|||
131620275|NCT01364597|473902836|FG000|Overall Study|Unreliable subject|0|||
131620276|NCT01364597|473902837|FG001|Overall Study|Unreliable subject|0|||
131620277|NCT01364597|473902838|FG002|Overall Study|Unreliable subject|0|||
131620278|NCT01364597|473902839|FG003|Overall Study|Unreliable subject|1|||
131620279|NCT01364597|473902836|FG000|Overall Study|Other|0|||
131620280|NCT01364597|473902837|FG001|Overall Study|Other|0|||
131620281|NCT01364597|473902838|FG002|Overall Study|Other|0|||
131620282|NCT01364597|473902839|FG003|Overall Study|Other|1|||
131443971|NCT03312231|473255011|FG002|Overall Study|Lost to Follow-up|1|||
131710233|NCT01264939|474217830|FG001|Overall Study|Physician Decision|1|||
131710234|NCT01264939|474217829|FG000|Overall Study|Patient/Guardian Decision|8|||
131710235|NCT01264939|474217830|FG001|Overall Study|Patient/Guardian Decision|10|||
131710236|NCT01264939|474217829|FG000|Overall Study|Disease Progression|8|||
131710237|NCT01264939|474217830|FG001|Overall Study|Disease Progression|11|||
131710238|NCT00737529|474217838|FG000|Overall Study|Disease Progression|95|||
131710239|NCT00737529|474217838|FG000|Overall Study|Adverse Event|24|||
131710240|NCT00737529|474217838|FG000|Overall Study|Withdrawal by Subject|5|||
131710241|NCT00737529|474217838|FG000|Overall Study|Death|4|||
131710242|NCT00737529|474217838|FG000|Overall Study|Protocol Violation|1|||
131710243|NCT00737529|474217838|FG000|Overall Study|Other|4|||
131710244|NCT01145560|474217839|FG000|Overall Study|Withdrawal by Subject|2|||
131710245|NCT01145560|474217840|FG001|Overall Study|Withdrawal by Subject|1|||
131710246|NCT01145560|474217841|FG002|Overall Study|Withdrawal by Subject|0|||
131710247|NCT01145560|474217839|FG000|Overall Study|Lost to Follow-up|1|||
131710248|NCT01145560|474217840|FG001|Overall Study|Lost to Follow-up|1|||
131710249|NCT01145560|474217841|FG002|Overall Study|Lost to Follow-up|1|||
131710250|NCT01145560|474217839|FG000|Overall Study|No study drug by 24h after organ failure|1|||
131710251|NCT01145560|474217840|FG001|Overall Study|No study drug by 24h after organ failure|0|||
131710252|NCT01145560|474217841|FG002|Overall Study|No study drug by 24h after organ failure|0|||
131710253|NCT01145560|474217839|FG000|Overall Study|Accidental unblinding of study treatment|0|||
131710254|NCT01145560|474217840|FG001|Overall Study|Accidental unblinding of study treatment|1|||
131710255|NCT01145560|474217841|FG002|Overall Study|Accidental unblinding of study treatment|0|||
131710256|NCT01145560|474217839|FG000|Overall Study|False insurance information|0|||
131710257|NCT01145560|474217840|FG001|Overall Study|False insurance information|1|||
131710258|NCT01145560|474217841|FG002|Overall Study|False insurance information|0|||
131710259|NCT01145560|474217839|FG000|Overall Study|Withdrawal of therapy|0|||
131710260|NCT01145560|474217840|FG001|Overall Study|Withdrawal of therapy|0|||
131710261|NCT01145560|474217841|FG002|Overall Study|Withdrawal of therapy|1|||
131710262|NCT03040024|474217842|FG000|Overall Study|Adverse Event|0|||
131710263|NCT03040024|474217843|FG001|Overall Study|Adverse Event|1|||
131710264|NCT03040024|474217844|FG002|Overall Study|Adverse Event|0|||
131710265|NCT03040024|474217842|FG000|Overall Study|Death|0|||
131710266|NCT03040024|474217843|FG001|Overall Study|Death|1|||
131710267|NCT03040024|474217844|FG002|Overall Study|Death|0|||
131710268|NCT03040024|474217842|FG000|Overall Study|Physician Decision|0|||
131710269|NCT03040024|474217843|FG001|Overall Study|Physician Decision|0|||
131710270|NCT03040024|474217844|FG002|Overall Study|Physician Decision|1|||
131710271|NCT01526148|474217853|FG000|Overall Study|Adverse Event|6|||
131710272|NCT01526148|474217854|FG001|Overall Study|Adverse Event|5|||
131710273|NCT01526148|474217853|FG000|Overall Study|Lost to Follow-up|3|||
131710274|NCT01526148|474217854|FG001|Overall Study|Lost to Follow-up|6|||
131710275|NCT01526148|474217853|FG000|Overall Study|Withdrawal by Subject|2|||
131710276|NCT01526148|474217854|FG001|Overall Study|Withdrawal by Subject|0|||
131710277|NCT01526148|474217853|FG000|Overall Study|Unstable Medical Condition|1|||
131710278|NCT01526148|474217854|FG001|Overall Study|Unstable Medical Condition|0|||
131710279|NCT01526148|474217853|FG000|Overall Study|Unable to discontinue concomitant med|1|||
131710280|NCT01526148|474217854|FG001|Overall Study|Unable to discontinue concomitant med|0|||
131710281|NCT01526148|474217853|FG000|Overall Study|Moved out of state|1|||
131710282|NCT01526148|474217854|FG001|Overall Study|Moved out of state|0|||
131710283|NCT01526148|474217853|FG000|Overall Study|Incarcerated|0|||
131710284|NCT01526148|474217854|FG001|Overall Study|Incarcerated|2|||
131710285|NCT01173653|474217855|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
131710286|NCT01173653|474217856|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
131710287|NCT01791855|474217859|FG000|Overall Study|Adverse Event|0|||
131710288|NCT01791855|474217860|FG001|Overall Study|Adverse Event|0|||
131710289|NCT01791855|474217861|FG002|Overall Study|Adverse Event|0|||
131710290|NCT01791855|474217862|FG003|Overall Study|Adverse Event|1|||
131710291|NCT01791855|474217859|FG000|Overall Study|Randomized, not treated|0|||
131710292|NCT01791855|474217860|FG001|Overall Study|Randomized, not treated|1|||
131710293|NCT01791855|474217861|FG002|Overall Study|Randomized, not treated|0|||
131710294|NCT01791855|474217862|FG003|Overall Study|Randomized, not treated|0|||
131710295|NCT03898063|474217866|FG000|Overall Study|Withdrawal by Subject|10|||
131710296|NCT03898063|474217867|FG001|Overall Study|Withdrawal by Subject|8|||
131710297|NCT02949830|474217868|FG000|Overall Study|Adverse Event|1|||
131710298|NCT02949830|474217868|FG000|Overall Study|Withdrawal by Subject|1|||
131710299|NCT00054132|474217869|FG000|Overall Study|Not Treated|1|||
131710300|NCT01290887|474217870|FG000|Overall Study|Adverse Event|6|||
131443972|NCT03312231|473255012|FG003|Overall Study|Lost to Follow-up|3|||
131710301|NCT01290887|474217871|FG001|Overall Study|Adverse Event|11|||
131710302|NCT01290887|474217870|FG000|Overall Study|Lack of Efficacy|4|||
131710303|NCT01290887|474217871|FG001|Overall Study|Lack of Efficacy|5|||
131710304|NCT01290887|474217870|FG000|Overall Study|Withdrawal by Subject|26|||
131710305|NCT01290887|474217871|FG001|Overall Study|Withdrawal by Subject|32|||
131710306|NCT01290887|474217870|FG000|Overall Study|Protocol Violation|2|||
131710307|NCT01290887|474217871|FG001|Overall Study|Protocol Violation|1|||
131710308|NCT01290887|474217870|FG000|Overall Study|Lost to Follow-up|4|||
131710309|NCT01290887|474217871|FG001|Overall Study|Lost to Follow-up|4|||
131710310|NCT01290887|474217870|FG000|Overall Study|Non-compliance to study procedures|0|||
131710311|NCT01290887|474217871|FG001|Overall Study|Non-compliance to study procedures|1|||
131710312|NCT01290887|474217870|FG000|Overall Study|Non-compliance to study medications|1|||
131710313|NCT01290887|474217871|FG001|Overall Study|Non-compliance to study medications|0|||
131710314|NCT01290887|474217870|FG000|Overall Study|Sponsor closure of study|420|||
131710315|NCT01290887|474217871|FG001|Overall Study|Sponsor closure of study|476|||
131710316|NCT01290887|474217870|FG000|Overall Study|Other|3|||
131710317|NCT01290887|474217871|FG001|Overall Study|Other|6|||
131710318|NCT02764541|474217874|FG000|Overall Study|Withdrawal by Subject|0|||
131710319|NCT02764541|474217875|FG001|Overall Study|Withdrawal by Subject|0|||
131710320|NCT02764541|474217876|FG002|Overall Study|Withdrawal by Subject|0|||
131710321|NCT02764541|474217877|FG003|Overall Study|Withdrawal by Subject|0|||
131710322|NCT02764541|474217878|FG004|Overall Study|Withdrawal by Subject|1|||
131710323|NCT02764541|474217879|FG005|Overall Study|Withdrawal by Subject|1|||
131710324|NCT02764541|474217880|FG006|Overall Study|Withdrawal by Subject|0|||
131710325|NCT02764541|474217881|FG007|Overall Study|Withdrawal by Subject|1|||
131710326|NCT02764541|474217874|FG000|Overall Study|Adverse Event|1|||
131710327|NCT02764541|474217875|FG001|Overall Study|Adverse Event|0|||
131710328|NCT02764541|474217876|FG002|Overall Study|Adverse Event|0|||
131710329|NCT02764541|474217877|FG003|Overall Study|Adverse Event|0|||
131710330|NCT02764541|474217878|FG004|Overall Study|Adverse Event|0|||
131710331|NCT02764541|474217879|FG005|Overall Study|Adverse Event|0|||
131710332|NCT02764541|474217880|FG006|Overall Study|Adverse Event|1|||
131710333|NCT02764541|474217881|FG007|Overall Study|Adverse Event|0|||
131710334|NCT02764541|474217874|FG000|Overall Study|Metastasis|1|||
131710335|NCT02764541|474217875|FG001|Overall Study|Metastasis|0|||
131710336|NCT02764541|474217876|FG002|Overall Study|Metastasis|0|||
131710337|NCT02764541|474217877|FG003|Overall Study|Metastasis|0|||
131710338|NCT02764541|474217878|FG004|Overall Study|Metastasis|0|||
131710339|NCT02764541|474217879|FG005|Overall Study|Metastasis|0|||
131443973|NCT03312231|473255013|FG004|Overall Study|Lost to Follow-up|1|||
131443974|NCT03312231|473255009|FG000|Overall Study|Withdrawal by Subject|0|||
131443975|NCT03312231|473255010|FG001|Overall Study|Withdrawal by Subject|3|||
131443976|NCT03312231|473255011|FG002|Overall Study|Withdrawal by Subject|1|||
131443977|NCT03312231|473255012|FG003|Overall Study|Withdrawal by Subject|0|||
131443978|NCT03312231|473255013|FG004|Overall Study|Withdrawal by Subject|0|||
131443979|NCT03312231|473255009|FG000|Overall Study|Death|0|||
131443980|NCT03312231|473255010|FG001|Overall Study|Death|1|||
131620331|NCT04083976|473902847|FG000|Overall Study|Lost to Follow-up|3|||
131620332|NCT04083976|473902848|FG001|Overall Study|Lost to Follow-up|0|||
131620333|NCT04083976|473902849|FG002|Overall Study|Lost to Follow-up|0|||
131620334|NCT04083976|473902850|FG003|Overall Study|Lost to Follow-up|1|||
131620335|NCT04083976|473902847|FG000|Overall Study|Withdrawal by Subject|16|||
131620336|NCT04083976|473902848|FG001|Overall Study|Withdrawal by Subject|1|||
131620337|NCT04083976|473902849|FG002|Overall Study|Withdrawal by Subject|9|||
131620338|NCT04083976|473902850|FG003|Overall Study|Withdrawal by Subject|0|||
131620339|NCT04083976|473902847|FG000|Overall Study|Sponsor Decision|14|||
131620340|NCT04083976|473902848|FG001|Overall Study|Sponsor Decision|0|||
131620341|NCT04083976|473902849|FG002|Overall Study|Sponsor Decision|0|||
131620342|NCT04083976|473902850|FG003|Overall Study|Sponsor Decision|7|||
131620343|NCT04083976|473902847|FG000|Overall Study|Other|1|||
131620344|NCT04083976|473902848|FG001|Overall Study|Other|0|||
131620345|NCT04083976|473902849|FG002|Overall Study|Other|1|||
131620346|NCT04083976|473902850|FG003|Overall Study|Other|0|||
131620347|NCT03690219|473902851|FG000|Overall Study|no injuries|9|||
131620348|NCT03690219|473902852|FG001|Overall Study|no injuries|20|||
131620349|NCT03690219|473902851|FG000|Overall Study|missing information|7|||
131620350|NCT03690219|473902852|FG001|Overall Study|missing information|7|||
131795617|NCT02729896|474534084|FG001|Overall Study|Other|2|||
131443981|NCT03312231|473255011|FG002|Overall Study|Death|1|||
131620378|NCT03648541|473902864|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
131620379|NCT03648541|473902865|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
131620380|NCT03648541|473902864|FG000|Re-induction Period Only|Lack of Efficacy|7|||
131620381|NCT03648541|473902865|FG001|Re-induction Period Only|Lack of Efficacy|0|||
131620382|NCT03648541|473902864|FG000|Maintenance Period Only|Missing|0|||
131620383|NCT03648541|473902865|FG001|Maintenance Period Only|Missing|1|||
131620384|NCT03648541|473902864|FG000|Maintenance Period Only|Other not listed below|0|||
131620385|NCT03648541|473902865|FG001|Maintenance Period Only|Other not listed below|4|||
131443982|NCT03312231|473255012|FG003|Overall Study|Death|0|||
131443983|NCT03312231|473255013|FG004|Overall Study|Death|0|||
131443984|NCT03312231|473255009|FG000|Overall Study|Study Vaccination not Received|1|||
131620386|NCT03648541|473902864|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
131620387|NCT03648541|473902865|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
131443985|NCT03312231|473255010|FG001|Overall Study|Study Vaccination not Received|1|||
131620388|NCT03648541|473902864|FG000|Maintenance Period Only|Protocol Violation|0|||
131620389|NCT03648541|473902865|FG001|Maintenance Period Only|Protocol Violation|1|||
131620390|NCT03648541|473902864|FG000|Maintenance Period Only|Lack of Efficacy|0|||
131795618|NCT02729896|474534085|FG002|Overall Study|Other|0|||
131710340|NCT02764541|474217880|FG006|Overall Study|Metastasis|0|||
131710341|NCT02764541|474217881|FG007|Overall Study|Metastasis|0|||
131710342|NCT02764541|474217874|FG000|Overall Study|Disease progression|1|||
131710343|NCT02764541|474217875|FG001|Overall Study|Disease progression|1|||
131710344|NCT02764541|474217876|FG002|Overall Study|Disease progression|0|||
131710345|NCT02764541|474217877|FG003|Overall Study|Disease progression|0|||
131710346|NCT02764541|474217878|FG004|Overall Study|Disease progression|0|||
131710347|NCT02764541|474217879|FG005|Overall Study|Disease progression|0|||
131710348|NCT02764541|474217880|FG006|Overall Study|Disease progression|0|||
131710349|NCT02764541|474217881|FG007|Overall Study|Disease progression|1|||
131710350|NCT02764541|474217874|FG000|Overall Study|Protocol Violation|0|||
131710351|NCT02764541|474217875|FG001|Overall Study|Protocol Violation|0|||
131710352|NCT02764541|474217876|FG002|Overall Study|Protocol Violation|0|||
131710353|NCT02764541|474217877|FG003|Overall Study|Protocol Violation|1|||
131710354|NCT02764541|474217878|FG004|Overall Study|Protocol Violation|0|||
131710355|NCT02764541|474217879|FG005|Overall Study|Protocol Violation|1|||
131710356|NCT02764541|474217880|FG006|Overall Study|Protocol Violation|0|||
131710357|NCT02764541|474217881|FG007|Overall Study|Protocol Violation|0|||
131710358|NCT02764541|474217874|FG000|Overall Study|Physician Decision|0|||
131710359|NCT02764541|474217875|FG001|Overall Study|Physician Decision|0|||
131710360|NCT02764541|474217876|FG002|Overall Study|Physician Decision|0|||
131710361|NCT02764541|474217877|FG003|Overall Study|Physician Decision|1|||
131710362|NCT02764541|474217878|FG004|Overall Study|Physician Decision|0|||
131710363|NCT02764541|474217879|FG005|Overall Study|Physician Decision|0|||
131710364|NCT02764541|474217880|FG006|Overall Study|Physician Decision|0|||
131710365|NCT02764541|474217881|FG007|Overall Study|Physician Decision|1|||
131710366|NCT02764541|474217874|FG000|Overall Study|Three Cycles completed before surgery|0|||
131710367|NCT02764541|474217875|FG001|Overall Study|Three Cycles completed before surgery|0|||
131710368|NCT02764541|474217876|FG002|Overall Study|Three Cycles completed before surgery|0|||
131710369|NCT02764541|474217877|FG003|Overall Study|Three Cycles completed before surgery|1|||
131710370|NCT02764541|474217878|FG004|Overall Study|Three Cycles completed before surgery|0|||
131710371|NCT02764541|474217879|FG005|Overall Study|Three Cycles completed before surgery|0|||
131710372|NCT02764541|474217880|FG006|Overall Study|Three Cycles completed before surgery|0|||
131710373|NCT02764541|474217881|FG007|Overall Study|Three Cycles completed before surgery|0|||
131710374|NCT02764541|474217874|FG000|Overall Study|Patient Compliance|0|||
131710375|NCT02764541|474217875|FG001|Overall Study|Patient Compliance|0|||
131710376|NCT02764541|474217876|FG002|Overall Study|Patient Compliance|1|||
131710377|NCT02764541|474217877|FG003|Overall Study|Patient Compliance|0|||
131710378|NCT02764541|474217878|FG004|Overall Study|Patient Compliance|0|||
131710379|NCT02764541|474217879|FG005|Overall Study|Patient Compliance|0|||
131710380|NCT02764541|474217880|FG006|Overall Study|Patient Compliance|0|||
131710381|NCT02764541|474217881|FG007|Overall Study|Patient Compliance|0|||
131710382|NCT02764541|474217874|FG000|Overall Study|Death|0|||
131710383|NCT02764541|474217875|FG001|Overall Study|Death|0|||
131710384|NCT02764541|474217876|FG002|Overall Study|Death|0|||
131710385|NCT02764541|474217877|FG003|Overall Study|Death|0|||
131710386|NCT02764541|474217878|FG004|Overall Study|Death|0|||
131710387|NCT02764541|474217879|FG005|Overall Study|Death|0|||
131710388|NCT02764541|474217880|FG006|Overall Study|Death|1|||
131710389|NCT02764541|474217881|FG007|Overall Study|Death|0|||
131710390|NCT02764541|474217874|FG000|Overall Study|Insurance reasons|0|||
131710391|NCT02764541|474217875|FG001|Overall Study|Insurance reasons|0|||
131710392|NCT02764541|474217876|FG002|Overall Study|Insurance reasons|0|||
131710393|NCT02764541|474217877|FG003|Overall Study|Insurance reasons|0|||
131710394|NCT02764541|474217878|FG004|Overall Study|Insurance reasons|0|||
131710395|NCT02764541|474217879|FG005|Overall Study|Insurance reasons|0|||
131710396|NCT02764541|474217880|FG006|Overall Study|Insurance reasons|1|||
131710397|NCT02764541|474217881|FG007|Overall Study|Insurance reasons|0|||
131710398|NCT02040142|474217887|FG000|Overall Study|Lost to Follow-up|5|||
131710399|NCT02040142|474217887|FG000|Overall Study|Death|17|||
131710400|NCT02040142|474217887|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
131710401|NCT02330419|474217888|FG000|Overall Study|Lost to Follow-up|3|||
131710402|NCT02330419|474217889|FG001|Overall Study|Lost to Follow-up|7|||
131710403|NCT01813890|474217892|FG000|Overall Study|Adverse Event|0|||
131710404|NCT01813890|474217893|FG001|Overall Study|Adverse Event|3|||
131710405|NCT01813890|474217894|FG002|Overall Study|Adverse Event|4|||
131710406|NCT01813890|474217892|FG000|Overall Study|Lack of Efficacy|9|||
131710407|NCT01813890|474217893|FG001|Overall Study|Lack of Efficacy|1|||
131710408|NCT01813890|474217894|FG002|Overall Study|Lack of Efficacy|2|||
131710409|NCT04439123|474217895|FG000|Overall Study|Adverse Event|11|||
131710410|NCT04439123|474217895|FG000|Overall Study|Death|1|||
131710411|NCT04439123|474217895|FG000|Overall Study|Disease progression|19|||
131710412|NCT04439123|474217895|FG000|Overall Study|Withdrawal by Subject|2|||
131710413|NCT04439123|474217895|FG000|Overall Study|Still on treatment|2|||
131710414|NCT03952559|474217896|FG000|Double Blind Treatment Period|Adverse Event|0|||
131710415|NCT03952559|474217897|FG001|Double Blind Treatment Period|Adverse Event|2|||
131620391|NCT03648541|473902865|FG001|Maintenance Period Only|Lack of Efficacy|18|||
131620392|NCT03648541|473902864|FG000|Maintenance Period Only|Adverse Event|0|||
131620393|NCT03648541|473902865|FG001|Maintenance Period Only|Adverse Event|4|||
131620394|NCT03648541|473902864|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
131620395|NCT03648541|473902865|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
131620396|NCT03901963|473902867|FG000|Overall Study|Lost to Follow-up|1|||
131620397|NCT03901963|473902868|FG001|Overall Study|Lost to Follow-up|1|||
131620398|NCT03901963|473902867|FG000|Overall Study|Physician Decision|1|||
131620399|NCT03901963|473902868|FG001|Overall Study|Physician Decision|2|||
131620400|NCT03901963|473902867|FG000|Overall Study|Protocol Violation|1|||
131620401|NCT03901963|473902868|FG001|Overall Study|Protocol Violation|1|||
131620402|NCT03901963|473902867|FG000|Overall Study|Withdrawal by Subject|4|||
131620403|NCT03901963|473902868|FG001|Overall Study|Withdrawal by Subject|11|||
131620404|NCT03901963|473902867|FG000|Overall Study|Ongoing|84|||
131620405|NCT03901963|473902868|FG001|Overall Study|Ongoing|73|||
131620406|NCT03901963|473902867|FG000|Overall Study|Randomized but not treated|3|||
131620407|NCT03901963|473902868|FG001|Overall Study|Randomized but not treated|3|||
131620408|NCT02854436|473902871|FG000|Overall Study|Adverse Event|1|||
131620409|NCT02854436|473902871|FG000|Overall Study|Death|208|||
131620410|NCT02854436|473902871|FG000|Overall Study|Lost to Follow-up|5|||
131620411|NCT02854436|473902871|FG000|Overall Study|Withdrawal by Subject|24|||
131620412|NCT02854436|473902871|FG000|Overall Study|Other|45|||
131620413|NCT02854436|473902871|FG000|Overall Study|Physician Decision|6|||
131795619|NCT02729896|474534083|FG000|Overall Study|Physician Decision|1|||
131620477|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
131620478|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
131620479|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620480|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620481|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620482|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
131620483|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
131620484|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620485|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620486|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620487|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620488|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620489|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620490|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131620491|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620492|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620493|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620494|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620495|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620496|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
131620497|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
131620498|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620499|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620500|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620501|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620502|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620503|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620504|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131620505|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
131620506|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620507|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620508|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620509|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620510|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620511|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
131620512|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620513|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620514|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620515|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620516|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620517|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620518|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131620519|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620520|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620521|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131795620|NCT02729896|474534084|FG001|Overall Study|Physician Decision|2|||
131620522|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620523|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620524|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
131620525|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
131620526|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620527|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620528|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620529|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620530|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620531|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620532|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131620533|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620534|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620535|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620536|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620537|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620538|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620539|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
131620540|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620541|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620542|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620543|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620544|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620545|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620546|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131620547|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
131620548|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
131620549|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
131620550|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620551|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620552|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
131620553|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
131620554|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620555|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620556|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620557|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620558|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620559|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620560|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131620561|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620562|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
131620563|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620564|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620565|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620566|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
131620567|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620568|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620569|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620570|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620571|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620572|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620573|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620574|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131620575|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
131620576|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620577|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620578|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620579|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620580|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
131620581|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620582|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620583|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620584|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620585|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620586|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620587|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620588|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131620589|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131710416|NCT03952559|474217898|FG002|Double Blind Treatment Period|Adverse Event|1|||
131710417|NCT03952559|474217899|FG003|Double Blind Treatment Period|Adverse Event|0|||
131710418|NCT03952559|474217900|FG004|Double Blind Treatment Period|Adverse Event|1|||
131710419|NCT03952559|474217896|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
131620590|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620591|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620592|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
131620593|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
131620594|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620595|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620596|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
131620597|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
131620598|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620599|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620600|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620601|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620602|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131620603|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620604|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620605|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620606|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620607|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620608|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620609|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620610|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
131620611|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
131620612|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620613|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620614|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620615|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620616|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131620617|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620618|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620619|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620620|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620621|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620622|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620623|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620624|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620625|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
131620626|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620627|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620628|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620629|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620630|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131620631|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620632|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620633|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620634|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
131620635|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620636|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620637|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620638|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620639|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620640|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131795621|NCT02729896|474534085|FG002|Overall Study|Physician Decision|3|||
131795622|NCT02729896|474534083|FG000|Overall Study|Progressive Disease|0|||
131795623|NCT02729896|474534084|FG001|Overall Study|Progressive Disease|1|||
131795624|NCT02729896|474534085|FG002|Overall Study|Progressive Disease|0|||
131795625|NCT02729896|474534083|FG000|Overall Study|Withdrawal by Subject|1|||
131795626|NCT02729896|474534084|FG001|Overall Study|Withdrawal by Subject|0|||
131795627|NCT02729896|474534085|FG002|Overall Study|Withdrawal by Subject|3|||
131795628|NCT01463683|474534086|FG000|Overall Study|Adverse Event|2|||
131795629|NCT01463683|474534087|FG001|Overall Study|Adverse Event|0|||
131795630|NCT01463683|474534088|FG002|Overall Study|Adverse Event|0|||
131620641|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620642|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620643|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620644|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131620645|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131795631|NCT01463683|474534086|FG000|Overall Study|Lost to Follow-up|10|||
131620646|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620647|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620648|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620649|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620650|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620651|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620652|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
131620653|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
131620654|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620655|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620656|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620657|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620658|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131620659|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620660|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620661|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620662|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620663|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620664|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620665|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620666|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
131620667|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620668|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620669|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620670|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620671|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620672|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131620673|NCT04033445|473902885|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620674|NCT04033445|473902886|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620675|NCT04033445|473902887|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620676|NCT04033445|473902888|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620677|NCT04033445|473902889|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620678|NCT04033445|473902890|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620679|NCT04033445|473902891|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620680|NCT04033445|473902892|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
131620681|NCT04033445|473902893|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620682|NCT04033445|473902894|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620683|NCT04033445|473902895|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620684|NCT04033445|473902896|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620685|NCT04033445|473902897|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620686|NCT04033445|473902898|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131620687|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620688|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620689|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620690|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620691|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620692|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620693|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620694|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620695|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131620696|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
131620697|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
131620698|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
131620699|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
131620700|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
131620701|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620702|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131710420|NCT03952559|474217897|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
131710421|NCT03952559|474217898|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
131710422|NCT03952559|474217899|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
131710423|NCT03952559|474217900|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
131710424|NCT03952559|474217896|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131710425|NCT03952559|474217897|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
131710426|NCT03952559|474217898|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
131620703|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620704|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620705|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620706|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620707|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620708|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620709|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131620710|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
131620711|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
131620712|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
131620713|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
131620714|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
131620715|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620716|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620717|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620718|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620719|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620720|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620721|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620722|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620723|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620724|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620725|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
131620726|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
131620727|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131620728|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
131620729|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620730|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620731|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620732|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620733|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620734|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620735|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620736|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620737|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620738|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131620739|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
131620740|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
131620741|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
131620742|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
131620743|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620744|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620745|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620746|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620747|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620748|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620749|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620750|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620751|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131620752|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
131620753|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
131620754|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
131620755|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
131620756|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
131620757|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620758|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620759|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620760|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620761|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620762|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620763|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131795632|NCT01463683|474534087|FG001|Overall Study|Lost to Follow-up|9|||
131795633|NCT01463683|474534088|FG002|Overall Study|Lost to Follow-up|7|||
131795634|NCT01463683|474534086|FG000|Overall Study|Physician Decision|0|||
131620764|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620765|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620766|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620767|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620768|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620769|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131620770|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
131620771|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620772|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620773|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620774|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620775|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620776|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620777|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620778|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620779|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
131620780|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
131620781|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
131620782|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
131620783|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
131620784|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
131620785|NCT04033445|473902885|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620786|NCT04033445|473902886|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620787|NCT04033445|473902887|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620788|NCT04033445|473902888|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620789|NCT04033445|473902889|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620790|NCT04033445|473902890|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620791|NCT04033445|473902891|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620792|NCT04033445|473902892|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620793|NCT04033445|473902893|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620794|NCT04033445|473902894|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
131620795|NCT04033445|473902895|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620796|NCT04033445|473902896|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
131620797|NCT04033445|473902897|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
131620798|NCT04033445|473902898|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131620800|NCT03748641|473902904|FG000|Overall Study|Ongoing|155|||
131620801|NCT03748641|473902905|FG001|Overall Study|Ongoing|148|||
131620802|NCT03748641|473902906|FG002|Overall Study|Ongoing|66|||
131620803|NCT03748641|473902907|FG003|Overall Study|Ongoing|79|||
131620804|NCT03748641|473902908|FG004|Overall Study|Ongoing|84|||
131620805|NCT03748641|473902904|FG000|Overall Study|Death|54|||
131620806|NCT03748641|473902905|FG001|Overall Study|Death|59|||
131620807|NCT03748641|473902906|FG002|Overall Study|Death|51|||
131620808|NCT03748641|473902907|FG003|Overall Study|Death|42|||
131620809|NCT03748641|473902908|FG004|Overall Study|Death|9|||
131620810|NCT03748641|473902904|FG000|Overall Study|Lost to Follow-up|0|||
131620811|NCT03748641|473902905|FG001|Overall Study|Lost to Follow-up|2|||
131620812|NCT03748641|473902906|FG002|Overall Study|Lost to Follow-up|1|||
131620813|NCT03748641|473902907|FG003|Overall Study|Lost to Follow-up|0|||
131620814|NCT03748641|473902908|FG004|Overall Study|Lost to Follow-up|0|||
131620815|NCT03748641|473902904|FG000|Overall Study|Withdrawal by Subject|3|||
131620816|NCT03748641|473902905|FG001|Overall Study|Withdrawal by Subject|2|||
131620817|NCT03748641|473902906|FG002|Overall Study|Withdrawal by Subject|5|||
131620818|NCT03748641|473902907|FG003|Overall Study|Withdrawal by Subject|3|||
131620819|NCT03748641|473902908|FG004|Overall Study|Withdrawal by Subject|2|||
131710427|NCT03952559|474217899|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
131710428|NCT03952559|474217900|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131710429|NCT03952559|474217896|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
131710430|NCT03952559|474217897|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
131710431|NCT03952559|474217898|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
131710432|NCT03952559|474217899|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
131710433|NCT03952559|474217900|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
131710434|NCT01870739|474217903|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
131710435|NCT01870739|474217904|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
131710436|NCT01870739|474217903|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
131710437|NCT01870739|474217904|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
131710438|NCT01870739|474217903|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
131710439|NCT01870739|474217904|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
131710440|NCT01870739|474217903|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
131710441|NCT01870739|474217904|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
131710442|NCT01870739|474217903|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
131710443|NCT01870739|474217904|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
131710444|NCT01870739|474217903|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
131710445|NCT01870739|474217904|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
131710446|NCT01870739|474217903|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
131710447|NCT01870739|474217904|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
131710448|NCT01986062|474217905|FG000|Overall Study|Lost to Follow-up|1|||
131710449|NCT01986062|474217906|FG001|Overall Study|Lost to Follow-up|0|||
131710450|NCT01986062|474217905|FG000|Overall Study|Withdrawal by Subject|0|||
131710451|NCT01986062|474217906|FG001|Overall Study|Withdrawal by Subject|1|||
131710452|NCT03538743|474217907|FG000|Overall Study|Adverse Event|0|||
131710453|NCT03538743|474217908|FG001|Overall Study|Adverse Event|0|||
131710454|NCT03538743|474217909|FG002|Overall Study|Adverse Event|1|||
131710455|NCT03538743|474217910|FG003|Overall Study|Adverse Event|1|||
131710456|NCT03538743|474217911|FG004|Overall Study|Adverse Event|0|||
131710457|NCT03538743|474217912|FG005|Overall Study|Adverse Event|0|||
131710458|NCT03538743|474217913|FG006|Overall Study|Adverse Event|0|||
131710459|NCT03538743|474217914|FG007|Overall Study|Adverse Event|0|||
131710460|NCT03538743|474217915|FG008|Overall Study|Adverse Event|0|||
131710461|NCT03538743|474217907|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
131710462|NCT03538743|474217908|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
131710463|NCT03538743|474217909|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
131710464|NCT03538743|474217910|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
131710465|NCT03538743|474217911|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
131710466|NCT03538743|474217912|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
131710467|NCT03538743|474217913|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
131710468|NCT03538743|474217914|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
131710469|NCT03538743|474217915|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
131710470|NCT03538743|474217907|FG000|Overall Study|Withdrawal by Subject|0|||
131710471|NCT03538743|474217908|FG001|Overall Study|Withdrawal by Subject|0|||
131710472|NCT03538743|474217909|FG002|Overall Study|Withdrawal by Subject|0|||
131710473|NCT03538743|474217910|FG003|Overall Study|Withdrawal by Subject|1|||
131710474|NCT03538743|474217911|FG004|Overall Study|Withdrawal by Subject|0|||
131710475|NCT03538743|474217912|FG005|Overall Study|Withdrawal by Subject|0|||
131710476|NCT03538743|474217913|FG006|Overall Study|Withdrawal by Subject|0|||
131710477|NCT03538743|474217914|FG007|Overall Study|Withdrawal by Subject|0|||
131710478|NCT03538743|474217915|FG008|Overall Study|Withdrawal by Subject|0|||
131710479|NCT01827384|474217917|FG000|Overall Study|Switched to alternative treatment|0|||
131710480|NCT01827384|474217918|FG001|Overall Study|Switched to alternative treatment|0|||
131710481|NCT01827384|474217919|FG002|Overall Study|Switched to alternative treatment|0|||
131710482|NCT01827384|474217920|FG003|Overall Study|Switched to alternative treatment|0|||
131710483|NCT01827384|474217921|FG004|Overall Study|Switched to alternative treatment|0|||
131710484|NCT01827384|474217922|FG005|Overall Study|Switched to alternative treatment|0|||
131710485|NCT01827384|474217923|FG006|Overall Study|Switched to alternative treatment|0|||
131795635|NCT01463683|474534087|FG001|Overall Study|Physician Decision|3|||
131795636|NCT01463683|474534088|FG002|Overall Study|Physician Decision|1|||
131795637|NCT01463683|474534086|FG000|Overall Study|Pregnancy|2|||
131795638|NCT01463683|474534087|FG001|Overall Study|Pregnancy|2|||
131795639|NCT01463683|474534088|FG002|Overall Study|Pregnancy|1|||
131710486|NCT01827384|474217924|FG007|Overall Study|Switched to alternative treatment|0|||
131710487|NCT01827384|474217925|FG008|Overall Study|Switched to alternative treatment|0|||
131710488|NCT01827384|474217926|FG009|Overall Study|Switched to alternative treatment|0|||
131710489|NCT01827384|474217927|FG010|Overall Study|Switched to alternative treatment|0|||
131710490|NCT01827384|474217928|FG011|Overall Study|Switched to alternative treatment|0|||
131795640|NCT01463683|474534086|FG000|Overall Study|Withdrawal by Subject|5|||
131795641|NCT01463683|474534087|FG001|Overall Study|Withdrawal by Subject|17|||
131710491|NCT01827384|474217929|FG012|Overall Study|Switched to alternative treatment|0|||
131710492|NCT01827384|474217930|FG013|Overall Study|Switched to alternative treatment|2|||
131710493|NCT01827384|474217917|FG000|Overall Study|Disease progression before treatment|0|||
131710494|NCT01827384|474217918|FG001|Overall Study|Disease progression before treatment|0|||
131620835|NCT05074433|473902913|FG000|Overall Study|Adverse Event|0|||
131620836|NCT05074433|473902914|FG001|Overall Study|Adverse Event|2|||
131620837|NCT05074433|473902915|FG002|Overall Study|Adverse Event|0|||
131620838|NCT05074433|473902916|FG003|Overall Study|Adverse Event|1|||
131620839|NCT05074433|473902913|FG000|Overall Study|Sponsor Request|0|||
131620840|NCT05074433|473902914|FG001|Overall Study|Sponsor Request|1|||
131620841|NCT05074433|473902915|FG002|Overall Study|Sponsor Request|1|||
131620842|NCT05074433|473902916|FG003|Overall Study|Sponsor Request|0|||
131620843|NCT05074433|473902913|FG000|Overall Study|Death|1|||
131620844|NCT05074433|473902914|FG001|Overall Study|Death|0|||
131795642|NCT01463683|474534088|FG002|Overall Study|Withdrawal by Subject|2|||
131795643|NCT01618305|474534089|FG000|Overall Study|Death|0|||
131795644|NCT01618305|474534090|FG001|Overall Study|Death|1|||
131795645|NCT01618305|474534089|FG000|Overall Study|Lost to Follow-up|11|||
131795646|NCT01618305|474534090|FG001|Overall Study|Lost to Follow-up|7|||
131795647|NCT01618305|474534089|FG000|Overall Study|Protocol Violation|1|||
131795648|NCT01618305|474534090|FG001|Overall Study|Protocol Violation|0|||
131795649|NCT01618305|474534089|FG000|Overall Study|Withdrawal by Subject|3|||
131795650|NCT01618305|474534090|FG001|Overall Study|Withdrawal by Subject|2|||
131795651|NCT01326026|474534126|FG000|Overall Study|Adverse Event|4|||
131795652|NCT01326026|474534127|FG001|Overall Study|Adverse Event|3|||
131795653|NCT01326026|474534126|FG000|Overall Study|Withdrawal Criteria|5|||
131795654|NCT01326026|474534127|FG001|Overall Study|Withdrawal Criteria|7|||
131795655|NCT01326026|474534126|FG000|Overall Study|Other|3|||
131795656|NCT01326026|474534127|FG001|Overall Study|Other|3|||
131795657|NCT04317053|474534128|FG000|Overall Study|Withdrawn (screen failure)|4|||
131795658|NCT04317053|474534129|FG001|Overall Study|Withdrawn (screen failure)|2|||
131795659|NCT01090765|474535897|FG000|Overall Study|Patient withdrew consent|0|||
131795660|NCT01090765|474535898|FG001|Overall Study|Patient withdrew consent|0|||
131795661|NCT01090765|474535899|FG002|Overall Study|Patient withdrew consent|0|||
131795662|NCT01090765|474535900|FG003|Overall Study|Patient withdrew consent|0|||
131795663|NCT01090765|474535901|FG004|Overall Study|Patient withdrew consent|1|||
131795664|NCT01090765|474535902|FG005|Overall Study|Patient withdrew consent|1|||
131795665|NCT01090765|474535897|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
131795666|NCT01090765|474535898|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
131795667|NCT01090765|474535899|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
131795668|NCT01090765|474535900|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
131620845|NCT05074433|473902915|FG002|Overall Study|Death|0|||
131620846|NCT05074433|473902916|FG003|Overall Study|Death|0|||
131620847|NCT05074433|473902913|FG000|Overall Study|Lost to Follow-up|0|||
131620848|NCT05074433|473902914|FG001|Overall Study|Lost to Follow-up|0|||
131620849|NCT05074433|473902915|FG002|Overall Study|Lost to Follow-up|2|||
131620850|NCT05074433|473902916|FG003|Overall Study|Lost to Follow-up|0|||
131620851|NCT05074433|473902913|FG000|Overall Study|Subject Decision|8|||
131620852|NCT05074433|473902914|FG001|Overall Study|Subject Decision|6|||
131620853|NCT05074433|473902915|FG002|Overall Study|Subject Decision|4|||
131620854|NCT05074433|473902916|FG003|Overall Study|Subject Decision|5|||
131620855|NCT04397263|473902917|FG000|Overall Study|Withdrawal by Subject|2|||
131795669|NCT01090765|474535901|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
131795670|NCT01090765|474535902|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
131795671|NCT01090765|474535897|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
131795672|NCT01090765|474535898|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
131795673|NCT01090765|474535899|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
131710495|NCT01827384|474217919|FG002|Overall Study|Disease progression before treatment|0|||
131710496|NCT01827384|474217920|FG003|Overall Study|Disease progression before treatment|0|||
131710497|NCT01827384|474217921|FG004|Overall Study|Disease progression before treatment|0|||
131710498|NCT01827384|474217922|FG005|Overall Study|Disease progression before treatment|0|||
131710499|NCT01827384|474217923|FG006|Overall Study|Disease progression before treatment|0|||
131710500|NCT01827384|474217924|FG007|Overall Study|Disease progression before treatment|0|||
131621010|NCT02365597|473902948|FG000|Overall Study|Lost to Follow-up|0|||
131621011|NCT02365597|473902949|FG001|Overall Study|Lost to Follow-up|1|||
131621012|NCT02365597|473902950|FG002|Overall Study|Lost to Follow-up|0|||
131621013|NCT02365597|473902951|FG003|Overall Study|Lost to Follow-up|1|||
131621014|NCT02365597|473902948|FG000|Overall Study|Withdrawal by Subject|1|||
131621015|NCT02365597|473902949|FG001|Overall Study|Withdrawal by Subject|8|||
131795674|NCT01090765|474535900|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
131621016|NCT02365597|473902950|FG002|Overall Study|Withdrawal by Subject|5|||
131621017|NCT02365597|473902951|FG003|Overall Study|Withdrawal by Subject|1|||
131621018|NCT02365597|473902948|FG000|Overall Study|Sponsor's decision|1|||
131621019|NCT02365597|473902949|FG001|Overall Study|Sponsor's decision|3|||
131621020|NCT02365597|473902950|FG002|Overall Study|Sponsor's decision|13|||
131795675|NCT01090765|474535901|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
131795676|NCT01090765|474535902|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
131795677|NCT00421174|474535903|FG000|Overall Study|Withdrawal by Subject|0|||
131621021|NCT02365597|473902951|FG003|Overall Study|Sponsor's decision|0|||
131621022|NCT02365597|473902948|FG000|Overall Study|Other|0|||
131621023|NCT02365597|473902949|FG001|Overall Study|Other|4|||
131621024|NCT02365597|473902950|FG002|Overall Study|Other|0|||
131621025|NCT02365597|473902951|FG003|Overall Study|Other|0|||
131710501|NCT01827384|474217925|FG008|Overall Study|Disease progression before treatment|0|||
131710502|NCT01827384|474217926|FG009|Overall Study|Disease progression before treatment|0|||
131710503|NCT01827384|474217927|FG010|Overall Study|Disease progression before treatment|0|||
131710504|NCT01827384|474217928|FG011|Overall Study|Disease progression before treatment|0|||
131710505|NCT01827384|474217929|FG012|Overall Study|Disease progression before treatment|0|||
131710506|NCT01827384|474217930|FG013|Overall Study|Disease progression before treatment|4|||
131710507|NCT01827384|474217917|FG000|Overall Study|Ineligible|0|||
131710508|NCT01827384|474217918|FG001|Overall Study|Ineligible|0|||
131710509|NCT01827384|474217919|FG002|Overall Study|Ineligible|0|||
131710510|NCT01827384|474217920|FG003|Overall Study|Ineligible|0|||
131710511|NCT01827384|474217921|FG004|Overall Study|Ineligible|0|||
131710512|NCT01827384|474217922|FG005|Overall Study|Ineligible|0|||
131710513|NCT01827384|474217923|FG006|Overall Study|Ineligible|0|||
131710514|NCT01827384|474217924|FG007|Overall Study|Ineligible|0|||
131710515|NCT01827384|474217925|FG008|Overall Study|Ineligible|0|||
131710516|NCT01827384|474217926|FG009|Overall Study|Ineligible|0|||
131710517|NCT01827384|474217927|FG010|Overall Study|Ineligible|0|||
131710518|NCT01827384|474217928|FG011|Overall Study|Ineligible|0|||
131710519|NCT01827384|474217929|FG012|Overall Study|Ineligible|0|||
131710520|NCT01827384|474217930|FG013|Overall Study|Ineligible|19|||
131710521|NCT01827384|474217917|FG000|Overall Study|Participant died before treatment|0|||
131710522|NCT01827384|474217918|FG001|Overall Study|Participant died before treatment|0|||
131710523|NCT01827384|474217919|FG002|Overall Study|Participant died before treatment|0|||
131710524|NCT01827384|474217920|FG003|Overall Study|Participant died before treatment|0|||
131710525|NCT01827384|474217921|FG004|Overall Study|Participant died before treatment|0|||
131710526|NCT01827384|474217922|FG005|Overall Study|Participant died before treatment|0|||
131710527|NCT01827384|474217923|FG006|Overall Study|Participant died before treatment|0|||
131710528|NCT01827384|474217924|FG007|Overall Study|Participant died before treatment|0|||
131710529|NCT01827384|474217925|FG008|Overall Study|Participant died before treatment|0|||
131710530|NCT01827384|474217926|FG009|Overall Study|Participant died before treatment|0|||
131710531|NCT01827384|474217927|FG010|Overall Study|Participant died before treatment|0|||
131710532|NCT01827384|474217928|FG011|Overall Study|Participant died before treatment|0|||
131710533|NCT01827384|474217929|FG012|Overall Study|Participant died before treatment|0|||
131710534|NCT01827384|474217930|FG013|Overall Study|Participant died before treatment|5|||
131710535|NCT01827384|474217917|FG000|Overall Study|Insufficient tumor cells|0|||
131710536|NCT01827384|474217918|FG001|Overall Study|Insufficient tumor cells|0|||
131710537|NCT01827384|474217919|FG002|Overall Study|Insufficient tumor cells|0|||
131710538|NCT01827384|474217920|FG003|Overall Study|Insufficient tumor cells|0|||
131710539|NCT01827384|474217921|FG004|Overall Study|Insufficient tumor cells|0|||
131710540|NCT01827384|474217922|FG005|Overall Study|Insufficient tumor cells|0|||
131710541|NCT01827384|474217923|FG006|Overall Study|Insufficient tumor cells|0|||
131710542|NCT01827384|474217924|FG007|Overall Study|Insufficient tumor cells|0|||
131710543|NCT01827384|474217925|FG008|Overall Study|Insufficient tumor cells|0|||
131710544|NCT01827384|474217926|FG009|Overall Study|Insufficient tumor cells|0|||
131710545|NCT01827384|474217927|FG010|Overall Study|Insufficient tumor cells|0|||
131710546|NCT01827384|474217928|FG011|Overall Study|Insufficient tumor cells|0|||
131710547|NCT01827384|474217929|FG012|Overall Study|Insufficient tumor cells|0|||
131710548|NCT01827384|474217930|FG013|Overall Study|Insufficient tumor cells|13|||
131710549|NCT01827384|474217917|FG000|Overall Study|No actionable mutation|0|||
131710550|NCT01827384|474217918|FG001|Overall Study|No actionable mutation|0|||
131710551|NCT01827384|474217919|FG002|Overall Study|No actionable mutation|0|||
131710552|NCT01827384|474217920|FG003|Overall Study|No actionable mutation|0|||
131710553|NCT01827384|474217921|FG004|Overall Study|No actionable mutation|0|||
131710554|NCT01827384|474217922|FG005|Overall Study|No actionable mutation|0|||
131710555|NCT01827384|474217923|FG006|Overall Study|No actionable mutation|0|||
131710556|NCT01827384|474217924|FG007|Overall Study|No actionable mutation|0|||
131710557|NCT01827384|474217925|FG008|Overall Study|No actionable mutation|0|||
131710558|NCT01827384|474217926|FG009|Overall Study|No actionable mutation|0|||
131710559|NCT01827384|474217927|FG010|Overall Study|No actionable mutation|0|||
131710560|NCT01827384|474217928|FG011|Overall Study|No actionable mutation|0|||
131710561|NCT01827384|474217929|FG012|Overall Study|No actionable mutation|0|||
131710562|NCT01827384|474217930|FG013|Overall Study|No actionable mutation|73|||
131710563|NCT01827384|474217917|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
131710564|NCT01827384|474217918|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
131710565|NCT01827384|474217919|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
131710566|NCT01827384|474217920|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
131710567|NCT01827384|474217921|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
131710568|NCT01827384|474217922|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
131710569|NCT01827384|474217923|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
131710570|NCT01827384|474217924|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
131710571|NCT01827384|474217925|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
131443986|NCT03312231|473255011|FG002|Overall Study|Study Vaccination not Received|1|||
131443987|NCT03312231|473255012|FG003|Overall Study|Study Vaccination not Received|0|||
131443988|NCT03312231|473255013|FG004|Overall Study|Study Vaccination not Received|0|||
131443989|NCT03157830|473255014|FG000|Overall Study|Lost to Follow-up|1|||
131443990|NCT03157830|473255014|FG000|Overall Study|Withdrawal by Subject|1|||
131443991|NCT03694353|473255016|FG000|Overall Study|Withdrawal by Subject|1|||
131621026|NCT02365597|473902948|FG000|Overall Study|Enrolled but not treated|0|||
131621027|NCT02365597|473902949|FG001|Overall Study|Enrolled but not treated|1|||
131621028|NCT02365597|473902950|FG002|Overall Study|Enrolled but not treated|1|||
131621029|NCT02365597|473902951|FG003|Overall Study|Enrolled but not treated|0|||
131621030|NCT02365597|473902948|FG000|Overall Study|Ongoing|0|||
131621031|NCT02365597|473902949|FG001|Overall Study|Ongoing|0|||
131621032|NCT02365597|473902950|FG002|Overall Study|Ongoing|0|||
131621033|NCT02365597|473902951|FG003|Overall Study|Ongoing|17|||
131621058|NCT04876391|473902959|FG000|Overall Study|Withdrawal by Subject|1|||
131621059|NCT04876391|473902960|FG001|Overall Study|Withdrawal by Subject|10|||
131621060|NCT04876391|473902959|FG000|Overall Study|Lost to Follow-up|2|||
131621061|NCT04876391|473902960|FG001|Overall Study|Lost to Follow-up|4|||
131621062|NCT04876391|473902959|FG000|Overall Study|Lack of Efficacy|0|||
131621063|NCT04876391|473902960|FG001|Overall Study|Lack of Efficacy|2|||
131621064|NCT04876391|473902959|FG000|Overall Study|Adverse Event|3|||
131621065|NCT04876391|473902960|FG001|Overall Study|Adverse Event|1|||
131621066|NCT04876391|473902959|FG000|Overall Study|Patient non-compliance|0|||
131621067|NCT04876391|473902960|FG001|Overall Study|Patient non-compliance|1|||
131621068|NCT04876391|473902959|FG000|Overall Study|Personal reasons|0|||
131621069|NCT04876391|473902960|FG001|Overall Study|Personal reasons|1|||
131621070|NCT04876391|473902959|FG000|Overall Study|Withdrawn as per protocol|2|||
131621071|NCT04876391|473902960|FG001|Overall Study|Withdrawn as per protocol|2|||
131621072|NCT03473743|473902961|FG000|Overall Study|Withdrawal by Subject|0|||
131621073|NCT03473743|473902962|FG001|Overall Study|Withdrawal by Subject|0|||
131621074|NCT03473743|473902963|FG002|Overall Study|Withdrawal by Subject|0|||
131621075|NCT03473743|473902964|FG003|Overall Study|Withdrawal by Subject|0|||
131621076|NCT03473743|473902965|FG004|Overall Study|Withdrawal by Subject|0|||
131621077|NCT03473743|473902966|FG005|Overall Study|Withdrawal by Subject|0|||
131621078|NCT03473743|473902967|FG006|Overall Study|Withdrawal by Subject|0|||
131621079|NCT03473743|473902968|FG007|Overall Study|Withdrawal by Subject|3|||
131621080|NCT03473743|473902961|FG000|Overall Study|Other|0|||
131621081|NCT03473743|473902962|FG001|Overall Study|Other|0|||
131621082|NCT03473743|473902963|FG002|Overall Study|Other|0|||
131621083|NCT03473743|473902964|FG003|Overall Study|Other|1|||
131621084|NCT03473743|473902965|FG004|Overall Study|Other|0|||
131621085|NCT03473743|473902966|FG005|Overall Study|Other|0|||
131621086|NCT03473743|473902967|FG006|Overall Study|Other|0|||
131621087|NCT03473743|473902968|FG007|Overall Study|Other|0|||
131621088|NCT03473743|473902961|FG000|Overall Study|Ongoing|0|||
131621089|NCT03473743|473902962|FG001|Overall Study|Ongoing|0|||
131621090|NCT03473743|473902963|FG002|Overall Study|Ongoing|6|||
131621091|NCT03473743|473902964|FG003|Overall Study|Ongoing|8|||
131621092|NCT03473743|473902965|FG004|Overall Study|Ongoing|1|||
131621093|NCT03473743|473902966|FG005|Overall Study|Ongoing|1|||
131621094|NCT03473743|473902967|FG006|Overall Study|Ongoing|22|||
131621095|NCT03473743|473902968|FG007|Overall Study|Ongoing|24|||
131621096|NCT03473743|473902961|FG000|Overall Study|Randomized but not treated|0|||
131621097|NCT03473743|473902962|FG001|Overall Study|Randomized but not treated|0|||
131621098|NCT03473743|473902963|FG002|Overall Study|Randomized but not treated|0|||
131621099|NCT03473743|473902964|FG003|Overall Study|Randomized but not treated|0|||
131621100|NCT03473743|473902965|FG004|Overall Study|Randomized but not treated|0|||
131621101|NCT03473743|473902966|FG005|Overall Study|Randomized but not treated|0|||
131621102|NCT03473743|473902967|FG006|Overall Study|Randomized but not treated|1|||
131621103|NCT03473743|473902968|FG007|Overall Study|Randomized but not treated|1|||
131621104|NCT03822832|473902973|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
131621105|NCT03822832|473902974|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
131621106|NCT03822832|473902973|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
131621107|NCT03822832|473902974|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
131621108|NCT03822832|473902973|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
131621109|NCT03822832|473902974|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
131621110|NCT03822832|473902973|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
131621111|NCT03822832|473902974|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
131621112|NCT03822832|473902973|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
131621113|NCT03822832|473902974|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
131621114|NCT03822832|473902973|FG000|Re-allocation|Not re-allocated to open label period|2|||
131621115|NCT03822832|473902974|FG001|Re-allocation|Not re-allocated to open label period|6|||
131621116|NCT03822832|473902973|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
131621117|NCT03822832|473902974|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
131621118|NCT03822832|473902973|FG000|Period 2 - Open Label Period|Adverse Event|0|||
131621119|NCT03822832|473902974|FG001|Period 2 - Open Label Period|Adverse Event|3|||
131621120|NCT05613088|473902975|FG000|Treatment|Ongoing Study Treatment|9|||
131621121|NCT05613088|473902976|FG001|Treatment|Ongoing Study Treatment|2|||
131621122|NCT05613088|473902975|FG000|Treatment|Adverse Event|3|||
131621123|NCT05613088|473902976|FG001|Treatment|Adverse Event|1|||
131621124|NCT05613088|473902975|FG000|Treatment|Other Reasons|0|||
131621125|NCT05613088|473902976|FG001|Treatment|Other Reasons|1|||
131710572|NCT01827384|474217926|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
131710573|NCT01827384|474217927|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
131710574|NCT01827384|474217928|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
131710575|NCT01827384|474217929|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
131710576|NCT01827384|474217930|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
131621126|NCT05613088|473902975|FG000|Treatment|Progressive Disease|58|||
131621127|NCT05613088|473902976|FG001|Treatment|Progressive Disease|26|||
131621128|NCT05613088|473902975|FG000|Treatment|Withdrawal by Subject|0|||
131621129|NCT05613088|473902976|FG001|Treatment|Withdrawal by Subject|4|||
131710577|NCT04640766|474217931|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
131710578|NCT01955707|474217932|FG000|Overall Study|Adverse Event|1|||
131710579|NCT01955707|474217933|FG001|Overall Study|Adverse Event|2|||
131710580|NCT01955707|474217932|FG000|Overall Study|Lost to Follow-up|2|||
131710581|NCT01955707|474217933|FG001|Overall Study|Lost to Follow-up|1|||
131710582|NCT01955707|474217932|FG000|Overall Study|Withdrawal by Subject|0|||
131710583|NCT01955707|474217933|FG001|Overall Study|Withdrawal by Subject|3|||
131710584|NCT01955707|474217932|FG000|Overall Study|Death|13|||
131710585|NCT01955707|474217933|FG001|Overall Study|Death|14|||
131710586|NCT01955707|474217932|FG000|Overall Study|Other|4|||
131710587|NCT01955707|474217933|FG001|Overall Study|Other|2|||
131710588|NCT03219164|474219598|FG000|Overall Study|Study Terminated by Sponsor|16|||
131710589|NCT03219164|474219599|FG001|Overall Study|Study Terminated by Sponsor|12|||
131710590|NCT03219164|474219598|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
131710591|NCT03219164|474219599|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
131710592|NCT03219164|474219598|FG000|Overall Study|Lost to Follow-up|1|||
131710593|NCT03219164|474219599|FG001|Overall Study|Lost to Follow-up|1|||
131710594|NCT03219164|474219598|FG000|Overall Study|Adverse Event|1|||
131710595|NCT03219164|474219599|FG001|Overall Study|Adverse Event|0|||
131710596|NCT03219164|474219598|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131710597|NCT03219164|474219599|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131710598|NCT03219164|474219598|FG000|Overall Study|Protocol Violation|0|||
131710599|NCT03219164|474219599|FG001|Overall Study|Protocol Violation|1|||
131710600|NCT03219164|474219598|FG000|Overall Study|Withdrew Assent|1|||
131710601|NCT03219164|474219599|FG001|Overall Study|Withdrew Assent|0|||
131710602|NCT02732951|474219600|FG000|Overall Study|Other than listed|1|||
131710603|NCT02732951|474219601|FG001|Overall Study|Other than listed|0|||
131710604|NCT02732951|474219600|FG000|Overall Study|Lost to Follow-up|0|||
131710605|NCT02732951|474219601|FG001|Overall Study|Lost to Follow-up|1|||
131710606|NCT02732951|474219600|FG000|Overall Study|Adverse Event|4|||
131710607|NCT02732951|474219601|FG001|Overall Study|Adverse Event|4|||
131710608|NCT02732951|474219600|FG000|Overall Study|Protocol Violation|0|||
131710609|NCT02732951|474219601|FG001|Overall Study|Protocol Violation|1|||
131710610|NCT01750918|474219602|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
131710611|NCT01750918|474219603|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
131710612|NCT01750918|474219604|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
131710613|NCT01750918|474219605|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
131710614|NCT01750918|474219606|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
131710615|NCT01750918|474219607|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
131710616|NCT01750918|474219608|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
131710617|NCT01750918|474219609|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
131710618|NCT01750918|474219602|FG000|Overall Study|Lost to Follow-up|0|||
131710619|NCT01750918|474219603|FG001|Overall Study|Lost to Follow-up|0|||
131710620|NCT01750918|474219604|FG002|Overall Study|Lost to Follow-up|2|||
131710621|NCT01750918|474219605|FG003|Overall Study|Lost to Follow-up|2|||
131710622|NCT01750918|474219606|FG004|Overall Study|Lost to Follow-up|0|||
131710623|NCT01750918|474219607|FG005|Overall Study|Lost to Follow-up|0|||
131710624|NCT01750918|474219608|FG006|Overall Study|Lost to Follow-up|0|||
131795678|NCT00421174|474535904|FG001|Overall Study|Withdrawal by Subject|1|||
131795679|NCT00421174|474535903|FG000|Overall Study|Ineligible due to infection|2|||
131710625|NCT01750918|474219609|FG007|Overall Study|Lost to Follow-up|1|||
131710626|NCT01750918|474219602|FG000|Overall Study|Withdrawal by Subject|0|||
131795680|NCT00421174|474535904|FG001|Overall Study|Ineligible due to infection|0|||
131795681|NCT00992407|474535905|FG000|Overall Study|Protocol Violation|2|||
131795682|NCT00992407|474535906|FG001|Overall Study|Protocol Violation|1|||
131795683|NCT00992407|474535905|FG000|Overall Study|Lost to Follow-up|3|||
131795684|NCT00992407|474535906|FG001|Overall Study|Lost to Follow-up|3|||
131795685|NCT00992407|474535905|FG000|Overall Study|Adverse Event|3|||
131795686|NCT00992407|474535906|FG001|Overall Study|Adverse Event|2|||
131621244|NCT01946204|473903001|FG000|Overall Study|Death|38|||
131621245|NCT01946204|473903002|FG001|Overall Study|Death|59|||
131621246|NCT01946204|473903001|FG000|Overall Study|Withdrawal by Subject|37|||
131621247|NCT01946204|473903002|FG001|Overall Study|Withdrawal by Subject|50|||
131621248|NCT01946204|473903001|FG000|Overall Study|Lost to Follow-up|3|||
131621249|NCT01946204|473903002|FG001|Overall Study|Lost to Follow-up|7|||
131621250|NCT01946204|473903001|FG000|Overall Study|Ongoing|316|||
131621251|NCT01946204|473903002|FG001|Overall Study|Ongoing|687|||
131621252|NCT01946204|473903001|FG000|Overall Study|Other|7|||
131621253|NCT01946204|473903002|FG001|Overall Study|Other|3|||
131900899|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131621281|NCT03462719|473903009|FG000|Overall Study|Withdrawal by Subject|4|||
131621282|NCT03462719|473903010|FG001|Overall Study|Withdrawal by Subject|3|||
131621283|NCT03462719|473903009|FG000|Overall Study|Ongoing|87|||
131621284|NCT03462719|473903010|FG001|Overall Study|Ongoing|72|||
131621285|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
131621286|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
131621287|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
131621288|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
131621289|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
131621290|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
131621291|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
131621292|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
131621293|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
131621294|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
131621295|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
131621296|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
131621297|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
131621298|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
131621299|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
131621300|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131621301|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
131621302|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131621303|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131621304|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131621305|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
131621306|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
131621307|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
131621308|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
131621309|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
131621310|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131621311|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
131621312|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131621313|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131621314|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131621315|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
131621316|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131621317|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131621318|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131621319|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131621320|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
131621321|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131621322|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131621323|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131621324|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131621325|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
131621326|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131621327|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131621328|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131621329|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131621330|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131621331|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
131621332|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131621333|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131621334|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131621335|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
131621336|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131621337|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131621338|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131621339|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131621340|NCT04951622|473903011|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131621341|NCT04951622|473903012|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
131621342|NCT04951622|473903013|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131621343|NCT04951622|473903014|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131621344|NCT04951622|473903015|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131621345|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
131621346|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
131621347|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
131621348|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
131621349|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
131621350|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
131621351|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
131621352|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
131621353|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
131621354|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
131621355|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
131621356|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
131621357|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
131621358|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
131621359|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
131621360|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
131621361|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
131621362|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
131621363|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
131621364|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
131621365|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131621366|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131621367|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
131621368|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131621369|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131621370|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
131621371|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
131621372|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
131621373|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
131621374|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
131621375|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
131621376|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
131621377|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
131621378|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
131621379|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
131621380|NCT04951622|473903011|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131621381|NCT04951622|473903012|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131621382|NCT04951622|473903013|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131621383|NCT04951622|473903014|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131621384|NCT04951622|473903015|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
131621391|NCT04108208|473903026|FG000|Overall Study|Withdrawal by Subject|2|||
131621392|NCT04108208|473903027|FG001|Overall Study|Withdrawal by Subject|6|||
131621393|NCT04108208|473903026|FG000|Overall Study|other-ongoing|20|||
131621394|NCT04108208|473903027|FG001|Overall Study|other-ongoing|40|||
131621395|NCT04108208|473903026|FG000|Overall Study|Death|1|||
131621396|NCT04108208|473903027|FG001|Overall Study|Death|4|||
131621397|NCT04108208|473903026|FG000|Overall Study|Lost to Follow-up|2|||
131710627|NCT01750918|474219603|FG001|Overall Study|Withdrawal by Subject|0|||
131710628|NCT01750918|474219604|FG002|Overall Study|Withdrawal by Subject|1|||
131710629|NCT01750918|474219605|FG003|Overall Study|Withdrawal by Subject|2|||
131621398|NCT04108208|473903027|FG001|Overall Study|Lost to Follow-up|0|||
131710630|NCT01750918|474219606|FG004|Overall Study|Withdrawal by Subject|1|||
131710631|NCT01750918|474219607|FG005|Overall Study|Withdrawal by Subject|1|||
131621417|NCT04181827|473903030|FG000|Overall Study|Ongoing|124|||
131621418|NCT04181827|473903031|FG001|Overall Study|Ongoing|157|||
131621419|NCT04181827|473903030|FG000|Overall Study|Death|82|||
131621420|NCT04181827|473903031|FG001|Overall Study|Death|50|||
131621421|NCT04181827|473903030|FG000|Overall Study|Lost to Follow-up|0|||
131621422|NCT04181827|473903031|FG001|Overall Study|Lost to Follow-up|1|||
131621423|NCT04181827|473903030|FG000|Overall Study|Withdrawal by Subject|5|||
131621424|NCT04181827|473903031|FG001|Overall Study|Withdrawal by Subject|0|||
131621425|NCT04248803|473903033|FG000|Overall Study|Lost to Follow-up|7|||
131621426|NCT04248803|473903034|FG001|Overall Study|Lost to Follow-up|7|||
131621427|NCT04248803|473903035|FG002|Overall Study|Lost to Follow-up|7|||
131621428|NCT04248803|473903036|FG003|Overall Study|Lost to Follow-up|7|||
131621429|NCT04248803|473903037|FG004|Overall Study|Lost to Follow-up|7|||
131621430|NCT04248803|473903038|FG005|Overall Study|Lost to Follow-up|7|||
131621519|NCT04399837|473903049|FG000|Overall Study|Other than listed|0|||
131621520|NCT04399837|473903050|FG001|Overall Study|Other than listed|2|||
131621521|NCT04399837|473903051|FG002|Overall Study|Other than listed|2|||
131621522|NCT04399837|473903052|FG003|Overall Study|Other than listed|3|||
131621523|NCT04399837|473903049|FG000|Overall Study|Withdrawal by Subject|1|||
131621524|NCT04399837|473903050|FG001|Overall Study|Withdrawal by Subject|2|||
131621525|NCT04399837|473903051|FG002|Overall Study|Withdrawal by Subject|1|||
131621526|NCT04399837|473903052|FG003|Overall Study|Withdrawal by Subject|1|||
131621542|NCT04677738|473903057|FG000|Overall Study|Withdrawal by Subject|4|||
131621543|NCT04677738|473903058|FG001|Overall Study|Withdrawal by Subject|2|||
131621558|NCT05163353|473903063|FG000|Overall Study|Adverse Event|1|||
131621559|NCT05163353|473903064|FG001|Overall Study|Adverse Event|0|||
131621560|NCT05163353|473903063|FG000|Overall Study|Withdrawal by Subject|21|||
131621561|NCT05163353|473903064|FG001|Overall Study|Withdrawal by Subject|6|||
131621562|NCT05163353|473903063|FG000|Overall Study|Protocol Violation|0|||
131621563|NCT05163353|473903064|FG001|Overall Study|Protocol Violation|1|||
131621564|NCT05163353|473903063|FG000|Overall Study|Lost to Follow-up|13|||
131621565|NCT05163353|473903064|FG001|Overall Study|Lost to Follow-up|2|||
131900900|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131900901|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131621636|NCT06086028|473903069|FG000|Overall Study|Withdrawal by Subject|1|||
131621637|NCT06086028|473903070|FG001|Overall Study|Withdrawal by Subject|1|||
131621638|NCT06086028|473903069|FG000|Overall Study|Lost to Follow-up|2|||
131621639|NCT06086028|473903070|FG001|Overall Study|Lost to Follow-up|3|||
131621646|NCT05182606|473903073|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
131621665|NCT02257736|473903077|FG000|Overall Study|Progressive disease|365|||
131621666|NCT02257736|473903078|FG001|Overall Study|Progressive disease|327|||
131621667|NCT02257736|473903077|FG000|Overall Study|Adverse Event|45|||
131621668|NCT02257736|473903078|FG001|Overall Study|Adverse Event|56|||
131621669|NCT02257736|473903077|FG000|Overall Study|Withdrawal by Subject|21|||
131621670|NCT02257736|473903078|FG001|Overall Study|Withdrawal by Subject|38|||
131621671|NCT02257736|473903077|FG000|Overall Study|Death|11|||
131621672|NCT02257736|473903078|FG001|Overall Study|Death|6|||
131621673|NCT02257736|473903077|FG000|Overall Study|Physician Decision|5|||
131621674|NCT02257736|473903078|FG001|Overall Study|Physician Decision|9|||
131621675|NCT02257736|473903077|FG000|Overall Study|Non-Compliance with study drug|1|||
131621676|NCT02257736|473903078|FG001|Overall Study|Non-Compliance with study drug|2|||
131621677|NCT02257736|473903077|FG000|Overall Study|Protocol Violation|1|||
131621678|NCT02257736|473903078|FG001|Overall Study|Protocol Violation|0|||
131621679|NCT02257736|473903077|FG000|Overall Study|Other|1|||
131621680|NCT02257736|473903078|FG001|Overall Study|Other|7|||
131621681|NCT02257736|473903077|FG000|Overall Study|Randomized, not treated|1|||
131621682|NCT02257736|473903078|FG001|Overall Study|Randomized, not treated|2|||
131710632|NCT01750918|474219608|FG006|Overall Study|Withdrawal by Subject|2|||
131710633|NCT01750918|474219609|FG007|Overall Study|Withdrawal by Subject|2|||
131710634|NCT04840667|474219614|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
131710635|NCT02338843|474219615|FG000|Overall Study|Adverse Event|2|||
131710636|NCT02338843|474219616|FG001|Overall Study|Adverse Event|1|||
131710637|NCT02338843|474219615|FG000|Overall Study|Death|40|||
131710638|NCT02338843|474219616|FG001|Overall Study|Death|53|||
131710639|NCT02338843|474219615|FG000|Overall Study|Physician Decision|1|||
131710640|NCT02338843|474219616|FG001|Overall Study|Physician Decision|0|||
131710641|NCT02338843|474219615|FG000|Overall Study|Withdrawal by Subject|0|||
131710642|NCT02338843|474219616|FG001|Overall Study|Withdrawal by Subject|2|||
131710643|NCT02338843|474219615|FG000|Overall Study|Subject Recovered|0|||
131710644|NCT02338843|474219616|FG001|Overall Study|Subject Recovered|2|||
131710645|NCT02338843|474219615|FG000|Overall Study|Discontinued prior to randomizat|1|||
131710646|NCT02338843|474219616|FG001|Overall Study|Discontinued prior to randomizat|0|||
131710647|NCT00023322|474219617|FG000|Overall Study|Lost to Follow-up|1|||
131900902|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131621693|NCT04083781|473903082|FG000|Main Part|Physician Decision|0|||
131621694|NCT04083781|473903083|FG001|Main Part|Physician Decision|1|||
131621695|NCT04083781|473903084|FG002|Main Part|Physician Decision|2|||
131621696|NCT04083781|473903085|FG003|Main Part|Physician Decision|0|||
131710648|NCT02185521|474219624|FG000|Overall Study|Withdrawal by Subject|1|||
131710649|NCT02185521|474219624|FG000|Overall Study|Protocol Violation|1|||
131710650|NCT03124459|474219627|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131710651|NCT03124459|474219628|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131710652|NCT03124459|474219629|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131710653|NCT03124459|474219630|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131710654|NCT03124459|474219631|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
131710655|NCT03124459|474219632|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131710656|NCT03124459|474219627|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131710657|NCT03124459|474219628|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131710658|NCT03124459|474219629|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131710659|NCT03124459|474219630|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131710660|NCT03124459|474219631|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
131710661|NCT03124459|474219632|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131710662|NCT03124459|474219627|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131710663|NCT03124459|474219628|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131710664|NCT03124459|474219629|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131710665|NCT03124459|474219630|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
131710666|NCT03124459|474219631|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
131710667|NCT03124459|474219632|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131710668|NCT03124459|474219627|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131710669|NCT03124459|474219628|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131710670|NCT03124459|474219629|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131710671|NCT03124459|474219630|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
131710672|NCT03124459|474219631|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
131710673|NCT03124459|474219632|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131710674|NCT03124459|474219627|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131710675|NCT03124459|474219628|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131710676|NCT03124459|474219629|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131710677|NCT03124459|474219630|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131710678|NCT03124459|474219631|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131710679|NCT03124459|474219632|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
131710680|NCT03124459|474219627|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131710681|NCT03124459|474219628|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131710682|NCT03124459|474219629|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131710683|NCT03124459|474219630|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131710684|NCT03124459|474219631|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131710685|NCT03124459|474219632|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
131710686|NCT01903876|474219633|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
131710687|NCT01903876|474219634|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
131710688|NCT01903876|474219633|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
131710689|NCT01903876|474219634|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
131710690|NCT01901224|474219635|FG000|Overall Study|study was not funded and terminated|2|||
131710691|NCT00434967|474219638|FG000|Overall Study|Adverse Event|2|||
131710692|NCT00434967|474219639|FG001|Overall Study|Adverse Event|4|||
131710693|NCT00434967|474219640|FG002|Overall Study|Adverse Event|3|||
131710694|NCT00434967|474219641|FG003|Overall Study|Adverse Event|3|||
131710695|NCT00434967|474219638|FG000|Overall Study|Lost to Follow-up|0|||
131710696|NCT00434967|474219639|FG001|Overall Study|Lost to Follow-up|0|||
131710697|NCT00434967|474219640|FG002|Overall Study|Lost to Follow-up|1|||
131710698|NCT00434967|474219641|FG003|Overall Study|Lost to Follow-up|0|||
131710699|NCT00434967|474219638|FG000|Overall Study|Withdrawal by Subject|2|||
131710700|NCT00434967|474219639|FG001|Overall Study|Withdrawal by Subject|2|||
131710701|NCT00434967|474219640|FG002|Overall Study|Withdrawal by Subject|4|||
131710702|NCT00434967|474219641|FG003|Overall Study|Withdrawal by Subject|6|||
131710703|NCT00434967|474219638|FG000|Overall Study|Randomized in error|0|||
131710704|NCT00434967|474219639|FG001|Overall Study|Randomized in error|0|||
131710705|NCT00434967|474219640|FG002|Overall Study|Randomized in error|0|||
131710706|NCT00434967|474219641|FG003|Overall Study|Randomized in error|1|||
131710707|NCT00434967|474219638|FG000|Overall Study|Protocol Violation|0|||
131710708|NCT00434967|474219639|FG001|Overall Study|Protocol Violation|1|||
131710709|NCT00434967|474219640|FG002|Overall Study|Protocol Violation|0|||
131710710|NCT00434967|474219641|FG003|Overall Study|Protocol Violation|1|||
131795687|NCT00992407|474535905|FG000|Overall Study|protocol Violation & Adverse events|2|||
131795688|NCT00992407|474535906|FG001|Overall Study|protocol Violation & Adverse events|4|||
131710711|NCT00434967|474219638|FG000|Overall Study|Physician Decision|1|||
131795689|NCT00992407|474535905|FG000|Overall Study|Other|2|||
131795690|NCT00992407|474535906|FG001|Overall Study|Other|0|||
131710712|NCT00434967|474219639|FG001|Overall Study|Physician Decision|1|||
131710713|NCT00434967|474219640|FG002|Overall Study|Physician Decision|1|||
131710714|NCT00434967|474219641|FG003|Overall Study|Physician Decision|0|||
131710715|NCT00434967|474219638|FG000|Overall Study|Patient Disposition Challenges|2|||
131710716|NCT00434967|474219639|FG001|Overall Study|Patient Disposition Challenges|0|||
131710717|NCT00434967|474219640|FG002|Overall Study|Patient Disposition Challenges|0|||
131710718|NCT00434967|474219641|FG003|Overall Study|Patient Disposition Challenges|3|||
131710719|NCT00501228|474219642|FG000|Overall Study|Withdrawal by Subject|1|||
131710720|NCT03804684|474219643|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
131710721|NCT03804684|474219644|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
131710722|NCT01756274|474219648|FG000|Overall Study|Protocol Violation|2|||
131710723|NCT01756274|474219648|FG000|Overall Study|Laboratory error|1|||
131710724|NCT01147926|474219649|FG000|Overall Study|Subject Withdrew Consent|9|||
131710725|NCT01147926|474219650|FG001|Overall Study|Subject Withdrew Consent|10|||
131710726|NCT01147926|474219649|FG000|Overall Study|Adverse Event|7|||
131710727|NCT01147926|474219650|FG001|Overall Study|Adverse Event|6|||
131710728|NCT01147926|474219649|FG000|Overall Study|Subject Non-Compliant|5|||
131710729|NCT01147926|474219650|FG001|Overall Study|Subject Non-Compliant|4|||
131710730|NCT01147926|474219649|FG000|Overall Study|Principal investigator left hospital|1|||
131710731|NCT01147926|474219650|FG001|Overall Study|Principal investigator left hospital|3|||
131710732|NCT01147926|474219649|FG000|Overall Study|Selection criteria not met|3|||
131710733|NCT01147926|474219650|FG001|Overall Study|Selection criteria not met|1|||
131710734|NCT01147926|474219649|FG000|Overall Study|Lost to Follow-up|0|||
131710735|NCT01147926|474219650|FG001|Overall Study|Lost to Follow-up|2|||
131710736|NCT01147926|474219649|FG000|Overall Study|Sponsor's Decision|0|||
131710737|NCT01147926|474219650|FG001|Overall Study|Sponsor's Decision|1|||
131710738|NCT01147926|474219649|FG000|Overall Study|Lack of Efficacy|1|||
131710739|NCT01147926|474219650|FG001|Overall Study|Lack of Efficacy|0|||
131710740|NCT01147926|474219649|FG000|Overall Study|Too busy, no time for study|1|||
131710741|NCT01147926|474219650|FG001|Overall Study|Too busy, no time for study|0|||
131710742|NCT01147926|474219649|FG000|Overall Study|Went on holiday|0|||
131710743|NCT01147926|474219650|FG001|Overall Study|Went on holiday|1|||
131710744|NCT01147926|474219649|FG000|Overall Study|Colonoscopy result|0|||
131710745|NCT01147926|474219650|FG001|Overall Study|Colonoscopy result|1|||
131710746|NCT00486603|474219655|FG000|Overall Study|Withdrawal by Subject|1|||
131710747|NCT00486603|474219656|FG001|Overall Study|Withdrawal by Subject|0|||
131621697|NCT04083781|473903082|FG000|Main Part|Death|1|||
131621698|NCT04083781|473903083|FG001|Main Part|Death|3|||
131621699|NCT04083781|473903084|FG002|Main Part|Death|1|||
131621700|NCT04083781|473903085|FG003|Main Part|Death|0|||
131621701|NCT04083781|473903082|FG000|Main Part|Withdrawal by Subject|5|||
131621702|NCT04083781|473903083|FG001|Main Part|Withdrawal by Subject|2|||
131621703|NCT04083781|473903084|FG002|Main Part|Withdrawal by Subject|3|||
131621704|NCT04083781|473903085|FG003|Main Part|Withdrawal by Subject|7|||
131621705|NCT04083781|473903082|FG000|Extension Part|Physician Decision|0|||
131621706|NCT04083781|473903083|FG001|Extension Part|Physician Decision|0|||
131621707|NCT04083781|473903084|FG002|Extension Part|Physician Decision|0|||
131621708|NCT04083781|473903085|FG003|Extension Part|Physician Decision|1|||
131621709|NCT04083781|473903082|FG000|Extension Part|Death|0|||
131621710|NCT04083781|473903083|FG001|Extension Part|Death|1|||
131621711|NCT04083781|473903084|FG002|Extension Part|Death|0|||
131621712|NCT04083781|473903085|FG003|Extension Part|Death|1|||
131621713|NCT04083781|473903082|FG000|Extension Part|Withdrawal by Subject|0|||
131621714|NCT04083781|473903083|FG001|Extension Part|Withdrawal by Subject|1|||
131621715|NCT04083781|473903084|FG002|Extension Part|Withdrawal by Subject|0|||
131621716|NCT04083781|473903085|FG003|Extension Part|Withdrawal by Subject|0|||
131621717|NCT04083781|473903082|FG000|Extension Part|Ongoing|13|||
131621718|NCT04083781|473903083|FG001|Extension Part|Ongoing|25|||
131621719|NCT04083781|473903084|FG002|Extension Part|Ongoing|15|||
131621720|NCT04083781|473903085|FG003|Extension Part|Ongoing|51|||
131621721|NCT03431350|473903086|FG000|Overall Study|ONGOING|0|||
131621722|NCT03431350|473903087|FG001|Overall Study|ONGOING|0|||
131710748|NCT00486603|474219657|FG002|Overall Study|Withdrawal by Subject|0|||
131710749|NCT00486603|474219658|FG003|Overall Study|Withdrawal by Subject|0|||
131710750|NCT00486603|474219659|FG004|Overall Study|Withdrawal by Subject|0|||
131621723|NCT03431350|473903088|FG002|Overall Study|ONGOING|2|||
131621724|NCT03431350|473903089|FG003|Overall Study|ONGOING|0|||
131710751|NCT00486603|474219655|FG000|Overall Study|Physician Decision|0|||
131710752|NCT00486603|474219656|FG001|Overall Study|Physician Decision|1|||
131621725|NCT03431350|473903090|FG004|Overall Study|ONGOING|1|||
131710753|NCT00486603|474219657|FG002|Overall Study|Physician Decision|0|||
131710754|NCT00486603|474219658|FG003|Overall Study|Physician Decision|0|||
131710755|NCT00486603|474219659|FG004|Overall Study|Physician Decision|0|||
131710756|NCT01670994|474219661|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
131621726|NCT03431350|473903091|FG005|Overall Study|ONGOING|3|||
131621727|NCT03431350|473903092|FG006|Overall Study|ONGOING|0|||
131621728|NCT03431350|473903093|FG007|Overall Study|ONGOING|1|||
131621729|NCT03431350|473903094|FG008|Overall Study|ONGOING|3|||
131621730|NCT03431350|473903095|FG009|Overall Study|ONGOING|4|||
131621731|NCT03431350|473903096|FG010|Overall Study|ONGOING|2|||
131621732|NCT03431350|473903097|FG011|Overall Study|ONGOING|1|||
131621733|NCT03431350|473903086|FG000|Overall Study|Death|6|||
131621734|NCT03431350|473903087|FG001|Overall Study|Death|5|||
131621735|NCT03431350|473903088|FG002|Overall Study|Death|18|||
131621736|NCT03431350|473903089|FG003|Overall Study|Death|7|||
131621737|NCT03431350|473903090|FG004|Overall Study|Death|4|||
131621738|NCT03431350|473903091|FG005|Overall Study|Death|3|||
131621739|NCT03431350|473903092|FG006|Overall Study|Death|2|||
131621740|NCT03431350|473903093|FG007|Overall Study|Death|0|||
131621741|NCT03431350|473903094|FG008|Overall Study|Death|0|||
131621742|NCT03431350|473903095|FG009|Overall Study|Death|0|||
131621743|NCT03431350|473903096|FG010|Overall Study|Death|4|||
131621744|NCT03431350|473903097|FG011|Overall Study|Death|0|||
131621745|NCT03431350|473903086|FG000|Overall Study|Lost to Follow-up|0|||
131621746|NCT03431350|473903087|FG001|Overall Study|Lost to Follow-up|1|||
131621747|NCT03431350|473903088|FG002|Overall Study|Lost to Follow-up|0|||
131621748|NCT03431350|473903089|FG003|Overall Study|Lost to Follow-up|0|||
131621749|NCT03431350|473903090|FG004|Overall Study|Lost to Follow-up|0|||
131621750|NCT03431350|473903091|FG005|Overall Study|Lost to Follow-up|0|||
131621751|NCT03431350|473903092|FG006|Overall Study|Lost to Follow-up|0|||
131621752|NCT03431350|473903093|FG007|Overall Study|Lost to Follow-up|0|||
131621753|NCT03431350|473903094|FG008|Overall Study|Lost to Follow-up|0|||
131621754|NCT03431350|473903095|FG009|Overall Study|Lost to Follow-up|0|||
131621755|NCT03431350|473903096|FG010|Overall Study|Lost to Follow-up|0|||
131621756|NCT03431350|473903097|FG011|Overall Study|Lost to Follow-up|0|||
131621757|NCT03431350|473903086|FG000|Overall Study|Withdrawal by Subject|0|||
131621758|NCT03431350|473903087|FG001|Overall Study|Withdrawal by Subject|0|||
131621759|NCT03431350|473903088|FG002|Overall Study|Withdrawal by Subject|0|||
131621760|NCT03431350|473903089|FG003|Overall Study|Withdrawal by Subject|1|||
131621761|NCT03431350|473903090|FG004|Overall Study|Withdrawal by Subject|1|||
131621762|NCT03431350|473903091|FG005|Overall Study|Withdrawal by Subject|1|||
131621763|NCT03431350|473903092|FG006|Overall Study|Withdrawal by Subject|0|||
131621764|NCT03431350|473903093|FG007|Overall Study|Withdrawal by Subject|0|||
131621765|NCT03431350|473903094|FG008|Overall Study|Withdrawal by Subject|0|||
131621766|NCT03431350|473903095|FG009|Overall Study|Withdrawal by Subject|2|||
131621767|NCT03431350|473903096|FG010|Overall Study|Withdrawal by Subject|0|||
131621768|NCT03431350|473903097|FG011|Overall Study|Withdrawal by Subject|1|||
131621769|NCT03431350|473903086|FG000|Overall Study|Other|0|||
131621770|NCT03431350|473903087|FG001|Overall Study|Other|0|||
131621771|NCT03431350|473903088|FG002|Overall Study|Other|1|||
131621772|NCT03431350|473903089|FG003|Overall Study|Other|3|||
131621773|NCT03431350|473903090|FG004|Overall Study|Other|2|||
131621774|NCT03431350|473903091|FG005|Overall Study|Other|2|||
131621775|NCT03431350|473903092|FG006|Overall Study|Other|4|||
131621776|NCT03431350|473903093|FG007|Overall Study|Other|0|||
131621777|NCT03431350|473903094|FG008|Overall Study|Other|14|||
131621778|NCT03431350|473903095|FG009|Overall Study|Other|11|||
131621779|NCT03431350|473903096|FG010|Overall Study|Other|11|||
131621780|NCT03431350|473903097|FG011|Overall Study|Other|15|||
131621791|NCT04325828|473903100|FG000|Overall Study|Ongoing|26|||
131621792|NCT04439188|473903101|FG000|Overall Study|Ineligible|3|||
131621793|NCT04439188|473903101|FG000|Overall Study|Adverse Event|4|||
131621794|NCT04439188|473903101|FG000|Overall Study|Death|1|||
131621795|NCT04439188|473903101|FG000|Overall Study|Disease Progression|25|||
131621796|NCT04439188|473903101|FG000|Overall Study|Withdrawal by Subject|2|||
131621801|NCT03683030|473903109|FG000|Overall Study|Enrolled but screen failures|12|||
131621802|NCT03683030|473903110|FG001|Overall Study|Enrolled but screen failures|7|||
131621803|NCT03683030|473903109|FG000|Overall Study|Enrolled but no catheter inserted|11|||
131621804|NCT03683030|473903110|FG001|Overall Study|Enrolled but no catheter inserted|13|||
131621805|NCT03683030|473903109|FG000|Overall Study|Withdrawal by Subject|0|||
131621806|NCT03683030|473903110|FG001|Overall Study|Withdrawal by Subject|2|||
131621807|NCT03683030|473903109|FG000|Overall Study|Early termination by subject|1|||
131621808|NCT03683030|473903110|FG001|Overall Study|Early termination by subject|0|||
131621809|NCT03683030|473903109|FG000|Overall Study|Lost to Follow-up|0|||
131621810|NCT03683030|473903110|FG001|Overall Study|Lost to Follow-up|6|||
131621811|NCT03683030|473903109|FG000|Overall Study|Death|0|||
131621812|NCT03683030|473903110|FG001|Overall Study|Death|2|||
131621813|NCT03683030|473903109|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
131621814|NCT03683030|473903110|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
131795691|NCT00992407|474535905|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
131621836|NCT03390504|473903115|FG000|Overall Study|Lost to Follow-up|2|||
131621837|NCT03390504|473903116|FG001|Overall Study|Lost to Follow-up|4|||
131710757|NCT01670994|474219662|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
131710758|NCT01670994|474219661|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
131710759|NCT01670994|474219662|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
131710760|NCT01670994|474219661|FG000|Overall Study|Patient experienced DLT|0|||
131710761|NCT01670994|474219662|FG001|Overall Study|Patient experienced DLT|1|||
131710762|NCT00763009|474219663|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
131710763|NCT01295125|474219665|FG000|Overall Study|Study stopped prematurely|9|||
131710764|NCT01824979|474219667|FG000|Overall Study|Withdrawal by Subject|5|||
131710765|NCT01824979|474219668|FG001|Overall Study|Withdrawal by Subject|0|||
131710766|NCT01824979|474219667|FG000|Overall Study|Physician Decision|2|||
131710767|NCT01824979|474219668|FG001|Overall Study|Physician Decision|0|||
131710768|NCT01824979|474219667|FG000|Overall Study|Protocol Violation|6|||
131710769|NCT01824979|474219668|FG001|Overall Study|Protocol Violation|13|||
131710770|NCT04336163|474219669|FG000|Overall Study|Lost to Follow-up|55|||
131710771|NCT04336163|474219670|FG001|Overall Study|Lost to Follow-up|0|||
131710772|NCT02452762|474219674|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
131710773|NCT02452762|474219675|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
131710774|NCT02452762|474219674|FG000|Overall Study|Withdrawal by Subject|1|||
131710775|NCT02452762|474219675|FG001|Overall Study|Withdrawal by Subject|0|||
131710776|NCT01818297|474219676|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
131710777|NCT01818297|474219677|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
131710778|NCT01818297|474219676|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
131710779|NCT01818297|474219677|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
131710780|NCT01818297|474219676|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
131710781|NCT01818297|474219677|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
131710782|NCT00584870|474219678|FG000|Overall Study|Adverse Event|4|||
131710783|NCT00584870|474219679|FG001|Overall Study|Adverse Event|3|||
131710784|NCT00584870|474219680|FG002|Overall Study|Adverse Event|2|||
131710785|NCT00584870|474219678|FG000|Overall Study|Lost to Follow-up|4|||
131710786|NCT00584870|474219679|FG001|Overall Study|Lost to Follow-up|1|||
131710787|NCT00584870|474219680|FG002|Overall Study|Lost to Follow-up|1|||
131710788|NCT00584870|474219678|FG000|Overall Study|Lack of Efficacy|7|||
131621838|NCT03390504|473903117|FG002|Overall Study|Lost to Follow-up|0|||
131621839|NCT03390504|473903118|FG003|Overall Study|Lost to Follow-up|1|||
131621840|NCT03390504|473903115|FG000|Overall Study|Withdrawal by Subject|3|||
131621841|NCT03390504|473903116|FG001|Overall Study|Withdrawal by Subject|15|||
131621842|NCT03390504|473903117|FG002|Overall Study|Withdrawal by Subject|5|||
131621843|NCT03390504|473903118|FG003|Overall Study|Withdrawal by Subject|2|||
131621844|NCT03390504|473903115|FG000|Overall Study|Other|1|||
131621845|NCT03390504|473903116|FG001|Overall Study|Other|2|||
131621846|NCT03390504|473903117|FG002|Overall Study|Other|2|||
131621847|NCT03390504|473903118|FG003|Overall Study|Other|6|||
131621848|NCT03492177|473903119|FG000|Overall Study|Adverse Event|1|||
131621849|NCT03492177|473903120|FG001|Overall Study|Adverse Event|0|||
131621850|NCT03492177|473903121|FG002|Overall Study|Adverse Event|0|||
131621851|NCT03492177|473903119|FG000|Overall Study|Death|3|||
131621852|NCT03492177|473903120|FG001|Overall Study|Death|0|||
131621853|NCT03492177|473903121|FG002|Overall Study|Death|3|||
131621854|NCT03492177|473903119|FG000|Overall Study|Lack of Efficacy|1|||
131621855|NCT03492177|473903120|FG001|Overall Study|Lack of Efficacy|2|||
131621856|NCT03492177|473903121|FG002|Overall Study|Lack of Efficacy|0|||
131621857|NCT03492177|473903119|FG000|Overall Study|Other|1|||
131621858|NCT03492177|473903120|FG001|Overall Study|Other|0|||
131621859|NCT03492177|473903121|FG002|Overall Study|Other|0|||
131621860|NCT03492177|473903119|FG000|Overall Study|Ongoing|16|||
131621861|NCT03492177|473903120|FG001|Overall Study|Ongoing|19|||
131621862|NCT03492177|473903121|FG002|Overall Study|Ongoing|17|||
131621863|NCT00980538|473903122|FG000|Overall Study|Lost to Follow-up|20|||
131621864|NCT00980538|473903122|FG000|Overall Study|Sponsor's Decision|4|||
131621865|NCT00980538|473903122|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
131621866|NCT00980538|473903122|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
131621867|NCT00980538|473903122|FG000|Overall Study|Switch to Commercially Available Medication|25|||
131621868|NCT00980538|473903122|FG000|Overall Study|Participant Non-Compliant|9|||
131621869|NCT00980538|473903122|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
131621870|NCT00980538|473903122|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
131621871|NCT00980538|473903122|FG000|Overall Study|Other|60|||
131621872|NCT00980538|473903122|FG000|Overall Study|Other|1|||
131621873|NCT04197713|473903123|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
131621874|NCT04197713|473903124|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
131621875|NCT04762277|473903125|FG000|Overall Study|Withdrawal by Subject|0|||
131621876|NCT04762277|473903126|FG001|Overall Study|Withdrawal by Subject|2|||
131621877|NCT04762277|473903125|FG000|Overall Study|Protocol Violation|0|||
131621878|NCT04762277|473903126|FG001|Overall Study|Protocol Violation|1|||
131621879|NCT04762277|473903125|FG000|Overall Study|Adverse Event|1|||
131621880|NCT04762277|473903126|FG001|Overall Study|Adverse Event|0|||
131621905|NCT03820986|473903131|FG000|Overall Study|Death|201|||
131621906|NCT03820986|473903132|FG001|Overall Study|Death|175|||
131621907|NCT03820986|473903131|FG000|Overall Study|Lost to Follow-up|1|||
131621908|NCT03820986|473903132|FG001|Overall Study|Lost to Follow-up|1|||
131621909|NCT03820986|473903131|FG000|Overall Study|Physician Decision|1|||
131621910|NCT03820986|473903132|FG001|Overall Study|Physician Decision|0|||
131621911|NCT03820986|473903131|FG000|Overall Study|Sponsor Decision|122|||
131621912|NCT03820986|473903132|FG001|Overall Study|Sponsor Decision|160|||
131621913|NCT03820986|473903131|FG000|Overall Study|Withdrawal by Subject|9|||
131621914|NCT03820986|473903132|FG001|Overall Study|Withdrawal by Subject|4|||
131710789|NCT00584870|474219679|FG001|Overall Study|Lack of Efficacy|14|||
131710790|NCT00584870|474219680|FG002|Overall Study|Lack of Efficacy|8|||
131710791|NCT00584870|474219678|FG000|Overall Study|Withdrawal by Subject|10|||
131710792|NCT00584870|474219679|FG001|Overall Study|Withdrawal by Subject|5|||
131710793|NCT00584870|474219680|FG002|Overall Study|Withdrawal by Subject|3|||
131710794|NCT00584870|474219678|FG000|Overall Study|Protocol Violation|1|||
131710795|NCT00584870|474219679|FG001|Overall Study|Protocol Violation|1|||
131710796|NCT00584870|474219680|FG002|Overall Study|Protocol Violation|2|||
131710797|NCT00584870|474219678|FG000|Overall Study|Did not met entrance criteria|1|||
131710798|NCT00584870|474219679|FG001|Overall Study|Did not met entrance criteria|0|||
131710799|NCT00584870|474219680|FG002|Overall Study|Did not met entrance criteria|0|||
131710800|NCT00584870|474219678|FG000|Overall Study|Other|2|||
131710801|NCT00584870|474219679|FG001|Overall Study|Other|0|||
131710802|NCT00584870|474219680|FG002|Overall Study|Other|0|||
131710803|NCT00584870|474219678|FG000|Overall Study|Randomized but not treated|0|||
131710804|NCT00584870|474219679|FG001|Overall Study|Randomized but not treated|1|||
131710805|NCT00584870|474219680|FG002|Overall Study|Randomized but not treated|2|||
131710806|NCT02675075|474219681|FG000|Overall Study|Lost to Follow-up|3|||
131710807|NCT02675075|474219682|FG001|Overall Study|Lost to Follow-up|0|||
131710808|NCT00675597|474219683|FG000|Overall Study|Withdrawal by Subject|3|||
131710809|NCT00631137|474219684|FG000|Overall Study|Withdrawal by Subject|1|||
131710810|NCT00631137|474219685|FG001|Overall Study|Withdrawal by Subject|0|||
131710811|NCT03682120|474219686|FG000|Overall Study|Lost to Follow-up|11|||
131710812|NCT03682120|474219687|FG001|Overall Study|Lost to Follow-up|4|||
131900903|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131710813|NCT03682120|474219688|FG002|Overall Study|Lost to Follow-up|5|||
131710814|NCT03682120|474219689|FG003|Overall Study|Lost to Follow-up|2|||
131710815|NCT03682120|474219686|FG000|Overall Study|Physician Decision|1|||
131622081|NCT05615363|473903159|FG000|Overall Study|Adverse Event|0|||
131622082|NCT05615363|473903160|FG001|Overall Study|Adverse Event|4|||
131622083|NCT05615363|473903161|FG002|Overall Study|Adverse Event|4|||
131622084|NCT05615363|473903162|FG003|Overall Study|Adverse Event|3|||
131622085|NCT05615363|473903163|FG004|Overall Study|Adverse Event|1|||
131622086|NCT05615363|473903159|FG000|Overall Study|Physician Decision|2|||
131795692|NCT00992407|474535906|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
131795693|NCT00992407|474535905|FG000|Overall Study|Study medication not administered|17|||
131622087|NCT05615363|473903160|FG001|Overall Study|Physician Decision|0|||
131622088|NCT05615363|473903161|FG002|Overall Study|Physician Decision|4|||
131795694|NCT00992407|474535906|FG001|Overall Study|Study medication not administered|13|||
131795695|NCT02396381|474535909|FG000|Overall Study|Adverse Event|3|||
131622089|NCT05615363|473903162|FG003|Overall Study|Physician Decision|1|||
131622090|NCT05615363|473903163|FG004|Overall Study|Physician Decision|3|||
131622091|NCT05615363|473903159|FG000|Overall Study|Protocol Violation|2|||
131622092|NCT05615363|473903160|FG001|Overall Study|Protocol Violation|0|||
131622093|NCT05615363|473903161|FG002|Overall Study|Protocol Violation|0|||
131622094|NCT05615363|473903162|FG003|Overall Study|Protocol Violation|0|||
131622095|NCT05615363|473903163|FG004|Overall Study|Protocol Violation|1|||
131622096|NCT05615363|473903159|FG000|Overall Study|Withdrawal by Subject|0|||
131622097|NCT05615363|473903160|FG001|Overall Study|Withdrawal by Subject|0|||
131622098|NCT05615363|473903161|FG002|Overall Study|Withdrawal by Subject|1|||
131622099|NCT05615363|473903162|FG003|Overall Study|Withdrawal by Subject|0|||
131622100|NCT05615363|473903163|FG004|Overall Study|Withdrawal by Subject|0|||
131795696|NCT02396381|474535910|FG001|Overall Study|Adverse Event|2|||
131795697|NCT02396381|474535909|FG000|Overall Study|Withdrawal by Subject|33|||
131795698|NCT02396381|474535910|FG001|Overall Study|Withdrawal by Subject|24|||
131795699|NCT02396381|474535909|FG000|Overall Study|Lost to Follow-up|49|||
131795700|NCT02396381|474535910|FG001|Overall Study|Lost to Follow-up|31|||
131795701|NCT02396381|474535909|FG000|Overall Study|Protocol Violation|1|||
131622202|NCT02159989|473905110|FG000|Overall Study|Adverse Event|1|||
131622203|NCT02159989|473905111|FG001|Overall Study|Adverse Event|0|||
131622204|NCT02159989|473905112|FG002|Overall Study|Adverse Event|0|||
131622205|NCT02159989|473905113|FG003|Overall Study|Adverse Event|0|||
131622206|NCT02159989|473905114|FG004|Overall Study|Adverse Event|1|||
131622207|NCT02159989|473905115|FG005|Overall Study|Adverse Event|0|||
131622208|NCT02159989|473905116|FG006|Overall Study|Adverse Event|1|||
131622209|NCT02159989|473905117|FG007|Overall Study|Adverse Event|2|||
131622210|NCT02159989|473905118|FG008|Overall Study|Adverse Event|0|||
131622211|NCT02159989|473905119|FG009|Overall Study|Adverse Event|2|||
131622212|NCT02159989|473905120|FG010|Overall Study|Adverse Event|1|||
131622213|NCT02159989|473905110|FG000|Overall Study|Death|0|||
131622214|NCT02159989|473905111|FG001|Overall Study|Death|0|||
131622215|NCT02159989|473905112|FG002|Overall Study|Death|0|||
131622216|NCT02159989|473905113|FG003|Overall Study|Death|0|||
131622217|NCT02159989|473905114|FG004|Overall Study|Death|0|||
131622218|NCT02159989|473905115|FG005|Overall Study|Death|0|||
131622219|NCT02159989|473905116|FG006|Overall Study|Death|0|||
131622220|NCT02159989|473905117|FG007|Overall Study|Death|0|||
131622221|NCT02159989|473905118|FG008|Overall Study|Death|0|||
131622222|NCT02159989|473905119|FG009|Overall Study|Death|0|||
131622223|NCT02159989|473905120|FG010|Overall Study|Death|1|||
131622224|NCT02159989|473905110|FG000|Overall Study|Lack of Efficacy|2|||
131622225|NCT02159989|473905111|FG001|Overall Study|Lack of Efficacy|3|||
131622226|NCT02159989|473905112|FG002|Overall Study|Lack of Efficacy|3|||
131622227|NCT02159989|473905113|FG003|Overall Study|Lack of Efficacy|0|||
131622228|NCT02159989|473905114|FG004|Overall Study|Lack of Efficacy|2|||
131622229|NCT02159989|473905115|FG005|Overall Study|Lack of Efficacy|3|||
131622230|NCT02159989|473905116|FG006|Overall Study|Lack of Efficacy|3|||
131622231|NCT02159989|473905117|FG007|Overall Study|Lack of Efficacy|1|||
131622232|NCT02159989|473905118|FG008|Overall Study|Lack of Efficacy|3|||
131622233|NCT02159989|473905119|FG009|Overall Study|Lack of Efficacy|6|||
131622234|NCT02159989|473905120|FG010|Overall Study|Lack of Efficacy|7|||
131622235|NCT02159989|473905110|FG000|Overall Study|Lost to Follow-up|0|||
131622236|NCT02159989|473905111|FG001|Overall Study|Lost to Follow-up|0|||
131622237|NCT02159989|473905112|FG002|Overall Study|Lost to Follow-up|0|||
131622238|NCT02159989|473905113|FG003|Overall Study|Lost to Follow-up|1|||
131710816|NCT03682120|474219687|FG001|Overall Study|Physician Decision|0|||
131622239|NCT02159989|473905114|FG004|Overall Study|Lost to Follow-up|0|||
131622240|NCT02159989|473905115|FG005|Overall Study|Lost to Follow-up|0|||
131622241|NCT02159989|473905116|FG006|Overall Study|Lost to Follow-up|0|||
131622242|NCT02159989|473905117|FG007|Overall Study|Lost to Follow-up|0|||
131622243|NCT02159989|473905118|FG008|Overall Study|Lost to Follow-up|0|||
131622244|NCT02159989|473905119|FG009|Overall Study|Lost to Follow-up|0|||
131443992|NCT03694353|473255016|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
131443993|NCT05720897|473255017|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
131443994|NCT05720897|473255018|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
131622245|NCT02159989|473905120|FG010|Overall Study|Lost to Follow-up|1|||
131622246|NCT02159989|473905110|FG000|Overall Study|Withdrawal by Subject|2|||
131622247|NCT02159989|473905111|FG001|Overall Study|Withdrawal by Subject|0|||
131622248|NCT02159989|473905112|FG002|Overall Study|Withdrawal by Subject|0|||
131622249|NCT02159989|473905113|FG003|Overall Study|Withdrawal by Subject|2|||
131622250|NCT02159989|473905114|FG004|Overall Study|Withdrawal by Subject|1|||
131622251|NCT02159989|473905115|FG005|Overall Study|Withdrawal by Subject|0|||
131622252|NCT02159989|473905116|FG006|Overall Study|Withdrawal by Subject|3|||
131622253|NCT02159989|473905117|FG007|Overall Study|Withdrawal by Subject|1|||
131622254|NCT02159989|473905118|FG008|Overall Study|Withdrawal by Subject|0|||
131622255|NCT02159989|473905119|FG009|Overall Study|Withdrawal by Subject|0|||
131622256|NCT02159989|473905120|FG010|Overall Study|Withdrawal by Subject|0|||
131622257|NCT02159989|473905110|FG000|Overall Study|New treatment|0|||
131622258|NCT02159989|473905111|FG001|Overall Study|New treatment|1|||
131622259|NCT02159989|473905112|FG002|Overall Study|New treatment|0|||
131622260|NCT02159989|473905113|FG003|Overall Study|New treatment|0|||
131622261|NCT02159989|473905114|FG004|Overall Study|New treatment|0|||
131622262|NCT02159989|473905115|FG005|Overall Study|New treatment|0|||
131622263|NCT02159989|473905116|FG006|Overall Study|New treatment|0|||
131622264|NCT02159989|473905117|FG007|Overall Study|New treatment|0|||
131622265|NCT02159989|473905118|FG008|Overall Study|New treatment|0|||
131622266|NCT02159989|473905119|FG009|Overall Study|New treatment|0|||
131622267|NCT02159989|473905120|FG010|Overall Study|New treatment|0|||
131622268|NCT02159989|473905110|FG000|Overall Study|Insurance Issues|0|||
131622269|NCT02159989|473905111|FG001|Overall Study|Insurance Issues|0|||
131622270|NCT02159989|473905112|FG002|Overall Study|Insurance Issues|0|||
131622271|NCT02159989|473905113|FG003|Overall Study|Insurance Issues|0|||
131622272|NCT02159989|473905114|FG004|Overall Study|Insurance Issues|0|||
131622273|NCT02159989|473905115|FG005|Overall Study|Insurance Issues|0|||
131622274|NCT02159989|473905116|FG006|Overall Study|Insurance Issues|0|||
131622275|NCT02159989|473905117|FG007|Overall Study|Insurance Issues|0|||
131622276|NCT02159989|473905118|FG008|Overall Study|Insurance Issues|0|||
131622277|NCT02159989|473905119|FG009|Overall Study|Insurance Issues|1|||
131622278|NCT02159989|473905120|FG010|Overall Study|Insurance Issues|0|||
131622288|NCT05338476|473905125|FG000|Period 2|Adverse Event|0|||
131622289|NCT05338476|473905126|FG001|Period 2|Adverse Event|1|||
131443995|NCT00400179|473255019|FG000|Overall Study|Adverse Event|2|||
131443996|NCT00400179|473255020|FG001|Overall Study|Adverse Event|2|||
131443997|NCT00400179|473255019|FG000|Overall Study|Death|1|||
131443998|NCT00400179|473255020|FG001|Overall Study|Death|2|||
131443999|NCT00400179|473255019|FG000|Overall Study|Withdrew Consent|1|||
131444000|NCT00400179|473255020|FG001|Overall Study|Withdrew Consent|5|||
131444001|NCT00400179|473255019|FG000|Overall Study|Disease progression|1|||
131444002|NCT00400179|473255020|FG001|Overall Study|Disease progression|1|||
131444003|NCT00400179|473255019|FG000|Overall Study|Intercurrent illness|0|||
131444004|NCT00400179|473255020|FG001|Overall Study|Intercurrent illness|1|||
131444005|NCT00400179|473255019|FG000|Overall Study|Investigator judgment|0|||
131622296|NCT05289037|473905132|FG000|Overall Study|Withdrawal by Subject|7|||
131622297|NCT05289037|473905133|FG001|Overall Study|Withdrawal by Subject|0|||
131444006|NCT00400179|473255020|FG001|Overall Study|Investigator judgment|1|||
131622298|NCT05289037|473905134|FG002|Overall Study|Withdrawal by Subject|3|||
131622299|NCT05289037|473905135|FG003|Overall Study|Withdrawal by Subject|3|||
131622300|NCT05289037|473905136|FG004|Overall Study|Withdrawal by Subject|1|||
131622301|NCT05289037|473905137|FG005|Overall Study|Withdrawal by Subject|5|||
131622302|NCT05289037|473905138|FG006|Overall Study|Withdrawal by Subject|2|||
131622303|NCT05289037|473905139|FG007|Overall Study|Withdrawal by Subject|1|||
131622304|NCT05289037|473905140|FG008|Overall Study|Withdrawal by Subject|2|||
131622305|NCT05289037|473905141|FG009|Overall Study|Withdrawal by Subject|2|||
131622306|NCT05289037|473905142|FG010|Overall Study|Withdrawal by Subject|1|||
131622307|NCT05289037|473905143|FG011|Overall Study|Withdrawal by Subject|0|||
131622308|NCT05289037|473905144|FG012|Overall Study|Withdrawal by Subject|1|||
131622309|NCT05289037|473905145|FG013|Overall Study|Withdrawal by Subject|2|||
131622310|NCT05289037|473905146|FG014|Overall Study|Withdrawal by Subject|0|||
131622311|NCT05289037|473905147|FG015|Overall Study|Withdrawal by Subject|3|||
131622312|NCT05289037|473905148|FG016|Overall Study|Withdrawal by Subject|3|||
131622313|NCT05289037|473905132|FG000|Overall Study|Lost to Follow-up|1|||
131622314|NCT05289037|473905133|FG001|Overall Study|Lost to Follow-up|4|||
131622315|NCT05289037|473905134|FG002|Overall Study|Lost to Follow-up|3|||
131622316|NCT05289037|473905135|FG003|Overall Study|Lost to Follow-up|3|||
131622317|NCT05289037|473905136|FG004|Overall Study|Lost to Follow-up|3|||
131622318|NCT05289037|473905137|FG005|Overall Study|Lost to Follow-up|2|||
131622319|NCT05289037|473905138|FG006|Overall Study|Lost to Follow-up|3|||
131622320|NCT05289037|473905139|FG007|Overall Study|Lost to Follow-up|2|||
131622321|NCT05289037|473905140|FG008|Overall Study|Lost to Follow-up|2|||
131622322|NCT05289037|473905141|FG009|Overall Study|Lost to Follow-up|1|||
131622323|NCT05289037|473905142|FG010|Overall Study|Lost to Follow-up|3|||
131622324|NCT05289037|473905143|FG011|Overall Study|Lost to Follow-up|4|||
131622325|NCT05289037|473905144|FG012|Overall Study|Lost to Follow-up|2|||
131622326|NCT05289037|473905145|FG013|Overall Study|Lost to Follow-up|7|||
131622327|NCT05289037|473905146|FG014|Overall Study|Lost to Follow-up|4|||
131622328|NCT05289037|473905147|FG015|Overall Study|Lost to Follow-up|6|||
131622329|NCT05289037|473905148|FG016|Overall Study|Lost to Follow-up|4|||
131622330|NCT05289037|473905132|FG000|Overall Study|Death|0|||
131622331|NCT05289037|473905133|FG001|Overall Study|Death|0|||
131622332|NCT05289037|473905134|FG002|Overall Study|Death|0|||
131622333|NCT05289037|473905135|FG003|Overall Study|Death|0|||
131622334|NCT05289037|473905136|FG004|Overall Study|Death|0|||
131622335|NCT05289037|473905137|FG005|Overall Study|Death|1|||
131622336|NCT05289037|473905138|FG006|Overall Study|Death|0|||
131622337|NCT05289037|473905139|FG007|Overall Study|Death|0|||
131622338|NCT05289037|473905140|FG008|Overall Study|Death|0|||
131622339|NCT05289037|473905141|FG009|Overall Study|Death|0|||
131622340|NCT05289037|473905142|FG010|Overall Study|Death|0|||
131622341|NCT05289037|473905143|FG011|Overall Study|Death|0|||
131622342|NCT05289037|473905144|FG012|Overall Study|Death|0|||
131622343|NCT05289037|473905145|FG013|Overall Study|Death|0|||
131622344|NCT05289037|473905146|FG014|Overall Study|Death|1|||
131622345|NCT05289037|473905147|FG015|Overall Study|Death|0|||
131622346|NCT05289037|473905148|FG016|Overall Study|Death|0|||
131622347|NCT05289037|473905132|FG000|Overall Study|Did not receive vaccine|0|||
131622348|NCT05289037|473905133|FG001|Overall Study|Did not receive vaccine|3|||
131622349|NCT05289037|473905134|FG002|Overall Study|Did not receive vaccine|0|||
131622350|NCT05289037|473905135|FG003|Overall Study|Did not receive vaccine|0|||
131622351|NCT05289037|473905136|FG004|Overall Study|Did not receive vaccine|1|||
131622352|NCT05289037|473905137|FG005|Overall Study|Did not receive vaccine|1|||
131622353|NCT05289037|473905138|FG006|Overall Study|Did not receive vaccine|1|||
131622354|NCT05289037|473905139|FG007|Overall Study|Did not receive vaccine|0|||
131622355|NCT05289037|473905140|FG008|Overall Study|Did not receive vaccine|0|||
131622356|NCT05289037|473905141|FG009|Overall Study|Did not receive vaccine|0|||
131622357|NCT05289037|473905142|FG010|Overall Study|Did not receive vaccine|0|||
131622358|NCT05289037|473905143|FG011|Overall Study|Did not receive vaccine|0|||
131622359|NCT05289037|473905144|FG012|Overall Study|Did not receive vaccine|0|||
131622360|NCT05289037|473905145|FG013|Overall Study|Did not receive vaccine|0|||
131622361|NCT05289037|473905146|FG014|Overall Study|Did not receive vaccine|1|||
131622362|NCT05289037|473905147|FG015|Overall Study|Did not receive vaccine|0|||
131622363|NCT05289037|473905148|FG016|Overall Study|Did not receive vaccine|0|||
131622364|NCT05289037|473905132|FG000|Overall Study|Unable to make last visit|0|||
131622365|NCT05289037|473905133|FG001|Overall Study|Unable to make last visit|0|||
131622366|NCT05289037|473905134|FG002|Overall Study|Unable to make last visit|1|||
131622367|NCT05289037|473905135|FG003|Overall Study|Unable to make last visit|0|||
131622368|NCT05289037|473905136|FG004|Overall Study|Unable to make last visit|0|||
131622369|NCT05289037|473905137|FG005|Overall Study|Unable to make last visit|0|||
131622370|NCT05289037|473905138|FG006|Overall Study|Unable to make last visit|0|||
131622371|NCT05289037|473905139|FG007|Overall Study|Unable to make last visit|0|||
131622372|NCT05289037|473905140|FG008|Overall Study|Unable to make last visit|0|||
131622373|NCT05289037|473905141|FG009|Overall Study|Unable to make last visit|0|||
131622374|NCT05289037|473905142|FG010|Overall Study|Unable to make last visit|0|||
131622375|NCT05289037|473905143|FG011|Overall Study|Unable to make last visit|0|||
131622376|NCT05289037|473905144|FG012|Overall Study|Unable to make last visit|0|||
131622377|NCT05289037|473905145|FG013|Overall Study|Unable to make last visit|0|||
131622378|NCT05289037|473905146|FG014|Overall Study|Unable to make last visit|0|||
131622379|NCT05289037|473905147|FG015|Overall Study|Unable to make last visit|0|||
131622380|NCT05289037|473905148|FG016|Overall Study|Unable to make last visit|0|||
131622381|NCT05289037|473905132|FG000|Overall Study|Protocol deviation|0|||
131622382|NCT05289037|473905133|FG001|Overall Study|Protocol deviation|0|||
131622383|NCT05289037|473905134|FG002|Overall Study|Protocol deviation|0|||
131622384|NCT05289037|473905135|FG003|Overall Study|Protocol deviation|0|||
131622385|NCT05289037|473905136|FG004|Overall Study|Protocol deviation|0|||
131622386|NCT05289037|473905137|FG005|Overall Study|Protocol deviation|0|||
131622387|NCT05289037|473905138|FG006|Overall Study|Protocol deviation|0|||
131622388|NCT05289037|473905139|FG007|Overall Study|Protocol deviation|0|||
131622389|NCT05289037|473905140|FG008|Overall Study|Protocol deviation|0|||
131622390|NCT05289037|473905141|FG009|Overall Study|Protocol deviation|0|||
131622391|NCT05289037|473905142|FG010|Overall Study|Protocol deviation|0|||
131622392|NCT05289037|473905143|FG011|Overall Study|Protocol deviation|0|||
131622393|NCT05289037|473905144|FG012|Overall Study|Protocol deviation|0|||
131622394|NCT05289037|473905145|FG013|Overall Study|Protocol deviation|0|||
131622395|NCT05289037|473905146|FG014|Overall Study|Protocol deviation|0|||
131622396|NCT05289037|473905147|FG015|Overall Study|Protocol deviation|1|||
131622397|NCT05289037|473905148|FG016|Overall Study|Protocol deviation|0|||
131622414|NCT04487080|473905155|FG000|Overall Study|Withdrawal by Subject|19|||
131622415|NCT04487080|473905156|FG001|Overall Study|Withdrawal by Subject|18|||
131622416|NCT04487080|473905157|FG002|Overall Study|Withdrawal by Subject|13|||
131622417|NCT04487080|473905155|FG000|Overall Study|Lost to Follow-up|3|||
131622418|NCT04487080|473905156|FG001|Overall Study|Lost to Follow-up|1|||
131622419|NCT04487080|473905157|FG002|Overall Study|Lost to Follow-up|0|||
131622420|NCT04487080|473905155|FG000|Overall Study|Ongoing|313|||
131622421|NCT04487080|473905156|FG001|Overall Study|Ongoing|297|||
131622422|NCT04487080|473905157|FG002|Overall Study|Ongoing|149|||
131444007|NCT00400179|473255019|FG000|Overall Study|Randomization error/patient ineligible|1|||
131622502|NCT03451851|473905176|FG000|PCP: Week 0 -16|Adverse Event|1|||
131622503|NCT03451851|473905177|FG001|PCP: Week 0 -16|Adverse Event|0|||
131622504|NCT03451851|473905178|FG002|PCP: Week 0 -16|Adverse Event|0|||
131622505|NCT03451851|473905179|FG003|PCP: Week 0 -16|Adverse Event|0|||
131622506|NCT03451851|473905180|FG004|PCP: Week 0 -16|Adverse Event|0|||
131622507|NCT03451851|473905181|FG005|PCP: Week 0 -16|Adverse Event|0|||
131444008|NCT00400179|473255020|FG001|Overall Study|Randomization error/patient ineligible|6|||
131622508|NCT03451851|473905182|FG006|PCP: Week 0 -16|Adverse Event|1|||
131622509|NCT03451851|473905183|FG007|PCP: Week 0 -16|Adverse Event|0|||
131622510|NCT03451851|473905176|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622511|NCT03451851|473905177|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622512|NCT03451851|473905178|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
131622513|NCT03451851|473905179|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622514|NCT03451851|473905180|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622515|NCT03451851|473905181|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622516|NCT03451851|473905182|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622517|NCT03451851|473905183|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
131622518|NCT03451851|473905176|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622519|NCT03451851|473905177|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622520|NCT03451851|473905178|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
131622521|NCT03451851|473905179|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622522|NCT03451851|473905180|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622523|NCT03451851|473905181|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622524|NCT03451851|473905182|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622525|NCT03451851|473905183|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131622526|NCT03451851|473905176|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131622527|NCT03451851|473905177|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131622528|NCT03451851|473905178|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131622529|NCT03451851|473905179|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131622530|NCT03451851|473905180|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
131622531|NCT03451851|473905181|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
131622532|NCT03451851|473905182|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131622533|NCT03451851|473905183|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131622534|NCT03451851|473905176|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622535|NCT03451851|473905177|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622536|NCT03451851|473905178|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622537|NCT03451851|473905179|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622538|NCT03451851|473905180|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
131622539|NCT03451851|473905181|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622540|NCT03451851|473905182|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622541|NCT03451851|473905183|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131622542|NCT03451851|473905176|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622543|NCT03451851|473905177|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622544|NCT03451851|473905178|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622545|NCT03451851|473905179|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622546|NCT03451851|473905180|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
131622547|NCT03451851|473905181|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622548|NCT03451851|473905182|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622549|NCT03451851|473905183|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131622570|NCT04852978|473905186|FG000|Overall Study|Physician Decision|0|||
131622571|NCT04852978|473905187|FG001|Overall Study|Physician Decision|1|||
131622572|NCT04852978|473905188|FG002|Overall Study|Physician Decision|0|||
131622573|NCT04852978|473905189|FG003|Overall Study|Physician Decision|0|||
131622574|NCT04852978|473905190|FG004|Overall Study|Physician Decision|0|||
131622575|NCT04852978|473905191|FG005|Overall Study|Physician Decision|0|||
131622576|NCT04852978|473905192|FG006|Overall Study|Physician Decision|0|||
131622577|NCT04852978|473905193|FG007|Overall Study|Physician Decision|2|||
131622578|NCT04852978|473905194|FG008|Overall Study|Physician Decision|0|||
131622579|NCT04852978|473905186|FG000|Overall Study|Sponsor request|0|||
131622580|NCT04852978|473905187|FG001|Overall Study|Sponsor request|0|||
131622581|NCT04852978|473905188|FG002|Overall Study|Sponsor request|1|||
131622582|NCT04852978|473905189|FG003|Overall Study|Sponsor request|0|||
131622583|NCT04852978|473905190|FG004|Overall Study|Sponsor request|0|||
131622584|NCT04852978|473905191|FG005|Overall Study|Sponsor request|0|||
131622585|NCT04852978|473905192|FG006|Overall Study|Sponsor request|0|||
131622586|NCT04852978|473905193|FG007|Overall Study|Sponsor request|0|||
131622587|NCT04852978|473905194|FG008|Overall Study|Sponsor request|0|||
131622588|NCT04852978|473905186|FG000|Overall Study|Death|0|||
131622589|NCT04852978|473905187|FG001|Overall Study|Death|0|||
131622590|NCT04852978|473905188|FG002|Overall Study|Death|0|||
131622591|NCT04852978|473905189|FG003|Overall Study|Death|0|||
131622592|NCT04852978|473905190|FG004|Overall Study|Death|0|||
131622593|NCT04852978|473905191|FG005|Overall Study|Death|0|||
131622594|NCT04852978|473905192|FG006|Overall Study|Death|1|||
131622595|NCT04852978|473905193|FG007|Overall Study|Death|0|||
131622596|NCT04852978|473905194|FG008|Overall Study|Death|0|||
131622597|NCT04852978|473905186|FG000|Overall Study|Lost to Follow-up|3|||
131622598|NCT04852978|473905187|FG001|Overall Study|Lost to Follow-up|2|||
131622599|NCT04852978|473905188|FG002|Overall Study|Lost to Follow-up|2|||
131622600|NCT04852978|473905189|FG003|Overall Study|Lost to Follow-up|0|||
131622601|NCT04852978|473905190|FG004|Overall Study|Lost to Follow-up|2|||
131622602|NCT04852978|473905191|FG005|Overall Study|Lost to Follow-up|4|||
131622603|NCT04852978|473905192|FG006|Overall Study|Lost to Follow-up|1|||
131622604|NCT04852978|473905193|FG007|Overall Study|Lost to Follow-up|2|||
131622605|NCT04852978|473905194|FG008|Overall Study|Lost to Follow-up|2|||
131622606|NCT04852978|473905186|FG000|Overall Study|Withdrawal by Subject|4|||
131622607|NCT04852978|473905187|FG001|Overall Study|Withdrawal by Subject|2|||
131622608|NCT04852978|473905188|FG002|Overall Study|Withdrawal by Subject|2|||
131900904|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131444009|NCT04780061|473255021|FG000|Overall Study|Withdrawal by Subject|5|||
131444010|NCT04780061|473255022|FG001|Overall Study|Withdrawal by Subject|8|||
131622609|NCT04852978|473905189|FG003|Overall Study|Withdrawal by Subject|1|||
131622610|NCT04852978|473905190|FG004|Overall Study|Withdrawal by Subject|5|||
131622611|NCT04852978|473905191|FG005|Overall Study|Withdrawal by Subject|3|||
131622612|NCT04852978|473905192|FG006|Overall Study|Withdrawal by Subject|2|||
131622613|NCT04852978|473905193|FG007|Overall Study|Withdrawal by Subject|2|||
131622614|NCT04852978|473905194|FG008|Overall Study|Withdrawal by Subject|1|||
131622615|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
131622616|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
131622617|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
131622618|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
131622619|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
131622620|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
131622621|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
131622622|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
131622623|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
131622624|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
131622625|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
131622626|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
131622627|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
131622628|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
131622629|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
131622630|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
131622631|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
131622632|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
131622633|NCT02294461|473905197|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
131622634|NCT02294461|473905198|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
131622635|NCT02294461|473905199|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
131622636|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
131622637|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
131622638|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
131622639|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
131622640|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
131622641|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
131622642|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
131622643|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
131622644|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
131622645|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
131622646|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
131622647|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
131622648|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
131622649|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
131622650|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
131622651|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
131622652|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
131622653|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
131622654|NCT02294461|473905197|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
131622655|NCT02294461|473905198|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
131622656|NCT02294461|473905199|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
131653733|NCT03083665|474018466|FG005|Double-Blind Period|Withdrawal by Subject|0|||
131653734|NCT03083665|474018461|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
131653735|NCT03083665|474018462|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131653736|NCT03083665|474018463|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131653737|NCT03083665|474018464|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131653738|NCT03083665|474018465|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131653739|NCT03083665|474018466|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131653740|NCT03083665|474018461|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
131653741|NCT03083665|474018462|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
131653742|NCT03083665|474018463|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
131653743|NCT03083665|474018464|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
131653744|NCT03083665|474018465|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
131653745|NCT03083665|474018466|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
131653746|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131653747|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131653748|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131653749|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
131653750|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131710817|NCT03682120|474219688|FG002|Overall Study|Physician Decision|0|||
131710818|NCT03682120|474219689|FG003|Overall Study|Physician Decision|0|||
131622657|NCT00949117|473906492|FG000|Overall Study|Lack of Efficacy|2|||
131622658|NCT00949117|473906493|FG001|Overall Study|Lack of Efficacy|3|||
131622659|NCT00949117|473906492|FG000|Overall Study|Protocol Violation|1|||
131622660|NCT00949117|473906493|FG001|Overall Study|Protocol Violation|1|||
131622661|NCT00949117|473906492|FG000|Overall Study|Adverse Event|0|||
131622662|NCT00949117|473906493|FG001|Overall Study|Adverse Event|1|||
131622663|NCT03769090|473906494|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
131795702|NCT02396381|474535910|FG001|Overall Study|Protocol Violation|0|||
131795703|NCT02396381|474535909|FG000|Overall Study|Site terminated by sponsor|7|||
131795704|NCT02396381|474535910|FG001|Overall Study|Site terminated by sponsor|8|||
131795705|NCT02396381|474535909|FG000|Overall Study|Physician Decision|5|||
131795706|NCT02396381|474535910|FG001|Overall Study|Physician Decision|5|||
131795707|NCT02396381|474535909|FG000|Overall Study|Pregnancy|2|||
131795708|NCT02396381|474535910|FG001|Overall Study|Pregnancy|0|||
131795709|NCT02396381|474535909|FG000|Overall Study|Non-compliance with study procedures|1|||
131795710|NCT02396381|474535910|FG001|Overall Study|Non-compliance with study procedures|0|||
131795711|NCT02396381|474535909|FG000|Overall Study|Moved out of town/state|1|||
131795712|NCT02396381|474535910|FG001|Overall Study|Moved out of town/state|3|||
131795713|NCT02396381|474535909|FG000|Overall Study|Could not complete visit|1|||
131795714|NCT02396381|474535910|FG001|Overall Study|Could not complete visit|0|||
131795715|NCT02396381|474535909|FG000|Overall Study|Possible conflict of interest|1|||
131795716|NCT02396381|474535910|FG001|Overall Study|Possible conflict of interest|0|||
131795717|NCT02396381|474535909|FG000|Overall Study|Randomization/Screening Error|3|||
131795718|NCT02396381|474535910|FG001|Overall Study|Randomization/Screening Error|1|||
131795719|NCT00356200|474535912|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
131795720|NCT00356200|474535913|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
131795721|NCT00356200|474535912|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
131900905|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131900906|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131622664|NCT03769090|473906495|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
131622665|NCT03769090|473906496|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
131444011|NCT04780061|473255021|FG000|Overall Study|Adverse Event|2|||
131444012|NCT04780061|473255022|FG001|Overall Study|Adverse Event|2|||
131444013|NCT04780061|473255021|FG000|Overall Study|Lost to Follow-up|1|||
131444014|NCT04780061|473255022|FG001|Overall Study|Lost to Follow-up|5|||
131444015|NCT05138653|473255023|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
131444016|NCT05138653|473255024|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444017|NCT05138653|473255025|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444018|NCT05138653|473255026|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444019|NCT05138653|473255027|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444020|NCT05138653|473255028|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444021|NCT05138653|473255029|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444022|NCT05138653|473255030|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444023|NCT05138653|473255031|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444024|NCT05138653|473255032|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444025|NCT05138653|473255033|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131622666|NCT03769090|473906494|FG000|Overall Study|Withdrawal by Subject|52|||
131622667|NCT03769090|473906495|FG001|Overall Study|Withdrawal by Subject|62|||
131622668|NCT03769090|473906496|FG002|Overall Study|Withdrawal by Subject|74|||
131622669|NCT03769090|473906494|FG000|Overall Study|Death|4|||
131622670|NCT03769090|473906495|FG001|Overall Study|Death|2|||
131622671|NCT03769090|473906496|FG002|Overall Study|Death|2|||
131622672|NCT03769090|473906494|FG000|Overall Study|Adverse Event|7|||
131622673|NCT03769090|473906495|FG001|Overall Study|Adverse Event|7|||
131622674|NCT03769090|473906496|FG002|Overall Study|Adverse Event|8|||
131622675|NCT03769090|473906494|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
131622676|NCT03769090|473906495|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
131622677|NCT03769090|473906496|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
131622678|NCT03769090|473906494|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
131622679|NCT03769090|473906495|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
131622680|NCT03769090|473906496|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
131622681|NCT03769090|473906494|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
131622682|NCT03769090|473906495|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
131622683|NCT03769090|473906496|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
131622684|NCT03769090|473906494|FG000|Overall Study|Protocol Violation|5|||
131622685|NCT03769090|473906495|FG001|Overall Study|Protocol Violation|6|||
131622686|NCT03769090|473906496|FG002|Overall Study|Protocol Violation|8|||
131622687|NCT03769090|473906494|FG000|Overall Study|Pregnancy|1|||
131622688|NCT03769090|473906495|FG001|Overall Study|Pregnancy|0|||
131622689|NCT03769090|473906496|FG002|Overall Study|Pregnancy|3|||
131622690|NCT03769090|473906494|FG000|Overall Study|Lost to Follow-up|19|||
131622691|NCT03769090|473906495|FG001|Overall Study|Lost to Follow-up|25|||
131622692|NCT03769090|473906496|FG002|Overall Study|Lost to Follow-up|21|||
131622693|NCT03769090|473906494|FG000|Overall Study|Condition under investigation worsened|2|||
131622694|NCT03769090|473906495|FG001|Overall Study|Condition under investigation worsened|0|||
131622695|NCT03769090|473906496|FG002|Overall Study|Condition under investigation worsened|1|||
131622696|NCT03769090|473906494|FG000|Overall Study|Lack of Efficacy|1|||
131622697|NCT03769090|473906495|FG001|Overall Study|Lack of Efficacy|2|||
131622698|NCT03769090|473906496|FG002|Overall Study|Lack of Efficacy|2|||
131622699|NCT03769090|473906494|FG000|Overall Study|Other reasons|8|||
131622700|NCT03769090|473906495|FG001|Overall Study|Other reasons|12|||
131622701|NCT03769090|473906496|FG002|Overall Study|Other reasons|15|||
131622702|NCT00799409|473906497|FG000|Overall Study|Withdrawal by Subject|1|||
131622703|NCT00799409|473906498|FG001|Overall Study|Withdrawal by Subject|0|||
131622704|NCT00799409|473906499|FG002|Overall Study|Withdrawal by Subject|0|||
131622705|NCT00799409|473906497|FG000|Overall Study|Lost to Follow-up|1|||
131622706|NCT00799409|473906498|FG001|Overall Study|Lost to Follow-up|0|||
131622707|NCT00799409|473906499|FG002|Overall Study|Lost to Follow-up|0|||
131622708|NCT00799409|473906497|FG000|Overall Study|Optimal Dose Not Achieved|2|||
131622709|NCT00799409|473906498|FG001|Overall Study|Optimal Dose Not Achieved|0|||
131622710|NCT00799409|473906499|FG002|Overall Study|Optimal Dose Not Achieved|0|||
131622711|NCT00799409|473906497|FG000|Overall Study|Failure to follow study protocol)|1|||
131622712|NCT00799409|473906498|FG001|Overall Study|Failure to follow study protocol)|0|||
131622713|NCT00799409|473906499|FG002|Overall Study|Failure to follow study protocol)|0|||
131622714|NCT00799409|473906497|FG000|Overall Study|Did not attend lab school day 1|1|||
131622715|NCT00799409|473906498|FG001|Overall Study|Did not attend lab school day 1|0|||
131622716|NCT00799409|473906499|FG002|Overall Study|Did not attend lab school day 1|0|||
131622717|NCT00799409|473906497|FG000|Overall Study|medication compliance|1|||
131622718|NCT00799409|473906498|FG001|Overall Study|medication compliance|0|||
131622719|NCT00799409|473906499|FG002|Overall Study|medication compliance|0|||
131622720|NCT03964974|473906500|FG000|Overall Study|Lost to Follow-up|3|||
131622721|NCT03964974|473906501|FG001|Overall Study|Lost to Follow-up|2|||
131622722|NCT03964974|473906500|FG000|Overall Study|Withdrawal by Subject|0|||
131622723|NCT03964974|473906501|FG001|Overall Study|Withdrawal by Subject|3|||
131622724|NCT04633200|473906502|FG000|Overall Study|Lost to Follow-up|3|||
131622725|NCT04633200|473906503|FG001|Overall Study|Lost to Follow-up|5|||
131622726|NCT02660086|473906504|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
131622727|NCT02660086|473906505|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
131622728|NCT02660086|473906504|FG000|Overall Study- 12-month|Left full-time employment|12|||
131622729|NCT02660086|473906505|FG001|Overall Study- 12-month|Left full-time employment|20|||
131622730|NCT02660086|473906504|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
131622731|NCT02660086|473906505|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
131622732|NCT02660086|473906504|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
131622733|NCT02660086|473906505|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
131622734|NCT02660086|473906504|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
131622735|NCT02660086|473906505|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
131622736|NCT02660086|473906504|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
131622737|NCT02660086|473906505|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
131622738|NCT01719172|473906506|FG000|Overall Study|Lost to Follow-up|1|||
131622739|NCT01719172|473906506|FG000|Overall Study|Death|1|||
131622740|NCT00587171|473906507|FG000|Overall Study|Lost to Follow-up|1|||
131622741|NCT00587171|473906508|FG001|Overall Study|Lost to Follow-up|1|||
131622742|NCT01148017|473906509|FG000|Overall Study|Withdrawal by Subject|31|||
131622743|NCT01148017|473906510|FG001|Overall Study|Withdrawal by Subject|14|||
131622744|NCT01148017|473906511|FG002|Overall Study|Withdrawal by Subject|0|||
131622745|NCT01148017|473906512|FG003|Overall Study|Withdrawal by Subject|0|||
131622746|NCT01148017|473906509|FG000|Overall Study|Lost to Follow-up|23|||
131622747|NCT01148017|473906510|FG001|Overall Study|Lost to Follow-up|10|||
131622748|NCT01148017|473906511|FG002|Overall Study|Lost to Follow-up|0|||
131622749|NCT01148017|473906512|FG003|Overall Study|Lost to Follow-up|0|||
131622750|NCT01148017|473906509|FG000|Overall Study|Inappropriate enrollment|1|||
131622751|NCT01148017|473906510|FG001|Overall Study|Inappropriate enrollment|0|||
131622752|NCT01148017|473906511|FG002|Overall Study|Inappropriate enrollment|0|||
131622753|NCT01148017|473906512|FG003|Overall Study|Inappropriate enrollment|0|||
131622754|NCT01148017|473906509|FG000|Overall Study|Administrative reason|22|||
131622755|NCT01148017|473906510|FG001|Overall Study|Administrative reason|9|||
131622756|NCT01148017|473906511|FG002|Overall Study|Administrative reason|0|||
131622757|NCT01148017|473906512|FG003|Overall Study|Administrative reason|0|||
131622758|NCT01148017|473906509|FG000|Overall Study|Unable to classify|3|||
131622759|NCT01148017|473906510|FG001|Overall Study|Unable to classify|1|||
131622760|NCT01148017|473906511|FG002|Overall Study|Unable to classify|0|||
131622761|NCT01148017|473906512|FG003|Overall Study|Unable to classify|0|||
131622762|NCT01848483|473906513|FG000|Overall Study|Death|2|||
131622763|NCT01848483|473906514|FG001|Overall Study|Death|1|||
131622764|NCT01848483|473906513|FG000|Overall Study|Lost to Follow-up|6|||
131622765|NCT01848483|473906514|FG001|Overall Study|Lost to Follow-up|8|||
131622766|NCT01848483|473906513|FG000|Overall Study|Withdrawal by Subject|1|||
131622767|NCT01848483|473906514|FG001|Overall Study|Withdrawal by Subject|0|||
131622768|NCT01848483|473906513|FG000|Overall Study|Incarceration|2|||
131622769|NCT01848483|473906514|FG001|Overall Study|Incarceration|2|||
131622770|NCT02605174|473906515|FG000|Overall Study|Adverse Event|0|||
131622771|NCT02605174|473906516|FG001|Overall Study|Adverse Event|0|||
131622772|NCT02605174|473906517|FG002|Overall Study|Adverse Event|1|||
131622773|NCT02605174|473906518|FG003|Overall Study|Adverse Event|0|||
131622774|NCT02605174|473906519|FG004|Overall Study|Adverse Event|4|||
131622775|NCT02605174|473906520|FG005|Overall Study|Adverse Event|0|||
131622776|NCT02605174|473906521|FG006|Overall Study|Adverse Event|0|||
131622777|NCT02605174|473906515|FG000|Overall Study|Lost to Follow-up|20|||
131622778|NCT02605174|473906516|FG001|Overall Study|Lost to Follow-up|7|||
131710819|NCT03682120|474219686|FG000|Overall Study|Withdrawal by Subject|1|||
131710820|NCT03682120|474219687|FG001|Overall Study|Withdrawal by Subject|2|||
131622779|NCT02605174|473906517|FG002|Overall Study|Lost to Follow-up|27|||
131622780|NCT02605174|473906518|FG003|Overall Study|Lost to Follow-up|10|||
131622781|NCT02605174|473906519|FG004|Overall Study|Lost to Follow-up|20|||
131622782|NCT02605174|473906520|FG005|Overall Study|Lost to Follow-up|10|||
131622783|NCT02605174|473906521|FG006|Overall Study|Lost to Follow-up|29|||
131622784|NCT02605174|473906515|FG000|Overall Study|Protocol Violation|10|||
131622785|NCT02605174|473906516|FG001|Overall Study|Protocol Violation|4|||
131622786|NCT02605174|473906517|FG002|Overall Study|Protocol Violation|14|||
131622787|NCT02605174|473906518|FG003|Overall Study|Protocol Violation|6|||
131710821|NCT03682120|474219688|FG002|Overall Study|Withdrawal by Subject|3|||
131622788|NCT02605174|473906519|FG004|Overall Study|Protocol Violation|7|||
131622789|NCT02605174|473906520|FG005|Overall Study|Protocol Violation|7|||
131622790|NCT02605174|473906521|FG006|Overall Study|Protocol Violation|12|||
131622791|NCT02605174|473906515|FG000|Overall Study|Pregnancy|1|||
131622792|NCT02605174|473906516|FG001|Overall Study|Pregnancy|0|||
131622793|NCT02605174|473906517|FG002|Overall Study|Pregnancy|0|||
131622794|NCT02605174|473906518|FG003|Overall Study|Pregnancy|2|||
131622795|NCT02605174|473906519|FG004|Overall Study|Pregnancy|0|||
131622796|NCT02605174|473906520|FG005|Overall Study|Pregnancy|0|||
131622797|NCT02605174|473906521|FG006|Overall Study|Pregnancy|0|||
131622798|NCT02605174|473906515|FG000|Overall Study|Withdrawal by Subject|9|||
131622799|NCT02605174|473906516|FG001|Overall Study|Withdrawal by Subject|6|||
131622800|NCT02605174|473906517|FG002|Overall Study|Withdrawal by Subject|14|||
131622801|NCT02605174|473906518|FG003|Overall Study|Withdrawal by Subject|11|||
131622802|NCT02605174|473906519|FG004|Overall Study|Withdrawal by Subject|6|||
131622803|NCT02605174|473906520|FG005|Overall Study|Withdrawal by Subject|4|||
131622804|NCT02605174|473906521|FG006|Overall Study|Withdrawal by Subject|15|||
131622805|NCT02605174|473906515|FG000|Overall Study|Physician Decision|2|||
131622806|NCT02605174|473906516|FG001|Overall Study|Physician Decision|0|||
131622807|NCT02605174|473906517|FG002|Overall Study|Physician Decision|0|||
131622808|NCT02605174|473906518|FG003|Overall Study|Physician Decision|0|||
131622809|NCT02605174|473906519|FG004|Overall Study|Physician Decision|0|||
131622810|NCT02605174|473906520|FG005|Overall Study|Physician Decision|0|||
131622811|NCT02605174|473906521|FG006|Overall Study|Physician Decision|3|||
131622812|NCT02605174|473906515|FG000|Overall Study|Randomization Failure|22|||
131622813|NCT02605174|473906516|FG001|Overall Study|Randomization Failure|6|||
131622814|NCT02605174|473906517|FG002|Overall Study|Randomization Failure|20|||
131622815|NCT02605174|473906518|FG003|Overall Study|Randomization Failure|7|||
131622816|NCT02605174|473906519|FG004|Overall Study|Randomization Failure|16|||
131622817|NCT02605174|473906520|FG005|Overall Study|Randomization Failure|11|||
131622818|NCT02605174|473906521|FG006|Overall Study|Randomization Failure|30|||
131622819|NCT04250636|473906524|FG000|Overall Study|Lost to Follow-up|2|||
131622820|NCT03041090|473906525|FG000|Overall Study|technical error|0|||
131622821|NCT03041090|473906526|FG001|Overall Study|technical error|3|||
131622822|NCT01779050|473906527|FG000|Overall Study|Withdrawal by Subject|1|||
131622823|NCT01779050|473906528|FG001|Overall Study|Withdrawal by Subject|0|||
131622824|NCT02202317|473906529|FG000|Overall Study|Lost to Follow-up|1|||
131622825|NCT01409837|473906530|FG000|Overall Study|Withdrawal by Subject|2|||
131622826|NCT01409837|473906531|FG001|Overall Study|Withdrawal by Subject|1|||
131622827|NCT01409837|473906530|FG000|Overall Study|Lost to Follow-up|1|||
131622828|NCT01409837|473906531|FG001|Overall Study|Lost to Follow-up|0|||
131622829|NCT01409837|473906530|FG000|Overall Study|Physician Decision|0|||
131622830|NCT01409837|473906531|FG001|Overall Study|Physician Decision|1|||
131622831|NCT03490032|473906537|FG000|Overall Study|family issue (child custody)|1|||
131622832|NCT03490032|473906538|FG001|Overall Study|family issue (child custody)|0|||
131622833|NCT03490032|473906539|FG002|Overall Study|family issue (child custody)|0|||
131622834|NCT01852045|473906540|FG000|Overall Study|Adverse Event|1|||
131622835|NCT01852045|473906541|FG001|Overall Study|Adverse Event|0|||
131622836|NCT01852045|473906542|FG002|Overall Study|Adverse Event|0|||
131622837|NCT01852045|473906540|FG000|Overall Study|Lack of Efficacy|3|||
131622838|NCT01852045|473906541|FG001|Overall Study|Lack of Efficacy|0|||
131622839|NCT01852045|473906542|FG002|Overall Study|Lack of Efficacy|0|||
131622840|NCT01852045|473906540|FG000|Overall Study|Lost to Follow-up|0|||
131622841|NCT01852045|473906541|FG001|Overall Study|Lost to Follow-up|1|||
131622842|NCT01852045|473906542|FG002|Overall Study|Lost to Follow-up|1|||
131622843|NCT01852045|473906540|FG000|Overall Study|Withdrawal by Subject|1|||
131622844|NCT01852045|473906541|FG001|Overall Study|Withdrawal by Subject|0|||
131622845|NCT01852045|473906542|FG002|Overall Study|Withdrawal by Subject|1|||
131622846|NCT01852045|473906540|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131622847|NCT01852045|473906541|FG001|Overall Study|Other Miscellaneous Reasons|3|||
131622848|NCT01852045|473906542|FG002|Overall Study|Other Miscellaneous Reasons|2|||
131622849|NCT02736188|473906543|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
131622850|NCT02736188|473906543|FG000|Overall Study|Adverse Event|1|||
131622851|NCT02736188|473906543|FG000|Overall Study|Withdrawal by Subject|1|||
131622852|NCT02736188|473906543|FG000|Overall Study|Other|6|||
131622853|NCT00878189|473906544|FG000|Overall Study|Death|0|||
131622854|NCT00878189|473906545|FG001|Overall Study|Death|1|||
131622855|NCT00878189|473906546|FG002|Overall Study|Death|0|||
131622856|NCT00878189|473906547|FG003|Overall Study|Death|1|||
131622857|NCT00878189|473906548|FG004|Overall Study|Death|0|||
131622858|NCT00878189|473906549|FG005|Overall Study|Death|0|||
131622859|NCT00878189|473906550|FG006|Overall Study|Death|0|||
131622860|NCT00878189|473906551|FG007|Overall Study|Death|0|||
131622861|NCT00878189|473906552|FG008|Overall Study|Death|1|||
131622862|NCT00878189|473906544|FG000|Overall Study|Participant Refused to Follow-up|0|||
131622863|NCT00878189|473906545|FG001|Overall Study|Participant Refused to Follow-up|0|||
131622864|NCT00878189|473906546|FG002|Overall Study|Participant Refused to Follow-up|0|||
131622865|NCT00878189|473906547|FG003|Overall Study|Participant Refused to Follow-up|0|||
131622866|NCT00878189|473906548|FG004|Overall Study|Participant Refused to Follow-up|0|||
131622867|NCT00878189|473906549|FG005|Overall Study|Participant Refused to Follow-up|4|||
131622868|NCT00878189|473906550|FG006|Overall Study|Participant Refused to Follow-up|0|||
131622869|NCT00878189|473906551|FG007|Overall Study|Participant Refused to Follow-up|0|||
131622870|NCT00878189|473906552|FG008|Overall Study|Participant Refused to Follow-up|0|||
131622871|NCT00878189|473906544|FG000|Overall Study|Other|3|||
131622872|NCT00878189|473906545|FG001|Overall Study|Other|2|||
131622873|NCT00878189|473906546|FG002|Overall Study|Other|4|||
131622874|NCT00878189|473906547|FG003|Overall Study|Other|7|||
131622875|NCT00878189|473906548|FG004|Overall Study|Other|4|||
131622876|NCT00878189|473906549|FG005|Overall Study|Other|18|||
131622877|NCT00878189|473906550|FG006|Overall Study|Other|15|||
131622878|NCT00878189|473906551|FG007|Overall Study|Other|3|||
131622879|NCT00878189|473906552|FG008|Overall Study|Other|4|||
131622880|NCT00878189|473906544|FG000|Overall Study|Lost to Follow-up|0|||
131622881|NCT00878189|473906545|FG001|Overall Study|Lost to Follow-up|0|||
131622882|NCT00878189|473906546|FG002|Overall Study|Lost to Follow-up|0|||
131622883|NCT00878189|473906547|FG003|Overall Study|Lost to Follow-up|0|||
131622884|NCT00878189|473906548|FG004|Overall Study|Lost to Follow-up|0|||
131622885|NCT00878189|473906549|FG005|Overall Study|Lost to Follow-up|1|||
131622886|NCT00878189|473906550|FG006|Overall Study|Lost to Follow-up|1|||
131622887|NCT00878189|473906551|FG007|Overall Study|Lost to Follow-up|0|||
131622888|NCT00878189|473906552|FG008|Overall Study|Lost to Follow-up|0|||
131622889|NCT00878189|473906544|FG000|Overall Study|Objection Progression or Relapse|0|||
131622890|NCT00878189|473906545|FG001|Overall Study|Objection Progression or Relapse|0|||
131622891|NCT00878189|473906546|FG002|Overall Study|Objection Progression or Relapse|0|||
131622892|NCT00878189|473906547|FG003|Overall Study|Objection Progression or Relapse|0|||
131622893|NCT00878189|473906548|FG004|Overall Study|Objection Progression or Relapse|0|||
131622894|NCT00878189|473906549|FG005|Overall Study|Objection Progression or Relapse|0|||
131622895|NCT00878189|473906550|FG006|Overall Study|Objection Progression or Relapse|0|||
131622896|NCT00878189|473906551|FG007|Overall Study|Objection Progression or Relapse|0|||
131622897|NCT00878189|473906552|FG008|Overall Study|Objection Progression or Relapse|3|||
131622898|NCT00703092|473906553|FG000|Overall Study|Withdrawal by Subject|2|||
131622899|NCT01480258|473906556|FG000|Infant Series|Protocol Violation|2|||
131622900|NCT01480258|473906557|FG001|Infant Series|Protocol Violation|0|||
131622901|NCT01480258|473906556|FG000|Infant Series|Physician Decision|0|||
131622902|NCT01480258|473906557|FG001|Infant Series|Physician Decision|1|||
131622903|NCT01480258|473906556|FG000|Infant Series|Not Vaccinated|3|||
131622904|NCT01480258|473906557|FG001|Infant Series|Not Vaccinated|0|||
131622905|NCT01480258|473906556|FG000|Infant Series|Adverse Event|1|||
131622906|NCT01480258|473906557|FG001|Infant Series|Adverse Event|1|||
131622907|NCT01480258|473906556|FG000|Infant Series|Withdrawal by Subject|1|||
131622908|NCT01480258|473906557|FG001|Infant Series|Withdrawal by Subject|6|||
131622909|NCT01480258|473906556|FG000|Interim Period|Lost to Follow-up|0|||
131622910|NCT01480258|473906557|FG001|Interim Period|Lost to Follow-up|2|||
131622911|NCT01480258|473906556|FG000|Interim Period|Physician Decision|1|||
131622912|NCT01480258|473906557|FG001|Interim Period|Physician Decision|0|||
131622913|NCT01480258|473906556|FG000|Interim Period|Protocol Violation|0|||
131622914|NCT01480258|473906557|FG001|Interim Period|Protocol Violation|1|||
131622915|NCT01480258|473906556|FG000|Interim Period|Withdrawal by Subject|9|||
131622916|NCT01480258|473906557|FG001|Interim Period|Withdrawal by Subject|6|||
131622917|NCT03316170|473906558|FG000|Overall Study|Death|1|||
131622918|NCT03316170|473906559|FG001|Overall Study|Death|0|||
131622919|NCT03316170|473906558|FG000|Overall Study|Lost to Follow-up|6|||
131622920|NCT03316170|473906559|FG001|Overall Study|Lost to Follow-up|7|||
131622921|NCT02169414|473906560|FG000|Overall Study|Withdrawal by Subject|1|||
131622922|NCT02169414|473906561|FG001|Overall Study|Withdrawal by Subject|0|||
131622923|NCT02169414|473906562|FG002|Overall Study|Withdrawal by Subject|0|||
131622924|NCT02169414|473906563|FG003|Overall Study|Withdrawal by Subject|0|||
131622925|NCT02169414|473906560|FG000|Overall Study|Adverse Event|0|||
131622926|NCT02169414|473906561|FG001|Overall Study|Adverse Event|1|||
131622927|NCT02169414|473906562|FG002|Overall Study|Adverse Event|0|||
131622928|NCT02169414|473906563|FG003|Overall Study|Adverse Event|0|||
131622929|NCT03374254|473906564|FG000|Overall Study|Death|5|||
131622930|NCT03374254|473906565|FG001|Overall Study|Death|16|||
131622931|NCT03374254|473906566|FG002|Overall Study|Death|13|||
131622932|NCT03374254|473906567|FG003|Overall Study|Death|11|||
131622933|NCT03374254|473906568|FG004|Overall Study|Death|9|||
131622934|NCT03374254|473906569|FG005|Overall Study|Death|12|||
131622935|NCT03374254|473906570|FG006|Overall Study|Death|11|||
131622936|NCT03374254|473906571|FG007|Overall Study|Death|6|||
131622937|NCT03374254|473906572|FG008|Overall Study|Death|7|||
131622938|NCT03374254|473906564|FG000|Overall Study|Lost to Follow-up|0|||
131622939|NCT03374254|473906565|FG001|Overall Study|Lost to Follow-up|0|||
131622940|NCT03374254|473906566|FG002|Overall Study|Lost to Follow-up|0|||
131622941|NCT03374254|473906567|FG003|Overall Study|Lost to Follow-up|0|||
131622942|NCT03374254|473906568|FG004|Overall Study|Lost to Follow-up|0|||
131622943|NCT03374254|473906569|FG005|Overall Study|Lost to Follow-up|0|||
131622944|NCT03374254|473906570|FG006|Overall Study|Lost to Follow-up|2|||
131622945|NCT03374254|473906571|FG007|Overall Study|Lost to Follow-up|0|||
131622946|NCT03374254|473906572|FG008|Overall Study|Lost to Follow-up|0|||
131622947|NCT03374254|473906564|FG000|Overall Study|Sponsor Decision|1|||
131622948|NCT03374254|473906565|FG001|Overall Study|Sponsor Decision|0|||
131622949|NCT03374254|473906566|FG002|Overall Study|Sponsor Decision|2|||
131622950|NCT03374254|473906567|FG003|Overall Study|Sponsor Decision|3|||
131622951|NCT03374254|473906568|FG004|Overall Study|Sponsor Decision|2|||
131622952|NCT03374254|473906569|FG005|Overall Study|Sponsor Decision|3|||
131622953|NCT03374254|473906570|FG006|Overall Study|Sponsor Decision|3|||
131900907|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
131622954|NCT03374254|473906571|FG007|Overall Study|Sponsor Decision|3|||
131622955|NCT03374254|473906572|FG008|Overall Study|Sponsor Decision|4|||
131622956|NCT03374254|473906564|FG000|Overall Study|Withdrawal by Subject|0|||
131900908|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
131622957|NCT03374254|473906565|FG001|Overall Study|Withdrawal by Subject|0|||
131622958|NCT03374254|473906566|FG002|Overall Study|Withdrawal by Subject|0|||
131622959|NCT03374254|473906567|FG003|Overall Study|Withdrawal by Subject|2|||
131622960|NCT03374254|473906568|FG004|Overall Study|Withdrawal by Subject|0|||
131622961|NCT03374254|473906569|FG005|Overall Study|Withdrawal by Subject|1|||
131622962|NCT03374254|473906570|FG006|Overall Study|Withdrawal by Subject|0|||
131710822|NCT03682120|474219689|FG003|Overall Study|Withdrawal by Subject|0|||
131710823|NCT03682120|474219686|FG000|Overall Study|Death|0|||
131710824|NCT03682120|474219687|FG001|Overall Study|Death|1|||
131710825|NCT03682120|474219688|FG002|Overall Study|Death|0|||
131710826|NCT03682120|474219689|FG003|Overall Study|Death|0|||
131710827|NCT03682120|474219686|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
131710828|NCT03682120|474219687|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
131710829|NCT03682120|474219688|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
131710830|NCT03682120|474219689|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
131710831|NCT03308188|474219690|FG000|Overall Study|Withdrawal by Subject|0|||
131710832|NCT03308188|474219691|FG001|Overall Study|Withdrawal by Subject|3|||
131710833|NCT03308188|474219690|FG000|Overall Study|Death|0|||
131710834|NCT03308188|474219691|FG001|Overall Study|Death|1|||
131710835|NCT01651780|474219696|FG000|Overall Study|Physician decision: No 30-day visit|2|||
131710836|NCT01651780|474219697|FG001|Overall Study|Physician decision: No 30-day visit|1|||
131710837|NCT01651780|474219696|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
131710838|NCT01651780|474219697|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
131710839|NCT01651780|474219696|FG000|Overall Study|Withdrawal by Subject|2|||
131710840|NCT01651780|474219697|FG001|Overall Study|Withdrawal by Subject|0|||
131710841|NCT01651780|474219696|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
131710842|NCT01651780|474219697|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131710843|NCT01651780|474219696|FG000|Overall Study|Lost to Follow-up|1|||
131710844|NCT01651780|474219697|FG001|Overall Study|Lost to Follow-up|2|||
131710845|NCT01651780|474219696|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
131710846|NCT01651780|474219697|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
131710847|NCT01628926|474219698|FG000|Overall Study|Adverse Event|13|||
131710848|NCT01628926|474219699|FG001|Overall Study|Adverse Event|11|||
131622963|NCT03374254|473906571|FG007|Overall Study|Withdrawal by Subject|0|||
131710849|NCT01628926|474219700|FG002|Overall Study|Adverse Event|9|||
131710850|NCT01628926|474219698|FG000|Overall Study|Lack of Efficacy|2|||
131710851|NCT01628926|474219699|FG001|Overall Study|Lack of Efficacy|1|||
131622964|NCT03374254|473906572|FG008|Overall Study|Withdrawal by Subject|0|||
131622965|NCT04803734|473906573|FG000|Overall Study|Withdrawal by Subject|0|||
131622966|NCT04803734|473906574|FG001|Overall Study|Withdrawal by Subject|1|||
131622967|NCT04803734|473906573|FG000|Overall Study|Protocol Violation|0|||
131622968|NCT04803734|473906574|FG001|Overall Study|Protocol Violation|1|||
131622969|NCT02309515|473906575|FG000|Overall Study|Withdrawal by Subject|0|||
131622970|NCT02309515|473906576|FG001|Overall Study|Withdrawal by Subject|1|||
131622971|NCT04070105|473906580|FG000|Overall Study|Lost to Follow-up|0|||
131622972|NCT04070105|473906581|FG001|Overall Study|Lost to Follow-up|0|||
131622973|NCT04070105|473906582|FG002|Overall Study|Lost to Follow-up|0|||
131622974|NCT04070105|473906583|FG003|Overall Study|Lost to Follow-up|0|||
131622975|NCT04070105|473906584|FG004|Overall Study|Lost to Follow-up|0|||
131622976|NCT04070105|473906585|FG005|Overall Study|Lost to Follow-up|1|||
131622977|NCT01858688|473906591|FG000|Overall Study|Withdrawal by Subject|8|||
131622978|NCT01858688|473906591|FG000|Overall Study|Participant began another therapy|3|||
131622979|NCT01858688|473906591|FG000|Overall Study|Physician Decision|2|||
131622980|NCT01858688|473906591|FG000|Overall Study|Progressive Disease|2|||
131622981|NCT01858688|473906591|FG000|Overall Study|Reason not reproted|5|||
131622982|NCT01999335|473906592|FG000|Overall Study|Discontinued before receiving treatment|0|||
131622983|NCT01999335|473906593|FG001|Overall Study|Discontinued before receiving treatment|0|||
131622984|NCT01999335|473906594|FG002|Overall Study|Discontinued before receiving treatment|0|||
131622985|NCT01999335|473906595|FG003|Overall Study|Discontinued before receiving treatment|0|||
131622986|NCT01999335|473906596|FG004|Overall Study|Discontinued before receiving treatment|2|||
131622987|NCT01218594|473906597|FG000|Overall Study|Death|1|||
131622988|NCT01218594|473906597|FG000|Overall Study|Withdrawal by Subject|3|||
131622989|NCT01218594|473906597|FG000|Overall Study|Adverse Event|2|||
131622990|NCT01218594|473906597|FG000|Overall Study|Physician Decision|6|||
131622991|NCT04748341|473906598|FG000|Overall Study|Lost to Follow-up|1|||
131622992|NCT04748341|473906599|FG001|Overall Study|Lost to Follow-up|1|||
131622993|NCT00452114|473906601|FG000|Overall Study|Physician Decision|3|||
131622994|NCT00452114|473906602|FG001|Overall Study|Physician Decision|3|||
131622995|NCT02334215|473906603|FG000|Overall Study|Death|1|||
131622996|NCT02334215|473906604|FG001|Overall Study|Death|1|||
131622997|NCT02334215|473906605|FG002|Overall Study|Death|0|||
131622998|NCT02334215|473906603|FG000|Overall Study|Lost to Follow-up|1|||
131622999|NCT02334215|473906604|FG001|Overall Study|Lost to Follow-up|0|||
131623000|NCT02334215|473906605|FG002|Overall Study|Lost to Follow-up|4|||
131623001|NCT02334215|473906603|FG000|Overall Study|Withdrawal by Subject|2|||
131623002|NCT02334215|473906604|FG001|Overall Study|Withdrawal by Subject|2|||
131623003|NCT02334215|473906605|FG002|Overall Study|Withdrawal by Subject|1|||
131623004|NCT02334215|473906603|FG000|Overall Study|Not released from incarceration on time|3|||
131623005|NCT02334215|473906604|FG001|Overall Study|Not released from incarceration on time|3|||
131623006|NCT02334215|473906605|FG002|Overall Study|Not released from incarceration on time|3|||
131623007|NCT02334215|473906603|FG000|Overall Study|Incarcerated|0|||
131623008|NCT02334215|473906604|FG001|Overall Study|Incarcerated|0|||
131623009|NCT02334215|473906605|FG002|Overall Study|Incarcerated|7|||
131623010|NCT03905642|473906606|FG000|Overall Study|Withdrawal by Subject|3|||
131623011|NCT03905642|473906606|FG000|Overall Study|Pregnancy|1|||
131623012|NCT03905642|473906606|FG000|Overall Study|Adverse Event|1|||
131623013|NCT03905642|473906606|FG000|Overall Study|Lack of Efficacy|1|||
131623014|NCT03905642|473906606|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
131623015|NCT04535414|473906610|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
131623016|NCT04535414|473906611|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
131623017|NCT04535414|473906610|FG000|Overall Study|Cancelled appointment|1|||
131623018|NCT04535414|473906611|FG001|Overall Study|Cancelled appointment|0|||
131623019|NCT04535414|473906610|FG000|Overall Study|cancelled - food in stomach|2|||
131623020|NCT04535414|473906611|FG001|Overall Study|cancelled - food in stomach|0|||
131623021|NCT04535414|473906610|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
131623022|NCT04535414|473906611|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
131623023|NCT04535414|473906610|FG000|Overall Study|Withdrawal by Subject|0|||
131623024|NCT04535414|473906611|FG001|Overall Study|Withdrawal by Subject|1|||
131623025|NCT01567852|473908371|FG000|Overall Study|Withdrawal by Subject|3|||
131623026|NCT01567852|473908372|FG001|Overall Study|Withdrawal by Subject|6|||
131623027|NCT01567852|473908371|FG000|Overall Study|ECT discontinued|1|||
131623028|NCT01567852|473908372|FG001|Overall Study|ECT discontinued|1|||
131623029|NCT02014402|473908376|FG000|Overall Study|Adverse Event|1|||
131623030|NCT02014402|473908377|FG001|Overall Study|Adverse Event|0|||
131623031|NCT02014402|473908378|FG002|Overall Study|Adverse Event|0|||
131623032|NCT02014402|473908379|FG003|Overall Study|Adverse Event|0|||
131623033|NCT02014402|473908376|FG000|Overall Study|Withdrawal by Subject|1|||
131623034|NCT02014402|473908377|FG001|Overall Study|Withdrawal by Subject|2|||
131623035|NCT02014402|473908378|FG002|Overall Study|Withdrawal by Subject|2|||
131623036|NCT02014402|473908379|FG003|Overall Study|Withdrawal by Subject|1|||
131623037|NCT02014402|473908376|FG000|Overall Study|Subject did not have transportation|0|||
131623038|NCT02014402|473908377|FG001|Overall Study|Subject did not have transportation|1|||
131623039|NCT02014402|473908378|FG002|Overall Study|Subject did not have transportation|0|||
131623040|NCT02014402|473908379|FG003|Overall Study|Subject did not have transportation|0|||
131623041|NCT02014402|473908376|FG000|Overall Study|Lost to Follow-up|0|||
131623042|NCT02014402|473908377|FG001|Overall Study|Lost to Follow-up|0|||
131623043|NCT02014402|473908378|FG002|Overall Study|Lost to Follow-up|1|||
131623044|NCT02014402|473908379|FG003|Overall Study|Lost to Follow-up|2|||
131623045|NCT00443820|473908380|FG000|Overall Study|Adverse Event|1|||
131623046|NCT00443820|473908381|FG001|Overall Study|Adverse Event|1|||
131623047|NCT00443820|473908382|FG002|Overall Study|Adverse Event|0|||
131623048|NCT00443820|473908383|FG003|Overall Study|Adverse Event|0|||
131623049|NCT00443820|473908380|FG000|Overall Study|Lack of Efficacy|3|||
131623050|NCT00443820|473908381|FG001|Overall Study|Lack of Efficacy|2|||
131623051|NCT00443820|473908382|FG002|Overall Study|Lack of Efficacy|1|||
131623052|NCT00443820|473908383|FG003|Overall Study|Lack of Efficacy|1|||
131623053|NCT00443820|473908380|FG000|Overall Study|Protocol Violation|2|||
131623054|NCT00443820|473908381|FG001|Overall Study|Protocol Violation|1|||
131623055|NCT00443820|473908382|FG002|Overall Study|Protocol Violation|2|||
131623056|NCT00443820|473908383|FG003|Overall Study|Protocol Violation|1|||
131623057|NCT00443820|473908380|FG000|Overall Study|Withdrawal by Subject|6|||
131623058|NCT00443820|473908381|FG001|Overall Study|Withdrawal by Subject|7|||
131623059|NCT00443820|473908382|FG002|Overall Study|Withdrawal by Subject|8|||
131623060|NCT00443820|473908383|FG003|Overall Study|Withdrawal by Subject|9|||
131623061|NCT00443820|473908380|FG000|Overall Study|Lost to Follow-up|9|||
131623062|NCT00443820|473908381|FG001|Overall Study|Lost to Follow-up|8|||
131623063|NCT00443820|473908382|FG002|Overall Study|Lost to Follow-up|6|||
131623064|NCT00443820|473908383|FG003|Overall Study|Lost to Follow-up|5|||
131623065|NCT00443820|473908380|FG000|Overall Study|Administrative problems|0|||
131623066|NCT00443820|473908381|FG001|Overall Study|Administrative problems|0|||
131623067|NCT00443820|473908382|FG002|Overall Study|Administrative problems|0|||
131623068|NCT00443820|473908383|FG003|Overall Study|Administrative problems|1|||
131623069|NCT00443820|473908380|FG000|Overall Study|Death|0|||
131623070|NCT00443820|473908381|FG001|Overall Study|Death|0|||
131623071|NCT00443820|473908382|FG002|Overall Study|Death|1|||
131623072|NCT00443820|473908383|FG003|Overall Study|Death|0|||
131623073|NCT03493282|473908384|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
131623074|NCT03493282|473908385|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
131623075|NCT03493282|473908386|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
131623076|NCT03493282|473908384|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
131623077|NCT03493282|473908385|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
131623078|NCT03493282|473908386|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
131623079|NCT00670449|473908387|FG000|Overall Study|Adverse Event|6|||
131623080|NCT00670449|473908388|FG001|Overall Study|Adverse Event|2|||
131623081|NCT00670449|473908389|FG002|Overall Study|Adverse Event|8|||
131623082|NCT00670449|473908390|FG003|Overall Study|Adverse Event|5|||
131623083|NCT00670449|473908387|FG000|Overall Study|Protocol Deviation|1|||
131623084|NCT00670449|473908388|FG001|Overall Study|Protocol Deviation|2|||
131623085|NCT00670449|473908389|FG002|Overall Study|Protocol Deviation|0|||
131623086|NCT00670449|473908390|FG003|Overall Study|Protocol Deviation|1|||
131623087|NCT00670449|473908387|FG000|Overall Study|Administrative Problems|0|||
131623088|NCT00670449|473908388|FG001|Overall Study|Administrative Problems|2|||
131623089|NCT00670449|473908389|FG002|Overall Study|Administrative Problems|0|||
131623090|NCT00670449|473908390|FG003|Overall Study|Administrative Problems|1|||
131623091|NCT00670449|473908387|FG000|Overall Study|Subject Withdrew Consent|0|||
131623092|NCT00670449|473908388|FG001|Overall Study|Subject Withdrew Consent|2|||
131623093|NCT00670449|473908389|FG002|Overall Study|Subject Withdrew Consent|0|||
131623094|NCT00670449|473908390|FG003|Overall Study|Subject Withdrew Consent|1|||
131623095|NCT00670449|473908387|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
131623096|NCT00670449|473908388|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131623097|NCT00670449|473908389|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131623098|NCT00670449|473908390|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131623099|NCT00670449|473908387|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
131623100|NCT00670449|473908388|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
131623101|NCT00670449|473908389|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131623102|NCT00670449|473908390|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
131623103|NCT01523392|473908391|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131623104|NCT01523392|473908392|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131710852|NCT01628926|474219700|FG002|Overall Study|Lack of Efficacy|5|||
131710853|NCT01628926|474219698|FG000|Overall Study|Withdrawal by Subject|6|||
131710854|NCT01628926|474219699|FG001|Overall Study|Withdrawal by Subject|4|||
131710855|NCT01628926|474219700|FG002|Overall Study|Withdrawal by Subject|2|||
131710856|NCT01628926|474219698|FG000|Overall Study|Protocol Violation|0|||
131710857|NCT01628926|474219699|FG001|Overall Study|Protocol Violation|1|||
131710858|NCT01628926|474219700|FG002|Overall Study|Protocol Violation|0|||
131710859|NCT01628926|474219698|FG000|Overall Study|Discontinuation criteria|3|||
131710860|NCT01628926|474219699|FG001|Overall Study|Discontinuation criteria|4|||
131710861|NCT01628926|474219700|FG002|Overall Study|Discontinuation criteria|0|||
131710862|NCT01628926|474219698|FG000|Overall Study|Physician Decision|2|||
131710863|NCT01628926|474219699|FG001|Overall Study|Physician Decision|2|||
131710864|NCT01628926|474219700|FG002|Overall Study|Physician Decision|1|||
131710865|NCT00151892|474219705|FG000|Overall Study|Lack of Efficacy|50|||
131710866|NCT00151892|474219706|FG001|Overall Study|Lack of Efficacy|57|||
131710867|NCT00151892|474219705|FG000|Overall Study|Patient request|10|||
131710868|NCT00151892|474219706|FG001|Overall Study|Patient request|7|||
131710869|NCT00151892|474219705|FG000|Overall Study|Lost to Follow-up|5|||
131710870|NCT00151892|474219706|FG001|Overall Study|Lost to Follow-up|10|||
131710871|NCT00151892|474219705|FG000|Overall Study|Adverse Event|6|||
131710872|NCT00151892|474219706|FG001|Overall Study|Adverse Event|3|||
131710873|NCT00151892|474219705|FG000|Overall Study|Protocol Violation|3|||
131710874|NCT00151892|474219706|FG001|Overall Study|Protocol Violation|3|||
131710875|NCT00151892|474219705|FG000|Overall Study|Non-compliance|0|||
131710876|NCT00151892|474219706|FG001|Overall Study|Non-compliance|1|||
131710877|NCT00151892|474219705|FG000|Overall Study|Pregnancy|0|||
131710878|NCT00151892|474219706|FG001|Overall Study|Pregnancy|1|||
131710879|NCT00151892|474219705|FG000|Overall Study|Did not return for a visit|1|||
131710880|NCT00151892|474219706|FG001|Overall Study|Did not return for a visit|0|||
131710881|NCT00151892|474219705|FG000|Overall Study|Used prohibited corticosteroids|1|||
131710882|NCT00151892|474219706|FG001|Overall Study|Used prohibited corticosteroids|0|||
131710883|NCT00151892|474219705|FG000|Overall Study|Lack of study medication at center|0|||
131710884|NCT00151892|474219706|FG001|Overall Study|Lack of study medication at center|1|||
131710885|NCT02901431|474219707|FG000|PK Part|Adverse Event|0|||
131710886|NCT02901431|474219708|FG001|PK Part|Adverse Event|1|||
131710887|NCT02901431|474219709|FG002|PK Part|Adverse Event|0|||
131710888|NCT02901431|474219710|FG003|PK Part|Adverse Event|0|||
131710889|NCT02901431|474219711|FG004|PK Part|Adverse Event|0|||
131900909|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131900910|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131710890|NCT02901431|474219712|FG005|PK Part|Adverse Event|0|||
131710891|NCT02901431|474219713|FG006|PK Part|Adverse Event|0|||
131710892|NCT02901431|474219714|FG007|PK Part|Adverse Event|0|||
131710893|NCT02901431|474219715|FG008|PK Part|Adverse Event|0|||
131710894|NCT02901431|474219716|FG009|PK Part|Adverse Event|0|||
131710895|NCT02901431|474219717|FG010|PK Part|Adverse Event|0|||
131710896|NCT02901431|474219718|FG011|PK Part|Adverse Event|0|||
131710897|NCT02901431|474219719|FG012|PK Part|Adverse Event|0|||
131710898|NCT02901431|474219707|FG000|PK Part|Lost to Follow-up|0|||
131710899|NCT02901431|474219708|FG001|PK Part|Lost to Follow-up|0|||
131710900|NCT02901431|474219709|FG002|PK Part|Lost to Follow-up|1|||
131710901|NCT02901431|474219710|FG003|PK Part|Lost to Follow-up|0|||
131710902|NCT02901431|474219711|FG004|PK Part|Lost to Follow-up|0|||
131710903|NCT02901431|474219712|FG005|PK Part|Lost to Follow-up|0|||
131710904|NCT02901431|474219713|FG006|PK Part|Lost to Follow-up|0|||
131710905|NCT02901431|474219714|FG007|PK Part|Lost to Follow-up|0|||
131710906|NCT02901431|474219715|FG008|PK Part|Lost to Follow-up|0|||
131710907|NCT02901431|474219716|FG009|PK Part|Lost to Follow-up|0|||
131710908|NCT02901431|474219717|FG010|PK Part|Lost to Follow-up|0|||
131710909|NCT02901431|474219718|FG011|PK Part|Lost to Follow-up|0|||
131710910|NCT02901431|474219719|FG012|PK Part|Lost to Follow-up|0|||
131710911|NCT02901431|474219707|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
131710912|NCT02901431|474219708|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710913|NCT02901431|474219709|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710914|NCT02901431|474219710|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710915|NCT02901431|474219711|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710916|NCT02901431|474219712|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710917|NCT02901431|474219713|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710918|NCT02901431|474219714|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710919|NCT02901431|474219715|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710920|NCT02901431|474219716|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710921|NCT02901431|474219717|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710922|NCT02901431|474219718|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131623105|NCT01523392|473908391|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
131623106|NCT01523392|473908392|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
131623107|NCT01523392|473908391|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
131623108|NCT01523392|473908392|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
131623109|NCT04809623|473908393|FG000|Overall Study|Study Terminated by Sponsor|1|||
131623110|NCT04809623|473908394|FG001|Overall Study|Study Terminated by Sponsor|0|||
131623111|NCT00671853|473908396|FG000|Overall Study|Lack of Efficacy|3|||
131623112|NCT00671853|473908397|FG001|Overall Study|Lack of Efficacy|7|||
131623113|NCT00671853|473908396|FG000|Overall Study|Adverse Event|7|||
131900911|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900912|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900913|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900914|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131623114|NCT00671853|473908397|FG001|Overall Study|Adverse Event|1|||
131623115|NCT00671853|473908396|FG000|Overall Study|Withdrawal by Subject|1|||
131900915|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900916|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900917|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900918|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900919|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900920|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900921|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131900922|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900923|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900924|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
131900925|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900926|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131623116|NCT00671853|473908397|FG001|Overall Study|Withdrawal by Subject|5|||
131623117|NCT00671853|473908396|FG000|Overall Study|Lost to Follow-up|8|||
131623118|NCT00671853|473908397|FG001|Overall Study|Lost to Follow-up|8|||
131623119|NCT00671853|473908396|FG000|Overall Study|Physician Decision|0|||
131623120|NCT00671853|473908397|FG001|Overall Study|Physician Decision|2|||
131623121|NCT00671853|473908396|FG000|Overall Study|Non-adherence with study procedures|1|||
131623122|NCT00671853|473908397|FG001|Overall Study|Non-adherence with study procedures|4|||
131623123|NCT03928743|473908399|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
131623124|NCT03928743|473908400|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
131623125|NCT03928743|473908401|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
131623126|NCT03928743|473908399|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
131623127|NCT03928743|473908400|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
131623128|NCT03928743|473908401|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
131623129|NCT03928743|473908399|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
131623130|NCT03928743|473908400|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
131623131|NCT03928743|473908401|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
131623132|NCT03928743|473908399|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
131623133|NCT03928743|473908400|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
131623134|NCT03928743|473908401|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
131623135|NCT03928743|473908399|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
131623136|NCT03928743|473908400|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
131623137|NCT03928743|473908401|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
131623138|NCT03928743|473908399|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
131623139|NCT03928743|473908400|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
131623140|NCT03928743|473908401|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
131623141|NCT03928743|473908399|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
131623142|NCT03928743|473908400|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
131623143|NCT03928743|473908401|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
131623144|NCT03928743|473908399|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
131623145|NCT03928743|473908400|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
131623146|NCT03928743|473908401|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
131623147|NCT03928743|473908399|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
131710923|NCT02901431|474219719|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131710924|NCT02901431|474219707|FG000|PK Part|Pending dose confirmation|0|||
131710925|NCT02901431|474219708|FG001|PK Part|Pending dose confirmation|1|||
131900927|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900928|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900929|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900930|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131623148|NCT03928743|473908400|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
131623149|NCT03928743|473908401|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
131623150|NCT03928743|473908399|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
131623151|NCT03928743|473908400|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
131623152|NCT03928743|473908401|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
131623153|NCT03928743|473908399|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
131623154|NCT03928743|473908400|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
131623155|NCT03928743|473908401|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
131623156|NCT02236611|473908403|FG000|Overall Study|Adverse Event|10|||
131623157|NCT02236611|473908404|FG001|Overall Study|Adverse Event|16|||
131623158|NCT02236611|473908403|FG000|Overall Study|Lack of Efficacy|4|||
131623159|NCT02236611|473908404|FG001|Overall Study|Lack of Efficacy|7|||
131623160|NCT02236611|473908403|FG000|Overall Study|Lost to Follow-up|0|||
131623161|NCT02236611|473908404|FG001|Overall Study|Lost to Follow-up|2|||
131623162|NCT02236611|473908403|FG000|Overall Study|Protocol deviation|3|||
131623163|NCT02236611|473908404|FG001|Overall Study|Protocol deviation|5|||
131623164|NCT02236611|473908403|FG000|Overall Study|Withdrew consent|9|||
131623165|NCT02236611|473908404|FG001|Overall Study|Withdrew consent|4|||
131623166|NCT01353274|473908406|FG000|Overall Study|No case report form (CRF) collected|28|||
131623167|NCT01450007|473908408|FG000|Overall Study|Late exclusion before treatment|2|||
131623168|NCT01450007|473908409|FG001|Overall Study|Late exclusion before treatment|3|||
131623169|NCT01450007|473908410|FG002|Overall Study|Late exclusion before treatment|2|||
131623170|NCT01450007|473908408|FG000|Overall Study|Protocol Violation|0|||
131623171|NCT01450007|473908409|FG001|Overall Study|Protocol Violation|1|||
131623172|NCT01450007|473908410|FG002|Overall Study|Protocol Violation|1|||
131623173|NCT01450007|473908408|FG000|Overall Study|Adverse Event|0|||
131623174|NCT01450007|473908409|FG001|Overall Study|Adverse Event|1|||
131623175|NCT01450007|473908410|FG002|Overall Study|Adverse Event|0|||
131623176|NCT03851094|473908412|FG000|Overall Study|Withdrawal by Subject|0|||
131623177|NCT03851094|473908413|FG001|Overall Study|Withdrawal by Subject|1|||
131623178|NCT03851094|473908412|FG000|Overall Study|Participant lost device|0|||
131623179|NCT03851094|473908413|FG001|Overall Study|Participant lost device|1|||
131795722|NCT00356200|474535913|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
131795723|NCT01000337|474535917|FG000|Overall Study|Lost to Follow-up|4|||
131795724|NCT01000337|474535918|FG001|Overall Study|Lost to Follow-up|3|||
131795725|NCT02173704|474535919|FG000|Overall Study|Adverse Event|1|||
131795726|NCT02173704|474535920|FG001|Overall Study|Adverse Event|0|||
131795727|NCT02173704|474535919|FG000|Overall Study|Lost to Follow-up|1|||
131795728|NCT02173704|474535920|FG001|Overall Study|Lost to Follow-up|0|||
131795729|NCT02173704|474535919|FG000|Overall Study|Other|1|||
131795730|NCT02173704|474535920|FG001|Overall Study|Other|0|||
131795731|NCT02173704|474535919|FG000|Overall Study|Protocol Violation|1|||
131795732|NCT02173704|474535920|FG001|Overall Study|Protocol Violation|0|||
131795733|NCT02173704|474535919|FG000|Overall Study|Withdrawal by Subject|9|||
131795734|NCT02173704|474535920|FG001|Overall Study|Withdrawal by Subject|4|||
131795735|NCT00419926|474535921|FG000|Overall Study|Withdrawal by Subject|7|||
131795736|NCT00419926|474535922|FG001|Overall Study|Withdrawal by Subject|3|||
131795737|NCT00419926|474535921|FG000|Overall Study|Administrative Problem|4|||
131795738|NCT00419926|474535922|FG001|Overall Study|Administrative Problem|4|||
131795739|NCT00419926|474535921|FG000|Overall Study|Lost to Follow-up|1|||
131795740|NCT00419926|474535922|FG001|Overall Study|Lost to Follow-up|2|||
131795741|NCT00419926|474535921|FG000|Overall Study|Death|2|||
131795742|NCT00419926|474535922|FG001|Overall Study|Death|1|||
131795743|NCT00622908|474535923|FG000|Overall Study|Protocol Violation|1|||
131795744|NCT00622908|474535924|FG001|Overall Study|Protocol Violation|0|||
131795745|NCT00622908|474535923|FG000|Overall Study|Adverse Event|0|||
131795746|NCT00622908|474535924|FG001|Overall Study|Adverse Event|1|||
131795747|NCT00622908|474535923|FG000|Overall Study|Lack of Efficacy|1|||
131795748|NCT00622908|474535924|FG001|Overall Study|Lack of Efficacy|7|||
131795749|NCT00622908|474535923|FG000|Overall Study|Lost to Follow-up|1|||
131623180|NCT03851094|473908412|FG000|Overall Study|Participant returned device|0|||
131623181|NCT03851094|473908413|FG001|Overall Study|Participant returned device|2|||
131623182|NCT01332266|473908414|FG000|Phase 1b|Death|3|||
131623183|NCT01332266|473908415|FG001|Phase 1b|Death|3|||
131623184|NCT01332266|473908416|FG002|Phase 1b|Death|2|||
131623185|NCT01332266|473908417|FG003|Phase 1b|Death|0|||
131623186|NCT01332266|473908418|FG004|Phase 1b|Death|0|||
131795750|NCT00622908|474535924|FG001|Overall Study|Lost to Follow-up|0|||
131795751|NCT00622908|474535923|FG000|Overall Study|Refusal|0|||
131795752|NCT00622908|474535924|FG001|Overall Study|Refusal|1|||
131623187|NCT01332266|473908414|FG000|Phase 1b|Lost to Follow-up|0|||
131623188|NCT01332266|473908415|FG001|Phase 1b|Lost to Follow-up|1|||
131623189|NCT01332266|473908416|FG002|Phase 1b|Lost to Follow-up|0|||
131623190|NCT01332266|473908417|FG003|Phase 1b|Lost to Follow-up|0|||
131623191|NCT01332266|473908418|FG004|Phase 1b|Lost to Follow-up|0|||
131795753|NCT00622908|474535923|FG000|Overall Study|Termination by study sponser|0|||
131795754|NCT00622908|474535924|FG001|Overall Study|Termination by study sponser|1|||
131795755|NCT03937466|474535925|FG000|Overall Study|not eligbile after the 2-week diary|9|||
131900931|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131623192|NCT01332266|473908414|FG000|Phase 1b|Withdrawal by Subject|1|||
131623193|NCT01332266|473908415|FG001|Phase 1b|Withdrawal by Subject|1|||
131623194|NCT01332266|473908416|FG002|Phase 1b|Withdrawal by Subject|1|||
131623195|NCT01332266|473908417|FG003|Phase 1b|Withdrawal by Subject|0|||
131623196|NCT01332266|473908418|FG004|Phase 1b|Withdrawal by Subject|0|||
131623197|NCT01332266|473908414|FG000|Phase 2|Death|0|||
131623198|NCT01332266|473908415|FG001|Phase 2|Death|0|||
131623199|NCT01332266|473908416|FG002|Phase 2|Death|0|||
131623200|NCT01332266|473908417|FG003|Phase 2|Death|33|||
131623201|NCT01332266|473908418|FG004|Phase 2|Death|36|||
131623202|NCT01332266|473908414|FG000|Phase 2|Lost to Follow-up|0|||
131623203|NCT01332266|473908415|FG001|Phase 2|Lost to Follow-up|0|||
131623204|NCT01332266|473908416|FG002|Phase 2|Lost to Follow-up|0|||
131623205|NCT01332266|473908417|FG003|Phase 2|Lost to Follow-up|2|||
131623206|NCT01332266|473908418|FG004|Phase 2|Lost to Follow-up|0|||
131623207|NCT01332266|473908414|FG000|Phase 2|Physician Decision|0|||
131623208|NCT01332266|473908415|FG001|Phase 2|Physician Decision|0|||
131623209|NCT01332266|473908416|FG002|Phase 2|Physician Decision|0|||
131623210|NCT01332266|473908417|FG003|Phase 2|Physician Decision|3|||
131623211|NCT01332266|473908418|FG004|Phase 2|Physician Decision|1|||
131623212|NCT01332266|473908414|FG000|Phase 2|Symptomatic deterioration|0|||
131623213|NCT01332266|473908415|FG001|Phase 2|Symptomatic deterioration|0|||
131623214|NCT01332266|473908416|FG002|Phase 2|Symptomatic deterioration|0|||
131623215|NCT01332266|473908417|FG003|Phase 2|Symptomatic deterioration|0|||
131623216|NCT01332266|473908418|FG004|Phase 2|Symptomatic deterioration|1|||
131623217|NCT01332266|473908414|FG000|Phase 2|Progression Disease|0|||
131623218|NCT01332266|473908415|FG001|Phase 2|Progression Disease|0|||
131623219|NCT01332266|473908416|FG002|Phase 2|Progression Disease|0|||
131623220|NCT01332266|473908417|FG003|Phase 2|Progression Disease|2|||
131623221|NCT01332266|473908418|FG004|Phase 2|Progression Disease|1|||
131623222|NCT01332266|473908414|FG000|Phase 2|Withdrawal by Subject|0|||
131710926|NCT02901431|474219709|FG002|PK Part|Pending dose confirmation|0|||
131900932|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131623223|NCT01332266|473908415|FG001|Phase 2|Withdrawal by Subject|0|||
131623224|NCT01332266|473908416|FG002|Phase 2|Withdrawal by Subject|0|||
131623225|NCT01332266|473908417|FG003|Phase 2|Withdrawal by Subject|2|||
131623226|NCT01332266|473908418|FG004|Phase 2|Withdrawal by Subject|2|||
131623227|NCT01536704|473908419|FG000|Washout Period 1|Withdrawal by Subject|1|||
131623228|NCT01536704|473908420|FG001|Washout Period 1|Withdrawal by Subject|2|||
131623229|NCT01536704|473908421|FG002|Washout Period 1|Withdrawal by Subject|0|||
131623230|NCT01536704|473908422|FG003|Washout Period 1|Withdrawal by Subject|0|||
131623231|NCT01536704|473908419|FG000|Washout Period 2|Adverse Event|1|||
131710927|NCT02901431|474219710|FG003|PK Part|Pending dose confirmation|0|||
131710928|NCT02901431|474219711|FG004|PK Part|Pending dose confirmation|0|||
131710929|NCT02901431|474219712|FG005|PK Part|Pending dose confirmation|0|||
131710930|NCT02901431|474219713|FG006|PK Part|Pending dose confirmation|0|||
131710931|NCT02901431|474219714|FG007|PK Part|Pending dose confirmation|0|||
131710932|NCT02901431|474219715|FG008|PK Part|Pending dose confirmation|0|||
131710933|NCT02901431|474219716|FG009|PK Part|Pending dose confirmation|0|||
131710934|NCT02901431|474219717|FG010|PK Part|Pending dose confirmation|0|||
131710935|NCT02901431|474219718|FG011|PK Part|Pending dose confirmation|0|||
131710936|NCT02901431|474219719|FG012|PK Part|Pending dose confirmation|0|||
131710937|NCT02901431|474219707|FG000|PK Part|8 weeks of treatment ran out|2|||
131710938|NCT02901431|474219708|FG001|PK Part|8 weeks of treatment ran out|0|||
131710939|NCT02901431|474219709|FG002|PK Part|8 weeks of treatment ran out|0|||
131710940|NCT02901431|474219710|FG003|PK Part|8 weeks of treatment ran out|0|||
131710941|NCT02901431|474219711|FG004|PK Part|8 weeks of treatment ran out|0|||
131710942|NCT02901431|474219712|FG005|PK Part|8 weeks of treatment ran out|0|||
131710943|NCT02901431|474219713|FG006|PK Part|8 weeks of treatment ran out|0|||
131710944|NCT02901431|474219714|FG007|PK Part|8 weeks of treatment ran out|0|||
131710945|NCT02901431|474219715|FG008|PK Part|8 weeks of treatment ran out|0|||
131710946|NCT02901431|474219716|FG009|PK Part|8 weeks of treatment ran out|0|||
131710947|NCT02901431|474219717|FG010|PK Part|8 weeks of treatment ran out|0|||
131710948|NCT02901431|474219718|FG011|PK Part|8 weeks of treatment ran out|0|||
131710949|NCT02901431|474219719|FG012|PK Part|8 weeks of treatment ran out|0|||
131710950|NCT02901431|474219707|FG000|PK Part|Stopped treatment after 8 weeks|1|||
131710951|NCT02901431|474219708|FG001|PK Part|Stopped treatment after 8 weeks|0|||
131710952|NCT02901431|474219709|FG002|PK Part|Stopped treatment after 8 weeks|1|||
131710953|NCT02901431|474219710|FG003|PK Part|Stopped treatment after 8 weeks|0|||
131710954|NCT02901431|474219711|FG004|PK Part|Stopped treatment after 8 weeks|0|||
131710955|NCT02901431|474219712|FG005|PK Part|Stopped treatment after 8 weeks|0|||
131710956|NCT02901431|474219713|FG006|PK Part|Stopped treatment after 8 weeks|0|||
131710957|NCT02901431|474219714|FG007|PK Part|Stopped treatment after 8 weeks|0|||
131710958|NCT02901431|474219715|FG008|PK Part|Stopped treatment after 8 weeks|0|||
131710959|NCT02901431|474219716|FG009|PK Part|Stopped treatment after 8 weeks|0|||
131710960|NCT02901431|474219717|FG010|PK Part|Stopped treatment after 8 weeks|0|||
131710961|NCT02901431|474219718|FG011|PK Part|Stopped treatment after 8 weeks|0|||
131710962|NCT02901431|474219719|FG012|PK Part|Stopped treatment after 8 weeks|0|||
131623232|NCT01536704|473908420|FG001|Washout Period 2|Adverse Event|0|||
131623233|NCT01536704|473908421|FG002|Washout Period 2|Adverse Event|0|||
131623234|NCT01536704|473908422|FG003|Washout Period 2|Adverse Event|0|||
131623235|NCT01536704|473908419|FG000|Washout Period 2|Withdrawal by Subject|0|||
131623236|NCT01536704|473908420|FG001|Washout Period 2|Withdrawal by Subject|0|||
131623237|NCT01536704|473908421|FG002|Washout Period 2|Withdrawal by Subject|0|||
131623238|NCT01536704|473908422|FG003|Washout Period 2|Withdrawal by Subject|1|||
131623239|NCT01536704|473908419|FG000|Period 3|Adverse Event|0|||
131623240|NCT01536704|473908420|FG001|Period 3|Adverse Event|0|||
131623241|NCT01536704|473908421|FG002|Period 3|Adverse Event|0|||
131795756|NCT03937466|474535925|FG000|Overall Study|never returned their diary|6|||
131795757|NCT03937466|474535925|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
131795758|NCT03937466|474535925|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
131795759|NCT00113490|474535926|FG000|Overall Study|Withdrawal by Subject|1|||
131795760|NCT00113490|474535927|FG001|Overall Study|Withdrawal by Subject|3|||
131795761|NCT00113490|474535926|FG000|Overall Study|Lost to Follow-up|1|||
131795762|NCT00113490|474535927|FG001|Overall Study|Lost to Follow-up|0|||
131795763|NCT02162758|474535928|FG000|Overall Study|Study termination|0|||
131795764|NCT02162758|474535929|FG001|Overall Study|Study termination|1|||
131795765|NCT04471935|474535930|FG000|Overall Study|Withdrawal by Subject|1|||
131795766|NCT04471935|474535930|FG000|Overall Study|Deemed ineligible to participate|1|||
131795767|NCT03019965|474535933|FG000|Overall Study|Withdrawal by Subject|1|||
131795768|NCT03019965|474535934|FG001|Overall Study|Withdrawal by Subject|0|||
131795769|NCT03019965|474535933|FG000|Overall Study|Protocol Violation|1|||
131795770|NCT03019965|474535934|FG001|Overall Study|Protocol Violation|3|||
131795771|NCT03019965|474535933|FG000|Overall Study|viral or fungal infection|3|||
131795772|NCT03019965|474535934|FG001|Overall Study|viral or fungal infection|4|||
131795773|NCT03019965|474535933|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
131795774|NCT03019965|474535934|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
131795775|NCT03019965|474535933|FG000|Overall Study|Physician Decision|1|||
131795776|NCT03019965|474535934|FG001|Overall Study|Physician Decision|1|||
131795777|NCT01659567|474535935|FG000|Overall Study|Lack of Efficacy|22|||
131795778|NCT01659567|474535935|FG000|Overall Study|Switched to Pegferon|6|||
131795779|NCT01659567|474535935|FG000|Overall Study|Adverse Event|12|||
131795780|NCT01659567|474535935|FG000|Overall Study|Good result at early stage of treatment|5|||
131795781|NCT01659567|474535935|FG000|Overall Study|Withdrawal by Subject|64|||
131795782|NCT01659567|474535935|FG000|Overall Study|Progression of the main disease|1|||
131795783|NCT01659567|474535935|FG000|Overall Study|Other|13|||
131795784|NCT03213210|474535936|FG000|Overall Study|Lost to Follow-up|2|||
131795785|NCT03213210|474535936|FG000|Overall Study|Study termination|3|||
131795786|NCT01325207|474535944|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131795787|NCT01325207|474535945|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131795788|NCT01325207|474535946|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131795789|NCT01325207|474535947|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131795790|NCT01325207|474535948|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
131795791|NCT01325207|474535949|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131795792|NCT01325207|474535944|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
131795793|NCT01325207|474535945|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
131795794|NCT01325207|474535946|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
131795795|NCT01325207|474535947|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
131795796|NCT01325207|474535948|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
131795797|NCT01325207|474535949|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
131795798|NCT01325207|474535944|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131795799|NCT01325207|474535945|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131795800|NCT01325207|474535946|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131795801|NCT01325207|474535947|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131795802|NCT01325207|474535948|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
131795803|NCT01325207|474535949|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
131795804|NCT01325207|474535944|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131795805|NCT01325207|474535945|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
131795806|NCT01325207|474535946|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131444026|NCT05138653|473255034|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131623242|NCT01536704|473908422|FG003|Period 3|Adverse Event|1|||
131623243|NCT01536704|473908419|FG000|Washout Period 3|Adverse Event|0|||
131623244|NCT01536704|473908420|FG001|Washout Period 3|Adverse Event|0|||
131623245|NCT01536704|473908421|FG002|Washout Period 3|Adverse Event|1|||
131623246|NCT01536704|473908422|FG003|Washout Period 3|Adverse Event|0|||
131795807|NCT01325207|474535947|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131795808|NCT01325207|474535948|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131623247|NCT02392507|473908423|FG000|Induction Regimen|Death|3|||
131623248|NCT02392507|473908423|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
131623249|NCT02392507|473908423|FG000|Induction Regimen|Physician Decision|1|||
131900933|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900934|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900935|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900936|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131900937|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900938|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900939|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
131900940|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900941|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900942|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900943|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900944|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900945|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900946|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900947|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900948|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131623250|NCT02392507|473908423|FG000|Induction Regimen|Withdrawal by Subject|2|||
131900949|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900950|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900951|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131900952|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900953|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900954|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
131623251|NCT02392507|473908423|FG000|Maintenance Regimen|Death|1|||
131623252|NCT02392507|473908423|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
131623253|NCT00240994|473908424|FG000|Overall Study|Lost to Follow-up|1|||
131623254|NCT00240994|473908424|FG000|Overall Study|Protocol Violation|1|||
131623255|NCT00240994|473908424|FG000|Overall Study|Graft failure|1|||
131623256|NCT02128269|473908429|FG000|Treatment Period|Adverse Event|1|||
131623257|NCT02128269|473908429|FG000|Treatment Period|Physician Decision|1|||
131623258|NCT01021748|473908430|FG000|Overall Study|Adverse Event|2|||
131623259|NCT01021748|473908431|FG001|Overall Study|Adverse Event|1|||
131623260|NCT01021748|473908432|FG002|Overall Study|Adverse Event|2|||
131623261|NCT01021748|473908433|FG003|Overall Study|Adverse Event|0|||
131623262|NCT01021748|473908434|FG004|Overall Study|Adverse Event|2|||
131623263|NCT01021748|473908435|FG005|Overall Study|Adverse Event|0|||
131623264|NCT01021748|473908436|FG006|Overall Study|Adverse Event|1|||
131623265|NCT01021748|473908437|FG007|Overall Study|Adverse Event|0|||
131623266|NCT01021748|473908438|FG008|Overall Study|Adverse Event|7|||
131623267|NCT01021748|473908430|FG000|Overall Study|Physician Decision|1|||
131623268|NCT01021748|473908431|FG001|Overall Study|Physician Decision|0|||
131623269|NCT01021748|473908432|FG002|Overall Study|Physician Decision|1|||
131623270|NCT01021748|473908433|FG003|Overall Study|Physician Decision|1|||
131623271|NCT01021748|473908434|FG004|Overall Study|Physician Decision|0|||
131623272|NCT01021748|473908435|FG005|Overall Study|Physician Decision|0|||
131623273|NCT01021748|473908436|FG006|Overall Study|Physician Decision|1|||
131623274|NCT01021748|473908437|FG007|Overall Study|Physician Decision|1|||
131623275|NCT01021748|473908438|FG008|Overall Study|Physician Decision|2|||
131623276|NCT01021748|473908430|FG000|Overall Study|Progressive Disease|3|||
131710963|NCT02901431|474219707|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
131710964|NCT02901431|474219708|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710965|NCT02901431|474219709|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
131710966|NCT02901431|474219710|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710967|NCT02901431|474219711|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710968|NCT02901431|474219712|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710969|NCT02901431|474219713|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710970|NCT02901431|474219714|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710971|NCT02901431|474219715|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710972|NCT02901431|474219716|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710973|NCT02901431|474219717|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710974|NCT02901431|474219718|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710975|NCT02901431|474219719|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131710976|NCT02901431|474219707|FG000|PK Part|Discontinued per Sponsor|0|||
131710977|NCT02901431|474219708|FG001|PK Part|Discontinued per Sponsor|3|||
131710978|NCT02901431|474219709|FG002|PK Part|Discontinued per Sponsor|0|||
131710979|NCT02901431|474219710|FG003|PK Part|Discontinued per Sponsor|0|||
131710980|NCT02901431|474219711|FG004|PK Part|Discontinued per Sponsor|0|||
131623277|NCT01021748|473908431|FG001|Overall Study|Progressive Disease|3|||
131623278|NCT01021748|473908432|FG002|Overall Study|Progressive Disease|4|||
131623279|NCT01021748|473908433|FG003|Overall Study|Progressive Disease|6|||
131795809|NCT01325207|474535949|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131795810|NCT01325207|474535944|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131795811|NCT01325207|474535945|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131795812|NCT01325207|474535946|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131795813|NCT01325207|474535947|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131795814|NCT01325207|474535948|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131795815|NCT01325207|474535949|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
131623280|NCT01021748|473908434|FG004|Overall Study|Progressive Disease|7|||
131623281|NCT01021748|473908435|FG005|Overall Study|Progressive Disease|3|||
131623282|NCT01021748|473908436|FG006|Overall Study|Progressive Disease|0|||
131623283|NCT01021748|473908437|FG007|Overall Study|Progressive Disease|5|||
131623284|NCT01021748|473908438|FG008|Overall Study|Progressive Disease|6|||
131795816|NCT01325207|474535944|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131795817|NCT01325207|474535945|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131795818|NCT01325207|474535946|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131795819|NCT01325207|474535947|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131795820|NCT01325207|474535948|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131795821|NCT01325207|474535949|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
131795822|NCT01325207|474535944|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131795823|NCT01325207|474535945|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131795824|NCT01325207|474535946|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131795825|NCT01325207|474535947|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131795826|NCT01325207|474535948|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
131795827|NCT01325207|474535949|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131795828|NCT00708422|474535950|FG000|Overall Study|Adverse Event|3|||
131795829|NCT00708422|474535951|FG001|Overall Study|Adverse Event|1|||
131900955|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131623285|NCT01021748|473908430|FG000|Overall Study|Withdrawal by Subject|0|||
131623286|NCT01021748|473908431|FG001|Overall Study|Withdrawal by Subject|0|||
131623287|NCT01021748|473908432|FG002|Overall Study|Withdrawal by Subject|0|||
131623288|NCT01021748|473908433|FG003|Overall Study|Withdrawal by Subject|0|||
131623289|NCT01021748|473908434|FG004|Overall Study|Withdrawal by Subject|0|||
131623290|NCT01021748|473908435|FG005|Overall Study|Withdrawal by Subject|0|||
131623291|NCT01021748|473908436|FG006|Overall Study|Withdrawal by Subject|1|||
131623292|NCT01021748|473908437|FG007|Overall Study|Withdrawal by Subject|0|||
131623293|NCT01021748|473908438|FG008|Overall Study|Withdrawal by Subject|1|||
131623294|NCT01021748|473908430|FG000|Overall Study|Not Treated|0|||
131623295|NCT01021748|473908431|FG001|Overall Study|Not Treated|1|||
131623296|NCT01021748|473908432|FG002|Overall Study|Not Treated|0|||
131623297|NCT01021748|473908433|FG003|Overall Study|Not Treated|0|||
131623298|NCT01021748|473908434|FG004|Overall Study|Not Treated|0|||
131623299|NCT01021748|473908435|FG005|Overall Study|Not Treated|0|||
131623300|NCT01021748|473908436|FG006|Overall Study|Not Treated|0|||
131623301|NCT01021748|473908437|FG007|Overall Study|Not Treated|0|||
131623302|NCT01021748|473908438|FG008|Overall Study|Not Treated|0|||
131623303|NCT01829711|473908443|FG000|Overall Study|Lost to Follow-up|2|||
131623304|NCT01829711|473908443|FG000|Overall Study|Withdrawal by Subject|3|||
131623305|NCT01829711|473908443|FG000|Overall Study|Death|4|||
131623306|NCT01829711|473908443|FG000|Overall Study|Started new therapies|17|||
131623307|NCT01829711|473908443|FG000|Overall Study|Adverse Event|3|||
131623308|NCT01829711|473908443|FG000|Overall Study|Due to progression of disease|13|||
131623309|NCT01829711|473908443|FG000|Overall Study|Due to lack of response|1|||
131623310|NCT00749944|473908446|FG000|Overall Study|Lost to Follow-up|2|||
131623311|NCT00749944|473908447|FG001|Overall Study|Lost to Follow-up|1|||
131623312|NCT00749944|473908446|FG000|Overall Study|Other|1|||
131623313|NCT00749944|473908447|FG001|Overall Study|Other|0|||
131623314|NCT00749944|473908446|FG000|Overall Study|Withdrawal by Subject|2|||
131623315|NCT00749944|473908447|FG001|Overall Study|Withdrawal by Subject|0|||
131623316|NCT02234141|473908450|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
131623317|NCT02234141|473908451|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
131623318|NCT02234141|473908452|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
131623319|NCT02234141|473908453|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
131623320|NCT02234141|473908454|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
131623321|NCT02234141|473908455|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
131623322|NCT02234141|473908456|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
131623323|NCT02234141|473908450|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131623324|NCT02234141|473908451|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
131623325|NCT02234141|473908452|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131623326|NCT02234141|473908453|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131623327|NCT02234141|473908454|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131623328|NCT02234141|473908455|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131623329|NCT02234141|473908456|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131623330|NCT02234141|473908450|FG000|Treatment Period (24 Weeks)|Death|1|||
131623331|NCT02234141|473908451|FG001|Treatment Period (24 Weeks)|Death|2|||
131623332|NCT02234141|473908452|FG002|Treatment Period (24 Weeks)|Death|0|||
131623333|NCT02234141|473908453|FG003|Treatment Period (24 Weeks)|Death|1|||
131623334|NCT02234141|473908454|FG004|Treatment Period (24 Weeks)|Death|0|||
131623335|NCT02234141|473908455|FG005|Treatment Period (24 Weeks)|Death|0|||
131623336|NCT02234141|473908456|FG006|Treatment Period (24 Weeks)|Death|0|||
131623337|NCT02234141|473908450|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
131623338|NCT02234141|473908451|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
131623339|NCT02234141|473908452|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
131623340|NCT02234141|473908453|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
131623341|NCT02234141|473908454|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
131623342|NCT02234141|473908455|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
131623343|NCT02234141|473908456|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
131623344|NCT02234141|473908450|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131623345|NCT02234141|473908451|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
131623346|NCT02234141|473908452|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131623347|NCT02234141|473908453|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131623348|NCT02234141|473908454|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131623349|NCT02234141|473908455|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131623350|NCT02234141|473908456|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131623351|NCT02234141|473908450|FG000|Long-Term Treatment Period|Death|0|||
131623352|NCT02234141|473908451|FG001|Long-Term Treatment Period|Death|0|||
131623353|NCT02234141|473908452|FG002|Long-Term Treatment Period|Death|0|||
131710981|NCT02901431|474219712|FG005|PK Part|Discontinued per Sponsor|0|||
131710982|NCT02901431|474219713|FG006|PK Part|Discontinued per Sponsor|0|||
131710983|NCT02901431|474219714|FG007|PK Part|Discontinued per Sponsor|0|||
131710984|NCT02901431|474219715|FG008|PK Part|Discontinued per Sponsor|0|||
131710985|NCT02901431|474219716|FG009|PK Part|Discontinued per Sponsor|0|||
131710986|NCT02901431|474219717|FG010|PK Part|Discontinued per Sponsor|0|||
131710987|NCT02901431|474219718|FG011|PK Part|Discontinued per Sponsor|0|||
131710988|NCT02901431|474219719|FG012|PK Part|Discontinued per Sponsor|0|||
131710989|NCT02901431|474219707|FG000|PK Part|Withdrawal by Subject|1|||
131710990|NCT02901431|474219708|FG001|PK Part|Withdrawal by Subject|1|||
131900956|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900957|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900958|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900959|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131444027|NCT05138653|473255035|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444028|NCT05138653|473255036|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444029|NCT05138653|473255037|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444030|NCT05138653|473255038|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
131444031|NCT05138653|473255023|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444032|NCT05138653|473255024|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
131444033|NCT05138653|473255025|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444034|NCT05138653|473255026|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444035|NCT05138653|473255027|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444036|NCT05138653|473255028|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444037|NCT05138653|473255029|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444038|NCT05138653|473255030|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444039|NCT05138653|473255031|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
131444040|NCT05138653|473255032|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131623354|NCT02234141|473908453|FG003|Long-Term Treatment Period|Death|0|||
131623355|NCT02234141|473908454|FG004|Long-Term Treatment Period|Death|0|||
131623356|NCT02234141|473908455|FG005|Long-Term Treatment Period|Death|1|||
131623357|NCT02234141|473908456|FG006|Long-Term Treatment Period|Death|0|||
131623358|NCT02234141|473908450|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
131623359|NCT02234141|473908451|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
131795830|NCT00708422|474535950|FG000|Overall Study|Withdrawal by Subject|1|||
131795831|NCT00708422|474535951|FG001|Overall Study|Withdrawal by Subject|0|||
131795832|NCT02015793|474535954|FG000|Overall Study|Adverse Event|3|||
131795833|NCT02015793|474535955|FG001|Overall Study|Adverse Event|3|||
131795834|NCT02015793|474535954|FG000|Overall Study|Withdrawal by Subject|1|||
131795835|NCT02015793|474535955|FG001|Overall Study|Withdrawal by Subject|1|||
131795836|NCT00437281|474535956|FG000|Overall Study|Adverse Event|0|||
131795837|NCT00437281|474535957|FG001|Overall Study|Adverse Event|0|||
131795838|NCT00437281|474535958|FG002|Overall Study|Adverse Event|0|||
131795839|NCT00437281|474535959|FG003|Overall Study|Adverse Event|1|||
131795840|NCT00437281|474535960|FG004|Overall Study|Adverse Event|0|||
131900960|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131623360|NCT02234141|473908452|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
131795841|NCT00437281|474535961|FG005|Overall Study|Adverse Event|1|||
131795842|NCT00437281|474535962|FG006|Overall Study|Adverse Event|0|||
131795843|NCT00437281|474535963|FG007|Overall Study|Adverse Event|0|||
131710991|NCT02901431|474219709|FG002|PK Part|Withdrawal by Subject|3|||
131710992|NCT02901431|474219710|FG003|PK Part|Withdrawal by Subject|0|||
131710993|NCT02901431|474219711|FG004|PK Part|Withdrawal by Subject|0|||
131710994|NCT02901431|474219712|FG005|PK Part|Withdrawal by Subject|0|||
131710995|NCT02901431|474219713|FG006|PK Part|Withdrawal by Subject|0|||
131710996|NCT02901431|474219714|FG007|PK Part|Withdrawal by Subject|0|||
131710997|NCT02901431|474219715|FG008|PK Part|Withdrawal by Subject|0|||
131710998|NCT02901431|474219716|FG009|PK Part|Withdrawal by Subject|0|||
131710999|NCT02901431|474219717|FG010|PK Part|Withdrawal by Subject|0|||
131711000|NCT02901431|474219718|FG011|PK Part|Withdrawal by Subject|0|||
131711001|NCT02901431|474219719|FG012|PK Part|Withdrawal by Subject|0|||
131711002|NCT02901431|474219707|FG000|Main Treatment Part|Adverse Event|0|||
131711003|NCT02901431|474219708|FG001|Main Treatment Part|Adverse Event|0|||
131711004|NCT02901431|474219709|FG002|Main Treatment Part|Adverse Event|0|||
131711005|NCT02901431|474219710|FG003|Main Treatment Part|Adverse Event|3|||
131711006|NCT02901431|474219711|FG004|Main Treatment Part|Adverse Event|3|||
131711007|NCT02901431|474219712|FG005|Main Treatment Part|Adverse Event|4|||
131900961|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900962|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900963|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900964|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900965|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900966|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131900967|NCT02326272|474923497|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900968|NCT02326272|474923498|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900969|NCT02326272|474923499|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
131900970|NCT02326272|474923500|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900971|NCT02326272|474923501|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900972|NCT02326272|474923502|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900973|NCT02326272|474923503|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900974|NCT02326272|474923504|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900975|NCT02326272|474923505|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900976|NCT02326272|474923506|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900977|NCT02326272|474923507|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900978|NCT02326272|474923508|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900979|NCT02326272|474923509|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900980|NCT02326272|474923510|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131900981|NCT02326272|474923511|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131623361|NCT02234141|473908453|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
131623362|NCT02234141|473908454|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
131623363|NCT02234141|473908455|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
131623364|NCT02234141|473908456|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
131623365|NCT02234141|473908450|FG000|Long-Term Treatment Period|Adverse Event|4|||
131623366|NCT02234141|473908451|FG001|Long-Term Treatment Period|Adverse Event|0|||
131623367|NCT02234141|473908452|FG002|Long-Term Treatment Period|Adverse Event|5|||
131623368|NCT02234141|473908453|FG003|Long-Term Treatment Period|Adverse Event|0|||
131623369|NCT02234141|473908454|FG004|Long-Term Treatment Period|Adverse Event|1|||
131623370|NCT02234141|473908455|FG005|Long-Term Treatment Period|Adverse Event|1|||
131623371|NCT02234141|473908456|FG006|Long-Term Treatment Period|Adverse Event|1|||
131623372|NCT02234141|473908450|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
131623373|NCT02234141|473908451|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
131623374|NCT02234141|473908452|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
131623375|NCT02234141|473908453|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
131623376|NCT02234141|473908454|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
131623377|NCT02234141|473908455|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
131623378|NCT02234141|473908456|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
131623379|NCT02234141|473908450|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
131623380|NCT02234141|473908451|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
131623381|NCT02234141|473908452|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
131623382|NCT02234141|473908453|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
131711008|NCT02901431|474219713|FG006|Main Treatment Part|Adverse Event|1|||
131711009|NCT02901431|474219714|FG007|Main Treatment Part|Adverse Event|0|||
131711010|NCT02901431|474219715|FG008|Main Treatment Part|Adverse Event|0|||
131711011|NCT02901431|474219716|FG009|Main Treatment Part|Adverse Event|0|||
131711012|NCT02901431|474219717|FG010|Main Treatment Part|Adverse Event|0|||
131711013|NCT02901431|474219718|FG011|Main Treatment Part|Adverse Event|0|||
131711014|NCT02901431|474219719|FG012|Main Treatment Part|Adverse Event|0|||
131900982|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900983|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900984|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900985|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900986|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
131900987|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
131900988|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
131900989|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
131900990|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
131900991|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900992|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900993|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900994|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900995|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900996|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131900997|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131900998|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131900999|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901000|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901001|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901002|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
131901003|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
131901004|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901005|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
131901006|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
131901007|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901008|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901009|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901010|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131444041|NCT05138653|473255033|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444042|NCT05138653|473255034|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131623383|NCT02234141|473908454|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
131623384|NCT02234141|473908455|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
131623385|NCT02234141|473908456|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
131623386|NCT00895245|473908457|FG000|Overall Study|Lack of Efficacy|6|||
131623387|NCT04248868|473908458|FG000|Overall Study|Death|1|||
131623388|NCT04248868|473908458|FG000|Overall Study|Lost to Follow-up|3|||
131623389|NCT04248868|473908458|FG000|Overall Study|Protocol Violation|2|||
131623390|NCT03131713|473908463|FG000|Overall Study|Lost to Follow-up|5|||
131623391|NCT03131713|473908464|FG001|Overall Study|Lost to Follow-up|0|||
131623392|NCT02208843|473908465|FG000|Overall Study|Clinical symptoms of progression|2|||
131623393|NCT02208843|473908465|FG000|Overall Study|Progression disease according to RECIST|24|||
131623394|NCT02208843|473908465|FG000|Overall Study|Adverse Event|12|||
131623395|NCT02208843|473908465|FG000|Overall Study|Protocol Violation|1|||
131623396|NCT02208843|473908465|FG000|Overall Study|Withdrawal by Subject|1|||
131623397|NCT02208843|473908465|FG000|Overall Study|Switched to commercial afatinib|20|||
131623398|NCT00089791|473908471|FG000|Overall Study|Physician Decision|6|||
131623399|NCT00089791|473908472|FG001|Overall Study|Physician Decision|3|||
131623400|NCT00089791|473908471|FG000|Overall Study|Adverse Event|81|||
131623401|NCT00089791|473908472|FG001|Overall Study|Adverse Event|93|||
131623402|NCT00089791|473908471|FG000|Overall Study|Withdrawal by Subject|403|||
131623403|NCT00089791|473908472|FG001|Overall Study|Withdrawal by Subject|344|||
131623404|NCT00089791|473908471|FG000|Overall Study|Death|78|||
131623405|NCT00089791|473908472|FG001|Overall Study|Death|62|||
131711015|NCT02901431|474219707|FG000|Main Treatment Part|Lack of Efficacy|0|||
131711016|NCT02901431|474219708|FG001|Main Treatment Part|Lack of Efficacy|0|||
131711017|NCT02901431|474219709|FG002|Main Treatment Part|Lack of Efficacy|0|||
131711018|NCT02901431|474219710|FG003|Main Treatment Part|Lack of Efficacy|1|||
131711019|NCT02901431|474219711|FG004|Main Treatment Part|Lack of Efficacy|0|||
131711020|NCT02901431|474219712|FG005|Main Treatment Part|Lack of Efficacy|0|||
131711021|NCT02901431|474219713|FG006|Main Treatment Part|Lack of Efficacy|0|||
131711022|NCT02901431|474219714|FG007|Main Treatment Part|Lack of Efficacy|0|||
131711023|NCT02901431|474219715|FG008|Main Treatment Part|Lack of Efficacy|0|||
131711024|NCT02901431|474219716|FG009|Main Treatment Part|Lack of Efficacy|0|||
131711025|NCT02901431|474219717|FG010|Main Treatment Part|Lack of Efficacy|0|||
131711026|NCT02901431|474219718|FG011|Main Treatment Part|Lack of Efficacy|0|||
131623406|NCT00089791|473908471|FG000|Overall Study|Disease progression|7|||
131623407|NCT00089791|473908472|FG001|Overall Study|Disease progression|3|||
131623408|NCT00089791|473908471|FG000|Overall Study|Ineligibility determined|12|||
131711027|NCT02901431|474219719|FG012|Main Treatment Part|Lack of Efficacy|0|||
131711028|NCT02901431|474219707|FG000|Main Treatment Part|Lost to Follow-up|0|||
131795844|NCT00437281|474535964|FG008|Overall Study|Adverse Event|0|||
131795845|NCT00437281|474535965|FG009|Overall Study|Adverse Event|1|||
131795846|NCT00437281|474535966|FG010|Overall Study|Adverse Event|0|||
131795847|NCT00437281|474535967|FG011|Overall Study|Adverse Event|0|||
131795848|NCT00437281|474535968|FG012|Overall Study|Adverse Event|0|||
131795849|NCT00437281|474535969|FG013|Overall Study|Adverse Event|1|||
131795850|NCT00437281|474535970|FG014|Overall Study|Adverse Event|1|||
131795851|NCT00437281|474535971|FG015|Overall Study|Adverse Event|0|||
131795852|NCT00437281|474535972|FG016|Overall Study|Adverse Event|0|||
131795853|NCT00437281|474535973|FG017|Overall Study|Adverse Event|0|||
131795854|NCT00437281|474535974|FG018|Overall Study|Adverse Event|1|||
131795855|NCT00437281|474535975|FG019|Overall Study|Adverse Event|0|||
131795856|NCT00437281|474535956|FG000|Overall Study|Lost to Follow-up|0|||
131795857|NCT00437281|474535957|FG001|Overall Study|Lost to Follow-up|0|||
131795858|NCT00437281|474535958|FG002|Overall Study|Lost to Follow-up|0|||
131795859|NCT00437281|474535959|FG003|Overall Study|Lost to Follow-up|0|||
131795860|NCT00437281|474535960|FG004|Overall Study|Lost to Follow-up|0|||
131795861|NCT00437281|474535961|FG005|Overall Study|Lost to Follow-up|0|||
131795862|NCT00437281|474535962|FG006|Overall Study|Lost to Follow-up|0|||
131795863|NCT00437281|474535963|FG007|Overall Study|Lost to Follow-up|0|||
131795864|NCT00437281|474535964|FG008|Overall Study|Lost to Follow-up|0|||
131795865|NCT00437281|474535965|FG009|Overall Study|Lost to Follow-up|0|||
131795866|NCT00437281|474535966|FG010|Overall Study|Lost to Follow-up|0|||
131795867|NCT00437281|474535967|FG011|Overall Study|Lost to Follow-up|0|||
131795868|NCT00437281|474535968|FG012|Overall Study|Lost to Follow-up|0|||
131795869|NCT00437281|474535969|FG013|Overall Study|Lost to Follow-up|0|||
131623409|NCT00089791|473908472|FG001|Overall Study|Ineligibility determined|9|||
131623410|NCT00089791|473908471|FG000|Overall Study|Lost to Follow-up|57|||
131623411|NCT00089791|473908472|FG001|Overall Study|Lost to Follow-up|57|||
131623412|NCT00089791|473908471|FG000|Overall Study|Noncompliance|17|||
131623413|NCT00089791|473908472|FG001|Overall Study|Noncompliance|13|||
131623414|NCT00089791|473908471|FG000|Overall Study|Other|20|||
131623415|NCT00089791|473908472|FG001|Overall Study|Other|32|||
131623416|NCT00089791|473908471|FG000|Overall Study|Protocol deviation|12|||
131623417|NCT00089791|473908472|FG001|Overall Study|Protocol deviation|10|||
131623418|NCT00089791|473908471|FG000|Overall Study|Requirement for alternative therapy|7|||
131623419|NCT00089791|473908472|FG001|Overall Study|Requirement for alternative therapy|4|||
131623420|NCT00148122|473908473|FG000|Overall Study|Withdrawal by Subject|2|||
131623421|NCT01543204|473908474|FG000|Overall Study|Non-compliance|1|||
131623422|NCT01543204|473908474|FG000|Overall Study|Adverse Event|1|||
131623423|NCT01543204|473908474|FG000|Overall Study|Withdrawal by Subject|4|||
131623424|NCT01543204|473908474|FG000|Overall Study|Requirement for Alternative Therapy|1|||
131623425|NCT01543204|473908474|FG000|Overall Study|Lost to Follow-up|1|||
131623426|NCT02449902|473908476|FG000|Overall Study|Adverse Event|0|||
131623427|NCT02449902|473908477|FG001|Overall Study|Adverse Event|1|||
131623428|NCT02449902|473908476|FG000|Overall Study|Withdrawal by Subject|0|||
131623429|NCT02449902|473908477|FG001|Overall Study|Withdrawal by Subject|1|||
131623430|NCT02362789|473908478|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
131623431|NCT02362789|473908479|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
131623432|NCT02362789|473908480|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
131623433|NCT02362789|473908478|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
131623434|NCT02362789|473908479|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
131623435|NCT02362789|473908480|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
131623436|NCT02362789|473908478|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
131623437|NCT02362789|473908479|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
131623438|NCT02362789|473908480|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
131623439|NCT02362789|473908478|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
131795870|NCT00437281|474535970|FG014|Overall Study|Lost to Follow-up|0|||
131795871|NCT00437281|474535971|FG015|Overall Study|Lost to Follow-up|0|||
131795872|NCT00437281|474535972|FG016|Overall Study|Lost to Follow-up|0|||
131795873|NCT00437281|474535973|FG017|Overall Study|Lost to Follow-up|0|||
131795874|NCT00437281|474535974|FG018|Overall Study|Lost to Follow-up|0|||
131795875|NCT00437281|474535975|FG019|Overall Study|Lost to Follow-up|1|||
131795876|NCT00947427|474535976|FG000|Overall Study|Withdrawal by Subject|1|||
131795877|NCT00947427|474535977|FG001|Overall Study|Withdrawal by Subject|3|||
131795878|NCT00947427|474535976|FG000|Overall Study|Protocol Violation|0|||
131623440|NCT02362789|473908479|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
131623441|NCT02362789|473908480|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
131623442|NCT02362789|473908478|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
131623443|NCT02362789|473908479|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
131623444|NCT02362789|473908480|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
131623445|NCT03326856|473908481|FG000|Overall Study|Lost to Follow-up|1|||
131623446|NCT03326856|473908482|FG001|Overall Study|Lost to Follow-up|1|||
131623447|NCT03326856|473908483|FG002|Overall Study|Lost to Follow-up|0|||
131623448|NCT03326856|473908484|FG003|Overall Study|Lost to Follow-up|0|||
131623449|NCT03326856|473908485|FG004|Overall Study|Lost to Follow-up|0|||
131623450|NCT01989689|473908486|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
131623451|NCT01989689|473908487|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
131623452|NCT01989689|473908486|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
131623453|NCT01989689|473908487|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
131623454|NCT03938272|473908488|FG000|Overall Study|Withdrawal by Subject|1|||
131623455|NCT03938272|473908489|FG001|Overall Study|Withdrawal by Subject|0|||
131623456|NCT03938272|473908488|FG000|Overall Study|Physician Decision|0|||
131623457|NCT03938272|473908489|FG001|Overall Study|Physician Decision|2|||
131623458|NCT03938272|473908488|FG000|Overall Study|Study termination by sponsor|10|||
131623459|NCT03938272|473908489|FG001|Overall Study|Study termination by sponsor|8|||
131623460|NCT03692871|473908493|FG000|Overall Study|Death|1|||
131623461|NCT03692871|473908494|FG001|Overall Study|Death|1|||
131623462|NCT03692871|473908493|FG000|Overall Study|Lost to Follow-up|24|||
131623463|NCT03692871|473908494|FG001|Overall Study|Lost to Follow-up|9|||
131623464|NCT03692871|473908493|FG000|Overall Study|Physician Decision|22|||
131623465|NCT03692871|473908494|FG001|Overall Study|Physician Decision|7|||
131623466|NCT03692871|473908493|FG000|Overall Study|Protocol Deviation|1|||
131623467|NCT03692871|473908494|FG001|Overall Study|Protocol Deviation|0|||
131623468|NCT03692871|473908493|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
131623469|NCT03692871|473908494|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
131623470|NCT03989232|473908495|FG000|Overall Study|Lost to Follow-up|3|||
131623471|NCT03989232|473908496|FG001|Overall Study|Lost to Follow-up|10|||
131623472|NCT03989232|473908495|FG000|Overall Study|Withdrawal by Subject|6|||
131623473|NCT03989232|473908496|FG001|Overall Study|Withdrawal by Subject|6|||
131623474|NCT03989232|473908495|FG000|Overall Study|Death|1|||
131623475|NCT03989232|473908496|FG001|Overall Study|Death|2|||
131623476|NCT02644122|473908497|FG000|Overall Study|Withdrawal by Subject|1|||
131623477|NCT02852824|473908505|FG000|Overall Study|Withdrawal by Subject|1|||
131623478|NCT02852824|473908506|FG001|Overall Study|Withdrawal by Subject|0|||
131623479|NCT02852824|473908507|FG002|Overall Study|Withdrawal by Subject|0|||
131623480|NCT02852824|473908508|FG003|Overall Study|Withdrawal by Subject|0|||
131623481|NCT02852824|473908509|FG004|Overall Study|Withdrawal by Subject|0|||
131623482|NCT02852824|473908510|FG005|Overall Study|Withdrawal by Subject|0|||
131623483|NCT02852824|473908511|FG006|Overall Study|Withdrawal by Subject|0|||
131623484|NCT02852824|473908505|FG000|Overall Study|Adverse Event|0|||
131623485|NCT02852824|473908506|FG001|Overall Study|Adverse Event|0|||
131901011|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131901012|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901013|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901014|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901015|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901016|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901017|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
131901018|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901019|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
131901020|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901021|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901022|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901023|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901024|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901025|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901026|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131901027|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901028|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901029|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901030|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131901031|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901032|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
131901033|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131901034|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131901035|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901036|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131901037|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131623486|NCT02852824|473908507|FG002|Overall Study|Adverse Event|0|||
131623487|NCT02852824|473908508|FG003|Overall Study|Adverse Event|0|||
131623488|NCT02852824|473908509|FG004|Overall Study|Adverse Event|2|||
131623489|NCT02852824|473908510|FG005|Overall Study|Adverse Event|0|||
131623490|NCT02852824|473908511|FG006|Overall Study|Adverse Event|0|||
131623491|NCT00680771|473908512|FG000|Overall Study|Withdrawal by Subject|1|||
131623492|NCT00680771|473908513|FG001|Overall Study|Withdrawal by Subject|0|||
131623493|NCT00680771|473908512|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
131623494|NCT00680771|473908513|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
131623495|NCT00680771|473908512|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
131623496|NCT00680771|473908513|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
131623497|NCT01316913|473908514|FG000|Overall Study|Adverse Event|17|||
131623498|NCT01316913|473908515|FG001|Overall Study|Adverse Event|20|||
131623499|NCT01316913|473908516|FG002|Overall Study|Adverse Event|15|||
131623500|NCT01316913|473908517|FG003|Overall Study|Adverse Event|11|||
131623501|NCT01316913|473908514|FG000|Overall Study|Lack of Efficacy|22|||
131623502|NCT01316913|473908515|FG001|Overall Study|Lack of Efficacy|12|||
131623503|NCT01316913|473908516|FG002|Overall Study|Lack of Efficacy|9|||
131623504|NCT01316913|473908517|FG003|Overall Study|Lack of Efficacy|13|||
131623505|NCT01316913|473908514|FG000|Overall Study|Protocol Violation|1|||
131623506|NCT01316913|473908515|FG001|Overall Study|Protocol Violation|4|||
131623507|NCT01316913|473908516|FG002|Overall Study|Protocol Violation|4|||
131623508|NCT01316913|473908517|FG003|Overall Study|Protocol Violation|1|||
131623509|NCT01316913|473908514|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
131623510|NCT01316913|473908515|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
131623511|NCT01316913|473908516|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
131623512|NCT01316913|473908517|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
131623513|NCT01316913|473908514|FG000|Overall Study|Lost to Follow-up|0|||
131623514|NCT01316913|473908515|FG001|Overall Study|Lost to Follow-up|1|||
131623515|NCT01316913|473908516|FG002|Overall Study|Lost to Follow-up|0|||
131623516|NCT01316913|473908517|FG003|Overall Study|Lost to Follow-up|2|||
131901038|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901039|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901040|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901041|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131901042|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901043|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131623517|NCT01316913|473908514|FG000|Overall Study|Withdrawal by Subject|10|||
131623518|NCT01316913|473908515|FG001|Overall Study|Withdrawal by Subject|9|||
131623519|NCT01316913|473908516|FG002|Overall Study|Withdrawal by Subject|10|||
131623520|NCT01316913|473908517|FG003|Overall Study|Withdrawal by Subject|6|||
131623521|NCT02691702|473908518|FG000|Overall Study|Adverse Event|1|||
131623522|NCT02691702|473908519|FG001|Overall Study|Adverse Event|0|||
131795879|NCT00947427|474535977|FG001|Overall Study|Protocol Violation|1|||
131795880|NCT00601354|474535978|FG000|Overall Study|Lost to Follow-up|4|||
131795881|NCT00601354|474535979|FG001|Overall Study|Lost to Follow-up|5|||
131795882|NCT01862328|474535982|FG000|Overall Study|Progressive Disease|3|||
131795883|NCT01862328|474535983|FG001|Overall Study|Progressive Disease|11|||
131795884|NCT01862328|474535984|FG002|Overall Study|Progressive Disease|5|||
131795885|NCT01862328|474535985|FG003|Overall Study|Progressive Disease|6|||
131795886|NCT01862328|474535986|FG004|Overall Study|Progressive Disease|7|||
131623523|NCT02691702|473908520|FG002|Overall Study|Adverse Event|0|||
131623524|NCT02691702|473908521|FG003|Overall Study|Adverse Event|0|||
131623525|NCT02691702|473908522|FG004|Overall Study|Adverse Event|0|||
131623526|NCT02691702|473908523|FG005|Overall Study|Adverse Event|0|||
131623527|NCT02691702|473908524|FG006|Overall Study|Adverse Event|0|||
131623528|NCT02691702|473908525|FG007|Overall Study|Adverse Event|0|||
131623529|NCT02691702|473908526|FG008|Overall Study|Adverse Event|1|||
131623530|NCT02691702|473908527|FG009|Overall Study|Adverse Event|0|||
131623531|NCT02691702|473908528|FG010|Overall Study|Adverse Event|1|||
131623532|NCT02691702|473908518|FG000|Overall Study|Lost to Follow-up|0|||
131623533|NCT02691702|473908519|FG001|Overall Study|Lost to Follow-up|0|||
131623534|NCT02691702|473908520|FG002|Overall Study|Lost to Follow-up|1|||
131623535|NCT02691702|473908521|FG003|Overall Study|Lost to Follow-up|0|||
131623536|NCT02691702|473908522|FG004|Overall Study|Lost to Follow-up|0|||
131623537|NCT02691702|473908523|FG005|Overall Study|Lost to Follow-up|2|||
131623538|NCT02691702|473908524|FG006|Overall Study|Lost to Follow-up|0|||
131623539|NCT02691702|473908525|FG007|Overall Study|Lost to Follow-up|0|||
131623540|NCT02691702|473908526|FG008|Overall Study|Lost to Follow-up|0|||
131623541|NCT02691702|473908527|FG009|Overall Study|Lost to Follow-up|0|||
131623542|NCT02691702|473908528|FG010|Overall Study|Lost to Follow-up|1|||
131623543|NCT02691702|473908518|FG000|Overall Study|Withdrawal by Subject|1|||
131623544|NCT02691702|473908519|FG001|Overall Study|Withdrawal by Subject|1|||
131623545|NCT02691702|473908520|FG002|Overall Study|Withdrawal by Subject|0|||
131623546|NCT02691702|473908521|FG003|Overall Study|Withdrawal by Subject|0|||
131623547|NCT02691702|473908522|FG004|Overall Study|Withdrawal by Subject|0|||
131623548|NCT02691702|473908523|FG005|Overall Study|Withdrawal by Subject|1|||
131623549|NCT02691702|473908524|FG006|Overall Study|Withdrawal by Subject|2|||
131623550|NCT02691702|473908525|FG007|Overall Study|Withdrawal by Subject|0|||
131623551|NCT02691702|473908526|FG008|Overall Study|Withdrawal by Subject|0|||
131623552|NCT02691702|473908527|FG009|Overall Study|Withdrawal by Subject|0|||
131623553|NCT02691702|473908528|FG010|Overall Study|Withdrawal by Subject|0|||
131623554|NCT02691702|473908518|FG000|Overall Study|Other|0|||
131623555|NCT02691702|473908519|FG001|Overall Study|Other|0|||
131623556|NCT02691702|473908520|FG002|Overall Study|Other|0|||
131623557|NCT02691702|473908521|FG003|Overall Study|Other|0|||
131623558|NCT02691702|473908522|FG004|Overall Study|Other|0|||
131623559|NCT02691702|473908523|FG005|Overall Study|Other|0|||
131623560|NCT02691702|473908524|FG006|Overall Study|Other|1|||
131623561|NCT02691702|473908525|FG007|Overall Study|Other|0|||
131623562|NCT02691702|473908526|FG008|Overall Study|Other|1|||
131623563|NCT02691702|473908527|FG009|Overall Study|Other|0|||
131623564|NCT02691702|473908528|FG010|Overall Study|Other|0|||
131795887|NCT01862328|474535987|FG005|Overall Study|Progressive Disease|4|||
131795888|NCT01862328|474535988|FG006|Overall Study|Progressive Disease|3|||
131795889|NCT01862328|474535982|FG000|Overall Study|Adverse Event|0|||
131795890|NCT01862328|474535983|FG001|Overall Study|Adverse Event|4|||
131623565|NCT02691702|473908518|FG000|Overall Study|Protocol Violation|0|||
131623566|NCT02691702|473908519|FG001|Overall Study|Protocol Violation|0|||
131623567|NCT02691702|473908520|FG002|Overall Study|Protocol Violation|0|||
131623568|NCT02691702|473908521|FG003|Overall Study|Protocol Violation|0|||
131623569|NCT02691702|473908522|FG004|Overall Study|Protocol Violation|0|||
131623570|NCT02691702|473908523|FG005|Overall Study|Protocol Violation|0|||
131623571|NCT02691702|473908524|FG006|Overall Study|Protocol Violation|0|||
131623572|NCT02691702|473908525|FG007|Overall Study|Protocol Violation|0|||
131623573|NCT02691702|473908526|FG008|Overall Study|Protocol Violation|0|||
131623574|NCT02691702|473908527|FG009|Overall Study|Protocol Violation|2|||
131795891|NCT01862328|474535984|FG002|Overall Study|Adverse Event|0|||
131623575|NCT02691702|473908528|FG010|Overall Study|Protocol Violation|0|||
131623576|NCT05169684|473908529|FG000|Overall Study|Adverse Event|1|||
131623577|NCT05169684|473908530|FG001|Overall Study|Adverse Event|3|||
131623578|NCT05169684|473908529|FG000|Overall Study|Physician Decision|0|||
131623579|NCT05169684|473908530|FG001|Overall Study|Physician Decision|1|||
131623580|NCT05169684|473908529|FG000|Overall Study|Progressive Disease|1|||
131623581|NCT05169684|473908530|FG001|Overall Study|Progressive Disease|1|||
131623582|NCT05169684|473908529|FG000|Overall Study|Participant request to discontinue treatment|0|||
131623583|NCT05169684|473908530|FG001|Overall Study|Participant request to discontinue treatment|1|||
131623584|NCT05169684|473908529|FG000|Overall Study|Other Reason|0|||
131623585|NCT05169684|473908530|FG001|Overall Study|Other Reason|1|||
131623586|NCT01668719|473908531|FG000|Phase I|On treatment|1|||
131623587|NCT01668719|473908532|FG001|Phase I|On treatment|0|||
131623588|NCT01668719|473908533|FG002|Phase I|On treatment|0|||
131623589|NCT01668719|473908531|FG000|Phase I|Adverse Event|2|||
131623590|NCT01668719|473908532|FG001|Phase I|Adverse Event|0|||
131623591|NCT01668719|473908533|FG002|Phase I|Adverse Event|0|||
131623592|NCT01668719|473908531|FG000|Phase I|Progression/relapse|1|||
131623593|NCT01668719|473908532|FG001|Phase I|Progression/relapse|0|||
131623594|NCT01668719|473908533|FG002|Phase I|Progression/relapse|0|||
131623595|NCT01668719|473908531|FG000|Phase I|not protocol specified|2|||
131623596|NCT01668719|473908532|FG001|Phase I|not protocol specified|0|||
131623597|NCT01668719|473908533|FG002|Phase I|not protocol specified|0|||
131623598|NCT01668719|473908531|FG000|Phase II|On treatment|0|||
131623599|NCT01668719|473908532|FG001|Phase II|On treatment|4|||
131623600|NCT01668719|473908533|FG002|Phase II|On treatment|3|||
131623601|NCT01668719|473908531|FG000|Phase II|Adverse Event|0|||
131623602|NCT01668719|473908532|FG001|Phase II|Adverse Event|18|||
131623603|NCT01668719|473908533|FG002|Phase II|Adverse Event|18|||
131623604|NCT01668719|473908531|FG000|Phase II|Refusal unrelated to adverse event|0|||
131623605|NCT01668719|473908532|FG001|Phase II|Refusal unrelated to adverse event|4|||
131795892|NCT01862328|474535985|FG003|Overall Study|Adverse Event|1|||
131795893|NCT01862328|474535986|FG004|Overall Study|Adverse Event|0|||
131795894|NCT01862328|474535987|FG005|Overall Study|Adverse Event|2|||
131795895|NCT01862328|474535988|FG006|Overall Study|Adverse Event|4|||
131795896|NCT01862328|474535982|FG000|Overall Study|Other|0|||
131795897|NCT01862328|474535983|FG001|Overall Study|Other|2|||
131795898|NCT01862328|474535984|FG002|Overall Study|Other|1|||
131795899|NCT01862328|474535985|FG003|Overall Study|Other|0|||
131795900|NCT01862328|474535986|FG004|Overall Study|Other|4|||
131795901|NCT01862328|474535987|FG005|Overall Study|Other|0|||
131795902|NCT01862328|474535988|FG006|Overall Study|Other|1|||
131795903|NCT01862328|474535982|FG000|Overall Study|Withdrawal by Subject|1|||
131795904|NCT01862328|474535983|FG001|Overall Study|Withdrawal by Subject|1|||
131795905|NCT01862328|474535984|FG002|Overall Study|Withdrawal by Subject|0|||
131795906|NCT01862328|474535985|FG003|Overall Study|Withdrawal by Subject|0|||
131795907|NCT01862328|474535986|FG004|Overall Study|Withdrawal by Subject|1|||
131795908|NCT01862328|474535987|FG005|Overall Study|Withdrawal by Subject|1|||
131795909|NCT01862328|474535988|FG006|Overall Study|Withdrawal by Subject|1|||
131795910|NCT01862328|474535982|FG000|Overall Study|Symptomatic Deterioration|0|||
131795911|NCT01862328|474535983|FG001|Overall Study|Symptomatic Deterioration|0|||
131795912|NCT01862328|474535984|FG002|Overall Study|Symptomatic Deterioration|0|||
131795913|NCT01862328|474535985|FG003|Overall Study|Symptomatic Deterioration|0|||
131795914|NCT01862328|474535986|FG004|Overall Study|Symptomatic Deterioration|0|||
131795915|NCT01862328|474535987|FG005|Overall Study|Symptomatic Deterioration|0|||
131795916|NCT01862328|474535988|FG006|Overall Study|Symptomatic Deterioration|1|||
131795917|NCT01411995|474535989|FG000|Overall Study|Failed IUD insertion|0|||
131795918|NCT01411995|474535990|FG001|Overall Study|Failed IUD insertion|1|||
131795919|NCT00936975|474535991|FG000|Overall Study|Withdrawal by Subject|1|||
131795920|NCT00936975|474535991|FG000|Overall Study|Disease progression|3|||
131795921|NCT00936975|474535991|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
131795922|NCT01656889|474535992|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
131795923|NCT01656889|474535993|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
131795924|NCT01656889|474535992|FG000|Treatment Period, 12 Weeks|Death|0|||
131795925|NCT01656889|474535993|FG001|Treatment Period, 12 Weeks|Death|1|||
131795926|NCT01656889|474535992|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
131623606|NCT01668719|473908533|FG002|Phase II|Refusal unrelated to adverse event|1|||
131623607|NCT01668719|473908531|FG000|Phase II|Progression/relapse|0|||
131623608|NCT01668719|473908532|FG001|Phase II|Progression/relapse|13|||
131623609|NCT01668719|473908533|FG002|Phase II|Progression/relapse|17|||
131623610|NCT01668719|473908531|FG000|Phase II|Death|0|||
131623611|NCT01668719|473908532|FG001|Phase II|Death|0|||
131623612|NCT01668719|473908533|FG002|Phase II|Death|2|||
131623613|NCT01668719|473908531|FG000|Phase II|not protocol specified|0|||
131623614|NCT01668719|473908532|FG001|Phase II|not protocol specified|13|||
131623615|NCT01668719|473908533|FG002|Phase II|not protocol specified|7|||
131795927|NCT01656889|474535993|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
131795928|NCT01656889|474535992|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
131795929|NCT01656889|474535993|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
131795930|NCT01656889|474535992|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
131444043|NCT05138653|473255035|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131623616|NCT02060487|473908534|FG000|Overall Study|Other|1|||
131623617|NCT02060487|473908535|FG001|Overall Study|Other|2|||
131623618|NCT02060487|473908536|FG002|Overall Study|Other|1|||
131623619|NCT02060487|473908534|FG000|Overall Study|Lack of Efficacy|0|||
131623620|NCT02060487|473908535|FG001|Overall Study|Lack of Efficacy|1|||
131623621|NCT02060487|473908536|FG002|Overall Study|Lack of Efficacy|0|||
131623622|NCT02060487|473908534|FG000|Overall Study|Withdrawal by Subject|3|||
131623623|NCT02060487|473908535|FG001|Overall Study|Withdrawal by Subject|10|||
131623624|NCT02060487|473908536|FG002|Overall Study|Withdrawal by Subject|4|||
131623625|NCT02060487|473908534|FG000|Overall Study|Study Terminated By Sponsor|87|||
131623626|NCT02060487|473908535|FG001|Overall Study|Study Terminated By Sponsor|89|||
131623627|NCT02060487|473908536|FG002|Overall Study|Study Terminated By Sponsor|100|||
131623628|NCT02060487|473908534|FG000|Overall Study|Randomized in error|1|||
131623629|NCT02060487|473908535|FG001|Overall Study|Randomized in error|0|||
131623630|NCT02060487|473908536|FG002|Overall Study|Randomized in error|0|||
131623631|NCT02060487|473908534|FG000|Overall Study|Protocol Violation|0|||
131623632|NCT02060487|473908535|FG001|Overall Study|Protocol Violation|1|||
131623633|NCT02060487|473908536|FG002|Overall Study|Protocol Violation|1|||
131623634|NCT02060487|473908534|FG000|Overall Study|Lost to Follow-up|3|||
131623635|NCT02060487|473908535|FG001|Overall Study|Lost to Follow-up|0|||
131623636|NCT02060487|473908536|FG002|Overall Study|Lost to Follow-up|2|||
131623637|NCT02060487|473908534|FG000|Overall Study|Death|34|||
131623638|NCT02060487|473908535|FG001|Overall Study|Death|25|||
131623639|NCT02060487|473908536|FG002|Overall Study|Death|19|||
131795931|NCT01656889|474535993|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
131795932|NCT01656889|474535992|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
131795933|NCT01656889|474535993|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
131795934|NCT01656889|474535992|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
131795935|NCT01656889|474535993|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
131795936|NCT01656889|474535992|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
131795937|NCT01656889|474535993|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
131795938|NCT01656889|474535992|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
131795939|NCT01656889|474535993|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
131795940|NCT01656889|474535992|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
131795941|NCT01656889|474535993|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
131795942|NCT02974153|474535994|FG000|Overall Study|Adverse Event|6|||
131795943|NCT02974153|474535995|FG001|Overall Study|Adverse Event|0|||
131795944|NCT02974153|474535996|FG002|Overall Study|Adverse Event|1|||
131795945|NCT02974153|474535994|FG000|Overall Study|Lack of Efficacy|6|||
131795946|NCT02974153|474535995|FG001|Overall Study|Lack of Efficacy|5|||
131795947|NCT02974153|474535996|FG002|Overall Study|Lack of Efficacy|10|||
131795948|NCT02974153|474535994|FG000|Overall Study|Lost to Follow-up|9|||
131795949|NCT02974153|474535995|FG001|Overall Study|Lost to Follow-up|10|||
131795950|NCT02974153|474535996|FG002|Overall Study|Lost to Follow-up|17|||
131795951|NCT02974153|474535994|FG000|Overall Study|Physician Decision|0|||
131795952|NCT02974153|474535995|FG001|Overall Study|Physician Decision|2|||
131795953|NCT02974153|474535996|FG002|Overall Study|Physician Decision|1|||
131795954|NCT02974153|474535994|FG000|Overall Study|Withdrawal by Subject|9|||
131795955|NCT02974153|474535995|FG001|Overall Study|Withdrawal by Subject|16|||
131795956|NCT02974153|474535996|FG002|Overall Study|Withdrawal by Subject|11|||
131795957|NCT02974153|474535994|FG000|Overall Study|Study Burden|8|||
131795958|NCT02974153|474535995|FG001|Overall Study|Study Burden|7|||
131795959|NCT02974153|474535996|FG002|Overall Study|Study Burden|3|||
131795960|NCT02974153|474535994|FG000|Overall Study|Other|14|||
131795961|NCT02974153|474535995|FG001|Overall Study|Other|8|||
131795962|NCT02974153|474535996|FG002|Overall Study|Other|7|||
131795963|NCT02521948|474535997|FG000|Overall Study|Adverse Event|2|||
131795964|NCT02521948|474535997|FG000|Overall Study|Death|4|||
131795965|NCT02521948|474535997|FG000|Overall Study|Lost to Follow-up|1|||
131795966|NCT02521948|474535997|FG000|Overall Study|Did not attend one or both follow-ups|6|||
131795967|NCT02427607|474535998|FG000|Overall Study|Withdrawal by Subject|1|||
131795968|NCT00423800|474535999|FG000|Overall Study|Protocol Violation|0|||
131623640|NCT02060487|473908534|FG000|Overall Study|Adverse Event|0|||
131623641|NCT02060487|473908535|FG001|Overall Study|Adverse Event|0|||
131623642|NCT02060487|473908536|FG002|Overall Study|Adverse Event|1|||
131623643|NCT05484661|473908537|FG000|Overall Study|Withdrawal by Subject|1|||
131623644|NCT05484661|473908538|FG001|Overall Study|Withdrawal by Subject|0|||
131623645|NCT00875706|473908544|FG000|Overall Study|Withdrawal by Subject|1|||
131623646|NCT00875706|473908545|FG001|Overall Study|Withdrawal by Subject|0|||
131623647|NCT00875706|473908546|FG002|Overall Study|Withdrawal by Subject|0|||
131623648|NCT03775213|473908547|FG000|Overall Study|Withdrawal by Subject|51|||
131623649|NCT03775213|473908548|FG001|Overall Study|Withdrawal by Subject|53|||
131623650|NCT03775213|473908547|FG000|Overall Study|Incomplete Survey|7|||
131795969|NCT00423800|474536000|FG001|Overall Study|Protocol Violation|1|||
131623651|NCT03775213|473908548|FG001|Overall Study|Incomplete Survey|7|||
131623652|NCT00786188|473908549|FG000|Overall Study|Adverse Event|3|||
131795970|NCT04000009|474536001|FG000|Overall Study|Adverse Event|13|||
131901044|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901045|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901046|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901047|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901048|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901049|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
131901050|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901051|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901052|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131623653|NCT00786188|473908550|FG001|Overall Study|Adverse Event|1|||
131623654|NCT00786188|473908549|FG000|Overall Study|Withdrawal by Subject|2|||
131623655|NCT00786188|473908550|FG001|Overall Study|Withdrawal by Subject|0|||
131623656|NCT02970318|473908554|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
131623657|NCT02970318|473908555|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
131623658|NCT02970318|473908556|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
131623659|NCT02970318|473908557|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
131623660|NCT02970318|473908554|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
131623661|NCT02970318|473908555|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
131623662|NCT02970318|473908556|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
131623663|NCT02970318|473908557|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
131623664|NCT02970318|473908554|FG000|Overall for Arm A & Main for Arm B|Death|41|||
131623665|NCT02970318|473908555|FG001|Overall for Arm A & Main for Arm B|Death|33|||
131623666|NCT02970318|473908556|FG002|Overall for Arm A & Main for Arm B|Death|0|||
131623667|NCT02970318|473908557|FG003|Overall for Arm A & Main for Arm B|Death|0|||
131623668|NCT02970318|473908554|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
131623669|NCT02970318|473908555|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
131623670|NCT02970318|473908556|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
131623671|NCT02970318|473908557|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
131623672|NCT02970318|473908554|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
131623673|NCT02970318|473908555|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
131623674|NCT02970318|473908556|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
131623675|NCT02970318|473908557|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
131623676|NCT02970318|473908554|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
131623677|NCT02970318|473908555|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
131623678|NCT02970318|473908556|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
131623679|NCT02970318|473908557|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
131623680|NCT02970318|473908554|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
131623681|NCT02970318|473908555|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
131623682|NCT02970318|473908556|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
131623683|NCT02970318|473908557|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
131623684|NCT00824408|473908558|FG000|Run-in Phase|Progressive disease|4|||
131623685|NCT00824408|473908559|FG001|Run-in Phase|Progressive disease|4|||
131623686|NCT00824408|473908560|FG002|Run-in Phase|Progressive disease|0|||
131623687|NCT00824408|473908561|FG003|Run-in Phase|Progressive disease|0|||
131623688|NCT00824408|473908562|FG004|Run-in Phase|Progressive disease|0|||
131623689|NCT00824408|473908558|FG000|Run-in Phase|Adverse Event|1|||
131623690|NCT00824408|473908559|FG001|Run-in Phase|Adverse Event|1|||
131623691|NCT00824408|473908560|FG002|Run-in Phase|Adverse Event|0|||
131623692|NCT00824408|473908561|FG003|Run-in Phase|Adverse Event|0|||
131623693|NCT00824408|473908562|FG004|Run-in Phase|Adverse Event|0|||
131623694|NCT00824408|473908558|FG000|Run-in Phase|Refused to continue medication|1|||
131623695|NCT00824408|473908559|FG001|Run-in Phase|Refused to continue medication|0|||
131623696|NCT00824408|473908560|FG002|Run-in Phase|Refused to continue medication|0|||
131623697|NCT00824408|473908561|FG003|Run-in Phase|Refused to continue medication|0|||
131623698|NCT00824408|473908562|FG004|Run-in Phase|Refused to continue medication|0|||
131623699|NCT00824408|473908558|FG000|Run-in Phase|Other reason not defined above|0|||
131623700|NCT00824408|473908559|FG001|Run-in Phase|Other reason not defined above|1|||
131623701|NCT00824408|473908560|FG002|Run-in Phase|Other reason not defined above|0|||
131623702|NCT00824408|473908561|FG003|Run-in Phase|Other reason not defined above|0|||
131623703|NCT00824408|473908562|FG004|Run-in Phase|Other reason not defined above|0|||
131623704|NCT00824408|473908558|FG000|Randomized Phase|Not treated|0|||
131711029|NCT02901431|474219708|FG001|Main Treatment Part|Lost to Follow-up|0|||
131711030|NCT02901431|474219709|FG002|Main Treatment Part|Lost to Follow-up|0|||
131711031|NCT02901431|474219710|FG003|Main Treatment Part|Lost to Follow-up|3|||
131711032|NCT02901431|474219711|FG004|Main Treatment Part|Lost to Follow-up|1|||
131711033|NCT02901431|474219712|FG005|Main Treatment Part|Lost to Follow-up|2|||
131711034|NCT02901431|474219713|FG006|Main Treatment Part|Lost to Follow-up|3|||
131711035|NCT02901431|474219714|FG007|Main Treatment Part|Lost to Follow-up|0|||
131711036|NCT02901431|474219715|FG008|Main Treatment Part|Lost to Follow-up|0|||
131711037|NCT02901431|474219716|FG009|Main Treatment Part|Lost to Follow-up|0|||
131444044|NCT05138653|473255036|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444045|NCT05138653|473255037|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444046|NCT05138653|473255038|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
131444047|NCT05138653|473255023|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131444048|NCT05138653|473255024|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
131444049|NCT05138653|473255025|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131444050|NCT05138653|473255026|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131444051|NCT05138653|473255027|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
131444052|NCT05138653|473255028|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131711038|NCT02901431|474219717|FG010|Main Treatment Part|Lost to Follow-up|0|||
131711039|NCT02901431|474219718|FG011|Main Treatment Part|Lost to Follow-up|0|||
131711040|NCT02901431|474219719|FG012|Main Treatment Part|Lost to Follow-up|0|||
131711041|NCT02901431|474219707|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
131711042|NCT02901431|474219708|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
131711043|NCT02901431|474219709|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
131711044|NCT02901431|474219710|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
131711045|NCT02901431|474219711|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
131711046|NCT02901431|474219712|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
131711047|NCT02901431|474219713|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
131711048|NCT02901431|474219714|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
131711049|NCT02901431|474219715|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
131711050|NCT02901431|474219716|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
131711051|NCT02901431|474219717|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
131711052|NCT02901431|474219718|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
131711053|NCT02901431|474219719|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
131711054|NCT02901431|474219707|FG000|Main Treatment Part|Physician Decision|0|||
131711055|NCT02901431|474219708|FG001|Main Treatment Part|Physician Decision|0|||
131711056|NCT02901431|474219709|FG002|Main Treatment Part|Physician Decision|0|||
131711057|NCT02901431|474219710|FG003|Main Treatment Part|Physician Decision|1|||
131711058|NCT02901431|474219711|FG004|Main Treatment Part|Physician Decision|0|||
131711059|NCT02901431|474219712|FG005|Main Treatment Part|Physician Decision|0|||
131711060|NCT02901431|474219713|FG006|Main Treatment Part|Physician Decision|1|||
131711061|NCT02901431|474219714|FG007|Main Treatment Part|Physician Decision|0|||
131711062|NCT02901431|474219715|FG008|Main Treatment Part|Physician Decision|0|||
131711063|NCT02901431|474219716|FG009|Main Treatment Part|Physician Decision|0|||
131711064|NCT02901431|474219717|FG010|Main Treatment Part|Physician Decision|0|||
131795971|NCT04000009|474536001|FG000|Overall Study|Lack of Efficacy|7|||
131795972|NCT04000009|474536001|FG000|Overall Study|Lost to Follow-up|8|||
131795973|NCT04000009|474536001|FG000|Overall Study|Noncompliance with study drug|4|||
131795974|NCT04000009|474536001|FG000|Overall Study|Physician Decision|1|||
131795975|NCT04000009|474536001|FG000|Overall Study|Use of prohibited medication|3|||
131795976|NCT04000009|474536001|FG000|Overall Study|Pregnancy|1|||
131795977|NCT04000009|474536001|FG000|Overall Study|Withdrawal by Subject|22|||
131795978|NCT04000009|474536001|FG000|Overall Study|Study terminated by sponsor|98|||
131795979|NCT04000009|474536001|FG000|Overall Study|Not further specified|8|||
131795980|NCT00679783|474536003|FG000|Overall Study|Adverse Event|0|||
131795981|NCT00679783|474536004|FG001|Overall Study|Adverse Event|0|||
131795982|NCT00679783|474536005|FG002|Overall Study|Adverse Event|0|||
131795983|NCT00679783|474536006|FG003|Overall Study|Adverse Event|3|||
131795984|NCT00679783|474536007|FG004|Overall Study|Adverse Event|0|||
131795985|NCT00679783|474536008|FG005|Overall Study|Adverse Event|0|||
131795986|NCT00679783|474536009|FG006|Overall Study|Adverse Event|1|||
131795987|NCT00679783|474536003|FG000|Overall Study|Lack of Efficacy|0|||
131795988|NCT00679783|474536004|FG001|Overall Study|Lack of Efficacy|1|||
131795989|NCT00679783|474536005|FG002|Overall Study|Lack of Efficacy|0|||
131795990|NCT00679783|474536006|FG003|Overall Study|Lack of Efficacy|2|||
131795991|NCT00679783|474536007|FG004|Overall Study|Lack of Efficacy|0|||
131795992|NCT00679783|474536008|FG005|Overall Study|Lack of Efficacy|0|||
131795993|NCT00679783|474536009|FG006|Overall Study|Lack of Efficacy|0|||
131795994|NCT00679783|474536003|FG000|Overall Study|Withdrawal by Subject|0|||
131795995|NCT00679783|474536004|FG001|Overall Study|Withdrawal by Subject|0|||
131795996|NCT00679783|474536005|FG002|Overall Study|Withdrawal by Subject|1|||
131795997|NCT00679783|474536006|FG003|Overall Study|Withdrawal by Subject|1|||
131623705|NCT00824408|473908559|FG001|Randomized Phase|Not treated|0|||
131623706|NCT00824408|473908560|FG002|Randomized Phase|Not treated|1|||
131623707|NCT00824408|473908561|FG003|Randomized Phase|Not treated|1|||
131623708|NCT00824408|473908562|FG004|Randomized Phase|Not treated|1|||
131623709|NCT00824408|473908558|FG000|Randomized Phase|Progressive disease|0|||
131623710|NCT00824408|473908559|FG001|Randomized Phase|Progressive disease|0|||
131623711|NCT00824408|473908560|FG002|Randomized Phase|Progressive disease|25|||
131623712|NCT00824408|473908561|FG003|Randomized Phase|Progressive disease|36|||
131623713|NCT00824408|473908562|FG004|Randomized Phase|Progressive disease|34|||
131623714|NCT00824408|473908558|FG000|Randomized Phase|Adverse Event|0|||
131623715|NCT00824408|473908559|FG001|Randomized Phase|Adverse Event|0|||
131623716|NCT00824408|473908560|FG002|Randomized Phase|Adverse Event|4|||
131623717|NCT00824408|473908561|FG003|Randomized Phase|Adverse Event|5|||
131623718|NCT00824408|473908562|FG004|Randomized Phase|Adverse Event|5|||
131623719|NCT00824408|473908558|FG000|Randomized Phase|Refused to continue medication|0|||
131623720|NCT00824408|473908559|FG001|Randomized Phase|Refused to continue medication|0|||
131623721|NCT00824408|473908560|FG002|Randomized Phase|Refused to continue medication|2|||
131623722|NCT00824408|473908561|FG003|Randomized Phase|Refused to continue medication|2|||
131623723|NCT00824408|473908562|FG004|Randomized Phase|Refused to continue medication|2|||
131711065|NCT02901431|474219718|FG011|Main Treatment Part|Physician Decision|0|||
131711066|NCT02901431|474219719|FG012|Main Treatment Part|Physician Decision|0|||
131711067|NCT02901431|474219707|FG000|Main Treatment Part|Withdrawal by Subject|0|||
131711068|NCT02901431|474219708|FG001|Main Treatment Part|Withdrawal by Subject|0|||
131711069|NCT02901431|474219709|FG002|Main Treatment Part|Withdrawal by Subject|0|||
131711070|NCT02901431|474219710|FG003|Main Treatment Part|Withdrawal by Subject|18|||
131711071|NCT02901431|474219711|FG004|Main Treatment Part|Withdrawal by Subject|3|||
131711072|NCT02901431|474219712|FG005|Main Treatment Part|Withdrawal by Subject|5|||
131711073|NCT02901431|474219713|FG006|Main Treatment Part|Withdrawal by Subject|6|||
131711074|NCT02901431|474219714|FG007|Main Treatment Part|Withdrawal by Subject|0|||
131711075|NCT02901431|474219715|FG008|Main Treatment Part|Withdrawal by Subject|0|||
131711076|NCT02901431|474219716|FG009|Main Treatment Part|Withdrawal by Subject|0|||
131711077|NCT02901431|474219717|FG010|Main Treatment Part|Withdrawal by Subject|0|||
131711078|NCT02901431|474219718|FG011|Main Treatment Part|Withdrawal by Subject|0|||
131711079|NCT02901431|474219719|FG012|Main Treatment Part|Withdrawal by Subject|0|||
131711080|NCT02901431|474219707|FG000|Open Label Part|Adverse Event|0|||
131711081|NCT02901431|474219708|FG001|Open Label Part|Adverse Event|0|||
131711082|NCT02901431|474219709|FG002|Open Label Part|Adverse Event|0|||
131711083|NCT02901431|474219710|FG003|Open Label Part|Adverse Event|0|||
131711084|NCT02901431|474219711|FG004|Open Label Part|Adverse Event|0|||
131711085|NCT02901431|474219712|FG005|Open Label Part|Adverse Event|0|||
131711086|NCT02901431|474219713|FG006|Open Label Part|Adverse Event|0|||
131711087|NCT02901431|474219714|FG007|Open Label Part|Adverse Event|0|||
131711088|NCT02901431|474219715|FG008|Open Label Part|Adverse Event|4|||
131711089|NCT02901431|474219716|FG009|Open Label Part|Adverse Event|4|||
131711090|NCT02901431|474219717|FG010|Open Label Part|Adverse Event|0|||
131711091|NCT02901431|474219718|FG011|Open Label Part|Adverse Event|4|||
131711092|NCT02901431|474219719|FG012|Open Label Part|Adverse Event|1|||
131711093|NCT02901431|474219707|FG000|Open Label Part|Lost to Follow-up|0|||
131711094|NCT02901431|474219708|FG001|Open Label Part|Lost to Follow-up|0|||
131711095|NCT02901431|474219709|FG002|Open Label Part|Lost to Follow-up|0|||
131711096|NCT02901431|474219710|FG003|Open Label Part|Lost to Follow-up|0|||
131711097|NCT02901431|474219711|FG004|Open Label Part|Lost to Follow-up|0|||
131711098|NCT02901431|474219712|FG005|Open Label Part|Lost to Follow-up|0|||
131711099|NCT02901431|474219713|FG006|Open Label Part|Lost to Follow-up|0|||
131711100|NCT02901431|474219714|FG007|Open Label Part|Lost to Follow-up|0|||
131711101|NCT02901431|474219715|FG008|Open Label Part|Lost to Follow-up|2|||
131711102|NCT02901431|474219716|FG009|Open Label Part|Lost to Follow-up|2|||
131711103|NCT02901431|474219717|FG010|Open Label Part|Lost to Follow-up|1|||
131711104|NCT02901431|474219718|FG011|Open Label Part|Lost to Follow-up|1|||
131711105|NCT02901431|474219719|FG012|Open Label Part|Lost to Follow-up|1|||
131711106|NCT02901431|474219707|FG000|Open Label Part|Physician Decision|0|||
131711107|NCT02901431|474219708|FG001|Open Label Part|Physician Decision|0|||
131711108|NCT02901431|474219709|FG002|Open Label Part|Physician Decision|0|||
131711109|NCT02901431|474219710|FG003|Open Label Part|Physician Decision|0|||
131711110|NCT02901431|474219711|FG004|Open Label Part|Physician Decision|0|||
131623724|NCT00824408|473908558|FG000|Randomized Phase|Other reason not defined above|0|||
131623725|NCT00824408|473908559|FG001|Randomized Phase|Other reason not defined above|0|||
131623726|NCT00824408|473908560|FG002|Randomized Phase|Other reason not defined above|4|||
131623727|NCT00824408|473908561|FG003|Randomized Phase|Other reason not defined above|2|||
131711111|NCT02901431|474219712|FG005|Open Label Part|Physician Decision|0|||
131711112|NCT02901431|474219713|FG006|Open Label Part|Physician Decision|0|||
131711113|NCT02901431|474219714|FG007|Open Label Part|Physician Decision|0|||
131711114|NCT02901431|474219715|FG008|Open Label Part|Physician Decision|1|||
131711115|NCT02901431|474219716|FG009|Open Label Part|Physician Decision|1|||
131711116|NCT02901431|474219717|FG010|Open Label Part|Physician Decision|0|||
131711117|NCT02901431|474219718|FG011|Open Label Part|Physician Decision|0|||
131711118|NCT02901431|474219719|FG012|Open Label Part|Physician Decision|0|||
131623728|NCT00824408|473908562|FG004|Randomized Phase|Other reason not defined above|4|||
131623729|NCT01668355|473910622|FG000|Overall Study|Death|3|||
131623730|NCT01668355|473910623|FG001|Overall Study|Death|1|||
131623731|NCT01668355|473910622|FG000|Overall Study|Withdrawal by Subject|6|||
131623732|NCT01668355|473910623|FG001|Overall Study|Withdrawal by Subject|1|||
131623733|NCT00535626|473910624|FG000|Overall Study|Death|15|||
131623734|NCT00535626|473910624|FG000|Overall Study|Lost to Follow-up|29|||
131623735|NCT00535626|473910624|FG000|Overall Study|Withdrawal by Subject|20|||
131623736|NCT00535626|473910624|FG000|Overall Study|Removal/revision of study component|8|||
131623737|NCT00535626|473910624|FG000|Overall Study|Subject terminated|31|||
131623738|NCT00535626|473910624|FG000|Overall Study|Unable to return|2|||
131623739|NCT01277302|473910625|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
131623740|NCT01277302|473910626|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
131623741|NCT01277302|473910627|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
131623742|NCT01277302|473910625|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
131623743|NCT01277302|473910626|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
131623744|NCT01277302|473910627|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
131623745|NCT01277302|473910625|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
131623746|NCT01277302|473910626|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
131623747|NCT01277302|473910627|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
131623748|NCT01277302|473910625|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
131623749|NCT01277302|473910626|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
131623750|NCT01277302|473910627|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
131623751|NCT01277302|473910625|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
131623752|NCT01277302|473910626|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
131623753|NCT01277302|473910627|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
131623754|NCT01277302|473910625|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
131623755|NCT01277302|473910626|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
131623756|NCT01277302|473910627|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
131623757|NCT01277302|473910625|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
131623758|NCT01277302|473910626|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
131623759|NCT01277302|473910627|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
131623760|NCT01277302|473910625|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
131623761|NCT01277302|473910626|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
131623762|NCT01277302|473910627|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
131623763|NCT01277302|473910625|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
131623764|NCT01277302|473910626|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
131623765|NCT01277302|473910627|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
131623766|NCT02710669|473910628|FG000|Overall Study|Physician Decision|2|||
131623767|NCT02710669|473910629|FG001|Overall Study|Physician Decision|1|||
131623768|NCT02710669|473910630|FG002|Overall Study|Physician Decision|0|||
131623769|NCT02710669|473910628|FG000|Overall Study|Institutional delays (including COVID)|2|||
131623770|NCT02710669|473910629|FG001|Overall Study|Institutional delays (including COVID)|2|||
131711119|NCT02901431|474219707|FG000|Open Label Part|Study Terminated By Sponsor|0|||
131795998|NCT00679783|474536007|FG004|Overall Study|Withdrawal by Subject|0|||
131795999|NCT00679783|474536008|FG005|Overall Study|Withdrawal by Subject|0|||
131796000|NCT00679783|474536009|FG006|Overall Study|Withdrawal by Subject|0|||
131796001|NCT00679783|474536003|FG000|Overall Study|Not Captured|0|||
131796002|NCT00679783|474536004|FG001|Overall Study|Not Captured|0|||
131796003|NCT00679783|474536005|FG002|Overall Study|Not Captured|0|||
131796004|NCT00679783|474536006|FG003|Overall Study|Not Captured|5|||
131796005|NCT00679783|474536007|FG004|Overall Study|Not Captured|0|||
131901053|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901054|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131623771|NCT02710669|473910630|FG002|Overall Study|Institutional delays (including COVID)|0|||
131711120|NCT02901431|474219708|FG001|Open Label Part|Study Terminated By Sponsor|0|||
131711121|NCT02901431|474219709|FG002|Open Label Part|Study Terminated By Sponsor|0|||
131711122|NCT02901431|474219710|FG003|Open Label Part|Study Terminated By Sponsor|0|||
131711123|NCT02901431|474219711|FG004|Open Label Part|Study Terminated By Sponsor|0|||
131711124|NCT02901431|474219712|FG005|Open Label Part|Study Terminated By Sponsor|0|||
131711125|NCT02901431|474219713|FG006|Open Label Part|Study Terminated By Sponsor|0|||
131711126|NCT02901431|474219714|FG007|Open Label Part|Study Terminated By Sponsor|0|||
131623772|NCT02710669|473910628|FG000|Overall Study|arrived in afib/aflutter|10|||
131623773|NCT02710669|473910629|FG001|Overall Study|arrived in afib/aflutter|8|||
131623774|NCT02710669|473910630|FG002|Overall Study|arrived in afib/aflutter|2|||
131623775|NCT01190124|473910633|FG000|Overall Study|Death|3|||
131623776|NCT01190124|473910634|FG001|Overall Study|Death|0|||
131796006|NCT00679783|474536008|FG005|Overall Study|Not Captured|0|||
131796007|NCT00679783|474536009|FG006|Overall Study|Not Captured|0|||
131711127|NCT02901431|474219715|FG008|Open Label Part|Study Terminated By Sponsor|35|||
131711128|NCT02901431|474219716|FG009|Open Label Part|Study Terminated By Sponsor|12|||
131711129|NCT02901431|474219717|FG010|Open Label Part|Study Terminated By Sponsor|21|||
131711130|NCT02901431|474219718|FG011|Open Label Part|Study Terminated By Sponsor|31|||
131711131|NCT02901431|474219719|FG012|Open Label Part|Study Terminated By Sponsor|0|||
131711132|NCT02901431|474219707|FG000|Open Label Part|Withdrawal by Subject|0|||
131711133|NCT02901431|474219708|FG001|Open Label Part|Withdrawal by Subject|0|||
131711134|NCT02901431|474219709|FG002|Open Label Part|Withdrawal by Subject|0|||
131711135|NCT02901431|474219710|FG003|Open Label Part|Withdrawal by Subject|0|||
131711136|NCT02901431|474219711|FG004|Open Label Part|Withdrawal by Subject|0|||
131711137|NCT02901431|474219712|FG005|Open Label Part|Withdrawal by Subject|0|||
131711138|NCT02901431|474219713|FG006|Open Label Part|Withdrawal by Subject|0|||
131711139|NCT02901431|474219714|FG007|Open Label Part|Withdrawal by Subject|0|||
131711140|NCT02901431|474219715|FG008|Open Label Part|Withdrawal by Subject|6|||
131711141|NCT02901431|474219716|FG009|Open Label Part|Withdrawal by Subject|5|||
131711142|NCT02901431|474219717|FG010|Open Label Part|Withdrawal by Subject|7|||
131711143|NCT02901431|474219718|FG011|Open Label Part|Withdrawal by Subject|3|||
131711144|NCT02901431|474219719|FG012|Open Label Part|Withdrawal by Subject|1|||
131711145|NCT01889602|474219720|FG000|First Intervention|Adverse Event|1|||
131711146|NCT01889602|474219721|FG001|First Intervention|Adverse Event|1|||
131711147|NCT01889602|474219722|FG002|First Intervention|Adverse Event|1|||
131711148|NCT01889602|474219720|FG000|First Intervention|Protocol Violation|0|||
131711149|NCT01889602|474219721|FG001|First Intervention|Protocol Violation|1|||
131711150|NCT01889602|474219722|FG002|First Intervention|Protocol Violation|1|||
131711151|NCT01889602|474219720|FG000|First Intervention|Study ending|0|||
131711152|NCT01889602|474219721|FG001|First Intervention|Study ending|1|||
131711153|NCT01889602|474219722|FG002|First Intervention|Study ending|0|||
131711154|NCT01889602|474219720|FG000|Second Intervention|Adverse Event|0|||
131711155|NCT01889602|474219721|FG001|Second Intervention|Adverse Event|0|||
131711156|NCT01889602|474219722|FG002|Second Intervention|Adverse Event|1|||
131711157|NCT01889602|474219720|FG000|Second Intervention|Study ending|1|||
131711158|NCT01889602|474219721|FG001|Second Intervention|Study ending|0|||
131711159|NCT01889602|474219722|FG002|Second Intervention|Study ending|0|||
131711160|NCT01889602|474219720|FG000|Second Intervention|Withdrawal by Subject|0|||
131711161|NCT01889602|474219721|FG001|Second Intervention|Withdrawal by Subject|0|||
131711162|NCT01889602|474219722|FG002|Second Intervention|Withdrawal by Subject|1|||
131711163|NCT01889602|474219720|FG000|Third Intervention|Protocol Violation|1|||
131901055|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901056|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131901057|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131711164|NCT01889602|474219721|FG001|Third Intervention|Protocol Violation|0|||
131711165|NCT01889602|474219722|FG002|Third Intervention|Protocol Violation|0|||
131711166|NCT01889602|474219720|FG000|Third Intervention|Withdrawal by Subject|2|||
131711167|NCT01889602|474219721|FG001|Third Intervention|Withdrawal by Subject|2|||
131711168|NCT01889602|474219722|FG002|Third Intervention|Withdrawal by Subject|0|||
131711169|NCT00591734|474219725|FG000|Overall Study|Lack of Efficacy|35|||
131711170|NCT00591734|474219725|FG000|Overall Study|Adverse Event|5|||
131711171|NCT00591734|474219725|FG000|Overall Study|Physician Decision|5|||
131711172|NCT00591734|474219725|FG000|Overall Study|Intercurrent Illness|8|||
131623777|NCT01190124|473910635|FG002|Overall Study|Death|0|||
131623778|NCT01190124|473910633|FG000|Overall Study|Therapeutic Failure|12|||
131623779|NCT01190124|473910634|FG001|Overall Study|Therapeutic Failure|0|||
131623780|NCT01190124|473910635|FG002|Overall Study|Therapeutic Failure|1|||
131623781|NCT01190124|473910633|FG000|Overall Study|Lost to Follow-up|2|||
131623782|NCT01190124|473910634|FG001|Overall Study|Lost to Follow-up|0|||
131623783|NCT01190124|473910635|FG002|Overall Study|Lost to Follow-up|0|||
131623784|NCT00070707|473910636|FG000|Overall Study|Adverse Event|1|||
131623785|NCT00070707|473910637|FG001|Overall Study|Adverse Event|2|||
131623786|NCT00070707|473910636|FG000|Overall Study|Lack of Efficacy|4|||
131623787|NCT00070707|473910637|FG001|Overall Study|Lack of Efficacy|1|||
131623788|NCT00070707|473910636|FG000|Overall Study|Protocol Violation|8|||
131711173|NCT04672083|474219726|FG000|Overall Study|Lost to Follow-up|1|||
131711174|NCT04672083|474219727|FG001|Overall Study|Lost to Follow-up|0|||
131711175|NCT04672083|474219728|FG002|Overall Study|Lost to Follow-up|0|||
131711176|NCT04672083|474219729|FG003|Overall Study|Lost to Follow-up|0|||
131711177|NCT04672083|474219730|FG004|Overall Study|Lost to Follow-up|0|||
131711178|NCT01661790|474219731|FG000|Overall Study|Lost to Follow-up|0|||
131711179|NCT01661790|474219732|FG001|Overall Study|Lost to Follow-up|2|||
131711180|NCT02048904|474219733|FG000|Overall Study|Withdrawal by Subject|7|||
131711181|NCT02048904|474219733|FG000|Overall Study|Physician Decision|70|||
131711182|NCT04752384|474219734|FG000|Overall Study|Withdrawal by Subject|1|||
131711183|NCT04752384|474219734|FG000|Overall Study|Death|1|||
131711184|NCT00891202|474219742|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
131711185|NCT00891202|474219743|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
131711186|NCT00891202|474219744|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
131711187|NCT00891202|474219745|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
131711188|NCT00891202|474219742|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
131711189|NCT00891202|474219743|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
131711190|NCT00891202|474219744|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
131711191|NCT00891202|474219745|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
131711192|NCT00891202|474219742|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
131711193|NCT00891202|474219743|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
131711194|NCT00891202|474219744|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
131711195|NCT00891202|474219745|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
131711196|NCT00891202|474219742|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
131711197|NCT00891202|474219743|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
131711198|NCT00891202|474219744|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
131711199|NCT00891202|474219745|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
131711200|NCT01291017|474219747|FG000|Overall Study|Lost to Follow-up|2|||
131711201|NCT01291017|474219747|FG000|Overall Study|Withdrawal by Subject|3|||
131711202|NCT04980391|474219748|FG000|Overall Study|Death|0|||
131711203|NCT04980391|474219749|FG001|Overall Study|Death|0|||
131711204|NCT04980391|474219750|FG002|Overall Study|Death|1|||
131711205|NCT04980391|474219751|FG003|Overall Study|Death|1|||
131711206|NCT04980391|474219748|FG000|Overall Study|Lost to Follow-up|3|||
131711207|NCT04980391|474219749|FG001|Overall Study|Lost to Follow-up|3|||
131623789|NCT00070707|473910637|FG001|Overall Study|Protocol Violation|4|||
131623790|NCT00070707|473910636|FG000|Overall Study|Unrelated to Study Medication|1|||
131623791|NCT00070707|473910637|FG001|Overall Study|Unrelated to Study Medication|0|||
131623792|NCT02002689|473910642|FG000|Overall Study|Disease Progression|7|||
131623793|NCT02002689|473910642|FG000|Overall Study|Adverse Event|3|||
131623794|NCT01128959|473910645|FG000|Lead in Period|Adverse Event|3|||
131623795|NCT01128959|473910645|FG000|Treatment Period|Adverse Event|3|||
131623796|NCT01128959|473910645|FG000|Treatment Period|Withdrawal by Subject|1|||
131623797|NCT02338999|473910646|FG000|First Intervention|Withdrawal by Subject|3|||
131623798|NCT02338999|473910647|FG001|First Intervention|Withdrawal by Subject|1|||
131623799|NCT02338999|473910646|FG000|Washout Period|Withdrawal by Subject|0|||
131623800|NCT02338999|473910647|FG001|Washout Period|Withdrawal by Subject|2|||
131623801|NCT02338999|473910646|FG000|Second Intervention|Withdrawal by Subject|0|||
131623802|NCT02338999|473910647|FG001|Second Intervention|Withdrawal by Subject|2|||
131623803|NCT02701296|473910648|FG000|Overall Study|Incomplete Data|0|||
131623804|NCT02701296|473910649|FG001|Overall Study|Incomplete Data|2|||
131623805|NCT00569166|473910650|FG000|Overall Study|Withdrawal by Subject|7|||
131796008|NCT00679783|474536003|FG000|Overall Study|Ongoing at data cut-off|2|||
131796009|NCT00679783|474536004|FG001|Overall Study|Ongoing at data cut-off|2|||
131796010|NCT00679783|474536005|FG002|Overall Study|Ongoing at data cut-off|0|||
131796011|NCT00679783|474536006|FG003|Overall Study|Ongoing at data cut-off|9|||
131796012|NCT00679783|474536007|FG004|Overall Study|Ongoing at data cut-off|1|||
131796013|NCT00679783|474536008|FG005|Overall Study|Ongoing at data cut-off|0|||
131796014|NCT00679783|474536009|FG006|Overall Study|Ongoing at data cut-off|0|||
131796015|NCT01754259|474536012|FG000|Overall Study|Withdrawal by Subject|2|||
131796016|NCT01754259|474536013|FG001|Overall Study|Withdrawal by Subject|4|||
131796017|NCT01754259|474536012|FG000|Overall Study|Adverse Event|3|||
131796018|NCT01754259|474536013|FG001|Overall Study|Adverse Event|1|||
131796019|NCT01754259|474536012|FG000|Overall Study|Lost to Follow-up|0|||
131796020|NCT01754259|474536013|FG001|Overall Study|Lost to Follow-up|1|||
131796021|NCT00814320|474536014|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
131796022|NCT00814320|474536015|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
131796023|NCT00814320|474536014|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
131796024|NCT00814320|474536015|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
131796025|NCT00814320|474536014|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
131796026|NCT00814320|474536015|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
131796027|NCT00814320|474536014|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
131796028|NCT00814320|474536015|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
131796029|NCT00814320|474536014|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
131796030|NCT00814320|474536015|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
131444053|NCT05138653|473255029|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131623806|NCT00569166|473910651|FG001|Overall Study|Withdrawal by Subject|5|||
131623807|NCT00569166|473910652|FG002|Overall Study|Withdrawal by Subject|3|||
131623808|NCT00569166|473910650|FG000|Overall Study|Lost to Follow-up|2|||
131623809|NCT00569166|473910651|FG001|Overall Study|Lost to Follow-up|1|||
131623810|NCT00569166|473910652|FG002|Overall Study|Lost to Follow-up|1|||
131623811|NCT05005247|473910653|FG000|Overall Study|Withdrawal by Subject|0|||
131623812|NCT05005247|473910654|FG001|Overall Study|Withdrawal by Subject|1|||
131623813|NCT05005247|473910655|FG002|Overall Study|Withdrawal by Subject|0|||
131623814|NCT03142932|473910656|FG000|Overall Study|Lost to Follow-up|2|||
131623815|NCT03142932|473910657|FG001|Overall Study|Lost to Follow-up|11|||
131623816|NCT00624377|473910658|FG000|Overall Study|Lost to Follow-up|355|||
131623817|NCT00624377|473910658|FG000|Overall Study|Withdrawal by Subject|100|||
131623818|NCT00624377|473910658|FG000|Overall Study|Adverse Event|14|||
131623819|NCT00624377|473910658|FG000|Overall Study|Other|91|||
131623820|NCT00624377|473910658|FG000|Overall Study|Non-evaluable population|84|||
131623821|NCT00923078|473910659|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
131623822|NCT00923078|473910660|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
131623823|NCT00923078|473910661|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
131623824|NCT00923078|473910659|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
131623825|NCT00923078|473910660|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
131623826|NCT00923078|473910661|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
131623827|NCT02404441|473910678|FG000|Phase 1 Part|Adverse Event|1|||
131623828|NCT02404441|473910679|FG001|Phase 1 Part|Adverse Event|0|||
131623829|NCT02404441|473910680|FG002|Phase 1 Part|Adverse Event|0|||
131623830|NCT02404441|473910681|FG003|Phase 1 Part|Adverse Event|0|||
131623831|NCT02404441|473910682|FG004|Phase 1 Part|Adverse Event|0|||
131623832|NCT02404441|473910683|FG005|Phase 1 Part|Adverse Event|0|||
131623833|NCT02404441|473910684|FG006|Phase 1 Part|Adverse Event|0|||
131623834|NCT02404441|473910685|FG007|Phase 1 Part|Adverse Event|0|||
131623835|NCT02404441|473910686|FG008|Phase 1 Part|Adverse Event|0|||
131796031|NCT00814320|474536014|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
131796032|NCT00814320|474536015|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
131796033|NCT00814320|474536014|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
131623836|NCT02404441|473910687|FG009|Phase 1 Part|Adverse Event|0|||
131623837|NCT02404441|473910678|FG000|Phase 1 Part|Physician Decision|0|||
131623838|NCT02404441|473910679|FG001|Phase 1 Part|Physician Decision|1|||
131623839|NCT02404441|473910680|FG002|Phase 1 Part|Physician Decision|0|||
131711208|NCT04980391|474219750|FG002|Overall Study|Lost to Follow-up|2|||
131711209|NCT04980391|474219751|FG003|Overall Study|Lost to Follow-up|3|||
131711210|NCT04980391|474219748|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
131711211|NCT04980391|474219749|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
131711212|NCT04980391|474219750|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
131711213|NCT04980391|474219751|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
131711214|NCT04980391|474219748|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131711215|NCT04980391|474219749|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131711216|NCT04980391|474219750|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131711217|NCT04980391|474219751|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131711218|NCT04980391|474219748|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
131711219|NCT04980391|474219749|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
131711220|NCT04980391|474219750|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
131711221|NCT04980391|474219751|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
131623840|NCT02404441|473910681|FG003|Phase 1 Part|Physician Decision|0|||
131623841|NCT02404441|473910682|FG004|Phase 1 Part|Physician Decision|0|||
131623842|NCT02404441|473910683|FG005|Phase 1 Part|Physician Decision|0|||
131623843|NCT02404441|473910684|FG006|Phase 1 Part|Physician Decision|0|||
131623844|NCT02404441|473910685|FG007|Phase 1 Part|Physician Decision|0|||
131623845|NCT02404441|473910686|FG008|Phase 1 Part|Physician Decision|0|||
131623846|NCT02404441|473910687|FG009|Phase 1 Part|Physician Decision|0|||
131623847|NCT02404441|473910678|FG000|Phase 1 Part|Progressive Disease|14|||
131623848|NCT02404441|473910679|FG001|Phase 1 Part|Progressive Disease|11|||
131623849|NCT02404441|473910680|FG002|Phase 1 Part|Progressive Disease|7|||
131623850|NCT02404441|473910681|FG003|Phase 1 Part|Progressive Disease|6|||
131623851|NCT02404441|473910682|FG004|Phase 1 Part|Progressive Disease|9|||
131623852|NCT02404441|473910683|FG005|Phase 1 Part|Progressive Disease|0|||
131623853|NCT02404441|473910684|FG006|Phase 1 Part|Progressive Disease|0|||
131623854|NCT02404441|473910685|FG007|Phase 1 Part|Progressive Disease|0|||
131623855|NCT02404441|473910686|FG008|Phase 1 Part|Progressive Disease|0|||
131623856|NCT02404441|473910687|FG009|Phase 1 Part|Progressive Disease|0|||
131623857|NCT02404441|473910678|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
131623858|NCT02404441|473910679|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
131623859|NCT02404441|473910680|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
131623860|NCT02404441|473910681|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
131623861|NCT02404441|473910682|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
131623862|NCT02404441|473910683|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
131623863|NCT02404441|473910684|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
131623864|NCT02404441|473910685|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
131623865|NCT02404441|473910686|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
131623866|NCT02404441|473910687|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
131623867|NCT02404441|473910678|FG000|Phase 1 Part|Death|1|||
131623868|NCT02404441|473910679|FG001|Phase 1 Part|Death|1|||
131623869|NCT02404441|473910680|FG002|Phase 1 Part|Death|1|||
131623870|NCT02404441|473910681|FG003|Phase 1 Part|Death|0|||
131623871|NCT02404441|473910682|FG004|Phase 1 Part|Death|1|||
131623872|NCT02404441|473910683|FG005|Phase 1 Part|Death|0|||
131623873|NCT02404441|473910684|FG006|Phase 1 Part|Death|0|||
131711222|NCT03690869|474219752|FG000|Overall Study|Adverse Event|0|||
131711223|NCT03690869|474219753|FG001|Overall Study|Adverse Event|0|||
131711224|NCT03690869|474219754|FG002|Overall Study|Adverse Event|0|||
131711225|NCT03690869|474219755|FG003|Overall Study|Adverse Event|1|||
131711226|NCT03690869|474219756|FG004|Overall Study|Adverse Event|0|||
131711227|NCT03690869|474219757|FG005|Overall Study|Adverse Event|0|||
131711228|NCT03690869|474219758|FG006|Overall Study|Adverse Event|0|||
131711229|NCT03690869|474219759|FG007|Overall Study|Adverse Event|1|||
131711230|NCT03690869|474219760|FG008|Overall Study|Adverse Event|0|||
131711231|NCT03690869|474219761|FG009|Overall Study|Adverse Event|1|||
131711232|NCT03690869|474219752|FG000|Overall Study|Death|1|||
131711233|NCT03690869|474219753|FG001|Overall Study|Death|1|||
131711234|NCT03690869|474219754|FG002|Overall Study|Death|1|||
131711235|NCT03690869|474219755|FG003|Overall Study|Death|4|||
131711236|NCT03690869|474219756|FG004|Overall Study|Death|2|||
131711237|NCT03690869|474219757|FG005|Overall Study|Death|5|||
131711238|NCT03690869|474219758|FG006|Overall Study|Death|3|||
131711239|NCT03690869|474219759|FG007|Overall Study|Death|2|||
131711240|NCT03690869|474219760|FG008|Overall Study|Death|0|||
131711241|NCT03690869|474219761|FG009|Overall Study|Death|3|||
131711242|NCT03690869|474219752|FG000|Overall Study|Lost to Follow-up|0|||
131711243|NCT03690869|474219753|FG001|Overall Study|Lost to Follow-up|0|||
131711244|NCT03690869|474219754|FG002|Overall Study|Lost to Follow-up|1|||
131623874|NCT02404441|473910685|FG007|Phase 1 Part|Death|0|||
131623875|NCT02404441|473910686|FG008|Phase 1 Part|Death|0|||
131623876|NCT02404441|473910687|FG009|Phase 1 Part|Death|0|||
131623877|NCT02404441|473910678|FG000|Phase 2 Part|Adverse Event|0|||
131623878|NCT02404441|473910679|FG001|Phase 2 Part|Adverse Event|0|||
131711245|NCT03690869|474219755|FG003|Overall Study|Lost to Follow-up|0|||
131711246|NCT03690869|474219756|FG004|Overall Study|Lost to Follow-up|0|||
131796034|NCT00814320|474536015|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
131796035|NCT00814320|474536014|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
131796036|NCT00814320|474536015|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
131796037|NCT00814320|474536014|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
131796038|NCT00814320|474536015|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
131796039|NCT00814320|474536014|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
131796040|NCT00814320|474536015|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
131796041|NCT00491504|474536016|FG000|Overall Study|Adverse Event|0|||
131796042|NCT00491504|474536017|FG001|Overall Study|Adverse Event|1|||
131796043|NCT00491504|474536018|FG002|Overall Study|Adverse Event|0|||
131444054|NCT05138653|473255030|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131444055|NCT05138653|473255031|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131623879|NCT02404441|473910680|FG002|Phase 2 Part|Adverse Event|0|||
131623880|NCT02404441|473910681|FG003|Phase 2 Part|Adverse Event|0|||
131623881|NCT02404441|473910682|FG004|Phase 2 Part|Adverse Event|0|||
131623882|NCT02404441|473910683|FG005|Phase 2 Part|Adverse Event|2|||
131623883|NCT02404441|473910684|FG006|Phase 2 Part|Adverse Event|3|||
131623884|NCT02404441|473910685|FG007|Phase 2 Part|Adverse Event|3|||
131623885|NCT02404441|473910686|FG008|Phase 2 Part|Adverse Event|6|||
131623886|NCT02404441|473910687|FG009|Phase 2 Part|Adverse Event|1|||
131623887|NCT02404441|473910678|FG000|Phase 2 Part|Physician Decision|0|||
131623888|NCT02404441|473910679|FG001|Phase 2 Part|Physician Decision|0|||
131623889|NCT02404441|473910680|FG002|Phase 2 Part|Physician Decision|0|||
131623890|NCT02404441|473910681|FG003|Phase 2 Part|Physician Decision|0|||
131623891|NCT02404441|473910682|FG004|Phase 2 Part|Physician Decision|0|||
131623892|NCT02404441|473910683|FG005|Phase 2 Part|Physician Decision|7|||
131623893|NCT02404441|473910684|FG006|Phase 2 Part|Physician Decision|9|||
131623894|NCT02404441|473910685|FG007|Phase 2 Part|Physician Decision|2|||
131623895|NCT02404441|473910686|FG008|Phase 2 Part|Physician Decision|1|||
131623896|NCT02404441|473910687|FG009|Phase 2 Part|Physician Decision|3|||
131623897|NCT02404441|473910678|FG000|Phase 2 Part|Progressive disease|0|||
131623898|NCT02404441|473910679|FG001|Phase 2 Part|Progressive disease|0|||
131623899|NCT02404441|473910680|FG002|Phase 2 Part|Progressive disease|0|||
131623900|NCT02404441|473910681|FG003|Phase 2 Part|Progressive disease|0|||
131623901|NCT02404441|473910682|FG004|Phase 2 Part|Progressive disease|0|||
131623902|NCT02404441|473910683|FG005|Phase 2 Part|Progressive disease|43|||
131623903|NCT02404441|473910684|FG006|Phase 2 Part|Progressive disease|32|||
131623904|NCT02404441|473910685|FG007|Phase 2 Part|Progressive disease|31|||
131623905|NCT02404441|473910686|FG008|Phase 2 Part|Progressive disease|39|||
131623906|NCT02404441|473910687|FG009|Phase 2 Part|Progressive disease|27|||
131623907|NCT02404441|473910678|FG000|Phase 2 Part|Subject/guardian decision|0|||
131623908|NCT02404441|473910679|FG001|Phase 2 Part|Subject/guardian decision|0|||
131623909|NCT02404441|473910680|FG002|Phase 2 Part|Subject/guardian decision|0|||
131623910|NCT02404441|473910681|FG003|Phase 2 Part|Subject/guardian decision|0|||
131623911|NCT02404441|473910682|FG004|Phase 2 Part|Subject/guardian decision|0|||
131623912|NCT02404441|473910683|FG005|Phase 2 Part|Subject/guardian decision|3|||
131623913|NCT02404441|473910684|FG006|Phase 2 Part|Subject/guardian decision|9|||
131623914|NCT02404441|473910685|FG007|Phase 2 Part|Subject/guardian decision|0|||
131623915|NCT02404441|473910686|FG008|Phase 2 Part|Subject/guardian decision|3|||
131623916|NCT02404441|473910687|FG009|Phase 2 Part|Subject/guardian decision|2|||
131623917|NCT02404441|473910678|FG000|Phase 2 Part|Death|0|||
131623918|NCT02404441|473910679|FG001|Phase 2 Part|Death|0|||
131623919|NCT02404441|473910680|FG002|Phase 2 Part|Death|0|||
131623920|NCT02404441|473910681|FG003|Phase 2 Part|Death|0|||
131623921|NCT02404441|473910682|FG004|Phase 2 Part|Death|0|||
131623922|NCT02404441|473910683|FG005|Phase 2 Part|Death|4|||
131623923|NCT02404441|473910684|FG006|Phase 2 Part|Death|8|||
131623924|NCT02404441|473910685|FG007|Phase 2 Part|Death|4|||
131623925|NCT02404441|473910686|FG008|Phase 2 Part|Death|10|||
131623926|NCT02404441|473910687|FG009|Phase 2 Part|Death|9|||
131623927|NCT02706483|473910688|FG000|Overall Study|Adverse Event|97|||
131623928|NCT02706483|473910688|FG000|Overall Study|Death|1|||
131623929|NCT02706483|473910688|FG000|Overall Study|Lack of Efficacy|39|||
131623930|NCT02706483|473910688|FG000|Overall Study|Lost to Follow-up|101|||
131623931|NCT02706483|473910688|FG000|Overall Study|Non-compliance with study drug|15|||
131796044|NCT00491504|474536019|FG003|Overall Study|Adverse Event|0|||
131796045|NCT00491504|474536016|FG000|Overall Study|Withdrawal by Subject|0|||
131796046|NCT00491504|474536017|FG001|Overall Study|Withdrawal by Subject|0|||
131796047|NCT00491504|474536018|FG002|Overall Study|Withdrawal by Subject|1|||
131796048|NCT00491504|474536019|FG003|Overall Study|Withdrawal by Subject|2|||
131623932|NCT02706483|473910688|FG000|Overall Study|Physician Decision|6|||
131623933|NCT02706483|473910688|FG000|Overall Study|Pregnancy|6|||
131623934|NCT02706483|473910688|FG000|Overall Study|Protocol Violation|18|||
131623935|NCT02706483|473910688|FG000|Overall Study|Withdrawal by Subject|136|||
131623936|NCT02706483|473910688|FG000|Overall Study|Non-compliance with visits|6|||
131623937|NCT02706483|473910688|FG000|Overall Study|Site closure|4|||
131623938|NCT02706483|473910688|FG000|Overall Study|Subject moved|1|||
131623939|NCT01976507|473910689|FG000|Overall Study|Adverse Event|6|||
131623940|NCT01976507|473910689|FG000|Overall Study|ablation not done, drug not given|1|||
131623941|NCT01972776|473910698|FG000|Part 1|Withdrawal by Subject|0|||
131623942|NCT01972776|473910699|FG001|Part 1|Withdrawal by Subject|0|||
131623943|NCT01972776|473910700|FG002|Part 1|Withdrawal by Subject|1|||
131623944|NCT01972776|473910701|FG003|Part 1|Withdrawal by Subject|0|||
131623945|NCT01972776|473910702|FG004|Part 1|Withdrawal by Subject|0|||
131623946|NCT01972776|473910703|FG005|Part 1|Withdrawal by Subject|0|||
131623947|NCT01972776|473910698|FG000|Part 1|Adverse Event|0|||
131623948|NCT01972776|473910699|FG001|Part 1|Adverse Event|0|||
131623949|NCT01972776|473910700|FG002|Part 1|Adverse Event|1|||
131623950|NCT01972776|473910701|FG003|Part 1|Adverse Event|1|||
131623951|NCT01972776|473910702|FG004|Part 1|Adverse Event|0|||
131623952|NCT01972776|473910703|FG005|Part 1|Adverse Event|0|||
131623953|NCT01972776|473910698|FG000|Part 2|Adverse Event|0|||
131623954|NCT01972776|473910699|FG001|Part 2|Adverse Event|0|||
131623955|NCT01972776|473910700|FG002|Part 2|Adverse Event|0|||
131623956|NCT01972776|473910701|FG003|Part 2|Adverse Event|0|||
131623957|NCT01972776|473910702|FG004|Part 2|Adverse Event|3|||
131623958|NCT01972776|473910703|FG005|Part 2|Adverse Event|0|||
131623959|NCT01972776|473910698|FG000|Part 2|Administrative problems|0|||
131623960|NCT01972776|473910699|FG001|Part 2|Administrative problems|0|||
131623961|NCT01972776|473910700|FG002|Part 2|Administrative problems|0|||
131623962|NCT01972776|473910701|FG003|Part 2|Administrative problems|0|||
131623963|NCT01972776|473910702|FG004|Part 2|Administrative problems|10|||
131623964|NCT01972776|473910703|FG005|Part 2|Administrative problems|7|||
131623965|NCT03042767|473910704|FG000|Overall Study|Lost to Follow-up|1|||
131623966|NCT03042767|473910705|FG001|Overall Study|Lost to Follow-up|2|||
131623967|NCT01220999|473910706|FG000|Overall Study|Progressive disease|0|||
131623968|NCT01220999|473910707|FG001|Overall Study|Progressive disease|0|||
131623969|NCT01220999|473910708|FG002|Overall Study|Progressive disease|1|||
131623970|NCT01220999|473910709|FG003|Overall Study|Progressive disease|0|||
131623971|NCT01220999|473910710|FG004|Overall Study|Progressive disease|0|||
131623972|NCT02037568|473910713|FG000|Overall Study|Withdrawal by Subject|17|||
131623973|NCT02037568|473910714|FG001|Overall Study|Withdrawal by Subject|24|||
131623974|NCT02037568|473910713|FG000|Overall Study|Lost to Follow-up|16|||
131623975|NCT02037568|473910714|FG001|Overall Study|Lost to Follow-up|13|||
131623976|NCT02037568|473910713|FG000|Overall Study|Screen Failure|3|||
131623977|NCT02037568|473910714|FG001|Overall Study|Screen Failure|1|||
131901058|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901059|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131623978|NCT02037568|473910713|FG000|Overall Study|Patient did not receive transplant|0|||
131623979|NCT02037568|473910714|FG001|Overall Study|Patient did not receive transplant|1|||
131623980|NCT00721734|473910718|FG000|Overall Study|Progressive Disease|3|||
131623981|NCT00721734|473910719|FG001|Overall Study|Progressive Disease|10|||
131623982|NCT00721734|473910720|FG002|Overall Study|Progressive Disease|4|||
131623983|NCT00721734|473910721|FG003|Overall Study|Progressive Disease|5|||
131623984|NCT00721734|473910722|FG004|Overall Study|Progressive Disease|2|||
131623985|NCT00721734|473910718|FG000|Overall Study|Adverse Event|3|||
131623986|NCT00721734|473910719|FG001|Overall Study|Adverse Event|1|||
131623987|NCT00721734|473910720|FG002|Overall Study|Adverse Event|4|||
131623988|NCT00721734|473910721|FG003|Overall Study|Adverse Event|0|||
131623989|NCT00721734|473910722|FG004|Overall Study|Adverse Event|3|||
131623990|NCT00721734|473910718|FG000|Overall Study|Withdrawal by Subject|2|||
131623991|NCT00721734|473910719|FG001|Overall Study|Withdrawal by Subject|1|||
131623992|NCT00721734|473910720|FG002|Overall Study|Withdrawal by Subject|0|||
131623993|NCT00721734|473910721|FG003|Overall Study|Withdrawal by Subject|0|||
131623994|NCT00721734|473910722|FG004|Overall Study|Withdrawal by Subject|1|||
131623995|NCT00721734|473910718|FG000|Overall Study|Other|0|||
131623996|NCT00721734|473910719|FG001|Overall Study|Other|0|||
131623997|NCT00721734|473910720|FG002|Overall Study|Other|0|||
131623998|NCT00721734|473910721|FG003|Overall Study|Other|1|||
131623999|NCT00721734|473910722|FG004|Overall Study|Other|0|||
131624000|NCT03861234|473910723|FG000|Overall Study|Not treated|0|||
131624001|NCT03861234|473910724|FG001|Overall Study|Not treated|0|||
131624002|NCT03861234|473910725|FG002|Overall Study|Not treated|0|||
131624003|NCT03861234|473910726|FG003|Overall Study|Not treated|0|||
131624004|NCT03861234|473910727|FG004|Overall Study|Not treated|0|||
131624005|NCT03861234|473910728|FG005|Overall Study|Not treated|1|||
131624006|NCT03861234|473910729|FG006|Overall Study|Not treated|0|||
131624007|NCT03861234|473910730|FG007|Overall Study|Not treated|0|||
131624008|NCT03861234|473910723|FG000|Overall Study|Adverse Event|0|||
131624009|NCT03861234|473910724|FG001|Overall Study|Adverse Event|0|||
131624010|NCT03861234|473910725|FG002|Overall Study|Adverse Event|0|||
131624011|NCT03861234|473910726|FG003|Overall Study|Adverse Event|0|||
131624012|NCT03861234|473910727|FG004|Overall Study|Adverse Event|0|||
131624013|NCT03861234|473910728|FG005|Overall Study|Adverse Event|1|||
131624014|NCT03861234|473910729|FG006|Overall Study|Adverse Event|0|||
131624015|NCT03861234|473910730|FG007|Overall Study|Adverse Event|0|||
131624016|NCT03861234|473910723|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
131624017|NCT03861234|473910724|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
131624018|NCT03861234|473910725|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
131624019|NCT03861234|473910726|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
131624020|NCT03861234|473910727|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
131624021|NCT03861234|473910728|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
131624022|NCT03861234|473910729|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
131624023|NCT03861234|473910730|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
131624024|NCT03861234|473910723|FG000|Overall Study|As per sponsor decision|0|||
131624025|NCT03861234|473910724|FG001|Overall Study|As per sponsor decision|0|||
131624026|NCT03861234|473910725|FG002|Overall Study|As per sponsor decision|0|||
131624027|NCT03861234|473910726|FG003|Overall Study|As per sponsor decision|0|||
131624028|NCT03861234|473910727|FG004|Overall Study|As per sponsor decision|0|||
131624029|NCT03861234|473910728|FG005|Overall Study|As per sponsor decision|0|||
131624030|NCT03861234|473910729|FG006|Overall Study|As per sponsor decision|1|||
131624031|NCT03861234|473910730|FG007|Overall Study|As per sponsor decision|0|||
131624032|NCT03861234|473910723|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
131624033|NCT03861234|473910724|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
131624034|NCT03861234|473910725|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
131624035|NCT03861234|473910726|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
131624036|NCT03861234|473910727|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
131624037|NCT03861234|473910728|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
131624038|NCT03861234|473910729|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
131624039|NCT03861234|473910730|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
131624040|NCT00621842|473910731|FG000|Overall Study|Adverse Event|6|||
131624041|NCT00621842|473910731|FG000|Overall Study|Withdrawal by Subject|7|||
131624042|NCT00621842|473910731|FG000|Overall Study|Protocol Violation|4|||
131624043|NCT00621842|473910731|FG000|Overall Study|Lack of Efficacy|2|||
131624044|NCT00526994|473910733|FG000|Overall Study|Lost to Follow-up|98|||
131624045|NCT00526994|473910734|FG001|Overall Study|Lost to Follow-up|108|||
131624046|NCT00526994|473910735|FG002|Overall Study|Lost to Follow-up|96|||
131624047|NCT00526994|473910733|FG000|Overall Study|Death|4|||
131624048|NCT00526994|473910734|FG001|Overall Study|Death|3|||
131624049|NCT00526994|473910735|FG002|Overall Study|Death|3|||
131624050|NCT00526994|473910733|FG000|Overall Study|Withdrawal by Subject|2|||
131624051|NCT00526994|473910734|FG001|Overall Study|Withdrawal by Subject|7|||
131624052|NCT00526994|473910735|FG002|Overall Study|Withdrawal by Subject|5|||
131624053|NCT00526994|473910733|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
131624054|NCT00526994|473910734|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
131624055|NCT00526994|473910735|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
131624056|NCT01419184|473910736|FG000|Overall Study|Site data not available|3|||
131624057|NCT01419184|473910737|FG001|Overall Study|Site data not available|2|||
131624058|NCT01419184|473910736|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
131624059|NCT01419184|473910737|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
131624060|NCT01419184|473910736|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
131624061|NCT01419184|473910737|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
131624062|NCT01419184|473910736|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
131624063|NCT01419184|473910737|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
131624064|NCT01419184|473910736|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
131624065|NCT01419184|473910737|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
131624066|NCT01419184|473910736|FG000|Overall Study|Participant randomized, not treated|1|||
131624067|NCT01419184|473910737|FG001|Overall Study|Participant randomized, not treated|0|||
131624068|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
131624069|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
131624070|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
131624071|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
131624072|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
131624073|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
131624074|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
131624075|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
131624076|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
131624077|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
131624078|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
131796049|NCT00491504|474536016|FG000|Overall Study|Protocol Violation|0|||
131796050|NCT00491504|474536017|FG001|Overall Study|Protocol Violation|0|||
131796051|NCT00491504|474536018|FG002|Overall Study|Protocol Violation|3|||
131796052|NCT00491504|474536019|FG003|Overall Study|Protocol Violation|2|||
131796053|NCT00619385|474536020|FG000|Overall Study|Adverse Event|0|||
131796054|NCT00619385|474536021|FG001|Overall Study|Adverse Event|0|||
131796055|NCT00619385|474536022|FG002|Overall Study|Adverse Event|3|||
131796056|NCT00619385|474536020|FG000|Overall Study|Other|1|||
131796057|NCT00619385|474536021|FG001|Overall Study|Other|2|||
131796058|NCT00619385|474536022|FG002|Overall Study|Other|1|||
131796059|NCT03271528|474536026|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
131796060|NCT03271528|474536027|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
131796061|NCT03271528|474536026|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
131796062|NCT03271528|474536027|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
131796063|NCT03271528|474536026|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
131796064|NCT03271528|474536027|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
131796065|NCT03271528|474536026|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
131796066|NCT03271528|474536027|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
131796067|NCT03271528|474536026|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
131796068|NCT03271528|474536027|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
131796069|NCT03271528|474536026|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
131796070|NCT03271528|474536027|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
131796071|NCT03271528|474536026|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
131796072|NCT03271528|474536027|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
131796073|NCT00673790|474536028|FG000|Overall Study|Adverse Event|23|||
131796074|NCT00673790|474536029|FG001|Overall Study|Adverse Event|14|||
131796075|NCT00673790|474536030|FG002|Overall Study|Adverse Event|2|||
131796076|NCT00673790|474536028|FG000|Overall Study|Lack of Efficacy|2|||
131796077|NCT00673790|474536029|FG001|Overall Study|Lack of Efficacy|2|||
131796078|NCT00673790|474536030|FG002|Overall Study|Lack of Efficacy|2|||
131796079|NCT00673790|474536028|FG000|Overall Study|Protocol Violation|6|||
131796080|NCT00673790|474536029|FG001|Overall Study|Protocol Violation|9|||
131796081|NCT00673790|474536030|FG002|Overall Study|Protocol Violation|1|||
131796082|NCT00673790|474536028|FG000|Overall Study|Withdrawal by Subject|7|||
131796083|NCT00673790|474536029|FG001|Overall Study|Withdrawal by Subject|4|||
131796084|NCT00673790|474536030|FG002|Overall Study|Withdrawal by Subject|1|||
131796085|NCT00673790|474536028|FG000|Overall Study|Lost to Follow-up|6|||
131796086|NCT00673790|474536029|FG001|Overall Study|Lost to Follow-up|6|||
131796087|NCT00673790|474536030|FG002|Overall Study|Lost to Follow-up|5|||
131796088|NCT00673790|474536028|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
131624079|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
131624080|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
131624081|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
131624082|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
131624083|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
131624084|NCT03182244|473910743|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
131624085|NCT03182244|473910744|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
131624086|NCT03182244|473910743|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
131624087|NCT03182244|473910744|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
131624088|NCT03182244|473910743|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
131624089|NCT03182244|473910744|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
131624090|NCT03182244|473910743|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
131624091|NCT03182244|473910744|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
131624092|NCT03182244|473910743|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
131796089|NCT00673790|474536029|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
131796090|NCT00673790|474536030|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
131796091|NCT00673790|474536028|FG000|Overall Study|Poor compliance|1|||
131796092|NCT00673790|474536029|FG001|Overall Study|Poor compliance|0|||
131796093|NCT00673790|474536030|FG002|Overall Study|Poor compliance|0|||
131796094|NCT00673790|474536028|FG000|Overall Study|Participated in two Nebivolol studies|0|||
131624093|NCT03182244|473910744|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
131624094|NCT01263496|473910751|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
131624095|NCT01263496|473910752|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624096|NCT01263496|473910753|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624097|NCT01263496|473910754|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624098|NCT01263496|473910755|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624099|NCT01263496|473910756|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624100|NCT01263496|473910757|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624101|NCT01263496|473910758|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624102|NCT01263496|473910759|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131624103|NCT01263496|473910751|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624104|NCT01263496|473910752|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624105|NCT01263496|473910753|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624106|NCT01263496|473910754|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
131624107|NCT01263496|473910755|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
131624108|NCT01263496|473910756|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624109|NCT01263496|473910757|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624110|NCT01263496|473910758|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624111|NCT01263496|473910759|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131624112|NCT01263496|473910751|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
131624113|NCT01263496|473910752|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
131624114|NCT01263496|473910753|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
131624115|NCT01263496|473910754|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
131624116|NCT01263496|473910755|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
131624117|NCT01263496|473910756|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
131624118|NCT01263496|473910757|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
131624119|NCT01263496|473910758|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
131624120|NCT01263496|473910759|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
131624121|NCT01263496|473910751|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624122|NCT01263496|473910752|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
131624123|NCT01263496|473910753|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624124|NCT01263496|473910754|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624125|NCT01263496|473910755|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624126|NCT01263496|473910756|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624127|NCT01263496|473910757|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624128|NCT01263496|473910758|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624129|NCT01263496|473910759|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131624130|NCT01263496|473910751|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131624131|NCT01263496|473910752|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131624132|NCT01263496|473910753|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131624133|NCT01263496|473910754|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131624134|NCT01263496|473910755|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
131624135|NCT01263496|473910756|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131624136|NCT01263496|473910757|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131624137|NCT01263496|473910758|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131624138|NCT01263496|473910759|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131624139|NCT01263496|473910751|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
131624140|NCT01263496|473910752|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
131624141|NCT01263496|473910753|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
131624142|NCT01263496|473910754|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131624143|NCT01263496|473910755|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
131624144|NCT01263496|473910756|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131624145|NCT01263496|473910757|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131624146|NCT01263496|473910758|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131624147|NCT01263496|473910759|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131624148|NCT01263496|473910751|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131711247|NCT03690869|474219757|FG005|Overall Study|Lost to Follow-up|0|||
131624149|NCT01263496|473910752|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131624150|NCT01263496|473910753|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131796095|NCT00673790|474536029|FG001|Overall Study|Participated in two Nebivolol studies|0|||
131796096|NCT00673790|474536030|FG002|Overall Study|Participated in two Nebivolol studies|1|||
131796097|NCT00673790|474536028|FG000|Overall Study|Unconfirmed pregnancy|0|||
131624151|NCT01263496|473910754|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131624152|NCT01263496|473910755|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131624153|NCT01263496|473910756|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131624154|NCT01263496|473910757|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131624155|NCT01263496|473910758|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
131624156|NCT01263496|473910759|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131624157|NCT02915783|473910760|FG000|Overall Study|Death|21|||
131624158|NCT02915783|473910760|FG000|Overall Study|Lost to Follow-up|1|||
131624159|NCT02915783|473910760|FG000|Overall Study|Withdrawal by Subject|2|||
131624160|NCT02950961|473910762|FG000|Overall Study|Study had to stop due to COVID.|7|||
131624161|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
131796098|NCT00673790|474536029|FG001|Overall Study|Unconfirmed pregnancy|1|||
131796099|NCT00673790|474536030|FG002|Overall Study|Unconfirmed pregnancy|0|||
131796100|NCT00673790|474536028|FG000|Overall Study|Randomization criteria not met|0|||
131796101|NCT00673790|474536029|FG001|Overall Study|Randomization criteria not met|1|||
131796102|NCT00673790|474536030|FG002|Overall Study|Randomization criteria not met|0|||
131796103|NCT01873859|474536031|FG000|Overall Study|Withdrawal by Subject|0|||
131796104|NCT01873859|474536032|FG001|Overall Study|Withdrawal by Subject|4|||
131796105|NCT03504852|474536033|FG000|Overall Study|Withdrawal of informed consent|2|||
131796106|NCT03504852|474536034|FG001|Overall Study|Withdrawal of informed consent|1|||
131796107|NCT03504852|474536035|FG002|Overall Study|Withdrawal of informed consent|0|||
131796108|NCT03504852|474536033|FG000|Overall Study|Withdrawal by Subject|5|||
131796109|NCT03504852|474536034|FG001|Overall Study|Withdrawal by Subject|5|||
131796110|NCT03504852|474536035|FG002|Overall Study|Withdrawal by Subject|1|||
131796111|NCT03504852|474536033|FG000|Overall Study|Lost to Follow-up|4|||
131796112|NCT03504852|474536034|FG001|Overall Study|Lost to Follow-up|1|||
131796113|NCT03504852|474536035|FG002|Overall Study|Lost to Follow-up|0|||
131796114|NCT03504852|474536033|FG000|Overall Study|New therapy for study indication|1|||
131796115|NCT03504852|474536034|FG001|Overall Study|New therapy for study indication|0|||
131796116|NCT03504852|474536035|FG002|Overall Study|New therapy for study indication|0|||
131796117|NCT03504852|474536033|FG000|Overall Study|Lack of Efficacy|1|||
131796118|NCT03504852|474536034|FG001|Overall Study|Lack of Efficacy|2|||
131796119|NCT03504852|474536035|FG002|Overall Study|Lack of Efficacy|0|||
131796120|NCT03504852|474536033|FG000|Overall Study|Death|0|||
131796121|NCT03504852|474536034|FG001|Overall Study|Death|1|||
131796122|NCT03504852|474536035|FG002|Overall Study|Death|0|||
131796123|NCT03504852|474536033|FG000|Overall Study|Adverse Event|4|||
131796124|NCT03504852|474536034|FG001|Overall Study|Adverse Event|8|||
131796125|NCT03504852|474536035|FG002|Overall Study|Adverse Event|2|||
131796126|NCT01066052|474536036|FG000|Overall Study|Enrolled But Not Treated|3|||
131796127|NCT01066052|474536037|FG001|Overall Study|Enrolled But Not Treated|0|||
131796128|NCT02928848|474536038|FG000|Arm 2|Withdrawal by Subject|1|||
131796129|NCT02928848|474536039|FG001|Arm 2|Withdrawal by Subject|0|||
131796130|NCT03850509|474536040|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
131796131|NCT03850509|474536041|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
131796132|NCT01200394|474536042|FG000|Overall Study|Adverse Event|0|||
131796133|NCT01200394|474536043|FG001|Overall Study|Adverse Event|14|||
131796134|NCT01200394|474536042|FG000|Overall Study|Death|1|||
131796135|NCT01200394|474536043|FG001|Overall Study|Death|0|||
131796136|NCT01200394|474536042|FG000|Overall Study|Lost to Follow-up|0|||
131796137|NCT01200394|474536043|FG001|Overall Study|Lost to Follow-up|1|||
131796138|NCT01200394|474536042|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131796139|NCT01200394|474536043|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
131796140|NCT01200394|474536042|FG000|Overall Study|Protocol Violation|0|||
131796141|NCT01200394|474536043|FG001|Overall Study|Protocol Violation|3|||
131796142|NCT01200394|474536042|FG000|Overall Study|Withdrawal by Subject|0|||
131796143|NCT01200394|474536043|FG001|Overall Study|Withdrawal by Subject|5|||
131624162|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
131624163|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
131624164|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
131624165|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
131624166|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
131624167|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
131796144|NCT01200394|474536042|FG000|Overall Study|Other|0|||
131796145|NCT01200394|474536043|FG001|Overall Study|Other|1|||
131796146|NCT00969332|474536044|FG000|Overall Study|Physician Decision|8|||
131796147|NCT00969332|474536044|FG000|Overall Study|Withdrawal by Subject|3|||
131796148|NCT01835145|474536048|FG000|Overall Study|Ineligible prior to treatment|1|||
131796149|NCT01835145|474536049|FG001|Overall Study|Ineligible prior to treatment|0|||
131796150|NCT00582309|474536050|FG000|Overall Study|Protocol Violation|0|||
131796151|NCT00582309|474536051|FG001|Overall Study|Protocol Violation|0|||
131444056|NCT05138653|473255032|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131624168|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
131624169|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
131624170|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
131624171|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
131624172|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
131624173|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
131624174|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
131624175|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
131624176|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
131624177|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
131624178|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
131796152|NCT00582309|474536052|FG002|Overall Study|Protocol Violation|2|||
131796153|NCT01565083|474536057|FG000|Overall Study|Withdrawal by Subject|6|||
131796154|NCT01565083|474536058|FG001|Overall Study|Withdrawal by Subject|4|||
131796155|NCT01565083|474536057|FG000|Overall Study|Lost to Follow-up|2|||
131796156|NCT01565083|474536058|FG001|Overall Study|Lost to Follow-up|7|||
131796157|NCT01565083|474536057|FG000|Overall Study|Death|22|||
131796158|NCT01565083|474536058|FG001|Overall Study|Death|23|||
131796159|NCT01565083|474536057|FG000|Overall Study|Other|3|||
131796160|NCT01565083|474536058|FG001|Overall Study|Other|5|||
131796161|NCT01960816|474536059|FG000|Overall Study|Lost to Follow-up|1|||
131796162|NCT01118728|474536062|FG000|Overall Study|Adverse Event|17|||
131796163|NCT01118728|474536062|FG000|Overall Study|Lack of Efficacy|27|||
131796164|NCT01118728|474536062|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
131796165|NCT01118728|474536062|FG000|Overall Study|Withdrawal by Subject|3|||
131796166|NCT01118728|474536062|FG000|Overall Study|Lost to Follow-up|4|||
131796167|NCT04345471|474536063|FG000|Overall Study|Adverse Event|8|||
131796168|NCT04345471|474536064|FG001|Overall Study|Adverse Event|5|||
131796169|NCT04345471|474536065|FG002|Overall Study|Adverse Event|6|||
131796170|NCT04345471|474536063|FG000|Overall Study|Lack of Efficacy|1|||
131796171|NCT04345471|474536064|FG001|Overall Study|Lack of Efficacy|1|||
131796172|NCT04345471|474536065|FG002|Overall Study|Lack of Efficacy|0|||
131796173|NCT04345471|474536063|FG000|Overall Study|Protocol Violation|0|||
131796174|NCT04345471|474536064|FG001|Overall Study|Protocol Violation|1|||
131444057|NCT05138653|473255033|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131444058|NCT05138653|473255034|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131624179|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
131796175|NCT04345471|474536065|FG002|Overall Study|Protocol Violation|2|||
131796176|NCT04345471|474536063|FG000|Overall Study|Withdrawal by Subject|10|||
131796177|NCT04345471|474536064|FG001|Overall Study|Withdrawal by Subject|5|||
131796178|NCT04345471|474536065|FG002|Overall Study|Withdrawal by Subject|10|||
131796179|NCT03896490|474536066|FG000|Overall Study|Withdrawal by Subject|1|||
131796180|NCT03896490|474536067|FG001|Overall Study|Withdrawal by Subject|1|||
131796181|NCT00003782|474536068|FG000|Overall Study|No follow up data|30|||
131901060|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901061|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901062|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901063|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
131901064|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901065|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901066|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901067|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901068|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901069|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901070|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901071|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131901072|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901073|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901074|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901075|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901076|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901077|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901078|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901079|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901080|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
131901081|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901082|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901083|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901084|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901085|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901086|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131901087|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901088|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901089|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901090|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901091|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901092|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
131901093|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
131901094|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
131901095|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
131901096|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901097|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901098|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901099|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901100|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901101|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131901102|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901103|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901104|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901105|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901106|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901107|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
131901108|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901109|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901110|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131796182|NCT00003782|474536069|FG001|Overall Study|No follow up data|31|||
131796183|NCT00003782|474536070|FG002|Overall Study|No follow up data|26|||
131796184|NCT01890707|474536071|FG000|Overall Study|Lost to Follow-up|1|||
131796185|NCT01890707|474536072|FG001|Overall Study|Lost to Follow-up|1|||
131796186|NCT00385541|474536074|FG000|Overall Study|severe pain, clinician requested unblind|0|||
131796187|NCT00385541|474536075|FG001|Overall Study|severe pain, clinician requested unblind|1|||
131796188|NCT00929708|474536076|FG000|Overall Study|Protocol Violation|2|||
131796189|NCT00929708|474536077|FG001|Overall Study|Protocol Violation|1|||
131796190|NCT00929708|474536078|FG002|Overall Study|Protocol Violation|1|||
131796191|NCT00929708|474536079|FG003|Overall Study|Protocol Violation|1|||
131796192|NCT00929708|474536080|FG004|Overall Study|Protocol Violation|1|||
131624180|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
131624181|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
131624182|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
131624183|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
131624184|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
131624185|NCT02203032|473910763|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
131624186|NCT02203032|473910764|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
131624187|NCT02203032|473910765|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
131901111|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901112|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901113|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901114|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901115|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901116|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
131901117|NCT02326272|474923497|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901118|NCT02326272|474923498|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901119|NCT02326272|474923499|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901120|NCT02326272|474923500|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901121|NCT02326272|474923501|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901122|NCT02326272|474923502|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901123|NCT02326272|474923503|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
131901124|NCT02326272|474923504|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901125|NCT02326272|474923505|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901126|NCT02326272|474923506|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901127|NCT02326272|474923507|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901128|NCT02326272|474923508|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901129|NCT02326272|474923509|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901130|NCT02326272|474923510|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901131|NCT02326272|474923511|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131901132|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
131901133|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
131901134|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
131624188|NCT02203032|473910766|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
131624189|NCT02203032|473910763|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
131624190|NCT02203032|473910764|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
131624191|NCT02203032|473910765|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
131624192|NCT02203032|473910766|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
131624193|NCT02203032|473910763|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
131624194|NCT02203032|473910764|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
131624195|NCT02203032|473910765|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
131624196|NCT02203032|473910766|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
131624197|NCT02203032|473910763|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
131624198|NCT02203032|473910764|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
131624199|NCT02203032|473910765|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
131624200|NCT02203032|473910766|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
131624201|NCT02203032|473910763|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
131624202|NCT02203032|473910764|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
131624203|NCT02203032|473910765|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
131624204|NCT02203032|473910766|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
131624205|NCT02203032|473910763|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
131624206|NCT02203032|473910764|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
131624207|NCT02203032|473910765|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
131624208|NCT02203032|473910766|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
131624209|NCT02241785|473910767|FG000|Overall Study|Sponsor Termination|43|||
131624210|NCT02241785|473910767|FG000|Overall Study|Withdrawal by Subject|1|||
131711248|NCT03690869|474219758|FG006|Overall Study|Lost to Follow-up|0|||
131711249|NCT03690869|474219759|FG007|Overall Study|Lost to Follow-up|0|||
131711250|NCT03690869|474219760|FG008|Overall Study|Lost to Follow-up|0|||
131711251|NCT03690869|474219761|FG009|Overall Study|Lost to Follow-up|0|||
131711252|NCT03690869|474219752|FG000|Overall Study|Other Treatment|1|||
131711253|NCT03690869|474219753|FG001|Overall Study|Other Treatment|1|||
131711254|NCT03690869|474219754|FG002|Overall Study|Other Treatment|1|||
131711255|NCT03690869|474219755|FG003|Overall Study|Other Treatment|2|||
131711256|NCT03690869|474219756|FG004|Overall Study|Other Treatment|3|||
131711257|NCT03690869|474219757|FG005|Overall Study|Other Treatment|1|||
131624211|NCT02241785|473910767|FG000|Overall Study|Lost to Follow-up|2|||
131624212|NCT02241785|473910767|FG000|Overall Study|Adverse Event|1|||
131624213|NCT03055988|473910770|FG000|Period 1|Adverse Event|0|||
131624214|NCT03055988|473910771|FG001|Period 1|Adverse Event|1|||
131624215|NCT03055988|473910770|FG000|Period 1|Lost to Follow-up|1|||
131624216|NCT03055988|473910771|FG001|Period 1|Lost to Follow-up|0|||
131624217|NCT03055988|473910770|FG000|Period 1|Withdrawal by Subject|0|||
131624218|NCT03055988|473910771|FG001|Period 1|Withdrawal by Subject|4|||
131624219|NCT03055988|473910770|FG000|Period 2|Adverse Event|0|||
131624220|NCT03055988|473910771|FG001|Period 2|Adverse Event|1|||
131624221|NCT03055988|473910770|FG000|Period 2|Other than listed|1|||
131624222|NCT03055988|473910771|FG001|Period 2|Other than listed|1|||
131624223|NCT01915914|473910772|FG000|Acute Phase|Withdrawal by Subject|4|||
131624224|NCT01915914|473910773|FG001|Acute Phase|Withdrawal by Subject|0|||
131624225|NCT01915914|473910774|FG002|Acute Phase|Withdrawal by Subject|0|||
131624226|NCT01915914|473910775|FG003|Acute Phase|Withdrawal by Subject|0|||
131624227|NCT01915914|473910772|FG000|Acute Phase|Lost to Follow-up|4|||
131624228|NCT01915914|473910773|FG001|Acute Phase|Lost to Follow-up|0|||
131624229|NCT01915914|473910774|FG002|Acute Phase|Lost to Follow-up|0|||
131624230|NCT01915914|473910775|FG003|Acute Phase|Lost to Follow-up|0|||
131624231|NCT01915914|473910772|FG000|Acute Phase|Physician Decision|1|||
131624232|NCT01915914|473910773|FG001|Acute Phase|Physician Decision|0|||
131624233|NCT01915914|473910774|FG002|Acute Phase|Physician Decision|0|||
131624234|NCT01915914|473910775|FG003|Acute Phase|Physician Decision|0|||
131624235|NCT01915914|473910772|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
131624236|NCT01915914|473910773|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
131624237|NCT01915914|473910774|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
131624238|NCT01915914|473910775|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
131624239|NCT01915914|473910772|FG000|Acute Phase|"Not Achieved treatment success"|1|||
131624240|NCT01915914|473910773|FG001|Acute Phase|"Not Achieved treatment success"|0|||
131624241|NCT01915914|473910774|FG002|Acute Phase|"Not Achieved treatment success"|0|||
131624242|NCT01915914|473910775|FG003|Acute Phase|"Not Achieved treatment success"|0|||
131624243|NCT01915914|473910772|FG000|Acute Phase|Missing|1|||
131624244|NCT01915914|473910773|FG001|Acute Phase|Missing|0|||
131624245|NCT01915914|473910774|FG002|Acute Phase|Missing|0|||
131624246|NCT01915914|473910775|FG003|Acute Phase|Missing|0|||
131624247|NCT01915914|473910772|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131624248|NCT01915914|473910773|FG001|Maintenance Phase|Withdrawal by Subject|1|||
131624249|NCT01915914|473910774|FG002|Maintenance Phase|Withdrawal by Subject|1|||
131624250|NCT01915914|473910775|FG003|Maintenance Phase|Withdrawal by Subject|0|||
131624251|NCT01915914|473910772|FG000|Maintenance Phase|Lost to Follow-up|0|||
131624252|NCT01915914|473910773|FG001|Maintenance Phase|Lost to Follow-up|4|||
131624253|NCT01915914|473910774|FG002|Maintenance Phase|Lost to Follow-up|1|||
131624254|NCT01915914|473910775|FG003|Maintenance Phase|Lost to Follow-up|0|||
131624255|NCT01915914|473910772|FG000|Maintenance Phase|Missing|0|||
131624256|NCT01915914|473910773|FG001|Maintenance Phase|Missing|1|||
131624257|NCT01915914|473910774|FG002|Maintenance Phase|Missing|0|||
131444059|NCT05138653|473255035|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131444060|NCT05138653|473255036|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131624258|NCT01915914|473910775|FG003|Maintenance Phase|Missing|0|||
131624259|NCT01915914|473910772|FG000|Follow-up Phase|Withdrawal by Subject|0|||
131624260|NCT01915914|473910773|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131624261|NCT01915914|473910774|FG002|Follow-up Phase|Withdrawal by Subject|0|||
131624262|NCT01915914|473910775|FG003|Follow-up Phase|Withdrawal by Subject|1|||
131624263|NCT01915914|473910772|FG000|Follow-up Phase|Physician Decision|0|||
131624264|NCT01915914|473910773|FG001|Follow-up Phase|Physician Decision|0|||
131624265|NCT01915914|473910774|FG002|Follow-up Phase|Physician Decision|0|||
131624266|NCT01915914|473910775|FG003|Follow-up Phase|Physician Decision|1|||
131624267|NCT01528605|473910776|FG000|Overall Study|Lost to Follow-up|1|||
131624268|NCT01528605|473910777|FG001|Overall Study|Lost to Follow-up|0|||
131624269|NCT01528605|473910778|FG002|Overall Study|Lost to Follow-up|1|||
131624270|NCT01528605|473910779|FG003|Overall Study|Lost to Follow-up|1|||
131624271|NCT01528605|473910780|FG004|Overall Study|Lost to Follow-up|0|||
131624272|NCT01528605|473910781|FG005|Overall Study|Lost to Follow-up|0|||
131624273|NCT01528605|473910776|FG000|Overall Study|Death|1|||
131624274|NCT01528605|473910777|FG001|Overall Study|Death|0|||
131624275|NCT01528605|473910778|FG002|Overall Study|Death|0|||
131624276|NCT01528605|473910779|FG003|Overall Study|Death|0|||
131711258|NCT03690869|474219758|FG006|Overall Study|Other Treatment|2|||
131711259|NCT03690869|474219759|FG007|Overall Study|Other Treatment|7|||
131711260|NCT03690869|474219760|FG008|Overall Study|Other Treatment|0|||
131624277|NCT01528605|473910780|FG004|Overall Study|Death|0|||
131624278|NCT01528605|473910781|FG005|Overall Study|Death|0|||
131711261|NCT03690869|474219761|FG009|Overall Study|Other Treatment|3|||
131711262|NCT03690869|474219752|FG000|Overall Study|Physician Decision|0|||
131711263|NCT03690869|474219753|FG001|Overall Study|Physician Decision|1|||
131711264|NCT03690869|474219754|FG002|Overall Study|Physician Decision|0|||
131711265|NCT03690869|474219755|FG003|Overall Study|Physician Decision|0|||
131624279|NCT00845520|473910782|FG000|Overall Study|Death|1|||
131624280|NCT00845520|473910783|FG001|Overall Study|Death|2|||
131624281|NCT00845520|473910784|FG002|Overall Study|Death|0|||
131624282|NCT00845520|473910782|FG000|Overall Study|Lost to Follow-up|1|||
131711266|NCT03690869|474219756|FG004|Overall Study|Physician Decision|0|||
131711267|NCT03690869|474219757|FG005|Overall Study|Physician Decision|0|||
131624283|NCT00845520|473910783|FG001|Overall Study|Lost to Follow-up|0|||
131624284|NCT00845520|473910784|FG002|Overall Study|Lost to Follow-up|0|||
131624285|NCT00845520|473910782|FG000|Overall Study|Adverse Event|0|||
131624286|NCT00845520|473910783|FG001|Overall Study|Adverse Event|0|||
131624287|NCT00845520|473910784|FG002|Overall Study|Adverse Event|1|||
131624288|NCT01736475|473910785|FG000|Overall Study|Adverse Event|4|||
131624289|NCT01736475|473910786|FG001|Overall Study|Adverse Event|0|||
131624290|NCT01736475|473910785|FG000|Overall Study|Withdrawal by Subject|2|||
131624291|NCT01736475|473910786|FG001|Overall Study|Withdrawal by Subject|0|||
131624292|NCT01736475|473910785|FG000|Overall Study|Protocol Violation|4|||
131624293|NCT01736475|473910786|FG001|Overall Study|Protocol Violation|0|||
131624294|NCT01736475|473910785|FG000|Overall Study|Other - Screen failure|1|||
131624295|NCT01736475|473910786|FG001|Overall Study|Other - Screen failure|0|||
131624296|NCT01736475|473910785|FG000|Overall Study|Other - Surgical procedure|1|||
131624297|NCT01736475|473910786|FG001|Overall Study|Other - Surgical procedure|0|||
131624298|NCT02807857|473910787|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
131624299|NCT02807857|473910787|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
131624300|NCT02807857|473910787|FG000|Follow-Up Set|Withdrawal by Subject|8|||
131624301|NCT02807857|473910787|FG000|Follow-Up Set|Lost to Follow-up|7|||
131624302|NCT02807857|473910787|FG000|Follow-Up Set|Physician Decision|6|||
131624303|NCT02807857|473910787|FG000|Follow-Up Set|Adverse Event|3|||
131624304|NCT02807857|473910787|FG000|Follow-Up Set|Death|27|||
131624305|NCT02807857|473910787|FG000|Follow-Up Set|Relocation|2|||
131624306|NCT00513071|473910790|FG000|Overall Study|Adverse Event|1|||
131624307|NCT00513071|473910790|FG000|Overall Study|Withdrawal by Subject|1|||
131624308|NCT00513071|473910790|FG000|Overall Study|Physician Decision|3|||
131624309|NCT02659540|473910794|FG000|Overall Study|Adverse Event|3|||
131624310|NCT02659540|473910795|FG001|Overall Study|Adverse Event|2|||
131624311|NCT02659540|473910794|FG000|Overall Study|Death|1|||
131624312|NCT02659540|473910795|FG001|Overall Study|Death|0|||
131624313|NCT02659540|473910794|FG000|Overall Study|Progressive disease|2|||
131624314|NCT02659540|473910795|FG001|Overall Study|Progressive disease|6|||
131624315|NCT01240590|473910798|FG000|Phase I|Refused further treatment|0|||
131624316|NCT01240590|473910799|FG001|Phase I|Refused further treatment|0|||
131624317|NCT01240590|473910800|FG002|Phase I|Refused further treatment|3|||
131624318|NCT01240590|473910801|FG003|Phase I|Refused further treatment|0|||
131624319|NCT01240590|473910802|FG004|Phase I|Refused further treatment|0|||
131711268|NCT03690869|474219758|FG006|Overall Study|Physician Decision|0|||
131711269|NCT03690869|474219759|FG007|Overall Study|Physician Decision|0|||
131711270|NCT03690869|474219760|FG008|Overall Study|Physician Decision|0|||
131711271|NCT03690869|474219761|FG009|Overall Study|Physician Decision|0|||
131711272|NCT03690869|474219752|FG000|Overall Study|Progressive Disease|1|||
131711273|NCT03690869|474219753|FG001|Overall Study|Progressive Disease|2|||
131711274|NCT03690869|474219754|FG002|Overall Study|Progressive Disease|0|||
131711275|NCT03690869|474219755|FG003|Overall Study|Progressive Disease|1|||
131711276|NCT03690869|474219756|FG004|Overall Study|Progressive Disease|0|||
131711277|NCT03690869|474219757|FG005|Overall Study|Progressive Disease|0|||
131711278|NCT03690869|474219758|FG006|Overall Study|Progressive Disease|0|||
131711279|NCT03690869|474219759|FG007|Overall Study|Progressive Disease|0|||
131711280|NCT03690869|474219760|FG008|Overall Study|Progressive Disease|1|||
131711281|NCT03690869|474219761|FG009|Overall Study|Progressive Disease|1|||
131711282|NCT03690869|474219752|FG000|Overall Study|Subject Decision|0|||
131711283|NCT03690869|474219753|FG001|Overall Study|Subject Decision|0|||
131711284|NCT03690869|474219754|FG002|Overall Study|Subject Decision|0|||
131711285|NCT03690869|474219755|FG003|Overall Study|Subject Decision|1|||
131711286|NCT03690869|474219756|FG004|Overall Study|Subject Decision|0|||
131711287|NCT03690869|474219757|FG005|Overall Study|Subject Decision|0|||
131711288|NCT03690869|474219758|FG006|Overall Study|Subject Decision|0|||
131711289|NCT03690869|474219759|FG007|Overall Study|Subject Decision|1|||
131711290|NCT03690869|474219760|FG008|Overall Study|Subject Decision|0|||
131711291|NCT03690869|474219761|FG009|Overall Study|Subject Decision|0|||
131711292|NCT06119191|474219762|FG000|Overall Study|Adverse Event|0|||
131711293|NCT06119191|474219763|FG001|Overall Study|Adverse Event|1|||
131711294|NCT06119191|474219762|FG000|Overall Study|Protocol Violation|1|||
131624320|NCT01240590|473910798|FG000|Phase II|Refused further treatment|0|||
131624321|NCT01240590|473910799|FG001|Phase II|Refused further treatment|0|||
131624322|NCT01240590|473910800|FG002|Phase II|Refused further treatment|0|||
131624323|NCT01240590|473910801|FG003|Phase II|Refused further treatment|2|||
131624324|NCT01240590|473910802|FG004|Phase II|Refused further treatment|1|||
131624325|NCT03890484|473910805|FG000|Overall Study|Lost to Follow-up|1|||
131624326|NCT03890484|473910806|FG001|Overall Study|Lost to Follow-up|1|||
131624327|NCT02106325|473910807|FG000|Phase 1|Lost to Follow-up|2|||
131624328|NCT02106325|473910808|FG001|Phase 1|Lost to Follow-up|2|||
131624329|NCT02106325|473910807|FG000|Phase 2|Lost to Follow-up|2|||
131624330|NCT02106325|473910808|FG001|Phase 2|Lost to Follow-up|3|||
131624331|NCT02106325|473910807|FG000|Phase 3|Lost to Follow-up|2|||
131624332|NCT02106325|473910808|FG001|Phase 3|Lost to Follow-up|1|||
131624333|NCT01075152|473910809|FG000|Overall Study|Withdrawal by Subject|1|||
131624334|NCT01075152|473910810|FG001|Overall Study|Withdrawal by Subject|0|||
131624335|NCT00731692|473912727|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
131624336|NCT00731692|473912728|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
131624337|NCT00731692|473912729|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
131624338|NCT00731692|473912727|FG000|Core Study (36 Months)|Physician Decision|1|||
131624339|NCT00731692|473912728|FG001|Core Study (36 Months)|Physician Decision|0|||
131624340|NCT00731692|473912729|FG002|Core Study (36 Months)|Physician Decision|2|||
131624341|NCT00731692|473912727|FG000|Core Study (36 Months)|Death|2|||
131624342|NCT00731692|473912728|FG001|Core Study (36 Months)|Death|1|||
131624343|NCT00731692|473912729|FG002|Core Study (36 Months)|Death|2|||
131624344|NCT00731692|473912727|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
131624345|NCT00731692|473912728|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
131624346|NCT00731692|473912729|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
131624347|NCT00731692|473912727|FG000|Core Study (36 Months)|Administrative|2|||
131624348|NCT00731692|473912728|FG001|Core Study (36 Months)|Administrative|2|||
131624349|NCT00731692|473912729|FG002|Core Study (36 Months)|Administrative|6|||
131624350|NCT00731692|473912727|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
131624351|NCT00731692|473912728|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
131624352|NCT00731692|473912729|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
131624353|NCT00731692|473912727|FG000|Core Study (36 Months)|Protocol Violation|4|||
131624354|NCT00731692|473912728|FG001|Core Study (36 Months)|Protocol Violation|5|||
131624355|NCT00731692|473912729|FG002|Core Study (36 Months)|Protocol Violation|8|||
131624356|NCT00731692|473912727|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
131901135|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
131901136|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
131624357|NCT00731692|473912728|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
131624358|NCT00731692|473912729|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
131711295|NCT06119191|474219763|FG001|Overall Study|Protocol Violation|0|||
131711296|NCT03896581|474221430|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
131711297|NCT03896581|474221431|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
131711298|NCT03896581|474221430|FG000|Overall Study|Withdrawal by Subject|4|||
131711299|NCT03896581|474221431|FG001|Overall Study|Withdrawal by Subject|1|||
131711300|NCT03896581|474221430|FG000|Overall Study|Lost to Follow-up|1|||
131711301|NCT03896581|474221431|FG001|Overall Study|Lost to Follow-up|0|||
131711302|NCT03896581|474221430|FG000|Overall Study|Lack of Efficacy|2|||
131711303|NCT03896581|474221431|FG001|Overall Study|Lack of Efficacy|1|||
131711304|NCT03896581|474221430|FG000|Overall Study|Adverse event, non-fatal|0|||
131711305|NCT03896581|474221431|FG001|Overall Study|Adverse event, non-fatal|2|||
131711306|NCT01431287|474221432|FG000|Overall Study|not treated|0|||
131711307|NCT01431287|474221433|FG001|Overall Study|not treated|0|||
131711308|NCT01431287|474221434|FG002|Overall Study|not treated|1|||
131711309|NCT01431287|474221435|FG003|Overall Study|not treated|0|||
131711310|NCT01431287|474221436|FG004|Overall Study|not treated|0|||
131711311|NCT01431287|474221432|FG000|Overall Study|Adverse Event|59|||
131711312|NCT01431287|474221433|FG001|Overall Study|Adverse Event|57|||
131711313|NCT01431287|474221434|FG002|Overall Study|Adverse Event|53|||
131711314|NCT01431287|474221435|FG003|Overall Study|Adverse Event|33|||
131711315|NCT01431287|474221436|FG004|Overall Study|Adverse Event|41|||
131711316|NCT01431287|474221432|FG000|Overall Study|Non compliant with protocol|6|||
131711317|NCT01431287|474221433|FG001|Overall Study|Non compliant with protocol|6|||
131711318|NCT01431287|474221434|FG002|Overall Study|Non compliant with protocol|5|||
131711319|NCT01431287|474221435|FG003|Overall Study|Non compliant with protocol|6|||
131711320|NCT01431287|474221436|FG004|Overall Study|Non compliant with protocol|5|||
131711321|NCT01431287|474221432|FG000|Overall Study|Lost to Follow-up|0|||
131711322|NCT01431287|474221433|FG001|Overall Study|Lost to Follow-up|3|||
131711323|NCT01431287|474221434|FG002|Overall Study|Lost to Follow-up|2|||
131711324|NCT01431287|474221435|FG003|Overall Study|Lost to Follow-up|3|||
131624359|NCT00731692|473912727|FG000|Core Study (36 Months)|Adverse Event|25|||
131624360|NCT00731692|473912728|FG001|Core Study (36 Months)|Adverse Event|28|||
131624361|NCT00731692|473912729|FG002|Core Study (36 Months)|Adverse Event|29|||
131711325|NCT01431287|474221436|FG004|Overall Study|Lost to Follow-up|1|||
131711326|NCT01431287|474221432|FG000|Overall Study|Consent withdrawn not due to AE|29|||
131711327|NCT01431287|474221433|FG001|Overall Study|Consent withdrawn not due to AE|30|||
131624362|NCT00731692|473912727|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
131624363|NCT00731692|473912728|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
131624364|NCT00731692|473912729|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
131624365|NCT00731692|473912727|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
131624366|NCT00731692|473912728|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
131624367|NCT00731692|473912729|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
131624368|NCT00731692|473912727|FG000|Extension Phase|Abnormal test procedure|0|||
131624369|NCT00731692|473912728|FG001|Extension Phase|Abnormal test procedure|0|||
131624370|NCT00731692|473912729|FG002|Extension Phase|Abnormal test procedure|1|||
131624371|NCT00731692|473912727|FG000|Extension Phase|Abnormal lab values|0|||
131624372|NCT00731692|473912728|FG001|Extension Phase|Abnormal lab values|0|||
131796193|NCT00929708|474536076|FG000|Overall Study|Withdrawal by Subject|2|||
131796194|NCT00929708|474536077|FG001|Overall Study|Withdrawal by Subject|0|||
131796195|NCT00929708|474536078|FG002|Overall Study|Withdrawal by Subject|0|||
131796196|NCT00929708|474536079|FG003|Overall Study|Withdrawal by Subject|2|||
131796197|NCT00929708|474536080|FG004|Overall Study|Withdrawal by Subject|1|||
131796198|NCT00929708|474536076|FG000|Overall Study|Adverse Event|0|||
131796199|NCT00929708|474536077|FG001|Overall Study|Adverse Event|0|||
131796200|NCT00929708|474536078|FG002|Overall Study|Adverse Event|0|||
131796201|NCT00929708|474536079|FG003|Overall Study|Adverse Event|0|||
131796202|NCT00929708|474536080|FG004|Overall Study|Adverse Event|3|||
131796203|NCT00929708|474536076|FG000|Overall Study|Physician Decision|0|||
131796204|NCT00929708|474536077|FG001|Overall Study|Physician Decision|2|||
131796205|NCT00929708|474536078|FG002|Overall Study|Physician Decision|2|||
131796206|NCT00929708|474536079|FG003|Overall Study|Physician Decision|2|||
131796207|NCT00929708|474536080|FG004|Overall Study|Physician Decision|1|||
131796208|NCT00929708|474536076|FG000|Overall Study|Lost to Follow-up|0|||
131796209|NCT00929708|474536077|FG001|Overall Study|Lost to Follow-up|0|||
131796210|NCT00929708|474536078|FG002|Overall Study|Lost to Follow-up|0|||
131796211|NCT00929708|474536079|FG003|Overall Study|Lost to Follow-up|1|||
131796212|NCT00929708|474536080|FG004|Overall Study|Lost to Follow-up|0|||
131796213|NCT01893138|474536081|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131796214|NCT01893138|474536082|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131796215|NCT01893138|474536081|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
131796216|NCT01893138|474536082|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
131796217|NCT01893138|474536081|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
131796218|NCT01893138|474536082|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
131796219|NCT01893138|474536081|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
131796220|NCT01893138|474536082|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
131796221|NCT01893138|474536081|FG000|Open Label - Unblinded Period|Adverse Event|1|||
131796222|NCT01893138|474536082|FG001|Open Label - Unblinded Period|Adverse Event|0|||
131796223|NCT03329027|474537922|FG000|Overall Study|Lost to Follow-up|1|||
131796224|NCT03329027|474537923|FG001|Overall Study|Lost to Follow-up|0|||
131796225|NCT03329027|474537924|FG002|Overall Study|Lost to Follow-up|1|||
131796226|NCT03329027|474537922|FG000|Overall Study|Protocol Violation|9|||
131796227|NCT03329027|474537923|FG001|Overall Study|Protocol Violation|5|||
131796228|NCT03329027|474537924|FG002|Overall Study|Protocol Violation|7|||
131624373|NCT00731692|473912729|FG002|Extension Phase|Abnormal lab values|1|||
131796229|NCT01052116|474537930|FG000|Overall Study|Lost to Follow-up|11|||
131796230|NCT01052116|474537931|FG001|Overall Study|Lost to Follow-up|17|||
131796231|NCT01052116|474537930|FG000|Overall Study|Withdrawal by Subject|3|||
131796232|NCT01052116|474537931|FG001|Overall Study|Withdrawal by Subject|6|||
131796233|NCT01052116|474537930|FG000|Overall Study|Spirometry not performed|0|||
131796234|NCT01052116|474537931|FG001|Overall Study|Spirometry not performed|4|||
131796235|NCT01768858|474537932|FG000|Overall Study|Lost to Follow-up|9|||
131901137|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
131901138|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
131901139|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
131796236|NCT01768858|474537932|FG000|Overall Study|Lack of Efficacy|8|||
131796237|NCT01768858|474537932|FG000|Overall Study|Serious Adverse Event|1|||
131796238|NCT01768858|474537932|FG000|Overall Study|Participant moved to Germany|1|||
131796239|NCT01768858|474537932|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
131796240|NCT01768858|474537932|FG000|Overall Study|Exanthema|1|||
131796241|NCT01768858|474537932|FG000|Overall Study|Withdrawal by Subject|1|||
131796242|NCT04820842|474537940|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131796243|NCT04820842|474537941|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
131796244|NCT04820842|474537942|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
131796245|NCT04820842|474537943|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131796246|NCT04820842|474537944|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131796247|NCT04820842|474537945|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131796248|NCT04820842|474537946|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131796249|NCT04820842|474537940|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
131796250|NCT04820842|474537941|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
131796251|NCT04820842|474537942|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
131796252|NCT04820842|474537943|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796253|NCT04820842|474537944|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796254|NCT04820842|474537945|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796255|NCT04820842|474537946|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796256|NCT04820842|474537940|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131796257|NCT04820842|474537941|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
131796258|NCT04820842|474537942|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131624374|NCT00731692|473912727|FG000|Extension Phase|Lost to Follow-up|0|||
131796259|NCT04820842|474537943|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131796260|NCT04820842|474537944|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131796261|NCT04820842|474537945|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131901140|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
131624375|NCT00731692|473912728|FG001|Extension Phase|Lost to Follow-up|1|||
131624376|NCT00731692|473912729|FG002|Extension Phase|Lost to Follow-up|4|||
131624377|NCT00731692|473912727|FG000|Extension Phase|Withdrawal by Subject|4|||
131624378|NCT00731692|473912728|FG001|Extension Phase|Withdrawal by Subject|5|||
131624379|NCT00731692|473912729|FG002|Extension Phase|Withdrawal by Subject|3|||
131624380|NCT00731692|473912727|FG000|Extension Phase|Adverse Event|1|||
131624381|NCT00731692|473912728|FG001|Extension Phase|Adverse Event|1|||
131624382|NCT00731692|473912729|FG002|Extension Phase|Adverse Event|15|||
131624383|NCT03332589|473912730|FG000|Overall Study|Lack of Efficacy|2|||
131624384|NCT03332589|473912731|FG001|Overall Study|Lack of Efficacy|0|||
131624385|NCT03332589|473912732|FG002|Overall Study|Lack of Efficacy|0|||
131624386|NCT03332589|473912730|FG000|Overall Study|Adverse Event|1|||
131624387|NCT03332589|473912731|FG001|Overall Study|Adverse Event|0|||
131624388|NCT03332589|473912732|FG002|Overall Study|Adverse Event|0|||
131624389|NCT03332589|473912730|FG000|Overall Study|Death|1|||
131624390|NCT03332589|473912731|FG001|Overall Study|Death|0|||
131624391|NCT03332589|473912732|FG002|Overall Study|Death|0|||
131624392|NCT00108355|473912737|FG000|Overall Study|Peritonitis at index paracentesis|1|||
131624393|NCT00108355|473912738|FG001|Overall Study|Peritonitis at index paracentesis|1|||
131624394|NCT00108355|473912737|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
131624395|NCT00108355|473912738|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
131624396|NCT00087516|473912739|FG000|Overall Study|Adverse Event|10|||
131624397|NCT00087516|473912740|FG001|Overall Study|Adverse Event|10|||
131624398|NCT00087516|473912741|FG002|Overall Study|Adverse Event|3|||
131624399|NCT00087516|473912742|FG003|Overall Study|Adverse Event|6|||
131624400|NCT00087516|473912739|FG000|Overall Study|Lack of Efficacy|82|||
131624401|NCT00087516|473912740|FG001|Overall Study|Lack of Efficacy|80|||
131624402|NCT00087516|473912741|FG002|Overall Study|Lack of Efficacy|39|||
131624403|NCT00087516|473912742|FG003|Overall Study|Lack of Efficacy|29|||
131624404|NCT00087516|473912739|FG000|Overall Study|Lost to Follow-up|8|||
131624405|NCT00087516|473912740|FG001|Overall Study|Lost to Follow-up|6|||
131624406|NCT00087516|473912741|FG002|Overall Study|Lost to Follow-up|5|||
131624407|NCT00087516|473912742|FG003|Overall Study|Lost to Follow-up|5|||
131624408|NCT00087516|473912739|FG000|Overall Study|Protocol Violation|4|||
131624409|NCT00087516|473912740|FG001|Overall Study|Protocol Violation|8|||
131624410|NCT00087516|473912741|FG002|Overall Study|Protocol Violation|3|||
131624411|NCT00087516|473912742|FG003|Overall Study|Protocol Violation|6|||
131624412|NCT00087516|473912739|FG000|Overall Study|Withdrawal by Subject|16|||
131624413|NCT00087516|473912740|FG001|Overall Study|Withdrawal by Subject|27|||
131624414|NCT00087516|473912741|FG002|Overall Study|Withdrawal by Subject|11|||
131624415|NCT00087516|473912742|FG003|Overall Study|Withdrawal by Subject|12|||
131624416|NCT00087516|473912739|FG000|Overall Study|Site terminated|0|||
131624417|NCT00087516|473912740|FG001|Overall Study|Site terminated|2|||
131624418|NCT00087516|473912741|FG002|Overall Study|Site terminated|1|||
131624419|NCT00087516|473912742|FG003|Overall Study|Site terminated|0|||
131624420|NCT00087516|473912739|FG000|Overall Study|Protocol specified discontinuation|35|||
131624421|NCT00087516|473912740|FG001|Overall Study|Protocol specified discontinuation|33|||
131624422|NCT00087516|473912741|FG002|Overall Study|Protocol specified discontinuation|33|||
131624423|NCT00087516|473912742|FG003|Overall Study|Protocol specified discontinuation|26|||
131624424|NCT00087516|473912739|FG000|Overall Study|Patient moved|3|||
131624425|NCT00087516|473912740|FG001|Overall Study|Patient moved|2|||
131624426|NCT00087516|473912741|FG002|Overall Study|Patient moved|1|||
131624427|NCT00087516|473912742|FG003|Overall Study|Patient moved|0|||
131624428|NCT00087516|473912739|FG000|Overall Study|Patient was non-compliant|3|||
131624429|NCT00087516|473912740|FG001|Overall Study|Patient was non-compliant|1|||
131796262|NCT04820842|474537946|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131796263|NCT04820842|474537940|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796264|NCT04820842|474537941|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796265|NCT04820842|474537942|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796266|NCT04820842|474537943|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
131796267|NCT04820842|474537944|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131796268|NCT04820842|474537945|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131624430|NCT00087516|473912741|FG002|Overall Study|Patient was non-compliant|0|||
131624431|NCT00087516|473912742|FG003|Overall Study|Patient was non-compliant|0|||
131624432|NCT00087516|473912739|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
131624433|NCT00087516|473912740|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
131624434|NCT00087516|473912741|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
131624435|NCT00087516|473912742|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
131624436|NCT00087516|473912739|FG000|Overall Study|Other|0|||
131624437|NCT00087516|473912740|FG001|Overall Study|Other|0|||
131624438|NCT00087516|473912741|FG002|Overall Study|Other|1|||
131624439|NCT00087516|473912742|FG003|Overall Study|Other|0|||
131624440|NCT02958553|473912745|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
131624441|NCT02958553|473912745|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
131624442|NCT00929526|473912746|FG000|Overall Study|Withdrawal by Subject|1|||
131624443|NCT00929526|473912747|FG001|Overall Study|Withdrawal by Subject|11|||
131624444|NCT00929526|473912746|FG000|Overall Study|Lost to Follow-up|8|||
131624445|NCT00929526|473912747|FG001|Overall Study|Lost to Follow-up|12|||
131624446|NCT00929526|473912746|FG000|Overall Study|Other|8|||
131624447|NCT00929526|473912747|FG001|Overall Study|Other|6|||
131624448|NCT02547974|473912748|FG000|Overall Study|Withdrawal by Subject|1|||
131624449|NCT02547974|473912749|FG001|Overall Study|Withdrawal by Subject|0|||
131624450|NCT02547974|473912750|FG002|Overall Study|Withdrawal by Subject|0|||
131624451|NCT02547974|473912751|FG003|Overall Study|Withdrawal by Subject|0|||
131624452|NCT04766996|473912752|FG000|Overall Study|Withdrawal by Subject|1|||
131624453|NCT04766996|473912753|FG001|Overall Study|Withdrawal by Subject|0|||
131624454|NCT04766996|473912754|FG002|Overall Study|Withdrawal by Subject|13|||
131624455|NCT01102426|473912757|FG000|Overall Study|Randomized but not treated|4|||
131624456|NCT01102426|473912758|FG001|Overall Study|Randomized but not treated|1|||
131624457|NCT01102426|473912757|FG000|Overall Study|Adverse Events (treatment-related)|15|||
131624458|NCT01102426|473912758|FG001|Overall Study|Adverse Events (treatment-related)|8|||
131624459|NCT01102426|473912757|FG000|Overall Study|Physician Decision|9|||
131624460|NCT01102426|473912758|FG001|Overall Study|Physician Decision|6|||
131624461|NCT01102426|473912757|FG000|Overall Study|Progressive Disease|85|||
131624462|NCT01102426|473912758|FG001|Overall Study|Progressive Disease|44|||
131796269|NCT04820842|474537946|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
131796270|NCT00635778|474537947|FG000|Overall Study|Adverse Event|1|||
131796271|NCT00635778|474537948|FG001|Overall Study|Adverse Event|0|||
131796272|NCT00635778|474537949|FG002|Overall Study|Adverse Event|0|||
131796273|NCT00635778|474537950|FG003|Overall Study|Adverse Event|3|||
131796274|NCT00635778|474537951|FG004|Overall Study|Adverse Event|3|||
131796275|NCT00635778|474537952|FG005|Overall Study|Adverse Event|6|||
131796276|NCT00635778|474537953|FG006|Overall Study|Adverse Event|1|||
131796277|NCT00635778|474537947|FG000|Overall Study|Withdrawal by Subject|0|||
131796278|NCT00635778|474537948|FG001|Overall Study|Withdrawal by Subject|0|||
131796279|NCT00635778|474537949|FG002|Overall Study|Withdrawal by Subject|0|||
131796280|NCT00635778|474537950|FG003|Overall Study|Withdrawal by Subject|1|||
131796281|NCT00635778|474537951|FG004|Overall Study|Withdrawal by Subject|0|||
131796282|NCT00635778|474537952|FG005|Overall Study|Withdrawal by Subject|1|||
131796283|NCT00635778|474537953|FG006|Overall Study|Withdrawal by Subject|1|||
131796284|NCT00635778|474537947|FG000|Overall Study|Progressive disease|0|||
131796285|NCT00635778|474537948|FG001|Overall Study|Progressive disease|3|||
131796286|NCT00635778|474537949|FG002|Overall Study|Progressive disease|3|||
131796287|NCT00635778|474537950|FG003|Overall Study|Progressive disease|4|||
131796288|NCT00635778|474537951|FG004|Overall Study|Progressive disease|5|||
131796289|NCT00635778|474537952|FG005|Overall Study|Progressive disease|14|||
131796290|NCT00635778|474537953|FG006|Overall Study|Progressive disease|4|||
131796291|NCT00812253|474537954|FG000|Overall Study|Withdrawal by Subject|3|||
131796292|NCT00812253|474537955|FG001|Overall Study|Withdrawal by Subject|2|||
131796293|NCT00812253|474537954|FG000|Overall Study|Protocol Violation|1|||
131796294|NCT00812253|474537955|FG001|Overall Study|Protocol Violation|1|||
131796295|NCT00812253|474537954|FG000|Overall Study|Lost to Follow-up|2|||
131796296|NCT00812253|474537955|FG001|Overall Study|Lost to Follow-up|0|||
131796297|NCT01884025|474537956|FG000|Overall Study|Lost to Follow-up|3|||
131796298|NCT01884025|474537957|FG001|Overall Study|Lost to Follow-up|4|||
131796299|NCT02918162|474537958|FG000|Overall Study|Withdrawal by Subject|1|||
131796300|NCT02918162|474537958|FG000|Overall Study|Omental Disease|1|||
131796301|NCT00395226|474537959|FG000|Overall Study|Adverse Event|4|||
131624463|NCT01102426|473912757|FG000|Overall Study|Adverse Events (unrelated to|9|||
131624464|NCT01102426|473912758|FG001|Overall Study|Adverse Events (unrelated to|1|||
131624465|NCT01102426|473912757|FG000|Overall Study|Patient Refusal|24|||
131796302|NCT00395226|474537960|FG001|Overall Study|Adverse Event|3|||
131796303|NCT00395226|474537959|FG000|Overall Study|Withdrawal by Subject|0|||
131796304|NCT00395226|474537960|FG001|Overall Study|Withdrawal by Subject|1|||
131796305|NCT00395226|474537959|FG000|Overall Study|Lost to Follow-up|0|||
131796306|NCT00395226|474537960|FG001|Overall Study|Lost to Follow-up|1|||
131796307|NCT02374918|474537961|FG000|Overall Study|Protocol Violation|2|||
131624466|NCT01102426|473912758|FG001|Overall Study|Patient Refusal|12|||
131796308|NCT02374918|474537962|FG001|Overall Study|Protocol Violation|0|||
131796309|NCT02374918|474537963|FG002|Overall Study|Protocol Violation|2|||
131796310|NCT02374918|474537964|FG003|Overall Study|Protocol Violation|1|||
131796311|NCT02374918|474537961|FG000|Overall Study|Withdrawal by Subject|1|||
131796312|NCT02374918|474537962|FG001|Overall Study|Withdrawal by Subject|1|||
131796313|NCT02374918|474537963|FG002|Overall Study|Withdrawal by Subject|1|||
131796314|NCT02374918|474537964|FG003|Overall Study|Withdrawal by Subject|0|||
131796315|NCT02374918|474537961|FG000|Overall Study|Lack of Efficacy|0|||
131796316|NCT02374918|474537962|FG001|Overall Study|Lack of Efficacy|0|||
131796317|NCT02374918|474537963|FG002|Overall Study|Lack of Efficacy|1|||
131796318|NCT02374918|474537964|FG003|Overall Study|Lack of Efficacy|1|||
131796319|NCT02204371|474537965|FG000|Overall Study|Adverse Event|1|||
131796320|NCT01180244|474537966|FG000|Overall Study|Lack of Efficacy|0|||
131796321|NCT01180244|474537967|FG001|Overall Study|Lack of Efficacy|7|||
131796322|NCT01180244|474537966|FG000|Overall Study|Physician Decision|3|||
131796323|NCT01180244|474537967|FG001|Overall Study|Physician Decision|0|||
131796324|NCT01180244|474537966|FG000|Overall Study|Adverse Event|1|||
131796325|NCT01180244|474537967|FG001|Overall Study|Adverse Event|0|||
131796326|NCT01180244|474537966|FG000|Overall Study|Withdrawal by Subject|0|||
131796327|NCT01180244|474537967|FG001|Overall Study|Withdrawal by Subject|1|||
131796328|NCT01180244|474537966|FG000|Overall Study|Protocol Violation|1|||
131624467|NCT01102426|473912757|FG000|Overall Study|Death (due to adverse events|0|||
131624468|NCT01102426|473912758|FG001|Overall Study|Death (due to adverse events|1|||
131624469|NCT01102426|473912757|FG000|Overall Study|Death (non-related to the study|19|||
131624470|NCT01102426|473912758|FG001|Overall Study|Death (non-related to the study|8|||
131624471|NCT03547154|473912760|FG000|Overall Study|Disease Progression/Recurrence|6|||
131624472|NCT03547154|473912761|FG001|Overall Study|Disease Progression/Recurrence|14|||
131624473|NCT03547154|473912760|FG000|Overall Study|Adverse Event|26|||
131624474|NCT03547154|473912761|FG001|Overall Study|Adverse Event|31|||
131624475|NCT03547154|473912760|FG000|Overall Study|Protocol Violation|6|||
131624476|NCT03547154|473912761|FG001|Overall Study|Protocol Violation|1|||
131624477|NCT03547154|473912760|FG000|Overall Study|Physician Decision|4|||
131624478|NCT03547154|473912761|FG001|Overall Study|Physician Decision|3|||
131624479|NCT03547154|473912760|FG000|Overall Study|Insufficient Therapeutic Response|13|||
131624480|NCT03547154|473912761|FG001|Overall Study|Insufficient Therapeutic Response|10|||
131624481|NCT03547154|473912760|FG000|Overall Study|Withdrawal by Subject|10|||
131624482|NCT03547154|473912761|FG001|Overall Study|Withdrawal by Subject|6|||
131624483|NCT03547154|473912760|FG000|Overall Study|Not Selected|0|||
131624484|NCT03547154|473912761|FG001|Overall Study|Not Selected|1|||
131624485|NCT03547154|473912760|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
131624486|NCT03547154|473912761|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
131624487|NCT02988713|473912762|FG000|Overall Study|Withdrawal by Subject|1|||
131624488|NCT02988713|473912762|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
131624489|NCT01918033|473912763|FG000|Overall Study|Adverse Event|1|||
131624490|NCT01918033|473912764|FG001|Overall Study|Adverse Event|0|||
131624491|NCT01918033|473912765|FG002|Overall Study|Adverse Event|2|||
131624492|NCT01918033|473912763|FG000|Overall Study|Lost to Follow-up|0|||
131624493|NCT01918033|473912764|FG001|Overall Study|Lost to Follow-up|1|||
131624494|NCT01918033|473912765|FG002|Overall Study|Lost to Follow-up|0|||
131624495|NCT01918033|473912763|FG000|Overall Study|Protocol Violation|2|||
131624496|NCT01918033|473912764|FG001|Overall Study|Protocol Violation|0|||
131624497|NCT01918033|473912765|FG002|Overall Study|Protocol Violation|1|||
131624498|NCT01918033|473912763|FG000|Overall Study|Withdrawal by Subject|2|||
131624499|NCT01918033|473912764|FG001|Overall Study|Withdrawal by Subject|1|||
131624500|NCT01918033|473912765|FG002|Overall Study|Withdrawal by Subject|0|||
131624501|NCT04679675|473912766|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
131624502|NCT04679675|473912767|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
131624503|NCT04679675|473912768|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
131796329|NCT01180244|474537967|FG001|Overall Study|Protocol Violation|0|||
131796330|NCT01180244|474537966|FG000|Overall Study|Lost to Follow-up|1|||
131796331|NCT01180244|474537967|FG001|Overall Study|Lost to Follow-up|0|||
131796332|NCT00368966|474537970|FG000|Infant Series|Withdrawal by Subject|11|||
131796333|NCT00368966|474537971|FG001|Infant Series|Withdrawal by Subject|6|||
131796334|NCT00368966|474537970|FG000|Infant Series|Protocol Violation|2|||
131796335|NCT00368966|474537971|FG001|Infant Series|Protocol Violation|1|||
131796336|NCT00368966|474537970|FG000|Infant Series|Lost to Follow-up|2|||
131796337|NCT00368966|474537971|FG001|Infant Series|Lost to Follow-up|0|||
131624504|NCT04679675|473912769|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
131624505|NCT04679675|473912766|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
131624506|NCT04679675|473912767|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
131624507|NCT04679675|473912768|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
131796338|NCT00368966|474537970|FG000|Infant Series|Randomization error|0|||
131624508|NCT04679675|473912769|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
131796339|NCT00368966|474537971|FG001|Infant Series|Randomization error|1|||
131624509|NCT03259568|473912776|FG000|Overall Study|Participant performance was low|3|||
131624510|NCT01794299|473912778|FG000|Overall Study|ATIR manufacturing not possible|1|||
131624511|NCT01794299|473912778|FG000|Overall Study|Death|14|||
131624512|NCT01794299|473912778|FG000|Overall Study|Graft failure|1|||
131624513|NCT01794299|473912778|FG000|Overall Study|ATIR batch rejected|2|||
131624514|NCT01794299|473912778|FG000|Overall Study|Relapse|2|||
131624515|NCT01794299|473912778|FG000|Overall Study|Discontinued from active follow-up|1|||
131624516|NCT01794299|473912778|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
131624517|NCT01029704|473912779|FG000|Overall Study|Adverse Event|0|||
131624518|NCT01029704|473912780|FG001|Overall Study|Adverse Event|0|||
131624519|NCT01029704|473912781|FG002|Overall Study|Adverse Event|0|||
131624520|NCT01029704|473912782|FG003|Overall Study|Adverse Event|0|||
131624521|NCT01029704|473912783|FG004|Overall Study|Adverse Event|0|||
131624522|NCT01029704|473912784|FG005|Overall Study|Adverse Event|0|||
131624523|NCT01029704|473912785|FG006|Overall Study|Adverse Event|1|||
131624524|NCT01029704|473912786|FG007|Overall Study|Adverse Event|1|||
131624525|NCT01029704|473912787|FG008|Overall Study|Adverse Event|0|||
131624526|NCT01029704|473912779|FG000|Overall Study|Withdrawal by Subject|0|||
131624527|NCT01029704|473912780|FG001|Overall Study|Withdrawal by Subject|0|||
131624528|NCT01029704|473912781|FG002|Overall Study|Withdrawal by Subject|0|||
131624529|NCT01029704|473912782|FG003|Overall Study|Withdrawal by Subject|0|||
131624530|NCT01029704|473912783|FG004|Overall Study|Withdrawal by Subject|2|||
131624531|NCT01029704|473912784|FG005|Overall Study|Withdrawal by Subject|1|||
131624532|NCT01029704|473912785|FG006|Overall Study|Withdrawal by Subject|1|||
131624533|NCT01029704|473912786|FG007|Overall Study|Withdrawal by Subject|1|||
131624534|NCT01029704|473912787|FG008|Overall Study|Withdrawal by Subject|0|||
131624535|NCT01029704|473912779|FG000|Overall Study|Lost to Follow-up|0|||
131624536|NCT01029704|473912780|FG001|Overall Study|Lost to Follow-up|0|||
131624537|NCT01029704|473912781|FG002|Overall Study|Lost to Follow-up|0|||
131711328|NCT01431287|474221434|FG002|Overall Study|Consent withdrawn not due to AE|34|||
131711329|NCT01431287|474221435|FG003|Overall Study|Consent withdrawn not due to AE|19|||
131711330|NCT01431287|474221436|FG004|Overall Study|Consent withdrawn not due to AE|29|||
131711331|NCT01431287|474221432|FG000|Overall Study|not stated above|4|||
131711332|NCT01431287|474221433|FG001|Overall Study|not stated above|2|||
131711333|NCT01431287|474221434|FG002|Overall Study|not stated above|2|||
131711334|NCT01431287|474221435|FG003|Overall Study|not stated above|2|||
131711335|NCT01431287|474221436|FG004|Overall Study|not stated above|1|||
131711336|NCT02224664|474221438|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
131711337|NCT02224664|474221439|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131711338|NCT02224664|474221440|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131711339|NCT02224664|474221441|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131711340|NCT02224664|474221442|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131711341|NCT02224664|474221438|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
131711342|NCT02224664|474221439|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
131711343|NCT02224664|474221440|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
131711344|NCT02224664|474221441|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
131711345|NCT02224664|474221442|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
131711346|NCT02224664|474221438|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
131711347|NCT02224664|474221439|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
131711348|NCT02224664|474221440|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
131711349|NCT02224664|474221441|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
131711350|NCT02224664|474221442|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
131711351|NCT00110305|474221444|FG000|Overall Study|Adverse Event|46|||
131711352|NCT00110305|474221445|FG001|Overall Study|Adverse Event|13|||
131624538|NCT01029704|473912782|FG003|Overall Study|Lost to Follow-up|0|||
131624539|NCT01029704|473912783|FG004|Overall Study|Lost to Follow-up|0|||
131901141|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
131624540|NCT01029704|473912784|FG005|Overall Study|Lost to Follow-up|0|||
131624541|NCT01029704|473912785|FG006|Overall Study|Lost to Follow-up|1|||
131624542|NCT01029704|473912786|FG007|Overall Study|Lost to Follow-up|1|||
131624543|NCT01029704|473912787|FG008|Overall Study|Lost to Follow-up|1|||
131624544|NCT01029704|473912779|FG000|Overall Study|Lack of Efficacy|0|||
131624545|NCT01029704|473912780|FG001|Overall Study|Lack of Efficacy|0|||
131624546|NCT01029704|473912781|FG002|Overall Study|Lack of Efficacy|0|||
131624547|NCT01029704|473912782|FG003|Overall Study|Lack of Efficacy|0|||
131624548|NCT01029704|473912783|FG004|Overall Study|Lack of Efficacy|2|||
131624549|NCT01029704|473912784|FG005|Overall Study|Lack of Efficacy|3|||
131624550|NCT01029704|473912785|FG006|Overall Study|Lack of Efficacy|1|||
131624551|NCT01029704|473912786|FG007|Overall Study|Lack of Efficacy|2|||
131624552|NCT01029704|473912787|FG008|Overall Study|Lack of Efficacy|0|||
131624553|NCT01029704|473912779|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
131624554|NCT01029704|473912780|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
131624555|NCT01029704|473912781|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
131624556|NCT01029704|473912782|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
131624557|NCT01029704|473912783|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
131624558|NCT01029704|473912784|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
131624559|NCT01029704|473912785|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
131624560|NCT01029704|473912786|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
131624561|NCT01029704|473912787|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
131624562|NCT03006393|473912788|FG000|Overall Study|Withdrawal by Subject|1|||
131624563|NCT03006393|473912789|FG001|Overall Study|Withdrawal by Subject|1|||
131624564|NCT03006393|473912788|FG000|Overall Study|Pregnancy|0|||
131624565|NCT03006393|473912789|FG001|Overall Study|Pregnancy|1|||
131624566|NCT03006393|473912788|FG000|Overall Study|Lost to Follow-up|0|||
131624567|NCT03006393|473912789|FG001|Overall Study|Lost to Follow-up|1|||
131624568|NCT03136861|473912790|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
131624569|NCT03136861|473912791|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
131624570|NCT03136861|473912792|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131624571|NCT03136861|473912793|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131624572|NCT03136861|473912794|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131624573|NCT03136861|473912795|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131624574|NCT03136861|473912796|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131624575|NCT03136861|473912790|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
131624576|NCT03136861|473912791|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
131624577|NCT03136861|473912792|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131624578|NCT03136861|473912793|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131624579|NCT03136861|473912794|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131624580|NCT03136861|473912795|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131624581|NCT03136861|473912796|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131624582|NCT03136861|473912790|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
131624583|NCT03136861|473912791|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
131624584|NCT03136861|473912792|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131624585|NCT03136861|473912793|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131624586|NCT03136861|473912794|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131624587|NCT03136861|473912795|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131624588|NCT03136861|473912796|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131624589|NCT03136861|473912790|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131624590|NCT03136861|473912791|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
131624591|NCT03136861|473912792|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131796340|NCT00368966|474537970|FG000|Infant Series|Failed to meet eligibility criteria|0|||
131796341|NCT00368966|474537971|FG001|Infant Series|Failed to meet eligibility criteria|1|||
131796342|NCT00368966|474537970|FG000|Infant Series|Adverse Event|0|||
131796343|NCT00368966|474537971|FG001|Infant Series|Adverse Event|1|||
131796344|NCT00368966|474537970|FG000|Infant Series|Failed to return|1|||
131796345|NCT00368966|474537971|FG001|Infant Series|Failed to return|0|||
131796346|NCT00368966|474537970|FG000|After Infant|Failed to return|3|||
131796347|NCT00368966|474537971|FG001|After Infant|Failed to return|1|||
131796348|NCT00368966|474537970|FG000|After Infant|Adverse Event|1|||
131796349|NCT00368966|474537971|FG001|After Infant|Adverse Event|2|||
131624592|NCT03136861|473912793|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131624593|NCT03136861|473912794|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131796350|NCT00368966|474537970|FG000|After Infant|Withdrawal by Subject|1|||
131796351|NCT00368966|474537971|FG001|After Infant|Withdrawal by Subject|1|||
131796352|NCT00368966|474537970|FG000|After Infant|Death|1|||
131624594|NCT03136861|473912795|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131796353|NCT00368966|474537971|FG001|After Infant|Death|0|||
131796354|NCT00368966|474537970|FG000|After Infant|Lost to Follow-up|0|||
131796355|NCT00368966|474537971|FG001|After Infant|Lost to Follow-up|1|||
131624595|NCT03136861|473912796|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131624596|NCT03136861|473912790|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
131624597|NCT03136861|473912791|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
131624598|NCT03136861|473912792|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131624599|NCT03136861|473912793|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131624600|NCT03136861|473912794|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131624601|NCT03136861|473912795|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131624602|NCT03136861|473912796|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131624603|NCT03136861|473912790|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131624604|NCT03136861|473912791|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131624605|NCT03136861|473912792|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131624606|NCT03136861|473912793|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
131624607|NCT03136861|473912794|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
131624608|NCT03136861|473912795|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131624609|NCT03136861|473912796|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
131624610|NCT03136861|473912790|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131624611|NCT03136861|473912791|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131624612|NCT03136861|473912792|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
131624613|NCT03136861|473912793|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131624614|NCT03136861|473912794|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131624615|NCT03136861|473912795|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131624616|NCT03136861|473912796|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131624617|NCT03136861|473912790|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131624618|NCT03136861|473912791|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131624619|NCT03136861|473912792|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
131624620|NCT03136861|473912793|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131624621|NCT03136861|473912794|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131624622|NCT03136861|473912795|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131624623|NCT03136861|473912796|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131901142|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
131901143|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
131901144|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
131901145|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
131901146|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
131901147|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901148|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901149|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901150|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901151|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901152|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901153|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901154|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901155|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901156|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901157|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
131901158|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
131901159|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
131901160|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
131901161|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
131901162|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901163|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901164|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901165|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901166|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901167|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901168|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901169|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901170|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901171|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131711353|NCT00110305|474221444|FG000|Overall Study|Sponsors Decision|1|||
131901172|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
131901173|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901174|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
131624624|NCT05376397|473912801|FG000|Overall Study|Lost to Follow-up|1|||
131624625|NCT01328756|473912802|FG000|Overall Study|Protocol Violation|4|||
131624626|NCT01328756|473912802|FG000|Overall Study|Adverse Event|39|||
131624627|NCT01328756|473912802|FG000|Overall Study|Lack of Efficacy|5|||
131624628|NCT01328756|473912802|FG000|Overall Study|Withdrawal by Subject|41|||
131624629|NCT01328756|473912802|FG000|Overall Study|Lost to Follow-up|5|||
131624630|NCT01328756|473912802|FG000|Overall Study|Other|29|||
131624631|NCT01365546|473912806|FG000|Overall Study|Withdrawal by Subject|1|||
131624632|NCT01365546|473912806|FG000|Overall Study|Screen failure|9|||
131624633|NCT01365546|473912806|FG000|Overall Study|Study termination|1|||
131624634|NCT00472082|473912807|FG000|Overall Study|Study prematurely terminated|5|||
131624635|NCT00761267|473912808|FG000|Overall Study|Death|1|||
131624636|NCT00761267|473912809|FG001|Overall Study|Death|2|||
131624637|NCT00761267|473912810|FG002|Overall Study|Death|5|||
131624638|NCT00761267|473912808|FG000|Overall Study|Lost to Follow-up|0|||
131624639|NCT00761267|473912809|FG001|Overall Study|Lost to Follow-up|0|||
131624640|NCT00761267|473912810|FG002|Overall Study|Lost to Follow-up|1|||
131624641|NCT00761267|473912808|FG000|Overall Study|Randomized but not treated|1|||
131624642|NCT00761267|473912809|FG001|Overall Study|Randomized but not treated|1|||
131624643|NCT00761267|473912810|FG002|Overall Study|Randomized but not treated|0|||
131624644|NCT00761267|473912808|FG000|Overall Study|Withdrawal by Subject|0|||
131624645|NCT00761267|473912809|FG001|Overall Study|Withdrawal by Subject|1|||
131624646|NCT00761267|473912810|FG002|Overall Study|Withdrawal by Subject|0|||
131624647|NCT04492475|473912811|FG000|Overall Study|Enrolled but not treated|8|||
131624648|NCT04492475|473912812|FG001|Overall Study|Enrolled but not treated|8|||
131624649|NCT04492475|473912811|FG000|Overall Study|Withdrawal by Subject|4|||
131624650|NCT04492475|473912812|FG001|Overall Study|Withdrawal by Subject|0|||
131624651|NCT04492475|473912811|FG000|Overall Study|Became ineligible after enrollment|2|||
131624652|NCT04492475|473912812|FG001|Overall Study|Became ineligible after enrollment|0|||
131624653|NCT03200574|473912828|FG000|Overall Study|Death|4|||
131624654|NCT03200574|473912828|FG000|Overall Study|Withdrawal by Subject|8|||
131624655|NCT03200574|473912828|FG000|Overall Study|Long-Term need for anticoagulation|1|||
131624656|NCT03200574|473912828|FG000|Overall Study|Relocation|2|||
131624657|NCT03200574|473912828|FG000|Overall Study|Lost to Follow-up|2|||
131624658|NCT04183491|473912829|FG000|Overall Study|Withdrawal by Subject|0|||
131624659|NCT04183491|473912830|FG001|Overall Study|Withdrawal by Subject|0|||
131624660|NCT04183491|473912831|FG002|Overall Study|Withdrawal by Subject|1|||
131624661|NCT04183491|473912832|FG003|Overall Study|Withdrawal by Subject|0|||
131624662|NCT04183491|473912833|FG004|Overall Study|Withdrawal by Subject|0|||
131624663|NCT04183491|473912834|FG005|Overall Study|Withdrawal by Subject|1|||
131624664|NCT04183491|473912835|FG006|Overall Study|Withdrawal by Subject|0|||
131624665|NCT02538094|473912836|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
131624666|NCT02538094|473912837|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
131624667|NCT02538094|473912836|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
131624668|NCT02538094|473912837|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
131624669|NCT00068107|473912840|FG000|Overall Study|end-stage renal disease|6|||
131624670|NCT00068107|473912840|FG000|Overall Study|Death|2|||
131624671|NCT00068107|473912840|FG000|Overall Study|Withdrawal by Subject|1|||
131624672|NCT03288506|473912841|FG000|Overall Study|Withdrawal by Subject|52|||
131624673|NCT03205488|473912842|FG000|Overall Study|Adverse Event|1|||
131624674|NCT03205488|473912843|FG001|Overall Study|Adverse Event|2|||
131624675|NCT03205488|473912844|FG002|Overall Study|Adverse Event|4|||
131624676|NCT03205488|473912842|FG000|Overall Study|Protocol Violation|0|||
131624677|NCT03205488|473912843|FG001|Overall Study|Protocol Violation|0|||
131624678|NCT03205488|473912844|FG002|Overall Study|Protocol Violation|1|||
131624679|NCT01856569|473912845|FG000|Overall Study|Other|1|||
131624680|NCT01856569|473912845|FG000|Overall Study|Changed Site/Structure|1|||
131624681|NCT01856569|473912845|FG000|Overall Study|Lost to Follow-up|3|||
131624682|NCT01856569|473912845|FG000|Overall Study|Did not met inclusion criteria|8|||
131624683|NCT03652610|473912848|FG000|Overall Study|Lost to Follow-up|1|||
131624684|NCT03652610|473912849|FG001|Overall Study|Lost to Follow-up|0|||
131624685|NCT03652610|473912848|FG000|Overall Study|Withdrawal by Subject|3|||
131624686|NCT03652610|473912849|FG001|Overall Study|Withdrawal by Subject|5|||
131624687|NCT01860079|473912850|FG000|Overall Study|Physician Decision|14|||
131624688|NCT01860079|473912851|FG001|Overall Study|Physician Decision|22|||
131624689|NCT00326183|473912852|FG000|Overall Study|Lost to Follow-up|104|||
131624690|NCT00326183|473912853|FG001|Overall Study|Lost to Follow-up|56|||
131624691|NCT00326183|473912852|FG000|Overall Study|Protocol Violation|6|||
131624692|NCT00326183|473912853|FG001|Overall Study|Protocol Violation|3|||
131624693|NCT00326183|473912852|FG000|Overall Study|Withdrawal by Subject|35|||
131624694|NCT00326183|473912853|FG001|Overall Study|Withdrawal by Subject|7|||
131624695|NCT00326183|473912852|FG000|Overall Study|Subject Moved|7|||
131624696|NCT00326183|473912853|FG001|Overall Study|Subject Moved|4|||
131624697|NCT00326183|473912852|FG000|Overall Study|Other|47|||
131624698|NCT00326183|473912853|FG001|Overall Study|Other|13|||
131624699|NCT00326183|473912852|FG000|Overall Study|Adverse Event|1|||
131624700|NCT00326183|473912853|FG001|Overall Study|Adverse Event|0|||
131624701|NCT02279732|473912855|FG000|Overall Study|Death|23|||
131624702|NCT02279732|473912856|FG001|Overall Study|Death|20|||
131624703|NCT02279732|473912855|FG000|Overall Study|Disease Progression|13|||
131624704|NCT02279732|473912856|FG001|Overall Study|Disease Progression|3|||
131624705|NCT02279732|473912855|FG000|Overall Study|Withdrawal by Subject|2|||
131624706|NCT02279732|473912856|FG001|Overall Study|Withdrawal by Subject|7|||
131624707|NCT02279732|473912855|FG000|Overall Study|Adverse Event|1|||
131624708|NCT02279732|473912856|FG001|Overall Study|Adverse Event|2|||
131624709|NCT02279732|473912855|FG000|Overall Study|Administrative Reason By Sponsor|0|||
131624710|NCT02279732|473912856|FG001|Overall Study|Administrative Reason By Sponsor|2|||
131624711|NCT02279732|473912855|FG000|Overall Study|Study Drug Toxicity|2|||
131624712|NCT02279732|473912856|FG001|Overall Study|Study Drug Toxicity|0|||
131624713|NCT02279732|473912855|FG000|Overall Study|Lost to Follow-up|0|||
131624714|NCT02279732|473912856|FG001|Overall Study|Lost to Follow-up|1|||
131624715|NCT02279732|473912855|FG000|Overall Study|Maximum Clinical Benefit|1|||
131796356|NCT00368966|474537970|FG000|Toddler Dose|Withdrawal by Subject|1|||
131796357|NCT00368966|474537971|FG001|Toddler Dose|Withdrawal by Subject|1|||
131796358|NCT00368966|474537970|FG000|Toddler Dose|Lost to Follow-up|0|||
131796359|NCT00368966|474537971|FG001|Toddler Dose|Lost to Follow-up|2|||
131796360|NCT02866175|474537972|FG000|Overall Study|Adverse Event|56|||
131796361|NCT02866175|474537973|FG001|Overall Study|Adverse Event|54|||
131796362|NCT02866175|474537972|FG000|Overall Study|Withdrawal by Subject|31|||
131796363|NCT02866175|474537973|FG001|Overall Study|Withdrawal by Subject|52|||
131796364|NCT02866175|474537972|FG000|Overall Study|Death|30|||
131796365|NCT02866175|474537973|FG001|Overall Study|Death|23|||
131796366|NCT02866175|474537972|FG000|Overall Study|Other|7|||
131796367|NCT02866175|474537973|FG001|Overall Study|Other|14|||
131796368|NCT02866175|474537972|FG000|Overall Study|Progressive disease|1|||
131796369|NCT02866175|474537973|FG001|Overall Study|Progressive disease|1|||
131624716|NCT02279732|473912856|FG001|Overall Study|Maximum Clinical Benefit|0|||
131624717|NCT02279732|473912855|FG000|Overall Study|Subject Requested to Discontinue|0|||
131624718|NCT02279732|473912856|FG001|Overall Study|Subject Requested to Discontinue|1|||
131624719|NCT02279732|473912855|FG000|Overall Study|Other|53|||
131624720|NCT02279732|473912856|FG001|Overall Study|Other|67|||
131624721|NCT02279732|473912855|FG000|Overall Study|Other|3|||
131624722|NCT02279732|473912856|FG001|Overall Study|Other|3|||
131624723|NCT01880736|473912857|FG000|Overall Study|Adverse Event|0|||
131624724|NCT01880736|473912858|FG001|Overall Study|Adverse Event|0|||
131796370|NCT02866175|474537972|FG000|Overall Study|Lost to Follow-up|2|||
131796371|NCT02866175|474537973|FG001|Overall Study|Lost to Follow-up|0|||
131796372|NCT02866175|474537972|FG000|Overall Study|Lack of Efficacy|0|||
131796373|NCT02866175|474537973|FG001|Overall Study|Lack of Efficacy|1|||
131624725|NCT01880736|473912859|FG002|Overall Study|Adverse Event|0|||
131624726|NCT01880736|473912860|FG003|Overall Study|Adverse Event|1|||
131624727|NCT01880736|473912857|FG000|Overall Study|Withdrawal Criteria|1|||
131624728|NCT01880736|473912858|FG001|Overall Study|Withdrawal Criteria|2|||
131624729|NCT01880736|473912859|FG002|Overall Study|Withdrawal Criteria|1|||
131796374|NCT02866175|474537972|FG000|Overall Study|Physician Decision|3|||
131796375|NCT02866175|474537973|FG001|Overall Study|Physician Decision|15|||
131796376|NCT02866175|474537972|FG000|Overall Study|Did not receive treatment|5|||
131796377|NCT02866175|474537973|FG001|Overall Study|Did not receive treatment|15|||
131624730|NCT01880736|473912860|FG003|Overall Study|Withdrawal Criteria|5|||
131624731|NCT00266656|473912870|FG000|Overall Study|Death|1|||
131624732|NCT00266656|473912871|FG001|Overall Study|Death|0|||
131624733|NCT00266656|473912870|FG000|Overall Study|Lost to Follow-up|4|||
131624734|NCT00266656|473912871|FG001|Overall Study|Lost to Follow-up|1|||
131624735|NCT00266656|473912870|FG000|Overall Study|Withdrawal by Subject|4|||
131624736|NCT00266656|473912871|FG001|Overall Study|Withdrawal by Subject|2|||
131624737|NCT00266656|473912870|FG000|Overall Study|Did Not Reach Final Height|4|||
131624738|NCT00266656|473912871|FG001|Overall Study|Did Not Reach Final Height|8|||
131624739|NCT00266656|473912870|FG000|Overall Study|Parent/Caregiver Decision|1|||
131624740|NCT00266656|473912871|FG001|Overall Study|Parent/Caregiver Decision|2|||
131624741|NCT00428714|473912875|FG000|Overall Study|Progressive Disease|28|||
131624742|NCT00428714|473912876|FG001|Overall Study|Progressive Disease|36|||
131624743|NCT00428714|473912875|FG000|Overall Study|Withdrawal by Subject|0|||
131624744|NCT00428714|473912876|FG001|Overall Study|Withdrawal by Subject|3|||
131624745|NCT00428714|473912875|FG000|Overall Study|Adverse Event|0|||
131624746|NCT00428714|473912876|FG001|Overall Study|Adverse Event|2|||
131624747|NCT00428714|473912875|FG000|Overall Study|Physician Decision|1|||
131624748|NCT00428714|473912876|FG001|Overall Study|Physician Decision|1|||
131624749|NCT00428714|473912875|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
131624750|NCT00428714|473912876|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
131624751|NCT00428714|473912875|FG000|Overall Study|Death due to other then PD|1|||
131624752|NCT00428714|473912876|FG001|Overall Study|Death due to other then PD|0|||
131624753|NCT02432274|473912890|FG000|Overall Study|Death|2|||
131624754|NCT02432274|473912891|FG001|Overall Study|Death|6|||
131624755|NCT02432274|473912892|FG002|Overall Study|Death|7|||
131624756|NCT02432274|473912893|FG003|Overall Study|Death|0|||
131624757|NCT02432274|473912894|FG004|Overall Study|Death|27|||
131624758|NCT02432274|473912895|FG005|Overall Study|Death|7|||
131624759|NCT02432274|473912896|FG006|Overall Study|Death|9|||
131624760|NCT02432274|473912897|FG007|Overall Study|Death|14|||
131624761|NCT02432274|473912890|FG000|Overall Study|Withdrawal of Consent|0|||
131624762|NCT02432274|473912891|FG001|Overall Study|Withdrawal of Consent|0|||
131624763|NCT02432274|473912892|FG002|Overall Study|Withdrawal of Consent|0|||
131624764|NCT02432274|473912893|FG003|Overall Study|Withdrawal of Consent|0|||
131624765|NCT02432274|473912894|FG004|Overall Study|Withdrawal of Consent|2|||
131624766|NCT02432274|473912895|FG005|Overall Study|Withdrawal of Consent|0|||
131624767|NCT02432274|473912896|FG006|Overall Study|Withdrawal of Consent|1|||
131624768|NCT02432274|473912897|FG007|Overall Study|Withdrawal of Consent|2|||
131624769|NCT00116649|473912898|FG000|Overall Study|Adverse Event|20|||
131624770|NCT00116649|473912898|FG000|Overall Study|Lack of Efficacy|1|||
131624771|NCT00116649|473912898|FG000|Overall Study|Lost to Follow-up|32|||
131624772|NCT00116649|473912898|FG000|Overall Study|Withdrawal by Subject|68|||
131624773|NCT00116649|473912898|FG000|Overall Study|Local Skin Reaction|9|||
131624774|NCT00116649|473912898|FG000|Overall Study|Various Reasons|18|||
131624775|NCT00116649|473912898|FG000|Overall Study|Protocol Specified|7|||
131624776|NCT02326220|473912899|FG000|Double-blind Treatment Period|Adverse Event|1|||
131624777|NCT02326220|473912900|FG001|Double-blind Treatment Period|Adverse Event|2|||
131624778|NCT02326220|473912901|FG002|Double-blind Treatment Period|Adverse Event|0|||
131624779|NCT02326220|473912899|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131796378|NCT00729859|474537974|FG000|Overall Study|Adverse Event|0|||
131796379|NCT00729859|474537975|FG001|Overall Study|Adverse Event|1|||
131796380|NCT00729859|474537976|FG002|Overall Study|Adverse Event|0|||
131796381|NCT00729859|474537974|FG000|Overall Study|Withdrawal by Subject|0|||
131796382|NCT00729859|474537975|FG001|Overall Study|Withdrawal by Subject|1|||
131796383|NCT00729859|474537976|FG002|Overall Study|Withdrawal by Subject|0|||
131624780|NCT02326220|473912900|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131624781|NCT02326220|473912901|FG002|Double-blind Treatment Period|Protocol Violation|0|||
131624782|NCT02326220|473912899|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131796384|NCT02623829|474537980|FG000|Overall Study|Lost to Follow-up|1|||
131624783|NCT02326220|473912900|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131624784|NCT02326220|473912901|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131796385|NCT02623829|474537981|FG001|Overall Study|Lost to Follow-up|1|||
131796386|NCT00662025|474537982|FG000|Overall Study|Objective progression or relapse|51|||
131796387|NCT00662025|474537982|FG000|Overall Study|Adverse Event|7|||
131624785|NCT02326220|473912899|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
131624786|NCT02326220|473912900|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131796388|NCT00662025|474537982|FG000|Overall Study|Withdrawal by Subject|1|||
131624787|NCT02326220|473912901|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
131624788|NCT02326220|473912899|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131796389|NCT00662025|474537982|FG000|Overall Study|Results of other clinical study|2|||
131624789|NCT02326220|473912900|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
131624790|NCT02326220|473912901|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
131624791|NCT00667732|473912903|FG000|Run -In (8 Weeks)|Adverse Event|4|||
131624792|NCT00667732|473912904|FG001|Run -In (8 Weeks)|Adverse Event|0|||
131624793|NCT00667732|473912905|FG002|Run -In (8 Weeks)|Adverse Event|0|||
131624794|NCT00667732|473912903|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
131624795|NCT00667732|473912904|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
131624796|NCT00667732|473912905|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
131624797|NCT00667732|473912903|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
131624798|NCT00667732|473912904|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
131624799|NCT00667732|473912905|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
131624800|NCT03659136|473912906|FG000|Overall Study|Not treated|2|||
131624801|NCT03659136|473912907|FG001|Overall Study|Not treated|0|||
131624802|NCT03659136|473912906|FG000|Overall Study|Covid-19 related|1|||
131624803|NCT03659136|473912907|FG001|Overall Study|Covid-19 related|1|||
131624804|NCT03659136|473912906|FG000|Overall Study|Withdrawal by Subject|1|||
131624805|NCT03659136|473912907|FG001|Overall Study|Withdrawal by Subject|6|||
131624806|NCT03659136|473912906|FG000|Overall Study|Adverse Event|4|||
131624807|NCT03659136|473912907|FG001|Overall Study|Adverse Event|6|||
131624808|NCT03659136|473912906|FG000|Overall Study|Progressive disease|37|||
131624809|NCT03659136|473912907|FG001|Overall Study|Progressive disease|31|||
131624810|NCT03659136|473912906|FG000|Overall Study|Study closure|2|||
131624811|NCT03659136|473912907|FG001|Overall Study|Study closure|2|||
131624812|NCT03659136|473912906|FG000|Overall Study|Sponsor decision/recommendation|3|||
131624813|NCT03659136|473912907|FG001|Overall Study|Sponsor decision/recommendation|2|||
131624814|NCT03659136|473912906|FG000|Overall Study|Switched to other drug/therapy|2|||
131624815|NCT03659136|473912907|FG001|Overall Study|Switched to other drug/therapy|2|||
131624816|NCT03659136|473912906|FG000|Overall Study|Lack of clinical benefit|0|||
131624817|NCT03659136|473912907|FG001|Overall Study|Lack of clinical benefit|1|||
131624818|NCT03786471|473912908|FG000|Overall Study|Death|254|||
131624819|NCT03786471|473912909|FG001|Overall Study|Death|223|||
131624820|NCT03786471|473912910|FG002|Overall Study|Death|37|||
131624821|NCT03786471|473912908|FG000|Overall Study|Lost to Follow-up|63|||
131624822|NCT03786471|473912909|FG001|Overall Study|Lost to Follow-up|50|||
131624823|NCT03786471|473912910|FG002|Overall Study|Lost to Follow-up|15|||
131624824|NCT03786471|473912908|FG000|Overall Study|Withdrawal by Subject|99|||
131796390|NCT00662025|474537982|FG000|Overall Study|Target lesion cannot be evaluated|1|||
131796391|NCT00662025|474537982|FG000|Overall Study|Domestic circumstances|1|||
131796392|NCT03349333|474537983|FG000|Overall Study|Progression of Disease|36|||
131796393|NCT03349333|474537983|FG000|Overall Study|Adverse Event|11|||
131796394|NCT03349333|474537983|FG000|Overall Study|Other|6|||
131796395|NCT03349333|474537983|FG000|Overall Study|Withdrawal by Subject|5|||
131796396|NCT03349333|474537983|FG000|Overall Study|Conditions interfere with participation|2|||
131796397|NCT03349333|474537983|FG000|Overall Study|Physician Decision|2|||
131796398|NCT03349333|474537983|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
131796399|NCT03349333|474537983|FG000|Overall Study|Patients in treatment less than 24 month|8|||
131796400|NCT00760383|474537984|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
131796401|NCT00760383|474537985|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
131796402|NCT00783796|474537986|FG000|Overall Study|Did not receive any stent|4|||
131796403|NCT00783796|474537986|FG000|Overall Study|Received non-XIENCE V stent|1|||
131796404|NCT00783796|474537986|FG000|Overall Study|Received commercial XIENCE V stent|1|||
131796405|NCT00626925|474537987|FG000|Overall Study|Lost to Follow-up|1|||
131796406|NCT00626925|474537988|FG001|Overall Study|Lost to Follow-up|2|||
131796407|NCT00626925|474537987|FG000|Overall Study|relapse|1|||
131796408|NCT00626925|474537988|FG001|Overall Study|relapse|0|||
131796409|NCT00626925|474537987|FG000|Overall Study|Adverse effect|6|||
131796410|NCT00626925|474537988|FG001|Overall Study|Adverse effect|2|||
131624825|NCT03786471|473912909|FG001|Overall Study|Withdrawal by Subject|81|||
131624826|NCT03786471|473912910|FG002|Overall Study|Withdrawal by Subject|11|||
131624827|NCT01276509|473914342|FG000|Overall Study|Adverse Event|9|||
131624828|NCT01276509|473914343|FG001|Overall Study|Adverse Event|8|||
131624829|NCT01276509|473914344|FG002|Overall Study|Adverse Event|4|||
131624830|NCT01276509|473914345|FG003|Overall Study|Adverse Event|3|||
131796411|NCT00626925|474537987|FG000|Overall Study|Lack of Efficacy|1|||
131796412|NCT00626925|474537988|FG001|Overall Study|Lack of Efficacy|4|||
131796413|NCT00626925|474537987|FG000|Overall Study|Time constraints|3|||
131796414|NCT00626925|474537988|FG001|Overall Study|Time constraints|1|||
131624831|NCT01276509|473914342|FG000|Overall Study|Lack of Efficacy|2|||
131624832|NCT01276509|473914343|FG001|Overall Study|Lack of Efficacy|1|||
131624833|NCT01276509|473914344|FG002|Overall Study|Lack of Efficacy|1|||
131624834|NCT01276509|473914345|FG003|Overall Study|Lack of Efficacy|2|||
131624835|NCT01276509|473914342|FG000|Overall Study|Pregnancy|1|||
131624836|NCT01276509|473914343|FG001|Overall Study|Pregnancy|0|||
131624837|NCT01276509|473914344|FG002|Overall Study|Pregnancy|0|||
131624838|NCT01276509|473914345|FG003|Overall Study|Pregnancy|0|||
131624839|NCT01276509|473914342|FG000|Overall Study|Withdrawal by Subject|1|||
131624840|NCT01276509|473914343|FG001|Overall Study|Withdrawal by Subject|2|||
131624841|NCT01276509|473914344|FG002|Overall Study|Withdrawal by Subject|0|||
131624842|NCT01276509|473914345|FG003|Overall Study|Withdrawal by Subject|0|||
131624843|NCT01276509|473914342|FG000|Overall Study|Other|0|||
131624844|NCT01276509|473914343|FG001|Overall Study|Other|1|||
131624845|NCT01276509|473914344|FG002|Overall Study|Other|0|||
131624846|NCT01276509|473914345|FG003|Overall Study|Other|0|||
131624847|NCT00647699|473914347|FG000|Overall Study|Lost to Follow-up|5|||
131624848|NCT00647699|473914348|FG001|Overall Study|Lost to Follow-up|4|||
131624849|NCT00647699|473914347|FG000|Overall Study|Withdrawal by Subject|3|||
131624850|NCT00647699|473914348|FG001|Overall Study|Withdrawal by Subject|8|||
131624851|NCT00413283|473914349|FG000|Overall Study|Withdrawal by Subject|1|||
131624852|NCT00413283|473914350|FG001|Overall Study|Withdrawal by Subject|0|||
131624853|NCT00413283|473914351|FG002|Overall Study|Withdrawal by Subject|0|||
131624854|NCT00413283|473914352|FG003|Overall Study|Withdrawal by Subject|1|||
131624855|NCT00413283|473914349|FG000|Overall Study|Death|0|||
131624856|NCT00413283|473914350|FG001|Overall Study|Death|0|||
131624857|NCT00413283|473914351|FG002|Overall Study|Death|1|||
131624858|NCT00413283|473914352|FG003|Overall Study|Death|1|||
131624859|NCT00413283|473914349|FG000|Overall Study|Adverse Event|0|||
131624860|NCT00413283|473914350|FG001|Overall Study|Adverse Event|0|||
131624861|NCT00413283|473914351|FG002|Overall Study|Adverse Event|0|||
131624862|NCT00413283|473914352|FG003|Overall Study|Adverse Event|1|||
131624863|NCT00413283|473914349|FG000|Overall Study|Ineligibility determined|0|||
131624864|NCT00413283|473914350|FG001|Overall Study|Ineligibility determined|0|||
131624865|NCT00413283|473914351|FG002|Overall Study|Ineligibility determined|0|||
131624866|NCT00413283|473914352|FG003|Overall Study|Ineligibility determined|1|||
131624867|NCT00413283|473914349|FG000|Overall Study|Protocol deviation|0|||
131624868|NCT00413283|473914350|FG001|Overall Study|Protocol deviation|1|||
131624869|NCT00413283|473914351|FG002|Overall Study|Protocol deviation|0|||
131624870|NCT00413283|473914352|FG003|Overall Study|Protocol deviation|0|||
131624871|NCT00413283|473914349|FG000|Overall Study|Requirement for alternative therapy|0|||
131624872|NCT00413283|473914350|FG001|Overall Study|Requirement for alternative therapy|2|||
131624873|NCT00413283|473914351|FG002|Overall Study|Requirement for alternative therapy|0|||
131624874|NCT00413283|473914352|FG003|Overall Study|Requirement for alternative therapy|0|||
131624875|NCT00413283|473914349|FG000|Overall Study|Other|0|||
131624876|NCT00413283|473914350|FG001|Overall Study|Other|0|||
131624877|NCT00413283|473914351|FG002|Overall Study|Other|1|||
131624878|NCT00413283|473914352|FG003|Overall Study|Other|0|||
131624879|NCT02354417|473914353|FG000|Overall Study|Physician Decision|1|||
131624880|NCT01377844|473914354|FG000|Overall Study|Withdrawal by Subject|25|||
131624881|NCT01377844|473914355|FG001|Overall Study|Withdrawal by Subject|28|||
131624882|NCT01377844|473914354|FG000|Overall Study|Protocol Violation|2|||
131796415|NCT01215942|474537994|FG000|Treatment Period|Adverse Event|15|||
131796416|NCT01215942|474537995|FG001|Treatment Period|Adverse Event|26|||
131624883|NCT01377844|473914355|FG001|Overall Study|Protocol Violation|3|||
131624884|NCT01377844|473914354|FG000|Overall Study|Adverse Event|3|||
131624885|NCT01377844|473914355|FG001|Overall Study|Adverse Event|0|||
131796417|NCT01215942|474537994|FG000|Treatment Period|Death|2|||
131624886|NCT01377844|473914354|FG000|Overall Study|Physician Decision|6|||
131624887|NCT01377844|473914355|FG001|Overall Study|Physician Decision|3|||
131624888|NCT01377844|473914354|FG000|Overall Study|Study terminated by Sponsor|0|||
131624889|NCT01377844|473914355|FG001|Overall Study|Study terminated by Sponsor|1|||
131624890|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
131624891|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131624892|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131624893|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131624894|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
131624895|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131624896|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131624897|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131624898|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
131624899|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131624900|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131624901|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131624902|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
131624903|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131624904|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131624905|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131624906|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
131624907|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131624908|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131624909|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131624910|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
131624911|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131624912|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131624913|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131624914|NCT01185340|473914358|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
131624915|NCT01185340|473914359|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131624916|NCT01185340|473914360|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131624917|NCT01185340|473914361|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131624918|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
131624919|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
131624920|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
131624921|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
131624922|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
131624923|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
131624924|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
131624925|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
131624926|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
131624927|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
131624928|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
131624929|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
131624930|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131624931|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131624932|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131624933|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131624934|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
131624935|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131624936|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
131624937|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131624938|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
131624939|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
131624940|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
131624941|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
131624942|NCT01185340|473914358|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131624943|NCT01185340|473914359|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131624944|NCT01185340|473914360|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
131624945|NCT01185340|473914361|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
131624946|NCT02065895|473914362|FG000|Overall Study|Protocol Violation|1|||
131624947|NCT02065895|473914363|FG001|Overall Study|Protocol Violation|0|||
131624948|NCT02065895|473914364|FG002|Overall Study|Protocol Violation|0|||
131624949|NCT02065895|473914365|FG003|Overall Study|Protocol Violation|1|||
131624950|NCT02065895|473914366|FG004|Overall Study|Protocol Violation|0|||
131624951|NCT02065895|473914367|FG005|Overall Study|Protocol Violation|0|||
131624952|NCT02065895|473914362|FG000|Overall Study|Scheduling conflicts|0|||
131624953|NCT02065895|473914363|FG001|Overall Study|Scheduling conflicts|1|||
131711354|NCT00110305|474221445|FG001|Overall Study|Sponsors Decision|0|||
131711355|NCT00110305|474221444|FG000|Overall Study|Subject Non-Compliant|9|||
131624954|NCT02065895|473914364|FG002|Overall Study|Scheduling conflicts|0|||
131624955|NCT02065895|473914365|FG003|Overall Study|Scheduling conflicts|0|||
131624956|NCT02065895|473914366|FG004|Overall Study|Scheduling conflicts|0|||
131624957|NCT02065895|473914367|FG005|Overall Study|Scheduling conflicts|0|||
131624958|NCT03469258|473914368|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
131624959|NCT03403036|473914375|FG000|Overall Study|Lack of Efficacy|5|||
131624960|NCT00484198|473914378|FG000|Overall Study|Participant Withdrew Consent|12|||
131624961|NCT00484198|473914379|FG001|Overall Study|Participant Withdrew Consent|21|||
131624962|NCT00484198|473914380|FG002|Overall Study|Participant Withdrew Consent|47|||
131624963|NCT00484198|473914381|FG003|Overall Study|Participant Withdrew Consent|59|||
131624964|NCT00484198|473914378|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
131624965|NCT00484198|473914379|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
131624966|NCT00484198|473914380|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
131624967|NCT00484198|473914381|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
131624968|NCT00484198|473914378|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
131624969|NCT00484198|473914379|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
131624970|NCT00484198|473914380|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
131624971|NCT00484198|473914381|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
131624972|NCT00484198|473914378|FG000|Overall Study|Adverse Event|3|||
131624973|NCT00484198|473914379|FG001|Overall Study|Adverse Event|11|||
131624974|NCT00484198|473914380|FG002|Overall Study|Adverse Event|32|||
131624975|NCT00484198|473914381|FG003|Overall Study|Adverse Event|31|||
131624976|NCT00484198|473914378|FG000|Overall Study|Protocol Violation|0|||
131624977|NCT00484198|473914379|FG001|Overall Study|Protocol Violation|5|||
131624978|NCT00484198|473914380|FG002|Overall Study|Protocol Violation|6|||
131624979|NCT00484198|473914381|FG003|Overall Study|Protocol Violation|8|||
131624980|NCT00484198|473914378|FG000|Overall Study|Other|7|||
131624981|NCT00484198|473914379|FG001|Overall Study|Other|10|||
131624982|NCT00484198|473914380|FG002|Overall Study|Other|31|||
131624983|NCT00484198|473914381|FG003|Overall Study|Other|28|||
131624984|NCT03340961|473914382|FG000|Overall Study|Adverse Event|1|||
131624985|NCT03340961|473914383|FG001|Overall Study|Adverse Event|3|||
131624986|NCT03340961|473914384|FG002|Overall Study|Adverse Event|2|||
131624987|NCT03340961|473914385|FG003|Overall Study|Adverse Event|4|||
131624988|NCT03340961|473914382|FG000|Overall Study|Lost to Follow-up|0|||
131624989|NCT03340961|473914383|FG001|Overall Study|Lost to Follow-up|1|||
131624990|NCT03340961|473914384|FG002|Overall Study|Lost to Follow-up|0|||
131796418|NCT01215942|474537995|FG001|Treatment Period|Death|4|||
131796419|NCT01215942|474537994|FG000|Treatment Period|Lack of Efficacy|23|||
131796420|NCT01215942|474537995|FG001|Treatment Period|Lack of Efficacy|62|||
131796421|NCT01215942|474537994|FG000|Treatment Period|Lost to Follow-up|3|||
131796422|NCT01215942|474537995|FG001|Treatment Period|Lost to Follow-up|4|||
131796423|NCT01215942|474537994|FG000|Treatment Period|Withdrawal by Subject|17|||
131796424|NCT01215942|474537995|FG001|Treatment Period|Withdrawal by Subject|40|||
131796425|NCT01215942|474537994|FG000|Treatment Period|Physician Decision|5|||
131796426|NCT01215942|474537995|FG001|Treatment Period|Physician Decision|5|||
131796427|NCT01215942|474537994|FG000|Treatment Period|Protocol Violation|0|||
131796428|NCT01215942|474537995|FG001|Treatment Period|Protocol Violation|1|||
131796429|NCT01215942|474537994|FG000|Treatment Period|Sponsor Decision|349|||
131796430|NCT01215942|474537995|FG001|Treatment Period|Sponsor Decision|530|||
131796431|NCT01215942|474537994|FG000|Post-Treatment Follow-Up Period|Death|0|||
131796432|NCT01215942|474537995|FG001|Post-Treatment Follow-Up Period|Death|1|||
131796433|NCT01215942|474537994|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
131796434|NCT01215942|474537995|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
131796435|NCT01215942|474537994|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
131796436|NCT01215942|474537995|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
131624991|NCT03340961|473914385|FG003|Overall Study|Lost to Follow-up|1|||
131624992|NCT03340961|473914382|FG000|Overall Study|Withdrawal by Subject|3|||
131624993|NCT03340961|473914383|FG001|Overall Study|Withdrawal by Subject|2|||
131624994|NCT03340961|473914384|FG002|Overall Study|Withdrawal by Subject|4|||
131624995|NCT03340961|473914385|FG003|Overall Study|Withdrawal by Subject|7|||
131624996|NCT03340961|473914382|FG000|Overall Study|Use of prohibited treatment|0|||
131624997|NCT03340961|473914383|FG001|Overall Study|Use of prohibited treatment|3|||
131796437|NCT01215942|474537994|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
131796438|NCT01215942|474537995|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
131796439|NCT01215942|474537994|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
131796440|NCT01215942|474537995|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
131796441|NCT03267264|474537996|FG000|Overall Study|Withdrawal by Subject|1|||
131796442|NCT03267264|474537997|FG001|Overall Study|Withdrawal by Subject|0|||
131796443|NCT03267264|474537998|FG002|Overall Study|Withdrawal by Subject|2|||
131796444|NCT03267264|474537999|FG003|Overall Study|Withdrawal by Subject|4|||
131796445|NCT03305055|474538000|FG000|Overall Study|Withdrawal by Subject|0|||
131796446|NCT03305055|474538001|FG001|Overall Study|Withdrawal by Subject|1|||
131796447|NCT03305055|474538000|FG000|Overall Study|Adverse Event|1|||
131796448|NCT03305055|474538001|FG001|Overall Study|Adverse Event|1|||
131796449|NCT01766921|474538002|FG000|Overall Study|Administrative Reason|5|||
131796450|NCT01766921|474538003|FG001|Overall Study|Administrative Reason|5|||
131796451|NCT01766921|474538002|FG000|Overall Study|Death|1|||
131796452|NCT01766921|474538003|FG001|Overall Study|Death|1|||
131796453|NCT01766921|474538002|FG000|Overall Study|Lost to Follow-up|1|||
131796454|NCT01766921|474538003|FG001|Overall Study|Lost to Follow-up|3|||
131796455|NCT01766921|474538002|FG000|Overall Study|Unclassified|2|||
131624998|NCT03340961|473914384|FG002|Overall Study|Use of prohibited treatment|2|||
131624999|NCT03340961|473914385|FG003|Overall Study|Use of prohibited treatment|4|||
131625000|NCT03340961|473914382|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
131625001|NCT03340961|473914383|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
131625002|NCT03340961|473914384|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
131625003|NCT03340961|473914385|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
131625004|NCT03340961|473914382|FG000|Overall Study|Subject developed an exclusion criterion|0|||
131625005|NCT03340961|473914383|FG001|Overall Study|Subject developed an exclusion criterion|1|||
131625006|NCT03340961|473914384|FG002|Overall Study|Subject developed an exclusion criterion|0|||
131625007|NCT03340961|473914385|FG003|Overall Study|Subject developed an exclusion criterion|0|||
131625008|NCT03340961|473914382|FG000|Overall Study|Protocol Violation|1|||
131625009|NCT03340961|473914383|FG001|Overall Study|Protocol Violation|0|||
131625010|NCT03340961|473914384|FG002|Overall Study|Protocol Violation|1|||
131625011|NCT03340961|473914385|FG003|Overall Study|Protocol Violation|0|||
131625012|NCT03340961|473914382|FG000|Overall Study|Adverse Event|1|||
131625013|NCT03340961|473914383|FG001|Overall Study|Adverse Event|1|||
131796456|NCT01766921|474538003|FG001|Overall Study|Unclassified|2|||
131796457|NCT01766921|474538002|FG000|Overall Study|Protocol Violation|1|||
131796458|NCT01766921|474538003|FG001|Overall Study|Protocol Violation|1|||
131796459|NCT01766921|474538002|FG000|Overall Study|Withdrawal by Subject|14|||
131796460|NCT01766921|474538003|FG001|Overall Study|Withdrawal by Subject|5|||
131796461|NCT01915732|474538006|FG000|Overall Study|Withdrawal by Subject|18|||
131796462|NCT01915732|474538007|FG001|Overall Study|Withdrawal by Subject|18|||
131796463|NCT01915732|474538006|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
131796464|NCT01915732|474538007|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131796465|NCT01915732|474538006|FG000|Overall Study|Adverse Event|12|||
131796466|NCT01915732|474538007|FG001|Overall Study|Adverse Event|4|||
131796467|NCT01915732|474538006|FG000|Overall Study|Protocol Violation|5|||
131796468|NCT01915732|474538007|FG001|Overall Study|Protocol Violation|5|||
131625014|NCT03340961|473914384|FG002|Overall Study|Adverse Event|0|||
131625015|NCT03340961|473914385|FG003|Overall Study|Adverse Event|0|||
131625016|NCT03340961|473914382|FG000|Overall Study|Lack of Efficacy|0|||
131625017|NCT03340961|473914383|FG001|Overall Study|Lack of Efficacy|0|||
131625018|NCT03340961|473914384|FG002|Overall Study|Lack of Efficacy|0|||
131625019|NCT03340961|473914385|FG003|Overall Study|Lack of Efficacy|1|||
131625020|NCT00308308|473914386|FG000|Overall Study|Adverse Event|17|||
131625021|NCT00308308|473914387|FG001|Overall Study|Adverse Event|2|||
131625022|NCT00308308|473914386|FG000|Overall Study|Lost to Follow-up|5|||
131625023|NCT00308308|473914387|FG001|Overall Study|Lost to Follow-up|5|||
131625024|NCT00308308|473914386|FG000|Overall Study|Physician Decision|15|||
131625025|NCT00308308|473914387|FG001|Overall Study|Physician Decision|7|||
131625026|NCT00308308|473914386|FG000|Overall Study|Protocol Violation|3|||
131625027|NCT00308308|473914387|FG001|Overall Study|Protocol Violation|14|||
131625028|NCT00308308|473914386|FG000|Overall Study|Withdrawal by Subject|47|||
131625029|NCT00308308|473914387|FG001|Overall Study|Withdrawal by Subject|19|||
131625030|NCT00308308|473914386|FG000|Overall Study|Various|7|||
131625031|NCT00308308|473914387|FG001|Overall Study|Various|5|||
131625032|NCT00308308|473914386|FG000|Overall Study|Randomized but not dosed|8|||
131625033|NCT00308308|473914387|FG001|Overall Study|Randomized but not dosed|16|||
131625034|NCT00308308|473914386|FG000|Overall Study|Other|1|||
131625035|NCT00308308|473914387|FG001|Overall Study|Other|0|||
131625036|NCT01686152|473914388|FG000|Overall Study|Withdrawal by Subject|11|||
131625037|NCT01686152|473914389|FG001|Overall Study|Withdrawal by Subject|11|||
131625038|NCT01686152|473914390|FG002|Overall Study|Withdrawal by Subject|3|||
131625039|NCT01686152|473914388|FG000|Overall Study|Drug Code Unblinded|0|||
131625040|NCT01686152|473914389|FG001|Overall Study|Drug Code Unblinded|1|||
131625041|NCT01686152|473914390|FG002|Overall Study|Drug Code Unblinded|0|||
131625042|NCT01686152|473914388|FG000|Overall Study|Protocol Violation|6|||
131625043|NCT01686152|473914389|FG001|Overall Study|Protocol Violation|1|||
131625044|NCT01686152|473914390|FG002|Overall Study|Protocol Violation|0|||
131625045|NCT01686152|473914388|FG000|Overall Study|Adverse Event|12|||
131625046|NCT01686152|473914389|FG001|Overall Study|Adverse Event|11|||
131625047|NCT01686152|473914390|FG002|Overall Study|Adverse Event|0|||
131625048|NCT01686152|473914388|FG000|Overall Study|Lack of Efficacy|0|||
131625049|NCT01686152|473914389|FG001|Overall Study|Lack of Efficacy|0|||
131625050|NCT01686152|473914390|FG002|Overall Study|Lack of Efficacy|1|||
131625051|NCT01686152|473914388|FG000|Overall Study|IP Non-compliance|5|||
131625052|NCT01686152|473914389|FG001|Overall Study|IP Non-compliance|5|||
131625053|NCT01686152|473914390|FG002|Overall Study|IP Non-compliance|0|||
131625054|NCT01686152|473914388|FG000|Overall Study|Lost to Follow-up|7|||
131625055|NCT01686152|473914389|FG001|Overall Study|Lost to Follow-up|6|||
131625056|NCT01686152|473914390|FG002|Overall Study|Lost to Follow-up|5|||
131625057|NCT01853384|473914391|FG000|Randomized|Adverse Event|5|||
131625058|NCT01853384|473914392|FG001|Randomized|Adverse Event|3|||
131625059|NCT01853384|473914391|FG000|Randomized|Death|1|||
131625060|NCT01853384|473914392|FG001|Randomized|Death|2|||
131625061|NCT01853384|473914391|FG000|Randomized|Lost to Follow-up|1|||
131625062|NCT01853384|473914392|FG001|Randomized|Lost to Follow-up|1|||
131625063|NCT01853384|473914391|FG000|Randomized|Withdrawal by Subject|5|||
131625064|NCT01853384|473914392|FG001|Randomized|Withdrawal by Subject|3|||
131625065|NCT01853384|473914391|FG000|Randomized|Sponsor Decision|47|||
131625066|NCT01853384|473914392|FG001|Randomized|Sponsor Decision|34|||
131796469|NCT01915732|474538006|FG000|Overall Study|Lack of Efficacy|6|||
131796470|NCT01915732|474538007|FG001|Overall Study|Lack of Efficacy|11|||
131796471|NCT01915732|474538006|FG000|Overall Study|Lost to Follow-up|22|||
131796472|NCT01915732|474538007|FG001|Overall Study|Lost to Follow-up|26|||
131796473|NCT01915732|474538006|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
131901175|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131625067|NCT01853384|473914391|FG000|Randomized|Other|3|||
131625068|NCT01853384|473914392|FG001|Randomized|Other|3|||
131625069|NCT01853384|473914391|FG000|Completed Follow up Visit 1|Early Termination|13|||
131625070|NCT01853384|473914392|FG001|Completed Follow up Visit 1|Early Termination|9|||
131625071|NCT01853384|473914391|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
131796474|NCT01915732|474538007|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
131796475|NCT01915732|474538006|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
131625072|NCT01853384|473914392|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
131625073|NCT01853384|473914391|FG000|Completed Follow up Visit 2|Adverse Event|1|||
131625074|NCT01853384|473914392|FG001|Completed Follow up Visit 2|Adverse Event|0|||
131625075|NCT01853384|473914391|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
131625076|NCT01853384|473914392|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
131625077|NCT01853384|473914391|FG000|Completed Follow up Visit 2|Death|1|||
131625078|NCT01853384|473914392|FG001|Completed Follow up Visit 2|Death|0|||
131625079|NCT01853384|473914391|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
131625080|NCT01853384|473914392|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
131625081|NCT01802333|473914393|FG000|Overall Study|Ineligible|2|||
131625082|NCT01802333|473914394|FG001|Overall Study|Ineligible|6|||
131625083|NCT01802333|473914395|FG002|Overall Study|Ineligible|8|||
131625084|NCT01802333|473914393|FG000|Overall Study|Adverse Event|1|||
131625085|NCT01802333|473914394|FG001|Overall Study|Adverse Event|8|||
131625086|NCT01802333|473914395|FG002|Overall Study|Adverse Event|8|||
131625087|NCT01802333|473914393|FG000|Overall Study|Withdrawal by Subject|6|||
131625088|NCT01802333|473914394|FG001|Overall Study|Withdrawal by Subject|6|||
131625089|NCT01802333|473914395|FG002|Overall Study|Withdrawal by Subject|5|||
131625090|NCT01802333|473914393|FG000|Overall Study|Progression/relapse|1|||
131625091|NCT01802333|473914394|FG001|Overall Study|Progression/relapse|3|||
131625092|NCT01802333|473914395|FG002|Overall Study|Progression/relapse|0|||
131625093|NCT01802333|473914393|FG000|Overall Study|Death|7|||
131625094|NCT01802333|473914394|FG001|Overall Study|Death|14|||
131625095|NCT01802333|473914395|FG002|Overall Study|Death|13|||
131625096|NCT01802333|473914393|FG000|Overall Study|Other - not protocol specified|32|||
131625097|NCT01802333|473914394|FG001|Overall Study|Other - not protocol specified|22|||
131625098|NCT01802333|473914395|FG002|Overall Study|Other - not protocol specified|24|||
131625099|NCT01802333|473914393|FG000|Overall Study|Did not start treatment|0|||
131625100|NCT01802333|473914394|FG001|Overall Study|Did not start treatment|2|||
131625101|NCT01802333|473914395|FG002|Overall Study|Did not start treatment|5|||
131625102|NCT01947491|473914396|FG000|Overall Study|Lost to Follow-up|5|||
131625103|NCT01947491|473914397|FG001|Overall Study|Lost to Follow-up|3|||
131625104|NCT01947491|473914398|FG002|Overall Study|Lost to Follow-up|1|||
131625105|NCT01947491|473914399|FG003|Overall Study|Lost to Follow-up|2|||
131625106|NCT01947491|473914396|FG000|Overall Study|Lack of Efficacy|1|||
131625107|NCT01947491|473914397|FG001|Overall Study|Lack of Efficacy|0|||
131625108|NCT01947491|473914398|FG002|Overall Study|Lack of Efficacy|0|||
131625109|NCT01947491|473914399|FG003|Overall Study|Lack of Efficacy|1|||
131625110|NCT01947491|473914396|FG000|Overall Study|Protocol Violation|1|||
131625111|NCT01947491|473914397|FG001|Overall Study|Protocol Violation|0|||
131625112|NCT01947491|473914398|FG002|Overall Study|Protocol Violation|0|||
131625113|NCT01947491|473914399|FG003|Overall Study|Protocol Violation|0|||
131625114|NCT01947491|473914396|FG000|Overall Study|Withdrawal by Subject|1|||
131625115|NCT01947491|473914397|FG001|Overall Study|Withdrawal by Subject|1|||
131625116|NCT01947491|473914398|FG002|Overall Study|Withdrawal by Subject|1|||
131625117|NCT01947491|473914399|FG003|Overall Study|Withdrawal by Subject|0|||
131625118|NCT01947491|473914396|FG000|Overall Study|Worsening of condition|0|||
131625119|NCT01947491|473914397|FG001|Overall Study|Worsening of condition|1|||
131625120|NCT01947491|473914398|FG002|Overall Study|Worsening of condition|0|||
131625121|NCT01947491|473914399|FG003|Overall Study|Worsening of condition|0|||
131625122|NCT01947491|473914396|FG000|Overall Study|Adverse Event|0|||
131625123|NCT01947491|473914397|FG001|Overall Study|Adverse Event|1|||
131625124|NCT01947491|473914398|FG002|Overall Study|Adverse Event|0|||
131625125|NCT01947491|473914399|FG003|Overall Study|Adverse Event|2|||
131625126|NCT02067663|473914401|FG000|Overall Study|Lost to Follow-up|13|||
131625127|NCT02067663|473914402|FG001|Overall Study|Lost to Follow-up|14|||
131625128|NCT00704340|473914403|FG000|Overall Study|Lost to Follow-up|2|||
131625129|NCT00704340|473914404|FG001|Overall Study|Lost to Follow-up|1|||
131625130|NCT00704340|473914403|FG000|Overall Study|Death|0|||
131625131|NCT00704340|473914404|FG001|Overall Study|Death|1|||
131625132|NCT03137784|473914405|FG000|Overall Study|Adverse Event|1|||
131625133|NCT03137784|473914406|FG001|Overall Study|Adverse Event|1|||
131625134|NCT03137784|473914407|FG002|Overall Study|Adverse Event|0|||
131625135|NCT03137784|473914408|FG003|Overall Study|Adverse Event|0|||
131625136|NCT03137784|473914409|FG004|Overall Study|Adverse Event|0|||
131625137|NCT03137784|473914410|FG005|Overall Study|Adverse Event|0|||
131625138|NCT03137784|473914405|FG000|Overall Study|Subject/guardian decision|1|||
131625139|NCT03137784|473914406|FG001|Overall Study|Subject/guardian decision|0|||
131711356|NCT00110305|474221445|FG001|Overall Study|Subject Non-Compliant|2|||
131444061|NCT05138653|473255037|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131625140|NCT03137784|473914407|FG002|Overall Study|Subject/guardian decision|0|||
131625141|NCT03137784|473914408|FG003|Overall Study|Subject/guardian decision|0|||
131625142|NCT03137784|473914409|FG004|Overall Study|Subject/guardian decision|0|||
131625143|NCT03137784|473914410|FG005|Overall Study|Subject/guardian decision|0|||
131625144|NCT03137784|473914405|FG000|Overall Study|Non-compliance with study treatment|0|||
131625145|NCT03137784|473914406|FG001|Overall Study|Non-compliance with study treatment|0|||
131625146|NCT03137784|473914407|FG002|Overall Study|Non-compliance with study treatment|0|||
131625147|NCT03137784|473914408|FG003|Overall Study|Non-compliance with study treatment|0|||
131625148|NCT03137784|473914409|FG004|Overall Study|Non-compliance with study treatment|1|||
131625149|NCT03137784|473914410|FG005|Overall Study|Non-compliance with study treatment|0|||
131625150|NCT01437540|473914411|FG000|Overall Study|Not listed below|7|||
131625151|NCT01437540|473914412|FG001|Overall Study|Not listed below|6|||
131625152|NCT01437540|473914411|FG000|Overall Study|COPD exacerbation|13|||
131625153|NCT01437540|473914412|FG001|Overall Study|COPD exacerbation|3|||
131625154|NCT01437540|473914411|FG000|Overall Study|Lost to Follow-up|3|||
131625155|NCT01437540|473914412|FG001|Overall Study|Lost to Follow-up|5|||
131625156|NCT01437540|473914411|FG000|Overall Study|Lack of Efficacy|23|||
131625157|NCT01437540|473914412|FG001|Overall Study|Lack of Efficacy|11|||
131625158|NCT01437540|473914411|FG000|Overall Study|Protocol Violation|24|||
131625159|NCT01437540|473914412|FG001|Overall Study|Protocol Violation|12|||
131625160|NCT01437540|473914411|FG000|Overall Study|Adverse Event|26|||
131625161|NCT01437540|473914412|FG001|Overall Study|Adverse Event|13|||
131625162|NCT01437540|473914411|FG000|Overall Study|Withdrawal by Subject|31|||
131625163|NCT01437540|473914412|FG001|Overall Study|Withdrawal by Subject|15|||
131625164|NCT01205126|473914414|FG000|Titration Phase|Adverse Event|5|||
131625165|NCT01205126|473914415|FG001|Titration Phase|Adverse Event|3|||
131625166|NCT01205126|473914414|FG000|Titration Phase|Withdrawal by Subject|5|||
131625167|NCT01205126|473914415|FG001|Titration Phase|Withdrawal by Subject|5|||
131625168|NCT01205126|473914414|FG000|Titration Phase|Lost to Follow-up|2|||
131625169|NCT01205126|473914415|FG001|Titration Phase|Lost to Follow-up|2|||
131625170|NCT01205126|473914414|FG000|Titration Phase|No stable titration dose|1|||
131625171|NCT01205126|473914415|FG001|Titration Phase|No stable titration dose|0|||
131625172|NCT01205126|473914414|FG000|Titration Phase|More than maximum dosage required|2|||
131625173|NCT01205126|473914415|FG001|Titration Phase|More than maximum dosage required|3|||
131625174|NCT01205126|473914414|FG000|Titration Phase|Other|8|||
131625175|NCT01205126|473914415|FG001|Titration Phase|Other|6|||
131625176|NCT01205126|473914414|FG000|Between Titration & Maintenance Phase|Other|0|||
131625177|NCT01205126|473914415|FG001|Between Titration & Maintenance Phase|Other|4|||
131625178|NCT01205126|473914414|FG000|Maintenance Phase|Adverse Event|3|||
131625179|NCT01205126|473914415|FG001|Maintenance Phase|Adverse Event|7|||
131625180|NCT01205126|473914414|FG000|Maintenance Phase|Death|4|||
131711357|NCT00110305|474221444|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
131711358|NCT00110305|474221445|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
131711359|NCT00110305|474221444|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
131711360|NCT00110305|474221445|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
131711361|NCT00110305|474221444|FG000|Overall Study|Protocol Violation|0|||
131711362|NCT00110305|474221445|FG001|Overall Study|Protocol Violation|1|||
131711363|NCT00110305|474221444|FG000|Overall Study|Withdrawal by Subject|7|||
131711364|NCT00110305|474221445|FG001|Overall Study|Withdrawal by Subject|7|||
131711365|NCT00110305|474221444|FG000|Overall Study|Lost to Follow-up|20|||
131711366|NCT00110305|474221445|FG001|Overall Study|Lost to Follow-up|3|||
131711367|NCT00110305|474221444|FG000|Overall Study|Other|8|||
131711368|NCT00110305|474221445|FG001|Overall Study|Other|2|||
131711369|NCT05047523|474221458|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131796476|NCT01915732|474538007|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
131796477|NCT01915732|474538006|FG000|Overall Study|Drug Release Error|1|||
131796478|NCT01915732|474538007|FG001|Overall Study|Drug Release Error|0|||
131796479|NCT01915732|474538006|FG000|Overall Study|Recovered|1|||
131796480|NCT01915732|474538007|FG001|Overall Study|Recovered|0|||
131796481|NCT01915732|474538006|FG000|Overall Study|Pregnancy|1|||
131796482|NCT01915732|474538007|FG001|Overall Study|Pregnancy|0|||
131796483|NCT01915732|474538006|FG000|Overall Study|Poor Perceived Efficacy|1|||
131796484|NCT01915732|474538007|FG001|Overall Study|Poor Perceived Efficacy|0|||
131796485|NCT01915732|474538006|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
131796486|NCT01915732|474538007|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
131796487|NCT01915732|474538006|FG000|Overall Study|Got Well|0|||
131796488|NCT01915732|474538007|FG001|Overall Study|Got Well|1|||
131796489|NCT01915732|474538006|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
131796490|NCT01915732|474538007|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
131625181|NCT01205126|473914415|FG001|Maintenance Phase|Death|4|||
131625182|NCT01205126|473914414|FG000|Maintenance Phase|More than the maximum dosage required|5|||
131625183|NCT01205126|473914415|FG001|Maintenance Phase|More than the maximum dosage required|5|||
131625184|NCT01205126|473914414|FG000|Maintenance Phase|Prohibited drugs used|1|||
131625185|NCT01205126|473914415|FG001|Maintenance Phase|Prohibited drugs used|0|||
131625186|NCT01205126|473914414|FG000|Maintenance Phase|Other|11|||
131625187|NCT01205126|473914415|FG001|Maintenance Phase|Other|8|||
131625188|NCT01205126|473914414|FG000|Maintenance Phase|Lost to Follow-up|5|||
131625189|NCT01205126|473914415|FG001|Maintenance Phase|Lost to Follow-up|5|||
131625190|NCT01205126|473914414|FG000|Maintenance Phase|Withdrawal by Subject|8|||
131625191|NCT01205126|473914415|FG001|Maintenance Phase|Withdrawal by Subject|11|||
131625192|NCT00486954|473914416|FG000|Pilot Part|Adverse Event|4|||
131625193|NCT00486954|473914417|FG001|Pilot Part|Adverse Event|0|||
131625194|NCT00486954|473914418|FG002|Pilot Part|Adverse Event|5|||
131625195|NCT00486954|473914419|FG003|Pilot Part|Adverse Event|0|||
131625196|NCT00486954|473914420|FG004|Pilot Part|Adverse Event|0|||
131625197|NCT00486954|473914416|FG000|Pilot Part|Disease Progression|2|||
131625198|NCT00486954|473914417|FG001|Pilot Part|Disease Progression|0|||
131625199|NCT00486954|473914418|FG002|Pilot Part|Disease Progression|1|||
131625200|NCT00486954|473914419|FG003|Pilot Part|Disease Progression|0|||
131625201|NCT00486954|473914420|FG004|Pilot Part|Disease Progression|0|||
131625202|NCT00486954|473914416|FG000|Randomized Part|Lost to Follow-up|0|||
131625203|NCT00486954|473914417|FG001|Randomized Part|Lost to Follow-up|0|||
131625204|NCT00486954|473914418|FG002|Randomized Part|Lost to Follow-up|0|||
131625205|NCT00486954|473914419|FG003|Randomized Part|Lost to Follow-up|0|||
131625206|NCT00486954|473914420|FG004|Randomized Part|Lost to Follow-up|1|||
131625207|NCT00486954|473914416|FG000|Randomized Part|Withdrawal by Subject|0|||
131625208|NCT00486954|473914417|FG001|Randomized Part|Withdrawal by Subject|0|||
131625209|NCT00486954|473914418|FG002|Randomized Part|Withdrawal by Subject|0|||
131625210|NCT00486954|473914419|FG003|Randomized Part|Withdrawal by Subject|1|||
131625211|NCT00486954|473914420|FG004|Randomized Part|Withdrawal by Subject|0|||
131625212|NCT00486954|473914416|FG000|Randomized Part|Sponsor Terminated Study|0|||
131625213|NCT00486954|473914417|FG001|Randomized Part|Sponsor Terminated Study|0|||
131625214|NCT00486954|473914418|FG002|Randomized Part|Sponsor Terminated Study|0|||
131625215|NCT00486954|473914419|FG003|Randomized Part|Sponsor Terminated Study|19|||
131625216|NCT00486954|473914420|FG004|Randomized Part|Sponsor Terminated Study|13|||
131625217|NCT01836523|473914421|FG000|Overall Study|Adverse Event|15|||
131625218|NCT01836523|473914422|FG001|Overall Study|Adverse Event|41|||
131625219|NCT01836523|473914423|FG002|Overall Study|Adverse Event|49|||
131625220|NCT01836523|473914424|FG003|Overall Study|Adverse Event|14|||
131625221|NCT01836523|473914421|FG000|Overall Study|Protocol Violation|6|||
131625222|NCT01836523|473914422|FG001|Overall Study|Protocol Violation|3|||
131625223|NCT01836523|473914423|FG002|Overall Study|Protocol Violation|2|||
131625224|NCT01836523|473914424|FG003|Overall Study|Protocol Violation|4|||
131625225|NCT01836523|473914421|FG000|Overall Study|Met Withdrawal Criteria|13|||
131625226|NCT01836523|473914422|FG001|Overall Study|Met Withdrawal Criteria|13|||
131625227|NCT01836523|473914423|FG002|Overall Study|Met Withdrawal Criteria|21|||
131625228|NCT01836523|473914424|FG003|Overall Study|Met Withdrawal Criteria|27|||
131625229|NCT01836523|473914421|FG000|Overall Study|Unclassified|17|||
131625230|NCT01836523|473914422|FG001|Overall Study|Unclassified|28|||
131625231|NCT01836523|473914423|FG002|Overall Study|Unclassified|19|||
131625232|NCT01836523|473914424|FG003|Overall Study|Unclassified|29|||
131625233|NCT01393600|473914430|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
131625234|NCT01393600|473914431|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
131625235|NCT01393600|473914432|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
131625236|NCT01393600|473914433|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
131625237|NCT01393600|473914430|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
131625238|NCT01393600|473914431|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
131711370|NCT05047523|474221459|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131711371|NCT05047523|474221460|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
131711372|NCT05047523|474221461|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131711373|NCT05047523|474221462|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131711374|NCT05047523|474221463|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131711375|NCT05047523|474221458|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131711376|NCT05047523|474221459|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
131711377|NCT05047523|474221460|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131625239|NCT01393600|473914432|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
131711378|NCT05047523|474221461|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131625240|NCT01393600|473914433|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
131625241|NCT01393600|473914430|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
131625242|NCT01393600|473914431|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
131625243|NCT01393600|473914432|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
131625244|NCT01393600|473914433|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
131625245|NCT01393600|473914430|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
131625246|NCT01393600|473914431|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
131625247|NCT01393600|473914432|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
131625248|NCT01393600|473914433|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
131625249|NCT01393600|473914430|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
131625250|NCT01393600|473914431|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
131625251|NCT01393600|473914432|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
131625252|NCT01393600|473914433|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
131625253|NCT01393600|473914430|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
131625254|NCT01393600|473914431|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
131625255|NCT01393600|473914432|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
131625256|NCT01393600|473914433|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
131625257|NCT01393600|473914430|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
131625258|NCT01393600|473914431|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
131625259|NCT01393600|473914432|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
131625260|NCT01393600|473914433|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
131625261|NCT02245620|473914434|FG000|Overall Study|Physician Decision|1|||
131625262|NCT02245620|473914435|FG001|Overall Study|Physician Decision|1|||
131625263|NCT00889863|473914436|FG000|Part I: Open Label|Death|1|||
131625264|NCT00889863|473914437|FG001|Part I: Open Label|Death|0|||
131625265|NCT00889863|473914436|FG000|Part I: Open Label|Adverse Event|4|||
131625266|NCT00889863|473914437|FG001|Part I: Open Label|Adverse Event|0|||
131625267|NCT00889863|473914436|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
131625268|NCT00889863|473914437|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
131625269|NCT00889863|473914436|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
131625270|NCT00889863|473914437|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
131625271|NCT00889863|473914436|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
131625272|NCT00889863|473914437|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
131625273|NCT00889863|473914436|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
131625274|NCT00889863|473914437|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
131625275|NCT00889863|473914436|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
131625276|NCT00889863|473914437|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
131625277|NCT04361617|473914438|FG000|Overall Study|Withdrawal by Subject|0|||
131625278|NCT04361617|473914439|FG001|Overall Study|Withdrawal by Subject|1|||
131711379|NCT05047523|474221462|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131711380|NCT05047523|474221463|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131711381|NCT05047523|474221458|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
131711382|NCT05047523|474221459|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
131711383|NCT05047523|474221460|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
131711384|NCT05047523|474221461|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
131711385|NCT05047523|474221462|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
131711386|NCT05047523|474221463|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
131711387|NCT05047523|474221458|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
131711388|NCT05047523|474221459|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131711389|NCT05047523|474221460|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131711390|NCT05047523|474221461|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131711391|NCT05047523|474221462|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131711392|NCT05047523|474221463|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131711393|NCT05047523|474221458|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131711394|NCT05047523|474221459|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131711395|NCT05047523|474221460|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131625279|NCT01393964|473914440|FG000|Overall Study|Disease Progression|4|||
131625280|NCT01393964|473914441|FG001|Overall Study|Disease Progression|3|||
131625281|NCT01393964|473914442|FG002|Overall Study|Disease Progression|5|||
131625282|NCT01393964|473914440|FG000|Overall Study|Study drug toxicity|1|||
131625283|NCT01393964|473914441|FG001|Overall Study|Study drug toxicity|0|||
131625284|NCT01393964|473914442|FG002|Overall Study|Study drug toxicity|0|||
131625285|NCT01393964|473914440|FG000|Overall Study|Withdrawal by Subject|0|||
131625286|NCT01393964|473914441|FG001|Overall Study|Withdrawal by Subject|0|||
131625287|NCT01393964|473914442|FG002|Overall Study|Withdrawal by Subject|1|||
131625288|NCT01393964|473914440|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131625289|NCT01393964|473914441|FG001|Overall Study|Adverse event unrelated to study drug|3|||
131625290|NCT01393964|473914442|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131625291|NCT01393964|473914440|FG000|Overall Study|Subject request stop study treatment|0|||
131625292|NCT01393964|473914441|FG001|Overall Study|Subject request stop study treatment|1|||
131711396|NCT05047523|474221461|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131711397|NCT05047523|474221462|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
131711398|NCT05047523|474221463|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
131711399|NCT05047523|474221458|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
131711400|NCT05047523|474221459|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
131711401|NCT05047523|474221460|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
131711402|NCT05047523|474221461|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
131711403|NCT05047523|474221462|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
131711404|NCT05047523|474221463|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
131711405|NCT03658889|474221464|FG000|Overall Study|Protocol Violation|2|||
131711406|NCT03658889|474221465|FG001|Overall Study|Protocol Violation|0|||
131711407|NCT01609933|474221472|FG000|Overall Study|Adverse Event|1|||
131711408|NCT01609933|474221472|FG000|Overall Study|Withdrawal by Subject|3|||
131711409|NCT00224016|474221473|FG000|Titration Period|Withdrawal by Subject|0|||
131711410|NCT00224016|474221474|FG001|Titration Period|Withdrawal by Subject|1|||
131711411|NCT00224016|474221473|FG000|Titration Period|Lost to Follow-up|1|||
131711412|NCT00224016|474221474|FG001|Titration Period|Lost to Follow-up|0|||
131711413|NCT00224016|474221473|FG000|Maintenance Period|Withdrawal by Subject|2|||
131711414|NCT00224016|474221474|FG001|Maintenance Period|Withdrawal by Subject|0|||
131796491|NCT01915732|474538006|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
131796492|NCT01915732|474538007|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
131796493|NCT01915732|474538006|FG000|Overall Study|Job Transfer|0|||
131796494|NCT01915732|474538007|FG001|Overall Study|Job Transfer|1|||
131796495|NCT01915732|474538006|FG000|Overall Study|Improper Facial Procedure|0|||
131796496|NCT01915732|474538007|FG001|Overall Study|Improper Facial Procedure|1|||
131796497|NCT01915732|474538006|FG000|Overall Study|Poor Conscious Effect|0|||
131796498|NCT01915732|474538007|FG001|Overall Study|Poor Conscious Effect|1|||
131796499|NCT02540356|474538019|FG000|Overall Study|Terminated due to disease progression|1|||
131796500|NCT02540356|474538020|FG001|Overall Study|Terminated due to disease progression|0|||
131796501|NCT01513148|474538021|FG000|Overall Study|Protocol Violation|2|||
131796502|NCT01513148|474538022|FG001|Overall Study|Protocol Violation|2|||
131796503|NCT01654380|474538023|FG000|Part B, Period 1|Physician Decision|0|||
131796504|NCT01654380|474538024|FG001|Part B, Period 1|Physician Decision|0|||
131796505|NCT01654380|474538025|FG002|Part B, Period 1|Physician Decision|1|||
131796506|NCT01654380|474538026|FG003|Part B, Period 1|Physician Decision|0|||
131796507|NCT04652453|474538029|FG000|Overall Study|Death|8|||
131796508|NCT04652453|474538030|FG001|Overall Study|Death|2|||
131796509|NCT04652453|474538031|FG002|Overall Study|Death|0|||
131796510|NCT04652453|474538029|FG000|Overall Study|Hospice|5|||
131796511|NCT04652453|474538030|FG001|Overall Study|Hospice|5|||
131796512|NCT04652453|474538031|FG002|Overall Study|Hospice|0|||
131796513|NCT04652453|474538029|FG000|Overall Study|Withdrawal by Subject|2|||
131796514|NCT04652453|474538030|FG001|Overall Study|Withdrawal by Subject|0|||
131796515|NCT04652453|474538031|FG002|Overall Study|Withdrawal by Subject|0|||
131796516|NCT02978326|474538037|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
131796517|NCT02978326|474538038|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
131796518|NCT02978326|474538039|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
131796519|NCT02978326|474538037|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
131796520|NCT02978326|474538038|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
131796521|NCT02978326|474538039|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
131796522|NCT02978326|474538037|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
131796523|NCT02978326|474538038|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
131796524|NCT02978326|474538039|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
131796525|NCT02978326|474538037|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
131796526|NCT02978326|474538038|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
131796527|NCT02978326|474538039|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
131796528|NCT04104646|474538042|FG000|Overall Study|Withdrawal by Subject|1|||
131796529|NCT04104646|474538043|FG001|Overall Study|Withdrawal by Subject|1|||
131796530|NCT04104646|474538042|FG000|Overall Study|Lost to Follow-up|1|||
131796531|NCT04104646|474538043|FG001|Overall Study|Lost to Follow-up|0|||
131796532|NCT04104646|474538042|FG000|Overall Study|Physician Decision|2|||
131796533|NCT04104646|474538043|FG001|Overall Study|Physician Decision|0|||
131796534|NCT02277769|474538044|FG000|Overall Study|Protocol Violation|3|||
131796535|NCT02277769|474538045|FG001|Overall Study|Protocol Violation|3|||
131796536|NCT02277769|474538046|FG002|Overall Study|Protocol Violation|5|||
131796537|NCT02277769|474538044|FG000|Overall Study|Lack of Efficacy|17|||
131711415|NCT00224016|474221473|FG000|Maintenance Period|Lost to Follow-up|0|||
131711416|NCT00224016|474221474|FG001|Maintenance Period|Lost to Follow-up|1|||
131796538|NCT02277769|474538045|FG001|Overall Study|Lack of Efficacy|0|||
131796539|NCT02277769|474538046|FG002|Overall Study|Lack of Efficacy|4|||
131796540|NCT02277769|474538044|FG000|Overall Study|Adverse Event|14|||
131796541|NCT02277769|474538045|FG001|Overall Study|Adverse Event|2|||
131711417|NCT01252966|474221475|FG000|Overall Study|Lost to Follow-up|16|||
131711418|NCT01252966|474221476|FG001|Overall Study|Lost to Follow-up|10|||
131711419|NCT01252966|474221475|FG000|Overall Study|Withdrawal by Subject|7|||
131711420|NCT01252966|474221476|FG001|Overall Study|Withdrawal by Subject|3|||
131796542|NCT02277769|474538046|FG002|Overall Study|Adverse Event|4|||
131796543|NCT02277769|474538044|FG000|Overall Study|Other than specified above|12|||
131796544|NCT02277769|474538045|FG001|Overall Study|Other than specified above|8|||
131796545|NCT02277769|474538046|FG002|Overall Study|Other than specified above|5|||
131796546|NCT02041702|474538047|FG000|Overall Study|Lost to Follow-up|1|||
131796547|NCT02041702|474538048|FG001|Overall Study|Lost to Follow-up|6|||
131796548|NCT02041702|474538047|FG000|Overall Study|Death|4|||
131625293|NCT01393964|473914442|FG002|Overall Study|Subject request stop study treatment|0|||
131625294|NCT01393964|473914440|FG000|Overall Study|Subject decided to move to transplant|1|||
131625295|NCT01393964|473914441|FG001|Overall Study|Subject decided to move to transplant|0|||
131625296|NCT01393964|473914442|FG002|Overall Study|Subject decided to move to transplant|0|||
131625297|NCT01393964|473914440|FG000|Overall Study|Subject switched to commercial supply|1|||
131625298|NCT01393964|473914441|FG001|Overall Study|Subject switched to commercial supply|0|||
131625299|NCT01393964|473914442|FG002|Overall Study|Subject switched to commercial supply|2|||
131625300|NCT01393964|473914440|FG000|Overall Study|Subject plateaued in terms of effect|1|||
131625301|NCT01393964|473914441|FG001|Overall Study|Subject plateaued in terms of effect|0|||
131625302|NCT01393964|473914442|FG002|Overall Study|Subject plateaued in terms of effect|0|||
131625303|NCT01393964|473914440|FG000|Overall Study|Investigator removed subject from study|0|||
131625304|NCT01393964|473914441|FG001|Overall Study|Investigator removed subject from study|1|||
131625305|NCT01393964|473914442|FG002|Overall Study|Investigator removed subject from study|0|||
131625306|NCT01393964|473914440|FG000|Overall Study|Subject converted to roll-over study|0|||
131625307|NCT01393964|473914441|FG001|Overall Study|Subject converted to roll-over study|1|||
131625308|NCT01393964|473914442|FG002|Overall Study|Subject converted to roll-over study|0|||
131625309|NCT01393964|473914440|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
131625310|NCT01393964|473914441|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
131625311|NCT01393964|473914442|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
131625312|NCT00687297|473914447|FG000|Randomization|Withdrawal by Subject|2|||
131625313|NCT00687297|473914448|FG001|Randomization|Withdrawal by Subject|0|||
131625314|NCT00687297|473914447|FG000|Randomization|Withdrew before treatment, ineligible|1|||
131625315|NCT00687297|473914448|FG001|Randomization|Withdrew before treatment, ineligible|1|||
131625316|NCT00687297|473914447|FG000|Induction|Withdrawal by Subject|4|||
131625317|NCT00687297|473914448|FG001|Induction|Withdrawal by Subject|4|||
131625318|NCT00687297|473914447|FG000|Induction|Adverse Event|16|||
131625319|NCT00687297|473914448|FG001|Induction|Adverse Event|15|||
131625320|NCT00687297|473914447|FG000|Induction|Death|7|||
131625321|NCT00687297|473914448|FG001|Induction|Death|11|||
131625322|NCT00687297|473914447|FG000|Induction|Lack of Efficacy|17|||
131625323|NCT00687297|473914448|FG001|Induction|Lack of Efficacy|21|||
131625324|NCT00687297|473914447|FG000|Induction|Ineligible|0|||
131625325|NCT00687297|473914448|FG001|Induction|Ineligible|1|||
131625326|NCT00687297|473914447|FG000|Induction|Patient Noncompliance|1|||
131625327|NCT00687297|473914448|FG001|Induction|Patient Noncompliance|0|||
131625328|NCT00687297|473914447|FG000|Induction|Physician Decision|0|||
131625329|NCT00687297|473914448|FG001|Induction|Physician Decision|2|||
131625330|NCT00687297|473914447|FG000|Induction|Other|0|||
131625331|NCT00687297|473914448|FG001|Induction|Other|1|||
131625332|NCT01228734|473914449|FG000|Overall Study|Randomized, but not treated|0|||
131625333|NCT01228734|473914450|FG001|Overall Study|Randomized, but not treated|4|||
131625334|NCT03128099|473914451|FG000|Overall Study|High dose task was too long|0|||
131625335|NCT03128099|473914452|FG001|Overall Study|High dose task was too long|4|||
131625336|NCT03128099|473914453|FG002|Overall Study|High dose task was too long|0|||
131625337|NCT03128099|473914451|FG000|Overall Study|Participant got a full time job.|1|||
131625338|NCT03128099|473914452|FG001|Overall Study|Participant got a full time job.|0|||
131625339|NCT03128099|473914453|FG002|Overall Study|Participant got a full time job.|0|||
131625340|NCT03128099|473914451|FG000|Overall Study|Became homeless and lost contact|1|||
131796549|NCT02041702|474538048|FG001|Overall Study|Death|0|||
131796550|NCT02041702|474538047|FG000|Overall Study|Withdrawal by Subject|4|||
131796551|NCT02041702|474538048|FG001|Overall Study|Withdrawal by Subject|3|||
131796552|NCT02041702|474538047|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
131796553|NCT02041702|474538048|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
131796554|NCT02041702|474538047|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
131796555|NCT02041702|474538048|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
131625341|NCT03128099|473914452|FG001|Overall Study|Became homeless and lost contact|0|||
131625342|NCT03128099|473914453|FG002|Overall Study|Became homeless and lost contact|0|||
131625343|NCT03128099|473914451|FG000|Overall Study|Did not complete all the assessments|0|||
131625344|NCT03128099|473914452|FG001|Overall Study|Did not complete all the assessments|0|||
131625345|NCT03128099|473914453|FG002|Overall Study|Did not complete all the assessments|1|||
131625346|NCT05445557|473914454|FG000|Double Blind Part|Lost to Follow-up|1|||
131625347|NCT01323790|473914455|FG000|Overall Study|Other|3|||
131625348|NCT01323790|473914456|FG001|Overall Study|Other|2|||
131625349|NCT01323790|473914457|FG002|Overall Study|Other|1|||
131796556|NCT00203307|474538049|FG000|First Intervention|Adverse Event|2|||
131625350|NCT01323790|473914455|FG000|Overall Study|Lost to Follow-up|11|||
131625351|NCT01323790|473914456|FG001|Overall Study|Lost to Follow-up|9|||
131625352|NCT01323790|473914457|FG002|Overall Study|Lost to Follow-up|9|||
131625353|NCT01323790|473914455|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
131625354|NCT01323790|473914456|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
131625355|NCT01323790|473914457|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
131625356|NCT01323790|473914455|FG000|Overall Study|Lack of Efficacy|3|||
131625357|NCT01323790|473914456|FG001|Overall Study|Lack of Efficacy|0|||
131625358|NCT01323790|473914457|FG002|Overall Study|Lack of Efficacy|3|||
131625359|NCT01323790|473914455|FG000|Overall Study|Adverse Event|11|||
131625360|NCT01323790|473914456|FG001|Overall Study|Adverse Event|24|||
131625361|NCT01323790|473914457|FG002|Overall Study|Adverse Event|12|||
131625362|NCT01323790|473914455|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131625363|NCT01323790|473914456|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131625364|NCT01323790|473914457|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
131625365|NCT01323790|473914455|FG000|Overall Study|Withdrawal by Subject|23|||
131625366|NCT01323790|473914456|FG001|Overall Study|Withdrawal by Subject|20|||
131625367|NCT01323790|473914457|FG002|Overall Study|Withdrawal by Subject|13|||
131625368|NCT01323790|473914455|FG000|Overall Study|Did Not Receive Treatment|2|||
131625369|NCT01323790|473914456|FG001|Overall Study|Did Not Receive Treatment|0|||
131625370|NCT01323790|473914457|FG002|Overall Study|Did Not Receive Treatment|1|||
131625371|NCT01323790|473914455|FG000|Overall Study|Severe non-compliance with protocol|2|||
131625372|NCT01323790|473914456|FG001|Overall Study|Severe non-compliance with protocol|2|||
131625373|NCT01323790|473914457|FG002|Overall Study|Severe non-compliance with protocol|2|||
131625374|NCT01681511|473914458|FG000|Overall Study|No Treatment Received|1|||
131625375|NCT01681511|473914459|FG001|Overall Study|No Treatment Received|3|||
131625376|NCT01681511|473914458|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
131711421|NCT00206726|474221484|FG000|Overall Study|Delayed recovery of blood counts|1|||
131711422|NCT00206726|474221484|FG000|Overall Study|Progressive disease or relapsed disease|18|||
131711423|NCT00206726|474221484|FG000|Overall Study|Placed on new protocol|1|||
131711424|NCT00206726|474221484|FG000|Overall Study|Bone marrow transplant|1|||
131711425|NCT00206726|474221484|FG000|Overall Study|Adverse Event|17|||
131711426|NCT00206726|474221484|FG000|Overall Study|Death|4|||
131711427|NCT00206726|474221484|FG000|Overall Study|Protocol Violation|1|||
131711428|NCT00206726|474221484|FG000|Overall Study|Withdrawal by Subject|8|||
131711429|NCT00496366|474221485|FG000|Overall Study|Death|1|||
131711430|NCT04317690|474221488|FG000|Overall Study|did not have complete information for primary outcome|0|||
131711431|NCT04317690|474221489|FG001|Overall Study|did not have complete information for primary outcome|4|||
131711432|NCT04317690|474221490|FG002|Overall Study|did not have complete information for primary outcome|0|||
131711433|NCT04317690|474221491|FG003|Overall Study|did not have complete information for primary outcome|2|||
131625377|NCT01681511|473914459|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
131625378|NCT01681511|473914458|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
131625379|NCT01681511|473914459|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
131625380|NCT01681511|473914458|FG000|Overall Study|No Daily Urine Sample Collected|0|||
131625381|NCT01681511|473914459|FG001|Overall Study|No Daily Urine Sample Collected|1|||
131625382|NCT01681511|473914458|FG000|Overall Study|No post-catheter sample collected|11|||
131625383|NCT01681511|473914459|FG001|Overall Study|No post-catheter sample collected|4|||
131625384|NCT02114515|473914460|FG000|Overall Study|Lost to Follow-up|52|||
131625385|NCT02114515|473914461|FG001|Overall Study|Lost to Follow-up|55|||
131625386|NCT02114515|473914460|FG000|Overall Study|Death|12|||
131625387|NCT02114515|473914461|FG001|Overall Study|Death|12|||
131625388|NCT02114515|473914460|FG000|Overall Study|Withdrawal by Subject|4|||
131625389|NCT02114515|473914461|FG001|Overall Study|Withdrawal by Subject|22|||
131625390|NCT02114515|473914460|FG000|Overall Study|Other|65|||
131625391|NCT02114515|473914461|FG001|Overall Study|Other|61|||
131625392|NCT02699099|473914462|FG000|Overall Study|Adverse Event|1|||
131625393|NCT02699099|473914463|FG001|Overall Study|Adverse Event|0|||
131625394|NCT02699099|473914464|FG002|Overall Study|Adverse Event|2|||
131625395|NCT02699099|473914462|FG000|Overall Study|Lost to Follow-up|0|||
131625396|NCT02699099|473914463|FG001|Overall Study|Lost to Follow-up|1|||
131625397|NCT02699099|473914464|FG002|Overall Study|Lost to Follow-up|0|||
131625398|NCT02699099|473914462|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
131625399|NCT02699099|473914463|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
131625400|NCT02699099|473914464|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
131625401|NCT00824850|473914466|FG000|Overall Study|Withdrawal by Subject|0|||
131625402|NCT00824850|473914467|FG001|Overall Study|Withdrawal by Subject|1|||
131625403|NCT04820491|473914468|FG000|Overall Study|Withdrawal by Subject|1|||
131625404|NCT04820491|473914469|FG001|Overall Study|Withdrawal by Subject|0|||
131625405|NCT01079949|473914472|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
131625406|NCT01079949|473914473|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
131625407|NCT01079949|473914472|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
131625408|NCT01079949|473914473|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
131625409|NCT01079949|473914472|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
131625410|NCT01079949|473914473|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
131625411|NCT01079949|473914472|FG000|Overall Study|Randomized but not treated|1|||
131625412|NCT01079949|473914473|FG001|Overall Study|Randomized but not treated|0|||
131625413|NCT02144285|473914474|FG000|Overall Study|Withdrawal by Subject|0|||
131625414|NCT02144285|473914475|FG001|Overall Study|Withdrawal by Subject|0|||
131625415|NCT02144285|473914476|FG002|Overall Study|Withdrawal by Subject|0|||
131625416|NCT02144285|473914477|FG003|Overall Study|Withdrawal by Subject|0|||
131625417|NCT02144285|473914478|FG004|Overall Study|Withdrawal by Subject|1|||
131625418|NCT02144285|473914479|FG005|Overall Study|Withdrawal by Subject|0|||
131625419|NCT02144285|473914480|FG006|Overall Study|Withdrawal by Subject|0|||
131625420|NCT02144285|473914481|FG007|Overall Study|Withdrawal by Subject|0|||
131625421|NCT02144285|473914482|FG008|Overall Study|Withdrawal by Subject|0|||
131625422|NCT02144285|473914483|FG009|Overall Study|Withdrawal by Subject|0|||
131625423|NCT01529632|473914484|FG000|Overall Study|Administrative problem|2|||
131625424|NCT01529632|473914485|FG001|Overall Study|Administrative problem|1|||
131625425|NCT01529632|473914484|FG000|Overall Study|Protocol Violation|0|||
131625426|NCT01529632|473914485|FG001|Overall Study|Protocol Violation|1|||
131625427|NCT01529632|473914484|FG000|Overall Study|Adverse Event|1|||
131625428|NCT01529632|473914485|FG001|Overall Study|Adverse Event|1|||
131625429|NCT00747149|473915786|FG000|Overall Study|Adverse Event|0|||
131625430|NCT00747149|473915787|FG001|Overall Study|Adverse Event|15|||
131625431|NCT00747149|473915786|FG000|Overall Study|Lost to Follow-up|0|||
131625432|NCT00747149|473915787|FG001|Overall Study|Lost to Follow-up|10|||
131625433|NCT00747149|473915786|FG000|Overall Study|Withdrawal by Subject|0|||
131625434|NCT00747149|473915787|FG001|Overall Study|Withdrawal by Subject|6|||
131625435|NCT00747149|473915786|FG000|Overall Study|Did not receive treatment|0|||
131625436|NCT00747149|473915787|FG001|Overall Study|Did not receive treatment|1|||
131625437|NCT00747149|473915786|FG000|Overall Study|Incorrect enrollment|0|||
131625438|NCT00747149|473915787|FG001|Overall Study|Incorrect enrollment|6|||
131625439|NCT00747149|473915786|FG000|Overall Study|Severe non-compliance to protocol|0|||
131625440|NCT00747149|473915787|FG001|Overall Study|Severe non-compliance to protocol|1|||
131625441|NCT00747149|473915786|FG000|Overall Study|Not reported|1|||
131625442|NCT00747149|473915787|FG001|Overall Study|Not reported|4|||
131625443|NCT02196259|473915788|FG000|Overall Study|Researcher choice|0|||
131625444|NCT02196259|473915789|FG001|Overall Study|Researcher choice|0|||
131625445|NCT02196259|473915790|FG002|Overall Study|Researcher choice|1|||
131625446|NCT02196259|473915788|FG000|Overall Study|Partial data analysis|0|||
131625447|NCT02196259|473915789|FG001|Overall Study|Partial data analysis|3|||
131625448|NCT02196259|473915790|FG002|Overall Study|Partial data analysis|0|||
131625449|NCT02830893|473915791|FG000|Overall Study|Relocation to out of the country|1|||
131625450|NCT02830893|473915792|FG001|Overall Study|Relocation to out of the country|0|||
131625451|NCT02830893|473915791|FG000|Overall Study|Lost to Follow-up|0|||
131625452|NCT02830893|473915792|FG001|Overall Study|Lost to Follow-up|2|||
131625453|NCT02830893|473915791|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
131625454|NCT02830893|473915792|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
131625455|NCT00215943|473915793|FG000|Overall Study|Disease Progression|3|||
131625456|NCT00215943|473915794|FG001|Overall Study|Disease Progression|5|||
131625457|NCT00215943|473915793|FG000|Overall Study|Alternate therapy|0|||
131625458|NCT00215943|473915794|FG001|Overall Study|Alternate therapy|1|||
131625459|NCT00215943|473915793|FG000|Overall Study|Adverse Event|3|||
131625460|NCT00215943|473915794|FG001|Overall Study|Adverse Event|6|||
131625461|NCT00215943|473915793|FG000|Overall Study|Other disease|0|||
131625462|NCT00215943|473915794|FG001|Overall Study|Other disease|1|||
131625463|NCT00215943|473915793|FG000|Overall Study|Other complications|3|||
131625464|NCT00215943|473915794|FG001|Overall Study|Other complications|1|||
131625465|NCT04311983|473915796|FG000|Overall Study|Lost to Follow-up|421|||
131625466|NCT04311983|473915797|FG001|Overall Study|Lost to Follow-up|456|||
131625467|NCT04311983|473915796|FG000|Overall Study|Incomplete survey|7|||
131625468|NCT04311983|473915797|FG001|Overall Study|Incomplete survey|9|||
131625469|NCT04311983|473915796|FG000|Overall Study|Death|1|||
131625470|NCT04311983|473915797|FG001|Overall Study|Death|0|||
131625471|NCT00638456|473915803|FG000|Overall Study|Withdrawal by Subject|6|||
131625472|NCT00638456|473915804|FG001|Overall Study|Withdrawal by Subject|2|||
131625473|NCT03236779|473915805|FG000|Overall Study|Lost to Follow-up|13|||
131625474|NCT03236779|473915806|FG001|Overall Study|Lost to Follow-up|21|||
131625475|NCT00403845|473915807|FG000|Treatment Period 1|Subject withdrew consent|1|||
131625476|NCT00403845|473915808|FG001|Treatment Period 1|Subject withdrew consent|0|||
131625477|NCT00403845|473915809|FG002|Treatment Period 1|Subject withdrew consent|0|||
131625478|NCT00403845|473915810|FG003|Treatment Period 1|Subject withdrew consent|0|||
131625479|NCT00403845|473915807|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
131625480|NCT00403845|473915808|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
131625481|NCT00403845|473915809|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
131625482|NCT00403845|473915810|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
131625483|NCT00403845|473915807|FG000|Treatment Period 2|Subject withdrew consent|1|||
131625484|NCT00403845|473915808|FG001|Treatment Period 2|Subject withdrew consent|0|||
131625485|NCT00403845|473915809|FG002|Treatment Period 2|Subject withdrew consent|0|||
131625486|NCT00403845|473915810|FG003|Treatment Period 2|Subject withdrew consent|0|||
131625487|NCT00403845|473915807|FG000|Treatment Period 3|Subject withdrew consent|0|||
131625488|NCT00403845|473915808|FG001|Treatment Period 3|Subject withdrew consent|0|||
131625489|NCT00403845|473915809|FG002|Treatment Period 3|Subject withdrew consent|0|||
131625490|NCT00403845|473915810|FG003|Treatment Period 3|Subject withdrew consent|1|||
131625491|NCT00403845|473915807|FG000|Treatment Period 3|Adverse Event|0|||
131796557|NCT00203307|474538050|FG001|First Intervention|Adverse Event|0|||
131796558|NCT01488578|474538051|FG000|Overall Study|Protocol Violation|1836|||
131796559|NCT00306384|474538052|FG000|Overall Study|Adverse Event|103|||
131796560|NCT00306384|474538053|FG001|Overall Study|Adverse Event|87|||
131796561|NCT00306384|474538054|FG002|Overall Study|Adverse Event|40|||
131796562|NCT00306384|474538052|FG000|Overall Study|Major protocol deviation|43|||
131796563|NCT00306384|474538053|FG001|Overall Study|Major protocol deviation|51|||
131796564|NCT00306384|474538054|FG002|Overall Study|Major protocol deviation|18|||
131796565|NCT00306384|474538052|FG000|Overall Study|Lost to Follow-up|57|||
131796566|NCT00306384|474538053|FG001|Overall Study|Lost to Follow-up|41|||
131796567|NCT00306384|474538054|FG002|Overall Study|Lost to Follow-up|35|||
131796568|NCT00306384|474538052|FG000|Overall Study|Voluntary withdrawal|199|||
131796569|NCT00306384|474538053|FG001|Overall Study|Voluntary withdrawal|187|||
131796570|NCT00306384|474538054|FG002|Overall Study|Voluntary withdrawal|91|||
131901176|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131901177|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901178|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901179|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901180|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901181|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131625492|NCT00403845|473915808|FG001|Treatment Period 3|Adverse Event|0|||
131625493|NCT00403845|473915809|FG002|Treatment Period 3|Adverse Event|0|||
131625494|NCT00403845|473915810|FG003|Treatment Period 3|Adverse Event|1|||
131625495|NCT00578344|473915811|FG000|Overall Study|Insurance problems|1|||
131625496|NCT00578344|473915811|FG000|Overall Study|Graft failure|1|||
131625497|NCT02935673|473915812|FG000|Overall Study|Adverse Event|0|||
131625498|NCT02935673|473915813|FG001|Overall Study|Adverse Event|1|||
131625499|NCT02935673|473915814|FG002|Overall Study|Adverse Event|0|||
131625500|NCT02935673|473915812|FG000|Overall Study|Withdrawal by Subject|1|||
131625501|NCT02935673|473915813|FG001|Overall Study|Withdrawal by Subject|2|||
131625502|NCT02935673|473915814|FG002|Overall Study|Withdrawal by Subject|0|||
131625503|NCT04328467|473915815|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
131625504|NCT04328467|473915816|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
131625505|NCT04328467|473915817|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
131796571|NCT00306384|474538052|FG000|Overall Study|Study termination|1|||
131796572|NCT00306384|474538053|FG001|Overall Study|Study termination|0|||
131625506|NCT00813709|473915818|FG000|Double Blind Period|Adverse Event|4|||
131625507|NCT00813709|473915819|FG001|Double Blind Period|Adverse Event|1|||
131625508|NCT00813709|473915820|FG002|Double Blind Period|Adverse Event|4|||
131625509|NCT00813709|473915821|FG003|Double Blind Period|Adverse Event|0|||
131625510|NCT00813709|473915822|FG004|Double Blind Period|Adverse Event|0|||
131625511|NCT00813709|473915823|FG005|Double Blind Period|Adverse Event|0|||
131625512|NCT00813709|473915818|FG000|Double Blind Period|Lost to Follow-up|3|||
131625513|NCT00813709|473915819|FG001|Double Blind Period|Lost to Follow-up|2|||
131625514|NCT00813709|473915820|FG002|Double Blind Period|Lost to Follow-up|2|||
131625515|NCT00813709|473915821|FG003|Double Blind Period|Lost to Follow-up|0|||
131625516|NCT00813709|473915822|FG004|Double Blind Period|Lost to Follow-up|0|||
131625517|NCT00813709|473915823|FG005|Double Blind Period|Lost to Follow-up|0|||
131625518|NCT00813709|473915818|FG000|Double Blind Period|Switched to open label phase|9|||
131625519|NCT00813709|473915819|FG001|Double Blind Period|Switched to open label phase|26|||
131625520|NCT00813709|473915820|FG002|Double Blind Period|Switched to open label phase|18|||
131625521|NCT00813709|473915821|FG003|Double Blind Period|Switched to open label phase|0|||
131625522|NCT00813709|473915822|FG004|Double Blind Period|Switched to open label phase|0|||
131625523|NCT00813709|473915823|FG005|Double Blind Period|Switched to open label phase|0|||
131625524|NCT00813709|473915818|FG000|Double Blind Period|Randomized but not treated|1|||
131625525|NCT00813709|473915819|FG001|Double Blind Period|Randomized but not treated|3|||
131625526|NCT00813709|473915820|FG002|Double Blind Period|Randomized but not treated|1|||
131625527|NCT00813709|473915821|FG003|Double Blind Period|Randomized but not treated|0|||
131625528|NCT00813709|473915822|FG004|Double Blind Period|Randomized but not treated|0|||
131625529|NCT00813709|473915823|FG005|Double Blind Period|Randomized but not treated|0|||
131625530|NCT00813709|473915818|FG000|Double Blind Period|Other|14|||
131625531|NCT00813709|473915819|FG001|Double Blind Period|Other|9|||
131625532|NCT00813709|473915820|FG002|Double Blind Period|Other|6|||
131625533|NCT00813709|473915821|FG003|Double Blind Period|Other|0|||
131625534|NCT00813709|473915822|FG004|Double Blind Period|Other|0|||
131711434|NCT04317690|474221492|FG004|Overall Study|did not have complete information for primary outcome|0|||
131711435|NCT02612909|474221493|FG000|Phase 2|Withdrawal by Subject|2|||
131711436|NCT02612909|474221494|FG001|Phase 2|Withdrawal by Subject|5|||
131711437|NCT02612909|474221495|FG002|Phase 2|Withdrawal by Subject|0|||
131711438|NCT02612909|474221496|FG003|Phase 2|Withdrawal by Subject|0|||
131711439|NCT02612909|474221497|FG004|Phase 2|Withdrawal by Subject|0|||
131711440|NCT02612909|474221493|FG000|Phase 2|Pregnancy|0|||
131711441|NCT02612909|474221494|FG001|Phase 2|Pregnancy|0|||
131711442|NCT02612909|474221495|FG002|Phase 2|Pregnancy|1|||
131711443|NCT02612909|474221496|FG003|Phase 2|Pregnancy|0|||
131711444|NCT02612909|474221497|FG004|Phase 2|Pregnancy|0|||
131711445|NCT02612909|474221493|FG000|Phase 3|Withdrawal by Subject|0|||
131711446|NCT02612909|474221494|FG001|Phase 3|Withdrawal by Subject|0|||
131711447|NCT02612909|474221495|FG002|Phase 3|Withdrawal by Subject|0|||
131711448|NCT02612909|474221496|FG003|Phase 3|Withdrawal by Subject|1|||
131711449|NCT02612909|474221497|FG004|Phase 3|Withdrawal by Subject|0|||
131711450|NCT01719757|474221499|FG000|Overall Study|Adverse Event|38|||
131711451|NCT01719757|474221499|FG000|Overall Study|Withdrawal by Subject|15|||
131711452|NCT01719757|474221499|FG000|Overall Study|Lost to Follow-up|20|||
131711453|NCT01719757|474221499|FG000|Overall Study|Protocol Violation|1|||
131711454|NCT01719757|474221499|FG000|Overall Study|well controlled pain|27|||
131711455|NCT02626338|474221500|FG000|Overall Study|Lack of Efficacy|3|||
131711456|NCT02626338|474221501|FG001|Overall Study|Lack of Efficacy|2|||
131711457|NCT02626338|474221502|FG002|Overall Study|Lack of Efficacy|0|||
131711458|NCT00450580|474221508|FG000|Overall Study|Adverse Event|5|||
131711459|NCT00450580|474221509|FG001|Overall Study|Adverse Event|7|||
131711460|NCT00450580|474221508|FG000|Overall Study|Lost to Follow-up|4|||
131711461|NCT00450580|474221509|FG001|Overall Study|Lost to Follow-up|5|||
131711462|NCT00450580|474221508|FG000|Overall Study|Withdrawal by Subject|2|||
131711463|NCT00450580|474221509|FG001|Overall Study|Withdrawal by Subject|2|||
131796573|NCT00306384|474538054|FG002|Overall Study|Study termination|1|||
131796574|NCT00306384|474538052|FG000|Overall Study|Pregnancy|3|||
131796575|NCT00306384|474538053|FG001|Overall Study|Pregnancy|1|||
131796576|NCT00306384|474538054|FG002|Overall Study|Pregnancy|1|||
131796577|NCT00306384|474538052|FG000|Overall Study|Lack of Efficacy|26|||
131625535|NCT00813709|473915823|FG005|Double Blind Period|Other|0|||
131625536|NCT00813709|473915818|FG000|Open Label Period|Adverse Event|0|||
131796578|NCT00306384|474538053|FG001|Overall Study|Lack of Efficacy|40|||
131625537|NCT00813709|473915819|FG001|Open Label Period|Adverse Event|0|||
131625538|NCT00813709|473915820|FG002|Open Label Period|Adverse Event|0|||
131625539|NCT00813709|473915821|FG003|Open Label Period|Adverse Event|5|||
131625540|NCT00813709|473915822|FG004|Open Label Period|Adverse Event|4|||
131625541|NCT00813709|473915823|FG005|Open Label Period|Adverse Event|3|||
131625542|NCT00813709|473915818|FG000|Open Label Period|Lack of Efficacy|0|||
131625543|NCT00813709|473915819|FG001|Open Label Period|Lack of Efficacy|0|||
131625544|NCT00813709|473915820|FG002|Open Label Period|Lack of Efficacy|0|||
131625545|NCT00813709|473915821|FG003|Open Label Period|Lack of Efficacy|3|||
131625546|NCT00813709|473915822|FG004|Open Label Period|Lack of Efficacy|1|||
131625547|NCT00813709|473915823|FG005|Open Label Period|Lack of Efficacy|1|||
131711464|NCT00450580|474221508|FG000|Overall Study|Protocol Violation|1|||
131444062|NCT05138653|473255038|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
131625548|NCT00813709|473915818|FG000|Open Label Period|Randomized but not treated|0|||
131625549|NCT00813709|473915819|FG001|Open Label Period|Randomized but not treated|0|||
131625550|NCT00813709|473915820|FG002|Open Label Period|Randomized but not treated|0|||
131625551|NCT00813709|473915821|FG003|Open Label Period|Randomized but not treated|1|||
131625552|NCT00813709|473915822|FG004|Open Label Period|Randomized but not treated|0|||
131625553|NCT00813709|473915823|FG005|Open Label Period|Randomized but not treated|1|||
131625554|NCT00813709|473915818|FG000|Open Label Period|Other|0|||
131711465|NCT00450580|474221509|FG001|Overall Study|Protocol Violation|1|||
131711466|NCT00450580|474221508|FG000|Overall Study|Protocol-defined virologic failure|1|||
131444063|NCT05138653|473255023|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131444064|NCT05138653|473255024|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131625555|NCT00813709|473915819|FG001|Open Label Period|Other|0|||
131625556|NCT00813709|473915820|FG002|Open Label Period|Other|0|||
131625557|NCT00813709|473915821|FG003|Open Label Period|Other|11|||
131625558|NCT00813709|473915822|FG004|Open Label Period|Other|5|||
131625559|NCT00813709|473915823|FG005|Open Label Period|Other|6|||
131625560|NCT02753075|473915824|FG000|Overall Study|Adverse Event|2|||
131625561|NCT02753075|473915825|FG001|Overall Study|Adverse Event|1|||
131625562|NCT02753075|473915826|FG002|Overall Study|Adverse Event|0|||
131625563|NCT02753075|473915824|FG000|Overall Study|Lost to Follow-up|2|||
131625564|NCT02753075|473915825|FG001|Overall Study|Lost to Follow-up|0|||
131625565|NCT02753075|473915826|FG002|Overall Study|Lost to Follow-up|0|||
131625566|NCT02753075|473915824|FG000|Overall Study|Withdrawal of Consent|1|||
131625567|NCT02753075|473915825|FG001|Overall Study|Withdrawal of Consent|1|||
131625568|NCT02753075|473915826|FG002|Overall Study|Withdrawal of Consent|3|||
131625569|NCT02753075|473915824|FG000|Overall Study|Physician Decision|3|||
131625570|NCT02753075|473915825|FG001|Overall Study|Physician Decision|1|||
131625571|NCT02753075|473915826|FG002|Overall Study|Physician Decision|0|||
131625572|NCT02152384|473915827|FG000|Period 1|Withdrawal by Subject|0|||
131625573|NCT02152384|473915828|FG001|Period 1|Withdrawal by Subject|1|||
131711467|NCT00450580|474221509|FG001|Overall Study|Protocol-defined virologic failure|0|||
131796579|NCT00306384|474538054|FG002|Overall Study|Lack of Efficacy|38|||
131711468|NCT00450580|474221508|FG000|Overall Study|Could not comply with scheduled visits|1|||
131711469|NCT00450580|474221509|FG001|Overall Study|Could not comply with scheduled visits|0|||
131711470|NCT00450580|474221508|FG000|Overall Study|Patient went to Brazil|1|||
131625574|NCT02152384|473915827|FG000|Period 1|Adverse Event|1|||
131625575|NCT02152384|473915828|FG001|Period 1|Adverse Event|1|||
131625576|NCT00603798|473915831|FG000|Overall Study|Adverse Event|4|||
131625577|NCT00603798|473915832|FG001|Overall Study|Adverse Event|2|||
131625578|NCT00603798|473915833|FG002|Overall Study|Adverse Event|1|||
131625579|NCT00603798|473915831|FG000|Overall Study|Withdrawal by Subject|4|||
131711471|NCT00450580|474221509|FG001|Overall Study|Patient went to Brazil|0|||
131711472|NCT00450580|474221508|FG000|Overall Study|Patient could not swallow Norvir|1|||
131711473|NCT00450580|474221509|FG001|Overall Study|Patient could not swallow Norvir|0|||
131711474|NCT00450580|474221508|FG000|Overall Study|Withdrawal due to pregnancy|0|||
131711475|NCT00450580|474221509|FG001|Overall Study|Withdrawal due to pregnancy|1|||
131711476|NCT01154101|474221511|FG000|Overall Study|Adverse Event|0|||
131711477|NCT01154101|474221512|FG001|Overall Study|Adverse Event|2|||
131711478|NCT01154101|474221513|FG002|Overall Study|Adverse Event|1|||
131711479|NCT01154101|474221514|FG003|Overall Study|Adverse Event|1|||
131711480|NCT01154101|474221515|FG004|Overall Study|Adverse Event|0|||
131711481|NCT01154101|474221511|FG000|Overall Study|Lost to Follow-up|0|||
131711482|NCT01154101|474221512|FG001|Overall Study|Lost to Follow-up|1|||
131711483|NCT01154101|474221513|FG002|Overall Study|Lost to Follow-up|0|||
131711484|NCT01154101|474221514|FG003|Overall Study|Lost to Follow-up|1|||
131711485|NCT01154101|474221515|FG004|Overall Study|Lost to Follow-up|0|||
131711486|NCT01154101|474221511|FG000|Overall Study|Withdrawal by Subject|0|||
131711487|NCT01154101|474221512|FG001|Overall Study|Withdrawal by Subject|1|||
131711488|NCT01154101|474221513|FG002|Overall Study|Withdrawal by Subject|2|||
131711489|NCT01154101|474221514|FG003|Overall Study|Withdrawal by Subject|0|||
131711490|NCT01154101|474221515|FG004|Overall Study|Withdrawal by Subject|1|||
131711491|NCT00393718|474221516|FG000|Overall Study|Adverse Event|20|||
131711492|NCT00393718|474221517|FG001|Overall Study|Adverse Event|8|||
131711493|NCT00393718|474221516|FG000|Overall Study|Protocol Violation|1|||
131711494|NCT00393718|474221517|FG001|Overall Study|Protocol Violation|2|||
131711495|NCT00393718|474221516|FG000|Overall Study|Lack of Efficacy|10|||
131711496|NCT00393718|474221517|FG001|Overall Study|Lack of Efficacy|9|||
131711497|NCT00393718|474221516|FG000|Overall Study|Hypoglycaemia|3|||
131711498|NCT00393718|474221517|FG001|Overall Study|Hypoglycaemia|2|||
131711499|NCT00393718|474221516|FG000|Overall Study|Subject decision|5|||
131711500|NCT00393718|474221517|FG001|Overall Study|Subject decision|0|||
131711501|NCT00393718|474221516|FG000|Overall Study|Withdrawal of consent|2|||
131711502|NCT00393718|474221517|FG001|Overall Study|Withdrawal of consent|1|||
131711503|NCT00393718|474221516|FG000|Overall Study|Missed measurement|1|||
131711504|NCT00393718|474221517|FG001|Overall Study|Missed measurement|0|||
131711505|NCT00393718|474221516|FG000|Overall Study|Move|1|||
131711506|NCT00393718|474221517|FG001|Overall Study|Move|0|||
131711507|NCT03902080|474221518|FG000|Overall Study|Adverse Event|17|||
131711508|NCT03902080|474221519|FG001|Overall Study|Adverse Event|15|||
131711509|NCT03902080|474221518|FG000|Overall Study|Withdrawal by Subject|28|||
131711510|NCT03902080|474221519|FG001|Overall Study|Withdrawal by Subject|35|||
131711511|NCT03902080|474221518|FG000|Overall Study|Lost to Follow-up|6|||
131711512|NCT03902080|474221519|FG001|Overall Study|Lost to Follow-up|7|||
131796580|NCT00306384|474538052|FG000|Overall Study|Investigator discretion|28|||
131625580|NCT00603798|473915832|FG001|Overall Study|Withdrawal by Subject|3|||
131625581|NCT00603798|473915833|FG002|Overall Study|Withdrawal by Subject|4|||
131625582|NCT00603798|473915831|FG000|Overall Study|Lost to Follow-up|1|||
131625583|NCT00603798|473915832|FG001|Overall Study|Lost to Follow-up|0|||
131625584|NCT00603798|473915833|FG002|Overall Study|Lost to Follow-up|1|||
131625585|NCT00603798|473915831|FG000|Overall Study|Non-compliance with study procedures|0|||
131796581|NCT00306384|474538053|FG001|Overall Study|Investigator discretion|31|||
131796582|NCT00306384|474538054|FG002|Overall Study|Investigator discretion|21|||
131796583|NCT00306384|474538052|FG000|Overall Study|Other|80|||
131796584|NCT00306384|474538053|FG001|Overall Study|Other|70|||
131796585|NCT00306384|474538054|FG002|Overall Study|Other|32|||
131796586|NCT00306384|474538052|FG000|Overall Study|Site closure|2|||
131796587|NCT00306384|474538053|FG001|Overall Study|Site closure|0|||
131796588|NCT00306384|474538054|FG002|Overall Study|Site closure|0|||
131796589|NCT03977584|474538057|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
131796590|NCT03977584|474538058|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
131796591|NCT03977584|474538059|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
131796592|NCT02708277|474538063|FG000|Overall Study|Lost to Follow-up|7|||
131796593|NCT02708277|474538064|FG001|Overall Study|Lost to Follow-up|4|||
131796594|NCT01058421|474538065|FG000|1 Month Outcomes|Death|10|||
131796595|NCT01058421|474538066|FG001|1 Month Outcomes|Death|6|||
131796596|NCT01058421|474538065|FG000|1 Month Outcomes|Lost to Follow-up|8|||
131796597|NCT01058421|474538066|FG001|1 Month Outcomes|Lost to Follow-up|7|||
131796598|NCT01058421|474538065|FG000|1 Month Outcomes|Remained in Hospital|5|||
131796599|NCT01058421|474538066|FG001|1 Month Outcomes|Remained in Hospital|12|||
131796600|NCT01058421|474538065|FG000|1 Month Outcomes|Remained in Other Facility|16|||
131796601|NCT01058421|474538066|FG001|1 Month Outcomes|Remained in Other Facility|17|||
131796602|NCT01058421|474538065|FG000|3 Month Outcomes|Death|3|||
131796603|NCT01058421|474538066|FG001|3 Month Outcomes|Death|5|||
131796604|NCT01058421|474538065|FG000|3 Month Outcomes|Lost to Follow-up|12|||
131796605|NCT01058421|474538066|FG001|3 Month Outcomes|Lost to Follow-up|11|||
131796606|NCT01058421|474538065|FG000|3 Month Outcomes|Remained in Hospital|0|||
131796607|NCT01058421|474538066|FG001|3 Month Outcomes|Remained in Hospital|2|||
131796608|NCT01058421|474538065|FG000|3 Month Outcomes|Remained in Other Facility|5|||
131796609|NCT01058421|474538066|FG001|3 Month Outcomes|Remained in Other Facility|8|||
131796610|NCT01058421|474538065|FG000|6 Month Outcomes|Death|2|||
131796611|NCT01058421|474538066|FG001|6 Month Outcomes|Death|2|||
131796612|NCT01058421|474538065|FG000|6 Month Outcomes|Lost to Follow-up|16|||
131796613|NCT01058421|474538066|FG001|6 Month Outcomes|Lost to Follow-up|21|||
131796614|NCT01058421|474538065|FG000|6 Month Outcomes|Remained in Other Facility|1|||
131796615|NCT01058421|474538066|FG001|6 Month Outcomes|Remained in Other Facility|3|||
131796616|NCT01309919|474538085|FG000|Overall Study|Did not receive a postpartum IUD|17|||
131796617|NCT01309919|474538086|FG001|Overall Study|Did not receive a postpartum IUD|48|||
131796618|NCT02102490|474538087|FG000|Overall Study|Death|6|||
131796619|NCT02102490|474538087|FG000|Overall Study|Lost to Follow-up|1|||
131796620|NCT01736553|474538092|FG000|Overall Study|Death|12|||
131796621|NCT01736553|474538093|FG001|Overall Study|Death|0|||
131796622|NCT01736553|474538092|FG000|Overall Study|Withdrawal by Subject|5|||
131796623|NCT01736553|474538093|FG001|Overall Study|Withdrawal by Subject|2|||
131796624|NCT01736553|474538092|FG000|Overall Study|Lost to Follow-up|2|||
131796625|NCT01736553|474538093|FG001|Overall Study|Lost to Follow-up|2|||
131796626|NCT02154529|474538094|FG000|Overall Study|Death|1|||
131796627|NCT02154529|474538095|FG001|Overall Study|Death|1|||
131796628|NCT02154529|474538096|FG002|Overall Study|Death|5|||
131796629|NCT02154529|474538097|FG003|Overall Study|Death|1|||
131796630|NCT02154529|474538094|FG000|Overall Study|Termination of study by sponsor|2|||
131796631|NCT02154529|474538095|FG001|Overall Study|Termination of study by sponsor|2|||
131796632|NCT02154529|474538096|FG002|Overall Study|Termination of study by sponsor|3|||
131796633|NCT02154529|474538097|FG003|Overall Study|Termination of study by sponsor|1|||
131796634|NCT02154529|474538094|FG000|Overall Study|Lost to Follow-up|1|||
131796635|NCT02154529|474538095|FG001|Overall Study|Lost to Follow-up|0|||
131796636|NCT02154529|474538096|FG002|Overall Study|Lost to Follow-up|0|||
131796637|NCT02154529|474538097|FG003|Overall Study|Lost to Follow-up|0|||
131796638|NCT00458302|474539698|FG000|Overall Study|Adverse Event|4|||
131796639|NCT00458302|474539699|FG001|Overall Study|Adverse Event|14|||
131796640|NCT00458302|474539698|FG000|Overall Study|Pregnancy|2|||
131625586|NCT00603798|473915832|FG001|Overall Study|Non-compliance with study procedures|1|||
131625587|NCT00603798|473915833|FG002|Overall Study|Non-compliance with study procedures|0|||
131796641|NCT00458302|474539699|FG001|Overall Study|Pregnancy|1|||
131796642|NCT00458302|474539698|FG000|Overall Study|Protocol Violation|0|||
131796643|NCT00458302|474539699|FG001|Overall Study|Protocol Violation|2|||
131796644|NCT00458302|474539698|FG000|Overall Study|Withdrawal by Subject|6|||
131796645|NCT00458302|474539699|FG001|Overall Study|Withdrawal by Subject|4|||
131796646|NCT00458302|474539698|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
131796647|NCT00458302|474539699|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
131625588|NCT00603798|473915831|FG000|Overall Study|Not due to AE|1|||
131625589|NCT00603798|473915832|FG001|Overall Study|Not due to AE|1|||
131901182|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901183|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901184|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901185|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901186|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901187|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901188|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
131901189|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901190|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901191|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
131901192|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901193|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901194|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901195|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901196|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901197|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901198|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901199|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901200|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901201|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901202|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
131901203|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901204|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
131901205|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131901206|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
131901207|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901208|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901209|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901210|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901211|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901212|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901213|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901214|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901215|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901216|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901217|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901218|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
131901219|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901220|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131901221|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
131901222|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901223|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901224|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901225|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901226|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901227|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901228|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901229|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901230|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901231|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901232|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901233|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
131901234|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
131901235|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131901236|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
131901237|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901238|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131444065|NCT05138653|473255025|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131444066|NCT05138653|473255026|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131625590|NCT00603798|473915833|FG002|Overall Study|Not due to AE|4|||
131625591|NCT03390166|473915837|FG000|Overall Study|Death|0|||
131625592|NCT03390166|473915838|FG001|Overall Study|Death|1|||
131625593|NCT03390166|473915837|FG000|Overall Study|Lost to Follow-up|6|||
131901239|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901240|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901241|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901242|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901243|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901244|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901245|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901246|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901247|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131625594|NCT03390166|473915838|FG001|Overall Study|Lost to Follow-up|4|||
131625595|NCT03390166|473915837|FG000|Overall Study|Physician Decision|2|||
131625596|NCT03390166|473915838|FG001|Overall Study|Physician Decision|1|||
131901248|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
131901249|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131625597|NCT03390166|473915837|FG000|Overall Study|Move from study area|3|||
131625598|NCT03390166|473915838|FG001|Overall Study|Move from study area|2|||
131625599|NCT03390166|473915837|FG000|Overall Study|To militarycamp for conscript|1|||
131625600|NCT03390166|473915838|FG001|Overall Study|To militarycamp for conscript|0|||
131625601|NCT03390166|473915837|FG000|Overall Study|To drug therapy course|0|||
131625602|NCT03390166|473915838|FG001|Overall Study|To drug therapy course|1|||
131625603|NCT03390166|473915837|FG000|Overall Study|Move to work oversea|0|||
131625604|NCT03390166|473915838|FG001|Overall Study|Move to work oversea|1|||
131625605|NCT01137682|473915839|FG000|Overall Study|Adverse Event-CORE|2|||
131625606|NCT01137682|473915840|FG001|Overall Study|Adverse Event-CORE|4|||
131625607|NCT01137682|473915841|FG002|Overall Study|Adverse Event-CORE|0|||
131625608|NCT01137682|473915839|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
131625609|NCT01137682|473915840|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
131625610|NCT01137682|473915841|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
131625611|NCT01137682|473915839|FG000|Overall Study|Administrative problems-CORE|2|||
131625612|NCT01137682|473915840|FG001|Overall Study|Administrative problems-CORE|1|||
131625613|NCT01137682|473915841|FG002|Overall Study|Administrative problems-CORE|0|||
131625614|NCT01137682|473915839|FG000|Overall Study|Protocol Violation-CORE|0|||
131625615|NCT01137682|473915840|FG001|Overall Study|Protocol Violation-CORE|1|||
131625616|NCT01137682|473915841|FG002|Overall Study|Protocol Violation-CORE|1|||
131711513|NCT03902080|474221518|FG000|Overall Study|Other|3|||
131625617|NCT01137682|473915839|FG000|Overall Study|Adverse Event-Extension|4|||
131625618|NCT01137682|473915840|FG001|Overall Study|Adverse Event-Extension|8|||
131625619|NCT01137682|473915841|FG002|Overall Study|Adverse Event-Extension|7|||
131625620|NCT01137682|473915839|FG000|Overall Study|Lack of Efficacy-Extension|15|||
131625621|NCT01137682|473915840|FG001|Overall Study|Lack of Efficacy-Extension|9|||
131711514|NCT03902080|474221519|FG001|Overall Study|Other|5|||
131711515|NCT03902080|474221518|FG000|Overall Study|Non compliance|4|||
131711516|NCT03902080|474221519|FG001|Overall Study|Non compliance|3|||
131711517|NCT03902080|474221518|FG000|Overall Study|Physician Decision|5|||
131711518|NCT03902080|474221519|FG001|Overall Study|Physician Decision|1|||
131711519|NCT03902080|474221518|FG000|Overall Study|Protocol Violation|3|||
131711520|NCT03902080|474221519|FG001|Overall Study|Protocol Violation|3|||
131711521|NCT03902080|474221518|FG000|Overall Study|Lack of Efficacy|1|||
131711522|NCT03902080|474221519|FG001|Overall Study|Lack of Efficacy|3|||
131711523|NCT03902080|474221518|FG000|Overall Study|Withdrawn prior to dosing|0|||
131711524|NCT03902080|474221519|FG001|Overall Study|Withdrawn prior to dosing|1|||
131711525|NCT04125680|474221521|FG000|Overall Study|Lost to Follow-up|15|||
131711526|NCT00391976|474221522|FG000|Overall Study|Adverse Event|0|||
131711527|NCT00391976|474221523|FG001|Overall Study|Adverse Event|0|||
131711528|NCT00391976|474221524|FG002|Overall Study|Adverse Event|1|||
131711529|NCT00391976|474221522|FG000|Overall Study|Withdrawal of consent|0|||
131711530|NCT00391976|474221523|FG001|Overall Study|Withdrawal of consent|1|||
131711531|NCT00391976|474221524|FG002|Overall Study|Withdrawal of consent|1|||
131711532|NCT00391976|474221522|FG000|Overall Study|Lost to Follow-up|1|||
131711533|NCT00391976|474221523|FG001|Overall Study|Lost to Follow-up|2|||
131711534|NCT00391976|474221524|FG002|Overall Study|Lost to Follow-up|0|||
131711535|NCT00391976|474221522|FG000|Overall Study|Inappropriate enrollment|1|||
131711536|NCT00391976|474221523|FG001|Overall Study|Inappropriate enrollment|1|||
131711537|NCT00391976|474221524|FG002|Overall Study|Inappropriate enrollment|0|||
131711538|NCT00391976|474221522|FG000|Overall Study|Protocol deviation/violation|4|||
131711539|NCT00391976|474221523|FG001|Overall Study|Protocol deviation/violation|2|||
131711540|NCT00391976|474221524|FG002|Overall Study|Protocol deviation/violation|1|||
131711541|NCT00391976|474221522|FG000|Overall Study|Recurrence/no eradication of infection|21|||
131711542|NCT00391976|474221523|FG001|Overall Study|Recurrence/no eradication of infection|19|||
131711543|NCT00391976|474221524|FG002|Overall Study|Recurrence/no eradication of infection|0|||
131711544|NCT00391976|474221522|FG000|Overall Study|Unable to classify|0|||
131711545|NCT00391976|474221523|FG001|Overall Study|Unable to classify|0|||
131711546|NCT00391976|474221524|FG002|Overall Study|Unable to classify|1|||
131711547|NCT00391976|474221522|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
131711548|NCT00391976|474221523|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
131711549|NCT00391976|474221524|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
131711550|NCT01701258|474221529|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
131711551|NCT01701258|474221530|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
131711552|NCT01701258|474221531|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
131711553|NCT01701258|474221532|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
131711554|NCT01701258|474221533|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
131711555|NCT01701258|474221534|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
131711556|NCT01701258|474221535|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
131711557|NCT01701258|474221536|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
131711558|NCT01701258|474221537|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
131711559|NCT01701258|474221538|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
131711560|NCT01701258|474221539|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
131711561|NCT01701258|474221540|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
131711562|NCT01701258|474221541|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
131711563|NCT01701258|474221529|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
131711564|NCT01701258|474221530|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
131711565|NCT01701258|474221531|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
131711566|NCT01701258|474221532|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
131711567|NCT01701258|474221533|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
131711568|NCT01701258|474221534|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
131711569|NCT01701258|474221535|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
131711570|NCT01701258|474221536|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
131711571|NCT01701258|474221537|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
131711572|NCT01701258|474221538|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
131711573|NCT01701258|474221539|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
131711574|NCT01701258|474221540|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
131711575|NCT01701258|474221541|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
131711576|NCT01701258|474221529|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
131711577|NCT01701258|474221530|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
131711578|NCT01701258|474221531|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
131711579|NCT01701258|474221532|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
131711580|NCT01701258|474221533|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
131711581|NCT01701258|474221534|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
131711582|NCT01701258|474221535|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
131711583|NCT01701258|474221536|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
131711584|NCT01701258|474221537|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
131711585|NCT01701258|474221538|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
131711586|NCT01701258|474221539|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
131711587|NCT01701258|474221540|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
131711588|NCT01701258|474221541|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
131711589|NCT01701258|474221529|FG000|Assessment and Scheduling|Investigator Terminated|2|||
131711590|NCT01701258|474221530|FG001|Assessment and Scheduling|Investigator Terminated|0|||
131711591|NCT01701258|474221531|FG002|Assessment and Scheduling|Investigator Terminated|0|||
131711592|NCT01701258|474221532|FG003|Assessment and Scheduling|Investigator Terminated|0|||
131711593|NCT01701258|474221533|FG004|Assessment and Scheduling|Investigator Terminated|0|||
131711594|NCT01701258|474221534|FG005|Assessment and Scheduling|Investigator Terminated|0|||
131711595|NCT01701258|474221535|FG006|Assessment and Scheduling|Investigator Terminated|0|||
131711596|NCT01701258|474221536|FG007|Assessment and Scheduling|Investigator Terminated|0|||
131711597|NCT01701258|474221537|FG008|Assessment and Scheduling|Investigator Terminated|0|||
131711598|NCT01701258|474221538|FG009|Assessment and Scheduling|Investigator Terminated|0|||
131711599|NCT01701258|474221539|FG010|Assessment and Scheduling|Investigator Terminated|0|||
131711600|NCT01701258|474221540|FG011|Assessment and Scheduling|Investigator Terminated|0|||
131711601|NCT01701258|474221541|FG012|Assessment and Scheduling|Investigator Terminated|0|||
131711602|NCT03093402|474221542|FG000|Overall Study|Lost to Follow-up|1|||
131711603|NCT03093402|474221543|FG001|Overall Study|Lost to Follow-up|0|||
131711604|NCT03093402|474221544|FG002|Overall Study|Lost to Follow-up|0|||
131711605|NCT03093402|474221545|FG003|Overall Study|Lost to Follow-up|0|||
131711606|NCT03093402|474221542|FG000|Overall Study|Withdrawal by Subject|3|||
131711607|NCT03093402|474221543|FG001|Overall Study|Withdrawal by Subject|3|||
131711608|NCT03093402|474221544|FG002|Overall Study|Withdrawal by Subject|0|||
131711609|NCT03093402|474221545|FG003|Overall Study|Withdrawal by Subject|1|||
131711610|NCT03093402|474221542|FG000|Overall Study|Withdrew prior to dosing|2|||
131711611|NCT03093402|474221543|FG001|Overall Study|Withdrew prior to dosing|1|||
131711612|NCT03093402|474221544|FG002|Overall Study|Withdrew prior to dosing|2|||
131711613|NCT03093402|474221545|FG003|Overall Study|Withdrew prior to dosing|3|||
131711614|NCT03093402|474221542|FG000|Overall Study|Ineligible for study|1|||
131711615|NCT03093402|474221543|FG001|Overall Study|Ineligible for study|0|||
131711616|NCT03093402|474221544|FG002|Overall Study|Ineligible for study|0|||
131711617|NCT03093402|474221545|FG003|Overall Study|Ineligible for study|0|||
131711618|NCT03093402|474221542|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
131711619|NCT03093402|474221543|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
131711620|NCT03093402|474221544|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
131796648|NCT00458302|474539698|FG000|Overall Study|Study Termination By Sponsor|1|||
131711621|NCT03093402|474221545|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
131711622|NCT02429856|474221548|FG000|Overall Study|Death|12|||
131711623|NCT02429856|474221549|FG001|Overall Study|Death|13|||
131711624|NCT02429856|474221548|FG000|Overall Study|Lost to Follow-up|6|||
131711625|NCT02429856|474221549|FG001|Overall Study|Lost to Follow-up|5|||
131711626|NCT02429856|474221548|FG000|Overall Study|Withdrawal by Subject|1|||
131711627|NCT02429856|474221549|FG001|Overall Study|Withdrawal by Subject|1|||
131711628|NCT03514914|474221553|FG000|Overall Study|Death|3|||
131711629|NCT03514914|474221554|FG001|Overall Study|Death|3|||
131711630|NCT03514914|474221553|FG000|Overall Study|Lost to Follow-up|117|||
131711631|NCT03514914|474221554|FG001|Overall Study|Lost to Follow-up|89|||
131711632|NCT00891735|474221555|FG000|Overall Study|Adverse Event|2|||
131711633|NCT00891735|474221556|FG001|Overall Study|Adverse Event|0|||
131796649|NCT00458302|474539699|FG001|Overall Study|Study Termination By Sponsor|0|||
131711634|NCT00891735|474221557|FG002|Overall Study|Adverse Event|2|||
131901250|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901251|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131901252|NCT02326272|474923497|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901253|NCT02326272|474923498|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901254|NCT02326272|474923499|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901255|NCT02326272|474923500|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901256|NCT02326272|474923501|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901257|NCT02326272|474923502|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901258|NCT02326272|474923503|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901259|NCT02326272|474923504|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901260|NCT02326272|474923505|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901261|NCT02326272|474923506|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901262|NCT02326272|474923507|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901263|NCT02326272|474923508|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901264|NCT02326272|474923509|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
131901265|NCT02326272|474923510|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901266|NCT02326272|474923511|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131901267|NCT00737100|474923515|FG000|Overall Study|Adverse Event|6|||
131901268|NCT00737100|474923516|FG001|Overall Study|Adverse Event|5|||
131901269|NCT00737100|474923517|FG002|Overall Study|Adverse Event|3|||
131901270|NCT00737100|474923515|FG000|Overall Study|Lost to Follow-up|0|||
131901271|NCT00737100|474923516|FG001|Overall Study|Lost to Follow-up|1|||
131901272|NCT00737100|474923517|FG002|Overall Study|Lost to Follow-up|0|||
131901273|NCT00737100|474923515|FG000|Overall Study|Withdrawal by Subject|0|||
131901274|NCT00737100|474923516|FG001|Overall Study|Withdrawal by Subject|0|||
131901275|NCT00737100|474923517|FG002|Overall Study|Withdrawal by Subject|3|||
131901276|NCT00737100|474923515|FG000|Overall Study|Reason discontinued not explained above|1|||
131901277|NCT00737100|474923516|FG001|Overall Study|Reason discontinued not explained above|1|||
131901278|NCT00737100|474923517|FG002|Overall Study|Reason discontinued not explained above|1|||
131901279|NCT01265394|474923520|FG000|Overall Study|Subjects withdrawn|37|||
131901280|NCT00735943|474923521|FG000|Overall Study|Lost to Follow-up|1|||
131901281|NCT00735943|474923521|FG000|Overall Study|Adverse Event|1|||
131901282|NCT00268983|474923524|FG000|Overall Study|Death|3|||
131901283|NCT00268983|474923525|FG001|Overall Study|Death|0|||
131901284|NCT01719380|474923528|FG000|Overall Study|Adverse Event|0|||
131901285|NCT01719380|474923529|FG001|Overall Study|Adverse Event|0|||
131901286|NCT01719380|474923530|FG002|Overall Study|Adverse Event|1|||
131901287|NCT01719380|474923531|FG003|Overall Study|Adverse Event|2|||
131901288|NCT01719380|474923532|FG004|Overall Study|Adverse Event|0|||
131901289|NCT01719380|474923533|FG005|Overall Study|Adverse Event|1|||
131901290|NCT01719380|474923534|FG006|Overall Study|Adverse Event|0|||
131901291|NCT01719380|474923535|FG007|Overall Study|Adverse Event|1|||
131901292|NCT01719380|474923536|FG008|Overall Study|Adverse Event|4|||
131711635|NCT00891735|474221558|FG003|Overall Study|Adverse Event|0|||
131711636|NCT00891735|474221555|FG000|Overall Study|Death|8|||
131711637|NCT00891735|474221556|FG001|Overall Study|Death|5|||
131711638|NCT00891735|474221557|FG002|Overall Study|Death|4|||
131711639|NCT00891735|474221558|FG003|Overall Study|Death|5|||
131711640|NCT00891735|474221555|FG000|Overall Study|Lost to Follow-up|2|||
131711641|NCT00891735|474221556|FG001|Overall Study|Lost to Follow-up|2|||
131711642|NCT00891735|474221557|FG002|Overall Study|Lost to Follow-up|2|||
131711643|NCT00891735|474221558|FG003|Overall Study|Lost to Follow-up|2|||
131711644|NCT00891735|474221555|FG000|Overall Study|Physician's decision to withdraw patient|1|||
131711645|NCT00891735|474221556|FG001|Overall Study|Physician's decision to withdraw patient|0|||
131711646|NCT00891735|474221557|FG002|Overall Study|Physician's decision to withdraw patient|0|||
131711647|NCT00891735|474221558|FG003|Overall Study|Physician's decision to withdraw patient|0|||
131711648|NCT00891735|474221555|FG000|Overall Study|Patient's decision to withdraw|4|||
131711649|NCT00891735|474221556|FG001|Overall Study|Patient's decision to withdraw|9|||
131901293|NCT01719380|474923537|FG009|Overall Study|Adverse Event|3|||
131901294|NCT01719380|474923528|FG000|Overall Study|Death|0|||
131901295|NCT01719380|474923529|FG001|Overall Study|Death|1|||
131901296|NCT01719380|474923530|FG002|Overall Study|Death|0|||
131711650|NCT00891735|474221557|FG002|Overall Study|Patient's decision to withdraw|4|||
131711651|NCT00891735|474221558|FG003|Overall Study|Patient's decision to withdraw|8|||
131901297|NCT01719380|474923531|FG003|Overall Study|Death|0|||
131901298|NCT01719380|474923532|FG004|Overall Study|Death|0|||
131901299|NCT01719380|474923533|FG005|Overall Study|Death|0|||
131625622|NCT01137682|473915841|FG002|Overall Study|Lack of Efficacy-Extension|13|||
131625623|NCT01137682|473915839|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
131625624|NCT01137682|473915840|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
131625625|NCT01137682|473915841|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
131625626|NCT01137682|473915839|FG000|Overall Study|Lost to Follow Up-Extension|0|||
131625627|NCT01137682|473915840|FG001|Overall Study|Lost to Follow Up-Extension|1|||
131625628|NCT01137682|473915841|FG002|Overall Study|Lost to Follow Up-Extension|0|||
131625629|NCT01137682|473915839|FG000|Overall Study|Administrative problems-Extension|0|||
131625630|NCT01137682|473915840|FG001|Overall Study|Administrative problems-Extension|2|||
131625631|NCT01137682|473915841|FG002|Overall Study|Administrative problems-Extension|0|||
131625632|NCT01137682|473915839|FG000|Overall Study|Death-Extension|2|||
131625633|NCT01137682|473915840|FG001|Overall Study|Death-Extension|0|||
131625634|NCT01137682|473915841|FG002|Overall Study|Death-Extension|0|||
131625635|NCT01137682|473915839|FG000|Overall Study|Protocol Violation-Extension|2|||
131625636|NCT01137682|473915840|FG001|Overall Study|Protocol Violation-Extension|1|||
131625637|NCT01137682|473915841|FG002|Overall Study|Protocol Violation-Extension|0|||
131625638|NCT01137682|473915839|FG000|Overall Study|Did not enter extension|2|||
131625639|NCT01137682|473915840|FG001|Overall Study|Did not enter extension|3|||
131625640|NCT01137682|473915841|FG002|Overall Study|Did not enter extension|2|||
131625641|NCT01137682|473915839|FG000|Overall Study|Did not receive treatment in extension|0|||
131625642|NCT01137682|473915840|FG001|Overall Study|Did not receive treatment in extension|0|||
131625643|NCT01137682|473915841|FG002|Overall Study|Did not receive treatment in extension|1|||
131711652|NCT03029832|474221562|FG000|Overall Study|Safety Follow-Up Completed|2|||
131796650|NCT00458302|474539698|FG000|Overall Study|Lost to Follow-up|2|||
131711653|NCT03029832|474221563|FG001|Overall Study|Safety Follow-Up Completed|0|||
131711654|NCT03029832|474221562|FG000|Overall Study|Death due to Disease Progression|1|||
131711655|NCT03029832|474221563|FG001|Overall Study|Death due to Disease Progression|0|||
131625644|NCT04421456|473915842|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
131625645|NCT04421456|473915843|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
131625646|NCT04421456|473915844|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
131711656|NCT03029832|474221562|FG000|Overall Study|Study Terminated By Sponsor|1|||
131711657|NCT03029832|474221563|FG001|Overall Study|Study Terminated By Sponsor|1|||
131711658|NCT01412229|474221564|FG000|Overall Study|Physician Decision|1|||
131711659|NCT00404092|474221567|FG000|Overall Study|Death|1|||
131711660|NCT00404092|474221568|FG001|Overall Study|Death|0|||
131711661|NCT00404092|474221569|FG002|Overall Study|Death|0|||
131711662|NCT00404092|474221570|FG003|Overall Study|Death|0|||
131711663|NCT00404092|474221567|FG000|Overall Study|Adverse Event|0|||
131711664|NCT00404092|474221568|FG001|Overall Study|Adverse Event|0|||
131711665|NCT00404092|474221569|FG002|Overall Study|Adverse Event|1|||
131711666|NCT00404092|474221570|FG003|Overall Study|Adverse Event|0|||
131711667|NCT04223609|474221575|FG000|Overall Study|Adverse Event|0|||
131711668|NCT04223609|474221576|FG001|Overall Study|Adverse Event|1|||
131711669|NCT04223609|474221575|FG000|Overall Study|Missed last visit|0|||
131711670|NCT04223609|474221576|FG001|Overall Study|Missed last visit|1|||
131711671|NCT01275222|474221577|FG000|Phase l by Treatment|Adverse Event|1|||
131711672|NCT01275222|474221578|FG001|Phase l by Treatment|Adverse Event|4|||
131711673|NCT01275222|474221579|FG002|Phase l by Treatment|Adverse Event|2|||
131711674|NCT01275222|474221580|FG003|Phase l by Treatment|Adverse Event|3|||
131711675|NCT01275222|474221581|FG004|Phase l by Treatment|Adverse Event|0|||
131711676|NCT01275222|474221582|FG005|Phase l by Treatment|Adverse Event|0|||
131711677|NCT01275222|474221577|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131711678|NCT01275222|474221578|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131711679|NCT01275222|474221579|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
131711680|NCT01275222|474221580|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131711681|NCT01275222|474221581|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131711682|NCT01275222|474221582|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131711683|NCT01275222|474221577|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131711684|NCT01275222|474221578|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131711685|NCT01275222|474221579|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131711686|NCT01275222|474221580|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
131711687|NCT01275222|474221581|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131711688|NCT01275222|474221582|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131711689|NCT01275222|474221577|FG000|Phase l by Treatment|Disease progression|12|||
131711690|NCT01275222|474221578|FG001|Phase l by Treatment|Disease progression|8|||
131711691|NCT01275222|474221579|FG002|Phase l by Treatment|Disease progression|2|||
131711692|NCT01275222|474221580|FG003|Phase l by Treatment|Disease progression|5|||
131711693|NCT01275222|474221581|FG004|Phase l by Treatment|Disease progression|0|||
131711694|NCT01275222|474221582|FG005|Phase l by Treatment|Disease progression|0|||
131711695|NCT01275222|474221577|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
131711696|NCT01275222|474221578|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
131711697|NCT01275222|474221579|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
131711698|NCT01275222|474221580|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
131711699|NCT01275222|474221581|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
131711700|NCT01275222|474221582|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
131711701|NCT01275222|474221577|FG000|Phase l by Treatment|Death|0|||
131711702|NCT01275222|474221578|FG001|Phase l by Treatment|Death|1|||
131711703|NCT01275222|474221579|FG002|Phase l by Treatment|Death|0|||
131711704|NCT01275222|474221580|FG003|Phase l by Treatment|Death|1|||
131711705|NCT01275222|474221581|FG004|Phase l by Treatment|Death|0|||
131711706|NCT01275222|474221582|FG005|Phase l by Treatment|Death|0|||
131711707|NCT01275222|474221577|FG000|Phase ll by Stratum|Adverse Event|0|||
131625647|NCT04421456|473915842|FG000|Randomized Treatment Period|Adverse Event|0|||
131625648|NCT04421456|473915843|FG001|Randomized Treatment Period|Adverse Event|1|||
131625649|NCT04421456|473915844|FG002|Randomized Treatment Period|Adverse Event|0|||
131625650|NCT04421456|473915842|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
131625651|NCT04421456|473915843|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
131625652|NCT04421456|473915844|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
131625653|NCT04421456|473915842|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
131625654|NCT04421456|473915843|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
131625655|NCT04421456|473915844|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
131625656|NCT04421456|473915842|FG000|Randomized Treatment Period|Participant non-compliance|1|||
131625657|NCT04421456|473915843|FG001|Randomized Treatment Period|Participant non-compliance|1|||
131625658|NCT04421456|473915844|FG002|Randomized Treatment Period|Participant non-compliance|2|||
131625659|NCT04421456|473915842|FG000|Randomized Treatment Period|Other|0|||
131625660|NCT04421456|473915843|FG001|Randomized Treatment Period|Other|1|||
131625661|NCT04421456|473915844|FG002|Randomized Treatment Period|Other|3|||
131625662|NCT00274287|473915845|FG000|Overall Study|Withdrawal by Subject|1|||
131625663|NCT00274287|473915845|FG000|Overall Study|subject non-compliance|1|||
131625664|NCT04617847|473915846|FG000|Overall Study|Withdrawal by Subject|1|||
131625665|NCT04617847|473915847|FG001|Overall Study|Withdrawal by Subject|0|||
131625666|NCT04617847|473915846|FG000|Overall Study|Adverse Event|0|||
131625667|NCT04617847|473915847|FG001|Overall Study|Adverse Event|2|||
131625668|NCT04617847|473915846|FG000|Overall Study|Death|0|||
131625669|NCT04617847|473915847|FG001|Overall Study|Death|1|||
131796651|NCT00458302|474539699|FG001|Overall Study|Lost to Follow-up|0|||
131796652|NCT00458302|474539698|FG000|Overall Study|Other|4|||
131796653|NCT00458302|474539699|FG001|Overall Study|Other|2|||
131796654|NCT01060670|474539701|FG000|Run In|screen failure|0|||
131796655|NCT01060670|474539702|FG001|Run In|screen failure|238|||
131796656|NCT02761980|474539707|FG000|Overall Study|Adverse Event|4|||
131796657|NCT02761980|474539708|FG001|Overall Study|Adverse Event|6|||
131796658|NCT02761980|474539709|FG002|Overall Study|Adverse Event|5|||
131796659|NCT02761980|474539710|FG003|Overall Study|Adverse Event|6|||
131796660|NCT02761980|474539707|FG000|Overall Study|Withdrawal by Subject|0|||
131796661|NCT02761980|474539708|FG001|Overall Study|Withdrawal by Subject|1|||
131796662|NCT02761980|474539709|FG002|Overall Study|Withdrawal by Subject|0|||
131796663|NCT02761980|474539710|FG003|Overall Study|Withdrawal by Subject|0|||
131796664|NCT02761980|474539707|FG000|Overall Study|Other|0|||
131796665|NCT02761980|474539708|FG001|Overall Study|Other|0|||
131796666|NCT02761980|474539709|FG002|Overall Study|Other|1|||
131796667|NCT02761980|474539710|FG003|Overall Study|Other|0|||
131796668|NCT03093324|474539711|FG000|Overall Study|Adverse Event|4|||
131796669|NCT03093324|474539712|FG001|Overall Study|Adverse Event|15|||
131796670|NCT03093324|474539711|FG000|Overall Study|Lost to Follow-up|1|||
131796671|NCT03093324|474539712|FG001|Overall Study|Lost to Follow-up|0|||
131796672|NCT03093324|474539711|FG000|Overall Study|Protocol Deviation|2|||
131796673|NCT03093324|474539712|FG001|Overall Study|Protocol Deviation|2|||
131796674|NCT03093324|474539711|FG000|Overall Study|Withdrawal by Subject|2|||
131796675|NCT03093324|474539712|FG001|Overall Study|Withdrawal by Subject|2|||
131796676|NCT02742090|474539713|FG000|Overall Study|Adverse Event|10|||
131796677|NCT02742090|474539713|FG000|Overall Study|Death|3|||
131796678|NCT02742090|474539713|FG000|Overall Study|Disease Progression|25|||
131796679|NCT02742090|474539713|FG000|Overall Study|Investigator's Decision|1|||
131796680|NCT02742090|474539713|FG000|Overall Study|Lost to Follow-up|1|||
131796681|NCT02742090|474539713|FG000|Overall Study|Non-compliance with Study|1|||
131796682|NCT02742090|474539713|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
131796683|NCT02742090|474539713|FG000|Overall Study|Withdrawal by Subject|4|||
131796684|NCT02742090|474539713|FG000|Overall Study|Reason Not Specified|1|||
131796685|NCT00836927|474539714|FG000|Overall Study|Progressive disease|2|||
131796686|NCT00836927|474539715|FG001|Overall Study|Progressive disease|0|||
131796687|NCT00836927|474539716|FG002|Overall Study|Progressive disease|0|||
131796688|NCT00836927|474539717|FG003|Overall Study|Progressive disease|1|||
131796689|NCT00836927|474539718|FG004|Overall Study|Progressive disease|1|||
131796690|NCT00836927|474539714|FG000|Overall Study|Withdrawal by Subject|1|||
131796691|NCT00836927|474539715|FG001|Overall Study|Withdrawal by Subject|0|||
131796692|NCT00836927|474539716|FG002|Overall Study|Withdrawal by Subject|0|||
131796693|NCT00836927|474539717|FG003|Overall Study|Withdrawal by Subject|0|||
131796694|NCT00836927|474539718|FG004|Overall Study|Withdrawal by Subject|0|||
131796695|NCT00614055|474539721|FG000|Overall Study|Adverse Event|1|||
131796696|NCT00614055|474539722|FG001|Overall Study|Adverse Event|0|||
131625670|NCT04617847|473915846|FG000|Overall Study|Termination of Study by Sponsor|2|||
131625671|NCT04617847|473915847|FG001|Overall Study|Termination of Study by Sponsor|21|||
131625672|NCT00244751|473915848|FG000|Overall Study|Adverse Event|7|||
131625673|NCT00244751|473915849|FG001|Overall Study|Adverse Event|7|||
131796697|NCT00614055|474539723|FG002|Overall Study|Adverse Event|0|||
131796698|NCT00614055|474539721|FG000|Overall Study|Protocol Violation|2|||
131796699|NCT00614055|474539722|FG001|Overall Study|Protocol Violation|2|||
131796700|NCT00614055|474539723|FG002|Overall Study|Protocol Violation|1|||
131901300|NCT01719380|474923534|FG006|Overall Study|Death|0|||
131625674|NCT00244751|473915850|FG002|Overall Study|Adverse Event|5|||
131625675|NCT00244751|473915848|FG000|Overall Study|Lost to Follow-up|0|||
131625676|NCT00244751|473915849|FG001|Overall Study|Lost to Follow-up|1|||
131625677|NCT00244751|473915850|FG002|Overall Study|Lost to Follow-up|0|||
131625678|NCT00244751|473915848|FG000|Overall Study|Protocol Violation|1|||
131625679|NCT00244751|473915849|FG001|Overall Study|Protocol Violation|0|||
131625680|NCT00244751|473915850|FG002|Overall Study|Protocol Violation|1|||
131625681|NCT00244751|473915848|FG000|Overall Study|Withdrawal by Subject|7|||
131625682|NCT00244751|473915849|FG001|Overall Study|Withdrawal by Subject|5|||
131625683|NCT00244751|473915850|FG002|Overall Study|Withdrawal by Subject|3|||
131625684|NCT00244751|473915848|FG000|Overall Study|Elevated liver enzymes|1|||
131625685|NCT00244751|473915849|FG001|Overall Study|Elevated liver enzymes|0|||
131625686|NCT00244751|473915850|FG002|Overall Study|Elevated liver enzymes|0|||
131625687|NCT00244751|473915848|FG000|Overall Study|Lack of compliance with protocol|0|||
131625688|NCT00244751|473915849|FG001|Overall Study|Lack of compliance with protocol|1|||
131625689|NCT00244751|473915850|FG002|Overall Study|Lack of compliance with protocol|0|||
131625690|NCT00244751|473915848|FG000|Overall Study|Safety reasons|0|||
131625691|NCT00244751|473915849|FG001|Overall Study|Safety reasons|1|||
131625692|NCT00244751|473915850|FG002|Overall Study|Safety reasons|0|||
131625693|NCT00244751|473915848|FG000|Overall Study|Participant randomized by mistake|0|||
131625694|NCT00244751|473915849|FG001|Overall Study|Participant randomized by mistake|0|||
131625695|NCT00244751|473915850|FG002|Overall Study|Participant randomized by mistake|1|||
131625696|NCT02206607|473915853|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
131625697|NCT02206607|473915854|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
131625698|NCT02206607|473915855|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
131625699|NCT02206607|473915856|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
131625700|NCT02206607|473915857|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
131625701|NCT02206607|473915853|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
131625702|NCT02206607|473915854|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
131625703|NCT02206607|473915855|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
131625704|NCT02206607|473915856|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
131901301|NCT01719380|474923535|FG007|Overall Study|Death|0|||
131901302|NCT01719380|474923536|FG008|Overall Study|Death|3|||
131901303|NCT01719380|474923537|FG009|Overall Study|Death|3|||
131901304|NCT01719380|474923528|FG000|Overall Study|Participant/Guardian Decision|0|||
131901305|NCT01719380|474923529|FG001|Overall Study|Participant/Guardian Decision|0|||
131901306|NCT01719380|474923530|FG002|Overall Study|Participant/Guardian Decision|1|||
131625705|NCT02206607|473915857|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
131625706|NCT01262456|473915858|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
131625707|NCT01262456|473915859|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
131625708|NCT01262456|473915860|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
131625709|NCT01262456|473915858|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
131901307|NCT01719380|474923531|FG003|Overall Study|Participant/Guardian Decision|0|||
131901308|NCT01719380|474923532|FG004|Overall Study|Participant/Guardian Decision|0|||
131901309|NCT01719380|474923533|FG005|Overall Study|Participant/Guardian Decision|0|||
131901310|NCT01719380|474923534|FG006|Overall Study|Participant/Guardian Decision|0|||
131901311|NCT01719380|474923535|FG007|Overall Study|Participant/Guardian Decision|0|||
131901312|NCT01719380|474923536|FG008|Overall Study|Participant/Guardian Decision|2|||
131901313|NCT01719380|474923537|FG009|Overall Study|Participant/Guardian Decision|2|||
131901314|NCT01719380|474923528|FG000|Overall Study|Physician Decision|0|||
131625710|NCT01262456|473915859|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
131625711|NCT01262456|473915860|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
131625712|NCT01262456|473915858|FG000|3-Month Double-Blind Period|Adverse Event|6|||
131625713|NCT01262456|473915859|FG001|3-Month Double-Blind Period|Adverse Event|4|||
131625714|NCT01262456|473915860|FG002|3-Month Double-Blind Period|Adverse Event|8|||
131625715|NCT01262456|473915858|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
131625716|NCT01262456|473915859|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
131625717|NCT01262456|473915860|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
131901315|NCT01719380|474923529|FG001|Overall Study|Physician Decision|0|||
131901316|NCT01719380|474923530|FG002|Overall Study|Physician Decision|2|||
131444067|NCT05138653|473255027|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131901317|NCT01719380|474923531|FG003|Overall Study|Physician Decision|0|||
131901318|NCT01719380|474923532|FG004|Overall Study|Physician Decision|0|||
131625718|NCT01262456|473915858|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
131625719|NCT01262456|473915859|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
131625720|NCT01262456|473915860|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
131625721|NCT01262456|473915858|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
131625722|NCT01262456|473915859|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
131625723|NCT01262456|473915860|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
131625724|NCT01262456|473915858|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
131625725|NCT01262456|473915859|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
131625726|NCT01262456|473915860|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
131901319|NCT01719380|474923533|FG005|Overall Study|Physician Decision|0|||
131901320|NCT01719380|474923534|FG006|Overall Study|Physician Decision|0|||
131901321|NCT01719380|474923535|FG007|Overall Study|Physician Decision|0|||
131901322|NCT01719380|474923536|FG008|Overall Study|Physician Decision|1|||
131901323|NCT01719380|474923537|FG009|Overall Study|Physician Decision|1|||
131901324|NCT01719380|474923528|FG000|Overall Study|Lack of Efficacy|2|||
131901325|NCT01719380|474923529|FG001|Overall Study|Lack of Efficacy|6|||
131901326|NCT01719380|474923530|FG002|Overall Study|Lack of Efficacy|5|||
131901327|NCT01719380|474923531|FG003|Overall Study|Lack of Efficacy|6|||
131901328|NCT01719380|474923532|FG004|Overall Study|Lack of Efficacy|3|||
131901329|NCT01719380|474923533|FG005|Overall Study|Lack of Efficacy|7|||
131901330|NCT01719380|474923534|FG006|Overall Study|Lack of Efficacy|10|||
131901331|NCT01719380|474923535|FG007|Overall Study|Lack of Efficacy|6|||
131901332|NCT01719380|474923536|FG008|Overall Study|Lack of Efficacy|39|||
131901333|NCT01719380|474923537|FG009|Overall Study|Lack of Efficacy|42|||
131901334|NCT01719380|474923528|FG000|Overall Study|Progressive Disease|0|||
131901335|NCT01719380|474923529|FG001|Overall Study|Progressive Disease|0|||
131901336|NCT01719380|474923530|FG002|Overall Study|Progressive Disease|0|||
131901337|NCT01719380|474923531|FG003|Overall Study|Progressive Disease|0|||
131901338|NCT01719380|474923532|FG004|Overall Study|Progressive Disease|0|||
131901339|NCT01719380|474923533|FG005|Overall Study|Progressive Disease|0|||
131901340|NCT01719380|474923534|FG006|Overall Study|Progressive Disease|0|||
131901341|NCT01719380|474923535|FG007|Overall Study|Progressive Disease|0|||
131901342|NCT01719380|474923536|FG008|Overall Study|Progressive Disease|1|||
131901343|NCT01719380|474923537|FG009|Overall Study|Progressive Disease|0|||
131901344|NCT01064414|474923538|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
131901345|NCT01064414|474923539|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
131901346|NCT01064414|474923540|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
131901347|NCT01064414|474923538|FG000|Core Period: Baseline to Week 26|Death|0|||
131901348|NCT01064414|474923539|FG001|Core Period: Baseline to Week 26|Death|1|||
131901349|NCT01064414|474923540|FG002|Core Period: Baseline to Week 26|Death|0|||
131901350|NCT01064414|474923538|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
131901351|NCT01064414|474923539|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
131901352|NCT01064414|474923540|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
131901353|NCT01064414|474923538|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
131901354|NCT01064414|474923539|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
131901355|NCT01064414|474923540|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
131901356|NCT01064414|474923538|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131901357|NCT01064414|474923539|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131901358|NCT01064414|474923540|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131901359|NCT01064414|474923538|FG000|Core Period: Baseline to Week 26|Other|4|||
131901360|NCT01064414|474923539|FG001|Core Period: Baseline to Week 26|Other|7|||
131901361|NCT01064414|474923540|FG002|Core Period: Baseline to Week 26|Other|2|||
131901362|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
131901363|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
131901364|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
131901365|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Death|0|||
131901366|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Death|1|||
131901367|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Death|0|||
131901368|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
131901369|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131901370|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131901371|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
131901372|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131901373|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131901374|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131901375|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131901376|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131901377|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
131901378|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
131901379|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
131901380|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131901381|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131901382|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131901383|NCT01064414|474923538|FG000|Extension Period: Week 26 to Week 52|Other|5|||
131901384|NCT01064414|474923539|FG001|Extension Period: Week 26 to Week 52|Other|2|||
131901385|NCT01064414|474923540|FG002|Extension Period: Week 26 to Week 52|Other|1|||
131901386|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Death|20|||
131901387|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Death|26|||
131901388|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
131901389|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
131625727|NCT01262456|473915858|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
131625728|NCT01262456|473915859|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
131625729|NCT01262456|473915860|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
131625730|NCT01262456|473915858|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
131625731|NCT01262456|473915859|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
131625732|NCT01262456|473915860|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
131625733|NCT02399449|473915861|FG000|Overall Study|Withdrawal by Subject|3|||
131625734|NCT02399449|473915862|FG001|Overall Study|Withdrawal by Subject|9|||
131625735|NCT02399449|473915861|FG000|Overall Study|Physician Decision|0|||
131625736|NCT02399449|473915862|FG001|Overall Study|Physician Decision|1|||
131625737|NCT00337610|473915863|FG000|Overall Study|Adverse Event|2|||
131444068|NCT05138653|473255028|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131711708|NCT01275222|474221578|FG001|Phase ll by Stratum|Adverse Event|0|||
131711709|NCT01275222|474221579|FG002|Phase ll by Stratum|Adverse Event|0|||
131711710|NCT01275222|474221580|FG003|Phase ll by Stratum|Adverse Event|0|||
131711711|NCT01275222|474221581|FG004|Phase ll by Stratum|Adverse Event|2|||
131711712|NCT01275222|474221582|FG005|Phase ll by Stratum|Adverse Event|10|||
131711713|NCT01275222|474221577|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
131711714|NCT01275222|474221578|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
131711715|NCT01275222|474221579|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
131711716|NCT01275222|474221580|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
131711717|NCT01275222|474221581|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
131711718|NCT01275222|474221582|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
131711719|NCT01275222|474221577|FG000|Phase ll by Stratum|Disease progression|0|||
131711720|NCT01275222|474221578|FG001|Phase ll by Stratum|Disease progression|0|||
131711721|NCT01275222|474221579|FG002|Phase ll by Stratum|Disease progression|0|||
131711722|NCT01275222|474221580|FG003|Phase ll by Stratum|Disease progression|0|||
131711723|NCT01275222|474221581|FG004|Phase ll by Stratum|Disease progression|23|||
131711724|NCT01275222|474221582|FG005|Phase ll by Stratum|Disease progression|31|||
131711725|NCT01275222|474221577|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
131711726|NCT01275222|474221578|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
131711727|NCT01275222|474221579|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
131711728|NCT01275222|474221580|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
131711729|NCT01275222|474221581|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
131711730|NCT01275222|474221582|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
131711731|NCT01275222|474221577|FG000|Phase ll by Stratum|Death|0|||
131711732|NCT01275222|474221578|FG001|Phase ll by Stratum|Death|0|||
131711733|NCT01275222|474221579|FG002|Phase ll by Stratum|Death|0|||
131711734|NCT01275222|474221580|FG003|Phase ll by Stratum|Death|0|||
131711735|NCT01275222|474221581|FG004|Phase ll by Stratum|Death|1|||
131711736|NCT01275222|474221582|FG005|Phase ll by Stratum|Death|1|||
131711737|NCT03440944|474221583|FG000|Overall Study|Physician Decision|1|||
131711738|NCT03440944|474221584|FG001|Overall Study|Physician Decision|0|||
131711739|NCT03440944|474221583|FG000|Overall Study|No Acceptable Vasculature|0|||
131711740|NCT03440944|474221584|FG001|Overall Study|No Acceptable Vasculature|1|||
131711741|NCT00784758|474221585|FG000|Overall Study|Withdrawal by Subject|3|||
131711742|NCT00784758|474221586|FG001|Overall Study|Withdrawal by Subject|0|||
131711743|NCT00784758|474221585|FG000|Overall Study|Adverse Event|1|||
131711744|NCT00784758|474221586|FG001|Overall Study|Adverse Event|0|||
131711745|NCT00960076|474224036|FG000|Overall Study|Adverse Event|1|||
131711746|NCT00960076|474224037|FG001|Overall Study|Adverse Event|7|||
131711747|NCT00960076|474224036|FG000|Overall Study|No longer met study criteria|1|||
131711748|NCT00960076|474224037|FG001|Overall Study|No longer met study criteria|5|||
131711749|NCT00960076|474224036|FG000|Overall Study|Withdrawal by Subject|1|||
131711750|NCT00960076|474224037|FG001|Overall Study|Withdrawal by Subject|2|||
131711751|NCT00960076|474224036|FG000|Overall Study|Lost to Follow-up|3|||
131711752|NCT00960076|474224037|FG001|Overall Study|Lost to Follow-up|3|||
131711753|NCT00960076|474224036|FG000|Overall Study|Severe non-compliance to protocol|1|||
131711754|NCT00960076|474224037|FG001|Overall Study|Severe non-compliance to protocol|2|||
131711755|NCT00960076|474224036|FG000|Overall Study|Hyperglycemia|1|||
131711756|NCT00960076|474224037|FG001|Overall Study|Hyperglycemia|5|||
131711757|NCT00960076|474224036|FG000|Overall Study|Did not attend the termination visit|0|||
131711758|NCT00960076|474224037|FG001|Overall Study|Did not attend the termination visit|1|||
131711759|NCT00500266|474224038|FG000|Overall Study|Death|3|||
131711760|NCT00500266|474224038|FG000|Overall Study|Lost to Follow-up|3|||
131711761|NCT00500266|474224038|FG000|Overall Study|Withdrawal by Subject|3|||
131711762|NCT00500266|474224038|FG000|Overall Study|Assigned, not treated|4|||
131711763|NCT03019549|474224039|FG000|Washout|DId not meet genotype criteria|11|||
131711764|NCT03019549|474224039|FG000|Period 2|Adverse Event|2|||
131711765|NCT03019549|474224039|FG000|Period 2|Physician Decision|2|||
131711766|NCT03019549|474224039|FG000|Period 2|Withdrawal by Subject|1|||
131796701|NCT00614055|474539721|FG000|Overall Study|Lack of Efficacy|0|||
131796702|NCT00614055|474539722|FG001|Overall Study|Lack of Efficacy|0|||
131625738|NCT00337610|473915864|FG001|Overall Study|Adverse Event|2|||
131711767|NCT03263806|474224042|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
131711768|NCT03263806|474224043|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
131796703|NCT00614055|474539723|FG002|Overall Study|Lack of Efficacy|2|||
131796704|NCT00614055|474539721|FG000|Overall Study|Unclassified|1|||
131796705|NCT00614055|474539722|FG001|Overall Study|Unclassified|4|||
131796706|NCT00614055|474539723|FG002|Overall Study|Unclassified|2|||
131796707|NCT02192905|474539725|FG000|Overall Study|Lost to Follow-up|1|||
131796708|NCT01691859|474539727|FG000|Overall Study|Adverse Event|19|||
131796709|NCT01691859|474539727|FG000|Overall Study|Lack of Efficacy|11|||
131796710|NCT01691859|474539727|FG000|Overall Study|Protocol Violation|4|||
131796711|NCT01691859|474539727|FG000|Overall Study|Product commercially available|221|||
131796712|NCT01691859|474539727|FG000|Overall Study|Study closed/terminated|50|||
131796713|NCT01691859|474539727|FG000|Overall Study|Lost to Follow-up|5|||
131796714|NCT01691859|474539727|FG000|Overall Study|Physician Decision|6|||
131796715|NCT01691859|474539727|FG000|Overall Study|Withdrawal by Subject|31|||
131796716|NCT04583579|474539728|FG000|Overall Study|Lost to Follow-up|4|||
131796717|NCT01296932|474539729|FG000|Overall Study|Dose limiting toxicity|0|||
131796718|NCT01296932|474539730|FG001|Overall Study|Dose limiting toxicity|0|||
131796719|NCT01296932|474539731|FG002|Overall Study|Dose limiting toxicity|0|||
131796720|NCT01296932|474539732|FG003|Overall Study|Dose limiting toxicity|0|||
131796721|NCT01296932|474539733|FG004|Overall Study|Dose limiting toxicity|0|||
131796722|NCT01296932|474539734|FG005|Overall Study|Dose limiting toxicity|0|||
131796723|NCT01296932|474539735|FG006|Overall Study|Dose limiting toxicity|1|||
131796724|NCT01296932|474539736|FG007|Overall Study|Dose limiting toxicity|0|||
131796725|NCT01296932|474539737|FG008|Overall Study|Dose limiting toxicity|1|||
131796726|NCT01296932|474539729|FG000|Overall Study|Progressive disease|2|||
131796727|NCT01296932|474539730|FG001|Overall Study|Progressive disease|0|||
131796728|NCT01296932|474539731|FG002|Overall Study|Progressive disease|1|||
131796729|NCT01296932|474539732|FG003|Overall Study|Progressive disease|1|||
131796730|NCT01296932|474539733|FG004|Overall Study|Progressive disease|2|||
131796731|NCT01296932|474539734|FG005|Overall Study|Progressive disease|3|||
131796732|NCT01296932|474539735|FG006|Overall Study|Progressive disease|1|||
131796733|NCT01296932|474539736|FG007|Overall Study|Progressive disease|0|||
131796734|NCT01296932|474539737|FG008|Overall Study|Progressive disease|0|||
131796735|NCT01296932|474539729|FG000|Overall Study|Withdrawal by Subject|0|||
131796736|NCT01296932|474539730|FG001|Overall Study|Withdrawal by Subject|0|||
131796737|NCT01296932|474539731|FG002|Overall Study|Withdrawal by Subject|1|||
131796738|NCT01296932|474539732|FG003|Overall Study|Withdrawal by Subject|1|||
131796739|NCT01296932|474539733|FG004|Overall Study|Withdrawal by Subject|0|||
131796740|NCT01296932|474539734|FG005|Overall Study|Withdrawal by Subject|0|||
131796741|NCT01296932|474539735|FG006|Overall Study|Withdrawal by Subject|3|||
131796742|NCT01296932|474539736|FG007|Overall Study|Withdrawal by Subject|0|||
131796743|NCT01296932|474539737|FG008|Overall Study|Withdrawal by Subject|0|||
131796744|NCT01296932|474539729|FG000|Overall Study|Adverse Event|1|||
131796745|NCT01296932|474539730|FG001|Overall Study|Adverse Event|1|||
131796746|NCT01296932|474539731|FG002|Overall Study|Adverse Event|1|||
131796747|NCT01296932|474539732|FG003|Overall Study|Adverse Event|2|||
131796748|NCT01296932|474539733|FG004|Overall Study|Adverse Event|1|||
131444069|NCT05138653|473255029|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
131444070|NCT05138653|473255030|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131444071|NCT05138653|473255031|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131444072|NCT05138653|473255032|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131444073|NCT05138653|473255033|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131444074|NCT05138653|473255034|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131625739|NCT00337610|473915863|FG000|Overall Study|Death|0|||
131625740|NCT00337610|473915864|FG001|Overall Study|Death|1|||
131625741|NCT00337610|473915863|FG000|Overall Study|Lack of Efficacy|6|||
131625742|NCT00337610|473915864|FG001|Overall Study|Lack of Efficacy|3|||
131625743|NCT00337610|473915863|FG000|Overall Study|Lost to Follow-up|3|||
131625744|NCT00337610|473915864|FG001|Overall Study|Lost to Follow-up|3|||
131625745|NCT00337610|473915863|FG000|Overall Study|Withdrawal by Subject|6|||
131625746|NCT00337610|473915864|FG001|Overall Study|Withdrawal by Subject|5|||
131625747|NCT03979040|473915865|FG000|Overall Study|Withdrawal by Subject|24|||
131625748|NCT03979040|473915866|FG001|Overall Study|Withdrawal by Subject|32|||
131625749|NCT03979040|473915865|FG000|Overall Study|randomized but never started treatment|32|||
131625750|NCT03979040|473915866|FG001|Overall Study|randomized but never started treatment|39|||
131625751|NCT03979040|473915865|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
131625752|NCT03979040|473915866|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
131625753|NCT03541369|473915869|FG000|Overall Study|Death|0|||
131625754|NCT03541369|473915870|FG001|Overall Study|Death|0|||
131625755|NCT03541369|473915871|FG002|Overall Study|Death|0|||
131625756|NCT03541369|473915872|FG003|Overall Study|Death|0|||
131625757|NCT03541369|473915873|FG004|Overall Study|Death|1|||
131625758|NCT03541369|473915874|FG005|Overall Study|Death|1|||
131625759|NCT03541369|473915875|FG006|Overall Study|Death|0|||
131625760|NCT03541369|473915876|FG007|Overall Study|Death|2|||
131625761|NCT03541369|473915877|FG008|Overall Study|Death|1|||
131625762|NCT03541369|473915878|FG009|Overall Study|Death|2|||
131625763|NCT03541369|473915879|FG010|Overall Study|Death|1|||
131711769|NCT03263806|474224042|FG000|Overall Study|Withdrawal by Subject|0|||
131711770|NCT03263806|474224043|FG001|Overall Study|Withdrawal by Subject|1|||
131711771|NCT03263806|474224042|FG000|Overall Study|Study Termination|5|||
131711772|NCT03263806|474224043|FG001|Overall Study|Study Termination|6|||
131711773|NCT01562028|474224046|FG000|Overall Study|Withdrawal by Subject|1|||
131711774|NCT01562028|474224047|FG001|Overall Study|Withdrawal by Subject|1|||
131711775|NCT01562028|474224046|FG000|Overall Study|Lost to Follow-up|2|||
131711776|NCT01562028|474224047|FG001|Overall Study|Lost to Follow-up|1|||
131711777|NCT02360098|474224048|FG000|Overall Study|Physician Decision|7|||
131711778|NCT04938648|474224053|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
131711779|NCT04938648|474224054|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
131711780|NCT04938648|474224053|FG000|Overall Study|Patient too ill|0|||
131711781|NCT04938648|474224054|FG001|Overall Study|Patient too ill|1|||
131711782|NCT04938648|474224053|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
131711783|NCT04938648|474224054|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
131711784|NCT04938648|474224053|FG000|Overall Study|Patient did not have memory problems|1|||
131711785|NCT04938648|474224054|FG001|Overall Study|Patient did not have memory problems|1|||
131711786|NCT04938648|474224053|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
131711787|NCT04938648|474224054|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
131711788|NCT04938648|474224053|FG000|Overall Study|Care partner could not be reached|0|||
131711789|NCT04938648|474224054|FG001|Overall Study|Care partner could not be reached|1|||
131711790|NCT04938648|474224053|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
131711791|NCT04938648|474224054|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
131711792|NCT04938648|474224053|FG000|Overall Study|Withdrawal by Subject|2|||
131711793|NCT04938648|474224054|FG001|Overall Study|Withdrawal by Subject|1|||
131711794|NCT03293654|474224055|FG000|Overall Study|Lost to Follow-up|0|||
131711795|NCT03293654|474224056|FG001|Overall Study|Lost to Follow-up|1|||
131711796|NCT03293654|474224057|FG002|Overall Study|Lost to Follow-up|0|||
131711797|NCT01919307|474224058|FG000|Overall Study|Withdrawal by Subject|9|||
131711798|NCT05113940|474224060|FG000|Part A (18 Days)|Adverse Event|0|||
131711799|NCT05113940|474224061|FG001|Part A (18 Days)|Adverse Event|0|||
131711800|NCT05113940|474224062|FG002|Part A (18 Days)|Adverse Event|1|||
131711801|NCT05113940|474224063|FG003|Part A (18 Days)|Adverse Event|1|||
131711802|NCT05113940|474224064|FG004|Part A (18 Days)|Adverse Event|1|||
131711803|NCT05113940|474224065|FG005|Part A (18 Days)|Adverse Event|0|||
131711804|NCT05113940|474224066|FG006|Part A (18 Days)|Adverse Event|0|||
131711805|NCT05113940|474224067|FG007|Part A (18 Days)|Adverse Event|0|||
131711806|NCT05113940|474224068|FG008|Part A (18 Days)|Adverse Event|0|||
131711807|NCT05113940|474224069|FG009|Part A (18 Days)|Adverse Event|0|||
131711808|NCT05113940|474224070|FG010|Part A (18 Days)|Adverse Event|0|||
131711809|NCT05113940|474224071|FG011|Part A (18 Days)|Adverse Event|2|||
131711810|NCT05113940|474224072|FG012|Part A (18 Days)|Adverse Event|0|||
131711811|NCT05113940|474224073|FG013|Part A (18 Days)|Adverse Event|0|||
131711812|NCT05113940|474224074|FG014|Part A (18 Days)|Adverse Event|0|||
131711813|NCT05113940|474224060|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711814|NCT05113940|474224061|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711815|NCT05113940|474224062|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711816|NCT05113940|474224063|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711817|NCT05113940|474224064|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711818|NCT05113940|474224065|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711819|NCT05113940|474224066|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711820|NCT05113940|474224067|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711821|NCT05113940|474224068|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711822|NCT05113940|474224069|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711823|NCT05113940|474224070|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711824|NCT05113940|474224071|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711825|NCT05113940|474224072|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711826|NCT05113940|474224073|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
131711827|NCT05113940|474224074|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
131711828|NCT02542267|474224075|FG000|Overall Study|Withdrawal by Subject|10|||
131711829|NCT02542267|474224075|FG000|Overall Study|Physician Decision|6|||
131711830|NCT02542267|474224075|FG000|Overall Study|Lost to Follow-up|4|||
131711831|NCT02542267|474224075|FG000|Overall Study|Death|13|||
131711832|NCT02542267|474224075|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
131711833|NCT02542267|474224075|FG000|Overall Study|Other|9|||
131711834|NCT01262898|474224076|FG000|Overall Study|Protocol Violation|1|||
131711835|NCT01262898|474224077|FG001|Overall Study|Protocol Violation|1|||
131711836|NCT01262898|474224078|FG002|Overall Study|Protocol Violation|0|||
131711837|NCT01262898|474224079|FG003|Overall Study|Protocol Violation|0|||
131711838|NCT01262898|474224076|FG000|Overall Study|Lost to Follow-up|1|||
131711839|NCT01262898|474224077|FG001|Overall Study|Lost to Follow-up|0|||
131711840|NCT01262898|474224078|FG002|Overall Study|Lost to Follow-up|0|||
131625764|NCT03541369|473915880|FG011|Overall Study|Death|0|||
131625765|NCT03541369|473915881|FG012|Overall Study|Death|2|||
131625766|NCT03541369|473915882|FG013|Overall Study|Death|1|||
131625767|NCT03541369|473915883|FG014|Overall Study|Death|1|||
131625768|NCT03541369|473915884|FG015|Overall Study|Death|1|||
131625769|NCT03541369|473915885|FG016|Overall Study|Death|0|||
131625770|NCT03541369|473915886|FG017|Overall Study|Death|1|||
131625771|NCT03541369|473915869|FG000|Overall Study|Decision by sponsor|0|||
131625772|NCT03541369|473915870|FG001|Overall Study|Decision by sponsor|0|||
131625773|NCT03541369|473915871|FG002|Overall Study|Decision by sponsor|0|||
131625774|NCT03541369|473915872|FG003|Overall Study|Decision by sponsor|1|||
131625775|NCT03541369|473915873|FG004|Overall Study|Decision by sponsor|0|||
131625776|NCT03541369|473915874|FG005|Overall Study|Decision by sponsor|2|||
131625777|NCT03541369|473915875|FG006|Overall Study|Decision by sponsor|0|||
131625778|NCT03541369|473915876|FG007|Overall Study|Decision by sponsor|1|||
131625779|NCT03541369|473915877|FG008|Overall Study|Decision by sponsor|2|||
131625780|NCT03541369|473915878|FG009|Overall Study|Decision by sponsor|0|||
131625781|NCT03541369|473915879|FG010|Overall Study|Decision by sponsor|0|||
131625782|NCT03541369|473915880|FG011|Overall Study|Decision by sponsor|0|||
131625783|NCT03541369|473915881|FG012|Overall Study|Decision by sponsor|2|||
131625784|NCT03541369|473915882|FG013|Overall Study|Decision by sponsor|2|||
131625785|NCT03541369|473915883|FG014|Overall Study|Decision by sponsor|0|||
131625786|NCT03541369|473915884|FG015|Overall Study|Decision by sponsor|1|||
131625787|NCT03541369|473915885|FG016|Overall Study|Decision by sponsor|1|||
131625788|NCT03541369|473915886|FG017|Overall Study|Decision by sponsor|1|||
131625789|NCT03541369|473915869|FG000|Overall Study|Withdrawal by Subject|0|||
131625790|NCT03541369|473915870|FG001|Overall Study|Withdrawal by Subject|0|||
131625791|NCT03541369|473915871|FG002|Overall Study|Withdrawal by Subject|0|||
131625792|NCT03541369|473915872|FG003|Overall Study|Withdrawal by Subject|0|||
131625793|NCT03541369|473915873|FG004|Overall Study|Withdrawal by Subject|0|||
131625794|NCT03541369|473915874|FG005|Overall Study|Withdrawal by Subject|0|||
131625795|NCT03541369|473915875|FG006|Overall Study|Withdrawal by Subject|1|||
131625796|NCT03541369|473915876|FG007|Overall Study|Withdrawal by Subject|0|||
131625797|NCT03541369|473915877|FG008|Overall Study|Withdrawal by Subject|0|||
131625798|NCT03541369|473915878|FG009|Overall Study|Withdrawal by Subject|0|||
131625799|NCT03541369|473915879|FG010|Overall Study|Withdrawal by Subject|0|||
131625800|NCT03541369|473915880|FG011|Overall Study|Withdrawal by Subject|1|||
131625801|NCT03541369|473915881|FG012|Overall Study|Withdrawal by Subject|0|||
131625802|NCT03541369|473915882|FG013|Overall Study|Withdrawal by Subject|0|||
131625803|NCT03541369|473915883|FG014|Overall Study|Withdrawal by Subject|3|||
131711841|NCT01262898|474224079|FG003|Overall Study|Lost to Follow-up|0|||
131711842|NCT01262898|474224076|FG000|Overall Study|Withdrawal by Subject|1|||
131625804|NCT03541369|473915884|FG015|Overall Study|Withdrawal by Subject|0|||
131625805|NCT03541369|473915885|FG016|Overall Study|Withdrawal by Subject|4|||
131625806|NCT03541369|473915886|FG017|Overall Study|Withdrawal by Subject|2|||
131625807|NCT03541369|473915869|FG000|Overall Study|Lost to Follow-up|0|||
131625808|NCT03541369|473915870|FG001|Overall Study|Lost to Follow-up|0|||
131625809|NCT03541369|473915871|FG002|Overall Study|Lost to Follow-up|0|||
131625810|NCT03541369|473915872|FG003|Overall Study|Lost to Follow-up|0|||
131625811|NCT03541369|473915873|FG004|Overall Study|Lost to Follow-up|1|||
131796749|NCT01296932|474539734|FG005|Overall Study|Adverse Event|0|||
131796750|NCT01296932|474539735|FG006|Overall Study|Adverse Event|0|||
131796751|NCT01296932|474539736|FG007|Overall Study|Adverse Event|0|||
131796752|NCT01296932|474539737|FG008|Overall Study|Adverse Event|1|||
131796753|NCT01296932|474539729|FG000|Overall Study|Investigator decision|0|||
131796754|NCT01296932|474539730|FG001|Overall Study|Investigator decision|1|||
131796755|NCT01296932|474539731|FG002|Overall Study|Investigator decision|0|||
131796756|NCT01296932|474539732|FG003|Overall Study|Investigator decision|1|||
131796757|NCT01296932|474539733|FG004|Overall Study|Investigator decision|0|||
131796758|NCT01296932|474539734|FG005|Overall Study|Investigator decision|0|||
131796759|NCT01296932|474539735|FG006|Overall Study|Investigator decision|1|||
131796760|NCT01296932|474539736|FG007|Overall Study|Investigator decision|0|||
131796761|NCT01296932|474539737|FG008|Overall Study|Investigator decision|1|||
131796762|NCT01296932|474539729|FG000|Overall Study|No clinical benefit anymore|0|||
131796763|NCT01296932|474539730|FG001|Overall Study|No clinical benefit anymore|1|||
131796764|NCT01296932|474539731|FG002|Overall Study|No clinical benefit anymore|0|||
131796765|NCT01296932|474539732|FG003|Overall Study|No clinical benefit anymore|0|||
131796766|NCT01296932|474539733|FG004|Overall Study|No clinical benefit anymore|0|||
131796767|NCT01296932|474539734|FG005|Overall Study|No clinical benefit anymore|0|||
131796768|NCT01296932|474539735|FG006|Overall Study|No clinical benefit anymore|0|||
131796769|NCT01296932|474539736|FG007|Overall Study|No clinical benefit anymore|0|||
131796770|NCT01296932|474539737|FG008|Overall Study|No clinical benefit anymore|0|||
131796771|NCT01296932|474539729|FG000|Overall Study|Physician Decision|0|||
131796772|NCT01296932|474539730|FG001|Overall Study|Physician Decision|0|||
131796773|NCT01296932|474539731|FG002|Overall Study|Physician Decision|1|||
131796774|NCT01296932|474539732|FG003|Overall Study|Physician Decision|0|||
131796775|NCT01296932|474539733|FG004|Overall Study|Physician Decision|0|||
131796776|NCT01296932|474539734|FG005|Overall Study|Physician Decision|0|||
131796777|NCT01296932|474539735|FG006|Overall Study|Physician Decision|0|||
131796778|NCT01296932|474539736|FG007|Overall Study|Physician Decision|0|||
131796779|NCT01296932|474539737|FG008|Overall Study|Physician Decision|0|||
131796780|NCT01296932|474539729|FG000|Overall Study|IV problems, administration not possible|0|||
131796781|NCT01296932|474539730|FG001|Overall Study|IV problems, administration not possible|0|||
131796782|NCT01296932|474539731|FG002|Overall Study|IV problems, administration not possible|1|||
131796783|NCT01296932|474539732|FG003|Overall Study|IV problems, administration not possible|0|||
131796784|NCT01296932|474539733|FG004|Overall Study|IV problems, administration not possible|0|||
131796785|NCT01296932|474539734|FG005|Overall Study|IV problems, administration not possible|0|||
131796786|NCT01296932|474539735|FG006|Overall Study|IV problems, administration not possible|0|||
131796787|NCT01296932|474539736|FG007|Overall Study|IV problems, administration not possible|0|||
131796788|NCT01296932|474539737|FG008|Overall Study|IV problems, administration not possible|0|||
131796789|NCT01296932|474539729|FG000|Overall Study|per protocol|0|||
131796790|NCT01296932|474539730|FG001|Overall Study|per protocol|0|||
131796791|NCT01296932|474539731|FG002|Overall Study|per protocol|1|||
131796792|NCT01296932|474539732|FG003|Overall Study|per protocol|1|||
131796793|NCT01296932|474539733|FG004|Overall Study|per protocol|0|||
131796794|NCT01296932|474539734|FG005|Overall Study|per protocol|0|||
131796795|NCT01296932|474539735|FG006|Overall Study|per protocol|0|||
131796796|NCT01296932|474539736|FG007|Overall Study|per protocol|0|||
131796797|NCT01296932|474539737|FG008|Overall Study|per protocol|0|||
131796798|NCT01296932|474539729|FG000|Overall Study|Low benefit and too many side effects|0|||
131796799|NCT01296932|474539730|FG001|Overall Study|Low benefit and too many side effects|0|||
131796800|NCT01296932|474539731|FG002|Overall Study|Low benefit and too many side effects|0|||
131901390|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
131901391|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
131901392|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
131901393|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
131796801|NCT01296932|474539732|FG003|Overall Study|Low benefit and too many side effects|0|||
131796802|NCT01296932|474539733|FG004|Overall Study|Low benefit and too many side effects|0|||
131796803|NCT01296932|474539734|FG005|Overall Study|Low benefit and too many side effects|0|||
131901394|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
131901395|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
131901396|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
131444075|NCT05138653|473255035|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131901397|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
131901398|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
131901399|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
131901400|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
131901401|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
131901402|NCT00643201|474923545|FG000|Randomized, Completed 6 Months of Study|Other|107|||
131901403|NCT00643201|474923546|FG001|Randomized, Completed 6 Months of Study|Other|107|||
131901404|NCT00643201|474923545|FG000|Completed Study Follow Up|Death|28|||
131901405|NCT00643201|474923546|FG001|Completed Study Follow Up|Death|34|||
131901406|NCT00643201|474923545|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
131901407|NCT00643201|474923546|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
131901408|NCT00643201|474923545|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
131901409|NCT00643201|474923546|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
131901410|NCT00643201|474923545|FG000|Completed Study Follow Up|non-specified|1|||
131901411|NCT00643201|474923546|FG001|Completed Study Follow Up|non-specified|0|||
131901412|NCT01278342|474923549|FG000|Overall Study|Physician Decision|0|||
131901413|NCT01278342|474923550|FG001|Overall Study|Physician Decision|1|||
131901414|NCT01278342|474923551|FG002|Overall Study|Physician Decision|0|||
131901415|NCT01278342|474923549|FG000|Overall Study|Lost to Follow-up|1|||
131901416|NCT01278342|474923550|FG001|Overall Study|Lost to Follow-up|0|||
131901417|NCT01278342|474923551|FG002|Overall Study|Lost to Follow-up|0|||
131901418|NCT01278342|474923549|FG000|Overall Study|Administrative problems|2|||
131901419|NCT01278342|474923550|FG001|Overall Study|Administrative problems|0|||
131901420|NCT01278342|474923551|FG002|Overall Study|Administrative problems|0|||
131901421|NCT01278342|474923549|FG000|Overall Study|Other|1|||
131901422|NCT01278342|474923550|FG001|Overall Study|Other|0|||
131444076|NCT05138653|473255036|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131901423|NCT01278342|474923551|FG002|Overall Study|Other|0|||
131444077|NCT05138653|473255037|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131901424|NCT00313846|474923557|FG000|Overall Study|Withdrawal by Subject|2|||
131901425|NCT00313846|474923558|FG001|Overall Study|Withdrawal by Subject|0|||
131901426|NCT00313846|474923557|FG000|Overall Study|Adverse Event|1|||
131901427|NCT00313846|474923558|FG001|Overall Study|Adverse Event|8|||
131901428|NCT00313846|474923557|FG000|Overall Study|Administrative|2|||
131444078|NCT05138653|473255038|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131796804|NCT01296932|474539735|FG006|Overall Study|Low benefit and too many side effects|0|||
131796805|NCT01296932|474539736|FG007|Overall Study|Low benefit and too many side effects|1|||
131796806|NCT01296932|474539737|FG008|Overall Study|Low benefit and too many side effects|0|||
131796807|NCT01296932|474539729|FG000|Overall Study|No adequate treatment response|0|||
131796808|NCT01296932|474539730|FG001|Overall Study|No adequate treatment response|0|||
131796809|NCT01296932|474539731|FG002|Overall Study|No adequate treatment response|0|||
131796810|NCT01296932|474539732|FG003|Overall Study|No adequate treatment response|0|||
131796811|NCT01296932|474539733|FG004|Overall Study|No adequate treatment response|0|||
131796812|NCT01296932|474539734|FG005|Overall Study|No adequate treatment response|0|||
131796813|NCT01296932|474539735|FG006|Overall Study|No adequate treatment response|0|||
131796814|NCT01296932|474539736|FG007|Overall Study|No adequate treatment response|1|||
131796815|NCT01296932|474539737|FG008|Overall Study|No adequate treatment response|0|||
131796816|NCT01296932|474539729|FG000|Overall Study|Dosage already reduced, AE still present|0|||
131796817|NCT01296932|474539730|FG001|Overall Study|Dosage already reduced, AE still present|0|||
131796818|NCT01296932|474539731|FG002|Overall Study|Dosage already reduced, AE still present|0|||
131796819|NCT01296932|474539732|FG003|Overall Study|Dosage already reduced, AE still present|0|||
131796820|NCT01296932|474539733|FG004|Overall Study|Dosage already reduced, AE still present|0|||
131796821|NCT01296932|474539734|FG005|Overall Study|Dosage already reduced, AE still present|0|||
131796822|NCT01296932|474539735|FG006|Overall Study|Dosage already reduced, AE still present|0|||
131796823|NCT01296932|474539736|FG007|Overall Study|Dosage already reduced, AE still present|0|||
131796824|NCT01296932|474539737|FG008|Overall Study|Dosage already reduced, AE still present|1|||
131796825|NCT02688400|474539742|FG000|Overall Study|Protocol Violation|2|||
131796826|NCT02688400|474539743|FG001|Overall Study|Protocol Violation|5|||
131796827|NCT02688400|474539742|FG000|Overall Study|Lack of Efficacy|7|||
131796828|NCT02688400|474539743|FG001|Overall Study|Lack of Efficacy|7|||
131796829|NCT02688400|474539742|FG000|Overall Study|Adverse Event|21|||
131796830|NCT02688400|474539743|FG001|Overall Study|Adverse Event|12|||
131796831|NCT02688400|474539742|FG000|Overall Study|Withdrawal by Subject|15|||
131796832|NCT02688400|474539743|FG001|Overall Study|Withdrawal by Subject|13|||
131796833|NCT02688400|474539742|FG000|Overall Study|No study medication intake|1|||
131796834|NCT02688400|474539743|FG001|Overall Study|No study medication intake|4|||
131796835|NCT02688400|474539742|FG000|Overall Study|Lost to Follow-up|0|||
131796836|NCT02688400|474539743|FG001|Overall Study|Lost to Follow-up|3|||
131796837|NCT02006706|474539745|FG000|Overall Study|Lost to Follow-up|1|||
131796838|NCT00958256|474539747|FG000|Overall Study|Adverse Event|3|||
131796839|NCT03036579|474539748|FG000|2 Years|Lost to Follow-up|1|||
131625812|NCT03541369|473915874|FG005|Overall Study|Lost to Follow-up|0|||
131625813|NCT03541369|473915875|FG006|Overall Study|Lost to Follow-up|0|||
131625814|NCT03541369|473915876|FG007|Overall Study|Lost to Follow-up|0|||
131625815|NCT03541369|473915877|FG008|Overall Study|Lost to Follow-up|1|||
131625816|NCT03541369|473915878|FG009|Overall Study|Lost to Follow-up|0|||
131625817|NCT03541369|473915879|FG010|Overall Study|Lost to Follow-up|0|||
131625818|NCT03541369|473915880|FG011|Overall Study|Lost to Follow-up|0|||
131625819|NCT03541369|473915881|FG012|Overall Study|Lost to Follow-up|1|||
131625820|NCT03541369|473915882|FG013|Overall Study|Lost to Follow-up|0|||
131625821|NCT03541369|473915883|FG014|Overall Study|Lost to Follow-up|0|||
131625822|NCT03541369|473915884|FG015|Overall Study|Lost to Follow-up|0|||
131625823|NCT03541369|473915885|FG016|Overall Study|Lost to Follow-up|0|||
131625824|NCT03541369|473915886|FG017|Overall Study|Lost to Follow-up|0|||
131625825|NCT04867382|473915893|FG000|Overall Study|Did not complete the survey|2|||
131625826|NCT04867382|473915894|FG001|Overall Study|Did not complete the survey|1|||
131796840|NCT03036579|474539749|FG001|2 Years|Lost to Follow-up|0|||
131796841|NCT03036579|474539748|FG000|3 Years|Lost to Follow-up|0|||
131796842|NCT03036579|474539749|FG001|3 Years|Lost to Follow-up|1|||
131796843|NCT02848599|474539750|FG000|Overall Study|Protocol Violation|7|||
131796844|NCT02848599|474539751|FG001|Overall Study|Protocol Violation|9|||
131796845|NCT05431153|474539752|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131796846|NCT05431153|474539753|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131796847|NCT05431153|474539754|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131796848|NCT05431153|474539755|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131796849|NCT05431153|474539756|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
131796850|NCT05431153|474539757|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131796851|NCT02352337|474539758|FG000|Overall Study|Patients never treated|4|||
131796852|NCT02352337|474539759|FG001|Overall Study|Patients never treated|1|||
131796853|NCT02352337|474539760|FG002|Overall Study|Patients never treated|2|||
131796854|NCT02458638|474539763|FG000|Overall Study|Death|309|||
131796855|NCT02458638|474539763|FG000|Overall Study|End of Cohort/End of Study|67|||
131796856|NCT02458638|474539763|FG000|Overall Study|Lost to Follow-up|31|||
131796857|NCT02458638|474539763|FG000|Overall Study|Other Reasons|4|||
131796858|NCT02458638|474539763|FG000|Overall Study|Physician Decision|1|||
131796859|NCT02458638|474539763|FG000|Overall Study|Withdrawal by Subject|47|||
131796860|NCT01829464|474539775|FG000|Overall Study|Adverse Event|1|||
131796861|NCT01829464|474539776|FG001|Overall Study|Adverse Event|0|||
131625827|NCT02102724|473915899|FG000|Overall Study|Lost to Follow-up|1|||
131625828|NCT02102724|473915900|FG001|Overall Study|Lost to Follow-up|0|||
131625829|NCT02102724|473915899|FG000|Overall Study|surgery for brain aneurysm|1|||
131625830|NCT02102724|473915900|FG001|Overall Study|surgery for brain aneurysm|1|||
131625831|NCT02008916|473915904|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
131796862|NCT01829464|474539777|FG002|Overall Study|Adverse Event|0|||
131796863|NCT01829464|474539775|FG000|Overall Study|Lost to Follow-up|0|||
131796864|NCT01829464|474539776|FG001|Overall Study|Lost to Follow-up|0|||
131796865|NCT01829464|474539777|FG002|Overall Study|Lost to Follow-up|1|||
131796866|NCT01829464|474539775|FG000|Overall Study|Withdrawal by Subject|2|||
131796867|NCT01829464|474539776|FG001|Overall Study|Withdrawal by Subject|0|||
131625832|NCT02008916|473915905|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
131625833|NCT02008916|473915906|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
131625834|NCT02008916|473915904|FG000|Week 16 - 156|Adverse Event|4|||
131625835|NCT02008916|473915905|FG001|Week 16 - 156|Adverse Event|2|||
131625836|NCT02008916|473915906|FG002|Week 16 - 156|Adverse Event|3|||
131625837|NCT02008916|473915904|FG000|Week 16 - 156|Withdrawal by Subject|7|||
131625838|NCT02008916|473915905|FG001|Week 16 - 156|Withdrawal by Subject|3|||
131625839|NCT02008916|473915906|FG002|Week 16 - 156|Withdrawal by Subject|5|||
131625840|NCT02008916|473915904|FG000|Week 16 - 156|No longer requires treatment|0|||
131625841|NCT02008916|473915905|FG001|Week 16 - 156|No longer requires treatment|1|||
131625842|NCT02008916|473915906|FG002|Week 16 - 156|No longer requires treatment|0|||
131625843|NCT02008916|473915904|FG000|Week 16 - 156|Lost to Follow-up|5|||
131625844|NCT02008916|473915905|FG001|Week 16 - 156|Lost to Follow-up|0|||
131625845|NCT02008916|473915906|FG002|Week 16 - 156|Lost to Follow-up|0|||
131625846|NCT02008916|473915904|FG000|Week 16 - 156|Lack of Efficacy|3|||
131625847|NCT02008916|473915905|FG001|Week 16 - 156|Lack of Efficacy|5|||
131625848|NCT02008916|473915906|FG002|Week 16 - 156|Lack of Efficacy|2|||
131625849|NCT02008916|473915904|FG000|Week 16 - 156|Pregnancy|0|||
131625850|NCT02008916|473915905|FG001|Week 16 - 156|Pregnancy|1|||
131625851|NCT02008916|473915906|FG002|Week 16 - 156|Pregnancy|0|||
131625852|NCT02008916|473915904|FG000|Week 16 - 156|Physician Decision|0|||
131625853|NCT02008916|473915905|FG001|Week 16 - 156|Physician Decision|1|||
131625854|NCT02008916|473915906|FG002|Week 16 - 156|Physician Decision|0|||
131625855|NCT03803475|473915907|FG000|Overall Study|Physician Decision|1|||
131625856|NCT05184062|473915909|FG000|Overall Study|Lost to Follow-up|5|||
131625857|NCT05184062|473915910|FG001|Overall Study|Lost to Follow-up|1|||
131625858|NCT05184062|473915909|FG000|Overall Study|Withdrawal by Subject|1|||
131625859|NCT05184062|473915910|FG001|Overall Study|Withdrawal by Subject|0|||
131625860|NCT04620733|473917652|FG000|Overall Study|Adverse Event|4|||
131625861|NCT04620733|473917653|FG001|Overall Study|Adverse Event|3|||
131625862|NCT04620733|473917652|FG000|Overall Study|Withdrawal by Subject|2|||
131711843|NCT01262898|474224077|FG001|Overall Study|Withdrawal by Subject|1|||
131625863|NCT04620733|473917653|FG001|Overall Study|Withdrawal by Subject|5|||
131625864|NCT04620733|473917652|FG000|Overall Study|Lost to Follow-up|1|||
131625865|NCT04620733|473917653|FG001|Overall Study|Lost to Follow-up|1|||
131625866|NCT04620733|473917652|FG000|Overall Study|Protocol Deviation|1|||
131625867|NCT04620733|473917653|FG001|Overall Study|Protocol Deviation|1|||
131625868|NCT04620733|473917652|FG000|Overall Study|Reason Not Specified|0|||
131711844|NCT01262898|474224078|FG002|Overall Study|Withdrawal by Subject|0|||
131711845|NCT01262898|474224079|FG003|Overall Study|Withdrawal by Subject|0|||
131711846|NCT00461175|474224080|FG000|Overall Study|Protocol Violation|522|||
131711847|NCT00461175|474224081|FG001|Overall Study|Protocol Violation|365|||
131711848|NCT00331760|474224082|FG000|Overall Study|Ineligible / no protocol treatment|15|||
131711849|NCT00331760|474224083|FG001|Overall Study|Ineligible / no protocol treatment|8|||
131711850|NCT01111604|474224084|FG000|Overall Study|Lost to Follow-up|0|||
131711851|NCT01111604|474224085|FG001|Overall Study|Lost to Follow-up|0|||
131711852|NCT01111604|474224086|FG002|Overall Study|Lost to Follow-up|1|||
131711853|NCT01111604|474224084|FG000|Overall Study|Withdrew Consent|3|||
131711854|NCT01111604|474224085|FG001|Overall Study|Withdrew Consent|0|||
131711855|NCT01111604|474224086|FG002|Overall Study|Withdrew Consent|2|||
131711856|NCT01111604|474224084|FG000|Overall Study|Withdrawal by Subject|2|||
131711857|NCT01111604|474224085|FG001|Overall Study|Withdrawal by Subject|0|||
131711858|NCT01111604|474224086|FG002|Overall Study|Withdrawal by Subject|0|||
131711859|NCT01111604|474224084|FG000|Overall Study|Death|1|||
131711860|NCT01111604|474224085|FG001|Overall Study|Death|0|||
131711861|NCT01111604|474224086|FG002|Overall Study|Death|0|||
131711862|NCT01111604|474224084|FG000|Overall Study|Met Exclusion Criteria|2|||
131711863|NCT01111604|474224085|FG001|Overall Study|Met Exclusion Criteria|0|||
131711864|NCT01111604|474224086|FG002|Overall Study|Met Exclusion Criteria|0|||
131711865|NCT01355289|474224087|FG000|Core Study|Adverse Event, Non-Fatal|1|||
131711866|NCT01355289|474224088|FG001|Core Study|Adverse Event, Non-Fatal|0|||
131711867|NCT01355289|474224089|FG002|Core Study|Adverse Event, Non-Fatal|0|||
131711868|NCT01355289|474224090|FG003|Core Study|Adverse Event, Non-Fatal|0|||
131711869|NCT01355289|474224091|FG004|Core Study|Adverse Event, Non-Fatal|0|||
131711870|NCT01355289|474224087|FG000|Core Study|Inadequate Therapeutic Effect|0|||
131711871|NCT01355289|474224088|FG001|Core Study|Inadequate Therapeutic Effect|0|||
131711872|NCT01355289|474224089|FG002|Core Study|Inadequate Therapeutic Effect|0|||
131711873|NCT01355289|474224090|FG003|Core Study|Inadequate Therapeutic Effect|1|||
131711874|NCT01355289|474224091|FG004|Core Study|Inadequate Therapeutic Effect|0|||
131711875|NCT01355289|474224087|FG000|Core Study|Other|0|||
131711876|NCT01355289|474224088|FG001|Core Study|Other|0|||
131711877|NCT01355289|474224089|FG002|Core Study|Other|0|||
131711878|NCT01355289|474224090|FG003|Core Study|Other|1|||
131711879|NCT01355289|474224091|FG004|Core Study|Other|0|||
131711880|NCT01355289|474224087|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
131711881|NCT01355289|474224088|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
131711882|NCT01355289|474224089|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
131711883|NCT01355289|474224090|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
131711884|NCT01355289|474224091|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
131711885|NCT01355289|474224087|FG000|Open Label Extension|Lost to Follow-up|0|||
131711886|NCT01355289|474224088|FG001|Open Label Extension|Lost to Follow-up|0|||
131711887|NCT01355289|474224089|FG002|Open Label Extension|Lost to Follow-up|0|||
131711888|NCT01355289|474224090|FG003|Open Label Extension|Lost to Follow-up|0|||
131711889|NCT01355289|474224091|FG004|Open Label Extension|Lost to Follow-up|1|||
131711890|NCT01355289|474224087|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
131711891|NCT01355289|474224088|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
131711892|NCT01355289|474224089|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
131711893|NCT01355289|474224090|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
131711894|NCT01355289|474224091|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
131711895|NCT01355289|474224087|FG000|Open Label Extension|Other|0|||
131711896|NCT01355289|474224088|FG001|Open Label Extension|Other|0|||
131711897|NCT01355289|474224089|FG002|Open Label Extension|Other|0|||
131711898|NCT01355289|474224090|FG003|Open Label Extension|Other|0|||
131711899|NCT01355289|474224091|FG004|Open Label Extension|Other|3|||
131711900|NCT01085682|474224092|FG000|Overall Study|Withdrawal by Subject|25|||
131711901|NCT01085682|474224093|FG001|Overall Study|Withdrawal by Subject|25|||
131711902|NCT01451645|474224094|FG000|Overall Study|Protocol Violation|1|||
131711903|NCT01451645|474224095|FG001|Overall Study|Protocol Violation|0|||
131711904|NCT01451645|474224094|FG000|Overall Study|Adverse Event|0|||
131711905|NCT01451645|474224095|FG001|Overall Study|Adverse Event|3|||
131711906|NCT01451645|474224094|FG000|Overall Study|Withdrawal by Subject|4|||
131711907|NCT01451645|474224095|FG001|Overall Study|Withdrawal by Subject|2|||
131711908|NCT01451645|474224094|FG000|Overall Study|Lost to Follow-up|4|||
131711909|NCT01451645|474224095|FG001|Overall Study|Lost to Follow-up|3|||
131711910|NCT03926143|474224098|FG000|Overall Study|Physician Decision|3|||
131711911|NCT03926143|474224098|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
131711912|NCT03926143|474224098|FG000|Overall Study|Adverse Event|2|||
131711913|NCT03926143|474224098|FG000|Overall Study|Progressive disease|3|||
131711914|NCT02207907|474224107|FG000|Overall Study|Lost to Follow-up|3|||
131711915|NCT02207907|474224108|FG001|Overall Study|Lost to Follow-up|1|||
131711916|NCT02207907|474224107|FG000|Overall Study|Withdrawal by Subject|5|||
131711917|NCT02207907|474224108|FG001|Overall Study|Withdrawal by Subject|6|||
131711918|NCT02207907|474224107|FG000|Overall Study|Did not meet study criteria|3|||
131796868|NCT01829464|474539777|FG002|Overall Study|Withdrawal by Subject|0|||
131796869|NCT01829464|474539775|FG000|Overall Study|Study terminated by sponsor|25|||
131796870|NCT01829464|474539776|FG001|Overall Study|Study terminated by sponsor|28|||
131796871|NCT01829464|474539777|FG002|Overall Study|Study terminated by sponsor|25|||
131796872|NCT01829464|474539775|FG000|Overall Study|Lack of Efficacy|0|||
131796873|NCT01829464|474539776|FG001|Overall Study|Lack of Efficacy|1|||
131796874|NCT01829464|474539777|FG002|Overall Study|Lack of Efficacy|0|||
131796875|NCT01290263|474539784|FG000|Overall Study|Adverse Event|0|||
131625869|NCT04620733|473917653|FG001|Overall Study|Reason Not Specified|1|||
131625870|NCT02507297|473917658|FG000|Overall Study|Withdrawal by Subject|1|||
131625871|NCT02507297|473917659|FG001|Overall Study|Withdrawal by Subject|0|||
131625872|NCT02507297|473917658|FG000|Overall Study|Lost to Follow-up|0|||
131625873|NCT02507297|473917659|FG001|Overall Study|Lost to Follow-up|1|||
131625874|NCT01018992|473917660|FG000|Overall Study|Adverse Event|8|||
131625875|NCT01018992|473917661|FG001|Overall Study|Adverse Event|3|||
131625876|NCT01018992|473917660|FG000|Overall Study|Withdrawal by Subject|3|||
131444079|NCT05138653|473255023|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444080|NCT05138653|473255024|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131625877|NCT01018992|473917661|FG001|Overall Study|Withdrawal by Subject|8|||
131796876|NCT01290263|474539785|FG001|Overall Study|Adverse Event|0|||
131625878|NCT01018992|473917660|FG000|Overall Study|Protocol Violation|0|||
131796877|NCT01290263|474539786|FG002|Overall Study|Adverse Event|0|||
131796878|NCT01290263|474539787|FG003|Overall Study|Adverse Event|1|||
131796879|NCT01290263|474539788|FG004|Overall Study|Adverse Event|1|||
131711919|NCT02207907|474224108|FG001|Overall Study|Did not meet study criteria|0|||
131711920|NCT02207907|474224107|FG000|Overall Study|Pregnancy|0|||
131711921|NCT02207907|474224108|FG001|Overall Study|Pregnancy|1|||
131711922|NCT00158184|474224109|FG000|Overall Study|personal issues|3|||
131711923|NCT00158184|474224110|FG001|Overall Study|personal issues|1|||
131711924|NCT00158184|474224109|FG000|Overall Study|failed for follow unit/study rules|2|||
131711925|NCT00158184|474224110|FG001|Overall Study|failed for follow unit/study rules|0|||
131711926|NCT00158184|474224109|FG000|Overall Study|Adverse Event|1|||
131711927|NCT00158184|474224110|FG001|Overall Study|Adverse Event|1|||
131625879|NCT01018992|473917661|FG001|Overall Study|Protocol Violation|4|||
131625880|NCT01018992|473917660|FG000|Overall Study|Lost to Follow-up|5|||
131625881|NCT01018992|473917661|FG001|Overall Study|Lost to Follow-up|1|||
131625882|NCT03029585|473917662|FG000|Overall Study|Death|1|||
131625883|NCT03029585|473917663|FG001|Overall Study|Death|1|||
131625884|NCT03029585|473917662|FG000|Overall Study|Withdrawal by Subject|1|||
131625885|NCT03029585|473917663|FG001|Overall Study|Withdrawal by Subject|0|||
131625886|NCT02092285|473917664|FG000|Induction Phase|Adverse Event|7|||
131625887|NCT02092285|473917664|FG000|Induction Phase|Physician Decision|4|||
131625888|NCT02092285|473917664|FG000|Induction Phase|Pregnancy|1|||
131625889|NCT02092285|473917664|FG000|Induction Phase|Relapse/Recurrence|7|||
131625890|NCT02092285|473917664|FG000|Induction Phase|Withdrawal by Subject|2|||
131625891|NCT02092285|473917664|FG000|Induction Phase|Lack of Efficacy|14|||
131625892|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
131625893|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
131625894|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
131625895|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
131625896|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
131625897|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
131625898|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
131625899|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
131625900|NCT02092285|473917664|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
131625901|NCT01825785|473917665|FG000|Overall Study|Adverse Event|0|||
131625902|NCT01825785|473917666|FG001|Overall Study|Adverse Event|0|||
131625903|NCT01825785|473917667|FG002|Overall Study|Adverse Event|0|||
131625904|NCT01825785|473917668|FG003|Overall Study|Adverse Event|0|||
131711928|NCT05340504|474224111|FG000|Overall Study|Withdrawal by Subject|1|||
131711929|NCT05340504|474224112|FG001|Overall Study|Withdrawal by Subject|0|||
131711930|NCT02620020|474224113|FG000|Overall Study|Adverse Event|8|||
131711931|NCT02620020|474224114|FG001|Overall Study|Adverse Event|4|||
131711932|NCT02620020|474224115|FG002|Overall Study|Adverse Event|3|||
131711933|NCT02620020|474224116|FG003|Overall Study|Adverse Event|5|||
131711934|NCT02620020|474224113|FG000|Overall Study|Lost to Follow-up|4|||
131711935|NCT02620020|474224114|FG001|Overall Study|Lost to Follow-up|8|||
131711936|NCT02620020|474224115|FG002|Overall Study|Lost to Follow-up|1|||
131711937|NCT02620020|474224116|FG003|Overall Study|Lost to Follow-up|4|||
131711938|NCT02620020|474224113|FG000|Overall Study|Physician Decision|7|||
131711939|NCT02620020|474224114|FG001|Overall Study|Physician Decision|4|||
131711940|NCT02620020|474224115|FG002|Overall Study|Physician Decision|3|||
131711941|NCT02620020|474224116|FG003|Overall Study|Physician Decision|4|||
131711942|NCT02620020|474224113|FG000|Overall Study|Protocol Violation|5|||
131711943|NCT02620020|474224114|FG001|Overall Study|Protocol Violation|2|||
131711944|NCT02620020|474224115|FG002|Overall Study|Protocol Violation|1|||
131711945|NCT02620020|474224116|FG003|Overall Study|Protocol Violation|1|||
131711946|NCT02620020|474224113|FG000|Overall Study|Withdrawal by Subject|20|||
131711947|NCT02620020|474224114|FG001|Overall Study|Withdrawal by Subject|16|||
131711948|NCT02620020|474224115|FG002|Overall Study|Withdrawal by Subject|17|||
131711949|NCT02620020|474224116|FG003|Overall Study|Withdrawal by Subject|12|||
131711950|NCT02620020|474224113|FG000|Overall Study|Death|0|||
131711951|NCT02620020|474224114|FG001|Overall Study|Death|1|||
131711952|NCT02620020|474224115|FG002|Overall Study|Death|0|||
131711953|NCT02620020|474224116|FG003|Overall Study|Death|0|||
131711954|NCT02393209|474224119|FG000|Overall Study|Study Terminated by Sponsor|1|||
131711955|NCT02393209|474224120|FG001|Overall Study|Study Terminated by Sponsor|1|||
131711956|NCT02393209|474224121|FG002|Overall Study|Study Terminated by Sponsor|0|||
131711957|NCT02393209|474224122|FG003|Overall Study|Study Terminated by Sponsor|0|||
131711958|NCT02393209|474224119|FG000|Overall Study|Withdrawal by Patient|1|||
131711959|NCT02393209|474224120|FG001|Overall Study|Withdrawal by Patient|0|||
131711960|NCT02393209|474224121|FG002|Overall Study|Withdrawal by Patient|0|||
131711961|NCT02393209|474224122|FG003|Overall Study|Withdrawal by Patient|0|||
131711962|NCT02393209|474224119|FG000|Overall Study|Death|2|||
131711963|NCT02393209|474224120|FG001|Overall Study|Death|2|||
131711964|NCT02393209|474224121|FG002|Overall Study|Death|0|||
131711965|NCT02393209|474224122|FG003|Overall Study|Death|0|||
131625905|NCT01825785|473917669|FG004|Overall Study|Adverse Event|1|||
131711966|NCT02393209|474224119|FG000|Overall Study|Death due to Disease Progression|2|||
131711967|NCT02393209|474224120|FG001|Overall Study|Death due to Disease Progression|2|||
131625906|NCT01825785|473917670|FG005|Overall Study|Adverse Event|0|||
131625907|NCT01825785|473917671|FG006|Overall Study|Adverse Event|0|||
131625908|NCT01825785|473917665|FG000|Overall Study|Withdrawal by Subject|0|||
131625909|NCT01825785|473917666|FG001|Overall Study|Withdrawal by Subject|0|||
131711968|NCT02393209|474224121|FG002|Overall Study|Death due to Disease Progression|0|||
131796880|NCT01290263|474539784|FG000|Overall Study|Lack of Efficacy|8|||
131625910|NCT01825785|473917667|FG002|Overall Study|Withdrawal by Subject|0|||
131625911|NCT01825785|473917668|FG003|Overall Study|Withdrawal by Subject|0|||
131625912|NCT01825785|473917669|FG004|Overall Study|Withdrawal by Subject|1|||
131625913|NCT01825785|473917670|FG005|Overall Study|Withdrawal by Subject|1|||
131625914|NCT01825785|473917671|FG006|Overall Study|Withdrawal by Subject|0|||
131625915|NCT01304940|473917673|FG000|Overall Study|not meet symptom severity requirement|3|||
131625916|NCT01304940|473917674|FG001|Overall Study|not meet symptom severity requirement|0|||
131625917|NCT00278395|473917677|FG000|Overall Study|Adverse Event|2|||
131625918|NCT00278395|473917677|FG000|Overall Study|Nonevaluable|1|||
131625919|NCT00246129|473917678|FG000|Overall Study|Lost to Follow-up|1|||
131625920|NCT00246129|473917679|FG001|Overall Study|Lost to Follow-up|0|||
131625921|NCT00246129|473917678|FG000|Overall Study|Death|2|||
131625922|NCT00246129|473917679|FG001|Overall Study|Death|1|||
131711969|NCT02393209|474224122|FG003|Overall Study|Death due to Disease Progression|0|||
131711970|NCT02393209|474224119|FG000|Overall Study|Death from Legionella Infection|0|||
131444081|NCT05138653|473255025|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444082|NCT05138653|473255026|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444083|NCT05138653|473255027|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131625923|NCT00246129|473917678|FG000|Overall Study|suffered primary non-function|1|||
131625924|NCT00246129|473917679|FG001|Overall Study|suffered primary non-function|0|||
131625925|NCT00246129|473917678|FG000|Overall Study|grafts failed|3|||
131796881|NCT01290263|474539785|FG001|Overall Study|Lack of Efficacy|2|||
131796882|NCT01290263|474539786|FG002|Overall Study|Lack of Efficacy|7|||
131796883|NCT01290263|474539787|FG003|Overall Study|Lack of Efficacy|24|||
131796884|NCT01290263|474539788|FG004|Overall Study|Lack of Efficacy|33|||
131796885|NCT01290263|474539784|FG000|Overall Study|Withdrawal by Subject|3|||
131796886|NCT01290263|474539785|FG001|Overall Study|Withdrawal by Subject|1|||
131796887|NCT01290263|474539786|FG002|Overall Study|Withdrawal by Subject|0|||
131796888|NCT01290263|474539787|FG003|Overall Study|Withdrawal by Subject|1|||
131796889|NCT01290263|474539788|FG004|Overall Study|Withdrawal by Subject|2|||
131796890|NCT01290263|474539784|FG000|Overall Study|Participant Non-Compliance|0|||
131796891|NCT01290263|474539785|FG001|Overall Study|Participant Non-Compliance|0|||
131796892|NCT01290263|474539786|FG002|Overall Study|Participant Non-Compliance|0|||
131796893|NCT01290263|474539787|FG003|Overall Study|Participant Non-Compliance|1|||
131796894|NCT01290263|474539788|FG004|Overall Study|Participant Non-Compliance|1|||
131796895|NCT03738332|474539789|FG000|Overall Study|Withdrawal by Subject|1|||
131796896|NCT02336737|474539790|FG000|Overall Study|Withdrawal by Subject|5|||
131796897|NCT02336737|474539790|FG000|Overall Study|Physician Decision|8|||
131796898|NCT02132247|474539791|FG000|Overall Study|Protocol Violation|1|||
131796899|NCT02132247|474539792|FG001|Overall Study|Protocol Violation|0|||
131796900|NCT02227862|474539796|FG000|Overall Study|Protocol Violation|7|||
131796901|NCT02227862|474539797|FG001|Overall Study|Protocol Violation|9|||
131796902|NCT02227862|474539796|FG000|Overall Study|Other|0|||
131796903|NCT02227862|474539797|FG001|Overall Study|Other|2|||
131796904|NCT02227862|474539796|FG000|Overall Study|Adverse Event|4|||
131796905|NCT02227862|474539797|FG001|Overall Study|Adverse Event|3|||
131796906|NCT02227862|474539796|FG000|Overall Study|Withdrawal by Subject|7|||
131796907|NCT02227862|474539797|FG001|Overall Study|Withdrawal by Subject|6|||
131796908|NCT02227862|474539796|FG000|Overall Study|Lost to Follow-up|1|||
131796909|NCT02227862|474539797|FG001|Overall Study|Lost to Follow-up|2|||
131796910|NCT00620763|474539800|FG000|Period: First Intervention|Withdrawal by Subject|0|||
131796911|NCT00620763|474539801|FG001|Period: First Intervention|Withdrawal by Subject|2|||
131796912|NCT00620763|474539800|FG000|Period: First Intervention|Protocol Violation|0|||
131796913|NCT00620763|474539801|FG001|Period: First Intervention|Protocol Violation|3|||
131796914|NCT00620763|474539800|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
131796915|NCT00620763|474539801|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
131796916|NCT01694485|474539805|FG000|Overall Study|Withdrawal by Subject|20|||
131796917|NCT01694485|474539806|FG001|Overall Study|Withdrawal by Subject|6|||
131796918|NCT01694485|474539807|FG002|Overall Study|Withdrawal by Subject|7|||
131796919|NCT01694485|474539808|FG003|Overall Study|Withdrawal by Subject|25|||
131796920|NCT01694485|474539809|FG004|Overall Study|Withdrawal by Subject|18|||
131796921|NCT01694485|474539805|FG000|Overall Study|Sponsor Decision|3|||
131796922|NCT01694485|474539806|FG001|Overall Study|Sponsor Decision|0|||
131796923|NCT01694485|474539807|FG002|Overall Study|Sponsor Decision|0|||
131901429|NCT00313846|474923558|FG001|Overall Study|Administrative|3|||
131901430|NCT02221648|474923562|FG000|Overall Study|Withdrawal by Subject|3|||
131444084|NCT05138653|473255028|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444085|NCT05138653|473255029|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444086|NCT05138653|473255030|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131625926|NCT00246129|473917679|FG001|Overall Study|grafts failed|1|||
131625927|NCT01286311|473917680|FG000|Overall Study|Physician did not want outreach sent|14|||
131625928|NCT01286311|473917681|FG001|Overall Study|Physician did not want outreach sent|0|||
131625929|NCT00805792|473917682|FG000|Overall Study|Death|3|||
131625930|NCT00805792|473917682|FG000|Overall Study|Lost to Follow-up|2|||
131625931|NCT01655498|473917686|FG000|Overall Study|Unrelated health issue|2|||
131625932|NCT01655498|473917686|FG000|Overall Study|Protocol Violation|2|||
131625933|NCT01655498|473917686|FG000|Overall Study|Withdrawal by Subject|1|||
131625934|NCT02784834|473917687|FG000|Overall Study|Lack of Efficacy|1|||
131625935|NCT01090739|473917690|FG000|Enrollment|Withdrawal by Subject|24|||
131625936|NCT01090739|473917690|FG000|Enrollment|Protocol Violation|14|||
131625937|NCT01090739|473917690|FG000|Enrollment|Lost to Follow-up|5|||
131625938|NCT01090739|473917690|FG000|Enrollment|Physician Decision|5|||
131625939|NCT01090739|473917690|FG000|Enrollment|Sponsor termination of site|4|||
131625940|NCT01090739|473917690|FG000|Enrollment|Study implant limit reached|2|||
131625941|NCT01090739|473917690|FG000|Enrollment|Adverse Event|1|||
131625942|NCT01090739|473917690|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
131625943|NCT01090739|473917690|FG000|12 Month Follow-up|Lost to Follow-up|1|||
131625944|NCT01090739|473917690|FG000|12 Month Follow-up|Physician Decision|1|||
131625945|NCT01090739|473917690|FG000|12 Month Follow-up|Death|1|||
131625946|NCT01090739|473917690|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
131625947|NCT01090739|473917690|FG000|24 Month Follow-up|Lost to Follow-up|1|||
131625948|NCT01090739|473917690|FG000|24 Month Follow-up|Death|1|||
131625949|NCT01090739|473917690|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
131625950|NCT01090739|473917690|FG000|36 Month Follow-up|Visit still pending|17|||
131625951|NCT00930644|473917691|FG000|Overall Study|Withdrawal by Subject|4|||
131625952|NCT00930644|473917691|FG000|Overall Study|Physician Decision|2|||
131625953|NCT00930644|473917691|FG000|Overall Study|Death|1|||
131625954|NCT00930644|473917691|FG000|Overall Study|Adverse Event|16|||
131625955|NCT03265132|473917698|FG000|Overall Study|Adverse Event|0|||
131625956|NCT03265132|473917699|FG001|Overall Study|Adverse Event|1|||
131625957|NCT03265132|473917698|FG000|Overall Study|Lack of Efficacy|0|||
131625958|NCT03265132|473917699|FG001|Overall Study|Lack of Efficacy|2|||
131625959|NCT03265132|473917698|FG000|Overall Study|Progressive disease|0|||
131625960|NCT03265132|473917699|FG001|Overall Study|Progressive disease|2|||
131625961|NCT03265132|473917698|FG000|Overall Study|Withdrawal by Subject|0|||
131625962|NCT03265132|473917699|FG001|Overall Study|Withdrawal by Subject|1|||
131625963|NCT03909100|473917700|FG000|Overall Study|Protocol Deviation|2|||
131625964|NCT03909100|473917700|FG000|Overall Study|Technical Problems|4|||
131625965|NCT03909100|473917700|FG000|Overall Study|Withdrawal by Subject|4|||
131625966|NCT03909100|473917700|FG000|Overall Study|Lost to Follow-up|1|||
131625967|NCT03909100|473917700|FG000|Overall Study|Reason not Specified|4|||
131625968|NCT00088166|473917701|FG000|Overall Study|Adverse Event|11|||
131625969|NCT00088166|473917702|FG001|Overall Study|Adverse Event|9|||
131711971|NCT02393209|474224120|FG001|Overall Study|Death from Legionella Infection|1|||
131901431|NCT02221648|474923563|FG001|Overall Study|Withdrawal by Subject|3|||
131625970|NCT00088166|473917701|FG000|Overall Study|Death|3|||
131625971|NCT00088166|473917702|FG001|Overall Study|Death|1|||
131625972|NCT00088166|473917701|FG000|Overall Study|Lost to Follow-up|0|||
131625973|NCT00088166|473917702|FG001|Overall Study|Lost to Follow-up|1|||
131625974|NCT00088166|473917701|FG000|Overall Study|Physician Decision|4|||
131625975|NCT00088166|473917702|FG001|Overall Study|Physician Decision|1|||
131625976|NCT00088166|473917701|FG000|Overall Study|Protocol Violation|1|||
131625977|NCT00088166|473917702|FG001|Overall Study|Protocol Violation|5|||
131625978|NCT00088166|473917701|FG000|Overall Study|Patient deterioration|29|||
131625979|NCT00088166|473917702|FG001|Overall Study|Patient deterioration|39|||
131625980|NCT00088166|473917701|FG000|Overall Study|Withdrawal by Subject|5|||
131625981|NCT00088166|473917702|FG001|Overall Study|Withdrawal by Subject|5|||
131625982|NCT02671266|473917703|FG000|Overall Study|Withdrawal by Subject|1|||
131796924|NCT01694485|474539808|FG003|Overall Study|Sponsor Decision|2|||
131796925|NCT01694485|474539809|FG004|Overall Study|Sponsor Decision|0|||
131796926|NCT01694485|474539805|FG000|Overall Study|Lost to Follow-up|9|||
131796927|NCT01694485|474539806|FG001|Overall Study|Lost to Follow-up|1|||
131796928|NCT01694485|474539807|FG002|Overall Study|Lost to Follow-up|6|||
131796929|NCT01694485|474539808|FG003|Overall Study|Lost to Follow-up|10|||
131901432|NCT01922258|474923564|FG000|Overall Study|Lost to Follow-up|1|||
131796930|NCT01694485|474539809|FG004|Overall Study|Lost to Follow-up|7|||
131796931|NCT01694485|474539805|FG000|Overall Study|Death|1|||
131796932|NCT01694485|474539806|FG001|Overall Study|Death|0|||
131796933|NCT01694485|474539807|FG002|Overall Study|Death|0|||
131901433|NCT01922258|474923565|FG001|Overall Study|Lost to Follow-up|1|||
131901434|NCT01922258|474923564|FG000|Overall Study|Adverse Event|9|||
131901435|NCT01922258|474923565|FG001|Overall Study|Adverse Event|2|||
131901436|NCT01922258|474923564|FG000|Overall Study|Met Withdrawal Criteria|0|||
131901437|NCT01922258|474923565|FG001|Overall Study|Met Withdrawal Criteria|4|||
131901438|NCT01922258|474923564|FG000|Overall Study|Withdrawn by the Investigator|1|||
131901439|NCT01922258|474923565|FG001|Overall Study|Withdrawn by the Investigator|4|||
131901440|NCT01922258|474923564|FG000|Overall Study|Withdrawal by participant|5|||
131901441|NCT01922258|474923565|FG001|Overall Study|Withdrawal by participant|5|||
131901442|NCT00673257|474923566|FG000|Overall Study|Withdrawal by Subject|4|||
131901443|NCT00673257|474923566|FG000|Overall Study|Unable to obtain specimen|1|||
131901444|NCT01497067|474923567|FG000|Overall Study|Lost to Follow-up|56|||
131901445|NCT01497067|474923567|FG000|Overall Study|Adverse Event|3|||
131901446|NCT01497067|474923567|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
131901447|NCT01497067|474923567|FG000|Overall Study|Other|13|||
131901448|NCT00490971|474923568|FG000|Acute/Continuation|Adverse Event|62|||
131901449|NCT00490971|474923569|FG001|Acute/Continuation|Adverse Event|13|||
131901450|NCT00490971|474923570|FG002|Acute/Continuation|Adverse Event|0|||
131901451|NCT00490971|474923571|FG003|Acute/Continuation|Adverse Event|0|||
131901452|NCT00490971|474923572|FG004|Acute/Continuation|Adverse Event|0|||
131901453|NCT00490971|474923568|FG000|Acute/Continuation|Death|2|||
131901454|NCT00490971|474923569|FG001|Acute/Continuation|Death|0|||
131901455|NCT00490971|474923570|FG002|Acute/Continuation|Death|0|||
131901456|NCT00490971|474923571|FG003|Acute/Continuation|Death|0|||
131901457|NCT00490971|474923572|FG004|Acute/Continuation|Death|0|||
131901458|NCT00490971|474923568|FG000|Acute/Continuation|Lack of Efficacy|106|||
131901459|NCT00490971|474923569|FG001|Acute/Continuation|Lack of Efficacy|12|||
131901460|NCT00490971|474923570|FG002|Acute/Continuation|Lack of Efficacy|0|||
131901461|NCT00490971|474923571|FG003|Acute/Continuation|Lack of Efficacy|0|||
131901462|NCT00490971|474923572|FG004|Acute/Continuation|Lack of Efficacy|0|||
131901463|NCT00490971|474923568|FG000|Acute/Continuation|Lost to Follow-up|23|||
131901464|NCT00490971|474923569|FG001|Acute/Continuation|Lost to Follow-up|7|||
131901465|NCT00490971|474923570|FG002|Acute/Continuation|Lost to Follow-up|0|||
131901466|NCT00490971|474923571|FG003|Acute/Continuation|Lost to Follow-up|0|||
131901467|NCT00490971|474923572|FG004|Acute/Continuation|Lost to Follow-up|0|||
131901468|NCT00490971|474923568|FG000|Acute/Continuation|Protocol Violation|10|||
131901469|NCT00490971|474923569|FG001|Acute/Continuation|Protocol Violation|2|||
131901470|NCT00490971|474923570|FG002|Acute/Continuation|Protocol Violation|0|||
131901471|NCT00490971|474923571|FG003|Acute/Continuation|Protocol Violation|0|||
131901472|NCT00490971|474923572|FG004|Acute/Continuation|Protocol Violation|0|||
131901473|NCT00490971|474923568|FG000|Acute/Continuation|Withdrawal by Subject|92|||
131711972|NCT02393209|474224121|FG002|Overall Study|Death from Legionella Infection|0|||
131901474|NCT00490971|474923569|FG001|Acute/Continuation|Withdrawal by Subject|24|||
131901475|NCT00490971|474923570|FG002|Acute/Continuation|Withdrawal by Subject|0|||
131901476|NCT00490971|474923571|FG003|Acute/Continuation|Withdrawal by Subject|0|||
131901477|NCT00490971|474923572|FG004|Acute/Continuation|Withdrawal by Subject|0|||
131901478|NCT00490971|474923568|FG000|Acute/Continuation|Other|11|||
131901479|NCT00490971|474923569|FG001|Acute/Continuation|Other|4|||
131901480|NCT00490971|474923570|FG002|Acute/Continuation|Other|0|||
131901481|NCT00490971|474923571|FG003|Acute/Continuation|Other|0|||
131901482|NCT00490971|474923572|FG004|Acute/Continuation|Other|0|||
131901483|NCT00490971|474923568|FG000|Maintenance|Adverse Event|0|||
131901484|NCT00490971|474923569|FG001|Maintenance|Adverse Event|0|||
131901485|NCT00490971|474923570|FG002|Maintenance|Adverse Event|4|||
131711973|NCT02393209|474224122|FG003|Overall Study|Death from Legionella Infection|0|||
131711974|NCT02393209|474224119|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
131711975|NCT02393209|474224120|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
131711976|NCT02393209|474224121|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
131711977|NCT02393209|474224122|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
131711978|NCT02393209|474224119|FG000|Overall Study|Lost to Follow-up|0|||
131711979|NCT02393209|474224120|FG001|Overall Study|Lost to Follow-up|1|||
131711980|NCT02393209|474224121|FG002|Overall Study|Lost to Follow-up|0|||
131711981|NCT02393209|474224122|FG003|Overall Study|Lost to Follow-up|0|||
131711982|NCT00755079|474224123|FG000|Overall Study|Lost to Follow-up|1|||
131711983|NCT00755079|474224124|FG001|Overall Study|Lost to Follow-up|3|||
131711984|NCT00755079|474224123|FG000|Overall Study|Adverse Event|0|||
131711985|NCT00755079|474224124|FG001|Overall Study|Adverse Event|1|||
131901486|NCT00490971|474923571|FG003|Maintenance|Adverse Event|5|||
131901487|NCT00490971|474923572|FG004|Maintenance|Adverse Event|7|||
131901488|NCT00490971|474923568|FG000|Maintenance|Death|0|||
131711986|NCT00755079|474224123|FG000|Overall Study|Withdrawal by Subject|0|||
131711987|NCT00755079|474224124|FG001|Overall Study|Withdrawal by Subject|2|||
131901489|NCT00490971|474923569|FG001|Maintenance|Death|0|||
131901490|NCT00490971|474923570|FG002|Maintenance|Death|0|||
131901491|NCT00490971|474923571|FG003|Maintenance|Death|2|||
131901492|NCT00490971|474923572|FG004|Maintenance|Death|0|||
131901493|NCT00490971|474923568|FG000|Maintenance|Lost to Follow-up|0|||
131901494|NCT00490971|474923569|FG001|Maintenance|Lost to Follow-up|0|||
131901495|NCT00490971|474923570|FG002|Maintenance|Lost to Follow-up|5|||
131901496|NCT00490971|474923571|FG003|Maintenance|Lost to Follow-up|8|||
131625983|NCT02671266|473917704|FG001|Overall Study|Withdrawal by Subject|1|||
131625984|NCT00666705|473917705|FG000|Overall Study|Withdrawal by Subject|1|||
131625985|NCT01109979|473917706|FG000|Overall Study|Physician Decision|2|||
131625986|NCT01109979|473917707|FG001|Overall Study|Physician Decision|0|||
131625987|NCT01109979|473917706|FG000|Overall Study|Withdrawal by Subject|0|||
131625988|NCT01109979|473917707|FG001|Overall Study|Withdrawal by Subject|1|||
131625989|NCT00807599|473917709|FG000|Overall Study|Not treated on protocol study|0|||
131625990|NCT00807599|473917710|FG001|Overall Study|Not treated on protocol study|0|||
131625991|NCT00807599|473917711|FG002|Overall Study|Not treated on protocol study|2|||
131625992|NCT00807599|473917709|FG000|Overall Study|Adverse Event|0|||
131625993|NCT00807599|473917710|FG001|Overall Study|Adverse Event|0|||
131625994|NCT00807599|473917711|FG002|Overall Study|Adverse Event|5|||
131625995|NCT00807599|473917709|FG000|Overall Study|Inadequate response to induction|0|||
131625996|NCT00807599|473917710|FG001|Overall Study|Inadequate response to induction|0|||
131625997|NCT00807599|473917711|FG002|Overall Study|Inadequate response to induction|9|||
131625998|NCT00807599|473917709|FG000|Overall Study|Withdrawal by Subject|0|||
131625999|NCT00807599|473917710|FG001|Overall Study|Withdrawal by Subject|0|||
131626000|NCT00807599|473917711|FG002|Overall Study|Withdrawal by Subject|1|||
131626001|NCT03456856|473917714|FG000|Overall Study|Lost to Follow-up|2|||
131626002|NCT03456856|473917714|FG000|Overall Study|Withdrawal by Subject|1|||
131626003|NCT02542696|473917717|FG000|Overall Study|Adverse Event|167|||
131626004|NCT02542696|473917717|FG000|Overall Study|Lack of Efficacy|26|||
131626005|NCT02542696|473917717|FG000|Overall Study|Lost to Follow-up|6|||
131626006|NCT02542696|473917717|FG000|Overall Study|Withdrawal by Subject|104|||
131626007|NCT02542696|473917717|FG000|Overall Study|Protocol Violation|5|||
131626008|NCT02542696|473917717|FG000|Overall Study|Death|8|||
131626009|NCT02542696|473917717|FG000|Overall Study|DECREASED OFF TIME|1|||
131626010|NCT02542696|473917717|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
131626011|NCT02542696|473917717|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
131626012|NCT02542696|473917717|FG000|Overall Study|MEDICAL HISTORY|1|||
131626013|NCT02542696|473917717|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
131626014|NCT02542696|473917717|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
131626015|NCT02542696|473917717|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
131626016|NCT02542696|473917717|FG000|Overall Study|SPONSOR DECISION|3|||
131626017|NCT02542696|473917717|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
131626018|NCT02542696|473917717|FG000|Overall Study|SUBJECT DECISION|2|||
131626019|NCT02137785|473917718|FG000|Overall Study|Lost to Follow-up|1|||
131626020|NCT02137785|473917719|FG001|Overall Study|Lost to Follow-up|0|||
131626021|NCT02137785|473917718|FG000|Overall Study|Withdrawal by Subject|1|||
131626022|NCT02137785|473917719|FG001|Overall Study|Withdrawal by Subject|4|||
131711988|NCT00481065|474224125|FG000|Overall Study|Adverse event or death|1|||
131711989|NCT00481065|474224126|FG001|Overall Study|Adverse event or death|1|||
131626023|NCT02137785|473917718|FG000|Overall Study|subject moved out of state|1|||
131626024|NCT02137785|473917719|FG001|Overall Study|subject moved out of state|0|||
131711990|NCT00481065|474224127|FG002|Overall Study|Adverse event or death|3|||
131711991|NCT00481065|474224128|FG003|Overall Study|Adverse event or death|0|||
131711992|NCT00481065|474224129|FG004|Overall Study|Adverse event or death|2|||
131711993|NCT00481065|474224130|FG005|Overall Study|Adverse event or death|0|||
131711994|NCT00481065|474224131|FG006|Overall Study|Adverse event or death|1|||
131711995|NCT00481065|474224132|FG007|Overall Study|Adverse event or death|1|||
131711996|NCT00481065|474224125|FG000|Overall Study|Withdrawal by Subject|11|||
131711997|NCT00481065|474224126|FG001|Overall Study|Withdrawal by Subject|12|||
131711998|NCT00481065|474224127|FG002|Overall Study|Withdrawal by Subject|7|||
131711999|NCT00481065|474224128|FG003|Overall Study|Withdrawal by Subject|11|||
131712000|NCT00481065|474224129|FG004|Overall Study|Withdrawal by Subject|13|||
131712001|NCT00481065|474224130|FG005|Overall Study|Withdrawal by Subject|12|||
131712002|NCT00481065|474224131|FG006|Overall Study|Withdrawal by Subject|9|||
131712003|NCT00481065|474224132|FG007|Overall Study|Withdrawal by Subject|10|||
131712004|NCT00481065|474224125|FG000|Overall Study|Lost to Follow-up|4|||
131712005|NCT00481065|474224126|FG001|Overall Study|Lost to Follow-up|2|||
131712006|NCT00481065|474224127|FG002|Overall Study|Lost to Follow-up|4|||
131712007|NCT00481065|474224128|FG003|Overall Study|Lost to Follow-up|3|||
131712008|NCT00481065|474224129|FG004|Overall Study|Lost to Follow-up|3|||
131712009|NCT00481065|474224130|FG005|Overall Study|Lost to Follow-up|3|||
131712010|NCT00481065|474224131|FG006|Overall Study|Lost to Follow-up|2|||
131712011|NCT00481065|474224132|FG007|Overall Study|Lost to Follow-up|5|||
131712012|NCT00481065|474224125|FG000|Overall Study|Inappropriate enrollment|4|||
131712013|NCT00481065|474224126|FG001|Overall Study|Inappropriate enrollment|0|||
131712014|NCT00481065|474224127|FG002|Overall Study|Inappropriate enrollment|2|||
131712015|NCT00481065|474224128|FG003|Overall Study|Inappropriate enrollment|0|||
131712016|NCT00481065|474224129|FG004|Overall Study|Inappropriate enrollment|2|||
131712017|NCT00481065|474224130|FG005|Overall Study|Inappropriate enrollment|1|||
131712018|NCT00481065|474224131|FG006|Overall Study|Inappropriate enrollment|0|||
131712019|NCT00481065|474224132|FG007|Overall Study|Inappropriate enrollment|1|||
131712020|NCT00481065|474224125|FG000|Overall Study|Administrative reason|0|||
131712021|NCT00481065|474224126|FG001|Overall Study|Administrative reason|0|||
131712022|NCT00481065|474224127|FG002|Overall Study|Administrative reason|0|||
131712023|NCT00481065|474224128|FG003|Overall Study|Administrative reason|0|||
131712024|NCT00481065|474224129|FG004|Overall Study|Administrative reason|0|||
131712025|NCT00481065|474224130|FG005|Overall Study|Administrative reason|2|||
131712026|NCT00481065|474224131|FG006|Overall Study|Administrative reason|1|||
131712027|NCT00481065|474224132|FG007|Overall Study|Administrative reason|0|||
131712028|NCT00481065|474224125|FG000|Overall Study|Protocol Violation|2|||
131712029|NCT00481065|474224126|FG001|Overall Study|Protocol Violation|1|||
131712030|NCT00481065|474224127|FG002|Overall Study|Protocol Violation|1|||
131712031|NCT00481065|474224128|FG003|Overall Study|Protocol Violation|1|||
131712032|NCT00481065|474224129|FG004|Overall Study|Protocol Violation|2|||
131712033|NCT00481065|474224130|FG005|Overall Study|Protocol Violation|6|||
131712034|NCT00481065|474224131|FG006|Overall Study|Protocol Violation|3|||
131712035|NCT00481065|474224132|FG007|Overall Study|Protocol Violation|2|||
131712036|NCT00481065|474224125|FG000|Overall Study|Unable to classify|0|||
131712037|NCT00481065|474224126|FG001|Overall Study|Unable to classify|1|||
131712038|NCT00481065|474224127|FG002|Overall Study|Unable to classify|2|||
131712039|NCT00481065|474224128|FG003|Overall Study|Unable to classify|0|||
131712040|NCT00481065|474224129|FG004|Overall Study|Unable to classify|1|||
131712041|NCT00481065|474224130|FG005|Overall Study|Unable to classify|0|||
131712042|NCT00481065|474224131|FG006|Overall Study|Unable to classify|0|||
131712043|NCT00481065|474224132|FG007|Overall Study|Unable to classify|0|||
131712044|NCT01709331|474224135|FG000|Overall Study|Adverse Event|1|||
131712045|NCT03896295|474224138|FG000|Overall Study|Adverse Event|0|||
131712046|NCT03896295|474224139|FG001|Overall Study|Adverse Event|1|||
131712047|NCT03896295|474224138|FG000|Overall Study|COVID-19|7|||
131712048|NCT03896295|474224139|FG001|Overall Study|COVID-19|29|||
131712049|NCT00700804|474224140|FG000|Overall Study|Withdrawal by Subject|1|||
131712050|NCT00700804|474224141|FG001|Overall Study|Withdrawal by Subject|2|||
131712051|NCT00700804|474224140|FG000|Overall Study|Protocol Violation|1|||
131712052|NCT00700804|474224141|FG001|Overall Study|Protocol Violation|1|||
131712053|NCT00700804|474224140|FG000|Overall Study|Loose Stools|1|||
131712054|NCT00700804|474224141|FG001|Overall Study|Loose Stools|1|||
131712055|NCT02500537|474224142|FG000|Overall Study|Death|2|||
131712056|NCT02500537|474224143|FG001|Overall Study|Death|0|||
131712057|NCT02500537|474224142|FG000|Overall Study|Lost to Follow-up|0|||
131712058|NCT02500537|474224143|FG001|Overall Study|Lost to Follow-up|1|||
131712059|NCT02500537|474224142|FG000|Overall Study|Withdrawal by Subject|1|||
131712060|NCT02500537|474224143|FG001|Overall Study|Withdrawal by Subject|0|||
131712061|NCT02875223|474224148|FG000|Overall Study|Other reasons|0|||
131712062|NCT02875223|474224149|FG001|Overall Study|Other reasons|0|||
131712063|NCT02875223|474224150|FG002|Overall Study|Other reasons|1|||
131712064|NCT02875223|474224151|FG003|Overall Study|Other reasons|0|||
131796934|NCT01694485|474539808|FG003|Overall Study|Death|1|||
131796935|NCT01694485|474539809|FG004|Overall Study|Death|0|||
131796936|NCT01595009|474539810|FG000|Core|Patients completed per protocol|85|||
131796937|NCT01595009|474539811|FG001|Core|Patients completed per protocol|44|||
131796938|NCT01595009|474539812|FG002|Core|Patients completed per protocol|0|||
131796939|NCT01595009|474539813|FG003|Core|Patients completed per protocol|0|||
131796940|NCT01595009|474539810|FG000|Core|Adverse Event|19|||
131796941|NCT01595009|474539811|FG001|Core|Adverse Event|23|||
131796942|NCT01595009|474539812|FG002|Core|Adverse Event|0|||
131796943|NCT01595009|474539813|FG003|Core|Adverse Event|0|||
131796944|NCT01595009|474539810|FG000|Core|Disease progression|14|||
131796945|NCT01595009|474539811|FG001|Core|Disease progression|26|||
131796946|NCT01595009|474539812|FG002|Core|Disease progression|0|||
131796947|NCT01595009|474539813|FG003|Core|Disease progression|0|||
131796948|NCT01595009|474539810|FG000|Core|Withdrawal by Subject|4|||
131796949|NCT01595009|474539811|FG001|Core|Withdrawal by Subject|17|||
131796950|NCT01595009|474539812|FG002|Core|Withdrawal by Subject|0|||
131796951|NCT01595009|474539813|FG003|Core|Withdrawal by Subject|0|||
131796952|NCT01595009|474539810|FG000|Core|Death|3|||
131796953|NCT01595009|474539811|FG001|Core|Death|6|||
131796954|NCT01595009|474539812|FG002|Core|Death|0|||
131796955|NCT01595009|474539813|FG003|Core|Death|0|||
131796956|NCT01595009|474539810|FG000|Core|Lost to Follow-up|1|||
131796957|NCT01595009|474539811|FG001|Core|Lost to Follow-up|2|||
131796958|NCT01595009|474539812|FG002|Core|Lost to Follow-up|0|||
131796959|NCT01595009|474539813|FG003|Core|Lost to Follow-up|0|||
131796960|NCT01595009|474539810|FG000|Core|Protocol deviation|0|||
131796961|NCT01595009|474539811|FG001|Core|Protocol deviation|1|||
131796962|NCT01595009|474539812|FG002|Core|Protocol deviation|0|||
131796963|NCT01595009|474539813|FG003|Core|Protocol deviation|0|||
131796964|NCT01595009|474539810|FG000|Core|Administrative problems|0|||
131796965|NCT01595009|474539811|FG001|Core|Administrative problems|1|||
131796966|NCT01595009|474539812|FG002|Core|Administrative problems|0|||
131796967|NCT01595009|474539813|FG003|Core|Administrative problems|0|||
131796968|NCT01595009|474539810|FG000|Extension|Administrative problems|0|||
131796969|NCT01595009|474539811|FG001|Extension|Administrative problems|0|||
131796970|NCT01595009|474539812|FG002|Extension|Administrative problems|0|||
131796971|NCT01595009|474539813|FG003|Extension|Administrative problems|1|||
131796972|NCT01595009|474539810|FG000|Extension|Patients completed per protocol|0|||
131796973|NCT01595009|474539811|FG001|Extension|Patients completed per protocol|0|||
131796974|NCT01595009|474539812|FG002|Extension|Patients completed per protocol|0|||
131901497|NCT00490971|474923572|FG004|Maintenance|Lost to Follow-up|10|||
131796975|NCT01595009|474539813|FG003|Extension|Patients completed per protocol|2|||
131796976|NCT01595009|474539810|FG000|Extension|Disease progression|0|||
131796977|NCT01595009|474539811|FG001|Extension|Disease progression|0|||
131796978|NCT01595009|474539812|FG002|Extension|Disease progression|4|||
131796979|NCT01595009|474539813|FG003|Extension|Disease progression|7|||
131796980|NCT01595009|474539810|FG000|Extension|Adverse Event|0|||
131796981|NCT01595009|474539811|FG001|Extension|Adverse Event|0|||
131796982|NCT01595009|474539812|FG002|Extension|Adverse Event|0|||
131796983|NCT01595009|474539813|FG003|Extension|Adverse Event|1|||
131796984|NCT02907203|474539814|FG000|Overall Study|Death|1|||
131796985|NCT02907203|474539814|FG000|Overall Study|Lost to Follow-up|3|||
131626025|NCT01584648|473917720|FG000|Overall Study|Death|136|||
131796986|NCT02907203|474539814|FG000|Overall Study|Withdrawal by Subject|3|||
131796987|NCT02907203|474539814|FG000|Overall Study|Surgical bypass|1|||
131796988|NCT04956666|474539815|FG000|Overall Study|Adverse Event|18|||
131901498|NCT00490971|474923568|FG000|Maintenance|Pregnancy|0|||
131796989|NCT04956666|474539815|FG000|Overall Study|Physician Decision|5|||
131796990|NCT01937364|474539819|FG000|Overall Study|Adverse Event|2|||
131796991|NCT01937364|474539820|FG001|Overall Study|Adverse Event|1|||
131796992|NCT03730103|474539822|FG000|Overall Study|Did not meet inclusion criteria|0|||
131796993|NCT03730103|474539823|FG001|Overall Study|Did not meet inclusion criteria|5|||
131626026|NCT01584648|473917721|FG001|Overall Study|Death|146|||
131626027|NCT01584648|473917720|FG000|Overall Study|Lost to Follow-up|9|||
131626028|NCT01584648|473917721|FG001|Overall Study|Lost to Follow-up|9|||
131626029|NCT01584648|473917720|FG000|Overall Study|Investigator discretion|3|||
131626030|NCT01584648|473917721|FG001|Overall Study|Investigator discretion|2|||
131626031|NCT01584648|473917720|FG000|Overall Study|Withdrew consent|13|||
131626032|NCT01584648|473917721|FG001|Overall Study|Withdrew consent|4|||
131626033|NCT01584648|473917720|FG000|Overall Study|Study closed/terminated|50|||
131626034|NCT01584648|473917721|FG001|Overall Study|Study closed/terminated|23|||
131901499|NCT00490971|474923569|FG001|Maintenance|Pregnancy|0|||
131901500|NCT00490971|474923570|FG002|Maintenance|Pregnancy|1|||
131901501|NCT00490971|474923571|FG003|Maintenance|Pregnancy|0|||
131901502|NCT00490971|474923572|FG004|Maintenance|Pregnancy|0|||
131901503|NCT00490971|474923568|FG000|Maintenance|Protocol Violation|0|||
131901504|NCT00490971|474923569|FG001|Maintenance|Protocol Violation|0|||
131901505|NCT00490971|474923570|FG002|Maintenance|Protocol Violation|4|||
131901506|NCT00490971|474923571|FG003|Maintenance|Protocol Violation|1|||
131901507|NCT00490971|474923572|FG004|Maintenance|Protocol Violation|1|||
131901508|NCT00490971|474923568|FG000|Maintenance|Withdrawal by Subject|0|||
131901509|NCT00490971|474923569|FG001|Maintenance|Withdrawal by Subject|0|||
131901510|NCT00490971|474923570|FG002|Maintenance|Withdrawal by Subject|26|||
131901511|NCT00490971|474923571|FG003|Maintenance|Withdrawal by Subject|28|||
131901512|NCT00490971|474923572|FG004|Maintenance|Withdrawal by Subject|18|||
131901513|NCT00490971|474923568|FG000|Maintenance|Other|0|||
131901514|NCT00490971|474923569|FG001|Maintenance|Other|0|||
131901515|NCT00490971|474923570|FG002|Maintenance|Other|11|||
131901516|NCT00490971|474923571|FG003|Maintenance|Other|9|||
131901517|NCT00490971|474923572|FG004|Maintenance|Other|3|||
131901518|NCT04888494|474923583|FG000|Overall Study|Lost to Follow-up|2|||
131901519|NCT04888494|474923584|FG001|Overall Study|Lost to Follow-up|3|||
131901520|NCT04888494|474923583|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
131901521|NCT04888494|474923584|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
131901522|NCT03430856|474923585|FG000|Overall Study|Adverse Event|0|||
131901523|NCT03430856|474923586|FG001|Overall Study|Adverse Event|1|||
131901524|NCT03430856|474923587|FG002|Overall Study|Adverse Event|0|||
131901525|NCT03430856|474923585|FG000|Overall Study|Rescue criteria|1|||
131901526|NCT03430856|474923586|FG001|Overall Study|Rescue criteria|1|||
131901527|NCT03430856|474923587|FG002|Overall Study|Rescue criteria|0|||
131901528|NCT03430856|474923585|FG000|Overall Study|Voluntary withdrawal of consent|1|||
131901529|NCT03430856|474923586|FG001|Overall Study|Voluntary withdrawal of consent|1|||
131901530|NCT03430856|474923587|FG002|Overall Study|Voluntary withdrawal of consent|1|||
131901531|NCT00565604|474923593|FG000|Overall Study|Failure to treat|2|||
131901532|NCT00565604|474923593|FG000|Overall Study|Lost to Follow-up|2|||
131901533|NCT05027815|474923594|FG000|Overall Study|Death|2|||
131901534|NCT05027815|474923595|FG001|Overall Study|Death|1|||
131901535|NCT01395810|474923596|FG000|Overall Study|Adverse Event|0|||
131901536|NCT01395810|474923597|FG001|Overall Study|Adverse Event|1|||
131901537|NCT01395810|474923598|FG002|Overall Study|Adverse Event|0|||
131901538|NCT01395810|474923599|FG003|Overall Study|Adverse Event|0|||
131901539|NCT01395810|474923596|FG000|Overall Study|Lack of Efficacy|0|||
131901540|NCT01395810|474923597|FG001|Overall Study|Lack of Efficacy|1|||
131901541|NCT01395810|474923598|FG002|Overall Study|Lack of Efficacy|0|||
131901542|NCT01395810|474923599|FG003|Overall Study|Lack of Efficacy|0|||
131901543|NCT01395810|474923596|FG000|Overall Study|Withdrawal criteria|0|||
131901544|NCT01395810|474923597|FG001|Overall Study|Withdrawal criteria|2|||
131901545|NCT01395810|474923598|FG002|Overall Study|Withdrawal criteria|0|||
131901546|NCT01395810|474923599|FG003|Overall Study|Withdrawal criteria|0|||
131901547|NCT01395810|474923596|FG000|Overall Study|Unclassified|2|||
131901548|NCT01395810|474923597|FG001|Overall Study|Unclassified|0|||
131901549|NCT01395810|474923598|FG002|Overall Study|Unclassified|0|||
131901550|NCT01395810|474923599|FG003|Overall Study|Unclassified|0|||
131901551|NCT03877224|474923604|FG000|Overall Study|Death|3|||
131901552|NCT03877224|474923605|FG001|Overall Study|Death|2|||
131901553|NCT03877224|474923604|FG000|Overall Study|Withdrawal by Subject|1|||
131901554|NCT03877224|474923605|FG001|Overall Study|Withdrawal by Subject|6|||
131901555|NCT03877224|474923604|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
131901556|NCT03877224|474923605|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
131901557|NCT04754542|474923606|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
131901558|NCT04754542|474923607|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
131901559|NCT02317991|474925109|FG000|Overall Study|Adverse Event|12|||
131901560|NCT02317991|474925109|FG000|Overall Study|Death|4|||
131901561|NCT02317991|474925109|FG000|Overall Study|Withdrawal by Subject|8|||
131901562|NCT02317991|474925109|FG000|Overall Study|Progressive Disease|41|||
131901563|NCT00379834|474925110|FG000|Overall Study|Time constraints|2|||
131901564|NCT00327340|474925111|FG000|Overall Study|Withdrawal by Subject|1|||
131901565|NCT00327340|474925112|FG001|Overall Study|Withdrawal by Subject|5|||
131901566|NCT00327340|474925111|FG000|Overall Study|Physician Decision|1|||
131901567|NCT00327340|474925112|FG001|Overall Study|Physician Decision|1|||
131901568|NCT00327340|474925111|FG000|Overall Study|Disease Progression|10|||
131901569|NCT00327340|474925112|FG001|Overall Study|Disease Progression|19|||
131901570|NCT00327340|474925111|FG000|Overall Study|Symptomatic Disease|0|||
131901571|NCT00327340|474925112|FG001|Overall Study|Symptomatic Disease|2|||
131901572|NCT00327340|474925111|FG000|Overall Study|Adverse Event|3|||
131901573|NCT00327340|474925112|FG001|Overall Study|Adverse Event|3|||
131796994|NCT02308111|474539824|FG000|Overall Study|Adverse Event|31|||
131796995|NCT02308111|474539825|FG001|Overall Study|Adverse Event|19|||
131796996|NCT02308111|474539824|FG000|Overall Study|Death|9|||
131796997|NCT02308111|474539825|FG001|Overall Study|Death|6|||
131796998|NCT02308111|474539824|FG000|Overall Study|Lost to Follow-up|2|||
131796999|NCT02308111|474539825|FG001|Overall Study|Lost to Follow-up|7|||
131797000|NCT02308111|474539824|FG000|Overall Study|Physician Decision|6|||
131797001|NCT02308111|474539825|FG001|Overall Study|Physician Decision|17|||
131797002|NCT02308111|474539824|FG000|Overall Study|Protocol Violation|0|||
131797003|NCT02308111|474539825|FG001|Overall Study|Protocol Violation|1|||
131797004|NCT02308111|474539824|FG000|Overall Study|Withdrawal by Subject|28|||
131797005|NCT02308111|474539825|FG001|Overall Study|Withdrawal by Subject|38|||
131797006|NCT02308111|474539824|FG000|Overall Study|Study Terminated by Sponsor|72|||
131797007|NCT02308111|474539825|FG001|Overall Study|Study Terminated by Sponsor|61|||
131797008|NCT02308111|474539824|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
131797009|NCT02308111|474539825|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
131797010|NCT02308111|474539824|FG000|Overall Study|Site Closure|3|||
131797011|NCT02308111|474539825|FG001|Overall Study|Site Closure|3|||
131797012|NCT02308111|474539824|FG000|Overall Study|Non-compliance with Study Drug|3|||
131797013|NCT02308111|474539825|FG001|Overall Study|Non-compliance with Study Drug|1|||
131797014|NCT02308111|474539824|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
131797015|NCT02308111|474539825|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
131797016|NCT02308111|474539824|FG000|Overall Study|Liver Transplant|3|||
131797017|NCT02308111|474539825|FG001|Overall Study|Liver Transplant|3|||
131797018|NCT02308111|474539824|FG000|Overall Study|Liver Transplant Waitlist|2|||
131797019|NCT02308111|474539825|FG001|Overall Study|Liver Transplant Waitlist|2|||
131797020|NCT02308111|474539824|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
131797021|NCT02308111|474539825|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
131797022|NCT00329602|474539828|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
131797023|NCT00329602|474539829|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
131797024|NCT00329602|474539830|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
131797025|NCT00329602|474539828|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
131797026|NCT00329602|474539829|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
131797027|NCT00329602|474539830|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
131797028|NCT00329602|474539828|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
131797029|NCT00329602|474539829|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
131797030|NCT00329602|474539830|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
131797031|NCT00329602|474539828|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
131797032|NCT00329602|474539829|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
131797033|NCT00329602|474539830|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
131797034|NCT00329602|474539828|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
131797035|NCT00329602|474539829|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
131797036|NCT00329602|474539830|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
131797037|NCT00329602|474539828|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
131797038|NCT00329602|474539829|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
131797039|NCT00329602|474539830|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
131797040|NCT00319449|474539833|FG000|Overall Study|Subject did not wish to continue|1|||
131797041|NCT00319449|474539834|FG001|Overall Study|Subject did not wish to continue|0|||
131797042|NCT00319449|474539833|FG000|Overall Study|Noncompliance with the protocol|1|||
131797043|NCT00319449|474539834|FG001|Overall Study|Noncompliance with the protocol|0|||
131797044|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
131797045|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
131797046|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
131797047|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
131797048|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
131797049|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
131797050|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
131797051|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
131797052|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
131797053|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
131797054|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
131797055|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
131797056|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
131797057|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
131797058|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
131797059|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
131797060|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
131797061|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
131797062|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
131797063|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
131797064|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
131797065|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
131797066|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
131797067|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
131797068|NCT00455533|474539835|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
131797069|NCT00455533|474539836|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
131797070|NCT00455533|474539837|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
131797071|NCT00455533|474539835|FG000|Period Two: Randomized Period|Death|0|||
131797072|NCT00455533|474539836|FG001|Period Two: Randomized Period|Death|0|||
131797073|NCT00455533|474539837|FG002|Period Two: Randomized Period|Death|3|||
131797074|NCT00455533|474539835|FG000|Period Two: Randomized Period|Disease Progression|0|||
131797075|NCT00455533|474539836|FG001|Period Two: Randomized Period|Disease Progression|1|||
131797076|NCT00455533|474539837|FG002|Period Two: Randomized Period|Disease Progression|1|||
131797077|NCT00455533|474539835|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
131797078|NCT00455533|474539836|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
131797079|NCT00455533|474539837|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
131797080|NCT00455533|474539835|FG000|Period Two: Randomized Period|Other - need reasons|0|||
131797081|NCT00455533|474539836|FG001|Period Two: Randomized Period|Other - need reasons|1|||
131797082|NCT00455533|474539837|FG002|Period Two: Randomized Period|Other - need reasons|0|||
131797083|NCT00455533|474539835|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
131797084|NCT00455533|474539836|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
131797085|NCT00455533|474539837|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
131797086|NCT00455533|474539835|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
131797087|NCT00455533|474539836|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
131797088|NCT00455533|474539837|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
131797089|NCT01346410|474539842|FG000|Overall Study|Death|1|||
131797090|NCT00979628|474539843|FG000|Overall Study|received regimen < 24 hours|7|||
131797091|NCT00979628|474539844|FG001|Overall Study|received regimen < 24 hours|6|||
131797092|NCT00979628|474539845|FG002|Overall Study|received regimen < 24 hours|5|||
131797093|NCT00979628|474539843|FG000|Overall Study|received steroids|1|||
131797094|NCT00979628|474539844|FG001|Overall Study|received steroids|1|||
131797095|NCT00979628|474539845|FG002|Overall Study|received steroids|0|||
131797096|NCT00979628|474539843|FG000|Overall Study|transferred to ICU|1|||
131797097|NCT00979628|474539844|FG001|Overall Study|transferred to ICU|2|||
131797098|NCT00979628|474539845|FG002|Overall Study|transferred to ICU|1|||
131797099|NCT02576990|474539846|FG000|Overall Study|Death|29|||
131626035|NCT01584648|473917720|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
131626036|NCT01584648|473917721|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
131626037|NCT01757288|473917723|FG000|Overall Study|Consent withdrawal|0|||
131626038|NCT01757288|473917724|FG001|Overall Study|Consent withdrawal|4|||
131626039|NCT01757288|473917725|FG002|Overall Study|Consent withdrawal|4|||
131626040|NCT01757288|473917723|FG000|Overall Study|Patient off study, IRB hold.|0|||
131626041|NCT01757288|473917724|FG001|Overall Study|Patient off study, IRB hold.|0|||
131626042|NCT01757288|473917725|FG002|Overall Study|Patient off study, IRB hold.|1|||
131626043|NCT01757288|473917723|FG000|Overall Study|Patient death prior to starting treatment|0|||
131626044|NCT01757288|473917724|FG001|Overall Study|Patient death prior to starting treatment|0|||
131626045|NCT01757288|473917725|FG002|Overall Study|Patient death prior to starting treatment|1|||
131626046|NCT01757288|473917723|FG000|Overall Study|Wrong medication administered|0|||
131626047|NCT01757288|473917724|FG001|Overall Study|Wrong medication administered|1|||
131626048|NCT01757288|473917725|FG002|Overall Study|Wrong medication administered|0|||
131626049|NCT01757288|473917723|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
131626050|NCT01757288|473917724|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
131626051|NCT01757288|473917725|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
131626052|NCT01757288|473917723|FG000|Overall Study|Not meeting protocol constraints|0|||
131626053|NCT01757288|473917724|FG001|Overall Study|Not meeting protocol constraints|1|||
131626054|NCT01757288|473917725|FG002|Overall Study|Not meeting protocol constraints|1|||
131626055|NCT01757288|473917723|FG000|Overall Study|Multiple missed appointments|0|||
131626056|NCT01757288|473917724|FG001|Overall Study|Multiple missed appointments|1|||
131626057|NCT01757288|473917725|FG002|Overall Study|Multiple missed appointments|0|||
131626058|NCT01757288|473917723|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
131626059|NCT01757288|473917724|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
131626060|NCT01757288|473917725|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
131626061|NCT01757288|473917723|FG000|Overall Study|>2 weeks treatment break|0|||
131797100|NCT02576990|474539847|FG001|Overall Study|Death|18|||
131626062|NCT01757288|473917724|FG001|Overall Study|>2 weeks treatment break|0|||
131626063|NCT01757288|473917725|FG002|Overall Study|>2 weeks treatment break|1|||
131626064|NCT02825550|473917727|FG000|Overall Study|Physician Decision|1|||
131626065|NCT00042939|473917731|FG000|Overall Study|Adverse Event|6|||
131712065|NCT02875223|474224152|FG004|Overall Study|Other reasons|1|||
131712066|NCT02875223|474224153|FG005|Overall Study|Other reasons|2|||
131712067|NCT02875223|474224154|FG006|Overall Study|Other reasons|0|||
131712068|NCT02875223|474224155|FG007|Overall Study|Other reasons|2|||
131712069|NCT02875223|474224156|FG008|Overall Study|Other reasons|0|||
131712070|NCT02875223|474224157|FG009|Overall Study|Other reasons|0|||
131712071|NCT02875223|474224158|FG010|Overall Study|Other reasons|0|||
131712072|NCT02875223|474224159|FG011|Overall Study|Other reasons|0|||
131712073|NCT02875223|474224160|FG012|Overall Study|Other reasons|0|||
131712074|NCT02875223|474224148|FG000|Overall Study|Withdrawal by Subject|0|||
131712075|NCT02875223|474224149|FG001|Overall Study|Withdrawal by Subject|0|||
131712076|NCT02875223|474224150|FG002|Overall Study|Withdrawal by Subject|0|||
131712077|NCT02875223|474224151|FG003|Overall Study|Withdrawal by Subject|0|||
131712078|NCT02875223|474224152|FG004|Overall Study|Withdrawal by Subject|1|||
131712079|NCT02875223|474224153|FG005|Overall Study|Withdrawal by Subject|1|||
131712080|NCT02875223|474224154|FG006|Overall Study|Withdrawal by Subject|0|||
131712081|NCT02875223|474224155|FG007|Overall Study|Withdrawal by Subject|0|||
131712082|NCT02875223|474224156|FG008|Overall Study|Withdrawal by Subject|1|||
131712083|NCT02875223|474224157|FG009|Overall Study|Withdrawal by Subject|0|||
131712084|NCT02875223|474224158|FG010|Overall Study|Withdrawal by Subject|0|||
131797101|NCT02576990|474539846|FG000|Overall Study|Physician Decision|1|||
131797102|NCT02576990|474539847|FG001|Overall Study|Physician Decision|0|||
131797103|NCT02576990|474539846|FG000|Overall Study|Screen failure|2|||
131797104|NCT02576990|474539847|FG001|Overall Study|Screen failure|0|||
131797105|NCT02576990|474539846|FG000|Overall Study|Sponsor's decision|24|||
131797106|NCT02576990|474539847|FG001|Overall Study|Sponsor's decision|4|||
131797107|NCT02576990|474539846|FG000|Overall Study|Withdrawal by Subject|0|||
131797108|NCT02576990|474539847|FG001|Overall Study|Withdrawal by Subject|2|||
131797109|NCT02415959|474539848|FG000|Overall Study|Adverse Event|0|||
131797110|NCT02415959|474539849|FG001|Overall Study|Adverse Event|1|||
131797111|NCT02415959|474539850|FG002|Overall Study|Adverse Event|0|||
131797112|NCT02415959|474539851|FG003|Overall Study|Adverse Event|0|||
131797113|NCT02415959|474539852|FG004|Overall Study|Adverse Event|0|||
131797114|NCT02415959|474539848|FG000|Overall Study|Protocol Violation|0|||
131797115|NCT02415959|474539849|FG001|Overall Study|Protocol Violation|0|||
131797116|NCT02415959|474539850|FG002|Overall Study|Protocol Violation|0|||
131797117|NCT02415959|474539851|FG003|Overall Study|Protocol Violation|1|||
131797118|NCT02415959|474539852|FG004|Overall Study|Protocol Violation|0|||
131797119|NCT00911859|474539853|FG000|Treatment Period|Adverse Event|3|||
131797120|NCT00911859|474539854|FG001|Treatment Period|Adverse Event|3|||
131797121|NCT00911859|474539855|FG002|Treatment Period|Adverse Event|7|||
131797122|NCT00911859|474539853|FG000|Treatment Period|Death|1|||
131797123|NCT00911859|474539854|FG001|Treatment Period|Death|3|||
131797124|NCT00911859|474539855|FG002|Treatment Period|Death|5|||
131797125|NCT00911859|474539853|FG000|Treatment Period|Lack of Efficacy|1|||
131797126|NCT00911859|474539854|FG001|Treatment Period|Lack of Efficacy|7|||
131797127|NCT00911859|474539855|FG002|Treatment Period|Lack of Efficacy|5|||
131797128|NCT00911859|474539853|FG000|Treatment Period|Physician Decision|3|||
131797129|NCT00911859|474539854|FG001|Treatment Period|Physician Decision|3|||
131797130|NCT00911859|474539855|FG002|Treatment Period|Physician Decision|3|||
131797131|NCT00911859|474539853|FG000|Treatment Period|Withdrawal by Subject|0|||
131797132|NCT00911859|474539854|FG001|Treatment Period|Withdrawal by Subject|4|||
131797133|NCT00911859|474539855|FG002|Treatment Period|Withdrawal by Subject|5|||
131797134|NCT00911859|474539853|FG000|Treatment Period|Did not receive study treatment|0|||
131797135|NCT00911859|474539854|FG001|Treatment Period|Did not receive study treatment|1|||
131797136|NCT00911859|474539855|FG002|Treatment Period|Did not receive study treatment|0|||
131797137|NCT00911859|474539853|FG000|Maintainance Period|Lack of Efficacy|0|||
131797138|NCT00911859|474539854|FG001|Maintainance Period|Lack of Efficacy|0|||
131797139|NCT00911859|474539855|FG002|Maintainance Period|Lack of Efficacy|9|||
131797140|NCT00911859|474539853|FG000|Maintainance Period|Physician Decision|0|||
131797141|NCT00911859|474539854|FG001|Maintainance Period|Physician Decision|0|||
131797142|NCT00911859|474539855|FG002|Maintainance Period|Physician Decision|9|||
131797143|NCT00911859|474539853|FG000|Maintainance Period|Withdrawal by Subject|0|||
131712085|NCT02875223|474224159|FG011|Overall Study|Withdrawal by Subject|0|||
131712086|NCT02875223|474224160|FG012|Overall Study|Withdrawal by Subject|0|||
131712087|NCT02875223|474224148|FG000|Overall Study|Progressive disease|0|||
131712088|NCT02875223|474224149|FG001|Overall Study|Progressive disease|0|||
131712089|NCT02875223|474224150|FG002|Overall Study|Progressive disease|1|||
131797144|NCT00911859|474539854|FG001|Maintainance Period|Withdrawal by Subject|0|||
131797145|NCT00911859|474539855|FG002|Maintainance Period|Withdrawal by Subject|3|||
131797146|NCT00911859|474539853|FG000|Follow-up Period|Death|5|||
131797147|NCT00911859|474539854|FG001|Follow-up Period|Death|8|||
131797148|NCT00911859|474539855|FG002|Follow-up Period|Death|10|||
131797149|NCT00911859|474539853|FG000|Follow-up Period|Lost to Follow-up|1|||
131797150|NCT00911859|474539854|FG001|Follow-up Period|Lost to Follow-up|1|||
131712090|NCT02875223|474224151|FG003|Overall Study|Progressive disease|0|||
131712091|NCT02875223|474224152|FG004|Overall Study|Progressive disease|0|||
131712092|NCT02875223|474224153|FG005|Overall Study|Progressive disease|0|||
131901574|NCT01716806|474925117|FG000|Overall Study|Patient withdrawal of consent|4|||
131901575|NCT01716806|474925118|FG001|Overall Study|Patient withdrawal of consent|2|||
131901576|NCT01716806|474925119|FG002|Overall Study|Patient withdrawal of consent|4|||
131901577|NCT01716806|474925120|FG003|Overall Study|Patient withdrawal of consent|3|||
131901578|NCT01716806|474925121|FG004|Overall Study|Patient withdrawal of consent|2|||
131901579|NCT01716806|474925122|FG005|Overall Study|Patient withdrawal of consent|0|||
131901580|NCT01716806|474925117|FG000|Overall Study|Lost to Follow-up|3|||
131901581|NCT01716806|474925118|FG001|Overall Study|Lost to Follow-up|3|||
131901582|NCT01716806|474925119|FG002|Overall Study|Lost to Follow-up|0|||
131901583|NCT01716806|474925120|FG003|Overall Study|Lost to Follow-up|2|||
131901584|NCT01716806|474925121|FG004|Overall Study|Lost to Follow-up|1|||
131901585|NCT01716806|474925122|FG005|Overall Study|Lost to Follow-up|0|||
131901586|NCT01716806|474925117|FG000|Overall Study|Death|13|||
131901587|NCT01716806|474925118|FG001|Overall Study|Death|9|||
131901588|NCT01716806|474925119|FG002|Overall Study|Death|12|||
131901589|NCT01716806|474925120|FG003|Overall Study|Death|4|||
131901590|NCT01716806|474925121|FG004|Overall Study|Death|10|||
131901591|NCT01716806|474925122|FG005|Overall Study|Death|5|||
131901592|NCT01716806|474925117|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
131901593|NCT01716806|474925118|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
131901594|NCT01716806|474925119|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
131901595|NCT01716806|474925120|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
131901596|NCT01716806|474925121|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
131901597|NCT01716806|474925122|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
131901598|NCT01716806|474925117|FG000|Overall Study|PI decision|0|||
131901599|NCT01716806|474925118|FG001|Overall Study|PI decision|0|||
131901600|NCT01716806|474925119|FG002|Overall Study|PI decision|0|||
131901601|NCT01716806|474925120|FG003|Overall Study|PI decision|0|||
131901602|NCT01716806|474925121|FG004|Overall Study|PI decision|1|||
131901603|NCT01716806|474925122|FG005|Overall Study|PI decision|0|||
131901604|NCT01716806|474925117|FG000|Overall Study|Change in performance status|1|||
131901605|NCT01716806|474925118|FG001|Overall Study|Change in performance status|0|||
131901606|NCT01716806|474925119|FG002|Overall Study|Change in performance status|0|||
131901607|NCT01716806|474925120|FG003|Overall Study|Change in performance status|0|||
131901608|NCT01716806|474925121|FG004|Overall Study|Change in performance status|0|||
131901609|NCT01716806|474925122|FG005|Overall Study|Change in performance status|0|||
131901610|NCT01716806|474925117|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
131901611|NCT01716806|474925118|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
131901612|NCT01716806|474925119|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
131901613|NCT01716806|474925120|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
131901614|NCT01716806|474925121|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
131901615|NCT01716806|474925122|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
131901616|NCT01716806|474925117|FG000|Overall Study|Sponsor direction|7|||
131901617|NCT01716806|474925118|FG001|Overall Study|Sponsor direction|8|||
131901618|NCT01716806|474925119|FG002|Overall Study|Sponsor direction|5|||
131901619|NCT01716806|474925120|FG003|Overall Study|Sponsor direction|12|||
131901620|NCT01716806|474925121|FG004|Overall Study|Sponsor direction|16|||
131901621|NCT01716806|474925122|FG005|Overall Study|Sponsor direction|1|||
131901622|NCT03316586|474925125|FG000|Overall Study|Adverse Event|2|||
131901623|NCT03316586|474925125|FG000|Overall Study|Physician Decision|3|||
131901624|NCT03316586|474925125|FG000|Overall Study|Lack of Efficacy|10|||
131901625|NCT03316586|474925125|FG000|Overall Study|still on treatment|1|||
131901626|NCT03316586|474925125|FG000|Overall Study|Patient needed radiation therapy|1|||
131901627|NCT03316586|474925125|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
131901628|NCT03934216|474925126|FG000|Overall Study|Other Reasons|5|||
131901629|NCT03934216|474925127|FG001|Overall Study|Other Reasons|5|||
131901630|NCT03934216|474925126|FG000|Overall Study|Adverse Event|22|||
131626066|NCT00042939|473917732|FG001|Overall Study|Adverse Event|7|||
131626067|NCT00042939|473917731|FG000|Overall Study|Death|3|||
131626068|NCT00042939|473917732|FG001|Overall Study|Death|2|||
131626069|NCT00042939|473917731|FG000|Overall Study|Withdrawal by Subject|3|||
131626070|NCT00042939|473917732|FG001|Overall Study|Withdrawal by Subject|4|||
131626071|NCT00042939|473917731|FG000|Overall Study|Other disease|1|||
131626072|NCT00042939|473917732|FG001|Overall Study|Other disease|0|||
131901631|NCT03934216|474925127|FG001|Overall Study|Adverse Event|11|||
131626073|NCT00042939|473917731|FG000|Overall Study|Ineligible|2|||
131626074|NCT00042939|473917732|FG001|Overall Study|Ineligible|2|||
131626075|NCT00042939|473917731|FG000|Overall Study|Deterioration of health|3|||
131626076|NCT00042939|473917732|FG001|Overall Study|Deterioration of health|4|||
131626077|NCT00042939|473917731|FG000|Overall Study|QOL diminished|1|||
131626078|NCT00042939|473917732|FG001|Overall Study|QOL diminished|0|||
131626079|NCT00042939|473917731|FG000|Overall Study|Rising ca 19-9|1|||
131626080|NCT00042939|473917732|FG001|Overall Study|Rising ca 19-9|0|||
131626081|NCT00042939|473917731|FG000|Overall Study|Patient non-compliance|1|||
131626082|NCT00042939|473917732|FG001|Overall Study|Patient non-compliance|0|||
131712093|NCT02875223|474224154|FG006|Overall Study|Progressive disease|0|||
131712094|NCT02875223|474224155|FG007|Overall Study|Progressive disease|0|||
131712095|NCT02875223|474224156|FG008|Overall Study|Progressive disease|0|||
131712096|NCT02875223|474224157|FG009|Overall Study|Progressive disease|12|||
131712097|NCT02875223|474224158|FG010|Overall Study|Progressive disease|2|||
131712098|NCT02875223|474224159|FG011|Overall Study|Progressive disease|3|||
131712099|NCT02875223|474224160|FG012|Overall Study|Progressive disease|6|||
131712100|NCT02875223|474224148|FG000|Overall Study|Death|4|||
131712101|NCT02875223|474224149|FG001|Overall Study|Death|4|||
131712102|NCT02875223|474224150|FG002|Overall Study|Death|3|||
131712103|NCT02875223|474224151|FG003|Overall Study|Death|4|||
131712104|NCT02875223|474224152|FG004|Overall Study|Death|2|||
131712105|NCT02875223|474224153|FG005|Overall Study|Death|3|||
131712106|NCT02875223|474224154|FG006|Overall Study|Death|5|||
131712107|NCT02875223|474224155|FG007|Overall Study|Death|7|||
131712108|NCT02875223|474224156|FG008|Overall Study|Death|3|||
131712109|NCT02875223|474224157|FG009|Overall Study|Death|2|||
131712110|NCT02875223|474224158|FG010|Overall Study|Death|0|||
131626083|NCT00042939|473917731|FG000|Overall Study|Still on treatment|1|||
131626084|NCT00042939|473917732|FG001|Overall Study|Still on treatment|0|||
131712111|NCT02875223|474224159|FG011|Overall Study|Death|0|||
131712112|NCT02875223|474224160|FG012|Overall Study|Death|0|||
131626085|NCT00042939|473917731|FG000|Overall Study|Treatment break > 4 weeks|0|||
131626086|NCT00042939|473917732|FG001|Overall Study|Treatment break > 4 weeks|1|||
131626087|NCT00042939|473917731|FG000|Overall Study|Did not start treatment|2|||
131626088|NCT00042939|473917732|FG001|Overall Study|Did not start treatment|1|||
131626089|NCT03349476|473917733|FG000|Overall Study|Physician Decision|3|||
131626090|NCT02525744|473917734|FG000|Period 1|Physician Decision|0|||
131626091|NCT02525744|473917735|FG001|Period 1|Physician Decision|0|||
131626092|NCT02525744|473917736|FG002|Period 1|Physician Decision|1|||
131626093|NCT02525744|473917737|FG003|Period 1|Physician Decision|0|||
131626094|NCT02525744|473917734|FG000|Period 3|Adverse Event|0|||
131626095|NCT02525744|473917735|FG001|Period 3|Adverse Event|1|||
131626096|NCT02525744|473917736|FG002|Period 3|Adverse Event|0|||
131626097|NCT02525744|473917737|FG003|Period 3|Adverse Event|0|||
131626098|NCT02525744|473917734|FG000|Period 4|Withdrawal by Subject|1|||
131626099|NCT02525744|473917735|FG001|Period 4|Withdrawal by Subject|0|||
131626100|NCT02525744|473917736|FG002|Period 4|Withdrawal by Subject|0|||
131626101|NCT02525744|473917737|FG003|Period 4|Withdrawal by Subject|0|||
131626102|NCT02525744|473917734|FG000|Period 5|Physician Decision|1|||
131797151|NCT00911859|474539855|FG002|Follow-up Period|Lost to Follow-up|0|||
131797152|NCT00911859|474539853|FG000|Follow-up Period|Withdrawal by Subject|0|||
131797153|NCT00911859|474539854|FG001|Follow-up Period|Withdrawal by Subject|4|||
131797154|NCT00911859|474539855|FG002|Follow-up Period|Withdrawal by Subject|4|||
131797155|NCT00911859|474539853|FG000|Follow-up Period|Study terminated by sponsor|5|||
131797156|NCT00911859|474539854|FG001|Follow-up Period|Study terminated by sponsor|33|||
131797157|NCT00911859|474539855|FG002|Follow-up Period|Study terminated by sponsor|27|||
131797158|NCT01048333|474539858|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131797159|NCT01048333|474539859|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
131797160|NCT01048333|474539860|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131797161|NCT01048333|474539861|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131797162|NCT01048333|474539862|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131797163|NCT01048333|474539863|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131797164|NCT02456909|474539864|FG000|Overall Study|Did not receive allocated intervention|24|||
131797165|NCT02456909|474539865|FG001|Overall Study|Did not receive allocated intervention|26|||
131797166|NCT02456909|474539864|FG000|Overall Study|Did not complete the primary outcome|0|||
131797167|NCT02456909|474539865|FG001|Overall Study|Did not complete the primary outcome|1|||
131797168|NCT02178709|474541535|FG000|Overall Study|Adverse Event|5|||
131797169|NCT02178709|474541535|FG000|Overall Study|Death|2|||
131797170|NCT02178709|474541535|FG000|Overall Study|Withdrawal by Subject|2|||
131797171|NCT02178709|474541535|FG000|Overall Study|Physician Decision|2|||
131797172|NCT02178709|474541535|FG000|Overall Study|Disease Progression|5|||
131797173|NCT02224456|474541536|FG000|Overall Study|Lack of Efficacy|1|||
131797174|NCT02224456|474541536|FG000|Overall Study|Lost to Follow-up|15|||
131797175|NCT02224456|474541536|FG000|Overall Study|Withdrawal by Subject|9|||
131797176|NCT02224456|474541536|FG000|Overall Study|Physician Decision|3|||
131797177|NCT02224456|474541536|FG000|Overall Study|Death|2|||
131797178|NCT02224456|474541536|FG000|Overall Study|Pregnancy|4|||
131797179|NCT02224456|474541536|FG000|Overall Study|Protocol Violation|1|||
131797180|NCT02224456|474541536|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
131901632|NCT03934216|474925126|FG000|Overall Study|Lack of Efficacy|8|||
131901633|NCT03934216|474925127|FG001|Overall Study|Lack of Efficacy|7|||
131797181|NCT02946385|474541537|FG000|Overall Study|Lost to Follow-up|0|||
131797182|NCT02946385|474541538|FG001|Overall Study|Lost to Follow-up|0|||
131797183|NCT02946385|474541539|FG002|Overall Study|Lost to Follow-up|3|||
131797184|NCT02946385|474541540|FG003|Overall Study|Lost to Follow-up|0|||
131797185|NCT02946385|474541541|FG004|Overall Study|Lost to Follow-up|2|||
131626103|NCT02525744|473917735|FG001|Period 5|Physician Decision|0|||
131797186|NCT02946385|474541542|FG005|Overall Study|Lost to Follow-up|1|||
131626104|NCT02525744|473917736|FG002|Period 5|Physician Decision|0|||
131626105|NCT02525744|473917737|FG003|Period 5|Physician Decision|0|||
131626106|NCT00879710|473917744|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
131626107|NCT00879710|473917745|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
131626108|NCT00879710|473917746|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
131626109|NCT00879710|473917747|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
131626110|NCT00879710|473917744|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
131626111|NCT00879710|473917745|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
131626112|NCT00879710|473917746|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
131626113|NCT00879710|473917747|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
131626114|NCT02514824|473917748|FG000|Overall Study|Withdrawal by Subject|1|||
131626115|NCT02514824|473917749|FG001|Overall Study|Withdrawal by Subject|0|||
131626116|NCT02514824|473917750|FG002|Overall Study|Withdrawal by Subject|0|||
131626117|NCT02514824|473917751|FG003|Overall Study|Withdrawal by Subject|0|||
131626118|NCT02514824|473917748|FG000|Overall Study|Dose-Limiting Toxicity|0|||
131626119|NCT02514824|473917749|FG001|Overall Study|Dose-Limiting Toxicity|1|||
131626120|NCT02514824|473917750|FG002|Overall Study|Dose-Limiting Toxicity|0|||
131626121|NCT02514824|473917751|FG003|Overall Study|Dose-Limiting Toxicity|0|||
131626122|NCT01930188|473917752|FG000|Overall Study|unclassified|4|||
131626123|NCT01930188|473917753|FG001|Overall Study|unclassified|5|||
131626124|NCT01930188|473917754|FG002|Overall Study|unclassified|3|||
131626125|NCT01930188|473917752|FG000|Overall Study|Missing follow-up information|2|||
131626126|NCT01930188|473917753|FG001|Overall Study|Missing follow-up information|2|||
131626127|NCT01930188|473917754|FG002|Overall Study|Missing follow-up information|3|||
131626128|NCT01930188|473917752|FG000|Overall Study|Lost to Follow-up|5|||
131626129|NCT01930188|473917753|FG001|Overall Study|Lost to Follow-up|2|||
131626130|NCT01930188|473917754|FG002|Overall Study|Lost to Follow-up|2|||
131626131|NCT01930188|473917752|FG000|Overall Study|Death|2|||
131626132|NCT01930188|473917753|FG001|Overall Study|Death|1|||
131626133|NCT01930188|473917754|FG002|Overall Study|Death|3|||
131626134|NCT01930188|473917752|FG000|Overall Study|Withdrawal by Subject|9|||
131626135|NCT01930188|473917753|FG001|Overall Study|Withdrawal by Subject|11|||
131626136|NCT01930188|473917754|FG002|Overall Study|Withdrawal by Subject|8|||
131626137|NCT04085614|473917755|FG000|Overall Study|Protocol Violation|9|||
131626138|NCT04085614|473917756|FG001|Overall Study|Protocol Violation|6|||
131626139|NCT02516202|473917757|FG000|Overall Study|Withdrawal by Subject|1|||
131626140|NCT02516202|473917758|FG001|Overall Study|Withdrawal by Subject|0|||
131626141|NCT02516202|473917759|FG002|Overall Study|Withdrawal by Subject|1|||
131626142|NCT02516202|473917757|FG000|Overall Study|Lost to Follow-up|1|||
131626143|NCT02516202|473917758|FG001|Overall Study|Lost to Follow-up|1|||
131626144|NCT02516202|473917759|FG002|Overall Study|Lost to Follow-up|1|||
131626145|NCT02516202|473917757|FG000|Overall Study|Stopped Follow-up|0|||
131626146|NCT02516202|473917758|FG001|Overall Study|Stopped Follow-up|0|||
131626147|NCT02516202|473917759|FG002|Overall Study|Stopped Follow-up|1|||
131626148|NCT00696241|473917760|FG000|Overall Study|Adverse Event|11|||
131626149|NCT00696241|473917761|FG001|Overall Study|Adverse Event|3|||
131626150|NCT00696241|473917762|FG002|Overall Study|Adverse Event|6|||
131626151|NCT00696241|473917763|FG003|Overall Study|Adverse Event|4|||
131626152|NCT00696241|473917764|FG004|Overall Study|Adverse Event|5|||
131626153|NCT00696241|473917760|FG000|Overall Study|Protocol Violation|1|||
131626154|NCT00696241|473917761|FG001|Overall Study|Protocol Violation|1|||
131626155|NCT00696241|473917762|FG002|Overall Study|Protocol Violation|2|||
131626156|NCT00696241|473917763|FG003|Overall Study|Protocol Violation|0|||
131626157|NCT00696241|473917764|FG004|Overall Study|Protocol Violation|3|||
131626158|NCT00696241|473917760|FG000|Overall Study|Lost to Follow-up|1|||
131626159|NCT00696241|473917761|FG001|Overall Study|Lost to Follow-up|4|||
131626160|NCT00696241|473917762|FG002|Overall Study|Lost to Follow-up|1|||
131626161|NCT00696241|473917763|FG003|Overall Study|Lost to Follow-up|2|||
131626162|NCT00696241|473917764|FG004|Overall Study|Lost to Follow-up|0|||
131626163|NCT00696241|473917760|FG000|Overall Study|Withdrawal by Subject|4|||
131712113|NCT02875223|474224148|FG000|Overall Study|Lost to Follow-up|0|||
131712114|NCT02875223|474224149|FG001|Overall Study|Lost to Follow-up|1|||
131626164|NCT00696241|473917761|FG001|Overall Study|Withdrawal by Subject|8|||
131626165|NCT00696241|473917762|FG002|Overall Study|Withdrawal by Subject|6|||
131626166|NCT00696241|473917763|FG003|Overall Study|Withdrawal by Subject|1|||
131626167|NCT00696241|473917764|FG004|Overall Study|Withdrawal by Subject|0|||
131626168|NCT00696241|473917760|FG000|Overall Study|Lack of Efficacy|1|||
131626169|NCT00696241|473917761|FG001|Overall Study|Lack of Efficacy|5|||
131626170|NCT00696241|473917762|FG002|Overall Study|Lack of Efficacy|4|||
131626171|NCT00696241|473917763|FG003|Overall Study|Lack of Efficacy|5|||
131626172|NCT00696241|473917764|FG004|Overall Study|Lack of Efficacy|3|||
131626173|NCT00696241|473917760|FG000|Overall Study|Other|6|||
131626174|NCT00696241|473917761|FG001|Overall Study|Other|1|||
131626175|NCT00696241|473917762|FG002|Overall Study|Other|5|||
131626176|NCT00696241|473917763|FG003|Overall Study|Other|2|||
131626177|NCT00696241|473917764|FG004|Overall Study|Other|1|||
131626178|NCT02203513|473917765|FG000|Overall Study|Refused further treatment|2|||
131712115|NCT02875223|474224150|FG002|Overall Study|Lost to Follow-up|1|||
131712116|NCT02875223|474224151|FG003|Overall Study|Lost to Follow-up|0|||
131712117|NCT02875223|474224152|FG004|Overall Study|Lost to Follow-up|1|||
131712118|NCT02875223|474224153|FG005|Overall Study|Lost to Follow-up|0|||
131712119|NCT02875223|474224154|FG006|Overall Study|Lost to Follow-up|1|||
131712120|NCT02875223|474224155|FG007|Overall Study|Lost to Follow-up|1|||
131712121|NCT02875223|474224156|FG008|Overall Study|Lost to Follow-up|0|||
131712122|NCT02875223|474224157|FG009|Overall Study|Lost to Follow-up|0|||
131712123|NCT02875223|474224158|FG010|Overall Study|Lost to Follow-up|0|||
131712124|NCT02875223|474224159|FG011|Overall Study|Lost to Follow-up|0|||
131712125|NCT02875223|474224160|FG012|Overall Study|Lost to Follow-up|0|||
131712126|NCT00924703|474224163|FG000|Overall Study|Withdrawal by Subject|11|||
131712127|NCT00924703|474224163|FG000|Overall Study|Physician Decision|5|||
131712128|NCT00924703|474224163|FG000|Overall Study|Lost to Follow-up|3|||
131712129|NCT00924703|474224163|FG000|Overall Study|Adverse Event|2|||
131712130|NCT00924703|474224163|FG000|Overall Study|Withdrawal by Sponsor|1|||
131712131|NCT00655928|474224164|FG000|Overall Study|Withdrawal by Subject|2|||
131712132|NCT00655928|474224165|FG001|Overall Study|Withdrawal by Subject|1|||
131712133|NCT00655928|474224164|FG000|Overall Study|Physician Decision|1|||
131712134|NCT00655928|474224165|FG001|Overall Study|Physician Decision|1|||
131712135|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
131712136|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
131712137|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
131712138|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
131712139|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
131712140|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
131712141|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
131712142|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
131712143|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
131712144|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
131712145|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
131712146|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
131712147|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
131712148|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
131712149|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
131712150|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
131712151|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
131626179|NCT02203513|473917766|FG001|Overall Study|Refused further treatment|0|||
131626180|NCT02203513|473917767|FG002|Overall Study|Refused further treatment|1|||
131626181|NCT02203513|473917768|FG003|Overall Study|Refused further treatment|0|||
131626182|NCT02203513|473917769|FG004|Overall Study|Refused further treatment|0|||
131626183|NCT02203513|473917765|FG000|Overall Study|Switched to alternative treatment|3|||
131626184|NCT02203513|473917766|FG001|Overall Study|Switched to alternative treatment|4|||
131626185|NCT02203513|473917767|FG002|Overall Study|Switched to alternative treatment|0|||
131626186|NCT02203513|473917768|FG003|Overall Study|Switched to alternative treatment|0|||
131626187|NCT02203513|473917769|FG004|Overall Study|Switched to alternative treatment|4|||
131626188|NCT02203513|473917765|FG000|Overall Study|Did not receive investigational product (IP)|0|||
131626189|NCT02203513|473917766|FG001|Overall Study|Did not receive investigational product (IP)|1|||
131626190|NCT02203513|473917767|FG002|Overall Study|Did not receive investigational product (IP)|0|||
131626191|NCT02203513|473917768|FG003|Overall Study|Did not receive investigational product (IP)|0|||
131626192|NCT02203513|473917769|FG004|Overall Study|Did not receive investigational product (IP)|0|||
131626193|NCT02203513|473917765|FG000|Overall Study|Death (unrelated to study therapy)|1|||
131626194|NCT02203513|473917766|FG001|Overall Study|Death (unrelated to study therapy)|3|||
131626195|NCT02203513|473917767|FG002|Overall Study|Death (unrelated to study therapy)|1|||
131712152|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
131712153|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
131712154|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131712155|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131712156|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131712157|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131797187|NCT01379781|474541543|FG000|Overall Study|Lost to Follow-up|11|||
131797188|NCT01379781|474541544|FG001|Overall Study|Lost to Follow-up|8|||
131626196|NCT02203513|473917768|FG003|Overall Study|Death (unrelated to study therapy)|0|||
131626197|NCT02203513|473917769|FG004|Overall Study|Death (unrelated to study therapy)|2|||
131626198|NCT02203513|473917765|FG000|Overall Study|Lost to Follow-up|0|||
131626199|NCT02203513|473917766|FG001|Overall Study|Lost to Follow-up|0|||
131626200|NCT02203513|473917767|FG002|Overall Study|Lost to Follow-up|1|||
131626201|NCT02203513|473917768|FG003|Overall Study|Lost to Follow-up|1|||
131626202|NCT02203513|473917769|FG004|Overall Study|Lost to Follow-up|0|||
131626203|NCT00392197|473917770|FG000|Overall Study|Adverse Event|4|||
131626204|NCT00392197|473917771|FG001|Overall Study|Adverse Event|12|||
131626205|NCT00392197|473917770|FG000|Overall Study|Lack of Efficacy|3|||
131626206|NCT00392197|473917771|FG001|Overall Study|Lack of Efficacy|4|||
131626207|NCT00392197|473917770|FG000|Overall Study|Lost to Follow-up|0|||
131626208|NCT00392197|473917771|FG001|Overall Study|Lost to Follow-up|1|||
131626209|NCT00392197|473917770|FG000|Overall Study|Physician Decision|3|||
131626210|NCT00392197|473917771|FG001|Overall Study|Physician Decision|2|||
131626211|NCT00392197|473917770|FG000|Overall Study|Protocol Violation|7|||
131626212|NCT00392197|473917771|FG001|Overall Study|Protocol Violation|5|||
131626213|NCT00392197|473917770|FG000|Overall Study|Withdrawal by Subject|4|||
131626214|NCT00392197|473917771|FG001|Overall Study|Withdrawal by Subject|6|||
131626215|NCT01156675|473917772|FG000|Overall Study|Death|5|||
131626216|NCT01156675|473917773|FG001|Overall Study|Death|3|||
131626217|NCT01156675|473917774|FG002|Overall Study|Death|0|||
131626218|NCT01156675|473917772|FG000|Overall Study|No data|29|||
131626219|NCT01156675|473917773|FG001|Overall Study|No data|22|||
131626220|NCT01156675|473917774|FG002|Overall Study|No data|2|||
131626221|NCT00090519|473917775|FG000|Overall Study|Adverse Event|5|||
131626222|NCT00090519|473917776|FG001|Overall Study|Adverse Event|4|||
131626223|NCT00090519|473917775|FG000|Overall Study|Death|9|||
131626224|NCT00090519|473917776|FG001|Overall Study|Death|9|||
131626225|NCT00090519|473917775|FG000|Overall Study|Lost to Follow-up|26|||
131626226|NCT00090519|473917776|FG001|Overall Study|Lost to Follow-up|29|||
131626227|NCT00090519|473917775|FG000|Overall Study|Withdrawal by Subject|28|||
131626228|NCT00090519|473917776|FG001|Overall Study|Withdrawal by Subject|29|||
131626229|NCT00090519|473917775|FG000|Overall Study|Physician Decision|2|||
131626230|NCT00090519|473917776|FG001|Overall Study|Physician Decision|3|||
131626231|NCT00090519|473917775|FG000|Overall Study|Sponsor Decision|3|||
131626232|NCT00090519|473917776|FG001|Overall Study|Sponsor Decision|1|||
131626233|NCT02161146|473917779|FG000|Overall Study|Adverse Event|1|||
131626234|NCT02161146|473917780|FG001|Overall Study|Adverse Event|1|||
131626235|NCT02161146|473917781|FG002|Overall Study|Adverse Event|0|||
131626236|NCT02161146|473917782|FG003|Overall Study|Adverse Event|1|||
131626237|NCT02161146|473917783|FG004|Overall Study|Adverse Event|0|||
131626238|NCT02161146|473917779|FG000|Overall Study|Lost to Follow-up|0|||
131626239|NCT02161146|473917780|FG001|Overall Study|Lost to Follow-up|1|||
131626240|NCT02161146|473917781|FG002|Overall Study|Lost to Follow-up|0|||
131626241|NCT02161146|473917782|FG003|Overall Study|Lost to Follow-up|0|||
131712158|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131626242|NCT02161146|473917783|FG004|Overall Study|Lost to Follow-up|0|||
131626243|NCT02161146|473917779|FG000|Overall Study|Personal Reasons|0|||
131626244|NCT02161146|473917780|FG001|Overall Study|Personal Reasons|1|||
131626245|NCT02161146|473917781|FG002|Overall Study|Personal Reasons|0|||
131626246|NCT02161146|473917782|FG003|Overall Study|Personal Reasons|2|||
131626247|NCT02161146|473917783|FG004|Overall Study|Personal Reasons|1|||
131626248|NCT02161146|473917779|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131626249|NCT02161146|473917780|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131626250|NCT02161146|473917781|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131626251|NCT02161146|473917782|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131626252|NCT02161146|473917783|FG004|Overall Study|Other Miscellaneous Reasons|0|||
131626253|NCT00800176|473917790|FG000|Overall Study|Adverse Event|2|||
131626254|NCT00800176|473917791|FG001|Overall Study|Adverse Event|1|||
131626255|NCT00800176|473917792|FG002|Overall Study|Adverse Event|0|||
131712159|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
131712160|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
131712161|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
131712162|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
131712163|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
131712164|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
131712165|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
131712166|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
131712167|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
131712168|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
131712169|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
131797189|NCT01644890|474541545|FG000|Overall Study|Adverse Event|7|||
131797190|NCT01644890|474541546|FG001|Overall Study|Adverse Event|20|||
131797191|NCT01644890|474541545|FG000|Overall Study|Death|1|||
131797192|NCT01644890|474541546|FG001|Overall Study|Death|3|||
131797193|NCT01644890|474541545|FG000|Overall Study|Physician Decision|3|||
131797194|NCT01644890|474541546|FG001|Overall Study|Physician Decision|9|||
131797195|NCT01644890|474541545|FG000|Overall Study|Protocol Violation|6|||
131797196|NCT01644890|474541546|FG001|Overall Study|Protocol Violation|7|||
131797197|NCT01644890|474541545|FG000|Overall Study|Withdrawal by Subject|19|||
131626256|NCT00800176|473917793|FG003|Overall Study|Adverse Event|2|||
131626257|NCT00800176|473917794|FG004|Overall Study|Adverse Event|1|||
131626258|NCT00800176|473917795|FG005|Overall Study|Adverse Event|1|||
131626259|NCT00800176|473917790|FG000|Overall Study|Refused treatment|3|||
131626260|NCT00800176|473917791|FG001|Overall Study|Refused treatment|2|||
131626261|NCT00800176|473917792|FG002|Overall Study|Refused treatment|0|||
131626262|NCT00800176|473917793|FG003|Overall Study|Refused treatment|0|||
131626263|NCT00800176|473917794|FG004|Overall Study|Refused treatment|1|||
131626264|NCT00800176|473917795|FG005|Overall Study|Refused treatment|4|||
131626265|NCT00800176|473917790|FG000|Overall Study|Failure to return|3|||
131626266|NCT00800176|473917791|FG001|Overall Study|Failure to return|3|||
131626267|NCT00800176|473917792|FG002|Overall Study|Failure to return|0|||
131626268|NCT00800176|473917793|FG003|Overall Study|Failure to return|2|||
131626269|NCT00800176|473917794|FG004|Overall Study|Failure to return|0|||
131797198|NCT01644890|474541546|FG001|Overall Study|Withdrawal by Subject|27|||
131797199|NCT01644890|474541545|FG000|Overall Study|Progression Disease|160|||
131797200|NCT01644890|474541546|FG001|Overall Study|Progression Disease|131|||
131797201|NCT01644890|474541545|FG000|Overall Study|Clinical Progression|6|||
131797202|NCT01644890|474541546|FG001|Overall Study|Clinical Progression|6|||
131797203|NCT01644890|474541545|FG000|Overall Study|> 28 days since last dose of study drug|6|||
131797204|NCT01644890|474541546|FG001|Overall Study|> 28 days since last dose of study drug|3|||
131797205|NCT01644890|474541545|FG000|Overall Study|Other|8|||
131797206|NCT01644890|474541546|FG001|Overall Study|Other|9|||
131797207|NCT00313703|474541547|FG000|Overall Study|Lost to Follow-up|11|||
131626270|NCT00800176|473917795|FG005|Overall Study|Failure to return|0|||
131626271|NCT00800176|473917790|FG000|Overall Study|Other|1|||
131626272|NCT00800176|473917791|FG001|Overall Study|Other|0|||
131626273|NCT00800176|473917792|FG002|Overall Study|Other|0|||
131626274|NCT00800176|473917793|FG003|Overall Study|Other|0|||
131626275|NCT00800176|473917794|FG004|Overall Study|Other|2|||
131626276|NCT00800176|473917795|FG005|Overall Study|Other|0|||
131626277|NCT02612285|473917803|FG000|Overall Study|Withdrawal by Subject|1|||
131626278|NCT02548585|473917804|FG000|Overall Study|Withdrawal by Subject|0|||
131626279|NCT02548585|473917805|FG001|Overall Study|Withdrawal by Subject|0|||
131626280|NCT02548585|473917806|FG002|Overall Study|Withdrawal by Subject|0|||
131626281|NCT02548585|473917807|FG003|Overall Study|Withdrawal by Subject|0|||
131626282|NCT02548585|473917808|FG004|Overall Study|Withdrawal by Subject|0|||
131626283|NCT02548585|473917809|FG005|Overall Study|Withdrawal by Subject|1|||
131626284|NCT02548585|473917810|FG006|Overall Study|Withdrawal by Subject|0|||
131626285|NCT02548585|473917804|FG000|Overall Study|Lost to Follow-up|1|||
131626286|NCT02548585|473917805|FG001|Overall Study|Lost to Follow-up|0|||
131626287|NCT02548585|473917806|FG002|Overall Study|Lost to Follow-up|0|||
131626288|NCT02548585|473917807|FG003|Overall Study|Lost to Follow-up|0|||
131626289|NCT02548585|473917808|FG004|Overall Study|Lost to Follow-up|0|||
131626290|NCT02548585|473917809|FG005|Overall Study|Lost to Follow-up|0|||
131626291|NCT02548585|473917810|FG006|Overall Study|Lost to Follow-up|0|||
131626292|NCT02548585|473917804|FG000|Overall Study|Other|1|||
131626293|NCT02548585|473917805|FG001|Overall Study|Other|0|||
131626294|NCT02548585|473917806|FG002|Overall Study|Other|0|||
131626295|NCT02548585|473917807|FG003|Overall Study|Other|2|||
131626296|NCT02548585|473917808|FG004|Overall Study|Other|3|||
131626297|NCT02548585|473917809|FG005|Overall Study|Other|0|||
131626298|NCT02548585|473917810|FG006|Overall Study|Other|1|||
131626299|NCT02548585|473917804|FG000|Overall Study|Randomized but not treated|0|||
131626300|NCT02548585|473917805|FG001|Overall Study|Randomized but not treated|0|||
131626301|NCT02548585|473917806|FG002|Overall Study|Randomized but not treated|0|||
131626302|NCT02548585|473917807|FG003|Overall Study|Randomized but not treated|0|||
131626303|NCT02548585|473917808|FG004|Overall Study|Randomized but not treated|0|||
131626304|NCT02548585|473917809|FG005|Overall Study|Randomized but not treated|1|||
131626305|NCT02548585|473917810|FG006|Overall Study|Randomized but not treated|0|||
131626306|NCT01986348|473917811|FG000|Overall Study|Death|8|||
131626307|NCT01986348|473917812|FG001|Overall Study|Death|22|||
131626308|NCT01986348|473917813|FG002|Overall Study|Death|10|||
131797208|NCT00313703|474541548|FG001|Overall Study|Lost to Follow-up|2|||
131797209|NCT00313703|474541549|FG002|Overall Study|Lost to Follow-up|5|||
131797210|NCT00313703|474541550|FG003|Overall Study|Lost to Follow-up|12|||
131797211|NCT04849988|474541555|FG000|Overall Study|Lack of Efficacy|3|||
131797212|NCT04849988|474541556|FG001|Overall Study|Lack of Efficacy|4|||
131797213|NCT04849988|474541557|FG002|Overall Study|Lack of Efficacy|1|||
131626309|NCT01986348|473917814|FG003|Overall Study|Death|21|||
131626310|NCT01986348|473917811|FG000|Overall Study|Lost to Follow-up|0|||
131797214|NCT04849988|474541558|FG003|Overall Study|Lack of Efficacy|4|||
131626311|NCT01986348|473917812|FG001|Overall Study|Lost to Follow-up|0|||
131626312|NCT01986348|473917813|FG002|Overall Study|Lost to Follow-up|0|||
131626313|NCT01986348|473917814|FG003|Overall Study|Lost to Follow-up|2|||
131626314|NCT01986348|473917811|FG000|Overall Study|Physician Decision|0|||
131626315|NCT01986348|473917812|FG001|Overall Study|Physician Decision|0|||
131626316|NCT01986348|473917813|FG002|Overall Study|Physician Decision|0|||
131444087|NCT05138653|473255031|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444088|NCT05138653|473255032|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444089|NCT05138653|473255033|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
131444090|NCT05138653|473255034|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444091|NCT05138653|473255035|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
131444092|NCT05138653|473255036|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444093|NCT05138653|473255037|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
131444094|NCT05138653|473255038|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
131444095|NCT05138653|473255023|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444096|NCT05138653|473255024|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444097|NCT05138653|473255025|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444098|NCT05138653|473255026|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444099|NCT05138653|473255027|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444100|NCT05138653|473255028|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444101|NCT05138653|473255029|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444102|NCT05138653|473255030|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444103|NCT05138653|473255031|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444104|NCT05138653|473255032|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444105|NCT05138653|473255033|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131626317|NCT01986348|473917814|FG003|Overall Study|Physician Decision|1|||
131626318|NCT01986348|473917811|FG000|Overall Study|Progressive Disease|0|||
131444106|NCT05138653|473255034|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444107|NCT05138653|473255035|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131626319|NCT01986348|473917812|FG001|Overall Study|Progressive Disease|0|||
131626320|NCT01986348|473917813|FG002|Overall Study|Progressive Disease|2|||
131797215|NCT04849988|474541555|FG000|Overall Study|Other reasons|1|||
131444108|NCT05138653|473255036|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444109|NCT05138653|473255037|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
131444110|NCT05138653|473255038|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
131444111|NCT05138653|473255023|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444112|NCT05138653|473255024|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444113|NCT05138653|473255025|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444114|NCT05138653|473255026|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444115|NCT05138653|473255027|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444116|NCT05138653|473255028|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444117|NCT05138653|473255029|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444118|NCT05138653|473255030|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444119|NCT05138653|473255031|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444120|NCT05138653|473255032|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444121|NCT05138653|473255033|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444122|NCT05138653|473255034|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444123|NCT05138653|473255035|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444124|NCT05138653|473255036|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
131444125|NCT05138653|473255037|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444126|NCT05138653|473255038|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
131444127|NCT01824836|473255039|FG000|Overall Study|Adverse Event|48|||
131444128|NCT01824836|473255039|FG000|Overall Study|Withdrawal by Subject|63|||
131444129|NCT01824836|473255039|FG000|Overall Study|Other complicating disease|116|||
131444130|NCT01824836|473255039|FG000|Overall Study|Disease progression|5|||
131444131|NCT01824836|473255039|FG000|Overall Study|Alternative therapy|2|||
131444132|NCT01824836|473255039|FG000|Overall Study|Depression|1|||
131444133|NCT01824836|473255039|FG000|Overall Study|Non-compliance|3|||
131444134|NCT01824836|473255039|FG000|Overall Study|Patient regained ovarian function|3|||
131444135|NCT01824836|473255039|FG000|Overall Study|Lost to Follow-up|8|||
131444136|NCT01824836|473255039|FG000|Overall Study|Physician Decision|2|||
131444137|NCT01824836|473255039|FG000|Overall Study|Research office was closed|3|||
131444138|NCT01824836|473255039|FG000|Overall Study|Relocation|3|||
131444139|NCT01824836|473255039|FG000|Overall Study|Insurance-related issue|1|||
131626321|NCT01986348|473917814|FG003|Overall Study|Progressive Disease|0|||
131626322|NCT01986348|473917811|FG000|Overall Study|Withdrawal by Participant|0|||
131626323|NCT01986348|473917812|FG001|Overall Study|Withdrawal by Participant|1|||
131626324|NCT01986348|473917813|FG002|Overall Study|Withdrawal by Participant|2|||
131626325|NCT01986348|473917814|FG003|Overall Study|Withdrawal by Participant|1|||
131626326|NCT01986348|473917811|FG000|Overall Study|Study Terminated by Sponsor|0|||
131797216|NCT04849988|474541556|FG001|Overall Study|Other reasons|2|||
131797217|NCT04849988|474541557|FG002|Overall Study|Other reasons|2|||
131797218|NCT04849988|474541558|FG003|Overall Study|Other reasons|1|||
131626327|NCT01986348|473917812|FG001|Overall Study|Study Terminated by Sponsor|0|||
131626328|NCT01986348|473917813|FG002|Overall Study|Study Terminated by Sponsor|0|||
131626329|NCT01986348|473917814|FG003|Overall Study|Study Terminated by Sponsor|3|||
131626330|NCT01986348|473917811|FG000|Overall Study|Other-unspecified|0|||
131626331|NCT01986348|473917812|FG001|Overall Study|Other-unspecified|1|||
131626332|NCT01986348|473917813|FG002|Overall Study|Other-unspecified|0|||
131626333|NCT01986348|473917814|FG003|Overall Study|Other-unspecified|2|||
131626334|NCT00805441|473917815|FG000|Overall Study|Adverse Event|5|||
131626335|NCT00805441|473917816|FG001|Overall Study|Adverse Event|2|||
131626336|NCT00805441|473917815|FG000|Overall Study|Lack of Efficacy|0|||
131626337|NCT00805441|473917816|FG001|Overall Study|Lack of Efficacy|2|||
131626338|NCT00805441|473917815|FG000|Overall Study|Protocol Violation|4|||
131626339|NCT00805441|473917816|FG001|Overall Study|Protocol Violation|8|||
131626340|NCT00805441|473917815|FG000|Overall Study|Lost to Follow-up|10|||
131626341|NCT00805441|473917816|FG001|Overall Study|Lost to Follow-up|13|||
131626342|NCT00805441|473917815|FG000|Overall Study|Withdrawal by Subject|15|||
131626343|NCT00805441|473917816|FG001|Overall Study|Withdrawal by Subject|9|||
131626344|NCT00805441|473917815|FG000|Overall Study|Physician Decision|0|||
131626345|NCT00805441|473917816|FG001|Overall Study|Physician Decision|1|||
131626346|NCT00805441|473917815|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
131626347|NCT00805441|473917816|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
131626348|NCT02935894|473917817|FG000|Overall Study|Subject dismissed|1|||
131626349|NCT03242863|473917820|FG000|Study Week 1|Withdrawal by Subject|0|||
131626350|NCT03242863|473917821|FG001|Study Week 1|Withdrawal by Subject|1|||
131626351|NCT03242863|473917822|FG002|Study Week 1|Withdrawal by Subject|0|||
131626352|NCT03242863|473917823|FG003|Study Week 1|Withdrawal by Subject|0|||
131626353|NCT03242863|473917824|FG004|Study Week 1|Withdrawal by Subject|3|||
131626354|NCT03242863|473917825|FG005|Study Week 1|Withdrawal by Subject|0|||
131626355|NCT04919499|473917829|FG000|Overall Study|Adverse Event|0|||
131797219|NCT00101582|474541561|FG000|Overall Study|Ineligibility determined|0|||
131797220|NCT00101582|474541562|FG001|Overall Study|Ineligibility determined|1|||
131797221|NCT00101582|474541561|FG000|Overall Study|Adverse Event|1|||
131797222|NCT00101582|474541562|FG001|Overall Study|Adverse Event|4|||
131797223|NCT00101582|474541561|FG000|Overall Study|Withdrawal by Subject|6|||
131797224|NCT00101582|474541562|FG001|Overall Study|Withdrawal by Subject|4|||
131797225|NCT00101582|474541561|FG000|Overall Study|Physician Decision|1|||
131797226|NCT00101582|474541562|FG001|Overall Study|Physician Decision|0|||
131797227|NCT00101582|474541561|FG000|Overall Study|Death|3|||
131797228|NCT00101582|474541562|FG001|Overall Study|Death|5|||
131797229|NCT00101582|474541561|FG000|Overall Study|Other|0|||
131797230|NCT00101582|474541562|FG001|Overall Study|Other|1|||
131797231|NCT00056160|474541563|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
131797232|NCT00056160|474541564|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
131797233|NCT00056160|474541563|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
131797234|NCT00056160|474541564|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
131797235|NCT00056160|474541563|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
131797236|NCT00056160|474541564|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
131797237|NCT00056160|474541563|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
131797238|NCT00056160|474541564|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
131797239|NCT00056160|474541563|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
131797240|NCT00056160|474541564|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
131797241|NCT00056160|474541563|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
131797242|NCT00056160|474541564|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
131797243|NCT00056160|474541563|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
131797244|NCT00056160|474541564|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
131797245|NCT00056160|474541563|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
131797246|NCT00056160|474541564|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
131797247|NCT00056160|474541563|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
131797248|NCT00056160|474541564|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
131797249|NCT00056160|474541563|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
131797250|NCT00056160|474541564|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
131797251|NCT00056160|474541563|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
131797252|NCT00056160|474541564|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
131797253|NCT00056160|474541563|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
131797254|NCT00056160|474541564|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
131626356|NCT04919499|473917830|FG001|Overall Study|Adverse Event|0|||
131626357|NCT04919499|473917831|FG002|Overall Study|Adverse Event|0|||
131626358|NCT04919499|473917832|FG003|Overall Study|Adverse Event|0|||
131626359|NCT04919499|473917833|FG004|Overall Study|Adverse Event|2|||
131626360|NCT04919499|473917829|FG000|Overall Study|Not treated|0|||
131626361|NCT04919499|473917830|FG001|Overall Study|Not treated|0|||
131626362|NCT04919499|473917831|FG002|Overall Study|Not treated|0|||
131626363|NCT04919499|473917832|FG003|Overall Study|Not treated|1|||
131626364|NCT04919499|473917833|FG004|Overall Study|Not treated|0|||
131626365|NCT04369664|473919403|FG000|Overall Study|Physician Decision|1|||
131797255|NCT00056160|474541563|FG000|Final Follow-up|Transferred into expanded access study.|3|||
131626366|NCT04369664|473919404|FG001|Overall Study|Physician Decision|0|||
131626367|NCT03840200|473919405|FG000|Overall Study|Death|6|||
131626368|NCT03840200|473919406|FG001|Overall Study|Death|3|||
131626369|NCT03840200|473919407|FG002|Overall Study|Death|6|||
131626370|NCT03840200|473919408|FG003|Overall Study|Death|10|||
131626371|NCT03840200|473919405|FG000|Overall Study|Reason Not Specified|2|||
131626372|NCT03840200|473919406|FG001|Overall Study|Reason Not Specified|2|||
131626373|NCT03840200|473919407|FG002|Overall Study|Reason Not Specified|1|||
131444140|NCT01824836|473255039|FG000|Overall Study|Transportation issue|1|||
131444141|NCT01824836|473255039|FG000|Overall Study|Patient transferred care|1|||
131444142|NCT01824836|473255039|FG000|Overall Study|Unknown reasons|4|||
131444143|NCT01824836|473255039|FG000|Overall Study|Never started treatment|16|||
131444144|NCT03204188|473255044|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
131444145|NCT03204188|473255044|FG000|Immunotherapy Phase (1 Year)|Death|1|||
131444146|NCT03204188|473255044|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
131444147|NCT03204188|473255044|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
131444148|NCT02608684|473257060|FG000|Overall Study|Physician Decision|2|||
131444149|NCT02608684|473257060|FG000|Overall Study|Withdrawal by Subject|1|||
131444150|NCT01972217|473257061|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
131444151|NCT01972217|473257062|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
131444152|NCT01972217|473257063|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
131444153|NCT01972217|473257064|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
131444154|NCT01972217|473257061|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
131444155|NCT01972217|473257062|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
131444156|NCT01972217|473257063|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
131444157|NCT01972217|473257064|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
131444158|NCT01972217|473257061|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
131444159|NCT01972217|473257062|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
131444160|NCT01972217|473257063|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
131444161|NCT01972217|473257064|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
131626374|NCT03840200|473919408|FG003|Overall Study|Reason Not Specified|15|||
131626375|NCT03840200|473919405|FG000|Overall Study|Physician Decision|0|||
131626376|NCT03840200|473919406|FG001|Overall Study|Physician Decision|0|||
131626377|NCT03840200|473919407|FG002|Overall Study|Physician Decision|0|||
131626378|NCT03840200|473919408|FG003|Overall Study|Physician Decision|2|||
131626379|NCT03840200|473919405|FG000|Overall Study|Progressive Disease|0|||
131626380|NCT03840200|473919406|FG001|Overall Study|Progressive Disease|0|||
131626381|NCT03840200|473919407|FG002|Overall Study|Progressive Disease|0|||
131626382|NCT03840200|473919408|FG003|Overall Study|Progressive Disease|1|||
131626383|NCT03840200|473919405|FG000|Overall Study|Withdrawal by Subject|0|||
131626384|NCT03840200|473919406|FG001|Overall Study|Withdrawal by Subject|1|||
131626385|NCT03840200|473919407|FG002|Overall Study|Withdrawal by Subject|0|||
131626386|NCT03840200|473919408|FG003|Overall Study|Withdrawal by Subject|2|||
131626387|NCT05522777|473919411|FG000|Overall Study|Lack of Efficacy|1|||
131626388|NCT05522777|473919411|FG000|Overall Study|Withdrawal by Subject|1|||
131626389|NCT05487300|473919414|FG000|Overall Study|Withdrawal by Subject|1|||
131626390|NCT05487300|473919415|FG001|Overall Study|Withdrawal by Subject|0|||
131626391|NCT05006703|473919416|FG000|Overall Study|Withdrawal by Subject|1|||
131626392|NCT05006703|473919417|FG001|Overall Study|Withdrawal by Subject|0|||
131626393|NCT05006703|473919416|FG000|Overall Study|Lost to Follow-up|13|||
131626394|NCT05006703|473919417|FG001|Overall Study|Lost to Follow-up|5|||
131626395|NCT00264576|473919421|FG000|Overall Study|Lost to Follow-up|1|||
131797256|NCT00056160|474541564|FG001|Final Follow-up|Transferred into expanded access study.|0|||
131797257|NCT00056160|474541563|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
131901634|NCT03934216|474925126|FG000|Overall Study|Lost to Follow-up|2|||
131626396|NCT00264576|473919422|FG001|Overall Study|Lost to Follow-up|1|||
131626397|NCT02659059|473919425|FG000|Overall Study|Other reasons|6|||
131626398|NCT02659059|473919426|FG001|Overall Study|Other reasons|1|||
131626399|NCT02659059|473919425|FG000|Overall Study|Disease Progression|143|||
131626400|NCT02659059|473919426|FG001|Overall Study|Disease Progression|16|||
131626401|NCT02659059|473919425|FG000|Overall Study|Study Drug toxicity|56|||
131626402|NCT02659059|473919426|FG001|Overall Study|Study Drug toxicity|9|||
131712170|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
131712171|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
131712172|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
131712173|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
131712174|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
131901635|NCT03934216|474925127|FG001|Overall Study|Lost to Follow-up|0|||
131901636|NCT03934216|474925126|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131901637|NCT03934216|474925127|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131901638|NCT03934216|474925126|FG000|Overall Study|Pregnancy|1|||
131901639|NCT03934216|474925127|FG001|Overall Study|Pregnancy|0|||
131901640|NCT03934216|474925126|FG000|Overall Study|Withdrawal by Subject|18|||
131901641|NCT03934216|474925127|FG001|Overall Study|Withdrawal by Subject|6|||
131901642|NCT03934216|474925126|FG000|Overall Study|Randomized but not treated|1|||
131901643|NCT03934216|474925127|FG001|Overall Study|Randomized but not treated|1|||
131901644|NCT02806713|474925130|FG000|Overall Study|Urethral injury during procedure|1|||
131901645|NCT02806713|474925131|FG001|Overall Study|Urethral injury during procedure|0|||
131901646|NCT02806713|474925130|FG000|Overall Study|cancelled surgery|1|||
131901647|NCT02806713|474925131|FG001|Overall Study|cancelled surgery|2|||
131901648|NCT01165307|474925132|FG000|Overall Study|Lost to Follow-up|11|||
131901649|NCT01165307|474925133|FG001|Overall Study|Lost to Follow-up|3|||
131901650|NCT01165307|474925132|FG000|Overall Study|Withdrawal by Subject|2|||
131626403|NCT02659059|473919425|FG000|Overall Study|Death|3|||
131626404|NCT02659059|473919426|FG001|Overall Study|Death|1|||
131626405|NCT02659059|473919425|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
131626406|NCT02659059|473919426|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
131626407|NCT02659059|473919425|FG000|Overall Study|Participant request to discontinue study treatment|5|||
131626408|NCT02659059|473919426|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131626409|NCT02659059|473919425|FG000|Overall Study|Participant withdrew consent|6|||
131626410|NCT02659059|473919426|FG001|Overall Study|Participant withdrew consent|1|||
131626411|NCT03976102|473919429|FG000|Overall Study|Withdrawal by Subject|4|||
131626412|NCT03976102|473919430|FG001|Overall Study|Withdrawal by Subject|4|||
131712175|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
131712176|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
131626413|NCT03976102|473919429|FG000|Overall Study|Adverse Event|2|||
131626414|NCT03976102|473919430|FG001|Overall Study|Adverse Event|4|||
131626415|NCT03976102|473919429|FG000|Overall Study|Not related to Covid-19|9|||
131626416|NCT03976102|473919430|FG001|Overall Study|Not related to Covid-19|13|||
131626417|NCT03976102|473919429|FG000|Overall Study|Lost to Follow-up|0|||
131626418|NCT03976102|473919430|FG001|Overall Study|Lost to Follow-up|2|||
131626419|NCT03976102|473919429|FG000|Overall Study|Death|3|||
131626420|NCT03976102|473919430|FG001|Overall Study|Death|2|||
131626421|NCT03976102|473919429|FG000|Overall Study|Physician Decision|1|||
131626422|NCT03976102|473919430|FG001|Overall Study|Physician Decision|1|||
131626423|NCT00092456|473919433|FG000|Overall Study|Adverse Event|0|||
131626424|NCT00092456|473919434|FG001|Overall Study|Adverse Event|0|||
131626425|NCT00092456|473919435|FG002|Overall Study|Adverse Event|1|||
131626426|NCT00092456|473919436|FG003|Overall Study|Adverse Event|1|||
131626427|NCT00092456|473919433|FG000|Overall Study|Lost to Follow-up|2|||
131626428|NCT00092456|473919434|FG001|Overall Study|Lost to Follow-up|2|||
131626429|NCT00092456|473919435|FG002|Overall Study|Lost to Follow-up|1|||
131626430|NCT00092456|473919436|FG003|Overall Study|Lost to Follow-up|2|||
131626431|NCT00092456|473919433|FG000|Overall Study|Protocol Violation|5|||
131626432|NCT00092456|473919434|FG001|Overall Study|Protocol Violation|7|||
131626433|NCT00092456|473919435|FG002|Overall Study|Protocol Violation|8|||
131626434|NCT00092456|473919436|FG003|Overall Study|Protocol Violation|6|||
131626435|NCT00092456|473919433|FG000|Overall Study|Withdrawal by Subject|13|||
131626436|NCT00092456|473919434|FG001|Overall Study|Withdrawal by Subject|5|||
131712177|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
131712178|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
131712179|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
131712180|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
131712181|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
131712182|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
131712183|NCT01707992|474224166|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
131712184|NCT01707992|474224167|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
131712185|NCT01707992|474224168|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
131712186|NCT01707992|474224169|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
131712187|NCT01707992|474224170|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
131712188|NCT01707992|474224171|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
131712189|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
131712190|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
131901651|NCT01165307|474925133|FG001|Overall Study|Withdrawal by Subject|0|||
131444162|NCT01972217|473257061|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
131626437|NCT00092456|473919435|FG002|Overall Study|Withdrawal by Subject|16|||
131626438|NCT00092456|473919436|FG003|Overall Study|Withdrawal by Subject|6|||
131626439|NCT00092456|473919433|FG000|Overall Study|Moved|1|||
131626440|NCT00092456|473919434|FG001|Overall Study|Moved|1|||
131626441|NCT00092456|473919435|FG002|Overall Study|Moved|0|||
131626442|NCT00092456|473919436|FG003|Overall Study|Moved|1|||
131626443|NCT00092456|473919433|FG000|Overall Study|Other|4|||
131626444|NCT00092456|473919434|FG001|Overall Study|Other|2|||
131626445|NCT00092456|473919435|FG002|Overall Study|Other|3|||
131626446|NCT00092456|473919436|FG003|Overall Study|Other|0|||
131626447|NCT04783389|473919437|FG000|Overall Study|Withdrawal by Subject|2|||
131626448|NCT04783389|473919438|FG001|Overall Study|Withdrawal by Subject|0|||
131626449|NCT04783389|473919439|FG002|Overall Study|Withdrawal by Subject|0|||
131626450|NCT04783389|473919437|FG000|Overall Study|Termination of Study by Sponsor|10|||
131626451|NCT04783389|473919438|FG001|Overall Study|Termination of Study by Sponsor|12|||
131626452|NCT04783389|473919439|FG002|Overall Study|Termination of Study by Sponsor|14|||
131626453|NCT02121808|473919440|FG000|Overall Study|Technical problem|3|||
131626454|NCT03924193|473919441|FG000|Overall Study|Adverse Event|10|||
131626455|NCT03924193|473919442|FG001|Overall Study|Adverse Event|0|||
131626456|NCT03924193|473919443|FG002|Overall Study|Adverse Event|10|||
131626457|NCT03924193|473919441|FG000|Overall Study|Withdrawal by Subject|5|||
131626458|NCT03924193|473919442|FG001|Overall Study|Withdrawal by Subject|10|||
131626459|NCT03924193|473919443|FG002|Overall Study|Withdrawal by Subject|2|||
131626460|NCT02489799|473919444|FG000|Overall Study|Lost to Follow-up|4|||
131626461|NCT02489799|473919445|FG001|Overall Study|Lost to Follow-up|1|||
131626462|NCT02489799|473919444|FG000|Overall Study|Failure to Maintain Eligibility|4|||
131626463|NCT02489799|473919445|FG001|Overall Study|Failure to Maintain Eligibility|6|||
131626464|NCT02489799|473919444|FG000|Overall Study|Withdrawal by Subject|1|||
131626465|NCT02489799|473919445|FG001|Overall Study|Withdrawal by Subject|1|||
131626466|NCT02489799|473919444|FG000|Overall Study|Death|0|||
131444163|NCT01972217|473257062|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
131444164|NCT01972217|473257063|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
131626467|NCT02489799|473919445|FG001|Overall Study|Death|1|||
131626468|NCT04909593|473919446|FG000|Overall Study|Withdrawal by Subject|1|||
131626469|NCT01241448|473919447|FG000|Overall Study|Adverse Event|1|||
131901652|NCT01165307|474925132|FG000|Overall Study|Subject not available for contact|1|||
131901653|NCT01165307|474925133|FG001|Overall Study|Subject not available for contact|0|||
131901654|NCT02163395|474925136|FG000|Overall Study|Withdrawal by Subject|1|||
131901655|NCT02163395|474925136|FG000|Overall Study|Lost to Follow-up|3|||
131901656|NCT02163395|474925136|FG000|Overall Study|Adverse Event|1|||
131901657|NCT03627832|474925138|FG000|Overall Study|Withdrawal by Subject|10|||
131901658|NCT03627832|474925139|FG001|Overall Study|Withdrawal by Subject|1|||
131901659|NCT03150082|474925140|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
131901660|NCT03150082|474925141|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
131901661|NCT04547140|474925142|FG000|Overall Study|Adverse Event|0|||
131901662|NCT04547140|474925143|FG001|Overall Study|Adverse Event|1|||
131901663|NCT04547140|474925142|FG000|Overall Study|Withdrawal by Subject|0|||
131901664|NCT04547140|474925143|FG001|Overall Study|Withdrawal by Subject|1|||
131901665|NCT04547140|474925142|FG000|Overall Study|Lost to Follow-up|3|||
131901666|NCT04547140|474925143|FG001|Overall Study|Lost to Follow-up|1|||
131901667|NCT04547140|474925142|FG000|Overall Study|Death|2|||
131901668|NCT04547140|474925143|FG001|Overall Study|Death|1|||
131901669|NCT04547140|474925142|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
131901670|NCT04547140|474925143|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
131901671|NCT04547140|474925142|FG000|Overall Study|Pregnancy|1|||
131901672|NCT04547140|474925143|FG001|Overall Study|Pregnancy|0|||
131901673|NCT04547140|474925142|FG000|Overall Study|Reason Not Specified|4|||
131901674|NCT04547140|474925143|FG001|Overall Study|Reason Not Specified|1|||
131901675|NCT00321906|474925153|FG000|Overall Study|Adverse Event|36|||
131901676|NCT00321906|474925154|FG001|Overall Study|Adverse Event|44|||
131901677|NCT00321906|474925153|FG000|Overall Study|Death|9|||
131901678|NCT00321906|474925154|FG001|Overall Study|Death|6|||
131901679|NCT00321906|474925153|FG000|Overall Study|Lost to Follow-up|1|||
131901680|NCT00321906|474925154|FG001|Overall Study|Lost to Follow-up|2|||
131901681|NCT00321906|474925153|FG000|Overall Study|Withdrawal by Subject|0|||
131901682|NCT00321906|474925154|FG001|Overall Study|Withdrawal by Subject|4|||
131901683|NCT03113968|474925157|FG000|Overall Study|Withdrawal by Subject|31|||
131901684|NCT03113968|474925158|FG001|Overall Study|Withdrawal by Subject|4|||
131901685|NCT04805671|474925161|FG000|Overall Study|Death|2|||
131901686|NCT04805671|474925162|FG001|Overall Study|Death|7|||
131901687|NCT04805671|474925161|FG000|Overall Study|Lost to Follow-up|1|||
131901688|NCT04805671|474925162|FG001|Overall Study|Lost to Follow-up|0|||
131901689|NCT04805671|474925161|FG000|Overall Study|Withdrawal by Subject|9|||
131901690|NCT04805671|474925162|FG001|Overall Study|Withdrawal by Subject|7|||
131901691|NCT04805671|474925161|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
131901692|NCT04805671|474925162|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
131901693|NCT02111174|474925167|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
131901694|NCT02111174|474925168|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
131901695|NCT02111174|474925167|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
131901696|NCT02111174|474925168|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
131901697|NCT02111174|474925167|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
131901698|NCT02111174|474925168|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
131901699|NCT02111174|474925167|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
131901700|NCT02111174|474925168|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
131901701|NCT01657162|474925169|FG000|Overall Study|Adverse Event|26|||
131901702|NCT01657162|474925170|FG001|Overall Study|Adverse Event|36|||
131901703|NCT01657162|474925169|FG000|Overall Study|Withdrawal by Subject|13|||
131901704|NCT01657162|474925170|FG001|Overall Study|Withdrawal by Subject|13|||
131901705|NCT01657162|474925169|FG000|Overall Study|Continuing Significant Deterioration|9|||
131901706|NCT01657162|474925170|FG001|Overall Study|Continuing Significant Deterioration|3|||
131901707|NCT01657162|474925169|FG000|Overall Study|Refusal of Treatment|4|||
131901708|NCT01657162|474925170|FG001|Overall Study|Refusal of Treatment|6|||
131901709|NCT01657162|474925169|FG000|Overall Study|Lost to Follow-up|3|||
131901710|NCT01657162|474925170|FG001|Overall Study|Lost to Follow-up|4|||
131901711|NCT01657162|474925169|FG000|Overall Study|Death|2|||
131901712|NCT01657162|474925170|FG001|Overall Study|Death|3|||
131901713|NCT01657162|474925169|FG000|Overall Study|Inability to Complete Study Procedures|1|||
131901714|NCT01657162|474925170|FG001|Overall Study|Inability to Complete Study Procedures|7|||
131901715|NCT01657162|474925169|FG000|Overall Study|Protocol Violation|1|||
131901716|NCT01657162|474925170|FG001|Overall Study|Protocol Violation|0|||
131901717|NCT01657162|474925169|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
131626470|NCT01241448|473919448|FG001|Overall Study|Adverse Event|0|||
131901718|NCT01657162|474925170|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
131901719|NCT01657162|474925169|FG000|Overall Study|Other than Specified|0|||
131901720|NCT01657162|474925170|FG001|Overall Study|Other than Specified|2|||
131901721|NCT00901342|474925171|FG000|Overall Study|Adverse Event|1|||
131901722|NCT00901342|474925171|FG000|Overall Study|Death|4|||
131901723|NCT00901342|474925171|FG000|Overall Study|Disease progression|1|||
131901724|NCT00901342|474925171|FG000|Overall Study|Withdrawal by Subject|9|||
131626471|NCT01241448|473919449|FG002|Overall Study|Adverse Event|2|||
131626472|NCT01241448|473919450|FG003|Overall Study|Adverse Event|2|||
131626473|NCT01241448|473919447|FG000|Overall Study|Lost to Follow-up|2|||
131626474|NCT01241448|473919448|FG001|Overall Study|Lost to Follow-up|1|||
131626475|NCT01241448|473919449|FG002|Overall Study|Lost to Follow-up|1|||
131626476|NCT01241448|473919450|FG003|Overall Study|Lost to Follow-up|1|||
131626477|NCT01241448|473919447|FG000|Overall Study|Physician Decision|0|||
131626478|NCT01241448|473919448|FG001|Overall Study|Physician Decision|2|||
131626479|NCT01241448|473919449|FG002|Overall Study|Physician Decision|0|||
131626480|NCT01241448|473919450|FG003|Overall Study|Physician Decision|0|||
131626481|NCT01241448|473919447|FG000|Overall Study|Protocol Violation|10|||
131626482|NCT01241448|473919448|FG001|Overall Study|Protocol Violation|5|||
131626483|NCT01241448|473919449|FG002|Overall Study|Protocol Violation|3|||
131626484|NCT01241448|473919450|FG003|Overall Study|Protocol Violation|6|||
131626485|NCT01241448|473919447|FG000|Overall Study|Sponsor Decision|17|||
131626486|NCT01241448|473919448|FG001|Overall Study|Sponsor Decision|14|||
131626487|NCT01241448|473919449|FG002|Overall Study|Sponsor Decision|12|||
131626488|NCT01241448|473919450|FG003|Overall Study|Sponsor Decision|6|||
131626489|NCT01241448|473919447|FG000|Overall Study|Withdrawal by Subject|4|||
131626490|NCT01241448|473919448|FG001|Overall Study|Withdrawal by Subject|5|||
131626491|NCT01241448|473919449|FG002|Overall Study|Withdrawal by Subject|3|||
131626492|NCT01241448|473919450|FG003|Overall Study|Withdrawal by Subject|6|||
131626493|NCT01241448|473919447|FG000|Overall Study|Excluded due to data integrity issues|3|||
131626494|NCT01241448|473919448|FG001|Overall Study|Excluded due to data integrity issues|2|||
131901725|NCT00838097|474925174|FG000|Overall Study|Ineligibility determined|6|||
131901726|NCT00838097|474925174|FG000|Overall Study|Adverse Event|2|||
131901727|NCT00838097|474925174|FG000|Overall Study|Withdrawal by Subject|3|||
131901728|NCT00838097|474925174|FG000|Overall Study|Requirement for alternative therapy|2|||
131901729|NCT00838097|474925174|FG000|Overall Study|Physician Decision|4|||
131901730|NCT00838097|474925174|FG000|Overall Study|Lost to Follow-up|11|||
131901731|NCT00838097|474925174|FG000|Overall Study|Death|6|||
131901732|NCT00838097|474925174|FG000|Overall Study|Protocol-specified criteria|142|||
131901733|NCT00871234|474925175|FG000|Overall Study|Adverse Event|2|||
131901734|NCT00871234|474925175|FG000|Overall Study|Lost to Follow-up|3|||
131901735|NCT03380377|474925178|FG000|Overall Study|Physician Decision|1|||
131901736|NCT03380377|474925178|FG000|Overall Study|Withdrawal by Subject|1|||
131901737|NCT02600923|474925181|FG000|Overall Study|Death|10|||
131901738|NCT02600923|474925181|FG000|Overall Study|Adverse Event|3|||
131901739|NCT02600923|474925181|FG000|Overall Study|Global deterioration of health status|2|||
131626495|NCT01241448|473919449|FG002|Overall Study|Excluded due to data integrity issues|2|||
131901740|NCT02600923|474925181|FG000|Overall Study|Insufficient clinical response|6|||
131626496|NCT01241448|473919450|FG003|Overall Study|Excluded due to data integrity issues|2|||
131626497|NCT03740737|473919451|FG000|Overall Study|Protocol deviation|13|||
131626498|NCT03740737|473919452|FG001|Overall Study|Protocol deviation|0|||
131626499|NCT03740737|473919451|FG000|Overall Study|Adverse Event|2|||
131626500|NCT03740737|473919452|FG001|Overall Study|Adverse Event|0|||
131626501|NCT03740737|473919451|FG000|Overall Study|Lost to Follow-up|1|||
131626502|NCT03740737|473919452|FG001|Overall Study|Lost to Follow-up|0|||
131626503|NCT03740737|473919451|FG000|Overall Study|Randomization failure|1|||
131626504|NCT03740737|473919452|FG001|Overall Study|Randomization failure|0|||
131626505|NCT03740737|473919451|FG000|Overall Study|Participant withdrew consent|1|||
131626506|NCT03740737|473919452|FG001|Overall Study|Participant withdrew consent|0|||
131626507|NCT03740737|473919451|FG000|Overall Study|Participant withdrew from trial|2|||
131626508|NCT03740737|473919452|FG001|Overall Study|Participant withdrew from trial|1|||
131626509|NCT01381549|473919459|FG000|Overall Study|Ineligible: No organisms isolated|0|||
131626510|NCT01381549|473919460|FG001|Overall Study|Ineligible: No organisms isolated|0|||
131626511|NCT01381549|473919461|FG002|Overall Study|Ineligible: No organisms isolated|1|||
131626512|NCT02981953|473919462|FG000|Overall Study|Death|9|||
131626513|NCT02981953|473919462|FG000|Overall Study|Withdrawal by Subject|1|||
131626514|NCT02981953|473919462|FG000|Overall Study|Withdrawal to non-compliance|1|||
131901741|NCT02600923|474925181|FG000|Overall Study|Lost to Follow-up|1|||
131901742|NCT02600923|474925181|FG000|Overall Study|Withdrawal by Subject|5|||
131626515|NCT02889900|473919465|FG000|Overall Study|Adverse Event|11|||
131626516|NCT02889900|473919465|FG000|Overall Study|Condition under investigation worsened|32|||
131626517|NCT02889900|473919465|FG000|Overall Study|Other|5|||
131626518|NCT02889900|473919465|FG000|Overall Study|Withdrawal by Subject|7|||
131626519|NCT02889900|473919465|FG000|Overall Study|Not treated|2|||
131626520|NCT01416285|473919471|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
131626521|NCT01416285|473919472|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
131626522|NCT00990184|473919480|FG000|Overall Study|Physician Decision|1|||
131626523|NCT03693989|473919483|FG000|Overall Study|Protocol Violation|3|||
131626524|NCT03693989|473919484|FG001|Overall Study|Protocol Violation|4|||
131626525|NCT00113529|473919487|FG000|Overall Study|Adverse Event|4|||
131901743|NCT02600923|474925181|FG000|Overall Study|Objective progression or relapse|50|||
131901744|NCT02600923|474925181|FG000|Overall Study|Study terminated by Sponsor|53|||
131901745|NCT02600923|474925181|FG000|Overall Study|Not treated|1|||
131626526|NCT00113529|473919487|FG000|Overall Study|Lack of Efficacy|20|||
131626527|NCT00113529|473919487|FG000|Overall Study|Decision of sponsor|6|||
131626528|NCT00113529|473919487|FG000|Overall Study|Withdrawal by Subject|4|||
131626529|NCT01535261|473919488|FG000|Overall Study|Physician Decision|8|||
131626530|NCT01535261|473919488|FG000|Overall Study|Protocol Violation|3|||
131626531|NCT01535261|473919488|FG000|Overall Study|Death|5|||
131626532|NCT01535261|473919488|FG000|Overall Study|Lost to Follow-up|8|||
131626533|NCT01535261|473919488|FG000|Overall Study|Withdrawal by Subject|14|||
131626534|NCT01535261|473919488|FG000|Overall Study|Adverse Event|12|||
131626535|NCT01777932|473919493|FG000|Overall Study|Disease progression|136|||
131626536|NCT01777932|473919493|FG000|Overall Study|Death|3|||
131626537|NCT01777932|473919493|FG000|Overall Study|Adverse Event|34|||
131626538|NCT01777932|473919493|FG000|Overall Study|Lost to Follow-up|3|||
131626539|NCT01777932|473919493|FG000|Overall Study|Investigator decision|10|||
131626540|NCT01777932|473919493|FG000|Overall Study|Reimbursement limit|9|||
131626541|NCT01777932|473919493|FG000|Overall Study|Patient refused further treatment|10|||
131626542|NCT02607956|473919497|FG000|Double-Blinded Phase|Withdrew Consent|17|||
131626543|NCT02607956|473919498|FG001|Double-Blinded Phase|Withdrew Consent|19|||
131626544|NCT02607956|473919499|FG002|Double-Blinded Phase|Withdrew Consent|0|||
131626545|NCT02607956|473919500|FG003|Double-Blinded Phase|Withdrew Consent|0|||
131626546|NCT02607956|473919497|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
131626547|NCT02607956|473919498|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
131626548|NCT02607956|473919499|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
131626549|NCT02607956|473919500|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
131626550|NCT02607956|473919497|FG000|Double-Blinded Phase|Randomized but never treated|7|||
131626551|NCT02607956|473919498|FG001|Double-Blinded Phase|Randomized but never treated|5|||
131626552|NCT02607956|473919499|FG002|Double-Blinded Phase|Randomized but never treated|0|||
131626553|NCT02607956|473919500|FG003|Double-Blinded Phase|Randomized but never treated|0|||
131626554|NCT02607956|473919497|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
131626555|NCT02607956|473919498|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
131626556|NCT02607956|473919499|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
131626557|NCT02607956|473919500|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
131626558|NCT02607956|473919497|FG000|Double-Blinded Phase|Death|4|||
131626559|NCT02607956|473919498|FG001|Double-Blinded Phase|Death|4|||
131626560|NCT02607956|473919499|FG002|Double-Blinded Phase|Death|0|||
131626561|NCT02607956|473919500|FG003|Double-Blinded Phase|Death|0|||
131626562|NCT02607956|473919497|FG000|Double-Blinded Phase|Adverse Event|4|||
131626563|NCT02607956|473919498|FG001|Double-Blinded Phase|Adverse Event|3|||
131626564|NCT02607956|473919499|FG002|Double-Blinded Phase|Adverse Event|0|||
131626565|NCT02607956|473919500|FG003|Double-Blinded Phase|Adverse Event|0|||
131626566|NCT02607956|473919497|FG000|Double-Blinded Phase|Protocol Violation|3|||
131626567|NCT02607956|473919498|FG001|Double-Blinded Phase|Protocol Violation|1|||
131626568|NCT02607956|473919499|FG002|Double-Blinded Phase|Protocol Violation|0|||
131626569|NCT02607956|473919500|FG003|Double-Blinded Phase|Protocol Violation|0|||
131626570|NCT02607956|473919497|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
131626571|NCT02607956|473919498|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
131626572|NCT02607956|473919499|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
131626573|NCT02607956|473919500|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
131626574|NCT02607956|473919497|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
131626575|NCT02607956|473919498|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
131626576|NCT02607956|473919499|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
131626577|NCT02607956|473919500|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
131626578|NCT02607956|473919497|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
131626579|NCT02607956|473919498|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
131626580|NCT02607956|473919499|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
131626581|NCT02607956|473919500|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
131626582|NCT02607956|473919497|FG000|Open-Label Extension Phase|Death|0|||
131626583|NCT02607956|473919498|FG001|Open-Label Extension Phase|Death|0|||
131626584|NCT02607956|473919499|FG002|Open-Label Extension Phase|Death|1|||
131626585|NCT02607956|473919500|FG003|Open-Label Extension Phase|Death|3|||
131626586|NCT02607956|473919497|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
131626587|NCT02607956|473919498|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
131626588|NCT02607956|473919499|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
131626589|NCT02607956|473919500|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
131626590|NCT02607956|473919497|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
131626591|NCT02607956|473919498|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
131712191|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
131901746|NCT00792909|474925182|FG000|Overall Study|Withdrawal by Subject|0|||
131901747|NCT00792909|474925183|FG001|Overall Study|Withdrawal by Subject|1|||
131626592|NCT02607956|473919499|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
131626593|NCT02607956|473919500|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
131626594|NCT02607956|473919497|FG000|Open-Label Extension Phase|Protocol Violation|0|||
131626595|NCT02607956|473919498|FG001|Open-Label Extension Phase|Protocol Violation|0|||
131626596|NCT02607956|473919499|FG002|Open-Label Extension Phase|Protocol Violation|0|||
131626597|NCT02607956|473919500|FG003|Open-Label Extension Phase|Protocol Violation|2|||
131626598|NCT02607956|473919497|FG000|Open-Label Extension Phase|Pregnancy|0|||
131626599|NCT02607956|473919498|FG001|Open-Label Extension Phase|Pregnancy|0|||
131626600|NCT02607956|473919499|FG002|Open-Label Extension Phase|Pregnancy|0|||
131626601|NCT02607956|473919500|FG003|Open-Label Extension Phase|Pregnancy|1|||
131626602|NCT02513667|473919501|FG000|Overall Study|Withdrawal by Subject|0|||
131626603|NCT02513667|473919502|FG001|Overall Study|Withdrawal by Subject|1|||
131626604|NCT03347396|473919509|FG000|Part A (26 Weeks)|Adverse Event|1|||
131626605|NCT03347396|473919510|FG001|Part A (26 Weeks)|Adverse Event|0|||
131626606|NCT03347396|473919509|FG000|Part A (26 Weeks)|Death|0|||
131626607|NCT03347396|473919510|FG001|Part A (26 Weeks)|Death|1|||
131626608|NCT03347396|473919509|FG000|Part B (149 Weeks)|Adverse Event|1|||
131626609|NCT03347396|473919510|FG001|Part B (149 Weeks)|Adverse Event|1|||
131626610|NCT03347396|473919509|FG000|Part B (149 Weeks)|Death|1|||
131626611|NCT03347396|473919510|FG001|Part B (149 Weeks)|Death|0|||
131626612|NCT03060525|473919512|FG000|Overall Study|moved out of state|1|||
131626613|NCT03060525|473919513|FG001|Overall Study|moved out of state|1|||
131626614|NCT03060525|473919514|FG002|Overall Study|moved out of state|1|||
131626615|NCT03060525|473919515|FG003|Overall Study|moved out of state|1|||
131626616|NCT03060525|473919512|FG000|Overall Study|unable to meet time commitment required of study|2|||
131626617|NCT03060525|473919513|FG001|Overall Study|unable to meet time commitment required of study|3|||
131626618|NCT03060525|473919514|FG002|Overall Study|unable to meet time commitment required of study|3|||
131626619|NCT03060525|473919515|FG003|Overall Study|unable to meet time commitment required of study|1|||
131626620|NCT03060525|473919512|FG000|Overall Study|no longer interested in doing intervention|0|||
131626621|NCT03060525|473919513|FG001|Overall Study|no longer interested in doing intervention|0|||
131626622|NCT03060525|473919514|FG002|Overall Study|no longer interested in doing intervention|0|||
131626623|NCT03060525|473919515|FG003|Overall Study|no longer interested in doing intervention|1|||
131626624|NCT00912964|473919516|FG000|Overall Study|Eligibility criterion not met|1|||
131626625|NCT00912964|473919517|FG001|Overall Study|Eligibility criterion not met|1|||
131626626|NCT00912964|473919518|FG002|Overall Study|Eligibility criterion not met|0|||
131626627|NCT00912964|473919516|FG000|Overall Study|Adverse Event|15|||
131626628|NCT00912964|473919517|FG001|Overall Study|Adverse Event|18|||
131626629|NCT00912964|473919518|FG002|Overall Study|Adverse Event|12|||
131626630|NCT00912964|473919516|FG000|Overall Study|Lack of Efficacy|11|||
131626631|NCT00912964|473919517|FG001|Overall Study|Lack of Efficacy|4|||
131626632|NCT00912964|473919518|FG002|Overall Study|Lack of Efficacy|3|||
131626633|NCT00912964|473919516|FG000|Overall Study|Withdrawal by Subject|20|||
131626634|NCT00912964|473919517|FG001|Overall Study|Withdrawal by Subject|12|||
131626635|NCT00912964|473919518|FG002|Overall Study|Withdrawal by Subject|18|||
131626636|NCT00912964|473919516|FG000|Overall Study|Lost to Follow-up|4|||
131626637|NCT00912964|473919517|FG001|Overall Study|Lost to Follow-up|3|||
131626638|NCT00912964|473919518|FG002|Overall Study|Lost to Follow-up|3|||
131626639|NCT00912964|473919516|FG000|Overall Study|Protocol Violation|5|||
131626640|NCT00912964|473919517|FG001|Overall Study|Protocol Violation|3|||
131626641|NCT00912964|473919518|FG002|Overall Study|Protocol Violation|8|||
131626642|NCT00912964|473919516|FG000|Overall Study|Taking exclusionary medications|7|||
131626643|NCT00912964|473919517|FG001|Overall Study|Taking exclusionary medications|4|||
131626644|NCT00912964|473919518|FG002|Overall Study|Taking exclusionary medications|8|||
131626645|NCT00912964|473919516|FG000|Overall Study|Medical History|1|||
131626646|NCT00912964|473919517|FG001|Overall Study|Medical History|0|||
131901748|NCT00792909|474925184|FG002|Overall Study|Withdrawal by Subject|0|||
131626647|NCT00912964|473919518|FG002|Overall Study|Medical History|0|||
131626648|NCT00912964|473919516|FG000|Overall Study|Non-compliance with study procedures|2|||
131626649|NCT00912964|473919517|FG001|Overall Study|Non-compliance with study procedures|0|||
131901749|NCT00128661|474925187|FG000|Overall Study|Adverse Event|14|||
131444165|NCT01972217|473257064|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
131626650|NCT00912964|473919518|FG002|Overall Study|Non-compliance with study procedures|0|||
131626651|NCT00912964|473919516|FG000|Overall Study|Violation of exclusion criterion|0|||
131626652|NCT00912964|473919517|FG001|Overall Study|Violation of exclusion criterion|0|||
131626653|NCT00912964|473919518|FG002|Overall Study|Violation of exclusion criterion|2|||
131626654|NCT00912964|473919516|FG000|Overall Study|Randomized but never received study drug|0|||
131626655|NCT00912964|473919517|FG001|Overall Study|Randomized but never received study drug|1|||
131626656|NCT00912964|473919518|FG002|Overall Study|Randomized but never received study drug|0|||
131626657|NCT02613403|473919519|FG000|Overall Study|Lost to Follow-up|0|||
131626658|NCT02613403|473919520|FG001|Overall Study|Lost to Follow-up|1|||
131444166|NCT01972217|473257061|FG000|Part B Double-blind, Randomised Period|Death|0|||
131444167|NCT01972217|473257062|FG001|Part B Double-blind, Randomised Period|Death|0|||
131626659|NCT02613403|473919521|FG002|Overall Study|Lost to Follow-up|0|||
131626660|NCT02613403|473919522|FG003|Overall Study|Lost to Follow-up|0|||
131626661|NCT02613403|473919523|FG004|Overall Study|Lost to Follow-up|0|||
131626662|NCT02613403|473919519|FG000|Overall Study|Withdrawal by Subject|2|||
131626663|NCT02613403|473919520|FG001|Overall Study|Withdrawal by Subject|0|||
131626664|NCT02613403|473919521|FG002|Overall Study|Withdrawal by Subject|0|||
131444168|NCT01972217|473257063|FG002|Part B Double-blind, Randomised Period|Death|43|||
131444169|NCT01972217|473257064|FG003|Part B Double-blind, Randomised Period|Death|44|||
131444170|NCT01972217|473257061|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
131626665|NCT02613403|473919522|FG003|Overall Study|Withdrawal by Subject|0|||
131626666|NCT02613403|473919523|FG004|Overall Study|Withdrawal by Subject|0|||
131626667|NCT02189759|473919524|FG000|Overall Study|Lost to Follow-up|0|||
131626668|NCT02189759|473919525|FG001|Overall Study|Lost to Follow-up|0|||
131626669|NCT02189759|473919526|FG002|Overall Study|Lost to Follow-up|2|||
131444171|NCT01972217|473257062|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
131444172|NCT01972217|473257063|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
131444173|NCT01972217|473257064|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
131444174|NCT01972217|473257061|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
131444175|NCT01972217|473257062|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
131444176|NCT01972217|473257063|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
131444177|NCT01972217|473257064|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
131444178|NCT01972217|473257061|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
131444179|NCT01972217|473257062|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
131444180|NCT01972217|473257063|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
131444181|NCT01972217|473257064|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
131444182|NCT01972217|473257061|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
131444183|NCT01972217|473257062|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
131444184|NCT01972217|473257063|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
131444185|NCT01972217|473257064|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
131444186|NCT00371150|473257067|FG000|Overall Study|Lost to Follow-up|3|||
131626670|NCT02189759|473919527|FG003|Overall Study|Lost to Follow-up|5|||
131444187|NCT00371150|473257068|FG001|Overall Study|Lost to Follow-up|2|||
131444188|NCT03714672|473257069|FG000|Overall Study|Adverse Event|0|||
131444189|NCT03714672|473257070|FG001|Overall Study|Adverse Event|0|||
131626671|NCT01147471|473919528|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
131626672|NCT01147471|473919529|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
131712192|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
131712193|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
131712194|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
131626673|NCT01147471|473919528|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
131626674|NCT01147471|473919529|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
131626675|NCT01147471|473919528|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
131626676|NCT01147471|473919529|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
131626677|NCT01147471|473919528|FG000|3 Month Follow Up|Lost to Follow-up|1|||
131626678|NCT01147471|473919529|FG001|3 Month Follow Up|Lost to Follow-up|1|||
131626679|NCT01147471|473919528|FG000|3 Month Follow Up|Physician Decision|0|||
131626680|NCT01147471|473919529|FG001|3 Month Follow Up|Physician Decision|1|||
131626681|NCT01147471|473919528|FG000|6 Month Follow Up|Lost to Follow-up|4|||
131626682|NCT01147471|473919529|FG001|6 Month Follow Up|Lost to Follow-up|2|||
131626683|NCT01294644|473919530|FG000|Overall Study|Adverse Event|2|||
131626684|NCT01294644|473919531|FG001|Overall Study|Adverse Event|0|||
131626685|NCT01294644|473919532|FG002|Overall Study|Adverse Event|1|||
131626686|NCT01294644|473919530|FG000|Overall Study|Withdrawal by Subject|3|||
131626687|NCT01294644|473919531|FG001|Overall Study|Withdrawal by Subject|7|||
131626688|NCT01294644|473919532|FG002|Overall Study|Withdrawal by Subject|4|||
131626689|NCT01294644|473919530|FG000|Overall Study|Lost to Follow-up|3|||
131626690|NCT01294644|473919531|FG001|Overall Study|Lost to Follow-up|2|||
131626691|NCT01294644|473919532|FG002|Overall Study|Lost to Follow-up|5|||
131626692|NCT01294644|473919530|FG000|Overall Study|Miscellaneous Reason|2|||
131626693|NCT01294644|473919531|FG001|Overall Study|Miscellaneous Reason|1|||
131626694|NCT01294644|473919532|FG002|Overall Study|Miscellaneous Reason|4|||
131626695|NCT02188459|473919533|FG000|Overall Study|Lost to Follow-up|3|||
131626696|NCT02188459|473919534|FG001|Overall Study|Lost to Follow-up|4|||
131626697|NCT02188459|473919533|FG000|Overall Study|Early Termination|0|||
131626698|NCT02188459|473919534|FG001|Overall Study|Early Termination|3|||
131626699|NCT02158806|473919537|FG000|Overall Study|Death|2|||
131626700|NCT02158806|473919538|FG001|Overall Study|Death|0|||
131626701|NCT02158806|473919537|FG000|Overall Study|Withdrawal by Subject|2|||
131626702|NCT02158806|473919538|FG001|Overall Study|Withdrawal by Subject|0|||
131626703|NCT02158806|473919537|FG000|Overall Study|Lost to Follow-up|0|||
131626704|NCT02158806|473919538|FG001|Overall Study|Lost to Follow-up|3|||
131626705|NCT02158806|473919537|FG000|Overall Study|Moved out of area|0|||
131626706|NCT02158806|473919538|FG001|Overall Study|Moved out of area|1|||
131626707|NCT02158806|473919537|FG000|Overall Study|Transferred to palliative care|0|||
131626708|NCT02158806|473919538|FG001|Overall Study|Transferred to palliative care|1|||
131626709|NCT01898299|473919539|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
131626710|NCT01898299|473919540|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
131626711|NCT00452452|473919541|FG000|Overall Study|Protocol Violation|0|||
131626712|NCT00452452|473919542|FG001|Overall Study|Protocol Violation|0|||
131626713|NCT00452452|473919543|FG002|Overall Study|Protocol Violation|1|||
131626714|NCT00452452|473919541|FG000|Overall Study|Withdrawal by Subject|1|||
131626715|NCT00452452|473919542|FG001|Overall Study|Withdrawal by Subject|0|||
131626716|NCT00452452|473919543|FG002|Overall Study|Withdrawal by Subject|0|||
131626717|NCT00452452|473919541|FG000|Overall Study|Lost to Follow-up|1|||
131626718|NCT00452452|473919542|FG001|Overall Study|Lost to Follow-up|0|||
131626719|NCT00452452|473919543|FG002|Overall Study|Lost to Follow-up|0|||
131626720|NCT05066230|473921208|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
131626721|NCT05066230|473921209|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
131626722|NCT05066230|473921208|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
131626723|NCT05066230|473921209|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
131626724|NCT05066230|473921208|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
131626725|NCT05066230|473921209|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
131626726|NCT05066230|473921208|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
131626727|NCT05066230|473921209|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
131626728|NCT05066230|473921208|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
131626729|NCT05066230|473921209|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
131626730|NCT05066230|473921208|FG000|After Week 48|Adverse Event|1|||
131712195|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
131712196|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
131712197|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
131626731|NCT05066230|473921209|FG001|After Week 48|Adverse Event|0|||
131626732|NCT05066230|473921208|FG000|After Week 48|Non-compliance with study schedule|1|||
131626733|NCT05066230|473921209|FG001|After Week 48|Non-compliance with study schedule|0|||
131626734|NCT05066230|473921208|FG000|After Week 48|Withdrawal by Subject|0|||
131626735|NCT05066230|473921209|FG001|After Week 48|Withdrawal by Subject|1|||
131712198|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
131626736|NCT05066230|473921208|FG000|After Week 48|Lost to Follow-up|3|||
131626737|NCT05066230|473921209|FG001|After Week 48|Lost to Follow-up|3|||
131626738|NCT05066230|473921208|FG000|After Week 48|Sponsor Request|115|||
131712199|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
131712200|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
131712201|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
131626739|NCT05066230|473921209|FG001|After Week 48|Sponsor Request|111|||
131626740|NCT02164578|473921210|FG000|Treatment Period|Withdrawal by Subject|3|||
131901750|NCT00128661|474925188|FG001|Overall Study|Adverse Event|11|||
131901751|NCT00128661|474925187|FG000|Overall Study|Lost to Follow-up|10|||
131901752|NCT00128661|474925188|FG001|Overall Study|Lost to Follow-up|7|||
131901753|NCT00128661|474925187|FG000|Overall Study|Withdrawal by Subject|243|||
131901754|NCT00128661|474925188|FG001|Overall Study|Withdrawal by Subject|232|||
131901755|NCT00128661|474925187|FG000|Overall Study|Other|7|||
131901756|NCT00128661|474925188|FG001|Overall Study|Other|8|||
131901757|NCT01261390|474925190|FG000|Overall Study|Significant Concurrent Illness|1|||
131901758|NCT01261390|474925191|FG001|Overall Study|Significant Concurrent Illness|0|||
131901759|NCT01261390|474925192|FG002|Overall Study|Significant Concurrent Illness|1|||
131901760|NCT01261390|474925193|FG003|Overall Study|Significant Concurrent Illness|0|||
131901761|NCT01261390|474925190|FG000|Overall Study|Dissatisfaction with Treatment|2|||
131901762|NCT01261390|474925191|FG001|Overall Study|Dissatisfaction with Treatment|1|||
131901763|NCT01261390|474925192|FG002|Overall Study|Dissatisfaction with Treatment|1|||
131901764|NCT01261390|474925193|FG003|Overall Study|Dissatisfaction with Treatment|2|||
131901765|NCT01261390|474925190|FG000|Overall Study|Relocation|0|||
131626741|NCT02164578|473921211|FG001|Treatment Period|Withdrawal by Subject|3|||
131626742|NCT02164578|473921210|FG000|Treatment Period|Adverse Event|13|||
131626743|NCT02164578|473921211|FG001|Treatment Period|Adverse Event|6|||
131626744|NCT02164578|473921210|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
131626745|NCT02164578|473921211|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
131626746|NCT02164578|473921210|FG000|Treatment Period|Protocol Violation|0|||
131626747|NCT02164578|473921211|FG001|Treatment Period|Protocol Violation|2|||
131626748|NCT02164578|473921210|FG000|Extension Period|Withdrawal by Subject|2|||
131626749|NCT02164578|473921211|FG001|Extension Period|Withdrawal by Subject|0|||
131626750|NCT02164578|473921210|FG000|Extension Period|Adverse Event|4|||
131626751|NCT02164578|473921211|FG001|Extension Period|Adverse Event|0|||
131626752|NCT02164578|473921210|FG000|Extension Period|Expiry of study medication|1|||
131626753|NCT02164578|473921211|FG001|Extension Period|Expiry of study medication|0|||
131626754|NCT02164578|473921210|FG000|Extension Period|Protocol Violation|0|||
131626755|NCT02164578|473921211|FG001|Extension Period|Protocol Violation|1|||
131712202|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
131901766|NCT01261390|474925191|FG001|Overall Study|Relocation|1|||
131901767|NCT01261390|474925192|FG002|Overall Study|Relocation|0|||
131901768|NCT01261390|474925193|FG003|Overall Study|Relocation|0|||
131626756|NCT01072149|473921214|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626757|NCT01072149|473921215|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131901769|NCT01261390|474925190|FG000|Overall Study|Loss of Interest in the Study|3|||
131444190|NCT03714672|473257071|FG002|Overall Study|Adverse Event|3|||
131444191|NCT03714672|473257072|FG003|Overall Study|Adverse Event|0|||
131444192|NCT03714672|473257069|FG000|Overall Study|Physician Decision|0|||
131626758|NCT01072149|473921216|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131626759|NCT01072149|473921217|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626760|NCT01072149|473921218|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626761|NCT01072149|473921219|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626762|NCT01072149|473921220|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626763|NCT01072149|473921221|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626764|NCT01072149|473921222|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626765|NCT01072149|473921223|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626766|NCT01072149|473921224|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626767|NCT01072149|473921225|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626768|NCT01072149|473921226|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626769|NCT01072149|473921227|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626770|NCT01072149|473921228|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626771|NCT01072149|473921229|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626772|NCT01072149|473921230|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626773|NCT01072149|473921231|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131626774|NCT01072149|473921214|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626775|NCT01072149|473921215|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626776|NCT01072149|473921216|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626777|NCT01072149|473921217|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626778|NCT01072149|473921218|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626779|NCT01072149|473921219|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626780|NCT01072149|473921220|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626781|NCT01072149|473921221|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626782|NCT01072149|473921222|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626783|NCT01072149|473921223|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626784|NCT01072149|473921224|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626785|NCT01072149|473921225|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626786|NCT01072149|473921226|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626787|NCT01072149|473921227|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626788|NCT01072149|473921228|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626789|NCT01072149|473921229|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626790|NCT01072149|473921230|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131626791|NCT01072149|473921231|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
131626792|NCT01072149|473921214|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626793|NCT01072149|473921215|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626794|NCT01072149|473921216|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626795|NCT01072149|473921217|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626796|NCT01072149|473921218|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626797|NCT01072149|473921219|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626798|NCT01072149|473921220|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626799|NCT01072149|473921221|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626800|NCT01072149|473921222|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626801|NCT01072149|473921223|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626802|NCT01072149|473921224|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
131626803|NCT01072149|473921225|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626804|NCT01072149|473921226|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626805|NCT01072149|473921227|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626806|NCT01072149|473921228|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626807|NCT01072149|473921229|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626808|NCT01072149|473921230|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626809|NCT01072149|473921231|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131626810|NCT01072149|473921214|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626811|NCT01072149|473921215|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
131626812|NCT01072149|473921216|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626813|NCT01072149|473921217|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626814|NCT01072149|473921218|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626815|NCT01072149|473921219|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626816|NCT01072149|473921220|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626817|NCT01072149|473921221|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626818|NCT01072149|473921222|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131797258|NCT00056160|474541564|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
131797259|NCT00056160|474541563|FG000|Final Follow-up|Adverse Event|1|||
131797260|NCT00056160|474541564|FG001|Final Follow-up|Adverse Event|0|||
131797261|NCT02146430|474541566|FG000|Overall Study|Protocol Violation|5|||
131797262|NCT02146430|474541567|FG001|Overall Study|Protocol Violation|4|||
131797263|NCT02146430|474541568|FG002|Overall Study|Protocol Violation|8|||
131797264|NCT02146430|474541569|FG003|Overall Study|Protocol Violation|6|||
131797265|NCT02146430|474541566|FG000|Overall Study|Lack of Efficacy|13|||
131797266|NCT02146430|474541567|FG001|Overall Study|Lack of Efficacy|11|||
131626819|NCT01072149|473921223|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626820|NCT01072149|473921224|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626821|NCT01072149|473921225|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626822|NCT01072149|473921226|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626823|NCT01072149|473921227|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626824|NCT01072149|473921228|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626825|NCT01072149|473921229|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626826|NCT01072149|473921230|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626827|NCT01072149|473921231|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131626828|NCT01072149|473921214|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626829|NCT01072149|473921215|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626830|NCT01072149|473921216|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
131626831|NCT01072149|473921217|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626832|NCT01072149|473921218|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626833|NCT01072149|473921219|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626834|NCT01072149|473921220|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626835|NCT01072149|473921221|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626836|NCT01072149|473921222|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626837|NCT01072149|473921223|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626838|NCT01072149|473921224|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626839|NCT01072149|473921225|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626840|NCT01072149|473921226|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626841|NCT01072149|473921227|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626842|NCT01072149|473921228|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626843|NCT01072149|473921229|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626844|NCT01072149|473921230|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626845|NCT01072149|473921231|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131626846|NCT01072149|473921214|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626847|NCT01072149|473921215|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626848|NCT01072149|473921216|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626849|NCT01072149|473921217|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626850|NCT01072149|473921218|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626851|NCT01072149|473921219|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626852|NCT01072149|473921220|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626853|NCT01072149|473921221|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
131626854|NCT01072149|473921222|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626855|NCT01072149|473921223|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626856|NCT01072149|473921224|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626857|NCT01072149|473921225|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626858|NCT01072149|473921226|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626859|NCT01072149|473921227|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626860|NCT01072149|473921228|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626861|NCT01072149|473921229|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626862|NCT01072149|473921230|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626863|NCT01072149|473921231|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
131626864|NCT01072149|473921214|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
131626865|NCT01072149|473921215|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
131626866|NCT01072149|473921216|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
131626867|NCT01072149|473921217|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
131626868|NCT01072149|473921218|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
131626869|NCT01072149|473921219|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
131626870|NCT01072149|473921220|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
131626871|NCT01072149|473921221|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
131626872|NCT01072149|473921222|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
131626873|NCT01072149|473921223|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
131626874|NCT01072149|473921224|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
131626875|NCT01072149|473921225|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
131626876|NCT01072149|473921226|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
131626877|NCT01072149|473921227|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
131626878|NCT01072149|473921228|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
131712203|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
131626879|NCT01072149|473921229|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
131712204|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
131626880|NCT01072149|473921230|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
131626881|NCT01072149|473921231|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
131626882|NCT01072149|473921214|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626883|NCT01072149|473921215|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626884|NCT01072149|473921216|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626885|NCT01072149|473921217|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626886|NCT01072149|473921218|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626887|NCT01072149|473921219|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626888|NCT01072149|473921220|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626889|NCT01072149|473921221|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626890|NCT01072149|473921222|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626891|NCT01072149|473921223|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626892|NCT01072149|473921224|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626893|NCT01072149|473921225|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131901770|NCT01261390|474925191|FG001|Overall Study|Loss of Interest in the Study|1|||
131901771|NCT01261390|474925192|FG002|Overall Study|Loss of Interest in the Study|0|||
131901772|NCT01261390|474925193|FG003|Overall Study|Loss of Interest in the Study|0|||
131901773|NCT01261390|474925190|FG000|Overall Study|Lost to Follow-up|1|||
131901774|NCT01261390|474925191|FG001|Overall Study|Lost to Follow-up|6|||
131901775|NCT01261390|474925192|FG002|Overall Study|Lost to Follow-up|5|||
131901776|NCT01261390|474925193|FG003|Overall Study|Lost to Follow-up|6|||
131901777|NCT00977613|474925199|FG000|Overall Study|Lost to Follow-up|16|||
131901778|NCT01691378|474925209|FG000|Overall Study|Withdrawal by Subject|2|||
131901779|NCT01691378|474925210|FG001|Overall Study|Withdrawal by Subject|0|||
131901780|NCT01691378|474925209|FG000|Overall Study|Lost to Follow-up|5|||
131901781|NCT01691378|474925210|FG001|Overall Study|Lost to Follow-up|2|||
131901782|NCT00751140|474925211|FG000|Overall Study|benign angioma excluded from analysis|1|||
131901783|NCT00808067|474925214|FG000|Overall Study|Major/minor bleed|30|||
131901784|NCT00808067|474925215|FG001|Overall Study|Major/minor bleed|44|||
131901785|NCT00808067|474925214|FG000|Overall Study|Outcome event - other|33|||
131901786|NCT00808067|474925215|FG001|Overall Study|Outcome event - other|25|||
131901787|NCT00808067|474925214|FG000|Overall Study|Adverse Event|111|||
131901788|NCT00808067|474925215|FG001|Overall Study|Adverse Event|121|||
131901789|NCT00808067|474925214|FG000|Overall Study|Hospitalization (not including surgery)|18|||
131901790|NCT00808067|474925215|FG001|Overall Study|Hospitalization (not including surgery)|17|||
131901791|NCT00808067|474925214|FG000|Overall Study|Hospitalization due to surgery|37|||
131901792|NCT00808067|474925215|FG001|Overall Study|Hospitalization due to surgery|40|||
131901793|NCT00808067|474925214|FG000|Overall Study|Reduced creatinine clearance|53|||
131901794|NCT00808067|474925215|FG001|Overall Study|Reduced creatinine clearance|55|||
131901795|NCT00808067|474925214|FG000|Overall Study|Elevated LFT results|7|||
131901796|NCT00808067|474925215|FG001|Overall Study|Elevated LFT results|3|||
131901797|NCT00808067|474925214|FG000|Overall Study|Patient refused to take study medication|65|||
131901798|NCT00808067|474925215|FG001|Overall Study|Patient refused to take study medication|76|||
131901799|NCT00808067|474925214|FG000|Overall Study|Missing|1|||
131901800|NCT00808067|474925215|FG001|Overall Study|Missing|0|||
131901801|NCT00808067|474925214|FG000|Overall Study|Death|1|||
131901802|NCT00808067|474925215|FG001|Overall Study|Death|1|||
131901803|NCT00808067|474925214|FG000|Overall Study|Procedure|6|||
131901804|NCT00808067|474925215|FG001|Overall Study|Procedure|7|||
131901805|NCT00808067|474925214|FG000|Overall Study|Withdrawal by Subject|21|||
131901806|NCT00808067|474925215|FG001|Overall Study|Withdrawal by Subject|25|||
131901807|NCT00808067|474925214|FG000|Overall Study|Site closed|4|||
131901808|NCT00808067|474925215|FG001|Overall Study|Site closed|3|||
131901809|NCT00808067|474925214|FG000|Overall Study|Physician Decision|47|||
131901810|NCT00808067|474925215|FG001|Overall Study|Physician Decision|38|||
131901811|NCT00808067|474925214|FG000|Overall Study|Protocol Violation|3|||
131901812|NCT00808067|474925215|FG001|Overall Study|Protocol Violation|11|||
131901813|NCT00808067|474925214|FG000|Overall Study|Patient elected|7|||
131901814|NCT00808067|474925215|FG001|Overall Study|Patient elected|9|||
131901815|NCT00808067|474925214|FG000|Overall Study|Site closed for cause|19|||
131901816|NCT00808067|474925215|FG001|Overall Study|Site closed for cause|19|||
131901817|NCT00808067|474925214|FG000|Overall Study|Other reason not defined above|5|||
131901818|NCT00808067|474925215|FG001|Overall Study|Other reason not defined above|5|||
131901819|NCT00808067|474925214|FG000|Overall Study|Excluded from analysis|13|||
131626894|NCT01072149|473921226|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626895|NCT01072149|473921227|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626896|NCT01072149|473921228|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626897|NCT01072149|473921229|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
131626898|NCT01072149|473921230|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131901820|NCT00808067|474925215|FG001|Overall Study|Excluded from analysis|19|||
131901821|NCT04001803|474925216|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
131901822|NCT04001803|474925216|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
131901823|NCT04001803|474925216|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
131901824|NCT04001803|474925216|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
131626899|NCT01072149|473921231|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131626900|NCT01072149|473921214|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
131626901|NCT01072149|473921215|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
131626902|NCT01072149|473921216|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
131626903|NCT01072149|473921217|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
131626904|NCT01072149|473921218|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
131626905|NCT01072149|473921219|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
131626906|NCT01072149|473921220|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
131626907|NCT01072149|473921221|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
131626908|NCT01072149|473921222|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
131626909|NCT01072149|473921223|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
131626910|NCT01072149|473921224|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
131626911|NCT01072149|473921225|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
131626912|NCT01072149|473921226|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
131626913|NCT01072149|473921227|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
131626914|NCT01072149|473921228|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
131626915|NCT01072149|473921229|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
131626916|NCT01072149|473921230|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
131626917|NCT01072149|473921231|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
131626918|NCT01072149|473921214|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626919|NCT01072149|473921215|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626920|NCT01072149|473921216|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626921|NCT01072149|473921217|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626922|NCT01072149|473921218|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626923|NCT01072149|473921219|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626924|NCT01072149|473921220|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626925|NCT01072149|473921221|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626926|NCT01072149|473921222|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626927|NCT01072149|473921223|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626928|NCT01072149|473921224|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626929|NCT01072149|473921225|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626930|NCT01072149|473921226|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
131626931|NCT01072149|473921227|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626932|NCT01072149|473921228|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626933|NCT01072149|473921229|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626934|NCT01072149|473921230|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626935|NCT01072149|473921231|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131626936|NCT01072149|473921214|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626937|NCT01072149|473921215|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626938|NCT01072149|473921216|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
131626939|NCT01072149|473921217|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626940|NCT01072149|473921218|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626941|NCT01072149|473921219|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626942|NCT01072149|473921220|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626943|NCT01072149|473921221|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626944|NCT01072149|473921222|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626945|NCT01072149|473921223|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626946|NCT01072149|473921224|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131444193|NCT03714672|473257070|FG001|Overall Study|Physician Decision|1|||
131444194|NCT03714672|473257071|FG002|Overall Study|Physician Decision|0|||
131626947|NCT01072149|473921225|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626948|NCT01072149|473921226|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626949|NCT01072149|473921227|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
131797267|NCT02146430|474541568|FG002|Overall Study|Lack of Efficacy|8|||
131626950|NCT01072149|473921228|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131797268|NCT02146430|474541569|FG003|Overall Study|Lack of Efficacy|5|||
131797269|NCT02146430|474541566|FG000|Overall Study|Adverse Event|20|||
131444195|NCT03714672|473257072|FG003|Overall Study|Physician Decision|0|||
131797270|NCT02146430|474541567|FG001|Overall Study|Adverse Event|40|||
131444196|NCT03714672|473257069|FG000|Overall Study|Other Reason|1|||
131626951|NCT01072149|473921229|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626952|NCT01072149|473921230|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626953|NCT01072149|473921231|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131626954|NCT01322386|473921233|FG000|Overall Study|Protocol Violation|0|||
131626955|NCT01322386|473921234|FG001|Overall Study|Protocol Violation|1|||
131626956|NCT01322386|473921233|FG000|Overall Study|Physician Decision|0|||
131626957|NCT01322386|473921234|FG001|Overall Study|Physician Decision|1|||
131626958|NCT00441168|473921236|FG000|Treatment Period|Death|3|||
131626959|NCT00441168|473921237|FG001|Treatment Period|Death|0|||
131626960|NCT00441168|473921236|FG000|Treatment Period|Adverse Event|1|||
131626961|NCT00441168|473921237|FG001|Treatment Period|Adverse Event|2|||
131626962|NCT00441168|473921236|FG000|Treatment Period|Progressive Disease|0|||
131626963|NCT00441168|473921237|FG001|Treatment Period|Progressive Disease|2|||
131626964|NCT00441168|473921236|FG000|Treatment Period|Protocol Violation|0|||
131626965|NCT00441168|473921237|FG001|Treatment Period|Protocol Violation|1|||
131626966|NCT00441168|473921236|FG000|Treatment Period|Lost to Follow-up|0|||
131626967|NCT00441168|473921237|FG001|Treatment Period|Lost to Follow-up|1|||
131626968|NCT00441168|473921236|FG000|Treatment Period|Withdrawal by Subject|3|||
131626969|NCT00441168|473921237|FG001|Treatment Period|Withdrawal by Subject|0|||
131626970|NCT00441168|473921236|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
131626971|NCT00441168|473921237|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
131626972|NCT00441168|473921236|FG000|Treatment Period|refractory disease|1|||
131626973|NCT00441168|473921237|FG001|Treatment Period|refractory disease|0|||
131626974|NCT00441168|473921236|FG000|Follow-up Period|Death|3|||
131626975|NCT00441168|473921237|FG001|Follow-up Period|Death|0|||
131626976|NCT00441168|473921236|FG000|Follow-up Period|Lost to Follow-up|5|||
131626977|NCT00441168|473921237|FG001|Follow-up Period|Lost to Follow-up|6|||
131626978|NCT00441168|473921236|FG000|Follow-up Period|Withdrawal by Subject|3|||
131626979|NCT00441168|473921237|FG001|Follow-up Period|Withdrawal by Subject|0|||
131626980|NCT00441168|473921236|FG000|Follow-up Period|Other|1|||
131626981|NCT00441168|473921237|FG001|Follow-up Period|Other|3|||
131626982|NCT02291861|473921238|FG000|Overall Study|Adverse Event|2|||
131626983|NCT02291861|473921239|FG001|Overall Study|Adverse Event|4|||
131626984|NCT02291861|473921240|FG002|Overall Study|Adverse Event|1|||
131712205|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
131901825|NCT04001803|474925216|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
131901826|NCT04001803|474925216|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
131444197|NCT03714672|473257070|FG001|Overall Study|Other Reason|2|||
131444198|NCT03714672|473257071|FG002|Overall Study|Other Reason|1|||
131444199|NCT03714672|473257072|FG003|Overall Study|Other Reason|1|||
131444200|NCT03714672|473257069|FG000|Overall Study|Lost to Follow-up|1|||
131626985|NCT02291861|473921241|FG003|Overall Study|Adverse Event|2|||
131626986|NCT02291861|473921238|FG000|Overall Study|Death|0|||
131626987|NCT02291861|473921239|FG001|Overall Study|Death|0|||
131626988|NCT02291861|473921240|FG002|Overall Study|Death|1|||
131626989|NCT02291861|473921241|FG003|Overall Study|Death|1|||
131626990|NCT02291861|473921238|FG000|Overall Study|Protocol Violation|1|||
131626991|NCT02291861|473921239|FG001|Overall Study|Protocol Violation|0|||
131626992|NCT02291861|473921240|FG002|Overall Study|Protocol Violation|0|||
131626993|NCT02291861|473921241|FG003|Overall Study|Protocol Violation|1|||
131626994|NCT02291861|473921238|FG000|Overall Study|Withdrawal by Subject|1|||
131626995|NCT02291861|473921239|FG001|Overall Study|Withdrawal by Subject|2|||
131626996|NCT02291861|473921240|FG002|Overall Study|Withdrawal by Subject|1|||
131626997|NCT02291861|473921241|FG003|Overall Study|Withdrawal by Subject|4|||
131626998|NCT02291861|473921238|FG000|Overall Study|Noncompliance|1|||
131626999|NCT02291861|473921239|FG001|Overall Study|Noncompliance|1|||
131627000|NCT02291861|473921240|FG002|Overall Study|Noncompliance|2|||
131627001|NCT02291861|473921241|FG003|Overall Study|Noncompliance|1|||
131627002|NCT02291861|473921238|FG000|Overall Study|Lost to Follow-up|2|||
131627003|NCT02291861|473921239|FG001|Overall Study|Lost to Follow-up|1|||
131627004|NCT02291861|473921240|FG002|Overall Study|Lost to Follow-up|4|||
131627005|NCT02291861|473921241|FG003|Overall Study|Lost to Follow-up|0|||
131627006|NCT02291861|473921238|FG000|Overall Study|Other|0|||
131627007|NCT02291861|473921239|FG001|Overall Study|Other|0|||
131901827|NCT04001803|474925216|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
131627008|NCT02291861|473921240|FG002|Overall Study|Other|0|||
131627009|NCT02291861|473921241|FG003|Overall Study|Other|1|||
131627010|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
131627011|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
131627012|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
131627013|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
131627014|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Death|0|||
131627015|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Death|0|||
131712206|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
131444201|NCT03714672|473257070|FG001|Overall Study|Lost to Follow-up|1|||
131627016|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Death|1|||
131627017|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Death|0|||
131901828|NCT04001803|474925216|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
131901829|NCT04001803|474925216|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
131901830|NCT04001803|474925216|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
131901831|NCT02493517|474925217|FG000|Overall Study|Protocol Violation|1|||
131901832|NCT02493517|474925218|FG001|Overall Study|Protocol Violation|2|||
131901833|NCT02493517|474925217|FG000|Overall Study|Withdrawal by Subject|1|||
131901834|NCT02493517|474925218|FG001|Overall Study|Withdrawal by Subject|2|||
131901835|NCT02493517|474925217|FG000|Overall Study|Adverse Event|0|||
131901836|NCT02493517|474925218|FG001|Overall Study|Adverse Event|2|||
131901837|NCT02493517|474925217|FG000|Overall Study|Missed study visit|0|||
131901838|NCT02493517|474925218|FG001|Overall Study|Missed study visit|1|||
131901839|NCT03718429|474925219|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
131901840|NCT03718429|474925220|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
131901841|NCT03718429|474925221|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
131901842|NCT03718429|474925222|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
131901843|NCT05404711|474925225|FG000|Completed Study Visit|Withdrawal by Subject|1|||
131901844|NCT05404711|474925225|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
131444202|NCT03714672|473257071|FG002|Overall Study|Lost to Follow-up|0|||
131444203|NCT03714672|473257072|FG003|Overall Study|Lost to Follow-up|0|||
131627018|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
131627019|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
131627020|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
131627021|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
131627022|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131627023|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
131627024|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131627025|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
131627026|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
131627027|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
131627028|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
131627029|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
131627030|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
131627031|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
131627032|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
131627033|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
131627034|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
131627035|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
131627036|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
131627037|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
131627038|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Other|2|||
131627039|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Other|0|||
131627040|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Other|0|||
131627041|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Other|0|||
131627042|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
131627043|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
131627044|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
131627045|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
131627046|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
131627047|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
131627048|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
131627049|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
131627050|NCT03845517|473921250|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
131901845|NCT05404711|474925225|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
131444204|NCT02345070|473257073|FG000|Overall Study|Adverse Event|12|||
131444205|NCT02345070|473257074|FG001|Overall Study|Adverse Event|8|||
131444206|NCT02345070|473257075|FG002|Overall Study|Adverse Event|16|||
131444207|NCT02345070|473257073|FG000|Overall Study|Poor compliance to protocol|2|||
131627051|NCT03845517|473921251|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
131901846|NCT05404711|474925225|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
131901847|NCT05404711|474925225|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
131444208|NCT02345070|473257074|FG001|Overall Study|Poor compliance to protocol|0|||
131627052|NCT03845517|473921252|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
131627053|NCT03845517|473921253|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
131627054|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
131627055|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
131627056|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
131627057|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
131901848|NCT05404711|474925225|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
131901849|NCT00325819|474925226|FG000|Overall Study|Study product lost in mail|2|||
131444209|NCT02345070|473257075|FG002|Overall Study|Poor compliance to protocol|0|||
131444210|NCT02345070|473257073|FG000|Overall Study|Other than specified above|6|||
131444211|NCT02345070|473257074|FG001|Overall Study|Other than specified above|3|||
131797271|NCT02146430|474541568|FG002|Overall Study|Adverse Event|32|||
131627058|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Death|0|||
131627059|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Death|0|||
131627060|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Death|1|||
131712207|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
131712208|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
131712209|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
131712210|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
131627061|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Death|1|||
131627062|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
131627063|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
131712211|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
131712212|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
131627064|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
131712213|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
131712214|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
131712215|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
131712216|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
131712217|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
131712218|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
131712219|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Death|0|||
131712220|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Death|0|||
131712221|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Death|0|||
131712222|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Death|2|||
131712223|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Death|0|||
131712224|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Death|0|||
131712225|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
131712226|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
131797272|NCT02146430|474541569|FG003|Overall Study|Adverse Event|49|||
131627065|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
131627066|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
131627067|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
131627068|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
131627069|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
131627070|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
131627071|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
131627072|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
131627073|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
131627074|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Other|1|||
131627075|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Other|0|||
131627076|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Other|1|||
131627077|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Other|0|||
131627078|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
131627079|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
131797273|NCT02146430|474541566|FG000|Overall Study|Reason missing or not reported|2|||
131797274|NCT02146430|474541567|FG001|Overall Study|Reason missing or not reported|3|||
131797275|NCT02146430|474541568|FG002|Overall Study|Reason missing or not reported|4|||
131797276|NCT02146430|474541569|FG003|Overall Study|Reason missing or not reported|5|||
131797277|NCT02146430|474541566|FG000|Overall Study|Withdrawal by Subject|27|||
131797278|NCT02146430|474541567|FG001|Overall Study|Withdrawal by Subject|29|||
131797279|NCT02146430|474541568|FG002|Overall Study|Withdrawal by Subject|30|||
131797280|NCT02146430|474541569|FG003|Overall Study|Withdrawal by Subject|34|||
131797281|NCT01893905|474541570|FG000|Overall Study|Withdrawal by Subject|1|||
131797282|NCT01893905|474541571|FG001|Overall Study|Withdrawal by Subject|0|||
131797283|NCT01893905|474541570|FG000|Overall Study|Adverse Event|9|||
131797284|NCT01893905|474541571|FG001|Overall Study|Adverse Event|3|||
131797285|NCT01893905|474541570|FG000|Overall Study|Lack of Efficacy|5|||
131797286|NCT01893905|474541571|FG001|Overall Study|Lack of Efficacy|7|||
131797287|NCT01893905|474541570|FG000|Overall Study|Lost to Follow-up|1|||
131797288|NCT01893905|474541571|FG001|Overall Study|Lost to Follow-up|0|||
131797289|NCT01893905|474541570|FG000|Overall Study|Protocol Violation|6|||
131797290|NCT01893905|474541571|FG001|Overall Study|Protocol Violation|1|||
131797291|NCT01893905|474541570|FG000|Overall Study|Lack of adherence to treatment|2|||
131797292|NCT01893905|474541571|FG001|Overall Study|Lack of adherence to treatment|0|||
131797293|NCT01893905|474541570|FG000|Overall Study|Other reason|1|||
131797294|NCT01893905|474541571|FG001|Overall Study|Other reason|3|||
131797295|NCT03312530|474541572|FG000|Overall Study|Death|5|||
131797296|NCT03312530|474541573|FG001|Overall Study|Death|5|||
131797297|NCT03312530|474541574|FG002|Overall Study|Death|4|||
131797298|NCT03312530|474541575|FG003|Overall Study|Death|10|||
131797299|NCT03312530|474541576|FG004|Overall Study|Death|8|||
131797300|NCT03312530|474541572|FG000|Overall Study|Lost to Follow-up|0|||
131797301|NCT03312530|474541573|FG001|Overall Study|Lost to Follow-up|0|||
131797302|NCT03312530|474541574|FG002|Overall Study|Lost to Follow-up|0|||
131797303|NCT03312530|474541575|FG003|Overall Study|Lost to Follow-up|1|||
131797304|NCT03312530|474541576|FG004|Overall Study|Lost to Follow-up|0|||
131797305|NCT03312530|474541572|FG000|Overall Study|Participant in another sponsor study.|0|||
131797306|NCT03312530|474541573|FG001|Overall Study|Participant in another sponsor study.|0|||
131797307|NCT03312530|474541574|FG002|Overall Study|Participant in another sponsor study.|0|||
131797308|NCT03312530|474541575|FG003|Overall Study|Participant in another sponsor study.|1|||
131797309|NCT03312530|474541576|FG004|Overall Study|Participant in another sponsor study.|0|||
131797310|NCT03312530|474541572|FG000|Overall Study|Study terminated by sponsor|1|||
131797311|NCT03312530|474541573|FG001|Overall Study|Study terminated by sponsor|0|||
131797312|NCT03312530|474541574|FG002|Overall Study|Study terminated by sponsor|2|||
131797313|NCT03312530|474541575|FG003|Overall Study|Study terminated by sponsor|3|||
131797314|NCT03312530|474541576|FG004|Overall Study|Study terminated by sponsor|7|||
131797315|NCT03312530|474541572|FG000|Overall Study|Withdrawal by Subject|0|||
131797316|NCT03312530|474541573|FG001|Overall Study|Withdrawal by Subject|1|||
131627080|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
131797317|NCT03312530|474541574|FG002|Overall Study|Withdrawal by Subject|0|||
131797318|NCT03312530|474541575|FG003|Overall Study|Withdrawal by Subject|0|||
131797319|NCT03312530|474541576|FG004|Overall Study|Withdrawal by Subject|0|||
131797320|NCT03312530|474541572|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131797321|NCT03312530|474541573|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131797322|NCT03312530|474541574|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131797323|NCT03312530|474541575|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
131804484|NCT03340727|474568539|FG001|Overall Study|Withdrawal by Subject|17|||
131627081|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
131627082|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
131627083|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
131627084|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
131627085|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
131627086|NCT03845517|473921250|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
131627087|NCT03845517|473921251|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
131627088|NCT03845517|473921252|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
131627089|NCT03845517|473921253|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
131627090|NCT02410278|473921256|FG000|Run-in Period|Adverse Event|5|||
131627091|NCT02410278|473921257|FG001|Run-in Period|Adverse Event|0|||
131627092|NCT02410278|473921258|FG002|Run-in Period|Adverse Event|0|||
131627093|NCT02410278|473921256|FG000|Run-in Period|GSRS Threshold Not Met|30|||
131627094|NCT02410278|473921257|FG001|Run-in Period|GSRS Threshold Not Met|0|||
131627095|NCT02410278|473921258|FG002|Run-in Period|GSRS Threshold Not Met|0|||
131627096|NCT02410278|473921256|FG000|Run-in Period|Lost to Follow-up|1|||
131627097|NCT02410278|473921257|FG001|Run-in Period|Lost to Follow-up|0|||
131627098|NCT02410278|473921258|FG002|Run-in Period|Lost to Follow-up|0|||
131627099|NCT02410278|473921256|FG000|Run-in Period|Withdrawal by Subject|1|||
131627100|NCT02410278|473921257|FG001|Run-in Period|Withdrawal by Subject|0|||
131627101|NCT02410278|473921258|FG002|Run-in Period|Withdrawal by Subject|0|||
131627102|NCT02410278|473921256|FG000|Run-in Period|Pregnancy|1|||
131627103|NCT02410278|473921257|FG001|Run-in Period|Pregnancy|0|||
131627104|NCT02410278|473921258|FG002|Run-in Period|Pregnancy|0|||
131627105|NCT02410278|473921256|FG000|Study Treatment Period|Adverse Event|0|||
131627106|NCT02410278|473921257|FG001|Study Treatment Period|Adverse Event|6|||
131627107|NCT02410278|473921258|FG002|Study Treatment Period|Adverse Event|3|||
131627108|NCT02410278|473921256|FG000|Study Treatment Period|Physician Decision|0|||
131627109|NCT02410278|473921257|FG001|Study Treatment Period|Physician Decision|0|||
131627110|NCT02410278|473921258|FG002|Study Treatment Period|Physician Decision|1|||
131627111|NCT02410278|473921256|FG000|Study Treatment Period|Withdrawal by Subject|0|||
131627112|NCT02410278|473921257|FG001|Study Treatment Period|Withdrawal by Subject|1|||
131627113|NCT02410278|473921258|FG002|Study Treatment Period|Withdrawal by Subject|0|||
131627114|NCT02410278|473921256|FG000|Study Treatment Period|Other|0|||
131627115|NCT02410278|473921257|FG001|Study Treatment Period|Other|3|||
131627116|NCT02410278|473921258|FG002|Study Treatment Period|Other|0|||
131627117|NCT02410278|473921256|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
131627118|NCT02410278|473921257|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
131627119|NCT02410278|473921258|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
131627120|NCT03695185|473921259|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
131627121|NCT03695185|473921259|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
131627122|NCT03695185|473921259|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
131627123|NCT03695185|473921259|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
131627124|NCT03695185|473921259|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
131627125|NCT03695185|473921259|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
131627126|NCT02584257|473921260|FG000|Period 1|Withdrawal by Subject|0|||
131627127|NCT02584257|473921261|FG001|Period 1|Withdrawal by Subject|0|||
131627128|NCT02584257|473921262|FG002|Period 1|Withdrawal by Subject|0|||
131627129|NCT02584257|473921263|FG003|Period 1|Withdrawal by Subject|0|||
131627130|NCT02584257|473921264|FG004|Period 1|Withdrawal by Subject|0|||
131627131|NCT02584257|473921265|FG005|Period 1|Withdrawal by Subject|0|||
131627132|NCT02584257|473921266|FG006|Period 1|Withdrawal by Subject|1|||
131627133|NCT02584257|473921267|FG007|Period 1|Withdrawal by Subject|0|||
131627134|NCT02584257|473921268|FG008|Period 1|Withdrawal by Subject|0|||
131627135|NCT02584257|473921260|FG000|Period 2|Physician Decision|1|||
131627136|NCT02584257|473921261|FG001|Period 2|Physician Decision|0|||
131627137|NCT02584257|473921262|FG002|Period 2|Physician Decision|0|||
131627138|NCT02584257|473921263|FG003|Period 2|Physician Decision|0|||
131627139|NCT02584257|473921264|FG004|Period 2|Physician Decision|0|||
131627140|NCT02584257|473921265|FG005|Period 2|Physician Decision|0|||
131627141|NCT02584257|473921266|FG006|Period 2|Physician Decision|0|||
131627142|NCT02584257|473921267|FG007|Period 2|Physician Decision|0|||
131627143|NCT02584257|473921268|FG008|Period 2|Physician Decision|0|||
131627144|NCT02584257|473921260|FG000|Period 2|Adverse Event|0|||
131627145|NCT02584257|473921261|FG001|Period 2|Adverse Event|1|||
131627146|NCT02584257|473921262|FG002|Period 2|Adverse Event|0|||
131627147|NCT02584257|473921263|FG003|Period 2|Adverse Event|0|||
131627148|NCT02584257|473921264|FG004|Period 2|Adverse Event|0|||
131627149|NCT02584257|473921265|FG005|Period 2|Adverse Event|0|||
131627150|NCT02584257|473921266|FG006|Period 2|Adverse Event|0|||
131627151|NCT02584257|473921267|FG007|Period 2|Adverse Event|0|||
131627152|NCT02584257|473921268|FG008|Period 2|Adverse Event|0|||
131627153|NCT01670877|473921269|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131627154|NCT01670877|473921270|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
131627155|NCT01670877|473921271|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131627156|NCT01670877|473921272|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131627157|NCT01670877|473921273|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131627158|NCT01670877|473921274|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131627159|NCT01670877|473921269|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131627160|NCT01670877|473921270|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131627161|NCT01670877|473921271|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
131627162|NCT01670877|473921272|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131627163|NCT01670877|473921273|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131627164|NCT01670877|473921274|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131627165|NCT01670877|473921269|FG000|Part I and Part 2|Grade 2 vomiting|0|||
131627166|NCT01670877|473921270|FG001|Part I and Part 2|Grade 2 vomiting|0|||
131627167|NCT01670877|473921271|FG002|Part I and Part 2|Grade 2 vomiting|0|||
131627168|NCT01670877|473921272|FG003|Part I and Part 2|Grade 2 vomiting|1|||
131627169|NCT01670877|473921273|FG004|Part I and Part 2|Grade 2 vomiting|0|||
131627170|NCT01670877|473921274|FG005|Part I and Part 2|Grade 2 vomiting|0|||
131627171|NCT01670877|473921269|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131627172|NCT01670877|473921270|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131627173|NCT01670877|473921271|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131627174|NCT01670877|473921272|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
131627175|NCT01670877|473921273|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131627176|NCT01670877|473921274|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131627177|NCT01670877|473921269|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131627178|NCT01670877|473921270|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131627179|NCT01670877|473921271|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131627180|NCT01670877|473921272|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
131627181|NCT01670877|473921273|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131627182|NCT01670877|473921274|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131627183|NCT03146845|473921276|FG000|Overall Study|Reference ulcer healed|1|||
131797324|NCT03312530|474541576|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131797325|NCT00278200|474541578|FG000|Overall Study|Death|1|||
131797326|NCT00278200|474541579|FG001|Overall Study|Death|3|||
131797327|NCT00278200|474541578|FG000|Overall Study|Physician Decision|0|||
131797328|NCT00278200|474541579|FG001|Overall Study|Physician Decision|1|||
131797329|NCT03519256|474541587|FG000|Overall Study|Disease recurrence|4|||
131797330|NCT03519256|474541588|FG001|Overall Study|Disease recurrence|4|||
131797331|NCT03519256|474541589|FG002|Overall Study|Disease recurrence|5|||
131797332|NCT03519256|474541590|FG003|Overall Study|Disease recurrence|2|||
131797333|NCT03519256|474541587|FG000|Overall Study|Study drug toxicity|0|||
131797334|NCT03519256|474541588|FG001|Overall Study|Study drug toxicity|2|||
131797335|NCT03519256|474541589|FG002|Overall Study|Study drug toxicity|5|||
131797336|NCT03519256|474541590|FG003|Overall Study|Study drug toxicity|2|||
131797337|NCT03519256|474541587|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131797338|NCT03519256|474541588|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131797339|NCT03519256|474541589|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131797340|NCT03519256|474541590|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131797341|NCT03519256|474541587|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131797342|NCT03519256|474541588|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131797343|NCT03519256|474541589|FG002|Overall Study|Participant request to discontinue study treatment|0|||
131797344|NCT03519256|474541590|FG003|Overall Study|Participant request to discontinue study treatment|2|||
131797345|NCT03519256|474541587|FG000|Overall Study|Other reasons|0|||
131797346|NCT03519256|474541588|FG001|Overall Study|Other reasons|0|||
131797347|NCT03519256|474541589|FG002|Overall Study|Other reasons|2|||
131797348|NCT03519256|474541590|FG003|Overall Study|Other reasons|0|||
131797349|NCT03519256|474541587|FG000|Overall Study|Disease progression|6|||
131797350|NCT03519256|474541588|FG001|Overall Study|Disease progression|3|||
131797351|NCT03519256|474541589|FG002|Overall Study|Disease progression|2|||
131797352|NCT03519256|474541590|FG003|Overall Study|Disease progression|1|||
131797353|NCT03519256|474541587|FG000|Overall Study|Lost to Follow-up|0|||
131797354|NCT03519256|474541588|FG001|Overall Study|Lost to Follow-up|1|||
131797355|NCT03519256|474541589|FG002|Overall Study|Lost to Follow-up|0|||
131797356|NCT03519256|474541590|FG003|Overall Study|Lost to Follow-up|0|||
131797357|NCT04828161|474541591|FG000|Overall Study|Withdrawal by Subject|0|||
131797358|NCT04828161|474541592|FG001|Overall Study|Withdrawal by Subject|3|||
131797359|NCT04828161|474541593|FG002|Overall Study|Withdrawal by Subject|3|||
131804485|NCT03603314|474568540|FG000|Overall Study|Lost to Follow-up|0|||
131797360|NCT04828161|474541594|FG003|Overall Study|Withdrawal by Subject|4|||
131797361|NCT04828161|474541591|FG000|Overall Study|Lost to Follow-up|1|||
131797362|NCT04828161|474541592|FG001|Overall Study|Lost to Follow-up|4|||
131797363|NCT04828161|474541593|FG002|Overall Study|Lost to Follow-up|2|||
131797364|NCT04828161|474541594|FG003|Overall Study|Lost to Follow-up|2|||
131627184|NCT03146845|473921277|FG001|Overall Study|Reference ulcer healed|0|||
131627185|NCT03146845|473921276|FG000|Overall Study|Physician Decision|1|||
131627186|NCT03146845|473921277|FG001|Overall Study|Physician Decision|0|||
131627187|NCT03146845|473921276|FG000|Overall Study|Adverse Event|1|||
131627188|NCT03146845|473921277|FG001|Overall Study|Adverse Event|0|||
131627189|NCT03146845|473921276|FG000|Overall Study|Withdrawal by Subject|2|||
131627190|NCT03146845|473921277|FG001|Overall Study|Withdrawal by Subject|0|||
131627191|NCT03146845|473921276|FG000|Overall Study|Noncompliance|0|||
131627192|NCT03146845|473921277|FG001|Overall Study|Noncompliance|1|||
131627193|NCT03146845|473921276|FG000|Overall Study|Protocol Violation|0|||
131627194|NCT03146845|473921277|FG001|Overall Study|Protocol Violation|2|||
131627195|NCT03146845|473921276|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
131627196|NCT03146845|473921277|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
131627197|NCT01912599|473921282|FG000|Overall Study|Withdrawal by Subject|0|||
131627198|NCT01912599|473921283|FG001|Overall Study|Withdrawal by Subject|1|||
131627199|NCT00795639|473921285|FG000|Overall Study|Death|1|||
131627200|NCT00795639|473921286|FG001|Overall Study|Death|6|||
131627201|NCT00795639|473921285|FG000|Overall Study|Withdrawal by Subject|1|||
131627202|NCT00795639|473921286|FG001|Overall Study|Withdrawal by Subject|3|||
131627203|NCT00795639|473921285|FG000|Overall Study|Pregnancy|1|||
131627204|NCT00795639|473921286|FG001|Overall Study|Pregnancy|0|||
131627205|NCT00795639|473921285|FG000|Overall Study|Adverse Event|5|||
131627206|NCT00795639|473921286|FG001|Overall Study|Adverse Event|2|||
131627207|NCT00795639|473921285|FG000|Overall Study|Other|0|||
131627208|NCT00795639|473921286|FG001|Overall Study|Other|2|||
131627209|NCT00795639|473921285|FG000|Overall Study|Terminated by sponsor|13|||
131627210|NCT00795639|473921286|FG001|Overall Study|Terminated by sponsor|12|||
131627211|NCT00795639|473921285|FG000|Overall Study|Randomized and not treated|0|||
131627212|NCT00795639|473921286|FG001|Overall Study|Randomized and not treated|1|||
131627213|NCT03150589|473921291|FG000|Overall Study|Withdrawal by Subject|16|||
131627214|NCT03150589|473921292|FG001|Overall Study|Withdrawal by Subject|9|||
131627215|NCT03150589|473921291|FG000|Overall Study|Adverse Event|7|||
131627216|NCT03150589|473921292|FG001|Overall Study|Adverse Event|6|||
131627217|NCT03150589|473921291|FG000|Overall Study|Protocol Violation|4|||
131627218|NCT03150589|473921292|FG001|Overall Study|Protocol Violation|3|||
131627219|NCT03150589|473921291|FG000|Overall Study|Lost to Follow-up|3|||
131627220|NCT03150589|473921292|FG001|Overall Study|Lost to Follow-up|3|||
131627221|NCT03150589|473921291|FG000|Overall Study|Death|2|||
131627222|NCT03150589|473921292|FG001|Overall Study|Death|3|||
131627223|NCT03150589|473921291|FG000|Overall Study|IP non-compliance and other reasons|12|||
131627224|NCT03150589|473921292|FG001|Overall Study|IP non-compliance and other reasons|3|||
131627225|NCT01405508|473921293|FG000|Overall Study|AE, non-serious non-fatal|1|||
131627226|NCT01405508|473921294|FG001|Overall Study|AE, non-serious non-fatal|1|||
131627227|NCT01405508|473921295|FG002|Overall Study|AE, non-serious non-fatal|0|||
131627228|NCT01405508|473921296|FG003|Overall Study|AE, non-serious non-fatal|0|||
131627229|NCT00476957|473921297|FG000|Overall Study|Lost to Follow-up|176|||
131627230|NCT00476957|473921298|FG001|Overall Study|Lost to Follow-up|193|||
131627231|NCT02159352|473921305|FG000|Overall Study|Adverse Event|3|||
131627232|NCT02159352|473921306|FG001|Overall Study|Adverse Event|1|||
131627233|NCT02159352|473921305|FG000|Overall Study|Withdrawal by Subject|0|||
131627234|NCT02159352|473921306|FG001|Overall Study|Withdrawal by Subject|1|||
131627235|NCT00529529|473921307|FG000|Overall Study|Adverse Event|12|||
131627236|NCT00529529|473921308|FG001|Overall Study|Adverse Event|17|||
131627237|NCT00529529|473921309|FG002|Overall Study|Adverse Event|8|||
131627238|NCT00529529|473921307|FG000|Overall Study|Subject withdrew consent|12|||
131627239|NCT00529529|473921308|FG001|Overall Study|Subject withdrew consent|9|||
131627240|NCT00529529|473921309|FG002|Overall Study|Subject withdrew consent|12|||
131627241|NCT00529529|473921307|FG000|Overall Study|Protocol deviation|8|||
131627242|NCT00529529|473921308|FG001|Overall Study|Protocol deviation|12|||
131627243|NCT00529529|473921309|FG002|Overall Study|Protocol deviation|5|||
131627244|NCT00529529|473921307|FG000|Overall Study|Lost to Follow-up|5|||
131627245|NCT00529529|473921308|FG001|Overall Study|Lost to Follow-up|3|||
131627246|NCT00529529|473921309|FG002|Overall Study|Lost to Follow-up|1|||
131627247|NCT00529529|473921307|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131627248|NCT00529529|473921308|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131627249|NCT00529529|473921309|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131627250|NCT00529529|473921307|FG000|Overall Study|Death|2|||
131627251|NCT00529529|473921308|FG001|Overall Study|Death|0|||
131627252|NCT00529529|473921309|FG002|Overall Study|Death|0|||
131627253|NCT00529529|473921307|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131627254|NCT00529529|473921308|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131797365|NCT04828161|474541591|FG000|Overall Study|Other|2|||
131627255|NCT00529529|473921309|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131627256|NCT00529529|473921307|FG000|Overall Study|Administrative problems|1|||
131627257|NCT00529529|473921308|FG001|Overall Study|Administrative problems|0|||
131627258|NCT00529529|473921309|FG002|Overall Study|Administrative problems|3|||
131627259|NCT01020435|473921314|FG000|Overall Study|Lost to Follow-up|0|||
131627260|NCT01020435|473921315|FG001|Overall Study|Lost to Follow-up|1|||
131627261|NCT01000649|473921316|FG000|Overall Study|Adverse Event|5|||
131627262|NCT01000649|473921317|FG001|Overall Study|Adverse Event|1|||
131627263|NCT01000649|473921318|FG002|Overall Study|Adverse Event|2|||
131627264|NCT01000649|473921319|FG003|Overall Study|Adverse Event|4|||
131627265|NCT01000649|473921316|FG000|Overall Study|Lost to Follow-up|0|||
131627266|NCT01000649|473921317|FG001|Overall Study|Lost to Follow-up|2|||
131627267|NCT01000649|473921318|FG002|Overall Study|Lost to Follow-up|0|||
131627268|NCT01000649|473921319|FG003|Overall Study|Lost to Follow-up|2|||
131627269|NCT00346398|473921320|FG000|Overall Study|Lost to Follow-up|3|||
131627270|NCT00346398|473921321|FG001|Overall Study|Lost to Follow-up|0|||
131627271|NCT00346398|473921320|FG000|Overall Study|Withdrawal by Subject|0|||
131627272|NCT00346398|473921321|FG001|Overall Study|Withdrawal by Subject|2|||
131627273|NCT01916109|473921322|FG000|Overall Study|Withdrawal by Subject|1|||
131627274|NCT00103857|473921323|FG000|54-Week Base Study|Adverse Event|12|||
131627275|NCT00103857|473921324|FG001|54-Week Base Study|Adverse Event|9|||
131627276|NCT00103857|473921325|FG002|54-Week Base Study|Adverse Event|11|||
131712227|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
131627277|NCT00103857|473921326|FG003|54-Week Base Study|Adverse Event|6|||
131627278|NCT00103857|473921327|FG004|54-Week Base Study|Adverse Event|5|||
131627279|NCT00103857|473921328|FG005|54-Week Base Study|Adverse Event|11|||
131627280|NCT00103857|473921329|FG006|54-Week Base Study|Adverse Event|3|||
131627281|NCT00103857|473921323|FG000|54-Week Base Study|Death|0|||
131712228|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
131627282|NCT00103857|473921324|FG001|54-Week Base Study|Death|0|||
131797366|NCT04828161|474541592|FG001|Overall Study|Other|0|||
131797367|NCT04828161|474541593|FG002|Overall Study|Other|2|||
131797368|NCT04828161|474541594|FG003|Overall Study|Other|0|||
131797369|NCT04828161|474541591|FG000|Overall Study|Death|0|||
131627283|NCT00103857|473921325|FG002|54-Week Base Study|Death|0|||
131797370|NCT04828161|474541592|FG001|Overall Study|Death|0|||
131627284|NCT00103857|473921326|FG003|54-Week Base Study|Death|0|||
131627285|NCT00103857|473921327|FG004|54-Week Base Study|Death|1|||
131627286|NCT00103857|473921328|FG005|54-Week Base Study|Death|1|||
131627287|NCT00103857|473921329|FG006|54-Week Base Study|Death|0|||
131627288|NCT00103857|473921323|FG000|54-Week Base Study|Lack of Efficacy|11|||
131627289|NCT00103857|473921324|FG001|54-Week Base Study|Lack of Efficacy|14|||
131627290|NCT00103857|473921325|FG002|54-Week Base Study|Lack of Efficacy|8|||
131627291|NCT00103857|473921326|FG003|54-Week Base Study|Lack of Efficacy|4|||
131627292|NCT00103857|473921327|FG004|54-Week Base Study|Lack of Efficacy|3|||
131627293|NCT00103857|473921328|FG005|54-Week Base Study|Lack of Efficacy|14|||
131627294|NCT00103857|473921329|FG006|54-Week Base Study|Lack of Efficacy|19|||
131627295|NCT00103857|473921323|FG000|54-Week Base Study|Lost to Follow-up|5|||
131627296|NCT00103857|473921324|FG001|54-Week Base Study|Lost to Follow-up|4|||
131627297|NCT00103857|473921325|FG002|54-Week Base Study|Lost to Follow-up|7|||
131627298|NCT00103857|473921326|FG003|54-Week Base Study|Lost to Follow-up|5|||
131627299|NCT00103857|473921327|FG004|54-Week Base Study|Lost to Follow-up|10|||
131627300|NCT00103857|473921328|FG005|54-Week Base Study|Lost to Follow-up|9|||
131627301|NCT00103857|473921329|FG006|54-Week Base Study|Lost to Follow-up|3|||
131627302|NCT00103857|473921323|FG000|54-Week Base Study|Physician Decision|1|||
131627303|NCT00103857|473921324|FG001|54-Week Base Study|Physician Decision|1|||
131627304|NCT00103857|473921325|FG002|54-Week Base Study|Physician Decision|0|||
131627305|NCT00103857|473921326|FG003|54-Week Base Study|Physician Decision|0|||
131627306|NCT00103857|473921327|FG004|54-Week Base Study|Physician Decision|1|||
131627307|NCT00103857|473921328|FG005|54-Week Base Study|Physician Decision|0|||
131627308|NCT00103857|473921329|FG006|54-Week Base Study|Physician Decision|0|||
131627309|NCT00103857|473921323|FG000|54-Week Base Study|Pregnancy|1|||
131627310|NCT00103857|473921324|FG001|54-Week Base Study|Pregnancy|0|||
131627311|NCT00103857|473921325|FG002|54-Week Base Study|Pregnancy|0|||
131627312|NCT00103857|473921326|FG003|54-Week Base Study|Pregnancy|0|||
131627313|NCT00103857|473921327|FG004|54-Week Base Study|Pregnancy|1|||
131627314|NCT00103857|473921328|FG005|54-Week Base Study|Pregnancy|0|||
131627315|NCT00103857|473921329|FG006|54-Week Base Study|Pregnancy|1|||
131797371|NCT04828161|474541593|FG002|Overall Study|Death|0|||
131797372|NCT04828161|474541594|FG003|Overall Study|Death|2|||
131797373|NCT00135707|474541599|FG000|Overall Study|Lost to Follow-up|94|||
131797374|NCT00135707|474541600|FG001|Overall Study|Lost to Follow-up|89|||
131797375|NCT00135707|474541599|FG000|Overall Study|Withdrawal by Subject|0|||
131797376|NCT00135707|474541600|FG001|Overall Study|Withdrawal by Subject|1|||
131797377|NCT00135707|474541599|FG000|Overall Study|Institutional review board request|1|||
131797378|NCT00135707|474541600|FG001|Overall Study|Institutional review board request|0|||
131797379|NCT03093454|474541601|FG000|Overall Study|Withdrawal by Subject|1|||
131797380|NCT03093454|474541602|FG001|Overall Study|Withdrawal by Subject|1|||
131797381|NCT03093454|474541601|FG000|Overall Study|Scheduling conflict|3|||
131797382|NCT03093454|474541602|FG001|Overall Study|Scheduling conflict|1|||
131797383|NCT03093454|474541601|FG000|Overall Study|Physician Decision|2|||
131797384|NCT03093454|474541602|FG001|Overall Study|Physician Decision|1|||
131797385|NCT04540497|474541606|FG000|Overall Study|Adverse Event|0|||
131797386|NCT04540497|474541607|FG001|Overall Study|Adverse Event|2|||
131797387|NCT04540497|474541606|FG000|Overall Study|Lost to Follow-up|1|||
131797388|NCT04540497|474541607|FG001|Overall Study|Lost to Follow-up|0|||
131797389|NCT04540497|474541606|FG000|Overall Study|Withdrawal by Subject|1|||
131797390|NCT04540497|474541607|FG001|Overall Study|Withdrawal by Subject|1|||
131797391|NCT04540497|474541606|FG000|Overall Study|Miscellaneous|2|||
131797392|NCT04540497|474541607|FG001|Overall Study|Miscellaneous|1|||
131627316|NCT00103857|473921323|FG000|54-Week Base Study|Protocol Violation|6|||
131627317|NCT00103857|473921324|FG001|54-Week Base Study|Protocol Violation|4|||
131627318|NCT00103857|473921325|FG002|54-Week Base Study|Protocol Violation|2|||
131627319|NCT00103857|473921326|FG003|54-Week Base Study|Protocol Violation|4|||
131627320|NCT00103857|473921327|FG004|54-Week Base Study|Protocol Violation|0|||
131627321|NCT00103857|473921328|FG005|54-Week Base Study|Protocol Violation|3|||
131627322|NCT00103857|473921329|FG006|54-Week Base Study|Protocol Violation|3|||
131797393|NCT02524379|474541608|FG000|Overall Study|Death|1|||
131797394|NCT04700449|474541609|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
131797395|NCT04700449|474541610|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
131797396|NCT04700449|474541611|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
131797397|NCT04700449|474541612|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
131797398|NCT04700449|474541609|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
131627323|NCT00103857|473921323|FG000|54-Week Base Study|Withdrawal by Subject|17|||
131797399|NCT04700449|474541610|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
131797400|NCT04700449|474541611|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
131797401|NCT04700449|474541612|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
131712229|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
131712230|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
131712231|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
131712232|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
131712233|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
131712234|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
131712235|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
131712236|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
131712237|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
131712238|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
131712239|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
131712240|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
131712241|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
131712242|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
131712243|NCT01707992|474224166|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131712244|NCT01707992|474224167|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131712245|NCT01707992|474224168|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131712246|NCT01707992|474224169|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131712247|NCT01707992|474224170|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
131712248|NCT01707992|474224171|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131712249|NCT02654002|474224173|FG000|Overall Study|Adverse Event|0|||
131712250|NCT02654002|474224174|FG001|Overall Study|Adverse Event|0|||
131712251|NCT02654002|474224175|FG002|Overall Study|Adverse Event|0|||
131712252|NCT02654002|474224176|FG003|Overall Study|Adverse Event|0|||
131712253|NCT02654002|474224177|FG004|Overall Study|Adverse Event|0|||
131712254|NCT02654002|474224178|FG005|Overall Study|Adverse Event|0|||
131712255|NCT02654002|474224179|FG006|Overall Study|Adverse Event|1|||
131712256|NCT02654002|474224180|FG007|Overall Study|Adverse Event|0|||
131712257|NCT02654002|474224181|FG008|Overall Study|Adverse Event|0|||
131712258|NCT02654002|474224173|FG000|Overall Study|Withdrew Consent|0|||
131627324|NCT00103857|473921324|FG001|54-Week Base Study|Withdrawal by Subject|16|||
131627325|NCT00103857|473921325|FG002|54-Week Base Study|Withdrawal by Subject|16|||
131627326|NCT00103857|473921326|FG003|54-Week Base Study|Withdrawal by Subject|15|||
131627327|NCT00103857|473921327|FG004|54-Week Base Study|Withdrawal by Subject|10|||
131627328|NCT00103857|473921328|FG005|54-Week Base Study|Withdrawal by Subject|15|||
131627329|NCT00103857|473921329|FG006|54-Week Base Study|Withdrawal by Subject|4|||
131627330|NCT00103857|473921323|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
131627331|NCT00103857|473921324|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
131627332|NCT00103857|473921325|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
131627333|NCT00103857|473921326|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
131627334|NCT00103857|473921327|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
131627335|NCT00103857|473921328|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
131627336|NCT00103857|473921329|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
131627337|NCT00103857|473921323|FG000|54-Week Base Study|patient moved|0|||
131627338|NCT00103857|473921324|FG001|54-Week Base Study|patient moved|1|||
131627339|NCT00103857|473921325|FG002|54-Week Base Study|patient moved|1|||
131627340|NCT00103857|473921326|FG003|54-Week Base Study|patient moved|2|||
131627341|NCT00103857|473921327|FG004|54-Week Base Study|patient moved|3|||
131627342|NCT00103857|473921328|FG005|54-Week Base Study|patient moved|1|||
131627343|NCT00103857|473921329|FG006|54-Week Base Study|patient moved|0|||
131627344|NCT00103857|473921323|FG000|54-Week Base Study|non-compliance with study procedures|1|||
131627345|NCT00103857|473921324|FG001|54-Week Base Study|non-compliance with study procedures|2|||
131627346|NCT00103857|473921325|FG002|54-Week Base Study|non-compliance with study procedures|0|||
131627347|NCT00103857|473921326|FG003|54-Week Base Study|non-compliance with study procedures|0|||
131627348|NCT00103857|473921327|FG004|54-Week Base Study|non-compliance with study procedures|0|||
131627349|NCT00103857|473921328|FG005|54-Week Base Study|non-compliance with study procedures|2|||
131627350|NCT00103857|473921329|FG006|54-Week Base Study|non-compliance with study procedures|0|||
131627351|NCT00103857|473921323|FG000|54-Week Base Study|patient incarcerated|0|||
131627352|NCT00103857|473921324|FG001|54-Week Base Study|patient incarcerated|0|||
131627353|NCT00103857|473921325|FG002|54-Week Base Study|patient incarcerated|0|||
131627354|NCT00103857|473921326|FG003|54-Week Base Study|patient incarcerated|0|||
131627355|NCT00103857|473921327|FG004|54-Week Base Study|patient incarcerated|1|||
131627356|NCT00103857|473921328|FG005|54-Week Base Study|patient incarcerated|1|||
131627357|NCT00103857|473921329|FG006|54-Week Base Study|patient incarcerated|0|||
131627358|NCT00103857|473921323|FG000|54-Week Base Study|laboratory reporting error|0|||
131627359|NCT00103857|473921324|FG001|54-Week Base Study|laboratory reporting error|0|||
131627360|NCT00103857|473921325|FG002|54-Week Base Study|laboratory reporting error|0|||
131712259|NCT02654002|474224174|FG001|Overall Study|Withdrew Consent|0|||
131712260|NCT02654002|474224175|FG002|Overall Study|Withdrew Consent|0|||
131712261|NCT02654002|474224176|FG003|Overall Study|Withdrew Consent|0|||
131712262|NCT02654002|474224177|FG004|Overall Study|Withdrew Consent|0|||
131712263|NCT02654002|474224178|FG005|Overall Study|Withdrew Consent|1|||
131712264|NCT02654002|474224179|FG006|Overall Study|Withdrew Consent|0|||
131712265|NCT02654002|474224180|FG007|Overall Study|Withdrew Consent|1|||
131712266|NCT02654002|474224181|FG008|Overall Study|Withdrew Consent|0|||
131712267|NCT01587989|474224182|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
131712268|NCT01587989|474224183|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
131712269|NCT01587989|474224184|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
131712270|NCT01587989|474224182|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
131712271|NCT01587989|474224183|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
131712272|NCT01587989|474224184|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
131712273|NCT01587989|474224182|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
131712274|NCT01587989|474224183|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
131712275|NCT01587989|474224184|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
131712276|NCT01587989|474224182|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
131712277|NCT01587989|474224183|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
131712278|NCT01587989|474224184|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
131712279|NCT01587989|474224182|FG000|Randomized Study Treatment|Screening failure|0|||
131712280|NCT01587989|474224183|FG001|Randomized Study Treatment|Screening failure|1|||
131712281|NCT01587989|474224184|FG002|Randomized Study Treatment|Screening failure|0|||
131627361|NCT00103857|473921326|FG003|54-Week Base Study|laboratory reporting error|0|||
131627362|NCT00103857|473921327|FG004|54-Week Base Study|laboratory reporting error|1|||
131627363|NCT00103857|473921328|FG005|54-Week Base Study|laboratory reporting error|0|||
131627364|NCT00103857|473921329|FG006|54-Week Base Study|laboratory reporting error|0|||
131627365|NCT00103857|473921323|FG000|54-Week Base Study|site error|0|||
131627366|NCT00103857|473921324|FG001|54-Week Base Study|site error|0|||
131627367|NCT00103857|473921325|FG002|54-Week Base Study|site error|0|||
131627368|NCT00103857|473921326|FG003|54-Week Base Study|site error|0|||
131627369|NCT00103857|473921327|FG004|54-Week Base Study|site error|0|||
131627370|NCT00103857|473921328|FG005|54-Week Base Study|site error|1|||
131627371|NCT00103857|473921329|FG006|54-Week Base Study|site error|0|||
131627372|NCT00103857|473921323|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
131627373|NCT00103857|473921324|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
131627374|NCT00103857|473921325|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
131712282|NCT01587989|474224182|FG000|Randomized Study Treatment|Physician Decision|0|||
131712283|NCT01587989|474224183|FG001|Randomized Study Treatment|Physician Decision|0|||
131712284|NCT01587989|474224184|FG002|Randomized Study Treatment|Physician Decision|1|||
131712285|NCT00998738|474224185|FG000|Overall Study|Uknown|1|||
131712286|NCT03313050|474224188|FG000|Stage 2: 12 Months|Adverse Event|0|||
131712287|NCT03313050|474224189|FG001|Stage 2: 12 Months|Adverse Event|0|||
131712288|NCT03313050|474224190|FG002|Stage 2: 12 Months|Adverse Event|0|||
131712289|NCT03313050|474224191|FG003|Stage 2: 12 Months|Adverse Event|1|||
131712290|NCT03313050|474224188|FG000|Stage 2: 12 Months|Death|0|||
131712291|NCT03313050|474224189|FG001|Stage 2: 12 Months|Death|0|||
131712292|NCT03313050|474224190|FG002|Stage 2: 12 Months|Death|3|||
131712293|NCT03313050|474224191|FG003|Stage 2: 12 Months|Death|0|||
131712294|NCT03313050|474224188|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
131712295|NCT03313050|474224189|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
131712296|NCT03313050|474224190|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
131712297|NCT03313050|474224191|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
131712298|NCT03313050|474224188|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
131712299|NCT03313050|474224189|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
131712300|NCT03313050|474224190|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
131712301|NCT03313050|474224191|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
131712302|NCT03313050|474224188|FG000|Stage 2: 12 Months|Protocol deviation|0|||
131712303|NCT03313050|474224189|FG001|Stage 2: 12 Months|Protocol deviation|0|||
131712304|NCT03313050|474224190|FG002|Stage 2: 12 Months|Protocol deviation|7|||
131712305|NCT03313050|474224191|FG003|Stage 2: 12 Months|Protocol deviation|7|||
131712306|NCT03313050|474224188|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
131712307|NCT03313050|474224189|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
131712308|NCT03313050|474224190|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
131712309|NCT03313050|474224191|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
131712310|NCT03313050|474224188|FG000|Stage 2: 12 Months|Other|0|||
131712311|NCT03313050|474224189|FG001|Stage 2: 12 Months|Other|0|||
131712312|NCT03313050|474224190|FG002|Stage 2: 12 Months|Other|0|||
131712313|NCT03313050|474224191|FG003|Stage 2: 12 Months|Other|1|||
131712314|NCT00684177|474224192|FG000|Overall Study|Adverse Event|4|||
131712315|NCT00684177|474224193|FG001|Overall Study|Adverse Event|3|||
131627375|NCT00103857|473921326|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
131627376|NCT00103857|473921327|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
131627377|NCT00103857|473921328|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
131627378|NCT00103857|473921329|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
131627379|NCT00103857|473921323|FG000|50-Week Extension Study|Adverse Event|2|||
131627380|NCT00103857|473921324|FG001|50-Week Extension Study|Adverse Event|3|||
131627381|NCT00103857|473921325|FG002|50-Week Extension Study|Adverse Event|2|||
131627382|NCT00103857|473921326|FG003|50-Week Extension Study|Adverse Event|0|||
131627383|NCT00103857|473921327|FG004|50-Week Extension Study|Adverse Event|1|||
131627384|NCT00103857|473921328|FG005|50-Week Extension Study|Adverse Event|1|||
131627385|NCT00103857|473921329|FG006|50-Week Extension Study|Adverse Event|0|||
131627386|NCT00103857|473921323|FG000|50-Week Extension Study|Death|0|||
131627387|NCT00103857|473921324|FG001|50-Week Extension Study|Death|0|||
131627388|NCT00103857|473921325|FG002|50-Week Extension Study|Death|0|||
131627389|NCT00103857|473921326|FG003|50-Week Extension Study|Death|1|||
131627390|NCT00103857|473921327|FG004|50-Week Extension Study|Death|0|||
131627391|NCT00103857|473921328|FG005|50-Week Extension Study|Death|1|||
131627392|NCT00103857|473921329|FG006|50-Week Extension Study|Death|0|||
131627393|NCT00103857|473921323|FG000|50-Week Extension Study|Lack of Efficacy|26|||
131627394|NCT00103857|473921324|FG001|50-Week Extension Study|Lack of Efficacy|15|||
131627395|NCT00103857|473921325|FG002|50-Week Extension Study|Lack of Efficacy|13|||
131627396|NCT00103857|473921326|FG003|50-Week Extension Study|Lack of Efficacy|16|||
131627397|NCT00103857|473921327|FG004|50-Week Extension Study|Lack of Efficacy|8|||
131627398|NCT00103857|473921328|FG005|50-Week Extension Study|Lack of Efficacy|8|||
131627399|NCT00103857|473921329|FG006|50-Week Extension Study|Lack of Efficacy|0|||
131627400|NCT00103857|473921323|FG000|50-Week Extension Study|Lost to Follow-up|4|||
131627401|NCT00103857|473921324|FG001|50-Week Extension Study|Lost to Follow-up|0|||
131627402|NCT00103857|473921325|FG002|50-Week Extension Study|Lost to Follow-up|1|||
131627403|NCT00103857|473921326|FG003|50-Week Extension Study|Lost to Follow-up|4|||
131627404|NCT00103857|473921327|FG004|50-Week Extension Study|Lost to Follow-up|3|||
131627405|NCT00103857|473921328|FG005|50-Week Extension Study|Lost to Follow-up|3|||
131627406|NCT00103857|473921329|FG006|50-Week Extension Study|Lost to Follow-up|0|||
131627407|NCT00103857|473921323|FG000|50-Week Extension Study|Physician Decision|0|||
131627408|NCT00103857|473921324|FG001|50-Week Extension Study|Physician Decision|1|||
131627409|NCT00103857|473921325|FG002|50-Week Extension Study|Physician Decision|1|||
131627410|NCT00103857|473921326|FG003|50-Week Extension Study|Physician Decision|0|||
131627411|NCT00103857|473921327|FG004|50-Week Extension Study|Physician Decision|0|||
131627412|NCT00103857|473921328|FG005|50-Week Extension Study|Physician Decision|0|||
131627413|NCT00103857|473921329|FG006|50-Week Extension Study|Physician Decision|0|||
131627414|NCT00103857|473921323|FG000|50-Week Extension Study|Pregnancy|0|||
131627415|NCT00103857|473921324|FG001|50-Week Extension Study|Pregnancy|0|||
131627416|NCT00103857|473921325|FG002|50-Week Extension Study|Pregnancy|1|||
131627417|NCT00103857|473921326|FG003|50-Week Extension Study|Pregnancy|0|||
131627418|NCT00103857|473921327|FG004|50-Week Extension Study|Pregnancy|1|||
131627419|NCT00103857|473921328|FG005|50-Week Extension Study|Pregnancy|0|||
131627420|NCT00103857|473921329|FG006|50-Week Extension Study|Pregnancy|0|||
131627421|NCT00103857|473921323|FG000|50-Week Extension Study|Protocol Violation|1|||
131627422|NCT00103857|473921324|FG001|50-Week Extension Study|Protocol Violation|1|||
131627423|NCT00103857|473921325|FG002|50-Week Extension Study|Protocol Violation|1|||
131627424|NCT00103857|473921326|FG003|50-Week Extension Study|Protocol Violation|2|||
131712316|NCT00684177|474224192|FG000|Overall Study|Lack of Efficacy|10|||
131712317|NCT00684177|474224193|FG001|Overall Study|Lack of Efficacy|15|||
131627425|NCT00103857|473921327|FG004|50-Week Extension Study|Protocol Violation|0|||
131627426|NCT00103857|473921328|FG005|50-Week Extension Study|Protocol Violation|1|||
131627427|NCT00103857|473921329|FG006|50-Week Extension Study|Protocol Violation|0|||
131627428|NCT00103857|473921323|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
131627429|NCT00103857|473921324|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
131627430|NCT00103857|473921325|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
131627431|NCT00103857|473921326|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
131627432|NCT00103857|473921327|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
131627433|NCT00103857|473921328|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
131627434|NCT00103857|473921329|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
131627435|NCT00103857|473921323|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
131627436|NCT00103857|473921324|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
131627437|NCT00103857|473921325|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
131627438|NCT00103857|473921326|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
131627439|NCT00103857|473921327|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
131627440|NCT00103857|473921328|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
131627441|NCT00103857|473921329|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
131627442|NCT00103857|473921323|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
131627443|NCT00103857|473921324|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
131627444|NCT00103857|473921325|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
131627445|NCT00103857|473921326|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
131627446|NCT00103857|473921327|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
131627447|NCT00103857|473921328|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
131627448|NCT00103857|473921329|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
131627449|NCT00103857|473921323|FG000|50-Week Extension Study|patient moved|0|||
131627450|NCT00103857|473921324|FG001|50-Week Extension Study|patient moved|0|||
131627451|NCT00103857|473921325|FG002|50-Week Extension Study|patient moved|1|||
131627452|NCT00103857|473921326|FG003|50-Week Extension Study|patient moved|2|||
131627453|NCT00103857|473921327|FG004|50-Week Extension Study|patient moved|0|||
131627454|NCT00103857|473921328|FG005|50-Week Extension Study|patient moved|0|||
131627455|NCT00103857|473921329|FG006|50-Week Extension Study|patient moved|0|||
131712318|NCT00684177|474224192|FG000|Overall Study|Protocol Violation|1|||
131712319|NCT00684177|474224193|FG001|Overall Study|Protocol Violation|0|||
131712320|NCT00684177|474224192|FG000|Overall Study|Lost to Follow-up|2|||
131712321|NCT00684177|474224193|FG001|Overall Study|Lost to Follow-up|1|||
131712322|NCT00684177|474224192|FG000|Overall Study|Physician Decision|2|||
131797402|NCT04700449|474541609|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
131797403|NCT04700449|474541610|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
131797404|NCT04700449|474541611|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
131797405|NCT04700449|474541612|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
131627456|NCT00103857|473921323|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
131627457|NCT00103857|473921324|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
131627458|NCT00103857|473921325|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
131627459|NCT00103857|473921326|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
131627460|NCT00103857|473921327|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
131627461|NCT00103857|473921328|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
131627462|NCT00103857|473921329|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
131627463|NCT00103857|473921323|FG000|50-Week Extension Study|reason unspecified|0|||
131627464|NCT00103857|473921324|FG001|50-Week Extension Study|reason unspecified|0|||
131627465|NCT00103857|473921325|FG002|50-Week Extension Study|reason unspecified|0|||
131627466|NCT00103857|473921326|FG003|50-Week Extension Study|reason unspecified|0|||
131797406|NCT04700449|474541609|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
131797407|NCT04700449|474541610|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
131797408|NCT04700449|474541611|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
131797409|NCT04700449|474541612|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
131797410|NCT04700449|474541609|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
131797411|NCT04700449|474541610|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
131797412|NCT04700449|474541611|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
131797413|NCT04700449|474541612|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
131797414|NCT04700449|474541609|FG000|Stage 1: Double-Blind Period|Other|0|||
131627467|NCT00103857|473921327|FG004|50-Week Extension Study|reason unspecified|1|||
131627468|NCT00103857|473921328|FG005|50-Week Extension Study|reason unspecified|0|||
131627469|NCT00103857|473921329|FG006|50-Week Extension Study|reason unspecified|0|||
131627470|NCT01005914|473921332|FG000|Overall Study|Adverse Event|4|||
131627471|NCT01005914|473921332|FG000|Overall Study|Death|4|||
131627472|NCT01005914|473921332|FG000|Overall Study|Lack of Efficacy|1|||
131627473|NCT01005914|473921332|FG000|Overall Study|Withdrawal by Subject|1|||
131627474|NCT02707952|473921333|FG000|Overall Study|Adverse Event|1|||
131627475|NCT02707952|473921334|FG001|Overall Study|Adverse Event|0|||
131627476|NCT02707952|473921335|FG002|Overall Study|Adverse Event|0|||
131627477|NCT02707952|473921336|FG003|Overall Study|Adverse Event|0|||
131627478|NCT02707952|473921333|FG000|Overall Study|Lost to Follow-up|1|||
131627479|NCT02707952|473921334|FG001|Overall Study|Lost to Follow-up|0|||
131627480|NCT02707952|473921335|FG002|Overall Study|Lost to Follow-up|0|||
131627481|NCT02707952|473921336|FG003|Overall Study|Lost to Follow-up|0|||
131627482|NCT02707952|473921333|FG000|Overall Study|Withdrawal by Subject|0|||
131627483|NCT02707952|473921334|FG001|Overall Study|Withdrawal by Subject|1|||
131627484|NCT02707952|473921335|FG002|Overall Study|Withdrawal by Subject|2|||
131627485|NCT02707952|473921336|FG003|Overall Study|Withdrawal by Subject|0|||
131627486|NCT01697956|473921338|FG000|Overall Study|Protocol Violation|1|||
131627487|NCT01697956|473921339|FG001|Overall Study|Protocol Violation|1|||
131627488|NCT02978716|473921343|FG000|Overall Study|Death|25|||
131627489|NCT02978716|473921344|FG001|Overall Study|Death|13|||
131627490|NCT02978716|473921345|FG002|Overall Study|Death|20|||
131627491|NCT02978716|473921343|FG000|Overall Study|Lost to Follow-up|0|||
131627492|NCT02978716|473921344|FG001|Overall Study|Lost to Follow-up|0|||
131627493|NCT02978716|473921345|FG002|Overall Study|Lost to Follow-up|1|||
131627494|NCT02978716|473921343|FG000|Overall Study|Withdrawal by Subject|6|||
131627495|NCT02978716|473921344|FG001|Overall Study|Withdrawal by Subject|4|||
131627496|NCT02978716|473921345|FG002|Overall Study|Withdrawal by Subject|5|||
131627497|NCT02978716|473921343|FG000|Overall Study|Sponsor terminated|2|||
131627498|NCT02978716|473921344|FG001|Overall Study|Sponsor terminated|13|||
131627499|NCT02978716|473921345|FG002|Overall Study|Sponsor terminated|9|||
131627500|NCT02978716|473921343|FG000|Overall Study|Other|1|||
131627501|NCT02978716|473921344|FG001|Overall Study|Other|3|||
131627502|NCT02978716|473921345|FG002|Overall Study|Other|0|||
131627503|NCT00960206|473921346|FG000|Overall Study|Death|7|||
131627504|NCT00960206|473921347|FG001|Overall Study|Death|4|||
131627505|NCT00960206|473921348|FG002|Overall Study|Death|1|||
131627506|NCT00960206|473921346|FG000|Overall Study|Unwilling/Unable to return|1|||
131627507|NCT00960206|473921347|FG001|Overall Study|Unwilling/Unable to return|2|||
131627508|NCT00960206|473921348|FG002|Overall Study|Unwilling/Unable to return|0|||
131627509|NCT00960206|473921346|FG000|Overall Study|Lost to Follow-up|8|||
131627510|NCT00960206|473921347|FG001|Overall Study|Lost to Follow-up|14|||
131627511|NCT00960206|473921348|FG002|Overall Study|Lost to Follow-up|8|||
131797415|NCT04700449|474541610|FG001|Stage 1: Double-Blind Period|Other|0|||
131627512|NCT00960206|473921346|FG000|Overall Study|Withdrawal by Subject|2|||
131627513|NCT00960206|473921347|FG001|Overall Study|Withdrawal by Subject|4|||
131627514|NCT00960206|473921348|FG002|Overall Study|Withdrawal by Subject|0|||
131797416|NCT04700449|474541611|FG002|Stage 1: Double-Blind Period|Other|1|||
131797417|NCT04700449|474541612|FG003|Stage 1: Double-Blind Period|Other|0|||
131627515|NCT00960206|473921346|FG000|Overall Study|Revision of study component|2|||
131627516|NCT00960206|473921347|FG001|Overall Study|Revision of study component|2|||
131627517|NCT00960206|473921348|FG002|Overall Study|Revision of study component|2|||
131627518|NCT00960206|473921346|FG000|Overall Study|Missing 10 year data|20|||
131627519|NCT00960206|473921347|FG001|Overall Study|Missing 10 year data|1|||
131627520|NCT00960206|473921348|FG002|Overall Study|Missing 10 year data|1|||
131627521|NCT00853957|473921356|FG000|Overall Study|Adverse Event|9|||
131627522|NCT00853957|473921357|FG001|Overall Study|Adverse Event|3|||
131627523|NCT00853957|473921356|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131627524|NCT00853957|473921357|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131627525|NCT00853957|473921356|FG000|Overall Study|Subject withdrew consent|4|||
131627526|NCT00853957|473921357|FG001|Overall Study|Subject withdrew consent|5|||
131627527|NCT00853957|473921356|FG000|Overall Study|Lost to Follow-up|1|||
131627528|NCT00853957|473921357|FG001|Overall Study|Lost to Follow-up|6|||
131627529|NCT00853957|473921356|FG000|Overall Study|Protocol deviation|0|||
131627530|NCT00853957|473921357|FG001|Overall Study|Protocol deviation|3|||
131627531|NCT00091572|473921358|FG000|Overall Study|Lost to Follow-up|1|||
131627532|NCT00091572|473921359|FG001|Overall Study|Lost to Follow-up|1|||
131627533|NCT00091572|473921358|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
131627534|NCT00091572|473921359|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
131627535|NCT00091572|473921358|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
131627536|NCT00091572|473921359|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
131797418|NCT04700449|474541609|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
131797419|NCT04700449|474541610|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
131797420|NCT04700449|474541611|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
131797421|NCT04700449|474541612|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
131797422|NCT04700449|474541609|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
131797423|NCT04700449|474541610|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
131797424|NCT04700449|474541611|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
131797425|NCT04700449|474541612|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
131797426|NCT04700449|474541609|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
131797427|NCT04700449|474541610|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
131797428|NCT04700449|474541611|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
131797429|NCT04700449|474541612|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
131797430|NCT04700449|474541609|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
131797431|NCT04700449|474541610|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
131797432|NCT04700449|474541611|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
131797433|NCT04700449|474541612|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
131797434|NCT04700449|474541609|FG000|Stage 2 Sub-study 1|Other|1|||
131797435|NCT04700449|474541610|FG001|Stage 2 Sub-study 1|Other|2|||
131797436|NCT04700449|474541611|FG002|Stage 2 Sub-study 1|Other|0|||
131797437|NCT04700449|474541612|FG003|Stage 2 Sub-study 1|Other|0|||
131797438|NCT04700449|474541609|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
131627537|NCT00091572|473921358|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
131627538|NCT00091572|473921359|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
131627539|NCT00091572|473921358|FG000|Overall Study|Other Reason|6|||
131627540|NCT00091572|473921359|FG001|Overall Study|Other Reason|13|||
131627541|NCT00091572|473921358|FG000|Overall Study|Ongoing (still on treatment)|8|||
131627542|NCT00091572|473921359|FG001|Overall Study|Ongoing (still on treatment)|12|||
131627543|NCT00091572|473921358|FG000|Overall Study|Major Protocol Violation|2|||
131627544|NCT00091572|473921359|FG001|Overall Study|Major Protocol Violation|0|||
131627545|NCT00091572|473921358|FG000|Overall Study|Toxicity (Related AE)|53|||
131627546|NCT00091572|473921359|FG001|Overall Study|Toxicity (Related AE)|9|||
131627547|NCT02942771|473921360|FG000|Overall Study|Adverse Event|1|||
131627548|NCT02942771|473921361|FG001|Overall Study|Adverse Event|0|||
131627549|NCT02942771|473921362|FG002|Overall Study|Adverse Event|0|||
131627550|NCT02942771|473921363|FG003|Overall Study|Adverse Event|0|||
131627551|NCT02942771|473921364|FG004|Overall Study|Adverse Event|2|||
131627552|NCT02942771|473921360|FG000|Overall Study|Lost to Follow-up|1|||
131627553|NCT02942771|473921361|FG001|Overall Study|Lost to Follow-up|0|||
131627554|NCT02942771|473921362|FG002|Overall Study|Lost to Follow-up|0|||
131627555|NCT02942771|473921363|FG003|Overall Study|Lost to Follow-up|0|||
131627556|NCT02942771|473921364|FG004|Overall Study|Lost to Follow-up|0|||
131627557|NCT02942771|473921360|FG000|Overall Study|Withdrawal by Subject|1|||
131627558|NCT02942771|473921361|FG001|Overall Study|Withdrawal by Subject|0|||
131627559|NCT02942771|473921362|FG002|Overall Study|Withdrawal by Subject|0|||
131797439|NCT04700449|474541610|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
131627560|NCT02942771|473921363|FG003|Overall Study|Withdrawal by Subject|0|||
131797440|NCT04700449|474541611|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
131797441|NCT04700449|474541612|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
131797442|NCT04700449|474541609|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
131797443|NCT04700449|474541610|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
131797444|NCT04700449|474541611|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
131797445|NCT04700449|474541612|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
131797446|NCT04700449|474541609|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
131797447|NCT04700449|474541610|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
131797448|NCT04700449|474541611|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
131797449|NCT04700449|474541612|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
131797450|NCT04700449|474541609|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
131797451|NCT04700449|474541610|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
131797452|NCT04700449|474541611|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
131797453|NCT04700449|474541612|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
131797454|NCT04700449|474541609|FG000|Stage 2 Sub-study 2|Other|0|||
131797455|NCT04700449|474541610|FG001|Stage 2 Sub-study 2|Other|0|||
131797456|NCT04700449|474541611|FG002|Stage 2 Sub-study 2|Other|0|||
131797457|NCT04700449|474541612|FG003|Stage 2 Sub-study 2|Other|5|||
131797458|NCT01521559|474541613|FG000|Overall Study|Adverse Event|0|||
131797459|NCT01521559|474541614|FG001|Overall Study|Adverse Event|4|||
131797460|NCT01521559|474541613|FG000|Overall Study|Death|1|||
131797461|NCT01521559|474541614|FG001|Overall Study|Death|0|||
131797462|NCT01521559|474541613|FG000|Overall Study|Withdrawal by Subject|9|||
131797463|NCT01521559|474541614|FG001|Overall Study|Withdrawal by Subject|11|||
131797464|NCT01521559|474541613|FG000|Overall Study|Lost to Follow-up|3|||
131797465|NCT01521559|474541614|FG001|Overall Study|Lost to Follow-up|1|||
131797466|NCT01521559|474541613|FG000|Overall Study|Protocol Violation|1|||
131797467|NCT01521559|474541614|FG001|Overall Study|Protocol Violation|0|||
131797468|NCT01521559|474541613|FG000|Overall Study|Other|1|||
131797469|NCT01521559|474541614|FG001|Overall Study|Other|2|||
131797470|NCT02228382|474541615|FG000|Overall Study|Death|5|||
131797471|NCT02228382|474541616|FG001|Overall Study|Death|7|||
131797472|NCT02228382|474541617|FG002|Overall Study|Death|5|||
131797473|NCT02228382|474541618|FG003|Overall Study|Death|0|||
131797474|NCT02228382|474541619|FG004|Overall Study|Death|2|||
131797475|NCT02228382|474541615|FG000|Overall Study|Participant refused further follow-up|0|||
131797476|NCT02228382|474541616|FG001|Overall Study|Participant refused further follow-up|0|||
131797477|NCT02228382|474541617|FG002|Overall Study|Participant refused further follow-up|1|||
131797478|NCT02228382|474541618|FG003|Overall Study|Participant refused further follow-up|0|||
131797479|NCT02228382|474541619|FG004|Overall Study|Participant refused further follow-up|0|||
131797480|NCT02228382|474541615|FG000|Overall Study|Study terminated by sponsor|3|||
131797481|NCT02228382|474541616|FG001|Overall Study|Study terminated by sponsor|5|||
131797482|NCT02228382|474541617|FG002|Overall Study|Study terminated by sponsor|7|||
131797483|NCT02228382|474541618|FG003|Overall Study|Study terminated by sponsor|0|||
131797484|NCT02228382|474541619|FG004|Overall Study|Study terminated by sponsor|0|||
131797485|NCT02228382|474541615|FG000|Overall Study|Lost to Follow-up|0|||
131797486|NCT02228382|474541616|FG001|Overall Study|Lost to Follow-up|0|||
131797487|NCT02228382|474541617|FG002|Overall Study|Lost to Follow-up|3|||
131797488|NCT02228382|474541618|FG003|Overall Study|Lost to Follow-up|1|||
131797489|NCT02228382|474541619|FG004|Overall Study|Lost to Follow-up|0|||
131797490|NCT02228382|474541615|FG000|Overall Study|Withdrawal by Subject|0|||
131797491|NCT02228382|474541616|FG001|Overall Study|Withdrawal by Subject|3|||
131797492|NCT02228382|474541617|FG002|Overall Study|Withdrawal by Subject|2|||
131797493|NCT02228382|474541618|FG003|Overall Study|Withdrawal by Subject|1|||
131797494|NCT02228382|474541619|FG004|Overall Study|Withdrawal by Subject|0|||
131797495|NCT02228382|474541615|FG000|Overall Study|Other|2|||
131797496|NCT02228382|474541616|FG001|Overall Study|Other|3|||
131797497|NCT02228382|474541617|FG002|Overall Study|Other|3|||
131797498|NCT02228382|474541618|FG003|Overall Study|Other|0|||
131797499|NCT02228382|474541619|FG004|Overall Study|Other|0|||
131797500|NCT00275002|474541621|FG000|Overall Study|Death|1|||
131797501|NCT00275002|474541622|FG001|Overall Study|Death|0|||
131797502|NCT00275002|474541621|FG000|Overall Study|Disease progression|21|||
131797503|NCT00275002|474541622|FG001|Overall Study|Disease progression|15|||
131797504|NCT00275002|474541621|FG000|Overall Study|Adverse Event|0|||
131797505|NCT00275002|474541622|FG001|Overall Study|Adverse Event|1|||
131797506|NCT00576381|474541632|FG000|Overall Study|Reoperation|3|||
131797507|NCT00576381|474541632|FG000|Overall Study|Adverse Event|4|||
131797508|NCT02324465|474541633|FG000|Overall Study|device failure|0|||
131797509|NCT02324465|474541634|FG001|Overall Study|device failure|1|||
131797510|NCT01031537|474541635|FG000|Overall Study|medical reasons not related to study|3|||
131797511|NCT01031537|474541635|FG000|Overall Study|Lack of Efficacy|1|||
131797512|NCT01031537|474541635|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
131797513|NCT01031537|474541635|FG000|Overall Study|moved, met exclusion criteria|10|||
131797514|NCT01031537|474541635|FG000|Overall Study|Withdrawal by Subject|5|||
131797515|NCT01031537|474541635|FG000|Overall Study|PI removal, no longer met eligibility|12|||
131797516|NCT02655237|474541638|FG000|Overall Study|Adverse Event|10|||
131797517|NCT02655237|474541639|FG001|Overall Study|Adverse Event|7|||
131797518|NCT02655237|474541638|FG000|Overall Study|Protocol Deviation|2|||
131797519|NCT02655237|474541639|FG001|Overall Study|Protocol Deviation|0|||
131797520|NCT02655237|474541638|FG000|Overall Study|Withdrawal by Participant|1|||
131797521|NCT02655237|474541639|FG001|Overall Study|Withdrawal by Participant|2|||
131627561|NCT02942771|473921364|FG004|Overall Study|Withdrawal by Subject|2|||
131901850|NCT00325819|474925227|FG001|Overall Study|Study product lost in mail|1|||
131901851|NCT00325819|474925226|FG000|Overall Study|Did not take a dose of study product|4|||
131901852|NCT00325819|474925227|FG001|Overall Study|Did not take a dose of study product|9|||
131901853|NCT00325819|474925226|FG000|Overall Study|Lost to Follow-up|3|||
131627562|NCT02340806|473921368|FG000|Overall Study|Protocol Violation|2|||
131627563|NCT02340806|473921369|FG001|Overall Study|Protocol Violation|0|||
131627564|NCT02340806|473921368|FG000|Overall Study|epidural catheter replaced|2|||
131627565|NCT02340806|473921369|FG001|Overall Study|epidural catheter replaced|1|||
131901854|NCT00325819|474925227|FG001|Overall Study|Lost to Follow-up|3|||
131901855|NCT02532283|474925230|FG000|Overall Study|Adverse Event|0|||
131901856|NCT02532283|474925231|FG001|Overall Study|Adverse Event|1|||
131901857|NCT02532283|474925230|FG000|Overall Study|Death|1|||
131901858|NCT02532283|474925231|FG001|Overall Study|Death|0|||
131901859|NCT02532283|474925230|FG000|Overall Study|Lost to Follow-up|0|||
131901860|NCT02532283|474925231|FG001|Overall Study|Lost to Follow-up|1|||
131901861|NCT02532283|474925230|FG000|Overall Study|Withdrawal by Subject|8|||
131901862|NCT02532283|474925231|FG001|Overall Study|Withdrawal by Subject|3|||
131901863|NCT04376515|474925232|FG000|Overall Study|Found to have been vaccinated before study start|6|||
131627566|NCT02340806|473921368|FG000|Overall Study|history of chronic pain medication|1|||
131627567|NCT02340806|473921369|FG001|Overall Study|history of chronic pain medication|0|||
131901864|NCT04376515|474925233|FG001|Overall Study|Found to have been vaccinated before study start|6|||
131901865|NCT03811821|474925234|FG000|Overall Study|Adverse Event|1|||
131627568|NCT02340806|473921368|FG000|Overall Study|re-dose < 90 min of CSE|1|||
131627569|NCT02340806|473921369|FG001|Overall Study|re-dose < 90 min of CSE|3|||
131627570|NCT01186809|473921370|FG000|Overall Study|Death|30|||
131627571|NCT04895085|473921371|FG000|Overall Study|Death|1|||
131627572|NCT04895085|473921371|FG000|Overall Study|Withdrawal by Subject|1|||
131627573|NCT04895085|473921371|FG000|Overall Study|No longer eligible: Moved from area|1|||
131627574|NCT04520256|473921379|FG000|Overall Study|Lost to Follow-up|6|||
131627575|NCT04520256|473921380|FG001|Overall Study|Lost to Follow-up|4|||
131627576|NCT04520256|473921381|FG002|Overall Study|Lost to Follow-up|2|||
131627577|NCT04520256|473921382|FG003|Overall Study|Lost to Follow-up|3|||
131627578|NCT04520256|473921383|FG004|Overall Study|Lost to Follow-up|6|||
131627579|NCT04520256|473921384|FG005|Overall Study|Lost to Follow-up|6|||
131627580|NCT04520256|473921385|FG006|Overall Study|Lost to Follow-up|4|||
131627581|NCT04520256|473921386|FG007|Overall Study|Lost to Follow-up|6|||
131627582|NCT04520256|473921387|FG008|Overall Study|Lost to Follow-up|1|||
131627583|NCT04520256|473921388|FG009|Overall Study|Lost to Follow-up|3|||
131627584|NCT04520256|473921389|FG010|Overall Study|Lost to Follow-up|3|||
131627585|NCT04520256|473921390|FG011|Overall Study|Lost to Follow-up|2|||
131627586|NCT04520256|473921391|FG012|Overall Study|Lost to Follow-up|5|||
131627587|NCT04520256|473921392|FG013|Overall Study|Lost to Follow-up|3|||
131627588|NCT04520256|473921393|FG014|Overall Study|Lost to Follow-up|3|||
131627589|NCT04520256|473921394|FG015|Overall Study|Lost to Follow-up|6|||
131627590|NCT04520256|473921395|FG016|Overall Study|Lost to Follow-up|6|||
131627591|NCT04520256|473921396|FG017|Overall Study|Lost to Follow-up|4|||
131627592|NCT04520256|473921397|FG018|Overall Study|Lost to Follow-up|3|||
131627593|NCT04520256|473921398|FG019|Overall Study|Lost to Follow-up|3|||
131627594|NCT04520256|473921399|FG020|Overall Study|Lost to Follow-up|7|||
131627595|NCT04520256|473921400|FG021|Overall Study|Lost to Follow-up|3|||
131627596|NCT04520256|473921401|FG022|Overall Study|Lost to Follow-up|3|||
131627597|NCT04520256|473921402|FG023|Overall Study|Lost to Follow-up|8|||
131627598|NCT04520256|473921403|FG024|Overall Study|Lost to Follow-up|5|||
131627599|NCT04520256|473921404|FG025|Overall Study|Lost to Follow-up|4|||
131627600|NCT04520256|473921405|FG026|Overall Study|Lost to Follow-up|3|||
131627601|NCT04520256|473921406|FG027|Overall Study|Lost to Follow-up|4|||
131627602|NCT04520256|473921407|FG028|Overall Study|Lost to Follow-up|3|||
131627603|NCT04520256|473921408|FG029|Overall Study|Lost to Follow-up|4|||
131627604|NCT04520256|473921409|FG030|Overall Study|Lost to Follow-up|4|||
131627605|NCT04520256|473921410|FG031|Overall Study|Lost to Follow-up|4|||
131627606|NCT00451906|473923110|FG000|Overall Study|Adverse Event|515|||
131627607|NCT00451906|473923110|FG000|Overall Study|Lost to Follow-up|31|||
131627608|NCT00451906|473923110|FG000|Overall Study|Withdrawal by Subject|111|||
131627609|NCT00451906|473923110|FG000|Overall Study|Protocol Violation|21|||
131627610|NCT00451906|473923110|FG000|Overall Study|Progressive disease|1328|||
131627611|NCT00451906|473923110|FG000|Overall Study|Termination of the study|108|||
131627612|NCT00451906|473923110|FG000|Overall Study|Other Reasons|121|||
131627613|NCT00451906|473923110|FG000|Overall Study|Did not complete final visit|4|||
131627614|NCT03072238|473923115|FG000|Overall Study|Withdrawal by Subject|44|||
131627615|NCT03072238|473923116|FG001|Overall Study|Withdrawal by Subject|64|||
131627616|NCT03072238|473923115|FG000|Overall Study|Lost to Follow-up|14|||
131627617|NCT03072238|473923116|FG001|Overall Study|Lost to Follow-up|5|||
131627618|NCT03072238|473923115|FG000|Overall Study|Physician Decision|4|||
131627619|NCT03072238|473923116|FG001|Overall Study|Physician Decision|6|||
131627620|NCT03072238|473923115|FG000|Overall Study|Death|351|||
131627621|NCT03072238|473923116|FG001|Overall Study|Death|318|||
131627622|NCT03072238|473923115|FG000|Overall Study|Progressive Disease|3|||
131627623|NCT03072238|473923116|FG001|Overall Study|Progressive Disease|4|||
131627624|NCT03072238|473923115|FG000|Overall Study|Reason Not Specified|138|||
131627625|NCT03072238|473923116|FG001|Overall Study|Reason Not Specified|150|||
131627626|NCT00307489|473923117|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
131627627|NCT00307489|473923118|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
131627628|NCT00307489|473923117|FG000|Baseline Through Week 48|Physician Decision|1|||
131627629|NCT00307489|473923118|FG001|Baseline Through Week 48|Physician Decision|0|||
131627630|NCT00307489|473923117|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
131627631|NCT00307489|473923118|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
131627632|NCT00307489|473923117|FG000|Week 48 Through Week 168|Adverse Event|1|||
131627633|NCT00307489|473923118|FG001|Week 48 Through Week 168|Adverse Event|0|||
131627634|NCT00307489|473923117|FG000|Week 48 Through Week 168|Physician Decision|1|||
131627635|NCT00307489|473923118|FG001|Week 48 Through Week 168|Physician Decision|0|||
131627636|NCT00307489|473923117|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
131627637|NCT00307489|473923118|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
131627638|NCT00307489|473923117|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
131627639|NCT00307489|473923118|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
131627640|NCT00307489|473923117|FG000|Week 48 Through Week 168|Death|0|||
131627641|NCT00307489|473923118|FG001|Week 48 Through Week 168|Death|1|||
131627642|NCT00307489|473923117|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
131627643|NCT00307489|473923118|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
131627644|NCT00307489|473923117|FG000|Week 48 Through Week 168|Seroconversion|1|||
131627645|NCT00307489|473923118|FG001|Week 48 Through Week 168|Seroconversion|0|||
131627646|NCT04025762|473923120|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
131627647|NCT04025762|473923121|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
131627648|NCT02165202|473923128|FG000|Oral Phase|Refused further participation|5|||
131627649|NCT02165202|473923129|FG001|Oral Phase|Refused further participation|1|||
131627650|NCT02165202|473923128|FG000|Oral Phase|Study product Related Toxicity|1|||
131627651|NCT02165202|473923129|FG001|Oral Phase|Study product Related Toxicity|0|||
131627652|NCT02165202|473923128|FG000|Oral Phase|Unable to contact Participant|1|||
131627653|NCT02165202|473923129|FG001|Oral Phase|Unable to contact Participant|1|||
131627654|NCT02165202|473923128|FG000|Oral Phase|Clinical reasons|1|||
131627655|NCT02165202|473923129|FG001|Oral Phase|Clinical reasons|0|||
131627656|NCT02165202|473923128|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
131901866|NCT03811821|474925235|FG001|Overall Study|Adverse Event|1|||
131627657|NCT02165202|473923129|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
131627658|NCT02165202|473923128|FG000|Oral Phase|CMC advised termination|1|||
131627659|NCT02165202|473923129|FG001|Oral Phase|CMC advised termination|0|||
131627660|NCT02165202|473923128|FG000|Oral Phase|Relocated, no follow-up planned|1|||
131627661|NCT02165202|473923129|FG001|Oral Phase|Relocated, no follow-up planned|0|||
131627662|NCT02165202|473923128|FG000|Oral Phase|Abnormal EKG|0|||
131627663|NCT02165202|473923129|FG001|Oral Phase|Abnormal EKG|1|||
131627664|NCT02165202|473923128|FG000|Injection Phase|Abnormal Lab Value|5|||
131627665|NCT02165202|473923129|FG001|Injection Phase|Abnormal Lab Value|1|||
131627666|NCT02165202|473923128|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
131627667|NCT02165202|473923129|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
131627668|NCT02165202|473923128|FG000|Injection Phase|Unable to attend within Visit Window|1|||
131627669|NCT02165202|473923129|FG001|Injection Phase|Unable to attend within Visit Window|0|||
131627670|NCT02165202|473923128|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
131627671|NCT02165202|473923129|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
131627672|NCT02165202|473923128|FG000|Injection Phase|End of Study|2|||
131627673|NCT02165202|473923129|FG001|Injection Phase|End of Study|1|||
131627674|NCT02165202|473923128|FG000|Injection Phase|Study Product related Toxicity|1|||
131627675|NCT02165202|473923129|FG001|Injection Phase|Study Product related Toxicity|0|||
131627676|NCT02165202|473923128|FG000|Injection Phase|No longer interested|0|||
131627677|NCT02165202|473923129|FG001|Injection Phase|No longer interested|1|||
131627678|NCT02165202|473923128|FG000|Injection Phase|Participant unwilling to comply|1|||
131627679|NCT02165202|473923129|FG001|Injection Phase|Participant unwilling to comply|0|||
131627680|NCT01975701|473923136|FG000|Overall Study|Lost to Follow-up|1|||
131627681|NCT01975701|473923136|FG000|Overall Study|Death|23|||
131627682|NCT01975701|473923136|FG000|Overall Study|Physician Decision|1|||
131627683|NCT02446015|473923139|FG000|Overall Study|Adverse Event|0|||
131627684|NCT02446015|473923140|FG001|Overall Study|Adverse Event|1|||
131627685|NCT02446015|473923139|FG000|Overall Study|Withdrawal by Subject|1|||
131627686|NCT02446015|473923140|FG001|Overall Study|Withdrawal by Subject|0|||
131627687|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
131627688|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
131627689|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
131627690|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
131627691|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Adverse Event|7|||
131627692|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Adverse Event|8|||
131627693|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Adverse Event|8|||
131627694|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Adverse Event|9|||
131627695|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
131627696|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
131627697|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
131627698|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
131627699|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
131797522|NCT02655237|474541638|FG000|Overall Study|Lack of Efficacy|0|||
131797523|NCT02655237|474541639|FG001|Overall Study|Lack of Efficacy|1|||
131797524|NCT02655237|474541638|FG000|Overall Study|Recovery Leading to Surgery|2|||
131797525|NCT02655237|474541639|FG001|Overall Study|Recovery Leading to Surgery|1|||
131797526|NCT02655237|474541638|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
131797527|NCT02655237|474541639|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
131797528|NCT02655237|474541638|FG000|Overall Study|Randomized but Not Treated|1|||
131444212|NCT02345070|473257075|FG002|Overall Study|Other than specified above|7|||
131444213|NCT03304626|473257080|FG000|Overall Study|Adverse Event|1|||
131444214|NCT03304626|473257081|FG001|Overall Study|Adverse Event|0|||
131444215|NCT03304626|473257080|FG000|Overall Study|Lack of Efficacy|1|||
131444216|NCT03304626|473257081|FG001|Overall Study|Lack of Efficacy|1|||
131444217|NCT02379728|473257084|FG000|Overall Study|Lost to Follow-up|1|||
131444218|NCT02379728|473257085|FG001|Overall Study|Lost to Follow-up|0|||
131444219|NCT02379728|473257086|FG002|Overall Study|Lost to Follow-up|3|||
131444220|NCT02379728|473257087|FG003|Overall Study|Lost to Follow-up|0|||
131627700|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
131627701|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
131627702|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
131627703|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Pregnancy|0|||
131627704|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Pregnancy|2|||
131627705|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Pregnancy|2|||
131627706|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Pregnancy|0|||
131627707|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Non-compliance|1|||
131797529|NCT02655237|474541639|FG001|Overall Study|Randomized but Not Treated|0|||
131797530|NCT00520741|474541640|FG000|Overall Study|Adverse Event|16|||
131797531|NCT00520741|474541641|FG001|Overall Study|Adverse Event|56|||
131797532|NCT00520741|474541640|FG000|Overall Study|Lack of Efficacy|11|||
131797533|NCT00520741|474541641|FG001|Overall Study|Lack of Efficacy|30|||
131797534|NCT00520741|474541640|FG000|Overall Study|Withdrawal by Subject|0|||
131444221|NCT02379728|473257084|FG000|Overall Study|Withdrawal by Subject|5|||
131444222|NCT02379728|473257085|FG001|Overall Study|Withdrawal by Subject|0|||
131444223|NCT02379728|473257086|FG002|Overall Study|Withdrawal by Subject|5|||
131627708|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Non-compliance|0|||
131627709|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Non-compliance|0|||
131627710|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Non-compliance|3|||
131444224|NCT02379728|473257087|FG003|Overall Study|Withdrawal by Subject|3|||
131627711|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Other|3|||
131627712|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Other|0|||
131627713|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Other|3|||
131627714|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Other|2|||
131627715|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
131627716|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
131627717|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
131797535|NCT00520741|474541641|FG001|Overall Study|Withdrawal by Subject|11|||
131797536|NCT00520741|474541640|FG000|Overall Study|Protocol Violation|2|||
131797537|NCT00520741|474541641|FG001|Overall Study|Protocol Violation|15|||
131797538|NCT00520741|474541640|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
131797539|NCT00520741|474541641|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
131797540|NCT00520741|474541640|FG000|Overall Study|Lost to Follow-up|4|||
131797541|NCT00520741|474541641|FG001|Overall Study|Lost to Follow-up|4|||
131627718|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
131627719|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
131627720|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
131627721|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
131627722|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
131627723|NCT02143713|473923143|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
131627724|NCT02143713|473923144|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
131627725|NCT02143713|473923145|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
131627726|NCT02143713|473923146|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
131627727|NCT02143713|473923143|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
131627728|NCT02143713|473923144|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
131627729|NCT02143713|473923145|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
131627730|NCT02143713|473923146|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
131627731|NCT02143713|473923143|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
131797542|NCT00520741|474541640|FG000|Overall Study|Other reasons for premature termination|0|||
131444225|NCT02379728|473257084|FG000|Overall Study|Protocol Violation|0|||
131627732|NCT02143713|473923144|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
131627733|NCT02143713|473923145|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
131627734|NCT02143713|473923146|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
131627735|NCT02143713|473923143|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
131627736|NCT02143713|473923144|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
131627737|NCT02143713|473923145|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
131627738|NCT02143713|473923146|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
131627739|NCT02143713|473923143|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
131627740|NCT02143713|473923144|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
131627741|NCT02143713|473923145|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
131627742|NCT02143713|473923146|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
131627743|NCT02143713|473923143|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
131627744|NCT02143713|473923144|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
131627745|NCT02143713|473923145|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
131627746|NCT02143713|473923146|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
131627747|NCT02143713|473923143|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
131627748|NCT02143713|473923144|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
131627749|NCT02143713|473923145|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
131627750|NCT02143713|473923146|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
131627751|NCT01768572|473923147|FG000|Overall Study|Adverse Event|7|||
131627752|NCT01768572|473923148|FG001|Overall Study|Adverse Event|8|||
131627753|NCT01768572|473923149|FG002|Overall Study|Adverse Event|4|||
131627754|NCT01768572|473923147|FG000|Overall Study|Lack of Efficacy|1|||
131627755|NCT01768572|473923148|FG001|Overall Study|Lack of Efficacy|3|||
131627756|NCT01768572|473923149|FG002|Overall Study|Lack of Efficacy|1|||
131627757|NCT01768572|473923147|FG000|Overall Study|Other, Not due to an adverse event|1|||
131627758|NCT01768572|473923148|FG001|Overall Study|Other, Not due to an adverse event|1|||
131627759|NCT01768572|473923149|FG002|Overall Study|Other, Not due to an adverse event|1|||
131627760|NCT00080119|473923152|FG000|Overall Study|Discontinued because of study closure|0|||
131627761|NCT00080119|473923153|FG001|Overall Study|Discontinued because of study closure|0|||
131627762|NCT00080119|473923154|FG002|Overall Study|Discontinued because of study closure|130|||
131627763|NCT00080119|473923155|FG003|Overall Study|Discontinued because of study closure|141|||
131627764|NCT00080119|473923152|FG000|Overall Study|Unable to get to clinic|24|||
131627765|NCT00080119|473923153|FG001|Overall Study|Unable to get to clinic|24|||
131627766|NCT00080119|473923154|FG002|Overall Study|Unable to get to clinic|7|||
131627767|NCT00080119|473923155|FG003|Overall Study|Unable to get to clinic|1|||
131627768|NCT00080119|473923152|FG000|Overall Study|Consent withdrawn|13|||
131627769|NCT00080119|473923153|FG001|Overall Study|Consent withdrawn|17|||
131627770|NCT00080119|473923154|FG002|Overall Study|Consent withdrawn|4|||
131627771|NCT00080119|473923155|FG003|Overall Study|Consent withdrawn|6|||
131627772|NCT00080119|473923152|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
131627773|NCT00080119|473923153|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
131627774|NCT00080119|473923154|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
131627775|NCT00080119|473923155|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
131627776|NCT00080119|473923152|FG000|Overall Study|Lost to Follow-up|16|||
131627777|NCT00080119|473923153|FG001|Overall Study|Lost to Follow-up|19|||
131627778|NCT00080119|473923154|FG002|Overall Study|Lost to Follow-up|19|||
131627779|NCT00080119|473923155|FG003|Overall Study|Lost to Follow-up|14|||
131627780|NCT01919489|473923156|FG000|Overall Study|Rejected the need of injections|4|||
131627781|NCT01919489|473923157|FG001|Overall Study|Rejected the need of injections|7|||
131627782|NCT01919489|473923156|FG000|Overall Study|Adverse Event|10|||
131627783|NCT01919489|473923157|FG001|Overall Study|Adverse Event|0|||
131797543|NCT00520741|474541641|FG001|Overall Study|Other reasons for premature termination|6|||
131797544|NCT03679741|474541642|FG000|Period 1|No longer meet eligibility criteria|1|||
131797545|NCT03679741|474541643|FG001|Period 1|No longer meet eligibility criteria|0|||
131797546|NCT03679741|474541642|FG000|Period 1|Lost to Follow-up|0|||
131797547|NCT03679741|474541643|FG001|Period 1|Lost to Follow-up|1|||
131797548|NCT03679741|474541642|FG000|Period 1|Adverse Event|1|||
131797549|NCT03679741|474541643|FG001|Period 1|Adverse Event|1|||
131797550|NCT03679741|474541642|FG000|Period 1|Withdrawal by Subject|0|||
131797551|NCT03679741|474541643|FG001|Period 1|Withdrawal by Subject|1|||
131627784|NCT01919489|473923156|FG000|Overall Study|Hospital readmission|2|||
131627785|NCT01919489|473923157|FG001|Overall Study|Hospital readmission|9|||
131627786|NCT01919489|473923156|FG000|Overall Study|Death|2|||
131627787|NCT01919489|473923157|FG001|Overall Study|Death|1|||
131627788|NCT01919489|473923156|FG000|Overall Study|Lost to Follow-up|38|||
131627789|NCT01919489|473923157|FG001|Overall Study|Lost to Follow-up|27|||
131627790|NCT00871494|473923160|FG000|Overall Study|Protocol Violation|5|||
131627791|NCT00871494|473923160|FG000|Overall Study|Lack of Efficacy|4|||
131627792|NCT00871494|473923160|FG000|Overall Study|Adverse Event|4|||
131627793|NCT00871494|473923160|FG000|Overall Study|Lost to Follow-up|1|||
131627794|NCT01190436|473923165|FG000|Overall Study|Lost to Follow-up|35|||
131797552|NCT03679741|474541642|FG000|Period 2|Adverse Event|2|||
131627795|NCT01190436|473923165|FG000|Overall Study|Other|4|||
131627796|NCT02721147|473923166|FG000|Overall Study|Lost to Follow-up|2|||
131627797|NCT02721147|473923167|FG001|Overall Study|Lost to Follow-up|0|||
131627798|NCT02721147|473923168|FG002|Overall Study|Lost to Follow-up|0|||
131627799|NCT03386344|473923169|FG000|Overall Study|Adverse Event|6|||
131627800|NCT03386344|473923170|FG001|Overall Study|Adverse Event|3|||
131627801|NCT03386344|473923171|FG002|Overall Study|Adverse Event|1|||
131627802|NCT03386344|473923169|FG000|Overall Study|Poor Compliance to Protocol|0|||
131627803|NCT03386344|473923170|FG001|Overall Study|Poor Compliance to Protocol|1|||
131627804|NCT03386344|473923171|FG002|Overall Study|Poor Compliance to Protocol|0|||
131797553|NCT03679741|474541643|FG001|Period 2|Adverse Event|1|||
131627805|NCT03386344|473923169|FG000|Overall Study|Study Terminated by Sponsor|101|||
131627806|NCT03386344|473923170|FG001|Overall Study|Study Terminated by Sponsor|102|||
131627807|NCT03386344|473923171|FG002|Overall Study|Study Terminated by Sponsor|106|||
131627808|NCT03386344|473923169|FG000|Overall Study|Lost to Follow-up|3|||
131627809|NCT03386344|473923170|FG001|Overall Study|Lost to Follow-up|2|||
131627810|NCT03386344|473923171|FG002|Overall Study|Lost to Follow-up|1|||
131627811|NCT03386344|473923169|FG000|Overall Study|At the Participant's own Request|7|||
131627812|NCT03386344|473923170|FG001|Overall Study|At the Participant's own Request|7|||
131627813|NCT03386344|473923171|FG002|Overall Study|At the Participant's own Request|8|||
131627814|NCT03386344|473923169|FG000|Overall Study|Reason not Specified|0|||
131627815|NCT03386344|473923170|FG001|Overall Study|Reason not Specified|1|||
131627816|NCT03386344|473923171|FG002|Overall Study|Reason not Specified|0|||
131627817|NCT01280721|473923174|FG000|Overall Study|Adverse Event|4|||
131627818|NCT01280721|473923174|FG000|Overall Study|Physician Decision|3|||
131627819|NCT01280721|473923174|FG000|Overall Study|Withdrawal by Subject|6|||
131627820|NCT01280721|473923174|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
131627821|NCT01280721|473923174|FG000|Overall Study|No tolerability for the lowest dose|2|||
131627822|NCT01180400|473923175|FG000|Overall Study|Withdrawal by Subject|5|||
131627823|NCT01180400|473923176|FG001|Overall Study|Withdrawal by Subject|6|||
131627824|NCT01180400|473923175|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131627825|NCT01180400|473923176|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
131627826|NCT01180400|473923175|FG000|Overall Study|Adverse Event|12|||
131627827|NCT01180400|473923176|FG001|Overall Study|Adverse Event|10|||
131627828|NCT01180400|473923175|FG000|Overall Study|Severe non-compliance to protocol|1|||
131627829|NCT01180400|473923176|FG001|Overall Study|Severe non-compliance to protocol|2|||
131627830|NCT01180400|473923175|FG000|Overall Study|Condition under investigation worsened|2|||
131627831|NCT01180400|473923176|FG001|Overall Study|Condition under investigation worsened|1|||
131627832|NCT01180400|473923175|FG000|Overall Study|Lack of Efficacy|2|||
131627833|NCT01180400|473923176|FG001|Overall Study|Lack of Efficacy|0|||
131627834|NCT01180400|473923175|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131627835|NCT01180400|473923176|FG001|Overall Study|Study-specific withdrawal criteria|2|||
131627836|NCT01180400|473923175|FG000|Overall Study|Lost to Follow-up|2|||
131627837|NCT01180400|473923176|FG001|Overall Study|Lost to Follow-up|3|||
131627838|NCT01180400|473923175|FG000|Overall Study|Other|0|||
131627839|NCT01180400|473923176|FG001|Overall Study|Other|1|||
131627840|NCT00963924|473923177|FG000|Overall Study|Adverse Event|1|||
131627841|NCT00963924|473923178|FG001|Overall Study|Adverse Event|0|||
131627842|NCT00963924|473923177|FG000|Overall Study|Withdrawal by Subject|0|||
131627843|NCT00963924|473923178|FG001|Overall Study|Withdrawal by Subject|1|||
131627844|NCT00963924|473923177|FG000|Overall Study|Changed antipsychotic|0|||
131627845|NCT00963924|473923178|FG001|Overall Study|Changed antipsychotic|1|||
131627846|NCT00963924|473923177|FG000|Overall Study|Lost to Follow-up|0|||
131627847|NCT00963924|473923178|FG001|Overall Study|Lost to Follow-up|1|||
131627848|NCT03031782|473923183|FG000|Treatment Period 1|Lack of Efficacy|3|||
131627849|NCT03031782|473923184|FG001|Treatment Period 1|Lack of Efficacy|0|||
131627850|NCT03031782|473923185|FG002|Treatment Period 1|Lack of Efficacy|0|||
131627851|NCT03031782|473923186|FG003|Treatment Period 1|Lack of Efficacy|0|||
131797554|NCT03679741|474541642|FG000|Period 2|Withdrawal by Subject|1|||
131797555|NCT03679741|474541643|FG001|Period 2|Withdrawal by Subject|1|||
131627852|NCT03031782|473923187|FG004|Treatment Period 1|Lack of Efficacy|0|||
131627853|NCT03031782|473923183|FG000|Treatment Period 2|Physician Decision|0|||
131627854|NCT03031782|473923184|FG001|Treatment Period 2|Physician Decision|1|||
131627855|NCT03031782|473923185|FG002|Treatment Period 2|Physician Decision|0|||
131627856|NCT03031782|473923186|FG003|Treatment Period 2|Physician Decision|0|||
131627857|NCT03031782|473923187|FG004|Treatment Period 2|Physician Decision|3|||
131627858|NCT03031782|473923183|FG000|Treatment Period 2|Lack of Efficacy|0|||
131627859|NCT03031782|473923184|FG001|Treatment Period 2|Lack of Efficacy|1|||
131627860|NCT03031782|473923185|FG002|Treatment Period 2|Lack of Efficacy|0|||
131627861|NCT03031782|473923186|FG003|Treatment Period 2|Lack of Efficacy|0|||
131627862|NCT03031782|473923187|FG004|Treatment Period 2|Lack of Efficacy|1|||
131627863|NCT03031782|473923183|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131627864|NCT03031782|473923184|FG001|Treatment Period 2|Withdrawal by Subject|3|||
131627865|NCT03031782|473923185|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131627866|NCT03031782|473923186|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131627867|NCT03031782|473923187|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131627868|NCT03031782|473923183|FG000|Treatment Period 2|Adverse Event|0|||
131627869|NCT03031782|473923184|FG001|Treatment Period 2|Adverse Event|1|||
131627870|NCT03031782|473923185|FG002|Treatment Period 2|Adverse Event|2|||
131627871|NCT03031782|473923186|FG003|Treatment Period 2|Adverse Event|0|||
131627872|NCT03031782|473923187|FG004|Treatment Period 2|Adverse Event|0|||
131627873|NCT03031782|473923183|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131627874|NCT03031782|473923184|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131627875|NCT03031782|473923185|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131627876|NCT03031782|473923186|FG003|Treatment Period 3|Withdrawal by Subject|1|||
131627877|NCT03031782|473923187|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131627878|NCT02170207|473923190|FG000|Overall Study|Case report forms unavailable|5|||
131627879|NCT00886834|473923191|FG000|Overall Study|Protocol Violation|0|||
131627880|NCT00886834|473923192|FG001|Overall Study|Protocol Violation|3|||
131627881|NCT03122860|473923193|FG000|Overall Study|Discontinued Before Treatment|1|||
131627882|NCT03122860|473923194|FG001|Overall Study|Discontinued Before Treatment|1|||
131627883|NCT03122860|473923195|FG002|Overall Study|Discontinued Before Treatment|2|||
131627884|NCT03122860|473923196|FG003|Overall Study|Discontinued Before Treatment|0|||
131627885|NCT03122860|473923197|FG004|Overall Study|Discontinued Before Treatment|1|||
131627886|NCT03122860|473923198|FG005|Overall Study|Discontinued Before Treatment|0|||
131627887|NCT03122860|473923193|FG000|Overall Study|Adverse Event|1|||
131627888|NCT03122860|473923194|FG001|Overall Study|Adverse Event|0|||
131627889|NCT03122860|473923195|FG002|Overall Study|Adverse Event|1|||
131627890|NCT03122860|473923196|FG003|Overall Study|Adverse Event|1|||
131627891|NCT03122860|473923197|FG004|Overall Study|Adverse Event|0|||
131627892|NCT03122860|473923198|FG005|Overall Study|Adverse Event|0|||
131627893|NCT03122860|473923193|FG000|Overall Study|Lost to Follow-up|5|||
131712323|NCT00684177|474224193|FG001|Overall Study|Physician Decision|0|||
131901867|NCT03811821|474925234|FG000|Overall Study|Withdrawal by Subject|5|||
131901868|NCT03811821|474925235|FG001|Overall Study|Withdrawal by Subject|4|||
131901869|NCT03811821|474925234|FG000|Overall Study|Lost to Follow-up|2|||
131901870|NCT03811821|474925235|FG001|Overall Study|Lost to Follow-up|2|||
131901871|NCT03811821|474925234|FG000|Overall Study|Contraindication for treatment|0|||
131901872|NCT03811821|474925235|FG001|Overall Study|Contraindication for treatment|1|||
131901873|NCT03811821|474925234|FG000|Overall Study|Tolerability|0|||
131901874|NCT03811821|474925235|FG001|Overall Study|Tolerability|3|||
131901875|NCT03811821|474925234|FG000|Overall Study|Comorbidities|0|||
131901876|NCT03811821|474925235|FG001|Overall Study|Comorbidities|2|||
131901877|NCT03677869|474925239|FG000|Overall Study|Withdrawal by Subject|1|||
131901878|NCT00956839|474926877|FG000|Overall Study|Lost to Follow-up|3|||
131901879|NCT00956839|474926878|FG001|Overall Study|Lost to Follow-up|0|||
131901880|NCT00956839|474926879|FG002|Overall Study|Lost to Follow-up|3|||
131901881|NCT01001429|474926880|FG000|Overall Study|surgery cancelled|0|||
131901882|NCT01001429|474926881|FG001|Overall Study|surgery cancelled|1|||
131901883|NCT03527277|474926882|FG000|Overall Study|Withdrawal by Subject|5|||
131901884|NCT03527277|474926883|FG001|Overall Study|Withdrawal by Subject|0|||
131901885|NCT03527277|474926882|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
131901886|NCT03527277|474926883|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
131901887|NCT03527277|474926882|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
131901888|NCT03527277|474926883|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
131901889|NCT03506438|474926884|FG000|Overall Study|Lost to Follow-up|8|||
131901890|NCT03506438|474926885|FG001|Overall Study|Lost to Follow-up|7|||
131901891|NCT03506438|474926886|FG002|Overall Study|Lost to Follow-up|8|||
131901892|NCT03506438|474926887|FG003|Overall Study|Lost to Follow-up|7|||
131901893|NCT03506438|474926888|FG004|Overall Study|Lost to Follow-up|0|||
131627894|NCT03122860|473923194|FG001|Overall Study|Lost to Follow-up|2|||
131627895|NCT03122860|473923195|FG002|Overall Study|Lost to Follow-up|3|||
131627896|NCT03122860|473923196|FG003|Overall Study|Lost to Follow-up|3|||
131627897|NCT03122860|473923197|FG004|Overall Study|Lost to Follow-up|5|||
131627898|NCT03122860|473923198|FG005|Overall Study|Lost to Follow-up|4|||
131627899|NCT03122860|473923193|FG000|Overall Study|Subject Non-Compliance|0|||
131627900|NCT03122860|473923194|FG001|Overall Study|Subject Non-Compliance|0|||
131627901|NCT03122860|473923195|FG002|Overall Study|Subject Non-Compliance|1|||
131627902|NCT03122860|473923196|FG003|Overall Study|Subject Non-Compliance|0|||
131627903|NCT03122860|473923197|FG004|Overall Study|Subject Non-Compliance|0|||
131627904|NCT03122860|473923198|FG005|Overall Study|Subject Non-Compliance|0|||
131712324|NCT00684177|474224192|FG000|Overall Study|Withdrawal by Subject|1|||
131901894|NCT03506438|474926889|FG005|Overall Study|Lost to Follow-up|0|||
131901895|NCT01396083|474926894|FG000|Overall Study|Adverse Event|2|||
131901896|NCT01396083|474926895|FG001|Overall Study|Adverse Event|28|||
131901897|NCT01396083|474926894|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131901898|NCT01396083|474926895|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
131797556|NCT02750761|474541644|FG000|Overall Study|Lost to Follow-up|0|||
131797557|NCT02750761|474541645|FG001|Overall Study|Lost to Follow-up|0|||
131797558|NCT02750761|474541646|FG002|Overall Study|Lost to Follow-up|1|||
131797559|NCT02750761|474541647|FG003|Overall Study|Lost to Follow-up|0|||
131797560|NCT02750761|474541648|FG004|Overall Study|Lost to Follow-up|0|||
131797561|NCT02750761|474541649|FG005|Overall Study|Lost to Follow-up|0|||
131797562|NCT01860976|474541650|FG000|Blinded Treatment|Adverse Event|1|||
131797563|NCT01860976|474541651|FG001|Blinded Treatment|Adverse Event|3|||
131797564|NCT01860976|474541650|FG000|Blinded Treatment|Lack of Efficacy|5|||
131797565|NCT01860976|474541651|FG001|Blinded Treatment|Lack of Efficacy|12|||
131797566|NCT01860976|474541650|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
131797567|NCT01860976|474541651|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
131797568|NCT01860976|474541650|FG000|Blinded Treatment|Withdrawal by Subject|3|||
131797569|NCT01860976|474541651|FG001|Blinded Treatment|Withdrawal by Subject|5|||
131797570|NCT01860976|474541650|FG000|Blinded Treatment|Subject no longer met criteria|1|||
131797571|NCT01860976|474541651|FG001|Blinded Treatment|Subject no longer met criteria|0|||
131797572|NCT01860976|474541650|FG000|Blinded Treatment|Entered Open-Label in error|0|||
131797573|NCT01860976|474541651|FG001|Blinded Treatment|Entered Open-Label in error|1|||
131797574|NCT01860976|474541650|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
131797575|NCT01860976|474541651|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
131797576|NCT01860976|474541650|FG000|Open-Label|Adverse Event|2|||
131797577|NCT01860976|474541651|FG001|Open-Label|Adverse Event|4|||
131797578|NCT01860976|474541650|FG000|Open-Label|Lack of Efficacy|16|||
131797579|NCT01860976|474541651|FG001|Open-Label|Lack of Efficacy|8|||
131797580|NCT01860976|474541650|FG000|Open-Label|Lost to Follow-up|1|||
131797581|NCT01860976|474541651|FG001|Open-Label|Lost to Follow-up|2|||
131797582|NCT01860976|474541650|FG000|Open-Label|Subject request discontinue treatment|4|||
131797583|NCT01860976|474541651|FG001|Open-Label|Subject request discontinue treatment|3|||
131797584|NCT01860976|474541650|FG000|Open-Label|Withdrawal by Subject|4|||
131797585|NCT01860976|474541651|FG001|Open-Label|Withdrawal by Subject|1|||
131797586|NCT01860976|474541650|FG000|Open-Label|Other Reasons|1|||
131797587|NCT01860976|474541651|FG001|Open-Label|Other Reasons|1|||
131797588|NCT01860976|474541650|FG000|Long Term Extension|Adverse Event|4|||
131797589|NCT01860976|474541651|FG001|Long Term Extension|Adverse Event|0|||
131797590|NCT01860976|474541650|FG000|Long Term Extension|Lack of Efficacy|2|||
131797591|NCT01860976|474541651|FG001|Long Term Extension|Lack of Efficacy|0|||
131797592|NCT01860976|474541650|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
131797593|NCT01860976|474541651|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
131797594|NCT01860976|474541650|FG000|Long Term Extension|Lost to Follow-up|2|||
131797595|NCT01860976|474541651|FG001|Long Term Extension|Lost to Follow-up|0|||
131797596|NCT01860976|474541650|FG000|Long Term Extension|subject withdrew consent|7|||
131797597|NCT01860976|474541651|FG001|Long Term Extension|subject withdrew consent|0|||
131797598|NCT01612000|474541653|FG000|Overall Study|Lost to Follow-up|6|||
131797599|NCT01612000|474541654|FG001|Overall Study|Lost to Follow-up|4|||
131797600|NCT01612000|474541655|FG002|Overall Study|Lost to Follow-up|4|||
131797601|NCT01612000|474541656|FG003|Overall Study|Lost to Follow-up|8|||
131797602|NCT01612000|474541653|FG000|Overall Study|Physician Decision|0|||
131797603|NCT01612000|474541654|FG001|Overall Study|Physician Decision|0|||
131797604|NCT01612000|474541655|FG002|Overall Study|Physician Decision|1|||
131797605|NCT01612000|474541656|FG003|Overall Study|Physician Decision|0|||
131797606|NCT01612000|474541653|FG000|Overall Study|Withdrawal by Subject|3|||
131797607|NCT01612000|474541654|FG001|Overall Study|Withdrawal by Subject|1|||
131797608|NCT01612000|474541655|FG002|Overall Study|Withdrawal by Subject|2|||
131797609|NCT01612000|474541656|FG003|Overall Study|Withdrawal by Subject|2|||
131797610|NCT02354586|474541660|FG000|Overall Study|Death|230|||
131797611|NCT02354586|474541660|FG000|Overall Study|Withdrawal by Subject|59|||
131797612|NCT02354586|474541660|FG000|Overall Study|Lost to Follow-up|11|||
131797613|NCT02354586|474541660|FG000|Overall Study|Sponsor decision|51|||
131797614|NCT02354586|474541660|FG000|Overall Study|Site closure|2|||
131797615|NCT02354586|474541660|FG000|Overall Study|Intercurrent illness|1|||
131797616|NCT02354586|474541660|FG000|Overall Study|Protocol Violation|3|||
131797617|NCT02354586|474541660|FG000|Overall Study|Physician Decision|13|||
131797618|NCT02354586|474541660|FG000|Overall Study|Lack of Efficacy|86|||
131797619|NCT02354586|474541660|FG000|Overall Study|Adverse Event|7|||
131797620|NCT00634907|474541664|FG000|Overall Study|Withdrawal by Subject|3|||
131797621|NCT00634907|474541665|FG001|Overall Study|Withdrawal by Subject|0|||
131797622|NCT00634907|474541664|FG000|Overall Study|Physician Decision|3|||
131797623|NCT00634907|474541665|FG001|Overall Study|Physician Decision|9|||
131797624|NCT00634907|474541664|FG000|Overall Study|Withdrawal by Subject|11|||
131797625|NCT00634907|474541665|FG001|Overall Study|Withdrawal by Subject|8|||
131797626|NCT02419313|474541672|FG000|First Intervention|Lost to Follow-up|2|||
131797627|NCT02419313|474541673|FG001|First Intervention|Lost to Follow-up|0|||
131804486|NCT03603314|474568541|FG001|Overall Study|Lost to Follow-up|3|||
131627905|NCT03122860|473923193|FG000|Overall Study|Withdrawal by Subject|3|||
131627906|NCT03122860|473923194|FG001|Overall Study|Withdrawal by Subject|2|||
131627907|NCT03122860|473923195|FG002|Overall Study|Withdrawal by Subject|5|||
131627908|NCT03122860|473923196|FG003|Overall Study|Withdrawal by Subject|7|||
131627909|NCT03122860|473923197|FG004|Overall Study|Withdrawal by Subject|9|||
131627910|NCT03122860|473923198|FG005|Overall Study|Withdrawal by Subject|8|||
131627911|NCT01138657|473923199|FG000|Overall Study|Adverse Event|3|||
131627912|NCT01138657|473923200|FG001|Overall Study|Adverse Event|10|||
131627913|NCT01138657|473923199|FG000|Overall Study|Lack of Efficacy|2|||
131627914|NCT01138657|473923200|FG001|Overall Study|Lack of Efficacy|1|||
131627915|NCT01138657|473923199|FG000|Overall Study|Lost to Follow-up|0|||
131627916|NCT01138657|473923200|FG001|Overall Study|Lost to Follow-up|3|||
131627917|NCT01138657|473923199|FG000|Overall Study|Miscellaneous Reasons|3|||
131627918|NCT01138657|473923200|FG001|Overall Study|Miscellaneous Reasons|4|||
131627919|NCT02574286|473923201|FG000|Overall Study|Adverse Event|3|||
131627920|NCT02574286|473923201|FG000|Overall Study|Withdrawal by Subject|2|||
131627921|NCT03875729|473923202|FG000|Overall Study|Adverse Event|0|||
131627922|NCT03875729|473923203|FG001|Overall Study|Adverse Event|5|||
131627923|NCT03875729|473923202|FG000|Overall Study|Withdrawal by Subject|8|||
131627924|NCT03875729|473923203|FG001|Overall Study|Withdrawal by Subject|11|||
131627925|NCT03875729|473923202|FG000|Overall Study|Pregnancy|0|||
131627926|NCT03875729|473923203|FG001|Overall Study|Pregnancy|1|||
131627927|NCT03875729|473923202|FG000|Overall Study|Lost to Follow-up|0|||
131627928|NCT03875729|473923203|FG001|Overall Study|Lost to Follow-up|5|||
131627929|NCT03875729|473923202|FG000|Overall Study|Personal reasons|2|||
131627930|NCT03875729|473923203|FG001|Overall Study|Personal reasons|0|||
131627931|NCT01280656|473923204|FG000|Overall Study|Adverse Event|1|||
131627932|NCT01280656|473923205|FG001|Overall Study|Adverse Event|14|||
131627933|NCT01280656|473923206|FG002|Overall Study|Adverse Event|13|||
131627934|NCT01280656|473923204|FG000|Overall Study|Lack of Efficacy|1|||
131627935|NCT01280656|473923205|FG001|Overall Study|Lack of Efficacy|22|||
131627936|NCT01280656|473923206|FG002|Overall Study|Lack of Efficacy|38|||
131627937|NCT01280656|473923204|FG000|Overall Study|Treatment shortening (RGT)|0|||
131627938|NCT01280656|473923205|FG001|Overall Study|Treatment shortening (RGT)|4|||
131627939|NCT01280656|473923206|FG002|Overall Study|Treatment shortening (RGT)|5|||
131627940|NCT01280656|473923204|FG000|Overall Study|Other|1|||
131627941|NCT01280656|473923205|FG001|Overall Study|Other|7|||
131627942|NCT01280656|473923206|FG002|Overall Study|Other|7|||
131627943|NCT00636168|473923207|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
131627944|NCT00636168|473923208|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
131627945|NCT00636168|473923207|FG000|Randomized to Study Drug|Adverse Event|1|||
131627946|NCT00636168|473923208|FG001|Randomized to Study Drug|Adverse Event|0|||
131627947|NCT00636168|473923207|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
131627948|NCT00636168|473923208|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
131627949|NCT00636168|473923207|FG000|Treated With Study Drug|Recurrence of disease|135|||
131627950|NCT00636168|473923208|FG001|Treated With Study Drug|Recurrence of disease|282|||
131627951|NCT00636168|473923207|FG000|Treated With Study Drug|Adverse Event|250|||
131627952|NCT00636168|473923208|FG001|Treated With Study Drug|Adverse Event|22|||
131627953|NCT00636168|473923207|FG000|Treated With Study Drug|Participant withdrew consent|16|||
131627954|NCT00636168|473923208|FG001|Treated With Study Drug|Participant withdrew consent|21|||
131627955|NCT00636168|473923207|FG000|Treated With Study Drug|Poor/non-compliance|1|||
131627956|NCT00636168|473923208|FG001|Treated With Study Drug|Poor/non-compliance|3|||
131627957|NCT00636168|473923207|FG000|Treated With Study Drug|Death|3|||
131627958|NCT00636168|473923208|FG001|Treated With Study Drug|Death|0|||
131627959|NCT00636168|473923207|FG000|Treated With Study Drug|Pregnancy|1|||
131627960|NCT00636168|473923208|FG001|Treated With Study Drug|Pregnancy|0|||
131627961|NCT00636168|473923207|FG000|Treated With Study Drug|No longer meets study criteria|1|||
131627962|NCT00636168|473923208|FG001|Treated With Study Drug|No longer meets study criteria|0|||
131627963|NCT00636168|473923207|FG000|Treated With Study Drug|Other reason|1|||
131627964|NCT00636168|473923208|FG001|Treated With Study Drug|Other reason|3|||
131627965|NCT00636168|473923207|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
131627966|NCT00636168|473923208|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
131627967|NCT00636168|473923207|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
131627968|NCT00636168|473923208|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
131712325|NCT00684177|474224193|FG001|Overall Study|Withdrawal by Subject|2|||
131712326|NCT00684177|474224192|FG000|Overall Study|Other|1|||
131712327|NCT00684177|474224193|FG001|Overall Study|Other|2|||
131712328|NCT04211337|474224194|FG000|Overall Study|On Treatment|175|||
131712329|NCT04211337|474224195|FG001|Overall Study|On Treatment|40|||
131712330|NCT04211337|474224194|FG000|Overall Study|Withdrawal by Subject|0|||
131712331|NCT04211337|474224195|FG001|Overall Study|Withdrawal by Subject|2|||
131627969|NCT00636168|473923207|FG000|Long Term Follow-Up|Death|8|||
131627970|NCT00636168|473923208|FG001|Long Term Follow-Up|Death|9|||
131627971|NCT01240785|473923209|FG000|Overall Study|Lost to Follow-up|1|||
131627972|NCT01240785|473923210|FG001|Overall Study|Lost to Follow-up|0|||
131444226|NCT02379728|473257085|FG001|Overall Study|Protocol Violation|0|||
131627973|NCT01240785|473923209|FG000|Overall Study|Protocol Violation|0|||
131627974|NCT01240785|473923210|FG001|Overall Study|Protocol Violation|3|||
131627975|NCT00237809|473923211|FG000|Overall Study|Lost to Follow-up|11|||
131627976|NCT00237809|473923212|FG001|Overall Study|Lost to Follow-up|10|||
131627977|NCT00237809|473923213|FG002|Overall Study|Lost to Follow-up|9|||
131627978|NCT00237809|473923214|FG003|Overall Study|Lost to Follow-up|9|||
131627979|NCT02006641|473923215|FG000|Overall Study|Withdrawal before treatment|2|||
131627980|NCT02006641|473923216|FG001|Overall Study|Withdrawal before treatment|5|||
131627981|NCT02006641|473923217|FG002|Overall Study|Withdrawal before treatment|3|||
131627982|NCT02006641|473923215|FG000|Overall Study|Adverse Event|15|||
131627983|NCT02006641|473923216|FG001|Overall Study|Adverse Event|11|||
131627984|NCT02006641|473923217|FG002|Overall Study|Adverse Event|15|||
131627985|NCT02006641|473923215|FG000|Overall Study|Protocol Violation|0|||
131627986|NCT02006641|473923216|FG001|Overall Study|Protocol Violation|2|||
131627987|NCT02006641|473923217|FG002|Overall Study|Protocol Violation|2|||
131712332|NCT02847598|474224206|FG000|Overall Study|Adverse Event|0|||
131712333|NCT02847598|474224207|FG001|Overall Study|Adverse Event|0|||
131712334|NCT02847598|474224208|FG002|Overall Study|Adverse Event|0|||
131712335|NCT02847598|474224209|FG003|Overall Study|Adverse Event|0|||
131712336|NCT02847598|474224210|FG004|Overall Study|Adverse Event|0|||
131712337|NCT02847598|474224211|FG005|Overall Study|Adverse Event|0|||
131712338|NCT02847598|474224212|FG006|Overall Study|Adverse Event|0|||
131712339|NCT02847598|474224213|FG007|Overall Study|Adverse Event|1|||
131712340|NCT02847598|474224206|FG000|Overall Study|Consent withdrawn|2|||
131712341|NCT02847598|474224207|FG001|Overall Study|Consent withdrawn|0|||
131712342|NCT02847598|474224208|FG002|Overall Study|Consent withdrawn|0|||
131712343|NCT02847598|474224209|FG003|Overall Study|Consent withdrawn|4|||
131712344|NCT02847598|474224210|FG004|Overall Study|Consent withdrawn|3|||
131712345|NCT02847598|474224211|FG005|Overall Study|Consent withdrawn|2|||
131712346|NCT02847598|474224212|FG006|Overall Study|Consent withdrawn|1|||
131712347|NCT02847598|474224213|FG007|Overall Study|Consent withdrawn|3|||
131627988|NCT02006641|473923215|FG000|Overall Study|Lost to Follow-up|0|||
131712348|NCT02847598|474224206|FG000|Overall Study|Death|3|||
131712349|NCT02847598|474224207|FG001|Overall Study|Death|0|||
131712350|NCT02847598|474224208|FG002|Overall Study|Death|0|||
131712351|NCT02847598|474224209|FG003|Overall Study|Death|0|||
131627989|NCT02006641|473923216|FG001|Overall Study|Lost to Follow-up|1|||
131627990|NCT02006641|473923217|FG002|Overall Study|Lost to Follow-up|0|||
131627991|NCT02006641|473923215|FG000|Overall Study|Withdrawal by Subject|7|||
131627992|NCT02006641|473923216|FG001|Overall Study|Withdrawal by Subject|12|||
131627993|NCT02006641|473923217|FG002|Overall Study|Withdrawal by Subject|11|||
131627994|NCT02006641|473923215|FG000|Overall Study|Other reason: patient didn't show up|1|||
131627995|NCT02006641|473923216|FG001|Overall Study|Other reason: patient didn't show up|0|||
131627996|NCT02006641|473923217|FG002|Overall Study|Other reason: patient didn't show up|0|||
131627997|NCT02006641|473923215|FG000|Overall Study|Other reason:patient didn't want to come|0|||
131627998|NCT02006641|473923216|FG001|Overall Study|Other reason:patient didn't want to come|0|||
131627999|NCT02006641|473923217|FG002|Overall Study|Other reason:patient didn't want to come|1|||
131628000|NCT02006641|473923215|FG000|Overall Study|Other reason: patient has moved|1|||
131628001|NCT02006641|473923216|FG001|Overall Study|Other reason: patient has moved|0|||
131628002|NCT02006641|473923217|FG002|Overall Study|Other reason: patient has moved|1|||
131628003|NCT02006641|473923215|FG000|Overall Study|Other reason: caregiver in hospital|0|||
131628004|NCT02006641|473923216|FG001|Overall Study|Other reason: caregiver in hospital|1|||
131628005|NCT02006641|473923217|FG002|Overall Study|Other reason: caregiver in hospital|0|||
131628006|NCT02006641|473923215|FG000|Overall Study|Other reason: patient's wife has died|0|||
131628007|NCT02006641|473923216|FG001|Overall Study|Other reason: patient's wife has died|0|||
131797628|NCT02419313|474541672|FG000|Second Intervention|Lost to Follow-up|1|||
131797629|NCT02419313|474541673|FG001|Second Intervention|Lost to Follow-up|0|||
131797630|NCT00429923|474541674|FG000|Overall Study|Adverse Event|0|||
131797631|NCT00429923|474541675|FG001|Overall Study|Adverse Event|2|||
131797632|NCT00429923|474541676|FG002|Overall Study|Adverse Event|3|||
131797633|NCT00429923|474541674|FG000|Overall Study|Lack of Efficacy|4|||
131797634|NCT00429923|474541675|FG001|Overall Study|Lack of Efficacy|1|||
131797635|NCT00429923|474541676|FG002|Overall Study|Lack of Efficacy|33|||
131797636|NCT00429923|474541674|FG000|Overall Study|Lost to Follow-up|0|||
131797637|NCT00429923|474541675|FG001|Overall Study|Lost to Follow-up|0|||
131797638|NCT00429923|474541676|FG002|Overall Study|Lost to Follow-up|2|||
131797639|NCT00429923|474541674|FG000|Overall Study|Withdrew Consent|1|||
131628008|NCT02006641|473923217|FG002|Overall Study|Other reason: patient's wife has died|1|||
131628009|NCT02006641|473923215|FG000|Overall Study|Other reason: hospitalisation|0|||
131628010|NCT02006641|473923216|FG001|Overall Study|Other reason: hospitalisation|1|||
131712352|NCT02847598|474224210|FG004|Overall Study|Death|0|||
131712353|NCT02847598|474224211|FG005|Overall Study|Death|0|||
131712354|NCT02847598|474224212|FG006|Overall Study|Death|0|||
131712355|NCT02847598|474224213|FG007|Overall Study|Death|0|||
131712356|NCT02847598|474224206|FG000|Overall Study|Lost to Follow-up|0|||
131712357|NCT02847598|474224207|FG001|Overall Study|Lost to Follow-up|0|||
131712358|NCT02847598|474224208|FG002|Overall Study|Lost to Follow-up|0|||
131712359|NCT02847598|474224209|FG003|Overall Study|Lost to Follow-up|0|||
131712360|NCT02847598|474224210|FG004|Overall Study|Lost to Follow-up|0|||
131712361|NCT02847598|474224211|FG005|Overall Study|Lost to Follow-up|1|||
131712362|NCT02847598|474224212|FG006|Overall Study|Lost to Follow-up|1|||
131712363|NCT02847598|474224213|FG007|Overall Study|Lost to Follow-up|0|||
131712364|NCT02848833|474224214|FG000|Overall Study|subject who are duplicated|1|||
131712365|NCT02848833|474224214|FG000|Overall Study|have not taken the study drug|11|||
131712366|NCT02848833|474224214|FG000|Overall Study|follow-up failure|6|||
131712367|NCT02848833|474224214|FG000|Overall Study|Protocol Violation|119|||
131712368|NCT04167345|474224215|FG000|Overall Study|Other|1|||
131712369|NCT04167345|474224216|FG001|Overall Study|Other|1|||
131712370|NCT04167345|474224217|FG002|Overall Study|Other|0|||
131712371|NCT04167345|474224218|FG003|Overall Study|Other|0|||
131712372|NCT04167345|474224219|FG004|Overall Study|Other|0|||
131712373|NCT05630846|474226165|FG000|Overall Study|Death|1|||
131712374|NCT05630846|474226166|FG001|Overall Study|Death|0|||
131712375|NCT05630846|474226167|FG002|Overall Study|Death|0|||
131712376|NCT05630846|474226168|FG003|Overall Study|Death|0|||
131712377|NCT05630846|474226165|FG000|Overall Study|Withdrawal by Subject|3|||
131712378|NCT05630846|474226166|FG001|Overall Study|Withdrawal by Subject|3|||
131712379|NCT05630846|474226167|FG002|Overall Study|Withdrawal by Subject|4|||
131712380|NCT05630846|474226168|FG003|Overall Study|Withdrawal by Subject|1|||
131712381|NCT05630846|474226165|FG000|Overall Study|Lost to Follow-up|6|||
131712382|NCT05630846|474226166|FG001|Overall Study|Lost to Follow-up|5|||
131712383|NCT05630846|474226167|FG002|Overall Study|Lost to Follow-up|2|||
131712384|NCT05630846|474226168|FG003|Overall Study|Lost to Follow-up|5|||
131712385|NCT05630846|474226165|FG000|Overall Study|Other|1|||
131712386|NCT05630846|474226166|FG001|Overall Study|Other|0|||
131712387|NCT05630846|474226167|FG002|Overall Study|Other|0|||
131712388|NCT05630846|474226168|FG003|Overall Study|Other|0|||
131712389|NCT01445171|474226175|FG000|Overall Study|Lost to Follow-up|11|||
131712390|NCT01445171|474226175|FG000|Overall Study|Withdrawal by Subject|16|||
131712391|NCT01445171|474226175|FG000|Overall Study|Death|51|||
131712392|NCT01445171|474226175|FG000|Overall Study|Subjects declined to return for followup|9|||
131712393|NCT01445171|474226175|FG000|Overall Study|Consented but did not receive device|8|||
131712394|NCT03195894|474226176|FG000|Overall Study|"An example is Started other treatment."|4|||
131628011|NCT02006641|473923217|FG002|Overall Study|Other reason: hospitalisation|0|||
131628012|NCT02006641|473923215|FG000|Overall Study|Other reason: caregiver impossibility|0|||
131628013|NCT02006641|473923216|FG001|Overall Study|Other reason: caregiver impossibility|0|||
131628014|NCT02006641|473923217|FG002|Overall Study|Other reason: caregiver impossibility|1|||
131628015|NCT02006641|473923215|FG000|Overall Study|Other reason: protocol non-compliance|0|||
131628016|NCT02006641|473923216|FG001|Overall Study|Other reason: protocol non-compliance|0|||
131628017|NCT02006641|473923217|FG002|Overall Study|Other reason: protocol non-compliance|1|||
131628018|NCT02132195|473923220|FG000|Initial Assignment|Relapsed|14|||
131628019|NCT02132195|473923221|FG001|Initial Assignment|Relapsed|0|||
131628020|NCT02132195|473923222|FG002|Initial Assignment|Relapsed|0|||
131628021|NCT02132195|473923220|FG000|Rescue Therapy|Relapsed|0|||
131628022|NCT02132195|473923221|FG001|Rescue Therapy|Relapsed|0|||
131628023|NCT02132195|473923222|FG002|Rescue Therapy|Relapsed|7|||
131628024|NCT02132195|473923220|FG000|Rescue Therapy|Physician Decision|0|||
131712395|NCT03195894|474226177|FG001|Overall Study|"An example is Started other treatment."|5|||
131712396|NCT03195894|474226176|FG000|Overall Study|Withdrawal by Subject|15|||
131444227|NCT02379728|473257086|FG002|Overall Study|Protocol Violation|2|||
131628025|NCT02132195|473923221|FG001|Rescue Therapy|Physician Decision|0|||
131628026|NCT02132195|473923222|FG002|Rescue Therapy|Physician Decision|1|||
131712397|NCT03195894|474226177|FG001|Overall Study|Withdrawal by Subject|4|||
131444228|NCT02379728|473257087|FG003|Overall Study|Protocol Violation|0|||
131628027|NCT02132195|473923220|FG000|Rescue Therapy|Withdrawal by Subject|0|||
131901899|NCT01396083|474926894|FG000|Overall Study|Consent withdrawn|4|||
131901900|NCT01396083|474926895|FG001|Overall Study|Consent withdrawn|5|||
131901901|NCT01396083|474926894|FG000|Overall Study|Protocol deviation(s)|0|||
131901902|NCT01396083|474926895|FG001|Overall Study|Protocol deviation(s)|1|||
131901903|NCT01396083|474926894|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131901904|NCT01396083|474926895|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131901905|NCT01396083|474926894|FG000|Overall Study|Administrative problems|1|||
131901906|NCT01396083|474926895|FG001|Overall Study|Administrative problems|0|||
131901907|NCT01396083|474926894|FG000|Overall Study|Lost to Follow-up|1|||
131901908|NCT01396083|474926895|FG001|Overall Study|Lost to Follow-up|0|||
131901909|NCT00735709|474926896|FG000|Overall Study|Adverse Event|2|||
131901910|NCT00735709|474926897|FG001|Overall Study|Adverse Event|3|||
131901911|NCT00735709|474926898|FG002|Overall Study|Adverse Event|1|||
131901912|NCT00735709|474926899|FG003|Overall Study|Adverse Event|5|||
131901913|NCT00735709|474926896|FG000|Overall Study|Lack of Efficacy|8|||
131901914|NCT00735709|474926897|FG001|Overall Study|Lack of Efficacy|4|||
131901915|NCT00735709|474926898|FG002|Overall Study|Lack of Efficacy|2|||
131901916|NCT00735709|474926899|FG003|Overall Study|Lack of Efficacy|3|||
131901917|NCT00735709|474926896|FG000|Overall Study|Noncompliance|0|||
131901918|NCT00735709|474926897|FG001|Overall Study|Noncompliance|0|||
131901919|NCT00735709|474926898|FG002|Overall Study|Noncompliance|1|||
131901920|NCT00735709|474926899|FG003|Overall Study|Noncompliance|0|||
131901921|NCT00735709|474926896|FG000|Overall Study|Protocol deviations|1|||
131901922|NCT00735709|474926897|FG001|Overall Study|Protocol deviations|2|||
131901923|NCT00735709|474926898|FG002|Overall Study|Protocol deviations|1|||
131901924|NCT00735709|474926899|FG003|Overall Study|Protocol deviations|1|||
131901925|NCT00735709|474926896|FG000|Overall Study|Voluntary Withdrawal|1|||
131901926|NCT00735709|474926897|FG001|Overall Study|Voluntary Withdrawal|3|||
131901927|NCT00735709|474926898|FG002|Overall Study|Voluntary Withdrawal|5|||
131901928|NCT00735709|474926899|FG003|Overall Study|Voluntary Withdrawal|7|||
131901929|NCT00735709|474926896|FG000|Overall Study|Lost to Follow-up|0|||
131901930|NCT00735709|474926897|FG001|Overall Study|Lost to Follow-up|1|||
131901931|NCT00735709|474926898|FG002|Overall Study|Lost to Follow-up|1|||
131901932|NCT00735709|474926899|FG003|Overall Study|Lost to Follow-up|1|||
131901933|NCT00735709|474926896|FG000|Overall Study|Excluded medication|1|||
131901934|NCT00735709|474926897|FG001|Overall Study|Excluded medication|0|||
131901935|NCT00735709|474926898|FG002|Overall Study|Excluded medication|0|||
131901936|NCT00735709|474926899|FG003|Overall Study|Excluded medication|1|||
131628028|NCT02132195|473923221|FG001|Rescue Therapy|Withdrawal by Subject|0|||
131628029|NCT02132195|473923222|FG002|Rescue Therapy|Withdrawal by Subject|1|||
131628030|NCT02132195|473923220|FG000|Rescue Therapy|Adverse Event|0|||
131628031|NCT02132195|473923221|FG001|Rescue Therapy|Adverse Event|0|||
131628032|NCT02132195|473923222|FG002|Rescue Therapy|Adverse Event|2|||
131628033|NCT01287832|473923223|FG000|Overall Study|Adverse Event|1|||
131628034|NCT01287832|473923224|FG001|Overall Study|Adverse Event|0|||
131628035|NCT01287832|473923223|FG000|Overall Study|Death|0|||
131628036|NCT01287832|473923224|FG001|Overall Study|Death|1|||
131628037|NCT03065400|473923226|FG000|Overall Study|Adverse Event|1|||
131628038|NCT03065400|473923226|FG000|Overall Study|Physician Decision|3|||
131628039|NCT03065400|473923226|FG000|Overall Study|Withdrawal by Subject|1|||
131628040|NCT03065400|473923226|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
131628041|NCT04749797|473923227|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
131628042|NCT04749797|473923228|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
131628043|NCT04749797|473923229|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
131628044|NCT03072862|473923230|FG000|Overall Study|Withdrawal by Subject|4|||
131628045|NCT03072862|473923230|FG000|Overall Study|Lost to Follow-up|6|||
131628046|NCT03072862|473923230|FG000|Overall Study|Protocol Violation|4|||
131628047|NCT03072862|473923230|FG000|Overall Study|Physician Decision|2|||
131628048|NCT03072862|473923230|FG000|Overall Study|Death|1|||
131628049|NCT03072862|473923230|FG000|Overall Study|Adverse Event|1|||
131628050|NCT01441596|473923231|FG000|Overall Study|Other reason not defined below|0|||
131628051|NCT01441596|473923232|FG001|Overall Study|Other reason not defined below|2|||
131901937|NCT00521365|474926905|FG000|Overall Study|Adverse Event|3|||
131901938|NCT00521365|474926905|FG000|Overall Study|Lost to Follow-up|6|||
131901939|NCT00521365|474926905|FG000|Overall Study|Protocol deviation|2|||
131901940|NCT00521365|474926905|FG000|Overall Study|Drug compliance|3|||
131901941|NCT00521365|474926905|FG000|Overall Study|Usage of not allowed drugs|6|||
131628052|NCT01441596|473923233|FG002|Overall Study|Other reason not defined below|1|||
131901942|NCT01718483|474926906|FG000|Overall Study|Withdrawal by Subject|14|||
131901943|NCT01718483|474926907|FG001|Overall Study|Withdrawal by Subject|12|||
131901944|NCT01718483|474926906|FG000|Overall Study|Adverse Event|5|||
131628053|NCT01441596|473923231|FG000|Overall Study|Withdrawal by Subject|4|||
131628054|NCT01441596|473923232|FG001|Overall Study|Withdrawal by Subject|0|||
131628055|NCT01441596|473923233|FG002|Overall Study|Withdrawal by Subject|2|||
131628056|NCT01441596|473923231|FG000|Overall Study|Not treated|0|||
131628057|NCT01441596|473923232|FG001|Overall Study|Not treated|1|||
131628058|NCT01441596|473923233|FG002|Overall Study|Not treated|1|||
131628059|NCT00871715|473923238|FG000|Overall Study|Withdrawal by Subject|6|||
131628060|NCT00871715|473923239|FG001|Overall Study|Withdrawal by Subject|10|||
131628061|NCT00871715|473923240|FG002|Overall Study|Withdrawal by Subject|15|||
131712398|NCT03195894|474226176|FG000|Overall Study|Lost to Follow-up|14|||
131712399|NCT03195894|474226177|FG001|Overall Study|Lost to Follow-up|19|||
131712400|NCT00826748|474226178|FG000|Overall Study|Withdrawal by Subject|0|||
131712401|NCT00826748|474226179|FG001|Overall Study|Withdrawal by Subject|0|||
131712402|NCT00826748|474226180|FG002|Overall Study|Withdrawal by Subject|2|||
131712403|NCT00826748|474226178|FG000|Overall Study|Physician Decision|0|||
131712404|NCT00826748|474226179|FG001|Overall Study|Physician Decision|0|||
131712405|NCT00826748|474226180|FG002|Overall Study|Physician Decision|1|||
131712406|NCT00826748|474226178|FG000|Overall Study|Samples Did Not pass QC|0|||
131712407|NCT00826748|474226179|FG001|Overall Study|Samples Did Not pass QC|0|||
131712408|NCT00826748|474226180|FG002|Overall Study|Samples Did Not pass QC|1|||
131712409|NCT03312218|474226183|FG000|Overall Study|Never signed in to access the app|54|||
131712410|NCT03312218|474226184|FG001|Overall Study|Never signed in to access the app|58|||
131712411|NCT01887912|474226186|FG000|Overall Study|Serious adverse event|400|||
131712412|NCT01887912|474226187|FG001|Overall Study|Serious adverse event|198|||
131712413|NCT01887912|474226186|FG000|Overall Study|Other Adverse Event|34|||
131712414|NCT01887912|474226187|FG001|Overall Study|Other Adverse Event|15|||
131712415|NCT01887912|474226186|FG000|Overall Study|Protocol Violation|67|||
131712416|NCT01887912|474226187|FG001|Overall Study|Protocol Violation|37|||
131712417|NCT01887912|474226186|FG000|Overall Study|Lost to Follow-up|163|||
131712418|NCT01887912|474226187|FG001|Overall Study|Lost to Follow-up|74|||
131712419|NCT01887912|474226186|FG000|Overall Study|Withdrawal by Subject|606|||
131712420|NCT01887912|474226187|FG001|Overall Study|Withdrawal by Subject|349|||
131712421|NCT01887912|474226186|FG000|Overall Study|Other|122|||
131712422|NCT01887912|474226187|FG001|Overall Study|Other|58|||
131712423|NCT05067127|474226190|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
131712424|NCT05067127|474226191|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
131712425|NCT05067127|474226192|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
131712426|NCT05067127|474226193|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
131712427|NCT05067127|474226190|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131712428|NCT05067127|474226191|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
131712429|NCT05067127|474226192|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131712430|NCT05067127|474226193|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131712431|NCT05067127|474226190|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
131712432|NCT05067127|474226191|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131712433|NCT05067127|474226192|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131712434|NCT05067127|474226193|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131712435|NCT05067127|474226190|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
131712436|NCT05067127|474226191|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
131712437|NCT05067127|474226192|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
131712438|NCT05067127|474226193|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
131712439|NCT05067127|474226190|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
131712440|NCT05067127|474226191|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
131712441|NCT05067127|474226192|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
131712442|NCT05067127|474226193|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
131712443|NCT05067127|474226190|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
131712444|NCT05067127|474226191|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
131712445|NCT05067127|474226192|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
131712446|NCT05067127|474226193|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
131712447|NCT05067127|474226190|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131712448|NCT05067127|474226191|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131712449|NCT05067127|474226192|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
131712450|NCT05067127|474226193|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
131712451|NCT04462536|474226194|FG000|Overall Study|Withdrawal by Subject|3|||
131712452|NCT04462536|474226195|FG001|Overall Study|Withdrawal by Subject|9|||
131712453|NCT04462536|474226194|FG000|Overall Study|Lost to Follow-up|2|||
131712454|NCT04462536|474226195|FG001|Overall Study|Lost to Follow-up|4|||
131712455|NCT04439266|474226199|FG000|Overall Study|Ineligible|1|||
131712456|NCT04439266|474226199|FG000|Overall Study|Adverse Event|1|||
131712457|NCT04439266|474226199|FG000|Overall Study|Death|1|||
131797640|NCT00429923|474541675|FG001|Overall Study|Withdrew Consent|0|||
131628062|NCT00871715|473923238|FG000|Overall Study|Physician Decision|6|||
131628063|NCT00871715|473923239|FG001|Overall Study|Physician Decision|0|||
131444229|NCT05101122|473257088|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
131444230|NCT05101122|473257088|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
131444231|NCT05101122|473257088|FG000|AD313 80/5|Withdrawal by Subject|1|||
131444232|NCT05101122|473257088|FG000|AD313 80/10|Physician Decision|1|||
131444233|NCT04945733|473257091|FG000|Overall Study|Physician Decision|1|||
131444234|NCT04945733|473257092|FG001|Overall Study|Physician Decision|3|||
131444235|NCT04945733|473257093|FG002|Overall Study|Physician Decision|0|||
131444236|NCT04945733|473257091|FG000|Overall Study|Withdrawal by Subject|3|||
131444237|NCT04945733|473257092|FG001|Overall Study|Withdrawal by Subject|3|||
131444238|NCT04945733|473257093|FG002|Overall Study|Withdrawal by Subject|0|||
131444239|NCT05660577|473257096|FG000|Overall Study|Discontinued|9|||
131444240|NCT02903771|473257103|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
131628064|NCT00871715|473923240|FG002|Overall Study|Physician Decision|2|||
131628065|NCT00871715|473923238|FG000|Overall Study|Lost to Follow-up|3|||
131628066|NCT00871715|473923239|FG001|Overall Study|Lost to Follow-up|6|||
131628067|NCT00871715|473923240|FG002|Overall Study|Lost to Follow-up|9|||
131628068|NCT03015220|473923244|FG000|Overall Study|Withdrawal by Subject|3|||
131628069|NCT03015220|473923245|FG001|Overall Study|Withdrawal by Subject|2|||
131797641|NCT00429923|474541676|FG002|Overall Study|Withdrew Consent|1|||
131797642|NCT00429923|474541674|FG000|Overall Study|Early Termination|0|||
131797643|NCT00429923|474541675|FG001|Overall Study|Early Termination|1|||
131797644|NCT00429923|474541676|FG002|Overall Study|Early Termination|0|||
131797645|NCT03387098|474541677|FG000|Overall Study|progressive disease|1|||
131797646|NCT03387098|474541677|FG000|Overall Study|Withdrawal by Subject|2|||
131797647|NCT03387098|474541677|FG000|Overall Study|study terminated by sponsor|1|||
131797648|NCT02799602|474541680|FG000|Overall Study|Protocol Violation|1|||
131797649|NCT02799602|474541681|FG001|Overall Study|Protocol Violation|0|||
131797650|NCT02799602|474541680|FG000|Overall Study|Physician Decision|5|||
131797651|NCT02799602|474541681|FG001|Overall Study|Physician Decision|6|||
131797652|NCT02799602|474541680|FG000|Overall Study|Lost to Follow-up|4|||
131797653|NCT02799602|474541681|FG001|Overall Study|Lost to Follow-up|2|||
131797654|NCT02799602|474541680|FG000|Overall Study|Additional primary malignancy|11|||
131797655|NCT02799602|474541681|FG001|Overall Study|Additional primary malignancy|6|||
131628070|NCT03015220|473923246|FG002|Overall Study|Withdrawal by Subject|2|||
131628071|NCT03015220|473923247|FG003|Overall Study|Withdrawal by Subject|2|||
131628072|NCT03015220|473923244|FG000|Overall Study|Lost to Follow-up|0|||
131628073|NCT03015220|473923245|FG001|Overall Study|Lost to Follow-up|0|||
131628074|NCT03015220|473923246|FG002|Overall Study|Lost to Follow-up|1|||
131628075|NCT03015220|473923247|FG003|Overall Study|Lost to Follow-up|0|||
131628076|NCT01670526|473923248|FG000|Overall Study|Withdrawal by Subject|3|||
131628077|NCT01670526|473923249|FG001|Overall Study|Withdrawal by Subject|1|||
131628078|NCT01670526|473923248|FG000|Overall Study|Lost to Follow-up|9|||
131628079|NCT01670526|473923249|FG001|Overall Study|Lost to Follow-up|5|||
131628080|NCT02291549|473923250|FG000|Overall Study|Lost to Follow-up|1|||
131628081|NCT02291549|473923251|FG001|Overall Study|Lost to Follow-up|0|||
131628082|NCT02291549|473923250|FG000|Overall Study|Withdrawal by Subject|0|||
131628083|NCT02291549|473923251|FG001|Overall Study|Withdrawal by Subject|1|||
131628084|NCT01794689|473923252|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
131628085|NCT01794689|473923253|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
131628086|NCT01794689|473923254|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
131628087|NCT01794689|473923255|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
131628088|NCT01794689|473923252|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
131628089|NCT01794689|473923253|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
131628090|NCT01794689|473923254|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
131628091|NCT01794689|473923255|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
131628092|NCT01794689|473923252|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
131628093|NCT01794689|473923253|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
131628094|NCT01794689|473923254|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
131628095|NCT01794689|473923255|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
131628096|NCT01794689|473923252|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
131628097|NCT01794689|473923253|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
131628098|NCT01794689|473923254|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
131628099|NCT01794689|473923255|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
131628100|NCT01970527|473923256|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
131628101|NCT01970527|473923257|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
131628102|NCT01970527|473923256|FG000|Treatment|Disease progression|0|||
131628103|NCT01970527|473923257|FG001|Treatment|Disease progression|1|||
131628104|NCT01970527|473923256|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
131628105|NCT01970527|473923257|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
131628106|NCT01970527|473923256|FG000|Treatment|Death|0|||
131628107|NCT01970527|473923257|FG001|Treatment|Death|1|||
131628108|NCT01970527|473923256|FG000|Follow-up Clinic Visit|Disease progression|1|||
131628109|NCT01970527|473923257|FG001|Follow-up Clinic Visit|Disease progression|1|||
131628110|NCT01970527|473923256|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
131628111|NCT01970527|473923257|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
131628112|NCT01970527|473923256|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
131628113|NCT01970527|473923257|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
131628114|NCT01964547|473923258|FG000|Overall Study|Adverse Event|8|||
131628115|NCT01964547|473923259|FG001|Overall Study|Adverse Event|2|||
131628116|NCT01964547|473923258|FG000|Overall Study|Withdrawal by Subject|4|||
131628117|NCT01964547|473923259|FG001|Overall Study|Withdrawal by Subject|7|||
131628118|NCT01964547|473923258|FG000|Overall Study|Lost to Follow-up|0|||
131628119|NCT01964547|473923259|FG001|Overall Study|Lost to Follow-up|1|||
131628120|NCT01964547|473923258|FG000|Overall Study|Withdrawal by Investigator|0|||
131628121|NCT01964547|473923259|FG001|Overall Study|Withdrawal by Investigator|1|||
131628122|NCT01115309|473923260|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
131628123|NCT01115309|473923260|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
131628124|NCT01115309|473923260|FG000|Long-term Follow-up|Lost to Follow-up|6|||
131628125|NCT01159600|473923261|FG000|Overall Study|Not treated|0|||
131628126|NCT01159600|473923262|FG001|Overall Study|Not treated|0|||
131628127|NCT01159600|473923263|FG002|Overall Study|Not treated|1|||
131628128|NCT01159600|473923264|FG003|Overall Study|Not treated|0|||
131628129|NCT01159600|473923265|FG004|Overall Study|Not treated|0|||
131628130|NCT01159600|473923266|FG005|Overall Study|Not treated|1|||
131628131|NCT01159600|473923267|FG006|Overall Study|Not treated|2|||
131628132|NCT01159600|473923268|FG007|Overall Study|Not treated|2|||
131628133|NCT01159600|473923261|FG000|Overall Study|Adverse Event|7|||
131628134|NCT01159600|473923262|FG001|Overall Study|Adverse Event|2|||
131628135|NCT01159600|473923263|FG002|Overall Study|Adverse Event|5|||
131628136|NCT01159600|473923264|FG003|Overall Study|Adverse Event|1|||
131628137|NCT01159600|473923265|FG004|Overall Study|Adverse Event|8|||
131628138|NCT01159600|473923266|FG005|Overall Study|Adverse Event|6|||
131628139|NCT01159600|473923267|FG006|Overall Study|Adverse Event|7|||
131628140|NCT01159600|473923268|FG007|Overall Study|Adverse Event|5|||
131628141|NCT01159600|473923261|FG000|Overall Study|Lack of Efficacy|0|||
131628142|NCT01159600|473923262|FG001|Overall Study|Lack of Efficacy|0|||
131628143|NCT01159600|473923263|FG002|Overall Study|Lack of Efficacy|0|||
131628144|NCT01159600|473923264|FG003|Overall Study|Lack of Efficacy|0|||
131628145|NCT01159600|473923265|FG004|Overall Study|Lack of Efficacy|2|||
131628146|NCT01159600|473923266|FG005|Overall Study|Lack of Efficacy|0|||
131628147|NCT01159600|473923267|FG006|Overall Study|Lack of Efficacy|0|||
131628148|NCT01159600|473923268|FG007|Overall Study|Lack of Efficacy|1|||
131628149|NCT01159600|473923261|FG000|Overall Study|Non compliant with protocol|2|||
131628150|NCT01159600|473923262|FG001|Overall Study|Non compliant with protocol|1|||
131628151|NCT01159600|473923263|FG002|Overall Study|Non compliant with protocol|0|||
131628152|NCT01159600|473923264|FG003|Overall Study|Non compliant with protocol|0|||
131628153|NCT01159600|473923265|FG004|Overall Study|Non compliant with protocol|2|||
131628154|NCT01159600|473923266|FG005|Overall Study|Non compliant with protocol|0|||
131628155|NCT01159600|473923267|FG006|Overall Study|Non compliant with protocol|2|||
131628156|NCT01159600|473923268|FG007|Overall Study|Non compliant with protocol|0|||
131712458|NCT04439266|474226199|FG000|Overall Study|Disease progression|1|||
131712459|NCT04439266|474226199|FG000|Overall Study|Still on treatment|1|||
131712460|NCT06161012|474226202|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
131712461|NCT06161012|474226203|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
131712462|NCT02601950|474226204|FG000|Overall Study|Participant enrolled in rollover study|0|||
131712463|NCT02601950|474226205|FG001|Overall Study|Participant enrolled in rollover study|0|||
131712464|NCT02601950|474226206|FG002|Overall Study|Participant enrolled in rollover study|1|||
131712465|NCT02601950|474226207|FG003|Overall Study|Participant enrolled in rollover study|0|||
131712466|NCT02601950|474226208|FG004|Overall Study|Participant enrolled in rollover study|1|||
131712467|NCT02601950|474226209|FG005|Overall Study|Participant enrolled in rollover study|1|||
131712468|NCT02601950|474226210|FG006|Overall Study|Participant enrolled in rollover study|1|||
131712469|NCT02601950|474226211|FG007|Overall Study|Participant enrolled in rollover study|0|||
131712470|NCT02601950|474226204|FG000|Overall Study|Disease progression - radiological|21|||
131712471|NCT02601950|474226205|FG001|Overall Study|Disease progression - radiological|26|||
131712472|NCT02601950|474226206|FG002|Overall Study|Disease progression - radiological|22|||
131712473|NCT02601950|474226207|FG003|Overall Study|Disease progression - radiological|11|||
131712474|NCT02601950|474226208|FG004|Overall Study|Disease progression - radiological|46|||
131712475|NCT02601950|474226209|FG005|Overall Study|Disease progression - radiological|52|||
131712476|NCT02601950|474226210|FG006|Overall Study|Disease progression - radiological|7|||
131712477|NCT02601950|474226211|FG007|Overall Study|Disease progression - radiological|5|||
131712478|NCT02601950|474226204|FG000|Overall Study|Disease progression - clinical|3|||
131712479|NCT02601950|474226205|FG001|Overall Study|Disease progression - clinical|5|||
131628157|NCT01159600|473923261|FG000|Overall Study|Lost to Follow-up|2|||
131628158|NCT01159600|473923262|FG001|Overall Study|Lost to Follow-up|3|||
131628159|NCT01159600|473923263|FG002|Overall Study|Lost to Follow-up|4|||
131628160|NCT01159600|473923264|FG003|Overall Study|Lost to Follow-up|3|||
131628161|NCT01159600|473923265|FG004|Overall Study|Lost to Follow-up|3|||
131628162|NCT01159600|473923266|FG005|Overall Study|Lost to Follow-up|0|||
131712480|NCT02601950|474226206|FG002|Overall Study|Disease progression - clinical|4|||
131628163|NCT01159600|473923267|FG006|Overall Study|Lost to Follow-up|3|||
131628164|NCT01159600|473923268|FG007|Overall Study|Lost to Follow-up|2|||
131628165|NCT01159600|473923261|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
131628166|NCT01159600|473923262|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
131628167|NCT01159600|473923263|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
131628168|NCT01159600|473923264|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
131628169|NCT01159600|473923265|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
131628170|NCT01159600|473923266|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
131628171|NCT01159600|473923267|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
131628172|NCT01159600|473923268|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
131628173|NCT01159600|473923261|FG000|Overall Study|Other reason not defined above|3|||
131628174|NCT01159600|473923262|FG001|Overall Study|Other reason not defined above|0|||
131628175|NCT01159600|473923263|FG002|Overall Study|Other reason not defined above|4|||
131628176|NCT01159600|473923264|FG003|Overall Study|Other reason not defined above|2|||
131628177|NCT01159600|473923265|FG004|Overall Study|Other reason not defined above|5|||
131628178|NCT01159600|473923266|FG005|Overall Study|Other reason not defined above|7|||
131628179|NCT01159600|473923267|FG006|Overall Study|Other reason not defined above|3|||
131628180|NCT01159600|473923268|FG007|Overall Study|Other reason not defined above|3|||
131628181|NCT04433091|473923269|FG000|Overall Study|Lost to Follow-up|1|||
131628182|NCT04433091|473923270|FG001|Overall Study|Lost to Follow-up|0|||
131628183|NCT04433091|473923269|FG000|Overall Study|Withdrawn .|2|||
131628184|NCT04433091|473923270|FG001|Overall Study|Withdrawn .|4|||
131628185|NCT04097535|473923271|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
131628186|NCT03070301|473923272|FG000|Overall Study|Progression of disease|16|||
131628187|NCT03070301|473923272|FG000|Overall Study|Physician Decision|3|||
131628188|NCT03070301|473923272|FG000|Overall Study|Withdrawal by Subject|1|||
131628189|NCT03761849|473924963|FG000|Overall Study|transferred to OpenLabelExtension|35|||
131628190|NCT03761849|473924964|FG001|Overall Study|transferred to OpenLabelExtension|34|||
131628191|NCT03761849|473924965|FG002|Overall Study|transferred to OpenLabelExtension|36|||
131628192|NCT03761849|473924966|FG003|Overall Study|transferred to OpenLabelExtension|0|||
131628193|NCT03761849|473924967|FG004|Overall Study|transferred to OpenLabelExtension|0|||
131628194|NCT03761849|473924968|FG005|Overall Study|transferred to OpenLabelExtension|0|||
131628195|NCT03761849|473924963|FG000|Overall Study|Adverse Event|1|||
131628196|NCT03761849|473924964|FG001|Overall Study|Adverse Event|0|||
131628197|NCT03761849|473924965|FG002|Overall Study|Adverse Event|0|||
131628198|NCT03761849|473924966|FG003|Overall Study|Adverse Event|0|||
131628199|NCT03761849|473924967|FG004|Overall Study|Adverse Event|2|||
131628200|NCT03761849|473924968|FG005|Overall Study|Adverse Event|3|||
131628201|NCT03761849|473924963|FG000|Overall Study|Withdrawal by Subject|0|||
131628202|NCT03761849|473924964|FG001|Overall Study|Withdrawal by Subject|0|||
131628203|NCT03761849|473924965|FG002|Overall Study|Withdrawal by Subject|0|||
131628204|NCT03761849|473924966|FG003|Overall Study|Withdrawal by Subject|41|||
131628205|NCT03761849|473924967|FG004|Overall Study|Withdrawal by Subject|43|||
131628206|NCT03761849|473924968|FG005|Overall Study|Withdrawal by Subject|35|||
131628207|NCT03761849|473924963|FG000|Overall Study|Lost to Follow-up|0|||
131628208|NCT03761849|473924964|FG001|Overall Study|Lost to Follow-up|1|||
131628209|NCT03761849|473924965|FG002|Overall Study|Lost to Follow-up|0|||
131628210|NCT03761849|473924966|FG003|Overall Study|Lost to Follow-up|2|||
131628211|NCT03761849|473924967|FG004|Overall Study|Lost to Follow-up|4|||
131628212|NCT03761849|473924968|FG005|Overall Study|Lost to Follow-up|5|||
131628213|NCT03761849|473924963|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
131628214|NCT03761849|473924964|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
131628215|NCT03761849|473924965|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
131628216|NCT03761849|473924966|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
131628217|NCT03761849|473924967|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
131628218|NCT03761849|473924968|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
131628219|NCT03761849|473924963|FG000|Overall Study|Physician Decision|0|||
131628220|NCT03761849|473924964|FG001|Overall Study|Physician Decision|0|||
131628221|NCT03761849|473924965|FG002|Overall Study|Physician Decision|0|||
131901945|NCT01718483|474926907|FG001|Overall Study|Adverse Event|12|||
131628222|NCT03761849|473924966|FG003|Overall Study|Physician Decision|1|||
131628223|NCT03761849|473924967|FG004|Overall Study|Physician Decision|4|||
131628224|NCT03761849|473924968|FG005|Overall Study|Physician Decision|4|||
131628225|NCT03761849|473924963|FG000|Overall Study|Death|0|||
131628226|NCT03761849|473924964|FG001|Overall Study|Death|0|||
131628227|NCT03761849|473924965|FG002|Overall Study|Death|0|||
131628228|NCT03761849|473924966|FG003|Overall Study|Death|1|||
131628229|NCT03761849|473924967|FG004|Overall Study|Death|1|||
131628230|NCT03761849|473924968|FG005|Overall Study|Death|3|||
131628231|NCT03761849|473924963|FG000|Overall Study|Protocol Violation|0|||
131628232|NCT03761849|473924964|FG001|Overall Study|Protocol Violation|0|||
131628233|NCT03761849|473924965|FG002|Overall Study|Protocol Violation|0|||
131628234|NCT03761849|473924966|FG003|Overall Study|Protocol Violation|2|||
131628235|NCT03761849|473924967|FG004|Overall Study|Protocol Violation|2|||
131628236|NCT03761849|473924968|FG005|Overall Study|Protocol Violation|1|||
131628237|NCT03761849|473924963|FG000|Overall Study|Participant could not come to site|0|||
131628238|NCT03761849|473924964|FG001|Overall Study|Participant could not come to site|0|||
131628239|NCT03761849|473924965|FG002|Overall Study|Participant could not come to site|0|||
131628240|NCT03761849|473924966|FG003|Overall Study|Participant could not come to site|0|||
131628241|NCT03761849|473924967|FG004|Overall Study|Participant could not come to site|1|||
131628242|NCT03761849|473924968|FG005|Overall Study|Participant could not come to site|0|||
131628243|NCT03761849|473924963|FG000|Overall Study|SF- safety Finding|0|||
131628244|NCT03761849|473924964|FG001|Overall Study|SF- safety Finding|0|||
131628245|NCT03761849|473924965|FG002|Overall Study|SF- safety Finding|0|||
131628246|NCT03761849|473924966|FG003|Overall Study|SF- safety Finding|0|||
131628247|NCT03761849|473924967|FG004|Overall Study|SF- safety Finding|0|||
131628248|NCT03761849|473924968|FG005|Overall Study|SF- safety Finding|1|||
131628249|NCT03761849|473924963|FG000|Overall Study|Patient did not attend visit|0|||
131628250|NCT03761849|473924964|FG001|Overall Study|Patient did not attend visit|0|||
131628251|NCT03761849|473924965|FG002|Overall Study|Patient did not attend visit|0|||
131628252|NCT03761849|473924966|FG003|Overall Study|Patient did not attend visit|0|||
131628253|NCT03761849|473924967|FG004|Overall Study|Patient did not attend visit|0|||
131628254|NCT03761849|473924968|FG005|Overall Study|Patient did not attend visit|1|||
131628255|NCT01131325|473924969|FG000|Overall Study|Adverse Event|1|||
131628256|NCT01131325|473924969|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
131628257|NCT03840993|473924970|FG000|Overall Study|Adverse Event|1|||
131628258|NCT03840993|473924971|FG001|Overall Study|Adverse Event|0|||
131628259|NCT03840993|473924970|FG000|Overall Study|Lost to Follow-up|4|||
131628260|NCT03840993|473924971|FG001|Overall Study|Lost to Follow-up|0|||
131628261|NCT03840993|473924970|FG000|Overall Study|Physician Decision|0|||
131628262|NCT03840993|473924971|FG001|Overall Study|Physician Decision|1|||
131628263|NCT03840993|473924970|FG000|Overall Study|Pregnancy|0|||
131628264|NCT03840993|473924971|FG001|Overall Study|Pregnancy|1|||
131628265|NCT03840993|473924970|FG000|Overall Study|Withdrawal by Subject|1|||
131628266|NCT03840993|473924971|FG001|Overall Study|Withdrawal by Subject|3|||
131628267|NCT03840993|473924970|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
131628268|NCT03840993|473924971|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
131628269|NCT02213094|473924972|FG000|Overall Study|Adverse Event|1|||
131628270|NCT02213094|473924973|FG001|Overall Study|Adverse Event|0|||
131628271|NCT00988429|473924974|FG000|Overall Study|Adverse Event|9|||
131628272|NCT00988429|473924975|FG001|Overall Study|Adverse Event|21|||
131628273|NCT00988429|473924976|FG002|Overall Study|Adverse Event|45|||
131628274|NCT00988429|473924974|FG000|Overall Study|Lack of Efficacy|0|||
131628275|NCT00988429|473924975|FG001|Overall Study|Lack of Efficacy|0|||
131628276|NCT00988429|473924976|FG002|Overall Study|Lack of Efficacy|1|||
131628277|NCT00988429|473924974|FG000|Overall Study|Non-Compliance with Study Drug|5|||
131628278|NCT00988429|473924975|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131628279|NCT00988429|473924976|FG002|Overall Study|Non-Compliance with Study Drug|3|||
131628280|NCT00988429|473924974|FG000|Overall Study|Physician Decision|1|||
131628281|NCT00988429|473924975|FG001|Overall Study|Physician Decision|0|||
131628282|NCT00988429|473924976|FG002|Overall Study|Physician Decision|3|||
131628283|NCT00988429|473924974|FG000|Overall Study|Pregnancy|2|||
131628284|NCT00988429|473924975|FG001|Overall Study|Pregnancy|1|||
131797656|NCT02799602|474541680|FG000|Overall Study|Non-compliance with study drug|14|||
131797657|NCT02799602|474541681|FG001|Overall Study|Non-compliance with study drug|12|||
131797658|NCT02799602|474541680|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
131797659|NCT02799602|474541681|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
131797660|NCT02799602|474541680|FG000|Overall Study|Withdrawal by Subject|26|||
131797661|NCT02799602|474541681|FG001|Overall Study|Withdrawal by Subject|40|||
131628285|NCT00988429|473924976|FG002|Overall Study|Pregnancy|0|||
131797662|NCT02799602|474541680|FG000|Overall Study|Progressive disease - clinical progression|131|||
131628286|NCT00988429|473924974|FG000|Overall Study|Protocol Violation|4|||
131628287|NCT00988429|473924975|FG001|Overall Study|Protocol Violation|3|||
131628288|NCT00988429|473924976|FG002|Overall Study|Protocol Violation|3|||
131628289|NCT00988429|473924974|FG000|Overall Study|Withdrawal by Subject|7|||
131628290|NCT00988429|473924975|FG001|Overall Study|Withdrawal by Subject|7|||
131628291|NCT00988429|473924976|FG002|Overall Study|Withdrawal by Subject|12|||
131628292|NCT00988429|473924974|FG000|Overall Study|Administrative Reasons|1|||
131628293|NCT00988429|473924975|FG001|Overall Study|Administrative Reasons|2|||
131628294|NCT00988429|473924976|FG002|Overall Study|Administrative Reasons|1|||
131628295|NCT00988429|473924974|FG000|Overall Study|other reasons|8|||
131628296|NCT00988429|473924975|FG001|Overall Study|other reasons|8|||
131628297|NCT00988429|473924976|FG002|Overall Study|other reasons|1|||
131628298|NCT02964234|473924977|FG000|Overall Study|Lost to Follow-up|22|||
131628299|NCT02964234|473924978|FG001|Overall Study|Lost to Follow-up|13|||
131628300|NCT01074229|473924979|FG000|Overall Study|Lost to Follow-up|1|||
131901946|NCT01718483|474926906|FG000|Overall Study|Lost to Follow-up|8|||
131901947|NCT01718483|474926907|FG001|Overall Study|Lost to Follow-up|3|||
131901948|NCT01718483|474926906|FG000|Overall Study|Protocol Violation|4|||
131901949|NCT01718483|474926907|FG001|Overall Study|Protocol Violation|2|||
131901950|NCT01718483|474926906|FG000|Overall Study|Other|1|||
131901951|NCT01718483|474926907|FG001|Overall Study|Other|4|||
131628301|NCT01074229|473924980|FG001|Overall Study|Lost to Follow-up|0|||
131628302|NCT01074229|473924981|FG002|Overall Study|Lost to Follow-up|0|||
131628303|NCT01074229|473924979|FG000|Overall Study|Change to open surgical procedure|1|||
131628304|NCT01074229|473924980|FG001|Overall Study|Change to open surgical procedure|3|||
131628305|NCT01074229|473924981|FG002|Overall Study|Change to open surgical procedure|4|||
131901952|NCT01718483|474926906|FG000|Overall Study|Pregnancy|1|||
131901953|NCT01718483|474926907|FG001|Overall Study|Pregnancy|1|||
131901954|NCT01718483|474926906|FG000|Overall Study|Lack of Efficacy|1|||
131901955|NCT01718483|474926907|FG001|Overall Study|Lack of Efficacy|0|||
131628306|NCT02163499|473924984|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
131628307|NCT02163499|473924984|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
131628308|NCT02163499|473924984|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
131628309|NCT02163499|473924984|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
131628310|NCT02163499|473924984|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
131628311|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
131628312|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
131628313|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
131628314|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
131628315|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
131628316|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
131628317|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
131628318|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
131628319|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
131628320|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Death|8|||
131628321|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
131628322|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
131628323|NCT02163499|473924984|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
131628324|NCT01540474|473924985|FG000|Vaccination Period|Lost to Follow-up|0|||
131628325|NCT01540474|473924986|FG001|Vaccination Period|Lost to Follow-up|1|||
131712481|NCT02601950|474226207|FG003|Overall Study|Disease progression - clinical|2|||
131712482|NCT02601950|474226208|FG004|Overall Study|Disease progression - clinical|6|||
131712483|NCT02601950|474226209|FG005|Overall Study|Disease progression - clinical|6|||
131712484|NCT02601950|474226210|FG006|Overall Study|Disease progression - clinical|5|||
131712485|NCT02601950|474226211|FG007|Overall Study|Disease progression - clinical|1|||
131712486|NCT02601950|474226204|FG000|Overall Study|Death|6|||
131712487|NCT02601950|474226205|FG001|Overall Study|Death|0|||
131712488|NCT02601950|474226206|FG002|Overall Study|Death|3|||
131712489|NCT02601950|474226207|FG003|Overall Study|Death|1|||
131712490|NCT02601950|474226208|FG004|Overall Study|Death|4|||
131712491|NCT02601950|474226209|FG005|Overall Study|Death|1|||
131712492|NCT02601950|474226210|FG006|Overall Study|Death|0|||
131712493|NCT02601950|474226211|FG007|Overall Study|Death|0|||
131712494|NCT02601950|474226204|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712495|NCT02601950|474226205|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712496|NCT02601950|474226206|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712497|NCT02601950|474226207|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712498|NCT02601950|474226208|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712499|NCT02601950|474226209|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
131712500|NCT02601950|474226210|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712501|NCT02601950|474226211|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131712502|NCT02601950|474226204|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
131712503|NCT02601950|474226205|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
131712504|NCT02601950|474226206|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
131628326|NCT01540474|473924987|FG002|Vaccination Period|Lost to Follow-up|0|||
131628327|NCT01540474|473924988|FG003|Vaccination Period|Lost to Follow-up|0|||
131628328|NCT00857311|473924989|FG000|Overall Study|Lost to Follow-up|1|||
131628329|NCT00857311|473924990|FG001|Overall Study|Lost to Follow-up|0|||
131712505|NCT02601950|474226207|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
131901956|NCT05137717|474926910|FG000|Overall Study|Death|2|||
131901957|NCT05137717|474926910|FG000|Overall Study|Withdrawal by Subject|6|||
131901958|NCT00509899|474926912|FG000|Overall Study|Progressive disease|1|||
131628330|NCT00857311|473924991|FG002|Overall Study|Lost to Follow-up|0|||
131628331|NCT00857311|473924992|FG003|Overall Study|Lost to Follow-up|0|||
131628332|NCT01799993|473924994|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
131628333|NCT01799993|473924995|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
131628334|NCT01799993|473924994|FG000|Overall Study|Death|61|||
131628335|NCT01799993|473924995|FG001|Overall Study|Death|45|||
131628336|NCT01799993|473924994|FG000|Overall Study|Withdrawal by Subject|23|||
131628337|NCT01799993|473924995|FG001|Overall Study|Withdrawal by Subject|24|||
131628338|NCT01799993|473924994|FG000|Overall Study|Lost to Follow-up|5|||
131628339|NCT01799993|473924995|FG001|Overall Study|Lost to Follow-up|8|||
131628340|NCT01799993|473924994|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
131628341|NCT01799993|473924995|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
131628342|NCT01799993|473924994|FG000|Overall Study|Protocol driven decision point|0|||
131628343|NCT01799993|473924995|FG001|Overall Study|Protocol driven decision point|3|||
131628344|NCT01799993|473924994|FG000|Overall Study|Protocol Violation|1|||
131628345|NCT01799993|473924995|FG001|Overall Study|Protocol Violation|1|||
131628346|NCT01799993|473924994|FG000|Overall Study|Deterioration of general conditions|2|||
131628347|NCT01799993|473924995|FG001|Overall Study|Deterioration of general conditions|0|||
131628348|NCT01799993|473924994|FG000|Overall Study|Screen failure|0|||
131628349|NCT01799993|473924995|FG001|Overall Study|Screen failure|1|||
131628350|NCT01799993|473924994|FG000|Overall Study|Adverse Event|1|||
131628351|NCT01799993|473924995|FG001|Overall Study|Adverse Event|0|||
131628352|NCT01799993|473924994|FG000|Overall Study|Lack of Efficacy|1|||
131628353|NCT01799993|473924995|FG001|Overall Study|Lack of Efficacy|0|||
131628354|NCT01799993|473924994|FG000|Overall Study|Recovery|0|||
131628355|NCT01799993|473924995|FG001|Overall Study|Recovery|1|||
131628356|NCT01799993|473924994|FG000|Overall Study|Logistical difficulties|1|||
131628357|NCT01799993|473924995|FG001|Overall Study|Logistical difficulties|0|||
131628358|NCT01799993|473924994|FG000|Overall Study|Protocol deviation|1|||
131628359|NCT01799993|473924995|FG001|Overall Study|Protocol deviation|0|||
131628360|NCT01799993|473924994|FG000|Overall Study|Non-compliance with medical device|1|||
131628361|NCT01799993|473924995|FG001|Overall Study|Non-compliance with medical device|0|||
131628362|NCT01799993|473924994|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131628363|NCT01799993|473924995|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131628364|NCT01799993|473924994|FG000|Overall Study|Other|1|||
131628365|NCT01799993|473924995|FG001|Overall Study|Other|0|||
131628366|NCT01799993|473924994|FG000|Overall Study|Subject didn't return for follow-up|0|||
131628367|NCT01799993|473924995|FG001|Overall Study|Subject didn't return for follow-up|1|||
131628368|NCT04271254|473924996|FG000|Overall Study|Withdrawal by Subject|3|||
131628369|NCT04410445|473924997|FG000|Overall Study|Lost to Follow-up|3|||
131628370|NCT04410445|473924998|FG001|Overall Study|Lost to Follow-up|9|||
131628371|NCT04410445|473924997|FG000|Overall Study|Withdrawal by Subject|27|||
131628372|NCT04410445|473924998|FG001|Overall Study|Withdrawal by Subject|15|||
131628373|NCT01320683|473924999|FG000|Overall Study|Positive antibody response|1|||
131628374|NCT01123356|473925000|FG000|Overall Study|Adverse Event|2|||
131628375|NCT01123356|473925000|FG000|Overall Study|Lack of Efficacy|4|||
131628376|NCT01123356|473925000|FG000|Overall Study|Withdrawal by Subject|1|||
131628377|NCT00759681|473925001|FG000|Overall Study|Death|2|||
131628378|NCT00759681|473925002|FG001|Overall Study|Death|5|||
131628379|NCT00759681|473925001|FG000|Overall Study|Lost to Follow-up|8|||
131628380|NCT00759681|473925002|FG001|Overall Study|Lost to Follow-up|5|||
131628381|NCT01129011|473925005|FG000|Overall Study|Adverse Event|20|||
131628382|NCT01129011|473925006|FG001|Overall Study|Adverse Event|30|||
131628383|NCT01129011|473925005|FG000|Overall Study|Withdrawal by Subject|24|||
131628384|NCT01129011|473925006|FG001|Overall Study|Withdrawal by Subject|8|||
131628385|NCT01129011|473925005|FG000|Overall Study|Lost to Follow-up|6|||
131628386|NCT01129011|473925006|FG001|Overall Study|Lost to Follow-up|7|||
131628387|NCT01129011|473925005|FG000|Overall Study|Duodenal Ulcer|2|||
131628388|NCT01129011|473925006|FG001|Overall Study|Duodenal Ulcer|8|||
131628389|NCT01129011|473925005|FG000|Overall Study|misc|7|||
131628390|NCT01129011|473925006|FG001|Overall Study|misc|4|||
131628391|NCT02005484|473925007|FG000|Overall Study|Death|1|||
131628392|NCT02005484|473925007|FG000|Overall Study|Disease progression|1|||
131628393|NCT02005484|473925007|FG000|Overall Study|Changed to a Different Study|1|||
131628394|NCT02005484|473925007|FG000|Overall Study|Sponsor decision|1|||
131628395|NCT02823574|473925011|FG000|Randomization|Disease Progression|0|||
131628396|NCT02823574|473925012|FG001|Randomization|Disease Progression|0|||
131628397|NCT02823574|473925013|FG002|Randomization|Disease Progression|1|||
131628398|NCT02823574|473925014|FG003|Randomization|Disease Progression|0|||
131628399|NCT02823574|473925011|FG000|Randomization|AE unrelated to Study Drug|1|||
131628400|NCT02823574|473925012|FG001|Randomization|AE unrelated to Study Drug|0|||
131628401|NCT02823574|473925013|FG002|Randomization|AE unrelated to Study Drug|0|||
131628402|NCT02823574|473925014|FG003|Randomization|AE unrelated to Study Drug|0|||
131628403|NCT02823574|473925011|FG000|Treatment Period|Poor/Non Compliance|1|||
131628404|NCT02823574|473925012|FG001|Treatment Period|Poor/Non Compliance|0|||
131628405|NCT02823574|473925013|FG002|Treatment Period|Poor/Non Compliance|0|||
131628406|NCT02823574|473925014|FG003|Treatment Period|Poor/Non Compliance|1|||
131628407|NCT02823574|473925011|FG000|Treatment Period|Maximum Clinical Benefit|8|||
131628408|NCT02823574|473925012|FG001|Treatment Period|Maximum Clinical Benefit|4|||
131628409|NCT02823574|473925013|FG002|Treatment Period|Maximum Clinical Benefit|7|||
131628410|NCT02823574|473925014|FG003|Treatment Period|Maximum Clinical Benefit|1|||
131628411|NCT02823574|473925011|FG000|Treatment Period|Lost to Follow-up|1|||
131628412|NCT02823574|473925012|FG001|Treatment Period|Lost to Follow-up|1|||
131628413|NCT02823574|473925013|FG002|Treatment Period|Lost to Follow-up|0|||
131628414|NCT02823574|473925014|FG003|Treatment Period|Lost to Follow-up|0|||
131628415|NCT02823574|473925011|FG000|Treatment Period|Participant withdrew consent|4|||
131628416|NCT02823574|473925012|FG001|Treatment Period|Participant withdrew consent|0|||
131628417|NCT02823574|473925013|FG002|Treatment Period|Participant withdrew consent|0|||
131628418|NCT02823574|473925014|FG003|Treatment Period|Participant withdrew consent|1|||
131628419|NCT02823574|473925011|FG000|Treatment Period|Participant request to discontinue|5|||
131628420|NCT02823574|473925012|FG001|Treatment Period|Participant request to discontinue|0|||
131628421|NCT02823574|473925013|FG002|Treatment Period|Participant request to discontinue|3|||
131628422|NCT02823574|473925014|FG003|Treatment Period|Participant request to discontinue|2|||
131628423|NCT02823574|473925011|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
131628424|NCT02823574|473925012|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
131628425|NCT02823574|473925013|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
131628426|NCT02823574|473925014|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
131628427|NCT02823574|473925011|FG000|Treatment Period|Study Drug Toxicity|11|||
131628428|NCT02823574|473925012|FG001|Treatment Period|Study Drug Toxicity|2|||
131628429|NCT02823574|473925013|FG002|Treatment Period|Study Drug Toxicity|14|||
131628430|NCT02823574|473925014|FG003|Treatment Period|Study Drug Toxicity|4|||
131628431|NCT02823574|473925011|FG000|Treatment Period|Disease Progression|113|||
131628432|NCT02823574|473925012|FG001|Treatment Period|Disease Progression|64|||
131628433|NCT02823574|473925013|FG002|Treatment Period|Disease Progression|82|||
131628434|NCT02823574|473925014|FG003|Treatment Period|Disease Progression|43|||
131628435|NCT02823574|473925011|FG000|Treatment Period|Other reasons|5|||
131628436|NCT02823574|473925012|FG001|Treatment Period|Other reasons|9|||
131628437|NCT02823574|473925013|FG002|Treatment Period|Other reasons|3|||
131628438|NCT02823574|473925014|FG003|Treatment Period|Other reasons|6|||
131628439|NCT02823574|473925011|FG000|Treatment Period|Participant no longer meets study criteria|0|||
131628440|NCT02823574|473925012|FG001|Treatment Period|Participant no longer meets study criteria|0|||
131628441|NCT02823574|473925013|FG002|Treatment Period|Participant no longer meets study criteria|1|||
131628442|NCT02823574|473925014|FG003|Treatment Period|Participant no longer meets study criteria|0|||
131628443|NCT02823574|473925011|FG000|Treatment Period|Death|0|||
131628444|NCT02823574|473925012|FG001|Treatment Period|Death|0|||
131628445|NCT02823574|473925013|FG002|Treatment Period|Death|3|||
131628446|NCT02823574|473925014|FG003|Treatment Period|Death|1|||
131628447|NCT00590759|473925015|FG000|Overall Study|Death|52|||
131628448|NCT00590759|473925015|FG000|Overall Study|Lost to Follow-up|28|||
131628449|NCT00417885|473925016|FG000|Overall Study|Adverse Event|1|||
131628450|NCT00417885|473925016|FG000|Overall Study|Objective Progression or Relapse|3|||
131628451|NCT00417885|473925016|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
131628452|NCT01722097|473925018|FG000|Overall Study|Patient sheets not returned|6|||
131628453|NCT01722097|473925019|FG001|Overall Study|Patient sheets not returned|5|||
131628454|NCT02009332|473925020|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131628455|NCT02009332|473925021|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
131712506|NCT02601950|474226208|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
131712507|NCT02601950|474226209|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
131712508|NCT02601950|474226210|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
131712509|NCT02601950|474226211|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
131712510|NCT02601950|474226204|FG000|Overall Study|Non-compliance|0|||
131712511|NCT02601950|474226205|FG001|Overall Study|Non-compliance|1|||
131712512|NCT02601950|474226206|FG002|Overall Study|Non-compliance|0|||
131712513|NCT02601950|474226207|FG003|Overall Study|Non-compliance|0|||
131712514|NCT02601950|474226208|FG004|Overall Study|Non-compliance|0|||
131712515|NCT02601950|474226209|FG005|Overall Study|Non-compliance|1|||
131712516|NCT02601950|474226210|FG006|Overall Study|Non-compliance|1|||
131712517|NCT02601950|474226211|FG007|Overall Study|Non-compliance|0|||
131712518|NCT02601950|474226204|FG000|Overall Study|Participant refused further study treatment|0|||
131712519|NCT02601950|474226205|FG001|Overall Study|Participant refused further study treatment|1|||
131712520|NCT02601950|474226206|FG002|Overall Study|Participant refused further study treatment|1|||
131712521|NCT02601950|474226207|FG003|Overall Study|Participant refused further study treatment|0|||
131712522|NCT02601950|474226208|FG004|Overall Study|Participant refused further study treatment|2|||
131712523|NCT02601950|474226209|FG005|Overall Study|Participant refused further study treatment|2|||
131712524|NCT02601950|474226210|FG006|Overall Study|Participant refused further study treatment|2|||
131712525|NCT02601950|474226211|FG007|Overall Study|Participant refused further study treatment|1|||
131712526|NCT02601950|474226204|FG000|Overall Study|Investigator discretion|1|||
131712527|NCT02601950|474226205|FG001|Overall Study|Investigator discretion|0|||
131712528|NCT02601950|474226206|FG002|Overall Study|Investigator discretion|1|||
131712529|NCT02601950|474226207|FG003|Overall Study|Investigator discretion|0|||
131712530|NCT02601950|474226208|FG004|Overall Study|Investigator discretion|1|||
131628456|NCT02009332|473925022|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131628457|NCT02009332|473925023|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131628458|NCT02009332|473925024|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131712531|NCT02601950|474226209|FG005|Overall Study|Investigator discretion|1|||
131712532|NCT02601950|474226210|FG006|Overall Study|Investigator discretion|1|||
131712533|NCT02601950|474226211|FG007|Overall Study|Investigator discretion|0|||
131712534|NCT02601950|474226204|FG000|Overall Study|Other|0|||
131797663|NCT02799602|474541681|FG001|Overall Study|Progressive disease - clinical progression|276|||
131444241|NCT02903771|473257104|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
131628459|NCT02009332|473925025|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131628460|NCT02009332|473925020|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131628461|NCT02009332|473925021|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131628462|NCT02009332|473925022|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131628463|NCT02009332|473925023|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131628464|NCT02009332|473925024|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
131628465|NCT02009332|473925025|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131628466|NCT02009332|473925020|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131628467|NCT02009332|473925021|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131628468|NCT02009332|473925022|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131628469|NCT02009332|473925023|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131628470|NCT02009332|473925024|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131628471|NCT02009332|473925025|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
131628472|NCT00096278|473925027|FG000|Overall Study|No follow-up data|15|||
131628473|NCT00096278|473925028|FG001|Overall Study|No follow-up data|18|||
131628474|NCT00096278|473925027|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
131628475|NCT00096278|473925028|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
131628476|NCT00248794|473925029|FG000|Overall Study|Lost to Follow-up|6|||
131628477|NCT00248794|473925030|FG001|Overall Study|Lost to Follow-up|8|||
131628478|NCT00248794|473925031|FG002|Overall Study|Lost to Follow-up|3|||
131628479|NCT02632747|473925032|FG000|Wash-out Period|Adverse Event|1|||
131628480|NCT02632747|473925033|FG001|Wash-out Period|Adverse Event|0|||
131628481|NCT03449979|473925034|FG000|Overall Study|Technical difficulty|0|||
131628482|NCT03449979|473925035|FG001|Overall Study|Technical difficulty|0|||
131628483|NCT03449979|473925036|FG002|Overall Study|Technical difficulty|0|||
131628484|NCT03449979|473925037|FG003|Overall Study|Technical difficulty|1|||
131628485|NCT02069379|473925038|FG000|Baseline Measurements|Lost to Follow-up|1|||
131628486|NCT02069379|473925039|FG001|Baseline Measurements|Lost to Follow-up|0|||
131628487|NCT02069379|473925040|FG002|Baseline Measurements|Lost to Follow-up|0|||
131628488|NCT02069379|473925041|FG003|Baseline Measurements|Lost to Follow-up|0|||
131628489|NCT02069379|473925038|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
131628490|NCT02069379|473925039|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
131712535|NCT02601950|474226205|FG001|Overall Study|Other|0|||
131712536|NCT02601950|474226206|FG002|Overall Study|Other|0|||
131712537|NCT02601950|474226207|FG003|Overall Study|Other|0|||
131712538|NCT02601950|474226208|FG004|Overall Study|Other|2|||
131712539|NCT02601950|474226209|FG005|Overall Study|Other|2|||
131712540|NCT02601950|474226210|FG006|Overall Study|Other|1|||
131712541|NCT02601950|474226211|FG007|Overall Study|Other|0|||
131712542|NCT03619213|474226218|FG000|Overall Study|Lost to Follow-up|2|||
131712543|NCT03619213|474226219|FG001|Overall Study|Lost to Follow-up|1|||
131712544|NCT03619213|474226218|FG000|Overall Study|Withdrawal by Subject|8|||
131628491|NCT02069379|473925040|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
131628492|NCT02069379|473925041|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
131628493|NCT02069379|473925038|FG000|First Treatment Arm|Lost to Follow-up|0|||
131628494|NCT02069379|473925039|FG001|First Treatment Arm|Lost to Follow-up|1|||
131628495|NCT02069379|473925040|FG002|First Treatment Arm|Lost to Follow-up|1|||
131628496|NCT02069379|473925041|FG003|First Treatment Arm|Lost to Follow-up|0|||
131628497|NCT02069379|473925038|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
131712545|NCT03619213|474226219|FG001|Overall Study|Withdrawal by Subject|10|||
131712546|NCT02886702|474226223|FG000|Overall Study|Other|4|||
131712547|NCT02886702|474226224|FG001|Overall Study|Other|3|||
131712548|NCT02886702|474226225|FG002|Overall Study|Other|9|||
131628498|NCT02069379|473925039|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
131628499|NCT02069379|473925040|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
131628500|NCT02069379|473925041|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
131628501|NCT02069379|473925038|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
131628502|NCT02069379|473925039|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
131628503|NCT02069379|473925040|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
131628504|NCT02069379|473925041|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
131628505|NCT02069379|473925038|FG000|Second Treatment Arm|Lost to Follow-up|0|||
131628506|NCT02069379|473925039|FG001|Second Treatment Arm|Lost to Follow-up|0|||
131628507|NCT02069379|473925040|FG002|Second Treatment Arm|Lost to Follow-up|1|||
131628508|NCT02069379|473925041|FG003|Second Treatment Arm|Lost to Follow-up|0|||
131628509|NCT00700999|473925044|FG000|Overall Study|Lost to Follow-up|7|||
131628510|NCT00700999|473925045|FG001|Overall Study|Lost to Follow-up|7|||
131628511|NCT00700999|473925044|FG000|Overall Study|Excluded - did not meet study criteria|0|||
131901959|NCT00509899|474926913|FG001|Overall Study|Progressive disease|3|||
131901960|NCT00509899|474926914|FG002|Overall Study|Progressive disease|5|||
131901961|NCT00509899|474926915|FG003|Overall Study|Progressive disease|1|||
131901962|NCT00509899|474926916|FG004|Overall Study|Progressive disease|0|||
131901963|NCT00509899|474926917|FG005|Overall Study|Progressive disease|1|||
131901964|NCT00509899|474926918|FG006|Overall Study|Progressive disease|0|||
131901965|NCT00509899|474926919|FG007|Overall Study|Progressive disease|0|||
131901966|NCT00509899|474926912|FG000|Overall Study|Unacceptable Toxicity|1|||
131901967|NCT00509899|474926913|FG001|Overall Study|Unacceptable Toxicity|0|||
131901968|NCT00509899|474926914|FG002|Overall Study|Unacceptable Toxicity|0|||
131901969|NCT00509899|474926915|FG003|Overall Study|Unacceptable Toxicity|2|||
131901970|NCT00509899|474926916|FG004|Overall Study|Unacceptable Toxicity|0|||
131628512|NCT00700999|473925045|FG001|Overall Study|Excluded - did not meet study criteria|1|||
131628513|NCT00700999|473925044|FG000|Overall Study|Withdrawal by Subject|8|||
131628514|NCT00700999|473925045|FG001|Overall Study|Withdrawal by Subject|1|||
131628515|NCT03481725|473925046|FG000|Overall Study|Withdrawal by Subject|1|||
131628516|NCT03481725|473925047|FG001|Overall Study|Withdrawal by Subject|0|||
131628517|NCT03651271|473925048|FG000|Overall Study|Death|4|||
131628518|NCT03651271|473925049|FG001|Overall Study|Death|37|||
131628519|NCT03651271|473925050|FG002|Overall Study|Death|0|||
131628520|NCT03651271|473925051|FG003|Overall Study|Death|2|||
131628521|NCT03651271|473925052|FG004|Overall Study|Death|6|||
131628522|NCT03651271|473925048|FG000|Overall Study|Lost to Follow-up|1|||
131628523|NCT03651271|473925049|FG001|Overall Study|Lost to Follow-up|5|||
131628524|NCT03651271|473925050|FG002|Overall Study|Lost to Follow-up|0|||
131628525|NCT03651271|473925051|FG003|Overall Study|Lost to Follow-up|1|||
131628526|NCT03651271|473925052|FG004|Overall Study|Lost to Follow-up|0|||
131628527|NCT03651271|473925048|FG000|Overall Study|Physician Decision|0|||
131628528|NCT03651271|473925049|FG001|Overall Study|Physician Decision|2|||
131628529|NCT03651271|473925050|FG002|Overall Study|Physician Decision|0|||
131628530|NCT03651271|473925051|FG003|Overall Study|Physician Decision|0|||
131628531|NCT03651271|473925052|FG004|Overall Study|Physician Decision|0|||
131628532|NCT03651271|473925048|FG000|Overall Study|Withdrawal by Subject|1|||
131628533|NCT03651271|473925049|FG001|Overall Study|Withdrawal by Subject|15|||
131628534|NCT03651271|473925050|FG002|Overall Study|Withdrawal by Subject|0|||
131628535|NCT03651271|473925051|FG003|Overall Study|Withdrawal by Subject|0|||
131628536|NCT03651271|473925052|FG004|Overall Study|Withdrawal by Subject|1|||
131628537|NCT03651271|473925048|FG000|Overall Study|Patient medically unable to continue|0|||
131628538|NCT03651271|473925049|FG001|Overall Study|Patient medically unable to continue|0|||
131628539|NCT03651271|473925050|FG002|Overall Study|Patient medically unable to continue|0|||
131628540|NCT03651271|473925051|FG003|Overall Study|Patient medically unable to continue|1|||
131628541|NCT03651271|473925052|FG004|Overall Study|Patient medically unable to continue|0|||
131628542|NCT03444155|473925055|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
131628543|NCT03444155|473925056|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
131628544|NCT01133678|473925061|FG000|Overall Study|Death|1|||
131628545|NCT01133678|473925062|FG001|Overall Study|Death|1|||
131628546|NCT00446095|473925063|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
131628547|NCT00446095|473925064|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
131628548|NCT00446095|473925065|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
131628549|NCT00446095|473925066|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
131628550|NCT00446095|473925067|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
131628551|NCT00446095|473925063|FG000|Phase II (8 Weeks)|Adverse Event|0|||
131628552|NCT00446095|473925064|FG001|Phase II (8 Weeks)|Adverse Event|1|||
131628553|NCT00446095|473925065|FG002|Phase II (8 Weeks)|Adverse Event|1|||
131628554|NCT00446095|473925066|FG003|Phase II (8 Weeks)|Adverse Event|0|||
131628555|NCT00446095|473925067|FG004|Phase II (8 Weeks)|Adverse Event|0|||
131628556|NCT00446095|473925063|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
131628557|NCT00446095|473925064|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131901971|NCT00509899|474926917|FG005|Overall Study|Unacceptable Toxicity|0|||
131901972|NCT00509899|474926918|FG006|Overall Study|Unacceptable Toxicity|0|||
131901973|NCT00509899|474926919|FG007|Overall Study|Unacceptable Toxicity|0|||
131901974|NCT00509899|474926912|FG000|Overall Study|Withdrawal by Subject|6|||
131901975|NCT00509899|474926913|FG001|Overall Study|Withdrawal by Subject|2|||
131797664|NCT02799602|474541680|FG000|Overall Study|Progressive disease - radiological progression|90|||
131797665|NCT02799602|474541681|FG001|Overall Study|Progressive disease - radiological progression|133|||
131628558|NCT00446095|473925065|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131628559|NCT00446095|473925066|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131628560|NCT00446095|473925067|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131628561|NCT00446095|473925063|FG000|Phase II (8 Weeks)|Physician Decision|1|||
131628562|NCT00446095|473925064|FG001|Phase II (8 Weeks)|Physician Decision|0|||
131628563|NCT00446095|473925065|FG002|Phase II (8 Weeks)|Physician Decision|0|||
131628564|NCT00446095|473925066|FG003|Phase II (8 Weeks)|Physician Decision|0|||
131628565|NCT00446095|473925067|FG004|Phase II (8 Weeks)|Physician Decision|0|||
131628566|NCT00446095|473925063|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
131628567|NCT00446095|473925064|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
131628568|NCT00446095|473925065|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
131628569|NCT00446095|473925066|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
131628570|NCT00446095|473925067|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
131628571|NCT00446095|473925063|FG000|Phase II (8 Weeks)|Ongoing|0|||
131628572|NCT00446095|473925064|FG001|Phase II (8 Weeks)|Ongoing|0|||
131628573|NCT00446095|473925065|FG002|Phase II (8 Weeks)|Ongoing|1|||
131628574|NCT00446095|473925066|FG003|Phase II (8 Weeks)|Ongoing|0|||
131628575|NCT00446095|473925067|FG004|Phase II (8 Weeks)|Ongoing|0|||
131628576|NCT00446095|473925063|FG000|Phase I (28 Days)|Adverse Event|0|||
131628577|NCT00446095|473925064|FG001|Phase I (28 Days)|Adverse Event|0|||
131628578|NCT00446095|473925065|FG002|Phase I (28 Days)|Adverse Event|0|||
131628579|NCT00446095|473925066|FG003|Phase I (28 Days)|Adverse Event|1|||
131628580|NCT00446095|473925067|FG004|Phase I (28 Days)|Adverse Event|0|||
131628581|NCT00446095|473925063|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
131628582|NCT00446095|473925064|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
131797666|NCT02799602|474541680|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
131797667|NCT02799602|474541681|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
131797668|NCT02799602|474541680|FG000|Overall Study|Death|9|||
131797669|NCT02799602|474541681|FG001|Overall Study|Death|5|||
131797670|NCT02799602|474541680|FG000|Overall Study|Other|287|||
131797671|NCT02799602|474541681|FG001|Overall Study|Other|118|||
131797672|NCT02799602|474541680|FG000|Overall Study|Study drug never administered|0|||
131797673|NCT02799602|474541681|FG001|Overall Study|Study drug never administered|3|||
131797674|NCT02626949|474541682|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
131797675|NCT02626949|474541683|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
131797676|NCT02626949|474541682|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
131797677|NCT02626949|474541683|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
131797678|NCT02626949|474541682|FG000|Enrolled|Lost to Follow-up|7|||
131797679|NCT02626949|474541683|FG001|Enrolled|Lost to Follow-up|6|||
131797680|NCT02626949|474541682|FG000|Enrolled|Withdrawal by Subject|3|||
131797681|NCT02626949|474541683|FG001|Enrolled|Withdrawal by Subject|2|||
131797682|NCT03072459|474541685|FG000|Overall Study|Device revised/removed|1|||
131797683|NCT03072459|474541685|FG000|Overall Study|Subject not able to return|1|||
131797684|NCT02275364|474541686|FG000|Period 1|Withdrawal by Subject|1|||
131797685|NCT02275364|474541687|FG001|Period 1|Withdrawal by Subject|0|||
131797686|NCT02275364|474541686|FG000|Period 1|Other reason|1|||
131797687|NCT02275364|474541687|FG001|Period 1|Other reason|0|||
131797688|NCT03595657|474541688|FG000|Overall Study|Adverse Event|14|||
131797689|NCT03595657|474541688|FG000|Overall Study|Death|1|||
131797690|NCT03595657|474541688|FG000|Overall Study|Lack of Efficacy|40|||
131797691|NCT03595657|474541688|FG000|Overall Study|Withdrawal by Subject|10|||
131797692|NCT03595657|474541688|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
131797693|NCT03595657|474541688|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
131797694|NCT02739984|474541689|FG000|Overall Study|Sponsor Decision|1|||
131797695|NCT02739984|474541690|FG001|Overall Study|Sponsor Decision|0|||
131797696|NCT02739984|474541689|FG000|Overall Study|Withdrawal by Subject|1|||
131628583|NCT00446095|473925065|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
131628584|NCT00446095|473925066|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
131628585|NCT00446095|473925067|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
131628586|NCT04447287|473925068|FG000|Period 1: Run-in Period|Adverse Event|3|||
131628587|NCT04447287|473925069|FG001|Period 1: Run-in Period|Adverse Event|0|||
131628588|NCT04447287|473925070|FG002|Period 1: Run-in Period|Adverse Event|0|||
131628589|NCT04447287|473925068|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
131628590|NCT04447287|473925069|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
131628591|NCT04447287|473925070|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
131628592|NCT04447287|473925068|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
131628593|NCT04447287|473925069|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
131628594|NCT04447287|473925070|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
131712549|NCT02886702|474226223|FG000|Overall Study|Withdrawal by Subject|24|||
131712550|NCT02886702|474226224|FG001|Overall Study|Withdrawal by Subject|18|||
131712551|NCT02886702|474226225|FG002|Overall Study|Withdrawal by Subject|22|||
131712552|NCT02886702|474226223|FG000|Overall Study|Significant Worsening of Condition|0|||
131712553|NCT02886702|474226224|FG001|Overall Study|Significant Worsening of Condition|1|||
131712554|NCT02886702|474226225|FG002|Overall Study|Significant Worsening of Condition|0|||
131712555|NCT02886702|474226223|FG000|Overall Study|Protocol Violation|2|||
131712556|NCT02886702|474226224|FG001|Overall Study|Protocol Violation|2|||
131712557|NCT02886702|474226225|FG002|Overall Study|Protocol Violation|1|||
131712558|NCT02886702|474226223|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131712559|NCT02886702|474226224|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131712560|NCT02886702|474226225|FG002|Overall Study|Non-Compliance With Study Drug|4|||
131712561|NCT02886702|474226223|FG000|Overall Study|Lost to Follow-up|11|||
131712562|NCT02886702|474226224|FG001|Overall Study|Lost to Follow-up|13|||
131712563|NCT02886702|474226225|FG002|Overall Study|Lost to Follow-up|8|||
131712564|NCT02886702|474226223|FG000|Overall Study|Lack of Efficacy|3|||
131712565|NCT02886702|474226224|FG001|Overall Study|Lack of Efficacy|4|||
131712566|NCT02886702|474226225|FG002|Overall Study|Lack of Efficacy|5|||
131712567|NCT02886702|474226223|FG000|Overall Study|Adverse Event|4|||
131712568|NCT02886702|474226224|FG001|Overall Study|Adverse Event|9|||
131712569|NCT02886702|474226225|FG002|Overall Study|Adverse Event|3|||
131712570|NCT02886702|474226223|FG000|Overall Study|Administrative Reasons|0|||
131712571|NCT02886702|474226224|FG001|Overall Study|Administrative Reasons|0|||
131712572|NCT02886702|474226225|FG002|Overall Study|Administrative Reasons|1|||
131712573|NCT02731742|474226228|FG000|Overall Study|Death|1|||
131712574|NCT02731742|474226229|FG001|Overall Study|Death|2|||
131712575|NCT02731742|474226230|FG002|Overall Study|Death|5|||
131712576|NCT02731742|474226231|FG003|Overall Study|Death|0|||
131712577|NCT02731742|474226228|FG000|Overall Study|Physician Decision|0|||
131712578|NCT02731742|474226229|FG001|Overall Study|Physician Decision|0|||
131712579|NCT02731742|474226230|FG002|Overall Study|Physician Decision|0|||
131712580|NCT02731742|474226231|FG003|Overall Study|Physician Decision|1|||
131712581|NCT02731742|474226228|FG000|Overall Study|Study Terminated by Sponsor|2|||
131712582|NCT02731742|474226229|FG001|Overall Study|Study Terminated by Sponsor|1|||
131712583|NCT02731742|474226230|FG002|Overall Study|Study Terminated by Sponsor|1|||
131712584|NCT02731742|474226231|FG003|Overall Study|Study Terminated by Sponsor|1|||
131712585|NCT00502840|474226232|FG000|Overall Study|Adverse Event|5|||
131712586|NCT00502840|474226232|FG000|Overall Study|Additional or changed therapy|48|||
131712587|NCT00502840|474226232|FG000|Overall Study|Lack of Efficacy|11|||
131712588|NCT00502840|474226232|FG000|Overall Study|Protocol Violation|4|||
131712589|NCT00502840|474226232|FG000|Overall Study|Withdrawal by Subject|5|||
131712590|NCT00502840|474226232|FG000|Overall Study|Lost to Follow-up|6|||
131712591|NCT00502840|474226232|FG000|Overall Study|Administrative problems|1|||
131712592|NCT00502840|474226232|FG000|Overall Study|Other|20|||
131712593|NCT01974323|474226233|FG000|Overall Study|Other Reasons|25|||
131712594|NCT01974323|474226234|FG001|Overall Study|Other Reasons|28|||
131712595|NCT01974323|474226233|FG000|Overall Study|Protocol Violation|2|||
131712596|NCT01974323|474226234|FG001|Overall Study|Protocol Violation|2|||
131712597|NCT01974323|474226233|FG000|Overall Study|Personal Reasons|15|||
131712598|NCT01974323|474226234|FG001|Overall Study|Personal Reasons|19|||
131712599|NCT01974323|474226233|FG000|Overall Study|Lost to Follow-up|45|||
131712600|NCT01974323|474226234|FG001|Overall Study|Lost to Follow-up|40|||
131712601|NCT01974323|474226233|FG000|Overall Study|Pregnancy|2|||
131712602|NCT01974323|474226234|FG001|Overall Study|Pregnancy|1|||
131712603|NCT01974323|474226233|FG000|Overall Study|Lack of Efficacy|1|||
131712604|NCT01974323|474226234|FG001|Overall Study|Lack of Efficacy|1|||
131712605|NCT01974323|474226233|FG000|Overall Study|Adverse Event|2|||
131712606|NCT01974323|474226234|FG001|Overall Study|Adverse Event|2|||
131712607|NCT03093155|474226236|FG000|Overall Study|Not Eligible|1|||
131712608|NCT03093155|474226237|FG001|Overall Study|Not Eligible|0|||
131712609|NCT03093155|474226236|FG000|Overall Study|Withdrawal by Subject|0|||
131712610|NCT03093155|474226237|FG001|Overall Study|Withdrawal by Subject|1|||
131712611|NCT00619229|474226238|FG000|Overall Study|Withdrawal by Subject|1|||
131712612|NCT00619229|474226239|FG001|Overall Study|Withdrawal by Subject|1|||
131712613|NCT00619229|474226238|FG000|Overall Study|Lost to Follow-up|1|||
131712614|NCT00619229|474226239|FG001|Overall Study|Lost to Follow-up|0|||
131712615|NCT00619229|474226238|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
131712616|NCT00619229|474226239|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
131712617|NCT00619229|474226238|FG000|Overall Study|Investigator planned Cataract Operation|1|||
131712618|NCT00619229|474226239|FG001|Overall Study|Investigator planned Cataract Operation|0|||
131712619|NCT01700829|474226240|FG000|Overall Study|Withdrawal by Subject|1|||
131712620|NCT01700829|474226241|FG001|Overall Study|Withdrawal by Subject|1|||
131712621|NCT02786901|474226242|FG000|Overall Study|Adverse Event|1|||
131712622|NCT02786901|474226243|FG001|Overall Study|Adverse Event|1|||
131628595|NCT02147093|473925071|FG000|Period 1|Lost to Follow-up|0|||
131628596|NCT02147093|473925072|FG001|Period 1|Lost to Follow-up|1|||
131628597|NCT02147093|473925071|FG000|Period 2|Protocol Violation|2|||
131628598|NCT02147093|473925072|FG001|Period 2|Protocol Violation|0|||
131628599|NCT03246724|473925073|FG000|Overall Study|Withdrawal by Subject|5|||
131628600|NCT03246724|473925074|FG001|Overall Study|Withdrawal by Subject|2|||
131628601|NCT03246724|473925075|FG002|Overall Study|Withdrawal by Subject|4|||
131628602|NCT03246724|473925076|FG003|Overall Study|Withdrawal by Subject|2|||
131628603|NCT03246724|473925073|FG000|Overall Study|Ineligible on day of surgery|7|||
131628604|NCT03246724|473925074|FG001|Overall Study|Ineligible on day of surgery|2|||
131628605|NCT03246724|473925075|FG002|Overall Study|Ineligible on day of surgery|0|||
131628606|NCT03246724|473925076|FG003|Overall Study|Ineligible on day of surgery|3|||
131628607|NCT03246724|473925073|FG000|Overall Study|Study completed before surgical date|2|||
131628608|NCT03246724|473925074|FG001|Overall Study|Study completed before surgical date|1|||
131628609|NCT03246724|473925075|FG002|Overall Study|Study completed before surgical date|8|||
131628610|NCT03246724|473925076|FG003|Overall Study|Study completed before surgical date|1|||
131628611|NCT03246724|473925073|FG000|Overall Study|Transferred to other arm|0|||
131628612|NCT03246724|473925074|FG001|Overall Study|Transferred to other arm|0|||
131628613|NCT03246724|473925075|FG002|Overall Study|Transferred to other arm|1|||
131628614|NCT03246724|473925076|FG003|Overall Study|Transferred to other arm|0|||
131628615|NCT03246724|473925073|FG000|Overall Study|Unable to obtain medication timely|0|||
131628616|NCT03246724|473925074|FG001|Overall Study|Unable to obtain medication timely|2|||
131628617|NCT03246724|473925075|FG002|Overall Study|Unable to obtain medication timely|2|||
131628618|NCT03246724|473925076|FG003|Overall Study|Unable to obtain medication timely|1|||
131628619|NCT03246724|473925073|FG000|Overall Study|Re-consented to participate|0|||
131628620|NCT03246724|473925074|FG001|Overall Study|Re-consented to participate|0|||
131628621|NCT03246724|473925075|FG002|Overall Study|Re-consented to participate|0|||
131628622|NCT03246724|473925076|FG003|Overall Study|Re-consented to participate|1|||
131628623|NCT00655824|473925077|FG000|Overall Study|Adverse Event|3|||
131628624|NCT00655824|473925077|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
131628625|NCT00655824|473925077|FG000|Overall Study|Protocol Violation|1|||
131628626|NCT00655824|473925077|FG000|Overall Study|Withdrawal by Subject|4|||
131628627|NCT00655824|473925077|FG000|Overall Study|Deterioration of Trial Disease|2|||
131628628|NCT00736502|473925082|FG000|Overall Study|Adverse Event|22|||
131628629|NCT00736502|473925082|FG000|Overall Study|Lack of Efficacy|16|||
131628630|NCT00736502|473925082|FG000|Overall Study|Lost to Follow-up|27|||
131628631|NCT02470806|473925083|FG000|Overall Study|Lost to Follow-up|1|||
131628632|NCT02470806|473925084|FG001|Overall Study|Lost to Follow-up|1|||
131628633|NCT02470806|473925083|FG000|Overall Study|Adverse Event|5|||
131628634|NCT02470806|473925084|FG001|Overall Study|Adverse Event|2|||
131628635|NCT02470806|473925083|FG000|Overall Study|Protocol Violation|4|||
131628636|NCT02470806|473925084|FG001|Overall Study|Protocol Violation|11|||
131628637|NCT02470806|473925083|FG000|Overall Study|Physician Decision|0|||
131628638|NCT02470806|473925084|FG001|Overall Study|Physician Decision|3|||
131628639|NCT02470806|473925083|FG000|Overall Study|Withdrawal by Subject|3|||
131628640|NCT02470806|473925084|FG001|Overall Study|Withdrawal by Subject|10|||
131628641|NCT02470806|473925083|FG000|Overall Study|Lack of Efficacy|5|||
131628642|NCT02470806|473925084|FG001|Overall Study|Lack of Efficacy|15|||
131628643|NCT03032198|473925085|FG000|Overall Study|Screen Fail|1|||
131628644|NCT03100370|473925087|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131628645|NCT03100370|473925088|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131628646|NCT03100370|473925089|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131712623|NCT02786901|474226244|FG002|Overall Study|Adverse Event|2|||
131712624|NCT02786901|474226242|FG000|Overall Study|Physician Decision|1|||
131712625|NCT02786901|474226243|FG001|Overall Study|Physician Decision|0|||
131712626|NCT02786901|474226244|FG002|Overall Study|Physician Decision|0|||
131712627|NCT02786901|474226242|FG000|Overall Study|Rescue Therapy Use|71|||
131712628|NCT02786901|474226243|FG001|Overall Study|Rescue Therapy Use|49|||
131712629|NCT02786901|474226244|FG002|Overall Study|Rescue Therapy Use|33|||
131712630|NCT02786901|474226242|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
131712631|NCT02786901|474226243|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
131712632|NCT02786901|474226244|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
131712633|NCT02786901|474226242|FG000|Overall Study|Disallowed medication|1|||
131712634|NCT02786901|474226243|FG001|Overall Study|Disallowed medication|1|||
131712635|NCT02786901|474226244|FG002|Overall Study|Disallowed medication|0|||
131712636|NCT02786901|474226242|FG000|Overall Study|Randomized in error|2|||
131712637|NCT02786901|474226243|FG001|Overall Study|Randomized in error|0|||
131712638|NCT02786901|474226244|FG002|Overall Study|Randomized in error|1|||
131712639|NCT01075178|474226245|FG000|Subject Matching|eligible but not matched|130|||
131712640|NCT01075178|474226246|FG001|Subject Matching|eligible but not matched|403|||
131712641|NCT01075178|474226245|FG000|Subject Chart Review|died before chart review period|0|||
131712642|NCT01075178|474226246|FG001|Subject Chart Review|died before chart review period|2|||
131712643|NCT01075178|474226245|FG000|Subject Chart Review|no data collected due to site closure|3|||
131712644|NCT01075178|474226246|FG001|Subject Chart Review|no data collected due to site closure|4|||
131712645|NCT01075178|474226245|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
131712646|NCT01075178|474226246|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
131628647|NCT03100370|473925090|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131628648|NCT03100370|473925091|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131628649|NCT03100370|473925092|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131628650|NCT01307800|473925093|FG000|Overall Study|Adverse Event|9|||
131712647|NCT03367871|474226247|FG000|Overall Study|Lost to Follow-up|1|||
131712648|NCT02983604|474226248|FG000|Overall Study|Enrolled but not Treated|0|||
131712649|NCT02983604|474226249|FG001|Overall Study|Enrolled but not Treated|0|||
131712650|NCT02983604|474226250|FG002|Overall Study|Enrolled but not Treated|1|||
131712651|NCT02983604|474226251|FG003|Overall Study|Enrolled but not Treated|0|||
131712652|NCT00316264|474226253|FG000|Overall Study|Lost to Follow-up|0|||
131712653|NCT00316264|474226254|FG001|Overall Study|Lost to Follow-up|1|||
131712654|NCT00316264|474226255|FG002|Overall Study|Lost to Follow-up|0|||
131628651|NCT01307800|473925094|FG001|Overall Study|Adverse Event|8|||
131628652|NCT01307800|473925095|FG002|Overall Study|Adverse Event|10|||
131628653|NCT01307800|473925096|FG003|Overall Study|Adverse Event|14|||
131628654|NCT01307800|473925093|FG000|Overall Study|Entry Criteria Not Met|0|||
131712655|NCT00316264|474226253|FG000|Overall Study|Withdrawal of Consent|3|||
131712656|NCT00316264|474226254|FG001|Overall Study|Withdrawal of Consent|5|||
131712657|NCT00316264|474226255|FG002|Overall Study|Withdrawal of Consent|6|||
131712658|NCT00316264|474226253|FG000|Overall Study|Death|2|||
131712659|NCT00316264|474226254|FG001|Overall Study|Death|0|||
131712660|NCT00316264|474226255|FG002|Overall Study|Death|0|||
131712661|NCT00316264|474226253|FG000|Overall Study|Other|1|||
131712662|NCT00316264|474226254|FG001|Overall Study|Other|1|||
131712663|NCT00316264|474226255|FG002|Overall Study|Other|0|||
131712664|NCT00607048|474226256|FG000|Overall Study|Adverse Event|0|||
131712665|NCT00607048|474226257|FG001|Overall Study|Adverse Event|1|||
131712666|NCT00607048|474226258|FG002|Overall Study|Adverse Event|0|||
131712667|NCT00607048|474226259|FG003|Overall Study|Adverse Event|0|||
131712668|NCT00607048|474226260|FG004|Overall Study|Adverse Event|4|||
131712669|NCT00607048|474226261|FG005|Overall Study|Adverse Event|0|||
131712670|NCT00607048|474226256|FG000|Overall Study|Global deterioration of health|1|||
131712671|NCT00607048|474226257|FG001|Overall Study|Global deterioration of health|0|||
131712672|NCT00607048|474226258|FG002|Overall Study|Global deterioration of health|0|||
131712673|NCT00607048|474226259|FG003|Overall Study|Global deterioration of health|0|||
131712674|NCT00607048|474226260|FG004|Overall Study|Global deterioration of health|0|||
131712675|NCT00607048|474226261|FG005|Overall Study|Global deterioration of health|0|||
131712676|NCT00607048|474226256|FG000|Overall Study|Objective disease progression - relapse|1|||
131712677|NCT00607048|474226257|FG001|Overall Study|Objective disease progression - relapse|2|||
131712678|NCT00607048|474226258|FG002|Overall Study|Objective disease progression - relapse|4|||
131712679|NCT00607048|474226259|FG003|Overall Study|Objective disease progression - relapse|2|||
131712680|NCT00607048|474226260|FG004|Overall Study|Objective disease progression - relapse|2|||
131712681|NCT00607048|474226261|FG005|Overall Study|Objective disease progression - relapse|2|||
131712682|NCT00607048|474226256|FG000|Overall Study|Withdrawal by Subject|0|||
131712683|NCT00607048|474226257|FG001|Overall Study|Withdrawal by Subject|0|||
131712684|NCT00607048|474226258|FG002|Overall Study|Withdrawal by Subject|0|||
131712685|NCT00607048|474226259|FG003|Overall Study|Withdrawal by Subject|1|||
131712686|NCT00607048|474226260|FG004|Overall Study|Withdrawal by Subject|0|||
131712687|NCT00607048|474226261|FG005|Overall Study|Withdrawal by Subject|2|||
131712688|NCT00607048|474226256|FG000|Overall Study|Other|1|||
131712689|NCT00607048|474226257|FG001|Overall Study|Other|1|||
131628655|NCT01307800|473925094|FG001|Overall Study|Entry Criteria Not Met|0|||
131628656|NCT01307800|473925095|FG002|Overall Study|Entry Criteria Not Met|0|||
131628657|NCT01307800|473925096|FG003|Overall Study|Entry Criteria Not Met|2|||
131628658|NCT01307800|473925093|FG000|Overall Study|Lost to Follow-up|5|||
131628659|NCT01307800|473925094|FG001|Overall Study|Lost to Follow-up|6|||
131628660|NCT01307800|473925095|FG002|Overall Study|Lost to Follow-up|2|||
131712690|NCT00607048|474226258|FG002|Overall Study|Other|0|||
131712691|NCT00607048|474226259|FG003|Overall Study|Other|0|||
131712692|NCT00607048|474226260|FG004|Overall Study|Other|0|||
131712693|NCT00607048|474226261|FG005|Overall Study|Other|1|||
131712694|NCT03545282|474226267|FG000|Overall Study|Lost to Follow-up|15|||
131797697|NCT02739984|474541690|FG001|Overall Study|Withdrawal by Subject|1|||
131797698|NCT02739984|474541689|FG000|Overall Study|Death|0|||
131797699|NCT02739984|474541690|FG001|Overall Study|Death|1|||
131797700|NCT02739984|474541689|FG000|Overall Study|Lost to Follow-up|3|||
131797701|NCT02739984|474541690|FG001|Overall Study|Lost to Follow-up|0|||
131712695|NCT03545282|474226268|FG001|Overall Study|Lost to Follow-up|10|||
131712696|NCT03545282|474226267|FG000|Overall Study|Withdrawal by Subject|2|||
131712697|NCT03545282|474226268|FG001|Overall Study|Withdrawal by Subject|2|||
131797702|NCT00767325|474541691|FG000|Overall Study|Lack of Efficacy|2|||
131712698|NCT02582671|474226269|FG000|Overall Study|Failure to return|1|||
131712699|NCT02582671|474226269|FG000|Overall Study|Other, not specified|1|||
131712700|NCT01287104|474226274|FG000|Overall Study|Patient developed progressive disease|1|||
131797703|NCT00767325|474541691|FG000|Overall Study|Adverse Event|7|||
131628661|NCT01307800|473925096|FG003|Overall Study|Lost to Follow-up|8|||
131628662|NCT01307800|473925093|FG000|Overall Study|Perceived Lack of Efficacy|24|||
131628663|NCT01307800|473925094|FG001|Overall Study|Perceived Lack of Efficacy|23|||
131628664|NCT01307800|473925095|FG002|Overall Study|Perceived Lack of Efficacy|20|||
131628665|NCT01307800|473925096|FG003|Overall Study|Perceived Lack of Efficacy|33|||
131628666|NCT01307800|473925093|FG000|Overall Study|Protocol Violation|0|||
131628667|NCT01307800|473925094|FG001|Overall Study|Protocol Violation|3|||
131628668|NCT01307800|473925095|FG002|Overall Study|Protocol Violation|4|||
131628669|NCT01307800|473925096|FG003|Overall Study|Protocol Violation|5|||
131628670|NCT01307800|473925093|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
131628671|NCT01307800|473925094|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
131628672|NCT01307800|473925095|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
131628673|NCT01307800|473925096|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
131628674|NCT01307800|473925093|FG000|Overall Study|Sponsor Decision|6|||
131628675|NCT01307800|473925094|FG001|Overall Study|Sponsor Decision|9|||
131628676|NCT01307800|473925095|FG002|Overall Study|Sponsor Decision|12|||
131628677|NCT01307800|473925096|FG003|Overall Study|Sponsor Decision|28|||
131628678|NCT01307800|473925093|FG000|Overall Study|Withdrawal by Subject|10|||
131628679|NCT01307800|473925094|FG001|Overall Study|Withdrawal by Subject|11|||
131628680|NCT01307800|473925095|FG002|Overall Study|Withdrawal by Subject|8|||
131628681|NCT01307800|473925096|FG003|Overall Study|Withdrawal by Subject|15|||
131628682|NCT01307800|473925093|FG000|Overall Study|Participant Moved|0|||
131628683|NCT01307800|473925094|FG001|Overall Study|Participant Moved|2|||
131628684|NCT01307800|473925095|FG002|Overall Study|Participant Moved|1|||
131628685|NCT01307800|473925096|FG003|Overall Study|Participant Moved|3|||
131628686|NCT00689351|473925097|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
131628687|NCT00689351|473925098|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
131628688|NCT00689351|473925097|FG000|Infant Series of Dosing|Adverse Event|1|||
131628689|NCT00689351|473925098|FG001|Infant Series of Dosing|Adverse Event|0|||
131628690|NCT00689351|473925097|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
131628691|NCT00689351|473925098|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
131628692|NCT00689351|473925097|FG000|After Infant Series|Parent/legal guardian request|1|||
131628693|NCT00689351|473925098|FG001|After Infant Series|Parent/legal guardian request|0|||
131628694|NCT01766206|473925099|FG000|Overall Study|Withdrawal by Subject|22|||
131628695|NCT01766206|473925099|FG000|Overall Study|Lost to Follow-up|10|||
131628696|NCT01766206|473925099|FG000|Overall Study|Inappropriate enrollment|18|||
131628697|NCT01766206|473925099|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
131628698|NCT01662505|473925100|FG000|Overall Study|Progressive disease|6|||
131628699|NCT01662505|473925101|FG001|Overall Study|Progressive disease|1|||
131628700|NCT01662505|473925102|FG002|Overall Study|Progressive disease|5|||
131628701|NCT01662505|473925100|FG000|Overall Study|Refused cont. medication|0|||
131628702|NCT01662505|473925101|FG001|Overall Study|Refused cont. medication|0|||
131628703|NCT01662505|473925102|FG002|Overall Study|Refused cont. medication|1|||
131628704|NCT01662505|473925100|FG000|Overall Study|Not specified above|1|||
131628705|NCT01662505|473925101|FG001|Overall Study|Not specified above|3|||
131628706|NCT01662505|473925102|FG002|Overall Study|Not specified above|2|||
131628707|NCT02255474|473925103|FG000|Overall Study|Lost to Follow-up|1|||
131628708|NCT02255474|473925104|FG001|Overall Study|Lost to Follow-up|1|||
131628709|NCT02255474|473925105|FG002|Overall Study|Lost to Follow-up|3|||
131628710|NCT02255474|473925103|FG000|Overall Study|Withdrawal by Subject|1|||
131628711|NCT02255474|473925104|FG001|Overall Study|Withdrawal by Subject|1|||
131628712|NCT02255474|473925105|FG002|Overall Study|Withdrawal by Subject|0|||
131628713|NCT01229176|473925106|FG000|Overall Study|Withdrawal by Subject|0|||
131628714|NCT01229176|473925107|FG001|Overall Study|Withdrawal by Subject|0|||
131628715|NCT01229176|473925108|FG002|Overall Study|Withdrawal by Subject|0|||
131628716|NCT01229176|473925109|FG003|Overall Study|Withdrawal by Subject|1|||
131628717|NCT01229176|473925110|FG004|Overall Study|Withdrawal by Subject|1|||
131628718|NCT01229176|473925111|FG005|Overall Study|Withdrawal by Subject|1|||
131628719|NCT01229176|473925112|FG006|Overall Study|Withdrawal by Subject|0|||
131628720|NCT01229176|473925113|FG007|Overall Study|Withdrawal by Subject|1|||
131628721|NCT01229176|473925106|FG000|Overall Study|Lost to Follow-up|0|||
131628722|NCT01229176|473925107|FG001|Overall Study|Lost to Follow-up|3|||
131628723|NCT01229176|473925108|FG002|Overall Study|Lost to Follow-up|0|||
131628724|NCT01229176|473925109|FG003|Overall Study|Lost to Follow-up|0|||
131628725|NCT01229176|473925110|FG004|Overall Study|Lost to Follow-up|1|||
131628726|NCT01229176|473925111|FG005|Overall Study|Lost to Follow-up|1|||
131628727|NCT01229176|473925112|FG006|Overall Study|Lost to Follow-up|0|||
131628728|NCT01229176|473925113|FG007|Overall Study|Lost to Follow-up|2|||
131628729|NCT03075878|473925118|FG000|Overall Study|Physician Decision|1|||
131628730|NCT00882050|473925124|FG000|Overall Study|Physician Decision|1|||
131628731|NCT00882050|473925125|FG001|Overall Study|Physician Decision|0|||
131628732|NCT00882050|473925126|FG002|Overall Study|Physician Decision|0|||
131628733|NCT02367794|473925127|FG000|Overall Study|Death|252|||
131628734|NCT02367794|473925128|FG001|Overall Study|Death|245|||
131628735|NCT02367794|473925129|FG002|Overall Study|Death|243|||
131628736|NCT02367794|473925127|FG000|Overall Study|Lost to Follow-up|1|||
131628737|NCT02367794|473925128|FG001|Overall Study|Lost to Follow-up|2|||
131628738|NCT02367794|473925129|FG002|Overall Study|Lost to Follow-up|2|||
131628739|NCT02367794|473925127|FG000|Overall Study|Physician Decision|0|||
131628740|NCT02367794|473925128|FG001|Overall Study|Physician Decision|5|||
131628741|NCT02367794|473925129|FG002|Overall Study|Physician Decision|3|||
131628742|NCT02367794|473925127|FG000|Overall Study|Protocol Violation|1|||
131628743|NCT02367794|473925128|FG001|Overall Study|Protocol Violation|0|||
131628744|NCT02367794|473925129|FG002|Overall Study|Protocol Violation|1|||
131628745|NCT02367794|473925127|FG000|Overall Study|Withdrawal by Subject|25|||
131628746|NCT02367794|473925128|FG001|Overall Study|Withdrawal by Subject|12|||
131628747|NCT02367794|473925129|FG002|Overall Study|Withdrawal by Subject|20|||
131628748|NCT02367794|473925127|FG000|Overall Study|Brain metastasis|1|||
131628749|NCT02367794|473925128|FG001|Overall Study|Brain metastasis|0|||
131628750|NCT02367794|473925129|FG002|Overall Study|Brain metastasis|0|||
131628751|NCT02367794|473925127|FG000|Overall Study|Randomized in error|0|||
131628752|NCT02367794|473925128|FG001|Overall Study|Randomized in error|0|||
131628753|NCT02367794|473925129|FG002|Overall Study|Randomized in error|1|||
131628754|NCT02367794|473925127|FG000|Overall Study|Patient unable to receive carboplatin|0|||
131628755|NCT02367794|473925128|FG001|Overall Study|Patient unable to receive carboplatin|0|||
131628756|NCT02367794|473925129|FG002|Overall Study|Patient unable to receive carboplatin|1|||
131628757|NCT02367794|473925127|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
131628758|NCT02367794|473925128|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
131628759|NCT02367794|473925129|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
131628760|NCT02367794|473925127|FG000|Overall Study|Adverse Event|0|||
131628761|NCT02367794|473925128|FG001|Overall Study|Adverse Event|0|||
131628762|NCT02367794|473925129|FG002|Overall Study|Adverse Event|2|||
131628763|NCT02367794|473925127|FG000|Overall Study|Study Terminated By Sponsor|0|||
131628764|NCT02367794|473925128|FG001|Overall Study|Study Terminated By Sponsor|1|||
131628765|NCT02367794|473925129|FG002|Overall Study|Study Terminated By Sponsor|1|||
131628766|NCT02367794|473925127|FG000|Overall Study|Moved to Roll-Over Study|0|||
131628767|NCT02367794|473925128|FG001|Overall Study|Moved to Roll-Over Study|15|||
131628768|NCT02367794|473925129|FG002|Overall Study|Moved to Roll-Over Study|13|||
131628769|NCT02367794|473925127|FG000|Overall Study|Sponsor Request|60|||
131628770|NCT02367794|473925128|FG001|Overall Study|Sponsor Request|57|||
131628771|NCT02367794|473925129|FG002|Overall Study|Sponsor Request|45|||
131628772|NCT02367794|473925127|FG000|Overall Study|Moved into PTAP Study|0|||
131628773|NCT02367794|473925128|FG001|Overall Study|Moved into PTAP Study|2|||
131628774|NCT02367794|473925129|FG002|Overall Study|Moved into PTAP Study|3|||
131628775|NCT02367794|473925127|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
131628776|NCT02367794|473925128|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
131628777|NCT02367794|473925129|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
131628778|NCT02367794|473925127|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
131628779|NCT02367794|473925128|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
131628780|NCT02367794|473925129|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
131628781|NCT02367794|473925127|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
131628782|NCT02367794|473925128|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
131628783|NCT02367794|473925129|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
131628784|NCT02367794|473925127|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
131628785|NCT02367794|473925128|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
131628786|NCT02367794|473925129|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
131628787|NCT02010684|473925130|FG000|Overall Study|Lost to Follow-up|8|||
131628788|NCT02010684|473925131|FG001|Overall Study|Lost to Follow-up|18|||
131628789|NCT02010684|473925130|FG000|Overall Study|Withdrawal by Subject|4|||
131628790|NCT02010684|473925131|FG001|Overall Study|Withdrawal by Subject|5|||
131628791|NCT01884571|473925136|FG000|Overall Study|Adverse Event|1|||
131628792|NCT01884571|473925136|FG000|Overall Study|Death|2|||
131628793|NCT01884571|473925136|FG000|Overall Study|Withdrawal by Subject|2|||
131628794|NCT01884571|473925136|FG000|Overall Study|Disease progression|3|||
131628795|NCT03978130|473926956|FG000|Overall Study|Lost to Follow-up|13|||
131628796|NCT03978130|473926957|FG001|Overall Study|Lost to Follow-up|14|||
131628797|NCT03978130|473926956|FG000|Overall Study|Withdrawal by Subject|12|||
131628798|NCT03978130|473926957|FG001|Overall Study|Withdrawal by Subject|2|||
131628799|NCT03978130|473926956|FG000|Overall Study|Adverse Event|2|||
131628800|NCT03978130|473926957|FG001|Overall Study|Adverse Event|1|||
131628801|NCT02880293|473926958|FG000|Overall Study|Inevaluable|5|||
131628802|NCT04820023|473926959|FG000|Overall Study|Death|0|||
131628803|NCT04820023|473926960|FG001|Overall Study|Death|0|||
131628804|NCT04820023|473926961|FG002|Overall Study|Death|0|||
131628805|NCT04820023|473926962|FG003|Overall Study|Death|0|||
131628806|NCT04820023|473926963|FG004|Overall Study|Death|0|||
131628807|NCT04820023|473926964|FG005|Overall Study|Death|0|||
131628808|NCT04820023|473926965|FG006|Overall Study|Death|1|||
131628809|NCT04820023|473926966|FG007|Overall Study|Death|0|||
131628810|NCT04820023|473926967|FG008|Overall Study|Death|1|||
131628811|NCT04820023|473926959|FG000|Overall Study|Withdrawal by Subject|1|||
131628812|NCT04820023|473926960|FG001|Overall Study|Withdrawal by Subject|2|||
131628813|NCT04820023|473926961|FG002|Overall Study|Withdrawal by Subject|2|||
131628814|NCT04820023|473926962|FG003|Overall Study|Withdrawal by Subject|1|||
131628815|NCT04820023|473926963|FG004|Overall Study|Withdrawal by Subject|4|||
131628816|NCT04820023|473926964|FG005|Overall Study|Withdrawal by Subject|3|||
131628817|NCT04820023|473926965|FG006|Overall Study|Withdrawal by Subject|3|||
131628818|NCT04820023|473926966|FG007|Overall Study|Withdrawal by Subject|6|||
131628819|NCT04820023|473926967|FG008|Overall Study|Withdrawal by Subject|5|||
131628820|NCT04820023|473926959|FG000|Overall Study|Progressive Disease|3|||
131628821|NCT04820023|473926960|FG001|Overall Study|Progressive Disease|0|||
131628822|NCT04820023|473926961|FG002|Overall Study|Progressive Disease|2|||
131628823|NCT04820023|473926962|FG003|Overall Study|Progressive Disease|2|||
131628824|NCT04820023|473926963|FG004|Overall Study|Progressive Disease|2|||
131628825|NCT04820023|473926964|FG005|Overall Study|Progressive Disease|0|||
131628826|NCT04820023|473926965|FG006|Overall Study|Progressive Disease|1|||
131628827|NCT04820023|473926966|FG007|Overall Study|Progressive Disease|1|||
131628828|NCT04820023|473926967|FG008|Overall Study|Progressive Disease|0|||
131628829|NCT04820023|473926959|FG000|Overall Study|New anti-cancer therapy|0|||
131628830|NCT04820023|473926960|FG001|Overall Study|New anti-cancer therapy|0|||
131628831|NCT04820023|473926961|FG002|Overall Study|New anti-cancer therapy|0|||
131628832|NCT04820023|473926962|FG003|Overall Study|New anti-cancer therapy|0|||
131628833|NCT04820023|473926963|FG004|Overall Study|New anti-cancer therapy|2|||
131628834|NCT04820023|473926964|FG005|Overall Study|New anti-cancer therapy|0|||
131628835|NCT04820023|473926965|FG006|Overall Study|New anti-cancer therapy|0|||
131628836|NCT04820023|473926966|FG007|Overall Study|New anti-cancer therapy|0|||
131628837|NCT04820023|473926967|FG008|Overall Study|New anti-cancer therapy|0|||
131628838|NCT04820023|473926959|FG000|Overall Study|Other|0|||
131628839|NCT04820023|473926960|FG001|Overall Study|Other|1|||
131628840|NCT04820023|473926961|FG002|Overall Study|Other|0|||
131628841|NCT04820023|473926962|FG003|Overall Study|Other|0|||
131628842|NCT04820023|473926963|FG004|Overall Study|Other|0|||
131628843|NCT04820023|473926964|FG005|Overall Study|Other|0|||
131628844|NCT04820023|473926965|FG006|Overall Study|Other|0|||
131628845|NCT04820023|473926966|FG007|Overall Study|Other|2|||
131628846|NCT04820023|473926967|FG008|Overall Study|Other|0|||
131628847|NCT01562275|473926973|FG000|Stage 1|Adverse Event|0|||
131628848|NCT01562275|473926974|FG001|Stage 1|Adverse Event|0|||
131628849|NCT01562275|473926975|FG002|Stage 1|Adverse Event|0|||
131628850|NCT01562275|473926976|FG003|Stage 1|Adverse Event|1|||
131628851|NCT01562275|473926977|FG004|Stage 1|Adverse Event|1|||
131628852|NCT01562275|473926978|FG005|Stage 1|Adverse Event|0|||
131628853|NCT01562275|473926979|FG006|Stage 1|Adverse Event|0|||
131628854|NCT01562275|473926980|FG007|Stage 1|Adverse Event|0|||
131628855|NCT01562275|473926981|FG008|Stage 1|Adverse Event|0|||
131628856|NCT01562275|473926982|FG009|Stage 1|Adverse Event|1|||
131628857|NCT01562275|473926983|FG010|Stage 1|Adverse Event|0|||
131628858|NCT01562275|473926984|FG011|Stage 1|Adverse Event|0|||
131628859|NCT01562275|473926985|FG012|Stage 1|Adverse Event|0|||
131628860|NCT01562275|473926973|FG000|Stage 1|Death|1|||
131628861|NCT01562275|473926974|FG001|Stage 1|Death|0|||
131628862|NCT01562275|473926975|FG002|Stage 1|Death|0|||
131628863|NCT01562275|473926976|FG003|Stage 1|Death|0|||
131628864|NCT01562275|473926977|FG004|Stage 1|Death|0|||
131628865|NCT01562275|473926978|FG005|Stage 1|Death|0|||
131628866|NCT01562275|473926979|FG006|Stage 1|Death|0|||
131628867|NCT01562275|473926980|FG007|Stage 1|Death|0|||
131628868|NCT01562275|473926981|FG008|Stage 1|Death|0|||
131444242|NCT02903771|473257105|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
131712701|NCT01287104|474226275|FG001|Overall Study|Patient developed progressive disease|1|||
131628869|NCT01562275|473926982|FG009|Stage 1|Death|0|||
131628870|NCT01562275|473926983|FG010|Stage 1|Death|0|||
131628871|NCT01562275|473926984|FG011|Stage 1|Death|0|||
131628872|NCT01562275|473926985|FG012|Stage 1|Death|0|||
131628873|NCT01562275|473926973|FG000|Stage 1|Non Compliance|0|||
131628874|NCT01562275|473926974|FG001|Stage 1|Non Compliance|0|||
131628875|NCT01562275|473926975|FG002|Stage 1|Non Compliance|1|||
131628876|NCT01562275|473926976|FG003|Stage 1|Non Compliance|0|||
131628877|NCT01562275|473926977|FG004|Stage 1|Non Compliance|0|||
131628878|NCT01562275|473926978|FG005|Stage 1|Non Compliance|0|||
131628879|NCT01562275|473926979|FG006|Stage 1|Non Compliance|0|||
131628880|NCT01562275|473926980|FG007|Stage 1|Non Compliance|0|||
131628881|NCT01562275|473926981|FG008|Stage 1|Non Compliance|0|||
131628882|NCT01562275|473926982|FG009|Stage 1|Non Compliance|0|||
131628883|NCT01562275|473926983|FG010|Stage 1|Non Compliance|0|||
131628884|NCT01562275|473926984|FG011|Stage 1|Non Compliance|0|||
131628885|NCT01562275|473926985|FG012|Stage 1|Non Compliance|0|||
131628886|NCT01562275|473926973|FG000|Stage 1|Physician Decision|0|||
131628887|NCT01562275|473926974|FG001|Stage 1|Physician Decision|0|||
131628888|NCT01562275|473926975|FG002|Stage 1|Physician Decision|0|||
131628889|NCT01562275|473926976|FG003|Stage 1|Physician Decision|0|||
131628890|NCT01562275|473926977|FG004|Stage 1|Physician Decision|1|||
131628891|NCT01562275|473926978|FG005|Stage 1|Physician Decision|0|||
131628892|NCT01562275|473926979|FG006|Stage 1|Physician Decision|1|||
131628893|NCT01562275|473926980|FG007|Stage 1|Physician Decision|0|||
131628894|NCT01562275|473926981|FG008|Stage 1|Physician Decision|1|||
131628895|NCT01562275|473926982|FG009|Stage 1|Physician Decision|0|||
131628896|NCT01562275|473926983|FG010|Stage 1|Physician Decision|0|||
131628897|NCT01562275|473926984|FG011|Stage 1|Physician Decision|0|||
131628898|NCT01562275|473926985|FG012|Stage 1|Physician Decision|0|||
131628899|NCT01562275|473926973|FG000|Stage 1|Progression of Disease|2|||
131628900|NCT01562275|473926974|FG001|Stage 1|Progression of Disease|6|||
131628901|NCT01562275|473926975|FG002|Stage 1|Progression of Disease|2|||
131628902|NCT01562275|473926976|FG003|Stage 1|Progression of Disease|1|||
131628903|NCT01562275|473926977|FG004|Stage 1|Progression of Disease|2|||
131628904|NCT01562275|473926978|FG005|Stage 1|Progression of Disease|4|||
131628905|NCT01562275|473926979|FG006|Stage 1|Progression of Disease|1|||
131628906|NCT01562275|473926980|FG007|Stage 1|Progression of Disease|7|||
131628907|NCT01562275|473926981|FG008|Stage 1|Progression of Disease|2|||
131628908|NCT01562275|473926982|FG009|Stage 1|Progression of Disease|5|||
131628909|NCT01562275|473926983|FG010|Stage 1|Progression of Disease|3|||
131628910|NCT01562275|473926984|FG011|Stage 1|Progression of Disease|0|||
131628911|NCT01562275|473926985|FG012|Stage 1|Progression of Disease|0|||
131628912|NCT01562275|473926973|FG000|Stage 1|Withdrawal by Subject|0|||
131628913|NCT01562275|473926974|FG001|Stage 1|Withdrawal by Subject|1|||
131628914|NCT01562275|473926975|FG002|Stage 1|Withdrawal by Subject|0|||
131628915|NCT01562275|473926976|FG003|Stage 1|Withdrawal by Subject|2|||
131628916|NCT01562275|473926977|FG004|Stage 1|Withdrawal by Subject|0|||
131628917|NCT01562275|473926978|FG005|Stage 1|Withdrawal by Subject|0|||
131628918|NCT01562275|473926979|FG006|Stage 1|Withdrawal by Subject|1|||
131628919|NCT01562275|473926980|FG007|Stage 1|Withdrawal by Subject|0|||
131628920|NCT01562275|473926981|FG008|Stage 1|Withdrawal by Subject|0|||
131628921|NCT01562275|473926982|FG009|Stage 1|Withdrawal by Subject|1|||
131628922|NCT01562275|473926983|FG010|Stage 1|Withdrawal by Subject|0|||
131628923|NCT01562275|473926984|FG011|Stage 1|Withdrawal by Subject|0|||
131628924|NCT01562275|473926985|FG012|Stage 1|Withdrawal by Subject|0|||
131628925|NCT01562275|473926973|FG000|Stage 2|Death|0|||
131628926|NCT01562275|473926974|FG001|Stage 2|Death|0|||
131628927|NCT01562275|473926975|FG002|Stage 2|Death|0|||
131628928|NCT01562275|473926976|FG003|Stage 2|Death|0|||
131628929|NCT01562275|473926977|FG004|Stage 2|Death|0|||
131628930|NCT01562275|473926978|FG005|Stage 2|Death|0|||
131628931|NCT01562275|473926979|FG006|Stage 2|Death|0|||
131628932|NCT01562275|473926980|FG007|Stage 2|Death|0|||
131628933|NCT01562275|473926981|FG008|Stage 2|Death|0|||
131628934|NCT01562275|473926982|FG009|Stage 2|Death|0|||
131712702|NCT01287104|474226276|FG002|Overall Study|Patient developed progressive disease|3|||
131628935|NCT01562275|473926983|FG010|Stage 2|Death|0|||
131628936|NCT01562275|473926984|FG011|Stage 2|Death|2|||
131628937|NCT01562275|473926985|FG012|Stage 2|Death|1|||
131628938|NCT01562275|473926973|FG000|Stage 2|Progression of Disease|0|||
131628939|NCT01562275|473926974|FG001|Stage 2|Progression of Disease|0|||
131628940|NCT01562275|473926975|FG002|Stage 2|Progression of Disease|0|||
131628941|NCT01562275|473926976|FG003|Stage 2|Progression of Disease|0|||
131628942|NCT01562275|473926977|FG004|Stage 2|Progression of Disease|0|||
131628943|NCT01562275|473926978|FG005|Stage 2|Progression of Disease|0|||
131628944|NCT01562275|473926979|FG006|Stage 2|Progression of Disease|0|||
131628945|NCT01562275|473926980|FG007|Stage 2|Progression of Disease|0|||
131628946|NCT01562275|473926981|FG008|Stage 2|Progression of Disease|0|||
131628947|NCT01562275|473926982|FG009|Stage 2|Progression of Disease|0|||
131628948|NCT01562275|473926983|FG010|Stage 2|Progression of Disease|0|||
131628949|NCT01562275|473926984|FG011|Stage 2|Progression of Disease|12|||
131628950|NCT01562275|473926985|FG012|Stage 2|Progression of Disease|4|||
131628951|NCT01863368|473926986|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
131628952|NCT01863368|473926987|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
131628953|NCT01863368|473926986|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
131712703|NCT01287104|474226277|FG003|Overall Study|Patient developed progressive disease|2|||
131628954|NCT01863368|473926987|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
131628955|NCT01863368|473926986|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
131628956|NCT01863368|473926987|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
131628957|NCT01863368|473926986|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
131628958|NCT01863368|473926987|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
131628959|NCT01863368|473926986|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
131628960|NCT01863368|473926987|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
131628961|NCT01863368|473926986|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
131628962|NCT01863368|473926987|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
131628963|NCT00515112|473926989|FG000|Overall Study|Death|0|||
131628964|NCT00515112|473926990|FG001|Overall Study|Death|1|||
131628965|NCT00515112|473926989|FG000|Overall Study|The study was terminated|3|||
131628966|NCT00515112|473926990|FG001|Overall Study|The study was terminated|2|||
131628967|NCT01020487|473926991|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
131712704|NCT01287104|474226274|FG000|Overall Study|Donor anaphylaxis|0|||
131712705|NCT01287104|474226275|FG001|Overall Study|Donor anaphylaxis|1|||
131712706|NCT01287104|474226276|FG002|Overall Study|Donor anaphylaxis|0|||
131712707|NCT01287104|474226277|FG003|Overall Study|Donor anaphylaxis|1|||
131712708|NCT01287104|474226274|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
131712709|NCT01287104|474226275|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
131712710|NCT01287104|474226276|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
131712711|NCT01287104|474226277|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
131712712|NCT01287104|474226274|FG000|Overall Study|Low donor chimerism|0|||
131712713|NCT01287104|474226275|FG001|Overall Study|Low donor chimerism|1|||
131901976|NCT00509899|474926914|FG002|Overall Study|Withdrawal by Subject|3|||
131901977|NCT00509899|474926915|FG003|Overall Study|Withdrawal by Subject|0|||
131901978|NCT00509899|474926916|FG004|Overall Study|Withdrawal by Subject|3|||
131901979|NCT00509899|474926917|FG005|Overall Study|Withdrawal by Subject|2|||
131901980|NCT00509899|474926918|FG006|Overall Study|Withdrawal by Subject|0|||
131901981|NCT00509899|474926919|FG007|Overall Study|Withdrawal by Subject|0|||
131628968|NCT01020487|473926992|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
131628969|NCT01020487|473926993|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
131628970|NCT01020487|473926991|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
131628971|NCT01020487|473926992|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
131628972|NCT01020487|473926993|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
131628973|NCT01020487|473926991|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
131628974|NCT01020487|473926992|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
131628975|NCT01020487|473926993|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
131628976|NCT01020487|473926991|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
131628977|NCT01020487|473926992|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
131628978|NCT01020487|473926993|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
131628979|NCT01020487|473926991|FG000|Part 2 Open-label Period|Adverse Event|0|||
131628980|NCT01020487|473926992|FG001|Part 2 Open-label Period|Adverse Event|4|||
131628981|NCT01020487|473926993|FG002|Part 2 Open-label Period|Adverse Event|1|||
131628982|NCT02400749|473926996|FG000|Week 0 -16|Withdrawal by Subject|5|||
131628983|NCT02400749|473926997|FG001|Week 0 -16|Withdrawal by Subject|5|||
131628984|NCT02400749|473926996|FG000|Week 0 -16|Adverse Event|3|||
131628985|NCT02400749|473926997|FG001|Week 0 -16|Adverse Event|1|||
131628986|NCT02400749|473926996|FG000|Week 0 -16|Lost to Follow-up|2|||
131628987|NCT02400749|473926997|FG001|Week 0 -16|Lost to Follow-up|0|||
131628988|NCT02400749|473926996|FG000|Week 0 -16|Protocol Violation|1|||
131628989|NCT02400749|473926997|FG001|Week 0 -16|Protocol Violation|0|||
131628990|NCT02400749|473926996|FG000|Week 17 - 32|Withdrawal by Subject|3|||
131628991|NCT02400749|473926997|FG001|Week 17 - 32|Withdrawal by Subject|2|||
131628992|NCT02400749|473926996|FG000|Week 17 - 32|Adverse Event|2|||
131628993|NCT02400749|473926997|FG001|Week 17 - 32|Adverse Event|1|||
131628994|NCT04425252|473927000|FG000|Overall Study|Withdrawal by Subject|2|||
131628995|NCT04425252|473927001|FG001|Overall Study|Withdrawal by Subject|1|||
131628996|NCT04425252|473927000|FG000|Overall Study|Lost to Follow-up|1|||
131628997|NCT04425252|473927001|FG001|Overall Study|Lost to Follow-up|0|||
131628998|NCT04425252|473927000|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
131628999|NCT04425252|473927001|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
131629000|NCT00304278|473927003|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
131629001|NCT00304278|473927003|FG000|Overall Study|PT had medical condition preventing TX|1|||
131629002|NCT00507429|473927006|FG000|Treatment Phase|Disease Progression|12|||
131629003|NCT00507429|473927007|FG001|Treatment Phase|Disease Progression|5|||
131901982|NCT00509899|474926912|FG000|Overall Study|Physician Decision|4|||
131629004|NCT00507429|473927006|FG000|Treatment Phase|Adverse Event|12|||
131712714|NCT01287104|474226276|FG002|Overall Study|Low donor chimerism|0|||
131901983|NCT00509899|474926913|FG001|Overall Study|Physician Decision|2|||
131629005|NCT00507429|473927007|FG001|Treatment Phase|Adverse Event|5|||
131629006|NCT00507429|473927006|FG000|Treatment Phase|Withdrawal by Subject|3|||
131629007|NCT00507429|473927007|FG001|Treatment Phase|Withdrawal by Subject|3|||
131629008|NCT00507429|473927006|FG000|Treatment Phase|Physician Decision|4|||
131629009|NCT00507429|473927007|FG001|Treatment Phase|Physician Decision|2|||
131629010|NCT00507429|473927006|FG000|Treatment Phase|Other|6|||
131629011|NCT00507429|473927007|FG001|Treatment Phase|Other|3|||
131629012|NCT00507429|473927006|FG000|Maintenance Phase|Progressive Disease|14|||
131712715|NCT01287104|474226277|FG003|Overall Study|Low donor chimerism|0|||
131712716|NCT01287104|474226274|FG000|Overall Study|NK cells did not meet release criteria|0|||
131712717|NCT01287104|474226275|FG001|Overall Study|NK cells did not meet release criteria|1|||
131712718|NCT01287104|474226276|FG002|Overall Study|NK cells did not meet release criteria|0|||
131712719|NCT01287104|474226277|FG003|Overall Study|NK cells did not meet release criteria|0|||
131712720|NCT03068715|474226278|FG000|Overall Study|No longer met inclusion criteria|1|||
131629013|NCT00507429|473927007|FG001|Maintenance Phase|Progressive Disease|0|||
131629014|NCT01279447|473927008|FG000|Overall Study|Lost to Follow-up|3|||
131629015|NCT01279447|473927009|FG001|Overall Study|Lost to Follow-up|1|||
131629016|NCT01215253|473927010|FG000|Overall Study|Withdrawal by Subject|57|||
131629017|NCT01215253|473927011|FG001|Overall Study|Withdrawal by Subject|35|||
131629018|NCT01215253|473927010|FG000|Overall Study|Physician Decision|9|||
131629019|NCT01215253|473927011|FG001|Overall Study|Physician Decision|12|||
131629020|NCT01215253|473927010|FG000|Overall Study|Lost to Follow-up|6|||
131712721|NCT03068715|474226279|FG001|Overall Study|No longer met inclusion criteria|0|||
131712722|NCT01276288|474226280|FG000|Overall Study|Adverse Event|1|||
131712723|NCT01276288|474226281|FG001|Overall Study|Adverse Event|1|||
131797704|NCT00767325|474541691|FG000|Overall Study|Lost to Follow-up|3|||
131797705|NCT00767325|474541691|FG000|Overall Study|No longer met study criteria|2|||
131797706|NCT00767325|474541691|FG000|Overall Study|Missed visit due to family reasons|1|||
131797707|NCT00752856|474541692|FG000|Overall Study|randomized but did not do viral kinetics|0|||
131797708|NCT00752856|474541693|FG001|Overall Study|randomized but did not do viral kinetics|1|||
131797709|NCT03131999|474541694|FG000|Overall Study|Withdrawal by Subject|0|||
131797710|NCT03131999|474541695|FG001|Overall Study|Withdrawal by Subject|1|||
131797711|NCT02688608|474541696|FG000|Overall Study|Lost to Follow-up|1|||
131797712|NCT01497938|474541697|FG000|Overall Study|Adverse Event|0|||
131797713|NCT01497938|474541698|FG001|Overall Study|Adverse Event|1|||
131797714|NCT01497938|474541697|FG000|Overall Study|Physician Decision|0|||
131797715|NCT01497938|474541698|FG001|Overall Study|Physician Decision|1|||
131797716|NCT01497938|474541697|FG000|Overall Study|Withdrawal by Subject|4|||
131797717|NCT01497938|474541698|FG001|Overall Study|Withdrawal by Subject|0|||
131797718|NCT01497938|474541697|FG000|Overall Study|Device Violation|1|||
131797719|NCT01497938|474541698|FG001|Overall Study|Device Violation|0|||
131797720|NCT05200858|474541699|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
131797721|NCT05200858|474541700|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
131797722|NCT05200858|474541701|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
131797723|NCT05200858|474541702|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
131797724|NCT01691508|474543383|FG000|Overall Study|Adverse Event|3|||
131797725|NCT01691508|474543384|FG001|Overall Study|Adverse Event|3|||
131797726|NCT01691508|474543383|FG000|Overall Study|Withdrawal by Subject|1|||
131797727|NCT01691508|474543384|FG001|Overall Study|Withdrawal by Subject|0|||
131797728|NCT01506947|474543385|FG000|Overall Study|Lost to Follow-up|7|||
131797729|NCT01506947|474543385|FG000|Overall Study|Adverse Event|5|||
131797730|NCT01506947|474543385|FG000|Overall Study|Death|1|||
131797731|NCT01506947|474543385|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
131797732|NCT01700621|474543386|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
131797733|NCT01700621|474543387|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
131797734|NCT01700621|474543386|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
131797735|NCT01700621|474543387|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
131797736|NCT01700621|474543386|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
131797737|NCT01700621|474543387|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
131797738|NCT02166697|474543388|FG000|Overall Study|Protocol Violation|347|||
131797739|NCT02720510|474543392|FG000|Overall Study|Study Terminated by the sponsor|2|||
131797740|NCT02720510|474543393|FG001|Overall Study|Study Terminated by the sponsor|0|||
131797741|NCT02720510|474543392|FG000|Overall Study|Adverse Event|0|||
131797742|NCT02720510|474543393|FG001|Overall Study|Adverse Event|1|||
131797743|NCT02720510|474543392|FG000|Overall Study|Physician Decision|1|||
131797744|NCT02720510|474543393|FG001|Overall Study|Physician Decision|2|||
131797745|NCT01618266|474543403|FG000|Overall Study|Lost to Follow-up|9|||
131797746|NCT01618266|474543403|FG000|Overall Study|Treatment satisfaction|10|||
131797747|NCT01618266|474543403|FG000|Overall Study|Other reasons|11|||
131797748|NCT01618266|474543403|FG000|Overall Study|Lack of Efficacy|23|||
131629021|NCT01215253|473927011|FG001|Overall Study|Lost to Follow-up|4|||
131629022|NCT01215253|473927010|FG000|Overall Study|Other|14|||
131629023|NCT01215253|473927011|FG001|Overall Study|Other|12|||
131712724|NCT01276288|474226282|FG002|Overall Study|Adverse Event|0|||
131629024|NCT01587703|473927012|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
131629025|NCT01587703|473927013|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629026|NCT01587703|473927014|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629027|NCT01587703|473927015|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629028|NCT01587703|473927016|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629029|NCT01587703|473927017|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629030|NCT01587703|473927018|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629031|NCT01587703|473927019|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629032|NCT01587703|473927020|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629033|NCT01587703|473927021|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629034|NCT01587703|473927022|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629035|NCT01587703|473927023|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629036|NCT01587703|473927024|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629037|NCT01587703|473927025|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629038|NCT01587703|473927026|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629039|NCT01587703|473927027|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629040|NCT01587703|473927028|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629041|NCT01587703|473927029|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629042|NCT01587703|473927030|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131629043|NCT01587703|473927012|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629044|NCT01587703|473927013|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629045|NCT01587703|473927014|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629046|NCT01587703|473927015|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629047|NCT01587703|473927016|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629048|NCT01587703|473927017|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
131629049|NCT01587703|473927018|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629050|NCT01587703|473927019|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
131629051|NCT01587703|473927020|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629052|NCT01587703|473927021|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629053|NCT01587703|473927022|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629054|NCT01587703|473927023|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629055|NCT01587703|473927024|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629056|NCT01587703|473927025|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629057|NCT01587703|473927026|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629058|NCT01587703|473927027|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629059|NCT01587703|473927028|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629060|NCT01587703|473927029|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629061|NCT01587703|473927030|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131629062|NCT01587703|473927012|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629063|NCT01587703|473927013|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629064|NCT01587703|473927014|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629065|NCT01587703|473927015|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629066|NCT01587703|473927016|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629067|NCT01587703|473927017|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629068|NCT01587703|473927018|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
131629069|NCT01587703|473927019|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629070|NCT01587703|473927020|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629071|NCT01587703|473927021|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629072|NCT01587703|473927022|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629073|NCT01587703|473927023|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629074|NCT01587703|473927024|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629075|NCT01587703|473927025|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629076|NCT01587703|473927026|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629077|NCT01587703|473927027|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629078|NCT01587703|473927028|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629079|NCT01587703|473927029|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131629080|NCT01587703|473927030|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131901984|NCT00509899|474926914|FG002|Overall Study|Physician Decision|7|||
131901985|NCT00509899|474926915|FG003|Overall Study|Physician Decision|0|||
131901986|NCT00509899|474926916|FG004|Overall Study|Physician Decision|1|||
131712725|NCT01276288|474226283|FG003|Overall Study|Adverse Event|0|||
131712726|NCT01276288|474226280|FG000|Overall Study|not treated|1|||
131712727|NCT01276288|474226281|FG001|Overall Study|not treated|0|||
131629081|NCT01587703|473927012|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
131629082|NCT01587703|473927013|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
131629083|NCT01587703|473927014|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
131629084|NCT01587703|473927015|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
131629085|NCT01587703|473927016|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
131629086|NCT01587703|473927017|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
131629087|NCT01587703|473927018|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
131629088|NCT01587703|473927019|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
131629089|NCT01587703|473927020|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629090|NCT01587703|473927021|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629091|NCT01587703|473927022|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131712728|NCT01276288|474226282|FG002|Overall Study|not treated|0|||
131712729|NCT01276288|474226283|FG003|Overall Study|not treated|0|||
131901987|NCT00509899|474926917|FG005|Overall Study|Physician Decision|4|||
131901988|NCT00509899|474926918|FG006|Overall Study|Physician Decision|0|||
131712730|NCT03168867|474226284|FG000|Overall Study|Withdrawal by Subject|1|||
131712731|NCT03168867|474226285|FG001|Overall Study|Withdrawal by Subject|5|||
131712732|NCT04964258|474226286|FG000|Overall Study|Lost to Follow-up|1|||
131712733|NCT04964258|474226287|FG001|Overall Study|Lost to Follow-up|0|||
131712734|NCT04964258|474226288|FG002|Overall Study|Lost to Follow-up|0|||
131712735|NCT04964258|474226289|FG003|Overall Study|Lost to Follow-up|0|||
131712736|NCT04964258|474226290|FG004|Overall Study|Lost to Follow-up|0|||
131712737|NCT04964258|474226291|FG005|Overall Study|Lost to Follow-up|1|||
131712738|NCT04964258|474226292|FG006|Overall Study|Lost to Follow-up|0|||
131712739|NCT04964258|474226293|FG007|Overall Study|Lost to Follow-up|0|||
131712740|NCT04964258|474226294|FG008|Overall Study|Lost to Follow-up|0|||
131712741|NCT04964258|474226295|FG009|Overall Study|Lost to Follow-up|0|||
131712742|NCT04964258|474226296|FG010|Overall Study|Lost to Follow-up|0|||
131712743|NCT02909153|474226302|FG000|Overall Study|Withdrawal by Subject|0|||
131712744|NCT02909153|474226303|FG001|Overall Study|Withdrawal by Subject|1|||
131712745|NCT02909153|474226304|FG002|Overall Study|Withdrawal by Subject|0|||
131712746|NCT02909153|474226305|FG003|Overall Study|Withdrawal by Subject|0|||
131712747|NCT02909153|474226306|FG004|Overall Study|Withdrawal by Subject|0|||
131712748|NCT01147809|474226309|FG000|Phase I (168 Days)|Adverse Event|0|||
131712749|NCT01147809|474226310|FG001|Phase I (168 Days)|Adverse Event|0|||
131712750|NCT01147809|474226311|FG002|Phase I (168 Days)|Adverse Event|0|||
131901989|NCT00509899|474926919|FG007|Overall Study|Physician Decision|0|||
131629092|NCT01587703|473927023|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629093|NCT01587703|473927024|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131712751|NCT01147809|474226312|FG003|Phase I (168 Days)|Adverse Event|1|||
131629094|NCT01587703|473927025|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629095|NCT01587703|473927026|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629096|NCT01587703|473927027|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629097|NCT01587703|473927028|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629098|NCT01587703|473927029|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629099|NCT01587703|473927030|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131629100|NCT01587703|473927012|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629101|NCT01587703|473927013|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629102|NCT01587703|473927014|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629103|NCT01587703|473927015|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629104|NCT01587703|473927016|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629105|NCT01587703|473927017|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629106|NCT01587703|473927018|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629107|NCT01587703|473927019|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629108|NCT01587703|473927020|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
131629109|NCT01587703|473927021|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
131629110|NCT01587703|473927022|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
131629111|NCT01587703|473927023|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629112|NCT01587703|473927024|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629113|NCT01587703|473927025|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629114|NCT01587703|473927026|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629115|NCT01587703|473927027|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131712752|NCT01147809|474226313|FG004|Phase I (168 Days)|Adverse Event|0|||
131712753|NCT01147809|474226314|FG005|Phase I (168 Days)|Adverse Event|0|||
131629116|NCT01587703|473927028|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131712754|NCT01147809|474226309|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
131712755|NCT01147809|474226310|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
131629117|NCT01587703|473927029|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131712756|NCT01147809|474226311|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
131712757|NCT01147809|474226312|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
131712758|NCT01147809|474226313|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
131901990|NCT00509899|474926912|FG000|Overall Study|Intercurrent Illness|1|||
131629118|NCT01587703|473927030|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131629119|NCT01587703|473927012|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629120|NCT01587703|473927013|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629121|NCT01587703|473927014|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629122|NCT01587703|473927015|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629123|NCT01587703|473927016|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629124|NCT01587703|473927017|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629125|NCT01587703|473927018|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629126|NCT01587703|473927019|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629127|NCT01587703|473927020|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
131629128|NCT01587703|473927021|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629129|NCT01587703|473927022|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
131629130|NCT01587703|473927023|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629131|NCT01587703|473927024|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629132|NCT01587703|473927025|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629133|NCT01587703|473927026|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629134|NCT01587703|473927027|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629135|NCT01587703|473927028|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629136|NCT01587703|473927029|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629137|NCT01587703|473927030|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131629138|NCT01587703|473927012|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629139|NCT01587703|473927013|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629140|NCT01587703|473927014|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629141|NCT01587703|473927015|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629142|NCT01587703|473927016|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629143|NCT01587703|473927017|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629144|NCT01587703|473927018|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629145|NCT01587703|473927019|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629146|NCT01587703|473927020|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131797749|NCT01618266|474543403|FG000|Overall Study|Protocol Violation|43|||
131629147|NCT01587703|473927021|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
131629148|NCT01587703|473927022|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
131629149|NCT01587703|473927023|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629150|NCT01587703|473927024|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629151|NCT01587703|473927025|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629152|NCT01587703|473927026|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629153|NCT01587703|473927027|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629154|NCT01587703|473927028|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629155|NCT01587703|473927029|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629156|NCT01587703|473927030|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131629157|NCT01587703|473927012|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629158|NCT01587703|473927013|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629159|NCT01587703|473927014|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629160|NCT01587703|473927015|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629161|NCT01587703|473927016|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629162|NCT01587703|473927017|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629163|NCT01587703|473927018|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629164|NCT01587703|473927019|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629165|NCT01587703|473927020|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
131629166|NCT01587703|473927021|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629167|NCT01587703|473927022|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629168|NCT01587703|473927023|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629169|NCT01587703|473927024|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629170|NCT01587703|473927025|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629171|NCT01587703|473927026|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629172|NCT01587703|473927027|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629173|NCT01587703|473927028|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629174|NCT01587703|473927029|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629175|NCT01587703|473927030|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131629176|NCT01587703|473927012|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629177|NCT01587703|473927013|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629178|NCT01587703|473927014|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629179|NCT01587703|473927015|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629180|NCT01587703|473927016|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629181|NCT01587703|473927017|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629182|NCT01587703|473927018|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629183|NCT01587703|473927019|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629184|NCT01587703|473927020|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629185|NCT01587703|473927021|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629186|NCT01587703|473927022|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629187|NCT01587703|473927023|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629188|NCT01587703|473927024|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629189|NCT01587703|473927025|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629190|NCT01587703|473927026|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629191|NCT01587703|473927027|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629192|NCT01587703|473927028|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629193|NCT01587703|473927029|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131629194|NCT01587703|473927030|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
131629195|NCT01587703|473927012|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629196|NCT01587703|473927013|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629197|NCT01587703|473927014|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629198|NCT01587703|473927015|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629199|NCT01587703|473927016|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629200|NCT01587703|473927017|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629201|NCT01587703|473927018|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629202|NCT01587703|473927019|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629203|NCT01587703|473927020|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629204|NCT01587703|473927021|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629205|NCT01587703|473927022|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629206|NCT01587703|473927023|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629207|NCT01587703|473927024|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131797750|NCT02985151|474543404|FG000|Original Randomization|Withdrawal by Subject|0|||
131797751|NCT02985151|474543405|FG001|Original Randomization|Withdrawal by Subject|1|||
131797752|NCT03522948|474543414|FG000|Overall Study|Lost to Follow-up|1|||
131629208|NCT01587703|473927025|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629209|NCT01587703|473927026|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629210|NCT01587703|473927027|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629211|NCT01587703|473927028|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131629212|NCT01587703|473927029|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
131629213|NCT01587703|473927030|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
131629214|NCT01587703|473927012|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629215|NCT01587703|473927013|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629216|NCT01587703|473927014|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629217|NCT01587703|473927015|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629218|NCT01587703|473927016|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629219|NCT01587703|473927017|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629220|NCT01587703|473927018|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629221|NCT01587703|473927019|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629222|NCT01587703|473927020|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629223|NCT01587703|473927021|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629224|NCT01587703|473927022|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629225|NCT01587703|473927023|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629226|NCT01587703|473927024|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629227|NCT01587703|473927025|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629228|NCT01587703|473927026|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629229|NCT01587703|473927027|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
131629230|NCT01587703|473927028|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629231|NCT01587703|473927029|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629232|NCT01587703|473927030|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131629233|NCT01587703|473927012|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629234|NCT01587703|473927013|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629235|NCT01587703|473927014|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629236|NCT01587703|473927015|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629237|NCT01587703|473927016|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629238|NCT01587703|473927017|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629239|NCT01587703|473927018|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629240|NCT01587703|473927019|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629241|NCT01587703|473927020|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629242|NCT01587703|473927021|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629243|NCT01587703|473927022|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629244|NCT01587703|473927023|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
131629245|NCT01587703|473927024|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629246|NCT01587703|473927025|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629247|NCT01587703|473927026|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
131629248|NCT01587703|473927027|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629249|NCT01587703|473927028|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629250|NCT01587703|473927029|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629251|NCT01587703|473927030|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131629252|NCT01587703|473927012|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629253|NCT01587703|473927013|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629254|NCT01587703|473927014|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629255|NCT01587703|473927015|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629256|NCT01587703|473927016|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629257|NCT01587703|473927017|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629258|NCT01587703|473927018|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629259|NCT01587703|473927019|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131712759|NCT01147809|474226314|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
131712760|NCT01147809|474226309|FG000|Phase I (168 Days)|Physician Decision|0|||
131712761|NCT01147809|474226310|FG001|Phase I (168 Days)|Physician Decision|1|||
131712762|NCT01147809|474226311|FG002|Phase I (168 Days)|Physician Decision|2|||
131712763|NCT01147809|474226312|FG003|Phase I (168 Days)|Physician Decision|0|||
131712764|NCT01147809|474226313|FG004|Phase I (168 Days)|Physician Decision|0|||
131712765|NCT01147809|474226314|FG005|Phase I (168 Days)|Physician Decision|0|||
131712766|NCT01147809|474226309|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
131712767|NCT01147809|474226310|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
131712768|NCT01147809|474226311|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
131712769|NCT01147809|474226312|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
131712770|NCT01147809|474226313|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
131712771|NCT01147809|474226314|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
131712772|NCT01147809|474226309|FG000|Phase II (168 Days)|Adverse Event|0|||
131712773|NCT01147809|474226310|FG001|Phase II (168 Days)|Adverse Event|0|||
131712774|NCT01147809|474226311|FG002|Phase II (168 Days)|Adverse Event|0|||
131712775|NCT01147809|474226312|FG003|Phase II (168 Days)|Adverse Event|0|||
131712776|NCT01147809|474226313|FG004|Phase II (168 Days)|Adverse Event|3|||
131712777|NCT01147809|474226314|FG005|Phase II (168 Days)|Adverse Event|6|||
131712778|NCT01147809|474226309|FG000|Phase II (168 Days)|Protocol Violation|0|||
131712779|NCT01147809|474226310|FG001|Phase II (168 Days)|Protocol Violation|0|||
131712780|NCT01147809|474226311|FG002|Phase II (168 Days)|Protocol Violation|0|||
131712781|NCT01147809|474226312|FG003|Phase II (168 Days)|Protocol Violation|0|||
131712782|NCT01147809|474226313|FG004|Phase II (168 Days)|Protocol Violation|0|||
131712783|NCT01147809|474226314|FG005|Phase II (168 Days)|Protocol Violation|1|||
131712784|NCT01147809|474226309|FG000|Phase II (168 Days)|Physician Decision|0|||
131712785|NCT01147809|474226310|FG001|Phase II (168 Days)|Physician Decision|0|||
131712786|NCT01147809|474226311|FG002|Phase II (168 Days)|Physician Decision|0|||
131712787|NCT01147809|474226312|FG003|Phase II (168 Days)|Physician Decision|0|||
131712788|NCT01147809|474226313|FG004|Phase II (168 Days)|Physician Decision|5|||
131712789|NCT01147809|474226314|FG005|Phase II (168 Days)|Physician Decision|11|||
131712790|NCT01147809|474226309|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
131712791|NCT01147809|474226310|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
131712792|NCT01147809|474226311|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
131712793|NCT01147809|474226312|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
131712794|NCT01147809|474226313|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
131712795|NCT01147809|474226314|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
131712796|NCT01147809|474226309|FG000|Phase II (168 Days)|Ongoing|0|||
131712797|NCT01147809|474226310|FG001|Phase II (168 Days)|Ongoing|0|||
131629260|NCT01587703|473927020|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629261|NCT01587703|473927021|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629262|NCT01587703|473927022|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629263|NCT01587703|473927023|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
131629264|NCT01587703|473927024|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
131629265|NCT01587703|473927025|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
131629266|NCT01587703|473927026|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
131629267|NCT01587703|473927027|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
131629268|NCT01587703|473927028|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
131629269|NCT01587703|473927029|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629270|NCT01587703|473927030|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131629271|NCT01587703|473927012|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629272|NCT01587703|473927013|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629273|NCT01587703|473927014|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629274|NCT01587703|473927015|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629275|NCT01587703|473927016|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629276|NCT01587703|473927017|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629277|NCT01587703|473927018|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629278|NCT01587703|473927019|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629279|NCT01587703|473927020|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629280|NCT01587703|473927021|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629281|NCT01587703|473927022|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629282|NCT01587703|473927023|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
131629283|NCT01587703|473927024|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
131712798|NCT01147809|474226311|FG002|Phase II (168 Days)|Ongoing|0|||
131712799|NCT01147809|474226312|FG003|Phase II (168 Days)|Ongoing|0|||
131712800|NCT01147809|474226313|FG004|Phase II (168 Days)|Ongoing|1|||
131629284|NCT01587703|473927025|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
131629285|NCT01587703|473927026|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
131629286|NCT01587703|473927027|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
131629287|NCT01587703|473927028|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
131629288|NCT01587703|473927029|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
131712801|NCT01147809|474226314|FG005|Phase II (168 Days)|Ongoing|0|||
131712802|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
131712803|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
131712804|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
131712805|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131712806|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131797753|NCT00084084|474543415|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
131712807|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131712808|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131712809|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131712810|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131712811|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
131797754|NCT00084084|474543415|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
131797755|NCT01802879|474543416|FG000|Overall Study|Administrative problems|2|||
131629289|NCT01587703|473927030|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
131629290|NCT01587703|473927012|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629291|NCT01587703|473927013|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629292|NCT01587703|473927014|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629293|NCT01587703|473927015|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629294|NCT01587703|473927016|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629295|NCT01587703|473927017|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629296|NCT01587703|473927018|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629297|NCT01587703|473927019|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629298|NCT01587703|473927020|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629299|NCT01587703|473927021|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629300|NCT01587703|473927022|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629301|NCT01587703|473927023|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
131629302|NCT01587703|473927024|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629303|NCT01587703|473927025|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629304|NCT01587703|473927026|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629305|NCT01587703|473927027|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629306|NCT01587703|473927028|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629307|NCT01587703|473927029|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629308|NCT01587703|473927030|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131629309|NCT00476151|473927031|FG000|Overall Study|Adverse Event|0|||
131629310|NCT00476151|473927032|FG001|Overall Study|Adverse Event|2|||
131629311|NCT00476151|473927031|FG000|Overall Study|Protocol Violation|1|||
131629312|NCT00476151|473927032|FG001|Overall Study|Protocol Violation|3|||
131629313|NCT00476151|473927031|FG000|Overall Study|Withdrawal by Subject|2|||
131629314|NCT00476151|473927032|FG001|Overall Study|Withdrawal by Subject|0|||
131629315|NCT00476151|473927031|FG000|Overall Study|Physician Decision|0|||
131629316|NCT00476151|473927032|FG001|Overall Study|Physician Decision|2|||
131629317|NCT01767376|473927043|FG000|Overall Study|Lost to Follow-up|3|||
131629318|NCT01767376|473927044|FG001|Overall Study|Lost to Follow-up|2|||
131629319|NCT01767376|473927045|FG002|Overall Study|Lost to Follow-up|0|||
131629320|NCT01767376|473927043|FG000|Overall Study|Withdrawal by Subject|1|||
131629321|NCT01767376|473927044|FG001|Overall Study|Withdrawal by Subject|1|||
131629322|NCT01767376|473927045|FG002|Overall Study|Withdrawal by Subject|0|||
131629323|NCT01113541|473927049|FG000|Overall Study|Withdrawal by Subject|1|||
131629324|NCT01113541|473927049|FG000|Overall Study|Protocol Violation|1|||
131629325|NCT01113541|473927049|FG000|Overall Study|Study Terminated by Sponsor|7|||
131629326|NCT01113541|473927049|FG000|Overall Study|Adverse Event|4|||
131629327|NCT03745651|473927050|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
131629328|NCT03745651|473927051|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
131629329|NCT03745651|473927052|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131629330|NCT03745651|473927053|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131629331|NCT03745651|473927054|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131629332|NCT03745651|473927055|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131629333|NCT03745651|473927056|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131629334|NCT03745651|473927050|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
131712812|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
131712813|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
131712814|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131712815|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131712816|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131712817|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131712818|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131712819|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131712820|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
131712821|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
131712822|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
131712823|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131712824|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131712825|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131712826|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131712827|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131712828|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131712829|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131712830|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131712831|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
131629335|NCT03745651|473927051|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
131629336|NCT03745651|473927052|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
131629337|NCT03745651|473927053|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131629338|NCT03745651|473927054|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131629339|NCT03745651|473927055|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131629340|NCT03745651|473927056|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131629341|NCT03745651|473927050|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
131629342|NCT03745651|473927051|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131629343|NCT03745651|473927052|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
131629344|NCT03745651|473927053|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131629345|NCT03745651|473927054|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131629346|NCT03745651|473927055|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131629347|NCT03745651|473927056|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131629348|NCT03745651|473927050|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131629349|NCT03745651|473927051|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
131629350|NCT03745651|473927052|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131629351|NCT03745651|473927053|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131629352|NCT03745651|473927054|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131629353|NCT03745651|473927055|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131629354|NCT03745651|473927056|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131629355|NCT03745651|473927050|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
131629356|NCT03745651|473927051|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
131629357|NCT03745651|473927052|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
131629358|NCT03745651|473927053|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131629359|NCT03745651|473927054|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131629360|NCT03745651|473927055|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131629361|NCT03745651|473927056|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131629362|NCT03745651|473927050|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
131629363|NCT03745651|473927051|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
131629364|NCT03745651|473927052|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
131629365|NCT03745651|473927053|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131629366|NCT03745651|473927054|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131629367|NCT03745651|473927055|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131629368|NCT03745651|473927056|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131629369|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131629370|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131629371|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131629372|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131629373|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131629374|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
131629375|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131629376|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131629377|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131629378|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131629379|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
131629380|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131629381|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
131629382|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
131629383|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131629384|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131629385|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131629386|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
131629387|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
131629388|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
131629389|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
131629390|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131629391|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131629392|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131629393|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
131629394|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131712832|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131712833|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131629395|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
131629396|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
131629397|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131629398|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131629399|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131797756|NCT01802879|474543416|FG000|Overall Study|Disease progression|6|||
131797757|NCT01816477|474543423|FG000|Overall Study|Withdrawal by Subject|13|||
131797758|NCT01816477|474543424|FG001|Overall Study|Withdrawal by Subject|1|||
131797759|NCT01816477|474543423|FG000|Overall Study|Unable to tolerate catheter placement|3|||
131797760|NCT01816477|474543424|FG001|Overall Study|Unable to tolerate catheter placement|0|||
131797761|NCT01047345|474543425|FG000|Base Study|Adverse Event|3|||
131797762|NCT01047345|474543426|FG001|Base Study|Adverse Event|0|||
131797763|NCT01047345|474543427|FG002|Base Study|Adverse Event|0|||
131797764|NCT01047345|474543425|FG000|Base Study|Lost to Follow-up|4|||
131797765|NCT01047345|474543426|FG001|Base Study|Lost to Follow-up|1|||
131797766|NCT01047345|474543427|FG002|Base Study|Lost to Follow-up|0|||
131797767|NCT01047345|474543425|FG000|Base Study|Protocol Violation|3|||
131797768|NCT01047345|474543426|FG001|Base Study|Protocol Violation|1|||
131797769|NCT01047345|474543427|FG002|Base Study|Protocol Violation|0|||
131797770|NCT01047345|474543425|FG000|Base Study|Withdrawal by Subject|12|||
131797771|NCT01047345|474543426|FG001|Base Study|Withdrawal by Subject|4|||
131797772|NCT01047345|474543427|FG002|Base Study|Withdrawal by Subject|0|||
131797773|NCT01047345|474543425|FG000|Extension|Withdrawal by Subject|0|||
131797774|NCT01047345|474543426|FG001|Extension|Withdrawal by Subject|0|||
131797775|NCT01047345|474543427|FG002|Extension|Withdrawal by Subject|1|||
131797776|NCT01047345|474543425|FG000|Extension|Lost to Follow-up|0|||
131797777|NCT01047345|474543426|FG001|Extension|Lost to Follow-up|0|||
131797778|NCT01047345|474543427|FG002|Extension|Lost to Follow-up|5|||
131797779|NCT00819247|474543428|FG000|Overall Study|Adverse Event|0|||
131797780|NCT00819247|474543429|FG001|Overall Study|Adverse Event|5|||
131797781|NCT00819247|474543430|FG002|Overall Study|Adverse Event|3|||
131797782|NCT00819247|474543428|FG000|Overall Study|Insufficient testosterone response|5|||
131797783|NCT00819247|474543429|FG001|Overall Study|Insufficient testosterone response|8|||
131797784|NCT00819247|474543430|FG002|Overall Study|Insufficient testosterone response|10|||
131797785|NCT00819247|474543428|FG000|Overall Study|Withdrawal by Subject|1|||
131797786|NCT00819247|474543429|FG001|Overall Study|Withdrawal by Subject|0|||
131797787|NCT00819247|474543430|FG002|Overall Study|Withdrawal by Subject|0|||
131797788|NCT00819247|474543428|FG000|Overall Study|Protocol Violation|1|||
131797789|NCT00819247|474543429|FG001|Overall Study|Protocol Violation|0|||
131797790|NCT00819247|474543430|FG002|Overall Study|Protocol Violation|1|||
131797791|NCT00819247|474543428|FG000|Overall Study|Mistakenly withdrawn|0|||
131797792|NCT00819247|474543429|FG001|Overall Study|Mistakenly withdrawn|1|||
131797793|NCT00819247|474543430|FG002|Overall Study|Mistakenly withdrawn|0|||
131797794|NCT00819247|474543428|FG000|Overall Study|Bad prostate-specific antigen response|3|||
131797795|NCT00819247|474543429|FG001|Overall Study|Bad prostate-specific antigen response|2|||
131797796|NCT00819247|474543430|FG002|Overall Study|Bad prostate-specific antigen response|0|||
131797797|NCT00819247|474543428|FG000|Overall Study|Other|1|||
131797798|NCT00819247|474543429|FG001|Overall Study|Other|0|||
131797799|NCT00819247|474543430|FG002|Overall Study|Other|0|||
131797800|NCT00108732|474543431|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
131797801|NCT00108732|474543431|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
131797802|NCT00108732|474543431|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
131797803|NCT00108732|474543431|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
131797804|NCT00108732|474543431|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
131797805|NCT00108732|474543431|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
131797806|NCT00108732|474543431|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
131797807|NCT02187042|474543432|FG000|Overall Study|Death|1|||
131797808|NCT02187042|474543433|FG001|Overall Study|Death|1|||
131797809|NCT02187042|474543432|FG000|Overall Study|Toxicity|6|||
131797810|NCT02187042|474543433|FG001|Overall Study|Toxicity|5|||
131797811|NCT02187042|474543432|FG000|Overall Study|Participant choice|1|||
131797812|NCT02187042|474543433|FG001|Overall Study|Participant choice|0|||
131797813|NCT02187042|474543432|FG000|Overall Study|Doctor choice|1|||
131797814|NCT02187042|474543433|FG001|Overall Study|Doctor choice|0|||
131797815|NCT02187042|474543432|FG000|Overall Study|Progressive disease|4|||
131444243|NCT02903771|473257106|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
131629400|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
131797816|NCT02187042|474543433|FG001|Overall Study|Progressive disease|8|||
131797817|NCT02116803|474543435|FG000|Overall Study|Adverse Event|2|||
131629401|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131629402|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131629403|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
131629404|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131629405|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131629406|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131629407|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131629408|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131629409|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
131629410|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131629411|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131629412|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131629413|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131629414|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
131629415|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
131629416|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
131629417|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
131629418|NCT03745651|473927050|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131629419|NCT03745651|473927051|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131629420|NCT03745651|473927052|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131629421|NCT03745651|473927053|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
131629422|NCT03745651|473927054|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
131797818|NCT02116803|474543436|FG001|Overall Study|Adverse Event|1|||
131797819|NCT02116803|474543435|FG000|Overall Study|Physician Decision|1|||
131797820|NCT02116803|474543436|FG001|Overall Study|Physician Decision|0|||
131797821|NCT02116803|474543435|FG000|Overall Study|Progressive disease|4|||
131797822|NCT02116803|474543436|FG001|Overall Study|Progressive disease|0|||
131797823|NCT02116803|474543435|FG000|Overall Study|Study terminated by sponsor|2|||
131797824|NCT02116803|474543436|FG001|Overall Study|Study terminated by sponsor|1|||
131797825|NCT02116803|474543435|FG000|Overall Study|Death|1|||
131797826|NCT02116803|474543436|FG001|Overall Study|Death|0|||
131797827|NCT00698685|474543439|FG000|Overall Study|Sister withdrew as donor|1|||
131797828|NCT00698685|474543439|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
131797829|NCT00282256|474543440|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
131797830|NCT00282256|474543440|FG000|Extension Treatment Period|Adverse Event|2|||
131797831|NCT01457053|474543443|FG000|Overall Study|Unable to undergo selected treatment|1|||
131797832|NCT01457053|474543444|FG001|Overall Study|Unable to undergo selected treatment|1|||
131797833|NCT01265784|474543446|FG000|Overall Study|Lost to Follow-up|5|||
131629423|NCT03745651|473927055|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
131629424|NCT03745651|473927056|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131629425|NCT04175834|473927057|FG000|Overall Study|Withdrawal by Subject|1|||
131629426|NCT04175834|473927058|FG001|Overall Study|Withdrawal by Subject|0|||
131629427|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
131629428|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
131629429|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
131629430|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
131629431|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
131629432|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
131629433|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
131629434|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
131629435|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
131629436|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
131629437|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
131629438|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
131629439|NCT01494467|473927063|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
131629440|NCT01494467|473927064|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
131629441|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
131629442|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
131629443|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
131629444|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
131629445|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
131629446|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
131797834|NCT01265784|474543447|FG001|Overall Study|Lost to Follow-up|3|||
131797835|NCT01265784|474543448|FG002|Overall Study|Lost to Follow-up|2|||
131797836|NCT01265784|474543446|FG000|Overall Study|Withdrawal by Subject|0|||
131797837|NCT01265784|474543447|FG001|Overall Study|Withdrawal by Subject|5|||
131797838|NCT01265784|474543448|FG002|Overall Study|Withdrawal by Subject|0|||
131629447|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
131629448|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
131629449|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
131629450|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
131629451|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
131629452|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
131629453|NCT01494467|473927063|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
131629454|NCT01494467|473927064|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
131629455|NCT02309892|473927065|FG000|Overall Study|Physician Decision|1|||
131629456|NCT02309892|473927066|FG001|Overall Study|Physician Decision|0|||
131629457|NCT02309892|473927067|FG002|Overall Study|Physician Decision|0|||
131629458|NCT02309892|473927068|FG003|Overall Study|Physician Decision|0|||
131629459|NCT02309892|473927069|FG004|Overall Study|Physician Decision|0|||
131629460|NCT02309892|473927070|FG005|Overall Study|Physician Decision|0|||
131629461|NCT02309892|473927071|FG006|Overall Study|Physician Decision|0|||
131629462|NCT02309892|473927065|FG000|Overall Study|Adverse Event|1|||
131629463|NCT02309892|473927066|FG001|Overall Study|Adverse Event|0|||
131629464|NCT02309892|473927067|FG002|Overall Study|Adverse Event|1|||
131629465|NCT02309892|473927068|FG003|Overall Study|Adverse Event|0|||
131629466|NCT02309892|473927069|FG004|Overall Study|Adverse Event|0|||
131629467|NCT02309892|473927070|FG005|Overall Study|Adverse Event|0|||
131629468|NCT02309892|473927071|FG006|Overall Study|Adverse Event|0|||
131629469|NCT02309892|473927065|FG000|Overall Study|Progressive Disease|0|||
131629470|NCT02309892|473927066|FG001|Overall Study|Progressive Disease|1|||
131629471|NCT02309892|473927067|FG002|Overall Study|Progressive Disease|0|||
131629472|NCT02309892|473927068|FG003|Overall Study|Progressive Disease|0|||
131629473|NCT02309892|473927069|FG004|Overall Study|Progressive Disease|1|||
131629474|NCT02309892|473927070|FG005|Overall Study|Progressive Disease|0|||
131629475|NCT02309892|473927071|FG006|Overall Study|Progressive Disease|0|||
131629476|NCT02309892|473927065|FG000|Overall Study|Death|0|||
131629477|NCT02309892|473927066|FG001|Overall Study|Death|0|||
131629478|NCT02309892|473927067|FG002|Overall Study|Death|0|||
131629479|NCT02309892|473927068|FG003|Overall Study|Death|0|||
131629480|NCT02309892|473927069|FG004|Overall Study|Death|0|||
131629481|NCT02309892|473927070|FG005|Overall Study|Death|1|||
131629482|NCT02309892|473927071|FG006|Overall Study|Death|0|||
131629483|NCT03262389|473927072|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
131629484|NCT03262389|473927072|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
131629485|NCT03262389|473927072|FG000|Overall Study|opted out of PET/MR|1|||
131629486|NCT01052272|473927073|FG000|Overall Study|Death|0|||
131629487|NCT01052272|473927074|FG001|Overall Study|Death|0|||
131629488|NCT01052272|473927075|FG002|Overall Study|Death|1|||
131629489|NCT01052272|473927076|FG003|Overall Study|Death|1|||
131629490|NCT01052272|473927073|FG000|Overall Study|Physician Decision|0|||
131629491|NCT01052272|473927074|FG001|Overall Study|Physician Decision|1|||
131629492|NCT01052272|473927075|FG002|Overall Study|Physician Decision|0|||
131629493|NCT01052272|473927076|FG003|Overall Study|Physician Decision|0|||
131629494|NCT01052272|473927073|FG000|Overall Study|patient refuses follow-up|5|||
131629495|NCT01052272|473927074|FG001|Overall Study|patient refuses follow-up|4|||
131629496|NCT01052272|473927075|FG002|Overall Study|patient refuses follow-up|2|||
131629497|NCT01052272|473927076|FG003|Overall Study|patient refuses follow-up|4|||
131629498|NCT01052272|473927073|FG000|Overall Study|Withdrawal by Subject|0|||
131629499|NCT01052272|473927074|FG001|Overall Study|Withdrawal by Subject|2|||
131629500|NCT01052272|473927075|FG002|Overall Study|Withdrawal by Subject|3|||
131629501|NCT01052272|473927076|FG003|Overall Study|Withdrawal by Subject|2|||
131629502|NCT01052272|473927073|FG000|Overall Study|placed in long-term care|0|||
131629503|NCT01052272|473927074|FG001|Overall Study|placed in long-term care|0|||
131629504|NCT01052272|473927075|FG002|Overall Study|placed in long-term care|1|||
131629505|NCT01052272|473927076|FG003|Overall Study|placed in long-term care|0|||
131629506|NCT01052272|473927073|FG000|Overall Study|decline in health|0|||
131629507|NCT01052272|473927074|FG001|Overall Study|decline in health|0|||
131629508|NCT01052272|473927075|FG002|Overall Study|decline in health|1|||
131629509|NCT01052272|473927076|FG003|Overall Study|decline in health|0|||
131629510|NCT04739306|473927077|FG000|Main Study Period|Adverse Event|6|||
131629511|NCT04739306|473927078|FG001|Main Study Period|Adverse Event|7|||
131629512|NCT04739306|473927077|FG000|Main Study Period|Lost to Follow-up|4|||
131629513|NCT04739306|473927078|FG001|Main Study Period|Lost to Follow-up|6|||
131629514|NCT04739306|473927077|FG000|Main Study Period|Physician Decision|1|||
131629515|NCT04739306|473927078|FG001|Main Study Period|Physician Decision|1|||
131629516|NCT04739306|473927077|FG000|Main Study Period|Withdrawal by Subject|8|||
131629517|NCT04739306|473927078|FG001|Main Study Period|Withdrawal by Subject|6|||
131629518|NCT04739306|473927077|FG000|Main Study Period|Protocol Violation|0|||
131629519|NCT04739306|473927078|FG001|Main Study Period|Protocol Violation|1|||
131629520|NCT04739306|473927077|FG000|Main Study Period|War in Ukraine|1|||
131629521|NCT04739306|473927078|FG001|Main Study Period|War in Ukraine|1|||
131629522|NCT01077284|473927079|FG000|Overall Study|Adverse Event|2|||
131712834|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131901991|NCT00509899|474926913|FG001|Overall Study|Intercurrent Illness|0|||
131901992|NCT00509899|474926914|FG002|Overall Study|Intercurrent Illness|0|||
131901993|NCT00509899|474926915|FG003|Overall Study|Intercurrent Illness|1|||
131901994|NCT00509899|474926916|FG004|Overall Study|Intercurrent Illness|0|||
131901995|NCT00509899|474926917|FG005|Overall Study|Intercurrent Illness|1|||
131901996|NCT00509899|474926918|FG006|Overall Study|Intercurrent Illness|0|||
131901997|NCT00509899|474926919|FG007|Overall Study|Intercurrent Illness|0|||
131901998|NCT00509899|474926912|FG000|Overall Study|Death|2|||
131901999|NCT00509899|474926913|FG001|Overall Study|Death|2|||
131902000|NCT00509899|474926914|FG002|Overall Study|Death|3|||
131902001|NCT00509899|474926915|FG003|Overall Study|Death|0|||
131902002|NCT00509899|474926916|FG004|Overall Study|Death|1|||
131902003|NCT00509899|474926917|FG005|Overall Study|Death|1|||
131902004|NCT00509899|474926918|FG006|Overall Study|Death|1|||
131902005|NCT00509899|474926919|FG007|Overall Study|Death|1|||
131902006|NCT00509899|474926912|FG000|Overall Study|Lack of Efficacy|1|||
131902007|NCT00509899|474926913|FG001|Overall Study|Lack of Efficacy|0|||
131902008|NCT00509899|474926914|FG002|Overall Study|Lack of Efficacy|2|||
131902009|NCT00509899|474926915|FG003|Overall Study|Lack of Efficacy|0|||
131902010|NCT00509899|474926916|FG004|Overall Study|Lack of Efficacy|0|||
131902011|NCT00509899|474926917|FG005|Overall Study|Lack of Efficacy|1|||
131902012|NCT00509899|474926918|FG006|Overall Study|Lack of Efficacy|0|||
131902013|NCT00509899|474926919|FG007|Overall Study|Lack of Efficacy|0|||
131902014|NCT02735980|474926920|FG000|Overall Study|Adverse Event|0|||
131902015|NCT02735980|474926921|FG001|Overall Study|Adverse Event|4|||
131902016|NCT02735980|474926922|FG002|Overall Study|Adverse Event|1|||
131902017|NCT02735980|474926920|FG000|Overall Study|Death|5|||
131902018|NCT02735980|474926921|FG001|Overall Study|Death|4|||
131902019|NCT02735980|474926922|FG002|Overall Study|Death|0|||
131902020|NCT02735980|474926920|FG000|Overall Study|Physician Decision|3|||
131712835|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131712836|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131712837|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131712838|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
131712839|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131712840|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
131712841|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131712842|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131712843|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131712844|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131712845|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131712846|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131712847|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131902021|NCT02735980|474926921|FG001|Overall Study|Physician Decision|1|||
131902022|NCT02735980|474926922|FG002|Overall Study|Physician Decision|0|||
131902023|NCT02735980|474926920|FG000|Overall Study|Screen failure|1|||
131629523|NCT01077284|473927080|FG001|Overall Study|Adverse Event|0|||
131902024|NCT02735980|474926921|FG001|Overall Study|Screen failure|0|||
131902025|NCT02735980|474926922|FG002|Overall Study|Screen failure|0|||
131902026|NCT02735980|474926920|FG000|Overall Study|Withdrawal by Subject|1|||
131902027|NCT02735980|474926921|FG001|Overall Study|Withdrawal by Subject|2|||
131902028|NCT02735980|474926922|FG002|Overall Study|Withdrawal by Subject|0|||
131629524|NCT01077284|473927081|FG002|Overall Study|Adverse Event|1|||
131629525|NCT01077284|473927079|FG000|Overall Study|Lost to Follow-up|1|||
131629526|NCT01077284|473927080|FG001|Overall Study|Lost to Follow-up|2|||
131629527|NCT01077284|473927081|FG002|Overall Study|Lost to Follow-up|0|||
131629528|NCT01077284|473927079|FG000|Overall Study|Withdrawal by Subject|2|||
131629529|NCT01077284|473927080|FG001|Overall Study|Withdrawal by Subject|3|||
131629530|NCT01077284|473927081|FG002|Overall Study|Withdrawal by Subject|1|||
131629531|NCT01077284|473927079|FG000|Overall Study|Other|0|||
131629532|NCT01077284|473927080|FG001|Overall Study|Other|0|||
131629533|NCT01077284|473927081|FG002|Overall Study|Other|1|||
131629534|NCT03209492|473927082|FG000|Overall Study|Case Report Forms Uncollected|5|||
131629535|NCT01762345|473927083|FG000|Overall Study|Adverse Event|5|||
131629536|NCT01762345|473927083|FG000|Overall Study|Protocol Violation|2|||
131629537|NCT02379078|473927084|FG000|Overall Study|Lost to Follow-up|33|||
131629538|NCT02379078|473927085|FG001|Overall Study|Lost to Follow-up|30|||
131629539|NCT02379078|473927084|FG000|Overall Study|Withdrawal by Subject|6|||
131629540|NCT02379078|473927085|FG001|Overall Study|Withdrawal by Subject|5|||
131629541|NCT04908488|473927088|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
131629542|NCT04908488|473927089|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
131629543|NCT04908488|473927088|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
131629544|NCT04908488|473927089|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
131629545|NCT01894620|473927090|FG000|Overall Study|Withdrawal by Subject|0|||
131629546|NCT01894620|473927091|FG001|Overall Study|Withdrawal by Subject|1|||
131629547|NCT02877680|473927092|FG000|Overall Study|Lost to Follow-up|1|||
131629548|NCT02877680|473927093|FG001|Overall Study|Lost to Follow-up|1|||
131629549|NCT05104242|473927100|FG000|Overall Study|Withdrawal by Subject|1|||
131629550|NCT05104242|473927101|FG001|Overall Study|Withdrawal by Subject|5|||
131629551|NCT05104242|473927100|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
131629552|NCT05104242|473927101|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
131629553|NCT01864200|473927106|FG000|Overall Study|Lost to Follow-up|1|||
131629554|NCT01864200|473927107|FG001|Overall Study|Lost to Follow-up|3|||
131629555|NCT01864200|473927106|FG000|Overall Study|Protocol Violation|1|||
131629556|NCT01864200|473927107|FG001|Overall Study|Protocol Violation|0|||
131629557|NCT02991118|473927108|FG000|Overall Study|Death|3|||
131629558|NCT02991118|473927109|FG001|Overall Study|Death|8|||
131629559|NCT02991118|473927108|FG000|Overall Study|Protocol Violation|0|||
131629560|NCT02991118|473927109|FG001|Overall Study|Protocol Violation|3|||
131629561|NCT02991118|473927108|FG000|Overall Study|Physician Decision|0|||
131629562|NCT02991118|473927109|FG001|Overall Study|Physician Decision|1|||
131629563|NCT02991118|473927108|FG000|Overall Study|Moved out of the country|0|||
131629564|NCT02991118|473927109|FG001|Overall Study|Moved out of the country|1|||
131629565|NCT02991118|473927108|FG000|Overall Study|Adverse Event|2|||
131629566|NCT02991118|473927109|FG001|Overall Study|Adverse Event|2|||
131712848|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712849|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712850|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712851|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712852|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712853|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712854|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712855|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131712856|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
131712857|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
131712858|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712859|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712860|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712861|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712862|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712863|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712864|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131712865|NCT01307423|474226315|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131712866|NCT01307423|474226316|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
131712867|NCT01307423|474226317|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
131712868|NCT01307423|474226318|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131719546|NCT01480180|474253341|FG002|Extension Phase, Part 1|Unclassified|1|||
131719547|NCT01480180|474253342|FG003|Extension Phase, Part 1|Unclassified|0|||
131629567|NCT02991118|473927108|FG000|Overall Study|Withdrawal by Subject|1|||
131629568|NCT02991118|473927109|FG001|Overall Study|Withdrawal by Subject|7|||
131719548|NCT01480180|474253343|FG004|Extension Phase, Part 1|Unclassified|0|||
131719549|NCT01480180|474253344|FG005|Extension Phase, Part 1|Unclassified|0|||
131629569|NCT02991118|473927108|FG000|Overall Study|Could not attend study visits|0|||
131629570|NCT02991118|473927109|FG001|Overall Study|Could not attend study visits|1|||
131629571|NCT02991118|473927108|FG000|Overall Study|Lost to Follow-up|1|||
131629572|NCT02991118|473927109|FG001|Overall Study|Lost to Follow-up|9|||
131629573|NCT00595959|473927110|FG000|Overall Study|Withdrawal by Subject|1|||
131629574|NCT00595959|473927110|FG000|Overall Study|Lost to Follow-up|1|||
131629575|NCT02077374|473927114|FG000|Overall Study|Withdrawal by Subject|0|||
131629576|NCT02077374|473927115|FG001|Overall Study|Withdrawal by Subject|1|||
131629577|NCT02077374|473927114|FG000|Overall Study|Protocol Violation|0|||
131629578|NCT02077374|473927115|FG001|Overall Study|Protocol Violation|1|||
131629579|NCT00424476|473927117|FG000|Overall Study|Withdrawal by Subject|7|||
131629580|NCT00424476|473927118|FG001|Overall Study|Withdrawal by Subject|6|||
131629581|NCT00424476|473927119|FG002|Overall Study|Withdrawal by Subject|3|||
131629582|NCT00424476|473927117|FG000|Overall Study|Adverse Event|19|||
131629583|NCT00424476|473927118|FG001|Overall Study|Adverse Event|16|||
131629584|NCT00424476|473927119|FG002|Overall Study|Adverse Event|15|||
131629585|NCT00424476|473927117|FG000|Overall Study|Lack of Efficacy|16|||
131629586|NCT00424476|473927118|FG001|Overall Study|Lack of Efficacy|12|||
131629587|NCT00424476|473927119|FG002|Overall Study|Lack of Efficacy|12|||
131629588|NCT00424476|473927117|FG000|Overall Study|Lack of Compliance|1|||
131629589|NCT00424476|473927118|FG001|Overall Study|Lack of Compliance|1|||
131629590|NCT00424476|473927119|FG002|Overall Study|Lack of Compliance|1|||
131629591|NCT00424476|473927117|FG000|Overall Study|Lost to Follow-up|4|||
131629592|NCT00424476|473927118|FG001|Overall Study|Lost to Follow-up|6|||
131629593|NCT00424476|473927119|FG002|Overall Study|Lost to Follow-up|3|||
131629594|NCT00424476|473927117|FG000|Overall Study|Protocol Violation|7|||
131629595|NCT00424476|473927118|FG001|Overall Study|Protocol Violation|2|||
131629596|NCT00424476|473927119|FG002|Overall Study|Protocol Violation|3|||
131629597|NCT00424476|473927117|FG000|Overall Study|Physician Decision|3|||
131629598|NCT00424476|473927118|FG001|Overall Study|Physician Decision|2|||
131629599|NCT00424476|473927119|FG002|Overall Study|Physician Decision|3|||
131629600|NCT00424476|473927117|FG000|Overall Study|Other|4|||
131629601|NCT00424476|473927118|FG001|Overall Study|Other|3|||
131629602|NCT00424476|473927119|FG002|Overall Study|Other|9|||
131629603|NCT02764320|473927120|FG000|Overall Study|Withdrawal by Subject|35|||
131629604|NCT02764320|473927121|FG001|Overall Study|Withdrawal by Subject|38|||
131629605|NCT02764320|473927120|FG000|Overall Study|Protocol Violation|11|||
131629606|NCT02764320|473927121|FG001|Overall Study|Protocol Violation|6|||
131629607|NCT02764320|473927120|FG000|Overall Study|Adverse Event|2|||
131629608|NCT02764320|473927121|FG001|Overall Study|Adverse Event|0|||
131629609|NCT02764320|473927120|FG000|Overall Study|Health Issues unable to continue|2|||
131712869|NCT01307423|474226319|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131712870|NCT01307423|474226320|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131712871|NCT01307423|474226321|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131712872|NCT01307423|474226322|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131712873|NCT01307423|474226323|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131712874|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131712875|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
131712876|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
131712877|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
131712878|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
131712879|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131712880|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131712881|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131712882|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131712883|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131712884|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
131712885|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
131712886|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
131712887|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
131712888|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131712889|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131712890|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131712891|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131629610|NCT02764320|473927121|FG001|Overall Study|Health Issues unable to continue|0|||
131629611|NCT02764320|473927120|FG000|Overall Study|Did not meet inclusion criteria|1|||
131629612|NCT02764320|473927121|FG001|Overall Study|Did not meet inclusion criteria|0|||
131629613|NCT02764320|473927120|FG000|Overall Study|Subject moved|0|||
131629614|NCT02764320|473927121|FG001|Overall Study|Subject moved|2|||
131629615|NCT02764320|473927120|FG000|Overall Study|Overused medication unavailable|0|||
131629616|NCT02764320|473927121|FG001|Overall Study|Overused medication unavailable|1|||
131629617|NCT02764320|473927120|FG000|Overall Study|Seeking care outside site|0|||
131629618|NCT02764320|473927121|FG001|Overall Study|Seeking care outside site|1|||
131629619|NCT02764320|473927120|FG000|Overall Study|Technology barriers|0|||
131629620|NCT02764320|473927121|FG001|Overall Study|Technology barriers|1|||
131629621|NCT00632736|473927127|FG000|Overall Study|Adverse Event|104|||
131629622|NCT00632736|473927127|FG000|Overall Study|Lost to Follow-up|15|||
131629623|NCT00632736|473927127|FG000|Overall Study|Protocol Violation|14|||
131629624|NCT00632736|473927127|FG000|Overall Study|Withdrawal by Subject|99|||
131629625|NCT00632736|473927127|FG000|Overall Study|Lack of Efficacy|5|||
131629626|NCT00632736|473927127|FG000|Overall Study|Sponsor terminated study|5|||
131629627|NCT00632736|473927127|FG000|Overall Study|Non-compliance|10|||
131629628|NCT00632736|473927127|FG000|Overall Study|Other|16|||
131629629|NCT05700851|473927128|FG000|Overall Study|Received a kidney transplant|1|||
131629630|NCT05700851|473927128|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
131629631|NCT05700851|473927128|FG000|Overall Study|Withdrawal by Subject|1|||
131629632|NCT00589628|473927129|FG000|Overall Study|Lost to Follow-up|0|||
131629633|NCT00589628|473927130|FG001|Overall Study|Lost to Follow-up|1|||
131629634|NCT00946998|473928736|FG000|Overall Study|Exited prior to first outcome assessment|5|||
131629635|NCT00946998|473928737|FG001|Overall Study|Exited prior to first outcome assessment|3|||
131629636|NCT04914897|473928740|FG000|Overall Study|Withdrawal by Subject|3|||
131629637|NCT04914897|473928741|FG001|Overall Study|Withdrawal by Subject|1|||
131629638|NCT04914897|473928742|FG002|Overall Study|Withdrawal by Subject|1|||
131629639|NCT04914897|473928743|FG003|Overall Study|Withdrawal by Subject|1|||
131629640|NCT04914897|473928740|FG000|Overall Study|Poor compliance to protocol|0|||
131629641|NCT04914897|473928741|FG001|Overall Study|Poor compliance to protocol|0|||
131629642|NCT04914897|473928742|FG002|Overall Study|Poor compliance to protocol|1|||
131629643|NCT04914897|473928743|FG003|Overall Study|Poor compliance to protocol|0|||
131629644|NCT04914897|473928740|FG000|Overall Study|Progressive disease|5|||
131797839|NCT01265784|474543446|FG000|Overall Study|Physician Decision|1|||
131797840|NCT01265784|474543447|FG001|Overall Study|Physician Decision|0|||
131797841|NCT01265784|474543448|FG002|Overall Study|Physician Decision|1|||
131797842|NCT01265784|474543446|FG000|Overall Study|Adverse Event|1|||
131797843|NCT01265784|474543447|FG001|Overall Study|Adverse Event|0|||
131797844|NCT01265784|474543448|FG002|Overall Study|Adverse Event|0|||
131797845|NCT01265784|474543446|FG000|Overall Study|Death|3|||
131797846|NCT01265784|474543447|FG001|Overall Study|Death|0|||
131797847|NCT01265784|474543448|FG002|Overall Study|Death|0|||
131797848|NCT01265784|474543446|FG000|Overall Study|Protocol Violation|2|||
131797849|NCT01265784|474543447|FG001|Overall Study|Protocol Violation|0|||
131797850|NCT01265784|474543448|FG002|Overall Study|Protocol Violation|0|||
131797851|NCT01265784|474543446|FG000|Overall Study|Incorrectly Randomized|0|||
131797852|NCT01265784|474543447|FG001|Overall Study|Incorrectly Randomized|0|||
131797853|NCT01265784|474543448|FG002|Overall Study|Incorrectly Randomized|1|||
131629645|NCT04914897|473928741|FG001|Overall Study|Progressive disease|14|||
131629646|NCT04914897|473928742|FG002|Overall Study|Progressive disease|30|||
131629647|NCT04914897|473928743|FG003|Overall Study|Progressive disease|21|||
131629648|NCT04914897|473928740|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
131629649|NCT04914897|473928741|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
131629650|NCT04914897|473928742|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
131797854|NCT00984295|474543451|FG000|Overall Study|Lost to Follow-up|31|||
131797855|NCT00984295|474543452|FG001|Overall Study|Lost to Follow-up|12|||
131797856|NCT00984295|474543453|FG002|Overall Study|Lost to Follow-up|13|||
131797857|NCT00984295|474543451|FG000|Overall Study|Protocol Violation|2|||
131797858|NCT00984295|474543452|FG001|Overall Study|Protocol Violation|1|||
131797859|NCT00984295|474543453|FG002|Overall Study|Protocol Violation|4|||
131629651|NCT04914897|473928743|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
131629652|NCT04914897|473928740|FG000|Overall Study|Other|1|||
131629653|NCT04914897|473928741|FG001|Overall Study|Other|0|||
131629654|NCT04914897|473928742|FG002|Overall Study|Other|0|||
131629655|NCT04914897|473928743|FG003|Overall Study|Other|1|||
131629656|NCT03020914|473928744|FG000|Overall Study|Surgery Cancelled|1|||
131629657|NCT03020914|473928745|FG001|Overall Study|Surgery Cancelled|0|||
131629658|NCT01945593|473928748|FG000|Overall Study|Adverse Event|0|||
131629659|NCT01945593|473928749|FG001|Overall Study|Adverse Event|0|||
131629660|NCT01945593|473928750|FG002|Overall Study|Adverse Event|0|||
131629661|NCT01945593|473928751|FG003|Overall Study|Adverse Event|5|||
131629662|NCT01945593|473928748|FG000|Overall Study|Physician Decision|0|||
131629663|NCT01945593|473928749|FG001|Overall Study|Physician Decision|0|||
131629664|NCT01945593|473928750|FG002|Overall Study|Physician Decision|1|||
131629665|NCT01945593|473928751|FG003|Overall Study|Physician Decision|1|||
131797860|NCT00984295|474543451|FG000|Overall Study|Withdrawal by Subject|18|||
131797861|NCT00984295|474543452|FG001|Overall Study|Withdrawal by Subject|9|||
131797862|NCT00984295|474543453|FG002|Overall Study|Withdrawal by Subject|12|||
131629666|NCT01945593|473928748|FG000|Overall Study|Withdrawal by Subject|0|||
131629667|NCT01945593|473928749|FG001|Overall Study|Withdrawal by Subject|2|||
131629668|NCT01945593|473928750|FG002|Overall Study|Withdrawal by Subject|0|||
131797863|NCT00984295|474543451|FG000|Overall Study|CAE - discontinued test vaccine|0|||
131629669|NCT01945593|473928751|FG003|Overall Study|Withdrawal by Subject|4|||
131629670|NCT01945593|473928748|FG000|Overall Study|Protocol Violation|0|||
131712892|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712893|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712894|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712895|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712896|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712897|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
131712898|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712899|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712900|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131712901|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131629671|NCT01945593|473928749|FG001|Overall Study|Protocol Violation|2|||
131712902|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
131712903|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
131712904|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131712905|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131712906|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
131712907|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
131712908|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131712909|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131712910|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712911|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712912|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712913|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
131712914|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712915|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712916|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131629672|NCT01945593|473928750|FG002|Overall Study|Protocol Violation|1|||
131629673|NCT01945593|473928751|FG003|Overall Study|Protocol Violation|3|||
131629674|NCT01945593|473928748|FG000|Overall Study|Death|0|||
131629675|NCT01945593|473928749|FG001|Overall Study|Death|0|||
131629676|NCT01945593|473928750|FG002|Overall Study|Death|1|||
131629677|NCT01945593|473928751|FG003|Overall Study|Death|0|||
131629678|NCT01945593|473928748|FG000|Overall Study|Other: Terminated|0|||
131629679|NCT01945593|473928749|FG001|Overall Study|Other: Terminated|0|||
131629680|NCT01945593|473928750|FG002|Overall Study|Other: Terminated|0|||
131629681|NCT01945593|473928751|FG003|Overall Study|Other: Terminated|1|||
131629682|NCT01945593|473928748|FG000|Overall Study|Other: Surgical Procedure|0|||
131712917|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712918|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131712919|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
131712920|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
131712921|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
131712922|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
131712923|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
131712924|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
131712925|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
131712926|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
131712927|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
131712928|NCT01307423|474226315|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712929|NCT01307423|474226316|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712930|NCT01307423|474226317|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712931|NCT01307423|474226318|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712932|NCT01307423|474226319|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712933|NCT01307423|474226320|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
131712934|NCT01307423|474226321|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712935|NCT01307423|474226322|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712936|NCT01307423|474226323|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131712937|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131712938|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
131712939|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
131712940|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131712941|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131712942|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131712943|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131629683|NCT01945593|473928749|FG001|Overall Study|Other: Surgical Procedure|2|||
131629684|NCT01945593|473928750|FG002|Overall Study|Other: Surgical Procedure|0|||
131712944|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
131629685|NCT01945593|473928751|FG003|Overall Study|Other: Surgical Procedure|6|||
131629686|NCT01945593|473928748|FG000|Overall Study|Other: Screen Failure|0|||
131629687|NCT01945593|473928749|FG001|Overall Study|Other: Screen Failure|2|||
131629688|NCT01945593|473928750|FG002|Overall Study|Other: Screen Failure|0|||
131629689|NCT01945593|473928751|FG003|Overall Study|Other: Screen Failure|0|||
131629690|NCT03605745|473928752|FG000|Overall Study|Study was terminated for business reasons|47|||
131629691|NCT00828139|473928753|FG000|Overall Study|Adverse Event|8|||
131629692|NCT00828139|473928754|FG001|Overall Study|Adverse Event|1|||
131629693|NCT00828139|473928755|FG002|Overall Study|Adverse Event|10|||
131629694|NCT00828139|473928756|FG003|Overall Study|Adverse Event|5|||
131629695|NCT00828139|473928753|FG000|Overall Study|Death|2|||
131629696|NCT00828139|473928754|FG001|Overall Study|Death|1|||
131629697|NCT00828139|473928755|FG002|Overall Study|Death|0|||
131629698|NCT00828139|473928756|FG003|Overall Study|Death|2|||
131629699|NCT00828139|473928753|FG000|Overall Study|Refusal unrelated to toxicity|3|||
131629700|NCT00828139|473928754|FG001|Overall Study|Refusal unrelated to toxicity|4|||
131629701|NCT00828139|473928755|FG002|Overall Study|Refusal unrelated to toxicity|5|||
131629702|NCT00828139|473928756|FG003|Overall Study|Refusal unrelated to toxicity|3|||
131629703|NCT00828139|473928753|FG000|Overall Study|Disease Progression|24|||
131629704|NCT00828139|473928754|FG001|Overall Study|Disease Progression|33|||
131629705|NCT00828139|473928755|FG002|Overall Study|Disease Progression|35|||
131629706|NCT00828139|473928756|FG003|Overall Study|Disease Progression|39|||
131629707|NCT00828139|473928753|FG000|Overall Study|Other|4|||
131629708|NCT00828139|473928754|FG001|Overall Study|Other|2|||
131629709|NCT00828139|473928755|FG002|Overall Study|Other|5|||
131629710|NCT00828139|473928756|FG003|Overall Study|Other|2|||
131629711|NCT01714947|473928757|FG000|Part B|Progressive Disease|3|||
131629712|NCT01922102|473928758|FG000|Overall Study|Withdrawal by Subject|7|||
131629713|NCT01922102|473928759|FG001|Overall Study|Withdrawal by Subject|3|||
131629714|NCT01922102|473928760|FG002|Overall Study|Withdrawal by Subject|7|||
131629715|NCT01922102|473928758|FG000|Overall Study|Physician Decision|0|||
131629716|NCT01922102|473928759|FG001|Overall Study|Physician Decision|2|||
131629717|NCT01922102|473928760|FG002|Overall Study|Physician Decision|1|||
131629718|NCT01922102|473928758|FG000|Overall Study|Adverse Event|1|||
131629719|NCT01922102|473928759|FG001|Overall Study|Adverse Event|2|||
131629720|NCT01922102|473928760|FG002|Overall Study|Adverse Event|0|||
131629721|NCT01922102|473928758|FG000|Overall Study|Lost to Follow-up|1|||
131629722|NCT01922102|473928759|FG001|Overall Study|Lost to Follow-up|0|||
131629723|NCT01922102|473928760|FG002|Overall Study|Lost to Follow-up|0|||
131629724|NCT01922102|473928758|FG000|Overall Study|Administrative problems|0|||
131629725|NCT01922102|473928759|FG001|Overall Study|Administrative problems|2|||
131629726|NCT01922102|473928760|FG002|Overall Study|Administrative problems|0|||
131629727|NCT03696342|473928761|FG000|Overall Study|Lost to Follow-up|1|||
131629728|NCT03696342|473928762|FG001|Overall Study|Lost to Follow-up|0|||
131629729|NCT05203822|473928763|FG000|Overall Study|Adverse Event|1|||
131629730|NCT05203822|473928763|FG000|Overall Study|Withdrawal by Subject|1|||
131629731|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
131629732|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
131629733|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
131629734|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
131629735|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
131629736|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
131629737|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
131629738|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
131629739|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
131629740|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
131629741|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
131629742|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
131629743|NCT01345253|473928767|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
131629744|NCT01345253|473928768|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
131629745|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
131629746|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
131629747|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
131629748|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
131629749|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
131629750|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
131629751|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
131629752|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
131629753|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
131629754|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
131629755|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
131797864|NCT00984295|474543452|FG001|Overall Study|CAE - discontinued test vaccine|1|||
131629756|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
131629757|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
131629758|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
131629759|NCT01345253|473928767|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
131629760|NCT01345253|473928768|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
131629761|NCT01877720|473928774|FG000|Overall Study|Adverse Event|1|||
131629762|NCT01877720|473928775|FG001|Overall Study|Adverse Event|0|||
131629763|NCT00447499|473928776|FG000|Overall Study|Adverse Event|1|||
131629764|NCT00447499|473928776|FG000|Overall Study|Patient Decision|4|||
131629765|NCT00447499|473928776|FG000|Overall Study|Sponsor Decision|1|||
131629766|NCT00447499|473928776|FG000|Overall Study|Physician Decision|1|||
131629767|NCT02068352|473928777|FG000|Overall Study|Lost to Follow-up|0|||
131629768|NCT02068352|473928778|FG001|Overall Study|Lost to Follow-up|2|||
131629769|NCT02068352|473928779|FG002|Overall Study|Lost to Follow-up|0|||
131629770|NCT02068352|473928777|FG000|Overall Study|Adverse Event|4|||
131629771|NCT02068352|473928778|FG001|Overall Study|Adverse Event|2|||
131629772|NCT02068352|473928779|FG002|Overall Study|Adverse Event|7|||
131629773|NCT02068352|473928777|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
131629774|NCT02068352|473928778|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
131629775|NCT02068352|473928779|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
131629776|NCT02068352|473928777|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
131629777|NCT02068352|473928778|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
131629778|NCT02068352|473928779|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
131629779|NCT02068352|473928777|FG000|Overall Study|Protocol Deviation|0|||
131629780|NCT02068352|473928778|FG001|Overall Study|Protocol Deviation|0|||
131629781|NCT02068352|473928779|FG002|Overall Study|Protocol Deviation|1|||
131629782|NCT01322347|473928780|FG000|Overall Study|Adverse Event|7|||
131629783|NCT01322347|473928781|FG001|Overall Study|Adverse Event|2|||
131629784|NCT01322347|473928780|FG000|Overall Study|Death|5|||
131629785|NCT01322347|473928781|FG001|Overall Study|Death|3|||
131629786|NCT01322347|473928780|FG000|Overall Study|Physician Decision|2|||
131629787|NCT01322347|473928781|FG001|Overall Study|Physician Decision|1|||
131629788|NCT01322347|473928780|FG000|Overall Study|Protocol Violation|5|||
131629789|NCT01322347|473928781|FG001|Overall Study|Protocol Violation|2|||
131629790|NCT01322347|473928780|FG000|Overall Study|Withdrawal by Subject|1|||
131629791|NCT01322347|473928781|FG001|Overall Study|Withdrawal by Subject|4|||
131629792|NCT01322347|473928780|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
131629793|NCT01322347|473928781|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
131629794|NCT01322347|473928780|FG000|Overall Study|blood transfusion|5|||
131629795|NCT01322347|473928781|FG001|Overall Study|blood transfusion|5|||
131629796|NCT01322347|473928780|FG000|Overall Study|sponsor decision|1|||
131629797|NCT01322347|473928781|FG001|Overall Study|sponsor decision|3|||
131629798|NCT01322347|473928780|FG000|Overall Study|ineligible|6|||
131629799|NCT01322347|473928781|FG001|Overall Study|ineligible|3|||
131629800|NCT01322347|473928780|FG000|Overall Study|kidney transplant|3|||
131629801|NCT01322347|473928781|FG001|Overall Study|kidney transplant|1|||
131629802|NCT01322347|473928780|FG000|Overall Study|study drug withheld > 12 wks|0|||
131629803|NCT01322347|473928781|FG001|Overall Study|study drug withheld > 12 wks|1|||
131629804|NCT01322347|473928780|FG000|Overall Study|moved/changed dialysis|2|||
131629805|NCT01322347|473928781|FG001|Overall Study|moved/changed dialysis|4|||
131629806|NCT01369147|473928783|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
131629807|NCT01369147|473928784|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
131629808|NCT01369147|473928785|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
131629809|NCT00648895|473928786|FG000|Overall Study|Lack of Efficacy|0|||
131629810|NCT00648895|473928787|FG001|Overall Study|Lack of Efficacy|1|||
131629811|NCT04626128|473928788|FG000|Overall Study|Withdrawal by Subject|0|||
131629812|NCT04626128|473928789|FG001|Overall Study|Withdrawal by Subject|1|||
131629813|NCT04626128|473928790|FG002|Overall Study|Withdrawal by Subject|0|||
131629814|NCT04626128|473928791|FG003|Overall Study|Withdrawal by Subject|0|||
131629815|NCT01525875|473928792|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
131629816|NCT01525875|473928793|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
131629817|NCT01525875|473928792|FG000|Open-label Period|Lost to Follow-up|0|||
131629818|NCT01525875|473928793|FG001|Open-label Period|Lost to Follow-up|2|||
131629819|NCT00657709|473928794|FG000|Overall Study|AE or Death|7|||
131629820|NCT00657709|473928795|FG001|Overall Study|AE or Death|7|||
131629821|NCT00657709|473928796|FG002|Overall Study|AE or Death|6|||
131629822|NCT00657709|473928797|FG003|Overall Study|AE or Death|7|||
131629823|NCT00657709|473928798|FG004|Overall Study|AE or Death|1|||
131629824|NCT00657709|473928794|FG000|Overall Study|Withdrawal by Subject|7|||
131629825|NCT00657709|473928795|FG001|Overall Study|Withdrawal by Subject|15|||
131629826|NCT00657709|473928796|FG002|Overall Study|Withdrawal by Subject|15|||
131712945|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
131712946|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131629827|NCT00657709|473928797|FG003|Overall Study|Withdrawal by Subject|5|||
131629828|NCT00657709|473928798|FG004|Overall Study|Withdrawal by Subject|9|||
131629829|NCT00657709|473928794|FG000|Overall Study|Lost to Follow-up|9|||
131629830|NCT00657709|473928795|FG001|Overall Study|Lost to Follow-up|9|||
131712947|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
131629831|NCT00657709|473928796|FG002|Overall Study|Lost to Follow-up|7|||
131902029|NCT03713684|474926923|FG000|Overall Study|Adverse Event|1|||
131902030|NCT03713684|474926924|FG001|Overall Study|Adverse Event|3|||
131902031|NCT03713684|474926925|FG002|Overall Study|Adverse Event|1|||
131902032|NCT03713684|474926926|FG003|Overall Study|Adverse Event|0|||
131902033|NCT03713684|474926923|FG000|Overall Study|Poor compliance to protocol|2|||
131629832|NCT00657709|473928797|FG003|Overall Study|Lost to Follow-up|1|||
131629833|NCT00657709|473928798|FG004|Overall Study|Lost to Follow-up|21|||
131629834|NCT00657709|473928794|FG000|Overall Study|Protocol Violation|0|||
131629835|NCT00657709|473928795|FG001|Overall Study|Protocol Violation|2|||
131629836|NCT00657709|473928796|FG002|Overall Study|Protocol Violation|0|||
131629837|NCT00657709|473928797|FG003|Overall Study|Protocol Violation|1|||
131629838|NCT00657709|473928798|FG004|Overall Study|Protocol Violation|2|||
131629839|NCT02959866|473928799|FG000|Overall Study|Withdrawal by Subject|1|||
131629840|NCT00952523|473928800|FG000|Overall Study|Withdrawal by Subject|7|||
131629841|NCT05265247|473928801|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
131629842|NCT05265247|473928802|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
131629843|NCT05265247|473928801|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
131629844|NCT05265247|473928802|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
131629845|NCT05265247|473928801|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
131629846|NCT05265247|473928802|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
131629847|NCT01029925|473928803|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
131629848|NCT01029925|473928803|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
131629849|NCT01029925|473928803|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
131629850|NCT00409747|473928806|FG000|Overall Study|Withdrawal by Subject|1|||
131629851|NCT02555397|473928811|FG000|Overall Study|Withdrawal by Subject|1|||
131629852|NCT02555397|473928812|FG001|Overall Study|Withdrawal by Subject|0|||
131629853|NCT02555397|473928813|FG002|Overall Study|Withdrawal by Subject|0|||
131629854|NCT02555397|473928814|FG003|Overall Study|Withdrawal by Subject|0|||
131629855|NCT02555397|473928815|FG004|Overall Study|Withdrawal by Subject|0|||
131629856|NCT00321555|473928816|FG000|Overall Study|Developed antibodies|1|||
131629857|NCT00321555|473928816|FG000|Overall Study|Switched to alternative treatment|3|||
131629858|NCT00321555|473928816|FG000|Overall Study|Physician Decision|1|||
131629859|NCT00321555|473928816|FG000|Overall Study|Disease progression on study|1|||
131629860|NCT00537914|473928817|FG000|Overall Study|Death|1|||
131629861|NCT00537914|473928817|FG000|Overall Study|Adverse Event|7|||
131629862|NCT00537914|473928817|FG000|Overall Study|Treatment failure|10|||
131629863|NCT00537914|473928817|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
131629864|NCT00537914|473928817|FG000|Overall Study|Lost to Follow-up|19|||
131629865|NCT00537914|473928817|FG000|Overall Study|Withdrawal of informed consent|59|||
131629866|NCT02312258|473928818|FG000|Overall Study|Lost to Follow-up|8|||
131629867|NCT02312258|473928819|FG001|Overall Study|Lost to Follow-up|8|||
131629868|NCT02312258|473928818|FG000|Overall Study|Withdrawal by Patient|49|||
131629869|NCT02312258|473928819|FG001|Overall Study|Withdrawal by Patient|76|||
131629870|NCT02312258|473928818|FG000|Overall Study|Reason not Specified|107|||
131629871|NCT02312258|473928819|FG001|Overall Study|Reason not Specified|159|||
131629872|NCT02312258|473928818|FG000|Overall Study|Missing|2|||
131629873|NCT02312258|473928819|FG001|Overall Study|Missing|1|||
131629874|NCT02312258|473928818|FG000|Overall Study|Death|115|||
131629875|NCT02312258|473928819|FG001|Overall Study|Death|181|||
131629876|NCT01468597|473928821|FG000|Overall Study|Found ineligible|17|||
131629877|NCT01468597|473928821|FG000|Overall Study|concomitant valves|12|||
131629878|NCT01468597|473928821|FG000|Overall Study|off-pump CABG|1|||
131629879|NCT01468597|473928821|FG000|Overall Study|no platelet function data|5|||
131629880|NCT03547167|473928827|FG000|Overall Study|Withdrawal by Subject|34|||
131629881|NCT03547167|473928828|FG001|Overall Study|Withdrawal by Subject|12|||
131629882|NCT03547167|473928827|FG000|Overall Study|Screen Failure|0|||
131629883|NCT03547167|473928828|FG001|Overall Study|Screen Failure|1|||
131629884|NCT03547167|473928827|FG000|Overall Study|Lost to Follow-up|59|||
131629885|NCT03547167|473928828|FG001|Overall Study|Lost to Follow-up|15|||
131629886|NCT03547167|473928827|FG000|Overall Study|Death|4|||
131629887|NCT03547167|473928828|FG001|Overall Study|Death|2|||
131629888|NCT00866619|473928829|FG000|Overall Study|Adverse Event|112|||
131629889|NCT00866619|473928830|FG001|Overall Study|Adverse Event|106|||
131629890|NCT00866619|473928831|FG002|Overall Study|Adverse Event|47|||
131629891|NCT00866619|473928832|FG003|Overall Study|Adverse Event|44|||
131629892|NCT00866619|473928829|FG000|Overall Study|Protocol Violation|2|||
131629893|NCT00866619|473928830|FG001|Overall Study|Protocol Violation|39|||
131629894|NCT00866619|473928831|FG002|Overall Study|Protocol Violation|2|||
131629895|NCT00866619|473928832|FG003|Overall Study|Protocol Violation|17|||
131629896|NCT00866619|473928829|FG000|Overall Study|Withdrawal by Subject|587|||
131629897|NCT00866619|473928830|FG001|Overall Study|Withdrawal by Subject|295|||
131629898|NCT00866619|473928831|FG002|Overall Study|Withdrawal by Subject|272|||
131629899|NCT00866619|473928832|FG003|Overall Study|Withdrawal by Subject|144|||
131629900|NCT00866619|473928829|FG000|Overall Study|Lost to Follow-up|1145|||
131629901|NCT00866619|473928830|FG001|Overall Study|Lost to Follow-up|830|||
131629902|NCT00866619|473928831|FG002|Overall Study|Lost to Follow-up|568|||
131902034|NCT03713684|474926924|FG001|Overall Study|Poor compliance to protocol|1|||
131629903|NCT00866619|473928832|FG003|Overall Study|Lost to Follow-up|425|||
131629904|NCT00645411|473928833|FG000|Overall Study|Adverse Event|0|||
131629905|NCT00645411|473928834|FG001|Overall Study|Adverse Event|0|||
131629906|NCT00645411|473928835|FG002|Overall Study|Adverse Event|0|||
131629907|NCT00645411|473928836|FG003|Overall Study|Adverse Event|2|||
131629908|NCT00645411|473928833|FG000|Overall Study|Withdrawal by Subject|2|||
131629909|NCT00645411|473928834|FG001|Overall Study|Withdrawal by Subject|1|||
131629910|NCT00645411|473928835|FG002|Overall Study|Withdrawal by Subject|19|||
131629911|NCT00645411|473928836|FG003|Overall Study|Withdrawal by Subject|21|||
131629912|NCT00645411|473928833|FG000|Overall Study|Lost to Follow-up|10|||
131712948|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
131712949|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131712950|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131712951|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131712952|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131712953|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
131712954|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
131712955|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712956|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712957|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
131712958|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712959|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712960|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712961|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712962|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712963|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131712964|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131712965|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
131712966|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
131712967|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131712968|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131712969|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131712970|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131712971|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
131712972|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
131712973|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131712974|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131712975|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131712976|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131712977|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131712978|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131712979|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131712980|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131712981|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131712982|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131712983|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
131712984|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
131712985|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131712986|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131712987|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131712988|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131712989|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
131712990|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
131712991|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131804487|NCT03603314|474568542|FG002|Overall Study|Lost to Follow-up|0|||
131804488|NCT03603314|474568540|FG000|Overall Study|Protocol Violation|0|||
131804489|NCT03603314|474568541|FG001|Overall Study|Protocol Violation|1|||
131804490|NCT03603314|474568542|FG002|Overall Study|Protocol Violation|0|||
131804491|NCT03603314|474568540|FG000|Overall Study|Adverse Event|2|||
131804492|NCT03603314|474568541|FG001|Overall Study|Adverse Event|0|||
131804493|NCT03603314|474568542|FG002|Overall Study|Adverse Event|0|||
131804494|NCT03603314|474568540|FG000|Overall Study|Physician Decision|1|||
131804495|NCT03603314|474568541|FG001|Overall Study|Physician Decision|1|||
131804496|NCT03603314|474568542|FG002|Overall Study|Physician Decision|0|||
131804497|NCT03603314|474568540|FG000|Overall Study|Withdrawal by Subject|4|||
131804498|NCT03603314|474568541|FG001|Overall Study|Withdrawal by Subject|5|||
131804499|NCT03603314|474568542|FG002|Overall Study|Withdrawal by Subject|3|||
131804500|NCT03603314|474568540|FG000|Overall Study|Other|0|||
131804501|NCT03603314|474568541|FG001|Overall Study|Other|1|||
131804502|NCT03603314|474568542|FG002|Overall Study|Other|0|||
131804503|NCT03450070|474568543|FG000|Overall Study|Withdrawal by Subject|8|||
131629913|NCT00645411|473928834|FG001|Overall Study|Lost to Follow-up|5|||
131629914|NCT00645411|473928835|FG002|Overall Study|Lost to Follow-up|124|||
131629915|NCT00645411|473928836|FG003|Overall Study|Lost to Follow-up|75|||
131629916|NCT00645411|473928833|FG000|Overall Study|Protocol Violation|1|||
131629917|NCT00645411|473928834|FG001|Overall Study|Protocol Violation|0|||
131629918|NCT00645411|473928835|FG002|Overall Study|Protocol Violation|1|||
131629919|NCT00645411|473928836|FG003|Overall Study|Protocol Violation|0|||
131629920|NCT00645411|473928833|FG000|Overall Study|Inappropriate enrollment|0|||
131629921|NCT00645411|473928834|FG001|Overall Study|Inappropriate enrollment|0|||
131629922|NCT00645411|473928835|FG002|Overall Study|Inappropriate enrollment|4|||
131629923|NCT00645411|473928836|FG003|Overall Study|Inappropriate enrollment|1|||
131629924|NCT00645411|473928833|FG000|Overall Study|Unable to classify|0|||
131629925|NCT00645411|473928834|FG001|Overall Study|Unable to classify|0|||
131629926|NCT00645411|473928835|FG002|Overall Study|Unable to classify|3|||
131629927|NCT00645411|473928836|FG003|Overall Study|Unable to classify|4|||
131629928|NCT02892019|473928839|FG000|Overall Study|randomized but not treated|0|||
131629929|NCT02892019|473928840|FG001|Overall Study|randomized but not treated|1|||
131629930|NCT02892019|473928839|FG000|Overall Study|Withdrawal by Subject|0|||
131629931|NCT02892019|473928840|FG001|Overall Study|Withdrawal by Subject|1|||
131629932|NCT02892019|473928839|FG000|Overall Study|Adverse Event|1|||
131629933|NCT02892019|473928840|FG001|Overall Study|Adverse Event|1|||
131629934|NCT01313663|473928841|FG000|Overall Study|Study Closed/Terminated|2|||
131629935|NCT01313663|473928842|FG001|Overall Study|Study Closed/Terminated|4|||
131629936|NCT01313663|473928841|FG000|Overall Study|Lost to Follow-up|0|||
131629937|NCT01313663|473928842|FG001|Overall Study|Lost to Follow-up|1|||
131629938|NCT01313663|473928841|FG000|Overall Study|Physician Decision|0|||
131629939|NCT01313663|473928842|FG001|Overall Study|Physician Decision|2|||
131629940|NCT01313663|473928841|FG000|Overall Study|Withdrawal by Subject|2|||
131629941|NCT01313663|473928842|FG001|Overall Study|Withdrawal by Subject|1|||
131629942|NCT02138838|473928843|FG000|Overall Study|Study Closure|7|||
131629943|NCT02138838|473928844|FG001|Overall Study|Study Closure|6|||
131629944|NCT02138838|473928843|FG000|Overall Study|Withdrawal by Subject|1|||
131629945|NCT02138838|473928844|FG001|Overall Study|Withdrawal by Subject|5|||
131629946|NCT00518206|473928845|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
131629947|NCT00518206|473928846|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
131629948|NCT00518206|473928845|FG000|Overall Study|Withdrawal by Subject|2|||
131629949|NCT00518206|473928846|FG001|Overall Study|Withdrawal by Subject|0|||
131629950|NCT00518206|473928845|FG000|Overall Study|Drug Supply Issue|1|||
131629951|NCT00518206|473928846|FG001|Overall Study|Drug Supply Issue|0|||
131629952|NCT00518206|473928845|FG000|Overall Study|Reason Unknown|1|||
131629953|NCT00518206|473928846|FG001|Overall Study|Reason Unknown|0|||
131629954|NCT00518206|473928845|FG000|Overall Study|Completion Status Unknown|1|||
131629955|NCT00518206|473928846|FG001|Overall Study|Completion Status Unknown|0|||
131629956|NCT01199302|473928850|FG000|Overall Study|Adverse Event|1|||
131629957|NCT01199302|473928851|FG001|Overall Study|Adverse Event|1|||
131629958|NCT01199302|473928852|FG002|Overall Study|Adverse Event|2|||
131629959|NCT01199302|473928853|FG003|Overall Study|Adverse Event|0|||
131629960|NCT01199302|473928850|FG000|Overall Study|Withdrawal by Subject|2|||
131629961|NCT01199302|473928851|FG001|Overall Study|Withdrawal by Subject|2|||
131629962|NCT01199302|473928852|FG002|Overall Study|Withdrawal by Subject|3|||
131629963|NCT01199302|473928853|FG003|Overall Study|Withdrawal by Subject|0|||
131629964|NCT01199302|473928850|FG000|Overall Study|Disease Progression|3|||
131629965|NCT01199302|473928851|FG001|Overall Study|Disease Progression|4|||
131629966|NCT01199302|473928852|FG002|Overall Study|Disease Progression|4|||
131629967|NCT01199302|473928853|FG003|Overall Study|Disease Progression|2|||
131629968|NCT01199302|473928850|FG000|Overall Study|Study Termination|13|||
131629969|NCT01199302|473928851|FG001|Overall Study|Study Termination|8|||
131629970|NCT01199302|473928852|FG002|Overall Study|Study Termination|11|||
131629971|NCT01199302|473928853|FG003|Overall Study|Study Termination|9|||
131629972|NCT01199302|473928850|FG000|Overall Study|Lost to Follow-up|0|||
131629973|NCT01199302|473928851|FG001|Overall Study|Lost to Follow-up|1|||
131629974|NCT01199302|473928852|FG002|Overall Study|Lost to Follow-up|0|||
131629975|NCT01199302|473928853|FG003|Overall Study|Lost to Follow-up|0|||
131629976|NCT01199302|473928850|FG000|Overall Study|Other|1|||
131629977|NCT01199302|473928851|FG001|Overall Study|Other|0|||
131629978|NCT01199302|473928852|FG002|Overall Study|Other|0|||
131629979|NCT01199302|473928853|FG003|Overall Study|Other|0|||
131629980|NCT01634165|473928856|FG000|Period 2|Adverse Event|0|||
131629981|NCT01634165|473928857|FG001|Period 2|Adverse Event|1|||
131629982|NCT01634165|473928858|FG002|Period 2|Adverse Event|0|||
131629983|NCT01634165|473928859|FG003|Period 2|Adverse Event|0|||
131629984|NCT03820024|473928860|FG000|Overall Study|Physician Decision|1|||
131629985|NCT03820024|473928861|FG001|Overall Study|Physician Decision|2|||
131629986|NCT00760877|473930455|FG000|Overall Study|Protocol Violation|1|||
131629987|NCT00760877|473930456|FG001|Overall Study|Protocol Violation|0|||
131629988|NCT00760877|473930455|FG000|Overall Study|Non-compliance with protocol treatment|2|||
131629989|NCT00760877|473930456|FG001|Overall Study|Non-compliance with protocol treatment|1|||
131629990|NCT00760877|473930455|FG000|Overall Study|Pregnancy|1|||
131629991|NCT00760877|473930456|FG001|Overall Study|Pregnancy|4|||
131629992|NCT00760877|473930455|FG000|Overall Study|Death|2|||
131629993|NCT00760877|473930456|FG001|Overall Study|Death|1|||
131629994|NCT00760877|473930455|FG000|Overall Study|Withdrawal by Subject|7|||
131629995|NCT00760877|473930456|FG001|Overall Study|Withdrawal by Subject|3|||
131629996|NCT00760877|473930455|FG000|Overall Study|Adverse Event|19|||
131629997|NCT00760877|473930456|FG001|Overall Study|Adverse Event|12|||
131629998|NCT00760877|473930455|FG000|Overall Study|Participant diagnosed with AML|0|||
131629999|NCT00760877|473930456|FG001|Overall Study|Participant diagnosed with AML|1|||
131630000|NCT00760877|473930455|FG000|Overall Study|Participant not eligible to cross-over|0|||
131630001|NCT00760877|473930456|FG001|Overall Study|Participant not eligible to cross-over|1|||
131630002|NCT00760877|473930455|FG000|Overall Study|Physician Decision|1|||
131630003|NCT00760877|473930456|FG001|Overall Study|Physician Decision|2|||
131630004|NCT00760877|473930455|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
131797865|NCT00984295|474543453|FG002|Overall Study|CAE - discontinued test vaccine|3|||
131630005|NCT00760877|473930456|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
131630006|NCT00760877|473930455|FG000|Overall Study|Treatment failure|1|||
131630007|NCT00760877|473930456|FG001|Overall Study|Treatment failure|0|||
131630008|NCT00711555|473930457|FG000|Overall Study|Adverse Event|3|||
131630009|NCT05379400|473930461|FG000|Overall Study|Lost to Follow-up|1|||
131630010|NCT05379400|473930462|FG001|Overall Study|Lost to Follow-up|1|||
131630011|NCT05356130|473930464|FG000|Overall Study|Withdrawal by Subject|0|||
131630012|NCT05356130|473930465|FG001|Overall Study|Withdrawal by Subject|0|||
131630013|NCT05356130|473930466|FG002|Overall Study|Withdrawal by Subject|3|||
131630014|NCT03141177|473930467|FG000|Overall Study|Death|62|||
131630015|NCT03141177|473930468|FG001|Overall Study|Death|13|||
131630016|NCT03141177|473930469|FG002|Overall Study|Death|84|||
131630017|NCT03141177|473930467|FG000|Overall Study|Participant withdrew consent|9|||
131630018|NCT03141177|473930468|FG001|Overall Study|Participant withdrew consent|2|||
131630019|NCT03141177|473930469|FG002|Overall Study|Participant withdrew consent|13|||
131630020|NCT03141177|473930467|FG000|Overall Study|Not reported|1|||
131630021|NCT03141177|473930468|FG001|Overall Study|Not reported|0|||
131630022|NCT03141177|473930469|FG002|Overall Study|Not reported|1|||
131630023|NCT03141177|473930467|FG000|Overall Study|Lost to Follow-up|2|||
131630024|NCT03141177|473930468|FG001|Overall Study|Lost to Follow-up|1|||
131630025|NCT03141177|473930469|FG002|Overall Study|Lost to Follow-up|1|||
131630026|NCT03141177|473930467|FG000|Overall Study|Other reasons|4|||
131630027|NCT03141177|473930468|FG001|Overall Study|Other reasons|0|||
131630028|NCT03141177|473930469|FG002|Overall Study|Other reasons|11|||
131630029|NCT03141177|473930467|FG000|Overall Study|Participants did not start treatment period|3|||
131630030|NCT03141177|473930468|FG001|Overall Study|Participants did not start treatment period|0|||
131630031|NCT03141177|473930469|FG002|Overall Study|Participants did not start treatment period|8|||
131797866|NCT00984295|474543451|FG000|Overall Study|Missed one or more blood samplings|3|||
131797867|NCT00984295|474543452|FG001|Overall Study|Missed one or more blood samplings|7|||
131797868|NCT00984295|474543453|FG002|Overall Study|Missed one or more blood samplings|2|||
131797869|NCT00984295|474543451|FG000|Overall Study|Incomplete safety follow-up|11|||
131797870|NCT00984295|474543452|FG001|Overall Study|Incomplete safety follow-up|2|||
131797871|NCT00984295|474543453|FG002|Overall Study|Incomplete safety follow-up|3|||
131797872|NCT04799158|474543454|FG000|Run-In Period|Adverse Event|6|||
131797873|NCT04799158|474543455|FG001|Run-In Period|Adverse Event|0|||
131797874|NCT04799158|474543456|FG002|Run-In Period|Adverse Event|0|||
131797875|NCT04799158|474543457|FG003|Run-In Period|Adverse Event|0|||
131797876|NCT04799158|474543458|FG004|Run-In Period|Adverse Event|0|||
131797877|NCT04799158|474543454|FG000|Run-In Period|Lost to Follow-up|4|||
131797878|NCT04799158|474543455|FG001|Run-In Period|Lost to Follow-up|0|||
131797879|NCT04799158|474543456|FG002|Run-In Period|Lost to Follow-up|0|||
131797880|NCT04799158|474543457|FG003|Run-In Period|Lost to Follow-up|0|||
131797881|NCT04799158|474543458|FG004|Run-In Period|Lost to Follow-up|0|||
131630032|NCT04049578|473930476|FG000|Overall Study|Physician Decision|1|||
131630033|NCT00409006|473930478|FG000|Overall Study|Death|15|||
131630034|NCT00409006|473930479|FG001|Overall Study|Death|6|||
131630035|NCT00409006|473930478|FG000|Overall Study|Lost to Follow-up|1|||
131630036|NCT00409006|473930479|FG001|Overall Study|Lost to Follow-up|2|||
131630037|NCT00409006|473930478|FG000|Overall Study|Withdrawal by Subject|3|||
131630038|NCT00409006|473930479|FG001|Overall Study|Withdrawal by Subject|2|||
131630039|NCT00409006|473930478|FG000|Overall Study|Physician Decision|1|||
131630040|NCT00409006|473930479|FG001|Overall Study|Physician Decision|2|||
131797882|NCT04799158|474543454|FG000|Run-In Period|Significant Protocol Deviation|1|||
131797883|NCT04799158|474543455|FG001|Run-In Period|Significant Protocol Deviation|0|||
131797884|NCT04799158|474543456|FG002|Run-In Period|Significant Protocol Deviation|0|||
131797885|NCT04799158|474543457|FG003|Run-In Period|Significant Protocol Deviation|0|||
131630041|NCT00228813|473930480|FG000|Overall Study|Death|4|||
131630042|NCT00608959|473930481|FG000|Part 1|Did not meet eligibility criteria|1|||
131630043|NCT01005602|473930482|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
131630044|NCT01005602|473930483|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
131804504|NCT00533273|474568548|FG000|Double-blind|Withdrew consent|0|||
131630045|NCT01248715|473930484|FG000|Overall Study|Not influenza positive|501|||
131630046|NCT01248715|473930485|FG001|Overall Study|Not influenza positive|510|||
131630047|NCT03409276|473930494|FG000|Overall Study|Withdrawal by Subject|0|||
131630048|NCT03409276|473930495|FG001|Overall Study|Withdrawal by Subject|0|||
131630049|NCT03409276|473930496|FG002|Overall Study|Withdrawal by Subject|0|||
131630050|NCT03409276|473930497|FG003|Overall Study|Withdrawal by Subject|0|||
131630051|NCT03409276|473930498|FG004|Overall Study|Withdrawal by Subject|1|||
131630052|NCT03409276|473930494|FG000|Overall Study|Lost to Follow-up|0|||
131630053|NCT03409276|473930495|FG001|Overall Study|Lost to Follow-up|0|||
131630054|NCT03409276|473930496|FG002|Overall Study|Lost to Follow-up|0|||
131630055|NCT03409276|473930497|FG003|Overall Study|Lost to Follow-up|2|||
131630056|NCT03409276|473930498|FG004|Overall Study|Lost to Follow-up|2|||
131630057|NCT03344458|473930503|FG000|Overall Study|Physician Decision|1|||
131630058|NCT03344458|473930503|FG000|Overall Study|Withdrawal by Subject|16|||
131630059|NCT03344458|473930503|FG000|Overall Study|Other reasons|10|||
131630060|NCT03344458|473930503|FG000|Overall Study|Lost to Follow-up|9|||
131630061|NCT03344458|473930503|FG000|Overall Study|Protocol Violation|3|||
131630062|NCT03884478|473930504|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
131630063|NCT03884478|473930505|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
131630064|NCT03884478|473930506|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
131630065|NCT03884478|473930504|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
131630066|NCT03884478|473930505|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
131630067|NCT03884478|473930506|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
131630068|NCT03884478|473930504|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
131630069|NCT03884478|473930505|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
131630070|NCT03884478|473930506|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
131630071|NCT03884478|473930504|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
131630072|NCT03884478|473930505|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
131630073|NCT03884478|473930506|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
131630074|NCT01807234|473930509|FG000|Overall Study|Lost to Follow-up|2|||
131630075|NCT01807234|473930510|FG001|Overall Study|Lost to Follow-up|5|||
131630076|NCT01807234|473930511|FG002|Overall Study|Lost to Follow-up|1|||
131630077|NCT01807234|473930512|FG003|Overall Study|Lost to Follow-up|1|||
131630078|NCT01807234|473930513|FG004|Overall Study|Lost to Follow-up|1|||
131630079|NCT01807234|473930514|FG005|Overall Study|Lost to Follow-up|2|||
131630080|NCT01807234|473930509|FG000|Overall Study|Withdrawal by Subject|3|||
131630081|NCT01807234|473930510|FG001|Overall Study|Withdrawal by Subject|1|||
131630082|NCT01807234|473930511|FG002|Overall Study|Withdrawal by Subject|1|||
131630083|NCT01807234|473930512|FG003|Overall Study|Withdrawal by Subject|1|||
131630084|NCT01807234|473930513|FG004|Overall Study|Withdrawal by Subject|2|||
131630085|NCT01807234|473930514|FG005|Overall Study|Withdrawal by Subject|1|||
131630086|NCT01807234|473930509|FG000|Overall Study|Lack of Efficacy|0|||
131630087|NCT01807234|473930510|FG001|Overall Study|Lack of Efficacy|0|||
131630088|NCT01807234|473930511|FG002|Overall Study|Lack of Efficacy|0|||
131630089|NCT01807234|473930512|FG003|Overall Study|Lack of Efficacy|0|||
131630090|NCT01807234|473930513|FG004|Overall Study|Lack of Efficacy|1|||
131630091|NCT01807234|473930514|FG005|Overall Study|Lack of Efficacy|1|||
131630092|NCT00538629|473930515|FG000|Overall Study|At subject's request|1|||
131630093|NCT00538629|473930515|FG000|Overall Study|Adverse Event|2|||
131630094|NCT00538629|473930515|FG000|Overall Study|Lack of Efficacy|12|||
131630095|NCT00538629|473930515|FG000|Overall Study|Lost to Follow-up|6|||
131630096|NCT00538629|473930515|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
131630097|NCT04454125|473930516|FG000|Overall Study|Lost to Follow-up|0|||
131630098|NCT04454125|473930517|FG001|Overall Study|Lost to Follow-up|1|||
131630099|NCT00555620|473930523|FG000|Overall Study|Death|0|||
131630100|NCT00555620|473930524|FG001|Overall Study|Death|1|||
131630101|NCT00555620|473930525|FG002|Overall Study|Death|0|||
131630102|NCT00555620|473930526|FG003|Overall Study|Death|0|||
131630103|NCT00555620|473930527|FG004|Overall Study|Death|0|||
131630104|NCT00555620|473930528|FG005|Overall Study|Death|1|||
131630105|NCT00555620|473930523|FG000|Overall Study|Study terminated by sponsor|0|||
131630106|NCT00555620|473930524|FG001|Overall Study|Study terminated by sponsor|0|||
131630107|NCT00555620|473930525|FG002|Overall Study|Study terminated by sponsor|1|||
131630108|NCT00555620|473930526|FG003|Overall Study|Study terminated by sponsor|0|||
131630109|NCT00555620|473930527|FG004|Overall Study|Study terminated by sponsor|0|||
131630110|NCT00555620|473930528|FG005|Overall Study|Study terminated by sponsor|0|||
131630111|NCT00555620|473930523|FG000|Overall Study|Adverse Event|0|||
131630112|NCT00555620|473930524|FG001|Overall Study|Adverse Event|0|||
131630113|NCT00555620|473930525|FG002|Overall Study|Adverse Event|1|||
131630114|NCT00555620|473930526|FG003|Overall Study|Adverse Event|5|||
131630115|NCT00555620|473930527|FG004|Overall Study|Adverse Event|0|||
131630116|NCT00555620|473930528|FG005|Overall Study|Adverse Event|1|||
131630117|NCT00555620|473930523|FG000|Overall Study|Objective progression or relapse|6|||
131630118|NCT00555620|473930524|FG001|Overall Study|Objective progression or relapse|5|||
131630119|NCT00555620|473930525|FG002|Overall Study|Objective progression or relapse|12|||
131630120|NCT00555620|473930526|FG003|Overall Study|Objective progression or relapse|17|||
131630121|NCT00555620|473930527|FG004|Overall Study|Objective progression or relapse|3|||
131630122|NCT00555620|473930528|FG005|Overall Study|Objective progression or relapse|16|||
131630123|NCT00555620|473930523|FG000|Overall Study|Participant refused treatment|0|||
131444244|NCT02903771|473257107|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
131630124|NCT00555620|473930524|FG001|Overall Study|Participant refused treatment|1|||
131630125|NCT00555620|473930525|FG002|Overall Study|Participant refused treatment|1|||
131630126|NCT00555620|473930526|FG003|Overall Study|Participant refused treatment|0|||
131630127|NCT00555620|473930527|FG004|Overall Study|Participant refused treatment|0|||
131630128|NCT00555620|473930528|FG005|Overall Study|Participant refused treatment|1|||
131630129|NCT00555620|473930523|FG000|Overall Study|Other|0|||
131630130|NCT00555620|473930524|FG001|Overall Study|Other|0|||
131630131|NCT00555620|473930525|FG002|Overall Study|Other|0|||
131630132|NCT00555620|473930526|FG003|Overall Study|Other|1|||
131630133|NCT00555620|473930527|FG004|Overall Study|Other|0|||
131630134|NCT00555620|473930528|FG005|Overall Study|Other|3|||
131630135|NCT05361304|473930534|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
131630136|NCT05361304|473930535|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
131630137|NCT05361304|473930534|FG000|Overall Study|COVID-19 Related|1|||
131630138|NCT05361304|473930535|FG001|Overall Study|COVID-19 Related|2|||
131630139|NCT05361304|473930534|FG000|Overall Study|Withdrawal by Subject|1|||
131630140|NCT05361304|473930535|FG001|Overall Study|Withdrawal by Subject|0|||
131630141|NCT01816165|473930536|FG000|Overall Study|Adverse Event|1|||
131630142|NCT01816165|473930537|FG001|Overall Study|Adverse Event|0|||
131630143|NCT01816165|473930538|FG002|Overall Study|Adverse Event|0|||
131630144|NCT01816165|473930539|FG003|Overall Study|Adverse Event|0|||
131630145|NCT00946088|473930540|FG000|Overall Study|Withdrawal by Subject|0|||
131630146|NCT00946088|473930541|FG001|Overall Study|Withdrawal by Subject|1|||
131630147|NCT04883541|473930542|FG000|Overall Study|Not attending regular yoga class|16|||
131630148|NCT04883541|473930543|FG001|Overall Study|Not attending regular yoga class|0|||
131630149|NCT04883541|473930542|FG000|Overall Study|Not attending the pregnancy school|0|||
131630150|NCT04883541|473930543|FG001|Overall Study|Not attending the pregnancy school|9|||
131630151|NCT04239911|473930547|FG000|Overall Study|Lost to Follow-up|2|||
131630152|NCT04239911|473930548|FG001|Overall Study|Lost to Follow-up|1|||
131630153|NCT02092909|473930558|FG000|Overall Study|Adverse Event|0|||
131630154|NCT02092909|473930559|FG001|Overall Study|Adverse Event|0|||
131630155|NCT02092909|473930560|FG002|Overall Study|Adverse Event|4|||
131630156|NCT02092909|473930561|FG003|Overall Study|Adverse Event|2|||
131630157|NCT02092909|473930558|FG000|Overall Study|Lack of Efficacy|0|||
131630158|NCT02092909|473930559|FG001|Overall Study|Lack of Efficacy|2|||
131630159|NCT02092909|473930560|FG002|Overall Study|Lack of Efficacy|1|||
131630160|NCT02092909|473930561|FG003|Overall Study|Lack of Efficacy|0|||
131630161|NCT02092909|473930558|FG000|Overall Study|Withdrawal by Subject|0|||
131630162|NCT02092909|473930559|FG001|Overall Study|Withdrawal by Subject|0|||
131630163|NCT02092909|473930560|FG002|Overall Study|Withdrawal by Subject|2|||
131630164|NCT02092909|473930561|FG003|Overall Study|Withdrawal by Subject|1|||
131630165|NCT02092909|473930558|FG000|Overall Study|Study terminated by Sponsor|0|||
131712992|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
131712993|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
131712994|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131712995|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131630166|NCT02092909|473930559|FG001|Overall Study|Study terminated by Sponsor|0|||
131630167|NCT02092909|473930560|FG002|Overall Study|Study terminated by Sponsor|0|||
131630168|NCT02092909|473930561|FG003|Overall Study|Study terminated by Sponsor|2|||
131630169|NCT02092909|473930558|FG000|Overall Study|Miscellaneous|1|||
131630170|NCT02092909|473930559|FG001|Overall Study|Miscellaneous|1|||
131630171|NCT02092909|473930560|FG002|Overall Study|Miscellaneous|2|||
131630172|NCT02092909|473930561|FG003|Overall Study|Miscellaneous|1|||
131630173|NCT02865083|473930562|FG000|Overall Study|Early Termination|3|||
131444245|NCT02903771|473257108|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
131630174|NCT02865083|473930563|FG001|Overall Study|Early Termination|1|||
131630175|NCT01182285|473930564|FG000|First Intervention Week 1-10|Disease progression|1|||
131630176|NCT01182285|473930565|FG001|First Intervention Week 1-10|Disease progression|0|||
131630177|NCT01182285|473930566|FG002|First Intervention Week 1-10|Disease progression|0|||
131630178|NCT01182285|473930564|FG000|First Intervention Week 1-10|Adverse Event|1|||
131630179|NCT01182285|473930565|FG001|First Intervention Week 1-10|Adverse Event|0|||
131630180|NCT01182285|473930566|FG002|First Intervention Week 1-10|Adverse Event|0|||
131630181|NCT01182285|473930564|FG000|First Intervention Week 1-10|Non-compliance|1|||
131630182|NCT01182285|473930565|FG001|First Intervention Week 1-10|Non-compliance|0|||
131630183|NCT01182285|473930566|FG002|First Intervention Week 1-10|Non-compliance|0|||
131630184|NCT01182285|473930564|FG000|Third Intervention Week 11-52|Disease Progression|0|||
131630185|NCT01182285|473930565|FG001|Third Intervention Week 11-52|Disease Progression|0|||
131630186|NCT01182285|473930566|FG002|Third Intervention Week 11-52|Disease Progression|6|||
131630187|NCT01182285|473930564|FG000|Third Intervention Week 11-52|Other|0|||
131630188|NCT01182285|473930565|FG001|Third Intervention Week 11-52|Other|0|||
131630189|NCT01182285|473930566|FG002|Third Intervention Week 11-52|Other|2|||
131630190|NCT00841321|473930567|FG000|Overall Study|Lost to Follow-up|1|||
131630191|NCT00841321|473930568|FG001|Overall Study|Lost to Follow-up|1|||
131630192|NCT00841321|473930567|FG000|Overall Study|Adverse Event|0|||
131630193|NCT00841321|473930568|FG001|Overall Study|Adverse Event|2|||
131630194|NCT00379210|473930571|FG000|Overall Study|Withdrawal by Subject|10|||
131630195|NCT00379210|473930572|FG001|Overall Study|Withdrawal by Subject|7|||
131630196|NCT01358175|473930573|FG000|Overall Study|Death|1|||
131630197|NCT01358175|473930574|FG001|Overall Study|Death|0|||
131630198|NCT01358175|473930575|FG002|Overall Study|Death|1|||
131630199|NCT01358175|473930573|FG000|Overall Study|Withdrawal by Subject|9|||
131630200|NCT01358175|473930574|FG001|Overall Study|Withdrawal by Subject|5|||
131630201|NCT01358175|473930575|FG002|Overall Study|Withdrawal by Subject|10|||
131630202|NCT01358175|473930573|FG000|Overall Study|Technical issues|0|||
131630203|NCT01358175|473930574|FG001|Overall Study|Technical issues|1|||
131630204|NCT01358175|473930575|FG002|Overall Study|Technical issues|0|||
131630205|NCT01358175|473930573|FG000|Overall Study|Pregnancy|0|||
131630206|NCT01358175|473930574|FG001|Overall Study|Pregnancy|1|||
131630207|NCT01358175|473930575|FG002|Overall Study|Pregnancy|0|||
131630208|NCT01358175|473930573|FG000|Overall Study|Physician Decision|1|||
131630209|NCT01358175|473930574|FG001|Overall Study|Physician Decision|0|||
131630210|NCT01358175|473930575|FG002|Overall Study|Physician Decision|0|||
131630211|NCT01358175|473930573|FG000|Overall Study|Non Compliance with Study Treatment|0|||
131630212|NCT01358175|473930574|FG001|Overall Study|Non Compliance with Study Treatment|1|||
131630213|NCT01358175|473930575|FG002|Overall Study|Non Compliance with Study Treatment|1|||
131630214|NCT01358175|473930573|FG000|Overall Study|Lost to Follow-up|1|||
131630215|NCT01358175|473930574|FG001|Overall Study|Lost to Follow-up|1|||
131630216|NCT01358175|473930575|FG002|Overall Study|Lost to Follow-up|3|||
131902035|NCT03713684|474926925|FG002|Overall Study|Poor compliance to protocol|0|||
131630217|NCT01358175|473930573|FG000|Overall Study|Lack of Efficacy|3|||
131630218|NCT01358175|473930574|FG001|Overall Study|Lack of Efficacy|8|||
131630219|NCT01358175|473930575|FG002|Overall Study|Lack of Efficacy|6|||
131630220|NCT01358175|473930573|FG000|Overall Study|Adverse Event|6|||
131630221|NCT01358175|473930574|FG001|Overall Study|Adverse Event|11|||
131630222|NCT01358175|473930575|FG002|Overall Study|Adverse Event|11|||
131630223|NCT05072795|473930576|FG000|Overall Study|Lost to Follow-up|5|||
131630224|NCT00821093|473930577|FG000|Overall Study|Adverse Event|20|||
131630225|NCT00821093|473930578|FG001|Overall Study|Adverse Event|12|||
131630226|NCT00821093|473930577|FG000|Overall Study|Withdrawal by Subject|9|||
131630227|NCT00821093|473930578|FG001|Overall Study|Withdrawal by Subject|13|||
131630228|NCT00821093|473930577|FG000|Overall Study|Lost to Follow-up|9|||
131630229|NCT00821093|473930578|FG001|Overall Study|Lost to Follow-up|3|||
131630230|NCT00821093|473930577|FG000|Overall Study|Protocol deviation|3|||
131630231|NCT00821093|473930578|FG001|Overall Study|Protocol deviation|6|||
131630232|NCT00821093|473930577|FG000|Overall Study|Abnormal laboratory value(s)|2|||
131630233|NCT00821093|473930578|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131630234|NCT00821093|473930577|FG000|Overall Study|Lack of Efficacy|2|||
131630235|NCT00821093|473930578|FG001|Overall Study|Lack of Efficacy|2|||
131630236|NCT00821093|473930577|FG000|Overall Study|Death|2|||
131630237|NCT00821093|473930578|FG001|Overall Study|Death|1|||
131630238|NCT00821093|473930577|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131630239|NCT00821093|473930578|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131630240|NCT00821093|473930577|FG000|Overall Study|Administrative problems|1|||
131630241|NCT00821093|473930578|FG001|Overall Study|Administrative problems|2|||
131630242|NCT01107912|473930581|FG000|Period 1|Adverse Event|0|||
131630243|NCT01107912|473930582|FG001|Period 1|Adverse Event|0|||
131630244|NCT01107912|473930583|FG002|Period 1|Adverse Event|0|||
131902036|NCT03713684|474926926|FG003|Overall Study|Poor compliance to protocol|1|||
131630245|NCT01107912|473930584|FG003|Period 1|Adverse Event|0|||
131630246|NCT01107912|473930585|FG004|Period 1|Adverse Event|2|||
131630247|NCT01107912|473930586|FG005|Period 1|Adverse Event|0|||
131630248|NCT01107912|473930581|FG000|Period 1|Physician Decision|0|||
131712996|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131712997|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131712998|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
131712999|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
131713000|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713001|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
131713002|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
131713003|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713004|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713005|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713006|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713007|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713008|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131713009|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131713010|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
131713011|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
131713012|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131713013|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131713014|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131713015|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131713016|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
131713017|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
131713018|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131713019|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
131713020|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
131713021|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131713022|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131713023|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131713024|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131713025|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
131713026|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
131713027|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713028|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131713029|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713030|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713031|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713032|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713033|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713034|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131713035|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131713036|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713037|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
131713038|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713039|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713040|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713041|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713042|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713043|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713044|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131713045|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713046|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
131713047|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713048|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713049|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713050|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713051|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713052|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131713053|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
131713054|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131713055|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
131713056|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
131713057|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131713058|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131713059|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131713060|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131713061|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
131713062|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
131630249|NCT01107912|473930582|FG001|Period 1|Physician Decision|0|||
131630250|NCT01107912|473930583|FG002|Period 1|Physician Decision|0|||
131630251|NCT01107912|473930584|FG003|Period 1|Physician Decision|0|||
131797886|NCT04799158|474543458|FG004|Run-In Period|Significant Protocol Deviation|0|||
131797887|NCT04799158|474543454|FG000|Run-In Period|Withdrawal by Subject|11|||
131797888|NCT04799158|474543455|FG001|Run-In Period|Withdrawal by Subject|0|||
131630252|NCT01107912|473930585|FG004|Period 1|Physician Decision|1|||
131630253|NCT01107912|473930586|FG005|Period 1|Physician Decision|0|||
131630254|NCT01107912|473930581|FG000|Period 1|Withdrawal by Subject|1|||
131630255|NCT01107912|473930582|FG001|Period 1|Withdrawal by Subject|0|||
131630256|NCT01107912|473930583|FG002|Period 1|Withdrawal by Subject|0|||
131630257|NCT01107912|473930584|FG003|Period 1|Withdrawal by Subject|0|||
131630258|NCT01107912|473930585|FG004|Period 1|Withdrawal by Subject|0|||
131630259|NCT01107912|473930586|FG005|Period 1|Withdrawal by Subject|0|||
131630260|NCT01107912|473930581|FG000|Period 2|Physician Decision|0|||
131630261|NCT01107912|473930582|FG001|Period 2|Physician Decision|0|||
131630262|NCT01107912|473930583|FG002|Period 2|Physician Decision|1|||
131630263|NCT01107912|473930584|FG003|Period 2|Physician Decision|0|||
131630264|NCT01107912|473930585|FG004|Period 2|Physician Decision|0|||
131630265|NCT01107912|473930586|FG005|Period 2|Physician Decision|0|||
131630266|NCT01107912|473930581|FG000|Period 3|Adverse Event|0|||
131630267|NCT01107912|473930582|FG001|Period 3|Adverse Event|1|||
131630268|NCT01107912|473930583|FG002|Period 3|Adverse Event|1|||
131630269|NCT01107912|473930584|FG003|Period 3|Adverse Event|0|||
131630270|NCT01107912|473930585|FG004|Period 3|Adverse Event|0|||
131630271|NCT01107912|473930586|FG005|Period 3|Adverse Event|0|||
131630272|NCT01107912|473930581|FG000|Period 3|Withdrawal by Subject|0|||
131630273|NCT01107912|473930582|FG001|Period 3|Withdrawal by Subject|0|||
131630274|NCT01107912|473930583|FG002|Period 3|Withdrawal by Subject|0|||
131630275|NCT01107912|473930584|FG003|Period 3|Withdrawal by Subject|1|||
131630276|NCT01107912|473930585|FG004|Period 3|Withdrawal by Subject|0|||
131630277|NCT01107912|473930586|FG005|Period 3|Withdrawal by Subject|0|||
131630278|NCT01124916|473930590|FG000|Overall Study|Lost to Follow-up|3|||
131630279|NCT01124916|473930591|FG001|Overall Study|Lost to Follow-up|2|||
131630280|NCT01901302|473930592|FG000|Overall Study|Adverse Event|2|||
131630281|NCT01901302|473930593|FG001|Overall Study|Adverse Event|1|||
131630282|NCT01901302|473930592|FG000|Overall Study|Lack of Efficacy|0|||
131630283|NCT01901302|473930593|FG001|Overall Study|Lack of Efficacy|2|||
131630284|NCT01901302|473930592|FG000|Overall Study|Study Terminated by Sponsor|23|||
131630285|NCT01901302|473930593|FG001|Overall Study|Study Terminated by Sponsor|20|||
131630286|NCT01901302|473930592|FG000|Overall Study|Withdrawal by Subject|2|||
131630287|NCT01901302|473930593|FG001|Overall Study|Withdrawal by Subject|0|||
131630288|NCT00901459|473930604|FG000|Overall Study|Withdrawal by Subject|6|||
131630289|NCT04765046|473930605|FG000|Overall Study|Screen Failure|2|||
131630290|NCT04765046|473930605|FG000|Overall Study|Withdrawal by Subject|4|||
131630291|NCT04765046|473930605|FG000|Overall Study|Physician Decision|4|||
131630292|NCT04765046|473930605|FG000|Overall Study|Surgery Cancelled|8|||
131630293|NCT01721109|473930606|FG000|Overall Study|Lack of Efficacy|1|||
131630294|NCT01721109|473930606|FG000|Overall Study|Non- Compliance with Study Drug|3|||
131630295|NCT01721109|473930606|FG000|Overall Study|Withdrew Consent|1|||
131630296|NCT01721109|473930606|FG000|Overall Study|Lost to Follow-up|2|||
131630297|NCT00134056|473930607|FG000|Randomization|Not eligible for assigned treatment|22|||
131630298|NCT00134056|473930608|FG001|Randomization|Not eligible for assigned treatment|20|||
131630299|NCT00134056|473930607|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
131630300|NCT00134056|473930608|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
131797889|NCT04799158|474543456|FG002|Run-In Period|Withdrawal by Subject|0|||
131797890|NCT04799158|474543457|FG003|Run-In Period|Withdrawal by Subject|0|||
131797891|NCT04799158|474543458|FG004|Run-In Period|Withdrawal by Subject|0|||
131797892|NCT04799158|474543454|FG000|Run-In Period|Miscellaneous|3|||
131797893|NCT04799158|474543455|FG001|Run-In Period|Miscellaneous|0|||
131797894|NCT04799158|474543456|FG002|Run-In Period|Miscellaneous|0|||
131630301|NCT00134056|473930607|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
131630302|NCT00134056|473930608|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
131630303|NCT00134056|473930607|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
131630304|NCT00134056|473930608|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
131630305|NCT00134056|473930607|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
131630306|NCT00134056|473930608|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
131630307|NCT02924051|473930613|FG000|Overall Study|Withdrawal by Subject|1|||
131630308|NCT02924051|473930614|FG001|Overall Study|Withdrawal by Subject|9|||
131797895|NCT04799158|474543457|FG003|Run-In Period|Miscellaneous|0|||
131630309|NCT02260154|473930615|FG000|Overall Study|Screening failure|2|||
131630310|NCT02561195|473930617|FG000|Vaccination 1 to 3|Adverse Event|4|||
131630311|NCT02561195|473930618|FG001|Vaccination 1 to 3|Adverse Event|5|||
131630312|NCT02561195|473930619|FG002|Vaccination 1 to 3|Adverse Event|0|||
131630313|NCT02561195|473930620|FG003|Vaccination 1 to 3|Adverse Event|3|||
131630314|NCT02561195|473930621|FG004|Vaccination 1 to 3|Adverse Event|4|||
131630315|NCT02561195|473930622|FG005|Vaccination 1 to 3|Adverse Event|0|||
131630316|NCT02561195|473930623|FG006|Vaccination 1 to 3|Adverse Event|0|||
131630317|NCT02561195|473930624|FG007|Vaccination 1 to 3|Adverse Event|0|||
131630318|NCT02561195|473930625|FG008|Vaccination 1 to 3|Adverse Event|0|||
131630319|NCT02561195|473930626|FG009|Vaccination 1 to 3|Adverse Event|0|||
131630320|NCT02561195|473930627|FG010|Vaccination 1 to 3|Adverse Event|0|||
131630321|NCT02561195|473930628|FG011|Vaccination 1 to 3|Adverse Event|0|||
131630322|NCT02561195|473930629|FG012|Vaccination 1 to 3|Adverse Event|0|||
131630323|NCT02561195|473930630|FG013|Vaccination 1 to 3|Adverse Event|0|||
131630324|NCT02561195|473930617|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
131630325|NCT02561195|473930618|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
131630326|NCT02561195|473930619|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
131630327|NCT02561195|473930620|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
131630328|NCT02561195|473930621|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
131630329|NCT02561195|473930622|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
131630330|NCT02561195|473930623|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
131630331|NCT02561195|473930624|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
131630332|NCT02561195|473930625|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
131630333|NCT02561195|473930626|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
131630334|NCT02561195|473930627|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
131630335|NCT02561195|473930628|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
131630336|NCT02561195|473930629|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
131630337|NCT02561195|473930630|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
131630338|NCT02561195|473930617|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630339|NCT02561195|473930618|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
131630340|NCT02561195|473930619|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630341|NCT02561195|473930620|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
131630342|NCT02561195|473930621|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
131630343|NCT02561195|473930622|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
131630344|NCT02561195|473930623|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630345|NCT02561195|473930624|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630346|NCT02561195|473930625|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630347|NCT02561195|473930626|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630348|NCT02561195|473930627|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630349|NCT02561195|473930628|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630350|NCT02561195|473930629|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630351|NCT02561195|473930630|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131630352|NCT02561195|473930617|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
131630353|NCT02561195|473930618|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
131630354|NCT02561195|473930619|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
131630355|NCT02561195|473930620|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
131630356|NCT02561195|473930621|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
131630357|NCT02561195|473930622|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
131630358|NCT02561195|473930623|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
131630359|NCT02561195|473930624|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
131630360|NCT02561195|473930625|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
131630361|NCT02561195|473930626|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
131630362|NCT02561195|473930627|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
131630363|NCT02561195|473930628|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
131630364|NCT02561195|473930629|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
131630365|NCT02561195|473930630|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
131630366|NCT02561195|473930617|FG000|Vaccination 1 to 3|Other|7|||
131797896|NCT04799158|474543458|FG004|Run-In Period|Miscellaneous|0|||
131797897|NCT04799158|474543454|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
131797898|NCT04799158|474543455|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131797899|NCT04799158|474543456|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131797900|NCT04799158|474543457|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131797901|NCT04799158|474543458|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131797902|NCT04799158|474543454|FG000|On-Demand Treatment Period|Adverse Event|0|||
131630367|NCT02561195|473930618|FG001|Vaccination 1 to 3|Other|3|||
131630368|NCT02561195|473930619|FG002|Vaccination 1 to 3|Other|1|||
131630369|NCT02561195|473930620|FG003|Vaccination 1 to 3|Other|7|||
131630370|NCT02561195|473930621|FG004|Vaccination 1 to 3|Other|5|||
131630371|NCT02561195|473930622|FG005|Vaccination 1 to 3|Other|1|||
131630372|NCT02561195|473930623|FG006|Vaccination 1 to 3|Other|0|||
131797903|NCT04799158|474543455|FG001|On-Demand Treatment Period|Adverse Event|1|||
131804505|NCT00533273|474568549|FG001|Double-blind|Withdrew consent|2|||
131630373|NCT02561195|473930624|FG007|Vaccination 1 to 3|Other|0|||
131630374|NCT02561195|473930625|FG008|Vaccination 1 to 3|Other|0|||
131630375|NCT02561195|473930626|FG009|Vaccination 1 to 3|Other|0|||
131630376|NCT02561195|473930627|FG010|Vaccination 1 to 3|Other|0|||
131630377|NCT02561195|473930628|FG011|Vaccination 1 to 3|Other|0|||
131630378|NCT02561195|473930629|FG012|Vaccination 1 to 3|Other|0|||
131630379|NCT02561195|473930630|FG013|Vaccination 1 to 3|Other|0|||
131630380|NCT02561195|473930617|FG000|Vaccination 1 to 3|Protocol Violation|1|||
131630381|NCT02561195|473930618|FG001|Vaccination 1 to 3|Protocol Violation|0|||
131630382|NCT02561195|473930619|FG002|Vaccination 1 to 3|Protocol Violation|1|||
131630383|NCT02561195|473930620|FG003|Vaccination 1 to 3|Protocol Violation|2|||
131630384|NCT02561195|473930621|FG004|Vaccination 1 to 3|Protocol Violation|5|||
131630385|NCT02561195|473930622|FG005|Vaccination 1 to 3|Protocol Violation|2|||
131630386|NCT02561195|473930623|FG006|Vaccination 1 to 3|Protocol Violation|0|||
131630387|NCT02561195|473930624|FG007|Vaccination 1 to 3|Protocol Violation|0|||
131630388|NCT02561195|473930625|FG008|Vaccination 1 to 3|Protocol Violation|0|||
131630389|NCT02561195|473930626|FG009|Vaccination 1 to 3|Protocol Violation|0|||
131630390|NCT02561195|473930627|FG010|Vaccination 1 to 3|Protocol Violation|0|||
131630391|NCT02561195|473930628|FG011|Vaccination 1 to 3|Protocol Violation|0|||
131630392|NCT02561195|473930629|FG012|Vaccination 1 to 3|Protocol Violation|0|||
131630393|NCT02561195|473930630|FG013|Vaccination 1 to 3|Protocol Violation|0|||
131630394|NCT02561195|473930617|FG000|Vaccination 1 to 3|Death|2|||
131630395|NCT02561195|473930618|FG001|Vaccination 1 to 3|Death|1|||
131630396|NCT02561195|473930619|FG002|Vaccination 1 to 3|Death|0|||
131630397|NCT02561195|473930620|FG003|Vaccination 1 to 3|Death|2|||
131630398|NCT02561195|473930621|FG004|Vaccination 1 to 3|Death|0|||
131630399|NCT02561195|473930622|FG005|Vaccination 1 to 3|Death|0|||
131630400|NCT02561195|473930623|FG006|Vaccination 1 to 3|Death|0|||
131630401|NCT02561195|473930624|FG007|Vaccination 1 to 3|Death|0|||
131630402|NCT02561195|473930625|FG008|Vaccination 1 to 3|Death|0|||
131630403|NCT02561195|473930626|FG009|Vaccination 1 to 3|Death|0|||
131630404|NCT02561195|473930627|FG010|Vaccination 1 to 3|Death|0|||
131630405|NCT02561195|473930628|FG011|Vaccination 1 to 3|Death|0|||
131630406|NCT02561195|473930629|FG012|Vaccination 1 to 3|Death|0|||
131630407|NCT02561195|473930630|FG013|Vaccination 1 to 3|Death|0|||
131630408|NCT02561195|473930617|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
131630409|NCT02561195|473930618|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
131630410|NCT02561195|473930619|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
131630411|NCT02561195|473930620|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
131630412|NCT02561195|473930621|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
131630413|NCT02561195|473930622|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630414|NCT02561195|473930623|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630415|NCT02561195|473930624|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630416|NCT02561195|473930625|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630417|NCT02561195|473930626|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630418|NCT02561195|473930627|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630419|NCT02561195|473930628|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630420|NCT02561195|473930629|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630421|NCT02561195|473930630|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
131630422|NCT02561195|473930617|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
131630423|NCT02561195|473930618|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
131630424|NCT02561195|473930619|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
131630425|NCT02561195|473930620|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
131630426|NCT02561195|473930621|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
131630427|NCT02561195|473930622|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
131630428|NCT02561195|473930623|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
131630429|NCT02561195|473930624|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
131630430|NCT02561195|473930625|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
131630431|NCT02561195|473930626|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
131630432|NCT02561195|473930627|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
131444246|NCT02903771|473257109|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
131444247|NCT02903771|473257103|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
131444248|NCT02903771|473257104|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
131444249|NCT02903771|473257105|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
131630433|NCT02561195|473930628|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
131630434|NCT02561195|473930629|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
131630435|NCT02561195|473930630|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
131713063|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131444250|NCT02903771|473257106|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
131630436|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630437|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630438|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630439|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630440|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630441|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630442|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630443|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630444|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
131630445|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
131630446|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
131630447|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
131630448|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
131630449|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131630450|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630451|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630452|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630453|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630454|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630455|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630456|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630457|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630458|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630459|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630460|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630461|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630462|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
131630463|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
131630464|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|Death|0|||
131630465|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|Death|0|||
131630466|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|Death|0|||
131630467|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|Death|0|||
131630468|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|Death|0|||
131630469|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|Death|0|||
131630470|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|Death|0|||
131630471|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|Death|0|||
131630472|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|Death|0|||
131630473|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|Death|1|||
131630474|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|Death|0|||
131630475|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|Death|0|||
131630476|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|Death|0|||
131630477|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|Death|0|||
131630478|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630479|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630480|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630481|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630482|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630483|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630484|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131630485|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131630486|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630487|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131630488|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
131630489|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131630490|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
131630491|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131630492|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630493|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630494|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630495|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630496|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630497|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630498|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630499|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630500|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630501|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630502|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131630503|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
131630504|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
131630505|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
131630506|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|Other|0|||
131630507|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|Other|0|||
131630508|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|Other|0|||
131630509|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|Other|0|||
131713064|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131630510|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|Other|0|||
131630511|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|Other|0|||
131630512|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|Other|0|||
131630513|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|Other|0|||
131630514|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|Other|0|||
131630515|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|Other|0|||
131630516|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|Other|2|||
131630517|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|Other|2|||
131630518|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|Other|1|||
131630519|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|Other|0|||
131630520|NCT02561195|473930617|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630521|NCT02561195|473930618|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630522|NCT02561195|473930619|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630523|NCT02561195|473930620|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630524|NCT02561195|473930621|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630525|NCT02561195|473930622|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630526|NCT02561195|473930623|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
131630527|NCT02561195|473930624|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630528|NCT02561195|473930625|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630529|NCT02561195|473930626|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630530|NCT02561195|473930627|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
131630531|NCT02561195|473930628|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
131630532|NCT02561195|473930629|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131630533|NCT02561195|473930630|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
131630534|NCT03905512|473930631|FG000|Overall Study|Withdrawal by Subject|9|||
131630535|NCT03905512|473930632|FG001|Overall Study|Withdrawal by Subject|8|||
131630536|NCT03905512|473930631|FG000|Overall Study|Adverse Event|1|||
131630537|NCT03905512|473930632|FG001|Overall Study|Adverse Event|2|||
131630538|NCT03905512|473930631|FG000|Overall Study|Lost to Follow-up|4|||
131630539|NCT03905512|473930632|FG001|Overall Study|Lost to Follow-up|3|||
131630540|NCT03905512|473930631|FG000|Overall Study|Other than Specified|7|||
131630541|NCT03905512|473930632|FG001|Overall Study|Other than Specified|4|||
131630542|NCT04198428|473931852|FG000|Overall Study|Withdrawal by Subject|150|||
131630543|NCT04198428|473931853|FG001|Overall Study|Withdrawal by Subject|156|||
131630544|NCT00753896|473931855|FG000|Overall Study|Adverse Event|4|||
131630545|NCT00753896|473931855|FG000|Overall Study|Death|1|||
131630546|NCT00753896|473931855|FG000|Overall Study|Lost to Follow-up|2|||
131630547|NCT00753896|473931855|FG000|Overall Study|Protocol Violation|1|||
131630548|NCT00753896|473931855|FG000|Overall Study|Withdrawal by Subject|4|||
131630549|NCT00753896|473931855|FG000|Overall Study|Entry Criteria Not Met|4|||
131630550|NCT00848198|473931857|FG000|Overall Study|Incomplete Case Report Forms|15|||
131630551|NCT03529942|473931861|FG000|Overall Study|Withdrawal by Subject|13|||
131630552|NCT03529942|473931861|FG000|Overall Study|Physician Decision|1|||
131630553|NCT03529942|473931861|FG000|Overall Study|Lost to Follow-up|7|||
131630554|NCT03529942|473931861|FG000|Overall Study|Needle inserted but no drug administered|1|||
131630555|NCT03529942|473931861|FG000|Overall Study|Personal reasons|1|||
131630556|NCT04930263|473931862|FG000|Overall Study|Withdrawal by Subject|3|||
131630557|NCT04930263|473931863|FG001|Overall Study|Withdrawal by Subject|5|||
131630558|NCT01989156|473931866|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
131630559|NCT01989156|473931867|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131630560|NCT01989156|473931868|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
131630561|NCT01989156|473931866|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
131630562|NCT01989156|473931867|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
131630563|NCT01989156|473931868|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
131630564|NCT01989156|473931866|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
131630565|NCT01989156|473931867|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
131630566|NCT01989156|473931868|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
131630567|NCT01989156|473931866|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
131630568|NCT01989156|473931867|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
131630569|NCT01989156|473931868|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
131630570|NCT01989156|473931866|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
131630571|NCT01989156|473931867|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
131797904|NCT04799158|474543456|FG002|On-Demand Treatment Period|Adverse Event|0|||
131630572|NCT01989156|473931868|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
131630573|NCT01989156|473931866|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
131630574|NCT01989156|473931867|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
131630575|NCT01989156|473931868|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
131630576|NCT01989156|473931866|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
131630577|NCT01989156|473931867|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
131797905|NCT04799158|474543457|FG003|On-Demand Treatment Period|Adverse Event|0|||
131797906|NCT04799158|474543458|FG004|On-Demand Treatment Period|Adverse Event|1|||
131630578|NCT01989156|473931868|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
131630579|NCT01989156|473931866|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
131630580|NCT01989156|473931867|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
131630581|NCT01989156|473931868|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
131630582|NCT00850993|473931869|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
131630583|NCT00850993|473931870|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
131630584|NCT00850993|473931871|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
131630585|NCT00850993|473931872|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
131630586|NCT03839355|473931873|FG000|Overall Study|Withdrawal by Subject|1|||
131630587|NCT03839355|473931874|FG001|Overall Study|Withdrawal by Subject|0|||
131630588|NCT04362176|473931883|FG000|Overall Study|Lost to Follow-up|5|||
131630589|NCT04362176|473931884|FG001|Overall Study|Lost to Follow-up|8|||
131630590|NCT04362176|473931883|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
131630591|NCT04362176|473931884|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
131630592|NCT00742560|473931885|FG000|Overall Study|Adverse Event|0|||
131630593|NCT00742560|473931886|FG001|Overall Study|Adverse Event|0|||
131630594|NCT00742560|473931887|FG002|Overall Study|Adverse Event|1|||
131630595|NCT00742560|473931888|FG003|Overall Study|Adverse Event|1|||
131630596|NCT00742560|473931889|FG004|Overall Study|Adverse Event|1|||
131630597|NCT00742560|473931885|FG000|Overall Study|Death|0|||
131630598|NCT00742560|473931886|FG001|Overall Study|Death|2|||
131630599|NCT00742560|473931887|FG002|Overall Study|Death|0|||
131630600|NCT00742560|473931888|FG003|Overall Study|Death|2|||
131630601|NCT00742560|473931889|FG004|Overall Study|Death|3|||
131630602|NCT00742560|473931885|FG000|Overall Study|Subject's Decision|1|||
131630603|NCT00742560|473931886|FG001|Overall Study|Subject's Decision|0|||
131630604|NCT00742560|473931887|FG002|Overall Study|Subject's Decision|2|||
131630605|NCT00742560|473931888|FG003|Overall Study|Subject's Decision|3|||
131630606|NCT00742560|473931889|FG004|Overall Study|Subject's Decision|3|||
131630607|NCT00742560|473931885|FG000|Overall Study|Investigator's Decision|0|||
131630608|NCT00742560|473931886|FG001|Overall Study|Investigator's Decision|0|||
131630609|NCT00742560|473931887|FG002|Overall Study|Investigator's Decision|4|||
131630610|NCT00742560|473931888|FG003|Overall Study|Investigator's Decision|1|||
131630611|NCT00742560|473931889|FG004|Overall Study|Investigator's Decision|0|||
131630612|NCT00742560|473931885|FG000|Overall Study|Disease Progression|1|||
131630613|NCT00742560|473931886|FG001|Overall Study|Disease Progression|0|||
131630614|NCT00742560|473931887|FG002|Overall Study|Disease Progression|5|||
131630615|NCT00742560|473931888|FG003|Overall Study|Disease Progression|17|||
131630616|NCT00742560|473931889|FG004|Overall Study|Disease Progression|16|||
131630617|NCT00742560|473931885|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
131630618|NCT00742560|473931886|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
131630619|NCT00742560|473931887|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
131630620|NCT00742560|473931888|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
131630621|NCT00742560|473931889|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
131630622|NCT00742560|473931885|FG000|Overall Study|Other|0|||
131630623|NCT00742560|473931886|FG001|Overall Study|Other|1|||
131630624|NCT00742560|473931887|FG002|Overall Study|Other|8|||
131630625|NCT00742560|473931888|FG003|Overall Study|Other|9|||
131630626|NCT00742560|473931889|FG004|Overall Study|Other|9|||
131630627|NCT00742560|473931885|FG000|Overall Study|MIssing|0|||
131630628|NCT00742560|473931886|FG001|Overall Study|MIssing|0|||
131630629|NCT00742560|473931887|FG002|Overall Study|MIssing|0|||
131630630|NCT00742560|473931888|FG003|Overall Study|MIssing|0|||
131630631|NCT00742560|473931889|FG004|Overall Study|MIssing|1|||
131630632|NCT01536795|473931890|FG000|Overall Study|Lost to Follow-up|0|||
131630633|NCT01536795|473931891|FG001|Overall Study|Lost to Follow-up|2|||
131630634|NCT01536795|473931890|FG000|Overall Study|Lack of Efficacy|1|||
131630635|NCT01536795|473931891|FG001|Overall Study|Lack of Efficacy|0|||
131630636|NCT04501614|473931892|FG000|Overall Study|Study Terminated by Sponsor|6|||
131630637|NCT04501614|473931893|FG001|Overall Study|Study Terminated by Sponsor|3|||
131630638|NCT04501614|473931892|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
131630639|NCT04501614|473931893|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
131630640|NCT04529941|473931894|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
131630641|NCT04529941|473931895|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
131630642|NCT01699178|473931897|FG000|Overall Study|Adverse Event|1|||
131630643|NCT01699178|473931898|FG001|Overall Study|Adverse Event|5|||
131630644|NCT01699178|473931897|FG000|Overall Study|Lost to Follow-up|1|||
131630645|NCT01699178|473931898|FG001|Overall Study|Lost to Follow-up|6|||
131630646|NCT01699178|473931897|FG000|Overall Study|Non-compliance with Study Drug|3|||
131630647|NCT01699178|473931898|FG001|Overall Study|Non-compliance with Study Drug|1|||
131797907|NCT04799158|474543454|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
131630648|NCT01699178|473931897|FG000|Overall Study|Physician Decision|1|||
131630649|NCT01699178|473931898|FG001|Overall Study|Physician Decision|0|||
131630650|NCT01699178|473931897|FG000|Overall Study|Withdrawal by Subject|4|||
131630651|NCT01699178|473931898|FG001|Overall Study|Withdrawal by Subject|12|||
131630652|NCT01699178|473931897|FG000|Overall Study|Hematocrit >54%|1|||
131630653|NCT01699178|473931898|FG001|Overall Study|Hematocrit >54%|1|||
131713065|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
131713066|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131713067|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131713068|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131713069|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131713070|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131713071|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131713072|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713073|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713074|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713075|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713076|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713077|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713078|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713079|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
131713080|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131713081|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131713082|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131713083|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131713084|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131713085|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131713086|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131713087|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131713088|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131713089|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131713090|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713091|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
131713092|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
131713093|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713094|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713095|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713096|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713097|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713098|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131713099|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131713100|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
131713101|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
131713102|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131713103|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131713104|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131713105|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131713106|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131713107|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131713108|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713109|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
131713110|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713111|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713112|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713113|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713114|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713115|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713116|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131713117|NCT01307423|474226315|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131713118|NCT01307423|474226316|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131713119|NCT01307423|474226317|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
131713120|NCT01307423|474226318|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131713121|NCT01307423|474226319|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131713122|NCT01307423|474226320|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131713123|NCT01307423|474226321|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131713124|NCT01307423|474226322|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
131713125|NCT01307423|474226323|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
131713126|NCT04052139|474226324|FG000|Overall Study|Lost to Follow-up|2|||
131713127|NCT04052139|474226325|FG001|Overall Study|Lost to Follow-up|0|||
131713128|NCT04052139|474226326|FG002|Overall Study|Lost to Follow-up|0|||
131713129|NCT04052139|474226324|FG000|Overall Study|Withdrawal by Subject|1|||
131713130|NCT04052139|474226325|FG001|Overall Study|Withdrawal by Subject|0|||
131713131|NCT04052139|474226326|FG002|Overall Study|Withdrawal by Subject|0|||
131713132|NCT03406962|474226327|FG000|Overall Study|Death|2|||
131713133|NCT03406962|474226327|FG000|Overall Study|Adverse Event|1|||
131713134|NCT00519077|474226328|FG000|Overall Study|Death|6|||
131713135|NCT00519077|474226328|FG000|Overall Study|Other|2|||
131902037|NCT03713684|474926923|FG000|Overall Study|Withdrawal by Subject|14|||
131902038|NCT03713684|474926924|FG001|Overall Study|Withdrawal by Subject|6|||
131902039|NCT03713684|474926925|FG002|Overall Study|Withdrawal by Subject|14|||
131902040|NCT03713684|474926926|FG003|Overall Study|Withdrawal by Subject|16|||
131902041|NCT03713684|474926923|FG000|Overall Study|Other than specified|69|||
131902042|NCT03713684|474926924|FG001|Overall Study|Other than specified|77|||
131902043|NCT03713684|474926925|FG002|Overall Study|Other than specified|73|||
131902044|NCT03713684|474926926|FG003|Overall Study|Other than specified|70|||
131902045|NCT02185417|474926927|FG000|Overall Study|Death|448|||
131902046|NCT02185417|474926928|FG001|Overall Study|Death|446|||
131902047|NCT02185417|474926929|FG002|Overall Study|Death|0|||
131902048|NCT02185417|474926927|FG000|Overall Study|Withdrawal by Subject|7|||
131902049|NCT02185417|474926928|FG001|Overall Study|Withdrawal by Subject|12|||
131902050|NCT02185417|474926929|FG002|Overall Study|Withdrawal by Subject|0|||
131902051|NCT02595502|474926930|FG000|Period 1|Adverse Event|0|||
131902052|NCT02595502|474926931|FG001|Period 1|Adverse Event|1|||
131902053|NCT02595502|474926930|FG000|Period 1|Withdrawal by Subject|1|||
131902054|NCT02595502|474926931|FG001|Period 1|Withdrawal by Subject|0|||
131902055|NCT02595502|474926930|FG000|Period 1|Lost to Follow-up|0|||
131902056|NCT02595502|474926931|FG001|Period 1|Lost to Follow-up|1|||
131902057|NCT02595502|474926930|FG000|Period 2|Adverse Event|1|||
131902058|NCT02595502|474926931|FG001|Period 2|Adverse Event|1|||
131902059|NCT02595502|474926930|FG000|Period 2|Received incorrect lens at Period 1|0|||
131902060|NCT02595502|474926931|FG001|Period 2|Received incorrect lens at Period 1|1|||
131902061|NCT02595502|474926930|FG000|Period 3|Protocol Violation|0|||
131902062|NCT02595502|474926931|FG001|Period 3|Protocol Violation|1|||
131630654|NCT01699178|473931897|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
131630655|NCT01699178|473931898|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
131630656|NCT01699178|473931897|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
131630657|NCT01699178|473931898|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
131630658|NCT02066389|473931901|FG000|Overall Study|Adverse Event|1|||
131630659|NCT02066389|473931902|FG001|Overall Study|Adverse Event|1|||
131630660|NCT02066389|473931903|FG002|Overall Study|Adverse Event|1|||
131630661|NCT02066389|473931904|FG003|Overall Study|Adverse Event|1|||
131630662|NCT02066389|473931905|FG004|Overall Study|Adverse Event|5|||
131630663|NCT02066389|473931906|FG005|Overall Study|Adverse Event|1|||
131630664|NCT02066389|473931901|FG000|Overall Study|Withdrawal by Subject|4|||
131630665|NCT02066389|473931902|FG001|Overall Study|Withdrawal by Subject|0|||
131630666|NCT02066389|473931903|FG002|Overall Study|Withdrawal by Subject|5|||
131630667|NCT02066389|473931904|FG003|Overall Study|Withdrawal by Subject|1|||
131630668|NCT02066389|473931905|FG004|Overall Study|Withdrawal by Subject|1|||
131630669|NCT02066389|473931906|FG005|Overall Study|Withdrawal by Subject|2|||
131630670|NCT02066389|473931901|FG000|Overall Study|Lost to Follow-up|0|||
131630671|NCT02066389|473931902|FG001|Overall Study|Lost to Follow-up|0|||
131630672|NCT02066389|473931903|FG002|Overall Study|Lost to Follow-up|0|||
131630673|NCT02066389|473931904|FG003|Overall Study|Lost to Follow-up|1|||
131630674|NCT02066389|473931905|FG004|Overall Study|Lost to Follow-up|1|||
131630675|NCT02066389|473931906|FG005|Overall Study|Lost to Follow-up|1|||
131630676|NCT02066389|473931901|FG000|Overall Study|Randomized in Error|0|||
131630677|NCT02066389|473931902|FG001|Overall Study|Randomized in Error|0|||
131630678|NCT02066389|473931903|FG002|Overall Study|Randomized in Error|0|||
131630679|NCT02066389|473931904|FG003|Overall Study|Randomized in Error|0|||
131630680|NCT02066389|473931905|FG004|Overall Study|Randomized in Error|0|||
131630681|NCT02066389|473931906|FG005|Overall Study|Randomized in Error|1|||
131630682|NCT01755598|473931909|FG000|Overall Study|Other|109|||
131630683|NCT01755598|473931910|FG001|Overall Study|Other|109|||
131630684|NCT01755598|473931909|FG000|Overall Study|Lost to Follow-up|32|||
131630685|NCT01755598|473931910|FG001|Overall Study|Lost to Follow-up|43|||
131630686|NCT01755598|473931909|FG000|Overall Study|Migrated/moved from study area|76|||
131630687|NCT01755598|473931910|FG001|Overall Study|Migrated/moved from study area|65|||
131630688|NCT01755598|473931909|FG000|Overall Study|Withdrawal by Subject|22|||
131630689|NCT01755598|473931910|FG001|Overall Study|Withdrawal by Subject|31|||
131630690|NCT01755598|473931909|FG000|Overall Study|Protocol Violation|7|||
131630691|NCT01755598|473931910|FG001|Overall Study|Protocol Violation|7|||
131630692|NCT01755598|473931909|FG000|Overall Study|Adverse Event|19|||
131630693|NCT01755598|473931910|FG001|Overall Study|Adverse Event|28|||
131630694|NCT05615870|473931915|FG000|Overall Study|Lost to Follow-up|10|||
131630695|NCT05615870|473931916|FG001|Overall Study|Lost to Follow-up|13|||
131630696|NCT05615870|473931915|FG000|Overall Study|Physician Decision|2|||
131630697|NCT05615870|473931916|FG001|Overall Study|Physician Decision|0|||
131630698|NCT05615870|473931915|FG000|Overall Study|Withdrawal by Subject|0|||
131902063|NCT02595502|474926930|FG000|Period 3|Lost to Follow-up|1|||
131902064|NCT02595502|474926931|FG001|Period 3|Lost to Follow-up|0|||
131902065|NCT02595502|474926930|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
131902066|NCT02595502|474926931|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
131630699|NCT05615870|473931916|FG001|Overall Study|Withdrawal by Subject|2|||
131630700|NCT05615870|473931915|FG000|Overall Study|Protocol Violation|0|||
131630701|NCT05615870|473931916|FG001|Overall Study|Protocol Violation|3|||
131630702|NCT05615870|473931915|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
131630703|NCT05615870|473931916|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
131630704|NCT05615870|473931915|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
131630705|NCT05615870|473931916|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
131630706|NCT05615870|473931915|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
131630707|NCT05615870|473931916|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
131630708|NCT00070317|473931919|FG000|Overall Study|Inevaluable (Never Treated)|1|||
131630709|NCT00070317|473931919|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
131630710|NCT00070317|473931919|FG000|Overall Study|Ineligible required test not done|1|||
131630711|NCT00070317|473931919|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
131630712|NCT00070317|473931919|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
131630713|NCT03560206|473931921|FG000|Overall Study|Lost to Follow-up|19|||
131630714|NCT03560206|473931922|FG001|Overall Study|Lost to Follow-up|11|||
131630715|NCT03560206|473931921|FG000|Overall Study|Withdrawal by Subject|2|||
131713136|NCT01967225|474226329|FG000|Overall Study|Adverse Event|3|||
131630716|NCT03560206|473931922|FG001|Overall Study|Withdrawal by Subject|4|||
131630717|NCT03560206|473931921|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
131630718|NCT03560206|473931922|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
131630719|NCT03560206|473931921|FG000|Overall Study|Busy schedule|14|||
131630720|NCT03560206|473931922|FG001|Overall Study|Busy schedule|2|||
131630721|NCT03560206|473931921|FG000|Overall Study|patients' new health condition such as cancer|10|||
131630722|NCT03560206|473931922|FG001|Overall Study|patients' new health condition such as cancer|1|||
131630723|NCT03987074|473931926|FG000|Overall Study|Withdrew Consent|1|||
131630724|NCT03987074|473931927|FG001|Overall Study|Withdrew Consent|1|||
131630725|NCT03987074|473931928|FG002|Overall Study|Withdrew Consent|0|||
131630726|NCT03987074|473931929|FG003|Overall Study|Withdrew Consent|2|||
131630727|NCT03987074|473931930|FG004|Overall Study|Withdrew Consent|1|||
131630728|NCT03987074|473931926|FG000|Overall Study|Adverse Event|2|||
131630729|NCT03987074|473931927|FG001|Overall Study|Adverse Event|1|||
131797908|NCT04799158|474543455|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
131797909|NCT04799158|474543456|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
131797910|NCT04799158|474543457|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
131797911|NCT04799158|474543458|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
131797912|NCT04799158|474543454|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131797913|NCT04799158|474543455|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131797914|NCT04799158|474543456|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131797915|NCT04799158|474543457|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
131797916|NCT04799158|474543458|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131797917|NCT04799158|474543454|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
131797918|NCT04799158|474543455|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
131797919|NCT04799158|474543456|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
131797920|NCT04799158|474543457|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
131797921|NCT04799158|474543458|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
131797922|NCT04799158|474543454|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
131630730|NCT03987074|473931928|FG002|Overall Study|Adverse Event|0|||
131630731|NCT03987074|473931929|FG003|Overall Study|Adverse Event|0|||
131630732|NCT03987074|473931930|FG004|Overall Study|Adverse Event|1|||
131630733|NCT03987074|473931926|FG000|Overall Study|Lost to Follow-up|0|||
131630734|NCT03987074|473931927|FG001|Overall Study|Lost to Follow-up|0|||
131630735|NCT03987074|473931928|FG002|Overall Study|Lost to Follow-up|1|||
131630736|NCT03987074|473931929|FG003|Overall Study|Lost to Follow-up|1|||
131630737|NCT03987074|473931930|FG004|Overall Study|Lost to Follow-up|0|||
131630738|NCT03987074|473931926|FG000|Overall Study|Investigator's Discretion|0|||
131630739|NCT03987074|473931927|FG001|Overall Study|Investigator's Discretion|0|||
131630740|NCT03987074|473931928|FG002|Overall Study|Investigator's Discretion|0|||
131630741|NCT03987074|473931929|FG003|Overall Study|Investigator's Discretion|1|||
131630742|NCT03987074|473931930|FG004|Overall Study|Investigator's Discretion|0|||
131630743|NCT01334606|473931933|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
131630744|NCT02674399|473931934|FG000|Overall Study|Lost to Follow-up|2|||
131630745|NCT02674399|473931935|FG001|Overall Study|Lost to Follow-up|0|||
131630746|NCT00508144|473931936|FG000|Overall Study|Not eligible|6|||
131630747|NCT00508144|473931936|FG000|Overall Study|Death|5|||
131630748|NCT01661972|473931937|FG000|Overall Study|Adverse Event|1|||
131630749|NCT01661972|473931938|FG001|Overall Study|Adverse Event|2|||
131630750|NCT01661972|473931937|FG000|Overall Study|Death during Treatment period|1|||
131630751|NCT01661972|473931938|FG001|Overall Study|Death during Treatment period|1|||
131630752|NCT01661972|473931937|FG000|Overall Study|Withdrawal by Subject|0|||
131630753|NCT01661972|473931938|FG001|Overall Study|Withdrawal by Subject|1|||
131630754|NCT02993926|473931941|FG000|Enantone Treatment Phase|Adverse Event|1|||
131630755|NCT02993926|473931942|FG001|Enantone Treatment Phase|Adverse Event|0|||
131630756|NCT02993926|473931943|FG002|Enantone Treatment Phase|Adverse Event|0|||
131630757|NCT02993926|473931941|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
131630758|NCT02993926|473931942|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
131630759|NCT02993926|473931943|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
131630760|NCT02993926|473931941|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
131630761|NCT02993926|473931942|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
131630762|NCT02993926|473931943|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
131797923|NCT04799158|474543455|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
131797924|NCT04799158|474543456|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
131797925|NCT04799158|474543457|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
131797926|NCT04799158|474543458|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
131630763|NCT02993926|473931941|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
131630764|NCT02993926|473931942|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
131630765|NCT02993926|473931943|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
131630766|NCT01084772|473931946|FG000|Baseline|Withdrawal by Subject|7|||
131630767|NCT01084772|473931947|FG001|Baseline|Withdrawal by Subject|6|||
131797927|NCT04799158|474543454|FG000|On-Demand Treatment Period|Miscellaneous|0|||
131797928|NCT04799158|474543455|FG001|On-Demand Treatment Period|Miscellaneous|0|||
131630768|NCT01084772|473931946|FG000|3 Months|Death|1|||
131630769|NCT01084772|473931947|FG001|3 Months|Death|0|||
131630770|NCT01084772|473931946|FG000|3 Months|Study Termination|2|||
131630771|NCT01084772|473931947|FG001|3 Months|Study Termination|2|||
131630772|NCT01084772|473931946|FG000|1 Year|Withdrawal by Subject|0|||
131630773|NCT01084772|473931947|FG001|1 Year|Withdrawal by Subject|1|||
131630774|NCT01084772|473931946|FG000|1 Year|Lost to Follow-up|3|||
131630775|NCT01084772|473931947|FG001|1 Year|Lost to Follow-up|0|||
131630776|NCT01084772|473931946|FG000|1 Year|Study Termination|0|||
131630777|NCT01084772|473931947|FG001|1 Year|Study Termination|7|||
131630778|NCT01084772|473931946|FG000|2 Years|Withdrawal by Subject|1|||
131630779|NCT01084772|473931947|FG001|2 Years|Withdrawal by Subject|0|||
131630780|NCT01084772|473931946|FG000|2 Years|Lost to Follow-up|5|||
131630781|NCT01084772|473931947|FG001|2 Years|Lost to Follow-up|2|||
131630782|NCT01084772|473931946|FG000|2 Years|Study Termination|3|||
131630783|NCT01084772|473931947|FG001|2 Years|Study Termination|2|||
131630784|NCT01867307|473931948|FG000|Overall Study|Protocol Violation|2|||
131630785|NCT01867307|473931949|FG001|Overall Study|Protocol Violation|0|||
131630786|NCT01867307|473931948|FG000|Overall Study|Other Adverse Event|1|||
131630787|NCT01867307|473931949|FG001|Overall Study|Other Adverse Event|3|||
131630788|NCT01517282|473931956|FG000|Overall Study|Consent withdrawn|0|||
131630789|NCT01517282|473931957|FG001|Overall Study|Consent withdrawn|1|||
131630790|NCT01517282|473931958|FG002|Overall Study|Consent withdrawn|1|||
131630791|NCT01517282|473931959|FG003|Overall Study|Consent withdrawn|1|||
131630792|NCT01517282|473931956|FG000|Overall Study|Physician Decision|1|||
131630793|NCT01517282|473931957|FG001|Overall Study|Physician Decision|0|||
131797929|NCT04799158|474543456|FG002|On-Demand Treatment Period|Miscellaneous|0|||
131797930|NCT04799158|474543457|FG003|On-Demand Treatment Period|Miscellaneous|0|||
131797931|NCT04799158|474543458|FG004|On-Demand Treatment Period|Miscellaneous|1|||
131797932|NCT03922477|474543461|FG000|Overall Study|Death|9|||
131797933|NCT03922477|474543461|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
131797934|NCT03922477|474543461|FG000|Overall Study|Physician Decision|1|||
131797935|NCT03922477|474543461|FG000|Overall Study|Withdrawal by Subject|2|||
131797936|NCT00662129|474543467|FG000|Overall Study|Protocol Violation|1|||
131797937|NCT00662129|474543467|FG000|Overall Study|Cancel prior to beginning treatment|1|||
131797938|NCT00662129|474543467|FG000|Overall Study|Ineligible|1|||
131797939|NCT00918567|474543470|FG000|Overall Study|Lack of Efficacy|3|||
131797940|NCT00918567|474543471|FG001|Overall Study|Lack of Efficacy|1|||
131797941|NCT00918567|474543470|FG000|Overall Study|Withdrawal by Subject|1|||
131797942|NCT00918567|474543471|FG001|Overall Study|Withdrawal by Subject|1|||
131797943|NCT00918567|474543470|FG000|Overall Study|Adverse Event|1|||
131797944|NCT00918567|474543471|FG001|Overall Study|Adverse Event|0|||
131902067|NCT00974311|474926932|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
131630794|NCT01517282|473931958|FG002|Overall Study|Physician Decision|0|||
131630795|NCT01517282|473931959|FG003|Overall Study|Physician Decision|0|||
131713137|NCT01967225|474226330|FG001|Overall Study|Adverse Event|1|||
131630796|NCT02332889|473931967|FG000|Overall Study|Physician Decision|1|||
131630797|NCT00668746|473932884|FG000|Overall Study|Lost to Follow-up|2|||
131630798|NCT00668746|473932885|FG001|Overall Study|Lost to Follow-up|1|||
131630799|NCT02109172|473932886|FG000|Overall Study|Withdrawal by Subject|1|||
131713138|NCT01967225|474226329|FG000|Overall Study|Withdrawal by Subject|2|||
131713139|NCT01967225|474226330|FG001|Overall Study|Withdrawal by Subject|1|||
131713140|NCT01967225|474226329|FG000|Overall Study|Lack of Efficacy|1|||
131713141|NCT01967225|474226330|FG001|Overall Study|Lack of Efficacy|1|||
131713142|NCT01967225|474226329|FG000|Overall Study|Switching to other therapy|2|||
131713143|NCT01967225|474226330|FG001|Overall Study|Switching to other therapy|0|||
131713144|NCT01967225|474226329|FG000|Overall Study|Protocol driven decision point|1|||
131713145|NCT01967225|474226330|FG001|Overall Study|Protocol driven decision point|0|||
131713146|NCT01967225|474226329|FG000|Overall Study|Logistical difficulties|1|||
131713147|NCT01967225|474226330|FG001|Overall Study|Logistical difficulties|0|||
131713148|NCT01967225|474226329|FG000|Overall Study|Protocol Violation|2|||
131713149|NCT01967225|474226330|FG001|Overall Study|Protocol Violation|0|||
131797945|NCT02153736|474543476|FG000|Overall Study|Lost to Follow-up|1|||
131797946|NCT02153736|474543477|FG001|Overall Study|Lost to Follow-up|0|||
131797947|NCT02153736|474543476|FG000|Overall Study|Medical status change made ineligible|1|||
131797948|NCT02153736|474543477|FG001|Overall Study|Medical status change made ineligible|0|||
131797949|NCT02153736|474543476|FG000|Overall Study|Death|0|||
131797950|NCT02153736|474543477|FG001|Overall Study|Death|1|||
131797951|NCT02153736|474543476|FG000|Overall Study|Withdrawal by Subject|0|||
131797952|NCT02153736|474543477|FG001|Overall Study|Withdrawal by Subject|1|||
131797953|NCT02568384|474543483|FG000|Overall Study|Mobile devices incompatible with App|2|||
131797954|NCT01485536|474543484|FG000|Overall Study|Withdrawal by Subject|3|||
131630800|NCT02109172|473932887|FG001|Overall Study|Withdrawal by Subject|0|||
131630801|NCT02109172|473932888|FG002|Overall Study|Withdrawal by Subject|0|||
131630802|NCT02109172|473932889|FG003|Overall Study|Withdrawal by Subject|1|||
131630803|NCT02109172|473932890|FG004|Overall Study|Withdrawal by Subject|0|||
131630804|NCT02109172|473932891|FG005|Overall Study|Withdrawal by Subject|0|||
131630805|NCT02109172|473932886|FG000|Overall Study|Adverse Event|0|||
131630806|NCT02109172|473932887|FG001|Overall Study|Adverse Event|0|||
131713150|NCT00327444|474226331|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
131713151|NCT00327444|474226332|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
131713152|NCT00327444|474226331|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
131630807|NCT02109172|473932888|FG002|Overall Study|Adverse Event|1|||
131630808|NCT02109172|473932889|FG003|Overall Study|Adverse Event|0|||
131630809|NCT02109172|473932890|FG004|Overall Study|Adverse Event|0|||
131630810|NCT02109172|473932891|FG005|Overall Study|Adverse Event|1|||
131630811|NCT02109172|473932886|FG000|Overall Study|Death|0|||
131630812|NCT02109172|473932887|FG001|Overall Study|Death|0|||
131713153|NCT00327444|474226332|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
131713154|NCT00327444|474226331|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
131713155|NCT00327444|474226332|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
131713156|NCT00327444|474226331|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
131713157|NCT00327444|474226332|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
131713158|NCT00327444|474226331|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
131713159|NCT00327444|474226332|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
131713160|NCT00327444|474226331|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
131713161|NCT00327444|474226332|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
131713162|NCT00327444|474226331|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
131713163|NCT00327444|474226332|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
131713164|NCT00327444|474226331|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
131713165|NCT00327444|474226332|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
131713166|NCT04439344|474226333|FG000|Overall Study|Never started threapy|3|||
131713167|NCT04439344|474226333|FG000|Overall Study|Ineligible|3|||
131713168|NCT04439344|474226333|FG000|Overall Study|Adverse Event|13|||
131713169|NCT04439344|474226333|FG000|Overall Study|Death|2|||
131713170|NCT04439344|474226333|FG000|Overall Study|Disease progression|29|||
131713171|NCT04439344|474226333|FG000|Overall Study|Withdrawal by Subject|2|||
131713172|NCT04439344|474226333|FG000|Overall Study|Alternative therapy|1|||
131713173|NCT01926626|474226334|FG000|Overall Study|Withdrawal by Subject|15|||
131713174|NCT01926626|474226334|FG000|Overall Study|Lost to Follow-up|7|||
131713175|NCT00666562|474226337|FG000|Overall Study|Withdrawal by Subject|0|||
131713176|NCT00666562|474226338|FG001|Overall Study|Withdrawal by Subject|1|||
131713177|NCT00666562|474226339|FG002|Overall Study|Withdrawal by Subject|0|||
131713178|NCT00666562|474226337|FG000|Overall Study|Concomitant Medication|0|||
131630813|NCT02109172|473932888|FG002|Overall Study|Death|0|||
131797955|NCT01485536|474543484|FG000|Overall Study|Adverse Event|1|||
131797956|NCT00796510|474543485|FG000|Overall Study|Death|1|||
131797957|NCT00796510|474543486|FG001|Overall Study|Death|0|||
131797958|NCT00796510|474543485|FG000|Overall Study|Study Terminated|2|||
131797959|NCT00796510|474543486|FG001|Overall Study|Study Terminated|0|||
131902068|NCT00974311|474926933|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
131630814|NCT02109172|473932889|FG003|Overall Study|Death|0|||
131630815|NCT02109172|473932890|FG004|Overall Study|Death|1|||
131630816|NCT02109172|473932891|FG005|Overall Study|Death|0|||
131630817|NCT02011568|473932892|FG000|Overall Study|Withdrawal by Subject|8|||
131630818|NCT02011568|473932893|FG001|Overall Study|Withdrawal by Subject|10|||
131630819|NCT02011568|473932892|FG000|Overall Study|Physician Decision|1|||
131630820|NCT02011568|473932893|FG001|Overall Study|Physician Decision|3|||
131630821|NCT04751929|473932897|FG000|Overall Study|Withdrawal by Subject|2|||
131630822|NCT04751929|473932898|FG001|Overall Study|Withdrawal by Subject|0|||
131630823|NCT04751929|473932899|FG002|Overall Study|Withdrawal by Subject|0|||
131630824|NCT04751929|473932900|FG003|Overall Study|Withdrawal by Subject|0|||
131630825|NCT04751929|473932897|FG000|Overall Study|Rising PSA|0|||
131630826|NCT04751929|473932898|FG001|Overall Study|Rising PSA|1|||
131630827|NCT04751929|473932899|FG002|Overall Study|Rising PSA|0|||
131630828|NCT04751929|473932900|FG003|Overall Study|Rising PSA|0|||
131630829|NCT04751929|473932897|FG000|Overall Study|Adverse Event|1|||
131630830|NCT04751929|473932898|FG001|Overall Study|Adverse Event|2|||
131630831|NCT04751929|473932899|FG002|Overall Study|Adverse Event|0|||
131630832|NCT04751929|473932900|FG003|Overall Study|Adverse Event|0|||
131630833|NCT04751929|473932897|FG000|Overall Study|Progressive Disease|3|||
131713179|NCT00666562|474226338|FG001|Overall Study|Concomitant Medication|1|||
131713180|NCT00666562|474226339|FG002|Overall Study|Concomitant Medication|0|||
131797960|NCT00720122|474543492|FG000|Overall Study|Lost to Follow-up|1|||
131797961|NCT00720122|474543492|FG000|Overall Study|Physician Decision|1|||
131797962|NCT00720122|474543492|FG000|Overall Study|Withdrawal by Subject|7|||
131630834|NCT04751929|473932898|FG001|Overall Study|Progressive Disease|4|||
131630835|NCT04751929|473932899|FG002|Overall Study|Progressive Disease|4|||
131630836|NCT04751929|473932900|FG003|Overall Study|Progressive Disease|0|||
131630837|NCT04751929|473932897|FG000|Overall Study|Death|1|||
131630838|NCT04751929|473932898|FG001|Overall Study|Death|1|||
131713181|NCT02382133|474226340|FG000|Overall Study|Death|22|||
131713182|NCT02382133|474226340|FG000|Overall Study|transfer out of ICU|4|||
131630839|NCT04751929|473932899|FG002|Overall Study|Death|0|||
131630840|NCT04751929|473932900|FG003|Overall Study|Death|0|||
131630841|NCT02409732|473932901|FG000|Overall Study|Withdrawal by Subject|4|||
131630842|NCT02409732|473932901|FG000|Overall Study|Lost to Follow-up|2|||
131630843|NCT00376259|473932902|FG000|Overall Study|Sponsor request - study termination|21|||
131630844|NCT00376259|473932903|FG001|Overall Study|Sponsor request - study termination|21|||
131630845|NCT00376259|473932902|FG000|Overall Study|Patient request|1|||
131630846|NCT00376259|473932903|FG001|Overall Study|Patient request|0|||
131630847|NCT03960437|473932905|FG000|Overall Study|Removed by PI|4|||
131630848|NCT03960437|473932905|FG000|Overall Study|Lost to Follow-up|2|||
131630849|NCT03960437|473932905|FG000|Overall Study|Withdrawal by Subject|1|||
131630850|NCT03960437|473932905|FG000|Overall Study|Death|2|||
131630851|NCT00473512|473932908|FG000|Period 1 (Phase 1)|Adverse Event|0|||
131630852|NCT00473512|473932909|FG001|Period 1 (Phase 1)|Adverse Event|0|||
131630853|NCT00473512|473932910|FG002|Period 1 (Phase 1)|Adverse Event|0|||
131713183|NCT02382133|474226340|FG000|Overall Study|Physician Decision|2|||
131713184|NCT02382133|474226340|FG000|Overall Study|arterial catheter loss|4|||
131713185|NCT02382133|474226340|FG000|Overall Study|pressure injury both sites|1|||
131713186|NCT04906707|474226341|FG000|Overall Study|Withdrawal by Subject|2|||
131713187|NCT04906707|474226342|FG001|Overall Study|Withdrawal by Subject|0|||
131713188|NCT04906707|474226341|FG000|Overall Study|Withdrawal due to PI decision|1|||
131713189|NCT04906707|474226342|FG001|Overall Study|Withdrawal due to PI decision|0|||
131713190|NCT04906707|474226341|FG000|Overall Study|Lost to Follow-up|0|||
131713191|NCT04906707|474226342|FG001|Overall Study|Lost to Follow-up|1|||
131713192|NCT01976806|474226343|FG000|Overall Study|Lost to Follow-up|1|||
131713193|NCT01976806|474226344|FG001|Overall Study|Lost to Follow-up|4|||
131713194|NCT01976806|474226343|FG000|Overall Study|Adverse Event|1|||
131713195|NCT01976806|474226344|FG001|Overall Study|Adverse Event|1|||
131713196|NCT01976806|474226343|FG000|Overall Study|Withdrawal by Subject|1|||
131713197|NCT01976806|474226344|FG001|Overall Study|Withdrawal by Subject|1|||
131713198|NCT01523873|474226352|FG000|Overall Study|Protocol Violation|422|||
131713199|NCT04375761|474228662|FG000|Overall Study|Death|1|||
131713200|NCT04375761|474228663|FG001|Overall Study|Death|2|||
131713201|NCT04375761|474228662|FG000|Overall Study|Lost to Follow-up|203|||
131713202|NCT04375761|474228663|FG001|Overall Study|Lost to Follow-up|380|||
131713203|NCT04375761|474228662|FG000|Overall Study|Withdrawal by Subject|47|||
131713204|NCT04375761|474228663|FG001|Overall Study|Withdrawal by Subject|98|||
131713205|NCT04375761|474228662|FG000|Overall Study|Noncompliance with study procedure|121|||
131713206|NCT04375761|474228663|FG001|Overall Study|Noncompliance with study procedure|251|||
131713207|NCT04375761|474228662|FG000|Overall Study|Reimbursement not enough|1|||
131713208|NCT04375761|474228663|FG001|Overall Study|Reimbursement not enough|2|||
131713209|NCT04375761|474228662|FG000|Overall Study|Unforeseen family circumstances|1|||
131713210|NCT04375761|474228663|FG001|Overall Study|Unforeseen family circumstances|3|||
131713211|NCT04375761|474228662|FG000|Overall Study|Test too painful|1|||
131713212|NCT04375761|474228663|FG001|Overall Study|Test too painful|1|||
131713213|NCT04375761|474228662|FG000|Overall Study|Moved|0|||
131713214|NCT04375761|474228663|FG001|Overall Study|Moved|2|||
131713215|NCT04375761|474228662|FG000|Overall Study|Nonresponsive|0|||
131713216|NCT04375761|474228663|FG001|Overall Study|Nonresponsive|5|||
131713217|NCT03797001|474228664|FG000|Overall Study|Withdrawn due to COVID19|4|||
131713218|NCT03797001|474228665|FG001|Overall Study|Withdrawn due to COVID19|0|||
131713219|NCT03797001|474228664|FG000|Overall Study|Withdrawal by Subject|7|||
131713220|NCT03797001|474228665|FG001|Overall Study|Withdrawal by Subject|6|||
131713221|NCT03797001|474228664|FG000|Overall Study|Adverse Event|0|||
131713222|NCT03797001|474228665|FG001|Overall Study|Adverse Event|1|||
131713223|NCT05556616|474228668|FG000|Overall Study|Withdrawal by Subject|1|||
131713224|NCT05556616|474228669|FG001|Overall Study|Withdrawal by Subject|0|||
131713225|NCT05556616|474228670|FG002|Overall Study|Withdrawal by Subject|0|||
131713226|NCT05556616|474228671|FG003|Overall Study|Withdrawal by Subject|0|||
131713227|NCT05556616|474228672|FG004|Overall Study|Withdrawal by Subject|0|||
131713228|NCT05556616|474228673|FG005|Overall Study|Withdrawal by Subject|0|||
131713229|NCT05556616|474228674|FG006|Overall Study|Withdrawal by Subject|0|||
131713230|NCT05556616|474228668|FG000|Overall Study|Death|0|||
131713231|NCT05556616|474228669|FG001|Overall Study|Death|0|||
131713232|NCT05556616|474228670|FG002|Overall Study|Death|2|||
131713233|NCT05556616|474228671|FG003|Overall Study|Death|1|||
131713234|NCT05556616|474228672|FG004|Overall Study|Death|0|||
131713235|NCT05556616|474228673|FG005|Overall Study|Death|0|||
131713236|NCT05556616|474228674|FG006|Overall Study|Death|0|||
131713237|NCT05556616|474228668|FG000|Overall Study|Study Terminated by Sponsor|0|||
131713238|NCT05556616|474228669|FG001|Overall Study|Study Terminated by Sponsor|3|||
131630854|NCT00473512|473932911|FG003|Period 1 (Phase 1)|Adverse Event|5|||
131630855|NCT00473512|473932912|FG004|Period 1 (Phase 1)|Adverse Event|0|||
131713239|NCT05556616|474228670|FG002|Overall Study|Study Terminated by Sponsor|0|||
131713240|NCT05556616|474228671|FG003|Overall Study|Study Terminated by Sponsor|0|||
131713241|NCT05556616|474228672|FG004|Overall Study|Study Terminated by Sponsor|0|||
131713242|NCT05556616|474228673|FG005|Overall Study|Study Terminated by Sponsor|0|||
131713243|NCT05556616|474228674|FG006|Overall Study|Study Terminated by Sponsor|0|||
131713244|NCT00075881|474228677|FG000|Overall Study|Lack of Efficacy|18|||
131713245|NCT00075881|474228677|FG000|Overall Study|Adverse Event|7|||
131713246|NCT00075881|474228677|FG000|Overall Study|Death|1|||
131630856|NCT00473512|473932908|FG000|Period 1 (Phase 1)|Death|0|||
131630857|NCT00473512|473932909|FG001|Period 1 (Phase 1)|Death|0|||
131630858|NCT00473512|473932910|FG002|Period 1 (Phase 1)|Death|0|||
131630859|NCT00473512|473932911|FG003|Period 1 (Phase 1)|Death|1|||
131630860|NCT00473512|473932912|FG004|Period 1 (Phase 1)|Death|0|||
131630861|NCT00473512|473932908|FG000|Period 1 (Phase 1)|Disease Progression|1|||
131630862|NCT00473512|473932909|FG001|Period 1 (Phase 1)|Disease Progression|1|||
131630863|NCT00473512|473932910|FG002|Period 1 (Phase 1)|Disease Progression|0|||
131630864|NCT00473512|473932911|FG003|Period 1 (Phase 1)|Disease Progression|10|||
131630865|NCT00473512|473932912|FG004|Period 1 (Phase 1)|Disease Progression|1|||
131630866|NCT00473512|473932908|FG000|Period 1 (Phase 1)|Other|0|||
131630867|NCT00473512|473932909|FG001|Period 1 (Phase 1)|Other|0|||
131630868|NCT00473512|473932910|FG002|Period 1 (Phase 1)|Other|0|||
131630869|NCT00473512|473932911|FG003|Period 1 (Phase 1)|Other|1|||
131630870|NCT00473512|473932912|FG004|Period 1 (Phase 1)|Other|0|||
131630871|NCT00473512|473932908|FG000|Period 2 (Phase 2)|Adverse Event|0|||
131630872|NCT00473512|473932909|FG001|Period 2 (Phase 2)|Adverse Event|0|||
131630873|NCT00473512|473932910|FG002|Period 2 (Phase 2)|Adverse Event|0|||
131630874|NCT00473512|473932911|FG003|Period 2 (Phase 2)|Adverse Event|1|||
131630875|NCT00473512|473932912|FG004|Period 2 (Phase 2)|Adverse Event|0|||
131630876|NCT00473512|473932908|FG000|Period 2 (Phase 2)|Death|0|||
131630877|NCT00473512|473932909|FG001|Period 2 (Phase 2)|Death|0|||
131630878|NCT00473512|473932910|FG002|Period 2 (Phase 2)|Death|0|||
131630879|NCT00473512|473932911|FG003|Period 2 (Phase 2)|Death|1|||
131630880|NCT00473512|473932912|FG004|Period 2 (Phase 2)|Death|1|||
131630881|NCT00473512|473932908|FG000|Period 2 (Phase 2)|Disease Progression|0|||
131630882|NCT00473512|473932909|FG001|Period 2 (Phase 2)|Disease Progression|2|||
131630883|NCT00473512|473932910|FG002|Period 2 (Phase 2)|Disease Progression|2|||
131630884|NCT00473512|473932911|FG003|Period 2 (Phase 2)|Disease Progression|17|||
131630885|NCT00473512|473932912|FG004|Period 2 (Phase 2)|Disease Progression|1|||
131630886|NCT00473512|473932908|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131630887|NCT00473512|473932909|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131630888|NCT00473512|473932910|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131630889|NCT00473512|473932911|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
131630890|NCT00473512|473932912|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131630891|NCT00473512|473932908|FG000|Period 2 (Phase 2)|Other|1|||
131630892|NCT00473512|473932909|FG001|Period 2 (Phase 2)|Other|0|||
131630893|NCT00473512|473932910|FG002|Period 2 (Phase 2)|Other|0|||
131630894|NCT00473512|473932911|FG003|Period 2 (Phase 2)|Other|3|||
131630895|NCT00473512|473932912|FG004|Period 2 (Phase 2)|Other|0|||
131630896|NCT00267956|473932913|FG000|Controlled Period|Adverse Event|4|||
131630897|NCT00267956|473932914|FG001|Controlled Period|Adverse Event|1|||
131630898|NCT00267956|473932915|FG002|Controlled Period|Adverse Event|0|||
131630899|NCT00267956|473932916|FG003|Controlled Period|Adverse Event|0|||
131630900|NCT00267956|473932913|FG000|Controlled Period|Lack of Efficacy|4|||
131630901|NCT00267956|473932914|FG001|Controlled Period|Lack of Efficacy|2|||
131630902|NCT00267956|473932915|FG002|Controlled Period|Lack of Efficacy|0|||
131630903|NCT00267956|473932916|FG003|Controlled Period|Lack of Efficacy|0|||
131630904|NCT00267956|473932913|FG000|Controlled Period|Lost to Follow-up|2|||
131630905|NCT00267956|473932914|FG001|Controlled Period|Lost to Follow-up|0|||
131630906|NCT00267956|473932915|FG002|Controlled Period|Lost to Follow-up|0|||
131630907|NCT00267956|473932916|FG003|Controlled Period|Lost to Follow-up|0|||
131630908|NCT00267956|473932913|FG000|Controlled Period|Withdrew consent|3|||
131630909|NCT00267956|473932914|FG001|Controlled Period|Withdrew consent|1|||
131630910|NCT00267956|473932915|FG002|Controlled Period|Withdrew consent|0|||
131630911|NCT00267956|473932916|FG003|Controlled Period|Withdrew consent|0|||
131630912|NCT00267956|473932913|FG000|After Controlled Period|Adverse Event|0|||
131630913|NCT00267956|473932914|FG001|After Controlled Period|Adverse Event|0|||
131630914|NCT00267956|473932915|FG002|After Controlled Period|Adverse Event|2|||
131630915|NCT00267956|473932916|FG003|After Controlled Period|Adverse Event|1|||
131630916|NCT00267956|473932913|FG000|After Controlled Period|Lack of Efficacy|0|||
131630917|NCT00267956|473932914|FG001|After Controlled Period|Lack of Efficacy|0|||
131630918|NCT00267956|473932915|FG002|After Controlled Period|Lack of Efficacy|1|||
131630919|NCT00267956|473932916|FG003|After Controlled Period|Lack of Efficacy|1|||
131630920|NCT00267956|473932913|FG000|After Controlled Period|Lost to Follow-up|0|||
131630921|NCT00267956|473932914|FG001|After Controlled Period|Lost to Follow-up|0|||
131630922|NCT00267956|473932915|FG002|After Controlled Period|Lost to Follow-up|1|||
131630923|NCT00267956|473932916|FG003|After Controlled Period|Lost to Follow-up|0|||
131630924|NCT00267956|473932913|FG000|After Controlled Period|Withdrew consent|0|||
131630925|NCT00267956|473932914|FG001|After Controlled Period|Withdrew consent|0|||
131630926|NCT00267956|473932915|FG002|After Controlled Period|Withdrew consent|1|||
131630927|NCT00267956|473932916|FG003|After Controlled Period|Withdrew consent|0|||
131630928|NCT01263223|473932917|FG000|Period 2|Withdrawal by Subject|0|||
131630929|NCT01263223|473932918|FG001|Period 2|Withdrawal by Subject|1|||
131630930|NCT01263223|473932917|FG000|7-day Follow-up|Withdrawal by Subject|0|||
131630931|NCT01263223|473932918|FG001|7-day Follow-up|Withdrawal by Subject|1|||
131630932|NCT01263223|473932917|FG000|7-day Follow-up|Lost to Follow-up|1|||
131630933|NCT01263223|473932918|FG001|7-day Follow-up|Lost to Follow-up|0|||
131630934|NCT02246647|473932919|FG000|Overall Study|Withdrawal by Subject|1|||
131630935|NCT02246647|473932920|FG001|Overall Study|Withdrawal by Subject|1|||
131630936|NCT01012999|473932921|FG000|Overall Study|Protocol Violation|1|||
131630937|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
131630938|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
131630939|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
131630940|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
131630941|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
131630942|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
131630943|NCT03557307|473932922|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
131630944|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
131630945|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|Death|3|||
131630946|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
131630947|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
131797963|NCT02097121|474543493|FG000|Overall Study|Other, not specified|4|||
131797964|NCT02097121|474543494|FG001|Overall Study|Other, not specified|2|||
131797965|NCT02097121|474543495|FG002|Overall Study|Other, not specified|3|||
131797966|NCT02097121|474543493|FG000|Overall Study|Lack of Efficacy|2|||
131797967|NCT02097121|474543494|FG001|Overall Study|Lack of Efficacy|1|||
131797968|NCT02097121|474543495|FG002|Overall Study|Lack of Efficacy|3|||
131630948|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
131630949|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
131630950|NCT03557307|473932922|FG000|Period 2: Maintenance Phase|other|3|||
131630951|NCT03184519|473932923|FG000|Overall Study|Lost to Follow-up|6|||
131797969|NCT02097121|474543493|FG000|Overall Study|Withdrawal by Subject|0|||
131797970|NCT02097121|474543494|FG001|Overall Study|Withdrawal by Subject|1|||
131797971|NCT02097121|474543495|FG002|Overall Study|Withdrawal by Subject|2|||
131713247|NCT00075881|474228677|FG000|Overall Study|Withdrawal by Subject|2|||
131713248|NCT00075881|474228677|FG000|Overall Study|Protocol Violation|4|||
131713249|NCT00075881|474228677|FG000|Overall Study|other complicating disease|3|||
131713250|NCT00075881|474228677|FG000|Overall Study|other|4|||
131713251|NCT00075881|474228677|FG000|Overall Study|missing data|2|||
131713252|NCT00075881|474228677|FG000|Overall Study|Ineligible|1|||
131713253|NCT00075881|474228677|FG000|Overall Study|never start protocol therapy|1|||
131713254|NCT02031679|474228678|FG000|Overall Study|Protocol Violation|0|||
131713255|NCT02031679|474228679|FG001|Overall Study|Protocol Violation|1|||
131713256|NCT02031679|474228678|FG000|Overall Study|Lack of Efficacy|0|||
131713257|NCT02031679|474228679|FG001|Overall Study|Lack of Efficacy|1|||
131713258|NCT04030195|474228680|FG000|Overall Study|Withdrawal by Subject|2|||
131713259|NCT04030195|474228681|FG001|Overall Study|Withdrawal by Subject|0|||
131713260|NCT04030195|474228682|FG002|Overall Study|Withdrawal by Subject|0|||
131713261|NCT01412879|474228683|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
131713262|NCT01412879|474228684|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
131713263|NCT01412879|474228685|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
131713264|NCT01412879|474228683|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
131713265|NCT01412879|474228684|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
131713266|NCT01412879|474228685|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
131713267|NCT01412879|474228683|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
131713268|NCT01412879|474228684|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
131713269|NCT01412879|474228685|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
131713270|NCT01412879|474228683|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
131713271|NCT01412879|474228684|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
131713272|NCT01412879|474228685|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
131713273|NCT01412879|474228683|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
131713274|NCT01412879|474228684|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
131713275|NCT01412879|474228685|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
131713276|NCT02109029|474228686|FG000|Part B|Adverse Event|0|||
131713277|NCT02109029|474228687|FG001|Part B|Adverse Event|0|||
131713278|NCT02109029|474228688|FG002|Part B|Adverse Event|0|||
131713279|NCT02109029|474228689|FG003|Part B|Adverse Event|0|||
131713280|NCT02109029|474228690|FG004|Part B|Adverse Event|1|||
131713281|NCT02109029|474228691|FG005|Part B|Adverse Event|1|||
131713282|NCT00162773|474228695|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
131713283|NCT02251743|474228697|FG000|Overall Study|Withdrawal by Subject|1|||
131713284|NCT02251743|474228698|FG001|Overall Study|Withdrawal by Subject|1|||
131713285|NCT00215150|474228699|FG000|Open Label Phase|Lost to Follow-up|7|||
131713286|NCT00215150|474228699|FG000|Open Label Phase|Withdrawal by Subject|1|||
131713287|NCT00215150|474228699|FG000|Open Label Phase|Did not complete a post base visit|13|||
131713288|NCT00215150|474228699|FG000|Open Label Phase|Did not meet randomization criteria|9|||
131797972|NCT02097121|474543493|FG000|Overall Study|Adverse Event|0|||
131797973|NCT02097121|474543494|FG001|Overall Study|Adverse Event|1|||
131797974|NCT02097121|474543495|FG002|Overall Study|Adverse Event|0|||
131797975|NCT02097121|474543493|FG000|Overall Study|Lost to Follow-up|1|||
131797976|NCT02097121|474543494|FG001|Overall Study|Lost to Follow-up|1|||
131797977|NCT02097121|474543495|FG002|Overall Study|Lost to Follow-up|2|||
131797978|NCT00661999|474543496|FG000|Overall Study|Adverse Event|11|||
131797979|NCT00661999|474543497|FG001|Overall Study|Adverse Event|5|||
131797980|NCT00661999|474543498|FG002|Overall Study|Adverse Event|8|||
131797981|NCT00661999|474543496|FG000|Overall Study|Death|8|||
131797982|NCT00661999|474543497|FG001|Overall Study|Death|6|||
131797983|NCT00661999|474543498|FG002|Overall Study|Death|3|||
131797984|NCT00661999|474543496|FG000|Overall Study|Other Reasons|5|||
131797985|NCT00661999|474543497|FG001|Overall Study|Other Reasons|12|||
131797986|NCT00661999|474543498|FG002|Overall Study|Other Reasons|23|||
131797987|NCT00661999|474543496|FG000|Overall Study|Withdrawal by Subject|30|||
131797988|NCT00661999|474543497|FG001|Overall Study|Withdrawal by Subject|23|||
131797989|NCT00661999|474543498|FG002|Overall Study|Withdrawal by Subject|14|||
131797990|NCT00661999|474543496|FG000|Overall Study|Alternative Treatment|1|||
131797991|NCT00661999|474543497|FG001|Overall Study|Alternative Treatment|0|||
131713289|NCT00215150|474228699|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
131713290|NCT00215150|474228699|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
131713291|NCT00215150|474228699|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
131713292|NCT01028352|474228704|FG000|Overall Study|Ineligible due to baseline average pain|5|||
131713293|NCT01028352|474228704|FG000|Overall Study|Withdrawal by Subject|1|||
131713294|NCT00260208|474228706|FG000|Overall Study|Subject withdrew consent|11|||
131713295|NCT00260208|474228707|FG001|Overall Study|Subject withdrew consent|7|||
131797992|NCT00661999|474543498|FG002|Overall Study|Alternative Treatment|0|||
131797993|NCT00661999|474543496|FG000|Overall Study|Other Medical Problems|4|||
131797994|NCT00661999|474543497|FG001|Overall Study|Other Medical Problems|4|||
131797995|NCT00661999|474543498|FG002|Overall Study|Other Medical Problems|9|||
131630952|NCT03184519|473932923|FG000|Overall Study|Physician Decision|21|||
131630953|NCT00584909|473932924|FG000|Overall Study|Adverse Event|4|||
131630954|NCT03345407|473932925|FG000|Overall Study|Withdrawal by Subject|11|||
131630955|NCT03345407|473932926|FG001|Overall Study|Withdrawal by Subject|1|||
131630956|NCT03345407|473932927|FG002|Overall Study|Withdrawal by Subject|5|||
131630957|NCT03345407|473932928|FG003|Overall Study|Withdrawal by Subject|6|||
131630958|NCT03345407|473932929|FG004|Overall Study|Withdrawal by Subject|3|||
131630959|NCT03345407|473932930|FG005|Overall Study|Withdrawal by Subject|6|||
131713296|NCT00260208|474228706|FG000|Overall Study|Lost to Follow-up|6|||
131713297|NCT00260208|474228707|FG001|Overall Study|Lost to Follow-up|1|||
131713298|NCT00260208|474228706|FG000|Overall Study|Death|12|||
131713299|NCT00260208|474228707|FG001|Overall Study|Death|10|||
131713300|NCT00260208|474228706|FG000|Overall Study|Missing|18|||
131713301|NCT00260208|474228707|FG001|Overall Study|Missing|16|||
131713302|NCT02091440|474228708|FG000|Overall Study|Death|2|||
131713303|NCT00768222|474228709|FG000|Overall Study|Lost to Follow-up|1|||
131713304|NCT00768222|474228710|FG001|Overall Study|Lost to Follow-up|1|||
131713305|NCT00768222|474228709|FG000|Overall Study|Withdrawal by Subject|3|||
131713306|NCT00768222|474228710|FG001|Overall Study|Withdrawal by Subject|1|||
131713307|NCT00768222|474228709|FG000|Overall Study|Protocol Violation|0|||
131713308|NCT00768222|474228710|FG001|Overall Study|Protocol Violation|2|||
131713309|NCT00278629|474228717|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
131713310|NCT03323749|474228718|FG000|Double-blind Period|Lost to Follow-up|4|||
131713311|NCT03323749|474228719|FG001|Double-blind Period|Lost to Follow-up|5|||
131713312|NCT03323749|474228718|FG000|Double-blind Period|Adverse Event|3|||
131713313|NCT03323749|474228719|FG001|Double-blind Period|Adverse Event|1|||
131713314|NCT03323749|474228718|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
131713315|NCT03323749|474228719|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
131713316|NCT03323749|474228718|FG000|Open-Label Period|Adverse Event|3|||
131713317|NCT03323749|474228719|FG001|Open-Label Period|Adverse Event|10|||
131713318|NCT03323749|474228718|FG000|Open-Label Period|Withdrawal by Subject|7|||
131713319|NCT03323749|474228719|FG001|Open-Label Period|Withdrawal by Subject|5|||
131713320|NCT03263091|474228721|FG000|OL Component|Withdrawal by Subject|1|||
131713321|NCT03263091|474228722|FG001|OL Component|Withdrawal by Subject|1|||
131713322|NCT03263091|474228723|FG002|OL Component|Withdrawal by Subject|0|||
131713323|NCT03263091|474228724|FG003|OL Component|Withdrawal by Subject|0|||
131713324|NCT03263091|474228725|FG004|OL Component|Withdrawal by Subject|0|||
131713325|NCT03263091|474228726|FG005|OL Component|Withdrawal by Subject|0|||
131713326|NCT03263091|474228721|FG000|OL Component|Physician Decision|0|||
131713327|NCT03263091|474228722|FG001|OL Component|Physician Decision|1|||
131713328|NCT03263091|474228723|FG002|OL Component|Physician Decision|2|||
131713329|NCT03263091|474228724|FG003|OL Component|Physician Decision|0|||
131713330|NCT03263091|474228725|FG004|OL Component|Physician Decision|0|||
131713331|NCT03263091|474228726|FG005|OL Component|Physician Decision|0|||
131713332|NCT03263091|474228721|FG000|OL Component|Death|1|||
131713333|NCT03263091|474228722|FG001|OL Component|Death|0|||
131713334|NCT03263091|474228723|FG002|OL Component|Death|0|||
131713335|NCT03263091|474228724|FG003|OL Component|Death|0|||
131713336|NCT03263091|474228725|FG004|OL Component|Death|0|||
131713337|NCT03263091|474228726|FG005|OL Component|Death|0|||
131713338|NCT03263091|474228721|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
131713339|NCT03263091|474228722|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
131713340|NCT03263091|474228723|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
131713341|NCT03263091|474228724|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
131713342|NCT03263091|474228725|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
131713343|NCT03263091|474228726|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
131713344|NCT03263091|474228721|FG000|OL High-EPO Component|Physician Decision|0|||
131713345|NCT03263091|474228722|FG001|OL High-EPO Component|Physician Decision|0|||
131713346|NCT03263091|474228723|FG002|OL High-EPO Component|Physician Decision|0|||
131713347|NCT03263091|474228724|FG003|OL High-EPO Component|Physician Decision|1|||
131713348|NCT03263091|474228725|FG004|OL High-EPO Component|Physician Decision|0|||
131713349|NCT03263091|474228726|FG005|OL High-EPO Component|Physician Decision|0|||
131713350|NCT03263091|474228721|FG000|OL High-EPO Component|Death|0|||
131902069|NCT00974311|474926932|FG000|DB Phase (up to 24 Months)|Death|561|||
131713351|NCT03263091|474228722|FG001|OL High-EPO Component|Death|0|||
131713352|NCT03263091|474228723|FG002|OL High-EPO Component|Death|0|||
131713353|NCT03263091|474228724|FG003|OL High-EPO Component|Death|3|||
131713354|NCT03263091|474228725|FG004|OL High-EPO Component|Death|0|||
131713355|NCT03263091|474228726|FG005|OL High-EPO Component|Death|0|||
131713356|NCT03263091|474228721|FG000|DB Component|Withdrawal by Subject|0|||
131713357|NCT03263091|474228722|FG001|DB Component|Withdrawal by Subject|0|||
131713358|NCT03263091|474228723|FG002|DB Component|Withdrawal by Subject|0|||
131713359|NCT03263091|474228724|FG003|DB Component|Withdrawal by Subject|0|||
131713360|NCT03263091|474228725|FG004|DB Component|Withdrawal by Subject|22|||
131630960|NCT03345407|473932931|FG006|Overall Study|Withdrawal by Subject|16|||
131630961|NCT03345407|473932925|FG000|Overall Study|Physician Decision|3|||
131630962|NCT03345407|473932926|FG001|Overall Study|Physician Decision|1|||
131630963|NCT03345407|473932927|FG002|Overall Study|Physician Decision|0|||
131630964|NCT03345407|473932928|FG003|Overall Study|Physician Decision|0|||
131630965|NCT03345407|473932929|FG004|Overall Study|Physician Decision|1|||
131630966|NCT03345407|473932930|FG005|Overall Study|Physician Decision|2|||
131630967|NCT03345407|473932931|FG006|Overall Study|Physician Decision|3|||
131630968|NCT03345407|473932925|FG000|Overall Study|Lost to Follow-up|2|||
131630969|NCT03345407|473932926|FG001|Overall Study|Lost to Follow-up|0|||
131630970|NCT03345407|473932927|FG002|Overall Study|Lost to Follow-up|1|||
131630971|NCT03345407|473932928|FG003|Overall Study|Lost to Follow-up|0|||
131630972|NCT03345407|473932929|FG004|Overall Study|Lost to Follow-up|1|||
131630973|NCT03345407|473932930|FG005|Overall Study|Lost to Follow-up|2|||
131630974|NCT03345407|473932931|FG006|Overall Study|Lost to Follow-up|3|||
131630975|NCT03345407|473932925|FG000|Overall Study|Protocol-defined stopping criteria|9|||
131630976|NCT03345407|473932926|FG001|Overall Study|Protocol-defined stopping criteria|0|||
131630977|NCT03345407|473932927|FG002|Overall Study|Protocol-defined stopping criteria|0|||
131797996|NCT03066999|474543499|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
131630978|NCT03345407|473932928|FG003|Overall Study|Protocol-defined stopping criteria|0|||
131797997|NCT03066999|474543500|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
131797998|NCT00510510|474543501|FG000|Overall Study|Adverse Event|4|||
131797999|NCT00510510|474543502|FG001|Overall Study|Adverse Event|3|||
131798000|NCT00510510|474543503|FG002|Overall Study|Adverse Event|6|||
131798001|NCT00510510|474543501|FG000|Overall Study|Lack of Efficacy|0|||
131798002|NCT00510510|474543502|FG001|Overall Study|Lack of Efficacy|1|||
131630979|NCT03345407|473932929|FG004|Overall Study|Protocol-defined stopping criteria|2|||
131630980|NCT03345407|473932930|FG005|Overall Study|Protocol-defined stopping criteria|1|||
131630981|NCT03345407|473932931|FG006|Overall Study|Protocol-defined stopping criteria|1|||
131630982|NCT03345407|473932925|FG000|Overall Study|Protocol Violation|2|||
131630983|NCT03345407|473932926|FG001|Overall Study|Protocol Violation|0|||
131630984|NCT03345407|473932927|FG002|Overall Study|Protocol Violation|0|||
131630985|NCT03345407|473932928|FG003|Overall Study|Protocol Violation|0|||
131630986|NCT03345407|473932929|FG004|Overall Study|Protocol Violation|1|||
131630987|NCT03345407|473932930|FG005|Overall Study|Protocol Violation|0|||
131630988|NCT03345407|473932931|FG006|Overall Study|Protocol Violation|3|||
131630989|NCT03345407|473932925|FG000|Overall Study|Lack of Efficacy|1|||
131630990|NCT03345407|473932926|FG001|Overall Study|Lack of Efficacy|1|||
131630991|NCT03345407|473932927|FG002|Overall Study|Lack of Efficacy|1|||
131630992|NCT03345407|473932928|FG003|Overall Study|Lack of Efficacy|1|||
131630993|NCT03345407|473932929|FG004|Overall Study|Lack of Efficacy|1|||
131630994|NCT03345407|473932930|FG005|Overall Study|Lack of Efficacy|0|||
131630995|NCT03345407|473932931|FG006|Overall Study|Lack of Efficacy|3|||
131630996|NCT03345407|473932925|FG000|Overall Study|Adverse Event|4|||
131630997|NCT03345407|473932926|FG001|Overall Study|Adverse Event|0|||
131630998|NCT03345407|473932927|FG002|Overall Study|Adverse Event|5|||
131630999|NCT03345407|473932928|FG003|Overall Study|Adverse Event|4|||
131631000|NCT03345407|473932929|FG004|Overall Study|Adverse Event|6|||
131631001|NCT03345407|473932930|FG005|Overall Study|Adverse Event|5|||
131631002|NCT03345407|473932931|FG006|Overall Study|Adverse Event|16|||
131631003|NCT01601821|473932932|FG000|Overall Study|Death|2|||
131631004|NCT01601821|473932933|FG001|Overall Study|Death|5|||
131631005|NCT01601821|473932932|FG000|Overall Study|Protocol Violation|2|||
131631006|NCT01601821|473932933|FG001|Overall Study|Protocol Violation|2|||
131631007|NCT01601821|473932932|FG000|Overall Study|Lost to Follow-up|6|||
131631008|NCT01601821|473932933|FG001|Overall Study|Lost to Follow-up|14|||
131631009|NCT01601821|473932932|FG000|Overall Study|Withdrawal by Subject|1|||
131631010|NCT01601821|473932933|FG001|Overall Study|Withdrawal by Subject|0|||
131631011|NCT01601821|473932932|FG000|Overall Study|Graft Loss|6|||
131631012|NCT01601821|473932933|FG001|Overall Study|Graft Loss|6|||
131631013|NCT01601821|473932932|FG000|Overall Study|Study Events|7|||
131631014|NCT01601821|473932933|FG001|Overall Study|Study Events|1|||
131798003|NCT00510510|474543503|FG002|Overall Study|Lack of Efficacy|1|||
131631015|NCT01601821|473932932|FG000|Overall Study|Other|5|||
131631016|NCT01601821|473932933|FG001|Overall Study|Other|1|||
131631017|NCT02469155|473932934|FG000|Overall Study|Adverse Event|6|||
131631018|NCT02469155|473932935|FG001|Overall Study|Adverse Event|0|||
131631019|NCT02469155|473932936|FG002|Overall Study|Adverse Event|1|||
131631020|NCT02469155|473932937|FG003|Overall Study|Adverse Event|10|||
131631021|NCT02469155|473932934|FG000|Overall Study|Lack of Efficacy|13|||
131631022|NCT02469155|473932935|FG001|Overall Study|Lack of Efficacy|10|||
131631023|NCT02469155|473932936|FG002|Overall Study|Lack of Efficacy|10|||
131631024|NCT02469155|473932937|FG003|Overall Study|Lack of Efficacy|8|||
131631025|NCT02469155|473932934|FG000|Overall Study|Death|0|||
131631026|NCT02469155|473932935|FG001|Overall Study|Death|0|||
131631027|NCT02469155|473932936|FG002|Overall Study|Death|0|||
131631028|NCT02469155|473932937|FG003|Overall Study|Death|1|||
131798004|NCT00510510|474543501|FG000|Overall Study|Subjects no longer requires study drug|0|||
131798005|NCT00510510|474543502|FG001|Overall Study|Subjects no longer requires study drug|0|||
131631029|NCT02469155|473932934|FG000|Overall Study|Lost to Follow-up|5|||
131631030|NCT02469155|473932935|FG001|Overall Study|Lost to Follow-up|2|||
131631031|NCT02469155|473932936|FG002|Overall Study|Lost to Follow-up|7|||
131631032|NCT02469155|473932937|FG003|Overall Study|Lost to Follow-up|2|||
131631033|NCT02469155|473932934|FG000|Overall Study|Physician Decision|0|||
131902070|NCT00974311|474926933|FG001|DB Phase (up to 24 Months)|Death|298|||
131902071|NCT00974311|474926932|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
131902072|NCT00974311|474926933|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
131902073|NCT00974311|474926932|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
131902074|NCT00974311|474926933|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
131902075|NCT00974311|474926932|FG000|DB Phase (up to 24 Months)|Other|1|||
131902076|NCT00974311|474926933|FG001|DB Phase (up to 24 Months)|Other|0|||
131902077|NCT00974311|474926932|FG000|OLE Phase (up to 77 Months)|Death|14|||
131902078|NCT00974311|474926933|FG001|OLE Phase (up to 77 Months)|Death|21|||
131902079|NCT00974311|474926932|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
131902080|NCT00974311|474926933|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
131902081|NCT00974311|474926932|FG000|OLE Phase (up to 77 Months)|Other|15|||
131902082|NCT00974311|474926933|FG001|OLE Phase (up to 77 Months)|Other|2|||
131902083|NCT00974311|474926932|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
131902084|NCT00974311|474926933|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
131902085|NCT05556148|474926934|FG000|Overall Study|Early Termination|29|||
131902086|NCT05556148|474926934|FG000|Overall Study|Baseline Tasks Expired|4|||
131631034|NCT02469155|473932935|FG001|Overall Study|Physician Decision|0|||
131902087|NCT05556148|474926934|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
131902088|NCT05556148|474926934|FG000|Overall Study|No Longer Wished to Participate|1|||
131902089|NCT05556148|474926934|FG000|Overall Study|Bacterial Conjunctivitis|1|||
131902090|NCT00458003|474926935|FG000|Overall Study|Non protocol spinal anesthesia|1|||
131631035|NCT02469155|473932936|FG002|Overall Study|Physician Decision|1|||
131631036|NCT02469155|473932937|FG003|Overall Study|Physician Decision|0|||
131631037|NCT02469155|473932934|FG000|Overall Study|Withdrawal by Subject|34|||
131631038|NCT02469155|473932935|FG001|Overall Study|Withdrawal by Subject|30|||
131631039|NCT02469155|473932936|FG002|Overall Study|Withdrawal by Subject|20|||
131631040|NCT02469155|473932937|FG003|Overall Study|Withdrawal by Subject|37|||
131631041|NCT02469155|473932934|FG000|Overall Study|Other|3|||
131631042|NCT02469155|473932935|FG001|Overall Study|Other|3|||
131631043|NCT02469155|473932936|FG002|Overall Study|Other|2|||
131631044|NCT02469155|473932937|FG003|Overall Study|Other|10|||
131631045|NCT02469155|473932934|FG000|Overall Study|Protocol Violation|0|||
131631046|NCT02469155|473932935|FG001|Overall Study|Protocol Violation|1|||
131631047|NCT02469155|473932936|FG002|Overall Study|Protocol Violation|0|||
131631048|NCT02469155|473932937|FG003|Overall Study|Protocol Violation|1|||
131631049|NCT00442559|473932938|FG000|Overall Study|Lost to Follow-up|32|||
131631050|NCT00442559|473932939|FG001|Overall Study|Lost to Follow-up|34|||
131631051|NCT00442559|473932938|FG000|Overall Study|Protocol Violation|1|||
131631052|NCT00442559|473932939|FG001|Overall Study|Protocol Violation|1|||
131631053|NCT00442559|473932938|FG000|Overall Study|Withdrawal by Subject|1|||
131631054|NCT00442559|473932939|FG001|Overall Study|Withdrawal by Subject|0|||
131631055|NCT03708744|473932944|FG000|Overall Study|Withdrawal by Subject|0|||
131631056|NCT03708744|473932945|FG001|Overall Study|Withdrawal by Subject|0|||
131631057|NCT03708744|473932946|FG002|Overall Study|Withdrawal by Subject|1|||
131631058|NCT03708744|473932947|FG003|Overall Study|Withdrawal by Subject|0|||
131631059|NCT02812706|473932953|FG000|Phase 1|Adverse Event|0|||
131631060|NCT02812706|473932954|FG001|Phase 1|Adverse Event|2|||
131631061|NCT02812706|473932955|FG002|Phase 1|Adverse Event|0|||
131631062|NCT02812706|473932953|FG000|Phase 1|Progressive disease|3|||
131631063|NCT02812706|473932954|FG001|Phase 1|Progressive disease|3|||
131631064|NCT02812706|473932955|FG002|Phase 1|Progressive disease|0|||
131631065|NCT02812706|473932953|FG000|Phase 2|Adverse Event|0|||
131631066|NCT02812706|473932954|FG001|Phase 2|Adverse Event|0|||
131631067|NCT02812706|473932955|FG002|Phase 2|Adverse Event|2|||
131631068|NCT02812706|473932953|FG000|Phase 2|Progressive disease|0|||
131631069|NCT02812706|473932954|FG001|Phase 2|Progressive disease|0|||
131631070|NCT02812706|473932955|FG002|Phase 2|Progressive disease|22|||
131631071|NCT02812706|473932953|FG000|Phase 2|Other-Unspecified|0|||
131631072|NCT02812706|473932954|FG001|Phase 2|Other-Unspecified|0|||
131631073|NCT02812706|473932955|FG002|Phase 2|Other-Unspecified|4|||
131631074|NCT01885559|473932960|FG000|Overall Study|Lost to Follow-up|15|||
131631075|NCT01885559|473932961|FG001|Overall Study|Lost to Follow-up|16|||
131631076|NCT01885559|473932960|FG000|Overall Study|Less than full participation|9|||
131631077|NCT01885559|473932961|FG001|Overall Study|Less than full participation|19|||
131631078|NCT01885559|473932960|FG000|Overall Study|Protocol Violation|0|||
131631079|NCT01885559|473932961|FG001|Overall Study|Protocol Violation|1|||
131631080|NCT02009865|473932964|FG000|Overall Study|Adverse Event|0|||
131631081|NCT02009865|473932965|FG001|Overall Study|Adverse Event|2|||
131631082|NCT02009865|473932964|FG000|Overall Study|Protocol Violation|0|||
131631083|NCT02009865|473932965|FG001|Overall Study|Protocol Violation|2|||
131631084|NCT02009865|473932964|FG000|Overall Study|Withdrawal by Subject|1|||
131631085|NCT02009865|473932965|FG001|Overall Study|Withdrawal by Subject|1|||
131631086|NCT01760876|473932966|FG000|Overall Study|Non-cardiac death (head injury)|1|||
131631087|NCT01760876|473932966|FG000|Overall Study|Carcinoma of prostate|1|||
131631088|NCT01760876|473932966|FG000|Overall Study|Impaired renal function|1|||
131631089|NCT01760876|473932966|FG000|Overall Study|Major depression|1|||
131631090|NCT01760876|473932966|FG000|Overall Study|Very poor baseline OCT quality|2|||
131631091|NCT00525915|473932969|FG000|Overall Study|Non-Compliance|0|||
131631092|NCT00525915|473932970|FG001|Overall Study|Non-Compliance|1|||
131631093|NCT00525915|473932969|FG000|Overall Study|Disease Progression|5|||
131631094|NCT00525915|473932970|FG001|Overall Study|Disease Progression|6|||
131631095|NCT00525915|473932969|FG000|Overall Study|Withdrawal by Subject|1|||
131631096|NCT00525915|473932970|FG001|Overall Study|Withdrawal by Subject|0|||
131631097|NCT00525915|473932969|FG000|Overall Study|Refused Surgery|1|||
131631098|NCT00525915|473932970|FG001|Overall Study|Refused Surgery|2|||
131631099|NCT00525915|473932969|FG000|Overall Study|Unrelated illness|1|||
131631100|NCT00525915|473932970|FG001|Overall Study|Unrelated illness|0|||
131631101|NCT02819141|473932971|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
131631102|NCT02819141|473932972|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
131631103|NCT05927753|473933658|FG000|Overall Study|Withdrawal by Subject|0|||
131713361|NCT03263091|474228726|FG005|DB Component|Withdrawal by Subject|8|||
131631104|NCT05927753|473933659|FG001|Overall Study|Withdrawal by Subject|2|||
131631105|NCT05927753|473933658|FG000|Overall Study|Physician Decision|0|||
131631106|NCT05927753|473933659|FG001|Overall Study|Physician Decision|1|||
131631107|NCT02069366|473933663|FG000|Overall Study|Lost to Follow-up|0|||
131713362|NCT03263091|474228721|FG000|DB Component|Physician Decision|0|||
131631108|NCT02069366|473933664|FG001|Overall Study|Lost to Follow-up|0|||
131631109|NCT02069366|473933665|FG002|Overall Study|Lost to Follow-up|1|||
131631110|NCT02069366|473933666|FG003|Overall Study|Lost to Follow-up|0|||
131631111|NCT02069366|473933667|FG004|Overall Study|Lost to Follow-up|0|||
131631112|NCT02069366|473933668|FG005|Overall Study|Lost to Follow-up|2|||
131631113|NCT02069366|473933663|FG000|Overall Study|Protocol Violation|0|||
131631114|NCT02069366|473933664|FG001|Overall Study|Protocol Violation|0|||
131713363|NCT03263091|474228722|FG001|DB Component|Physician Decision|0|||
131631115|NCT02069366|473933665|FG002|Overall Study|Protocol Violation|1|||
131631116|NCT02069366|473933666|FG003|Overall Study|Protocol Violation|0|||
131631117|NCT02069366|473933667|FG004|Overall Study|Protocol Violation|0|||
131631118|NCT02069366|473933668|FG005|Overall Study|Protocol Violation|0|||
131631119|NCT02069366|473933663|FG000|Overall Study|Withdrawal by Subject|1|||
131631120|NCT02069366|473933664|FG001|Overall Study|Withdrawal by Subject|0|||
131631121|NCT02069366|473933665|FG002|Overall Study|Withdrawal by Subject|1|||
131631122|NCT02069366|473933666|FG003|Overall Study|Withdrawal by Subject|2|||
131631123|NCT02069366|473933667|FG004|Overall Study|Withdrawal by Subject|0|||
131631124|NCT02069366|473933668|FG005|Overall Study|Withdrawal by Subject|0|||
131631125|NCT02256553|473933669|FG000|Period I|Adverse Event|5|||
131631126|NCT02256553|473933669|FG000|Period I|Protocol Violation|1|||
131631127|NCT02256553|473933669|FG000|Period II|Adverse Event|1|||
131631128|NCT02256553|473933669|FG000|Period II|Subject Moved|1|||
131631129|NCT02256553|473933669|FG000|Period III|Adverse Event|3|||
131631130|NCT03436797|473933670|FG000|Main Study|Withdrawal by Subject|2|||
131631131|NCT03436797|473933670|FG000|Main Study|Adverse Event|4|||
131631132|NCT03436797|473933670|FG000|Main Study|Lost to Follow-up|1|||
131631133|NCT03436797|473933670|FG000|Main Study|Death|1|||
131631134|NCT03436797|473933670|FG000|Main Study|Non-Specific|2|||
131631135|NCT03436797|473933670|FG000|Extended Dosing|Patient decision|1|||
131631136|NCT01951105|473933675|FG000|Overall Study|Adverse Event|0|||
131631137|NCT01951105|473933676|FG001|Overall Study|Adverse Event|5|||
131631138|NCT01951105|473933677|FG002|Overall Study|Adverse Event|0|||
131631139|NCT01951105|473933675|FG000|Overall Study|Lost to Follow-up|0|||
131631140|NCT01951105|473933676|FG001|Overall Study|Lost to Follow-up|1|||
131631141|NCT01951105|473933677|FG002|Overall Study|Lost to Follow-up|0|||
131631142|NCT01951105|473933675|FG000|Overall Study|Protocol Violation|1|||
131631143|NCT01951105|473933676|FG001|Overall Study|Protocol Violation|1|||
131631144|NCT01951105|473933677|FG002|Overall Study|Protocol Violation|1|||
131631145|NCT01951105|473933675|FG000|Overall Study|Withdrawal by Subject|0|||
131631146|NCT01951105|473933676|FG001|Overall Study|Withdrawal by Subject|3|||
131631147|NCT01951105|473933677|FG002|Overall Study|Withdrawal by Subject|1|||
131631148|NCT04175392|473933678|FG000|Overall Study|Withdrawal by Subject|3|||
131631149|NCT04175392|473933679|FG001|Overall Study|Withdrawal by Subject|2|||
131631150|NCT02727998|473933680|FG000|Overall Study|Lost to Follow-up|3|||
131631151|NCT02727998|473933681|FG001|Overall Study|Lost to Follow-up|3|||
131631152|NCT02727998|473933680|FG000|Overall Study|Withdrawal by Subject|0|||
131631153|NCT02727998|473933681|FG001|Overall Study|Withdrawal by Subject|1|||
131631154|NCT02105688|473933682|FG000|Part A: Double-Blind|Adverse Event|1|||
131631155|NCT02105688|473933683|FG001|Part A: Double-Blind|Adverse Event|0|||
131631156|NCT02105688|473933682|FG000|Part A: Double-Blind|Death|0|||
131631157|NCT02105688|473933683|FG001|Part A: Double-Blind|Death|1|||
131631158|NCT02105688|473933682|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
131631159|NCT02105688|473933683|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
131631160|NCT02105688|473933682|FG000|Part A: Double-Blind|Physician Decision|0|||
131631161|NCT02105688|473933683|FG001|Part A: Double-Blind|Physician Decision|1|||
131631162|NCT02105688|473933682|FG000|Part A: Double-Blind|Status Unknown|0|||
131631163|NCT02105688|473933683|FG001|Part A: Double-Blind|Status Unknown|2|||
131631164|NCT02105688|473933682|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
131631165|NCT02105688|473933683|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
131631166|NCT02105688|473933682|FG000|Part B: Observational Follow-up|Death|2|||
131631167|NCT02105688|473933683|FG001|Part B: Observational Follow-up|Death|1|||
131631168|NCT02105688|473933682|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
131631169|NCT02105688|473933683|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
131631170|NCT02105688|473933682|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
131631171|NCT02105688|473933683|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
131631172|NCT02105688|473933682|FG000|Part B: Observational Follow-up|Physician Decision|3|||
131631173|NCT02105688|473933683|FG001|Part B: Observational Follow-up|Physician Decision|1|||
131631174|NCT02062827|473933690|FG000|Overall Study|Death|1|||
131631175|NCT02062827|473933691|FG001|Overall Study|Death|0|||
131631176|NCT02062827|473933692|FG002|Overall Study|Death|0|||
131631177|NCT02062827|473933693|FG003|Overall Study|Death|0|||
131631178|NCT02062827|473933694|FG004|Overall Study|Death|0|||
131798006|NCT00510510|474543503|FG002|Overall Study|Subjects no longer requires study drug|2|||
131798007|NCT00510510|474543501|FG000|Overall Study|Withdrawal by Subject|1|||
131798008|NCT00510510|474543502|FG001|Overall Study|Withdrawal by Subject|2|||
131798009|NCT00510510|474543503|FG002|Overall Study|Withdrawal by Subject|3|||
131798010|NCT00510510|474543501|FG000|Overall Study|Lost to Follow-up|0|||
131798011|NCT00510510|474543502|FG001|Overall Study|Lost to Follow-up|0|||
131798012|NCT00510510|474543503|FG002|Overall Study|Lost to Follow-up|1|||
131631179|NCT02062827|473933695|FG005|Overall Study|Death|0|||
131631180|NCT02062827|473933696|FG006|Overall Study|Death|0|||
131631181|NCT02062827|473933697|FG007|Overall Study|Death|0|||
131798013|NCT00510510|474543501|FG000|Overall Study|Protocol Violation|0|||
131631182|NCT02062827|473933690|FG000|Overall Study|Withdrawal by Subject|3|||
131631183|NCT02062827|473933691|FG001|Overall Study|Withdrawal by Subject|1|||
131631184|NCT02062827|473933692|FG002|Overall Study|Withdrawal by Subject|1|||
131631185|NCT02062827|473933693|FG003|Overall Study|Withdrawal by Subject|2|||
131631186|NCT02062827|473933694|FG004|Overall Study|Withdrawal by Subject|6|||
131631187|NCT02062827|473933695|FG005|Overall Study|Withdrawal by Subject|0|||
131631188|NCT02062827|473933696|FG006|Overall Study|Withdrawal by Subject|5|||
131631189|NCT02062827|473933697|FG007|Overall Study|Withdrawal by Subject|0|||
131631190|NCT02062827|473933690|FG000|Overall Study|Screen Fail|0|||
131631191|NCT02062827|473933691|FG001|Overall Study|Screen Fail|0|||
131631192|NCT02062827|473933692|FG002|Overall Study|Screen Fail|0|||
131631193|NCT02062827|473933693|FG003|Overall Study|Screen Fail|0|||
131631194|NCT02062827|473933694|FG004|Overall Study|Screen Fail|0|||
131631195|NCT02062827|473933695|FG005|Overall Study|Screen Fail|0|||
131631196|NCT02062827|473933696|FG006|Overall Study|Screen Fail|0|||
131631197|NCT02062827|473933697|FG007|Overall Study|Screen Fail|8|||
131631198|NCT02604199|473933698|FG000|Overall Study|Pregnancy|0|||
131631199|NCT02604199|473933699|FG001|Overall Study|Pregnancy|0|||
131631200|NCT02604199|473933700|FG002|Overall Study|Pregnancy|0|||
131631201|NCT02604199|473933701|FG003|Overall Study|Pregnancy|1|||
131631202|NCT02604199|473933698|FG000|Overall Study|Study terminated by sponsor|0|||
131631203|NCT02604199|473933699|FG001|Overall Study|Study terminated by sponsor|2|||
131631204|NCT02604199|473933700|FG002|Overall Study|Study terminated by sponsor|0|||
131631205|NCT02604199|473933701|FG003|Overall Study|Study terminated by sponsor|2|||
131631206|NCT02604199|473933698|FG000|Overall Study|Withdrawal by Subject|0|||
131631207|NCT02604199|473933699|FG001|Overall Study|Withdrawal by Subject|1|||
131631208|NCT02604199|473933700|FG002|Overall Study|Withdrawal by Subject|0|||
131631209|NCT02604199|473933701|FG003|Overall Study|Withdrawal by Subject|0|||
131631210|NCT03166215|473933705|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
131631211|NCT03166215|473933706|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
131631212|NCT03166215|473933707|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
131631213|NCT03166215|473933705|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
131631214|NCT03166215|473933706|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
131631215|NCT03166215|473933707|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
131902091|NCT00458003|474926936|FG001|Overall Study|Non protocol spinal anesthesia|1|||
131631216|NCT01426217|473933709|FG000|Overall Study|lost sample|8|||
131631217|NCT01426217|473933710|FG001|Overall Study|lost sample|14|||
131631218|NCT01812837|473933711|FG000|Overall Study|Lost to Follow-up|1|||
131631219|NCT01812837|473933712|FG001|Overall Study|Lost to Follow-up|1|||
131631220|NCT01812837|473933713|FG002|Overall Study|Lost to Follow-up|0|||
131631221|NCT01812837|473933711|FG000|Overall Study|Protocol Violation|1|||
131631222|NCT01812837|473933712|FG001|Overall Study|Protocol Violation|0|||
131631223|NCT01812837|473933713|FG002|Overall Study|Protocol Violation|0|||
131631224|NCT00288353|473933714|FG000|Overall Study|Lack of Efficacy|2|||
131631225|NCT00288353|473933715|FG001|Overall Study|Lack of Efficacy|2|||
131631226|NCT00288353|473933714|FG000|Overall Study|Withdrawal by Subject|5|||
131631227|NCT00288353|473933715|FG001|Overall Study|Withdrawal by Subject|5|||
131631228|NCT05008224|473933716|FG000|Overall Study|Death|3|||
131631229|NCT05008224|473933716|FG000|Overall Study|Lost to Follow-up|2|||
131631230|NCT05008224|473933716|FG000|Overall Study|Did Not Continue on Extension Study|39|||
131631231|NCT05008224|473933716|FG000|Overall Study|Transferred to Extension Study|100|||
131631232|NCT05008224|473933716|FG000|Overall Study|Withdrawal by Subject|2|||
131631233|NCT05234632|473933717|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
131631234|NCT05234632|473933718|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
131631235|NCT05234632|473933717|FG000|Overall Study|Withdrawal by Subject|2|||
131631236|NCT05234632|473933718|FG001|Overall Study|Withdrawal by Subject|0|||
131631237|NCT05234632|473933717|FG000|Overall Study|Adverse Event|0|||
131631238|NCT05234632|473933718|FG001|Overall Study|Adverse Event|4|||
131631239|NCT05234632|473933717|FG000|Overall Study|Physician Decision|1|||
131631240|NCT05234632|473933718|FG001|Overall Study|Physician Decision|1|||
131631241|NCT05234632|473933717|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
131631242|NCT05234632|473933718|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
131631243|NCT05234632|473933717|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
131631244|NCT05234632|473933718|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
131713364|NCT03263091|474228723|FG002|DB Component|Physician Decision|0|||
131713365|NCT03263091|474228724|FG003|DB Component|Physician Decision|0|||
131713366|NCT03263091|474228725|FG004|DB Component|Physician Decision|3|||
131713367|NCT03263091|474228726|FG005|DB Component|Physician Decision|1|||
131713368|NCT03263091|474228721|FG000|DB Component|Adverse Event|0|||
131713369|NCT03263091|474228722|FG001|DB Component|Adverse Event|0|||
131713370|NCT03263091|474228723|FG002|DB Component|Adverse Event|0|||
131902092|NCT00809445|474926937|FG000|1 Month Follow-up|Lost contact|1|||
131631245|NCT04985604|473933719|FG000|Overall Study|Death|4|||
131631246|NCT04985604|473933720|FG001|Overall Study|Death|6|||
131631247|NCT04985604|473933719|FG000|Overall Study|Withdrawal by Subject|0|||
131713371|NCT03263091|474228724|FG003|DB Component|Adverse Event|0|||
131713372|NCT03263091|474228725|FG004|DB Component|Adverse Event|2|||
131713373|NCT03263091|474228726|FG005|DB Component|Adverse Event|1|||
131713374|NCT03263091|474228721|FG000|DB Component|Lost to Follow-up|0|||
131713375|NCT03263091|474228722|FG001|DB Component|Lost to Follow-up|0|||
131713376|NCT03263091|474228723|FG002|DB Component|Lost to Follow-up|0|||
131713377|NCT03263091|474228724|FG003|DB Component|Lost to Follow-up|0|||
131713378|NCT03263091|474228725|FG004|DB Component|Lost to Follow-up|2|||
131713379|NCT03263091|474228726|FG005|DB Component|Lost to Follow-up|1|||
131713380|NCT03263091|474228721|FG000|DB Component|Death|0|||
131713381|NCT03263091|474228722|FG001|DB Component|Death|0|||
131713382|NCT03263091|474228723|FG002|DB Component|Death|0|||
131713383|NCT03263091|474228724|FG003|DB Component|Death|0|||
131713384|NCT03263091|474228725|FG004|DB Component|Death|7|||
131713385|NCT03263091|474228726|FG005|DB Component|Death|4|||
131713386|NCT03263091|474228721|FG000|DB Component|Other than specified|0|||
131713387|NCT03263091|474228722|FG001|DB Component|Other than specified|0|||
131713388|NCT03263091|474228723|FG002|DB Component|Other than specified|0|||
131713389|NCT03263091|474228724|FG003|DB Component|Other than specified|0|||
131713390|NCT03263091|474228725|FG004|DB Component|Other than specified|8|||
131713391|NCT03263091|474228726|FG005|DB Component|Other than specified|6|||
131713392|NCT02468193|474228727|FG000|Overall Study|Adverse Event|4|||
131713393|NCT02468193|474228727|FG000|Overall Study|Subject/ Guardian decision|2|||
131713394|NCT03095703|474228734|FG000|Overall Study|Withdrawal by Subject|1|||
131713395|NCT04889209|474228735|FG000|All Cohorts Except 15E|Adverse Event|0|||
131713396|NCT04889209|474228736|FG001|All Cohorts Except 15E|Adverse Event|0|||
131713397|NCT04889209|474228737|FG002|All Cohorts Except 15E|Adverse Event|0|||
131713398|NCT04889209|474228738|FG003|All Cohorts Except 15E|Adverse Event|0|||
131713399|NCT04889209|474228739|FG004|All Cohorts Except 15E|Adverse Event|0|||
131713400|NCT04889209|474228740|FG005|All Cohorts Except 15E|Adverse Event|0|||
131713401|NCT04889209|474228741|FG006|All Cohorts Except 15E|Adverse Event|1|||
131713402|NCT04889209|474228742|FG007|All Cohorts Except 15E|Adverse Event|0|||
131798014|NCT00510510|474543502|FG001|Overall Study|Protocol Violation|3|||
131798015|NCT00510510|474543503|FG002|Overall Study|Protocol Violation|4|||
131798016|NCT01361126|474543504|FG000|Overall Study|Sponsor decision|0|||
131798017|NCT01361126|474543505|FG001|Overall Study|Sponsor decision|2|||
131798018|NCT00663871|474543507|FG000|Overall Study|Lost to Follow-up|5|||
131798019|NCT00663871|474543508|FG001|Overall Study|Lost to Follow-up|5|||
131798020|NCT00663871|474543507|FG000|Overall Study|Withdrawal by Subject|5|||
131798021|NCT00663871|474543508|FG001|Overall Study|Withdrawal by Subject|2|||
131798022|NCT04094870|474543509|FG000|Overall Study|Lost to Follow-up|1|||
131798023|NCT04094870|474543510|FG001|Overall Study|Lost to Follow-up|1|||
131798024|NCT03384745|474543513|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131798025|NCT03384745|474543514|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131798026|NCT03384745|474543515|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
131798027|NCT03384745|474543516|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
131798028|NCT03384745|474543517|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131798029|NCT03384745|474543518|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131798030|NCT03384745|474543513|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131798031|NCT03384745|474543514|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131798032|NCT03384745|474543515|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131798033|NCT03384745|474543516|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131798034|NCT03384745|474543517|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
131798035|NCT03384745|474543518|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
131798036|NCT03384745|474543513|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
131798037|NCT03384745|474543514|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
131798038|NCT03384745|474543515|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
131798039|NCT03384745|474543516|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
131798040|NCT03384745|474543517|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
131798041|NCT03384745|474543518|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
131798042|NCT03384745|474543513|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131798043|NCT03384745|474543514|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131713403|NCT04889209|474228743|FG008|All Cohorts Except 15E|Adverse Event|0|||
131713404|NCT04889209|474228744|FG009|All Cohorts Except 15E|Adverse Event|0|||
131713405|NCT04889209|474228745|FG010|All Cohorts Except 15E|Adverse Event|0|||
131804506|NCT00533273|474568548|FG000|Open-label|Withdrawal by Subject|6|||
131713406|NCT04889209|474228746|FG011|All Cohorts Except 15E|Adverse Event|0|||
131713407|NCT04889209|474228747|FG012|All Cohorts Except 15E|Adverse Event|0|||
131713408|NCT04889209|474228748|FG013|All Cohorts Except 15E|Adverse Event|0|||
131631248|NCT04985604|473933720|FG001|Overall Study|Withdrawal by Subject|1|||
131631249|NCT02282761|473933721|FG000|Overall Study|Death|0|||
131631250|NCT02282761|473933722|FG001|Overall Study|Death|0|||
131631251|NCT02282761|473933723|FG002|Overall Study|Death|1|||
131631252|NCT02282761|473933721|FG000|Overall Study|Adverse Event|6|||
131631253|NCT02282761|473933722|FG001|Overall Study|Adverse Event|2|||
131631254|NCT02282761|473933723|FG002|Overall Study|Adverse Event|0|||
131631255|NCT02282761|473933721|FG000|Overall Study|Lack of Efficacy|11|||
131631256|NCT02282761|473933722|FG001|Overall Study|Lack of Efficacy|6|||
131631257|NCT02282761|473933723|FG002|Overall Study|Lack of Efficacy|17|||
131631258|NCT02282761|473933721|FG000|Overall Study|Lost to Follow-up|2|||
131631259|NCT02282761|473933722|FG001|Overall Study|Lost to Follow-up|2|||
131631260|NCT02282761|473933723|FG002|Overall Study|Lost to Follow-up|1|||
131631261|NCT02282761|473933721|FG000|Overall Study|Physician Decision|0|||
131631262|NCT02282761|473933722|FG001|Overall Study|Physician Decision|0|||
131631263|NCT02282761|473933723|FG002|Overall Study|Physician Decision|2|||
131631264|NCT02282761|473933721|FG000|Overall Study|Withdrawal by Subject|8|||
131631265|NCT02282761|473933722|FG001|Overall Study|Withdrawal by Subject|10|||
131631266|NCT02282761|473933723|FG002|Overall Study|Withdrawal by Subject|16|||
131631267|NCT02282761|473933721|FG000|Overall Study|Other|3|||
131631268|NCT02282761|473933722|FG001|Overall Study|Other|2|||
131631269|NCT02282761|473933723|FG002|Overall Study|Other|1|||
131631270|NCT00658632|473933724|FG000|Overall Study|Adverse Event|13|||
131631271|NCT00658632|473933725|FG001|Overall Study|Adverse Event|11|||
131631272|NCT00658632|473933724|FG000|Overall Study|Lost to Follow-up|25|||
131631273|NCT00658632|473933725|FG001|Overall Study|Lost to Follow-up|23|||
131631274|NCT00658632|473933724|FG000|Overall Study|Withdrawal by Subject|10|||
131631275|NCT00658632|473933725|FG001|Overall Study|Withdrawal by Subject|7|||
131631276|NCT00658632|473933724|FG000|Overall Study|Lack of Efficacy|0|||
131631277|NCT00658632|473933725|FG001|Overall Study|Lack of Efficacy|1|||
131631278|NCT00658632|473933724|FG000|Overall Study|Withdrawal of consent|8|||
131631279|NCT00658632|473933725|FG001|Overall Study|Withdrawal of consent|14|||
131631280|NCT00658632|473933724|FG000|Overall Study|Pregnancy|1|||
131631281|NCT00658632|473933725|FG001|Overall Study|Pregnancy|1|||
131631282|NCT00658632|473933724|FG000|Overall Study|Other|7|||
131631283|NCT00658632|473933725|FG001|Overall Study|Other|8|||
131631284|NCT02632045|473933726|FG000|Overall Study|Withdrawal by Subject|1|||
131631285|NCT02632045|473933727|FG001|Overall Study|Withdrawal by Subject|2|||
131631286|NCT05878522|473933728|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631287|NCT05878522|473933729|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631288|NCT05878522|473933730|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631289|NCT05878522|473933731|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631290|NCT05878522|473933732|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631291|NCT05878522|473933733|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131713409|NCT04889209|474228749|FG014|All Cohorts Except 15E|Adverse Event|0|||
131631292|NCT05878522|473933734|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631293|NCT05878522|473933735|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631294|NCT05878522|473933736|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
131631295|NCT05878522|473933737|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631296|NCT05878522|473933738|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631297|NCT05878522|473933739|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131631298|NCT05878522|473933728|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
131631299|NCT05878522|473933729|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631300|NCT05878522|473933730|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631301|NCT05878522|473933731|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631302|NCT05878522|473933732|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631303|NCT05878522|473933733|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631304|NCT05878522|473933734|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631305|NCT05878522|473933735|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631306|NCT05878522|473933736|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631307|NCT05878522|473933737|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
131631308|NCT05878522|473933738|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631309|NCT05878522|473933739|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131631310|NCT05878522|473933728|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631311|NCT05878522|473933729|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
131631312|NCT05878522|473933730|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631313|NCT05878522|473933731|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
131631314|NCT05878522|473933732|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631315|NCT05878522|473933733|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631316|NCT05878522|473933734|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631317|NCT05878522|473933735|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631318|NCT05878522|473933736|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631319|NCT05878522|473933737|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131713410|NCT04889209|474228750|FG015|All Cohorts Except 15E|Adverse Event|0|||
131631320|NCT05878522|473933738|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631321|NCT05878522|473933739|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131631322|NCT05878522|473933728|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631323|NCT05878522|473933729|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631324|NCT05878522|473933730|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631325|NCT05878522|473933731|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631326|NCT05878522|473933732|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
131631327|NCT05878522|473933733|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631328|NCT05878522|473933734|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631329|NCT05878522|473933735|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631330|NCT05878522|473933736|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631331|NCT05878522|473933737|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131902093|NCT00809445|474926938|FG001|1 Month Follow-up|Lost contact|2|||
131902094|NCT00809445|474926939|FG002|1 Month Follow-up|Lost contact|1|||
131902095|NCT00809445|474926937|FG000|1 Month Follow-up|Withdrew consent|1|||
131902096|NCT00809445|474926938|FG001|1 Month Follow-up|Withdrew consent|1|||
131902097|NCT00809445|474926939|FG002|1 Month Follow-up|Withdrew consent|1|||
131902098|NCT00809445|474926937|FG000|1 Month Follow-up|Death|0|||
131902099|NCT00809445|474926938|FG001|1 Month Follow-up|Death|1|||
131902100|NCT00809445|474926939|FG002|1 Month Follow-up|Death|1|||
131902101|NCT00809445|474926937|FG000|1 Month Follow-up|Incarcerated|0|||
131902102|NCT00809445|474926938|FG001|1 Month Follow-up|Incarcerated|0|||
131902103|NCT00809445|474926939|FG002|1 Month Follow-up|Incarcerated|1|||
131902104|NCT00809445|474926937|FG000|6 Month Follow-up|Lost contact|16|||
131902105|NCT00809445|474926938|FG001|6 Month Follow-up|Lost contact|14|||
131902106|NCT00809445|474926939|FG002|6 Month Follow-up|Lost contact|14|||
131902107|NCT00809445|474926937|FG000|6 Month Follow-up|Death|2|||
131902108|NCT00809445|474926938|FG001|6 Month Follow-up|Death|1|||
131902109|NCT00809445|474926939|FG002|6 Month Follow-up|Death|1|||
131902110|NCT00809445|474926937|FG000|6 Month Follow-up|Incarcerated|6|||
131902111|NCT00809445|474926938|FG001|6 Month Follow-up|Incarcerated|8|||
131902112|NCT00809445|474926939|FG002|6 Month Follow-up|Incarcerated|8|||
131902113|NCT00809445|474926937|FG000|6 Month Follow-up|Withdrew consent|0|||
131902114|NCT00809445|474926938|FG001|6 Month Follow-up|Withdrew consent|0|||
131902115|NCT00809445|474926939|FG002|6 Month Follow-up|Withdrew consent|1|||
131902116|NCT02048722|474926940|FG000|2 Cycles of Treatment|Adverse Event|2|||
131902117|NCT02048722|474926940|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
131902118|NCT02048722|474926940|FG000|2 Cycles of Treatment|Progressive Disease|2|||
131902119|NCT02048722|474926940|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
131902120|NCT02048722|474926940|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
131902121|NCT02048722|474926940|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
131902122|NCT04144322|474926941|FG000|Overall Study|Lack of Efficacy|2|||
131902123|NCT04144322|474926942|FG001|Overall Study|Lack of Efficacy|2|||
131902124|NCT01272908|474926946|FG000|Initial Treatment Period|Adverse Event|1|||
131902125|NCT01272908|474926946|FG000|Initial Treatment Period|Lack of Efficacy|5|||
131902126|NCT01272908|474926946|FG000|Initial Treatment Period|Protocol Violation|1|||
131902127|NCT01272908|474926946|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
131902128|NCT01272908|474926946|FG000|Re-Treatment Period|Adverse Event|2|||
131902129|NCT01272908|474926946|FG000|Re-Treatment Period|Lack of Efficacy|3|||
131902130|NCT01272908|474926946|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
131902131|NCT02131064|474926949|FG000|Overall Study|Death|5|||
131902132|NCT02131064|474926950|FG001|Overall Study|Death|6|||
131902133|NCT02131064|474926949|FG000|Overall Study|Lost to Follow-up|4|||
131902134|NCT02131064|474926950|FG001|Overall Study|Lost to Follow-up|8|||
131902135|NCT02131064|474926949|FG000|Overall Study|Withdrawal by Subject|14|||
131631332|NCT05878522|473933738|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631333|NCT05878522|473933739|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131631334|NCT05263492|473933740|FG000|Overall Study|Adverse Event|1|||
131631335|NCT05263492|473933740|FG000|Overall Study|Disease progression during active treatment|3|||
131631336|NCT03345420|473933743|FG000|Overall Study|Withdrawal by Subject|1|||
131631337|NCT02991456|473933747|FG000|Overall Study|Adverse Event|2|||
131631338|NCT02991456|473933748|FG001|Overall Study|Adverse Event|0|||
131631339|NCT02991456|473933747|FG000|Overall Study|Lost to Follow-up|0|||
131631340|NCT02991456|473933748|FG001|Overall Study|Lost to Follow-up|2|||
131631341|NCT02991456|473933747|FG000|Overall Study|Withdrawal by Subject|1|||
131631342|NCT02991456|473933748|FG001|Overall Study|Withdrawal by Subject|0|||
131631343|NCT04016415|473933749|FG000|Overall Study|Adverse Event|2|||
131902136|NCT02131064|474926950|FG001|Overall Study|Withdrawal by Subject|18|||
131902137|NCT02131064|474926949|FG000|Overall Study|Other|2|||
131902138|NCT02131064|474926950|FG001|Overall Study|Other|2|||
131902139|NCT03489343|474926951|FG000|Overall Study|Documented progressive disease|1|||
131902140|NCT03489343|474926952|FG001|Overall Study|Documented progressive disease|0|||
131631344|NCT04016415|473933750|FG001|Overall Study|Adverse Event|1|||
131631345|NCT04016415|473933749|FG000|Overall Study|Lost to Follow-up|6|||
131631346|NCT04016415|473933750|FG001|Overall Study|Lost to Follow-up|2|||
131631347|NCT04016415|473933749|FG000|Overall Study|Physician Decision|5|||
131631348|NCT04016415|473933750|FG001|Overall Study|Physician Decision|1|||
131631349|NCT04016415|473933749|FG000|Overall Study|Pregnancy|0|||
131631350|NCT04016415|473933750|FG001|Overall Study|Pregnancy|1|||
131631351|NCT04016415|473933749|FG000|Overall Study|Withdrawal by Subject|24|||
131631352|NCT04016415|473933750|FG001|Overall Study|Withdrawal by Subject|27|||
131631353|NCT04016415|473933749|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
131631354|NCT04016415|473933750|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
131631355|NCT03556891|473933753|FG000|Initial Pivotal Study|Adverse Event|4|||
131631356|NCT03556891|473933753|FG000|Initial Pivotal Study|MRI Need|3|||
131631357|NCT03556891|473933753|FG000|Initial Pivotal Study|Device Failure|1|||
131631358|NCT03556891|473933753|FG000|Initial Pivotal Study|Death|1|||
131631359|NCT03556891|473933753|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
131631360|NCT03556891|473933753|FG000|Initial Pivotal Study|Missing at random|1|||
131631361|NCT03556891|473933753|FG000|Initial Pivotal Study|Missing due to COVID|1|||
131631362|NCT03556891|473933753|FG000|Initial Pivotal Study|Protocol Violation|1|||
131631363|NCT01730118|473934891|FG000|Dose Escalation|Death on study|5|||
131631364|NCT01730118|473934892|FG001|Dose Escalation|Death on study|7|||
131631365|NCT01730118|473934893|FG002|Dose Escalation|Death on study|2|||
131631366|NCT01730118|473934894|FG003|Dose Escalation|Death on study|6|||
131631367|NCT01730118|473934895|FG004|Dose Escalation|Death on study|0|||
131631368|NCT01730118|473934896|FG005|Dose Escalation|Death on study|0|||
131631369|NCT01730118|473934897|FG006|Dose Escalation|Death on study|0|||
131631370|NCT01730118|473934891|FG000|Dose Escalation|Died before treatment|0|||
131631371|NCT01730118|473934892|FG001|Dose Escalation|Died before treatment|0|||
131631372|NCT01730118|473934893|FG002|Dose Escalation|Died before treatment|0|||
131631373|NCT01730118|473934894|FG003|Dose Escalation|Died before treatment|0|||
131631374|NCT01730118|473934895|FG004|Dose Escalation|Died before treatment|0|||
131631375|NCT01730118|473934896|FG005|Dose Escalation|Died before treatment|0|||
131631376|NCT01730118|473934897|FG006|Dose Escalation|Died before treatment|1|||
131631377|NCT01730118|473934891|FG000|Dose Escalation|Chose to start a different treatment|1|||
131631378|NCT01730118|473934892|FG001|Dose Escalation|Chose to start a different treatment|0|||
131631379|NCT01730118|473934893|FG002|Dose Escalation|Chose to start a different treatment|0|||
131631380|NCT01730118|473934894|FG003|Dose Escalation|Chose to start a different treatment|0|||
131631381|NCT01730118|473934895|FG004|Dose Escalation|Chose to start a different treatment|0|||
131631382|NCT01730118|473934896|FG005|Dose Escalation|Chose to start a different treatment|0|||
131631383|NCT01730118|473934897|FG006|Dose Escalation|Chose to start a different treatment|0|||
131631384|NCT01730118|473934891|FG000|Dose Escalation|Withdrawal by Subject|0|||
131631385|NCT01730118|473934892|FG001|Dose Escalation|Withdrawal by Subject|0|||
131631386|NCT01730118|473934893|FG002|Dose Escalation|Withdrawal by Subject|1|||
131631387|NCT01730118|473934894|FG003|Dose Escalation|Withdrawal by Subject|0|||
131631388|NCT01730118|473934895|FG004|Dose Escalation|Withdrawal by Subject|0|||
131631389|NCT01730118|473934896|FG005|Dose Escalation|Withdrawal by Subject|0|||
131631390|NCT01730118|473934897|FG006|Dose Escalation|Withdrawal by Subject|0|||
131631391|NCT01730118|473934891|FG000|Dose Escalation|Disease progression prior to treatment|0|||
131631392|NCT01730118|473934892|FG001|Dose Escalation|Disease progression prior to treatment|0|||
131631393|NCT01730118|473934893|FG002|Dose Escalation|Disease progression prior to treatment|0|||
131631394|NCT01730118|473934894|FG003|Dose Escalation|Disease progression prior to treatment|0|||
131631395|NCT01730118|473934895|FG004|Dose Escalation|Disease progression prior to treatment|0|||
131631396|NCT01730118|473934896|FG005|Dose Escalation|Disease progression prior to treatment|0|||
131631397|NCT01730118|473934897|FG006|Dose Escalation|Disease progression prior to treatment|1|||
131631398|NCT01730118|473934891|FG000|Dose Expansion|Death|0|||
131631399|NCT01730118|473934892|FG001|Dose Expansion|Death|0|||
131631400|NCT01730118|473934893|FG002|Dose Expansion|Death|0|||
131631401|NCT01730118|473934894|FG003|Dose Expansion|Death|0|||
131631402|NCT01730118|473934895|FG004|Dose Expansion|Death|1|||
131631403|NCT01730118|473934896|FG005|Dose Expansion|Death|0|||
131631404|NCT01730118|473934897|FG006|Dose Expansion|Death|0|||
131631405|NCT01730118|473934891|FG000|Dose Expansion|Other medical condition|0|||
131631406|NCT01730118|473934892|FG001|Dose Expansion|Other medical condition|0|||
131631407|NCT01730118|473934893|FG002|Dose Expansion|Other medical condition|0|||
131631408|NCT01730118|473934894|FG003|Dose Expansion|Other medical condition|0|||
131631409|NCT01730118|473934895|FG004|Dose Expansion|Other medical condition|1|||
131631410|NCT01730118|473934896|FG005|Dose Expansion|Other medical condition|0|||
131631411|NCT01730118|473934897|FG006|Dose Expansion|Other medical condition|0|||
131631412|NCT01730118|473934891|FG000|Dose Expansion|Withdrawal by Subject|0|||
131631413|NCT01730118|473934892|FG001|Dose Expansion|Withdrawal by Subject|0|||
131631414|NCT01730118|473934893|FG002|Dose Expansion|Withdrawal by Subject|0|||
131631415|NCT01730118|473934894|FG003|Dose Expansion|Withdrawal by Subject|0|||
131713411|NCT04889209|474228751|FG016|All Cohorts Except 15E|Adverse Event|0|||
131713412|NCT04889209|474228752|FG017|All Cohorts Except 15E|Adverse Event|0|||
131631416|NCT01730118|473934895|FG004|Dose Expansion|Withdrawal by Subject|1|||
131631417|NCT01730118|473934896|FG005|Dose Expansion|Withdrawal by Subject|0|||
131631418|NCT01730118|473934897|FG006|Dose Expansion|Withdrawal by Subject|0|||
131631419|NCT01730118|473934891|FG000|Dose Expansion|Disease progression|0|||
131631420|NCT01730118|473934892|FG001|Dose Expansion|Disease progression|0|||
131631421|NCT01730118|473934893|FG002|Dose Expansion|Disease progression|0|||
131631422|NCT01730118|473934894|FG003|Dose Expansion|Disease progression|0|||
131631423|NCT01730118|473934895|FG004|Dose Expansion|Disease progression|0|||
131631424|NCT01730118|473934896|FG005|Dose Expansion|Disease progression|1|||
131798044|NCT03384745|474543515|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
131798045|NCT03384745|474543516|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131798046|NCT03384745|474543517|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131798047|NCT03384745|474543518|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131798048|NCT03384745|474543513|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131798049|NCT03384745|474543514|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131798050|NCT03384745|474543515|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131798051|NCT03384745|474543516|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
131798052|NCT03384745|474543517|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
131798053|NCT03384745|474543518|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131798054|NCT03384745|474543513|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131798055|NCT03384745|474543514|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131798056|NCT03384745|474543515|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131798057|NCT03384745|474543516|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131798058|NCT03384745|474543517|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
131798059|NCT03384745|474543518|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131798060|NCT03384745|474543513|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131798061|NCT03384745|474543514|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131798062|NCT03384745|474543515|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
131798063|NCT03384745|474543516|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
131798064|NCT03384745|474543517|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131798065|NCT03384745|474543518|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131631425|NCT01730118|473934897|FG006|Dose Expansion|Disease progression|0|||
131631426|NCT01730118|473934891|FG000|Dose Expansion|Inability to return|0|||
131631427|NCT01730118|473934892|FG001|Dose Expansion|Inability to return|0|||
131631428|NCT01730118|473934893|FG002|Dose Expansion|Inability to return|0|||
131631429|NCT01730118|473934894|FG003|Dose Expansion|Inability to return|0|||
131631430|NCT01730118|473934895|FG004|Dose Expansion|Inability to return|0|||
131631431|NCT01730118|473934896|FG005|Dose Expansion|Inability to return|1|||
131631432|NCT01730118|473934897|FG006|Dose Expansion|Inability to return|0|||
131631433|NCT01730118|473934891|FG000|Dose Expansion|Physician Decision|0|||
131631434|NCT01730118|473934892|FG001|Dose Expansion|Physician Decision|0|||
131631435|NCT01730118|473934893|FG002|Dose Expansion|Physician Decision|0|||
131631436|NCT01730118|473934894|FG003|Dose Expansion|Physician Decision|0|||
131631437|NCT01730118|473934895|FG004|Dose Expansion|Physician Decision|0|||
131631438|NCT01730118|473934896|FG005|Dose Expansion|Physician Decision|1|||
131631439|NCT01730118|473934897|FG006|Dose Expansion|Physician Decision|0|||
131631440|NCT00489489|473934899|FG000|Overall Study|Not treated due to protocol violation|0|||
131631441|NCT00489489|473934900|FG001|Overall Study|Not treated due to protocol violation|1|||
131631442|NCT00489489|473934901|FG002|Overall Study|Not treated due to protocol violation|1|||
131631443|NCT00489489|473934899|FG000|Overall Study|Adverse Event|1|||
131631444|NCT00489489|473934900|FG001|Overall Study|Adverse Event|1|||
131631445|NCT00489489|473934901|FG002|Overall Study|Adverse Event|1|||
131631446|NCT00489489|473934899|FG000|Overall Study|Protocol Violation|1|||
131631447|NCT00489489|473934900|FG001|Overall Study|Protocol Violation|0|||
131631448|NCT00489489|473934901|FG002|Overall Study|Protocol Violation|1|||
131631449|NCT00489489|473934899|FG000|Overall Study|Progressive disease|0|||
131631450|NCT00489489|473934900|FG001|Overall Study|Progressive disease|1|||
131631451|NCT00489489|473934901|FG002|Overall Study|Progressive disease|0|||
131631452|NCT00489489|473934899|FG000|Overall Study|Participant did not wish to continue|1|||
131631453|NCT00489489|473934900|FG001|Overall Study|Participant did not wish to continue|1|||
131631454|NCT00489489|473934901|FG002|Overall Study|Participant did not wish to continue|0|||
131631455|NCT00489489|473934899|FG000|Overall Study|Other than above|0|||
131631456|NCT00489489|473934900|FG001|Overall Study|Other than above|1|||
131631457|NCT00489489|473934901|FG002|Overall Study|Other than above|0|||
131631458|NCT04385849|473934906|FG000|Overall Study|Lost to Follow-up|1|||
131798066|NCT03384745|474543513|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
131798067|NCT03384745|474543514|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
131798068|NCT03384745|474543515|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
131631459|NCT04385849|473934907|FG001|Overall Study|Lost to Follow-up|0|||
131631460|NCT01375777|473934908|FG000|Overall Study|Withdrawal by Subject|0|||
131902141|NCT03489343|474926953|FG002|Overall Study|Documented progressive disease|3|||
131631461|NCT01375777|473934909|FG001|Overall Study|Withdrawal by Subject|2|||
131631462|NCT01375777|473934910|FG002|Overall Study|Withdrawal by Subject|1|||
131631463|NCT01375777|473934911|FG003|Overall Study|Withdrawal by Subject|0|||
131631464|NCT01375777|473934912|FG004|Overall Study|Withdrawal by Subject|1|||
131631465|NCT01375777|473934913|FG005|Overall Study|Withdrawal by Subject|1|||
131631466|NCT01375777|473934914|FG006|Overall Study|Withdrawal by Subject|1|||
131631467|NCT01375777|473934915|FG007|Overall Study|Withdrawal by Subject|2|||
131902142|NCT03489343|474926954|FG003|Overall Study|Documented progressive disease|1|||
131902143|NCT03489343|474926955|FG004|Overall Study|Documented progressive disease|3|||
131902144|NCT03489343|474926956|FG005|Overall Study|Documented progressive disease|5|||
131902145|NCT03489343|474926957|FG006|Overall Study|Documented progressive disease|4|||
131902146|NCT03489343|474926951|FG000|Overall Study|Adverse Event|0|||
131902147|NCT03489343|474926952|FG001|Overall Study|Adverse Event|1|||
131902148|NCT03489343|474926953|FG002|Overall Study|Adverse Event|0|||
131902149|NCT03489343|474926954|FG003|Overall Study|Adverse Event|0|||
131902150|NCT03489343|474926955|FG004|Overall Study|Adverse Event|0|||
131902151|NCT03489343|474926956|FG005|Overall Study|Adverse Event|1|||
131902152|NCT03489343|474926957|FG006|Overall Study|Adverse Event|0|||
131902153|NCT03489343|474926951|FG000|Overall Study|Withdrawal by Subject|0|||
131902154|NCT03489343|474926952|FG001|Overall Study|Withdrawal by Subject|0|||
131902155|NCT03489343|474926953|FG002|Overall Study|Withdrawal by Subject|0|||
131902156|NCT03489343|474926954|FG003|Overall Study|Withdrawal by Subject|1|||
131902157|NCT03489343|474926955|FG004|Overall Study|Withdrawal by Subject|0|||
131902158|NCT03489343|474926956|FG005|Overall Study|Withdrawal by Subject|1|||
131902159|NCT03489343|474926957|FG006|Overall Study|Withdrawal by Subject|1|||
131902160|NCT03489343|474926951|FG000|Overall Study|Clinical progression|0|||
131631468|NCT01375777|473934916|FG008|Overall Study|Withdrawal by Subject|1|||
131631469|NCT01375777|473934908|FG000|Overall Study|Lost to Follow-up|1|||
131902161|NCT03489343|474926952|FG001|Overall Study|Clinical progression|0|||
131902162|NCT03489343|474926953|FG002|Overall Study|Clinical progression|0|||
131902163|NCT03489343|474926954|FG003|Overall Study|Clinical progression|1|||
131902164|NCT03489343|474926955|FG004|Overall Study|Clinical progression|0|||
131902165|NCT03489343|474926956|FG005|Overall Study|Clinical progression|0|||
131902166|NCT03489343|474926957|FG006|Overall Study|Clinical progression|1|||
131902167|NCT01158261|474926958|FG000|Overall Study|Lost to Follow-up|9|||
131902168|NCT01158261|474926958|FG000|Overall Study|Death|7|||
131902169|NCT01158261|474926958|FG000|Overall Study|Withdrawal by Subject|1|||
131902170|NCT03143101|474926959|FG000|Overall Study|Withdrawal by Subject|0|||
131902171|NCT03143101|474926960|FG001|Overall Study|Withdrawal by Subject|1|||
131902172|NCT03143101|474926961|FG002|Overall Study|Withdrawal by Subject|0|||
131902173|NCT03143101|474926959|FG000|Overall Study|Lost to Follow-up|2|||
131902174|NCT03143101|474926960|FG001|Overall Study|Lost to Follow-up|2|||
131902175|NCT03143101|474926961|FG002|Overall Study|Lost to Follow-up|0|||
131902176|NCT01630135|474926966|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
131902177|NCT01630135|474926967|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
131902178|NCT02899065|474926968|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
131902179|NCT02899065|474926969|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
131902180|NCT02899065|474926968|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
131902181|NCT02899065|474926969|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
131902182|NCT02899065|474926968|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
131902183|NCT02899065|474926969|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
131902184|NCT00971867|474926970|FG000|Overall Study|Adverse Event|4|||
131902185|NCT00971867|474926970|FG000|Overall Study|Participant Withdrew Consent|1|||
131902186|NCT00971867|474926970|FG000|Overall Study|Disease Progression|6|||
131902187|NCT05227118|474926974|FG000|Overall Study|Adverse Event|0|||
131902188|NCT05227118|474926975|FG001|Overall Study|Adverse Event|0|||
131902189|NCT05227118|474926976|FG002|Overall Study|Adverse Event|1|||
131902190|NCT05227118|474926977|FG003|Overall Study|Adverse Event|0|||
131902191|NCT05227118|474926974|FG000|Overall Study|Withdrawal by Subject|0|||
131902192|NCT05227118|474926975|FG001|Overall Study|Withdrawal by Subject|0|||
131902193|NCT05227118|474926976|FG002|Overall Study|Withdrawal by Subject|2|||
131902194|NCT05227118|474926977|FG003|Overall Study|Withdrawal by Subject|0|||
131902195|NCT03727841|474926983|FG000|Overall Study|Physician Decision|3|||
131631470|NCT01375777|473934909|FG001|Overall Study|Lost to Follow-up|0|||
131631471|NCT01375777|473934910|FG002|Overall Study|Lost to Follow-up|0|||
131902196|NCT03727841|474926984|FG001|Overall Study|Physician Decision|1|||
131902197|NCT01601496|474926985|FG000|Overall Study|Physician Decision|1|||
131902198|NCT01601496|474926985|FG000|Overall Study|Withdrawal by Subject|1|||
131902199|NCT01601496|474926985|FG000|Overall Study|Lost to Follow-up|6|||
131631472|NCT01375777|473934911|FG003|Overall Study|Lost to Follow-up|0|||
131631473|NCT01375777|473934912|FG004|Overall Study|Lost to Follow-up|0|||
131631474|NCT01375777|473934913|FG005|Overall Study|Lost to Follow-up|0|||
131631475|NCT01375777|473934914|FG006|Overall Study|Lost to Follow-up|1|||
131902200|NCT01601496|474926985|FG000|Overall Study|Death|4|||
131902201|NCT01601496|474926985|FG000|Overall Study|Other: patient refusal to continue|3|||
131902202|NCT03243305|474926986|FG000|Overall Study|Lost to Follow-up|250|||
131902203|NCT03243305|474926986|FG000|Overall Study|Withdrawal by Subject|170|||
131902204|NCT03243305|474926986|FG000|Overall Study|Pregnancy|104|||
131631476|NCT01375777|473934915|FG007|Overall Study|Lost to Follow-up|0|||
131631477|NCT01375777|473934916|FG008|Overall Study|Lost to Follow-up|0|||
131631478|NCT01375777|473934908|FG000|Overall Study|Other|1|||
131631479|NCT01375777|473934909|FG001|Overall Study|Other|1|||
131631480|NCT01375777|473934910|FG002|Overall Study|Other|0|||
131631481|NCT01375777|473934911|FG003|Overall Study|Other|0|||
131631482|NCT01375777|473934912|FG004|Overall Study|Other|0|||
131631483|NCT01375777|473934913|FG005|Overall Study|Other|0|||
131631484|NCT01375777|473934914|FG006|Overall Study|Other|0|||
131631485|NCT01375777|473934915|FG007|Overall Study|Other|0|||
131631486|NCT01375777|473934916|FG008|Overall Study|Other|1|||
131631487|NCT05878990|473934917|FG000|Overall Study|Lost to Follow-up|7|||
131631488|NCT05878990|473934917|FG000|Overall Study|Withdrawal by Subject|1|||
131631489|NCT01136733|473934920|FG000|Phase 1b|Adverse Event|0|||
131631490|NCT01136733|473934921|FG001|Phase 1b|Adverse Event|3|||
131631491|NCT01136733|473934922|FG002|Phase 1b|Adverse Event|1|||
131631492|NCT01136733|473934923|FG003|Phase 1b|Adverse Event|0|||
131631493|NCT01136733|473934924|FG004|Phase 1b|Adverse Event|0|||
131631494|NCT01136733|473934925|FG005|Phase 1b|Adverse Event|0|||
131631495|NCT01136733|473934926|FG006|Phase 1b|Adverse Event|0|||
131631496|NCT01136733|473934920|FG000|Phase 1b|Participant Choice|0|||
131631497|NCT01136733|473934921|FG001|Phase 1b|Participant Choice|0|||
131631498|NCT01136733|473934922|FG002|Phase 1b|Participant Choice|1|||
131631499|NCT01136733|473934923|FG003|Phase 1b|Participant Choice|0|||
131631500|NCT01136733|473934924|FG004|Phase 1b|Participant Choice|0|||
131631501|NCT01136733|473934925|FG005|Phase 1b|Participant Choice|0|||
131631502|NCT01136733|473934926|FG006|Phase 1b|Participant Choice|0|||
131631503|NCT01136733|473934920|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
131631504|NCT01136733|473934921|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
131631505|NCT01136733|473934922|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
131631506|NCT01136733|473934923|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
131631507|NCT01136733|473934924|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
131631508|NCT01136733|473934925|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
131631509|NCT01136733|473934926|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
131631510|NCT01136733|473934920|FG000|Phase 1b|Clinical Progression|1|||
131631511|NCT01136733|473934921|FG001|Phase 1b|Clinical Progression|1|||
131631512|NCT01136733|473934922|FG002|Phase 1b|Clinical Progression|0|||
131631513|NCT01136733|473934923|FG003|Phase 1b|Clinical Progression|0|||
131631514|NCT01136733|473934924|FG004|Phase 1b|Clinical Progression|0|||
131631515|NCT01136733|473934925|FG005|Phase 1b|Clinical Progression|0|||
131631516|NCT01136733|473934926|FG006|Phase 1b|Clinical Progression|0|||
131631517|NCT01136733|473934920|FG000|Phase 2|Disease Progression|0|||
131798069|NCT03384745|474543516|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
131798070|NCT03384745|474543517|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
131798071|NCT03384745|474543518|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
131798072|NCT03384745|474543513|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
131798073|NCT03384745|474543514|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
131798074|NCT03384745|474543515|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
131798075|NCT03384745|474543516|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
131798076|NCT03384745|474543517|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
131798077|NCT03384745|474543518|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
131798078|NCT03384745|474543513|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131798079|NCT03384745|474543514|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131798080|NCT03384745|474543515|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131798081|NCT03384745|474543516|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
131798082|NCT03384745|474543517|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131798083|NCT03384745|474543518|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131798084|NCT03384745|474543513|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
131798085|NCT03384745|474543514|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
131798086|NCT03384745|474543515|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
131631518|NCT01136733|473934921|FG001|Phase 2|Disease Progression|0|||
131631519|NCT01136733|473934922|FG002|Phase 2|Disease Progression|0|||
131631520|NCT01136733|473934923|FG003|Phase 2|Disease Progression|0|||
131631521|NCT01136733|473934924|FG004|Phase 2|Disease Progression|30|||
131631522|NCT01136733|473934925|FG005|Phase 2|Disease Progression|32|||
131631523|NCT01136733|473934926|FG006|Phase 2|Disease Progression|38|||
131631524|NCT01136733|473934920|FG000|Phase 2|Adverse Event|0|||
131631525|NCT01136733|473934921|FG001|Phase 2|Adverse Event|0|||
131798087|NCT03384745|474543516|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
131798088|NCT03384745|474543517|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
131798089|NCT03384745|474543518|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
131631526|NCT01136733|473934922|FG002|Phase 2|Adverse Event|0|||
131631527|NCT01136733|473934923|FG003|Phase 2|Adverse Event|0|||
131631528|NCT01136733|473934924|FG004|Phase 2|Adverse Event|11|||
131631529|NCT01136733|473934925|FG005|Phase 2|Adverse Event|13|||
131631530|NCT01136733|473934926|FG006|Phase 2|Adverse Event|5|||
131631531|NCT01136733|473934920|FG000|Phase 2|Participant Choice|0|||
131631532|NCT01136733|473934921|FG001|Phase 2|Participant Choice|0|||
131631533|NCT01136733|473934922|FG002|Phase 2|Participant Choice|0|||
131902205|NCT03243305|474926986|FG000|Overall Study|Non-Compliance with Study Drug|38|||
131902206|NCT03243305|474926986|FG000|Overall Study|Adverse Event|23|||
131902207|NCT03243305|474926986|FG000|Overall Study|No sexually active|26|||
131902208|NCT03243305|474926986|FG000|Overall Study|Physician Decision|22|||
131902209|NCT03243305|474926986|FG000|Overall Study|Protocol Violation|22|||
131902210|NCT03243305|474926986|FG000|Overall Study|Study method no longer primary method|12|||
131902211|NCT03243305|474926986|FG000|Overall Study|Study Terminated by Sponsor|1|||
131902212|NCT03243305|474926986|FG000|Overall Study|Early terminations|267|||
131902213|NCT02689804|474926987|FG000|Overall Study|Withdrawal by Subject|2|||
131902214|NCT02689804|474926988|FG001|Overall Study|Withdrawal by Subject|0|||
131902215|NCT01166750|474926996|FG000|Overall Study|Lost to Follow-up|1|||
131902216|NCT01166750|474926997|FG001|Overall Study|Lost to Follow-up|0|||
131902217|NCT01585246|474926998|FG000|Overall Study|Lost to Follow-up|0|||
131902218|NCT01585246|474926999|FG001|Overall Study|Lost to Follow-up|0|||
131902219|NCT01585246|474927000|FG002|Overall Study|Lost to Follow-up|2|||
131902220|NCT01585246|474927001|FG003|Overall Study|Lost to Follow-up|1|||
131902221|NCT01585246|474927002|FG004|Overall Study|Lost to Follow-up|0|||
131902222|NCT01585246|474926998|FG000|Overall Study|Protocol Violation|0|||
131631534|NCT01136733|473934923|FG003|Phase 2|Participant Choice|0|||
131798090|NCT02984683|474543521|FG000|Overall Study|Adverse Event|3|||
131798091|NCT02984683|474543522|FG001|Overall Study|Adverse Event|3|||
131798092|NCT02984683|474543521|FG000|Overall Study|Withdrawal by Subject|1|||
131798093|NCT02984683|474543522|FG001|Overall Study|Withdrawal by Subject|0|||
131798094|NCT02984683|474543521|FG000|Overall Study|Disease progression|7|||
131798095|NCT02984683|474543522|FG001|Overall Study|Disease progression|9|||
131798096|NCT02742181|474543523|FG000|Overall Study|Physician Decision|1|||
131798097|NCT02742181|474543524|FG001|Overall Study|Physician Decision|0|||
131798098|NCT03008460|474543525|FG000|Overall Study|Protocol deviation|0|||
131798099|NCT03008460|474543526|FG001|Overall Study|Protocol deviation|2|||
131798100|NCT03008460|474543525|FG000|Overall Study|Study drug not dispensed|0|||
131798101|NCT03008460|474543526|FG001|Overall Study|Study drug not dispensed|1|||
131798102|NCT03008460|474543525|FG000|Overall Study|Adverse Event|0|||
131798103|NCT03008460|474543526|FG001|Overall Study|Adverse Event|1|||
131798104|NCT03008460|474543525|FG000|Overall Study|Withdrawal by Subject|5|||
131798105|NCT03008460|474543526|FG001|Overall Study|Withdrawal by Subject|6|||
131798106|NCT03008460|474543525|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
131798107|NCT03008460|474543526|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
131798108|NCT03008460|474543525|FG000|Overall Study|End of study visit outside permitted time window|0|||
131798109|NCT03008460|474543526|FG001|Overall Study|End of study visit outside permitted time window|1|||
131798110|NCT03008460|474543525|FG000|Overall Study|Lost to Follow-up|1|||
131798111|NCT03008460|474543526|FG001|Overall Study|Lost to Follow-up|3|||
131798112|NCT00634179|474543536|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
131798113|NCT03538756|474543537|FG000|Long-Term Follow-up|Adverse Event|0|||
131798114|NCT03538756|474543538|FG001|Long-Term Follow-up|Adverse Event|0|||
131798115|NCT03538756|474543539|FG002|Long-Term Follow-up|Adverse Event|6|||
131798116|NCT03538756|474543537|FG000|Long-Term Follow-up|Death|0|||
131902223|NCT01585246|474926999|FG001|Overall Study|Protocol Violation|0|||
131902224|NCT01585246|474927000|FG002|Overall Study|Protocol Violation|0|||
131631535|NCT01136733|473934924|FG004|Phase 2|Participant Choice|3|||
131798117|NCT03538756|474543538|FG001|Long-Term Follow-up|Death|0|||
131798118|NCT03538756|474543539|FG002|Long-Term Follow-up|Death|1|||
131798119|NCT03538756|474543537|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
131798120|NCT03538756|474543538|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
131902225|NCT01585246|474927001|FG003|Overall Study|Protocol Violation|0|||
131631536|NCT01136733|473934925|FG005|Phase 2|Participant Choice|0|||
131631537|NCT01136733|473934926|FG006|Phase 2|Participant Choice|1|||
131631538|NCT01136733|473934920|FG000|Phase 2|Administrative-Withdrew Consent|0|||
131631539|NCT01136733|473934921|FG001|Phase 2|Administrative-Withdrew Consent|0|||
131631540|NCT01136733|473934922|FG002|Phase 2|Administrative-Withdrew Consent|0|||
131631541|NCT01136733|473934923|FG003|Phase 2|Administrative-Withdrew Consent|0|||
131631542|NCT01136733|473934924|FG004|Phase 2|Administrative-Withdrew Consent|1|||
131631543|NCT01136733|473934925|FG005|Phase 2|Administrative-Withdrew Consent|0|||
131631544|NCT01136733|473934926|FG006|Phase 2|Administrative-Withdrew Consent|0|||
131798121|NCT03538756|474543539|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
131798122|NCT03538756|474543537|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
131798123|NCT03538756|474543538|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
131798124|NCT03538756|474543539|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
131798125|NCT03538756|474543537|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
131798126|NCT03538756|474543538|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
131798127|NCT03538756|474543539|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
131798128|NCT02260492|474543540|FG000|Overall Study|Adverse Event|6|||
131798129|NCT02260492|474543541|FG001|Overall Study|Adverse Event|1|||
131798130|NCT02260492|474543542|FG002|Overall Study|Adverse Event|2|||
131798131|NCT02260492|474543540|FG000|Overall Study|Death|0|||
131798132|NCT02260492|474543541|FG001|Overall Study|Death|1|||
131798133|NCT02260492|474543542|FG002|Overall Study|Death|0|||
131798134|NCT02260492|474543540|FG000|Overall Study|Lost to Follow-up|12|||
131798135|NCT02260492|474543541|FG001|Overall Study|Lost to Follow-up|9|||
131798136|NCT02260492|474543542|FG002|Overall Study|Lost to Follow-up|0|||
131631545|NCT01136733|473934920|FG000|Phase 2|Other|0|||
131631546|NCT01136733|473934921|FG001|Phase 2|Other|0|||
131631547|NCT01136733|473934922|FG002|Phase 2|Other|0|||
131631548|NCT01136733|473934923|FG003|Phase 2|Other|0|||
131631549|NCT01136733|473934924|FG004|Phase 2|Other|6|||
131631550|NCT01136733|473934925|FG005|Phase 2|Other|7|||
131631551|NCT01136733|473934926|FG006|Phase 2|Other|6|||
131631552|NCT03314233|473934933|FG000|Overall Study|No longer eligible at time of delivery|1|||
131631553|NCT00168805|473934935|FG000|Overall Study|Adverse Event|7|||
131631554|NCT00168805|473934936|FG001|Overall Study|Adverse Event|11|||
131631555|NCT00168805|473934937|FG002|Overall Study|Adverse Event|16|||
131631556|NCT00168805|473934935|FG000|Overall Study|Protocol Violation|12|||
131631557|NCT00168805|473934936|FG001|Overall Study|Protocol Violation|11|||
131631558|NCT00168805|473934937|FG002|Overall Study|Protocol Violation|8|||
131631559|NCT00168805|473934935|FG000|Overall Study|Lost to Follow-up|12|||
131713413|NCT04889209|474228735|FG000|All Cohorts Except 15E|Death|0|||
131713414|NCT04889209|474228736|FG001|All Cohorts Except 15E|Death|1|||
131713415|NCT04889209|474228737|FG002|All Cohorts Except 15E|Death|0|||
131798137|NCT02260492|474543540|FG000|Overall Study|Physician Decision|2|||
131798138|NCT02260492|474543541|FG001|Overall Study|Physician Decision|0|||
131798139|NCT02260492|474543542|FG002|Overall Study|Physician Decision|1|||
131798140|NCT02260492|474543540|FG000|Overall Study|Withdrawal by Subject|3|||
131798141|NCT02260492|474543541|FG001|Overall Study|Withdrawal by Subject|2|||
131798142|NCT02260492|474543542|FG002|Overall Study|Withdrawal by Subject|2|||
131798143|NCT00996736|474543548|FG000|Overall Study|Death|1|||
131798144|NCT00996736|474543549|FG001|Overall Study|Death|1|||
131798145|NCT00996736|474543548|FG000|Overall Study|Lost to Follow-up|15|||
131902226|NCT01585246|474927002|FG004|Overall Study|Protocol Violation|1|||
131902227|NCT01585246|474926998|FG000|Overall Study|Withdrawal by Subject|0|||
131444251|NCT02903771|473257107|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
131444252|NCT02903771|473257108|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
131444253|NCT02903771|473257109|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
131631560|NCT00168805|473934936|FG001|Overall Study|Lost to Follow-up|17|||
131631561|NCT00168805|473934937|FG002|Overall Study|Lost to Follow-up|11|||
131631562|NCT00168805|473934935|FG000|Overall Study|Withdrawal by Subject|16|||
131631563|NCT00168805|473934936|FG001|Overall Study|Withdrawal by Subject|18|||
131631564|NCT00168805|473934937|FG002|Overall Study|Withdrawal by Subject|21|||
131631565|NCT00168805|473934935|FG000|Overall Study|Other|24|||
131713416|NCT04889209|474228738|FG003|All Cohorts Except 15E|Death|0|||
131713417|NCT04889209|474228739|FG004|All Cohorts Except 15E|Death|0|||
131713418|NCT04889209|474228740|FG005|All Cohorts Except 15E|Death|0|||
131713419|NCT04889209|474228741|FG006|All Cohorts Except 15E|Death|0|||
131713420|NCT04889209|474228742|FG007|All Cohorts Except 15E|Death|0|||
131798146|NCT00996736|474543549|FG001|Overall Study|Lost to Follow-up|14|||
131798147|NCT00996736|474543548|FG000|Overall Study|Visit not within 3-month window|5|||
131798148|NCT00996736|474543549|FG001|Overall Study|Visit not within 3-month window|3|||
131631566|NCT00168805|473934936|FG001|Overall Study|Other|21|||
131631567|NCT00168805|473934937|FG002|Overall Study|Other|22|||
131713421|NCT04889209|474228743|FG008|All Cohorts Except 15E|Death|0|||
131798149|NCT00365352|474543550|FG000|Overall Study|Adverse Event|6|||
131798150|NCT00365352|474543551|FG001|Overall Study|Adverse Event|7|||
131798151|NCT00365352|474543552|FG002|Overall Study|Adverse Event|8|||
131798152|NCT00365352|474543550|FG000|Overall Study|Participant Withdrew Consent|8|||
131798153|NCT00365352|474543551|FG001|Overall Study|Participant Withdrew Consent|3|||
131631568|NCT00168805|473934935|FG000|Treatment|Adverse Event|25|||
131631569|NCT00168805|473934936|FG001|Treatment|Adverse Event|26|||
131631570|NCT00168805|473934937|FG002|Treatment|Adverse Event|32|||
131631571|NCT00168805|473934935|FG000|Treatment|Protocol Violation|3|||
131631572|NCT00168805|473934936|FG001|Treatment|Protocol Violation|5|||
131631573|NCT00168805|473934937|FG002|Treatment|Protocol Violation|5|||
131631574|NCT00168805|473934935|FG000|Treatment|Withdrawal by Subject|3|||
131631575|NCT00168805|473934936|FG001|Treatment|Withdrawal by Subject|7|||
131631576|NCT00168805|473934937|FG002|Treatment|Withdrawal by Subject|8|||
131631577|NCT00168805|473934935|FG000|Treatment|Other|18|||
131631578|NCT00168805|473934936|FG001|Treatment|Other|18|||
131631579|NCT00168805|473934937|FG002|Treatment|Other|17|||
131631580|NCT01114217|473934938|FG000|Overall Study|Adverse Event|5|||
131631581|NCT01114217|473934939|FG001|Overall Study|Adverse Event|3|||
131631582|NCT01114217|473934938|FG000|Overall Study|Lost to Follow-up|17|||
131798154|NCT00365352|474543552|FG002|Overall Study|Participant Withdrew Consent|4|||
131798155|NCT00365352|474543550|FG000|Overall Study|Lack of Efficacy|3|||
131798156|NCT00365352|474543551|FG001|Overall Study|Lack of Efficacy|0|||
131798157|NCT00365352|474543552|FG002|Overall Study|Lack of Efficacy|0|||
131798158|NCT00365352|474543550|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
131798159|NCT00365352|474543551|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
131798160|NCT00365352|474543552|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
131798161|NCT00365352|474543550|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
131798162|NCT00365352|474543551|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
131798163|NCT00365352|474543552|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
131798164|NCT00365352|474543550|FG000|Overall Study|Lost to Follow-up|1|||
131631583|NCT01114217|473934939|FG001|Overall Study|Lost to Follow-up|33|||
131631584|NCT01114217|473934938|FG000|Overall Study|Withdrawal by Subject|21|||
131631585|NCT01114217|473934939|FG001|Overall Study|Withdrawal by Subject|28|||
131631586|NCT01114217|473934938|FG000|Overall Study|Other-Clerical Error|3|||
131631587|NCT01114217|473934939|FG001|Overall Study|Other-Clerical Error|0|||
131631588|NCT01114217|473934938|FG000|Overall Study|Other-Early termination|6|||
131631589|NCT01114217|473934939|FG001|Overall Study|Other-Early termination|10|||
131631590|NCT01114217|473934938|FG000|Overall Study|Other-Procedure|1|||
131631591|NCT01114217|473934939|FG001|Overall Study|Other-Procedure|1|||
131631592|NCT01114217|473934938|FG000|Overall Study|Other-Pregnancy|2|||
131631593|NCT01114217|473934939|FG001|Overall Study|Other-Pregnancy|4|||
131631594|NCT01114217|473934938|FG000|Overall Study|Other-Protocol Violation|1|||
131631595|NCT01114217|473934939|FG001|Overall Study|Other-Protocol Violation|3|||
131631596|NCT01114217|473934938|FG000|Overall Study|Other-Lack of Efficacy|1|||
131631597|NCT01114217|473934939|FG001|Overall Study|Other-Lack of Efficacy|0|||
131631598|NCT01114217|473934938|FG000|Overall Study|Other-Non Compliance|2|||
131631599|NCT01114217|473934939|FG001|Overall Study|Other-Non Compliance|0|||
131631600|NCT01114217|473934938|FG000|Overall Study|Other-Physician Decision|1|||
131798165|NCT00365352|474543551|FG001|Overall Study|Lost to Follow-up|1|||
131798166|NCT00365352|474543552|FG002|Overall Study|Lost to Follow-up|0|||
131804507|NCT00533273|474568549|FG001|Open-label|Withdrawal by Subject|0|||
131804508|NCT02794974|474568550|FG000|Overall Study|Physician Decision|0|||
131631601|NCT01114217|473934939|FG001|Overall Study|Other-Physician Decision|1|||
131631602|NCT01114217|473934938|FG000|Overall Study|Other-Sponsor Decision|10|||
131631603|NCT01114217|473934939|FG001|Overall Study|Other-Sponsor Decision|12|||
131631604|NCT01114217|473934938|FG000|Overall Study|Other-Study Termination|0|||
131631605|NCT01114217|473934939|FG001|Overall Study|Other-Study Termination|1|||
131631606|NCT01114217|473934938|FG000|Overall Study|Other-Study Withdrawn|1|||
131631607|NCT01114217|473934939|FG001|Overall Study|Other-Study Withdrawn|1|||
131631608|NCT01114217|473934938|FG000|Overall Study|Other-Site Stopped Communicating|2|||
131631609|NCT01114217|473934939|FG001|Overall Study|Other-Site Stopped Communicating|0|||
131631610|NCT01114217|473934938|FG000|Overall Study|Other-Lost to Follow-up|1|||
131631611|NCT01114217|473934939|FG001|Overall Study|Other-Lost to Follow-up|0|||
131631612|NCT01114217|473934938|FG000|Overall Study|Other-Withdrawal by Subject|1|||
131631613|NCT01114217|473934939|FG001|Overall Study|Other-Withdrawal by Subject|1|||
131631614|NCT01183013|473934942|FG000|Overall Study|Adverse Event|6|||
131631615|NCT01183013|473934943|FG001|Overall Study|Adverse Event|8|||
131631616|NCT01183013|473934944|FG002|Overall Study|Adverse Event|5|||
131631617|NCT01183013|473934945|FG003|Overall Study|Adverse Event|5|||
131631618|NCT01183013|473934946|FG004|Overall Study|Adverse Event|10|||
131631619|NCT01183013|473934947|FG005|Overall Study|Adverse Event|10|||
131631620|NCT01183013|473934948|FG006|Overall Study|Adverse Event|6|||
131631621|NCT01183013|473934942|FG000|Overall Study|Lack of Efficacy|3|||
131631622|NCT01183013|473934943|FG001|Overall Study|Lack of Efficacy|2|||
131631623|NCT01183013|473934944|FG002|Overall Study|Lack of Efficacy|1|||
131631624|NCT01183013|473934945|FG003|Overall Study|Lack of Efficacy|2|||
131631625|NCT01183013|473934946|FG004|Overall Study|Lack of Efficacy|1|||
131631626|NCT01183013|473934947|FG005|Overall Study|Lack of Efficacy|2|||
131631627|NCT01183013|473934948|FG006|Overall Study|Lack of Efficacy|0|||
131631628|NCT01183013|473934942|FG000|Overall Study|Protocol Violation|5|||
131631629|NCT01183013|473934943|FG001|Overall Study|Protocol Violation|2|||
131631630|NCT01183013|473934944|FG002|Overall Study|Protocol Violation|4|||
131631631|NCT01183013|473934945|FG003|Overall Study|Protocol Violation|0|||
131631632|NCT01183013|473934946|FG004|Overall Study|Protocol Violation|4|||
131631633|NCT01183013|473934947|FG005|Overall Study|Protocol Violation|3|||
131631634|NCT01183013|473934948|FG006|Overall Study|Protocol Violation|3|||
131631635|NCT01183013|473934942|FG000|Overall Study|Lost to Follow-up|7|||
131631636|NCT01183013|473934943|FG001|Overall Study|Lost to Follow-up|3|||
131631637|NCT01183013|473934944|FG002|Overall Study|Lost to Follow-up|4|||
131631638|NCT01183013|473934945|FG003|Overall Study|Lost to Follow-up|3|||
131631639|NCT01183013|473934946|FG004|Overall Study|Lost to Follow-up|2|||
131631640|NCT01183013|473934947|FG005|Overall Study|Lost to Follow-up|6|||
131631641|NCT01183013|473934948|FG006|Overall Study|Lost to Follow-up|5|||
131631642|NCT01183013|473934942|FG000|Overall Study|Withdrawal by Subject|9|||
131631643|NCT01183013|473934943|FG001|Overall Study|Withdrawal by Subject|13|||
131713422|NCT04889209|474228744|FG009|All Cohorts Except 15E|Death|0|||
131444254|NCT02903771|473257103|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
131713423|NCT04889209|474228745|FG010|All Cohorts Except 15E|Death|0|||
131713424|NCT04889209|474228746|FG011|All Cohorts Except 15E|Death|0|||
131713425|NCT04889209|474228747|FG012|All Cohorts Except 15E|Death|0|||
131713426|NCT04889209|474228748|FG013|All Cohorts Except 15E|Death|0|||
131713427|NCT04889209|474228749|FG014|All Cohorts Except 15E|Death|0|||
131713428|NCT04889209|474228750|FG015|All Cohorts Except 15E|Death|0|||
131713429|NCT04889209|474228751|FG016|All Cohorts Except 15E|Death|0|||
131713430|NCT04889209|474228752|FG017|All Cohorts Except 15E|Death|0|||
131713431|NCT04889209|474228735|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
131713432|NCT04889209|474228736|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
131713433|NCT04889209|474228737|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
131713434|NCT04889209|474228738|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
131713435|NCT04889209|474228739|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
131713436|NCT04889209|474228740|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
131713437|NCT04889209|474228741|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
131713438|NCT04889209|474228742|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
131713439|NCT04889209|474228743|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
131713440|NCT04889209|474228744|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
131713441|NCT04889209|474228745|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
131713442|NCT04889209|474228746|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
131631644|NCT01183013|473934944|FG002|Overall Study|Withdrawal by Subject|10|||
131631645|NCT01183013|473934945|FG003|Overall Study|Withdrawal by Subject|8|||
131631646|NCT01183013|473934946|FG004|Overall Study|Withdrawal by Subject|7|||
131713443|NCT04889209|474228747|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
131713444|NCT04889209|474228748|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
131713445|NCT04889209|474228749|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
131631647|NCT01183013|473934947|FG005|Overall Study|Withdrawal by Subject|9|||
131631648|NCT01183013|473934948|FG006|Overall Study|Withdrawal by Subject|10|||
131631649|NCT01183013|473934942|FG000|Overall Study|Reasons other than stated above|15|||
131631650|NCT01183013|473934943|FG001|Overall Study|Reasons other than stated above|11|||
131631651|NCT01183013|473934944|FG002|Overall Study|Reasons other than stated above|17|||
131631652|NCT01183013|473934945|FG003|Overall Study|Reasons other than stated above|12|||
131713446|NCT04889209|474228750|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
131713447|NCT04889209|474228751|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
131631653|NCT01183013|473934946|FG004|Overall Study|Reasons other than stated above|12|||
131631654|NCT01183013|473934947|FG005|Overall Study|Reasons other than stated above|15|||
131631655|NCT01183013|473934948|FG006|Overall Study|Reasons other than stated above|13|||
131631656|NCT03785210|473934952|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
131631657|NCT03785210|473934953|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
131631658|NCT00472199|473934954|FG000|Overall Study|Adverse Event|19|||
131631659|NCT00472199|473934955|FG001|Overall Study|Adverse Event|23|||
131631660|NCT00472199|473934954|FG000|Overall Study|Lack of Efficacy|4|||
131631661|NCT00472199|473934955|FG001|Overall Study|Lack of Efficacy|25|||
131631662|NCT00472199|473934954|FG000|Overall Study|Lost to Follow-up|2|||
131631663|NCT00472199|473934955|FG001|Overall Study|Lost to Follow-up|4|||
131631664|NCT00472199|473934954|FG000|Overall Study|Protocol Violation|3|||
131631665|NCT00472199|473934955|FG001|Overall Study|Protocol Violation|2|||
131631666|NCT00472199|473934954|FG000|Overall Study|Withdrawal by Subject|6|||
131631667|NCT00472199|473934955|FG001|Overall Study|Withdrawal by Subject|5|||
131631668|NCT00472199|473934954|FG000|Overall Study|personal reason|0|||
131631669|NCT00472199|473934955|FG001|Overall Study|personal reason|1|||
131631670|NCT00472199|473934954|FG000|Overall Study|patient was asymptomatic|1|||
131631671|NCT00472199|473934955|FG001|Overall Study|patient was asymptomatic|0|||
131631672|NCT01757171|473934956|FG000|Overall Study|Adverse Event|5|||
131631673|NCT01757171|473934957|FG001|Overall Study|Adverse Event|1|||
131631674|NCT01757171|473934956|FG000|Overall Study|Disease Progression|1|||
131631675|NCT01757171|473934957|FG001|Overall Study|Disease Progression|0|||
131631676|NCT01757171|473934956|FG000|Overall Study|Hospitalization|1|||
131631677|NCT01757171|473934957|FG001|Overall Study|Hospitalization|0|||
131631678|NCT01757171|473934956|FG000|Overall Study|ECOG decline|1|||
131631679|NCT01757171|473934957|FG001|Overall Study|ECOG decline|0|||
131631680|NCT02213458|473934962|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
131631681|NCT02213458|473934963|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
131631682|NCT02213458|473934962|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
131631683|NCT02213458|473934963|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
131631684|NCT02213458|473934962|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
131631685|NCT02213458|473934963|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
131631686|NCT02213458|473934962|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
131631687|NCT02213458|473934963|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
131631688|NCT02213458|473934962|FG000|Overall Study|Refused re-consent|6|||
131631689|NCT02213458|473934963|FG001|Overall Study|Refused re-consent|0|||
131631690|NCT02213458|473934962|FG000|Overall Study|Lost to Follow-up|2|||
131631691|NCT02213458|473934963|FG001|Overall Study|Lost to Follow-up|2|||
131631692|NCT02213458|473934962|FG000|Overall Study|Withdrawal by Subject|26|||
131631693|NCT02213458|473934963|FG001|Overall Study|Withdrawal by Subject|8|||
131631694|NCT05216835|473934964|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131631695|NCT05216835|473934965|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131631696|NCT05216835|473934966|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131631697|NCT05216835|473934967|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131631698|NCT05216835|473934968|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
131631699|NCT05216835|473934969|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
131631700|NCT05216835|473934970|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
131713448|NCT04889209|474228752|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
131713449|NCT04889209|474228735|FG000|All Cohorts Except 15E|Physician Decision|0|||
131713450|NCT04889209|474228736|FG001|All Cohorts Except 15E|Physician Decision|0|||
131713451|NCT04889209|474228737|FG002|All Cohorts Except 15E|Physician Decision|0|||
131713452|NCT04889209|474228738|FG003|All Cohorts Except 15E|Physician Decision|0|||
131713453|NCT04889209|474228739|FG004|All Cohorts Except 15E|Physician Decision|1|||
131713454|NCT04889209|474228740|FG005|All Cohorts Except 15E|Physician Decision|0|||
131713455|NCT04889209|474228741|FG006|All Cohorts Except 15E|Physician Decision|0|||
131713456|NCT04889209|474228742|FG007|All Cohorts Except 15E|Physician Decision|1|||
131713457|NCT04889209|474228743|FG008|All Cohorts Except 15E|Physician Decision|0|||
131713458|NCT04889209|474228744|FG009|All Cohorts Except 15E|Physician Decision|1|||
131713459|NCT04889209|474228745|FG010|All Cohorts Except 15E|Physician Decision|0|||
131713460|NCT04889209|474228746|FG011|All Cohorts Except 15E|Physician Decision|1|||
131713461|NCT04889209|474228747|FG012|All Cohorts Except 15E|Physician Decision|1|||
131713462|NCT04889209|474228748|FG013|All Cohorts Except 15E|Physician Decision|0|||
131713463|NCT04889209|474228749|FG014|All Cohorts Except 15E|Physician Decision|0|||
131713464|NCT04889209|474228750|FG015|All Cohorts Except 15E|Physician Decision|0|||
131713465|NCT04889209|474228751|FG016|All Cohorts Except 15E|Physician Decision|0|||
131713466|NCT04889209|474228752|FG017|All Cohorts Except 15E|Physician Decision|0|||
131713467|NCT04889209|474228735|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
131713468|NCT04889209|474228736|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
131631701|NCT05216835|473934971|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
131631702|NCT05216835|473934964|FG000|Overall Study|Death|0|||
131631703|NCT05216835|473934965|FG001|Overall Study|Death|0|||
131713469|NCT04889209|474228737|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
131631704|NCT05216835|473934966|FG002|Overall Study|Death|0|||
131631705|NCT05216835|473934967|FG003|Overall Study|Death|1|||
131631706|NCT05216835|473934968|FG004|Overall Study|Death|1|||
131631707|NCT05216835|473934969|FG005|Overall Study|Death|1|||
131631708|NCT05216835|473934970|FG006|Overall Study|Death|1|||
131631709|NCT05216835|473934971|FG007|Overall Study|Death|1|||
131631710|NCT05216835|473934964|FG000|Overall Study|Physician Decision|0|||
131631711|NCT05216835|473934965|FG001|Overall Study|Physician Decision|0|||
131631712|NCT05216835|473934966|FG002|Overall Study|Physician Decision|0|||
131631713|NCT05216835|473934967|FG003|Overall Study|Physician Decision|0|||
131631714|NCT05216835|473934968|FG004|Overall Study|Physician Decision|0|||
131631715|NCT05216835|473934969|FG005|Overall Study|Physician Decision|1|||
131631716|NCT05216835|473934970|FG006|Overall Study|Physician Decision|1|||
131631717|NCT05216835|473934971|FG007|Overall Study|Physician Decision|0|||
131631718|NCT05216835|473934964|FG000|Overall Study|Study terminated by Sponsor|0|||
131631719|NCT05216835|473934965|FG001|Overall Study|Study terminated by Sponsor|0|||
131631720|NCT05216835|473934966|FG002|Overall Study|Study terminated by Sponsor|0|||
131631721|NCT05216835|473934967|FG003|Overall Study|Study terminated by Sponsor|0|||
131631722|NCT05216835|473934968|FG004|Overall Study|Study terminated by Sponsor|0|||
131631723|NCT05216835|473934969|FG005|Overall Study|Study terminated by Sponsor|0|||
131631724|NCT05216835|473934970|FG006|Overall Study|Study terminated by Sponsor|0|||
131631725|NCT05216835|473934971|FG007|Overall Study|Study terminated by Sponsor|1|||
131631726|NCT05216835|473934964|FG000|Overall Study|Withdrawal by Subject|1|||
131631727|NCT05216835|473934965|FG001|Overall Study|Withdrawal by Subject|0|||
131631728|NCT05216835|473934966|FG002|Overall Study|Withdrawal by Subject|1|||
131631729|NCT05216835|473934967|FG003|Overall Study|Withdrawal by Subject|0|||
131631730|NCT05216835|473934968|FG004|Overall Study|Withdrawal by Subject|1|||
131631731|NCT05216835|473934969|FG005|Overall Study|Withdrawal by Subject|0|||
131631732|NCT05216835|473934970|FG006|Overall Study|Withdrawal by Subject|0|||
131631733|NCT05216835|473934971|FG007|Overall Study|Withdrawal by Subject|1|||
131631734|NCT05216835|473934964|FG000|Overall Study|Other|0|||
131631735|NCT05216835|473934965|FG001|Overall Study|Other|1|||
131631736|NCT05216835|473934966|FG002|Overall Study|Other|0|||
131631737|NCT05216835|473934967|FG003|Overall Study|Other|0|||
131631738|NCT05216835|473934968|FG004|Overall Study|Other|0|||
131631739|NCT05216835|473934969|FG005|Overall Study|Other|0|||
131631740|NCT05216835|473934970|FG006|Overall Study|Other|0|||
131631741|NCT05216835|473934971|FG007|Overall Study|Other|0|||
131631742|NCT05179603|473934972|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
131631743|NCT05179603|473934972|FG000|Overall Study|Withdrawal by Subject|1|||
131631744|NCT05179603|473934972|FG000|Overall Study|Progressive disease|4|||
131631745|NCT05179603|473934972|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
131631746|NCT05740371|473934973|FG000|Overall Study|Death|1|||
131631747|NCT01549951|473934974|FG000|Overall Study|Adverse Event|15|||
131631748|NCT01549951|473934974|FG000|Overall Study|Withdrawal by Subject|2|||
131631749|NCT01549951|473934974|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
131631750|NCT01549951|473934974|FG000|Overall Study|Progressive disease|29|||
131631751|NCT01549951|473934974|FG000|Overall Study|Symptomatic deterioration|1|||
131631752|NCT01549951|473934974|FG000|Overall Study|Other|2|||
131631753|NCT00738400|473934975|FG000|Overall Study|Adverse Event|3|||
131631754|NCT00738400|473934976|FG001|Overall Study|Adverse Event|1|||
131631755|NCT00738400|473934975|FG000|Overall Study|Withdrawal by Subject|0|||
131631756|NCT00738400|473934976|FG001|Overall Study|Withdrawal by Subject|1|||
131631757|NCT00738400|473934975|FG000|Overall Study|Lack of Efficacy|0|||
131631758|NCT00738400|473934976|FG001|Overall Study|Lack of Efficacy|1|||
131631759|NCT00738400|473934975|FG000|Overall Study|Lost to Follow-up|0|||
131631760|NCT00738400|473934976|FG001|Overall Study|Lost to Follow-up|3|||
131631761|NCT00738400|473934975|FG000|Overall Study|Protocol Violation|1|||
131631762|NCT00738400|473934976|FG001|Overall Study|Protocol Violation|0|||
131631763|NCT00738400|473934975|FG000|Overall Study|Non-compliant with study medication|0|||
131631764|NCT00738400|473934976|FG001|Overall Study|Non-compliant with study medication|1|||
131631765|NCT03138499|473934977|FG000|Overall Study|Lost to Follow-up|1|||
131631766|NCT03138499|473934978|FG001|Overall Study|Lost to Follow-up|0|||
131631767|NCT03138499|473934977|FG000|Overall Study|Participants withdrew consent|1|||
131631768|NCT03138499|473934978|FG001|Overall Study|Participants withdrew consent|0|||
131631769|NCT03138499|473934977|FG000|Overall Study|Participant discontinued study before treatment|0|||
131631770|NCT03138499|473934978|FG001|Overall Study|Participant discontinued study before treatment|1|||
131631771|NCT03138499|473934977|FG000|Overall Study|Disease Progression|2|||
131631772|NCT03138499|473934978|FG001|Overall Study|Disease Progression|6|||
131631773|NCT03138499|473934977|FG000|Overall Study|Study drug toxicity|2|||
131631774|NCT03138499|473934978|FG001|Overall Study|Study drug toxicity|2|||
131631775|NCT03138499|473934977|FG000|Overall Study|Participant request to discontinue study treatment|1|||
131631776|NCT03138499|473934978|FG001|Overall Study|Participant request to discontinue study treatment|1|||
131631777|NCT03138499|473934977|FG000|Overall Study|Other reasons|2|||
131631778|NCT03138499|473934978|FG001|Overall Study|Other reasons|0|||
131631779|NCT02312245|473934979|FG000|Overall Study|Death|0|||
131902228|NCT01585246|474926999|FG001|Overall Study|Withdrawal by Subject|0|||
131902229|NCT01585246|474927000|FG002|Overall Study|Withdrawal by Subject|1|||
131902230|NCT01585246|474927001|FG003|Overall Study|Withdrawal by Subject|2|||
131902231|NCT01585246|474927002|FG004|Overall Study|Withdrawal by Subject|1|||
131902232|NCT01585246|474926998|FG000|Overall Study|Other|0|||
131902233|NCT01585246|474926999|FG001|Overall Study|Other|1|||
131902234|NCT01585246|474927000|FG002|Overall Study|Other|1|||
131902235|NCT01585246|474927001|FG003|Overall Study|Other|1|||
131902236|NCT01585246|474927002|FG004|Overall Study|Other|0|||
131902237|NCT04396626|474927003|FG000|Overall Study|Premature termination of study|975|||
131631780|NCT02312245|473934980|FG001|Overall Study|Death|0|||
131631781|NCT02312245|473934981|FG002|Overall Study|Death|0|||
131631782|NCT02312245|473934982|FG003|Overall Study|Death|1|||
131631783|NCT02312245|473934979|FG000|Overall Study|Withdrawal by Subject|1|||
131631784|NCT02312245|473934980|FG001|Overall Study|Withdrawal by Subject|1|||
131631785|NCT02312245|473934981|FG002|Overall Study|Withdrawal by Subject|0|||
131631786|NCT02312245|473934982|FG003|Overall Study|Withdrawal by Subject|2|||
131631787|NCT02312245|473934979|FG000|Overall Study|Alternative Therapy|1|||
131631788|NCT02312245|473934980|FG001|Overall Study|Alternative Therapy|0|||
131631789|NCT02312245|473934981|FG002|Overall Study|Alternative Therapy|0|||
131631790|NCT02312245|473934982|FG003|Overall Study|Alternative Therapy|0|||
131631791|NCT02312245|473934979|FG000|Overall Study|Progression|0|||
131631792|NCT02312245|473934980|FG001|Overall Study|Progression|0|||
131631793|NCT02312245|473934981|FG002|Overall Study|Progression|0|||
131631794|NCT02312245|473934982|FG003|Overall Study|Progression|5|||
131631795|NCT02312245|473934979|FG000|Overall Study|Patient went to hospice|0|||
131631796|NCT02312245|473934980|FG001|Overall Study|Patient went to hospice|0|||
131631797|NCT02312245|473934981|FG002|Overall Study|Patient went to hospice|0|||
131631798|NCT02312245|473934982|FG003|Overall Study|Patient went to hospice|1|||
131631799|NCT02312245|473934979|FG000|Overall Study|Ineligible|1|||
131631800|NCT02312245|473934980|FG001|Overall Study|Ineligible|0|||
131631801|NCT02312245|473934981|FG002|Overall Study|Ineligible|0|||
131631802|NCT02312245|473934982|FG003|Overall Study|Ineligible|0|||
131631803|NCT01123200|473934984|FG000|Overall Study|Withdrawal by Subject|1|||
131631804|NCT01052714|473934987|FG000|Overall Study|Adverse Event|6|||
131631805|NCT01052714|473934988|FG001|Overall Study|Adverse Event|3|||
131631806|NCT01052714|473934989|FG002|Overall Study|Adverse Event|0|||
131631807|NCT01052714|473934987|FG000|Overall Study|Death|1|||
131631808|NCT01052714|473934988|FG001|Overall Study|Death|2|||
131631809|NCT01052714|473934989|FG002|Overall Study|Death|0|||
131631810|NCT01052714|473934987|FG000|Overall Study|Lost to Follow-up|2|||
131631811|NCT01052714|473934988|FG001|Overall Study|Lost to Follow-up|3|||
131631812|NCT01052714|473934989|FG002|Overall Study|Lost to Follow-up|0|||
131631813|NCT01052714|473934987|FG000|Overall Study|Physician Decision|9|||
131631814|NCT01052714|473934988|FG001|Overall Study|Physician Decision|9|||
131631815|NCT01052714|473934989|FG002|Overall Study|Physician Decision|1|||
131631816|NCT01052714|473934987|FG000|Overall Study|Withdrawal by Subject|7|||
131631817|NCT01052714|473934988|FG001|Overall Study|Withdrawal by Subject|12|||
131631818|NCT01052714|473934989|FG002|Overall Study|Withdrawal by Subject|1|||
131631819|NCT03689452|473934993|FG000|Overall Study|Lost to Follow-up|1|||
131902238|NCT02417753|474927004|FG000|Overall Study|Death|1|||
131902239|NCT03771963|474927007|FG000|Overall Study|Lost to Follow-up|22|||
131902240|NCT03771963|474927007|FG000|Overall Study|Withdrawal of Consent|10|||
131631820|NCT03689452|473934994|FG001|Overall Study|Lost to Follow-up|1|||
131631821|NCT02676778|473934995|FG000|Overall Study|Disease Progression|7|||
131631822|NCT02676778|473934996|FG001|Overall Study|Disease Progression|3|||
131631823|NCT02676778|473934997|FG002|Overall Study|Disease Progression|1|||
131631824|NCT02676778|473934995|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
131631825|NCT02676778|473934996|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
131631826|NCT02676778|473934997|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
131631827|NCT02676778|473934995|FG000|Overall Study|Withdrawal by Subject|3|||
131631828|NCT02676778|473934996|FG001|Overall Study|Withdrawal by Subject|2|||
131631829|NCT02676778|473934997|FG002|Overall Study|Withdrawal by Subject|0|||
131631830|NCT02676778|473934995|FG000|Overall Study|Other|4|||
131631831|NCT02676778|473934996|FG001|Overall Study|Other|3|||
131631832|NCT02676778|473934997|FG002|Overall Study|Other|0|||
131631833|NCT02676778|473934995|FG000|Overall Study|Adverse Event|2|||
131631834|NCT02676778|473934996|FG001|Overall Study|Adverse Event|3|||
131631835|NCT02676778|473934997|FG002|Overall Study|Adverse Event|0|||
131631836|NCT00732498|473935001|FG000|Overall Study|Ineligible|1|||
131631837|NCT00732498|473935001|FG000|Overall Study|Adverse Event|2|||
131631838|NCT00732498|473935001|FG000|Overall Study|Physician Decision|3|||
131631839|NCT03394508|473935004|FG000|Overall Study|Protocol Violation|0|||
131631840|NCT03394508|473935005|FG001|Overall Study|Protocol Violation|3|||
131631841|NCT03394508|473935004|FG000|Overall Study|Lost to Follow-up|1|||
131631842|NCT03394508|473935005|FG001|Overall Study|Lost to Follow-up|0|||
131631843|NCT03214198|473935010|FG000|Overall Study|Case Report Forms Uncollected|18|||
131631844|NCT03214198|473935010|FG000|Overall Study|Protocol Deviation|18|||
131631845|NCT04295499|473935011|FG000|Overall Study|moving out of state|1|||
131631846|NCT04295499|473935012|FG001|Overall Study|moving out of state|0|||
131631847|NCT04295499|473935011|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
131631848|NCT04295499|473935012|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
131631849|NCT03122548|473935013|FG000|Overall Study|Death|2|||
131631850|NCT03122548|473935013|FG000|Overall Study|Progression - subject went into hospice|1|||
131631851|NCT03122548|473935013|FG000|Overall Study|Study Terminated by Sponsor|2|||
131631852|NCT02135445|473935014|FG000|Overall Study|Lost to Follow-up|1|||
131631853|NCT02135445|473935015|FG001|Overall Study|Lost to Follow-up|0|||
131631854|NCT02135445|473935014|FG000|Overall Study|Withdrawal by Subject|1|||
131631855|NCT02135445|473935015|FG001|Overall Study|Withdrawal by Subject|0|||
131653751|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131653752|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131653753|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131653754|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131653755|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131653756|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131653757|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
131653758|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
131653759|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
131653760|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
131653761|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
131653762|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
131653763|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
131653764|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131653765|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131653766|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131653767|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131653768|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131653769|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
131653770|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131653771|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131653772|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131653773|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
131653774|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131653775|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131804509|NCT02794974|474568551|FG001|Overall Study|Physician Decision|1|||
131631856|NCT04851587|473936648|FG000|Overall Study|Lost to Follow-up|18|||
131631857|NCT02101554|473936650|FG000|Overall Study|Protocol Violation|0|||
131631858|NCT02101554|473936651|FG001|Overall Study|Protocol Violation|1|||
131631859|NCT02101554|473936652|FG002|Overall Study|Protocol Violation|0|||
131631860|NCT02101554|473936650|FG000|Overall Study|Insufficient Clinical Response|0|||
131902241|NCT03014206|474927008|FG000|Overall Study|Registration Violation|12|||
131902242|NCT02155985|474927009|FG000|Overall Study|Withdrawal by Subject|0|||
131902243|NCT02155985|474927010|FG001|Overall Study|Withdrawal by Subject|0|||
131902244|NCT02155985|474927011|FG002|Overall Study|Withdrawal by Subject|1|||
131902245|NCT02155985|474927009|FG000|Overall Study|Lost to Follow-up|1|||
131902246|NCT02155985|474927010|FG001|Overall Study|Lost to Follow-up|0|||
131902247|NCT02155985|474927011|FG002|Overall Study|Lost to Follow-up|0|||
131902248|NCT02998151|474927012|FG000|Overall Study|Withdrawal by Subject|3|||
131902249|NCT02998151|474927012|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
131902250|NCT02998151|474927012|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
131631861|NCT02101554|473936651|FG001|Overall Study|Insufficient Clinical Response|2|||
131631862|NCT02101554|473936652|FG002|Overall Study|Insufficient Clinical Response|0|||
131902251|NCT01367249|474927016|FG000|Overall Study|Withdrawal by Subject|6|||
131631863|NCT02101554|473936650|FG000|Overall Study|Adverse Event|2|||
131631864|NCT02101554|473936651|FG001|Overall Study|Adverse Event|1|||
131631865|NCT02101554|473936652|FG002|Overall Study|Adverse Event|1|||
131631866|NCT02101554|473936650|FG000|Overall Study|Lost to Follow-up|0|||
131631867|NCT02101554|473936651|FG001|Overall Study|Lost to Follow-up|1|||
131631868|NCT02101554|473936652|FG002|Overall Study|Lost to Follow-up|0|||
131631869|NCT02101554|473936650|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
131631870|NCT02101554|473936651|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
131631871|NCT02101554|473936652|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
131631872|NCT01350102|473936653|FG000|Overall Study|Adverse Event|0|||
131631873|NCT01350102|473936654|FG001|Overall Study|Adverse Event|0|||
131631874|NCT01350102|473936655|FG002|Overall Study|Adverse Event|1|||
131631875|NCT01350102|473936656|FG003|Overall Study|Adverse Event|0|||
131631876|NCT02136797|473936658|FG000|Overall Study|Not Treated|8|||
131631877|NCT04523571|473936659|FG000|Received 2 Doses|Withdrawal by Subject|0|||
131631878|NCT04523571|473936660|FG001|Received 2 Doses|Withdrawal by Subject|0|||
131631879|NCT04523571|473936661|FG002|Received 2 Doses|Withdrawal by Subject|0|||
131631880|NCT04523571|473936662|FG003|Received 2 Doses|Withdrawal by Subject|1|||
131631881|NCT04523571|473936663|FG004|Received 2 Doses|Withdrawal by Subject|1|||
131631882|NCT04523571|473936664|FG005|Received 2 Doses|Withdrawal by Subject|0|||
131902252|NCT01367249|474927017|FG001|Overall Study|Withdrawal by Subject|6|||
131902253|NCT01367249|474927016|FG000|Overall Study|Other|3|||
131902254|NCT01367249|474927017|FG001|Overall Study|Other|10|||
131902255|NCT02346877|474927018|FG000|Overall Study|Adverse Event|1|||
131631883|NCT04523571|473936659|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
131631884|NCT04523571|473936660|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131631885|NCT04523571|473936661|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
131631886|NCT04523571|473936662|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131631887|NCT04523571|473936663|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131631888|NCT04523571|473936664|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131631889|NCT04523571|473936659|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131631890|NCT04523571|473936660|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131631891|NCT04523571|473936661|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131631892|NCT04523571|473936662|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131631893|NCT04523571|473936663|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131631894|NCT04523571|473936664|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
131631895|NCT04523571|473936659|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131902256|NCT02346877|474927019|FG001|Overall Study|Adverse Event|0|||
131902257|NCT02346877|474927018|FG000|Overall Study|Administrative Decision|1|||
131631896|NCT04523571|473936660|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131902258|NCT02346877|474927019|FG001|Overall Study|Administrative Decision|0|||
131902259|NCT02346877|474927018|FG000|Overall Study|Sponsor Decision|12|||
131902260|NCT02346877|474927019|FG001|Overall Study|Sponsor Decision|0|||
131631897|NCT04523571|473936661|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131631898|NCT04523571|473936662|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
131631899|NCT04523571|473936663|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
131631900|NCT04523571|473936664|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131902261|NCT02346877|474927018|FG000|Overall Study|Missing|5|||
131902262|NCT02346877|474927019|FG001|Overall Study|Missing|0|||
131902263|NCT01683604|474927022|FG000|Overall Study|Adverse Event|2|||
131631901|NCT03694210|473936666|FG000|Overall Study|Death|1|||
131631902|NCT03694210|473936666|FG000|Overall Study|Screen Failure|7|||
131631903|NCT02706834|473936667|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131631904|NCT02706834|473936668|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131631905|NCT02706834|473936669|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131631906|NCT02706834|473936670|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
131631907|NCT02706834|473936671|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131631908|NCT02706834|473936672|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
131631909|NCT02706834|473936673|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
131631910|NCT02706834|473936674|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
131631911|NCT02706834|473936675|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
131631912|NCT02706834|473936676|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
131631913|NCT02706834|473936677|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
131631914|NCT02706834|473936667|FG000|Overall Study|Lost to Follow-up|0|||
131631915|NCT02706834|473936668|FG001|Overall Study|Lost to Follow-up|0|||
131631916|NCT02706834|473936669|FG002|Overall Study|Lost to Follow-up|1|||
131631917|NCT02706834|473936670|FG003|Overall Study|Lost to Follow-up|0|||
131631918|NCT02706834|473936671|FG004|Overall Study|Lost to Follow-up|0|||
131631919|NCT02706834|473936672|FG005|Overall Study|Lost to Follow-up|0|||
131631920|NCT02706834|473936673|FG006|Overall Study|Lost to Follow-up|0|||
131631921|NCT02706834|473936674|FG007|Overall Study|Lost to Follow-up|0|||
131631922|NCT02706834|473936675|FG008|Overall Study|Lost to Follow-up|0|||
131631923|NCT02706834|473936676|FG009|Overall Study|Lost to Follow-up|0|||
131631924|NCT02706834|473936677|FG010|Overall Study|Lost to Follow-up|0|||
131631925|NCT02706834|473936667|FG000|Overall Study|Voluntary Withdrawal|1|||
131631926|NCT02706834|473936668|FG001|Overall Study|Voluntary Withdrawal|0|||
131631927|NCT02706834|473936669|FG002|Overall Study|Voluntary Withdrawal|0|||
131631928|NCT02706834|473936670|FG003|Overall Study|Voluntary Withdrawal|0|||
131631929|NCT02706834|473936671|FG004|Overall Study|Voluntary Withdrawal|0|||
131631930|NCT02706834|473936672|FG005|Overall Study|Voluntary Withdrawal|0|||
131631931|NCT02706834|473936673|FG006|Overall Study|Voluntary Withdrawal|0|||
131631932|NCT02706834|473936674|FG007|Overall Study|Voluntary Withdrawal|0|||
131631933|NCT02706834|473936675|FG008|Overall Study|Voluntary Withdrawal|0|||
131631934|NCT02706834|473936676|FG009|Overall Study|Voluntary Withdrawal|1|||
131631935|NCT02706834|473936677|FG010|Overall Study|Voluntary Withdrawal|0|||
131631936|NCT02706834|473936667|FG000|Overall Study|Other Reason Not Specified|1|||
131631937|NCT02706834|473936668|FG001|Overall Study|Other Reason Not Specified|0|||
131631938|NCT02706834|473936669|FG002|Overall Study|Other Reason Not Specified|0|||
131631939|NCT02706834|473936670|FG003|Overall Study|Other Reason Not Specified|0|||
131631940|NCT02706834|473936671|FG004|Overall Study|Other Reason Not Specified|1|||
131631941|NCT02706834|473936672|FG005|Overall Study|Other Reason Not Specified|0|||
131631942|NCT02706834|473936673|FG006|Overall Study|Other Reason Not Specified|0|||
131631943|NCT02706834|473936674|FG007|Overall Study|Other Reason Not Specified|0|||
131631944|NCT02706834|473936675|FG008|Overall Study|Other Reason Not Specified|0|||
131631945|NCT02706834|473936676|FG009|Overall Study|Other Reason Not Specified|0|||
131631946|NCT02706834|473936677|FG010|Overall Study|Other Reason Not Specified|0|||
131631947|NCT00627523|473936678|FG000|Overall Study|Lack of Efficacy|1|||
131631948|NCT00627523|473936679|FG001|Overall Study|Lack of Efficacy|0|||
131631949|NCT00627523|473936678|FG000|Overall Study|Withdrawal by Subject|0|||
131631950|NCT00627523|473936679|FG001|Overall Study|Withdrawal by Subject|2|||
131631951|NCT00627523|473936678|FG000|Overall Study|Other|1|||
131631952|NCT00627523|473936679|FG001|Overall Study|Other|0|||
131631953|NCT02543294|473936682|FG000|Overall Study|Lost to Follow-up|3|||
131631954|NCT02543294|473936682|FG000|Overall Study|Physician Decision|2|||
131631955|NCT02543294|473936682|FG000|Overall Study|Withdrawal by Subject|7|||
131631956|NCT01038128|473936684|FG000|Overall Study|Lack of Efficacy|1|||
131631957|NCT01038128|473936684|FG000|Overall Study|Lost to Follow-up|1|||
131631958|NCT01038128|473936684|FG000|Overall Study|Withdrawal by Subject|2|||
131631959|NCT03672188|473936691|FG000|Overall Study|Withdrawal by Subject|0|||
131631960|NCT03672188|473936692|FG001|Overall Study|Withdrawal by Subject|0|||
131631961|NCT03672188|473936693|FG002|Overall Study|Withdrawal by Subject|0|||
131631962|NCT03672188|473936694|FG003|Overall Study|Withdrawal by Subject|3|||
131713470|NCT04889209|474228738|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
131631963|NCT03672188|473936695|FG004|Overall Study|Withdrawal by Subject|0|||
131631964|NCT03672188|473936696|FG005|Overall Study|Withdrawal by Subject|0|||
131631965|NCT03672188|473936697|FG006|Overall Study|Withdrawal by Subject|0|||
131631966|NCT03672188|473936698|FG007|Overall Study|Withdrawal by Subject|0|||
131631967|NCT03672188|473936699|FG008|Overall Study|Withdrawal by Subject|0|||
131631968|NCT03672188|473936700|FG009|Overall Study|Withdrawal by Subject|0|||
131631969|NCT03672188|473936701|FG010|Overall Study|Withdrawal by Subject|0|||
131631970|NCT03672188|473936702|FG011|Overall Study|Withdrawal by Subject|0|||
131631971|NCT03672188|473936703|FG012|Overall Study|Withdrawal by Subject|0|||
131631972|NCT03672188|473936704|FG013|Overall Study|Withdrawal by Subject|0|||
131631973|NCT03672188|473936705|FG014|Overall Study|Withdrawal by Subject|0|||
131713471|NCT04889209|474228739|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
131713472|NCT04889209|474228740|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
131631974|NCT03672188|473936691|FG000|Overall Study|Death|0|||
131631975|NCT03672188|473936692|FG001|Overall Study|Death|0|||
131631976|NCT03672188|473936693|FG002|Overall Study|Death|0|||
131631977|NCT03672188|473936694|FG003|Overall Study|Death|0|||
131631978|NCT03672188|473936695|FG004|Overall Study|Death|0|||
131631979|NCT03672188|473936696|FG005|Overall Study|Death|0|||
131631980|NCT03672188|473936697|FG006|Overall Study|Death|0|||
131631981|NCT03672188|473936698|FG007|Overall Study|Death|0|||
131631982|NCT03672188|473936699|FG008|Overall Study|Death|0|||
131631983|NCT03672188|473936700|FG009|Overall Study|Death|0|||
131631984|NCT03672188|473936701|FG010|Overall Study|Death|0|||
131631985|NCT03672188|473936702|FG011|Overall Study|Death|0|||
131631986|NCT03672188|473936703|FG012|Overall Study|Death|1|||
131631987|NCT03672188|473936704|FG013|Overall Study|Death|0|||
131631988|NCT03672188|473936705|FG014|Overall Study|Death|0|||
131631989|NCT03672188|473936691|FG000|Overall Study|Lost to Follow-up|0|||
131631990|NCT03672188|473936692|FG001|Overall Study|Lost to Follow-up|0|||
131631991|NCT03672188|473936693|FG002|Overall Study|Lost to Follow-up|1|||
131631992|NCT03672188|473936694|FG003|Overall Study|Lost to Follow-up|0|||
131631993|NCT03672188|473936695|FG004|Overall Study|Lost to Follow-up|0|||
131631994|NCT03672188|473936696|FG005|Overall Study|Lost to Follow-up|0|||
131631995|NCT03672188|473936697|FG006|Overall Study|Lost to Follow-up|0|||
131631996|NCT03672188|473936698|FG007|Overall Study|Lost to Follow-up|0|||
131631997|NCT03672188|473936699|FG008|Overall Study|Lost to Follow-up|0|||
131631998|NCT03672188|473936700|FG009|Overall Study|Lost to Follow-up|0|||
131631999|NCT03672188|473936701|FG010|Overall Study|Lost to Follow-up|0|||
131632000|NCT03672188|473936702|FG011|Overall Study|Lost to Follow-up|0|||
131632001|NCT03672188|473936703|FG012|Overall Study|Lost to Follow-up|0|||
131632002|NCT03672188|473936704|FG013|Overall Study|Lost to Follow-up|0|||
131632003|NCT03672188|473936705|FG014|Overall Study|Lost to Follow-up|0|||
131632004|NCT03614923|473936713|FG000|Overall Study|Withdrawal by Subject|2|||
131632005|NCT03614923|473936714|FG001|Overall Study|Withdrawal by Subject|1|||
131632006|NCT03614923|473936715|FG002|Overall Study|Withdrawal by Subject|1|||
131632007|NCT03614923|473936713|FG000|Overall Study|Adverse Event|0|||
131632008|NCT03614923|473936714|FG001|Overall Study|Adverse Event|2|||
131632009|NCT03614923|473936715|FG002|Overall Study|Adverse Event|1|||
131632010|NCT03614923|473936713|FG000|Overall Study|Lost to Follow-up|1|||
131632011|NCT03614923|473936714|FG001|Overall Study|Lost to Follow-up|0|||
131632012|NCT03614923|473936715|FG002|Overall Study|Lost to Follow-up|1|||
131632013|NCT03614923|473936713|FG000|Overall Study|Lack of Efficacy|2|||
131632014|NCT03614923|473936714|FG001|Overall Study|Lack of Efficacy|0|||
131632015|NCT03614923|473936715|FG002|Overall Study|Lack of Efficacy|1|||
131632016|NCT03614923|473936713|FG000|Overall Study|Non-compliance|0|||
131632017|NCT03614923|473936714|FG001|Overall Study|Non-compliance|1|||
131632018|NCT03614923|473936715|FG002|Overall Study|Non-compliance|0|||
131632019|NCT03614923|473936713|FG000|Overall Study|Other|0|||
131632020|NCT03614923|473936714|FG001|Overall Study|Other|1|||
131632021|NCT03614923|473936715|FG002|Overall Study|Other|1|||
131632022|NCT03360071|473936716|FG000|Overall Study|Lost to Follow-up|1|||
131632023|NCT03360071|473936717|FG001|Overall Study|Lost to Follow-up|0|||
131632024|NCT01745380|473936718|FG000|Overall Study|Lost to Follow-up|1|||
131632025|NCT01745380|473936719|FG001|Overall Study|Lost to Follow-up|0|||
131632026|NCT01745380|473936718|FG000|Overall Study|Lack of Efficacy|0|||
131632027|NCT01745380|473936719|FG001|Overall Study|Lack of Efficacy|1|||
131632028|NCT01882088|473936720|FG000|Overall Study|Intolerance of esophageal manometry|1|||
131632029|NCT01882088|473936720|FG000|Overall Study|no possibility to place the catheter|1|||
131632030|NCT01882088|473936720|FG000|Overall Study|Protocol Violation|1|||
131632031|NCT01882088|473936720|FG000|Overall Study|inadequate pH-impedance tracings|2|||
131632032|NCT01193283|473936724|FG000|Overall Study|Death|1|||
131632033|NCT02368691|473936725|FG000|Overall Study|Death|13|||
131632034|NCT02368691|473936725|FG000|Overall Study|Lack of Efficacy|15|||
131632035|NCT02368691|473936725|FG000|Overall Study|Physician Decision|4|||
131632036|NCT02720198|473936726|FG000|Overall Study|Withdrawal by Subject|0|||
131632037|NCT02720198|473936727|FG001|Overall Study|Withdrawal by Subject|1|||
131632038|NCT01268488|473936753|FG000|Overall Study|Adverse Event|3|||
131632039|NCT01268488|473936753|FG000|Overall Study|Physician Decision|2|||
131632040|NCT01014013|473936754|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
131632041|NCT01014013|473936755|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
131632042|NCT01014013|473936754|FG000|Overall Study|Clinical adverse experience|4|||
131632043|NCT01014013|473936755|FG001|Overall Study|Clinical adverse experience|2|||
131632044|NCT01014013|473936754|FG000|Overall Study|Laboratory adverse experience|1|||
131632045|NCT01014013|473936755|FG001|Overall Study|Laboratory adverse experience|1|||
131632046|NCT01014013|473936754|FG000|Overall Study|Protocol Violation|1|||
131632047|NCT01014013|473936755|FG001|Overall Study|Protocol Violation|3|||
131632048|NCT01014013|473936754|FG000|Overall Study|Withdrawal by Subject|7|||
131632049|NCT01014013|473936755|FG001|Overall Study|Withdrawal by Subject|4|||
131632050|NCT01014013|473936754|FG000|Overall Study|Clinical/microbiologic failure|1|||
131632051|NCT01014013|473936755|FG001|Overall Study|Clinical/microbiologic failure|2|||
131632052|NCT01014013|473936754|FG000|Overall Study|Pathogen culture = no growth|26|||
131632053|NCT01014013|473936755|FG001|Overall Study|Pathogen culture = no growth|34|||
131632054|NCT01014013|473936754|FG000|Overall Study|Negative urine culture|2|||
131632055|NCT01014013|473936755|FG001|Overall Study|Negative urine culture|0|||
131632056|NCT01014013|473936754|FG000|Overall Study|Pathogen resistant|7|||
131632057|NCT01014013|473936755|FG001|Overall Study|Pathogen resistant|4|||
131632058|NCT01014013|473936754|FG000|Overall Study|Physician Decision|0|||
131632059|NCT01014013|473936755|FG001|Overall Study|Physician Decision|1|||
131632060|NCT01014013|473936754|FG000|Overall Study|Another antibiotic therapy required|0|||
131632061|NCT01014013|473936755|FG001|Overall Study|Another antibiotic therapy required|1|||
131632062|NCT01014013|473936754|FG000|Overall Study|Appendectomy|1|||
131632063|NCT01014013|473936755|FG001|Overall Study|Appendectomy|0|||
131632064|NCT01014013|473936754|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
131632065|NCT01014013|473936755|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
131632066|NCT00316121|473936756|FG000|Overall Study|Death|1|||
131632067|NCT00316121|473936757|FG001|Overall Study|Death|0|||
131632068|NCT00316121|473936756|FG000|Overall Study|Lost to Follow-up|14|||
131632069|NCT00316121|473936757|FG001|Overall Study|Lost to Follow-up|8|||
131632070|NCT00316121|473936756|FG000|Overall Study|Withdrawal by Subject|2|||
131632071|NCT00316121|473936757|FG001|Overall Study|Withdrawal by Subject|0|||
131632072|NCT00316121|473936756|FG000|Overall Study|Reason is missing|1|||
131632073|NCT00316121|473936757|FG001|Overall Study|Reason is missing|0|||
131632074|NCT00316121|473936756|FG000|Overall Study|Subject relocated|1|||
131632075|NCT00316121|473936757|FG001|Overall Study|Subject relocated|1|||
131632076|NCT00316121|473936756|FG000|Overall Study|Subject refused to return|1|||
131632077|NCT00316121|473936757|FG001|Overall Study|Subject refused to return|0|||
131632078|NCT00316121|473936756|FG000|Overall Study|Subject no show for visit x 3|1|||
131632079|NCT00316121|473936757|FG001|Overall Study|Subject no show for visit x 3|0|||
131632080|NCT00316121|473936756|FG000|Overall Study|Subject did not have 24 month visit|1|||
131632081|NCT00316121|473936757|FG001|Overall Study|Subject did not have 24 month visit|0|||
131632082|NCT05274906|473936758|FG000|Overall Study|Withdrawal by Subject|2|||
131632083|NCT05274906|473936759|FG001|Overall Study|Withdrawal by Subject|1|||
131632084|NCT00910871|473936761|FG000|Overall Study|Adverse Event|5|||
131632085|NCT00910871|473936761|FG000|Overall Study|Death|12|||
131632086|NCT00910871|473936761|FG000|Overall Study|Lost to Follow-up|8|||
131632087|NCT00910871|473936761|FG000|Overall Study|Protocol Violation|11|||
131632088|NCT00910871|473936761|FG000|Overall Study|Withdrawal by Subject|12|||
131632089|NCT00910871|473936761|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
131632090|NCT00910871|473936761|FG000|Overall Study|Undefined|1|||
131632091|NCT01047306|473936762|FG000|Overall Study|Withdrawal by Subject|2|||
131632092|NCT01047306|473936763|FG001|Overall Study|Withdrawal by Subject|0|||
131632093|NCT01047306|473936762|FG000|Overall Study|Lost to Follow-up|1|||
131632094|NCT01047306|473936763|FG001|Overall Study|Lost to Follow-up|0|||
131632095|NCT04799587|473936764|FG000|Overall Study|Withdrawal by Subject|0|||
131632096|NCT04799587|473936765|FG001|Overall Study|Withdrawal by Subject|1|||
131632097|NCT04551053|473936768|FG000|Overall Study|Death|10|||
131632098|NCT04551053|473936769|FG001|Overall Study|Death|9|||
131632099|NCT04551053|473936768|FG000|Overall Study|Lost to Follow-up|0|||
131632100|NCT04551053|473936769|FG001|Overall Study|Lost to Follow-up|2|||
131798167|NCT00365352|474543550|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
131798168|NCT00365352|474543551|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
131798169|NCT00365352|474543552|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
131798170|NCT00409578|474543557|FG000|Overall Study|Adverse Event|27|||
131798171|NCT00409578|474543558|FG001|Overall Study|Adverse Event|37|||
131798172|NCT00409578|474543559|FG002|Overall Study|Adverse Event|25|||
131798173|NCT00409578|474543560|FG003|Overall Study|Adverse Event|33|||
131798174|NCT00409578|474543557|FG000|Overall Study|Abnormal laboratory value(s)|2|||
131798175|NCT00409578|474543558|FG001|Overall Study|Abnormal laboratory value(s)|2|||
131798176|NCT00409578|474543559|FG002|Overall Study|Abnormal laboratory value(s)|2|||
131798177|NCT00409578|474543560|FG003|Overall Study|Abnormal laboratory value(s)|4|||
131798178|NCT00409578|474543557|FG000|Overall Study|Lack of Efficacy|0|||
131798179|NCT00409578|474543558|FG001|Overall Study|Lack of Efficacy|0|||
131798180|NCT00409578|474543559|FG002|Overall Study|Lack of Efficacy|0|||
131798181|NCT00409578|474543560|FG003|Overall Study|Lack of Efficacy|2|||
131798182|NCT00409578|474543557|FG000|Overall Study|Subject no longer requires study drug|0|||
131632101|NCT04551053|473936768|FG000|Overall Study|Study Terminated by Sponsor|57|||
131632102|NCT04551053|473936769|FG001|Overall Study|Study Terminated by Sponsor|65|||
131632103|NCT04551053|473936768|FG000|Overall Study|Withdrawal by Subject|12|||
131798183|NCT00409578|474543558|FG001|Overall Study|Subject no longer requires study drug|0|||
131632104|NCT04551053|473936769|FG001|Overall Study|Withdrawal by Subject|5|||
131632105|NCT04551053|473936768|FG000|Overall Study|Adverse Event|2|||
131632106|NCT04551053|473936769|FG001|Overall Study|Adverse Event|0|||
131632107|NCT04551053|473936768|FG000|Overall Study|Lack of Efficacy|2|||
131798184|NCT00409578|474543559|FG002|Overall Study|Subject no longer requires study drug|0|||
131632108|NCT04551053|473936769|FG001|Overall Study|Lack of Efficacy|1|||
131632109|NCT04551053|473936768|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
131798185|NCT00409578|474543560|FG003|Overall Study|Subject no longer requires study drug|1|||
131632110|NCT04551053|473936769|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
131632111|NCT04551053|473936768|FG000|Overall Study|Splenapendectomi|1|||
131632112|NCT04551053|473936769|FG001|Overall Study|Splenapendectomi|0|||
131632113|NCT04551053|473936768|FG000|Overall Study|Medical Decision|1|||
131632114|NCT04551053|473936769|FG001|Overall Study|Medical Decision|1|||
131632115|NCT01613599|473936770|FG000|Overall Study|Death|9|||
131632116|NCT01613599|473936770|FG000|Overall Study|Lost to Follow-up|5|||
131632117|NCT01613599|473936770|FG000|Overall Study|Withdrawal by Subject|8|||
131632118|NCT01613599|473936770|FG000|Overall Study|Reason not specified|3|||
131632119|NCT01075815|473936772|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
131632120|NCT01075815|473936773|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
131632121|NCT01075815|473936772|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
131632122|NCT01075815|473936773|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
131632123|NCT01075815|473936772|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
131632124|NCT01075815|473936773|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
131632125|NCT03503188|473936774|FG000|Overall Study|Non eligible in the sub study|0|||
131632126|NCT03503188|473936775|FG001|Overall Study|Non eligible in the sub study|1|||
131632127|NCT03747575|473936782|FG000|Overall Study|Withdrawal by Subject|6|||
131632128|NCT03747575|473936783|FG001|Overall Study|Withdrawal by Subject|3|||
131632129|NCT03747575|473936782|FG000|Overall Study|Lost to Follow-up|3|||
131632130|NCT03747575|473936783|FG001|Overall Study|Lost to Follow-up|3|||
131632131|NCT03747575|473936782|FG000|Overall Study|Adverse Event|0|||
131632132|NCT03747575|473936783|FG001|Overall Study|Adverse Event|1|||
131632133|NCT03005106|473936786|FG000|Overall Study|Lost to Follow-up|16|||
131632134|NCT03005106|473936786|FG000|Overall Study|Adverse Event|1|||
131632135|NCT03005106|473936786|FG000|Overall Study|Physician Decision|1|||
131632136|NCT03005106|473936786|FG000|Overall Study|Death|2|||
131632137|NCT03019289|473936789|FG000|Overall Study|Adverse Event|1|||
131632138|NCT03019289|473936790|FG001|Overall Study|Adverse Event|0|||
131632139|NCT03019289|473936791|FG002|Overall Study|Adverse Event|0|||
131632140|NCT03019289|473936792|FG003|Overall Study|Adverse Event|0|||
131632141|NCT03019289|473936793|FG004|Overall Study|Adverse Event|0|||
131632142|NCT03019289|473936794|FG005|Overall Study|Adverse Event|0|||
131632143|NCT03019289|473936795|FG006|Overall Study|Adverse Event|0|||
131632144|NCT03019289|473936796|FG007|Overall Study|Adverse Event|0|||
131632145|NCT03019289|473936797|FG008|Overall Study|Adverse Event|1|||
131632146|NCT03019289|473936789|FG000|Overall Study|Other|1|||
131632147|NCT03019289|473936790|FG001|Overall Study|Other|0|||
131632148|NCT03019289|473936791|FG002|Overall Study|Other|0|||
131632149|NCT03019289|473936792|FG003|Overall Study|Other|0|||
131632150|NCT03019289|473936793|FG004|Overall Study|Other|0|||
131632151|NCT03019289|473936794|FG005|Overall Study|Other|0|||
131632152|NCT03019289|473936795|FG006|Overall Study|Other|0|||
131632153|NCT03019289|473936796|FG007|Overall Study|Other|0|||
131632154|NCT03019289|473936797|FG008|Overall Study|Other|0|||
131632155|NCT02389894|473936798|FG000|Overall Study|Death|4|||
131632156|NCT02389894|473936799|FG001|Overall Study|Death|5|||
131632157|NCT02389894|473936800|FG002|Overall Study|Death|3|||
131632158|NCT02389894|473936798|FG000|Overall Study|Withdrawal by Subject|2|||
131632159|NCT02389894|473936799|FG001|Overall Study|Withdrawal by Subject|4|||
131632160|NCT02389894|473936800|FG002|Overall Study|Withdrawal by Subject|5|||
131632161|NCT02389894|473936798|FG000|Overall Study|Lost to Follow-up|2|||
131632162|NCT02389894|473936799|FG001|Overall Study|Lost to Follow-up|1|||
131632163|NCT02389894|473936800|FG002|Overall Study|Lost to Follow-up|1|||
131632164|NCT00145496|473936801|FG000|Overall Study|Adverse Event|42|||
131632165|NCT00145496|473936802|FG001|Overall Study|Adverse Event|30|||
131632166|NCT00145496|473936801|FG000|Overall Study|Lack of Efficacy|12|||
131632167|NCT00145496|473936802|FG001|Overall Study|Lack of Efficacy|7|||
131632168|NCT00145496|473936801|FG000|Overall Study|Withdrawal by Subject|32|||
131632169|NCT00145496|473936802|FG001|Overall Study|Withdrawal by Subject|26|||
131632170|NCT00145496|473936801|FG000|Overall Study|Lost to Follow-up|12|||
131632171|NCT00145496|473936802|FG001|Overall Study|Lost to Follow-up|5|||
131632172|NCT00145496|473936801|FG000|Overall Study|Other|25|||
131632173|NCT00145496|473936802|FG001|Overall Study|Other|13|||
131632174|NCT01429285|473936803|FG000|Overall Study|Protocol Violation|9|||
131632175|NCT01429285|473936804|FG001|Overall Study|Protocol Violation|4|||
131632176|NCT01429285|473936803|FG000|Overall Study|Missing Data|5|||
131632177|NCT01429285|473936804|FG001|Overall Study|Missing Data|3|||
131632178|NCT01429285|473936803|FG000|Overall Study|Erroneously Enrolled Twice|8|||
131632179|NCT01429285|473936804|FG001|Overall Study|Erroneously Enrolled Twice|2|||
131632180|NCT03686176|473936807|FG000|Overall Study|Procedure cancelled|1|||
131798186|NCT00409578|474543557|FG000|Overall Study|Withdrawal by Subject|8|||
131632181|NCT03686176|473936808|FG001|Overall Study|Procedure cancelled|0|||
131632182|NCT03686176|473936809|FG002|Overall Study|Procedure cancelled|0|||
131632183|NCT03686176|473936807|FG000|Overall Study|VR Malfunction|1|||
131632184|NCT03686176|473936808|FG001|Overall Study|VR Malfunction|0|||
131632185|NCT03686176|473936809|FG002|Overall Study|VR Malfunction|0|||
131632186|NCT04448561|473936815|FG000|Overall Study|Noncompliance|1|||
131632187|NCT04448561|473936816|FG001|Overall Study|Noncompliance|0|||
131632188|NCT03050372|473937849|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
131632189|NCT03050372|473937850|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
131632190|NCT03050372|473937849|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
131632191|NCT03050372|473937850|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
131632192|NCT03320941|473937855|FG000|Overall Study|subject/guardian decision|0|||
131632193|NCT03320941|473937856|FG001|Overall Study|subject/guardian decision|0|||
131632194|NCT03320941|473937857|FG002|Overall Study|subject/guardian decision|0|||
131632195|NCT03320941|473937858|FG003|Overall Study|subject/guardian decision|1|||
131632196|NCT03320941|473937859|FG004|Overall Study|subject/guardian decision|0|||
131632197|NCT01838499|473937861|FG000|Overall Study|Protocol Violation|0|||
131632198|NCT01838499|473937862|FG001|Overall Study|Protocol Violation|1|||
131632199|NCT01838499|473937861|FG000|Overall Study|Lost to Follow-up|2|||
131632200|NCT01838499|473937862|FG001|Overall Study|Lost to Follow-up|4|||
131632201|NCT01838499|473937861|FG000|Overall Study|Lack of Efficacy|1|||
131632202|NCT01838499|473937862|FG001|Overall Study|Lack of Efficacy|2|||
131632203|NCT01838499|473937861|FG000|Overall Study|Adverse Event|2|||
131632204|NCT01838499|473937862|FG001|Overall Study|Adverse Event|1|||
131632205|NCT01838499|473937861|FG000|Overall Study|Withdrawal by Subject|19|||
131632206|NCT01838499|473937862|FG001|Overall Study|Withdrawal by Subject|9|||
131632207|NCT01107353|473937863|FG000|Overall Study|Positive Drug Screen|1|||
131632208|NCT01107353|473937864|FG001|Overall Study|Positive Drug Screen|0|||
131632209|NCT01533181|473937865|FG000|Overall Study|Disease progression pre-active treatment|0|||
131632210|NCT01533181|473937866|FG001|Overall Study|Disease progression pre-active treatment|1|||
131632211|NCT01533181|473937865|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
131632212|NCT01533181|473937866|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
131632213|NCT06247488|473937867|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
131632214|NCT06247488|473937868|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131632215|NCT06247488|473937869|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131632216|NCT06247488|473937870|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131632217|NCT06247488|473937871|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131632218|NCT06247488|473937872|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131632219|NCT06247488|473937867|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131632220|NCT06247488|473937868|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131632221|NCT06247488|473937869|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131632222|NCT06247488|473937870|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
131632223|NCT06247488|473937871|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131632224|NCT06247488|473937872|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131632225|NCT06247488|473937867|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
131632226|NCT06247488|473937868|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131632227|NCT06247488|473937869|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131632228|NCT06247488|473937870|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131632229|NCT06247488|473937871|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131632230|NCT06247488|473937872|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131632231|NCT06247488|473937867|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131632232|NCT06247488|473937868|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131632233|NCT06247488|473937869|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131632234|NCT06247488|473937870|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
131632235|NCT06247488|473937871|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131632236|NCT06247488|473937872|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131632237|NCT06247488|473937867|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131632238|NCT06247488|473937868|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131632239|NCT06247488|473937869|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131632240|NCT06247488|473937870|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131632241|NCT06247488|473937871|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131632242|NCT06247488|473937872|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
131632243|NCT06247488|473937867|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
131632244|NCT06247488|473937868|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
131713473|NCT04889209|474228741|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
131713474|NCT04889209|474228742|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
131713475|NCT04889209|474228743|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
131713476|NCT04889209|474228744|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
131713477|NCT04889209|474228745|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
131713478|NCT04889209|474228746|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
131713479|NCT04889209|474228747|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
131902264|NCT01683604|474927022|FG000|Overall Study|Lack of Efficacy|1|||
131902265|NCT01683604|474927022|FG000|Overall Study|Other|2|||
131632245|NCT06247488|473937869|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
131713480|NCT04889209|474228748|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
131632246|NCT06247488|473937870|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
131632247|NCT06247488|473937871|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
131632248|NCT06247488|473937872|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
131632249|NCT06247488|473937867|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131632250|NCT06247488|473937868|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131632251|NCT06247488|473937869|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131632252|NCT06247488|473937870|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131632253|NCT06247488|473937871|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131632254|NCT06247488|473937872|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
131632255|NCT02995733|473937873|FG000|Overall Study|Study site closed|9|||
131632256|NCT02995733|473937874|FG001|Overall Study|Study site closed|10|||
131632257|NCT02995733|473937873|FG000|Overall Study|Death|3|||
131632258|NCT02995733|473937874|FG001|Overall Study|Death|4|||
131632259|NCT02995733|473937873|FG000|Overall Study|Withdrawal by Subject|6|||
131632260|NCT02995733|473937874|FG001|Overall Study|Withdrawal by Subject|2|||
131632261|NCT02995733|473937873|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
131632262|NCT02995733|473937874|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
131632263|NCT02995733|473937873|FG000|Overall Study|Lost to Follow-up|48|||
131632264|NCT02995733|473937874|FG001|Overall Study|Lost to Follow-up|37|||
131632265|NCT02995733|473937873|FG000|Overall Study|Other|0|||
131632266|NCT02995733|473937874|FG001|Overall Study|Other|1|||
131632267|NCT00203502|473937877|FG000|Overall Study|Death|1|||
131632268|NCT02023099|473937878|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
131632269|NCT02023099|473937879|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
131632270|NCT02023099|473937880|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
131632271|NCT02023099|473937878|FG000|Overall Study|Withdrawn Consent|3|||
131632272|NCT02023099|473937879|FG001|Overall Study|Withdrawn Consent|0|||
131632273|NCT02023099|473937880|FG002|Overall Study|Withdrawn Consent|1|||
131632274|NCT02023099|473937878|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
131632275|NCT02023099|473937879|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
131632276|NCT02023099|473937880|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
131632277|NCT02446912|473937881|FG000|Overall Study|Adverse Event|3|||
131632278|NCT02446912|473937882|FG001|Overall Study|Adverse Event|13|||
131632279|NCT02446912|473937883|FG002|Overall Study|Adverse Event|5|||
131632280|NCT02446912|473937881|FG000|Overall Study|Condition under investigation worsened|0|||
131632281|NCT02446912|473937882|FG001|Overall Study|Condition under investigation worsened|1|||
131632282|NCT02446912|473937883|FG002|Overall Study|Condition under investigation worsened|1|||
131632283|NCT02446912|473937881|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131632284|NCT02446912|473937882|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131632285|NCT02446912|473937883|FG002|Overall Study|Study-specific withdrawal criteria|0|||
131632286|NCT02446912|473937881|FG000|Overall Study|Lack of Efficacy|1|||
131632287|NCT02446912|473937882|FG001|Overall Study|Lack of Efficacy|4|||
131632288|NCT02446912|473937883|FG002|Overall Study|Lack of Efficacy|7|||
131632289|NCT02446912|473937881|FG000|Overall Study|Lost to Follow-up|0|||
131632290|NCT02446912|473937882|FG001|Overall Study|Lost to Follow-up|0|||
131632291|NCT02446912|473937883|FG002|Overall Study|Lost to Follow-up|2|||
131632292|NCT02446912|473937881|FG000|Overall Study|Severe non-compliance to protocol|1|||
131632293|NCT02446912|473937882|FG001|Overall Study|Severe non-compliance to protocol|0|||
131632294|NCT02446912|473937883|FG002|Overall Study|Severe non-compliance to protocol|1|||
131632295|NCT02446912|473937881|FG000|Overall Study|Withdrawal by Subject|10|||
131632296|NCT02446912|473937882|FG001|Overall Study|Withdrawal by Subject|15|||
131632297|NCT02446912|473937883|FG002|Overall Study|Withdrawal by Subject|15|||
131798187|NCT00409578|474543558|FG001|Overall Study|Withdrawal by Subject|15|||
131632298|NCT02446912|473937881|FG000|Overall Study|Miscellaneous|2|||
131632299|NCT02446912|473937882|FG001|Overall Study|Miscellaneous|2|||
131632300|NCT02446912|473937883|FG002|Overall Study|Miscellaneous|4|||
131632301|NCT00510783|473937886|FG000|Overall Study|Lost to Follow-up|29|||
131632302|NCT00510783|473937887|FG001|Overall Study|Lost to Follow-up|25|||
131632303|NCT00510783|473937886|FG000|Overall Study|Withdrawal by Subject|2|||
131632304|NCT00510783|473937887|FG001|Overall Study|Withdrawal by Subject|3|||
131632305|NCT00510783|473937886|FG000|Overall Study|Protocol Violation|0|||
131798188|NCT00409578|474543559|FG002|Overall Study|Withdrawal by Subject|16|||
131632306|NCT00510783|473937887|FG001|Overall Study|Protocol Violation|1|||
131798189|NCT00409578|474543560|FG003|Overall Study|Withdrawal by Subject|17|||
131632307|NCT00422162|473937888|FG000|Overall Study|Adverse Event|11|||
131632308|NCT00422162|473937889|FG001|Overall Study|Adverse Event|9|||
131632309|NCT00422162|473937888|FG000|Overall Study|Lack of Efficacy|4|||
131632310|NCT00422162|473937889|FG001|Overall Study|Lack of Efficacy|10|||
131632311|NCT00422162|473937888|FG000|Overall Study|Withdrawal by Subject|7|||
131632312|NCT00422162|473937889|FG001|Overall Study|Withdrawal by Subject|6|||
131632313|NCT00422162|473937888|FG000|Overall Study|Lost to Follow-up|1|||
131632314|NCT00422162|473937889|FG001|Overall Study|Lost to Follow-up|2|||
131632315|NCT00422162|473937888|FG000|Overall Study|Non-Compliant with Protocol|1|||
131632316|NCT00422162|473937889|FG001|Overall Study|Non-Compliant with Protocol|1|||
131632317|NCT00422162|473937888|FG000|Overall Study|Other|0|||
131632318|NCT00422162|473937889|FG001|Overall Study|Other|1|||
131632319|NCT00422162|473937888|FG000|Overall Study|Didn't Receive Treatment|0|||
131632320|NCT00422162|473937889|FG001|Overall Study|Didn't Receive Treatment|1|||
131632321|NCT00460577|473937892|FG000|Overall Study|Protocol Violation|2|||
131632322|NCT00460577|473937893|FG001|Overall Study|Protocol Violation|6|||
131632323|NCT01878253|473937894|FG000|Overall Study|Death|1|||
131632324|NCT01878253|473937894|FG000|Overall Study|SIdus System Removal|3|||
131632325|NCT01878253|473937894|FG000|Overall Study|Withdrawal by Subject|1|||
131632326|NCT01878253|473937894|FG000|Overall Study|Lost to Follow-up|2|||
131632327|NCT01878253|473937894|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
131632328|NCT04043806|473937895|FG000|Overall Study|Commercial drug is available for participants|13|||
131632329|NCT04043806|473937895|FG000|Overall Study|Physician Decision|2|||
131632330|NCT04043806|473937895|FG000|Overall Study|Other|12|||
131632331|NCT04043806|473937895|FG000|Overall Study|Adverse Event|2|||
131632332|NCT04043806|473937895|FG000|Overall Study|Lost to Follow-up|6|||
131632333|NCT04043806|473937895|FG000|Overall Study|Other non-compliance|2|||
131632334|NCT04043806|473937895|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
131632335|NCT04043806|473937895|FG000|Overall Study|Never Dosed|1|||
131632336|NCT01622088|473937896|FG000|Overall Study|Adverse Event|20|||
131632337|NCT01622088|473937896|FG000|Overall Study|Lost to Follow-up|1|||
131632338|NCT01622088|473937896|FG000|Overall Study|Withdrawal by Subject|20|||
131632339|NCT01622088|473937896|FG000|Overall Study|Investigator Decision|1|||
131632340|NCT01622088|473937896|FG000|Overall Study|Death|53|||
131632341|NCT01622088|473937896|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
131632342|NCT03045302|473937897|FG000|Overall Study|Pre-treatment adverse event|1|||
131632343|NCT02267746|473937901|FG000|Overall Study|Adverse Event|0|||
131632344|NCT02267746|473937902|FG001|Overall Study|Adverse Event|2|||
131632345|NCT02267746|473937903|FG002|Overall Study|Adverse Event|1|||
131632346|NCT02267746|473937901|FG000|Overall Study|Protocol Violation|8|||
131632347|NCT02267746|473937902|FG001|Overall Study|Protocol Violation|7|||
131632348|NCT02267746|473937903|FG002|Overall Study|Protocol Violation|3|||
131632349|NCT02267746|473937901|FG000|Overall Study|Lack of Efficacy|11|||
131632350|NCT02267746|473937902|FG001|Overall Study|Lack of Efficacy|11|||
131632351|NCT02267746|473937903|FG002|Overall Study|Lack of Efficacy|15|||
131632352|NCT02267746|473937901|FG000|Overall Study|Protocol Violation|1|||
131632353|NCT02267746|473937902|FG001|Overall Study|Protocol Violation|2|||
131632354|NCT02267746|473937903|FG002|Overall Study|Protocol Violation|1|||
131632355|NCT02267746|473937901|FG000|Overall Study|Miscellaneous|1|||
131632356|NCT02267746|473937902|FG001|Overall Study|Miscellaneous|0|||
131632357|NCT02267746|473937903|FG002|Overall Study|Miscellaneous|1|||
131632358|NCT00617708|473937913|FG000|Overall Study|Adverse Event|0|||
131632359|NCT00617708|473937914|FG001|Overall Study|Adverse Event|6|||
131632360|NCT00617708|473937915|FG002|Overall Study|Adverse Event|9|||
131632361|NCT00617708|473937913|FG000|Overall Study|Withdrawal by Subject|1|||
131632362|NCT00617708|473937914|FG001|Overall Study|Withdrawal by Subject|1|||
131632363|NCT00617708|473937915|FG002|Overall Study|Withdrawal by Subject|7|||
131632364|NCT00617708|473937913|FG000|Overall Study|Death|0|||
131632365|NCT00617708|473937914|FG001|Overall Study|Death|6|||
131632366|NCT00617708|473937915|FG002|Overall Study|Death|5|||
131632367|NCT00617708|473937913|FG000|Overall Study|Progression/Relapse|7|||
131632368|NCT00617708|473937914|FG001|Overall Study|Progression/Relapse|40|||
131632369|NCT00617708|473937915|FG002|Overall Study|Progression/Relapse|36|||
131632370|NCT00617708|473937913|FG000|Overall Study|Not protocol specified|1|||
131632371|NCT00617708|473937914|FG001|Overall Study|Not protocol specified|4|||
131632372|NCT00617708|473937915|FG002|Overall Study|Not protocol specified|2|||
131632373|NCT00617708|473937913|FG000|Overall Study|Not eligible|1|||
131632374|NCT00617708|473937914|FG001|Overall Study|Not eligible|3|||
131632375|NCT00617708|473937915|FG002|Overall Study|Not eligible|5|||
131632376|NCT02058992|473937916|FG000|Overall Study|Lost to Follow-up|4|||
131632377|NCT02058992|473937916|FG000|Overall Study|Protocol Violation|92|||
131632378|NCT02058992|473937916|FG000|Overall Study|CRF Uncollected|20|||
131632379|NCT02130401|473937917|FG000|Overall Study|Poor enrollment|6|||
131632380|NCT00321672|473937918|FG000|Overall Study|Withdrawal by Subject|5|||
131632381|NCT00321672|473937919|FG001|Overall Study|Withdrawal by Subject|1|||
131632382|NCT00321672|473937920|FG002|Overall Study|Withdrawal by Subject|2|||
131632383|NCT00321672|473937921|FG003|Overall Study|Withdrawal by Subject|0|||
131632384|NCT00321672|473937918|FG000|Overall Study|Noncompliance|1|||
131632385|NCT00321672|473937919|FG001|Overall Study|Noncompliance|2|||
131632386|NCT00321672|473937920|FG002|Overall Study|Noncompliance|1|||
131632387|NCT00321672|473937921|FG003|Overall Study|Noncompliance|0|||
131632388|NCT00321672|473937918|FG000|Overall Study|Adverse Event|1|||
131632389|NCT00321672|473937919|FG001|Overall Study|Adverse Event|1|||
131632390|NCT00321672|473937920|FG002|Overall Study|Adverse Event|0|||
131632391|NCT00321672|473937921|FG003|Overall Study|Adverse Event|0|||
131632392|NCT00321672|473937918|FG000|Overall Study|Lack of Efficacy|1|||
131632393|NCT00321672|473937919|FG001|Overall Study|Lack of Efficacy|1|||
131632394|NCT00321672|473937920|FG002|Overall Study|Lack of Efficacy|0|||
131632395|NCT00321672|473937921|FG003|Overall Study|Lack of Efficacy|0|||
131632396|NCT00321672|473937918|FG000|Overall Study|Lost to Follow-up|2|||
131632397|NCT00321672|473937919|FG001|Overall Study|Lost to Follow-up|0|||
131632398|NCT00321672|473937920|FG002|Overall Study|Lost to Follow-up|4|||
131632399|NCT00321672|473937921|FG003|Overall Study|Lost to Follow-up|2|||
131632400|NCT00321672|473937918|FG000|Overall Study|Death|1|||
131632401|NCT00321672|473937919|FG001|Overall Study|Death|0|||
131632402|NCT00321672|473937920|FG002|Overall Study|Death|0|||
131632403|NCT00321672|473937921|FG003|Overall Study|Death|0|||
131632404|NCT00321672|473937918|FG000|Overall Study|Too far to travel for visits|1|||
131632405|NCT00321672|473937919|FG001|Overall Study|Too far to travel for visits|0|||
131632406|NCT00321672|473937920|FG002|Overall Study|Too far to travel for visits|0|||
131632407|NCT00321672|473937921|FG003|Overall Study|Too far to travel for visits|0|||
131632408|NCT00321672|473937918|FG000|Overall Study|Incarcerated|0|||
131632409|NCT00321672|473937919|FG001|Overall Study|Incarcerated|0|||
131632410|NCT00321672|473937920|FG002|Overall Study|Incarcerated|2|||
131632411|NCT00321672|473937921|FG003|Overall Study|Incarcerated|0|||
131632412|NCT00321672|473937918|FG000|Overall Study|Moved out of state|0|||
131632413|NCT00321672|473937919|FG001|Overall Study|Moved out of state|1|||
131632414|NCT00321672|473937920|FG002|Overall Study|Moved out of state|1|||
131632415|NCT00321672|473937921|FG003|Overall Study|Moved out of state|0|||
131632416|NCT00321672|473937918|FG000|Overall Study|Protocol Violation|0|||
131632417|NCT00321672|473937919|FG001|Overall Study|Protocol Violation|0|||
131632418|NCT00321672|473937920|FG002|Overall Study|Protocol Violation|1|||
131632419|NCT00321672|473937921|FG003|Overall Study|Protocol Violation|0|||
131632420|NCT00321672|473937918|FG000|Overall Study|Diagnosis of testicular cancer|0|||
131632421|NCT00321672|473937919|FG001|Overall Study|Diagnosis of testicular cancer|1|||
131632422|NCT00321672|473937920|FG002|Overall Study|Diagnosis of testicular cancer|0|||
131632423|NCT00321672|473937921|FG003|Overall Study|Diagnosis of testicular cancer|0|||
131632424|NCT00321672|473937918|FG000|Overall Study|Extensive travel required for new job|0|||
131632425|NCT00321672|473937919|FG001|Overall Study|Extensive travel required for new job|1|||
131632426|NCT00321672|473937920|FG002|Overall Study|Extensive travel required for new job|0|||
131632427|NCT00321672|473937921|FG003|Overall Study|Extensive travel required for new job|0|||
131632428|NCT00512902|473937922|FG000|Overall Study|Adverse Event|7|||
131632429|NCT00512902|473937922|FG000|Overall Study|Lost to Follow-up|1|||
131632430|NCT00936065|473937923|FG000|Overall Study|Adverse Event|1|||
131632431|NCT00936065|473937924|FG001|Overall Study|Adverse Event|0|||
131632432|NCT00936065|473937925|FG002|Overall Study|Adverse Event|1|||
131632433|NCT00936065|473937923|FG000|Overall Study|Lack of Efficacy|1|||
131632434|NCT00936065|473937924|FG001|Overall Study|Lack of Efficacy|0|||
131632435|NCT00936065|473937925|FG002|Overall Study|Lack of Efficacy|1|||
131632436|NCT00936065|473937923|FG000|Overall Study|Lost to Follow-up|1|||
131632437|NCT00936065|473937924|FG001|Overall Study|Lost to Follow-up|0|||
131632438|NCT00936065|473937925|FG002|Overall Study|Lost to Follow-up|0|||
131632439|NCT00936065|473937923|FG000|Overall Study|Protocol Violation|1|||
131632440|NCT00936065|473937924|FG001|Overall Study|Protocol Violation|2|||
131632441|NCT00936065|473937925|FG002|Overall Study|Protocol Violation|1|||
131632442|NCT00936065|473937923|FG000|Overall Study|Withdrawal by Subject|0|||
131632443|NCT00936065|473937924|FG001|Overall Study|Withdrawal by Subject|2|||
131632444|NCT00936065|473937925|FG002|Overall Study|Withdrawal by Subject|4|||
131632445|NCT00448344|473937928|FG000|Overall Study|Lost to Follow-up|20|||
131632446|NCT00448344|473937929|FG001|Overall Study|Lost to Follow-up|22|||
131632447|NCT00448344|473937928|FG000|Overall Study|Withdrawal by Subject|6|||
131632448|NCT00448344|473937929|FG001|Overall Study|Withdrawal by Subject|8|||
131632449|NCT00448344|473937928|FG000|Overall Study|Death|3|||
131632450|NCT00448344|473937929|FG001|Overall Study|Death|4|||
131632451|NCT00448344|473937928|FG000|Overall Study|Physician Decision|1|||
131632452|NCT00448344|473937929|FG001|Overall Study|Physician Decision|2|||
131632453|NCT00990314|473937932|FG000|Overall Study|Death|2|||
131798190|NCT00409578|474543557|FG000|Overall Study|Lost to Follow-up|2|||
131798191|NCT00409578|474543558|FG001|Overall Study|Lost to Follow-up|0|||
131798192|NCT00409578|474543559|FG002|Overall Study|Lost to Follow-up|2|||
131798193|NCT00409578|474543560|FG003|Overall Study|Lost to Follow-up|2|||
131798194|NCT00409578|474543557|FG000|Overall Study|Administrative problems|8|||
131798195|NCT00409578|474543558|FG001|Overall Study|Administrative problems|9|||
131632454|NCT00990314|473937932|FG000|Overall Study|Adverse Event|2|||
131632455|NCT00990314|473937932|FG000|Overall Study|Withdrawal by Subject|3|||
131632456|NCT00990314|473937932|FG000|Overall Study|Non-Compliance|1|||
131632457|NCT00990314|473937932|FG000|Overall Study|Physician Decision|3|||
131632458|NCT00990314|473937932|FG000|Overall Study|Lack of Efficacy|1|||
131632459|NCT01288729|473937939|FG000|Overall Study|Withdrawal by Subject|1|||
131632460|NCT01288729|473937940|FG001|Overall Study|Withdrawal by Subject|0|||
131632461|NCT00267865|473937941|FG000|Induction Treatment|Died before completing.|2|||
131798196|NCT00409578|474543559|FG002|Overall Study|Administrative problems|2|||
131798197|NCT00409578|474543560|FG003|Overall Study|Administrative problems|4|||
131798198|NCT00409578|474543557|FG000|Overall Study|Death|2|||
131632462|NCT00267865|473937941|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
131632463|NCT03530345|473937946|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
131632464|NCT03530345|473937947|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
131632465|NCT03530345|473937946|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
131632466|NCT03530345|473937947|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
131632467|NCT03530345|473937946|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
131632468|NCT03530345|473937947|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
131632469|NCT03530345|473937946|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
131632470|NCT03530345|473937947|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
131632471|NCT04212299|473937953|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
131632472|NCT00814632|473939585|FG000|Overall Study|Lack of Efficacy|2|||
131632473|NCT03602053|473939588|FG000|Overall Study|Withdrawal by Subject|7|||
131632474|NCT03602053|473939589|FG001|Overall Study|Withdrawal by Subject|9|||
131632475|NCT03602053|473939590|FG002|Overall Study|Withdrawal by Subject|7|||
131632476|NCT03602053|473939588|FG000|Overall Study|Lost to Follow-up|5|||
131632477|NCT03602053|473939589|FG001|Overall Study|Lost to Follow-up|6|||
131632478|NCT03602053|473939590|FG002|Overall Study|Lost to Follow-up|0|||
131632479|NCT03602053|473939588|FG000|Overall Study|Protocol Violation|3|||
131632480|NCT03602053|473939589|FG001|Overall Study|Protocol Violation|0|||
131632481|NCT03602053|473939590|FG002|Overall Study|Protocol Violation|4|||
131632482|NCT03602053|473939588|FG000|Overall Study|Physician Decision|1|||
131632483|NCT03602053|473939589|FG001|Overall Study|Physician Decision|0|||
131632484|NCT03602053|473939590|FG002|Overall Study|Physician Decision|0|||
131632485|NCT03602053|473939588|FG000|Overall Study|migration|2|||
131632486|NCT03602053|473939589|FG001|Overall Study|migration|3|||
131632487|NCT03602053|473939590|FG002|Overall Study|migration|0|||
131632488|NCT03602053|473939588|FG000|Overall Study|Other|1|||
131632489|NCT03602053|473939589|FG001|Overall Study|Other|0|||
131632490|NCT03602053|473939590|FG002|Overall Study|Other|0|||
131632491|NCT00396409|473939591|FG000|Period 1 - 2007|Adverse Event|0|||
131632492|NCT00396409|473939592|FG001|Period 1 - 2007|Adverse Event|1|||
131632493|NCT00396409|473939591|FG000|Period 1 - 2007|Lack of Efficacy|0|||
131632494|NCT00396409|473939592|FG001|Period 1 - 2007|Lack of Efficacy|1|||
131632495|NCT00396409|473939591|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
131632496|NCT00396409|473939592|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
131632497|NCT00396409|473939591|FG000|Period 1 - 2007|Lost to Follow-up|2|||
131632498|NCT00396409|473939592|FG001|Period 1 - 2007|Lost to Follow-up|3|||
131632499|NCT00396409|473939591|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
131632500|NCT00396409|473939592|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
131632501|NCT00396409|473939591|FG000|Period 2 - 2008|Protocol Violation|1|||
131632502|NCT00396409|473939592|FG001|Period 2 - 2008|Protocol Violation|0|||
131632503|NCT00396409|473939591|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
131632504|NCT00396409|473939592|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
131632505|NCT00396409|473939591|FG000|Period 2 - 2008|Lost to Follow-up|3|||
131632506|NCT00396409|473939592|FG001|Period 2 - 2008|Lost to Follow-up|1|||
131632507|NCT00331799|473939593|FG000|Overall Study|Withdrawal by Subject|2|||
131632508|NCT00331799|473939593|FG000|Overall Study|Sedation|1|||
131632509|NCT02889809|473939594|FG000|Overall Study|Withdrawal by Subject|30|||
131632510|NCT02889809|473939595|FG001|Overall Study|Withdrawal by Subject|21|||
131632511|NCT02889809|473939594|FG000|Overall Study|Lost to Follow-up|1|||
131632512|NCT02889809|473939595|FG001|Overall Study|Lost to Follow-up|1|||
131632513|NCT02889809|473939594|FG000|Overall Study|Site Closed|12|||
131632514|NCT02889809|473939595|FG001|Overall Study|Site Closed|11|||
131632515|NCT04203199|473939596|FG000|First Intervention Period|Lost to Follow-up|0|||
131632516|NCT04203199|473939597|FG001|First Intervention Period|Lost to Follow-up|1|||
131632517|NCT04203199|473939596|FG000|Second Intervention Period|Medication change|1|||
131632518|NCT04203199|473939597|FG001|Second Intervention Period|Medication change|0|||
131632519|NCT01870999|473939605|FG000|Overall Study|Adverse Event|0|||
131632520|NCT01870999|473939606|FG001|Overall Study|Adverse Event|4|||
131798199|NCT00409578|474543558|FG001|Overall Study|Death|4|||
131798200|NCT00409578|474543559|FG002|Overall Study|Death|4|||
131798201|NCT00409578|474543560|FG003|Overall Study|Death|2|||
131798202|NCT00409578|474543557|FG000|Overall Study|Protocol Violation|3|||
131798203|NCT00409578|474543558|FG001|Overall Study|Protocol Violation|2|||
131798204|NCT00409578|474543559|FG002|Overall Study|Protocol Violation|3|||
131798205|NCT00409578|474543560|FG003|Overall Study|Protocol Violation|1|||
131798206|NCT00409578|474543557|FG000|Overall Study|Missing|0|||
131798207|NCT00409578|474543558|FG001|Overall Study|Missing|1|||
131798208|NCT00409578|474543559|FG002|Overall Study|Missing|0|||
131798209|NCT00409578|474543560|FG003|Overall Study|Missing|1|||
131632521|NCT01870999|473939607|FG002|Overall Study|Adverse Event|1|||
131632522|NCT01870999|473939605|FG000|Overall Study|Subject met withdrawal criteria|3|||
131632523|NCT01870999|473939606|FG001|Overall Study|Subject met withdrawal criteria|2|||
131632524|NCT01870999|473939607|FG002|Overall Study|Subject met withdrawal criteria|0|||
131632525|NCT01870999|473939605|FG000|Overall Study|Subject withdrawn by Investigator|1|||
131632526|NCT01870999|473939606|FG001|Overall Study|Subject withdrawn by Investigator|0|||
131632527|NCT01870999|473939607|FG002|Overall Study|Subject withdrawn by Investigator|0|||
131632528|NCT01870999|473939605|FG000|Overall Study|Withdrawal by Subject|0|||
131798210|NCT02109133|474543563|FG000|Overall Study|Lost to Follow-up|1|||
131798211|NCT02109133|474543564|FG001|Overall Study|Lost to Follow-up|0|||
131632529|NCT01870999|473939606|FG001|Overall Study|Withdrawal by Subject|2|||
131632530|NCT01870999|473939607|FG002|Overall Study|Withdrawal by Subject|5|||
131632531|NCT01870999|473939605|FG000|Overall Study|Protocol Violation|0|||
131632532|NCT01870999|473939606|FG001|Overall Study|Protocol Violation|0|||
131632533|NCT01870999|473939607|FG002|Overall Study|Protocol Violation|1|||
131632534|NCT03034772|473939608|FG000|Overall Study|Adverse Event|0|||
131632535|NCT03034772|473939609|FG001|Overall Study|Adverse Event|1|||
131632536|NCT03034772|473939608|FG000|Overall Study|Withdrawal by Subject|0|||
131632537|NCT03034772|473939609|FG001|Overall Study|Withdrawal by Subject|1|||
131632538|NCT02186015|473939610|FG000|Overall Study|Physician Decision|1|||
131632539|NCT02186015|473939611|FG001|Overall Study|Physician Decision|0|||
131632540|NCT02660034|473939612|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
131632541|NCT02660034|473939613|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
131632542|NCT02660034|473939614|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
131632543|NCT02660034|473939615|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
131632544|NCT02660034|473939616|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
131632545|NCT02660034|473939617|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
131632546|NCT02660034|473939618|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
131632547|NCT02660034|473939619|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
131632548|NCT02660034|473939620|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
131632549|NCT02660034|473939621|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
131632550|NCT02660034|473939622|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
131632551|NCT02660034|473939623|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
131632552|NCT02660034|473939624|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
131632553|NCT02660034|473939625|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
131632554|NCT02660034|473939612|FG000|Overall Study|Progressive Disease (Clinical)|7|||
131632555|NCT02660034|473939613|FG001|Overall Study|Progressive Disease (Clinical)|8|||
131632556|NCT02660034|473939614|FG002|Overall Study|Progressive Disease (Clinical)|3|||
131632557|NCT02660034|473939615|FG003|Overall Study|Progressive Disease (Clinical)|9|||
131632558|NCT02660034|473939616|FG004|Overall Study|Progressive Disease (Clinical)|3|||
131632559|NCT02660034|473939617|FG005|Overall Study|Progressive Disease (Clinical)|0|||
131632560|NCT02660034|473939618|FG006|Overall Study|Progressive Disease (Clinical)|0|||
131632561|NCT02660034|473939619|FG007|Overall Study|Progressive Disease (Clinical)|0|||
131632562|NCT02660034|473939620|FG008|Overall Study|Progressive Disease (Clinical)|0|||
131632563|NCT02660034|473939621|FG009|Overall Study|Progressive Disease (Clinical)|0|||
131632564|NCT02660034|473939622|FG010|Overall Study|Progressive Disease (Clinical)|0|||
131632565|NCT02660034|473939623|FG011|Overall Study|Progressive Disease (Clinical)|0|||
131632566|NCT02660034|473939624|FG012|Overall Study|Progressive Disease (Clinical)|0|||
131632567|NCT02660034|473939625|FG013|Overall Study|Progressive Disease (Clinical)|0|||
131632568|NCT02660034|473939612|FG000|Overall Study|Lost to Follow-up|0|||
131632569|NCT02660034|473939613|FG001|Overall Study|Lost to Follow-up|0|||
131632570|NCT02660034|473939614|FG002|Overall Study|Lost to Follow-up|1|||
131632571|NCT02660034|473939615|FG003|Overall Study|Lost to Follow-up|1|||
131632572|NCT02660034|473939616|FG004|Overall Study|Lost to Follow-up|0|||
131632573|NCT02660034|473939617|FG005|Overall Study|Lost to Follow-up|0|||
131632574|NCT02660034|473939618|FG006|Overall Study|Lost to Follow-up|0|||
131632575|NCT02660034|473939619|FG007|Overall Study|Lost to Follow-up|0|||
131632576|NCT02660034|473939620|FG008|Overall Study|Lost to Follow-up|0|||
131632577|NCT02660034|473939621|FG009|Overall Study|Lost to Follow-up|1|||
131632578|NCT02660034|473939622|FG010|Overall Study|Lost to Follow-up|1|||
131632579|NCT02660034|473939623|FG011|Overall Study|Lost to Follow-up|1|||
131632580|NCT02660034|473939624|FG012|Overall Study|Lost to Follow-up|0|||
131632581|NCT02660034|473939625|FG013|Overall Study|Lost to Follow-up|0|||
131632582|NCT02660034|473939612|FG000|Overall Study|Participant moved into special access scheme|1|||
131632583|NCT02660034|473939613|FG001|Overall Study|Participant moved into special access scheme|2|||
131632584|NCT02660034|473939614|FG002|Overall Study|Participant moved into special access scheme|0|||
131632585|NCT02660034|473939615|FG003|Overall Study|Participant moved into special access scheme|0|||
131632586|NCT02660034|473939616|FG004|Overall Study|Participant moved into special access scheme|0|||
131632587|NCT02660034|473939617|FG005|Overall Study|Participant moved into special access scheme|0|||
131632588|NCT02660034|473939618|FG006|Overall Study|Participant moved into special access scheme|0|||
131632589|NCT02660034|473939619|FG007|Overall Study|Participant moved into special access scheme|0|||
131632590|NCT02660034|473939620|FG008|Overall Study|Participant moved into special access scheme|0|||
131713481|NCT04889209|474228749|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
131713482|NCT04889209|474228750|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
131713483|NCT04889209|474228751|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
131713484|NCT04889209|474228752|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
131713485|NCT04889209|474228735|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
131713486|NCT04889209|474228736|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
131713487|NCT04889209|474228737|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131798212|NCT00623103|474545906|FG000|Overall Study|Adverse Event|70|||
131798213|NCT00623103|474545907|FG001|Overall Study|Adverse Event|60|||
131804510|NCT01873586|474568553|FG000|Overall Study|Lost to Follow-up|3|||
131902266|NCT01949142|474927023|FG000|Overall Study|Withdrawal of consent|1|||
131902267|NCT01949142|474927024|FG001|Overall Study|Withdrawal of consent|0|||
131902268|NCT01949142|474927023|FG000|Overall Study|Lost to Follow-up|1|||
131902269|NCT01949142|474927024|FG001|Overall Study|Lost to Follow-up|1|||
131902270|NCT01949142|474927023|FG000|Overall Study|Parent changed their mind|1|||
131902271|NCT01949142|474927024|FG001|Overall Study|Parent changed their mind|0|||
131632591|NCT02660034|473939621|FG009|Overall Study|Participant moved into special access scheme|0|||
131632592|NCT02660034|473939622|FG010|Overall Study|Participant moved into special access scheme|0|||
131632593|NCT02660034|473939623|FG011|Overall Study|Participant moved into special access scheme|0|||
131632594|NCT02660034|473939624|FG012|Overall Study|Participant moved into special access scheme|0|||
131632595|NCT02660034|473939625|FG013|Overall Study|Participant moved into special access scheme|0|||
131632596|NCT02660034|473939612|FG000|Overall Study|Adverse Event|1|||
131632597|NCT02660034|473939613|FG001|Overall Study|Adverse Event|0|||
131632598|NCT02660034|473939614|FG002|Overall Study|Adverse Event|0|||
131632599|NCT02660034|473939615|FG003|Overall Study|Adverse Event|0|||
131632600|NCT02660034|473939616|FG004|Overall Study|Adverse Event|0|||
131632601|NCT02660034|473939617|FG005|Overall Study|Adverse Event|0|||
131632602|NCT02660034|473939618|FG006|Overall Study|Adverse Event|0|||
131632603|NCT02660034|473939619|FG007|Overall Study|Adverse Event|0|||
131632604|NCT02660034|473939620|FG008|Overall Study|Adverse Event|0|||
131632605|NCT02660034|473939621|FG009|Overall Study|Adverse Event|0|||
131632606|NCT02660034|473939622|FG010|Overall Study|Adverse Event|0|||
131632607|NCT02660034|473939623|FG011|Overall Study|Adverse Event|0|||
131632608|NCT02660034|473939624|FG012|Overall Study|Adverse Event|0|||
131632609|NCT02660034|473939625|FG013|Overall Study|Adverse Event|0|||
131632610|NCT02660034|473939612|FG000|Overall Study|Sponsor Decision|0|||
131632611|NCT02660034|473939613|FG001|Overall Study|Sponsor Decision|1|||
131632612|NCT02660034|473939614|FG002|Overall Study|Sponsor Decision|2|||
131632613|NCT02660034|473939615|FG003|Overall Study|Sponsor Decision|2|||
131632614|NCT02660034|473939616|FG004|Overall Study|Sponsor Decision|3|||
131632615|NCT02660034|473939617|FG005|Overall Study|Sponsor Decision|0|||
131632616|NCT02660034|473939618|FG006|Overall Study|Sponsor Decision|0|||
131713488|NCT04889209|474228738|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713489|NCT04889209|474228739|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713490|NCT04889209|474228740|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131713491|NCT04889209|474228741|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713492|NCT04889209|474228742|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131713493|NCT04889209|474228743|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713494|NCT04889209|474228744|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131713495|NCT04889209|474228745|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713496|NCT04889209|474228746|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713497|NCT04889209|474228747|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713498|NCT04889209|474228748|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713499|NCT04889209|474228749|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713500|NCT04889209|474228750|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713501|NCT04889209|474228751|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131713502|NCT04889209|474228752|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131713503|NCT04889209|474228735|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713504|NCT04889209|474228736|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713505|NCT04889209|474228737|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713506|NCT04889209|474228738|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
131713507|NCT04889209|474228739|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713508|NCT04889209|474228740|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713509|NCT04889209|474228741|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713510|NCT04889209|474228742|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713511|NCT04889209|474228743|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713512|NCT04889209|474228744|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713513|NCT04889209|474228745|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713514|NCT04889209|474228746|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713515|NCT04889209|474228747|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713516|NCT04889209|474228748|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713517|NCT04889209|474228749|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713518|NCT04889209|474228750|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713519|NCT04889209|474228751|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131632617|NCT02660034|473939619|FG007|Overall Study|Sponsor Decision|0|||
131632618|NCT02660034|473939620|FG008|Overall Study|Sponsor Decision|0|||
131632619|NCT02660034|473939621|FG009|Overall Study|Sponsor Decision|0|||
131632620|NCT02660034|473939622|FG010|Overall Study|Sponsor Decision|0|||
131632621|NCT02660034|473939623|FG011|Overall Study|Sponsor Decision|0|||
131632622|NCT02660034|473939624|FG012|Overall Study|Sponsor Decision|0|||
131632623|NCT02660034|473939625|FG013|Overall Study|Sponsor Decision|1|||
131632624|NCT02660034|473939612|FG000|Overall Study|Withdrawal by Subject|0|||
131632625|NCT02660034|473939613|FG001|Overall Study|Withdrawal by Subject|0|||
131632626|NCT02660034|473939614|FG002|Overall Study|Withdrawal by Subject|0|||
131632627|NCT02660034|473939615|FG003|Overall Study|Withdrawal by Subject|0|||
131632628|NCT02660034|473939616|FG004|Overall Study|Withdrawal by Subject|0|||
131632629|NCT02660034|473939617|FG005|Overall Study|Withdrawal by Subject|0|||
131632630|NCT02660034|473939618|FG006|Overall Study|Withdrawal by Subject|1|||
131632631|NCT02660034|473939619|FG007|Overall Study|Withdrawal by Subject|1|||
131632632|NCT02660034|473939620|FG008|Overall Study|Withdrawal by Subject|1|||
131632633|NCT02660034|473939621|FG009|Overall Study|Withdrawal by Subject|0|||
131632634|NCT02660034|473939622|FG010|Overall Study|Withdrawal by Subject|0|||
131632635|NCT02660034|473939623|FG011|Overall Study|Withdrawal by Subject|1|||
131632636|NCT02660034|473939624|FG012|Overall Study|Withdrawal by Subject|2|||
131632637|NCT02660034|473939625|FG013|Overall Study|Withdrawal by Subject|0|||
131632638|NCT02660034|473939612|FG000|Overall Study|Death|0|||
131632639|NCT02660034|473939613|FG001|Overall Study|Death|0|||
131632640|NCT02660034|473939614|FG002|Overall Study|Death|0|||
131632641|NCT02660034|473939615|FG003|Overall Study|Death|0|||
131632642|NCT02660034|473939616|FG004|Overall Study|Death|0|||
131632643|NCT02660034|473939617|FG005|Overall Study|Death|13|||
131632644|NCT02660034|473939618|FG006|Overall Study|Death|14|||
131632645|NCT02660034|473939619|FG007|Overall Study|Death|10|||
131632646|NCT02660034|473939620|FG008|Overall Study|Death|9|||
131632647|NCT02660034|473939621|FG009|Overall Study|Death|21|||
131632648|NCT02660034|473939622|FG010|Overall Study|Death|17|||
131632649|NCT02660034|473939623|FG011|Overall Study|Death|15|||
131632650|NCT02660034|473939624|FG012|Overall Study|Death|18|||
131632651|NCT02660034|473939625|FG013|Overall Study|Death|7|||
131632652|NCT02660034|473939612|FG000|Overall Study|Physician Decision|0|||
131632653|NCT02660034|473939613|FG001|Overall Study|Physician Decision|0|||
131632654|NCT02660034|473939614|FG002|Overall Study|Physician Decision|0|||
131632655|NCT02660034|473939615|FG003|Overall Study|Physician Decision|0|||
131632656|NCT02660034|473939616|FG004|Overall Study|Physician Decision|0|||
131632657|NCT02660034|473939617|FG005|Overall Study|Physician Decision|0|||
131632658|NCT02660034|473939618|FG006|Overall Study|Physician Decision|0|||
131632659|NCT02660034|473939619|FG007|Overall Study|Physician Decision|0|||
131632660|NCT02660034|473939620|FG008|Overall Study|Physician Decision|0|||
131632661|NCT02660034|473939621|FG009|Overall Study|Physician Decision|0|||
131632662|NCT02660034|473939622|FG010|Overall Study|Physician Decision|0|||
131632663|NCT02660034|473939623|FG011|Overall Study|Physician Decision|0|||
131632664|NCT02660034|473939624|FG012|Overall Study|Physician Decision|0|||
131632665|NCT02660034|473939625|FG013|Overall Study|Physician Decision|1|||
131632666|NCT02660034|473939612|FG000|Overall Study|Participants transferred to LTE|0|||
131632667|NCT02660034|473939613|FG001|Overall Study|Participants transferred to LTE|0|||
131632668|NCT02660034|473939614|FG002|Overall Study|Participants transferred to LTE|0|||
131632669|NCT02660034|473939615|FG003|Overall Study|Participants transferred to LTE|0|||
131632670|NCT02660034|473939616|FG004|Overall Study|Participants transferred to LTE|0|||
131632671|NCT02660034|473939617|FG005|Overall Study|Participants transferred to LTE|10|||
131632672|NCT02660034|473939618|FG006|Overall Study|Participants transferred to LTE|8|||
131632673|NCT02660034|473939619|FG007|Overall Study|Participants transferred to LTE|8|||
131632674|NCT02660034|473939620|FG008|Overall Study|Participants transferred to LTE|10|||
131632675|NCT02660034|473939621|FG009|Overall Study|Participants transferred to LTE|1|||
131632676|NCT02660034|473939622|FG010|Overall Study|Participants transferred to LTE|2|||
131632677|NCT02660034|473939623|FG011|Overall Study|Participants transferred to LTE|4|||
131632678|NCT02660034|473939624|FG012|Overall Study|Participants transferred to LTE|1|||
131632679|NCT02660034|473939625|FG013|Overall Study|Participants transferred to LTE|1|||
131632680|NCT01838447|473939626|FG000|Overall Study|Change in surgical plan|1|||
131632681|NCT01838447|473939627|FG001|Overall Study|Change in surgical plan|2|||
131632682|NCT01838447|473939626|FG000|Overall Study|Withdrawal by Subject|1|||
131632683|NCT01838447|473939627|FG001|Overall Study|Withdrawal by Subject|1|||
131632684|NCT02030847|473939630|FG000|Overall Study|Death|10|||
131632685|NCT02030847|473939630|FG000|Overall Study|Disease Progression|15|||
131632686|NCT02030847|473939630|FG000|Overall Study|New Cancer Therapy|8|||
131632687|NCT02030847|473939630|FG000|Overall Study|Physician Decision|3|||
131632688|NCT02030847|473939630|FG000|Overall Study|Withdrawal by Subject|1|||
131632689|NCT01837719|473939633|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
131632690|NCT01837719|473939633|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
131632691|NCT01703988|473939634|FG000|Overall Study|Investigator Judgment|0|||
131632692|NCT01703988|473939635|FG001|Overall Study|Investigator Judgment|0|||
131632693|NCT01703988|473939636|FG002|Overall Study|Investigator Judgment|0|||
131632694|NCT01703988|473939637|FG003|Overall Study|Investigator Judgment|1|||
131632695|NCT04879823|473939638|FG000|Overall Study|Physician Decision|3|||
131632696|NCT04879823|473939639|FG001|Overall Study|Physician Decision|1|||
131632697|NCT04879823|473939638|FG000|Overall Study|Protocol Violation|2|||
131632698|NCT04879823|473939639|FG001|Overall Study|Protocol Violation|3|||
131632699|NCT04879823|473939638|FG000|Overall Study|Lost to Follow-up|43|||
131713520|NCT04889209|474228752|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131713521|NCT04889209|474228735|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713522|NCT04889209|474228736|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713523|NCT04889209|474228737|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713524|NCT04889209|474228738|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713525|NCT04889209|474228739|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131632700|NCT04879823|473939639|FG001|Overall Study|Lost to Follow-up|35|||
131632701|NCT00460434|473939642|FG000|Overall Study|Lost to Follow-up|3|||
131804511|NCT02202850|474568554|FG000|Overall Study|Other|2|||
131804512|NCT02202850|474568555|FG001|Overall Study|Other|2|||
131632702|NCT00460434|473939643|FG001|Overall Study|Lost to Follow-up|7|||
131632703|NCT02722278|473939644|FG000|Overall Study|Withdrawal by Subject|5|||
131632704|NCT02722278|473939645|FG001|Overall Study|Withdrawal by Subject|3|||
131632705|NCT02722278|473939644|FG000|Overall Study|Adverse Event|4|||
131632706|NCT02722278|473939645|FG001|Overall Study|Adverse Event|1|||
131804513|NCT02202850|474568554|FG000|Overall Study|Enbrel treatment discontinued|15|||
131804514|NCT02202850|474568555|FG001|Overall Study|Enbrel treatment discontinued|3|||
131804515|NCT02202850|474568554|FG000|Overall Study|Lost to Follow-up|7|||
131804516|NCT02202850|474568555|FG001|Overall Study|Lost to Follow-up|1|||
131804517|NCT02914600|474568556|FG000|Overall Study|Adverse Event|298|||
131804518|NCT02914600|474568557|FG001|Overall Study|Adverse Event|35|||
131902272|NCT04265261|474927025|FG000|Overall Study|Adverse Event|2|||
131902273|NCT04265261|474927026|FG001|Overall Study|Adverse Event|0|||
131902274|NCT04265261|474927027|FG002|Overall Study|Adverse Event|0|||
131902275|NCT04265261|474927025|FG000|Overall Study|Death|1|||
131902276|NCT04265261|474927026|FG001|Overall Study|Death|0|||
131902277|NCT04265261|474927027|FG002|Overall Study|Death|0|||
131902278|NCT04265261|474927025|FG000|Overall Study|Lost to Follow-up|4|||
131902279|NCT04265261|474927026|FG001|Overall Study|Lost to Follow-up|1|||
131902280|NCT04265261|474927027|FG002|Overall Study|Lost to Follow-up|3|||
131902281|NCT04265261|474927025|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131902282|NCT04265261|474927026|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131902283|NCT04265261|474927027|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131902284|NCT04265261|474927025|FG000|Overall Study|Physician Decision|0|||
131902285|NCT04265261|474927026|FG001|Overall Study|Physician Decision|0|||
131902286|NCT04265261|474927027|FG002|Overall Study|Physician Decision|1|||
131902287|NCT04265261|474927025|FG000|Overall Study|Protocol Deviation|0|||
131902288|NCT04265261|474927026|FG001|Overall Study|Protocol Deviation|2|||
131902289|NCT04265261|474927027|FG002|Overall Study|Protocol Deviation|0|||
131902290|NCT04265261|474927025|FG000|Overall Study|Withdrawal by Subject|2|||
131902291|NCT04265261|474927026|FG001|Overall Study|Withdrawal by Subject|1|||
131902292|NCT04265261|474927027|FG002|Overall Study|Withdrawal by Subject|4|||
131902293|NCT00447902|474927028|FG000|Overall Study|Adverse Event|0|||
131902294|NCT00447902|474927029|FG001|Overall Study|Adverse Event|3|||
131902295|NCT00447902|474927028|FG000|Overall Study|Protocol Violation|1|||
131632707|NCT02722278|473939644|FG000|Overall Study|Lost to Follow-up|2|||
131632708|NCT02722278|473939645|FG001|Overall Study|Lost to Follow-up|0|||
131632709|NCT02722278|473939644|FG000|Overall Study|Protocol Violation|1|||
131902296|NCT00447902|474927029|FG001|Overall Study|Protocol Violation|0|||
131902297|NCT00447902|474927028|FG000|Overall Study|Withdrawal by Subject|0|||
131902298|NCT00447902|474927029|FG001|Overall Study|Withdrawal by Subject|1|||
131902299|NCT00447902|474927028|FG000|Overall Study|included patients who discontinued|1|||
131632710|NCT02722278|473939645|FG001|Overall Study|Protocol Violation|0|||
131632711|NCT02722278|473939644|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
131632712|NCT02722278|473939645|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
131632713|NCT02722278|473939644|FG000|Overall Study|Subject declined after tx assignment|0|||
131632714|NCT02722278|473939645|FG001|Overall Study|Subject declined after tx assignment|1|||
131632715|NCT02722278|473939644|FG000|Overall Study|Site closure not study related|0|||
131632716|NCT02722278|473939645|FG001|Overall Study|Site closure not study related|1|||
131632717|NCT02465866|473939646|FG000|Period 3|Withdrawal by Subject|0|||
131632718|NCT02465866|473939647|FG001|Period 3|Withdrawal by Subject|1|||
131632719|NCT02465866|473939648|FG002|Period 3|Withdrawal by Subject|0|||
131632720|NCT02465866|473939649|FG003|Period 3|Withdrawal by Subject|0|||
131632721|NCT01469819|473939650|FG000|Overall Study|Withdrawal by Subject|1|||
131632722|NCT01469819|473939650|FG000|Overall Study|Did not meet inclusionary criteria|2|||
131632723|NCT01469819|473939650|FG000|Overall Study|Could not swallow SmartPill|2|||
131632724|NCT01469819|473939650|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
131632725|NCT04057937|473939651|FG000|Placebo-controlled Phase|Adverse Event|3|||
131632726|NCT04057937|473939652|FG001|Placebo-controlled Phase|Adverse Event|0|||
131632727|NCT04057937|473939651|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
131632728|NCT04057937|473939652|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
131632729|NCT04057937|473939651|FG000|Active-treatment Phase|Pregnancy|0|||
131632730|NCT04057937|473939652|FG001|Active-treatment Phase|Pregnancy|1|||
131632731|NCT04057937|473939651|FG000|Active-treatment Phase|Physician Decision|0|||
131632732|NCT04057937|473939652|FG001|Active-treatment Phase|Physician Decision|1|||
131632733|NCT00147745|473939655|FG000|Overall Study|Withdrawal by Subject|1|||
131632734|NCT00147745|473939656|FG001|Overall Study|Withdrawal by Subject|0|||
131632735|NCT00147745|473939657|FG002|Overall Study|Withdrawal by Subject|0|||
131632736|NCT02744898|473939663|FG000|Overall Study|Progressive Disease|2|||
131632737|NCT02744898|473939663|FG000|Overall Study|Physician Decision|1|||
131632738|NCT02744898|473939663|FG000|Overall Study|Toxicity|1|||
131902300|NCT00447902|474927029|FG001|Overall Study|included patients who discontinued|1|||
131902301|NCT00447902|474927028|FG000|Overall Study|Lack of Efficacy|2|||
131902302|NCT00447902|474927029|FG001|Overall Study|Lack of Efficacy|1|||
131902303|NCT02358031|474929221|FG000|Overall Study|Death|253|||
131902304|NCT02358031|474929222|FG001|Overall Study|Death|237|||
131632739|NCT02305797|473939670|FG000|Overall Study|Adverse Event|11|||
131632740|NCT02305797|473939671|FG001|Overall Study|Adverse Event|2|||
131902305|NCT02358031|474929223|FG002|Overall Study|Death|266|||
131632741|NCT02305797|473939670|FG000|Overall Study|Withdrawal by Subject|9|||
131632742|NCT02305797|473939671|FG001|Overall Study|Withdrawal by Subject|10|||
131902306|NCT02358031|474929221|FG000|Overall Study|Lost to Follow-up|1|||
131902307|NCT02358031|474929222|FG001|Overall Study|Lost to Follow-up|1|||
131902308|NCT02358031|474929223|FG002|Overall Study|Lost to Follow-up|0|||
131902309|NCT02358031|474929221|FG000|Overall Study|Withdrawal by Subject|19|||
131632743|NCT02305797|473939670|FG000|Overall Study|Lack of Efficacy|6|||
131902310|NCT02358031|474929222|FG001|Overall Study|Withdrawal by Subject|14|||
131902311|NCT02358031|474929223|FG002|Overall Study|Withdrawal by Subject|18|||
131902312|NCT02358031|474929221|FG000|Overall Study|Sponsor Decision|26|||
131902313|NCT02358031|474929222|FG001|Overall Study|Sponsor Decision|28|||
131902314|NCT02358031|474929223|FG002|Overall Study|Sponsor Decision|16|||
131902315|NCT05664581|474929224|FG000|Overall Study|Withdrawal by Subject|2|||
131902316|NCT03101150|474929225|FG000|Overall Study|Lost to Follow-up|2|||
131902317|NCT03101150|474929226|FG001|Overall Study|Lost to Follow-up|4|||
131902318|NCT03101150|474929225|FG000|Overall Study|Miscarriage|3|||
131902319|NCT03101150|474929226|FG001|Overall Study|Miscarriage|6|||
131632744|NCT02305797|473939671|FG001|Overall Study|Lack of Efficacy|0|||
131632745|NCT02305797|473939670|FG000|Overall Study|Lost to Follow-up|5|||
131632746|NCT02305797|473939671|FG001|Overall Study|Lost to Follow-up|11|||
131632747|NCT02305797|473939670|FG000|Overall Study|Pregnancy|0|||
131632748|NCT02305797|473939671|FG001|Overall Study|Pregnancy|2|||
131632749|NCT02305797|473939670|FG000|Overall Study|Noncompliance|14|||
131632750|NCT02305797|473939671|FG001|Overall Study|Noncompliance|12|||
131632751|NCT02305797|473939670|FG000|Overall Study|Reason not collected|0|||
131632752|NCT02305797|473939671|FG001|Overall Study|Reason not collected|1|||
131632753|NCT02522299|473939672|FG000|Overall Study|Adverse Event|2|||
131632754|NCT02522299|473939673|FG001|Overall Study|Adverse Event|0|||
131632755|NCT02522299|473939672|FG000|Overall Study|Physician Decision|0|||
131632756|NCT02522299|473939673|FG001|Overall Study|Physician Decision|1|||
131632757|NCT02522299|473939672|FG000|Overall Study|Withdrawal by Subject|2|||
131632758|NCT02522299|473939673|FG001|Overall Study|Withdrawal by Subject|0|||
131632759|NCT00274846|473939685|FG000|Overall Study|Did not receive adequate NK cells|1|||
131632760|NCT05287178|473939686|FG000|Overall Study|Lost to Follow-up|2|||
131632761|NCT01648699|473939687|FG000|Overall Study|Death|1|||
131632762|NCT01648699|473939687|FG000|Overall Study|Lost to Follow-up|2|||
131632763|NCT01648699|473939687|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
131632764|NCT04598776|473939688|FG000|Overall Study|Protocol Violation|5|||
131632765|NCT04598776|473939688|FG000|Overall Study|Physician Decision|4|||
131632766|NCT00728884|473939689|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
131632767|NCT00728884|473939689|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
131632768|NCT00348283|473939690|FG000|Induction|Adverse Event|0|||
131632769|NCT00348283|473939691|FG001|Induction|Adverse Event|2|||
131632770|NCT00348283|473939690|FG000|Induction|Protocol Violation|0|||
131632771|NCT00348283|473939691|FG001|Induction|Protocol Violation|4|||
131632772|NCT00348283|473939690|FG000|Double Blind|Adverse Event|2|||
131632773|NCT00348283|473939691|FG001|Double Blind|Adverse Event|5|||
131632774|NCT00348283|473939690|FG000|Double Blind|Withdrawal by Subject|1|||
131632775|NCT00348283|473939691|FG001|Double Blind|Withdrawal by Subject|1|||
131632776|NCT00348283|473939690|FG000|Double Blind|Protocol Violation|0|||
131632777|NCT00348283|473939691|FG001|Double Blind|Protocol Violation|1|||
131632778|NCT00348283|473939690|FG000|Double Blind|Lack of Efficacy|2|||
131632779|NCT00348283|473939691|FG001|Double Blind|Lack of Efficacy|2|||
131632780|NCT00348283|473939690|FG000|Double Blind|Pregnancy|0|||
131632781|NCT00348283|473939691|FG001|Double Blind|Pregnancy|1|||
131632782|NCT00348283|473939690|FG000|Open Label|Adverse Event|0|||
131632783|NCT00348283|473939691|FG001|Open Label|Adverse Event|8|||
131632784|NCT00348283|473939690|FG000|Open Label|Withdrawal by Subject|0|||
131632785|NCT00348283|473939691|FG001|Open Label|Withdrawal by Subject|4|||
131632786|NCT00348283|473939690|FG000|Open Label|Lost to Follow-up|0|||
131632787|NCT00348283|473939691|FG001|Open Label|Lost to Follow-up|1|||
131632788|NCT00348283|473939690|FG000|Open Label|Lack of Efficacy|0|||
131632789|NCT00348283|473939691|FG001|Open Label|Lack of Efficacy|13|||
131632790|NCT00348283|473939690|FG000|Open Label|Administrative reasons|0|||
131632791|NCT00348283|473939691|FG001|Open Label|Administrative reasons|5|||
131632792|NCT00348283|473939690|FG000|Open Label|Subject moved to the United States|0|||
131632793|NCT00348283|473939691|FG001|Open Label|Subject moved to the United States|1|||
131632794|NCT00348283|473939690|FG000|Open Label|Pregnancy|0|||
131632795|NCT00348283|473939691|FG001|Open Label|Pregnancy|1|||
131632796|NCT00348283|473939690|FG000|Open Label|Sponsor decision|0|||
131632797|NCT00348283|473939691|FG001|Open Label|Sponsor decision|1|||
131632798|NCT06312566|473939696|FG000|Overall Study|Protocol Violation|0|||
131632799|NCT06312566|473939697|FG001|Overall Study|Protocol Violation|1|||
131632800|NCT04736472|473939698|FG000|Overall Study|Lost to Follow-up|1|||
131713526|NCT04889209|474228740|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131632801|NCT04736472|473939699|FG001|Overall Study|Lost to Follow-up|0|||
131632802|NCT04736472|473939700|FG002|Overall Study|Lost to Follow-up|0|||
131632803|NCT04736472|473939698|FG000|Overall Study|Withdrawal by Subject|2|||
131632804|NCT04736472|473939699|FG001|Overall Study|Withdrawal by Subject|0|||
131632805|NCT04736472|473939700|FG002|Overall Study|Withdrawal by Subject|0|||
131632806|NCT04736472|473939698|FG000|Overall Study|Protocol Violation|48|||
131632807|NCT04736472|473939699|FG001|Overall Study|Protocol Violation|0|||
131902320|NCT02787304|474929227|FG000|Overall Study|Adverse Event|9|||
131632808|NCT04736472|473939700|FG002|Overall Study|Protocol Violation|6|||
131632809|NCT03861078|473939701|FG000|Overall Study|COVID-19 shut down|4|||
131632810|NCT03861078|473939701|FG000|Overall Study|Lost to Follow-up|1|||
131632811|NCT03861078|473939701|FG000|Overall Study|Protocol Violation|2|||
131632812|NCT03861078|473939701|FG000|Overall Study|lack of venous access|1|||
131632813|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
131632814|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
131632815|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
131632816|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
131632817|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
131632818|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
131632819|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
131632820|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
131632821|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
131632822|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
131632823|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
131632824|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
131632825|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
131632826|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
131632827|NCT02971683|473939702|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
131632828|NCT02971683|473939703|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
131632829|NCT02971683|473939702|FG000|Open-Label|Lost to Follow-up|1|||
131632830|NCT02971683|473939703|FG001|Open-Label|Lost to Follow-up|0|||
131632831|NCT02971683|473939702|FG000|Open-Label|Participants withdrew consent|0|||
131632832|NCT02971683|473939703|FG001|Open-Label|Participants withdrew consent|2|||
131632833|NCT02971683|473939702|FG000|Open-Label|Participant request to discontinue study treatment|1|||
131632834|NCT02971683|473939703|FG001|Open-Label|Participant request to discontinue study treatment|0|||
131632835|NCT02971683|473939702|FG000|Open-Label|Lack of Efficacy|2|||
131632836|NCT02971683|473939703|FG001|Open-Label|Lack of Efficacy|0|||
131632837|NCT02971683|473939702|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
131632838|NCT02971683|473939703|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
131632839|NCT02971683|473939702|FG000|Long-Term Open Label|Participant withdrew consent|1|||
131632840|NCT02971683|473939703|FG001|Long-Term Open Label|Participant withdrew consent|0|||
131632841|NCT02971683|473939702|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
131632842|NCT02971683|473939703|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
131632843|NCT02971683|473939702|FG000|Long-Term Open Label|Adverse Event|1|||
131632844|NCT02971683|473939703|FG001|Long-Term Open Label|Adverse Event|2|||
131632845|NCT02971683|473939702|FG000|Long-Term Open Label|Lack of Efficacy|1|||
131632846|NCT02971683|473939703|FG001|Long-Term Open Label|Lack of Efficacy|1|||
131632847|NCT02268526|473939706|FG000|Overall Study|Adverse Event|0|||
131632848|NCT02268526|473939707|FG001|Overall Study|Adverse Event|2|||
131632849|NCT02268526|473939708|FG002|Overall Study|Adverse Event|1|||
131632850|NCT02268526|473939706|FG000|Overall Study|Death|1|||
131632851|NCT02268526|473939707|FG001|Overall Study|Death|11|||
131632852|NCT02268526|473939708|FG002|Overall Study|Death|0|||
131632853|NCT02268526|473939706|FG000|Overall Study|protocol deviation|0|||
131632854|NCT02268526|473939707|FG001|Overall Study|protocol deviation|1|||
131632855|NCT02268526|473939708|FG002|Overall Study|protocol deviation|0|||
131632856|NCT02268526|473939706|FG000|Overall Study|Physician Decision|0|||
131632857|NCT02268526|473939707|FG001|Overall Study|Physician Decision|0|||
131632858|NCT02268526|473939708|FG002|Overall Study|Physician Decision|1|||
131632859|NCT02268526|473939706|FG000|Overall Study|Subject/guardian decision|0|||
131632860|NCT02268526|473939707|FG001|Overall Study|Subject/guardian decision|7|||
131632861|NCT02268526|473939708|FG002|Overall Study|Subject/guardian decision|3|||
131632862|NCT00596960|473939709|FG000|Overall Study|Death|1|||
131632863|NCT00596960|473939710|FG001|Overall Study|Death|2|||
131632864|NCT00596960|473939709|FG000|Overall Study|Lost to Follow-up|6|||
131632865|NCT00596960|473939710|FG001|Overall Study|Lost to Follow-up|5|||
131632866|NCT00596960|473939709|FG000|Overall Study|Withdrawal by Subject|1|||
131632867|NCT00596960|473939710|FG001|Overall Study|Withdrawal by Subject|0|||
131632868|NCT00596960|473939709|FG000|Overall Study|Incarcerated|2|||
131632869|NCT00596960|473939710|FG001|Overall Study|Incarcerated|0|||
131632870|NCT00596960|473939709|FG000|Overall Study|Physician Decision|1|||
131632871|NCT00596960|473939710|FG001|Overall Study|Physician Decision|0|||
131632872|NCT00596960|473939709|FG000|Overall Study|Protocol Violation|0|||
131632873|NCT00596960|473939710|FG001|Overall Study|Protocol Violation|1|||
131632874|NCT00596960|473939709|FG000|Overall Study|No alcohol use data|0|||
131632875|NCT00596960|473939710|FG001|Overall Study|No alcohol use data|1|||
131632876|NCT02374476|473939713|FG000|VT Induced Ablation|Screening Failures|36|||
131632877|NCT02374476|473939714|FG001|VT Induced Ablation|Screening Failures|0|||
131632878|NCT02374476|473939715|FG002|VT Induced Ablation|Screening Failures|0|||
131632879|NCT02374476|473939713|FG000|Arm Assignment|Withdrawal by Subject|0|||
131632880|NCT02374476|473939714|FG001|Arm Assignment|Withdrawal by Subject|0|||
131632881|NCT02374476|473939715|FG002|Arm Assignment|Withdrawal by Subject|1|||
131632882|NCT03305458|473939716|FG000|Overall Study|Withdrawal by Subject|50|||
131632883|NCT03305458|473939717|FG001|Overall Study|Withdrawal by Subject|46|||
131632884|NCT03305458|473939718|FG002|Overall Study|Withdrawal by Subject|93|||
131632885|NCT03305458|473939716|FG000|Overall Study|Lost to Follow-up|85|||
131632886|NCT03305458|473939717|FG001|Overall Study|Lost to Follow-up|85|||
131632887|NCT03305458|473939718|FG002|Overall Study|Lost to Follow-up|35|||
131632888|NCT01636778|473939721|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
131632889|NCT01636778|473939722|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
131632890|NCT01636778|473939723|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
131632891|NCT01636778|473939721|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
131632892|NCT01636778|473939722|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
131632893|NCT01636778|473939723|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
131632894|NCT01636778|473939721|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
131632895|NCT01636778|473939722|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
131632896|NCT01636778|473939723|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
131632897|NCT01636778|473939721|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
131632898|NCT01636778|473939722|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
131632899|NCT01636778|473939723|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
131632900|NCT01636778|473939721|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
131632901|NCT01636778|473939722|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
131632902|NCT01636778|473939723|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
131632903|NCT01636778|473939721|FG000|Follow-up Period After Part 2|Other|0|||
131632904|NCT01636778|473939722|FG001|Follow-up Period After Part 2|Other|0|||
131632905|NCT01636778|473939723|FG002|Follow-up Period After Part 2|Other|1|||
131632906|NCT01636778|473939721|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
131632907|NCT01636778|473939722|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
131632908|NCT01636778|473939723|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
131632909|NCT01636778|473939721|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
131632910|NCT01636778|473939722|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
131632911|NCT01636778|473939723|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
131632912|NCT04853394|473939728|FG000|Follow-up Interviews|Lost to Follow-up|22|||
131632913|NCT04853394|473939729|FG001|Follow-up Interviews|Lost to Follow-up|15|||
131632914|NCT04413149|473941580|FG000|Overall Study|Death|10|||
131632915|NCT04413149|473941581|FG001|Overall Study|Death|5|||
131632916|NCT04413149|473941580|FG000|Overall Study|Lung transplantation|1|||
131632917|NCT04413149|473941581|FG001|Overall Study|Lung transplantation|0|||
131632918|NCT00705614|473941582|FG000|Initial Intervention|Adverse Event|40|||
131632919|NCT00705614|473941583|FG001|Initial Intervention|Adverse Event|21|||
131632920|NCT00705614|473941582|FG000|Initial Intervention|Lost to Follow-up|310|||
131632921|NCT00705614|473941583|FG001|Initial Intervention|Lost to Follow-up|191|||
131632922|NCT00705614|473941582|FG000|Initial Intervention|Withdrawal by Subject|114|||
131632923|NCT00705614|473941583|FG001|Initial Intervention|Withdrawal by Subject|71|||
131632924|NCT00705614|473941582|FG000|Initial Intervention|Administrative Reason|51|||
131632925|NCT00705614|473941583|FG001|Initial Intervention|Administrative Reason|38|||
131632926|NCT00705614|473941582|FG000|Initial Intervention|Status completion unknown|3|||
131632927|NCT00705614|473941583|FG001|Initial Intervention|Status completion unknown|0|||
131632928|NCT00705614|473941582|FG000|Switch to Remicade|Adverse Event|0|||
131632929|NCT00705614|473941583|FG001|Switch to Remicade|Adverse Event|5|||
131632930|NCT00705614|473941582|FG000|Switch to Remicade|Lost to Follow-up|0|||
131632931|NCT00705614|473941583|FG001|Switch to Remicade|Lost to Follow-up|23|||
131632932|NCT00705614|473941582|FG000|Switch to Remicade|Withdrawal by Subject|0|||
131632933|NCT00705614|473941583|FG001|Switch to Remicade|Withdrawal by Subject|12|||
131632934|NCT00705614|473941582|FG000|Switch to Remicade|Administrative Reason|0|||
131632935|NCT00705614|473941583|FG001|Switch to Remicade|Administrative Reason|9|||
131632936|NCT00676195|473941584|FG000|Overall Study|Lost to Follow-up|1|||
131632937|NCT00676195|473941584|FG000|Overall Study|Adverse Event|1|||
131632938|NCT00676195|473941584|FG000|Overall Study|Physician Decision|1|||
131632939|NCT02878590|473941585|FG000|Overall Study|Withdrawal by Subject|2|||
131632940|NCT02661490|473941586|FG000|Overall Study|Lost to Follow-up|0|||
131632941|NCT02661490|473941587|FG001|Overall Study|Lost to Follow-up|1|||
131632942|NCT02661490|473941588|FG002|Overall Study|Lost to Follow-up|0|||
131632943|NCT02661490|473941589|FG003|Overall Study|Lost to Follow-up|0|||
131632944|NCT02661490|473941590|FG004|Overall Study|Lost to Follow-up|2|||
131632945|NCT02661490|473941586|FG000|Overall Study|Withdrawal by Subject|2|||
131632946|NCT02661490|473941587|FG001|Overall Study|Withdrawal by Subject|0|||
131632947|NCT02661490|473941588|FG002|Overall Study|Withdrawal by Subject|2|||
131632948|NCT02661490|473941589|FG003|Overall Study|Withdrawal by Subject|0|||
131632949|NCT02661490|473941590|FG004|Overall Study|Withdrawal by Subject|0|||
131632950|NCT02661490|473941586|FG000|Overall Study|Death|1|||
131632951|NCT02661490|473941587|FG001|Overall Study|Death|1|||
131632952|NCT02661490|473941588|FG002|Overall Study|Death|0|||
131632953|NCT02661490|473941589|FG003|Overall Study|Death|1|||
131713527|NCT04889209|474228741|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131902321|NCT02787304|474929228|FG001|Overall Study|Adverse Event|3|||
131902322|NCT02787304|474929229|FG002|Overall Study|Adverse Event|8|||
131902323|NCT02787304|474929230|FG003|Overall Study|Adverse Event|1|||
131902324|NCT02787304|474929227|FG000|Overall Study|Withdrawal by Subject|1|||
131902325|NCT02787304|474929228|FG001|Overall Study|Withdrawal by Subject|4|||
131902326|NCT02787304|474929229|FG002|Overall Study|Withdrawal by Subject|0|||
131902327|NCT02787304|474929230|FG003|Overall Study|Withdrawal by Subject|0|||
131902328|NCT02787304|474929227|FG000|Overall Study|Lost to Follow-up|1|||
131902329|NCT02787304|474929228|FG001|Overall Study|Lost to Follow-up|0|||
131902330|NCT02787304|474929229|FG002|Overall Study|Lost to Follow-up|0|||
131902331|NCT02787304|474929230|FG003|Overall Study|Lost to Follow-up|1|||
131902332|NCT02787304|474929227|FG000|Overall Study|Noncompliance with study drug|0|||
131902333|NCT02787304|474929228|FG001|Overall Study|Noncompliance with study drug|0|||
131902334|NCT02787304|474929229|FG002|Overall Study|Noncompliance with study drug|1|||
131902335|NCT02787304|474929230|FG003|Overall Study|Noncompliance with study drug|0|||
131902336|NCT02787304|474929227|FG000|Overall Study|Physician Decision|0|||
131632954|NCT02661490|473941590|FG004|Overall Study|Death|0|||
131632955|NCT02661490|473941586|FG000|Overall Study|Reason not Specified|0|||
131632956|NCT02661490|473941587|FG001|Overall Study|Reason not Specified|0|||
131632957|NCT02661490|473941588|FG002|Overall Study|Reason not Specified|0|||
131632958|NCT02661490|473941589|FG003|Overall Study|Reason not Specified|0|||
131632959|NCT02661490|473941590|FG004|Overall Study|Reason not Specified|1|||
131632960|NCT03322514|473941591|FG000|Overall Study|Withdrawal by Subject|1|||
131632961|NCT03322514|473941592|FG001|Overall Study|Withdrawal by Subject|1|||
131632962|NCT01904019|473941593|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
131632963|NCT01904019|473941593|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
131632964|NCT01904019|473941593|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
131632965|NCT01904019|473941593|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
131632966|NCT01904019|473941593|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
131632967|NCT01904019|473941593|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
131632968|NCT02388932|473941595|FG000|Overall Study|Death|1|||
131632969|NCT05335005|473941596|FG000|Overall Study|Lost to Follow-up|1|||
131632970|NCT04050722|473941597|FG000|Overall Study|Withdrawal by Subject|1|||
131632971|NCT04050722|473941598|FG001|Overall Study|Withdrawal by Subject|0|||
131632972|NCT00644332|473941602|FG000|Overall Study|Adverse Event|11|||
131632973|NCT00644332|473941602|FG000|Overall Study|Withdrawal by Subject|6|||
131632974|NCT00644332|473941602|FG000|Overall Study|Completion Status Unknown|2|||
131632975|NCT00644332|473941602|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
131632976|NCT00644332|473941602|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
131632977|NCT03451292|473941606|FG000|Overall Study|Death|44|||
131632978|NCT03451292|473941607|FG001|Overall Study|Death|59|||
131632979|NCT03451292|473941606|FG000|Overall Study|Withdrawal by Subject|18|||
131632980|NCT03451292|473941607|FG001|Overall Study|Withdrawal by Subject|13|||
131632981|NCT03451292|473941606|FG000|Overall Study|Transplantation|18|||
131632982|NCT03451292|473941607|FG001|Overall Study|Transplantation|12|||
131632983|NCT03451292|473941606|FG000|Overall Study|Lost to Follow-up|4|||
131632984|NCT03451292|473941607|FG001|Overall Study|Lost to Follow-up|12|||
131632985|NCT03451292|473941606|FG000|Overall Study|Physician Decision|4|||
131632986|NCT03451292|473941607|FG001|Overall Study|Physician Decision|3|||
131632987|NCT03451292|473941606|FG000|Overall Study|Adverse Event|3|||
131632988|NCT03451292|473941607|FG001|Overall Study|Adverse Event|3|||
131632989|NCT03451292|473941606|FG000|Overall Study|Non-compliance with Study Drug|2|||
131632990|NCT03451292|473941607|FG001|Overall Study|Non-compliance with Study Drug|0|||
131632991|NCT00355784|473941608|FG000|Overall Study|Withdrawal by Subject|0|||
131632992|NCT00355784|473941609|FG001|Overall Study|Withdrawal by Subject|0|||
131632993|NCT00355784|473941610|FG002|Overall Study|Withdrawal by Subject|2|||
131632994|NCT01572493|473941615|FG000|Overall Study|Physician Decision|1|||
131632995|NCT01572493|473941616|FG001|Overall Study|Physician Decision|0|||
131632996|NCT01572493|473941617|FG002|Overall Study|Physician Decision|0|||
131632997|NCT01572493|473941618|FG003|Overall Study|Physician Decision|0|||
131632998|NCT01572493|473941619|FG004|Overall Study|Physician Decision|0|||
131632999|NCT01572493|473941620|FG005|Overall Study|Physician Decision|0|||
131633000|NCT01572493|473941621|FG006|Overall Study|Physician Decision|0|||
131633001|NCT01572493|473941622|FG007|Overall Study|Physician Decision|0|||
131633002|NCT01572493|473941623|FG008|Overall Study|Physician Decision|0|||
131633003|NCT01572493|473941615|FG000|Overall Study|Switched to alternative treatment|0|||
131633004|NCT01572493|473941616|FG001|Overall Study|Switched to alternative treatment|1|||
131902337|NCT02787304|474929228|FG001|Overall Study|Physician Decision|0|||
131902338|NCT02787304|474929229|FG002|Overall Study|Physician Decision|1|||
131902339|NCT02787304|474929230|FG003|Overall Study|Physician Decision|0|||
131633005|NCT01572493|473941617|FG002|Overall Study|Switched to alternative treatment|2|||
131633006|NCT01572493|473941618|FG003|Overall Study|Switched to alternative treatment|1|||
131633007|NCT01572493|473941619|FG004|Overall Study|Switched to alternative treatment|2|||
131633008|NCT01572493|473941620|FG005|Overall Study|Switched to alternative treatment|0|||
131633009|NCT01572493|473941621|FG006|Overall Study|Switched to alternative treatment|2|||
131633010|NCT01572493|473941622|FG007|Overall Study|Switched to alternative treatment|0|||
131633011|NCT01572493|473941623|FG008|Overall Study|Switched to alternative treatment|2|||
131633012|NCT01572493|473941615|FG000|Overall Study|Death|0|||
131633013|NCT01572493|473941616|FG001|Overall Study|Death|0|||
131633014|NCT01572493|473941617|FG002|Overall Study|Death|0|||
131633015|NCT01572493|473941618|FG003|Overall Study|Death|1|||
131633016|NCT01572493|473941619|FG004|Overall Study|Death|0|||
131633017|NCT01572493|473941620|FG005|Overall Study|Death|1|||
131633018|NCT01572493|473941621|FG006|Overall Study|Death|0|||
131633019|NCT01572493|473941622|FG007|Overall Study|Death|0|||
131633020|NCT01572493|473941623|FG008|Overall Study|Death|0|||
131633021|NCT01572493|473941615|FG000|Overall Study|Adverse Event|0|||
131633022|NCT01572493|473941616|FG001|Overall Study|Adverse Event|0|||
131633023|NCT01572493|473941617|FG002|Overall Study|Adverse Event|0|||
131633024|NCT01572493|473941618|FG003|Overall Study|Adverse Event|0|||
131633025|NCT01572493|473941619|FG004|Overall Study|Adverse Event|0|||
131633026|NCT01572493|473941620|FG005|Overall Study|Adverse Event|0|||
131633027|NCT01572493|473941621|FG006|Overall Study|Adverse Event|1|||
131633028|NCT01572493|473941622|FG007|Overall Study|Adverse Event|0|||
131633029|NCT01572493|473941623|FG008|Overall Study|Adverse Event|0|||
131633030|NCT01234675|473941624|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
131633031|NCT01234675|473941625|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
131633032|NCT01234675|473941624|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131633033|NCT01234675|473941625|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
131633034|NCT00609245|473941626|FG000|Overall Study|Adverse Event|1|||
131633035|NCT01636258|473941628|FG000|Overall Study|Lost to Follow-up|1|||
131798214|NCT00623103|474545906|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131798215|NCT00623103|474545907|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
131798216|NCT00623103|474545906|FG000|Overall Study|Withdrawal by Subject|18|||
131798217|NCT00623103|474545907|FG001|Overall Study|Withdrawal by Subject|24|||
131798218|NCT00623103|474545906|FG000|Overall Study|Lost to Follow-up|4|||
131798219|NCT00623103|474545907|FG001|Overall Study|Lost to Follow-up|1|||
131798220|NCT00623103|474545906|FG000|Overall Study|Administrative problems|2|||
131798221|NCT00623103|474545907|FG001|Overall Study|Administrative problems|4|||
131798222|NCT00623103|474545906|FG000|Overall Study|Death|11|||
131798223|NCT00623103|474545907|FG001|Overall Study|Death|11|||
131798224|NCT00623103|474545906|FG000|Overall Study|Protocol deviation|2|||
131798225|NCT00623103|474545907|FG001|Overall Study|Protocol deviation|1|||
131798226|NCT00625807|474545910|FG000|Overall Study|schedule conflict|2|||
131798227|NCT00625807|474545911|FG001|Overall Study|schedule conflict|8|||
131798228|NCT02224391|474545912|FG000|Overall Study|Lost to Follow-up|26|||
131798229|NCT02224391|474545913|FG001|Overall Study|Lost to Follow-up|19|||
131798230|NCT02224391|474545912|FG000|Overall Study|Withdrawal by Subject|6|||
131798231|NCT02224391|474545913|FG001|Overall Study|Withdrawal by Subject|5|||
131798232|NCT01901055|474545914|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
131798233|NCT01901055|474545915|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
131798234|NCT01901055|474545914|FG000|Randomization But Not Titrated|Physician Decision|0|||
131798235|NCT01901055|474545915|FG001|Randomization But Not Titrated|Physician Decision|1|||
131798236|NCT01901055|474545914|FG000|Started Protocol to Week 6|Physician Decision|2|||
131633036|NCT01636258|473941629|FG001|Overall Study|Lost to Follow-up|0|||
131633037|NCT02798861|473941632|FG000|Overall Study|Lost to Follow-up|22|||
131633038|NCT02798861|473941632|FG000|Overall Study|Withdrawal by Subject|1|||
131633039|NCT01797705|473941636|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
131633040|NCT01797705|473941636|FG000|Overall Study|Withdrawal by Subject|1|||
131633041|NCT04468633|473941637|FG000|Overall Study|Withdrawal by Subject|4|||
131633042|NCT04468633|473941638|FG001|Overall Study|Withdrawal by Subject|0|||
131798237|NCT01901055|474545915|FG001|Started Protocol to Week 6|Physician Decision|1|||
131633043|NCT02592434|473941639|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
131633044|NCT02592434|473941640|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
131633045|NCT02592434|473941641|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
131633046|NCT02592434|473941639|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
131633047|NCT02592434|473941640|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
131633048|NCT02592434|473941641|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
131633049|NCT02592434|473941639|FG000|Open-Label Phase (18 Weeks)|Other|3|||
131633050|NCT02592434|473941640|FG001|Open-Label Phase (18 Weeks)|Other|0|||
131633051|NCT02592434|473941641|FG002|Open-Label Phase (18 Weeks)|Other|0|||
131633052|NCT02592434|473941639|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
131633053|NCT02592434|473941640|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
131633054|NCT02592434|473941641|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
131633055|NCT02592434|473941639|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
131633056|NCT02592434|473941640|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
131633057|NCT02592434|473941641|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
131633058|NCT02592434|473941639|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
131633059|NCT02592434|473941640|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
131633060|NCT02592434|473941641|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
131633061|NCT02592434|473941639|FG000|Double Blind Phase (26 Weeks)|Other|0|||
131633062|NCT02592434|473941640|FG001|Double Blind Phase (26 Weeks)|Other|1|||
131633063|NCT02592434|473941641|FG002|Double Blind Phase (26 Weeks)|Other|0|||
131633064|NCT02592434|473941639|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
131633065|NCT02592434|473941640|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
131633066|NCT02592434|473941641|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
131633067|NCT02592434|473941639|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
131633068|NCT02592434|473941640|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
131633069|NCT02592434|473941641|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
131633070|NCT02592434|473941639|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
131633071|NCT02592434|473941640|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
131633072|NCT02592434|473941641|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
131633073|NCT00561678|473941642|FG000|Overall Study|Withdrawal by Subject|4|||
131633074|NCT00561678|473941643|FG001|Overall Study|Withdrawal by Subject|3|||
131633075|NCT00561678|473941642|FG000|Overall Study|surgery cancelled|1|||
131633076|NCT00561678|473941643|FG001|Overall Study|surgery cancelled|1|||
131633077|NCT00561678|473941642|FG000|Overall Study|surgery rescheduled to different site|2|||
131633078|NCT00561678|473941643|FG001|Overall Study|surgery rescheduled to different site|2|||
131633079|NCT00561678|473941642|FG000|Overall Study|anesthesia provider refusal|1|||
131633080|NCT00561678|473941643|FG001|Overall Study|anesthesia provider refusal|0|||
131633081|NCT01403805|473941644|FG000|Overall Study|Withdrawal by Subject|0|||
131633082|NCT01403805|473941645|FG001|Overall Study|Withdrawal by Subject|4|||
131633083|NCT01403805|473941644|FG000|Overall Study|Lost to Follow-up|0|||
131633084|NCT01403805|473941645|FG001|Overall Study|Lost to Follow-up|2|||
131633085|NCT01403805|473941644|FG000|Overall Study|Death|0|||
131633086|NCT01403805|473941645|FG001|Overall Study|Death|1|||
131633087|NCT01103141|473941648|FG000|Overall Study|Death|0|||
131633088|NCT01103141|473941649|FG001|Overall Study|Death|1|||
131633089|NCT01103141|473941648|FG000|Overall Study|Lost to Follow-up|2|||
131633090|NCT01103141|473941649|FG001|Overall Study|Lost to Follow-up|1|||
131633091|NCT01695993|473941650|FG000|Overall Study|Lost to Follow-up|2|||
131633092|NCT01695993|473941651|FG001|Overall Study|Lost to Follow-up|1|||
131633093|NCT01695993|473941652|FG002|Overall Study|Lost to Follow-up|3|||
131633094|NCT01695993|473941650|FG000|Overall Study|Withdrawal by Subject|2|||
131633095|NCT01695993|473941651|FG001|Overall Study|Withdrawal by Subject|2|||
131633096|NCT01695993|473941652|FG002|Overall Study|Withdrawal by Subject|2|||
131633097|NCT01695993|473941650|FG000|Overall Study|To ill to continue|1|||
131633098|NCT01695993|473941651|FG001|Overall Study|To ill to continue|2|||
131633099|NCT01695993|473941652|FG002|Overall Study|To ill to continue|0|||
131633100|NCT01695993|473941650|FG000|Overall Study|Changed Medical Facility|0|||
131633101|NCT01695993|473941651|FG001|Overall Study|Changed Medical Facility|0|||
131633102|NCT01695993|473941652|FG002|Overall Study|Changed Medical Facility|1|||
131633103|NCT02029521|473941654|FG000|Overall Study|Protocol Violation|1|||
131633104|NCT02029521|473941655|FG001|Overall Study|Protocol Violation|0|||
131633105|NCT02029521|473941654|FG000|Overall Study|Withdrawal by Subject|1|||
131633106|NCT02029521|473941655|FG001|Overall Study|Withdrawal by Subject|1|||
131633107|NCT01072396|473941656|FG000|Period One|Adverse Event|1|||
131633108|NCT01072396|473941657|FG001|Period One|Adverse Event|1|||
131633109|NCT01072396|473941656|FG000|Period One|Protocol Violation|2|||
131633110|NCT01072396|473941657|FG001|Period One|Protocol Violation|1|||
131633111|NCT01072396|473941656|FG000|Period One|Withdrawal by Subject|2|||
131633112|NCT01072396|473941657|FG001|Period One|Withdrawal by Subject|0|||
131633113|NCT01072396|473941656|FG000|Washout Period|Missing termination information|0|||
131633114|NCT01072396|473941657|FG001|Washout Period|Missing termination information|1|||
131633115|NCT01072396|473941656|FG000|Period Two|Adverse Event|0|||
131633116|NCT01072396|473941657|FG001|Period Two|Adverse Event|3|||
131633117|NCT01072396|473941656|FG000|Period Two|Lost to Follow-up|1|||
131633118|NCT01072396|473941657|FG001|Period Two|Lost to Follow-up|0|||
131633119|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Adverse Event|3|||
131633120|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Adverse Event|0|||
131633121|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
131633122|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
131633123|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Disease Progression|23|||
131633124|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Disease Progression|22|||
131633125|NCT01379521|473941658|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
131633126|NCT01379521|473941659|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
131633127|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
131633128|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
131633129|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
131633130|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
131633131|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
131633132|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
131633133|NCT01379521|473941658|FG000|Overall Study -Treatment Period|Death|2|||
131633134|NCT01379521|473941659|FG001|Overall Study -Treatment Period|Death|1|||
131633135|NCT01379521|473941658|FG000|Post-Treatment Evaluations|Disease Progression|22|||
131633136|NCT01379521|473941659|FG001|Post-Treatment Evaluations|Disease Progression|20|||
131633137|NCT01379521|473941658|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
131633138|NCT01379521|473941659|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
131633139|NCT01379521|473941658|FG000|Post-Treatment Evaluations|Death|1|||
131633140|NCT01379521|473941659|FG001|Post-Treatment Evaluations|Death|0|||
131633141|NCT00105521|473941660|FG000|Overall Study|Other|1|||
131633142|NCT00105521|473941661|FG001|Overall Study|Other|1|||
131633143|NCT00105521|473941662|FG002|Overall Study|Other|2|||
131633144|NCT00105521|473941663|FG003|Overall Study|Other|0|||
131633145|NCT00105521|473941660|FG000|Overall Study|Adverse Event|10|||
131633146|NCT00105521|473941661|FG001|Overall Study|Adverse Event|4|||
131633147|NCT00105521|473941662|FG002|Overall Study|Adverse Event|10|||
131633148|NCT00105521|473941663|FG003|Overall Study|Adverse Event|8|||
131633149|NCT00105521|473941660|FG000|Overall Study|Withdrawal by Subject|1|||
131633150|NCT00105521|473941661|FG001|Overall Study|Withdrawal by Subject|0|||
131633151|NCT00105521|473941662|FG002|Overall Study|Withdrawal by Subject|1|||
131633152|NCT00105521|473941663|FG003|Overall Study|Withdrawal by Subject|4|||
131633153|NCT00105521|473941660|FG000|Overall Study|Lack of Efficacy|0|||
131633154|NCT00105521|473941661|FG001|Overall Study|Lack of Efficacy|0|||
131633155|NCT00105521|473941662|FG002|Overall Study|Lack of Efficacy|0|||
131633156|NCT00105521|473941663|FG003|Overall Study|Lack of Efficacy|1|||
131633157|NCT00105521|473941660|FG000|Overall Study|Protocol Violation|3|||
131633158|NCT00105521|473941661|FG001|Overall Study|Protocol Violation|5|||
131633159|NCT00105521|473941662|FG002|Overall Study|Protocol Violation|4|||
131633160|NCT00105521|473941663|FG003|Overall Study|Protocol Violation|4|||
131633161|NCT00105521|473941660|FG000|Overall Study|Lost to Follow-up|0|||
131633162|NCT00105521|473941661|FG001|Overall Study|Lost to Follow-up|1|||
131633163|NCT00105521|473941662|FG002|Overall Study|Lost to Follow-up|0|||
131633164|NCT00105521|473941663|FG003|Overall Study|Lost to Follow-up|0|||
131633165|NCT02504502|473941664|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
131633166|NCT02504502|473941665|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
131633167|NCT02504502|473941664|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
131633168|NCT02504502|473941665|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
131633169|NCT03508830|473941670|FG000|Overall Study|Withdrawal by Subject|3|||
131633170|NCT03508830|473941671|FG001|Overall Study|Withdrawal by Subject|4|||
131633171|NCT03508830|473941670|FG000|Overall Study|Physician Decision|2|||
131633172|NCT03508830|473941671|FG001|Overall Study|Physician Decision|2|||
131633173|NCT03906240|473941672|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
131633174|NCT03906240|473941673|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
131633175|NCT03906240|473941672|FG000|Overall Study|Lost to Follow-up|1|||
131633176|NCT03906240|473941673|FG001|Overall Study|Lost to Follow-up|0|||
131633177|NCT03906240|473941672|FG000|Overall Study|Withdrawal by Subject|0|||
131633178|NCT03906240|473941673|FG001|Overall Study|Withdrawal by Subject|1|||
131633179|NCT04908800|473941681|FG000|Overall Study|Adverse Event|0|||
131633180|NCT04908800|473941682|FG001|Overall Study|Adverse Event|0|||
131633181|NCT04908800|473941683|FG002|Overall Study|Adverse Event|0|||
131633182|NCT04908800|473941684|FG003|Overall Study|Adverse Event|0|||
131633183|NCT04908800|473941685|FG004|Overall Study|Adverse Event|0|||
131633184|NCT04908800|473941686|FG005|Overall Study|Adverse Event|0|||
131633185|NCT04908800|473941687|FG006|Overall Study|Adverse Event|0|||
131633186|NCT04908800|473941688|FG007|Overall Study|Adverse Event|0|||
131633187|NCT04908800|473941689|FG008|Overall Study|Adverse Event|0|||
131633188|NCT04908800|473941690|FG009|Overall Study|Adverse Event|0|||
131633189|NCT04908800|473941691|FG010|Overall Study|Adverse Event|1|||
131633190|NCT04908800|473941692|FG011|Overall Study|Adverse Event|0|||
131633191|NCT04908800|473941693|FG012|Overall Study|Adverse Event|0|||
131633192|NCT00296504|473941694|FG000|Interim Analysis|Withdrawal by Subject|8|||
131633193|NCT00296504|473941695|FG001|Interim Analysis|Withdrawal by Subject|0|||
131633194|NCT00296504|473941696|FG002|Interim Analysis|Withdrawal by Subject|12|||
131633195|NCT00296504|473941697|FG003|Interim Analysis|Withdrawal by Subject|0|||
131633196|NCT00296504|473941698|FG004|Interim Analysis|Withdrawal by Subject|5|||
131633197|NCT00296504|473941699|FG005|Interim Analysis|Withdrawal by Subject|5|||
131633198|NCT00296504|473941700|FG006|Interim Analysis|Withdrawal by Subject|9|||
131633199|NCT00296504|473941701|FG007|Interim Analysis|Withdrawal by Subject|3|||
131633200|NCT00296504|473941702|FG008|Interim Analysis|Withdrawal by Subject|0|||
131633201|NCT00296504|473941694|FG000|Interim Analysis|Lost to Follow-up|13|||
131633202|NCT00296504|473941695|FG001|Interim Analysis|Lost to Follow-up|3|||
131633203|NCT00296504|473941696|FG002|Interim Analysis|Lost to Follow-up|26|||
131633204|NCT00296504|473941697|FG003|Interim Analysis|Lost to Follow-up|8|||
131633205|NCT00296504|473941698|FG004|Interim Analysis|Lost to Follow-up|14|||
131633206|NCT00296504|473941699|FG005|Interim Analysis|Lost to Follow-up|4|||
131633207|NCT00296504|473941700|FG006|Interim Analysis|Lost to Follow-up|11|||
131633208|NCT00296504|473941701|FG007|Interim Analysis|Lost to Follow-up|4|||
131633209|NCT00296504|473941702|FG008|Interim Analysis|Lost to Follow-up|0|||
131633210|NCT00296504|473941694|FG000|Interim Analysis|Clinical Progression|1|||
131633211|NCT00296504|473941695|FG001|Interim Analysis|Clinical Progression|0|||
131633212|NCT00296504|473941696|FG002|Interim Analysis|Clinical Progression|1|||
131633213|NCT00296504|473941697|FG003|Interim Analysis|Clinical Progression|1|||
131633214|NCT00296504|473941698|FG004|Interim Analysis|Clinical Progression|0|||
131633215|NCT00296504|473941699|FG005|Interim Analysis|Clinical Progression|2|||
131633216|NCT00296504|473941700|FG006|Interim Analysis|Clinical Progression|1|||
131633217|NCT00296504|473941701|FG007|Interim Analysis|Clinical Progression|2|||
131633218|NCT00296504|473941702|FG008|Interim Analysis|Clinical Progression|0|||
131633219|NCT00296504|473941694|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
131633220|NCT00296504|473941695|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
131633221|NCT00296504|473941696|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
131633222|NCT00296504|473941697|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
131633223|NCT00296504|473941698|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
131633224|NCT00296504|473941699|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
131633225|NCT00296504|473941700|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
131633226|NCT00296504|473941701|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
131633227|NCT00296504|473941702|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
131633228|NCT00296504|473941694|FG000|Interim Analysis|Adverse Event|0|||
131633229|NCT00296504|473941695|FG001|Interim Analysis|Adverse Event|0|||
131633230|NCT00296504|473941696|FG002|Interim Analysis|Adverse Event|13|||
131633231|NCT00296504|473941697|FG003|Interim Analysis|Adverse Event|4|||
131633232|NCT00296504|473941698|FG004|Interim Analysis|Adverse Event|6|||
131633233|NCT00296504|473941699|FG005|Interim Analysis|Adverse Event|3|||
131633234|NCT00296504|473941700|FG006|Interim Analysis|Adverse Event|4|||
131633235|NCT00296504|473941701|FG007|Interim Analysis|Adverse Event|5|||
131633236|NCT00296504|473941702|FG008|Interim Analysis|Adverse Event|0|||
131633237|NCT00296504|473941694|FG000|Interim Analysis|Protocol Violation|0|||
131633238|NCT00296504|473941695|FG001|Interim Analysis|Protocol Violation|0|||
131633239|NCT00296504|473941696|FG002|Interim Analysis|Protocol Violation|2|||
131633240|NCT00296504|473941697|FG003|Interim Analysis|Protocol Violation|0|||
131633241|NCT00296504|473941698|FG004|Interim Analysis|Protocol Violation|1|||
131633242|NCT00296504|473941699|FG005|Interim Analysis|Protocol Violation|0|||
131633243|NCT00296504|473941700|FG006|Interim Analysis|Protocol Violation|0|||
131633244|NCT00296504|473941701|FG007|Interim Analysis|Protocol Violation|1|||
131633245|NCT00296504|473941702|FG008|Interim Analysis|Protocol Violation|0|||
131633246|NCT00296504|473941694|FG000|Interim Analysis|Insufficient CD4 Response|0|||
131633247|NCT00296504|473941695|FG001|Interim Analysis|Insufficient CD4 Response|0|||
131633248|NCT00296504|473941696|FG002|Interim Analysis|Insufficient CD4 Response|0|||
131633249|NCT00296504|473941697|FG003|Interim Analysis|Insufficient CD4 Response|0|||
131633250|NCT00296504|473941698|FG004|Interim Analysis|Insufficient CD4 Response|1|||
131633251|NCT00296504|473941699|FG005|Interim Analysis|Insufficient CD4 Response|1|||
131633252|NCT00296504|473941700|FG006|Interim Analysis|Insufficient CD4 Response|0|||
131633253|NCT00296504|473941701|FG007|Interim Analysis|Insufficient CD4 Response|0|||
131633254|NCT00296504|473941702|FG008|Interim Analysis|Insufficient CD4 Response|0|||
131633255|NCT00296504|473941694|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
131633256|NCT00296504|473941695|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
131633257|NCT00296504|473941696|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
131633258|NCT00296504|473941697|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
131633259|NCT00296504|473941698|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
131633260|NCT00296504|473941699|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
131633261|NCT00296504|473941700|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
131633262|NCT00296504|473941701|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
131633263|NCT00296504|473941702|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
131633264|NCT00296504|473941694|FG000|Interim Analysis|Pregnancy|4|||
131633265|NCT00296504|473941695|FG001|Interim Analysis|Pregnancy|1|||
131633266|NCT00296504|473941696|FG002|Interim Analysis|Pregnancy|4|||
131713528|NCT04889209|474228742|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131713529|NCT04889209|474228743|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713530|NCT04889209|474228744|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131713531|NCT04889209|474228745|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131713532|NCT04889209|474228746|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713533|NCT04889209|474228747|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131713534|NCT04889209|474228748|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713535|NCT04889209|474228749|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713536|NCT04889209|474228750|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713537|NCT04889209|474228751|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131713538|NCT04889209|474228752|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131713539|NCT04889209|474228735|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713540|NCT04889209|474228736|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713541|NCT04889209|474228737|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713542|NCT04889209|474228738|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713543|NCT04889209|474228739|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713544|NCT04889209|474228740|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713545|NCT04889209|474228741|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713546|NCT04889209|474228742|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713547|NCT04889209|474228743|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713548|NCT04889209|474228744|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131633267|NCT00296504|473941697|FG003|Interim Analysis|Pregnancy|2|||
131633268|NCT00296504|473941698|FG004|Interim Analysis|Pregnancy|0|||
131633269|NCT00296504|473941699|FG005|Interim Analysis|Pregnancy|1|||
131633270|NCT00296504|473941700|FG006|Interim Analysis|Pregnancy|1|||
131633271|NCT00296504|473941701|FG007|Interim Analysis|Pregnancy|1|||
131633272|NCT00296504|473941702|FG008|Interim Analysis|Pregnancy|0|||
131633273|NCT00296504|473941694|FG000|Interim Analysis|Death|1|||
131633274|NCT00296504|473941695|FG001|Interim Analysis|Death|0|||
131633275|NCT00296504|473941696|FG002|Interim Analysis|Death|3|||
131633276|NCT00296504|473941697|FG003|Interim Analysis|Death|0|||
131633277|NCT00296504|473941698|FG004|Interim Analysis|Death|0|||
131633278|NCT00296504|473941699|FG005|Interim Analysis|Death|0|||
131633279|NCT00296504|473941700|FG006|Interim Analysis|Death|0|||
131633280|NCT00296504|473941701|FG007|Interim Analysis|Death|0|||
131633281|NCT00296504|473941702|FG008|Interim Analysis|Death|0|||
131633282|NCT00296504|473941694|FG000|Interim Analysis|Participant Non-compliant|0|||
131633283|NCT00296504|473941695|FG001|Interim Analysis|Participant Non-compliant|1|||
131633284|NCT00296504|473941696|FG002|Interim Analysis|Participant Non-compliant|2|||
131633285|NCT00296504|473941697|FG003|Interim Analysis|Participant Non-compliant|1|||
131633286|NCT00296504|473941698|FG004|Interim Analysis|Participant Non-compliant|1|||
131633287|NCT00296504|473941699|FG005|Interim Analysis|Participant Non-compliant|3|||
131633288|NCT00296504|473941700|FG006|Interim Analysis|Participant Non-compliant|6|||
131633289|NCT00296504|473941701|FG007|Interim Analysis|Participant Non-compliant|2|||
131633290|NCT00296504|473941702|FG008|Interim Analysis|Participant Non-compliant|0|||
131633291|NCT00296504|473941694|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633292|NCT00296504|473941695|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633293|NCT00296504|473941696|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
131633294|NCT00296504|473941697|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633295|NCT00296504|473941698|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633296|NCT00296504|473941699|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
131633297|NCT00296504|473941700|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633298|NCT00296504|473941701|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633299|NCT00296504|473941702|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131633300|NCT00296504|473941694|FG000|Interim Analysis|To Simplify Treatment|0|||
131633301|NCT00296504|473941695|FG001|Interim Analysis|To Simplify Treatment|0|||
131633302|NCT00296504|473941696|FG002|Interim Analysis|To Simplify Treatment|1|||
131633303|NCT00296504|473941697|FG003|Interim Analysis|To Simplify Treatment|0|||
131633304|NCT00296504|473941698|FG004|Interim Analysis|To Simplify Treatment|0|||
131633305|NCT00296504|473941699|FG005|Interim Analysis|To Simplify Treatment|0|||
131633306|NCT00296504|473941700|FG006|Interim Analysis|To Simplify Treatment|2|||
131633307|NCT00296504|473941701|FG007|Interim Analysis|To Simplify Treatment|0|||
131633308|NCT00296504|473941702|FG008|Interim Analysis|To Simplify Treatment|0|||
131633309|NCT00296504|473941694|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633310|NCT00296504|473941695|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633311|NCT00296504|473941696|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
131633312|NCT00296504|473941697|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633313|NCT00296504|473941698|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633314|NCT00296504|473941699|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633315|NCT00296504|473941700|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
131798238|NCT01901055|474545914|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
131798239|NCT01901055|474545915|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
131798240|NCT01901055|474545914|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
131798241|NCT01901055|474545915|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
131798242|NCT01901055|474545914|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
131798243|NCT01901055|474545915|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
131798244|NCT01901055|474545914|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
131798245|NCT01901055|474545915|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
131798246|NCT01901055|474545914|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
131798247|NCT01901055|474545915|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
131798248|NCT01901055|474545914|FG000|Week 24|Withdrawal by Subject|13|||
131798249|NCT01901055|474545915|FG001|Week 24|Withdrawal by Subject|19|||
131902340|NCT02787304|474929227|FG000|Overall Study|Study terminated by sponsor|25|||
131633316|NCT00296504|473941701|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633317|NCT00296504|473941702|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
131633318|NCT00296504|473941694|FG000|Interim Analysis|Participant Moved|1|||
131633319|NCT00296504|473941695|FG001|Interim Analysis|Participant Moved|0|||
131633320|NCT00296504|473941696|FG002|Interim Analysis|Participant Moved|1|||
131633321|NCT00296504|473941697|FG003|Interim Analysis|Participant Moved|0|||
131633322|NCT00296504|473941698|FG004|Interim Analysis|Participant Moved|0|||
131633323|NCT00296504|473941699|FG005|Interim Analysis|Participant Moved|1|||
131633324|NCT00296504|473941700|FG006|Interim Analysis|Participant Moved|1|||
131902341|NCT02787304|474929228|FG001|Overall Study|Study terminated by sponsor|31|||
131902342|NCT02787304|474929229|FG002|Overall Study|Study terminated by sponsor|31|||
131902343|NCT02787304|474929230|FG003|Overall Study|Study terminated by sponsor|32|||
131902344|NCT01051921|474929231|FG000|Overall Study|Physician Decision|9|||
131902345|NCT01051921|474929231|FG000|Overall Study|Adverse Event|8|||
131902346|NCT01051921|474929231|FG000|Overall Study|Withdrawal by Subject|7|||
131902347|NCT01051921|474929231|FG000|Overall Study|Lost to Follow-up|4|||
131902348|NCT01051921|474929231|FG000|Overall Study|virological failure|1|||
131902349|NCT01051921|474929231|FG000|Overall Study|patient moved|1|||
131902350|NCT01325350|474929234|FG000|Overall Study|Adverse Event|3|||
131902351|NCT01325350|474929235|FG001|Overall Study|Adverse Event|3|||
131902352|NCT01325350|474929236|FG002|Overall Study|Adverse Event|3|||
131902353|NCT01325350|474929237|FG003|Overall Study|Adverse Event|1|||
131902354|NCT01325350|474929238|FG004|Overall Study|Adverse Event|2|||
131902355|NCT01325350|474929234|FG000|Overall Study|Pregnancy|0|||
131902356|NCT01325350|474929235|FG001|Overall Study|Pregnancy|0|||
131902357|NCT01325350|474929236|FG002|Overall Study|Pregnancy|1|||
131902358|NCT01325350|474929237|FG003|Overall Study|Pregnancy|0|||
131902359|NCT01325350|474929238|FG004|Overall Study|Pregnancy|1|||
131902360|NCT01325350|474929234|FG000|Overall Study|Lost to Follow-up|1|||
131902361|NCT01325350|474929235|FG001|Overall Study|Lost to Follow-up|0|||
131902362|NCT01325350|474929236|FG002|Overall Study|Lost to Follow-up|5|||
131902363|NCT01325350|474929237|FG003|Overall Study|Lost to Follow-up|1|||
131902364|NCT01325350|474929238|FG004|Overall Study|Lost to Follow-up|5|||
131902365|NCT01325350|474929234|FG000|Overall Study|Personal Reasons|2|||
131902366|NCT01325350|474929235|FG001|Overall Study|Personal Reasons|1|||
131902367|NCT01325350|474929236|FG002|Overall Study|Personal Reasons|6|||
131902368|NCT01325350|474929237|FG003|Overall Study|Personal Reasons|5|||
131902369|NCT01325350|474929238|FG004|Overall Study|Personal Reasons|3|||
131902370|NCT01325350|474929234|FG000|Overall Study|Protocol Violation|0|||
131902371|NCT01325350|474929235|FG001|Overall Study|Protocol Violation|0|||
131902372|NCT01325350|474929236|FG002|Overall Study|Protocol Violation|0|||
131902373|NCT01325350|474929237|FG003|Overall Study|Protocol Violation|1|||
131902374|NCT01325350|474929238|FG004|Overall Study|Protocol Violation|0|||
131902375|NCT01325350|474929234|FG000|Overall Study|Withdrawal by Subject|0|||
131902376|NCT01325350|474929235|FG001|Overall Study|Withdrawal by Subject|0|||
131902377|NCT01325350|474929236|FG002|Overall Study|Withdrawal by Subject|1|||
131902378|NCT01325350|474929237|FG003|Overall Study|Withdrawal by Subject|1|||
131902379|NCT01325350|474929238|FG004|Overall Study|Withdrawal by Subject|0|||
131902380|NCT01325350|474929234|FG000|Overall Study|Did Not Receive Treatment|0|||
131902381|NCT01325350|474929235|FG001|Overall Study|Did Not Receive Treatment|1|||
131902382|NCT01325350|474929236|FG002|Overall Study|Did Not Receive Treatment|1|||
131902383|NCT01325350|474929237|FG003|Overall Study|Did Not Receive Treatment|0|||
131633325|NCT00296504|473941701|FG007|Interim Analysis|Participant Moved|0|||
131633326|NCT00296504|473941702|FG008|Interim Analysis|Participant Moved|0|||
131633327|NCT00296504|473941694|FG000|Interim Analysis|Participant Was Incarcerated|2|||
131633328|NCT00296504|473941695|FG001|Interim Analysis|Participant Was Incarcerated|0|||
131633329|NCT00296504|473941696|FG002|Interim Analysis|Participant Was Incarcerated|1|||
131633330|NCT00296504|473941697|FG003|Interim Analysis|Participant Was Incarcerated|0|||
131633331|NCT00296504|473941698|FG004|Interim Analysis|Participant Was Incarcerated|0|||
131633332|NCT00296504|473941699|FG005|Interim Analysis|Participant Was Incarcerated|0|||
131633333|NCT00296504|473941700|FG006|Interim Analysis|Participant Was Incarcerated|0|||
131633334|NCT00296504|473941701|FG007|Interim Analysis|Participant Was Incarcerated|0|||
131633335|NCT00296504|473941702|FG008|Interim Analysis|Participant Was Incarcerated|0|||
131633336|NCT00296504|473941694|FG000|Interim Analysis|Resistance to FPV|0|||
131633337|NCT00296504|473941695|FG001|Interim Analysis|Resistance to FPV|0|||
131633338|NCT00296504|473941696|FG002|Interim Analysis|Resistance to FPV|1|||
131633339|NCT00296504|473941697|FG003|Interim Analysis|Resistance to FPV|0|||
131633340|NCT00296504|473941698|FG004|Interim Analysis|Resistance to FPV|0|||
131633341|NCT00296504|473941699|FG005|Interim Analysis|Resistance to FPV|0|||
131633342|NCT00296504|473941700|FG006|Interim Analysis|Resistance to FPV|0|||
131633343|NCT00296504|473941701|FG007|Interim Analysis|Resistance to FPV|0|||
131902384|NCT01325350|474929238|FG004|Overall Study|Did Not Receive Treatment|1|||
131902385|NCT01053741|474929243|FG000|2nd Study Intervention|Physician Decision|0|||
131902386|NCT01053741|474929244|FG001|2nd Study Intervention|Physician Decision|1|||
131902387|NCT00619827|474929245|FG000|Overall Study|Adverse Event|1|||
131444255|NCT02903771|473257104|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
131633344|NCT00296504|473941702|FG008|Interim Analysis|Resistance to FPV|0|||
131633345|NCT00296504|473941694|FG000|Interim Analysis|Physician Decision|0|||
131902388|NCT00619827|474929246|FG001|Overall Study|Adverse Event|2|||
131902389|NCT00619827|474929245|FG000|Overall Study|Withdrawal by Subject|2|||
131902390|NCT00619827|474929246|FG001|Overall Study|Withdrawal by Subject|2|||
131902391|NCT01063855|474929247|FG000|Overall Study|Adverse Event|4|||
131902392|NCT01063855|474929248|FG001|Overall Study|Adverse Event|4|||
131633346|NCT00296504|473941695|FG001|Interim Analysis|Physician Decision|0|||
131633347|NCT00296504|473941696|FG002|Interim Analysis|Physician Decision|1|||
131633348|NCT00296504|473941697|FG003|Interim Analysis|Physician Decision|0|||
131633349|NCT00296504|473941698|FG004|Interim Analysis|Physician Decision|0|||
131633350|NCT00296504|473941699|FG005|Interim Analysis|Physician Decision|0|||
131633351|NCT00296504|473941700|FG006|Interim Analysis|Physician Decision|0|||
131633352|NCT00296504|473941701|FG007|Interim Analysis|Physician Decision|0|||
131633353|NCT00296504|473941702|FG008|Interim Analysis|Physician Decision|0|||
131633354|NCT00296504|473941694|FG000|Interim Analysis|Principle Investigator Discretion|2|||
131633355|NCT00296504|473941695|FG001|Interim Analysis|Principle Investigator Discretion|0|||
131633356|NCT00296504|473941696|FG002|Interim Analysis|Principle Investigator Discretion|1|||
131633357|NCT00296504|473941697|FG003|Interim Analysis|Principle Investigator Discretion|1|||
131633358|NCT00296504|473941698|FG004|Interim Analysis|Principle Investigator Discretion|0|||
131633359|NCT00296504|473941699|FG005|Interim Analysis|Principle Investigator Discretion|0|||
131633360|NCT00296504|473941700|FG006|Interim Analysis|Principle Investigator Discretion|0|||
131633361|NCT00296504|473941701|FG007|Interim Analysis|Principle Investigator Discretion|0|||
131633362|NCT00296504|473941702|FG008|Interim Analysis|Principle Investigator Discretion|0|||
131633363|NCT00296504|473941694|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
131633364|NCT00296504|473941695|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
131633365|NCT00296504|473941696|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
131633366|NCT00296504|473941697|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
131633367|NCT00296504|473941698|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
131633368|NCT00296504|473941699|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
131633369|NCT00296504|473941700|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
131633370|NCT00296504|473941701|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
131633371|NCT00296504|473941702|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
131633372|NCT00296504|473941694|FG000|Interim Analysis|Non-adherence|2|||
131633373|NCT00296504|473941695|FG001|Interim Analysis|Non-adherence|0|||
131633374|NCT00296504|473941696|FG002|Interim Analysis|Non-adherence|0|||
131633375|NCT00296504|473941697|FG003|Interim Analysis|Non-adherence|0|||
131633376|NCT00296504|473941698|FG004|Interim Analysis|Non-adherence|1|||
131633377|NCT00296504|473941699|FG005|Interim Analysis|Non-adherence|0|||
131633378|NCT00296504|473941700|FG006|Interim Analysis|Non-adherence|0|||
131633379|NCT00296504|473941701|FG007|Interim Analysis|Non-adherence|1|||
131633380|NCT00296504|473941702|FG008|Interim Analysis|Non-adherence|0|||
131633381|NCT00296504|473941694|FG000|Interim Analysis|Site Closing|1|||
131633382|NCT00296504|473941695|FG001|Interim Analysis|Site Closing|0|||
131633383|NCT00296504|473941696|FG002|Interim Analysis|Site Closing|0|||
131633384|NCT00296504|473941697|FG003|Interim Analysis|Site Closing|0|||
131633385|NCT00296504|473941698|FG004|Interim Analysis|Site Closing|0|||
131633386|NCT00296504|473941699|FG005|Interim Analysis|Site Closing|1|||
131633387|NCT00296504|473941700|FG006|Interim Analysis|Site Closing|2|||
131633388|NCT00296504|473941701|FG007|Interim Analysis|Site Closing|0|||
131633389|NCT00296504|473941702|FG008|Interim Analysis|Site Closing|0|||
131633390|NCT00296504|473941694|FG000|Interim Analysis|Lack of Personnel at Site|1|||
131633391|NCT00296504|473941695|FG001|Interim Analysis|Lack of Personnel at Site|0|||
131633392|NCT00296504|473941696|FG002|Interim Analysis|Lack of Personnel at Site|0|||
131633393|NCT00296504|473941697|FG003|Interim Analysis|Lack of Personnel at Site|0|||
131633394|NCT00296504|473941698|FG004|Interim Analysis|Lack of Personnel at Site|0|||
131633395|NCT00296504|473941699|FG005|Interim Analysis|Lack of Personnel at Site|0|||
131633396|NCT00296504|473941700|FG006|Interim Analysis|Lack of Personnel at Site|0|||
131633397|NCT00296504|473941701|FG007|Interim Analysis|Lack of Personnel at Site|0|||
131633398|NCT00296504|473941702|FG008|Interim Analysis|Lack of Personnel at Site|0|||
131633399|NCT00296504|473941694|FG000|Interim Analysis|Missed Schedule Date|1|||
131633400|NCT00296504|473941695|FG001|Interim Analysis|Missed Schedule Date|0|||
131633401|NCT00296504|473941696|FG002|Interim Analysis|Missed Schedule Date|0|||
131633402|NCT00296504|473941697|FG003|Interim Analysis|Missed Schedule Date|0|||
131633403|NCT00296504|473941698|FG004|Interim Analysis|Missed Schedule Date|0|||
131633404|NCT00296504|473941699|FG005|Interim Analysis|Missed Schedule Date|0|||
131633405|NCT00296504|473941700|FG006|Interim Analysis|Missed Schedule Date|0|||
131633406|NCT00296504|473941701|FG007|Interim Analysis|Missed Schedule Date|0|||
131633407|NCT00296504|473941702|FG008|Interim Analysis|Missed Schedule Date|0|||
131633408|NCT00296504|473941694|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
131633409|NCT00296504|473941695|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
131633410|NCT00296504|473941696|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
131633411|NCT00296504|473941697|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
131633412|NCT00296504|473941698|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
131633413|NCT00296504|473941699|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
131902393|NCT01063855|474929247|FG000|Overall Study|Death|0|||
131633414|NCT00296504|473941700|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
131633415|NCT00296504|473941701|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
131633416|NCT00296504|473941702|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
131633417|NCT00296504|473941694|FG000|Interim Analysis|Participant Stopped|0|||
131633418|NCT00296504|473941695|FG001|Interim Analysis|Participant Stopped|0|||
131633419|NCT00296504|473941696|FG002|Interim Analysis|Participant Stopped|0|||
131633420|NCT00296504|473941697|FG003|Interim Analysis|Participant Stopped|0|||
131633421|NCT00296504|473941698|FG004|Interim Analysis|Participant Stopped|1|||
131633422|NCT00296504|473941699|FG005|Interim Analysis|Participant Stopped|0|||
131633423|NCT00296504|473941700|FG006|Interim Analysis|Participant Stopped|0|||
131633424|NCT00296504|473941701|FG007|Interim Analysis|Participant Stopped|0|||
131633425|NCT00296504|473941702|FG008|Interim Analysis|Participant Stopped|0|||
131633426|NCT00296504|473941694|FG000|Interim Analysis|Physician and Participant Decision|0|||
131633427|NCT00296504|473941695|FG001|Interim Analysis|Physician and Participant Decision|0|||
131633428|NCT00296504|473941696|FG002|Interim Analysis|Physician and Participant Decision|0|||
131633429|NCT00296504|473941697|FG003|Interim Analysis|Physician and Participant Decision|0|||
131633430|NCT00296504|473941698|FG004|Interim Analysis|Physician and Participant Decision|0|||
131633431|NCT00296504|473941699|FG005|Interim Analysis|Physician and Participant Decision|1|||
131633432|NCT00296504|473941700|FG006|Interim Analysis|Physician and Participant Decision|0|||
131633433|NCT00296504|473941701|FG007|Interim Analysis|Physician and Participant Decision|0|||
131633434|NCT00296504|473941702|FG008|Interim Analysis|Physician and Participant Decision|0|||
131633435|NCT00296504|473941694|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
131633436|NCT00296504|473941695|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
131798250|NCT01901055|474545914|FG000|Week 24|Physician Decision|1|||
131798251|NCT01901055|474545915|FG001|Week 24|Physician Decision|0|||
131798252|NCT01901055|474545914|FG000|Week 36|Withdrawal by Subject|0|||
131798253|NCT01901055|474545915|FG001|Week 36|Withdrawal by Subject|5|||
131798254|NCT01974895|474545918|FG000|Overall Study|Protocol Violation|1|||
131798255|NCT01974895|474545919|FG001|Overall Study|Protocol Violation|0|||
131798256|NCT01974895|474545918|FG000|Overall Study|Lost to Follow-up|4|||
131798257|NCT01974895|474545919|FG001|Overall Study|Lost to Follow-up|6|||
131798258|NCT01974895|474545918|FG000|Overall Study|Withdrawal by Subject|0|||
131798259|NCT01974895|474545919|FG001|Overall Study|Withdrawal by Subject|1|||
131798260|NCT01974895|474545918|FG000|Overall Study|Other (Missed Visit)|1|||
131798261|NCT01974895|474545919|FG001|Overall Study|Other (Missed Visit)|0|||
131798262|NCT01974895|474545918|FG000|Overall Study|Other (Reason unknown)|9|||
131798263|NCT01974895|474545919|FG001|Overall Study|Other (Reason unknown)|8|||
131798264|NCT00635154|474545920|FG000|Overall Study|Alternative Treatment|8|||
131798265|NCT00635154|474545920|FG000|Overall Study|Other|4|||
131798266|NCT00635154|474545920|FG000|Overall Study|Still on treatment|21|||
131798267|NCT01399736|474545921|FG000|Overall Study|Withdrawal by Subject|4|||
131798268|NCT01399736|474545922|FG001|Overall Study|Withdrawal by Subject|2|||
131798269|NCT01399736|474545921|FG000|Overall Study|Lost to Follow-up|0|||
131798270|NCT01399736|474545922|FG001|Overall Study|Lost to Follow-up|2|||
131798271|NCT03500484|474545923|FG000|Overall Study|Adverse Event|2|||
131902394|NCT01063855|474929248|FG001|Overall Study|Death|1|||
131902395|NCT01063855|474929247|FG000|Overall Study|Lost to Follow-up|8|||
131902396|NCT01063855|474929248|FG001|Overall Study|Lost to Follow-up|4|||
131902397|NCT01063855|474929247|FG000|Overall Study|Pregnancy|1|||
131902398|NCT01063855|474929248|FG001|Overall Study|Pregnancy|0|||
131902399|NCT01063855|474929247|FG000|Overall Study|Lack of Efficacy|0|||
131633437|NCT00296504|473941696|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
131633438|NCT00296504|473941697|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
131633439|NCT00296504|473941698|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
131633440|NCT00296504|473941699|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
131633441|NCT00296504|473941700|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
131633442|NCT00296504|473941701|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
131633443|NCT00296504|473941702|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
131633444|NCT00296504|473941694|FG000|Interim Analysis|Study Ended|0|||
131633445|NCT00296504|473941695|FG001|Interim Analysis|Study Ended|0|||
131633446|NCT00296504|473941696|FG002|Interim Analysis|Study Ended|0|||
131633447|NCT00296504|473941697|FG003|Interim Analysis|Study Ended|0|||
131633448|NCT00296504|473941698|FG004|Interim Analysis|Study Ended|0|||
131633449|NCT00296504|473941699|FG005|Interim Analysis|Study Ended|0|||
131633450|NCT00296504|473941700|FG006|Interim Analysis|Study Ended|1|||
131633451|NCT00296504|473941701|FG007|Interim Analysis|Study Ended|0|||
131633452|NCT00296504|473941702|FG008|Interim Analysis|Study Ended|0|||
131633453|NCT00296504|473941694|FG000|Interim Analysis|Participant Needed Interferon|0|||
131633454|NCT00296504|473941695|FG001|Interim Analysis|Participant Needed Interferon|0|||
131633455|NCT00296504|473941696|FG002|Interim Analysis|Participant Needed Interferon|0|||
131633456|NCT00296504|473941697|FG003|Interim Analysis|Participant Needed Interferon|0|||
131633457|NCT00296504|473941698|FG004|Interim Analysis|Participant Needed Interferon|0|||
131633458|NCT00296504|473941699|FG005|Interim Analysis|Participant Needed Interferon|0|||
131633459|NCT00296504|473941700|FG006|Interim Analysis|Participant Needed Interferon|0|||
131633460|NCT00296504|473941701|FG007|Interim Analysis|Participant Needed Interferon|1|||
131633461|NCT00296504|473941702|FG008|Interim Analysis|Participant Needed Interferon|0|||
131633462|NCT00296504|473941694|FG000|Interim Analysis|Ongoing|32|||
131633463|NCT00296504|473941695|FG001|Interim Analysis|Ongoing|12|||
131633464|NCT00296504|473941696|FG002|Interim Analysis|Ongoing|16|||
131633465|NCT00296504|473941697|FG003|Interim Analysis|Ongoing|22|||
131633466|NCT00296504|473941698|FG004|Interim Analysis|Ongoing|0|||
131633467|NCT00296504|473941699|FG005|Interim Analysis|Ongoing|0|||
131798272|NCT03500484|474545924|FG001|Overall Study|Adverse Event|0|||
131798273|NCT03500484|474545923|FG000|Overall Study|Physician Decision|1|||
131798274|NCT03500484|474545924|FG001|Overall Study|Physician Decision|0|||
131798275|NCT03500484|474545923|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
131798276|NCT03500484|474545924|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
131798277|NCT02795104|474545925|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
131798278|NCT02795104|474545926|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
131798279|NCT02795104|474545927|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
131798280|NCT02795104|474545925|FG000|Overall Study|Withdrawal by Subject|0|||
131798281|NCT02795104|474545926|FG001|Overall Study|Withdrawal by Subject|2|||
131902400|NCT01063855|474929248|FG001|Overall Study|Lack of Efficacy|1|||
131633468|NCT00296504|473941700|FG006|Interim Analysis|Ongoing|30|||
131633469|NCT00296504|473941701|FG007|Interim Analysis|Ongoing|1|||
131633470|NCT00296504|473941702|FG008|Interim Analysis|Ongoing|0|||
131633471|NCT00296504|473941694|FG000|Final Analysis|Withdrawal by Subject|0|||
131633472|NCT00296504|473941695|FG001|Final Analysis|Withdrawal by Subject|0|||
131902401|NCT01063855|474929247|FG000|Overall Study|Withdrawal by Subject|11|||
131902402|NCT01063855|474929248|FG001|Overall Study|Withdrawal by Subject|8|||
131633473|NCT00296504|473941696|FG002|Final Analysis|Withdrawal by Subject|0|||
131633474|NCT00296504|473941697|FG003|Final Analysis|Withdrawal by Subject|0|||
131633475|NCT00296504|473941698|FG004|Final Analysis|Withdrawal by Subject|0|||
131633476|NCT00296504|473941699|FG005|Final Analysis|Withdrawal by Subject|0|||
131902403|NCT01063855|474929247|FG000|Overall Study|Reason not specified|13|||
131633477|NCT00296504|473941700|FG006|Final Analysis|Withdrawal by Subject|0|||
131633478|NCT00296504|473941701|FG007|Final Analysis|Withdrawal by Subject|0|||
131633479|NCT00296504|473941702|FG008|Final Analysis|Withdrawal by Subject|1|||
131633480|NCT00296504|473941694|FG000|Final Analysis|Lost to Follow-up|0|||
131633481|NCT00296504|473941695|FG001|Final Analysis|Lost to Follow-up|0|||
131633482|NCT00296504|473941696|FG002|Final Analysis|Lost to Follow-up|0|||
131633483|NCT00296504|473941697|FG003|Final Analysis|Lost to Follow-up|0|||
131444256|NCT02903771|473257105|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
131444257|NCT02903771|473257106|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
131444258|NCT02903771|473257107|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
131444259|NCT02903771|473257108|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
131444260|NCT02903771|473257109|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
131444261|NCT02903771|473257103|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
131444262|NCT02903771|473257104|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
131444263|NCT02903771|473257105|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
131444264|NCT02903771|473257106|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
131444265|NCT02903771|473257107|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
131444266|NCT02903771|473257108|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
131444267|NCT02903771|473257109|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
131444268|NCT02903771|473257103|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
131444269|NCT02903771|473257104|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
131444270|NCT02903771|473257105|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
131444271|NCT02903771|473257106|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
131444272|NCT02903771|473257107|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
131444273|NCT02903771|473257108|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
131444274|NCT02903771|473257109|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
131444275|NCT02903771|473257103|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
131444276|NCT02903771|473257104|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
131444277|NCT02903771|473257105|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
131444278|NCT02903771|473257106|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
131444279|NCT02903771|473257107|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
131444280|NCT02903771|473257108|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
131444281|NCT02903771|473257109|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
131444282|NCT02903771|473257103|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
131444283|NCT02903771|473257104|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
131444284|NCT02903771|473257105|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
131444285|NCT02903771|473257106|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
131444286|NCT02903771|473257107|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
131444287|NCT02903771|473257108|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
131444288|NCT02903771|473257109|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
131444289|NCT02903771|473257103|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
131444290|NCT02903771|473257104|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
131444291|NCT02903771|473257105|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
131444292|NCT02903771|473257106|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
131444293|NCT02903771|473257107|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
131444294|NCT02903771|473257108|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
131444295|NCT02903771|473257109|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
131444296|NCT02903771|473257103|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
131444297|NCT02903771|473257104|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
131444298|NCT02903771|473257105|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
131444299|NCT02903771|473257106|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
131444300|NCT02903771|473257107|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
131798282|NCT02795104|474545927|FG002|Overall Study|Withdrawal by Subject|0|||
131798283|NCT02795104|474545925|FG000|Overall Study|Lost to Follow-up|0|||
131798284|NCT02795104|474545926|FG001|Overall Study|Lost to Follow-up|0|||
131798285|NCT02795104|474545927|FG002|Overall Study|Lost to Follow-up|1|||
131798286|NCT00948675|474545928|FG000|Overall Study|Lost to Follow-up|1|||
131798287|NCT00948675|474545929|FG001|Overall Study|Lost to Follow-up|0|||
131444301|NCT02903771|473257108|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
131444302|NCT02903771|473257109|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
131444303|NCT02903771|473257103|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
131633484|NCT00296504|473941698|FG004|Final Analysis|Lost to Follow-up|0|||
131633485|NCT00296504|473941699|FG005|Final Analysis|Lost to Follow-up|0|||
131633486|NCT00296504|473941700|FG006|Final Analysis|Lost to Follow-up|0|||
131633487|NCT00296504|473941701|FG007|Final Analysis|Lost to Follow-up|0|||
131633488|NCT00296504|473941702|FG008|Final Analysis|Lost to Follow-up|5|||
131633489|NCT00296504|473941694|FG000|Final Analysis|Insufficient Viral Load Response|0|||
131633490|NCT00296504|473941695|FG001|Final Analysis|Insufficient Viral Load Response|0|||
131633491|NCT00296504|473941696|FG002|Final Analysis|Insufficient Viral Load Response|0|||
131633492|NCT00296504|473941697|FG003|Final Analysis|Insufficient Viral Load Response|0|||
131633493|NCT00296504|473941698|FG004|Final Analysis|Insufficient Viral Load Response|0|||
131902404|NCT01063855|474929248|FG001|Overall Study|Reason not specified|11|||
131902405|NCT02498678|474929249|FG000|Overall Study|interference from the surgical team|0|||
131902406|NCT02498678|474929250|FG001|Overall Study|interference from the surgical team|2|||
131902407|NCT01831427|474929253|FG000|Overall Study|Adverse Event|0|||
131902408|NCT01831427|474929254|FG001|Overall Study|Adverse Event|1|||
131902409|NCT01831427|474929255|FG002|Overall Study|Adverse Event|0|||
131902410|NCT01831427|474929256|FG003|Overall Study|Adverse Event|0|||
131902411|NCT01831427|474929257|FG004|Overall Study|Adverse Event|0|||
131902412|NCT01831427|474929258|FG005|Overall Study|Adverse Event|1|||
131902413|NCT01831427|474929259|FG006|Overall Study|Adverse Event|0|||
131902414|NCT01831427|474929260|FG007|Overall Study|Adverse Event|1|||
131902415|NCT01831427|474929261|FG008|Overall Study|Adverse Event|0|||
131902416|NCT01831427|474929262|FG009|Overall Study|Adverse Event|0|||
131902417|NCT01831427|474929263|FG010|Overall Study|Adverse Event|2|||
131902418|NCT01831427|474929253|FG000|Overall Study|Investigator's Discretion|0|||
131902419|NCT01831427|474929254|FG001|Overall Study|Investigator's Discretion|0|||
131902420|NCT01831427|474929255|FG002|Overall Study|Investigator's Discretion|0|||
131902421|NCT01831427|474929256|FG003|Overall Study|Investigator's Discretion|1|||
131902422|NCT01831427|474929257|FG004|Overall Study|Investigator's Discretion|0|||
131902423|NCT01831427|474929258|FG005|Overall Study|Investigator's Discretion|0|||
131902424|NCT01831427|474929259|FG006|Overall Study|Investigator's Discretion|0|||
131902425|NCT01831427|474929260|FG007|Overall Study|Investigator's Discretion|0|||
131902426|NCT01831427|474929261|FG008|Overall Study|Investigator's Discretion|0|||
131902427|NCT01831427|474929262|FG009|Overall Study|Investigator's Discretion|0|||
131902428|NCT01831427|474929263|FG010|Overall Study|Investigator's Discretion|0|||
131902429|NCT01831427|474929253|FG000|Overall Study|Withdrew Consent|0|||
131902430|NCT01831427|474929254|FG001|Overall Study|Withdrew Consent|0|||
131902431|NCT01831427|474929255|FG002|Overall Study|Withdrew Consent|0|||
131902432|NCT01831427|474929256|FG003|Overall Study|Withdrew Consent|0|||
131902433|NCT01831427|474929257|FG004|Overall Study|Withdrew Consent|0|||
131902434|NCT01831427|474929258|FG005|Overall Study|Withdrew Consent|0|||
131902435|NCT01831427|474929259|FG006|Overall Study|Withdrew Consent|2|||
131902436|NCT01831427|474929260|FG007|Overall Study|Withdrew Consent|0|||
131444304|NCT02903771|473257104|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
131633494|NCT00296504|473941699|FG005|Final Analysis|Insufficient Viral Load Response|0|||
131633495|NCT00296504|473941700|FG006|Final Analysis|Insufficient Viral Load Response|0|||
131713549|NCT04889209|474228745|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131902437|NCT01831427|474929261|FG008|Overall Study|Withdrew Consent|0|||
131902438|NCT01831427|474929262|FG009|Overall Study|Withdrew Consent|1|||
131902439|NCT01831427|474929263|FG010|Overall Study|Withdrew Consent|1|||
131902440|NCT00536510|474929264|FG000|Overall Study|Adverse Event|27|||
131902441|NCT00536510|474929265|FG001|Overall Study|Adverse Event|4|||
131633496|NCT00296504|473941701|FG007|Final Analysis|Insufficient Viral Load Response|0|||
131633497|NCT00296504|473941702|FG008|Final Analysis|Insufficient Viral Load Response|6|||
131633498|NCT00296504|473941694|FG000|Final Analysis|Adverse Event|0|||
131633499|NCT00296504|473941695|FG001|Final Analysis|Adverse Event|0|||
131633500|NCT00296504|473941696|FG002|Final Analysis|Adverse Event|0|||
131633501|NCT00296504|473941697|FG003|Final Analysis|Adverse Event|0|||
131633502|NCT00296504|473941698|FG004|Final Analysis|Adverse Event|0|||
131633503|NCT00296504|473941699|FG005|Final Analysis|Adverse Event|0|||
131633504|NCT00296504|473941700|FG006|Final Analysis|Adverse Event|0|||
131633505|NCT00296504|473941701|FG007|Final Analysis|Adverse Event|0|||
131633506|NCT00296504|473941702|FG008|Final Analysis|Adverse Event|2|||
131633507|NCT00296504|473941694|FG000|Final Analysis|Pregnancy|0|||
131633508|NCT00296504|473941695|FG001|Final Analysis|Pregnancy|0|||
131633509|NCT00296504|473941696|FG002|Final Analysis|Pregnancy|0|||
131633510|NCT00296504|473941697|FG003|Final Analysis|Pregnancy|0|||
131633511|NCT00296504|473941698|FG004|Final Analysis|Pregnancy|0|||
131633512|NCT00296504|473941699|FG005|Final Analysis|Pregnancy|0|||
131633513|NCT00296504|473941700|FG006|Final Analysis|Pregnancy|0|||
131633514|NCT00296504|473941701|FG007|Final Analysis|Pregnancy|0|||
131633515|NCT00296504|473941702|FG008|Final Analysis|Pregnancy|4|||
131633516|NCT00296504|473941694|FG000|Final Analysis|Tuberculosis|0|||
131633517|NCT00296504|473941695|FG001|Final Analysis|Tuberculosis|0|||
131633518|NCT00296504|473941696|FG002|Final Analysis|Tuberculosis|0|||
131633519|NCT00296504|473941697|FG003|Final Analysis|Tuberculosis|0|||
131633520|NCT00296504|473941698|FG004|Final Analysis|Tuberculosis|0|||
131633521|NCT00296504|473941699|FG005|Final Analysis|Tuberculosis|0|||
131633522|NCT00296504|473941700|FG006|Final Analysis|Tuberculosis|0|||
131633523|NCT00296504|473941701|FG007|Final Analysis|Tuberculosis|0|||
131633524|NCT00296504|473941702|FG008|Final Analysis|Tuberculosis|1|||
131633525|NCT00296504|473941694|FG000|Final Analysis|Participant Moved to Another Country|0|||
131633526|NCT00296504|473941695|FG001|Final Analysis|Participant Moved to Another Country|0|||
131633527|NCT00296504|473941696|FG002|Final Analysis|Participant Moved to Another Country|0|||
131633528|NCT00296504|473941697|FG003|Final Analysis|Participant Moved to Another Country|0|||
131633529|NCT00296504|473941698|FG004|Final Analysis|Participant Moved to Another Country|0|||
131633530|NCT00296504|473941699|FG005|Final Analysis|Participant Moved to Another Country|0|||
131633531|NCT00296504|473941700|FG006|Final Analysis|Participant Moved to Another Country|0|||
131633532|NCT00296504|473941701|FG007|Final Analysis|Participant Moved to Another Country|0|||
131633533|NCT00296504|473941702|FG008|Final Analysis|Participant Moved to Another Country|1|||
131633534|NCT00296504|473941694|FG000|Final Analysis|Poor Adherence|0|||
131633535|NCT00296504|473941695|FG001|Final Analysis|Poor Adherence|0|||
131633536|NCT00296504|473941696|FG002|Final Analysis|Poor Adherence|0|||
131633537|NCT00296504|473941697|FG003|Final Analysis|Poor Adherence|0|||
131633538|NCT00296504|473941698|FG004|Final Analysis|Poor Adherence|0|||
131633539|NCT00296504|473941699|FG005|Final Analysis|Poor Adherence|0|||
131633540|NCT00296504|473941700|FG006|Final Analysis|Poor Adherence|0|||
131633541|NCT00296504|473941701|FG007|Final Analysis|Poor Adherence|0|||
131633542|NCT00296504|473941702|FG008|Final Analysis|Poor Adherence|1|||
131633543|NCT01190228|473941703|FG000|Overall Study|Protocol Violation|4|||
131633544|NCT01190228|473941704|FG001|Overall Study|Protocol Violation|0|||
131633545|NCT01190228|473941705|FG002|Overall Study|Protocol Violation|0|||
131633546|NCT01190228|473941703|FG000|Overall Study|Withdrawal by Subject|1|||
131633547|NCT01190228|473941704|FG001|Overall Study|Withdrawal by Subject|0|||
131798288|NCT01984242|474545933|FG000|Overall Study|Death|52|||
131798289|NCT01984242|474545934|FG001|Overall Study|Death|50|||
131798290|NCT01984242|474545935|FG002|Overall Study|Death|52|||
131798291|NCT01984242|474545933|FG000|Overall Study|Withdrawal by Subject|5|||
131798292|NCT01984242|474545934|FG001|Overall Study|Withdrawal by Subject|3|||
131798293|NCT01984242|474545935|FG002|Overall Study|Withdrawal by Subject|10|||
131798294|NCT01984242|474545933|FG000|Overall Study|Physician Decision|0|||
131798295|NCT01984242|474545934|FG001|Overall Study|Physician Decision|0|||
131798296|NCT01984242|474545935|FG002|Overall Study|Physician Decision|1|||
131798297|NCT01984242|474545933|FG000|Overall Study|Lost to Follow-up|4|||
131633548|NCT01190228|473941705|FG002|Overall Study|Withdrawal by Subject|0|||
131633549|NCT02038803|473941711|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
131633550|NCT02038803|473941711|FG000|Overall Study|Lost to Follow-up|1|||
131633551|NCT04372186|473941712|FG000|Overall Study|Death|24|||
131633552|NCT04372186|473941713|FG001|Overall Study|Death|11|||
131633553|NCT04372186|473941712|FG000|Overall Study|Transferred to a different facility for care|0|||
131798298|NCT01984242|474545934|FG001|Overall Study|Lost to Follow-up|0|||
131633554|NCT04372186|473941713|FG001|Overall Study|Transferred to a different facility for care|2|||
131633555|NCT03219216|473941714|FG000|Overall Study|Lost to Follow-up|0|||
131633556|NCT03219216|473941715|FG001|Overall Study|Lost to Follow-up|1|||
131633557|NCT05431543|473941716|FG000|Overall Study|Medical History|1|||
131633558|NCT05431543|473941717|FG001|Overall Study|Medical History|0|||
131633559|NCT05431543|473941718|FG002|Overall Study|Medical History|0|||
131633560|NCT02332824|473941719|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
131633561|NCT02332824|473941720|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131798299|NCT01984242|474545935|FG002|Overall Study|Lost to Follow-up|3|||
131633562|NCT02332824|473941721|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
131633563|NCT02332824|473941722|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
131633564|NCT02332824|473941723|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
131633565|NCT02332824|473941724|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
131633566|NCT02332824|473941719|FG000|Overall Study|Voluntary Withdrawal|1|||
131633567|NCT02332824|473941720|FG001|Overall Study|Voluntary Withdrawal|0|||
131633568|NCT02332824|473941721|FG002|Overall Study|Voluntary Withdrawal|0|||
131633569|NCT02332824|473941722|FG003|Overall Study|Voluntary Withdrawal|0|||
131633570|NCT02332824|473941723|FG004|Overall Study|Voluntary Withdrawal|0|||
131633571|NCT02332824|473941724|FG005|Overall Study|Voluntary Withdrawal|0|||
131633572|NCT02332824|473941719|FG000|Overall Study|Inconvenient schedule|1|||
131633573|NCT02332824|473941720|FG001|Overall Study|Inconvenient schedule|1|||
131633574|NCT02332824|473941721|FG002|Overall Study|Inconvenient schedule|0|||
131633575|NCT02332824|473941722|FG003|Overall Study|Inconvenient schedule|0|||
131633576|NCT02332824|473941723|FG004|Overall Study|Inconvenient schedule|0|||
131633577|NCT02332824|473941724|FG005|Overall Study|Inconvenient schedule|0|||
131633578|NCT02332824|473941719|FG000|Overall Study|Transfer|0|||
131633579|NCT02332824|473941720|FG001|Overall Study|Transfer|0|||
131633580|NCT02332824|473941721|FG002|Overall Study|Transfer|1|||
131633581|NCT02332824|473941722|FG003|Overall Study|Transfer|1|||
131633582|NCT02332824|473941723|FG004|Overall Study|Transfer|0|||
131633583|NCT02332824|473941724|FG005|Overall Study|Transfer|0|||
131633584|NCT00440037|473941725|FG000|Overall Study|Withdrawal by Subject|6|||
131633585|NCT00440037|473941725|FG000|Overall Study|Administrative decision|3|||
131633586|NCT00498797|473941726|FG000|Overall Study|Withdrawal by Subject|4|||
131633587|NCT00498797|473941727|FG001|Overall Study|Withdrawal by Subject|2|||
131633588|NCT00498797|473941726|FG000|Overall Study|Adverse Event|12|||
131798300|NCT01984242|474545933|FG000|Overall Study|Sponsor Decision|1|||
131798301|NCT01984242|474545934|FG001|Overall Study|Sponsor Decision|0|||
131798302|NCT01984242|474545935|FG002|Overall Study|Sponsor Decision|0|||
131633589|NCT00498797|473941727|FG001|Overall Study|Adverse Event|5|||
131633590|NCT00498797|473941726|FG000|Overall Study|Condition under investigation worsened|19|||
131633591|NCT00498797|473941727|FG001|Overall Study|Condition under investigation worsened|21|||
131633592|NCT00498797|473941726|FG000|Overall Study|Other|3|||
131633593|NCT00498797|473941727|FG001|Overall Study|Other|1|||
131633594|NCT00914732|473941728|FG000|Overall Study|Lost to Follow-up|6|||
131633595|NCT00914732|473941729|FG001|Overall Study|Lost to Follow-up|7|||
131633596|NCT00914732|473941730|FG002|Overall Study|Lost to Follow-up|9|||
131633597|NCT00914732|473941728|FG000|Overall Study|Withdrawal by Subject|3|||
131633598|NCT00914732|473941729|FG001|Overall Study|Withdrawal by Subject|0|||
131633599|NCT00914732|473941730|FG002|Overall Study|Withdrawal by Subject|2|||
131633600|NCT00914732|473941728|FG000|Overall Study|Adverse Event|1|||
131633601|NCT00914732|473941729|FG001|Overall Study|Adverse Event|0|||
131633602|NCT00914732|473941730|FG002|Overall Study|Adverse Event|0|||
131633603|NCT01855399|473941731|FG000|6 Month|Lost to Follow-up|12|||
131633604|NCT01855399|473941732|FG001|6 Month|Lost to Follow-up|9|||
131633605|NCT01855399|473941731|FG000|6 Month|Withdrawal by Subject|8|||
131633606|NCT01855399|473941732|FG001|6 Month|Withdrawal by Subject|6|||
131633607|NCT01855399|473941731|FG000|12 Month|Lost to Follow-up|7|||
131633608|NCT01855399|473941732|FG001|12 Month|Lost to Follow-up|11|||
131633609|NCT03953079|473941733|FG000|Core Study|Withdrawal by Subject|1|||
131633610|NCT03953079|473941734|FG001|Core Study|Withdrawal by Subject|2|||
131633611|NCT03953079|473941735|FG002|Core Study|Withdrawal by Subject|1|||
131633612|NCT03953079|473941733|FG000|Core Study|COVID-19|0|||
131633613|NCT03953079|473941734|FG001|Core Study|COVID-19|1|||
131633614|NCT03953079|473941735|FG002|Core Study|COVID-19|0|||
131633615|NCT03953079|473941733|FG000|Core Study|Difficulties leaving the house|0|||
131633616|NCT03953079|473941734|FG001|Core Study|Difficulties leaving the house|1|||
131633617|NCT03953079|473941735|FG002|Core Study|Difficulties leaving the house|0|||
131633618|NCT03953079|473941733|FG000|Extension Study|Withdrawal by Subject|1|||
131633619|NCT03953079|473941734|FG001|Extension Study|Withdrawal by Subject|0|||
131633620|NCT03953079|473941735|FG002|Extension Study|Withdrawal by Subject|0|||
131798303|NCT01984242|474545933|FG000|Overall Study|Non-Compliance|1|||
131798304|NCT01984242|474545934|FG001|Overall Study|Non-Compliance|0|||
131798305|NCT01984242|474545935|FG002|Overall Study|Non-Compliance|0|||
131798306|NCT01984242|474545933|FG000|Overall Study|Study terminated by Sponsor|38|||
131633621|NCT03953079|473941733|FG000|Extension Study|Received Rescue Treatment|5|||
131633622|NCT03953079|473941734|FG001|Extension Study|Received Rescue Treatment|6|||
131633623|NCT03953079|473941735|FG002|Extension Study|Received Rescue Treatment|5|||
131633624|NCT04394624|473941736|FG000|Overall Study|Adverse Event|6|||
131633625|NCT04394624|473941737|FG001|Overall Study|Adverse Event|0|||
131633626|NCT04394624|473941736|FG000|Overall Study|Progressive disease|24|||
131633627|NCT04394624|473941737|FG001|Overall Study|Progressive disease|0|||
131633628|NCT04394624|473941736|FG000|Overall Study|Not related to COVID-19|1|||
131633629|NCT04394624|473941737|FG001|Overall Study|Not related to COVID-19|0|||
131633630|NCT00141271|473941743|FG000|Overall Study|Adverse Event|31|||
131633631|NCT00141271|473941744|FG001|Overall Study|Adverse Event|19|||
131798307|NCT01984242|474545934|FG001|Overall Study|Study terminated by Sponsor|50|||
131804519|NCT02914600|474568558|FG002|Overall Study|Adverse Event|25|||
131633632|NCT00141271|473941745|FG002|Overall Study|Adverse Event|17|||
131633633|NCT00141271|473941743|FG000|Overall Study|Laboratory Abnormality|2|||
131633634|NCT00141271|473941744|FG001|Overall Study|Laboratory Abnormality|1|||
131633635|NCT00141271|473941745|FG002|Overall Study|Laboratory Abnormality|1|||
131633636|NCT00141271|473941743|FG000|Overall Study|Lack of Efficacy|7|||
131633637|NCT00141271|473941744|FG001|Overall Study|Lack of Efficacy|7|||
131633638|NCT00141271|473941745|FG002|Overall Study|Lack of Efficacy|3|||
131633639|NCT00141271|473941743|FG000|Overall Study|Lost to Follow-up|15|||
131633640|NCT00141271|473941744|FG001|Overall Study|Lost to Follow-up|15|||
131633641|NCT00141271|473941745|FG002|Overall Study|Lost to Follow-up|21|||
131633642|NCT00141271|473941743|FG000|Overall Study|Withdrawal by Subject|14|||
131633643|NCT00141271|473941744|FG001|Overall Study|Withdrawal by Subject|9|||
131633644|NCT00141271|473941745|FG002|Overall Study|Withdrawal by Subject|10|||
131633645|NCT00141271|473941743|FG000|Overall Study|Other|11|||
131633646|NCT00141271|473941744|FG001|Overall Study|Other|12|||
131633647|NCT00141271|473941745|FG002|Overall Study|Other|5|||
131633648|NCT02442622|473941752|FG000|Overall Study|Withdrawal by Subject|3|||
131633649|NCT02442622|473941753|FG001|Overall Study|Withdrawal by Subject|1|||
131633650|NCT01184859|473943522|FG000|Period 1: Single Dose|Insufficient urine production|0|||
131633651|NCT01184859|473943523|FG001|Period 1: Single Dose|Insufficient urine production|1|||
131633652|NCT01184859|473943524|FG002|Period 1: Single Dose|Insufficient urine production|0|||
131633653|NCT01184859|473943525|FG003|Period 1: Single Dose|Insufficient urine production|0|||
131633654|NCT01184859|473943526|FG004|Period 1: Single Dose|Insufficient urine production|0|||
131633655|NCT01184859|473943522|FG000|Period 1: Single Dose|Protocol Violation|0|||
131633656|NCT01184859|473943523|FG001|Period 1: Single Dose|Protocol Violation|1|||
131633657|NCT01184859|473943524|FG002|Period 1: Single Dose|Protocol Violation|0|||
131633658|NCT01184859|473943525|FG003|Period 1: Single Dose|Protocol Violation|0|||
131633659|NCT01184859|473943526|FG004|Period 1: Single Dose|Protocol Violation|0|||
131633660|NCT01184859|473943522|FG000|Period 1: Single Dose|Adverse Event|0|||
131633661|NCT01184859|473943523|FG001|Period 1: Single Dose|Adverse Event|0|||
131633662|NCT01184859|473943524|FG002|Period 1: Single Dose|Adverse Event|0|||
131633663|NCT01184859|473943525|FG003|Period 1: Single Dose|Adverse Event|0|||
131633664|NCT01184859|473943526|FG004|Period 1: Single Dose|Adverse Event|1|||
131633665|NCT01184859|473943522|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131633666|NCT01184859|473943523|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131633667|NCT01184859|473943524|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131633668|NCT01184859|473943525|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131633669|NCT01184859|473943526|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
131633670|NCT01184859|473943522|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
131633671|NCT01184859|473943523|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131633672|NCT01184859|473943524|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131633673|NCT01184859|473943525|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131633674|NCT01184859|473943526|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131633675|NCT00961298|473943527|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
131633676|NCT00961298|473943527|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
131633677|NCT00961298|473943527|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
131633678|NCT01232569|473943528|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
131633679|NCT01232569|473943529|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131633680|NCT01232569|473943530|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131633681|NCT01232569|473943531|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
131633682|NCT01232569|473943528|FG000|Double-blind Treatment Period|Escape|2|||
131633683|NCT01232569|473943529|FG001|Double-blind Treatment Period|Escape|2|||
131633684|NCT01232569|473943530|FG002|Double-blind Treatment Period|Escape|0|||
131633685|NCT01232569|473943531|FG003|Double-blind Treatment Period|Escape|0|||
131633686|NCT01232569|473943528|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
131633687|NCT01232569|473943529|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131633688|NCT01232569|473943530|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131633689|NCT01232569|473943531|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131633690|NCT01232569|473943528|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
131633691|NCT01232569|473943529|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
131633692|NCT01232569|473943530|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
131633693|NCT01232569|473943531|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
131633694|NCT01232569|473943528|FG000|Double-blind Treatment Period|Physician Decision|1|||
131633695|NCT01232569|473943529|FG001|Double-blind Treatment Period|Physician Decision|0|||
131713550|NCT04889209|474228746|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713551|NCT04889209|474228747|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713552|NCT04889209|474228748|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713553|NCT04889209|474228749|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713554|NCT04889209|474228750|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713555|NCT04889209|474228751|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131713556|NCT04889209|474228752|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
131713557|NCT04889209|474228735|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713558|NCT04889209|474228736|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713559|NCT04889209|474228737|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713560|NCT04889209|474228738|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713561|NCT04889209|474228739|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713562|NCT04889209|474228740|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131798308|NCT01984242|474545935|FG002|Overall Study|Study terminated by Sponsor|34|||
131798309|NCT01984242|474545933|FG000|Overall Study|Disease Progression|0|||
131798310|NCT01984242|474545934|FG001|Overall Study|Disease Progression|0|||
131798311|NCT01984242|474545935|FG002|Overall Study|Disease Progression|1|||
131798312|NCT04543136|474545941|FG000|Overall Study|Withdrawal by Subject|0|||
131798313|NCT04543136|474545942|FG001|Overall Study|Withdrawal by Subject|1|||
131798314|NCT04543136|474545943|FG002|Overall Study|Withdrawal by Subject|0|||
131798315|NCT04543136|474545944|FG003|Overall Study|Withdrawal by Subject|1|||
131798316|NCT04543136|474545945|FG004|Overall Study|Withdrawal by Subject|0|||
131798317|NCT04543136|474545946|FG005|Overall Study|Withdrawal by Subject|0|||
131798318|NCT02192099|474545947|FG000|Overall Study|Adverse Event|1|||
131798319|NCT02192099|474545947|FG000|Overall Study|Lost to Follow-up|2|||
131798320|NCT02192099|474545947|FG000|Overall Study|Physician Decision|1|||
131798321|NCT02192099|474545947|FG000|Overall Study|Pregnancy|1|||
131798322|NCT02192099|474545947|FG000|Overall Study|Protocol Violation|8|||
131798323|NCT02192099|474545947|FG000|Overall Study|Study Terminated by Sponsor|32|||
131798324|NCT02192099|474545947|FG000|Overall Study|Withdrawal by Subject|11|||
131798325|NCT02192099|474545947|FG000|Overall Study|Miscellaneous Reasons|5|||
131798326|NCT00536575|474545950|FG000|Overall Study|Withdrawal by Subject|1|||
131798327|NCT00536575|474545950|FG000|Overall Study|Death|1|||
131798328|NCT00927810|474545954|FG000|Overall Study|Withdrawal by Subject|0|||
131798329|NCT00927810|474545955|FG001|Overall Study|Withdrawal by Subject|3|||
131798330|NCT00927810|474545956|FG002|Overall Study|Withdrawal by Subject|0|||
131798331|NCT00927810|474545957|FG003|Overall Study|Withdrawal by Subject|1|||
131798332|NCT00927810|474545954|FG000|Overall Study|Lost to Follow-up|0|||
131798333|NCT00927810|474545955|FG001|Overall Study|Lost to Follow-up|2|||
131798334|NCT00927810|474545956|FG002|Overall Study|Lost to Follow-up|1|||
131798335|NCT00927810|474545957|FG003|Overall Study|Lost to Follow-up|1|||
131798336|NCT00927810|474545954|FG000|Overall Study|Death|0|||
131798337|NCT00927810|474545955|FG001|Overall Study|Death|2|||
131798338|NCT00927810|474545956|FG002|Overall Study|Death|0|||
131798339|NCT00927810|474545957|FG003|Overall Study|Death|0|||
131798340|NCT00927810|474545954|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131798341|NCT00927810|474545955|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131798342|NCT00927810|474545956|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131798343|NCT00927810|474545957|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131798344|NCT00198029|474545961|FG000|Overall Study|Withdrawal by Subject|4|||
131798345|NCT02001558|474545962|FG000|Overall Study|Lost to Follow-up|8|||
131798346|NCT02001558|474545963|FG001|Overall Study|Lost to Follow-up|14|||
131798347|NCT04128007|474545964|FG000|Overall Study|Withdrawal by Subject|9|||
131798348|NCT04128007|474545965|FG001|Overall Study|Withdrawal by Subject|6|||
131798349|NCT04128007|474545964|FG000|Overall Study|Protocol Violation|1|||
131798350|NCT04128007|474545965|FG001|Overall Study|Protocol Violation|0|||
131798351|NCT04128007|474545964|FG000|Overall Study|Lost to Follow-up|8|||
131798352|NCT04128007|474545965|FG001|Overall Study|Lost to Follow-up|7|||
131798353|NCT04128007|474545964|FG000|Overall Study|Adverse Event|5|||
131798354|NCT04128007|474545965|FG001|Overall Study|Adverse Event|2|||
131798355|NCT04128007|474545964|FG000|Overall Study|Not reported|0|||
131798356|NCT04128007|474545965|FG001|Overall Study|Not reported|2|||
131798357|NCT04117607|474545966|FG000|Overall Study|Early Termination|0|||
131798358|NCT04117607|474545967|FG001|Overall Study|Early Termination|1|||
131798359|NCT04117607|474545968|FG002|Overall Study|Early Termination|0|||
131713563|NCT04889209|474228741|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131798360|NCT04117607|474545969|FG003|Overall Study|Early Termination|0|||
131798361|NCT04117607|474545970|FG004|Overall Study|Early Termination|0|||
131798362|NCT04117607|474545971|FG005|Overall Study|Early Termination|0|||
131798363|NCT04117607|474545972|FG006|Overall Study|Early Termination|1|||
131798364|NCT04117607|474545973|FG007|Overall Study|Early Termination|0|||
131798365|NCT04117607|474545974|FG008|Overall Study|Early Termination|0|||
131798366|NCT04117607|474545975|FG009|Overall Study|Early Termination|0|||
131798367|NCT04117607|474545976|FG010|Overall Study|Early Termination|0|||
131798368|NCT04117607|474545977|FG011|Overall Study|Early Termination|0|||
131902442|NCT00536510|474929264|FG000|Overall Study|Lost to Follow-up|11|||
131633696|NCT01232569|473943530|FG002|Double-blind Treatment Period|Physician Decision|0|||
131633697|NCT01232569|473943531|FG003|Double-blind Treatment Period|Physician Decision|0|||
131633698|NCT01232569|473943528|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
131633699|NCT01232569|473943529|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
131633700|NCT01232569|473943530|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
131633701|NCT01232569|473943531|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
131633702|NCT01232569|473943528|FG000|Double-blind Treatment Period|Death|2|||
131633703|NCT01232569|473943529|FG001|Double-blind Treatment Period|Death|0|||
131633704|NCT01232569|473943530|FG002|Double-blind Treatment Period|Death|0|||
131633705|NCT01232569|473943531|FG003|Double-blind Treatment Period|Death|0|||
131633706|NCT01503515|473943536|FG000|Overall Study|Adverse Event|4|||
131633707|NCT01503515|473943537|FG001|Overall Study|Adverse Event|5|||
131633708|NCT01503515|473943536|FG000|Overall Study|Death|0|||
131633709|NCT01503515|473943537|FG001|Overall Study|Death|1|||
131633710|NCT01503515|473943536|FG000|Overall Study|Physician Decision|14|||
131633711|NCT01503515|473943537|FG001|Overall Study|Physician Decision|23|||
131633712|NCT01503515|473943536|FG000|Overall Study|Withdrawal by Subject|0|||
131633713|NCT01503515|473943537|FG001|Overall Study|Withdrawal by Subject|1|||
131633714|NCT01503515|473943536|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
131633715|NCT01503515|473943537|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
131633716|NCT01503515|473943536|FG000|Overall Study|Ineligible|1|||
131633717|NCT01503515|473943537|FG001|Overall Study|Ineligible|1|||
131633718|NCT03087851|473943539|FG000|Overall Study|Withdraw on medical grounds|0|||
131633719|NCT03087851|473943540|FG001|Overall Study|Withdraw on medical grounds|1|||
131633720|NCT03087851|473943541|FG002|Overall Study|Withdraw on medical grounds|2|||
131633721|NCT02123797|473943544|FG000|Baseline Intervention|Death|9|||
131633722|NCT02123797|473943545|FG001|Baseline Intervention|Death|16|||
131633723|NCT02123797|473943546|FG002|Baseline Intervention|Death|0|||
131633724|NCT02123797|473943547|FG003|Baseline Intervention|Death|0|||
131633725|NCT02123797|473943548|FG004|Baseline Intervention|Death|0|||
131633726|NCT02123797|473943544|FG000|Baseline Intervention|Withdrawal by Subject|2|||
131633727|NCT02123797|473943545|FG001|Baseline Intervention|Withdrawal by Subject|8|||
131633728|NCT02123797|473943546|FG002|Baseline Intervention|Withdrawal by Subject|0|||
131633729|NCT02123797|473943547|FG003|Baseline Intervention|Withdrawal by Subject|0|||
131633730|NCT02123797|473943548|FG004|Baseline Intervention|Withdrawal by Subject|0|||
131633731|NCT02123797|473943544|FG000|Baseline Intervention|Relocation|2|||
131633732|NCT02123797|473943545|FG001|Baseline Intervention|Relocation|0|||
131633733|NCT02123797|473943546|FG002|Baseline Intervention|Relocation|0|||
131633734|NCT02123797|473943547|FG003|Baseline Intervention|Relocation|0|||
131633735|NCT02123797|473943548|FG004|Baseline Intervention|Relocation|0|||
131798369|NCT04117607|474545978|FG012|Overall Study|Early Termination|0|||
131798370|NCT04117607|474545979|FG013|Overall Study|Early Termination|0|||
131798371|NCT01626079|474545983|FG000|Overall Study|Death|167|||
131798372|NCT01626079|474545984|FG001|Overall Study|Death|192|||
131798373|NCT01626079|474545985|FG002|Overall Study|Death|39|||
131798374|NCT01626079|474545983|FG000|Overall Study|Withdrawal by Subject|23|||
131798375|NCT01626079|474545984|FG001|Overall Study|Withdrawal by Subject|37|||
131633736|NCT02123797|473943544|FG000|Baseline Intervention|Out of window for initial survey|6|||
131633737|NCT02123797|473943545|FG001|Baseline Intervention|Out of window for initial survey|13|||
131633738|NCT02123797|473943546|FG002|Baseline Intervention|Out of window for initial survey|0|||
131633739|NCT02123797|473943547|FG003|Baseline Intervention|Out of window for initial survey|0|||
131633740|NCT02123797|473943548|FG004|Baseline Intervention|Out of window for initial survey|0|||
131633741|NCT02123797|473943544|FG000|Baseline Intervention|Lost to Follow-up|0|||
131633742|NCT02123797|473943545|FG001|Baseline Intervention|Lost to Follow-up|5|||
131633743|NCT02123797|473943546|FG002|Baseline Intervention|Lost to Follow-up|0|||
131633744|NCT02123797|473943547|FG003|Baseline Intervention|Lost to Follow-up|0|||
131633745|NCT02123797|473943548|FG004|Baseline Intervention|Lost to Follow-up|0|||
131633746|NCT02123797|473943544|FG000|Baseline Intervention|Other Disease|3|||
131633747|NCT02123797|473943545|FG001|Baseline Intervention|Other Disease|0|||
131633748|NCT02123797|473943546|FG002|Baseline Intervention|Other Disease|0|||
131633749|NCT02123797|473943547|FG003|Baseline Intervention|Other Disease|0|||
131633750|NCT02123797|473943548|FG004|Baseline Intervention|Other Disease|0|||
131633751|NCT02123797|473943544|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
131633752|NCT02123797|473943545|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
131633753|NCT02123797|473943546|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
131633754|NCT02123797|473943547|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
131444305|NCT02903771|473257105|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
131444306|NCT02903771|473257106|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
131444307|NCT02903771|473257107|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
131444308|NCT02903771|473257108|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
131444309|NCT02903771|473257109|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
131444310|NCT02903771|473257103|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
131444311|NCT02903771|473257104|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
131444312|NCT02903771|473257105|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
131444313|NCT02903771|473257106|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
131444314|NCT02903771|473257107|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
131444315|NCT02903771|473257108|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
131444316|NCT02903771|473257109|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
131444317|NCT03041038|473257133|FG000|Overall Study|Withdrawal by Subject|4|||
131444318|NCT03041038|473257134|FG001|Overall Study|Withdrawal by Subject|0|||
131444319|NCT03041038|473257133|FG000|Overall Study|Lost to Follow-up|1|||
131444320|NCT03041038|473257134|FG001|Overall Study|Lost to Follow-up|1|||
131444321|NCT03041038|473257133|FG000|Overall Study|Protocol Violation|1|||
131444322|NCT03041038|473257134|FG001|Overall Study|Protocol Violation|1|||
131444323|NCT03331315|473257135|FG000|Overall Study|Physician Decision|18|||
131444324|NCT03331315|473257136|FG001|Overall Study|Physician Decision|14|||
131444325|NCT01709721|473257137|FG000|Open Label Phase|Withdrawal by Subject|0|||
131444326|NCT01709721|473257138|FG001|Open Label Phase|Withdrawal by Subject|0|||
131444327|NCT01709721|473257139|FG002|Open Label Phase|Withdrawal by Subject|5|||
131444328|NCT01709721|473257137|FG000|Open Label Phase|Adverse Event|0|||
131444329|NCT01709721|473257138|FG001|Open Label Phase|Adverse Event|0|||
131444330|NCT01709721|473257139|FG002|Open Label Phase|Adverse Event|8|||
131444331|NCT01709721|473257137|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
131444332|NCT01709721|473257138|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
131444333|NCT01709721|473257139|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
131444334|NCT01709721|473257137|FG000|Open Label Phase|Investigator Decision|0|||
131444335|NCT01709721|473257138|FG001|Open Label Phase|Investigator Decision|0|||
131444336|NCT01709721|473257139|FG002|Open Label Phase|Investigator Decision|1|||
131444337|NCT01709721|473257137|FG000|Open Label Phase|Sponsor Decision|0|||
131444338|NCT01709721|473257138|FG001|Open Label Phase|Sponsor Decision|0|||
131444339|NCT01709721|473257139|FG002|Open Label Phase|Sponsor Decision|2|||
131444340|NCT01709721|473257137|FG000|Open Label Phase|Protocol Violation|0|||
131444341|NCT01709721|473257138|FG001|Open Label Phase|Protocol Violation|0|||
131444342|NCT01709721|473257139|FG002|Open Label Phase|Protocol Violation|1|||
131444343|NCT01709721|473257137|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
131444344|NCT01709721|473257138|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
131444345|NCT01709721|473257139|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
131444346|NCT01709721|473257137|FG000|Open Label Phase|Inadequate Pain Control|0|||
131444347|NCT01709721|473257138|FG001|Open Label Phase|Inadequate Pain Control|0|||
131444348|NCT01709721|473257139|FG002|Open Label Phase|Inadequate Pain Control|37|||
131444349|NCT01709721|473257137|FG000|Open Label Phase|Other, Specify in text field in database|0|||
131444350|NCT01709721|473257138|FG001|Open Label Phase|Other, Specify in text field in database|0|||
131444351|NCT01709721|473257139|FG002|Open Label Phase|Other, Specify in text field in database|14|||
131902443|NCT00536510|474929265|FG001|Overall Study|Lost to Follow-up|8|||
131902444|NCT00536510|474929264|FG000|Overall Study|Protocol Violation|4|||
131444352|NCT01709721|473257137|FG000|Randomized Phase|Adverse Event|0|||
131713564|NCT04889209|474228742|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713565|NCT04889209|474228743|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713566|NCT04889209|474228744|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713567|NCT04889209|474228745|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713568|NCT04889209|474228746|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713569|NCT04889209|474228747|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713570|NCT04889209|474228748|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713571|NCT04889209|474228749|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713572|NCT04889209|474228750|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713573|NCT04889209|474228751|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131713574|NCT04889209|474228752|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
131713575|NCT04889209|474228735|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713576|NCT04889209|474228736|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713577|NCT04889209|474228737|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713578|NCT04889209|474228738|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131902445|NCT00536510|474929265|FG001|Overall Study|Protocol Violation|5|||
131902446|NCT00536510|474929264|FG000|Overall Study|Withdrawal by Subject|16|||
131444353|NCT01709721|473257138|FG001|Randomized Phase|Adverse Event|1|||
131444354|NCT01709721|473257139|FG002|Randomized Phase|Adverse Event|0|||
131713579|NCT04889209|474228739|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713580|NCT04889209|474228740|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713581|NCT04889209|474228741|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713582|NCT04889209|474228742|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713583|NCT04889209|474228743|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713584|NCT04889209|474228744|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713585|NCT04889209|474228745|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713586|NCT04889209|474228746|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713587|NCT04889209|474228747|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713588|NCT04889209|474228748|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713589|NCT04889209|474228749|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
131713590|NCT04889209|474228750|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713591|NCT04889209|474228751|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713592|NCT04889209|474228752|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131713593|NCT01725165|474228755|FG000|Overall Study|Death|11|||
131444355|NCT01709721|473257137|FG000|Randomized Phase|Lost to Follow-up|1|||
131444356|NCT01709721|473257138|FG001|Randomized Phase|Lost to Follow-up|0|||
131444357|NCT01709721|473257139|FG002|Randomized Phase|Lost to Follow-up|0|||
131444358|NCT01709721|473257137|FG000|Randomized Phase|Inadequate Pain Control|1|||
131444359|NCT01709721|473257138|FG001|Randomized Phase|Inadequate Pain Control|2|||
131444360|NCT01709721|473257139|FG002|Randomized Phase|Inadequate Pain Control|0|||
131444361|NCT01709721|473257137|FG000|Randomized Phase|Other, Specify text field in database|1|||
131444362|NCT01709721|473257138|FG001|Randomized Phase|Other, Specify text field in database|3|||
131444363|NCT01709721|473257139|FG002|Randomized Phase|Other, Specify text field in database|0|||
131444364|NCT00360230|473257142|FG000|Overall Study|Withdrawal by Subject|1|||
131444365|NCT00360230|473257143|FG001|Overall Study|Withdrawal by Subject|1|||
131444366|NCT00360230|473257144|FG002|Overall Study|Withdrawal by Subject|0|||
131444367|NCT00360230|473257145|FG003|Overall Study|Withdrawal by Subject|1|||
131444368|NCT00360230|473257146|FG004|Overall Study|Withdrawal by Subject|1|||
131444369|NCT00360230|473257147|FG005|Overall Study|Withdrawal by Subject|1|||
131444370|NCT00360230|473257148|FG006|Overall Study|Withdrawal by Subject|0|||
131444371|NCT00360230|473257142|FG000|Overall Study|Migrated|4|||
131444372|NCT00360230|473257143|FG001|Overall Study|Migrated|1|||
131444373|NCT00360230|473257144|FG002|Overall Study|Migrated|3|||
131444374|NCT00360230|473257145|FG003|Overall Study|Migrated|1|||
131444375|NCT00360230|473257146|FG004|Overall Study|Migrated|4|||
131444376|NCT00360230|473257147|FG005|Overall Study|Migrated|1|||
131444377|NCT00360230|473257148|FG006|Overall Study|Migrated|1|||
131444378|NCT00360230|473257142|FG000|Overall Study|Other|1|||
131444379|NCT00360230|473257143|FG001|Overall Study|Other|0|||
131444380|NCT00360230|473257144|FG002|Overall Study|Other|0|||
131444381|NCT00360230|473257145|FG003|Overall Study|Other|0|||
131444382|NCT00360230|473257146|FG004|Overall Study|Other|0|||
131444383|NCT00360230|473257147|FG005|Overall Study|Other|0|||
131444384|NCT00360230|473257148|FG006|Overall Study|Other|0|||
131444385|NCT00360230|473257142|FG000|Overall Study|Protocol Violation|0|||
131444386|NCT00360230|473257143|FG001|Overall Study|Protocol Violation|0|||
131444387|NCT00360230|473257144|FG002|Overall Study|Protocol Violation|0|||
131444388|NCT00360230|473257145|FG003|Overall Study|Protocol Violation|0|||
131444389|NCT00360230|473257146|FG004|Overall Study|Protocol Violation|0|||
131444390|NCT00360230|473257147|FG005|Overall Study|Protocol Violation|1|||
131444391|NCT00360230|473257148|FG006|Overall Study|Protocol Violation|0|||
131444392|NCT00360230|473257142|FG000|Overall Study|Death|0|||
131444393|NCT00360230|473257143|FG001|Overall Study|Death|1|||
131444394|NCT00360230|473257144|FG002|Overall Study|Death|0|||
131444395|NCT00360230|473257145|FG003|Overall Study|Death|0|||
131444396|NCT00360230|473257146|FG004|Overall Study|Death|0|||
131444397|NCT00360230|473257147|FG005|Overall Study|Death|1|||
131444398|NCT00360230|473257148|FG006|Overall Study|Death|1|||
131444399|NCT00581308|473257149|FG000|Pre Discharge|Lost to Follow-up|1|||
131444400|NCT00581308|473257149|FG000|Pre Discharge|Device Removed|1|||
131444401|NCT00581308|473257149|FG000|Month 1|Lost to Follow-up|3|||
131444402|NCT00581308|473257149|FG000|Month 1|Withdrawal by Subject|2|||
131444403|NCT00581308|473257149|FG000|Month 1|Device Removed|2|||
131444404|NCT00581308|473257149|FG000|Month 1|Uknown|1|||
131444405|NCT00581308|473257149|FG000|Month 6|Lost to Follow-up|1|||
131444406|NCT00581308|473257149|FG000|Month 6|Withdrawal by Subject|2|||
131444407|NCT00581308|473257149|FG000|Month 12|Death|1|||
131444408|NCT00581308|473257149|FG000|Month 12|Lost to Follow-up|14|||
131444409|NCT00581308|473257149|FG000|Month 12|Withdrawal by Subject|3|||
131444410|NCT00581308|473257149|FG000|Month 12|Device Removed|1|||
131444411|NCT00581308|473257149|FG000|Month 12|Other|1|||
131444412|NCT04558125|473257150|FG000|Overall Study|Death|1|||
131444413|NCT03219723|473257151|FG000|Overall Study|Case Report Forms Uncollected|6|||
131444414|NCT03219723|473257151|FG000|Overall Study|Protocol Deviation|4|||
131444415|NCT00459316|473257156|FG000|Steps 1 & 2|Other eligibility failure|1|||
131444416|NCT00459316|473257157|FG001|Steps 1 & 2|Other eligibility failure|1|||
131444417|NCT00459316|473257158|FG002|Steps 1 & 2|Other eligibility failure|0|||
131444418|NCT00459316|473257156|FG000|Steps 1 & 2|Death|1|||
131444419|NCT00459316|473257157|FG001|Steps 1 & 2|Death|1|||
131444420|NCT00459316|473257158|FG002|Steps 1 & 2|Death|0|||
131444421|NCT00459316|473257156|FG000|Steps 1 & 2|Not able to get to clinic|7|||
131444422|NCT00459316|473257157|FG001|Steps 1 & 2|Not able to get to clinic|4|||
131444423|NCT00459316|473257158|FG002|Steps 1 & 2|Not able to get to clinic|0|||
131444424|NCT00459316|473257156|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
131444425|NCT00459316|473257157|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
131444426|NCT00459316|473257158|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
131444427|NCT00459316|473257156|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
131444428|NCT00459316|473257157|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
131444429|NCT00459316|473257158|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
131444430|NCT00459316|473257156|FG000|Steps 1 & 2|Lost to Follow-up|5|||
131444431|NCT00459316|473257157|FG001|Steps 1 & 2|Lost to Follow-up|0|||
131444432|NCT00459316|473257158|FG002|Steps 1 & 2|Lost to Follow-up|2|||
131444433|NCT00459316|473257156|FG000|Step 3|Withdrawal by Subject|3|||
131633755|NCT02123797|473943548|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
131444434|NCT00459316|473257157|FG001|Step 3|Withdrawal by Subject|0|||
131444435|NCT00459316|473257158|FG002|Step 3|Withdrawal by Subject|1|||
131444436|NCT01614886|473257159|FG000|Overall Study|Adverse Event|15|||
131444437|NCT01614886|473257160|FG001|Overall Study|Adverse Event|20|||
131444438|NCT01614886|473257159|FG000|Overall Study|Withdrawal by Subject|4|||
131444439|NCT01614886|473257160|FG001|Overall Study|Withdrawal by Subject|4|||
131444440|NCT01614886|473257159|FG000|Overall Study|Death|1|||
131444441|NCT01614886|473257160|FG001|Overall Study|Death|0|||
131444442|NCT01614886|473257159|FG000|Overall Study|Protocol deviation|0|||
131444443|NCT01614886|473257160|FG001|Overall Study|Protocol deviation|2|||
131444444|NCT01527370|473257162|FG000|Overall Study|Withdrawal by Subject|4|||
131444445|NCT01527370|473257162|FG000|Overall Study|Physician Decision|1|||
131444446|NCT01527370|473257162|FG000|Overall Study|Death|1|||
131444447|NCT02057250|473257165|FG000|AID Assessment Phase|Adverse Event|3|||
131444448|NCT02057250|473257166|FG001|AID Assessment Phase|Adverse Event|2|||
131633756|NCT02123797|473943544|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
131633757|NCT02123797|473943545|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
131633758|NCT02123797|473943546|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
131633759|NCT02123797|473943547|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
131633760|NCT02123797|473943548|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
131633761|NCT02123797|473943544|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
131633762|NCT02123797|473943545|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
131633763|NCT02123797|473943546|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131633764|NCT02123797|473943547|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131633765|NCT02123797|473943548|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131633766|NCT02123797|473943544|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
131902447|NCT00536510|474929265|FG001|Overall Study|Withdrawal by Subject|9|||
131444449|NCT02057250|473257167|FG002|AID Assessment Phase|Adverse Event|6|||
131444450|NCT02057250|473257168|FG003|AID Assessment Phase|Adverse Event|1|||
131444451|NCT02057250|473257169|FG004|AID Assessment Phase|Adverse Event|0|||
131444452|NCT02057250|473257165|FG000|AID Assessment Phase|Other than specified above|1|||
131444453|NCT02057250|473257166|FG001|AID Assessment Phase|Other than specified above|1|||
131444454|NCT02057250|473257167|FG002|AID Assessment Phase|Other than specified above|1|||
131444455|NCT02057250|473257168|FG003|AID Assessment Phase|Other than specified above|1|||
131444456|NCT02057250|473257169|FG004|AID Assessment Phase|Other than specified above|0|||
131444457|NCT02057250|473257165|FG000|Extension Phase|Adverse Event|0|||
131444458|NCT02057250|473257166|FG001|Extension Phase|Adverse Event|0|||
131444459|NCT02057250|473257167|FG002|Extension Phase|Adverse Event|0|||
131444460|NCT02057250|473257168|FG003|Extension Phase|Adverse Event|0|||
131444461|NCT02057250|473257169|FG004|Extension Phase|Adverse Event|15|||
131444462|NCT02057250|473257165|FG000|Extension Phase|Lack of Efficacy|0|||
131444463|NCT02057250|473257166|FG001|Extension Phase|Lack of Efficacy|0|||
131444464|NCT02057250|473257167|FG002|Extension Phase|Lack of Efficacy|0|||
131444465|NCT02057250|473257168|FG003|Extension Phase|Lack of Efficacy|0|||
131444466|NCT02057250|473257169|FG004|Extension Phase|Lack of Efficacy|10|||
131444467|NCT02057250|473257165|FG000|Extension Phase|Entered in this period but not treated|0|||
131444468|NCT02057250|473257166|FG001|Extension Phase|Entered in this period but not treated|0|||
131444469|NCT02057250|473257167|FG002|Extension Phase|Entered in this period but not treated|0|||
131444470|NCT02057250|473257168|FG003|Extension Phase|Entered in this period but not treated|0|||
131444471|NCT02057250|473257169|FG004|Extension Phase|Entered in this period but not treated|4|||
131444472|NCT02057250|473257165|FG000|Extension Phase|Other than specified above|0|||
131444473|NCT02057250|473257166|FG001|Extension Phase|Other than specified above|0|||
131444474|NCT02057250|473257167|FG002|Extension Phase|Other than specified above|0|||
131444475|NCT02057250|473257168|FG003|Extension Phase|Other than specified above|0|||
131444476|NCT02057250|473257169|FG004|Extension Phase|Other than specified above|7|||
131444477|NCT01435382|473257171|FG000|Overall Study|Lost to Follow-up|1|||
131444478|NCT01435382|473257172|FG001|Overall Study|Lost to Follow-up|0|||
131713594|NCT01725165|474228756|FG001|Overall Study|Death|18|||
131713595|NCT03049449|474228757|FG000|Overall Study|Did not receive treatment.|0|||
131713596|NCT03049449|474228758|FG001|Overall Study|Did not receive treatment.|0|||
131713597|NCT03049449|474228759|FG002|Overall Study|Did not receive treatment.|0|||
131713598|NCT03049449|474228760|FG003|Overall Study|Did not receive treatment.|0|||
131713599|NCT03049449|474228761|FG004|Overall Study|Did not receive treatment.|0|||
131713600|NCT03049449|474228762|FG005|Overall Study|Did not receive treatment.|0|||
131713601|NCT03049449|474228763|FG006|Overall Study|Did not receive treatment.|0|||
131713602|NCT03049449|474228764|FG007|Overall Study|Did not receive treatment.|0|||
131713603|NCT03049449|474228765|FG008|Overall Study|Did not receive treatment.|1|||
131713604|NCT03049449|474228766|FG009|Overall Study|Did not receive treatment.|0|||
131713605|NCT03049449|474228757|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
131713606|NCT03049449|474228758|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
131713607|NCT03049449|474228759|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
131713608|NCT03049449|474228760|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
131713609|NCT03049449|474228761|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
131713610|NCT03049449|474228762|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
131713611|NCT03049449|474228763|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
131713612|NCT03049449|474228764|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
131713613|NCT03049449|474228765|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
131713614|NCT03049449|474228766|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
131713615|NCT03049449|474228757|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713616|NCT03049449|474228758|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713617|NCT03049449|474228759|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713618|NCT03049449|474228760|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713619|NCT03049449|474228761|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713620|NCT03049449|474228762|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713621|NCT03049449|474228763|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713622|NCT03049449|474228764|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
131713623|NCT03049449|474228765|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131713624|NCT03049449|474228766|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
131713625|NCT00442598|474228767|FG000|Overall Study|Adverse Event|1|||
131713626|NCT00442598|474228768|FG001|Overall Study|Adverse Event|0|||
131713627|NCT00442598|474228769|FG002|Overall Study|Adverse Event|0|||
131713628|NCT00442598|474228767|FG000|Overall Study|Tumor progression|3|||
131713629|NCT00442598|474228768|FG001|Overall Study|Tumor progression|4|||
131713630|NCT00442598|474228769|FG002|Overall Study|Tumor progression|0|||
131713631|NCT00442598|474228767|FG000|Overall Study|Clinical deterioration|1|||
131713632|NCT00442598|474228768|FG001|Overall Study|Clinical deterioration|2|||
131713633|NCT00442598|474228769|FG002|Overall Study|Clinical deterioration|0|||
131713634|NCT00442598|474228767|FG000|Overall Study|CA125 progression|0|||
131713635|NCT00442598|474228768|FG001|Overall Study|CA125 progression|1|||
131713636|NCT00442598|474228769|FG002|Overall Study|CA125 progression|0|||
131713637|NCT00442598|474228767|FG000|Overall Study|Reduced creatinine clearance|1|||
131713638|NCT00442598|474228768|FG001|Overall Study|Reduced creatinine clearance|0|||
131713639|NCT00442598|474228769|FG002|Overall Study|Reduced creatinine clearance|0|||
131713640|NCT00442598|474228767|FG000|Overall Study|Death|0|||
131713641|NCT00442598|474228768|FG001|Overall Study|Death|1|||
131713642|NCT00442598|474228769|FG002|Overall Study|Death|0|||
131713643|NCT01147497|474228770|FG000|Overall Study|failed insertion|2|||
131713644|NCT01147497|474228771|FG001|Overall Study|failed insertion|0|||
131713645|NCT00355264|474228774|FG000|Extension (Variable Duration)|Adverse Event|1|||
131444479|NCT01435382|473257173|FG002|Overall Study|Lost to Follow-up|1|||
131444480|NCT01435382|473257174|FG003|Overall Study|Lost to Follow-up|0|||
131444481|NCT01435382|473257171|FG000|Overall Study|Withdrawal by Subject|0|||
131713646|NCT00355264|474228774|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
131713647|NCT01157117|474228775|FG000|Overall Study|Dosing Symptoms|0|||
131713648|NCT01157117|474228776|FG001|Overall Study|Dosing Symptoms|4|||
131713649|NCT01157117|474228777|FG002|Overall Study|Dosing Symptoms|0|||
131713650|NCT01157117|474228775|FG000|Overall Study|Withdrawal by Subject|4|||
131713651|NCT01157117|474228776|FG001|Overall Study|Withdrawal by Subject|1|||
131713652|NCT01157117|474228777|FG002|Overall Study|Withdrawal by Subject|1|||
131713653|NCT01157117|474228775|FG000|Overall Study|Lack of Efficacy|1|||
131713654|NCT01157117|474228776|FG001|Overall Study|Lack of Efficacy|1|||
131713655|NCT01157117|474228777|FG002|Overall Study|Lack of Efficacy|0|||
131713656|NCT01157117|474228775|FG000|Overall Study|Lost to Follow-up|0|||
131713657|NCT01157117|474228776|FG001|Overall Study|Lost to Follow-up|0|||
131713658|NCT01157117|474228777|FG002|Overall Study|Lost to Follow-up|1|||
131713659|NCT01157117|474228775|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
131713660|NCT01157117|474228776|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
131713661|NCT01157117|474228777|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
131713662|NCT00826514|474228778|FG000|Overall Study|Adverse Event|1|||
131713663|NCT00826514|474228779|FG001|Overall Study|Adverse Event|1|||
131713664|NCT00826514|474228778|FG000|Overall Study|Lack of Efficacy|0|||
131713665|NCT00826514|474228779|FG001|Overall Study|Lack of Efficacy|1|||
131713666|NCT00826514|474228778|FG000|Overall Study|Withdrawal by Subject|2|||
131713667|NCT00826514|474228779|FG001|Overall Study|Withdrawal by Subject|3|||
131713668|NCT03663166|474228780|FG000|Overall Study|Withdrawal by Subject|1|||
131713669|NCT02209506|474228786|FG000|Overall Study|Withdrawal by Subject|0|||
131713670|NCT02209506|474228787|FG001|Overall Study|Withdrawal by Subject|0|||
131713671|NCT02209506|474228788|FG002|Overall Study|Withdrawal by Subject|0|||
131713672|NCT02209506|474228789|FG003|Overall Study|Withdrawal by Subject|0|||
131713673|NCT02209506|474228790|FG004|Overall Study|Withdrawal by Subject|1|||
131633767|NCT02123797|473943545|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
131633768|NCT02123797|473943546|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
131633769|NCT02123797|473943547|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
131633770|NCT02123797|473943548|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
131633771|NCT02123797|473943544|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
131633772|NCT02123797|473943545|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
131633773|NCT02123797|473943546|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
131633774|NCT02123797|473943547|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
131633775|NCT02123797|473943548|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
131633776|NCT02123797|473943544|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
131633777|NCT02123797|473943545|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
131633778|NCT02123797|473943546|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
131633779|NCT02123797|473943547|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
131633780|NCT02123797|473943548|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
131633781|NCT02123797|473943544|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
131633782|NCT02123797|473943545|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
131633783|NCT02123797|473943546|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
131713674|NCT00098787|474228791|FG000|Overall Study|Never started treatment|3|||
131633784|NCT02123797|473943547|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
131633785|NCT02123797|473943548|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
131633786|NCT02123797|473943544|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
131633787|NCT02123797|473943545|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
131633788|NCT02123797|473943546|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131633789|NCT02123797|473943547|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131633790|NCT02123797|473943548|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131633791|NCT02123797|473943544|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
131633792|NCT02123797|473943545|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
131444482|NCT01435382|473257172|FG001|Overall Study|Withdrawal by Subject|2|||
131444483|NCT01435382|473257173|FG002|Overall Study|Withdrawal by Subject|0|||
131444484|NCT01435382|473257174|FG003|Overall Study|Withdrawal by Subject|1|||
131444485|NCT00910650|473257175|FG000|Overall Study|Death|2|||
131444486|NCT02435992|473257176|FG000|Overall Study|non compliance with protocol|2|||
131444487|NCT02435992|473257177|FG001|Overall Study|non compliance with protocol|0|||
131444488|NCT02435992|473257178|FG002|Overall Study|non compliance with protocol|1|||
131444489|NCT02435992|473257179|FG003|Overall Study|non compliance with protocol|0|||
131444490|NCT02435992|473257180|FG004|Overall Study|non compliance with protocol|0|||
131444491|NCT02435992|473257176|FG000|Overall Study|Adverse Event|11|||
131444492|NCT02435992|473257177|FG001|Overall Study|Adverse Event|6|||
131444493|NCT02435992|473257178|FG002|Overall Study|Adverse Event|12|||
131633793|NCT02123797|473943546|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
131633794|NCT02123797|473943547|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
131633795|NCT02123797|473943548|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
131633796|NCT00443755|473943549|FG000|Overall Study|Withdrawal by Subject|2|||
131633797|NCT00443755|473943550|FG001|Overall Study|Withdrawal by Subject|1|||
131633798|NCT00678899|473943556|FG000|Overall Study|Adverse Event|1|||
131633799|NCT01116440|473943566|FG000|Treatment|Withdrawal by Subject|2|||
131633800|NCT01116440|473943567|FG001|Treatment|Withdrawal by Subject|2|||
131633801|NCT01116440|473943566|FG000|Treatment|Lost to Follow-up|1|||
131633802|NCT01116440|473943567|FG001|Treatment|Lost to Follow-up|1|||
131633803|NCT01116440|473943566|FG000|Treatment|Protocol Violation|0|||
131633804|NCT01116440|473943567|FG001|Treatment|Protocol Violation|2|||
131633805|NCT01116440|473943566|FG000|Treatment|Lack of Efficacy|0|||
131633806|NCT01116440|473943567|FG001|Treatment|Lack of Efficacy|1|||
131633807|NCT01116440|473943566|FG000|Treatment|Adverse Event|0|||
131633808|NCT01116440|473943567|FG001|Treatment|Adverse Event|1|||
131633809|NCT01116440|473943566|FG000|Withdrawal|Withdrawal by Subject|0|||
131633810|NCT01116440|473943567|FG001|Withdrawal|Withdrawal by Subject|1|||
131633811|NCT01116440|473943566|FG000|Withdrawal|Lost to Follow-up|0|||
131633812|NCT01116440|473943567|FG001|Withdrawal|Lost to Follow-up|1|||
131633813|NCT01116440|473943566|FG000|Follow-up|Lost to Follow-up|0|||
131633814|NCT01116440|473943567|FG001|Follow-up|Lost to Follow-up|1|||
131633815|NCT01116440|473943566|FG000|Follow-up|Withdrawal by Subject|0|||
131633816|NCT01116440|473943567|FG001|Follow-up|Withdrawal by Subject|1|||
131633817|NCT00907517|473943568|FG000|Overall Study|Progressive Disease|3|||
131633818|NCT00907517|473943569|FG001|Overall Study|Progressive Disease|3|||
131633819|NCT00907517|473943570|FG002|Overall Study|Progressive Disease|4|||
131633820|NCT00907517|473943571|FG003|Overall Study|Progressive Disease|4|||
131633821|NCT00907517|473943572|FG004|Overall Study|Progressive Disease|4|||
131633822|NCT00907517|473943568|FG000|Overall Study|Symptomatic Deterioration|0|||
131633823|NCT00907517|473943569|FG001|Overall Study|Symptomatic Deterioration|0|||
131633824|NCT00907517|473943570|FG002|Overall Study|Symptomatic Deterioration|0|||
131633825|NCT00907517|473943571|FG003|Overall Study|Symptomatic Deterioration|0|||
131633826|NCT00907517|473943572|FG004|Overall Study|Symptomatic Deterioration|1|||
131633827|NCT01498445|473943573|FG000|Overall Study|Lack of Efficacy|0|||
131633828|NCT01498445|473943574|FG001|Overall Study|Lack of Efficacy|0|||
131633829|NCT01498445|473943575|FG002|Overall Study|Lack of Efficacy|1|||
131633830|NCT01498445|473943576|FG003|Overall Study|Lack of Efficacy|2|||
131633831|NCT01498445|473943577|FG004|Overall Study|Lack of Efficacy|0|||
131633832|NCT01498445|473943578|FG005|Overall Study|Lack of Efficacy|0|||
131633833|NCT01498445|473943573|FG000|Overall Study|Screen Failure|0|||
131633834|NCT01498445|473943574|FG001|Overall Study|Screen Failure|0|||
131633835|NCT01498445|473943575|FG002|Overall Study|Screen Failure|0|||
131633836|NCT01498445|473943576|FG003|Overall Study|Screen Failure|0|||
131633837|NCT01498445|473943577|FG004|Overall Study|Screen Failure|1|||
131633838|NCT01498445|473943578|FG005|Overall Study|Screen Failure|1|||
131633839|NCT04748445|473943579|FG000|Overall Study|No longer met eligibility criteria|12|||
131713675|NCT00098787|474228792|FG001|Overall Study|Never started treatment|2|||
131633840|NCT04748445|473943579|FG000|Overall Study|Other|36|||
131633841|NCT04748445|473943579|FG000|Overall Study|Withdrawal by Subject|553|||
131713676|NCT00098787|474228793|FG002|Overall Study|Never started treatment|1|||
131444494|NCT02435992|473257179|FG003|Overall Study|Adverse Event|0|||
131633842|NCT04748445|473943579|FG000|Overall Study|Lost to Follow-up|30|||
131713677|NCT00098787|474228791|FG000|Overall Study|Ineligible|9|||
131444495|NCT02435992|473257180|FG004|Overall Study|Adverse Event|0|||
131444496|NCT02435992|473257176|FG000|Overall Study|Lack of Efficacy|4|||
131633843|NCT01106586|473943580|FG000|Overall Study|Adverse Event|9|||
131633844|NCT01106586|473943581|FG001|Overall Study|Adverse Event|15|||
131633845|NCT01106586|473943580|FG000|Overall Study|Death|1|||
131633846|NCT01106586|473943581|FG001|Overall Study|Death|3|||
131633847|NCT01106586|473943580|FG000|Overall Study|Pregnancy|2|||
131633848|NCT01106586|473943581|FG001|Overall Study|Pregnancy|2|||
131633849|NCT01106586|473943580|FG000|Overall Study|Lack of Efficacy|1|||
131633850|NCT01106586|473943581|FG001|Overall Study|Lack of Efficacy|0|||
131633851|NCT01106586|473943580|FG000|Overall Study|Investigator's Discretion|5|||
131633852|NCT01106586|473943581|FG001|Overall Study|Investigator's Discretion|8|||
131633853|NCT01106586|473943580|FG000|Overall Study|Withdrew Consent|18|||
131444497|NCT02435992|473257177|FG001|Overall Study|Lack of Efficacy|10|||
131444498|NCT02435992|473257178|FG002|Overall Study|Lack of Efficacy|9|||
131444499|NCT02435992|473257179|FG003|Overall Study|Lack of Efficacy|0|||
131444500|NCT02435992|473257180|FG004|Overall Study|Lack of Efficacy|0|||
131444501|NCT02435992|473257176|FG000|Overall Study|Withdrawal by Subject|10|||
131444502|NCT02435992|473257177|FG001|Overall Study|Withdrawal by Subject|8|||
131444503|NCT02435992|473257178|FG002|Overall Study|Withdrawal by Subject|20|||
131444504|NCT02435992|473257179|FG003|Overall Study|Withdrawal by Subject|0|||
131444505|NCT02435992|473257180|FG004|Overall Study|Withdrawal by Subject|0|||
131444506|NCT02435992|473257176|FG000|Overall Study|Other Reason|1|||
131444507|NCT02435992|473257177|FG001|Overall Study|Other Reason|0|||
131444508|NCT02435992|473257178|FG002|Overall Study|Other Reason|0|||
131444509|NCT02435992|473257179|FG003|Overall Study|Other Reason|0|||
131444510|NCT02435992|473257180|FG004|Overall Study|Other Reason|0|||
131444511|NCT02435992|473257176|FG000|Overall Study|Physician Decision|0|||
131444512|NCT02435992|473257177|FG001|Overall Study|Physician Decision|0|||
131444513|NCT02435992|473257178|FG002|Overall Study|Physician Decision|1|||
131444514|NCT02435992|473257179|FG003|Overall Study|Physician Decision|0|||
131444515|NCT02435992|473257180|FG004|Overall Study|Physician Decision|0|||
131444516|NCT00260533|473257181|FG000|Overall Study|Other|3|||
131444517|NCT00260533|473257182|FG001|Overall Study|Other|3|||
131444518|NCT01761877|473257183|FG000|Overall Study|Adverse Event|7|||
131444519|NCT01761877|473257184|FG001|Overall Study|Adverse Event|0|||
131444520|NCT01761877|473257183|FG000|Overall Study|Withdrawal by Subject|6|||
131444521|NCT01761877|473257184|FG001|Overall Study|Withdrawal by Subject|4|||
131444522|NCT01761877|473257183|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
131713678|NCT00098787|474228792|FG001|Overall Study|Ineligible|7|||
131713679|NCT00098787|474228793|FG002|Overall Study|Ineligible|3|||
131713680|NCT00098787|474228791|FG000|Overall Study|Disease progression|28|||
131713681|NCT00098787|474228792|FG001|Overall Study|Disease progression|17|||
131713682|NCT00098787|474228793|FG002|Overall Study|Disease progression|23|||
131713683|NCT00098787|474228791|FG000|Overall Study|Adverse Event|8|||
131713684|NCT00098787|474228792|FG001|Overall Study|Adverse Event|17|||
131713685|NCT00098787|474228793|FG002|Overall Study|Adverse Event|8|||
131713686|NCT00098787|474228791|FG000|Overall Study|Death|6|||
131713687|NCT00098787|474228792|FG001|Overall Study|Death|1|||
131713688|NCT00098787|474228793|FG002|Overall Study|Death|0|||
131713689|NCT00098787|474228791|FG000|Overall Study|Withdrawal by Subject|4|||
131713690|NCT00098787|474228792|FG001|Overall Study|Withdrawal by Subject|12|||
131713691|NCT00098787|474228793|FG002|Overall Study|Withdrawal by Subject|6|||
131713692|NCT00098787|474228791|FG000|Overall Study|Alternative therapy|8|||
131713693|NCT00098787|474228792|FG001|Overall Study|Alternative therapy|13|||
131713694|NCT00098787|474228793|FG002|Overall Study|Alternative therapy|13|||
131713695|NCT00098787|474228791|FG000|Overall Study|Other|7|||
131713696|NCT00098787|474228792|FG001|Overall Study|Other|6|||
131713697|NCT00098787|474228793|FG002|Overall Study|Other|9|||
131713698|NCT02537678|474228796|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
131713699|NCT02537678|474228797|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
131713700|NCT02537678|474228796|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
131713701|NCT02537678|474228797|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
131713702|NCT02537678|474228796|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
131713703|NCT02537678|474228797|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
131713704|NCT02537678|474228796|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
131713705|NCT02537678|474228797|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
131713706|NCT02537678|474228796|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
131713707|NCT02537678|474228797|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
131713708|NCT02537678|474228796|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
131713709|NCT02537678|474228797|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
131713710|NCT02537678|474228796|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
131713711|NCT02537678|474228797|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
131713712|NCT01360996|474228798|FG000|Overall Study|Withdrawal by Subject|4|||
131713713|NCT01360996|474228799|FG001|Overall Study|Withdrawal by Subject|3|||
131713714|NCT01360996|474228800|FG002|Overall Study|Withdrawal by Subject|2|||
131713715|NCT01360996|474228798|FG000|Overall Study|Noncompliant|2|||
131713716|NCT01360996|474228799|FG001|Overall Study|Noncompliant|0|||
131713717|NCT01360996|474228800|FG002|Overall Study|Noncompliant|0|||
131713718|NCT04348851|474228801|FG000|Post-Test 1|Withdrawal by Subject|0|||
131713719|NCT04348851|474228802|FG001|Post-Test 1|Withdrawal by Subject|1|||
131713720|NCT04348851|474228803|FG002|Post-Test 1|Withdrawal by Subject|0|||
131798376|NCT01626079|474545985|FG002|Overall Study|Withdrawal by Subject|5|||
131633854|NCT01106586|473943581|FG001|Overall Study|Withdrew Consent|30|||
131633855|NCT01106586|473943580|FG000|Overall Study|Lost to Follow-up|24|||
131633856|NCT01106586|473943581|FG001|Overall Study|Lost to Follow-up|20|||
131798377|NCT01626079|474545983|FG000|Overall Study|Lost to Follow-up|7|||
131798378|NCT01626079|474545984|FG001|Overall Study|Lost to Follow-up|4|||
131798379|NCT01626079|474545985|FG002|Overall Study|Lost to Follow-up|2|||
131798380|NCT01626079|474545983|FG000|Overall Study|Missed Visits|1|||
131798381|NCT01626079|474545984|FG001|Overall Study|Missed Visits|4|||
131798382|NCT01626079|474545985|FG002|Overall Study|Missed Visits|6|||
131798383|NCT00814463|474545986|FG000|Overall Study|Lost to Follow-up|1|||
131798384|NCT02430870|474545988|FG000|Part 2|Voluntary Withdrawal|0|||
131798385|NCT02430870|474545989|FG001|Part 2|Voluntary Withdrawal|0|||
131798386|NCT02430870|474545990|FG002|Part 2|Voluntary Withdrawal|0|||
131798387|NCT02430870|474545991|FG003|Part 2|Voluntary Withdrawal|0|||
131798388|NCT02430870|474545992|FG004|Part 2|Voluntary Withdrawal|0|||
131798389|NCT02430870|474545993|FG005|Part 2|Voluntary Withdrawal|0|||
131798390|NCT02430870|474545994|FG006|Part 2|Voluntary Withdrawal|1|||
131798391|NCT02430870|474545995|FG007|Part 2|Voluntary Withdrawal|0|||
131798392|NCT02430870|474545988|FG000|Part 2|Other Reason Not Specified|0|||
131798393|NCT02430870|474545989|FG001|Part 2|Other Reason Not Specified|0|||
131798394|NCT02430870|474545990|FG002|Part 2|Other Reason Not Specified|0|||
131798395|NCT02430870|474545991|FG003|Part 2|Other Reason Not Specified|0|||
131798396|NCT02430870|474545992|FG004|Part 2|Other Reason Not Specified|0|||
131798397|NCT02430870|474545993|FG005|Part 2|Other Reason Not Specified|0|||
131798398|NCT02430870|474545994|FG006|Part 2|Other Reason Not Specified|0|||
131798399|NCT02430870|474545995|FG007|Part 2|Other Reason Not Specified|1|||
131798400|NCT03982433|474545996|FG000|Overall Study|Lost to Follow-up|1|||
131798401|NCT00865709|474545997|FG000|Treatment|Adverse Event|9|||
131798402|NCT00865709|474545998|FG001|Treatment|Adverse Event|6|||
131798403|NCT00865709|474545997|FG000|Treatment|Withdrawal by Subject|10|||
131798404|NCT00865709|474545998|FG001|Treatment|Withdrawal by Subject|7|||
131798405|NCT00865709|474545997|FG000|Treatment|Physician Decision|3|||
131798406|NCT00865709|474545998|FG001|Treatment|Physician Decision|2|||
131798407|NCT00865709|474545997|FG000|Treatment|Surgery|8|||
131798408|NCT00865709|474545998|FG001|Treatment|Surgery|3|||
131798409|NCT00788957|474546005|FG000|Part 1|Death|8|||
131798410|NCT00788957|474546006|FG001|Part 1|Death|0|||
131798411|NCT00788957|474546007|FG002|Part 1|Death|0|||
131798412|NCT00788957|474546008|FG003|Part 1|Death|0|||
131713721|NCT04348851|474228804|FG003|Post-Test 1|Withdrawal by Subject|0|||
131713722|NCT04348851|474228801|FG000|Post-Test 1|Lost to Follow-up|0|||
131713723|NCT04348851|474228802|FG001|Post-Test 1|Lost to Follow-up|1|||
131713724|NCT04348851|474228803|FG002|Post-Test 1|Lost to Follow-up|0|||
131713725|NCT04348851|474228804|FG003|Post-Test 1|Lost to Follow-up|0|||
131713726|NCT04348851|474228801|FG000|Post-Test 2|Stroke survivor death|0|||
131713727|NCT04348851|474228802|FG001|Post-Test 2|Stroke survivor death|1|||
131713728|NCT04348851|474228803|FG002|Post-Test 2|Stroke survivor death|0|||
131713729|NCT04348851|474228804|FG003|Post-Test 2|Stroke survivor death|1|||
131713730|NCT02965378|474228805|FG000|Overall Study|Progression|16|||
131713731|NCT02965378|474228806|FG001|Overall Study|Progression|4|||
131713732|NCT02965378|474228805|FG000|Overall Study|Adverse Event|5|||
131713733|NCT02965378|474228806|FG001|Overall Study|Adverse Event|2|||
131713734|NCT02965378|474228805|FG000|Overall Study|Death|2|||
131713735|NCT02965378|474228806|FG001|Overall Study|Death|0|||
131713736|NCT02965378|474228805|FG000|Overall Study|Refusal|2|||
131713737|NCT02965378|474228806|FG001|Overall Study|Refusal|1|||
131798413|NCT00788957|474546009|FG004|Part 1|Death|0|||
131798414|NCT00788957|474546010|FG005|Part 1|Death|0|||
131798415|NCT00788957|474546005|FG000|Part 1|Lost to Follow-up|1|||
131798416|NCT00788957|474546006|FG001|Part 1|Lost to Follow-up|0|||
131444523|NCT01761877|473257184|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
131444524|NCT01761877|473257183|FG000|Overall Study|Death|0|||
131444525|NCT01761877|473257184|FG001|Overall Study|Death|1|||
131444526|NCT01761877|473257183|FG000|Overall Study|MRI intolerant|1|||
131444527|NCT01761877|473257184|FG001|Overall Study|MRI intolerant|6|||
131444528|NCT01310777|473257186|FG000|Overall Study|Adverse Event|23|||
131444529|NCT01310777|473257187|FG001|Overall Study|Adverse Event|1|||
131444530|NCT01310777|473257188|FG002|Overall Study|Adverse Event|15|||
131444531|NCT01310777|473257186|FG000|Overall Study|Lost to Follow-up|0|||
131444532|NCT01310777|473257187|FG001|Overall Study|Lost to Follow-up|4|||
131444533|NCT01310777|473257188|FG002|Overall Study|Lost to Follow-up|1|||
131444534|NCT01310777|473257186|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
131444535|NCT01310777|473257187|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
131444536|NCT01310777|473257188|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
131444537|NCT01310777|473257186|FG000|Overall Study|Inadequate Control of IOP|5|||
131444538|NCT01310777|473257187|FG001|Overall Study|Inadequate Control of IOP|7|||
131444539|NCT01310777|473257188|FG002|Overall Study|Inadequate Control of IOP|10|||
131444540|NCT01310777|473257186|FG000|Overall Study|Other|4|||
131444541|NCT01310777|473257187|FG001|Overall Study|Other|1|||
131444542|NCT01310777|473257188|FG002|Overall Study|Other|2|||
131444543|NCT03697252|473257189|FG000|Overall Study|Adverse Event|3|||
131444544|NCT03697252|473257190|FG001|Overall Study|Adverse Event|2|||
131444545|NCT03697252|473257189|FG000|Overall Study|Withdrawal by Subject|14|||
131444546|NCT03697252|473257190|FG001|Overall Study|Withdrawal by Subject|14|||
131444547|NCT03697252|473257189|FG000|Overall Study|Lost to Follow-up|0|||
131444548|NCT03697252|473257190|FG001|Overall Study|Lost to Follow-up|1|||
131444549|NCT03697252|473257189|FG000|Overall Study|Physician Decision|1|||
131444550|NCT03697252|473257190|FG001|Overall Study|Physician Decision|1|||
131444551|NCT03697252|473257189|FG000|Overall Study|Other|0|||
131444552|NCT03697252|473257190|FG001|Overall Study|Other|1|||
131444553|NCT00106704|473257191|FG000|Overall Study|Adverse Event|10|||
131444554|NCT00106704|473257192|FG001|Overall Study|Adverse Event|7|||
131444555|NCT00106704|473257191|FG000|Overall Study|Death|2|||
131444556|NCT00106704|473257192|FG001|Overall Study|Death|1|||
131444557|NCT00106704|473257191|FG000|Overall Study|Lack of Efficacy|67|||
131444558|NCT00106704|473257192|FG001|Overall Study|Lack of Efficacy|69|||
131444559|NCT00106704|473257191|FG000|Overall Study|Lost to Follow-up|7|||
131444560|NCT00106704|473257192|FG001|Overall Study|Lost to Follow-up|3|||
131444561|NCT00106704|473257191|FG000|Overall Study|Pregnancy|1|||
131798417|NCT00788957|474546007|FG002|Part 1|Lost to Follow-up|0|||
131798418|NCT00788957|474546008|FG003|Part 1|Lost to Follow-up|0|||
131444562|NCT00106704|473257192|FG001|Overall Study|Pregnancy|0|||
131444563|NCT00106704|473257191|FG000|Overall Study|Protocol Violation|4|||
131444564|NCT00106704|473257192|FG001|Overall Study|Protocol Violation|7|||
131633857|NCT01106586|473943580|FG000|Overall Study|Participant Noncompliance|12|||
131633858|NCT01106586|473943581|FG001|Overall Study|Participant Noncompliance|10|||
131633859|NCT01106586|473943580|FG000|Overall Study|Protocol Violation|1|||
131633860|NCT01106586|473943581|FG001|Overall Study|Protocol Violation|0|||
131633861|NCT01106586|473943580|FG000|Overall Study|Participant Transferred to Another Study|212|||
131633862|NCT01106586|473943581|FG001|Overall Study|Participant Transferred to Another Study|197|||
131633863|NCT00938041|473943582|FG000|Overall Study|Lost to Follow-up|6|||
131633864|NCT00938041|473943582|FG000|Overall Study|Received Alternative Therapy|1|||
131633865|NCT00938041|473943582|FG000|Overall Study|Progressive Disease|5|||
131633866|NCT00938041|473943582|FG000|Overall Study|Death|12|||
131633867|NCT00938041|473943582|FG000|Overall Study|Adrenal Insufficiency|3|||
131633868|NCT01026103|473943583|FG000|Overall Study|Physician Decision|1|||
131633869|NCT01026103|473943583|FG000|Overall Study|did not receive study device bc of error|1|||
131633870|NCT00428441|473943584|FG000|Overall Study|Lost to Follow-up|1|||
131633871|NCT02475733|473943585|FG000|Overall Study|Withdrawal by Subject|1|||
131633872|NCT02475733|473943586|FG001|Overall Study|Withdrawal by Subject|0|||
131633873|NCT02475733|473943585|FG000|Overall Study|Physician Decision|1|||
131633874|NCT02475733|473943586|FG001|Overall Study|Physician Decision|0|||
131633875|NCT00404547|473943587|FG000|Overall Study|Adverse Event|39|||
131633876|NCT00404547|473943588|FG001|Overall Study|Adverse Event|6|||
131633877|NCT00404547|473943587|FG000|Overall Study|Withdrawal by Subject|19|||
131444565|NCT00106704|473257191|FG000|Overall Study|Withdrawal by Subject|14|||
131444566|NCT00106704|473257192|FG001|Overall Study|Withdrawal by Subject|21|||
131444567|NCT00106704|473257191|FG000|Overall Study|Patient moved|1|||
131633878|NCT00404547|473943588|FG001|Overall Study|Withdrawal by Subject|2|||
131633879|NCT00404547|473943587|FG000|Overall Study|Protocol Violation|0|||
131444568|NCT00106704|473257192|FG001|Overall Study|Patient moved|0|||
131444569|NCT00106704|473257191|FG000|Overall Study|Site terminated|0|||
131444570|NCT00106704|473257192|FG001|Overall Study|Site terminated|1|||
131444571|NCT00106704|473257191|FG000|Overall Study|Planned major surgery|1|||
131444572|NCT00106704|473257192|FG001|Overall Study|Planned major surgery|0|||
131633880|NCT00404547|473943588|FG001|Overall Study|Protocol Violation|1|||
131633881|NCT00404547|473943587|FG000|Overall Study|Lost to Follow-up|20|||
131633882|NCT00404547|473943588|FG001|Overall Study|Lost to Follow-up|9|||
131633883|NCT00404547|473943587|FG000|Overall Study|Lack of compliance|5|||
131798419|NCT00788957|474546009|FG004|Part 1|Lost to Follow-up|0|||
131444573|NCT00106704|473257191|FG000|Overall Study|Patient Received Glycemic Medication|22|||
131444574|NCT00106704|473257192|FG001|Overall Study|Patient Received Glycemic Medication|41|||
131444575|NCT00106704|473257191|FG000|Overall Study|Unable to re-enter US|1|||
131444576|NCT00106704|473257192|FG001|Overall Study|Unable to re-enter US|0|||
131444577|NCT00106704|473257191|FG000|Overall Study|Laboratory test|1|||
131444578|NCT00106704|473257192|FG001|Overall Study|Laboratory test|1|||
131444579|NCT02461758|473257193|FG000|Overall Study|Lost to Follow-up|0|||
131444580|NCT02461758|473257194|FG001|Overall Study|Lost to Follow-up|1|||
131444581|NCT02461758|473257195|FG002|Overall Study|Lost to Follow-up|1|||
131444582|NCT02461758|473257196|FG003|Overall Study|Lost to Follow-up|0|||
131444583|NCT03224819|473257199|FG000|Overall Study|Withdrawal by Subject|0|||
131633884|NCT00404547|473943588|FG001|Overall Study|Lack of compliance|1|||
131633885|NCT00404547|473943587|FG000|Overall Study|Other|4|||
131633886|NCT00404547|473943588|FG001|Overall Study|Other|0|||
131633887|NCT00404547|473943587|FG000|Overall Study|Reason not stated|3|||
131633888|NCT00404547|473943588|FG001|Overall Study|Reason not stated|6|||
131633889|NCT02162771|473943592|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
131633890|NCT02162771|473943593|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
131633891|NCT02162771|473943592|FG000|Core Study Period (Part 2)|Adverse Event|4|||
131633892|NCT02162771|473943593|FG001|Core Study Period (Part 2)|Adverse Event|1|||
131633893|NCT02162771|473943592|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
131633894|NCT02162771|473943593|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
131633895|NCT02162771|473943592|FG000|Core Study Period (Part 2)|Physician Decision|0|||
131633896|NCT02162771|473943593|FG001|Core Study Period (Part 2)|Physician Decision|2|||
131633897|NCT02162771|473943592|FG000|Core Study Period (Part 2)|Death|1|||
131633898|NCT02162771|473943593|FG001|Core Study Period (Part 2)|Death|0|||
131633899|NCT02162771|473943592|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
131633900|NCT02162771|473943593|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
131633901|NCT02162771|473943592|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
131633902|NCT02162771|473943593|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
131633903|NCT02162771|473943592|FG000|Maintenance Study Period (Part 2)|Death|2|||
131633904|NCT02162771|473943593|FG001|Maintenance Study Period (Part 2)|Death|1|||
131633905|NCT02162771|473943592|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
131633906|NCT02162771|473943593|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
131633907|NCT02162771|473943592|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
131633908|NCT02162771|473943593|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
131633909|NCT02162771|473943592|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
131633910|NCT02162771|473943593|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
131633911|NCT01348763|473943594|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
131633912|NCT01348763|473943594|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
131633913|NCT01078571|473943598|FG000|Overall Study|Adverse Event|36|||
131633914|NCT01078571|473943598|FG000|Overall Study|Lack of effectiveness|36|||
131633915|NCT01078571|473943598|FG000|Overall Study|Reason not reported|21|||
131633916|NCT01078571|473943598|FG000|Overall Study|Withdrawal by Subject|12|||
131444584|NCT03224819|473257200|FG001|Overall Study|Withdrawal by Subject|0|||
131444585|NCT03224819|473257201|FG002|Overall Study|Withdrawal by Subject|0|||
131444586|NCT03224819|473257202|FG003|Overall Study|Withdrawal by Subject|0|||
131444587|NCT03224819|473257203|FG004|Overall Study|Withdrawal by Subject|0|||
131444588|NCT03224819|473257204|FG005|Overall Study|Withdrawal by Subject|0|||
131444589|NCT03224819|473257205|FG006|Overall Study|Withdrawal by Subject|0|||
131444590|NCT03224819|473257206|FG007|Overall Study|Withdrawal by Subject|0|||
131444591|NCT03224819|473257207|FG008|Overall Study|Withdrawal by Subject|0|||
131444592|NCT03224819|473257208|FG009|Overall Study|Withdrawal by Subject|0|||
131444593|NCT03224819|473257209|FG010|Overall Study|Withdrawal by Subject|0|||
131444594|NCT03224819|473257210|FG011|Overall Study|Withdrawal by Subject|0|||
131444595|NCT03224819|473257211|FG012|Overall Study|Withdrawal by Subject|1|||
131444596|NCT03224819|473257212|FG013|Overall Study|Withdrawal by Subject|0|||
131444597|NCT03224819|473257199|FG000|Overall Study|Sponsor Decision|0|||
131444598|NCT03224819|473257200|FG001|Overall Study|Sponsor Decision|0|||
131633917|NCT01078571|473943598|FG000|Overall Study|Lost to Follow-up|8|||
131633918|NCT01078571|473943598|FG000|Overall Study|Protocol Violation|2|||
131633919|NCT03647709|473943603|FG000|Overall Study|Lost to Follow-up|5|||
131633920|NCT03647709|473943603|FG000|Overall Study|Physician Decision|6|||
131633921|NCT03647709|473943603|FG000|Overall Study|Withdrawal by Subject|3|||
131633922|NCT00449033|473943606|FG000|Treatment Period|Adverse Event|117|||
131444599|NCT03224819|473257201|FG002|Overall Study|Sponsor Decision|0|||
131444600|NCT03224819|473257202|FG003|Overall Study|Sponsor Decision|1|||
131444601|NCT03224819|473257203|FG004|Overall Study|Sponsor Decision|1|||
131444602|NCT03224819|473257204|FG005|Overall Study|Sponsor Decision|2|||
131633923|NCT00449033|473943607|FG001|Treatment Period|Adverse Event|83|||
131633924|NCT00449033|473943606|FG000|Treatment Period|Death|21|||
131633925|NCT00449033|473943607|FG001|Treatment Period|Death|12|||
131633926|NCT00449033|473943606|FG000|Treatment Period|Lost to Follow-up|0|||
131633927|NCT00449033|473943607|FG001|Treatment Period|Lost to Follow-up|2|||
131633928|NCT00449033|473943606|FG000|Treatment Period|Physician Decision|4|||
131633929|NCT00449033|473943607|FG001|Treatment Period|Physician Decision|5|||
131633930|NCT00449033|473943606|FG000|Treatment Period|Protocol Violation|8|||
131633931|NCT00449033|473943607|FG001|Treatment Period|Protocol Violation|7|||
131633932|NCT00449033|473943606|FG000|Treatment Period|Disease Progression|231|||
131633933|NCT00449033|473943607|FG001|Treatment Period|Disease Progression|288|||
131633934|NCT00449033|473943606|FG000|Treatment Period|Consent Withdrawn|36|||
131798420|NCT00788957|474546010|FG005|Part 1|Lost to Follow-up|0|||
131798421|NCT00788957|474546005|FG000|Part 2|Withdrawal by Subject|0|||
131798422|NCT00788957|474546006|FG001|Part 2|Withdrawal by Subject|9|||
131798423|NCT00788957|474546007|FG002|Part 2|Withdrawal by Subject|5|||
131798424|NCT00788957|474546008|FG003|Part 2|Withdrawal by Subject|3|||
131798425|NCT00788957|474546009|FG004|Part 2|Withdrawal by Subject|0|||
131798426|NCT00788957|474546010|FG005|Part 2|Withdrawal by Subject|0|||
131798427|NCT00788957|474546005|FG000|Part 2|Death|0|||
131798428|NCT00788957|474546006|FG001|Part 2|Death|32|||
131798429|NCT00788957|474546007|FG002|Part 2|Death|35|||
131798430|NCT00788957|474546008|FG003|Part 2|Death|37|||
131798431|NCT00788957|474546009|FG004|Part 2|Death|0|||
131798432|NCT00788957|474546010|FG005|Part 2|Death|0|||
131633935|NCT00449033|473943607|FG001|Treatment Period|Consent Withdrawn|20|||
131633936|NCT00449033|473943606|FG000|Treatment Period|Amended Protocol Criteria|22|||
131633937|NCT00449033|473943607|FG001|Treatment Period|Amended Protocol Criteria|18|||
131798433|NCT00788957|474546005|FG000|Part 2|Lost to Follow-up|0|||
131798434|NCT00788957|474546006|FG001|Part 2|Lost to Follow-up|0|||
131798435|NCT00788957|474546007|FG002|Part 2|Lost to Follow-up|3|||
131798436|NCT00788957|474546008|FG003|Part 2|Lost to Follow-up|0|||
131798437|NCT00788957|474546009|FG004|Part 2|Lost to Follow-up|0|||
131633938|NCT00449033|473943606|FG000|Treatment Period|Non-compliance|7|||
131633939|NCT00449033|473943607|FG001|Treatment Period|Non-compliance|8|||
131633940|NCT00449033|473943606|FG000|Treatment Period|Second Malignancy|0|||
131633941|NCT00449033|473943607|FG001|Treatment Period|Second Malignancy|1|||
131633942|NCT00449033|473943606|FG000|Treatment Period|Reason Missing|0|||
131633943|NCT00449033|473943607|FG001|Treatment Period|Reason Missing|4|||
131633944|NCT00449033|473943606|FG000|Treatment Period|Treatment Ongoing|6|||
131633945|NCT00449033|473943607|FG001|Treatment Period|Treatment Ongoing|4|||
131633946|NCT00449033|473943606|FG000|Follow-up Period|Death|299|||
131633947|NCT00449033|473943607|FG001|Follow-up Period|Death|311|||
131633948|NCT00449033|473943606|FG000|Follow-up Period|Lost to Follow-up|6|||
131713738|NCT02965378|474228805|FG000|Overall Study|Not protocol specified|0|||
131713739|NCT02965378|474228806|FG001|Overall Study|Not protocol specified|2|||
131633949|NCT00449033|473943607|FG001|Follow-up Period|Lost to Follow-up|10|||
131713740|NCT00629083|474228807|FG000|Overall Study|Adverse Event|0|||
131713741|NCT00629083|474228808|FG001|Overall Study|Adverse Event|2|||
131713742|NCT00629083|474228807|FG000|Overall Study|Lack of Efficacy|3|||
131713743|NCT00629083|474228808|FG001|Overall Study|Lack of Efficacy|1|||
131713744|NCT00629083|474228807|FG000|Overall Study|Withdrawal by Subject|10|||
131713745|NCT00629083|474228808|FG001|Overall Study|Withdrawal by Subject|2|||
131713746|NCT00629083|474228807|FG000|Overall Study|Lost to Follow-up|12|||
131713747|NCT00629083|474228808|FG001|Overall Study|Lost to Follow-up|8|||
131713748|NCT00629083|474228807|FG000|Overall Study|Moved out of country/state|2|||
131713749|NCT00629083|474228808|FG001|Overall Study|Moved out of country/state|1|||
131713750|NCT00629083|474228807|FG000|Overall Study|Refused to return for 12 month visit|1|||
131713751|NCT00629083|474228808|FG001|Overall Study|Refused to return for 12 month visit|0|||
131713752|NCT01499290|474228809|FG000|Overall Study|Withdrawal by Subject|22|||
131713753|NCT01499290|474228810|FG001|Overall Study|Withdrawal by Subject|15|||
131713754|NCT01499290|474228809|FG000|Overall Study|Not specified in study report|11|||
131713755|NCT01499290|474228810|FG001|Overall Study|Not specified in study report|5|||
131713756|NCT01499290|474228809|FG000|Overall Study|Condition improved/subject recovered|1|||
131713757|NCT01499290|474228810|FG001|Overall Study|Condition improved/subject recovered|0|||
131713758|NCT01499290|474228809|FG000|Overall Study|Lack of Efficacy|7|||
131713759|NCT01499290|474228810|FG001|Overall Study|Lack of Efficacy|8|||
131713760|NCT01499290|474228809|FG000|Overall Study|Adverse Event|14|||
131713761|NCT01499290|474228810|FG001|Overall Study|Adverse Event|7|||
131713762|NCT00190775|474228811|FG000|Overall Study|Adverse Event|57|||
131713763|NCT00190775|474228812|FG001|Overall Study|Adverse Event|22|||
131713764|NCT00190775|474228811|FG000|Overall Study|Satisfactory Response|1|||
131713765|NCT00190775|474228812|FG001|Overall Study|Satisfactory Response|0|||
131713766|NCT00190775|474228811|FG000|Overall Study|Lack of Efficacy|28|||
131713767|NCT00190775|474228812|FG001|Overall Study|Lack of Efficacy|32|||
131633950|NCT00449033|473943606|FG000|Follow-up Period|Reason Missing|120|||
131633951|NCT00449033|473943607|FG001|Follow-up Period|Reason Missing|113|||
131713768|NCT00190775|474228811|FG000|Overall Study|Lost to Follow-up|31|||
131444603|NCT03224819|473257205|FG006|Overall Study|Sponsor Decision|1|||
131444604|NCT03224819|473257206|FG007|Overall Study|Sponsor Decision|1|||
131444605|NCT03224819|473257207|FG008|Overall Study|Sponsor Decision|1|||
131444606|NCT03224819|473257208|FG009|Overall Study|Sponsor Decision|2|||
131444607|NCT03224819|473257209|FG010|Overall Study|Sponsor Decision|1|||
131444608|NCT03224819|473257210|FG011|Overall Study|Sponsor Decision|1|||
131633952|NCT01257698|473943608|FG000|Overall Study|Protocol Violation|4|||
131633953|NCT01257698|473943609|FG001|Overall Study|Protocol Violation|0|||
131633954|NCT04393779|473943610|FG000|Overall Study|Death|1|||
131633955|NCT04393779|473943610|FG000|Overall Study|Device reintervention or explant|4|||
131633956|NCT02588027|473943624|FG000|Overall Study|Withdrawal by Subject|1|||
131633957|NCT02588027|473943625|FG001|Overall Study|Withdrawal by Subject|3|||
131633958|NCT02588027|473943624|FG000|Overall Study|Protocol Violation|4|||
131633959|NCT02588027|473943625|FG001|Overall Study|Protocol Violation|1|||
131633960|NCT02116582|473943626|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
131633961|NCT02116582|473943626|FG000|Overall Study|Adverse Event|22|||
131633962|NCT02116582|473943626|FG000|Overall Study|Death|9|||
131633963|NCT02116582|473943626|FG000|Overall Study|Progressive Disease|148|||
131633964|NCT02116582|473943626|FG000|Overall Study|Protocol Violation|3|||
131633965|NCT02116582|473943626|FG000|Overall Study|Withdrawal by Subject|8|||
131633966|NCT02116582|473943626|FG000|Overall Study|Other: Miscellaneous|11|||
131633967|NCT02116582|473943626|FG000|Overall Study|Lost to Follow-up|1|||
131633968|NCT02116582|473943626|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
131633969|NCT01770509|473943627|FG000|Overall Study|Injury|0|||
131633970|NCT01770509|473943628|FG001|Overall Study|Injury|1|||
131633971|NCT01770509|473943627|FG000|Overall Study|Lost to Follow-up|1|||
131444609|NCT03224819|473257211|FG012|Overall Study|Sponsor Decision|1|||
131633972|NCT01770509|473943628|FG001|Overall Study|Lost to Follow-up|2|||
131633973|NCT00603278|473943630|FG000|Overall Study|Lack of Efficacy|35|||
131633974|NCT00603278|473943631|FG001|Overall Study|Lack of Efficacy|10|||
131633975|NCT00603278|473943632|FG002|Overall Study|Lack of Efficacy|11|||
131633976|NCT00603278|473943633|FG003|Overall Study|Lack of Efficacy|8|||
131633977|NCT00603278|473943634|FG004|Overall Study|Lack of Efficacy|7|||
131633978|NCT00603278|473943635|FG005|Overall Study|Lack of Efficacy|14|||
131633979|NCT00603278|473943630|FG000|Overall Study|Adverse Event|0|||
131633980|NCT00603278|473943631|FG001|Overall Study|Adverse Event|3|||
131633981|NCT00603278|473943632|FG002|Overall Study|Adverse Event|1|||
131633982|NCT00603278|473943633|FG003|Overall Study|Adverse Event|0|||
131633983|NCT00603278|473943634|FG004|Overall Study|Adverse Event|2|||
131633984|NCT00603278|473943635|FG005|Overall Study|Adverse Event|1|||
131633985|NCT00603278|473943630|FG000|Overall Study|Withdrawal by Subject|2|||
131633986|NCT00603278|473943631|FG001|Overall Study|Withdrawal by Subject|3|||
131633987|NCT00603278|473943632|FG002|Overall Study|Withdrawal by Subject|1|||
131633988|NCT00603278|473943633|FG003|Overall Study|Withdrawal by Subject|2|||
131633989|NCT00603278|473943634|FG004|Overall Study|Withdrawal by Subject|1|||
131633990|NCT00603278|473943635|FG005|Overall Study|Withdrawal by Subject|2|||
131633991|NCT00603278|473943630|FG000|Overall Study|Protocol Violation|3|||
131633992|NCT00603278|473943631|FG001|Overall Study|Protocol Violation|0|||
131633993|NCT00603278|473943632|FG002|Overall Study|Protocol Violation|1|||
131633994|NCT00603278|473943633|FG003|Overall Study|Protocol Violation|1|||
131633995|NCT00603278|473943634|FG004|Overall Study|Protocol Violation|0|||
131633996|NCT00603278|473943635|FG005|Overall Study|Protocol Violation|1|||
131633997|NCT00603278|473943630|FG000|Overall Study|Physician Decision|0|||
131633998|NCT00603278|473943631|FG001|Overall Study|Physician Decision|1|||
131633999|NCT00603278|473943632|FG002|Overall Study|Physician Decision|0|||
131634000|NCT00603278|473943633|FG003|Overall Study|Physician Decision|0|||
131634001|NCT00603278|473943634|FG004|Overall Study|Physician Decision|2|||
131634002|NCT00603278|473943635|FG005|Overall Study|Physician Decision|1|||
131634003|NCT00603278|473943630|FG000|Overall Study|Lost to Follow-up|1|||
131634004|NCT00603278|473943631|FG001|Overall Study|Lost to Follow-up|0|||
131634005|NCT00603278|473943632|FG002|Overall Study|Lost to Follow-up|0|||
131634006|NCT00603278|473943633|FG003|Overall Study|Lost to Follow-up|0|||
131634007|NCT00603278|473943634|FG004|Overall Study|Lost to Follow-up|1|||
131634008|NCT00603278|473943635|FG005|Overall Study|Lost to Follow-up|0|||
131634009|NCT04374253|473943636|FG000|Overall Study|Adverse Event|0|||
131634010|NCT04374253|473943637|FG001|Overall Study|Adverse Event|26|||
131634011|NCT04374253|473943638|FG002|Overall Study|Adverse Event|2|||
131634012|NCT04374253|473943639|FG003|Overall Study|Adverse Event|12|||
131634013|NCT04374253|473943636|FG000|Overall Study|Study terminated by sponsor|13|||
131634014|NCT04374253|473943637|FG001|Overall Study|Study terminated by sponsor|593|||
131444610|NCT03224819|473257212|FG013|Overall Study|Sponsor Decision|0|||
131444611|NCT03224819|473257199|FG000|Overall Study|Lost to Follow-up|0|||
131444612|NCT03224819|473257200|FG001|Overall Study|Lost to Follow-up|0|||
131444613|NCT03224819|473257201|FG002|Overall Study|Lost to Follow-up|0|||
131444614|NCT03224819|473257202|FG003|Overall Study|Lost to Follow-up|0|||
131444615|NCT03224819|473257203|FG004|Overall Study|Lost to Follow-up|0|||
131444616|NCT03224819|473257204|FG005|Overall Study|Lost to Follow-up|0|||
131444617|NCT03224819|473257205|FG006|Overall Study|Lost to Follow-up|0|||
131444618|NCT03224819|473257206|FG007|Overall Study|Lost to Follow-up|0|||
131444619|NCT03224819|473257207|FG008|Overall Study|Lost to Follow-up|1|||
131444620|NCT03224819|473257208|FG009|Overall Study|Lost to Follow-up|0|||
131444621|NCT03224819|473257209|FG010|Overall Study|Lost to Follow-up|0|||
131444622|NCT03224819|473257210|FG011|Overall Study|Lost to Follow-up|0|||
131444623|NCT03224819|473257211|FG012|Overall Study|Lost to Follow-up|0|||
131444624|NCT03224819|473257212|FG013|Overall Study|Lost to Follow-up|0|||
131444625|NCT03224819|473257199|FG000|Overall Study|Death|0|||
131444626|NCT03224819|473257200|FG001|Overall Study|Death|1|||
131444627|NCT03224819|473257201|FG002|Overall Study|Death|0|||
131444628|NCT03224819|473257202|FG003|Overall Study|Death|0|||
131444629|NCT03224819|473257203|FG004|Overall Study|Death|0|||
131444630|NCT03224819|473257204|FG005|Overall Study|Death|0|||
131444631|NCT03224819|473257205|FG006|Overall Study|Death|0|||
131444632|NCT03224819|473257206|FG007|Overall Study|Death|1|||
131444633|NCT03224819|473257207|FG008|Overall Study|Death|0|||
131444634|NCT03224819|473257208|FG009|Overall Study|Death|0|||
131444635|NCT03224819|473257209|FG010|Overall Study|Death|0|||
131444636|NCT03224819|473257210|FG011|Overall Study|Death|1|||
131634015|NCT04374253|473943638|FG002|Overall Study|Study terminated by sponsor|21|||
131634016|NCT04374253|473943639|FG003|Overall Study|Study terminated by sponsor|567|||
131634017|NCT04374253|473943636|FG000|Overall Study|Withdrawal by Subject|0|||
131634018|NCT04374253|473943637|FG001|Overall Study|Withdrawal by Subject|55|||
131444637|NCT03224819|473257211|FG012|Overall Study|Death|0|||
131444638|NCT03224819|473257212|FG013|Overall Study|Death|0|||
131444639|NCT04973449|473257217|FG000|Overall Study|Withdrawal by Subject|3|||
131444640|NCT04973449|473257218|FG001|Overall Study|Withdrawal by Subject|3|||
131444641|NCT04973449|473257219|FG002|Overall Study|Withdrawal by Subject|2|||
131444642|NCT04973449|473257220|FG003|Overall Study|Withdrawal by Subject|5|||
131634019|NCT04374253|473943638|FG002|Overall Study|Withdrawal by Subject|3|||
131634020|NCT04374253|473943639|FG003|Overall Study|Withdrawal by Subject|40|||
131634021|NCT04374253|473943636|FG000|Overall Study|Physician Decision|1|||
131634022|NCT04374253|473943637|FG001|Overall Study|Physician Decision|10|||
131634023|NCT04374253|473943638|FG002|Overall Study|Physician Decision|1|||
131634024|NCT04374253|473943639|FG003|Overall Study|Physician Decision|10|||
131634025|NCT04374253|473943636|FG000|Overall Study|Protocol Violation|0|||
131634026|NCT04374253|473943637|FG001|Overall Study|Protocol Violation|0|||
131634027|NCT04374253|473943638|FG002|Overall Study|Protocol Violation|0|||
131634028|NCT04374253|473943639|FG003|Overall Study|Protocol Violation|2|||
131634029|NCT04374253|473943636|FG000|Overall Study|Death|0|||
131634030|NCT04374253|473943637|FG001|Overall Study|Death|3|||
131634031|NCT04374253|473943638|FG002|Overall Study|Death|1|||
131634032|NCT04374253|473943639|FG003|Overall Study|Death|1|||
131634033|NCT04374253|473943636|FG000|Overall Study|Lack of Efficacy|0|||
131634034|NCT04374253|473943637|FG001|Overall Study|Lack of Efficacy|0|||
131634035|NCT04374253|473943638|FG002|Overall Study|Lack of Efficacy|0|||
131713769|NCT00190775|474228812|FG001|Overall Study|Lost to Follow-up|23|||
131902448|NCT00536510|474929264|FG000|Overall Study|Flushing with Product|20|||
131902449|NCT00536510|474929265|FG001|Overall Study|Flushing with Product|0|||
131902450|NCT00536510|474929264|FG000|Overall Study|Laboratory Adverse Event|2|||
131444643|NCT04973449|473257221|FG004|Overall Study|Withdrawal by Subject|5|||
131444644|NCT04973449|473257222|FG005|Overall Study|Withdrawal by Subject|4|||
131444645|NCT04973449|473257223|FG006|Overall Study|Withdrawal by Subject|7|||
131444646|NCT04973449|473257224|FG007|Overall Study|Withdrawal by Subject|5|||
131444647|NCT04973449|473257217|FG000|Overall Study|Lost to Follow-up|15|||
131444648|NCT04973449|473257218|FG001|Overall Study|Lost to Follow-up|16|||
131444649|NCT04973449|473257219|FG002|Overall Study|Lost to Follow-up|16|||
131634036|NCT04374253|473943639|FG003|Overall Study|Lack of Efficacy|1|||
131713770|NCT00190775|474228811|FG000|Overall Study|Participant Moved|0|||
131634037|NCT04374253|473943636|FG000|Overall Study|Lost to Follow-up|1|||
131634038|NCT04374253|473943637|FG001|Overall Study|Lost to Follow-up|1|||
131713771|NCT00190775|474228812|FG001|Overall Study|Participant Moved|1|||
131444650|NCT04973449|473257220|FG003|Overall Study|Lost to Follow-up|13|||
131444651|NCT04973449|473257221|FG004|Overall Study|Lost to Follow-up|5|||
131444652|NCT04973449|473257222|FG005|Overall Study|Lost to Follow-up|6|||
131444653|NCT04973449|473257223|FG006|Overall Study|Lost to Follow-up|10|||
131444654|NCT04973449|473257224|FG007|Overall Study|Lost to Follow-up|6|||
131444655|NCT04973449|473257217|FG000|Overall Study|Death|1|||
131902451|NCT00536510|474929265|FG001|Overall Study|Laboratory Adverse Event|1|||
131444656|NCT04973449|473257218|FG001|Overall Study|Death|0|||
131634039|NCT04374253|473943638|FG002|Overall Study|Lost to Follow-up|0|||
131634040|NCT04374253|473943639|FG003|Overall Study|Lost to Follow-up|2|||
131634041|NCT04374253|473943636|FG000|Overall Study|Reason Not Specified|0|||
131902452|NCT00536510|474929264|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
131902453|NCT00536510|474929265|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
131902454|NCT02169505|474929266|FG000|Overall Study|Withdrawal by Subject|1|||
131902455|NCT00048035|474929267|FG000|Core Period|Early Withdrawals|4|||
131902456|NCT00048035|474929268|FG001|Core Period|Early Withdrawals|2|||
131902457|NCT00048035|474929269|FG002|Core Period|Early Withdrawals|1|||
131902458|NCT00048035|474929270|FG003|Core Period|Early Withdrawals|1|||
131902459|NCT00048035|474929271|FG004|Core Period|Early Withdrawals|1|||
131902460|NCT00048035|474929272|FG005|Core Period|Early Withdrawals|1|||
131902461|NCT00048035|474929273|FG006|Core Period|Early Withdrawals|0|||
131902462|NCT00048035|474929274|FG007|Core Period|Early Withdrawals|0|||
131902463|NCT00048035|474929267|FG000|Extension Year 1|Early Withdrawals|0|||
131902464|NCT00048035|474929268|FG001|Extension Year 1|Early Withdrawals|0|||
131902465|NCT00048035|474929269|FG002|Extension Year 1|Early Withdrawals|0|||
131902466|NCT00048035|474929270|FG003|Extension Year 1|Early Withdrawals|0|||
131902467|NCT00048035|474929271|FG004|Extension Year 1|Early Withdrawals|0|||
131902468|NCT00048035|474929272|FG005|Extension Year 1|Early Withdrawals|0|||
131902469|NCT00048035|474929273|FG006|Extension Year 1|Early Withdrawals|11|||
131902470|NCT00048035|474929274|FG007|Extension Year 1|Early Withdrawals|11|||
131902471|NCT00048035|474929267|FG000|Extension Year 2|Early Withdrawals|0|||
131902472|NCT00048035|474929268|FG001|Extension Year 2|Early Withdrawals|0|||
131902473|NCT00048035|474929269|FG002|Extension Year 2|Early Withdrawals|0|||
131902474|NCT00048035|474929270|FG003|Extension Year 2|Early Withdrawals|0|||
131902475|NCT00048035|474929271|FG004|Extension Year 2|Early Withdrawals|0|||
131902476|NCT00048035|474929272|FG005|Extension Year 2|Early Withdrawals|0|||
131902477|NCT00048035|474929273|FG006|Extension Year 2|Early Withdrawals|3|||
131902478|NCT00048035|474929274|FG007|Extension Year 2|Early Withdrawals|3|||
131902479|NCT02035553|474929275|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
131902480|NCT02035553|474929276|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
131902481|NCT02035553|474929275|FG000|Overall Study|Adverse Event|10|||
131902482|NCT02035553|474929276|FG001|Overall Study|Adverse Event|6|||
131902483|NCT02035553|474929275|FG000|Overall Study|Physician Decision|3|||
131902484|NCT02035553|474929276|FG001|Overall Study|Physician Decision|2|||
131902485|NCT02035553|474929275|FG000|Overall Study|Lack of Efficacy|1|||
131902486|NCT02035553|474929276|FG001|Overall Study|Lack of Efficacy|1|||
131902487|NCT02035553|474929275|FG000|Overall Study|Withdrawal by Subject|4|||
131902488|NCT02035553|474929276|FG001|Overall Study|Withdrawal by Subject|7|||
131902489|NCT02035553|474929275|FG000|Overall Study|Non-compliance with Study Drug|0|||
131902490|NCT02035553|474929276|FG001|Overall Study|Non-compliance with Study Drug|1|||
131902491|NCT02035553|474929275|FG000|Overall Study|Lost to Follow-up|0|||
131902492|NCT02035553|474929276|FG001|Overall Study|Lost to Follow-up|1|||
131902493|NCT02035553|474929275|FG000|Overall Study|Other Reason|0|||
131902494|NCT02035553|474929276|FG001|Overall Study|Other Reason|4|||
131902495|NCT00115778|474929280|FG000|Overall Study|Withdrawal by Subject|0|||
131902496|NCT00115778|474929281|FG001|Overall Study|Withdrawal by Subject|1|||
131902497|NCT00528424|474929282|FG000|Overall Study|Lost to Follow-up|13|||
131902498|NCT00528424|474929282|FG000|Overall Study|Withdrew consent|2|||
131444657|NCT04973449|473257219|FG002|Overall Study|Death|0|||
131444658|NCT04973449|473257220|FG003|Overall Study|Death|0|||
131444659|NCT04973449|473257221|FG004|Overall Study|Death|0|||
131444660|NCT04973449|473257222|FG005|Overall Study|Death|1|||
131444661|NCT04973449|473257223|FG006|Overall Study|Death|0|||
131444662|NCT04973449|473257224|FG007|Overall Study|Death|0|||
131444663|NCT04973449|473257217|FG000|Overall Study|Other|1|||
131444664|NCT04973449|473257218|FG001|Overall Study|Other|1|||
131444665|NCT04973449|473257219|FG002|Overall Study|Other|2|||
131444666|NCT04973449|473257220|FG003|Overall Study|Other|1|||
131444667|NCT04973449|473257221|FG004|Overall Study|Other|4|||
131444668|NCT04973449|473257222|FG005|Overall Study|Other|0|||
131444669|NCT04973449|473257223|FG006|Overall Study|Other|2|||
131634042|NCT04374253|473943637|FG001|Overall Study|Reason Not Specified|8|||
131634043|NCT04374253|473943638|FG002|Overall Study|Reason Not Specified|0|||
131634044|NCT04374253|473943639|FG003|Overall Study|Reason Not Specified|8|||
131634045|NCT02577315|473943640|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131634046|NCT02577315|473943641|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
131634047|NCT00417989|473943644|FG000|Overall Study|Withdrawal by Subject|13|||
131902499|NCT00528424|474929282|FG000|Overall Study|Administrative reason|2|||
131444670|NCT04973449|473257224|FG007|Overall Study|Other|2|||
131444671|NCT00521079|473257225|FG000|Overall Study|Adverse Event|7|||
131444672|NCT00521079|473257226|FG001|Overall Study|Adverse Event|1|||
131444673|NCT00521079|473257225|FG000|Overall Study|Lost to Follow-up|2|||
131634048|NCT00417989|473943645|FG001|Overall Study|Withdrawal by Subject|13|||
131634049|NCT00417989|473943644|FG000|Overall Study|Lost to Follow-up|1|||
131444674|NCT00521079|473257226|FG001|Overall Study|Lost to Follow-up|1|||
131444675|NCT00521079|473257225|FG000|Overall Study|Withdrawal by Subject|5|||
131444676|NCT00521079|473257226|FG001|Overall Study|Withdrawal by Subject|3|||
131634050|NCT00417989|473943645|FG001|Overall Study|Lost to Follow-up|6|||
131634051|NCT00417989|473943644|FG000|Overall Study|Protocol Violation|1|||
131444677|NCT00888173|473257228|FG000|Overall Study|Wrong Primary|1|||
131444678|NCT00888173|473257228|FG000|Overall Study|Ineligible: required test not done|1|||
131634052|NCT00417989|473943645|FG001|Overall Study|Protocol Violation|0|||
131634053|NCT00417989|473943644|FG000|Overall Study|Death|0|||
131634054|NCT00417989|473943645|FG001|Overall Study|Death|1|||
131634055|NCT00417989|473943644|FG000|Overall Study|Physician Decision|5|||
131634056|NCT00417989|473943645|FG001|Overall Study|Physician Decision|2|||
131634057|NCT00990821|473943650|FG000|Overall Study|Withdrawal by Subject|0|||
131444679|NCT00651742|473257244|FG000|Overall Study|Objective Disease Progression|22|||
131444680|NCT00651742|473257244|FG000|Overall Study|Toxicity|3|||
131444681|NCT00651742|473257244|FG000|Overall Study|Investigator Judgment|1|||
131444682|NCT00651742|473257244|FG000|Overall Study|Withdrawal of Consent|1|||
131444683|NCT00651742|473257244|FG000|Overall Study|Enrolled but not treated|1|||
131444684|NCT04050553|473257245|FG000|Period 1|Physician Decision|2|||
131444685|NCT04050553|473257246|FG001|Period 1|Physician Decision|2|||
131444686|NCT04050553|473257245|FG000|Period 1|Adverse Event|1|||
131444687|NCT04050553|473257246|FG001|Period 1|Adverse Event|1|||
131444688|NCT04050553|473257245|FG000|Period 1|Withdrawal by Subject|0|||
131444689|NCT04050553|473257246|FG001|Period 1|Withdrawal by Subject|1|||
131634058|NCT00990821|473943651|FG001|Overall Study|Withdrawal by Subject|2|||
131634059|NCT00990821|473943652|FG002|Overall Study|Withdrawal by Subject|0|||
131444690|NCT04050553|473257245|FG000|Wash-out|Adverse Event|0|||
131444691|NCT04050553|473257246|FG001|Wash-out|Adverse Event|1|||
131444692|NCT04050553|473257245|FG000|Wash-out|Withdrawal by Subject|0|||
131444693|NCT04050553|473257246|FG001|Wash-out|Withdrawal by Subject|1|||
131444694|NCT05523089|473257247|FG000|Overall Study|Withdrawal by Subject|1|||
131444695|NCT05523089|473257248|FG001|Overall Study|Withdrawal by Subject|0|||
131444696|NCT05523089|473257249|FG002|Overall Study|Withdrawal by Subject|0|||
131444697|NCT05523089|473257247|FG000|Overall Study|Lost to Follow-up|1|||
131444698|NCT05523089|473257248|FG001|Overall Study|Lost to Follow-up|0|||
131444699|NCT05523089|473257249|FG002|Overall Study|Lost to Follow-up|0|||
131444700|NCT02681523|473257250|FG000|Overall Study|Adverse Event|1|||
131444701|NCT02681523|473257250|FG000|Overall Study|Patient Non-compliance|1|||
131444702|NCT02892344|473258690|FG000|Overall Study|Protocol deviation|3|||
131444703|NCT02892344|473258691|FG001|Overall Study|Protocol deviation|4|||
131634060|NCT00990821|473943653|FG003|Overall Study|Withdrawal by Subject|0|||
131634061|NCT00990821|473943654|FG004|Overall Study|Withdrawal by Subject|3|||
131634062|NCT00990821|473943655|FG005|Overall Study|Withdrawal by Subject|3|||
131634063|NCT00990821|473943656|FG006|Overall Study|Withdrawal by Subject|1|||
131634064|NCT00990821|473943657|FG007|Overall Study|Withdrawal by Subject|0|||
131634065|NCT00990821|473943658|FG008|Overall Study|Withdrawal by Subject|0|||
131634066|NCT00990821|473943659|FG009|Overall Study|Withdrawal by Subject|1|||
131634067|NCT00990821|473943660|FG010|Overall Study|Withdrawal by Subject|3|||
131634068|NCT00990821|473943661|FG011|Overall Study|Withdrawal by Subject|5|||
131634069|NCT00990821|473943662|FG012|Overall Study|Withdrawal by Subject|2|||
131634070|NCT00990821|473943663|FG013|Overall Study|Withdrawal by Subject|1|||
131634071|NCT04150250|473943664|FG000|Overall Study|Lost to Follow-up|0|||
131634072|NCT04150250|473943665|FG001|Overall Study|Lost to Follow-up|2|||
131634073|NCT01786551|473943666|FG000|Overall Study|Participant withdrew consent|2|||
131634074|NCT01945086|473943667|FG000|Overall Study|Withdrawal by Subject|1|||
131634075|NCT01945086|473943668|FG001|Overall Study|Withdrawal by Subject|0|||
131634076|NCT01945086|473943669|FG002|Overall Study|Withdrawal by Subject|1|||
131634077|NCT01945086|473943667|FG000|Overall Study|Adverse Event|0|||
131634078|NCT01945086|473943668|FG001|Overall Study|Adverse Event|0|||
131444704|NCT02892344|473258690|FG000|Overall Study|Adverse Event|1|||
131444705|NCT02892344|473258691|FG001|Overall Study|Adverse Event|8|||
131634079|NCT01945086|473943669|FG002|Overall Study|Adverse Event|1|||
131634080|NCT00308113|473943671|FG000|Overall Study|Protocol closure|0|||
131634081|NCT00308113|473943672|FG001|Overall Study|Protocol closure|0|||
131634082|NCT00308113|473943673|FG002|Overall Study|Protocol closure|0|||
131634083|NCT00308113|473943674|FG003|Overall Study|Protocol closure|1|||
131634084|NCT00748098|473943675|FG000|First Treatment Intervention Period|Adverse Event|1|||
131634085|NCT00748098|473943676|FG001|First Treatment Intervention Period|Adverse Event|1|||
131634086|NCT00748098|473943675|FG000|First Treatment Intervention Period|Protocol Violation|1|||
131634087|NCT00748098|473943676|FG001|First Treatment Intervention Period|Protocol Violation|0|||
131634088|NCT00748098|473943675|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
131798438|NCT00788957|474546010|FG005|Part 2|Lost to Follow-up|0|||
131798439|NCT00788957|474546005|FG000|Part 2|On-study at time of data cut-off|0|||
131634089|NCT00748098|473943676|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
131634090|NCT00748098|473943675|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
131634091|NCT00748098|473943676|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
131444706|NCT02892344|473258690|FG000|Overall Study|Lost to Follow-up|0|||
131634092|NCT00748098|473943675|FG000|First Taper Period|Protocol Violation|1|||
131634093|NCT00748098|473943676|FG001|First Taper Period|Protocol Violation|0|||
131634094|NCT00748098|473943675|FG000|First Taper Period|Withdrawal by Subject|2|||
131634095|NCT00748098|473943676|FG001|First Taper Period|Withdrawal by Subject|0|||
131634096|NCT00748098|473943675|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
131634097|NCT00748098|473943676|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
131634098|NCT00748098|473943675|FG000|1-Week Washout Period|Adverse Event|0|||
131634099|NCT00748098|473943676|FG001|1-Week Washout Period|Adverse Event|1|||
131634100|NCT00748098|473943675|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
131634101|NCT00748098|473943676|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
131634102|NCT00748098|473943675|FG000|Second Treatment Intervention Period|Adverse Event|4|||
131634103|NCT00748098|473943676|FG001|Second Treatment Intervention Period|Adverse Event|1|||
131634104|NCT00748098|473943675|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
131634105|NCT00748098|473943676|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
131634106|NCT00748098|473943675|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
131634107|NCT00748098|473943676|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
131634108|NCT01123642|473943680|FG000|Overall Study|Lost to Follow-up|23|||
131634109|NCT01123642|473943680|FG000|Overall Study|Withdrawal by Subject|9|||
131634110|NCT01123642|473943680|FG000|Overall Study|ineligible at baseline assessment|36|||
131634111|NCT01537120|473945108|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
131634112|NCT01537120|473945108|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
131634113|NCT02514577|473945109|FG000|Overall Study|Lost to Follow-up|6|||
131634114|NCT02514577|473945110|FG001|Overall Study|Lost to Follow-up|6|||
131634115|NCT02514577|473945109|FG000|Overall Study|Protocol Violation|1|||
131634116|NCT02514577|473945110|FG001|Overall Study|Protocol Violation|0|||
131634117|NCT02514577|473945109|FG000|Overall Study|Withdrawal by Subject|6|||
131634118|NCT02514577|473945110|FG001|Overall Study|Withdrawal by Subject|6|||
131634119|NCT02514577|473945109|FG000|Overall Study|Adverse Event|1|||
131634120|NCT02514577|473945110|FG001|Overall Study|Adverse Event|1|||
131634121|NCT04816708|473945113|FG000|Overall Study|Lost to Follow-up|10|||
131634122|NCT04816708|473945114|FG001|Overall Study|Lost to Follow-up|4|||
131634123|NCT02339506|473945117|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
131634124|NCT02339506|473945118|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
131634125|NCT02339506|473945117|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
131634126|NCT02339506|473945118|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
131634127|NCT03997409|473945119|FG000|Overall Study|Protocol Violation|1|||
131634128|NCT03997409|473945120|FG001|Overall Study|Protocol Violation|1|||
131634129|NCT03997409|473945121|FG002|Overall Study|Protocol Violation|0|||
131634130|NCT03997409|473945119|FG000|Overall Study|Withdrawal by Subject|3|||
131634131|NCT03997409|473945120|FG001|Overall Study|Withdrawal by Subject|0|||
131634132|NCT03997409|473945121|FG002|Overall Study|Withdrawal by Subject|0|||
131634133|NCT03997409|473945119|FG000|Overall Study|Lost to Follow-up|0|||
131634134|NCT03997409|473945120|FG001|Overall Study|Lost to Follow-up|0|||
131634135|NCT03997409|473945121|FG002|Overall Study|Lost to Follow-up|1|||
131634136|NCT01090076|473945122|FG000|Overall Study|Death|1|||
131713772|NCT00190775|474228811|FG000|Overall Study|Withdrawal by Subject|24|||
131713773|NCT00190775|474228812|FG001|Overall Study|Withdrawal by Subject|13|||
131713774|NCT00190775|474228811|FG000|Overall Study|Sponsor Decision|1|||
131713775|NCT00190775|474228812|FG001|Overall Study|Sponsor Decision|0|||
131713776|NCT00190775|474228811|FG000|Overall Study|Physician Decision|3|||
131713777|NCT00190775|474228812|FG001|Overall Study|Physician Decision|0|||
131713778|NCT00190775|474228811|FG000|Overall Study|Noncompliance|3|||
131713779|NCT00190775|474228812|FG001|Overall Study|Noncompliance|5|||
131713780|NCT00190775|474228811|FG000|Overall Study|Protocol Violation|0|||
131713781|NCT00190775|474228812|FG001|Overall Study|Protocol Violation|1|||
131713782|NCT00190775|474228811|FG000|Overall Study|Exclusion Criteria Met|1|||
131713783|NCT00190775|474228812|FG001|Overall Study|Exclusion Criteria Met|3|||
131713784|NCT00552110|474228813|FG000|Overall Study|Serious or Life-Threatening AE|0|||
131713785|NCT00552110|474228814|FG001|Overall Study|Serious or Life-Threatening AE|0|||
131713786|NCT00552110|474228815|FG002|Overall Study|Serious or Life-Threatening AE|1|||
131713787|NCT00552110|474228816|FG003|Overall Study|Serious or Life-Threatening AE|0|||
131713788|NCT00552110|474228817|FG004|Overall Study|Serious or Life-Threatening AE|0|||
131713789|NCT00552110|474228813|FG000|Overall Study|Lack of Efficacy|1|||
131713790|NCT00552110|474228814|FG001|Overall Study|Lack of Efficacy|0|||
131713791|NCT00552110|474228815|FG002|Overall Study|Lack of Efficacy|0|||
131713792|NCT00552110|474228816|FG003|Overall Study|Lack of Efficacy|1|||
131713793|NCT00552110|474228817|FG004|Overall Study|Lack of Efficacy|4|||
131713794|NCT00552110|474228813|FG000|Overall Study|Withdrawal by Subject|0|||
131634137|NCT01090076|473945123|FG001|Overall Study|Death|1|||
131634138|NCT01090076|473945122|FG000|Overall Study|Withdrawal by Subject|0|||
131634139|NCT01090076|473945123|FG001|Overall Study|Withdrawal by Subject|1|||
131634140|NCT01753323|473945124|FG000|Overall Study|Lack of Efficacy|0|||
131634141|NCT01753323|473945125|FG001|Overall Study|Lack of Efficacy|0|||
131634142|NCT01753323|473945126|FG002|Overall Study|Lack of Efficacy|8|||
131634143|NCT01753323|473945124|FG000|Overall Study|Protocol deviation|1|||
131634144|NCT01753323|473945125|FG001|Overall Study|Protocol deviation|0|||
131634145|NCT01753323|473945126|FG002|Overall Study|Protocol deviation|0|||
131634146|NCT01753323|473945124|FG000|Overall Study|Adverse Event|0|||
131634147|NCT01753323|473945125|FG001|Overall Study|Adverse Event|0|||
131634148|NCT01753323|473945126|FG002|Overall Study|Adverse Event|1|||
131634149|NCT00116584|473945141|FG000|Overall Study|Withdrawal by Subject|1|||
131634150|NCT00116584|473945142|FG001|Overall Study|Withdrawal by Subject|0|||
131634151|NCT00116584|473945141|FG000|Overall Study|Protocol Violation|1|||
131634152|NCT00116584|473945142|FG001|Overall Study|Protocol Violation|1|||
131634153|NCT01732588|473945143|FG000|First Intervention (7 Days)|Adverse Event|0|||
131634154|NCT01732588|473945144|FG001|First Intervention (7 Days)|Adverse Event|1|||
131634155|NCT01732588|473945145|FG002|First Intervention (7 Days)|Adverse Event|0|||
131634156|NCT00730925|473945152|FG000|Overall Study|Progressive Disease|21|||
131634157|NCT00730925|473945152|FG000|Overall Study|Dose reducing Event|2|||
131634158|NCT00730925|473945152|FG000|Overall Study|Other Averse Event|7|||
131634159|NCT00730925|473945152|FG000|Overall Study|Protocol Violation|1|||
131634160|NCT00730925|473945152|FG000|Overall Study|Withdrawal by Subject|1|||
131634161|NCT00730925|473945152|FG000|Overall Study|Switch to combination therapy|8|||
131634162|NCT00730925|473945152|FG000|Overall Study|Other|1|||
131634163|NCT00191984|473945153|FG000|Overall Study|Disease Progression|21|||
131634164|NCT00191984|473945153|FG000|Overall Study|Adverse Event|4|||
131634165|NCT00191984|473945153|FG000|Overall Study|Death|2|||
131634166|NCT00191984|473945153|FG000|Overall Study|Entry Criteria Exclusion|1|||
131634167|NCT00191984|473945153|FG000|Overall Study|Withdrawal by Subject|7|||
131634168|NCT00191984|473945153|FG000|Overall Study|Physician Decision|4|||
131634169|NCT01732627|473945154|FG000|Overall Study|Withdrawal by Subject|1|||
131634170|NCT01732627|473945155|FG001|Overall Study|Withdrawal by Subject|0|||
131634171|NCT00005908|473945158|FG000|Overall Study|Withdrawal by Subject|1|||
131634172|NCT00005908|473945159|FG001|Overall Study|Withdrawal by Subject|0|||
131634173|NCT04736602|473945164|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
131634174|NCT04736602|473945164|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
131634175|NCT01446042|473945166|FG000|Overall Study|Withdrawal by Subject|12|||
131634176|NCT01446042|473945167|FG001|Overall Study|Withdrawal by Subject|2|||
131634177|NCT01446042|473945168|FG002|Overall Study|Withdrawal by Subject|4|||
131634178|NCT01446042|473945166|FG000|Overall Study|Adverse Event|1|||
131634179|NCT01446042|473945167|FG001|Overall Study|Adverse Event|0|||
131634180|NCT01446042|473945168|FG002|Overall Study|Adverse Event|4|||
131634181|NCT01446042|473945166|FG000|Overall Study|Lost to Follow-up|5|||
131634182|NCT01446042|473945167|FG001|Overall Study|Lost to Follow-up|0|||
131634183|NCT01446042|473945168|FG002|Overall Study|Lost to Follow-up|0|||
131634184|NCT01446042|473945166|FG000|Overall Study|Other reasons|2|||
131634185|NCT01446042|473945167|FG001|Overall Study|Other reasons|1|||
131634186|NCT01446042|473945168|FG002|Overall Study|Other reasons|1|||
131634187|NCT03575572|473945170|FG000|Overall Study|Withdrawal by Subject|2|||
131634188|NCT03575572|473945170|FG000|Overall Study|Physician Decision|2|||
131634189|NCT00157209|473945171|FG000|Overall Study|Ongoing at data cut-off|10|||
131634190|NCT00157209|473945172|FG001|Overall Study|Ongoing at data cut-off|0|||
131634191|NCT03751280|473945173|FG000|Overall Study|Adverse Event|0|||
131634192|NCT03751280|473945174|FG001|Overall Study|Adverse Event|1|||
131634193|NCT03751280|473945173|FG000|Overall Study|Lost to Follow-up|3|||
131634194|NCT03751280|473945174|FG001|Overall Study|Lost to Follow-up|5|||
131634195|NCT03751280|473945173|FG000|Overall Study|Physician Decision|0|||
131634196|NCT03751280|473945174|FG001|Overall Study|Physician Decision|2|||
131634197|NCT03751280|473945173|FG000|Overall Study|Protocol Violation|0|||
131634198|NCT03751280|473945174|FG001|Overall Study|Protocol Violation|2|||
131634199|NCT03751280|473945173|FG000|Overall Study|Withdrawal by Subject|5|||
131634200|NCT03751280|473945174|FG001|Overall Study|Withdrawal by Subject|2|||
131713795|NCT00552110|474228814|FG001|Overall Study|Withdrawal by Subject|2|||
131713796|NCT00552110|474228815|FG002|Overall Study|Withdrawal by Subject|0|||
131713797|NCT00552110|474228816|FG003|Overall Study|Withdrawal by Subject|3|||
131713798|NCT00552110|474228817|FG004|Overall Study|Withdrawal by Subject|2|||
131713799|NCT00552110|474228813|FG000|Overall Study|Lost to Follow-up|0|||
131713800|NCT00552110|474228814|FG001|Overall Study|Lost to Follow-up|0|||
131713801|NCT00552110|474228815|FG002|Overall Study|Lost to Follow-up|0|||
131713802|NCT00552110|474228816|FG003|Overall Study|Lost to Follow-up|1|||
131713803|NCT00552110|474228817|FG004|Overall Study|Lost to Follow-up|1|||
131713804|NCT00552110|474228813|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
131713805|NCT00552110|474228814|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
131713806|NCT00552110|474228815|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
131713807|NCT00552110|474228816|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
131634201|NCT02359552|473945181|FG000|Overall Study|Lost to Follow-up|3|||
131634202|NCT02359552|473945182|FG001|Overall Study|Lost to Follow-up|4|||
131634203|NCT03802513|473945185|FG000|Overall Study|Lost to Follow-up|1|||
131634204|NCT01395914|473945191|FG000|Overall Study|Unrelated to study drug AE|6|||
131634205|NCT01395914|473945192|FG001|Overall Study|Unrelated to study drug AE|1|||
131444707|NCT02892344|473258691|FG001|Overall Study|Lost to Follow-up|1|||
131444708|NCT02892344|473258690|FG000|Overall Study|Non-compliance with study treatment|0|||
131444709|NCT02892344|473258691|FG001|Overall Study|Non-compliance with study treatment|1|||
131444710|NCT02892344|473258690|FG000|Overall Study|Physician Decision|0|||
131444711|NCT02892344|473258691|FG001|Overall Study|Physician Decision|2|||
131444712|NCT02892344|473258690|FG000|Overall Study|Subject/guardian decision|0|||
131444713|NCT02892344|473258691|FG001|Overall Study|Subject/guardian decision|4|||
131444714|NCT02892344|473258690|FG000|Overall Study|Technical problems|0|||
131444715|NCT02892344|473258691|FG001|Overall Study|Technical problems|1|||
131444716|NCT01520506|473258692|FG000|Overall Study|Missed Visit|4|||
131444717|NCT01520506|473258692|FG000|Overall Study|Lost to Follow-up|1|||
131444718|NCT01520506|473258692|FG000|Overall Study|Withdrawal by Subject|1|||
131444719|NCT00425269|473258693|FG000|Overall Study|Pregnancy|5|||
131444720|NCT00425269|473258694|FG001|Overall Study|Pregnancy|7|||
131444721|NCT00425269|473258693|FG000|Overall Study|Lost to Follow-up|9|||
131444722|NCT00425269|473258694|FG001|Overall Study|Lost to Follow-up|9|||
131444723|NCT00425269|473258693|FG000|Overall Study|moved or medical reason|5|||
131444724|NCT00425269|473258694|FG001|Overall Study|moved or medical reason|4|||
131444725|NCT01084655|473258699|FG000|Overall Study|Radiographic disease progression|3|||
131444726|NCT01084655|473258700|FG001|Overall Study|Radiographic disease progression|2|||
131444727|NCT01084655|473258701|FG002|Overall Study|Radiographic disease progression|8|||
131444728|NCT01084655|473258699|FG000|Overall Study|Withdrawal by Subject|1|||
131444729|NCT01084655|473258700|FG001|Overall Study|Withdrawal by Subject|0|||
131444730|NCT01084655|473258701|FG002|Overall Study|Withdrawal by Subject|4|||
131444731|NCT01084655|473258699|FG000|Overall Study|Adverse Event|2|||
131444732|NCT01084655|473258700|FG001|Overall Study|Adverse Event|1|||
131444733|NCT01084655|473258701|FG002|Overall Study|Adverse Event|2|||
131444734|NCT01084655|473258699|FG000|Overall Study|Other|0|||
131444735|NCT01084655|473258700|FG001|Overall Study|Other|3|||
131444736|NCT01084655|473258701|FG002|Overall Study|Other|2|||
131444737|NCT01084655|473258699|FG000|Overall Study|Symptomatic deterioration|0|||
131444738|NCT01084655|473258700|FG001|Overall Study|Symptomatic deterioration|0|||
131444739|NCT01084655|473258701|FG002|Overall Study|Symptomatic deterioration|2|||
131444740|NCT01084655|473258699|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
131444741|NCT01084655|473258700|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
131444742|NCT01084655|473258701|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
131444743|NCT00335777|473258703|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
131444744|NCT00335777|473258703|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
131444745|NCT00335777|473258703|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
131444746|NCT00335777|473258703|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
131444747|NCT00335777|473258703|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
131444748|NCT00535496|473258704|FG000|Overall Study|Lost to Follow-up|0|||
131444749|NCT00535496|473258705|FG001|Overall Study|Lost to Follow-up|1|||
131444750|NCT00535496|473258706|FG002|Overall Study|Lost to Follow-up|0|||
131444751|NCT00535496|473258707|FG003|Overall Study|Lost to Follow-up|0|||
131444752|NCT00535496|473258704|FG000|Overall Study|Not treated with sugammadex|0|||
131902500|NCT00528424|474929282|FG000|Overall Study|Other|12|||
131444753|NCT00535496|473258705|FG001|Overall Study|Not treated with sugammadex|1|||
131444754|NCT00535496|473258706|FG002|Overall Study|Not treated with sugammadex|0|||
131444755|NCT00535496|473258707|FG003|Overall Study|Not treated with sugammadex|0|||
131444756|NCT02326155|473258708|FG000|Overall Study|Adverse Event|21|||
131634206|NCT01395914|473945191|FG000|Overall Study|Death|23|||
131634207|NCT01395914|473945192|FG001|Overall Study|Death|17|||
131634208|NCT01395914|473945191|FG000|Overall Study|Other|9|||
131634209|NCT01395914|473945192|FG001|Overall Study|Other|3|||
131634210|NCT01395914|473945191|FG000|Overall Study|Withdrawal by patient|27|||
131634211|NCT01395914|473945192|FG001|Overall Study|Withdrawal by patient|14|||
131634212|NCT01395914|473945191|FG000|Overall Study|Study drug-related AE|1|||
131634213|NCT01395914|473945192|FG001|Overall Study|Study drug-related AE|0|||
131634214|NCT01395914|473945191|FG000|Overall Study|Lost to Follow-up|6|||
131634215|NCT01395914|473945192|FG001|Overall Study|Lost to Follow-up|2|||
131634216|NCT03023878|473945193|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
131634217|NCT03023878|473945193|FG000|Pre-Study Run-In Period|Death|1|||
131634218|NCT03023878|473945193|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
131634219|NCT03023878|473945193|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
131634220|NCT03023878|473945193|FG000|Treatment Period|Disease Progression|1|||
131444757|NCT02326155|473258709|FG001|Overall Study|Adverse Event|5|||
131444758|NCT02326155|473258708|FG000|Overall Study|Death|3|||
131444759|NCT02326155|473258709|FG001|Overall Study|Death|0|||
131634221|NCT03023878|473945193|FG000|Treatment Period|Withdrawal by Subject|1|||
131634222|NCT03023878|473945193|FG000|Treatment Period|Adverse Event|1|||
131634223|NCT03023878|473945193|FG000|Long Term Follow-Up Period|Death|2|||
131444760|NCT02326155|473258708|FG000|Overall Study|Lack of Efficacy|49|||
131444761|NCT02326155|473258709|FG001|Overall Study|Lack of Efficacy|5|||
131444762|NCT02326155|473258708|FG000|Overall Study|Lost to Follow-up|14|||
131444763|NCT02326155|473258709|FG001|Overall Study|Lost to Follow-up|3|||
131444764|NCT02326155|473258708|FG000|Overall Study|Protocol Violation|2|||
131444765|NCT02326155|473258709|FG001|Overall Study|Protocol Violation|0|||
131444766|NCT02326155|473258708|FG000|Overall Study|Withdrawal by Subject|34|||
131444767|NCT02326155|473258709|FG001|Overall Study|Withdrawal by Subject|11|||
131444768|NCT02326155|473258708|FG000|Overall Study|Disease progression|37|||
131444769|NCT02326155|473258709|FG001|Overall Study|Disease progression|4|||
131444770|NCT02326155|473258708|FG000|Overall Study|Study close|188|||
131444771|NCT02326155|473258709|FG001|Overall Study|Study close|21|||
131444772|NCT02326155|473258708|FG000|Overall Study|except for study close|46|||
131444773|NCT02326155|473258709|FG001|Overall Study|except for study close|13|||
131444774|NCT05024032|473258710|FG000|Overall Study|Withdrawal by Subject|0|||
131444775|NCT05024032|473258711|FG001|Overall Study|Withdrawal by Subject|3|||
131444776|NCT05024032|473258712|FG002|Overall Study|Withdrawal by Subject|4|||
131444777|NCT05024032|473258710|FG000|Overall Study|Adverse Event|0|||
131444778|NCT05024032|473258711|FG001|Overall Study|Adverse Event|1|||
131444779|NCT05024032|473258712|FG002|Overall Study|Adverse Event|0|||
131444780|NCT05024032|473258710|FG000|Overall Study|Protocol Deviation|1|||
131444781|NCT05024032|473258711|FG001|Overall Study|Protocol Deviation|0|||
131444782|NCT05024032|473258712|FG002|Overall Study|Protocol Deviation|0|||
131444783|NCT00939393|473258717|FG000|Overall Study|Withdrawal by Subject|1|||
131444784|NCT00939393|473258718|FG001|Overall Study|Withdrawal by Subject|0|||
131444785|NCT00939393|473258717|FG000|Overall Study|Lost to Follow-up|3|||
131444786|NCT00939393|473258718|FG001|Overall Study|Lost to Follow-up|0|||
131444787|NCT00124943|473258721|FG000|Phase II|Adverse Event|0|||
131444788|NCT00124943|473258722|FG001|Phase II|Adverse Event|2|||
131444789|NCT00124943|473258723|FG002|Phase II|Adverse Event|0|||
131444790|NCT00124943|473258724|FG003|Phase II|Adverse Event|1|||
131444791|NCT00124943|473258721|FG000|Phase II|Protocol Violation|0|||
131444792|NCT00124943|473258722|FG001|Phase II|Protocol Violation|0|||
131444793|NCT00124943|473258723|FG002|Phase II|Protocol Violation|0|||
131444794|NCT00124943|473258724|FG003|Phase II|Protocol Violation|1|||
131444795|NCT00124943|473258721|FG000|Phase II|Lost to Follow-up|0|||
131444796|NCT00124943|473258722|FG001|Phase II|Lost to Follow-up|0|||
131444797|NCT00124943|473258723|FG002|Phase II|Lost to Follow-up|0|||
131798440|NCT00788957|474546006|FG001|Part 2|On-study at time of data cut-off|1|||
131798441|NCT00788957|474546007|FG002|Part 2|On-study at time of data cut-off|1|||
131798442|NCT00788957|474546008|FG003|Part 2|On-study at time of data cut-off|1|||
131798443|NCT00788957|474546009|FG004|Part 2|On-study at time of data cut-off|0|||
131798444|NCT00788957|474546010|FG005|Part 2|On-study at time of data cut-off|0|||
131798445|NCT00788957|474546005|FG000|Part 3|Withdrawal by Subject|0|||
131798446|NCT00788957|474546006|FG001|Part 3|Withdrawal by Subject|0|||
131798447|NCT00788957|474546007|FG002|Part 3|Withdrawal by Subject|0|||
131798448|NCT00788957|474546008|FG003|Part 3|Withdrawal by Subject|0|||
131798449|NCT00788957|474546009|FG004|Part 3|Withdrawal by Subject|0|||
131798450|NCT00788957|474546010|FG005|Part 3|Withdrawal by Subject|2|||
131798451|NCT00788957|474546005|FG000|Part 3|Death|0|||
131798452|NCT00788957|474546006|FG001|Part 3|Death|0|||
131798453|NCT00788957|474546007|FG002|Part 3|Death|0|||
131798454|NCT00788957|474546008|FG003|Part 3|Death|0|||
131798455|NCT00788957|474546009|FG004|Part 3|Death|8|||
131798456|NCT00788957|474546010|FG005|Part 3|Death|8|||
131798457|NCT00788957|474546005|FG000|Part 3|On-study at time of data cut-off|0|||
131798458|NCT00788957|474546006|FG001|Part 3|On-study at time of data cut-off|0|||
131798459|NCT00788957|474546007|FG002|Part 3|On-study at time of data cut-off|0|||
131798460|NCT00788957|474546008|FG003|Part 3|On-study at time of data cut-off|0|||
131798461|NCT00788957|474546009|FG004|Part 3|On-study at time of data cut-off|1|||
131798462|NCT00788957|474546010|FG005|Part 3|On-study at time of data cut-off|0|||
131798463|NCT03276975|474546011|FG000|Overall Study|Withdrawal by Subject|1|||
131798464|NCT03276975|474546012|FG001|Overall Study|Withdrawal by Subject|0|||
131798465|NCT03283709|474546022|FG000|Overall Study|trial terminated|0|||
131444798|NCT00124943|473258724|FG003|Phase II|Lost to Follow-up|1|||
131444799|NCT00124943|473258721|FG000|Phase II|Withdrawal by Subject|0|||
131444800|NCT00124943|473258722|FG001|Phase II|Withdrawal by Subject|0|||
131444801|NCT00124943|473258723|FG002|Phase II|Withdrawal by Subject|0|||
131444802|NCT00124943|473258724|FG003|Phase II|Withdrawal by Subject|2|||
131444803|NCT01747876|473258725|FG000|Overall Study|Adverse Event|1|||
131444804|NCT01747876|473258726|FG001|Overall Study|Adverse Event|0|||
131444805|NCT01747876|473258727|FG002|Overall Study|Adverse Event|2|||
131444806|NCT01747876|473258725|FG000|Overall Study|Withdrawal by Subject|0|||
131444807|NCT01747876|473258726|FG001|Overall Study|Withdrawal by Subject|1|||
131798466|NCT03283709|474546023|FG001|Overall Study|trial terminated|1|||
131798467|NCT01734772|474546024|FG000|Overall Study|Adverse Event|1|||
131798468|NCT01734772|474546025|FG001|Overall Study|Adverse Event|2|||
131798469|NCT01734772|474546024|FG000|Overall Study|Withdrawal by Subject|0|||
131798470|NCT01734772|474546025|FG001|Overall Study|Withdrawal by Subject|1|||
131798471|NCT02579096|474546028|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
131444808|NCT01747876|473258727|FG002|Overall Study|Withdrawal by Subject|1|||
131444809|NCT01747876|473258725|FG000|Overall Study|Disease progression|4|||
131444810|NCT01747876|473258726|FG001|Overall Study|Disease progression|13|||
131444811|NCT01747876|473258727|FG002|Overall Study|Disease progression|8|||
131444812|NCT01747876|473258725|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
131444813|NCT01747876|473258726|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
131444814|NCT01747876|473258727|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
131444815|NCT03363841|473258730|FG000|Overall Study|Adverse Event|1|||
131444816|NCT03363841|473258730|FG000|Overall Study|Withdrawal by Subject|1|||
131444817|NCT03363841|473258730|FG000|Overall Study|Death|7|||
131444818|NCT03363841|473258730|FG000|Overall Study|Physician Decision|1|||
131444819|NCT00886379|473258733|FG000|Overall Study|Transferred Schools|0|||
131444820|NCT00886379|473258734|FG001|Overall Study|Transferred Schools|0|||
131444821|NCT00886379|473258735|FG002|Overall Study|Transferred Schools|2|||
131444822|NCT00886379|473258736|FG003|Overall Study|Transferred Schools|1|||
131444823|NCT00886379|473258737|FG004|Overall Study|Transferred Schools|1|||
131444824|NCT00886379|473258733|FG000|Overall Study|Final blood draw not obtained|3|||
131444825|NCT00886379|473258734|FG001|Overall Study|Final blood draw not obtained|3|||
131444826|NCT00886379|473258735|FG002|Overall Study|Final blood draw not obtained|4|||
131444827|NCT00886379|473258736|FG003|Overall Study|Final blood draw not obtained|2|||
131444828|NCT00886379|473258737|FG004|Overall Study|Final blood draw not obtained|2|||
131444829|NCT03137381|473258738|FG000|Overall Study|Adverse Event|3|||
131444830|NCT03137381|473258739|FG001|Overall Study|Adverse Event|0|||
131444831|NCT03137381|473258740|FG002|Overall Study|Adverse Event|2|||
131444832|NCT03137381|473258741|FG003|Overall Study|Adverse Event|0|||
131444833|NCT03137381|473258738|FG000|Overall Study|Lost to Follow-up|2|||
131444834|NCT03137381|473258739|FG001|Overall Study|Lost to Follow-up|1|||
131444835|NCT03137381|473258740|FG002|Overall Study|Lost to Follow-up|1|||
131444836|NCT03137381|473258741|FG003|Overall Study|Lost to Follow-up|0|||
131444837|NCT03137381|473258738|FG000|Overall Study|Protocol deviation|1|||
131444838|NCT03137381|473258739|FG001|Overall Study|Protocol deviation|1|||
131444839|NCT03137381|473258740|FG002|Overall Study|Protocol deviation|0|||
131444840|NCT03137381|473258741|FG003|Overall Study|Protocol deviation|1|||
131444841|NCT03137381|473258738|FG000|Overall Study|Withdrawal by Investigator|0|||
131444842|NCT03137381|473258739|FG001|Overall Study|Withdrawal by Investigator|1|||
131444843|NCT03137381|473258740|FG002|Overall Study|Withdrawal by Investigator|1|||
131444844|NCT03137381|473258741|FG003|Overall Study|Withdrawal by Investigator|0|||
131444845|NCT03137381|473258738|FG000|Overall Study|Withdrawal by Subject|3|||
131444846|NCT03137381|473258739|FG001|Overall Study|Withdrawal by Subject|4|||
131444847|NCT03137381|473258740|FG002|Overall Study|Withdrawal by Subject|3|||
131444848|NCT03137381|473258741|FG003|Overall Study|Withdrawal by Subject|0|||
131444849|NCT03137381|473258738|FG000|Overall Study|Pregnancy|0|||
131444850|NCT03137381|473258739|FG001|Overall Study|Pregnancy|0|||
131444851|NCT03137381|473258740|FG002|Overall Study|Pregnancy|1|||
131444852|NCT03137381|473258741|FG003|Overall Study|Pregnancy|0|||
131634224|NCT01247922|473945197|FG000|Overall Study|Disease progression|4|||
131634225|NCT01876823|473945200|FG000|Overall Study|Withdrawal by Subject|5|||
131634226|NCT01876823|473945200|FG000|Overall Study|Physician Decision|2|||
131634227|NCT01876823|473945200|FG000|Overall Study|Patients moved|2|||
131634228|NCT02849509|473945201|FG000|Overall Study|Worsening of disease under study|1|||
131634229|NCT02849509|473945202|FG001|Overall Study|Worsening of disease under study|1|||
131634230|NCT02849509|473945203|FG002|Overall Study|Worsening of disease under study|1|||
131634231|NCT02849509|473945201|FG000|Overall Study|Worsening of other pre-existing disease|0|||
131444853|NCT01980017|473258742|FG000|Overall Study|Lost to Follow-up|30|||
131444854|NCT01980017|473258743|FG001|Overall Study|Lost to Follow-up|21|||
131444855|NCT01980017|473258742|FG000|Overall Study|Death|0|||
131444856|NCT01980017|473258743|FG001|Overall Study|Death|1|||
131634232|NCT02849509|473945202|FG001|Overall Study|Worsening of other pre-existing disease|1|||
131634233|NCT02849509|473945203|FG002|Overall Study|Worsening of other pre-existing disease|2|||
131444857|NCT03367793|473258744|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
131444858|NCT03367793|473258745|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
131444859|NCT03367793|473258746|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
131444860|NCT03367793|473258747|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
131444861|NCT03367793|473258748|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
131444862|NCT03367793|473258749|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
131444863|NCT00423579|473258750|FG000|Overall Study|Lost to Follow-up|3|||
131634234|NCT02849509|473945201|FG000|Overall Study|Other adverse event|36|||
131634235|NCT02849509|473945202|FG001|Overall Study|Other adverse event|41|||
131634236|NCT02849509|473945203|FG002|Overall Study|Other adverse event|8|||
131634237|NCT02849509|473945201|FG000|Overall Study|Withdrawal by Subject|6|||
131634238|NCT02849509|473945202|FG001|Overall Study|Withdrawal by Subject|17|||
131634239|NCT02849509|473945203|FG002|Overall Study|Withdrawal by Subject|12|||
131634240|NCT02849509|473945201|FG000|Overall Study|Lost to Follow-up|27|||
131634241|NCT02849509|473945202|FG001|Overall Study|Lost to Follow-up|67|||
131634242|NCT02849509|473945203|FG002|Overall Study|Lost to Follow-up|36|||
131634243|NCT02849509|473945201|FG000|Overall Study|Other, reason not specified|14|||
131634244|NCT02849509|473945202|FG001|Overall Study|Other, reason not specified|29|||
131634245|NCT02849509|473945203|FG002|Overall Study|Other, reason not specified|25|||
131634246|NCT02849509|473945201|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
131634247|NCT02849509|473945202|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
131634248|NCT02849509|473945203|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
131634249|NCT03928821|473945204|FG000|Overall Study|Death|0|||
131634250|NCT03928821|473945205|FG001|Overall Study|Death|1|||
131634251|NCT03928821|473945206|FG002|Overall Study|Death|0|||
131634252|NCT03928821|473945207|FG003|Overall Study|Death|0|||
131634253|NCT03928821|473945204|FG000|Overall Study|Lost to Follow-up|0|||
131634254|NCT03928821|473945205|FG001|Overall Study|Lost to Follow-up|2|||
131634255|NCT03928821|473945206|FG002|Overall Study|Lost to Follow-up|3|||
131634256|NCT03928821|473945207|FG003|Overall Study|Lost to Follow-up|0|||
131444864|NCT00423579|473258751|FG001|Overall Study|Lost to Follow-up|0|||
131634257|NCT03928821|473945204|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131634258|NCT03928821|473945205|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131634259|NCT03928821|473945206|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131634260|NCT03928821|473945207|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
131634261|NCT00985621|473945215|FG000|Overall Study|Adverse Event|2|||
131634262|NCT00985621|473945216|FG001|Overall Study|Adverse Event|3|||
131634263|NCT00985621|473945217|FG002|Overall Study|Adverse Event|4|||
131634264|NCT00985621|473945218|FG003|Overall Study|Adverse Event|16|||
131634265|NCT00985621|473945215|FG000|Overall Study|Lack of Efficacy|10|||
131444865|NCT00423579|473258750|FG000|Overall Study|Protocol Violation|1|||
131634266|NCT00985621|473945216|FG001|Overall Study|Lack of Efficacy|6|||
131634267|NCT00985621|473945217|FG002|Overall Study|Lack of Efficacy|5|||
131634268|NCT00985621|473945218|FG003|Overall Study|Lack of Efficacy|12|||
131634269|NCT00985621|473945215|FG000|Overall Study|Lost to Follow-up|2|||
131634270|NCT00985621|473945216|FG001|Overall Study|Lost to Follow-up|3|||
131634271|NCT00985621|473945217|FG002|Overall Study|Lost to Follow-up|4|||
131634272|NCT00985621|473945218|FG003|Overall Study|Lost to Follow-up|4|||
131634273|NCT00985621|473945215|FG000|Overall Study|Study Terminated by Sponsor|89|||
131634274|NCT00985621|473945216|FG001|Overall Study|Study Terminated by Sponsor|108|||
131634275|NCT00985621|473945217|FG002|Overall Study|Study Terminated by Sponsor|99|||
131634276|NCT00985621|473945218|FG003|Overall Study|Study Terminated by Sponsor|92|||
131444866|NCT00423579|473258751|FG001|Overall Study|Protocol Violation|3|||
131634277|NCT00985621|473945215|FG000|Overall Study|Protocol Violation|1|||
131444867|NCT00423579|473258750|FG000|Overall Study|Diagnosis of diabetes|0|||
131444868|NCT00423579|473258751|FG001|Overall Study|Diagnosis of diabetes|1|||
131444869|NCT02224560|473258755|FG000|Overall Study|Protocol Deviation|1|||
131444870|NCT02224560|473258756|FG001|Overall Study|Protocol Deviation|0|||
131444871|NCT02224560|473258757|FG002|Overall Study|Protocol Deviation|0|||
131444872|NCT02224560|473258755|FG000|Overall Study|Withdrawal by Subject|2|||
131444873|NCT02224560|473258756|FG001|Overall Study|Withdrawal by Subject|0|||
131444874|NCT02224560|473258757|FG002|Overall Study|Withdrawal by Subject|1|||
131444875|NCT02224560|473258755|FG000|Overall Study|Met Withdrawal Criteria|1|||
131444876|NCT02224560|473258756|FG001|Overall Study|Met Withdrawal Criteria|0|||
131444877|NCT02224560|473258757|FG002|Overall Study|Met Withdrawal Criteria|0|||
131444878|NCT02224560|473258755|FG000|Overall Study|Adverse Event|4|||
131444879|NCT02224560|473258756|FG001|Overall Study|Adverse Event|1|||
131444880|NCT02224560|473258757|FG002|Overall Study|Adverse Event|1|||
131444881|NCT02224560|473258755|FG000|Overall Study|Withdrawn by Investigator|1|||
131444882|NCT02224560|473258756|FG001|Overall Study|Withdrawn by Investigator|1|||
131444883|NCT02224560|473258757|FG002|Overall Study|Withdrawn by Investigator|0|||
131444884|NCT01210313|473258762|FG000|Overall Study|Withdrawal by Subject|3|||
131444885|NCT01210313|473258762|FG000|Overall Study|Adverse Event|2|||
131444886|NCT01210313|473258762|FG000|Overall Study|Distant recurrence|4|||
131444887|NCT01210313|473258762|FG000|Overall Study|Non-compliance|7|||
131444888|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
131444889|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
131444890|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
131634278|NCT00985621|473945216|FG001|Overall Study|Protocol Violation|1|||
131634279|NCT00985621|473945217|FG002|Overall Study|Protocol Violation|1|||
131634280|NCT00985621|473945218|FG003|Overall Study|Protocol Violation|0|||
131634281|NCT00985621|473945215|FG000|Overall Study|Withdrawal by Subject|8|||
131634282|NCT00985621|473945216|FG001|Overall Study|Withdrawal by Subject|10|||
131634283|NCT00985621|473945217|FG002|Overall Study|Withdrawal by Subject|8|||
131634284|NCT00985621|473945218|FG003|Overall Study|Withdrawal by Subject|12|||
131634285|NCT00985621|473945215|FG000|Overall Study|Other|1|||
131634286|NCT00985621|473945216|FG001|Overall Study|Other|0|||
131634287|NCT00985621|473945217|FG002|Overall Study|Other|0|||
131634288|NCT00985621|473945218|FG003|Overall Study|Other|0|||
131634289|NCT00985621|473945215|FG000|Overall Study|Randomized but not Treated|1|||
131634290|NCT00985621|473945216|FG001|Overall Study|Randomized but not Treated|0|||
131634291|NCT00985621|473945217|FG002|Overall Study|Randomized but not Treated|2|||
131444891|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
131444892|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
131444893|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
131444894|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
131444895|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
131444896|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
131444897|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
131444898|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
131444899|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
131444900|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
131444901|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
131444902|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
131444903|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
131444904|NCT03773978|473258765|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
131444905|NCT03773978|473258766|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
131444906|NCT03773978|473258765|FG000|DBW Period|Adverse Event|2|||
131444907|NCT03773978|473258766|FG001|DBW Period|Adverse Event|2|||
131444908|NCT03773978|473258765|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
131444909|NCT03773978|473258766|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
131634292|NCT00985621|473945218|FG003|Overall Study|Randomized but not Treated|1|||
131634293|NCT03840148|473945219|FG000|Study Drug Disposition|Adverse Event|13|||
131634294|NCT03840148|473945220|FG001|Study Drug Disposition|Adverse Event|2|||
131634295|NCT03840148|473945219|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
131634296|NCT03840148|473945220|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
131798472|NCT02579096|474546029|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
131798473|NCT02579096|474546028|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
131798474|NCT02579096|474546029|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
131798475|NCT02579096|474546028|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
131444910|NCT03773978|473258765|FG000|DBW Period|Withdrawal by Subject|2|||
131444911|NCT03773978|473258766|FG001|DBW Period|Withdrawal by Subject|1|||
131634297|NCT03840148|473945219|FG000|Study Drug Disposition|Lack of Efficacy|3|||
131634298|NCT03840148|473945220|FG001|Study Drug Disposition|Lack of Efficacy|0|||
131634299|NCT03840148|473945219|FG000|Study Drug Disposition|Physician Decision|2|||
131634300|NCT03840148|473945220|FG001|Study Drug Disposition|Physician Decision|0|||
131634301|NCT03840148|473945219|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
131804520|NCT02914600|474568556|FG000|Overall Study|Sponsors decision|287|||
131444912|NCT03773978|473258765|FG000|DBW Period|Due to epidemic or pandemic|5|||
131444913|NCT03773978|473258766|FG001|DBW Period|Due to epidemic or pandemic|6|||
131444914|NCT03773978|473258765|FG000|DBW Period|Study team decision|1|||
131444915|NCT03773978|473258766|FG001|DBW Period|Study team decision|0|||
131444916|NCT01710345|473258775|FG000|Overall Study|Adverse Event|0|||
131798476|NCT02579096|474546029|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
131798477|NCT02579096|474546028|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
131798478|NCT02579096|474546029|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
131798479|NCT02579096|474546028|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
131798480|NCT02579096|474546029|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
131798481|NCT02579096|474546028|FG000|Phase 2, Weeks 25 - 48|Death|2|||
131798482|NCT02579096|474546029|FG001|Phase 2, Weeks 25 - 48|Death|4|||
131798483|NCT02579096|474546028|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
131444917|NCT01710345|473258776|FG001|Overall Study|Adverse Event|2|||
131444918|NCT01710345|473258777|FG002|Overall Study|Adverse Event|0|||
131444919|NCT01710345|473258775|FG000|Overall Study|Lack of Efficacy|2|||
131444920|NCT01710345|473258776|FG001|Overall Study|Lack of Efficacy|3|||
131444921|NCT01710345|473258777|FG002|Overall Study|Lack of Efficacy|1|||
131444922|NCT01710345|473258775|FG000|Overall Study|Drug Dosing Error|1|||
131444923|NCT01710345|473258776|FG001|Overall Study|Drug Dosing Error|0|||
131444924|NCT01710345|473258777|FG002|Overall Study|Drug Dosing Error|0|||
131444925|NCT04298697|473258780|FG000|Overall Study|Lost to Follow-up|5|||
131444926|NCT04298697|473258781|FG001|Overall Study|Lost to Follow-up|5|||
131444927|NCT04298697|473258782|FG002|Overall Study|Lost to Follow-up|1|||
131444928|NCT04298697|473258783|FG003|Overall Study|Lost to Follow-up|0|||
131444929|NCT04298697|473258780|FG000|Overall Study|Withdrawal by Subject|0|||
131444930|NCT04298697|473258781|FG001|Overall Study|Withdrawal by Subject|3|||
131444931|NCT04298697|473258782|FG002|Overall Study|Withdrawal by Subject|2|||
131444932|NCT04298697|473258783|FG003|Overall Study|Withdrawal by Subject|3|||
131444933|NCT00449696|473258784|FG000|Overall Study|Other Treatment Required|6|||
131444934|NCT00449696|473258785|FG001|Overall Study|Other Treatment Required|1|||
131444935|NCT00449696|473258784|FG000|Overall Study|Withdrawal by Subject|5|||
131444936|NCT00449696|473258785|FG001|Overall Study|Withdrawal by Subject|5|||
131634302|NCT03840148|473945220|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
131634303|NCT03840148|473945219|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
131634304|NCT03840148|473945220|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
131634305|NCT03840148|473945219|FG000|Study Completion Disposition|Physician Decision|2|||
131634306|NCT03840148|473945220|FG001|Study Completion Disposition|Physician Decision|0|||
131634307|NCT03840148|473945219|FG000|Study Completion Disposition|Covid-19 related|2|||
131634308|NCT03840148|473945220|FG001|Study Completion Disposition|Covid-19 related|0|||
131634309|NCT03840148|473945219|FG000|Study Completion Disposition|Lost to Follow-up|1|||
131634310|NCT03840148|473945220|FG001|Study Completion Disposition|Lost to Follow-up|1|||
131634311|NCT03840148|473945219|FG000|Study Completion Disposition|Death|1|||
131634312|NCT03840148|473945220|FG001|Study Completion Disposition|Death|0|||
131634313|NCT03840148|473945219|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
131634314|NCT03840148|473945220|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
131634315|NCT03615404|473945221|FG000|Overall Study|Death|1|||
131713808|NCT00552110|474228817|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
131713809|NCT00552110|474228813|FG000|Overall Study|Withdrawn per Sponsor|0|||
131713810|NCT00552110|474228814|FG001|Overall Study|Withdrawn per Sponsor|1|||
131713811|NCT00552110|474228815|FG002|Overall Study|Withdrawn per Sponsor|0|||
131713812|NCT00552110|474228816|FG003|Overall Study|Withdrawn per Sponsor|0|||
131713813|NCT00552110|474228817|FG004|Overall Study|Withdrawn per Sponsor|1|||
131713814|NCT00552110|474228813|FG000|Overall Study|Use of Prohibited Medication|1|||
131713815|NCT00552110|474228814|FG001|Overall Study|Use of Prohibited Medication|1|||
131713816|NCT00552110|474228815|FG002|Overall Study|Use of Prohibited Medication|0|||
131798484|NCT02579096|474546029|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
131444937|NCT00449696|473258784|FG000|Overall Study|Lost to Follow-up|2|||
131444938|NCT00449696|473258785|FG001|Overall Study|Lost to Follow-up|3|||
131444939|NCT00449696|473258784|FG000|Overall Study|Others|7|||
131444940|NCT00449696|473258785|FG001|Overall Study|Others|0|||
131444941|NCT01033019|473258786|FG000|Overall Study|Withdrawal by Subject|1|||
131444942|NCT01033019|473258787|FG001|Overall Study|Withdrawal by Subject|0|||
131798485|NCT02579096|474546028|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
131798486|NCT02579096|474546029|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
131798487|NCT02579096|474546028|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
131798488|NCT02579096|474546029|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
131798489|NCT02579096|474546028|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
131798490|NCT02579096|474546029|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
131798491|NCT02579096|474546028|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
131444943|NCT05386329|473258790|FG000|Overall Study|Lost to Follow-up|3|||
131444944|NCT03041181|473258792|FG000|Overall Study|Disease Progression|1|||
131798492|NCT02579096|474546029|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
131798493|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Death|3|||
131798494|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Death|2|||
131798495|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
131798496|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
131798497|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
131444945|NCT03041181|473258793|FG001|Overall Study|Disease Progression|2|||
131444946|NCT01903460|473258794|FG000|Overall Study|Adverse Event|0|||
131634316|NCT03615404|473945221|FG000|Overall Study|vaccine did not pass quality assurance|1|||
131634317|NCT01774929|473945222|FG000|Overall Study|Adverse Event|3|||
131634318|NCT04382053|473945229|FG000|Overall Study|Death|6|||
131634319|NCT04382053|473945230|FG001|Overall Study|Death|8|||
131634320|NCT04382053|473945229|FG000|Overall Study|Lost to Follow-up|0|||
131634321|NCT04382053|473945230|FG001|Overall Study|Lost to Follow-up|2|||
131634322|NCT04382053|473945229|FG000|Overall Study|Protocol Deviation|1|||
131634323|NCT04382053|473945230|FG001|Overall Study|Protocol Deviation|2|||
131798498|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
131798499|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
131798500|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
131798501|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
131798502|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
131798503|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
131634324|NCT04382053|473945229|FG000|Overall Study|Withdrawal by Subject|2|||
131634325|NCT04382053|473945230|FG001|Overall Study|Withdrawal by Subject|1|||
131634326|NCT01399905|473945234|FG000|Overall Study|Withdrawal by Subject|1|||
131634327|NCT01399905|473945235|FG001|Overall Study|Withdrawal by Subject|1|||
131634328|NCT00170950|473945238|FG000|Overall Study|Death|236|||
131798504|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
131798505|NCT02579096|474546028|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
131902501|NCT02515630|474929283|FG000|Overall Study|Withdrawal by Subject|5|||
131902502|NCT02515630|474929283|FG000|Overall Study|Adverse Event|4|||
131902503|NCT02515630|474929283|FG000|Overall Study|Physician Decision|4|||
131634329|NCT00170950|473945239|FG001|Overall Study|Death|274|||
131634330|NCT00170950|473945238|FG000|Overall Study|Withdrawal by Subject|496|||
131634331|NCT00170950|473945239|FG001|Overall Study|Withdrawal by Subject|498|||
131634332|NCT00170950|473945238|FG000|Overall Study|Lost to Follow-up|134|||
131634333|NCT00170950|473945239|FG001|Overall Study|Lost to Follow-up|115|||
131634334|NCT00170950|473945238|FG000|Overall Study|Missing|2|||
131634335|NCT00170950|473945239|FG001|Overall Study|Missing|1|||
131634336|NCT00170950|473945238|FG000|Overall Study|Termination Data Not Recorded|17|||
131634337|NCT00170950|473945239|FG001|Overall Study|Termination Data Not Recorded|22|||
131634338|NCT04044352|473946981|FG000|Overall Study|Lost to Follow-up|9|||
131634339|NCT04044352|473946981|FG000|Overall Study|Withdrawal by Subject|2|||
131634340|NCT00651937|473946982|FG000|Overall Study|Withdrawal by Subject|4|||
131634341|NCT00651937|473946983|FG001|Overall Study|Withdrawal by Subject|1|||
131634342|NCT00635570|473946985|FG000|Overall Study|Lost to Follow-up|8|||
131902504|NCT02515630|474929283|FG000|Overall Study|Death|2|||
131444947|NCT01903460|473258795|FG001|Overall Study|Adverse Event|0|||
131444948|NCT01903460|473258796|FG002|Overall Study|Adverse Event|0|||
131634343|NCT00635570|473946986|FG001|Overall Study|Lost to Follow-up|8|||
131634344|NCT00635570|473946985|FG000|Overall Study|Withdrawal by Subject|1|||
131634345|NCT00635570|473946986|FG001|Overall Study|Withdrawal by Subject|1|||
131634346|NCT00635570|473946985|FG000|Overall Study|Adverse Event|2|||
131634347|NCT00635570|473946986|FG001|Overall Study|Adverse Event|0|||
131444949|NCT01903460|473258797|FG003|Overall Study|Adverse Event|1|||
131634348|NCT00635570|473946985|FG000|Overall Study|Physician Decision|1|||
131798506|NCT02579096|474546029|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
131798507|NCT02994056|474546034|FG000|Overall Study|Death|8|||
131902505|NCT02515630|474929283|FG000|Overall Study|Disease Progression|1|||
131444950|NCT03104868|473258798|FG000|6 Week Follow up|Lost to Follow-up|5|||
131444951|NCT03104868|473258799|FG001|6 Week Follow up|Lost to Follow-up|8|||
131444952|NCT03104868|473258798|FG000|6 Week Follow up|Death|1|||
131444953|NCT03104868|473258799|FG001|6 Week Follow up|Death|1|||
131444954|NCT03104868|473258798|FG000|6 Week Follow up|Withdrawal by Subject|7|||
131444955|NCT03104868|473258799|FG001|6 Week Follow up|Withdrawal by Subject|6|||
131444956|NCT03104868|473258798|FG000|6 Week Follow up|Completed Later Timepoint|24|||
131444957|NCT03104868|473258799|FG001|6 Week Follow up|Completed Later Timepoint|22|||
131444958|NCT03104868|473258798|FG000|6 Month Follow up|Lost to Follow-up|2|||
131444959|NCT03104868|473258799|FG001|6 Month Follow up|Lost to Follow-up|2|||
131444960|NCT03104868|473258798|FG000|6 Month Follow up|Death|0|||
131444961|NCT03104868|473258799|FG001|6 Month Follow up|Death|1|||
131444962|NCT03104868|473258798|FG000|6 Month Follow up|Completed Later Timepoint|22|||
131444963|NCT03104868|473258799|FG001|6 Month Follow up|Completed Later Timepoint|32|||
131444964|NCT03104868|473258798|FG000|12 Month Follow up|Lost to Follow-up|1|||
131634349|NCT00635570|473946986|FG001|Overall Study|Physician Decision|0|||
131634350|NCT00635570|473946985|FG000|Overall Study|Did not complete survey|2|||
131634351|NCT00635570|473946986|FG001|Overall Study|Did not complete survey|1|||
131634352|NCT00635570|473946985|FG000|Overall Study|Early termination(No sexual activity)|1|||
131634353|NCT00635570|473946986|FG001|Overall Study|Early termination(No sexual activity)|1|||
131634354|NCT00377312|473946997|FG000|Overall Study|Adverse Event|1|||
131798508|NCT02994056|474546034|FG000|Overall Study|Withdrew Consent|1|||
131798509|NCT02199509|474546037|FG000|Overall Study|Suicidal Ideation|0|||
131798510|NCT02199509|474546038|FG001|Overall Study|Suicidal Ideation|1|||
131798511|NCT02199509|474546037|FG000|Overall Study|Misunderstood titration schedule|1|||
131798512|NCT02199509|474546038|FG001|Overall Study|Misunderstood titration schedule|0|||
131798513|NCT04947579|474546042|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131798514|NCT04947579|474546043|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131798515|NCT04947579|474546044|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131798516|NCT04947579|474546045|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
131798517|NCT04947579|474546046|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131798518|NCT04947579|474546047|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131798519|NCT04947579|474546042|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131798520|NCT04947579|474546043|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131798521|NCT04947579|474546044|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
131798522|NCT04947579|474546045|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131798523|NCT04947579|474546046|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131798524|NCT04947579|474546047|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131798525|NCT04947579|474546042|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
131798526|NCT04947579|474546043|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
131798527|NCT04947579|474546044|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
131798528|NCT04947579|474546045|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
131798529|NCT04947579|474546046|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
131798530|NCT04947579|474546047|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
131798531|NCT04947579|474546042|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
131798532|NCT04947579|474546043|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
131634355|NCT00377312|473946998|FG001|Overall Study|Adverse Event|1|||
131634356|NCT02775214|473946999|FG000|Overall Study|Withdrawal by Subject|2|||
131634357|NCT02775214|473947000|FG001|Overall Study|Withdrawal by Subject|0|||
131634358|NCT00762723|473947001|FG000|Overall Study|Study Terminated slow enrollement|5|||
131634359|NCT00762723|473947002|FG001|Overall Study|Study Terminated slow enrollement|5|||
131634360|NCT00762723|473947003|FG002|Overall Study|Study Terminated slow enrollement|3|||
131634361|NCT01145417|473947004|FG000|Overall Study|Death|1|||
131634362|NCT01145417|473947005|FG001|Overall Study|Death|0|||
131634363|NCT01145417|473947004|FG000|Overall Study|Lost to Follow-up|2|||
131634364|NCT01145417|473947005|FG001|Overall Study|Lost to Follow-up|1|||
131444965|NCT03104868|473258799|FG001|12 Month Follow up|Lost to Follow-up|2|||
131634365|NCT01145417|473947004|FG000|Overall Study|Withdrawal by Subject|1|||
131634366|NCT01145417|473947005|FG001|Overall Study|Withdrawal by Subject|2|||
131634367|NCT01145417|473947004|FG000|Overall Study|Pregnancy|1|||
131798533|NCT04947579|474546044|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
131713817|NCT00552110|474228816|FG003|Overall Study|Use of Prohibited Medication|0|||
131713818|NCT00552110|474228817|FG004|Overall Study|Use of Prohibited Medication|0|||
131713819|NCT00552110|474228813|FG000|Overall Study|Delay of Study due to Relabeling|0|||
131713820|NCT00552110|474228814|FG001|Overall Study|Delay of Study due to Relabeling|0|||
131713821|NCT00552110|474228815|FG002|Overall Study|Delay of Study due to Relabeling|0|||
131713822|NCT00552110|474228816|FG003|Overall Study|Delay of Study due to Relabeling|1|||
131713823|NCT00552110|474228817|FG004|Overall Study|Delay of Study due to Relabeling|0|||
131713824|NCT00552110|474228813|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
131713825|NCT00552110|474228814|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
131713826|NCT00552110|474228815|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
131713827|NCT00552110|474228816|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
131713828|NCT00552110|474228817|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
131713829|NCT00552110|474228813|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
131713830|NCT00552110|474228814|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
131713831|NCT00552110|474228815|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
131713832|NCT00552110|474228816|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
131713833|NCT00552110|474228817|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
131713834|NCT04373460|474228826|FG000|Overall Study|Did not receive tranfusion|18|||
131713835|NCT04373460|474228827|FG001|Overall Study|Did not receive tranfusion|26|||
131713836|NCT01672957|474228828|FG000|Overall Study|Protocol Violation|48|||
131713837|NCT01672957|474228828|FG000|Overall Study|Death|2|||
131713838|NCT01672957|474228828|FG000|Overall Study|ICF Signed After Transplantation|5|||
131713839|NCT00642642|474228829|FG000|Treatment & Follow Up|Adverse Event|2|||
131713840|NCT00642642|474228829|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
131713841|NCT00642642|474228829|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
131713842|NCT01511445|474228832|FG000|Overall Study|Lost to Follow-up|3|||
131713843|NCT01511445|474228833|FG001|Overall Study|Lost to Follow-up|1|||
131713844|NCT01511445|474228832|FG000|Overall Study|Protocol Violation|1|||
131713845|NCT01511445|474228833|FG001|Overall Study|Protocol Violation|3|||
131713846|NCT01511445|474228832|FG000|Overall Study|Protocol Violation|1|||
131713847|NCT01511445|474228833|FG001|Overall Study|Protocol Violation|0|||
131713848|NCT01856114|474228836|FG000|Overall Study|Withdrawal by Subject|1|||
131713849|NCT01856114|474228837|FG001|Overall Study|Withdrawal by Subject|0|||
131713850|NCT01856114|474228836|FG000|Overall Study|Adverse Event|1|||
131713851|NCT01856114|474228837|FG001|Overall Study|Adverse Event|0|||
131713852|NCT02272790|474228838|FG000|Overall Study|Physician Decision|0|||
131713853|NCT02272790|474228839|FG001|Overall Study|Physician Decision|1|||
131713854|NCT02272790|474228840|FG002|Overall Study|Physician Decision|0|||
131713855|NCT02272790|474228841|FG003|Overall Study|Physician Decision|0|||
131713856|NCT02272790|474228842|FG004|Overall Study|Physician Decision|0|||
131713857|NCT02272790|474228843|FG005|Overall Study|Physician Decision|0|||
131713858|NCT00332202|474228844|FG000|Overall Study|Adverse Event|72|||
131713859|NCT00332202|474228845|FG001|Overall Study|Adverse Event|28|||
131713860|NCT00332202|474228844|FG000|Overall Study|Lost to Follow-up|2|||
131713861|NCT00332202|474228845|FG001|Overall Study|Lost to Follow-up|1|||
131713862|NCT00332202|474228844|FG000|Overall Study|Physician Decision|6|||
131713863|NCT00332202|474228845|FG001|Overall Study|Physician Decision|8|||
131713864|NCT00332202|474228844|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
131798534|NCT04947579|474546045|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
131798535|NCT04947579|474546046|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
131798536|NCT04947579|474546047|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
131798537|NCT04947579|474546042|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
131798538|NCT04947579|474546043|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131798539|NCT04947579|474546044|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131798540|NCT04947579|474546045|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131798541|NCT04947579|474546046|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131798542|NCT04947579|474546047|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131798543|NCT04947579|474546042|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131798544|NCT04947579|474546043|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131798545|NCT04947579|474546044|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
131798546|NCT04947579|474546045|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131713865|NCT00332202|474228845|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
131713866|NCT00332202|474228844|FG000|Overall Study|Protocol Violation|7|||
131713867|NCT00332202|474228845|FG001|Overall Study|Protocol Violation|2|||
131713868|NCT00332202|474228844|FG000|Overall Study|Sponsor Decision|1|||
131713869|NCT00332202|474228845|FG001|Overall Study|Sponsor Decision|2|||
131713870|NCT00332202|474228844|FG000|Overall Study|Withdrawal by Subject|36|||
131713871|NCT00332202|474228845|FG001|Overall Study|Withdrawal by Subject|17|||
131713872|NCT00332202|474228844|FG000|Overall Study|Progressive Disease|106|||
131713873|NCT00332202|474228845|FG001|Overall Study|Progressive Disease|60|||
131798547|NCT04947579|474546046|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131713874|NCT00332202|474228844|FG000|Overall Study|Death|5|||
131798548|NCT04947579|474546047|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131798549|NCT04947579|474546042|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131798550|NCT04947579|474546043|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
131798551|NCT04947579|474546044|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131798552|NCT04947579|474546045|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131798553|NCT04947579|474546046|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131798554|NCT04947579|474546047|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
131798555|NCT04947579|474546042|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131798556|NCT04947579|474546043|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131798557|NCT04947579|474546044|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
131798558|NCT04947579|474546045|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131798559|NCT04947579|474546046|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131798560|NCT04947579|474546047|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131798561|NCT04947579|474546042|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
131798562|NCT04947579|474546043|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
131798563|NCT04947579|474546044|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
131798564|NCT04947579|474546045|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
131798565|NCT04947579|474546046|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
131798566|NCT04947579|474546047|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
131798567|NCT04947579|474546042|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
131798568|NCT04947579|474546043|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
131798569|NCT04947579|474546044|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
131634368|NCT01145417|473947005|FG001|Overall Study|Pregnancy|0|||
131634369|NCT01145417|473947004|FG000|Overall Study|Adverse Event|0|||
131902506|NCT03075267|474929292|FG000|Overall Study|Protocol Violation|1|||
131902507|NCT03075267|474929293|FG001|Overall Study|Protocol Violation|0|||
131444966|NCT03104868|473258798|FG000|12 Month Follow up|Death|0|||
131444967|NCT03104868|473258799|FG001|12 Month Follow up|Death|1|||
131444968|NCT03104868|473258798|FG000|12 Month Follow up|Withdrawal by Subject|0|||
131444969|NCT03104868|473258799|FG001|12 Month Follow up|Withdrawal by Subject|3|||
131444970|NCT03104868|473258798|FG000|12 Month Follow up|Completed Later Timepoint|32|||
131444971|NCT03104868|473258799|FG001|12 Month Follow up|Completed Later Timepoint|29|||
131444972|NCT03104868|473258798|FG000|18 Month Follow up|Lost to Follow-up|7|||
131444973|NCT03104868|473258799|FG001|18 Month Follow up|Lost to Follow-up|11|||
131444974|NCT03104868|473258798|FG000|18 Month Follow up|Death|2|||
131444975|NCT03104868|473258799|FG001|18 Month Follow up|Death|1|||
131444976|NCT03104868|473258798|FG000|18 Month Follow up|Withdrawal by Subject|1|||
131444977|NCT03104868|473258799|FG001|18 Month Follow up|Withdrawal by Subject|2|||
131444978|NCT03104868|473258798|FG000|18 Month Follow up|Graft Loss|1|||
131444979|NCT03104868|473258799|FG001|18 Month Follow up|Graft Loss|1|||
131444980|NCT03104868|473258798|FG000|18 Month Follow up|Completed Later Timepoint|19|||
131444981|NCT03104868|473258799|FG001|18 Month Follow up|Completed Later Timepoint|20|||
131444982|NCT03104868|473258798|FG000|24 Month Follow up|Lost to Follow-up|15|||
131444983|NCT03104868|473258799|FG001|24 Month Follow up|Lost to Follow-up|16|||
131444984|NCT03104868|473258798|FG000|24 Month Follow up|Death|3|||
131634370|NCT01145417|473947005|FG001|Overall Study|Adverse Event|1|||
131634371|NCT01145417|473947004|FG000|Overall Study|Study terminated by sponsor|35|||
131634372|NCT01145417|473947005|FG001|Overall Study|Study terminated by sponsor|43|||
131634373|NCT01145417|473947004|FG000|Overall Study|Other|1|||
131634374|NCT01145417|473947005|FG001|Overall Study|Other|0|||
131634375|NCT01191697|473947006|FG000|Overall Study|Death|1|||
131634376|NCT01191697|473947006|FG000|Overall Study|Physician Decision|2|||
131634377|NCT01191697|473947006|FG000|Overall Study|Pursue chemoradiation|2|||
131634378|NCT01191697|473947006|FG000|Overall Study|Break from chemotherapy|2|||
131634379|NCT01191697|473947006|FG000|Overall Study|Withdrawal by Subject|1|||
131634380|NCT01191697|473947006|FG000|Overall Study|Surveillance|1|||
131634381|NCT01191697|473947006|FG000|Overall Study|Adverse Event|2|||
131634382|NCT01191697|473947006|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
131634383|NCT01191697|473947006|FG000|Overall Study|Not completed but analyzed|25|||
131634384|NCT03568708|473947011|FG000|Overall Study|Withdrawal by Subject|1|||
131634385|NCT03568708|473947012|FG001|Overall Study|Withdrawal by Subject|1|||
131444985|NCT03104868|473258799|FG001|24 Month Follow up|Death|2|||
131444986|NCT03104868|473258798|FG000|24 Month Follow up|Withdrawal by Subject|1|||
131444987|NCT03104868|473258799|FG001|24 Month Follow up|Withdrawal by Subject|0|||
131444988|NCT03104868|473258798|FG000|24 Month Follow up|Graft Loss|2|||
131444989|NCT03104868|473258799|FG001|24 Month Follow up|Graft Loss|0|||
131444990|NCT03050801|473258802|FG000|Experiment 1|Lost to Follow-up|0|||
131444991|NCT03050801|473258803|FG001|Experiment 1|Lost to Follow-up|1|||
131444992|NCT03050801|473258804|FG002|Experiment 1|Lost to Follow-up|0|||
131444993|NCT03050801|473258805|FG003|Experiment 1|Lost to Follow-up|0|||
131444994|NCT03050801|473258806|FG004|Experiment 1|Lost to Follow-up|0|||
131444995|NCT03050801|473258807|FG005|Experiment 1|Lost to Follow-up|0|||
131444996|NCT03050801|473258802|FG000|Experiment 1|Physician Decision|0|||
131444997|NCT03050801|473258803|FG001|Experiment 1|Physician Decision|3|||
131444998|NCT03050801|473258804|FG002|Experiment 1|Physician Decision|0|||
131444999|NCT03050801|473258805|FG003|Experiment 1|Physician Decision|0|||
131445000|NCT03050801|473258806|FG004|Experiment 1|Physician Decision|0|||
131445001|NCT03050801|473258807|FG005|Experiment 1|Physician Decision|0|||
131445002|NCT03050801|473258802|FG000|Experiment 1|Change of experimental design|0|||
131445003|NCT03050801|473258803|FG001|Experiment 1|Change of experimental design|3|||
131634386|NCT03568708|473947011|FG000|Overall Study|Lost to Follow-up|0|||
131634387|NCT03568708|473947012|FG001|Overall Study|Lost to Follow-up|1|||
131634388|NCT00511147|473947015|FG000|Overall Study|Withdrawal by Subject|1|||
131634389|NCT00511147|473947015|FG000|Overall Study|Disease progression|5|||
131798570|NCT04947579|474546045|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
131798571|NCT04947579|474546046|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
131798572|NCT04947579|474546047|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
131798573|NCT04947579|474546042|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
131798574|NCT04947579|474546043|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
131798575|NCT04947579|474546044|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
131798576|NCT04947579|474546045|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
131798577|NCT04947579|474546046|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
131798578|NCT04947579|474546047|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
131798579|NCT02448771|474546048|FG000|Overall Study|Disease Progression|30|||
131798580|NCT02448771|474546048|FG000|Overall Study|Unacceptable Toxicity|1|||
131798581|NCT02448771|474546048|FG000|Overall Study|Physician Decision|3|||
131445004|NCT03050801|473258804|FG002|Experiment 1|Change of experimental design|0|||
131445005|NCT03050801|473258805|FG003|Experiment 1|Change of experimental design|0|||
131445006|NCT03050801|473258806|FG004|Experiment 1|Change of experimental design|0|||
131445007|NCT03050801|473258807|FG005|Experiment 1|Change of experimental design|0|||
131445008|NCT03050801|473258802|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
131445009|NCT03050801|473258803|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
131445010|NCT03050801|473258804|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
131445011|NCT03050801|473258805|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
131445012|NCT03050801|473258806|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
131445013|NCT03050801|473258807|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
131445014|NCT03050801|473258802|FG000|Experiment 2|Lost to Follow-up|0|||
131445015|NCT03050801|473258803|FG001|Experiment 2|Lost to Follow-up|0|||
131445016|NCT03050801|473258804|FG002|Experiment 2|Lost to Follow-up|0|||
131445017|NCT03050801|473258805|FG003|Experiment 2|Lost to Follow-up|1|||
131445018|NCT03050801|473258806|FG004|Experiment 2|Lost to Follow-up|1|||
131445019|NCT03050801|473258807|FG005|Experiment 2|Lost to Follow-up|0|||
131445020|NCT03050801|473258802|FG000|Experiment 2|Physician Decision|0|||
131445021|NCT03050801|473258803|FG001|Experiment 2|Physician Decision|0|||
131634390|NCT00511147|473947015|FG000|Overall Study|Required platelet transfusion|1|||
131798582|NCT02448771|474546048|FG000|Overall Study|Started new therapy|2|||
131445022|NCT03050801|473258804|FG002|Experiment 2|Physician Decision|0|||
131445023|NCT03050801|473258805|FG003|Experiment 2|Physician Decision|0|||
131445024|NCT03050801|473258806|FG004|Experiment 2|Physician Decision|1|||
131798583|NCT02683187|474546049|FG000|Overall Study|Failed IV access|3|||
131798584|NCT02683187|474546049|FG000|Overall Study|Withdrawal by Subject|5|||
131798585|NCT00770315|474546050|FG000|Overall Study|Adverse Event|11|||
131798586|NCT00770315|474546051|FG001|Overall Study|Adverse Event|17|||
131798587|NCT00770315|474546052|FG002|Overall Study|Adverse Event|16|||
131798588|NCT00770315|474546053|FG003|Overall Study|Adverse Event|6|||
131798589|NCT00770315|474546050|FG000|Overall Study|Lost to Follow-up|9|||
131798590|NCT00770315|474546051|FG001|Overall Study|Lost to Follow-up|5|||
131798591|NCT00770315|474546052|FG002|Overall Study|Lost to Follow-up|10|||
131798592|NCT00770315|474546053|FG003|Overall Study|Lost to Follow-up|3|||
131798593|NCT00770315|474546050|FG000|Overall Study|Withdrawal by Subject|13|||
131798594|NCT00770315|474546051|FG001|Overall Study|Withdrawal by Subject|17|||
131798595|NCT00770315|474546052|FG002|Overall Study|Withdrawal by Subject|24|||
131798596|NCT00770315|474546053|FG003|Overall Study|Withdrawal by Subject|20|||
131902508|NCT03075267|474929294|FG002|Overall Study|Protocol Violation|0|||
131445025|NCT03050801|473258807|FG005|Experiment 2|Physician Decision|0|||
131445026|NCT03050801|473258802|FG000|Experiment 2|Pregnancy|0|||
131445027|NCT03050801|473258803|FG001|Experiment 2|Pregnancy|0|||
131445028|NCT03050801|473258804|FG002|Experiment 2|Pregnancy|0|||
131445029|NCT03050801|473258805|FG003|Experiment 2|Pregnancy|0|||
131445030|NCT03050801|473258806|FG004|Experiment 2|Pregnancy|1|||
131445031|NCT03050801|473258807|FG005|Experiment 2|Pregnancy|0|||
131445032|NCT03050801|473258802|FG000|Experiment 2|Withdrawal by Subject|0|||
131445033|NCT03050801|473258803|FG001|Experiment 2|Withdrawal by Subject|0|||
131445034|NCT03050801|473258804|FG002|Experiment 2|Withdrawal by Subject|0|||
131445035|NCT03050801|473258805|FG003|Experiment 2|Withdrawal by Subject|1|||
131445036|NCT03050801|473258806|FG004|Experiment 2|Withdrawal by Subject|0|||
131634391|NCT00809783|473947016|FG000|Overall Study|Death|1|||
131798597|NCT00770315|474546050|FG000|Overall Study|Noncompliance with Protocol|7|||
131798598|NCT00770315|474546051|FG001|Overall Study|Noncompliance with Protocol|4|||
131798599|NCT00770315|474546052|FG002|Overall Study|Noncompliance with Protocol|7|||
131445037|NCT03050801|473258807|FG005|Experiment 2|Withdrawal by Subject|0|||
131445038|NCT03050801|473258802|FG000|Experiment 2|Poor data quality|0|||
131445039|NCT03050801|473258803|FG001|Experiment 2|Poor data quality|0|||
131445040|NCT03050801|473258804|FG002|Experiment 2|Poor data quality|0|||
131445041|NCT03050801|473258805|FG003|Experiment 2|Poor data quality|4|||
131445042|NCT03050801|473258806|FG004|Experiment 2|Poor data quality|1|||
131445043|NCT03050801|473258807|FG005|Experiment 2|Poor data quality|0|||
131445044|NCT03050801|473258802|FG000|Experiment 2|Discomfort during stimulation|0|||
131798600|NCT00770315|474546053|FG003|Overall Study|Noncompliance with Protocol|9|||
131902509|NCT01746862|474929295|FG000|Overall Study|Withdrawal by Subject|1|||
131713875|NCT00332202|474228845|FG001|Overall Study|Death|2|||
131713876|NCT00490542|474228850|FG000|Overall Study|Lost to Follow-up|3|||
131713877|NCT00490542|474228851|FG001|Overall Study|Lost to Follow-up|0|||
131713878|NCT00490542|474228850|FG000|Overall Study|Adverse Event|3|||
131713879|NCT00490542|474228851|FG001|Overall Study|Adverse Event|3|||
131634392|NCT00809783|473947017|FG001|Overall Study|Death|0|||
131634393|NCT00809783|473947018|FG002|Overall Study|Death|0|||
131634394|NCT00809783|473947016|FG000|Overall Study|Adverse Event|34|||
131634395|NCT00809783|473947017|FG001|Overall Study|Adverse Event|52|||
131634396|NCT00809783|473947018|FG002|Overall Study|Adverse Event|71|||
131634397|NCT00809783|473947016|FG000|Overall Study|Lack of Efficacy|39|||
131634398|NCT00809783|473947017|FG001|Overall Study|Lack of Efficacy|52|||
131634399|NCT00809783|473947018|FG002|Overall Study|Lack of Efficacy|63|||
131634400|NCT00809783|473947016|FG000|Overall Study|Lost to Follow-up|0|||
131634401|NCT00809783|473947017|FG001|Overall Study|Lost to Follow-up|3|||
131634402|NCT00809783|473947018|FG002|Overall Study|Lost to Follow-up|4|||
131634403|NCT00809783|473947016|FG000|Overall Study|Withdrawal by Subject|47|||
131634404|NCT00809783|473947017|FG001|Overall Study|Withdrawal by Subject|72|||
131634405|NCT00809783|473947018|FG002|Overall Study|Withdrawal by Subject|64|||
131634406|NCT00809783|473947016|FG000|Overall Study|Protocol Violation|2|||
131634407|NCT00809783|473947017|FG001|Overall Study|Protocol Violation|6|||
131634408|NCT00809783|473947018|FG002|Overall Study|Protocol Violation|5|||
131634409|NCT00809783|473947016|FG000|Overall Study|Randomized, but not treated|3|||
131634410|NCT00809783|473947017|FG001|Overall Study|Randomized, but not treated|0|||
131634411|NCT00809783|473947018|FG002|Overall Study|Randomized, but not treated|2|||
131634412|NCT00809783|473947016|FG000|Overall Study|Study Terminated by Sponsor|378|||
131634413|NCT00809783|473947017|FG001|Overall Study|Study Terminated by Sponsor|626|||
131634414|NCT00809783|473947018|FG002|Overall Study|Study Terminated by Sponsor|565|||
131634415|NCT00809783|473947016|FG000|Overall Study|Other|21|||
131634416|NCT00809783|473947017|FG001|Overall Study|Other|21|||
131634417|NCT00809783|473947018|FG002|Overall Study|Other|16|||
131634418|NCT00126555|473947019|FG000|Overall Study|Withdrawal by Subject|1|||
131634419|NCT00126555|473947019|FG000|Overall Study|Adverse Event|2|||
131634420|NCT00126555|473947019|FG000|Overall Study|Progressive Disease|3|||
131634421|NCT02137239|473947030|FG000|Overall Study|Discontinued Study Treatment|0|||
131634422|NCT02137239|473947031|FG001|Overall Study|Discontinued Study Treatment|3|||
131713880|NCT00490542|474228850|FG000|Overall Study|Lack of Efficacy|1|||
131713881|NCT00490542|474228851|FG001|Overall Study|Lack of Efficacy|1|||
131713882|NCT04696861|474228852|FG000|Overall Study|Death|1|||
131713883|NCT04696861|474228853|FG001|Overall Study|Death|0|||
131713884|NCT04696861|474228852|FG000|Overall Study|Lost to Follow-up|3|||
131713885|NCT04696861|474228853|FG001|Overall Study|Lost to Follow-up|0|||
131713886|NCT00818259|474228854|FG000|Part I|Withdrawal by Subject|1|||
131713887|NCT00818259|474228855|FG001|Part I|Withdrawal by Subject|0|||
131713888|NCT00818259|474228856|FG002|Part I|Withdrawal by Subject|0|||
131713889|NCT00818259|474228857|FG003|Part I|Withdrawal by Subject|0|||
131713890|NCT00818259|474228858|FG004|Part I|Withdrawal by Subject|0|||
131713891|NCT00818259|474228859|FG005|Part I|Withdrawal by Subject|0|||
131713892|NCT00818259|474228860|FG006|Part I|Withdrawal by Subject|0|||
131713893|NCT00818259|474228861|FG007|Part I|Withdrawal by Subject|0|||
131713894|NCT00818259|474228862|FG008|Part I|Withdrawal by Subject|0|||
131713895|NCT00818259|474228854|FG000|Part II|Physician Decision|0|||
131713896|NCT00818259|474228855|FG001|Part II|Physician Decision|0|||
131713897|NCT00818259|474228856|FG002|Part II|Physician Decision|1|||
131713898|NCT00818259|474228857|FG003|Part II|Physician Decision|0|||
131713899|NCT00818259|474228858|FG004|Part II|Physician Decision|0|||
131713900|NCT00818259|474228859|FG005|Part II|Physician Decision|0|||
131713901|NCT00818259|474228860|FG006|Part II|Physician Decision|0|||
131713902|NCT00818259|474228861|FG007|Part II|Physician Decision|0|||
131713903|NCT00818259|474228862|FG008|Part II|Physician Decision|0|||
131634423|NCT02137239|473947030|FG000|Overall Study|Withdrew Consent|1|||
131634424|NCT02137239|473947031|FG001|Overall Study|Withdrew Consent|1|||
131634425|NCT02137239|473947030|FG000|Overall Study|Adverse Event|2|||
131634426|NCT02137239|473947031|FG001|Overall Study|Adverse Event|2|||
131634427|NCT02498418|473947037|FG000|Overall Study|Lack of Efficacy|0|||
131634428|NCT02498418|473947038|FG001|Overall Study|Lack of Efficacy|0|||
131634429|NCT02498418|473947039|FG002|Overall Study|Lack of Efficacy|1|||
131634430|NCT02498418|473947037|FG000|Overall Study|Withdrawal by Subject|2|||
131634431|NCT02498418|473947038|FG001|Overall Study|Withdrawal by Subject|0|||
131634432|NCT02498418|473947039|FG002|Overall Study|Withdrawal by Subject|3|||
131634433|NCT02498418|473947037|FG000|Overall Study|Lost to Follow-up|0|||
131634434|NCT02498418|473947038|FG001|Overall Study|Lost to Follow-up|1|||
131634435|NCT02498418|473947039|FG002|Overall Study|Lost to Follow-up|1|||
131634436|NCT02498418|473947037|FG000|Overall Study|Participant taken prohibited medication|0|||
131634437|NCT02498418|473947038|FG001|Overall Study|Participant taken prohibited medication|1|||
131634438|NCT02498418|473947039|FG002|Overall Study|Participant taken prohibited medication|1|||
131634439|NCT00762502|473947040|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
131634440|NCT00762502|473947041|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
131634441|NCT00762502|473947042|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
131634442|NCT00762502|473947040|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
131634443|NCT00762502|473947041|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
131634444|NCT00762502|473947042|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
131634445|NCT00762502|473947040|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
131634446|NCT00762502|473947041|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
131634447|NCT00762502|473947042|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
131634448|NCT03042559|473947043|FG000|Overall Study|drop out|1|||
131634449|NCT03042559|473947044|FG001|Overall Study|drop out|1|||
131634450|NCT01485991|473947048|FG000|Overall Study|Adverse Event|0|||
131634451|NCT01485991|473947049|FG001|Overall Study|Adverse Event|4|||
131634452|NCT01485991|473947048|FG000|Overall Study|Lost to Follow-up|13|||
131634453|NCT01485991|473947049|FG001|Overall Study|Lost to Follow-up|10|||
131634454|NCT01485991|473947048|FG000|Overall Study|Withdrawal by Subject|13|||
131634455|NCT01485991|473947049|FG001|Overall Study|Withdrawal by Subject|20|||
131634456|NCT01485991|473947048|FG000|Overall Study|randomized but not treated|6|||
131713904|NCT00818259|474228854|FG000|Part II|Lack of Efficacy|0|||
131713905|NCT00818259|474228855|FG001|Part II|Lack of Efficacy|0|||
131713906|NCT00818259|474228856|FG002|Part II|Lack of Efficacy|0|||
131634457|NCT01485991|473947049|FG001|Overall Study|randomized but not treated|2|||
131634458|NCT00385697|473947050|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
131634459|NCT00385697|473947051|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
131634460|NCT00385697|473947052|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
131634461|NCT00385697|473947053|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
131634462|NCT00385697|473947054|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
131634463|NCT00385697|473947050|FG000|Open-label Segment 1|Lost to Follow-up|1|||
131634464|NCT00385697|473947051|FG001|Open-label Segment 1|Lost to Follow-up|0|||
131634465|NCT00385697|473947052|FG002|Open-label Segment 1|Lost to Follow-up|0|||
131634466|NCT00385697|473947053|FG003|Open-label Segment 1|Lost to Follow-up|0|||
131634467|NCT00385697|473947054|FG004|Open-label Segment 1|Lost to Follow-up|0|||
131634468|NCT00385697|473947050|FG000|Double-blind Segment 2|Adverse Event|0|||
131634469|NCT00385697|473947051|FG001|Double-blind Segment 2|Adverse Event|3|||
131634470|NCT00385697|473947052|FG002|Double-blind Segment 2|Adverse Event|1|||
131634471|NCT00385697|473947053|FG003|Double-blind Segment 2|Adverse Event|0|||
131634472|NCT00385697|473947054|FG004|Double-blind Segment 2|Adverse Event|0|||
131634473|NCT00385697|473947050|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
131634474|NCT00385697|473947051|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
131634475|NCT00385697|473947052|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
131634476|NCT00385697|473947053|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
131634477|NCT00385697|473947054|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
131634478|NCT00385697|473947050|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
131634479|NCT00385697|473947051|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
131634480|NCT00385697|473947052|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
131634481|NCT00385697|473947053|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
131634482|NCT00385697|473947054|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
131634483|NCT00385697|473947050|FG000|Double-blind Segment 2|Other|0|||
131902510|NCT01746862|474929296|FG001|Overall Study|Withdrawal by Subject|1|||
131902511|NCT01746862|474929295|FG000|Overall Study|Protocol Violation|1|||
131902512|NCT01746862|474929296|FG001|Overall Study|Protocol Violation|0|||
131902513|NCT01746862|474929295|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
131902514|NCT01746862|474929296|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
131902515|NCT01746862|474929295|FG000|Overall Study|Entered puberty during the study|1|||
131902516|NCT01746862|474929296|FG001|Overall Study|Entered puberty during the study|0|||
131902517|NCT04742673|474929297|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
131904618|NCT00830219|474937040|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131634484|NCT00385697|473947051|FG001|Double-blind Segment 2|Other|2|||
131634485|NCT00385697|473947052|FG002|Double-blind Segment 2|Other|0|||
131634486|NCT00385697|473947053|FG003|Double-blind Segment 2|Other|0|||
131634487|NCT00385697|473947054|FG004|Double-blind Segment 2|Other|0|||
131634488|NCT02538471|473947056|FG000|Overall Study|Progression of disease|2|||
131634489|NCT01475370|473947057|FG000|Overall Study|Exacerbation of primary disease|2|||
131634490|NCT01475370|473947058|FG001|Overall Study|Exacerbation of primary disease|2|||
131634491|NCT01475370|473947059|FG002|Overall Study|Exacerbation of primary disease|2|||
131634492|NCT01475370|473947057|FG000|Overall Study|Study drug administration difficult|0|||
131634493|NCT01475370|473947058|FG001|Overall Study|Study drug administration difficult|1|||
131634494|NCT01475370|473947059|FG002|Overall Study|Study drug administration difficult|1|||
131634495|NCT01475370|473947057|FG000|Overall Study|Other than specified|1|||
131634496|NCT01475370|473947058|FG001|Overall Study|Other than specified|0|||
131634497|NCT01475370|473947059|FG002|Overall Study|Other than specified|0|||
131634498|NCT02131155|473947062|FG000|Overall Study|Adverse Event|1|||
131798601|NCT02585258|474546054|FG000|Overall Study|Adverse Event|28|||
131798602|NCT02585258|474546055|FG001|Overall Study|Adverse Event|29|||
131798603|NCT02585258|474546054|FG000|Overall Study|Death|3|||
131798604|NCT02585258|474546055|FG001|Overall Study|Death|2|||
131798605|NCT02585258|474546054|FG000|Overall Study|Lack of Efficacy|7|||
131798606|NCT02585258|474546055|FG001|Overall Study|Lack of Efficacy|9|||
131798607|NCT02585258|474546054|FG000|Overall Study|includes covid-related access problems|42|||
131798608|NCT02585258|474546055|FG001|Overall Study|includes covid-related access problems|46|||
131798609|NCT02585258|474546054|FG000|Overall Study|Lost to Follow-up|5|||
131798610|NCT02585258|474546055|FG001|Overall Study|Lost to Follow-up|2|||
131804521|NCT02914600|474568557|FG001|Overall Study|Sponsors decision|41|||
131804522|NCT02914600|474568558|FG002|Overall Study|Sponsors decision|12|||
131804523|NCT02914600|474568556|FG000|Overall Study|Withdrawal by Subject|158|||
131804524|NCT02914600|474568557|FG001|Overall Study|Withdrawal by Subject|20|||
131804525|NCT02914600|474568558|FG002|Overall Study|Withdrawal by Subject|18|||
131634499|NCT02131155|473947063|FG001|Overall Study|Adverse Event|0|||
131634500|NCT02131155|473947062|FG000|Overall Study|Treatment completed|1|||
131804526|NCT02914600|474568556|FG000|Overall Study|Investigators discretion|169|||
131804527|NCT02914600|474568557|FG001|Overall Study|Investigators discretion|14|||
131804528|NCT02914600|474568558|FG002|Overall Study|Investigators discretion|13|||
131634501|NCT02131155|473947063|FG001|Overall Study|Treatment completed|0|||
131634502|NCT02131155|473947062|FG000|Overall Study|Primary tumour recurrence|2|||
131634503|NCT02131155|473947063|FG001|Overall Study|Primary tumour recurrence|1|||
131634504|NCT02131155|473947062|FG000|Overall Study|Refused to continue study medication|1|||
131634505|NCT02131155|473947063|FG001|Overall Study|Refused to continue study medication|0|||
131634506|NCT02131155|473947062|FG000|Overall Study|Study early termination|20|||
131634507|NCT02131155|473947063|FG001|Overall Study|Study early termination|10|||
131634508|NCT01887418|473947064|FG000|Overall Study|Travelling difficulties|0|||
131634509|NCT01887418|473947065|FG001|Overall Study|Travelling difficulties|0|||
131634510|NCT01887418|473947066|FG002|Overall Study|Travelling difficulties|1|||
131634511|NCT00475735|473947067|FG000|Treatment Period 1|Adverse Event|2|||
131634512|NCT00475735|473947068|FG001|Treatment Period 1|Adverse Event|0|||
131634513|NCT00475735|473947069|FG002|Treatment Period 1|Adverse Event|0|||
131634514|NCT00475735|473947070|FG003|Treatment Period 1|Adverse Event|0|||
131634515|NCT00475735|473947071|FG004|Treatment Period 1|Adverse Event|0|||
131634516|NCT00475735|473947072|FG005|Treatment Period 1|Adverse Event|0|||
131634517|NCT00475735|473947067|FG000|Treatment Period 1|Lack of Efficacy|1|||
131634518|NCT00475735|473947068|FG001|Treatment Period 1|Lack of Efficacy|0|||
131634519|NCT00475735|473947069|FG002|Treatment Period 1|Lack of Efficacy|0|||
131634520|NCT00475735|473947070|FG003|Treatment Period 1|Lack of Efficacy|0|||
131634521|NCT00475735|473947071|FG004|Treatment Period 1|Lack of Efficacy|0|||
131634522|NCT00475735|473947072|FG005|Treatment Period 1|Lack of Efficacy|0|||
131634523|NCT00475735|473947067|FG000|Treatment Period 1|Lost to Follow-up|0|||
131634524|NCT00475735|473947068|FG001|Treatment Period 1|Lost to Follow-up|0|||
131634525|NCT00475735|473947069|FG002|Treatment Period 1|Lost to Follow-up|0|||
131634526|NCT00475735|473947070|FG003|Treatment Period 1|Lost to Follow-up|0|||
131634527|NCT00475735|473947071|FG004|Treatment Period 1|Lost to Follow-up|0|||
131713907|NCT00818259|474228857|FG003|Part II|Lack of Efficacy|1|||
131713908|NCT00818259|474228858|FG004|Part II|Lack of Efficacy|0|||
131634528|NCT00475735|473947072|FG005|Treatment Period 1|Lost to Follow-up|1|||
131634529|NCT00475735|473947067|FG000|Treatment Period 1|Protocol Violation|0|||
131634530|NCT00475735|473947068|FG001|Treatment Period 1|Protocol Violation|0|||
131634531|NCT00475735|473947069|FG002|Treatment Period 1|Protocol Violation|0|||
131634532|NCT00475735|473947070|FG003|Treatment Period 1|Protocol Violation|1|||
131634533|NCT00475735|473947071|FG004|Treatment Period 1|Protocol Violation|0|||
131634534|NCT00475735|473947072|FG005|Treatment Period 1|Protocol Violation|0|||
131634535|NCT00475735|473947067|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131634536|NCT00475735|473947068|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131634537|NCT00475735|473947069|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131634538|NCT00475735|473947070|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131634539|NCT00475735|473947071|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131634540|NCT00475735|473947072|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131634541|NCT00475735|473947067|FG000|Treatment Period 1|DC due to AE but continuing|0|||
131634542|NCT00475735|473947068|FG001|Treatment Period 1|DC due to AE but continuing|0|||
131634543|NCT00475735|473947069|FG002|Treatment Period 1|DC due to AE but continuing|0|||
131634544|NCT00475735|473947070|FG003|Treatment Period 1|DC due to AE but continuing|1|||
131634545|NCT00475735|473947071|FG004|Treatment Period 1|DC due to AE but continuing|2|||
131634546|NCT00475735|473947072|FG005|Treatment Period 1|DC due to AE but continuing|2|||
131634547|NCT00475735|473947067|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131634548|NCT00475735|473947068|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
131634549|NCT00475735|473947069|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131634550|NCT00475735|473947070|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131634551|NCT00475735|473947071|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131634552|NCT00475735|473947072|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131634553|NCT00475735|473947067|FG000|Treatment Washout|Lost to Follow-up|0|||
131634554|NCT00475735|473947068|FG001|Treatment Washout|Lost to Follow-up|1|||
131634555|NCT00475735|473947069|FG002|Treatment Washout|Lost to Follow-up|0|||
131634556|NCT00475735|473947070|FG003|Treatment Washout|Lost to Follow-up|0|||
131634557|NCT00475735|473947071|FG004|Treatment Washout|Lost to Follow-up|0|||
131634558|NCT00475735|473947072|FG005|Treatment Washout|Lost to Follow-up|0|||
131634559|NCT00475735|473947067|FG000|Treatment Washout|Protocol Violation|0|||
131634560|NCT00475735|473947068|FG001|Treatment Washout|Protocol Violation|1|||
131634561|NCT00475735|473947069|FG002|Treatment Washout|Protocol Violation|0|||
131634562|NCT00475735|473947070|FG003|Treatment Washout|Protocol Violation|0|||
131634563|NCT00475735|473947071|FG004|Treatment Washout|Protocol Violation|0|||
131634564|NCT00475735|473947072|FG005|Treatment Washout|Protocol Violation|0|||
131634565|NCT00475735|473947067|FG000|Treatment Period 2|Adverse Event|0|||
131634566|NCT00475735|473947068|FG001|Treatment Period 2|Adverse Event|1|||
131634567|NCT00475735|473947069|FG002|Treatment Period 2|Adverse Event|0|||
131634568|NCT00475735|473947070|FG003|Treatment Period 2|Adverse Event|2|||
131634569|NCT00475735|473947071|FG004|Treatment Period 2|Adverse Event|0|||
131634570|NCT00475735|473947072|FG005|Treatment Period 2|Adverse Event|0|||
131634571|NCT00475735|473947067|FG000|Treatment Period 2|Lack of Efficacy|0|||
131634572|NCT00475735|473947068|FG001|Treatment Period 2|Lack of Efficacy|0|||
131634573|NCT00475735|473947069|FG002|Treatment Period 2|Lack of Efficacy|0|||
131634574|NCT00475735|473947070|FG003|Treatment Period 2|Lack of Efficacy|0|||
131634575|NCT00475735|473947071|FG004|Treatment Period 2|Lack of Efficacy|0|||
131634576|NCT00475735|473947072|FG005|Treatment Period 2|Lack of Efficacy|1|||
131634577|NCT00475735|473947067|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131713909|NCT00818259|474228859|FG005|Part II|Lack of Efficacy|0|||
131713910|NCT00818259|474228860|FG006|Part II|Lack of Efficacy|0|||
131713911|NCT00818259|474228861|FG007|Part II|Lack of Efficacy|0|||
131713912|NCT00818259|474228862|FG008|Part II|Lack of Efficacy|0|||
131713913|NCT00818259|474228854|FG000|Part II|Not Treated|0|||
131713914|NCT00818259|474228855|FG001|Part II|Not Treated|0|||
131798611|NCT01919190|474548743|FG000|Overall Study|Intra-op findings, etc.|3|||
131798612|NCT01919190|474548744|FG001|Overall Study|Intra-op findings, etc.|0|||
131798613|NCT02322047|474548750|FG000|Overall Study|Physician Decision|1|||
131634578|NCT00475735|473947068|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131713915|NCT00818259|474228856|FG002|Part II|Not Treated|0|||
131713916|NCT00818259|474228857|FG003|Part II|Not Treated|1|||
131713917|NCT00818259|474228858|FG004|Part II|Not Treated|0|||
131713918|NCT00818259|474228859|FG005|Part II|Not Treated|0|||
131713919|NCT00818259|474228860|FG006|Part II|Not Treated|0|||
131713920|NCT00818259|474228861|FG007|Part II|Not Treated|0|||
131634579|NCT00475735|473947069|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131634580|NCT00475735|473947070|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131634581|NCT00475735|473947071|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131634582|NCT00475735|473947072|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131713921|NCT00818259|474228862|FG008|Part II|Not Treated|0|||
131713922|NCT00818259|474228854|FG000|Part IV|Physician Decision|0|||
131713923|NCT00818259|474228855|FG001|Part IV|Physician Decision|0|||
131713924|NCT00818259|474228856|FG002|Part IV|Physician Decision|0|||
131713925|NCT00818259|474228857|FG003|Part IV|Physician Decision|0|||
131798614|NCT02322047|474548751|FG001|Overall Study|Physician Decision|0|||
131798615|NCT02322047|474548752|FG002|Overall Study|Physician Decision|0|||
131634583|NCT03132753|473947073|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
131634584|NCT03132753|473947074|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
131634585|NCT03132753|473947073|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
131634586|NCT03132753|473947074|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
131634587|NCT00084747|473947075|FG000|Overall Study|Relapsed|8|||
131634588|NCT00084747|473947075|FG000|Overall Study|Death|3|||
131634589|NCT00084747|473947075|FG000|Overall Study|Withdrawal by Subject|2|||
131634590|NCT00125853|473947078|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
131634591|NCT00125853|473947079|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
131634592|NCT02350127|473947083|FG000|4-Month Assessment|Withdrawal by Subject|10|||
131634593|NCT02350127|473947084|FG001|4-Month Assessment|Withdrawal by Subject|9|||
131634594|NCT02350127|473947083|FG000|4-Month Assessment|Death|1|||
131634595|NCT02350127|473947084|FG001|4-Month Assessment|Death|0|||
131634596|NCT02350127|473947083|FG000|8-Month Assessment|Death|1|||
131634597|NCT02350127|473947084|FG001|8-Month Assessment|Death|1|||
131634598|NCT02350127|473947083|FG000|8-Month Assessment|Withdrawal by Subject|5|||
131634599|NCT02350127|473947084|FG001|8-Month Assessment|Withdrawal by Subject|8|||
131634600|NCT02097056|473947085|FG000|Overall Study|Protocol Violation|2|||
131634601|NCT02097056|473947085|FG000|Overall Study|Withdrawal by Subject|15|||
131634602|NCT02097056|473947085|FG000|Overall Study|Lost to Follow-up|2|||
131634603|NCT02097056|473947085|FG000|Overall Study|Adverse Event|37|||
131634604|NCT02097056|473947085|FG000|Overall Study|Other|2|||
131634605|NCT00794573|473947091|FG000|Overall Study|Death|3|||
131634606|NCT00794573|473947092|FG001|Overall Study|Death|0|||
131634607|NCT00794573|473947091|FG000|Overall Study|Withdrawal by Subject|9|||
131634608|NCT00794573|473947092|FG001|Overall Study|Withdrawal by Subject|12|||
131634609|NCT00794573|473947091|FG000|Overall Study|Lost to Follow-up|26|||
131634610|NCT00794573|473947092|FG001|Overall Study|Lost to Follow-up|33|||
131634611|NCT01911819|473947093|FG000|Overall Study|Adverse Event|0|||
131634612|NCT01911819|473947094|FG001|Overall Study|Adverse Event|1|||
131634613|NCT01911819|473947095|FG002|Overall Study|Adverse Event|0|||
131634614|NCT01911819|473947093|FG000|Overall Study|Withdrawal by Subject|1|||
131634615|NCT01911819|473947094|FG001|Overall Study|Withdrawal by Subject|1|||
131634616|NCT01911819|473947095|FG002|Overall Study|Withdrawal by Subject|0|||
131634617|NCT00257556|473947096|FG000|Overall Study|Adverse Event|1|||
131634618|NCT00257556|473947097|FG001|Overall Study|Adverse Event|4|||
131634619|NCT00257556|473947096|FG000|Overall Study|Physician Decision|6|||
131634620|NCT00257556|473947097|FG001|Overall Study|Physician Decision|0|||
131634621|NCT00257556|473947096|FG000|Overall Study|Did not meet hCG criterion|3|||
131634622|NCT00257556|473947097|FG001|Overall Study|Did not meet hCG criterion|0|||
131634623|NCT00257556|473947096|FG000|Overall Study|other reason|4|||
131634624|NCT00257556|473947097|FG001|Overall Study|other reason|6|||
131634625|NCT03849300|473947101|FG000|Overall Study|move out to different area|1|||
131634626|NCT03849300|473947102|FG001|Overall Study|move out to different area|3|||
131634627|NCT03849300|473947103|FG002|Overall Study|move out to different area|1|||
131634628|NCT03849300|473947104|FG003|Overall Study|move out to different area|4|||
131634629|NCT03849300|473947101|FG000|Overall Study|scheduling/transportation conflict|4|||
131634630|NCT03849300|473947102|FG001|Overall Study|scheduling/transportation conflict|4|||
131634631|NCT03849300|473947103|FG002|Overall Study|scheduling/transportation conflict|3|||
131634632|NCT03849300|473947104|FG003|Overall Study|scheduling/transportation conflict|2|||
131634633|NCT04839289|473947105|FG000|Overall Study|Withdrawal by Subject|1|||
131634634|NCT04839289|473947106|FG001|Overall Study|Withdrawal by Subject|0|||
131634635|NCT02418819|473947111|FG000|Overall Study|Adverse Event|0|||
131634636|NCT02418819|473947112|FG001|Overall Study|Adverse Event|0|||
131634637|NCT02418819|473947113|FG002|Overall Study|Adverse Event|1|||
131634638|NCT02418819|473947114|FG003|Overall Study|Adverse Event|0|||
131634639|NCT02418819|473947111|FG000|Overall Study|Lost to Follow-up|1|||
131798616|NCT02322047|474548753|FG003|Overall Study|Physician Decision|0|||
131798617|NCT02322047|474548750|FG000|Overall Study|Withdrawal by Subject|1|||
131798618|NCT02322047|474548751|FG001|Overall Study|Withdrawal by Subject|0|||
131798619|NCT02322047|474548752|FG002|Overall Study|Withdrawal by Subject|0|||
131798620|NCT02322047|474548753|FG003|Overall Study|Withdrawal by Subject|1|||
131634640|NCT02418819|473947112|FG001|Overall Study|Lost to Follow-up|0|||
131634641|NCT02418819|473947113|FG002|Overall Study|Lost to Follow-up|0|||
131634642|NCT02418819|473947114|FG003|Overall Study|Lost to Follow-up|0|||
131634643|NCT02418819|473947111|FG000|Overall Study|No longer meets eligibility criteria|0|||
131634644|NCT02418819|473947112|FG001|Overall Study|No longer meets eligibility criteria|0|||
131634645|NCT02418819|473947113|FG002|Overall Study|No longer meets eligibility criteria|1|||
131634646|NCT02418819|473947114|FG003|Overall Study|No longer meets eligibility criteria|0|||
131634647|NCT02418819|473947111|FG000|Overall Study|No longer willing to participate|0|||
131634648|NCT02418819|473947112|FG001|Overall Study|No longer willing to participate|0|||
131634649|NCT02418819|473947113|FG002|Overall Study|No longer willing to participate|2|||
131634650|NCT02418819|473947114|FG003|Overall Study|No longer willing to participate|1|||
131634651|NCT04743999|473947115|FG000|3-month Questionnaire|Death|1|||
131634652|NCT04743999|473947115|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
131798621|NCT02322047|474548750|FG000|Overall Study|Adverse Event|0|||
131634653|NCT04743999|473947115|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
131634654|NCT04743999|473947115|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
131634655|NCT01721759|473947116|FG000|Treatment Period|Disease Progression|85|||
131634656|NCT01721759|473947116|FG000|Treatment Period|Study drug toxicity|14|||
131634657|NCT01721759|473947116|FG000|Treatment Period|Death|1|||
131634658|NCT01721759|473947116|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
131634659|NCT01721759|473947116|FG000|Treatment Period|Participant request to withdraw|3|||
131634660|NCT01721759|473947116|FG000|Treatment Period|Other Reasons|3|||
131634661|NCT01721759|473947116|FG000|End of Study Period|Participant Withdrew Consent|5|||
131634662|NCT01721759|473947116|FG000|End of Study Period|Death|101|||
131634663|NCT01721759|473947116|FG000|End of Study Period|Lost to Follow-up|1|||
131634664|NCT01721759|473947116|FG000|End of Study Period|Other Reasons|10|||
131634665|NCT00464737|473947117|FG000|Overall Study|Adverse Event|12|||
131634666|NCT00464737|473947118|FG001|Overall Study|Adverse Event|17|||
131634667|NCT00464737|473947119|FG002|Overall Study|Adverse Event|33|||
131634668|NCT00464737|473947117|FG000|Overall Study|Lack of Efficacy|7|||
131634669|NCT00464737|473947118|FG001|Overall Study|Lack of Efficacy|7|||
131634670|NCT00464737|473947119|FG002|Overall Study|Lack of Efficacy|4|||
131634671|NCT00464737|473947117|FG000|Overall Study|Withdrawal by Subject|5|||
131634672|NCT00464737|473947118|FG001|Overall Study|Withdrawal by Subject|3|||
131634673|NCT00464737|473947119|FG002|Overall Study|Withdrawal by Subject|5|||
131634674|NCT00464737|473947117|FG000|Overall Study|Protocol Violation|1|||
131634675|NCT00464737|473947118|FG001|Overall Study|Protocol Violation|1|||
131634676|NCT00464737|473947119|FG002|Overall Study|Protocol Violation|5|||
131634677|NCT00464737|473947117|FG000|Overall Study|Non-compliance|0|||
131634678|NCT00464737|473947118|FG001|Overall Study|Non-compliance|1|||
131634679|NCT00464737|473947119|FG002|Overall Study|Non-compliance|1|||
131634680|NCT00464737|473947117|FG000|Overall Study|Lost to Follow-up|5|||
131634681|NCT00464737|473947118|FG001|Overall Study|Lost to Follow-up|2|||
131634682|NCT00464737|473947119|FG002|Overall Study|Lost to Follow-up|5|||
131634683|NCT00464737|473947117|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
131634684|NCT00464737|473947118|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
131634685|NCT00464737|473947119|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
131634686|NCT00464737|473947117|FG000|Overall Study|Other: Subject left town; family illness|1|||
131634687|NCT00464737|473947118|FG001|Overall Study|Other: Subject left town; family illness|0|||
131634688|NCT00464737|473947119|FG002|Overall Study|Other: Subject left town; family illness|0|||
131634689|NCT00464737|473947117|FG000|Overall Study|Other: Study demands too great|0|||
131634690|NCT00464737|473947118|FG001|Overall Study|Other: Study demands too great|1|||
131634691|NCT00464737|473947119|FG002|Overall Study|Other: Study demands too great|0|||
131634692|NCT00464737|473947117|FG000|Overall Study|Other: Personal family reasons|0|||
131634693|NCT00464737|473947118|FG001|Overall Study|Other: Personal family reasons|0|||
131634694|NCT00464737|473947119|FG002|Overall Study|Other: Personal family reasons|1|||
131634695|NCT00464737|473947117|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
131634696|NCT00464737|473947118|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
131634697|NCT00464737|473947119|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
131634698|NCT01207453|473947120|FG000|First Intervention|Adverse Event|2|||
131634699|NCT01207453|473947121|FG001|First Intervention|Adverse Event|1|||
131634700|NCT01207453|473947120|FG000|Washout|Adverse Event|1|||
131634701|NCT01207453|473947121|FG001|Washout|Adverse Event|0|||
131634702|NCT01207453|473947120|FG000|Washout|Lost to Follow-up|1|||
131634703|NCT01207453|473947121|FG001|Washout|Lost to Follow-up|0|||
131713926|NCT00818259|474228858|FG004|Part IV|Physician Decision|0|||
131713927|NCT00818259|474228859|FG005|Part IV|Physician Decision|1|||
131713928|NCT00818259|474228860|FG006|Part IV|Physician Decision|0|||
131713929|NCT00818259|474228861|FG007|Part IV|Physician Decision|0|||
131713930|NCT00818259|474228862|FG008|Part IV|Physician Decision|0|||
131713931|NCT00818259|474228854|FG000|Part V|Adverse Event|0|||
131713932|NCT00818259|474228855|FG001|Part V|Adverse Event|0|||
131713933|NCT00818259|474228856|FG002|Part V|Adverse Event|0|||
131713934|NCT00818259|474228857|FG003|Part V|Adverse Event|0|||
131713935|NCT00818259|474228858|FG004|Part V|Adverse Event|0|||
131713936|NCT00818259|474228859|FG005|Part V|Adverse Event|0|||
131713937|NCT00818259|474228860|FG006|Part V|Adverse Event|0|||
131713938|NCT00818259|474228861|FG007|Part V|Adverse Event|1|||
131634704|NCT01207453|473947120|FG000|2nd Intervention|Adverse Event|1|||
131634705|NCT01207453|473947121|FG001|2nd Intervention|Adverse Event|2|||
131634706|NCT01207453|473947120|FG000|2nd Intervention|Lost to Follow-up|1|||
131634707|NCT01207453|473947121|FG001|2nd Intervention|Lost to Follow-up|0|||
131634708|NCT00676663|473947124|FG000|Overall Study|Death|43|||
131634709|NCT00676663|473947125|FG001|Overall Study|Death|27|||
131634710|NCT00676663|473947124|FG000|Overall Study|Withdrew Consent|1|||
131634711|NCT00676663|473947125|FG001|Overall Study|Withdrew Consent|8|||
131634712|NCT00676663|473947124|FG000|Overall Study|Lost to Follow-up|1|||
131713939|NCT00818259|474228862|FG008|Part V|Adverse Event|0|||
131713940|NCT01237951|474228866|FG000|Overall Study|Death|1|||
131634713|NCT00676663|473947125|FG001|Overall Study|Lost to Follow-up|3|||
131634714|NCT00580047|473947126|FG000|Overall Study|Lost to Follow-up|1|||
131713941|NCT01053429|474228869|FG000|Overall Study|Adverse Event|64|||
131634715|NCT00580047|473947127|FG001|Overall Study|Lost to Follow-up|1|||
131634716|NCT00580047|473947128|FG002|Overall Study|Lost to Follow-up|0|||
131634717|NCT00580047|473947126|FG000|Overall Study|Withdrawal by Subject|1|||
131634718|NCT00580047|473947127|FG001|Overall Study|Withdrawal by Subject|1|||
131902518|NCT04742673|474929298|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
131902519|NCT06058390|474929300|FG000|Overall Study|Lost to Follow-up|0|||
131902520|NCT06058390|474929301|FG001|Overall Study|Lost to Follow-up|0|||
131634719|NCT00580047|473947128|FG002|Overall Study|Withdrawal by Subject|2|||
131634720|NCT00580047|473947126|FG000|Overall Study|Withdrawal by Subject|1|||
131634721|NCT00580047|473947127|FG001|Overall Study|Withdrawal by Subject|0|||
131634722|NCT00580047|473947128|FG002|Overall Study|Withdrawal by Subject|0|||
131634723|NCT00390806|473947131|FG000|Overall Study|Lost to Follow-up|7|||
131634724|NCT00390806|473947132|FG001|Overall Study|Lost to Follow-up|6|||
131634725|NCT00390806|473947131|FG000|Overall Study|Protocol Violation|2|||
131634726|NCT00390806|473947132|FG001|Overall Study|Protocol Violation|2|||
131634727|NCT00390806|473947131|FG000|Overall Study|Withdrawal by Subject|12|||
131634728|NCT00390806|473947132|FG001|Overall Study|Withdrawal by Subject|15|||
131634729|NCT00390806|473947131|FG000|Overall Study|Investigator Decision|4|||
131634730|NCT00390806|473947132|FG001|Overall Study|Investigator Decision|6|||
131634731|NCT00390806|473947131|FG000|Overall Study|Death|1|||
131634732|NCT00390806|473947132|FG001|Overall Study|Death|0|||
131634733|NCT00390806|473947131|FG000|Overall Study|Physician Decision|0|||
131634734|NCT00390806|473947132|FG001|Overall Study|Physician Decision|1|||
131634735|NCT00390806|473947131|FG000|Overall Study|Ongoing|4|||
131634736|NCT00390806|473947132|FG001|Overall Study|Ongoing|2|||
131634737|NCT00714688|473947140|FG000|Overall Study|Lack of Efficacy|14|||
131634738|NCT00714688|473947141|FG001|Overall Study|Lack of Efficacy|1|||
131634739|NCT00714688|473947142|FG002|Overall Study|Lack of Efficacy|4|||
131634740|NCT00714688|473947140|FG000|Overall Study|Withdrawal by Subject|4|||
131634741|NCT00714688|473947141|FG001|Overall Study|Withdrawal by Subject|3|||
131634742|NCT00714688|473947142|FG002|Overall Study|Withdrawal by Subject|3|||
131634743|NCT00714688|473947140|FG000|Overall Study|Lost to Follow-up|5|||
131634744|NCT00714688|473947141|FG001|Overall Study|Lost to Follow-up|2|||
131634745|NCT00714688|473947142|FG002|Overall Study|Lost to Follow-up|0|||
131634746|NCT00714688|473947140|FG000|Overall Study|Adverse Event|2|||
131634747|NCT00714688|473947141|FG001|Overall Study|Adverse Event|15|||
131634748|NCT00714688|473947142|FG002|Overall Study|Adverse Event|19|||
131634749|NCT00714688|473947140|FG000|Overall Study|Subject Non-compliant|3|||
131634750|NCT00714688|473947141|FG001|Overall Study|Subject Non-compliant|5|||
131634751|NCT00714688|473947142|FG002|Overall Study|Subject Non-compliant|5|||
131634752|NCT00714688|473947140|FG000|Overall Study|Ineligible to Continue the Study|0|||
131634753|NCT00714688|473947141|FG001|Overall Study|Ineligible to Continue the Study|1|||
131634754|NCT00714688|473947142|FG002|Overall Study|Ineligible to Continue the Study|1|||
131634755|NCT00714688|473947140|FG000|Overall Study|Sponsor's Decision|0|||
131634756|NCT00714688|473947141|FG001|Overall Study|Sponsor's Decision|2|||
131634757|NCT00714688|473947142|FG002|Overall Study|Sponsor's Decision|0|||
131634758|NCT00714688|473947140|FG000|Overall Study|Other|1|||
131634759|NCT00714688|473947141|FG001|Overall Study|Other|6|||
131634760|NCT00714688|473947142|FG002|Overall Study|Other|5|||
131902521|NCT06058390|474929302|FG002|Overall Study|Lost to Follow-up|2|||
131902522|NCT06058390|474929303|FG003|Overall Study|Lost to Follow-up|1|||
131902523|NCT06058390|474929300|FG000|Overall Study|Physician Decision|0|||
131902524|NCT06058390|474929301|FG001|Overall Study|Physician Decision|0|||
131902525|NCT06058390|474929302|FG002|Overall Study|Physician Decision|0|||
131902526|NCT06058390|474929303|FG003|Overall Study|Physician Decision|1|||
131902527|NCT06058390|474929300|FG000|Overall Study|Participants did not receive any study intervention|0|||
131902528|NCT06058390|474929301|FG001|Overall Study|Participants did not receive any study intervention|0|||
131902529|NCT06058390|474929302|FG002|Overall Study|Participants did not receive any study intervention|0|||
131902530|NCT06058390|474929303|FG003|Overall Study|Participants did not receive any study intervention|1|||
131634761|NCT01808144|473947144|FG000|Overall Study|Death|1|||
131634762|NCT01808144|473947145|FG001|Overall Study|Death|0|||
131902531|NCT03361306|474929304|FG000|Overall Study|Death|6|||
131902532|NCT04073303|474929305|FG000|Overall Study|Adverse Event|0|||
131634763|NCT01808144|473947144|FG000|Overall Study|Withdrawal by Subject|16|||
131634764|NCT01808144|473947145|FG001|Overall Study|Withdrawal by Subject|23|||
131634765|NCT01808144|473947144|FG000|Overall Study|Lost to Follow-up|6|||
131634766|NCT01808144|473947145|FG001|Overall Study|Lost to Follow-up|3|||
131902533|NCT04073303|474929306|FG001|Overall Study|Adverse Event|2|||
131634767|NCT01808144|473947144|FG000|Overall Study|Protocol Violation|6|||
131634768|NCT01808144|473947145|FG001|Overall Study|Protocol Violation|6|||
131634769|NCT01808144|473947144|FG000|Overall Study|Gout flare|0|||
131634770|NCT01808144|473947145|FG001|Overall Study|Gout flare|1|||
131634771|NCT01808144|473947144|FG000|Overall Study|Adverse Event|11|||
131634772|NCT01808144|473947145|FG001|Overall Study|Adverse Event|15|||
131634773|NCT02176356|473948771|FG000|Overall Study|Screen Failure|14|||
131634774|NCT02176356|473948771|FG000|Overall Study|Lost to Follow-up|4|||
131634775|NCT02176356|473948771|FG000|Overall Study|Personal Reasons|3|||
131634776|NCT02176356|473948771|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131713942|NCT01053429|474228869|FG000|Overall Study|Other|309|||
131713943|NCT00752986|474228870|FG000|Overall Study|Withdrawal by Subject|2|||
131713944|NCT00752986|474228871|FG001|Overall Study|Withdrawal by Subject|1|||
131713945|NCT00752986|474228872|FG002|Overall Study|Withdrawal by Subject|2|||
131713946|NCT00752986|474228870|FG000|Overall Study|Protocol Violation|3|||
131713947|NCT00752986|474228871|FG001|Overall Study|Protocol Violation|0|||
131713948|NCT00752986|474228872|FG002|Overall Study|Protocol Violation|0|||
131713949|NCT00275561|474228874|FG000|Overall Study|Withdrawal by Subject|0|||
131713950|NCT00275561|474228875|FG001|Overall Study|Withdrawal by Subject|1|||
131713951|NCT00275561|474228874|FG000|Overall Study|Travel|1|||
131713952|NCT00275561|474228875|FG001|Overall Study|Travel|1|||
131713953|NCT00275561|474228874|FG000|Overall Study|Scheduling|1|||
131713954|NCT00275561|474228875|FG001|Overall Study|Scheduling|2|||
131713955|NCT00275561|474228874|FG000|Overall Study|Family Issues|0|||
131713956|NCT00275561|474228875|FG001|Overall Study|Family Issues|2|||
131713957|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
131713958|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
131713959|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
131713960|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
131713961|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
131713962|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
131713963|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
131713964|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
131713965|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
131713966|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
131713967|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
131713968|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131713969|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131713970|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131713971|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131713972|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131713973|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
131713974|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131713975|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131713976|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131713977|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
131713978|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
131713979|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
131713980|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
131713981|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
131713982|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
131713983|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
131713984|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
131713985|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
131713986|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
131713987|NCT02660580|474231056|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
131713988|NCT02660580|474231057|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
131713989|NCT02660580|474231058|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
131713990|NCT02660580|474231059|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
131713991|NCT02660580|474231060|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
131713992|NCT02660580|474231056|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
131713993|NCT02660580|474231057|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
131713994|NCT02660580|474231058|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
131713995|NCT02660580|474231059|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
131713996|NCT02660580|474231060|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
131713997|NCT02660580|474231056|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
131713998|NCT02660580|474231057|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
131713999|NCT02660580|474231058|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
131714000|NCT02660580|474231059|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
131714001|NCT02660580|474231060|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
131714002|NCT02660580|474231056|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
131714003|NCT02660580|474231057|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
131714004|NCT02660580|474231058|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
131714005|NCT02660580|474231059|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
131714006|NCT02660580|474231060|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
131798622|NCT02322047|474548751|FG001|Overall Study|Adverse Event|1|||
131634777|NCT00332488|473948772|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
131634778|NCT00332488|473948773|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
131634779|NCT00332488|473948774|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
131634780|NCT00332488|473948772|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
131634781|NCT00332488|473948773|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
131634782|NCT00332488|473948774|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
131634783|NCT00332488|473948772|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
131634784|NCT00332488|473948773|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
131634785|NCT00332488|473948774|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
131634786|NCT00332488|473948772|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
131634787|NCT00332488|473948773|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
131634788|NCT00332488|473948774|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
131634789|NCT00332488|473948772|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
131634790|NCT00332488|473948773|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
131634791|NCT00332488|473948774|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
131634792|NCT00332488|473948772|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
131634793|NCT00332488|473948773|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
131634794|NCT00332488|473948774|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
131634795|NCT00332488|473948772|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
131634796|NCT00332488|473948773|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
131634797|NCT00332488|473948774|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
131634798|NCT00332488|473948772|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
131634799|NCT00332488|473948773|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
131634800|NCT00332488|473948774|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
131634801|NCT00332488|473948772|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
131634802|NCT00332488|473948773|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
131634803|NCT00332488|473948774|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
131634804|NCT00332488|473948772|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
131634805|NCT00332488|473948773|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
131634806|NCT00332488|473948774|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
131634807|NCT00332488|473948772|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
131634808|NCT00332488|473948773|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
131634809|NCT00332488|473948774|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
131634810|NCT00332488|473948772|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
131634811|NCT00332488|473948773|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
131634812|NCT00332488|473948774|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
131634813|NCT00371462|473948775|FG000|Overall Study|Withdrawal by Subject|1|||
131634814|NCT00371462|473948776|FG001|Overall Study|Withdrawal by Subject|0|||
131634815|NCT00371462|473948775|FG000|Overall Study|Other|7|||
131634816|NCT00371462|473948776|FG001|Overall Study|Other|8|||
131634817|NCT02507687|473948777|FG000|Overall Study|Adverse Event|3|||
131634818|NCT02507687|473948778|FG001|Overall Study|Adverse Event|2|||
131634819|NCT02507687|473948779|FG002|Overall Study|Adverse Event|2|||
131634820|NCT02507687|473948780|FG003|Overall Study|Adverse Event|2|||
131634821|NCT02507687|473948777|FG000|Overall Study|Withdrawal by Subject|1|||
131634822|NCT02507687|473948778|FG001|Overall Study|Withdrawal by Subject|4|||
131634823|NCT02507687|473948779|FG002|Overall Study|Withdrawal by Subject|6|||
131634824|NCT02507687|473948780|FG003|Overall Study|Withdrawal by Subject|6|||
131634825|NCT02507687|473948777|FG000|Overall Study|Protocol Violation|1|||
131634826|NCT02507687|473948778|FG001|Overall Study|Protocol Violation|0|||
131634827|NCT02507687|473948779|FG002|Overall Study|Protocol Violation|2|||
131634828|NCT02507687|473948780|FG003|Overall Study|Protocol Violation|0|||
131634829|NCT02507687|473948777|FG000|Overall Study|Lost to Follow-up|0|||
131634830|NCT02507687|473948778|FG001|Overall Study|Lost to Follow-up|0|||
131634831|NCT02507687|473948779|FG002|Overall Study|Lost to Follow-up|2|||
131634832|NCT02507687|473948780|FG003|Overall Study|Lost to Follow-up|1|||
131634833|NCT02507687|473948777|FG000|Overall Study|Screen Failure|0|||
131634834|NCT02507687|473948778|FG001|Overall Study|Screen Failure|0|||
131634835|NCT02507687|473948779|FG002|Overall Study|Screen Failure|1|||
131634836|NCT02507687|473948780|FG003|Overall Study|Screen Failure|0|||
131634837|NCT02507687|473948777|FG000|Overall Study|Other, Not Specified|0|||
131634838|NCT02507687|473948778|FG001|Overall Study|Other, Not Specified|0|||
131634839|NCT02507687|473948779|FG002|Overall Study|Other, Not Specified|2|||
131634840|NCT02507687|473948780|FG003|Overall Study|Other, Not Specified|4|||
131634841|NCT05372913|473948785|FG000|Overall Study|Withdrawal by Subject|0|||
131634842|NCT05372913|473948786|FG001|Overall Study|Withdrawal by Subject|2|||
131634843|NCT05372913|473948785|FG000|Overall Study|Protocol Violation|2|||
131634844|NCT05372913|473948786|FG001|Overall Study|Protocol Violation|2|||
131634845|NCT05372913|473948785|FG000|Overall Study|Adverse Event|0|||
131634846|NCT05372913|473948786|FG001|Overall Study|Adverse Event|1|||
131634847|NCT03275402|473948787|FG000|Overall Study|Death|17|||
131634848|NCT03275402|473948787|FG000|Overall Study|Study terminated by sponsor|21|||
131634849|NCT03275402|473948787|FG000|Overall Study|Withdrawal by Subject|1|||
131634850|NCT05135156|473948791|FG000|Overall Study|Lost to Follow-up|0|||
131634851|NCT05135156|473948792|FG001|Overall Study|Lost to Follow-up|0|||
131634852|NCT05135156|473948793|FG002|Overall Study|Lost to Follow-up|2|||
131634853|NCT02986659|473948794|FG000|First Intervention Period|Adverse Event|3|||
131634854|NCT02986659|473948795|FG001|First Intervention Period|Adverse Event|1|||
131634855|NCT02986659|473948794|FG000|First Intervention Period|Lost to Follow-up|1|||
131634856|NCT02986659|473948795|FG001|First Intervention Period|Lost to Follow-up|0|||
131634857|NCT02986659|473948794|FG000|First Intervention Period|Withdrawal by Subject|0|||
131634858|NCT02986659|473948795|FG001|First Intervention Period|Withdrawal by Subject|1|||
131634859|NCT02986659|473948794|FG000|Second Intervention Period|Adverse Event|0|||
131634860|NCT02986659|473948795|FG001|Second Intervention Period|Adverse Event|6|||
131634861|NCT00396097|473948803|FG000|Overall Study|Withdrawal by Subject|17|||
131634862|NCT00396097|473948804|FG001|Overall Study|Withdrawal by Subject|17|||
131634863|NCT00396097|473948803|FG000|Overall Study|Lost to Follow-up|4|||
131634864|NCT00396097|473948804|FG001|Overall Study|Lost to Follow-up|9|||
131634865|NCT00396097|473948803|FG000|Overall Study|Other|3|||
131634866|NCT00396097|473948804|FG001|Overall Study|Other|5|||
131634867|NCT00396097|473948803|FG000|Overall Study|Protocol Violation|0|||
131634868|NCT00396097|473948804|FG001|Overall Study|Protocol Violation|6|||
131634869|NCT00396097|473948803|FG000|Overall Study|Adverse Event|1|||
131634870|NCT00396097|473948804|FG001|Overall Study|Adverse Event|5|||
131634871|NCT00396097|473948803|FG000|Overall Study|Insufficient Clinical Response|1|||
131634872|NCT00396097|473948804|FG001|Overall Study|Insufficient Clinical Response|4|||
131634873|NCT03461211|473948806|FG000|Overall Study|Adverse Event|1|||
131634874|NCT03461211|473948807|FG001|Overall Study|Adverse Event|1|||
131634875|NCT03461211|473948806|FG000|Overall Study|Lack of Efficacy|0|||
131634876|NCT03461211|473948807|FG001|Overall Study|Lack of Efficacy|1|||
131634877|NCT01284634|473948808|FG000|Overall Study|Adverse Event|1|||
131634878|NCT01284634|473948809|FG001|Overall Study|Adverse Event|0|||
131634879|NCT01284634|473948810|FG002|Overall Study|Adverse Event|2|||
131634880|NCT01284634|473948811|FG003|Overall Study|Adverse Event|1|||
131634881|NCT01059526|473948812|FG000|Overall Study|Patient enrolled but not treated|20|||
131634882|NCT01059526|473948813|FG001|Overall Study|Patient enrolled but not treated|17|||
131634883|NCT01059526|473948812|FG000|Overall Study|Adverse Event|2|||
131634884|NCT01059526|473948813|FG001|Overall Study|Adverse Event|2|||
131634885|NCT01059526|473948812|FG000|Overall Study|Protocol Violation|0|||
131634886|NCT01059526|473948813|FG001|Overall Study|Protocol Violation|1|||
131634887|NCT01059526|473948812|FG000|Overall Study|Withdrawal by Subject|3|||
131634888|NCT01059526|473948813|FG001|Overall Study|Withdrawal by Subject|1|||
131634889|NCT01059526|473948812|FG000|Overall Study|Lost to Follow-up|4|||
131634890|NCT01059526|473948813|FG001|Overall Study|Lost to Follow-up|1|||
131634891|NCT01059526|473948812|FG000|Overall Study|Patient found to be dermatographic|1|||
131634892|NCT01059526|473948813|FG001|Overall Study|Patient found to be dermatographic|0|||
131634893|NCT02720081|473948814|FG000|Overall Study|Adverse Event|0|||
131634894|NCT02720081|473948815|FG001|Overall Study|Adverse Event|3|||
131634895|NCT02720081|473948814|FG000|Overall Study|Protocol Violation|4|||
131634896|NCT02720081|473948815|FG001|Overall Study|Protocol Violation|1|||
131634897|NCT02005029|473948817|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
131634898|NCT02005029|473948818|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
131634899|NCT03772041|473948820|FG000|Overall Study|Adverse Event|8|||
131634900|NCT03772041|473948821|FG001|Overall Study|Adverse Event|3|||
131634901|NCT03772041|473948820|FG000|Overall Study|Withdrawal by Subject|0|||
131634902|NCT03772041|473948821|FG001|Overall Study|Withdrawal by Subject|2|||
131634903|NCT03772041|473948820|FG000|Overall Study|Protocol Violation|4|||
131634904|NCT03772041|473948821|FG001|Overall Study|Protocol Violation|2|||
131634905|NCT03772041|473948820|FG000|Overall Study|Physician Decision|2|||
131634906|NCT03772041|473948821|FG001|Overall Study|Physician Decision|3|||
131634907|NCT01525641|473948822|FG000|Overall Study|Case report form not collected|25|||
131634908|NCT01525641|473948822|FG000|Overall Study|No visit since the first visit|16|||
131634909|NCT01525641|473948822|FG000|Overall Study|Adverse Event|73|||
131634910|NCT01525641|473948822|FG000|Overall Study|Lack of Efficacy|24|||
131634911|NCT01525641|473948822|FG000|Overall Study|Improvement|5|||
131634912|NCT01525641|473948822|FG000|Overall Study|Lost to follow-up (relocation)|1|||
131634913|NCT01525641|473948822|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
131634914|NCT01525641|473948822|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
131634915|NCT01525641|473948822|FG000|Overall Study|Other than stated above|7|||
131634916|NCT05012397|473948832|FG000|Overall Study|Death|10|||
131634917|NCT05012397|473948832|FG000|Overall Study|Physician Decision|9|||
131634918|NCT05012397|473948832|FG000|Overall Study|Withdrawal by Subject|5|||
131634919|NCT05012397|473948832|FG000|Overall Study|Lost to Follow-up|2|||
131634920|NCT03334747|473948833|FG000|Treatment Phase|Technical problems|0|||
131634921|NCT03334747|473948834|FG001|Treatment Phase|Technical problems|0|||
131634922|NCT03334747|473948835|FG002|Treatment Phase|Technical problems|0|||
131634923|NCT03334747|473948836|FG003|Treatment Phase|Technical problems|0|||
131634924|NCT03334747|473948837|FG004|Treatment Phase|Technical problems|1|||
131634925|NCT03334747|473948838|FG005|Treatment Phase|Technical problems|0|||
131634926|NCT03334747|473948839|FG006|Treatment Phase|Technical problems|0|||
131634927|NCT03334747|473948840|FG007|Treatment Phase|Technical problems|0|||
131634928|NCT03334747|473948841|FG008|Treatment Phase|Technical problems|0|||
131634929|NCT03334747|473948833|FG000|Treatment Phase|Subject/guardian decision|1|||
131634930|NCT03334747|473948834|FG001|Treatment Phase|Subject/guardian decision|0|||
131634931|NCT03334747|473948835|FG002|Treatment Phase|Subject/guardian decision|0|||
131634932|NCT03334747|473948836|FG003|Treatment Phase|Subject/guardian decision|0|||
131634933|NCT03334747|473948837|FG004|Treatment Phase|Subject/guardian decision|0|||
131634934|NCT03334747|473948838|FG005|Treatment Phase|Subject/guardian decision|1|||
131634935|NCT03334747|473948839|FG006|Treatment Phase|Subject/guardian decision|0|||
131634936|NCT03334747|473948840|FG007|Treatment Phase|Subject/guardian decision|0|||
131634937|NCT03334747|473948841|FG008|Treatment Phase|Subject/guardian decision|0|||
131634938|NCT03334747|473948833|FG000|Follow-Up Phase|Subject/guardian decision|0|||
131634939|NCT03334747|473948834|FG001|Follow-Up Phase|Subject/guardian decision|0|||
131634940|NCT03334747|473948835|FG002|Follow-Up Phase|Subject/guardian decision|0|||
131634941|NCT03334747|473948836|FG003|Follow-Up Phase|Subject/guardian decision|0|||
131634942|NCT03334747|473948837|FG004|Follow-Up Phase|Subject/guardian decision|0|||
131634943|NCT03334747|473948838|FG005|Follow-Up Phase|Subject/guardian decision|0|||
131634944|NCT03334747|473948839|FG006|Follow-Up Phase|Subject/guardian decision|1|||
131634945|NCT03334747|473948840|FG007|Follow-Up Phase|Subject/guardian decision|0|||
131634946|NCT03334747|473948841|FG008|Follow-Up Phase|Subject/guardian decision|1|||
131634947|NCT02567227|473948842|FG000|9 Weeks|Adverse Event|5|||
131634948|NCT02567227|473948843|FG001|9 Weeks|Adverse Event|5|||
131634949|NCT02567227|473948842|FG000|9 Weeks|Withdrawal by Subject|18|||
131634950|NCT02567227|473948843|FG001|9 Weeks|Withdrawal by Subject|8|||
131634951|NCT02567227|473948842|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
131634952|NCT02567227|473948843|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
131634953|NCT02567227|473948842|FG000|6 Month|Death|2|||
131634954|NCT02567227|473948843|FG001|6 Month|Death|0|||
131634955|NCT02567227|473948842|FG000|6 Month|Lost to Follow-up|43|||
131634956|NCT02567227|473948843|FG001|6 Month|Lost to Follow-up|40|||
131634957|NCT02567227|473948842|FG000|12 Months|Lost to Follow-up|31|||
131634958|NCT02567227|473948843|FG001|12 Months|Lost to Follow-up|32|||
131634959|NCT02567227|473948842|FG000|12 Months|Death|0|||
131634960|NCT02567227|473948843|FG001|12 Months|Death|2|||
131634961|NCT02382406|473948847|FG000|Study Treatment|Disease Progression|8|||
131634962|NCT02382406|473948848|FG001|Study Treatment|Disease Progression|0|||
131634963|NCT02382406|473948849|FG002|Study Treatment|Disease Progression|20|||
131634964|NCT02382406|473948847|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
131634965|NCT02382406|473948848|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
131634966|NCT02382406|473948849|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
131634967|NCT02382406|473948847|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
131634968|NCT02382406|473948848|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
131634969|NCT02382406|473948849|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
131634970|NCT02382406|473948847|FG000|Study Treatment|symptomatic deterioration|1|||
131634971|NCT02382406|473948848|FG001|Study Treatment|symptomatic deterioration|0|||
131634972|NCT02382406|473948849|FG002|Study Treatment|symptomatic deterioration|1|||
131634973|NCT02382406|473948847|FG000|Study Treatment|Death|0|||
131634974|NCT02382406|473948848|FG001|Study Treatment|Death|0|||
131634975|NCT02382406|473948849|FG002|Study Treatment|Death|2|||
131634976|NCT02382406|473948847|FG000|Follow up|Death|11|||
131634977|NCT02382406|473948848|FG001|Follow up|Death|0|||
131634978|NCT02382406|473948849|FG002|Follow up|Death|19|||
131714007|NCT02660580|474231056|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
131714008|NCT02660580|474231057|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
131714009|NCT02660580|474231058|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
131714010|NCT02660580|474231059|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
131714011|NCT02660580|474231060|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
131714012|NCT02660580|474231056|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
131714013|NCT02660580|474231057|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
131714014|NCT02660580|474231058|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
131714015|NCT02660580|474231059|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
131714016|NCT02660580|474231060|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
131714017|NCT02660580|474231056|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
131714018|NCT02660580|474231057|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
131714019|NCT02660580|474231058|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
131714020|NCT02660580|474231059|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
131634979|NCT02382406|473948847|FG000|Follow up|Symptomatic deterioration|1|||
131634980|NCT02382406|473948848|FG001|Follow up|Symptomatic deterioration|0|||
131634981|NCT02382406|473948849|FG002|Follow up|Symptomatic deterioration|1|||
131634982|NCT02382406|473948847|FG000|Follow up|Patient Refused Follow-up|1|||
131634983|NCT02382406|473948848|FG001|Follow up|Patient Refused Follow-up|0|||
131634984|NCT02382406|473948849|FG002|Follow up|Patient Refused Follow-up|0|||
131634985|NCT02382406|473948847|FG000|Follow up|Study Terminated|1|||
131634986|NCT02382406|473948848|FG001|Follow up|Study Terminated|0|||
131634987|NCT02382406|473948849|FG002|Follow up|Study Terminated|8|||
131634988|NCT02382406|473948847|FG000|Follow up|Withdrawal by Subject|0|||
131634989|NCT02382406|473948848|FG001|Follow up|Withdrawal by Subject|0|||
131634990|NCT02382406|473948849|FG002|Follow up|Withdrawal by Subject|2|||
131634991|NCT04543942|473948852|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
131634992|NCT04543942|473948853|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
131634993|NCT04543942|473948852|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
131634994|NCT04543942|473948853|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
131634995|NCT01323309|473948854|FG000|Overall Study|Death|9|||
131634996|NCT01323309|473948855|FG001|Overall Study|Death|15|||
131634997|NCT01323309|473948856|FG002|Overall Study|Death|5|||
131634998|NCT01323309|473948854|FG000|Overall Study|Lost to Follow-up|11|||
131634999|NCT01323309|473948855|FG001|Overall Study|Lost to Follow-up|14|||
131635000|NCT01323309|473948856|FG002|Overall Study|Lost to Follow-up|24|||
131635001|NCT01323309|473948854|FG000|Overall Study|Withdrawal by Subject|14|||
131635002|NCT01323309|473948855|FG001|Overall Study|Withdrawal by Subject|14|||
131635003|NCT01323309|473948856|FG002|Overall Study|Withdrawal by Subject|18|||
131635004|NCT01323309|473948854|FG000|Overall Study|Disease progression|5|||
131635005|NCT01323309|473948855|FG001|Overall Study|Disease progression|11|||
131635006|NCT01323309|473948856|FG002|Overall Study|Disease progression|4|||
131635007|NCT03048058|473948858|FG000|Overall Study|Lost to Follow-up|4|||
131635008|NCT03048058|473948859|FG001|Overall Study|Lost to Follow-up|0|||
131635009|NCT03048058|473948858|FG000|Overall Study|Withdrawal by Subject|0|||
131635010|NCT03048058|473948859|FG001|Overall Study|Withdrawal by Subject|4|||
131635011|NCT04414397|473948876|FG000|Control Period|Withdrawal by Subject|2|||
131635012|NCT04414397|473948877|FG001|Control Period|Withdrawal by Subject|2|||
131635013|NCT04414397|473948876|FG000|Control Period|Lost to Follow-up|0|||
131635014|NCT04414397|473948877|FG001|Control Period|Lost to Follow-up|4|||
131635015|NCT04414397|473948876|FG000|Control Period|Protocol deviation|0|||
131635016|NCT04414397|473948877|FG001|Control Period|Protocol deviation|1|||
131635017|NCT04414397|473948876|FG000|Post-Control Period|Withdrawal by Subject|3|||
131635018|NCT04414397|473948877|FG001|Post-Control Period|Withdrawal by Subject|6|||
131635019|NCT04414397|473948876|FG000|Post-Control Period|Lost to Follow-up|4|||
131635020|NCT04414397|473948877|FG001|Post-Control Period|Lost to Follow-up|9|||
131635021|NCT04414397|473948876|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
131635022|NCT04414397|473948877|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
131635023|NCT04414397|473948876|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
131635024|NCT04414397|473948877|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
131635025|NCT01920178|473948881|FG000|Overall Study|Lost to Follow-up|2|||
131798623|NCT02322047|474548752|FG002|Overall Study|Adverse Event|0|||
131798624|NCT02322047|474548753|FG003|Overall Study|Adverse Event|0|||
131798625|NCT02322047|474548750|FG000|Overall Study|Lost to Follow-up|0|||
131798626|NCT02322047|474548751|FG001|Overall Study|Lost to Follow-up|0|||
131798627|NCT02322047|474548752|FG002|Overall Study|Lost to Follow-up|1|||
131798628|NCT02322047|474548753|FG003|Overall Study|Lost to Follow-up|1|||
131798629|NCT02207231|474548754|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
131798630|NCT02207231|474548755|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
131798631|NCT02207231|474548756|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
131798632|NCT02207231|474548757|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
131798633|NCT02207231|474548754|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
131798634|NCT02207231|474548755|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
131798635|NCT02207231|474548756|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
131798636|NCT02207231|474548757|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
131798637|NCT02207231|474548754|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
131798638|NCT02207231|474548755|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
131798639|NCT02207231|474548756|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
131798640|NCT02207231|474548757|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
131798641|NCT02207231|474548754|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
131798642|NCT02207231|474548755|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
131635026|NCT01920178|473948882|FG001|Overall Study|Lost to Follow-up|1|||
131798643|NCT02207231|474548756|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
131635027|NCT01261793|473948885|FG000|Overall Study|Lack of Efficacy|44|||
131635028|NCT01261793|473948886|FG001|Overall Study|Lack of Efficacy|37|||
131635029|NCT01261793|473948887|FG002|Overall Study|Lack of Efficacy|32|||
131798644|NCT02207231|474548757|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
131798645|NCT02207231|474548754|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
131804529|NCT02914600|474568556|FG000|Overall Study|Lost to Follow-up|10|||
131635030|NCT01261793|473948885|FG000|Overall Study|Protocol Violation|3|||
131635031|NCT01261793|473948886|FG001|Overall Study|Protocol Violation|5|||
131635032|NCT01261793|473948887|FG002|Overall Study|Protocol Violation|6|||
131635033|NCT01261793|473948885|FG000|Overall Study|Lost to Follow-up|10|||
131635034|NCT01261793|473948886|FG001|Overall Study|Lost to Follow-up|3|||
131635035|NCT01261793|473948887|FG002|Overall Study|Lost to Follow-up|7|||
131635036|NCT01261793|473948885|FG000|Overall Study|Withdrawal by Subject|12|||
131635037|NCT01261793|473948886|FG001|Overall Study|Withdrawal by Subject|14|||
131635038|NCT01261793|473948887|FG002|Overall Study|Withdrawal by Subject|14|||
131635039|NCT01261793|473948885|FG000|Overall Study|Death|3|||
131635040|NCT01261793|473948886|FG001|Overall Study|Death|1|||
131635041|NCT01261793|473948887|FG002|Overall Study|Death|0|||
131635042|NCT01261793|473948885|FG000|Overall Study|Adverse Event|9|||
131635043|NCT01261793|473948886|FG001|Overall Study|Adverse Event|24|||
131635044|NCT01261793|473948887|FG002|Overall Study|Adverse Event|19|||
131635045|NCT01261793|473948885|FG000|Overall Study|Patient non-availability|1|||
131635046|NCT01261793|473948886|FG001|Overall Study|Patient non-availability|1|||
131635047|NCT01261793|473948887|FG002|Overall Study|Patient non-availability|1|||
131635048|NCT01261793|473948885|FG000|Overall Study|Suspected pregnancy|1|||
131635049|NCT01261793|473948886|FG001|Overall Study|Suspected pregnancy|1|||
131635050|NCT01261793|473948887|FG002|Overall Study|Suspected pregnancy|0|||
131635051|NCT01261793|473948885|FG000|Overall Study|Patient non-compliance|1|||
131635052|NCT01261793|473948886|FG001|Overall Study|Patient non-compliance|0|||
131635053|NCT01261793|473948887|FG002|Overall Study|Patient non-compliance|1|||
131635054|NCT01261793|473948885|FG000|Overall Study|Patient pregnant|1|||
131635055|NCT01261793|473948886|FG001|Overall Study|Patient pregnant|0|||
131635056|NCT01261793|473948887|FG002|Overall Study|Patient pregnant|0|||
131635057|NCT01261793|473948885|FG000|Overall Study|Outside the study area|0|||
131635058|NCT01261793|473948886|FG001|Overall Study|Outside the study area|2|||
131635059|NCT01261793|473948887|FG002|Overall Study|Outside the study area|1|||
131635060|NCT01261793|473948885|FG000|Overall Study|Lack of efficacy & patient not available|0|||
131635061|NCT01261793|473948886|FG001|Overall Study|Lack of efficacy & patient not available|1|||
131635062|NCT01261793|473948887|FG002|Overall Study|Lack of efficacy & patient not available|0|||
131635063|NCT01261793|473948885|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
131635064|NCT01261793|473948886|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
131635065|NCT01261793|473948887|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
131635066|NCT01261793|473948885|FG000|Overall Study|Randomization error|0|||
131635067|NCT01261793|473948886|FG001|Overall Study|Randomization error|1|||
131635068|NCT01261793|473948887|FG002|Overall Study|Randomization error|0|||
131635069|NCT01261793|473948885|FG000|Overall Study|Patient unable to start IV line|0|||
131635070|NCT01261793|473948886|FG001|Overall Study|Patient unable to start IV line|0|||
131635071|NCT01261793|473948887|FG002|Overall Study|Patient unable to start IV line|1|||
131635072|NCT00577096|473948888|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
131635073|NCT00577096|473948889|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
131635074|NCT00577096|473948888|FG000|Short Term Participation|Withdrawal by Subject|3|||
131635075|NCT00577096|473948889|FG001|Short Term Participation|Withdrawal by Subject|5|||
131635076|NCT00577096|473948888|FG000|Short Term Participation|Death|1|||
131635077|NCT00577096|473948889|FG001|Short Term Participation|Death|1|||
131635078|NCT00832650|473948890|FG000|Overall Study|Randomized but not treated|0|||
131635079|NCT00832650|473948891|FG001|Overall Study|Randomized but not treated|0|||
131635080|NCT00832650|473948892|FG002|Overall Study|Randomized but not treated|1|||
131635081|NCT03562117|473948893|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
131635082|NCT03562117|473948894|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
131635083|NCT03562117|473948895|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
131635084|NCT01294358|473948896|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131635085|NCT01294358|473948897|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
131635086|NCT01294358|473948898|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131635087|NCT01294358|473948899|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131635088|NCT01294358|473948900|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131635089|NCT01294358|473948896|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131635090|NCT01294358|473948897|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131635091|NCT01294358|473948898|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
131635092|NCT01294358|473948899|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131635093|NCT01294358|473948900|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131635094|NCT01294358|473948896|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131635095|NCT01294358|473948897|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131635096|NCT01294358|473948898|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131635097|NCT01294358|473948899|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
131635098|NCT01294358|473948900|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131635099|NCT01294358|473948896|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131635100|NCT01294358|473948897|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131635101|NCT01294358|473948898|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131635102|NCT01294358|473948899|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131635103|NCT01294358|473948900|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
131635104|NCT02784535|473948907|FG000|Overall Study|Adverse Event|1|||
131635105|NCT02784535|473948908|FG001|Overall Study|Adverse Event|0|||
131635106|NCT02784535|473948907|FG000|Overall Study|Withdrawal by Subject|0|||
131902534|NCT04073303|474929305|FG000|Overall Study|Withdrawal by Subject|16|||
131635107|NCT02784535|473948908|FG001|Overall Study|Withdrawal by Subject|1|||
131635108|NCT02784535|473948907|FG000|Overall Study|Physician Decision|0|||
131635109|NCT02784535|473948908|FG001|Overall Study|Physician Decision|1|||
131635110|NCT03740919|473948913|FG000|Lead-in Period|Lost to Follow-up|1|||
131635111|NCT03740919|473948914|FG001|Lead-in Period|Lost to Follow-up|0|||
131635112|NCT03740919|473948915|FG002|Lead-in Period|Lost to Follow-up|0|||
131635113|NCT03740919|473948916|FG003|Lead-in Period|Lost to Follow-up|0|||
131635114|NCT03740919|473948913|FG000|Lead-in Period|Physician Decision|2|||
131635115|NCT03740919|473948914|FG001|Lead-in Period|Physician Decision|0|||
131635116|NCT03740919|473948915|FG002|Lead-in Period|Physician Decision|0|||
131635117|NCT03740919|473948916|FG003|Lead-in Period|Physician Decision|0|||
131635118|NCT03740919|473948913|FG000|Lead-in Period|Protocol Violation|1|||
131635119|NCT03740919|473948914|FG001|Lead-in Period|Protocol Violation|0|||
131635120|NCT03740919|473948915|FG002|Lead-in Period|Protocol Violation|0|||
131635121|NCT03740919|473948916|FG003|Lead-in Period|Protocol Violation|0|||
131635122|NCT03740919|473948913|FG000|Lead-in Period|Withdrawal by Subject|10|||
131635123|NCT03740919|473948914|FG001|Lead-in Period|Withdrawal by Subject|0|||
131635124|NCT03740919|473948915|FG002|Lead-in Period|Withdrawal by Subject|0|||
131635125|NCT03740919|473948916|FG003|Lead-in Period|Withdrawal by Subject|0|||
131635126|NCT03740919|473948913|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
131635127|NCT03740919|473948914|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
131635128|NCT03740919|473948915|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
131635129|NCT03740919|473948916|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
131635130|NCT03740919|473948913|FG000|Lead-in Period|Study Task Too Burdensome|1|||
131798646|NCT02207231|474548755|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
131798647|NCT02207231|474548756|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
131798648|NCT02207231|474548757|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
131798649|NCT02207231|474548754|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
131798650|NCT02207231|474548755|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
131798651|NCT02207231|474548756|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
131798652|NCT02207231|474548757|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
131798653|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
131798654|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
131798655|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
131798656|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
131798657|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
131798658|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
131798659|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
131798660|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
131798661|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
131798662|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
131798663|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
131798664|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
131798665|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
131798666|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
131798667|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
131798668|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
131798669|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
131798670|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
131798671|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
131798672|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
131798673|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
131798674|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
131798675|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
131798676|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
131798677|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
131798678|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
131798679|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
131902535|NCT04073303|474929306|FG001|Overall Study|Withdrawal by Subject|36|||
131635131|NCT03740919|473948914|FG001|Lead-in Period|Study Task Too Burdensome|0|||
131635132|NCT03740919|473948915|FG002|Lead-in Period|Study Task Too Burdensome|0|||
131635133|NCT03740919|473948916|FG003|Lead-in Period|Study Task Too Burdensome|0|||
131635134|NCT03740919|473948913|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
131635135|NCT03740919|473948914|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
131635136|NCT03740919|473948915|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
131635137|NCT03740919|473948916|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
131635138|NCT03740919|473948913|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
131635139|NCT03740919|473948914|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
131635140|NCT03740919|473948915|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
131635141|NCT03740919|473948916|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
131635142|NCT03740919|473948913|FG000|Treatment Period|Adverse Event|0|||
131635143|NCT03740919|473948914|FG001|Treatment Period|Adverse Event|0|||
131635144|NCT03740919|473948915|FG002|Treatment Period|Adverse Event|2|||
131635145|NCT03740919|473948916|FG003|Treatment Period|Adverse Event|0|||
131635146|NCT03740919|473948913|FG000|Treatment Period|Protocol Violation|0|||
131635147|NCT03740919|473948914|FG001|Treatment Period|Protocol Violation|1|||
131635148|NCT03740919|473948915|FG002|Treatment Period|Protocol Violation|0|||
131635149|NCT03740919|473948916|FG003|Treatment Period|Protocol Violation|0|||
131635150|NCT03740919|473948913|FG000|Treatment Period|Withdrawal by Subject|0|||
131635151|NCT03740919|473948914|FG001|Treatment Period|Withdrawal by Subject|7|||
131635152|NCT03740919|473948915|FG002|Treatment Period|Withdrawal by Subject|6|||
131635153|NCT03740919|473948916|FG003|Treatment Period|Withdrawal by Subject|2|||
131635154|NCT03740919|473948913|FG000|Treatment Period|Terminated by Sponsor|0|||
131635155|NCT03740919|473948914|FG001|Treatment Period|Terminated by Sponsor|1|||
131635156|NCT03740919|473948915|FG002|Treatment Period|Terminated by Sponsor|0|||
131635157|NCT03740919|473948916|FG003|Treatment Period|Terminated by Sponsor|0|||
131635158|NCT03740919|473948913|FG000|Treatment Period|Issue with Insulin Pump|0|||
131635159|NCT03740919|473948914|FG001|Treatment Period|Issue with Insulin Pump|1|||
131635160|NCT03740919|473948915|FG002|Treatment Period|Issue with Insulin Pump|0|||
131635161|NCT03740919|473948916|FG003|Treatment Period|Issue with Insulin Pump|0|||
131635162|NCT03740919|473948913|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
131635163|NCT03740919|473948914|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
131635164|NCT03740919|473948915|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
131635165|NCT03740919|473948916|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
131635166|NCT03740919|473948913|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
131635167|NCT03740919|473948914|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
131635168|NCT03740919|473948915|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
131635169|NCT03740919|473948916|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
131635170|NCT03740919|473948913|FG000|Treatment Period|Not Completing Diary|0|||
131635171|NCT03740919|473948914|FG001|Treatment Period|Not Completing Diary|0|||
131635172|NCT03740919|473948915|FG002|Treatment Period|Not Completing Diary|1|||
131635173|NCT03740919|473948916|FG003|Treatment Period|Not Completing Diary|0|||
131635174|NCT03740919|473948913|FG000|Treatment Period|Insulin Painful to Participant|0|||
131635175|NCT03740919|473948914|FG001|Treatment Period|Insulin Painful to Participant|0|||
131635176|NCT03740919|473948915|FG002|Treatment Period|Insulin Painful to Participant|1|||
131635177|NCT03740919|473948916|FG003|Treatment Period|Insulin Painful to Participant|0|||
131635178|NCT02335242|473948917|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
131635179|NCT02335242|473948918|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
131635180|NCT02335242|473948917|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
131635181|NCT02335242|473948918|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131635182|NCT02335242|473948917|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
131635183|NCT02335242|473948918|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
131635184|NCT02133131|473948921|FG000|Overall Study|Adverse Event|0|||
131635185|NCT02133131|473948922|FG001|Overall Study|Adverse Event|0|||
131635186|NCT02133131|473948923|FG002|Overall Study|Adverse Event|0|||
131635187|NCT02133131|473948924|FG003|Overall Study|Adverse Event|1|||
131635188|NCT02133131|473948925|FG004|Overall Study|Adverse Event|0|||
131635189|NCT02133131|473948926|FG005|Overall Study|Adverse Event|0|||
131635190|NCT02133131|473948927|FG006|Overall Study|Adverse Event|0|||
131635191|NCT02133131|473948921|FG000|Overall Study|Lost to Follow-up|1|||
131635192|NCT02133131|473948922|FG001|Overall Study|Lost to Follow-up|0|||
131635193|NCT02133131|473948923|FG002|Overall Study|Lost to Follow-up|0|||
131635194|NCT02133131|473948924|FG003|Overall Study|Lost to Follow-up|1|||
131635195|NCT02133131|473948925|FG004|Overall Study|Lost to Follow-up|0|||
131635196|NCT02133131|473948926|FG005|Overall Study|Lost to Follow-up|0|||
131635197|NCT02133131|473948927|FG006|Overall Study|Lost to Follow-up|0|||
131635198|NCT02133131|473948921|FG000|Overall Study|Status not recorded|4|||
131635199|NCT02133131|473948922|FG001|Overall Study|Status not recorded|5|||
131635200|NCT02133131|473948923|FG002|Overall Study|Status not recorded|1|||
131635201|NCT02133131|473948924|FG003|Overall Study|Status not recorded|4|||
131635202|NCT02133131|473948925|FG004|Overall Study|Status not recorded|0|||
131635203|NCT02133131|473948926|FG005|Overall Study|Status not recorded|0|||
131635204|NCT02133131|473948927|FG006|Overall Study|Status not recorded|0|||
131635205|NCT02133131|473948921|FG000|Overall Study|Ongoing in study|0|||
131635206|NCT02133131|473948922|FG001|Overall Study|Ongoing in study|0|||
131635207|NCT02133131|473948923|FG002|Overall Study|Ongoing in study|0|||
131635208|NCT02133131|473948924|FG003|Overall Study|Ongoing in study|0|||
131635209|NCT02133131|473948925|FG004|Overall Study|Ongoing in study|15|||
131635210|NCT02133131|473948926|FG005|Overall Study|Ongoing in study|14|||
131714021|NCT02660580|474231060|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
131714022|NCT00377962|474231061|FG000|Core Study: 0-12 Months|Adverse Event|18|||
131714023|NCT00377962|474231062|FG001|Core Study: 0-12 Months|Adverse Event|2|||
131714024|NCT00377962|474231061|FG000|Core Study: 0-12 Months|Death|3|||
131714025|NCT00377962|474231062|FG001|Core Study: 0-12 Months|Death|0|||
131635211|NCT02133131|473948927|FG006|Overall Study|Ongoing in study|11|||
131714026|NCT00377962|474231061|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
131714027|NCT00377962|474231062|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
131714028|NCT00377962|474231061|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
131714029|NCT00377962|474231062|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
131714030|NCT00377962|474231061|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
131714031|NCT00377962|474231062|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
131714032|NCT00377962|474231061|FG000|Extension Study: 12-24 Months|Death|1|||
131714033|NCT00377962|474231062|FG001|Extension Study: 12-24 Months|Death|1|||
131714034|NCT00377962|474231061|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
131714035|NCT00377962|474231062|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
131714036|NCT00377962|474231061|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
131714037|NCT00377962|474231062|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
131714038|NCT00377962|474231061|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
131714039|NCT00377962|474231062|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
131714040|NCT02665689|474231076|FG000|Overall Study|Adverse Event|1|||
131714041|NCT02665689|474231077|FG001|Overall Study|Adverse Event|0|||
131714042|NCT02665689|474231076|FG000|Overall Study|Trial termination|1|||
131714043|NCT02665689|474231077|FG001|Overall Study|Trial termination|1|||
131714044|NCT02665689|474231076|FG000|Overall Study|Lost to Follow-up|0|||
131714045|NCT02665689|474231077|FG001|Overall Study|Lost to Follow-up|1|||
131714046|NCT00824564|474231078|FG000|Overall Study|Lost to Follow-up|5|||
131714047|NCT00824564|474231079|FG001|Overall Study|Lost to Follow-up|7|||
131714048|NCT00824564|474231078|FG000|Overall Study|Withdrawal by Subject|1|||
131714049|NCT00824564|474231079|FG001|Overall Study|Withdrawal by Subject|1|||
131714050|NCT00824564|474231078|FG000|Overall Study|Other|1|||
131714051|NCT00824564|474231079|FG001|Overall Study|Other|2|||
131714052|NCT00824564|474231078|FG000|Overall Study|Randomized, but not treated|1|||
131714053|NCT00824564|474231079|FG001|Overall Study|Randomized, but not treated|0|||
131714054|NCT00486902|474231080|FG000|Overall Study|Withdrawal by Subject|1|||
131714055|NCT00486902|474231081|FG001|Overall Study|Withdrawal by Subject|2|||
131714056|NCT00486902|474231080|FG000|Overall Study|decision for postpartum tubal ligation|3|||
131714057|NCT00486902|474231081|FG001|Overall Study|decision for postpartum tubal ligation|1|||
131714058|NCT00486902|474231080|FG000|Overall Study|spinal anesthetic protocal violation|1|||
131714059|NCT00486902|474231081|FG001|Overall Study|spinal anesthetic protocal violation|1|||
131714060|NCT00486902|474231080|FG000|Overall Study|Did not meet inclusion criteria|1|||
131714061|NCT00486902|474231081|FG001|Overall Study|Did not meet inclusion criteria|0|||
131714062|NCT00486902|474231080|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
131714063|NCT00486902|474231081|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
131798680|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
131635212|NCT02133131|473948921|FG000|Overall Study|Protocol Violation|0|||
131635213|NCT02133131|473948922|FG001|Overall Study|Protocol Violation|0|||
131798681|NCT02207231|474548754|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
131798682|NCT02207231|474548755|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
131635214|NCT02133131|473948923|FG002|Overall Study|Protocol Violation|0|||
131635215|NCT02133131|473948924|FG003|Overall Study|Protocol Violation|0|||
131635216|NCT02133131|473948925|FG004|Overall Study|Protocol Violation|0|||
131635217|NCT02133131|473948926|FG005|Overall Study|Protocol Violation|0|||
131635218|NCT02133131|473948927|FG006|Overall Study|Protocol Violation|1|||
131635219|NCT00884793|473948928|FG000|Overall Study|Withdrawal by Subject|1|||
131635220|NCT04783519|473948929|FG000|Overall Study|Withdrawal by Subject|2|||
131635221|NCT04783519|473948930|FG001|Overall Study|Withdrawal by Subject|7|||
131635222|NCT04783519|473948931|FG002|Overall Study|Withdrawal by Subject|3|||
131635223|NCT04783519|473948929|FG000|Overall Study|Lost to Follow-up|9|||
131635224|NCT04783519|473948930|FG001|Overall Study|Lost to Follow-up|7|||
131635225|NCT04783519|473948931|FG002|Overall Study|Lost to Follow-up|6|||
131635226|NCT01032200|473948932|FG000|Overall Study|Death|1|||
131635227|NCT01032200|473948933|FG001|Overall Study|Death|1|||
131714064|NCT01552057|474231092|FG000|Overall Study|Adverse Event|14|||
131714065|NCT01552057|474231093|FG001|Overall Study|Adverse Event|15|||
131714066|NCT01552057|474231092|FG000|Overall Study|Lack of Efficacy|8|||
131714067|NCT01552057|474231093|FG001|Overall Study|Lack of Efficacy|23|||
131714068|NCT01552057|474231092|FG000|Overall Study|Withdrawal by Subject|5|||
131714069|NCT01552057|474231093|FG001|Overall Study|Withdrawal by Subject|8|||
131714070|NCT01552057|474231092|FG000|Overall Study|Entry Criteria Not Met|2|||
131714071|NCT01552057|474231093|FG001|Overall Study|Entry Criteria Not Met|2|||
131714072|NCT01552057|474231092|FG000|Overall Study|Physician Decision|1|||
131714073|NCT01552057|474231093|FG001|Overall Study|Physician Decision|0|||
131714074|NCT00476086|474231094|FG000|Overall Study|Alternative therapy|1|||
131714075|NCT00476086|474231094|FG000|Overall Study|Progressive Disease|4|||
131902536|NCT04073303|474929305|FG000|Overall Study|Lost to Follow-up|6|||
131902537|NCT04073303|474929306|FG001|Overall Study|Lost to Follow-up|1|||
131902538|NCT04073303|474929305|FG000|Overall Study|Protocol Deviation|0|||
131902539|NCT04073303|474929306|FG001|Overall Study|Protocol Deviation|4|||
131902540|NCT04073303|474929305|FG000|Overall Study|Other|1|||
131902541|NCT04073303|474929306|FG001|Overall Study|Other|1|||
131902542|NCT03589807|474929314|FG000|Overall Study|Lost to Follow-up|0|||
131902543|NCT03589807|474929315|FG001|Overall Study|Lost to Follow-up|2|||
131902544|NCT03589807|474929316|FG002|Overall Study|Lost to Follow-up|2|||
131902545|NCT03589807|474929317|FG003|Overall Study|Lost to Follow-up|3|||
131902546|NCT03589807|474929318|FG004|Overall Study|Lost to Follow-up|1|||
131902547|NCT03589807|474929319|FG005|Overall Study|Lost to Follow-up|1|||
131902548|NCT03589807|474929314|FG000|Overall Study|Withdrawal by Subject|0|||
131902549|NCT03589807|474929315|FG001|Overall Study|Withdrawal by Subject|5|||
131902550|NCT03589807|474929316|FG002|Overall Study|Withdrawal by Subject|0|||
131902551|NCT03589807|474929317|FG003|Overall Study|Withdrawal by Subject|0|||
131902552|NCT03589807|474929318|FG004|Overall Study|Withdrawal by Subject|0|||
131902553|NCT03589807|474929319|FG005|Overall Study|Withdrawal by Subject|0|||
131902554|NCT03589807|474929314|FG000|Overall Study|Protocol Violation|0|||
131902555|NCT03589807|474929315|FG001|Overall Study|Protocol Violation|0|||
131902556|NCT03589807|474929316|FG002|Overall Study|Protocol Violation|0|||
131902557|NCT03589807|474929317|FG003|Overall Study|Protocol Violation|1|||
131902558|NCT03589807|474929318|FG004|Overall Study|Protocol Violation|0|||
131902559|NCT03589807|474929319|FG005|Overall Study|Protocol Violation|0|||
131902560|NCT03589807|474929314|FG000|Overall Study|Enrolled but treatment not administered|0|||
131902561|NCT03589807|474929315|FG001|Overall Study|Enrolled but treatment not administered|0|||
131902562|NCT03589807|474929316|FG002|Overall Study|Enrolled but treatment not administered|0|||
131902563|NCT03589807|474929317|FG003|Overall Study|Enrolled but treatment not administered|0|||
131902564|NCT03589807|474929318|FG004|Overall Study|Enrolled but treatment not administered|1|||
131635228|NCT01032200|473948932|FG000|Overall Study|Withdrawal by Subject|1|||
131635229|NCT01032200|473948933|FG001|Overall Study|Withdrawal by Subject|3|||
131635230|NCT01032200|473948932|FG000|Overall Study|Toxicity|0|||
131635231|NCT01032200|473948933|FG001|Overall Study|Toxicity|2|||
131635232|NCT01032200|473948932|FG000|Overall Study|Progression|1|||
131635233|NCT01032200|473948933|FG001|Overall Study|Progression|0|||
131635234|NCT01032200|473948932|FG000|Overall Study|Multiple|1|||
131635235|NCT01032200|473948933|FG001|Overall Study|Multiple|1|||
131635236|NCT00383500|473948934|FG000|Overall Study|Withdrawal by Subject|8|||
131635237|NCT00383500|473948935|FG001|Overall Study|Withdrawal by Subject|3|||
131635238|NCT00383500|473948936|FG002|Overall Study|Withdrawal by Subject|0|||
131635239|NCT00383500|473948934|FG000|Overall Study|Lost to Follow-up|0|||
131635240|NCT00383500|473948935|FG001|Overall Study|Lost to Follow-up|0|||
131635241|NCT00383500|473948936|FG002|Overall Study|Lost to Follow-up|2|||
131635242|NCT00497198|473948940|FG000|Overall Study|Adverse Event|4|||
131635243|NCT00497198|473948941|FG001|Overall Study|Adverse Event|2|||
131635244|NCT00497198|473948940|FG000|Overall Study|Physician Decision|1|||
131635245|NCT00497198|473948941|FG001|Overall Study|Physician Decision|2|||
131635246|NCT00497198|473948940|FG000|Overall Study|Withdrawal by Subject|0|||
131635247|NCT00497198|473948941|FG001|Overall Study|Withdrawal by Subject|1|||
131635248|NCT00925288|473950704|FG000|Overall Study|Lost to Follow-up|9|||
131635249|NCT00925288|473950705|FG001|Overall Study|Lost to Follow-up|7|||
131635250|NCT00434577|473950706|FG000|Months 0-3|Serious Adverse Event|0|||
131635251|NCT00434577|473950707|FG001|Months 0-3|Serious Adverse Event|0|||
131635252|NCT00434577|473950708|FG002|Months 0-3|Serious Adverse Event|1|||
131635253|NCT00434577|473950709|FG003|Months 0-3|Serious Adverse Event|0|||
131635254|NCT00434577|473950710|FG004|Months 0-3|Serious Adverse Event|0|||
131635255|NCT00434577|473950706|FG000|Months 0-3|Adverse Event|0|||
131635256|NCT00434577|473950707|FG001|Months 0-3|Adverse Event|1|||
131635257|NCT00434577|473950708|FG002|Months 0-3|Adverse Event|1|||
131635258|NCT00434577|473950709|FG003|Months 0-3|Adverse Event|0|||
131902565|NCT03589807|474929319|FG005|Overall Study|Enrolled but treatment not administered|0|||
131902566|NCT00810069|474929320|FG000|Lead-in Period I|Adverse Event|43|||
131635259|NCT00434577|473950710|FG004|Months 0-3|Adverse Event|0|||
131635260|NCT00434577|473950706|FG000|Months 0-3|Lost to Follow-up|0|||
131635261|NCT00434577|473950707|FG001|Months 0-3|Lost to Follow-up|0|||
131635262|NCT00434577|473950708|FG002|Months 0-3|Lost to Follow-up|0|||
131635263|NCT00434577|473950709|FG003|Months 0-3|Lost to Follow-up|0|||
131635264|NCT00434577|473950710|FG004|Months 0-3|Lost to Follow-up|2|||
131635265|NCT00434577|473950706|FG000|Months 0-3|Protocol Violation|1|||
131635266|NCT00434577|473950707|FG001|Months 0-3|Protocol Violation|0|||
131635267|NCT00434577|473950708|FG002|Months 0-3|Protocol Violation|1|||
131902567|NCT00810069|474929321|FG001|Lead-in Period I|Adverse Event|0|||
131902568|NCT00810069|474929322|FG002|Lead-in Period I|Adverse Event|0|||
131902569|NCT00810069|474929320|FG000|Lead-in Period I|Lack of Efficacy|1|||
131902570|NCT00810069|474929321|FG001|Lead-in Period I|Lack of Efficacy|0|||
131902571|NCT00810069|474929322|FG002|Lead-in Period I|Lack of Efficacy|0|||
131635268|NCT00434577|473950709|FG003|Months 0-3|Protocol Violation|0|||
131635269|NCT00434577|473950710|FG004|Months 0-3|Protocol Violation|0|||
131635270|NCT00434577|473950706|FG000|Months 0-3|Withdrawal by Subject|2|||
131635271|NCT00434577|473950707|FG001|Months 0-3|Withdrawal by Subject|1|||
131635272|NCT00434577|473950708|FG002|Months 0-3|Withdrawal by Subject|1|||
131635273|NCT00434577|473950709|FG003|Months 0-3|Withdrawal by Subject|1|||
131635274|NCT00434577|473950710|FG004|Months 0-3|Withdrawal by Subject|1|||
131635275|NCT01589523|473950723|FG000|Overall Study|Withdrawal by Subject|1|||
131635276|NCT00792259|473950724|FG000|Overall Study|Poor Quality Scans|1|||
131635277|NCT00792259|473950725|FG001|Overall Study|Poor Quality Scans|0|||
131635278|NCT00792259|473950726|FG002|Overall Study|Poor Quality Scans|0|||
131635279|NCT03721978|473950727|FG000|Overall Study|Withdrawal by Subject|6|||
131635280|NCT03721978|473950728|FG001|Overall Study|Withdrawal by Subject|1|||
131635281|NCT03721978|473950727|FG000|Overall Study|Adverse Event|1|||
131635282|NCT03721978|473950728|FG001|Overall Study|Adverse Event|1|||
131635283|NCT03721978|473950727|FG000|Overall Study|Progressive Disease|1|||
131635284|NCT03721978|473950728|FG001|Overall Study|Progressive Disease|0|||
131635285|NCT03721978|473950727|FG000|Overall Study|Lost to Follow-up|5|||
131635286|NCT03721978|473950728|FG001|Overall Study|Lost to Follow-up|1|||
131635287|NCT03721978|473950727|FG000|Overall Study|Reason not Specified|0|||
131635288|NCT03721978|473950728|FG001|Overall Study|Reason not Specified|2|||
131635289|NCT05244226|473950729|FG000|Overall Study|Adverse Event|1|||
131635290|NCT05244226|473950730|FG001|Overall Study|Adverse Event|0|||
131635291|NCT05244226|473950731|FG002|Overall Study|Adverse Event|0|||
131635292|NCT05244226|473950729|FG000|Overall Study|Lost to Follow-up|0|||
131635293|NCT05244226|473950730|FG001|Overall Study|Lost to Follow-up|0|||
131635294|NCT05244226|473950731|FG002|Overall Study|Lost to Follow-up|1|||
131635295|NCT05244226|473950729|FG000|Overall Study|Protocol Violation|0|||
131635296|NCT05244226|473950730|FG001|Overall Study|Protocol Violation|2|||
131635297|NCT05244226|473950731|FG002|Overall Study|Protocol Violation|2|||
131635298|NCT02675998|473950738|FG000|8-Week Treatment Period|Adverse Event|6|||
131635299|NCT02675998|473950739|FG001|8-Week Treatment Period|Adverse Event|5|||
131635300|NCT02675998|473950740|FG002|8-Week Treatment Period|Adverse Event|6|||
131635301|NCT02675998|473950741|FG003|8-Week Treatment Period|Adverse Event|0|||
131635302|NCT02675998|473950738|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
131635303|NCT02675998|473950739|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
131635304|NCT02675998|473950740|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
131635305|NCT02675998|473950741|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
131635306|NCT02675998|473950738|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
131635307|NCT02675998|473950739|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
131635308|NCT02675998|473950740|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
131635309|NCT02675998|473950741|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
131635310|NCT02675998|473950738|FG000|8-Week Treatment Period|Physician Decision|1|||
131635311|NCT02675998|473950739|FG001|8-Week Treatment Period|Physician Decision|0|||
131635312|NCT02675998|473950740|FG002|8-Week Treatment Period|Physician Decision|2|||
131635313|NCT02675998|473950741|FG003|8-Week Treatment Period|Physician Decision|0|||
131798683|NCT02207231|474548756|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
131798684|NCT02207231|474548757|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
131798685|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
131798686|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
131798687|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
131798688|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
131798689|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
131798690|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
131798691|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
131798692|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
131798693|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
131635314|NCT02675998|473950738|FG000|8-Week Treatment Period|GI side Effects|1|||
131635315|NCT02675998|473950739|FG001|8-Week Treatment Period|GI side Effects|4|||
131635316|NCT02675998|473950740|FG002|8-Week Treatment Period|GI side Effects|2|||
131635317|NCT02675998|473950741|FG003|8-Week Treatment Period|GI side Effects|0|||
131635318|NCT02675998|473950738|FG000|8-Week Treatment Period|Protocol Violation|1|||
131635319|NCT02675998|473950739|FG001|8-Week Treatment Period|Protocol Violation|1|||
131635320|NCT02675998|473950740|FG002|8-Week Treatment Period|Protocol Violation|1|||
131635321|NCT02675998|473950741|FG003|8-Week Treatment Period|Protocol Violation|0|||
131635322|NCT02675998|473950738|FG000|8-Week Treatment Period|Other|3|||
131635323|NCT02675998|473950739|FG001|8-Week Treatment Period|Other|1|||
131635324|NCT02675998|473950740|FG002|8-Week Treatment Period|Other|2|||
131635325|NCT02675998|473950741|FG003|8-Week Treatment Period|Other|0|||
131635326|NCT02675998|473950738|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
131635327|NCT02675998|473950739|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
131635328|NCT02675998|473950740|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
131635329|NCT02675998|473950741|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
131635330|NCT02675998|473950738|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
131635331|NCT02675998|473950739|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
131635332|NCT02675998|473950740|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
131635333|NCT02675998|473950741|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
131635334|NCT02675998|473950738|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
131635335|NCT02675998|473950739|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
131635336|NCT02675998|473950740|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
131635337|NCT02675998|473950741|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
131635338|NCT02675998|473950738|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
131635339|NCT02675998|473950739|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
131635340|NCT02675998|473950740|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
131635341|NCT02675998|473950741|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
131635342|NCT02675998|473950738|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
131635343|NCT02675998|473950739|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
131635344|NCT02675998|473950740|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
131635345|NCT02675998|473950741|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
131635346|NCT00275301|473950742|FG000|Overall Study|Adverse Event|5|||
131635347|NCT04357964|473950743|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
131714076|NCT02900092|474231095|FG000|Overall Study|Adverse Event|1|||
131714077|NCT00364793|474231096|FG000|Overall Study|Adverse Event|2|||
131714078|NCT00364793|474231097|FG001|Overall Study|Adverse Event|0|||
131714079|NCT00364793|474231098|FG002|Overall Study|Adverse Event|0|||
131714080|NCT00364793|474231099|FG003|Overall Study|Adverse Event|0|||
131714081|NCT00364793|474231096|FG000|Overall Study|Death|1|||
131714082|NCT00364793|474231097|FG001|Overall Study|Death|0|||
131714083|NCT00364793|474231098|FG002|Overall Study|Death|1|||
131714084|NCT00364793|474231099|FG003|Overall Study|Death|0|||
131714085|NCT00364793|474231096|FG000|Overall Study|Lack of Efficacy|3|||
131714086|NCT00364793|474231097|FG001|Overall Study|Lack of Efficacy|3|||
131714087|NCT00364793|474231098|FG002|Overall Study|Lack of Efficacy|1|||
131714088|NCT00364793|474231099|FG003|Overall Study|Lack of Efficacy|1|||
131714089|NCT00364793|474231096|FG000|Overall Study|Lost to Follow-up|1|||
131714090|NCT00364793|474231097|FG001|Overall Study|Lost to Follow-up|0|||
131714091|NCT00364793|474231098|FG002|Overall Study|Lost to Follow-up|2|||
131714092|NCT00364793|474231099|FG003|Overall Study|Lost to Follow-up|0|||
131714093|NCT00364793|474231096|FG000|Overall Study|Poor or non-compliance|1|||
131714094|NCT00364793|474231097|FG001|Overall Study|Poor or non-compliance|1|||
131714095|NCT00364793|474231098|FG002|Overall Study|Poor or non-compliance|0|||
131714096|NCT00364793|474231099|FG003|Overall Study|Poor or non-compliance|1|||
131714097|NCT00364793|474231096|FG000|Overall Study|No longer meets criteria|0|||
131714098|NCT00364793|474231097|FG001|Overall Study|No longer meets criteria|0|||
131714099|NCT00364793|474231098|FG002|Overall Study|No longer meets criteria|0|||
131714100|NCT00364793|474231099|FG003|Overall Study|No longer meets criteria|1|||
131714101|NCT00364793|474231096|FG000|Overall Study|Withdrawal by Subject|0|||
131714102|NCT00364793|474231097|FG001|Overall Study|Withdrawal by Subject|1|||
131714103|NCT00364793|474231098|FG002|Overall Study|Withdrawal by Subject|0|||
131714104|NCT00364793|474231099|FG003|Overall Study|Withdrawal by Subject|0|||
131714105|NCT05127486|474231100|FG000|Overall Study|Adverse Event|2|||
131714106|NCT05127486|474231101|FG001|Overall Study|Adverse Event|4|||
131714107|NCT05127486|474231100|FG000|Overall Study|Lack of Efficacy|1|||
131635348|NCT04357964|473950744|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
131635349|NCT04357964|473950743|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
131635350|NCT04357964|473950744|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
131714108|NCT05127486|474231101|FG001|Overall Study|Lack of Efficacy|0|||
131714109|NCT05127486|474231100|FG000|Overall Study|Pregnancy|0|||
131714110|NCT05127486|474231101|FG001|Overall Study|Pregnancy|1|||
131714111|NCT05127486|474231100|FG000|Overall Study|Physician Decision|4|||
131714112|NCT05127486|474231101|FG001|Overall Study|Physician Decision|1|||
131804530|NCT02914600|474568557|FG001|Overall Study|Lost to Follow-up|4|||
131635351|NCT04357964|473950743|FG000|Overall Study|Adipose sample was insufficient quality|0|||
131635352|NCT04357964|473950744|FG001|Overall Study|Adipose sample was insufficient quality|1|||
131635353|NCT00733226|473950747|FG000|Overall Study|Withdrawal by Subject|1|||
131635354|NCT00733226|473950748|FG001|Overall Study|Withdrawal by Subject|0|||
131635355|NCT00733226|473950747|FG000|Overall Study|Lost to Follow-up|2|||
131635356|NCT00733226|473950748|FG001|Overall Study|Lost to Follow-up|0|||
131635357|NCT00733226|473950747|FG000|Overall Study|moved to another place|2|||
131635358|NCT00733226|473950748|FG001|Overall Study|moved to another place|0|||
131635359|NCT00848393|473950755|FG000|Overall Study|Protocol Violation|0|||
131635360|NCT00848393|473950756|FG001|Overall Study|Protocol Violation|0|||
131635361|NCT00848393|473950757|FG002|Overall Study|Protocol Violation|1|||
131635362|NCT00848393|473950755|FG000|Overall Study|surgical complications unrelated to stud|0|||
131635363|NCT00848393|473950756|FG001|Overall Study|surgical complications unrelated to stud|0|||
131635364|NCT00848393|473950757|FG002|Overall Study|surgical complications unrelated to stud|2|||
131635365|NCT02561078|473950758|FG000|Overall Study|Adverse Event|5|||
131635366|NCT02561078|473950759|FG001|Overall Study|Adverse Event|2|||
131635367|NCT02561078|473950758|FG000|Overall Study|Death|2|||
131635368|NCT02561078|473950759|FG001|Overall Study|Death|1|||
131635369|NCT02561078|473950758|FG000|Overall Study|Lost to Follow-up|2|||
131635370|NCT02561078|473950759|FG001|Overall Study|Lost to Follow-up|6|||
131635371|NCT02561078|473950758|FG000|Overall Study|Non-Compliance with Study Drug|6|||
131635372|NCT02561078|473950759|FG001|Overall Study|Non-Compliance with Study Drug|3|||
131635373|NCT02561078|473950758|FG000|Overall Study|Physician Decision|2|||
131635374|NCT02561078|473950759|FG001|Overall Study|Physician Decision|3|||
131635375|NCT02561078|473950758|FG000|Overall Study|Withdrawal by Subject|13|||
131635376|NCT02561078|473950759|FG001|Overall Study|Withdrawal by Subject|10|||
131635377|NCT00043186|473950766|FG000|Overall Study|Physician Decision|0|||
131635378|NCT00043186|473950767|FG001|Overall Study|Physician Decision|0|||
131635379|NCT00043186|473950768|FG002|Overall Study|Physician Decision|3|||
131635380|NCT00043186|473950769|FG003|Overall Study|Physician Decision|0|||
131635381|NCT00043186|473950770|FG004|Overall Study|Physician Decision|1|||
131635382|NCT00043186|473950771|FG005|Overall Study|Physician Decision|0|||
131635383|NCT00043186|473950772|FG006|Overall Study|Physician Decision|0|||
131635384|NCT00043186|473950773|FG007|Overall Study|Physician Decision|1|||
131635385|NCT00043186|473950774|FG008|Overall Study|Physician Decision|1|||
131635386|NCT00043186|473950766|FG000|Overall Study|Adverse Event|2|||
131635387|NCT00043186|473950767|FG001|Overall Study|Adverse Event|2|||
131635388|NCT00043186|473950768|FG002|Overall Study|Adverse Event|2|||
131635389|NCT00043186|473950769|FG003|Overall Study|Adverse Event|3|||
131635390|NCT00043186|473950770|FG004|Overall Study|Adverse Event|2|||
131635391|NCT00043186|473950771|FG005|Overall Study|Adverse Event|1|||
131635392|NCT00043186|473950772|FG006|Overall Study|Adverse Event|2|||
131635393|NCT00043186|473950773|FG007|Overall Study|Adverse Event|1|||
131635394|NCT00043186|473950774|FG008|Overall Study|Adverse Event|3|||
131635395|NCT00043186|473950766|FG000|Overall Study|Withdrawal by Subject|11|||
131635396|NCT00043186|473950767|FG001|Overall Study|Withdrawal by Subject|8|||
131635397|NCT00043186|473950768|FG002|Overall Study|Withdrawal by Subject|11|||
131635398|NCT00043186|473950769|FG003|Overall Study|Withdrawal by Subject|13|||
131635399|NCT00043186|473950770|FG004|Overall Study|Withdrawal by Subject|14|||
131635400|NCT00043186|473950771|FG005|Overall Study|Withdrawal by Subject|6|||
131798694|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
131798695|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
131798696|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
131798697|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
131798698|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
131798699|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
131445045|NCT03050801|473258803|FG001|Experiment 2|Discomfort during stimulation|0|||
131445046|NCT03050801|473258804|FG002|Experiment 2|Discomfort during stimulation|0|||
131445047|NCT03050801|473258805|FG003|Experiment 2|Discomfort during stimulation|0|||
131635401|NCT00043186|473950772|FG006|Overall Study|Withdrawal by Subject|12|||
131635402|NCT00043186|473950773|FG007|Overall Study|Withdrawal by Subject|9|||
131635403|NCT00043186|473950774|FG008|Overall Study|Withdrawal by Subject|10|||
131635404|NCT00043186|473950766|FG000|Overall Study|Death|0|||
131635405|NCT00043186|473950767|FG001|Overall Study|Death|0|||
131635406|NCT00043186|473950768|FG002|Overall Study|Death|1|||
131445048|NCT03050801|473258806|FG004|Experiment 2|Discomfort during stimulation|0|||
131445049|NCT03050801|473258807|FG005|Experiment 2|Discomfort during stimulation|2|||
131635407|NCT00043186|473950769|FG003|Overall Study|Death|0|||
131635408|NCT00043186|473950770|FG004|Overall Study|Death|0|||
131635409|NCT00043186|473950771|FG005|Overall Study|Death|0|||
131798700|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
131635410|NCT00043186|473950772|FG006|Overall Study|Death|2|||
131635411|NCT00043186|473950773|FG007|Overall Study|Death|0|||
131635412|NCT00043186|473950774|FG008|Overall Study|Death|0|||
131635413|NCT00043186|473950766|FG000|Overall Study|Disease progression|1|||
131635414|NCT00043186|473950767|FG001|Overall Study|Disease progression|0|||
131635415|NCT00043186|473950768|FG002|Overall Study|Disease progression|0|||
131635416|NCT00043186|473950769|FG003|Overall Study|Disease progression|3|||
131635417|NCT00043186|473950770|FG004|Overall Study|Disease progression|0|||
131635418|NCT00043186|473950771|FG005|Overall Study|Disease progression|0|||
131635419|NCT00043186|473950772|FG006|Overall Study|Disease progression|0|||
131635420|NCT00043186|473950773|FG007|Overall Study|Disease progression|4|||
131635421|NCT00043186|473950774|FG008|Overall Study|Disease progression|0|||
131635422|NCT00043186|473950766|FG000|Overall Study|Ineligibility determined|0|||
131635423|NCT00043186|473950767|FG001|Overall Study|Ineligibility determined|0|||
131635424|NCT00043186|473950768|FG002|Overall Study|Ineligibility determined|0|||
131635425|NCT00043186|473950769|FG003|Overall Study|Ineligibility determined|0|||
131635426|NCT00043186|473950770|FG004|Overall Study|Ineligibility determined|0|||
131635427|NCT00043186|473950771|FG005|Overall Study|Ineligibility determined|0|||
131635428|NCT00043186|473950772|FG006|Overall Study|Ineligibility determined|0|||
131635429|NCT00043186|473950773|FG007|Overall Study|Ineligibility determined|0|||
131635430|NCT00043186|473950774|FG008|Overall Study|Ineligibility determined|1|||
131635431|NCT00043186|473950766|FG000|Overall Study|Lost to Follow-up|3|||
131635432|NCT00043186|473950767|FG001|Overall Study|Lost to Follow-up|5|||
131635433|NCT00043186|473950768|FG002|Overall Study|Lost to Follow-up|1|||
131635434|NCT00043186|473950769|FG003|Overall Study|Lost to Follow-up|1|||
131635435|NCT00043186|473950770|FG004|Overall Study|Lost to Follow-up|1|||
131635436|NCT00043186|473950771|FG005|Overall Study|Lost to Follow-up|1|||
131635437|NCT00043186|473950772|FG006|Overall Study|Lost to Follow-up|1|||
131635438|NCT00043186|473950773|FG007|Overall Study|Lost to Follow-up|1|||
131635439|NCT00043186|473950774|FG008|Overall Study|Lost to Follow-up|2|||
131635440|NCT00043186|473950766|FG000|Overall Study|Noncompliance|0|||
131635441|NCT00043186|473950767|FG001|Overall Study|Noncompliance|0|||
131635442|NCT00043186|473950768|FG002|Overall Study|Noncompliance|1|||
131635443|NCT00043186|473950769|FG003|Overall Study|Noncompliance|1|||
131635444|NCT00043186|473950770|FG004|Overall Study|Noncompliance|0|||
131635445|NCT00043186|473950771|FG005|Overall Study|Noncompliance|0|||
131635446|NCT00043186|473950772|FG006|Overall Study|Noncompliance|0|||
131635447|NCT00043186|473950773|FG007|Overall Study|Noncompliance|0|||
131635448|NCT00043186|473950774|FG008|Overall Study|Noncompliance|0|||
131635449|NCT00043186|473950766|FG000|Overall Study|Other|0|||
131635450|NCT00043186|473950767|FG001|Overall Study|Other|0|||
131635451|NCT00043186|473950768|FG002|Overall Study|Other|1|||
131635452|NCT00043186|473950769|FG003|Overall Study|Other|1|||
131635453|NCT00043186|473950770|FG004|Overall Study|Other|0|||
131635454|NCT00043186|473950771|FG005|Overall Study|Other|0|||
131635455|NCT00043186|473950772|FG006|Overall Study|Other|0|||
131635456|NCT00043186|473950773|FG007|Overall Study|Other|0|||
131635457|NCT00043186|473950774|FG008|Overall Study|Other|0|||
131635458|NCT03722485|473950775|FG000|Overall Study|Withdrawal by Subject|1|||
131635459|NCT03722485|473950776|FG001|Overall Study|Withdrawal by Subject|0|||
131635460|NCT03722485|473950775|FG000|Overall Study|Adverse Event|0|||
131635461|NCT03722485|473950776|FG001|Overall Study|Adverse Event|2|||
131635462|NCT03722485|473950775|FG000|Overall Study|subject discharged prior to study completion|1|||
131798701|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
131798702|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
131798703|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
131798704|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
131798705|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
131798706|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
131798707|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
131798708|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
131798709|NCT02207231|474548754|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
131798710|NCT02207231|474548755|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
131798711|NCT02207231|474548756|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
131902572|NCT00810069|474929320|FG000|Lead-in Period I|Lost to Follow-up|19|||
131902573|NCT00810069|474929321|FG001|Lead-in Period I|Lost to Follow-up|0|||
131902574|NCT00810069|474929322|FG002|Lead-in Period I|Lost to Follow-up|0|||
131635463|NCT03722485|473950776|FG001|Overall Study|subject discharged prior to study completion|5|||
131635464|NCT03722485|473950775|FG000|Overall Study|eligibility criteria not met|2|||
131635465|NCT03722485|473950776|FG001|Overall Study|eligibility criteria not met|0|||
131635466|NCT00349622|473950777|FG000|Overall Study|Death|168|||
131635467|NCT00349622|473950778|FG001|Overall Study|Death|86|||
131902575|NCT00810069|474929320|FG000|Lead-in Period I|Physician Decision|1|||
131635468|NCT00349622|473950777|FG000|Overall Study|Lost to Follow-up|5|||
131635469|NCT00349622|473950778|FG001|Overall Study|Lost to Follow-up|1|||
131635470|NCT00349622|473950777|FG000|Overall Study|Withdrawal by Subject|5|||
131635471|NCT00349622|473950778|FG001|Overall Study|Withdrawal by Subject|9|||
131635472|NCT01902381|473950779|FG000|Overall Study|Withdrawal by Subject|1|||
131635473|NCT00755716|473950783|FG000|Overall Study|Adverse Event|1|||
131635474|NCT00755716|473950784|FG001|Overall Study|Adverse Event|4|||
131635475|NCT00755716|473950785|FG002|Overall Study|Adverse Event|1|||
131635476|NCT00755716|473950783|FG000|Overall Study|Lack of Efficacy|2|||
131635477|NCT00755716|473950784|FG001|Overall Study|Lack of Efficacy|0|||
131635478|NCT00755716|473950785|FG002|Overall Study|Lack of Efficacy|0|||
131635479|NCT00755716|473950783|FG000|Overall Study|Lost to Follow-up|5|||
131635480|NCT00755716|473950784|FG001|Overall Study|Lost to Follow-up|3|||
131635481|NCT00755716|473950785|FG002|Overall Study|Lost to Follow-up|1|||
131635482|NCT00755716|473950783|FG000|Overall Study|work schedule issues|0|||
131635483|NCT00755716|473950784|FG001|Overall Study|work schedule issues|1|||
131635484|NCT00755716|473950785|FG002|Overall Study|work schedule issues|1|||
131635485|NCT02762500|473950786|FG000|Overall Study|Lack of Efficacy|1|||
131635486|NCT02762500|473950787|FG001|Overall Study|Lack of Efficacy|0|||
131635487|NCT02762500|473950786|FG000|Overall Study|Withdrawal by Subject|1|||
131635488|NCT02762500|473950787|FG001|Overall Study|Withdrawal by Subject|1|||
131635489|NCT02762500|473950786|FG000|Overall Study|Adverse Event|0|||
131635490|NCT02762500|473950787|FG001|Overall Study|Adverse Event|2|||
131635491|NCT02229396|473950788|FG000|Overall Study|Adverse Event|6|||
131635492|NCT02229396|473950789|FG001|Overall Study|Adverse Event|12|||
131635493|NCT02229396|473950790|FG002|Overall Study|Adverse Event|12|||
131635494|NCT02229396|473950788|FG000|Overall Study|Death|2|||
131635495|NCT02229396|473950789|FG001|Overall Study|Death|3|||
131635496|NCT02229396|473950790|FG002|Overall Study|Death|1|||
131635497|NCT02229396|473950788|FG000|Overall Study|Lost to Follow-up|14|||
131635498|NCT02229396|473950789|FG001|Overall Study|Lost to Follow-up|14|||
131635499|NCT02229396|473950790|FG002|Overall Study|Lost to Follow-up|21|||
131635500|NCT02229396|473950788|FG000|Overall Study|Protocol Violation|2|||
131635501|NCT02229396|473950789|FG001|Overall Study|Protocol Violation|1|||
131635502|NCT02229396|473950790|FG002|Overall Study|Protocol Violation|0|||
131635503|NCT02229396|473950788|FG000|Overall Study|Patient Incorrectly Randomized|0|||
131635504|NCT02229396|473950789|FG001|Overall Study|Patient Incorrectly Randomized|0|||
131635505|NCT02229396|473950790|FG002|Overall Study|Patient Incorrectly Randomized|1|||
131635506|NCT02229396|473950788|FG000|Overall Study|Other|10|||
131635507|NCT02229396|473950789|FG001|Overall Study|Other|18|||
131635508|NCT02229396|473950790|FG002|Overall Study|Other|15|||
131635509|NCT02229396|473950788|FG000|Overall Study|Withdrawal by Subject|42|||
131635510|NCT02229396|473950789|FG001|Overall Study|Withdrawal by Subject|28|||
131635511|NCT02229396|473950790|FG002|Overall Study|Withdrawal by Subject|41|||
131635512|NCT02229396|473950788|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
131635513|NCT02229396|473950789|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
131635514|NCT02229396|473950790|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
131635515|NCT02229396|473950788|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
131635516|NCT02229396|473950789|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
131635517|NCT02229396|473950790|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
131635518|NCT00730847|473950791|FG000|Overall Study|Adverse Event|1|||
131635519|NCT00730847|473950791|FG000|Overall Study|Protocol Violation|2|||
131635520|NCT00730847|473950791|FG000|Overall Study|Withdrawal by Subject|16|||
131635521|NCT00730847|473950791|FG000|Overall Study|Lost to Follow-up|67|||
131635522|NCT00730847|473950791|FG000|Overall Study|Unknown completion status|21|||
131635523|NCT00730847|473950791|FG000|Overall Study|Other|24|||
131635524|NCT03022578|473950792|FG000|Overall Study|Adverse Event|1|||
131635525|NCT03022578|473950792|FG000|Overall Study|Lack of Efficacy|2|||
131804531|NCT02914600|474568558|FG002|Overall Study|Lost to Follow-up|0|||
131635526|NCT03022578|473950792|FG000|Overall Study|Withdrawal by Subject|1|||
131635527|NCT03681353|473950798|FG000|Overall Study|Lost to Follow-up|2|||
131635528|NCT03681353|473950798|FG000|Overall Study|Withdrawal by Subject|3|||
131635529|NCT03681353|473950798|FG000|Overall Study|withdrawn by PI|2|||
131635530|NCT00726388|473950801|FG000|Overall Study|Withdrawal by Subject|5|||
131635531|NCT00726388|473950801|FG000|Overall Study|Adverse Event|3|||
131635532|NCT00726388|473950801|FG000|Overall Study|Lost to Follow-up|10|||
131635533|NCT00726388|473950801|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
131635534|NCT00726388|473950801|FG000|Overall Study|Other|5|||
131635535|NCT00726388|473950801|FG000|Overall Study|Enrolled, Not Treated|79|||
131635536|NCT01370018|473950802|FG000|Overall Study|Did not meet criteria for analysis|1|||
131635537|NCT01536535|473950806|FG000|Overall Study|Withdrawal by Subject|10|||
131804532|NCT02914600|474568556|FG000|Overall Study|Pregnancy|8|||
131804533|NCT02914600|474568557|FG001|Overall Study|Pregnancy|0|||
131804534|NCT02914600|474568558|FG002|Overall Study|Pregnancy|0|||
131804535|NCT02914600|474568556|FG000|Overall Study|Protocol Violation|5|||
131804536|NCT02914600|474568557|FG001|Overall Study|Protocol Violation|3|||
131804537|NCT02914600|474568558|FG002|Overall Study|Protocol Violation|0|||
131804538|NCT02914600|474568556|FG000|Overall Study|Non-compliance with study drug|6|||
131804539|NCT02914600|474568557|FG001|Overall Study|Non-compliance with study drug|1|||
131804540|NCT02914600|474568558|FG002|Overall Study|Non-compliance with study drug|0|||
131804541|NCT02914600|474568556|FG000|Overall Study|Death|3|||
131804542|NCT02914600|474568557|FG001|Overall Study|Death|1|||
131804543|NCT02914600|474568558|FG002|Overall Study|Death|1|||
131635538|NCT01536535|473950807|FG001|Overall Study|Withdrawal by Subject|5|||
131635539|NCT01536535|473950806|FG000|Overall Study|Lost to Follow-up|4|||
131635540|NCT01536535|473950807|FG001|Overall Study|Lost to Follow-up|6|||
131635541|NCT01536535|473950806|FG000|Overall Study|Physician Decision|1|||
131635542|NCT01536535|473950807|FG001|Overall Study|Physician Decision|1|||
131635543|NCT01536535|473950806|FG000|Overall Study|Participant moved|0|||
131635544|NCT01536535|473950807|FG001|Overall Study|Participant moved|1|||
131635545|NCT03794609|473950808|FG000|Overall Study|Other|10|||
131635546|NCT03794609|473950808|FG000|Overall Study|Withdrawal by Subject|66|||
131635547|NCT03794609|473950808|FG000|Overall Study|The child is enrolled in an interventional study|70|||
131635548|NCT03794609|473950808|FG000|Overall Study|Inclusion/exclusion criteria|8|||
131798712|NCT02207231|474548757|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
131798713|NCT00502775|474548761|FG000|Overall Study|Adverse Event|1|||
131798714|NCT00502775|474548762|FG001|Overall Study|Adverse Event|2|||
131798715|NCT00502775|474548763|FG002|Overall Study|Adverse Event|1|||
131798716|NCT00502775|474548761|FG000|Overall Study|Protocol Violation|1|||
131798717|NCT00502775|474548762|FG001|Overall Study|Protocol Violation|5|||
131798718|NCT00502775|474548763|FG002|Overall Study|Protocol Violation|2|||
131798719|NCT00502775|474548761|FG000|Overall Study|Withdrawal by Subject|1|||
131798720|NCT00502775|474548762|FG001|Overall Study|Withdrawal by Subject|1|||
131798721|NCT00502775|474548763|FG002|Overall Study|Withdrawal by Subject|2|||
131798722|NCT00502775|474548761|FG000|Overall Study|Sponsor Terminated Study|1|||
131798723|NCT00502775|474548762|FG001|Overall Study|Sponsor Terminated Study|0|||
131798724|NCT00502775|474548763|FG002|Overall Study|Sponsor Terminated Study|1|||
131798725|NCT00502775|474548761|FG000|Overall Study|Non-compliance with eDiary|4|||
131798726|NCT00502775|474548762|FG001|Overall Study|Non-compliance with eDiary|1|||
131798727|NCT00502775|474548763|FG002|Overall Study|Non-compliance with eDiary|1|||
131798728|NCT00502775|474548761|FG000|Overall Study|Subject unable to swallow capsule|1|||
131798729|NCT00502775|474548762|FG001|Overall Study|Subject unable to swallow capsule|0|||
131798730|NCT00502775|474548763|FG002|Overall Study|Subject unable to swallow capsule|1|||
131798731|NCT00502775|474548761|FG000|Overall Study|Logpad compliance <80%|1|||
131798732|NCT00502775|474548762|FG001|Overall Study|Logpad compliance <80%|0|||
131798733|NCT00502775|474548763|FG002|Overall Study|Logpad compliance <80%|0|||
131798734|NCT00502775|474548761|FG000|Overall Study|Randomized in error|0|||
131798735|NCT00502775|474548762|FG001|Overall Study|Randomized in error|1|||
131798736|NCT00502775|474548763|FG002|Overall Study|Randomized in error|1|||
131798737|NCT00502775|474548761|FG000|Overall Study|Non-compliance|0|||
131798738|NCT00502775|474548762|FG001|Overall Study|Non-compliance|2|||
131798739|NCT00502775|474548763|FG002|Overall Study|Non-compliance|2|||
131798740|NCT00502775|474548761|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
131798741|NCT00502775|474548762|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
131798742|NCT00502775|474548763|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
131798743|NCT00502775|474548761|FG000|Overall Study|Declining pollen counts|0|||
131798744|NCT00502775|474548762|FG001|Overall Study|Declining pollen counts|1|||
131798745|NCT00502775|474548763|FG002|Overall Study|Declining pollen counts|1|||
131798746|NCT00502775|474548761|FG000|Overall Study|Subject in jail|0|||
131798747|NCT00502775|474548762|FG001|Overall Study|Subject in jail|1|||
131798748|NCT00502775|474548763|FG002|Overall Study|Subject in jail|0|||
131798749|NCT00502775|474548761|FG000|Overall Study|Subject took disallowed drug|0|||
131798750|NCT00502775|474548762|FG001|Overall Study|Subject took disallowed drug|0|||
131798751|NCT00502775|474548763|FG002|Overall Study|Subject took disallowed drug|1|||
131798752|NCT02309099|474548769|FG000|Overall Study|Adverse Event|2|||
131798753|NCT02309099|474548770|FG001|Overall Study|Adverse Event|0|||
131798754|NCT02016300|474548771|FG000|Overall Study|Lost to Follow-up|0|||
131798755|NCT02016300|474548772|FG001|Overall Study|Lost to Follow-up|3|||
131798756|NCT06165744|474548778|FG000|Overall Study|Non device-related adverse event|1|||
131798757|NCT05456529|474548779|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
131798758|NCT05456529|474548779|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
131798759|NCT05456529|474548779|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
131798760|NCT05456529|474548779|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
131798761|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
131798762|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
131635549|NCT03794609|473950808|FG000|Overall Study|At sponsor's request|151|||
131635550|NCT03794609|473950808|FG000|Overall Study|Physician Decision|1|||
131635551|NCT03794609|473950808|FG000|Overall Study|Lost to Follow-up|5|||
131635552|NCT04474691|473950815|FG000|Overall Study|Withdrawal by Subject|9|||
131635553|NCT00139659|473950816|FG000|Overall Study|Adverse Event|12|||
131635554|NCT00139659|473950817|FG001|Overall Study|Adverse Event|1|||
131635555|NCT00139659|473950816|FG000|Overall Study|Lack of Efficacy|1|||
131635556|NCT00139659|473950817|FG001|Overall Study|Lack of Efficacy|1|||
131635557|NCT00139659|473950816|FG000|Overall Study|Lost to Follow-up|7|||
131635558|NCT00139659|473950817|FG001|Overall Study|Lost to Follow-up|3|||
131635559|NCT00139659|473950816|FG000|Overall Study|Reason not Specified|6|||
131635560|NCT00139659|473950817|FG001|Overall Study|Reason not Specified|3|||
131635561|NCT00139659|473950816|FG000|Overall Study|Withdrawal by Subject|14|||
131635562|NCT00139659|473950817|FG001|Overall Study|Withdrawal by Subject|10|||
131635563|NCT02625922|473950819|FG000|Overall Study|Non-availability of IMP|1|||
131635564|NCT02625922|473950820|FG001|Overall Study|Non-availability of IMP|1|||
131635565|NCT02625922|473950819|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
131635566|NCT02625922|473950820|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
131635567|NCT02391116|473950821|FG000|Treatment|Withdrawal by Subject|1|||
131635568|NCT02391116|473950821|FG000|Treatment|Protocol Violation|1|||
131635569|NCT02391116|473950821|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
131635570|NCT02391116|473950821|FG000|Treatment|AE with Clinical PD|3|||
131635571|NCT02391116|473950821|FG000|Safety Follow-up|Adverse Event|1|||
131635572|NCT02391116|473950821|FG000|Safety Follow-up|Withdrawal by Subject|4|||
131635573|NCT02391116|473950821|FG000|Safety Follow-up|Switching to Other Therapy|4|||
131635574|NCT02391116|473950821|FG000|Safety Follow-up|No Follow Up|1|||
131635575|NCT02391116|473950821|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
131635576|NCT02391116|473950821|FG000|Active Follow-up|Withdrawal by Subject|1|||
131798763|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Physician Decision|2|||
131798764|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
131798765|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
131798766|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
131798767|NCT05456529|474548779|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
131798768|NCT02518113|474548780|FG000|Overall Study|Adverse Event|1|||
131798769|NCT02518113|474548781|FG001|Overall Study|Adverse Event|0|||
131798770|NCT02518113|474548782|FG002|Overall Study|Adverse Event|1|||
131798771|NCT02518113|474548783|FG003|Overall Study|Adverse Event|0|||
131798772|NCT02518113|474548780|FG000|Overall Study|Death|1|||
131798773|NCT02518113|474548781|FG001|Overall Study|Death|2|||
131798774|NCT02518113|474548782|FG002|Overall Study|Death|0|||
131798775|NCT02518113|474548783|FG003|Overall Study|Death|0|||
131798776|NCT02518113|474548780|FG000|Overall Study|Physician Decision|0|||
131798777|NCT02518113|474548781|FG001|Overall Study|Physician Decision|1|||
131798778|NCT02518113|474548782|FG002|Overall Study|Physician Decision|0|||
131798779|NCT02518113|474548783|FG003|Overall Study|Physician Decision|0|||
131798780|NCT02518113|474548780|FG000|Overall Study|Progressive Disease|1|||
131902576|NCT00810069|474929321|FG001|Lead-in Period I|Physician Decision|0|||
131902577|NCT00810069|474929322|FG002|Lead-in Period I|Physician Decision|0|||
131635577|NCT02391116|473950821|FG000|Active Follow-up|Switching to Other Therapy|2|||
131635578|NCT02391116|473950821|FG000|Survival Follow-up|Withdrawal by Subject|3|||
131635579|NCT02391116|473950821|FG000|Survival Follow-up|Switching to Other Therapy|1|||
131635580|NCT01747629|473950822|FG000|Overall Study|Adverse Event|1|||
131635581|NCT01747629|473950823|FG001|Overall Study|Adverse Event|2|||
131635582|NCT01747629|473950822|FG000|Overall Study|Withdrawal by Subject|2|||
131635583|NCT01747629|473950823|FG001|Overall Study|Withdrawal by Subject|2|||
131714113|NCT05127486|474231100|FG000|Overall Study|Withdrawal by Subject|14|||
131714114|NCT05127486|474231101|FG001|Overall Study|Withdrawal by Subject|13|||
131714115|NCT05127486|474231100|FG000|Overall Study|Lost to Follow-up|5|||
131714116|NCT05127486|474231101|FG001|Overall Study|Lost to Follow-up|8|||
131714117|NCT01287754|474231104|FG000|Overall Study|Death|2|||
131714118|NCT01287754|474231105|FG001|Overall Study|Death|12|||
131714119|NCT01287754|474231104|FG000|Overall Study|Lost to Follow-up|1|||
131714120|NCT01287754|474231105|FG001|Overall Study|Lost to Follow-up|6|||
131714121|NCT01287754|474231104|FG000|Overall Study|Protocol Violation|0|||
131714122|NCT01287754|474231105|FG001|Overall Study|Protocol Violation|3|||
131714123|NCT04971226|474231116|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
131798781|NCT02518113|474548781|FG001|Overall Study|Progressive Disease|2|||
131798782|NCT02518113|474548782|FG002|Overall Study|Progressive Disease|3|||
131798783|NCT02518113|474548783|FG003|Overall Study|Progressive Disease|0|||
131798784|NCT00797108|474548784|FG000|Overall Study|Adverse Event|1|||
131902578|NCT00810069|474929320|FG000|Lead-in Period I|Protocol Violation|1|||
131635584|NCT01747629|473950822|FG000|Overall Study|Noncompliance|1|||
131635585|NCT01747629|473950823|FG001|Overall Study|Noncompliance|1|||
131714124|NCT04971226|474231117|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131714125|NCT04971226|474231118|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
131714126|NCT04971226|474231119|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
131714127|NCT04971226|474231116|FG000|Overall Study|Adverse Event|6|||
131714128|NCT04971226|474231117|FG001|Overall Study|Adverse Event|5|||
131714129|NCT04971226|474231118|FG002|Overall Study|Adverse Event|11|||
131635586|NCT01747629|473950822|FG000|Overall Study|Inclusion criteria not met|1|||
131635587|NCT01747629|473950823|FG001|Overall Study|Inclusion criteria not met|0|||
131635588|NCT01747629|473950822|FG000|Overall Study|Not treated|1|||
131635589|NCT01747629|473950823|FG001|Overall Study|Not treated|0|||
131635590|NCT01747629|473950822|FG000|Overall Study|Other|2|||
131635591|NCT01747629|473950823|FG001|Overall Study|Other|1|||
131635592|NCT03873038|473950824|FG000|Part 2|Withdrawal by Subject|0|||
131635593|NCT03873038|473950825|FG001|Part 2|Withdrawal by Subject|0|||
131635594|NCT03873038|473950826|FG002|Part 2|Withdrawal by Subject|0|||
131635595|NCT03873038|473950827|FG003|Part 2|Withdrawal by Subject|0|||
131635596|NCT03873038|473950828|FG004|Part 2|Withdrawal by Subject|0|||
131635597|NCT03873038|473950829|FG005|Part 2|Withdrawal by Subject|1|||
131635598|NCT03873038|473950824|FG000|Part 2|Unknon|0|||
131635599|NCT03873038|473950825|FG001|Part 2|Unknon|0|||
131635600|NCT03873038|473950826|FG002|Part 2|Unknon|0|||
131635601|NCT03873038|473950827|FG003|Part 2|Unknon|0|||
131635602|NCT03873038|473950828|FG004|Part 2|Unknon|1|||
131635603|NCT03873038|473950829|FG005|Part 2|Unknon|0|||
131635604|NCT04222088|473950830|FG000|Overall Study|Lost to Follow-up|5|||
131635605|NCT04222088|473950831|FG001|Overall Study|Lost to Follow-up|1|||
131635606|NCT04222088|473950830|FG000|Overall Study|Withdrawal by Subject|4|||
131635607|NCT04222088|473950831|FG001|Overall Study|Withdrawal by Subject|0|||
131635608|NCT00905255|473950832|FG000|Overall Study|Adverse Event|7|||
131635609|NCT00905255|473950833|FG001|Overall Study|Adverse Event|5|||
131635610|NCT00905255|473950832|FG000|Overall Study|Withdrawal by Subject|5|||
131635611|NCT00905255|473950833|FG001|Overall Study|Withdrawal by Subject|4|||
131635612|NCT00905255|473950832|FG000|Overall Study|Familial and Personal Reasons|1|||
131635613|NCT00905255|473950833|FG001|Overall Study|Familial and Personal Reasons|0|||
131635614|NCT01544153|473950836|FG000|Overall Study|Under 18|0|||
131635615|NCT01544153|473950837|FG001|Overall Study|Under 18|1|||
131635616|NCT01544153|473950838|FG002|Overall Study|Under 18|0|||
131635617|NCT01544153|473950839|FG003|Overall Study|Under 18|0|||
131635618|NCT01544153|473950836|FG000|Overall Study|Non-smoker|0|||
131635619|NCT01544153|473950837|FG001|Overall Study|Non-smoker|0|||
131635620|NCT01544153|473950838|FG002|Overall Study|Non-smoker|1|||
131635621|NCT01544153|473950839|FG003|Overall Study|Non-smoker|0|||
131635622|NCT02785900|473950844|FG000|Overall Study|Study Termination by Sponsor|64|||
131635623|NCT02785900|473950845|FG001|Overall Study|Study Termination by Sponsor|81|||
131635624|NCT02785900|473950844|FG000|Overall Study|Death|46|||
131635625|NCT02785900|473950845|FG001|Overall Study|Death|32|||
131635626|NCT02785900|473950844|FG000|Overall Study|Withdrawal by Subject|4|||
131635627|NCT02785900|473950845|FG001|Overall Study|Withdrawal by Subject|8|||
131635628|NCT02785900|473950844|FG000|Overall Study|Physician Decision|3|||
131635629|NCT02785900|473950845|FG001|Overall Study|Physician Decision|2|||
131635630|NCT03993054|473950846|FG000|Overall Study|PI Decision|1|||
131635631|NCT02799745|473950848|FG000|Overall Study|Participant moved out of state|1|||
131635632|NCT02799745|473950849|FG001|Overall Study|Participant moved out of state|0|||
131635633|NCT02799745|473950848|FG000|Overall Study|Discontinued due to planned surgery|1|||
131635634|NCT02799745|473950849|FG001|Overall Study|Discontinued due to planned surgery|0|||
131635635|NCT02799745|473950848|FG000|Overall Study|Withdrawal by Subject|16|||
131635636|NCT02799745|473950849|FG001|Overall Study|Withdrawal by Subject|25|||
131635637|NCT02799745|473950848|FG000|Overall Study|Protocol Deviation|4|||
131635638|NCT02799745|473950849|FG001|Overall Study|Protocol Deviation|5|||
131635639|NCT02799745|473950848|FG000|Overall Study|Progressive Disease|28|||
131635640|NCT02799745|473950849|FG001|Overall Study|Progressive Disease|38|||
131635641|NCT02799745|473950848|FG000|Overall Study|Lost to Follow-up|3|||
131635642|NCT02799745|473950849|FG001|Overall Study|Lost to Follow-up|2|||
131635643|NCT02799745|473950848|FG000|Overall Study|Death|3|||
131635644|NCT02799745|473950849|FG001|Overall Study|Death|0|||
131635645|NCT02799745|473950848|FG000|Overall Study|Adverse Event|0|||
131635646|NCT02799745|473950849|FG001|Overall Study|Adverse Event|1|||
131635647|NCT04853238|473950850|FG000|Overall Study|Death|4|||
131635648|NCT04853238|473950851|FG001|Overall Study|Death|0|||
131635649|NCT04853238|473950852|FG002|Overall Study|Death|2|||
131635650|NCT04853238|473950850|FG000|Overall Study|Lost to Follow-up|16|||
131635651|NCT04853238|473950851|FG001|Overall Study|Lost to Follow-up|2|||
131635652|NCT04853238|473950852|FG002|Overall Study|Lost to Follow-up|37|||
131635653|NCT04853238|473950850|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
131635654|NCT04853238|473950851|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
131635655|NCT04853238|473950852|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
131635656|NCT04853238|473950850|FG000|Overall Study|Withdrawal by Subject|6|||
131635657|NCT04853238|473950851|FG001|Overall Study|Withdrawal by Subject|0|||
131635658|NCT04853238|473950852|FG002|Overall Study|Withdrawal by Subject|21|||
131635659|NCT04853238|473950850|FG000|Overall Study|Physician Decision|0|||
131635660|NCT04853238|473950851|FG001|Overall Study|Physician Decision|0|||
131635661|NCT04853238|473950852|FG002|Overall Study|Physician Decision|2|||
131635662|NCT04853238|473950850|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
131635663|NCT04853238|473950851|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
131635664|NCT04853238|473950852|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
131635665|NCT01002547|473952558|FG000|Overall Study|Withdrawal by Subject|4|||
131635666|NCT01002547|473952559|FG001|Overall Study|Withdrawal by Subject|0|||
131635667|NCT01002547|473952560|FG002|Overall Study|Withdrawal by Subject|5|||
131635668|NCT01002547|473952558|FG000|Overall Study|Lost to Follow-up|2|||
131635669|NCT01002547|473952559|FG001|Overall Study|Lost to Follow-up|1|||
131635670|NCT01002547|473952560|FG002|Overall Study|Lost to Follow-up|1|||
131635671|NCT01002547|473952558|FG000|Overall Study|Physician Decision|1|||
131635672|NCT01002547|473952559|FG001|Overall Study|Physician Decision|0|||
131635673|NCT01002547|473952560|FG002|Overall Study|Physician Decision|0|||
131635674|NCT01002547|473952558|FG000|Overall Study|Death|0|||
131635675|NCT01002547|473952559|FG001|Overall Study|Death|2|||
131635676|NCT01002547|473952560|FG002|Overall Study|Death|2|||
131635677|NCT01002547|473952558|FG000|Overall Study|Adverse Event|1|||
131635678|NCT01002547|473952559|FG001|Overall Study|Adverse Event|0|||
131635679|NCT01002547|473952560|FG002|Overall Study|Adverse Event|0|||
131635680|NCT00088452|473952565|FG000|Overall Study|Did not receive intervention|1|||
131635681|NCT00088452|473952566|FG001|Overall Study|Did not receive intervention|0|||
131635682|NCT00088452|473952567|FG002|Overall Study|Did not receive intervention|1|||
131635683|NCT02081196|473952569|FG000|Overall Study|Lost to Follow-up|1|||
131635684|NCT00961896|473952574|FG000|Overall Study|Abnormal laboratory value|0|||
131635685|NCT00961896|473952575|FG001|Overall Study|Abnormal laboratory value|0|||
131635686|NCT00961896|473952576|FG002|Overall Study|Abnormal laboratory value|1|||
131635687|NCT00506922|473952577|FG000|Overall Study|Physician Decision|0|||
131635688|NCT00506922|473952578|FG001|Overall Study|Physician Decision|0|||
131635689|NCT00506922|473952579|FG002|Overall Study|Physician Decision|0|||
131635690|NCT00506922|473952580|FG003|Overall Study|Physician Decision|2|||
131635691|NCT00506922|473952581|FG004|Overall Study|Physician Decision|0|||
131635692|NCT00506922|473952577|FG000|Overall Study|Withdrawal by Subject|0|||
131635693|NCT00506922|473952578|FG001|Overall Study|Withdrawal by Subject|0|||
131635694|NCT00506922|473952579|FG002|Overall Study|Withdrawal by Subject|0|||
131635695|NCT00506922|473952580|FG003|Overall Study|Withdrawal by Subject|0|||
131798785|NCT00797108|474548785|FG001|Overall Study|Adverse Event|0|||
131798786|NCT00797108|474548786|FG002|Overall Study|Adverse Event|3|||
131798787|NCT00797108|474548784|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
131798788|NCT00797108|474548785|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
131798789|NCT00797108|474548786|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
131798790|NCT00797108|474548784|FG000|Overall Study|Global Deterioration of Health Status|0|||
131798791|NCT00797108|474548785|FG001|Overall Study|Global Deterioration of Health Status|1|||
131798792|NCT00797108|474548786|FG002|Overall Study|Global Deterioration of Health Status|0|||
131798793|NCT00797108|474548784|FG000|Overall Study|Lack of Efficacy|1|||
131635696|NCT00506922|473952581|FG004|Overall Study|Withdrawal by Subject|1|||
131635697|NCT01580995|473952583|FG000|Overall Study|Lost to Follow-up|2|||
131635698|NCT01580995|473952584|FG001|Overall Study|Lost to Follow-up|2|||
131635699|NCT00598871|473952585|FG000|Overall Study|Adverse Event|0|||
131635700|NCT00598871|473952586|FG001|Overall Study|Adverse Event|1|||
131635701|NCT00111839|473952587|FG000|Overall Study|Disease Progression|30|||
131635702|NCT00111839|473952588|FG001|Overall Study|Disease Progression|33|||
131635703|NCT00111839|473952589|FG002|Overall Study|Disease Progression|33|||
131635704|NCT00111839|473952587|FG000|Overall Study|Adverse Event|5|||
131635705|NCT00111839|473952588|FG001|Overall Study|Adverse Event|3|||
131635706|NCT00111839|473952589|FG002|Overall Study|Adverse Event|1|||
131635707|NCT00111839|473952587|FG000|Overall Study|Protocol Violation|2|||
131635708|NCT00111839|473952588|FG001|Overall Study|Protocol Violation|4|||
131635709|NCT00111839|473952589|FG002|Overall Study|Protocol Violation|2|||
131635710|NCT00111839|473952587|FG000|Overall Study|Death|1|||
131635711|NCT00111839|473952588|FG001|Overall Study|Death|1|||
131635712|NCT00111839|473952589|FG002|Overall Study|Death|6|||
131635713|NCT00111839|473952587|FG000|Overall Study|Withdrawal by Subject|2|||
131635714|NCT00111839|473952588|FG001|Overall Study|Withdrawal by Subject|2|||
131635715|NCT00111839|473952589|FG002|Overall Study|Withdrawal by Subject|2|||
131635716|NCT00111839|473952587|FG000|Overall Study|Lost to Follow-up|1|||
131635717|NCT00111839|473952588|FG001|Overall Study|Lost to Follow-up|0|||
131635718|NCT00111839|473952589|FG002|Overall Study|Lost to Follow-up|0|||
131635719|NCT00111839|473952587|FG000|Overall Study|Logistical Constraint|1|||
131635720|NCT00111839|473952588|FG001|Overall Study|Logistical Constraint|0|||
131635721|NCT00111839|473952589|FG002|Overall Study|Logistical Constraint|0|||
131635722|NCT00111839|473952587|FG000|Overall Study|Other|6|||
131635723|NCT00111839|473952588|FG001|Overall Study|Other|3|||
131635724|NCT00111839|473952589|FG002|Overall Study|Other|3|||
131635725|NCT00111839|473952587|FG000|Overall Study|Randomized but Not Treated|0|||
131635726|NCT00111839|473952588|FG001|Overall Study|Randomized but Not Treated|0|||
131635727|NCT00111839|473952589|FG002|Overall Study|Randomized but Not Treated|2|||
131635728|NCT01011049|473952590|FG000|Overall Study|Protocol Violation|0|||
131635729|NCT01011049|473952591|FG001|Overall Study|Protocol Violation|0|||
131635730|NCT01011049|473952592|FG002|Overall Study|Protocol Violation|2|||
131635731|NCT01011049|473952593|FG003|Overall Study|Protocol Violation|0|||
131635732|NCT01011049|473952590|FG000|Overall Study|Lost to Follow-up|1|||
131635733|NCT01011049|473952591|FG001|Overall Study|Lost to Follow-up|2|||
131635734|NCT01011049|473952592|FG002|Overall Study|Lost to Follow-up|1|||
131635735|NCT01011049|473952593|FG003|Overall Study|Lost to Follow-up|0|||
131635736|NCT01011049|473952590|FG000|Overall Study|Withdrawal by Subject|0|||
131635737|NCT01011049|473952591|FG001|Overall Study|Withdrawal by Subject|0|||
131635738|NCT01011049|473952592|FG002|Overall Study|Withdrawal by Subject|1|||
131635739|NCT01011049|473952593|FG003|Overall Study|Withdrawal by Subject|0|||
131635740|NCT00382408|473952594|FG000|Overall Study|Did not meet protocol requirement|3|||
131635741|NCT00382408|473952595|FG001|Overall Study|Did not meet protocol requirement|3|||
131635742|NCT00382408|473952594|FG000|Overall Study|Protocol Violation|2|||
131635743|NCT00382408|473952595|FG001|Overall Study|Protocol Violation|2|||
131635744|NCT00382408|473952594|FG000|Overall Study|Physician Decision|1|||
131635745|NCT00382408|473952595|FG001|Overall Study|Physician Decision|0|||
131635746|NCT00382408|473952594|FG000|Overall Study|Withdrawal by Subject|17|||
131635747|NCT00382408|473952595|FG001|Overall Study|Withdrawal by Subject|6|||
131635748|NCT00382408|473952594|FG000|Overall Study|Pregnancy|2|||
131635749|NCT00382408|473952595|FG001|Overall Study|Pregnancy|0|||
131635750|NCT00382408|473952594|FG000|Overall Study|Lost to Follow-up|19|||
131635751|NCT00382408|473952595|FG001|Overall Study|Lost to Follow-up|8|||
131635752|NCT00382408|473952594|FG000|Overall Study|Other|100|||
131635753|NCT00382408|473952595|FG001|Overall Study|Other|35|||
131635754|NCT00352053|473952601|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
131635755|NCT00352053|473952602|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
131635756|NCT00352053|473952601|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
131635757|NCT00352053|473952602|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
131635758|NCT00352053|473952601|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
131445050|NCT00005780|473258808|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
131445051|NCT03600909|473258809|FG000|Overall Study|Not treated|0|||
131445052|NCT03600909|473258810|FG001|Overall Study|Not treated|3|||
131445053|NCT03600909|473258811|FG002|Overall Study|Not treated|0|||
131635759|NCT00352053|473952602|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
131635760|NCT00352053|473952601|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
131635761|NCT00352053|473952602|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
131635762|NCT00352053|473952601|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
131635763|NCT00352053|473952602|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
131635764|NCT00352053|473952601|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
131635765|NCT00352053|473952602|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
131635766|NCT00352053|473952601|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
131635767|NCT00352053|473952602|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
131635768|NCT00352053|473952601|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
131635769|NCT00352053|473952602|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
131635770|NCT00352053|473952601|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
131635771|NCT00352053|473952602|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
131635772|NCT00352053|473952601|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
131635773|NCT00352053|473952602|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
131635774|NCT00352053|473952601|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
131635775|NCT00352053|473952602|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
131635776|NCT00352053|473952601|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
131635777|NCT00352053|473952602|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
131635778|NCT00352053|473952601|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
131635779|NCT00352053|473952602|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
131635780|NCT02254681|473952607|FG000|Overall Study|Lack of Efficacy|6|||
131635781|NCT02402465|473952608|FG000|Overall Study|Withdrawal by Subject|0|||
131635782|NCT02402465|473952609|FG001|Overall Study|Withdrawal by Subject|0|||
131635783|NCT02402465|473952610|FG002|Overall Study|Withdrawal by Subject|0|||
131635784|NCT02402465|473952611|FG003|Overall Study|Withdrawal by Subject|0|||
131635785|NCT02402465|473952612|FG004|Overall Study|Withdrawal by Subject|0|||
131635786|NCT02402465|473952613|FG005|Overall Study|Withdrawal by Subject|1|||
131635787|NCT02402465|473952608|FG000|Overall Study|Lost to Follow-up|0|||
131635788|NCT02402465|473952609|FG001|Overall Study|Lost to Follow-up|1|||
131635789|NCT02402465|473952610|FG002|Overall Study|Lost to Follow-up|0|||
131635790|NCT02402465|473952611|FG003|Overall Study|Lost to Follow-up|0|||
131635791|NCT02402465|473952612|FG004|Overall Study|Lost to Follow-up|1|||
131635792|NCT02402465|473952613|FG005|Overall Study|Lost to Follow-up|0|||
131635793|NCT03807700|473952614|FG000|Overall Study|Withdrawal by Subject|2|||
131635794|NCT03807700|473952615|FG001|Overall Study|Withdrawal by Subject|1|||
131635795|NCT02621047|473952616|FG000|Overall Study|Adverse Event|0|||
131635796|NCT02621047|473952617|FG001|Overall Study|Adverse Event|0|||
131635797|NCT02621047|473952618|FG002|Overall Study|Adverse Event|1|||
131635798|NCT02236598|473952622|FG000|Overall Study|Adverse Event|0|||
131635799|NCT02236598|473952623|FG001|Overall Study|Adverse Event|1|||
131635800|NCT02236598|473952622|FG000|Overall Study|Withdrawal by Subject|0|||
131635801|NCT02236598|473952623|FG001|Overall Study|Withdrawal by Subject|1|||
131635802|NCT01675050|473952626|FG000|Period One Treatment|Withdrawal by Subject|1|||
131635803|NCT01675050|473952627|FG001|Period One Treatment|Withdrawal by Subject|0|||
131635804|NCT02282917|473952629|FG000|Overall Study|Withdrawal by Subject|1|||
131635805|NCT02282917|473952629|FG000|Overall Study|Screen Failure/Not Eligible|1|||
131635806|NCT01313299|473952631|FG000|Overall Study|Adverse Event|3|||
131635807|NCT01313299|473952632|FG001|Overall Study|Adverse Event|1|||
131635808|NCT01313299|473952633|FG002|Overall Study|Adverse Event|1|||
131635809|NCT01313299|473952631|FG000|Overall Study|Lost to Follow-up|1|||
131635810|NCT01313299|473952632|FG001|Overall Study|Lost to Follow-up|0|||
131635811|NCT01313299|473952633|FG002|Overall Study|Lost to Follow-up|0|||
131635812|NCT01313299|473952631|FG000|Overall Study|Protocol Violation|2|||
131635813|NCT01313299|473952632|FG001|Overall Study|Protocol Violation|0|||
131635814|NCT01313299|473952633|FG002|Overall Study|Protocol Violation|0|||
131635815|NCT01313299|473952631|FG000|Overall Study|Withdrawal by Subject|1|||
131635816|NCT01313299|473952632|FG001|Overall Study|Withdrawal by Subject|0|||
131635817|NCT01313299|473952633|FG002|Overall Study|Withdrawal by Subject|2|||
131635818|NCT01313299|473952631|FG000|Overall Study|Family reason and moved out of state|0|||
131635819|NCT01313299|473952632|FG001|Overall Study|Family reason and moved out of state|2|||
131635820|NCT01313299|473952633|FG002|Overall Study|Family reason and moved out of state|0|||
131635821|NCT01313299|473952631|FG000|Overall Study|Lack of subject compliance|0|||
131714130|NCT04971226|474231119|FG003|Overall Study|Adverse Event|10|||
131714131|NCT04971226|474231116|FG000|Overall Study|Progressive disease|2|||
131714132|NCT04971226|474231117|FG001|Overall Study|Progressive disease|0|||
131902579|NCT00810069|474929321|FG001|Lead-in Period I|Protocol Violation|0|||
131902580|NCT00810069|474929322|FG002|Lead-in Period I|Protocol Violation|0|||
131902581|NCT00810069|474929320|FG000|Lead-in Period I|Withdrawal by Subject|46|||
131902582|NCT00810069|474929321|FG001|Lead-in Period I|Withdrawal by Subject|0|||
131902583|NCT00810069|474929322|FG002|Lead-in Period I|Withdrawal by Subject|0|||
131902584|NCT00810069|474929320|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
131635822|NCT01313299|473952632|FG001|Overall Study|Lack of subject compliance|0|||
131635823|NCT01313299|473952633|FG002|Overall Study|Lack of subject compliance|1|||
131635824|NCT02391545|473952634|FG000|Overall Study|Death|0|||
131635825|NCT02391545|473952635|FG001|Overall Study|Death|2|||
131635826|NCT02391545|473952634|FG000|Overall Study|Lost to Follow-up|0|||
131635827|NCT02391545|473952635|FG001|Overall Study|Lost to Follow-up|1|||
131635828|NCT02391545|473952634|FG000|Overall Study|Termination of study by sponsor|20|||
131635829|NCT02391545|473952635|FG001|Overall Study|Termination of study by sponsor|20|||
131635830|NCT02391545|473952634|FG000|Overall Study|Withdrawal by Subject|0|||
131635831|NCT02391545|473952635|FG001|Overall Study|Withdrawal by Subject|1|||
131635832|NCT02391545|473952634|FG000|Overall Study|Other Reasons|6|||
131635833|NCT02391545|473952635|FG001|Overall Study|Other Reasons|4|||
131635834|NCT00975130|473952638|FG000|Study Part 1|Adverse Event|150|||
131635835|NCT00975130|473952639|FG001|Study Part 1|Adverse Event|0|||
131635836|NCT00975130|473952640|FG002|Study Part 1|Adverse Event|0|||
131635837|NCT00975130|473952638|FG000|Study Part 1|Lost to Follow-up|19|||
131635838|NCT00975130|473952639|FG001|Study Part 1|Lost to Follow-up|0|||
131714133|NCT04971226|474231118|FG002|Overall Study|Progressive disease|3|||
131635839|NCT00975130|473952640|FG002|Study Part 1|Lost to Follow-up|0|||
131635840|NCT00975130|473952638|FG000|Study Part 1|Withdrawal by Subject|61|||
131635841|NCT00975130|473952639|FG001|Study Part 1|Withdrawal by Subject|0|||
131635842|NCT00975130|473952640|FG002|Study Part 1|Withdrawal by Subject|0|||
131635843|NCT00975130|473952638|FG000|Study Part 1|Protocol Violation|13|||
131635844|NCT00975130|473952639|FG001|Study Part 1|Protocol Violation|0|||
131635845|NCT00975130|473952640|FG002|Study Part 1|Protocol Violation|0|||
131635846|NCT00975130|473952638|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
131798794|NCT00797108|474548785|FG001|Overall Study|Lack of Efficacy|0|||
131798795|NCT00797108|474548786|FG002|Overall Study|Lack of Efficacy|1|||
131798796|NCT00797108|474548784|FG000|Overall Study|Other|0|||
131798797|NCT00797108|474548785|FG001|Overall Study|Other|0|||
131798798|NCT00797108|474548786|FG002|Overall Study|Other|2|||
131798799|NCT00797108|474548784|FG000|Overall Study|Randomized but not Treated|2|||
131798800|NCT00797108|474548785|FG001|Overall Study|Randomized but not Treated|0|||
131798801|NCT00797108|474548786|FG002|Overall Study|Randomized but not Treated|0|||
131798802|NCT00287118|474548787|FG000|Overall Study|Adverse Event|30|||
131798803|NCT00287118|474548787|FG000|Overall Study|Death|1|||
131798804|NCT00287118|474548787|FG000|Overall Study|Lack of Efficacy|11|||
131798805|NCT00287118|474548787|FG000|Overall Study|Lost to Follow-up|1|||
131798806|NCT00287118|474548787|FG000|Overall Study|Protocol Violation|2|||
131798807|NCT00287118|474548787|FG000|Overall Study|Other|7|||
131798808|NCT02270736|474548788|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131635847|NCT00975130|473952639|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
131635848|NCT00975130|473952640|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
131635849|NCT00975130|473952638|FG000|Study Part 1|Administrative|4|||
131635850|NCT00975130|473952639|FG001|Study Part 1|Administrative|0|||
131798809|NCT02270736|474548789|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
131798810|NCT02270736|474548790|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131798811|NCT02270736|474548791|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131798812|NCT02270736|474548792|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131798813|NCT02270736|474548788|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
131798814|NCT02270736|474548789|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
131798815|NCT02270736|474548790|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
131798816|NCT02270736|474548791|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
131798817|NCT02270736|474548792|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
131798818|NCT02270736|474548788|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131798819|NCT02270736|474548789|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
131798820|NCT02270736|474548790|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131635851|NCT00975130|473952640|FG002|Study Part 1|Administrative|0|||
131635852|NCT00975130|473952638|FG000|Study Part 1|Withdrew Consent|24|||
131635853|NCT00975130|473952639|FG001|Study Part 1|Withdrew Consent|0|||
131635854|NCT00975130|473952640|FG002|Study Part 1|Withdrew Consent|0|||
131635855|NCT00975130|473952638|FG000|Study Part 2|Adverse Event|0|||
131635856|NCT00975130|473952639|FG001|Study Part 2|Adverse Event|14|||
131635857|NCT00975130|473952640|FG002|Study Part 2|Adverse Event|7|||
131635858|NCT00975130|473952638|FG000|Study Part 2|Lost to Follow-up|0|||
131635859|NCT00975130|473952639|FG001|Study Part 2|Lost to Follow-up|0|||
131635860|NCT00975130|473952640|FG002|Study Part 2|Lost to Follow-up|1|||
131635861|NCT00975130|473952638|FG000|Study Part 2|Withdrawal by Subject|0|||
131635862|NCT00975130|473952639|FG001|Study Part 2|Withdrawal by Subject|13|||
131635863|NCT00975130|473952640|FG002|Study Part 2|Withdrawal by Subject|5|||
131635864|NCT00975130|473952638|FG000|Study Part 2|Withdrew Consent|0|||
131635865|NCT00975130|473952639|FG001|Study Part 2|Withdrew Consent|6|||
131635866|NCT00975130|473952640|FG002|Study Part 2|Withdrew Consent|2|||
131635867|NCT00975130|473952638|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
131635868|NCT00975130|473952639|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
131635869|NCT00975130|473952640|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
131635870|NCT00975130|473952638|FG000|Study Part 2|Administrative|0|||
131635871|NCT00975130|473952639|FG001|Study Part 2|Administrative|1|||
131635872|NCT00975130|473952640|FG002|Study Part 2|Administrative|0|||
131635873|NCT00975130|473952638|FG000|Study Part 2|Protocol Violation|0|||
131635874|NCT00975130|473952639|FG001|Study Part 2|Protocol Violation|0|||
131635875|NCT00975130|473952640|FG002|Study Part 2|Protocol Violation|1|||
131635876|NCT00734851|473952641|FG000|Overall Study|Withdrawal by Subject|2|||
131635877|NCT00734851|473952641|FG000|Overall Study|Lost to Follow-up|1|||
131635878|NCT00734851|473952641|FG000|Overall Study|Physician Decision|18|||
131635879|NCT00655668|473952651|FG000|Overall Study|Adverse Event|6|||
131635880|NCT00655668|473952651|FG000|Overall Study|Death|5|||
131635881|NCT00655668|473952651|FG000|Overall Study|Disease Progression|27|||
131635882|NCT00655668|473952651|FG000|Overall Study|Study Terminated|9|||
131635883|NCT00655668|473952651|FG000|Overall Study|Other|1|||
131635884|NCT00655668|473952651|FG000|Overall Study|New Lymphoma Treatment Started|4|||
131635885|NCT00655668|473952651|FG000|Overall Study|Withdrawal by Subject|2|||
131635886|NCT00595764|473952653|FG000|Overall Study|Protocol Violation|24|||
131635887|NCT00595764|473952654|FG001|Overall Study|Protocol Violation|19|||
131635888|NCT00595764|473952653|FG000|Overall Study|Missed Medication >1 week|10|||
131635889|NCT00595764|473952654|FG001|Overall Study|Missed Medication >1 week|17|||
131635890|NCT00595764|473952653|FG000|Overall Study|Missed 3 PM visits|1|||
131635891|NCT00595764|473952654|FG001|Overall Study|Missed 3 PM visits|7|||
131635892|NCT00595764|473952653|FG000|Overall Study|Withdrawal by Subject|4|||
131635893|NCT00595764|473952654|FG001|Overall Study|Withdrawal by Subject|0|||
131635894|NCT01332318|473952655|FG000|Overall Study|Adverse Event|0|||
131635895|NCT01332318|473952656|FG001|Overall Study|Adverse Event|3|||
131635896|NCT01332318|473952657|FG002|Overall Study|Adverse Event|0|||
131635897|NCT01332318|473952658|FG003|Overall Study|Adverse Event|0|||
131635898|NCT01332318|473952655|FG000|Overall Study|Withdrawal by Subject|1|||
131635899|NCT01332318|473952656|FG001|Overall Study|Withdrawal by Subject|1|||
131635900|NCT01332318|473952657|FG002|Overall Study|Withdrawal by Subject|0|||
131635901|NCT01332318|473952658|FG003|Overall Study|Withdrawal by Subject|1|||
131635902|NCT01332318|473952655|FG000|Overall Study|Protocol Violation|1|||
131635903|NCT01332318|473952656|FG001|Overall Study|Protocol Violation|0|||
131635904|NCT01332318|473952657|FG002|Overall Study|Protocol Violation|1|||
131635905|NCT01332318|473952658|FG003|Overall Study|Protocol Violation|1|||
131635906|NCT02820298|473952659|FG000|Overall Study|Withdrawal by Subject|0|||
131635907|NCT02820298|473952660|FG001|Overall Study|Withdrawal by Subject|1|||
131635908|NCT02820298|473952659|FG000|Overall Study|Physician Decision|1|||
131635909|NCT02820298|473952660|FG001|Overall Study|Physician Decision|0|||
131635910|NCT02820298|473952659|FG000|Overall Study|Protocol Violation|0|||
131635911|NCT02820298|473952660|FG001|Overall Study|Protocol Violation|1|||
131635912|NCT01894256|473952661|FG000|Part A|Adverse Event|0|||
131635913|NCT01894256|473952662|FG001|Part A|Adverse Event|1|||
131635914|NCT01894256|473952663|FG002|Part A|Adverse Event|0|||
131635915|NCT01894256|473952661|FG000|Part B|Death|0|||
131635916|NCT01894256|473952662|FG001|Part B|Death|1|||
131635917|NCT01894256|473952663|FG002|Part B|Death|1|||
131635918|NCT01894256|473952661|FG000|Part B|Withdrawal by Subject|0|||
131635919|NCT01894256|473952662|FG001|Part B|Withdrawal by Subject|1|||
131635920|NCT01894256|473952663|FG002|Part B|Withdrawal by Subject|0|||
131635921|NCT01894256|473952661|FG000|Part B|Lack of Efficacy|15|||
131635922|NCT01894256|473952662|FG001|Part B|Lack of Efficacy|12|||
131635923|NCT01894256|473952663|FG002|Part B|Lack of Efficacy|13|||
131635924|NCT01780584|473952664|FG000|Overall Study|Death|1|||
131635925|NCT01780584|473952665|FG001|Overall Study|Death|0|||
131635926|NCT01780584|473952666|FG002|Overall Study|Death|1|||
131635927|NCT01780584|473952664|FG000|Overall Study|Adverse Event|0|||
131635928|NCT01780584|473952665|FG001|Overall Study|Adverse Event|1|||
131635929|NCT01780584|473952666|FG002|Overall Study|Adverse Event|0|||
131635930|NCT01780584|473952664|FG000|Overall Study|Protocol Violation|0|||
131635931|NCT01780584|473952665|FG001|Overall Study|Protocol Violation|0|||
131635932|NCT01780584|473952666|FG002|Overall Study|Protocol Violation|1|||
131635933|NCT00727259|473952670|FG000|Overall Study|Not all questionnaires completed|1055|||
131635934|NCT01021683|473952671|FG000|Overall Study|Lack of Efficacy|12|||
131635935|NCT01021683|473952671|FG000|Overall Study|Recovery of neutrophil count|51|||
131635936|NCT01021683|473952671|FG000|Overall Study|Other|8|||
131635937|NCT00500539|473952672|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
131635938|NCT00500539|473952672|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
131635939|NCT00500539|473952672|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
131635940|NCT00500539|473952672|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
131635941|NCT00500539|473952672|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
131635942|NCT00500539|473952672|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
131635943|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
131635944|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
131635945|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
131635946|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
131635947|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Death|1|||
131635948|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
131635949|NCT00500539|473952672|FG000|Follow-up Period (16 Weeks)|Missing|3|||
131635950|NCT00645099|473952673|FG000|Overall Study|Lack of Efficacy|15|||
131635951|NCT00645099|473952674|FG001|Overall Study|Lack of Efficacy|6|||
131635952|NCT00645099|473952673|FG000|Overall Study|Withdrawal by Subject|30|||
131635953|NCT00645099|473952674|FG001|Overall Study|Withdrawal by Subject|22|||
131635954|NCT00645099|473952673|FG000|Overall Study|Lost to Follow-up|6|||
131635955|NCT00645099|473952674|FG001|Overall Study|Lost to Follow-up|4|||
131635956|NCT00645099|473952673|FG000|Overall Study|Adverse Event|11|||
131635957|NCT00645099|473952674|FG001|Overall Study|Adverse Event|5|||
131635958|NCT00645099|473952673|FG000|Overall Study|Other|9|||
131635959|NCT00645099|473952674|FG001|Overall Study|Other|5|||
131635960|NCT01201915|473952675|FG000|Overall Study|Adverse Event|2|||
131635961|NCT01201915|473952676|FG001|Overall Study|Adverse Event|1|||
131635962|NCT01201915|473952677|FG002|Overall Study|Adverse Event|1|||
131635963|NCT01201915|473952675|FG000|Overall Study|Lost to Follow-up|0|||
131635964|NCT01201915|473952676|FG001|Overall Study|Lost to Follow-up|4|||
131635965|NCT01201915|473952677|FG002|Overall Study|Lost to Follow-up|0|||
131635966|NCT01201915|473952675|FG000|Overall Study|Physician Decision|3|||
131635967|NCT01201915|473952676|FG001|Overall Study|Physician Decision|0|||
131635968|NCT01201915|473952677|FG002|Overall Study|Physician Decision|0|||
131635969|NCT01201915|473952675|FG000|Overall Study|Subject Decision|3|||
131635970|NCT01201915|473952676|FG001|Overall Study|Subject Decision|3|||
131635971|NCT01201915|473952677|FG002|Overall Study|Subject Decision|5|||
131635972|NCT01201915|473952675|FG000|Overall Study|Target Lesion Progression|0|||
131635973|NCT01201915|473952676|FG001|Overall Study|Target Lesion Progression|3|||
131635974|NCT01201915|473952677|FG002|Overall Study|Target Lesion Progression|0|||
131635975|NCT03406507|473952678|FG000|Extension Period|Lack of Efficacy|0|||
131635976|NCT03406507|473952679|FG001|Extension Period|Lack of Efficacy|1|||
131635977|NCT00663923|473952680|FG000|Overall Study|Lost to Follow-up|2|||
131635978|NCT02316171|473952683|FG000|Overall Study|difficulties with urinary catheter|1|||
131635979|NCT02316171|473952684|FG001|Overall Study|difficulties with urinary catheter|0|||
131635980|NCT02316171|473952685|FG002|Overall Study|difficulties with urinary catheter|0|||
131635981|NCT02316171|473952686|FG003|Overall Study|difficulties with urinary catheter|0|||
131635982|NCT01524887|473952688|FG000|Overall Study|Withdrawal by Subject|6|||
131635983|NCT01524887|473952689|FG001|Overall Study|Withdrawal by Subject|2|||
131635984|NCT01524887|473952690|FG002|Overall Study|Withdrawal by Subject|3|||
131635985|NCT01524887|473952688|FG000|Overall Study|Adverse Event|5|||
131635986|NCT01524887|473952689|FG001|Overall Study|Adverse Event|1|||
131635987|NCT01524887|473952690|FG002|Overall Study|Adverse Event|1|||
131635988|NCT01524887|473952688|FG000|Overall Study|Protocol Violation|0|||
131635989|NCT01524887|473952689|FG001|Overall Study|Protocol Violation|0|||
131635990|NCT01524887|473952690|FG002|Overall Study|Protocol Violation|1|||
131635991|NCT01524887|473952688|FG000|Overall Study|Study termination|73|||
131635992|NCT01524887|473952689|FG001|Overall Study|Study termination|87|||
131635993|NCT01524887|473952690|FG002|Overall Study|Study termination|79|||
131635994|NCT01524887|473952688|FG000|Overall Study|Withdrawal by Caregiver|0|||
131635995|NCT01524887|473952689|FG001|Overall Study|Withdrawal by Caregiver|0|||
131635996|NCT01524887|473952690|FG002|Overall Study|Withdrawal by Caregiver|2|||
131635997|NCT01524887|473952688|FG000|Overall Study|Use of prohibited medication|1|||
131635998|NCT01524887|473952689|FG001|Overall Study|Use of prohibited medication|0|||
131635999|NCT01524887|473952690|FG002|Overall Study|Use of prohibited medication|0|||
131636000|NCT01804140|473952691|FG000|Overall Study|No sampling or biopsy procedures done|114|||
131636001|NCT00547300|473952694|FG000|Overall Study|Study was Administratively Terminated|25|||
131636002|NCT00547300|473952695|FG001|Overall Study|Study was Administratively Terminated|24|||
131636003|NCT00547300|473952694|FG000|Overall Study|Did not Meet Entry Criteria|0|||
131636004|NCT00547300|473952695|FG001|Overall Study|Did not Meet Entry Criteria|2|||
131636005|NCT04380688|473952696|FG000|Overall Study|Death|2|||
131636006|NCT04380688|473952697|FG001|Overall Study|Death|2|||
131636007|NCT04380688|473952696|FG000|Overall Study|Lost to Follow-up|2|||
131636008|NCT04380688|473952697|FG001|Overall Study|Lost to Follow-up|4|||
131636009|NCT04380688|473952696|FG000|Overall Study|Withdrawal by Subject|3|||
131636010|NCT04380688|473952697|FG001|Overall Study|Withdrawal by Subject|3|||
131636011|NCT04341584|473952698|FG000|Overall Study|Withdrew consent|0|||
131636012|NCT04341584|473952699|FG001|Overall Study|Withdrew consent|2|||
131636013|NCT04341584|473952700|FG002|Overall Study|Withdrew consent|2|||
131636014|NCT04341584|473952701|FG003|Overall Study|Withdrew consent|1|||
131636015|NCT04267393|473952704|FG000|Randomization|Adverse Event|1|||
131636016|NCT04267393|473952705|FG001|Randomization|Adverse Event|0|||
131636017|NCT04267393|473952706|FG002|Randomization|Adverse Event|0|||
131636018|NCT04267393|473952704|FG000|Randomization|Administrative Reasons by Sponsor|0|||
131636019|NCT04267393|473952705|FG001|Randomization|Administrative Reasons by Sponsor|1|||
131636020|NCT04267393|473952706|FG002|Randomization|Administrative Reasons by Sponsor|0|||
131636021|NCT04267393|473952704|FG000|Treatment Period|Adverse Event|0|||
131636022|NCT04267393|473952705|FG001|Treatment Period|Adverse Event|2|||
131636023|NCT04267393|473952706|FG002|Treatment Period|Adverse Event|3|||
131636024|NCT04267393|473952704|FG000|Treatment Period|Participant Withdrew Consent|0|||
131636025|NCT04267393|473952705|FG001|Treatment Period|Participant Withdrew Consent|0|||
131636026|NCT04267393|473952706|FG002|Treatment Period|Participant Withdrew Consent|1|||
131636027|NCT04267393|473952704|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
131636028|NCT04267393|473952705|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
131636029|NCT04267393|473952706|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
131636030|NCT02329223|473954441|FG000|Overall Study|Withdrawal by Subject|1|||
131636031|NCT02329223|473954442|FG001|Overall Study|Withdrawal by Subject|2|||
131636032|NCT02329223|473954443|FG002|Overall Study|Withdrawal by Subject|5|||
131636033|NCT02329223|473954441|FG000|Overall Study|Physician Decision|0|||
131636034|NCT02329223|473954442|FG001|Overall Study|Physician Decision|0|||
131636035|NCT02329223|473954443|FG002|Overall Study|Physician Decision|1|||
131636036|NCT02329223|473954441|FG000|Overall Study|Adverse Event|0|||
131636037|NCT02329223|473954442|FG001|Overall Study|Adverse Event|1|||
131636038|NCT02329223|473954443|FG002|Overall Study|Adverse Event|0|||
131636039|NCT00381888|473954444|FG000|Overall Study|Death|1|||
131636040|NCT00381888|473954444|FG000|Overall Study|Withdrawal by Subject|1|||
131636041|NCT00381888|473954444|FG000|Overall Study|Physician Decision|1|||
131636042|NCT00381888|473954444|FG000|Overall Study|Protocol Violation|9|||
131636043|NCT00381888|473954444|FG000|Overall Study|Had laparoscopic surgery|2|||
131636044|NCT00381888|473954444|FG000|Overall Study|Surgery was cancelled|2|||
131636045|NCT00381888|473954444|FG000|Overall Study|Adverse Event|1|||
131636046|NCT02916706|473954448|FG000|Overall Study|Adverse Event|0|||
131636047|NCT02916706|473954449|FG001|Overall Study|Adverse Event|1|||
131636048|NCT02916706|473954448|FG000|Overall Study|Lost to Follow-up|0|||
131636049|NCT02916706|473954449|FG001|Overall Study|Lost to Follow-up|1|||
131636050|NCT02916706|473954448|FG000|Overall Study|Physician Decision|1|||
131636051|NCT02916706|473954449|FG001|Overall Study|Physician Decision|0|||
131636052|NCT02916706|473954448|FG000|Overall Study|Protocol Violation|3|||
131636053|NCT02916706|473954449|FG001|Overall Study|Protocol Violation|1|||
131636054|NCT02916706|473954448|FG000|Overall Study|Withdrawal by Subject|6|||
131636055|NCT02916706|473954449|FG001|Overall Study|Withdrawal by Subject|9|||
131636056|NCT02916706|473954448|FG000|Overall Study|Other|5|||
131636057|NCT02916706|473954449|FG001|Overall Study|Other|19|||
131636058|NCT00381797|473954450|FG000|Overall Study|Withdrawal by Subject|1|||
131636059|NCT00381797|473954451|FG001|Overall Study|Withdrawal by Subject|1|||
131636060|NCT00381797|473954452|FG002|Overall Study|Withdrawal by Subject|0|||
131636061|NCT00381797|473954453|FG003|Overall Study|Withdrawal by Subject|0|||
131636062|NCT00381797|473954454|FG004|Overall Study|Withdrawal by Subject|2|||
131636063|NCT00381797|473954450|FG000|Overall Study|Ineligible|0|||
131636064|NCT00381797|473954451|FG001|Overall Study|Ineligible|0|||
131636065|NCT00381797|473954452|FG002|Overall Study|Ineligible|0|||
131636066|NCT00381797|473954453|FG003|Overall Study|Ineligible|1|||
131636067|NCT00381797|473954454|FG004|Overall Study|Ineligible|0|||
131636068|NCT00958711|473954455|FG000|Overall Study|Withdrawal by Subject|0|||
131445054|NCT02651675|473258812|FG000|Overall Study|Death|0|||
131445055|NCT02651675|473258813|FG001|Overall Study|Death|0|||
131445056|NCT02651675|473258814|FG002|Overall Study|Death|1|||
131445057|NCT03674411|473258815|FG000|Overall Study|Non-treatment|4|||
131636069|NCT00958711|473954456|FG001|Overall Study|Withdrawal by Subject|4|||
131636070|NCT00958711|473954455|FG000|Overall Study|Physician Decision|5|||
131636071|NCT00958711|473954456|FG001|Overall Study|Physician Decision|7|||
131445058|NCT04408989|473258816|FG000|Overall Study|Lost to Follow-up|0|||
131636072|NCT00958711|473954455|FG000|Overall Study|Lost to Follow-up|4|||
131636073|NCT00958711|473954456|FG001|Overall Study|Lost to Follow-up|1|||
131636074|NCT00958711|473954455|FG000|Overall Study|Other|2|||
131636075|NCT00958711|473954456|FG001|Overall Study|Other|5|||
131636076|NCT00958711|473954455|FG000|Overall Study|Death|1|||
131636077|NCT00958711|473954456|FG001|Overall Study|Death|2|||
131636078|NCT00958711|473954455|FG000|Overall Study|Adverse Event|1|||
131636079|NCT00958711|473954456|FG001|Overall Study|Adverse Event|2|||
131636080|NCT00550771|473954461|FG000|Overall Study|Adverse Event|11|||
131798821|NCT02270736|474548791|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131445059|NCT04408989|473258817|FG001|Overall Study|Lost to Follow-up|0|||
131636081|NCT00550771|473954462|FG001|Overall Study|Adverse Event|3|||
131445060|NCT04408989|473258818|FG002|Overall Study|Lost to Follow-up|1|||
131445061|NCT04408989|473258816|FG000|Overall Study|Withdrawal by Subject|0|||
131445062|NCT04408989|473258817|FG001|Overall Study|Withdrawal by Subject|0|||
131445063|NCT04408989|473258818|FG002|Overall Study|Withdrawal by Subject|2|||
131445064|NCT02694185|473258819|FG000|Overall Study|Withdrawal by Subject|45|||
131445065|NCT02694185|473258820|FG001|Overall Study|Withdrawal by Subject|0|||
131445066|NCT05082857|473258821|FG000|Overall Study|participants relocated and could not continue|2|||
131445067|NCT05082857|473258822|FG001|Overall Study|participants relocated and could not continue|1|||
131445068|NCT05082857|473258821|FG000|Overall Study|Lost to Follow-up|1|||
131445069|NCT05082857|473258822|FG001|Overall Study|Lost to Follow-up|3|||
131445070|NCT04363320|473258823|FG000|Overall Study|Lost to Follow-up|43|||
131445071|NCT04363320|473258824|FG001|Overall Study|Lost to Follow-up|42|||
131445072|NCT04363320|473258825|FG002|Overall Study|Lost to Follow-up|24|||
131445073|NCT04363320|473258826|FG003|Overall Study|Lost to Follow-up|29|||
131445074|NCT04363320|473258823|FG000|Overall Study|Death|0|||
131445075|NCT04363320|473258824|FG001|Overall Study|Death|0|||
131445076|NCT04363320|473258825|FG002|Overall Study|Death|1|||
131445077|NCT04363320|473258826|FG003|Overall Study|Death|0|||
131445078|NCT05632211|473258827|FG000|Overall Study|Withdrawal by Subject|2|||
131445079|NCT05632211|473258828|FG001|Overall Study|Withdrawal by Subject|0|||
131636082|NCT00550771|473954461|FG000|Overall Study|Discontinued for study-related reasons|0|||
131636083|NCT00550771|473954462|FG001|Overall Study|Discontinued for study-related reasons|1|||
131636084|NCT00550771|473954461|FG000|Overall Study|Physician Decision|2|||
131636085|NCT00550771|473954462|FG001|Overall Study|Physician Decision|0|||
131636086|NCT00550771|473954461|FG000|Overall Study|Withdrawal by Subject|0|||
131636087|NCT00550771|473954462|FG001|Overall Study|Withdrawal by Subject|1|||
131636088|NCT00550771|473954461|FG000|Overall Study|Protocol Violation|4|||
131636089|NCT00550771|473954462|FG001|Overall Study|Protocol Violation|5|||
131636090|NCT04150341|473954463|FG000|Overall Study|Physician Decision|0|||
131636091|NCT04150341|473954464|FG001|Overall Study|Physician Decision|0|||
131636092|NCT04150341|473954465|FG002|Overall Study|Physician Decision|1|||
131636093|NCT04150341|473954466|FG003|Overall Study|Physician Decision|0|||
131636094|NCT04150341|473954467|FG004|Overall Study|Physician Decision|0|||
131636095|NCT04150341|473954468|FG005|Overall Study|Physician Decision|0|||
131636096|NCT04150341|473954463|FG000|Overall Study|Adverse Event|0|||
131636097|NCT04150341|473954464|FG001|Overall Study|Adverse Event|0|||
131636098|NCT04150341|473954465|FG002|Overall Study|Adverse Event|0|||
131636099|NCT04150341|473954466|FG003|Overall Study|Adverse Event|0|||
131636100|NCT04150341|473954467|FG004|Overall Study|Adverse Event|1|||
131636101|NCT04150341|473954468|FG005|Overall Study|Adverse Event|0|||
131636102|NCT00405912|473954469|FG000|Overall Study|Withdrawal by Subject|12|||
131636103|NCT00405912|473954470|FG001|Overall Study|Withdrawal by Subject|11|||
131636104|NCT00405912|473954471|FG002|Overall Study|Withdrawal by Subject|12|||
131636105|NCT00405912|473954469|FG000|Overall Study|Lost to Follow-up|4|||
131636106|NCT00405912|473954470|FG001|Overall Study|Lost to Follow-up|8|||
131636107|NCT00405912|473954471|FG002|Overall Study|Lost to Follow-up|4|||
131636108|NCT01797562|473954472|FG000|Overall Study|Protocol Violation|5|||
131636109|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
131636110|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
131636111|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
131636112|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
131636113|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
131636114|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
131636115|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
131636116|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
131636117|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Death|6|||
131636118|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Death|2|||
131636119|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Death|2|||
131636120|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Death|9|||
131636121|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
131636122|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131798822|NCT02270736|474548792|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131798823|NCT02270736|474548788|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
131798824|NCT02270736|474548789|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
131798825|NCT02270736|474548790|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
131445080|NCT05632211|473258829|FG002|Overall Study|Withdrawal by Subject|2|||
131445081|NCT05632211|473258827|FG000|Overall Study|Other reasons|1|||
131445082|NCT05632211|473258828|FG001|Overall Study|Other reasons|1|||
131445083|NCT05632211|473258829|FG002|Overall Study|Other reasons|1|||
131636123|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131636124|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
131636125|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
131636126|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
131636127|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
131636128|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
131636129|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
131636130|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
131636131|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
131636132|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
131636133|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
131636134|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
131636135|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
131636136|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
131636137|NCT03730662|473954473|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
131636138|NCT03730662|473954474|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
131636139|NCT03730662|473954475|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
131636140|NCT03730662|473954476|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
131636141|NCT03730662|473954473|FG000|Variable Treatment Period|Adverse Event|1|||
131636142|NCT03730662|473954474|FG001|Variable Treatment Period|Adverse Event|2|||
131636143|NCT03730662|473954475|FG002|Variable Treatment Period|Adverse Event|0|||
131636144|NCT03730662|473954476|FG003|Variable Treatment Period|Adverse Event|7|||
131636145|NCT03730662|473954473|FG000|Variable Treatment Period|Death|9|||
131636146|NCT03730662|473954474|FG001|Variable Treatment Period|Death|0|||
131636147|NCT03730662|473954475|FG002|Variable Treatment Period|Death|6|||
131636148|NCT03730662|473954476|FG003|Variable Treatment Period|Death|26|||
131636149|NCT03730662|473954473|FG000|Variable Treatment Period|Lost to Follow-up|2|||
131636150|NCT03730662|473954474|FG001|Variable Treatment Period|Lost to Follow-up|1|||
131636151|NCT03730662|473954475|FG002|Variable Treatment Period|Lost to Follow-up|4|||
131636152|NCT03730662|473954476|FG003|Variable Treatment Period|Lost to Follow-up|11|||
131636153|NCT03730662|473954473|FG000|Variable Treatment Period|Personal Reason|0|||
131636154|NCT03730662|473954474|FG001|Variable Treatment Period|Personal Reason|2|||
131636155|NCT03730662|473954475|FG002|Variable Treatment Period|Personal Reason|1|||
131636156|NCT03730662|473954476|FG003|Variable Treatment Period|Personal Reason|6|||
131636157|NCT03730662|473954473|FG000|Variable Treatment Period|Physician Decision|0|||
131636158|NCT03730662|473954474|FG001|Variable Treatment Period|Physician Decision|0|||
131636159|NCT03730662|473954475|FG002|Variable Treatment Period|Physician Decision|0|||
131636160|NCT03730662|473954476|FG003|Variable Treatment Period|Physician Decision|3|||
131636161|NCT03730662|473954473|FG000|Variable Treatment Period|Protocol Violation|0|||
131636162|NCT03730662|473954474|FG001|Variable Treatment Period|Protocol Violation|1|||
131636163|NCT03730662|473954475|FG002|Variable Treatment Period|Protocol Violation|1|||
131636164|NCT03730662|473954476|FG003|Variable Treatment Period|Protocol Violation|1|||
131636165|NCT03730662|473954473|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
131636166|NCT03730662|473954474|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
131636167|NCT03730662|473954475|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
131636168|NCT03730662|473954476|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
131636169|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
131636170|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
131636171|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
131636172|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
131636173|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Death|0|||
131636174|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Death|1|||
131636175|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
131636176|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
131636177|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
131636178|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
131636179|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
131636180|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
131636181|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
131636182|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
131636183|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
131714134|NCT04971226|474231119|FG003|Overall Study|Progressive disease|1|||
131714135|NCT04971226|474231116|FG000|Overall Study|Protocol Deviation|1|||
131714136|NCT04971226|474231117|FG001|Overall Study|Protocol Deviation|0|||
131714137|NCT04971226|474231118|FG002|Overall Study|Protocol Deviation|1|||
131714138|NCT04971226|474231119|FG003|Overall Study|Protocol Deviation|1|||
131714139|NCT04971226|474231116|FG000|Overall Study|Subject Decision|0|||
131714140|NCT04971226|474231117|FG001|Overall Study|Subject Decision|1|||
131714141|NCT04971226|474231118|FG002|Overall Study|Subject Decision|1|||
131714142|NCT04971226|474231119|FG003|Overall Study|Subject Decision|1|||
131714143|NCT04971226|474231116|FG000|Overall Study|Pregnancy|0|||
131714144|NCT04971226|474231117|FG001|Overall Study|Pregnancy|0|||
131714145|NCT04971226|474231118|FG002|Overall Study|Pregnancy|0|||
131714146|NCT04971226|474231119|FG003|Overall Study|Pregnancy|1|||
131636184|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
131714147|NCT04971226|474231116|FG000|Overall Study|Participants not treated|1|||
131714148|NCT04971226|474231117|FG001|Overall Study|Participants not treated|0|||
131714149|NCT04971226|474231118|FG002|Overall Study|Participants not treated|2|||
131714150|NCT04971226|474231119|FG003|Overall Study|Participants not treated|1|||
131714151|NCT00001337|474231121|FG000|Overall Study|Switched to alternate treatment|2|||
131636185|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
131636186|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
131636187|NCT01309243|473954477|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
131636188|NCT01309243|473954478|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
131636189|NCT01309243|473954477|FG000|Extension Phase|Lost to Follow-up|6|||
131902585|NCT00810069|474929321|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
131902586|NCT00810069|474929322|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
131902587|NCT00810069|474929320|FG000|Lead-in Period I|Randomization criteria not met|158|||
131902588|NCT00810069|474929321|FG001|Lead-in Period I|Randomization criteria not met|0|||
131902589|NCT00810069|474929322|FG002|Lead-in Period I|Randomization criteria not met|0|||
131902590|NCT00810069|474929320|FG000|Double-Blind Period II|Adverse Event|0|||
131902591|NCT00810069|474929321|FG001|Double-Blind Period II|Adverse Event|9|||
131636190|NCT01309243|473954478|FG001|Extension Phase|Lost to Follow-up|0|||
131636191|NCT00632931|473954481|FG000|Part 1, Period 1|Protocol Violation|1|||
131636192|NCT00632931|473954482|FG001|Part 1, Period 1|Protocol Violation|0|||
131636193|NCT00632931|473954483|FG002|Part 1, Period 1|Protocol Violation|0|||
131636194|NCT00632931|473954481|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
131636195|NCT00632931|473954482|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
131636196|NCT00632931|473954483|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
131636197|NCT00632931|473954481|FG000|Part 2|Adverse Event|0|||
131636198|NCT00632931|473954482|FG001|Part 2|Adverse Event|0|||
131636199|NCT00632931|473954483|FG002|Part 2|Adverse Event|3|||
131636200|NCT00632931|473954481|FG000|Part 2|Death|0|||
131636201|NCT00632931|473954482|FG001|Part 2|Death|0|||
131636202|NCT00632931|473954483|FG002|Part 2|Death|1|||
131636203|NCT00632931|473954481|FG000|Part 2|Lack of Efficacy|0|||
131636204|NCT00632931|473954482|FG001|Part 2|Lack of Efficacy|0|||
131636205|NCT00632931|473954483|FG002|Part 2|Lack of Efficacy|17|||
131636206|NCT00632931|473954481|FG000|Part 2|Withdrawal by Subject|0|||
131636207|NCT00632931|473954482|FG001|Part 2|Withdrawal by Subject|0|||
131636208|NCT00632931|473954483|FG002|Part 2|Withdrawal by Subject|3|||
131636209|NCT01441583|473954486|FG000|Overall Study|Withdrawal by Subject|1|||
131636210|NCT01441583|473954487|FG001|Overall Study|Withdrawal by Subject|1|||
131636211|NCT01441583|473954488|FG002|Overall Study|Withdrawal by Subject|1|||
131636212|NCT01441583|473954486|FG000|Overall Study|Death|1|||
131636213|NCT01441583|473954487|FG001|Overall Study|Death|0|||
131636214|NCT01441583|473954488|FG002|Overall Study|Death|4|||
131636215|NCT01441583|473954486|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
131798826|NCT02270736|474548791|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
131445084|NCT04672239|473258830|FG000|Week 2 Survey|Failed survey check items|1|||
131445085|NCT04672239|473258831|FG001|Week 2 Survey|Failed survey check items|2|||
131636216|NCT01441583|473954487|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
131636217|NCT01441583|473954488|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
131798827|NCT02270736|474548792|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
131798828|NCT02270736|474548788|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
131798829|NCT02270736|474548789|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
131798830|NCT02270736|474548790|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
131445086|NCT04672239|473258832|FG002|Week 2 Survey|Failed survey check items|3|||
131798831|NCT02270736|474548791|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
131798832|NCT02270736|474548792|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
131798833|NCT02270736|474548788|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
131798834|NCT02270736|474548789|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
131798835|NCT02270736|474548790|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
131798836|NCT02270736|474548791|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
131902592|NCT00810069|474929322|FG002|Double-Blind Period II|Adverse Event|8|||
131902593|NCT00810069|474929320|FG000|Double-Blind Period II|Lack of Efficacy|0|||
131636218|NCT03341312|473954489|FG000|Period 1|Withdrawal by Subject|0|||
131636219|NCT03341312|473954490|FG001|Period 1|Withdrawal by Subject|1|||
131636220|NCT03341312|473954491|FG002|Period 1|Withdrawal by Subject|0|||
131636221|NCT03341312|473954492|FG003|Period 1|Withdrawal by Subject|0|||
131636222|NCT00839306|473954493|FG000|Overall Study|Adverse Event|3|||
131445087|NCT04672239|473258830|FG000|Week 2 Survey|Partially completed survey|7|||
131636223|NCT00839306|473954494|FG001|Overall Study|Adverse Event|5|||
131636224|NCT00839306|473954493|FG000|Overall Study|Lost to Follow-up|6|||
131636225|NCT00839306|473954494|FG001|Overall Study|Lost to Follow-up|9|||
131636226|NCT00839306|473954493|FG000|Overall Study|Withdrawal by Subject|5|||
131636227|NCT00839306|473954494|FG001|Overall Study|Withdrawal by Subject|7|||
131636228|NCT00839306|473954493|FG000|Overall Study|Lack of Efficacy|5|||
131636229|NCT00839306|473954494|FG001|Overall Study|Lack of Efficacy|4|||
131636230|NCT00839306|473954493|FG000|Overall Study|Other|6|||
131636231|NCT00839306|473954494|FG001|Overall Study|Other|18|||
131636232|NCT01812707|473954495|FG000|Overall Study|Adverse Event|0|||
131636233|NCT01812707|473954496|FG001|Overall Study|Adverse Event|0|||
131636234|NCT01812707|473954497|FG002|Overall Study|Adverse Event|0|||
131636235|NCT01812707|473954498|FG003|Overall Study|Adverse Event|2|||
131636236|NCT01812707|473954495|FG000|Overall Study|Poor compliance to protocol|1|||
131636237|NCT01812707|473954496|FG001|Overall Study|Poor compliance to protocol|0|||
131636238|NCT01812707|473954497|FG002|Overall Study|Poor compliance to protocol|0|||
131636239|NCT01812707|473954498|FG003|Overall Study|Poor compliance to protocol|0|||
131636240|NCT01812707|473954495|FG000|Overall Study|Consent withdrawn by participant|1|||
131636241|NCT01812707|473954496|FG001|Overall Study|Consent withdrawn by participant|0|||
131636242|NCT01812707|473954497|FG002|Overall Study|Consent withdrawn by participant|0|||
131636243|NCT01812707|473954498|FG003|Overall Study|Consent withdrawn by participant|0|||
131636244|NCT05060237|473954499|FG000|Overall Study|Withdrawal by Subject|4|||
131636245|NCT05060237|473954499|FG000|Overall Study|Screening failure|8|||
131798837|NCT02270736|474548792|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
131636246|NCT01066897|473954500|FG000|Overall Study|Withdrawal by Subject|1|||
131636247|NCT01066897|473954501|FG001|Overall Study|Withdrawal by Subject|0|||
131798838|NCT02270736|474548788|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131798839|NCT02270736|474548789|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131798840|NCT02270736|474548790|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131798841|NCT02270736|474548791|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
131798842|NCT02270736|474548792|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131798843|NCT02270736|474548788|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131798844|NCT02270736|474548789|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131798845|NCT02270736|474548790|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131798846|NCT02270736|474548791|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
131798847|NCT02270736|474548792|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131798848|NCT02270736|474548788|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131798849|NCT02270736|474548789|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131798850|NCT02270736|474548790|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131798851|NCT02270736|474548791|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
131798852|NCT02270736|474548792|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131798853|NCT01631864|474548793|FG000|Overall Study|Withdrawal by Subject|0|||
131798854|NCT01631864|474548794|FG001|Overall Study|Withdrawal by Subject|1|||
131798855|NCT01631864|474548793|FG000|Overall Study|Adverse Event|2|||
131798856|NCT01631864|474548794|FG001|Overall Study|Adverse Event|3|||
131798857|NCT00262600|474548795|FG000|Overall Study|Lost to Follow-up|17|||
131798858|NCT00262600|474548796|FG001|Overall Study|Lost to Follow-up|31|||
131798859|NCT00262600|474548797|FG002|Overall Study|Lost to Follow-up|41|||
131798860|NCT00262600|474548795|FG000|Overall Study|Withdrawal by Subject|128|||
131798861|NCT00262600|474548796|FG001|Overall Study|Withdrawal by Subject|145|||
131798862|NCT00262600|474548797|FG002|Overall Study|Withdrawal by Subject|139|||
131798863|NCT00262600|474548795|FG000|Overall Study|Not Treated|32|||
131798864|NCT00262600|474548796|FG001|Overall Study|Not Treated|17|||
131798865|NCT00262600|474548797|FG002|Overall Study|Not Treated|24|||
131798866|NCT00262600|474548795|FG000|Overall Study|Other|58|||
131798867|NCT00262600|474548796|FG001|Overall Study|Other|59|||
131798868|NCT00262600|474548797|FG002|Overall Study|Other|62|||
131798869|NCT00527423|474548820|FG000|Overall Study|Protocol Violation|1|||
131798870|NCT00527423|474548820|FG000|Overall Study|Adverse Event|5|||
131445088|NCT04672239|473258831|FG001|Week 2 Survey|Partially completed survey|1|||
131636248|NCT01066897|473954500|FG000|Overall Study|stopped study after developing the flu.|1|||
131636249|NCT01066897|473954501|FG001|Overall Study|stopped study after developing the flu.|0|||
131636250|NCT01697592|473954502|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
131636251|NCT01697592|473954503|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636252|NCT01697592|473954504|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636253|NCT01697592|473954505|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131798871|NCT00527423|474548820|FG000|Overall Study|Physician Decision|4|||
131798872|NCT00527423|474548820|FG000|Overall Study|Withdrawal by Subject|10|||
131798873|NCT00527423|474548820|FG000|Overall Study|Lost to Follow-up|4|||
131798874|NCT00527423|474548820|FG000|Overall Study|OTHER|4|||
131798875|NCT00527423|474548820|FG000|Overall Study|Death|9|||
131798876|NCT03702621|474548821|FG000|Overall Study|Physician Decision|6|||
131798877|NCT03702621|474548822|FG001|Overall Study|Physician Decision|6|||
131798878|NCT03194464|474548826|FG000|Overall Study|data not usable|2|||
131798879|NCT03103100|474548827|FG000|Overall Study|Adverse Event|1|||
131798880|NCT03103100|474548828|FG001|Overall Study|Adverse Event|0|||
131798881|NCT03103100|474548829|FG002|Overall Study|Adverse Event|0|||
131636254|NCT01697592|473954506|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636255|NCT01697592|473954507|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131902594|NCT00810069|474929321|FG001|Double-Blind Period II|Lack of Efficacy|7|||
131902595|NCT00810069|474929322|FG002|Double-Blind Period II|Lack of Efficacy|12|||
131902596|NCT00810069|474929320|FG000|Double-Blind Period II|Lost to Follow-up|0|||
131902597|NCT00810069|474929321|FG001|Double-Blind Period II|Lost to Follow-up|9|||
131902598|NCT00810069|474929322|FG002|Double-Blind Period II|Lost to Follow-up|9|||
131902599|NCT00810069|474929320|FG000|Double-Blind Period II|Physician Decision|0|||
131902600|NCT00810069|474929321|FG001|Double-Blind Period II|Physician Decision|0|||
131902601|NCT00810069|474929322|FG002|Double-Blind Period II|Physician Decision|1|||
131902602|NCT00810069|474929320|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
131902603|NCT00810069|474929321|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
131902604|NCT00810069|474929322|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
131902605|NCT00810069|474929320|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
131798882|NCT03103100|474548827|FG000|Overall Study|Physician Decision|1|||
131798883|NCT03103100|474548828|FG001|Overall Study|Physician Decision|0|||
131798884|NCT03103100|474548829|FG002|Overall Study|Physician Decision|2|||
131798885|NCT02906709|474548836|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
131798886|NCT02906709|474548837|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
131798887|NCT02906709|474548836|FG000|Phase A (Week 0 to Week 16)|Death|0|||
131798888|NCT02906709|474548837|FG001|Phase A (Week 0 to Week 16)|Death|1|||
131798889|NCT02906709|474548836|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
131798890|NCT02906709|474548837|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
131902606|NCT00810069|474929321|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
131636256|NCT01697592|473954508|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636257|NCT01697592|473954509|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636258|NCT01697592|473954510|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636259|NCT01697592|473954511|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131636260|NCT01697592|473954502|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636261|NCT01697592|473954503|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636262|NCT01697592|473954504|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636263|NCT01697592|473954505|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636264|NCT01697592|473954506|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636265|NCT01697592|473954507|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
131636266|NCT01697592|473954508|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636267|NCT01697592|473954509|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636268|NCT01697592|473954510|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636269|NCT01697592|473954511|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131636270|NCT01697592|473954502|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
131636271|NCT01697592|473954503|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636272|NCT01697592|473954504|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636273|NCT01697592|473954505|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636274|NCT01697592|473954506|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636275|NCT01697592|473954507|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636276|NCT01697592|473954508|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636277|NCT01697592|473954509|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636278|NCT01697592|473954510|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636279|NCT01697592|473954511|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131636280|NCT01697592|473954502|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131636281|NCT01697592|473954503|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131636282|NCT01697592|473954504|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131636283|NCT01697592|473954505|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131636284|NCT01697592|473954506|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131636285|NCT01697592|473954507|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131636286|NCT01697592|473954508|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131636287|NCT01697592|473954509|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131636288|NCT01697592|473954510|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131636289|NCT01697592|473954511|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131636290|NCT01697592|473954502|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131636291|NCT01697592|473954503|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
131636292|NCT01697592|473954504|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
131636293|NCT01697592|473954505|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
131636294|NCT01697592|473954506|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131636295|NCT01697592|473954507|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131636296|NCT01697592|473954508|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
131636297|NCT01697592|473954509|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131636298|NCT01697592|473954510|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131636299|NCT01697592|473954511|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
131798891|NCT02906709|474548836|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
131902607|NCT00810069|474929322|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
131902608|NCT00810069|474929320|FG000|Double-Blind Period II|Clinical relapse|0|||
131798892|NCT02906709|474548837|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
131902609|NCT00810069|474929321|FG001|Double-Blind Period II|Clinical relapse|3|||
131902610|NCT00810069|474929322|FG002|Double-Blind Period II|Clinical relapse|0|||
131902611|NCT00810069|474929320|FG000|Double-Blind Period II|Protocol Violation|0|||
131902612|NCT00810069|474929321|FG001|Double-Blind Period II|Protocol Violation|7|||
131902613|NCT00810069|474929322|FG002|Double-Blind Period II|Protocol Violation|6|||
131902614|NCT04767373|474929325|FG000|Overall Study|Death|6|||
131902615|NCT04767373|474929326|FG001|Overall Study|Death|3|||
131902616|NCT04767373|474929325|FG000|Overall Study|Lost to Follow-up|67|||
131902617|NCT04767373|474929326|FG001|Overall Study|Lost to Follow-up|35|||
131902618|NCT04767373|474929325|FG000|Overall Study|Physician Decision|15|||
131902619|NCT04767373|474929326|FG001|Overall Study|Physician Decision|4|||
131902620|NCT04767373|474929325|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131902621|NCT04767373|474929326|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131902622|NCT04767373|474929325|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
131902623|NCT04767373|474929326|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
131902624|NCT04767373|474929325|FG000|Overall Study|Other|1|||
131902625|NCT04767373|474929326|FG001|Overall Study|Other|2|||
131902626|NCT02983045|474929327|FG000|Overall Study|Withdrawal by Subject|0|||
131902627|NCT02983045|474929328|FG001|Overall Study|Withdrawal by Subject|1|||
131902628|NCT02983045|474929329|FG002|Overall Study|Withdrawal by Subject|0|||
131902629|NCT02983045|474929330|FG003|Overall Study|Withdrawal by Subject|5|||
131902630|NCT02983045|474929331|FG004|Overall Study|Withdrawal by Subject|0|||
131902631|NCT02983045|474929332|FG005|Overall Study|Withdrawal by Subject|72|||
131902632|NCT02983045|474929333|FG006|Overall Study|Withdrawal by Subject|0|||
131902633|NCT02983045|474929334|FG007|Overall Study|Withdrawal by Subject|0|||
131902634|NCT02983045|474929335|FG008|Overall Study|Withdrawal by Subject|0|||
131902635|NCT02983045|474929336|FG009|Overall Study|Withdrawal by Subject|2|||
131902636|NCT02983045|474929327|FG000|Overall Study|Lost to Follow-up|0|||
131902637|NCT02983045|474929328|FG001|Overall Study|Lost to Follow-up|0|||
131636300|NCT01697592|473954502|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
131636301|NCT01697592|473954503|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636302|NCT01697592|473954504|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636303|NCT01697592|473954505|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
131636304|NCT01697592|473954506|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636305|NCT01697592|473954507|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636306|NCT01697592|473954508|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636307|NCT01697592|473954509|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636308|NCT01697592|473954510|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636309|NCT01697592|473954511|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131636310|NCT01697592|473954502|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
131636311|NCT01697592|473954503|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636312|NCT01697592|473954504|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636313|NCT01697592|473954505|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636314|NCT01697592|473954506|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636315|NCT01697592|473954507|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
131636316|NCT01697592|473954508|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636317|NCT01697592|473954509|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
131636318|NCT01697592|473954510|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636319|NCT01697592|473954511|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131636320|NCT01697592|473954502|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
131636321|NCT01697592|473954503|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131636322|NCT01697592|473954504|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131636323|NCT01697592|473954505|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
131636324|NCT01697592|473954506|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
131636325|NCT01697592|473954507|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131636326|NCT01697592|473954508|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131636327|NCT01697592|473954509|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
131636328|NCT01697592|473954510|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
131636329|NCT01697592|473954511|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
131636330|NCT02396758|473954512|FG000|Overall Study|Withdrawal by Subject|2|||
131636331|NCT02396758|473954513|FG001|Overall Study|Withdrawal by Subject|0|||
131636332|NCT02396758|473954514|FG002|Overall Study|Withdrawal by Subject|0|||
131636333|NCT02396758|473954515|FG003|Overall Study|Withdrawal by Subject|1|||
131902638|NCT02983045|474929329|FG002|Overall Study|Lost to Follow-up|0|||
131902639|NCT02983045|474929330|FG003|Overall Study|Lost to Follow-up|0|||
131902640|NCT02983045|474929331|FG004|Overall Study|Lost to Follow-up|0|||
131902641|NCT02983045|474929332|FG005|Overall Study|Lost to Follow-up|10|||
131902642|NCT02983045|474929333|FG006|Overall Study|Lost to Follow-up|0|||
131636334|NCT02396758|473954512|FG000|Overall Study|Lost to Follow-up|8|||
131902643|NCT02983045|474929334|FG007|Overall Study|Lost to Follow-up|0|||
131902644|NCT02983045|474929335|FG008|Overall Study|Lost to Follow-up|0|||
131902645|NCT02983045|474929336|FG009|Overall Study|Lost to Follow-up|0|||
131902646|NCT00593918|474929337|FG000|Overall Study|Withdrawal by Subject|5|||
131636335|NCT02396758|473954513|FG001|Overall Study|Lost to Follow-up|5|||
131636336|NCT02396758|473954514|FG002|Overall Study|Lost to Follow-up|3|||
131636337|NCT02396758|473954515|FG003|Overall Study|Lost to Follow-up|3|||
131636338|NCT02396758|473954512|FG000|Overall Study|Death|1|||
131636339|NCT02396758|473954513|FG001|Overall Study|Death|1|||
131636340|NCT02396758|473954514|FG002|Overall Study|Death|0|||
131636341|NCT02396758|473954515|FG003|Overall Study|Death|1|||
131636342|NCT02396758|473954512|FG000|Overall Study|Randomized but not treated|1|||
131636343|NCT02396758|473954513|FG001|Overall Study|Randomized but not treated|0|||
131636344|NCT02396758|473954514|FG002|Overall Study|Randomized but not treated|1|||
131636345|NCT02396758|473954515|FG003|Overall Study|Randomized but not treated|0|||
131636346|NCT00265096|473954516|FG000|Overall Study|Adverse Event|14|||
131636347|NCT00265096|473954517|FG001|Overall Study|Adverse Event|18|||
131636348|NCT00265096|473954518|FG002|Overall Study|Adverse Event|18|||
131636349|NCT00265096|473954516|FG000|Overall Study|Lost to Follow-up|2|||
131636350|NCT00265096|473954517|FG001|Overall Study|Lost to Follow-up|5|||
131636351|NCT00265096|473954518|FG002|Overall Study|Lost to Follow-up|3|||
131636352|NCT00265096|473954516|FG000|Overall Study|Death|0|||
131636353|NCT00265096|473954517|FG001|Overall Study|Death|1|||
131636354|NCT00265096|473954518|FG002|Overall Study|Death|2|||
131636355|NCT00265096|473954516|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
131636356|NCT00265096|473954517|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131636357|NCT00265096|473954518|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
131636358|NCT00265096|473954516|FG000|Overall Study|Other|11|||
131636359|NCT00265096|473954517|FG001|Overall Study|Other|19|||
131636360|NCT00265096|473954518|FG002|Overall Study|Other|10|||
131636361|NCT00774306|473954519|FG000|Overall Study|Adverse Event|3|||
131636362|NCT00774306|473954520|FG001|Overall Study|Adverse Event|0|||
131636363|NCT00774306|473954521|FG002|Overall Study|Adverse Event|0|||
131636364|NCT00774306|473954522|FG003|Overall Study|Adverse Event|0|||
131636365|NCT00774306|473954519|FG000|Overall Study|Protocol Violation|2|||
131636366|NCT00774306|473954520|FG001|Overall Study|Protocol Violation|0|||
131636367|NCT00774306|473954521|FG002|Overall Study|Protocol Violation|3|||
131636368|NCT00774306|473954522|FG003|Overall Study|Protocol Violation|0|||
131902647|NCT00593918|474929338|FG001|Overall Study|Withdrawal by Subject|24|||
131445089|NCT04672239|473258832|FG002|Week 2 Survey|Partially completed survey|4|||
131445090|NCT04672239|473258830|FG000|Week 2 Survey|Withdrawal by Subject|0|||
131445091|NCT04672239|473258831|FG001|Week 2 Survey|Withdrawal by Subject|1|||
131636369|NCT00774306|473954519|FG000|Overall Study|Withdrawal by Subject|6|||
131636370|NCT00774306|473954520|FG001|Overall Study|Withdrawal by Subject|1|||
131636371|NCT00774306|473954521|FG002|Overall Study|Withdrawal by Subject|1|||
131636372|NCT00774306|473954522|FG003|Overall Study|Withdrawal by Subject|0|||
131636373|NCT00774306|473954519|FG000|Overall Study|Lost to Follow-up|6|||
131636374|NCT00774306|473954520|FG001|Overall Study|Lost to Follow-up|0|||
131636375|NCT00774306|473954521|FG002|Overall Study|Lost to Follow-up|4|||
131636376|NCT00774306|473954522|FG003|Overall Study|Lost to Follow-up|5|||
131636377|NCT00774306|473954519|FG000|Overall Study|Death|1|||
131636378|NCT00774306|473954520|FG001|Overall Study|Death|1|||
131636379|NCT00774306|473954521|FG002|Overall Study|Death|0|||
131636380|NCT00774306|473954522|FG003|Overall Study|Death|0|||
131636381|NCT00666835|473954523|FG000|Overall Study|Withdrawal by Subject|5|||
131636382|NCT00666835|473954524|FG001|Overall Study|Withdrawal by Subject|2|||
131636383|NCT00666835|473954523|FG000|Overall Study|Lack of Efficacy|0|||
131636384|NCT00666835|473954524|FG001|Overall Study|Lack of Efficacy|1|||
131636385|NCT00666835|473954523|FG000|Overall Study|Incl./excl. not fulfilled|7|||
131636386|NCT00666835|473954524|FG001|Overall Study|Incl./excl. not fulfilled|2|||
131636387|NCT00666835|473954523|FG000|Overall Study|Adverse Event|7|||
131636388|NCT00666835|473954524|FG001|Overall Study|Adverse Event|6|||
131636389|NCT00666835|473954523|FG000|Overall Study|Protocol Violation|2|||
131636390|NCT00666835|473954524|FG001|Overall Study|Protocol Violation|0|||
131636391|NCT00666835|473954523|FG000|Overall Study|Death|15|||
131636392|NCT00666835|473954524|FG001|Overall Study|Death|4|||
131636393|NCT00666835|473954523|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
131636394|NCT00666835|473954524|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
131636395|NCT00666835|473954523|FG000|Overall Study|Hemoglobulin concentration|4|||
131636396|NCT00666835|473954524|FG001|Overall Study|Hemoglobulin concentration|3|||
131636397|NCT00666835|473954523|FG000|Overall Study|Planned operation|2|||
131445092|NCT04672239|473258832|FG002|Week 2 Survey|Withdrawal by Subject|0|||
131636398|NCT00666835|473954524|FG001|Overall Study|Planned operation|0|||
131636399|NCT00666835|473954523|FG000|Overall Study|Physician Decision|1|||
131636400|NCT00666835|473954524|FG001|Overall Study|Physician Decision|2|||
131636401|NCT01126879|473954525|FG000|Overall Study|Progressive Disease|3|||
131636402|NCT01126879|473954526|FG001|Overall Study|Progressive Disease|1|||
131636403|NCT01126879|473954525|FG000|Overall Study|Withdrawal by Subject|1|||
131636404|NCT01126879|473954526|FG001|Overall Study|Withdrawal by Subject|0|||
131636405|NCT01126879|473954525|FG000|Overall Study|Adverse Event|0|||
131636406|NCT01126879|473954526|FG001|Overall Study|Adverse Event|1|||
131636407|NCT01126879|473954525|FG000|Overall Study|Physician Decision|1|||
131636408|NCT01126879|473954526|FG001|Overall Study|Physician Decision|0|||
131636409|NCT03319719|473954529|FG000|Overall Study|Lost to Follow-up|1|||
131636410|NCT00498433|473954530|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
131636411|NCT00498433|473954531|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
131636412|NCT00498433|473954532|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
131636413|NCT00498433|473954530|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
131636414|NCT00498433|473954531|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
131636415|NCT00498433|473954532|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
131636416|NCT00498433|473954530|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
131636417|NCT00498433|473954531|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
131636418|NCT00498433|473954532|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
131636419|NCT00498433|473954530|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
131636420|NCT00498433|473954531|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
131636421|NCT00498433|473954532|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
131636422|NCT00744796|473954533|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
131636423|NCT03193216|473954534|FG000|Overall Study|Lost to Follow-up|1|||
131636424|NCT03193216|473954535|FG001|Overall Study|Lost to Follow-up|0|||
131636425|NCT03193216|473954534|FG000|Overall Study|Withdrawal by Subject|5|||
131636426|NCT03193216|473954535|FG001|Overall Study|Withdrawal by Subject|0|||
131636427|NCT03193216|473954534|FG000|Overall Study|Physician Decision|4|||
131636428|NCT03193216|473954535|FG001|Overall Study|Physician Decision|0|||
131636429|NCT01514864|473954536|FG000|Overall Study|Disease progression|7|||
131636430|NCT01514864|473954537|FG001|Overall Study|Disease progression|5|||
131636431|NCT01514864|473954536|FG000|Overall Study|Study drug toxicity|2|||
131636432|NCT01514864|473954537|FG001|Overall Study|Study drug toxicity|0|||
131636433|NCT02253147|473954538|FG000|Overall Study|Protocol Violation|30|||
131636434|NCT02253147|473954538|FG000|Overall Study|Did not consent to study extension|9|||
131636435|NCT02253147|473954538|FG000|Overall Study|Conditional re-treatment at W52|5|||
131636436|NCT02253147|473954538|FG000|Overall Study|Lost to Follow-up|2|||
131636437|NCT02253147|473954538|FG000|Overall Study|Withdrawal by Subject|1|||
131636438|NCT02316847|473954539|FG000|Overall Study|Adverse Event|0|||
131636439|NCT02316847|473954540|FG001|Overall Study|Adverse Event|3|||
131636440|NCT02316847|473954539|FG000|Overall Study|Lost to Follow-up|0|||
131636441|NCT02316847|473954540|FG001|Overall Study|Lost to Follow-up|2|||
131636442|NCT02316847|473954539|FG000|Overall Study|Physician Decision|0|||
131636443|NCT02316847|473954540|FG001|Overall Study|Physician Decision|1|||
131636444|NCT02316847|473954539|FG000|Overall Study|Pregnancy|0|||
131636445|NCT02316847|473954540|FG001|Overall Study|Pregnancy|1|||
131798893|NCT00436007|474548840|FG000|Overall Study|Withdrawal by Subject|5|||
131798894|NCT00436007|474548841|FG001|Overall Study|Withdrawal by Subject|3|||
131798895|NCT00436007|474548842|FG002|Overall Study|Withdrawal by Subject|4|||
131798896|NCT00436007|474548840|FG000|Overall Study|Lost to Follow-up|14|||
131798897|NCT00436007|474548841|FG001|Overall Study|Lost to Follow-up|10|||
131798898|NCT00436007|474548842|FG002|Overall Study|Lost to Follow-up|13|||
131798899|NCT00436007|474548840|FG000|Overall Study|Physician Decision|0|||
131798900|NCT00436007|474548841|FG001|Overall Study|Physician Decision|0|||
131798901|NCT00436007|474548842|FG002|Overall Study|Physician Decision|2|||
131798902|NCT00436007|474548840|FG000|Overall Study|Death|0|||
131798903|NCT00436007|474548841|FG001|Overall Study|Death|1|||
131798904|NCT00436007|474548842|FG002|Overall Study|Death|3|||
131798905|NCT00436007|474548840|FG000|Overall Study|Other|0|||
131798906|NCT00436007|474548841|FG001|Overall Study|Other|0|||
131798907|NCT00436007|474548842|FG002|Overall Study|Other|1|||
131798908|NCT02153398|474548843|FG000|Overall Study|Withdrawal by Subject|1|||
131798909|NCT02153398|474548844|FG001|Overall Study|Withdrawal by Subject|0|||
131798910|NCT02153398|474548845|FG002|Overall Study|Withdrawal by Subject|0|||
131798911|NCT02153398|474548846|FG003|Overall Study|Withdrawal by Subject|0|||
131798912|NCT02153398|474548847|FG004|Overall Study|Withdrawal by Subject|0|||
131798913|NCT02153398|474548843|FG000|Overall Study|Adverse Event|0|||
131798914|NCT02153398|474548844|FG001|Overall Study|Adverse Event|0|||
131798915|NCT02153398|474548845|FG002|Overall Study|Adverse Event|1|||
131798916|NCT02153398|474548846|FG003|Overall Study|Adverse Event|1|||
131798917|NCT02153398|474548847|FG004|Overall Study|Adverse Event|0|||
131798918|NCT01957488|474548848|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
131636446|NCT02316847|473954539|FG000|Overall Study|Withdrawal by Subject|2|||
131798919|NCT01957488|474548849|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
131798920|NCT01957488|474548850|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
131636447|NCT02316847|473954540|FG001|Overall Study|Withdrawal by Subject|9|||
131636448|NCT02316847|473954539|FG000|Overall Study|Noncompliance with study drug|0|||
131636449|NCT02316847|473954540|FG001|Overall Study|Noncompliance with study drug|3|||
131636450|NCT02316847|473954539|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
131636451|NCT02316847|473954540|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
131798921|NCT01957488|474548851|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
131798922|NCT01957488|474548852|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
131798923|NCT01957488|474548853|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
131798924|NCT01957488|474548848|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
131798925|NCT01957488|474548849|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
131798926|NCT01957488|474548850|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
131636452|NCT01264887|473954543|FG000|Overall Study|Adverse Event|5|||
131636453|NCT01264887|473954543|FG000|Overall Study|Death|7|||
131636454|NCT01264887|473954543|FG000|Overall Study|Lack of Efficacy|5|||
131636455|NCT01264887|473954543|FG000|Overall Study|Physician Decision|4|||
131636456|NCT01264887|473954543|FG000|Overall Study|Withdrawal by Subject|6|||
131636457|NCT01264887|473954543|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
131636458|NCT01264887|473954543|FG000|Overall Study|Other|2|||
131636459|NCT02171130|473954544|FG000|Overall Study|Death|1|||
131636460|NCT02171130|473954544|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
131636461|NCT02171130|473954544|FG000|Overall Study|Discontinued; Site Termination|5|||
131636462|NCT02171130|473954544|FG000|Overall Study|Withdrawal by Subject|3|||
131636463|NCT02171130|473954544|FG000|Overall Study|Physician Decision|1|||
131636464|NCT02171130|473954544|FG000|Overall Study|Lost to Follow-up|1|||
131636465|NCT02171130|473954544|FG000|Overall Study|Met Exclusion Criteria|1|||
131636466|NCT03544229|473954545|FG000|Overall Study|Adverse Event|1|||
131636467|NCT03544229|473954546|FG001|Overall Study|Adverse Event|0|||
131636468|NCT03544229|473954547|FG002|Overall Study|Adverse Event|1|||
131636469|NCT03544229|473954548|FG003|Overall Study|Adverse Event|0|||
131636470|NCT03544229|473954545|FG000|Overall Study|Protocol Deviation|0|||
131636471|NCT03544229|473954546|FG001|Overall Study|Protocol Deviation|0|||
131636472|NCT03544229|473954547|FG002|Overall Study|Protocol Deviation|1|||
131636473|NCT03544229|473954548|FG003|Overall Study|Protocol Deviation|0|||
131636474|NCT03544229|473954545|FG000|Overall Study|Lost to Follow-up|3|||
131636475|NCT03544229|473954546|FG001|Overall Study|Lost to Follow-up|0|||
131636476|NCT03544229|473954547|FG002|Overall Study|Lost to Follow-up|0|||
131636477|NCT03544229|473954548|FG003|Overall Study|Lost to Follow-up|2|||
131636478|NCT03544229|473954545|FG000|Overall Study|Voluntary Withdrawal|2|||
131636479|NCT03544229|473954546|FG001|Overall Study|Voluntary Withdrawal|1|||
131714152|NCT00001337|474231122|FG001|Overall Study|Switched to alternate treatment|2|||
131714153|NCT00001337|474231123|FG002|Overall Study|Switched to alternate treatment|0|||
131636480|NCT03544229|473954547|FG002|Overall Study|Voluntary Withdrawal|3|||
131714154|NCT00001337|474231121|FG000|Overall Study|Refused further treatment|2|||
131714155|NCT00001337|474231122|FG001|Overall Study|Refused further treatment|1|||
131714156|NCT00001337|474231123|FG002|Overall Study|Refused further treatment|0|||
131714157|NCT00001337|474231121|FG000|Overall Study|Began other Tx|1|||
131714158|NCT00001337|474231122|FG001|Overall Study|Began other Tx|0|||
131714159|NCT00001337|474231123|FG002|Overall Study|Began other Tx|0|||
131714160|NCT00001337|474231121|FG000|Overall Study|Physician Decision|3|||
131714161|NCT00001337|474231122|FG001|Overall Study|Physician Decision|1|||
131714162|NCT00001337|474231123|FG002|Overall Study|Physician Decision|0|||
131714163|NCT00001337|474231121|FG000|Overall Study|Doesn't have NHL|0|||
131714164|NCT00001337|474231122|FG001|Overall Study|Doesn't have NHL|1|||
131714165|NCT00001337|474231123|FG002|Overall Study|Doesn't have NHL|0|||
131714166|NCT00001337|474231121|FG000|Overall Study|Non protocol tx needed|3|||
131714167|NCT00001337|474231122|FG001|Overall Study|Non protocol tx needed|1|||
131714168|NCT00001337|474231123|FG002|Overall Study|Non protocol tx needed|0|||
131714169|NCT00001337|474231121|FG000|Overall Study|Protocol change|1|||
131714170|NCT00001337|474231122|FG001|Overall Study|Protocol change|0|||
131714171|NCT00001337|474231123|FG002|Overall Study|Protocol change|0|||
131714172|NCT00001337|474231121|FG000|Overall Study|2nd primary disease|0|||
131714173|NCT00001337|474231122|FG001|Overall Study|2nd primary disease|0|||
131714174|NCT00001337|474231123|FG002|Overall Study|2nd primary disease|1|||
131714175|NCT00001337|474231121|FG000|Overall Study|Death during follow up period|9|||
131714176|NCT00001337|474231122|FG001|Overall Study|Death during follow up period|4|||
131636481|NCT03544229|473954548|FG003|Overall Study|Voluntary Withdrawal|0|||
131714177|NCT00001337|474231123|FG002|Overall Study|Death during follow up period|0|||
131714178|NCT00001337|474231121|FG000|Overall Study|Death on study|19|||
131714179|NCT00001337|474231122|FG001|Overall Study|Death on study|9|||
131636482|NCT03544229|473954545|FG000|Overall Study|Lack of Efficacy|0|||
131714180|NCT00001337|474231123|FG002|Overall Study|Death on study|0|||
131636483|NCT03544229|473954546|FG001|Overall Study|Lack of Efficacy|1|||
131714181|NCT00001337|474231121|FG000|Overall Study|Disease progression during follow-up period|3|||
131714182|NCT00001337|474231122|FG001|Overall Study|Disease progression during follow-up period|1|||
131714183|NCT00001337|474231123|FG002|Overall Study|Disease progression during follow-up period|0|||
131714184|NCT00001337|474231121|FG000|Overall Study|Disease progression on study|33|||
131714185|NCT00001337|474231122|FG001|Overall Study|Disease progression on study|41|||
131714186|NCT00001337|474231123|FG002|Overall Study|Disease progression on study|0|||
131636484|NCT03544229|473954547|FG002|Overall Study|Lack of Efficacy|0|||
131798927|NCT01957488|474548851|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
131798928|NCT01957488|474548852|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
131798929|NCT01957488|474548853|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
131798930|NCT01957488|474548848|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
131798931|NCT01957488|474548849|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
131798932|NCT01957488|474548850|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
131798933|NCT01957488|474548851|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
131798934|NCT01957488|474548852|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
131798935|NCT01957488|474548853|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
131636485|NCT03544229|473954548|FG003|Overall Study|Lack of Efficacy|0|||
131636486|NCT04772313|473954549|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
131636487|NCT04772313|473954549|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
131636488|NCT01836198|473954550|FG000|Part A, Period 2|Protocol Violation|0|||
131636489|NCT01836198|473954551|FG001|Part A, Period 2|Protocol Violation|1|||
131636490|NCT01836198|473954552|FG002|Part A, Period 2|Protocol Violation|0|||
131636491|NCT03187353|473954553|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
131636492|NCT03187353|473954554|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
131636493|NCT03187353|473954553|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
131636494|NCT03187353|473954554|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131636495|NCT03187353|473954553|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
131636496|NCT03187353|473954554|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
131636497|NCT03187353|473954553|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
131636498|NCT03187353|473954554|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
131636499|NCT03187353|473954553|FG000|Washout (2 Weeks)|Adverse Event|2|||
131636500|NCT03187353|473954554|FG001|Washout (2 Weeks)|Adverse Event|0|||
131636501|NCT03187353|473954553|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
131636502|NCT03187353|473954554|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
131636503|NCT02215954|473954555|FG000|Overall Study|Adverse Event|0|||
131636504|NCT02215954|473954556|FG001|Overall Study|Adverse Event|0|||
131636505|NCT02215954|473954557|FG002|Overall Study|Adverse Event|1|||
131636506|NCT02215954|473954555|FG000|Overall Study|Withdrawal by Subject|0|||
131636507|NCT02215954|473954556|FG001|Overall Study|Withdrawal by Subject|0|||
131636508|NCT02215954|473954557|FG002|Overall Study|Withdrawal by Subject|2|||
131636509|NCT02215954|473954555|FG000|Overall Study|Not exposed|1|||
131636510|NCT02215954|473954556|FG001|Overall Study|Not exposed|1|||
131636511|NCT02215954|473954557|FG002|Overall Study|Not exposed|3|||
131636512|NCT02460562|473954558|FG000|Overall Study|Lost to Follow-up|15|||
131636513|NCT02460562|473954559|FG001|Overall Study|Lost to Follow-up|16|||
131636514|NCT01061775|473954560|FG000|Overall Study|Physician Decision|2|||
131636515|NCT01061775|473954560|FG000|Overall Study|Lost to Follow-up|1|||
131636516|NCT03303521|473954561|FG000|Overall Study|Withdrawal by Subject|2|||
131636517|NCT03303521|473954562|FG001|Overall Study|Withdrawal by Subject|0|||
131636518|NCT03303521|473954561|FG000|Overall Study|Death|1|||
131636519|NCT03303521|473954562|FG001|Overall Study|Death|0|||
131636520|NCT03303521|473954561|FG000|Overall Study|Kidney transplantation|0|||
131636521|NCT03303521|473954562|FG001|Overall Study|Kidney transplantation|1|||
131636522|NCT03303521|473954561|FG000|Overall Study|Investigational product discontinuation|0|||
131636523|NCT03303521|473954562|FG001|Overall Study|Investigational product discontinuation|1|||
131636524|NCT03303521|473954561|FG000|Overall Study|Transferred to non-study dialysis center|1|||
131636525|NCT03303521|473954562|FG001|Overall Study|Transferred to non-study dialysis center|0|||
131636526|NCT03303521|473954561|FG000|Overall Study|Non-comliance to study protocol|0|||
131636527|NCT03303521|473954562|FG001|Overall Study|Non-comliance to study protocol|1|||
131636528|NCT03303521|473954561|FG000|Overall Study|Adverse Event|1|||
131636529|NCT03303521|473954562|FG001|Overall Study|Adverse Event|0|||
131636530|NCT01654289|473954563|FG000|Overall Study|Withdrawal by Subject|10|||
131636531|NCT01654289|473954564|FG001|Overall Study|Withdrawal by Subject|8|||
131636532|NCT01654289|473954565|FG002|Overall Study|Withdrawal by Subject|5|||
131636533|NCT01654289|473954563|FG000|Overall Study|Withdrew from intervention only|17|||
131636534|NCT01654289|473954564|FG001|Overall Study|Withdrew from intervention only|20|||
131636535|NCT01654289|473954565|FG002|Overall Study|Withdrew from intervention only|0|||
131636536|NCT04194541|473954566|FG000|Day 1 Through 13|Lost to Follow-up|3|||
131636537|NCT04194541|473954566|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
131902648|NCT02658669|474929339|FG000|Overall Study|Lost to Follow-up|7|||
131636538|NCT04194541|473954566|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
131636539|NCT02642159|473954567|FG000|Overall Study|Randomized but not treated|1|||
131636540|NCT02642159|473954568|FG001|Overall Study|Randomized but not treated|0|||
131636541|NCT02642159|473954567|FG000|Overall Study|Adverse Event|10|||
131798936|NCT01957488|474548848|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131902649|NCT02658669|474929340|FG001|Overall Study|Lost to Follow-up|5|||
131636542|NCT02642159|473954568|FG001|Overall Study|Adverse Event|4|||
131636543|NCT02642159|473954567|FG000|Overall Study|Withdrawal by Subject|9|||
131798937|NCT01957488|474548849|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131636544|NCT02642159|473954568|FG001|Overall Study|Withdrawal by Subject|1|||
131798938|NCT01957488|474548850|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131798939|NCT01957488|474548851|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
131798940|NCT01957488|474548852|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
131636545|NCT02642159|473954567|FG000|Overall Study|Poor compliance to study protocol|1|||
131636546|NCT02642159|473954568|FG001|Overall Study|Poor compliance to study protocol|0|||
131636547|NCT02642159|473954567|FG000|Overall Study|Other than specified above|10|||
131636548|NCT02642159|473954568|FG001|Overall Study|Other than specified above|3|||
131636549|NCT03746483|473954569|FG000|Overall Study|Adverse Event|0|||
131636550|NCT03746483|473954570|FG001|Overall Study|Adverse Event|1|||
131636551|NCT03746483|473954569|FG000|Overall Study|Lack of Efficacy|3|||
131636552|NCT03746483|473954570|FG001|Overall Study|Lack of Efficacy|2|||
131636553|NCT03746483|473954569|FG000|Overall Study|Lost to Follow-up|1|||
131636554|NCT03746483|473954570|FG001|Overall Study|Lost to Follow-up|0|||
131636555|NCT03746483|473954569|FG000|Overall Study|Protocol Violation|2|||
131636556|NCT03746483|473954570|FG001|Overall Study|Protocol Violation|0|||
131636557|NCT00187135|473954571|FG000|Visit One|Withdrawal by Subject|1|||
131636558|NCT00187135|473954572|FG001|Visit One|Withdrawal by Subject|0|||
131636559|NCT00187135|473954573|FG002|Visit One|Withdrawal by Subject|0|||
131636560|NCT00187135|473954574|FG003|Visit One|Withdrawal by Subject|0|||
131636561|NCT00187135|473954575|FG004|Visit One|Withdrawal by Subject|0|||
131636562|NCT00187135|473954576|FG005|Visit One|Withdrawal by Subject|1|||
131636563|NCT00187135|473954571|FG000|Visit One|Physician Decision|3|||
131636564|NCT00187135|473954572|FG001|Visit One|Physician Decision|1|||
131636565|NCT00187135|473954573|FG002|Visit One|Physician Decision|0|||
131636566|NCT00187135|473954574|FG003|Visit One|Physician Decision|0|||
131636567|NCT00187135|473954575|FG004|Visit One|Physician Decision|0|||
131636568|NCT00187135|473954576|FG005|Visit One|Physician Decision|1|||
131636569|NCT00187135|473954571|FG000|Visit Two|Death|0|||
131636570|NCT00187135|473954572|FG001|Visit Two|Death|0|||
131636571|NCT00187135|473954573|FG002|Visit Two|Death|0|||
131636572|NCT00187135|473954574|FG003|Visit Two|Death|1|||
131636573|NCT00187135|473954575|FG004|Visit Two|Death|0|||
131636574|NCT00187135|473954576|FG005|Visit Two|Death|1|||
131636575|NCT00187135|473954571|FG000|Visit Two|Physician Decision|1|||
131636576|NCT00187135|473954572|FG001|Visit Two|Physician Decision|0|||
131636577|NCT00187135|473954573|FG002|Visit Two|Physician Decision|0|||
131636578|NCT00187135|473954574|FG003|Visit Two|Physician Decision|0|||
131636579|NCT00187135|473954575|FG004|Visit Two|Physician Decision|0|||
131636580|NCT00187135|473954576|FG005|Visit Two|Physician Decision|0|||
131636581|NCT00187135|473954571|FG000|Visit Two|Withdrawal by Subject|1|||
131636582|NCT00187135|473954572|FG001|Visit Two|Withdrawal by Subject|1|||
131636583|NCT00187135|473954573|FG002|Visit Two|Withdrawal by Subject|1|||
131636584|NCT00187135|473954574|FG003|Visit Two|Withdrawal by Subject|0|||
131798941|NCT01957488|474548853|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
131798942|NCT01957488|474548848|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131798943|NCT01957488|474548849|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131798944|NCT01957488|474548850|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131798945|NCT01957488|474548851|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131798946|NCT01957488|474548852|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
131798947|NCT01957488|474548853|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131798948|NCT01957488|474548848|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
131798949|NCT01957488|474548849|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
131798950|NCT01957488|474548850|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
131798951|NCT01957488|474548851|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
131798952|NCT01957488|474548852|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
131798953|NCT01957488|474548853|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
131798954|NCT01957488|474548848|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
131798955|NCT01957488|474548849|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
131636585|NCT00187135|473954575|FG004|Visit Two|Withdrawal by Subject|1|||
131636586|NCT00187135|473954576|FG005|Visit Two|Withdrawal by Subject|1|||
131798956|NCT01957488|474548850|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
131798957|NCT01957488|474548851|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
131798958|NCT01957488|474548852|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
131636587|NCT00187135|473954571|FG000|Visit Two|Study Discontinued|3|||
131636588|NCT00187135|473954572|FG001|Visit Two|Study Discontinued|2|||
131798959|NCT01957488|474548853|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
131798960|NCT01957488|474548848|FG000|Test Period 2 (2 Weeks)|Other|1|||
131798961|NCT01957488|474548849|FG001|Test Period 2 (2 Weeks)|Other|0|||
131798962|NCT01957488|474548850|FG002|Test Period 2 (2 Weeks)|Other|0|||
131636589|NCT00187135|473954573|FG002|Visit Two|Study Discontinued|1|||
131636590|NCT00187135|473954574|FG003|Visit Two|Study Discontinued|7|||
131636591|NCT00187135|473954575|FG004|Visit Two|Study Discontinued|5|||
131636592|NCT00187135|473954576|FG005|Visit Two|Study Discontinued|6|||
131636593|NCT00187135|473954571|FG000|Visit Three|Death|0|||
131636594|NCT00187135|473954572|FG001|Visit Three|Death|0|||
131636595|NCT00187135|473954573|FG002|Visit Three|Death|1|||
131636596|NCT00187135|473954574|FG003|Visit Three|Death|0|||
131636597|NCT00187135|473954575|FG004|Visit Three|Death|1|||
131636598|NCT00187135|473954576|FG005|Visit Three|Death|0|||
131636599|NCT00187135|473954571|FG000|Visit Three|Withdrawal by Subject|0|||
131636600|NCT00187135|473954572|FG001|Visit Three|Withdrawal by Subject|1|||
131636601|NCT00187135|473954573|FG002|Visit Three|Withdrawal by Subject|1|||
131636602|NCT00187135|473954574|FG003|Visit Three|Withdrawal by Subject|2|||
131636603|NCT00187135|473954575|FG004|Visit Three|Withdrawal by Subject|0|||
131636604|NCT00187135|473954576|FG005|Visit Three|Withdrawal by Subject|0|||
131636605|NCT00187135|473954571|FG000|Visit Three|Study Discontinued|7|||
131636606|NCT00187135|473954572|FG001|Visit Three|Study Discontinued|6|||
131636607|NCT00187135|473954573|FG002|Visit Three|Study Discontinued|7|||
131636608|NCT00187135|473954574|FG003|Visit Three|Study Discontinued|7|||
131636609|NCT00187135|473954575|FG004|Visit Three|Study Discontinued|7|||
131636610|NCT00187135|473954576|FG005|Visit Three|Study Discontinued|6|||
131902650|NCT03421379|474929342|FG000|Period 1|Withdrawal by Subject|0|||
131902651|NCT03421379|474929343|FG001|Period 1|Withdrawal by Subject|1|||
131902652|NCT03421379|474929342|FG000|Period 1|Physician Decision|1|||
131902653|NCT03421379|474929343|FG001|Period 1|Physician Decision|1|||
131902654|NCT03421379|474929342|FG000|Period 1|Did not receive treatment|1|||
131902655|NCT03421379|474929343|FG001|Period 1|Did not receive treatment|2|||
131902656|NCT02782741|474929344|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
131902657|NCT02782741|474929345|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
131902658|NCT02782741|474929346|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
131902659|NCT02782741|474929344|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
131902660|NCT02782741|474929345|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
131636611|NCT01951261|473954579|FG000|Overall Study|Death|1|||
131636612|NCT01951261|473954580|FG001|Overall Study|Death|0|||
131636613|NCT01951261|473954579|FG000|Overall Study|Lost to Follow-up|4|||
131636614|NCT01951261|473954580|FG001|Overall Study|Lost to Follow-up|3|||
131636615|NCT01951261|473954579|FG000|Overall Study|Protocol Violation|4|||
131636616|NCT01951261|473954580|FG001|Overall Study|Protocol Violation|3|||
131636617|NCT01924806|473954581|FG000|Overall Study|Physician Decision|2|||
131636618|NCT01924806|473954582|FG001|Overall Study|Physician Decision|1|||
131636619|NCT00297778|473954586|FG000|Overall Study|Adverse Event|16|||
131636620|NCT00297778|473954587|FG001|Overall Study|Adverse Event|10|||
131636621|NCT00297778|473954586|FG000|Overall Study|Withdrawal by Subject|1|||
131636622|NCT00297778|473954587|FG001|Overall Study|Withdrawal by Subject|5|||
131636623|NCT00297778|473954586|FG000|Overall Study|Lack of Efficacy|2|||
131636624|NCT00297778|473954587|FG001|Overall Study|Lack of Efficacy|1|||
131636625|NCT00297778|473954586|FG000|Overall Study|Non-compliant with trial protocol|0|||
131636626|NCT00297778|473954587|FG001|Overall Study|Non-compliant with trial protocol|3|||
131902661|NCT02782741|474929346|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
131902662|NCT02782741|474929344|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
131902663|NCT02782741|474929345|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
131902664|NCT02782741|474929346|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
131902665|NCT02782741|474929344|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
131902666|NCT02782741|474929345|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
131902667|NCT02782741|474929346|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
131902668|NCT02782741|474929344|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
131902669|NCT02782741|474929345|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
131902670|NCT02782741|474929346|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
131902671|NCT04157088|474929347|FG000|Overall Study|Study terminated by sponsor|23|||
131902672|NCT04157088|474929347|FG000|Overall Study|Withdrawal by Subject|4|||
131636627|NCT00297778|473954586|FG000|Overall Study|Other|0|||
131636628|NCT00297778|473954587|FG001|Overall Study|Other|1|||
131636629|NCT00679549|473954588|FG000|Overall Study|dropout|2|||
131636630|NCT00679549|473954589|FG001|Overall Study|dropout|4|||
131636631|NCT00679549|473954588|FG000|Overall Study|missing outcome echocardiograms|4|||
131636632|NCT00679549|473954589|FG001|Overall Study|missing outcome echocardiograms|5|||
131902673|NCT04157088|474929347|FG000|Overall Study|Lost to Follow-up|2|||
131902674|NCT04157088|474929347|FG000|Overall Study|Death|1|||
131902675|NCT00196105|474929350|FG000|Overall Study|Lost to Follow-up|4|||
131636633|NCT02201771|473954590|FG000|Overall Study|Death|3|||
131636634|NCT02201771|473954591|FG001|Overall Study|Death|2|||
131636635|NCT02201771|473954592|FG002|Overall Study|Death|0|||
131636636|NCT02201771|473954590|FG000|Overall Study|Protocol Violation|10|||
131636637|NCT02201771|473954591|FG001|Overall Study|Protocol Violation|8|||
131636638|NCT02201771|473954592|FG002|Overall Study|Protocol Violation|10|||
131636639|NCT01820637|473954593|FG000|Overall Study|Death|2|||
131636640|NCT01820637|473954593|FG000|Overall Study|Withdrawal by Subject|1|||
131636641|NCT00264498|473954594|FG000|Randomized Treatment|Death|0|||
131636642|NCT00264498|473954595|FG001|Randomized Treatment|Death|3|||
131636643|NCT00264498|473954594|FG000|Randomized Treatment|Withdrawal by Subject|0|||
131636644|NCT00264498|473954595|FG001|Randomized Treatment|Withdrawal by Subject|1|||
131636645|NCT00264498|473954594|FG000|Randomized Treatment|Objective disease Progression|13|||
131636646|NCT00264498|473954595|FG001|Randomized Treatment|Objective disease Progression|14|||
131636647|NCT00264498|473954594|FG000|Randomized Treatment|Physician Decision|1|||
131636648|NCT00264498|473954595|FG001|Randomized Treatment|Physician Decision|0|||
131636649|NCT00264498|473954594|FG000|Randomized Treatment|Incorrectly randomized|1|||
131636650|NCT00264498|473954595|FG001|Randomized Treatment|Incorrectly randomized|0|||
131636651|NCT00264498|473954594|FG000|Randomized Treatment|Study Closure|1|||
131636652|NCT00264498|473954595|FG001|Randomized Treatment|Study Closure|0|||
131636653|NCT00264498|473954594|FG000|Randomized Treatment|Protocol Violation|1|||
131636654|NCT00264498|473954595|FG001|Randomized Treatment|Protocol Violation|0|||
131636655|NCT00264498|473954594|FG000|Crossover Treatment|Death|1|||
131636656|NCT00264498|473954595|FG001|Crossover Treatment|Death|3|||
131636657|NCT00264498|473954594|FG000|Crossover Treatment|Objective disease progression|4|||
131636658|NCT00264498|473954595|FG001|Crossover Treatment|Objective disease progression|5|||
131636659|NCT00264498|473954594|FG000|Crossover Treatment|Study closure|0|||
131636660|NCT00264498|473954595|FG001|Crossover Treatment|Study closure|1|||
131636661|NCT00264498|473954594|FG000|Crossover Treatment|Withdrawal by Subject|1|||
131636662|NCT00264498|473954595|FG001|Crossover Treatment|Withdrawal by Subject|0|||
131636663|NCT02205476|473954596|FG000|Overall Study|Study termination by Sponsor|7|||
131636664|NCT02205476|473954597|FG001|Overall Study|Study termination by Sponsor|3|||
131636665|NCT04089332|473954601|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
131636666|NCT04089332|473954601|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
131636667|NCT04089332|473954601|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
131636668|NCT04754594|473954602|FG000|Blinded Period|Withdrawal by Subject|4|||
131636669|NCT04754594|473954603|FG001|Blinded Period|Withdrawal by Subject|9|||
131636670|NCT04754594|473954604|FG002|Blinded Period|Withdrawal by Subject|0|||
131636671|NCT04754594|473954605|FG003|Blinded Period|Withdrawal by Subject|0|||
131636672|NCT04754594|473954602|FG000|Blinded Period|Protocol Violation|2|||
131636673|NCT04754594|473954603|FG001|Blinded Period|Protocol Violation|2|||
131636674|NCT04754594|473954604|FG002|Blinded Period|Protocol Violation|0|||
131636675|NCT04754594|473954605|FG003|Blinded Period|Protocol Violation|0|||
131636676|NCT04754594|473954602|FG000|Blinded Period|Lost to Follow-up|1|||
131636677|NCT04754594|473954603|FG001|Blinded Period|Lost to Follow-up|1|||
131636678|NCT04754594|473954604|FG002|Blinded Period|Lost to Follow-up|0|||
131636679|NCT04754594|473954605|FG003|Blinded Period|Lost to Follow-up|0|||
131798963|NCT01957488|474548851|FG003|Test Period 2 (2 Weeks)|Other|0|||
131798964|NCT01957488|474548852|FG004|Test Period 2 (2 Weeks)|Other|0|||
131798965|NCT01957488|474548853|FG005|Test Period 2 (2 Weeks)|Other|0|||
131798966|NCT01957488|474548848|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131798967|NCT01957488|474548849|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
131798968|NCT01957488|474548850|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131798969|NCT01957488|474548851|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131798970|NCT01957488|474548852|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131798971|NCT01957488|474548853|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131798972|NCT01957488|474548848|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
131798973|NCT01957488|474548849|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
131798974|NCT01957488|474548850|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
131798975|NCT01957488|474548851|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
131798976|NCT01957488|474548852|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
131798977|NCT01957488|474548853|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
131636680|NCT04754594|473954602|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
131636681|NCT04754594|473954603|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
131636682|NCT04754594|473954604|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
131636683|NCT04754594|473954605|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
131798978|NCT01957488|474548848|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131636684|NCT04754594|473954602|FG000|Unblinded Period|Withdrawal by Subject|6|||
131636685|NCT04754594|473954603|FG001|Unblinded Period|Withdrawal by Subject|8|||
131798979|NCT01957488|474548849|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131902676|NCT00196105|474929351|FG001|Overall Study|Lost to Follow-up|5|||
131636686|NCT04754594|473954604|FG002|Unblinded Period|Withdrawal by Subject|0|||
131636687|NCT04754594|473954605|FG003|Unblinded Period|Withdrawal by Subject|0|||
131902677|NCT00196105|474929352|FG002|Overall Study|Lost to Follow-up|7|||
131636688|NCT04754594|473954602|FG000|Unblinded Period|Lost to Follow-up|5|||
131714187|NCT00001337|474231121|FG000|Overall Study|Lost to further follow-up|10|||
131714188|NCT00001337|474231122|FG001|Overall Study|Lost to further follow-up|6|||
131714189|NCT00001337|474231123|FG002|Overall Study|Lost to further follow-up|0|||
131714190|NCT00001337|474231121|FG000|Overall Study|2nd malignancy|1|||
131714191|NCT00001337|474231122|FG001|Overall Study|2nd malignancy|0|||
131714192|NCT00001337|474231123|FG002|Overall Study|2nd malignancy|0|||
131714193|NCT00001337|474231121|FG000|Overall Study|Treatment for second lymphoma|0|||
131714194|NCT00001337|474231122|FG001|Overall Study|Treatment for second lymphoma|1|||
131714195|NCT00001337|474231123|FG002|Overall Study|Treatment for second lymphoma|0|||
131714196|NCT00001337|474231121|FG000|Overall Study|Transfer to transplant|0|||
131714197|NCT00001337|474231122|FG001|Overall Study|Transfer to transplant|1|||
131714198|NCT00001337|474231123|FG002|Overall Study|Transfer to transplant|0|||
131714199|NCT05817045|474231126|FG000|Overall Study|Protocol Violation|0|||
131714200|NCT05817045|474231127|FG001|Overall Study|Protocol Violation|3|||
131714201|NCT05817045|474231126|FG000|Overall Study|Withdrawal by Subject|10|||
131714202|NCT05817045|474231127|FG001|Overall Study|Withdrawal by Subject|7|||
131714203|NCT05817045|474231126|FG000|Overall Study|Physician Decision|3|||
131714204|NCT05817045|474231127|FG001|Overall Study|Physician Decision|0|||
131714205|NCT05817045|474231126|FG000|Overall Study|Lost to Follow-up|0|||
131714206|NCT05817045|474231127|FG001|Overall Study|Lost to Follow-up|1|||
131714207|NCT05817045|474231126|FG000|Overall Study|Device Deficiency|1|||
131714208|NCT05817045|474231127|FG001|Overall Study|Device Deficiency|0|||
131714209|NCT05817045|474231126|FG000|Overall Study|System Error|1|||
131714210|NCT05817045|474231127|FG001|Overall Study|System Error|0|||
131714211|NCT05590377|474231134|FG000|Overall Study|Death|1|||
131714212|NCT05590377|474231135|FG001|Overall Study|Death|1|||
131714213|NCT05590377|474231136|FG002|Overall Study|Death|2|||
131714214|NCT05590377|474231137|FG003|Overall Study|Death|0|||
131714215|NCT05590377|474231138|FG004|Overall Study|Death|0|||
131714216|NCT05590377|474231134|FG000|Overall Study|Study Terminated by Sponsor|1|||
131714217|NCT05590377|474231135|FG001|Overall Study|Study Terminated by Sponsor|5|||
131714218|NCT05590377|474231136|FG002|Overall Study|Study Terminated by Sponsor|4|||
131714219|NCT05590377|474231137|FG003|Overall Study|Study Terminated by Sponsor|0|||
131714220|NCT05590377|474231138|FG004|Overall Study|Study Terminated by Sponsor|0|||
131714221|NCT05590377|474231134|FG000|Overall Study|Withdrawal by Subject|1|||
131714222|NCT05590377|474231135|FG001|Overall Study|Withdrawal by Subject|0|||
131714223|NCT05590377|474231136|FG002|Overall Study|Withdrawal by Subject|0|||
131714224|NCT05590377|474231137|FG003|Overall Study|Withdrawal by Subject|0|||
131714225|NCT05590377|474231138|FG004|Overall Study|Withdrawal by Subject|0|||
131714226|NCT02688647|474231139|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
131714227|NCT02688647|474231140|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
131714228|NCT02688647|474231139|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
131714229|NCT02688647|474231140|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
131714230|NCT02688647|474231139|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
131714231|NCT02688647|474231140|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
131714232|NCT02688647|474231139|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
131714233|NCT02688647|474231140|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
131714234|NCT02688647|474231139|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
131714235|NCT02688647|474231140|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
131714236|NCT02688647|474231139|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
131714237|NCT02688647|474231140|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
131714238|NCT02688647|474231139|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
131714239|NCT02688647|474231140|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
131714240|NCT00382967|474231141|FG000|Overall Study|Protocol Violation|1|||
131902678|NCT04863872|474929353|FG000|Overall Study|Withdrawal by Subject|4|||
131902679|NCT04863872|474929354|FG001|Overall Study|Withdrawal by Subject|15|||
131902680|NCT04863872|474929353|FG000|Overall Study|Death|5|||
131902681|NCT04863872|474929354|FG001|Overall Study|Death|2|||
131902682|NCT04863872|474929353|FG000|Overall Study|Lost to Follow-up|2|||
131902683|NCT04863872|474929354|FG001|Overall Study|Lost to Follow-up|1|||
131902684|NCT04058028|474929355|FG000|Overall Study|Withdrawal of Consent from Study|12|||
131714241|NCT00382967|474231142|FG001|Overall Study|Protocol Violation|1|||
131714242|NCT00828464|474231143|FG000|Overall Study|Withdrawal by Subject|1|||
131714243|NCT00474240|474231147|FG000|Overall Study|Withdrawal by Subject|1|||
131714244|NCT00474240|474231148|FG001|Overall Study|Withdrawal by Subject|1|||
131714245|NCT00474240|474231149|FG002|Overall Study|Withdrawal by Subject|0|||
131714246|NCT00474240|474231150|FG003|Overall Study|Withdrawal by Subject|2|||
131714247|NCT00474240|474231151|FG004|Overall Study|Withdrawal by Subject|3|||
131714248|NCT00474240|474231152|FG005|Overall Study|Withdrawal by Subject|1|||
131902685|NCT04058028|474929356|FG001|Overall Study|Withdrawal of Consent from Study|8|||
131798980|NCT01957488|474548850|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131798981|NCT01957488|474548851|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131798982|NCT01957488|474548852|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131798983|NCT01957488|474548853|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
131798984|NCT01957488|474548848|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
131798985|NCT01957488|474548849|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131798986|NCT01957488|474548850|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131798987|NCT01957488|474548851|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131636689|NCT04754594|473954603|FG001|Unblinded Period|Lost to Follow-up|3|||
131636690|NCT04754594|473954604|FG002|Unblinded Period|Lost to Follow-up|0|||
131636691|NCT04754594|473954605|FG003|Unblinded Period|Lost to Follow-up|0|||
131636692|NCT04754594|473954602|FG000|Unblinded Period|Protocol Violation|2|||
131636693|NCT04754594|473954603|FG001|Unblinded Period|Protocol Violation|4|||
131636694|NCT04754594|473954604|FG002|Unblinded Period|Protocol Violation|0|||
131636695|NCT04754594|473954605|FG003|Unblinded Period|Protocol Violation|0|||
131636696|NCT04754594|473954602|FG000|Unblinded Period|Other|3|||
131636697|NCT04754594|473954603|FG001|Unblinded Period|Other|0|||
131636698|NCT04754594|473954604|FG002|Unblinded Period|Other|0|||
131636699|NCT04754594|473954605|FG003|Unblinded Period|Other|0|||
131636700|NCT04754594|473954602|FG000|Infant Participants|Withdrawal by Subject|0|||
131636701|NCT04754594|473954603|FG001|Infant Participants|Withdrawal by Subject|0|||
131636702|NCT04754594|473954604|FG002|Infant Participants|Withdrawal by Subject|9|||
131636703|NCT04754594|473954605|FG003|Infant Participants|Withdrawal by Subject|17|||
131636704|NCT04754594|473954602|FG000|Infant Participants|Lost to Follow-up|0|||
131636705|NCT04754594|473954603|FG001|Infant Participants|Lost to Follow-up|0|||
131636706|NCT04754594|473954604|FG002|Infant Participants|Lost to Follow-up|4|||
131636707|NCT04754594|473954605|FG003|Infant Participants|Lost to Follow-up|10|||
131636708|NCT04754594|473954602|FG000|Infant Participants|Death|0|||
131636709|NCT04754594|473954603|FG001|Infant Participants|Death|0|||
131636710|NCT04754594|473954604|FG002|Infant Participants|Death|1|||
131636711|NCT04754594|473954605|FG003|Infant Participants|Death|1|||
131636712|NCT04754594|473954602|FG000|Infant Participants|Other|0|||
131798988|NCT01957488|474548852|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131798989|NCT01957488|474548853|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131798990|NCT01957488|474548848|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131798991|NCT01957488|474548849|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
131798992|NCT01957488|474548850|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131798993|NCT01957488|474548851|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131798994|NCT01957488|474548852|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131798995|NCT01957488|474548853|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131798996|NCT00721409|474548855|FG000|Overall Study|Global deterioration of health status|2|||
131798997|NCT00721409|474548856|FG001|Overall Study|Global deterioration of health status|6|||
131798998|NCT00721409|474548857|FG002|Overall Study|Global deterioration of health status|3|||
131798999|NCT00721409|474548855|FG000|Overall Study|Death|0|||
131799000|NCT00721409|474548856|FG001|Overall Study|Death|1|||
131799001|NCT00721409|474548857|FG002|Overall Study|Death|0|||
131799002|NCT00721409|474548855|FG000|Overall Study|Randomized not Treated|0|||
131799003|NCT00721409|474548856|FG001|Overall Study|Randomized not Treated|1|||
131799004|NCT00721409|474548857|FG002|Overall Study|Randomized not Treated|4|||
131799005|NCT00721409|474548855|FG000|Overall Study|Reason not specified|1|||
131799006|NCT00721409|474548856|FG001|Overall Study|Reason not specified|0|||
131799007|NCT00721409|474548857|FG002|Overall Study|Reason not specified|2|||
131799008|NCT00721409|474548855|FG000|Overall Study|Adverse Event|0|||
131799009|NCT00721409|474548856|FG001|Overall Study|Adverse Event|13|||
131445093|NCT04672239|473258830|FG000|Week 2 Survey|Lost to Follow-up|3|||
131636713|NCT04754594|473954603|FG001|Infant Participants|Other|0|||
131636714|NCT04754594|473954604|FG002|Infant Participants|Other|1|||
131636715|NCT04754594|473954605|FG003|Infant Participants|Other|1|||
131636716|NCT03340766|473954608|FG000|Overall Study|Withdrawal by Subject|2|||
131636717|NCT03340766|473954609|FG001|Overall Study|Withdrawal by Subject|1|||
131636718|NCT03340766|473954610|FG002|Overall Study|Withdrawal by Subject|3|||
131636719|NCT03340766|473954608|FG000|Overall Study|Lost to Follow-up|0|||
131636720|NCT03340766|473954609|FG001|Overall Study|Lost to Follow-up|0|||
131636721|NCT03340766|473954610|FG002|Overall Study|Lost to Follow-up|1|||
131636722|NCT03340766|473954608|FG000|Overall Study|Death|6|||
131636723|NCT03340766|473954609|FG001|Overall Study|Death|7|||
131636724|NCT03340766|473954610|FG002|Overall Study|Death|4|||
131636725|NCT02256488|473954611|FG000|Overall Study|Lost to Follow-up|6|||
131799010|NCT00721409|474548857|FG002|Overall Study|Adverse Event|2|||
131799011|NCT00721409|474548855|FG000|Overall Study|Lost to Follow-up|0|||
131902686|NCT04058028|474929357|FG002|Overall Study|Withdrawal of Consent from Study|6|||
131636726|NCT02256488|473954612|FG001|Overall Study|Lost to Follow-up|6|||
131636727|NCT02256488|473954613|FG002|Overall Study|Lost to Follow-up|9|||
131636728|NCT02256488|473954614|FG003|Overall Study|Lost to Follow-up|3|||
131636729|NCT02256488|473954611|FG000|Overall Study|OTHER|1|||
131636730|NCT02256488|473954612|FG001|Overall Study|OTHER|0|||
131636731|NCT02256488|473954613|FG002|Overall Study|OTHER|1|||
131799012|NCT00721409|474548856|FG001|Overall Study|Lost to Follow-up|0|||
131799013|NCT00721409|474548857|FG002|Overall Study|Lost to Follow-up|1|||
131799014|NCT00721409|474548855|FG000|Overall Study|Withdrawal by Subject|1|||
131799015|NCT00721409|474548856|FG001|Overall Study|Withdrawal by Subject|6|||
131799016|NCT00721409|474548857|FG002|Overall Study|Withdrawal by Subject|5|||
131636732|NCT02256488|473954614|FG003|Overall Study|OTHER|1|||
131636733|NCT02256488|473954611|FG000|Overall Study|Withdrawal by Subject|1|||
131636734|NCT02256488|473954612|FG001|Overall Study|Withdrawal by Subject|0|||
131636735|NCT02256488|473954613|FG002|Overall Study|Withdrawal by Subject|0|||
131636736|NCT02256488|473954614|FG003|Overall Study|Withdrawal by Subject|2|||
131636737|NCT00240097|473954618|FG000|Part I|Adverse Event|1|||
131636738|NCT00240097|473954618|FG000|Part I|Death|1|||
131636739|NCT00240097|473954618|FG000|Part I|histology|1|||
131636740|NCT00240097|473954618|FG000|Part I|unevaluable|1|||
131636741|NCT00240097|473954618|FG000|Part II|did not continue from Part I|23|||
131636742|NCT00818519|473954619|FG000|Overall Study|Adverse Event|2|||
131636743|NCT00818519|473954620|FG001|Overall Study|Adverse Event|2|||
131636744|NCT00818519|473954619|FG000|Overall Study|Lost to Follow-up|4|||
131636745|NCT00818519|473954620|FG001|Overall Study|Lost to Follow-up|6|||
131636746|NCT00818519|473954619|FG000|Overall Study|Protocol Violation|2|||
131636747|NCT00818519|473954620|FG001|Overall Study|Protocol Violation|1|||
131636748|NCT00818519|473954619|FG000|Overall Study|Pregnancy|0|||
131636749|NCT00818519|473954620|FG001|Overall Study|Pregnancy|1|||
131636750|NCT00818519|473954619|FG000|Overall Study|Withdrawal by Subject|4|||
131636751|NCT00818519|473954620|FG001|Overall Study|Withdrawal by Subject|9|||
131636752|NCT00818519|473954619|FG000|Overall Study|participant recovered completely|1|||
131636753|NCT00818519|473954620|FG001|Overall Study|participant recovered completely|0|||
131636754|NCT00818519|473954619|FG000|Overall Study|participant will leave for long tme|1|||
131636755|NCT00818519|473954620|FG001|Overall Study|participant will leave for long tme|0|||
131636756|NCT02965599|473954621|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
131636757|NCT02965599|473954622|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
131636758|NCT02093897|473956212|FG000|Overall Study|Physician Decision|1|||
131636759|NCT02093897|473956212|FG000|Overall Study|Planned age group closure - no's reached|17|||
131636760|NCT02093897|473956212|FG000|Overall Study|Adverse event, non-fatal|1|||
131636761|NCT03098797|473956213|FG000|Part 2 Open Label Extension|Adverse Event|2|||
131636762|NCT03098797|473956214|FG001|Part 2 Open Label Extension|Adverse Event|0|||
131636763|NCT02956278|473956215|FG000|Overall Study|Withdrawal by Subject|6|||
131636764|NCT02956278|473956216|FG001|Overall Study|Withdrawal by Subject|2|||
131636765|NCT02956278|473956217|FG002|Overall Study|Withdrawal by Subject|0|||
131636766|NCT01967719|473956218|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
131636767|NCT01967719|473956219|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
131636768|NCT01967719|473956220|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131636769|NCT01967719|473956221|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
131636770|NCT01967719|473956218|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
131636771|NCT01967719|473956219|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
131636772|NCT01967719|473956220|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
131636773|NCT01967719|473956221|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
131636774|NCT00796614|473956231|FG000|Overall Study|Adverse Event|1|||
131636775|NCT00796614|473956232|FG001|Overall Study|Adverse Event|2|||
131636776|NCT00796614|473956233|FG002|Overall Study|Adverse Event|0|||
131636777|NCT00796614|473956234|FG003|Overall Study|Adverse Event|0|||
131636778|NCT00796614|473956231|FG000|Overall Study|Protocol Violation|0|||
131636779|NCT00796614|473956232|FG001|Overall Study|Protocol Violation|0|||
131636780|NCT00796614|473956233|FG002|Overall Study|Protocol Violation|2|||
131636781|NCT00796614|473956234|FG003|Overall Study|Protocol Violation|0|||
131636782|NCT00796614|473956231|FG000|Overall Study|Lost to Follow-up|2|||
131636783|NCT00796614|473956232|FG001|Overall Study|Lost to Follow-up|2|||
131636784|NCT00796614|473956233|FG002|Overall Study|Lost to Follow-up|1|||
131636785|NCT00796614|473956234|FG003|Overall Study|Lost to Follow-up|0|||
131636786|NCT00796614|473956231|FG000|Overall Study|Withdrawal by Subject|1|||
131636787|NCT00796614|473956232|FG001|Overall Study|Withdrawal by Subject|0|||
131636788|NCT00796614|473956233|FG002|Overall Study|Withdrawal by Subject|0|||
131636789|NCT00796614|473956234|FG003|Overall Study|Withdrawal by Subject|1|||
131636790|NCT00796614|473956231|FG000|Overall Study|Other than stated|1|||
131636791|NCT00796614|473956232|FG001|Overall Study|Other than stated|0|||
131636792|NCT00796614|473956233|FG002|Overall Study|Other than stated|0|||
131799017|NCT00721409|474548855|FG000|Overall Study|Objective progression or relapse|8|||
131636793|NCT00796614|473956234|FG003|Overall Study|Other than stated|0|||
131636794|NCT00509821|473956235|FG000|Study Period 1 (Induction)|Death|0|||
131636795|NCT00509821|473956236|FG001|Study Period 1 (Induction)|Death|1|||
131636796|NCT00509821|473956235|FG000|Study Period 1 (Induction)|Adverse Event|0|||
131636797|NCT00509821|473956236|FG001|Study Period 1 (Induction)|Adverse Event|2|||
131636798|NCT00509821|473956235|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
131636799|NCT00509821|473956236|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
131636800|NCT02720185|473956238|FG000|Overall Study|Lost to Follow-up|1|||
131636801|NCT01231464|473956239|FG000|Overall Study|Adverse Event|0|||
131636802|NCT01231464|473956240|FG001|Overall Study|Adverse Event|1|||
131636803|NCT01231464|473956239|FG000|Overall Study|Protocol Violation|1|||
131636804|NCT01231464|473956240|FG001|Overall Study|Protocol Violation|2|||
131636805|NCT01231464|473956239|FG000|Overall Study|Lost to Follow-up|1|||
131636806|NCT01231464|473956240|FG001|Overall Study|Lost to Follow-up|2|||
131636807|NCT01231464|473956239|FG000|Overall Study|Withdrawal by Subject|3|||
131636808|NCT01231464|473956240|FG001|Overall Study|Withdrawal by Subject|2|||
131636809|NCT03449134|473956241|FG000|52-Week Treatment Period|Death|2|||
131636810|NCT03449134|473956242|FG001|52-Week Treatment Period|Death|1|||
131636811|NCT03449134|473956243|FG002|52-Week Treatment Period|Death|0|||
131636812|NCT03449134|473956241|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
131636813|NCT03449134|473956242|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
131636814|NCT03449134|473956243|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
131636815|NCT03449134|473956241|FG000|52-Week Treatment Period|Physician Decision|2|||
131636816|NCT03449134|473956242|FG001|52-Week Treatment Period|Physician Decision|3|||
131636817|NCT03449134|473956243|FG002|52-Week Treatment Period|Physician Decision|3|||
131636818|NCT03449134|473956241|FG000|52-Week Treatment Period|Screen Failure|1|||
131636819|NCT03449134|473956242|FG001|52-Week Treatment Period|Screen Failure|0|||
131636820|NCT03449134|473956243|FG002|52-Week Treatment Period|Screen Failure|1|||
131636821|NCT03449134|473956241|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
131636822|NCT03449134|473956242|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
131636823|NCT03449134|473956243|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
131636824|NCT03449134|473956241|FG000|52-Week Treatment Period|Site Closure|1|||
131636825|NCT03449134|473956242|FG001|52-Week Treatment Period|Site Closure|0|||
131636826|NCT03449134|473956243|FG002|52-Week Treatment Period|Site Closure|0|||
131636827|NCT00957996|473956249|FG000|Overall Study|Death|4|||
131636828|NCT00957996|473956250|FG001|Overall Study|Death|10|||
131636829|NCT00957996|473956249|FG000|Overall Study|Lost to Follow-up|4|||
131636830|NCT00957996|473956250|FG001|Overall Study|Lost to Follow-up|7|||
131636831|NCT00957996|473956249|FG000|Overall Study|Withdrawal by Subject|9|||
131636832|NCT00957996|473956250|FG001|Overall Study|Withdrawal by Subject|2|||
131636833|NCT00957996|473956249|FG000|Overall Study|Adverse Event|2|||
131636834|NCT00957996|473956250|FG001|Overall Study|Adverse Event|1|||
131636835|NCT00957996|473956249|FG000|Overall Study|Physician Decision|1|||
131636836|NCT00957996|473956250|FG001|Overall Study|Physician Decision|1|||
131636837|NCT00957996|473956249|FG000|Overall Study|Influenza-related complication|0|||
131636838|NCT00957996|473956250|FG001|Overall Study|Influenza-related complication|1|||
131636839|NCT00957996|473956249|FG000|Overall Study|Missing|1|||
131799018|NCT00721409|474548856|FG001|Overall Study|Objective progression or relapse|55|||
131799019|NCT00721409|474548857|FG002|Overall Study|Objective progression or relapse|62|||
131799020|NCT02402166|474548858|FG000|Overall Study|Adverse Event|2|||
131799021|NCT02402166|474548858|FG000|Overall Study|Withdrawal by Subject|2|||
131799022|NCT02402166|474548858|FG000|Overall Study|Lost to Follow-up|1|||
131799023|NCT01439165|474548859|FG000|Overall Study|Protocol Violation|3|||
131799024|NCT01439165|474548860|FG001|Overall Study|Protocol Violation|0|||
131799025|NCT01439165|474548859|FG000|Overall Study|Lost to Follow-up|11|||
131799026|NCT01439165|474548860|FG001|Overall Study|Lost to Follow-up|1|||
131799027|NCT01439165|474548859|FG000|Overall Study|Withdrawal by Subject|7|||
131799028|NCT01439165|474548860|FG001|Overall Study|Withdrawal by Subject|1|||
131799029|NCT00810368|474548864|FG000|Overall Study|Lost to Follow-up|4|||
131799030|NCT00810368|474548865|FG001|Overall Study|Lost to Follow-up|2|||
131799031|NCT00810368|474548864|FG000|Overall Study|Lack of Efficacy|2|||
131799032|NCT00810368|474548865|FG001|Overall Study|Lack of Efficacy|0|||
131799033|NCT02428699|474548867|FG000|Washout Period 1|Screen Failure|1|||
131799034|NCT02428699|474548868|FG001|Washout Period 1|Screen Failure|2|||
131799035|NCT02433678|474548869|FG000|Overall Study|Lost to Follow-up|1|||
131799036|NCT02433678|474548870|FG001|Overall Study|Lost to Follow-up|2|||
131799037|NCT00995410|474548878|FG000|Overall Study|Adverse Event|51|||
131799038|NCT00995410|474548878|FG000|Overall Study|Withdrawal by Subject|7|||
131799039|NCT00995410|474548878|FG000|Overall Study|Lost to Follow-up|2|||
131799040|NCT00995410|474548878|FG000|Overall Study|Misc|28|||
131799041|NCT02483975|474548879|FG000|Overall Study|Adverse Event|0|||
131799042|NCT02483975|474548880|FG001|Overall Study|Adverse Event|1|||
131799043|NCT02483975|474548879|FG000|Overall Study|Lost to Follow-up|0|||
131799044|NCT02483975|474548880|FG001|Overall Study|Lost to Follow-up|1|||
131799045|NCT02483975|474548879|FG000|Overall Study|Physician Decision|2|||
131799046|NCT02483975|474548880|FG001|Overall Study|Physician Decision|0|||
131799047|NCT03365375|474548881|FG000|Overall Study|Withdrawal by Subject|0|||
131799048|NCT03365375|474548882|FG001|Overall Study|Withdrawal by Subject|1|||
131636840|NCT00957996|473956250|FG001|Overall Study|Missing|0|||
131636841|NCT00957996|473956249|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
131636842|NCT00957996|473956250|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
131636843|NCT01960348|473956255|FG000|Overall Study|Adverse event, not serious|2|||
131636844|NCT01960348|473956256|FG001|Overall Study|Adverse event, not serious|2|||
131799049|NCT03365375|474548881|FG000|Overall Study|Lost to Follow-up|0|||
131799050|NCT03365375|474548882|FG001|Overall Study|Lost to Follow-up|4|||
131445094|NCT04672239|473258831|FG001|Week 2 Survey|Lost to Follow-up|2|||
131636845|NCT01960348|473956255|FG000|Overall Study|Adverse event, serious fatal|6|||
131636846|NCT01960348|473956256|FG001|Overall Study|Adverse event, serious fatal|5|||
131636847|NCT01960348|473956255|FG000|Overall Study|Adverse event, serious non-fatal|0|||
131636848|NCT01960348|473956256|FG001|Overall Study|Adverse event, serious non-fatal|3|||
131636849|NCT01960348|473956255|FG000|Overall Study|Withdrawal by Subject|1|||
131636850|NCT01960348|473956256|FG001|Overall Study|Withdrawal by Subject|11|||
131636851|NCT01960348|473956255|FG000|Overall Study|Physician Decision|0|||
131636852|NCT01960348|473956256|FG001|Overall Study|Physician Decision|1|||
131636853|NCT01960348|473956255|FG000|Overall Study|Protocol Violation|1|||
131636854|NCT01960348|473956256|FG001|Overall Study|Protocol Violation|0|||
131636855|NCT01194271|473956257|FG000|Overall Study|Withdrawal by Subject|1|||
131636856|NCT01194271|473956257|FG000|Overall Study|Ineligible, Screen Failure|1|||
131636857|NCT01194271|473956257|FG000|Overall Study|Death|1|||
131636858|NCT01983462|473956258|FG000|Overall Study|Adverse Event|1|||
131636859|NCT01983462|473956259|FG001|Overall Study|Adverse Event|0|||
131636860|NCT01983462|473956260|FG002|Overall Study|Adverse Event|0|||
131636861|NCT00443898|473956261|FG000|Overall Study|Adverse Event|0|||
131636862|NCT00443898|473956262|FG001|Overall Study|Adverse Event|0|||
131636863|NCT00443898|473956263|FG002|Overall Study|Adverse Event|1|||
131636864|NCT00443898|473956264|FG003|Overall Study|Adverse Event|1|||
131636865|NCT00443898|473956261|FG000|Overall Study|Lack of Efficacy|2|||
131636866|NCT00443898|473956262|FG001|Overall Study|Lack of Efficacy|3|||
131636867|NCT00443898|473956263|FG002|Overall Study|Lack of Efficacy|3|||
131636868|NCT00443898|473956264|FG003|Overall Study|Lack of Efficacy|1|||
131636869|NCT00443898|473956261|FG000|Overall Study|Protocol Violation|1|||
131636870|NCT00443898|473956262|FG001|Overall Study|Protocol Violation|1|||
131636871|NCT00443898|473956263|FG002|Overall Study|Protocol Violation|1|||
131636872|NCT00443898|473956264|FG003|Overall Study|Protocol Violation|0|||
131636873|NCT00443898|473956261|FG000|Overall Study|Withdrawal by Subject|11|||
131636874|NCT00443898|473956262|FG001|Overall Study|Withdrawal by Subject|10|||
131636875|NCT00443898|473956263|FG002|Overall Study|Withdrawal by Subject|10|||
131636876|NCT00443898|473956264|FG003|Overall Study|Withdrawal by Subject|6|||
131636877|NCT00443898|473956261|FG000|Overall Study|Lost to Follow-up|10|||
131636878|NCT00443898|473956262|FG001|Overall Study|Lost to Follow-up|10|||
131636879|NCT00443898|473956263|FG002|Overall Study|Lost to Follow-up|14|||
131636880|NCT00443898|473956264|FG003|Overall Study|Lost to Follow-up|10|||
131636881|NCT00443898|473956261|FG000|Overall Study|Death|0|||
131636882|NCT00443898|473956262|FG001|Overall Study|Death|1|||
131636883|NCT00443898|473956263|FG002|Overall Study|Death|0|||
131636884|NCT00443898|473956264|FG003|Overall Study|Death|0|||
131636885|NCT02151643|473956265|FG000|Overall Study|Adverse Event|2|||
131636886|NCT02151643|473956266|FG001|Overall Study|Adverse Event|0|||
131636887|NCT02151643|473956267|FG002|Overall Study|Adverse Event|1|||
131636888|NCT02151643|473956268|FG003|Overall Study|Adverse Event|4|||
131636889|NCT02151643|473956269|FG004|Overall Study|Adverse Event|0|||
131636890|NCT02151643|473956265|FG000|Overall Study|Withdrawal by Subject|0|||
131636891|NCT02151643|473956266|FG001|Overall Study|Withdrawal by Subject|1|||
131636892|NCT02151643|473956267|FG002|Overall Study|Withdrawal by Subject|1|||
131636893|NCT02151643|473956268|FG003|Overall Study|Withdrawal by Subject|1|||
131636894|NCT02151643|473956269|FG004|Overall Study|Withdrawal by Subject|1|||
131636895|NCT02151643|473956265|FG000|Overall Study|Hyperphosphataemia|1|||
131636896|NCT02151643|473956266|FG001|Overall Study|Hyperphosphataemia|0|||
131636897|NCT02151643|473956267|FG002|Overall Study|Hyperphosphataemia|0|||
131636898|NCT02151643|473956268|FG003|Overall Study|Hyperphosphataemia|0|||
131636899|NCT02151643|473956269|FG004|Overall Study|Hyperphosphataemia|1|||
131636900|NCT02151643|473956265|FG000|Overall Study|High Ferritin levels|3|||
131636901|NCT02151643|473956266|FG001|Overall Study|High Ferritin levels|3|||
131636902|NCT02151643|473956267|FG002|Overall Study|High Ferritin levels|2|||
131636903|NCT02151643|473956268|FG003|Overall Study|High Ferritin levels|2|||
131636904|NCT02151643|473956269|FG004|Overall Study|High Ferritin levels|1|||
131636905|NCT00508274|473956272|FG000|Overall Study|Adverse Event|5|||
131636906|NCT00508274|473956272|FG000|Overall Study|Death|7|||
131636907|NCT00508274|473956272|FG000|Overall Study|Disease progression|32|||
131636908|NCT00508274|473956272|FG000|Overall Study|Withdrawal by Subject|1|||
131636909|NCT00508274|473956272|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
131636910|NCT00508274|473956272|FG000|Overall Study|Missing|3|||
131636911|NCT03296566|473956273|FG000|Overall Study|Lost to Follow-up|19|||
131636912|NCT03296566|473956274|FG001|Overall Study|Lost to Follow-up|46|||
131636913|NCT03296566|473956273|FG000|Overall Study|Withdrawal by Subject|0|||
131636914|NCT03296566|473956274|FG001|Overall Study|Withdrawal by Subject|3|||
131636915|NCT00197106|473956275|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
131636916|NCT00197106|473956276|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
131636917|NCT00197106|473956277|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
131636918|NCT00197106|473956275|FG000|Overall Treatment Period|Lack of Efficacy|0|||
131636919|NCT00197106|473956276|FG001|Overall Treatment Period|Lack of Efficacy|1|||
131636920|NCT00197106|473956277|FG002|Overall Treatment Period|Lack of Efficacy|0|||
131636921|NCT00197106|473956275|FG000|Overall Treatment Period|Lost to Follow-up|0|||
131636922|NCT00197106|473956276|FG001|Overall Treatment Period|Lost to Follow-up|0|||
131636923|NCT00197106|473956277|FG002|Overall Treatment Period|Lost to Follow-up|2|||
131636924|NCT00197106|473956275|FG000|Overall Treatment Period|Protocol Violation|0|||
131636925|NCT00197106|473956276|FG001|Overall Treatment Period|Protocol Violation|0|||
131636926|NCT00197106|473956277|FG002|Overall Treatment Period|Protocol Violation|2|||
131636927|NCT00197106|473956275|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
131636928|NCT00197106|473956276|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
131636929|NCT00197106|473956277|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
131636930|NCT01084239|473956284|FG000|28-Day Follow-up|Lost to Follow-up|4|||
131636931|NCT01084239|473956285|FG001|28-Day Follow-up|Lost to Follow-up|9|||
131636932|NCT02679079|473956287|FG000|Overall Study|Adverse Event|2|||
131636933|NCT02679079|473956288|FG001|Overall Study|Adverse Event|0|||
131636934|NCT02679079|473956289|FG002|Overall Study|Adverse Event|2|||
131636935|NCT02679079|473956287|FG000|Overall Study|Protocol Violation|0|||
131636936|NCT02679079|473956288|FG001|Overall Study|Protocol Violation|1|||
131636937|NCT02679079|473956289|FG002|Overall Study|Protocol Violation|0|||
131636938|NCT02679079|473956287|FG000|Overall Study|Withdrawal by Subject|2|||
131636939|NCT02679079|473956288|FG001|Overall Study|Withdrawal by Subject|1|||
131636940|NCT02679079|473956289|FG002|Overall Study|Withdrawal by Subject|0|||
131636941|NCT00520403|473956290|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
131636942|NCT00520403|473956290|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
131799051|NCT01505530|474548883|FG000|Overall Study|Progressive Disease|19|||
131636943|NCT00520403|473956290|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
131636944|NCT00520403|473956290|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
131636945|NCT00520403|473956290|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
131636946|NCT00520403|473956290|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
131799052|NCT01505530|474548884|FG001|Overall Study|Progressive Disease|17|||
131636947|NCT00520403|473956290|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
131636948|NCT00520403|473956290|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
131636949|NCT02435381|473956291|FG000|Overall Study|Lost to Follow-up|2|||
131636950|NCT02435381|473956292|FG001|Overall Study|Lost to Follow-up|1|||
131636951|NCT03924947|473956293|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131636952|NCT03924947|473956294|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131636953|NCT03924947|473956295|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
131636954|NCT03924947|473956296|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131636955|NCT03924947|473956297|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131636956|NCT03924947|473956298|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131636957|NCT00833898|473956306|FG000|Overall Study|Withdrawal by Subject|33|||
131799053|NCT01505530|474548885|FG002|Overall Study|Progressive Disease|18|||
131799054|NCT01505530|474548883|FG000|Overall Study|Adverse Event|1|||
131799055|NCT01505530|474548884|FG001|Overall Study|Adverse Event|1|||
131799056|NCT01505530|474548885|FG002|Overall Study|Adverse Event|0|||
131799057|NCT01505530|474548883|FG000|Overall Study|Withdrawal by Subject|7|||
131799058|NCT01505530|474548884|FG001|Overall Study|Withdrawal by Subject|8|||
131799059|NCT01505530|474548885|FG002|Overall Study|Withdrawal by Subject|6|||
131799060|NCT01505530|474548883|FG000|Overall Study|Physician Decision|6|||
131799061|NCT01505530|474548884|FG001|Overall Study|Physician Decision|2|||
131799062|NCT01505530|474548885|FG002|Overall Study|Physician Decision|5|||
131799063|NCT01505530|474548883|FG000|Overall Study|Sponsor Decision|1|||
131799064|NCT01505530|474548884|FG001|Overall Study|Sponsor Decision|8|||
131799065|NCT01505530|474548885|FG002|Overall Study|Sponsor Decision|7|||
131799066|NCT01505530|474548883|FG000|Overall Study|Death|7|||
131799067|NCT01505530|474548884|FG001|Overall Study|Death|6|||
131799068|NCT01505530|474548885|FG002|Overall Study|Death|5|||
131636958|NCT00833898|473956307|FG001|Overall Study|Withdrawal by Subject|27|||
131636959|NCT00833898|473956306|FG000|Overall Study|Lost to Follow-up|7|||
131799069|NCT01505530|474548883|FG000|Overall Study|entry criteria not met|0|||
131799070|NCT01505530|474548884|FG001|Overall Study|entry criteria not met|1|||
131799071|NCT01505530|474548885|FG002|Overall Study|entry criteria not met|0|||
131636960|NCT00833898|473956307|FG001|Overall Study|Lost to Follow-up|7|||
131799072|NCT01966042|474548889|FG000|Overall Study|Death|2|||
131799073|NCT02752776|474548890|FG000|Overall Study|Adverse Event|15|||
131636961|NCT00833898|473956306|FG000|Overall Study|Patient did not receive transplant|0|||
131636962|NCT00833898|473956307|FG001|Overall Study|Patient did not receive transplant|2|||
131636963|NCT00805285|473956308|FG000|Overall Study|Lack of Efficacy|1|||
131799074|NCT02752776|474548891|FG001|Overall Study|Adverse Event|23|||
131799075|NCT02752776|474548892|FG002|Overall Study|Adverse Event|11|||
131799076|NCT02752776|474548890|FG000|Overall Study|Lack of Efficacy|2|||
131799077|NCT02752776|474548891|FG001|Overall Study|Lack of Efficacy|6|||
131799078|NCT02752776|474548892|FG002|Overall Study|Lack of Efficacy|14|||
131636964|NCT00917462|473956309|FG000|Overall Study|Clinical Deterioration|1|||
131636965|NCT01402063|473956310|FG000|Overall Study|Withdrawal by Subject|3|||
131636966|NCT01402063|473956311|FG001|Overall Study|Withdrawal by Subject|3|||
131636967|NCT03280108|473956312|FG000|Overall Study|Lost to Follow-up|2|||
131636968|NCT03280108|473956313|FG001|Overall Study|Lost to Follow-up|0|||
131636969|NCT02016690|473956315|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
131636970|NCT02016690|473956315|FG000|Overall Study|Excluded from SAS: Duplication|2|||
131636971|NCT02016690|473956315|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
131636972|NCT02016690|473956315|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
131636973|NCT02016690|473956315|FG000|Overall Study|Did not meet inclusion criteria|13|||
131636974|NCT02016690|473956315|FG000|Overall Study|Hospitalized for RSV at study start|3|||
131636975|NCT06016127|473956320|FG000|Overall Study|Withdrawal by Subject|4|||
131636976|NCT06016127|473956321|FG001|Overall Study|Withdrawal by Subject|3|||
131636977|NCT02864147|473956325|FG000|Overall Study|Withdrawal by Subject|3|||
131636978|NCT02864147|473956326|FG001|Overall Study|Withdrawal by Subject|2|||
131636979|NCT02864147|473956327|FG002|Overall Study|Withdrawal by Subject|1|||
131636980|NCT02864147|473956325|FG000|Overall Study|Lost to Follow-up|0|||
131636981|NCT02864147|473956326|FG001|Overall Study|Lost to Follow-up|4|||
131636982|NCT02864147|473956327|FG002|Overall Study|Lost to Follow-up|0|||
131636983|NCT02864147|473956325|FG000|Overall Study|Adverse Event|0|||
131636984|NCT02864147|473956326|FG001|Overall Study|Adverse Event|1|||
131636985|NCT02864147|473956327|FG002|Overall Study|Adverse Event|0|||
131636986|NCT02864147|473956325|FG000|Overall Study|Pregnancy|4|||
131636987|NCT02864147|473956326|FG001|Overall Study|Pregnancy|0|||
131636988|NCT02864147|473956327|FG002|Overall Study|Pregnancy|0|||
131636989|NCT02864147|473956325|FG000|Overall Study|Physician Decision|0|||
131636990|NCT02864147|473956326|FG001|Overall Study|Physician Decision|0|||
131636991|NCT02864147|473956327|FG002|Overall Study|Physician Decision|1|||
131636992|NCT02864147|473956325|FG000|Overall Study|Opted for excisional procedures|0|||
131636993|NCT02864147|473956326|FG001|Overall Study|Opted for excisional procedures|0|||
131636994|NCT02864147|473956327|FG002|Overall Study|Opted for excisional procedures|3|||
131636995|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
131636996|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
131636997|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
131636998|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
131636999|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
131637000|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
131637001|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
131637002|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
131637003|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
131637004|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
131637005|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
131637006|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
131637007|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
131637008|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
131637009|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
131637010|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
131637011|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
131637012|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
131637013|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
131637014|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
131637015|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
131637016|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
131714249|NCT00474240|474231147|FG000|Overall Study|Adverse Event|0|||
131637017|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
131637018|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
131637019|NCT02269917|473956328|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
131637020|NCT02269917|473956329|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
131714250|NCT00474240|474231148|FG001|Overall Study|Adverse Event|0|||
131714251|NCT00474240|474231149|FG002|Overall Study|Adverse Event|9|||
131714252|NCT00474240|474231150|FG003|Overall Study|Adverse Event|14|||
131714253|NCT00474240|474231151|FG004|Overall Study|Adverse Event|5|||
131714254|NCT00474240|474231152|FG005|Overall Study|Adverse Event|16|||
131714255|NCT00474240|474231147|FG000|Overall Study|Removed due to lab value|0|||
131637021|NCT02269917|473956330|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
131637022|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
131637023|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
131637024|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
131637025|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
131714256|NCT00474240|474231148|FG001|Overall Study|Removed due to lab value|0|||
131714257|NCT00474240|474231149|FG002|Overall Study|Removed due to lab value|0|||
131637026|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
131637027|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
131637028|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
131637029|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
131637030|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
131637031|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
131637032|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
131637033|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
131637034|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
131637035|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
131637036|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
131637037|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
131637038|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
131637039|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
131637040|NCT02269917|473956328|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
131637041|NCT02269917|473956329|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
131637042|NCT02269917|473956330|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
131637043|NCT02383927|473956331|FG000|Overall Study|Disease Progression|8|||
131637044|NCT02383927|473956332|FG001|Overall Study|Disease Progression|8|||
131637045|NCT02383927|473956333|FG002|Overall Study|Disease Progression|15|||
131637046|NCT02383927|473956334|FG003|Overall Study|Disease Progression|4|||
131637047|NCT02383927|473956331|FG000|Overall Study|Physician Decision|0|||
131637048|NCT02383927|473956332|FG001|Overall Study|Physician Decision|0|||
131637049|NCT02383927|473956333|FG002|Overall Study|Physician Decision|2|||
131637050|NCT02383927|473956334|FG003|Overall Study|Physician Decision|0|||
131637051|NCT02383927|473956331|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
131637052|NCT02383927|473956332|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
131637053|NCT02383927|473956333|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
131637054|NCT02383927|473956334|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
131637055|NCT02383927|473956331|FG000|Overall Study|Adverse Event|4|||
131637056|NCT02383927|473956332|FG001|Overall Study|Adverse Event|1|||
131637057|NCT02383927|473956333|FG002|Overall Study|Adverse Event|3|||
131637058|NCT02383927|473956334|FG003|Overall Study|Adverse Event|5|||
131637059|NCT02383927|473956331|FG000|Overall Study|Miscellaneous|1|||
131637060|NCT02383927|473956332|FG001|Overall Study|Miscellaneous|0|||
131637061|NCT02383927|473956333|FG002|Overall Study|Miscellaneous|0|||
131637062|NCT02383927|473956334|FG003|Overall Study|Miscellaneous|1|||
131637063|NCT02383927|473956331|FG000|Overall Study|Withdrawal by Subject|0|||
131637064|NCT02383927|473956332|FG001|Overall Study|Withdrawal by Subject|1|||
131637065|NCT02383927|473956333|FG002|Overall Study|Withdrawal by Subject|4|||
131637066|NCT02383927|473956334|FG003|Overall Study|Withdrawal by Subject|0|||
131637067|NCT03613454|473956337|FG000|Overall Study|Protocol Violation|1|||
131637068|NCT03613454|473956338|FG001|Overall Study|Protocol Violation|0|||
131637069|NCT03613454|473956337|FG000|Overall Study|Protocol Violation|0|||
131637070|NCT03613454|473956338|FG001|Overall Study|Protocol Violation|1|||
131637071|NCT03356145|473956339|FG000|Overall Study|Withdrawal by Subject|2|||
131637072|NCT03356145|473956340|FG001|Overall Study|Withdrawal by Subject|1|||
131637073|NCT03356145|473956339|FG000|Overall Study|Did not meet inclusion criteria|1|||
131637074|NCT03356145|473956340|FG001|Overall Study|Did not meet inclusion criteria|0|||
131637075|NCT02963922|473956341|FG000|Overall Study|Adverse Event|15|||
131637076|NCT02963922|473956342|FG001|Overall Study|Adverse Event|6|||
131637077|NCT02963922|473956341|FG000|Overall Study|Protocol deviation|6|||
131637078|NCT02963922|473956342|FG001|Overall Study|Protocol deviation|6|||
131637079|NCT02963922|473956341|FG000|Overall Study|Lack of Efficacy|1|||
131637080|NCT02963922|473956342|FG001|Overall Study|Lack of Efficacy|1|||
131637081|NCT02963922|473956341|FG000|Overall Study|Lost to Follow-up|2|||
131637082|NCT02963922|473956342|FG001|Overall Study|Lost to Follow-up|3|||
131637083|NCT02963922|473956341|FG000|Overall Study|Other|8|||
131637084|NCT02963922|473956342|FG001|Overall Study|Other|14|||
131637085|NCT02040532|473956344|FG000|Overall Study|Lost to Follow-up|1|||
131637086|NCT02040532|473956344|FG000|Overall Study|Physician Decision|4|||
131637087|NCT02040532|473956344|FG000|Overall Study|Adverse Event|4|||
131637088|NCT02040532|473956344|FG000|Overall Study|Withdrawal by Subject|3|||
131637089|NCT03640754|473956349|FG000|Overall Study|Withdrawal by Subject|1|||
131637090|NCT03640754|473956350|FG001|Overall Study|Withdrawal by Subject|0|||
131637091|NCT03640754|473956349|FG000|Overall Study|Lost to Follow-up|0|||
131637092|NCT03640754|473956350|FG001|Overall Study|Lost to Follow-up|1|||
131637093|NCT01679613|473956356|FG000|Overall Study|other than stated above|0|||
131637094|NCT01679613|473956357|FG001|Overall Study|other than stated above|1|||
131637095|NCT01679613|473956358|FG002|Overall Study|other than stated above|2|||
131637096|NCT01679613|473956359|FG003|Overall Study|other than stated above|2|||
131637097|NCT03169530|473956360|FG000|Overall Study|Study ended by NIH|15|||
131637098|NCT03169530|473956361|FG001|Overall Study|Study ended by NIH|17|||
131637099|NCT00230971|473956362|FG000|Randomization|No study drug administered|3|||
131637100|NCT00230971|473956363|FG001|Randomization|No study drug administered|3|||
131637101|NCT00230971|473956362|FG000|Baseline Participants|Lost to Follow-up|5|||
131637102|NCT00230971|473956363|FG001|Baseline Participants|Lost to Follow-up|12|||
131637103|NCT00230971|473956362|FG000|Baseline Participants|Death|6|||
131637104|NCT00230971|473956363|FG001|Baseline Participants|Death|5|||
131637105|NCT00230971|473956362|FG000|Baseline Participants|Withdrawal by Subject|7|||
131637106|NCT00230971|473956363|FG001|Baseline Participants|Withdrawal by Subject|1|||
131637107|NCT00230971|473956362|FG000|Baseline Participants|Adverse Event|1|||
131637108|NCT00230971|473956363|FG001|Baseline Participants|Adverse Event|0|||
131637109|NCT00230971|473956362|FG000|Baseline Participants|No bacteria observed|1|||
131637110|NCT00230971|473956363|FG001|Baseline Participants|No bacteria observed|0|||
131637111|NCT00230971|473956362|FG000|Baseline Participants|Failure to return|1|||
131637112|NCT00230971|473956363|FG001|Baseline Participants|Failure to return|1|||
131637113|NCT00230971|473956362|FG000|Baseline Participants|Reintervention|1|||
131637114|NCT00230971|473956363|FG001|Baseline Participants|Reintervention|0|||
131637115|NCT00329550|473958413|FG000|Overall Study|Adverse Event|3|||
131637116|NCT00329550|473958414|FG001|Overall Study|Adverse Event|4|||
131637117|NCT00329550|473958415|FG002|Overall Study|Adverse Event|2|||
131637118|NCT00329550|473958413|FG000|Overall Study|Withdrawal of Consent|1|||
131637119|NCT00329550|473958414|FG001|Overall Study|Withdrawal of Consent|0|||
131637120|NCT00329550|473958415|FG002|Overall Study|Withdrawal of Consent|1|||
131637121|NCT00329550|473958413|FG000|Overall Study|Due to Relocation|0|||
131637122|NCT00329550|473958414|FG001|Overall Study|Due to Relocation|0|||
131637123|NCT00329550|473958415|FG002|Overall Study|Due to Relocation|1|||
131637124|NCT01631825|473958428|FG000|Overall Study|Adverse Event|42|||
131637125|NCT01631825|473958428|FG000|Overall Study|Lack of Efficacy|7|||
131637126|NCT01631825|473958428|FG000|Overall Study|Withdrawal by Subject|9|||
131637127|NCT01631825|473958428|FG000|Overall Study|Protocol Violation|4|||
131637128|NCT01631825|473958428|FG000|Overall Study|Discontinuation criteria|1|||
131637129|NCT01631825|473958428|FG000|Overall Study|Physician Decision|2|||
131637130|NCT02110225|473958429|FG000|Overall Study|Lost to Follow-up|0|||
131637131|NCT02110225|473958430|FG001|Overall Study|Lost to Follow-up|1|||
131637132|NCT02110225|473958431|FG002|Overall Study|Lost to Follow-up|0|||
131637133|NCT02176018|473958432|FG000|Overall Study|Adverse Event|0|||
131637134|NCT02176018|473958433|FG001|Overall Study|Adverse Event|2|||
131637135|NCT02176018|473958432|FG000|Overall Study|Lost to Follow-up|3|||
131637136|NCT02176018|473958433|FG001|Overall Study|Lost to Follow-up|1|||
131637137|NCT02176018|473958432|FG000|Overall Study|Protocol Violation|1|||
131637138|NCT02176018|473958433|FG001|Overall Study|Protocol Violation|1|||
131637139|NCT02176018|473958432|FG000|Overall Study|Withdrawal by Subject|1|||
131637140|NCT02176018|473958433|FG001|Overall Study|Withdrawal by Subject|2|||
131637141|NCT03022045|473958434|FG000|Overall Study|Adverse Event|0|||
131637142|NCT03022045|473958435|FG001|Overall Study|Adverse Event|1|||
131637143|NCT03022045|473958434|FG000|Overall Study|Withdrawal by Subject|1|||
131637144|NCT03022045|473958435|FG001|Overall Study|Withdrawal by Subject|1|||
131637145|NCT02499835|473958439|FG000|Overall Study|Withdrawal by Subject|1|||
131637146|NCT02499835|473958440|FG001|Overall Study|Withdrawal by Subject|0|||
131637147|NCT02499835|473958441|FG002|Overall Study|Withdrawal by Subject|0|||
131637148|NCT02499835|473958442|FG003|Overall Study|Withdrawal by Subject|1|||
131637149|NCT02499835|473958439|FG000|Overall Study|Physician Decision|0|||
131637150|NCT02499835|473958440|FG001|Overall Study|Physician Decision|3|||
131637151|NCT02499835|473958441|FG002|Overall Study|Physician Decision|18|||
131637152|NCT02499835|473958442|FG003|Overall Study|Physician Decision|7|||
131637153|NCT02499835|473958439|FG000|Overall Study|Adverse Event|0|||
131637154|NCT02499835|473958440|FG001|Overall Study|Adverse Event|0|||
131637155|NCT02499835|473958441|FG002|Overall Study|Adverse Event|0|||
131637156|NCT02499835|473958442|FG003|Overall Study|Adverse Event|1|||
131637157|NCT02499835|473958439|FG000|Overall Study|Disease progression|2|||
131637158|NCT02499835|473958440|FG001|Overall Study|Disease progression|1|||
131637159|NCT02499835|473958441|FG002|Overall Study|Disease progression|0|||
131637160|NCT02499835|473958442|FG003|Overall Study|Disease progression|7|||
131637161|NCT05109117|473958443|FG000|Overall Study|Lost to Follow-up|1|||
131637162|NCT05109117|473958443|FG000|Overall Study|Discontinued for non-compliance|1|||
131637163|NCT03972137|473958447|FG000|Overall Study|Lost to Follow-up|2|||
131637164|NCT03972137|473958447|FG000|Overall Study|Withdrawal by Subject|4|||
131637165|NCT00899379|473958448|FG000|Overall Study|Adverse Event|2|||
131637166|NCT00899379|473958449|FG001|Overall Study|Adverse Event|2|||
131637167|NCT00899379|473958450|FG002|Overall Study|Adverse Event|1|||
131637168|NCT00899379|473958451|FG003|Overall Study|Adverse Event|1|||
131637169|NCT00899379|473958452|FG004|Overall Study|Adverse Event|2|||
131637170|NCT00899379|473958448|FG000|Overall Study|Lack of Efficacy|0|||
131637171|NCT00899379|473958449|FG001|Overall Study|Lack of Efficacy|4|||
131637172|NCT00899379|473958450|FG002|Overall Study|Lack of Efficacy|3|||
131637173|NCT00899379|473958451|FG003|Overall Study|Lack of Efficacy|0|||
131637174|NCT00899379|473958452|FG004|Overall Study|Lack of Efficacy|1|||
131637175|NCT00899379|473958448|FG000|Overall Study|Lost to Follow-up|9|||
131637176|NCT00899379|473958449|FG001|Overall Study|Lost to Follow-up|3|||
131902687|NCT04058028|474929358|FG003|Overall Study|Withdrawal of Consent from Study|7|||
131902688|NCT04058028|474929355|FG000|Overall Study|Decision by Sponsor|13|||
131902689|NCT04058028|474929356|FG001|Overall Study|Decision by Sponsor|4|||
131902690|NCT04058028|474929357|FG002|Overall Study|Decision by Sponsor|1|||
131902691|NCT04058028|474929358|FG003|Overall Study|Decision by Sponsor|35|||
131902692|NCT04058028|474929355|FG000|Overall Study|Lost to Follow-up|1|||
131902693|NCT04058028|474929356|FG001|Overall Study|Lost to Follow-up|1|||
131902694|NCT04058028|474929357|FG002|Overall Study|Lost to Follow-up|1|||
131902695|NCT04058028|474929358|FG003|Overall Study|Lost to Follow-up|0|||
131902696|NCT04058028|474929355|FG000|Overall Study|Death|0|||
131902697|NCT04058028|474929356|FG001|Overall Study|Death|1|||
131637177|NCT00899379|473958450|FG002|Overall Study|Lost to Follow-up|0|||
131637178|NCT00899379|473958451|FG003|Overall Study|Lost to Follow-up|6|||
131637179|NCT00899379|473958452|FG004|Overall Study|Lost to Follow-up|2|||
131637180|NCT00899379|473958448|FG000|Overall Study|Protocol Violation|0|||
131637181|NCT00899379|473958449|FG001|Overall Study|Protocol Violation|0|||
131637182|NCT00899379|473958450|FG002|Overall Study|Protocol Violation|1|||
131637183|NCT00899379|473958451|FG003|Overall Study|Protocol Violation|1|||
131637184|NCT00899379|473958452|FG004|Overall Study|Protocol Violation|0|||
131637185|NCT00899379|473958448|FG000|Overall Study|Withdrawal by Subject|2|||
131637186|NCT00899379|473958449|FG001|Overall Study|Withdrawal by Subject|4|||
131637187|NCT00899379|473958450|FG002|Overall Study|Withdrawal by Subject|2|||
131637188|NCT00899379|473958451|FG003|Overall Study|Withdrawal by Subject|3|||
131637189|NCT00899379|473958452|FG004|Overall Study|Withdrawal by Subject|6|||
131637190|NCT00899379|473958448|FG000|Overall Study|Pregnancy|0|||
131637191|NCT00899379|473958449|FG001|Overall Study|Pregnancy|0|||
131637192|NCT00899379|473958450|FG002|Overall Study|Pregnancy|1|||
131637193|NCT00899379|473958451|FG003|Overall Study|Pregnancy|0|||
131637194|NCT00899379|473958452|FG004|Overall Study|Pregnancy|1|||
131637195|NCT00899379|473958448|FG000|Overall Study|Patient Uncooperative|0|||
131637196|NCT00899379|473958449|FG001|Overall Study|Patient Uncooperative|1|||
131637197|NCT00899379|473958450|FG002|Overall Study|Patient Uncooperative|0|||
131637198|NCT00899379|473958451|FG003|Overall Study|Patient Uncooperative|1|||
131637199|NCT00899379|473958452|FG004|Overall Study|Patient Uncooperative|2|||
131902698|NCT04058028|474929357|FG002|Overall Study|Death|0|||
131902699|NCT04058028|474929358|FG003|Overall Study|Death|0|||
131902700|NCT00485069|474929359|FG000|Overall Study|Adverse Event|10|||
131902701|NCT00485069|474929360|FG001|Overall Study|Adverse Event|4|||
131902702|NCT00485069|474929359|FG000|Overall Study|Lack of Efficacy|2|||
131637200|NCT00899379|473958448|FG000|Overall Study|Abnormal Baseline ECG|0|||
131637201|NCT00899379|473958449|FG001|Overall Study|Abnormal Baseline ECG|0|||
131902703|NCT00485069|474929360|FG001|Overall Study|Lack of Efficacy|1|||
131902704|NCT00485069|474929359|FG000|Overall Study|Protocol Violation|0|||
131637202|NCT00899379|473958450|FG002|Overall Study|Abnormal Baseline ECG|0|||
131637203|NCT00899379|473958451|FG003|Overall Study|Abnormal Baseline ECG|1|||
131637204|NCT00899379|473958452|FG004|Overall Study|Abnormal Baseline ECG|0|||
131637205|NCT00899379|473958448|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131902705|NCT00485069|474929360|FG001|Overall Study|Protocol Violation|1|||
131637206|NCT00899379|473958449|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131637207|NCT00899379|473958450|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131637208|NCT00899379|473958451|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131637209|NCT00899379|473958452|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131637210|NCT00899379|473958448|FG000|Overall Study|Not Completed/Entered Extn|5|||
131637211|NCT00899379|473958449|FG001|Overall Study|Not Completed/Entered Extn|1|||
131637212|NCT00899379|473958450|FG002|Overall Study|Not Completed/Entered Extn|6|||
131637213|NCT00899379|473958451|FG003|Overall Study|Not Completed/Entered Extn|4|||
131637214|NCT00899379|473958452|FG004|Overall Study|Not Completed/Entered Extn|3|||
131637215|NCT00899379|473958448|FG000|Overall Study|Study Terminated|3|||
131637216|NCT00899379|473958449|FG001|Overall Study|Study Terminated|0|||
131637217|NCT00899379|473958450|FG002|Overall Study|Study Terminated|3|||
131637218|NCT00899379|473958451|FG003|Overall Study|Study Terminated|3|||
131637219|NCT00899379|473958452|FG004|Overall Study|Study Terminated|1|||
131637220|NCT00899379|473958448|FG000|Overall Study|Lost to Follow-up|3|||
131637221|NCT00899379|473958449|FG001|Overall Study|Lost to Follow-up|1|||
131637222|NCT00899379|473958450|FG002|Overall Study|Lost to Follow-up|0|||
131637223|NCT00899379|473958451|FG003|Overall Study|Lost to Follow-up|2|||
131637224|NCT00899379|473958452|FG004|Overall Study|Lost to Follow-up|5|||
131637225|NCT00899379|473958448|FG000|Overall Study|Withdrawal by Subject|4|||
131637226|NCT00899379|473958449|FG001|Overall Study|Withdrawal by Subject|7|||
131637227|NCT00899379|473958450|FG002|Overall Study|Withdrawal by Subject|4|||
131637228|NCT00899379|473958451|FG003|Overall Study|Withdrawal by Subject|7|||
131637229|NCT00899379|473958452|FG004|Overall Study|Withdrawal by Subject|2|||
131637230|NCT00899379|473958448|FG000|Overall Study|Pregnancy|1|||
131637231|NCT00899379|473958449|FG001|Overall Study|Pregnancy|0|||
131637232|NCT00899379|473958450|FG002|Overall Study|Pregnancy|0|||
131637233|NCT00899379|473958451|FG003|Overall Study|Pregnancy|0|||
131637234|NCT00899379|473958452|FG004|Overall Study|Pregnancy|0|||
131637235|NCT00899379|473958448|FG000|Overall Study|Patient Uncooperative|0|||
131637236|NCT00899379|473958449|FG001|Overall Study|Patient Uncooperative|0|||
131637237|NCT00899379|473958450|FG002|Overall Study|Patient Uncooperative|0|||
131637238|NCT00899379|473958451|FG003|Overall Study|Patient Uncooperative|1|||
131637239|NCT00899379|473958452|FG004|Overall Study|Patient Uncooperative|0|||
131637240|NCT00899379|473958448|FG000|Overall Study|Abnormal Prestudy Labs|0|||
131637241|NCT00899379|473958449|FG001|Overall Study|Abnormal Prestudy Labs|0|||
131637242|NCT00899379|473958450|FG002|Overall Study|Abnormal Prestudy Labs|0|||
131637243|NCT00899379|473958451|FG003|Overall Study|Abnormal Prestudy Labs|0|||
131637244|NCT00899379|473958452|FG004|Overall Study|Abnormal Prestudy Labs|2|||
131637245|NCT00899379|473958448|FG000|Overall Study|Abnormal Baseline ECG|0|||
131637246|NCT00899379|473958449|FG001|Overall Study|Abnormal Baseline ECG|0|||
131637247|NCT00899379|473958450|FG002|Overall Study|Abnormal Baseline ECG|1|||
131637248|NCT00899379|473958451|FG003|Overall Study|Abnormal Baseline ECG|1|||
131637249|NCT00899379|473958452|FG004|Overall Study|Abnormal Baseline ECG|0|||
131637250|NCT00899379|473958448|FG000|Overall Study|No Attack Pretreatment|3|||
131637251|NCT00899379|473958449|FG001|Overall Study|No Attack Pretreatment|5|||
131637252|NCT00899379|473958450|FG002|Overall Study|No Attack Pretreatment|5|||
131637253|NCT00899379|473958451|FG003|Overall Study|No Attack Pretreatment|6|||
131637254|NCT00899379|473958452|FG004|Overall Study|No Attack Pretreatment|4|||
131637255|NCT00899379|473958448|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131637256|NCT00899379|473958449|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131637257|NCT00899379|473958450|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131637258|NCT00899379|473958451|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131637259|NCT00899379|473958452|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131637260|NCT00899379|473958448|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
131637261|NCT00899379|473958449|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
131637262|NCT00899379|473958450|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
131637263|NCT00899379|473958451|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
131637264|NCT00899379|473958452|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
131637265|NCT03220776|473958457|FG000|Overall Study|Claustrophobia|0|||
131637266|NCT03220776|473958458|FG001|Overall Study|Claustrophobia|1|||
131637267|NCT03220776|473958459|FG002|Overall Study|Claustrophobia|1|||
131637268|NCT03220776|473958460|FG003|Overall Study|Claustrophobia|0|||
131637269|NCT03220776|473958461|FG004|Overall Study|Claustrophobia|1|||
131637270|NCT03220776|473958462|FG005|Overall Study|Claustrophobia|0|||
131637271|NCT03220776|473958457|FG000|Overall Study|MRI Equipment Failure|1|||
131637272|NCT03220776|473958458|FG001|Overall Study|MRI Equipment Failure|0|||
131637273|NCT03220776|473958459|FG002|Overall Study|MRI Equipment Failure|0|||
131637274|NCT03220776|473958460|FG003|Overall Study|MRI Equipment Failure|0|||
131637275|NCT03220776|473958461|FG004|Overall Study|MRI Equipment Failure|0|||
131637276|NCT03220776|473958462|FG005|Overall Study|MRI Equipment Failure|0|||
131637277|NCT03220776|473958457|FG000|Overall Study|Inclimate Weather|0|||
131637278|NCT03220776|473958458|FG001|Overall Study|Inclimate Weather|0|||
131637279|NCT03220776|473958459|FG002|Overall Study|Inclimate Weather|0|||
131637280|NCT03220776|473958460|FG003|Overall Study|Inclimate Weather|0|||
131637281|NCT03220776|473958461|FG004|Overall Study|Inclimate Weather|0|||
131637282|NCT03220776|473958462|FG005|Overall Study|Inclimate Weather|1|||
131637283|NCT03220776|473958457|FG000|Overall Study|Physician Decision|0|||
131637284|NCT03220776|473958458|FG001|Overall Study|Physician Decision|0|||
131637285|NCT03220776|473958459|FG002|Overall Study|Physician Decision|0|||
131637286|NCT03220776|473958460|FG003|Overall Study|Physician Decision|1|||
131637287|NCT03220776|473958461|FG004|Overall Study|Physician Decision|0|||
131637288|NCT03220776|473958462|FG005|Overall Study|Physician Decision|0|||
131637289|NCT03220776|473958457|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131637290|NCT03220776|473958458|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131637291|NCT03220776|473958459|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131637292|NCT03220776|473958460|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
131637293|NCT03220776|473958461|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131637294|NCT03220776|473958462|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131637295|NCT03220776|473958457|FG000|Overall Study|Protocol Violation|0|||
131637296|NCT03220776|473958458|FG001|Overall Study|Protocol Violation|0|||
131637297|NCT03220776|473958459|FG002|Overall Study|Protocol Violation|0|||
131637298|NCT03220776|473958460|FG003|Overall Study|Protocol Violation|2|||
131637299|NCT03220776|473958461|FG004|Overall Study|Protocol Violation|0|||
131637300|NCT03220776|473958462|FG005|Overall Study|Protocol Violation|1|||
131637301|NCT03220776|473958457|FG000|Overall Study|Withdrawal by Subject|1|||
131637302|NCT03220776|473958458|FG001|Overall Study|Withdrawal by Subject|0|||
131637303|NCT03220776|473958459|FG002|Overall Study|Withdrawal by Subject|0|||
131637304|NCT03220776|473958460|FG003|Overall Study|Withdrawal by Subject|0|||
131637305|NCT03220776|473958461|FG004|Overall Study|Withdrawal by Subject|0|||
131637306|NCT03220776|473958462|FG005|Overall Study|Withdrawal by Subject|0|||
131637307|NCT03226353|473958463|FG000|Overall Study|Withdrawal by Subject|1|||
131799079|NCT02752776|474548890|FG000|Overall Study|Lost to Follow-up|11|||
131799080|NCT02752776|474548891|FG001|Overall Study|Lost to Follow-up|12|||
131799081|NCT02752776|474548892|FG002|Overall Study|Lost to Follow-up|4|||
131799082|NCT02752776|474548890|FG000|Overall Study|Non-compliance with study treatment|0|||
131799083|NCT02752776|474548891|FG001|Overall Study|Non-compliance with study treatment|0|||
131799084|NCT02752776|474548892|FG002|Overall Study|Non-compliance with study treatment|1|||
131799085|NCT02752776|474548890|FG000|Overall Study|Physician Decision|2|||
131799086|NCT02752776|474548891|FG001|Overall Study|Physician Decision|6|||
131799087|NCT02752776|474548892|FG002|Overall Study|Physician Decision|2|||
131799088|NCT02752776|474548890|FG000|Overall Study|Pregnancy|1|||
131799089|NCT02752776|474548891|FG001|Overall Study|Pregnancy|6|||
131799090|NCT02752776|474548892|FG002|Overall Study|Pregnancy|3|||
131799091|NCT02752776|474548890|FG000|Overall Study|Protocol Violation|10|||
131799092|NCT02752776|474548891|FG001|Overall Study|Protocol Violation|13|||
131799093|NCT02752776|474548892|FG002|Overall Study|Protocol Violation|6|||
131799094|NCT02752776|474548890|FG000|Overall Study|Subject/guardian decision|8|||
131799095|NCT02752776|474548891|FG001|Overall Study|Subject/guardian decision|6|||
131799096|NCT02752776|474548892|FG002|Overall Study|Subject/guardian decision|4|||
131799097|NCT02752776|474548890|FG000|Overall Study|Death|0|||
131799098|NCT02752776|474548891|FG001|Overall Study|Death|0|||
131799099|NCT02752776|474548892|FG002|Overall Study|Death|1|||
131799100|NCT02752776|474548890|FG000|Overall Study|Withdrawal by Subject|3|||
131799101|NCT02752776|474548891|FG001|Overall Study|Withdrawal by Subject|4|||
131799102|NCT02752776|474548892|FG002|Overall Study|Withdrawal by Subject|2|||
131799103|NCT02492958|474548893|FG000|Overall Study|Withdrawal by Subject|0|||
131799104|NCT02492958|474548894|FG001|Overall Study|Withdrawal by Subject|0|||
131799105|NCT02492958|474548895|FG002|Overall Study|Withdrawal by Subject|1|||
131637308|NCT03226353|473958463|FG000|Overall Study|Screen Failure|5|||
131637309|NCT03441789|473958465|FG000|Overall Study|Withdrawal by Subject|1|||
131637310|NCT03441789|473958466|FG001|Overall Study|Withdrawal by Subject|1|||
131637311|NCT03441789|473958465|FG000|Overall Study|Adverse Event|0|||
131637312|NCT03441789|473958466|FG001|Overall Study|Adverse Event|1|||
131637313|NCT03441789|473958465|FG000|Overall Study|Protocol Violation|0|||
131637314|NCT03441789|473958466|FG001|Overall Study|Protocol Violation|1|||
131637315|NCT03441789|473958465|FG000|Overall Study|Lost to Follow-up|0|||
131637316|NCT03441789|473958466|FG001|Overall Study|Lost to Follow-up|1|||
131637317|NCT01780545|473958467|FG000|Overall Study|Withdrawal by Subject|3|||
131637318|NCT01780545|473958468|FG001|Overall Study|Withdrawal by Subject|1|||
131637319|NCT01780545|473958467|FG000|Overall Study|Lost to Follow-up|1|||
131637320|NCT01780545|473958468|FG001|Overall Study|Lost to Follow-up|1|||
131637321|NCT03168425|473958469|FG000|Overall Study|Lost to Follow-up|5|||
131799106|NCT02492958|474548896|FG003|Overall Study|Withdrawal by Subject|0|||
131799107|NCT02492958|474548893|FG000|Overall Study|Adverse Event|1|||
131799108|NCT02492958|474548894|FG001|Overall Study|Adverse Event|0|||
131799109|NCT02492958|474548895|FG002|Overall Study|Adverse Event|1|||
131799110|NCT02492958|474548896|FG003|Overall Study|Adverse Event|0|||
131799111|NCT01193608|474548898|FG000|Overall Study|Other|0|||
131799112|NCT01193608|474548899|FG001|Overall Study|Other|1|||
131799113|NCT01193608|474548900|FG002|Overall Study|Other|0|||
131799114|NCT01193608|474548901|FG003|Overall Study|Other|0|||
131799115|NCT01193608|474548902|FG004|Overall Study|Other|0|||
131799116|NCT01193608|474548903|FG005|Overall Study|Other|0|||
131799117|NCT01193608|474548898|FG000|Overall Study|Withdrawal by Subject|0|||
131799118|NCT01193608|474548899|FG001|Overall Study|Withdrawal by Subject|1|||
131799119|NCT01193608|474548900|FG002|Overall Study|Withdrawal by Subject|2|||
131799120|NCT01193608|474548901|FG003|Overall Study|Withdrawal by Subject|3|||
131799121|NCT01193608|474548902|FG004|Overall Study|Withdrawal by Subject|3|||
131799122|NCT01193608|474548903|FG005|Overall Study|Withdrawal by Subject|0|||
131799123|NCT01193608|474548898|FG000|Overall Study|Lost to Follow-up|0|||
131799124|NCT01193608|474548899|FG001|Overall Study|Lost to Follow-up|0|||
131799125|NCT01193608|474548900|FG002|Overall Study|Lost to Follow-up|0|||
131799126|NCT01193608|474548901|FG003|Overall Study|Lost to Follow-up|0|||
131799127|NCT01193608|474548902|FG004|Overall Study|Lost to Follow-up|1|||
131799128|NCT01193608|474548903|FG005|Overall Study|Lost to Follow-up|2|||
131799129|NCT01193608|474548898|FG000|Overall Study|Adverse Event|0|||
131799130|NCT01193608|474548899|FG001|Overall Study|Adverse Event|0|||
131799131|NCT01193608|474548900|FG002|Overall Study|Adverse Event|0|||
131799132|NCT01193608|474548901|FG003|Overall Study|Adverse Event|0|||
131799133|NCT01193608|474548902|FG004|Overall Study|Adverse Event|1|||
131799134|NCT01193608|474548903|FG005|Overall Study|Adverse Event|0|||
131799135|NCT00266409|474548904|FG000|Overall Study|Lack of Efficacy|2|||
131799136|NCT00266409|474548905|FG001|Overall Study|Lack of Efficacy|6|||
131799137|NCT00266409|474548906|FG002|Overall Study|Lack of Efficacy|1|||
131799138|NCT00266409|474548907|FG003|Overall Study|Lack of Efficacy|2|||
131799139|NCT00266409|474548904|FG000|Overall Study|Adverse Event|7|||
131799140|NCT00266409|474548905|FG001|Overall Study|Adverse Event|2|||
131799141|NCT00266409|474548906|FG002|Overall Study|Adverse Event|1|||
131799142|NCT00266409|474548907|FG003|Overall Study|Adverse Event|1|||
131637322|NCT03168425|473958470|FG001|Overall Study|Lost to Follow-up|8|||
131637323|NCT03168425|473958469|FG000|Overall Study|unable to confirm post op opioids|2|||
131637324|NCT03168425|473958470|FG001|Overall Study|unable to confirm post op opioids|3|||
131637325|NCT04491006|473958474|FG000|Overall Study|Adverse Event|0|||
131637326|NCT04491006|473958475|FG001|Overall Study|Adverse Event|3|||
131637327|NCT04491006|473958476|FG002|Overall Study|Adverse Event|5|||
131637328|NCT04491006|473958474|FG000|Overall Study|Withdrawal by Subject|1|||
131637329|NCT04491006|473958475|FG001|Overall Study|Withdrawal by Subject|0|||
131637330|NCT04491006|473958476|FG002|Overall Study|Withdrawal by Subject|2|||
131637331|NCT02581189|473958482|FG000|Overall Study|Failure to return|36|||
131637332|NCT02581189|473958482|FG000|Overall Study|Withdrew consent|5|||
131637333|NCT02581189|473958482|FG000|Overall Study|Death|3|||
131637334|NCT02581189|473958482|FG000|Overall Study|Insufficient virological response|2|||
131637335|NCT02581189|473958482|FG000|Overall Study|Other, not specified|7|||
131637336|NCT01960114|473958483|FG000|Overall Study|Adverse Event|1|||
131637337|NCT01960114|473958484|FG001|Overall Study|Adverse Event|0|||
131637338|NCT01960114|473958483|FG000|Overall Study|Could not swallow study medication|0|||
131637339|NCT01960114|473958484|FG001|Overall Study|Could not swallow study medication|1|||
131637340|NCT02469077|473958485|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
131637341|NCT02469077|473958486|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
131637342|NCT02469077|473958485|FG000|Post Randomization/Intervention Period|Relocated|1|||
131637343|NCT02469077|473958486|FG001|Post Randomization/Intervention Period|Relocated|1|||
131637344|NCT02469077|473958485|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
131637345|NCT02469077|473958486|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
131637346|NCT02469077|473958485|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
131637347|NCT02469077|473958486|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
131799143|NCT00266409|474548904|FG000|Overall Study|Lost to Follow-up|18|||
131799144|NCT00266409|474548905|FG001|Overall Study|Lost to Follow-up|21|||
131799145|NCT00266409|474548906|FG002|Overall Study|Lost to Follow-up|6|||
131799146|NCT00266409|474548907|FG003|Overall Study|Lost to Follow-up|8|||
131799147|NCT00266409|474548904|FG000|Overall Study|Withdrawal by Subject|6|||
131799148|NCT00266409|474548905|FG001|Overall Study|Withdrawal by Subject|10|||
131799149|NCT00266409|474548906|FG002|Overall Study|Withdrawal by Subject|3|||
131799150|NCT00266409|474548907|FG003|Overall Study|Withdrawal by Subject|9|||
131799151|NCT00266409|474548904|FG000|Overall Study|Protocol Violation|5|||
131799152|NCT00266409|474548905|FG001|Overall Study|Protocol Violation|3|||
131637348|NCT01040403|473958487|FG000|Overall Study|Adverse Event|10|||
131637349|NCT01040403|473958487|FG000|Overall Study|Protocol Violation|2|||
131637350|NCT01040403|473958487|FG000|Overall Study|Lost to Follow-up|1|||
131799153|NCT00266409|474548906|FG002|Overall Study|Protocol Violation|4|||
131799154|NCT00266409|474548907|FG003|Overall Study|Protocol Violation|2|||
131799155|NCT00266409|474548904|FG000|Overall Study|Other|7|||
131799156|NCT00266409|474548905|FG001|Overall Study|Other|4|||
131637351|NCT01040403|473958487|FG000|Overall Study|Not treated|1|||
131637352|NCT01040403|473958487|FG000|Overall Study|Other reason not defined above|6|||
131637353|NCT01885936|473958488|FG000|Overall Study|Withdrawal by Subject|1|||
131637354|NCT01885936|473958489|FG001|Overall Study|Withdrawal by Subject|0|||
131637355|NCT00797511|473958490|FG000|Overall Study|Withdrawal by Subject|1|||
131637356|NCT03036150|473958491|FG000|Overall Study|Withdrawal by Subject|8|||
131637357|NCT03036150|473958492|FG001|Overall Study|Withdrawal by Subject|3|||
131637358|NCT03036150|473958491|FG000|Overall Study|Lost to Follow-up|2|||
131637359|NCT03036150|473958492|FG001|Overall Study|Lost to Follow-up|2|||
131637360|NCT00427778|473958493|FG000|First Intervention (4 Weeks)|no longer interested|1|||
131637361|NCT00427778|473958494|FG001|First Intervention (4 Weeks)|no longer interested|0|||
131637362|NCT00427778|473958493|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
131637363|NCT00427778|473958494|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
131637364|NCT00427778|473958493|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
131637365|NCT00427778|473958494|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
131637366|NCT00427778|473958493|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
131637367|NCT00427778|473958494|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
131637368|NCT00439647|473958495|FG000|Overall Study|Withdrawal by Subject|25|||
131637369|NCT00439647|473958496|FG001|Overall Study|Withdrawal by Subject|22|||
131637370|NCT00439647|473958495|FG000|Overall Study|Death|15|||
131637371|NCT00439647|473958496|FG001|Overall Study|Death|18|||
131637372|NCT00439647|473958495|FG000|Overall Study|Adverse Event|11|||
131637373|NCT00439647|473958496|FG001|Overall Study|Adverse Event|11|||
131637374|NCT00439647|473958495|FG000|Overall Study|Lost to Follow-up|4|||
131637375|NCT00439647|473958496|FG001|Overall Study|Lost to Follow-up|12|||
131637376|NCT00439647|473958495|FG000|Overall Study|Protocol Violation|3|||
131637377|NCT00439647|473958496|FG001|Overall Study|Protocol Violation|4|||
131637378|NCT00439647|473958495|FG000|Overall Study|Lack of Efficacy|0|||
131637379|NCT00439647|473958496|FG001|Overall Study|Lack of Efficacy|4|||
131637380|NCT00843115|473958497|FG000|Overall Study|Death|4|||
131637381|NCT00843115|473958497|FG000|Overall Study|Adverse Event|30|||
131637382|NCT00843115|473958497|FG000|Overall Study|Lost to Follow-up|4|||
131637383|NCT00843115|473958497|FG000|Overall Study|Withdrawal by Subject|17|||
131637384|NCT00843115|473958497|FG000|Overall Study|Family wanted meds stopped|1|||
131637385|NCT00843115|473958497|FG000|Overall Study|Family does not want continuation|1|||
131637386|NCT00843115|473958497|FG000|Overall Study|Patient forgot to take meds|1|||
131637387|NCT00843115|473958497|FG000|Overall Study|Does not meet entrance criteria|1|||
131637388|NCT00843115|473958497|FG000|Overall Study|Physician Decision|1|||
131637389|NCT00843115|473958497|FG000|Overall Study|Family discontinued meds|1|||
131637390|NCT00843115|473958497|FG000|Overall Study|patient took for 2 days then stopped|1|||
131637391|NCT00843115|473958497|FG000|Overall Study|patient never took the medication|1|||
131637392|NCT00843115|473958497|FG000|Overall Study|hospitalized due to deterioration|1|||
131799157|NCT00266409|474548906|FG002|Overall Study|Other|2|||
131799158|NCT00266409|474548907|FG003|Overall Study|Other|0|||
131799159|NCT00712010|474548911|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
131799160|NCT01946165|474548912|FG000|Overall Study|Physician Decision|2|||
131799161|NCT01946165|474548913|FG001|Overall Study|Physician Decision|0|||
131799162|NCT01946165|474548912|FG000|Overall Study|Withdrawal by Subject|0|||
131799163|NCT01946165|474548913|FG001|Overall Study|Withdrawal by Subject|2|||
131799164|NCT01400113|474548914|FG000|Overall Study|Withdrawal by Subject|1|||
131799165|NCT01400113|474548915|FG001|Overall Study|Withdrawal by Subject|1|||
131799166|NCT01179919|474548916|FG000|Overall Study|Protocol Violation|1|||
131799167|NCT01179919|474548916|FG000|Overall Study|Adverse Event|1|||
131799168|NCT02660242|474548920|FG000|Glucose Tabs|Lost to Follow-up|1|||
131799169|NCT02660242|474548920|FG000|Glucagon Injection|Lost to Follow-up|1|||
131799170|NCT00770510|474548921|FG000|Overall Study|Lost to Follow-up|2|||
131799171|NCT00770510|474548921|FG000|Overall Study|Pregnancy|1|||
131799172|NCT00770510|474548921|FG000|Overall Study|Withdrawal by Subject|2|||
131637393|NCT00843115|473958497|FG000|Overall Study|week 12 not done|1|||
131637394|NCT00843115|473958497|FG000|Overall Study|Syndrome De Glissement|1|||
131637395|NCT02845375|473958498|FG000|Overall Study|upper airway obstruction|1|||
131637396|NCT02845375|473958499|FG001|Overall Study|upper airway obstruction|2|||
131637397|NCT02845375|473958500|FG002|Overall Study|upper airway obstruction|1|||
131637398|NCT01037413|473958501|FG000|Part A: Skin Testing|Adverse Event|1|||
131637399|NCT01037413|473958502|FG001|Part A: Skin Testing|Adverse Event|0|||
131637400|NCT01037413|473958501|FG000|Part A: Skin Testing|Protocol Violation|1|||
131637401|NCT01037413|473958502|FG001|Part A: Skin Testing|Protocol Violation|0|||
131637402|NCT01037413|473958501|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
131637403|NCT01037413|473958502|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
131799173|NCT02796664|474548924|FG000|Overall Study|Withdrawal by Subject|0|||
131799174|NCT02796664|474548925|FG001|Overall Study|Withdrawal by Subject|3|||
131637404|NCT01037413|473958501|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
131637405|NCT01037413|473958502|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
131637406|NCT00619983|473958506|FG000|Test Drug Alone|Withdrawal by Subject|1|||
131637407|NCT00619983|473958507|FG001|Test Drug Alone|Withdrawal by Subject|0|||
131637408|NCT00619983|473958508|FG002|Test Drug Alone|Withdrawal by Subject|0|||
131637409|NCT00619983|473958509|FG003|Test Drug Alone|Withdrawal by Subject|1|||
131637410|NCT00619983|473958506|FG000|Test Drug Alone|Failure of daily diary device|1|||
131637411|NCT00619983|473958507|FG001|Test Drug Alone|Failure of daily diary device|1|||
131637412|NCT00619983|473958508|FG002|Test Drug Alone|Failure of daily diary device|2|||
131637413|NCT00619983|473958509|FG003|Test Drug Alone|Failure of daily diary device|2|||
131637414|NCT02204319|473958513|FG000|Overall Study|Pregnancy|1|||
131637415|NCT02204319|473958513|FG000|Overall Study|Withdrawal by Subject|2|||
131637416|NCT03371485|473958518|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
131637417|NCT03371485|473958518|FG000|2-year Follow-up|Death|5|||
131637418|NCT01177137|473958519|FG000|Overall Study|Withdrawal by Subject|10|||
131637419|NCT01177137|473958520|FG001|Overall Study|Withdrawal by Subject|10|||
131637420|NCT01177137|473958521|FG002|Overall Study|Withdrawal by Subject|2|||
131637421|NCT02959177|473958522|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
131637422|NCT02959177|473958523|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
131637423|NCT02959177|473958524|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
131637424|NCT02959177|473958522|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
131637425|NCT02959177|473958523|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
131637426|NCT02959177|473958524|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
131637427|NCT02959177|473958522|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
131637428|NCT02959177|473958523|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
131637429|NCT02959177|473958524|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
131637430|NCT02959177|473958522|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131637431|NCT02959177|473958523|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131637432|NCT02959177|473958524|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131637433|NCT02959177|473958522|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
131637434|NCT02959177|473958523|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
131637435|NCT02959177|473958524|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
131637436|NCT02959177|473958522|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
131637437|NCT02959177|473958523|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
131637438|NCT02959177|473958524|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
131637439|NCT02959177|473958522|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
131637440|NCT02959177|473958523|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
131799175|NCT02796664|474548924|FG000|Overall Study|Noncompliance|1|||
131799176|NCT02796664|474548925|FG001|Overall Study|Noncompliance|1|||
131799177|NCT02796664|474548924|FG000|Overall Study|Death|0|||
131799178|NCT02796664|474548925|FG001|Overall Study|Death|1|||
131799179|NCT03495869|474548927|FG000|Overall Study|Lost to Follow-up|4|||
131799180|NCT03495869|474548928|FG001|Overall Study|Lost to Follow-up|17|||
131799181|NCT03495869|474548929|FG002|Overall Study|Lost to Follow-up|8|||
131799182|NCT03495869|474548930|FG003|Overall Study|Lost to Follow-up|14|||
131799183|NCT03495869|474548927|FG000|Overall Study|Withdrawal by Subject|0|||
131799184|NCT03495869|474548928|FG001|Overall Study|Withdrawal by Subject|3|||
131799185|NCT03495869|474548929|FG002|Overall Study|Withdrawal by Subject|0|||
131799186|NCT03495869|474548930|FG003|Overall Study|Withdrawal by Subject|3|||
131799187|NCT03495869|474548927|FG000|Overall Study|Dropped from study|0|||
131799188|NCT03495869|474548928|FG001|Overall Study|Dropped from study|7|||
131799189|NCT03495869|474548929|FG002|Overall Study|Dropped from study|2|||
131799190|NCT03495869|474548930|FG003|Overall Study|Dropped from study|4|||
131799191|NCT04634409|474548932|FG000|Overall Study|Death|0|||
131799192|NCT04634409|474548933|FG001|Overall Study|Death|0|||
131799193|NCT04634409|474548934|FG002|Overall Study|Death|0|||
131799194|NCT04634409|474548935|FG003|Overall Study|Death|0|||
131799195|NCT04634409|474548936|FG004|Overall Study|Death|0|||
131799196|NCT04634409|474548937|FG005|Overall Study|Death|0|||
131799197|NCT04634409|474548938|FG006|Overall Study|Death|0|||
131799198|NCT04634409|474548939|FG007|Overall Study|Death|0|||
131799199|NCT04634409|474548940|FG008|Overall Study|Death|0|||
131799200|NCT04634409|474548941|FG009|Overall Study|Death|0|||
131799201|NCT04634409|474548942|FG010|Overall Study|Death|1|||
131799202|NCT04634409|474548943|FG011|Overall Study|Death|0|||
131799203|NCT04634409|474548944|FG012|Overall Study|Death|1|||
131799204|NCT04634409|474548945|FG013|Overall Study|Death|0|||
131799205|NCT04634409|474548946|FG014|Overall Study|Death|0|||
131799206|NCT04634409|474548947|FG015|Overall Study|Death|0|||
131637441|NCT02959177|473958524|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
131637442|NCT04531813|473958529|FG000|Overall Study|Protocol Violation|1|||
131637443|NCT04531813|473958529|FG000|Overall Study|Withdrawal by Subject|1|||
131799207|NCT04634409|474548948|FG016|Overall Study|Death|0|||
131799208|NCT04634409|474548949|FG017|Overall Study|Death|0|||
131799209|NCT04634409|474548950|FG018|Overall Study|Death|0|||
131799210|NCT04634409|474548951|FG019|Overall Study|Death|0|||
131902706|NCT00485069|474929359|FG000|Overall Study|Withdrawal by Subject|6|||
131902707|NCT00485069|474929360|FG001|Overall Study|Withdrawal by Subject|6|||
131902708|NCT00992017|474929362|FG000|Overall Study|Lost to Follow-up|2|||
131902709|NCT00992017|474929362|FG000|Overall Study|Withdrawal by Subject|2|||
131902710|NCT00992017|474929362|FG000|Overall Study|Unable to get to clinic|5|||
131902711|NCT00992017|474929362|FG000|Overall Study|Not adhere to study requirements|1|||
131902712|NCT02864407|474929363|FG000|Overall Study|Protocol Violation|3|||
131902713|NCT02864407|474929363|FG000|Overall Study|Lost to Follow-up|115|||
131902714|NCT02864407|474929363|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
131902715|NCT02864407|474929363|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
131902716|NCT02864407|474929363|FG000|Overall Study|Consent prior to the contract date|1|||
131902717|NCT04577794|474929373|FG000|Overall Study|Adverse Event|1|||
131902718|NCT04577794|474929374|FG001|Overall Study|Adverse Event|1|||
131445095|NCT04672239|473258832|FG002|Week 2 Survey|Lost to Follow-up|5|||
131637444|NCT02853305|473958532|FG000|Overall Study|Death|287|||
131637445|NCT02853305|473958533|FG001|Overall Study|Death|249|||
131637446|NCT02853305|473958534|FG002|Overall Study|Death|300|||
131637447|NCT02853305|473958532|FG000|Overall Study|Withdrawal by Subject|2|||
131637448|NCT02853305|473958533|FG001|Overall Study|Withdrawal by Subject|8|||
131637449|NCT02853305|473958534|FG002|Overall Study|Withdrawal by Subject|3|||
131637450|NCT02853305|473958532|FG000|Overall Study|Transferred to Extension Study|46|||
131637451|NCT02853305|473958533|FG001|Overall Study|Transferred to Extension Study|30|||
131637452|NCT02853305|473958534|FG002|Overall Study|Transferred to Extension Study|25|||
131637453|NCT02853305|473958532|FG000|Overall Study|Did Not Continue on Extension Study|16|||
131637454|NCT02853305|473958533|FG001|Overall Study|Did Not Continue on Extension Study|20|||
131637455|NCT02853305|473958534|FG002|Overall Study|Did Not Continue on Extension Study|24|||
131637456|NCT02381652|473958539|FG000|Overall Study|Withdrawal by Subject|0|||
131637457|NCT02381652|473958540|FG001|Overall Study|Withdrawal by Subject|0|||
131637458|NCT02381652|473958541|FG002|Overall Study|Withdrawal by Subject|1|||
131637459|NCT01340300|473958542|FG000|Overall Study|Lost to Follow-up|3|||
131637460|NCT01340300|473958543|FG001|Overall Study|Lost to Follow-up|0|||
131637461|NCT01340300|473958544|FG002|Overall Study|Lost to Follow-up|5|||
131637462|NCT01340300|473958545|FG003|Overall Study|Lost to Follow-up|10|||
131637463|NCT01340300|473958542|FG000|Overall Study|Withdrawal by Subject|5|||
131637464|NCT01340300|473958543|FG001|Overall Study|Withdrawal by Subject|6|||
131637465|NCT01340300|473958544|FG002|Overall Study|Withdrawal by Subject|6|||
131637466|NCT01340300|473958545|FG003|Overall Study|Withdrawal by Subject|3|||
131637467|NCT01340300|473958542|FG000|Overall Study|Adverse Event|1|||
131637468|NCT01340300|473958543|FG001|Overall Study|Adverse Event|0|||
131637469|NCT01340300|473958544|FG002|Overall Study|Adverse Event|4|||
131637470|NCT01340300|473958545|FG003|Overall Study|Adverse Event|0|||
131637471|NCT01340300|473958542|FG000|Overall Study|Physician Decision|0|||
131902719|NCT02849080|474929375|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
131902720|NCT02849080|474929376|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
131902721|NCT02849080|474929377|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
131637472|NCT01340300|473958543|FG001|Overall Study|Physician Decision|1|||
131637473|NCT01340300|473958544|FG002|Overall Study|Physician Decision|0|||
131637474|NCT01340300|473958545|FG003|Overall Study|Physician Decision|0|||
131637475|NCT01340300|473958542|FG000|Overall Study|Unrelated sickness|0|||
131637476|NCT01340300|473958543|FG001|Overall Study|Unrelated sickness|2|||
131637477|NCT01340300|473958544|FG002|Overall Study|Unrelated sickness|0|||
131637478|NCT01340300|473958545|FG003|Overall Study|Unrelated sickness|1|||
131637479|NCT01954771|473958549|FG000|Overall Study|Missing HbA1c of end-point|1|||
131637480|NCT01954771|473958550|FG001|Overall Study|Missing HbA1c of end-point|1|||
131637481|NCT01954771|473958551|FG002|Overall Study|Missing HbA1c of end-point|0|||
131637482|NCT01954771|473958549|FG000|Overall Study|Missing CGMS of end-point|1|||
131637483|NCT01954771|473958550|FG001|Overall Study|Missing CGMS of end-point|1|||
131637484|NCT01954771|473958551|FG002|Overall Study|Missing CGMS of end-point|0|||
131637485|NCT01954771|473958549|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
131637486|NCT01954771|473958550|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
131637487|NCT01954771|473958551|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
131637488|NCT03635775|473958552|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
131637489|NCT03635775|473958553|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
131637490|NCT03635775|473958554|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
131637491|NCT03635775|473958555|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
131637492|NCT01287416|473958560|FG000|Pre-post Training|Withdrawal by Subject|17|||
131637493|NCT01287416|473958561|FG001|Pre-post Training|Withdrawal by Subject|24|||
131637494|NCT01287416|473958560|FG000|Pre-post Training|Lost to Follow-up|5|||
131637495|NCT01287416|473958561|FG001|Pre-post Training|Lost to Follow-up|1|||
131637496|NCT01287416|473958560|FG000|6 Month Follow-up|Lost to Follow-up|3|||
131637497|NCT01287416|473958561|FG001|6 Month Follow-up|Lost to Follow-up|2|||
131637498|NCT02506881|473958567|FG000|First Intervention (Day 1)|Protocol Violation|0|||
131637499|NCT02506881|473958568|FG001|First Intervention (Day 1)|Protocol Violation|0|||
131637500|NCT02506881|473958569|FG002|First Intervention (Day 1)|Protocol Violation|1|||
131637501|NCT02506881|473958570|FG003|First Intervention (Day 1)|Protocol Violation|0|||
131637502|NCT02506881|473958567|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
131637503|NCT02506881|473958568|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
131637504|NCT02506881|473958569|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131637505|NCT02506881|473958570|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
131637506|NCT02506881|473958567|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
131637507|NCT02506881|473958568|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
131637508|NCT02506881|473958569|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
131637509|NCT02506881|473958570|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
131637510|NCT01919398|473958571|FG000|Overall Study|Progressive Disease|0|||
131637511|NCT01919398|473958572|FG001|Overall Study|Progressive Disease|0|||
131637512|NCT01919398|473958573|FG002|Overall Study|Progressive Disease|4|||
131637513|NCT00050167|473958575|FG000|Overall Study|not eligible not invasive|1|||
131637514|NCT00050167|473958576|FG001|Overall Study|not eligible not invasive|1|||
131637515|NCT00495612|473958577|FG000|Overall Study|Lost to Follow-up|1|||
131637516|NCT00495612|473958578|FG001|Overall Study|Lost to Follow-up|0|||
131637517|NCT00495612|473958577|FG000|Overall Study|Subject's Decision to Withdraw|3|||
131637518|NCT00495612|473958578|FG001|Overall Study|Subject's Decision to Withdraw|0|||
131637519|NCT02154516|473958581|FG000|Overall Study|Withdrawal by Subject|0|||
131637520|NCT02154516|473958582|FG001|Overall Study|Withdrawal by Subject|1|||
131637521|NCT02154516|473958581|FG000|Overall Study|Lost to Follow-up|1|||
131637522|NCT02154516|473958582|FG001|Overall Study|Lost to Follow-up|0|||
131637523|NCT02154516|473958581|FG000|Overall Study|Removal/revision of device|1|||
131637524|NCT02154516|473958582|FG001|Overall Study|Removal/revision of device|0|||
131637525|NCT02154516|473958581|FG000|Overall Study|Death|2|||
131637526|NCT02154516|473958582|FG001|Overall Study|Death|1|||
131637527|NCT01772147|473960083|FG000|Overall Study|Adverse Event|13|||
131637528|NCT01772147|473960084|FG001|Overall Study|Adverse Event|10|||
131799211|NCT04634409|474548952|FG020|Overall Study|Death|0|||
131799212|NCT04634409|474548953|FG021|Overall Study|Death|0|||
131799213|NCT04634409|474548954|FG022|Overall Study|Death|0|||
131799214|NCT04634409|474548955|FG023|Overall Study|Death|0|||
131799215|NCT04634409|474548956|FG024|Overall Study|Death|0|||
131799216|NCT04634409|474548957|FG025|Overall Study|Death|0|||
131799217|NCT04634409|474548958|FG026|Overall Study|Death|0|||
131799218|NCT04634409|474548932|FG000|Overall Study|Adverse Event|0|||
131799219|NCT04634409|474548933|FG001|Overall Study|Adverse Event|0|||
131799220|NCT04634409|474548934|FG002|Overall Study|Adverse Event|1|||
131799221|NCT04634409|474548935|FG003|Overall Study|Adverse Event|0|||
131799222|NCT04634409|474548936|FG004|Overall Study|Adverse Event|0|||
131799223|NCT04634409|474548937|FG005|Overall Study|Adverse Event|1|||
131902722|NCT02849080|474929378|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
131902723|NCT02849080|474929375|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
131637529|NCT01772147|473960085|FG002|Overall Study|Adverse Event|6|||
131637530|NCT01772147|473960083|FG000|Overall Study|Withdrew Consent|7|||
131637531|NCT01772147|473960084|FG001|Overall Study|Withdrew Consent|8|||
131637532|NCT01772147|473960085|FG002|Overall Study|Withdrew Consent|4|||
131637533|NCT01772147|473960083|FG000|Overall Study|Lost to Follow-up|1|||
131637534|NCT01772147|473960084|FG001|Overall Study|Lost to Follow-up|0|||
131637535|NCT01772147|473960085|FG002|Overall Study|Lost to Follow-up|1|||
131799224|NCT04634409|474548938|FG006|Overall Study|Adverse Event|0|||
131902724|NCT02849080|474929376|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
131637536|NCT01772147|473960083|FG000|Overall Study|Protocol Deviation|2|||
131637537|NCT01772147|473960084|FG001|Overall Study|Protocol Deviation|1|||
131637538|NCT01772147|473960085|FG002|Overall Study|Protocol Deviation|1|||
131637539|NCT01772147|473960083|FG000|Overall Study|Lack of Efficacy|8|||
131637540|NCT01772147|473960084|FG001|Overall Study|Lack of Efficacy|6|||
131637541|NCT01772147|473960085|FG002|Overall Study|Lack of Efficacy|6|||
131637542|NCT02972242|473960086|FG000|Overall Study|Withdrawal by Subject|1|||
131637543|NCT02972242|473960087|FG001|Overall Study|Withdrawal by Subject|0|||
131637544|NCT04572997|473960088|FG000|Overall Study|Adverse Event|1|||
131637545|NCT00740597|473960089|FG000|Overall Study|insurance would not cover treatment|1|||
131637546|NCT00552513|473960092|FG000|Overall Study|Lost to Follow-up|5|||
131637547|NCT00552513|473960093|FG001|Overall Study|Lost to Follow-up|1|||
131637548|NCT01816685|473960094|FG000|Overall Study|Lost to Follow-up|7|||
131637549|NCT01816685|473960095|FG001|Overall Study|Lost to Follow-up|9|||
131637550|NCT01816685|473960094|FG000|Overall Study|Surgery Cancelled|3|||
131637551|NCT01816685|473960095|FG001|Overall Study|Surgery Cancelled|2|||
131637552|NCT01157351|473960096|FG000|Overall Study|Adverse Event|5|||
131637553|NCT01157351|473960097|FG001|Overall Study|Adverse Event|4|||
131637554|NCT01157351|473960096|FG000|Overall Study|Death|1|||
131637555|NCT01157351|473960097|FG001|Overall Study|Death|0|||
131637556|NCT01157351|473960096|FG000|Overall Study|Lost to Follow-up|53|||
131637557|NCT01157351|473960097|FG001|Overall Study|Lost to Follow-up|55|||
131637558|NCT01157351|473960096|FG000|Overall Study|Withdrawal by Subject|37|||
131637559|NCT01157351|473960097|FG001|Overall Study|Withdrawal by Subject|27|||
131637560|NCT01157351|473960096|FG000|Overall Study|Physician Decision|5|||
131637561|NCT01157351|473960097|FG001|Overall Study|Physician Decision|4|||
131637562|NCT01157351|473960096|FG000|Overall Study|Protocol Violation|0|||
131637563|NCT01157351|473960097|FG001|Overall Study|Protocol Violation|1|||
131637564|NCT01157351|473960096|FG000|Overall Study|Other|32|||
131637565|NCT01157351|473960097|FG001|Overall Study|Other|36|||
131637566|NCT01157351|473960096|FG000|Overall Study|Noncompliance with Study Drug|0|||
131637567|NCT01157351|473960097|FG001|Overall Study|Noncompliance with Study Drug|3|||
131637568|NCT01157351|473960096|FG000|Overall Study|Randomized but not Treated|4|||
131637569|NCT01157351|473960097|FG001|Overall Study|Randomized but not Treated|2|||
131637570|NCT00746785|473960098|FG000|Overall Study|Lost to Follow-up|29|||
131637571|NCT00746785|473960099|FG001|Overall Study|Lost to Follow-up|25|||
131637572|NCT00746785|473960100|FG002|Overall Study|Lost to Follow-up|27|||
131637573|NCT02517528|473960102|FG000|Overall Study|Withdrawal by Subject|1|||
131637574|NCT00684203|473960103|FG000|Overall Study|Adverse Event|6|||
131637575|NCT00684203|473960104|FG001|Overall Study|Adverse Event|4|||
131637576|NCT00684203|473960105|FG002|Overall Study|Adverse Event|8|||
131637577|NCT00684203|473960106|FG003|Overall Study|Adverse Event|0|||
131637578|NCT00684203|473960107|FG004|Overall Study|Adverse Event|0|||
131637579|NCT00684203|473960108|FG005|Overall Study|Adverse Event|0|||
131637580|NCT00684203|473960103|FG000|Overall Study|Protocol-defined clinical event|3|||
131637581|NCT00684203|473960104|FG001|Overall Study|Protocol-defined clinical event|1|||
131637582|NCT00684203|473960105|FG002|Overall Study|Protocol-defined clinical event|0|||
131637583|NCT00684203|473960106|FG003|Overall Study|Protocol-defined clinical event|0|||
131637584|NCT00684203|473960107|FG004|Overall Study|Protocol-defined clinical event|0|||
131637585|NCT00684203|473960108|FG005|Overall Study|Protocol-defined clinical event|0|||
131637586|NCT00684203|473960103|FG000|Overall Study|Withdrawal by Subject|0|||
131714258|NCT00474240|474231150|FG003|Overall Study|Removed due to lab value|0|||
131637587|NCT00684203|473960104|FG001|Overall Study|Withdrawal by Subject|2|||
131637588|NCT00684203|473960105|FG002|Overall Study|Withdrawal by Subject|1|||
131637589|NCT00684203|473960106|FG003|Overall Study|Withdrawal by Subject|0|||
131637590|NCT00684203|473960107|FG004|Overall Study|Withdrawal by Subject|0|||
131637591|NCT00684203|473960108|FG005|Overall Study|Withdrawal by Subject|0|||
131637592|NCT00684203|473960103|FG000|Overall Study|Did not meet protocol eligibility|0|||
131637593|NCT00684203|473960104|FG001|Overall Study|Did not meet protocol eligibility|1|||
131637594|NCT00684203|473960105|FG002|Overall Study|Did not meet protocol eligibility|0|||
131637595|NCT00684203|473960106|FG003|Overall Study|Did not meet protocol eligibility|0|||
131637596|NCT00684203|473960107|FG004|Overall Study|Did not meet protocol eligibility|0|||
131637597|NCT00684203|473960108|FG005|Overall Study|Did not meet protocol eligibility|0|||
131637598|NCT03418493|473960111|FG000|Overall Study|Adverse Event|1|||
131637599|NCT03418493|473960112|FG001|Overall Study|Adverse Event|0|||
131637600|NCT03418493|473960113|FG002|Overall Study|Adverse Event|0|||
131637601|NCT03418493|473960114|FG003|Overall Study|Adverse Event|0|||
131637602|NCT03418493|473960115|FG004|Overall Study|Adverse Event|0|||
131637603|NCT03418493|473960116|FG005|Overall Study|Adverse Event|0|||
131637604|NCT03418493|473960117|FG006|Overall Study|Adverse Event|0|||
131637605|NCT03418493|473960118|FG007|Overall Study|Adverse Event|0|||
131637606|NCT03418493|473960119|FG008|Overall Study|Adverse Event|0|||
131637607|NCT03418493|473960120|FG009|Overall Study|Adverse Event|0|||
131637608|NCT03418493|473960121|FG010|Overall Study|Adverse Event|0|||
131637609|NCT03418493|473960111|FG000|Overall Study|Protocol Violation|0|||
131714259|NCT00474240|474231151|FG004|Overall Study|Removed due to lab value|0|||
131637610|NCT03418493|473960112|FG001|Overall Study|Protocol Violation|0|||
131637611|NCT03418493|473960113|FG002|Overall Study|Protocol Violation|0|||
131637612|NCT03418493|473960114|FG003|Overall Study|Protocol Violation|0|||
131637613|NCT03418493|473960115|FG004|Overall Study|Protocol Violation|0|||
131637614|NCT03418493|473960116|FG005|Overall Study|Protocol Violation|0|||
131637615|NCT03418493|473960117|FG006|Overall Study|Protocol Violation|0|||
131637616|NCT03418493|473960118|FG007|Overall Study|Protocol Violation|0|||
131637617|NCT03418493|473960119|FG008|Overall Study|Protocol Violation|0|||
131637618|NCT03418493|473960120|FG009|Overall Study|Protocol Violation|1|||
131637619|NCT03418493|473960121|FG010|Overall Study|Protocol Violation|0|||
131637620|NCT00719212|473960122|FG000|Overall Study|Death|41|||
131637621|NCT00719212|473960122|FG000|Overall Study|Lost to Follow-up|2|||
131637622|NCT00719212|473960122|FG000|Overall Study|Withdrawal by Subject|1|||
131637623|NCT05446714|473960123|FG000|Overall Study|Lost to Follow-up|1|||
131637624|NCT05446714|473960124|FG001|Overall Study|Lost to Follow-up|3|||
131637625|NCT05446714|473960125|FG002|Overall Study|Lost to Follow-up|2|||
131637626|NCT05446714|473960123|FG000|Overall Study|Protocol Violation|2|||
131637627|NCT05446714|473960124|FG001|Overall Study|Protocol Violation|0|||
131637628|NCT05446714|473960125|FG002|Overall Study|Protocol Violation|0|||
131637629|NCT01990313|473960128|FG000|Overall Study|Lost to Follow-up|1|||
131637630|NCT03511378|473960129|FG000|Overall Study|Withdrawal by Subject|2|||
131637631|NCT03511378|473960130|FG001|Overall Study|Withdrawal by Subject|2|||
131637632|NCT03511378|473960129|FG000|Overall Study|Patient not coming or schedule visit|1|||
131637633|NCT03511378|473960130|FG001|Overall Study|Patient not coming or schedule visit|0|||
131637634|NCT00837096|473960131|FG000|Overall Study|Physician Decision|1|||
131637635|NCT00837096|473960132|FG001|Overall Study|Physician Decision|1|||
131637636|NCT00837096|473960131|FG000|Overall Study|Not reported|9|||
131637637|NCT00837096|473960132|FG001|Overall Study|Not reported|8|||
131637638|NCT03226106|473960133|FG000|Overall Study|Withdrawal by Subject|2|||
131637639|NCT03226106|473960134|FG001|Overall Study|Withdrawal by Subject|0|||
131637640|NCT03226106|473960133|FG000|Overall Study|Adverse Event|1|||
131637641|NCT03226106|473960134|FG001|Overall Study|Adverse Event|0|||
131637642|NCT03226106|473960133|FG000|Overall Study|Lost to Follow-up|2|||
131637643|NCT03226106|473960134|FG001|Overall Study|Lost to Follow-up|0|||
131637644|NCT00721214|473960135|FG000|Overall Study|Chose another center for transplant|1|||
131637645|NCT00721214|473960135|FG000|Overall Study|Death|3|||
131637646|NCT00280683|473960136|FG000|Overall Study|Withdrawal by Subject|1|||
131637647|NCT00280683|473960137|FG001|Overall Study|Withdrawal by Subject|2|||
131637648|NCT00280683|473960136|FG000|Overall Study|Adverse Event|1|||
131637649|NCT00280683|473960137|FG001|Overall Study|Adverse Event|1|||
131637650|NCT01243411|473960138|FG000|Overall Study|Withdrawal by Subject|18|||
131637651|NCT01243411|473960138|FG000|Overall Study|Lost to Follow-up|10|||
131637652|NCT01243411|473960138|FG000|Overall Study|Adverse Event|5|||
131637653|NCT01243411|473960138|FG000|Overall Study|Other|8|||
131637654|NCT02396953|473960141|FG000|Overall Study|Withdrawal by Subject|0|||
131637655|NCT02396953|473960142|FG001|Overall Study|Withdrawal by Subject|0|||
131637656|NCT02396953|473960143|FG002|Overall Study|Withdrawal by Subject|1|||
131637657|NCT02396953|473960141|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
131637658|NCT02396953|473960142|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
131637659|NCT02396953|473960143|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
131637660|NCT02396953|473960141|FG000|Overall Study|Personal Reasons|1|||
131637661|NCT02396953|473960142|FG001|Overall Study|Personal Reasons|1|||
131637662|NCT02396953|473960143|FG002|Overall Study|Personal Reasons|0|||
131637663|NCT00510198|473960144|FG000|Overall Study|Withdrawal by Subject|5|||
131637664|NCT00510198|473960145|FG001|Overall Study|Withdrawal by Subject|4|||
131637665|NCT00488319|473960146|FG000|Overall Study|Adverse Event|1|||
131637666|NCT00488319|473960147|FG001|Overall Study|Adverse Event|2|||
131714260|NCT00474240|474231152|FG005|Overall Study|Removed due to lab value|1|||
131714261|NCT04026568|474231153|FG000|Overall Study|study terminated|0|||
131714262|NCT04026568|474231154|FG001|Overall Study|study terminated|1|||
131714263|NCT02197377|474231157|FG000|Overall Study|Insertion Failure|0|||
131714264|NCT02197377|474231158|FG001|Overall Study|Insertion Failure|3|||
131714265|NCT01773473|474231159|FG000|Overall Study|Adverse Event|3|||
131714266|NCT01773473|474231160|FG001|Overall Study|Adverse Event|2|||
131714267|NCT01773473|474231159|FG000|Overall Study|Protocol Violation|0|||
131714268|NCT01773473|474231160|FG001|Overall Study|Protocol Violation|4|||
131714269|NCT01773473|474231159|FG000|Overall Study|Physician Decision|3|||
131714270|NCT01773473|474231160|FG001|Overall Study|Physician Decision|5|||
131714271|NCT01773473|474231159|FG000|Overall Study|Sponsor Decision|2|||
131637667|NCT00488319|473960148|FG002|Overall Study|Adverse Event|23|||
131637668|NCT00488319|473960146|FG000|Overall Study|Lack of Efficacy|6|||
131714272|NCT01773473|474231160|FG001|Overall Study|Sponsor Decision|0|||
131714273|NCT01773473|474231159|FG000|Overall Study|Lack of Efficacy|0|||
131714274|NCT01773473|474231160|FG001|Overall Study|Lack of Efficacy|1|||
131637669|NCT00488319|473960147|FG001|Overall Study|Lack of Efficacy|12|||
131637670|NCT00488319|473960148|FG002|Overall Study|Lack of Efficacy|27|||
131637671|NCT00488319|473960146|FG000|Overall Study|Lost to Follow-up|3|||
131637672|NCT00488319|473960147|FG001|Overall Study|Lost to Follow-up|5|||
131637673|NCT00488319|473960148|FG002|Overall Study|Lost to Follow-up|16|||
131637674|NCT00488319|473960146|FG000|Overall Study|Withdrawal by Subject|5|||
131714275|NCT01773473|474231159|FG000|Overall Study|Non-Compliance with study drug|1|||
131799225|NCT04634409|474548939|FG007|Overall Study|Adverse Event|0|||
131799226|NCT04634409|474548940|FG008|Overall Study|Adverse Event|0|||
131637675|NCT00488319|473960147|FG001|Overall Study|Withdrawal by Subject|20|||
131637676|NCT00488319|473960148|FG002|Overall Study|Withdrawal by Subject|44|||
131637677|NCT00488319|473960146|FG000|Overall Study|Other reasons for withdrawal|0|||
131637678|NCT00488319|473960147|FG001|Overall Study|Other reasons for withdrawal|4|||
131637679|NCT00488319|473960148|FG002|Overall Study|Other reasons for withdrawal|12|||
131637680|NCT03712449|473960152|FG000|Overall Study|Withdraw Consent|0|||
131637681|NCT03712449|473960153|FG001|Overall Study|Withdraw Consent|1|||
131637682|NCT05153499|473960159|FG000|Overall Study|Withdrawal by Subject|1|||
131637683|NCT05153499|473960160|FG001|Overall Study|Withdrawal by Subject|0|||
131637684|NCT05153499|473960159|FG000|Overall Study|Clinical Hold|1|||
131637685|NCT05153499|473960160|FG001|Overall Study|Clinical Hold|0|||
131637686|NCT05153499|473960159|FG000|Overall Study|Study Termination|6|||
131637687|NCT05153499|473960160|FG001|Overall Study|Study Termination|5|||
131637688|NCT02166047|473960162|FG000|Overall Study|Withdrawal by Participant|0|||
131637689|NCT02166047|473960163|FG001|Overall Study|Withdrawal by Participant|1|||
131637690|NCT02166047|473960164|FG002|Overall Study|Withdrawal by Participant|2|||
131637691|NCT02166047|473960165|FG003|Overall Study|Withdrawal by Participant|0|||
131637692|NCT02166047|473960166|FG004|Overall Study|Withdrawal by Participant|0|||
131637693|NCT02166047|473960167|FG005|Overall Study|Withdrawal by Participant|0|||
131637694|NCT02166047|473960168|FG006|Overall Study|Withdrawal by Participant|1|||
131637695|NCT02166047|473960169|FG007|Overall Study|Withdrawal by Participant|0|||
131637696|NCT02166047|473960170|FG008|Overall Study|Withdrawal by Participant|0|||
131637697|NCT02166047|473960171|FG009|Overall Study|Withdrawal by Participant|0|||
131637698|NCT02166047|473960172|FG010|Overall Study|Withdrawal by Participant|0|||
131637699|NCT02166047|473960173|FG011|Overall Study|Withdrawal by Participant|0|||
131637700|NCT02166047|473960162|FG000|Overall Study|Adverse Event|0|||
131637701|NCT02166047|473960163|FG001|Overall Study|Adverse Event|0|||
131637702|NCT02166047|473960164|FG002|Overall Study|Adverse Event|0|||
131637703|NCT02166047|473960165|FG003|Overall Study|Adverse Event|0|||
131637704|NCT02166047|473960166|FG004|Overall Study|Adverse Event|1|||
131637705|NCT02166047|473960167|FG005|Overall Study|Adverse Event|0|||
131637706|NCT02166047|473960168|FG006|Overall Study|Adverse Event|1|||
131637707|NCT02166047|473960169|FG007|Overall Study|Adverse Event|0|||
131637708|NCT02166047|473960170|FG008|Overall Study|Adverse Event|0|||
131637709|NCT02166047|473960171|FG009|Overall Study|Adverse Event|0|||
131637710|NCT02166047|473960172|FG010|Overall Study|Adverse Event|2|||
131637711|NCT02166047|473960173|FG011|Overall Study|Adverse Event|0|||
131637712|NCT00451555|473960180|FG000|Overall Study|Protocol Violation|2|||
131714276|NCT01773473|474231160|FG001|Overall Study|Non-Compliance with study drug|4|||
131714277|NCT01773473|474231159|FG000|Overall Study|Withdrawal by Subject|5|||
131714278|NCT01773473|474231160|FG001|Overall Study|Withdrawal by Subject|3|||
131714279|NCT01773473|474231159|FG000|Overall Study|Lost to Follow-up|2|||
131714280|NCT01773473|474231160|FG001|Overall Study|Lost to Follow-up|0|||
131714281|NCT02561156|474231161|FG000|Part 2|Adverse Event|0|||
131714282|NCT02561156|474231162|FG001|Part 2|Adverse Event|0|||
131714283|NCT02561156|474231163|FG002|Part 2|Adverse Event|0|||
131714284|NCT02561156|474231164|FG003|Part 2|Adverse Event|0|||
131714285|NCT02561156|474231165|FG004|Part 2|Adverse Event|0|||
131799227|NCT04634409|474548941|FG009|Overall Study|Adverse Event|0|||
131799228|NCT04634409|474548942|FG010|Overall Study|Adverse Event|0|||
131799229|NCT04634409|474548943|FG011|Overall Study|Adverse Event|0|||
131799230|NCT04634409|474548944|FG012|Overall Study|Adverse Event|0|||
131799231|NCT04634409|474548945|FG013|Overall Study|Adverse Event|0|||
131799232|NCT04634409|474548946|FG014|Overall Study|Adverse Event|0|||
131799233|NCT04634409|474548947|FG015|Overall Study|Adverse Event|0|||
131799234|NCT04634409|474548948|FG016|Overall Study|Adverse Event|0|||
131799235|NCT04634409|474548949|FG017|Overall Study|Adverse Event|0|||
131799236|NCT04634409|474548950|FG018|Overall Study|Adverse Event|0|||
131799237|NCT04634409|474548951|FG019|Overall Study|Adverse Event|0|||
131799238|NCT04634409|474548952|FG020|Overall Study|Adverse Event|0|||
131799239|NCT04634409|474548953|FG021|Overall Study|Adverse Event|0|||
131799240|NCT04634409|474548954|FG022|Overall Study|Adverse Event|0|||
131799241|NCT04634409|474548955|FG023|Overall Study|Adverse Event|0|||
131799242|NCT04634409|474548956|FG024|Overall Study|Adverse Event|0|||
131799243|NCT04634409|474548957|FG025|Overall Study|Adverse Event|0|||
131799244|NCT04634409|474548958|FG026|Overall Study|Adverse Event|0|||
131637713|NCT00451555|473960181|FG001|Overall Study|Protocol Violation|2|||
131637714|NCT00451555|473960180|FG000|Overall Study|Adverse Event|3|||
131637715|NCT00451555|473960181|FG001|Overall Study|Adverse Event|1|||
131637716|NCT00451555|473960180|FG000|Overall Study|Withdrawal by Subject|6|||
131637717|NCT00451555|473960181|FG001|Overall Study|Withdrawal by Subject|0|||
131637718|NCT00451555|473960180|FG000|Overall Study|Physician Decision|2|||
131637719|NCT00451555|473960181|FG001|Overall Study|Physician Decision|1|||
131637720|NCT00922441|473960184|FG000|Overall Study|Protocol Violation|0|||
131637721|NCT00922441|473960185|FG001|Overall Study|Protocol Violation|0|||
131637722|NCT00922441|473960186|FG002|Overall Study|Protocol Violation|2|||
131637723|NCT00922441|473960184|FG000|Overall Study|Withdrawal by Subject|0|||
131799245|NCT04634409|474548932|FG000|Overall Study|Lost to Follow-up|3|||
131799246|NCT04634409|474548933|FG001|Overall Study|Lost to Follow-up|1|||
131799247|NCT04634409|474548934|FG002|Overall Study|Lost to Follow-up|1|||
131637724|NCT00922441|473960185|FG001|Overall Study|Withdrawal by Subject|0|||
131637725|NCT00922441|473960186|FG002|Overall Study|Withdrawal by Subject|1|||
131637726|NCT02973477|473960189|FG000|First Intervention|Lost to Follow-up|0|||
131637727|NCT02973477|473960190|FG001|First Intervention|Lost to Follow-up|2|||
131637728|NCT02973477|473960189|FG000|Washout|Withdrawal by Subject|1|||
131637729|NCT02973477|473960190|FG001|Washout|Withdrawal by Subject|0|||
131637730|NCT02973477|473960189|FG000|Second Intervention|Lost to Follow-up|1|||
131637731|NCT02973477|473960190|FG001|Second Intervention|Lost to Follow-up|0|||
131637732|NCT00317603|473960193|FG000|Overall Study|Progressive Disease|3|||
131637733|NCT00523549|473960194|FG000|Overall Study|Adverse Event|6|||
131637734|NCT00523549|473960195|FG001|Overall Study|Adverse Event|3|||
131637735|NCT00523549|473960194|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131637736|NCT00523549|473960195|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131637737|NCT00523549|473960194|FG000|Overall Study|Protocol Deviation|3|||
131637738|NCT00523549|473960195|FG001|Overall Study|Protocol Deviation|1|||
131637739|NCT00523549|473960194|FG000|Overall Study|Patient withdrew consent|7|||
131637740|NCT00523549|473960195|FG001|Overall Study|Patient withdrew consent|6|||
131637741|NCT00523549|473960194|FG000|Overall Study|Lost to Follow-up|3|||
131637742|NCT00523549|473960195|FG001|Overall Study|Lost to Follow-up|5|||
131637743|NCT00588341|473960196|FG000|Overall Study|Withdrawal by Subject|3|||
131637744|NCT00588341|473960196|FG000|Overall Study|Not treated due to metastatic disease|1|||
131637745|NCT00588341|473960196|FG000|Overall Study|Patient ineligible|1|||
131637746|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
131637747|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131637748|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131637749|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131637750|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131637751|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
131637752|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131637753|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131637754|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131637755|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131637756|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
131637757|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131637758|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131637759|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131637760|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131637761|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
131637762|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131637763|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131637764|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131637765|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131637766|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
131637767|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131637768|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131637769|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131637770|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131637771|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
131637772|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131637773|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131637774|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131637775|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131637776|NCT01187407|473960198|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
131637777|NCT01187407|473960199|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131637778|NCT01187407|473960200|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131637779|NCT01187407|473960201|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131637780|NCT01187407|473960202|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131637781|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
131637782|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
131637783|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
131637784|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
131637785|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
131799248|NCT04634409|474548935|FG003|Overall Study|Lost to Follow-up|3|||
131799249|NCT04634409|474548936|FG004|Overall Study|Lost to Follow-up|1|||
131799250|NCT04634409|474548937|FG005|Overall Study|Lost to Follow-up|1|||
131714286|NCT02561156|474231166|FG005|Part 2|Adverse Event|0|||
131714287|NCT02561156|474231167|FG006|Part 2|Adverse Event|0|||
131714288|NCT02561156|474231168|FG007|Part 2|Adverse Event|0|||
131714289|NCT02561156|474231169|FG008|Part 2|Adverse Event|0|||
131714290|NCT02561156|474231170|FG009|Part 2|Adverse Event|0|||
131714291|NCT02561156|474231171|FG010|Part 2|Adverse Event|0|||
131714292|NCT02561156|474231172|FG011|Part 2|Adverse Event|1|||
131714293|NCT02561156|474231173|FG012|Part 2|Adverse Event|0|||
131714294|NCT01071070|474231177|FG000|Overall Study|Adverse Event|0|||
131714295|NCT01071070|474231178|FG001|Overall Study|Adverse Event|3|||
131714296|NCT01071070|474231177|FG000|Overall Study|Withdrawal by Subject|1|||
131714297|NCT01071070|474231178|FG001|Overall Study|Withdrawal by Subject|0|||
131714298|NCT01071070|474231177|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
131714299|NCT01071070|474231178|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
131714300|NCT01071070|474231177|FG000|Overall Study|Hypercalcemia|1|||
131714301|NCT01071070|474231178|FG001|Overall Study|Hypercalcemia|0|||
131714302|NCT02203149|474231181|FG000|Part 1|Adverse Event|0|||
131714303|NCT02203149|474231182|FG001|Part 1|Adverse Event|1|||
131714304|NCT02203149|474231183|FG002|Part 1|Adverse Event|0|||
131714305|NCT02203149|474231184|FG003|Part 1|Adverse Event|0|||
131714306|NCT02203149|474231185|FG004|Part 1|Adverse Event|0|||
131714307|NCT02203149|474231181|FG000|Part 2|Death|0|||
131714308|NCT02203149|474231182|FG001|Part 2|Death|0|||
131714309|NCT02203149|474231183|FG002|Part 2|Death|1|||
131714310|NCT02203149|474231184|FG003|Part 2|Death|1|||
131714311|NCT02203149|474231185|FG004|Part 2|Death|0|||
131714312|NCT02203149|474231181|FG000|Part 2|Withdrawal by Subject|0|||
131714313|NCT02203149|474231182|FG001|Part 2|Withdrawal by Subject|0|||
131714314|NCT02203149|474231183|FG002|Part 2|Withdrawal by Subject|0|||
131714315|NCT02203149|474231184|FG003|Part 2|Withdrawal by Subject|1|||
131714316|NCT02203149|474231185|FG004|Part 2|Withdrawal by Subject|0|||
131714317|NCT02203149|474231181|FG000|Part 2|Adverse Event|0|||
131714318|NCT02203149|474231182|FG001|Part 2|Adverse Event|0|||
131714319|NCT02203149|474231183|FG002|Part 2|Adverse Event|0|||
131714320|NCT02203149|474231184|FG003|Part 2|Adverse Event|1|||
131714321|NCT02203149|474231185|FG004|Part 2|Adverse Event|1|||
131714322|NCT01454076|474231187|FG000|Overall Study|Other|2|||
131714323|NCT01454076|474231188|FG001|Overall Study|Other|0|||
131714324|NCT01454076|474231189|FG002|Overall Study|Other|0|||
131714325|NCT01454076|474231190|FG003|Overall Study|Other|1|||
131714326|NCT01454076|474231191|FG004|Overall Study|Other|2|||
131714327|NCT01454076|474231187|FG000|Overall Study|Withdrawal by Subject|3|||
131714328|NCT01454076|474231188|FG001|Overall Study|Withdrawal by Subject|4|||
131714329|NCT01454076|474231189|FG002|Overall Study|Withdrawal by Subject|2|||
131714330|NCT01454076|474231190|FG003|Overall Study|Withdrawal by Subject|1|||
131714331|NCT01454076|474231191|FG004|Overall Study|Withdrawal by Subject|2|||
131714332|NCT01454076|474231187|FG000|Overall Study|Adverse Event|8|||
131714333|NCT01454076|474231188|FG001|Overall Study|Adverse Event|2|||
131714334|NCT01454076|474231189|FG002|Overall Study|Adverse Event|7|||
131714335|NCT01454076|474231190|FG003|Overall Study|Adverse Event|0|||
131714336|NCT01454076|474231191|FG004|Overall Study|Adverse Event|2|||
131714337|NCT01478958|474231192|FG000|Overall Study|Withdrawal by Subject|1|||
131714338|NCT01478958|474231193|FG001|Overall Study|Withdrawal by Subject|1|||
131714339|NCT01478958|474231194|FG002|Overall Study|Withdrawal by Subject|1|||
131714340|NCT01478958|474231192|FG000|Overall Study|Weight loss|1|||
131714341|NCT01478958|474231193|FG001|Overall Study|Weight loss|0|||
131714342|NCT01478958|474231194|FG002|Overall Study|Weight loss|0|||
131714343|NCT01478958|474231192|FG000|Overall Study|Re-located|0|||
131714344|NCT01478958|474231193|FG001|Overall Study|Re-located|1|||
131714345|NCT01478958|474231194|FG002|Overall Study|Re-located|0|||
131714346|NCT01478958|474231192|FG000|Overall Study|Unable to comply|0|||
131714347|NCT01478958|474231193|FG001|Overall Study|Unable to comply|0|||
131714348|NCT01478958|474231194|FG002|Overall Study|Unable to comply|2|||
131714349|NCT03401749|474231195|FG000|Overall Study|Lost to Follow-up|20|||
131714350|NCT03401749|474231196|FG001|Overall Study|Lost to Follow-up|16|||
131714351|NCT03401749|474231197|FG002|Overall Study|Lost to Follow-up|26|||
131714352|NCT01193686|474231198|FG000|Overall Study|Withdrawal by Subject|4|||
131714353|NCT01193686|474231199|FG001|Overall Study|Withdrawal by Subject|1|||
131714354|NCT01193686|474231198|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
131714355|NCT01193686|474231199|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
131714356|NCT00432809|474231200|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
131714357|NCT00432809|474231201|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
131714358|NCT00432809|474231202|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
131714359|NCT00432809|474231200|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
131714360|NCT00432809|474231201|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
131714361|NCT00432809|474231202|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
131714362|NCT03075839|474231203|FG000|Overall Study|Lost to Follow-up|4|||
131714363|NCT04433117|474231204|FG000|Overall Study|Withdrawal by Subject|1|||
131637786|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
131637787|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
131637788|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
131637789|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
131637790|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
131637791|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
131637792|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
131637793|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
131637794|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
131637795|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
131637796|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131637797|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131637798|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131637799|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131637800|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
131637801|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
131637802|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
131637803|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131637804|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
131637805|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
131637806|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
131637807|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
131637808|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
131637809|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
131637810|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
131637811|NCT01187407|473960198|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131637812|NCT01187407|473960199|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131637813|NCT01187407|473960200|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131637814|NCT01187407|473960201|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131637815|NCT01187407|473960202|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
131637816|NCT02996097|473960203|FG000|Overall Study|Lost to Follow-up|11|||
131637817|NCT02996097|473960204|FG001|Overall Study|Lost to Follow-up|11|||
131637818|NCT00583115|473960205|FG000|Overall Study|Death|1|||
131637819|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
131637820|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
131637821|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
131637822|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
131637823|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
131637824|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
131637825|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
131637826|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
131637827|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
131637828|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
131637829|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
131637830|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
131637831|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
131637832|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
131637833|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
131637834|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
131637835|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
131637836|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
131637837|NCT03569475|473960206|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
131637838|NCT03569475|473960207|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
131637839|NCT03569475|473960208|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
131637840|NCT03569475|473960206|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
131637841|NCT03569475|473960207|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
131637842|NCT03569475|473960208|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
131637843|NCT03569475|473960206|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
131637844|NCT03569475|473960207|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
131637845|NCT03569475|473960208|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
131637846|NCT03638258|473960209|FG000|Overall Study|Adverse Event|1|||
131637847|NCT03638258|473960210|FG001|Overall Study|Adverse Event|0|||
131637848|NCT03638258|473960211|FG002|Overall Study|Adverse Event|2|||
131637849|NCT03638258|473960209|FG000|Overall Study|Lost to Follow-up|2|||
131637850|NCT03638258|473960210|FG001|Overall Study|Lost to Follow-up|4|||
131637851|NCT03638258|473960211|FG002|Overall Study|Lost to Follow-up|5|||
131637852|NCT03638258|473960209|FG000|Overall Study|Pregnancy|0|||
131637853|NCT03638258|473960210|FG001|Overall Study|Pregnancy|0|||
131637854|NCT03638258|473960211|FG002|Overall Study|Pregnancy|1|||
131637855|NCT03638258|473960209|FG000|Overall Study|Protocol Violation|0|||
131637856|NCT03638258|473960210|FG001|Overall Study|Protocol Violation|0|||
131637857|NCT03638258|473960211|FG002|Overall Study|Protocol Violation|1|||
131637858|NCT03638258|473960209|FG000|Overall Study|Withdrawal by Subject|4|||
131637859|NCT03638258|473960210|FG001|Overall Study|Withdrawal by Subject|5|||
131637860|NCT03638258|473960211|FG002|Overall Study|Withdrawal by Subject|12|||
131637861|NCT03638258|473960209|FG000|Overall Study|Lack of Efficacy|0|||
131637862|NCT03638258|473960210|FG001|Overall Study|Lack of Efficacy|0|||
131637863|NCT03638258|473960211|FG002|Overall Study|Lack of Efficacy|2|||
131637864|NCT02109107|473960214|FG000|Overall Study|Lost to Follow-up|2|||
131637865|NCT02865135|473960215|FG000|Overall Study|Death|0|||
131637866|NCT02865135|473960216|FG001|Overall Study|Death|1|||
131637867|NCT02865135|473960217|FG002|Overall Study|Death|0|||
131637868|NCT02865135|473960215|FG000|Overall Study|Progression|6|||
131637869|NCT02865135|473960216|FG001|Overall Study|Progression|2|||
131637870|NCT02865135|473960217|FG002|Overall Study|Progression|2|||
131637871|NCT01071317|473960218|FG000|Overall Study|Lost to Follow-up|2|||
131637872|NCT01071317|473960219|FG001|Overall Study|Lost to Follow-up|2|||
131637873|NCT02273180|473960220|FG000|Overall Study|Adverse Event|2|||
131637874|NCT02273180|473960221|FG001|Overall Study|Adverse Event|2|||
131637875|NCT02273180|473960220|FG000|Overall Study|Lack of Efficacy|1|||
131637876|NCT02273180|473960221|FG001|Overall Study|Lack of Efficacy|0|||
131637877|NCT02273180|473960220|FG000|Overall Study|Protocol Violation|1|||
131637878|NCT02273180|473960221|FG001|Overall Study|Protocol Violation|7|||
131637879|NCT02273180|473960220|FG000|Overall Study|Randomized but not treated|1|||
131637880|NCT02273180|473960221|FG001|Overall Study|Randomized but not treated|0|||
131637881|NCT02273180|473960220|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
131637882|NCT02273180|473960221|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
131637883|NCT02273180|473960220|FG000|Overall Study|Other than specified above|21|||
131637884|NCT02273180|473960221|FG001|Overall Study|Other than specified above|10|||
131637885|NCT00509925|473960222|FG000|Overall Study|Personal reasons|0|||
131637886|NCT00509925|473960223|FG001|Overall Study|Personal reasons|1|||
131637887|NCT03749616|473960226|FG000|Overall Study|Lost to Follow-up|4|||
131637888|NCT03749616|473960227|FG001|Overall Study|Lost to Follow-up|7|||
131637889|NCT03749616|473960226|FG000|Overall Study|Screen Failure|1|||
131637890|NCT03749616|473960227|FG001|Overall Study|Screen Failure|1|||
131637891|NCT03749616|473960226|FG000|Overall Study|Withdrawal by Subject|2|||
131637892|NCT03749616|473960227|FG001|Overall Study|Withdrawal by Subject|0|||
131637893|NCT04435522|473960230|FG000|Overall Study|Withdrawal by Subject|2|||
131714364|NCT04433117|474231205|FG001|Overall Study|Withdrawal by Subject|0|||
131714365|NCT00707577|474231206|FG000|Overall Study|Withdrawal by Subject|3|||
131637894|NCT03302559|473960231|FG000|Overall Study|Adverse Event|2|||
131637895|NCT03302559|473960231|FG000|Overall Study|Lost to Follow-up|1|||
131637896|NCT03302559|473960231|FG000|Overall Study|Withdrew Consent|3|||
131637897|NCT00951171|473960232|FG000|Overall Study|Adverse Event|2|||
131714366|NCT00707577|474231207|FG001|Overall Study|Withdrawal by Subject|2|||
131637898|NCT00951171|473960233|FG001|Overall Study|Adverse Event|0|||
131637899|NCT00919061|473960234|FG000|Overall Study|Adverse Event|1|||
131637900|NCT00919061|473960234|FG000|Overall Study|Withdrawal by Subject|1|||
131637901|NCT04130061|473960237|FG000|Overall Study|OR team forgot to request membrane|1|||
131637902|NCT04130061|473960238|FG001|Overall Study|OR team forgot to request membrane|0|||
131637903|NCT05294328|473960245|FG000|Overall Study|Adverse Event|1|||
131637904|NCT05294328|473960246|FG001|Overall Study|Adverse Event|0|||
131637905|NCT05294328|473960247|FG002|Overall Study|Adverse Event|0|||
131637906|NCT05294328|473960245|FG000|Overall Study|Physician Decision|1|||
131637907|NCT05294328|473960246|FG001|Overall Study|Physician Decision|1|||
131637908|NCT05294328|473960247|FG002|Overall Study|Physician Decision|0|||
131637909|NCT05294328|473960245|FG000|Overall Study|Withdrawal by Subject|0|||
131637910|NCT05294328|473960246|FG001|Overall Study|Withdrawal by Subject|2|||
131637911|NCT05294328|473960247|FG002|Overall Study|Withdrawal by Subject|1|||
131637912|NCT05294328|473960245|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
131637913|NCT05294328|473960246|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
131637914|NCT05294328|473960247|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
131637915|NCT02056873|473960248|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
131637916|NCT00113269|473961785|FG000|Overall Study|Not transplanted, donor issues|4|||
131637917|NCT00113269|473961786|FG001|Overall Study|Not transplanted, donor issues|0|||
131637918|NCT00113269|473961787|FG002|Overall Study|Not transplanted, donor issues|2|||
131637919|NCT00113269|473961788|FG003|Overall Study|Not transplanted, donor issues|2|||
131637920|NCT00113269|473961785|FG000|Overall Study|Not transplanted, recipient issues|2|||
131637921|NCT00113269|473961786|FG001|Overall Study|Not transplanted, recipient issues|1|||
131637922|NCT00113269|473961787|FG002|Overall Study|Not transplanted, recipient issues|7|||
131637923|NCT00113269|473961788|FG003|Overall Study|Not transplanted, recipient issues|4|||
131637924|NCT00113269|473961785|FG000|Overall Study|Early graft loss, technical|0|||
131637925|NCT00113269|473961786|FG001|Overall Study|Early graft loss, technical|0|||
131637926|NCT00113269|473961787|FG002|Overall Study|Early graft loss, technical|2|||
131637927|NCT00113269|473961788|FG003|Overall Study|Early graft loss, technical|0|||
131637928|NCT00113269|473961785|FG000|Overall Study|Death in operating room|0|||
131637929|NCT00113269|473961786|FG001|Overall Study|Death in operating room|0|||
131637930|NCT00113269|473961787|FG002|Overall Study|Death in operating room|0|||
131637931|NCT00113269|473961788|FG003|Overall Study|Death in operating room|1|||
131637932|NCT00113269|473961785|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
131637933|NCT00113269|473961786|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
131637934|NCT00113269|473961787|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
131637935|NCT00113269|473961788|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
131637936|NCT00113269|473961785|FG000|Overall Study|Adverse Event|2|||
131637937|NCT00113269|473961786|FG001|Overall Study|Adverse Event|7|||
131637938|NCT00113269|473961787|FG002|Overall Study|Adverse Event|11|||
131637939|NCT00113269|473961788|FG003|Overall Study|Adverse Event|7|||
131714367|NCT00707577|474231206|FG000|Overall Study|Lost to Follow-up|34|||
131445096|NCT04672239|473258830|FG000|Week 6 Survey|Failed survey check items|2|||
131445097|NCT04672239|473258831|FG001|Week 6 Survey|Failed survey check items|2|||
131445098|NCT04672239|473258832|FG002|Week 6 Survey|Failed survey check items|2|||
131637940|NCT00113269|473961785|FG000|Overall Study|Withdrawal by Subject|4|||
131637941|NCT00113269|473961786|FG001|Overall Study|Withdrawal by Subject|3|||
131637942|NCT00113269|473961787|FG002|Overall Study|Withdrawal by Subject|4|||
131637943|NCT00113269|473961788|FG003|Overall Study|Withdrawal by Subject|2|||
131637944|NCT00113269|473961785|FG000|Overall Study|Graft loss|6|||
131637945|NCT00113269|473961786|FG001|Overall Study|Graft loss|6|||
131637946|NCT00113269|473961787|FG002|Overall Study|Graft loss|4|||
131637947|NCT00113269|473961788|FG003|Overall Study|Graft loss|9|||
131637948|NCT00113269|473961785|FG000|Overall Study|Protocol Violation|1|||
131637949|NCT00113269|473961786|FG001|Overall Study|Protocol Violation|0|||
131637950|NCT00113269|473961787|FG002|Overall Study|Protocol Violation|4|||
131637951|NCT00113269|473961788|FG003|Overall Study|Protocol Violation|2|||
131637952|NCT00113269|473961785|FG000|Overall Study|Lost to Follow-up|2|||
131637953|NCT00113269|473961786|FG001|Overall Study|Lost to Follow-up|3|||
131637954|NCT00113269|473961787|FG002|Overall Study|Lost to Follow-up|6|||
131637955|NCT00113269|473961788|FG003|Overall Study|Lost to Follow-up|3|||
131637956|NCT00113269|473961785|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
131637957|NCT00113269|473961786|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
131637958|NCT00113269|473961787|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
131637959|NCT00113269|473961788|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
131637960|NCT00113269|473961785|FG000|Overall Study|Discontinued due to rejection|0|||
131637961|NCT00113269|473961786|FG001|Overall Study|Discontinued due to rejection|0|||
131637962|NCT00113269|473961787|FG002|Overall Study|Discontinued due to rejection|1|||
131637963|NCT00113269|473961788|FG003|Overall Study|Discontinued due to rejection|0|||
131637964|NCT00113269|473961785|FG000|Overall Study|Moved|0|||
131637965|NCT00113269|473961786|FG001|Overall Study|Moved|1|||
131637966|NCT00113269|473961787|FG002|Overall Study|Moved|0|||
131637967|NCT00113269|473961788|FG003|Overall Study|Moved|3|||
131637968|NCT00113269|473961785|FG000|Overall Study|Received pancreas transplant|0|||
131637969|NCT00113269|473961786|FG001|Overall Study|Received pancreas transplant|0|||
131637970|NCT00113269|473961787|FG002|Overall Study|Received pancreas transplant|0|||
131637971|NCT00113269|473961788|FG003|Overall Study|Received pancreas transplant|2|||
131637972|NCT00113269|473961785|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
131637973|NCT00113269|473961786|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
131637974|NCT00113269|473961787|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
131714368|NCT00707577|474231207|FG001|Overall Study|Lost to Follow-up|25|||
131714369|NCT00707577|474231206|FG000|Overall Study|Left employment|13|||
131714370|NCT00707577|474231207|FG001|Overall Study|Left employment|10|||
131714371|NCT00707577|474231206|FG000|Overall Study|Pregnancy|4|||
131714372|NCT00707577|474231207|FG001|Overall Study|Pregnancy|1|||
131714373|NCT03853694|474231208|FG000|Overall Study|Protocol Violation|3|||
131714374|NCT03853694|474231209|FG001|Overall Study|Protocol Violation|5|||
131714375|NCT03853694|474231210|FG002|Overall Study|Protocol Violation|3|||
131714376|NCT03853694|474231208|FG000|Overall Study|Delivered early|0|||
131714377|NCT03853694|474231209|FG001|Overall Study|Delivered early|1|||
131714378|NCT03853694|474231210|FG002|Overall Study|Delivered early|0|||
131714379|NCT03853694|474231208|FG000|Overall Study|not suitable to proceed|0|||
131714380|NCT03853694|474231209|FG001|Overall Study|not suitable to proceed|1|||
131714381|NCT03853694|474231210|FG002|Overall Study|not suitable to proceed|0|||
131714382|NCT03853694|474231208|FG000|Overall Study|difficult surgery|0|||
131714383|NCT03853694|474231209|FG001|Overall Study|difficult surgery|0|||
131714384|NCT03853694|474231210|FG002|Overall Study|difficult surgery|1|||
131714385|NCT03853694|474231208|FG000|Overall Study|Lost to Follow-up|0|||
131714386|NCT03853694|474231209|FG001|Overall Study|Lost to Follow-up|1|||
131714387|NCT03853694|474231210|FG002|Overall Study|Lost to Follow-up|0|||
131714388|NCT03853694|474231208|FG000|Overall Study|Withdrawal by Subject|0|||
131714389|NCT03853694|474231209|FG001|Overall Study|Withdrawal by Subject|1|||
131714390|NCT03853694|474231210|FG002|Overall Study|Withdrawal by Subject|0|||
131714391|NCT05089708|474231211|FG000|Overall Study|Lost to Follow-up|9|||
131714392|NCT05089708|474231212|FG001|Overall Study|Lost to Follow-up|7|||
131714393|NCT05089708|474231211|FG000|Overall Study|Withdrawal by Subject|3|||
131714394|NCT05089708|474231212|FG001|Overall Study|Withdrawal by Subject|1|||
131714395|NCT05089708|474231211|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
131799251|NCT04634409|474548938|FG006|Overall Study|Lost to Follow-up|1|||
131799252|NCT04634409|474548939|FG007|Overall Study|Lost to Follow-up|3|||
131799253|NCT04634409|474548940|FG008|Overall Study|Lost to Follow-up|3|||
131799254|NCT04634409|474548941|FG009|Overall Study|Lost to Follow-up|11|||
131799255|NCT04634409|474548942|FG010|Overall Study|Lost to Follow-up|8|||
131799256|NCT04634409|474548943|FG011|Overall Study|Lost to Follow-up|15|||
131799257|NCT04634409|474548944|FG012|Overall Study|Lost to Follow-up|3|||
131799258|NCT04634409|474548945|FG013|Overall Study|Lost to Follow-up|2|||
131799259|NCT04634409|474548946|FG014|Overall Study|Lost to Follow-up|7|||
131799260|NCT04634409|474548947|FG015|Overall Study|Lost to Follow-up|0|||
131799261|NCT04634409|474548948|FG016|Overall Study|Lost to Follow-up|0|||
131637975|NCT00113269|473961788|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
131637976|NCT00113269|473961785|FG000|Overall Study|Did not meet eligibility criteria|1|||
131637977|NCT00113269|473961786|FG001|Overall Study|Did not meet eligibility criteria|0|||
131637978|NCT00113269|473961787|FG002|Overall Study|Did not meet eligibility criteria|0|||
131637979|NCT00113269|473961788|FG003|Overall Study|Did not meet eligibility criteria|1|||
131714396|NCT05089708|474231212|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
131714397|NCT05089708|474231211|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
131714398|NCT05089708|474231212|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
131714399|NCT02209766|474231214|FG000|Overall Study|Withdrawal by Subject|0|||
131714400|NCT02209766|474231215|FG001|Overall Study|Withdrawal by Subject|0|||
131714401|NCT02209766|474231216|FG002|Overall Study|Withdrawal by Subject|0|||
131714402|NCT02209766|474231217|FG003|Overall Study|Withdrawal by Subject|1|||
131714403|NCT02209766|474231218|FG004|Overall Study|Withdrawal by Subject|0|||
131799262|NCT04634409|474548949|FG017|Overall Study|Lost to Follow-up|0|||
131799263|NCT04634409|474548950|FG018|Overall Study|Lost to Follow-up|0|||
131799264|NCT04634409|474548951|FG019|Overall Study|Lost to Follow-up|0|||
131799265|NCT04634409|474548952|FG020|Overall Study|Lost to Follow-up|0|||
131637980|NCT00113269|473961785|FG000|Overall Study|Unable to return for follow up|2|||
131637981|NCT00113269|473961786|FG001|Overall Study|Unable to return for follow up|1|||
131637982|NCT00113269|473961787|FG002|Overall Study|Unable to return for follow up|0|||
131637983|NCT00113269|473961788|FG003|Overall Study|Unable to return for follow up|0|||
131637984|NCT01821729|473961789|FG000|Overall Study|Withdrawal by Subject|1|||
131637985|NCT01093599|473961792|FG000|Overall Study|Lost to Follow-up|32|||
131637986|NCT01093599|473961793|FG001|Overall Study|Lost to Follow-up|46|||
131637987|NCT01703845|473961794|FG000|Overall Study|Adverse Event|1|||
131637988|NCT01703845|473961795|FG001|Overall Study|Adverse Event|0|||
131637989|NCT01703845|473961794|FG000|Overall Study|Protocol Violation|1|||
131637990|NCT01703845|473961795|FG001|Overall Study|Protocol Violation|0|||
131637991|NCT01703845|473961794|FG000|Overall Study|other than stated above|1|||
131637992|NCT01703845|473961795|FG001|Overall Study|other than stated above|0|||
131637993|NCT01644188|473961796|FG000|Overall Study|Adverse Event|44|||
131637994|NCT01644188|473961797|FG001|Overall Study|Adverse Event|20|||
131637995|NCT01644188|473961796|FG000|Overall Study|Poor compliance to protocol|26|||
131637996|NCT01644188|473961797|FG001|Overall Study|Poor compliance to protocol|14|||
131637997|NCT01644188|473961796|FG000|Overall Study|Physician Decision|1|||
131637998|NCT01644188|473961797|FG001|Overall Study|Physician Decision|3|||
131637999|NCT01644188|473961796|FG000|Overall Study|Participant moved|7|||
131638000|NCT01644188|473961797|FG001|Overall Study|Participant moved|2|||
131638001|NCT01644188|473961796|FG000|Overall Study|Related to auto-injector administration|2|||
131638002|NCT01644188|473961797|FG001|Overall Study|Related to auto-injector administration|2|||
131638003|NCT01644188|473961796|FG000|Overall Study|Consent withdrawn by participant|14|||
131638004|NCT01644188|473961797|FG001|Overall Study|Consent withdrawn by participant|7|||
131638005|NCT01644188|473961796|FG000|Overall Study|Selection criteria finally not met|2|||
131638006|NCT01644188|473961797|FG001|Overall Study|Selection criteria finally not met|0|||
131638007|NCT01644188|473961796|FG000|Overall Study|Lost to Follow-up|1|||
131638008|NCT01644188|473961797|FG001|Overall Study|Lost to Follow-up|0|||
131638009|NCT01644188|473961796|FG000|Overall Study|Death|4|||
131638010|NCT01644188|473961797|FG001|Overall Study|Death|3|||
131638011|NCT01644188|473961796|FG000|Overall Study|Last visit outside protocol visit window|14|||
131638012|NCT01644188|473961797|FG001|Overall Study|Last visit outside protocol visit window|16|||
131638013|NCT01644188|473961796|FG000|Overall Study|Site closure|1|||
131638014|NCT01644188|473961797|FG001|Overall Study|Site closure|1|||
131638015|NCT01644188|473961796|FG000|Overall Study|Other than specified above|6|||
131638016|NCT01644188|473961797|FG001|Overall Study|Other than specified above|7|||
131638017|NCT00966979|473961801|FG000|Overall Study|Death|1|||
131714404|NCT00805207|474231219|FG000|Overall Study|Protocol Violation|0|||
131714405|NCT00805207|474231220|FG001|Overall Study|Protocol Violation|0|||
131714406|NCT00805207|474231221|FG002|Overall Study|Protocol Violation|1|||
131714407|NCT00805207|474231222|FG003|Overall Study|Protocol Violation|0|||
131714408|NCT00805207|474231223|FG004|Overall Study|Protocol Violation|0|||
131714409|NCT00805207|474231224|FG005|Overall Study|Protocol Violation|0|||
131714410|NCT00805207|474231225|FG006|Overall Study|Protocol Violation|0|||
131714411|NCT00805207|474231226|FG007|Overall Study|Protocol Violation|0|||
131714412|NCT00805207|474231227|FG008|Overall Study|Protocol Violation|0|||
131714413|NCT00805207|474231219|FG000|Overall Study|Physician Decision|0|||
131714414|NCT00805207|474231220|FG001|Overall Study|Physician Decision|1|||
131714415|NCT00805207|474231221|FG002|Overall Study|Physician Decision|0|||
131714416|NCT00805207|474231222|FG003|Overall Study|Physician Decision|0|||
131714417|NCT00805207|474231223|FG004|Overall Study|Physician Decision|0|||
131714418|NCT00805207|474231224|FG005|Overall Study|Physician Decision|1|||
131714419|NCT00805207|474231225|FG006|Overall Study|Physician Decision|0|||
131638018|NCT00966979|473961801|FG000|Overall Study|Lost to Follow-up|6|||
131714420|NCT00805207|474231226|FG007|Overall Study|Physician Decision|0|||
131714421|NCT00805207|474231227|FG008|Overall Study|Physician Decision|0|||
131799266|NCT04634409|474548953|FG021|Overall Study|Lost to Follow-up|0|||
131638019|NCT00966979|473961801|FG000|Overall Study|Withdrawal by Subject|14|||
131638020|NCT00966979|473961801|FG000|Overall Study|Adverse Event|5|||
131638021|NCT00966979|473961801|FG000|Overall Study|Sponsor terminated early|49|||
131638022|NCT00966979|473961801|FG000|Overall Study|Censored because surgery not done|2|||
131638023|NCT00966979|473961801|FG000|Overall Study|Censored because study device was not implanted|14|||
131638024|NCT00966979|473961801|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
131638025|NCT04140266|473961802|FG000|Overall Study|Physician Decision|2|||
131714422|NCT00805207|474231219|FG000|Overall Study|Withdrawal by Subject|0|||
131714423|NCT00805207|474231220|FG001|Overall Study|Withdrawal by Subject|1|||
131714424|NCT00805207|474231221|FG002|Overall Study|Withdrawal by Subject|0|||
131714425|NCT00805207|474231222|FG003|Overall Study|Withdrawal by Subject|0|||
131714426|NCT00805207|474231223|FG004|Overall Study|Withdrawal by Subject|1|||
131714427|NCT00805207|474231224|FG005|Overall Study|Withdrawal by Subject|2|||
131714428|NCT00805207|474231225|FG006|Overall Study|Withdrawal by Subject|0|||
131714429|NCT00805207|474231226|FG007|Overall Study|Withdrawal by Subject|0|||
131714430|NCT00805207|474231227|FG008|Overall Study|Withdrawal by Subject|0|||
131714431|NCT00064701|474231228|FG000|One Year Post-transplant|Did not receive study drug|7|||
131714432|NCT00064701|474231229|FG001|One Year Post-transplant|Did not receive study drug|12|||
131714433|NCT00064701|474231230|FG002|One Year Post-transplant|Did not receive study drug|11|||
131714434|NCT00064701|474231228|FG000|One Year Post-transplant|Adverse Event|23|||
131714435|NCT00064701|474231229|FG001|One Year Post-transplant|Adverse Event|19|||
131714436|NCT00064701|474231230|FG002|One Year Post-transplant|Adverse Event|37|||
131714437|NCT00064701|474231228|FG000|One Year Post-transplant|Rejection|0|||
131714438|NCT00064701|474231229|FG001|One Year Post-transplant|Rejection|1|||
131714439|NCT00064701|474231230|FG002|One Year Post-transplant|Rejection|16|||
131714440|NCT00064701|474231228|FG000|One Year Post-transplant|Non-compliance|4|||
131714441|NCT00064701|474231229|FG001|One Year Post-transplant|Non-compliance|2|||
131714442|NCT00064701|474231230|FG002|One Year Post-transplant|Non-compliance|5|||
131714443|NCT00064701|474231228|FG000|One Year Post-transplant|Graft Failure|3|||
131714444|NCT00064701|474231229|FG001|One Year Post-transplant|Graft Failure|2|||
131714445|NCT00064701|474231230|FG002|One Year Post-transplant|Graft Failure|1|||
131714446|NCT00064701|474231228|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
131714447|NCT00064701|474231229|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
131714448|NCT00064701|474231230|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
131714449|NCT00064701|474231228|FG000|One Year Post-transplant|Lost to Follow-up|1|||
131714450|NCT00064701|474231229|FG001|One Year Post-transplant|Lost to Follow-up|0|||
131714451|NCT00064701|474231230|FG002|One Year Post-transplant|Lost to Follow-up|0|||
131714452|NCT00064701|474231228|FG000|One Year Post-transplant|Converted to rapamycin|1|||
131714453|NCT00064701|474231229|FG001|One Year Post-transplant|Converted to rapamycin|0|||
131714454|NCT00064701|474231230|FG002|One Year Post-transplant|Converted to rapamycin|0|||
131714455|NCT00064701|474231228|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
131714456|NCT00064701|474231229|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
131714457|NCT00064701|474231230|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
131714458|NCT00064701|474231228|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
131714459|NCT00064701|474231229|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
131714460|NCT00064701|474231230|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
131714461|NCT00064701|474231228|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
131714462|NCT00064701|474231229|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
131714463|NCT00064701|474231230|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
131714464|NCT00064701|474231228|FG000|One Year Post-transplant|Poor absorption|0|||
131714465|NCT00064701|474231229|FG001|One Year Post-transplant|Poor absorption|1|||
131714466|NCT00064701|474231230|FG002|One Year Post-transplant|Poor absorption|0|||
131714467|NCT00064701|474231228|FG000|One Year Post-transplant|Pancreas transplant|0|||
131714468|NCT00064701|474231229|FG001|One Year Post-transplant|Pancreas transplant|0|||
131714469|NCT00064701|474231230|FG002|One Year Post-transplant|Pancreas transplant|1|||
131714470|NCT00064701|474231228|FG000|Clinical Continuation Phase|Adverse Event|12|||
131714471|NCT00064701|474231229|FG001|Clinical Continuation Phase|Adverse Event|21|||
131714472|NCT00064701|474231230|FG002|Clinical Continuation Phase|Adverse Event|14|||
131714473|NCT00064701|474231228|FG000|Clinical Continuation Phase|Non-compliance|8|||
131714474|NCT00064701|474231229|FG001|Clinical Continuation Phase|Non-compliance|6|||
131638026|NCT04140266|473961803|FG001|Overall Study|Physician Decision|0|||
131638027|NCT04140266|473961802|FG000|Overall Study|Withdrawal by Subject|4|||
131638028|NCT04140266|473961803|FG001|Overall Study|Withdrawal by Subject|2|||
131638029|NCT00666198|473961807|FG000|Overall Study|Protocol Violation|10|||
131638030|NCT00666198|473961807|FG000|Overall Study|No Visit After First Day of Treatment|13|||
131638031|NCT00666198|473961807|FG000|Overall Study|Safety Not Assessable|6|||
131638032|NCT00666198|473961807|FG000|Overall Study|No Drug Administration|4|||
131638033|NCT02490878|473961808|FG000|Overall Study|deemed ineligible|0|||
131714475|NCT00064701|474231230|FG002|Clinical Continuation Phase|Non-compliance|7|||
131714476|NCT00064701|474231228|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
131799267|NCT04634409|474548954|FG022|Overall Study|Lost to Follow-up|0|||
131638034|NCT02490878|473961809|FG001|Overall Study|deemed ineligible|1|||
131638035|NCT02490878|473961808|FG000|Overall Study|progression prior to treatment|0|||
131638036|NCT02490878|473961809|FG001|Overall Study|progression prior to treatment|1|||
131714477|NCT00064701|474231229|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
131714478|NCT00064701|474231230|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
131714479|NCT00064701|474231228|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
131714480|NCT00064701|474231229|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
131714481|NCT00064701|474231230|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
131714482|NCT00064701|474231228|FG000|Clinical Continuation Phase|Graft Failure|5|||
131714483|NCT00064701|474231229|FG001|Clinical Continuation Phase|Graft Failure|5|||
131714484|NCT00064701|474231230|FG002|Clinical Continuation Phase|Graft Failure|2|||
131714485|NCT00064701|474231228|FG000|Clinical Continuation Phase|Rejection|1|||
131714486|NCT00064701|474231229|FG001|Clinical Continuation Phase|Rejection|2|||
131638037|NCT02490878|473961808|FG000|Overall Study|only submitted baseline QOL|0|||
131638038|NCT02490878|473961809|FG001|Overall Study|only submitted baseline QOL|1|||
131638039|NCT03041701|473961813|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
131638040|NCT03041701|473961814|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
131638041|NCT03041701|473961815|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
131638042|NCT03041701|473961813|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
131638043|NCT03041701|473961814|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
131638044|NCT03041701|473961815|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
131638045|NCT02101268|473961819|FG000|Randomized Treatment Phase|Subject Decision|8|||
131638046|NCT02101268|473961820|FG001|Randomized Treatment Phase|Subject Decision|4|||
131638047|NCT02101268|473961821|FG002|Randomized Treatment Phase|Subject Decision|0|||
131638048|NCT02101268|473961822|FG003|Randomized Treatment Phase|Subject Decision|0|||
131638049|NCT02101268|473961819|FG000|Randomized Treatment Phase|Physician Decision|4|||
131638050|NCT02101268|473961820|FG001|Randomized Treatment Phase|Physician Decision|1|||
131638051|NCT02101268|473961821|FG002|Randomized Treatment Phase|Physician Decision|0|||
131638052|NCT02101268|473961822|FG003|Randomized Treatment Phase|Physician Decision|0|||
131638053|NCT02101268|473961819|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
131638054|NCT02101268|473961820|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
131638055|NCT02101268|473961821|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
131638056|NCT02101268|473961822|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
131638057|NCT02101268|473961819|FG000|Randomized Treatment Phase|Adverse Event|6|||
131638058|NCT02101268|473961820|FG001|Randomized Treatment Phase|Adverse Event|0|||
131638059|NCT02101268|473961821|FG002|Randomized Treatment Phase|Adverse Event|0|||
131638060|NCT02101268|473961822|FG003|Randomized Treatment Phase|Adverse Event|0|||
131638061|NCT02101268|473961819|FG000|Randomized Treatment Phase|Death|5|||
131638062|NCT02101268|473961820|FG001|Randomized Treatment Phase|Death|4|||
131638063|NCT02101268|473961821|FG002|Randomized Treatment Phase|Death|0|||
131638064|NCT02101268|473961822|FG003|Randomized Treatment Phase|Death|0|||
131638065|NCT02101268|473961819|FG000|Randomized Treatment Phase|Disease Progression|4|||
131638066|NCT02101268|473961820|FG001|Randomized Treatment Phase|Disease Progression|1|||
131638067|NCT02101268|473961821|FG002|Randomized Treatment Phase|Disease Progression|0|||
131638068|NCT02101268|473961822|FG003|Randomized Treatment Phase|Disease Progression|0|||
131638069|NCT02101268|473961819|FG000|Extended Treatment Phase|Subject Decision|0|||
131638070|NCT02101268|473961820|FG001|Extended Treatment Phase|Subject Decision|0|||
131638071|NCT02101268|473961821|FG002|Extended Treatment Phase|Subject Decision|3|||
131638072|NCT02101268|473961822|FG003|Extended Treatment Phase|Subject Decision|2|||
131638073|NCT02101268|473961819|FG000|Extended Treatment Phase|Physician Decision|0|||
131638074|NCT02101268|473961820|FG001|Extended Treatment Phase|Physician Decision|0|||
131638075|NCT02101268|473961821|FG002|Extended Treatment Phase|Physician Decision|5|||
131638076|NCT02101268|473961822|FG003|Extended Treatment Phase|Physician Decision|2|||
131638077|NCT02101268|473961819|FG000|Extended Treatment Phase|Adverse Event|0|||
131638078|NCT02101268|473961820|FG001|Extended Treatment Phase|Adverse Event|0|||
131638079|NCT02101268|473961821|FG002|Extended Treatment Phase|Adverse Event|14|||
131638080|NCT02101268|473961822|FG003|Extended Treatment Phase|Adverse Event|18|||
131638081|NCT02101268|473961819|FG000|Extended Treatment Phase|Death|0|||
131638082|NCT02101268|473961820|FG001|Extended Treatment Phase|Death|0|||
131638083|NCT02101268|473961821|FG002|Extended Treatment Phase|Death|5|||
131638084|NCT02101268|473961822|FG003|Extended Treatment Phase|Death|1|||
131638085|NCT02101268|473961819|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
131638086|NCT02101268|473961820|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
131638087|NCT02101268|473961821|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
131638088|NCT02101268|473961822|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
131638089|NCT02101268|473961819|FG000|Extended Treatment Phase|Disease Progression|0|||
131638090|NCT02101268|473961820|FG001|Extended Treatment Phase|Disease Progression|0|||
131638091|NCT02101268|473961821|FG002|Extended Treatment Phase|Disease Progression|13|||
131638092|NCT02101268|473961822|FG003|Extended Treatment Phase|Disease Progression|6|||
131638093|NCT02101268|473961819|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
131638094|NCT02101268|473961820|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
131638095|NCT02101268|473961821|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
131638096|NCT02101268|473961822|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
131638097|NCT00740870|473961823|FG000|Overall Study|Not Catheterized|4|||
131638098|NCT00740870|473961823|FG000|Overall Study|Further testing contraindicated implant|17|||
131638099|NCT00607997|473961825|FG000|Overall Study|Lack of Efficacy|6|||
131638100|NCT00607997|473961826|FG001|Overall Study|Lack of Efficacy|20|||
131638101|NCT00607997|473961827|FG002|Overall Study|Lack of Efficacy|14|||
131638102|NCT00607997|473961828|FG003|Overall Study|Lack of Efficacy|10|||
131638103|NCT00607997|473961825|FG000|Overall Study|Death|8|||
131638104|NCT00607997|473961826|FG001|Overall Study|Death|5|||
131638105|NCT00607997|473961827|FG002|Overall Study|Death|2|||
131638106|NCT00607997|473961828|FG003|Overall Study|Death|5|||
131638107|NCT00607997|473961825|FG000|Overall Study|Adverse Event|3|||
131638108|NCT00607997|473961826|FG001|Overall Study|Adverse Event|1|||
131638109|NCT00607997|473961827|FG002|Overall Study|Adverse Event|2|||
131638110|NCT00607997|473961828|FG003|Overall Study|Adverse Event|0|||
131638111|NCT00607997|473961825|FG000|Overall Study|Physician Decision|4|||
131638112|NCT00607997|473961826|FG001|Overall Study|Physician Decision|1|||
131638113|NCT00607997|473961827|FG002|Overall Study|Physician Decision|0|||
131638114|NCT00607997|473961828|FG003|Overall Study|Physician Decision|0|||
131638115|NCT00607997|473961825|FG000|Overall Study|Relapse, recurrent illness|4|||
131638116|NCT00607997|473961826|FG001|Overall Study|Relapse, recurrent illness|0|||
131638117|NCT00607997|473961827|FG002|Overall Study|Relapse, recurrent illness|2|||
131638118|NCT00607997|473961828|FG003|Overall Study|Relapse, recurrent illness|0|||
131638119|NCT00607997|473961825|FG000|Overall Study|Other without explanation|2|||
131638120|NCT00607997|473961826|FG001|Overall Study|Other without explanation|0|||
131638121|NCT00607997|473961827|FG002|Overall Study|Other without explanation|4|||
131638122|NCT00607997|473961828|FG003|Overall Study|Other without explanation|1|||
131638123|NCT00839332|473961832|FG000|Phase 1|Disease Progression|38|||
131638124|NCT00839332|473961833|FG001|Phase 1|Disease Progression|0|||
131638125|NCT00839332|473961834|FG002|Phase 1|Disease Progression|0|||
131638126|NCT00839332|473961832|FG000|Phase 1|Adverse Event|6|||
131638127|NCT00839332|473961833|FG001|Phase 1|Adverse Event|0|||
131638128|NCT00839332|473961834|FG002|Phase 1|Adverse Event|0|||
131638129|NCT00839332|473961832|FG000|Phase 1|Withdrawal by Subject|4|||
131638130|NCT00839332|473961833|FG001|Phase 1|Withdrawal by Subject|0|||
131638131|NCT00839332|473961834|FG002|Phase 1|Withdrawal by Subject|0|||
131638132|NCT00839332|473961832|FG000|Phase 1|Physician Decision|2|||
131638133|NCT00839332|473961833|FG001|Phase 1|Physician Decision|0|||
131638134|NCT00839332|473961834|FG002|Phase 1|Physician Decision|0|||
131638135|NCT00839332|473961832|FG000|Phase 2|Protocol Violation|0|||
131638136|NCT00839332|473961833|FG001|Phase 2|Protocol Violation|1|||
131638137|NCT00839332|473961834|FG002|Phase 2|Protocol Violation|0|||
131638138|NCT00839332|473961832|FG000|Phase 2|Disease Progression|0|||
131638139|NCT00839332|473961833|FG001|Phase 2|Disease Progression|46|||
131638140|NCT00839332|473961834|FG002|Phase 2|Disease Progression|21|||
131638141|NCT00839332|473961832|FG000|Phase 2|Adverse Event|0|||
131638142|NCT00839332|473961833|FG001|Phase 2|Adverse Event|8|||
131638143|NCT00839332|473961834|FG002|Phase 2|Adverse Event|6|||
131638144|NCT00839332|473961832|FG000|Phase 2|Death|0|||
131638145|NCT00839332|473961833|FG001|Phase 2|Death|4|||
131638146|NCT00839332|473961834|FG002|Phase 2|Death|2|||
131638147|NCT00839332|473961832|FG000|Phase 2|Withdrawal by Subject|0|||
131638148|NCT00839332|473961833|FG001|Phase 2|Withdrawal by Subject|5|||
131638149|NCT00839332|473961834|FG002|Phase 2|Withdrawal by Subject|8|||
131638150|NCT00839332|473961832|FG000|Phase 2|Physician Decision|0|||
131638151|NCT00839332|473961833|FG001|Phase 2|Physician Decision|4|||
131638152|NCT00839332|473961834|FG002|Phase 2|Physician Decision|1|||
131638153|NCT00839332|473961832|FG000|Phase 2|Lost to Follow-up|0|||
131638154|NCT00839332|473961833|FG001|Phase 2|Lost to Follow-up|0|||
131638155|NCT00839332|473961834|FG002|Phase 2|Lost to Follow-up|1|||
131638156|NCT01200485|473961835|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
131638157|NCT01200485|473961836|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
131638158|NCT01200485|473961837|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
131638159|NCT01200485|473961835|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
131638160|NCT01200485|473961836|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
131638161|NCT01200485|473961837|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
131638162|NCT06080438|473961838|FG000|Overall Study|Lost to Follow-up|2|||
131638163|NCT02630706|473961842|FG000|Overall Study|Adverse Event|2|||
131638164|NCT02630706|473961843|FG001|Overall Study|Adverse Event|1|||
131638165|NCT02630706|473961844|FG002|Overall Study|Adverse Event|1|||
131638166|NCT02630706|473961842|FG000|Overall Study|Lost to Follow-up|0|||
131638167|NCT02630706|473961843|FG001|Overall Study|Lost to Follow-up|1|||
131638168|NCT02630706|473961844|FG002|Overall Study|Lost to Follow-up|2|||
131638169|NCT02630706|473961842|FG000|Overall Study|Physician Decision|1|||
131638170|NCT02630706|473961843|FG001|Overall Study|Physician Decision|1|||
131638171|NCT02630706|473961844|FG002|Overall Study|Physician Decision|0|||
131638172|NCT02630706|473961842|FG000|Overall Study|Pregnancy|0|||
131638173|NCT02630706|473961843|FG001|Overall Study|Pregnancy|1|||
131638174|NCT02630706|473961844|FG002|Overall Study|Pregnancy|0|||
131638175|NCT02630706|473961842|FG000|Overall Study|Withdrawal by Subject|4|||
131638176|NCT02630706|473961843|FG001|Overall Study|Withdrawal by Subject|5|||
131638177|NCT02630706|473961844|FG002|Overall Study|Withdrawal by Subject|7|||
131638178|NCT01678898|473961845|FG000|PB-102-F01|Adverse Event|0|||
131638179|NCT01678898|473961846|FG001|PB-102-F01|Adverse Event|1|||
131638180|NCT01678898|473961847|FG002|PB-102-F01|Adverse Event|0|||
131638181|NCT01678898|473961845|FG000|PB-102-F01|Physician Decision|0|||
131638182|NCT01678898|473961846|FG001|PB-102-F01|Physician Decision|1|||
131638183|NCT01678898|473961847|FG002|PB-102-F01|Physician Decision|0|||
131638184|NCT00640042|473961849|FG000|Enrollment|Did not receive study drug|83|||
131638185|NCT01527500|473961852|FG000|Part A|Administrative|11|||
131638186|NCT01527500|473961853|FG001|Part A|Administrative|7|||
131638187|NCT01527500|473961852|FG000|Part A|Adverse Event|4|||
131638188|NCT01527500|473961853|FG001|Part A|Adverse Event|2|||
131799268|NCT04634409|474548955|FG023|Overall Study|Lost to Follow-up|0|||
131799269|NCT04634409|474548956|FG024|Overall Study|Lost to Follow-up|0|||
131799270|NCT04634409|474548957|FG025|Overall Study|Lost to Follow-up|0|||
131799271|NCT04634409|474548958|FG026|Overall Study|Lost to Follow-up|0|||
131799272|NCT04634409|474548932|FG000|Overall Study|Withdrawal by Subject|3|||
131799273|NCT04634409|474548933|FG001|Overall Study|Withdrawal by Subject|1|||
131799274|NCT04634409|474548934|FG002|Overall Study|Withdrawal by Subject|6|||
131799275|NCT04634409|474548935|FG003|Overall Study|Withdrawal by Subject|4|||
131799276|NCT04634409|474548936|FG004|Overall Study|Withdrawal by Subject|2|||
131799277|NCT04634409|474548937|FG005|Overall Study|Withdrawal by Subject|0|||
131799278|NCT04634409|474548938|FG006|Overall Study|Withdrawal by Subject|0|||
131799279|NCT04634409|474548939|FG007|Overall Study|Withdrawal by Subject|2|||
131799280|NCT04634409|474548940|FG008|Overall Study|Withdrawal by Subject|3|||
131799281|NCT04634409|474548941|FG009|Overall Study|Withdrawal by Subject|2|||
131902725|NCT02849080|474929377|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
131902726|NCT02849080|474929378|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
131638189|NCT01527500|473961852|FG000|Part A|Death|4|||
131638190|NCT01527500|473961853|FG001|Part A|Death|1|||
131638191|NCT01527500|473961852|FG000|Part A|Lost to Follow-up|0|||
131638192|NCT01527500|473961853|FG001|Part A|Lost to Follow-up|1|||
131638193|NCT01527500|473961852|FG000|Part A|Protocol Deviation|9|||
131638194|NCT01527500|473961853|FG001|Part A|Protocol Deviation|2|||
131638195|NCT01527500|473961852|FG000|Part A|Withdrawal by Subject|2|||
131638196|NCT01527500|473961853|FG001|Part A|Withdrawal by Subject|0|||
131638197|NCT01527500|473961852|FG000|Part B|Adverse Event|1|||
131638198|NCT01527500|473961853|FG001|Part B|Adverse Event|0|||
131638199|NCT02864342|473961856|FG000|Overall Study|Eligibility Criteria Deviation|2|||
131638200|NCT02864342|473961857|FG001|Overall Study|Eligibility Criteria Deviation|3|||
131638201|NCT02864342|473961856|FG000|Overall Study|Withdrawal by Subject|4|||
131638202|NCT02864342|473961857|FG001|Overall Study|Withdrawal by Subject|2|||
131638203|NCT02864342|473961856|FG000|Overall Study|Device Technology Issue|6|||
131638204|NCT02864342|473961857|FG001|Overall Study|Device Technology Issue|7|||
131638205|NCT02864342|473961856|FG000|Overall Study|Death|0|||
131638206|NCT02864342|473961857|FG001|Overall Study|Death|1|||
131638207|NCT02864342|473961856|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
131638208|NCT02864342|473961857|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
131638209|NCT02864342|473961856|FG000|Overall Study|Lost to Follow-up|1|||
131638210|NCT02864342|473961857|FG001|Overall Study|Lost to Follow-up|5|||
131638211|NCT02864342|473961856|FG000|Overall Study|Lost Device|1|||
131638212|NCT02864342|473961857|FG001|Overall Study|Lost Device|0|||
131638213|NCT02864342|473961856|FG000|Overall Study|Adverse Event|1|||
131638214|NCT02864342|473961857|FG001|Overall Study|Adverse Event|0|||
131638215|NCT03078751|473961870|FG000|Overall Study|Adverse Event|4|||
131638216|NCT03078751|473961871|FG001|Overall Study|Adverse Event|0|||
131638217|NCT03078751|473961870|FG000|Overall Study|Physician Decision|1|||
131638218|NCT03078751|473961871|FG001|Overall Study|Physician Decision|0|||
131638219|NCT03078751|473961870|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
131638220|NCT03078751|473961871|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
131638221|NCT03078751|473961870|FG000|Overall Study|Subject/guardian decision|8|||
131638222|NCT03078751|473961871|FG001|Overall Study|Subject/guardian decision|1|||
131638223|NCT03078751|473961870|FG000|Overall Study|Untreated|0|||
131638224|NCT03078751|473961871|FG001|Overall Study|Untreated|4|||
131638225|NCT00607789|473961872|FG000|Overall Study|Adverse Event|3|||
131638226|NCT00607789|473961873|FG001|Overall Study|Adverse Event|0|||
131638227|NCT00607789|473961872|FG000|Overall Study|Lack of Efficacy|0|||
131638228|NCT00607789|473961873|FG001|Overall Study|Lack of Efficacy|1|||
131638229|NCT00607789|473961872|FG000|Overall Study|Inadequate adherence|3|||
131638230|NCT00607789|473961873|FG001|Overall Study|Inadequate adherence|0|||
131638231|NCT00607789|473961872|FG000|Overall Study|Lost to Follow-up|0|||
131638232|NCT00607789|473961873|FG001|Overall Study|Lost to Follow-up|5|||
131638233|NCT00607789|473961872|FG000|Overall Study|Withdrawal by Subject|1|||
131638234|NCT00607789|473961873|FG001|Overall Study|Withdrawal by Subject|0|||
131638235|NCT01209286|473961874|FG000|Overall Study|Adverse Event|4|||
131638236|NCT01209286|473961875|FG001|Overall Study|Adverse Event|3|||
131638237|NCT01209286|473961876|FG002|Overall Study|Adverse Event|1|||
131638238|NCT01209286|473961874|FG000|Overall Study|Hematological Relapse After Remission|0|||
131638239|NCT01209286|473961875|FG001|Overall Study|Hematological Relapse After Remission|1|||
131799282|NCT04634409|474548942|FG010|Overall Study|Withdrawal by Subject|3|||
131799283|NCT04634409|474548943|FG011|Overall Study|Withdrawal by Subject|2|||
131638240|NCT01209286|473961876|FG002|Overall Study|Hematological Relapse After Remission|1|||
131638241|NCT01209286|473961874|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
131638242|NCT01209286|473961875|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
131638243|NCT01209286|473961876|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
131638244|NCT01209286|473961874|FG000|Overall Study|Physician Decision|0|||
131638245|NCT01209286|473961875|FG001|Overall Study|Physician Decision|2|||
131638246|NCT01209286|473961876|FG002|Overall Study|Physician Decision|0|||
131638247|NCT01209286|473961874|FG000|Overall Study|Other|0|||
131638248|NCT01209286|473961875|FG001|Overall Study|Other|1|||
131638249|NCT01209286|473961876|FG002|Overall Study|Other|0|||
131638250|NCT02725008|473961879|FG000|Overall Study|Lost to Follow-up|7|||
131638251|NCT02725008|473961880|FG001|Overall Study|Lost to Follow-up|9|||
131638252|NCT02725008|473961879|FG000|Overall Study|Withdrawal by Subject|2|||
131638253|NCT02725008|473961880|FG001|Overall Study|Withdrawal by Subject|2|||
131638254|NCT02725008|473961879|FG000|Overall Study|Admitted to hospital|0|||
131638255|NCT02725008|473961880|FG001|Overall Study|Admitted to hospital|1|||
131638256|NCT01560585|473961881|FG000|Overall Study|Physician Decision|3|||
131638257|NCT01363297|473961883|FG000|Overall Study|Other|0|||
131638258|NCT01363297|473961884|FG001|Overall Study|Other|0|||
131638259|NCT01363297|473961885|FG002|Overall Study|Other|0|||
131638260|NCT01363297|473961886|FG003|Overall Study|Other|0|||
131638261|NCT01363297|473961887|FG004|Overall Study|Other|1|||
131638262|NCT01363297|473961883|FG000|Overall Study|Death|3|||
131638263|NCT01363297|473961884|FG001|Overall Study|Death|6|||
131638264|NCT01363297|473961885|FG002|Overall Study|Death|6|||
131638265|NCT01363297|473961886|FG003|Overall Study|Death|10|||
131638266|NCT01363297|473961887|FG004|Overall Study|Death|30|||
131638267|NCT02515097|473961888|FG000|Overall Study|Lost to Follow-up|4|||
131638268|NCT02515097|473961889|FG001|Overall Study|Lost to Follow-up|2|||
131638269|NCT02515097|473961888|FG000|Overall Study|Withdrawal by Subject|1|||
131638270|NCT02515097|473961889|FG001|Overall Study|Withdrawal by Subject|3|||
131638271|NCT02515097|473961888|FG000|Overall Study|Adverse Event|2|||
131638272|NCT02515097|473961889|FG001|Overall Study|Adverse Event|1|||
131638273|NCT03915951|473961890|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
131638274|NCT03915951|473961891|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
131638275|NCT03915951|473961890|FG000|Overall Study|Adverse Event|12|||
131638276|NCT03915951|473961891|FG001|Overall Study|Adverse Event|6|||
131638277|NCT03915951|473961890|FG000|Overall Study|Disease progression (radiological)|17|||
131638278|NCT03915951|473961891|FG001|Overall Study|Disease progression (radiological)|15|||
131638279|NCT03915951|473961890|FG000|Overall Study|Disease progression (clinical)|4|||
131638280|NCT03915951|473961891|FG001|Overall Study|Disease progression (clinical)|1|||
131638281|NCT03915951|473961890|FG000|Overall Study|Patient decision|0|||
131638282|NCT03915951|473961891|FG001|Overall Study|Patient decision|4|||
131638283|NCT03915951|473961890|FG000|Overall Study|Investigator decision|0|||
131638284|NCT03915951|473961891|FG001|Overall Study|Investigator decision|1|||
131638285|NCT03915951|473961890|FG000|Overall Study|Consent withdrawn|1|||
131638286|NCT03915951|473961891|FG001|Overall Study|Consent withdrawn|1|||
131638287|NCT03915951|473961890|FG000|Overall Study|Death|0|||
131638288|NCT03915951|473961891|FG001|Overall Study|Death|3|||
131638289|NCT01121185|473961898|FG000|Overall Study|Not infused|0|||
131638290|NCT01121185|473961899|FG001|Overall Study|Not infused|1|||
131638291|NCT01121185|473961898|FG000|Overall Study|Not transplanted|1|||
131638292|NCT01121185|473961899|FG001|Overall Study|Not transplanted|0|||
131638293|NCT01196741|473961902|FG000|Overall Study|Disease progression|34|||
131638294|NCT01196741|473961903|FG001|Overall Study|Disease progression|14|||
131638295|NCT01196741|473961902|FG000|Overall Study|Adverse Event|10|||
131638296|NCT01196741|473961903|FG001|Overall Study|Adverse Event|6|||
131638297|NCT01196741|473961902|FG000|Overall Study|Serious Adverse Event|3|||
131638298|NCT01196741|473961903|FG001|Overall Study|Serious Adverse Event|1|||
131638299|NCT01196741|473961902|FG000|Overall Study|Dose limiting Adverse Event|2|||
131638300|NCT01196741|473961903|FG001|Overall Study|Dose limiting Adverse Event|1|||
131638301|NCT01196741|473961902|FG000|Overall Study|Withdrawal by Subject|3|||
131638302|NCT01196741|473961903|FG001|Overall Study|Withdrawal by Subject|0|||
131638303|NCT01196741|473961902|FG000|Overall Study|Other reason|3|||
131638304|NCT01196741|473961903|FG001|Overall Study|Other reason|3|||
131638305|NCT01196741|473961902|FG000|Overall Study|Other|3|||
131638306|NCT01196741|473961903|FG001|Overall Study|Other|2|||
131638307|NCT01196741|473961902|FG000|Overall Study|Protocol Violation|2|||
131638308|NCT01196741|473961903|FG001|Overall Study|Protocol Violation|1|||
131638309|NCT01180790|473961905|FG000|Overall Study|Adverse Event|1|||
131638310|NCT01180790|473961906|FG001|Overall Study|Adverse Event|1|||
131638311|NCT01180790|473961907|FG002|Overall Study|Adverse Event|2|||
131638312|NCT01180790|473961908|FG003|Overall Study|Adverse Event|0|||
131638313|NCT01180790|473961909|FG004|Overall Study|Adverse Event|1|||
131638314|NCT01180790|473961910|FG005|Overall Study|Adverse Event|3|||
131638315|NCT01180790|473961911|FG006|Overall Study|Adverse Event|0|||
131638316|NCT01180790|473961905|FG000|Overall Study|Withdrawal by Subject|3|||
131638317|NCT01180790|473961906|FG001|Overall Study|Withdrawal by Subject|0|||
131638318|NCT01180790|473961907|FG002|Overall Study|Withdrawal by Subject|5|||
131638319|NCT01180790|473961908|FG003|Overall Study|Withdrawal by Subject|0|||
131638320|NCT01180790|473961909|FG004|Overall Study|Withdrawal by Subject|2|||
131638321|NCT01180790|473961910|FG005|Overall Study|Withdrawal by Subject|1|||
131638322|NCT01180790|473961911|FG006|Overall Study|Withdrawal by Subject|0|||
131638323|NCT01180790|473961905|FG000|Overall Study|Lost to Follow-up|3|||
131638324|NCT01180790|473961906|FG001|Overall Study|Lost to Follow-up|1|||
131638325|NCT01180790|473961907|FG002|Overall Study|Lost to Follow-up|0|||
131638326|NCT01180790|473961908|FG003|Overall Study|Lost to Follow-up|2|||
131638327|NCT01180790|473961909|FG004|Overall Study|Lost to Follow-up|1|||
131638328|NCT01180790|473961910|FG005|Overall Study|Lost to Follow-up|0|||
131638329|NCT01180790|473961911|FG006|Overall Study|Lost to Follow-up|1|||
131638330|NCT01180790|473961905|FG000|Overall Study|Physician Decision|1|||
131638331|NCT01180790|473961906|FG001|Overall Study|Physician Decision|0|||
131638332|NCT01180790|473961907|FG002|Overall Study|Physician Decision|0|||
131638333|NCT01180790|473961908|FG003|Overall Study|Physician Decision|1|||
131638334|NCT01180790|473961909|FG004|Overall Study|Physician Decision|0|||
131638335|NCT01180790|473961910|FG005|Overall Study|Physician Decision|0|||
131638336|NCT01180790|473961911|FG006|Overall Study|Physician Decision|0|||
131638337|NCT01180790|473961905|FG000|Overall Study|Lack of Efficacy|1|||
131638338|NCT01180790|473961906|FG001|Overall Study|Lack of Efficacy|2|||
131638339|NCT01180790|473961907|FG002|Overall Study|Lack of Efficacy|5|||
131638340|NCT01180790|473961908|FG003|Overall Study|Lack of Efficacy|6|||
131638341|NCT01180790|473961909|FG004|Overall Study|Lack of Efficacy|1|||
131638342|NCT01180790|473961910|FG005|Overall Study|Lack of Efficacy|3|||
131638343|NCT01180790|473961911|FG006|Overall Study|Lack of Efficacy|0|||
131638344|NCT01180790|473961905|FG000|Overall Study|compliance|0|||
131638345|NCT01180790|473961906|FG001|Overall Study|compliance|1|||
131638346|NCT01180790|473961907|FG002|Overall Study|compliance|0|||
131638347|NCT01180790|473961908|FG003|Overall Study|compliance|0|||
131638348|NCT01180790|473961909|FG004|Overall Study|compliance|0|||
131638349|NCT01180790|473961910|FG005|Overall Study|compliance|0|||
131638350|NCT01180790|473961911|FG006|Overall Study|compliance|0|||
131638351|NCT01180790|473961905|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
131714487|NCT00064701|474231230|FG002|Clinical Continuation Phase|Rejection|2|||
131714488|NCT00064701|474231228|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
131714489|NCT00064701|474231229|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
131714490|NCT00064701|474231230|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
131714491|NCT00064701|474231228|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
131714492|NCT00064701|474231229|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
131714493|NCT00064701|474231230|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
131714494|NCT00064701|474231228|FG000|Clinical Continuation Phase|Physician Decision|1|||
131714495|NCT00064701|474231229|FG001|Clinical Continuation Phase|Physician Decision|3|||
131714496|NCT00064701|474231230|FG002|Clinical Continuation Phase|Physician Decision|0|||
131714497|NCT00064701|474231228|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
131714498|NCT00064701|474231229|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
131714499|NCT00064701|474231230|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
131714500|NCT00064701|474231228|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
131714501|NCT00064701|474231229|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
131714502|NCT00064701|474231230|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
131714503|NCT00064701|474231228|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
131714504|NCT00064701|474231229|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
131714505|NCT00064701|474231230|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
131714506|NCT00064701|474231228|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
131714507|NCT00064701|474231229|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
131714508|NCT00064701|474231230|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
131714509|NCT00064701|474231228|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
131714510|NCT00064701|474231229|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
131714511|NCT00064701|474231230|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
131714512|NCT00064701|474231228|FG000|Clinical Continuation Phase|Patient opted out|0|||
131714513|NCT00064701|474231229|FG001|Clinical Continuation Phase|Patient opted out|0|||
131714514|NCT00064701|474231230|FG002|Clinical Continuation Phase|Patient opted out|1|||
131714515|NCT01491945|474231232|FG000|Overall Study|Death|30|||
131714516|NCT01491945|474231232|FG000|Overall Study|Withdrwan/LTF|16|||
131714517|NCT01491945|474231232|FG000|Overall Study|Conversion|4|||
131714518|NCT01491945|474231232|FG000|Overall Study|Missed Visit|1|||
131714519|NCT05681715|474231233|FG000|Training Period (6-weeks)|Adverse Event|3|||
131714520|NCT05681715|474231234|FG001|Training Period (6-weeks)|Adverse Event|0|||
131714521|NCT05681715|474231235|FG002|Training Period (6-weeks)|Adverse Event|0|||
131714522|NCT05681715|474231233|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
131714523|NCT05681715|474231234|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
131714524|NCT05681715|474231235|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
131714525|NCT05681715|474231233|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
131799284|NCT04634409|474548944|FG012|Overall Study|Withdrawal by Subject|2|||
131799285|NCT04634409|474548945|FG013|Overall Study|Withdrawal by Subject|1|||
131638352|NCT01180790|473961906|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
131638353|NCT01180790|473961907|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
131638354|NCT01180790|473961908|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
131638355|NCT01180790|473961909|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
131638356|NCT01180790|473961910|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
131638357|NCT01180790|473961911|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
131638358|NCT01064856|473961912|FG000|Double-blind (DB) Period|Adverse Event|1|||
131638359|NCT01064856|473961913|FG001|Double-blind (DB) Period|Adverse Event|0|||
131638360|NCT01064856|473961914|FG002|Double-blind (DB) Period|Adverse Event|0|||
131638361|NCT01064856|473961915|FG003|Double-blind (DB) Period|Adverse Event|0|||
131638362|NCT01064856|473961912|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
131638363|NCT01064856|473961913|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
131638364|NCT01064856|473961914|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
131638365|NCT01064856|473961915|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
131638366|NCT01064856|473961912|FG000|Open-label (OL) Period|Adverse Event|0|||
131638367|NCT01064856|473961913|FG001|Open-label (OL) Period|Adverse Event|0|||
131638368|NCT01064856|473961914|FG002|Open-label (OL) Period|Adverse Event|12|||
131638369|NCT01064856|473961915|FG003|Open-label (OL) Period|Adverse Event|6|||
131638370|NCT01064856|473961912|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
131638371|NCT01064856|473961913|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
131638372|NCT01064856|473961914|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
131638373|NCT01064856|473961915|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
131638374|NCT01064856|473961912|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
131638375|NCT01064856|473961913|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
131638376|NCT01064856|473961914|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
131638377|NCT01064856|473961915|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
131638378|NCT01064856|473961912|FG000|Open-label (OL) Period|Other|0|||
131638379|NCT01064856|473961913|FG001|Open-label (OL) Period|Other|0|||
131638380|NCT01064856|473961914|FG002|Open-label (OL) Period|Other|7|||
131638381|NCT01064856|473961915|FG003|Open-label (OL) Period|Other|7|||
131638382|NCT01204775|473961918|FG000|Overall Study|Poor/non-compliance|0|||
131638383|NCT01204775|473961919|FG001|Overall Study|Poor/non-compliance|1|||
131638384|NCT01204775|473961918|FG000|Overall Study|Withdrawal by Subject|1|||
131638385|NCT01204775|473961919|FG001|Overall Study|Withdrawal by Subject|0|||
131638386|NCT01568112|473961920|FG000|Overall Study|Randomized But Not Treated|0|||
131638387|NCT01568112|473961921|FG001|Overall Study|Randomized But Not Treated|1|||
131638388|NCT01568112|473961922|FG002|Overall Study|Randomized But Not Treated|0|||
131638389|NCT01568112|473961923|FG003|Overall Study|Randomized But Not Treated|0|||
131638390|NCT01568112|473961920|FG000|Overall Study|Withdrew due to Adverse Event|2|||
131638391|NCT01568112|473961921|FG001|Overall Study|Withdrew due to Adverse Event|4|||
131638392|NCT01568112|473961922|FG002|Overall Study|Withdrew due to Adverse Event|6|||
131638393|NCT01568112|473961923|FG003|Overall Study|Withdrew due to Adverse Event|3|||
131638394|NCT01568112|473961920|FG000|Overall Study|Lost to Follow-up|0|||
131714526|NCT05681715|474231234|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
131714527|NCT05681715|474231235|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
131714528|NCT05681715|474231233|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
131714529|NCT05681715|474231234|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
131714530|NCT05681715|474231235|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
131714531|NCT05681715|474231233|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
131714532|NCT05681715|474231234|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
131714533|NCT05681715|474231235|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
131714534|NCT05681715|474231233|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
131714535|NCT05681715|474231234|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
131714536|NCT05681715|474231235|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
131714537|NCT05681715|474231233|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
131714538|NCT05681715|474231234|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
131714539|NCT05681715|474231235|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
131714540|NCT05681715|474231233|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
131714541|NCT05681715|474231234|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
131714542|NCT05681715|474231235|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
131714543|NCT03770403|474231236|FG000|Overall Study|Adverse Event|8|||
131714544|NCT03770403|474231236|FG000|Overall Study|Death|5|||
131714545|NCT03770403|474231236|FG000|Overall Study|Physician Decision|1|||
131714546|NCT03770403|474231236|FG000|Overall Study|Sponsor decision|1|||
131714547|NCT03770403|474231236|FG000|Overall Study|Study terminated by Sponsor|1|||
131714548|NCT03770403|474231236|FG000|Overall Study|Withdrawal by Subject|13|||
131714549|NCT03770403|474231236|FG000|Overall Study|Other|88|||
131714550|NCT02305563|474231241|FG000|Treatment Period|Disease progression|0|||
131714551|NCT02305563|474231242|FG001|Treatment Period|Disease progression|0|||
131638395|NCT01568112|473961921|FG001|Overall Study|Lost to Follow-up|0|||
131638396|NCT01568112|473961922|FG002|Overall Study|Lost to Follow-up|0|||
131638397|NCT01568112|473961923|FG003|Overall Study|Lost to Follow-up|1|||
131799286|NCT04634409|474548946|FG014|Overall Study|Withdrawal by Subject|5|||
131799287|NCT04634409|474548947|FG015|Overall Study|Withdrawal by Subject|0|||
131799288|NCT04634409|474548948|FG016|Overall Study|Withdrawal by Subject|0|||
131799289|NCT04634409|474548949|FG017|Overall Study|Withdrawal by Subject|1|||
131799290|NCT04634409|474548950|FG018|Overall Study|Withdrawal by Subject|0|||
131799291|NCT04634409|474548951|FG019|Overall Study|Withdrawal by Subject|0|||
131799292|NCT04634409|474548952|FG020|Overall Study|Withdrawal by Subject|0|||
131799293|NCT04634409|474548953|FG021|Overall Study|Withdrawal by Subject|0|||
131799294|NCT04634409|474548954|FG022|Overall Study|Withdrawal by Subject|0|||
131799295|NCT04634409|474548955|FG023|Overall Study|Withdrawal by Subject|1|||
131799296|NCT04634409|474548956|FG024|Overall Study|Withdrawal by Subject|0|||
131799297|NCT04634409|474548957|FG025|Overall Study|Withdrawal by Subject|0|||
131799298|NCT04634409|474548958|FG026|Overall Study|Withdrawal by Subject|0|||
131799299|NCT04634409|474548932|FG000|Overall Study|Other - As reported by Investigator|1|||
131799300|NCT04634409|474548933|FG001|Overall Study|Other - As reported by Investigator|0|||
131799301|NCT04634409|474548934|FG002|Overall Study|Other - As reported by Investigator|0|||
131799302|NCT04634409|474548935|FG003|Overall Study|Other - As reported by Investigator|0|||
131799303|NCT04634409|474548936|FG004|Overall Study|Other - As reported by Investigator|0|||
131799304|NCT04634409|474548937|FG005|Overall Study|Other - As reported by Investigator|0|||
131799305|NCT04634409|474548938|FG006|Overall Study|Other - As reported by Investigator|0|||
131799306|NCT04634409|474548939|FG007|Overall Study|Other - As reported by Investigator|6|||
131799307|NCT04634409|474548940|FG008|Overall Study|Other - As reported by Investigator|4|||
131799308|NCT04634409|474548941|FG009|Overall Study|Other - As reported by Investigator|0|||
131799309|NCT04634409|474548942|FG010|Overall Study|Other - As reported by Investigator|1|||
131799310|NCT04634409|474548943|FG011|Overall Study|Other - As reported by Investigator|2|||
131799311|NCT04634409|474548944|FG012|Overall Study|Other - As reported by Investigator|2|||
131799312|NCT04634409|474548945|FG013|Overall Study|Other - As reported by Investigator|1|||
131799313|NCT04634409|474548946|FG014|Overall Study|Other - As reported by Investigator|0|||
131799314|NCT04634409|474548947|FG015|Overall Study|Other - As reported by Investigator|0|||
131799315|NCT04634409|474548948|FG016|Overall Study|Other - As reported by Investigator|0|||
131799316|NCT04634409|474548949|FG017|Overall Study|Other - As reported by Investigator|0|||
131799317|NCT04634409|474548950|FG018|Overall Study|Other - As reported by Investigator|0|||
131799318|NCT04634409|474548951|FG019|Overall Study|Other - As reported by Investigator|0|||
131799319|NCT04634409|474548952|FG020|Overall Study|Other - As reported by Investigator|0|||
131799320|NCT04634409|474548953|FG021|Overall Study|Other - As reported by Investigator|0|||
131799321|NCT04634409|474548954|FG022|Overall Study|Other - As reported by Investigator|0|||
131799322|NCT04634409|474548955|FG023|Overall Study|Other - As reported by Investigator|0|||
131799323|NCT04634409|474548956|FG024|Overall Study|Other - As reported by Investigator|0|||
131799324|NCT04634409|474548957|FG025|Overall Study|Other - As reported by Investigator|0|||
131799325|NCT04634409|474548958|FG026|Overall Study|Other - As reported by Investigator|0|||
131799326|NCT03708211|474548960|FG000|Overall Study|Progressive Disease|10|||
131799327|NCT03708211|474548961|FG001|Overall Study|Progressive Disease|7|||
131799328|NCT03708211|474548960|FG000|Overall Study|Withdrawal by Subject|0|||
131799329|NCT03708211|474548961|FG001|Overall Study|Withdrawal by Subject|1|||
131799330|NCT03708211|474548960|FG000|Overall Study|Other|2|||
131799331|NCT03708211|474548961|FG001|Overall Study|Other|0|||
131799332|NCT00462982|474548963|FG000|Overall Study|Adverse Event|1|||
131799333|NCT00462982|474548963|FG000|Overall Study|Patient Not Treated|2|||
131799334|NCT00679367|474548964|FG000|Overall Study|Adverse Event|7|||
131799335|NCT00679367|474548964|FG000|Overall Study|inability to swallow oral drugs|1|||
131799336|NCT00679367|474548964|FG000|Overall Study|Lack of Efficacy|3|||
131799337|NCT00679367|474548964|FG000|Overall Study|Withdrawal by Subject|1|||
131799338|NCT04603937|474548967|FG000|Overall Study|Adverse Event|9|||
131799339|NCT04603937|474548968|FG001|Overall Study|Adverse Event|10|||
131799340|NCT04603937|474548967|FG000|Overall Study|Withdrawal by Subject|7|||
131799341|NCT04603937|474548968|FG001|Overall Study|Withdrawal by Subject|6|||
131799342|NCT04603937|474548967|FG000|Overall Study|Lost to Follow-up|5|||
131799343|NCT04603937|474548968|FG001|Overall Study|Lost to Follow-up|6|||
131799344|NCT04603937|474548967|FG000|Overall Study|Physician Decision|0|||
131799345|NCT04603937|474548968|FG001|Overall Study|Physician Decision|1|||
131638398|NCT01568112|473961920|FG000|Overall Study|Withdrawal by Subject|2|||
131638399|NCT01568112|473961921|FG001|Overall Study|Withdrawal by Subject|3|||
131799346|NCT04603937|474548967|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
131799347|NCT04603937|474548968|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
131799348|NCT02518685|474548969|FG000|Overall Study|Adverse Event|29|||
131799349|NCT02518685|474548970|FG001|Overall Study|Adverse Event|1|||
131799350|NCT02518685|474548969|FG000|Overall Study|Withdrawal by Subject|10|||
131799351|NCT02518685|474548970|FG001|Overall Study|Withdrawal by Subject|3|||
131799352|NCT02518685|474548969|FG000|Overall Study|relocation, study fatigue|7|||
131902727|NCT02849080|474929375|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
131799353|NCT02518685|474548970|FG001|Overall Study|relocation, study fatigue|2|||
131799354|NCT02518685|474548969|FG000|Overall Study|Pregnancy|1|||
131799355|NCT02518685|474548970|FG001|Overall Study|Pregnancy|0|||
131799356|NCT02518685|474548969|FG000|Overall Study|Physician Decision|1|||
131799357|NCT02518685|474548970|FG001|Overall Study|Physician Decision|0|||
131799358|NCT02518685|474548969|FG000|Overall Study|Lost to Follow-up|1|||
131799359|NCT02518685|474548970|FG001|Overall Study|Lost to Follow-up|4|||
131799360|NCT01922349|474548971|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
131799361|NCT01922349|474548972|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
131799362|NCT01922349|474548973|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
131799363|NCT01922349|474548974|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
131799364|NCT01611090|474548975|FG000|Randomized Period|Lost to Follow-up|8|||
131799365|NCT01611090|474548976|FG001|Randomized Period|Lost to Follow-up|3|||
131799366|NCT01611090|474548977|FG002|Randomized Period|Lost to Follow-up|0|||
131799367|NCT01611090|474548975|FG000|Randomized Period|Withdrawal by Subject|22|||
131799368|NCT01611090|474548976|FG001|Randomized Period|Withdrawal by Subject|26|||
131799369|NCT01611090|474548977|FG002|Randomized Period|Withdrawal by Subject|0|||
131799370|NCT01611090|474548975|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
131799371|NCT01611090|474548976|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
131799372|NCT01611090|474548977|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
131799373|NCT01611090|474548975|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
131799374|NCT01611090|474548976|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
131799375|NCT01611090|474548977|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
131799376|NCT00524459|474550301|FG000|Overall Study|Withdrawal by Subject|1|||
131799377|NCT00524459|474550301|FG000|Overall Study|Other|1|||
131799378|NCT01574248|474550302|FG000|Overall Study|Withdrawal by Subject|2|||
131799379|NCT01574248|474550303|FG001|Overall Study|Withdrawal by Subject|0|||
131799380|NCT01574248|474550302|FG000|Overall Study|Missing primary endpoint data|1|||
131799381|NCT01574248|474550303|FG001|Overall Study|Missing primary endpoint data|0|||
131799382|NCT01424722|474550304|FG000|Overall Study|Sponsor terminated investigation|2258|||
131799383|NCT00818883|474550305|FG000|Overall Study|Adverse Event|28|||
131799384|NCT00818883|474550306|FG001|Overall Study|Adverse Event|19|||
131799385|NCT00818883|474550305|FG000|Overall Study|Protocol Violation|2|||
131799386|NCT00818883|474550306|FG001|Overall Study|Protocol Violation|2|||
131799387|NCT00818883|474550305|FG000|Overall Study|Lost to Follow-up|3|||
131799388|NCT00818883|474550306|FG001|Overall Study|Lost to Follow-up|2|||
131799389|NCT00818883|474550305|FG000|Overall Study|Withdrawal by Subject|16|||
131799390|NCT00818883|474550306|FG001|Overall Study|Withdrawal by Subject|14|||
131799391|NCT00818883|474550305|FG000|Overall Study|Lack of Efficacy|0|||
131799392|NCT00818883|474550306|FG001|Overall Study|Lack of Efficacy|2|||
131799393|NCT00818883|474550305|FG000|Overall Study|Other|2|||
131799394|NCT00818883|474550306|FG001|Overall Study|Other|7|||
131799395|NCT00806156|474550308|FG000|Overall Study|Death|35|||
131799396|NCT00806156|474550309|FG001|Overall Study|Death|95|||
131799397|NCT00806156|474550308|FG000|Overall Study|Did not meet eligibility criteria|1|||
131799398|NCT00806156|474550309|FG001|Overall Study|Did not meet eligibility criteria|0|||
131799399|NCT00806156|474550308|FG000|Overall Study|Study terminated by Sponsor|2|||
131799400|NCT00806156|474550309|FG001|Overall Study|Study terminated by Sponsor|40|||
131799401|NCT00806156|474550308|FG000|Overall Study|Consent withdrawn by subject|1|||
131799402|NCT00806156|474550309|FG001|Overall Study|Consent withdrawn by subject|3|||
131799403|NCT00806156|474550308|FG000|Overall Study|Lost to Follow-up|0|||
131799404|NCT00806156|474550309|FG001|Overall Study|Lost to Follow-up|1|||
131799405|NCT00525590|474550314|FG000|Overall Study|Adverse Event|3|||
131799406|NCT00525590|474550314|FG000|Overall Study|Physician Decision|3|||
131799407|NCT00525590|474550314|FG000|Overall Study|Withdrawal by Subject|16|||
131799408|NCT00525590|474550314|FG000|Overall Study|Lost to Follow-up|1|||
131799409|NCT00525590|474550314|FG000|Overall Study|Death|9|||
131799410|NCT00525590|474550314|FG000|Overall Study|Other|13|||
131799411|NCT02114697|474550315|FG000|Overall Study|Study terminated|5|||
131799412|NCT02114697|474550316|FG001|Overall Study|Study terminated|4|||
131799413|NCT00424489|474550317|FG000|Overall Study|Death|3|||
131799414|NCT00449150|474550324|FG000|Overall Study|Adverse Event|11|||
131799415|NCT00449150|474550325|FG001|Overall Study|Adverse Event|18|||
131799416|NCT00449150|474550326|FG002|Overall Study|Adverse Event|9|||
131799417|NCT00449150|474550324|FG000|Overall Study|Lack of Efficacy|1|||
131799418|NCT00449150|474550325|FG001|Overall Study|Lack of Efficacy|2|||
131799419|NCT00449150|474550326|FG002|Overall Study|Lack of Efficacy|2|||
131799420|NCT00449150|474550324|FG000|Overall Study|Other|16|||
131799421|NCT00449150|474550325|FG001|Overall Study|Other|13|||
131799422|NCT00449150|474550326|FG002|Overall Study|Other|14|||
131799423|NCT00449150|474550324|FG000|Overall Study|Withdrawal by Subject|17|||
131799424|NCT00449150|474550325|FG001|Overall Study|Withdrawal by Subject|18|||
131799425|NCT00449150|474550326|FG002|Overall Study|Withdrawal by Subject|21|||
131638400|NCT01568112|473961922|FG002|Overall Study|Withdrawal by Subject|0|||
131638401|NCT01568112|473961923|FG003|Overall Study|Withdrawal by Subject|7|||
131638402|NCT01568112|473961920|FG000|Overall Study|Withdrawal by Physician|1|||
131638403|NCT01568112|473961921|FG001|Overall Study|Withdrawal by Physician|0|||
131638404|NCT01568112|473961922|FG002|Overall Study|Withdrawal by Physician|1|||
131638405|NCT01568112|473961923|FG003|Overall Study|Withdrawal by Physician|1|||
131638406|NCT00560313|473963494|FG000|Overall Study|Adverse Events or Death|2|||
131638407|NCT00560313|473963494|FG000|Overall Study|Withdrawal by Subject|2|||
131638408|NCT00560313|473963494|FG000|Overall Study|Lost to Follow-up|1|||
131638409|NCT00560313|473963494|FG000|Overall Study|Protocol Violation|1|||
131638410|NCT00943618|473963495|FG000|Overall Study|Lost to Follow-up|38|||
131638411|NCT00943618|473963496|FG001|Overall Study|Lost to Follow-up|48|||
131638412|NCT00943618|473963497|FG002|Overall Study|Lost to Follow-up|20|||
131638413|NCT00943618|473963495|FG000|Overall Study|Discontinued Medication|17|||
131638414|NCT00943618|473963496|FG001|Overall Study|Discontinued Medication|29|||
131638415|NCT00943618|473963497|FG002|Overall Study|Discontinued Medication|11|||
131638416|NCT03713281|473963498|FG000|Overall Study|Lens handling difficuluties|2|||
131638417|NCT03713281|473963498|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
131638418|NCT03119688|473963500|FG000|Overall Study|Adverse Event|4|||
131638419|NCT05006417|473963502|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
131638420|NCT01649557|473963509|FG000|Overall Study|Lost to Follow-up|5|||
131638421|NCT01649557|473963510|FG001|Overall Study|Lost to Follow-up|0|||
131638422|NCT01649557|473963511|FG002|Overall Study|Lost to Follow-up|3|||
131638423|NCT01649557|473963509|FG000|Overall Study|Adverse Event|7|||
131638424|NCT01649557|473963510|FG001|Overall Study|Adverse Event|5|||
131638425|NCT01649557|473963511|FG002|Overall Study|Adverse Event|1|||
131638426|NCT01649557|473963509|FG000|Overall Study|Met withdrawal criteria|4|||
131638427|NCT01649557|473963510|FG001|Overall Study|Met withdrawal criteria|0|||
131638428|NCT01649557|473963511|FG002|Overall Study|Met withdrawal criteria|0|||
131638429|NCT01649557|473963509|FG000|Overall Study|Physician Decision|8|||
131638430|NCT01649557|473963510|FG001|Overall Study|Physician Decision|2|||
131638431|NCT01649557|473963511|FG002|Overall Study|Physician Decision|1|||
131638432|NCT01649557|473963509|FG000|Overall Study|Withdrawal by Subject|15|||
131638433|NCT01649557|473963510|FG001|Overall Study|Withdrawal by Subject|5|||
131638434|NCT01649557|473963511|FG002|Overall Study|Withdrawal by Subject|4|||
131638435|NCT01649557|473963509|FG000|Overall Study|Protocol deviation|0|||
131638436|NCT01649557|473963510|FG001|Overall Study|Protocol deviation|2|||
131638437|NCT01649557|473963511|FG002|Overall Study|Protocol deviation|0|||
131638438|NCT01649557|473963509|FG000|Overall Study|Lack of Efficacy|5|||
131638439|NCT01649557|473963510|FG001|Overall Study|Lack of Efficacy|0|||
131638440|NCT01649557|473963511|FG002|Overall Study|Lack of Efficacy|0|||
131638441|NCT01772823|473963514|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
131638442|NCT01772823|473963515|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
131638443|NCT01772823|473963514|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
131638444|NCT01772823|473963515|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
131638445|NCT01772823|473963514|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
131638446|NCT01772823|473963515|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
131638447|NCT01772823|473963514|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
131638448|NCT01772823|473963515|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
131638449|NCT01772823|473963514|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
131638450|NCT01772823|473963515|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
131638451|NCT01772823|473963514|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
131799426|NCT00449150|474550324|FG000|Overall Study|Protocol Violation|1|||
131799427|NCT00449150|474550325|FG001|Overall Study|Protocol Violation|2|||
131799428|NCT00449150|474550326|FG002|Overall Study|Protocol Violation|1|||
131638452|NCT01772823|473963515|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
131799429|NCT03552757|474550327|FG000|Overall Study|Withdrawal by Subject|10|||
131638453|NCT01772823|473963514|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
131638454|NCT01772823|473963515|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
131638455|NCT01772823|473963514|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
131638456|NCT01772823|473963515|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
131638457|NCT01772823|473963514|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
131638458|NCT01772823|473963515|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
131638459|NCT01772823|473963514|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
131638460|NCT01772823|473963515|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
131638461|NCT01772823|473963514|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
131638462|NCT01772823|473963515|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
131638463|NCT01772823|473963514|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
131638464|NCT01772823|473963515|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
131638465|NCT01772823|473963514|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
131638466|NCT01772823|473963515|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
131638467|NCT01772823|473963514|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
131638468|NCT01772823|473963515|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
131638469|NCT01772823|473963514|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
131638470|NCT01772823|473963515|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
131638471|NCT01772823|473963514|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
131638472|NCT01772823|473963515|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
131638473|NCT03029234|473963522|FG000|Overall Study|Sponsor Decision|1|||
131638474|NCT03029234|473963522|FG000|Overall Study|Withdrawal by Subject|5|||
131638475|NCT03029234|473963522|FG000|Overall Study|Death|91|||
131638476|NCT03029234|473963522|FG000|Overall Study|Lost to Follow-up|2|||
131638477|NCT01649297|473963523|FG000|Overall Study|Adverse Event|5|||
131638478|NCT01649297|473963524|FG001|Overall Study|Adverse Event|5|||
131638479|NCT01649297|473963525|FG002|Overall Study|Adverse Event|4|||
131638480|NCT01649297|473963526|FG003|Overall Study|Adverse Event|13|||
131638481|NCT01649297|473963527|FG004|Overall Study|Adverse Event|1|||
131638482|NCT01649297|473963523|FG000|Overall Study|Lack of Efficacy|0|||
131799430|NCT03552757|474550328|FG001|Overall Study|Withdrawal by Subject|5|||
131799431|NCT03552757|474550329|FG002|Overall Study|Withdrawal by Subject|12|||
131638483|NCT01649297|473963524|FG001|Overall Study|Lack of Efficacy|0|||
131638484|NCT01649297|473963525|FG002|Overall Study|Lack of Efficacy|0|||
131638485|NCT01649297|473963526|FG003|Overall Study|Lack of Efficacy|0|||
131638486|NCT01649297|473963527|FG004|Overall Study|Lack of Efficacy|1|||
131638487|NCT01649297|473963523|FG000|Overall Study|Non compliant with Protocol|1|||
131638488|NCT01649297|473963524|FG001|Overall Study|Non compliant with Protocol|0|||
131638489|NCT01649297|473963525|FG002|Overall Study|Non compliant with Protocol|3|||
131638490|NCT01649297|473963526|FG003|Overall Study|Non compliant with Protocol|2|||
131638491|NCT01649297|473963527|FG004|Overall Study|Non compliant with Protocol|1|||
131638492|NCT01649297|473963523|FG000|Overall Study|Lost to Follow-up|1|||
131638493|NCT01649297|473963524|FG001|Overall Study|Lost to Follow-up|1|||
131638494|NCT01649297|473963525|FG002|Overall Study|Lost to Follow-up|4|||
131638495|NCT01649297|473963526|FG003|Overall Study|Lost to Follow-up|3|||
131638496|NCT01649297|473963527|FG004|Overall Study|Lost to Follow-up|0|||
131638497|NCT01649297|473963523|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
131799432|NCT03552757|474550327|FG000|Overall Study|Lost to Follow-up|2|||
131799433|NCT03552757|474550328|FG001|Overall Study|Lost to Follow-up|7|||
131799434|NCT03552757|474550329|FG002|Overall Study|Lost to Follow-up|7|||
131799435|NCT03552757|474550327|FG000|Overall Study|Death|1|||
131799436|NCT03552757|474550328|FG001|Overall Study|Death|1|||
131799437|NCT03552757|474550329|FG002|Overall Study|Death|1|||
131799438|NCT02674334|474550330|FG000|Overall Study|Lost to Follow-up|5|||
131799439|NCT02674334|474550331|FG001|Overall Study|Lost to Follow-up|3|||
131799440|NCT02674334|474550330|FG000|Overall Study|participant difficulty breathing|1|||
131799441|NCT02674334|474550331|FG001|Overall Study|participant difficulty breathing|0|||
131799442|NCT02674334|474550330|FG000|Overall Study|NIRS not recording|1|||
131799443|NCT02674334|474550331|FG001|Overall Study|NIRS not recording|0|||
131902728|NCT02849080|474929376|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
131902729|NCT02849080|474929377|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
131638498|NCT01649297|473963524|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
131638499|NCT01649297|473963525|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
131638500|NCT01649297|473963526|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
131638501|NCT01649297|473963527|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
131638502|NCT01649297|473963523|FG000|Overall Study|For other reason|4|||
131638503|NCT01649297|473963524|FG001|Overall Study|For other reason|1|||
131638504|NCT01649297|473963525|FG002|Overall Study|For other reason|2|||
131799444|NCT01345019|474550342|FG000|Blinded Treatment Phase|Death|147|||
131799445|NCT01345019|474550343|FG001|Blinded Treatment Phase|Death|137|||
131799446|NCT01345019|474550342|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
131799447|NCT01345019|474550343|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
131799448|NCT01345019|474550342|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
131638505|NCT01649297|473963526|FG003|Overall Study|For other reason|0|||
131638506|NCT01649297|473963527|FG004|Overall Study|For other reason|0|||
131638507|NCT01685047|473963528|FG000|Overall Study|Withdrawal by Subject|20|||
131638508|NCT01685047|473963528|FG000|Overall Study|Death|26|||
131638509|NCT01685047|473963528|FG000|Overall Study|Lost to Follow-up|8|||
131638510|NCT01685047|473963528|FG000|Overall Study|Physician Decision|25|||
131638511|NCT01685047|473963528|FG000|Overall Study|Adverse Event|5|||
131638512|NCT01685047|473963528|FG000|Overall Study|patient withdrawn by sponsor|1|||
131638513|NCT02544113|473963529|FG000|Overall Study|Death|3|||
131638514|NCT02544113|473963530|FG001|Overall Study|Death|4|||
131638515|NCT02847637|473963532|FG000|Overall Study|Withdrawal by Subject|0|||
131638516|NCT02847637|473963533|FG001|Overall Study|Withdrawal by Subject|1|||
131638517|NCT02847637|473963534|FG002|Overall Study|Withdrawal by Subject|1|||
131638518|NCT02847637|473963535|FG003|Overall Study|Withdrawal by Subject|0|||
131638519|NCT02847637|473963532|FG000|Overall Study|Lost to Follow-up|1|||
131638520|NCT02847637|473963533|FG001|Overall Study|Lost to Follow-up|1|||
131638521|NCT02847637|473963534|FG002|Overall Study|Lost to Follow-up|0|||
131638522|NCT02847637|473963535|FG003|Overall Study|Lost to Follow-up|0|||
131638523|NCT01746108|473963538|FG000|Overall Study|Migrated /moved from study area|0|||
131638524|NCT01746108|473963539|FG001|Overall Study|Migrated /moved from study area|1|||
131638525|NCT01746108|473963540|FG002|Overall Study|Migrated /moved from study area|0|||
131638526|NCT01746108|473963538|FG000|Overall Study|Adverse event, non-fatal|0|||
131638527|NCT01746108|473963539|FG001|Overall Study|Adverse event, non-fatal|1|||
131638528|NCT01746108|473963540|FG002|Overall Study|Adverse event, non-fatal|0|||
131638529|NCT01746108|473963538|FG000|Overall Study|Withdrawal by Subject|0|||
131638530|NCT01746108|473963539|FG001|Overall Study|Withdrawal by Subject|1|||
131638531|NCT01746108|473963540|FG002|Overall Study|Withdrawal by Subject|0|||
131638532|NCT01746108|473963538|FG000|Overall Study|Lost to Follow-up|0|||
131638533|NCT01746108|473963539|FG001|Overall Study|Lost to Follow-up|1|||
131638534|NCT01746108|473963540|FG002|Overall Study|Lost to Follow-up|0|||
131638535|NCT00468858|473963546|FG000|Overall Study|Adverse Event|0|||
131638536|NCT00468858|473963547|FG001|Overall Study|Adverse Event|1|||
131638537|NCT00468858|473963548|FG002|Overall Study|Adverse Event|0|||
131638538|NCT00468858|473963546|FG000|Overall Study|Withdrawal by Subject|7|||
131638539|NCT00468858|473963547|FG001|Overall Study|Withdrawal by Subject|4|||
131638540|NCT00468858|473963548|FG002|Overall Study|Withdrawal by Subject|5|||
131638541|NCT00468858|473963546|FG000|Overall Study|Relocation|1|||
131638542|NCT00468858|473963547|FG001|Overall Study|Relocation|3|||
131638543|NCT00468858|473963548|FG002|Overall Study|Relocation|3|||
131638544|NCT00468858|473963546|FG000|Overall Study|Lost to Follow-up|1|||
131638545|NCT00468858|473963547|FG001|Overall Study|Lost to Follow-up|2|||
131638546|NCT00468858|473963548|FG002|Overall Study|Lost to Follow-up|5|||
131638547|NCT00468858|473963546|FG000|Overall Study|Other|0|||
131638548|NCT00468858|473963547|FG001|Overall Study|Other|0|||
131638549|NCT00468858|473963548|FG002|Overall Study|Other|1|||
131638550|NCT00053352|473963553|FG000|Overall Study|Lost to Follow-up|0|||
131638551|NCT00053352|473963554|FG001|Overall Study|Lost to Follow-up|1|||
131638552|NCT00053352|473963553|FG000|Overall Study|Physician Decision|11|||
131638553|NCT00053352|473963554|FG001|Overall Study|Physician Decision|1|||
131638554|NCT00053352|473963553|FG000|Overall Study|Withdrawal by Subject|1|||
131638555|NCT00053352|473963554|FG001|Overall Study|Withdrawal by Subject|0|||
131638556|NCT00053352|473963553|FG000|Overall Study|Ineligible|8|||
131638557|NCT00053352|473963554|FG001|Overall Study|Ineligible|8|||
131638558|NCT00053352|473963553|FG000|Overall Study|Disease at new site|1|||
131638559|NCT00053352|473963554|FG001|Overall Study|Disease at new site|0|||
131638560|NCT01388478|473963555|FG000|Overall Study|Adverse Event|4|||
131638561|NCT01388478|473963555|FG000|Overall Study|Withdrawal by Subject|1|||
131638562|NCT01990664|473963556|FG000|Overall Study|Lost to Follow-up|2|||
131638563|NCT01990664|473963557|FG001|Overall Study|Lost to Follow-up|6|||
131638564|NCT01990664|473963556|FG000|Overall Study|Withdrawal by Subject|2|||
131638565|NCT01990664|473963557|FG001|Overall Study|Withdrawal by Subject|3|||
131638566|NCT01990664|473963556|FG000|Overall Study|Protocol Violation|1|||
131638567|NCT01990664|473963557|FG001|Overall Study|Protocol Violation|0|||
131638568|NCT01990664|473963556|FG000|Overall Study|Lens Discomfort|1|||
131638569|NCT01990664|473963557|FG001|Overall Study|Lens Discomfort|1|||
131638570|NCT01990664|473963556|FG000|Overall Study|Lens Handling Difficulties|1|||
131638571|NCT01990664|473963557|FG001|Overall Study|Lens Handling Difficulties|0|||
131638572|NCT01990664|473963556|FG000|Overall Study|Unsatisfactory Visual Response|0|||
131638573|NCT01990664|473963557|FG001|Overall Study|Unsatisfactory Visual Response|1|||
131638574|NCT00931918|473963558|FG000|Overall Study|Adverse Event|4|||
131638575|NCT00931918|473963559|FG001|Overall Study|Adverse Event|6|||
131638576|NCT00931918|473963558|FG000|Overall Study|Progressive Disease|2|||
131714552|NCT02305563|474231243|FG002|Treatment Period|Disease progression|15|||
131714553|NCT02305563|474231244|FG003|Treatment Period|Disease progression|6|||
131638577|NCT00931918|473963559|FG001|Overall Study|Progressive Disease|1|||
131638578|NCT00931918|473963558|FG000|Overall Study|Symptomatic Deterioration|1|||
131638579|NCT00931918|473963559|FG001|Overall Study|Symptomatic Deterioration|0|||
131638580|NCT00931918|473963558|FG000|Overall Study|Withdrawal by Patient|3|||
131714554|NCT02305563|474231245|FG004|Treatment Period|Disease progression|6|||
131638581|NCT00931918|473963559|FG001|Overall Study|Withdrawal by Patient|4|||
131638582|NCT00931918|473963558|FG000|Overall Study|Other Reason not Specified|4|||
131638583|NCT00931918|473963559|FG001|Overall Study|Other Reason not Specified|4|||
131638584|NCT00931918|473963558|FG000|Overall Study|Did not receive study drug|3|||
131638585|NCT00931918|473963559|FG001|Overall Study|Did not receive study drug|2|||
131638586|NCT00570921|473963560|FG000|Overall Study|Protocol Violation|1|||
131638587|NCT00570921|473963560|FG000|Overall Study|Physician Decision|1|||
131638588|NCT02246218|473963562|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131638589|NCT02246218|473963563|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131638590|NCT02246218|473963562|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
131638591|NCT02246218|473963563|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
131638592|NCT02246218|473963562|FG000|Overall Study|Adverse Event|1|||
131638593|NCT02246218|473963563|FG001|Overall Study|Adverse Event|1|||
131638594|NCT02246218|473963562|FG000|Overall Study|Lost to Follow-up|1|||
131638595|NCT02246218|473963563|FG001|Overall Study|Lost to Follow-up|0|||
131638596|NCT03891641|473963564|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
131638597|NCT03891641|473963565|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
131638598|NCT00784277|473963566|FG000|IR Treatment|Adverse Event|4|||
131638599|NCT00784277|473963567|FG001|IR Treatment|Adverse Event|8|||
131638600|NCT00784277|473963568|FG002|IR Treatment|Adverse Event|19|||
131638601|NCT00784277|473963569|FG003|IR Treatment|Adverse Event|35|||
131638602|NCT00784277|473963570|FG004|IR Treatment|Adverse Event|0|||
131638603|NCT00784277|473963571|FG005|IR Treatment|Adverse Event|0|||
131638604|NCT00784277|473963572|FG006|IR Treatment|Adverse Event|0|||
131638605|NCT00784277|473963566|FG000|IR Treatment|Lack of Efficacy|4|||
131638606|NCT00784277|473963567|FG001|IR Treatment|Lack of Efficacy|4|||
131638607|NCT00784277|473963568|FG002|IR Treatment|Lack of Efficacy|1|||
131638608|NCT00784277|473963569|FG003|IR Treatment|Lack of Efficacy|0|||
131638609|NCT00784277|473963570|FG004|IR Treatment|Lack of Efficacy|0|||
131638610|NCT00784277|473963571|FG005|IR Treatment|Lack of Efficacy|0|||
131638611|NCT00784277|473963572|FG006|IR Treatment|Lack of Efficacy|0|||
131638612|NCT00784277|473963566|FG000|IR Treatment|Lost to Follow-up|1|||
131638613|NCT00784277|473963567|FG001|IR Treatment|Lost to Follow-up|0|||
131638614|NCT00784277|473963568|FG002|IR Treatment|Lost to Follow-up|1|||
131638615|NCT00784277|473963569|FG003|IR Treatment|Lost to Follow-up|0|||
131638616|NCT00784277|473963570|FG004|IR Treatment|Lost to Follow-up|0|||
131638617|NCT00784277|473963571|FG005|IR Treatment|Lost to Follow-up|0|||
131638618|NCT00784277|473963572|FG006|IR Treatment|Lost to Follow-up|0|||
131638619|NCT00784277|473963566|FG000|IR Treatment|Withdrawal by Subject|5|||
131638620|NCT00784277|473963567|FG001|IR Treatment|Withdrawal by Subject|1|||
131902730|NCT02849080|474929378|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
131902731|NCT02849080|474929375|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
131638621|NCT00784277|473963568|FG002|IR Treatment|Withdrawal by Subject|4|||
131638622|NCT00784277|473963569|FG003|IR Treatment|Withdrawal by Subject|6|||
131638623|NCT00784277|473963570|FG004|IR Treatment|Withdrawal by Subject|0|||
131638624|NCT00784277|473963571|FG005|IR Treatment|Withdrawal by Subject|0|||
131638625|NCT00784277|473963572|FG006|IR Treatment|Withdrawal by Subject|0|||
131638626|NCT00784277|473963566|FG000|IR Treatment|Resolution Of Pain|0|||
131638627|NCT00784277|473963567|FG001|IR Treatment|Resolution Of Pain|1|||
131638628|NCT00784277|473963568|FG002|IR Treatment|Resolution Of Pain|0|||
131638629|NCT00784277|473963569|FG003|IR Treatment|Resolution Of Pain|0|||
131638630|NCT00784277|473963570|FG004|IR Treatment|Resolution Of Pain|0|||
131638631|NCT00784277|473963571|FG005|IR Treatment|Resolution Of Pain|0|||
131638632|NCT00784277|473963572|FG006|IR Treatment|Resolution Of Pain|0|||
131638633|NCT00784277|473963566|FG000|IR Treatment|Other|2|||
131638634|NCT00784277|473963567|FG001|IR Treatment|Other|3|||
131638635|NCT00784277|473963568|FG002|IR Treatment|Other|3|||
131638636|NCT00784277|473963569|FG003|IR Treatment|Other|2|||
131638637|NCT00784277|473963570|FG004|IR Treatment|Other|0|||
131638638|NCT00784277|473963571|FG005|IR Treatment|Other|0|||
131638639|NCT00784277|473963572|FG006|IR Treatment|Other|0|||
131638640|NCT00784277|473963566|FG000|ER Treatment|Adverse Event|0|||
131638641|NCT00784277|473963567|FG001|ER Treatment|Adverse Event|0|||
131638642|NCT00784277|473963568|FG002|ER Treatment|Adverse Event|0|||
131638643|NCT00784277|473963569|FG003|ER Treatment|Adverse Event|0|||
131638644|NCT00784277|473963570|FG004|ER Treatment|Adverse Event|1|||
131638645|NCT00784277|473963571|FG005|ER Treatment|Adverse Event|7|||
131638646|NCT00784277|473963572|FG006|ER Treatment|Adverse Event|7|||
131638647|NCT00784277|473963566|FG000|ER Treatment|Lack of Efficacy|0|||
131638648|NCT00784277|473963567|FG001|ER Treatment|Lack of Efficacy|0|||
131638649|NCT00784277|473963568|FG002|ER Treatment|Lack of Efficacy|0|||
131638650|NCT00784277|473963569|FG003|ER Treatment|Lack of Efficacy|0|||
131638651|NCT00784277|473963570|FG004|ER Treatment|Lack of Efficacy|3|||
131638652|NCT00784277|473963571|FG005|ER Treatment|Lack of Efficacy|4|||
131638653|NCT00784277|473963572|FG006|ER Treatment|Lack of Efficacy|0|||
131638654|NCT00784277|473963566|FG000|ER Treatment|Lost to Follow-up|0|||
131638655|NCT00784277|473963567|FG001|ER Treatment|Lost to Follow-up|0|||
131638656|NCT00784277|473963568|FG002|ER Treatment|Lost to Follow-up|0|||
131638657|NCT00784277|473963569|FG003|ER Treatment|Lost to Follow-up|0|||
131638658|NCT00784277|473963570|FG004|ER Treatment|Lost to Follow-up|0|||
131638659|NCT00784277|473963571|FG005|ER Treatment|Lost to Follow-up|2|||
131638660|NCT00784277|473963572|FG006|ER Treatment|Lost to Follow-up|0|||
131638661|NCT00784277|473963566|FG000|ER Treatment|Withdrawal by Subject|0|||
131638662|NCT00784277|473963567|FG001|ER Treatment|Withdrawal by Subject|0|||
131638663|NCT00784277|473963568|FG002|ER Treatment|Withdrawal by Subject|0|||
131638664|NCT00784277|473963569|FG003|ER Treatment|Withdrawal by Subject|0|||
131638665|NCT00784277|473963570|FG004|ER Treatment|Withdrawal by Subject|2|||
131638666|NCT00784277|473963571|FG005|ER Treatment|Withdrawal by Subject|5|||
131638667|NCT00784277|473963572|FG006|ER Treatment|Withdrawal by Subject|3|||
131638668|NCT00784277|473963566|FG000|ER Treatment|Study Medication Non-Compliant|0|||
131638669|NCT00784277|473963567|FG001|ER Treatment|Study Medication Non-Compliant|0|||
131638670|NCT00784277|473963568|FG002|ER Treatment|Study Medication Non-Compliant|0|||
131638671|NCT00784277|473963569|FG003|ER Treatment|Study Medication Non-Compliant|0|||
131638672|NCT00784277|473963570|FG004|ER Treatment|Study Medication Non-Compliant|2|||
131638673|NCT00784277|473963571|FG005|ER Treatment|Study Medication Non-Compliant|3|||
131638674|NCT00784277|473963572|FG006|ER Treatment|Study Medication Non-Compliant|3|||
131638675|NCT00784277|473963566|FG000|ER Treatment|Other|0|||
131638676|NCT00784277|473963567|FG001|ER Treatment|Other|0|||
131638677|NCT00784277|473963568|FG002|ER Treatment|Other|0|||
131638678|NCT00784277|473963569|FG003|ER Treatment|Other|0|||
131638679|NCT00784277|473963570|FG004|ER Treatment|Other|1|||
131638680|NCT00784277|473963571|FG005|ER Treatment|Other|3|||
131638681|NCT00784277|473963572|FG006|ER Treatment|Other|2|||
131638682|NCT01093222|473963573|FG000|Overall Study|Ineligible|6|||
131445099|NCT04672239|473258830|FG000|Week 6 Survey|Partially completed survey|3|||
131445100|NCT04672239|473258831|FG001|Week 6 Survey|Partially completed survey|3|||
131445101|NCT04672239|473258832|FG002|Week 6 Survey|Partially completed survey|2|||
131638683|NCT01093222|473963573|FG000|Overall Study|Adverse Event|7|||
131638684|NCT01093222|473963573|FG000|Overall Study|Progression/relapse|24|||
131638685|NCT01093222|473963573|FG000|Overall Study|Death|2|||
131638686|NCT01093222|473963573|FG000|Overall Study|Not protocol specified|1|||
131638687|NCT01670188|473963574|FG000|Overall Study|Death|0|||
131638688|NCT01670188|473963575|FG001|Overall Study|Death|1|||
131638689|NCT02212301|473963579|FG000|Period 1|Lost to Follow-up|0|||
131638690|NCT02212301|473963580|FG001|Period 1|Lost to Follow-up|1|||
131638691|NCT03927222|473963581|FG000|Overall Study|Progression|3|||
131638692|NCT03927222|473963581|FG000|Overall Study|CMV testing results inconclusive|1|||
131638693|NCT03927222|473963581|FG000|Overall Study|Unable to generate enough vaccines|1|||
131638694|NCT03927222|473963581|FG000|Overall Study|Early study termination|1|||
131638695|NCT00745121|473963582|FG000|Overall Study|Death|3|||
131638696|NCT00745121|473963583|FG001|Overall Study|Death|0|||
131638697|NCT00745121|473963582|FG000|Overall Study|Adverse Event|1|||
131638698|NCT00745121|473963583|FG001|Overall Study|Adverse Event|0|||
131638699|NCT00745121|473963582|FG000|Overall Study|Lost to Follow-up|1|||
131638700|NCT00745121|473963583|FG001|Overall Study|Lost to Follow-up|0|||
131638701|NCT00745121|473963582|FG000|Overall Study|Withdrawal by Subject|4|||
131638702|NCT00745121|473963583|FG001|Overall Study|Withdrawal by Subject|2|||
131638703|NCT01713998|473963584|FG000|Overall Study|Lost to Follow-up|2|||
131638704|NCT01713998|473963585|FG001|Overall Study|Lost to Follow-up|0|||
131638705|NCT01713998|473963586|FG002|Overall Study|Lost to Follow-up|2|||
131638706|NCT01713998|473963584|FG000|Overall Study|Withdrawal by Subject|1|||
131638707|NCT01713998|473963585|FG001|Overall Study|Withdrawal by Subject|0|||
131638708|NCT01713998|473963586|FG002|Overall Study|Withdrawal by Subject|0|||
131638709|NCT03589300|473963587|FG000|Overall Study|Adverse Event|2|||
131638710|NCT03589300|473963587|FG000|Overall Study|Death|4|||
131638711|NCT03589300|473963587|FG000|Overall Study|Lost to Follow-up|12|||
131638712|NCT03589300|473963587|FG000|Overall Study|Withdrawal by Subject|5|||
131638713|NCT02573883|473963590|FG000|Six Month Follow Up|Lost to Follow-up|1|||
131638714|NCT02573883|473963591|FG001|Six Month Follow Up|Lost to Follow-up|0|||
131638715|NCT02573883|473963592|FG002|Six Month Follow Up|Lost to Follow-up|0|||
131638716|NCT02573883|473963593|FG003|Six Month Follow Up|Lost to Follow-up|0|||
131638717|NCT02573883|473963590|FG000|One Year Follow Up|Lost to Follow-up|2|||
131638718|NCT02573883|473963591|FG001|One Year Follow Up|Lost to Follow-up|1|||
131638719|NCT02573883|473963592|FG002|One Year Follow Up|Lost to Follow-up|0|||
131638720|NCT02573883|473963593|FG003|One Year Follow Up|Lost to Follow-up|0|||
131638721|NCT00853021|473963598|FG000|Overall Study|Adverse Event|2|||
131638722|NCT00853021|473963598|FG000|Overall Study|Withdrawal by Subject|2|||
131638723|NCT00853021|473963598|FG000|Overall Study|Death|1|||
131638724|NCT01220856|473963599|FG000|Overall Study|graft loss|3|||
131638725|NCT01220856|473963600|FG001|Overall Study|graft loss|3|||
131638726|NCT01220856|473963599|FG000|Overall Study|Lost to Follow-up|1|||
131638727|NCT01220856|473963600|FG001|Overall Study|Lost to Follow-up|0|||
131638728|NCT04088500|473963601|FG000|Overall Study|Reason unknown|1|||
131638729|NCT04088500|473963601|FG000|Overall Study|Participant withdrew consent|1|||
131638730|NCT04088500|473963601|FG000|Overall Study|Disease progression|3|||
131638731|NCT00981578|473963602|FG000|Overall Study|Death|1|||
131638732|NCT00981578|473963602|FG000|Overall Study|Withdrawal by Subject|2|||
131638733|NCT02212197|473963603|FG000|Overall Study|Need for radiotherapy|1|||
131638734|NCT02212197|473963604|FG001|Overall Study|Need for radiotherapy|0|||
131638735|NCT02212197|473963605|FG002|Overall Study|Need for radiotherapy|0|||
131638736|NCT01078584|473963606|FG000|Overall Study|Final Status Unknown|1073|||
131638737|NCT01078584|473963606|FG000|Overall Study|Lost to Follow-up|670|||
131638738|NCT01078584|473963606|FG000|Overall Study|Non-serious Adverse Event|577|||
131638739|NCT01078584|473963606|FG000|Overall Study|Withdrawal of Consent|244|||
131638740|NCT01078584|473963606|FG000|Overall Study|Physician Withdrew from Study|90|||
131638741|NCT01078584|473963606|FG000|Overall Study|Non-compliance|67|||
131638742|NCT01078584|473963606|FG000|Overall Study|Blood Pressure Controlled|49|||
131638743|NCT01078584|473963606|FG000|Overall Study|Physician Switched Medication|26|||
131638744|NCT01078584|473963606|FG000|Overall Study|Physician Discontinued Patient|12|||
131638745|NCT01078584|473963606|FG000|Overall Study|Lack of Efficacy|98|||
131638746|NCT01078584|473963606|FG000|Overall Study|Protocol Violation|75|||
131638747|NCT01078584|473963606|FG000|Overall Study|Serious Adverse Event|27|||
131799449|NCT01345019|474550343|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
131799450|NCT01345019|474550342|FG000|Blinded Treatment Phase|Disease Progression|12|||
131799451|NCT01345019|474550343|FG001|Blinded Treatment Phase|Disease Progression|10|||
131799452|NCT01345019|474550342|FG000|Blinded Treatment Phase|Adverse Event|6|||
131799453|NCT01345019|474550343|FG001|Blinded Treatment Phase|Adverse Event|13|||
131799454|NCT01345019|474550342|FG000|Blinded Treatment Phase|Administrative Decision|10|||
131638748|NCT01078584|473963606|FG000|Overall Study|Multiple Reasons|2|||
131638749|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
131638750|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
131638751|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
131638752|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Other|1|||
131638753|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Other|0|||
131638754|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Other|0|||
131638755|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Physician Decision|3|||
131638756|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Physician Decision|0|||
131638757|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Physician Decision|0|||
131638758|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
131638759|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
131638760|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
131638761|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
131638762|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
131799455|NCT01345019|474550343|FG001|Blinded Treatment Phase|Administrative Decision|8|||
131799456|NCT01345019|474550342|FG000|Blinded Treatment Phase|Noncompliance|5|||
131638763|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
131638764|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Adverse Event|18|||
131638765|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Adverse Event|0|||
131638766|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Adverse Event|0|||
131638767|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
131638768|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
131638769|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
131638770|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
131638771|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
131638772|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
131638773|NCT03030599|473963609|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
131638774|NCT03030599|473963610|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
131638775|NCT03030599|473963611|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
131638776|NCT03030599|473963609|FG000|Stable Dose|Protocol deviation|3|||
131638777|NCT03030599|473963610|FG001|Stable Dose|Protocol deviation|0|||
131638778|NCT03030599|473963611|FG002|Stable Dose|Protocol deviation|0|||
131638779|NCT03030599|473963609|FG000|Stable Dose|Adverse Event|1|||
131638780|NCT03030599|473963610|FG001|Stable Dose|Adverse Event|0|||
131638781|NCT03030599|473963611|FG002|Stable Dose|Adverse Event|0|||
131638782|NCT03030599|473963609|FG000|Stable Dose|Lost to Follow-up|1|||
131638783|NCT03030599|473963610|FG001|Stable Dose|Lost to Follow-up|0|||
131638784|NCT03030599|473963611|FG002|Stable Dose|Lost to Follow-up|0|||
131638785|NCT03030599|473963609|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
131638786|NCT03030599|473963610|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
131638787|NCT03030599|473963611|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
131638788|NCT03030599|473963609|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
131638789|NCT03030599|473963610|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
131638790|NCT03030599|473963611|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
131638791|NCT03030599|473963609|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
131638792|NCT03030599|473963610|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
131638793|NCT03030599|473963611|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
131638794|NCT03030599|473963609|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
131638795|NCT03030599|473963610|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
131638796|NCT03030599|473963611|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
131638797|NCT03030599|473963609|FG000|Open-label Extension|Adverse Event|3|||
131638798|NCT03030599|473963610|FG001|Open-label Extension|Adverse Event|0|||
131638799|NCT03030599|473963611|FG002|Open-label Extension|Adverse Event|0|||
131638800|NCT03030599|473963609|FG000|Open-label Extension|Lost to Follow-up|2|||
131638801|NCT03030599|473963610|FG001|Open-label Extension|Lost to Follow-up|0|||
131638802|NCT03030599|473963611|FG002|Open-label Extension|Lost to Follow-up|0|||
131638803|NCT03030599|473963609|FG000|Open-label Extension|Lack of Efficacy|1|||
131638804|NCT03030599|473963610|FG001|Open-label Extension|Lack of Efficacy|0|||
131638805|NCT03030599|473963611|FG002|Open-label Extension|Lack of Efficacy|0|||
131638806|NCT03030599|473963609|FG000|Open-label Extension|Other Reason|1|||
131638807|NCT03030599|473963610|FG001|Open-label Extension|Other Reason|0|||
131638808|NCT03030599|473963611|FG002|Open-label Extension|Other Reason|0|||
131638809|NCT01592383|473963612|FG000|Overall Study|Adverse Event|1|||
131638810|NCT04582864|473963613|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
131638811|NCT04582864|473963613|FG000|Overall Study|Death|1|||
131638812|NCT04167085|473963614|FG000|Baseline|Withdrawal by Subject|2|||
131638813|NCT04167085|473963615|FG001|Baseline|Withdrawal by Subject|1|||
131638814|NCT04167085|473963614|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
131638815|NCT04167085|473963615|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
131638816|NCT00702520|473963618|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
131638817|NCT00702520|473963619|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
131714555|NCT02305563|474231241|FG000|Treatment Period|Study drug toxicity|0|||
131714556|NCT02305563|474231242|FG001|Treatment Period|Study drug toxicity|0|||
131714557|NCT02305563|474231243|FG002|Treatment Period|Study drug toxicity|0|||
131714558|NCT02305563|474231244|FG003|Treatment Period|Study drug toxicity|1|||
131714559|NCT02305563|474231245|FG004|Treatment Period|Study drug toxicity|2|||
131714560|NCT02305563|474231241|FG000|Treatment Period|Death|0|||
131714561|NCT02305563|474231242|FG001|Treatment Period|Death|0|||
131714562|NCT02305563|474231243|FG002|Treatment Period|Death|1|||
131638818|NCT00702520|473963620|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
131714563|NCT02305563|474231244|FG003|Treatment Period|Death|2|||
131714564|NCT02305563|474231245|FG004|Treatment Period|Death|1|||
131714565|NCT02305563|474231241|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
131799457|NCT01345019|474550343|FG001|Blinded Treatment Phase|Noncompliance|3|||
131799458|NCT01345019|474550342|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
131799459|NCT01345019|474550343|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
131714566|NCT02305563|474231242|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
131714567|NCT02305563|474231243|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
131714568|NCT02305563|474231244|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
131714569|NCT02305563|474231245|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
131714570|NCT02305563|474231241|FG000|Treatment Period|Participant request to stop therapy|0|||
131714571|NCT02305563|474231242|FG001|Treatment Period|Participant request to stop therapy|2|||
131714572|NCT02305563|474231243|FG002|Treatment Period|Participant request to stop therapy|0|||
131714573|NCT02305563|474231244|FG003|Treatment Period|Participant request to stop therapy|1|||
131714574|NCT02305563|474231245|FG004|Treatment Period|Participant request to stop therapy|0|||
131714575|NCT02305563|474231241|FG000|Treatment Period|Participant withdrew consent|0|||
131714576|NCT02305563|474231242|FG001|Treatment Period|Participant withdrew consent|0|||
131714577|NCT02305563|474231243|FG002|Treatment Period|Participant withdrew consent|1|||
131714578|NCT02305563|474231244|FG003|Treatment Period|Participant withdrew consent|1|||
131714579|NCT02305563|474231245|FG004|Treatment Period|Participant withdrew consent|1|||
131714580|NCT02305563|474231241|FG000|Treatment Period|Maximum clinical benefit|0|||
131714581|NCT02305563|474231242|FG001|Treatment Period|Maximum clinical benefit|0|||
131714582|NCT02305563|474231243|FG002|Treatment Period|Maximum clinical benefit|0|||
131714583|NCT02305563|474231244|FG003|Treatment Period|Maximum clinical benefit|0|||
131714584|NCT02305563|474231245|FG004|Treatment Period|Maximum clinical benefit|1|||
131714585|NCT02305563|474231241|FG000|Treatment Period|Poor/non-compliance|0|||
131714586|NCT02305563|474231242|FG001|Treatment Period|Poor/non-compliance|0|||
131714587|NCT02305563|474231243|FG002|Treatment Period|Poor/non-compliance|0|||
131714588|NCT02305563|474231244|FG003|Treatment Period|Poor/non-compliance|0|||
131799460|NCT01345019|474550342|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
131799461|NCT01345019|474550343|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
131799462|NCT01345019|474550342|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
131799463|NCT01345019|474550343|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
131799464|NCT01345019|474550342|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
131799465|NCT01345019|474550343|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
131638819|NCT00702520|473963621|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
131638820|NCT00702520|473963618|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
131638821|NCT00702520|473963619|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
131638822|NCT00702520|473963620|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
131638823|NCT00702520|473963621|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
131638824|NCT00702520|473963618|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
131638825|NCT00702520|473963619|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
131638826|NCT00702520|473963620|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
131638827|NCT00702520|473963621|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
131638828|NCT02481934|473963622|FG000|Overall Study|Death|2|||
131638829|NCT00942188|473963623|FG000|Overall Study|Adverse Event|0|||
131638830|NCT00942188|473963624|FG001|Overall Study|Adverse Event|3|||
131638831|NCT00942188|473963625|FG002|Overall Study|Adverse Event|2|||
131638832|NCT00942188|473963626|FG003|Overall Study|Adverse Event|0|||
131638833|NCT00942188|473963623|FG000|Overall Study|Lack of Efficacy|0|||
131638834|NCT00942188|473963624|FG001|Overall Study|Lack of Efficacy|0|||
131638835|NCT00942188|473963625|FG002|Overall Study|Lack of Efficacy|0|||
131638836|NCT00942188|473963626|FG003|Overall Study|Lack of Efficacy|1|||
131638837|NCT00942188|473963623|FG000|Overall Study|Protocol Violation|1|||
131638838|NCT00942188|473963624|FG001|Overall Study|Protocol Violation|1|||
131638839|NCT00942188|473963625|FG002|Overall Study|Protocol Violation|0|||
131638840|NCT00942188|473963626|FG003|Overall Study|Protocol Violation|0|||
131638841|NCT00942188|473963623|FG000|Overall Study|Lost to Follow-up|2|||
131638842|NCT00942188|473963624|FG001|Overall Study|Lost to Follow-up|1|||
131638843|NCT00942188|473963625|FG002|Overall Study|Lost to Follow-up|2|||
131638844|NCT00942188|473963626|FG003|Overall Study|Lost to Follow-up|0|||
131638845|NCT00942188|473963623|FG000|Overall Study|Withdrawal by Subject|1|||
131638846|NCT00942188|473963624|FG001|Overall Study|Withdrawal by Subject|3|||
131638847|NCT00942188|473963625|FG002|Overall Study|Withdrawal by Subject|4|||
131714589|NCT02305563|474231245|FG004|Treatment Period|Poor/non-compliance|1|||
131714590|NCT02305563|474231241|FG000|Treatment Period|Administrative reason by Sponsor|0|||
131714591|NCT02305563|474231242|FG001|Treatment Period|Administrative reason by Sponsor|0|||
131799466|NCT01345019|474550342|FG000|Open Label Treatment Phase|Death|49|||
131638848|NCT00942188|473963626|FG003|Overall Study|Withdrawal by Subject|2|||
131638849|NCT00942188|473963623|FG000|Overall Study|Physician Decision|0|||
131638850|NCT00942188|473963624|FG001|Overall Study|Physician Decision|0|||
131638851|NCT00942188|473963625|FG002|Overall Study|Physician Decision|1|||
131638852|NCT00942188|473963626|FG003|Overall Study|Physician Decision|0|||
131638853|NCT00942188|473963623|FG000|Overall Study|Sponsor Decision|0|||
131638854|NCT00942188|473963624|FG001|Overall Study|Sponsor Decision|2|||
131638855|NCT00942188|473963625|FG002|Overall Study|Sponsor Decision|0|||
131638856|NCT00942188|473963626|FG003|Overall Study|Sponsor Decision|1|||
131638857|NCT00276016|473963627|FG000|Intervention 1|Withdrawal by Subject|0|||
131638858|NCT00276016|473963628|FG001|Intervention 1|Withdrawal by Subject|1|||
131638859|NCT00276016|473963629|FG002|Intervention 1|Withdrawal by Subject|0|||
131638860|NCT00276016|473963630|FG003|Intervention 1|Withdrawal by Subject|0|||
131638861|NCT00276016|473963631|FG004|Intervention 1|Withdrawal by Subject|0|||
131638862|NCT00276016|473963632|FG005|Intervention 1|Withdrawal by Subject|0|||
131638863|NCT01374971|473963633|FG000|Overall Study|Withdrawal by Subject|1|||
131638864|NCT01947517|473966179|FG000|Overall Study|Withdrawal by Subject|1|||
131638865|NCT01947517|473966180|FG001|Overall Study|Withdrawal by Subject|1|||
131638866|NCT00526097|473966184|FG000|Overall Study|Adverse Event|6|||
131638867|NCT00526097|473966185|FG001|Overall Study|Adverse Event|44|||
131638868|NCT00526097|473966184|FG000|Overall Study|Protocol Violation|4|||
131638869|NCT00526097|473966185|FG001|Overall Study|Protocol Violation|10|||
131638870|NCT00526097|473966184|FG000|Overall Study|Withdrawal by Subject|3|||
131638871|NCT00526097|473966185|FG001|Overall Study|Withdrawal by Subject|1|||
131638872|NCT00526097|473966184|FG000|Overall Study|Other|2|||
131638873|NCT00526097|473966185|FG001|Overall Study|Other|1|||
131638874|NCT00320398|473966199|FG000|Overall Study|Adverse Event|1|||
131638875|NCT00320398|473966200|FG001|Overall Study|Adverse Event|4|||
131638876|NCT00320398|473966199|FG000|Overall Study|Other|1|||
131638877|NCT00320398|473966200|FG001|Overall Study|Other|0|||
131638878|NCT00630552|473966201|FG000|Overall Study|Adverse Event|0|||
131638879|NCT00630552|473966202|FG001|Overall Study|Adverse Event|1|||
131638880|NCT00630552|473966203|FG002|Overall Study|Adverse Event|5|||
131638881|NCT00630552|473966204|FG003|Overall Study|Adverse Event|4|||
131638882|NCT00630552|473966205|FG004|Overall Study|Adverse Event|2|||
131638883|NCT00630552|473966201|FG000|Overall Study|Disease progression|5|||
131638884|NCT00630552|473966202|FG001|Overall Study|Disease progression|6|||
131638885|NCT00630552|473966203|FG002|Overall Study|Disease progression|27|||
131638886|NCT00630552|473966204|FG003|Overall Study|Disease progression|22|||
131638887|NCT00630552|473966205|FG004|Overall Study|Disease progression|31|||
131638888|NCT00630552|473966201|FG000|Overall Study|Never received IP|0|||
131638889|NCT00630552|473966202|FG001|Overall Study|Never received IP|0|||
131638890|NCT00630552|473966203|FG002|Overall Study|Never received IP|0|||
131638891|NCT00630552|473966204|FG003|Overall Study|Never received IP|2|||
131638892|NCT00630552|473966205|FG004|Overall Study|Never received IP|2|||
131638893|NCT00630552|473966201|FG000|Overall Study|Ineligibility determined|0|||
131638894|NCT00630552|473966202|FG001|Overall Study|Ineligibility determined|0|||
131638895|NCT00630552|473966203|FG002|Overall Study|Ineligibility determined|0|||
131638896|NCT00630552|473966204|FG003|Overall Study|Ineligibility determined|0|||
131638897|NCT00630552|473966205|FG004|Overall Study|Ineligibility determined|1|||
131638898|NCT00630552|473966201|FG000|Overall Study|Protocol Violation|0|||
131638899|NCT00630552|473966202|FG001|Overall Study|Protocol Violation|0|||
131638900|NCT00630552|473966203|FG002|Overall Study|Protocol Violation|0|||
131638901|NCT00630552|473966204|FG003|Overall Study|Protocol Violation|1|||
131638902|NCT00630552|473966205|FG004|Overall Study|Protocol Violation|0|||
131638903|NCT00630552|473966201|FG000|Overall Study|Physician Decision|0|||
131638904|NCT00630552|473966202|FG001|Overall Study|Physician Decision|0|||
131638905|NCT00630552|473966203|FG002|Overall Study|Physician Decision|0|||
131638906|NCT00630552|473966204|FG003|Overall Study|Physician Decision|0|||
131638907|NCT00630552|473966205|FG004|Overall Study|Physician Decision|1|||
131638908|NCT00630552|473966201|FG000|Overall Study|Death|0|||
131638909|NCT00630552|473966202|FG001|Overall Study|Death|0|||
131638910|NCT00630552|473966203|FG002|Overall Study|Death|1|||
131638911|NCT00630552|473966204|FG003|Overall Study|Death|2|||
131638912|NCT00630552|473966205|FG004|Overall Study|Death|2|||
131638913|NCT00630552|473966201|FG000|Overall Study|Withdrawal by Subject|0|||
131638914|NCT00630552|473966202|FG001|Overall Study|Withdrawal by Subject|0|||
131638915|NCT00630552|473966203|FG002|Overall Study|Withdrawal by Subject|0|||
131638916|NCT00630552|473966204|FG003|Overall Study|Withdrawal by Subject|1|||
131638917|NCT00630552|473966205|FG004|Overall Study|Withdrawal by Subject|0|||
131638918|NCT00630552|473966201|FG000|Overall Study|Other|0|||
131638919|NCT00630552|473966202|FG001|Overall Study|Other|0|||
131638920|NCT00630552|473966203|FG002|Overall Study|Other|4|||
131638921|NCT00630552|473966204|FG003|Overall Study|Other|2|||
131638922|NCT00630552|473966205|FG004|Overall Study|Other|0|||
131638923|NCT04349644|473966206|FG000|Allocation/Pretest|Lost to pretest|0|||
131638924|NCT04349644|473966207|FG001|Allocation/Pretest|Lost to pretest|3|||
131638925|NCT04349644|473966206|FG000|Posttest|Lost to posttest|0|||
131638926|NCT04349644|473966207|FG001|Posttest|Lost to posttest|8|||
131638927|NCT04349644|473966206|FG000|Posttest|Discontinued intervention|6|||
131799467|NCT01345019|474550343|FG001|Open Label Treatment Phase|Death|48|||
131638928|NCT04349644|473966207|FG001|Posttest|Discontinued intervention|0|||
131638929|NCT04349644|473966206|FG000|Follow-up|Lost to Follow-up|0|||
131638930|NCT04349644|473966207|FG001|Follow-up|Lost to Follow-up|2|||
131638931|NCT02158247|473966209|FG000|Overall Study|Invisible vocal cords|5|||
131638932|NCT00875615|473966210|FG000|Overall Study|Withdrawal by Subject|1|||
131638933|NCT00809341|473966211|FG000|Overall Study|Physician Decision|0|||
131638934|NCT00809341|473966212|FG001|Overall Study|Physician Decision|1|||
131638935|NCT00225277|473966216|FG000|Overall Study|Adverse Event|30|||
131638936|NCT00225277|473966217|FG001|Overall Study|Adverse Event|34|||
131638937|NCT00225277|473966216|FG000|Overall Study|Lack of Efficacy|4|||
131638938|NCT00225277|473966217|FG001|Overall Study|Lack of Efficacy|1|||
131638939|NCT00225277|473966216|FG000|Overall Study|Lost to Follow-up|4|||
131638940|NCT00225277|473966217|FG001|Overall Study|Lost to Follow-up|6|||
131638941|NCT00225277|473966216|FG000|Overall Study|Physician Decision|6|||
131638942|NCT00225277|473966217|FG001|Overall Study|Physician Decision|8|||
131638943|NCT00225277|473966216|FG000|Overall Study|Protocol Violation|6|||
131638944|NCT00225277|473966217|FG001|Overall Study|Protocol Violation|3|||
131638945|NCT00225277|473966216|FG000|Overall Study|Withdrawal by Subject|40|||
131638946|NCT00225277|473966217|FG001|Overall Study|Withdrawal by Subject|34|||
131638947|NCT00225277|473966216|FG000|Overall Study|Other|7|||
131638948|NCT00225277|473966217|FG001|Overall Study|Other|9|||
131638949|NCT04582669|473966224|FG000|Overall Study|Subject missed appointment(s).|1|||
131638950|NCT04582669|473966225|FG001|Overall Study|Subject missed appointment(s).|0|||
131638951|NCT04582669|473966226|FG002|Overall Study|Subject missed appointment(s).|1|||
131638952|NCT04582669|473966227|FG003|Overall Study|Subject missed appointment(s).|2|||
131638953|NCT04582669|473966224|FG000|Overall Study|Protocol Violation|0|||
131638954|NCT04582669|473966225|FG001|Overall Study|Protocol Violation|1|||
131638955|NCT04582669|473966226|FG002|Overall Study|Protocol Violation|1|||
131638956|NCT04582669|473966227|FG003|Overall Study|Protocol Violation|0|||
131638957|NCT00591409|473966228|FG000|Overall Study|Not Treated|0|||
131638958|NCT00591409|473966229|FG001|Overall Study|Not Treated|0|||
131638959|NCT00591409|473966230|FG002|Overall Study|Not Treated|0|||
131638960|NCT00591409|473966231|FG003|Overall Study|Not Treated|0|||
131638961|NCT00591409|473966232|FG004|Overall Study|Not Treated|1|||
131638962|NCT00591409|473966233|FG005|Overall Study|Not Treated|0|||
131638963|NCT00591409|473966234|FG006|Overall Study|Not Treated|0|||
131638964|NCT00591409|473966235|FG007|Overall Study|Not Treated|0|||
131638965|NCT00591409|473966236|FG008|Overall Study|Not Treated|0|||
131638966|NCT00591409|473966237|FG009|Overall Study|Not Treated|1|||
131638967|NCT00677092|473966238|FG000|Overall Study|Adverse Event|1|||
131638968|NCT00677092|473966238|FG000|Overall Study|Lost to Follow-up|1|||
131638969|NCT00677092|473966238|FG000|Overall Study|Withdrawal by Subject|3|||
131638970|NCT00677092|473966238|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
131638971|NCT00550446|473966239|FG000|Up To Week 12|Adverse Event|2|||
131638972|NCT00550446|473966240|FG001|Up To Week 12|Adverse Event|2|||
131638973|NCT00550446|473966241|FG002|Up To Week 12|Adverse Event|0|||
131638974|NCT00550446|473966242|FG003|Up To Week 12|Adverse Event|0|||
131638975|NCT00550446|473966243|FG004|Up To Week 12|Adverse Event|2|||
131638976|NCT00550446|473966244|FG005|Up To Week 12|Adverse Event|2|||
131638977|NCT00550446|473966245|FG006|Up To Week 12|Adverse Event|1|||
131638978|NCT00550446|473966246|FG007|Up To Week 12|Adverse Event|0|||
131638979|NCT00550446|473966247|FG008|Up To Week 12|Adverse Event|0|||
131638980|NCT00550446|473966248|FG009|Up To Week 12|Adverse Event|0|||
131638981|NCT00550446|473966249|FG010|Up To Week 12|Adverse Event|0|||
131638982|NCT00550446|473966239|FG000|Up To Week 12|Lack of Efficacy|3|||
131638983|NCT00550446|473966240|FG001|Up To Week 12|Lack of Efficacy|1|||
131638984|NCT00550446|473966241|FG002|Up To Week 12|Lack of Efficacy|0|||
131638985|NCT00550446|473966242|FG003|Up To Week 12|Lack of Efficacy|1|||
131638986|NCT00550446|473966243|FG004|Up To Week 12|Lack of Efficacy|0|||
131638987|NCT00550446|473966244|FG005|Up To Week 12|Lack of Efficacy|3|||
131638988|NCT00550446|473966245|FG006|Up To Week 12|Lack of Efficacy|3|||
131638989|NCT00550446|473966246|FG007|Up To Week 12|Lack of Efficacy|0|||
131799468|NCT01345019|474550342|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
131638990|NCT00550446|473966247|FG008|Up To Week 12|Lack of Efficacy|0|||
131638991|NCT00550446|473966248|FG009|Up To Week 12|Lack of Efficacy|0|||
131638992|NCT00550446|473966249|FG010|Up To Week 12|Lack of Efficacy|0|||
131638993|NCT00550446|473966239|FG000|Up To Week 12|Lost to Follow-up|0|||
131638994|NCT00550446|473966240|FG001|Up To Week 12|Lost to Follow-up|1|||
131638995|NCT00550446|473966241|FG002|Up To Week 12|Lost to Follow-up|0|||
131638996|NCT00550446|473966242|FG003|Up To Week 12|Lost to Follow-up|0|||
131638997|NCT00550446|473966243|FG004|Up To Week 12|Lost to Follow-up|1|||
131638998|NCT00550446|473966244|FG005|Up To Week 12|Lost to Follow-up|1|||
131638999|NCT00550446|473966245|FG006|Up To Week 12|Lost to Follow-up|2|||
131639000|NCT00550446|473966246|FG007|Up To Week 12|Lost to Follow-up|0|||
131639001|NCT00550446|473966247|FG008|Up To Week 12|Lost to Follow-up|0|||
131639002|NCT00550446|473966248|FG009|Up To Week 12|Lost to Follow-up|0|||
131639003|NCT00550446|473966249|FG010|Up To Week 12|Lost to Follow-up|0|||
131639004|NCT00550446|473966239|FG000|Up To Week 12|Withdrawal by Subject|2|||
131639005|NCT00550446|473966240|FG001|Up To Week 12|Withdrawal by Subject|0|||
131714592|NCT02305563|474231243|FG002|Treatment Period|Administrative reason by Sponsor|0|||
131714593|NCT02305563|474231244|FG003|Treatment Period|Administrative reason by Sponsor|0|||
131714594|NCT02305563|474231245|FG004|Treatment Period|Administrative reason by Sponsor|1|||
131714595|NCT02305563|474231241|FG000|Treatment Period|other reason|2|||
131714596|NCT02305563|474231242|FG001|Treatment Period|other reason|0|||
131714597|NCT02305563|474231243|FG002|Treatment Period|other reason|2|||
131714598|NCT02305563|474231244|FG003|Treatment Period|other reason|2|||
131714599|NCT02305563|474231245|FG004|Treatment Period|other reason|1|||
131714600|NCT02305563|474231241|FG000|Treatment Period|Randomized but not treated|0|||
131714601|NCT02305563|474231242|FG001|Treatment Period|Randomized but not treated|0|||
131714602|NCT02305563|474231243|FG002|Treatment Period|Randomized but not treated|0|||
131714603|NCT02305563|474231244|FG003|Treatment Period|Randomized but not treated|0|||
131714604|NCT02305563|474231245|FG004|Treatment Period|Randomized but not treated|2|||
131714605|NCT02305563|474231241|FG000|Treatment Period|added ULO, then disease progression|0|||
131714606|NCT02305563|474231242|FG001|Treatment Period|added ULO, then disease progression|0|||
131714607|NCT02305563|474231243|FG002|Treatment Period|added ULO, then disease progression|0|||
131714608|NCT02305563|474231244|FG003|Treatment Period|added ULO, then disease progression|0|||
131714609|NCT02305563|474231245|FG004|Treatment Period|added ULO, then disease progression|4|||
131714610|NCT02305563|474231241|FG000|Treatment Period|added ULO; then other reason|0|||
131714611|NCT02305563|474231242|FG001|Treatment Period|added ULO; then other reason|0|||
131714612|NCT02305563|474231243|FG002|Treatment Period|added ULO; then other reason|0|||
131714613|NCT02305563|474231244|FG003|Treatment Period|added ULO; then other reason|0|||
131714614|NCT02305563|474231245|FG004|Treatment Period|added ULO; then other reason|1|||
131714615|NCT02305563|474231241|FG000|Treatment Period|added ULO, then request to stop|0|||
131714616|NCT02305563|474231242|FG001|Treatment Period|added ULO, then request to stop|0|||
131714617|NCT02305563|474231243|FG002|Treatment Period|added ULO, then request to stop|0|||
131714618|NCT02305563|474231244|FG003|Treatment Period|added ULO, then request to stop|0|||
131714619|NCT02305563|474231245|FG004|Treatment Period|added ULO, then request to stop|1|||
131714620|NCT02305563|474231241|FG000|Follow-up Period|Death|0|||
131714621|NCT02305563|474231242|FG001|Follow-up Period|Death|0|||
131714622|NCT02305563|474231243|FG002|Follow-up Period|Death|5|||
131714623|NCT02305563|474231244|FG003|Follow-up Period|Death|4|||
131714624|NCT02305563|474231245|FG004|Follow-up Period|Death|7|||
131714625|NCT02305563|474231241|FG000|Follow-up Period|Participant withdrew consent|0|||
131714626|NCT02305563|474231242|FG001|Follow-up Period|Participant withdrew consent|0|||
131714627|NCT02305563|474231243|FG002|Follow-up Period|Participant withdrew consent|2|||
131714628|NCT02305563|474231244|FG003|Follow-up Period|Participant withdrew consent|1|||
131714629|NCT02305563|474231245|FG004|Follow-up Period|Participant withdrew consent|0|||
131714630|NCT02305563|474231241|FG000|Follow-up Period|other reason|0|||
131714631|NCT02305563|474231242|FG001|Follow-up Period|other reason|0|||
131714632|NCT02305563|474231243|FG002|Follow-up Period|other reason|0|||
131714633|NCT02305563|474231244|FG003|Follow-up Period|other reason|0|||
131714634|NCT02305563|474231245|FG004|Follow-up Period|other reason|1|||
131714635|NCT02305563|474231241|FG000|Follow-up Period|Followup no longer required per protocol|3|||
131714636|NCT02305563|474231242|FG001|Follow-up Period|Followup no longer required per protocol|3|||
131714637|NCT02305563|474231243|FG002|Follow-up Period|Followup no longer required per protocol|4|||
131714638|NCT02305563|474231244|FG003|Follow-up Period|Followup no longer required per protocol|1|||
131714639|NCT02305563|474231245|FG004|Follow-up Period|Followup no longer required per protocol|4|||
131714640|NCT02700451|474231249|FG000|Overall Study|Protocol Violation|2|||
131714641|NCT02700451|474231250|FG001|Overall Study|Protocol Violation|2|||
131714642|NCT02700451|474231251|FG002|Overall Study|Protocol Violation|3|||
131714643|NCT02700451|474231249|FG000|Overall Study|Discontinued intervention|14|||
131714644|NCT02700451|474231250|FG001|Overall Study|Discontinued intervention|15|||
131714645|NCT02700451|474231251|FG002|Overall Study|Discontinued intervention|14|||
131714646|NCT00454207|474231252|FG000|Overall Study|Adverse Event|3|||
131714647|NCT00454207|474231253|FG001|Overall Study|Adverse Event|1|||
131714648|NCT00454207|474231252|FG000|Overall Study|Lack of Efficacy|1|||
131714649|NCT00454207|474231253|FG001|Overall Study|Lack of Efficacy|0|||
131714650|NCT00454207|474231252|FG000|Overall Study|Protocol Violation|0|||
131714651|NCT00454207|474231253|FG001|Overall Study|Protocol Violation|1|||
131714652|NCT02337387|474231256|FG000|Overall Study|Adverse Event|0|||
131714653|NCT02337387|474231257|FG001|Overall Study|Adverse Event|1|||
131714654|NCT02337387|474231258|FG002|Overall Study|Adverse Event|0|||
131714655|NCT02337387|474231259|FG003|Overall Study|Adverse Event|0|||
131714656|NCT02337387|474231256|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
131714657|NCT02337387|474231257|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
131714658|NCT02337387|474231258|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
131714659|NCT02337387|474231259|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
131714660|NCT00742781|474233656|FG000|Overall Study|Withdrawal by Subject|3|||
131714661|NCT00506389|474233657|FG000|In-treatment Period|Other|3|||
131714662|NCT00506389|474233658|FG001|In-treatment Period|Other|3|||
131714663|NCT00506389|474233659|FG002|In-treatment Period|Other|4|||
131714664|NCT00506389|474233657|FG000|In-treatment Period|Lost to Follow-up|0|||
131714665|NCT00506389|474233658|FG001|In-treatment Period|Lost to Follow-up|0|||
131714666|NCT00506389|474233659|FG002|In-treatment Period|Lost to Follow-up|1|||
131639006|NCT00550446|473966241|FG002|Up To Week 12|Withdrawal by Subject|3|||
131639007|NCT00550446|473966242|FG003|Up To Week 12|Withdrawal by Subject|2|||
131639008|NCT00550446|473966243|FG004|Up To Week 12|Withdrawal by Subject|0|||
131639009|NCT00550446|473966244|FG005|Up To Week 12|Withdrawal by Subject|1|||
131639010|NCT00550446|473966245|FG006|Up To Week 12|Withdrawal by Subject|3|||
131639011|NCT00550446|473966246|FG007|Up To Week 12|Withdrawal by Subject|0|||
131639012|NCT00550446|473966247|FG008|Up To Week 12|Withdrawal by Subject|0|||
131639013|NCT00550446|473966248|FG009|Up To Week 12|Withdrawal by Subject|0|||
131639014|NCT00550446|473966249|FG010|Up To Week 12|Withdrawal by Subject|0|||
131639015|NCT00550446|473966239|FG000|Up To Week 12|Other|3|||
131639016|NCT00550446|473966240|FG001|Up To Week 12|Other|0|||
131639017|NCT00550446|473966241|FG002|Up To Week 12|Other|0|||
131639018|NCT00550446|473966242|FG003|Up To Week 12|Other|0|||
131639019|NCT00550446|473966243|FG004|Up To Week 12|Other|0|||
131639020|NCT00550446|473966244|FG005|Up To Week 12|Other|1|||
131639021|NCT00550446|473966245|FG006|Up To Week 12|Other|4|||
131639022|NCT00550446|473966246|FG007|Up To Week 12|Other|0|||
131639023|NCT00550446|473966247|FG008|Up To Week 12|Other|0|||
131639024|NCT00550446|473966248|FG009|Up To Week 12|Other|0|||
131639025|NCT00550446|473966249|FG010|Up To Week 12|Other|0|||
131639026|NCT00550446|473966239|FG000|Up To Week 12|Randomized not treated|0|||
131639027|NCT00550446|473966240|FG001|Up To Week 12|Randomized not treated|1|||
131639028|NCT00550446|473966241|FG002|Up To Week 12|Randomized not treated|1|||
131639029|NCT00550446|473966242|FG003|Up To Week 12|Randomized not treated|0|||
131639030|NCT00550446|473966243|FG004|Up To Week 12|Randomized not treated|0|||
131639031|NCT00550446|473966244|FG005|Up To Week 12|Randomized not treated|0|||
131639032|NCT00550446|473966245|FG006|Up To Week 12|Randomized not treated|0|||
131639033|NCT00550446|473966246|FG007|Up To Week 12|Randomized not treated|0|||
131639034|NCT00550446|473966247|FG008|Up To Week 12|Randomized not treated|0|||
131639035|NCT00550446|473966248|FG009|Up To Week 12|Randomized not treated|0|||
131639036|NCT00550446|473966249|FG010|Up To Week 12|Randomized not treated|0|||
131639037|NCT00550446|473966239|FG000|Post Week 12|Adverse Event|2|||
131639038|NCT00550446|473966240|FG001|Post Week 12|Adverse Event|1|||
131639039|NCT00550446|473966241|FG002|Post Week 12|Adverse Event|1|||
131639040|NCT00550446|473966242|FG003|Post Week 12|Adverse Event|1|||
131639041|NCT00550446|473966243|FG004|Post Week 12|Adverse Event|1|||
131639042|NCT00550446|473966244|FG005|Post Week 12|Adverse Event|1|||
131639043|NCT00550446|473966245|FG006|Post Week 12|Adverse Event|0|||
131639044|NCT00550446|473966246|FG007|Post Week 12|Adverse Event|0|||
131639045|NCT00550446|473966247|FG008|Post Week 12|Adverse Event|0|||
131639046|NCT00550446|473966248|FG009|Post Week 12|Adverse Event|4|||
131639047|NCT00550446|473966249|FG010|Post Week 12|Adverse Event|0|||
131639048|NCT00550446|473966239|FG000|Post Week 12|Lack of Efficacy|0|||
131639049|NCT00550446|473966240|FG001|Post Week 12|Lack of Efficacy|0|||
131639050|NCT00550446|473966241|FG002|Post Week 12|Lack of Efficacy|1|||
131639051|NCT00550446|473966242|FG003|Post Week 12|Lack of Efficacy|0|||
131639052|NCT00550446|473966243|FG004|Post Week 12|Lack of Efficacy|0|||
131639053|NCT00550446|473966244|FG005|Post Week 12|Lack of Efficacy|0|||
131639054|NCT00550446|473966245|FG006|Post Week 12|Lack of Efficacy|0|||
131639055|NCT00550446|473966246|FG007|Post Week 12|Lack of Efficacy|1|||
131639056|NCT00550446|473966247|FG008|Post Week 12|Lack of Efficacy|1|||
131639057|NCT00550446|473966248|FG009|Post Week 12|Lack of Efficacy|2|||
131639058|NCT00550446|473966249|FG010|Post Week 12|Lack of Efficacy|1|||
131639059|NCT00550446|473966239|FG000|Post Week 12|Lost to Follow-up|0|||
131639060|NCT00550446|473966240|FG001|Post Week 12|Lost to Follow-up|0|||
131639061|NCT00550446|473966241|FG002|Post Week 12|Lost to Follow-up|1|||
131639062|NCT00550446|473966242|FG003|Post Week 12|Lost to Follow-up|1|||
131639063|NCT00550446|473966243|FG004|Post Week 12|Lost to Follow-up|0|||
131639064|NCT00550446|473966244|FG005|Post Week 12|Lost to Follow-up|0|||
131639065|NCT00550446|473966245|FG006|Post Week 12|Lost to Follow-up|1|||
131639066|NCT00550446|473966246|FG007|Post Week 12|Lost to Follow-up|0|||
131639067|NCT00550446|473966247|FG008|Post Week 12|Lost to Follow-up|0|||
131639068|NCT00550446|473966248|FG009|Post Week 12|Lost to Follow-up|0|||
131639069|NCT00550446|473966249|FG010|Post Week 12|Lost to Follow-up|0|||
131639070|NCT00550446|473966239|FG000|Post Week 12|Withdrawal by Subject|0|||
131639071|NCT00550446|473966240|FG001|Post Week 12|Withdrawal by Subject|0|||
131639072|NCT00550446|473966241|FG002|Post Week 12|Withdrawal by Subject|0|||
131639073|NCT00550446|473966242|FG003|Post Week 12|Withdrawal by Subject|0|||
131639074|NCT00550446|473966243|FG004|Post Week 12|Withdrawal by Subject|1|||
131639075|NCT00550446|473966244|FG005|Post Week 12|Withdrawal by Subject|0|||
131639076|NCT00550446|473966245|FG006|Post Week 12|Withdrawal by Subject|0|||
131639077|NCT00550446|473966246|FG007|Post Week 12|Withdrawal by Subject|0|||
131639078|NCT00550446|473966247|FG008|Post Week 12|Withdrawal by Subject|0|||
131639079|NCT00550446|473966248|FG009|Post Week 12|Withdrawal by Subject|0|||
131639080|NCT00550446|473966249|FG010|Post Week 12|Withdrawal by Subject|0|||
131639081|NCT00550446|473966239|FG000|Post Week 12|Other|1|||
131639082|NCT00550446|473966240|FG001|Post Week 12|Other|1|||
131639083|NCT00550446|473966241|FG002|Post Week 12|Other|0|||
131639084|NCT00550446|473966242|FG003|Post Week 12|Other|1|||
131639085|NCT00550446|473966243|FG004|Post Week 12|Other|0|||
131799469|NCT01345019|474550343|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
131799470|NCT01345019|474550342|FG000|Open Label Treatment Phase|Adverse Event|30|||
131799471|NCT01345019|474550343|FG001|Open Label Treatment Phase|Adverse Event|51|||
131799472|NCT01345019|474550342|FG000|Open Label Treatment Phase|Administrative Decision|30|||
131799473|NCT01345019|474550343|FG001|Open Label Treatment Phase|Administrative Decision|15|||
131799474|NCT01345019|474550342|FG000|Open Label Treatment Phase|Disease Progression|17|||
131639086|NCT00550446|473966244|FG005|Post Week 12|Other|0|||
131639087|NCT00550446|473966245|FG006|Post Week 12|Other|1|||
131639088|NCT00550446|473966246|FG007|Post Week 12|Other|0|||
131639089|NCT00550446|473966247|FG008|Post Week 12|Other|1|||
131639090|NCT00550446|473966248|FG009|Post Week 12|Other|1|||
131639091|NCT00550446|473966249|FG010|Post Week 12|Other|0|||
131639092|NCT03503162|473966250|FG000|Overall Study|did not meet eligibility|1|||
131639093|NCT04952701|473966251|FG000|Control Lens|Physician Decision|4|||
131639094|NCT04952701|473966251|FG000|Test Lens|Physician Decision|1|||
131639095|NCT02025985|473966260|FG000|Overall Study|Consent withdrawn|0|||
131639096|NCT02025985|473966261|FG001|Overall Study|Consent withdrawn|0|||
131639097|NCT02025985|473966262|FG002|Overall Study|Consent withdrawn|1|||
131639098|NCT02025985|473966263|FG003|Overall Study|Consent withdrawn|0|||
131639099|NCT02025985|473966264|FG004|Overall Study|Consent withdrawn|0|||
131639100|NCT02025985|473966260|FG000|Overall Study|Termination of study by Sponsor|4|||
131639101|NCT02025985|473966261|FG001|Overall Study|Termination of study by Sponsor|3|||
131639102|NCT02025985|473966262|FG002|Overall Study|Termination of study by Sponsor|1|||
131639103|NCT02025985|473966263|FG003|Overall Study|Termination of study by Sponsor|1|||
131639104|NCT02025985|473966264|FG004|Overall Study|Termination of study by Sponsor|3|||
131639105|NCT02025985|473966260|FG000|Overall Study|Death|21|||
131639106|NCT02025985|473966261|FG001|Overall Study|Death|20|||
131639107|NCT02025985|473966262|FG002|Overall Study|Death|23|||
131639108|NCT02025985|473966263|FG003|Overall Study|Death|20|||
131639109|NCT02025985|473966264|FG004|Overall Study|Death|17|||
131639110|NCT03723915|473966268|FG000|Screening|Failed to meet screening requirements.|2|||
131639111|NCT03723915|473966268|FG000|On Treatment|Failed to meet treatment requirements|2|||
131639112|NCT01978236|473966277|FG000|Overall Study|Discontinued due to study close|2|||
131639113|NCT00634920|473966279|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
131639114|NCT00634920|473966280|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
131639115|NCT00634920|473966281|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
131639116|NCT00634920|473966279|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
131639117|NCT00634920|473966280|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
131639118|NCT00634920|473966281|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
131639119|NCT00634920|473966279|FG000|Period 1 - Pre-Randomization|Rejections|0|||
131639120|NCT00634920|473966280|FG001|Period 1 - Pre-Randomization|Rejections|0|||
131639121|NCT00634920|473966281|FG002|Period 1 - Pre-Randomization|Rejections|55|||
131639122|NCT00634920|473966279|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
131639123|NCT00634920|473966280|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
131639124|NCT00634920|473966281|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
131639125|NCT00634920|473966279|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
131639126|NCT00634920|473966280|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
131639127|NCT00634920|473966281|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
131639128|NCT00634920|473966279|FG000|Period 1 - Pre-Randomization|Other issues|0|||
131639129|NCT00634920|473966280|FG001|Period 1 - Pre-Randomization|Other issues|0|||
131639130|NCT00634920|473966281|FG002|Period 1 - Pre-Randomization|Other issues|6|||
131639131|NCT00634920|473966279|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
131639132|NCT00634920|473966280|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
131639133|NCT00634920|473966281|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
131639134|NCT00634920|473966279|FG000|Period 2 - Post-Randomization|Rejection|11|||
131639135|NCT00634920|473966280|FG001|Period 2 - Post-Randomization|Rejection|5|||
131639136|NCT00634920|473966281|FG002|Period 2 - Post-Randomization|Rejection|0|||
131639137|NCT00634920|473966279|FG000|Period 2 - Post-Randomization|Death|2|||
131639138|NCT00634920|473966280|FG001|Period 2 - Post-Randomization|Death|5|||
131799475|NCT01345019|474550343|FG001|Open Label Treatment Phase|Disease Progression|18|||
131799476|NCT01345019|474550342|FG000|Open Label Treatment Phase|Noncompliance|5|||
131799477|NCT01345019|474550343|FG001|Open Label Treatment Phase|Noncompliance|4|||
131799478|NCT01345019|474550342|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
131799479|NCT01345019|474550343|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
131639139|NCT00634920|473966281|FG002|Period 2 - Post-Randomization|Death|0|||
131639140|NCT00634920|473966279|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
131639141|NCT00634920|473966280|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
131639142|NCT00634920|473966281|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
131639143|NCT00634920|473966279|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
131799480|NCT01345019|474550342|FG000|Open Label Treatment Phase|Pregnancy|1|||
131639144|NCT00634920|473966280|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
131799481|NCT01345019|474550343|FG001|Open Label Treatment Phase|Pregnancy|0|||
131799482|NCT01345019|474550342|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
131639145|NCT00634920|473966281|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
131639146|NCT00819013|473966282|FG000|Overall Study|Not meeting continuing study eligibility|2|||
131639147|NCT00819013|473966283|FG001|Overall Study|Not meeting continuing study eligibility|1|||
131639148|NCT00819013|473966284|FG002|Overall Study|Not meeting continuing study eligibility|2|||
131639149|NCT00819013|473966285|FG003|Overall Study|Not meeting continuing study eligibility|1|||
131639150|NCT00819013|473966282|FG000|Overall Study|Adverse Event|0|||
131639151|NCT00819013|473966283|FG001|Overall Study|Adverse Event|0|||
131639152|NCT00819013|473966284|FG002|Overall Study|Adverse Event|1|||
131639153|NCT00819013|473966285|FG003|Overall Study|Adverse Event|0|||
131639154|NCT00819013|473966282|FG000|Overall Study|Withdrawal by Subject|1|||
131639155|NCT00819013|473966283|FG001|Overall Study|Withdrawal by Subject|0|||
131639156|NCT00819013|473966284|FG002|Overall Study|Withdrawal by Subject|1|||
131639157|NCT00819013|473966285|FG003|Overall Study|Withdrawal by Subject|0|||
131639158|NCT00819013|473966282|FG000|Overall Study|Lost to Follow-up|0|||
131639159|NCT00819013|473966283|FG001|Overall Study|Lost to Follow-up|0|||
131639160|NCT00819013|473966284|FG002|Overall Study|Lost to Follow-up|1|||
131639161|NCT00819013|473966285|FG003|Overall Study|Lost to Follow-up|2|||
131639162|NCT00819013|473966282|FG000|Overall Study|Death|0|||
131639163|NCT00819013|473966283|FG001|Overall Study|Death|0|||
131639164|NCT00819013|473966284|FG002|Overall Study|Death|0|||
131639165|NCT00819013|473966285|FG003|Overall Study|Death|1|||
131639166|NCT00576823|473966288|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
131639167|NCT00576823|473966289|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
131639168|NCT00576823|473966290|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
131639169|NCT00576823|473966288|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
131639170|NCT00576823|473966289|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
131639171|NCT00576823|473966290|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
131639172|NCT00510146|473966291|FG000|Double-Blind Treatment|Adverse Event|30|||
131639173|NCT00510146|473966292|FG001|Double-Blind Treatment|Adverse Event|13|||
131639174|NCT00510146|473966291|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
131639175|NCT00510146|473966292|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
131639176|NCT00510146|473966291|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
131639177|NCT00510146|473966292|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
131639178|NCT00510146|473966291|FG000|Double-Blind Treatment|Physician Decision|6|||
131639179|NCT00510146|473966292|FG001|Double-Blind Treatment|Physician Decision|0|||
131639180|NCT00510146|473966291|FG000|Double-Blind Treatment|Protocol Violation|1|||
131639181|NCT00510146|473966292|FG001|Double-Blind Treatment|Protocol Violation|2|||
131639182|NCT00510146|473966291|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
131639183|NCT00510146|473966292|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
131639184|NCT00510146|473966291|FG000|Double-Blind Treatment|Clinical Relapse|0|||
131639185|NCT00510146|473966292|FG001|Double-Blind Treatment|Clinical Relapse|1|||
131639186|NCT00510146|473966291|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
131639187|NCT00510146|473966292|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
131639188|NCT00510146|473966291|FG000|Open-Label Treatment|Adverse Event|22|||
131639189|NCT00510146|473966292|FG001|Open-Label Treatment|Adverse Event|8|||
131639190|NCT00510146|473966291|FG000|Open-Label Treatment|Death|1|||
131639191|NCT00510146|473966292|FG001|Open-Label Treatment|Death|1|||
131639192|NCT00510146|473966291|FG000|Open-Label Treatment|Lack of Efficacy|4|||
131714667|NCT00506389|474233657|FG000|In-treatment Period|Lack of compliance|1|||
131714668|NCT00506389|474233658|FG001|In-treatment Period|Lack of compliance|0|||
131714669|NCT00506389|474233659|FG002|In-treatment Period|Lack of compliance|0|||
131714670|NCT00506389|474233657|FG000|In-treatment Period|Reasons not related to trial|4|||
131714671|NCT00506389|474233658|FG001|In-treatment Period|Reasons not related to trial|1|||
131714672|NCT00506389|474233659|FG002|In-treatment Period|Reasons not related to trial|0|||
131714673|NCT00506389|474233657|FG000|In-treatment Period|Withdrawal by Subject|3|||
131714674|NCT00506389|474233658|FG001|In-treatment Period|Withdrawal by Subject|3|||
131714675|NCT00506389|474233659|FG002|In-treatment Period|Withdrawal by Subject|4|||
131714676|NCT00506389|474233657|FG000|In-treatment Period|Lack of Efficacy|0|||
131639193|NCT00510146|473966292|FG001|Open-Label Treatment|Lack of Efficacy|0|||
131639194|NCT00510146|473966291|FG000|Open-Label Treatment|Lost to Follow-up|10|||
131639195|NCT00510146|473966292|FG001|Open-Label Treatment|Lost to Follow-up|1|||
131639196|NCT00510146|473966291|FG000|Open-Label Treatment|Physician Decision|3|||
131639197|NCT00510146|473966292|FG001|Open-Label Treatment|Physician Decision|1|||
131639198|NCT00510146|473966291|FG000|Open-Label Treatment|Protocol Violation|4|||
131639199|NCT00510146|473966292|FG001|Open-Label Treatment|Protocol Violation|2|||
131639200|NCT00510146|473966291|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
131639201|NCT00510146|473966292|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
131639202|NCT00510146|473966291|FG000|Open-Label Treatment|Clinical Relapse|1|||
131639203|NCT00510146|473966292|FG001|Open-Label Treatment|Clinical Relapse|1|||
131639204|NCT00510146|473966291|FG000|Open-Label Treatment|Sponsor Decision|2|||
131639205|NCT00510146|473966292|FG001|Open-Label Treatment|Sponsor Decision|0|||
131639206|NCT03188536|473966295|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
131639207|NCT03188536|473966295|FG000|Overall Study|Not participated/met inclusion criteria|1|||
131639208|NCT01930214|473966297|FG000|Overall Study|Death|4|||
131639209|NCT01930214|473966298|FG001|Overall Study|Death|4|||
131639210|NCT01930214|473966299|FG002|Overall Study|Death|11|||
131639211|NCT01930214|473966297|FG000|Overall Study|Lost to Follow-up|12|||
131639212|NCT01930214|473966298|FG001|Overall Study|Lost to Follow-up|13|||
131639213|NCT01930214|473966299|FG002|Overall Study|Lost to Follow-up|12|||
131639214|NCT01930214|473966297|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
131639215|NCT01930214|473966298|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
131639216|NCT01930214|473966299|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
131639217|NCT01930214|473966297|FG000|Overall Study|Physician Decision|2|||
131639218|NCT01930214|473966298|FG001|Overall Study|Physician Decision|0|||
131639219|NCT01930214|473966299|FG002|Overall Study|Physician Decision|0|||
131639220|NCT02132117|473966300|FG000|Overall Study|Adverse Event|6|||
131639221|NCT02132117|473966301|FG001|Overall Study|Adverse Event|1|||
131639222|NCT02132117|473966300|FG000|Overall Study|Lost to Follow-up|2|||
131639223|NCT02132117|473966301|FG001|Overall Study|Lost to Follow-up|2|||
131639224|NCT02132117|473966300|FG000|Overall Study|Personal Reasons|1|||
131639225|NCT02132117|473966301|FG001|Overall Study|Personal Reasons|2|||
131639226|NCT02132117|473966300|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131639227|NCT02132117|473966301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131639228|NCT00776984|473966306|FG000|Overall Study|Adverse Event|8|||
131639229|NCT00776984|473966307|FG001|Overall Study|Adverse Event|2|||
131639230|NCT00776984|473966306|FG000|Overall Study|Protocol Violation|4|||
131639231|NCT00776984|473966307|FG001|Overall Study|Protocol Violation|2|||
131639232|NCT00776984|473966306|FG000|Overall Study|Lost to Follow-up|2|||
131639233|NCT00776984|473966307|FG001|Overall Study|Lost to Follow-up|0|||
131639234|NCT00776984|473966306|FG000|Overall Study|Withdrawal by Subject|12|||
131639235|NCT00776984|473966307|FG001|Overall Study|Withdrawal by Subject|7|||
131639236|NCT00776984|473966306|FG000|Overall Study|Lack of Efficacy|0|||
131639237|NCT00776984|473966307|FG001|Overall Study|Lack of Efficacy|1|||
131639238|NCT00776984|473966306|FG000|Overall Study|Other|5|||
131639239|NCT00776984|473966307|FG001|Overall Study|Other|9|||
131639240|NCT01544309|473966308|FG000|Overall Study|Withdrawal by Subject|12|||
131639241|NCT01544309|473966309|FG001|Overall Study|Withdrawal by Subject|7|||
131639242|NCT01544309|473966308|FG000|Overall Study|Protocol Violation|2|||
131639243|NCT01544309|473966309|FG001|Overall Study|Protocol Violation|1|||
131639244|NCT01544309|473966308|FG000|Overall Study|Physician Decision|4|||
131639245|NCT01544309|473966309|FG001|Overall Study|Physician Decision|1|||
131639246|NCT01544309|473966308|FG000|Overall Study|Not performed pre-dose examination|1|||
131639247|NCT01544309|473966309|FG001|Overall Study|Not performed pre-dose examination|2|||
131639248|NCT01544309|473966308|FG000|Overall Study|Administered prohibit prior medication|1|||
131639249|NCT01544309|473966309|FG001|Overall Study|Administered prohibit prior medication|0|||
131639250|NCT00118703|473966310|FG000|Overall Study|Protocol Violation|1|||
131639251|NCT00118703|473966311|FG001|Overall Study|Protocol Violation|0|||
131639252|NCT00118703|473966310|FG000|Overall Study|Adverse Event|1|||
131639253|NCT00118703|473966311|FG001|Overall Study|Adverse Event|1|||
131639254|NCT00118703|473966310|FG000|Overall Study|Participant took two different treatment|0|||
131639255|NCT00118703|473966311|FG001|Overall Study|Participant took two different treatment|1|||
131639256|NCT00118703|473966310|FG000|Overall Study|Withdrawal by Subject|2|||
131639257|NCT00118703|473966311|FG001|Overall Study|Withdrawal by Subject|5|||
131639258|NCT00118703|473966310|FG000|Overall Study|Lost to Follow-up|1|||
131639259|NCT00118703|473966311|FG001|Overall Study|Lost to Follow-up|2|||
131714677|NCT00506389|474233658|FG001|In-treatment Period|Lack of Efficacy|2|||
131639260|NCT03796208|473966318|FG000|Overall Study|Withdrawal by Subject|3|||
131639261|NCT03796208|473966319|FG001|Overall Study|Withdrawal by Subject|0|||
131639262|NCT03796208|473966318|FG000|Overall Study|Loss of pregnancy|1|||
131639263|NCT03796208|473966319|FG001|Overall Study|Loss of pregnancy|1|||
131639264|NCT03796208|473966318|FG000|Overall Study|Changed prenatal clinics|0|||
131639265|NCT03796208|473966319|FG001|Overall Study|Changed prenatal clinics|5|||
131714678|NCT00506389|474233659|FG002|In-treatment Period|Lack of Efficacy|0|||
131714679|NCT00506389|474233657|FG000|In-treatment Period|Adverse Event|11|||
131639266|NCT03796208|473966318|FG000|Overall Study|Lost to Follow-up|20|||
131639267|NCT03796208|473966319|FG001|Overall Study|Lost to Follow-up|16|||
131639268|NCT00519285|473966320|FG000|Overall Study|Adverse Event|127|||
131639269|NCT00519285|473966321|FG001|Overall Study|Adverse Event|266|||
131639270|NCT00519285|473966320|FG000|Overall Study|Disease progression|334|||
131639271|NCT00519285|473966321|FG001|Overall Study|Disease progression|186|||
131714680|NCT00506389|474233658|FG001|In-treatment Period|Adverse Event|5|||
131714681|NCT00506389|474233659|FG002|In-treatment Period|Adverse Event|2|||
131714682|NCT00506389|474233657|FG000|In-treatment Period|Randomized but not treated|4|||
131639272|NCT00519285|473966320|FG000|Overall Study|Physician Decision|75|||
131639273|NCT00519285|473966321|FG001|Overall Study|Physician Decision|47|||
131445102|NCT04672239|473258830|FG000|Week 6 Survey|Withdrawal by Subject|1|||
131445103|NCT04672239|473258831|FG001|Week 6 Survey|Withdrawal by Subject|1|||
131445104|NCT04672239|473258832|FG002|Week 6 Survey|Withdrawal by Subject|1|||
131445105|NCT04672239|473258830|FG000|Week 6 Survey|Withdrawn by PI|0|||
131445106|NCT04672239|473258831|FG001|Week 6 Survey|Withdrawn by PI|1|||
131445107|NCT04672239|473258832|FG002|Week 6 Survey|Withdrawn by PI|0|||
131445108|NCT04672239|473258830|FG000|Week 6 Survey|Lost to Follow-up|12|||
131445109|NCT04672239|473258831|FG001|Week 6 Survey|Lost to Follow-up|2|||
131445110|NCT04672239|473258832|FG002|Week 6 Survey|Lost to Follow-up|5|||
131445111|NCT04672239|473258830|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
131445112|NCT04672239|473258831|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
131445113|NCT04672239|473258832|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
131445114|NCT04672239|473258830|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
131445115|NCT04672239|473258831|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
131445116|NCT04672239|473258832|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
131445117|NCT04672239|473258830|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
131445118|NCT04672239|473258831|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
131445119|NCT04672239|473258832|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
131445120|NCT04672239|473258830|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
131445121|NCT04672239|473258831|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
131445122|NCT04672239|473258832|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
131445123|NCT04672239|473258830|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
131639274|NCT00519285|473966320|FG000|Overall Study|Participant's request|53|||
131639275|NCT00519285|473966321|FG001|Overall Study|Participant's request|84|||
131639276|NCT00519285|473966320|FG000|Overall Study|Consent withdrawn|4|||
131639277|NCT00519285|473966321|FG001|Overall Study|Consent withdrawn|5|||
131639278|NCT00519285|473966320|FG000|Overall Study|Poor compliance to protocol|5|||
131639279|NCT00519285|473966321|FG001|Overall Study|Poor compliance to protocol|7|||
131639280|NCT00519285|473966320|FG000|Overall Study|Reason unspecified|5|||
131639281|NCT00519285|473966321|FG001|Overall Study|Reason unspecified|8|||
131639282|NCT00519285|473966320|FG000|Overall Study|Not treated|8|||
131639283|NCT00519285|473966321|FG001|Overall Study|Not treated|7|||
131639284|NCT00519285|473966320|FG000|Overall Study|Treatment ongoing|1|||
131639285|NCT00519285|473966321|FG001|Overall Study|Treatment ongoing|2|||
131639286|NCT01020747|473966322|FG000|Overall Study|Withdrawal by Subject|1|||
131639287|NCT01222078|473966327|FG000|Overall Study|Early termination of the study|1|||
131639288|NCT02175745|473966328|FG000|Overall Study|Not Eligible|1|||
131639289|NCT00808899|473966330|FG000|Overall Study|Death|1|||
131639290|NCT00808899|473966330|FG000|Overall Study|Physician Decision|3|||
131639291|NCT04688086|473966335|FG000|Overall Study|Lost to Follow-up|164|||
131639292|NCT04688086|473966335|FG000|Overall Study|Imaging error;|64|||
131639293|NCT00988117|473966336|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
131639294|NCT00988117|473966336|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
131639295|NCT01329419|473966337|FG000|Overall Study|Protocol Violation|235|||
131639296|NCT03512288|473966341|FG000|Overall Study|Adverse Event|1|||
131639297|NCT03512288|473966342|FG001|Overall Study|Adverse Event|0|||
131639298|NCT03512288|473966341|FG000|Overall Study|Lost to Follow-up|12|||
131639299|NCT03512288|473966342|FG001|Overall Study|Lost to Follow-up|15|||
131639300|NCT03512288|473966341|FG000|Overall Study|Physician Decision|0|||
131639301|NCT03512288|473966342|FG001|Overall Study|Physician Decision|2|||
131639302|NCT03512288|473966341|FG000|Overall Study|Protocol Violation|6|||
131639303|NCT03512288|473966342|FG001|Overall Study|Protocol Violation|4|||
131639304|NCT03512288|473966341|FG000|Overall Study|Medication error without associated adverse event|1|||
131639305|NCT03512288|473966342|FG001|Overall Study|Medication error without associated adverse event|0|||
131639306|NCT03512288|473966341|FG000|Overall Study|No longer met eligibility criteria|5|||
131639307|NCT03512288|473966342|FG001|Overall Study|No longer met eligibility criteria|2|||
131639308|NCT03512288|473966341|FG000|Overall Study|Withdrawal by parent/guardian|14|||
131639309|NCT03512288|473966342|FG001|Overall Study|Withdrawal by parent/guardian|18|||
131639310|NCT03512288|473966341|FG000|Overall Study|Other|1|||
131639311|NCT03512288|473966342|FG001|Overall Study|Other|1|||
131639312|NCT03512288|473966341|FG000|Overall Study|Randomized but not treated|1|||
131639313|NCT03512288|473966342|FG001|Overall Study|Randomized but not treated|1|||
131639314|NCT04206384|473966343|FG000|Overall Study|Withdrawal by Subject|8|||
131639315|NCT04206384|473966343|FG000|Overall Study|Adverse Event|2|||
131639316|NCT01208870|473966346|FG000|Overall Study|Lost to Follow-up|2|||
131639317|NCT01208870|473966347|FG001|Overall Study|Lost to Follow-up|8|||
131639318|NCT03015181|473966348|FG000|Overall Study|Enrolled, but product never administered|1|||
131639319|NCT03015181|473966349|FG001|Overall Study|Enrolled, but product never administered|0|||
131639320|NCT03015181|473966350|FG002|Overall Study|Enrolled, but product never administered|0|||
131639321|NCT03015181|473966351|FG003|Overall Study|Enrolled, but product never administered|0|||
131902732|NCT02849080|474929376|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
131902733|NCT02849080|474929377|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
131445124|NCT04672239|473258831|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
131445125|NCT04672239|473258832|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
131639322|NCT03015181|473966352|FG004|Overall Study|Enrolled, but product never administered|0|||
131639323|NCT03015181|473966353|FG005|Overall Study|Enrolled, but product never administered|0|||
131639324|NCT03015181|473966354|FG006|Overall Study|Enrolled, but product never administered|0|||
131639325|NCT03015181|473966348|FG000|Overall Study|Withdrawal by Subject|0|||
131639326|NCT03015181|473966349|FG001|Overall Study|Withdrawal by Subject|0|||
131639327|NCT03015181|473966350|FG002|Overall Study|Withdrawal by Subject|0|||
131639328|NCT03015181|473966351|FG003|Overall Study|Withdrawal by Subject|0|||
131639329|NCT03015181|473966352|FG004|Overall Study|Withdrawal by Subject|0|||
131639330|NCT03015181|473966353|FG005|Overall Study|Withdrawal by Subject|1|||
131639331|NCT03015181|473966354|FG006|Overall Study|Withdrawal by Subject|0|||
131639332|NCT03015181|473966348|FG000|Overall Study|Physician Decision|0|||
131639333|NCT03015181|473966349|FG001|Overall Study|Physician Decision|0|||
131639334|NCT03015181|473966350|FG002|Overall Study|Physician Decision|0|||
131639335|NCT03015181|473966351|FG003|Overall Study|Physician Decision|0|||
131639336|NCT03015181|473966352|FG004|Overall Study|Physician Decision|0|||
131639337|NCT03015181|473966353|FG005|Overall Study|Physician Decision|0|||
131639338|NCT03015181|473966354|FG006|Overall Study|Physician Decision|1|||
131639339|NCT02551692|473966358|FG000|Overall Study|Lost to Follow-up|0|||
131639340|NCT02551692|473966359|FG001|Overall Study|Lost to Follow-up|1|||
131639341|NCT02551692|473966360|FG002|Overall Study|Lost to Follow-up|4|||
131639342|NCT02551692|473966358|FG000|Overall Study|Withdrawal by Subject|1|||
131639343|NCT02551692|473966359|FG001|Overall Study|Withdrawal by Subject|0|||
131639344|NCT02551692|473966360|FG002|Overall Study|Withdrawal by Subject|1|||
131639345|NCT01091519|473966361|FG000|Overall Study|Adverse Event|12|||
131639346|NCT01091519|473966362|FG001|Overall Study|Adverse Event|16|||
131639347|NCT01091519|473966361|FG000|Overall Study|Death|1|||
131639348|NCT01091519|473966362|FG001|Overall Study|Death|0|||
131639349|NCT01091519|473966361|FG000|Overall Study|Lack of Efficacy|16|||
131639350|NCT01091519|473966362|FG001|Overall Study|Lack of Efficacy|19|||
131639351|NCT01091519|473966361|FG000|Overall Study|Lost to Follow-up|14|||
131639352|NCT01091519|473966362|FG001|Overall Study|Lost to Follow-up|24|||
131639353|NCT01091519|473966361|FG000|Overall Study|Withdrawal by Subject|2|||
131639354|NCT01091519|473966362|FG001|Overall Study|Withdrawal by Subject|2|||
131639355|NCT01091519|473966361|FG000|Overall Study|Other|6|||
131639356|NCT01091519|473966362|FG001|Overall Study|Other|8|||
131639357|NCT01091519|473966361|FG000|Overall Study|Randomized not treated|4|||
131639358|NCT01091519|473966362|FG001|Overall Study|Randomized not treated|4|||
131639359|NCT01177228|473966363|FG000|Overall Study|Positive tuberculosis test|0|||
131639360|NCT01177228|473966364|FG001|Overall Study|Positive tuberculosis test|1|||
131639361|NCT01177228|473966365|FG002|Overall Study|Positive tuberculosis test|0|||
131639362|NCT01177228|473966366|FG003|Overall Study|Positive tuberculosis test|0|||
131639363|NCT01177228|473966363|FG000|Overall Study|Worsening disease activity|1|||
131639364|NCT01177228|473966364|FG001|Overall Study|Worsening disease activity|0|||
131639365|NCT01177228|473966365|FG002|Overall Study|Worsening disease activity|0|||
131639366|NCT01177228|473966366|FG003|Overall Study|Worsening disease activity|0|||
131639367|NCT01177228|473966363|FG000|Overall Study|Withdrawal by Subject|0|||
131639368|NCT01177228|473966364|FG001|Overall Study|Withdrawal by Subject|1|||
131639369|NCT01177228|473966365|FG002|Overall Study|Withdrawal by Subject|0|||
131639370|NCT01177228|473966366|FG003|Overall Study|Withdrawal by Subject|0|||
131639371|NCT01494298|473966367|FG000|Overall Study|Protocol Violation|2|||
131639372|NCT01494298|473966368|FG001|Overall Study|Protocol Violation|8|||
131639373|NCT00006436|473966370|FG000|Overall Study|Refused further treatment|2|||
131639374|NCT00006436|473966370|FG000|Overall Study|Declined to participate (before treatment started)|1|||
131639375|NCT01904136|473967905|FG000|Overall Study|Physician Decision|0|||
131639376|NCT01904136|473967906|FG001|Overall Study|Physician Decision|0|||
131639377|NCT01904136|473967907|FG002|Overall Study|Physician Decision|0|||
131639378|NCT01904136|473967908|FG003|Overall Study|Physician Decision|0|||
131639379|NCT01904136|473967909|FG004|Overall Study|Physician Decision|0|||
131639380|NCT01904136|473967910|FG005|Overall Study|Physician Decision|1|||
131639381|NCT01904136|473967911|FG006|Overall Study|Physician Decision|0|||
131714683|NCT00506389|474233658|FG001|In-treatment Period|Randomized but not treated|1|||
131714684|NCT00506389|474233659|FG002|In-treatment Period|Randomized but not treated|1|||
131639382|NCT01904136|473967912|FG007|Overall Study|Physician Decision|0|||
131639383|NCT01904136|473967913|FG008|Overall Study|Physician Decision|0|||
131639384|NCT01929876|473967922|FG000|Period 2|Non-Compliance|1|||
131639385|NCT01845649|473967925|FG000|Overall Study|Adverse Event|7|||
131639386|NCT01845649|473967926|FG001|Overall Study|Adverse Event|10|||
131639387|NCT01845649|473967925|FG000|Overall Study|Lack of Efficacy|1|||
131639388|NCT01845649|473967926|FG001|Overall Study|Lack of Efficacy|1|||
131639389|NCT01845649|473967925|FG000|Overall Study|Lost to Follow-up|2|||
131639390|NCT01845649|473967926|FG001|Overall Study|Lost to Follow-up|2|||
131714685|NCT05224258|474233660|FG000|Overall Study|Withdrawal by Subject|1|||
131639391|NCT01845649|473967925|FG000|Overall Study|Withdrew Consent|12|||
131639392|NCT01845649|473967926|FG001|Overall Study|Withdrew Consent|4|||
131639393|NCT01845649|473967925|FG000|Overall Study|Protocol Deviation|7|||
131639394|NCT01845649|473967926|FG001|Overall Study|Protocol Deviation|4|||
131639395|NCT01845649|473967925|FG000|Overall Study|Reason not Specified|2|||
131714686|NCT05224258|474233661|FG001|Overall Study|Withdrawal by Subject|1|||
131639396|NCT01845649|473967926|FG001|Overall Study|Reason not Specified|1|||
131639397|NCT03991988|473967927|FG000|Overall Study|Withdrawal by Subject|2|||
131639398|NCT03991988|473967928|FG001|Overall Study|Withdrawal by Subject|2|||
131639399|NCT01222533|473967929|FG000|Overall Study|Adverse Event|5|||
131639400|NCT01222533|473967929|FG000|Overall Study|Withdrawal by Subject|5|||
131639401|NCT01222533|473967929|FG000|Overall Study|Other|4|||
131639402|NCT00460564|473967930|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
131639403|NCT00460564|473967931|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
131639404|NCT00460564|473967932|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131639405|NCT00460564|473967933|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131639406|NCT00460564|473967934|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131639407|NCT00460564|473967935|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131639408|NCT00460564|473967936|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131639409|NCT00460564|473967937|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131639410|NCT00460564|473967930|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
131639411|NCT00460564|473967931|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639412|NCT00460564|473967932|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639413|NCT00460564|473967933|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639414|NCT00460564|473967934|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639415|NCT00460564|473967935|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639416|NCT00460564|473967936|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639417|NCT00460564|473967937|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131639418|NCT00460564|473967930|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131639419|NCT00460564|473967931|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131639420|NCT00460564|473967932|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131639421|NCT00460564|473967933|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131639422|NCT00460564|473967934|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
131639423|NCT00460564|473967935|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
131639424|NCT00460564|473967936|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
131639425|NCT00460564|473967937|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131639426|NCT00460564|473967930|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131639427|NCT00460564|473967931|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131639428|NCT00460564|473967932|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131639429|NCT00460564|473967933|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131639430|NCT00460564|473967934|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
131639431|NCT00460564|473967935|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
131639432|NCT00460564|473967936|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131639433|NCT00460564|473967937|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131639434|NCT00460564|473967930|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639435|NCT00460564|473967931|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639436|NCT00460564|473967932|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639437|NCT00460564|473967933|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639438|NCT00460564|473967934|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
131714687|NCT05224258|474233660|FG000|Overall Study|Physician Decision|1|||
131714688|NCT05224258|474233661|FG001|Overall Study|Physician Decision|1|||
131714689|NCT05224258|474233660|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131714690|NCT05224258|474233661|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131714691|NCT05224258|474233660|FG000|Overall Study|Study Product No Longer in Use|1|||
131714692|NCT05224258|474233661|FG001|Overall Study|Study Product No Longer in Use|0|||
131714693|NCT05224258|474233660|FG000|Overall Study|Adverse Event|0|||
131714694|NCT05224258|474233661|FG001|Overall Study|Adverse Event|1|||
131714695|NCT05224258|474233660|FG000|Overall Study|Protocol Deviation|0|||
131714696|NCT05224258|474233661|FG001|Overall Study|Protocol Deviation|1|||
131714697|NCT03539432|474233662|FG000|Overall Study|Lost to Follow-up|0|||
131714698|NCT03539432|474233663|FG001|Overall Study|Lost to Follow-up|1|||
131714699|NCT02443402|474233666|FG000|Overall Study|Withdrawal by Subject|3|||
131714700|NCT02443402|474233667|FG001|Overall Study|Withdrawal by Subject|1|||
131714701|NCT02443402|474233666|FG000|Overall Study|Screen Failure|1|||
131714702|NCT02443402|474233667|FG001|Overall Study|Screen Failure|2|||
131714703|NCT01934504|474233668|FG000|Overall Study|Protocol Deviation|0|||
131714704|NCT01934504|474233669|FG001|Overall Study|Protocol Deviation|0|||
131714705|NCT01934504|474233670|FG002|Overall Study|Protocol Deviation|0|||
131714706|NCT01934504|474233671|FG003|Overall Study|Protocol Deviation|2|||
131714707|NCT01934504|474233668|FG000|Overall Study|Study Terminated by Sponsor|1|||
131714708|NCT01934504|474233669|FG001|Overall Study|Study Terminated by Sponsor|0|||
131714709|NCT01934504|474233670|FG002|Overall Study|Study Terminated by Sponsor|5|||
131714710|NCT01934504|474233671|FG003|Overall Study|Study Terminated by Sponsor|5|||
131714711|NCT04178590|474233674|FG000|Overall Study|Pregnancy|1|||
131714712|NCT04178590|474233674|FG000|Overall Study|Lost to Follow-up|1|||
131902734|NCT02849080|474929378|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
131445126|NCT04672239|473258830|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
131714713|NCT00996840|474233675|FG000|Overall Study|Adverse Event|0|||
131714714|NCT00996840|474233676|FG001|Overall Study|Adverse Event|1|||
131639439|NCT00460564|473967935|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639440|NCT00460564|473967936|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639441|NCT00460564|473967937|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131639442|NCT02412111|473967938|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
131639443|NCT02412111|473967939|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
131639444|NCT02412111|473967940|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
131639445|NCT02412111|473967938|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
131639446|NCT02412111|473967939|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
131639447|NCT02412111|473967940|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
131639448|NCT02412111|473967938|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
131639449|NCT02412111|473967939|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
131639450|NCT02412111|473967940|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
131639451|NCT02412111|473967938|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
131639452|NCT02412111|473967939|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
131639453|NCT02412111|473967940|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
131639454|NCT02412111|473967938|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
131639455|NCT02412111|473967939|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
131639456|NCT02412111|473967940|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
131639457|NCT02412111|473967938|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
131639458|NCT02412111|473967939|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
131639459|NCT02412111|473967940|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
131639460|NCT02412111|473967938|FG000|Active Comparator Period (8 Weeks)|Other|0|||
131639461|NCT02412111|473967939|FG001|Active Comparator Period (8 Weeks)|Other|0|||
131639462|NCT02412111|473967940|FG002|Active Comparator Period (8 Weeks)|Other|2|||
131639463|NCT00487552|473967941|FG000|Overall Study|Unsuccessful magnet placements|3|||
131639464|NCT00487552|473967941|FG000|Overall Study|Death due to progressive malignancy|2|||
131639465|NCT00487552|473967941|FG000|Overall Study|Stent not placed|1|||
131639466|NCT00983905|473967942|FG000|Theophylline Alone|Adverse Event|1|||
131639467|NCT00983905|473967942|FG000|Colchicine Alone|Adverse Event|2|||
131639468|NCT01169636|473967943|FG000|Overall Study|Adverse Event|0|||
131639469|NCT01169636|473967944|FG001|Overall Study|Adverse Event|0|||
131639470|NCT01169636|473967945|FG002|Overall Study|Adverse Event|1|||
131639471|NCT01169636|473967946|FG003|Overall Study|Adverse Event|1|||
131639472|NCT01169636|473967947|FG004|Overall Study|Adverse Event|0|||
131639473|NCT01169636|473967943|FG000|Overall Study|Screen failure|0|||
131639474|NCT01169636|473967944|FG001|Overall Study|Screen failure|0|||
131639475|NCT01169636|473967945|FG002|Overall Study|Screen failure|2|||
131639476|NCT01169636|473967946|FG003|Overall Study|Screen failure|0|||
131639477|NCT01169636|473967947|FG004|Overall Study|Screen failure|0|||
131639478|NCT01169636|473967943|FG000|Overall Study|Withdrawal by Subject|0|||
131639479|NCT01169636|473967944|FG001|Overall Study|Withdrawal by Subject|0|||
131639480|NCT01169636|473967945|FG002|Overall Study|Withdrawal by Subject|0|||
131639481|NCT01169636|473967946|FG003|Overall Study|Withdrawal by Subject|0|||
131639482|NCT01169636|473967947|FG004|Overall Study|Withdrawal by Subject|3|||
131639483|NCT02705625|473967948|FG000|Overall Study|Protocol Violation|1|||
131639484|NCT02705625|473967949|FG001|Overall Study|Protocol Violation|0|||
131639485|NCT02705625|473967950|FG002|Overall Study|Protocol Violation|0|||
131639486|NCT02705625|473967948|FG000|Overall Study|Adverse Event|6|||
131639487|NCT02705625|473967949|FG001|Overall Study|Adverse Event|5|||
131639488|NCT02705625|473967950|FG002|Overall Study|Adverse Event|2|||
131639489|NCT02705625|473967948|FG000|Overall Study|Death|0|||
131639490|NCT02705625|473967949|FG001|Overall Study|Death|0|||
131639491|NCT02705625|473967950|FG002|Overall Study|Death|1|||
131639492|NCT02705625|473967948|FG000|Overall Study|Withdrawal by Subject|1|||
131639493|NCT02705625|473967949|FG001|Overall Study|Withdrawal by Subject|4|||
131639494|NCT02705625|473967950|FG002|Overall Study|Withdrawal by Subject|5|||
131639495|NCT02705625|473967948|FG000|Overall Study|Lost to Follow-up|0|||
131639496|NCT02705625|473967949|FG001|Overall Study|Lost to Follow-up|0|||
131639497|NCT02705625|473967950|FG002|Overall Study|Lost to Follow-up|1|||
131639498|NCT02705625|473967948|FG000|Overall Study|Non-compliance|0|||
131639499|NCT02705625|473967949|FG001|Overall Study|Non-compliance|1|||
131639500|NCT02705625|473967950|FG002|Overall Study|Non-compliance|1|||
131639501|NCT02705625|473967948|FG000|Overall Study|Overdosing|0|||
131639502|NCT02705625|473967949|FG001|Overall Study|Overdosing|0|||
131639503|NCT02705625|473967950|FG002|Overall Study|Overdosing|1|||
131639504|NCT00494026|473967951|FG000|Overall Study|Sponsor Decision|4|||
131639505|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
131639506|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
131639507|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
131639508|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
131639509|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
131639510|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
131639511|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
131639512|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
131639513|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
131639514|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
131639515|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
131639516|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
131639517|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
131639518|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
131639519|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
131639520|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
131639521|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
131639522|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
131639523|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
131639524|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
131639525|NCT02637856|473967953|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
131639526|NCT02637856|473967954|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
131639527|NCT02637856|473967953|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
131639528|NCT02637856|473967954|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
131639529|NCT02637856|473967953|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
131639530|NCT02637856|473967954|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
131639531|NCT04544865|473967955|FG000|Overall Study|Death|0|||
131639532|NCT04544865|473967956|FG001|Overall Study|Death|2|||
131639533|NCT04544865|473967955|FG000|Overall Study|Lost to Follow-up|11|||
131639534|NCT04544865|473967956|FG001|Overall Study|Lost to Follow-up|7|||
131639535|NCT04544865|473967955|FG000|Overall Study|Withdrawal by Subject|0|||
131639536|NCT04544865|473967956|FG001|Overall Study|Withdrawal by Subject|1|||
131639537|NCT04544865|473967955|FG000|Overall Study|Other|0|||
131639538|NCT04544865|473967956|FG001|Overall Study|Other|1|||
131639539|NCT02815735|473967960|FG000|First Intervention (4 Weeks)|Discomfort|1|||
131639540|NCT02815735|473967961|FG001|First Intervention (4 Weeks)|Discomfort|0|||
131639541|NCT02815735|473967960|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
131639542|NCT02815735|473967961|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131639543|NCT02815735|473967960|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
131639544|NCT02815735|473967961|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
131639545|NCT02815735|473967960|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
131639546|NCT02815735|473967961|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
131639547|NCT03357471|473967962|FG000|Overall Study|Adverse Event|1|||
131639548|NCT03357471|473967963|FG001|Overall Study|Adverse Event|0|||
131639549|NCT03357471|473967962|FG000|Overall Study|Lost to Follow-up|1|||
131639550|NCT03357471|473967963|FG001|Overall Study|Lost to Follow-up|0|||
131639551|NCT02973802|473967964|FG000|Overall Study|Lost to Follow-up|1|||
131639552|NCT02973802|473967964|FG000|Overall Study|Withdrawal by Subject|1|||
131639553|NCT01850823|473967965|FG000|Overall Study|Early Visit Window|0|||
131639554|NCT01850823|473967966|FG001|Overall Study|Early Visit Window|1|||
131639555|NCT01850823|473967967|FG002|Overall Study|Early Visit Window|4|||
131639556|NCT01850823|473967965|FG000|Overall Study|Enrolled in Error|0|||
131639557|NCT01850823|473967966|FG001|Overall Study|Enrolled in Error|1|||
131639558|NCT01850823|473967967|FG002|Overall Study|Enrolled in Error|2|||
131639559|NCT01850823|473967965|FG000|Overall Study|Lack of Efficacy|1|||
131639560|NCT01850823|473967966|FG001|Overall Study|Lack of Efficacy|0|||
131639561|NCT01850823|473967967|FG002|Overall Study|Lack of Efficacy|0|||
131639562|NCT01850823|473967965|FG000|Overall Study|Lost to Follow-up|0|||
131639563|NCT01850823|473967966|FG001|Overall Study|Lost to Follow-up|0|||
131639564|NCT01850823|473967967|FG002|Overall Study|Lost to Follow-up|1|||
131639565|NCT01850823|473967965|FG000|Overall Study|Restricted Medication|0|||
131639566|NCT01850823|473967966|FG001|Overall Study|Restricted Medication|0|||
131639567|NCT01850823|473967967|FG002|Overall Study|Restricted Medication|2|||
131639568|NCT01850823|473967965|FG000|Overall Study|Significant worstening of SAR|0|||
131639569|NCT01850823|473967966|FG001|Overall Study|Significant worstening of SAR|1|||
131639570|NCT01850823|473967967|FG002|Overall Study|Significant worstening of SAR|0|||
131639571|NCT01850823|473967965|FG000|Overall Study|Withdrawal by Subject|2|||
131714715|NCT00996840|474233677|FG002|Overall Study|Adverse Event|0|||
131902735|NCT02849080|474929375|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
131639572|NCT01850823|473967966|FG001|Overall Study|Withdrawal by Subject|0|||
131639573|NCT01850823|473967967|FG002|Overall Study|Withdrawal by Subject|1|||
131639574|NCT01751165|473967968|FG000|Overall Study|Adverse event, serious fatal|1|||
131639575|NCT01751165|473967969|FG001|Overall Study|Adverse event, serious fatal|0|||
131639576|NCT01751165|473967970|FG002|Overall Study|Adverse event, serious fatal|1|||
131639577|NCT01751165|473967968|FG000|Overall Study|Withdrawal by Subject|0|||
131639578|NCT01751165|473967969|FG001|Overall Study|Withdrawal by Subject|0|||
131639579|NCT01751165|473967970|FG002|Overall Study|Withdrawal by Subject|1|||
131639580|NCT01751165|473967968|FG000|Overall Study|Serious adverse event|0|||
131639581|NCT01751165|473967969|FG001|Overall Study|Serious adverse event|2|||
131639582|NCT01751165|473967970|FG002|Overall Study|Serious adverse event|0|||
131639583|NCT01751165|473967968|FG000|Overall Study|Lost to Follow-up|1|||
131639584|NCT01751165|473967969|FG001|Overall Study|Lost to Follow-up|1|||
131639585|NCT01751165|473967970|FG002|Overall Study|Lost to Follow-up|1|||
131639586|NCT02895360|473967971|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
131639587|NCT02895360|473967972|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131639588|NCT02895360|473967973|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131639589|NCT02895360|473967974|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131639590|NCT02895360|473967975|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131639591|NCT02895360|473967976|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131639592|NCT02895360|473967971|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131639593|NCT02895360|473967972|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
131639594|NCT02895360|473967973|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131639595|NCT02895360|473967974|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131639596|NCT02895360|473967975|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131639597|NCT02895360|473967976|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131639598|NCT02895360|473967971|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131639599|NCT02895360|473967972|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131639600|NCT02895360|473967973|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
131639601|NCT02895360|473967974|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131639602|NCT02895360|473967975|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131639603|NCT02895360|473967976|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131639604|NCT02895360|473967971|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131639605|NCT02895360|473967972|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131639606|NCT02895360|473967973|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
131639607|NCT02895360|473967974|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131639608|NCT02895360|473967975|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131639609|NCT02895360|473967976|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131639610|NCT02895360|473967971|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131639611|NCT02895360|473967972|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131639612|NCT02895360|473967973|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131639613|NCT02895360|473967974|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
131639614|NCT02895360|473967975|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131639615|NCT02895360|473967976|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131639616|NCT02895360|473967971|FG000|Phase 2a|Adverse Event|0|||
131639617|NCT02895360|473967972|FG001|Phase 2a|Adverse Event|0|||
131639618|NCT02895360|473967973|FG002|Phase 2a|Adverse Event|0|||
131639619|NCT02895360|473967974|FG003|Phase 2a|Adverse Event|0|||
131639620|NCT02895360|473967975|FG004|Phase 2a|Adverse Event|0|||
131639621|NCT02895360|473967976|FG005|Phase 2a|Adverse Event|1|||
131639622|NCT02895360|473967971|FG000|Phase 2a|Progressive disease|0|||
131639623|NCT02895360|473967972|FG001|Phase 2a|Progressive disease|0|||
131639624|NCT02895360|473967973|FG002|Phase 2a|Progressive disease|0|||
131639625|NCT02895360|473967974|FG003|Phase 2a|Progressive disease|0|||
131639626|NCT02895360|473967975|FG004|Phase 2a|Progressive disease|11|||
131639627|NCT02895360|473967976|FG005|Phase 2a|Progressive disease|11|||
131639628|NCT00307164|473967979|FG000|Overall Study|Death|1|||
131639629|NCT00307164|473967980|FG001|Overall Study|Death|0|||
131639630|NCT00307164|473967979|FG000|Overall Study|Severe debilitation, unable to continue|1|||
131639631|NCT00307164|473967980|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131639632|NCT00307164|473967979|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
131639633|NCT00307164|473967980|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
131639634|NCT00307164|473967979|FG000|Overall Study|Withdrawal by Subject|1|||
131639635|NCT00307164|473967980|FG001|Overall Study|Withdrawal by Subject|8|||
131639636|NCT00307164|473967979|FG000|Overall Study|Not compliant with requirements|4|||
131639637|NCT00307164|473967980|FG001|Overall Study|Not compliant with requirements|4|||
131639638|NCT00307164|473967979|FG000|Overall Study|Lost to Follow-up|6|||
131639639|NCT00307164|473967980|FG001|Overall Study|Lost to Follow-up|1|||
131639640|NCT01732926|473967982|FG000|Overall Study|Study Terminated by Sponsor|168|||
131639641|NCT01732926|473967983|FG001|Overall Study|Study Terminated by Sponsor|80|||
131639642|NCT01732926|473967982|FG000|Overall Study|Withdrawal by Subject|46|||
131639643|NCT01732926|473967983|FG001|Overall Study|Withdrawal by Subject|8|||
131639644|NCT01732926|473967982|FG000|Overall Study|Physician Decision|24|||
131639645|NCT01732926|473967983|FG001|Overall Study|Physician Decision|11|||
131639646|NCT01732926|473967982|FG000|Overall Study|Other Reason|21|||
131639647|NCT01732926|473967983|FG001|Overall Study|Other Reason|4|||
131639648|NCT01732926|473967982|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
131639649|NCT01732926|473967983|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
131639650|NCT01732926|473967982|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
131639651|NCT01732926|473967983|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
131902736|NCT02849080|474929376|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
131902737|NCT02849080|474929377|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
131445127|NCT04672239|473258831|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
131639652|NCT02262364|473967987|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
131639653|NCT01049984|473967988|FG000|Overall Study|Withdrawal by Subject|1|||
131639654|NCT01049984|473967989|FG001|Overall Study|Withdrawal by Subject|5|||
131639655|NCT01049984|473967988|FG000|Overall Study|Protocol Violation|3|||
131639656|NCT01049984|473967989|FG001|Overall Study|Protocol Violation|4|||
131639657|NCT01049984|473967988|FG000|Overall Study|Lost to Follow-up|2|||
131639658|NCT01049984|473967989|FG001|Overall Study|Lost to Follow-up|1|||
131639659|NCT01049984|473967988|FG000|Overall Study|Adverse Event|13|||
131639660|NCT01049984|473967989|FG001|Overall Study|Adverse Event|7|||
131639661|NCT01049984|473967988|FG000|Overall Study|Treatment failure|0|||
131639662|NCT01049984|473967989|FG001|Overall Study|Treatment failure|2|||
131639663|NCT02741713|473967994|FG000|Overall Study|Surgery type changed intra-operatively|2|||
131639664|NCT02741713|473967995|FG001|Overall Study|Surgery type changed intra-operatively|1|||
131639665|NCT02716298|473967998|FG000|First Intervention (1 Month)|Lens discomfort|1|||
131639666|NCT02716298|473967999|FG001|First Intervention (1 Month)|Lens discomfort|1|||
131639667|NCT00578318|473968000|FG000|Overall Study|Lost to Follow-up|2|||
131639668|NCT00578318|473968001|FG001|Overall Study|Lost to Follow-up|0|||
131639669|NCT00578318|473968000|FG000|Overall Study|Physician Decision|1|||
131639670|NCT00578318|473968001|FG001|Overall Study|Physician Decision|0|||
131639671|NCT00866918|473968002|FG000|Overall Study|Death|1|||
131639672|NCT00866918|473968003|FG001|Overall Study|Death|5|||
131639673|NCT00866918|473968002|FG000|Overall Study|Lack of Efficacy|1|||
131639674|NCT00866918|473968003|FG001|Overall Study|Lack of Efficacy|1|||
131639675|NCT00866918|473968002|FG000|Overall Study|Physician Decision|10|||
131639676|NCT00866918|473968003|FG001|Overall Study|Physician Decision|2|||
131639677|NCT00866918|473968002|FG000|Overall Study|Ineligible|2|||
131639678|NCT00866918|473968003|FG001|Overall Study|Ineligible|4|||
131639679|NCT00866918|473968002|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
131639680|NCT00866918|473968003|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
131639681|NCT00866918|473968002|FG000|Overall Study|Secondary malignancy|1|||
131639682|NCT00866918|473968003|FG001|Overall Study|Secondary malignancy|0|||
131639683|NCT00527514|473968005|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
131639684|NCT00527514|473968005|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
131639685|NCT00527514|473968005|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
131639686|NCT00527514|473968005|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
131639687|NCT00527514|473968005|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
131639688|NCT00527514|473968005|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
131639689|NCT00527514|473968005|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
131639690|NCT00920699|473968008|FG000|Overall Study|Withdrawal by Subject|2|||
131639691|NCT00920699|473968009|FG001|Overall Study|Withdrawal by Subject|0|||
131639692|NCT00920699|473968010|FG002|Overall Study|Withdrawal by Subject|2|||
131639693|NCT00920699|473968008|FG000|Overall Study|no longer met eligibility|0|||
131639694|NCT00920699|473968009|FG001|Overall Study|no longer met eligibility|1|||
131639695|NCT00920699|473968010|FG002|Overall Study|no longer met eligibility|0|||
131639696|NCT00920699|473968008|FG000|Overall Study|Lost to Follow-up|0|||
131639697|NCT00920699|473968009|FG001|Overall Study|Lost to Follow-up|0|||
131639698|NCT00920699|473968010|FG002|Overall Study|Lost to Follow-up|2|||
131639699|NCT00001941|473968015|FG000|Overall Study|not treated- rapidly progressing disease|0|||
131639700|NCT00001941|473968016|FG001|Overall Study|not treated- rapidly progressing disease|0|||
131639701|NCT00001941|473968017|FG002|Overall Study|not treated- rapidly progressing disease|0|||
131639702|NCT00001941|473968018|FG003|Overall Study|not treated- rapidly progressing disease|0|||
131639703|NCT00001941|473968019|FG004|Overall Study|not treated- rapidly progressing disease|1|||
131639704|NCT01281917|473968028|FG000|Overall Study|Withdrawal by Subject|1|||
131639705|NCT00363649|473968030|FG000|Overall Study|Withdrawal by Subject|1|||
131639706|NCT00363649|473968031|FG001|Overall Study|Withdrawal by Subject|1|||
131639707|NCT00363649|473968030|FG000|Overall Study|Adverse Event|6|||
131639708|NCT00363649|473968031|FG001|Overall Study|Adverse Event|0|||
131639709|NCT04947436|473968034|FG000|Overall Study|Lost to Follow-up|3|||
131639710|NCT04947436|473968035|FG001|Overall Study|Lost to Follow-up|7|||
131639711|NCT04947436|473968036|FG002|Overall Study|Lost to Follow-up|5|||
131639712|NCT04947436|473968034|FG000|Overall Study|Death|1|||
131639713|NCT04947436|473968035|FG001|Overall Study|Death|1|||
131639714|NCT04947436|473968036|FG002|Overall Study|Death|1|||
131639715|NCT02161185|473968038|FG000|Treatment Phase|Administrative/Other|7|||
131639716|NCT02970305|473968044|FG000|Overall Study|Adverse Event|10|||
131639717|NCT02970305|473968045|FG001|Overall Study|Adverse Event|6|||
131639718|NCT02970305|473968044|FG000|Overall Study|Lack of Efficacy|1|||
131639719|NCT02970305|473968045|FG001|Overall Study|Lack of Efficacy|1|||
131639720|NCT02970305|473968044|FG000|Overall Study|Noncompliance with study drug|2|||
131714716|NCT00996840|474233678|FG003|Overall Study|Adverse Event|0|||
131639721|NCT02970305|473968045|FG001|Overall Study|Noncompliance with study drug|4|||
131639722|NCT02970305|473968044|FG000|Overall Study|Protocol Violation|2|||
131639723|NCT02970305|473968045|FG001|Overall Study|Protocol Violation|2|||
131639724|NCT02970305|473968044|FG000|Overall Study|Withdrawal by Subject|12|||
131714717|NCT00996840|474233679|FG004|Overall Study|Adverse Event|0|||
131639725|NCT02970305|473968045|FG001|Overall Study|Withdrawal by Subject|11|||
131639726|NCT02970305|473968044|FG000|Overall Study|Not further specified|1|||
131639727|NCT02970305|473968045|FG001|Overall Study|Not further specified|2|||
131639728|NCT02970305|473968044|FG000|Overall Study|Lost to Follow-up|1|||
131639729|NCT02970305|473968045|FG001|Overall Study|Lost to Follow-up|2|||
131639730|NCT00983892|473968046|FG000|Overall Study|Withdrawal by Subject|10|||
131639731|NCT00983892|473968047|FG001|Overall Study|Withdrawal by Subject|12|||
131639732|NCT02930837|473968048|FG000|Overall Study|Adverse Event|6|||
131639733|NCT02930837|473968048|FG000|Overall Study|Lost to Follow-up|5|||
131639734|NCT02930837|473968048|FG000|Overall Study|Withdrawal by Subject|1|||
131639735|NCT01393613|473968049|FG000|Overall Study|Adverse Event|11|||
131639736|NCT01393613|473968050|FG001|Overall Study|Adverse Event|11|||
131639737|NCT01393613|473968051|FG002|Overall Study|Adverse Event|13|||
131639738|NCT01393613|473968052|FG003|Overall Study|Adverse Event|22|||
131639739|NCT01393613|473968049|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
131639740|NCT01393613|473968050|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
131639741|NCT01393613|473968051|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
131639742|NCT01393613|473968052|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
131639743|NCT01393613|473968049|FG000|Overall Study|Physician Decision|2|||
131639744|NCT01393613|473968050|FG001|Overall Study|Physician Decision|0|||
131639745|NCT01393613|473968051|FG002|Overall Study|Physician Decision|0|||
131639746|NCT01393613|473968052|FG003|Overall Study|Physician Decision|1|||
131639747|NCT01393613|473968049|FG000|Overall Study|Withdrawal by Subject|15|||
131639748|NCT01393613|473968050|FG001|Overall Study|Withdrawal by Subject|25|||
131639749|NCT01393613|473968051|FG002|Overall Study|Withdrawal by Subject|23|||
131639750|NCT01393613|473968052|FG003|Overall Study|Withdrawal by Subject|21|||
131639751|NCT01393613|473968049|FG000|Overall Study|Protocol Deviation|2|||
131639752|NCT01393613|473968050|FG001|Overall Study|Protocol Deviation|1|||
131639753|NCT01393613|473968051|FG002|Overall Study|Protocol Deviation|0|||
131639754|NCT01393613|473968052|FG003|Overall Study|Protocol Deviation|0|||
131639755|NCT01393613|473968049|FG000|Overall Study|Lack of Efficacy|9|||
131639756|NCT01393613|473968050|FG001|Overall Study|Lack of Efficacy|20|||
131639757|NCT01393613|473968051|FG002|Overall Study|Lack of Efficacy|16|||
131639758|NCT01393613|473968052|FG003|Overall Study|Lack of Efficacy|21|||
131639759|NCT00316589|473968053|FG000|Overall Study|Withdrawal by Subject|0|||
131639760|NCT00316589|473968054|FG001|Overall Study|Withdrawal by Subject|5|||
131639761|NCT00316589|473968055|FG002|Overall Study|Withdrawal by Subject|0|||
131639762|NCT00316589|473968056|FG003|Overall Study|Withdrawal by Subject|1|||
131639763|NCT00316589|473968053|FG000|Overall Study|Subject unwilling/unable to comply|0|||
131639764|NCT00316589|473968054|FG001|Overall Study|Subject unwilling/unable to comply|6|||
131639765|NCT00316589|473968055|FG002|Overall Study|Subject unwilling/unable to comply|0|||
131639766|NCT00316589|473968056|FG003|Overall Study|Subject unwilling/unable to comply|2|||
131639767|NCT00316589|473968053|FG000|Overall Study|Adverse Event|1|||
131639768|NCT00316589|473968054|FG001|Overall Study|Adverse Event|0|||
131639769|NCT00316589|473968055|FG002|Overall Study|Adverse Event|0|||
131639770|NCT00316589|473968056|FG003|Overall Study|Adverse Event|1|||
131639771|NCT00316589|473968053|FG000|Overall Study|Physician Decision|0|||
131639772|NCT00316589|473968054|FG001|Overall Study|Physician Decision|1|||
131639773|NCT00316589|473968055|FG002|Overall Study|Physician Decision|0|||
131639774|NCT00316589|473968056|FG003|Overall Study|Physician Decision|0|||
131639775|NCT00316589|473968053|FG000|Overall Study|Other reason|0|||
131639776|NCT00316589|473968054|FG001|Overall Study|Other reason|12|||
131639777|NCT00316589|473968055|FG002|Overall Study|Other reason|1|||
131639778|NCT00316589|473968056|FG003|Overall Study|Other reason|1|||
131639779|NCT01482819|473968057|FG000|Overall Study|Lost to Follow-up|2|||
131639780|NCT01283971|473968058|FG000|Overall Study|Adverse Event|3|||
131639781|NCT01283971|473968059|FG001|Overall Study|Adverse Event|5|||
131639782|NCT01283971|473968058|FG000|Overall Study|Insufficient therapeutic responses|3|||
131639783|NCT01283971|473968059|FG001|Overall Study|Insufficient therapeutic responses|3|||
131639784|NCT01283971|473968058|FG000|Overall Study|Protocol Violation|5|||
131639785|NCT01283971|473968059|FG001|Overall Study|Protocol Violation|1|||
131639786|NCT01283971|473968058|FG000|Overall Study|Refused treatment|3|||
131639787|NCT01283971|473968059|FG001|Overall Study|Refused treatment|1|||
131639788|NCT01283971|473968058|FG000|Overall Study|Failure to return|0|||
131639789|NCT01283971|473968059|FG001|Overall Study|Failure to return|1|||
131639790|NCT01283971|473968058|FG000|Overall Study|Administrative reasons|1|||
131639791|NCT01283971|473968059|FG001|Overall Study|Administrative reasons|1|||
131639792|NCT00562484|473968061|FG000|Overall Study|Adverse Event|6|||
131639793|NCT00562484|473968062|FG001|Overall Study|Adverse Event|1|||
131639794|NCT00562484|473968061|FG000|Overall Study|Protocol Violation|11|||
131639795|NCT00562484|473968062|FG001|Overall Study|Protocol Violation|2|||
131639796|NCT00562484|473968061|FG000|Overall Study|Withdrawal by Subject|12|||
131639797|NCT00562484|473968062|FG001|Overall Study|Withdrawal by Subject|9|||
131639798|NCT00562484|473968061|FG000|Overall Study|Moved away from the study area|20|||
131639799|NCT00562484|473968062|FG001|Overall Study|Moved away from the study area|9|||
131639800|NCT00562484|473968061|FG000|Overall Study|Lost to Follow-up|132|||
131639801|NCT00562484|473968062|FG001|Overall Study|Lost to Follow-up|71|||
131639802|NCT00562484|473968061|FG000|Overall Study|Reason not provided or not specified|25|||
131639803|NCT00562484|473968062|FG001|Overall Study|Reason not provided or not specified|12|||
131639804|NCT05041439|473968064|FG000|Overall Study|Withdrawal by Subject|1|||
131639805|NCT05041439|473968065|FG001|Overall Study|Withdrawal by Subject|1|||
131639806|NCT05041439|473968064|FG000|Overall Study|Death|1|||
131639807|NCT05041439|473968065|FG001|Overall Study|Death|0|||
131639808|NCT00853372|473969353|FG000|Overall Study|Death|30|||
131639809|NCT00853372|473969354|FG001|Overall Study|Death|26|||
131639810|NCT00853372|473969353|FG000|Overall Study|Lost to Follow-up|1|||
131639811|NCT00853372|473969354|FG001|Overall Study|Lost to Follow-up|2|||
131639812|NCT00853372|473969353|FG000|Overall Study|Full Consent Withdrawn|1|||
131639813|NCT00853372|473969354|FG001|Overall Study|Full Consent Withdrawn|1|||
131639814|NCT01268098|473969355|FG000|Overall Study|Adverse Event|1|||
131639815|NCT01268098|473969356|FG001|Overall Study|Adverse Event|0|||
131639816|NCT02418845|473969359|FG000|Overall Study|Lost to Follow-up|7|||
131639817|NCT02418845|473969360|FG001|Overall Study|Lost to Follow-up|2|||
131639818|NCT02418845|473969359|FG000|Overall Study|Lack of Efficacy|0|||
131639819|NCT02418845|473969360|FG001|Overall Study|Lack of Efficacy|3|||
131639820|NCT02418845|473969359|FG000|Overall Study|Physician Decision|5|||
131639821|NCT02418845|473969360|FG001|Overall Study|Physician Decision|5|||
131639822|NCT02418845|473969359|FG000|Overall Study|Protocol Violation|1|||
131639823|NCT02418845|473969360|FG001|Overall Study|Protocol Violation|0|||
131639824|NCT02418845|473969359|FG000|Overall Study|Withdrawal by Subject|3|||
131639825|NCT02418845|473969360|FG001|Overall Study|Withdrawal by Subject|2|||
131639826|NCT02994784|473969361|FG000|6 Months Follow-up|Lost to Follow-up|3|||
131639827|NCT02466243|473969362|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
131639828|NCT02466243|473969363|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
131639829|NCT02466243|473969362|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
131639830|NCT02466243|473969363|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
131639831|NCT02466243|473969362|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
131639832|NCT02466243|473969363|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
131639833|NCT02466243|473969362|FG000|Part B Open-label Treatment Period|Missing|2|||
131639834|NCT02466243|473969363|FG001|Part B Open-label Treatment Period|Missing|2|||
131639835|NCT00863798|473969364|FG000|Overall Study|Adverse Event|5|||
131639836|NCT00863798|473969365|FG001|Overall Study|Adverse Event|2|||
131639837|NCT00863798|473969366|FG002|Overall Study|Adverse Event|4|||
131639838|NCT00863798|473969364|FG000|Overall Study|Participant failed to return|2|||
131639839|NCT00863798|473969365|FG001|Overall Study|Participant failed to return|1|||
131639840|NCT00863798|473969366|FG002|Overall Study|Participant failed to return|0|||
131639841|NCT00863798|473969364|FG000|Overall Study|Investigator request|1|||
131639842|NCT00863798|473969365|FG001|Overall Study|Investigator request|2|||
131639843|NCT00863798|473969366|FG002|Overall Study|Investigator request|1|||
131639844|NCT00863798|473969364|FG000|Overall Study|Lack of Efficacy|4|||
131639845|NCT00863798|473969365|FG001|Overall Study|Lack of Efficacy|3|||
131639846|NCT00863798|473969366|FG002|Overall Study|Lack of Efficacy|6|||
131639847|NCT00863798|473969364|FG000|Overall Study|Lost to Follow-up|6|||
131639848|NCT00863798|473969365|FG001|Overall Study|Lost to Follow-up|9|||
131639849|NCT00863798|473969366|FG002|Overall Study|Lost to Follow-up|5|||
131639850|NCT00863798|473969364|FG000|Overall Study|Other|2|||
131639851|NCT00863798|473969365|FG001|Overall Study|Other|3|||
131639852|NCT00863798|473969366|FG002|Overall Study|Other|1|||
131639853|NCT00863798|473969364|FG000|Overall Study|Protocol Violation|0|||
131639854|NCT00863798|473969365|FG001|Overall Study|Protocol Violation|1|||
131639855|NCT00863798|473969366|FG002|Overall Study|Protocol Violation|1|||
131639856|NCT00863798|473969364|FG000|Overall Study|Withdrawal by Subject|8|||
131639857|NCT00863798|473969365|FG001|Overall Study|Withdrawal by Subject|7|||
131639858|NCT00863798|473969366|FG002|Overall Study|Withdrawal by Subject|4|||
131639859|NCT00863798|473969364|FG000|Overall Study|Randomized not treated|4|||
131639860|NCT00863798|473969365|FG001|Overall Study|Randomized not treated|2|||
131639861|NCT00863798|473969366|FG002|Overall Study|Randomized not treated|3|||
131639862|NCT01470599|473969367|FG000|Overall Study|Did not meet entrance criteria|1|||
131714718|NCT00996840|474233675|FG000|Overall Study|Physician Decision|0|||
131714719|NCT00996840|474233676|FG001|Overall Study|Physician Decision|0|||
131714720|NCT00996840|474233677|FG002|Overall Study|Physician Decision|1|||
131714721|NCT00996840|474233678|FG003|Overall Study|Physician Decision|1|||
131639863|NCT01470599|473969368|FG001|Overall Study|Did not meet entrance criteria|0|||
131639864|NCT01470599|473969367|FG000|Overall Study|Lost to Follow-up|2|||
131639865|NCT01470599|473969368|FG001|Overall Study|Lost to Follow-up|1|||
131639866|NCT01470599|473969367|FG000|Overall Study|Withdrawal by Subject|3|||
131639867|NCT01470599|473969368|FG001|Overall Study|Withdrawal by Subject|4|||
131639868|NCT01470599|473969367|FG000|Overall Study|Other|1|||
131639869|NCT01470599|473969368|FG001|Overall Study|Other|0|||
131639870|NCT01470599|473969367|FG000|Overall Study|Protocol Violation|3|||
131639871|NCT01470599|473969368|FG001|Overall Study|Protocol Violation|1|||
131714722|NCT00996840|474233679|FG004|Overall Study|Physician Decision|2|||
131714723|NCT00996840|474233675|FG000|Overall Study|Withdrawal by Subject|1|||
131639872|NCT01470599|473969367|FG000|Overall Study|Adverse event related to study drug|2|||
131639873|NCT01470599|473969368|FG001|Overall Study|Adverse event related to study drug|5|||
131639874|NCT01470599|473969367|FG000|Overall Study|Insufficient clinical response|6|||
131639875|NCT01470599|473969368|FG001|Overall Study|Insufficient clinical response|27|||
131639876|NCT01470599|473969367|FG000|Overall Study|Adverse event not related to study drug|1|||
131639877|NCT01470599|473969368|FG001|Overall Study|Adverse event not related to study drug|5|||
131639878|NCT01036165|473969372|FG000|Overall Study|Adverse Event|6|||
131639879|NCT01036165|473969372|FG000|Overall Study|Lost to Follow-up|2|||
131639880|NCT01036165|473969372|FG000|Overall Study|Withdrawal by Subject|3|||
131639881|NCT01036165|473969372|FG000|Overall Study|Device Related Issues|3|||
131639882|NCT01036165|473969372|FG000|Overall Study|Problems finding proper area to inject|1|||
131639883|NCT02560389|473969377|FG000|Overall Study|Lost to Follow-up|1|||
131639884|NCT02560389|473969378|FG001|Overall Study|Lost to Follow-up|2|||
131639885|NCT02560389|473969379|FG002|Overall Study|Lost to Follow-up|2|||
131639886|NCT02560389|473969377|FG000|Overall Study|Tested positive for illicit substance|0|||
131639887|NCT02560389|473969378|FG001|Overall Study|Tested positive for illicit substance|1|||
131639888|NCT02560389|473969379|FG002|Overall Study|Tested positive for illicit substance|0|||
131639889|NCT00827775|473969388|FG000|Overall Study|Withdrawal by Subject|0|||
131639890|NCT00827775|473969389|FG001|Overall Study|Withdrawal by Subject|5|||
131639891|NCT02287883|473969393|FG000|Overall Study|Death|8|||
131639892|NCT02287883|473969394|FG001|Overall Study|Death|7|||
131639893|NCT02287883|473969393|FG000|Overall Study|No longer eligible|222|||
131639894|NCT02287883|473969394|FG001|Overall Study|No longer eligible|182|||
131639895|NCT02287883|473969393|FG000|Overall Study|Non-response to survey|229|||
131639896|NCT02287883|473969394|FG001|Overall Study|Non-response to survey|237|||
131639897|NCT00802438|473969395|FG000|Overall Study|Screen Failure|20|||
131639898|NCT00802438|473969395|FG000|Overall Study|Withdrawal by Subject|7|||
131639899|NCT00802438|473969395|FG000|Overall Study|Physician Decision|1|||
131639900|NCT04016805|473969396|FG000|Overall Study|Sponsor's Discretion|30|||
131639901|NCT04016805|473969397|FG001|Overall Study|Sponsor's Discretion|6|||
131639902|NCT04016805|473969398|FG002|Overall Study|Sponsor's Discretion|5|||
131639903|NCT03175198|473969399|FG000|Overall Study|Adverse Event|480|||
131639904|NCT03175198|473969399|FG000|Overall Study|No actual visit|120|||
131639905|NCT03175198|473969399|FG000|Overall Study|Registration rule not followed|4|||
131639906|NCT03175198|473969399|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
131639907|NCT03175198|473969399|FG000|Overall Study|Other personal reason|509|||
131639908|NCT03175198|473969399|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
131639909|NCT03175198|473969399|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
131639910|NCT03175198|473969399|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
131639911|NCT03175198|473969399|FG000|Overall Study|To conduct invasive treatment of operation|53|||
131639912|NCT03175198|473969399|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
131639913|NCT00372255|473969401|FG000|Overall Study|Withdrawn for other reasons|2|||
131639914|NCT00372255|473969402|FG001|Overall Study|Withdrawn for other reasons|1|||
131639915|NCT01349036|473969403|FG000|Overall Study|Disease progression|13|||
131639916|NCT01349036|473969404|FG001|Overall Study|Disease progression|22|||
131639917|NCT01349036|473969403|FG000|Overall Study|Other|1|||
131639918|NCT01349036|473969404|FG001|Overall Study|Other|0|||
131639919|NCT01349036|473969403|FG000|Overall Study|Withdrawal by Subject|0|||
131639920|NCT01349036|473969404|FG001|Overall Study|Withdrawal by Subject|2|||
131639921|NCT03028012|473969407|FG000|Overall Study|Lost to Follow-up|2|||
131639922|NCT03028012|473969408|FG001|Overall Study|Lost to Follow-up|3|||
131639923|NCT03028012|473969409|FG002|Overall Study|Lost to Follow-up|3|||
131639924|NCT01424189|473969417|FG000|Overall Study|Adverse Event|1|||
131639925|NCT01424189|473969418|FG001|Overall Study|Adverse Event|0|||
131639926|NCT01424189|473969417|FG000|Overall Study|Lost to Follow-up|4|||
131639927|NCT01424189|473969418|FG001|Overall Study|Lost to Follow-up|1|||
131639928|NCT01424189|473969417|FG000|Overall Study|Withdrawal by Subject|4|||
131639929|NCT01424189|473969418|FG001|Overall Study|Withdrawal by Subject|4|||
131639930|NCT01424189|473969417|FG000|Overall Study|Subject moved|1|||
131639931|NCT01424189|473969418|FG001|Overall Study|Subject moved|0|||
131639932|NCT01424189|473969417|FG000|Overall Study|Death|3|||
131639933|NCT01424189|473969418|FG001|Overall Study|Death|1|||
131639934|NCT03120949|473969419|FG000|Overall Study|randomized in error|1|||
131639935|NCT03120949|473969420|FG001|Overall Study|randomized in error|0|||
131639936|NCT03120949|473969419|FG000|Overall Study|Death|13|||
131639937|NCT03120949|473969420|FG001|Overall Study|Death|13|||
131639938|NCT03120949|473969419|FG000|Overall Study|Lost to Follow-up|23|||
131639939|NCT03120949|473969420|FG001|Overall Study|Lost to Follow-up|13|||
131639940|NCT03120949|473969419|FG000|Overall Study|Withdrawal by Subject|139|||
131639941|NCT03120949|473969420|FG001|Overall Study|Withdrawal by Subject|124|||
131639942|NCT03120949|473969419|FG000|Overall Study|Covid-19|43|||
131639943|NCT03120949|473969420|FG001|Overall Study|Covid-19|34|||
131639944|NCT03120949|473969419|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
131639945|NCT03120949|473969420|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
131639946|NCT03120949|473969419|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
131639947|NCT03120949|473969420|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
131639948|NCT03120949|473969419|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
131639949|NCT03120949|473969420|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
131639950|NCT03120949|473969419|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
131639951|NCT03120949|473969420|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
131639952|NCT03120949|473969419|FG000|Overall Study|Site was closed|2|||
131639953|NCT03120949|473969420|FG001|Overall Study|Site was closed|3|||
131639954|NCT03120949|473969419|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
131639955|NCT03120949|473969420|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
131639956|NCT03120949|473969419|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
131639957|NCT03120949|473969420|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
131639958|NCT03120949|473969419|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
131639959|NCT03120949|473969420|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
131639960|NCT03120949|473969419|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
131639961|NCT03120949|473969420|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
131639962|NCT03120949|473969419|FG000|Overall Study|Other: Adverse Event|0|||
131639963|NCT03120949|473969420|FG001|Overall Study|Other: Adverse Event|1|||
131639964|NCT03120949|473969419|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
131639965|NCT03120949|473969420|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
131639966|NCT03120949|473969419|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
131639967|NCT03120949|473969420|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
131639968|NCT03120949|473969419|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
131639969|NCT03120949|473969420|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
131639970|NCT03120949|473969419|FG000|Overall Study|Personal Reasons|0|||
131639971|NCT03120949|473969420|FG001|Overall Study|Personal Reasons|1|||
131639972|NCT03120949|473969419|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
131639973|NCT03120949|473969420|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
131639974|NCT03120949|473969419|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
131639975|NCT03120949|473969420|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
131639976|NCT03120949|473969419|FG000|Overall Study|Compliance With Medication|0|||
131639977|NCT03120949|473969420|FG001|Overall Study|Compliance With Medication|1|||
131639978|NCT03120949|473969419|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
131639979|NCT03120949|473969420|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
131639980|NCT03120949|473969419|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
131639981|NCT03120949|473969420|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
131639982|NCT03120949|473969419|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
131639983|NCT03120949|473969420|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
131639984|NCT01705145|473969421|FG000|Part B|Adverse Event|1|||
131639985|NCT04522778|473969424|FG000|Overall Study|Patient did not want to wear the device|1|||
131639986|NCT04522778|473969425|FG001|Overall Study|Patient did not want to wear the device|0|||
131639987|NCT04522778|473969424|FG000|Overall Study|Lost to Follow-up|0|||
131639988|NCT04522778|473969425|FG001|Overall Study|Lost to Follow-up|1|||
131639989|NCT00069277|473969426|FG000|Overall Study|Adverse Event|3|||
131639990|NCT00069277|473969426|FG000|Overall Study|Withdrawal by Subject|1|||
131639991|NCT00069277|473969426|FG000|Overall Study|Progressive Disease|15|||
131639992|NCT00069277|473969426|FG000|Overall Study|Physician Decision|2|||
131639993|NCT01225159|473969427|FG000|Overall Study|Change operation|1|||
131639994|NCT01225159|473969428|FG001|Overall Study|Change operation|0|||
131639995|NCT00312845|473969429|FG000|Overall Study|Adverse Event|19|||
131639996|NCT00312845|473969430|FG001|Overall Study|Adverse Event|5|||
131639997|NCT00312845|473969429|FG000|Overall Study|Death|2|||
131639998|NCT00312845|473969430|FG001|Overall Study|Death|2|||
131639999|NCT00312845|473969429|FG000|Overall Study|Withdrawal by Subject|14|||
131640000|NCT00312845|473969430|FG001|Overall Study|Withdrawal by Subject|6|||
131640001|NCT00312845|473969429|FG000|Overall Study|Disease Progression|56|||
131640002|NCT00312845|473969430|FG001|Overall Study|Disease Progression|77|||
131640003|NCT00312845|473969429|FG000|Overall Study|Lost to Follow-up|2|||
131640004|NCT00312845|473969430|FG001|Overall Study|Lost to Follow-up|0|||
131640005|NCT00312845|473969429|FG000|Overall Study|Other|6|||
131640006|NCT00312845|473969430|FG001|Overall Study|Other|5|||
131640007|NCT00361842|473969433|FG000|Overall Study|Withdrawal by Subject|2|||
131640008|NCT00361842|473969434|FG001|Overall Study|Withdrawal by Subject|3|||
131640009|NCT00361842|473969433|FG000|Overall Study|Death|2|||
131640010|NCT00361842|473969434|FG001|Overall Study|Death|1|||
131640011|NCT00361842|473969433|FG000|Overall Study|Disease progression|19|||
131640012|NCT00361842|473969434|FG001|Overall Study|Disease progression|20|||
131640013|NCT00361842|473969433|FG000|Overall Study|Adverse Event|2|||
131640014|NCT00361842|473969434|FG001|Overall Study|Adverse Event|3|||
131640015|NCT00361842|473969433|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
131640016|NCT00361842|473969434|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
131640017|NCT00361842|473969433|FG000|Overall Study|Other|1|||
131640018|NCT00361842|473969434|FG001|Overall Study|Other|0|||
131640019|NCT00361842|473969433|FG000|Overall Study|Other|0|||
131640020|NCT00361842|473969434|FG001|Overall Study|Other|2|||
131640021|NCT01077622|473969435|FG000|Overall Study|Physician Decision|2|||
131640022|NCT01077622|473969435|FG000|Overall Study|Withdrawal by Subject|1|||
131640023|NCT01260142|473969436|FG000|Treatment Period 1|Study on hold|1|||
131640024|NCT01260142|473969437|FG001|Treatment Period 1|Study on hold|1|||
131640025|NCT01260142|473969438|FG002|Treatment Period 1|Study on hold|0|||
131640026|NCT01260142|473969439|FG003|Treatment Period 1|Study on hold|0|||
131640027|NCT01260142|473969440|FG004|Treatment Period 1|Study on hold|1|||
131640028|NCT01260142|473969441|FG005|Treatment Period 1|Study on hold|2|||
131640029|NCT01260142|473969436|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
131640030|NCT01260142|473969437|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
131640031|NCT01260142|473969438|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
131640032|NCT01260142|473969439|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
131640033|NCT01260142|473969440|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
131640034|NCT01260142|473969441|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
131640035|NCT01260142|473969436|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131640036|NCT01260142|473969437|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131640037|NCT01260142|473969438|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131640038|NCT01260142|473969439|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131640039|NCT01260142|473969440|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131640040|NCT01260142|473969441|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131640041|NCT00424177|473969442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
131640042|NCT00424177|473969442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
131640043|NCT00424177|473969442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
131640044|NCT00424177|473969442|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
131640045|NCT00424177|473969442|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
131640046|NCT00424177|473969442|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
131640047|NCT00424177|473969442|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
131640048|NCT00424177|473969442|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
131640049|NCT00424177|473969442|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
131640050|NCT00424177|473969442|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
131640051|NCT00496834|473969446|FG000|Overall Study|Withdrawal by Subject|4|||
131640052|NCT00496834|473969447|FG001|Overall Study|Withdrawal by Subject|6|||
131640053|NCT00496834|473969446|FG000|Overall Study|Contraindicated medication administered|0|||
131640054|NCT00496834|473969447|FG001|Overall Study|Contraindicated medication administered|1|||
131640055|NCT00496834|473969446|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
131640056|NCT00496834|473969447|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
131640057|NCT00496834|473969446|FG000|Overall Study|Adverse Event|5|||
131640058|NCT00496834|473969447|FG001|Overall Study|Adverse Event|3|||
131640059|NCT00496834|473969446|FG000|Overall Study|IP administration violation|2|||
131640060|NCT00496834|473969447|FG001|Overall Study|IP administration violation|0|||
131640061|NCT00496834|473969446|FG000|Overall Study|Lost to Follow-up|2|||
131714724|NCT00996840|474233676|FG001|Overall Study|Withdrawal by Subject|1|||
131714725|NCT00996840|474233677|FG002|Overall Study|Withdrawal by Subject|0|||
131640062|NCT00496834|473969447|FG001|Overall Study|Lost to Follow-up|0|||
131714726|NCT00996840|474233678|FG003|Overall Study|Withdrawal by Subject|0|||
131640063|NCT00496834|473969446|FG000|Overall Study|Blood Pressure control failure|2|||
131640064|NCT00496834|473969447|FG001|Overall Study|Blood Pressure control failure|1|||
131640065|NCT01227928|473969448|FG000|Overall Study|Lost to Follow-up|4|||
131640066|NCT01227928|473969449|FG001|Overall Study|Lost to Follow-up|2|||
131640067|NCT01227928|473969448|FG000|Overall Study|Withdrawal by Subject|4|||
131640068|NCT01227928|473969449|FG001|Overall Study|Withdrawal by Subject|3|||
131640069|NCT01227928|473969448|FG000|Overall Study|Death|14|||
131640070|NCT01227928|473969449|FG001|Overall Study|Death|12|||
131640071|NCT04159805|473969452|FG000|Overall Study|Withdrawal by Subject|0|||
131640072|NCT04159805|473969453|FG001|Overall Study|Withdrawal by Subject|2|||
131640073|NCT04159805|473969454|FG002|Overall Study|Withdrawal by Subject|2|||
131640074|NCT03821064|473969455|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
131640075|NCT01502371|473969466|FG000|Overall Study|Withdrawal by Subject|1|||
131640076|NCT01502371|473969467|FG001|Overall Study|Withdrawal by Subject|2|||
131640077|NCT01502371|473969468|FG002|Overall Study|Withdrawal by Subject|1|||
131640078|NCT01502371|473969469|FG003|Overall Study|Withdrawal by Subject|1|||
131640079|NCT01502371|473969470|FG004|Overall Study|Withdrawal by Subject|1|||
131640080|NCT01502371|473969466|FG000|Overall Study|Adverse Event|2|||
131640081|NCT01502371|473969467|FG001|Overall Study|Adverse Event|1|||
131640082|NCT01502371|473969468|FG002|Overall Study|Adverse Event|0|||
131640083|NCT01502371|473969469|FG003|Overall Study|Adverse Event|4|||
131640084|NCT01502371|473969470|FG004|Overall Study|Adverse Event|3|||
131640085|NCT01502371|473969466|FG000|Overall Study|Treatment Failure|22|||
131640086|NCT01502371|473969467|FG001|Overall Study|Treatment Failure|20|||
131640087|NCT01502371|473969468|FG002|Overall Study|Treatment Failure|12|||
131640088|NCT01502371|473969469|FG003|Overall Study|Treatment Failure|19|||
131640089|NCT01502371|473969470|FG004|Overall Study|Treatment Failure|30|||
131640090|NCT01502371|473969466|FG000|Overall Study|Lack of Efficacy|3|||
131640091|NCT01502371|473969467|FG001|Overall Study|Lack of Efficacy|3|||
131640092|NCT01502371|473969468|FG002|Overall Study|Lack of Efficacy|2|||
131640093|NCT01502371|473969469|FG003|Overall Study|Lack of Efficacy|2|||
131640094|NCT01502371|473969470|FG004|Overall Study|Lack of Efficacy|4|||
131640095|NCT01502371|473969466|FG000|Overall Study|Physician Decision|3|||
131640096|NCT01502371|473969467|FG001|Overall Study|Physician Decision|0|||
131640097|NCT01502371|473969468|FG002|Overall Study|Physician Decision|0|||
131640098|NCT01502371|473969469|FG003|Overall Study|Physician Decision|0|||
131640099|NCT01502371|473969470|FG004|Overall Study|Physician Decision|1|||
131640100|NCT01502371|473969466|FG000|Overall Study|Noncompliance with Study Drug|0|||
131640101|NCT01502371|473969467|FG001|Overall Study|Noncompliance with Study Drug|0|||
131640102|NCT01502371|473969468|FG002|Overall Study|Noncompliance with Study Drug|1|||
131640103|NCT01502371|473969469|FG003|Overall Study|Noncompliance with Study Drug|2|||
131640104|NCT01502371|473969470|FG004|Overall Study|Noncompliance with Study Drug|1|||
131640105|NCT01502371|473969466|FG000|Overall Study|Technical Problems|1|||
131640106|NCT01502371|473969467|FG001|Overall Study|Technical Problems|0|||
131640107|NCT01502371|473969468|FG002|Overall Study|Technical Problems|2|||
131640108|NCT01502371|473969469|FG003|Overall Study|Technical Problems|4|||
131640109|NCT01502371|473969470|FG004|Overall Study|Technical Problems|1|||
131640110|NCT01502371|473969466|FG000|Overall Study|Protocol Violation|9|||
131714727|NCT00996840|474233679|FG004|Overall Study|Withdrawal by Subject|0|||
131714728|NCT01389245|474233680|FG000|Overall Study|Protocol Violation|10|||
131714729|NCT01389245|474233680|FG000|Overall Study|Lost to Follow-up|3|||
131714730|NCT01389245|474233680|FG000|Overall Study|Withdrawal by Subject|2|||
131714731|NCT02292849|474233681|FG000|Overall Study|Lost to Follow-up|0|||
131714732|NCT02292849|474233682|FG001|Overall Study|Lost to Follow-up|2|||
131714733|NCT02292849|474233683|FG002|Overall Study|Lost to Follow-up|2|||
131714734|NCT02292849|474233681|FG000|Overall Study|Physician Decision|4|||
131714735|NCT02292849|474233682|FG001|Overall Study|Physician Decision|0|||
131714736|NCT02292849|474233683|FG002|Overall Study|Physician Decision|0|||
131714737|NCT00363415|474233684|FG000|Overall Study|Progressive Disease|196|||
131714738|NCT00363415|474233685|FG001|Overall Study|Progressive Disease|107|||
131714739|NCT00363415|474233684|FG000|Overall Study|Sponsor Decision|67|||
131714740|NCT00363415|474233685|FG001|Overall Study|Sponsor Decision|31|||
131714741|NCT00363415|474233684|FG000|Overall Study|Death|32|||
131714742|NCT00363415|474233685|FG001|Overall Study|Death|29|||
131714743|NCT00363415|474233684|FG000|Overall Study|Adverse Event|24|||
131714744|NCT00363415|474233685|FG001|Overall Study|Adverse Event|15|||
131640111|NCT01502371|473969467|FG001|Overall Study|Protocol Violation|5|||
131640112|NCT01502371|473969468|FG002|Overall Study|Protocol Violation|6|||
131640113|NCT01502371|473969469|FG003|Overall Study|Protocol Violation|5|||
131714745|NCT00363415|474233684|FG000|Overall Study|Physician Decision|18|||
131714746|NCT00363415|474233685|FG001|Overall Study|Physician Decision|35|||
131799483|NCT01345019|474550343|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
131640114|NCT01502371|473969470|FG004|Overall Study|Protocol Violation|10|||
131714747|NCT00363415|474233684|FG000|Overall Study|Entry Criteria Not Met|11|||
131714748|NCT00363415|474233685|FG001|Overall Study|Entry Criteria Not Met|10|||
131714749|NCT00363415|474233684|FG000|Overall Study|Withdrawal by Subject|9|||
131640115|NCT01502371|473969466|FG000|Overall Study|Excluded Medication|0|||
131640116|NCT01502371|473969467|FG001|Overall Study|Excluded Medication|1|||
131640117|NCT01502371|473969468|FG002|Overall Study|Excluded Medication|1|||
131640118|NCT01502371|473969469|FG003|Overall Study|Excluded Medication|0|||
131640119|NCT01502371|473969470|FG004|Overall Study|Excluded Medication|1|||
131640120|NCT02598934|473969474|FG000|Overall Study|Adverse Event|11|||
131640121|NCT02598934|473969475|FG001|Overall Study|Adverse Event|13|||
131714750|NCT00363415|474233685|FG001|Overall Study|Withdrawal by Subject|15|||
131714751|NCT00363415|474233684|FG000|Overall Study|Lost to Follow-up|3|||
131714752|NCT00363415|474233685|FG001|Overall Study|Lost to Follow-up|3|||
131714753|NCT00363415|474233684|FG000|Overall Study|Protocol Violation|1|||
131714754|NCT00363415|474233685|FG001|Overall Study|Protocol Violation|4|||
131640122|NCT02598934|473969474|FG000|Overall Study|Failure to Return|3|||
131640123|NCT02598934|473969475|FG001|Overall Study|Failure to Return|3|||
131640124|NCT02598934|473969474|FG000|Overall Study|Withdrawal by Subject|2|||
131640125|NCT02598934|473969475|FG001|Overall Study|Withdrawal by Subject|3|||
131640126|NCT02598934|473969474|FG000|Overall Study|Administrative|2|||
131640127|NCT02598934|473969475|FG001|Overall Study|Administrative|1|||
131640128|NCT02598934|473969474|FG000|Overall Study|Protocol Violation|1|||
131640129|NCT02598934|473969475|FG001|Overall Study|Protocol Violation|2|||
131640130|NCT03325608|473969478|FG000|Overall Study|Lost to Follow-up|23|||
131640131|NCT03325608|473969479|FG001|Overall Study|Lost to Follow-up|23|||
131640132|NCT03325608|473969480|FG002|Overall Study|Lost to Follow-up|30|||
131640133|NCT03325608|473969481|FG003|Overall Study|Lost to Follow-up|30|||
131640134|NCT03325608|473969478|FG000|Overall Study|Death of Caregiver|0|||
131640135|NCT03325608|473969479|FG001|Overall Study|Death of Caregiver|0|||
131640136|NCT03325608|473969480|FG002|Overall Study|Death of Caregiver|2|||
131640137|NCT03325608|473969481|FG003|Overall Study|Death of Caregiver|2|||
131640138|NCT03325608|473969478|FG000|Overall Study|Death of Care Recipient|34|||
131640139|NCT03325608|473969479|FG001|Overall Study|Death of Care Recipient|34|||
131640140|NCT03325608|473969480|FG002|Overall Study|Death of Care Recipient|28|||
131640141|NCT03325608|473969481|FG003|Overall Study|Death of Care Recipient|28|||
131640142|NCT03325608|473969478|FG000|Overall Study|Withdrawal by Subject|49|||
131640143|NCT03325608|473969479|FG001|Overall Study|Withdrawal by Subject|49|||
131640144|NCT03325608|473969480|FG002|Overall Study|Withdrawal by Subject|35|||
131640145|NCT03325608|473969481|FG003|Overall Study|Withdrawal by Subject|35|||
131640146|NCT03325608|473969478|FG000|Overall Study|Ineligible|7|||
131640147|NCT03325608|473969479|FG001|Overall Study|Ineligible|7|||
131640148|NCT03325608|473969480|FG002|Overall Study|Ineligible|5|||
131640149|NCT03325608|473969481|FG003|Overall Study|Ineligible|5|||
131640150|NCT02154347|473969482|FG000|Double-blind Period|Adverse Event|1|||
131640151|NCT02154347|473969483|FG001|Double-blind Period|Adverse Event|2|||
131640152|NCT02154347|473969482|FG000|Double-blind Period|Lack of Efficacy|1|||
131640153|NCT02154347|473969483|FG001|Double-blind Period|Lack of Efficacy|0|||
131640154|NCT02154347|473969482|FG000|Double-blind Period|Physician Decision|0|||
131640155|NCT02154347|473969483|FG001|Double-blind Period|Physician Decision|1|||
131640156|NCT02154347|473969482|FG000|Double-blind Period|Withdrawal by Subject|1|||
131640157|NCT02154347|473969483|FG001|Double-blind Period|Withdrawal by Subject|1|||
131640158|NCT02154347|473969482|FG000|Open-label Period|Adverse Event|3|||
131640159|NCT02154347|473969483|FG001|Open-label Period|Adverse Event|4|||
131640160|NCT02154347|473969482|FG000|Open-label Period|Lack of Efficacy|4|||
131640161|NCT02154347|473969483|FG001|Open-label Period|Lack of Efficacy|19|||
131640162|NCT02154347|473969482|FG000|Open-label Period|Protocol Violation|0|||
131640163|NCT02154347|473969483|FG001|Open-label Period|Protocol Violation|1|||
131640164|NCT02154347|473969482|FG000|Open-label Period|Withdrawal by Subject|0|||
131640165|NCT02154347|473969483|FG001|Open-label Period|Withdrawal by Subject|1|||
131640166|NCT02188784|473969484|FG000|Overall Study|Death|3|||
131640167|NCT02188784|473969485|FG001|Overall Study|Death|1|||
131640168|NCT02188784|473969484|FG000|Overall Study|Lost to Follow-up|1|||
131640169|NCT02188784|473969485|FG001|Overall Study|Lost to Follow-up|0|||
131640170|NCT02188784|473969484|FG000|Overall Study|Withdrawal by Subject|3|||
131640171|NCT02188784|473969485|FG001|Overall Study|Withdrawal by Subject|9|||
131640172|NCT02188784|473969484|FG000|Overall Study|Physician Decision|2|||
131640173|NCT02188784|473969485|FG001|Overall Study|Physician Decision|3|||
131640174|NCT02473913|473969486|FG000|Overall Study|Lost to Follow-up|3|||
131640175|NCT02473913|473969487|FG001|Overall Study|Lost to Follow-up|3|||
131640176|NCT01190449|473969491|FG000|Overall Study|Ineligible|0|||
131640177|NCT01190449|473969492|FG001|Overall Study|Ineligible|4|||
131640178|NCT03282799|473969493|FG000|Overall Study|Pregnancy|1|||
131640179|NCT03282799|473969494|FG001|Overall Study|Pregnancy|0|||
131640180|NCT03282799|473969493|FG000|Overall Study|Physician Decision|1|||
131640181|NCT03282799|473969494|FG001|Overall Study|Physician Decision|0|||
131640182|NCT04944784|473969501|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
131640183|NCT04944784|473969502|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
131640184|NCT04944784|473969503|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
131640185|NCT04944784|473969504|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
131640186|NCT04944784|473969501|FG000|Double-blind Period|Adverse Event|20|||
131640187|NCT04944784|473969502|FG001|Double-blind Period|Adverse Event|4|||
131640188|NCT04944784|473969503|FG002|Double-blind Period|Adverse Event|0|||
131640189|NCT04944784|473969504|FG003|Double-blind Period|Adverse Event|0|||
131640190|NCT04944784|473969501|FG000|Double-blind Period|Withdrawal by Subject|15|||
131640191|NCT04944784|473969502|FG001|Double-blind Period|Withdrawal by Subject|4|||
131640192|NCT04944784|473969503|FG002|Double-blind Period|Withdrawal by Subject|0|||
131640193|NCT04944784|473969504|FG003|Double-blind Period|Withdrawal by Subject|0|||
131640194|NCT04944784|473969501|FG000|Double-blind Period|Death|7|||
131640195|NCT04944784|473969502|FG001|Double-blind Period|Death|2|||
131640196|NCT04944784|473969503|FG002|Double-blind Period|Death|0|||
131640197|NCT04944784|473969504|FG003|Double-blind Period|Death|0|||
131640198|NCT04944784|473969501|FG000|Double-blind Period|Physician Decision|2|||
131640199|NCT04944784|473969502|FG001|Double-blind Period|Physician Decision|1|||
131640200|NCT04944784|473969503|FG002|Double-blind Period|Physician Decision|0|||
131640201|NCT04944784|473969504|FG003|Double-blind Period|Physician Decision|0|||
131640202|NCT04944784|473969501|FG000|Double-blind Period|Lack of Efficacy|0|||
131640203|NCT04944784|473969502|FG001|Double-blind Period|Lack of Efficacy|1|||
131799484|NCT01345019|474550342|FG000|Open Label Treatment Phase|Protocol Violation|0|||
131714755|NCT05027802|474233688|FG000|Overall Study|Adverse Event|2|||
131714756|NCT05027802|474233688|FG000|Overall Study|Withdrawal by Subject|18|||
131714757|NCT05027802|474233688|FG000|Overall Study|Death|2|||
131714758|NCT05027802|474233688|FG000|Overall Study|Other|1|||
131714759|NCT03872180|474233691|FG000|Overall Study|Adverse Event|4|||
131714760|NCT03872180|474233691|FG000|Overall Study|Lack of Efficacy|2|||
131714761|NCT01506141|474233692|FG000|Overall Study|Adverse Event|0|||
131714762|NCT01506141|474233693|FG001|Overall Study|Adverse Event|2|||
131714763|NCT01506141|474233692|FG000|Overall Study|Participation Terminated by Investigator|1|||
131640204|NCT04944784|473969503|FG002|Double-blind Period|Lack of Efficacy|0|||
131640205|NCT04944784|473969504|FG003|Double-blind Period|Lack of Efficacy|0|||
131640206|NCT04944784|473969501|FG000|Double-blind Period|Sponsor Request|2|||
131640207|NCT04944784|473969502|FG001|Double-blind Period|Sponsor Request|1|||
131640208|NCT04944784|473969503|FG002|Double-blind Period|Sponsor Request|0|||
131640209|NCT04944784|473969504|FG003|Double-blind Period|Sponsor Request|0|||
131640210|NCT04944784|473969501|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
131640211|NCT04944784|473969502|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
131640212|NCT04944784|473969503|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
131640213|NCT04944784|473969504|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
131640214|NCT04944784|473969501|FG000|Double-blind Period|Participant Choice|1|||
131640215|NCT04944784|473969502|FG001|Double-blind Period|Participant Choice|1|||
131714764|NCT01506141|474233693|FG001|Overall Study|Participation Terminated by Investigator|1|||
131714765|NCT01506141|474233692|FG000|Overall Study|Site Terminated by Sponsor|2|||
131714766|NCT01506141|474233693|FG001|Overall Study|Site Terminated by Sponsor|0|||
131714767|NCT01506141|474233692|FG000|Overall Study|Reason Not Specified|4|||
131714768|NCT01506141|474233693|FG001|Overall Study|Reason Not Specified|2|||
131714769|NCT04607408|474233694|FG000|Overall Study|Lost to Follow-up|0|||
131714770|NCT04607408|474233695|FG001|Overall Study|Lost to Follow-up|0|||
131714771|NCT04607408|474233696|FG002|Overall Study|Lost to Follow-up|0|||
131714772|NCT04607408|474233697|FG003|Overall Study|Lost to Follow-up|1|||
131714773|NCT04607408|474233698|FG004|Overall Study|Lost to Follow-up|0|||
131714774|NCT04607408|474233694|FG000|Overall Study|Withdrawal by Subject|0|||
131714775|NCT04607408|474233695|FG001|Overall Study|Withdrawal by Subject|1|||
131714776|NCT04607408|474233696|FG002|Overall Study|Withdrawal by Subject|0|||
131714777|NCT04607408|474233697|FG003|Overall Study|Withdrawal by Subject|1|||
131714778|NCT04607408|474233698|FG004|Overall Study|Withdrawal by Subject|0|||
131714779|NCT02725788|474233703|FG000|Overall Study|Lost to Follow-up|1|||
131714780|NCT02725788|474233704|FG001|Overall Study|Lost to Follow-up|1|||
131714781|NCT02725788|474233703|FG000|Overall Study|Protocol Violation|0|||
131714782|NCT02725788|474233704|FG001|Overall Study|Protocol Violation|1|||
131714783|NCT02599402|474233705|FG000|Overall Study|Disease progression|153|||
131714784|NCT02599402|474233705|FG000|Overall Study|Study drug toxicity|201|||
131714785|NCT02599402|474233705|FG000|Overall Study|Death|26|||
131714786|NCT02599402|474233705|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
131714787|NCT02599402|474233705|FG000|Overall Study|Participant request to discontinue study treatment|13|||
131714788|NCT02599402|474233705|FG000|Overall Study|Participant withdrew consent|5|||
131714789|NCT02599402|474233705|FG000|Overall Study|Lost to Follow-up|1|||
131714790|NCT02599402|474233705|FG000|Overall Study|Maximum Clinical Benefit|7|||
131640216|NCT04944784|473969503|FG002|Double-blind Period|Participant Choice|0|||
131714791|NCT02599402|474233705|FG000|Overall Study|Poor/non-compliance|1|||
131714792|NCT02599402|474233705|FG000|Overall Study|Pregnancy|1|||
131714793|NCT02599402|474233705|FG000|Overall Study|Participant no longer met study criteria|7|||
131714794|NCT02599402|474233705|FG000|Overall Study|Other Reasons|95|||
131714795|NCT00809133|474233706|FG000|Overall Study|Progressive disease|2|||
131714796|NCT00809133|474233707|FG001|Overall Study|Progressive disease|5|||
131714797|NCT00809133|474233708|FG002|Overall Study|Progressive disease|5|||
131714798|NCT00809133|474233709|FG003|Overall Study|Progressive disease|3|||
131714799|NCT00809133|474233710|FG004|Overall Study|Progressive disease|4|||
131714800|NCT00809133|474233711|FG005|Overall Study|Progressive disease|1|||
131799485|NCT01345019|474550343|FG001|Open Label Treatment Phase|Protocol Violation|1|||
131799486|NCT03830164|474550347|FG000|Overall Study|Adverse Event|0|||
131640217|NCT04944784|473969504|FG003|Double-blind Period|Participant Choice|0|||
131714801|NCT00809133|474233712|FG006|Overall Study|Progressive disease|3|||
131714802|NCT00809133|474233713|FG007|Overall Study|Progressive disease|3|||
131714803|NCT00809133|474233714|FG008|Overall Study|Progressive disease|3|||
131714804|NCT00809133|474233715|FG009|Overall Study|Progressive disease|9|||
131640218|NCT04944784|473969501|FG000|Double-blind Period|Progressive Disease|2|||
131640219|NCT04944784|473969502|FG001|Double-blind Period|Progressive Disease|2|||
131714805|NCT00809133|474233716|FG010|Overall Study|Progressive disease|5|||
131714806|NCT00809133|474233717|FG011|Overall Study|Progressive disease|7|||
131714807|NCT00809133|474233718|FG012|Overall Study|Progressive disease|5|||
131714808|NCT00809133|474233719|FG013|Overall Study|Progressive disease|4|||
131799487|NCT03830164|474550348|FG001|Overall Study|Adverse Event|2|||
131640220|NCT04944784|473969503|FG002|Double-blind Period|Progressive Disease|0|||
131640221|NCT04944784|473969504|FG003|Double-blind Period|Progressive Disease|0|||
131640222|NCT04944784|473969501|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
131640223|NCT04944784|473969502|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
131640224|NCT04944784|473969503|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
131640225|NCT04944784|473969504|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
131640226|NCT04944784|473969501|FG000|Active Drug Period|Adverse Event|0|||
131640227|NCT04944784|473969502|FG001|Active Drug Period|Adverse Event|0|||
131640228|NCT04944784|473969503|FG002|Active Drug Period|Adverse Event|3|||
131640229|NCT04944784|473969504|FG003|Active Drug Period|Adverse Event|6|||
131640230|NCT04944784|473969501|FG000|Active Drug Period|Withdrawal by Subject|0|||
131640231|NCT04944784|473969502|FG001|Active Drug Period|Withdrawal by Subject|0|||
131640232|NCT04944784|473969503|FG002|Active Drug Period|Withdrawal by Subject|4|||
131640233|NCT04944784|473969504|FG003|Active Drug Period|Withdrawal by Subject|7|||
131640234|NCT04944784|473969501|FG000|Active Drug Period|Death|0|||
131640235|NCT04944784|473969502|FG001|Active Drug Period|Death|0|||
131640236|NCT04944784|473969503|FG002|Active Drug Period|Death|3|||
131640237|NCT04944784|473969504|FG003|Active Drug Period|Death|4|||
131640238|NCT04944784|473969501|FG000|Active Drug Period|Lack of Efficacy|0|||
131640239|NCT04944784|473969502|FG001|Active Drug Period|Lack of Efficacy|0|||
131640240|NCT04944784|473969503|FG002|Active Drug Period|Lack of Efficacy|2|||
131640241|NCT04944784|473969504|FG003|Active Drug Period|Lack of Efficacy|2|||
131640242|NCT04944784|473969501|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
131640243|NCT04944784|473969502|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
131640244|NCT04944784|473969503|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
131640245|NCT04944784|473969504|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
131640246|NCT04944784|473969501|FG000|Active Drug Period|Participant Choice|0|||
131640247|NCT04944784|473969502|FG001|Active Drug Period|Participant Choice|0|||
131640248|NCT04944784|473969503|FG002|Active Drug Period|Participant Choice|0|||
131640249|NCT04944784|473969504|FG003|Active Drug Period|Participant Choice|1|||
131640250|NCT04944784|473969501|FG000|Active Drug Period|Progressive Disease|0|||
131640251|NCT04944784|473969502|FG001|Active Drug Period|Progressive Disease|0|||
131640252|NCT04944784|473969503|FG002|Active Drug Period|Progressive Disease|4|||
131640253|NCT04944784|473969504|FG003|Active Drug Period|Progressive Disease|4|||
131640254|NCT04944784|473969501|FG000|Active Drug Period|Lost to Follow-up|0|||
131640255|NCT04944784|473969502|FG001|Active Drug Period|Lost to Follow-up|0|||
131640256|NCT04944784|473969503|FG002|Active Drug Period|Lost to Follow-up|0|||
131640257|NCT04944784|473969504|FG003|Active Drug Period|Lost to Follow-up|1|||
131640258|NCT04190225|473971423|FG000|Overall Study|Lost to Follow-up|2|||
131640259|NCT04190225|473971424|FG001|Overall Study|Lost to Follow-up|3|||
131640260|NCT04190225|473971423|FG000|Overall Study|Withdrawal by Subject|3|||
131640261|NCT04190225|473971424|FG001|Overall Study|Withdrawal by Subject|2|||
131640262|NCT04190225|473971423|FG000|Overall Study|Unrelated health condition|2|||
131640263|NCT04190225|473971424|FG001|Overall Study|Unrelated health condition|0|||
131640264|NCT00477464|473971428|FG000|Overall Study|Lost to Follow-up|1|||
131640265|NCT00477464|473971428|FG000|Overall Study|Death|36|||
131640266|NCT00477464|473971428|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
131640267|NCT00639769|473971429|FG000|Overall Study|Death|2|||
131640268|NCT00639769|473971429|FG000|Overall Study|Adverse Event|7|||
131640269|NCT00639769|473971429|FG000|Overall Study|Lack of Efficacy|1|||
131640270|NCT00639769|473971429|FG000|Overall Study|Disease progression|26|||
131640271|NCT00639769|473971429|FG000|Overall Study|Withdrawal by Subject|4|||
131640272|NCT04238520|473971430|FG000|Overall Study|Withdrawal by Subject|1|||
131640273|NCT04238520|473971431|FG001|Overall Study|Withdrawal by Subject|1|||
131640274|NCT04238520|473971430|FG000|Overall Study|Lost to Follow-up|1|||
131640275|NCT04238520|473971431|FG001|Overall Study|Lost to Follow-up|2|||
131640276|NCT04238520|473971430|FG000|Overall Study|Death|0|||
131640277|NCT04238520|473971431|FG001|Overall Study|Death|2|||
131640278|NCT04238520|473971430|FG000|Overall Study|Unsafe home environment for research staff|0|||
131640279|NCT04238520|473971431|FG001|Overall Study|Unsafe home environment for research staff|1|||
131640280|NCT00195442|473971432|FG000|Overall Study|Less than expected therapeutic effect|38|||
131640281|NCT00195442|473971432|FG000|Overall Study|Lost to Follow-up|27|||
131640282|NCT00195442|473971432|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
131640283|NCT00195442|473971432|FG000|Overall Study|Intermittent product shortage|21|||
131640284|NCT00195442|473971432|FG000|Overall Study|Death|7|||
131640285|NCT00195442|473971432|FG000|Overall Study|No reason specified|4|||
131640286|NCT00195442|473971432|FG000|Overall Study|Poor cooperation|2|||
131640287|NCT00195442|473971432|FG000|Overall Study|Other|14|||
131640288|NCT01917006|473971433|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
131640289|NCT01917006|473971434|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
131640290|NCT01917006|473971435|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
131640291|NCT01917006|473971436|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
131640292|NCT01917006|473971437|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
131640293|NCT01917006|473971438|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
131640294|NCT01917006|473971439|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
131799488|NCT03830164|474550349|FG002|Overall Study|Adverse Event|0|||
131902738|NCT02849080|474929378|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
131902739|NCT02849080|474929375|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
131902740|NCT02849080|474929376|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
131902741|NCT02849080|474929377|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
131445128|NCT04672239|473258832|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
131445129|NCT04672239|473258830|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
131640295|NCT01917006|473971440|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
131640296|NCT01917006|473971433|FG000|Randomized-treatment Period|Personal Reasons|0|||
131640297|NCT01917006|473971434|FG001|Randomized-treatment Period|Personal Reasons|0|||
131640298|NCT01917006|473971435|FG002|Randomized-treatment Period|Personal Reasons|0|||
131640299|NCT01917006|473971436|FG003|Randomized-treatment Period|Personal Reasons|0|||
131640300|NCT01917006|473971437|FG004|Randomized-treatment Period|Personal Reasons|0|||
131640301|NCT01917006|473971438|FG005|Randomized-treatment Period|Personal Reasons|1|||
131640302|NCT01917006|473971439|FG006|Randomized-treatment Period|Personal Reasons|0|||
131640303|NCT01917006|473971440|FG007|Randomized-treatment Period|Personal Reasons|0|||
131640304|NCT01917006|473971433|FG000|Randomized-treatment Period|Protocol Violation|1|||
131640305|NCT01917006|473971434|FG001|Randomized-treatment Period|Protocol Violation|0|||
131640306|NCT01917006|473971435|FG002|Randomized-treatment Period|Protocol Violation|0|||
131640307|NCT01917006|473971436|FG003|Randomized-treatment Period|Protocol Violation|0|||
131640308|NCT01917006|473971437|FG004|Randomized-treatment Period|Protocol Violation|0|||
131640309|NCT01917006|473971438|FG005|Randomized-treatment Period|Protocol Violation|0|||
131640310|NCT01917006|473971439|FG006|Randomized-treatment Period|Protocol Violation|0|||
131640311|NCT01917006|473971440|FG007|Randomized-treatment Period|Protocol Violation|0|||
131640312|NCT01917006|473971433|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640313|NCT01917006|473971434|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640314|NCT01917006|473971435|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640315|NCT01917006|473971436|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640316|NCT01917006|473971437|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640317|NCT01917006|473971438|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640318|NCT01917006|473971439|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
131640319|NCT01917006|473971440|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131640320|NCT01917006|473971433|FG000|Open-label Period|Adverse Event|0|||
131640321|NCT01917006|473971434|FG001|Open-label Period|Adverse Event|0|||
131640322|NCT01917006|473971435|FG002|Open-label Period|Adverse Event|0|||
131640323|NCT01917006|473971436|FG003|Open-label Period|Adverse Event|0|||
131640324|NCT01917006|473971437|FG004|Open-label Period|Adverse Event|0|||
131640325|NCT01917006|473971438|FG005|Open-label Period|Adverse Event|0|||
131640326|NCT01917006|473971439|FG006|Open-label Period|Adverse Event|0|||
131640327|NCT01917006|473971440|FG007|Open-label Period|Adverse Event|1|||
131640328|NCT01917006|473971433|FG000|Open-label Period|Lost to Follow-up|0|||
131640329|NCT01917006|473971434|FG001|Open-label Period|Lost to Follow-up|0|||
131640330|NCT01917006|473971435|FG002|Open-label Period|Lost to Follow-up|0|||
131640331|NCT01917006|473971436|FG003|Open-label Period|Lost to Follow-up|0|||
131640332|NCT01917006|473971437|FG004|Open-label Period|Lost to Follow-up|0|||
131640333|NCT01917006|473971438|FG005|Open-label Period|Lost to Follow-up|0|||
131640334|NCT01917006|473971439|FG006|Open-label Period|Lost to Follow-up|0|||
131640335|NCT01917006|473971440|FG007|Open-label Period|Lost to Follow-up|1|||
131640336|NCT00847132|473971441|FG000|Overall Study|Death|1|||
131640337|NCT00847132|473971442|FG001|Overall Study|Death|1|||
131640338|NCT00784147|473971443|FG000|Overall Study|Lost to Follow-up|2|||
131714809|NCT00809133|474233706|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714810|NCT00809133|474233707|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714811|NCT00809133|474233708|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714812|NCT00809133|474233709|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714813|NCT00809133|474233710|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714814|NCT00809133|474233711|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131714815|NCT00809133|474233712|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131714816|NCT00809133|474233713|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131714817|NCT00809133|474233714|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714818|NCT00809133|474233715|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714819|NCT00809133|474233716|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714820|NCT00809133|474233717|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714821|NCT00809133|474233718|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131714822|NCT00809133|474233719|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131640339|NCT00784147|473971444|FG001|Overall Study|Lost to Follow-up|4|||
131640340|NCT00784147|473971443|FG000|Overall Study|Withdrawal by Subject|1|||
131640341|NCT00784147|473971444|FG001|Overall Study|Withdrawal by Subject|3|||
131640342|NCT00784147|473971443|FG000|Overall Study|Physician Decision|2|||
131714823|NCT00809133|474233706|FG000|Overall Study|Other adverse event|1|||
131714824|NCT00809133|474233707|FG001|Overall Study|Other adverse event|1|||
131445130|NCT04672239|473258831|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
131640343|NCT00784147|473971444|FG001|Overall Study|Physician Decision|1|||
131799489|NCT03830164|474550347|FG000|Overall Study|Lack of Efficacy|1|||
131799490|NCT03830164|474550348|FG001|Overall Study|Lack of Efficacy|5|||
131799491|NCT03830164|474550349|FG002|Overall Study|Lack of Efficacy|0|||
131799492|NCT03830164|474550347|FG000|Overall Study|Lost to Follow-up|0|||
131799493|NCT03830164|474550348|FG001|Overall Study|Lost to Follow-up|1|||
131799494|NCT03830164|474550349|FG002|Overall Study|Lost to Follow-up|0|||
131640344|NCT00784147|473971443|FG000|Overall Study|Protocol Violation|1|||
131640345|NCT00784147|473971444|FG001|Overall Study|Protocol Violation|1|||
131640346|NCT00784147|473971443|FG000|Overall Study|Death|2|||
131640347|NCT00784147|473971444|FG001|Overall Study|Death|0|||
131640348|NCT01057251|473971445|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
131640349|NCT01057251|473971446|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
131640350|NCT01057251|473971445|FG000|Overall Study|Adverse Event|4|||
131640351|NCT01057251|473971446|FG001|Overall Study|Adverse Event|2|||
131640352|NCT01057251|473971445|FG000|Overall Study|Lack of Efficacy|2|||
131640353|NCT01057251|473971446|FG001|Overall Study|Lack of Efficacy|11|||
131640354|NCT01057251|473971445|FG000|Overall Study|Protocol Violation|6|||
131640355|NCT01057251|473971446|FG001|Overall Study|Protocol Violation|2|||
131640356|NCT01057251|473971445|FG000|Overall Study|Withdrawal by Subject|4|||
131640357|NCT01057251|473971446|FG001|Overall Study|Withdrawal by Subject|5|||
131640358|NCT01057251|473971445|FG000|Overall Study|Lost to Follow-up|7|||
131640359|NCT01057251|473971446|FG001|Overall Study|Lost to Follow-up|6|||
131640360|NCT01057251|473971445|FG000|Overall Study|Other Reason|1|||
131640361|NCT01057251|473971446|FG001|Overall Study|Other Reason|1|||
131640362|NCT03596242|473971448|FG000|Overall Study|Lost to Follow-up|2|||
131640363|NCT03596242|473971449|FG001|Overall Study|Lost to Follow-up|2|||
131640364|NCT02509312|473971450|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
131640365|NCT02509312|473971451|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
131640366|NCT02509312|473971450|FG000|Overall Study|Obstetrician refusal|0|||
131640367|NCT02509312|473971451|FG001|Overall Study|Obstetrician refusal|1|||
131640368|NCT02509312|473971450|FG000|Overall Study|Patient elected for TOLAC|1|||
131640369|NCT02509312|473971451|FG001|Overall Study|Patient elected for TOLAC|0|||
131640370|NCT02509312|473971450|FG000|Overall Study|Cesarean deemed stat|1|||
131640371|NCT02509312|473971451|FG001|Overall Study|Cesarean deemed stat|0|||
131640372|NCT02509312|473971450|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
131640373|NCT02509312|473971451|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
131640374|NCT00706914|473971454|FG000|Overall Study|Lack of Efficacy|0|||
131640375|NCT00706914|473971455|FG001|Overall Study|Lack of Efficacy|1|||
131640376|NCT00706914|473971456|FG002|Overall Study|Lack of Efficacy|0|||
131640377|NCT00706914|473971454|FG000|Overall Study|Lost to Follow-up|1|||
131640378|NCT00706914|473971455|FG001|Overall Study|Lost to Follow-up|0|||
131640379|NCT00706914|473971456|FG002|Overall Study|Lost to Follow-up|0|||
131640380|NCT00706914|473971454|FG000|Overall Study|Adverse Event|2|||
131640381|NCT00706914|473971455|FG001|Overall Study|Adverse Event|2|||
131640382|NCT00706914|473971456|FG002|Overall Study|Adverse Event|0|||
131640383|NCT00706914|473971454|FG000|Overall Study|Protocol Violation|3|||
131640384|NCT00706914|473971455|FG001|Overall Study|Protocol Violation|1|||
131640385|NCT00706914|473971456|FG002|Overall Study|Protocol Violation|1|||
131640386|NCT00702650|473971457|FG000|Overall Study|Withdrawal by Subject|9|||
131640387|NCT00702650|473971457|FG000|Overall Study|Non-Compliance of Study Drug|3|||
131640388|NCT00702650|473971457|FG000|Overall Study|Lost to Follow-up|2|||
131640389|NCT00702650|473971457|FG000|Overall Study|Non-Compliance with Site Directives|1|||
131640390|NCT00702650|473971457|FG000|Overall Study|Sponsor Request|1|||
131640391|NCT00702650|473971457|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
131640392|NCT00702650|473971457|FG000|Overall Study|Adverse Event|3|||
131640393|NCT00988533|473971463|FG000|Overall Study|Lost to Follow-up|3|||
131640394|NCT00943722|473971466|FG000|Base Study|Adverse Event|0|||
131640395|NCT00943722|473971467|FG001|Base Study|Adverse Event|0|||
131640396|NCT00943722|473971468|FG002|Base Study|Adverse Event|0|||
131640397|NCT00943722|473971469|FG003|Base Study|Adverse Event|1|||
131799495|NCT03830164|474550347|FG000|Overall Study|Withdrawal by Subject|1|||
131799496|NCT03830164|474550348|FG001|Overall Study|Withdrawal by Subject|0|||
131902742|NCT02849080|474929378|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
131902743|NCT02573259|474929381|FG000|Overall Study|Death|1|||
131902744|NCT02573259|474929382|FG001|Overall Study|Death|6|||
131902745|NCT02573259|474929383|FG002|Overall Study|Death|5|||
131902746|NCT02573259|474929384|FG003|Overall Study|Death|6|||
131640398|NCT00943722|473971470|FG004|Base Study|Adverse Event|0|||
131640399|NCT00943722|473971471|FG005|Base Study|Adverse Event|0|||
131640400|NCT00943722|473971472|FG006|Base Study|Adverse Event|0|||
131640401|NCT00943722|473971466|FG000|Base Study|Lost to Follow-up|12|||
131640402|NCT00943722|473971467|FG001|Base Study|Lost to Follow-up|8|||
131640403|NCT00943722|473971468|FG002|Base Study|Lost to Follow-up|10|||
131640404|NCT00943722|473971469|FG003|Base Study|Lost to Follow-up|8|||
131640405|NCT00943722|473971470|FG004|Base Study|Lost to Follow-up|11|||
131640406|NCT00943722|473971471|FG005|Base Study|Lost to Follow-up|0|||
131640407|NCT00943722|473971472|FG006|Base Study|Lost to Follow-up|0|||
131640408|NCT00943722|473971466|FG000|Base Study|Physician Decision|1|||
131640409|NCT00943722|473971467|FG001|Base Study|Physician Decision|0|||
131640410|NCT00943722|473971468|FG002|Base Study|Physician Decision|0|||
131640411|NCT00943722|473971469|FG003|Base Study|Physician Decision|0|||
131640412|NCT00943722|473971470|FG004|Base Study|Physician Decision|1|||
131640413|NCT00943722|473971471|FG005|Base Study|Physician Decision|0|||
131640414|NCT00943722|473971472|FG006|Base Study|Physician Decision|0|||
131640415|NCT00943722|473971466|FG000|Base Study|Pregnancy|0|||
131640416|NCT00943722|473971467|FG001|Base Study|Pregnancy|0|||
131640417|NCT00943722|473971468|FG002|Base Study|Pregnancy|1|||
131640418|NCT00943722|473971469|FG003|Base Study|Pregnancy|0|||
131640419|NCT00943722|473971470|FG004|Base Study|Pregnancy|2|||
131640420|NCT00943722|473971471|FG005|Base Study|Pregnancy|0|||
131640421|NCT00943722|473971472|FG006|Base Study|Pregnancy|0|||
131640422|NCT00943722|473971466|FG000|Base Study|Protocol Violation|0|||
131640423|NCT00943722|473971467|FG001|Base Study|Protocol Violation|1|||
131640424|NCT00943722|473971468|FG002|Base Study|Protocol Violation|0|||
131640425|NCT00943722|473971469|FG003|Base Study|Protocol Violation|0|||
131640426|NCT00943722|473971470|FG004|Base Study|Protocol Violation|2|||
131640427|NCT00943722|473971471|FG005|Base Study|Protocol Violation|0|||
131640428|NCT00943722|473971472|FG006|Base Study|Protocol Violation|0|||
131640429|NCT00943722|473971466|FG000|Base Study|Withdrawal by Subject|12|||
131640430|NCT00943722|473971467|FG001|Base Study|Withdrawal by Subject|13|||
131640431|NCT00943722|473971468|FG002|Base Study|Withdrawal by Subject|2|||
131640432|NCT00943722|473971469|FG003|Base Study|Withdrawal by Subject|13|||
131640433|NCT00943722|473971470|FG004|Base Study|Withdrawal by Subject|8|||
131640434|NCT00943722|473971471|FG005|Base Study|Withdrawal by Subject|0|||
131640435|NCT00943722|473971472|FG006|Base Study|Withdrawal by Subject|0|||
131640436|NCT00943722|473971466|FG000|Base Study|Month 12 visit not completed|0|||
131640437|NCT00943722|473971467|FG001|Base Study|Month 12 visit not completed|0|||
131640438|NCT00943722|473971468|FG002|Base Study|Month 12 visit not completed|0|||
131640439|NCT00943722|473971469|FG003|Base Study|Month 12 visit not completed|0|||
131640440|NCT00943722|473971470|FG004|Base Study|Month 12 visit not completed|2|||
131640441|NCT00943722|473971471|FG005|Base Study|Month 12 visit not completed|0|||
131640442|NCT00943722|473971472|FG006|Base Study|Month 12 visit not completed|0|||
131640443|NCT00943722|473971466|FG000|First Extension Study: EXT 1|Adverse Event|0|||
131640444|NCT00943722|473971467|FG001|First Extension Study: EXT 1|Adverse Event|0|||
131640445|NCT00943722|473971468|FG002|First Extension Study: EXT 1|Adverse Event|0|||
131640446|NCT00943722|473971469|FG003|First Extension Study: EXT 1|Adverse Event|0|||
131640447|NCT00943722|473971470|FG004|First Extension Study: EXT 1|Adverse Event|0|||
131640448|NCT00943722|473971471|FG005|First Extension Study: EXT 1|Adverse Event|1|||
131640449|NCT00943722|473971472|FG006|First Extension Study: EXT 1|Adverse Event|0|||
131640450|NCT00943722|473971466|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
131640451|NCT00943722|473971467|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
131640452|NCT00943722|473971468|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
131640453|NCT00943722|473971469|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
131640454|NCT00943722|473971470|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
131640455|NCT00943722|473971471|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
131640456|NCT00943722|473971472|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
131640457|NCT00943722|473971466|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131640458|NCT00943722|473971467|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131640459|NCT00943722|473971468|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131640460|NCT00943722|473971469|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131640461|NCT00943722|473971470|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131714825|NCT00809133|474233708|FG002|Overall Study|Other adverse event|1|||
131640462|NCT00943722|473971471|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
131640463|NCT00943722|473971472|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
131640464|NCT00943722|473971466|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
131640465|NCT00943722|473971467|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
131640466|NCT00943722|473971468|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
131714826|NCT00809133|474233709|FG003|Overall Study|Other adverse event|0|||
131640467|NCT00943722|473971469|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
131640468|NCT00943722|473971470|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
131640469|NCT00943722|473971471|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
131714827|NCT00809133|474233710|FG004|Overall Study|Other adverse event|0|||
131714828|NCT00809133|474233711|FG005|Overall Study|Other adverse event|3|||
131714829|NCT00809133|474233712|FG006|Overall Study|Other adverse event|2|||
131714830|NCT00809133|474233713|FG007|Overall Study|Other adverse event|4|||
131714831|NCT00809133|474233714|FG008|Overall Study|Other adverse event|0|||
131714832|NCT00809133|474233715|FG009|Overall Study|Other adverse event|0|||
131714833|NCT00809133|474233716|FG010|Overall Study|Other adverse event|1|||
131714834|NCT00809133|474233717|FG011|Overall Study|Other adverse event|1|||
131714835|NCT00809133|474233718|FG012|Overall Study|Other adverse event|0|||
131714836|NCT00809133|474233719|FG013|Overall Study|Other adverse event|1|||
131714837|NCT00809133|474233706|FG000|Overall Study|Lost to Follow-up|0|||
131714838|NCT00809133|474233707|FG001|Overall Study|Lost to Follow-up|0|||
131714839|NCT00809133|474233708|FG002|Overall Study|Lost to Follow-up|0|||
131799497|NCT03830164|474550349|FG002|Overall Study|Withdrawal by Subject|0|||
131799498|NCT02246478|474550350|FG000|Multiple-dose Phase|Protocol Violation|1|||
131799499|NCT02246478|474550351|FG001|Multiple-dose Phase|Protocol Violation|0|||
131799500|NCT02246478|474550352|FG002|Multiple-dose Phase|Protocol Violation|0|||
131799501|NCT02246478|474550353|FG003|Multiple-dose Phase|Protocol Violation|1|||
131799502|NCT00386009|474550354|FG000|Overall Study|Adverse Event|0|||
131799503|NCT00386009|474550355|FG001|Overall Study|Adverse Event|2|||
131799504|NCT00386009|474550354|FG000|Overall Study|Death|1|||
131799505|NCT00386009|474550355|FG001|Overall Study|Death|0|||
131799506|NCT00386009|474550354|FG000|Overall Study|Entry Criteria Not Met|0|||
131799507|NCT00386009|474550355|FG001|Overall Study|Entry Criteria Not Met|2|||
131799508|NCT00386009|474550354|FG000|Overall Study|Lost to Follow-up|1|||
131799509|NCT00386009|474550355|FG001|Overall Study|Lost to Follow-up|1|||
131799510|NCT00386009|474550354|FG000|Overall Study|Protocol Violation|1|||
131799511|NCT00386009|474550355|FG001|Overall Study|Protocol Violation|0|||
131799512|NCT00386009|474550354|FG000|Overall Study|Sponsor Decision|1|||
131799513|NCT00386009|474550355|FG001|Overall Study|Sponsor Decision|1|||
131799514|NCT00386009|474550354|FG000|Overall Study|Withdrawal by Subject|5|||
131799515|NCT00386009|474550355|FG001|Overall Study|Withdrawal by Subject|4|||
131799516|NCT01089647|474550357|FG000|Overall Study|Lost to Follow-up|2|||
131640470|NCT00943722|473971472|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
131640471|NCT00943722|473971466|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
131640472|NCT00943722|473971467|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
131640473|NCT00943722|473971468|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
131640474|NCT00943722|473971469|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
131640475|NCT00943722|473971470|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
131640476|NCT00943722|473971471|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
131640477|NCT00943722|473971472|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
131640478|NCT00943722|473971466|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131640479|NCT00943722|473971467|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131640480|NCT00943722|473971468|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131640481|NCT00943722|473971469|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131640482|NCT00943722|473971470|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131640483|NCT00943722|473971471|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
131640484|NCT00943722|473971472|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
131640485|NCT00943722|473971466|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
131640486|NCT00943722|473971467|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
131640487|NCT00943722|473971468|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
131640488|NCT00943722|473971469|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
131640489|NCT00943722|473971470|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
131640490|NCT00943722|473971471|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
131640491|NCT00943722|473971472|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
131640492|NCT00943722|473971466|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
131640493|NCT00943722|473971467|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
131640494|NCT00943722|473971468|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
131640495|NCT00943722|473971469|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
131640496|NCT00943722|473971470|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
131640497|NCT00943722|473971471|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
131640498|NCT00943722|473971472|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
131640499|NCT00943722|473971466|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131640500|NCT00943722|473971467|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131640501|NCT00943722|473971468|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131640502|NCT00943722|473971469|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131640503|NCT00943722|473971470|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131799517|NCT01089647|474550358|FG001|Overall Study|Lost to Follow-up|2|||
131799518|NCT01089647|474550357|FG000|Overall Study|Withdrawal by Subject|2|||
131799519|NCT01089647|474550358|FG001|Overall Study|Withdrawal by Subject|1|||
131799520|NCT01089647|474550357|FG000|Overall Study|Adverse Event|0|||
131640504|NCT00943722|473971471|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
131640505|NCT00943722|473971472|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
131640506|NCT00913523|473971481|FG000|Overall Study|Withdrawal by Subject|3|||
131640507|NCT00913523|473971482|FG001|Overall Study|Withdrawal by Subject|2|||
131640508|NCT00913523|473971483|FG002|Overall Study|Withdrawal by Subject|2|||
131640509|NCT00913523|473971481|FG000|Overall Study|Lost to Follow-up|1|||
131640510|NCT00913523|473971482|FG001|Overall Study|Lost to Follow-up|1|||
131799521|NCT01089647|474550358|FG001|Overall Study|Adverse Event|1|||
131640511|NCT00913523|473971483|FG002|Overall Study|Lost to Follow-up|1|||
131799522|NCT00995553|474550359|FG000|Overall Study|Withdrawal by Subject|2|||
131640512|NCT00913523|473971481|FG000|Overall Study|Adverse Event|1|||
131799523|NCT00995553|474550360|FG001|Overall Study|Withdrawal by Subject|6|||
131799524|NCT01531205|474550361|FG000|Overall Study|Did not proceed to surgery|1|||
131799525|NCT02465567|474550364|FG000|Overall Study|Adverse Event|118|||
131640513|NCT00913523|473971482|FG001|Overall Study|Adverse Event|0|||
131799526|NCT02465567|474550365|FG001|Overall Study|Adverse Event|113|||
131640514|NCT00913523|473971483|FG002|Overall Study|Adverse Event|0|||
131640515|NCT00913523|473971481|FG000|Overall Study|Protocol Violation|5|||
131640516|NCT00913523|473971482|FG001|Overall Study|Protocol Violation|8|||
131640517|NCT00913523|473971483|FG002|Overall Study|Protocol Violation|8|||
131640518|NCT00913523|473971481|FG000|Overall Study|Pregnancy|1|||
131640519|NCT00913523|473971482|FG001|Overall Study|Pregnancy|3|||
131640520|NCT00913523|473971483|FG002|Overall Study|Pregnancy|0|||
131640521|NCT00913523|473971481|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
131640522|NCT00913523|473971482|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
131640523|NCT00913523|473971483|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
131640524|NCT01844726|473971484|FG000|Overall Study|Withdrawal by Subject|0|||
131640525|NCT01844726|473971485|FG001|Overall Study|Withdrawal by Subject|1|||
131640526|NCT01844726|473971484|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
131640527|NCT01844726|473971485|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
131640528|NCT00916305|473971486|FG000|Overall Study|Lost to Follow-up|21|||
131640529|NCT00916305|473971487|FG001|Overall Study|Lost to Follow-up|27|||
131640530|NCT00916305|473971486|FG000|Overall Study|Withdrawal by Subject|0|||
131640531|NCT00916305|473971487|FG001|Overall Study|Withdrawal by Subject|1|||
131640532|NCT01475461|473971488|FG000|Run-in Period|Not meet eligibility criteria|16|||
131640533|NCT01475461|473971489|FG001|Run-in Period|Not meet eligibility criteria|0|||
131640534|NCT01475461|473971490|FG002|Run-in Period|Not meet eligibility criteria|0|||
131640535|NCT01475461|473971491|FG003|Run-in Period|Not meet eligibility criteria|0|||
131640536|NCT01475461|473971492|FG004|Run-in Period|Not meet eligibility criteria|0|||
131640537|NCT01475461|473971493|FG005|Run-in Period|Not meet eligibility criteria|0|||
131640538|NCT01475461|473971494|FG006|Run-in Period|Not meet eligibility criteria|0|||
131640539|NCT01475461|473971488|FG000|Run-in Period|Lost to Follow-up|7|||
131640540|NCT01475461|473971489|FG001|Run-in Period|Lost to Follow-up|0|||
131640541|NCT01475461|473971490|FG002|Run-in Period|Lost to Follow-up|0|||
131640542|NCT01475461|473971491|FG003|Run-in Period|Lost to Follow-up|0|||
131640543|NCT01475461|473971492|FG004|Run-in Period|Lost to Follow-up|0|||
131640544|NCT01475461|473971493|FG005|Run-in Period|Lost to Follow-up|0|||
131640545|NCT01475461|473971494|FG006|Run-in Period|Lost to Follow-up|0|||
131640546|NCT01475461|473971488|FG000|Run-in Period|Withdrawal by Subject|11|||
131640547|NCT01475461|473971489|FG001|Run-in Period|Withdrawal by Subject|0|||
131640548|NCT01475461|473971490|FG002|Run-in Period|Withdrawal by Subject|0|||
131640549|NCT01475461|473971491|FG003|Run-in Period|Withdrawal by Subject|0|||
131640550|NCT01475461|473971492|FG004|Run-in Period|Withdrawal by Subject|0|||
131640551|NCT01475461|473971493|FG005|Run-in Period|Withdrawal by Subject|0|||
131640552|NCT01475461|473971494|FG006|Run-in Period|Withdrawal by Subject|0|||
131640553|NCT01475461|473971488|FG000|Run-in Period|Other|3|||
131640554|NCT01475461|473971489|FG001|Run-in Period|Other|0|||
131640555|NCT01475461|473971490|FG002|Run-in Period|Other|0|||
131640556|NCT01475461|473971491|FG003|Run-in Period|Other|0|||
131640557|NCT01475461|473971492|FG004|Run-in Period|Other|0|||
131640558|NCT01475461|473971493|FG005|Run-in Period|Other|0|||
131640559|NCT01475461|473971494|FG006|Run-in Period|Other|0|||
131640560|NCT01475461|473971488|FG000|Run-in Period|Protocol Violation|4|||
131640561|NCT01475461|473971489|FG001|Run-in Period|Protocol Violation|0|||
131640562|NCT01475461|473971490|FG002|Run-in Period|Protocol Violation|0|||
131640563|NCT01475461|473971491|FG003|Run-in Period|Protocol Violation|0|||
131640564|NCT01475461|473971492|FG004|Run-in Period|Protocol Violation|0|||
131640565|NCT01475461|473971493|FG005|Run-in Period|Protocol Violation|0|||
131640566|NCT01475461|473971494|FG006|Run-in Period|Protocol Violation|0|||
131640567|NCT01475461|473971488|FG000|Treatment Period|Death|0|||
131640568|NCT01475461|473971489|FG001|Treatment Period|Death|0|||
131640569|NCT01475461|473971490|FG002|Treatment Period|Death|0|||
131640570|NCT01475461|473971491|FG003|Treatment Period|Death|1|||
131640571|NCT01475461|473971492|FG004|Treatment Period|Death|0|||
131640572|NCT01475461|473971493|FG005|Treatment Period|Death|0|||
131640573|NCT01475461|473971494|FG006|Treatment Period|Death|0|||
131640574|NCT01475461|473971488|FG000|Treatment Period|Lost to Follow-up|0|||
131799527|NCT02465567|474550366|FG002|Overall Study|Adverse Event|147|||
131640575|NCT01475461|473971489|FG001|Treatment Period|Lost to Follow-up|3|||
131799528|NCT02465567|474550367|FG003|Overall Study|Adverse Event|138|||
131799529|NCT02465567|474550364|FG000|Overall Study|Lack of Efficacy|103|||
131799530|NCT02465567|474550365|FG001|Overall Study|Lack of Efficacy|102|||
131640576|NCT01475461|473971490|FG002|Treatment Period|Lost to Follow-up|2|||
131640577|NCT01475461|473971491|FG003|Treatment Period|Lost to Follow-up|3|||
131640578|NCT01475461|473971492|FG004|Treatment Period|Lost to Follow-up|1|||
131640579|NCT01475461|473971493|FG005|Treatment Period|Lost to Follow-up|2|||
131799531|NCT02465567|474550366|FG002|Overall Study|Lack of Efficacy|171|||
131640580|NCT01475461|473971494|FG006|Treatment Period|Lost to Follow-up|1|||
131640581|NCT01475461|473971488|FG000|Treatment Period|Withdrawal by Subject|0|||
131799532|NCT02465567|474550367|FG003|Overall Study|Lack of Efficacy|135|||
131640582|NCT01475461|473971489|FG001|Treatment Period|Withdrawal by Subject|2|||
131640583|NCT01475461|473971490|FG002|Treatment Period|Withdrawal by Subject|2|||
131640584|NCT01475461|473971491|FG003|Treatment Period|Withdrawal by Subject|0|||
131640585|NCT01475461|473971492|FG004|Treatment Period|Withdrawal by Subject|2|||
131640586|NCT01475461|473971493|FG005|Treatment Period|Withdrawal by Subject|2|||
131640587|NCT01475461|473971494|FG006|Treatment Period|Withdrawal by Subject|0|||
131640588|NCT01475461|473971488|FG000|Treatment Period|Other|0|||
131640589|NCT01475461|473971489|FG001|Treatment Period|Other|1|||
131640590|NCT01475461|473971490|FG002|Treatment Period|Other|0|||
131640591|NCT01475461|473971491|FG003|Treatment Period|Other|0|||
131640592|NCT01475461|473971492|FG004|Treatment Period|Other|0|||
131640593|NCT01475461|473971493|FG005|Treatment Period|Other|0|||
131640594|NCT01475461|473971494|FG006|Treatment Period|Other|0|||
131640595|NCT01475461|473971488|FG000|Treatment Period|Protocol Violation|0|||
131640596|NCT01475461|473971489|FG001|Treatment Period|Protocol Violation|1|||
131640597|NCT01475461|473971490|FG002|Treatment Period|Protocol Violation|0|||
131640598|NCT01475461|473971491|FG003|Treatment Period|Protocol Violation|0|||
131640599|NCT01475461|473971492|FG004|Treatment Period|Protocol Violation|0|||
131640600|NCT01475461|473971493|FG005|Treatment Period|Protocol Violation|0|||
131640601|NCT01475461|473971494|FG006|Treatment Period|Protocol Violation|1|||
131640602|NCT01475461|473971488|FG000|Treatment Period|Lack of Efficacy|0|||
131640603|NCT01475461|473971489|FG001|Treatment Period|Lack of Efficacy|2|||
131640604|NCT01475461|473971490|FG002|Treatment Period|Lack of Efficacy|0|||
131640605|NCT01475461|473971491|FG003|Treatment Period|Lack of Efficacy|2|||
131640606|NCT01475461|473971492|FG004|Treatment Period|Lack of Efficacy|1|||
131640607|NCT01475461|473971493|FG005|Treatment Period|Lack of Efficacy|1|||
131640608|NCT01475461|473971494|FG006|Treatment Period|Lack of Efficacy|0|||
131640609|NCT01475461|473971488|FG000|Treatment Period|Medication Error|0|||
131640610|NCT01475461|473971489|FG001|Treatment Period|Medication Error|0|||
131640611|NCT01475461|473971490|FG002|Treatment Period|Medication Error|0|||
131640612|NCT01475461|473971491|FG003|Treatment Period|Medication Error|1|||
131640613|NCT01475461|473971492|FG004|Treatment Period|Medication Error|0|||
131640614|NCT01475461|473971493|FG005|Treatment Period|Medication Error|0|||
131640615|NCT01475461|473971494|FG006|Treatment Period|Medication Error|0|||
131640616|NCT01475461|473971488|FG000|Treatment Period|Adverse Event|0|||
131640617|NCT01475461|473971489|FG001|Treatment Period|Adverse Event|0|||
131640618|NCT01475461|473971490|FG002|Treatment Period|Adverse Event|0|||
131640619|NCT01475461|473971491|FG003|Treatment Period|Adverse Event|1|||
131640620|NCT01475461|473971492|FG004|Treatment Period|Adverse Event|0|||
131640621|NCT01475461|473971493|FG005|Treatment Period|Adverse Event|0|||
131640622|NCT01475461|473971494|FG006|Treatment Period|Adverse Event|0|||
131640623|NCT02512861|473971502|FG000|Overall Study|Protocol Violation|3|||
131640624|NCT02512861|473971503|FG001|Overall Study|Protocol Violation|7|||
131640625|NCT02512861|473971502|FG000|Overall Study|Physician Decision|3|||
131640626|NCT02512861|473971503|FG001|Overall Study|Physician Decision|1|||
131640627|NCT02512861|473971502|FG000|Overall Study|Withdrawal by Subject|0|||
131640628|NCT02512861|473971503|FG001|Overall Study|Withdrawal by Subject|1|||
131640629|NCT03214250|473971506|FG000|Overall Study|Death|5|||
131640630|NCT03214250|473971507|FG001|Overall Study|Death|5|||
131640631|NCT03214250|473971508|FG002|Overall Study|Death|7|||
131640632|NCT03214250|473971509|FG003|Overall Study|Death|4|||
131640633|NCT03214250|473971510|FG004|Overall Study|Death|23|||
131640634|NCT03214250|473971511|FG005|Overall Study|Death|23|||
131640635|NCT03214250|473971512|FG006|Overall Study|Death|24|||
131640636|NCT03214250|473971506|FG000|Overall Study|Lost to Follow-up|0|||
131640637|NCT03214250|473971507|FG001|Overall Study|Lost to Follow-up|0|||
131640638|NCT03214250|473971508|FG002|Overall Study|Lost to Follow-up|0|||
131640639|NCT03214250|473971509|FG003|Overall Study|Lost to Follow-up|1|||
131640640|NCT03214250|473971510|FG004|Overall Study|Lost to Follow-up|1|||
131640641|NCT03214250|473971511|FG005|Overall Study|Lost to Follow-up|2|||
131640642|NCT03214250|473971512|FG006|Overall Study|Lost to Follow-up|0|||
131640643|NCT03214250|473971506|FG000|Overall Study|Other|0|||
131640644|NCT03214250|473971507|FG001|Overall Study|Other|0|||
131640645|NCT03214250|473971508|FG002|Overall Study|Other|0|||
131640646|NCT03214250|473971509|FG003|Overall Study|Other|0|||
131640647|NCT03214250|473971510|FG004|Overall Study|Other|1|||
131640648|NCT03214250|473971511|FG005|Overall Study|Other|1|||
131640649|NCT03214250|473971512|FG006|Overall Study|Other|2|||
131640650|NCT03214250|473971506|FG000|Overall Study|Remains on Study|2|||
131640651|NCT03214250|473971507|FG001|Overall Study|Remains on Study|2|||
131640652|NCT03214250|473971508|FG002|Overall Study|Remains on Study|0|||
131640653|NCT03214250|473971509|FG003|Overall Study|Remains on Study|1|||
131640654|NCT03214250|473971510|FG004|Overall Study|Remains on Study|7|||
131640655|NCT03214250|473971511|FG005|Overall Study|Remains on Study|5|||
131640656|NCT03214250|473971512|FG006|Overall Study|Remains on Study|3|||
131640657|NCT03214250|473971506|FG000|Overall Study|Withdrawal by Subject|0|||
131640658|NCT03214250|473971507|FG001|Overall Study|Withdrawal by Subject|0|||
131640659|NCT03214250|473971508|FG002|Overall Study|Withdrawal by Subject|1|||
131640660|NCT03214250|473971509|FG003|Overall Study|Withdrawal by Subject|2|||
131640661|NCT03214250|473971510|FG004|Overall Study|Withdrawal by Subject|5|||
131640662|NCT03214250|473971511|FG005|Overall Study|Withdrawal by Subject|0|||
131640663|NCT03214250|473971512|FG006|Overall Study|Withdrawal by Subject|2|||
131640664|NCT00292981|473971516|FG000|Overall Study|Adverse Event|1|||
131640665|NCT00292981|473971516|FG000|Overall Study|Lost to Follow-up|13|||
131640666|NCT00292981|473971516|FG000|Overall Study|Withdrawal by Subject|22|||
131640667|NCT00292981|473971516|FG000|Overall Study|Other|3|||
131640668|NCT00594178|473971517|FG000|Overall Study|Physician Decision|5|||
131640669|NCT04191148|473971522|FG000|Overall Study|Withdrawal by Subject|1|||
131640670|NCT04191148|473971523|FG001|Overall Study|Withdrawal by Subject|0|||
131640671|NCT04191148|473971522|FG000|Overall Study|Adverse Event|1|||
131640672|NCT04191148|473971523|FG001|Overall Study|Adverse Event|0|||
131640673|NCT01274559|473971526|FG000|Overall Study|Adverse Event|57|||
131640674|NCT01274559|473971527|FG001|Overall Study|Adverse Event|13|||
131640675|NCT01274559|473971526|FG000|Overall Study|Death|1|||
131640676|NCT01274559|473971527|FG001|Overall Study|Death|1|||
131640677|NCT01274559|473971526|FG000|Overall Study|Lost to Follow-up|3|||
131640678|NCT01274559|473971527|FG001|Overall Study|Lost to Follow-up|3|||
131640679|NCT01274559|473971526|FG000|Overall Study|Non-compliance with Study Drug|2|||
131640680|NCT01274559|473971527|FG001|Overall Study|Non-compliance with Study Drug|4|||
131640681|NCT01274559|473971526|FG000|Overall Study|Physician Decision|2|||
131640682|NCT01274559|473971527|FG001|Overall Study|Physician Decision|1|||
131640683|NCT01274559|473971526|FG000|Overall Study|Protocol Violation|28|||
131640684|NCT01274559|473971527|FG001|Overall Study|Protocol Violation|23|||
131640685|NCT01274559|473971526|FG000|Overall Study|Study Terminated by Sponsor|79|||
131640686|NCT01274559|473971527|FG001|Overall Study|Study Terminated by Sponsor|87|||
131640687|NCT01274559|473971526|FG000|Overall Study|Withdrawal by Subject|25|||
131640688|NCT01274559|473971527|FG001|Overall Study|Withdrawal by Subject|13|||
131640689|NCT02971228|473971528|FG000|Overall Study|Withdrawal by Subject|1|||
131640690|NCT02971228|473971529|FG001|Overall Study|Withdrawal by Subject|1|||
131640691|NCT02971228|473971530|FG002|Overall Study|Withdrawal by Subject|0|||
131640692|NCT02971228|473971531|FG003|Overall Study|Withdrawal by Subject|0|||
131640693|NCT02971228|473971532|FG004|Overall Study|Withdrawal by Subject|0|||
131640694|NCT02971228|473971528|FG000|Overall Study|Logistical challenges|0|||
131640695|NCT02971228|473971529|FG001|Overall Study|Logistical challenges|1|||
131640696|NCT02971228|473971530|FG002|Overall Study|Logistical challenges|0|||
131640697|NCT02971228|473971531|FG003|Overall Study|Logistical challenges|0|||
131640698|NCT02971228|473971532|FG004|Overall Study|Logistical challenges|0|||
131640699|NCT01321723|473971543|FG000|Overall Study|Adverse Event|3|||
131640700|NCT01321723|473971544|FG001|Overall Study|Adverse Event|5|||
131640701|NCT01321723|473971545|FG002|Overall Study|Adverse Event|2|||
131640702|NCT01321723|473971543|FG000|Overall Study|Withdrawal by Subject|2|||
131640703|NCT01321723|473971544|FG001|Overall Study|Withdrawal by Subject|0|||
131640704|NCT01321723|473971545|FG002|Overall Study|Withdrawal by Subject|2|||
131640705|NCT00025506|473971546|FG000|Overall Study|Ineligible: clerical error|1|||
131640706|NCT00025506|473971546|FG000|Overall Study|Ineligible: wrong cell type|5|||
131640707|NCT00025506|473971546|FG000|Overall Study|Ineligible: inadequate pathology|2|||
131640708|NCT00025506|473971546|FG000|Overall Study|Never Treated|2|||
131640709|NCT00713206|473971547|FG000|Overall Study|Lost to Follow-up|4|||
131640710|NCT00713206|473971548|FG001|Overall Study|Lost to Follow-up|4|||
131640711|NCT00713206|473971547|FG000|Overall Study|Death|1|||
131640712|NCT00713206|473971548|FG001|Overall Study|Death|0|||
131640713|NCT02561806|473971549|FG000|Induction Period|Adverse Event|0|||
131640714|NCT02561806|473971550|FG001|Induction Period|Adverse Event|2|||
131640715|NCT02561806|473971549|FG000|Induction Period|Lack of Efficacy|1|||
131640716|NCT02561806|473971550|FG001|Induction Period|Lack of Efficacy|0|||
131640717|NCT02561806|473971549|FG000|Induction Period|Withdrawal by Subject|0|||
131640718|NCT02561806|473971550|FG001|Induction Period|Withdrawal by Subject|2|||
131640719|NCT02561806|473971549|FG000|Induction Period|Site staff became unblinded|1|||
131640720|NCT02561806|473971550|FG001|Induction Period|Site staff became unblinded|0|||
131640721|NCT02561806|473971549|FG000|Induction Period|Randomized but not treated|0|||
131640722|NCT02561806|473971550|FG001|Induction Period|Randomized but not treated|1|||
131640723|NCT02561806|473971549|FG000|Maintenance Period|Adverse Event|2|||
131714840|NCT00809133|474233709|FG003|Overall Study|Lost to Follow-up|0|||
131714841|NCT00809133|474233710|FG004|Overall Study|Lost to Follow-up|0|||
131714842|NCT00809133|474233711|FG005|Overall Study|Lost to Follow-up|1|||
131714843|NCT00809133|474233712|FG006|Overall Study|Lost to Follow-up|0|||
131714844|NCT00809133|474233713|FG007|Overall Study|Lost to Follow-up|0|||
131714845|NCT00809133|474233714|FG008|Overall Study|Lost to Follow-up|0|||
131714846|NCT00809133|474233715|FG009|Overall Study|Lost to Follow-up|0|||
131714847|NCT00809133|474233716|FG010|Overall Study|Lost to Follow-up|0|||
131714848|NCT00809133|474233717|FG011|Overall Study|Lost to Follow-up|0|||
131714849|NCT00809133|474233718|FG012|Overall Study|Lost to Follow-up|0|||
131714850|NCT00809133|474233719|FG013|Overall Study|Lost to Follow-up|0|||
131714851|NCT00809133|474233706|FG000|Overall Study|Consent withdrawn|0|||
131640724|NCT02561806|473971550|FG001|Maintenance Period|Adverse Event|1|||
131640725|NCT02561806|473971549|FG000|Maintenance Period|Lack of Efficacy|3|||
131640726|NCT02561806|473971550|FG001|Maintenance Period|Lack of Efficacy|1|||
131640727|NCT02561806|473971549|FG000|Maintenance Period|Lost to Follow-up|2|||
131640728|NCT02561806|473971550|FG001|Maintenance Period|Lost to Follow-up|2|||
131640729|NCT02561806|473971549|FG000|Maintenance Period|Protocol Violation|1|||
131714852|NCT00809133|474233707|FG001|Overall Study|Consent withdrawn|0|||
131640730|NCT02561806|473971550|FG001|Maintenance Period|Protocol Violation|0|||
131714853|NCT00809133|474233708|FG002|Overall Study|Consent withdrawn|0|||
131799533|NCT02465567|474550364|FG000|Overall Study|Withdrawal by Subject|104|||
131799534|NCT02465567|474550365|FG001|Overall Study|Withdrawal by Subject|94|||
131640731|NCT02561806|473971549|FG000|Maintenance Period|Withdrawal by Subject|5|||
131640732|NCT02561806|473971550|FG001|Maintenance Period|Withdrawal by Subject|3|||
131640733|NCT02561806|473971549|FG000|Maintenance Period|Site staff became unblinded|0|||
131640734|NCT02561806|473971550|FG001|Maintenance Period|Site staff became unblinded|1|||
131640735|NCT02561806|473971549|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
131640736|NCT02561806|473971550|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
131640737|NCT02561806|473971549|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
131640738|NCT02561806|473971550|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
131640739|NCT02547441|473971551|FG000|Double-Blind Study Period|Adverse Event|4|||
131640740|NCT02547441|473971552|FG001|Double-Blind Study Period|Adverse Event|9|||
131640741|NCT02547441|473971551|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
131640742|NCT02547441|473971552|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
131640743|NCT02547441|473971551|FG000|Double-Blind Study Period|Physician Decision|1|||
131640744|NCT02547441|473971552|FG001|Double-Blind Study Period|Physician Decision|0|||
131640745|NCT02547441|473971551|FG000|Double-Blind Study Period|Protocol Violation|1|||
131640746|NCT02547441|473971552|FG001|Double-Blind Study Period|Protocol Violation|2|||
131640747|NCT02547441|473971551|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
131640748|NCT02547441|473971552|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
131640749|NCT02547441|473971551|FG000|Double-Blind Study Period|Sponsor Decision|1|||
131640750|NCT02547441|473971552|FG001|Double-Blind Study Period|Sponsor Decision|0|||
131640751|NCT02547441|473971551|FG000|Open-Label Study Period|Adverse Event|10|||
131640752|NCT02547441|473971552|FG001|Open-Label Study Period|Adverse Event|11|||
131640753|NCT02547441|473971551|FG000|Open-Label Study Period|Lack of Efficacy|3|||
131640754|NCT02547441|473971552|FG001|Open-Label Study Period|Lack of Efficacy|2|||
131640755|NCT02547441|473971551|FG000|Open-Label Study Period|Lost to Follow-up|7|||
131640756|NCT02547441|473971552|FG001|Open-Label Study Period|Lost to Follow-up|8|||
131640757|NCT02547441|473971551|FG000|Open-Label Study Period|Physician Decision|1|||
131640758|NCT02547441|473971552|FG001|Open-Label Study Period|Physician Decision|0|||
131640759|NCT02547441|473971551|FG000|Open-Label Study Period|Protocol Violation|2|||
131640760|NCT02547441|473971552|FG001|Open-Label Study Period|Protocol Violation|0|||
131640761|NCT02547441|473971551|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
131640762|NCT02547441|473971552|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
131640763|NCT02547441|473971551|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
131640764|NCT02547441|473971552|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
131640765|NCT01322009|473971554|FG000|Overall Study|Death|0|||
131640766|NCT01322009|473971555|FG001|Overall Study|Death|1|||
131640767|NCT01322009|473971554|FG000|Overall Study|Adverse Event|0|||
131640768|NCT01322009|473971555|FG001|Overall Study|Adverse Event|1|||
131640769|NCT01322009|473971554|FG000|Overall Study|ng tube discontinued|0|||
131640770|NCT01322009|473971555|FG001|Overall Study|ng tube discontinued|1|||
131640771|NCT00905034|473971556|FG000|Overall Study|Withdrawal by Subject|1|||
131640772|NCT00394589|473971557|FG000|Overall Study|Adverse Event|2|||
131640773|NCT00394589|473971558|FG001|Overall Study|Adverse Event|1|||
131640774|NCT00394589|473971559|FG002|Overall Study|Adverse Event|2|||
131640775|NCT00394589|473971557|FG000|Overall Study|Lack of Efficacy|2|||
131640776|NCT00394589|473971558|FG001|Overall Study|Lack of Efficacy|2|||
131640777|NCT00394589|473971559|FG002|Overall Study|Lack of Efficacy|3|||
131640778|NCT00394589|473971557|FG000|Overall Study|Protocol Violation|4|||
131640779|NCT00394589|473971558|FG001|Overall Study|Protocol Violation|0|||
131640780|NCT00394589|473971559|FG002|Overall Study|Protocol Violation|2|||
131640781|NCT04081389|473971561|FG000|Overall Study|Withdrawal by Subject|0|||
131640782|NCT04081389|473971562|FG001|Overall Study|Withdrawal by Subject|0|||
131640783|NCT04081389|473971563|FG002|Overall Study|Withdrawal by Subject|1|||
131640784|NCT04081389|473971564|FG003|Overall Study|Withdrawal by Subject|0|||
131640785|NCT03409731|473971565|FG000|Overall Study|Withdrawal by Subject|17|||
131640786|NCT03409731|473971565|FG000|Overall Study|Death|4|||
131640787|NCT02427958|473971571|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
131640788|NCT02427958|473971571|FG000|Overall Study|Lost to Follow-up|6|||
131640789|NCT02427958|473971571|FG000|Overall Study|Withdrawal by Subject|14|||
131640790|NCT02427958|473971571|FG000|Overall Study|Lack of Efficacy|1|||
131640791|NCT00545571|473971574|FG000|Overall Study|Administrative Reasons|1|||
131640792|NCT00545571|473971574|FG000|Overall Study|Adverse Event|2|||
131640793|NCT00545571|473971574|FG000|Overall Study|Death|5|||
131640794|NCT00545571|473971574|FG000|Overall Study|Lack of Efficacy|1|||
131640795|NCT00545571|473971574|FG000|Overall Study|Protocol Violation|2|||
131799535|NCT02465567|474550366|FG002|Overall Study|Withdrawal by Subject|123|||
131640796|NCT00545571|473971574|FG000|Overall Study|Refused Treatment|1|||
131640797|NCT00545571|473971574|FG000|Overall Study|Screen Failure|16|||
131640798|NCT00545571|473971574|FG000|Overall Study|Transfusion|12|||
131640799|NCT00545571|473971574|FG000|Overall Study|Early Termination of Study|24|||
131640800|NCT00545571|473971574|FG000|Overall Study|Kidney Transplantation|3|||
131640801|NCT01193218|473971575|FG000|0-12 Weeks|Adverse Event|6|||
131640802|NCT01193218|473971576|FG001|0-12 Weeks|Adverse Event|0|||
131640803|NCT01193218|473971577|FG002|0-12 Weeks|Adverse Event|1|||
131640804|NCT01193218|473971578|FG003|0-12 Weeks|Adverse Event|0|||
131640805|NCT01193218|473971579|FG004|0-12 Weeks|Adverse Event|0|||
131640806|NCT01193218|473971580|FG005|0-12 Weeks|Adverse Event|2|||
131640807|NCT01193218|473971581|FG006|0-12 Weeks|Adverse Event|2|||
131640808|NCT01193218|473971582|FG007|0-12 Weeks|Adverse Event|0|||
131640809|NCT01193218|473971575|FG000|0-12 Weeks|Protocol Violation|0|||
131640810|NCT01193218|473971576|FG001|0-12 Weeks|Protocol Violation|0|||
131640811|NCT01193218|473971577|FG002|0-12 Weeks|Protocol Violation|0|||
131640812|NCT01193218|473971578|FG003|0-12 Weeks|Protocol Violation|0|||
131640813|NCT01193218|473971579|FG004|0-12 Weeks|Protocol Violation|1|||
131640814|NCT01193218|473971580|FG005|0-12 Weeks|Protocol Violation|1|||
131640815|NCT01193218|473971581|FG006|0-12 Weeks|Protocol Violation|0|||
131640816|NCT01193218|473971582|FG007|0-12 Weeks|Protocol Violation|0|||
131640817|NCT01193218|473971575|FG000|0-12 Weeks|Withdrawal by Subject|3|||
131640818|NCT01193218|473971576|FG001|0-12 Weeks|Withdrawal by Subject|0|||
131640819|NCT01193218|473971577|FG002|0-12 Weeks|Withdrawal by Subject|2|||
131640820|NCT01193218|473971578|FG003|0-12 Weeks|Withdrawal by Subject|0|||
131640821|NCT01193218|473971579|FG004|0-12 Weeks|Withdrawal by Subject|0|||
131640822|NCT01193218|473971580|FG005|0-12 Weeks|Withdrawal by Subject|0|||
131640823|NCT01193218|473971581|FG006|0-12 Weeks|Withdrawal by Subject|1|||
131640824|NCT01193218|473971582|FG007|0-12 Weeks|Withdrawal by Subject|0|||
131640825|NCT01193218|473971575|FG000|12-52 Weeks|Adverse Event|1|||
131640826|NCT01193218|473971576|FG001|12-52 Weeks|Adverse Event|0|||
131640827|NCT01193218|473971577|FG002|12-52 Weeks|Adverse Event|1|||
131640828|NCT01193218|473971578|FG003|12-52 Weeks|Adverse Event|2|||
131640829|NCT01193218|473971579|FG004|12-52 Weeks|Adverse Event|3|||
131640830|NCT01193218|473971580|FG005|12-52 Weeks|Adverse Event|3|||
131640831|NCT01193218|473971581|FG006|12-52 Weeks|Adverse Event|1|||
131640832|NCT01193218|473971582|FG007|12-52 Weeks|Adverse Event|2|||
131640833|NCT01193218|473971575|FG000|12-52 Weeks|Lack of Efficacy|0|||
131640834|NCT01193218|473971576|FG001|12-52 Weeks|Lack of Efficacy|0|||
131640835|NCT01193218|473971577|FG002|12-52 Weeks|Lack of Efficacy|0|||
131640836|NCT01193218|473971578|FG003|12-52 Weeks|Lack of Efficacy|0|||
131640837|NCT01193218|473971579|FG004|12-52 Weeks|Lack of Efficacy|0|||
131640838|NCT01193218|473971580|FG005|12-52 Weeks|Lack of Efficacy|0|||
131640839|NCT01193218|473971581|FG006|12-52 Weeks|Lack of Efficacy|1|||
131640840|NCT01193218|473971582|FG007|12-52 Weeks|Lack of Efficacy|0|||
131640841|NCT01193218|473971575|FG000|12-52 Weeks|Withdrawal by Subject|3|||
131640842|NCT01193218|473971576|FG001|12-52 Weeks|Withdrawal by Subject|0|||
131640843|NCT01193218|473971577|FG002|12-52 Weeks|Withdrawal by Subject|3|||
131640844|NCT01193218|473971578|FG003|12-52 Weeks|Withdrawal by Subject|0|||
131640845|NCT01193218|473971579|FG004|12-52 Weeks|Withdrawal by Subject|0|||
131640846|NCT01193218|473971580|FG005|12-52 Weeks|Withdrawal by Subject|2|||
131640847|NCT01193218|473971581|FG006|12-52 Weeks|Withdrawal by Subject|1|||
131640848|NCT01193218|473971582|FG007|12-52 Weeks|Withdrawal by Subject|2|||
131640849|NCT01193218|473971575|FG000|12-52 Weeks|Other reason than above|1|||
131640850|NCT01193218|473971576|FG001|12-52 Weeks|Other reason than above|0|||
131640851|NCT01193218|473971577|FG002|12-52 Weeks|Other reason than above|0|||
131640852|NCT01193218|473971578|FG003|12-52 Weeks|Other reason than above|1|||
131640853|NCT01193218|473971579|FG004|12-52 Weeks|Other reason than above|1|||
131640854|NCT01193218|473971580|FG005|12-52 Weeks|Other reason than above|0|||
131640855|NCT01193218|473971581|FG006|12-52 Weeks|Other reason than above|0|||
131640856|NCT01193218|473971582|FG007|12-52 Weeks|Other reason than above|0|||
131640857|NCT01013740|473971583|FG000|Overall Study|Lost to Follow-up|3|||
131640858|NCT01013740|473971584|FG001|Overall Study|Lost to Follow-up|5|||
131640859|NCT01013740|473971583|FG000|Overall Study|Physician Decision|2|||
131640860|NCT01013740|473971584|FG001|Overall Study|Physician Decision|0|||
131640861|NCT01013740|473971583|FG000|Overall Study|Withdrawal by Subject|2|||
131640862|NCT01013740|473971584|FG001|Overall Study|Withdrawal by Subject|10|||
131714854|NCT00809133|474233709|FG003|Overall Study|Consent withdrawn|0|||
131640863|NCT01013740|473971583|FG000|Overall Study|study close / terminated : done in error|2|||
131640864|NCT01013740|473971584|FG001|Overall Study|study close / terminated : done in error|1|||
131640865|NCT01013740|473971583|FG000|Overall Study|Missing|2|||
131714855|NCT00809133|474233710|FG004|Overall Study|Consent withdrawn|1|||
131714856|NCT00809133|474233711|FG005|Overall Study|Consent withdrawn|0|||
131714857|NCT00809133|474233712|FG006|Overall Study|Consent withdrawn|0|||
131640866|NCT01013740|473971584|FG001|Overall Study|Missing|1|||
131640867|NCT01013740|473971583|FG000|Overall Study|Ongoing: Study records not completed|0|||
131640868|NCT01013740|473971584|FG001|Overall Study|Ongoing: Study records not completed|2|||
131640869|NCT00338949|473971585|FG000|Subject Screening|Screen failures|11|||
131640870|NCT00338949|473971586|FG001|Subject Screening|Screen failures|11|||
131640871|NCT00338949|473971585|FG000|Randomization|Withdrawal by Subject|1|||
131640872|NCT00338949|473971586|FG001|Randomization|Withdrawal by Subject|0|||
131640873|NCT00338949|473971585|FG000|Randomization|Adverse Event|0|||
131640874|NCT00338949|473971586|FG001|Randomization|Adverse Event|5|||
131640875|NCT03811834|473971587|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
131640876|NCT01242371|473971588|FG000|Overall Study|Withdrawal by Subject|2|||
131640877|NCT01242371|473971589|FG001|Overall Study|Withdrawal by Subject|2|||
131640878|NCT01242371|473971588|FG000|Overall Study|Protocol Violation|0|||
131640879|NCT01242371|473971589|FG001|Overall Study|Protocol Violation|3|||
131640880|NCT00025662|473971590|FG000|Overall Study|Withdrawal by Subject|2|||
131640881|NCT00025662|473971590|FG000|Overall Study|Technical failure of manipulation|1|||
131640882|NCT01215032|473971591|FG000|Overall Study|Adverse Event|3|||
131640883|NCT01215032|473971591|FG000|Overall Study|Lack of Efficacy|17|||
131640884|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
131640885|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
131640886|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
131640887|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
131640888|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
131640889|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
131640890|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
131640891|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
131640892|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
131640893|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
131640894|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
131640895|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
131640896|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
131640897|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
131640898|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
131640899|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
131640900|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
131640901|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
131640902|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
131640903|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
131640904|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
131640905|NCT01125566|473971592|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
131640906|NCT01125566|473971593|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
131640907|NCT01125566|473971594|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
131640908|NCT01125566|473971592|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
131640909|NCT01125566|473971593|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
131640910|NCT01125566|473971594|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
131640911|NCT01125566|473971592|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
131640912|NCT01125566|473971593|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
131640913|NCT01125566|473971594|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
131640914|NCT01125566|473971592|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
131640915|NCT01125566|473971593|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
131640916|NCT01125566|473971594|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
131640917|NCT01125566|473971592|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
131640918|NCT01125566|473971593|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
131640919|NCT01125566|473971594|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
131640920|NCT02484547|473971597|FG000|Placebo-Controlled Period|Adverse Event|10|||
131640921|NCT02484547|473971598|FG001|Placebo-Controlled Period|Adverse Event|13|||
131640922|NCT02484547|473971599|FG002|Placebo-Controlled Period|Adverse Event|20|||
131640923|NCT02484547|473971600|FG003|Placebo-Controlled Period|Adverse Event|0|||
131640924|NCT02484547|473971601|FG004|Placebo-Controlled Period|Adverse Event|0|||
131640925|NCT02484547|473971602|FG005|Placebo-Controlled Period|Adverse Event|0|||
131640926|NCT02484547|473971603|FG006|Placebo-Controlled Period|Adverse Event|0|||
131640927|NCT02484547|473971597|FG000|Placebo-Controlled Period|Change of Treatment|0|||
131640928|NCT02484547|473971598|FG001|Placebo-Controlled Period|Change of Treatment|0|||
131640929|NCT02484547|473971599|FG002|Placebo-Controlled Period|Change of Treatment|1|||
131640930|NCT02484547|473971600|FG003|Placebo-Controlled Period|Change of Treatment|0|||
131640931|NCT02484547|473971601|FG004|Placebo-Controlled Period|Change of Treatment|0|||
131640932|NCT02484547|473971602|FG005|Placebo-Controlled Period|Change of Treatment|0|||
131640933|NCT02484547|473971603|FG006|Placebo-Controlled Period|Change of Treatment|0|||
131640934|NCT02484547|473971597|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
131640935|NCT02484547|473971598|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
131640936|NCT02484547|473971599|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
131640937|NCT02484547|473971600|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
131640938|NCT02484547|473971601|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
131640939|NCT02484547|473971602|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
131640940|NCT02484547|473971603|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
131902747|NCT02573259|474929385|FG004|Overall Study|Death|9|||
131902748|NCT02573259|474929386|FG005|Overall Study|Death|32|||
131640941|NCT02484547|473971597|FG000|Placebo-Controlled Period|Death|5|||
131640942|NCT02484547|473971598|FG001|Placebo-Controlled Period|Death|0|||
131640943|NCT02484547|473971599|FG002|Placebo-Controlled Period|Death|6|||
131640944|NCT02484547|473971600|FG003|Placebo-Controlled Period|Death|0|||
131640945|NCT02484547|473971601|FG004|Placebo-Controlled Period|Death|0|||
131640946|NCT02484547|473971602|FG005|Placebo-Controlled Period|Death|0|||
131640947|NCT02484547|473971603|FG006|Placebo-Controlled Period|Death|0|||
131640948|NCT02484547|473971597|FG000|Placebo-Controlled Period|Disease Progression|2|||
131640949|NCT02484547|473971598|FG001|Placebo-Controlled Period|Disease Progression|0|||
131640950|NCT02484547|473971599|FG002|Placebo-Controlled Period|Disease Progression|1|||
131640951|NCT02484547|473971600|FG003|Placebo-Controlled Period|Disease Progression|0|||
131640952|NCT02484547|473971601|FG004|Placebo-Controlled Period|Disease Progression|0|||
131640953|NCT02484547|473971602|FG005|Placebo-Controlled Period|Disease Progression|0|||
131640954|NCT02484547|473971603|FG006|Placebo-Controlled Period|Disease Progression|0|||
131640955|NCT02484547|473971597|FG000|Placebo-Controlled Period|Investigator Decision|2|||
131640956|NCT02484547|473971598|FG001|Placebo-Controlled Period|Investigator Decision|2|||
131640957|NCT02484547|473971599|FG002|Placebo-Controlled Period|Investigator Decision|5|||
131640958|NCT02484547|473971600|FG003|Placebo-Controlled Period|Investigator Decision|0|||
131640959|NCT02484547|473971601|FG004|Placebo-Controlled Period|Investigator Decision|0|||
131640960|NCT02484547|473971602|FG005|Placebo-Controlled Period|Investigator Decision|0|||
131640961|NCT02484547|473971603|FG006|Placebo-Controlled Period|Investigator Decision|0|||
131640962|NCT02484547|473971597|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
131640963|NCT02484547|473971598|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
131640964|NCT02484547|473971599|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
131640965|NCT02484547|473971600|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
131640966|NCT02484547|473971601|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
131640967|NCT02484547|473971602|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
131640968|NCT02484547|473971603|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
131640969|NCT02484547|473971597|FG000|Placebo-Controlled Period|Relocation|1|||
131640970|NCT02484547|473971598|FG001|Placebo-Controlled Period|Relocation|1|||
131640971|NCT02484547|473971599|FG002|Placebo-Controlled Period|Relocation|1|||
131640972|NCT02484547|473971600|FG003|Placebo-Controlled Period|Relocation|0|||
131640973|NCT02484547|473971601|FG004|Placebo-Controlled Period|Relocation|0|||
131640974|NCT02484547|473971602|FG005|Placebo-Controlled Period|Relocation|0|||
131640975|NCT02484547|473971603|FG006|Placebo-Controlled Period|Relocation|0|||
131640976|NCT02484547|473971597|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
131640977|NCT02484547|473971598|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
131640978|NCT02484547|473971599|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
131640979|NCT02484547|473971600|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
131640980|NCT02484547|473971601|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
131640981|NCT02484547|473971602|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
131640982|NCT02484547|473971603|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
131640983|NCT02484547|473971597|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
131640984|NCT02484547|473971598|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131640985|NCT02484547|473971599|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131640986|NCT02484547|473971600|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131640987|NCT02484547|473971601|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131640988|NCT02484547|473971602|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131640989|NCT02484547|473971603|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131640990|NCT02484547|473971597|FG000|Placebo-Controlled Period|Reason not Specified|216|||
131640991|NCT02484547|473971598|FG001|Placebo-Controlled Period|Reason not Specified|194|||
131714858|NCT00809133|474233713|FG007|Overall Study|Consent withdrawn|0|||
131714859|NCT00809133|474233714|FG008|Overall Study|Consent withdrawn|0|||
131714860|NCT00809133|474233715|FG009|Overall Study|Consent withdrawn|0|||
131714861|NCT00809133|474233716|FG010|Overall Study|Consent withdrawn|0|||
131714862|NCT00809133|474233717|FG011|Overall Study|Consent withdrawn|0|||
131714863|NCT00809133|474233718|FG012|Overall Study|Consent withdrawn|0|||
131714864|NCT00809133|474233719|FG013|Overall Study|Consent withdrawn|0|||
131714865|NCT00809133|474233706|FG000|Overall Study|Other not mentioned above|0|||
131714866|NCT00809133|474233707|FG001|Overall Study|Other not mentioned above|1|||
131714867|NCT00809133|474233708|FG002|Overall Study|Other not mentioned above|0|||
131902749|NCT02573259|474929387|FG006|Overall Study|Death|21|||
131640992|NCT02484547|473971599|FG002|Placebo-Controlled Period|Reason not Specified|183|||
131640993|NCT02484547|473971600|FG003|Placebo-Controlled Period|Reason not Specified|0|||
131640994|NCT02484547|473971601|FG004|Placebo-Controlled Period|Reason not Specified|0|||
131902750|NCT02573259|474929381|FG000|Overall Study|Lost to Follow-up|0|||
131640995|NCT02484547|473971602|FG005|Placebo-Controlled Period|Reason not Specified|0|||
131640996|NCT02484547|473971603|FG006|Placebo-Controlled Period|Reason not Specified|0|||
131640997|NCT02484547|473971597|FG000|Long-Term Extension Period|Adverse Event|0|||
131640998|NCT02484547|473971598|FG001|Long-Term Extension Period|Adverse Event|0|||
131714868|NCT00809133|474233709|FG003|Overall Study|Other not mentioned above|0|||
131640999|NCT02484547|473971599|FG002|Long-Term Extension Period|Adverse Event|0|||
131641000|NCT02484547|473971600|FG003|Long-Term Extension Period|Adverse Event|0|||
131641001|NCT02484547|473971601|FG004|Long-Term Extension Period|Adverse Event|1|||
131641002|NCT02484547|473971602|FG005|Long-Term Extension Period|Adverse Event|3|||
131641003|NCT02484547|473971603|FG006|Long-Term Extension Period|Adverse Event|2|||
131641004|NCT02484547|473971597|FG000|Long-Term Extension Period|Death|0|||
131641005|NCT02484547|473971598|FG001|Long-Term Extension Period|Death|0|||
131641006|NCT02484547|473971599|FG002|Long-Term Extension Period|Death|0|||
131641007|NCT02484547|473971600|FG003|Long-Term Extension Period|Death|0|||
131641008|NCT02484547|473971601|FG004|Long-Term Extension Period|Death|0|||
131641009|NCT02484547|473971602|FG005|Long-Term Extension Period|Death|3|||
131641010|NCT02484547|473971603|FG006|Long-Term Extension Period|Death|0|||
131641011|NCT02484547|473971597|FG000|Long-Term Extension Period|Disease Progression|0|||
131641012|NCT02484547|473971598|FG001|Long-Term Extension Period|Disease Progression|0|||
131641013|NCT02484547|473971599|FG002|Long-Term Extension Period|Disease Progression|0|||
131641014|NCT02484547|473971600|FG003|Long-Term Extension Period|Disease Progression|0|||
131641015|NCT02484547|473971601|FG004|Long-Term Extension Period|Disease Progression|2|||
131641016|NCT02484547|473971602|FG005|Long-Term Extension Period|Disease Progression|4|||
131641017|NCT02484547|473971603|FG006|Long-Term Extension Period|Disease Progression|0|||
131641018|NCT02484547|473971597|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
131641019|NCT02484547|473971598|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
131641020|NCT02484547|473971599|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
131641021|NCT02484547|473971600|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
131641022|NCT02484547|473971601|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
131641023|NCT02484547|473971602|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
131641024|NCT02484547|473971603|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
131641025|NCT02484547|473971597|FG000|Long-Term Extension Period|Loss of Capacity|0|||
131641026|NCT02484547|473971598|FG001|Long-Term Extension Period|Loss of Capacity|0|||
131641027|NCT02484547|473971599|FG002|Long-Term Extension Period|Loss of Capacity|0|||
131641028|NCT02484547|473971600|FG003|Long-Term Extension Period|Loss of Capacity|0|||
131641029|NCT02484547|473971601|FG004|Long-Term Extension Period|Loss of Capacity|1|||
131641030|NCT02484547|473971602|FG005|Long-Term Extension Period|Loss of Capacity|0|||
131641031|NCT02484547|473971603|FG006|Long-Term Extension Period|Loss of Capacity|0|||
131641032|NCT02484547|473971597|FG000|Long-Term Extension Period|Change of Treatment|0|||
131641033|NCT02484547|473971598|FG001|Long-Term Extension Period|Change of Treatment|0|||
131641034|NCT02484547|473971599|FG002|Long-Term Extension Period|Change of Treatment|0|||
131641035|NCT02484547|473971600|FG003|Long-Term Extension Period|Change of Treatment|0|||
131641036|NCT02484547|473971601|FG004|Long-Term Extension Period|Change of Treatment|0|||
131641037|NCT02484547|473971602|FG005|Long-Term Extension Period|Change of Treatment|0|||
131641038|NCT02484547|473971603|FG006|Long-Term Extension Period|Change of Treatment|1|||
131641039|NCT02484547|473971597|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
131641040|NCT02484547|473971598|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
131641041|NCT02484547|473971599|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
131641042|NCT02484547|473971600|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
131641043|NCT02484547|473971601|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
131714869|NCT00809133|474233710|FG004|Overall Study|Other not mentioned above|0|||
131714870|NCT00809133|474233711|FG005|Overall Study|Other not mentioned above|1|||
131714871|NCT00809133|474233712|FG006|Overall Study|Other not mentioned above|0|||
131714872|NCT00809133|474233713|FG007|Overall Study|Other not mentioned above|0|||
131714873|NCT00809133|474233714|FG008|Overall Study|Other not mentioned above|0|||
131714874|NCT00809133|474233715|FG009|Overall Study|Other not mentioned above|0|||
131714875|NCT00809133|474233716|FG010|Overall Study|Other not mentioned above|0|||
131714876|NCT00809133|474233717|FG011|Overall Study|Other not mentioned above|0|||
131714877|NCT00809133|474233718|FG012|Overall Study|Other not mentioned above|0|||
131714878|NCT00809133|474233719|FG013|Overall Study|Other not mentioned above|0|||
131714879|NCT00833092|474233720|FG000|Overall Study|Withdrawal by Subject|2|||
131714880|NCT00833092|474233721|FG001|Overall Study|Withdrawal by Subject|3|||
131714881|NCT00833092|474233720|FG000|Overall Study|Protocol Violation|2|||
131714882|NCT00833092|474233721|FG001|Overall Study|Protocol Violation|1|||
131714883|NCT00833092|474233720|FG000|Overall Study|Diarrhea|0|||
131714884|NCT00833092|474233721|FG001|Overall Study|Diarrhea|2|||
131714885|NCT00833092|474233720|FG000|Overall Study|constipation|0|||
131714886|NCT00833092|474233721|FG001|Overall Study|constipation|1|||
131714887|NCT00699192|474233722|FG000|Overall Study|Missing|1|||
131714888|NCT00699192|474233723|FG001|Overall Study|Missing|1|||
131714889|NCT00699192|474233724|FG002|Overall Study|Missing|1|||
131902751|NCT02573259|474929382|FG001|Overall Study|Lost to Follow-up|0|||
131641044|NCT02484547|473971602|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
131641045|NCT02484547|473971603|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
131641046|NCT02484547|473971597|FG000|Long-Term Extension Period|Investigator Decision|0|||
131641047|NCT02484547|473971598|FG001|Long-Term Extension Period|Investigator Decision|0|||
131714890|NCT00699192|474233722|FG000|Overall Study|Adverse Event|9|||
131714891|NCT00699192|474233723|FG001|Overall Study|Adverse Event|4|||
131714892|NCT00699192|474233724|FG002|Overall Study|Adverse Event|3|||
131641048|NCT02484547|473971599|FG002|Long-Term Extension Period|Investigator Decision|0|||
131641049|NCT02484547|473971600|FG003|Long-Term Extension Period|Investigator Decision|2|||
131641050|NCT02484547|473971601|FG004|Long-Term Extension Period|Investigator Decision|1|||
131641051|NCT02484547|473971602|FG005|Long-Term Extension Period|Investigator Decision|0|||
131641052|NCT02484547|473971603|FG006|Long-Term Extension Period|Investigator Decision|1|||
131641053|NCT02484547|473971597|FG000|Long-Term Extension Period|Relocation|0|||
131641054|NCT02484547|473971598|FG001|Long-Term Extension Period|Relocation|0|||
131641055|NCT02484547|473971599|FG002|Long-Term Extension Period|Relocation|0|||
131641056|NCT02484547|473971600|FG003|Long-Term Extension Period|Relocation|1|||
131641057|NCT02484547|473971601|FG004|Long-Term Extension Period|Relocation|1|||
131641058|NCT02484547|473971602|FG005|Long-Term Extension Period|Relocation|0|||
131641059|NCT02484547|473971603|FG006|Long-Term Extension Period|Relocation|0|||
131641060|NCT02484547|473971597|FG000|Long-Term Extension Period|Study Visit Burden|0|||
131641061|NCT02484547|473971598|FG001|Long-Term Extension Period|Study Visit Burden|0|||
131641062|NCT02484547|473971599|FG002|Long-Term Extension Period|Study Visit Burden|0|||
131641063|NCT02484547|473971600|FG003|Long-Term Extension Period|Study Visit Burden|2|||
131641064|NCT02484547|473971601|FG004|Long-Term Extension Period|Study Visit Burden|0|||
131641065|NCT02484547|473971602|FG005|Long-Term Extension Period|Study Visit Burden|0|||
131641066|NCT02484547|473971603|FG006|Long-Term Extension Period|Study Visit Burden|3|||
131641067|NCT02484547|473971597|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131641068|NCT02484547|473971598|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131641069|NCT02484547|473971599|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131641070|NCT02484547|473971600|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131641071|NCT02484547|473971601|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
131641072|NCT02484547|473971602|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
131641073|NCT02484547|473971603|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
131641074|NCT02484547|473971597|FG000|Long-Term Extension Period|Reason not Specified|0|||
131641075|NCT02484547|473971598|FG001|Long-Term Extension Period|Reason not Specified|0|||
131641076|NCT02484547|473971599|FG002|Long-Term Extension Period|Reason not Specified|0|||
131641077|NCT02484547|473971600|FG003|Long-Term Extension Period|Reason not Specified|119|||
131641078|NCT02484547|473971601|FG004|Long-Term Extension Period|Reason not Specified|117|||
131641079|NCT02484547|473971602|FG005|Long-Term Extension Period|Reason not Specified|223|||
131641080|NCT02484547|473971603|FG006|Long-Term Extension Period|Reason not Specified|231|||
131641081|NCT01813305|473971604|FG000|Overall Study|Withdrawal by Subject|12|||
131641082|NCT01813305|473971605|FG001|Overall Study|Withdrawal by Subject|5|||
131641083|NCT01813305|473971604|FG000|Overall Study|Safety Concern|4|||
131641084|NCT01813305|473971605|FG001|Overall Study|Safety Concern|0|||
131641085|NCT01813305|473971604|FG000|Overall Study|Ulcer became worse|4|||
131641086|NCT01813305|473971605|FG001|Overall Study|Ulcer became worse|0|||
131641087|NCT01813305|473971604|FG000|Overall Study|Physician Decision|4|||
131641088|NCT01813305|473971605|FG001|Overall Study|Physician Decision|0|||
131641089|NCT01813305|473971604|FG000|Overall Study|Lost to Follow-up|3|||
131641090|NCT01813305|473971605|FG001|Overall Study|Lost to Follow-up|1|||
131641091|NCT01813305|473971604|FG000|Overall Study|Protocol Violation|1|||
131641092|NCT01813305|473971605|FG001|Overall Study|Protocol Violation|0|||
131641093|NCT01813305|473971604|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
131641094|NCT01813305|473971605|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
131641095|NCT01665599|473971606|FG000|Overall Study|Adverse Event|1|||
131641096|NCT01665599|473971606|FG000|Overall Study|Consent Withdrawn|1|||
131641097|NCT01665599|473971606|FG000|Overall Study|Investigator/Sponsor decision|1|||
131641098|NCT01665599|473971606|FG000|Overall Study|Death|1|||
131641099|NCT01665599|473971606|FG000|Overall Study|Lost to Follow-up|2|||
131641100|NCT01665599|473971606|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
131641101|NCT01665599|473971606|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
131641102|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
131641103|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
131641104|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
131641105|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
131641106|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
131641107|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
131641108|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
131641109|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
131641110|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
131641111|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
131714893|NCT00699192|474233722|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131641112|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
131641113|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
131641114|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
131641115|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
131641116|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
131641117|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
131641118|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
131641119|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
131641120|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
131641121|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
131641122|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
131641123|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
131641124|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
131641125|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
131641126|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
131641127|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
131641128|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
131641129|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
131641130|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
131641131|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
131641132|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
131641133|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
131641134|NCT00092521|473972934|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
131641135|NCT00092521|473972935|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
131641136|NCT00092521|473972936|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
131641137|NCT00092521|473972937|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
131641138|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
131641139|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
131641140|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
131641141|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
131641142|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
131641143|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
131641144|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
131641145|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
131641146|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
131641147|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
131641148|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
131641149|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
131641150|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Death|2|||
131641151|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Death|0|||
131641152|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Death|1|||
131641153|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Death|0|||
131641154|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
131641155|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
131641156|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
131641157|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
131641158|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
131641159|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
131641160|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
131641161|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
131641162|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
131641163|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
131641164|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
131641165|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
131641166|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Moved|32|||
131641167|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Moved|2|||
131641168|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Moved|28|||
131641169|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Moved|0|||
131641170|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
131641171|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
131641172|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
131641173|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
131641174|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Travel|2|||
131641175|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Travel|0|||
131641176|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Travel|0|||
131641177|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Travel|0|||
131641178|NCT00092521|473972934|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
131641179|NCT00092521|473972935|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
131641180|NCT00092521|473972936|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
131641181|NCT00092521|473972937|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
131641182|NCT00092521|473972934|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
131641183|NCT00092521|473972935|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
131641184|NCT00092521|473972936|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
131641185|NCT00092521|473972937|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
131641186|NCT00092521|473972934|FG000|Extension Study (Group 4)|Adverse Event|0|||
131641187|NCT00092521|473972935|FG001|Extension Study (Group 4)|Adverse Event|0|||
131641188|NCT00092521|473972936|FG002|Extension Study (Group 4)|Adverse Event|0|||
131641189|NCT00092521|473972937|FG003|Extension Study (Group 4)|Adverse Event|2|||
131641190|NCT00092521|473972934|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
131641191|NCT00092521|473972935|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
131641192|NCT00092521|473972936|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
131641193|NCT00092521|473972937|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
131641194|NCT00092521|473972934|FG000|Extension Study (Group 4)|Pregnancy|0|||
131641195|NCT00092521|473972935|FG001|Extension Study (Group 4)|Pregnancy|0|||
131641196|NCT00092521|473972936|FG002|Extension Study (Group 4)|Pregnancy|0|||
131641197|NCT00092521|473972937|FG003|Extension Study (Group 4)|Pregnancy|4|||
131641198|NCT00092521|473972934|FG000|Extension Study (Group 4)|Protocol Violation|0|||
131641199|NCT00092521|473972935|FG001|Extension Study (Group 4)|Protocol Violation|0|||
131641200|NCT00092521|473972936|FG002|Extension Study (Group 4)|Protocol Violation|0|||
131641201|NCT00092521|473972937|FG003|Extension Study (Group 4)|Protocol Violation|2|||
131641202|NCT00092521|473972934|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
131641203|NCT00092521|473972935|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
131641204|NCT00092521|473972936|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
131641205|NCT00092521|473972937|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
131641206|NCT00092521|473972934|FG000|Extension Study (Group 4)|Moved|0|||
131641207|NCT00092521|473972935|FG001|Extension Study (Group 4)|Moved|0|||
131641208|NCT00092521|473972936|FG002|Extension Study (Group 4)|Moved|0|||
131641209|NCT00092521|473972937|FG003|Extension Study (Group 4)|Moved|16|||
131641210|NCT00092521|473972934|FG000|Extension Study (Group 4)|Site Terminated|0|||
131641211|NCT00092521|473972935|FG001|Extension Study (Group 4)|Site Terminated|0|||
131641212|NCT00092521|473972936|FG002|Extension Study (Group 4)|Site Terminated|0|||
131641213|NCT00092521|473972937|FG003|Extension Study (Group 4)|Site Terminated|4|||
131641214|NCT00092521|473972934|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
131641215|NCT00092521|473972935|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
131641216|NCT00092521|473972936|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
131641217|NCT00092521|473972937|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
131641218|NCT03464383|473972938|FG000|Overall Study|Lost to Follow-up|1|||
131641219|NCT03464383|473972939|FG001|Overall Study|Lost to Follow-up|0|||
131641220|NCT03464383|473972940|FG002|Overall Study|Lost to Follow-up|0|||
131641221|NCT03464383|473972938|FG000|Overall Study|Withdrawal by Subject|0|||
131641222|NCT03464383|473972939|FG001|Overall Study|Withdrawal by Subject|1|||
131641223|NCT03464383|473972940|FG002|Overall Study|Withdrawal by Subject|0|||
131641224|NCT00605566|473972941|FG000|Overall Study|Adverse Event|1|||
131641225|NCT00605566|473972941|FG000|Overall Study|Clinical deterioration|1|||
131641226|NCT00605566|473972941|FG000|Overall Study|Poor compliance in run-in period|1|||
131799536|NCT02465567|474550367|FG003|Overall Study|Withdrawal by Subject|130|||
131799537|NCT02465567|474550364|FG000|Overall Study|Physician Decision|23|||
131799538|NCT02465567|474550365|FG001|Overall Study|Physician Decision|33|||
131799539|NCT02465567|474550366|FG002|Overall Study|Physician Decision|38|||
131799540|NCT02465567|474550367|FG003|Overall Study|Physician Decision|28|||
131799541|NCT02465567|474550364|FG000|Overall Study|Major Protocol Deviation|24|||
131799542|NCT02465567|474550365|FG001|Overall Study|Major Protocol Deviation|26|||
131799543|NCT02465567|474550366|FG002|Overall Study|Major Protocol Deviation|22|||
131799544|NCT02465567|474550367|FG003|Overall Study|Major Protocol Deviation|25|||
131799545|NCT02465567|474550364|FG000|Overall Study|Lost to Follow-up|25|||
131799546|NCT02465567|474550365|FG001|Overall Study|Lost to Follow-up|21|||
131799547|NCT02465567|474550366|FG002|Overall Study|Lost to Follow-up|19|||
131799548|NCT02465567|474550367|FG003|Overall Study|Lost to Follow-up|15|||
131902752|NCT02573259|474929383|FG002|Overall Study|Lost to Follow-up|0|||
131902753|NCT02573259|474929384|FG003|Overall Study|Lost to Follow-up|0|||
131902754|NCT02573259|474929385|FG004|Overall Study|Lost to Follow-up|0|||
131902755|NCT02573259|474929386|FG005|Overall Study|Lost to Follow-up|2|||
131902756|NCT02573259|474929387|FG006|Overall Study|Lost to Follow-up|1|||
131902757|NCT02573259|474929381|FG000|Overall Study|Participant refused further follow-up|0|||
131902758|NCT02573259|474929382|FG001|Overall Study|Participant refused further follow-up|2|||
131902759|NCT02573259|474929383|FG002|Overall Study|Participant refused further follow-up|1|||
131902760|NCT02573259|474929384|FG003|Overall Study|Participant refused further follow-up|0|||
131902761|NCT02573259|474929385|FG004|Overall Study|Participant refused further follow-up|3|||
131902762|NCT02573259|474929386|FG005|Overall Study|Participant refused further follow-up|20|||
131902763|NCT02573259|474929387|FG006|Overall Study|Participant refused further follow-up|7|||
131641227|NCT02210208|473972945|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
131902764|NCT02573259|474929381|FG000|Overall Study|Other|0|||
131641228|NCT02210208|473972945|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
131641229|NCT02210208|473972945|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
131902765|NCT02573259|474929382|FG001|Overall Study|Other|0|||
131641230|NCT01171183|473972946|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
131641231|NCT01171183|473972947|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
131641232|NCT01171183|473972946|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
131799549|NCT02465567|474550364|FG000|Overall Study|Protocol Specified Criteria|20|||
131799550|NCT02465567|474550365|FG001|Overall Study|Protocol Specified Criteria|10|||
131902766|NCT02573259|474929383|FG002|Overall Study|Other|0|||
131641233|NCT01171183|473972947|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
131641234|NCT01171183|473972946|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
131641235|NCT01171183|473972947|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
131641236|NCT01171183|473972946|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
131902767|NCT02573259|474929384|FG003|Overall Study|Other|0|||
131641237|NCT01171183|473972947|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
131641238|NCT01171183|473972946|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
131641239|NCT01171183|473972947|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
131641240|NCT01171183|473972946|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
131641241|NCT01171183|473972947|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
131641242|NCT01066936|473972952|FG000|Overall Study|Death|2|||
131641243|NCT01066936|473972952|FG000|Overall Study|Device revised/removed|1|||
131641244|NCT01066936|473972952|FG000|Overall Study|Lost to Follow-up|3|||
131641245|NCT01066936|473972952|FG000|Overall Study|Withdrawal by Subject|4|||
131641246|NCT00695136|473972953|FG000|Overall Study|Withdrawal by Subject|1|||
131641247|NCT00695136|473972953|FG000|Overall Study|unrelated adverse event|1|||
131641248|NCT01726049|473972955|FG000|Overall Study|Death|1|||
131641249|NCT01726049|473972956|FG001|Overall Study|Death|1|||
131641250|NCT01726049|473972955|FG000|Overall Study|Adverse Event|4|||
131641251|NCT01726049|473972956|FG001|Overall Study|Adverse Event|1|||
131641252|NCT01726049|473972955|FG000|Overall Study|refused second HC|0|||
131641253|NCT01726049|473972956|FG001|Overall Study|refused second HC|2|||
131641254|NCT02826798|473972958|FG000|Overall Study|Withdrawal by Subject|0|||
131641255|NCT02826798|473972959|FG001|Overall Study|Withdrawal by Subject|1|||
131641256|NCT02826798|473972960|FG002|Overall Study|Withdrawal by Subject|0|||
131641257|NCT02826798|473972961|FG003|Overall Study|Withdrawal by Subject|1|||
131641258|NCT02826798|473972962|FG004|Overall Study|Withdrawal by Subject|0|||
131641259|NCT02806505|473972963|FG000|Overall Study|Adverse event/intercurrent illness|1|||
131641260|NCT02806505|473972964|FG001|Overall Study|Adverse event/intercurrent illness|3|||
131641261|NCT02806505|473972963|FG000|Overall Study|Death|4|||
131641262|NCT02806505|473972964|FG001|Overall Study|Death|0|||
131641263|NCT02806505|473972963|FG000|Overall Study|Did not cooperate/refused treatment|3|||
131641264|NCT02806505|473972964|FG001|Overall Study|Did not cooperate/refused treatment|3|||
131641265|NCT02806505|473972963|FG000|Overall Study|Failure to return|0|||
131641266|NCT02806505|473972964|FG001|Overall Study|Failure to return|1|||
131641267|NCT02806505|473972963|FG000|Overall Study|Insufficient therapeutic response|2|||
131641268|NCT02806505|473972964|FG001|Overall Study|Insufficient therapeutic response|4|||
131641269|NCT04156399|473972971|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
131641270|NCT04156399|473972971|FG000|Overall Study|study suspension due to COVID pandemic|3|||
131641271|NCT03440047|473972972|FG000|Overall Study|Withdrawal by Subject|2|||
131641272|NCT01181609|473972973|FG000|Overall Study|Adverse Event|1|||
131641273|NCT01181609|473972973|FG000|Overall Study|Withdrawal by Subject|1|||
131641274|NCT01181609|473972973|FG000|Overall Study|Lost to Follow-up|1|||
131641275|NCT01181609|473972973|FG000|Overall Study|Death|50|||
131641276|NCT01722045|473972974|FG000|Overall Study|Adverse Event|8|||
131641277|NCT01722045|473972974|FG000|Overall Study|Death|3|||
131641278|NCT01722045|473972974|FG000|Overall Study|Withdrawal by Subject|8|||
131641279|NCT01722045|473972974|FG000|Overall Study|Lost to Follow-up|4|||
131641280|NCT01722045|473972974|FG000|Overall Study|Protocol Deviation|1|||
131641281|NCT01722045|473972974|FG000|Overall Study|Physician Decision|3|||
131641282|NCT01722045|473972974|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
131641283|NCT01333111|473972977|FG000|Overall Study|patient undergoing major surgery|0|||
131641284|NCT01333111|473972978|FG001|Overall Study|patient undergoing major surgery|2|||
131902768|NCT02573259|474929385|FG004|Overall Study|Other|1|||
131641285|NCT01333111|473972979|FG002|Overall Study|patient undergoing major surgery|0|||
131714894|NCT00699192|474233723|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131714895|NCT00699192|474233724|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131714896|NCT00699192|474233722|FG000|Overall Study|Lack of Efficacy|0|||
131714897|NCT00699192|474233723|FG001|Overall Study|Lack of Efficacy|0|||
131714898|NCT00699192|474233724|FG002|Overall Study|Lack of Efficacy|1|||
131714899|NCT00699192|474233722|FG000|Overall Study|Withdrawal by Subject|3|||
131714900|NCT00699192|474233723|FG001|Overall Study|Withdrawal by Subject|2|||
131902769|NCT02573259|474929386|FG005|Overall Study|Other|4|||
131902770|NCT02573259|474929387|FG006|Overall Study|Other|5|||
131902771|NCT01817075|474929390|FG000|Overall Study|Adverse Event|7|||
131902772|NCT01817075|474929391|FG001|Overall Study|Adverse Event|5|||
131902773|NCT01817075|474929390|FG000|Overall Study|Physician Decision|9|||
131902774|NCT01817075|474929391|FG001|Overall Study|Physician Decision|12|||
131902775|NCT01817075|474929390|FG000|Overall Study|Withdrawal by Subject|31|||
131902776|NCT01817075|474929391|FG001|Overall Study|Withdrawal by Subject|15|||
131902777|NCT01817075|474929390|FG000|Overall Study|Received Sorafenib after enrollment|0|||
131902778|NCT01817075|474929391|FG001|Overall Study|Received Sorafenib after enrollment|1|||
131902779|NCT01817075|474929390|FG000|Overall Study|Ineligible|0|||
131902780|NCT01817075|474929391|FG001|Overall Study|Ineligible|2|||
131902781|NCT03163446|474931290|FG000|Overall Study|Unable to return for Day 180 visit|2|||
131902782|NCT03163446|474931291|FG001|Overall Study|Unable to return for Day 180 visit|0|||
131902783|NCT03163446|474931290|FG000|Overall Study|Withdrawal by Subject|2|||
131902784|NCT03163446|474931291|FG001|Overall Study|Withdrawal by Subject|6|||
131902785|NCT03163446|474931290|FG000|Overall Study|Death|16|||
131902786|NCT03163446|474931291|FG001|Overall Study|Death|5|||
131902787|NCT03163446|474931290|FG000|Overall Study|Lost to Follow-up|6|||
131902788|NCT03163446|474931291|FG001|Overall Study|Lost to Follow-up|5|||
131902789|NCT03163446|474931290|FG000|Overall Study|Physician Decision|1|||
131902790|NCT03163446|474931291|FG001|Overall Study|Physician Decision|1|||
131902791|NCT03163446|474931290|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
131902792|NCT03163446|474931291|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
131902793|NCT01317641|474931292|FG000|Overall Study|Not treated|0|||
131902794|NCT01317641|474931293|FG001|Overall Study|Not treated|0|||
131902795|NCT01317641|474931294|FG002|Overall Study|Not treated|0|||
131902796|NCT01317641|474931295|FG003|Overall Study|Not treated|0|||
131902797|NCT01317641|474931296|FG004|Overall Study|Not treated|0|||
131902798|NCT01317641|474931297|FG005|Overall Study|Not treated|0|||
131902799|NCT01317641|474931298|FG006|Overall Study|Not treated|0|||
131641286|NCT01333111|473972977|FG000|Overall Study|personal reasons|0|||
131641287|NCT01333111|473972978|FG001|Overall Study|personal reasons|0|||
131641288|NCT01333111|473972979|FG002|Overall Study|personal reasons|1|||
131641289|NCT01333111|473972977|FG000|Overall Study|unclassified|1|||
131641290|NCT01333111|473972978|FG001|Overall Study|unclassified|0|||
131641291|NCT01333111|473972979|FG002|Overall Study|unclassified|0|||
131641292|NCT01333111|473972977|FG000|Overall Study|withdrawal criteria|0|||
131641293|NCT01333111|473972978|FG001|Overall Study|withdrawal criteria|1|||
131641294|NCT01333111|473972979|FG002|Overall Study|withdrawal criteria|0|||
131641295|NCT01333111|473972977|FG000|Overall Study|Non-compliance|1|||
131641296|NCT01333111|473972978|FG001|Overall Study|Non-compliance|0|||
131641297|NCT01333111|473972979|FG002|Overall Study|Non-compliance|0|||
131641298|NCT01333111|473972977|FG000|Overall Study|Ineffective therapy|0|||
131641299|NCT01333111|473972978|FG001|Overall Study|Ineffective therapy|0|||
131641300|NCT01333111|473972979|FG002|Overall Study|Ineffective therapy|1|||
131641301|NCT02161406|473972980|FG000|Overall Study|Death|2|||
131641302|NCT02161406|473972981|FG001|Overall Study|Death|1|||
131641303|NCT02161406|473972980|FG000|Overall Study|Lost to Follow-up|2|||
131641304|NCT02161406|473972981|FG001|Overall Study|Lost to Follow-up|1|||
131641305|NCT02161406|473972980|FG000|Overall Study|Withdrawal by Subject|2|||
131641306|NCT02161406|473972981|FG001|Overall Study|Withdrawal by Subject|4|||
131641307|NCT02161406|473972980|FG000|Overall Study|investigator withdrew subject|3|||
131641308|NCT02161406|473972981|FG001|Overall Study|investigator withdrew subject|1|||
131641309|NCT02161406|473972980|FG000|Overall Study|Lack of Efficacy|1|||
131641310|NCT02161406|473972981|FG001|Overall Study|Lack of Efficacy|1|||
131641311|NCT02161406|473972980|FG000|Overall Study|relocation|0|||
131641312|NCT02161406|473972981|FG001|Overall Study|relocation|1|||
131714901|NCT00699192|474233724|FG002|Overall Study|Withdrawal by Subject|4|||
131714902|NCT00699192|474233722|FG000|Overall Study|Administrative problems|1|||
131641313|NCT04732871|473972984|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
131641314|NCT04732871|473972985|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
131641315|NCT04732871|473972986|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
131641316|NCT04732871|473972984|FG000|Overall Study|Lost to Follow-up|7|||
131714903|NCT00699192|474233723|FG001|Overall Study|Administrative problems|3|||
131902800|NCT01317641|474931299|FG007|Overall Study|Not treated|1|||
131902801|NCT01317641|474931300|FG008|Overall Study|Not treated|1|||
131641317|NCT04732871|473972985|FG001|Overall Study|Lost to Follow-up|4|||
131641318|NCT04732871|473972986|FG002|Overall Study|Lost to Follow-up|3|||
131641319|NCT04732871|473972984|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
131714904|NCT00699192|474233724|FG002|Overall Study|Administrative problems|1|||
131641320|NCT04732871|473972985|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
131641321|NCT04732871|473972986|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
131641322|NCT04732871|473972984|FG000|Overall Study|Migrated / moved from the study area|5|||
131641323|NCT04732871|473972985|FG001|Overall Study|Migrated / moved from the study area|0|||
131641324|NCT04732871|473972986|FG002|Overall Study|Migrated / moved from the study area|0|||
131641325|NCT04732871|473972984|FG000|Overall Study|Other|1|||
131641326|NCT04732871|473972985|FG001|Overall Study|Other|0|||
131641327|NCT04732871|473972986|FG002|Overall Study|Other|1|||
131641328|NCT04732871|473972984|FG000|Overall Study|Ongoing|6|||
131641329|NCT04732871|473972985|FG001|Overall Study|Ongoing|0|||
131641330|NCT04732871|473972986|FG002|Overall Study|Ongoing|1|||
131641331|NCT04732871|473972984|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
131641332|NCT04732871|473972985|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
131641333|NCT04732871|473972986|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
131641334|NCT02034162|473972989|FG000|Double-blind|Lost to Follow-up|3|||
131641335|NCT02034162|473972990|FG001|Double-blind|Lost to Follow-up|0|||
131641336|NCT02034162|473972991|FG002|Double-blind|Lost to Follow-up|0|||
131641337|NCT02034162|473972989|FG000|Double-blind|Physician Decision|1|||
131641338|NCT02034162|473972990|FG001|Double-blind|Physician Decision|0|||
131641339|NCT02034162|473972991|FG002|Double-blind|Physician Decision|0|||
131641340|NCT02034162|473972989|FG000|Double-blind|Protocol Violation|0|||
131641341|NCT02034162|473972990|FG001|Double-blind|Protocol Violation|1|||
131641342|NCT02034162|473972991|FG002|Double-blind|Protocol Violation|0|||
131641343|NCT02034162|473972989|FG000|Double-blind|Withdrawal by Subject|5|||
131641344|NCT02034162|473972990|FG001|Double-blind|Withdrawal by Subject|7|||
131641345|NCT02034162|473972991|FG002|Double-blind|Withdrawal by Subject|0|||
131641346|NCT03458728|473972997|FG000|Overall Study|Adverse Event|1|||
131641347|NCT03458728|473972998|FG001|Overall Study|Adverse Event|0|||
131641348|NCT03458728|473972997|FG000|Overall Study|Physician Decision|1|||
131641349|NCT03458728|473972998|FG001|Overall Study|Physician Decision|0|||
131641350|NCT03458728|473972997|FG000|Overall Study|Progressive disease - clinical assessment|1|||
131641351|NCT03458728|473972998|FG001|Overall Study|Progressive disease - clinical assessment|0|||
131641352|NCT03458728|473972997|FG000|Overall Study|Progressive disease - radiological progression|21|||
131641353|NCT03458728|473972998|FG001|Overall Study|Progressive disease - radiological progression|6|||
131641354|NCT03458728|473972997|FG000|Overall Study|Withdrawal by Subject|0|||
131641355|NCT03458728|473972998|FG001|Overall Study|Withdrawal by Subject|1|||
131641356|NCT00908349|473973004|FG000|Overall Study|Adverse Event|10|||
131641357|NCT00908349|473973004|FG000|Overall Study|Withdrawal by Subject|9|||
131641358|NCT00908349|473973004|FG000|Overall Study|Physician Decision|5|||
131641359|NCT00908349|473973004|FG000|Overall Study|Lost to Follow-up|5|||
131641360|NCT00908349|473973004|FG000|Overall Study|Various|6|||
131641361|NCT03834623|473973008|FG000|Overall Study|Progression|0|||
131641362|NCT03834623|473973009|FG001|Overall Study|Progression|1|||
131641363|NCT00478647|473973010|FG000|Overall Study|Adverse Event|1|||
131641364|NCT00478647|473973010|FG000|Overall Study|Withdrawal by Subject|1|||
131641365|NCT00511836|473973011|FG000|Double-blind Period|Lost to Follow-up|1|||
131641366|NCT00511836|473973012|FG001|Double-blind Period|Lost to Follow-up|0|||
131641367|NCT01755546|473973016|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
131641368|NCT01755546|473973016|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
131641369|NCT01755546|473973016|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
131641370|NCT01755546|473973016|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
131641371|NCT01755546|473973016|FG000|Titration Phase|Adverse Event|11|||
131641372|NCT01755546|473973016|FG000|Titration Phase|Lack of Efficacy|18|||
131641373|NCT01755546|473973016|FG000|Titration Phase|Protocol Violation|9|||
131641374|NCT01755546|473973016|FG000|Titration Phase|Lost to Follow-up|2|||
131641375|NCT01755546|473973016|FG000|Titration Phase|Other and Continuing|22|||
131641376|NCT01755546|473973016|FG000|Titration Phase|Withdrawal by Subject|8|||
131714905|NCT00699192|474233722|FG000|Overall Study|Protocol Violation|2|||
131902802|NCT01317641|474931292|FG000|Overall Study|Adverse Event|0|||
131641377|NCT01755546|473973016|FG000|Long Term Treatment|Adverse Event|12|||
131641378|NCT01755546|473973016|FG000|Long Term Treatment|Lack of Efficacy|6|||
131641379|NCT01755546|473973016|FG000|Long Term Treatment|Protocol Violation|10|||
131641380|NCT01755546|473973016|FG000|Long Term Treatment|Withdrawal by Subject|35|||
131641381|NCT01755546|473973016|FG000|Long Term Treatment|Lost to Follow-up|17|||
131641382|NCT01755546|473973016|FG000|Long Term Treatment|other and ongoing|41|||
131641383|NCT00362375|473973017|FG000|Overall Study|Lost to Follow-up|40|||
131641384|NCT00362375|473973018|FG001|Overall Study|Lost to Follow-up|35|||
131902803|NCT01317641|474931293|FG001|Overall Study|Adverse Event|1|||
131641385|NCT04984239|473973019|FG000|Overall Study|Lost to Follow-up|1|||
131641386|NCT04606199|473973020|FG000|Overall Study|Withdrawal by Subject|2|||
131641387|NCT01114139|473973023|FG000|Overall Study|Adverse Event|3|||
131641388|NCT01114139|473973024|FG001|Overall Study|Adverse Event|2|||
131641389|NCT01114139|473973023|FG000|Overall Study|Lost to Follow-up|15|||
131641390|NCT01114139|473973024|FG001|Overall Study|Lost to Follow-up|3|||
131641391|NCT01114139|473973023|FG000|Overall Study|Withdrawal by Subject|17|||
131641392|NCT01114139|473973024|FG001|Overall Study|Withdrawal by Subject|6|||
131641393|NCT01114139|473973023|FG000|Overall Study|Other-Missed 1 visit|1|||
131641394|NCT01114139|473973024|FG001|Overall Study|Other-Missed 1 visit|0|||
131641395|NCT01114139|473973023|FG000|Overall Study|Other-Protocol Violation|1|||
131641396|NCT01114139|473973024|FG001|Overall Study|Other-Protocol Violation|0|||
131799551|NCT02465567|474550366|FG002|Overall Study|Protocol Specified Criteria|9|||
131799552|NCT02465567|474550367|FG003|Overall Study|Protocol Specified Criteria|12|||
131799553|NCT02465567|474550364|FG000|Overall Study|Administrative Reasons|12|||
131641397|NCT01114139|473973023|FG000|Overall Study|Other-Out of window for study drug dose|1|||
131641398|NCT01114139|473973024|FG001|Overall Study|Other-Out of window for study drug dose|0|||
131641399|NCT01114139|473973023|FG000|Overall Study|Other-Participant falsified records|0|||
131641400|NCT01114139|473973024|FG001|Overall Study|Other-Participant falsified records|1|||
131641401|NCT01114139|473973023|FG000|Overall Study|Other-Participant went on hospice|0|||
131641402|NCT01114139|473973024|FG001|Overall Study|Other-Participant went on hospice|1|||
131641403|NCT01114139|473973023|FG000|Overall Study|Other-Physician changed treatment|1|||
131641404|NCT01114139|473973024|FG001|Overall Study|Other-Physician changed treatment|0|||
131641405|NCT01114139|473973023|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
131641406|NCT01114139|473973024|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
131641407|NCT02624869|473973025|FG000|Overall Study|Lost to Follow-up|0|||
131641408|NCT02624869|473973026|FG001|Overall Study|Lost to Follow-up|0|||
131641409|NCT02624869|473973027|FG002|Overall Study|Lost to Follow-up|1|||
131641410|NCT02624869|473973025|FG000|Overall Study|Withdrawal by Subject|1|||
131641411|NCT02624869|473973026|FG001|Overall Study|Withdrawal by Subject|3|||
131641412|NCT02624869|473973027|FG002|Overall Study|Withdrawal by Subject|1|||
131641413|NCT03294941|473973031|FG000|Overall Study|Withdrawal by Subject|0|||
131641414|NCT03294941|473973032|FG001|Overall Study|Withdrawal by Subject|2|||
131641415|NCT00553605|473973033|FG000|Overall Study|Did not meet entrance criteria|1|||
131641416|NCT00553605|473973034|FG001|Overall Study|Did not meet entrance criteria|3|||
131641417|NCT00553605|473973033|FG000|Overall Study|Did not receive full dose|1|||
131641418|NCT00553605|473973034|FG001|Overall Study|Did not receive full dose|0|||
131641419|NCT00553605|473973033|FG000|Overall Study|Randomized but not treated|2|||
131641420|NCT00553605|473973034|FG001|Overall Study|Randomized but not treated|0|||
131641421|NCT01004185|473973035|FG000|Overall Study|Adverse Event|1|||
131641422|NCT01004185|473973036|FG001|Overall Study|Adverse Event|1|||
131641423|NCT01004185|473973035|FG000|Overall Study|Lost to Follow-up|0|||
131641424|NCT01004185|473973036|FG001|Overall Study|Lost to Follow-up|1|||
131641425|NCT01004185|473973035|FG000|Overall Study|Lack of Efficacy|2|||
131641426|NCT01004185|473973036|FG001|Overall Study|Lack of Efficacy|1|||
131799554|NCT02465567|474550365|FG001|Overall Study|Administrative Reasons|9|||
131799555|NCT02465567|474550366|FG002|Overall Study|Administrative Reasons|11|||
131799556|NCT02465567|474550367|FG003|Overall Study|Administrative Reasons|5|||
131799557|NCT02465567|474550364|FG000|Overall Study|Randomized but not treated|1|||
131799558|NCT02465567|474550365|FG001|Overall Study|Randomized but not treated|5|||
131799559|NCT02465567|474550366|FG002|Overall Study|Randomized but not treated|4|||
131799560|NCT02465567|474550367|FG003|Overall Study|Randomized but not treated|5|||
131799561|NCT02465567|474550364|FG000|Overall Study|enrolled in >1 studies|18|||
131799562|NCT02465567|474550365|FG001|Overall Study|enrolled in >1 studies|11|||
131799563|NCT02465567|474550366|FG002|Overall Study|enrolled in >1 studies|19|||
131799564|NCT02465567|474550367|FG003|Overall Study|enrolled in >1 studies|15|||
131799565|NCT02465567|474550364|FG000|Overall Study|missing PI Signature|1|||
131799566|NCT02465567|474550365|FG001|Overall Study|missing PI Signature|0|||
131799567|NCT02465567|474550366|FG002|Overall Study|missing PI Signature|0|||
131445131|NCT04672239|473258832|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
131445132|NCT04606134|473258833|FG000|Overall Study|Adverse Event|0|||
131445133|NCT04606134|473258834|FG001|Overall Study|Adverse Event|1|||
131445134|NCT02638220|473258838|FG000|Overall Study|Lost to Follow-up|6|||
131445135|NCT02638220|473258838|FG000|Overall Study|Withdrawal by Subject|3|||
131445136|NCT02638220|473258838|FG000|Overall Study|Physician Decision|1|||
131445137|NCT02638220|473258838|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
131445138|NCT04323124|473258842|FG000|Overall Study|Adverse Event|0|||
131641427|NCT01004185|473973035|FG000|Overall Study|Sponsor Terminated Study|4|||
131641428|NCT01004185|473973036|FG001|Overall Study|Sponsor Terminated Study|5|||
131641429|NCT01004185|473973035|FG000|Overall Study|Withdrawal by Subject|2|||
131641430|NCT01004185|473973036|FG001|Overall Study|Withdrawal by Subject|1|||
131641431|NCT01101997|473973037|FG000|Overall Study|Withdrawal by Subject|2|||
131799568|NCT02465567|474550367|FG003|Overall Study|missing PI Signature|0|||
131799569|NCT00950807|474550372|FG000|Treatment Period 1|Lack of Efficacy|1|||
131799570|NCT00950807|474550373|FG001|Treatment Period 1|Lack of Efficacy|0|||
131641432|NCT00496626|473973040|FG000|Overall Study|Lost to Follow-up|0|||
131641433|NCT00496626|473973041|FG001|Overall Study|Lost to Follow-up|1|||
131641434|NCT00496626|473973040|FG000|Overall Study|Protocol Violation|1|||
131641435|NCT00496626|473973041|FG001|Overall Study|Protocol Violation|0|||
131902804|NCT01317641|474931294|FG002|Overall Study|Adverse Event|0|||
131641436|NCT00496626|473973040|FG000|Overall Study|Withdrawal by Subject|5|||
131641437|NCT00496626|473973041|FG001|Overall Study|Withdrawal by Subject|4|||
131641438|NCT00496626|473973040|FG000|Overall Study|Relocated|0|||
131641439|NCT00496626|473973041|FG001|Overall Study|Relocated|1|||
131641440|NCT01233999|473973043|FG000|Overall Study|Withdrawal by Subject|1|||
131641441|NCT01233999|473973043|FG000|Overall Study|Lost to Follow-up|1|||
131641442|NCT01167192|473973044|FG000|Overall Study|Adverse Event|1|||
131641443|NCT01167192|473973044|FG000|Overall Study|Death|1|||
131641444|NCT01167192|473973044|FG000|Overall Study|Withdrawal by Subject|1|||
131641445|NCT01167192|473973044|FG000|Overall Study|Insurance denial|1|||
131641446|NCT00129649|473973045|FG000|Overall Study|Withdrawal by Subject|76|||
131641447|NCT00129649|473973046|FG001|Overall Study|Withdrawal by Subject|65|||
131641448|NCT00582114|473973047|FG000|Overall Study|Death|4|||
131641449|NCT00582114|473973048|FG001|Overall Study|Death|4|||
131641450|NCT00582114|473973047|FG000|Overall Study|Kidney Transplant|3|||
131641451|NCT00582114|473973048|FG001|Overall Study|Kidney Transplant|1|||
131641452|NCT00582114|473973047|FG000|Overall Study|Lost to Follow-up|7|||
131641453|NCT00582114|473973048|FG001|Overall Study|Lost to Follow-up|6|||
131641454|NCT00582114|473973047|FG000|Overall Study|Withdrawal by Subject|8|||
131641455|NCT00582114|473973048|FG001|Overall Study|Withdrawal by Subject|16|||
131641456|NCT00582114|473973047|FG000|Overall Study|Adverse Event|1|||
131641457|NCT00582114|473973048|FG001|Overall Study|Adverse Event|1|||
131641458|NCT00582114|473973047|FG000|Overall Study|Physician Decision|0|||
131641459|NCT00582114|473973048|FG001|Overall Study|Physician Decision|6|||
131641460|NCT00582114|473973047|FG000|Overall Study|Stopped by data safety monitoring board|19|||
131641461|NCT00582114|473973048|FG001|Overall Study|Stopped by data safety monitoring board|20|||
131641462|NCT02604342|473973049|FG000|Overall Study|Death|32|||
131641463|NCT02604342|473973050|FG001|Overall Study|Death|16|||
131641464|NCT02604342|473973049|FG000|Overall Study|Progression of disease|1|||
131641465|NCT02604342|473973050|FG001|Overall Study|Progression of disease|0|||
131641466|NCT02604342|473973049|FG000|Overall Study|Withdrawal by Subject|5|||
131641467|NCT02604342|473973050|FG001|Overall Study|Withdrawal by Subject|6|||
131641468|NCT02604342|473973049|FG000|Overall Study|Other|1|||
131641469|NCT02604342|473973050|FG001|Overall Study|Other|0|||
131641470|NCT02604342|473973049|FG000|Overall Study|Study Termination by Sponsor|1|||
131641471|NCT02604342|473973050|FG001|Overall Study|Study Termination by Sponsor|0|||
131641472|NCT02604342|473973049|FG000|Overall Study|Lost to Follow-up|1|||
131641473|NCT02604342|473973050|FG001|Overall Study|Lost to Follow-up|1|||
131641474|NCT02604342|473973049|FG000|Overall Study|Physician Decision|2|||
131641475|NCT02604342|473973050|FG001|Overall Study|Physician Decision|0|||
131641476|NCT00130728|473973051|FG000|Overall Study|Death|258|||
131641477|NCT00130728|473973052|FG001|Overall Study|Death|258|||
131641478|NCT00130728|473973051|FG000|Overall Study|Lost to Follow-up|4|||
131641479|NCT00130728|473973052|FG001|Overall Study|Lost to Follow-up|0|||
131641480|NCT00130728|473973051|FG000|Overall Study|Withdrawal by Subject|0|||
131641481|NCT00130728|473973052|FG001|Overall Study|Withdrawal by Subject|2|||
131641482|NCT00746356|473973053|FG000|Overall Study|Withdrawal by Subject|2|||
131641483|NCT00746356|473973054|FG001|Overall Study|Withdrawal by Subject|3|||
131641484|NCT00746356|473973053|FG000|Overall Study|Death|7|||
131641485|NCT00746356|473973054|FG001|Overall Study|Death|3|||
131641486|NCT00746356|473973053|FG000|Overall Study|Lost to Follow-up|1|||
131641487|NCT00746356|473973054|FG001|Overall Study|Lost to Follow-up|0|||
131641488|NCT00746356|473973053|FG000|Overall Study|Removal of Device|0|||
131641489|NCT00746356|473973054|FG001|Overall Study|Removal of Device|1|||
131641490|NCT00746356|473973053|FG000|Overall Study|Patient relocated|1|||
131641491|NCT00746356|473973054|FG001|Overall Study|Patient relocated|0|||
131641492|NCT02881047|473973059|FG000|Overall Study|Adverse Event|1|||
131641493|NCT02881047|473973059|FG000|Overall Study|Withdrawal by Subject|1|||
131641494|NCT01203956|473973065|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
131714906|NCT00699192|474233723|FG001|Overall Study|Protocol Violation|2|||
131714907|NCT00699192|474233724|FG002|Overall Study|Protocol Violation|0|||
131714908|NCT01025635|474233734|FG000|Overall Study|Withdrawal by Subject|6|||
131714909|NCT01025635|474233735|FG001|Overall Study|Withdrawal by Subject|7|||
131714910|NCT01025635|474233734|FG000|Overall Study|Protocol Violation|4|||
131714911|NCT01025635|474233735|FG001|Overall Study|Protocol Violation|2|||
131714912|NCT01025635|474233734|FG000|Overall Study|Lack of Efficacy|0|||
131714913|NCT01025635|474233735|FG001|Overall Study|Lack of Efficacy|1|||
131445139|NCT04323124|473258843|FG001|Overall Study|Adverse Event|0|||
131445140|NCT04323124|473258844|FG002|Overall Study|Adverse Event|0|||
131641495|NCT01203956|473973066|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
131641496|NCT02230306|473973067|FG000|Overall Study|Did not receive study treatment|1|||
131641497|NCT01503164|473973071|FG000|Overall Study|Withdrawal by Subject|2|||
131641498|NCT01503164|473973072|FG001|Overall Study|Withdrawal by Subject|1|||
131641499|NCT00514813|473973075|FG000|Overall Study|Study terminated|14|||
131641500|NCT00514813|473973076|FG001|Overall Study|Study terminated|74|||
131641501|NCT00514813|473973077|FG002|Overall Study|Study terminated|40|||
131641502|NCT00514813|473973078|FG003|Overall Study|Study terminated|2|||
131902805|NCT01317641|474931295|FG003|Overall Study|Adverse Event|1|||
131799571|NCT00950807|474550374|FG002|Treatment Period 1|Lack of Efficacy|0|||
131799572|NCT00950807|474550375|FG003|Treatment Period 1|Lack of Efficacy|0|||
131799573|NCT00950807|474550376|FG004|Treatment Period 1|Lack of Efficacy|0|||
131799574|NCT00950807|474550377|FG005|Treatment Period 1|Lack of Efficacy|1|||
131799575|NCT00950807|474550378|FG006|Treatment Period 1|Lack of Efficacy|0|||
131799576|NCT00950807|474550379|FG007|Treatment Period 1|Lack of Efficacy|0|||
131799577|NCT00950807|474550380|FG008|Treatment Period 1|Lack of Efficacy|0|||
131799578|NCT00950807|474550381|FG009|Treatment Period 1|Lack of Efficacy|0|||
131799579|NCT00950807|474550372|FG000|Treatment Period 1|Protocol Violation|1|||
131799580|NCT00950807|474550373|FG001|Treatment Period 1|Protocol Violation|0|||
131799581|NCT00950807|474550374|FG002|Treatment Period 1|Protocol Violation|0|||
131799582|NCT00950807|474550375|FG003|Treatment Period 1|Protocol Violation|0|||
131799583|NCT00950807|474550376|FG004|Treatment Period 1|Protocol Violation|0|||
131799584|NCT00950807|474550377|FG005|Treatment Period 1|Protocol Violation|0|||
131799585|NCT00950807|474550378|FG006|Treatment Period 1|Protocol Violation|0|||
131799586|NCT00950807|474550379|FG007|Treatment Period 1|Protocol Violation|0|||
131799587|NCT00950807|474550380|FG008|Treatment Period 1|Protocol Violation|0|||
131799588|NCT00950807|474550381|FG009|Treatment Period 1|Protocol Violation|0|||
131799589|NCT00950807|474550372|FG000|Treatment Period 1|Lost to Follow-up|0|||
131799590|NCT00950807|474550373|FG001|Treatment Period 1|Lost to Follow-up|0|||
131799591|NCT00950807|474550374|FG002|Treatment Period 1|Lost to Follow-up|1|||
131799592|NCT00950807|474550375|FG003|Treatment Period 1|Lost to Follow-up|0|||
131799593|NCT00950807|474550376|FG004|Treatment Period 1|Lost to Follow-up|0|||
131799594|NCT00950807|474550377|FG005|Treatment Period 1|Lost to Follow-up|0|||
131799595|NCT00950807|474550378|FG006|Treatment Period 1|Lost to Follow-up|0|||
131799596|NCT00950807|474550379|FG007|Treatment Period 1|Lost to Follow-up|0|||
131799597|NCT00950807|474550380|FG008|Treatment Period 1|Lost to Follow-up|0|||
131799598|NCT00950807|474550381|FG009|Treatment Period 1|Lost to Follow-up|0|||
131799599|NCT00950807|474550372|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131799600|NCT00950807|474550373|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131799601|NCT00950807|474550374|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131799602|NCT00950807|474550375|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131799603|NCT00950807|474550376|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131799604|NCT00950807|474550377|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131799605|NCT00950807|474550378|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131799606|NCT00950807|474550379|FG007|Treatment Period 1|Withdrawal by Subject|0|||
131799607|NCT00950807|474550380|FG008|Treatment Period 1|Withdrawal by Subject|1|||
131799608|NCT00950807|474550381|FG009|Treatment Period 1|Withdrawal by Subject|0|||
131799609|NCT00950807|474550372|FG000|Treatment Period 1|Adverse Event|0|||
131799610|NCT00950807|474550373|FG001|Treatment Period 1|Adverse Event|0|||
131799611|NCT00950807|474550374|FG002|Treatment Period 1|Adverse Event|0|||
131799612|NCT00950807|474550375|FG003|Treatment Period 1|Adverse Event|0|||
131799613|NCT00950807|474550376|FG004|Treatment Period 1|Adverse Event|0|||
131799614|NCT00950807|474550377|FG005|Treatment Period 1|Adverse Event|1|||
131799615|NCT00950807|474550378|FG006|Treatment Period 1|Adverse Event|0|||
131799616|NCT00950807|474550379|FG007|Treatment Period 1|Adverse Event|0|||
131799617|NCT00950807|474550380|FG008|Treatment Period 1|Adverse Event|0|||
131799618|NCT00950807|474550381|FG009|Treatment Period 1|Adverse Event|0|||
131799619|NCT00950807|474550372|FG000|Washout Period 1|Lack of Efficacy|0|||
131799620|NCT00950807|474550373|FG001|Washout Period 1|Lack of Efficacy|0|||
131799621|NCT00950807|474550374|FG002|Washout Period 1|Lack of Efficacy|0|||
131799622|NCT00950807|474550375|FG003|Washout Period 1|Lack of Efficacy|0|||
131799623|NCT00950807|474550376|FG004|Washout Period 1|Lack of Efficacy|0|||
131799624|NCT00950807|474550377|FG005|Washout Period 1|Lack of Efficacy|0|||
131799625|NCT00950807|474550378|FG006|Washout Period 1|Lack of Efficacy|1|||
131799626|NCT00950807|474550379|FG007|Washout Period 1|Lack of Efficacy|0|||
131799627|NCT00950807|474550380|FG008|Washout Period 1|Lack of Efficacy|0|||
131799628|NCT00950807|474550381|FG009|Washout Period 1|Lack of Efficacy|0|||
131799629|NCT00950807|474550372|FG000|Washout Period 1|Withdrawal by Subject|0|||
131799630|NCT00950807|474550373|FG001|Washout Period 1|Withdrawal by Subject|0|||
131799631|NCT00950807|474550374|FG002|Washout Period 1|Withdrawal by Subject|0|||
131799632|NCT00950807|474550375|FG003|Washout Period 1|Withdrawal by Subject|0|||
131799633|NCT00950807|474550376|FG004|Washout Period 1|Withdrawal by Subject|0|||
131799634|NCT00950807|474550377|FG005|Washout Period 1|Withdrawal by Subject|0|||
131799635|NCT00950807|474550378|FG006|Washout Period 1|Withdrawal by Subject|0|||
131799636|NCT00950807|474550379|FG007|Washout Period 1|Withdrawal by Subject|0|||
131799637|NCT00950807|474550380|FG008|Washout Period 1|Withdrawal by Subject|1|||
131799638|NCT00950807|474550381|FG009|Washout Period 1|Withdrawal by Subject|0|||
131799639|NCT00950807|474550372|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
131799640|NCT00950807|474550373|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799641|NCT00950807|474550374|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799642|NCT00950807|474550375|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799643|NCT00950807|474550376|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799644|NCT00950807|474550377|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799645|NCT00950807|474550378|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
131799646|NCT00950807|474550379|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
131799647|NCT00950807|474550380|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799648|NCT00950807|474550381|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131799649|NCT00950807|474550372|FG000|Washout Period 1|Adverse Event|2|||
131799650|NCT00950807|474550373|FG001|Washout Period 1|Adverse Event|0|||
131799651|NCT00950807|474550374|FG002|Washout Period 1|Adverse Event|0|||
131799652|NCT00950807|474550375|FG003|Washout Period 1|Adverse Event|1|||
131799653|NCT00950807|474550376|FG004|Washout Period 1|Adverse Event|1|||
131799654|NCT00950807|474550377|FG005|Washout Period 1|Adverse Event|0|||
131799655|NCT00950807|474550378|FG006|Washout Period 1|Adverse Event|0|||
131641503|NCT00514813|473973075|FG000|Overall Study|Adverse Event|0|||
131641504|NCT00514813|473973076|FG001|Overall Study|Adverse Event|2|||
131641505|NCT00514813|473973077|FG002|Overall Study|Adverse Event|2|||
131641506|NCT00514813|473973078|FG003|Overall Study|Adverse Event|0|||
131641507|NCT00514813|473973075|FG000|Overall Study|Protocol Violation|1|||
131641508|NCT00514813|473973076|FG001|Overall Study|Protocol Violation|0|||
131641509|NCT00514813|473973077|FG002|Overall Study|Protocol Violation|0|||
131641510|NCT00514813|473973078|FG003|Overall Study|Protocol Violation|0|||
131641511|NCT00514813|473973075|FG000|Overall Study|Withdrawal by Subject|0|||
131641512|NCT00514813|473973076|FG001|Overall Study|Withdrawal by Subject|1|||
131641513|NCT00514813|473973077|FG002|Overall Study|Withdrawal by Subject|0|||
131641514|NCT00514813|473973078|FG003|Overall Study|Withdrawal by Subject|0|||
131641515|NCT00514813|473973075|FG000|Overall Study|Lack of Efficacy|0|||
131641516|NCT00514813|473973076|FG001|Overall Study|Lack of Efficacy|1|||
131641517|NCT00514813|473973077|FG002|Overall Study|Lack of Efficacy|0|||
131641518|NCT00514813|473973078|FG003|Overall Study|Lack of Efficacy|0|||
131641519|NCT00514813|473973075|FG000|Overall Study|Kidney transplant|0|||
131641520|NCT00514813|473973076|FG001|Overall Study|Kidney transplant|6|||
131641521|NCT00514813|473973077|FG002|Overall Study|Kidney transplant|2|||
131641522|NCT00514813|473973078|FG003|Overall Study|Kidney transplant|0|||
131641523|NCT00514813|473973075|FG000|Overall Study|Death|0|||
131641524|NCT00514813|473973076|FG001|Overall Study|Death|2|||
131641525|NCT00514813|473973077|FG002|Overall Study|Death|3|||
131641526|NCT00514813|473973078|FG003|Overall Study|Death|2|||
131641527|NCT02979613|473973079|FG000|Double-Blind Phase|Withdrew Consent|2|||
131641528|NCT02979613|473973080|FG001|Double-Blind Phase|Withdrew Consent|4|||
131641529|NCT02979613|473973079|FG000|Double-Blind Phase|Pregnancy|2|||
131641530|NCT02979613|473973080|FG001|Double-Blind Phase|Pregnancy|2|||
131641531|NCT02979613|473973079|FG000|Double-Blind Phase|Adverse Event|2|||
131641532|NCT02979613|473973080|FG001|Double-Blind Phase|Adverse Event|0|||
131641533|NCT02979613|473973079|FG000|Double-Blind Phase|Lost to Follow-up|1|||
131641534|NCT02979613|473973080|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131641535|NCT02979613|473973079|FG000|Double-Blind Phase|Protocol Violation|1|||
131641536|NCT02979613|473973080|FG001|Double-Blind Phase|Protocol Violation|1|||
131641537|NCT02979613|473973079|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
131641538|NCT02979613|473973080|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
131641539|NCT02979613|473973079|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
131641540|NCT02979613|473973080|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
131641541|NCT02979613|473973079|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
131641542|NCT02979613|473973080|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131641543|NCT02979613|473973079|FG000|Open-Label Extension (OLE) Phase|Death|0|||
131641544|NCT02979613|473973080|FG001|Open-Label Extension (OLE) Phase|Death|1|||
131641545|NCT02979613|473973079|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
131641546|NCT02979613|473973080|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
131641547|NCT03927690|473974545|FG000|Overall Study|Withdrawal by Subject|3|||
131641548|NCT03927690|473974546|FG001|Overall Study|Withdrawal by Subject|1|||
131641549|NCT03927690|473974547|FG002|Overall Study|Withdrawal by Subject|1|||
131641550|NCT03927690|473974545|FG000|Overall Study|Adverse Event|1|||
131641551|NCT03927690|473974546|FG001|Overall Study|Adverse Event|0|||
131641552|NCT03927690|473974547|FG002|Overall Study|Adverse Event|0|||
131799656|NCT00950807|474550379|FG007|Washout Period 1|Adverse Event|0|||
131902806|NCT01317641|474931296|FG004|Overall Study|Adverse Event|0|||
131902807|NCT01317641|474931297|FG005|Overall Study|Adverse Event|0|||
131902808|NCT01317641|474931298|FG006|Overall Study|Adverse Event|2|||
131641553|NCT03927690|473974545|FG000|Overall Study|Death|1|||
131641554|NCT03927690|473974546|FG001|Overall Study|Death|0|||
131641555|NCT03927690|473974547|FG002|Overall Study|Death|0|||
131641556|NCT03927690|473974545|FG000|Overall Study|Lost to Follow-up|2|||
131641557|NCT03927690|473974546|FG001|Overall Study|Lost to Follow-up|2|||
131799657|NCT00950807|474550380|FG008|Washout Period 1|Adverse Event|0|||
131799658|NCT00950807|474550381|FG009|Washout Period 1|Adverse Event|0|||
131799659|NCT00950807|474550372|FG000|Treatment Period 2|Lack of Efficacy|1|||
131799660|NCT00950807|474550373|FG001|Treatment Period 2|Lack of Efficacy|0|||
131799661|NCT00950807|474550374|FG002|Treatment Period 2|Lack of Efficacy|0|||
131641558|NCT03927690|473974547|FG002|Overall Study|Lost to Follow-up|1|||
131641559|NCT04051242|473974553|FG000|Overall Study|Withdrawal by Subject|1|||
131641560|NCT04051242|473974553|FG000|Overall Study|Physician Decision|1|||
131799662|NCT00950807|474550375|FG003|Treatment Period 2|Lack of Efficacy|0|||
131799663|NCT00950807|474550376|FG004|Treatment Period 2|Lack of Efficacy|0|||
131799664|NCT00950807|474550377|FG005|Treatment Period 2|Lack of Efficacy|0|||
131799665|NCT00950807|474550378|FG006|Treatment Period 2|Lack of Efficacy|0|||
131799666|NCT00950807|474550379|FG007|Treatment Period 2|Lack of Efficacy|0|||
131799667|NCT00950807|474550380|FG008|Treatment Period 2|Lack of Efficacy|0|||
131799668|NCT00950807|474550381|FG009|Treatment Period 2|Lack of Efficacy|0|||
131799669|NCT00950807|474550372|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131799670|NCT00950807|474550373|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131799671|NCT00950807|474550374|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131799672|NCT00950807|474550375|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131799673|NCT00950807|474550376|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131799674|NCT00950807|474550377|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131799675|NCT00950807|474550378|FG006|Treatment Period 2|Withdrawal by Subject|1|||
131799676|NCT00950807|474550379|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131799677|NCT00950807|474550380|FG008|Treatment Period 2|Withdrawal by Subject|0|||
131641561|NCT01202409|473974555|FG000|Overall Study|Adverse Event|1|||
131641562|NCT01202409|473974555|FG000|Overall Study|Ineligible - KRAS mutants|7|||
131641563|NCT00337285|473974556|FG000|Overall Study|Withdrawal by Subject|42|||
131641564|NCT00337285|473974556|FG000|Overall Study|Lost to Follow-up|41|||
131641565|NCT00337285|473974556|FG000|Overall Study|Adverse Event|28|||
131641566|NCT00337285|473974556|FG000|Overall Study|Protocol Violation|27|||
131641567|NCT00337285|473974556|FG000|Overall Study|Lack of Efficacy|11|||
131641568|NCT00337285|473974556|FG000|Overall Study|Death|1|||
131641569|NCT00337285|473974556|FG000|Overall Study|Physician Decision|1|||
131641570|NCT00337285|473974556|FG000|Overall Study|Lack of protocol compliance|7|||
131641571|NCT01774019|473974557|FG000|Overall Study|No longer meets protocol criteria|2|||
131641572|NCT01774019|473974558|FG001|Overall Study|No longer meets protocol criteria|0|||
131641573|NCT01774019|473974557|FG000|Overall Study|Withdrawal by Subject|1|||
131641574|NCT01774019|473974558|FG001|Overall Study|Withdrawal by Subject|0|||
131641575|NCT01774019|473974557|FG000|Overall Study|Surgery delayed > 120 days|1|||
131641576|NCT01774019|473974558|FG001|Overall Study|Surgery delayed > 120 days|0|||
131641577|NCT01774019|473974557|FG000|Overall Study|Patient refused surgery|1|||
131641578|NCT01774019|473974558|FG001|Overall Study|Patient refused surgery|1|||
131641579|NCT01774019|473974557|FG000|Overall Study|Unable to implant study device|1|||
131641580|NCT01774019|473974558|FG001|Overall Study|Unable to implant study device|0|||
131641581|NCT01774019|473974557|FG000|Overall Study|Lost to Follow-up|0|||
131641582|NCT01774019|473974558|FG001|Overall Study|Lost to Follow-up|3|||
131641583|NCT03481556|473974563|FG000|Overall Study|Adverse Event|1|||
131641584|NCT03481556|473974564|FG001|Overall Study|Adverse Event|0|||
131641585|NCT03481556|473974565|FG002|Overall Study|Adverse Event|0|||
131799678|NCT00950807|474550381|FG009|Treatment Period 2|Withdrawal by Subject|0|||
131799679|NCT00950807|474550372|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
131799680|NCT00950807|474550373|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131641586|NCT03481556|473974566|FG003|Overall Study|Adverse Event|0|||
131641587|NCT03481556|473974563|FG000|Overall Study|Death|4|||
131799681|NCT00950807|474550374|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799682|NCT00950807|474550375|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799683|NCT00950807|474550376|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799684|NCT00950807|474550377|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799685|NCT00950807|474550378|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799686|NCT00950807|474550379|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799687|NCT00950807|474550380|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799688|NCT00950807|474550381|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131799689|NCT00950807|474550372|FG000|Treatment Period 2|Adverse Event|0|||
131799690|NCT00950807|474550373|FG001|Treatment Period 2|Adverse Event|1|||
131799691|NCT00950807|474550374|FG002|Treatment Period 2|Adverse Event|0|||
131799692|NCT00950807|474550375|FG003|Treatment Period 2|Adverse Event|1|||
131799693|NCT00950807|474550376|FG004|Treatment Period 2|Adverse Event|0|||
131641588|NCT03481556|473974564|FG001|Overall Study|Death|2|||
131641589|NCT03481556|473974565|FG002|Overall Study|Death|3|||
131799694|NCT00950807|474550377|FG005|Treatment Period 2|Adverse Event|1|||
131799695|NCT00950807|474550378|FG006|Treatment Period 2|Adverse Event|0|||
131799696|NCT00950807|474550379|FG007|Treatment Period 2|Adverse Event|1|||
131799697|NCT00950807|474550380|FG008|Treatment Period 2|Adverse Event|0|||
131799698|NCT00950807|474550381|FG009|Treatment Period 2|Adverse Event|0|||
131641590|NCT03481556|473974566|FG003|Overall Study|Death|16|||
131799699|NCT00950807|474550372|FG000|Washout Period 2|Lack of Efficacy|1|||
131799700|NCT00950807|474550373|FG001|Washout Period 2|Lack of Efficacy|0|||
131799701|NCT00950807|474550374|FG002|Washout Period 2|Lack of Efficacy|0|||
131799702|NCT00950807|474550375|FG003|Washout Period 2|Lack of Efficacy|0|||
131799703|NCT00950807|474550376|FG004|Washout Period 2|Lack of Efficacy|0|||
131799704|NCT00950807|474550377|FG005|Washout Period 2|Lack of Efficacy|0|||
131641591|NCT03481556|473974563|FG000|Overall Study|Study Terminated by Sponsor|10|||
131641592|NCT03481556|473974564|FG001|Overall Study|Study Terminated by Sponsor|5|||
131641593|NCT03481556|473974565|FG002|Overall Study|Study Terminated by Sponsor|2|||
131641594|NCT03481556|473974566|FG003|Overall Study|Study Terminated by Sponsor|9|||
131902809|NCT01317641|474931299|FG007|Overall Study|Adverse Event|1|||
131902810|NCT01317641|474931300|FG008|Overall Study|Adverse Event|0|||
131641595|NCT03463577|473974567|FG000|Overall Study|Lost to Follow-up|238|||
131641596|NCT03463577|473974568|FG001|Overall Study|Lost to Follow-up|435|||
131641597|NCT03463577|473974569|FG002|Overall Study|Lost to Follow-up|0|||
131641598|NCT03463577|473974570|FG003|Overall Study|Lost to Follow-up|0|||
131641599|NCT03463577|473974571|FG004|Overall Study|Lost to Follow-up|0|||
131641600|NCT03463577|473974572|FG005|Overall Study|Lost to Follow-up|0|||
131641601|NCT03463577|473974567|FG000|Overall Study|With unknown pregnancy outcome|0|||
131641602|NCT03463577|473974568|FG001|Overall Study|With unknown pregnancy outcome|5|||
131641603|NCT03463577|473974569|FG002|Overall Study|With unknown pregnancy outcome|0|||
131641604|NCT03463577|473974570|FG003|Overall Study|With unknown pregnancy outcome|0|||
131641605|NCT03463577|473974571|FG004|Overall Study|With unknown pregnancy outcome|0|||
131641606|NCT03463577|473974572|FG005|Overall Study|With unknown pregnancy outcome|0|||
131641607|NCT03463577|473974567|FG000|Overall Study|Maternal death|2|||
131641608|NCT03463577|473974568|FG001|Overall Study|Maternal death|0|||
131641609|NCT03463577|473974569|FG002|Overall Study|Maternal death|0|||
131641610|NCT03463577|473974570|FG003|Overall Study|Maternal death|0|||
131641611|NCT03463577|473974571|FG004|Overall Study|Maternal death|0|||
131641612|NCT03463577|473974572|FG005|Overall Study|Maternal death|0|||
131641613|NCT03463577|473974567|FG000|Overall Study|Neonatal death|0|||
131641614|NCT03463577|473974568|FG001|Overall Study|Neonatal death|0|||
131641615|NCT03463577|473974569|FG002|Overall Study|Neonatal death|0|||
131641616|NCT03463577|473974570|FG003|Overall Study|Neonatal death|15|||
131641617|NCT03463577|473974571|FG004|Overall Study|Neonatal death|17|||
131641618|NCT03463577|473974572|FG005|Overall Study|Neonatal death|0|||
131641619|NCT01085812|473974574|FG000|Open-Label Period|Adverse Event|0|||
131641620|NCT01085812|473974575|FG001|Open-Label Period|Adverse Event|80|||
131714914|NCT01025635|474233734|FG000|Overall Study|Lost to Follow-up|9|||
131641621|NCT01085812|473974574|FG000|Open-Label Period|Lack of Efficacy|0|||
131641622|NCT01085812|473974575|FG001|Open-Label Period|Lack of Efficacy|26|||
131641623|NCT01085812|473974574|FG000|Open-Label Period|Protocol Violation|0|||
131641624|NCT01085812|473974575|FG001|Open-Label Period|Protocol Violation|39|||
131714915|NCT01025635|474233735|FG001|Overall Study|Lost to Follow-up|13|||
131714916|NCT01025635|474233734|FG000|Overall Study|Reason not known|4|||
131714917|NCT01025635|474233735|FG001|Overall Study|Reason not known|2|||
131714918|NCT00727402|474233736|FG000|Overall Study|Physician Decision|116|||
131714919|NCT00929240|474233737|FG000|Initial Treatment Phase|Adverse Event|31|||
131714920|NCT00929240|474233738|FG001|Initial Treatment Phase|Adverse Event|0|||
131714921|NCT00929240|474233739|FG002|Initial Treatment Phase|Adverse Event|0|||
131641625|NCT01085812|473974574|FG000|Open-Label Period|Withdrawal by Subject|0|||
131714922|NCT00929240|474233737|FG000|Initial Treatment Phase|Disease progression|41|||
131714923|NCT00929240|474233738|FG001|Initial Treatment Phase|Disease progression|0|||
131714924|NCT00929240|474233739|FG002|Initial Treatment Phase|Disease progression|0|||
131714925|NCT00929240|474233737|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
131902811|NCT01317641|474931292|FG000|Overall Study|Protocol Violation|1|||
131445141|NCT04323124|473258845|FG003|Overall Study|Adverse Event|0|||
131641626|NCT01085812|473974575|FG001|Open-Label Period|Withdrawal by Subject|53|||
131714926|NCT00929240|474233738|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
131641627|NCT01085812|473974574|FG000|Open-Label Period|Lost to Follow-up|0|||
131641628|NCT01085812|473974575|FG001|Open-Label Period|Lost to Follow-up|42|||
131641629|NCT01085812|473974574|FG000|Double-Blind Period|Adverse Event|3|||
131641630|NCT01085812|473974575|FG001|Double-Blind Period|Adverse Event|8|||
131641631|NCT01085812|473974574|FG000|Double-Blind Period|Protocol Violation|2|||
131641632|NCT01085812|473974575|FG001|Double-Blind Period|Protocol Violation|7|||
131641633|NCT01085812|473974574|FG000|Double-Blind Period|Withdrawal by Subject|11|||
131641634|NCT01085812|473974575|FG001|Double-Blind Period|Withdrawal by Subject|24|||
131641635|NCT01085812|473974574|FG000|Double-Blind Period|Lost to Follow-up|5|||
131641636|NCT01085812|473974575|FG001|Double-Blind Period|Lost to Follow-up|17|||
131641637|NCT01085812|473974574|FG000|Double-Blind Period|Other Reasons|0|||
131641638|NCT01085812|473974575|FG001|Double-Blind Period|Other Reasons|2|||
131641639|NCT01085812|473974574|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
131641640|NCT01085812|473974575|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
131641641|NCT01085812|473974574|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
131641642|NCT01085812|473974575|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
131641643|NCT01085812|473974574|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
131641644|NCT01085812|473974575|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
131641645|NCT01085812|473974574|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
131641646|NCT01085812|473974575|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
131641647|NCT01085812|473974574|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
131641648|NCT01085812|473974575|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
131641649|NCT01874665|473974580|FG000|Overall Study|Adverse Event|6|||
131641650|NCT01874665|473974581|FG001|Overall Study|Adverse Event|2|||
131641651|NCT01874665|473974580|FG000|Overall Study|Withdrawal by Subject|4|||
131641652|NCT01874665|473974581|FG001|Overall Study|Withdrawal by Subject|1|||
131641653|NCT01874665|473974580|FG000|Overall Study|Physician Decision|3|||
131641654|NCT01874665|473974581|FG001|Overall Study|Physician Decision|0|||
131641655|NCT01874665|473974580|FG000|Overall Study|Clinical Progressive Disease|4|||
131641656|NCT01874665|473974581|FG001|Overall Study|Clinical Progressive Disease|3|||
131641657|NCT01874665|473974580|FG000|Overall Study|Study Terminated by Sponsor|0|||
131641658|NCT01874665|473974581|FG001|Overall Study|Study Terminated by Sponsor|2|||
131641659|NCT01874665|473974580|FG000|Overall Study|Documented Progressive Disease|11|||
131641660|NCT01874665|473974581|FG001|Overall Study|Documented Progressive Disease|7|||
131641661|NCT01874665|473974580|FG000|Overall Study|Other|2|||
131641662|NCT01874665|473974581|FG001|Overall Study|Other|0|||
131641663|NCT00853229|473974582|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
131641664|NCT00853229|473974583|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
131641665|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
131641666|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
131641667|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
131641668|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
131641669|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
131641670|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
131641671|NCT03201900|473974584|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
131799705|NCT00950807|474550378|FG006|Washout Period 2|Lack of Efficacy|0|||
131799706|NCT00950807|474550379|FG007|Washout Period 2|Lack of Efficacy|0|||
131799707|NCT00950807|474550380|FG008|Washout Period 2|Lack of Efficacy|0|||
131799708|NCT00950807|474550381|FG009|Washout Period 2|Lack of Efficacy|0|||
131799709|NCT00950807|474550372|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131799710|NCT00950807|474550373|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131799711|NCT00950807|474550374|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131799712|NCT00950807|474550375|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131799713|NCT00950807|474550376|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131799714|NCT00950807|474550377|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131799715|NCT00950807|474550378|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131799716|NCT00950807|474550379|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131799717|NCT00950807|474550380|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131799718|NCT00950807|474550381|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131799719|NCT00950807|474550372|FG000|Washout Period 2|Adverse Event|3|||
131799720|NCT00950807|474550373|FG001|Washout Period 2|Adverse Event|0|||
131799721|NCT00950807|474550374|FG002|Washout Period 2|Adverse Event|0|||
131799722|NCT00950807|474550375|FG003|Washout Period 2|Adverse Event|1|||
131799723|NCT00950807|474550376|FG004|Washout Period 2|Adverse Event|0|||
131445142|NCT04323124|473258846|FG004|Overall Study|Adverse Event|0|||
131641672|NCT03201900|473974584|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
131641673|NCT03201900|473974584|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
131641674|NCT03201900|473974584|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
131641675|NCT03201900|473974584|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
131799724|NCT00950807|474550377|FG005|Washout Period 2|Adverse Event|0|||
131799725|NCT00950807|474550378|FG006|Washout Period 2|Adverse Event|0|||
131799726|NCT00950807|474550379|FG007|Washout Period 2|Adverse Event|0|||
131799727|NCT00950807|474550380|FG008|Washout Period 2|Adverse Event|0|||
131799728|NCT00950807|474550381|FG009|Washout Period 2|Adverse Event|0|||
131799729|NCT00950807|474550372|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131799730|NCT00950807|474550373|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131799731|NCT00950807|474550374|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131799732|NCT00950807|474550375|FG003|Treatment Period 3|Withdrawal by Subject|0|||
131799733|NCT00950807|474550376|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131799734|NCT00950807|474550377|FG005|Treatment Period 3|Withdrawal by Subject|0|||
131799735|NCT00950807|474550378|FG006|Treatment Period 3|Withdrawal by Subject|0|||
131799736|NCT00950807|474550379|FG007|Treatment Period 3|Withdrawal by Subject|0|||
131799737|NCT00950807|474550380|FG008|Treatment Period 3|Withdrawal by Subject|0|||
131799738|NCT00950807|474550381|FG009|Treatment Period 3|Withdrawal by Subject|1|||
131799739|NCT00950807|474550372|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
131799740|NCT00950807|474550373|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799741|NCT00950807|474550374|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799742|NCT00950807|474550375|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799743|NCT00950807|474550376|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799744|NCT00950807|474550377|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799745|NCT00950807|474550378|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799746|NCT00950807|474550379|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
131799747|NCT00950807|474550380|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799748|NCT00950807|474550381|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131799749|NCT00950807|474550372|FG000|Treatment Period 3|Adverse Event|0|||
131799750|NCT00950807|474550373|FG001|Treatment Period 3|Adverse Event|0|||
131799751|NCT00950807|474550374|FG002|Treatment Period 3|Adverse Event|0|||
131799752|NCT00950807|474550375|FG003|Treatment Period 3|Adverse Event|0|||
131799753|NCT00950807|474550376|FG004|Treatment Period 3|Adverse Event|0|||
131799754|NCT00950807|474550377|FG005|Treatment Period 3|Adverse Event|0|||
131799755|NCT00950807|474550378|FG006|Treatment Period 3|Adverse Event|1|||
131799756|NCT00950807|474550379|FG007|Treatment Period 3|Adverse Event|0|||
131799757|NCT00950807|474550380|FG008|Treatment Period 3|Adverse Event|0|||
131641676|NCT03201900|473974584|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
131641677|NCT03201900|473974584|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
131799758|NCT00950807|474550381|FG009|Treatment Period 3|Adverse Event|0|||
131799759|NCT00337077|474550382|FG000|Overall Study|Progressive disease|25|||
131799760|NCT00337077|474550383|FG001|Overall Study|Progressive disease|37|||
131799761|NCT00337077|474550384|FG002|Overall Study|Progressive disease|19|||
131641678|NCT00776659|473974603|FG000|Overall Study|Lost to Follow-up|15|||
131799762|NCT00337077|474550382|FG000|Overall Study|Adverse Event|7|||
131799763|NCT00337077|474550383|FG001|Overall Study|Adverse Event|7|||
131641679|NCT00776659|473974603|FG000|Overall Study|Withdrawal by Subject|10|||
131799764|NCT00337077|474550384|FG002|Overall Study|Adverse Event|1|||
131799765|NCT00337077|474550382|FG000|Overall Study|Death|0|||
131799766|NCT00337077|474550383|FG001|Overall Study|Death|1|||
131799767|NCT00337077|474550384|FG002|Overall Study|Death|0|||
131799768|NCT00337077|474550382|FG000|Overall Study|Withdrawal by Subject|7|||
131799769|NCT00337077|474550383|FG001|Overall Study|Withdrawal by Subject|2|||
131799770|NCT00337077|474550384|FG002|Overall Study|Withdrawal by Subject|2|||
131799771|NCT00337077|474550382|FG000|Overall Study|Alternative therapy|1|||
131799772|NCT00337077|474550383|FG001|Overall Study|Alternative therapy|0|||
131799773|NCT00337077|474550384|FG002|Overall Study|Alternative therapy|0|||
131799774|NCT00337077|474550382|FG000|Overall Study|Physician Decision|1|||
131799775|NCT00337077|474550383|FG001|Overall Study|Physician Decision|4|||
131799776|NCT00337077|474550384|FG002|Overall Study|Physician Decision|2|||
131902812|NCT01317641|474931293|FG001|Overall Study|Protocol Violation|0|||
131902813|NCT01317641|474931294|FG002|Overall Study|Protocol Violation|0|||
131902814|NCT01317641|474931295|FG003|Overall Study|Protocol Violation|0|||
131902815|NCT01317641|474931296|FG004|Overall Study|Protocol Violation|0|||
131902816|NCT01317641|474931297|FG005|Overall Study|Protocol Violation|0|||
131902817|NCT01317641|474931298|FG006|Overall Study|Protocol Violation|0|||
131902818|NCT01317641|474931299|FG007|Overall Study|Protocol Violation|0|||
131799777|NCT00337077|474550382|FG000|Overall Study|Never started treatment|1|||
131799778|NCT00337077|474550383|FG001|Overall Study|Never started treatment|1|||
131799779|NCT00337077|474550384|FG002|Overall Study|Never started treatment|0|||
131799780|NCT00337077|474550382|FG000|Overall Study|Ineligible|1|||
131799781|NCT00337077|474550383|FG001|Overall Study|Ineligible|1|||
131799782|NCT00337077|474550384|FG002|Overall Study|Ineligible|1|||
131799783|NCT02780687|474550397|FG000|Overall Study|Adverse Event|1|||
131799784|NCT02780687|474550398|FG001|Overall Study|Adverse Event|1|||
131799785|NCT02780687|474550397|FG000|Overall Study|Withdrawal by Subject|2|||
131799786|NCT02780687|474550398|FG001|Overall Study|Withdrawal by Subject|1|||
131799787|NCT02780687|474550397|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
131799788|NCT02780687|474550398|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
131799789|NCT02780687|474550397|FG000|Overall Study|progressive disease|29|||
131799790|NCT02780687|474550398|FG001|Overall Study|progressive disease|6|||
131799791|NCT00368277|474550399|FG000|Overall Study|Adverse Event|33|||
131799792|NCT00368277|474550400|FG001|Overall Study|Adverse Event|49|||
131799793|NCT00368277|474550399|FG000|Overall Study|Death|2|||
131799794|NCT00368277|474550400|FG001|Overall Study|Death|1|||
131799795|NCT00368277|474550399|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
131799796|NCT00368277|474550400|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
131799797|NCT00368277|474550399|FG000|Overall Study|Protocol deviation|7|||
131799798|NCT00368277|474550400|FG001|Overall Study|Protocol deviation|0|||
131799799|NCT00368277|474550399|FG000|Overall Study|Patient withdrew consent|32|||
131799800|NCT00368277|474550400|FG001|Overall Study|Patient withdrew consent|28|||
131799801|NCT00368277|474550399|FG000|Overall Study|Lost to Follow-up|8|||
131641680|NCT00776659|473974603|FG000|Overall Study|Study Terminated by Sponsor|1|||
131641681|NCT02835092|473974611|FG000|Overall Study|Withdrawal by Subject|3|||
131641682|NCT02835092|473974612|FG001|Overall Study|Withdrawal by Subject|6|||
131641683|NCT02835092|473974613|FG002|Overall Study|Withdrawal by Subject|3|||
131641684|NCT02835092|473974611|FG000|Overall Study|Lost to Follow-up|0|||
131641685|NCT02835092|473974612|FG001|Overall Study|Lost to Follow-up|2|||
131641686|NCT02835092|473974613|FG002|Overall Study|Lost to Follow-up|0|||
131641687|NCT01710800|473974615|FG000|Overall Study|Withdrawal by Subject|21|||
131641688|NCT01710800|473974615|FG000|Overall Study|Protocol Violation|1|||
131641689|NCT02586415|473974616|FG000|Overall Study|Death|13|||
131641690|NCT02586415|473974617|FG001|Overall Study|Death|23|||
131641691|NCT02586415|473974616|FG000|Overall Study|Lost to Follow-up|1|||
131641692|NCT02586415|473974617|FG001|Overall Study|Lost to Follow-up|2|||
131641693|NCT02872311|473974618|FG000|Overall Study|Death|2|||
131641694|NCT02872311|473974619|FG001|Overall Study|Death|0|||
131641695|NCT02872311|473974620|FG002|Overall Study|Death|0|||
131641696|NCT02872311|473974621|FG003|Overall Study|Death|0|||
131799802|NCT00368277|474550400|FG001|Overall Study|Lost to Follow-up|6|||
131799803|NCT04646109|474550407|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
131799804|NCT04646109|474550408|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
131799805|NCT01867242|474550411|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
131799806|NCT01867242|474550412|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
131902819|NCT01317641|474931300|FG008|Overall Study|Protocol Violation|0|||
131902820|NCT01317641|474931292|FG000|Overall Study|Disease progression|0|||
131902821|NCT01317641|474931293|FG001|Overall Study|Disease progression|0|||
131445143|NCT04323124|473258847|FG005|Overall Study|Adverse Event|1|||
131799807|NCT01867242|474550413|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
131641697|NCT02872311|473974622|FG004|Overall Study|Death|0|||
131641698|NCT02872311|473974618|FG000|Overall Study|Lost to Follow-up|2|||
131641699|NCT02872311|473974619|FG001|Overall Study|Lost to Follow-up|0|||
131641700|NCT02872311|473974620|FG002|Overall Study|Lost to Follow-up|0|||
131641701|NCT02872311|473974621|FG003|Overall Study|Lost to Follow-up|0|||
131902822|NCT01317641|474931294|FG002|Overall Study|Disease progression|0|||
131902823|NCT01317641|474931295|FG003|Overall Study|Disease progression|0|||
131902824|NCT01317641|474931296|FG004|Overall Study|Disease progression|0|||
131902825|NCT01317641|474931297|FG005|Overall Study|Disease progression|0|||
131641702|NCT02872311|473974622|FG004|Overall Study|Lost to Follow-up|0|||
131641703|NCT02872311|473974618|FG000|Overall Study|Protocol Violation|0|||
131799808|NCT01790568|474550419|FG000|Overall Study|Progression prior to transplant|0|||
131799809|NCT01790568|474550420|FG001|Overall Study|Progression prior to transplant|1|||
131799810|NCT00264810|474550421|FG000|Baseline|Withdrawal by Subject|10|||
131799811|NCT00264810|474550422|FG001|Baseline|Withdrawal by Subject|10|||
131799812|NCT00264810|474550421|FG000|Baseline|Physician Decision|7|||
131799813|NCT00264810|474550422|FG001|Baseline|Physician Decision|8|||
131799814|NCT00264810|474550421|FG000|Baseline|Subject Compliance Failure|3|||
131799815|NCT00264810|474550422|FG001|Baseline|Subject Compliance Failure|3|||
131799816|NCT00264810|474550421|FG000|Baseline|Insufficient Seizure Frequency|2|||
131799817|NCT00264810|474550422|FG001|Baseline|Insufficient Seizure Frequency|2|||
131799818|NCT00264810|474550421|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
131799819|NCT00264810|474550422|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
131799820|NCT00264810|474550421|FG000|Baseline|Other|0|||
131799821|NCT00264810|474550422|FG001|Baseline|Other|1|||
131799822|NCT00264810|474550421|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
131799823|NCT00264810|474550422|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
131799824|NCT00264810|474550421|FG000|Stimulation Optimization Period|Death|0|||
131799825|NCT00264810|474550422|FG001|Stimulation Optimization Period|Death|1|||
131799826|NCT00264810|474550421|FG000|Blinded Evaluation Period|Explant due to infection|1|||
131799827|NCT00264810|474550422|FG001|Blinded Evaluation Period|Explant due to infection|1|||
131799828|NCT00264810|474550421|FG000|Open Label Evaluation Period|Explant due to infection|1|||
131799829|NCT00264810|474550422|FG001|Open Label Evaluation Period|Explant due to infection|1|||
131799830|NCT00264810|474550421|FG000|Open Label Evaluation Period|Death|3|||
131799831|NCT00264810|474550422|FG001|Open Label Evaluation Period|Death|2|||
131799832|NCT00264810|474550421|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
131799833|NCT00264810|474550422|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
131799834|NCT04803357|474550425|FG000|Overall Study|Withdrawal by Subject|31|||
131799835|NCT04803357|474550426|FG001|Overall Study|Withdrawal by Subject|5|||
131799836|NCT02093689|474550427|FG000|Overall Study|Physician Decision|4|||
131799837|NCT02093689|474550428|FG001|Overall Study|Physician Decision|0|||
131799838|NCT02093689|474550429|FG002|Overall Study|Physician Decision|0|||
131799839|NCT01575054|474550430|FG000|Overall Study|Other Reasons|5|||
131799840|NCT01575054|474550431|FG001|Overall Study|Other Reasons|3|||
131799841|NCT01575054|474550430|FG000|Overall Study|Protocol Violation|2|||
131799842|NCT01575054|474550431|FG001|Overall Study|Protocol Violation|1|||
131799843|NCT01575054|474550430|FG000|Overall Study|Personal Reasons|10|||
131799844|NCT01575054|474550431|FG001|Overall Study|Personal Reasons|11|||
131799845|NCT01575054|474550430|FG000|Overall Study|Lost to Follow-up|3|||
131799846|NCT01575054|474550431|FG001|Overall Study|Lost to Follow-up|3|||
131799847|NCT01575054|474550430|FG000|Overall Study|Adverse Event|9|||
131799848|NCT01575054|474550431|FG001|Overall Study|Adverse Event|8|||
131799849|NCT03481309|474550432|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
131799850|NCT03481309|474550433|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131799851|NCT03481309|474550434|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131799852|NCT03481309|474550435|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131799853|NCT03481309|474550436|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131799854|NCT03481309|474550437|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131799855|NCT03309956|474550438|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
131641704|NCT02872311|473974619|FG001|Overall Study|Protocol Violation|2|||
131641705|NCT02872311|473974620|FG002|Overall Study|Protocol Violation|1|||
131641706|NCT02872311|473974621|FG003|Overall Study|Protocol Violation|0|||
131641707|NCT02872311|473974622|FG004|Overall Study|Protocol Violation|0|||
131641708|NCT04545476|473974623|FG000|Overall Study|Lost to Follow-up|1|||
131641709|NCT04545476|473974624|FG001|Overall Study|Lost to Follow-up|1|||
131641710|NCT04545476|473974625|FG002|Overall Study|Lost to Follow-up|0|||
131641711|NCT04545476|473974626|FG003|Overall Study|Lost to Follow-up|0|||
131641712|NCT00511797|473974627|FG000|Overall Study|Adverse Event|1|||
131641713|NCT00511797|473974628|FG001|Overall Study|Adverse Event|2|||
131799856|NCT02768298|474550441|FG000|Overall Study|Adverse Event|1|||
131799857|NCT02768298|474550442|FG001|Overall Study|Adverse Event|4|||
131799858|NCT02768298|474550441|FG000|Overall Study|Death|2|||
131799859|NCT02768298|474550442|FG001|Overall Study|Death|1|||
131799860|NCT02768298|474550441|FG000|Overall Study|Non-compliance with study treatment|0|||
131799861|NCT02768298|474550442|FG001|Overall Study|Non-compliance with study treatment|1|||
131641714|NCT00511797|473974629|FG002|Overall Study|Adverse Event|2|||
131799862|NCT02768298|474550441|FG000|Overall Study|Subject/guardian decision|1|||
131641715|NCT00511797|473974630|FG003|Overall Study|Adverse Event|2|||
131641716|NCT00511797|473974627|FG000|Overall Study|Lost to Follow-up|1|||
131799863|NCT02768298|474550442|FG001|Overall Study|Subject/guardian decision|0|||
131799864|NCT02768298|474550441|FG000|Overall Study|Withdrawal of informed consent|0|||
131799865|NCT02768298|474550442|FG001|Overall Study|Withdrawal of informed consent|1|||
131799866|NCT02346201|474550443|FG000|Overall Study|Adverse Event|3|||
131799867|NCT02346201|474550444|FG001|Overall Study|Adverse Event|2|||
131799868|NCT02346201|474550443|FG000|Overall Study|Lost to Follow-up|1|||
131799869|NCT02346201|474550444|FG001|Overall Study|Lost to Follow-up|0|||
131799870|NCT02346201|474550443|FG000|Overall Study|Withdrawal by Subject|6|||
131799871|NCT02346201|474550444|FG001|Overall Study|Withdrawal by Subject|3|||
131799872|NCT02346201|474550443|FG000|Overall Study|Unavailable for future follow-up|0|||
131799873|NCT02346201|474550444|FG001|Overall Study|Unavailable for future follow-up|1|||
131799874|NCT02346201|474550443|FG000|Overall Study|Physician Decision|0|||
131799875|NCT02346201|474550444|FG001|Overall Study|Physician Decision|1|||
131799876|NCT02346201|474550443|FG000|Overall Study|Missed final visit|0|||
131799877|NCT02346201|474550444|FG001|Overall Study|Missed final visit|2|||
131799878|NCT01508936|474550445|FG000|Overall Study|Adverse Event|11|||
131799879|NCT01508936|474550446|FG001|Overall Study|Adverse Event|32|||
131799880|NCT01508936|474550445|FG000|Overall Study|Lack of Efficacy|0|||
131799881|NCT01508936|474550446|FG001|Overall Study|Lack of Efficacy|1|||
131799882|NCT01508936|474550445|FG000|Overall Study|Withdrawal by Subject|4|||
131799883|NCT01508936|474550446|FG001|Overall Study|Withdrawal by Subject|18|||
131799884|NCT01508936|474550445|FG000|Overall Study|Protocol Violation|2|||
131799885|NCT01508936|474550446|FG001|Overall Study|Protocol Violation|3|||
131799886|NCT01508936|474550445|FG000|Overall Study|Lost to Follow-up|2|||
131799887|NCT01508936|474550446|FG001|Overall Study|Lost to Follow-up|9|||
131799888|NCT01508936|474550445|FG000|Overall Study|Other|0|||
131799889|NCT01508936|474550446|FG001|Overall Study|Other|5|||
131799890|NCT01508936|474550445|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
131799891|NCT01508936|474550446|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
131799892|NCT00922779|474550447|FG000|Overall Study|Adverse Event|67|||
131799893|NCT00922779|474550447|FG000|Overall Study|Pregnancy|7|||
131799894|NCT00922779|474550447|FG000|Overall Study|Withdrawal by Subject|308|||
131799895|NCT00922779|474550447|FG000|Overall Study|Lost to Follow-up|44|||
131799896|NCT00922779|474550447|FG000|Overall Study|Other|27|||
131799897|NCT00922779|474550447|FG000|Overall Study|Missing|1874|||
131799898|NCT05665595|474552372|FG000|Overall Study|Ongoing|692|||
131799899|NCT05665595|474552373|FG001|Overall Study|Ongoing|698|||
131799900|NCT05665595|474552372|FG000|Overall Study|Withdrawal by Subject|2|||
131799901|NCT05665595|474552373|FG001|Overall Study|Withdrawal by Subject|2|||
131799902|NCT05665595|474552372|FG000|Overall Study|Lost to Follow-up|1|||
131799903|NCT05665595|474552373|FG001|Overall Study|Lost to Follow-up|0|||
131799904|NCT05665595|474552372|FG000|Overall Study|Death|6|||
131799905|NCT05665595|474552373|FG001|Overall Study|Death|1|||
131799906|NCT05771428|474552374|FG000|Overall Study|Adverse Event|0|||
131799907|NCT05771428|474552375|FG001|Overall Study|Adverse Event|1|||
131799908|NCT05771428|474552376|FG002|Overall Study|Adverse Event|1|||
131799909|NCT05771428|474552377|FG003|Overall Study|Adverse Event|1|||
131799910|NCT05771428|474552374|FG000|Overall Study|Withdrawal by Subject|3|||
131799911|NCT05771428|474552375|FG001|Overall Study|Withdrawal by Subject|2|||
131799912|NCT05771428|474552376|FG002|Overall Study|Withdrawal by Subject|1|||
131799913|NCT05771428|474552377|FG003|Overall Study|Withdrawal by Subject|4|||
131799914|NCT05771428|474552374|FG000|Overall Study|Other|0|||
131799915|NCT05771428|474552375|FG001|Overall Study|Other|1|||
131799916|NCT05771428|474552376|FG002|Overall Study|Other|2|||
131799917|NCT05771428|474552377|FG003|Overall Study|Other|1|||
131799918|NCT05771428|474552374|FG000|Overall Study|Randomized but Not Treated|0|||
131799919|NCT05771428|474552375|FG001|Overall Study|Randomized but Not Treated|0|||
131799920|NCT05771428|474552376|FG002|Overall Study|Randomized but Not Treated|1|||
131799921|NCT05771428|474552377|FG003|Overall Study|Randomized but Not Treated|0|||
131799922|NCT04025229|474552378|FG000|Overall Study|Adverse Event|1|||
131799923|NCT04025229|474552379|FG001|Overall Study|Adverse Event|0|||
131799924|NCT04025229|474552378|FG000|Overall Study|Withdrawal by Subject|0|||
131445144|NCT04323124|473258848|FG006|Overall Study|Adverse Event|0|||
131641717|NCT00511797|473974628|FG001|Overall Study|Lost to Follow-up|0|||
131641718|NCT00511797|473974629|FG002|Overall Study|Lost to Follow-up|0|||
131641719|NCT00511797|473974630|FG003|Overall Study|Lost to Follow-up|1|||
131799925|NCT04025229|474552379|FG001|Overall Study|Withdrawal by Subject|2|||
131799926|NCT04025229|474552378|FG000|Overall Study|Death|0|||
131799927|NCT04025229|474552379|FG001|Overall Study|Death|1|||
131799928|NCT04025229|474552378|FG000|Overall Study|Physician Decision|0|||
131641720|NCT00511797|473974627|FG000|Overall Study|Pregnancy|0|||
131799929|NCT04025229|474552379|FG001|Overall Study|Physician Decision|1|||
131799930|NCT01298570|474552380|FG000|Overall Study|Disease progression, relapse during acti|64|||
131799931|NCT01298570|474552381|FG001|Overall Study|Disease progression, relapse during acti|40|||
131799932|NCT01298570|474552380|FG000|Overall Study|Adverse Event|20|||
131641721|NCT00511797|473974628|FG001|Overall Study|Pregnancy|0|||
131641722|NCT00511797|473974629|FG002|Overall Study|Pregnancy|0|||
131799933|NCT01298570|474552381|FG001|Overall Study|Adverse Event|2|||
131799934|NCT01298570|474552380|FG000|Overall Study|Withdrawal by Subject|21|||
131799935|NCT01298570|474552381|FG001|Overall Study|Withdrawal by Subject|6|||
131799936|NCT01298570|474552380|FG000|Overall Study|Treatment delay > 4 weeks|4|||
131799937|NCT01298570|474552381|FG001|Overall Study|Treatment delay > 4 weeks|5|||
131799938|NCT01298570|474552380|FG000|Overall Study|Physician Decision|4|||
131799939|NCT01298570|474552381|FG001|Overall Study|Physician Decision|2|||
131799940|NCT01298570|474552380|FG000|Overall Study|Other complicating disease|2|||
131799941|NCT01298570|474552381|FG001|Overall Study|Other complicating disease|1|||
131799942|NCT01298570|474552380|FG000|Overall Study|Surgery|2|||
131641723|NCT00511797|473974630|FG003|Overall Study|Pregnancy|1|||
131641724|NCT00511797|473974627|FG000|Overall Study|Protocol Violation|0|||
131641725|NCT00511797|473974628|FG001|Overall Study|Protocol Violation|2|||
131641726|NCT00511797|473974629|FG002|Overall Study|Protocol Violation|2|||
131641727|NCT00511797|473974630|FG003|Overall Study|Protocol Violation|3|||
131641728|NCT00511797|473974627|FG000|Overall Study|Withdrawal by Subject|3|||
131641729|NCT00511797|473974628|FG001|Overall Study|Withdrawal by Subject|3|||
131641730|NCT00511797|473974629|FG002|Overall Study|Withdrawal by Subject|4|||
131641731|NCT00511797|473974630|FG003|Overall Study|Withdrawal by Subject|2|||
131641732|NCT00511797|473974627|FG000|Overall Study|Never dispensed|1|||
131714927|NCT00929240|474233739|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
131714928|NCT00929240|474233737|FG000|Initial Treatment Phase|Protocol Violation|5|||
131714929|NCT00929240|474233738|FG001|Initial Treatment Phase|Protocol Violation|0|||
131714930|NCT00929240|474233739|FG002|Initial Treatment Phase|Protocol Violation|0|||
131714931|NCT00929240|474233737|FG000|Initial Treatment Phase|Death|2|||
131714932|NCT00929240|474233738|FG001|Initial Treatment Phase|Death|0|||
131714933|NCT00929240|474233739|FG002|Initial Treatment Phase|Death|0|||
131714934|NCT00929240|474233737|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
131714935|NCT00929240|474233738|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
131714936|NCT00929240|474233739|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
131714937|NCT00929240|474233737|FG000|Initial Treatment Phase|Physician Decision|4|||
131714938|NCT00929240|474233738|FG001|Initial Treatment Phase|Physician Decision|0|||
131714939|NCT00929240|474233739|FG002|Initial Treatment Phase|Physician Decision|0|||
131714940|NCT00929240|474233737|FG000|Maintenance Phase|Disease progression|0|||
131714941|NCT00929240|474233738|FG001|Maintenance Phase|Disease progression|73|||
131714942|NCT00929240|474233739|FG002|Maintenance Phase|Disease progression|60|||
131714943|NCT00929240|474233737|FG000|Maintenance Phase|Adverse Event|0|||
131714944|NCT00929240|474233738|FG001|Maintenance Phase|Adverse Event|9|||
131714945|NCT00929240|474233739|FG002|Maintenance Phase|Adverse Event|12|||
131714946|NCT00929240|474233737|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131714947|NCT00929240|474233738|FG001|Maintenance Phase|Withdrawal by Subject|2|||
131714948|NCT00929240|474233739|FG002|Maintenance Phase|Withdrawal by Subject|6|||
131714949|NCT00929240|474233737|FG000|Maintenance Phase|Protocol Violation|0|||
131714950|NCT00929240|474233738|FG001|Maintenance Phase|Protocol Violation|1|||
131714951|NCT00929240|474233739|FG002|Maintenance Phase|Protocol Violation|0|||
131714952|NCT00929240|474233737|FG000|Maintenance Phase|Health authority/Study termination|0|||
131714953|NCT00929240|474233738|FG001|Maintenance Phase|Health authority/Study termination|1|||
131714954|NCT00929240|474233739|FG002|Maintenance Phase|Health authority/Study termination|2|||
131714955|NCT00929240|474233737|FG000|Maintenance Phase|Physician Decision|0|||
131799943|NCT01298570|474552381|FG001|Overall Study|Surgery|1|||
131799944|NCT01298570|474552380|FG000|Overall Study|Symptomatic progression/deterioration|3|||
131799945|NCT01298570|474552381|FG001|Overall Study|Symptomatic progression/deterioration|2|||
131799946|NCT01298570|474552380|FG000|Overall Study|Death|0|||
131799947|NCT01298570|474552381|FG001|Overall Study|Death|1|||
131799948|NCT01298570|474552380|FG000|Overall Study|Ineligibility|0|||
131799949|NCT01298570|474552381|FG001|Overall Study|Ineligibility|1|||
131799950|NCT01210001|474552382|FG000|Overall Study|Not treated|1|||
131799951|NCT01210001|474552383|FG001|Overall Study|Not treated|0|||
131799952|NCT01210001|474552384|FG002|Overall Study|Not treated|0|||
131799953|NCT01210001|474552382|FG000|Overall Study|Adverse Event|4|||
131799954|NCT01210001|474552383|FG001|Overall Study|Adverse Event|2|||
131799955|NCT01210001|474552384|FG002|Overall Study|Adverse Event|5|||
131799956|NCT01210001|474552382|FG000|Overall Study|Non compliant with protocol|2|||
131799957|NCT01210001|474552383|FG001|Overall Study|Non compliant with protocol|2|||
131799958|NCT01210001|474552384|FG002|Overall Study|Non compliant with protocol|3|||
131799959|NCT01210001|474552382|FG000|Overall Study|Lost to Follow-up|4|||
131799960|NCT01210001|474552383|FG001|Overall Study|Lost to Follow-up|3|||
131799961|NCT01210001|474552384|FG002|Overall Study|Lost to Follow-up|2|||
131799962|NCT01210001|474552382|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
131799963|NCT01210001|474552383|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
131799964|NCT01210001|474552384|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
131799965|NCT01210001|474552382|FG000|Overall Study|Other reason not defined above|2|||
131799966|NCT01210001|474552383|FG001|Overall Study|Other reason not defined above|2|||
131799967|NCT01210001|474552384|FG002|Overall Study|Other reason not defined above|1|||
131799968|NCT02180711|474552385|FG000|Overall Study|Death|0|||
131799969|NCT02180711|474552386|FG001|Overall Study|Death|1|||
131799970|NCT02180711|474552387|FG002|Overall Study|Death|0|||
131714956|NCT00929240|474233738|FG001|Maintenance Phase|Physician Decision|2|||
131714957|NCT00929240|474233739|FG002|Maintenance Phase|Physician Decision|1|||
131799971|NCT02180711|474552388|FG003|Overall Study|Death|0|||
131799972|NCT02180711|474552389|FG004|Overall Study|Death|7|||
131799973|NCT02180711|474552390|FG005|Overall Study|Death|0|||
131799974|NCT02180711|474552391|FG006|Overall Study|Death|1|||
131799975|NCT02180711|474552392|FG007|Overall Study|Death|3|||
131799976|NCT02180711|474552385|FG000|Overall Study|Lost to Follow-up|0|||
131799977|NCT02180711|474552386|FG001|Overall Study|Lost to Follow-up|1|||
131641733|NCT00511797|473974628|FG001|Overall Study|Never dispensed|0|||
131641734|NCT00511797|473974629|FG002|Overall Study|Never dispensed|1|||
131799978|NCT02180711|474552387|FG002|Overall Study|Lost to Follow-up|0|||
131799979|NCT02180711|474552388|FG003|Overall Study|Lost to Follow-up|0|||
131799980|NCT02180711|474552389|FG004|Overall Study|Lost to Follow-up|1|||
131799981|NCT02180711|474552390|FG005|Overall Study|Lost to Follow-up|1|||
131799982|NCT02180711|474552391|FG006|Overall Study|Lost to Follow-up|0|||
131799983|NCT02180711|474552392|FG007|Overall Study|Lost to Follow-up|3|||
131799984|NCT02180711|474552385|FG000|Overall Study|Withdrawal by Subject|2|||
131799985|NCT02180711|474552386|FG001|Overall Study|Withdrawal by Subject|1|||
131799986|NCT02180711|474552387|FG002|Overall Study|Withdrawal by Subject|0|||
131799987|NCT02180711|474552388|FG003|Overall Study|Withdrawal by Subject|4|||
131641735|NCT00511797|473974630|FG003|Overall Study|Never dispensed|3|||
131641736|NCT00511797|473974627|FG000|Overall Study|Study drug not taken|0|||
131641737|NCT00511797|473974628|FG001|Overall Study|Study drug not taken|1|||
131641738|NCT00511797|473974629|FG002|Overall Study|Study drug not taken|0|||
131641739|NCT00511797|473974630|FG003|Overall Study|Study drug not taken|1|||
131641740|NCT00511797|473974627|FG000|Overall Study|Partially missing diary|0|||
131641741|NCT00511797|473974628|FG001|Overall Study|Partially missing diary|0|||
131641742|NCT00511797|473974629|FG002|Overall Study|Partially missing diary|1|||
131641743|NCT00511797|473974630|FG003|Overall Study|Partially missing diary|0|||
131641744|NCT00511797|473974627|FG000|Overall Study|Other (moving etc)|1|||
131641745|NCT00511797|473974628|FG001|Overall Study|Other (moving etc)|0|||
131641746|NCT00511797|473974629|FG002|Overall Study|Other (moving etc)|1|||
131641747|NCT00511797|473974630|FG003|Overall Study|Other (moving etc)|2|||
131641748|NCT03974100|473974631|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
131641749|NCT03974100|473974632|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
131799988|NCT02180711|474552389|FG004|Overall Study|Withdrawal by Subject|3|||
131799989|NCT02180711|474552390|FG005|Overall Study|Withdrawal by Subject|0|||
131799990|NCT02180711|474552391|FG006|Overall Study|Withdrawal by Subject|3|||
131641750|NCT03974100|473974633|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
131641751|NCT03974100|473974634|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
131641752|NCT03974100|473974635|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
131641753|NCT03974100|473974631|FG000|TP1 - Day 1 to Week 52|Death|1|||
131641754|NCT03974100|473974632|FG001|TP1 - Day 1 to Week 52|Death|0|||
131641755|NCT03974100|473974633|FG002|TP1 - Day 1 to Week 52|Death|0|||
131641756|NCT03974100|473974634|FG003|TP1 - Day 1 to Week 52|Death|0|||
131641757|NCT03974100|473974635|FG004|TP1 - Day 1 to Week 52|Death|0|||
131641758|NCT03974100|473974631|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131641759|NCT03974100|473974632|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
131641760|NCT03974100|473974633|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131641761|NCT03974100|473974634|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131641762|NCT03974100|473974635|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131641763|NCT03974100|473974631|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
131641764|NCT03974100|473974632|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
131641765|NCT03974100|473974633|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
131641766|NCT03974100|473974634|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
131641767|NCT03974100|473974635|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
131641768|NCT03974100|473974631|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
131641769|NCT03974100|473974632|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
131641770|NCT03974100|473974633|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
131641771|NCT03974100|473974634|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
131641772|NCT03974100|473974635|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
131641773|NCT03974100|473974631|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131641774|NCT03974100|473974632|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131641775|NCT03974100|473974633|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131641776|NCT03974100|473974634|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
131641777|NCT03974100|473974635|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131799991|NCT02180711|474552392|FG007|Overall Study|Withdrawal by Subject|2|||
131799992|NCT02180711|474552385|FG000|Overall Study|- Disease Progression|0|||
131799993|NCT02180711|474552386|FG001|Overall Study|- Disease Progression|1|||
131799994|NCT02180711|474552387|FG002|Overall Study|- Disease Progression|0|||
131799995|NCT02180711|474552388|FG003|Overall Study|- Disease Progression|0|||
131799996|NCT02180711|474552389|FG004|Overall Study|- Disease Progression|0|||
131902826|NCT01317641|474931298|FG006|Overall Study|Disease progression|0|||
131641778|NCT03974100|473974631|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
131641779|NCT03974100|473974632|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
131641780|NCT03974100|473974633|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
131641781|NCT03974100|473974634|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
131641782|NCT03974100|473974635|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
131641783|NCT00690378|473974638|FG000|Overall Study|Adverse Event|1|||
131641784|NCT00690378|473974639|FG001|Overall Study|Adverse Event|0|||
131641785|NCT00690378|473974638|FG000|Overall Study|Withdrawal by Subject|2|||
131799997|NCT02180711|474552390|FG005|Overall Study|- Disease Progression|0|||
131799998|NCT02180711|474552391|FG006|Overall Study|- Disease Progression|0|||
131641786|NCT00690378|473974639|FG001|Overall Study|Withdrawal by Subject|0|||
131641787|NCT00690378|473974638|FG000|Overall Study|Protocol Violation|1|||
131641788|NCT00690378|473974639|FG001|Overall Study|Protocol Violation|0|||
131641789|NCT00690378|473974638|FG000|Overall Study|Lost to Follow-up|2|||
131641790|NCT00690378|473974639|FG001|Overall Study|Lost to Follow-up|3|||
131641791|NCT00690378|473974638|FG000|Overall Study|Did not meet inc/exc criteria|13|||
131641792|NCT00690378|473974639|FG001|Overall Study|Did not meet inc/exc criteria|11|||
131641793|NCT00690378|473974638|FG000|Overall Study|Social problem|1|||
131641794|NCT00690378|473974639|FG001|Overall Study|Social problem|0|||
131641795|NCT01560871|473974640|FG000|Overall Study|transportation issues|2|||
131641796|NCT01560871|473974641|FG001|Overall Study|transportation issues|1|||
131641797|NCT01560871|473974640|FG000|Overall Study|relocation|1|||
131641798|NCT01560871|473974641|FG001|Overall Study|relocation|0|||
131641799|NCT01560871|473974640|FG000|Overall Study|readmission to a hospital|2|||
131641800|NCT01560871|473974641|FG001|Overall Study|readmission to a hospital|1|||
131641801|NCT01560871|473974640|FG000|Overall Study|Lost to Follow-up|1|||
131641802|NCT01560871|473974641|FG001|Overall Study|Lost to Follow-up|0|||
131641803|NCT00878553|473974642|FG000|Sleep Study|Withdrawal by Subject|2|||
131902827|NCT01317641|474931299|FG007|Overall Study|Disease progression|3|||
131902828|NCT01317641|474931300|FG008|Overall Study|Disease progression|4|||
131902829|NCT01317641|474931292|FG000|Overall Study|Withdrawal by Subject|0|||
131902830|NCT01317641|474931293|FG001|Overall Study|Withdrawal by Subject|0|||
131902831|NCT01317641|474931294|FG002|Overall Study|Withdrawal by Subject|0|||
131902832|NCT01317641|474931295|FG003|Overall Study|Withdrawal by Subject|0|||
131902833|NCT01317641|474931296|FG004|Overall Study|Withdrawal by Subject|0|||
131902834|NCT01317641|474931297|FG005|Overall Study|Withdrawal by Subject|0|||
131902835|NCT01317641|474931298|FG006|Overall Study|Withdrawal by Subject|1|||
131902836|NCT01317641|474931299|FG007|Overall Study|Withdrawal by Subject|0|||
131902837|NCT01317641|474931300|FG008|Overall Study|Withdrawal by Subject|0|||
131902838|NCT00611806|474931301|FG000|Overall Study|Withdrawal by Subject|8|||
131902839|NCT00611806|474931302|FG001|Overall Study|Withdrawal by Subject|2|||
131902840|NCT00611806|474931301|FG000|Overall Study|Adverse Event|2|||
131902841|NCT00611806|474931302|FG001|Overall Study|Adverse Event|1|||
131902842|NCT00611806|474931301|FG000|Overall Study|Lost to Follow-up|6|||
131902843|NCT00611806|474931302|FG001|Overall Study|Lost to Follow-up|0|||
131641804|NCT00878553|473974643|FG001|Sleep Study|Withdrawal by Subject|0|||
131641805|NCT00878553|473974644|FG002|Sleep Study|Withdrawal by Subject|0|||
131641806|NCT00878553|473974645|FG003|Sleep Study|Withdrawal by Subject|0|||
131902844|NCT00715559|474931303|FG000|Overall Study|medication not tolerated - nausea|1|||
131902845|NCT02063672|474931304|FG000|Overall Study|Ongoing Follow-up|27|||
131902846|NCT02063672|474931305|FG001|Overall Study|Ongoing Follow-up|14|||
131799999|NCT02180711|474552392|FG007|Overall Study|- Disease Progression|0|||
131800000|NCT02180711|474552385|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
131800001|NCT02180711|474552386|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
131800002|NCT02180711|474552387|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
131800003|NCT02180711|474552388|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
131800004|NCT02180711|474552389|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131800005|NCT02180711|474552390|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131800006|NCT02180711|474552391|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131800007|NCT02180711|474552392|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131800008|NCT02180711|474552385|FG000|Overall Study|- Study Terminated by Sponsor|2|||
131800009|NCT02180711|474552386|FG001|Overall Study|- Study Terminated by Sponsor|3|||
131800010|NCT02180711|474552387|FG002|Overall Study|- Study Terminated by Sponsor|0|||
131800011|NCT02180711|474552388|FG003|Overall Study|- Study Terminated by Sponsor|5|||
131800012|NCT02180711|474552389|FG004|Overall Study|- Study Terminated by Sponsor|32|||
131800013|NCT02180711|474552390|FG005|Overall Study|- Study Terminated by Sponsor|0|||
131800014|NCT02180711|474552391|FG006|Overall Study|- Study Terminated by Sponsor|4|||
131800015|NCT02180711|474552392|FG007|Overall Study|- Study Terminated by Sponsor|13|||
131800016|NCT02180711|474552385|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
131800017|NCT02180711|474552386|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
131800018|NCT02180711|474552387|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
131800019|NCT02180711|474552388|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
131800020|NCT02180711|474552389|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
131800021|NCT02180711|474552390|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
131800022|NCT02180711|474552391|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
131800023|NCT02180711|474552392|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
131800024|NCT02180711|474552385|FG000|Overall Study|- Other|1|||
131800025|NCT02180711|474552386|FG001|Overall Study|- Other|0|||
131800026|NCT02180711|474552387|FG002|Overall Study|- Other|0|||
131800027|NCT02180711|474552388|FG003|Overall Study|- Other|1|||
131800028|NCT02180711|474552389|FG004|Overall Study|- Other|0|||
131800029|NCT02180711|474552390|FG005|Overall Study|- Other|0|||
131800030|NCT02180711|474552391|FG006|Overall Study|- Other|0|||
131800031|NCT02180711|474552392|FG007|Overall Study|- Other|0|||
131800032|NCT01739790|474552393|FG000|Overall Study|Early Trial Termination|2|||
131800033|NCT01739790|474552394|FG001|Overall Study|Early Trial Termination|4|||
131800034|NCT01374919|474552397|FG000|Overall Study|Withdrawal by Subject|2|||
131800035|NCT01451762|474552401|FG000|Overall Study|Lost to Follow-up|3|||
131800036|NCT01451762|474552402|FG001|Overall Study|Lost to Follow-up|6|||
131800037|NCT01451762|474552403|FG002|Overall Study|Lost to Follow-up|6|||
131800038|NCT03569293|474552407|FG000|Overall Study|Adverse Event|4|||
131800039|NCT03569293|474552408|FG001|Overall Study|Adverse Event|1|||
131800040|NCT03569293|474552409|FG002|Overall Study|Adverse Event|5|||
131800041|NCT03569293|474552410|FG003|Overall Study|Adverse Event|1|||
131800042|NCT03569293|474552411|FG004|Overall Study|Adverse Event|0|||
131800043|NCT03569293|474552412|FG005|Overall Study|Adverse Event|0|||
131800044|NCT03569293|474552407|FG000|Overall Study|Withdrawal by Subject|16|||
131800045|NCT03569293|474552408|FG001|Overall Study|Withdrawal by Subject|2|||
131800046|NCT03569293|474552409|FG002|Overall Study|Withdrawal by Subject|4|||
131800047|NCT03569293|474552410|FG003|Overall Study|Withdrawal by Subject|1|||
131800048|NCT03569293|474552411|FG004|Overall Study|Withdrawal by Subject|0|||
131800049|NCT03569293|474552412|FG005|Overall Study|Withdrawal by Subject|0|||
131800050|NCT03569293|474552407|FG000|Overall Study|Lost to Follow-up|1|||
131800051|NCT03569293|474552408|FG001|Overall Study|Lost to Follow-up|3|||
131902847|NCT02063672|474931304|FG000|Overall Study|Death|5|||
131902848|NCT02063672|474931305|FG001|Overall Study|Death|3|||
131641807|NCT00878553|473974646|FG004|Sleep Study|Withdrawal by Subject|0|||
131641808|NCT00878553|473974642|FG000|Sleep Study|Lost to Follow-up|1|||
131641809|NCT00878553|473974643|FG001|Sleep Study|Lost to Follow-up|0|||
131641810|NCT00878553|473974644|FG002|Sleep Study|Lost to Follow-up|0|||
131641811|NCT00878553|473974645|FG003|Sleep Study|Lost to Follow-up|0|||
131641812|NCT00878553|473974646|FG004|Sleep Study|Lost to Follow-up|0|||
131641813|NCT00878553|473974642|FG000|Sleep Study|car accident|1|||
131641814|NCT00878553|473974643|FG001|Sleep Study|car accident|0|||
131641815|NCT00878553|473974644|FG002|Sleep Study|car accident|0|||
131641816|NCT00878553|473974645|FG003|Sleep Study|car accident|0|||
131641817|NCT00878553|473974646|FG004|Sleep Study|car accident|0|||
131641818|NCT00878553|473974642|FG000|Sleep Study|family emergency|1|||
131641819|NCT00878553|473974643|FG001|Sleep Study|family emergency|0|||
131641820|NCT00878553|473974644|FG002|Sleep Study|family emergency|0|||
131800052|NCT03569293|474552409|FG002|Overall Study|Lost to Follow-up|1|||
131800053|NCT03569293|474552410|FG003|Overall Study|Lost to Follow-up|1|||
131800054|NCT03569293|474552411|FG004|Overall Study|Lost to Follow-up|0|||
131800055|NCT03569293|474552412|FG005|Overall Study|Lost to Follow-up|0|||
131800056|NCT03569293|474552407|FG000|Overall Study|Other|8|||
131800057|NCT03569293|474552408|FG001|Overall Study|Other|2|||
131800058|NCT03569293|474552409|FG002|Overall Study|Other|1|||
131902849|NCT02063672|474931304|FG000|Overall Study|Lost to Follow-up|1|||
131800059|NCT03569293|474552410|FG003|Overall Study|Other|1|||
131800060|NCT03569293|474552411|FG004|Overall Study|Other|0|||
131800061|NCT03569293|474552412|FG005|Overall Study|Other|0|||
131800062|NCT03569293|474552407|FG000|Overall Study|Ongoing at Time of Analysis|8|||
131800063|NCT03569293|474552408|FG001|Overall Study|Ongoing at Time of Analysis|1|||
131800064|NCT03569293|474552409|FG002|Overall Study|Ongoing at Time of Analysis|3|||
131800065|NCT03569293|474552410|FG003|Overall Study|Ongoing at Time of Analysis|0|||
131800066|NCT03569293|474552411|FG004|Overall Study|Ongoing at Time of Analysis|0|||
131800067|NCT03569293|474552412|FG005|Overall Study|Ongoing at Time of Analysis|0|||
131800068|NCT01171898|474552413|FG000|Overall Study|Death|0|||
131800069|NCT01171898|474552414|FG001|Overall Study|Death|0|||
131800070|NCT01171898|474552415|FG002|Overall Study|Death|2|||
131800071|NCT01171898|474552416|FG003|Overall Study|Death|0|||
131800072|NCT01171898|474552413|FG000|Overall Study|Lost to Follow-up|0|||
131800073|NCT01171898|474552414|FG001|Overall Study|Lost to Follow-up|1|||
131800074|NCT01171898|474552415|FG002|Overall Study|Lost to Follow-up|1|||
131800075|NCT01171898|474552416|FG003|Overall Study|Lost to Follow-up|1|||
131800076|NCT01171898|474552413|FG000|Overall Study|Withdrawal by Subject|1|||
131800077|NCT01171898|474552414|FG001|Overall Study|Withdrawal by Subject|4|||
131800078|NCT01171898|474552415|FG002|Overall Study|Withdrawal by Subject|6|||
131800079|NCT01171898|474552416|FG003|Overall Study|Withdrawal by Subject|3|||
131800080|NCT01171898|474552413|FG000|Overall Study|Terminated by Sponsor|1|||
131800081|NCT01171898|474552414|FG001|Overall Study|Terminated by Sponsor|0|||
131800082|NCT01171898|474552415|FG002|Overall Study|Terminated by Sponsor|0|||
131800083|NCT01171898|474552416|FG003|Overall Study|Terminated by Sponsor|0|||
131800084|NCT01171898|474552413|FG000|Overall Study|Ongoing|1|||
131800085|NCT01171898|474552414|FG001|Overall Study|Ongoing|9|||
131800086|NCT01171898|474552415|FG002|Overall Study|Ongoing|3|||
131902850|NCT02063672|474931305|FG001|Overall Study|Lost to Follow-up|3|||
131445145|NCT04323124|473258849|FG007|Overall Study|Adverse Event|1|||
131445146|NCT04323124|473258850|FG008|Overall Study|Adverse Event|1|||
131445147|NCT04323124|473258851|FG009|Overall Study|Adverse Event|0|||
131445148|NCT04323124|473258852|FG010|Overall Study|Adverse Event|0|||
131445149|NCT04323124|473258853|FG011|Overall Study|Adverse Event|0|||
131445150|NCT04323124|473258854|FG012|Overall Study|Adverse Event|0|||
131445151|NCT04323124|473258855|FG013|Overall Study|Adverse Event|0|||
131445152|NCT04323124|473258856|FG014|Overall Study|Adverse Event|0|||
131641821|NCT00878553|473974645|FG003|Sleep Study|family emergency|0|||
131641822|NCT00878553|473974646|FG004|Sleep Study|family emergency|0|||
131641823|NCT00878553|473974642|FG000|PK Study|Withdrawal by Subject|0|||
131641824|NCT00878553|473974643|FG001|PK Study|Withdrawal by Subject|0|||
131445153|NCT04323124|473258842|FG000|Overall Study|Other|0|||
131445154|NCT04323124|473258843|FG001|Overall Study|Other|0|||
131445155|NCT04323124|473258844|FG002|Overall Study|Other|0|||
131445156|NCT04323124|473258845|FG003|Overall Study|Other|0|||
131445157|NCT04323124|473258846|FG004|Overall Study|Other|1|||
131445158|NCT04323124|473258847|FG005|Overall Study|Other|0|||
131445159|NCT04323124|473258848|FG006|Overall Study|Other|0|||
131445160|NCT04323124|473258849|FG007|Overall Study|Other|0|||
131445161|NCT04323124|473258850|FG008|Overall Study|Other|1|||
131445162|NCT04323124|473258851|FG009|Overall Study|Other|0|||
131445163|NCT04323124|473258852|FG010|Overall Study|Other|0|||
131445164|NCT04323124|473258853|FG011|Overall Study|Other|0|||
131445165|NCT04323124|473258854|FG012|Overall Study|Other|0|||
131445166|NCT04323124|473258855|FG013|Overall Study|Other|0|||
131445167|NCT04323124|473258856|FG014|Overall Study|Other|0|||
131445168|NCT04323124|473258842|FG000|Overall Study|Coming from a red zone (COVID)|0|||
131641825|NCT00878553|473974644|FG002|PK Study|Withdrawal by Subject|0|||
131641826|NCT00878553|473974645|FG003|PK Study|Withdrawal by Subject|1|||
131641827|NCT00878553|473974646|FG004|PK Study|Withdrawal by Subject|0|||
131641828|NCT00912223|473974647|FG000|Overall Study|Withdrawal by Subject|1|||
131641829|NCT00912223|473974647|FG000|Overall Study|Not transplanted|1|||
131445169|NCT04323124|473258843|FG001|Overall Study|Coming from a red zone (COVID)|0|||
131445170|NCT04323124|473258844|FG002|Overall Study|Coming from a red zone (COVID)|0|||
131641830|NCT00912223|473974647|FG000|Overall Study|Transformed disease|1|||
131800087|NCT01171898|474552416|FG003|Overall Study|Ongoing|0|||
131800088|NCT01171898|474552413|FG000|Overall Study|Other|1|||
131641831|NCT00461123|473974648|FG000|Overall Study|Adverse Event|1|||
131641832|NCT00461123|473974649|FG001|Overall Study|Adverse Event|0|||
131800089|NCT01171898|474552414|FG001|Overall Study|Other|5|||
131800090|NCT01171898|474552415|FG002|Overall Study|Other|0|||
131800091|NCT01171898|474552416|FG003|Overall Study|Other|2|||
131641833|NCT00461123|473974648|FG000|Overall Study|Lost to Follow-up|1|||
131800092|NCT05037097|474552417|FG000|Overall Study|Withdrawal by Subject|0|||
131445171|NCT04323124|473258845|FG003|Overall Study|Coming from a red zone (COVID)|0|||
131445172|NCT04323124|473258846|FG004|Overall Study|Coming from a red zone (COVID)|1|||
131445173|NCT04323124|473258847|FG005|Overall Study|Coming from a red zone (COVID)|1|||
131445174|NCT04323124|473258848|FG006|Overall Study|Coming from a red zone (COVID)|0|||
131800093|NCT05037097|474552418|FG001|Overall Study|Withdrawal by Subject|1|||
131800094|NCT05037097|474552419|FG002|Overall Study|Withdrawal by Subject|0|||
131800095|NCT05037097|474552420|FG003|Overall Study|Withdrawal by Subject|1|||
131800096|NCT05037097|474552421|FG004|Overall Study|Withdrawal by Subject|0|||
131800097|NCT05037097|474552422|FG005|Overall Study|Withdrawal by Subject|2|||
131800098|NCT05037097|474552423|FG006|Overall Study|Withdrawal by Subject|0|||
131800099|NCT05037097|474552424|FG007|Overall Study|Withdrawal by Subject|0|||
131800100|NCT05037097|474552417|FG000|Overall Study|Lost to Follow-up|0|||
131800101|NCT05037097|474552418|FG001|Overall Study|Lost to Follow-up|1|||
131800102|NCT05037097|474552419|FG002|Overall Study|Lost to Follow-up|0|||
131800103|NCT05037097|474552420|FG003|Overall Study|Lost to Follow-up|0|||
131641834|NCT00461123|473974649|FG001|Overall Study|Lost to Follow-up|1|||
131641835|NCT00461123|473974648|FG000|Overall Study|Protocol Violation|3|||
131641836|NCT00461123|473974649|FG001|Overall Study|Protocol Violation|2|||
131641837|NCT00461123|473974648|FG000|Overall Study|Withdrawal by Subject|1|||
131641838|NCT00461123|473974649|FG001|Overall Study|Withdrawal by Subject|3|||
131641839|NCT02024750|473974650|FG000|Overall Study|Withdrawal by Subject|2|||
131641840|NCT02024750|473974651|FG001|Overall Study|Withdrawal by Subject|1|||
131641841|NCT03029819|473974652|FG000|Overall Study|Lost to Follow-up|3|||
131641842|NCT03029819|473974653|FG001|Overall Study|Lost to Follow-up|5|||
131641843|NCT03029819|473974652|FG000|Overall Study|Removed due to disruptive behavior|0|||
131641844|NCT03029819|473974653|FG001|Overall Study|Removed due to disruptive behavior|1|||
131641845|NCT02650466|473974656|FG000|Overall Study|Physician Decision|1|||
131641846|NCT02650466|473974656|FG000|Overall Study|Withdrawal by Subject|5|||
131641847|NCT02650466|473974656|FG000|Overall Study|Lost to Follow-up|1|||
131641848|NCT01837797|473974657|FG000|Period 1|Adverse Event|9|||
131800104|NCT05037097|474552421|FG004|Overall Study|Lost to Follow-up|1|||
131800105|NCT05037097|474552422|FG005|Overall Study|Lost to Follow-up|1|||
131800106|NCT05037097|474552423|FG006|Overall Study|Lost to Follow-up|0|||
131800107|NCT05037097|474552424|FG007|Overall Study|Lost to Follow-up|0|||
131800108|NCT04510857|474552425|FG000|Overall Study|Withdrawal by Subject|1|||
131800109|NCT04510857|474552426|FG001|Overall Study|Withdrawal by Subject|2|||
131800110|NCT02819362|474552427|FG000|Overall Study|On-site MRI could not be performed|70|||
131800111|NCT05301751|474552428|FG000|Overall Study|Withdrawal by Subject|0|||
131800112|NCT05301751|474552429|FG001|Overall Study|Withdrawal by Subject|0|||
131800113|NCT05301751|474552430|FG002|Overall Study|Withdrawal by Subject|1|||
131800114|NCT05301751|474552431|FG003|Overall Study|Withdrawal by Subject|0|||
131800115|NCT01546987|474552434|FG000|Overall Study|Protocol Violation|3|||
131800116|NCT01546987|474552435|FG001|Overall Study|Protocol Violation|4|||
131800117|NCT02710123|474552436|FG000|Overall Study|Lost to Follow-up|3|||
131800118|NCT02710123|474552437|FG001|Overall Study|Lost to Follow-up|4|||
131800119|NCT02710123|474552436|FG000|Overall Study|Withdrawal by Subject|1|||
131800120|NCT02710123|474552437|FG001|Overall Study|Withdrawal by Subject|1|||
131800121|NCT02710123|474552436|FG000|Overall Study|Illness unrelated to study intervention|1|||
131641849|NCT01837797|473974658|FG001|Period 1|Adverse Event|0|||
131641850|NCT01837797|473974659|FG002|Period 1|Adverse Event|0|||
131641851|NCT01837797|473974660|FG003|Period 1|Adverse Event|0|||
131800122|NCT02710123|474552437|FG001|Overall Study|Illness unrelated to study intervention|0|||
131800123|NCT05381948|474552438|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
131641852|NCT01837797|473974661|FG004|Period 1|Adverse Event|0|||
131800124|NCT05381948|474552439|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
131800125|NCT05381948|474552440|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
131800126|NCT05381948|474552438|FG000|Overall Study|Adverse Event: Non-ocular|0|||
131800127|NCT05381948|474552439|FG001|Overall Study|Adverse Event: Non-ocular|1|||
131800128|NCT05381948|474552440|FG002|Overall Study|Adverse Event: Non-ocular|0|||
131800129|NCT05381948|474552438|FG000|Overall Study|Lost to Follow-up|1|||
131800130|NCT05381948|474552439|FG001|Overall Study|Lost to Follow-up|0|||
131800131|NCT05381948|474552440|FG002|Overall Study|Lost to Follow-up|0|||
131800132|NCT05381948|474552438|FG000|Overall Study|Protocol Deviation|0|||
131800133|NCT05381948|474552439|FG001|Overall Study|Protocol Deviation|2|||
131800134|NCT05381948|474552440|FG002|Overall Study|Protocol Deviation|0|||
131800135|NCT05381948|474552438|FG000|Overall Study|Withdrawal by Subject|1|||
131800136|NCT05381948|474552439|FG001|Overall Study|Withdrawal by Subject|0|||
131800137|NCT05381948|474552440|FG002|Overall Study|Withdrawal by Subject|1|||
131800138|NCT05381948|474552438|FG000|Overall Study|Death|0|||
131800139|NCT05381948|474552439|FG001|Overall Study|Death|2|||
131800140|NCT05381948|474552440|FG002|Overall Study|Death|0|||
131800141|NCT05381948|474552438|FG000|Overall Study|Discontinued study without receiving study drug|0|||
131800142|NCT05381948|474552439|FG001|Overall Study|Discontinued study without receiving study drug|0|||
131800143|NCT05381948|474552440|FG002|Overall Study|Discontinued study without receiving study drug|1|||
131800144|NCT04471207|474552441|FG000|Overall Study|Lost to Follow-up|4|||
131800145|NCT04471207|474552442|FG001|Overall Study|Lost to Follow-up|1|||
131800146|NCT04471207|474552441|FG000|Overall Study|Medication Contraindication|0|||
131800147|NCT04471207|474552442|FG001|Overall Study|Medication Contraindication|1|||
131800148|NCT04471207|474552441|FG000|Overall Study|Loss of Interest|2|||
131800149|NCT04471207|474552442|FG001|Overall Study|Loss of Interest|1|||
131800150|NCT04471207|474552441|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
131800151|NCT04471207|474552442|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
131800152|NCT04471207|474552441|FG000|Overall Study|Scheduling Conflicts|3|||
131800153|NCT04471207|474552442|FG001|Overall Study|Scheduling Conflicts|1|||
131800154|NCT04471207|474552441|FG000|Overall Study|Physician Decision|1|||
131800155|NCT04471207|474552442|FG001|Overall Study|Physician Decision|0|||
131800156|NCT04471207|474552441|FG000|Overall Study|Unwilling to Use System|0|||
131800157|NCT04471207|474552442|FG001|Overall Study|Unwilling to Use System|1|||
131800158|NCT00561730|474552445|FG000|Overall Study|Adverse Event|2|||
131800159|NCT00561730|474552445|FG000|Overall Study|Handling of the drug|1|||
131800160|NCT00561730|474552445|FG000|Overall Study|Lost to Follow-up|5|||
131800161|NCT00561730|474552445|FG000|Overall Study|Not specified reasons|1|||
131800162|NCT02446132|474552448|FG000|Overall Study|Adverse Event|10|||
131800163|NCT02446132|474552449|FG001|Overall Study|Adverse Event|27|||
131800164|NCT02446132|474552450|FG002|Overall Study|Adverse Event|27|||
131800165|NCT02446132|474552448|FG000|Overall Study|Death|2|||
131800166|NCT02446132|474552449|FG001|Overall Study|Death|13|||
131800167|NCT02446132|474552450|FG002|Overall Study|Death|10|||
131800168|NCT02446132|474552448|FG000|Overall Study|Lack of Efficacy|1|||
131800169|NCT02446132|474552449|FG001|Overall Study|Lack of Efficacy|10|||
131800170|NCT02446132|474552450|FG002|Overall Study|Lack of Efficacy|6|||
131800171|NCT02446132|474552448|FG000|Overall Study|Lost to Follow-up|2|||
131800172|NCT02446132|474552449|FG001|Overall Study|Lost to Follow-up|4|||
131800173|NCT02446132|474552450|FG002|Overall Study|Lost to Follow-up|5|||
131800174|NCT02446132|474552448|FG000|Overall Study|Non-compliance With Study Drug|2|||
131800175|NCT02446132|474552449|FG001|Overall Study|Non-compliance With Study Drug|2|||
131800176|NCT02446132|474552450|FG002|Overall Study|Non-compliance With Study Drug|3|||
131800177|NCT02446132|474552448|FG000|Overall Study|Physician Decision|1|||
131800178|NCT02446132|474552449|FG001|Overall Study|Physician Decision|8|||
131800179|NCT02446132|474552450|FG002|Overall Study|Physician Decision|13|||
131800180|NCT02446132|474552448|FG000|Overall Study|Protocol Deviation|0|||
131800181|NCT02446132|474552449|FG001|Overall Study|Protocol Deviation|0|||
131902851|NCT02063672|474931304|FG000|Overall Study|Withdrawal by Subject|2|||
131902852|NCT02063672|474931305|FG001|Overall Study|Withdrawal by Subject|2|||
131902853|NCT02619617|474931327|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
131800182|NCT02446132|474552450|FG002|Overall Study|Protocol Deviation|1|||
131800183|NCT02446132|474552448|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
131902854|NCT02619617|474931328|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
131800184|NCT02446132|474552449|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
131800185|NCT02446132|474552450|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
131800186|NCT02446132|474552448|FG000|Overall Study|Study Terminated by Sponsor|4|||
131800187|NCT02446132|474552449|FG001|Overall Study|Study Terminated by Sponsor|35|||
131800188|NCT02446132|474552450|FG002|Overall Study|Study Terminated by Sponsor|58|||
131800189|NCT02446132|474552448|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
131800190|NCT02446132|474552449|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
131800191|NCT02446132|474552450|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
131800192|NCT02446132|474552448|FG000|Overall Study|Withdrawal by Subject|11|||
131800193|NCT02446132|474552449|FG001|Overall Study|Withdrawal by Subject|29|||
131800194|NCT02446132|474552450|FG002|Overall Study|Withdrawal by Subject|25|||
131800195|NCT02446132|474552448|FG000|Overall Study|Reason not Specified|4|||
131800196|NCT02446132|474552449|FG001|Overall Study|Reason not Specified|16|||
131641853|NCT01837797|473974657|FG000|Period 1|Withdrawal by Subject|6|||
131641854|NCT01837797|473974658|FG001|Period 1|Withdrawal by Subject|0|||
131641855|NCT01837797|473974659|FG002|Period 1|Withdrawal by Subject|0|||
131641856|NCT01837797|473974660|FG003|Period 1|Withdrawal by Subject|0|||
131641857|NCT01837797|473974661|FG004|Period 1|Withdrawal by Subject|0|||
131641858|NCT01837797|473974657|FG000|Period 1|Administrative reasons|76|||
131800197|NCT02446132|474552450|FG002|Overall Study|Reason not Specified|10|||
131800198|NCT02446132|474552448|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
131800199|NCT02446132|474552449|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
131800200|NCT02446132|474552450|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
131800201|NCT05526248|474552451|FG000|Overall Study|Lost to Follow-up|1|||
131800202|NCT05526248|474552451|FG000|Overall Study|Adverse Event|2|||
131800203|NCT05526248|474552451|FG000|Overall Study|Withdrawal by Subject|1|||
131800204|NCT01644500|474552452|FG000|Overall Study|Adverse Event|6|||
131800205|NCT01644500|474552453|FG001|Overall Study|Adverse Event|1|||
131800206|NCT01644500|474552454|FG002|Overall Study|Adverse Event|2|||
131800207|NCT01644500|474552452|FG000|Overall Study|Death|0|||
131800208|NCT01644500|474552453|FG001|Overall Study|Death|1|||
131800209|NCT01644500|474552454|FG002|Overall Study|Death|0|||
131800210|NCT01644500|474552452|FG000|Overall Study|Lost to Follow-up|3|||
131800211|NCT01644500|474552453|FG001|Overall Study|Lost to Follow-up|8|||
131800212|NCT01644500|474552454|FG002|Overall Study|Lost to Follow-up|0|||
131800213|NCT01644500|474552452|FG000|Overall Study|Protocol Violation|1|||
131800214|NCT01644500|474552453|FG001|Overall Study|Protocol Violation|1|||
131800215|NCT01644500|474552454|FG002|Overall Study|Protocol Violation|0|||
131800216|NCT01644500|474552452|FG000|Overall Study|Withdrawal by Subject|11|||
131800217|NCT01644500|474552453|FG001|Overall Study|Withdrawal by Subject|12|||
131800218|NCT01644500|474552454|FG002|Overall Study|Withdrawal by Subject|12|||
131800219|NCT01644500|474552452|FG000|Overall Study|Physician Decision|1|||
131800220|NCT01644500|474552453|FG001|Overall Study|Physician Decision|1|||
131800221|NCT01644500|474552454|FG002|Overall Study|Physician Decision|1|||
131800222|NCT03331042|474552461|FG000|Overall Study|Protocol Violation|1|||
131800223|NCT03331042|474552462|FG001|Overall Study|Protocol Violation|0|||
131800224|NCT03331042|474552463|FG002|Overall Study|Protocol Violation|0|||
131800225|NCT03331042|474552464|FG003|Overall Study|Protocol Violation|0|||
131800226|NCT03331042|474552461|FG000|Overall Study|Physician Decision|0|||
131800227|NCT03331042|474552462|FG001|Overall Study|Physician Decision|0|||
131800228|NCT03331042|474552463|FG002|Overall Study|Physician Decision|1|||
131800229|NCT03331042|474552464|FG003|Overall Study|Physician Decision|0|||
131800230|NCT03331042|474552461|FG000|Overall Study|Lost to Follow-up|0|||
131800231|NCT03331042|474552462|FG001|Overall Study|Lost to Follow-up|0|||
131800232|NCT03331042|474552463|FG002|Overall Study|Lost to Follow-up|0|||
131800233|NCT03331042|474552464|FG003|Overall Study|Lost to Follow-up|1|||
131800234|NCT00322491|474552468|FG000|Overall Study|Adverse Event|1|||
131800235|NCT00322491|474552469|FG001|Overall Study|Adverse Event|0|||
131800236|NCT00322491|474552468|FG000|Overall Study|Death|1|||
131800237|NCT00322491|474552469|FG001|Overall Study|Death|2|||
131800238|NCT01400425|474552471|FG000|Overall Study|Withdrawal by Subject|10|||
131800239|NCT00688064|474552473|FG000|Overall Study|Protocol Violation|0|||
131445175|NCT04323124|473258849|FG007|Overall Study|Coming from a red zone (COVID)|0|||
131641859|NCT01837797|473974658|FG001|Period 1|Administrative reasons|0|||
131641860|NCT01837797|473974659|FG002|Period 1|Administrative reasons|0|||
131800240|NCT00688064|474552474|FG001|Overall Study|Protocol Violation|1|||
131800241|NCT00688064|474552473|FG000|Overall Study|Adverse Event|2|||
131800242|NCT00688064|474552474|FG001|Overall Study|Adverse Event|4|||
131641861|NCT01837797|473974660|FG003|Period 1|Administrative reasons|0|||
131800243|NCT00688064|474552473|FG000|Overall Study|Withdrawal by Subject|7|||
131800244|NCT00688064|474552474|FG001|Overall Study|Withdrawal by Subject|7|||
131800245|NCT00688064|474552473|FG000|Overall Study|Lost to Follow-up|10|||
131800246|NCT00688064|474552474|FG001|Overall Study|Lost to Follow-up|10|||
131800247|NCT00688064|474552473|FG000|Overall Study|Lack of Efficacy|0|||
131800248|NCT00688064|474552474|FG001|Overall Study|Lack of Efficacy|1|||
131800249|NCT00688064|474552473|FG000|Overall Study|Pregnancy|1|||
131445176|NCT04323124|473258850|FG008|Overall Study|Coming from a red zone (COVID)|0|||
131800250|NCT00688064|474552474|FG001|Overall Study|Pregnancy|0|||
131800251|NCT00688064|474552473|FG000|Overall Study|Any other reasons|1|||
131800252|NCT00688064|474552474|FG001|Overall Study|Any other reasons|3|||
131800253|NCT04557124|474552475|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
131800254|NCT04557124|474552476|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
131800255|NCT04557124|474552475|FG000|Mid-point (1 Month)|Missed testing|5|||
131800256|NCT04557124|474552476|FG001|Mid-point (1 Month)|Missed testing|4|||
131800257|NCT04557124|474552475|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
131800258|NCT04557124|474552476|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
131800259|NCT04557124|474552475|FG000|Post-testing (2 Months)|Missed testing|1|||
131800260|NCT04557124|474552476|FG001|Post-testing (2 Months)|Missed testing|5|||
131800261|NCT04557124|474552475|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
131800262|NCT04557124|474552476|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
131800263|NCT04557124|474552475|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
131800264|NCT04557124|474552476|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
131800265|NCT00001849|474552477|FG000|Overall Study|Death|4|||
131800266|NCT00001849|474552477|FG000|Overall Study|Lost to Follow-up|2|||
131800267|NCT00001849|474552477|FG000|Overall Study|Withdrawal by Subject|2|||
131800268|NCT00001849|474552477|FG000|Overall Study|tumor remained occult|6|||
131800269|NCT00442936|474552478|FG000|Overall Study|Protocol Violation|1|||
131800270|NCT00442936|474552479|FG001|Overall Study|Protocol Violation|0|||
131800271|NCT00442936|474552480|FG002|Overall Study|Protocol Violation|1|||
131800272|NCT00442936|474552481|FG003|Overall Study|Protocol Violation|1|||
131800273|NCT04424407|474552482|FG000|Overall Study|Withdrawal by Subject|2|||
131800274|NCT04424407|474552482|FG000|Overall Study|Lost to Follow-up|1|||
131800275|NCT03803943|474552485|FG000|Overall Study|Withdrawal by Subject|2|||
131800276|NCT03803943|474552486|FG001|Overall Study|Withdrawal by Subject|2|||
131800277|NCT03803943|474552487|FG002|Overall Study|Withdrawal by Subject|2|||
131800278|NCT03803943|474552488|FG003|Overall Study|Withdrawal by Subject|2|||
131800279|NCT01781286|474552489|FG000|Overall Study|Lost to Follow-up|0|||
131800280|NCT01781286|474552490|FG001|Overall Study|Lost to Follow-up|0|||
131800281|NCT01781286|474552491|FG002|Overall Study|Lost to Follow-up|0|||
131800282|NCT01781286|474552492|FG003|Overall Study|Lost to Follow-up|0|||
131800283|NCT01781286|474552493|FG004|Overall Study|Lost to Follow-up|0|||
131800284|NCT01781286|474552494|FG005|Overall Study|Lost to Follow-up|1|||
131800285|NCT01781286|474552489|FG000|Overall Study|Time Constraints|2|||
131800286|NCT01781286|474552490|FG001|Overall Study|Time Constraints|0|||
131800287|NCT01781286|474552491|FG002|Overall Study|Time Constraints|2|||
131800288|NCT01781286|474552492|FG003|Overall Study|Time Constraints|0|||
131800289|NCT01781286|474552493|FG004|Overall Study|Time Constraints|0|||
131800290|NCT01781286|474552494|FG005|Overall Study|Time Constraints|0|||
131800291|NCT01781286|474552489|FG000|Overall Study|Noncompliance|0|||
131800292|NCT01781286|474552490|FG001|Overall Study|Noncompliance|0|||
131800293|NCT01781286|474552491|FG002|Overall Study|Noncompliance|0|||
131800294|NCT01781286|474552492|FG003|Overall Study|Noncompliance|1|||
131800295|NCT01781286|474552493|FG004|Overall Study|Noncompliance|0|||
131800296|NCT01781286|474552494|FG005|Overall Study|Noncompliance|0|||
131800297|NCT03594123|474552495|FG000|Overall Study|Lost to Follow-up|0|||
131800298|NCT03594123|474552496|FG001|Overall Study|Lost to Follow-up|1|||
131800299|NCT03594123|474552495|FG000|Overall Study|Adverse Event|8|||
131800300|NCT03594123|474552496|FG001|Overall Study|Adverse Event|5|||
131800301|NCT03594123|474552495|FG000|Overall Study|Site Terminated by Sponsor|4|||
131800302|NCT03594123|474552496|FG001|Overall Study|Site Terminated by Sponsor|1|||
131800303|NCT03594123|474552495|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
131800304|NCT03594123|474552496|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
131800305|NCT03594123|474552495|FG000|Overall Study|Lack of Efficacy|1|||
131800306|NCT03594123|474552496|FG001|Overall Study|Lack of Efficacy|0|||
131800307|NCT03594123|474552495|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
131800308|NCT03594123|474552496|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
131800309|NCT00973700|474552499|FG000|Overall Study|Withdrawal by Subject|2|||
131800310|NCT00973700|474552500|FG001|Overall Study|Withdrawal by Subject|2|||
131800311|NCT00973700|474552501|FG002|Overall Study|Withdrawal by Subject|8|||
131800312|NCT00973700|474552502|FG003|Overall Study|Withdrawal by Subject|4|||
131800313|NCT00973700|474552503|FG004|Overall Study|Withdrawal by Subject|4|||
131800314|NCT00973700|474552499|FG000|Overall Study|Lost to Follow-up|5|||
131800315|NCT00973700|474552500|FG001|Overall Study|Lost to Follow-up|0|||
131641862|NCT01837797|473974661|FG004|Period 1|Administrative reasons|0|||
131641863|NCT01837797|473974657|FG000|Period 1|Withdrawal of consent before treatment|1|||
131641864|NCT01837797|473974658|FG001|Period 1|Withdrawal of consent before treatment|0|||
131800316|NCT00973700|474552501|FG002|Overall Study|Lost to Follow-up|1|||
131641865|NCT01837797|473974659|FG002|Period 1|Withdrawal of consent before treatment|0|||
131641866|NCT01837797|473974660|FG003|Period 1|Withdrawal of consent before treatment|0|||
131800317|NCT00973700|474552502|FG003|Overall Study|Lost to Follow-up|8|||
131800318|NCT00973700|474552503|FG004|Overall Study|Lost to Follow-up|5|||
131800319|NCT00973700|474552499|FG000|Overall Study|Inappropriate enrolment|0|||
131800320|NCT00973700|474552500|FG001|Overall Study|Inappropriate enrolment|0|||
131800321|NCT00973700|474552501|FG002|Overall Study|Inappropriate enrolment|0|||
131800322|NCT00973700|474552502|FG003|Overall Study|Inappropriate enrolment|4|||
131800323|NCT00973700|474552503|FG004|Overall Study|Inappropriate enrolment|0|||
131800324|NCT00973700|474552499|FG000|Overall Study|Unable to Classify|0|||
131800325|NCT00973700|474552500|FG001|Overall Study|Unable to Classify|0|||
131800326|NCT00973700|474552501|FG002|Overall Study|Unable to Classify|1|||
131800327|NCT00973700|474552502|FG003|Overall Study|Unable to Classify|2|||
131800328|NCT00973700|474552503|FG004|Overall Study|Unable to Classify|1|||
131800329|NCT05518487|474552506|FG000|Overall Study|Withdrawal by Subject|3|||
131902855|NCT02619617|474931327|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
131902856|NCT02619617|474931328|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
131902857|NCT01854697|474931329|FG000|Overall Study|Adverse Event|1|||
131902858|NCT01854697|474931330|FG001|Overall Study|Adverse Event|0|||
131902859|NCT01854697|474931331|FG002|Overall Study|Adverse Event|0|||
131902860|NCT01854697|474931332|FG003|Overall Study|Adverse Event|0|||
131902861|NCT01854697|474931333|FG004|Overall Study|Adverse Event|1|||
131902862|NCT01854697|474931329|FG000|Overall Study|Lost to Follow-up|4|||
131902863|NCT01854697|474931330|FG001|Overall Study|Lost to Follow-up|1|||
131902864|NCT01854697|474931331|FG002|Overall Study|Lost to Follow-up|1|||
131902865|NCT01854697|474931332|FG003|Overall Study|Lost to Follow-up|2|||
131902866|NCT01854697|474931333|FG004|Overall Study|Lost to Follow-up|0|||
131902867|NCT01854697|474931329|FG000|Overall Study|To enter another AbbVie study|1|||
131902868|NCT01854697|474931330|FG001|Overall Study|To enter another AbbVie study|0|||
131902869|NCT01854697|474931331|FG002|Overall Study|To enter another AbbVie study|0|||
131902870|NCT01854697|474931332|FG003|Overall Study|To enter another AbbVie study|0|||
131902871|NCT01854697|474931333|FG004|Overall Study|To enter another AbbVie study|1|||
131902872|NCT01854697|474931329|FG000|Overall Study|Withdrew Consent|0|||
131902873|NCT01854697|474931330|FG001|Overall Study|Withdrew Consent|1|||
131902874|NCT01854697|474931331|FG002|Overall Study|Withdrew Consent|0|||
131902875|NCT01854697|474931332|FG003|Overall Study|Withdrew Consent|1|||
131902876|NCT01854697|474931333|FG004|Overall Study|Withdrew Consent|0|||
131902877|NCT01854697|474931329|FG000|Overall Study|Other|0|||
131902878|NCT01854697|474931330|FG001|Overall Study|Other|1|||
131902879|NCT01854697|474931331|FG002|Overall Study|Other|1|||
131902880|NCT01854697|474931332|FG003|Overall Study|Other|0|||
131902881|NCT01854697|474931333|FG004|Overall Study|Other|0|||
131902882|NCT00483652|474931336|FG000|Double-blind Treatment Period|Protocol Violation|2|||
131902883|NCT00483652|474931337|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131800330|NCT03499964|474552507|FG000|Overall Study|Lack of Efficacy|6|||
131641867|NCT01837797|473974661|FG004|Period 1|Withdrawal of consent before treatment|0|||
131641868|NCT01837797|473974657|FG000|Period 1|Other|10|||
131641869|NCT01837797|473974658|FG001|Period 1|Other|0|||
131641870|NCT01837797|473974659|FG002|Period 1|Other|0|||
131641871|NCT01837797|473974660|FG003|Period 1|Other|0|||
131641872|NCT01837797|473974661|FG004|Period 1|Other|0|||
131641873|NCT01837797|473974657|FG000|Period 2|Administrative or other reasons|0|||
131641874|NCT01837797|473974658|FG001|Period 2|Administrative or other reasons|5|||
131641875|NCT01837797|473974659|FG002|Period 2|Administrative or other reasons|2|||
131800331|NCT03499964|474552508|FG001|Overall Study|Lack of Efficacy|26|||
131800332|NCT03499964|474552507|FG000|Overall Study|Adverse Event|1|||
131800333|NCT03499964|474552508|FG001|Overall Study|Adverse Event|0|||
131800334|NCT03499964|474552507|FG000|Overall Study|Death|1|||
131800335|NCT03499964|474552508|FG001|Overall Study|Death|0|||
131800336|NCT03499964|474552507|FG000|Overall Study|Withdrawal by Subject|2|||
131641876|NCT01837797|473974660|FG003|Period 2|Administrative or other reasons|4|||
131641877|NCT01837797|473974661|FG004|Period 2|Administrative or other reasons|0|||
131641878|NCT01837797|473974657|FG000|Period 2|Adverse Event|0|||
131641879|NCT01837797|473974658|FG001|Period 2|Adverse Event|0|||
131641880|NCT01837797|473974659|FG002|Period 2|Adverse Event|0|||
131641881|NCT01837797|473974660|FG003|Period 2|Adverse Event|1|||
131800337|NCT03499964|474552508|FG001|Overall Study|Withdrawal by Subject|1|||
131800338|NCT03499964|474552507|FG000|Overall Study|Lost to Follow-up|1|||
131800339|NCT03499964|474552508|FG001|Overall Study|Lost to Follow-up|0|||
131800340|NCT00454636|474552509|FG000|Overall Study|Adverse Event|10|||
131641882|NCT01837797|473974661|FG004|Period 2|Adverse Event|0|||
131641883|NCT01837797|473974657|FG000|Period 3|Adverse Event|0|||
131641884|NCT01837797|473974658|FG001|Period 3|Adverse Event|0|||
131800341|NCT00454636|474552510|FG001|Overall Study|Adverse Event|6|||
131800342|NCT00454636|474552511|FG002|Overall Study|Adverse Event|9|||
131800343|NCT00454636|474552512|FG003|Overall Study|Adverse Event|15|||
131902884|NCT00483652|474931336|FG000|Double-blind Treatment Period|Adverse Event|3|||
131641885|NCT01837797|473974659|FG002|Period 3|Adverse Event|0|||
131902885|NCT00483652|474931337|FG001|Double-blind Treatment Period|Adverse Event|4|||
131641886|NCT01837797|473974660|FG003|Period 3|Adverse Event|0|||
131800344|NCT00454636|474552509|FG000|Overall Study|Disease Progression|11|||
131800345|NCT00454636|474552510|FG001|Overall Study|Disease Progression|12|||
131800346|NCT00454636|474552511|FG002|Overall Study|Disease Progression|4|||
131800347|NCT00454636|474552512|FG003|Overall Study|Disease Progression|11|||
131800348|NCT00454636|474552509|FG000|Overall Study|Protocol Violation|3|||
131800349|NCT00454636|474552510|FG001|Overall Study|Protocol Violation|2|||
131800350|NCT00454636|474552511|FG002|Overall Study|Protocol Violation|3|||
131800351|NCT00454636|474552512|FG003|Overall Study|Protocol Violation|3|||
131800352|NCT00454636|474552509|FG000|Overall Study|Death|6|||
131800353|NCT00454636|474552510|FG001|Overall Study|Death|1|||
131800354|NCT00454636|474552511|FG002|Overall Study|Death|1|||
131800355|NCT00454636|474552512|FG003|Overall Study|Death|1|||
131800356|NCT00454636|474552509|FG000|Overall Study|Patient refusal|1|||
131800357|NCT00454636|474552510|FG001|Overall Study|Patient refusal|1|||
131800358|NCT00454636|474552511|FG002|Overall Study|Patient refusal|3|||
131800359|NCT00454636|474552512|FG003|Overall Study|Patient refusal|2|||
131800360|NCT00454636|474552509|FG000|Overall Study|Lost to Follow-up|0|||
131800361|NCT00454636|474552510|FG001|Overall Study|Lost to Follow-up|1|||
131800362|NCT00454636|474552511|FG002|Overall Study|Lost to Follow-up|0|||
131800363|NCT00454636|474552512|FG003|Overall Study|Lost to Follow-up|0|||
131800364|NCT01025037|474552516|FG000|Overall Study|Adverse Event|3|||
131800365|NCT01025037|474552516|FG000|Overall Study|Lost to Follow-up|7|||
131800366|NCT01025037|474552516|FG000|Overall Study|Withdrawal by Subject|1|||
131800367|NCT00337571|474552517|FG000|Overall Study|Lack of Efficacy|3|||
131800368|NCT00337571|474552518|FG001|Overall Study|Lack of Efficacy|0|||
131800369|NCT00337571|474552519|FG002|Overall Study|Lack of Efficacy|0|||
131800370|NCT00337571|474552520|FG003|Overall Study|Lack of Efficacy|0|||
131800371|NCT00337571|474552517|FG000|Overall Study|Adverse Event|4|||
131800372|NCT00337571|474552518|FG001|Overall Study|Adverse Event|5|||
131800373|NCT00337571|474552519|FG002|Overall Study|Adverse Event|8|||
131800374|NCT00337571|474552520|FG003|Overall Study|Adverse Event|4|||
131800375|NCT00337571|474552517|FG000|Overall Study|Withdrawal by Subject|2|||
131800376|NCT00337571|474552518|FG001|Overall Study|Withdrawal by Subject|2|||
131800377|NCT00337571|474552519|FG002|Overall Study|Withdrawal by Subject|1|||
131800378|NCT00337571|474552520|FG003|Overall Study|Withdrawal by Subject|0|||
131800379|NCT00337571|474552517|FG000|Overall Study|Lost to Follow-up|3|||
131800380|NCT00337571|474552518|FG001|Overall Study|Lost to Follow-up|1|||
131800381|NCT00337571|474552519|FG002|Overall Study|Lost to Follow-up|0|||
131800382|NCT00337571|474552520|FG003|Overall Study|Lost to Follow-up|1|||
131800383|NCT00337571|474552517|FG000|Overall Study|Poor/noncompliance|1|||
131800384|NCT00337571|474552518|FG001|Overall Study|Poor/noncompliance|1|||
131800385|NCT00337571|474552519|FG002|Overall Study|Poor/noncompliance|1|||
131800386|NCT00337571|474552520|FG003|Overall Study|Poor/noncompliance|1|||
131800387|NCT00337571|474552517|FG000|Overall Study|No longer met study criteria|1|||
131800388|NCT00337571|474552518|FG001|Overall Study|No longer met study criteria|0|||
131800389|NCT00337571|474552519|FG002|Overall Study|No longer met study criteria|0|||
131800390|NCT00337571|474552520|FG003|Overall Study|No longer met study criteria|0|||
131800391|NCT00337571|474552517|FG000|Overall Study|High Potassium level|0|||
131800392|NCT00337571|474552518|FG001|Overall Study|High Potassium level|0|||
131800393|NCT00337571|474552519|FG002|Overall Study|High Potassium level|0|||
131800394|NCT00337571|474552520|FG003|Overall Study|High Potassium level|1|||
131800395|NCT01890915|474552522|FG000|Overall Study|Adverse Event|1|||
131800396|NCT01890915|474552523|FG001|Overall Study|Adverse Event|0|||
131800397|NCT01890915|474552522|FG000|Overall Study|Protocol Violation|2|||
131800398|NCT01890915|474552523|FG001|Overall Study|Protocol Violation|0|||
131800399|NCT01890915|474552522|FG000|Overall Study|Equipment Malfunction|0|||
131800400|NCT01890915|474552523|FG001|Overall Study|Equipment Malfunction|1|||
131800401|NCT05014412|474552525|FG000|Overall Study|Death|11|||
131800402|NCT05014412|474552526|FG001|Overall Study|Death|7|||
131800403|NCT05014412|474552527|FG002|Overall Study|Death|4|||
131800404|NCT05014412|474552528|FG003|Overall Study|Death|7|||
131800405|NCT05014412|474552525|FG000|Overall Study|Withdrawal by Subject|1|||
131800406|NCT05014412|474552526|FG001|Overall Study|Withdrawal by Subject|1|||
131800407|NCT05014412|474552527|FG002|Overall Study|Withdrawal by Subject|1|||
131800408|NCT05014412|474552528|FG003|Overall Study|Withdrawal by Subject|2|||
131800409|NCT05014412|474552525|FG000|Overall Study|Ongoing|21|||
131800410|NCT05014412|474552526|FG001|Overall Study|Ongoing|4|||
131800411|NCT05014412|474552527|FG002|Overall Study|Ongoing|6|||
131800412|NCT05014412|474552528|FG003|Overall Study|Ongoing|20|||
131800413|NCT04981912|474552535|FG000|Overall Study|Physician Decision|2|||
131800414|NCT00980954|474552536|FG000|Overall Study|Protocol Violation|9|||
131800415|NCT00980954|474552537|FG001|Overall Study|Protocol Violation|15|||
131800416|NCT05630547|474552538|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
131800417|NCT05630547|474552539|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
131800418|NCT05630547|474552540|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
131800419|NCT05630547|474552541|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
131800420|NCT05630547|474552538|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
131800421|NCT05630547|474552539|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
131445177|NCT04323124|473258851|FG009|Overall Study|Coming from a red zone (COVID)|0|||
131714958|NCT00929240|474233737|FG000|Maintenance Phase|Change of treatment|0|||
131714959|NCT00929240|474233738|FG001|Maintenance Phase|Change of treatment|4|||
131714960|NCT00929240|474233739|FG002|Maintenance Phase|Change of treatment|0|||
131714961|NCT00929240|474233737|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
131714962|NCT00929240|474233738|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
131714963|NCT00929240|474233739|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
131714964|NCT00929240|474233737|FG000|Maintenance Phase|Participant not treated|0|||
131714965|NCT00929240|474233738|FG001|Maintenance Phase|Participant not treated|2|||
131714966|NCT00929240|474233739|FG002|Maintenance Phase|Participant not treated|0|||
131714967|NCT05292755|474233740|FG000|Overall Study|Lost to Follow-up|5|||
131714968|NCT05292755|474233741|FG001|Overall Study|Lost to Follow-up|9|||
131714969|NCT04325503|474233743|FG000|Overall Study|Withdrawal by Subject|1|||
131714970|NCT04325503|474233743|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
131714971|NCT00144170|474233744|FG000|Overall Study|Adverse Event|84|||
131714972|NCT00144170|474233745|FG001|Overall Study|Adverse Event|41|||
131714973|NCT00144170|474233744|FG000|Overall Study|Protocol Violation|23|||
131714974|NCT00144170|474233745|FG001|Overall Study|Protocol Violation|16|||
131714975|NCT00144170|474233744|FG000|Overall Study|Lost to Follow-up|5|||
131714976|NCT00144170|474233745|FG001|Overall Study|Lost to Follow-up|10|||
131714977|NCT00144170|474233744|FG000|Overall Study|Withdrawal by Subject|29|||
131714978|NCT00144170|474233745|FG001|Overall Study|Withdrawal by Subject|13|||
131714979|NCT00144170|474233744|FG000|Overall Study|Other reason not defined above|211|||
131714980|NCT00144170|474233745|FG001|Overall Study|Other reason not defined above|316|||
131714981|NCT00981526|474233746|FG000|Overall Study|Withdrawal by Subject|0|||
131714982|NCT00981526|474233747|FG001|Overall Study|Withdrawal by Subject|2|||
131714983|NCT00981526|474233746|FG000|Overall Study|Physician Decision|4|||
131714984|NCT00981526|474233747|FG001|Overall Study|Physician Decision|4|||
131714985|NCT01564784|474233748|FG000|Overall Study|Other|1|||
131714986|NCT01564784|474233749|FG001|Overall Study|Other|0|||
131714987|NCT01564784|474233748|FG000|Overall Study|Subject refused further follow-up|1|||
131714988|NCT01564784|474233749|FG001|Overall Study|Subject refused further follow-up|6|||
131714989|NCT01564784|474233748|FG000|Overall Study|Lost to Follow-up|1|||
131714990|NCT01564784|474233749|FG001|Overall Study|Lost to Follow-up|1|||
131714991|NCT01564784|474233748|FG000|Overall Study|Death|131|||
131714992|NCT01564784|474233749|FG001|Overall Study|Death|126|||
131714993|NCT03871491|474233750|FG000|Overall Study|Withdrawal by Subject|14|||
131714994|NCT03871491|474233751|FG001|Overall Study|Withdrawal by Subject|14|||
131714995|NCT03871491|474233752|FG002|Overall Study|Withdrawal by Subject|14|||
131714996|NCT03871491|474233753|FG003|Overall Study|Withdrawal by Subject|14|||
131714997|NCT03871491|474233750|FG000|Overall Study|Physician Decision|0|||
131714998|NCT03871491|474233751|FG001|Overall Study|Physician Decision|0|||
131714999|NCT03871491|474233752|FG002|Overall Study|Physician Decision|1|||
131715000|NCT03871491|474233753|FG003|Overall Study|Physician Decision|1|||
131715001|NCT03871491|474233750|FG000|Overall Study|Lost to Follow-up|50|||
131715002|NCT03871491|474233751|FG001|Overall Study|Lost to Follow-up|15|||
131715003|NCT03871491|474233752|FG002|Overall Study|Lost to Follow-up|36|||
131715004|NCT03871491|474233753|FG003|Overall Study|Lost to Follow-up|11|||
131715005|NCT05202808|474233754|FG000|Overall Study|Lost to Follow-up|3|||
131715006|NCT05202808|474233755|FG001|Overall Study|Lost to Follow-up|1|||
131715007|NCT04996797|474233756|FG000|Overall Study|Adverse Event|0|||
131715008|NCT04996797|474233757|FG001|Overall Study|Adverse Event|2|||
131715009|NCT04996797|474233758|FG002|Overall Study|Adverse Event|0|||
131715010|NCT04996797|474233759|FG003|Overall Study|Adverse Event|1|||
131715011|NCT04996797|474233756|FG000|Overall Study|Lack of Efficacy|0|||
131715012|NCT04996797|474233757|FG001|Overall Study|Lack of Efficacy|2|||
131715013|NCT04996797|474233758|FG002|Overall Study|Lack of Efficacy|0|||
131715014|NCT04996797|474233759|FG003|Overall Study|Lack of Efficacy|0|||
131715015|NCT04996797|474233756|FG000|Overall Study|Prohibited Medication|0|||
131715016|NCT04996797|474233757|FG001|Overall Study|Prohibited Medication|1|||
131715017|NCT04996797|474233758|FG002|Overall Study|Prohibited Medication|0|||
131715018|NCT04996797|474233759|FG003|Overall Study|Prohibited Medication|0|||
131715019|NCT04996797|474233756|FG000|Overall Study|Ongoing|68|||
131715020|NCT04996797|474233757|FG001|Overall Study|Ongoing|60|||
131715021|NCT04996797|474233758|FG002|Overall Study|Ongoing|22|||
131715022|NCT04996797|474233759|FG003|Overall Study|Ongoing|20|||
131715023|NCT04996797|474233756|FG000|Overall Study|Withdrawal by Subject|0|||
131715024|NCT04996797|474233757|FG001|Overall Study|Withdrawal by Subject|2|||
131715025|NCT04996797|474233758|FG002|Overall Study|Withdrawal by Subject|0|||
131715026|NCT04996797|474233759|FG003|Overall Study|Withdrawal by Subject|0|||
131715027|NCT04439331|474233760|FG000|Overall Study|Never Start Protocol Therapy|2|||
131715028|NCT04439331|474233760|FG000|Overall Study|Ineligible|2|||
131715029|NCT04439331|474233760|FG000|Overall Study|Mutation Status Not Confirmed|1|||
131715030|NCT04439331|474233760|FG000|Overall Study|Adverse Event|1|||
131715031|NCT04439331|474233760|FG000|Overall Study|Death|1|||
131715032|NCT04439331|474233760|FG000|Overall Study|Disease Progression|20|||
131715033|NCT04439331|474233760|FG000|Overall Study|Withdrawal by Subject|6|||
131715034|NCT04439331|474233760|FG000|Overall Study|Physician Decision|1|||
131800422|NCT05630547|474552540|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
131800423|NCT05630547|474552541|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
131800424|NCT05630547|474552538|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
131800425|NCT05630547|474552539|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
131800426|NCT05630547|474552540|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
131800427|NCT05630547|474552541|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
131800428|NCT05630547|474552538|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
131800429|NCT05630547|474552539|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
131641887|NCT01837797|473974661|FG004|Period 3|Adverse Event|1|||
131641888|NCT01837797|473974657|FG000|Period 3|Administrative reasons|0|||
131641889|NCT01837797|473974658|FG001|Period 3|Administrative reasons|0|||
131641890|NCT01837797|473974659|FG002|Period 3|Administrative reasons|0|||
131641891|NCT01837797|473974660|FG003|Period 3|Administrative reasons|0|||
131641892|NCT01837797|473974661|FG004|Period 3|Administrative reasons|20|||
131641893|NCT01837797|473974657|FG000|Period 3|Other|0|||
131641894|NCT01837797|473974658|FG001|Period 3|Other|0|||
131641895|NCT01837797|473974659|FG002|Period 3|Other|0|||
131641896|NCT01837797|473974660|FG003|Period 3|Other|0|||
131641897|NCT01837797|473974661|FG004|Period 3|Other|2|||
131641898|NCT03797989|473974662|FG000|VAC069A|Withdrawal by Subject|0|||
131641899|NCT03797989|473974663|FG001|VAC069A|Withdrawal by Subject|0|||
131641900|NCT03797989|473974664|FG002|VAC069A|Withdrawal by Subject|1|||
131641901|NCT03797989|473974665|FG003|VAC069A|Withdrawal by Subject|0|||
131641902|NCT03797989|473974666|FG004|VAC069A|Withdrawal by Subject|0|||
131641903|NCT03797989|473974667|FG005|VAC069A|Withdrawal by Subject|0|||
131641904|NCT03797989|473974668|FG006|VAC069A|Withdrawal by Subject|0|||
131641905|NCT03797989|473974669|FG007|VAC069A|Withdrawal by Subject|0|||
131641906|NCT03797989|473974670|FG008|VAC069A|Withdrawal by Subject|0|||
131641907|NCT03797989|473974671|FG009|VAC069A|Withdrawal by Subject|0|||
131641908|NCT03797989|473974672|FG010|VAC069A|Withdrawal by Subject|0|||
131641909|NCT03797989|473974673|FG011|VAC069A|Withdrawal by Subject|0|||
131641910|NCT04814992|473974682|FG000|Overall Study|Withdrawal by Subject|6|||
131800430|NCT05630547|474552540|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
131800431|NCT05630547|474552541|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
131800432|NCT05630547|474552538|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
131800433|NCT05630547|474552539|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
131800434|NCT05630547|474552540|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
131800435|NCT05630547|474552541|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
131800436|NCT05630547|474552538|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
131800437|NCT05630547|474552539|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
131800438|NCT05630547|474552540|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
131800439|NCT05630547|474552541|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
131800440|NCT05630547|474552538|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
131800441|NCT05630547|474552539|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
131800442|NCT05630547|474552540|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
131800443|NCT05630547|474552541|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
131800444|NCT05630547|474552538|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
131800445|NCT05630547|474552539|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
131800446|NCT05630547|474552540|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
131800447|NCT05630547|474552541|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
131800448|NCT05630547|474552538|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
131800449|NCT05630547|474552539|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
131800450|NCT05630547|474552540|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
131800451|NCT05630547|474552541|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
131800452|NCT05630547|474552538|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
131800453|NCT05630547|474552539|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
131641911|NCT04814992|473974683|FG001|Overall Study|Withdrawal by Subject|3|||
131641912|NCT04814992|473974682|FG000|Overall Study|Lost to Follow-up|1|||
131641913|NCT04814992|473974683|FG001|Overall Study|Lost to Follow-up|4|||
131641914|NCT00604188|473974685|FG000|Overall Study|Adverse Event|1|||
131641915|NCT00604188|473974686|FG001|Overall Study|Adverse Event|4|||
131641916|NCT00604188|473974685|FG000|Overall Study|Lost to Follow-up|17|||
131641917|NCT00604188|473974686|FG001|Overall Study|Lost to Follow-up|15|||
131641918|NCT00604188|473974685|FG000|Overall Study|Withdrawal by Subject|5|||
131641919|NCT00604188|473974686|FG001|Overall Study|Withdrawal by Subject|1|||
131641920|NCT00604188|473974685|FG000|Overall Study|Non-compliance with protocol|4|||
131641921|NCT00604188|473974686|FG001|Overall Study|Non-compliance with protocol|4|||
131641922|NCT00604188|473974685|FG000|Overall Study|Did not receive study drug|0|||
131641923|NCT00604188|473974686|FG001|Overall Study|Did not receive study drug|1|||
131800454|NCT05630547|474552540|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
131800455|NCT05630547|474552541|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
131800456|NCT05956665|474552542|FG000|Overall Study|Death|1|||
131800457|NCT05956665|474552542|FG000|Overall Study|Withdrawal by Subject|1|||
131800458|NCT00977470|474552543|FG000|Overall Study|Lack of Efficacy|32|||
131800459|NCT00977470|474552544|FG001|Overall Study|Lack of Efficacy|30|||
131800460|NCT00977470|474552543|FG000|Overall Study|Physician Decision|2|||
131800461|NCT00977470|474552544|FG001|Overall Study|Physician Decision|0|||
131800462|NCT00977470|474552543|FG000|Overall Study|Adverse Event|1|||
131800463|NCT00977470|474552544|FG001|Overall Study|Adverse Event|2|||
131800464|NCT00977470|474552543|FG000|Overall Study|Protocol Violation|1|||
131800465|NCT00977470|474552544|FG001|Overall Study|Protocol Violation|0|||
131800466|NCT00977470|474552543|FG000|Overall Study|Withdrawal by Subject|0|||
131800467|NCT00977470|474552544|FG001|Overall Study|Withdrawal by Subject|2|||
131800468|NCT00977470|474552543|FG000|Overall Study|Death|0|||
131800469|NCT00977470|474552544|FG001|Overall Study|Death|2|||
131800470|NCT00977470|474552543|FG000|Overall Study|clinical decline|0|||
131800471|NCT00977470|474552544|FG001|Overall Study|clinical decline|1|||
131800472|NCT00977470|474552543|FG000|Overall Study|prolonged recovery post-surgery|0|||
131800473|NCT00977470|474552544|FG001|Overall Study|prolonged recovery post-surgery|1|||
131800474|NCT00977470|474552543|FG000|Overall Study|Still on-study|2|||
131800475|NCT00977470|474552544|FG001|Overall Study|Still on-study|0|||
131800476|NCT02364557|474552547|FG000|Overall Study|Protocol Violation|3|||
131800477|NCT02364557|474552548|FG001|Overall Study|Protocol Violation|1|||
131800478|NCT03978624|474552549|FG000|Overall Study|Protocol Violation|1|||
131800479|NCT03978624|474552550|FG001|Overall Study|Protocol Violation|0|||
131800480|NCT04347239|474552551|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
131800481|NCT04347239|474552552|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
131800482|NCT04347239|474552553|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
131800483|NCT04347239|474552551|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
131800484|NCT04347239|474552552|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
131800485|NCT04347239|474552553|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
131800486|NCT05097989|474552555|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800487|NCT05097989|474552556|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800488|NCT05097989|474552557|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800489|NCT05097989|474552558|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800490|NCT05097989|474552559|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800491|NCT05097989|474552560|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
131800492|NCT05097989|474552561|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800493|NCT05097989|474552562|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800494|NCT05097989|474552563|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131800495|NCT05097989|474552555|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
131641924|NCT00691678|473974687|FG000|Overall Study|Adverse Event|5|||
131641925|NCT00691678|473974687|FG000|Overall Study|life events, pain|11|||
131641926|NCT00356759|473974688|FG000|Overall Study|Death|5|||
131641927|NCT00356759|473974689|FG001|Overall Study|Death|2|||
131641928|NCT00356759|473974688|FG000|Overall Study|Withdrawal by Subject|2|||
131641929|NCT00356759|473974689|FG001|Overall Study|Withdrawal by Subject|2|||
131641930|NCT00356759|473974688|FG000|Overall Study|Adverse Event|1|||
131641931|NCT00356759|473974689|FG001|Overall Study|Adverse Event|3|||
131641932|NCT00356759|473974688|FG000|Overall Study|Lost to Follow-up|1|||
131641933|NCT00356759|473974689|FG001|Overall Study|Lost to Follow-up|1|||
131641934|NCT00356759|473974688|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
131641935|NCT00356759|473974689|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
131641936|NCT00934700|473974690|FG000|Overall Study|missing scan|5|||
131641937|NCT00934700|473974691|FG001|Overall Study|missing scan|9|||
131641938|NCT00934700|473974690|FG000|Overall Study|Death|8|||
131641939|NCT00934700|473974691|FG001|Overall Study|Death|3|||
131641940|NCT01831726|473974694|FG000|Overall Study|Adverse Event|16|||
131641941|NCT01831726|473974694|FG000|Overall Study|Death|7|||
131641942|NCT01831726|473974694|FG000|Overall Study|Disease Progression|49|||
131641943|NCT01831726|473974694|FG000|Overall Study|Physician Decision|1|||
131641944|NCT01831726|473974694|FG000|Overall Study|Subject/guardian decision|7|||
131641945|NCT03049306|473974695|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
131641946|NCT03049306|473974696|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
131641947|NCT03151551|473974697|FG000|Open-Label Treatment Period|Adverse Event|0|||
131641948|NCT03151551|473974698|FG001|Open-Label Treatment Period|Adverse Event|2|||
131641949|NCT03151551|473974697|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
131641950|NCT03151551|473974698|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
131641951|NCT03151551|473974697|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
131641952|NCT03151551|473974698|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
131641953|NCT03151551|473974697|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
131800496|NCT05097989|474552556|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
131800497|NCT05097989|474552557|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
131800498|NCT05097989|474552558|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
131800499|NCT05097989|474552559|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
131800500|NCT05097989|474552560|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
131800501|NCT05097989|474552561|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
131800502|NCT05097989|474552562|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
131800503|NCT05097989|474552563|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
131800504|NCT05097989|474552555|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131800505|NCT05097989|474552556|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131800506|NCT05097989|474552557|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131800507|NCT05097989|474552558|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131800508|NCT05097989|474552559|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131800509|NCT05097989|474552560|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
131800510|NCT05097989|474552561|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
131800511|NCT05097989|474552562|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
131800512|NCT05097989|474552563|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131800513|NCT05097989|474552555|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131800514|NCT05097989|474552556|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131800515|NCT05097989|474552557|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
131800516|NCT05097989|474552558|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131800517|NCT05097989|474552559|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131800518|NCT05097989|474552560|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
131800519|NCT05097989|474552561|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131800520|NCT05097989|474552562|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
131800521|NCT05097989|474552563|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131800522|NCT05097989|474552555|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800523|NCT05097989|474552556|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800524|NCT05097989|474552557|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
131800525|NCT05097989|474552558|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800526|NCT05097989|474552559|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800527|NCT05097989|474552560|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800528|NCT05097989|474552561|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800529|NCT05097989|474552562|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800530|NCT05097989|474552563|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131800531|NCT05097989|474552555|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800532|NCT05097989|474552556|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
131800533|NCT05097989|474552557|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800534|NCT05097989|474552558|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800535|NCT05097989|474552559|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800536|NCT05097989|474552560|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800537|NCT05097989|474552561|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800538|NCT05097989|474552562|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800539|NCT05097989|474552563|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131800540|NCT05097989|474552555|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800541|NCT05097989|474552556|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800542|NCT05097989|474552557|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800543|NCT05097989|474552558|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800544|NCT05097989|474552559|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131800545|NCT05097989|474552560|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800546|NCT05097989|474552561|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800547|NCT05097989|474552562|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800548|NCT05097989|474552563|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131800549|NCT05097989|474552555|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800550|NCT05097989|474552556|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800551|NCT05097989|474552557|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800552|NCT05097989|474552558|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800553|NCT05097989|474552559|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
131800554|NCT05097989|474552560|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800555|NCT05097989|474552561|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800556|NCT05097989|474552562|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800557|NCT05097989|474552563|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131800558|NCT05097989|474552555|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131800559|NCT05097989|474552556|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131800560|NCT05097989|474552557|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131641954|NCT03151551|473974698|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
131800561|NCT05097989|474552558|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131800562|NCT05097989|474552559|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131800563|NCT05097989|474552560|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131800564|NCT05097989|474552561|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131800565|NCT05097989|474552562|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131800566|NCT05097989|474552563|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131800567|NCT05097989|474552555|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
131800568|NCT05097989|474552556|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
131800569|NCT05097989|474552557|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
131800570|NCT05097989|474552558|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
131800571|NCT05097989|474552559|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
131800572|NCT05097989|474552560|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
131800573|NCT05097989|474552561|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
131800574|NCT05097989|474552562|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
131800575|NCT05097989|474552563|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
131800576|NCT05097989|474552555|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
131800577|NCT05097989|474552556|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
131800578|NCT05097989|474552557|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
131800579|NCT05097989|474552558|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
131800580|NCT05097989|474552559|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
131800581|NCT05097989|474552560|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
131800582|NCT05097989|474552561|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
131800583|NCT05097989|474552562|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
131800584|NCT05097989|474552563|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
131800585|NCT05097989|474552555|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800586|NCT05097989|474552556|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800587|NCT05097989|474552557|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800588|NCT05097989|474552558|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800589|NCT05097989|474552559|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
131800590|NCT05097989|474552560|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800591|NCT05097989|474552561|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800592|NCT05097989|474552562|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800593|NCT05097989|474552563|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
131800594|NCT05097989|474552555|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
131800595|NCT05097989|474552556|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
131800596|NCT05097989|474552557|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800597|NCT05097989|474552558|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800598|NCT05097989|474552559|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800599|NCT05097989|474552560|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800600|NCT05097989|474552561|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800601|NCT05097989|474552562|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800602|NCT05097989|474552563|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131800603|NCT05097989|474552555|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
131800604|NCT05097989|474552556|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
131800605|NCT05097989|474552557|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
131800606|NCT05097989|474552558|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
131800607|NCT05097989|474552559|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
131800608|NCT05097989|474552560|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
131800609|NCT05097989|474552561|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
131800610|NCT05097989|474552562|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
131800611|NCT05097989|474552563|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
131800612|NCT00182091|474552564|FG000|Overall Study|Withdrawal by Subject|1|||
131800613|NCT00182091|474552565|FG001|Overall Study|Withdrawal by Subject|0|||
131800614|NCT00182091|474552566|FG002|Overall Study|Withdrawal by Subject|0|||
131800615|NCT00182091|474552567|FG003|Overall Study|Withdrawal by Subject|0|||
131641955|NCT03151551|473974697|FG000|Open-Label Treatment Period|Physician Decision|3|||
131641956|NCT03151551|473974698|FG001|Open-Label Treatment Period|Physician Decision|0|||
131800616|NCT03968224|474552572|FG000|Overall Study|Lost to Follow-up|11|||
131800617|NCT03968224|474552573|FG001|Overall Study|Lost to Follow-up|18|||
131800618|NCT03815942|474553765|FG000|Overall Study|Withdrawal by Subject|0|||
131800619|NCT03815942|474553766|FG001|Overall Study|Withdrawal by Subject|17|||
131800620|NCT02785913|474553767|FG000|Overall Study|Adverse Event|5|||
131800621|NCT02785913|474553767|FG000|Overall Study|Death|2|||
131800622|NCT02785913|474553767|FG000|Overall Study|Progression|18|||
131800623|NCT02785913|474553767|FG000|Overall Study|Not protocol specified|1|||
131800624|NCT03717064|474553768|FG000|Period 2|Adverse Event|1|||
131800625|NCT02841709|474553769|FG000|5th Intervention|Adverse Event|2|||
131800626|NCT02841709|474553770|FG001|5th Intervention|Adverse Event|0|||
131800627|NCT02841709|474553771|FG002|5th Intervention|Adverse Event|0|||
131800628|NCT02841709|474553772|FG003|5th Intervention|Adverse Event|0|||
131800629|NCT02841709|474553773|FG004|5th Intervention|Adverse Event|2|||
131800630|NCT01929109|474553774|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
131800631|NCT01929109|474553775|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
131800632|NCT01929109|474553776|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
131800633|NCT01929109|474553777|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
131800634|NCT01929109|474553778|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
131800635|NCT00076102|474553779|FG000|Overall Study|Clinical progression|1|||
131800636|NCT00076102|474553779|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
131800637|NCT00076102|474553779|FG000|Overall Study|plexiform neurofibroma surgery|1|||
131800638|NCT00076102|474553779|FG000|Overall Study|refusal of further therapy|2|||
131800639|NCT01402908|474553782|FG000|Overall Study|Withdrawal by Subject|30|||
131800640|NCT01402908|474553783|FG001|Overall Study|Withdrawal by Subject|17|||
131800641|NCT01402908|474553782|FG000|Overall Study|Lost to Follow-up|3|||
131800642|NCT01402908|474553783|FG001|Overall Study|Lost to Follow-up|1|||
131800643|NCT01402908|474553782|FG000|Overall Study|Physician Decision|1|||
131800644|NCT01402908|474553783|FG001|Overall Study|Physician Decision|0|||
131800645|NCT01545076|474553784|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
131800646|NCT01545076|474553785|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
131800647|NCT01545076|474553786|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
131800648|NCT01545076|474553787|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
131800649|NCT01545076|474553788|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
131800650|NCT01545076|474553784|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
131800651|NCT01545076|474553785|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
131800652|NCT01545076|474553786|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
131800653|NCT01545076|474553787|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
131800654|NCT01545076|474553788|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
131800655|NCT01545076|474553784|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
131800656|NCT01545076|474553785|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
131800657|NCT01545076|474553786|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
131800658|NCT01545076|474553787|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
131800659|NCT01545076|474553788|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
131800660|NCT01545076|474553784|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
131800661|NCT01545076|474553785|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
131800662|NCT01545076|474553786|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
131800663|NCT01545076|474553787|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
131800664|NCT01545076|474553788|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
131800665|NCT01545076|474553784|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
131800666|NCT01545076|474553785|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
131800667|NCT01545076|474553786|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
131800668|NCT01545076|474553787|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
131800669|NCT01545076|474553788|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
131800670|NCT01545076|474553784|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
131800671|NCT01545076|474553785|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
131800672|NCT01545076|474553786|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
131641957|NCT03151551|473974697|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
131800673|NCT01545076|474553787|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
131800674|NCT01545076|474553788|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
131800675|NCT01545076|474553784|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
131800676|NCT01545076|474553785|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
131800677|NCT01545076|474553786|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
131800678|NCT01545076|474553787|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
131800679|NCT01545076|474553788|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
131800680|NCT01545076|474553784|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
131800681|NCT01545076|474553785|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
131800682|NCT01545076|474553786|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
131800683|NCT01545076|474553787|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
131800684|NCT01545076|474553788|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
131800685|NCT01545076|474553784|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
131800686|NCT01545076|474553785|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
131800687|NCT01545076|474553786|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
131800688|NCT01545076|474553787|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
131800689|NCT01545076|474553788|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
131800690|NCT03444038|474553789|FG000|Overall Study|Adverse Event|12|||
131800691|NCT03444038|474553789|FG000|Overall Study|Withdrawal by Subject|7|||
131800692|NCT03444038|474553789|FG000|Overall Study|Lost to Follow-up|1|||
131800693|NCT03444038|474553789|FG000|Overall Study|Physician Decision|2|||
131800694|NCT03444038|474553789|FG000|Overall Study|Lack of Efficacy|7|||
131800695|NCT00264797|474553790|FG000|Overall Study|Withdrawal by Subject|11|||
131800696|NCT00264797|474553791|FG001|Overall Study|Withdrawal by Subject|11|||
131800697|NCT00264797|474553790|FG000|Overall Study|Lost to Follow-up|9|||
131800698|NCT00264797|474553791|FG001|Overall Study|Lost to Follow-up|17|||
131800699|NCT00264797|474553790|FG000|Overall Study|Moved from area|3|||
131800700|NCT00264797|474553791|FG001|Overall Study|Moved from area|1|||
131800701|NCT00264797|474553790|FG000|Overall Study|Practical Problems|2|||
131800702|NCT00264797|474553791|FG001|Overall Study|Practical Problems|3|||
131800703|NCT00264797|474553790|FG000|Overall Study|Incarceration|4|||
131800704|NCT00264797|474553791|FG001|Overall Study|Incarceration|5|||
131800705|NCT00264797|474553790|FG000|Overall Study|Pressure/advice from Outsiders|1|||
131800706|NCT00264797|474553791|FG001|Overall Study|Pressure/advice from Outsiders|1|||
131800707|NCT00264797|474553790|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
131800708|NCT00264797|474553791|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
131800709|NCT00264797|474553790|FG000|Overall Study|Other|3|||
131800710|NCT00264797|474553791|FG001|Overall Study|Other|4|||
131800711|NCT00048048|474553792|FG000|Core Treatment|Withdrawal by Subject|0|||
131800712|NCT00048048|474553793|FG001|Core Treatment|Withdrawal by Subject|0|||
131800713|NCT00048048|474553794|FG002|Core Treatment|Withdrawal by Subject|1|||
131800714|NCT00048048|474553795|FG003|Core Treatment|Withdrawal by Subject|0|||
131800715|NCT00048048|474553796|FG004|Core Treatment|Withdrawal by Subject|0|||
131800716|NCT00048048|474553797|FG005|Core Treatment|Withdrawal by Subject|0|||
131800717|NCT00048048|474553798|FG006|Core Treatment|Withdrawal by Subject|0|||
131800718|NCT00048048|474553799|FG007|Core Treatment|Withdrawal by Subject|0|||
131800719|NCT00048048|474553800|FG008|Core Treatment|Withdrawal by Subject|0|||
131800720|NCT00048048|474553801|FG009|Core Treatment|Withdrawal by Subject|0|||
131800721|NCT00048048|474553802|FG010|Core Treatment|Withdrawal by Subject|0|||
131800722|NCT00048048|474553803|FG011|Core Treatment|Withdrawal by Subject|0|||
131800723|NCT00048048|474553792|FG000|Core Treatment|Adverse Event|0|||
131800724|NCT00048048|474553793|FG001|Core Treatment|Adverse Event|0|||
131800725|NCT00048048|474553794|FG002|Core Treatment|Adverse Event|0|||
131800726|NCT00048048|474553795|FG003|Core Treatment|Adverse Event|0|||
131800727|NCT00048048|474553796|FG004|Core Treatment|Adverse Event|0|||
131800728|NCT00048048|474553797|FG005|Core Treatment|Adverse Event|0|||
131800729|NCT00048048|474553798|FG006|Core Treatment|Adverse Event|0|||
131800730|NCT00048048|474553799|FG007|Core Treatment|Adverse Event|1|||
131800731|NCT00048048|474553800|FG008|Core Treatment|Adverse Event|0|||
131800732|NCT00048048|474553801|FG009|Core Treatment|Adverse Event|0|||
131800733|NCT00048048|474553802|FG010|Core Treatment|Adverse Event|0|||
131800734|NCT00048048|474553803|FG011|Core Treatment|Adverse Event|0|||
131800735|NCT00048048|474553792|FG000|Extension Year 1|Early withdrawals|0|||
131800736|NCT00048048|474553793|FG001|Extension Year 1|Early withdrawals|0|||
131800737|NCT00048048|474553794|FG002|Extension Year 1|Early withdrawals|0|||
131800738|NCT00048048|474553795|FG003|Extension Year 1|Early withdrawals|0|||
131800739|NCT00048048|474553796|FG004|Extension Year 1|Early withdrawals|0|||
131800740|NCT00048048|474553797|FG005|Extension Year 1|Early withdrawals|0|||
131800741|NCT00048048|474553798|FG006|Extension Year 1|Early withdrawals|0|||
131800742|NCT00048048|474553799|FG007|Extension Year 1|Early withdrawals|0|||
131800743|NCT00048048|474553800|FG008|Extension Year 1|Early withdrawals|0|||
131800744|NCT00048048|474553801|FG009|Extension Year 1|Early withdrawals|2|||
131800745|NCT00048048|474553802|FG010|Extension Year 1|Early withdrawals|2|||
131800746|NCT00048048|474553803|FG011|Extension Year 1|Early withdrawals|4|||
131800747|NCT00048048|474553792|FG000|Extension Year 2|Early withdrawals|0|||
131800748|NCT00048048|474553793|FG001|Extension Year 2|Early withdrawals|0|||
131800749|NCT00048048|474553794|FG002|Extension Year 2|Early withdrawals|0|||
131902886|NCT00483652|474931336|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
131800750|NCT00048048|474553795|FG003|Extension Year 2|Early withdrawals|0|||
131800751|NCT00048048|474553796|FG004|Extension Year 2|Early withdrawals|0|||
131800752|NCT00048048|474553797|FG005|Extension Year 2|Early withdrawals|0|||
131800753|NCT00048048|474553798|FG006|Extension Year 2|Early withdrawals|0|||
131800754|NCT00048048|474553799|FG007|Extension Year 2|Early withdrawals|0|||
131800755|NCT00048048|474553800|FG008|Extension Year 2|Early withdrawals|0|||
131800756|NCT00048048|474553801|FG009|Extension Year 2|Early withdrawals|0|||
131800757|NCT00048048|474553802|FG010|Extension Year 2|Early withdrawals|4|||
131800758|NCT00048048|474553803|FG011|Extension Year 2|Early withdrawals|2|||
131800759|NCT02684578|474553804|FG000|Overall Study|Withdrawal by Subject|10|||
131800760|NCT02684578|474553805|FG001|Overall Study|Withdrawal by Subject|7|||
131800761|NCT02684578|474553804|FG000|Overall Study|Lost to Follow-up|0|||
131800762|NCT02684578|474553805|FG001|Overall Study|Lost to Follow-up|3|||
131800763|NCT02684578|474553804|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
131800764|NCT02684578|474553805|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
131800765|NCT02684578|474553804|FG000|Overall Study|Missing follow-up data|0|||
131800766|NCT02684578|474553805|FG001|Overall Study|Missing follow-up data|1|||
131800767|NCT02236130|474553812|FG000|Overall Study|Lost to Follow-up|7|||
131800768|NCT02236130|474553813|FG001|Overall Study|Lost to Follow-up|12|||
131800769|NCT01492400|474553814|FG000|Overall Study|Miscellaneous Reasons|2|||
131800770|NCT01492400|474553815|FG001|Overall Study|Miscellaneous Reasons|3|||
131800771|NCT01492400|474553814|FG000|Overall Study|Personal Reasons|0|||
131800772|NCT01492400|474553815|FG001|Overall Study|Personal Reasons|5|||
131800773|NCT01492400|474553814|FG000|Overall Study|Lost to Follow-up|3|||
131800774|NCT01492400|474553815|FG001|Overall Study|Lost to Follow-up|1|||
131800775|NCT01492400|474553814|FG000|Overall Study|Pregnancy|0|||
131800776|NCT01492400|474553815|FG001|Overall Study|Pregnancy|1|||
131800777|NCT01492400|474553814|FG000|Overall Study|Lack of Efficacy|1|||
131800778|NCT01492400|474553815|FG001|Overall Study|Lack of Efficacy|1|||
131800779|NCT01492400|474553814|FG000|Overall Study|Adverse Event|10|||
131800780|NCT01492400|474553815|FG001|Overall Study|Adverse Event|5|||
131800781|NCT00320112|474553817|FG000|Overall Study|Lost to Follow-up|3|||
131800782|NCT00320112|474553818|FG001|Overall Study|Lost to Follow-up|4|||
131800783|NCT00320112|474553817|FG000|Overall Study|Withdrawal by Subject|3|||
131800784|NCT00320112|474553818|FG001|Overall Study|Withdrawal by Subject|0|||
131800785|NCT00320112|474553817|FG000|Overall Study|Death|2|||
131800786|NCT00320112|474553818|FG001|Overall Study|Death|1|||
131800787|NCT02899338|474553819|FG000|Overall Study|Adverse Event|1|||
131800788|NCT02899338|474553820|FG001|Overall Study|Adverse Event|2|||
131800789|NCT02899338|474553819|FG000|Overall Study|Withdrawal by Subject|2|||
131800790|NCT02899338|474553820|FG001|Overall Study|Withdrawal by Subject|0|||
131800791|NCT06176768|474553825|FG000|Overall Study|Adverse Event|1|||
131800792|NCT06176768|474553826|FG001|Overall Study|Adverse Event|0|||
131800793|NCT06176768|474553825|FG000|Overall Study|Assigned treatment by mistake|1|||
131641958|NCT03151551|473974698|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
131641959|NCT03151551|473974697|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
131641960|NCT03151551|473974698|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
131800794|NCT06176768|474553826|FG001|Overall Study|Assigned treatment by mistake|0|||
131800795|NCT06176768|474553825|FG000|Overall Study|Lost to Follow-up|0|||
131800796|NCT06176768|474553826|FG001|Overall Study|Lost to Follow-up|3|||
131800797|NCT06176768|474553825|FG000|Overall Study|Physician Decision|1|||
131800798|NCT06176768|474553826|FG001|Overall Study|Physician Decision|0|||
131800799|NCT06176768|474553825|FG000|Overall Study|Protocol deviation|3|||
131800800|NCT06176768|474553826|FG001|Overall Study|Protocol deviation|1|||
131800801|NCT06176768|474553825|FG000|Overall Study|Other|1|||
131800802|NCT06176768|474553826|FG001|Overall Study|Other|0|||
131800803|NCT06176768|474553825|FG000|Overall Study|Withdrawal by Subject|6|||
131800804|NCT06176768|474553826|FG001|Overall Study|Withdrawal by Subject|9|||
131800805|NCT00117949|474553827|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
131800806|NCT00117949|474553828|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
131800807|NCT00117949|474553829|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
131800808|NCT00117949|474553830|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
131800809|NCT00117949|474553827|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
131800810|NCT00117949|474553828|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
131800811|NCT00117949|474553829|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
131800812|NCT00117949|474553830|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
131800813|NCT00117949|474553827|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
131800814|NCT00117949|474553828|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
131800815|NCT00117949|474553829|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
131800816|NCT00117949|474553830|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
131800817|NCT00117949|474553827|FG000|Overall Study|PSA increase >=10ng/mL|0|||
131800818|NCT00117949|474553828|FG001|Overall Study|PSA increase >=10ng/mL|1|||
131800819|NCT00117949|474553829|FG002|Overall Study|PSA increase >=10ng/mL|1|||
131800820|NCT00117949|474553830|FG003|Overall Study|PSA increase >=10ng/mL|0|||
131800821|NCT00117949|474553827|FG000|Overall Study|PSA reduction <=50%|0|||
131800822|NCT00117949|474553828|FG001|Overall Study|PSA reduction <=50%|2|||
131800823|NCT00117949|474553829|FG002|Overall Study|PSA reduction <=50%|2|||
131641961|NCT03151551|473974697|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
131800824|NCT00117949|474553830|FG003|Overall Study|PSA reduction <=50%|4|||
131800825|NCT00117949|474553827|FG000|Overall Study|Hepatic abnormalities|0|||
131800826|NCT00117949|474553828|FG001|Overall Study|Hepatic abnormalities|1|||
131902887|NCT00483652|474931337|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
131902888|NCT00483652|474931336|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
131902889|NCT00483652|474931337|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
131902890|NCT00468585|474931338|FG000|Overall Study|Patient not treated|1|||
131902891|NCT00468585|474931339|FG001|Overall Study|Patient not treated|0|||
131902892|NCT00468585|474931340|FG002|Overall Study|Patient not treated|1|||
131902893|NCT00468585|474931341|FG003|Overall Study|Patient not treated|0|||
131902894|NCT00468585|474931338|FG000|Overall Study|Patient found to be ineligible|0|||
131902895|NCT00468585|474931339|FG001|Overall Study|Patient found to be ineligible|0|||
131715035|NCT04439331|474233760|FG000|Overall Study|Other Complicating Disease|1|||
131715036|NCT02495948|474233761|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
131715037|NCT02495948|474233762|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
131715038|NCT02495948|474233761|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
131902896|NCT00468585|474931340|FG002|Overall Study|Patient found to be ineligible|1|||
131902897|NCT00468585|474931341|FG003|Overall Study|Patient found to be ineligible|0|||
131902898|NCT00468585|474931338|FG000|Overall Study|Adverse Event|0|||
131902899|NCT00468585|474931339|FG001|Overall Study|Adverse Event|0|||
131902900|NCT00468585|474931340|FG002|Overall Study|Adverse Event|1|||
131902901|NCT00468585|474931341|FG003|Overall Study|Adverse Event|0|||
131902902|NCT00468585|474931338|FG000|Overall Study|Withdrawal by Subject|0|||
131902903|NCT00468585|474931339|FG001|Overall Study|Withdrawal by Subject|0|||
131902904|NCT00468585|474931340|FG002|Overall Study|Withdrawal by Subject|2|||
131902905|NCT00468585|474931341|FG003|Overall Study|Withdrawal by Subject|1|||
131902906|NCT02154139|474931342|FG000|Overall Study|Injection not administered|2|||
131902907|NCT02154139|474931342|FG000|Overall Study|Other|2|||
131902908|NCT02154139|474931342|FG000|Overall Study|Investigator transferred|3|||
131902909|NCT02087774|474931345|FG000|Overall Study|Were absent day of data collection|8|||
131902910|NCT02087774|474931346|FG001|Overall Study|Were absent day of data collection|20|||
131902911|NCT02157519|474931352|FG000|Overall Study|Death|3|||
131902912|NCT02157519|474931353|FG001|Overall Study|Death|1|||
131902913|NCT02157519|474931352|FG000|Overall Study|Withdrawal by Subject|7|||
131902914|NCT02157519|474931353|FG001|Overall Study|Withdrawal by Subject|0|||
131902915|NCT02157519|474931352|FG000|Overall Study|Lost to Follow-up|1|||
131902916|NCT02157519|474931353|FG001|Overall Study|Lost to Follow-up|0|||
131902917|NCT01656395|474931354|FG000|Overall Study|Adverse Event|1|||
131902918|NCT01656395|474931355|FG001|Overall Study|Adverse Event|14|||
131902919|NCT01656395|474931356|FG002|Overall Study|Adverse Event|5|||
131902920|NCT01656395|474931357|FG003|Overall Study|Adverse Event|4|||
131902921|NCT01656395|474931358|FG004|Overall Study|Adverse Event|5|||
131902922|NCT01656395|474931359|FG005|Overall Study|Adverse Event|7|||
131902923|NCT01656395|474931360|FG006|Overall Study|Adverse Event|0|||
131902924|NCT01656395|474931361|FG007|Overall Study|Adverse Event|0|||
131902925|NCT01656395|474931354|FG000|Overall Study|Lack of Efficacy|1|||
131902926|NCT01656395|474931355|FG001|Overall Study|Lack of Efficacy|8|||
131902927|NCT01656395|474931356|FG002|Overall Study|Lack of Efficacy|6|||
131902928|NCT01656395|474931357|FG003|Overall Study|Lack of Efficacy|1|||
131715039|NCT02495948|474233762|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
131715040|NCT02747004|474233764|FG000|Overall Study|Withdrawal by Subject|8|||
131715041|NCT02747004|474233765|FG001|Overall Study|Withdrawal by Subject|5|||
131715042|NCT02747004|474233766|FG002|Overall Study|Withdrawal by Subject|4|||
131715043|NCT02747004|474233764|FG000|Overall Study|Lost to Follow-up|1|||
131715044|NCT02747004|474233765|FG001|Overall Study|Lost to Follow-up|2|||
131715045|NCT02747004|474233766|FG002|Overall Study|Lost to Follow-up|2|||
131715046|NCT02747004|474233764|FG000|Overall Study|on study treatment/follow-up|48|||
131715047|NCT02747004|474233765|FG001|Overall Study|on study treatment/follow-up|42|||
131715048|NCT02747004|474233766|FG002|Overall Study|on study treatment/follow-up|41|||
131715049|NCT06218251|474233767|FG000|Overall Study|Lost to Follow-up|4|||
131715050|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
131715051|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
131715052|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
131715053|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
131902929|NCT01656395|474931358|FG004|Overall Study|Lack of Efficacy|1|||
131902930|NCT01656395|474931359|FG005|Overall Study|Lack of Efficacy|6|||
131902931|NCT01656395|474931360|FG006|Overall Study|Lack of Efficacy|0|||
131902932|NCT01656395|474931361|FG007|Overall Study|Lack of Efficacy|0|||
131902933|NCT01656395|474931354|FG000|Overall Study|Lost to Follow-up|1|||
131902934|NCT01656395|474931355|FG001|Overall Study|Lost to Follow-up|0|||
131902935|NCT01656395|474931356|FG002|Overall Study|Lost to Follow-up|0|||
131902936|NCT01656395|474931357|FG003|Overall Study|Lost to Follow-up|0|||
131902937|NCT01656395|474931358|FG004|Overall Study|Lost to Follow-up|0|||
131902938|NCT01656395|474931359|FG005|Overall Study|Lost to Follow-up|0|||
131800827|NCT00117949|474553829|FG002|Overall Study|Hepatic abnormalities|0|||
131800828|NCT00117949|474553830|FG003|Overall Study|Hepatic abnormalities|1|||
131800829|NCT04028843|474553836|FG000|Overall Study|Lost to Follow-up|32|||
131800830|NCT04028843|474553837|FG001|Overall Study|Lost to Follow-up|39|||
131800831|NCT04028843|474553836|FG000|Overall Study|Adverse Event|1|||
131800832|NCT04028843|474553837|FG001|Overall Study|Adverse Event|0|||
131800833|NCT04028843|474553836|FG000|Overall Study|Non-viable Pregnancy|0|||
131800834|NCT04028843|474553837|FG001|Overall Study|Non-viable Pregnancy|1|||
131800835|NCT04028843|474553836|FG000|Overall Study|Withdrawal by Subject|4|||
131800836|NCT04028843|474553837|FG001|Overall Study|Withdrawal by Subject|2|||
131800837|NCT03298451|474553838|FG000|Overall Study|Death|275|||
131800838|NCT03298451|474553839|FG001|Overall Study|Death|260|||
131800839|NCT03298451|474553840|FG002|Overall Study|Death|122|||
131800840|NCT03298451|474553841|FG003|Overall Study|Death|280|||
131800841|NCT03298451|474553838|FG000|Overall Study|Lost to Follow-up|1|||
131800842|NCT03298451|474553839|FG001|Overall Study|Lost to Follow-up|1|||
131800843|NCT03298451|474553840|FG002|Overall Study|Lost to Follow-up|0|||
131800844|NCT03298451|474553841|FG003|Overall Study|Lost to Follow-up|7|||
131800845|NCT03298451|474553838|FG000|Overall Study|Withdrawal by Subject|9|||
131800846|NCT03298451|474553839|FG001|Overall Study|Withdrawal by Subject|7|||
131800847|NCT03298451|474553840|FG002|Overall Study|Withdrawal by Subject|1|||
131800848|NCT03298451|474553841|FG003|Overall Study|Withdrawal by Subject|20|||
131800849|NCT03633721|474553846|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
131800850|NCT03633721|474553847|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
131800851|NCT03633721|474553848|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
131800852|NCT03633721|474553849|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
131800853|NCT02457832|474553850|FG000|Training|Lost to Follow-up|10|||
131800854|NCT02457832|474553851|FG001|Training|Lost to Follow-up|6|||
131800855|NCT02457832|474553852|FG002|Training|Lost to Follow-up|3|||
131800856|NCT02457832|474553850|FG000|One Month Washout|Lost to Follow-up|0|||
131800857|NCT02457832|474553851|FG001|One Month Washout|Lost to Follow-up|1|||
131800858|NCT02457832|474553852|FG002|One Month Washout|Lost to Follow-up|1|||
131800859|NCT03184441|474553853|FG000|Overall Study|Withdrawal by Subject|1|||
131800860|NCT03069937|474553856|FG000|Overall Study|Second primary malignancy noted|1|||
131800861|NCT01868009|474553857|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
131800862|NCT01868009|474553858|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
131800863|NCT01868009|474553857|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
131800864|NCT01868009|474553858|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
131800865|NCT01868009|474553857|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
131800866|NCT01868009|474553858|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
131800867|NCT03589326|474553860|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
131800868|NCT03589326|474553861|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
131800869|NCT03589326|474553860|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
131800870|NCT03589326|474553861|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
131800871|NCT03589326|474553860|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
131800872|NCT03589326|474553861|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
131800873|NCT03589326|474553860|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
131800874|NCT03589326|474553861|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
131800875|NCT03589326|474553860|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
131800876|NCT03589326|474553861|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
131800877|NCT04484142|474553862|FG000|Overall Study|Adverse Event|13|||
131800878|NCT04484142|474553862|FG000|Overall Study|Progressive Disease|87|||
131800879|NCT04484142|474553862|FG000|Overall Study|Clinical Progression|10|||
131800880|NCT04484142|474553862|FG000|Overall Study|Withdrawal by Subject|6|||
131800881|NCT04484142|474553862|FG000|Overall Study|Physician Decision|1|||
131800882|NCT02101853|474553865|FG000|Block 1 Induction|Adverse Event|11|||
131800883|NCT02101853|474553866|FG001|Block 1 Induction|Adverse Event|0|||
131902939|NCT01656395|474931360|FG006|Overall Study|Lost to Follow-up|0|||
131902940|NCT01656395|474931361|FG007|Overall Study|Lost to Follow-up|0|||
131800884|NCT02101853|474553867|FG002|Block 1 Induction|Adverse Event|0|||
131800885|NCT02101853|474553868|FG003|Block 1 Induction|Adverse Event|0|||
131800886|NCT02101853|474553869|FG004|Block 1 Induction|Adverse Event|0|||
131800887|NCT02101853|474553870|FG005|Block 1 Induction|Adverse Event|0|||
131800888|NCT02101853|474553865|FG000|Block 1 Induction|Death|20|||
131800889|NCT02101853|474553866|FG001|Block 1 Induction|Death|0|||
131800890|NCT02101853|474553867|FG002|Block 1 Induction|Death|0|||
131800891|NCT02101853|474553868|FG003|Block 1 Induction|Death|0|||
131800892|NCT02101853|474553869|FG004|Block 1 Induction|Death|0|||
131800893|NCT02101853|474553870|FG005|Block 1 Induction|Death|0|||
131800894|NCT02101853|474553865|FG000|Block 1 Induction|Lack of Efficacy|6|||
131800895|NCT02101853|474553866|FG001|Block 1 Induction|Lack of Efficacy|0|||
131800896|NCT02101853|474553867|FG002|Block 1 Induction|Lack of Efficacy|0|||
131800897|NCT02101853|474553868|FG003|Block 1 Induction|Lack of Efficacy|0|||
131800898|NCT02101853|474553869|FG004|Block 1 Induction|Lack of Efficacy|0|||
131800899|NCT02101853|474553870|FG005|Block 1 Induction|Lack of Efficacy|0|||
131800900|NCT02101853|474553865|FG000|Block 1 Induction|Physician Decision|61|||
131800901|NCT02101853|474553866|FG001|Block 1 Induction|Physician Decision|0|||
131800902|NCT02101853|474553867|FG002|Block 1 Induction|Physician Decision|0|||
131800903|NCT02101853|474553868|FG003|Block 1 Induction|Physician Decision|0|||
131800904|NCT02101853|474553869|FG004|Block 1 Induction|Physician Decision|0|||
131800905|NCT02101853|474553870|FG005|Block 1 Induction|Physician Decision|0|||
131800906|NCT02101853|474553865|FG000|Block 1 Induction|Protocol Violation|2|||
131800907|NCT02101853|474553866|FG001|Block 1 Induction|Protocol Violation|0|||
131800908|NCT02101853|474553867|FG002|Block 1 Induction|Protocol Violation|0|||
131800909|NCT02101853|474553868|FG003|Block 1 Induction|Protocol Violation|0|||
131800910|NCT02101853|474553869|FG004|Block 1 Induction|Protocol Violation|0|||
131800911|NCT02101853|474553870|FG005|Block 1 Induction|Protocol Violation|0|||
131800912|NCT02101853|474553865|FG000|Block 1 Induction|Withdrawal by Subject|65|||
131800913|NCT02101853|474553866|FG001|Block 1 Induction|Withdrawal by Subject|0|||
131800914|NCT02101853|474553867|FG002|Block 1 Induction|Withdrawal by Subject|0|||
131800915|NCT02101853|474553868|FG003|Block 1 Induction|Withdrawal by Subject|0|||
131800916|NCT02101853|474553869|FG004|Block 1 Induction|Withdrawal by Subject|0|||
131800917|NCT02101853|474553870|FG005|Block 1 Induction|Withdrawal by Subject|0|||
131800918|NCT02101853|474553865|FG000|Block 1 Induction|Ineligible|8|||
131800919|NCT02101853|474553866|FG001|Block 1 Induction|Ineligible|0|||
131800920|NCT02101853|474553867|FG002|Block 1 Induction|Ineligible|0|||
131800921|NCT02101853|474553868|FG003|Block 1 Induction|Ineligible|0|||
131800922|NCT02101853|474553869|FG004|Block 1 Induction|Ineligible|0|||
131800923|NCT02101853|474553870|FG005|Block 1 Induction|Ineligible|0|||
131800924|NCT02101853|474553865|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
131800925|NCT02101853|474553866|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131800926|NCT02101853|474553867|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131800927|NCT02101853|474553868|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131800928|NCT02101853|474553869|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131800929|NCT02101853|474553870|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131800930|NCT02101853|474553865|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
131800931|NCT02101853|474553866|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800932|NCT02101853|474553867|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800933|NCT02101853|474553868|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800934|NCT02101853|474553869|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800935|NCT02101853|474553870|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800936|NCT02101853|474553865|FG000|Post Induction Randomization|Adverse Event|0|||
131800937|NCT02101853|474553866|FG001|Post Induction Randomization|Adverse Event|3|||
131800938|NCT02101853|474553867|FG002|Post Induction Randomization|Adverse Event|8|||
131800939|NCT02101853|474553868|FG003|Post Induction Randomization|Adverse Event|4|||
131800940|NCT02101853|474553869|FG004|Post Induction Randomization|Adverse Event|4|||
131800941|NCT02101853|474553870|FG005|Post Induction Randomization|Adverse Event|0|||
131800942|NCT02101853|474553865|FG000|Post Induction Randomization|Death|0|||
131800943|NCT02101853|474553866|FG001|Post Induction Randomization|Death|9|||
131800944|NCT02101853|474553867|FG002|Post Induction Randomization|Death|2|||
131800945|NCT02101853|474553868|FG003|Post Induction Randomization|Death|2|||
131800946|NCT02101853|474553869|FG004|Post Induction Randomization|Death|0|||
131800947|NCT02101853|474553870|FG005|Post Induction Randomization|Death|0|||
131800948|NCT02101853|474553865|FG000|Post Induction Randomization|Lack of Efficacy|0|||
131800949|NCT02101853|474553866|FG001|Post Induction Randomization|Lack of Efficacy|14|||
131800950|NCT02101853|474553867|FG002|Post Induction Randomization|Lack of Efficacy|23|||
131800951|NCT02101853|474553868|FG003|Post Induction Randomization|Lack of Efficacy|18|||
131800952|NCT02101853|474553869|FG004|Post Induction Randomization|Lack of Efficacy|21|||
131641962|NCT03151551|473974698|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
131641963|NCT03151551|473974697|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
131641964|NCT03151551|473974698|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
131641965|NCT03151551|473974697|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
131641966|NCT03151551|473974698|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
131641967|NCT01075100|473974703|FG000|Overall Study|Adverse Event|15|||
131641968|NCT01075100|473974704|FG001|Overall Study|Adverse Event|18|||
131641969|NCT01075100|473974703|FG000|Overall Study|Patient Request|4|||
131641970|NCT01075100|473974704|FG001|Overall Study|Patient Request|4|||
131641971|NCT01075100|473974703|FG000|Overall Study|Investigator Request|2|||
131641972|NCT01075100|473974704|FG001|Overall Study|Investigator Request|1|||
131641973|NCT01075100|473974703|FG000|Overall Study|Disease Progression|25|||
131641974|NCT01075100|473974704|FG001|Overall Study|Disease Progression|29|||
131641975|NCT01075100|473974703|FG000|Overall Study|Other|3|||
131641976|NCT01075100|473974704|FG001|Overall Study|Other|1|||
131641977|NCT05896696|473974705|FG000|Overall Study|Screening Failure|7|||
131641978|NCT05896696|473974705|FG000|Overall Study|Withdrawal by Subject|2|||
131641979|NCT00143598|473974706|FG000|Overall Study|Lost to Follow-up|23|||
131641980|NCT00143598|473974707|FG001|Overall Study|Lost to Follow-up|21|||
131641981|NCT00143598|473974706|FG000|Overall Study|Withdrawal by Subject|33|||
131641982|NCT00143598|473974707|FG001|Overall Study|Withdrawal by Subject|37|||
131641983|NCT00143598|473974706|FG000|Overall Study|Death|36|||
131641984|NCT00143598|473974707|FG001|Overall Study|Death|36|||
131641985|NCT03900715|473974708|FG000|Overall Study|Protocol Deviation|1|||
131641986|NCT03900715|473974708|FG000|Overall Study|Lack of Efficacy|1|||
131641987|NCT03900715|473974708|FG000|Overall Study|Progressive Disease|6|||
131641988|NCT03900715|473974708|FG000|Overall Study|Adverse Event|2|||
131800953|NCT02101853|474553870|FG005|Post Induction Randomization|Lack of Efficacy|0|||
131641989|NCT03900715|473974708|FG000|Overall Study|Other reasons|11|||
131641990|NCT01878383|473976546|FG000|Overall Study|Lost to Follow-up|0|||
131641991|NCT01878383|473976547|FG001|Overall Study|Lost to Follow-up|1499|||
131641992|NCT03475056|473976548|FG000|Overall Study|Lost to Follow-up|0|||
131641993|NCT03475056|473976549|FG001|Overall Study|Lost to Follow-up|1|||
131641994|NCT03475056|473976548|FG000|Overall Study|Moved from Area|0|||
131641995|NCT03475056|473976549|FG001|Overall Study|Moved from Area|2|||
131641996|NCT01932762|473976552|FG000|Overall Study|Withdrawal by Subject|1|||
131641997|NCT01932762|473976553|FG001|Overall Study|Withdrawal by Subject|2|||
131641998|NCT01932762|473976554|FG002|Overall Study|Withdrawal by Subject|0|||
131641999|NCT01932762|473976555|FG003|Overall Study|Withdrawal by Subject|0|||
131642000|NCT01932762|473976552|FG000|Overall Study|Lost to Follow-up|4|||
131642001|NCT01932762|473976553|FG001|Overall Study|Lost to Follow-up|0|||
131642002|NCT01932762|473976554|FG002|Overall Study|Lost to Follow-up|0|||
131642003|NCT01932762|473976555|FG003|Overall Study|Lost to Follow-up|1|||
131642004|NCT01932762|473976552|FG000|Overall Study|Physician Decision|1|||
131642005|NCT01932762|473976553|FG001|Overall Study|Physician Decision|0|||
131642006|NCT01932762|473976554|FG002|Overall Study|Physician Decision|0|||
131642007|NCT01932762|473976555|FG003|Overall Study|Physician Decision|0|||
131642008|NCT00612352|473976556|FG000|Overall Study|Adverse Event|1|||
131642009|NCT00612352|473976557|FG001|Overall Study|Adverse Event|0|||
131642010|NCT00612352|473976556|FG000|Overall Study|Withdrawal by Subject|3|||
131642011|NCT00612352|473976557|FG001|Overall Study|Withdrawal by Subject|5|||
131642012|NCT00612352|473976556|FG000|Overall Study|moved out of state|1|||
131642013|NCT00612352|473976557|FG001|Overall Study|moved out of state|0|||
131642014|NCT00612352|473976556|FG000|Overall Study|didn't return calls/show up on test date|4|||
131642015|NCT00612352|473976557|FG001|Overall Study|didn't return calls/show up on test date|1|||
131642016|NCT00664105|473976558|FG000|Overall Study|Death|3|||
131642017|NCT00664105|473976558|FG000|Overall Study|Withdrawal by Subject|5|||
131642018|NCT00664105|473976558|FG000|Overall Study|Adverse Event|9|||
131642019|NCT00664105|473976558|FG000|Overall Study|Disease progression|7|||
131642020|NCT00760513|473976559|FG000|Overall Study|Withdrawal by Subject|5|||
131642021|NCT00760513|473976560|FG001|Overall Study|Withdrawal by Subject|7|||
131642022|NCT01951378|473976563|FG000|Overall Study|Study Terminated-Not completed|23|||
131642023|NCT01951378|473976564|FG001|Overall Study|Study Terminated-Not completed|17|||
131642024|NCT03065933|473976565|FG000|Overall Study|study terminated|5|||
131642025|NCT02536742|473976566|FG000|Overall Study|Did not start protocol therapy|1|||
131642026|NCT02536742|473976566|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
131642027|NCT01172639|473976571|FG000|Overall Study|Death|1|||
131642028|NCT01172639|473976572|FG001|Overall Study|Death|1|||
131642029|NCT01172639|473976573|FG002|Overall Study|Death|0|||
131642030|NCT01172639|473976574|FG003|Overall Study|Death|0|||
131642031|NCT01172639|473976575|FG004|Overall Study|Death|0|||
131642032|NCT01172639|473976571|FG000|Overall Study|Lost to Follow-up|9|||
131642033|NCT01172639|473976572|FG001|Overall Study|Lost to Follow-up|7|||
131642034|NCT01172639|473976573|FG002|Overall Study|Lost to Follow-up|11|||
131642035|NCT01172639|473976574|FG003|Overall Study|Lost to Follow-up|6|||
131642036|NCT01172639|473976575|FG004|Overall Study|Lost to Follow-up|6|||
131800954|NCT02101853|474553865|FG000|Post Induction Randomization|Physician Decision|0|||
131800955|NCT02101853|474553866|FG001|Post Induction Randomization|Physician Decision|43|||
131800956|NCT02101853|474553867|FG002|Post Induction Randomization|Physician Decision|23|||
131800957|NCT02101853|474553868|FG003|Post Induction Randomization|Physician Decision|14|||
131800958|NCT02101853|474553869|FG004|Post Induction Randomization|Physician Decision|14|||
131800959|NCT02101853|474553870|FG005|Post Induction Randomization|Physician Decision|0|||
131800960|NCT02101853|474553865|FG000|Post Induction Randomization|Protocol Violation|0|||
131800961|NCT02101853|474553866|FG001|Post Induction Randomization|Protocol Violation|3|||
131800962|NCT02101853|474553867|FG002|Post Induction Randomization|Protocol Violation|0|||
131800963|NCT02101853|474553868|FG003|Post Induction Randomization|Protocol Violation|0|||
131800964|NCT02101853|474553869|FG004|Post Induction Randomization|Protocol Violation|0|||
131800965|NCT02101853|474553870|FG005|Post Induction Randomization|Protocol Violation|0|||
131800966|NCT02101853|474553865|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
131800967|NCT02101853|474553866|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
131800968|NCT02101853|474553867|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
131800969|NCT02101853|474553868|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
131800970|NCT02101853|474553869|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
131800971|NCT02101853|474553870|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
131800972|NCT02101853|474553865|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800973|NCT02101853|474553866|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800974|NCT02101853|474553867|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800975|NCT02101853|474553868|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
131800976|NCT02101853|474553869|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800977|NCT02101853|474553870|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131800978|NCT02101853|474553865|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131800979|NCT02101853|474553866|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
131642037|NCT01172639|473976571|FG000|Overall Study|Withdrawal by Subject|3|||
131642038|NCT01172639|473976572|FG001|Overall Study|Withdrawal by Subject|3|||
131642039|NCT01172639|473976573|FG002|Overall Study|Withdrawal by Subject|5|||
131642040|NCT01172639|473976574|FG003|Overall Study|Withdrawal by Subject|5|||
131642041|NCT01172639|473976575|FG004|Overall Study|Withdrawal by Subject|0|||
131642042|NCT02172950|473976576|FG000|Overall Study|Physician Decision|3|||
131642043|NCT02172950|473976577|FG001|Overall Study|Physician Decision|3|||
131642044|NCT02172950|473976576|FG000|Overall Study|Lack of Efficacy|1|||
131642045|NCT02172950|473976577|FG001|Overall Study|Lack of Efficacy|0|||
131642046|NCT02172950|473976576|FG000|Overall Study|Adverse Event|4|||
131642047|NCT02172950|473976577|FG001|Overall Study|Adverse Event|1|||
131642048|NCT02172950|473976576|FG000|Overall Study|Withdrawal by Subject|10|||
131642049|NCT02172950|473976577|FG001|Overall Study|Withdrawal by Subject|0|||
131642050|NCT02172950|473976576|FG000|Overall Study|Protocol Violation|1|||
131642051|NCT02172950|473976577|FG001|Overall Study|Protocol Violation|0|||
131642052|NCT02172950|473976576|FG000|Overall Study|Lost to Follow-up|1|||
131642053|NCT02172950|473976577|FG001|Overall Study|Lost to Follow-up|0|||
131642054|NCT02172950|473976576|FG000|Overall Study|Death|1|||
131642055|NCT02172950|473976577|FG001|Overall Study|Death|0|||
131800980|NCT02101853|474553867|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
131800981|NCT02101853|474553868|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131800982|NCT02101853|474553869|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131800983|NCT02101853|474553870|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131800984|NCT02101853|474553865|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131800985|NCT02101853|474553866|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
131800986|NCT02101853|474553867|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131642056|NCT02172950|473976576|FG000|Overall Study|Patient traveling|1|||
131642057|NCT02172950|473976577|FG001|Overall Study|Patient traveling|0|||
131642058|NCT02172950|473976576|FG000|Overall Study|Patient went to other country|1|||
131642059|NCT02172950|473976577|FG001|Overall Study|Patient went to other country|0|||
131642060|NCT02172950|473976576|FG000|Overall Study|Patient relocated overseas|1|||
131642061|NCT02172950|473976577|FG001|Overall Study|Patient relocated overseas|1|||
131800987|NCT02101853|474553868|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131800988|NCT02101853|474553869|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131800989|NCT02101853|474553870|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131800990|NCT02101853|474553865|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131800991|NCT02101853|474553866|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131642062|NCT02172950|473976576|FG000|Overall Study|Patient moving|1|||
131642063|NCT02172950|473976577|FG001|Overall Study|Patient moving|0|||
131642064|NCT00469456|473976578|FG000|Overall Study|Adverse Event|4|||
131642065|NCT00469456|473976579|FG001|Overall Study|Adverse Event|3|||
131800992|NCT02101853|474553867|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131800993|NCT02101853|474553868|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
131800994|NCT02101853|474553869|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
131800995|NCT02101853|474553870|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131800996|NCT02101853|474553865|FG000|Blinatumomab Salvage Therapy|Death|0|||
131800997|NCT02101853|474553866|FG001|Blinatumomab Salvage Therapy|Death|0|||
131800998|NCT02101853|474553867|FG002|Blinatumomab Salvage Therapy|Death|0|||
131800999|NCT02101853|474553868|FG003|Blinatumomab Salvage Therapy|Death|0|||
131801000|NCT02101853|474553869|FG004|Blinatumomab Salvage Therapy|Death|0|||
131801001|NCT02101853|474553870|FG005|Blinatumomab Salvage Therapy|Death|2|||
131801002|NCT02101853|474553865|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131801003|NCT02101853|474553866|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131801004|NCT02101853|474553867|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131801005|NCT02101853|474553868|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131801006|NCT02101853|474553869|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131801007|NCT02101853|474553870|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
131801008|NCT02101853|474553865|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
131801009|NCT02101853|474553866|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
131801010|NCT02101853|474553867|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
131801011|NCT02101853|474553868|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
131801012|NCT02101853|474553869|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
131801013|NCT02101853|474553870|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
131801014|NCT02101853|474553865|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131801015|NCT02101853|474553866|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131801016|NCT02101853|474553867|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131642066|NCT00469456|473976578|FG000|Overall Study|Protocol Violation|1|||
131801017|NCT02101853|474553868|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131801018|NCT02101853|474553869|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131801019|NCT02101853|474553870|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
131801020|NCT01638546|474553871|FG000|Overall Study|Adverse Event|1|||
131801021|NCT01638546|474553872|FG001|Overall Study|Adverse Event|3|||
131801022|NCT00936390|474553874|FG000|Overall Study|Protocol Violation|21|||
131801023|NCT00936390|474553875|FG001|Overall Study|Protocol Violation|25|||
131801024|NCT05905783|474553876|FG000|Overall Study|Lost to Follow-up|12|||
131801025|NCT05905783|474553877|FG001|Overall Study|Lost to Follow-up|18|||
131801026|NCT05905783|474553876|FG000|Overall Study|Withdrawal by Subject|29|||
131801027|NCT05905783|474553877|FG001|Overall Study|Withdrawal by Subject|37|||
131801028|NCT05905783|474553876|FG000|Overall Study|Decision by sponsor|69|||
131801029|NCT05905783|474553877|FG001|Overall Study|Decision by sponsor|65|||
131801030|NCT03907488|474553878|FG000|Overall Study|Adverse Event|20|||
131801031|NCT03907488|474553879|FG001|Overall Study|Adverse Event|20|||
131801032|NCT03907488|474553878|FG000|Overall Study|Withdrawal by Subject|9|||
131801033|NCT03907488|474553879|FG001|Overall Study|Withdrawal by Subject|13|||
131801034|NCT03907488|474553878|FG000|Overall Study|Lack of Efficacy|0|||
131801035|NCT03907488|474553879|FG001|Overall Study|Lack of Efficacy|9|||
131801036|NCT03907488|474553878|FG000|Overall Study|Death|3|||
131801037|NCT03907488|474553879|FG001|Overall Study|Death|8|||
131801038|NCT03907488|474553878|FG000|Overall Study|not protocol specified|5|||
131801039|NCT03907488|474553879|FG001|Overall Study|not protocol specified|8|||
131801040|NCT03907488|474553878|FG000|Overall Study|Ineligible|9|||
131801041|NCT03907488|474553879|FG001|Overall Study|Ineligible|15|||
131801042|NCT00336024|474553885|FG000|Overall Study|Death|2|||
131801043|NCT00336024|474553886|FG001|Overall Study|Death|1|||
131801044|NCT00336024|474553885|FG000|Overall Study|Physician Decision|4|||
131801045|NCT00336024|474553886|FG001|Overall Study|Physician Decision|1|||
131801046|NCT00336024|474553885|FG000|Overall Study|Protocol Violation|1|||
131801047|NCT00336024|474553886|FG001|Overall Study|Protocol Violation|0|||
131801048|NCT00336024|474553885|FG000|Overall Study|Withdrawal by Subject|1|||
131642067|NCT00469456|473976579|FG001|Overall Study|Protocol Violation|0|||
131642068|NCT00469456|473976578|FG000|Overall Study|Withdrawal by Subject|4|||
131801049|NCT00336024|474553886|FG001|Overall Study|Withdrawal by Subject|2|||
131801050|NCT00336024|474553885|FG000|Overall Study|Failure to fulfill consolidation|1|||
131801051|NCT00336024|474553886|FG001|Overall Study|Failure to fulfill consolidation|1|||
131801052|NCT00336024|474553885|FG000|Overall Study|Progressive Disease|4|||
131801053|NCT00336024|474553886|FG001|Overall Study|Progressive Disease|7|||
131801054|NCT00336024|474553885|FG000|Overall Study|Ineligible|7|||
131801055|NCT00336024|474553886|FG001|Overall Study|Ineligible|7|||
131801056|NCT05809596|474553887|FG000|Overall Study|Death|16|||
131801057|NCT05809596|474553887|FG000|Overall Study|Withdrawal by Subject|4|||
131642069|NCT00469456|473976579|FG001|Overall Study|Withdrawal by Subject|1|||
131801058|NCT05809596|474553887|FG000|Overall Study|Physician Decision|1|||
131801059|NCT05809596|474553887|FG000|Overall Study|Missed Visit|2|||
131801060|NCT05809596|474553887|FG000|Overall Study|Other|3|||
131801061|NCT05125952|474553888|FG000|Overall Study|Physician Decision|1|||
131642070|NCT00611715|473976580|FG000|Overall Study|Disease Progression|24|||
131642071|NCT00611715|473976581|FG001|Overall Study|Disease Progression|4|||
131642072|NCT00611715|473976580|FG000|Overall Study|Withdrawal by Subject|5|||
131642073|NCT00611715|473976581|FG001|Overall Study|Withdrawal by Subject|1|||
131642074|NCT00611715|473976580|FG000|Overall Study|Adverse Event|9|||
131642075|NCT00611715|473976581|FG001|Overall Study|Adverse Event|1|||
131642076|NCT00611715|473976580|FG000|Overall Study|Death|1|||
131642077|NCT00611715|473976581|FG001|Overall Study|Death|0|||
131642078|NCT00611715|473976580|FG000|Overall Study|two patients are still on treatment|2|||
131642079|NCT00611715|473976581|FG001|Overall Study|two patients are still on treatment|0|||
131642080|NCT00107978|473976582|FG000|Overall Study|Adverse Event|1|||
131642081|NCT00107978|473976583|FG001|Overall Study|Adverse Event|5|||
131642082|NCT00107978|473976582|FG000|Overall Study|Death|3|||
131642083|NCT00107978|473976583|FG001|Overall Study|Death|3|||
131642084|NCT00107978|473976582|FG000|Overall Study|Lost to Follow-up|20|||
131642085|NCT00107978|473976583|FG001|Overall Study|Lost to Follow-up|28|||
131642086|NCT00107978|473976582|FG000|Overall Study|Withdrawal by Subject|4|||
131642087|NCT00107978|473976583|FG001|Overall Study|Withdrawal by Subject|9|||
131642088|NCT00107978|473976582|FG000|Overall Study|Protocol Violation|0|||
131642089|NCT00107978|473976583|FG001|Overall Study|Protocol Violation|1|||
131642090|NCT00107978|473976582|FG000|Overall Study|Other|5|||
131642091|NCT00107978|473976583|FG001|Overall Study|Other|4|||
131642092|NCT02669407|473976586|FG000|Overall Study|Physician Decision|3|||
131642093|NCT00727415|473976587|FG000|Phase I|Dose Limiting Toxicity|2|||
131642094|NCT00350298|473976589|FG000|Overall Study|Death|7|||
131642095|NCT00350298|473976590|FG001|Overall Study|Death|8|||
131642096|NCT00350298|473976589|FG000|Overall Study|Lost to Follow-up|1|||
131642097|NCT00350298|473976590|FG001|Overall Study|Lost to Follow-up|2|||
131642098|NCT00350298|473976589|FG000|Overall Study|Withdrawal by Subject|1|||
131642099|NCT00350298|473976590|FG001|Overall Study|Withdrawal by Subject|3|||
131642100|NCT03634839|473976593|FG000|First Intervention (2 Hours)|Adverse Event|0|||
131642101|NCT03634839|473976594|FG001|First Intervention (2 Hours)|Adverse Event|2|||
131642102|NCT02647788|473976597|FG000|Overall Study|Lost to Follow-up|13|||
131642103|NCT02647788|473976598|FG001|Overall Study|Lost to Follow-up|11|||
131642104|NCT02647788|473976597|FG000|Overall Study|Did not want opiate|0|||
131642105|NCT02647788|473976598|FG001|Overall Study|Did not want opiate|1|||
131642106|NCT02647788|473976597|FG000|Overall Study|Withdrawal by Subject|1|||
131642107|NCT02647788|473976598|FG001|Overall Study|Withdrawal by Subject|0|||
131642108|NCT02647788|473976597|FG000|Overall Study|Felt itchy with assigned medication|1|||
131642109|NCT02647788|473976598|FG001|Overall Study|Felt itchy with assigned medication|0|||
131642110|NCT02647788|473976597|FG000|Overall Study|Felt nauseous with assigned medication|1|||
131642111|NCT02647788|473976598|FG001|Overall Study|Felt nauseous with assigned medication|1|||
131642112|NCT02447432|473976599|FG000|Epoch 001|Adverse Event|1|||
131642113|NCT02447432|473976600|FG001|Epoch 001|Adverse Event|1|||
131642114|NCT02447432|473976599|FG000|Epoch 001|Withdrawal by Subject|0|||
131642115|NCT02447432|473976600|FG001|Epoch 001|Withdrawal by Subject|4|||
131642116|NCT02447432|473976599|FG000|Epoch 001|Migrated/moved from study area|3|||
131642117|NCT02447432|473976600|FG001|Epoch 001|Migrated/moved from study area|5|||
131642118|NCT02447432|473976599|FG000|Epoch 001|Lost to Follow-up|1|||
131642119|NCT02447432|473976600|FG001|Epoch 001|Lost to Follow-up|3|||
131642120|NCT03245619|473976608|FG000|Part A (Up to Day 22)|Physician Decision|4|||
131642121|NCT03245619|473976609|FG001|Part A (Up to Day 22)|Physician Decision|6|||
131642122|NCT03245619|473976610|FG002|Part A (Up to Day 22)|Physician Decision|6|||
131642123|NCT03245619|473976611|FG003|Part A (Up to Day 22)|Physician Decision|0|||
131642124|NCT03245619|473976612|FG004|Part A (Up to Day 22)|Physician Decision|0|||
131642125|NCT03245619|473976613|FG005|Part A (Up to Day 22)|Physician Decision|0|||
131642126|NCT03245619|473976614|FG006|Part A (Up to Day 22)|Physician Decision|0|||
131642127|NCT03245619|473976615|FG007|Part A (Up to Day 22)|Physician Decision|0|||
131642128|NCT03245619|473976616|FG008|Part A (Up to Day 22)|Physician Decision|0|||
131642129|NCT03245619|473976617|FG009|Part A (Up to Day 22)|Physician Decision|0|||
131642130|NCT03245619|473976618|FG010|Part A (Up to Day 22)|Physician Decision|0|||
131642131|NCT03245619|473976619|FG011|Part A (Up to Day 22)|Physician Decision|0|||
131642132|NCT03245619|473976620|FG012|Part A (Up to Day 22)|Physician Decision|0|||
131642133|NCT03245619|473976621|FG013|Part A (Up to Day 22)|Physician Decision|0|||
131642134|NCT03245619|473976622|FG014|Part A (Up to Day 22)|Physician Decision|0|||
131642135|NCT03245619|473976623|FG015|Part A (Up to Day 22)|Physician Decision|0|||
131642136|NCT03245619|473976624|FG016|Part A (Up to Day 22)|Physician Decision|0|||
131801062|NCT03946449|474553889|FG000|Treatment Extension II|Rolled over to another study|0|||
131642137|NCT04962698|473976627|FG000|Motor Imagery|Technical difficulty|1|||
131642138|NCT04962698|473976628|FG001|Motor Imagery|Technical difficulty|0|||
131642139|NCT04962698|473976627|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
131642140|NCT04962698|473976628|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
131642141|NCT04962698|473976627|FG000|Kinesthetic MI|Technical difficulty|1|||
131642142|NCT04962698|473976628|FG001|Kinesthetic MI|Technical difficulty|0|||
131801063|NCT03946449|474553890|FG001|Treatment Extension II|Rolled over to another study|0|||
131801064|NCT03946449|474553891|FG002|Treatment Extension II|Rolled over to another study|2|||
131801065|NCT03946449|474553889|FG000|Treatment Extension II|Withdrawal by Subject|0|||
131801066|NCT03946449|474553890|FG001|Treatment Extension II|Withdrawal by Subject|0|||
131801067|NCT03946449|474553891|FG002|Treatment Extension II|Withdrawal by Subject|1|||
131801068|NCT05067504|474553895|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
131801069|NCT05067504|474553896|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
131801070|NCT05067504|474553895|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
131801071|NCT05067504|474553896|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
131801072|NCT05067504|474553895|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
131642143|NCT04962698|473976627|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
131642144|NCT04962698|473976628|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
131642145|NCT04962698|473976627|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
131642146|NCT04962698|473976628|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
131642147|NCT04962698|473976627|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
131801073|NCT05067504|474553896|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
131801074|NCT02581345|474555508|FG000|Part 1: up to Week 16|Adverse Event|3|||
131801075|NCT02581345|474555509|FG001|Part 1: up to Week 16|Adverse Event|8|||
131642148|NCT04962698|473976628|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
131642149|NCT04962698|473976627|FG000|Virtual-hand Interaction|Technical difficulty|1|||
131642150|NCT04962698|473976628|FG001|Virtual-hand Interaction|Technical difficulty|0|||
131642151|NCT04962698|473976627|FG000|Robotic Action Observation|Technical difficulty|1|||
131642152|NCT04962698|473976628|FG001|Robotic Action Observation|Technical difficulty|0|||
131642153|NCT04962698|473976627|FG000|Rest|Technical difficulty|1|||
131642154|NCT04962698|473976628|FG001|Rest|Technical difficulty|0|||
131642155|NCT04962698|473976627|FG000|Rest|Exclusion criteria met after enrollment|0|||
131642156|NCT04962698|473976628|FG001|Rest|Exclusion criteria met after enrollment|2|||
131642157|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
131642158|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
131642159|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
131642160|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
131642161|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
131642162|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
131642163|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
131642164|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
131642165|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
131642166|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
131642167|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
131801076|NCT02581345|474555510|FG002|Part 1: up to Week 16|Adverse Event|0|||
131801077|NCT02581345|474555511|FG003|Part 1: up to Week 16|Adverse Event|0|||
131801078|NCT02581345|474555508|FG000|Part 1: up to Week 16|Physician Decision|2|||
131801079|NCT02581345|474555509|FG001|Part 1: up to Week 16|Physician Decision|4|||
131801080|NCT02581345|474555510|FG002|Part 1: up to Week 16|Physician Decision|0|||
131801081|NCT02581345|474555511|FG003|Part 1: up to Week 16|Physician Decision|0|||
131801082|NCT02581345|474555508|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
131801083|NCT02581345|474555509|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
131801084|NCT02581345|474555510|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
131801085|NCT02581345|474555511|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
131801086|NCT02581345|474555508|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
131801087|NCT02581345|474555509|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
131801088|NCT02581345|474555510|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
131801089|NCT02581345|474555511|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
131801090|NCT02581345|474555508|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
131801091|NCT02581345|474555509|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
131801092|NCT02581345|474555510|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
131801093|NCT02581345|474555511|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
131801094|NCT02581345|474555508|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
131801095|NCT02581345|474555509|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
131801096|NCT02581345|474555510|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
131801097|NCT02581345|474555511|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
131801098|NCT02581345|474555508|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
131801099|NCT02581345|474555509|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
131801100|NCT02581345|474555510|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
131801101|NCT02581345|474555511|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
131801102|NCT02581345|474555508|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
131801103|NCT02581345|474555509|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
131801104|NCT02581345|474555510|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
131642168|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
131642169|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
131642170|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
131642171|NCT01664923|473976632|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
131642172|NCT01664923|473976633|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
131642173|NCT01664923|473976632|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
131642174|NCT01664923|473976633|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
131642175|NCT01664923|473976632|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
131642176|NCT01664923|473976633|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
131642177|NCT01664923|473976632|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
131642178|NCT01664923|473976633|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
131642179|NCT01664923|473976632|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
131642180|NCT01664923|473976633|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
131642181|NCT01664923|473976632|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
131642182|NCT01664923|473976633|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
131642183|NCT01664923|473976632|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
131642184|NCT01664923|473976633|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
131642185|NCT01336205|473976636|FG000|Overall Study|Other|22|||
131642186|NCT01336205|473976637|FG001|Overall Study|Other|9|||
131642187|NCT01336205|473976636|FG000|Overall Study|Lost to Follow-up|40|||
131642188|NCT01336205|473976637|FG001|Overall Study|Lost to Follow-up|20|||
131642189|NCT01336205|473976636|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
131642190|NCT01336205|473976637|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
131642191|NCT01336205|473976636|FG000|Overall Study|Lack of Efficacy|4|||
131642192|NCT01336205|473976637|FG001|Overall Study|Lack of Efficacy|0|||
131642193|NCT01336205|473976636|FG000|Overall Study|Severe noncompliance with protocol|9|||
131642194|NCT01336205|473976637|FG001|Overall Study|Severe noncompliance with protocol|2|||
131642195|NCT01336205|473976636|FG000|Overall Study|Adverse Event|56|||
131642196|NCT01336205|473976637|FG001|Overall Study|Adverse Event|6|||
131642197|NCT01336205|473976636|FG000|Overall Study|Death|1|||
131642198|NCT01336205|473976637|FG001|Overall Study|Death|1|||
131642199|NCT01336205|473976636|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
131642200|NCT01336205|473976637|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
131642201|NCT01336205|473976636|FG000|Overall Study|Withdrawal by Subject|72|||
131642202|NCT01336205|473976637|FG001|Overall Study|Withdrawal by Subject|38|||
131642203|NCT01336205|473976636|FG000|Overall Study|Did not receive treatment|4|||
131642204|NCT01336205|473976637|FG001|Overall Study|Did not receive treatment|0|||
131642205|NCT02482935|473976638|FG000|Period 1|Withdrawal by Subject|1|||
131642206|NCT02482935|473976639|FG001|Period 1|Withdrawal by Subject|0|||
131642207|NCT01657877|473976641|FG000|Overall Study|Withdrawal by Subject|4|||
131642208|NCT01657877|473976641|FG000|Overall Study|Protocol Violation|6|||
131642209|NCT01657877|473976641|FG000|Overall Study|Adverse Event|2|||
131642210|NCT01657877|473976641|FG000|Overall Study|Other Reason|2|||
131642211|NCT01114672|473976642|FG000|Overall Study|Death|0|||
131642212|NCT01114672|473976643|FG001|Overall Study|Death|1|||
131642213|NCT01114672|473976642|FG000|Overall Study|Withdrawal by Subject|2|||
131642214|NCT01114672|473976643|FG001|Overall Study|Withdrawal by Subject|1|||
131642215|NCT01114672|473976642|FG000|Overall Study|Lost to Follow-up|1|||
131642216|NCT01114672|473976643|FG001|Overall Study|Lost to Follow-up|0|||
131642217|NCT01114672|473976642|FG000|Overall Study|transplanted|1|||
131642218|NCT01114672|473976643|FG001|Overall Study|transplanted|0|||
131642219|NCT01585298|473976650|FG000|Overall Study|Study completion was not documented.|1|||
131642220|NCT01585298|473976650|FG000|Overall Study|Protocol deviation|1|||
131642221|NCT01585298|473976650|FG000|Overall Study|Administrative problems|4|||
131642222|NCT01585298|473976650|FG000|Overall Study|Lost to Follow-up|2|||
131642223|NCT01585298|473976650|FG000|Overall Study|Withdrawal by Subject|4|||
131642224|NCT01585298|473976650|FG000|Overall Study|Abnormal test procedure results|1|||
131642225|NCT01585298|473976650|FG000|Overall Study|Adverse Event|24|||
131642226|NCT01898442|473976653|FG000|Overall Study|Hemolysis/technical problems|1|||
131642227|NCT01898442|473976654|FG001|Overall Study|Hemolysis/technical problems|2|||
131642228|NCT01898442|473976655|FG002|Overall Study|Hemolysis/technical problems|2|||
131642229|NCT01898442|473976653|FG000|Overall Study|Patient vomited pills|0|||
131642230|NCT01898442|473976654|FG001|Overall Study|Patient vomited pills|0|||
131642231|NCT01898442|473976655|FG002|Overall Study|Patient vomited pills|1|||
131642232|NCT05178979|473976656|FG000|Overall Study|Death|0|||
131642233|NCT05178979|473976657|FG001|Overall Study|Death|5|||
131642234|NCT05178979|473976658|FG002|Overall Study|Death|0|||
131642235|NCT05178979|473976659|FG003|Overall Study|Death|3|||
131642236|NCT05178979|473976656|FG000|Overall Study|Adverse Event|0|||
131642237|NCT05178979|473976657|FG001|Overall Study|Adverse Event|1|||
131642238|NCT05178979|473976658|FG002|Overall Study|Adverse Event|0|||
131642239|NCT05178979|473976659|FG003|Overall Study|Adverse Event|0|||
131642240|NCT05178979|473976656|FG000|Overall Study|Lost to Follow-up|1|||
131642241|NCT05178979|473976657|FG001|Overall Study|Lost to Follow-up|8|||
131642242|NCT05178979|473976658|FG002|Overall Study|Lost to Follow-up|3|||
131642243|NCT05178979|473976659|FG003|Overall Study|Lost to Follow-up|8|||
131642244|NCT02019641|473976666|FG000|10-Week Follow up|Withdrawal by investigator|2|||
131642245|NCT02019641|473976667|FG001|10-Week Follow up|Withdrawal by investigator|0|||
131642246|NCT02019641|473976668|FG002|10-Week Follow up|Withdrawal by investigator|0|||
131642247|NCT02019641|473976666|FG000|10-Week Follow up|Withdrawal by Subject|1|||
131642248|NCT02019641|473976667|FG001|10-Week Follow up|Withdrawal by Subject|1|||
131642249|NCT02019641|473976668|FG002|10-Week Follow up|Withdrawal by Subject|0|||
131642250|NCT02019641|473976666|FG000|20-Week Follow up|Withdrawal by investigator|0|||
131642251|NCT02019641|473976667|FG001|20-Week Follow up|Withdrawal by investigator|0|||
131642252|NCT02019641|473976668|FG002|20-Week Follow up|Withdrawal by investigator|1|||
131642253|NCT03318783|473976669|FG000|Overall Study|Withdrawal by Subject|0|||
131642254|NCT03318783|473976670|FG001|Overall Study|Withdrawal by Subject|1|||
131642255|NCT03318783|473976669|FG000|Overall Study|Death|0|||
131642256|NCT03318783|473976670|FG001|Overall Study|Death|1|||
131642257|NCT03410108|473976673|FG000|Overall Study|Ongoing|41|||
131642258|NCT03410108|473976673|FG000|Overall Study|Adverse Event|4|||
131642259|NCT03410108|473976673|FG000|Overall Study|Progressive Disease|58|||
131642260|NCT03410108|473976673|FG000|Overall Study|Withdrawal by Subject|1|||
131642261|NCT03269695|473976674|FG000|Overall Study|Adverse Event|2|||
131642262|NCT03269695|473976675|FG001|Overall Study|Adverse Event|1|||
131715054|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
131715055|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
131715056|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
131715057|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
131715058|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
131715059|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
131715060|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
131715061|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131715062|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131715063|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131715064|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131715065|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
131715066|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131715067|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131715068|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131715069|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131715070|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Death|0|||
131715071|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Death|1|||
131715072|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Death|0|||
131715073|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Death|0|||
131715074|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Death|0|||
131715075|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131715076|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
131715077|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131715078|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131715079|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131715080|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
131715081|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131715082|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131715083|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131715084|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131715085|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
131715086|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131715087|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131715088|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131715089|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131715090|NCT05087030|474233768|FG000|Main Period (Week 0 to Week 52)|Other|1|||
131715091|NCT05087030|474233769|FG001|Main Period (Week 0 to Week 52)|Other|2|||
131715092|NCT05087030|474233770|FG002|Main Period (Week 0 to Week 52)|Other|0|||
131715093|NCT05087030|474233771|FG003|Main Period (Week 0 to Week 52)|Other|0|||
131715094|NCT05087030|474233772|FG004|Main Period (Week 0 to Week 52)|Other|0|||
131715095|NCT05087030|474233768|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131715096|NCT05087030|474233769|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131715097|NCT05087030|474233770|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131801105|NCT02581345|474555511|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
131642263|NCT03269695|473976674|FG000|Overall Study|Lack of Efficacy|0|||
131642264|NCT03269695|473976675|FG001|Overall Study|Lack of Efficacy|1|||
131642265|NCT03269695|473976674|FG000|Overall Study|Withdrawal by Subject|0|||
131642266|NCT03269695|473976675|FG001|Overall Study|Withdrawal by Subject|1|||
131642267|NCT01313624|473976677|FG000|Double-Blind Phase|Adverse Event|27|||
131801106|NCT02581345|474555508|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
131801107|NCT02581345|474555509|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
131801108|NCT02581345|474555510|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
131801109|NCT02581345|474555511|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
131801110|NCT02581345|474555508|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
131801111|NCT02581345|474555509|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
131801112|NCT02581345|474555510|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
131801113|NCT02581345|474555511|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
131801114|NCT02581345|474555508|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
131801115|NCT02581345|474555509|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
131801116|NCT02581345|474555510|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
131801117|NCT02581345|474555511|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
131801118|NCT02581345|474555508|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
131801119|NCT02581345|474555509|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
131801120|NCT02581345|474555510|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
131801121|NCT02581345|474555511|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
131801122|NCT01244126|474555514|FG000|Overall Study|Protocol Violation|3|||
131801123|NCT01244126|474555515|FG001|Overall Study|Protocol Violation|3|||
131801124|NCT01244126|474555516|FG002|Overall Study|Protocol Violation|9|||
131801125|NCT00863746|474555519|FG000|Treatment|Not treated|4|||
131801126|NCT00863746|474555520|FG001|Treatment|Not treated|2|||
131801127|NCT00863746|474555519|FG000|Treatment|Adverse Event|41|||
131801128|NCT00863746|474555520|FG001|Treatment|Adverse Event|16|||
131801129|NCT00863746|474555519|FG000|Treatment|non-compliant with study medication|4|||
131801130|NCT00863746|474555520|FG001|Treatment|non-compliant with study medication|0|||
131801131|NCT00863746|474555519|FG000|Treatment|Consent withdrawn|15|||
131801132|NCT00863746|474555520|FG001|Treatment|Consent withdrawn|14|||
131801133|NCT00863746|474555519|FG000|Treatment|Lost to Follow-up|1|||
131801134|NCT00863746|474555520|FG001|Treatment|Lost to Follow-up|0|||
131801135|NCT00863746|474555519|FG000|Treatment|Protocol Violation|5|||
131801136|NCT00863746|474555520|FG001|Treatment|Protocol Violation|3|||
131801137|NCT00863746|474555519|FG000|Treatment|Other|1|||
131801138|NCT00863746|474555520|FG001|Treatment|Other|0|||
131801139|NCT00863746|474555519|FG000|Survival Follow up|Death|244|||
131801140|NCT00863746|474555520|FG001|Survival Follow up|Death|271|||
131801141|NCT00863746|474555519|FG000|Survival Follow up|Lost to Follow-up|2|||
131642268|NCT01313624|473976678|FG001|Double-Blind Phase|Adverse Event|4|||
131642269|NCT01313624|473976677|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
131642270|NCT01313624|473976678|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
131642271|NCT01313624|473976677|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131642272|NCT01313624|473976678|FG001|Double-Blind Phase|Lost to Follow-up|2|||
131642273|NCT01313624|473976677|FG000|Double-Blind Phase|Physician Decision|1|||
131642274|NCT01313624|473976678|FG001|Double-Blind Phase|Physician Decision|0|||
131642275|NCT01313624|473976677|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131801142|NCT00863746|474555520|FG001|Survival Follow up|Lost to Follow-up|1|||
131801143|NCT00863746|474555519|FG000|Survival Follow up|Consent Withdrawn|7|||
131801144|NCT00863746|474555520|FG001|Survival Follow up|Consent Withdrawn|8|||
131642276|NCT01313624|473976678|FG001|Double-Blind Phase|Lack of Efficacy|0|||
131642277|NCT01313624|473976677|FG000|Open-Label Phase|Adverse Event|1|||
131642278|NCT01313624|473976678|FG001|Open-Label Phase|Adverse Event|10|||
131642279|NCT01313624|473976677|FG000|Open-Label Phase|Withdrawal by Subject|2|||
131642280|NCT01313624|473976678|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131642281|NCT01313624|473976677|FG000|Open-Label Phase|Lost to Follow-up|1|||
131642282|NCT01313624|473976678|FG001|Open-Label Phase|Lost to Follow-up|1|||
131642283|NCT00104637|473976679|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
131801145|NCT00376220|474555522|FG000|Overall Study|Lost to Follow-up|7|||
131801146|NCT00376220|474555523|FG001|Overall Study|Lost to Follow-up|10|||
131642284|NCT00104637|473976680|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
131801147|NCT00376220|474555522|FG000|Overall Study|Withdrawal by Subject|3|||
131801148|NCT00376220|474555523|FG001|Overall Study|Withdrawal by Subject|2|||
131801149|NCT00531206|474555526|FG000|Overall Study|Adverse Event related|5|||
131801150|NCT00531206|474555526|FG000|Overall Study|Lack of Efficacy|2|||
131801151|NCT00531206|474555526|FG000|Overall Study|Lost to Follow-up|5|||
131642285|NCT00505414|473976681|FG000|Titration Phase|Adverse Event|0|||
131801152|NCT00531206|474555526|FG000|Overall Study|including non-related adverse events|8|||
131801153|NCT00920140|474555528|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
131801154|NCT00920140|474555529|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
131801155|NCT00920140|474555530|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
131801156|NCT00920140|474555531|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
131801157|NCT00920140|474555532|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
131642286|NCT00505414|473976682|FG001|Titration Phase|Adverse Event|0|||
131642287|NCT00505414|473976683|FG002|Titration Phase|Adverse Event|0|||
131642288|NCT00505414|473976684|FG003|Titration Phase|Adverse Event|8|||
131642289|NCT00505414|473976685|FG004|Titration Phase|Adverse Event|3|||
131642290|NCT00505414|473976681|FG000|Titration Phase|Death|0|||
131801158|NCT00920140|474555528|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
131801159|NCT00920140|474555529|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
131801160|NCT00920140|474555530|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
131801161|NCT00920140|474555531|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
131801162|NCT00920140|474555532|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
131801163|NCT00920140|474555528|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131801164|NCT00920140|474555529|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
131801165|NCT00920140|474555530|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131801166|NCT00920140|474555531|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131801167|NCT00920140|474555532|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131801168|NCT00920140|474555528|FG000|Phase 2|Adverse Event|0|||
131801169|NCT00920140|474555529|FG001|Phase 2|Adverse Event|0|||
131801170|NCT00920140|474555530|FG002|Phase 2|Adverse Event|14|||
131801171|NCT00920140|474555531|FG003|Phase 2|Adverse Event|2|||
131801172|NCT00920140|474555532|FG004|Phase 2|Adverse Event|3|||
131801173|NCT00920140|474555528|FG000|Phase 2|Lack of Efficacy|0|||
131801174|NCT00920140|474555529|FG001|Phase 2|Lack of Efficacy|0|||
131801175|NCT00920140|474555530|FG002|Phase 2|Lack of Efficacy|29|||
131801176|NCT00920140|474555531|FG003|Phase 2|Lack of Efficacy|14|||
131801177|NCT00920140|474555532|FG004|Phase 2|Lack of Efficacy|5|||
131801178|NCT00920140|474555528|FG000|Phase 2|Lost to Follow-up|0|||
131642291|NCT00505414|473976682|FG001|Titration Phase|Death|0|||
131642292|NCT00505414|473976683|FG002|Titration Phase|Death|0|||
131642293|NCT00505414|473976684|FG003|Titration Phase|Death|2|||
131642294|NCT00505414|473976685|FG004|Titration Phase|Death|0|||
131642295|NCT00505414|473976681|FG000|Titration Phase|Lack of Efficacy|0|||
131642296|NCT00505414|473976682|FG001|Titration Phase|Lack of Efficacy|0|||
131642297|NCT00505414|473976683|FG002|Titration Phase|Lack of Efficacy|0|||
131642298|NCT00505414|473976684|FG003|Titration Phase|Lack of Efficacy|10|||
131642299|NCT00505414|473976685|FG004|Titration Phase|Lack of Efficacy|1|||
131642300|NCT00505414|473976681|FG000|Titration Phase|Protocol Violation|0|||
131642301|NCT00505414|473976682|FG001|Titration Phase|Protocol Violation|0|||
131642302|NCT00505414|473976683|FG002|Titration Phase|Protocol Violation|0|||
131642303|NCT00505414|473976684|FG003|Titration Phase|Protocol Violation|0|||
131642304|NCT00505414|473976685|FG004|Titration Phase|Protocol Violation|1|||
131642305|NCT00505414|473976681|FG000|Titration Phase|Withdrawal by Subject|0|||
131642306|NCT00505414|473976682|FG001|Titration Phase|Withdrawal by Subject|0|||
131642307|NCT00505414|473976683|FG002|Titration Phase|Withdrawal by Subject|0|||
131642308|NCT00505414|473976684|FG003|Titration Phase|Withdrawal by Subject|3|||
131642309|NCT00505414|473976685|FG004|Titration Phase|Withdrawal by Subject|4|||
131642310|NCT00505414|473976681|FG000|Titration Phase|Underlying disease and therapy required|0|||
131642311|NCT00505414|473976682|FG001|Titration Phase|Underlying disease and therapy required|0|||
131642312|NCT00505414|473976683|FG002|Titration Phase|Underlying disease and therapy required|0|||
131642313|NCT00505414|473976684|FG003|Titration Phase|Underlying disease and therapy required|7|||
131642314|NCT00505414|473976685|FG004|Titration Phase|Underlying disease and therapy required|3|||
131642315|NCT00505414|473976681|FG000|Maintenance Phase|Adverse Event|2|||
131642316|NCT00505414|473976682|FG001|Maintenance Phase|Adverse Event|2|||
131642317|NCT00505414|473976683|FG002|Maintenance Phase|Adverse Event|3|||
131642318|NCT00505414|473976684|FG003|Maintenance Phase|Adverse Event|0|||
131642319|NCT00505414|473976685|FG004|Maintenance Phase|Adverse Event|0|||
131642320|NCT00505414|473976681|FG000|Maintenance Phase|Death|2|||
131642321|NCT00505414|473976682|FG001|Maintenance Phase|Death|0|||
131642322|NCT00505414|473976683|FG002|Maintenance Phase|Death|1|||
131642323|NCT00505414|473976684|FG003|Maintenance Phase|Death|0|||
131642324|NCT00505414|473976685|FG004|Maintenance Phase|Death|0|||
131642325|NCT00505414|473976681|FG000|Maintenance Phase|Lack of Efficacy|2|||
131642326|NCT00505414|473976682|FG001|Maintenance Phase|Lack of Efficacy|1|||
131642327|NCT00505414|473976683|FG002|Maintenance Phase|Lack of Efficacy|1|||
131642328|NCT00505414|473976684|FG003|Maintenance Phase|Lack of Efficacy|0|||
131642329|NCT00505414|473976685|FG004|Maintenance Phase|Lack of Efficacy|0|||
131642330|NCT00505414|473976681|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131801179|NCT00920140|474555529|FG001|Phase 2|Lost to Follow-up|0|||
131642331|NCT00505414|473976682|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131642332|NCT00505414|473976683|FG002|Maintenance Phase|Withdrawal by Subject|1|||
131642333|NCT00505414|473976684|FG003|Maintenance Phase|Withdrawal by Subject|0|||
131801180|NCT00920140|474555530|FG002|Phase 2|Lost to Follow-up|0|||
131801181|NCT00920140|474555531|FG003|Phase 2|Lost to Follow-up|1|||
131801182|NCT00920140|474555532|FG004|Phase 2|Lost to Follow-up|0|||
131642334|NCT00505414|473976685|FG004|Maintenance Phase|Withdrawal by Subject|0|||
131642335|NCT00505414|473976681|FG000|Maintenance Phase|underlying disease and therapy required|0|||
131642336|NCT00505414|473976682|FG001|Maintenance Phase|underlying disease and therapy required|2|||
131642337|NCT00505414|473976683|FG002|Maintenance Phase|underlying disease and therapy required|2|||
131642338|NCT00505414|473976684|FG003|Maintenance Phase|underlying disease and therapy required|0|||
131801183|NCT00920140|474555528|FG000|Phase 2|Physician Decision|0|||
131801184|NCT00920140|474555529|FG001|Phase 2|Physician Decision|0|||
131801185|NCT00920140|474555530|FG002|Phase 2|Physician Decision|3|||
131642339|NCT00505414|473976685|FG004|Maintenance Phase|underlying disease and therapy required|0|||
131642340|NCT00846768|473976686|FG000|Overall Study|Adverse Event|0|||
131642341|NCT00846768|473976687|FG001|Overall Study|Adverse Event|1|||
131642342|NCT00846768|473976688|FG002|Overall Study|Adverse Event|0|||
131642343|NCT00846768|473976689|FG003|Overall Study|Adverse Event|0|||
131642344|NCT00644878|473976690|FG000|Overall Study|Adverse Event|2|||
131642345|NCT00644878|473976690|FG000|Overall Study|Abnormal laboratory value|3|||
131902941|NCT01656395|474931354|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131902942|NCT01656395|474931355|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131902943|NCT01656395|474931356|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131902944|NCT01656395|474931357|FG003|Overall Study|Non-Compliance with Study Drug|0|||
131902945|NCT01656395|474931358|FG004|Overall Study|Non-Compliance with Study Drug|1|||
131902946|NCT01656395|474931359|FG005|Overall Study|Non-Compliance with Study Drug|1|||
131902947|NCT01656395|474931360|FG006|Overall Study|Non-Compliance with Study Drug|0|||
131642346|NCT00644878|473976690|FG000|Overall Study|Protocol deviation|2|||
131642347|NCT00644878|473976690|FG000|Overall Study|Treatment duration completed as per protocol|11|||
131642348|NCT00468130|473976698|FG000|Overall Study|Adverse Event|2|||
131642349|NCT00468130|473976699|FG001|Overall Study|Adverse Event|1|||
131642350|NCT00468130|473976698|FG000|Overall Study|Withdrawal by Subject|0|||
131642351|NCT00468130|473976699|FG001|Overall Study|Withdrawal by Subject|1|||
131642352|NCT00436956|473976700|FG000|Overall Study|Not evaluable|1|||
131642353|NCT00436956|473976701|FG001|Overall Study|Not evaluable|0|||
131642354|NCT01841112|473976703|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
131715098|NCT05087030|474233771|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131715099|NCT05087030|474233772|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
131715100|NCT01444300|474233773|FG000|Overall Study|Adverse Event|4|||
131715101|NCT01444300|474233774|FG001|Overall Study|Adverse Event|0|||
131715102|NCT04826900|474233775|FG000|Overall Study|Family factor|1|||
131715103|NCT04826900|474233776|FG001|Overall Study|Family factor|1|||
131715104|NCT00609622|474233780|FG000|Overall Study|Adverse Event|14|||
131715105|NCT00609622|474233781|FG001|Overall Study|Adverse Event|10|||
131715106|NCT00609622|474233780|FG000|Overall Study|Withdrawal by Subject|4|||
131715107|NCT00609622|474233781|FG001|Overall Study|Withdrawal by Subject|20|||
131715108|NCT00609622|474233780|FG000|Overall Study|Death|1|||
131715109|NCT00609622|474233781|FG001|Overall Study|Death|4|||
131715110|NCT00609622|474233780|FG000|Overall Study|Protocol Violation|1|||
131715111|NCT00609622|474233781|FG001|Overall Study|Protocol Violation|1|||
131715112|NCT00609622|474233780|FG000|Overall Study|Objective progression or relapse|47|||
131715113|NCT00609622|474233781|FG001|Overall Study|Objective progression or relapse|41|||
131715114|NCT00609622|474233780|FG000|Overall Study|Study terminated by sponsor|16|||
131715115|NCT00609622|474233781|FG001|Overall Study|Study terminated by sponsor|3|||
131715116|NCT00609622|474233780|FG000|Overall Study|Other|7|||
131715117|NCT00609622|474233781|FG001|Overall Study|Other|14|||
131715118|NCT00609622|474233780|FG000|Overall Study|Global deterioration of health status|6|||
131715119|NCT00609622|474233781|FG001|Overall Study|Global deterioration of health status|2|||
131715120|NCT00686543|474233782|FG000|Overall Study|Adverse Event|9|||
131715121|NCT00686543|474233783|FG001|Overall Study|Adverse Event|1|||
131715122|NCT00686543|474233784|FG002|Overall Study|Adverse Event|3|||
131715123|NCT00686543|474233785|FG003|Overall Study|Adverse Event|2|||
131715124|NCT00686543|474233782|FG000|Overall Study|Withdrawal by Subject|2|||
131715125|NCT00686543|474233783|FG001|Overall Study|Withdrawal by Subject|0|||
131715126|NCT00686543|474233784|FG002|Overall Study|Withdrawal by Subject|0|||
131715127|NCT00686543|474233785|FG003|Overall Study|Withdrawal by Subject|0|||
131715128|NCT00686543|474233782|FG000|Overall Study|Protocol Violation|3|||
131715129|NCT00686543|474233783|FG001|Overall Study|Protocol Violation|0|||
131715130|NCT00686543|474233784|FG002|Overall Study|Protocol Violation|2|||
131715131|NCT00686543|474233785|FG003|Overall Study|Protocol Violation|1|||
131715132|NCT02370121|474233786|FG000|Overall Study|Lost to Follow-up|1|||
131642355|NCT01841112|473976704|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
131642356|NCT01841112|473976705|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
131902948|NCT01656395|474931361|FG007|Overall Study|Non-Compliance with Study Drug|0|||
131902949|NCT01656395|474931354|FG000|Overall Study|Other|0|||
131642357|NCT01841112|473976706|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
131642358|NCT01841112|473976707|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
131715133|NCT02370121|474233787|FG001|Overall Study|Lost to Follow-up|1|||
131715134|NCT04429022|474233789|FG000|Overall Study|Protocol Violation|18|||
131715135|NCT04429022|474233790|FG001|Overall Study|Protocol Violation|1|||
131715136|NCT01769105|474233791|FG000|First Intervention|Protocol Violation|2|||
131715137|NCT01769105|474233792|FG001|First Intervention|Protocol Violation|2|||
131715138|NCT01769105|474233791|FG000|Cross-over|Lost to Follow-up|5|||
131801186|NCT00920140|474555531|FG003|Phase 2|Physician Decision|3|||
131801187|NCT00920140|474555532|FG004|Phase 2|Physician Decision|2|||
131801188|NCT00920140|474555528|FG000|Phase 2|Withdrawal by Subject|0|||
131801189|NCT00920140|474555529|FG001|Phase 2|Withdrawal by Subject|0|||
131801190|NCT00920140|474555530|FG002|Phase 2|Withdrawal by Subject|4|||
131801191|NCT00920140|474555531|FG003|Phase 2|Withdrawal by Subject|2|||
131801192|NCT00920140|474555532|FG004|Phase 2|Withdrawal by Subject|1|||
131801193|NCT01124149|474555533|FG000|Acute Phase|Withdrawal by Subject|22|||
131801194|NCT01124149|474555533|FG000|Acute Phase|Adverse Event|21|||
131801195|NCT01124149|474555533|FG000|Acute Phase|Lack of Efficacy|17|||
131801196|NCT01124149|474555533|FG000|Acute Phase|Protocol Violation|14|||
131801197|NCT01124149|474555533|FG000|Acute Phase|Lost to Follow-up|2|||
131801198|NCT01124149|474555533|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
131801199|NCT01124149|474555533|FG000|Acute Phase|Sponsor request|1|||
131801200|NCT01124149|474555533|FG000|Acute Phase|UC symptoms not ameliorated|1|||
131801201|NCT01124149|474555533|FG000|Acute Phase|Non-compliance|1|||
131801202|NCT01124149|474555533|FG000|Acute Phase|Low hemoglobin|1|||
131801203|NCT01124149|474555533|FG000|Acute Phase|Travelling to another country|1|||
131801204|NCT01124149|474555533|FG000|Acute Phase|Sponsor decision|1|||
131801205|NCT01124149|474555533|FG000|Maintenance Phase|Lack of Efficacy|40|||
131801206|NCT01124149|474555533|FG000|Maintenance Phase|Adverse Event|24|||
131801207|NCT01124149|474555533|FG000|Maintenance Phase|Lost to Follow-up|15|||
131801208|NCT01124149|474555533|FG000|Maintenance Phase|Withdrawal by Subject|10|||
131801209|NCT01124149|474555533|FG000|Maintenance Phase|Protocol Violation|5|||
131801210|NCT01124149|474555533|FG000|Maintenance Phase|Coordinator error|1|||
131801211|NCT01124149|474555533|FG000|Maintenance Phase|Non-compliance|1|||
131801212|NCT00977106|474555534|FG000|Overall Study|Adverse Event|5|||
131801213|NCT00977106|474555535|FG001|Overall Study|Adverse Event|6|||
131801214|NCT00977106|474555534|FG000|Overall Study|Withdrawal by Subject|2|||
131801215|NCT00977106|474555535|FG001|Overall Study|Withdrawal by Subject|2|||
131801216|NCT00977106|474555534|FG000|Overall Study|Lack of Efficacy|2|||
131801217|NCT00977106|474555535|FG001|Overall Study|Lack of Efficacy|2|||
131801218|NCT00977106|474555534|FG000|Overall Study|Protocol Violation|0|||
131801219|NCT00977106|474555535|FG001|Overall Study|Protocol Violation|1|||
131801220|NCT00977106|474555534|FG000|Overall Study|Other|1|||
131801221|NCT00977106|474555535|FG001|Overall Study|Other|0|||
131801222|NCT00720096|474555536|FG000|Overall Study|Withdrawal by Subject|0|||
131801223|NCT00720096|474555537|FG001|Overall Study|Withdrawal by Subject|2|||
131801224|NCT03992196|474555541|FG000|Enrollment|lost to follow-up prior dosing|1|||
131801225|NCT03992196|474555542|FG001|Enrollment|lost to follow-up prior dosing|0|||
131801226|NCT03992196|474555543|FG002|Enrollment|lost to follow-up prior dosing|0|||
131801227|NCT03992196|474555541|FG000|Treatment|Protocol Violation|0|||
131801228|NCT03992196|474555542|FG001|Treatment|Protocol Violation|0|||
131801229|NCT03992196|474555543|FG002|Treatment|Protocol Violation|1|||
131801230|NCT03992196|474555541|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
131801231|NCT03992196|474555542|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
131801232|NCT03992196|474555543|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
131801233|NCT03992196|474555541|FG000|Treatment|Withdrawal due to non-compliance|0|||
131902950|NCT01656395|474931355|FG001|Overall Study|Other|0|||
131902951|NCT01656395|474931356|FG002|Overall Study|Other|1|||
131902952|NCT01656395|474931357|FG003|Overall Study|Other|0|||
131902953|NCT01656395|474931358|FG004|Overall Study|Other|0|||
131902954|NCT01656395|474931359|FG005|Overall Study|Other|1|||
131715139|NCT01769105|474233792|FG001|Cross-over|Lost to Follow-up|0|||
131715140|NCT00963807|474233793|FG000|Overall Study|Physician Decision|2|||
131715141|NCT00963807|474233793|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
131715142|NCT00963807|474233793|FG000|Overall Study|Disease progression|15|||
131715143|NCT00045032|474233795|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
131715144|NCT00045032|474233796|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
131715145|NCT00045032|474233797|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
131715146|NCT00045032|474233795|FG000|Overall Study|Death|22|||
131715147|NCT00045032|474233796|FG001|Overall Study|Death|24|||
131715148|NCT00045032|474233797|FG002|Overall Study|Death|17|||
131715149|NCT00045032|474233795|FG000|Overall Study|Insufficient Therapeutic Response|542|||
131715150|NCT00045032|474233796|FG001|Overall Study|Insufficient Therapeutic Response|437|||
131715151|NCT00045032|474233797|FG002|Overall Study|Insufficient Therapeutic Response|445|||
131715152|NCT00045032|474233795|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
131715153|NCT00045032|474233796|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
131715154|NCT00045032|474233797|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
131715155|NCT00045032|474233795|FG000|Overall Study|Other Protocol Violation|2|||
131715156|NCT00045032|474233796|FG001|Overall Study|Other Protocol Violation|0|||
131715157|NCT00045032|474233797|FG002|Overall Study|Other Protocol Violation|1|||
131715158|NCT00045032|474233795|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
131715159|NCT00045032|474233796|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
131715160|NCT00045032|474233797|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
131715161|NCT00045032|474233795|FG000|Overall Study|Failure to Return|57|||
131642359|NCT00927901|473976708|FG000|Treatment Period 1|Subject withdrew consent|0|||
131642360|NCT00927901|473976709|FG001|Treatment Period 1|Subject withdrew consent|0|||
131642361|NCT00927901|473976710|FG002|Treatment Period 1|Subject withdrew consent|1|||
131642362|NCT00927901|473976711|FG003|Treatment Period 1|Subject withdrew consent|0|||
131642363|NCT00927901|473976708|FG000|Treatment Period 4|Adverse Event|0|||
131642364|NCT00927901|473976709|FG001|Treatment Period 4|Adverse Event|0|||
131642365|NCT00927901|473976710|FG002|Treatment Period 4|Adverse Event|0|||
131642366|NCT00927901|473976711|FG003|Treatment Period 4|Adverse Event|1|||
131642367|NCT00927901|473976708|FG000|Treatment Period 4|Subject withdrew consent|0|||
131642368|NCT00927901|473976709|FG001|Treatment Period 4|Subject withdrew consent|0|||
131642369|NCT00927901|473976710|FG002|Treatment Period 4|Subject withdrew consent|1|||
131642370|NCT00927901|473976711|FG003|Treatment Period 4|Subject withdrew consent|0|||
131642371|NCT03605368|473976712|FG000|Overall Study|Lost to Follow-up|2|||
131642372|NCT03605368|473976713|FG001|Overall Study|Lost to Follow-up|1|||
131642373|NCT03605368|473976714|FG002|Overall Study|Lost to Follow-up|3|||
131715162|NCT00045032|474233796|FG001|Overall Study|Failure to Return|62|||
131715163|NCT00045032|474233797|FG002|Overall Study|Failure to Return|61|||
131715164|NCT00045032|474233795|FG000|Overall Study|Other|93|||
131715165|NCT00045032|474233796|FG001|Overall Study|Other|84|||
131715166|NCT00045032|474233797|FG002|Overall Study|Other|105|||
131719550|NCT01480180|474253339|FG000|Extension Phase, Part 1|Adverse Event|0|||
131719551|NCT01480180|474253340|FG001|Extension Phase, Part 1|Adverse Event|0|||
131719552|NCT01480180|474253341|FG002|Extension Phase, Part 1|Adverse Event|4|||
131719553|NCT01480180|474253342|FG003|Extension Phase, Part 1|Adverse Event|1|||
131719554|NCT01480180|474253343|FG004|Extension Phase, Part 1|Adverse Event|0|||
131719555|NCT01480180|474253344|FG005|Extension Phase, Part 1|Adverse Event|0|||
131719556|NCT01480180|474253339|FG000|Extension Phase, Part 1|Change of treatment|0|||
131719557|NCT01480180|474253340|FG001|Extension Phase, Part 1|Change of treatment|0|||
131719558|NCT01480180|474253341|FG002|Extension Phase, Part 1|Change of treatment|0|||
131719559|NCT01480180|474253342|FG003|Extension Phase, Part 1|Change of treatment|9|||
131719560|NCT01480180|474253343|FG004|Extension Phase, Part 1|Change of treatment|0|||
131719561|NCT01480180|474253344|FG005|Extension Phase, Part 1|Change of treatment|0|||
131719562|NCT01480180|474253339|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
131719563|NCT01480180|474253340|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
131719564|NCT01480180|474253341|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
131719565|NCT01480180|474253342|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
131719566|NCT01480180|474253343|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
131719567|NCT01480180|474253344|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
131719568|NCT01480180|474253339|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
131719569|NCT01480180|474253340|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
131719570|NCT01480180|474253341|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
131719571|NCT01480180|474253342|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
131719572|NCT01480180|474253343|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
131719573|NCT01480180|474253344|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
131719574|NCT01480180|474253339|FG000|Extension Phase, Part 2|Unclassified|0|||
131719575|NCT01480180|474253340|FG001|Extension Phase, Part 2|Unclassified|0|||
131719576|NCT01480180|474253341|FG002|Extension Phase, Part 2|Unclassified|3|||
131719577|NCT01480180|474253342|FG003|Extension Phase, Part 2|Unclassified|1|||
131719578|NCT01480180|474253343|FG004|Extension Phase, Part 2|Unclassified|1|||
131719579|NCT01480180|474253344|FG005|Extension Phase, Part 2|Unclassified|0|||
131719580|NCT00184054|474253346|FG000|Overall Study|Adverse Event|1|||
131719581|NCT05121103|474253350|FG000|Overall Study|Progressive disease|2|||
131719582|NCT05121103|474253351|FG001|Overall Study|Progressive disease|1|||
131719583|NCT05121103|474253352|FG002|Overall Study|Progressive disease|6|||
131719584|NCT05121103|474253350|FG000|Overall Study|Physician Decision|2|||
131719585|NCT05121103|474253351|FG001|Overall Study|Physician Decision|1|||
131719586|NCT05121103|474253352|FG002|Overall Study|Physician Decision|0|||
131719587|NCT05121103|474253350|FG000|Overall Study|Withdrawal by Subject|0|||
131719588|NCT05121103|474253351|FG001|Overall Study|Withdrawal by Subject|1|||
131719589|NCT05121103|474253352|FG002|Overall Study|Withdrawal by Subject|0|||
131719590|NCT00814710|474253355|FG000|Overall Study|Adverse Event|1|||
131719591|NCT00814710|474253356|FG001|Overall Study|Adverse Event|0|||
131719592|NCT00814710|474253355|FG000|Overall Study|Lost to Follow-up|7|||
131719593|NCT00814710|474253356|FG001|Overall Study|Lost to Follow-up|3|||
131719594|NCT03443024|474253357|FG000|Overall Study|Adverse Event|2|||
131719595|NCT03443024|474253358|FG001|Overall Study|Adverse Event|4|||
131719596|NCT03443024|474253359|FG002|Overall Study|Adverse Event|3|||
131719597|NCT03443024|474253360|FG003|Overall Study|Adverse Event|1|||
131719598|NCT03443024|474253357|FG000|Overall Study|Lost to Follow-up|9|||
131642374|NCT03605368|473976715|FG003|Overall Study|Lost to Follow-up|2|||
131719599|NCT03443024|474253358|FG001|Overall Study|Lost to Follow-up|9|||
131642375|NCT03605368|473976712|FG000|Overall Study|Withdrawal by Subject|0|||
131719600|NCT03443024|474253359|FG002|Overall Study|Lost to Follow-up|7|||
131719601|NCT03443024|474253360|FG003|Overall Study|Lost to Follow-up|5|||
131719602|NCT03443024|474253357|FG000|Overall Study|Withdrawal by Subject|8|||
131719603|NCT03443024|474253358|FG001|Overall Study|Withdrawal by Subject|15|||
131801234|NCT03992196|474555542|FG001|Treatment|Withdrawal due to non-compliance|0|||
131801235|NCT03992196|474555543|FG002|Treatment|Withdrawal due to non-compliance|1|||
131801236|NCT03992196|474555541|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
131801237|NCT03992196|474555542|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
131801238|NCT03992196|474555543|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
131801239|NCT03992196|474555541|FG000|Treatment|Withdrawal by parent/guardian|0|||
131801240|NCT03992196|474555542|FG001|Treatment|Withdrawal by parent/guardian|0|||
131801241|NCT03992196|474555543|FG002|Treatment|Withdrawal by parent/guardian|2|||
131801242|NCT02388763|474555546|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
131801243|NCT02388763|474555547|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
131801244|NCT02388763|474555546|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
131801245|NCT02388763|474555547|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
131801246|NCT01153984|474555548|FG000|Overall Study|Withdrawal by Subject|1|||
131801247|NCT01153984|474555548|FG000|Overall Study|Adverse Event|1|||
131801248|NCT02460159|474555549|FG000|Overall Study|Adverse Event|4|||
131801249|NCT02460159|474555550|FG001|Overall Study|Adverse Event|1|||
131801250|NCT02460159|474555549|FG000|Overall Study|Withdrawal by Subject|2|||
131801251|NCT02460159|474555550|FG001|Overall Study|Withdrawal by Subject|0|||
131801252|NCT01458405|474555555|FG000|Phase 1 (up to 12 Months)|Other|0|||
131801253|NCT01458405|474555556|FG001|Phase 1 (up to 12 Months)|Other|1|||
131801254|NCT01458405|474555557|FG002|Phase 1 (up to 12 Months)|Other|0|||
131801255|NCT01458405|474555558|FG003|Phase 1 (up to 12 Months)|Other|0|||
131801256|NCT01458405|474555555|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
131801257|NCT01458405|474555556|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
131801258|NCT01458405|474555557|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
131902955|NCT01656395|474931360|FG006|Overall Study|Other|0|||
131902956|NCT01656395|474931361|FG007|Overall Study|Other|0|||
131902957|NCT01656395|474931354|FG000|Overall Study|Physician Decision|2|||
131902958|NCT01656395|474931355|FG001|Overall Study|Physician Decision|3|||
131902959|NCT01656395|474931356|FG002|Overall Study|Physician Decision|3|||
131902960|NCT01656395|474931357|FG003|Overall Study|Physician Decision|2|||
131902961|NCT01656395|474931358|FG004|Overall Study|Physician Decision|3|||
131902962|NCT01656395|474931359|FG005|Overall Study|Physician Decision|3|||
131902963|NCT01656395|474931360|FG006|Overall Study|Physician Decision|0|||
131902964|NCT01656395|474931361|FG007|Overall Study|Physician Decision|0|||
131902965|NCT01656395|474931354|FG000|Overall Study|Pregnancy|0|||
131902966|NCT01656395|474931355|FG001|Overall Study|Pregnancy|0|||
131902967|NCT01656395|474931356|FG002|Overall Study|Pregnancy|1|||
131902968|NCT01656395|474931357|FG003|Overall Study|Pregnancy|0|||
131902969|NCT01656395|474931358|FG004|Overall Study|Pregnancy|0|||
131902970|NCT01656395|474931359|FG005|Overall Study|Pregnancy|0|||
131902971|NCT01656395|474931360|FG006|Overall Study|Pregnancy|0|||
131902972|NCT01656395|474931361|FG007|Overall Study|Pregnancy|0|||
131902973|NCT01656395|474931354|FG000|Overall Study|Progressive Disease|0|||
131902974|NCT01656395|474931355|FG001|Overall Study|Progressive Disease|0|||
131902975|NCT01656395|474931356|FG002|Overall Study|Progressive Disease|0|||
131902976|NCT01656395|474931357|FG003|Overall Study|Progressive Disease|0|||
131902977|NCT01656395|474931358|FG004|Overall Study|Progressive Disease|0|||
131902978|NCT01656395|474931359|FG005|Overall Study|Progressive Disease|1|||
131902979|NCT01656395|474931360|FG006|Overall Study|Progressive Disease|0|||
131902980|NCT01656395|474931361|FG007|Overall Study|Progressive Disease|0|||
131902981|NCT01656395|474931354|FG000|Overall Study|Protocol Violation|6|||
131902982|NCT01656395|474931355|FG001|Overall Study|Protocol Violation|6|||
131902983|NCT01656395|474931356|FG002|Overall Study|Protocol Violation|9|||
131902984|NCT01656395|474931357|FG003|Overall Study|Protocol Violation|2|||
131902985|NCT01656395|474931358|FG004|Overall Study|Protocol Violation|4|||
131902986|NCT01656395|474931359|FG005|Overall Study|Protocol Violation|10|||
131902987|NCT01656395|474931360|FG006|Overall Study|Protocol Violation|0|||
131902988|NCT01656395|474931361|FG007|Overall Study|Protocol Violation|0|||
131902989|NCT01656395|474931354|FG000|Overall Study|Screen Failure|2|||
131801259|NCT01458405|474555558|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
131801260|NCT01458405|474555555|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
131801261|NCT01458405|474555556|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
131801262|NCT01458405|474555557|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
131902990|NCT01656395|474931355|FG001|Overall Study|Screen Failure|1|||
131902991|NCT01656395|474931356|FG002|Overall Study|Screen Failure|7|||
131902992|NCT01656395|474931357|FG003|Overall Study|Screen Failure|1|||
131902993|NCT01656395|474931358|FG004|Overall Study|Screen Failure|0|||
131902994|NCT01656395|474931359|FG005|Overall Study|Screen Failure|8|||
131801263|NCT01458405|474555558|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
131801264|NCT01458405|474555555|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
131801265|NCT01458405|474555556|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
131801266|NCT01458405|474555557|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
131902995|NCT01656395|474931360|FG006|Overall Study|Screen Failure|0|||
131902996|NCT01656395|474931361|FG007|Overall Study|Screen Failure|0|||
131902997|NCT01656395|474931354|FG000|Overall Study|Withdrawal by Subject|3|||
131902998|NCT01656395|474931355|FG001|Overall Study|Withdrawal by Subject|1|||
131801267|NCT01458405|474555558|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
131801268|NCT02194998|474555559|FG000|On-HCV Treatment|Did not pick up study medication|0|||
131801269|NCT02194998|474555560|FG001|On-HCV Treatment|Did not pick up study medication|1|||
131801270|NCT02194998|474555561|FG002|On-HCV Treatment|Did not pick up study medication|0|||
131801271|NCT02194998|474555562|FG003|On-HCV Treatment|Did not pick up study medication|0|||
131801272|NCT02194998|474555559|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
131801273|NCT02194998|474555560|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
131801274|NCT02194998|474555561|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
131801275|NCT02194998|474555562|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
131801276|NCT02497781|474555563|FG000|Overall Study|Withdrawal by Subject|2|||
131801277|NCT02497781|474555564|FG001|Overall Study|Withdrawal by Subject|0|||
131801278|NCT02497781|474555563|FG000|Overall Study|Lack of Efficacy|0|||
131801279|NCT02497781|474555564|FG001|Overall Study|Lack of Efficacy|1|||
131801280|NCT02497781|474555563|FG000|Overall Study|Randomised but not treated|1|||
131801281|NCT02497781|474555564|FG001|Overall Study|Randomised but not treated|1|||
131801282|NCT02497781|474555563|FG000|Overall Study|Lost to Follow-up|1|||
131801283|NCT02497781|474555564|FG001|Overall Study|Lost to Follow-up|1|||
131801284|NCT00762086|474555565|FG000|Overall Study|Adverse Event|2|||
131801285|NCT00762086|474555566|FG001|Overall Study|Adverse Event|0|||
131801286|NCT00762086|474555565|FG000|Overall Study|Lost to Follow-up|0|||
131801287|NCT00762086|474555566|FG001|Overall Study|Lost to Follow-up|2|||
131801288|NCT00762086|474555565|FG000|Overall Study|Non compliance|1|||
131801289|NCT00762086|474555566|FG001|Overall Study|Non compliance|0|||
131801290|NCT00762086|474555565|FG000|Overall Study|Withdrawal by Subject|2|||
131801291|NCT00762086|474555566|FG001|Overall Study|Withdrawal by Subject|2|||
131801292|NCT00762086|474555565|FG000|Overall Study|Ineligible to participate in the study|1|||
131801293|NCT00762086|474555566|FG001|Overall Study|Ineligible to participate in the study|0|||
131801294|NCT00860405|474555571|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
131801295|NCT00860405|474555572|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
131801296|NCT00497796|474555573|FG000|Overall Study|Adverse event (not related)|9|||
131801297|NCT00497796|474555574|FG001|Overall Study|Adverse event (not related)|9|||
131801298|NCT00497796|474555573|FG000|Overall Study|Adverse event (related)|5|||
131801299|NCT00497796|474555574|FG001|Overall Study|Adverse event (related)|4|||
131801300|NCT00497796|474555573|FG000|Overall Study|CMV infection or disease treatment|30|||
131801301|NCT00497796|474555574|FG001|Overall Study|CMV infection or disease treatment|4|||
131801302|NCT00497796|474555573|FG000|Overall Study|Consent withdrawn|10|||
131801303|NCT00497796|474555574|FG001|Overall Study|Consent withdrawn|3|||
131801304|NCT00497796|474555573|FG000|Overall Study|Investigator/sponsor discretion|31|||
131801305|NCT00497796|474555574|FG001|Overall Study|Investigator/sponsor discretion|34|||
131801306|NCT00497796|474555573|FG000|Overall Study|Lost to Follow-up|0|||
131801307|NCT00497796|474555574|FG001|Overall Study|Lost to Follow-up|1|||
131801308|NCT00497796|474555573|FG000|Overall Study|Not applicable (randomized not treated)|0|||
131801309|NCT00497796|474555574|FG001|Overall Study|Not applicable (randomized not treated)|4|||
131801310|NCT00604500|474555575|FG000|Overall Study|Adverse Event|2|||
131801311|NCT00604500|474555575|FG000|Overall Study|Protocol Violation|2|||
131801312|NCT00604500|474555575|FG000|Overall Study|Treatment Failure|1|||
131801313|NCT00604500|474555575|FG000|Overall Study|Withdrawal by Subject|4|||
131801314|NCT00604500|474555575|FG000|Overall Study|Administrative|1|||
131801315|NCT00604500|474555575|FG000|Overall Study|Did not meet protocol eligibility|1|||
131801316|NCT01370408|474555579|FG000|Overall Study|treatment failure|9|||
131801317|NCT02073643|474555581|FG000|Overall Study|Lost to Follow-up|24|||
131801318|NCT02353169|474555584|FG000|Overall Study|QTc > 450 msec|1|||
131801319|NCT02353169|474555585|FG001|Overall Study|QTc > 450 msec|1|||
131801320|NCT02353169|474555586|FG002|Overall Study|QTc > 450 msec|1|||
131801321|NCT02353169|474555587|FG003|Overall Study|QTc > 450 msec|1|||
131801322|NCT02353169|474555584|FG000|Overall Study|OR team declined|2|||
131801323|NCT02353169|474555585|FG001|Overall Study|OR team declined|0|||
131801324|NCT02353169|474555586|FG002|Overall Study|OR team declined|0|||
131801325|NCT02353169|474555587|FG003|Overall Study|OR team declined|0|||
131801326|NCT02353169|474555584|FG000|Overall Study|Inhalational induction|0|||
131801327|NCT02353169|474555585|FG001|Overall Study|Inhalational induction|2|||
131801328|NCT02353169|474555586|FG002|Overall Study|Inhalational induction|0|||
131801329|NCT02353169|474555587|FG003|Overall Study|Inhalational induction|0|||
131801330|NCT02353169|474555584|FG000|Overall Study|ECG data error|0|||
131801331|NCT02353169|474555585|FG001|Overall Study|ECG data error|3|||
131801332|NCT02353169|474555586|FG002|Overall Study|ECG data error|2|||
131801333|NCT02353169|474555587|FG003|Overall Study|ECG data error|2|||
131801334|NCT02353169|474555584|FG000|Overall Study|Pre-op medication|0|||
131801335|NCT02353169|474555585|FG001|Overall Study|Pre-op medication|0|||
131801336|NCT02353169|474555586|FG002|Overall Study|Pre-op medication|1|||
131801337|NCT02353169|474555587|FG003|Overall Study|Pre-op medication|0|||
131801338|NCT00414765|474555588|FG000|Overall Study|Adverse Event|5|||
131801339|NCT00414765|474555589|FG001|Overall Study|Adverse Event|9|||
131801340|NCT00414765|474555588|FG000|Overall Study|Withdrawal by Subject|1|||
131801341|NCT00414765|474555589|FG001|Overall Study|Withdrawal by Subject|1|||
131801342|NCT00414765|474555588|FG000|Overall Study|Disease Progression|0|||
131801343|NCT00414765|474555589|FG001|Overall Study|Disease Progression|1|||
131801344|NCT01199861|474555590|FG000|Overall Study|Administrative problems|1|||
131801345|NCT01199861|474555591|FG001|Overall Study|Administrative problems|0|||
131801346|NCT01199861|474555590|FG000|Overall Study|Adverse Event|1|||
131801347|NCT01199861|474555591|FG001|Overall Study|Adverse Event|0|||
131801348|NCT04534283|474555592|FG000|Overall Study|Physician Decision|2|||
131801349|NCT04534283|474555592|FG000|Overall Study|Withdrawal by Subject|1|||
131801350|NCT04534283|474555592|FG000|Overall Study|Disease Progression|12|||
131801351|NCT04534283|474555592|FG000|Overall Study|Adverse Event|1|||
131801352|NCT00661505|474555593|FG000|Overall Study|Adverse Event|3|||
131801353|NCT00661505|474555593|FG000|Overall Study|Protocol Violation|14|||
131801354|NCT00661505|474555593|FG000|Overall Study|Withdrawal by Subject|8|||
131801355|NCT00661505|474555593|FG000|Overall Study|Lost to Follow-up|3|||
131801356|NCT00661505|474555593|FG000|Overall Study|Other|2|||
131801357|NCT00796822|474555594|FG000|Overall Study|Lost to Follow-up|2|||
131801358|NCT00796822|474555595|FG001|Overall Study|Lost to Follow-up|0|||
131801359|NCT00796822|474555594|FG000|Overall Study|Adverse Event|1|||
131801360|NCT00796822|474555595|FG001|Overall Study|Adverse Event|0|||
131801361|NCT00680121|474555599|FG000|Overall Study|Lost to Follow-up|27|||
131801362|NCT00680121|474555600|FG001|Overall Study|Lost to Follow-up|23|||
131801363|NCT02545998|474555611|FG000|Overall Study|Lost to Follow-up|12|||
131801364|NCT02545998|474555612|FG001|Overall Study|Lost to Follow-up|3|||
131801365|NCT02545998|474555611|FG000|Overall Study|Withdrawal by Subject|3|||
131801366|NCT02545998|474555612|FG001|Overall Study|Withdrawal by Subject|2|||
131801367|NCT02603952|474555618|FG000|Overall Study|Withdrawal by Subject|1|||
131801368|NCT02603952|474555619|FG001|Overall Study|Withdrawal by Subject|0|||
131801369|NCT02603952|474555620|FG002|Overall Study|Withdrawal by Subject|0|||
131801370|NCT02603952|474555621|FG003|Overall Study|Withdrawal by Subject|0|||
131801371|NCT02603952|474555618|FG000|Overall Study|Received oseltamivir by error|0|||
131801372|NCT02603952|474555619|FG001|Overall Study|Received oseltamivir by error|0|||
131801373|NCT02603952|474555620|FG002|Overall Study|Received oseltamivir by error|0|||
131801374|NCT02603952|474555621|FG003|Overall Study|Received oseltamivir by error|1|||
131801375|NCT00577460|474555629|FG000|Overall Study|Adverse Event|11|||
131801376|NCT00577460|474555630|FG001|Overall Study|Adverse Event|7|||
131801377|NCT00577460|474555631|FG002|Overall Study|Adverse Event|14|||
131801378|NCT00577460|474555629|FG000|Overall Study|Protocol Violation|0|||
131801379|NCT00577460|474555630|FG001|Overall Study|Protocol Violation|1|||
131801380|NCT00577460|474555631|FG002|Overall Study|Protocol Violation|1|||
131801381|NCT00577460|474555629|FG000|Overall Study|Lost to Follow-up|0|||
131801382|NCT00577460|474555630|FG001|Overall Study|Lost to Follow-up|3|||
131801383|NCT00577460|474555631|FG002|Overall Study|Lost to Follow-up|4|||
131801384|NCT00577460|474555629|FG000|Overall Study|Withdrawal by Subject|5|||
131801385|NCT00577460|474555630|FG001|Overall Study|Withdrawal by Subject|5|||
131801386|NCT00577460|474555631|FG002|Overall Study|Withdrawal by Subject|6|||
131801387|NCT00577460|474555629|FG000|Overall Study|Other|0|||
131801388|NCT00577460|474555630|FG001|Overall Study|Other|3|||
131801389|NCT00577460|474555631|FG002|Overall Study|Other|2|||
131801390|NCT01046253|474555633|FG000|Second Intervention|Adverse Event|0|||
131801391|NCT01046253|474555634|FG001|Second Intervention|Adverse Event|1|||
131801392|NCT01046253|474555633|FG000|Second Intervention|Protocol Violation|0|||
131801393|NCT01046253|474555634|FG001|Second Intervention|Protocol Violation|1|||
131801394|NCT01658943|474555640|FG000|Overall Study|Adverse Event|6|||
131801395|NCT01658943|474555641|FG001|Overall Study|Adverse Event|13|||
131801396|NCT01658943|474555640|FG000|Overall Study|Withdrawal by Subject|9|||
131642376|NCT03605368|473976713|FG001|Overall Study|Withdrawal by Subject|0|||
131642377|NCT03605368|473976714|FG002|Overall Study|Withdrawal by Subject|4|||
131642378|NCT03605368|473976715|FG003|Overall Study|Withdrawal by Subject|3|||
131801397|NCT01658943|474555641|FG001|Overall Study|Withdrawal by Subject|2|||
131801398|NCT01658943|474555640|FG000|Overall Study|Progression/Relapse|39|||
131801399|NCT01658943|474555641|FG001|Overall Study|Progression/Relapse|40|||
131801400|NCT01658943|474555640|FG000|Overall Study|Death|4|||
131801401|NCT01658943|474555641|FG001|Overall Study|Death|2|||
131642379|NCT03765164|473976720|FG000|Pre-intervention|Withdrawal by Subject|5|||
131801402|NCT01658943|474555640|FG000|Overall Study|not protocol specified|4|||
131801403|NCT01658943|474555641|FG001|Overall Study|not protocol specified|1|||
131801404|NCT01658943|474555640|FG000|Overall Study|Not eligible|7|||
131801405|NCT01658943|474555641|FG001|Overall Study|Not eligible|9|||
131801406|NCT01658943|474555640|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
131801407|NCT01658943|474555641|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
131801408|NCT00475020|474555642|FG000|Overall Study|Physician Decision|3|||
131801409|NCT00475020|474555642|FG000|Overall Study|Insurance Denial|1|||
131642380|NCT03765164|473976721|FG001|Pre-intervention|Withdrawal by Subject|6|||
131642381|NCT04052997|473976722|FG000|Overall Study|Withdrawal by Subject|17|||
131642382|NCT04052997|473976722|FG000|Overall Study|Physician Decision|50|||
131801410|NCT00475020|474555642|FG000|Overall Study|Donor not able to donate the last minute|1|||
131642383|NCT04052997|473976722|FG000|Overall Study|Death|43|||
131642384|NCT04052997|473976722|FG000|Overall Study|Lost to Follow-up|5|||
131642385|NCT04052997|473976722|FG000|Overall Study|Progression of Disease|1|||
131642386|NCT04088136|473976727|FG000|Overall Study|Withdrawal by Subject|5|||
131642387|NCT04088136|473976728|FG001|Overall Study|Withdrawal by Subject|0|||
131642388|NCT04088136|473976727|FG000|Overall Study|Lack of Efficacy|0|||
131642389|NCT04088136|473976728|FG001|Overall Study|Lack of Efficacy|1|||
131642390|NCT02250183|473976729|FG000|Overall Study|Withdrawal by Subject|2|||
131642391|NCT02250183|473976729|FG000|Overall Study|Adverse Event|5|||
131642392|NCT02250183|473976729|FG000|Overall Study|Lost to Follow-up|1|||
131642393|NCT02080403|473979094|FG000|Overall Study|Adverse Event|5|||
131642394|NCT02080403|473979095|FG001|Overall Study|Adverse Event|1|||
131642395|NCT02080403|473979094|FG000|Overall Study|Death|0|||
131801411|NCT02514174|474555646|FG000|Overall Study|Patient refused to continue medication|1|||
131801412|NCT02514174|474555646|FG000|Overall Study|Adverse Event|2|||
131801413|NCT02514174|474555646|FG000|Overall Study|Study closed by sponsor|9|||
131801414|NCT02514174|474555646|FG000|Overall Study|Progressive disease|11|||
131801415|NCT02514174|474555646|FG000|Overall Study|Treatment change|1|||
131801416|NCT02514174|474555646|FG000|Overall Study|Treated off study with Afatinib.|1|||
131801417|NCT02130466|474555647|FG000|Overall Study|Death|4|||
131801418|NCT02130466|474555648|FG001|Overall Study|Death|1|||
131801419|NCT02130466|474555649|FG002|Overall Study|Death|1|||
131801420|NCT02130466|474555650|FG003|Overall Study|Death|3|||
131801421|NCT02130466|474555651|FG004|Overall Study|Death|2|||
131801422|NCT02130466|474555652|FG005|Overall Study|Death|30|||
131801423|NCT02130466|474555653|FG006|Overall Study|Death|45|||
131801424|NCT02130466|474555654|FG007|Overall Study|Death|2|||
131801425|NCT02130466|474555655|FG008|Overall Study|Death|3|||
131801426|NCT02130466|474555656|FG009|Overall Study|Death|4|||
131801427|NCT02130466|474555657|FG010|Overall Study|Death|5|||
131801428|NCT02130466|474555658|FG011|Overall Study|Death|3|||
131801429|NCT02130466|474555659|FG012|Overall Study|Death|11|||
131801430|NCT02130466|474555660|FG013|Overall Study|Death|7|||
131801431|NCT02130466|474555647|FG000|Overall Study|Lost to Follow-up|1|||
131801432|NCT02130466|474555648|FG001|Overall Study|Lost to Follow-up|0|||
131801433|NCT02130466|474555649|FG002|Overall Study|Lost to Follow-up|0|||
131801434|NCT02130466|474555650|FG003|Overall Study|Lost to Follow-up|0|||
131801435|NCT02130466|474555651|FG004|Overall Study|Lost to Follow-up|0|||
131801436|NCT02130466|474555652|FG005|Overall Study|Lost to Follow-up|1|||
131801437|NCT02130466|474555653|FG006|Overall Study|Lost to Follow-up|0|||
131801438|NCT02130466|474555654|FG007|Overall Study|Lost to Follow-up|0|||
131801439|NCT02130466|474555655|FG008|Overall Study|Lost to Follow-up|0|||
131801440|NCT02130466|474555656|FG009|Overall Study|Lost to Follow-up|0|||
131801441|NCT02130466|474555657|FG010|Overall Study|Lost to Follow-up|0|||
131801442|NCT02130466|474555658|FG011|Overall Study|Lost to Follow-up|0|||
131801443|NCT02130466|474555659|FG012|Overall Study|Lost to Follow-up|1|||
131801444|NCT02130466|474555660|FG013|Overall Study|Lost to Follow-up|0|||
131801445|NCT02130466|474555647|FG000|Overall Study|Physician Decision|0|||
131801446|NCT02130466|474555648|FG001|Overall Study|Physician Decision|0|||
131801447|NCT02130466|474555649|FG002|Overall Study|Physician Decision|0|||
131801448|NCT02130466|474555650|FG003|Overall Study|Physician Decision|0|||
131801449|NCT02130466|474555651|FG004|Overall Study|Physician Decision|0|||
131801450|NCT02130466|474555652|FG005|Overall Study|Physician Decision|1|||
131801451|NCT02130466|474555653|FG006|Overall Study|Physician Decision|1|||
131642396|NCT02080403|473979095|FG001|Overall Study|Death|2|||
131642397|NCT02080403|473979094|FG000|Overall Study|Lost to Follow-up|2|||
131801452|NCT02130466|474555654|FG007|Overall Study|Physician Decision|0|||
131801453|NCT02130466|474555655|FG008|Overall Study|Physician Decision|0|||
131801454|NCT02130466|474555656|FG009|Overall Study|Physician Decision|0|||
131801455|NCT02130466|474555657|FG010|Overall Study|Physician Decision|0|||
131801456|NCT02130466|474555658|FG011|Overall Study|Physician Decision|0|||
131642398|NCT02080403|473979095|FG001|Overall Study|Lost to Follow-up|0|||
131642399|NCT02080403|473979094|FG000|Overall Study|Pregnancy|0|||
131642400|NCT02080403|473979095|FG001|Overall Study|Pregnancy|1|||
131801457|NCT02130466|474555659|FG012|Overall Study|Physician Decision|0|||
131801458|NCT02130466|474555660|FG013|Overall Study|Physician Decision|0|||
131801459|NCT02130466|474555647|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
131801460|NCT02130466|474555648|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
131801461|NCT02130466|474555649|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
131801462|NCT02130466|474555650|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
131801463|NCT02130466|474555651|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
131642401|NCT02080403|473979094|FG000|Overall Study|Protocol Violation|3|||
131642402|NCT02080403|473979095|FG001|Overall Study|Protocol Violation|7|||
131642403|NCT02080403|473979094|FG000|Overall Study|Withdrawal by Subject|5|||
131801464|NCT02130466|474555652|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
131642404|NCT02080403|473979095|FG001|Overall Study|Withdrawal by Subject|1|||
131642405|NCT01101334|473979096|FG000|Overall Study|Adverse Event|9|||
131642406|NCT01101334|473979097|FG001|Overall Study|Adverse Event|4|||
131642407|NCT01101334|473979096|FG000|Overall Study|Death|7|||
131642408|NCT01101334|473979097|FG001|Overall Study|Death|1|||
131642409|NCT01101334|473979096|FG000|Overall Study|Withdrawal by Subject|4|||
131642410|NCT01101334|473979097|FG001|Overall Study|Withdrawal by Subject|3|||
131642411|NCT01101334|473979096|FG000|Overall Study|Withdrawal by Sponsor|1|||
131642412|NCT01101334|473979097|FG001|Overall Study|Withdrawal by Sponsor|1|||
131642413|NCT01101334|473979096|FG000|Overall Study|Progressive Disease|22|||
131642414|NCT01101334|473979097|FG001|Overall Study|Progressive Disease|35|||
131642415|NCT01101334|473979096|FG000|Overall Study|Other|2|||
131642416|NCT01101334|473979097|FG001|Overall Study|Other|1|||
131642417|NCT03864341|473979100|FG000|Overall Study|Withdrawal by Subject|1|||
131642418|NCT02202109|473979102|FG000|Overall Study|Lost to Follow-up|88|||
131642419|NCT02202109|473979103|FG001|Overall Study|Lost to Follow-up|87|||
131642420|NCT02202109|473979102|FG000|Overall Study|Withdrawal by Subject|2|||
131642421|NCT02202109|473979103|FG001|Overall Study|Withdrawal by Subject|0|||
131642422|NCT00263211|473979105|FG000|Overall Study|Death|1|||
131642423|NCT00263211|473979106|FG001|Overall Study|Death|0|||
131642424|NCT00263211|473979105|FG000|Overall Study|Withdrawal by Subject|3|||
131642425|NCT00263211|473979106|FG001|Overall Study|Withdrawal by Subject|0|||
131642426|NCT00263211|473979105|FG000|Overall Study|Protocol Violation|1|||
131642427|NCT00263211|473979106|FG001|Overall Study|Protocol Violation|0|||
131642428|NCT00263211|473979105|FG000|Overall Study|Disease Progression|0|||
131642429|NCT00263211|473979106|FG001|Overall Study|Disease Progression|1|||
131642430|NCT01468077|473979111|FG000|Overall Study|Adverse Event|2|||
131642431|NCT01468077|473979112|FG001|Overall Study|Adverse Event|2|||
131642432|NCT01468077|473979111|FG000|Overall Study|Lack of Efficacy|1|||
131642433|NCT01468077|473979112|FG001|Overall Study|Lack of Efficacy|1|||
131642434|NCT01468077|473979111|FG000|Overall Study|Physician Decision|1|||
131642435|NCT01468077|473979112|FG001|Overall Study|Physician Decision|0|||
131642436|NCT04843579|473979113|FG000|Overall Study|Adverse Event|1|||
131642437|NCT04843579|473979113|FG000|Overall Study|Disease Progression|1|||
131642438|NCT00761956|473979114|FG000|Overall Study|Lost to Follow-up|6|||
131642439|NCT00761956|473979115|FG001|Overall Study|Lost to Follow-up|11|||
131642440|NCT00761956|473979114|FG000|Overall Study|Withdrawal by Subject|3|||
131642441|NCT00761956|473979115|FG001|Overall Study|Withdrawal by Subject|8|||
131801465|NCT02130466|474555653|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
131801466|NCT02130466|474555654|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
131642442|NCT00761956|473979114|FG000|Overall Study|Death|0|||
131642443|NCT00761956|473979115|FG001|Overall Study|Death|1|||
131642444|NCT00761956|473979114|FG000|Overall Study|Adverse Event|26|||
131642445|NCT00761956|473979115|FG001|Overall Study|Adverse Event|34|||
131642446|NCT02808975|473979117|FG000|Overall Study|Adverse Event|3|||
131642447|NCT02808975|473979118|FG001|Overall Study|Adverse Event|4|||
131642448|NCT02808975|473979117|FG000|Overall Study|Withdrew consent|9|||
131642449|NCT02808975|473979118|FG001|Overall Study|Withdrew consent|8|||
131642450|NCT02808975|473979117|FG000|Overall Study|Lost to Follow-up|4|||
131801467|NCT02130466|474555655|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
131801468|NCT02130466|474555656|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
131801469|NCT02130466|474555657|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
131801470|NCT02130466|474555658|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
131801471|NCT02130466|474555659|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
131801472|NCT02130466|474555660|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
131801473|NCT02130466|474555647|FG000|Overall Study|Withdrawal by Subject|1|||
131801474|NCT02130466|474555648|FG001|Overall Study|Withdrawal by Subject|0|||
131801475|NCT02130466|474555649|FG002|Overall Study|Withdrawal by Subject|0|||
131801476|NCT02130466|474555650|FG003|Overall Study|Withdrawal by Subject|0|||
131801477|NCT02130466|474555651|FG004|Overall Study|Withdrawal by Subject|0|||
131801478|NCT02130466|474555652|FG005|Overall Study|Withdrawal by Subject|1|||
131801479|NCT02130466|474555653|FG006|Overall Study|Withdrawal by Subject|0|||
131801480|NCT02130466|474555654|FG007|Overall Study|Withdrawal by Subject|0|||
131801481|NCT02130466|474555655|FG008|Overall Study|Withdrawal by Subject|1|||
131801482|NCT02130466|474555656|FG009|Overall Study|Withdrawal by Subject|0|||
131801483|NCT02130466|474555657|FG010|Overall Study|Withdrawal by Subject|0|||
131801484|NCT02130466|474555658|FG011|Overall Study|Withdrawal by Subject|0|||
131801485|NCT02130466|474555659|FG012|Overall Study|Withdrawal by Subject|0|||
131801486|NCT02130466|474555660|FG013|Overall Study|Withdrawal by Subject|0|||
131801487|NCT00993616|474555661|FG000|Overall Study|No tumor at entry|1|||
131801488|NCT00993616|474555661|FG000|Overall Study|Never treated|1|||
131801489|NCT00453362|474557157|FG000|Overall Study|Adverse Event|5|||
131801490|NCT00453362|474557157|FG000|Overall Study|Death|7|||
131801491|NCT00453362|474557157|FG000|Overall Study|Physician Decision|2|||
131801492|NCT00453362|474557157|FG000|Overall Study|Withdrawal by Subject|3|||
131801493|NCT00453362|474557157|FG000|Overall Study|Progression of disease|56|||
131801494|NCT00453362|474557157|FG000|Overall Study|Screening Failure|14|||
131801495|NCT02127281|474557158|FG000|Overall Study|Lost to Follow-up|1|||
131801496|NCT02127281|474557159|FG001|Overall Study|Lost to Follow-up|0|||
131801497|NCT04885296|474557160|FG000|Period 1|Covid-19 Related|1|||
131801498|NCT04885296|474557161|FG001|Period 1|Covid-19 Related|0|||
131801499|NCT04885296|474557160|FG000|Period 1|Adverse Event|0|||
131801500|NCT04885296|474557161|FG001|Period 1|Adverse Event|1|||
131801501|NCT04885296|474557160|FG000|Period 1|Withdrawal by Subject|1|||
131801502|NCT04885296|474557161|FG001|Period 1|Withdrawal by Subject|1|||
131801503|NCT04885296|474557160|FG000|Period 1|Test Article No Longer Available|1|||
131801504|NCT04885296|474557161|FG001|Period 1|Test Article No Longer Available|0|||
131801505|NCT04885296|474557160|FG000|Period 1|Dispensed Study lens in Error|1|||
131801506|NCT04885296|474557161|FG001|Period 1|Dispensed Study lens in Error|0|||
131801507|NCT04885296|474557160|FG000|Period 1|Lost to Follow-up|1|||
131801508|NCT04885296|474557161|FG001|Period 1|Lost to Follow-up|0|||
131801509|NCT04885296|474557160|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
131801510|NCT04885296|474557161|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
131801511|NCT00862979|474557164|FG000|Overall Study|Adverse Event|6|||
131801512|NCT00862979|474557165|FG001|Overall Study|Adverse Event|3|||
131801513|NCT00862979|474557164|FG000|Overall Study|Protocol Violation|0|||
131801514|NCT00862979|474557165|FG001|Overall Study|Protocol Violation|1|||
131801515|NCT00862979|474557164|FG000|Overall Study|Patient withdrew consent|2|||
131801516|NCT00862979|474557165|FG001|Overall Study|Patient withdrew consent|1|||
131801517|NCT00862979|474557164|FG000|Overall Study|Administrative problems|0|||
131801518|NCT00862979|474557165|FG001|Overall Study|Administrative problems|1|||
131801519|NCT00862979|474557164|FG000|Overall Study|Death|0|||
131801520|NCT00862979|474557165|FG001|Overall Study|Death|1|||
131801521|NCT05346055|474557166|FG000|Overall Study|Withdrawal by Subject|1|||
131801522|NCT05346055|474557166|FG000|Overall Study|Protocol Violation|1|||
131642451|NCT02808975|473979118|FG001|Overall Study|Lost to Follow-up|6|||
131642452|NCT02808975|473979117|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
131642453|NCT02808975|473979118|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
131801523|NCT05346055|474557166|FG000|Overall Study|Therapist decision|1|||
131801524|NCT02564263|474557169|FG000|Overall Study|Adverse Event|31|||
131642454|NCT02808975|473979117|FG000|Overall Study|Other, not specified|5|||
131642455|NCT02808975|473979118|FG001|Overall Study|Other, not specified|1|||
131642456|NCT03024996|473979119|FG000|Overall Study|Death|57|||
131801525|NCT02564263|474557170|FG001|Overall Study|Adverse Event|29|||
131642457|NCT03024996|473979120|FG001|Overall Study|Death|55|||
131642458|NCT03024996|473979119|FG000|Overall Study|Disease relapse|1|||
131801526|NCT02564263|474557169|FG000|Overall Study|Death|270|||
131801527|NCT02564263|474557170|FG001|Overall Study|Death|262|||
131801528|NCT02564263|474557169|FG000|Overall Study|Withdrawal by Subject|4|||
131801529|NCT02564263|474557170|FG001|Overall Study|Withdrawal by Subject|19|||
131801530|NCT02564263|474557169|FG000|Overall Study|Sponsor's decision|9|||
131801531|NCT02564263|474557170|FG001|Overall Study|Sponsor's decision|4|||
131801532|NCT03311646|474557171|FG000|Overall Study|Physician Decision|1|||
131801533|NCT03311646|474557171|FG000|Overall Study|Withdrawal by Subject|5|||
131801534|NCT03311646|474557171|FG000|Overall Study|Lost to Follow-up|5|||
131801535|NCT03311646|474557171|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
131801536|NCT00728949|474557177|FG000|Overall Study|Adverse Event|8|||
131801537|NCT00728949|474557178|FG001|Overall Study|Adverse Event|0|||
131801538|NCT00728949|474557177|FG000|Overall Study|Withdrawal by Subject|2|||
131801539|NCT00728949|474557178|FG001|Overall Study|Withdrawal by Subject|2|||
131801540|NCT00728949|474557177|FG000|Overall Study|Abnormal Lab Results|0|||
131801541|NCT00728949|474557178|FG001|Overall Study|Abnormal Lab Results|2|||
131801542|NCT00728949|474557177|FG000|Overall Study|On treatment at cutoff date|1|||
131801543|NCT00728949|474557178|FG001|Overall Study|On treatment at cutoff date|0|||
131801544|NCT03127137|474557179|FG000|Overall Study|Requested sedation after consent|1|||
131801545|NCT03127137|474557180|FG001|Overall Study|Requested sedation after consent|0|||
131801546|NCT03127137|474557179|FG000|Overall Study|Malfunction in electronic data collection|1|||
131801547|NCT03127137|474557180|FG001|Overall Study|Malfunction in electronic data collection|0|||
131801548|NCT03127137|474557179|FG000|Overall Study|Post procedure testing could not be obtained|0|||
131801549|NCT03127137|474557180|FG001|Overall Study|Post procedure testing could not be obtained|1|||
131801550|NCT01239121|474557186|FG000|Overall Study|Withdrawal by Subject|2|||
131801551|NCT01239121|474557187|FG001|Overall Study|Withdrawal by Subject|4|||
131445178|NCT04323124|473258852|FG010|Overall Study|Coming from a red zone (COVID)|0|||
131445179|NCT04323124|473258853|FG011|Overall Study|Coming from a red zone (COVID)|0|||
131445180|NCT04323124|473258854|FG012|Overall Study|Coming from a red zone (COVID)|0|||
131445181|NCT04323124|473258855|FG013|Overall Study|Coming from a red zone (COVID)|0|||
131445182|NCT04323124|473258856|FG014|Overall Study|Coming from a red zone (COVID)|0|||
131445183|NCT04323124|473258842|FG000|Overall Study|No longer meets eligibility criteria|0|||
131445184|NCT04323124|473258843|FG001|Overall Study|No longer meets eligibility criteria|0|||
131445185|NCT04323124|473258844|FG002|Overall Study|No longer meets eligibility criteria|0|||
131445186|NCT04323124|473258845|FG003|Overall Study|No longer meets eligibility criteria|0|||
131445187|NCT04323124|473258846|FG004|Overall Study|No longer meets eligibility criteria|0|||
131445188|NCT04323124|473258847|FG005|Overall Study|No longer meets eligibility criteria|0|||
131445189|NCT04323124|473258848|FG006|Overall Study|No longer meets eligibility criteria|0|||
131445190|NCT04323124|473258849|FG007|Overall Study|No longer meets eligibility criteria|1|||
131445191|NCT04323124|473258850|FG008|Overall Study|No longer meets eligibility criteria|0|||
131445192|NCT04323124|473258851|FG009|Overall Study|No longer meets eligibility criteria|0|||
131445193|NCT04323124|473258852|FG010|Overall Study|No longer meets eligibility criteria|0|||
131445194|NCT04323124|473258853|FG011|Overall Study|No longer meets eligibility criteria|0|||
131445195|NCT04323124|473258854|FG012|Overall Study|No longer meets eligibility criteria|0|||
131445196|NCT04323124|473258855|FG013|Overall Study|No longer meets eligibility criteria|1|||
131445197|NCT04323124|473258856|FG014|Overall Study|No longer meets eligibility criteria|1|||
131445198|NCT04323124|473258842|FG000|Overall Study|Study terminated by sponsor|0|||
131445199|NCT04323124|473258843|FG001|Overall Study|Study terminated by sponsor|0|||
131445200|NCT04323124|473258844|FG002|Overall Study|Study terminated by sponsor|0|||
131445201|NCT04323124|473258845|FG003|Overall Study|Study terminated by sponsor|0|||
131445202|NCT04323124|473258846|FG004|Overall Study|Study terminated by sponsor|0|||
131445203|NCT04323124|473258847|FG005|Overall Study|Study terminated by sponsor|0|||
131445204|NCT04323124|473258848|FG006|Overall Study|Study terminated by sponsor|0|||
131445205|NCT04323124|473258849|FG007|Overall Study|Study terminated by sponsor|0|||
131445206|NCT04323124|473258850|FG008|Overall Study|Study terminated by sponsor|0|||
131445207|NCT04323124|473258851|FG009|Overall Study|Study terminated by sponsor|0|||
131445208|NCT04323124|473258852|FG010|Overall Study|Study terminated by sponsor|0|||
131445209|NCT04323124|473258853|FG011|Overall Study|Study terminated by sponsor|2|||
131445210|NCT04323124|473258854|FG012|Overall Study|Study terminated by sponsor|1|||
131445211|NCT04323124|473258855|FG013|Overall Study|Study terminated by sponsor|0|||
131445212|NCT04323124|473258856|FG014|Overall Study|Study terminated by sponsor|0|||
131642459|NCT03024996|473979120|FG001|Overall Study|Disease relapse|0|||
131642460|NCT03024996|473979119|FG000|Overall Study|Lost to Follow-up|5|||
131642461|NCT03024996|473979120|FG001|Overall Study|Lost to Follow-up|10|||
131801552|NCT01239121|474557188|FG002|Overall Study|Withdrawal by Subject|0|||
131801553|NCT00623779|474557191|FG000|Overall Study|Adverse Event|1|||
131801554|NCT00623779|474557192|FG001|Overall Study|Adverse Event|3|||
131801555|NCT00623779|474557193|FG002|Overall Study|Adverse Event|0|||
131801556|NCT00623779|474557191|FG000|Overall Study|Criteria from CSR|2|||
131801557|NCT00623779|474557192|FG001|Overall Study|Criteria from CSR|0|||
131801558|NCT00623779|474557193|FG002|Overall Study|Criteria from CSR|1|||
131801559|NCT04276883|474557194|FG000|Overall Study|Withdrawal by Subject|2|||
131902999|NCT01656395|474931356|FG002|Overall Study|Withdrawal by Subject|4|||
131903000|NCT01656395|474931357|FG003|Overall Study|Withdrawal by Subject|2|||
131642462|NCT03024996|473979119|FG000|Overall Study|Other|3|||
131642463|NCT03024996|473979120|FG001|Overall Study|Other|3|||
131801560|NCT04276883|474557195|FG001|Overall Study|Withdrawal by Subject|3|||
131445213|NCT00489307|473258857|FG000|Overall Study|Death|1|||
131445214|NCT00489307|473258858|FG001|Overall Study|Death|1|||
131642464|NCT03024996|473979119|FG000|Overall Study|Physician Decision|0|||
131801561|NCT04276883|474557196|FG002|Overall Study|Withdrawal by Subject|6|||
131801562|NCT04276883|474557194|FG000|Overall Study|Lost to Follow-up|1|||
131642465|NCT03024996|473979120|FG001|Overall Study|Physician Decision|1|||
131642466|NCT03024996|473979119|FG000|Overall Study|Study terminated by sponsor|303|||
131642467|NCT03024996|473979120|FG001|Overall Study|Study terminated by sponsor|283|||
131642468|NCT03024996|473979119|FG000|Overall Study|Withdrawal by Subject|21|||
131642469|NCT03024996|473979120|FG001|Overall Study|Withdrawal by Subject|36|||
131642470|NCT04333147|473979124|FG000|Overall Study|Adverse Event|43|||
131642471|NCT04333147|473979125|FG001|Overall Study|Adverse Event|40|||
131642472|NCT04333147|473979124|FG000|Overall Study|Lack of Efficacy|49|||
131642473|NCT04333147|473979125|FG001|Overall Study|Lack of Efficacy|48|||
131715167|NCT00473694|474235369|FG000|Overall Study|Adverse Event|0|||
131715168|NCT00473694|474235370|FG001|Overall Study|Adverse Event|1|||
131715169|NCT00473694|474235371|FG002|Overall Study|Adverse Event|0|||
131715170|NCT00473694|474235372|FG003|Overall Study|Adverse Event|0|||
131715171|NCT00473694|474235369|FG000|Overall Study|Participants did not receive treatment|11|||
131715172|NCT00473694|474235370|FG001|Overall Study|Participants did not receive treatment|3|||
131715173|NCT00473694|474235371|FG002|Overall Study|Participants did not receive treatment|5|||
131715174|NCT00473694|474235372|FG003|Overall Study|Participants did not receive treatment|6|||
131715175|NCT00473694|474235369|FG000|Overall Study|Lost to Follow-up|0|||
131715176|NCT00473694|474235370|FG001|Overall Study|Lost to Follow-up|0|||
131715177|NCT00473694|474235371|FG002|Overall Study|Lost to Follow-up|0|||
131715178|NCT00473694|474235372|FG003|Overall Study|Lost to Follow-up|1|||
131715179|NCT01381094|474235380|FG000|Overall Study|Adverse Event|1|||
131715180|NCT01381094|474235381|FG001|Overall Study|Adverse Event|2|||
131715181|NCT01381094|474235382|FG002|Overall Study|Adverse Event|0|||
131715182|NCT01381094|474235383|FG003|Overall Study|Adverse Event|1|||
131715183|NCT01381094|474235384|FG004|Overall Study|Adverse Event|0|||
131715184|NCT01381094|474235380|FG000|Overall Study|Lost to Follow-up|0|||
131715185|NCT01381094|474235381|FG001|Overall Study|Lost to Follow-up|0|||
131715186|NCT01381094|474235382|FG002|Overall Study|Lost to Follow-up|0|||
131715187|NCT01381094|474235383|FG003|Overall Study|Lost to Follow-up|0|||
131715188|NCT01381094|474235384|FG004|Overall Study|Lost to Follow-up|1|||
131715189|NCT01381094|474235380|FG000|Overall Study|Withdrawal of informed consent|0|||
131715190|NCT01381094|474235381|FG001|Overall Study|Withdrawal of informed consent|1|||
131715191|NCT01381094|474235382|FG002|Overall Study|Withdrawal of informed consent|0|||
131715192|NCT01381094|474235383|FG003|Overall Study|Withdrawal of informed consent|0|||
131715193|NCT01381094|474235384|FG004|Overall Study|Withdrawal of informed consent|0|||
131715194|NCT01381094|474235380|FG000|Overall Study|Participant given Aranesp injection|1|||
131715195|NCT01381094|474235381|FG001|Overall Study|Participant given Aranesp injection|0|||
131715196|NCT01381094|474235382|FG002|Overall Study|Participant given Aranesp injection|0|||
131715197|NCT01381094|474235383|FG003|Overall Study|Participant given Aranesp injection|0|||
131715198|NCT01381094|474235384|FG004|Overall Study|Participant given Aranesp injection|0|||
131715199|NCT00541307|474235385|FG000|Overall Study|Death|5|||
131715200|NCT00541307|474235385|FG000|Overall Study|Physician Decision|3|||
131715201|NCT00541307|474235385|FG000|Overall Study|Withdrawal by Subject|6|||
131715202|NCT00541307|474235385|FG000|Overall Study|Lost to Follow-up|4|||
131715203|NCT00541307|474235385|FG000|Overall Study|Subject returned early (outside window)|1|||
131715204|NCT00541307|474235385|FG000|Overall Study|Surgical Bypass|5|||
131715205|NCT03615222|474235390|FG000|Overall Study|Ineligible|26|||
131715206|NCT03615222|474235390|FG000|Overall Study|Withdrawal by Subject|7|||
131715207|NCT03615222|474235390|FG000|Overall Study|Death|1|||
131715208|NCT03895203|474235391|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
131715209|NCT03895203|474235392|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
131715210|NCT03895203|474235393|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
131715211|NCT03895203|474235394|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
131715212|NCT03895203|474235395|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
131715213|NCT03895203|474235396|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
131715214|NCT03895203|474235391|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
131715215|NCT03895203|474235392|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131715216|NCT03895203|474235393|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131715217|NCT03895203|474235394|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131715218|NCT03895203|474235395|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131715219|NCT03895203|474235396|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131715220|NCT03895203|474235391|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
131715221|NCT03895203|474235392|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131715222|NCT03895203|474235393|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131642474|NCT04333147|473979124|FG000|Overall Study|Lost to Follow-up|19|||
131642475|NCT04333147|473979125|FG001|Overall Study|Lost to Follow-up|16|||
131642476|NCT04333147|473979124|FG000|Overall Study|Physician Decision|17|||
131642477|NCT04333147|473979125|FG001|Overall Study|Physician Decision|20|||
131642478|NCT04333147|473979124|FG000|Overall Study|Withdrawal by Subject|65|||
131642479|NCT04333147|473979125|FG001|Overall Study|Withdrawal by Subject|68|||
131642480|NCT04333147|473979124|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
131642481|NCT04333147|473979125|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
131642482|NCT04333147|473979124|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
131642483|NCT04333147|473979125|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
131642484|NCT04333147|473979124|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
131642485|NCT04333147|473979125|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
131642486|NCT02106195|473979126|FG000|Overall Study|Adverse Event|2|||
131642487|NCT02106195|473979126|FG000|Overall Study|Protocol Violation|1|||
131642488|NCT00464945|473979127|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
131642489|NCT00464945|473979128|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
131642490|NCT00464945|473979127|FG000|Infant Series|Protocol Violation|1|||
131715223|NCT03895203|474235394|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131715224|NCT03895203|474235395|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131715225|NCT03895203|474235396|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131715226|NCT03895203|474235391|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
131715227|NCT03895203|474235392|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
131715228|NCT03895203|474235393|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
131715229|NCT03895203|474235394|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
131715230|NCT03895203|474235395|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
131715231|NCT03895203|474235396|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
131715232|NCT03895203|474235391|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131715233|NCT03895203|474235392|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
131715234|NCT03895203|474235393|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131715235|NCT03895203|474235394|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131715236|NCT03895203|474235395|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131715237|NCT03895203|474235396|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131715238|NCT03895203|474235391|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131715239|NCT03895203|474235392|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
131715240|NCT03895203|474235393|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131715241|NCT03895203|474235394|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131715242|NCT03895203|474235395|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131715243|NCT03895203|474235396|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131715244|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131715245|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131715246|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131715247|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
131715248|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131715249|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131715250|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
131715251|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
131715252|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
131715253|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
131715254|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
131715255|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
131715256|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
131715257|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
131715258|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
131715259|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
131715260|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
131642491|NCT00464945|473979128|FG001|Infant Series|Protocol Violation|0|||
131642492|NCT00464945|473979127|FG000|Infant Series|Lost to Follow-up|1|||
131903001|NCT01656395|474931358|FG004|Overall Study|Withdrawal by Subject|0|||
131903002|NCT01656395|474931359|FG005|Overall Study|Withdrawal by Subject|3|||
131903003|NCT01656395|474931360|FG006|Overall Study|Withdrawal by Subject|0|||
131903004|NCT01656395|474931361|FG007|Overall Study|Withdrawal by Subject|0|||
131903005|NCT00230048|474931362|FG000|Overall Study|Lost to Follow-up|13|||
131642493|NCT00464945|473979128|FG001|Infant Series|Lost to Follow-up|0|||
131642494|NCT00464945|473979127|FG000|After Infant Series|Withdrawal by Subject|0|||
131642495|NCT00464945|473979128|FG001|After Infant Series|Withdrawal by Subject|2|||
131642496|NCT00464945|473979127|FG000|Toddler Dose|Lost to Follow-up|0|||
131642497|NCT00464945|473979128|FG001|Toddler Dose|Lost to Follow-up|1|||
131642498|NCT04629443|473979131|FG000|Overall Study|Adverse Event|2|||
131642499|NCT04629443|473979132|FG001|Overall Study|Adverse Event|1|||
131642500|NCT04629443|473979133|FG002|Overall Study|Adverse Event|2|||
131642501|NCT04629443|473979131|FG000|Overall Study|Progressive Disease|2|||
131642502|NCT04629443|473979132|FG001|Overall Study|Progressive Disease|3|||
131715261|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
131642503|NCT04629443|473979133|FG002|Overall Study|Progressive Disease|3|||
131642504|NCT04629443|473979131|FG000|Overall Study|Physician Decision|1|||
131642505|NCT04629443|473979132|FG001|Overall Study|Physician Decision|3|||
131642506|NCT04629443|473979133|FG002|Overall Study|Physician Decision|0|||
131642507|NCT01547117|473979134|FG000|Overall Study|Physician Decision|0|||
131642508|NCT01547117|473979135|FG001|Overall Study|Physician Decision|1|||
131642509|NCT01547117|473979136|FG002|Overall Study|Physician Decision|1|||
131642510|NCT01547117|473979137|FG003|Overall Study|Physician Decision|3|||
131642511|NCT01547117|473979134|FG000|Overall Study|Withdrawal by Subject|1|||
131642512|NCT01547117|473979135|FG001|Overall Study|Withdrawal by Subject|2|||
131642513|NCT01547117|473979136|FG002|Overall Study|Withdrawal by Subject|1|||
131642514|NCT01547117|473979137|FG003|Overall Study|Withdrawal by Subject|2|||
131642515|NCT03491215|473979139|FG000|Overall Study|Death|6|||
131642516|NCT03491215|473979140|FG001|Overall Study|Death|2|||
131642517|NCT03491215|473979141|FG002|Overall Study|Death|1|||
131642518|NCT03491215|473979142|FG003|Overall Study|Death|0|||
131642519|NCT03491215|473979139|FG000|Overall Study|Physician Decision|1|||
131642520|NCT03491215|473979140|FG001|Overall Study|Physician Decision|0|||
131642521|NCT03491215|473979141|FG002|Overall Study|Physician Decision|0|||
131642522|NCT03491215|473979142|FG003|Overall Study|Physician Decision|0|||
131642523|NCT00704171|473979147|FG000|Overall Study|Withdrawal by Subject|1|||
131642524|NCT00704171|473979148|FG001|Overall Study|Withdrawal by Subject|0|||
131642525|NCT00233389|473979149|FG000|Overall Study|Adverse Event|5|||
131642526|NCT00233389|473979150|FG001|Overall Study|Adverse Event|5|||
131642527|NCT00233389|473979149|FG000|Overall Study|Lack of Efficacy|11|||
131642528|NCT00233389|473979150|FG001|Overall Study|Lack of Efficacy|8|||
131642529|NCT00233389|473979149|FG000|Overall Study|Lost to Follow-up|1|||
131642530|NCT00233389|473979150|FG001|Overall Study|Lost to Follow-up|1|||
131642531|NCT00233389|473979149|FG000|Overall Study|Physician Decision|1|||
131642532|NCT00233389|473979150|FG001|Overall Study|Physician Decision|0|||
131642533|NCT00233389|473979149|FG000|Overall Study|Protocol Violation|0|||
131642534|NCT00233389|473979150|FG001|Overall Study|Protocol Violation|1|||
131642535|NCT00233389|473979149|FG000|Overall Study|Withdrawal by Subject|0|||
131642536|NCT00233389|473979150|FG001|Overall Study|Withdrawal by Subject|1|||
131642537|NCT00719043|473979151|FG000|Overall Study|Adverse Event|5|||
131642538|NCT00719043|473979152|FG001|Overall Study|Adverse Event|1|||
131642539|NCT00719043|473979153|FG002|Overall Study|Adverse Event|2|||
131642540|NCT00719043|473979154|FG003|Overall Study|Adverse Event|2|||
131715262|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131642541|NCT00719043|473979155|FG004|Overall Study|Adverse Event|1|||
131642542|NCT00719043|473979156|FG005|Overall Study|Adverse Event|4|||
131642543|NCT00719043|473979157|FG006|Overall Study|Adverse Event|4|||
131642544|NCT00719043|473979151|FG000|Overall Study|Lost to Follow-up|14|||
131642545|NCT00719043|473979152|FG001|Overall Study|Lost to Follow-up|10|||
131642546|NCT00719043|473979153|FG002|Overall Study|Lost to Follow-up|8|||
131642547|NCT00719043|473979154|FG003|Overall Study|Lost to Follow-up|9|||
131642548|NCT00719043|473979155|FG004|Overall Study|Lost to Follow-up|10|||
131642549|NCT00719043|473979156|FG005|Overall Study|Lost to Follow-up|9|||
131642550|NCT00719043|473979157|FG006|Overall Study|Lost to Follow-up|9|||
131642551|NCT00719043|473979151|FG000|Overall Study|Protocol Violation|0|||
131642552|NCT00719043|473979152|FG001|Overall Study|Protocol Violation|0|||
131642553|NCT00719043|473979153|FG002|Overall Study|Protocol Violation|0|||
131642554|NCT00719043|473979154|FG003|Overall Study|Protocol Violation|0|||
131642555|NCT00719043|473979155|FG004|Overall Study|Protocol Violation|0|||
131642556|NCT00719043|473979156|FG005|Overall Study|Protocol Violation|1|||
131642557|NCT00719043|473979157|FG006|Overall Study|Protocol Violation|0|||
131642558|NCT00719043|473979151|FG000|Overall Study|Other|1|||
131642559|NCT00719043|473979152|FG001|Overall Study|Other|0|||
131642560|NCT00719043|473979153|FG002|Overall Study|Other|1|||
131642561|NCT00719043|473979154|FG003|Overall Study|Other|2|||
131642562|NCT00719043|473979155|FG004|Overall Study|Other|0|||
131642563|NCT00719043|473979156|FG005|Overall Study|Other|2|||
131642564|NCT00719043|473979157|FG006|Overall Study|Other|1|||
131642565|NCT00719043|473979151|FG000|Overall Study|Withdrawal by Subject|12|||
131642566|NCT00719043|473979152|FG001|Overall Study|Withdrawal by Subject|14|||
131642567|NCT00719043|473979153|FG002|Overall Study|Withdrawal by Subject|9|||
131642568|NCT00719043|473979154|FG003|Overall Study|Withdrawal by Subject|10|||
131642569|NCT00719043|473979155|FG004|Overall Study|Withdrawal by Subject|16|||
131642570|NCT00719043|473979156|FG005|Overall Study|Withdrawal by Subject|18|||
131642571|NCT00719043|473979157|FG006|Overall Study|Withdrawal by Subject|14|||
131642572|NCT01588366|473979158|FG000|Overall Study|Adverse Event|0|||
131642573|NCT01588366|473979159|FG001|Overall Study|Adverse Event|1|||
131642574|NCT01588366|473979160|FG002|Overall Study|Adverse Event|0|||
131642575|NCT01588366|473979161|FG003|Overall Study|Adverse Event|1|||
131642576|NCT01588366|473979162|FG004|Overall Study|Adverse Event|0|||
131642577|NCT01588366|473979163|FG005|Overall Study|Adverse Event|2|||
131642578|NCT00302159|473979164|FG000|Overall Study|pt declined before treatment started|1|||
131642579|NCT00302159|473979164|FG000|Overall Study|pt started Avastin|1|||
131642580|NCT03470545|473979165|FG000|Overall Study|Death|0|||
131642581|NCT03470545|473979166|FG001|Overall Study|Death|1|||
131642582|NCT03470545|473979165|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
131642583|NCT03470545|473979166|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
131642584|NCT03470545|473979165|FG000|Overall Study|Adverse Event|2|||
131642585|NCT03470545|473979166|FG001|Overall Study|Adverse Event|0|||
131642586|NCT03470545|473979165|FG000|Overall Study|Withdrawal by Subject|1|||
131642587|NCT03470545|473979166|FG001|Overall Study|Withdrawal by Subject|1|||
131642588|NCT03470545|473979165|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
131642589|NCT03470545|473979166|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
131715263|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131715264|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131715265|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
131715266|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
131715267|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131715268|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
131715269|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
131715270|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
131715271|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
131715272|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
131715273|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
131715274|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131715275|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131715276|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131715277|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
131715278|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131715279|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131715280|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131715281|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131715282|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131801563|NCT04276883|474557195|FG001|Overall Study|Lost to Follow-up|3|||
131642590|NCT01006616|473979167|FG000|Period 1 (6 Months)|Adverse Event|10|||
131642591|NCT01006616|473979168|FG001|Period 1 (6 Months)|Adverse Event|31|||
131642592|NCT01006616|473979169|FG002|Period 1 (6 Months)|Adverse Event|37|||
131642593|NCT01006616|473979170|FG003|Period 1 (6 Months)|Adverse Event|9|||
131642594|NCT01006616|473979167|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
131642595|NCT01006616|473979168|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
131642596|NCT01006616|473979169|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
131642597|NCT01006616|473979170|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
131642598|NCT01006616|473979167|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
131642599|NCT01006616|473979168|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
131642600|NCT01006616|473979169|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
131642601|NCT01006616|473979170|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
131642602|NCT01006616|473979167|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
131642603|NCT01006616|473979168|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
131642604|NCT01006616|473979169|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
131642605|NCT01006616|473979170|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
131642606|NCT01006616|473979167|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
131642607|NCT01006616|473979168|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
131642608|NCT01006616|473979169|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
131642609|NCT01006616|473979170|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
131642610|NCT01006616|473979167|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
131642611|NCT01006616|473979168|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
131642612|NCT01006616|473979169|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
131642613|NCT01006616|473979170|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
131642614|NCT01006616|473979167|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
131642615|NCT01006616|473979168|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
131642616|NCT01006616|473979169|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
131642617|NCT01006616|473979170|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
131642618|NCT01006616|473979167|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
131642619|NCT01006616|473979168|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
131642620|NCT01006616|473979169|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
131642621|NCT01006616|473979170|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
131642622|NCT01006616|473979167|FG000|Period 1 (6 Months)|Not Treated|0|||
131642623|NCT01006616|473979168|FG001|Period 1 (6 Months)|Not Treated|0|||
131642624|NCT01006616|473979169|FG002|Period 1 (6 Months)|Not Treated|1|||
131642625|NCT01006616|473979170|FG003|Period 1 (6 Months)|Not Treated|1|||
131642626|NCT01006616|473979167|FG000|Period 2 (18 Months)|Adverse Event|6|||
131642627|NCT01006616|473979168|FG001|Period 2 (18 Months)|Adverse Event|6|||
131642628|NCT01006616|473979169|FG002|Period 2 (18 Months)|Adverse Event|6|||
131642629|NCT01006616|473979170|FG003|Period 2 (18 Months)|Adverse Event|4|||
131642630|NCT01006616|473979167|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
131642631|NCT01006616|473979168|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
131642632|NCT01006616|473979169|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
131642633|NCT01006616|473979170|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
131642634|NCT01006616|473979167|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
131642635|NCT01006616|473979168|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
131642636|NCT01006616|473979169|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
131642637|NCT01006616|473979170|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
131642638|NCT01006616|473979167|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
131642639|NCT01006616|473979168|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
131642640|NCT01006616|473979169|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
131642641|NCT01006616|473979170|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
131642642|NCT01006616|473979167|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
131642643|NCT01006616|473979168|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
131642644|NCT01006616|473979169|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
131642645|NCT01006616|473979170|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
131642646|NCT01006616|473979167|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
131642647|NCT01006616|473979168|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
131642648|NCT01006616|473979169|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
131642649|NCT01006616|473979170|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
131642650|NCT01006616|473979167|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
131642651|NCT01006616|473979168|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
131642652|NCT01006616|473979169|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
131642653|NCT01006616|473979170|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
131642654|NCT01006616|473979167|FG000|Period 2 (18 Months)|Study Terminated|63|||
131642655|NCT01006616|473979168|FG001|Period 2 (18 Months)|Study Terminated|46|||
131642656|NCT01006616|473979169|FG002|Period 2 (18 Months)|Study Terminated|44|||
131801564|NCT04276883|474557196|FG002|Overall Study|Lost to Follow-up|0|||
131642657|NCT01006616|473979170|FG003|Period 2 (18 Months)|Study Terminated|70|||
131642658|NCT03672175|473979171|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
131642659|NCT03672175|473979172|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
131642660|NCT03672175|473979173|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
131642661|NCT03672175|473979171|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
131445215|NCT00489307|473258857|FG000|Overall Study|Lost to Follow-up|2|||
131801565|NCT04276883|474557194|FG000|Overall Study|Adverse Event|0|||
131801566|NCT04276883|474557195|FG001|Overall Study|Adverse Event|1|||
131801567|NCT04276883|474557196|FG002|Overall Study|Adverse Event|0|||
131801568|NCT04276883|474557194|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
131445216|NCT00489307|473258858|FG001|Overall Study|Lost to Follow-up|2|||
131642662|NCT03672175|473979172|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
131642663|NCT03672175|473979173|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
131642664|NCT03672175|473979171|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
131642665|NCT03672175|473979172|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
131642666|NCT03672175|473979173|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
131642667|NCT03672175|473979171|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
131642668|NCT03672175|473979172|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
131642669|NCT03672175|473979173|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
131642670|NCT03672175|473979171|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
131642671|NCT03672175|473979172|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
131642672|NCT03672175|473979173|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
131642673|NCT03672175|473979171|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
131642674|NCT03672175|473979172|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
131642675|NCT03672175|473979173|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
131642676|NCT03672175|473979171|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
131642677|NCT03672175|473979172|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
131642678|NCT03672175|473979173|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
131642679|NCT03672175|473979171|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
131642680|NCT03672175|473979172|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
131642681|NCT03672175|473979173|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
131642682|NCT03672175|473979171|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
131642683|NCT03672175|473979172|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
131642684|NCT03672175|473979173|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
131642685|NCT03672175|473979171|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
131642686|NCT03672175|473979172|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
131715283|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
131715284|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131715285|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131715286|NCT03895203|474235391|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131715287|NCT03895203|474235392|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131715288|NCT03895203|474235393|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131715289|NCT03895203|474235394|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131715290|NCT03895203|474235395|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131715291|NCT03895203|474235396|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
131715292|NCT00886938|474235397|FG000|Overall Study|Adverse Event|1|||
131715293|NCT00886938|474235397|FG000|Overall Study|Withdrawal by Subject|1|||
131715294|NCT00049127|474235398|FG000|Overall Study|Withdrawal by Subject|0|||
131715295|NCT00049127|474235399|FG001|Overall Study|Withdrawal by Subject|0|||
131715296|NCT00049127|474235400|FG002|Overall Study|Withdrawal by Subject|1|||
131715297|NCT00049127|474235401|FG003|Overall Study|Withdrawal by Subject|0|||
131715298|NCT00049127|474235402|FG004|Overall Study|Withdrawal by Subject|0|||
131715299|NCT02582515|474235403|FG000|Overall Study|Withdrawal by Subject|0|||
131715300|NCT02582515|474235404|FG001|Overall Study|Withdrawal by Subject|1|||
131715301|NCT00775021|474235405|FG000|First Intervention|Lost to Follow-up|1|||
131715302|NCT00775021|474235406|FG001|First Intervention|Lost to Follow-up|0|||
131715303|NCT00775021|474235405|FG000|Second Intervention|Adverse Event|0|||
131715304|NCT00775021|474235406|FG001|Second Intervention|Adverse Event|1|||
131715305|NCT00870688|474235407|FG000|Overall Study|Lost to Follow-up|2|||
131715306|NCT00870688|474235407|FG000|Overall Study|Death, Unrelated|1|||
131715307|NCT00870688|474235407|FG000|Overall Study|Granules in the Stools|1|||
131715308|NCT04927312|474235408|FG000|Overall Study|Adverse Event|1|||
131715309|NCT04927312|474235408|FG000|Overall Study|Death|1|||
131715310|NCT04927312|474235408|FG000|Overall Study|Withdrawal by Subject|1|||
131715311|NCT04927312|474235408|FG000|Overall Study|Other|1|||
131715312|NCT04919564|474235416|FG000|Overall Study|Lost to Follow-up|1|||
131715313|NCT04919564|474235417|FG001|Overall Study|Lost to Follow-up|0|||
131715314|NCT04919564|474235416|FG000|Overall Study|Physician Decision|1|||
131715315|NCT04919564|474235417|FG001|Overall Study|Physician Decision|1|||
131715316|NCT01241786|474235418|FG000|Overall Study|Lack of Efficacy|5|||
131715317|NCT01122927|474235419|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
131715318|NCT01122927|474235420|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
131715319|NCT01122927|474235419|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
131715320|NCT01122927|474235420|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
131715321|NCT01122927|474235419|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
131801569|NCT04276883|474557195|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
131801570|NCT04276883|474557196|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
131801571|NCT02732210|474557197|FG000|Overall Study|Site Closed|0|||
131801572|NCT02732210|474557198|FG001|Overall Study|Site Closed|11|||
131801573|NCT02732210|474557197|FG000|Overall Study|Study Ended|13|||
131801574|NCT02732210|474557198|FG001|Overall Study|Study Ended|13|||
131801575|NCT02732210|474557197|FG000|Overall Study|Withdrawal by Subject|28|||
131801576|NCT02732210|474557198|FG001|Overall Study|Withdrawal by Subject|87|||
131801577|NCT02732210|474557197|FG000|Overall Study|Lost to Follow-up|5|||
131801578|NCT02732210|474557198|FG001|Overall Study|Lost to Follow-up|57|||
131801579|NCT02732210|474557197|FG000|Overall Study|Death|4|||
131801580|NCT02732210|474557198|FG001|Overall Study|Death|15|||
131801581|NCT02732210|474557197|FG000|Overall Study|Other|35|||
131801582|NCT02732210|474557198|FG001|Overall Study|Other|103|||
131801583|NCT02732210|474557197|FG000|Overall Study|Missing|0|||
131801584|NCT02732210|474557198|FG001|Overall Study|Missing|8|||
131801585|NCT01876706|474557199|FG000|Overall Study|BPH Intervention|9|||
131801586|NCT01876706|474557199|FG000|Overall Study|Lost to Follow-up|7|||
131801587|NCT01876706|474557199|FG000|Overall Study|Withdrawals|6|||
131801588|NCT01876706|474557199|FG000|Overall Study|Death|3|||
131801589|NCT00659607|474557200|FG000|Overall Study|No blood pressure recorded|147|||
131801590|NCT00659607|474557200|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
131801591|NCT00659607|474557200|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
131801592|NCT00659607|474557200|FG000|Overall Study|No recorded efficacy data|15|||
131801593|NCT00659607|474557200|FG000|Overall Study|Inconsistent BP measuring date|2|||
131801594|NCT02191891|474557201|FG000|Overall Study|Withdrawal by Subject|0|||
131801595|NCT02191891|474557202|FG001|Overall Study|Withdrawal by Subject|1|||
131801596|NCT02191891|474557203|FG002|Overall Study|Withdrawal by Subject|0|||
131801597|NCT02191891|474557204|FG003|Overall Study|Withdrawal by Subject|0|||
131801598|NCT02191891|474557205|FG004|Overall Study|Withdrawal by Subject|1|||
131801599|NCT02191891|474557201|FG000|Overall Study|Adverse Event|0|||
131801600|NCT02191891|474557202|FG001|Overall Study|Adverse Event|1|||
131801601|NCT02191891|474557203|FG002|Overall Study|Adverse Event|0|||
131801602|NCT02191891|474557204|FG003|Overall Study|Adverse Event|0|||
131801603|NCT02191891|474557205|FG004|Overall Study|Adverse Event|2|||
131801604|NCT02191891|474557201|FG000|Overall Study|Disease Progression|4|||
131801605|NCT02191891|474557202|FG001|Overall Study|Disease Progression|10|||
131801606|NCT02191891|474557203|FG002|Overall Study|Disease Progression|4|||
131801607|NCT02191891|474557204|FG003|Overall Study|Disease Progression|2|||
131801608|NCT02191891|474557205|FG004|Overall Study|Disease Progression|7|||
131801609|NCT01062256|474557206|FG000|Overall Study|Adverse Event|1|||
131801610|NCT01062256|474557207|FG001|Overall Study|Adverse Event|0|||
131801611|NCT01062256|474557208|FG002|Overall Study|Adverse Event|0|||
131445217|NCT00489307|473258857|FG000|Overall Study|Physician Decision|1|||
131445218|NCT00489307|473258858|FG001|Overall Study|Physician Decision|0|||
131642687|NCT03672175|473979173|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
131801612|NCT01062256|474557206|FG000|Overall Study|Withdrawal by Subject|1|||
131801613|NCT01062256|474557207|FG001|Overall Study|Withdrawal by Subject|1|||
131801614|NCT01062256|474557208|FG002|Overall Study|Withdrawal by Subject|1|||
131801615|NCT01062256|474557206|FG000|Overall Study|Ineligible|1|||
131801616|NCT01062256|474557207|FG001|Overall Study|Ineligible|4|||
131801617|NCT01062256|474557208|FG002|Overall Study|Ineligible|3|||
131801618|NCT01062256|474557206|FG000|Overall Study|Administrative|0|||
131801619|NCT01062256|474557207|FG001|Overall Study|Administrative|2|||
131801620|NCT01062256|474557208|FG002|Overall Study|Administrative|0|||
131642688|NCT03672175|473979171|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
131642689|NCT03672175|473979172|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
131642690|NCT03672175|473979173|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
131642691|NCT03672175|473979171|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
131642692|NCT03672175|473979172|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
131642693|NCT03672175|473979173|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
131642694|NCT01772563|473979174|FG000|Cycle 1|Dose limiting toxicity|2|||
131642695|NCT01772563|473979174|FG000|Cycle 1|Progressive disease|2|||
131642696|NCT01772563|473979174|FG000|Cycle 2 and Beyond|Progressive disease|17|||
131801621|NCT03049488|474557209|FG000|Overall Study|Lost to Follow-up|1|||
131642697|NCT01772563|473979174|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
131642698|NCT01772563|473979174|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
131642699|NCT01192776|473979175|FG000|Overall Study|Death|8|||
131903006|NCT00230048|474931363|FG001|Overall Study|Lost to Follow-up|18|||
131642700|NCT01192776|473979176|FG001|Overall Study|Death|15|||
131642701|NCT01192776|473979177|FG002|Overall Study|Death|18|||
131801622|NCT03049488|474557210|FG001|Overall Study|Lost to Follow-up|1|||
131642702|NCT01192776|473979178|FG003|Overall Study|Death|15|||
131801623|NCT03049488|474557211|FG002|Overall Study|Lost to Follow-up|0|||
131801624|NCT03049488|474557212|FG003|Overall Study|Lost to Follow-up|0|||
131445219|NCT00489307|473258857|FG000|Overall Study|Withdrawal by Subject|2|||
131801625|NCT03049488|474557213|FG004|Overall Study|Lost to Follow-up|0|||
131801626|NCT03049488|474557214|FG005|Overall Study|Lost to Follow-up|0|||
131801627|NCT03049488|474557209|FG000|Overall Study|Moved from Area|1|||
131801628|NCT03049488|474557210|FG001|Overall Study|Moved from Area|0|||
131642703|NCT01192776|473979175|FG000|Overall Study|Lost to Follow-up|3|||
131801629|NCT03049488|474557211|FG002|Overall Study|Moved from Area|0|||
131801630|NCT03049488|474557212|FG003|Overall Study|Moved from Area|1|||
131801631|NCT03049488|474557213|FG004|Overall Study|Moved from Area|1|||
131801632|NCT03049488|474557214|FG005|Overall Study|Moved from Area|0|||
131801633|NCT03049488|474557209|FG000|Overall Study|Physician Decision|0|||
131801634|NCT03049488|474557210|FG001|Overall Study|Physician Decision|1|||
131801635|NCT03049488|474557211|FG002|Overall Study|Physician Decision|0|||
131801636|NCT03049488|474557212|FG003|Overall Study|Physician Decision|0|||
131801637|NCT03049488|474557213|FG004|Overall Study|Physician Decision|0|||
131801638|NCT03049488|474557214|FG005|Overall Study|Physician Decision|0|||
131801639|NCT03049488|474557209|FG000|Overall Study|Withdrawal by Subject|0|||
131801640|NCT03049488|474557210|FG001|Overall Study|Withdrawal by Subject|0|||
131801641|NCT03049488|474557211|FG002|Overall Study|Withdrawal by Subject|0|||
131801642|NCT03049488|474557212|FG003|Overall Study|Withdrawal by Subject|1|||
131801643|NCT03049488|474557213|FG004|Overall Study|Withdrawal by Subject|1|||
131801644|NCT03049488|474557214|FG005|Overall Study|Withdrawal by Subject|0|||
131801645|NCT00891293|474557216|FG000|Overall Study|Adverse Event|2|||
131801646|NCT00891293|474557216|FG000|Overall Study|Protocol Violation|2|||
131801647|NCT00891293|474557216|FG000|Overall Study|Laboratory abnormality|4|||
131801648|NCT00891293|474557216|FG000|Overall Study|Lost to Follow-up|7|||
131801649|NCT00891293|474557216|FG000|Overall Study|Subject withdrew consent|7|||
131801650|NCT00891293|474557216|FG000|Overall Study|Sponsor termination|62|||
131801651|NCT01448057|474557217|FG000|Overall Study|Protocol Violation|3|||
131801652|NCT01448057|474557218|FG001|Overall Study|Protocol Violation|2|||
131801653|NCT01448057|474557217|FG000|Overall Study|Lost to Follow-up|3|||
131801654|NCT01448057|474557218|FG001|Overall Study|Lost to Follow-up|0|||
131801655|NCT01448057|474557217|FG000|Overall Study|Adverse Event|0|||
131801656|NCT01448057|474557218|FG001|Overall Study|Adverse Event|2|||
131801657|NCT01448057|474557217|FG000|Overall Study|Withdrawal by Subject|2|||
131801658|NCT01448057|474557218|FG001|Overall Study|Withdrawal by Subject|0|||
131801659|NCT03883906|474557223|FG000|Overall Study|Withdrawal by Subject|2|||
131801660|NCT03883906|474557223|FG000|Overall Study|Physician Decision|5|||
131801661|NCT00486837|474557225|FG000|Overall Study|Withdrawal by Subject|1|||
131801662|NCT00486837|474557226|FG001|Overall Study|Withdrawal by Subject|0|||
131801663|NCT00486837|474557225|FG000|Overall Study|Adverse Event|1|||
131801664|NCT00486837|474557226|FG001|Overall Study|Adverse Event|1|||
131801665|NCT00486837|474557225|FG000|Overall Study|Protocol Violation|4|||
131801666|NCT00486837|474557226|FG001|Overall Study|Protocol Violation|2|||
131801667|NCT00486837|474557225|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
131801668|NCT00486837|474557226|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
131801669|NCT02468778|474557229|FG000|Overall Study|Death|2|||
131801670|NCT02468778|474557230|FG001|Overall Study|Death|1|||
131801671|NCT02468778|474557231|FG002|Overall Study|Death|0|||
131801672|NCT02468778|474557229|FG000|Overall Study|Lost to Follow-up|1|||
131801673|NCT02468778|474557230|FG001|Overall Study|Lost to Follow-up|2|||
131801674|NCT02468778|474557231|FG002|Overall Study|Lost to Follow-up|2|||
131801675|NCT02468778|474557229|FG000|Overall Study|Withdrawal by Subject|0|||
131801676|NCT02468778|474557230|FG001|Overall Study|Withdrawal by Subject|1|||
131801677|NCT02468778|474557231|FG002|Overall Study|Withdrawal by Subject|1|||
131801678|NCT03130699|474557238|FG000|Overall Study|Lost to Follow-up|34|||
131801679|NCT03130699|474557239|FG001|Overall Study|Lost to Follow-up|37|||
131801680|NCT03130699|474557240|FG002|Overall Study|Lost to Follow-up|26|||
131801681|NCT03130699|474557238|FG000|Overall Study|Withdrawal by Subject|5|||
131801682|NCT03130699|474557239|FG001|Overall Study|Withdrawal by Subject|1|||
131801683|NCT03130699|474557240|FG002|Overall Study|Withdrawal by Subject|0|||
131801684|NCT03130699|474557238|FG000|Overall Study|Withdrawal by PI|1|||
131801685|NCT03130699|474557239|FG001|Overall Study|Withdrawal by PI|2|||
131801686|NCT03130699|474557240|FG002|Overall Study|Withdrawal by PI|5|||
131801687|NCT03130699|474557238|FG000|Overall Study|Death|0|||
131801688|NCT03130699|474557239|FG001|Overall Study|Death|0|||
131801689|NCT03130699|474557240|FG002|Overall Study|Death|1|||
131642704|NCT01192776|473979176|FG001|Overall Study|Lost to Follow-up|6|||
131801690|NCT00669864|474557243|FG000|Overall Study|Lost to Follow-up|2|||
131642705|NCT01192776|473979177|FG002|Overall Study|Lost to Follow-up|3|||
131642706|NCT01192776|473979178|FG003|Overall Study|Lost to Follow-up|5|||
131801691|NCT00669864|474557243|FG000|Overall Study|Protocol Violation|2|||
131801692|NCT00669864|474557243|FG000|Overall Study|Withdrawal by Subject|3|||
131801693|NCT00669864|474557243|FG000|Overall Study|Other|2|||
131801694|NCT00906347|474557244|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
131801695|NCT00906347|474557245|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
131801696|NCT00906347|474557244|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
131642707|NCT01086384|473979181|FG000|2-week Run-in Period|Adverse Event|1|||
131801697|NCT00906347|474557245|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
131801698|NCT00906347|474557244|FG000|Received Study Drug|Refused study drug|1|||
131801699|NCT00906347|474557245|FG001|Received Study Drug|Refused study drug|0|||
131801700|NCT00906347|474557244|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
131801701|NCT00906347|474557245|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
131642708|NCT01086384|473979182|FG001|2-week Run-in Period|Adverse Event|0|||
131642709|NCT01086384|473979183|FG002|2-week Run-in Period|Adverse Event|0|||
131642710|NCT01086384|473979181|FG000|2-week Run-in Period|Protocol Violation|1|||
131642711|NCT01086384|473979182|FG001|2-week Run-in Period|Protocol Violation|0|||
131642712|NCT01086384|473979183|FG002|2-week Run-in Period|Protocol Violation|0|||
131801702|NCT01226797|474557255|FG000|Overall Study|Adverse Event|1|||
131801703|NCT01226797|474557256|FG001|Overall Study|Adverse Event|0|||
131801704|NCT01226797|474557255|FG000|Overall Study|No longer willing to participate|1|||
131801705|NCT01226797|474557256|FG001|Overall Study|No longer willing to participate|0|||
131642713|NCT01086384|473979181|FG000|2-week Run-in Period|Lost to Follow-up|1|||
131642714|NCT01086384|473979182|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131642715|NCT01086384|473979183|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131642716|NCT01086384|473979181|FG000|2-week Run-in Period|Physician Decision|6|||
131642717|NCT01086384|473979182|FG001|2-week Run-in Period|Physician Decision|0|||
131642718|NCT01086384|473979183|FG002|2-week Run-in Period|Physician Decision|0|||
131642719|NCT01086384|473979181|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
131642720|NCT01086384|473979182|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131801706|NCT01226797|474557255|FG000|Overall Study|Protocol Violation|0|||
131801707|NCT01226797|474557256|FG001|Overall Study|Protocol Violation|1|||
131801708|NCT01318499|474557257|FG000|Overall Study|Adverse Event|16|||
131801709|NCT01318499|474557258|FG001|Overall Study|Adverse Event|11|||
131642721|NCT01086384|473979183|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131642722|NCT01086384|473979181|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
131642723|NCT01086384|473979182|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
131642724|NCT01086384|473979183|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
131642725|NCT01086384|473979181|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
131642726|NCT01086384|473979182|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
131642727|NCT01086384|473979183|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
131642728|NCT01086384|473979181|FG000|2-week Run-in Period|Randomized in Error|1|||
131642729|NCT01086384|473979182|FG001|2-week Run-in Period|Randomized in Error|0|||
131642730|NCT01086384|473979183|FG002|2-week Run-in Period|Randomized in Error|0|||
131642731|NCT01086384|473979181|FG000|Treatment Period|Withdrawal by Subject|0|||
131642732|NCT01086384|473979182|FG001|Treatment Period|Withdrawal by Subject|53|||
131801710|NCT01318499|474557259|FG002|Overall Study|Adverse Event|6|||
131801711|NCT01318499|474557257|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
131801712|NCT01318499|474557258|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
131801713|NCT01318499|474557259|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
131801714|NCT01318499|474557257|FG000|Overall Study|Noncompliance|2|||
131642733|NCT01086384|473979183|FG002|Treatment Period|Withdrawal by Subject|55|||
131642734|NCT01086384|473979181|FG000|Treatment Period|Protocol Violation|0|||
131642735|NCT01086384|473979182|FG001|Treatment Period|Protocol Violation|26|||
131642736|NCT01086384|473979183|FG002|Treatment Period|Protocol Violation|17|||
131642737|NCT01086384|473979181|FG000|Treatment Period|Lack of Efficacy|0|||
131801715|NCT01318499|474557258|FG001|Overall Study|Noncompliance|3|||
131801716|NCT01318499|474557259|FG002|Overall Study|Noncompliance|0|||
131801717|NCT01318499|474557257|FG000|Overall Study|Treatment Failure|19|||
131801718|NCT01318499|474557258|FG001|Overall Study|Treatment Failure|19|||
131801719|NCT01318499|474557259|FG002|Overall Study|Treatment Failure|101|||
131801720|NCT01318499|474557257|FG000|Overall Study|Protocol Violation|2|||
131801721|NCT01318499|474557258|FG001|Overall Study|Protocol Violation|4|||
131801722|NCT01318499|474557259|FG002|Overall Study|Protocol Violation|2|||
131801723|NCT01318499|474557257|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
131801724|NCT01318499|474557258|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
131801725|NCT01318499|474557259|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
131801726|NCT01318499|474557257|FG000|Overall Study|Other|7|||
131801727|NCT01318499|474557258|FG001|Overall Study|Other|10|||
131801728|NCT01318499|474557259|FG002|Overall Study|Other|22|||
131642738|NCT01086384|473979182|FG001|Treatment Period|Lack of Efficacy|22|||
131801729|NCT01347710|474557262|FG000|Overall Study|Withdrawal by Subject|2|||
131801730|NCT01347710|474557262|FG000|Overall Study|Adverse Event|4|||
131801731|NCT01347710|474557262|FG000|Overall Study|Angio or SPECT not completed|18|||
131801732|NCT01347710|474557262|FG000|Overall Study|issue with vitals prior to dosing|1|||
131801733|NCT01347710|474557262|FG000|Overall Study|Lost to Follow-up|1|||
131801734|NCT01347710|474557262|FG000|Overall Study|Physician Decision|2|||
131801735|NCT01347710|474557262|FG000|Overall Study|Other|3|||
131801736|NCT04591626|474557264|FG000|Overall Study|Adverse Event|4|||
131801737|NCT04591626|474557265|FG001|Overall Study|Adverse Event|0|||
131801738|NCT04591626|474557264|FG000|Overall Study|Withdrawal by Subject|5|||
131642739|NCT01086384|473979183|FG002|Treatment Period|Lack of Efficacy|13|||
131642740|NCT01086384|473979181|FG000|Treatment Period|Adverse Event|0|||
131642741|NCT01086384|473979182|FG001|Treatment Period|Adverse Event|19|||
131642742|NCT01086384|473979183|FG002|Treatment Period|Adverse Event|15|||
131642743|NCT01086384|473979181|FG000|Treatment Period|Lost to Follow-up|0|||
131801739|NCT04591626|474557265|FG001|Overall Study|Withdrawal by Subject|3|||
131801740|NCT04591626|474557264|FG000|Overall Study|Physician Decision|0|||
131801741|NCT04591626|474557265|FG001|Overall Study|Physician Decision|1|||
131801742|NCT04591626|474557264|FG000|Overall Study|Death|0|||
131801743|NCT04591626|474557265|FG001|Overall Study|Death|1|||
131801744|NCT04591626|474557264|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131801745|NCT04591626|474557265|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131801746|NCT02672553|474557270|FG000|Overall Study|Death|3|||
131801747|NCT02672553|474557271|FG001|Overall Study|Death|5|||
131801748|NCT02672553|474557270|FG000|Overall Study|Valve Explant|1|||
131801749|NCT02672553|474557271|FG001|Overall Study|Valve Explant|0|||
131801750|NCT02672553|474557270|FG000|Overall Study|Conversion to Commercial Valve|3|||
131801751|NCT02672553|474557271|FG001|Overall Study|Conversion to Commercial Valve|0|||
131801752|NCT02672553|474557270|FG000|Overall Study|Withdrawal by Subject|3|||
131801753|NCT02672553|474557271|FG001|Overall Study|Withdrawal by Subject|3|||
131801754|NCT02672553|474557270|FG000|Overall Study|Intraoperative screen failure|2|||
131801755|NCT02672553|474557271|FG001|Overall Study|Intraoperative screen failure|0|||
131801756|NCT01004172|474557272|FG000|Overall Study|Progressive Disease in CNS Only|16|||
131801757|NCT01004172|474557272|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
131801758|NCT01004172|474557272|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
131801759|NCT01004172|474557272|FG000|Overall Study|Adverse Event|1|||
131801760|NCT01004172|474557272|FG000|Overall Study|Physician Decision|1|||
131801761|NCT01004172|474557272|FG000|Overall Study|Symptomatic Deterioration|2|||
131801762|NCT01606306|474557273|FG000|Overall Study|Lack of Efficacy|2|||
131801763|NCT01606306|474557274|FG001|Overall Study|Lack of Efficacy|1|||
131801764|NCT01606306|474557275|FG002|Overall Study|Lack of Efficacy|4|||
131801765|NCT01606306|474557276|FG003|Overall Study|Lack of Efficacy|4|||
131801766|NCT01606306|474557277|FG004|Overall Study|Lack of Efficacy|1|||
131801767|NCT01606306|474557278|FG005|Overall Study|Lack of Efficacy|2|||
131801768|NCT01606306|474557273|FG000|Overall Study|Adverse Event|1|||
131801769|NCT01606306|474557274|FG001|Overall Study|Adverse Event|0|||
131801770|NCT01606306|474557275|FG002|Overall Study|Adverse Event|1|||
131801771|NCT01606306|474557276|FG003|Overall Study|Adverse Event|1|||
131801772|NCT01606306|474557277|FG004|Overall Study|Adverse Event|2|||
131801773|NCT01606306|474557278|FG005|Overall Study|Adverse Event|0|||
131801774|NCT01606306|474557273|FG000|Overall Study|Lost to Follow-up|7|||
131801775|NCT01606306|474557274|FG001|Overall Study|Lost to Follow-up|4|||
131801776|NCT01606306|474557275|FG002|Overall Study|Lost to Follow-up|5|||
131801777|NCT01606306|474557276|FG003|Overall Study|Lost to Follow-up|4|||
131801778|NCT01606306|474557277|FG004|Overall Study|Lost to Follow-up|3|||
131801779|NCT01606306|474557278|FG005|Overall Study|Lost to Follow-up|5|||
131801780|NCT01606306|474557273|FG000|Overall Study|Withdrawal by Subject|4|||
131801781|NCT01606306|474557274|FG001|Overall Study|Withdrawal by Subject|3|||
131801782|NCT01606306|474557275|FG002|Overall Study|Withdrawal by Subject|4|||
131801783|NCT01606306|474557276|FG003|Overall Study|Withdrawal by Subject|4|||
131642744|NCT01086384|473979182|FG001|Treatment Period|Lost to Follow-up|11|||
131642745|NCT01086384|473979183|FG002|Treatment Period|Lost to Follow-up|9|||
131801784|NCT01606306|474557277|FG004|Overall Study|Withdrawal by Subject|5|||
131801785|NCT01606306|474557278|FG005|Overall Study|Withdrawal by Subject|4|||
131801786|NCT01606306|474557273|FG000|Overall Study|Physician Decision|1|||
131801787|NCT01606306|474557274|FG001|Overall Study|Physician Decision|2|||
131801788|NCT01606306|474557275|FG002|Overall Study|Physician Decision|0|||
131801789|NCT01606306|474557276|FG003|Overall Study|Physician Decision|0|||
131801790|NCT01606306|474557277|FG004|Overall Study|Physician Decision|0|||
131801791|NCT01606306|474557278|FG005|Overall Study|Physician Decision|0|||
131801792|NCT00950872|474557281|FG000|Overall Study|Withdrawal by Subject|1|||
131801793|NCT00950872|474557281|FG000|Overall Study|Did not have surgery|2|||
131801794|NCT00408902|474557282|FG000|Overall Study|Lack of Efficacy|7|||
131801795|NCT00408902|474557282|FG000|Overall Study|Adverse Event|3|||
131801796|NCT00970281|474557283|FG000|Overall Study|Lack of Efficacy|1|||
131801797|NCT00970281|474557284|FG001|Overall Study|Lack of Efficacy|14|||
131801798|NCT00970281|474557283|FG000|Overall Study|Withdrawal by Subject|0|||
131801799|NCT00970281|474557284|FG001|Overall Study|Withdrawal by Subject|1|||
131801800|NCT00970281|474557283|FG000|Overall Study|Physician Decision|1|||
131801801|NCT00970281|474557284|FG001|Overall Study|Physician Decision|1|||
131801802|NCT02003183|474557285|FG000|Overall Study|Lost to Follow-up|0|||
131801803|NCT02003183|474557286|FG001|Overall Study|Lost to Follow-up|2|||
131801804|NCT01139164|474557289|FG000|Overall Study|Withdrawn prior to study start|0|||
131801805|NCT01139164|474557290|FG001|Overall Study|Withdrawn prior to study start|2|||
131801806|NCT01139164|474557291|FG002|Overall Study|Withdrawn prior to study start|0|||
131801807|NCT00878995|474557292|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
131801808|NCT00878995|474557293|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
131642746|NCT01086384|473979181|FG000|Treatment Period|Physician Decision|0|||
131801809|NCT00841100|474557294|FG000|Phase 1 (28 Days)|Adverse Event|1|||
131801810|NCT00841100|474557294|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
131445220|NCT00489307|473258858|FG001|Overall Study|Withdrawal by Subject|4|||
131445221|NCT00489307|473258857|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
131445222|NCT00489307|473258858|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
131445223|NCT00489307|473258857|FG000|Overall Study|Surgery after assignment|1|||
131445224|NCT00489307|473258858|FG001|Overall Study|Surgery after assignment|0|||
131445225|NCT00489307|473258857|FG000|Overall Study|Did not fill up the forms|2|||
131445226|NCT00489307|473258858|FG001|Overall Study|Did not fill up the forms|1|||
131445227|NCT00489307|473258857|FG000|Overall Study|Patient or family refusal|5|||
131445228|NCT00489307|473258858|FG001|Overall Study|Patient or family refusal|9|||
131445229|NCT01615939|473260313|FG000|Overall Study|Lost to Follow-up|5|||
131445230|NCT01615939|473260314|FG001|Overall Study|Lost to Follow-up|0|||
131445231|NCT02121535|473260318|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
131445232|NCT02121535|473260319|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
131445233|NCT02121535|473260318|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
131445234|NCT02121535|473260319|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
131445235|NCT04328077|473260320|FG000|Overall Study|Lost to Follow-up|0|||
131445236|NCT04328077|473260321|FG001|Overall Study|Lost to Follow-up|1|||
131445237|NCT04328077|473260322|FG002|Overall Study|Lost to Follow-up|0|||
131445238|NCT04328077|473260323|FG003|Overall Study|Lost to Follow-up|0|||
131445239|NCT04328077|473260320|FG000|Overall Study|Withdrawal by Subject|0|||
131445240|NCT04328077|473260321|FG001|Overall Study|Withdrawal by Subject|1|||
131445241|NCT04328077|473260322|FG002|Overall Study|Withdrawal by Subject|1|||
131445242|NCT04328077|473260323|FG003|Overall Study|Withdrawal by Subject|3|||
131445243|NCT03591406|473260325|FG000|Overall Study|Adverse Event|5|||
131445244|NCT03591406|473260326|FG001|Overall Study|Adverse Event|3|||
131445245|NCT03591406|473260325|FG000|Overall Study|Protocol Violation|2|||
131445246|NCT03591406|473260326|FG001|Overall Study|Protocol Violation|1|||
131445247|NCT03591406|473260325|FG000|Overall Study|Withdrawal by Subject|0|||
131801811|NCT03338972|474557295|FG000|Overall Study|Death|1|||
131801812|NCT03338972|474557296|FG001|Overall Study|Death|1|||
131801813|NCT03338972|474557297|FG002|Overall Study|Death|0|||
131801814|NCT03338972|474557298|FG003|Overall Study|Death|0|||
131801815|NCT03338972|474557295|FG000|Overall Study|Withdrawal by Subject|1|||
131801816|NCT03338972|474557296|FG001|Overall Study|Withdrawal by Subject|0|||
131801817|NCT03338972|474557297|FG002|Overall Study|Withdrawal by Subject|0|||
131801818|NCT03338972|474557298|FG003|Overall Study|Withdrawal by Subject|0|||
131801819|NCT02480764|474557299|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
131801820|NCT02480764|474557300|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
131801821|NCT02480764|474557301|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
131801822|NCT02480764|474557299|FG000|Overall Study|Major Protocol Deviation|1|||
131801823|NCT02480764|474557300|FG001|Overall Study|Major Protocol Deviation|4|||
131801824|NCT02480764|474557301|FG002|Overall Study|Major Protocol Deviation|3|||
131801825|NCT02480764|474557299|FG000|Overall Study|Lost to Follow-up|0|||
131801826|NCT02480764|474557300|FG001|Overall Study|Lost to Follow-up|1|||
131801827|NCT02480764|474557301|FG002|Overall Study|Lost to Follow-up|2|||
131801828|NCT02480764|474557299|FG000|Overall Study|Voluntary Withdrawal|6|||
131801829|NCT02480764|474557300|FG001|Overall Study|Voluntary Withdrawal|5|||
131801830|NCT02480764|474557301|FG002|Overall Study|Voluntary Withdrawal|10|||
131801831|NCT02480764|474557299|FG000|Overall Study|Lack of Efficacy|0|||
131801832|NCT02480764|474557300|FG001|Overall Study|Lack of Efficacy|3|||
131801833|NCT02480764|474557301|FG002|Overall Study|Lack of Efficacy|3|||
131801834|NCT02480764|474557299|FG000|Overall Study|Reason not Specified|0|||
131801835|NCT02480764|474557300|FG001|Overall Study|Reason not Specified|1|||
131801836|NCT02480764|474557301|FG002|Overall Study|Reason not Specified|0|||
131801837|NCT01355081|474557302|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
131801838|NCT01355081|474557303|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
131445248|NCT03591406|473260326|FG001|Overall Study|Withdrawal by Subject|5|||
131445249|NCT01083771|473260327|FG000|Overall Study|non-compliant|2|||
131445250|NCT01083771|473260327|FG000|Overall Study|Withdrawal by Subject|3|||
131445251|NCT02066181|473260328|FG000|Overall Study|Withdrawal by Subject|1|||
131445252|NCT02066181|473260329|FG001|Overall Study|Withdrawal by Subject|1|||
131445253|NCT02851615|473260330|FG000|Overall Study|Cognitive Issue|1|||
131445254|NCT02851615|473260331|FG001|Overall Study|Cognitive Issue|0|||
131801839|NCT01355081|474557304|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
131801840|NCT01355081|474557302|FG000|Overall Study|Major Protocol Deviation|0|||
131801841|NCT01355081|474557303|FG001|Overall Study|Major Protocol Deviation|1|||
131801842|NCT01355081|474557304|FG002|Overall Study|Major Protocol Deviation|0|||
131801843|NCT01355081|474557302|FG000|Overall Study|Lost to Follow-up|0|||
131801844|NCT01355081|474557303|FG001|Overall Study|Lost to Follow-up|0|||
131801845|NCT01355081|474557304|FG002|Overall Study|Lost to Follow-up|1|||
131801846|NCT01355081|474557302|FG000|Overall Study|Withdrawal of Consent|2|||
131801847|NCT01355081|474557303|FG001|Overall Study|Withdrawal of Consent|3|||
131801848|NCT01355081|474557304|FG002|Overall Study|Withdrawal of Consent|3|||
131801849|NCT01355081|474557302|FG000|Overall Study|Lack of Efficacy|2|||
131801850|NCT01355081|474557303|FG001|Overall Study|Lack of Efficacy|1|||
131801851|NCT01355081|474557304|FG002|Overall Study|Lack of Efficacy|1|||
131903007|NCT00676403|474931364|FG000|Overall Study|Adverse Event|1|||
131801852|NCT01355081|474557302|FG000|Overall Study|Non Compliance with Study Medication|0|||
131801853|NCT01355081|474557303|FG001|Overall Study|Non Compliance with Study Medication|1|||
131801854|NCT01355081|474557304|FG002|Overall Study|Non Compliance with Study Medication|0|||
131801855|NCT01475474|474557305|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
131801856|NCT01475474|474557305|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
131801857|NCT02339909|474557308|FG000|Overall Study|Became ineligible after randomisation|89|||
131801858|NCT02339909|474557309|FG001|Overall Study|Became ineligible after randomisation|63|||
131801859|NCT02339909|474557310|FG002|Overall Study|Became ineligible after randomisation|71|||
131801860|NCT00860028|474557313|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
131801861|NCT00860028|474557314|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
131801862|NCT04529109|474557315|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
131801863|NCT04529109|474557316|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
131801864|NCT00788125|474559062|FG000|Overall Study|Death|6|||
131801865|NCT03471078|474559076|FG000|Overall Study|Withdrawal by Subject|9|||
131801866|NCT03471078|474559077|FG001|Overall Study|Withdrawal by Subject|1|||
131801867|NCT03471078|474559076|FG000|Overall Study|Adverse Event|4|||
131801868|NCT03471078|474559077|FG001|Overall Study|Adverse Event|1|||
131801869|NCT03471078|474559076|FG000|Overall Study|Physician Decision|3|||
131801870|NCT03471078|474559077|FG001|Overall Study|Physician Decision|2|||
131801871|NCT03471078|474559076|FG000|Overall Study|Death|2|||
131801872|NCT03471078|474559077|FG001|Overall Study|Death|0|||
131801873|NCT03471078|474559076|FG000|Overall Study|Other|3|||
131801874|NCT03471078|474559077|FG001|Overall Study|Other|2|||
131801875|NCT00433147|474559083|FG000|Overall Study|Adverse Event|0|||
131801876|NCT00433147|474559084|FG001|Overall Study|Adverse Event|1|||
131801877|NCT00433147|474559085|FG002|Overall Study|Adverse Event|0|||
131801878|NCT00433147|474559086|FG003|Overall Study|Adverse Event|0|||
131801879|NCT01882647|474559087|FG000|Overall Study|Lost to Follow-up|2|||
131801880|NCT01882647|474559088|FG001|Overall Study|Lost to Follow-up|2|||
131801881|NCT01882647|474559087|FG000|Overall Study|Withdrawal by Subject|0|||
131801882|NCT01882647|474559088|FG001|Overall Study|Withdrawal by Subject|4|||
131801883|NCT01027143|474559091|FG000|Overall Study|Lost to Follow-up|9|||
131801884|NCT01027143|474559092|FG001|Overall Study|Lost to Follow-up|4|||
131801885|NCT03292653|474559094|FG000|Overall Study|Adverse Event|0|||
131801886|NCT03292653|474559095|FG001|Overall Study|Adverse Event|0|||
131801887|NCT03292653|474559096|FG002|Overall Study|Adverse Event|1|||
131801888|NCT03292653|474559094|FG000|Overall Study|Did not Receive Treatment|1|||
131801889|NCT03292653|474559095|FG001|Overall Study|Did not Receive Treatment|0|||
131801890|NCT03292653|474559096|FG002|Overall Study|Did not Receive Treatment|0|||
131801891|NCT01367275|474559099|FG000|Overall Study|Ineligible|1|||
131801892|NCT01367275|474559099|FG000|Overall Study|Disease Progression|2|||
131801893|NCT02319148|474559102|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
131801894|NCT02319148|474559103|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
131801895|NCT02319148|474559104|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
131801896|NCT02319148|474559105|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
131801897|NCT02319148|474559102|FG000|Second Intervention Period|No longer willing to participate|0|||
131801898|NCT02319148|474559103|FG001|Second Intervention Period|No longer willing to participate|1|||
131801899|NCT02319148|474559104|FG002|Second Intervention Period|No longer willing to participate|0|||
131801900|NCT02319148|474559105|FG003|Second Intervention Period|No longer willing to participate|0|||
131801901|NCT02319148|474559102|FG000|Second Intervention Period|Other|0|||
131801902|NCT02319148|474559103|FG001|Second Intervention Period|Other|0|||
131642747|NCT01086384|473979182|FG001|Treatment Period|Physician Decision|9|||
131642748|NCT01086384|473979183|FG002|Treatment Period|Physician Decision|6|||
131642749|NCT01086384|473979181|FG000|Treatment Period|Study Closed/Terminated|0|||
131801903|NCT02319148|474559104|FG002|Second Intervention Period|Other|0|||
131801904|NCT02319148|474559105|FG003|Second Intervention Period|Other|1|||
131801905|NCT01087970|474559107|FG000|Overall Study|Protocol Violation|2|||
131801906|NCT00543309|474559108|FG000|Overall Study|Physician Decision|0|||
131801907|NCT00543309|474559109|FG001|Overall Study|Physician Decision|1|||
131801908|NCT00543309|474559110|FG002|Overall Study|Physician Decision|0|||
131801909|NCT01249664|474559111|FG000|Overall Study|Withdrawal by Subject|5|||
131801910|NCT01249664|474559112|FG001|Overall Study|Withdrawal by Subject|0|||
131801911|NCT01249664|474559111|FG000|Overall Study|Adverse Event|1|||
131801912|NCT01249664|474559112|FG001|Overall Study|Adverse Event|0|||
131801913|NCT02636907|474559113|FG000|Autoinjector Assessment Period|Adverse Event|2|||
131903008|NCT00676403|474931365|FG001|Overall Study|Adverse Event|2|||
131801914|NCT02636907|474559113|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
131801915|NCT02636907|474559113|FG000|Extension Phase|Adverse Event|2|||
131801916|NCT02636907|474559113|FG000|Extension Phase|Withdrawal by Subject|4|||
131801917|NCT02636907|474559113|FG000|Extension Phase|Physician Decision|1|||
131801918|NCT02636907|474559113|FG000|Extension Phase|Lost to Follow-up|2|||
131801919|NCT02636907|474559113|FG000|Extension Phase|Lack of Efficacy|1|||
131801920|NCT01682083|474559122|FG000|Overall Study|Lost to Follow-up|11|||
131642750|NCT01086384|473979182|FG001|Treatment Period|Study Closed/Terminated|7|||
131642751|NCT01086384|473979183|FG002|Treatment Period|Study Closed/Terminated|8|||
131642752|NCT01086384|473979181|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
131642753|NCT01086384|473979182|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
131642754|NCT01086384|473979183|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
131642755|NCT01086384|473979181|FG000|Treatment Period|Received Treatment in Error|0|||
131801921|NCT01682083|474559123|FG001|Overall Study|Lost to Follow-up|18|||
131801922|NCT01682083|474559122|FG000|Overall Study|Withdrawal by Subject|31|||
131801923|NCT01682083|474559123|FG001|Overall Study|Withdrawal by Subject|40|||
131801924|NCT01682083|474559122|FG000|Overall Study|Death|60|||
131801925|NCT01682083|474559123|FG001|Overall Study|Death|93|||
131801926|NCT01682083|474559122|FG000|Overall Study|Physician Decision|5|||
131801927|NCT01682083|474559123|FG001|Overall Study|Physician Decision|4|||
131801928|NCT01866319|474559124|FG000|Overall Study|Adverse Event|12|||
131801929|NCT01866319|474559125|FG001|Overall Study|Adverse Event|5|||
131801930|NCT01866319|474559126|FG002|Overall Study|Adverse Event|9|||
131801931|NCT01866319|474559124|FG000|Overall Study|Clinical progression|3|||
131801932|NCT01866319|474559125|FG001|Overall Study|Clinical progression|2|||
131801933|NCT01866319|474559126|FG002|Overall Study|Clinical progression|2|||
131801934|NCT01866319|474559124|FG000|Overall Study|Death|153|||
131801935|NCT01866319|474559125|FG001|Overall Study|Death|154|||
131801936|NCT01866319|474559126|FG002|Overall Study|Death|147|||
131801937|NCT01866319|474559124|FG000|Overall Study|Lost to Follow-up|6|||
131801938|NCT01866319|474559125|FG001|Overall Study|Lost to Follow-up|3|||
131801939|NCT01866319|474559126|FG002|Overall Study|Lost to Follow-up|8|||
131801940|NCT01866319|474559124|FG000|Overall Study|Physician Decision|1|||
131801941|NCT01866319|474559125|FG001|Overall Study|Physician Decision|0|||
131801942|NCT01866319|474559126|FG002|Overall Study|Physician Decision|1|||
131801943|NCT01866319|474559124|FG000|Overall Study|Protocol Violation|0|||
131801944|NCT01866319|474559125|FG001|Overall Study|Protocol Violation|0|||
131801945|NCT01866319|474559126|FG002|Overall Study|Protocol Violation|1|||
131801946|NCT01866319|474559124|FG000|Overall Study|Withdrawal by Subject|32|||
131801947|NCT01866319|474559125|FG001|Overall Study|Withdrawal by Subject|14|||
131801948|NCT01866319|474559126|FG002|Overall Study|Withdrawal by Subject|12|||
131801949|NCT03980483|474559129|FG000|Overall Study|Adverse Event|13|||
131801950|NCT03980483|474559130|FG001|Overall Study|Adverse Event|29|||
131801951|NCT03980483|474559131|FG002|Overall Study|Adverse Event|11|||
131801952|NCT03980483|474559132|FG003|Overall Study|Adverse Event|2|||
131801953|NCT03980483|474559133|FG004|Overall Study|Adverse Event|2|||
131801954|NCT03980483|474559134|FG005|Overall Study|Adverse Event|2|||
131801955|NCT03980483|474559129|FG000|Overall Study|Lack of Efficacy|7|||
131801956|NCT03980483|474559130|FG001|Overall Study|Lack of Efficacy|6|||
131801957|NCT03980483|474559131|FG002|Overall Study|Lack of Efficacy|0|||
131801958|NCT03980483|474559132|FG003|Overall Study|Lack of Efficacy|3|||
131801959|NCT03980483|474559133|FG004|Overall Study|Lack of Efficacy|1|||
131642756|NCT01086384|473979182|FG001|Treatment Period|Received Treatment in Error|1|||
131642757|NCT01086384|473979183|FG002|Treatment Period|Received Treatment in Error|0|||
131642758|NCT01704547|473979186|FG000|Overall Study|Physician Decision|4|||
131642759|NCT01704547|473979186|FG000|Overall Study|Withdrawal by Subject|1|||
131642760|NCT04035577|473979189|FG000|Overall Study|Lost to Follow-up|1|||
131642761|NCT04035577|473979189|FG000|Overall Study|Withdrawal by Subject|1|||
131642762|NCT01721746|473979190|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
131642763|NCT01721746|473979191|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
131642764|NCT01721746|473979190|FG000|Pre-Treatment|Withdrawal by Subject|1|||
131642765|NCT01721746|473979191|FG001|Pre-Treatment|Withdrawal by Subject|16|||
131642766|NCT01721746|473979190|FG000|Pre-Treatment|Poor/Non-compliance|1|||
131642767|NCT01721746|473979191|FG001|Pre-Treatment|Poor/Non-compliance|0|||
131642768|NCT01721746|473979190|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
131642769|NCT01721746|473979191|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
131642770|NCT01721746|473979190|FG000|Treatment|Disease Progression|192|||
131642771|NCT01721746|473979191|FG001|Treatment|Disease Progression|74|||
131642772|NCT01721746|473979190|FG000|Treatment|Study Drug Toxicity|19|||
131642773|NCT01721746|473979191|FG001|Treatment|Study Drug Toxicity|11|||
131801960|NCT03980483|474559134|FG005|Overall Study|Lack of Efficacy|1|||
131445255|NCT02851615|473260330|FG000|Overall Study|Lost to Follow-up|0|||
131445256|NCT02851615|473260331|FG001|Overall Study|Lost to Follow-up|4|||
131642774|NCT01721746|473979190|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
131642775|NCT01721746|473979191|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
131801961|NCT03980483|474559129|FG000|Overall Study|Lost to Follow-up|2|||
131801962|NCT03980483|474559130|FG001|Overall Study|Lost to Follow-up|4|||
131801963|NCT03980483|474559131|FG002|Overall Study|Lost to Follow-up|2|||
131801964|NCT03980483|474559132|FG003|Overall Study|Lost to Follow-up|1|||
131801965|NCT03980483|474559133|FG004|Overall Study|Lost to Follow-up|2|||
131801966|NCT03980483|474559134|FG005|Overall Study|Lost to Follow-up|0|||
131801967|NCT03980483|474559129|FG000|Overall Study|Protocol Violation|4|||
131801968|NCT03980483|474559130|FG001|Overall Study|Protocol Violation|2|||
131801969|NCT03980483|474559131|FG002|Overall Study|Protocol Violation|1|||
131801970|NCT03980483|474559132|FG003|Overall Study|Protocol Violation|1|||
131642776|NCT01721746|473979190|FG000|Treatment|Participant request to discontinue Study treatment|26|||
131642777|NCT01721746|473979191|FG001|Treatment|Participant request to discontinue Study treatment|7|||
131642778|NCT01721746|473979190|FG000|Treatment|Participant withdrew consent|4|||
131642779|NCT01721746|473979191|FG001|Treatment|Participant withdrew consent|2|||
131642780|NCT01721746|473979190|FG000|Treatment|Maximum Clinical Benefit|9|||
131642781|NCT01721746|473979191|FG001|Treatment|Maximum Clinical Benefit|3|||
131642782|NCT01721746|473979190|FG000|Treatment|Poor/Non-compliance|2|||
131642783|NCT01721746|473979191|FG001|Treatment|Poor/Non-compliance|0|||
131642784|NCT01721746|473979190|FG000|Treatment|Participant no longer met Study criteria|4|||
131642785|NCT01721746|473979191|FG001|Treatment|Participant no longer met Study criteria|0|||
131642786|NCT01721746|473979190|FG000|Treatment|Other reasons|6|||
131642787|NCT01721746|473979191|FG001|Treatment|Other reasons|2|||
131642788|NCT04358068|473979192|FG000|Overall Study|Did not initiate study treatment|2|||
131642789|NCT04358068|473979193|FG001|Overall Study|Did not initiate study treatment|2|||
131642790|NCT00591591|473979194|FG000|Overall Study|Withdrawal by Subject|1|||
131642791|NCT00591591|473979195|FG001|Overall Study|Withdrawal by Subject|37|||
131642792|NCT00591591|473979194|FG000|Overall Study|Lack of Efficacy|10|||
131642793|NCT00591591|473979195|FG001|Overall Study|Lack of Efficacy|2|||
131642794|NCT02143063|473979196|FG000|Overall Study|Lost to Follow-up|16|||
131642795|NCT02143063|473979197|FG001|Overall Study|Lost to Follow-up|28|||
131642796|NCT02143063|473979198|FG002|Overall Study|Lost to Follow-up|29|||
131642797|NCT02143063|473979196|FG000|Overall Study|Withdrawal by Subject|0|||
131642798|NCT02143063|473979197|FG001|Overall Study|Withdrawal by Subject|1|||
131642799|NCT02143063|473979198|FG002|Overall Study|Withdrawal by Subject|0|||
131642800|NCT02143063|473979196|FG000|Overall Study|Death|0|||
131642801|NCT02143063|473979197|FG001|Overall Study|Death|1|||
131642802|NCT02143063|473979198|FG002|Overall Study|Death|1|||
131642803|NCT01099579|473979203|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
131642804|NCT01099579|473979204|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
131642805|NCT01099579|473979205|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
131642806|NCT01099579|473979203|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
131642807|NCT01099579|473979204|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
131642808|NCT01099579|473979205|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
131642809|NCT01099579|473979203|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
131642810|NCT01099579|473979204|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
131642811|NCT01099579|473979205|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
131642812|NCT01099579|473979203|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
131642813|NCT01099579|473979204|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
131642814|NCT01099579|473979205|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
131642815|NCT01099579|473979203|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
131642816|NCT01099579|473979204|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
131642817|NCT01099579|473979205|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
131642818|NCT01099579|473979203|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
131642819|NCT01099579|473979204|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
131642820|NCT01099579|473979205|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
131642821|NCT01099579|473979203|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
131642822|NCT01099579|473979204|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
131642823|NCT01099579|473979205|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
131642824|NCT01099579|473979203|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
131642825|NCT01099579|473979204|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
131642826|NCT01099579|473979205|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
131642827|NCT01099579|473979203|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
131642828|NCT01099579|473979204|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
131642829|NCT01099579|473979205|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
131642830|NCT01099579|473979203|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
131642831|NCT01099579|473979204|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
131642832|NCT01099579|473979205|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
131642833|NCT01438840|473979206|FG000|Core Study|Adverse Event|0|||
131642834|NCT01438840|473979207|FG001|Core Study|Adverse Event|3|||
131642835|NCT01438840|473979208|FG002|Core Study|Adverse Event|0|||
131642836|NCT01438840|473979206|FG000|Core Study|Lack of Efficacy|15|||
131642837|NCT01438840|473979207|FG001|Core Study|Lack of Efficacy|7|||
131642838|NCT01438840|473979208|FG002|Core Study|Lack of Efficacy|0|||
131642839|NCT01438840|473979206|FG000|Core Study|Withdrawal of consent|1|||
131715322|NCT01122927|474235420|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
131801971|NCT03980483|474559133|FG004|Overall Study|Protocol Violation|0|||
131642840|NCT01438840|473979207|FG001|Core Study|Withdrawal of consent|0|||
131642841|NCT01438840|473979208|FG002|Core Study|Withdrawal of consent|0|||
131642842|NCT01438840|473979206|FG000|Extension Phase|Adverse Event|0|||
131642843|NCT01438840|473979207|FG001|Extension Phase|Adverse Event|0|||
131642844|NCT01438840|473979208|FG002|Extension Phase|Adverse Event|3|||
131642845|NCT01438840|473979206|FG000|Extension Phase|Lost to Follow-up|0|||
131642846|NCT01438840|473979207|FG001|Extension Phase|Lost to Follow-up|0|||
131642847|NCT01438840|473979208|FG002|Extension Phase|Lost to Follow-up|1|||
131642848|NCT01438840|473979206|FG000|Extension Phase|Withdrawal by Subject|0|||
131642849|NCT01438840|473979207|FG001|Extension Phase|Withdrawal by Subject|0|||
131642850|NCT01438840|473979208|FG002|Extension Phase|Withdrawal by Subject|3|||
131642851|NCT01438840|473979206|FG000|Extension Phase|Lack of Efficacy|0|||
131642852|NCT01438840|473979207|FG001|Extension Phase|Lack of Efficacy|0|||
131642853|NCT01438840|473979208|FG002|Extension Phase|Lack of Efficacy|2|||
131642854|NCT01438840|473979206|FG000|Extension Phase|Other|0|||
131642855|NCT01438840|473979207|FG001|Extension Phase|Other|0|||
131642856|NCT01438840|473979208|FG002|Extension Phase|Other|1|||
131642857|NCT01774305|473979209|FG000|Overall Study|Physician Decision|1|||
131642858|NCT01774305|473979210|FG001|Overall Study|Physician Decision|0|||
131642859|NCT01157377|473979212|FG000|Overall Study|Lost to Follow-up|0|||
131642860|NCT01157377|473979213|FG001|Overall Study|Lost to Follow-up|0|||
131642861|NCT01157377|473979214|FG002|Overall Study|Lost to Follow-up|1|||
131642862|NCT01157377|473979215|FG003|Overall Study|Lost to Follow-up|0|||
131642863|NCT01157377|473979216|FG004|Overall Study|Lost to Follow-up|1|||
131642864|NCT01157377|473979217|FG005|Overall Study|Lost to Follow-up|1|||
131642865|NCT01157377|473979218|FG006|Overall Study|Lost to Follow-up|0|||
131642866|NCT01157377|473979212|FG000|Overall Study|Personal Reasons|2|||
131642867|NCT01157377|473979213|FG001|Overall Study|Personal Reasons|1|||
131642868|NCT01157377|473979214|FG002|Overall Study|Personal Reasons|0|||
131642869|NCT01157377|473979215|FG003|Overall Study|Personal Reasons|1|||
131642870|NCT01157377|473979216|FG004|Overall Study|Personal Reasons|0|||
131642871|NCT01157377|473979217|FG005|Overall Study|Personal Reasons|0|||
131642872|NCT01157377|473979218|FG006|Overall Study|Personal Reasons|0|||
131642873|NCT01157377|473979212|FG000|Overall Study|Protocol Violation|0|||
131642874|NCT01157377|473979213|FG001|Overall Study|Protocol Violation|0|||
131642875|NCT01157377|473979214|FG002|Overall Study|Protocol Violation|0|||
131642876|NCT01157377|473979215|FG003|Overall Study|Protocol Violation|0|||
131642877|NCT01157377|473979216|FG004|Overall Study|Protocol Violation|0|||
131642878|NCT01157377|473979217|FG005|Overall Study|Protocol Violation|1|||
131642879|NCT01157377|473979218|FG006|Overall Study|Protocol Violation|0|||
131642880|NCT01157377|473979212|FG000|Overall Study|Lack of Efficacy|0|||
131642881|NCT01157377|473979213|FG001|Overall Study|Lack of Efficacy|0|||
131642882|NCT01157377|473979214|FG002|Overall Study|Lack of Efficacy|0|||
131642883|NCT01157377|473979215|FG003|Overall Study|Lack of Efficacy|0|||
131642884|NCT01157377|473979216|FG004|Overall Study|Lack of Efficacy|0|||
131642885|NCT01157377|473979217|FG005|Overall Study|Lack of Efficacy|0|||
131642886|NCT01157377|473979218|FG006|Overall Study|Lack of Efficacy|1|||
131642887|NCT01157377|473979212|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131642888|NCT01157377|473979213|FG001|Overall Study|Other Miscellaneous Reasons|2|||
131642889|NCT01157377|473979214|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131642890|NCT01157377|473979215|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131642891|NCT01157377|473979216|FG004|Overall Study|Other Miscellaneous Reasons|1|||
131642892|NCT01157377|473979217|FG005|Overall Study|Other Miscellaneous Reasons|1|||
131642893|NCT01157377|473979218|FG006|Overall Study|Other Miscellaneous Reasons|1|||
131642894|NCT02261285|473979221|FG000|Overall Study|Disease progression|0|||
131642895|NCT02261285|473979222|FG001|Overall Study|Disease progression|0|||
131642896|NCT02261285|473979223|FG002|Overall Study|Disease progression|1|||
131642897|NCT01702519|473979224|FG000|Washout Period|Lost to Follow-up|1|||
131642898|NCT01702519|473979225|FG001|Washout Period|Lost to Follow-up|0|||
131642899|NCT01702519|473979224|FG000|Washout Period|Withdrawal by Subject|0|||
131642900|NCT01702519|473979225|FG001|Washout Period|Withdrawal by Subject|2|||
131642901|NCT03738397|473979228|FG000|Overall Study|Adverse Event|3|||
131642902|NCT03738397|473979229|FG001|Overall Study|Adverse Event|7|||
131642903|NCT03738397|473979228|FG000|Overall Study|Withdrawal by Subject|8|||
131642904|NCT03738397|473979229|FG001|Overall Study|Withdrawal by Subject|11|||
131642905|NCT03738397|473979228|FG000|Overall Study|Lost to Follow-up|7|||
131642906|NCT03738397|473979229|FG001|Overall Study|Lost to Follow-up|5|||
131642907|NCT03738397|473979228|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
131642908|NCT03738397|473979229|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
131642909|NCT03738397|473979228|FG000|Overall Study|Other|4|||
131642910|NCT03738397|473979229|FG001|Overall Study|Other|6|||
131903009|NCT00676403|474931366|FG002|Overall Study|Adverse Event|0|||
131903010|NCT00676403|474931367|FG003|Overall Study|Adverse Event|5|||
131903011|NCT00676403|474931368|FG004|Overall Study|Adverse Event|1|||
131903012|NCT00676403|474931369|FG005|Overall Study|Adverse Event|2|||
131642911|NCT01263925|473979236|FG000|Overall Study|Protocol Violation|1|||
131642912|NCT01263925|473979237|FG001|Overall Study|Protocol Violation|0|||
131642913|NCT01263925|473979236|FG000|Overall Study|Lack of Efficacy|0|||
131642914|NCT01263925|473979237|FG001|Overall Study|Lack of Efficacy|1|||
131642915|NCT01263925|473979236|FG000|Overall Study|Adverse Event|23|||
131642916|NCT01263925|473979237|FG001|Overall Study|Adverse Event|22|||
131642917|NCT01263925|473979236|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
131642918|NCT01263925|473979237|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
131642919|NCT01263925|473979236|FG000|Overall Study|Withdrawal by Subject|6|||
131642920|NCT01263925|473979237|FG001|Overall Study|Withdrawal by Subject|8|||
131642921|NCT01263925|473979236|FG000|Overall Study|Other|4|||
131642922|NCT01263925|473979237|FG001|Overall Study|Other|4|||
131642923|NCT01263925|473979236|FG000|Overall Study|Lost to Follow-up|3|||
131642924|NCT01263925|473979237|FG001|Overall Study|Lost to Follow-up|1|||
131642925|NCT01263925|473979236|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
131642926|NCT01263925|473979237|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
131642927|NCT01263925|473979236|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
131642928|NCT01263925|473979237|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
131642929|NCT01263925|473979236|FG000|Overall Study|AE/ Withdrawal|1|||
131642930|NCT01263925|473979237|FG001|Overall Study|AE/ Withdrawal|4|||
131642931|NCT01263925|473979236|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
131642932|NCT01263925|473979237|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
131642933|NCT01263925|473979236|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
131642934|NCT01263925|473979237|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
131642935|NCT01263925|473979236|FG000|Overall Study|Withdrawal/ Not specified|0|||
131642936|NCT01263925|473979237|FG001|Overall Study|Withdrawal/ Not specified|1|||
131642937|NCT01726517|473979241|FG000|Overall Study|Withdrawal by Subject|0|||
131642938|NCT01726517|473979242|FG001|Overall Study|Withdrawal by Subject|0|||
131642939|NCT01726517|473979243|FG002|Overall Study|Withdrawal by Subject|1|||
131642940|NCT01726517|473979244|FG003|Overall Study|Withdrawal by Subject|0|||
131642941|NCT01726517|473979245|FG004|Overall Study|Withdrawal by Subject|0|||
131642942|NCT00573651|473979246|FG000|Overall Study|Lost to Follow-up|3|||
131642943|NCT00573651|473979246|FG000|Overall Study|Withdrawal by Subject|1|||
131642944|NCT03448536|473979248|FG000|Overall Study|Protocol Violation|2|||
131642945|NCT03448536|473979249|FG001|Overall Study|Protocol Violation|0|||
131642946|NCT03448536|473979248|FG000|Overall Study|Pregnancy|1|||
131642947|NCT03448536|473979249|FG001|Overall Study|Pregnancy|0|||
131642948|NCT03448536|473979248|FG000|Overall Study|Withdrawal by Subject|1|||
131642949|NCT03448536|473979249|FG001|Overall Study|Withdrawal by Subject|2|||
131642950|NCT03448536|473979248|FG000|Overall Study|Lost to Follow-up|3|||
131642951|NCT03448536|473979249|FG001|Overall Study|Lost to Follow-up|2|||
131642952|NCT03448536|473979248|FG000|Overall Study|Inadequate pain reporter|1|||
131642953|NCT03448536|473979249|FG001|Overall Study|Inadequate pain reporter|0|||
131642954|NCT03448536|473979248|FG000|Overall Study|Other|3|||
131642955|NCT03448536|473979249|FG001|Overall Study|Other|0|||
131642956|NCT03448536|473979248|FG000|Overall Study|Physician Decision|1|||
131642957|NCT03448536|473979249|FG001|Overall Study|Physician Decision|0|||
131642958|NCT01024036|473979272|FG000|Blinded Treatment|Adverse Event|1|||
131642959|NCT01024036|473979273|FG001|Blinded Treatment|Adverse Event|1|||
131642960|NCT01024036|473979272|FG000|Blinded Treatment|Lack of Efficacy|16|||
131642961|NCT01024036|473979273|FG001|Blinded Treatment|Lack of Efficacy|14|||
131642962|NCT01024036|473979272|FG000|Blinded Treatment|Physician Decision|1|||
131642963|NCT01024036|473979273|FG001|Blinded Treatment|Physician Decision|0|||
131642964|NCT01024036|473979272|FG000|Blinded Treatment|Death|0|||
131642965|NCT01024036|473979273|FG001|Blinded Treatment|Death|2|||
131642966|NCT01024036|473979272|FG000|Blinded Treatment|Withdrawal by Subject|4|||
131642967|NCT01024036|473979273|FG001|Blinded Treatment|Withdrawal by Subject|3|||
131642968|NCT01024036|473979272|FG000|Unblinded Treatment|Adverse Event|0|||
131642969|NCT01024036|473979273|FG001|Unblinded Treatment|Adverse Event|1|||
131642970|NCT01024036|473979272|FG000|Unblinded Treatment|Lack of Efficacy|0|||
131642971|NCT01024036|473979273|FG001|Unblinded Treatment|Lack of Efficacy|2|||
131642972|NCT01024036|473979272|FG000|Follow-Up Period|Lost to Follow-up|1|||
131642973|NCT01024036|473979273|FG001|Follow-Up Period|Lost to Follow-up|1|||
131642974|NCT01024036|473979272|FG000|Follow-Up Period|Withdrawal by Subject|0|||
131642975|NCT01024036|473979273|FG001|Follow-Up Period|Withdrawal by Subject|1|||
131642976|NCT01024036|473979272|FG000|Follow-Up Period|Adverse Event|4|||
131642977|NCT01024036|473979273|FG001|Follow-Up Period|Adverse Event|1|||
131642978|NCT00474383|473979275|FG000|Main Study|Adverse Event|11|||
131642979|NCT00474383|473979276|FG001|Main Study|Adverse Event|0|||
131642980|NCT00474383|473979275|FG000|Main Study|Symptomatic Deterioration|1|||
131642981|NCT00474383|473979276|FG001|Main Study|Symptomatic Deterioration|0|||
131642982|NCT00474383|473979275|FG000|Main Study|Progressive Disease|23|||
131642983|NCT00474383|473979276|FG001|Main Study|Progressive Disease|0|||
131642984|NCT00474383|473979275|FG000|Main Study|Other|1|||
131642985|NCT00474383|473979276|FG001|Main Study|Other|0|||
131642986|NCT00474383|473979275|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
131642987|NCT00474383|473979276|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
131642988|NCT00474383|473979275|FG000|Extension|Progressive Disease|0|||
131801972|NCT03980483|474559134|FG005|Overall Study|Protocol Violation|0|||
131801973|NCT03980483|474559129|FG000|Overall Study|Physician Decision|14|||
131642989|NCT00474383|473979276|FG001|Extension|Progressive Disease|5|||
131642990|NCT02998918|473979277|FG000|Overall Study|Withdrawal by Subject|1|||
131642991|NCT02998918|473979278|FG001|Overall Study|Withdrawal by Subject|0|||
131642992|NCT00443599|473979286|FG000|Overall Study|Physician Decision|2|||
131642993|NCT00443599|473979287|FG001|Overall Study|Physician Decision|1|||
131642994|NCT00443599|473979286|FG000|Overall Study|Death|1|||
131642995|NCT00443599|473979287|FG001|Overall Study|Death|1|||
131642996|NCT00443599|473979286|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
131642997|NCT00443599|473979287|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
131642998|NCT03062449|473981128|FG000|Overall Study|Withdrawal by Subject|7|||
131642999|NCT03062449|473981129|FG001|Overall Study|Withdrawal by Subject|1|||
131643000|NCT04702893|473981131|FG000|Overall Study|Other reasons than listed|11|||
131643001|NCT04702893|473981131|FG000|Overall Study|Withdrawal by Subject|3|||
131643002|NCT04702893|473981131|FG000|Overall Study|Lost to Follow-up|7|||
131643003|NCT04702893|473981131|FG000|Overall Study|Death|10|||
131643004|NCT04702893|473981131|FG000|Overall Study|Not treated|6|||
131643005|NCT00408928|473981132|FG000|Overall Study|Withdrawal by Subject|1|||
131643006|NCT00408928|473981132|FG000|Overall Study|Death|1|||
131643007|NCT00408928|473981132|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
131643008|NCT04469465|473981134|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
131643009|NCT04469465|473981135|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
131643010|NCT04469465|473981134|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
131643011|NCT04469465|473981135|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
131643012|NCT04469465|473981134|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
131643013|NCT04469465|473981135|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
131643014|NCT04469465|473981134|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
131643015|NCT04469465|473981135|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
131643016|NCT04469465|473981134|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
131643017|NCT04469465|473981135|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
131643018|NCT04469465|473981134|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
131643019|NCT04469465|473981135|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
131643020|NCT04469465|473981134|FG000|Long-Term Extension (LTE)|Death|0|||
131643021|NCT04469465|473981135|FG001|Long-Term Extension (LTE)|Death|1|||
131643022|NCT04469465|473981134|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
131643023|NCT04469465|473981135|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
131643024|NCT03194867|473981136|FG000|Overall Study|Incorrect completion of end of study form|0|||
131643025|NCT03194867|473981137|FG001|Overall Study|Incorrect completion of end of study form|0|||
131643026|NCT03194867|473981138|FG002|Overall Study|Incorrect completion of end of study form|1|||
131643027|NCT03194867|473981139|FG003|Overall Study|Incorrect completion of end of study form|0|||
131643028|NCT03305809|473981140|FG000|Overall Study|Adverse Event|2|||
131643029|NCT03305809|473981141|FG001|Overall Study|Adverse Event|2|||
131643030|NCT03305809|473981142|FG002|Overall Study|Adverse Event|6|||
131643031|NCT03305809|473981143|FG003|Overall Study|Adverse Event|6|||
131643032|NCT03305809|473981140|FG000|Overall Study|Death|0|||
131643033|NCT03305809|473981141|FG001|Overall Study|Death|0|||
131643034|NCT03305809|473981142|FG002|Overall Study|Death|1|||
131643035|NCT03305809|473981143|FG003|Overall Study|Death|1|||
131643036|NCT03305809|473981140|FG000|Overall Study|Lost to Follow-up|1|||
131643037|NCT03305809|473981141|FG001|Overall Study|Lost to Follow-up|2|||
131643038|NCT03305809|473981142|FG002|Overall Study|Lost to Follow-up|0|||
131643039|NCT03305809|473981143|FG003|Overall Study|Lost to Follow-up|0|||
131643040|NCT03305809|473981140|FG000|Overall Study|Sponsor Decision|1|||
131643041|NCT03305809|473981141|FG001|Overall Study|Sponsor Decision|0|||
131643042|NCT03305809|473981142|FG002|Overall Study|Sponsor Decision|1|||
131643043|NCT03305809|473981143|FG003|Overall Study|Sponsor Decision|8|||
131643044|NCT03305809|473981140|FG000|Overall Study|Physician Decision|0|||
131643045|NCT03305809|473981141|FG001|Overall Study|Physician Decision|0|||
131643046|NCT03305809|473981142|FG002|Overall Study|Physician Decision|2|||
131643047|NCT03305809|473981143|FG003|Overall Study|Physician Decision|4|||
131643048|NCT03305809|473981140|FG000|Overall Study|Progressive Disease|0|||
131643049|NCT03305809|473981141|FG001|Overall Study|Progressive Disease|0|||
131643050|NCT03305809|473981142|FG002|Overall Study|Progressive Disease|1|||
131643051|NCT03305809|473981143|FG003|Overall Study|Progressive Disease|0|||
131643052|NCT03305809|473981140|FG000|Overall Study|Protocol Violation|1|||
131643053|NCT03305809|473981141|FG001|Overall Study|Protocol Violation|0|||
131643054|NCT03305809|473981142|FG002|Overall Study|Protocol Violation|2|||
131643055|NCT03305809|473981143|FG003|Overall Study|Protocol Violation|3|||
131643056|NCT03305809|473981140|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
131643057|NCT03305809|473981141|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
131643058|NCT03305809|473981142|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
131643059|NCT03305809|473981143|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
131643060|NCT03305809|473981140|FG000|Overall Study|Withdrawal by Subject|2|||
131643061|NCT03305809|473981141|FG001|Overall Study|Withdrawal by Subject|4|||
131643062|NCT03305809|473981142|FG002|Overall Study|Withdrawal by Subject|5|||
131643063|NCT03305809|473981143|FG003|Overall Study|Withdrawal by Subject|2|||
131643064|NCT03305809|473981140|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
131643065|NCT03305809|473981141|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
131643066|NCT03305809|473981142|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
131643067|NCT03305809|473981143|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
131643068|NCT00816556|473981144|FG000|Overall Study|Adverse Event|1|||
131643069|NCT00816556|473981145|FG001|Overall Study|Adverse Event|1|||
131643070|NCT00816556|473981146|FG002|Overall Study|Adverse Event|1|||
131643071|NCT00816556|473981144|FG000|Overall Study|Withdrawal by Subject|1|||
131643072|NCT00816556|473981145|FG001|Overall Study|Withdrawal by Subject|1|||
131643073|NCT00816556|473981146|FG002|Overall Study|Withdrawal by Subject|1|||
131643074|NCT00816556|473981144|FG000|Overall Study|Lost to Follow-up|0|||
131643075|NCT00816556|473981145|FG001|Overall Study|Lost to Follow-up|0|||
131643076|NCT00816556|473981146|FG002|Overall Study|Lost to Follow-up|1|||
131643077|NCT03546816|473981147|FG000|Overall Study|Adverse Event|5|||
131643078|NCT03546816|473981148|FG001|Overall Study|Adverse Event|3|||
131643079|NCT03546816|473981147|FG000|Overall Study|Lack of Efficacy|2|||
131643080|NCT03546816|473981148|FG001|Overall Study|Lack of Efficacy|4|||
131643081|NCT03546816|473981147|FG000|Overall Study|Pregnancy|1|||
131643082|NCT03546816|473981148|FG001|Overall Study|Pregnancy|0|||
131445257|NCT03131219|473260342|FG000|Initial Evaluation Period|Adverse Event|2|||
131445258|NCT03131219|473260343|FG001|Initial Evaluation Period|Adverse Event|0|||
131445259|NCT03131219|473260342|FG000|Initial Evaluation Period|Protocol Violation|1|||
131445260|NCT03131219|473260343|FG001|Initial Evaluation Period|Protocol Violation|0|||
131445261|NCT03131219|473260342|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
131445262|NCT03131219|473260343|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
131445263|NCT03131219|473260342|FG000|Initial Evaluation Period|Physician Decision|1|||
131445264|NCT03131219|473260343|FG001|Initial Evaluation Period|Physician Decision|0|||
131643083|NCT03546816|473981147|FG000|Overall Study|Physician Decision|2|||
131643084|NCT03546816|473981148|FG001|Overall Study|Physician Decision|0|||
131643085|NCT03546816|473981147|FG000|Overall Study|Withdrawal by Subject|8|||
131643086|NCT03546816|473981148|FG001|Overall Study|Withdrawal by Subject|10|||
131643087|NCT03546816|473981147|FG000|Overall Study|Lost to Follow-up|3|||
131643088|NCT03546816|473981148|FG001|Overall Study|Lost to Follow-up|2|||
131445265|NCT03131219|473260342|FG000|Extension Period|Physician Decision|1|||
131445266|NCT03131219|473260343|FG001|Extension Period|Physician Decision|0|||
131445267|NCT01391546|473260346|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
131445268|NCT01391546|473260347|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
131445269|NCT01744977|473260348|FG000|Overall Study|Withdrawal by Subject|1|||
131643089|NCT02438371|473981149|FG000|Overall Study|Lost to Follow-up|3|||
131643090|NCT02438371|473981150|FG001|Overall Study|Lost to Follow-up|2|||
131643091|NCT02438371|473981149|FG000|Overall Study|Withdrawal by Subject|1|||
131643092|NCT02438371|473981150|FG001|Overall Study|Withdrawal by Subject|1|||
131643093|NCT01161446|473981151|FG000|Overall Study|Lost to Follow-up|18|||
131643094|NCT01161446|473981152|FG001|Overall Study|Lost to Follow-up|14|||
131643095|NCT01161446|473981151|FG000|Overall Study|Withdrawal by Subject|0|||
131643096|NCT01161446|473981152|FG001|Overall Study|Withdrawal by Subject|1|||
131643097|NCT01010204|473981155|FG000|Overall Study|Lost to Follow-up|2|||
131643098|NCT01010204|473981156|FG001|Overall Study|Lost to Follow-up|2|||
131643099|NCT01010204|473981155|FG000|Overall Study|Adverse Event|1|||
131643100|NCT01010204|473981156|FG001|Overall Study|Adverse Event|3|||
131643101|NCT01010204|473981155|FG000|Overall Study|Withdrawal by Subject|2|||
131643102|NCT01010204|473981156|FG001|Overall Study|Withdrawal by Subject|3|||
131643103|NCT01010204|473981155|FG000|Overall Study|psychiatric hospitalization|2|||
131643104|NCT01010204|473981156|FG001|Overall Study|psychiatric hospitalization|1|||
131643105|NCT01660256|473981159|FG000|Overall Study|Adverse Event|4|||
131643106|NCT01660256|473981160|FG001|Overall Study|Adverse Event|0|||
131643107|NCT01660256|473981161|FG002|Overall Study|Adverse Event|2|||
131643108|NCT01660256|473981159|FG000|Overall Study|Withdrawal by Subject|1|||
131643109|NCT01660256|473981160|FG001|Overall Study|Withdrawal by Subject|0|||
131643110|NCT01660256|473981161|FG002|Overall Study|Withdrawal by Subject|2|||
131643111|NCT01162135|473981163|FG000|Overall Study|Withdrawal by Subject|1|||
131643112|NCT01162135|473981163|FG000|Overall Study|Severe back pain|1|||
131643113|NCT01162135|473981163|FG000|Overall Study|Ineligible|1|||
131643114|NCT00551135|473981164|FG000|Overall Study|Adverse Event|1|||
131643115|NCT00551135|473981165|FG001|Overall Study|Adverse Event|0|||
131643116|NCT00551135|473981166|FG002|Overall Study|Adverse Event|1|||
131643117|NCT00551135|473981167|FG003|Overall Study|Adverse Event|1|||
131643118|NCT00551135|473981164|FG000|Overall Study|Lost to Follow-up|0|||
131643119|NCT00551135|473981165|FG001|Overall Study|Lost to Follow-up|0|||
131715323|NCT01122927|474235419|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
131445270|NCT01744977|473260349|FG001|Overall Study|Withdrawal by Subject|2|||
131445271|NCT01744977|473260348|FG000|Overall Study|Death|2|||
131445272|NCT01744977|473260349|FG001|Overall Study|Death|3|||
131445273|NCT01744977|473260348|FG000|Overall Study|Lost to Follow-up|2|||
131445274|NCT01744977|473260349|FG001|Overall Study|Lost to Follow-up|0|||
131643120|NCT00551135|473981166|FG002|Overall Study|Lost to Follow-up|0|||
131643121|NCT00551135|473981167|FG003|Overall Study|Lost to Follow-up|1|||
131643122|NCT00551135|473981164|FG000|Overall Study|Other|3|||
131643123|NCT00551135|473981165|FG001|Overall Study|Other|2|||
131643124|NCT00551135|473981166|FG002|Overall Study|Other|1|||
131643125|NCT00551135|473981167|FG003|Overall Study|Other|2|||
131643126|NCT00551135|473981164|FG000|Overall Study|Withdrawal by Subject|1|||
131643127|NCT00551135|473981165|FG001|Overall Study|Withdrawal by Subject|0|||
131643128|NCT00551135|473981166|FG002|Overall Study|Withdrawal by Subject|3|||
131643129|NCT00551135|473981167|FG003|Overall Study|Withdrawal by Subject|1|||
131643130|NCT00858247|473981168|FG000|Baseline Assessment|Withdrawal by Subject|1|||
131643131|NCT00858247|473981169|FG001|Baseline Assessment|Withdrawal by Subject|1|||
131643132|NCT00858247|473981168|FG000|Baseline Assessment|Poor IV access|1|||
131643133|NCT00858247|473981169|FG001|Baseline Assessment|Poor IV access|0|||
131643134|NCT00858247|473981168|FG000|Baseline Assessment|Protocol Violation|0|||
131643135|NCT00858247|473981169|FG001|Baseline Assessment|Protocol Violation|1|||
131643136|NCT00858247|473981168|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
131643137|NCT00858247|473981169|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
131643138|NCT03898960|473981172|FG000|Overall Study|Death|10|||
131643139|NCT00548847|473981173|FG000|Overall Study|Disease progression|7|||
131643140|NCT01379703|473981174|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
131643141|NCT01379703|473981175|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
131643142|NCT01379703|473981176|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
131643143|NCT01379703|473981174|FG000|Study Start Through 9 Months|Adverse Event|0|||
131643144|NCT01379703|473981175|FG001|Study Start Through 9 Months|Adverse Event|14|||
131643145|NCT01379703|473981176|FG002|Study Start Through 9 Months|Adverse Event|10|||
131643146|NCT01379703|473981174|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
131643147|NCT01379703|473981175|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
131643148|NCT01379703|473981176|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
131643149|NCT01379703|473981174|FG000|Study Start Through 9 Months|Treatment Failure|0|||
131643150|NCT01379703|473981175|FG001|Study Start Through 9 Months|Treatment Failure|2|||
131643151|NCT01379703|473981176|FG002|Study Start Through 9 Months|Treatment Failure|2|||
131643152|NCT01379703|473981174|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
131643153|NCT01379703|473981175|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
131643154|NCT01379703|473981176|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
131643155|NCT01379703|473981174|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
131643156|NCT01379703|473981175|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
131643157|NCT01379703|473981176|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
131643158|NCT01379703|473981174|FG000|Study Start Through 9 Months|Medication not available|0|||
131643159|NCT01379703|473981175|FG001|Study Start Through 9 Months|Medication not available|2|||
131643160|NCT01379703|473981176|FG002|Study Start Through 9 Months|Medication not available|1|||
131643161|NCT01379703|473981174|FG000|Study Start Through 9 Months|Poor general condition|0|||
131643162|NCT01379703|473981175|FG001|Study Start Through 9 Months|Poor general condition|1|||
131643163|NCT01379703|473981176|FG002|Study Start Through 9 Months|Poor general condition|0|||
131643164|NCT01379703|473981174|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
131643165|NCT01379703|473981175|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
131643166|NCT01379703|473981176|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
131643167|NCT01379703|473981174|FG000|Study Start Through 9 Months|Reason unknown|2|||
131643168|NCT01379703|473981175|FG001|Study Start Through 9 Months|Reason unknown|31|||
131643169|NCT01379703|473981176|FG002|Study Start Through 9 Months|Reason unknown|24|||
131643170|NCT01379703|473981174|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
131643171|NCT01379703|473981175|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
131643172|NCT01379703|473981176|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
131643173|NCT01379703|473981174|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
131643174|NCT01379703|473981175|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
131643175|NCT01379703|473981176|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
131643176|NCT01379703|473981174|FG000|9 Months Through 18 Months|Adverse Event|0|||
131643177|NCT01379703|473981175|FG001|9 Months Through 18 Months|Adverse Event|6|||
131643178|NCT01379703|473981176|FG002|9 Months Through 18 Months|Adverse Event|0|||
131643179|NCT01379703|473981174|FG000|9 Months Through 18 Months|Treatment failure|0|||
131643180|NCT01379703|473981175|FG001|9 Months Through 18 Months|Treatment failure|5|||
131643181|NCT01379703|473981176|FG002|9 Months Through 18 Months|Treatment failure|0|||
131643182|NCT01379703|473981174|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
131643183|NCT01379703|473981175|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
131643184|NCT01379703|473981176|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
131643185|NCT01379703|473981174|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
131643186|NCT01379703|473981175|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
131643187|NCT01379703|473981176|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
131643188|NCT01379703|473981174|FG000|9 Months Through 18 Months|Fatigue|0|||
131643189|NCT01379703|473981175|FG001|9 Months Through 18 Months|Fatigue|1|||
131643190|NCT01379703|473981176|FG002|9 Months Through 18 Months|Fatigue|0|||
131643191|NCT01379703|473981174|FG000|9 Months Through 18 Months|Reason Unknown|0|||
131643192|NCT01379703|473981175|FG001|9 Months Through 18 Months|Reason Unknown|23|||
131643193|NCT01379703|473981176|FG002|9 Months Through 18 Months|Reason Unknown|0|||
131643194|NCT01316887|473981177|FG000|Overall Study|Adverse Event|13|||
131643195|NCT01316887|473981178|FG001|Overall Study|Adverse Event|21|||
131643196|NCT01316887|473981179|FG002|Overall Study|Adverse Event|17|||
131643197|NCT01316887|473981177|FG000|Overall Study|Lack of Efficacy|9|||
131643198|NCT01316887|473981178|FG001|Overall Study|Lack of Efficacy|3|||
131643199|NCT01316887|473981179|FG002|Overall Study|Lack of Efficacy|1|||
131643200|NCT01316887|473981177|FG000|Overall Study|Protocol Violation|2|||
131715324|NCT01122927|474235420|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
131715325|NCT01122927|474235419|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
131715326|NCT01122927|474235420|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
131715327|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
131715328|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
131715329|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
131715330|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
131715331|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
131715332|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
131715333|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
131715334|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
131715335|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
131715336|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
131715337|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
131715338|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
131715339|NCT01122927|474235419|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
131715340|NCT01122927|474235420|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
131715341|NCT00684814|474235421|FG000|Washout Period of 7 Days|Adverse Event|1|||
131715342|NCT00684814|474235422|FG001|Washout Period of 7 Days|Adverse Event|2|||
131715343|NCT00684814|474235421|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131715344|NCT00684814|474235422|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
131715345|NCT00684814|474235421|FG000|Second Intervention|Adverse Event|1|||
131715346|NCT00684814|474235422|FG001|Second Intervention|Adverse Event|0|||
131715347|NCT01676961|474235427|FG000|Overall Study|Death|3|||
131643201|NCT01316887|473981178|FG001|Overall Study|Protocol Violation|6|||
131643202|NCT01316887|473981179|FG002|Overall Study|Protocol Violation|6|||
131643203|NCT01316887|473981177|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
131643204|NCT01316887|473981178|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
131643205|NCT01316887|473981179|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
131643206|NCT01316887|473981177|FG000|Overall Study|Study Closed/Terminated|2|||
131643207|NCT01316887|473981178|FG001|Overall Study|Study Closed/Terminated|4|||
131643208|NCT01316887|473981179|FG002|Overall Study|Study Closed/Terminated|3|||
131643209|NCT01316887|473981177|FG000|Overall Study|Lost to Follow-up|1|||
131643210|NCT01316887|473981178|FG001|Overall Study|Lost to Follow-up|7|||
131643211|NCT01316887|473981179|FG002|Overall Study|Lost to Follow-up|5|||
131643212|NCT01316887|473981177|FG000|Overall Study|Withdrawal by Subject|8|||
131643213|NCT01316887|473981178|FG001|Overall Study|Withdrawal by Subject|16|||
131643214|NCT01316887|473981179|FG002|Overall Study|Withdrawal by Subject|15|||
131445275|NCT01744977|473260348|FG000|Overall Study|No longer meets inclusion|6|||
131445276|NCT01744977|473260349|FG001|Overall Study|No longer meets inclusion|0|||
131445277|NCT02156076|473260352|FG000|Treatment Period|no longer meets study criteria|0|||
131445278|NCT02156076|473260353|FG001|Treatment Period|no longer meets study criteria|0|||
131445279|NCT02156076|473260354|FG002|Treatment Period|no longer meets study criteria|1|||
131715348|NCT01676961|474235427|FG000|Overall Study|Lost to Follow-up|1|||
131715349|NCT01676961|474235427|FG000|Overall Study|Withdrawal by Subject|1|||
131715350|NCT00768560|474235428|FG000|Intervention Set 1|Adverse Event|0|||
131445280|NCT02156076|473260355|FG003|Treatment Period|no longer meets study criteria|0|||
131445281|NCT02156076|473260352|FG000|Treatment Period|Poor/non-compliance|0|||
131715351|NCT00768560|474235429|FG001|Intervention Set 1|Adverse Event|1|||
131643215|NCT00813098|473981182|FG000|Overall Study|Adverse Event|2|||
131715352|NCT00768560|474235430|FG002|Intervention Set 1|Adverse Event|0|||
131715353|NCT00768560|474235431|FG003|Intervention Set 1|Adverse Event|0|||
131715354|NCT00768560|474235432|FG004|Intervention Set 1|Adverse Event|0|||
131715355|NCT00768560|474235433|FG005|Intervention Set 1|Adverse Event|0|||
131715356|NCT00195650|474235434|FG000|Overall Study|Adverse Event|194|||
131715357|NCT00195650|474235434|FG000|Overall Study|Lack of Efficacy|99|||
131715358|NCT00195650|474235434|FG000|Overall Study|Withdrawal by Subject|67|||
131715359|NCT00195650|474235434|FG000|Overall Study|Lost to Follow-up|44|||
131715360|NCT00195650|474235434|FG000|Overall Study|Death|23|||
131715361|NCT00195650|474235434|FG000|Overall Study|Protocol Violation|15|||
131715362|NCT00195650|474235434|FG000|Overall Study|Administrative reasons|83|||
131715363|NCT01128387|474235435|FG000|Overall Study|Physician Decision|0|||
131715364|NCT01128387|474235436|FG001|Overall Study|Physician Decision|1|||
131715365|NCT01535235|474235437|FG000|Overall Study|Adverse Event|1|||
131715366|NCT01535235|474235438|FG001|Overall Study|Adverse Event|0|||
131715367|NCT00858832|474235439|FG000|Overall Study|became ineligible: delivered vaginally|1|||
131715368|NCT00858832|474235440|FG001|Overall Study|became ineligible: delivered vaginally|0|||
131715369|NCT00858832|474235439|FG000|Overall Study|Adverse Event|0|||
131715370|NCT00858832|474235440|FG001|Overall Study|Adverse Event|1|||
131715371|NCT02371629|474235448|FG000|Overall Study|Patient decision|14|||
131715372|NCT02371629|474235449|FG001|Overall Study|Patient decision|10|||
131715373|NCT02371629|474235448|FG000|Overall Study|Adverse Event|8|||
131715374|NCT02371629|474235449|FG001|Overall Study|Adverse Event|8|||
131715375|NCT02371629|474235448|FG000|Overall Study|Physician Decision|2|||
131715376|NCT02371629|474235449|FG001|Overall Study|Physician Decision|3|||
131715377|NCT02371629|474235448|FG000|Overall Study|Death|1|||
131715378|NCT02371629|474235449|FG001|Overall Study|Death|1|||
131715379|NCT02371629|474235448|FG000|Overall Study|Noncompliance with study treatment|1|||
131715380|NCT02371629|474235449|FG001|Overall Study|Noncompliance with study treatment|0|||
131715381|NCT02371629|474235448|FG000|Overall Study|Lack of Efficacy|0|||
131715382|NCT02371629|474235449|FG001|Overall Study|Lack of Efficacy|2|||
131715383|NCT02371629|474235448|FG000|Overall Study|Protocol deviation|0|||
131715384|NCT02371629|474235449|FG001|Overall Study|Protocol deviation|1|||
131715385|NCT01051739|474235450|FG000|Overall Study|Death|3|||
131715386|NCT01051739|474235451|FG001|Overall Study|Death|3|||
131715387|NCT01051739|474235450|FG000|Overall Study|Withdrawal by Subject|25|||
131715388|NCT01051739|474235451|FG001|Overall Study|Withdrawal by Subject|10|||
131715389|NCT01794780|474235452|FG000|Overall Study|Adverse Event|0|||
131715390|NCT01794780|474235453|FG001|Overall Study|Adverse Event|1|||
131715391|NCT01794780|474235454|FG002|Overall Study|Adverse Event|2|||
131715392|NCT01794780|474235455|FG003|Overall Study|Adverse Event|0|||
131715393|NCT01794780|474235456|FG004|Overall Study|Adverse Event|0|||
131715394|NCT01794780|474235457|FG005|Overall Study|Adverse Event|0|||
131801974|NCT03980483|474559130|FG001|Overall Study|Physician Decision|10|||
131801975|NCT03980483|474559131|FG002|Overall Study|Physician Decision|7|||
131643216|NCT00813098|473981183|FG001|Overall Study|Adverse Event|4|||
131643217|NCT00813098|473981184|FG002|Overall Study|Adverse Event|1|||
131643218|NCT00813098|473981182|FG000|Overall Study|Withdrawal by Subject|0|||
131643219|NCT00813098|473981183|FG001|Overall Study|Withdrawal by Subject|1|||
131643220|NCT00813098|473981184|FG002|Overall Study|Withdrawal by Subject|0|||
131643221|NCT00813098|473981182|FG000|Overall Study|Inability to complete study procedures|1|||
131643222|NCT00813098|473981183|FG001|Overall Study|Inability to complete study procedures|0|||
131643223|NCT00813098|473981184|FG002|Overall Study|Inability to complete study procedures|0|||
131643224|NCT00813098|473981182|FG000|Overall Study|Lost to Follow-up|0|||
131643225|NCT00813098|473981183|FG001|Overall Study|Lost to Follow-up|1|||
131643226|NCT00813098|473981184|FG002|Overall Study|Lost to Follow-up|0|||
131643227|NCT00813098|473981182|FG000|Overall Study|Protocol Violation|0|||
131643228|NCT00813098|473981183|FG001|Overall Study|Protocol Violation|0|||
131643229|NCT00813098|473981184|FG002|Overall Study|Protocol Violation|1|||
131643230|NCT00813098|473981182|FG000|Overall Study|Principal Investigator decision|0|||
131643231|NCT00813098|473981183|FG001|Overall Study|Principal Investigator decision|1|||
131643232|NCT00813098|473981184|FG002|Overall Study|Principal Investigator decision|0|||
131801976|NCT03980483|474559132|FG003|Overall Study|Physician Decision|4|||
131715395|NCT01794780|474235458|FG006|Overall Study|Adverse Event|0|||
131715396|NCT01794780|474235459|FG007|Overall Study|Adverse Event|0|||
131715397|NCT01794780|474235452|FG000|Overall Study|Death|0|||
131715398|NCT01794780|474235453|FG001|Overall Study|Death|2|||
131715399|NCT01794780|474235454|FG002|Overall Study|Death|14|||
131801977|NCT03980483|474559133|FG004|Overall Study|Physician Decision|4|||
131643233|NCT00813098|473981182|FG000|Overall Study|Withdrew Consent|0|||
131643234|NCT00813098|473981183|FG001|Overall Study|Withdrew Consent|1|||
131643235|NCT00813098|473981184|FG002|Overall Study|Withdrew Consent|0|||
131643236|NCT00585975|473981187|FG000|Overall Study|Withdrawal by Subject|3|||
131715400|NCT01794780|474235455|FG003|Overall Study|Death|1|||
131715401|NCT01794780|474235456|FG004|Overall Study|Death|0|||
131715402|NCT01794780|474235457|FG005|Overall Study|Death|9|||
131715403|NCT01794780|474235458|FG006|Overall Study|Death|4|||
131715404|NCT01794780|474235459|FG007|Overall Study|Death|0|||
131715405|NCT01794780|474235452|FG000|Overall Study|Lost to Follow-up|10|||
131715406|NCT01794780|474235453|FG001|Overall Study|Lost to Follow-up|64|||
131643237|NCT00585975|473981188|FG001|Overall Study|Withdrawal by Subject|3|||
131643238|NCT00585975|473981187|FG000|Overall Study|Lost to Follow-up|2|||
131643239|NCT00585975|473981188|FG001|Overall Study|Lost to Follow-up|1|||
131643240|NCT00585975|473981187|FG000|Overall Study|Enrollment met/over-enrolled|10|||
131643241|NCT00585975|473981188|FG001|Overall Study|Enrollment met/over-enrolled|9|||
131643242|NCT03414047|473981189|FG000|Overall Study|Adverse Event|0|||
131643243|NCT03414047|473981190|FG001|Overall Study|Adverse Event|0|||
131643244|NCT03414047|473981191|FG002|Overall Study|Adverse Event|1|||
131643245|NCT03414047|473981192|FG003|Overall Study|Adverse Event|1|||
131643246|NCT03414047|473981189|FG000|Overall Study|Physician Decision|1|||
131643247|NCT03414047|473981190|FG001|Overall Study|Physician Decision|0|||
131643248|NCT03414047|473981191|FG002|Overall Study|Physician Decision|0|||
131643249|NCT03414047|473981192|FG003|Overall Study|Physician Decision|1|||
131643250|NCT03414047|473981189|FG000|Overall Study|Withdrawal by Subject|1|||
131643251|NCT03414047|473981190|FG001|Overall Study|Withdrawal by Subject|0|||
131643252|NCT03414047|473981191|FG002|Overall Study|Withdrawal by Subject|2|||
131643253|NCT03414047|473981192|FG003|Overall Study|Withdrawal by Subject|0|||
131643254|NCT00832000|473981198|FG000|Overall Study|Adverse Event|2|||
131643255|NCT00832000|473981199|FG001|Overall Study|Adverse Event|0|||
131643256|NCT00832000|473981198|FG000|Overall Study|Withdrawal by Subject|1|||
131643257|NCT00832000|473981199|FG001|Overall Study|Withdrawal by Subject|0|||
131643258|NCT00832000|473981198|FG000|Overall Study|No calls to IVR in either period|1|||
131643259|NCT00832000|473981199|FG001|Overall Study|No calls to IVR in either period|1|||
131643260|NCT00832000|473981198|FG000|Overall Study|No calls to IVR in period 2|2|||
131643261|NCT00832000|473981199|FG001|Overall Study|No calls to IVR in period 2|0|||
131643262|NCT02725567|473981201|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
131643263|NCT02725567|473981202|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
131643264|NCT02725567|473981201|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
131643265|NCT02725567|473981202|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
131643266|NCT02725567|473981201|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
131643267|NCT02725567|473981202|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
131643268|NCT02777242|473981203|FG000|Overall Study|Other|2|||
131643269|NCT02777242|473981203|FG000|Overall Study|Lost to Follow-up|1|||
131643270|NCT02777242|473981203|FG000|Overall Study|Multiple|1|||
131643271|NCT02777242|473981203|FG000|Overall Study|Sponsor's request|1|||
131643272|NCT02777242|473981203|FG000|Overall Study|Withdrawal by Subject|1|||
131643273|NCT00255944|473981204|FG000|Overall Study|Lost to Follow-up|797|||
131643274|NCT00255944|473981205|FG001|Overall Study|Lost to Follow-up|834|||
131643275|NCT01129115|473981206|FG000|Overall Study|Adverse Event|1|||
131643276|NCT01129115|473981207|FG001|Overall Study|Adverse Event|2|||
131643277|NCT01129115|473981208|FG002|Overall Study|Adverse Event|3|||
131643278|NCT01129115|473981209|FG003|Overall Study|Adverse Event|3|||
131643279|NCT01129115|473981206|FG000|Overall Study|Withdrawal by Subject|1|||
131643280|NCT01129115|473981207|FG001|Overall Study|Withdrawal by Subject|3|||
131643281|NCT01129115|473981208|FG002|Overall Study|Withdrawal by Subject|1|||
131643282|NCT01129115|473981209|FG003|Overall Study|Withdrawal by Subject|4|||
131643283|NCT01129115|473981206|FG000|Overall Study|Protocol Violation|0|||
131643284|NCT01129115|473981207|FG001|Overall Study|Protocol Violation|2|||
131643285|NCT01129115|473981208|FG002|Overall Study|Protocol Violation|2|||
131643286|NCT01129115|473981209|FG003|Overall Study|Protocol Violation|2|||
131643287|NCT01747837|473981211|FG000|Overall Study|Lost to Follow-up|5|||
131643288|NCT01747837|473981212|FG001|Overall Study|Lost to Follow-up|2|||
131643289|NCT01747837|473981211|FG000|Overall Study|Death|4|||
131643290|NCT01747837|473981212|FG001|Overall Study|Death|4|||
131643291|NCT00817336|473981214|FG000|Overall Study|Withdrawal by Subject|1|||
131643292|NCT00817336|473981215|FG001|Overall Study|Withdrawal by Subject|1|||
131643293|NCT01253447|473981216|FG000|Overall Study|Adverse Event|2|||
131643294|NCT01435798|473981217|FG000|Overall Study|Withdrawal by Subject|1|||
131643295|NCT02299427|473981218|FG000|Overall Study|Withdrawal by Subject|1|||
131643296|NCT02299427|473981219|FG001|Overall Study|Withdrawal by Subject|0|||
131643297|NCT02299427|473981218|FG000|Overall Study|Lost to Follow-up|1|||
131643298|NCT02299427|473981219|FG001|Overall Study|Lost to Follow-up|3|||
131643299|NCT02299427|473981218|FG000|Overall Study|not adherent to dog website use|21|||
131643300|NCT02299427|473981219|FG001|Overall Study|not adherent to dog website use|0|||
131643301|NCT02108652|473981220|FG000|Overall Study|Death|253|||
131643302|NCT02108652|473981220|FG000|Overall Study|Lost to Follow-up|2|||
131643303|NCT02108652|473981220|FG000|Overall Study|Withdrawal by Subject|16|||
131643304|NCT02108652|473981220|FG000|Overall Study|Study Terminated By Sponsor|31|||
131643305|NCT02108652|473981220|FG000|Overall Study|Non-Compliance|1|||
131643306|NCT02108652|473981220|FG000|Overall Study|Physician Decision|6|||
131643307|NCT02108652|473981220|FG000|Overall Study|Progression Of Disease|1|||
131643308|NCT01121913|473981228|FG000|First Intervention Period|Adverse Event|0|||
131643309|NCT01121913|473981229|FG001|First Intervention Period|Adverse Event|0|||
131643310|NCT01121913|473981230|FG002|First Intervention Period|Adverse Event|1|||
131643311|NCT01121913|473981231|FG003|First Intervention Period|Adverse Event|0|||
131643312|NCT01121913|473981228|FG000|First Washout Period|Withdrawal by Subject|1|||
131643313|NCT01121913|473981229|FG001|First Washout Period|Withdrawal by Subject|0|||
131643314|NCT01121913|473981230|FG002|First Washout Period|Withdrawal by Subject|0|||
131643315|NCT01121913|473981231|FG003|First Washout Period|Withdrawal by Subject|0|||
131643316|NCT01121913|473981228|FG000|Second Intervention Period|Adverse Event|0|||
131643317|NCT01121913|473981229|FG001|Second Intervention Period|Adverse Event|0|||
131643318|NCT01121913|473981230|FG002|Second Intervention Period|Adverse Event|1|||
131643319|NCT01121913|473981231|FG003|Second Intervention Period|Adverse Event|0|||
131643320|NCT01121913|473981228|FG000|Second Washout Period|Withdrawal by Subject|0|||
131643321|NCT01121913|473981229|FG001|Second Washout Period|Withdrawal by Subject|0|||
131643322|NCT01121913|473981230|FG002|Second Washout Period|Withdrawal by Subject|1|||
131643323|NCT01121913|473981231|FG003|Second Washout Period|Withdrawal by Subject|0|||
131643324|NCT01121913|473981228|FG000|Third Washout Period|Adverse Event|1|||
131643325|NCT01121913|473981229|FG001|Third Washout Period|Adverse Event|0|||
131643326|NCT01121913|473981230|FG002|Third Washout Period|Adverse Event|0|||
131643327|NCT01121913|473981231|FG003|Third Washout Period|Adverse Event|0|||
131643328|NCT02564718|473981234|FG000|Overall Study|Withdrew from treatment|0|||
131643329|NCT02564718|473981235|FG001|Overall Study|Withdrew from treatment|1|||
131643330|NCT00935259|473981236|FG000|Period 1|Administrative (scheduling conflict)|1|||
131643331|NCT00935259|473981237|FG001|Period 1|Administrative (scheduling conflict)|1|||
131643332|NCT00937521|473981239|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131643333|NCT00937521|473981240|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131643334|NCT00937521|473981241|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
131643335|NCT00937521|473981242|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131643336|NCT00937521|473981243|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131643337|NCT00937521|473981244|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131643338|NCT00937521|473981245|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
131643339|NCT00937521|473981246|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131643340|NCT00937521|473981239|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
131643341|NCT00937521|473981240|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
131643342|NCT00937521|473981241|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
131643343|NCT00937521|473981242|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
131643344|NCT00937521|473981243|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
131643345|NCT00937521|473981244|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
131643346|NCT00937521|473981245|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
131643347|NCT00937521|473981246|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
131643348|NCT00937521|473981239|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131643349|NCT00937521|473981240|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131643350|NCT00937521|473981241|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
131643351|NCT00937521|473981242|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
131643352|NCT00937521|473981243|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131643353|NCT00937521|473981244|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131643354|NCT00937521|473981245|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131643355|NCT00937521|473981246|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131643356|NCT00937521|473981239|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131643357|NCT00937521|473981240|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
131643358|NCT00937521|473981241|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131643359|NCT00937521|473981242|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131643360|NCT00937521|473981243|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
131643361|NCT00937521|473981244|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
131643362|NCT00937521|473981245|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
131643363|NCT00937521|473981246|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131643364|NCT00937521|473981239|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
131643365|NCT00937521|473981240|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131715407|NCT01794780|474235454|FG002|Overall Study|Lost to Follow-up|165|||
131715408|NCT01794780|474235455|FG003|Overall Study|Lost to Follow-up|53|||
131715409|NCT01794780|474235456|FG004|Overall Study|Lost to Follow-up|2|||
131643366|NCT00937521|473981241|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131643367|NCT00937521|473981242|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131643368|NCT00937521|473981243|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131643369|NCT00937521|473981244|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131643370|NCT00937521|473981245|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
131643371|NCT00937521|473981246|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131643372|NCT00937521|473981239|FG000|Booster Phase|Adverse Event|0|||
131643373|NCT00937521|473981240|FG001|Booster Phase|Adverse Event|0|||
131643374|NCT00937521|473981241|FG002|Booster Phase|Adverse Event|0|||
131643375|NCT00937521|473981242|FG003|Booster Phase|Adverse Event|0|||
131643376|NCT00937521|473981243|FG004|Booster Phase|Adverse Event|0|||
131643377|NCT00937521|473981244|FG005|Booster Phase|Adverse Event|0|||
131643378|NCT00937521|473981245|FG006|Booster Phase|Adverse Event|1|||
131643379|NCT00937521|473981246|FG007|Booster Phase|Adverse Event|0|||
131643380|NCT00937521|473981239|FG000|Booster Phase|Withdrawal by Subject|1|||
131643381|NCT00937521|473981240|FG001|Booster Phase|Withdrawal by Subject|0|||
131643382|NCT00937521|473981241|FG002|Booster Phase|Withdrawal by Subject|0|||
131643383|NCT00937521|473981242|FG003|Booster Phase|Withdrawal by Subject|1|||
131643384|NCT00937521|473981243|FG004|Booster Phase|Withdrawal by Subject|0|||
131643385|NCT00937521|473981244|FG005|Booster Phase|Withdrawal by Subject|0|||
131643386|NCT00937521|473981245|FG006|Booster Phase|Withdrawal by Subject|0|||
131643387|NCT00937521|473981246|FG007|Booster Phase|Withdrawal by Subject|2|||
131643388|NCT00937521|473981239|FG000|Booster Phase|Lost to Follow-up|2|||
131643389|NCT00937521|473981240|FG001|Booster Phase|Lost to Follow-up|2|||
131643390|NCT00937521|473981241|FG002|Booster Phase|Lost to Follow-up|4|||
131643391|NCT00937521|473981242|FG003|Booster Phase|Lost to Follow-up|2|||
131643392|NCT00937521|473981243|FG004|Booster Phase|Lost to Follow-up|4|||
131643393|NCT00937521|473981244|FG005|Booster Phase|Lost to Follow-up|4|||
131643394|NCT00937521|473981245|FG006|Booster Phase|Lost to Follow-up|3|||
131643395|NCT00937521|473981246|FG007|Booster Phase|Lost to Follow-up|0|||
131643396|NCT00937521|473981239|FG000|Booster Phase|Administrative Reason|0|||
131643397|NCT00937521|473981240|FG001|Booster Phase|Administrative Reason|0|||
131643398|NCT00937521|473981241|FG002|Booster Phase|Administrative Reason|1|||
131643399|NCT00937521|473981242|FG003|Booster Phase|Administrative Reason|0|||
131643400|NCT00937521|473981243|FG004|Booster Phase|Administrative Reason|1|||
131643401|NCT00937521|473981244|FG005|Booster Phase|Administrative Reason|1|||
131643402|NCT00937521|473981245|FG006|Booster Phase|Administrative Reason|0|||
131643403|NCT00937521|473981246|FG007|Booster Phase|Administrative Reason|0|||
131643404|NCT00937521|473981239|FG000|Booster Phase|Protocol Deviation|0|||
131643405|NCT00937521|473981240|FG001|Booster Phase|Protocol Deviation|0|||
131643406|NCT00937521|473981241|FG002|Booster Phase|Protocol Deviation|0|||
131643407|NCT00937521|473981242|FG003|Booster Phase|Protocol Deviation|0|||
131643408|NCT00937521|473981243|FG004|Booster Phase|Protocol Deviation|0|||
131643409|NCT00937521|473981244|FG005|Booster Phase|Protocol Deviation|0|||
131643410|NCT00937521|473981245|FG006|Booster Phase|Protocol Deviation|1|||
131643411|NCT00937521|473981246|FG007|Booster Phase|Protocol Deviation|0|||
131643412|NCT00874497|473981250|FG000|Overall Study|Lost to Follow-up|2|||
131643413|NCT00874497|473981251|FG001|Overall Study|Lost to Follow-up|4|||
131643414|NCT00874497|473981250|FG000|Overall Study|Adverse Event|9|||
131643415|NCT00874497|473981251|FG001|Overall Study|Adverse Event|4|||
131643416|NCT00874497|473981250|FG000|Overall Study|Sponsor Discontinued Trial|7|||
131643417|NCT00874497|473981251|FG001|Overall Study|Sponsor Discontinued Trial|3|||
131643418|NCT00874497|473981250|FG000|Overall Study|Met Withdrawal Criteria|4|||
131643419|NCT00874497|473981251|FG001|Overall Study|Met Withdrawal Criteria|2|||
131643420|NCT00874497|473981250|FG000|Overall Study|Physician Decision|1|||
131643421|NCT00874497|473981251|FG001|Overall Study|Physician Decision|1|||
131643422|NCT00874497|473981250|FG000|Overall Study|Withdrawal by Subject|5|||
131643423|NCT00874497|473981251|FG001|Overall Study|Withdrawal by Subject|4|||
131643424|NCT01017263|473981252|FG000|Overall Study|not eligible|12|||
131643425|NCT02980705|473981253|FG000|Overall Study|Adverse Event|0|||
131643426|NCT02980705|473981254|FG001|Overall Study|Adverse Event|1|||
131643427|NCT02980705|473981253|FG000|Overall Study|Withdrawal by Subject|6|||
131643428|NCT02980705|473981254|FG001|Overall Study|Withdrawal by Subject|9|||
131643429|NCT02980705|473981253|FG000|Overall Study|withdrew participation|0|||
131643430|NCT02980705|473981254|FG001|Overall Study|withdrew participation|1|||
131643431|NCT02980705|473981253|FG000|Overall Study|Lost to Follow-up|2|||
131643432|NCT02980705|473981254|FG001|Overall Study|Lost to Follow-up|0|||
131643433|NCT00263575|473981255|FG000|Titration Period|Adverse Event|14|||
131643434|NCT00263575|473981255|FG000|Titration Period|Withdrawal by Subject|10|||
131715410|NCT01794780|474235457|FG005|Overall Study|Lost to Follow-up|99|||
131643435|NCT00263575|473981255|FG000|Titration Period|Protocol Violation|9|||
131643436|NCT00263575|473981255|FG000|Titration Period|Sponsor Decision|2|||
131643437|NCT00263575|473981255|FG000|Titration Period|Other|2|||
131643438|NCT00263575|473981255|FG000|Titration Period|Lack of Efficacy|6|||
131643439|NCT00263575|473981255|FG000|Maintence Period|Adverse Event|23|||
131643440|NCT00263575|473981255|FG000|Maintence Period|Withdrawal by Subject|8|||
131643441|NCT00263575|473981255|FG000|Maintence Period|Protocol Violation|4|||
131643442|NCT00263575|473981255|FG000|Maintence Period|Lack of Efficacy|4|||
131643443|NCT00263575|473981255|FG000|Maintence Period|Physician Decision|6|||
131643444|NCT00263575|473981255|FG000|Maintence Period|Lost to Follow-up|1|||
131643445|NCT00263575|473981255|FG000|Maintence Period|Sponsor Decision|24|||
131643446|NCT00263575|473981255|FG000|Maintence Period|Other|7|||
131643447|NCT04353817|473981256|FG000|Overall Study|Adverse Event|0|||
131643448|NCT04353817|473981257|FG001|Overall Study|Adverse Event|1|||
131643449|NCT03599622|473981262|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
131643450|NCT03599622|473981263|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
131643451|NCT03599622|473981264|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
131643452|NCT03599622|473981265|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
131643453|NCT03599622|473981262|FG000|Pre-Treatment Period|Other reasons|1|||
131643454|NCT03599622|473981263|FG001|Pre-Treatment Period|Other reasons|1|||
131643455|NCT03599622|473981264|FG002|Pre-Treatment Period|Other reasons|1|||
131643456|NCT03599622|473981265|FG003|Pre-Treatment Period|Other reasons|0|||
131643457|NCT03599622|473981262|FG000|Treatment Period|Adverse Event|11|||
131643458|NCT03599622|473981263|FG001|Treatment Period|Adverse Event|20|||
131643459|NCT03599622|473981264|FG002|Treatment Period|Adverse Event|18|||
131643460|NCT03599622|473981265|FG003|Treatment Period|Adverse Event|2|||
131643461|NCT03599622|473981262|FG000|Treatment Period|Lack of Efficacy|18|||
131643462|NCT03599622|473981263|FG001|Treatment Period|Lack of Efficacy|12|||
131643463|NCT03599622|473981264|FG002|Treatment Period|Lack of Efficacy|13|||
131643464|NCT03599622|473981265|FG003|Treatment Period|Lack of Efficacy|2|||
131643465|NCT03599622|473981262|FG000|Treatment Period|Withdrawal by Subject|5|||
131643466|NCT03599622|473981263|FG001|Treatment Period|Withdrawal by Subject|11|||
131643467|NCT03599622|473981264|FG002|Treatment Period|Withdrawal by Subject|16|||
131643468|NCT03599622|473981265|FG003|Treatment Period|Withdrawal by Subject|1|||
131643469|NCT03599622|473981262|FG000|Treatment Period|Other reasons|4|||
131643470|NCT03599622|473981263|FG001|Treatment Period|Other reasons|6|||
131643471|NCT03599622|473981264|FG002|Treatment Period|Other reasons|7|||
131643472|NCT03599622|473981265|FG003|Treatment Period|Other reasons|0|||
131643473|NCT03599622|473981262|FG000|Treatment Period|Lost to Follow-up|1|||
131643474|NCT03599622|473981263|FG001|Treatment Period|Lost to Follow-up|0|||
131643475|NCT03599622|473981264|FG002|Treatment Period|Lost to Follow-up|0|||
131643476|NCT03599622|473981265|FG003|Treatment Period|Lost to Follow-up|0|||
131643477|NCT03599622|473981262|FG000|Treatment Period|Study terminated by sponsor|7|||
131643478|NCT03599622|473981263|FG001|Treatment Period|Study terminated by sponsor|20|||
131643479|NCT03599622|473981264|FG002|Treatment Period|Study terminated by sponsor|15|||
131643480|NCT03599622|473981265|FG003|Treatment Period|Study terminated by sponsor|0|||
131643481|NCT03599622|473981262|FG000|Treatment Period|Site terminated by sponsor|0|||
131643482|NCT03599622|473981263|FG001|Treatment Period|Site terminated by sponsor|1|||
131643483|NCT03599622|473981264|FG002|Treatment Period|Site terminated by sponsor|0|||
131643484|NCT03599622|473981265|FG003|Treatment Period|Site terminated by sponsor|0|||
131643485|NCT00770588|473981266|FG000|Overall Study|Adverse Event|9|||
131643486|NCT00770588|473981267|FG001|Overall Study|Adverse Event|2|||
131643487|NCT00770588|473981266|FG000|Overall Study|Death caused by progression of disease|70|||
131643488|NCT00770588|473981267|FG001|Overall Study|Death caused by progression of disease|91|||
131643489|NCT00770588|473981266|FG000|Overall Study|Lost to Follow-up|1|||
131643490|NCT00770588|473981267|FG001|Overall Study|Lost to Follow-up|1|||
131643491|NCT00770588|473981266|FG000|Overall Study|Withdrawal by Subject|1|||
131643492|NCT00770588|473981267|FG001|Overall Study|Withdrawal by Subject|1|||
131643493|NCT00665223|473981268|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
131643494|NCT00665223|473981269|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
131643495|NCT00665223|473981270|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
131643496|NCT00665223|473981268|FG000|Randomized Phase (26 Weeks)|Death|0|||
131643497|NCT00665223|473981269|FG001|Randomized Phase (26 Weeks)|Death|0|||
131643498|NCT00665223|473981270|FG002|Randomized Phase (26 Weeks)|Death|1|||
131643499|NCT00665223|473981268|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
131643500|NCT00665223|473981269|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
131643501|NCT00665223|473981270|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
131643502|NCT00665223|473981268|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
131643503|NCT00665223|473981269|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
131643504|NCT00665223|473981270|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
131643505|NCT00665223|473981268|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
131643506|NCT00665223|473981269|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
131643507|NCT00665223|473981270|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
131643508|NCT00665223|473981268|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
131643509|NCT00665223|473981269|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
131643510|NCT00665223|473981270|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
131643511|NCT00665223|473981268|FG000|Open-Label Period (26 Weeks)|Death|0|||
131643512|NCT00665223|473981269|FG001|Open-Label Period (26 Weeks)|Death|1|||
131643513|NCT00665223|473981270|FG002|Open-Label Period (26 Weeks)|Death|0|||
131643514|NCT00665223|473981268|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
131643515|NCT00665223|473981269|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
131643516|NCT00665223|473981270|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
131643517|NCT00665223|473981268|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
131643518|NCT00665223|473981269|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
131643519|NCT00665223|473981270|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
131643520|NCT00665223|473981268|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
131643521|NCT00665223|473981269|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
131643522|NCT00665223|473981270|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
131643523|NCT00665223|473981268|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
131643524|NCT00665223|473981269|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
131643525|NCT00665223|473981270|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
131643526|NCT00002597|473981271|FG000|Overall Study|Protocol Violation|19|||
131643527|NCT00002597|473981272|FG001|Overall Study|Protocol Violation|17|||
131643528|NCT00002597|473981271|FG000|Overall Study|Withdrawal by Subject|7|||
131643529|NCT00002597|473981272|FG001|Overall Study|Withdrawal by Subject|6|||
131643530|NCT01426113|473981273|FG000|Overall Study|Study Discontinued|1|||
131643531|NCT01426113|473981274|FG001|Overall Study|Study Discontinued|1|||
131643532|NCT01426113|473981273|FG000|Overall Study|Adverse Event|0|||
131643533|NCT01426113|473981274|FG001|Overall Study|Adverse Event|1|||
131643534|NCT02485899|473981275|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
131643535|NCT02485899|473981276|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131643536|NCT02485899|473981275|FG000|Overall Study|Withdrawal by Subject|1|||
131643537|NCT02485899|473981276|FG001|Overall Study|Withdrawal by Subject|0|||
131643538|NCT02485899|473981275|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
131643539|NCT02485899|473981276|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
131643540|NCT01918371|473981277|FG000|Overall Study|Missing Data|1|||
131643541|NCT01918371|473981278|FG001|Overall Study|Missing Data|1|||
131643542|NCT01006889|473981279|FG000|Overall Study|Withdrawal by Subject|3|||
131643543|NCT00623363|473981280|FG000|Overall Study|Adverse Event|2|||
131643544|NCT00623363|473981281|FG001|Overall Study|Adverse Event|2|||
131643545|NCT00909532|473981282|FG000|Overall Study|Adverse Event|4|||
131643546|NCT00909532|473981283|FG001|Overall Study|Adverse Event|1|||
131643547|NCT00909532|473981282|FG000|Overall Study|Pregnancy|0|||
131643548|NCT00909532|473981283|FG001|Overall Study|Pregnancy|1|||
131643549|NCT00909532|473981282|FG000|Overall Study|Prohibited Medication|2|||
131643550|NCT00909532|473981283|FG001|Overall Study|Prohibited Medication|1|||
131643551|NCT00909532|473981282|FG000|Overall Study|Withdrawal of Consent|1|||
131643552|NCT00909532|473981283|FG001|Overall Study|Withdrawal of Consent|1|||
131643553|NCT00909532|473981282|FG000|Overall Study|Noncompliance with Study Requirements|0|||
131643554|NCT00909532|473981283|FG001|Overall Study|Noncompliance with Study Requirements|2|||
131643555|NCT00909532|473981282|FG000|Overall Study|Physician Decision|1|||
131643556|NCT00909532|473981283|FG001|Overall Study|Physician Decision|0|||
131643557|NCT00909532|473981282|FG000|Overall Study|Wrong Genotype|1|||
131643558|NCT00909532|473981283|FG001|Overall Study|Wrong Genotype|0|||
131643559|NCT00909532|473981282|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
131643560|NCT00909532|473981283|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
131643561|NCT01130168|473981284|FG000|Period 1|Withdrawal by Subject|0|||
131643562|NCT01130168|473981285|FG001|Period 1|Withdrawal by Subject|1|||
131643563|NCT01130168|473981286|FG002|Period 1|Withdrawal by Subject|0|||
131643564|NCT01130168|473981287|FG003|Period 1|Withdrawal by Subject|1|||
131643565|NCT01130168|473981288|FG004|Period 1|Withdrawal by Subject|0|||
131643566|NCT01130168|473981289|FG005|Period 1|Withdrawal by Subject|0|||
131643567|NCT01130168|473981284|FG000|Period 1|Discontinued For Other Reason|0|||
131643568|NCT01130168|473981285|FG001|Period 1|Discontinued For Other Reason|0|||
131715411|NCT01794780|474235458|FG006|Overall Study|Lost to Follow-up|30|||
131715412|NCT01794780|474235459|FG007|Overall Study|Lost to Follow-up|5|||
131715413|NCT01794780|474235452|FG000|Overall Study|Withdrew informed consent|7|||
131715414|NCT01794780|474235453|FG001|Overall Study|Withdrew informed consent|17|||
131643569|NCT01130168|473981286|FG002|Period 1|Discontinued For Other Reason|1|||
131643570|NCT01130168|473981287|FG003|Period 1|Discontinued For Other Reason|1|||
131643571|NCT01130168|473981288|FG004|Period 1|Discontinued For Other Reason|0|||
131643572|NCT01130168|473981289|FG005|Period 1|Discontinued For Other Reason|0|||
131643573|NCT01130168|473981284|FG000|Period 1|Adverse Event|0|||
131643574|NCT01130168|473981285|FG001|Period 1|Adverse Event|0|||
131715415|NCT01794780|474235454|FG002|Overall Study|Withdrew informed consent|36|||
131715416|NCT01794780|474235455|FG003|Overall Study|Withdrew informed consent|9|||
131715417|NCT01794780|474235456|FG004|Overall Study|Withdrew informed consent|0|||
131715418|NCT01794780|474235457|FG005|Overall Study|Withdrew informed consent|48|||
131715419|NCT01794780|474235458|FG006|Overall Study|Withdrew informed consent|4|||
131643575|NCT01130168|473981286|FG002|Period 1|Adverse Event|0|||
131715420|NCT01794780|474235459|FG007|Overall Study|Withdrew informed consent|3|||
131643576|NCT01130168|473981287|FG003|Period 1|Adverse Event|1|||
131643577|NCT01130168|473981288|FG004|Period 1|Adverse Event|0|||
131643578|NCT01130168|473981289|FG005|Period 1|Adverse Event|0|||
131643579|NCT04811339|473981301|FG000|Overall Study|lack of transportation not wanting to return|4|||
131643580|NCT04811339|473981302|FG001|Overall Study|lack of transportation not wanting to return|8|||
131715421|NCT01794780|474235452|FG000|Overall Study|Other|0|||
131801978|NCT03980483|474559134|FG005|Overall Study|Physician Decision|2|||
131643581|NCT04811339|473981303|FG002|Overall Study|lack of transportation not wanting to return|0|||
131643582|NCT04811339|473981301|FG000|Overall Study|Adverse Event|3|||
131643583|NCT04811339|473981302|FG001|Overall Study|Adverse Event|0|||
131643584|NCT04811339|473981303|FG002|Overall Study|Adverse Event|0|||
131643585|NCT04811339|473981301|FG000|Overall Study|Lost to Follow-up|1|||
131643586|NCT04811339|473981302|FG001|Overall Study|Lost to Follow-up|0|||
131643587|NCT04811339|473981303|FG002|Overall Study|Lost to Follow-up|0|||
131643588|NCT04811339|473981301|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
131643589|NCT04811339|473981302|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
131643590|NCT04811339|473981303|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
131643591|NCT04811339|473981301|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
131643592|NCT04811339|473981302|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
131643593|NCT04811339|473981303|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
131643594|NCT04811339|473981301|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
131643595|NCT04811339|473981302|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
131643596|NCT04811339|473981303|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
131643597|NCT04811339|473981301|FG000|Overall Study|Withdrawal by Subject|0|||
131643598|NCT04811339|473981302|FG001|Overall Study|Withdrawal by Subject|3|||
131643599|NCT04811339|473981303|FG002|Overall Study|Withdrawal by Subject|0|||
131643600|NCT04811339|473981301|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
131643601|NCT04811339|473981302|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
131643602|NCT04811339|473981303|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
131643603|NCT04811339|473981301|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
131643604|NCT04811339|473981302|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
131643605|NCT04811339|473981303|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
131643606|NCT00497874|473983139|FG000|Overall Study|Withdrawal by Subject|48|||
131643607|NCT00497874|473983140|FG001|Overall Study|Withdrawal by Subject|17|||
131643608|NCT00497874|473983139|FG000|Overall Study|Illness|8|||
131643609|NCT00497874|473983140|FG001|Overall Study|Illness|4|||
131643610|NCT00497874|473983139|FG000|Overall Study|Death|2|||
131643611|NCT00497874|473983140|FG001|Overall Study|Death|4|||
131643612|NCT00497874|473983139|FG000|Overall Study|Unable to contact|52|||
131643613|NCT00497874|473983140|FG001|Overall Study|Unable to contact|67|||
131643614|NCT00497874|473983139|FG000|Overall Study|Unable to schedule|37|||
131643615|NCT00497874|473983140|FG001|Overall Study|Unable to schedule|24|||
131643616|NCT01999972|473983141|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
131643617|NCT01999972|473983142|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
131643618|NCT01999972|473983143|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
131643619|NCT01999972|473983144|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
131643620|NCT01999972|473983145|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
131643621|NCT01999972|473983146|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
131643622|NCT01999972|473983141|FG000|Dose Escalation Part|Death|0|||
131643623|NCT01999972|473983142|FG001|Dose Escalation Part|Death|1|||
131643624|NCT01999972|473983143|FG002|Dose Escalation Part|Death|0|||
131643625|NCT01999972|473983144|FG003|Dose Escalation Part|Death|0|||
131643626|NCT01999972|473983145|FG004|Dose Escalation Part|Death|0|||
131643627|NCT01999972|473983146|FG005|Dose Escalation Part|Death|0|||
131643628|NCT01999972|473983141|FG000|Dose Escalation Part|Enrolled but not treated|0|||
131643629|NCT01999972|473983142|FG001|Dose Escalation Part|Enrolled but not treated|0|||
131643630|NCT01999972|473983143|FG002|Dose Escalation Part|Enrolled but not treated|1|||
131643631|NCT01999972|473983144|FG003|Dose Escalation Part|Enrolled but not treated|1|||
131643632|NCT01999972|473983145|FG004|Dose Escalation Part|Enrolled but not treated|0|||
131643633|NCT01999972|473983146|FG005|Dose Escalation Part|Enrolled but not treated|0|||
131643634|NCT01999972|473983141|FG000|Dose Escalation Part|Disease progression|3|||
131643635|NCT01999972|473983142|FG001|Dose Escalation Part|Disease progression|2|||
131643636|NCT01999972|473983143|FG002|Dose Escalation Part|Disease progression|3|||
131643637|NCT01999972|473983144|FG003|Dose Escalation Part|Disease progression|6|||
131643638|NCT01999972|473983145|FG004|Dose Escalation Part|Disease progression|0|||
131643639|NCT01999972|473983146|FG005|Dose Escalation Part|Disease progression|0|||
131643640|NCT01999972|473983141|FG000|Dose Escalation Part|Adverse Event|0|||
131643641|NCT01999972|473983142|FG001|Dose Escalation Part|Adverse Event|0|||
131643642|NCT01999972|473983143|FG002|Dose Escalation Part|Adverse Event|0|||
131643643|NCT01999972|473983144|FG003|Dose Escalation Part|Adverse Event|2|||
131643644|NCT01999972|473983145|FG004|Dose Escalation Part|Adverse Event|0|||
131643645|NCT01999972|473983146|FG005|Dose Escalation Part|Adverse Event|0|||
131643646|NCT01999972|473983141|FG000|Dose Escalation Part|Global deterioration of health status|1|||
131643647|NCT01999972|473983142|FG001|Dose Escalation Part|Global deterioration of health status|0|||
131643648|NCT01999972|473983143|FG002|Dose Escalation Part|Global deterioration of health status|0|||
131715422|NCT01794780|474235453|FG001|Overall Study|Other|12|||
131715423|NCT01794780|474235454|FG002|Overall Study|Other|25|||
131715424|NCT01794780|474235455|FG003|Overall Study|Other|20|||
131715425|NCT01794780|474235456|FG004|Overall Study|Other|1|||
131715426|NCT01794780|474235457|FG005|Overall Study|Other|24|||
131715427|NCT01794780|474235458|FG006|Overall Study|Other|4|||
131715428|NCT01794780|474235459|FG007|Overall Study|Other|1|||
131715429|NCT02499952|474235460|FG000|Overall Study|Lost to Follow-up|1|||
131715430|NCT02499952|474235460|FG000|Overall Study|Death|9|||
131715431|NCT01440101|474235461|FG000|Overall Study|Adverse Event|2|||
131643649|NCT01999972|473983144|FG003|Dose Escalation Part|Global deterioration of health status|1|||
131643650|NCT01999972|473983145|FG004|Dose Escalation Part|Global deterioration of health status|0|||
131643651|NCT01999972|473983146|FG005|Dose Escalation Part|Global deterioration of health status|0|||
131643652|NCT01999972|473983141|FG000|Dose Expansion Part|Death|0|||
131643653|NCT01999972|473983142|FG001|Dose Expansion Part|Death|0|||
131643654|NCT01999972|473983143|FG002|Dose Expansion Part|Death|0|||
131643655|NCT01999972|473983144|FG003|Dose Expansion Part|Death|0|||
131643656|NCT01999972|473983145|FG004|Dose Expansion Part|Death|2|||
131643657|NCT01999972|473983146|FG005|Dose Expansion Part|Death|1|||
131643658|NCT01999972|473983141|FG000|Dose Expansion Part|Disease progression|0|||
131643659|NCT01999972|473983142|FG001|Dose Expansion Part|Disease progression|0|||
131715432|NCT01440101|474235462|FG001|Overall Study|Adverse Event|0|||
131643660|NCT01999972|473983143|FG002|Dose Expansion Part|Disease progression|0|||
131643661|NCT01999972|473983144|FG003|Dose Expansion Part|Disease progression|0|||
131643662|NCT01999972|473983145|FG004|Dose Expansion Part|Disease progression|9|||
131643663|NCT01999972|473983146|FG005|Dose Expansion Part|Disease progression|3|||
131643664|NCT01999972|473983141|FG000|Dose Expansion Part|Sponsor decision|0|||
131643665|NCT01999972|473983142|FG001|Dose Expansion Part|Sponsor decision|0|||
131643666|NCT01999972|473983143|FG002|Dose Expansion Part|Sponsor decision|0|||
131643667|NCT01999972|473983144|FG003|Dose Expansion Part|Sponsor decision|0|||
131643668|NCT01999972|473983145|FG004|Dose Expansion Part|Sponsor decision|1|||
131643669|NCT01999972|473983146|FG005|Dose Expansion Part|Sponsor decision|0|||
131643670|NCT01999972|473983141|FG000|Dose Expansion Part|Adverse Event|0|||
131643671|NCT01999972|473983142|FG001|Dose Expansion Part|Adverse Event|0|||
131643672|NCT01999972|473983143|FG002|Dose Expansion Part|Adverse Event|0|||
131715433|NCT01440101|474235463|FG002|Overall Study|Adverse Event|0|||
131715434|NCT01440101|474235461|FG000|Overall Study|Withdrawal by Subject|0|||
131715435|NCT01440101|474235462|FG001|Overall Study|Withdrawal by Subject|3|||
131715436|NCT01440101|474235463|FG002|Overall Study|Withdrawal by Subject|1|||
131715437|NCT01440101|474235461|FG000|Overall Study|Other|0|||
131715438|NCT01440101|474235462|FG001|Overall Study|Other|1|||
131715439|NCT01440101|474235463|FG002|Overall Study|Other|0|||
131715440|NCT00201851|474235464|FG000|Overall Study|Lost to Follow-up|2|||
131715441|NCT00201851|474235465|FG001|Overall Study|Lost to Follow-up|1|||
131715442|NCT00201851|474235466|FG002|Overall Study|Lost to Follow-up|0|||
131715443|NCT00201851|474235464|FG000|Overall Study|Ineligible post enrollment|6|||
131903013|NCT00676403|474931364|FG000|Overall Study|Lost to Follow-up|0|||
131903014|NCT00676403|474931365|FG001|Overall Study|Lost to Follow-up|0|||
131643673|NCT01999972|473983144|FG003|Dose Expansion Part|Adverse Event|0|||
131643674|NCT01999972|473983145|FG004|Dose Expansion Part|Adverse Event|4|||
131643675|NCT01999972|473983146|FG005|Dose Expansion Part|Adverse Event|2|||
131643676|NCT01999972|473983141|FG000|Dose Expansion Part|Participant's non-compliance|0|||
131643677|NCT01999972|473983142|FG001|Dose Expansion Part|Participant's non-compliance|0|||
131643678|NCT01999972|473983143|FG002|Dose Expansion Part|Participant's non-compliance|0|||
131643679|NCT01999972|473983144|FG003|Dose Expansion Part|Participant's non-compliance|0|||
131643680|NCT01999972|473983145|FG004|Dose Expansion Part|Participant's non-compliance|0|||
131643681|NCT01999972|473983146|FG005|Dose Expansion Part|Participant's non-compliance|1|||
131643682|NCT01999972|473983141|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
131643683|NCT01999972|473983142|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
131643684|NCT01999972|473983143|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
131715444|NCT00201851|474235465|FG001|Overall Study|Ineligible post enrollment|1|||
131715445|NCT00201851|474235466|FG002|Overall Study|Ineligible post enrollment|1|||
131715446|NCT00636818|474235470|FG000|Overall Study|Adverse Event|1|||
131715447|NCT00636818|474235470|FG000|Overall Study|Lost to Follow-up|2|||
131903015|NCT00676403|474931366|FG002|Overall Study|Lost to Follow-up|0|||
131643685|NCT01999972|473983144|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
131903016|NCT00676403|474931367|FG003|Overall Study|Lost to Follow-up|0|||
131903017|NCT00676403|474931368|FG004|Overall Study|Lost to Follow-up|0|||
131903018|NCT00676403|474931369|FG005|Overall Study|Lost to Follow-up|1|||
131643686|NCT01999972|473983145|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
131643687|NCT01999972|473983146|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
131643688|NCT01999972|473983141|FG000|Dose Expansion Part|Changed to standard of care|0|||
131643689|NCT01999972|473983142|FG001|Dose Expansion Part|Changed to standard of care|0|||
131643690|NCT01999972|473983143|FG002|Dose Expansion Part|Changed to standard of care|0|||
131715448|NCT00636818|474235470|FG000|Overall Study|Entry Criteria Exclusion|3|||
131715449|NCT00636818|474235470|FG000|Overall Study|Protocol Violation|1|||
131643691|NCT01999972|473983144|FG003|Dose Expansion Part|Changed to standard of care|0|||
131643692|NCT01999972|473983145|FG004|Dose Expansion Part|Changed to standard of care|1|||
131643693|NCT01999972|473983146|FG005|Dose Expansion Part|Changed to standard of care|0|||
131643694|NCT01256671|473983150|FG000|Overall Study|Adverse Event|29|||
131643695|NCT01256671|473983150|FG000|Overall Study|Lost to Follow-up|16|||
131643696|NCT01256671|473983150|FG000|Overall Study|Withdrawal by Subject|31|||
131643697|NCT01256671|473983150|FG000|Overall Study|Physician Decision|3|||
131643698|NCT01256671|473983150|FG000|Overall Study|Lack of Efficacy|4|||
131643699|NCT01256671|473983150|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
131643700|NCT01986114|473983151|FG000|Overall Study|Adverse Event|59|||
131643701|NCT01986114|473983151|FG000|Overall Study|Lack of Efficacy|23|||
131643702|NCT01986114|473983151|FG000|Overall Study|Withdrawal by Subject|58|||
131643703|NCT01986114|473983151|FG000|Overall Study|Noncompliance|3|||
131643704|NCT01986114|473983151|FG000|Overall Study|Protocol Violation|1|||
131643705|NCT01986114|473983151|FG000|Overall Study|Lost to Follow-up|5|||
131643706|NCT01986114|473983151|FG000|Overall Study|Other reason|7|||
131643707|NCT04009629|473983152|FG000|Overall Study|Withdrawal by Subject|2|||
131643708|NCT04009629|473983153|FG001|Overall Study|Withdrawal by Subject|0|||
131643709|NCT03602586|473983154|FG000|Overall Study|Withdrawal by Subject|3|||
131643710|NCT00030823|473983157|FG000|Overall Study|Withdrawal by Subject|1|||
131643711|NCT00891046|473983162|FG000|Overall Study|Protocol Violation|1|||
131643712|NCT00891046|473983163|FG001|Overall Study|Protocol Violation|1|||
131643713|NCT00891046|473983164|FG002|Overall Study|Protocol Violation|0|||
131643714|NCT00891046|473983165|FG003|Overall Study|Protocol Violation|0|||
131643715|NCT00891046|473983166|FG004|Overall Study|Protocol Violation|1|||
131643716|NCT00891046|473983162|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131643717|NCT00891046|473983163|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131643718|NCT00891046|473983164|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
131643719|NCT00891046|473983165|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131643720|NCT00891046|473983166|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
131643721|NCT00891046|473983162|FG000|Overall Study|Administrative problems|0|||
131643722|NCT00891046|473983163|FG001|Overall Study|Administrative problems|0|||
131643723|NCT00891046|473983164|FG002|Overall Study|Administrative problems|0|||
131643724|NCT00891046|473983165|FG003|Overall Study|Administrative problems|0|||
131643725|NCT00891046|473983166|FG004|Overall Study|Administrative problems|1|||
131643726|NCT00891046|473983162|FG000|Overall Study|Participant no longer required drug|0|||
131643727|NCT00891046|473983163|FG001|Overall Study|Participant no longer required drug|2|||
131643728|NCT00891046|473983164|FG002|Overall Study|Participant no longer required drug|0|||
131643729|NCT00891046|473983165|FG003|Overall Study|Participant no longer required drug|0|||
131643730|NCT00891046|473983166|FG004|Overall Study|Participant no longer required drug|1|||
131643731|NCT00891046|473983162|FG000|Overall Study|Adverse Event|4|||
131643732|NCT00891046|473983163|FG001|Overall Study|Adverse Event|3|||
131643733|NCT00891046|473983164|FG002|Overall Study|Adverse Event|2|||
131643734|NCT00891046|473983165|FG003|Overall Study|Adverse Event|0|||
131643735|NCT00891046|473983166|FG004|Overall Study|Adverse Event|14|||
131643736|NCT00891046|473983162|FG000|Overall Study|Withdrawal by Subject|2|||
131643737|NCT00891046|473983163|FG001|Overall Study|Withdrawal by Subject|1|||
131643738|NCT00891046|473983164|FG002|Overall Study|Withdrawal by Subject|2|||
131643739|NCT00891046|473983165|FG003|Overall Study|Withdrawal by Subject|1|||
131643740|NCT00891046|473983166|FG004|Overall Study|Withdrawal by Subject|1|||
131643741|NCT00891046|473983162|FG000|Overall Study|Lost to Follow-up|0|||
131643742|NCT00891046|473983163|FG001|Overall Study|Lost to Follow-up|0|||
131643743|NCT00891046|473983164|FG002|Overall Study|Lost to Follow-up|0|||
131643744|NCT00891046|473983165|FG003|Overall Study|Lost to Follow-up|0|||
131643745|NCT00891046|473983166|FG004|Overall Study|Lost to Follow-up|1|||
131643746|NCT04523207|473983169|FG000|Overall Study|Adverse Event|5|||
131643747|NCT04523207|473983170|FG001|Overall Study|Adverse Event|1|||
131643748|NCT04523207|473983169|FG000|Overall Study|Lost to Follow-up|2|||
131643749|NCT04523207|473983170|FG001|Overall Study|Lost to Follow-up|0|||
131643750|NCT04523207|473983169|FG000|Overall Study|Withdrawal by Subject|2|||
131643751|NCT04523207|473983170|FG001|Overall Study|Withdrawal by Subject|0|||
131643752|NCT04523207|473983169|FG000|Overall Study|Progressive Disease|2|||
131643753|NCT04523207|473983170|FG001|Overall Study|Progressive Disease|1|||
131643754|NCT04523207|473983169|FG000|Overall Study|Other|7|||
131643755|NCT04523207|473983170|FG001|Overall Study|Other|1|||
131715450|NCT00636818|474235470|FG000|Overall Study|Withdrawal by Subject|4|||
131715451|NCT00074958|474235471|FG000|Overall Study|Adverse Event|1|||
131715452|NCT02115308|474235477|FG000|Overall Study|Safety Screening|2|||
131643756|NCT03113383|473983171|FG000|Overall Study|Death|4|||
131643757|NCT03113383|473983172|FG001|Overall Study|Death|0|||
131643758|NCT03568812|473983174|FG000|Overall Study|Physician Decision|0|||
131643759|NCT03568812|473983175|FG001|Overall Study|Physician Decision|1|||
131643760|NCT00328562|473983178|FG000|Overall Study|Disease progression|1|||
131643761|NCT04014790|473983179|FG000|Overall Study|Death|4|||
131643762|NCT04014790|473983179|FG000|Overall Study|Adverse Event|1|||
131643763|NCT04014790|473983179|FG000|Overall Study|Withdrawal by Subject|1|||
131643764|NCT01519778|473983180|FG000|Overall Study|Withdrawal by Subject|3|||
131715453|NCT02115308|474235478|FG001|Overall Study|Safety Screening|2|||
131445282|NCT02156076|473260353|FG001|Treatment Period|Poor/non-compliance|1|||
131445283|NCT02156076|473260354|FG002|Treatment Period|Poor/non-compliance|0|||
131445284|NCT02156076|473260355|FG003|Treatment Period|Poor/non-compliance|0|||
131643765|NCT01519778|473983180|FG000|Overall Study|Lost to Follow-up|10|||
131643766|NCT01519778|473983180|FG000|Overall Study|Physician Decision|1|||
131643767|NCT02330562|473983181|FG000|Overall Study|Adverse Event|0|||
131643768|NCT02330562|473983182|FG001|Overall Study|Adverse Event|0|||
131643769|NCT02330562|473983183|FG002|Overall Study|Adverse Event|3|||
131643770|NCT02330562|473983184|FG003|Overall Study|Adverse Event|0|||
131643771|NCT02330562|473983185|FG004|Overall Study|Adverse Event|3|||
131643772|NCT02330562|473983186|FG005|Overall Study|Adverse Event|1|||
131643773|NCT02330562|473983187|FG006|Overall Study|Adverse Event|0|||
131643774|NCT02330562|473983188|FG007|Overall Study|Adverse Event|0|||
131643775|NCT02330562|473983189|FG008|Overall Study|Adverse Event|0|||
131643776|NCT02330562|473983190|FG009|Overall Study|Adverse Event|1|||
131643777|NCT02330562|473983191|FG010|Overall Study|Adverse Event|1|||
131643778|NCT02330562|473983181|FG000|Overall Study|Participant decision|1|||
131643779|NCT02330562|473983182|FG001|Overall Study|Participant decision|0|||
131643780|NCT02330562|473983183|FG002|Overall Study|Participant decision|4|||
131643781|NCT02330562|473983184|FG003|Overall Study|Participant decision|1|||
131643782|NCT02330562|473983185|FG004|Overall Study|Participant decision|5|||
131643783|NCT02330562|473983186|FG005|Overall Study|Participant decision|2|||
131643784|NCT02330562|473983187|FG006|Overall Study|Participant decision|0|||
131643785|NCT02330562|473983188|FG007|Overall Study|Participant decision|0|||
131643786|NCT02330562|473983189|FG008|Overall Study|Participant decision|0|||
131643787|NCT02330562|473983190|FG009|Overall Study|Participant decision|3|||
131643788|NCT02330562|473983191|FG010|Overall Study|Participant decision|0|||
131643789|NCT02330562|473983181|FG000|Overall Study|Disease progression|5|||
131643790|NCT02330562|473983182|FG001|Overall Study|Disease progression|3|||
131643791|NCT02330562|473983183|FG002|Overall Study|Disease progression|20|||
131643792|NCT02330562|473983184|FG003|Overall Study|Disease progression|28|||
131643793|NCT02330562|473983185|FG004|Overall Study|Disease progression|23|||
131643794|NCT02330562|473983186|FG005|Overall Study|Disease progression|7|||
131643795|NCT02330562|473983187|FG006|Overall Study|Disease progression|1|||
131643796|NCT02330562|473983188|FG007|Overall Study|Disease progression|1|||
131643797|NCT02330562|473983189|FG008|Overall Study|Disease progression|1|||
131643798|NCT02330562|473983190|FG009|Overall Study|Disease progression|0|||
131643799|NCT02330562|473983191|FG010|Overall Study|Disease progression|5|||
131643800|NCT02330562|473983181|FG000|Overall Study|Other reasons|0|||
131643801|NCT02330562|473983182|FG001|Overall Study|Other reasons|0|||
131643802|NCT02330562|473983183|FG002|Overall Study|Other reasons|0|||
131643803|NCT02330562|473983184|FG003|Overall Study|Other reasons|1|||
131643804|NCT02330562|473983185|FG004|Overall Study|Other reasons|0|||
131643805|NCT02330562|473983186|FG005|Overall Study|Other reasons|0|||
131643806|NCT02330562|473983187|FG006|Overall Study|Other reasons|0|||
131643807|NCT02330562|473983188|FG007|Overall Study|Other reasons|0|||
131643808|NCT02330562|473983189|FG008|Overall Study|Other reasons|0|||
131643809|NCT02330562|473983190|FG009|Overall Study|Other reasons|0|||
131643810|NCT02330562|473983191|FG010|Overall Study|Other reasons|0|||
131643811|NCT02330562|473983181|FG000|Overall Study|Withdrawal by Subject|0|||
131643812|NCT02330562|473983182|FG001|Overall Study|Withdrawal by Subject|0|||
131643813|NCT02330562|473983183|FG002|Overall Study|Withdrawal by Subject|0|||
131643814|NCT02330562|473983184|FG003|Overall Study|Withdrawal by Subject|0|||
131643815|NCT02330562|473983185|FG004|Overall Study|Withdrawal by Subject|0|||
131643816|NCT02330562|473983186|FG005|Overall Study|Withdrawal by Subject|0|||
131643817|NCT02330562|473983187|FG006|Overall Study|Withdrawal by Subject|0|||
131643818|NCT02330562|473983188|FG007|Overall Study|Withdrawal by Subject|0|||
131643819|NCT02330562|473983189|FG008|Overall Study|Withdrawal by Subject|0|||
131643820|NCT02330562|473983190|FG009|Overall Study|Withdrawal by Subject|1|||
131643821|NCT02330562|473983191|FG010|Overall Study|Withdrawal by Subject|0|||
131643822|NCT01657799|473983192|FG000|Overall Study|Adverse Event Related to progression|6|||
131643823|NCT01657799|473983193|FG001|Overall Study|Adverse Event Related to progression|8|||
131643824|NCT01657799|473983194|FG002|Overall Study|Adverse Event Related to progression|12|||
131445285|NCT02156076|473260352|FG000|Treatment Period|Lost to Follow-up|0|||
131445286|NCT02156076|473260353|FG001|Treatment Period|Lost to Follow-up|0|||
131643825|NCT01657799|473983192|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
131643826|NCT01657799|473983193|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
131643827|NCT01657799|473983194|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
131643828|NCT01657799|473983192|FG000|Overall Study|Withdrawal by Subject|13|||
131643829|NCT01657799|473983193|FG001|Overall Study|Withdrawal by Subject|10|||
131643830|NCT01657799|473983194|FG002|Overall Study|Withdrawal by Subject|10|||
131643831|NCT01657799|473983192|FG000|Overall Study|Lost to Follow-up|1|||
131643832|NCT01657799|473983193|FG001|Overall Study|Lost to Follow-up|0|||
131643833|NCT01657799|473983194|FG002|Overall Study|Lost to Follow-up|1|||
131643834|NCT01657799|473983192|FG000|Overall Study|Disease Progression|2|||
131643835|NCT01657799|473983193|FG001|Overall Study|Disease Progression|4|||
131643836|NCT01657799|473983194|FG002|Overall Study|Disease Progression|4|||
131643837|NCT01657799|473983192|FG000|Overall Study|Progressive Disease Clinical|7|||
131643838|NCT01657799|473983193|FG001|Overall Study|Progressive Disease Clinical|4|||
131643839|NCT01657799|473983194|FG002|Overall Study|Progressive Disease Clinical|7|||
131643840|NCT01657799|473983192|FG000|Overall Study|Radiographic & Clinical Progression|16|||
131643841|NCT01657799|473983193|FG001|Overall Study|Radiographic & Clinical Progression|11|||
131643842|NCT01657799|473983194|FG002|Overall Study|Radiographic & Clinical Progression|15|||
131643843|NCT01657799|473983192|FG000|Overall Study|Other|52|||
131643844|NCT01657799|473983193|FG001|Overall Study|Other|62|||
131643845|NCT01657799|473983194|FG002|Overall Study|Other|49|||
131643846|NCT00412880|473983195|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
131643847|NCT00412880|473983195|FG000|Overall Study|Consent withdrawn|1|||
131643848|NCT00412880|473983195|FG000|Overall Study|Adverse Event|1|||
131643849|NCT00412880|473983195|FG000|Overall Study|Progressive disease|20|||
131643850|NCT01496365|473983196|FG000|Overall Study|Adverse Event|2|||
131643851|NCT01496365|473983197|FG001|Overall Study|Adverse Event|3|||
131643852|NCT01496365|473983198|FG002|Overall Study|Adverse Event|3|||
131643853|NCT01496365|473983199|FG003|Overall Study|Adverse Event|2|||
131643854|NCT01496365|473983200|FG004|Overall Study|Adverse Event|5|||
131643855|NCT01496365|473983201|FG005|Overall Study|Adverse Event|6|||
131643856|NCT01496365|473983202|FG006|Overall Study|Adverse Event|4|||
131643857|NCT01496365|473983196|FG000|Overall Study|Withdrawal by Subject|6|||
131643858|NCT01496365|473983197|FG001|Overall Study|Withdrawal by Subject|6|||
131643859|NCT01496365|473983198|FG002|Overall Study|Withdrawal by Subject|0|||
131643860|NCT01496365|473983199|FG003|Overall Study|Withdrawal by Subject|1|||
131643861|NCT01496365|473983200|FG004|Overall Study|Withdrawal by Subject|3|||
131643862|NCT01496365|473983201|FG005|Overall Study|Withdrawal by Subject|2|||
131643863|NCT01496365|473983202|FG006|Overall Study|Withdrawal by Subject|1|||
131643864|NCT01496365|473983196|FG000|Overall Study|Protocol Violation|2|||
131643865|NCT01496365|473983197|FG001|Overall Study|Protocol Violation|1|||
131643866|NCT01496365|473983198|FG002|Overall Study|Protocol Violation|1|||
131643867|NCT01496365|473983199|FG003|Overall Study|Protocol Violation|0|||
131643868|NCT01496365|473983200|FG004|Overall Study|Protocol Violation|0|||
131643869|NCT01496365|473983201|FG005|Overall Study|Protocol Violation|1|||
131643870|NCT01496365|473983202|FG006|Overall Study|Protocol Violation|0|||
131643871|NCT01496365|473983196|FG000|Overall Study|Lack of Efficacy|1|||
131643872|NCT01496365|473983197|FG001|Overall Study|Lack of Efficacy|0|||
131643873|NCT01496365|473983198|FG002|Overall Study|Lack of Efficacy|0|||
131643874|NCT01496365|473983199|FG003|Overall Study|Lack of Efficacy|0|||
131643875|NCT01496365|473983200|FG004|Overall Study|Lack of Efficacy|0|||
131643876|NCT01496365|473983201|FG005|Overall Study|Lack of Efficacy|1|||
131643877|NCT01496365|473983202|FG006|Overall Study|Lack of Efficacy|0|||
131643878|NCT01496365|473983196|FG000|Overall Study|Lost to Follow-up|0|||
131643879|NCT01496365|473983197|FG001|Overall Study|Lost to Follow-up|1|||
131643880|NCT01496365|473983198|FG002|Overall Study|Lost to Follow-up|0|||
131643881|NCT01496365|473983199|FG003|Overall Study|Lost to Follow-up|0|||
131643882|NCT01496365|473983200|FG004|Overall Study|Lost to Follow-up|2|||
131643883|NCT01496365|473983201|FG005|Overall Study|Lost to Follow-up|0|||
131643884|NCT01496365|473983202|FG006|Overall Study|Lost to Follow-up|0|||
131643885|NCT01496365|473983196|FG000|Overall Study|Other|4|||
131643886|NCT01496365|473983197|FG001|Overall Study|Other|4|||
131643887|NCT01496365|473983198|FG002|Overall Study|Other|2|||
131643888|NCT01496365|473983199|FG003|Overall Study|Other|1|||
131643889|NCT01496365|473983200|FG004|Overall Study|Other|3|||
131643890|NCT01496365|473983201|FG005|Overall Study|Other|0|||
131643891|NCT01496365|473983202|FG006|Overall Study|Other|1|||
131643892|NCT01288209|473983203|FG000|Overall Study|Withdrawal by Subject|1|||
131643893|NCT01288209|473983204|FG001|Overall Study|Withdrawal by Subject|3|||
131643894|NCT01288209|473983203|FG000|Overall Study|Other|1|||
131643895|NCT01288209|473983204|FG001|Overall Study|Other|0|||
131643896|NCT01015677|473983206|FG000|Overall Study|Adverse Event|0|||
131643897|NCT01015677|473983207|FG001|Overall Study|Adverse Event|1|||
131643898|NCT01015677|473983208|FG002|Overall Study|Adverse Event|0|||
131643899|NCT01015677|473983206|FG000|Overall Study|Lack of Efficacy|0|||
131643900|NCT01015677|473983207|FG001|Overall Study|Lack of Efficacy|1|||
131643901|NCT01015677|473983208|FG002|Overall Study|Lack of Efficacy|0|||
131643902|NCT01015677|473983206|FG000|Overall Study|Protocol Violation|0|||
131643903|NCT01015677|473983207|FG001|Overall Study|Protocol Violation|1|||
131643904|NCT01015677|473983208|FG002|Overall Study|Protocol Violation|0|||
131643905|NCT01015677|473983206|FG000|Overall Study|Withdrawal by Subject|1|||
131643906|NCT01015677|473983207|FG001|Overall Study|Withdrawal by Subject|1|||
131643907|NCT01015677|473983208|FG002|Overall Study|Withdrawal by Subject|0|||
131643908|NCT02165397|473983210|FG000|Overall Study|Death|7|||
131643909|NCT02165397|473983211|FG001|Overall Study|Death|10|||
131643910|NCT02165397|473983212|FG002|Overall Study|Death|8|||
131715454|NCT01658514|474235486|FG000|Overall Study|Protocol Violation|1|||
131643911|NCT02165397|473983210|FG000|Overall Study|Lost to Follow-up|1|||
131643912|NCT02165397|473983211|FG001|Overall Study|Lost to Follow-up|3|||
131643913|NCT02165397|473983212|FG002|Overall Study|Lost to Follow-up|0|||
131643914|NCT02165397|473983210|FG000|Overall Study|Withdrawal by Subject|6|||
131643915|NCT02165397|473983211|FG001|Overall Study|Withdrawal by Subject|6|||
131643916|NCT02165397|473983212|FG002|Overall Study|Withdrawal by Subject|1|||
131643917|NCT02165397|473983210|FG000|Overall Study|Other, Not Specified|0|||
131643918|NCT02165397|473983211|FG001|Overall Study|Other, Not Specified|0|||
131643919|NCT02165397|473983212|FG002|Overall Study|Other, Not Specified|1|||
131643920|NCT04799418|473983213|FG000|Overall Study|Death|1|||
131643921|NCT04799418|473983214|FG001|Overall Study|Death|1|||
131643922|NCT04799418|473983213|FG000|Overall Study|Lack of Efficacy|14|||
131643923|NCT04799418|473983214|FG001|Overall Study|Lack of Efficacy|14|||
131643924|NCT04799418|473983213|FG000|Overall Study|Withdrawal by Subject|10|||
131643925|NCT04799418|473983214|FG001|Overall Study|Withdrawal by Subject|7|||
131643926|NCT04799418|473983213|FG000|Overall Study|Adverse Event|3|||
131643927|NCT04799418|473983214|FG001|Overall Study|Adverse Event|2|||
131643928|NCT03297398|473983215|FG000|Overall Study|Sponsor's decision|6|||
131643929|NCT03297398|473983216|FG001|Overall Study|Sponsor's decision|9|||
131643930|NCT03297398|473983217|FG002|Overall Study|Sponsor's decision|7|||
131643931|NCT03297398|473983215|FG000|Overall Study|Adverse Event|1|||
131643932|NCT03297398|473983216|FG001|Overall Study|Adverse Event|4|||
131643933|NCT03297398|473983217|FG002|Overall Study|Adverse Event|4|||
131643934|NCT03297398|473983215|FG000|Overall Study|Withdrawal by Subject|1|||
131643935|NCT03297398|473983216|FG001|Overall Study|Withdrawal by Subject|2|||
131643936|NCT03297398|473983217|FG002|Overall Study|Withdrawal by Subject|2|||
131643937|NCT03297398|473983215|FG000|Overall Study|Protocol Violation|0|||
131643938|NCT03297398|473983216|FG001|Overall Study|Protocol Violation|2|||
131643939|NCT03297398|473983217|FG002|Overall Study|Protocol Violation|0|||
131643940|NCT03297398|473983215|FG000|Overall Study|Physician Decision|0|||
131643941|NCT03297398|473983216|FG001|Overall Study|Physician Decision|0|||
131643942|NCT03297398|473983217|FG002|Overall Study|Physician Decision|1|||
131643943|NCT03297398|473983215|FG000|Overall Study|Lost to Follow-up|0|||
131643944|NCT03297398|473983216|FG001|Overall Study|Lost to Follow-up|0|||
131643945|NCT03297398|473983217|FG002|Overall Study|Lost to Follow-up|1|||
131643946|NCT00236184|473983222|FG000|Overall Study|Adverse Event|5|||
131643947|NCT00236184|473983223|FG001|Overall Study|Adverse Event|2|||
131643948|NCT00236184|473983222|FG000|Overall Study|Lack of Efficacy|0|||
131643949|NCT00236184|473983223|FG001|Overall Study|Lack of Efficacy|1|||
131643950|NCT00236184|473983222|FG000|Overall Study|Lost to Follow-up|3|||
131643951|NCT00236184|473983223|FG001|Overall Study|Lost to Follow-up|4|||
131643952|NCT00236184|473983222|FG000|Overall Study|Physician Decision|1|||
131643953|NCT00236184|473983223|FG001|Overall Study|Physician Decision|1|||
131643954|NCT00236184|473983222|FG000|Overall Study|Withdrawal by Subject|3|||
131643955|NCT00236184|473983223|FG001|Overall Study|Withdrawal by Subject|0|||
131643956|NCT00236184|473983222|FG000|Overall Study|Protocol Violation|3|||
131643957|NCT00236184|473983223|FG001|Overall Study|Protocol Violation|0|||
131643958|NCT00236184|473983222|FG000|Overall Study|non-compliance with study drug|2|||
131643959|NCT00236184|473983223|FG001|Overall Study|non-compliance with study drug|1|||
131643960|NCT00236184|473983222|FG000|Overall Study|other|1|||
131643961|NCT00236184|473983223|FG001|Overall Study|other|2|||
131643962|NCT02312206|473983224|FG000|Overall Study|Adverse Event|3|||
131643963|NCT02312206|473983225|FG001|Overall Study|Adverse Event|6|||
131643964|NCT02312206|473983224|FG000|Overall Study|Withdrawal by Subject|6|||
131643965|NCT02312206|473983225|FG001|Overall Study|Withdrawal by Subject|6|||
131643966|NCT02312206|473983224|FG000|Overall Study|Physician Decision|7|||
131643967|NCT02312206|473983225|FG001|Overall Study|Physician Decision|6|||
131643968|NCT02312206|473983224|FG000|Overall Study|Death|31|||
131643969|NCT02312206|473983225|FG001|Overall Study|Death|36|||
131643970|NCT02312206|473983224|FG000|Overall Study|Study Terminated by Sponsor|81|||
131643971|NCT02312206|473983225|FG001|Overall Study|Study Terminated by Sponsor|74|||
131643972|NCT02312206|473983224|FG000|Overall Study|Patient transferred to hospice|0|||
131643973|NCT02312206|473983225|FG001|Overall Study|Patient transferred to hospice|1|||
131643974|NCT02312206|473983224|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
131643975|NCT02312206|473983225|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
131643976|NCT02312206|473983224|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
131643977|NCT02312206|473983225|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
131643978|NCT02312206|473983224|FG000|Overall Study|Disease Progression|1|||
131643979|NCT02312206|473983225|FG001|Overall Study|Disease Progression|0|||
131643980|NCT03082612|473983226|FG000|Overall Study|Lost to Follow-up|2|||
131643981|NCT03082612|473983227|FG001|Overall Study|Lost to Follow-up|0|||
131643982|NCT00992992|473983233|FG000|Overall Study|Lost to Follow-up|3|||
131643983|NCT00992992|473983233|FG000|Overall Study|Death|16|||
131643984|NCT00992992|473983233|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
131643985|NCT00992992|473983233|FG000|Overall Study|Sponsor Closed the Study|4|||
131643986|NCT00239681|473983234|FG000|Overall Study|Adverse Event|100|||
131643987|NCT00239681|473983235|FG001|Overall Study|Adverse Event|99|||
131643988|NCT00239681|473983234|FG000|Overall Study|Withdrawal by Subject|458|||
131643989|NCT00239681|473983235|FG001|Overall Study|Withdrawal by Subject|489|||
131643990|NCT00239681|473983234|FG000|Overall Study|Lost to Follow-up|28|||
131643991|NCT00239681|473983235|FG001|Overall Study|Lost to Follow-up|22|||
131643992|NCT00239681|473983234|FG000|Overall Study|Protocol Violation|4|||
131643993|NCT00239681|473983235|FG001|Overall Study|Protocol Violation|4|||
131643994|NCT00239681|473983234|FG000|Overall Study|Physician Decision|13|||
131643995|NCT00239681|473983235|FG001|Overall Study|Physician Decision|17|||
131643996|NCT00239681|473983234|FG000|Overall Study|No information chacked on CaseReportForm|90|||
131643997|NCT00239681|473983235|FG001|Overall Study|No information chacked on CaseReportForm|84|||
131643998|NCT02447718|473983236|FG000|Overall Study|Lost to Follow-up|8|||
131643999|NCT02447718|473983237|FG001|Overall Study|Lost to Follow-up|0|||
131903019|NCT00676403|474931364|FG000|Overall Study|Reason Unspecified|1|||
131644000|NCT02447718|473983236|FG000|Overall Study|Withdrawal by Subject|3|||
131644001|NCT02447718|473983237|FG001|Overall Study|Withdrawal by Subject|0|||
131644002|NCT02447718|473983236|FG000|Overall Study|Screen Failure|1|||
131644003|NCT02447718|473983237|FG001|Overall Study|Screen Failure|0|||
131644004|NCT01278615|473983240|FG000|Overall Study|Withdrawal by Subject|2|||
131644005|NCT00905359|473983241|FG000|Overall Study|Lost to Follow-up|17|||
131644006|NCT00905359|473983242|FG001|Overall Study|Lost to Follow-up|10|||
131644007|NCT00905359|473983241|FG000|Overall Study|Death|2|||
131644008|NCT00905359|473983242|FG001|Overall Study|Death|0|||
131644009|NCT00905359|473983241|FG000|Overall Study|Withdrawal consent|5|||
131644010|NCT00905359|473983242|FG001|Overall Study|Withdrawal consent|6|||
131644011|NCT02138253|473983243|FG000|Overall Study|Adverse Event|3|||
131644012|NCT02138253|473983244|FG001|Overall Study|Adverse Event|3|||
131644013|NCT02138253|473983243|FG000|Overall Study|Lost to Follow-up|2|||
131644014|NCT02138253|473983244|FG001|Overall Study|Lost to Follow-up|1|||
131644015|NCT02138253|473983243|FG000|Overall Study|Physician Decision|2|||
131644016|NCT02138253|473983244|FG001|Overall Study|Physician Decision|0|||
131644017|NCT02138253|473983243|FG000|Overall Study|Non compliance|1|||
131644018|NCT02138253|473983244|FG001|Overall Study|Non compliance|0|||
131644019|NCT02138253|473983243|FG000|Overall Study|Withdrawal by Subject|1|||
131644020|NCT02138253|473983244|FG001|Overall Study|Withdrawal by Subject|0|||
131644021|NCT02654132|473983245|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
131644022|NCT02654132|473983246|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
131644023|NCT02654132|473983245|FG000|Treatment Period|Disease progression|43|||
131644024|NCT02654132|473983246|FG001|Treatment Period|Disease progression|38|||
131644025|NCT02654132|473983245|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
131644026|NCT02654132|473983246|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
131644027|NCT02654132|473983245|FG000|Treatment Period|Other reasons|4|||
131644028|NCT02654132|473983246|FG001|Treatment Period|Other reasons|2|||
131644029|NCT02654132|473983245|FG000|Treatment Period|Study drug toxicity|2|||
131644030|NCT02654132|473983246|FG001|Treatment Period|Study drug toxicity|2|||
131644031|NCT02654132|473983245|FG000|Treatment Period|Withdrawal by Subject|2|||
131644032|NCT02654132|473983246|FG001|Treatment Period|Withdrawal by Subject|1|||
131644033|NCT02654132|473983245|FG000|Treatment Period|Maximum Clinical Benefit|0|||
131644034|NCT02654132|473983246|FG001|Treatment Period|Maximum Clinical Benefit|2|||
131644035|NCT02654132|473983245|FG000|Treatment Period|Participant request to discontinue|2|||
131644036|NCT02654132|473983246|FG001|Treatment Period|Participant request to discontinue|0|||
131644037|NCT02654132|473983245|FG000|Treatment Period|Administrative reasons by sponsor|0|||
131644038|NCT02654132|473983246|FG001|Treatment Period|Administrative reasons by sponsor|1|||
131644039|NCT02654132|473983245|FG000|Treatment Period|Death|1|||
131644040|NCT02654132|473983246|FG001|Treatment Period|Death|0|||
131644041|NCT00823836|473983249|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
131644042|NCT00823836|473983250|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
131644043|NCT00823836|473983249|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
131644044|NCT00823836|473983250|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
131644045|NCT00823836|473983249|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
131644046|NCT00823836|473983250|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
131644047|NCT00823836|473983249|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
131644048|NCT00823836|473983250|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
131644049|NCT00823836|473983249|FG000|Long-term Phase|Adverse Event|3|||
131644050|NCT00823836|473983250|FG001|Long-term Phase|Adverse Event|2|||
131644051|NCT00823836|473983249|FG000|Long-term Phase|Physician Decision|1|||
131903020|NCT00676403|474931365|FG001|Overall Study|Reason Unspecified|0|||
131644052|NCT00823836|473983250|FG001|Long-term Phase|Physician Decision|2|||
131644053|NCT00823836|473983249|FG000|Long-term Phase|Withdrawal by Subject|1|||
131644054|NCT00823836|473983250|FG001|Long-term Phase|Withdrawal by Subject|1|||
131644055|NCT01880437|473983251|FG000|Overall Study|Death|12|||
131644056|NCT01880437|473983252|FG001|Overall Study|Death|4|||
131715455|NCT01658514|474235487|FG001|Overall Study|Protocol Violation|0|||
131715456|NCT01658514|474235488|FG002|Overall Study|Protocol Violation|2|||
131903021|NCT00676403|474931366|FG002|Overall Study|Reason Unspecified|1|||
131644057|NCT01880437|473983253|FG002|Overall Study|Death|17|||
131644058|NCT01880437|473983251|FG000|Overall Study|Study terminated by Sponsor|3|||
131644059|NCT01880437|473983252|FG001|Overall Study|Study terminated by Sponsor|0|||
131644060|NCT01880437|473983253|FG002|Overall Study|Study terminated by Sponsor|2|||
131644061|NCT02725528|473983258|FG000|Overall Study|Lost to Follow-up|1|||
131644062|NCT02725528|473983259|FG001|Overall Study|Lost to Follow-up|4|||
131644063|NCT02725528|473983258|FG000|Overall Study|Withdrawal by Subject|0|||
131644064|NCT02725528|473983259|FG001|Overall Study|Withdrawal by Subject|1|||
131644065|NCT04354168|473983262|FG000|Overall Study|Lost to Follow-up|22|||
131644066|NCT01781832|473983263|FG000|Overall Study|Withdrawal by Subject|1|||
131644067|NCT02719743|473983264|FG000|Overall Study|Consent withdrawal|0|||
131644068|NCT02719743|473983265|FG001|Overall Study|Consent withdrawal|2|||
131644069|NCT02719743|473983266|FG002|Overall Study|Consent withdrawal|0|||
131644070|NCT02719743|473983267|FG003|Overall Study|Consent withdrawal|1|||
131644071|NCT02719743|473983268|FG004|Overall Study|Consent withdrawal|0|||
131644072|NCT02719743|473983264|FG000|Overall Study|Migrated/moved from study area|0|||
131644073|NCT02719743|473983265|FG001|Overall Study|Migrated/moved from study area|0|||
131644074|NCT02719743|473983266|FG002|Overall Study|Migrated/moved from study area|0|||
131644075|NCT02719743|473983267|FG003|Overall Study|Migrated/moved from study area|0|||
131644076|NCT02719743|473983268|FG004|Overall Study|Migrated/moved from study area|2|||
131644077|NCT02719743|473983264|FG000|Overall Study|Lost to Follow-up|1|||
131644078|NCT02719743|473983265|FG001|Overall Study|Lost to Follow-up|1|||
131644079|NCT02719743|473983266|FG002|Overall Study|Lost to Follow-up|0|||
131644080|NCT02719743|473983267|FG003|Overall Study|Lost to Follow-up|0|||
131644081|NCT02719743|473983268|FG004|Overall Study|Lost to Follow-up|0|||
131644082|NCT01209598|473983271|FG000|Overall Study|Withdrawal by Subject|1|||
131644083|NCT01209598|473983272|FG001|Overall Study|Withdrawal by Subject|0|||
131644084|NCT02601209|473983273|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
131644085|NCT02601209|473983274|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
131445287|NCT02156076|473260354|FG002|Treatment Period|Lost to Follow-up|0|||
131445288|NCT02156076|473260355|FG003|Treatment Period|Lost to Follow-up|1|||
131644086|NCT02601209|473983275|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
131644087|NCT02601209|473983276|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131644088|NCT02601209|473983277|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131644089|NCT02601209|473983278|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131644090|NCT02601209|473983279|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131644091|NCT02601209|473983280|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131644092|NCT02601209|473983281|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131644093|NCT02601209|473983273|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131644094|NCT02601209|473983274|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131644095|NCT02601209|473983275|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131644096|NCT02601209|473983276|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131644097|NCT02601209|473983277|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
131644098|NCT02601209|473983278|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
131644099|NCT02601209|473983279|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
131644100|NCT02601209|473983280|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131644101|NCT02601209|473983281|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131644102|NCT02062645|473983284|FG000|Overall Study|Adverse Event|2|||
131644103|NCT02062645|473983284|FG000|Overall Study|Protocol Violation|8|||
131644104|NCT02062645|473983284|FG000|Overall Study|Lost to Follow-up|5|||
131644105|NCT02804399|473983285|FG000|Period 2|Adverse Event|0|||
131644106|NCT02804399|473983286|FG001|Period 2|Adverse Event|1|||
131644107|NCT03636373|473983287|FG000|Overall Study|Study closure due to Covid-19|1|||
131644108|NCT03636373|473983288|FG001|Overall Study|Study closure due to Covid-19|0|||
131644109|NCT00572533|473983289|FG000|Overall Study|Death|4|||
131644110|NCT00572533|473983290|FG001|Overall Study|Death|1|||
131644111|NCT00572533|473983289|FG000|Overall Study|Received Kidney Transplant|2|||
131644112|NCT00572533|473983290|FG001|Overall Study|Received Kidney Transplant|1|||
131644113|NCT00572533|473983289|FG000|Overall Study|Social Issues|1|||
131644114|NCT00572533|473983290|FG001|Overall Study|Social Issues|0|||
131644115|NCT00572533|473983289|FG000|Overall Study|Transfer out of Facility|0|||
131644116|NCT00572533|473983290|FG001|Overall Study|Transfer out of Facility|1|||
131644117|NCT00798304|473983291|FG000|Overall Study|Adverse Event|0|||
131644118|NCT00798304|473983292|FG001|Overall Study|Adverse Event|1|||
131715457|NCT02344576|474235492|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
131715458|NCT02344576|474235493|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
131644119|NCT00798304|473983293|FG002|Overall Study|Adverse Event|1|||
131644120|NCT00798304|473983291|FG000|Overall Study|Discontinuation by Sponsor|14|||
131644121|NCT00798304|473983292|FG001|Overall Study|Discontinuation by Sponsor|21|||
131644122|NCT00798304|473983293|FG002|Overall Study|Discontinuation by Sponsor|9|||
131715459|NCT02344576|474235494|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
131644123|NCT04211389|473983294|FG000|Overall Study|Adverse Event|1|||
131644124|NCT04211389|473983295|FG001|Overall Study|Adverse Event|2|||
131644125|NCT04211389|473983294|FG000|Overall Study|Lost to Follow-up|15|||
131644126|NCT04211389|473983295|FG001|Overall Study|Lost to Follow-up|7|||
131644127|NCT04211389|473983294|FG000|Overall Study|Protocol Violation|0|||
131644128|NCT04211389|473983295|FG001|Overall Study|Protocol Violation|1|||
131644129|NCT04211389|473983294|FG000|Overall Study|Withdrawal by Subject|10|||
131644130|NCT04211389|473983295|FG001|Overall Study|Withdrawal by Subject|11|||
131644131|NCT01062971|473983304|FG000|Overall Study|Protocol Violation|1|||
131644132|NCT01062971|473983305|FG001|Overall Study|Protocol Violation|3|||
131644133|NCT01062971|473983304|FG000|Overall Study|Lost to Follow-up|3|||
131644134|NCT01062971|473983305|FG001|Overall Study|Lost to Follow-up|4|||
131644135|NCT01530087|473983306|FG000|Overall Study|Physician Decision|2|||
131644136|NCT05523219|473983307|FG000|Overall Study|Wrong inclusion|1|||
131644137|NCT05523219|473983307|FG000|Overall Study|Lost to Follow-up|7|||
131644138|NCT01161628|473983308|FG000|Overall Study|Death|6|||
131644139|NCT01161628|473983308|FG000|Overall Study|Lack of Efficacy|2|||
131644140|NCT03614676|473985322|FG000|Overall Study|Delivery before planned visit|2|||
131644141|NCT03614676|473985323|FG001|Overall Study|Delivery before planned visit|0|||
131644142|NCT03614676|473985322|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
131644143|NCT03614676|473985323|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
131644144|NCT03614676|473985322|FG000|Overall Study|Migrated / moved from the study area|30|||
131644145|NCT03614676|473985323|FG001|Overall Study|Migrated / moved from the study area|22|||
131644146|NCT03614676|473985322|FG000|Overall Study|Lost to Follow-up|17|||
131644147|NCT03614676|473985323|FG001|Overall Study|Lost to Follow-up|42|||
131644148|NCT03614676|473985322|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
131644149|NCT03614676|473985323|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
131644150|NCT03614676|473985322|FG000|Overall Study|Other|16|||
131644151|NCT03614676|473985323|FG001|Overall Study|Other|47|||
131644152|NCT03614676|473985322|FG000|Overall Study|Protocol Violation|0|||
131644153|NCT03614676|473985323|FG001|Overall Study|Protocol Violation|2|||
131644154|NCT03614676|473985322|FG000|Overall Study|Neonatal event of interest|0|||
131644155|NCT03614676|473985323|FG001|Overall Study|Neonatal event of interest|6|||
131644156|NCT03614676|473985322|FG000|Overall Study|Death in infant greater than 28 days old|0|||
131644157|NCT03614676|473985323|FG001|Overall Study|Death in infant greater than 28 days old|12|||
131644158|NCT03614676|473985322|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
131644159|NCT03614676|473985323|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
131644160|NCT04398368|473985327|FG000|Overall Study|Withdrawal by Subject|2|||
131644161|NCT02166476|473985334|FG000|Overall Study|Withdrawal by Subject|5|||
131644162|NCT02166476|473985335|FG001|Overall Study|Withdrawal by Subject|7|||
131644163|NCT02166476|473985334|FG000|Overall Study|Adverse Event|3|||
131644164|NCT02166476|473985335|FG001|Overall Study|Adverse Event|3|||
131644165|NCT02166476|473985334|FG000|Overall Study|Lost to Follow-up|5|||
131644166|NCT02166476|473985335|FG001|Overall Study|Lost to Follow-up|10|||
131644167|NCT02166476|473985334|FG000|Overall Study|Physician Decision|1|||
131644168|NCT02166476|473985335|FG001|Overall Study|Physician Decision|0|||
131644169|NCT02166476|473985334|FG000|Overall Study|Unable to Come for Visit|0|||
131644170|NCT02166476|473985335|FG001|Overall Study|Unable to Come for Visit|3|||
131715460|NCT02344576|474235495|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
131715461|NCT02344576|474235492|FG000|1-Month Follow-Up|Death|13|||
131715462|NCT02344576|474235493|FG001|1-Month Follow-Up|Death|8|||
131715463|NCT02344576|474235494|FG002|1-Month Follow-Up|Death|0|||
131644171|NCT02053610|473985339|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
131644172|NCT02053610|473985340|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
131644173|NCT02053610|473985339|FG000|Overall Study|Withdrew Consent|2|||
131644174|NCT02053610|473985340|FG001|Overall Study|Withdrew Consent|9|||
131715464|NCT02344576|474235495|FG003|1-Month Follow-Up|Death|0|||
131715465|NCT02344576|474235492|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
131715466|NCT02344576|474235493|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
131715467|NCT02344576|474235494|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
131715468|NCT02344576|474235495|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
131903022|NCT00676403|474931367|FG003|Overall Study|Reason Unspecified|0|||
131644175|NCT02053610|473985339|FG000|Overall Study|Death|5|||
131715469|NCT02344576|474235492|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
131715470|NCT02344576|474235493|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
131644176|NCT02053610|473985340|FG001|Overall Study|Death|5|||
131715471|NCT02344576|474235494|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
131644177|NCT02053610|473985339|FG000|Overall Study|Administrative/Other|1|||
131644178|NCT02053610|473985340|FG001|Overall Study|Administrative/Other|1|||
131715472|NCT02344576|474235495|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
131715473|NCT02344576|474235492|FG000|6-Month Follow-Up|Death|14|||
131644179|NCT02053610|473985339|FG000|Overall Study|Disease Progression|2|||
131644180|NCT02053610|473985340|FG001|Overall Study|Disease Progression|3|||
131445289|NCT02156076|473260352|FG000|Treatment Period|Withdrawal by Subject|0|||
131445290|NCT02156076|473260353|FG001|Treatment Period|Withdrawal by Subject|0|||
131445291|NCT02156076|473260354|FG002|Treatment Period|Withdrawal by Subject|1|||
131445292|NCT02156076|473260355|FG003|Treatment Period|Withdrawal by Subject|0|||
131445293|NCT02156076|473260352|FG000|Treatment Period|Subject request to discontinue treatment|0|||
131445294|NCT02156076|473260353|FG001|Treatment Period|Subject request to discontinue treatment|1|||
131445295|NCT02156076|473260354|FG002|Treatment Period|Subject request to discontinue treatment|0|||
131445296|NCT02156076|473260355|FG003|Treatment Period|Subject request to discontinue treatment|0|||
131445297|NCT02156076|473260352|FG000|Treatment Period|Adverse Event|0|||
131445298|NCT02156076|473260353|FG001|Treatment Period|Adverse Event|0|||
131445299|NCT02156076|473260354|FG002|Treatment Period|Adverse Event|0|||
131644181|NCT02053610|473985339|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
131644182|NCT02053610|473985340|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
131445300|NCT02156076|473260355|FG003|Treatment Period|Adverse Event|1|||
131445301|NCT02156076|473260352|FG000|Follow-up Period|Withdrawal by Subject|1|||
131445302|NCT02156076|473260353|FG001|Follow-up Period|Withdrawal by Subject|0|||
131445303|NCT02156076|473260354|FG002|Follow-up Period|Withdrawal by Subject|0|||
131445304|NCT02156076|473260355|FG003|Follow-up Period|Withdrawal by Subject|0|||
131644183|NCT02053610|473985339|FG000|Overall Study|Did not Receive Treatment|4|||
131644184|NCT02053610|473985340|FG001|Overall Study|Did not Receive Treatment|2|||
131644185|NCT02053610|473985339|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131644186|NCT02053610|473985340|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131644187|NCT02053610|473985339|FG000|Overall Study|Violation of Selection Criteria|1|||
131644188|NCT02053610|473985340|FG001|Overall Study|Violation of Selection Criteria|0|||
131644189|NCT00543062|473985344|FG000|Overall Study|Withdrawal by Subject|1|||
131644190|NCT00543062|473985345|FG001|Overall Study|Withdrawal by Subject|0|||
131644191|NCT00543062|473985346|FG002|Overall Study|Withdrawal by Subject|2|||
131445305|NCT04225897|473260361|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445306|NCT04225897|473260362|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
131445307|NCT04225897|473260363|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445308|NCT04225897|473260364|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445309|NCT04225897|473260365|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445310|NCT04225897|473260366|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445311|NCT04225897|473260367|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445312|NCT04225897|473260368|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445313|NCT04225897|473260369|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445314|NCT04225897|473260370|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445315|NCT04225897|473260371|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445316|NCT04225897|473260372|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
131445317|NCT04225897|473260361|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445318|NCT04225897|473260362|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445319|NCT04225897|473260363|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
131445320|NCT04225897|473260364|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445321|NCT04225897|473260365|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445322|NCT04225897|473260366|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131644192|NCT00543062|473985347|FG003|Overall Study|Withdrawal by Subject|0|||
131644193|NCT00543062|473985344|FG000|Overall Study|Adverse Event|0|||
131644194|NCT00543062|473985345|FG001|Overall Study|Adverse Event|1|||
131644195|NCT00543062|473985346|FG002|Overall Study|Adverse Event|1|||
131644196|NCT00543062|473985347|FG003|Overall Study|Adverse Event|1|||
131644197|NCT00543062|473985344|FG000|Overall Study|Protocol Violation|1|||
131644198|NCT00543062|473985345|FG001|Overall Study|Protocol Violation|0|||
131644199|NCT00543062|473985346|FG002|Overall Study|Protocol Violation|0|||
131644200|NCT00543062|473985347|FG003|Overall Study|Protocol Violation|0|||
131644201|NCT03021551|473985352|FG000|Overall Study|Equipment Issues|2|||
131644202|NCT03021551|473985352|FG000|Overall Study|Protocol Violation|1|||
131644203|NCT02232399|473985353|FG000|Overall Study|Adverse Event|1|||
131445323|NCT04225897|473260367|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445324|NCT04225897|473260368|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445325|NCT04225897|473260369|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445326|NCT04225897|473260370|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131644204|NCT02232399|473985354|FG001|Overall Study|Adverse Event|0|||
131644205|NCT02232399|473985353|FG000|Overall Study|Withdrawal by Subject|0|||
131715474|NCT02344576|474235493|FG001|6-Month Follow-Up|Death|14|||
131715475|NCT02344576|474235494|FG002|6-Month Follow-Up|Death|0|||
131715476|NCT02344576|474235495|FG003|6-Month Follow-Up|Death|0|||
131715477|NCT02344576|474235492|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
131445327|NCT04225897|473260371|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445328|NCT04225897|473260372|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
131445329|NCT04225897|473260361|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445330|NCT04225897|473260362|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131715478|NCT02344576|474235493|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
131644206|NCT02232399|473985354|FG001|Overall Study|Withdrawal by Subject|1|||
131644207|NCT01646385|473985358|FG000|Overall Study|Death|202|||
131644208|NCT01646385|473985359|FG001|Overall Study|Death|222|||
131644209|NCT01646385|473985358|FG000|Overall Study|Switched to alternate biologic|636|||
131644210|NCT01646385|473985359|FG001|Overall Study|Switched to alternate biologic|649|||
131644211|NCT01843777|473985360|FG000|Overall Study|Withdrawal by Subject|1|||
131644212|NCT01843777|473985361|FG001|Overall Study|Withdrawal by Subject|0|||
131644213|NCT01777334|473985365|FG000|Overall Study|Adverse Event|18|||
131644214|NCT01777334|473985366|FG001|Overall Study|Adverse Event|14|||
131644215|NCT01777334|473985365|FG000|Overall Study|Lack of Efficacy|15|||
131644216|NCT01777334|473985366|FG001|Overall Study|Lack of Efficacy|29|||
131644217|NCT01777334|473985365|FG000|Overall Study|Protocol Violation|3|||
131644218|NCT01777334|473985366|FG001|Overall Study|Protocol Violation|7|||
131644219|NCT01777334|473985365|FG000|Overall Study|Lost to Follow-up|3|||
131644220|NCT01777334|473985366|FG001|Overall Study|Lost to Follow-up|2|||
131644221|NCT01777334|473985365|FG000|Overall Study|Withdrawal by Subject|14|||
131644222|NCT01777334|473985366|FG001|Overall Study|Withdrawal by Subject|11|||
131644223|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
131644224|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
131644225|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
131644226|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
131644227|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
131644228|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
131644229|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
131644230|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
131644231|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
131644232|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
131644233|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
131644234|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
131644235|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
131644236|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
131644237|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
131644238|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
131644239|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
131644240|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
131644241|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
131644242|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
131644243|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
131644244|NCT04599855|473985373|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
131644245|NCT04599855|473985374|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
131644246|NCT04599855|473985375|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
131644247|NCT04599855|473985373|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
131644248|NCT04599855|473985374|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
131644249|NCT04599855|473985375|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
131644250|NCT04599855|473985373|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
131644251|NCT04599855|473985374|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
131644252|NCT04599855|473985375|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
131644253|NCT04599855|473985373|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
131644254|NCT04599855|473985374|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
131715479|NCT02344576|474235494|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
131715480|NCT02344576|474235495|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
131715481|NCT02344576|474235492|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
131715482|NCT02344576|474235493|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
131715483|NCT02344576|474235494|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
131644255|NCT04599855|473985375|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
131644256|NCT04599855|473985373|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
131644257|NCT04599855|473985374|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
131644258|NCT04599855|473985375|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
131644259|NCT04599855|473985373|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
131644260|NCT04599855|473985374|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
131644261|NCT04599855|473985375|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
131644262|NCT04599855|473985373|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
131644263|NCT04599855|473985374|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
131644264|NCT04599855|473985375|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
131644265|NCT02250534|473985382|FG000|Overall Study|Lost to Follow-up|18|||
131644266|NCT02250534|473985383|FG001|Overall Study|Lost to Follow-up|28|||
131644267|NCT02250534|473985384|FG002|Overall Study|Lost to Follow-up|33|||
131644268|NCT02250534|473985382|FG000|Overall Study|Personal reasons|7|||
131644269|NCT02250534|473985383|FG001|Overall Study|Personal reasons|8|||
131644270|NCT02250534|473985384|FG002|Overall Study|Personal reasons|14|||
131644271|NCT02250534|473985382|FG000|Overall Study|Adverse Event|6|||
131644272|NCT02250534|473985383|FG001|Overall Study|Adverse Event|3|||
131644273|NCT02250534|473985384|FG002|Overall Study|Adverse Event|8|||
131644274|NCT02250534|473985382|FG000|Overall Study|incarcerated|2|||
131644275|NCT02250534|473985383|FG001|Overall Study|incarcerated|1|||
131644276|NCT02250534|473985384|FG002|Overall Study|incarcerated|2|||
131644277|NCT02250534|473985382|FG000|Overall Study|Withdrawal by Subject|0|||
131644278|NCT02250534|473985383|FG001|Overall Study|Withdrawal by Subject|1|||
131644279|NCT02250534|473985384|FG002|Overall Study|Withdrawal by Subject|2|||
131644280|NCT02250534|473985382|FG000|Overall Study|Death|0|||
131644281|NCT02250534|473985383|FG001|Overall Study|Death|1|||
131644282|NCT02250534|473985384|FG002|Overall Study|Death|1|||
131644283|NCT02250534|473985382|FG000|Overall Study|Physician Decision|1|||
131644284|NCT02250534|473985383|FG001|Overall Study|Physician Decision|3|||
131644285|NCT02250534|473985384|FG002|Overall Study|Physician Decision|1|||
131644286|NCT02250534|473985382|FG000|Overall Study|Protocol Violation|1|||
131644287|NCT02250534|473985383|FG001|Overall Study|Protocol Violation|0|||
131644288|NCT02250534|473985384|FG002|Overall Study|Protocol Violation|1|||
131644289|NCT02250534|473985382|FG000|Overall Study|Reason unknown|1|||
131644290|NCT02250534|473985383|FG001|Overall Study|Reason unknown|0|||
131644291|NCT02250534|473985384|FG002|Overall Study|Reason unknown|0|||
131644292|NCT00217022|473985385|FG000|Overall Study|Withdrawal by Subject|1|||
131644293|NCT00217022|473985386|FG001|Overall Study|Withdrawal by Subject|1|||
131644294|NCT01182181|473985387|FG000|First Intervention|Adverse Event|1|||
131644295|NCT01182181|473985388|FG001|First Intervention|Adverse Event|0|||
131644296|NCT01182181|473985387|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
131644297|NCT01182181|473985388|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
131644298|NCT03845075|473985389|FG000|Part 1 - DB|Withdrawal by Subject|1|||
131644299|NCT03845075|473985390|FG001|Part 1 - DB|Withdrawal by Subject|1|||
131644300|NCT03845075|473985391|FG002|Part 1 - DB|Withdrawal by Subject|0|||
131644301|NCT03845075|473985392|FG003|Part 1 - DB|Withdrawal by Subject|0|||
131644302|NCT03845075|473985389|FG000|Part 1 - DB|Adverse Event|0|||
131644303|NCT03845075|473985390|FG001|Part 1 - DB|Adverse Event|1|||
131644304|NCT03845075|473985391|FG002|Part 1 - DB|Adverse Event|0|||
131644305|NCT03845075|473985392|FG003|Part 1 - DB|Adverse Event|0|||
131644306|NCT03845075|473985389|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
131644307|NCT03845075|473985390|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
131644308|NCT03845075|473985391|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
131644309|NCT03845075|473985392|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
131644310|NCT03856047|473985393|FG000|Overall Study|Withdrawal by Subject|0|||
131644311|NCT03856047|473985394|FG001|Overall Study|Withdrawal by Subject|1|||
131644312|NCT03856047|473985395|FG002|Overall Study|Withdrawal by Subject|1|||
131644313|NCT03856047|473985396|FG003|Overall Study|Withdrawal by Subject|0|||
131644314|NCT03856047|473985397|FG004|Overall Study|Withdrawal by Subject|3|||
131644315|NCT03856047|473985398|FG005|Overall Study|Withdrawal by Subject|0|||
131644316|NCT03856047|473985399|FG006|Overall Study|Withdrawal by Subject|2|||
131644317|NCT03856047|473985393|FG000|Overall Study|Lost to Follow-up|4|||
131644318|NCT03856047|473985394|FG001|Overall Study|Lost to Follow-up|2|||
131644319|NCT03856047|473985395|FG002|Overall Study|Lost to Follow-up|3|||
131644320|NCT03856047|473985396|FG003|Overall Study|Lost to Follow-up|1|||
131644321|NCT03856047|473985397|FG004|Overall Study|Lost to Follow-up|4|||
131644322|NCT03856047|473985398|FG005|Overall Study|Lost to Follow-up|4|||
131644323|NCT03856047|473985399|FG006|Overall Study|Lost to Follow-up|4|||
131715484|NCT02344576|474235495|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
131715485|NCT03832387|474235509|FG000|Overall Study|Protocol Violation|2|||
131715486|NCT03832387|474235510|FG001|Overall Study|Protocol Violation|6|||
131903023|NCT00676403|474931368|FG004|Overall Study|Reason Unspecified|0|||
131644324|NCT02872012|473985400|FG000|Overall Study|Withdrawal by Subject|1|||
131644325|NCT02872012|473985401|FG001|Overall Study|Withdrawal by Subject|0|||
131644326|NCT02872012|473985402|FG002|Overall Study|Withdrawal by Subject|0|||
131644327|NCT02872012|473985403|FG003|Overall Study|Withdrawal by Subject|0|||
131644328|NCT02872012|473985404|FG004|Overall Study|Withdrawal by Subject|0|||
131644329|NCT01728623|473985405|FG000|Overall Study|Disease progression|26|||
131644330|NCT01728623|473985405|FG000|Overall Study|Adverse Event|1|||
131644331|NCT01728623|473985405|FG000|Overall Study|Withdrawal by Subject|1|||
131644332|NCT00243022|473985406|FG000|Overall Study|Withdrawal by Subject|1|||
131644333|NCT00243022|473985407|FG001|Overall Study|Withdrawal by Subject|0|||
131644334|NCT00243022|473985406|FG000|Overall Study|Death|1|||
131644335|NCT00243022|473985407|FG001|Overall Study|Death|0|||
131715487|NCT03832387|474235509|FG000|Overall Study|EXCLUSION CRITERIA|3|||
131903024|NCT00676403|474931369|FG005|Overall Study|Reason Unspecified|1|||
131644336|NCT00243022|473985406|FG000|Overall Study|Difficult Travel Distance|0|||
131644337|NCT00243022|473985407|FG001|Overall Study|Difficult Travel Distance|1|||
131644338|NCT03517111|473985412|FG000|Enrolled|Withdrawal by Subject|0|||
131644339|NCT03517111|473985413|FG001|Enrolled|Withdrawal by Subject|1|||
131644340|NCT03517111|473985414|FG002|Enrolled|Withdrawal by Subject|0|||
131644341|NCT03517111|473985412|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
131644342|NCT03517111|473985413|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
131644343|NCT03517111|473985414|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
131644344|NCT03517111|473985412|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
131644345|NCT03517111|473985413|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
131644346|NCT03517111|473985414|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
131644347|NCT03517111|473985412|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
131644348|NCT03517111|473985413|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
131644349|NCT03517111|473985414|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
131644350|NCT03517111|473985412|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
131644351|NCT03517111|473985413|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
131644352|NCT03517111|473985414|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
131644353|NCT00621192|473985415|FG000|Overall Study|Withdrawal by Subject|0|||
131644354|NCT00621192|473985416|FG001|Overall Study|Withdrawal by Subject|0|||
131644355|NCT00621192|473985417|FG002|Overall Study|Withdrawal by Subject|2|||
131644356|NCT00621192|473985418|FG003|Overall Study|Withdrawal by Subject|0|||
131644357|NCT00621192|473985415|FG000|Overall Study|Physician Decision|1|||
131644358|NCT00621192|473985416|FG001|Overall Study|Physician Decision|3|||
131644359|NCT00621192|473985417|FG002|Overall Study|Physician Decision|0|||
131644360|NCT00621192|473985418|FG003|Overall Study|Physician Decision|0|||
131644361|NCT00621192|473985415|FG000|Overall Study|Protocol Violation|1|||
131644362|NCT00621192|473985416|FG001|Overall Study|Protocol Violation|0|||
131644363|NCT00621192|473985417|FG002|Overall Study|Protocol Violation|0|||
131644364|NCT00621192|473985418|FG003|Overall Study|Protocol Violation|1|||
131644365|NCT00621192|473985415|FG000|Overall Study|Adverse Event|0|||
131644366|NCT00621192|473985416|FG001|Overall Study|Adverse Event|1|||
131644367|NCT00621192|473985417|FG002|Overall Study|Adverse Event|0|||
131644368|NCT00621192|473985418|FG003|Overall Study|Adverse Event|1|||
131644369|NCT00621192|473985415|FG000|Overall Study|Death|2|||
131644370|NCT00621192|473985416|FG001|Overall Study|Death|5|||
131644371|NCT00621192|473985417|FG002|Overall Study|Death|0|||
131644372|NCT00621192|473985418|FG003|Overall Study|Death|0|||
131644373|NCT00621192|473985415|FG000|Overall Study|Final Assessments not Completed|0|||
131644374|NCT00621192|473985416|FG001|Overall Study|Final Assessments not Completed|0|||
131644375|NCT00621192|473985417|FG002|Overall Study|Final Assessments not Completed|3|||
131644376|NCT00621192|473985418|FG003|Overall Study|Final Assessments not Completed|1|||
131644377|NCT04706793|473985419|FG000|Treatment|Disease worsening|10|||
131644378|NCT04706793|473985420|FG001|Treatment|Disease worsening|10|||
131644379|NCT04706793|473985419|FG000|Follow-up|Lack of Efficacy|1|||
131644380|NCT04706793|473985420|FG001|Follow-up|Lack of Efficacy|0|||
131644381|NCT04706793|473985419|FG000|Follow-up|Disease worsening|8|||
131644382|NCT04706793|473985420|FG001|Follow-up|Disease worsening|10|||
131644383|NCT04706793|473985419|FG000|Follow-up|Adverse Event|1|||
131644384|NCT04706793|473985420|FG001|Follow-up|Adverse Event|0|||
131644385|NCT03713320|473985423|FG000|Randomized Period|Adverse Event|1|||
131644386|NCT03713320|473985424|FG001|Randomized Period|Adverse Event|5|||
131644387|NCT03713320|473985425|FG002|Randomized Period|Adverse Event|0|||
131644388|NCT03713320|473985423|FG000|Randomized Period|Physician Decision|1|||
131644389|NCT03713320|473985424|FG001|Randomized Period|Physician Decision|1|||
131644390|NCT03713320|473985425|FG002|Randomized Period|Physician Decision|0|||
131644391|NCT03713320|473985423|FG000|Randomized Period|Withdrawal by Subject|4|||
131644392|NCT03713320|473985424|FG001|Randomized Period|Withdrawal by Subject|0|||
131644393|NCT03713320|473985425|FG002|Randomized Period|Withdrawal by Subject|0|||
131644394|NCT03713320|473985423|FG000|Randomized Period|Participant decision|3|||
131644395|NCT03713320|473985424|FG001|Randomized Period|Participant decision|1|||
131644396|NCT03713320|473985425|FG002|Randomized Period|Participant decision|0|||
131644397|NCT03713320|473985423|FG000|Randomized Period|Study terminated by sponsor|6|||
131644398|NCT03713320|473985424|FG001|Randomized Period|Study terminated by sponsor|3|||
131644399|NCT03713320|473985425|FG002|Randomized Period|Study terminated by sponsor|0|||
131644400|NCT03713320|473985423|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
131644401|NCT03713320|473985424|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
131644402|NCT03713320|473985425|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
131644403|NCT03713320|473985423|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
131644404|NCT03713320|473985424|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
131644405|NCT03713320|473985425|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
131644406|NCT02569957|473985426|FG000|Overall Study|Withdrawal by Subject|0|||
131644407|NCT02569957|473985427|FG001|Overall Study|Withdrawal by Subject|1|||
131644408|NCT00763451|473985428|FG000|Overall Study|Adverse Event|4|||
131644409|NCT00763451|473985429|FG001|Overall Study|Adverse Event|6|||
131644410|NCT00763451|473985430|FG002|Overall Study|Adverse Event|19|||
131644411|NCT00763451|473985431|FG003|Overall Study|Adverse Event|14|||
131644412|NCT00763451|473985428|FG000|Overall Study|Lack of Efficacy|1|||
131644413|NCT00763451|473985429|FG001|Overall Study|Lack of Efficacy|4|||
131644414|NCT00763451|473985430|FG002|Overall Study|Lack of Efficacy|3|||
131445331|NCT04225897|473260363|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
131445332|NCT04225897|473260364|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445333|NCT04225897|473260365|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445334|NCT04225897|473260366|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445335|NCT04225897|473260367|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445336|NCT04225897|473260368|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131644415|NCT00763451|473985431|FG003|Overall Study|Lack of Efficacy|2|||
131644416|NCT00763451|473985428|FG000|Overall Study|Withdrawal by Subject|1|||
131644417|NCT00763451|473985429|FG001|Overall Study|Withdrawal by Subject|6|||
131644418|NCT00763451|473985430|FG002|Overall Study|Withdrawal by Subject|9|||
131644419|NCT00763451|473985431|FG003|Overall Study|Withdrawal by Subject|7|||
131644420|NCT00763451|473985428|FG000|Overall Study|Protocol Violation|0|||
131644421|NCT00763451|473985429|FG001|Overall Study|Protocol Violation|0|||
131644422|NCT00763451|473985430|FG002|Overall Study|Protocol Violation|1|||
131644423|NCT00763451|473985431|FG003|Overall Study|Protocol Violation|0|||
131644424|NCT00763451|473985428|FG000|Overall Study|Poor Compliance to Protocol|1|||
131445337|NCT04225897|473260369|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445338|NCT04225897|473260370|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445339|NCT04225897|473260371|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445340|NCT04225897|473260372|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131445341|NCT04225897|473260361|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445342|NCT04225897|473260362|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445343|NCT04225897|473260363|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445344|NCT04225897|473260364|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445345|NCT04225897|473260365|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445346|NCT04225897|473260366|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445347|NCT04225897|473260367|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445348|NCT04225897|473260368|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
131445349|NCT04225897|473260369|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445350|NCT04225897|473260370|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445351|NCT04225897|473260371|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445352|NCT04225897|473260372|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131445353|NCT02703597|473260373|FG000|Assignment to Baseline|Lost to Follow-up|17|||
131445354|NCT02703597|473260374|FG001|Assignment to Baseline|Lost to Follow-up|16|||
131445355|NCT02703597|473260373|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
131445356|NCT02703597|473260374|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
131445357|NCT02703597|473260373|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
131445358|NCT02703597|473260374|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
131445359|NCT02703597|473260373|FG000|First Post-test to First Follow-up|Site drop out|0|||
131445360|NCT02703597|473260374|FG001|First Post-test to First Follow-up|Site drop out|58|||
131445361|NCT02703597|473260373|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
131445362|NCT02703597|473260374|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
131445363|NCT02703597|473260373|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
131445364|NCT02703597|473260374|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
131445365|NCT02703597|473260373|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
131445366|NCT02703597|473260374|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
131445367|NCT02131259|473260375|FG000|Overall Study|Progressive disease|751|||
131445368|NCT02131259|473260375|FG000|Overall Study|Adverse Event|341|||
131445369|NCT02131259|473260375|FG000|Overall Study|Lost to Follow-up|7|||
131445370|NCT02131259|473260375|FG000|Overall Study|Relocation|32|||
131445371|NCT02131259|473260375|FG000|Overall Study|Other|63|||
131445372|NCT02131259|473260375|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
131445373|NCT02131259|473260375|FG000|Overall Study|Progressive disease/relocation|1|||
131644425|NCT00763451|473985429|FG001|Overall Study|Poor Compliance to Protocol|1|||
131644426|NCT00763451|473985430|FG002|Overall Study|Poor Compliance to Protocol|2|||
131644427|NCT00763451|473985431|FG003|Overall Study|Poor Compliance to Protocol|2|||
131644428|NCT00763451|473985428|FG000|Overall Study|Familial and Personal Reasons|5|||
131715488|NCT03832387|474235510|FG001|Overall Study|EXCLUSION CRITERIA|1|||
131644429|NCT00763451|473985429|FG001|Overall Study|Familial and Personal Reasons|3|||
131644430|NCT00763451|473985430|FG002|Overall Study|Familial and Personal Reasons|5|||
131644431|NCT00763451|473985431|FG003|Overall Study|Familial and Personal Reasons|4|||
131644432|NCT00763451|473985428|FG000|Overall Study|Randomized but not Treated|1|||
131644433|NCT00763451|473985429|FG001|Overall Study|Randomized but not Treated|1|||
131644434|NCT00763451|473985430|FG002|Overall Study|Randomized but not Treated|0|||
131644435|NCT00763451|473985431|FG003|Overall Study|Randomized but not Treated|0|||
131644436|NCT00763451|473985428|FG000|Overall Study|Study Site Reason|0|||
131644437|NCT00763451|473985429|FG001|Overall Study|Study Site Reason|1|||
131644438|NCT00763451|473985430|FG002|Overall Study|Study Site Reason|1|||
131644439|NCT00763451|473985431|FG003|Overall Study|Study Site Reason|1|||
131644440|NCT00725543|473985435|FG000|Overall Study|Adverse Event|10|||
131644441|NCT00725543|473985435|FG000|Overall Study|Lack of Efficacy|3|||
131644442|NCT00725543|473985435|FG000|Overall Study|Withdrawal by Subject|10|||
131644443|NCT00725543|473985435|FG000|Overall Study|Physician Decision|5|||
131644444|NCT00725543|473985435|FG000|Overall Study|Lost to Follow-up|4|||
131644445|NCT00725543|473985435|FG000|Overall Study|Non-compliance|2|||
131644446|NCT00725543|473985435|FG000|Overall Study|Other|119|||
131644447|NCT05594589|473985436|FG000|Overall Study|Other|0|||
131644448|NCT05594589|473985437|FG001|Overall Study|Other|1|||
131644449|NCT05594589|473985438|FG002|Overall Study|Other|0|||
131644450|NCT02760485|473985439|FG000|Phase 1|Death|3|||
131644451|NCT02760485|473985440|FG001|Phase 1|Death|6|||
131644452|NCT02760485|473985441|FG002|Phase 1|Death|0|||
131644453|NCT02760485|473985439|FG000|Phase 1|Withdrawal by Subject|2|||
131644454|NCT02760485|473985440|FG001|Phase 1|Withdrawal by Subject|0|||
131644455|NCT02760485|473985441|FG002|Phase 1|Withdrawal by Subject|0|||
131644456|NCT02760485|473985439|FG000|Phase 1|Progressive Disease|1|||
131644457|NCT02760485|473985440|FG001|Phase 1|Progressive Disease|0|||
131644458|NCT02760485|473985441|FG002|Phase 1|Progressive Disease|0|||
131644459|NCT02760485|473985439|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
131644460|NCT02760485|473985440|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
131644461|NCT02760485|473985441|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
131644462|NCT02760485|473985439|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
131644463|NCT02760485|473985440|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
131644464|NCT02760485|473985441|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
131644465|NCT02760485|473985439|FG000|Phase 2|Death|0|||
131644466|NCT02760485|473985440|FG001|Phase 2|Death|0|||
131644467|NCT02760485|473985441|FG002|Phase 2|Death|12|||
131644468|NCT02760485|473985439|FG000|Phase 2|Withdrawal by Subject|0|||
131644469|NCT02760485|473985440|FG001|Phase 2|Withdrawal by Subject|0|||
131644470|NCT02760485|473985441|FG002|Phase 2|Withdrawal by Subject|3|||
131644471|NCT02760485|473985439|FG000|Phase 2|Progressive Disease|0|||
131644472|NCT02760485|473985440|FG001|Phase 2|Progressive Disease|0|||
131644473|NCT02760485|473985441|FG002|Phase 2|Progressive Disease|1|||
131644474|NCT02760485|473985439|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
131644475|NCT02760485|473985440|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
131644476|NCT02760485|473985441|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
131644477|NCT02344173|473985442|FG000|Procedure|Ablation Procedure Not Performed|7|||
131644478|NCT02344173|473985442|FG000|12-month Visit|Death|8|||
131644479|NCT02344173|473985442|FG000|12-month Visit|Withdrawal by Subject|30|||
131644480|NCT02344173|473985442|FG000|12-month Visit|Lost to Follow-up|58|||
131644481|NCT03772613|473985443|FG000|Overall Study|Lost to Follow-up|0|||
131644482|NCT03772613|473985444|FG001|Overall Study|Lost to Follow-up|1|||
131644483|NCT03772613|473985445|FG002|Overall Study|Lost to Follow-up|1|||
131644484|NCT00904722|473985446|FG000|Overall Study|Physician Decision|1|||
131644485|NCT01182207|473985447|FG000|First Intervention|Positive Hepatitis Results|0|||
131644486|NCT01182207|473985448|FG001|First Intervention|Positive Hepatitis Results|1|||
131644487|NCT01182207|473985447|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
131644488|NCT01182207|473985448|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
131644489|NCT01087814|473985449|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
131644490|NCT01087814|473985450|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
131644491|NCT01087814|473985449|FG000|Second Intervention (5 Days)|Physician Decision|1|||
131644492|NCT01087814|473985450|FG001|Second Intervention (5 Days)|Physician Decision|0|||
131644493|NCT01891890|473985451|FG000|Overall Study|Lost to Follow-up|0|||
131644494|NCT01891890|473985452|FG001|Overall Study|Lost to Follow-up|0|||
131644495|NCT01891890|473985453|FG002|Overall Study|Lost to Follow-up|1|||
131644496|NCT01891890|473985451|FG000|Overall Study|Study ended before endpoint reached|7|||
131644497|NCT01891890|473985452|FG001|Overall Study|Study ended before endpoint reached|3|||
131644498|NCT01891890|473985453|FG002|Overall Study|Study ended before endpoint reached|6|||
131644499|NCT01427738|473985454|FG000|Overall Study|Death|12|||
131644500|NCT01427738|473985455|FG001|Overall Study|Death|9|||
131644501|NCT01427738|473985454|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131715489|NCT01243268|474235511|FG000|Overall Study|Lost to Follow-up|4|||
131715490|NCT01243268|474235511|FG000|Overall Study|Protocol Violation|51|||
131715491|NCT01243268|474235511|FG000|Overall Study|Deviation with contract date|7|||
131715492|NCT01243268|474235511|FG000|Overall Study|Duplicate subject|2|||
131644502|NCT01427738|473985455|FG001|Overall Study|Severe debilitation, unable to continue|1|||
131644503|NCT01427738|473985454|FG000|Overall Study|Subject unable to get to clinic|5|||
131644504|NCT01427738|473985455|FG001|Overall Study|Subject unable to get to clinic|2|||
131644505|NCT01427738|473985454|FG000|Overall Study|Withdrawal by Subject|0|||
131644506|NCT01427738|473985455|FG001|Overall Study|Withdrawal by Subject|2|||
131644507|NCT01427738|473985454|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
131644508|NCT01427738|473985455|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
131644509|NCT01427738|473985454|FG000|Overall Study|Lost to Follow-up|1|||
131644510|NCT01427738|473985455|FG001|Overall Study|Lost to Follow-up|5|||
131644511|NCT00661713|473985456|FG000|Overall Study|Death|1|||
131644512|NCT00661713|473985457|FG001|Overall Study|Death|0|||
131644513|NCT00661713|473985458|FG002|Overall Study|Death|0|||
131644514|NCT00661713|473985459|FG003|Overall Study|Death|0|||
131644515|NCT00661713|473985460|FG004|Overall Study|Death|1|||
131644516|NCT00661713|473985461|FG005|Overall Study|Death|0|||
131644517|NCT00661713|473985462|FG006|Overall Study|Death|0|||
131644518|NCT00661713|473985463|FG007|Overall Study|Death|0|||
131644519|NCT00661713|473985456|FG000|Overall Study|Unable to Classify|1|||
131644520|NCT00661713|473985457|FG001|Overall Study|Unable to Classify|0|||
131644521|NCT00661713|473985458|FG002|Overall Study|Unable to Classify|0|||
131644522|NCT00661713|473985459|FG003|Overall Study|Unable to Classify|0|||
131644523|NCT00661713|473985460|FG004|Overall Study|Unable to Classify|0|||
131644524|NCT00661713|473985461|FG005|Overall Study|Unable to Classify|0|||
131644525|NCT00661713|473985462|FG006|Overall Study|Unable to Classify|0|||
131644526|NCT00661713|473985463|FG007|Overall Study|Unable to Classify|0|||
131644527|NCT00661713|473985456|FG000|Overall Study|Protocol Violation|1|||
131644528|NCT00661713|473985457|FG001|Overall Study|Protocol Violation|6|||
131644529|NCT00661713|473985458|FG002|Overall Study|Protocol Violation|3|||
131644530|NCT00661713|473985459|FG003|Overall Study|Protocol Violation|3|||
131644531|NCT00661713|473985460|FG004|Overall Study|Protocol Violation|0|||
131644532|NCT00661713|473985461|FG005|Overall Study|Protocol Violation|2|||
131644533|NCT00661713|473985462|FG006|Overall Study|Protocol Violation|2|||
131644534|NCT00661713|473985463|FG007|Overall Study|Protocol Violation|1|||
131644535|NCT00661713|473985456|FG000|Overall Study|Withdrawal by Subject|11|||
131644536|NCT00661713|473985457|FG001|Overall Study|Withdrawal by Subject|25|||
131644537|NCT00661713|473985458|FG002|Overall Study|Withdrawal by Subject|12|||
131644538|NCT00661713|473985459|FG003|Overall Study|Withdrawal by Subject|21|||
131644539|NCT00661713|473985460|FG004|Overall Study|Withdrawal by Subject|12|||
131644540|NCT00661713|473985461|FG005|Overall Study|Withdrawal by Subject|26|||
131644541|NCT00661713|473985462|FG006|Overall Study|Withdrawal by Subject|45|||
131644542|NCT00661713|473985463|FG007|Overall Study|Withdrawal by Subject|9|||
131644543|NCT00661713|473985456|FG000|Overall Study|Lost to Follow-up|2|||
131644544|NCT00661713|473985457|FG001|Overall Study|Lost to Follow-up|7|||
131644545|NCT00661713|473985458|FG002|Overall Study|Lost to Follow-up|2|||
131644546|NCT00661713|473985459|FG003|Overall Study|Lost to Follow-up|2|||
131644547|NCT00661713|473985460|FG004|Overall Study|Lost to Follow-up|5|||
131715493|NCT00957853|474235512|FG000|Overall Study|Withdrawal by Subject|1|||
131715494|NCT00957853|474235513|FG001|Overall Study|Withdrawal by Subject|0|||
131445374|NCT02131259|473260375|FG000|Overall Study|Progressive disease/other|2|||
131445375|NCT02131259|473260375|FG000|Overall Study|AE/lost to follow-up|1|||
131445376|NCT02131259|473260375|FG000|Overall Study|AE/other|1|||
131644548|NCT00661713|473985461|FG005|Overall Study|Lost to Follow-up|7|||
131644549|NCT00661713|473985462|FG006|Overall Study|Lost to Follow-up|14|||
131644550|NCT00661713|473985463|FG007|Overall Study|Lost to Follow-up|1|||
131644551|NCT00661713|473985456|FG000|Overall Study|Administrative Reason|0|||
131644552|NCT00661713|473985457|FG001|Overall Study|Administrative Reason|1|||
131644553|NCT00661713|473985458|FG002|Overall Study|Administrative Reason|0|||
131644554|NCT00661713|473985459|FG003|Overall Study|Administrative Reason|2|||
131715495|NCT00957853|474235514|FG002|Overall Study|Withdrawal by Subject|0|||
131644555|NCT00661713|473985460|FG004|Overall Study|Administrative Reason|2|||
131644556|NCT00661713|473985461|FG005|Overall Study|Administrative Reason|2|||
131644557|NCT00661713|473985462|FG006|Overall Study|Administrative Reason|1|||
131644558|NCT00661713|473985463|FG007|Overall Study|Administrative Reason|0|||
131644559|NCT00661713|473985456|FG000|Overall Study|Adverse Event|0|||
131715496|NCT00004980|474235515|FG000|Overall Study|Withdrawal by Subject|1|||
131644560|NCT00661713|473985457|FG001|Overall Study|Adverse Event|0|||
131644561|NCT00661713|473985458|FG002|Overall Study|Adverse Event|0|||
131644562|NCT00661713|473985459|FG003|Overall Study|Adverse Event|0|||
131644563|NCT00661713|473985460|FG004|Overall Study|Adverse Event|0|||
131644564|NCT00661713|473985461|FG005|Overall Study|Adverse Event|0|||
131644565|NCT00661713|473985462|FG006|Overall Study|Adverse Event|1|||
131644566|NCT00661713|473985463|FG007|Overall Study|Adverse Event|0|||
131644567|NCT00661713|473985456|FG000|Overall Study|Inappropriate Enrollment|0|||
131644568|NCT00661713|473985457|FG001|Overall Study|Inappropriate Enrollment|0|||
131644569|NCT00661713|473985458|FG002|Overall Study|Inappropriate Enrollment|0|||
131445377|NCT02131259|473260375|FG000|Overall Study|Progressive disease/AE/other|1|||
131445378|NCT02131259|473260375|FG000|Overall Study|Missing|3|||
131445379|NCT02796170|473260376|FG000|Overall Study|Lost to Follow-up|3|||
131445380|NCT02796170|473260377|FG001|Overall Study|Lost to Follow-up|0|||
131445381|NCT00003475|473260380|FG000|Overall Study|Not evaluable|13|||
131445382|NCT03818321|473260381|FG000|Overall Study|Withdrawal by Subject|1|||
131445383|NCT03818321|473260382|FG001|Overall Study|Withdrawal by Subject|2|||
131445384|NCT01867671|473260386|FG000|Overall Study|Adverse Event|5|||
131445385|NCT01867671|473260387|FG001|Overall Study|Adverse Event|3|||
131445386|NCT01867671|473260386|FG000|Overall Study|Anaphylaxis|0|||
131445387|NCT01867671|473260387|FG001|Overall Study|Anaphylaxis|1|||
131445388|NCT01867671|473260386|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
131445389|NCT01867671|473260387|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
131445390|NCT01867671|473260386|FG000|Overall Study|Lost to Follow-up|0|||
131445391|NCT01867671|473260387|FG001|Overall Study|Lost to Follow-up|1|||
131445392|NCT01867671|473260386|FG000|Overall Study|Non-compliance with Study Drug|1|||
131445393|NCT01867671|473260387|FG001|Overall Study|Non-compliance with Study Drug|2|||
131445394|NCT01867671|473260386|FG000|Overall Study|Withdrawal by Subject|21|||
131445395|NCT01867671|473260387|FG001|Overall Study|Withdrawal by Subject|21|||
131445396|NCT01523366|473260388|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131445397|NCT01523366|473260389|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131445398|NCT01523366|473260388|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
131445399|NCT01523366|473260389|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
131445400|NCT01099267|473260391|FG000|MDS-003 Study|Adverse Event|37|||
131445401|NCT01099267|473260391|FG000|MDS-003 Study|Lack of Efficacy|52|||
131445402|NCT01099267|473260391|FG000|MDS-003 Study|Withdrawal by Subject|8|||
131445403|NCT01099267|473260391|FG000|MDS-003 Study|Lost to Follow-up|1|||
131445404|NCT01099267|473260391|FG000|MDS-003 Study|Death|11|||
131445405|NCT01099267|473260391|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
131445406|NCT01099267|473260391|FG000|MDS-003 Study|Disease Progression|7|||
131445407|NCT01099267|473260391|FG000|MDS-003 Study|Investigator Decision|2|||
131445408|NCT01099267|473260391|FG000|MDS-003 Study|Non-Compliance|2|||
131445409|NCT01099267|473260391|FG000|MDS-003 Study|Loss of Response|1|||
131445410|NCT01099267|473260391|FG000|MDS-003 Study|Secondary Malign Disease|1|||
131445411|NCT01838395|473260399|FG000|Overall Study|Withdrawal by Subject|0|||
131445412|NCT01838395|473260400|FG001|Overall Study|Withdrawal by Subject|0|||
131445413|NCT01838395|473260401|FG002|Overall Study|Withdrawal by Subject|0|||
131445414|NCT01838395|473260402|FG003|Overall Study|Withdrawal by Subject|0|||
131445415|NCT01838395|473260403|FG004|Overall Study|Withdrawal by Subject|1|||
131445416|NCT01838395|473260404|FG005|Overall Study|Withdrawal by Subject|0|||
131445417|NCT01838395|473260399|FG000|Overall Study|Death|0|||
131445418|NCT01838395|473260400|FG001|Overall Study|Death|0|||
131445419|NCT01838395|473260401|FG002|Overall Study|Death|1|||
131445420|NCT01838395|473260402|FG003|Overall Study|Death|0|||
131445421|NCT01838395|473260403|FG004|Overall Study|Death|0|||
131445422|NCT01838395|473260404|FG005|Overall Study|Death|0|||
131445423|NCT01838395|473260399|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
131445424|NCT01838395|473260400|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
131445425|NCT01838395|473260401|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
131445426|NCT01838395|473260402|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
131445427|NCT01838395|473260403|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
131445428|NCT01838395|473260404|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
131445429|NCT01535040|473260405|FG000|Overall Study|Physician Decision|0|||
131445430|NCT01535040|473260406|FG001|Overall Study|Physician Decision|1|||
131445431|NCT01535040|473260405|FG000|Overall Study|Withdrawal by Subject|13|||
131445432|NCT01535040|473260406|FG001|Overall Study|Withdrawal by Subject|10|||
131445433|NCT01535040|473260405|FG000|Overall Study|Never Started|9|||
131445434|NCT01535040|473260406|FG001|Overall Study|Never Started|4|||
131445435|NCT01535040|473260405|FG000|Overall Study|Toxicity|7|||
131644570|NCT00661713|473985459|FG003|Overall Study|Inappropriate Enrollment|0|||
131644571|NCT00661713|473985460|FG004|Overall Study|Inappropriate Enrollment|0|||
131445436|NCT01535040|473260406|FG001|Overall Study|Toxicity|5|||
131644572|NCT00661713|473985461|FG005|Overall Study|Inappropriate Enrollment|0|||
131445437|NCT01535040|473260405|FG000|Overall Study|Multiple Reasons|1|||
131715497|NCT00004980|474235516|FG001|Overall Study|Withdrawal by Subject|0|||
131445438|NCT01535040|473260406|FG001|Overall Study|Multiple Reasons|1|||
131445439|NCT01074970|473260408|FG000|Overall Study|Never Treated|0|||
131445440|NCT01074970|473260409|FG001|Overall Study|Never Treated|0|||
131445441|NCT01074970|473260410|FG002|Overall Study|Never Treated|8|||
131445442|NCT01074970|473260411|FG003|Overall Study|Never Treated|1|||
131445443|NCT01074970|473260408|FG000|Overall Study|Adverse Event|1|||
131445444|NCT01074970|473260409|FG001|Overall Study|Adverse Event|0|||
131445445|NCT01074970|473260410|FG002|Overall Study|Adverse Event|4|||
131445446|NCT01074970|473260411|FG003|Overall Study|Adverse Event|3|||
131445447|NCT01074970|473260408|FG000|Overall Study|Disease progression during treatment|3|||
131445448|NCT01074970|473260409|FG001|Overall Study|Disease progression during treatment|1|||
131445449|NCT01074970|473260410|FG002|Overall Study|Disease progression during treatment|2|||
131445450|NCT01074970|473260411|FG003|Overall Study|Disease progression during treatment|9|||
131445451|NCT01074970|473260408|FG000|Overall Study|Lost to Follow-up|0|||
131445452|NCT01074970|473260409|FG001|Overall Study|Lost to Follow-up|0|||
131445453|NCT01074970|473260410|FG002|Overall Study|Lost to Follow-up|1|||
131445454|NCT01074970|473260411|FG003|Overall Study|Lost to Follow-up|0|||
131445455|NCT01074970|473260408|FG000|Overall Study|Withdrawal by Subject|0|||
131445456|NCT01074970|473260409|FG001|Overall Study|Withdrawal by Subject|0|||
131445457|NCT01074970|473260410|FG002|Overall Study|Withdrawal by Subject|6|||
131445458|NCT01074970|473260411|FG003|Overall Study|Withdrawal by Subject|4|||
131445459|NCT00734149|473260412|FG000|Overall Study|Withdrawal by Subject|1|||
131445460|NCT05430854|473260413|FG000|Overall Study|Trial terminated by Sponsor|39|||
131445461|NCT05430854|473260414|FG001|Overall Study|Trial terminated by Sponsor|50|||
131445462|NCT05430854|473260415|FG002|Overall Study|Trial terminated by Sponsor|46|||
131445463|NCT05430854|473260413|FG000|Overall Study|Withdrawal by Subject|0|||
131445464|NCT05430854|473260414|FG001|Overall Study|Withdrawal by Subject|3|||
131445465|NCT05430854|473260415|FG002|Overall Study|Withdrawal by Subject|0|||
131445466|NCT04314284|473260416|FG000|Overall Study|Withdrawal by Subject|4|||
131445467|NCT04314284|473260417|FG001|Overall Study|Withdrawal by Subject|7|||
131445468|NCT04314284|473260416|FG000|Overall Study|Consented but did not complete survey|0|||
131445469|NCT04314284|473260417|FG001|Overall Study|Consented but did not complete survey|6|||
131445470|NCT01652235|473260420|FG000|Overall Study|Death|9|||
131445471|NCT01652235|473260420|FG000|Overall Study|Lost to Follow-up|5|||
131445472|NCT01652235|473260420|FG000|Overall Study|Withdrawal by Subject|2|||
131445473|NCT02023086|473260423|FG000|Overall Study|Withdrawal by Subject|2|||
131445474|NCT02023086|473260424|FG001|Overall Study|Withdrawal by Subject|0|||
131445475|NCT05565742|473260427|FG000|Overall Study|Withdrawal by Subject|0|||
131445476|NCT05565742|473260428|FG001|Overall Study|Withdrawal by Subject|0|||
131445477|NCT05565742|473260429|FG002|Overall Study|Withdrawal by Subject|2|||
131445478|NCT05565742|473260430|FG003|Overall Study|Withdrawal by Subject|2|||
131445479|NCT05565742|473260431|FG004|Overall Study|Withdrawal by Subject|2|||
131445480|NCT05565742|473260427|FG000|Overall Study|Death|1|||
131445481|NCT05565742|473260428|FG001|Overall Study|Death|0|||
131445482|NCT05565742|473260429|FG002|Overall Study|Death|0|||
131445483|NCT05565742|473260430|FG003|Overall Study|Death|0|||
131445484|NCT05565742|473260431|FG004|Overall Study|Death|0|||
131445485|NCT05565742|473260427|FG000|Overall Study|Participant Travelled Abroad|0|||
131445486|NCT05565742|473260428|FG001|Overall Study|Participant Travelled Abroad|0|||
131445487|NCT05565742|473260429|FG002|Overall Study|Participant Travelled Abroad|0|||
131445488|NCT05565742|473260430|FG003|Overall Study|Participant Travelled Abroad|0|||
131445489|NCT05565742|473260431|FG004|Overall Study|Participant Travelled Abroad|1|||
131445490|NCT04163341|473260432|FG000|Overall Study|Withdrawal by Subject|2|||
131445491|NCT04163341|473260433|FG001|Overall Study|Withdrawal by Subject|0|||
131445492|NCT04163341|473260432|FG000|Overall Study|Lost to Follow-up|3|||
131445493|NCT04163341|473260433|FG001|Overall Study|Lost to Follow-up|4|||
131445494|NCT03472885|473260434|FG000|24-Week Treatment Period|Adverse Event|1|||
131445495|NCT02201953|473260435|FG000|Overall Study|Randomized but Never Treated|1|||
131445496|NCT02201953|473260436|FG001|Overall Study|Randomized but Never Treated|5|||
131445497|NCT02201953|473260435|FG000|Overall Study|Lack of Efficacy|9|||
131445498|NCT02201953|473260436|FG001|Overall Study|Lack of Efficacy|30|||
131445499|NCT02201953|473260435|FG000|Overall Study|Lost to Follow-up|8|||
131445500|NCT02201953|473260436|FG001|Overall Study|Lost to Follow-up|8|||
131445501|NCT02201953|473260435|FG000|Overall Study|Withdrew Consent|2|||
131445502|NCT02201953|473260436|FG001|Overall Study|Withdrew Consent|5|||
131445503|NCT02201953|473260435|FG000|Overall Study|Adverse Event|0|||
131445504|NCT02201953|473260436|FG001|Overall Study|Adverse Event|5|||
131445505|NCT02201953|473260435|FG000|Overall Study|Death|0|||
131445506|NCT02201953|473260436|FG001|Overall Study|Death|3|||
131445507|NCT04586205|473260439|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
131445508|NCT04586205|473260440|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
131445509|NCT01586364|473262203|FG000|Overall Study|Withdrawal by Subject|40|||
131445510|NCT01586364|473262203|FG000|Overall Study|Adverse Event|37|||
131445511|NCT01586364|473262203|FG000|Overall Study|Lost to Follow-up|17|||
131445512|NCT01586364|473262203|FG000|Overall Study|Protocol Violation|16|||
131445513|NCT01586364|473262203|FG000|Overall Study|Lack of Efficacy|1|||
131715498|NCT00004980|474235515|FG000|Overall Study|memory difficulties|1|||
131445514|NCT01586364|473262203|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
131445515|NCT01586364|473262203|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
131445516|NCT01586364|473262203|FG000|Overall Study|Other-Site closure due to PI illness|1|||
131445517|NCT01586364|473262203|FG000|Overall Study|Other-PI discretion, site closing|2|||
131445518|NCT01586364|473262203|FG000|Overall Study|Other-Not specified|1|||
131445519|NCT00091949|473262204|FG000|Overall Study|Withdrawal by Subject|117|||
131445520|NCT00091949|473262205|FG001|Overall Study|Withdrawal by Subject|110|||
131445521|NCT00091949|473262204|FG000|Overall Study|Lost to Follow-up|58|||
131445522|NCT00091949|473262205|FG001|Overall Study|Lost to Follow-up|41|||
131445523|NCT02083354|473262206|FG000|Overall Study|Withdrawal by Subject|9|||
131445524|NCT02083354|473262206|FG000|Overall Study|Lost to Follow-up|1|||
131445525|NCT02083354|473262206|FG000|Overall Study|Adverse Event|3|||
131445526|NCT02083354|473262206|FG000|Overall Study|Disease progression|46|||
131445527|NCT02083354|473262206|FG000|Overall Study|Study closed/terminated|5|||
131445528|NCT02419001|473262217|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
131445529|NCT02419001|473262218|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
131445530|NCT00313014|473262219|FG000|Overall Study|Withdrawal by Subject|11|||
131445531|NCT00313014|473262220|FG001|Overall Study|Withdrawal by Subject|7|||
131445532|NCT00313014|473262221|FG002|Overall Study|Withdrawal by Subject|5|||
131445533|NCT00313014|473262219|FG000|Overall Study|Adverse Event|14|||
131445534|NCT00313014|473262220|FG001|Overall Study|Adverse Event|29|||
131445535|NCT00313014|473262221|FG002|Overall Study|Adverse Event|16|||
131445536|NCT00313014|473262219|FG000|Overall Study|Lost to Follow-up|7|||
131445537|NCT00313014|473262220|FG001|Overall Study|Lost to Follow-up|6|||
131445538|NCT00313014|473262221|FG002|Overall Study|Lost to Follow-up|10|||
131445539|NCT00313014|473262219|FG000|Overall Study|Administrative|9|||
131445540|NCT00313014|473262220|FG001|Overall Study|Administrative|6|||
131445541|NCT00313014|473262221|FG002|Overall Study|Administrative|14|||
131445542|NCT00313014|473262219|FG000|Overall Study|Lack of Efficacy|52|||
131445543|NCT00313014|473262220|FG001|Overall Study|Lack of Efficacy|25|||
131445544|NCT00313014|473262221|FG002|Overall Study|Lack of Efficacy|16|||
131445545|NCT04543279|473262227|FG000|Overall Study|Withdrawal by Subject|1|||
131445546|NCT04543279|473262228|FG001|Overall Study|Withdrawal by Subject|0|||
131445547|NCT04543279|473262227|FG000|Overall Study|Adverse Event|1|||
131445548|NCT04543279|473262228|FG001|Overall Study|Adverse Event|0|||
131445549|NCT04543279|473262227|FG000|Overall Study|Physician Decision|1|||
131445550|NCT04543279|473262228|FG001|Overall Study|Physician Decision|0|||
131445551|NCT00929695|473262229|FG000|Overall Study|Death|2|||
131445552|NCT00929695|473262230|FG001|Overall Study|Death|1|||
131445553|NCT00929695|473262229|FG000|Overall Study|Withdrawal by Subject|0|||
131445554|NCT00929695|473262230|FG001|Overall Study|Withdrawal by Subject|2|||
131445555|NCT00929695|473262229|FG000|Overall Study|discharge home|4|||
131445556|NCT00929695|473262230|FG001|Overall Study|discharge home|3|||
131445557|NCT00929695|473262229|FG000|Overall Study|incorrect stratification|2|||
131445558|NCT00929695|473262230|FG001|Overall Study|incorrect stratification|0|||
131445559|NCT00887809|473262232|FG000|Overall Study|Patient Not Treated|3|||
131445560|NCT00887809|473262233|FG001|Overall Study|Patient Not Treated|0|||
131445561|NCT00887809|473262232|FG000|Overall Study|Death|1|||
131445562|NCT00887809|473262233|FG001|Overall Study|Death|0|||
131445563|NCT01352715|473262236|FG000|Overall Study|Death|3|||
131445564|NCT01352715|473262237|FG001|Overall Study|Death|3|||
131445565|NCT01352715|473262236|FG000|Overall Study|Lost to Follow-up|5|||
131445566|NCT01352715|473262237|FG001|Overall Study|Lost to Follow-up|7|||
131445567|NCT01352715|473262236|FG000|Overall Study|Withdrawal by Subject|4|||
131445568|NCT01352715|473262237|FG001|Overall Study|Withdrawal by Subject|8|||
131445569|NCT01352715|473262236|FG000|Overall Study|site closure|16|||
131445570|NCT01352715|473262237|FG001|Overall Study|site closure|15|||
131445571|NCT01352715|473262236|FG000|Overall Study|no final visit in closeout period|15|||
131445572|NCT01352715|473262237|FG001|Overall Study|no final visit in closeout period|12|||
131445573|NCT01352715|473262236|FG000|Overall Study|major ineligibility|2|||
131715499|NCT00004980|474235516|FG001|Overall Study|memory difficulties|1|||
131445574|NCT01352715|473262237|FG001|Overall Study|major ineligibility|1|||
131445575|NCT00071058|473262238|FG000|Overall Study|brain tumor-removed from study|1|||
131715500|NCT00004980|474235515|FG000|Overall Study|Physician Decision|0|||
131445576|NCT00871975|473262239|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
131445577|NCT00871975|473262239|FG000|Overall Study|Catheters could not be inserted|1|||
131445578|NCT00871975|473262239|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
131445579|NCT00871975|473262239|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
131445580|NCT05249582|473262240|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
131445581|NCT05249582|473262241|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
131445582|NCT05249582|473262240|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
131445583|NCT05249582|473262241|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
131445584|NCT05249582|473262240|FG000|Overall Study|Declined to use virtual reality headset|1|||
131445585|NCT05249582|473262241|FG001|Overall Study|Declined to use virtual reality headset|0|||
131715501|NCT00004980|474235516|FG001|Overall Study|Physician Decision|1|||
131644573|NCT00661713|473985462|FG006|Overall Study|Inappropriate Enrollment|1|||
131644574|NCT00661713|473985463|FG007|Overall Study|Inappropriate Enrollment|0|||
131644575|NCT05314374|473985464|FG000|Overall Study|Adverse Event|2|||
131644576|NCT05314374|473985465|FG001|Overall Study|Adverse Event|2|||
131445586|NCT03675126|473262242|FG000|Overall Study|Study Terminated by Sponsor|9|||
131445587|NCT03675126|473262242|FG000|Overall Study|Death|2|||
131445588|NCT03675126|473262242|FG000|Overall Study|Withdrawal by Subject|4|||
131445589|NCT00001959|473262243|FG000|Overall Study|newly diagnosed colon cancer|1|||
131445590|NCT00001959|473262243|FG000|Overall Study|disabling sedation|1|||
131445591|NCT00001959|473262243|FG000|Overall Study|non-compliance|1|||
131445592|NCT04189952|473262245|FG000|Follow-up Period|Death|1|||
131644577|NCT02658175|473985466|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
131644578|NCT02658175|473985467|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
131644579|NCT02658175|473985468|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
131644580|NCT02658175|473985466|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
131644581|NCT02658175|473985467|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
131644582|NCT02658175|473985468|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
131644583|NCT02658175|473985466|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
131644584|NCT02658175|473985467|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
131644585|NCT02658175|473985468|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
131644586|NCT02658175|473985466|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
131801979|NCT03980483|474559129|FG000|Overall Study|Withdrawal by Subject|38|||
131445593|NCT04189952|473262245|FG000|Follow-up Period|Withdrawal by Subject|1|||
131445594|NCT01052493|473262248|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
131445595|NCT01052493|473262249|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
131445596|NCT01052493|473262250|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
131445597|NCT01498068|473262251|FG000|Overall Study|Withdrawal by Subject|1|||
131445598|NCT01498068|473262252|FG001|Overall Study|Withdrawal by Subject|1|||
131445599|NCT00551642|473262254|FG000|Treatment Period|Protocol Deviation|6|||
131445600|NCT00551642|473262255|FG001|Treatment Period|Protocol Deviation|11|||
131445601|NCT00551642|473262254|FG000|Treatment Period|Delivery device failure|1|||
131445602|NCT00551642|473262255|FG001|Treatment Period|Delivery device failure|3|||
131445603|NCT00551642|473262254|FG000|Treatment Period|Physician Decision|0|||
131445604|NCT00551642|473262255|FG001|Treatment Period|Physician Decision|1|||
131445605|NCT00551642|473262254|FG000|Treatment Period|Death|33|||
131445606|NCT00551642|473262255|FG001|Treatment Period|Death|31|||
131445607|NCT00551642|473262254|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
131445608|NCT00551642|473262255|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
131445609|NCT00551642|473262254|FG000|Treatment Period|Adverse Event|15|||
131445610|NCT00551642|473262255|FG001|Treatment Period|Adverse Event|12|||
131445611|NCT00551642|473262254|FG000|Treatment Period|Withdrawal by Subject|2|||
131445612|NCT00551642|473262255|FG001|Treatment Period|Withdrawal by Subject|1|||
131445613|NCT03011099|473262258|FG000|Overall Study|Withdrawal by Subject|0|||
131445614|NCT03011099|473262259|FG001|Overall Study|Withdrawal by Subject|2|||
131445615|NCT00283296|473262263|FG000|Overall Study|in-home trial not completed|5|||
131445616|NCT01353898|473262264|FG000|Overall Study|Study site terminated|0|||
131445617|NCT01353898|473262265|FG001|Overall Study|Study site terminated|0|||
131445618|NCT01353898|473262266|FG002|Overall Study|Study site terminated|0|||
131445619|NCT01353898|473262267|FG003|Overall Study|Study site terminated|0|||
131445620|NCT01353898|473262268|FG004|Overall Study|Study site terminated|0|||
131445621|NCT01353898|473262269|FG005|Overall Study|Study site terminated|1|||
131445622|NCT03558737|473262272|FG000|Overall Study|Death|1|||
131445623|NCT03558737|473262273|FG001|Overall Study|Death|1|||
131445624|NCT02158442|473262274|FG000|Overall Study|Withdrawal by Subject|1|||
131445625|NCT02158442|473262275|FG001|Overall Study|Withdrawal by Subject|0|||
131445626|NCT02158442|473262274|FG000|Overall Study|Perfusion staff not available|1|||
131445627|NCT02158442|473262275|FG001|Overall Study|Perfusion staff not available|0|||
131445628|NCT01318915|473262278|FG000|Overall Study|Lost to Follow-up|1|||
131445629|NCT00453206|473262280|FG000|Overall Study|Death|1|||
131445630|NCT00632229|473262286|FG000|Overall Study|Adverse Event|6|||
131445631|NCT00632229|473262287|FG001|Overall Study|Adverse Event|0|||
131445632|NCT00632229|473262286|FG000|Overall Study|Lost to Follow-up|0|||
131445633|NCT00632229|473262287|FG001|Overall Study|Lost to Follow-up|3|||
131445634|NCT00632229|473262286|FG000|Overall Study|Lack of Efficacy|0|||
131445635|NCT00632229|473262287|FG001|Overall Study|Lack of Efficacy|2|||
131445636|NCT00632229|473262286|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
131445637|NCT00632229|473262287|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
131445638|NCT02667119|473262288|FG000|Overall Study|Lost to Follow-up|3|||
131445639|NCT02667119|473262289|FG001|Overall Study|Lost to Follow-up|0|||
131445640|NCT03783078|473262290|FG000|Overall Study|Death|31|||
131445641|NCT03783078|473262290|FG000|Overall Study|Sponsor Decision|23|||
131445642|NCT03783078|473262290|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131445643|NCT00541658|473262292|FG000|Overall Study|Adverse Event|28|||
131445644|NCT00541658|473262293|FG001|Overall Study|Adverse Event|37|||
131445645|NCT00541658|473262294|FG002|Overall Study|Adverse Event|25|||
131445646|NCT00541658|473262292|FG000|Overall Study|Physician Decision|0|||
131445647|NCT00541658|473262293|FG001|Overall Study|Physician Decision|0|||
131445648|NCT00541658|473262294|FG002|Overall Study|Physician Decision|4|||
131445649|NCT00541658|473262292|FG000|Overall Study|Lost to Follow-up|3|||
131445650|NCT00541658|473262293|FG001|Overall Study|Lost to Follow-up|3|||
131445651|NCT00541658|473262294|FG002|Overall Study|Lost to Follow-up|6|||
131445652|NCT00541658|473262292|FG000|Overall Study|Protocol Violation|0|||
131445653|NCT00541658|473262293|FG001|Overall Study|Protocol Violation|1|||
131445654|NCT00541658|473262294|FG002|Overall Study|Protocol Violation|1|||
131445655|NCT00541658|473262292|FG000|Overall Study|Withdrawal by Subject|28|||
131445656|NCT00541658|473262293|FG001|Overall Study|Withdrawal by Subject|32|||
131445657|NCT00541658|473262294|FG002|Overall Study|Withdrawal by Subject|32|||
131445658|NCT00541658|473262292|FG000|Overall Study|Took No Study Drug|1|||
131445659|NCT00541658|473262293|FG001|Overall Study|Took No Study Drug|0|||
131445660|NCT00541658|473262294|FG002|Overall Study|Took No Study Drug|0|||
131445661|NCT04123470|473262295|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
131445662|NCT04123470|473262296|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
131445663|NCT04123470|473262295|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
131445664|NCT04123470|473262296|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
131445665|NCT04123470|473262295|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
131445666|NCT04123470|473262296|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
131445667|NCT04123470|473262295|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
131445668|NCT04123470|473262296|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
131445669|NCT05408429|473262308|FG000|Overall Study|Lost to Follow-up|1|||
131445670|NCT05408429|473262309|FG001|Overall Study|Lost to Follow-up|1|||
131445671|NCT05408429|473262310|FG002|Overall Study|Lost to Follow-up|0|||
131445672|NCT05408429|473262308|FG000|Overall Study|Withdrawal by Subject|5|||
131445673|NCT05408429|473262309|FG001|Overall Study|Withdrawal by Subject|0|||
131445674|NCT05408429|473262310|FG002|Overall Study|Withdrawal by Subject|1|||
131445675|NCT05972993|473262312|FG000|Overall Study|Lost to Follow-up|2|||
131445676|NCT05972993|473262313|FG001|Overall Study|Lost to Follow-up|0|||
131445677|NCT05972993|473262314|FG002|Overall Study|Lost to Follow-up|1|||
131445678|NCT05972993|473262315|FG003|Overall Study|Lost to Follow-up|0|||
131445679|NCT05972993|473262316|FG004|Overall Study|Lost to Follow-up|0|||
131445680|NCT05972993|473262317|FG005|Overall Study|Lost to Follow-up|0|||
131445681|NCT05972993|473262318|FG006|Overall Study|Lost to Follow-up|0|||
131445682|NCT05972993|473262319|FG007|Overall Study|Lost to Follow-up|2|||
131445683|NCT05972993|473262320|FG008|Overall Study|Lost to Follow-up|0|||
131445684|NCT03866577|473262323|FG000|Overall Study|Protocol Violation|0|||
131445685|NCT03866577|473262324|FG001|Overall Study|Protocol Violation|0|||
131445686|NCT03866577|473262325|FG002|Overall Study|Protocol Violation|0|||
131445687|NCT03866577|473262326|FG003|Overall Study|Protocol Violation|0|||
131445688|NCT03866577|473262327|FG004|Overall Study|Protocol Violation|0|||
131445689|NCT03866577|473262328|FG005|Overall Study|Protocol Violation|0|||
131445690|NCT03866577|473262329|FG006|Overall Study|Protocol Violation|0|||
131445691|NCT03866577|473262330|FG007|Overall Study|Protocol Violation|0|||
131445692|NCT03866577|473262331|FG008|Overall Study|Protocol Violation|0|||
131445693|NCT03866577|473262332|FG009|Overall Study|Protocol Violation|0|||
131445694|NCT03866577|473262333|FG010|Overall Study|Protocol Violation|0|||
131445695|NCT03866577|473262334|FG011|Overall Study|Protocol Violation|1|||
131445696|NCT03866577|473262335|FG012|Overall Study|Protocol Violation|0|||
131445697|NCT03866577|473262323|FG000|Overall Study|Withdrawal by Subject|0|||
131644587|NCT02658175|473985467|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
131644588|NCT02658175|473985468|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
131644589|NCT02658175|473985466|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
131644590|NCT02658175|473985467|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
131445698|NCT03866577|473262324|FG001|Overall Study|Withdrawal by Subject|0|||
131445699|NCT03866577|473262325|FG002|Overall Study|Withdrawal by Subject|0|||
131445700|NCT03866577|473262326|FG003|Overall Study|Withdrawal by Subject|0|||
131445701|NCT03866577|473262327|FG004|Overall Study|Withdrawal by Subject|0|||
131445702|NCT03866577|473262328|FG005|Overall Study|Withdrawal by Subject|0|||
131445703|NCT03866577|473262329|FG006|Overall Study|Withdrawal by Subject|0|||
131445704|NCT03866577|473262330|FG007|Overall Study|Withdrawal by Subject|0|||
131445705|NCT03866577|473262331|FG008|Overall Study|Withdrawal by Subject|1|||
131445706|NCT03866577|473262332|FG009|Overall Study|Withdrawal by Subject|1|||
131445707|NCT03866577|473262333|FG010|Overall Study|Withdrawal by Subject|0|||
131445708|NCT03866577|473262334|FG011|Overall Study|Withdrawal by Subject|0|||
131445709|NCT03866577|473262335|FG012|Overall Study|Withdrawal by Subject|0|||
131445710|NCT03866577|473262323|FG000|Overall Study|Not qualified for IVIg infusion|0|||
131445711|NCT03866577|473262324|FG001|Overall Study|Not qualified for IVIg infusion|0|||
131445712|NCT03866577|473262325|FG002|Overall Study|Not qualified for IVIg infusion|0|||
131644591|NCT02658175|473985468|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
131644592|NCT02658175|473985466|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
131445713|NCT03866577|473262326|FG003|Overall Study|Not qualified for IVIg infusion|0|||
131445714|NCT03866577|473262327|FG004|Overall Study|Not qualified for IVIg infusion|0|||
131445715|NCT03866577|473262328|FG005|Overall Study|Not qualified for IVIg infusion|0|||
131445716|NCT03866577|473262329|FG006|Overall Study|Not qualified for IVIg infusion|0|||
131445717|NCT03866577|473262330|FG007|Overall Study|Not qualified for IVIg infusion|0|||
131445718|NCT03866577|473262331|FG008|Overall Study|Not qualified for IVIg infusion|0|||
131445719|NCT03866577|473262332|FG009|Overall Study|Not qualified for IVIg infusion|1|||
131445720|NCT03866577|473262333|FG010|Overall Study|Not qualified for IVIg infusion|0|||
131445721|NCT03866577|473262334|FG011|Overall Study|Not qualified for IVIg infusion|0|||
131445722|NCT03866577|473262335|FG012|Overall Study|Not qualified for IVIg infusion|0|||
131445723|NCT04825678|473262336|FG000|Overall Study|Decision by Sponsor|2|||
131445724|NCT04825678|473262337|FG001|Overall Study|Decision by Sponsor|3|||
131445725|NCT04825678|473262336|FG000|Overall Study|Withdrawal of Consent From Study|7|||
131445726|NCT04825678|473262337|FG001|Overall Study|Withdrawal of Consent From Study|9|||
131445727|NCT04825678|473262336|FG000|Overall Study|Lost to Follow-up|3|||
131445728|NCT04825678|473262337|FG001|Overall Study|Lost to Follow-up|4|||
131445729|NCT04825678|473262336|FG000|Overall Study|Never Received Investigational Product|1|||
131445730|NCT04825678|473262337|FG001|Overall Study|Never Received Investigational Product|1|||
131445731|NCT05530252|473262338|FG000|Overall Study|Lost to Follow-up|1|||
131445732|NCT05530252|473262339|FG001|Overall Study|Lost to Follow-up|1|||
131445733|NCT05530252|473262340|FG002|Overall Study|Lost to Follow-up|1|||
131445734|NCT03818256|473262341|FG000|Overall Study|Withdrawal by Subject|2|||
131445735|NCT03818256|473262342|FG001|Overall Study|Withdrawal by Subject|2|||
131445736|NCT03818256|473262341|FG000|Overall Study|Adverse Event|3|||
131445737|NCT03818256|473262342|FG001|Overall Study|Adverse Event|1|||
131445738|NCT03818256|473262341|FG000|Overall Study|Lost to Follow-up|0|||
131445739|NCT03818256|473262342|FG001|Overall Study|Lost to Follow-up|5|||
131445740|NCT03818256|473262341|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
131445741|NCT03818256|473262342|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
131445742|NCT03818256|473262341|FG000|Overall Study|Not reporting for scheduled visits|1|||
131445743|NCT03818256|473262342|FG001|Overall Study|Not reporting for scheduled visits|0|||
131445744|NCT03818256|473262341|FG000|Overall Study|Non-compliant with investigational product|1|||
131445745|NCT03818256|473262342|FG001|Overall Study|Non-compliant with investigational product|0|||
131445746|NCT03043794|473262350|FG000|Overall Study|Lost to Follow-up|1|||
131801980|NCT03980483|474559130|FG001|Overall Study|Withdrawal by Subject|21|||
131445747|NCT04482647|473262351|FG000|Overall Study|Time constraints|2|||
131445748|NCT04482647|473262351|FG000|Overall Study|Health issues|1|||
131445749|NCT04482647|473262351|FG000|Overall Study|Death in the family|1|||
131445750|NCT04482647|473262351|FG000|Overall Study|Disliked the intervention|1|||
131445751|NCT04482647|473262351|FG000|Overall Study|No reasons specified|7|||
131801981|NCT03980483|474559131|FG002|Overall Study|Withdrawal by Subject|15|||
131801982|NCT03980483|474559132|FG003|Overall Study|Withdrawal by Subject|5|||
131801983|NCT03980483|474559133|FG004|Overall Study|Withdrawal by Subject|3|||
131801984|NCT03980483|474559134|FG005|Overall Study|Withdrawal by Subject|4|||
131801985|NCT03980483|474559129|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
131801986|NCT03980483|474559130|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
131801987|NCT03980483|474559131|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131801988|NCT03980483|474559132|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
131801989|NCT03980483|474559133|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131801990|NCT03980483|474559134|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131801991|NCT03980483|474559129|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
131801992|NCT03980483|474559130|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
131801993|NCT03980483|474559131|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
131801994|NCT03980483|474559132|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
131801995|NCT03980483|474559133|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
131801996|NCT03980483|474559134|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
131801997|NCT03980483|474559129|FG000|Overall Study|Other|0|||
131801998|NCT03980483|474559130|FG001|Overall Study|Other|1|||
131801999|NCT03980483|474559131|FG002|Overall Study|Other|0|||
131802000|NCT03980483|474559132|FG003|Overall Study|Other|0|||
131802001|NCT03980483|474559133|FG004|Overall Study|Other|0|||
131802002|NCT03980483|474559134|FG005|Overall Study|Other|0|||
131802003|NCT01225146|474559138|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
131802004|NCT01225146|474559139|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
131802005|NCT01074554|474559140|FG000|Overall Study|Adverse Event|3|||
131802006|NCT01074554|474559141|FG001|Overall Study|Adverse Event|3|||
131802007|NCT01074554|474559140|FG000|Overall Study|Lost to Follow-up|0|||
131802008|NCT01074554|474559141|FG001|Overall Study|Lost to Follow-up|1|||
131802009|NCT00220337|474559143|FG000|Overall Study|Adverse Event|70|||
131802010|NCT00220337|474559143|FG000|Overall Study|Lack of Efficacy|17|||
131802011|NCT00220337|474559143|FG000|Overall Study|Withdrawal by Subject|68|||
131644593|NCT02658175|473985467|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
131802012|NCT00220337|474559143|FG000|Overall Study|Protocol Violation|2|||
131802013|NCT00220337|474559143|FG000|Overall Study|Lost to Follow-up|5|||
131802014|NCT00220337|474559143|FG000|Overall Study|Other|12|||
131445752|NCT02855125|473262352|FG000|Overall Study|Withdrawal by Subject|2|||
131445753|NCT02855125|473262353|FG001|Overall Study|Withdrawal by Subject|2|||
131445754|NCT02855125|473262352|FG000|Overall Study|Clinical Disease Progression|5|||
131802015|NCT00220337|474559143|FG000|Overall Study|Unsatisfactory compliance|5|||
131802016|NCT00944697|474559146|FG000|Overall Study|Withdrawal by Subject|1|||
131445755|NCT02855125|473262353|FG001|Overall Study|Clinical Disease Progression|4|||
131445756|NCT02855125|473262352|FG000|Overall Study|Radiologic Disease Progression|36|||
131445757|NCT02855125|473262353|FG001|Overall Study|Radiologic Disease Progression|39|||
131445758|NCT02855125|473262352|FG000|Overall Study|Adverse Event|11|||
131445759|NCT02855125|473262353|FG001|Overall Study|Adverse Event|7|||
131445760|NCT02855125|473262352|FG000|Overall Study|Physician Decision|1|||
131445761|NCT02855125|473262353|FG001|Overall Study|Physician Decision|0|||
131445762|NCT02855125|473262352|FG000|Overall Study|On Treatment|9|||
131445763|NCT02855125|473262353|FG001|Overall Study|On Treatment|11|||
131445764|NCT02855125|473262352|FG000|Overall Study|Randomized but not treated|0|||
131445765|NCT02855125|473262353|FG001|Overall Study|Randomized but not treated|1|||
131445766|NCT04467905|473262354|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
131445767|NCT04467905|473262355|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
131445768|NCT04467905|473262356|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
131445769|NCT04467905|473262354|FG000|Overall Study|Conversion to SR|0|||
131445770|NCT04467905|473262355|FG001|Overall Study|Conversion to SR|0|||
131445771|NCT04467905|473262356|FG002|Overall Study|Conversion to SR|3|||
131445772|NCT04467905|473262354|FG000|Overall Study|Technical issue with Holter ECG|0|||
131445773|NCT04467905|473262355|FG001|Overall Study|Technical issue with Holter ECG|0|||
131445774|NCT04467905|473262356|FG002|Overall Study|Technical issue with Holter ECG|3|||
131445775|NCT04467905|473262354|FG000|Overall Study|Hemodynamic instability|0|||
131445776|NCT04467905|473262355|FG001|Overall Study|Hemodynamic instability|0|||
131445777|NCT04467905|473262356|FG002|Overall Study|Hemodynamic instability|1|||
131445778|NCT04467905|473262354|FG000|Overall Study|Site misinterpretation of protocol|0|||
131445779|NCT04467905|473262355|FG001|Overall Study|Site misinterpretation of protocol|0|||
131445780|NCT04467905|473262356|FG002|Overall Study|Site misinterpretation of protocol|1|||
131445781|NCT02484391|473262357|FG000|Overall Study|Lack of Efficacy|15|||
131445782|NCT02484391|473262358|FG001|Overall Study|Lack of Efficacy|14|||
131445783|NCT02484391|473262359|FG002|Overall Study|Lack of Efficacy|3|||
131445784|NCT02484391|473262357|FG000|Overall Study|Lost to Follow-up|0|||
131445785|NCT02484391|473262358|FG001|Overall Study|Lost to Follow-up|0|||
131445786|NCT02484391|473262359|FG002|Overall Study|Lost to Follow-up|2|||
131445787|NCT02484391|473262357|FG000|Overall Study|Physician Decision|1|||
131445788|NCT02484391|473262358|FG001|Overall Study|Physician Decision|3|||
131445789|NCT02484391|473262359|FG002|Overall Study|Physician Decision|0|||
131445790|NCT02484391|473262357|FG000|Overall Study|Went to Transplant|5|||
131445791|NCT02484391|473262358|FG001|Overall Study|Went to Transplant|3|||
131445792|NCT02484391|473262359|FG002|Overall Study|Went to Transplant|2|||
131445793|NCT00911170|473262360|FG000|Treatment Period|Randomized in error|1|||
131445794|NCT00911170|473262361|FG001|Treatment Period|Randomized in error|1|||
131445795|NCT00911170|473262360|FG000|Treatment Period|Ineligibility determined|1|||
131445796|NCT00911170|473262361|FG001|Treatment Period|Ineligibility determined|3|||
131445797|NCT00911170|473262360|FG000|Treatment Period|Protocol deviation|1|||
131445798|NCT00911170|473262361|FG001|Treatment Period|Protocol deviation|2|||
131445799|NCT00911170|473262360|FG000|Treatment Period|Adverse Event|9|||
131445800|NCT00911170|473262361|FG001|Treatment Period|Adverse Event|10|||
131445801|NCT00911170|473262360|FG000|Treatment Period|Withdrawal by Subject|4|||
131445802|NCT00911170|473262361|FG001|Treatment Period|Withdrawal by Subject|4|||
131445803|NCT00911170|473262360|FG000|Treatment Period|Disease progression|0|||
131445804|NCT00911170|473262361|FG001|Treatment Period|Disease progression|2|||
131445805|NCT00911170|473262360|FG000|Treatment Period|Physician Decision|5|||
131445806|NCT00911170|473262361|FG001|Treatment Period|Physician Decision|5|||
131445807|NCT00911170|473262360|FG000|Treatment Period|Lost to Follow-up|0|||
131445808|NCT00911170|473262361|FG001|Treatment Period|Lost to Follow-up|1|||
131445809|NCT00911170|473262360|FG000|Treatment Period|Death|6|||
131445810|NCT00911170|473262361|FG001|Treatment Period|Death|9|||
131445811|NCT00911170|473262360|FG000|Long Term Follow-Up|Continuing in study|274|||
131445812|NCT00911170|473262361|FG001|Long Term Follow-Up|Continuing in study|269|||
131445813|NCT00911170|473262360|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
131445814|NCT00911170|473262361|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
131445815|NCT00911170|473262360|FG000|Long Term Follow-Up|Physician Decision|5|||
131445816|NCT00911170|473262361|FG001|Long Term Follow-Up|Physician Decision|4|||
131445817|NCT00911170|473262360|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
131445818|NCT00911170|473262361|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
131445819|NCT00911170|473262360|FG000|Long Term Follow-Up|Death|116|||
131445820|NCT00911170|473262361|FG001|Long Term Follow-Up|Death|121|||
131644594|NCT02658175|473985468|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
131445821|NCT02514083|473262362|FG000|Overall Study|Adverse Event|1|||
131445822|NCT01671319|473265210|FG000|Overall Study|Withdrawal by Subject|1|||
131445823|NCT01389596|473265211|FG000|Overall Study|Protocol Violation|3|||
131445824|NCT01389596|473265212|FG001|Overall Study|Protocol Violation|4|||
131445825|NCT01389596|473265213|FG002|Overall Study|Protocol Violation|3|||
131445826|NCT01389596|473265211|FG000|Overall Study|Withdrawal by Subject|1|||
131445827|NCT01389596|473265212|FG001|Overall Study|Withdrawal by Subject|2|||
131715502|NCT00702143|474235517|FG000|Overall Study|Lost to Follow-up|0|||
131445828|NCT01389596|473265213|FG002|Overall Study|Withdrawal by Subject|2|||
131445829|NCT01389596|473265211|FG000|Overall Study|Insufficient Clinical Response|3|||
131445830|NCT01389596|473265212|FG001|Overall Study|Insufficient Clinical Response|4|||
131445831|NCT01389596|473265213|FG002|Overall Study|Insufficient Clinical Response|5|||
131445832|NCT01389596|473265211|FG000|Overall Study|Adverse Event|1|||
131445833|NCT01389596|473265212|FG001|Overall Study|Adverse Event|4|||
131445834|NCT01389596|473265213|FG002|Overall Study|Adverse Event|0|||
131445835|NCT01389596|473265211|FG000|Overall Study|Death|0|||
131445836|NCT01389596|473265212|FG001|Overall Study|Death|1|||
131445837|NCT01389596|473265213|FG002|Overall Study|Death|0|||
131445838|NCT01389596|473265211|FG000|Overall Study|Other Unspecified|2|||
131445839|NCT01389596|473265212|FG001|Overall Study|Other Unspecified|1|||
131445840|NCT01389596|473265213|FG002|Overall Study|Other Unspecified|0|||
131445841|NCT01709084|473265214|FG000|Overall Study|Lost to Follow-up|4|||
131445842|NCT01709084|473265215|FG001|Overall Study|Lost to Follow-up|7|||
131445843|NCT01709084|473265214|FG000|Overall Study|Withdrawal by Subject|2|||
131445844|NCT01709084|473265215|FG001|Overall Study|Withdrawal by Subject|2|||
131445845|NCT01709084|473265214|FG000|Overall Study|Adverse Event|5|||
131445846|NCT01709084|473265215|FG001|Overall Study|Adverse Event|0|||
131445847|NCT01709084|473265214|FG000|Overall Study|Other|5|||
131445848|NCT01709084|473265215|FG001|Overall Study|Other|3|||
131445849|NCT01709084|473265214|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
131445850|NCT01709084|473265215|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
131445851|NCT01709084|473265214|FG000|Overall Study|Not Treated|0|||
131445852|NCT01709084|473265215|FG001|Overall Study|Not Treated|2|||
131445853|NCT02144610|473265216|FG000|Overall Study|Physician Decision|1|||
131445854|NCT02144610|473265217|FG001|Overall Study|Physician Decision|0|||
131445855|NCT02144610|473265216|FG000|Overall Study|Withdrawal by Subject|1|||
131445856|NCT02144610|473265217|FG001|Overall Study|Withdrawal by Subject|5|||
131445857|NCT02144610|473265216|FG000|Overall Study|Death|2|||
131445858|NCT02144610|473265217|FG001|Overall Study|Death|2|||
131445859|NCT02144610|473265216|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
131445860|NCT02144610|473265217|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
131445861|NCT02144610|473265216|FG000|Overall Study|Other|0|||
131445862|NCT02144610|473265217|FG001|Overall Study|Other|1|||
131644595|NCT02658175|473985466|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
131644596|NCT02658175|473985467|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
131644597|NCT02658175|473985468|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
131644598|NCT02658175|473985466|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
131644599|NCT02658175|473985467|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
131644600|NCT02658175|473985468|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
131644601|NCT02658175|473985466|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
131644602|NCT02658175|473985467|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
131644603|NCT02658175|473985468|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
131644604|NCT02658175|473985466|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
131644605|NCT02658175|473985467|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
131644606|NCT02658175|473985468|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
131644607|NCT02554383|473985472|FG000|Overall Study|Ineligible|3|||
131644608|NCT02554383|473985473|FG001|Overall Study|Ineligible|2|||
131644609|NCT02554383|473985472|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
131644610|NCT02554383|473985473|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
131644611|NCT02554383|473985472|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
131644612|NCT02554383|473985473|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
131644613|NCT02554383|473985472|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
131644614|NCT02554383|473985473|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
131445863|NCT01054885|473265218|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
131445864|NCT01054885|473265219|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131445865|NCT01054885|473265220|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131445866|NCT01054885|473265221|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131445867|NCT01054885|473265222|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131445868|NCT01054885|473265223|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131445869|NCT01054885|473265224|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131445870|NCT01054885|473265218|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
131445871|NCT01054885|473265219|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
131445872|NCT01054885|473265220|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
131445873|NCT01054885|473265221|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
131445874|NCT01054885|473265222|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
131445875|NCT01054885|473265223|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
131445876|NCT01054885|473265224|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
131445877|NCT01054885|473265218|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
131445878|NCT01054885|473265219|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131445879|NCT01054885|473265220|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131445880|NCT01054885|473265221|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131445881|NCT01054885|473265222|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131445882|NCT01054885|473265223|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131445883|NCT01054885|473265224|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131445884|NCT01054885|473265218|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
131445885|NCT01054885|473265219|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131445886|NCT01054885|473265220|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131445887|NCT01054885|473265221|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131445888|NCT01054885|473265222|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131445889|NCT01054885|473265223|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131445890|NCT01054885|473265224|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131445891|NCT01054885|473265218|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
131445892|NCT01054885|473265219|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
131445893|NCT01054885|473265220|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
131445894|NCT01054885|473265221|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
131445895|NCT01054885|473265222|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
131445896|NCT01054885|473265223|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
131445897|NCT01054885|473265224|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
131445898|NCT01054885|473265218|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
131445899|NCT01054885|473265219|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131445900|NCT01054885|473265220|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131445901|NCT01054885|473265221|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131445902|NCT01054885|473265222|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131445903|NCT01054885|473265223|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131445904|NCT01054885|473265224|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131445905|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
131445906|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
131445907|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
131445908|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
131445909|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
131445910|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
131445911|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
131445912|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131445913|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131445914|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
131445915|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
131445916|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131445917|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
131644615|NCT01801982|473985476|FG000|Overall Study|Lost to Follow-up|1|||
131644616|NCT02918292|473985477|FG000|Study Enrollment Prior to Transplant|Death|1|||
131644617|NCT02918292|473985477|FG000|Study Follow up After Transplant|Death|6|||
131644618|NCT01185171|473985478|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
131644619|NCT01185171|473985478|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
131644620|NCT01185171|473985478|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
131644621|NCT01185171|473985478|FG000|Maintenance|Elevated liver transaminases|3|||
131644622|NCT01185171|473985478|FG000|Maintenance|Rush|2|||
131644623|NCT01185171|473985478|FG000|Maintenance|Diarrhea|1|||
131644624|NCT01185171|473985478|FG000|Maintenance|Xerostomia|1|||
131644625|NCT01185171|473985478|FG000|Maintenance|Nausea|1|||
131644626|NCT01185171|473985478|FG000|Maintenance|Comorbid Illness|2|||
131644627|NCT01185171|473985478|FG000|Maintenance|Withdrawal by Subject|1|||
131644628|NCT01185171|473985478|FG000|Maintenance|Disease Recurrence|1|||
131644629|NCT00727506|473985479|FG000|Overall Study|Adverse Event|0|||
131644630|NCT00727506|473985480|FG001|Overall Study|Adverse Event|0|||
131644631|NCT00727506|473985481|FG002|Overall Study|Adverse Event|4|||
131644632|NCT00727506|473985482|FG003|Overall Study|Adverse Event|4|||
131644633|NCT00727506|473985483|FG004|Overall Study|Adverse Event|1|||
131644634|NCT00727506|473985484|FG005|Overall Study|Adverse Event|8|||
131644635|NCT00727506|473985479|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131644636|NCT00727506|473985480|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131644637|NCT00727506|473985481|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131644638|NCT00727506|473985482|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131644639|NCT00727506|473985483|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131644640|NCT00727506|473985484|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131644641|NCT00727506|473985479|FG000|Overall Study|Progressive disease|4|||
131644642|NCT00727506|473985480|FG001|Overall Study|Progressive disease|7|||
131644643|NCT00727506|473985481|FG002|Overall Study|Progressive disease|9|||
131644644|NCT00727506|473985482|FG003|Overall Study|Progressive disease|28|||
131644645|NCT00727506|473985483|FG004|Overall Study|Progressive disease|38|||
131644646|NCT00727506|473985484|FG005|Overall Study|Progressive disease|28|||
131644647|NCT00727506|473985479|FG000|Overall Study|Refused to continue medication|0|||
131644648|NCT00727506|473985480|FG001|Overall Study|Refused to continue medication|1|||
131644649|NCT00727506|473985481|FG002|Overall Study|Refused to continue medication|2|||
131644650|NCT00727506|473985482|FG003|Overall Study|Refused to continue medication|3|||
131644651|NCT00727506|473985483|FG004|Overall Study|Refused to continue medication|1|||
131644652|NCT00727506|473985484|FG005|Overall Study|Refused to continue medication|2|||
131644653|NCT00727506|473985479|FG000|Overall Study|Other reason not described above|0|||
131644654|NCT00727506|473985480|FG001|Overall Study|Other reason not described above|0|||
131644655|NCT00727506|473985481|FG002|Overall Study|Other reason not described above|1|||
131644656|NCT00727506|473985482|FG003|Overall Study|Other reason not described above|4|||
131644657|NCT00727506|473985483|FG004|Overall Study|Other reason not described above|1|||
131644658|NCT00727506|473985484|FG005|Overall Study|Other reason not described above|1|||
131644659|NCT01482429|473985485|FG000|Care Usual|Protocol Violation|0|||
131644660|NCT01482429|473985486|FG001|Care Usual|Protocol Violation|172|||
131644661|NCT01482429|473985485|FG000|Care Usual|Lost to Follow-up|0|||
131644662|NCT01482429|473985486|FG001|Care Usual|Lost to Follow-up|1|||
131644663|NCT01482429|473985485|FG000|Protocol|Protocol Violation|275|||
131644664|NCT01482429|473985486|FG001|Protocol|Protocol Violation|0|||
131644665|NCT01214421|473985487|FG000|Overall Study|Lost to Follow-up|7|||
131644666|NCT01214421|473985488|FG001|Overall Study|Lost to Follow-up|3|||
131644667|NCT01214421|473985489|FG002|Overall Study|Lost to Follow-up|7|||
131903025|NCT00676403|474931364|FG000|Overall Study|Withdrawal by Subject|0|||
131445918|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131445919|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
131445920|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
131445921|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
131445922|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
131445923|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
131445924|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
131445925|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
131445926|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131445927|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
131445928|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
131445929|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
131445930|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
131445931|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
131445932|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
131445933|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
131445934|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
131445935|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
131445936|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
131445937|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
131445938|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
131445939|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
131445940|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
131445941|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
131445942|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
131445943|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
131445944|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
131445945|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
131445946|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
131445947|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131445948|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
131445949|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
131445950|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131445951|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131445952|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
131445953|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131644668|NCT01214421|473985490|FG003|Overall Study|Lost to Follow-up|3|||
131644669|NCT01214421|473985487|FG000|Overall Study|Adverse Event|16|||
131644670|NCT01214421|473985488|FG001|Overall Study|Adverse Event|35|||
131644671|NCT01214421|473985489|FG002|Overall Study|Adverse Event|14|||
131644672|NCT01214421|473985490|FG003|Overall Study|Adverse Event|3|||
131644673|NCT01214421|473985487|FG000|Overall Study|Sponsor Discontinued Site|1|||
131644674|NCT01214421|473985488|FG001|Overall Study|Sponsor Discontinued Site|2|||
131644675|NCT01214421|473985489|FG002|Overall Study|Sponsor Discontinued Site|0|||
131644676|NCT01214421|473985490|FG003|Overall Study|Sponsor Discontinued Site|0|||
131644677|NCT01214421|473985487|FG000|Overall Study|Withdrawal Criteria Met|3|||
131644678|NCT01214421|473985488|FG001|Overall Study|Withdrawal Criteria Met|0|||
131644679|NCT01214421|473985489|FG002|Overall Study|Withdrawal Criteria Met|2|||
131644680|NCT01214421|473985490|FG003|Overall Study|Withdrawal Criteria Met|1|||
131644681|NCT01214421|473985487|FG000|Overall Study|Physician Decision|2|||
131644682|NCT01214421|473985488|FG001|Overall Study|Physician Decision|0|||
131445954|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
131445955|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
131445956|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
131445957|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
131445958|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
131445959|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
131445960|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
131445961|NCT01054885|473265218|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131445962|NCT01054885|473265219|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
131445963|NCT01054885|473265220|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
131445964|NCT01054885|473265221|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
131445965|NCT01054885|473265222|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
131445966|NCT01054885|473265223|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
131445967|NCT01054885|473265224|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
131445968|NCT00214201|473265226|FG000|Overall Study|Withdrawal by Subject|2|||
131445969|NCT00214201|473265227|FG001|Overall Study|Withdrawal by Subject|0|||
131445970|NCT00214201|473265226|FG000|Overall Study|Death|0|||
131445971|NCT00214201|473265227|FG001|Overall Study|Death|2|||
131445972|NCT01198795|473265231|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
131445973|NCT01198795|473265231|FG000|Overall Study|Withdrawal by Subject|17|||
131445974|NCT01198795|473265231|FG000|Overall Study|Lost to Follow-up|15|||
131644683|NCT01214421|473985489|FG002|Overall Study|Physician Decision|4|||
131644684|NCT01214421|473985490|FG003|Overall Study|Physician Decision|0|||
131644685|NCT01214421|473985487|FG000|Overall Study|Withdrawal by Subject|21|||
131445975|NCT01198795|473265231|FG000|Overall Study|Adverse Event|9|||
131445976|NCT01198795|473265231|FG000|Overall Study|Lack of Efficacy|5|||
131445977|NCT01198795|473265231|FG000|Overall Study|Protocol Violation|2|||
131445978|NCT01198795|473265231|FG000|Overall Study|Other Reason|4|||
131445979|NCT00744497|473265232|FG000|Overall Study|Withdrawal by Subject|21|||
131445980|NCT00744497|473265233|FG001|Overall Study|Withdrawal by Subject|18|||
131445981|NCT00744497|473265232|FG000|Overall Study|Death|11|||
131445982|NCT00744497|473265233|FG001|Overall Study|Death|9|||
131445983|NCT00744497|473265232|FG000|Overall Study|Lost to Follow-up|4|||
131445984|NCT00744497|473265233|FG001|Overall Study|Lost to Follow-up|2|||
131445985|NCT00744497|473265232|FG000|Overall Study|Poor compliance/noncompliance|9|||
131445986|NCT00744497|473265233|FG001|Overall Study|Poor compliance/noncompliance|5|||
131445987|NCT00744497|473265232|FG000|Overall Study|No longer meets study criteria|7|||
131445988|NCT00744497|473265233|FG001|Overall Study|No longer meets study criteria|3|||
131445989|NCT00744497|473265232|FG000|Overall Study|Administrative Reason By Sponsor|25|||
131445990|NCT00744497|473265233|FG001|Overall Study|Administrative Reason By Sponsor|8|||
131445991|NCT00744497|473265232|FG000|Overall Study|Disease progression|312|||
131445992|NCT00744497|473265233|FG001|Overall Study|Disease progression|219|||
131445993|NCT00744497|473265232|FG000|Overall Study|Study drug toxicity|68|||
131445994|NCT00744497|473265233|FG001|Overall Study|Study drug toxicity|141|||
131445995|NCT00744497|473265232|FG000|Overall Study|Adverse event unrelated to study drug|78|||
131445996|NCT00744497|473265233|FG001|Overall Study|Adverse event unrelated to study drug|122|||
131445997|NCT00744497|473265232|FG000|Overall Study|Patient requested to stop study drug|65|||
131445998|NCT00744497|473265233|FG001|Overall Study|Patient requested to stop study drug|80|||
131445999|NCT00744497|473265232|FG000|Overall Study|Maximum clinical benefit|141|||
131446000|NCT00744497|473265233|FG001|Overall Study|Maximum clinical benefit|142|||
131446001|NCT00744497|473265232|FG000|Overall Study|Not defined|19|||
131446002|NCT00744497|473265233|FG001|Overall Study|Not defined|13|||
131446003|NCT04154904|473265266|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
131446004|NCT04154904|473265267|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
131446005|NCT04154904|473265268|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
131446006|NCT00936715|473265269|FG000|Overall Study|Investigators Discretion|1|||
131644686|NCT01214421|473985488|FG001|Overall Study|Withdrawal by Subject|18|||
131644687|NCT01214421|473985489|FG002|Overall Study|Withdrawal by Subject|11|||
131446007|NCT00936715|473265269|FG000|Overall Study|Protocol Violation|1|||
131446008|NCT00936715|473265269|FG000|Overall Study|Safety or Tolerability Reasons|4|||
131446009|NCT03819114|473265270|FG000|Overall Study|Protocol Violation|0|||
131446010|NCT03819114|473265271|FG001|Overall Study|Protocol Violation|1|||
131446011|NCT03819114|473265272|FG002|Overall Study|Protocol Violation|1|||
131446012|NCT03819114|473265273|FG003|Overall Study|Protocol Violation|0|||
131446013|NCT03819114|473265270|FG000|Overall Study|Lost to Follow-up|0|||
131446014|NCT03819114|473265271|FG001|Overall Study|Lost to Follow-up|0|||
131446015|NCT03819114|473265272|FG002|Overall Study|Lost to Follow-up|1|||
131446016|NCT03819114|473265273|FG003|Overall Study|Lost to Follow-up|0|||
131446017|NCT04226742|473265274|FG000|Overall Study|Lost to Follow-up|16|||
131446018|NCT04226742|473265275|FG001|Overall Study|Lost to Follow-up|13|||
131446019|NCT04226742|473265274|FG000|Overall Study|Withdrawal by Subject|5|||
131446020|NCT04226742|473265275|FG001|Overall Study|Withdrawal by Subject|3|||
131446021|NCT02492763|473265276|FG000|Overall Study|Withdrawal by Subject|0|||
131446022|NCT02492763|473265277|FG001|Overall Study|Withdrawal by Subject|2|||
131446023|NCT02492763|473265278|FG002|Overall Study|Withdrawal by Subject|1|||
131446024|NCT02492763|473265279|FG003|Overall Study|Withdrawal by Subject|0|||
131446025|NCT02492763|473265276|FG000|Overall Study|Adverse Event|3|||
131446026|NCT02492763|473265277|FG001|Overall Study|Adverse Event|1|||
131644688|NCT01214421|473985490|FG003|Overall Study|Withdrawal by Subject|2|||
131644689|NCT03561597|473985491|FG000|Overall Study|Lost to Follow-up|20|||
131644690|NCT03783689|473985493|FG000|Overall Study|Adverse Event|2|||
131644691|NCT03783689|473985494|FG001|Overall Study|Adverse Event|0|||
131644692|NCT03783689|473985493|FG000|Overall Study|Lost to Follow-up|2|||
131644693|NCT03783689|473985494|FG001|Overall Study|Lost to Follow-up|1|||
131644694|NCT03783689|473985493|FG000|Overall Study|Physician Decision|2|||
131644695|NCT03783689|473985494|FG001|Overall Study|Physician Decision|1|||
131644696|NCT03783689|473985493|FG000|Overall Study|Withdrawal by Subject|3|||
131644697|NCT03783689|473985494|FG001|Overall Study|Withdrawal by Subject|3|||
131644698|NCT04680637|473985497|FG000|Overall Study|Lost to Follow-up|0|||
131644699|NCT04680637|473985498|FG001|Overall Study|Lost to Follow-up|1|||
131644700|NCT04680637|473985499|FG002|Overall Study|Lost to Follow-up|0|||
131644701|NCT04680637|473985500|FG003|Overall Study|Lost to Follow-up|1|||
131644702|NCT04680637|473985497|FG000|Overall Study|Death|1|||
131644703|NCT04680637|473985498|FG001|Overall Study|Death|0|||
131644704|NCT04680637|473985499|FG002|Overall Study|Death|0|||
131644705|NCT04680637|473985500|FG003|Overall Study|Death|0|||
131644706|NCT04680637|473985497|FG000|Overall Study|Withdrawal by Subject|7|||
131644707|NCT04680637|473985498|FG001|Overall Study|Withdrawal by Subject|10|||
131644708|NCT04680637|473985499|FG002|Overall Study|Withdrawal by Subject|17|||
131802017|NCT00944697|474559147|FG001|Overall Study|Withdrawal by Subject|1|||
131802018|NCT00944697|474559146|FG000|Overall Study|Adverse Event|0|||
131802019|NCT00944697|474559147|FG001|Overall Study|Adverse Event|3|||
131802020|NCT00944697|474559146|FG000|Overall Study|Administrative|1|||
131802021|NCT00944697|474559147|FG001|Overall Study|Administrative|1|||
131802022|NCT00745095|474559151|FG000|Overall Study|Declined to participate|1|||
131802023|NCT00745095|474559152|FG001|Overall Study|Declined to participate|0|||
131802024|NCT00745095|474559153|FG002|Overall Study|Declined to participate|0|||
131802025|NCT00745095|474559154|FG003|Overall Study|Declined to participate|0|||
131802026|NCT00745095|474559155|FG004|Overall Study|Declined to participate|92|||
131802027|NCT00745095|474559156|FG005|Overall Study|Declined to participate|95|||
131802028|NCT00745095|474559151|FG000|Overall Study|Ineligible due to GFR criteria|0|||
131802029|NCT00745095|474559152|FG001|Overall Study|Ineligible due to GFR criteria|2|||
131802030|NCT00745095|474559153|FG002|Overall Study|Ineligible due to GFR criteria|3|||
131802031|NCT00745095|474559154|FG003|Overall Study|Ineligible due to GFR criteria|3|||
131802032|NCT00745095|474559155|FG004|Overall Study|Ineligible due to GFR criteria|30|||
131802033|NCT00745095|474559156|FG005|Overall Study|Ineligible due to GFR criteria|28|||
131802034|NCT00958243|474559157|FG000|Overall Study|Withdrawal by Subject|0|||
131802035|NCT00958243|474559158|FG001|Overall Study|Withdrawal by Subject|1|||
131802036|NCT00958243|474559159|FG002|Overall Study|Withdrawal by Subject|3|||
131802037|NCT00958243|474559160|FG003|Overall Study|Withdrawal by Subject|1|||
131802038|NCT00958243|474559161|FG004|Overall Study|Withdrawal by Subject|1|||
131802039|NCT00958243|474559162|FG005|Overall Study|Withdrawal by Subject|5|||
131802040|NCT00958243|474559157|FG000|Overall Study|Lost to Follow-up|2|||
131802041|NCT00958243|474559158|FG001|Overall Study|Lost to Follow-up|5|||
131802042|NCT00958243|474559159|FG002|Overall Study|Lost to Follow-up|11|||
131802043|NCT00958243|474559160|FG003|Overall Study|Lost to Follow-up|2|||
131802044|NCT00958243|474559161|FG004|Overall Study|Lost to Follow-up|8|||
131644709|NCT04680637|473985500|FG003|Overall Study|Withdrawal by Subject|15|||
131644710|NCT04680637|473985497|FG000|Overall Study|Decision by Sponsor|21|||
131644711|NCT04680637|473985498|FG001|Overall Study|Decision by Sponsor|15|||
131802045|NCT00958243|474559162|FG005|Overall Study|Lost to Follow-up|5|||
131802046|NCT01974141|474559165|FG000|Overall Study|Other Reasons|28|||
131802047|NCT01974141|474559166|FG001|Overall Study|Other Reasons|18|||
131802048|NCT01974141|474559165|FG000|Overall Study|Protocol Violation|2|||
131802049|NCT01974141|474559166|FG001|Overall Study|Protocol Violation|6|||
131802050|NCT01974141|474559165|FG000|Overall Study|Personal Reasons|21|||
131644712|NCT04680637|473985499|FG002|Overall Study|Decision by Sponsor|7|||
131802051|NCT01974141|474559166|FG001|Overall Study|Personal Reasons|20|||
131446027|NCT02492763|473265278|FG002|Overall Study|Adverse Event|1|||
131446028|NCT02492763|473265279|FG003|Overall Study|Adverse Event|2|||
131446029|NCT02492763|473265276|FG000|Overall Study|Death|0|||
131644713|NCT04680637|473985500|FG003|Overall Study|Decision by Sponsor|32|||
131644714|NCT02037256|473985501|FG000|Overall Study|Protocol Violation|0|||
131644715|NCT02037256|473985502|FG001|Overall Study|Protocol Violation|1|||
131644716|NCT02037256|473985501|FG000|Overall Study|Withdrawn prior to Velcade|0|||
131644717|NCT02037256|473985502|FG001|Overall Study|Withdrawn prior to Velcade|2|||
131644718|NCT02388347|473986811|FG000|Overall Study|Withdrawal by Subject|0|||
131644719|NCT02388347|473986812|FG001|Overall Study|Withdrawal by Subject|0|||
131644720|NCT02388347|473986813|FG002|Overall Study|Withdrawal by Subject|1|||
131644721|NCT02388347|473986814|FG003|Overall Study|Withdrawal by Subject|0|||
131644722|NCT02388347|473986815|FG004|Overall Study|Withdrawal by Subject|0|||
131644723|NCT01845805|473986816|FG000|Overall Study|Withdrawal by Subject|1|||
131644724|NCT01845805|473986817|FG001|Overall Study|Withdrawal by Subject|2|||
131644725|NCT01845805|473986816|FG000|Overall Study|Disease Progression|13|||
131644726|NCT01845805|473986817|FG001|Overall Study|Disease Progression|14|||
131644727|NCT01845805|473986816|FG000|Overall Study|Drug-related Toxicity|4|||
131446030|NCT02492763|473265277|FG001|Overall Study|Death|0|||
131446031|NCT02492763|473265278|FG002|Overall Study|Death|1|||
131446032|NCT02492763|473265279|FG003|Overall Study|Death|0|||
131446033|NCT02492763|473265276|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
131446034|NCT02492763|473265277|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
131446035|NCT02492763|473265278|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
131446036|NCT02492763|473265279|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
131446037|NCT02492763|473265276|FG000|Overall Study|Lost to Follow-up|0|||
131446038|NCT02492763|473265277|FG001|Overall Study|Lost to Follow-up|0|||
131446039|NCT02492763|473265278|FG002|Overall Study|Lost to Follow-up|1|||
131446040|NCT02492763|473265279|FG003|Overall Study|Lost to Follow-up|0|||
131446041|NCT02492763|473265276|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131446042|NCT02492763|473265277|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131446043|NCT02492763|473265278|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131446044|NCT02492763|473265279|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131446045|NCT02492763|473265276|FG000|Overall Study|Screen Failure|0|||
131446046|NCT02492763|473265277|FG001|Overall Study|Screen Failure|0|||
131446047|NCT02492763|473265278|FG002|Overall Study|Screen Failure|0|||
131446048|NCT02492763|473265279|FG003|Overall Study|Screen Failure|1|||
131446049|NCT02492763|473265276|FG000|Overall Study|Study Terminated by Sponsor|13|||
131446050|NCT02492763|473265277|FG001|Overall Study|Study Terminated by Sponsor|10|||
131446051|NCT02492763|473265278|FG002|Overall Study|Study Terminated by Sponsor|6|||
131446052|NCT02492763|473265279|FG003|Overall Study|Study Terminated by Sponsor|10|||
131446053|NCT01337960|473265280|FG000|Overall Study|Lost to Follow-up|1|||
131446054|NCT01337960|473265281|FG001|Overall Study|Lost to Follow-up|0|||
131446055|NCT01337960|473265282|FG002|Overall Study|Lost to Follow-up|0|||
131446056|NCT01337960|473265280|FG000|Overall Study|Withdrawal by Subject|1|||
131446057|NCT01337960|473265281|FG001|Overall Study|Withdrawal by Subject|0|||
131446058|NCT01337960|473265282|FG002|Overall Study|Withdrawal by Subject|0|||
131446059|NCT01772316|473265283|FG000|Overall Study|Serious adverse event|1|||
131446060|NCT01772316|473265283|FG000|Overall Study|Inform consent withdrawn|1|||
131446061|NCT01772316|473265283|FG000|Overall Study|Withdrawn by sponsor decision|5|||
131446062|NCT00914316|473265287|FG000|Phase 1|Physician Decision|4|||
131446063|NCT00914316|473265288|FG001|Phase 1|Physician Decision|0|||
131446064|NCT00914316|473265289|FG002|Phase 1|Physician Decision|1|||
131644728|NCT01845805|473986817|FG001|Overall Study|Drug-related Toxicity|0|||
131644729|NCT02820597|473986819|FG000|Overall Study|Lost to Follow-up|12|||
131644730|NCT00575042|473986820|FG000|Overall Study|Adverse Event|2|||
131644731|NCT00575042|473986820|FG000|Overall Study|Lost to Follow-up|1|||
131644732|NCT04795336|473986821|FG000|Overall Study|Withdrawal by Subject|3|||
131644733|NCT04795336|473986822|FG001|Overall Study|Withdrawal by Subject|4|||
131644734|NCT04795336|473986823|FG002|Overall Study|Withdrawal by Subject|3|||
131446065|NCT00914316|473265290|FG003|Phase 1|Physician Decision|2|||
131644735|NCT04795336|473986824|FG003|Overall Study|Withdrawal by Subject|12|||
131644736|NCT04795336|473986821|FG000|Overall Study|Lost study logs|0|||
131644737|NCT04795336|473986822|FG001|Overall Study|Lost study logs|1|||
131644738|NCT04795336|473986823|FG002|Overall Study|Lost study logs|0|||
131644739|NCT04795336|473986824|FG003|Overall Study|Lost study logs|2|||
131802052|NCT01974141|474559165|FG000|Overall Study|Lost to Follow-up|38|||
131644740|NCT04795336|473986821|FG000|Overall Study|Did not take study medication|2|||
131644741|NCT04795336|473986822|FG001|Overall Study|Did not take study medication|0|||
131644742|NCT04795336|473986823|FG002|Overall Study|Did not take study medication|0|||
131644743|NCT04795336|473986824|FG003|Overall Study|Did not take study medication|0|||
131446066|NCT00914316|473265287|FG000|Phase 1|Withdrawal by Subject|0|||
131446067|NCT00914316|473265288|FG001|Phase 1|Withdrawal by Subject|2|||
131644744|NCT03898700|473986825|FG000|Overall Study|Withdrawal by Subject|2|||
131644745|NCT02666664|473986826|FG000|Overall Study|Physician Decision|0|||
131446068|NCT00914316|473265289|FG002|Phase 1|Withdrawal by Subject|4|||
131446069|NCT00914316|473265290|FG003|Phase 1|Withdrawal by Subject|0|||
131446070|NCT00914316|473265287|FG000|Phase 1|Adverse Event|1|||
131446071|NCT00914316|473265288|FG001|Phase 1|Adverse Event|0|||
131446072|NCT00914316|473265289|FG002|Phase 1|Adverse Event|0|||
131446073|NCT00914316|473265290|FG003|Phase 1|Adverse Event|0|||
131644746|NCT02666664|473986827|FG001|Overall Study|Physician Decision|1|||
131644747|NCT02666664|473986826|FG000|Overall Study|Protocol Violation|0|||
131644748|NCT02666664|473986827|FG001|Overall Study|Protocol Violation|2|||
131644749|NCT02666664|473986826|FG000|Overall Study|Other|0|||
131644750|NCT02666664|473986827|FG001|Overall Study|Other|1|||
131644751|NCT02666664|473986826|FG000|Overall Study|Adverse Event|12|||
131644752|NCT02666664|473986827|FG001|Overall Study|Adverse Event|37|||
131644753|NCT02666664|473986826|FG000|Overall Study|Withdrawal by participant|23|||
131903026|NCT00676403|474931365|FG001|Overall Study|Withdrawal by Subject|0|||
131903027|NCT00676403|474931366|FG002|Overall Study|Withdrawal by Subject|0|||
131446074|NCT00914316|473265287|FG000|Phase 2|Withdrawal by Subject|1|||
131446075|NCT00914316|473265288|FG001|Phase 2|Withdrawal by Subject|0|||
131644754|NCT02666664|473986827|FG001|Overall Study|Withdrawal by participant|40|||
131644755|NCT02666664|473986826|FG000|Overall Study|Sponsor decision|0|||
131903028|NCT00676403|474931367|FG003|Overall Study|Withdrawal by Subject|0|||
131446076|NCT00914316|473265289|FG002|Phase 2|Withdrawal by Subject|1|||
131446077|NCT00914316|473265290|FG003|Phase 2|Withdrawal by Subject|0|||
131446078|NCT01759446|473265292|FG000|Overall Study|Protocol Violation|1|||
131446079|NCT01759446|473265293|FG001|Overall Study|Protocol Violation|0|||
131644756|NCT02666664|473986827|FG001|Overall Study|Sponsor decision|1|||
131446080|NCT01759446|473265294|FG002|Overall Study|Protocol Violation|1|||
131446081|NCT01759446|473265295|FG003|Overall Study|Protocol Violation|0|||
131446082|NCT01759446|473265296|FG004|Overall Study|Protocol Violation|0|||
131446083|NCT01759446|473265292|FG000|Overall Study|Withdrawal by Subject|0|||
131446084|NCT01759446|473265293|FG001|Overall Study|Withdrawal by Subject|1|||
131446085|NCT01759446|473265294|FG002|Overall Study|Withdrawal by Subject|0|||
131644757|NCT02666664|473986826|FG000|Overall Study|Lost to Follow-up|1|||
131644758|NCT02666664|473986827|FG001|Overall Study|Lost to Follow-up|2|||
131644759|NCT03616964|473986828|FG000|Overall Study|Adverse Event|15|||
131644760|NCT03616964|473986829|FG001|Overall Study|Adverse Event|10|||
131644761|NCT03616964|473986830|FG002|Overall Study|Adverse Event|16|||
131644762|NCT03616964|473986828|FG000|Overall Study|Death|3|||
131644763|NCT03616964|473986829|FG001|Overall Study|Death|0|||
131644764|NCT03616964|473986830|FG002|Overall Study|Death|4|||
131644765|NCT03616964|473986828|FG000|Overall Study|Lack of Efficacy|4|||
131644766|NCT03616964|473986829|FG001|Overall Study|Lack of Efficacy|8|||
131644767|NCT03616964|473986830|FG002|Overall Study|Lack of Efficacy|8|||
131644768|NCT03616964|473986828|FG000|Overall Study|Lost to Follow-up|2|||
131644769|NCT03616964|473986829|FG001|Overall Study|Lost to Follow-up|1|||
131644770|NCT03616964|473986830|FG002|Overall Study|Lost to Follow-up|3|||
131644771|NCT03616964|473986828|FG000|Overall Study|Withdrawal by Subject|18|||
131644772|NCT03616964|473986829|FG001|Overall Study|Withdrawal by Subject|14|||
131644773|NCT03616964|473986830|FG002|Overall Study|Withdrawal by Subject|21|||
131644774|NCT03616964|473986828|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
131446086|NCT01759446|473265295|FG003|Overall Study|Withdrawal by Subject|1|||
131446087|NCT01759446|473265296|FG004|Overall Study|Withdrawal by Subject|0|||
131446088|NCT01907854|473265301|FG000|Overall Study|Protocol Violation|1|||
131446089|NCT01907854|473265302|FG001|Overall Study|Protocol Violation|1|||
131446090|NCT01907854|473265301|FG000|Overall Study|Withdrawal by Subject|9|||
131446091|NCT01907854|473265302|FG001|Overall Study|Withdrawal by Subject|7|||
131446092|NCT01907854|473265301|FG000|Overall Study|Lost to Follow-up|2|||
131446093|NCT01907854|473265302|FG001|Overall Study|Lost to Follow-up|2|||
131446094|NCT01907854|473265301|FG000|Overall Study|Unclassified|4|||
131446095|NCT01907854|473265302|FG001|Overall Study|Unclassified|3|||
131446096|NCT02215252|473265303|FG000|Overall Study|Adverse Event|1|||
131446097|NCT02215252|473265304|FG001|Overall Study|Adverse Event|5|||
131446098|NCT02215252|473265305|FG002|Overall Study|Adverse Event|2|||
131446099|NCT02215252|473265303|FG000|Overall Study|Lost to Follow-up|0|||
131446100|NCT02215252|473265304|FG001|Overall Study|Lost to Follow-up|0|||
131446101|NCT02215252|473265305|FG002|Overall Study|Lost to Follow-up|1|||
131446102|NCT02215252|473265303|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
131446103|NCT02215252|473265304|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
131446104|NCT02215252|473265305|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
131446105|NCT02215252|473265303|FG000|Overall Study|Protocol Violation|0|||
131446106|NCT02215252|473265304|FG001|Overall Study|Protocol Violation|1|||
131446107|NCT02215252|473265305|FG002|Overall Study|Protocol Violation|0|||
131446108|NCT02215252|473265303|FG000|Overall Study|Withdrawal by Subject|1|||
131446109|NCT02215252|473265304|FG001|Overall Study|Withdrawal by Subject|0|||
131446110|NCT02215252|473265305|FG002|Overall Study|Withdrawal by Subject|0|||
131446111|NCT02215252|473265303|FG000|Overall Study|Other|0|||
131446112|NCT02215252|473265304|FG001|Overall Study|Other|1|||
131446113|NCT02215252|473265305|FG002|Overall Study|Other|1|||
131446114|NCT02633306|473265306|FG000|Overall Study|Withdrawal by Subject|3|||
131446115|NCT01213472|473265308|FG000|Overall Study|Recurrence/Progressive disease|25|||
131446116|NCT01213472|473265308|FG000|Overall Study|Withdrawal by Subject|1|||
131446117|NCT01213472|473265308|FG000|Overall Study|Physician Decision|1|||
131446118|NCT01472289|473265311|FG000|Overall Study|Death|2|||
131644775|NCT03616964|473986829|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
131644776|NCT03616964|473986830|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
131715503|NCT00702143|474235518|FG001|Overall Study|Lost to Follow-up|0|||
131715504|NCT00702143|474235519|FG002|Overall Study|Lost to Follow-up|1|||
131446119|NCT03879772|473265312|FG000|Overall Study|Adverse Event|2|||
131446120|NCT03879772|473265313|FG001|Overall Study|Adverse Event|2|||
131446121|NCT03879772|473265314|FG002|Overall Study|Adverse Event|3|||
131446122|NCT03879772|473265315|FG003|Overall Study|Adverse Event|4|||
131446123|NCT03879772|473265316|FG004|Overall Study|Adverse Event|3|||
131446124|NCT03879772|473265312|FG000|Overall Study|Treatment Failure|1|||
131446125|NCT03879772|473265313|FG001|Overall Study|Treatment Failure|0|||
131446126|NCT03879772|473265314|FG002|Overall Study|Treatment Failure|0|||
131446127|NCT03879772|473265315|FG003|Overall Study|Treatment Failure|2|||
131446128|NCT03879772|473265316|FG004|Overall Study|Treatment Failure|1|||
131446129|NCT03879772|473265312|FG000|Overall Study|Lost to Follow-up|0|||
131446130|NCT03879772|473265313|FG001|Overall Study|Lost to Follow-up|0|||
131446131|NCT03879772|473265314|FG002|Overall Study|Lost to Follow-up|0|||
131446132|NCT03879772|473265315|FG003|Overall Study|Lost to Follow-up|0|||
131446133|NCT03879772|473265316|FG004|Overall Study|Lost to Follow-up|1|||
131446134|NCT03879772|473265312|FG000|Overall Study|Withdrawal by Subject|0|||
131446135|NCT03879772|473265313|FG001|Overall Study|Withdrawal by Subject|1|||
131446136|NCT03879772|473265314|FG002|Overall Study|Withdrawal by Subject|3|||
131446137|NCT03879772|473265315|FG003|Overall Study|Withdrawal by Subject|1|||
131446138|NCT03879772|473265316|FG004|Overall Study|Withdrawal by Subject|1|||
131446139|NCT03879772|473265312|FG000|Overall Study|Protocol Violation|0|||
131644777|NCT03616964|473986828|FG000|Overall Study|Sponsor's Decision|1|||
131644778|NCT03616964|473986829|FG001|Overall Study|Sponsor's Decision|0|||
131644779|NCT03616964|473986830|FG002|Overall Study|Sponsor's Decision|0|||
131644780|NCT03616964|473986828|FG000|Overall Study|Physician Decision|0|||
131644781|NCT03616964|473986829|FG001|Overall Study|Physician Decision|2|||
131644782|NCT03616964|473986830|FG002|Overall Study|Physician Decision|0|||
131644783|NCT03616964|473986828|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
131644784|NCT03616964|473986829|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
131644785|NCT03616964|473986830|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
131446140|NCT03879772|473265313|FG001|Overall Study|Protocol Violation|0|||
131446141|NCT03879772|473265314|FG002|Overall Study|Protocol Violation|3|||
131446142|NCT03879772|473265315|FG003|Overall Study|Protocol Violation|1|||
131446143|NCT03879772|473265316|FG004|Overall Study|Protocol Violation|2|||
131446144|NCT03879772|473265312|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
131446145|NCT03879772|473265313|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
131446146|NCT03879772|473265314|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
131446147|NCT03879772|473265315|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
131446148|NCT03879772|473265316|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
131644786|NCT03616964|473986828|FG000|Overall Study|Protocol Violation|0|||
131644787|NCT03616964|473986829|FG001|Overall Study|Protocol Violation|1|||
131644788|NCT03616964|473986830|FG002|Overall Study|Protocol Violation|0|||
131644789|NCT03616964|473986828|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
131644790|NCT03616964|473986829|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
131644791|NCT03616964|473986830|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
131644792|NCT03616964|473986828|FG000|Overall Study|Randomized but Never Treated|1|||
131644793|NCT03616964|473986829|FG001|Overall Study|Randomized but Never Treated|1|||
131644794|NCT03616964|473986830|FG002|Overall Study|Randomized but Never Treated|1|||
131644795|NCT00971997|473986831|FG000|Overall Study|Adverse Event|2|||
131644796|NCT00971997|473986831|FG000|Overall Study|Death|1|||
131644797|NCT00971997|473986831|FG000|Overall Study|Protocol Violation|4|||
131644798|NCT00971997|473986831|FG000|Overall Study|Withdrawal by Subject|5|||
131644799|NCT00971997|473986831|FG000|Overall Study|Physician Decision|7|||
131644800|NCT01266018|473986834|FG000|Overall Study|Physician Decision|1|||
131644801|NCT01266018|473986835|FG001|Overall Study|Physician Decision|0|||
131644802|NCT01266018|473986834|FG000|Overall Study|Progressive disease|0|||
131644803|NCT01266018|473986835|FG001|Overall Study|Progressive disease|1|||
131644804|NCT03167151|473986836|FG000|Overall Study|Withdrawal by Subject|1|||
131644805|NCT03167151|473986837|FG001|Overall Study|Withdrawal by Subject|0|||
131644806|NCT03167151|473986838|FG002|Overall Study|Withdrawal by Subject|0|||
131644807|NCT03167151|473986836|FG000|Overall Study|No evidence of tumour at surgery|0|||
131644808|NCT03167151|473986837|FG001|Overall Study|No evidence of tumour at surgery|1|||
131644809|NCT03167151|473986838|FG002|Overall Study|No evidence of tumour at surgery|1|||
131644810|NCT01458522|473986839|FG000|Overall Study|Withdrawal by Subject|2|||
131644811|NCT01458522|473986840|FG001|Overall Study|Withdrawal by Subject|2|||
131644812|NCT01458522|473986839|FG000|Overall Study|Physician Decision|1|||
131644813|NCT01458522|473986840|FG001|Overall Study|Physician Decision|9|||
131644814|NCT02684123|473986841|FG000|Phase 1|Lack of Efficacy|5|||
131446149|NCT00930046|473265317|FG000|Overall Study|Wound catheter malfunctioned|1|||
131446150|NCT00930046|473265318|FG001|Overall Study|Wound catheter malfunctioned|2|||
131446151|NCT01598532|473265319|FG000|Overall Study|Lost to Follow-up|3|||
131446152|NCT01598532|473265319|FG000|Overall Study|Did not meet inclusion criteria|8|||
131446153|NCT00912808|473265320|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
131446154|NCT00912808|473265321|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
131644815|NCT02684123|473986842|FG001|Phase 1|Lack of Efficacy|0|||
131644816|NCT02684123|473986841|FG000|Phase 1|Adverse Event|3|||
131644817|NCT02684123|473986842|FG001|Phase 1|Adverse Event|0|||
131644818|NCT02684123|473986841|FG000|Phase 1|Lost to Follow-up|0|||
131644819|NCT02684123|473986842|FG001|Phase 1|Lost to Follow-up|1|||
131644820|NCT02684123|473986841|FG000|Phase 2|Lack of Efficacy|1|||
131644821|NCT02684123|473986842|FG001|Phase 2|Lack of Efficacy|8|||
131644822|NCT00516139|473986843|FG000|Overall Study|Adverse Event|27|||
131644823|NCT00516139|473986843|FG000|Overall Study|Lost to Follow-up|1|||
131644824|NCT00516139|473986843|FG000|Overall Study|Protocol Violation|1|||
131446155|NCT00912808|473265320|FG000|Washout|Withdrawal by Subject|0|||
131446156|NCT00912808|473265321|FG001|Washout|Withdrawal by Subject|1|||
131446157|NCT00912808|473265320|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
131446158|NCT00912808|473265321|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
131446159|NCT00912808|473265320|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
131446160|NCT00912808|473265321|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
131446161|NCT03873116|473265322|FG000|Part 1|Study drug discontinuation due to rash|0|||
131644825|NCT00516139|473986843|FG000|Overall Study|Withdrawal by Subject|8|||
131644826|NCT00516139|473986843|FG000|Overall Study|Lack of Efficacy|1|||
131644827|NCT00416598|473986846|FG000|Induction & Intensification|Adverse Event|38|||
131644828|NCT00416598|473986846|FG000|Induction & Intensification|Death|32|||
131644829|NCT00416598|473986846|FG000|Induction & Intensification|Withdrawal by Subject|46|||
131644830|NCT00416598|473986846|FG000|Induction & Intensification|Alternative Treatment|135|||
131644831|NCT00416598|473986846|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
131644832|NCT00416598|473986846|FG000|Induction & Intensification|Relapse/progression|29|||
131644833|NCT00416598|473986846|FG000|Induction & Intensification|Failed induction|87|||
131644834|NCT00416598|473986846|FG000|Decitabine Maintenance|Adverse Event|5|||
131644835|NCT00416598|473986846|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
131644836|NCT00416598|473986846|FG000|Decitabine Maintenance|Progression/relapse|38|||
131644837|NCT00416598|473986846|FG000|Decitabine Maintenance|Alternative treatment|2|||
131644838|NCT00416598|473986846|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
131644839|NCT04367480|473986847|FG000|Overall Study|Adverse Event|1|||
131644840|NCT04367480|473986848|FG001|Overall Study|Adverse Event|1|||
131446162|NCT03873116|473265323|FG001|Part 1|Study drug discontinuation due to rash|0|||
131446163|NCT03873116|473265324|FG002|Part 1|Study drug discontinuation due to rash|0|||
131446164|NCT03873116|473265325|FG003|Part 1|Study drug discontinuation due to rash|0|||
131446165|NCT03873116|473265326|FG004|Part 1|Study drug discontinuation due to rash|0|||
131446166|NCT03873116|473265327|FG005|Part 1|Study drug discontinuation due to rash|1|||
131446167|NCT03873116|473265322|FG000|Part 2|Withdrawal by Subject|0|||
131446168|NCT03873116|473265323|FG001|Part 2|Withdrawal by Subject|0|||
131446169|NCT03873116|473265324|FG002|Part 2|Withdrawal by Subject|1|||
131446170|NCT03873116|473265325|FG003|Part 2|Withdrawal by Subject|0|||
131446171|NCT03873116|473265326|FG004|Part 2|Withdrawal by Subject|0|||
131446172|NCT03873116|473265327|FG005|Part 2|Withdrawal by Subject|0|||
131446173|NCT03873116|473265322|FG000|Part 2|Lab abnormality or AE|0|||
131446174|NCT03873116|473265323|FG001|Part 2|Lab abnormality or AE|0|||
131446175|NCT03873116|473265324|FG002|Part 2|Lab abnormality or AE|0|||
131644841|NCT04367480|473986847|FG000|Overall Study|Death|1|||
131644842|NCT04367480|473986848|FG001|Overall Study|Death|0|||
131644843|NCT04367480|473986847|FG000|Overall Study|Lost to Follow-up|1|||
131644844|NCT04367480|473986848|FG001|Overall Study|Lost to Follow-up|1|||
131644845|NCT04367480|473986847|FG000|Overall Study|Withdrawal by Subject|0|||
131644846|NCT04367480|473986848|FG001|Overall Study|Withdrawal by Subject|3|||
131644847|NCT04367480|473986847|FG000|Overall Study|App glitch during the study|1|||
131644848|NCT04367480|473986848|FG001|Overall Study|App glitch during the study|0|||
131644849|NCT04367480|473986847|FG000|Overall Study|Device Distribution Error|0|||
131644850|NCT04367480|473986848|FG001|Overall Study|Device Distribution Error|2|||
131644851|NCT04367480|473986847|FG000|Overall Study|Ineligible after Randomization|0|||
131644852|NCT04367480|473986848|FG001|Overall Study|Ineligible after Randomization|1|||
131644853|NCT04367480|473986847|FG000|Overall Study|Other Medical Reasons|0|||
131644854|NCT04367480|473986848|FG001|Overall Study|Other Medical Reasons|2|||
131644855|NCT00634842|473986851|FG000|Overall Study|Adverse Event|2|||
131644856|NCT00634842|473986852|FG001|Overall Study|Adverse Event|3|||
131644857|NCT00634842|473986851|FG000|Overall Study|Protocol Violation|8|||
131644858|NCT00634842|473986852|FG001|Overall Study|Protocol Violation|4|||
131644859|NCT00634842|473986851|FG000|Overall Study|Move to another state|1|||
131644860|NCT00634842|473986852|FG001|Overall Study|Move to another state|0|||
131644861|NCT00634842|473986851|FG000|Overall Study|Inclusion criteria were not met|1|||
131644862|NCT00634842|473986852|FG001|Overall Study|Inclusion criteria were not met|0|||
131644863|NCT00634842|473986851|FG000|Overall Study|Lost to Follow-up|1|||
131644864|NCT00634842|473986852|FG001|Overall Study|Lost to Follow-up|2|||
131644865|NCT00634842|473986851|FG000|Overall Study|Physician Decision|1|||
131644866|NCT00634842|473986852|FG001|Overall Study|Physician Decision|0|||
131644867|NCT00634842|473986851|FG000|Overall Study|Withdrawal by Subject|1|||
131644868|NCT00634842|473986852|FG001|Overall Study|Withdrawal by Subject|3|||
131644869|NCT00634842|473986851|FG000|Overall Study|Lack of time and intolerance to drug|0|||
131446176|NCT03873116|473265325|FG003|Part 2|Lab abnormality or AE|0|||
131446177|NCT03873116|473265326|FG004|Part 2|Lab abnormality or AE|1|||
131446178|NCT03873116|473265327|FG005|Part 2|Lab abnormality or AE|0|||
131446179|NCT03873116|473265322|FG000|Part 3|Withdrawal by Subject|0|||
131644870|NCT00634842|473986852|FG001|Overall Study|Lack of time and intolerance to drug|1|||
131644871|NCT00634842|473986851|FG000|Overall Study|Discontinued due to injection|0|||
131644872|NCT00634842|473986852|FG001|Overall Study|Discontinued due to injection|2|||
131715505|NCT02793544|474235524|FG000|Overall Study|Death|10|||
131446180|NCT03873116|473265323|FG001|Part 3|Withdrawal by Subject|0|||
131446181|NCT03873116|473265324|FG002|Part 3|Withdrawal by Subject|0|||
131446182|NCT03873116|473265325|FG003|Part 3|Withdrawal by Subject|0|||
131446183|NCT03873116|473265326|FG004|Part 3|Withdrawal by Subject|1|||
131446184|NCT03873116|473265327|FG005|Part 3|Withdrawal by Subject|0|||
131446185|NCT04682366|473265328|FG000|Overall Study|Lost to Follow-up|1|||
131715506|NCT02793544|474235525|FG001|Overall Study|Death|8|||
131446186|NCT04682366|473265329|FG001|Overall Study|Lost to Follow-up|1|||
131446187|NCT00702221|473265330|FG000|Overall Study|Adverse Event|4|||
131446188|NCT00702221|473265331|FG001|Overall Study|Adverse Event|3|||
131446189|NCT02531802|473265332|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
131446190|NCT02531802|473265333|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
131446191|NCT02531802|473265334|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
131446192|NCT02531802|473265335|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
131446193|NCT02531802|473265336|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
131446194|NCT02531802|473265337|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
131446195|NCT02531802|473265338|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
131446196|NCT02531802|473265339|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
131446197|NCT02531802|473265340|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
131446198|NCT02531802|473265341|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
131446199|NCT02531802|473265342|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
131446200|NCT02531802|473265343|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
131446201|NCT02531802|473265344|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
131446202|NCT02531802|473265345|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
131446203|NCT02531802|473265346|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
131446204|NCT02531802|473265347|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
131446205|NCT02531802|473265348|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
131446206|NCT02531802|473265349|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
131446207|NCT02531802|473265350|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
131446208|NCT02531802|473265351|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
131446209|NCT02531802|473265352|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
131446210|NCT02531802|473265332|FG000|Received Vaccination 2|Physician Decision|0|||
131446211|NCT02531802|473265333|FG001|Received Vaccination 2|Physician Decision|0|||
131446212|NCT02531802|473265334|FG002|Received Vaccination 2|Physician Decision|0|||
131446213|NCT02531802|473265335|FG003|Received Vaccination 2|Physician Decision|0|||
131446214|NCT02531802|473265336|FG004|Received Vaccination 2|Physician Decision|0|||
131446215|NCT02531802|473265337|FG005|Received Vaccination 2|Physician Decision|1|||
131446216|NCT02531802|473265338|FG006|Received Vaccination 2|Physician Decision|0|||
131446217|NCT02531802|473265339|FG007|Received Vaccination 2|Physician Decision|0|||
131446218|NCT02531802|473265340|FG008|Received Vaccination 2|Physician Decision|0|||
131446219|NCT02531802|473265341|FG009|Received Vaccination 2|Physician Decision|2|||
131446220|NCT02531802|473265342|FG010|Received Vaccination 2|Physician Decision|0|||
131446221|NCT02531802|473265343|FG011|Received Vaccination 2|Physician Decision|0|||
131446222|NCT02531802|473265344|FG012|Received Vaccination 2|Physician Decision|0|||
131446223|NCT02531802|473265345|FG013|Received Vaccination 2|Physician Decision|1|||
131446224|NCT02531802|473265346|FG014|Received Vaccination 2|Physician Decision|0|||
131446225|NCT02531802|473265347|FG015|Received Vaccination 2|Physician Decision|0|||
131446226|NCT02531802|473265348|FG016|Received Vaccination 2|Physician Decision|0|||
131446227|NCT02531802|473265349|FG017|Received Vaccination 2|Physician Decision|1|||
131446228|NCT02531802|473265350|FG018|Received Vaccination 2|Physician Decision|0|||
131446229|NCT02531802|473265351|FG019|Received Vaccination 2|Physician Decision|0|||
131446230|NCT02531802|473265352|FG020|Received Vaccination 2|Physician Decision|0|||
131446231|NCT02531802|473265332|FG000|Received Vaccination 2|Adverse Event|0|||
131446232|NCT02531802|473265333|FG001|Received Vaccination 2|Adverse Event|0|||
131446233|NCT02531802|473265334|FG002|Received Vaccination 2|Adverse Event|0|||
131446234|NCT02531802|473265335|FG003|Received Vaccination 2|Adverse Event|0|||
131446235|NCT02531802|473265336|FG004|Received Vaccination 2|Adverse Event|0|||
131446236|NCT02531802|473265337|FG005|Received Vaccination 2|Adverse Event|2|||
131446237|NCT02531802|473265338|FG006|Received Vaccination 2|Adverse Event|0|||
131446238|NCT02531802|473265339|FG007|Received Vaccination 2|Adverse Event|0|||
131446239|NCT02531802|473265340|FG008|Received Vaccination 2|Adverse Event|0|||
131446240|NCT02531802|473265341|FG009|Received Vaccination 2|Adverse Event|0|||
131446241|NCT02531802|473265342|FG010|Received Vaccination 2|Adverse Event|0|||
131446242|NCT02531802|473265343|FG011|Received Vaccination 2|Adverse Event|0|||
131446243|NCT02531802|473265344|FG012|Received Vaccination 2|Adverse Event|0|||
131446244|NCT02531802|473265345|FG013|Received Vaccination 2|Adverse Event|0|||
131446245|NCT02531802|473265346|FG014|Received Vaccination 2|Adverse Event|0|||
131446246|NCT02531802|473265347|FG015|Received Vaccination 2|Adverse Event|0|||
131446247|NCT02531802|473265348|FG016|Received Vaccination 2|Adverse Event|0|||
131446248|NCT02531802|473265349|FG017|Received Vaccination 2|Adverse Event|2|||
131446249|NCT02531802|473265350|FG018|Received Vaccination 2|Adverse Event|1|||
131446250|NCT02531802|473265351|FG019|Received Vaccination 2|Adverse Event|0|||
131446251|NCT02531802|473265352|FG020|Received Vaccination 2|Adverse Event|1|||
131446252|NCT02531802|473265332|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
131446253|NCT02531802|473265333|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
131446254|NCT02531802|473265334|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
131446255|NCT02531802|473265335|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
131446256|NCT02531802|473265336|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
131446257|NCT02531802|473265337|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
131446258|NCT02531802|473265338|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
131446259|NCT02531802|473265339|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
131446260|NCT02531802|473265340|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
131446261|NCT02531802|473265341|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
131644873|NCT00634842|473986851|FG000|Overall Study|No need of study drug to treat diabetes|0|||
131644874|NCT00634842|473986852|FG001|Overall Study|No need of study drug to treat diabetes|1|||
131446262|NCT02531802|473265342|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
131446263|NCT02531802|473265343|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
131446264|NCT02531802|473265344|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
131446265|NCT02531802|473265345|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
131446266|NCT02531802|473265346|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
131446267|NCT02531802|473265347|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
131644875|NCT00634842|473986851|FG000|Overall Study|No wish to keep taking Avandia|0|||
131644876|NCT00634842|473986852|FG001|Overall Study|No wish to keep taking Avandia|1|||
131644877|NCT00634842|473986851|FG000|Overall Study|Subject off study drug for too long|0|||
131644878|NCT00634842|473986852|FG001|Overall Study|Subject off study drug for too long|1|||
131644879|NCT01513330|473986853|FG000|SenSura Mio First,|Adverse Event|2|||
131644880|NCT01513330|473986854|FG001|SenSura Mio First,|Adverse Event|0|||
131644881|NCT01513330|473986853|FG000|SenSura Mio First,|Lack of Efficacy|0|||
131644882|NCT01513330|473986854|FG001|SenSura Mio First,|Lack of Efficacy|1|||
131644883|NCT01513330|473986853|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
131644884|NCT01513330|473986854|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
131644885|NCT01513330|473986853|FG000|SenSura Mio First,|Other|1|||
131644886|NCT01513330|473986854|FG001|SenSura Mio First,|Other|0|||
131644887|NCT01513330|473986853|FG000|Standard Care First,|Lack of Efficacy|2|||
131644888|NCT01513330|473986854|FG001|Standard Care First,|Lack of Efficacy|2|||
131644889|NCT01513330|473986853|FG000|Standard Care First,|Withdrawal by Subject|1|||
131644890|NCT01513330|473986854|FG001|Standard Care First,|Withdrawal by Subject|2|||
131644891|NCT01513330|473986853|FG000|Standard Care First,|Other|1|||
131644892|NCT01513330|473986854|FG001|Standard Care First,|Other|0|||
131644893|NCT04486313|473986859|FG000|Overall Study|Lost to Follow-up|7|||
131644894|NCT04486313|473986860|FG001|Overall Study|Lost to Follow-up|9|||
131644895|NCT04486313|473986859|FG000|Overall Study|Withdrawal by Subject|8|||
131644896|NCT04486313|473986860|FG001|Overall Study|Withdrawal by Subject|6|||
131644897|NCT04486313|473986859|FG000|Overall Study|Physician Decision|1|||
131644898|NCT04486313|473986860|FG001|Overall Study|Physician Decision|1|||
131644899|NCT04486313|473986859|FG000|Overall Study|Death|2|||
131644900|NCT04486313|473986860|FG001|Overall Study|Death|0|||
131644901|NCT04486313|473986859|FG000|Overall Study|Protocol Violation|1|||
131644902|NCT04486313|473986860|FG001|Overall Study|Protocol Violation|1|||
131644903|NCT03432390|473986870|FG000|Apnea Period|Protocol Violation|2|||
131644904|NCT03432390|473986871|FG001|Apnea Period|Protocol Violation|2|||
131644905|NCT02058836|473986872|FG000|Overall Study|Withdrawal by Subject|1|||
131644906|NCT02058836|473986873|FG001|Overall Study|Withdrawal by Subject|1|||
131644907|NCT00547534|473986877|FG000|Overall Study|Adverse Event|7|||
131644908|NCT00547534|473986877|FG000|Overall Study|Disease Progression|4|||
131644909|NCT04206085|473986880|FG000|Overall Study|Lost to Follow-up|0|||
131644910|NCT04206085|473986881|FG001|Overall Study|Lost to Follow-up|1|||
131644911|NCT04206085|473986882|FG002|Overall Study|Lost to Follow-up|0|||
131644912|NCT04206085|473986880|FG000|Overall Study|Lost to Follow-up|0|||
131644913|NCT04206085|473986881|FG001|Overall Study|Lost to Follow-up|0|||
131644914|NCT04206085|473986882|FG002|Overall Study|Lost to Follow-up|1|||
131644915|NCT02168478|473986883|FG000|Overall Study|Withdrawal by Subject|1|||
131644916|NCT02168478|473986883|FG000|Overall Study|Did Not Consent to Participation|2|||
131644917|NCT02168478|473986883|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
131644918|NCT00087555|473986884|FG000|Overall Study|Adverse Event|3|||
131644919|NCT00087555|473986885|FG001|Overall Study|Adverse Event|6|||
131644920|NCT00087555|473986886|FG002|Overall Study|Adverse Event|14|||
131802053|NCT01974141|474559166|FG001|Overall Study|Lost to Follow-up|29|||
131446268|NCT02531802|473265348|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
131446269|NCT02531802|473265349|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
131446270|NCT02531802|473265350|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
131446271|NCT02531802|473265351|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
131644921|NCT00087555|473986884|FG000|Overall Study|Lost to Follow-up|0|||
131644922|NCT00087555|473986885|FG001|Overall Study|Lost to Follow-up|1|||
131644923|NCT00087555|473986886|FG002|Overall Study|Lost to Follow-up|1|||
131446272|NCT02531802|473265352|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
131644924|NCT00087555|473986884|FG000|Overall Study|Non - Compliance|1|||
131644925|NCT00087555|473986885|FG001|Overall Study|Non - Compliance|0|||
131644926|NCT00087555|473986886|FG002|Overall Study|Non - Compliance|0|||
131644927|NCT00087555|473986884|FG000|Overall Study|Protocol Violation|0|||
131644928|NCT00087555|473986885|FG001|Overall Study|Protocol Violation|0|||
131644929|NCT00087555|473986886|FG002|Overall Study|Protocol Violation|2|||
131644930|NCT00087555|473986884|FG000|Overall Study|Screen Failure|1|||
131446273|NCT03345784|473265355|FG000|Overall Study|Withdrawal by Subject|2|||
131446274|NCT03345784|473265356|FG001|Overall Study|Withdrawal by Subject|1|||
131644931|NCT00087555|473986885|FG001|Overall Study|Screen Failure|1|||
131644932|NCT00087555|473986886|FG002|Overall Study|Screen Failure|0|||
131644933|NCT00087555|473986884|FG000|Overall Study|Pregnancy|0|||
131644934|NCT00087555|473986885|FG001|Overall Study|Pregnancy|1|||
131644935|NCT00087555|473986886|FG002|Overall Study|Pregnancy|1|||
131644936|NCT00087555|473986884|FG000|Overall Study|Withdrawal by Subject|3|||
131644937|NCT00087555|473986885|FG001|Overall Study|Withdrawal by Subject|2|||
131446275|NCT04798196|473265357|FG000|Overall Study|Lost to Follow-up|3|||
131446276|NCT04798196|473265358|FG001|Overall Study|Lost to Follow-up|1|||
131446277|NCT04798196|473265359|FG002|Overall Study|Lost to Follow-up|3|||
131446278|NCT00728689|473265369|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
131446279|NCT00728689|473265370|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
131446280|NCT03216226|473265371|FG000|Overall Study|Adverse Event|3|||
131446281|NCT03216226|473265372|FG001|Overall Study|Adverse Event|0|||
131446282|NCT03216226|473265371|FG000|Overall Study|Protocol Violation|1|||
131446283|NCT03216226|473265372|FG001|Overall Study|Protocol Violation|3|||
131446284|NCT03216226|473265371|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
131446285|NCT03216226|473265372|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
131446286|NCT03216226|473265371|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
131446287|NCT03216226|473265372|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
131446288|NCT03216226|473265371|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
131446289|NCT03216226|473265372|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
131446290|NCT04596267|473265375|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
131446291|NCT04596267|473265376|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
131446292|NCT04596267|473265375|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
131446293|NCT04596267|473265376|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
131446294|NCT02000440|473265377|FG000|Overall Study|Adverse Event|3|||
131446295|NCT02000440|473265377|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
131446296|NCT04109547|473265378|FG000|Overall Study|Withdrawal by Subject|3|||
131446297|NCT04109547|473265379|FG001|Overall Study|Withdrawal by Subject|2|||
131644938|NCT00087555|473986886|FG002|Overall Study|Withdrawal by Subject|1|||
131644939|NCT00087555|473986884|FG000|Overall Study|Lack of Efficacy|2|||
131644940|NCT00087555|473986885|FG001|Overall Study|Lack of Efficacy|0|||
131644941|NCT00087555|473986886|FG002|Overall Study|Lack of Efficacy|1|||
131446298|NCT04109547|473265380|FG002|Overall Study|Withdrawal by Subject|6|||
131446299|NCT04109547|473265381|FG003|Overall Study|Withdrawal by Subject|6|||
131446300|NCT04109547|473265378|FG000|Overall Study|Lost to Follow-up|0|||
131446301|NCT04109547|473265379|FG001|Overall Study|Lost to Follow-up|0|||
131446302|NCT04109547|473265380|FG002|Overall Study|Lost to Follow-up|0|||
131446303|NCT04109547|473265381|FG003|Overall Study|Lost to Follow-up|1|||
131446304|NCT04109547|473265378|FG000|Overall Study|Physician Decision|1|||
131446305|NCT04109547|473265379|FG001|Overall Study|Physician Decision|2|||
131446306|NCT04109547|473265380|FG002|Overall Study|Physician Decision|0|||
131446307|NCT04109547|473265381|FG003|Overall Study|Physician Decision|0|||
131446308|NCT01550003|473265382|FG000|Overall Study|Adverse Event|0|||
131446309|NCT01550003|473265383|FG001|Overall Study|Adverse Event|9|||
131446310|NCT01550003|473265384|FG002|Overall Study|Adverse Event|15|||
131446311|NCT01550003|473265382|FG000|Overall Study|Lack of Efficacy|4|||
131446312|NCT01550003|473265383|FG001|Overall Study|Lack of Efficacy|11|||
131446313|NCT01550003|473265384|FG002|Overall Study|Lack of Efficacy|15|||
131446314|NCT01550003|473265382|FG000|Overall Study|Protocol Violation|0|||
131446315|NCT01550003|473265383|FG001|Overall Study|Protocol Violation|3|||
131446316|NCT01550003|473265384|FG002|Overall Study|Protocol Violation|2|||
131446317|NCT01550003|473265382|FG000|Overall Study|Lost to Follow-up|1|||
131446318|NCT01550003|473265383|FG001|Overall Study|Lost to Follow-up|4|||
131446319|NCT01550003|473265384|FG002|Overall Study|Lost to Follow-up|8|||
131446320|NCT01550003|473265382|FG000|Overall Study|Consent withdrawn|2|||
131446321|NCT01550003|473265383|FG001|Overall Study|Consent withdrawn|11|||
131446322|NCT01550003|473265384|FG002|Overall Study|Consent withdrawn|23|||
131446323|NCT01550003|473265382|FG000|Overall Study|Missing|1|||
131446324|NCT01550003|473265383|FG001|Overall Study|Missing|0|||
131446325|NCT01550003|473265384|FG002|Overall Study|Missing|2|||
131446326|NCT01550003|473265382|FG000|Overall Study|Study closure as announced by sponsor|7|||
131446327|NCT01550003|473265383|FG001|Overall Study|Study closure as announced by sponsor|6|||
131446328|NCT01550003|473265384|FG002|Overall Study|Study closure as announced by sponsor|24|||
131446329|NCT01550003|473265382|FG000|Overall Study|Protocol Noncompliance|1|||
131446330|NCT01550003|473265383|FG001|Overall Study|Protocol Noncompliance|0|||
131446331|NCT01550003|473265384|FG002|Overall Study|Protocol Noncompliance|0|||
131446332|NCT01550003|473265382|FG000|Overall Study|Study closure|0|||
131446333|NCT01550003|473265383|FG001|Overall Study|Study closure|1|||
131446334|NCT01550003|473265384|FG002|Overall Study|Study closure|1|||
131446335|NCT01550003|473265382|FG000|Overall Study|Patient reached adulthood|0|||
131446336|NCT01550003|473265383|FG001|Overall Study|Patient reached adulthood|1|||
131446337|NCT01550003|473265384|FG002|Overall Study|Patient reached adulthood|0|||
131446338|NCT01550003|473265382|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
131446339|NCT01550003|473265383|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
131446340|NCT01550003|473265384|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
131446341|NCT01550003|473265382|FG000|Overall Study|Sponsor's order|0|||
131446342|NCT01550003|473265383|FG001|Overall Study|Sponsor's order|3|||
131446343|NCT01550003|473265384|FG002|Overall Study|Sponsor's order|3|||
131446344|NCT01550003|473265382|FG000|Overall Study|Sponsor's decision|1|||
131446345|NCT01550003|473265383|FG001|Overall Study|Sponsor's decision|5|||
131446346|NCT01550003|473265384|FG002|Overall Study|Sponsor's decision|4|||
131446347|NCT01550003|473265382|FG000|Overall Study|Subject mother passed away|0|||
131446348|NCT01550003|473265383|FG001|Overall Study|Subject mother passed away|1|||
131446349|NCT01550003|473265384|FG002|Overall Study|Subject mother passed away|0|||
131446350|NCT01550003|473265382|FG000|Overall Study|Discontinuation|0|||
131446351|NCT01550003|473265383|FG001|Overall Study|Discontinuation|1|||
131446352|NCT01550003|473265384|FG002|Overall Study|Discontinuation|0|||
131446353|NCT01550003|473265382|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
131446354|NCT01550003|473265383|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
131446355|NCT01550003|473265384|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
131446356|NCT01550003|473265382|FG000|Overall Study|Site closure|0|||
131903029|NCT00676403|474931368|FG004|Overall Study|Withdrawal by Subject|0|||
131903030|NCT00676403|474931369|FG005|Overall Study|Withdrawal by Subject|1|||
131903031|NCT01566604|474931370|FG000|Overall Study|Patient's inability to use the device|1|||
131446357|NCT01550003|473265383|FG001|Overall Study|Site closure|2|||
131446358|NCT01550003|473265384|FG002|Overall Study|Site closure|0|||
131446359|NCT01550003|473265382|FG000|Overall Study|Pregnancy|0|||
131446360|NCT01550003|473265383|FG001|Overall Study|Pregnancy|1|||
131446361|NCT01550003|473265384|FG002|Overall Study|Pregnancy|0|||
131446362|NCT01550003|473265382|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
131446363|NCT01550003|473265383|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
131446364|NCT01550003|473265384|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
131446365|NCT01550003|473265382|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
131446366|NCT01550003|473265383|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
131446367|NCT01550003|473265384|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
131446368|NCT01550003|473265382|FG000|Overall Study|Switching to adult rheumatologist|0|||
131446369|NCT01550003|473265383|FG001|Overall Study|Switching to adult rheumatologist|0|||
131446370|NCT01550003|473265384|FG002|Overall Study|Switching to adult rheumatologist|1|||
131446371|NCT01550003|473265382|FG000|Overall Study|Patient transition to adult care|0|||
131446372|NCT01550003|473265383|FG001|Overall Study|Patient transition to adult care|0|||
131446373|NCT01550003|473265384|FG002|Overall Study|Patient transition to adult care|1|||
131446374|NCT01550003|473265382|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
131446375|NCT01550003|473265383|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
131446376|NCT01550003|473265384|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
131446377|NCT01550003|473265382|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
131446378|NCT01550003|473265383|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
131446379|NCT01550003|473265384|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
131446380|NCT01550003|473265382|FG000|Overall Study|Per Sponsor request|1|||
131446381|NCT01550003|473265383|FG001|Overall Study|Per Sponsor request|0|||
131446382|NCT01550003|473265384|FG002|Overall Study|Per Sponsor request|1|||
131446383|NCT01550003|473265382|FG000|Overall Study|Patient not compliance|0|||
131446384|NCT01550003|473265383|FG001|Overall Study|Patient not compliance|0|||
131446385|NCT01550003|473265384|FG002|Overall Study|Patient not compliance|1|||
131446386|NCT01550003|473265382|FG000|Overall Study|Non-compliance|0|||
131446387|NCT01550003|473265383|FG001|Overall Study|Non-compliance|0|||
131644942|NCT00087555|473986884|FG000|Overall Study|Non Compliance|0|||
131644943|NCT00087555|473986885|FG001|Overall Study|Non Compliance|0|||
131446388|NCT01550003|473265384|FG002|Overall Study|Non-compliance|1|||
131644944|NCT00087555|473986886|FG002|Overall Study|Non Compliance|1|||
131903032|NCT01566604|474931371|FG001|Overall Study|Patient's inability to use the device|0|||
131903033|NCT01566604|474931370|FG000|Overall Study|Administrative problems|1|||
131903034|NCT01566604|474931371|FG001|Overall Study|Administrative problems|0|||
131903035|NCT01566604|474931370|FG000|Overall Study|Lack of Efficacy|1|||
131903036|NCT01566604|474931371|FG001|Overall Study|Lack of Efficacy|2|||
131903037|NCT01566604|474931370|FG000|Overall Study|Protocol deviation|2|||
131903038|NCT01566604|474931371|FG001|Overall Study|Protocol deviation|0|||
131903039|NCT01566604|474931370|FG000|Overall Study|Abnormal laboratory value|2|||
131903040|NCT01566604|474931371|FG001|Overall Study|Abnormal laboratory value|0|||
131903041|NCT01566604|474931370|FG000|Overall Study|Death|4|||
131903042|NCT01566604|474931371|FG001|Overall Study|Death|1|||
131903043|NCT01566604|474931370|FG000|Overall Study|Adverse Event|4|||
131903044|NCT01566604|474931371|FG001|Overall Study|Adverse Event|2|||
131903045|NCT01566604|474931370|FG000|Overall Study|Withdrawal by Subject|9|||
131903046|NCT01566604|474931371|FG001|Overall Study|Withdrawal by Subject|6|||
131903047|NCT03225170|474931373|FG000|Overall Study|Lost to Follow-up|4|||
131903048|NCT03225170|474931374|FG001|Overall Study|Lost to Follow-up|4|||
131903049|NCT03225170|474931375|FG002|Overall Study|Lost to Follow-up|0|||
131903050|NCT03225170|474931373|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
131903051|NCT03225170|474931374|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
131903052|NCT03225170|474931375|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
131903053|NCT00661089|474931384|FG000|Overall Study|1 subject withdrawal|0|||
131903054|NCT00661089|474931385|FG001|Overall Study|1 subject withdrawal|1|||
131903055|NCT00661089|474931384|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
131903056|NCT00661089|474931385|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
131903057|NCT00274742|474931386|FG000|Overall Study|Adverse Event|0|||
131903058|NCT00274742|474931387|FG001|Overall Study|Adverse Event|4|||
131903059|NCT00274742|474931388|FG002|Overall Study|Adverse Event|1|||
131903060|NCT00274742|474931389|FG003|Overall Study|Adverse Event|4|||
131903061|NCT00274742|474931390|FG004|Overall Study|Adverse Event|12|||
131903062|NCT00274742|474931391|FG005|Overall Study|Adverse Event|3|||
131903063|NCT00274742|474931386|FG000|Overall Study|Lost to Follow-up|0|||
131903064|NCT00274742|474931387|FG001|Overall Study|Lost to Follow-up|0|||
131903065|NCT00274742|474931388|FG002|Overall Study|Lost to Follow-up|0|||
131903066|NCT00274742|474931389|FG003|Overall Study|Lost to Follow-up|0|||
131903067|NCT00274742|474931390|FG004|Overall Study|Lost to Follow-up|1|||
131903068|NCT00274742|474931391|FG005|Overall Study|Lost to Follow-up|0|||
131903069|NCT00274742|474931386|FG000|Overall Study|End of Study|0|||
131903070|NCT00274742|474931387|FG001|Overall Study|End of Study|0|||
131903071|NCT00274742|474931388|FG002|Overall Study|End of Study|0|||
131903072|NCT00274742|474931389|FG003|Overall Study|End of Study|1|||
131903073|NCT00274742|474931390|FG004|Overall Study|End of Study|0|||
131903074|NCT00274742|474931391|FG005|Overall Study|End of Study|0|||
131903075|NCT00274742|474931386|FG000|Overall Study|Disease Progression|0|||
131903076|NCT00274742|474931387|FG001|Overall Study|Disease Progression|1|||
131903077|NCT00274742|474931388|FG002|Overall Study|Disease Progression|1|||
131903078|NCT00274742|474931389|FG003|Overall Study|Disease Progression|0|||
131903079|NCT00274742|474931390|FG004|Overall Study|Disease Progression|1|||
131903080|NCT00274742|474931391|FG005|Overall Study|Disease Progression|0|||
131903081|NCT00274742|474931386|FG000|Overall Study|Other|0|||
131644945|NCT00087555|473986884|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
131644946|NCT00087555|473986885|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
131644947|NCT00087555|473986886|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
131644948|NCT00087555|473986884|FG000|Overall Study|Patient wanted to go back on Med|1|||
131644949|NCT00087555|473986885|FG001|Overall Study|Patient wanted to go back on Med|0|||
131644950|NCT00087555|473986886|FG002|Overall Study|Patient wanted to go back on Med|0|||
131644951|NCT03845023|473986895|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
131644952|NCT03845023|473986896|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
131644953|NCT03845023|473986897|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
131644954|NCT03845023|473986898|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
131644955|NCT03845023|473986895|FG000|Follow-Up (14 Days)|Adverse Event|0|||
131644956|NCT03845023|473986896|FG001|Follow-Up (14 Days)|Adverse Event|0|||
131644957|NCT03845023|473986897|FG002|Follow-Up (14 Days)|Adverse Event|1|||
131644958|NCT03845023|473986898|FG003|Follow-Up (14 Days)|Adverse Event|1|||
131644959|NCT00715117|473986899|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
131644960|NCT00715117|473986900|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
131644961|NCT02581059|473986903|FG000|Study Treatment|Disease Progression|1|||
131644962|NCT02581059|473986904|FG001|Study Treatment|Disease Progression|1|||
131644963|NCT02581059|473986903|FG000|Study Treatment|Adverse Event|2|||
131644964|NCT02581059|473986904|FG001|Study Treatment|Adverse Event|1|||
131644965|NCT02581059|473986903|FG000|Study Treatment|Death|1|||
131644966|NCT02581059|473986904|FG001|Study Treatment|Death|1|||
131644967|NCT02581059|473986903|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
131644968|NCT02581059|473986904|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
131644969|NCT02581059|473986903|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
131644970|NCT02581059|473986904|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
131644971|NCT02581059|473986903|FG000|Follow up|Death|1|||
131644972|NCT02581059|473986904|FG001|Follow up|Death|3|||
131644973|NCT02581059|473986903|FG000|Follow up|study terminated|1|||
131644974|NCT02581059|473986904|FG001|Follow up|study terminated|1|||
131644975|NCT02581059|473986903|FG000|Follow up|screen failure|0|||
131644976|NCT02581059|473986904|FG001|Follow up|screen failure|1|||
131644977|NCT02581059|473986903|FG000|Follow up|Patient started new clinical trial|1|||
131644978|NCT02581059|473986904|FG001|Follow up|Patient started new clinical trial|0|||
131644979|NCT02392104|473986905|FG000|Overall Study|discontinuation of warfarin|3|||
131644980|NCT02392104|473986905|FG000|Overall Study|bleeding event|1|||
131644981|NCT02392104|473986905|FG000|Overall Study|transferred care to another doctor|2|||
131644982|NCT02392104|473986905|FG000|Overall Study|INR goal range changed|1|||
131644983|NCT02392104|473986905|FG000|Overall Study|admitted to skilled nursing facility|3|||
131644984|NCT02392104|473986905|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
131644985|NCT04887506|473986906|FG000|Overall Study|Death|1|||
131644986|NCT04887506|473986907|FG001|Overall Study|Death|1|||
131644987|NCT04887506|473986906|FG000|Overall Study|Withdrawal by Subject|0|||
131644988|NCT04887506|473986907|FG001|Overall Study|Withdrawal by Subject|3|||
131644989|NCT04887506|473986906|FG000|Overall Study|Adverse Event|4|||
131644990|NCT04887506|473986907|FG001|Overall Study|Adverse Event|3|||
131644991|NCT04887506|473986906|FG000|Overall Study|Other - Not Reported|1|||
131644992|NCT04887506|473986907|FG001|Overall Study|Other - Not Reported|1|||
131644993|NCT02394665|473986910|FG000|Overall Study|Physician Decision|1|||
131644994|NCT02394665|473986911|FG001|Overall Study|Physician Decision|0|||
131644995|NCT02394665|473986912|FG002|Overall Study|Physician Decision|0|||
131903082|NCT00274742|474931387|FG001|Overall Study|Other|3|||
131903083|NCT00274742|474931388|FG002|Overall Study|Other|0|||
131903084|NCT00274742|474931389|FG003|Overall Study|Other|0|||
131644996|NCT02636608|473986913|FG000|Overall Study|Failure to Return|4|||
131644997|NCT02636608|473986913|FG000|Overall Study|Insufficient Virological Response|1|||
131644998|NCT02636608|473986913|FG000|Overall Study|Death|3|||
131903085|NCT00274742|474931390|FG004|Overall Study|Other|2|||
131446389|NCT01550003|473265382|FG000|Overall Study|Study closed|0|||
131644999|NCT02636608|473986913|FG000|Overall Study|Other|2|||
131645000|NCT02636608|473986913|FG000|Overall Study|Did Not Receive Treatment|1|||
131645001|NCT01255761|473986914|FG000|Overall Study|Adverse Event|29|||
131645002|NCT01255761|473986915|FG001|Overall Study|Adverse Event|43|||
131903086|NCT00274742|474931391|FG005|Overall Study|Other|0|||
131903087|NCT00490035|474931395|FG000|Overall Study|AE, non-serious non-fatal|3|||
131903088|NCT00490035|474931396|FG001|Overall Study|AE, non-serious non-fatal|4|||
131903089|NCT00490035|474931397|FG002|Overall Study|AE, non-serious non-fatal|4|||
131903090|NCT00490035|474931398|FG003|Overall Study|AE, non-serious non-fatal|5|||
131903091|NCT00490035|474931395|FG000|Overall Study|Lost to Follow-up|2|||
131645003|NCT01255761|473986914|FG000|Overall Study|Lack of Efficacy|86|||
131645004|NCT01255761|473986915|FG001|Overall Study|Lack of Efficacy|74|||
131645005|NCT01255761|473986914|FG000|Overall Study|Protocol Violation|9|||
131645006|NCT01255761|473986915|FG001|Overall Study|Protocol Violation|5|||
131645007|NCT01255761|473986914|FG000|Overall Study|Lost to Follow-up|10|||
131645008|NCT01255761|473986915|FG001|Overall Study|Lost to Follow-up|8|||
131645009|NCT01255761|473986914|FG000|Overall Study|Withdrawal by Subject|11|||
131645010|NCT01255761|473986915|FG001|Overall Study|Withdrawal by Subject|27|||
131645011|NCT01255761|473986914|FG000|Overall Study|Other Reasons|37|||
131645012|NCT01255761|473986915|FG001|Overall Study|Other Reasons|18|||
131645013|NCT03912532|473986919|FG000|Overall Study|Adverse Event|3|||
131645014|NCT03912532|473986920|FG001|Overall Study|Adverse Event|3|||
131645015|NCT03912532|473986921|FG002|Overall Study|Adverse Event|2|||
131645016|NCT03912532|473986922|FG003|Overall Study|Adverse Event|2|||
131645017|NCT03912532|473986919|FG000|Overall Study|Lost to Follow-up|3|||
131903092|NCT00490035|474931396|FG001|Overall Study|Lost to Follow-up|0|||
131903093|NCT00490035|474931397|FG002|Overall Study|Lost to Follow-up|1|||
131903094|NCT00490035|474931398|FG003|Overall Study|Lost to Follow-up|0|||
131903095|NCT00490035|474931395|FG000|Overall Study|Withdrawal by Subject|2|||
131903096|NCT00490035|474931396|FG001|Overall Study|Withdrawal by Subject|1|||
131903097|NCT00490035|474931397|FG002|Overall Study|Withdrawal by Subject|1|||
131903098|NCT00490035|474931398|FG003|Overall Study|Withdrawal by Subject|0|||
131903099|NCT00490035|474931395|FG000|Overall Study|Other reason|0|||
131903100|NCT00490035|474931396|FG001|Overall Study|Other reason|1|||
131903101|NCT00490035|474931397|FG002|Overall Study|Other reason|3|||
131903102|NCT00490035|474931398|FG003|Overall Study|Other reason|1|||
131903103|NCT00490035|474931395|FG000|Overall Study|AE, serious fatal|1|||
131903104|NCT00490035|474931396|FG001|Overall Study|AE, serious fatal|0|||
131903105|NCT00490035|474931397|FG002|Overall Study|AE, serious fatal|0|||
131903106|NCT00490035|474931398|FG003|Overall Study|AE, serious fatal|0|||
131903107|NCT00490035|474931395|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
131903108|NCT00490035|474931396|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
131903109|NCT00490035|474931397|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
131903110|NCT00490035|474931398|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
131903111|NCT00490035|474931395|FG000|Overall Study|AE of unknown type|0|||
131903112|NCT00490035|474931396|FG001|Overall Study|AE of unknown type|0|||
131903113|NCT00490035|474931397|FG002|Overall Study|AE of unknown type|2|||
131903114|NCT00490035|474931398|FG003|Overall Study|AE of unknown type|0|||
131903115|NCT04817332|474931399|FG000|Overall Study|Lost to Follow-up|3|||
131903116|NCT04817332|474931400|FG001|Overall Study|Lost to Follow-up|3|||
131903117|NCT04817332|474931399|FG000|Overall Study|Protocol Violation|2|||
131903118|NCT04817332|474931400|FG001|Overall Study|Protocol Violation|0|||
131903119|NCT05635045|474931406|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
131903120|NCT05635045|474931407|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
131903121|NCT05635045|474931408|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
131903122|NCT05635045|474931409|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
131645018|NCT03912532|473986920|FG001|Overall Study|Lost to Follow-up|2|||
131645019|NCT03912532|473986921|FG002|Overall Study|Lost to Follow-up|1|||
131645020|NCT03912532|473986922|FG003|Overall Study|Lost to Follow-up|2|||
131903123|NCT01435759|474931413|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
131903124|NCT01435759|474931414|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
131903125|NCT01435759|474931415|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
131903126|NCT01435759|474931416|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
131903127|NCT01435759|474931417|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
131645021|NCT03912532|473986919|FG000|Overall Study|Withdrawal by Subject|1|||
131645022|NCT03912532|473986920|FG001|Overall Study|Withdrawal by Subject|1|||
131645023|NCT03912532|473986921|FG002|Overall Study|Withdrawal by Subject|2|||
131645024|NCT03912532|473986922|FG003|Overall Study|Withdrawal by Subject|0|||
131645025|NCT03912532|473986919|FG000|Overall Study|Physician Decision|1|||
131645026|NCT03912532|473986920|FG001|Overall Study|Physician Decision|0|||
131645027|NCT03912532|473986921|FG002|Overall Study|Physician Decision|0|||
131645028|NCT03912532|473986922|FG003|Overall Study|Physician Decision|3|||
131645029|NCT03912532|473986919|FG000|Overall Study|Other|0|||
131645030|NCT03912532|473986920|FG001|Overall Study|Other|1|||
131645031|NCT03912532|473986921|FG002|Overall Study|Other|1|||
131645032|NCT03912532|473986922|FG003|Overall Study|Other|0|||
131645033|NCT03783871|473986927|FG000|Overall Study|Withdrawal by Subject|15|||
131645034|NCT03783871|473986927|FG000|Overall Study|Death|13|||
131645035|NCT03783871|473986927|FG000|Overall Study|Lost to Follow-up|2|||
131645036|NCT03569891|473986929|FG000|Lead-in|Ineligible during lead-in|8|||
131645037|NCT03569891|473986929|FG000|Lead-in|Withdrawal by Subject|3|||
131645038|NCT03569891|473986929|FG000|Lead-in|Risks related to COVID-19|2|||
131645039|NCT03569891|473986929|FG000|AMT-061|Adverse Event|1|||
131645040|NCT04594733|473986930|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131645041|NCT04594733|473986931|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
131645042|NCT04594733|473986930|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
131645043|NCT04594733|473986931|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
131645044|NCT04594733|473986930|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
131645045|NCT04594733|473986931|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
131645046|NCT00815919|473986932|FG000|Overall Study|Unrelated Fungal Infection|1|||
131645047|NCT00815919|473986932|FG000|Overall Study|AML Relapse|1|||
131645048|NCT00815919|473986932|FG000|Overall Study|Lack of Efficacy|2|||
131645049|NCT02647645|473986935|FG000|Overall Study|Lost to Follow-up|2|||
131645050|NCT02647645|473986936|FG001|Overall Study|Lost to Follow-up|1|||
131645051|NCT00356811|473986939|FG000|Overall Study|Death|35|||
131645052|NCT00356811|473986939|FG000|Overall Study|Lost to Follow-up|2|||
131645053|NCT00356811|473986939|FG000|Overall Study|Withdrawal by Subject|6|||
131645054|NCT00356811|473986939|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
131645055|NCT00356811|473986939|FG000|Overall Study|Study Is Terminating|3|||
131645056|NCT00356811|473986939|FG000|Overall Study|Site Closed during Follow-up|2|||
131645057|NCT02386839|473986940|FG000|Overall Study|Death|1|||
131645058|NCT02386839|473986941|FG001|Overall Study|Death|0|||
131645059|NCT02386839|473986940|FG000|Overall Study|Withdrawal by Subject|9|||
131645060|NCT02386839|473986941|FG001|Overall Study|Withdrawal by Subject|10|||
131645061|NCT02386839|473986940|FG000|Overall Study|Lost to Follow-up|4|||
131645062|NCT02386839|473986941|FG001|Overall Study|Lost to Follow-up|4|||
131645063|NCT02386839|473986940|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
131645064|NCT02386839|473986941|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
131645065|NCT02386839|473986940|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
131645066|NCT02386839|473986941|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
131645067|NCT02386839|473986940|FG000|Overall Study|Other (unspecified)|1|||
131645068|NCT02386839|473986941|FG001|Overall Study|Other (unspecified)|0|||
131645069|NCT02101983|473986942|FG000|Overall Study|Physician Decision|1|||
131645070|NCT02101983|473986943|FG001|Overall Study|Physician Decision|0|||
131645071|NCT00826228|473989113|FG000|Overall Study|Withdrawal by Subject|1|||
131645072|NCT00307047|473989114|FG000|Overall Study|Lost to Follow-up|35|||
131645073|NCT00307047|473989115|FG001|Overall Study|Lost to Follow-up|24|||
131645074|NCT00307047|473989114|FG000|Overall Study|Withdrawal by Subject|6|||
131645075|NCT00307047|473989115|FG001|Overall Study|Withdrawal by Subject|6|||
131645076|NCT00307047|473989114|FG000|Overall Study|Physician Decision|1|||
131645077|NCT00307047|473989115|FG001|Overall Study|Physician Decision|2|||
131645078|NCT00307047|473989114|FG000|Overall Study|Lost to follow-up for other reasons|0|||
131645079|NCT00307047|473989115|FG001|Overall Study|Lost to follow-up for other reasons|1|||
131645080|NCT00307047|473989114|FG000|Overall Study|All death, all MI, all Revascularization|27|||
131645081|NCT00307047|473989115|FG001|Overall Study|All death, all MI, all Revascularization|16|||
131645082|NCT00903760|473989116|FG000|Overall Study|Disease Progression/Death|8|||
131645083|NCT00903760|473989117|FG001|Overall Study|Disease Progression/Death|6|||
131645084|NCT00903760|473989116|FG000|Overall Study|Stem Cell Transplant|8|||
131645085|NCT00903760|473989117|FG001|Overall Study|Stem Cell Transplant|4|||
131645086|NCT00903760|473989116|FG000|Overall Study|Physician Decision|1|||
131645087|NCT00903760|473989117|FG001|Overall Study|Physician Decision|2|||
131645088|NCT00903760|473989116|FG000|Overall Study|Death|0|||
131645089|NCT00903760|473989117|FG001|Overall Study|Death|1|||
131645090|NCT00903760|473989116|FG000|Overall Study|Lost to Follow-up|1|||
131645091|NCT00903760|473989117|FG001|Overall Study|Lost to Follow-up|0|||
131645092|NCT00903760|473989116|FG000|Overall Study|Withdrawal by Subject|1|||
131645093|NCT00903760|473989117|FG001|Overall Study|Withdrawal by Subject|2|||
131645094|NCT00903760|473989116|FG000|Overall Study|Off treatment for long period|0|||
131645095|NCT00903760|473989117|FG001|Overall Study|Off treatment for long period|1|||
131645096|NCT02825251|473989119|FG000|Overall Study|Adverse Event|0|||
131645097|NCT02825251|473989120|FG001|Overall Study|Adverse Event|1|||
131645098|NCT02825251|473989119|FG000|Overall Study|Lost to Follow-up|0|||
131645099|NCT02825251|473989120|FG001|Overall Study|Lost to Follow-up|1|||
131645100|NCT02825251|473989119|FG000|Overall Study|Withdrawal by Subject|1|||
131645101|NCT02825251|473989120|FG001|Overall Study|Withdrawal by Subject|4|||
131645102|NCT02825251|473989119|FG000|Overall Study|Unclassified|2|||
131645103|NCT02825251|473989120|FG001|Overall Study|Unclassified|0|||
131645104|NCT00487825|473989121|FG000|Overall Study|Adverse Event|2|||
131645105|NCT00487825|473989122|FG001|Overall Study|Adverse Event|2|||
131645106|NCT00487825|473989121|FG000|Overall Study|Lack of Efficacy|1|||
131645107|NCT00487825|473989122|FG001|Overall Study|Lack of Efficacy|1|||
131645108|NCT00487825|473989121|FG000|Overall Study|Other|3|||
131645109|NCT00487825|473989122|FG001|Overall Study|Other|2|||
131645110|NCT02104505|473989123|FG000|First Intervention (14 Days)|Adverse Event|2|||
131645111|NCT02104505|473989124|FG001|First Intervention (14 Days)|Adverse Event|0|||
131645112|NCT02104505|473989123|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
131645113|NCT02104505|473989124|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
131645114|NCT02104505|473989123|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
131645115|NCT02104505|473989124|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
131645116|NCT02104505|473989123|FG000|First Intervention (14 Days)|exclusionary condition|0|||
131645117|NCT02104505|473989124|FG001|First Intervention (14 Days)|exclusionary condition|1|||
131645118|NCT02104505|473989123|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
131645119|NCT02104505|473989124|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
131645120|NCT02104505|473989123|FG000|Second Intervention (14 Days)|Adverse Event|2|||
131645121|NCT02104505|473989124|FG001|Second Intervention (14 Days)|Adverse Event|0|||
131645122|NCT01639742|473989125|FG000|Overall Study|Study Ongoing|17|||
131645123|NCT01639742|473989125|FG000|Overall Study|Lost to Follow-up|1|||
131645124|NCT01190644|473989126|FG000|Overall Study|Death|2|||
131645125|NCT01190644|473989126|FG000|Overall Study|Disease progression|1|||
131645126|NCT02366143|473989127|FG000|Overall Study|Death|307|||
131645127|NCT02366143|473989128|FG001|Overall Study|Death|278|||
131645128|NCT02366143|473989129|FG002|Overall Study|Death|280|||
131645129|NCT02366143|473989127|FG000|Overall Study|Lost to Follow-up|2|||
131645130|NCT02366143|473989128|FG001|Overall Study|Lost to Follow-up|4|||
131645131|NCT02366143|473989129|FG002|Overall Study|Lost to Follow-up|2|||
131645132|NCT02366143|473989127|FG000|Overall Study|Physician Decision|1|||
131645133|NCT02366143|473989128|FG001|Overall Study|Physician Decision|2|||
131645134|NCT02366143|473989129|FG002|Overall Study|Physician Decision|1|||
131645135|NCT02366143|473989127|FG000|Overall Study|Protocol Violation|0|||
131645136|NCT02366143|473989128|FG001|Overall Study|Protocol Violation|0|||
131645137|NCT02366143|473989129|FG002|Overall Study|Protocol Violation|2|||
131645138|NCT02366143|473989127|FG000|Overall Study|Withdrawal by Subject|16|||
131645139|NCT02366143|473989128|FG001|Overall Study|Withdrawal by Subject|17|||
131645140|NCT02366143|473989129|FG002|Overall Study|Withdrawal by Subject|22|||
131645141|NCT02366143|473989127|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
131645142|NCT02366143|473989128|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
131645143|NCT02366143|473989129|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
131645144|NCT02366143|473989127|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
131645145|NCT02366143|473989128|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
131645146|NCT02366143|473989129|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
131645147|NCT02366143|473989127|FG000|Overall Study|Randomization Error|1|||
131645148|NCT02366143|473989128|FG001|Overall Study|Randomization Error|0|||
131645149|NCT02366143|473989129|FG002|Overall Study|Randomization Error|0|||
131645150|NCT02366143|473989127|FG000|Overall Study|PI Move and Site Closure|1|||
131645151|NCT02366143|473989128|FG001|Overall Study|PI Move and Site Closure|0|||
131645152|NCT02366143|473989129|FG002|Overall Study|PI Move and Site Closure|1|||
131645153|NCT02366143|473989127|FG000|Overall Study|Study Terminated By Sponsor|0|||
131645154|NCT02366143|473989128|FG001|Overall Study|Study Terminated By Sponsor|0|||
131645155|NCT02366143|473989129|FG002|Overall Study|Study Terminated By Sponsor|2|||
131645156|NCT02366143|473989127|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
131645157|NCT02366143|473989128|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
131645158|NCT02366143|473989129|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
131645159|NCT02366143|473989127|FG000|Overall Study|Patient moved to roll-over study|1|||
131645160|NCT02366143|473989128|FG001|Overall Study|Patient moved to roll-over study|19|||
131645161|NCT02366143|473989129|FG002|Overall Study|Patient moved to roll-over study|28|||
131645162|NCT02366143|473989127|FG000|Overall Study|Patient moved to commercial stock|0|||
131645163|NCT02366143|473989128|FG001|Overall Study|Patient moved to commercial stock|0|||
131645164|NCT02366143|473989129|FG002|Overall Study|Patient moved to commercial stock|1|||
131645165|NCT02366143|473989127|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
131645166|NCT02366143|473989128|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
131645167|NCT02366143|473989129|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
131645168|NCT02366143|473989127|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
131645169|NCT02366143|473989128|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
131645170|NCT02366143|473989129|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
131645171|NCT02366143|473989127|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
131645172|NCT02366143|473989128|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
131645173|NCT02366143|473989129|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
131446390|NCT01550003|473265383|FG001|Overall Study|Study closed|1|||
131446391|NCT01550003|473265384|FG002|Overall Study|Study closed|0|||
131446392|NCT01550003|473265382|FG000|Overall Study|Transitioned to adult rheumatology|0|||
131446393|NCT01550003|473265383|FG001|Overall Study|Transitioned to adult rheumatology|0|||
131446394|NCT01550003|473265384|FG002|Overall Study|Transitioned to adult rheumatology|1|||
131446395|NCT01656408|473265385|FG000|Overall Study|Adverse Event|0|||
131446396|NCT01656408|473265386|FG001|Overall Study|Adverse Event|0|||
131446397|NCT01656408|473265387|FG002|Overall Study|Adverse Event|1|||
131645174|NCT02366143|473989127|FG000|Overall Study|Requester's instructions|1|||
131903128|NCT01435759|474931418|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
131903129|NCT01435759|474931413|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
131446398|NCT01656408|473265388|FG003|Overall Study|Adverse Event|0|||
131446399|NCT01656408|473265389|FG004|Overall Study|Adverse Event|0|||
131446400|NCT01656408|473265390|FG005|Overall Study|Adverse Event|1|||
131446401|NCT01656408|473265391|FG006|Overall Study|Adverse Event|1|||
131446402|NCT01656408|473265392|FG007|Overall Study|Adverse Event|0|||
131446403|NCT01656408|473265393|FG008|Overall Study|Adverse Event|1|||
131446404|NCT01656408|473265394|FG009|Overall Study|Adverse Event|0|||
131446405|NCT01656408|473265385|FG000|Overall Study|Physician Decision|1|||
131446406|NCT01656408|473265386|FG001|Overall Study|Physician Decision|0|||
131446407|NCT01656408|473265387|FG002|Overall Study|Physician Decision|1|||
131446408|NCT01656408|473265388|FG003|Overall Study|Physician Decision|0|||
131446409|NCT01656408|473265389|FG004|Overall Study|Physician Decision|1|||
131446410|NCT01656408|473265390|FG005|Overall Study|Physician Decision|1|||
131446411|NCT01656408|473265391|FG006|Overall Study|Physician Decision|0|||
131446412|NCT01656408|473265392|FG007|Overall Study|Physician Decision|1|||
131446413|NCT01656408|473265393|FG008|Overall Study|Physician Decision|1|||
131446414|NCT01656408|473265394|FG009|Overall Study|Physician Decision|3|||
131446415|NCT00870740|473265395|FG000|Overall Study|Adverse Event|2|||
131446416|NCT00870740|473265396|FG001|Overall Study|Adverse Event|1|||
131446417|NCT00870740|473265397|FG002|Overall Study|Adverse Event|3|||
131446418|NCT00870740|473265398|FG003|Overall Study|Adverse Event|2|||
131446419|NCT00870740|473265399|FG004|Overall Study|Adverse Event|1|||
131446420|NCT00870740|473265400|FG005|Overall Study|Adverse Event|6|||
131446421|NCT00870740|473265395|FG000|Overall Study|Consent Withdrawn|6|||
131645175|NCT02366143|473989128|FG001|Overall Study|Requester's instructions|1|||
131645176|NCT02366143|473989129|FG002|Overall Study|Requester's instructions|1|||
131645177|NCT02366143|473989127|FG000|Overall Study|Uneligible|0|||
131645178|NCT02366143|473989128|FG001|Overall Study|Uneligible|1|||
131645179|NCT02366143|473989129|FG002|Overall Study|Uneligible|0|||
131645180|NCT02366143|473989127|FG000|Overall Study|Post Trial Migration|0|||
131645181|NCT02366143|473989128|FG001|Overall Study|Post Trial Migration|1|||
131645182|NCT02366143|473989129|FG002|Overall Study|Post Trial Migration|0|||
131645183|NCT02366143|473989127|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
131715507|NCT02793544|474235524|FG000|Overall Study|Lost to Follow-up|2|||
131903130|NCT01435759|474931414|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
131446422|NCT00870740|473265396|FG001|Overall Study|Consent Withdrawn|3|||
131446423|NCT00870740|473265397|FG002|Overall Study|Consent Withdrawn|4|||
131446424|NCT00870740|473265398|FG003|Overall Study|Consent Withdrawn|6|||
131446425|NCT00870740|473265399|FG004|Overall Study|Consent Withdrawn|6|||
131446426|NCT00870740|473265400|FG005|Overall Study|Consent Withdrawn|5|||
131446427|NCT00870740|473265395|FG000|Overall Study|Investigator Decision|2|||
131446428|NCT00870740|473265396|FG001|Overall Study|Investigator Decision|0|||
131645184|NCT02366143|473989128|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
131645185|NCT02366143|473989129|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
131645186|NCT02366143|473989127|FG000|Overall Study|Patient switched to PTAP|0|||
131645187|NCT02366143|473989128|FG001|Overall Study|Patient switched to PTAP|1|||
131645188|NCT02366143|473989129|FG002|Overall Study|Patient switched to PTAP|0|||
131645189|NCT02366143|473989127|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
131645190|NCT02366143|473989128|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
131645191|NCT02366143|473989129|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
131446429|NCT00870740|473265397|FG002|Overall Study|Investigator Decision|1|||
131446430|NCT00870740|473265398|FG003|Overall Study|Investigator Decision|0|||
131446431|NCT00870740|473265399|FG004|Overall Study|Investigator Decision|0|||
131446432|NCT00870740|473265400|FG005|Overall Study|Investigator Decision|0|||
131446433|NCT00870740|473265395|FG000|Overall Study|Subject Non-compliance|0|||
131446434|NCT00870740|473265396|FG001|Overall Study|Subject Non-compliance|0|||
131645192|NCT04411186|473989130|FG000|Overall Study|Withdrawn due to protocol violation|0|||
131645193|NCT04411186|473989131|FG001|Overall Study|Withdrawn due to protocol violation|1|||
131645194|NCT01053247|473989132|FG000|Overall Study|Withdrawal by Subject|9|||
131645195|NCT01053247|473989133|FG001|Overall Study|Withdrawal by Subject|4|||
131645196|NCT01053247|473989134|FG002|Overall Study|Withdrawal by Subject|15|||
131645197|NCT01053247|473989132|FG000|Overall Study|Lack of Efficacy|1|||
131645198|NCT01053247|473989133|FG001|Overall Study|Lack of Efficacy|0|||
131645199|NCT01053247|473989134|FG002|Overall Study|Lack of Efficacy|1|||
131645200|NCT01053247|473989132|FG000|Overall Study|Protocol Violation|2|||
131645201|NCT01053247|473989133|FG001|Overall Study|Protocol Violation|1|||
131645202|NCT01053247|473989134|FG002|Overall Study|Protocol Violation|2|||
131645203|NCT01053247|473989132|FG000|Overall Study|Lost to Follow-up|8|||
131645204|NCT01053247|473989133|FG001|Overall Study|Lost to Follow-up|5|||
131645205|NCT01053247|473989134|FG002|Overall Study|Lost to Follow-up|7|||
131645206|NCT01053247|473989132|FG000|Overall Study|Adverse Event|0|||
131645207|NCT01053247|473989133|FG001|Overall Study|Adverse Event|9|||
131645208|NCT01053247|473989134|FG002|Overall Study|Adverse Event|3|||
131446435|NCT00870740|473265397|FG002|Overall Study|Subject Non-compliance|0|||
131446436|NCT00870740|473265398|FG003|Overall Study|Subject Non-compliance|0|||
131446437|NCT00870740|473265399|FG004|Overall Study|Subject Non-compliance|0|||
131446438|NCT00870740|473265400|FG005|Overall Study|Subject Non-compliance|1|||
131446439|NCT00870740|473265395|FG000|Overall Study|Death|0|||
131446440|NCT00870740|473265396|FG001|Overall Study|Death|0|||
131446441|NCT00870740|473265397|FG002|Overall Study|Death|0|||
131446442|NCT00870740|473265398|FG003|Overall Study|Death|0|||
131446443|NCT00870740|473265399|FG004|Overall Study|Death|1|||
131446444|NCT00870740|473265400|FG005|Overall Study|Death|0|||
131446445|NCT00870740|473265395|FG000|Overall Study|Other|2|||
131446446|NCT00870740|473265396|FG001|Overall Study|Other|5|||
131446447|NCT00870740|473265397|FG002|Overall Study|Other|2|||
131446448|NCT00870740|473265398|FG003|Overall Study|Other|4|||
131645209|NCT00701909|473989135|FG000|Overall Study|Withdrawal by Subject|0|||
131645210|NCT00701909|473989136|FG001|Overall Study|Withdrawal by Subject|1|||
131645211|NCT01385748|473989137|FG000|Overall Study|Withdrawal by Subject|7|||
131645212|NCT01385748|473989138|FG001|Overall Study|Withdrawal by Subject|4|||
131645213|NCT01385748|473989139|FG002|Overall Study|Withdrawal by Subject|5|||
131645214|NCT01385748|473989137|FG000|Overall Study|Noncompliance|3|||
131645215|NCT01385748|473989138|FG001|Overall Study|Noncompliance|1|||
131645216|NCT01385748|473989139|FG002|Overall Study|Noncompliance|6|||
131645217|NCT01385748|473989137|FG000|Overall Study|Other|1|||
131645218|NCT01385748|473989138|FG001|Overall Study|Other|7|||
131645219|NCT01385748|473989139|FG002|Overall Study|Other|1|||
131802054|NCT01974141|474559165|FG000|Overall Study|Pregnancy|3|||
131802055|NCT01974141|474559166|FG001|Overall Study|Pregnancy|3|||
131802056|NCT01974141|474559165|FG000|Overall Study|Lack of Efficacy|0|||
131802057|NCT01974141|474559166|FG001|Overall Study|Lack of Efficacy|1|||
131802058|NCT01974141|474559165|FG000|Overall Study|Adverse Event|4|||
131802059|NCT01974141|474559166|FG001|Overall Study|Adverse Event|5|||
131802060|NCT04977336|474559167|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
131802061|NCT04977336|474559168|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
131802062|NCT04977336|474559169|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
131802063|NCT04977336|474559170|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
131802064|NCT04977336|474559171|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
131802065|NCT04977336|474559167|FG000|Overall Study|Lost to Follow-up|0|||
131446449|NCT00870740|473265399|FG004|Overall Study|Other|3|||
131446450|NCT00870740|473265400|FG005|Overall Study|Other|5|||
131446451|NCT03995368|473265401|FG000|Overall Study|Lost to Follow-up|1|||
131446452|NCT03995368|473265402|FG001|Overall Study|Lost to Follow-up|4|||
131446453|NCT03995368|473265403|FG002|Overall Study|Lost to Follow-up|1|||
131645220|NCT01385748|473989137|FG000|Overall Study|Adverse Event|4|||
131645221|NCT01385748|473989138|FG001|Overall Study|Adverse Event|2|||
131446454|NCT03995368|473265401|FG000|Overall Study|Did not meet inclusion criteria|1|||
131446455|NCT03995368|473265402|FG001|Overall Study|Did not meet inclusion criteria|6|||
131446456|NCT03995368|473265403|FG002|Overall Study|Did not meet inclusion criteria|3|||
131446457|NCT03995368|473265401|FG000|Overall Study|Withdrawal by Subject|0|||
131446458|NCT03995368|473265402|FG001|Overall Study|Withdrawal by Subject|1|||
131446459|NCT03995368|473265403|FG002|Overall Study|Withdrawal by Subject|1|||
131446460|NCT03592186|473265404|FG000|Overall Study|Withdrawal by Subject|1|||
131446461|NCT03592186|473265405|FG001|Overall Study|Withdrawal by Subject|0|||
131446462|NCT03592186|473265404|FG000|Overall Study|Lost to Follow-up|16|||
131446463|NCT03592186|473265405|FG001|Overall Study|Lost to Follow-up|11|||
131446464|NCT00307801|473265406|FG000|Overall Study|Adverse Event|12|||
131446465|NCT00307801|473265407|FG001|Overall Study|Adverse Event|4|||
131446466|NCT00307801|473265406|FG000|Overall Study|Withdrawal by Subject|9|||
131446467|NCT00307801|473265407|FG001|Overall Study|Withdrawal by Subject|4|||
131446468|NCT00307801|473265406|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
131446469|NCT00307801|473265407|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
131446470|NCT00307801|473265406|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
131446471|NCT00307801|473265407|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
131446472|NCT00307801|473265406|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
131645222|NCT01385748|473989139|FG002|Overall Study|Adverse Event|1|||
131645223|NCT04120376|473989142|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
131645224|NCT04120376|473989143|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
131645225|NCT02641587|473989144|FG000|Confinement Period|Adverse Event|1|||
131903131|NCT01435759|474931415|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
131446473|NCT00307801|473265407|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
131446474|NCT00307801|473265406|FG000|Overall Study|Wrong Randomization|1|||
131446475|NCT00307801|473265407|FG001|Overall Study|Wrong Randomization|0|||
131446476|NCT00307801|473265406|FG000|Overall Study|Lack of Efficacy|0|||
131446477|NCT00307801|473265407|FG001|Overall Study|Lack of Efficacy|2|||
131446478|NCT00307801|473265406|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
131446479|NCT00307801|473265407|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
131446480|NCT00307801|473265406|FG000|Overall Study|Frustration with e-diary|1|||
131446481|NCT00307801|473265407|FG001|Overall Study|Frustration with e-diary|0|||
131446482|NCT00307801|473265406|FG000|Overall Study|Protocol Violation|3|||
131446483|NCT00307801|473265407|FG001|Overall Study|Protocol Violation|2|||
131446484|NCT00307801|473265406|FG000|Overall Study|No reason specified|2|||
131446485|NCT00307801|473265407|FG001|Overall Study|No reason specified|0|||
131446486|NCT00307801|473265406|FG000|Overall Study|Pregnancy|0|||
131446487|NCT00307801|473265407|FG001|Overall Study|Pregnancy|1|||
131446488|NCT01294553|473265412|FG000|Overall Study|Duplicated Participants|1|||
131446489|NCT01294553|473265412|FG000|Overall Study|Protocol Violation|268|||
131446490|NCT01217229|473265413|FG000|Overall Study|Adverse Event|1|||
131446491|NCT01217229|473265413|FG000|Overall Study|Disease progression, deterioration|2|||
131446492|NCT01217229|473265413|FG000|Overall Study|Disease progression, Cheson criteria|14|||
131446493|NCT01217229|473265413|FG000|Overall Study|Protocol Violation|1|||
131446494|NCT01217229|473265413|FG000|Overall Study|Disease progression not confirmed|2|||
131446495|NCT00926237|473265414|FG000|Overall Study|Withdrawal by Subject|2|||
131446496|NCT00926237|473265415|FG001|Overall Study|Withdrawal by Subject|1|||
131446497|NCT00474812|473265423|FG000|Overall Study|Withdrawal by Subject|5|||
131446498|NCT00474812|473265423|FG000|Overall Study|No Initiation of treatment|2|||
131446499|NCT00737672|473265430|FG000|Overall Study|Graft Abandonment|48|||
131446500|NCT00737672|473265431|FG001|Overall Study|Graft Abandonment|56|||
131446501|NCT00737672|473265430|FG000|Overall Study|Death|23|||
131446502|NCT00737672|473265431|FG001|Overall Study|Death|22|||
131446503|NCT00737672|473265430|FG000|Overall Study|Withdrawal by Subject|1|||
131446504|NCT00737672|473265431|FG001|Overall Study|Withdrawal by Subject|2|||
131446505|NCT00737672|473265430|FG000|Overall Study|Lost to Follow-up|1|||
131446506|NCT00737672|473265431|FG001|Overall Study|Lost to Follow-up|0|||
131446507|NCT00737672|473265430|FG000|Overall Study|Miscellaneous|7|||
131446508|NCT00737672|473265431|FG001|Overall Study|Miscellaneous|1|||
131446509|NCT00737672|473265430|FG000|Overall Study|Physician Decision|0|||
131446510|NCT00737672|473265431|FG001|Overall Study|Physician Decision|2|||
131446511|NCT02628873|473265432|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
131446512|NCT02628873|473265433|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
131446513|NCT02628873|473265432|FG000|Second Test (1 Hour)|Physician Decision|1|||
131446514|NCT02628873|473265433|FG001|Second Test (1 Hour)|Physician Decision|0|||
131446515|NCT02594124|473265434|FG000|Overall Study|Adverse Event|0|||
131446516|NCT02594124|473265435|FG001|Overall Study|Adverse Event|5|||
131446517|NCT02594124|473265436|FG002|Overall Study|Adverse Event|8|||
131446518|NCT02594124|473265437|FG003|Overall Study|Adverse Event|1|||
131446519|NCT02594124|473265438|FG004|Overall Study|Adverse Event|0|||
131645226|NCT02641587|473989145|FG001|Confinement Period|Adverse Event|0|||
131645227|NCT02641587|473989144|FG000|Confinement Period|Withdrawal by Subject|2|||
131446520|NCT02594124|473265439|FG005|Overall Study|Adverse Event|0|||
131446521|NCT02594124|473265440|FG006|Overall Study|Adverse Event|2|||
131446522|NCT02594124|473265441|FG007|Overall Study|Adverse Event|2|||
131645228|NCT02641587|473989145|FG001|Confinement Period|Withdrawal by Subject|1|||
131645229|NCT02641587|473989144|FG000|Ambulatory Period|Withdrawal by Subject|1|||
131645230|NCT02641587|473989145|FG001|Ambulatory Period|Withdrawal by Subject|0|||
131645231|NCT01165177|473989146|FG000|Overall Study|Serious Adverse Event|227|||
131645232|NCT01165177|473989147|FG001|Overall Study|Serious Adverse Event|235|||
131645233|NCT01165177|473989146|FG000|Overall Study|Withdrawal by Subject|368|||
131645234|NCT01165177|473989147|FG001|Overall Study|Withdrawal by Subject|354|||
131645235|NCT01165177|473989146|FG000|Overall Study|Protocol Violation|19|||
131645236|NCT01165177|473989147|FG001|Overall Study|Protocol Violation|21|||
131645237|NCT01165177|473989146|FG000|Overall Study|Non-serious adverse event|30|||
131645238|NCT01165177|473989147|FG001|Overall Study|Non-serious adverse event|18|||
131645239|NCT01165177|473989146|FG000|Overall Study|Other unspecified reasons|47|||
131645240|NCT01165177|473989147|FG001|Overall Study|Other unspecified reasons|35|||
131645241|NCT01165177|473989146|FG000|Overall Study|Suspected HZ episode|0|||
131715508|NCT02793544|474235525|FG001|Overall Study|Lost to Follow-up|0|||
131903132|NCT01435759|474931416|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
131645242|NCT01165177|473989147|FG001|Overall Study|Suspected HZ episode|2|||
131446523|NCT02594124|473265442|FG008|Overall Study|Adverse Event|0|||
131446524|NCT02594124|473265434|FG000|Overall Study|Withdrawal by Subject|2|||
131446525|NCT02594124|473265435|FG001|Overall Study|Withdrawal by Subject|3|||
131446526|NCT02594124|473265436|FG002|Overall Study|Withdrawal by Subject|5|||
131446527|NCT02594124|473265437|FG003|Overall Study|Withdrawal by Subject|1|||
131446528|NCT02594124|473265438|FG004|Overall Study|Withdrawal by Subject|8|||
131446529|NCT02594124|473265439|FG005|Overall Study|Withdrawal by Subject|4|||
131446530|NCT02594124|473265440|FG006|Overall Study|Withdrawal by Subject|13|||
131446531|NCT02594124|473265441|FG007|Overall Study|Withdrawal by Subject|19|||
131446532|NCT02594124|473265442|FG008|Overall Study|Withdrawal by Subject|0|||
131446533|NCT02594124|473265434|FG000|Overall Study|Physician Decision|0|||
131446534|NCT02594124|473265435|FG001|Overall Study|Physician Decision|2|||
131446535|NCT02594124|473265436|FG002|Overall Study|Physician Decision|0|||
131446536|NCT02594124|473265437|FG003|Overall Study|Physician Decision|0|||
131446537|NCT02594124|473265438|FG004|Overall Study|Physician Decision|0|||
131446538|NCT02594124|473265439|FG005|Overall Study|Physician Decision|0|||
131446539|NCT02594124|473265440|FG006|Overall Study|Physician Decision|0|||
131446540|NCT02594124|473265441|FG007|Overall Study|Physician Decision|1|||
131903133|NCT01435759|474931417|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
131903134|NCT01435759|474931418|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
131903135|NCT01435759|474931413|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
131903136|NCT01435759|474931414|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131903137|NCT01435759|474931415|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131903138|NCT01435759|474931416|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131446541|NCT02594124|473265442|FG008|Overall Study|Physician Decision|0|||
131446542|NCT02594124|473265434|FG000|Overall Study|Commercial drug|0|||
131446543|NCT02594124|473265435|FG001|Overall Study|Commercial drug|1|||
131446544|NCT02594124|473265436|FG002|Overall Study|Commercial drug|6|||
131446545|NCT02594124|473265437|FG003|Overall Study|Commercial drug|3|||
131446546|NCT02594124|473265438|FG004|Overall Study|Commercial drug|0|||
131446547|NCT02594124|473265439|FG005|Overall Study|Commercial drug|0|||
131446548|NCT02594124|473265440|FG006|Overall Study|Commercial drug|7|||
131446549|NCT02594124|473265441|FG007|Overall Study|Commercial drug|11|||
131446550|NCT02594124|473265442|FG008|Overall Study|Commercial drug|2|||
131645243|NCT01165177|473989146|FG000|Overall Study|Lost to Follow-up|183|||
131645244|NCT01165177|473989147|FG001|Overall Study|Lost to Follow-up|194|||
131645245|NCT01165177|473989146|FG000|Overall Study|Migrated/ moved from study area|48|||
131645246|NCT01165177|473989147|FG001|Overall Study|Migrated/ moved from study area|43|||
131645247|NCT00810342|473989151|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
131645248|NCT00810342|473989152|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
131645249|NCT00810342|473989151|FG000|Month 1 Follow-up|Pregnancy|1|||
131645250|NCT00810342|473989152|FG001|Month 1 Follow-up|Pregnancy|0|||
131645251|NCT00810342|473989151|FG000|6-month Follow-up|Lost to Follow-up|18|||
131645252|NCT00810342|473989152|FG001|6-month Follow-up|Lost to Follow-up|6|||
131645253|NCT00810342|473989151|FG000|6-month Follow-up|Pregnancy|6|||
131645254|NCT00810342|473989152|FG001|6-month Follow-up|Pregnancy|2|||
131645255|NCT00810342|473989151|FG000|12-month Followup|Pregnancy|9|||
131645256|NCT00810342|473989152|FG001|12-month Followup|Pregnancy|10|||
131645257|NCT00810342|473989151|FG000|12-month Followup|Lost to Follow-up|3|||
131645258|NCT00810342|473989152|FG001|12-month Followup|Lost to Follow-up|1|||
131645259|NCT04504630|473989154|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
131645260|NCT04504630|473989155|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
131645261|NCT04504630|473989154|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
131645262|NCT04504630|473989155|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
131645263|NCT00174447|473989157|FG000|Overall Study|Adverse Event|19|||
131645264|NCT00174447|473989157|FG000|Overall Study|Withdrawal by Subject|15|||
131645265|NCT00174447|473989157|FG000|Overall Study|Protocol Violation|1|||
131645266|NCT00174447|473989157|FG000|Overall Study|Lack of Efficacy|1|||
131645267|NCT00174447|473989157|FG000|Overall Study|Administrative reason/Other|2|||
131645268|NCT01437423|473989160|FG000|Overall Study|Lost to Follow-up|12|||
131645269|NCT01437423|473989160|FG000|Overall Study|Off label usage|3|||
131645270|NCT00633945|473989161|FG000|Overall Study|Physician Decision|2|||
131645271|NCT01271504|473989172|FG000|Overall Study|Death|7|||
131645272|NCT01271504|473989173|FG001|Overall Study|Death|6|||
131645273|NCT01271504|473989174|FG002|Overall Study|Death|32|||
131645274|NCT01271504|473989175|FG003|Overall Study|Death|32|||
131645275|NCT01271504|473989172|FG000|Overall Study|Lost to Follow-up|0|||
131645276|NCT01271504|473989173|FG001|Overall Study|Lost to Follow-up|1|||
131645277|NCT01271504|473989174|FG002|Overall Study|Lost to Follow-up|3|||
131645278|NCT01271504|473989175|FG003|Overall Study|Lost to Follow-up|1|||
131645279|NCT01271504|473989172|FG000|Overall Study|Protocol Violation|0|||
131645280|NCT01271504|473989173|FG001|Overall Study|Protocol Violation|0|||
131645281|NCT01271504|473989174|FG002|Overall Study|Protocol Violation|0|||
131645282|NCT01271504|473989175|FG003|Overall Study|Protocol Violation|2|||
131645283|NCT01271504|473989172|FG000|Overall Study|Administrative Reasons|0|||
131645284|NCT01271504|473989173|FG001|Overall Study|Administrative Reasons|0|||
131645285|NCT01271504|473989174|FG002|Overall Study|Administrative Reasons|6|||
131802066|NCT04977336|474559168|FG001|Overall Study|Lost to Follow-up|0|||
131802067|NCT04977336|474559169|FG002|Overall Study|Lost to Follow-up|1|||
131446551|NCT02594124|473265434|FG000|Overall Study|Reason Not Specified|1|||
131446552|NCT02594124|473265435|FG001|Overall Study|Reason Not Specified|3|||
131446553|NCT02594124|473265436|FG002|Overall Study|Reason Not Specified|4|||
131446554|NCT02594124|473265437|FG003|Overall Study|Reason Not Specified|0|||
131446555|NCT02594124|473265438|FG004|Overall Study|Reason Not Specified|0|||
131446556|NCT02594124|473265439|FG005|Overall Study|Reason Not Specified|1|||
131446557|NCT02594124|473265440|FG006|Overall Study|Reason Not Specified|1|||
131446558|NCT02594124|473265441|FG007|Overall Study|Reason Not Specified|6|||
131446559|NCT02594124|473265442|FG008|Overall Study|Reason Not Specified|1|||
131446560|NCT01899040|473265447|FG000|Overall Study|Randomized in error|0|||
131645286|NCT01271504|473989175|FG003|Overall Study|Administrative Reasons|5|||
131645287|NCT01271504|473989172|FG000|Overall Study|Withdrawal by Subject|0|||
131645288|NCT01271504|473989173|FG001|Overall Study|Withdrawal by Subject|0|||
131645289|NCT01271504|473989174|FG002|Overall Study|Withdrawal by Subject|1|||
131645290|NCT01271504|473989175|FG003|Overall Study|Withdrawal by Subject|3|||
131645291|NCT01271504|473989172|FG000|Overall Study|Other|0|||
131645292|NCT01271504|473989173|FG001|Overall Study|Other|1|||
131645293|NCT01271504|473989174|FG002|Overall Study|Other|2|||
131645294|NCT01271504|473989175|FG003|Overall Study|Other|0|||
131446561|NCT01899040|473265448|FG001|Overall Study|Randomized in error|1|||
131645295|NCT03865953|473989176|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
131645296|NCT03865953|473989177|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131645297|NCT03865953|473989176|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
131645298|NCT03865953|473989177|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
131645299|NCT03865953|473989176|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
131645300|NCT03865953|473989177|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
131645301|NCT02229578|473989178|FG000|Overall Study|Withdrawal by Subject|1|||
131446562|NCT01899040|473265449|FG002|Overall Study|Randomized in error|1|||
131446563|NCT01899040|473265447|FG000|Overall Study|Adverse Event|3|||
131446564|NCT01899040|473265448|FG001|Overall Study|Adverse Event|1|||
131645302|NCT02229578|473989179|FG001|Overall Study|Withdrawal by Subject|3|||
131446565|NCT01899040|473265449|FG002|Overall Study|Adverse Event|2|||
131446566|NCT01899040|473265447|FG000|Overall Study|Unspecified reasons|4|||
131446567|NCT01899040|473265448|FG001|Overall Study|Unspecified reasons|4|||
131446568|NCT01899040|473265449|FG002|Overall Study|Unspecified reasons|0|||
131446569|NCT01899040|473265447|FG000|Overall Study|Compliance issues|1|||
131446570|NCT01899040|473265448|FG001|Overall Study|Compliance issues|2|||
131446571|NCT01899040|473265449|FG002|Overall Study|Compliance issues|0|||
131446572|NCT00905164|473265455|FG000|Period 1|Protocol Violation|0|||
131446573|NCT00905164|473265456|FG001|Period 1|Protocol Violation|1|||
131446574|NCT01256788|473267324|FG000|Overall Study|Lost to Follow-up|5|||
131446575|NCT01256788|473267325|FG001|Overall Study|Lost to Follow-up|8|||
131446576|NCT01256788|473267326|FG002|Overall Study|Lost to Follow-up|3|||
131446577|NCT05366738|473267327|FG000|Overall Study|Adverse Event|0|||
131446578|NCT05366738|473267328|FG001|Overall Study|Adverse Event|1|||
131446579|NCT05366738|473267329|FG002|Overall Study|Adverse Event|0|||
131446580|NCT00906204|473267330|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
131446581|NCT00906204|473267331|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
131446582|NCT00906204|473267330|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
131446583|NCT00906204|473267331|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
131446584|NCT00906204|473267330|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
131446585|NCT00906204|473267331|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
131446586|NCT00906204|473267330|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
131446587|NCT00906204|473267331|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
131446588|NCT00906204|473267330|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
131446589|NCT00906204|473267331|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
131446590|NCT05291520|473267332|FG000|Overall Study|Lost to Follow-up|0|||
131446591|NCT05291520|473267333|FG001|Overall Study|Lost to Follow-up|0|||
131446592|NCT05291520|473267334|FG002|Overall Study|Lost to Follow-up|1|||
131446593|NCT01347112|473267335|FG000|Overall Study|Withdrawal by Subject|1|||
131446594|NCT01347112|473267336|FG001|Overall Study|Withdrawal by Subject|7|||
131446595|NCT01347112|473267335|FG000|Overall Study|Lost to Follow-up|3|||
131446596|NCT01347112|473267336|FG001|Overall Study|Lost to Follow-up|5|||
131446597|NCT00696072|473267337|FG000|Overall Study|continuing active treatment|10|||
131446598|NCT00696072|473267338|FG001|Overall Study|continuing active treatment|13|||
131446599|NCT00696072|473267337|FG000|Overall Study|Adverse Event|10|||
131446600|NCT00696072|473267338|FG001|Overall Study|Adverse Event|6|||
131446601|NCT00696072|473267337|FG000|Overall Study|Patient Request|3|||
131446602|NCT00696072|473267338|FG001|Overall Study|Patient Request|7|||
131446603|NCT00696072|473267337|FG000|Overall Study|Investigator Request|1|||
131446604|NCT00696072|473267338|FG001|Overall Study|Investigator Request|4|||
131446605|NCT00696072|473267337|FG000|Overall Study|Sponsor Request|0|||
131446606|NCT00696072|473267338|FG001|Overall Study|Sponsor Request|1|||
131446607|NCT00696072|473267337|FG000|Overall Study|Disease Progression|32|||
131446608|NCT00696072|473267338|FG001|Overall Study|Disease Progression|30|||
131446609|NCT00696072|473267337|FG000|Overall Study|Non-specified|1|||
131446610|NCT00696072|473267338|FG001|Overall Study|Non-specified|2|||
131446611|NCT01597596|473267339|FG000|Overall Study|Study terminated by sponsor|1|||
131446612|NCT01597596|473267340|FG001|Overall Study|Study terminated by sponsor|0|||
131446613|NCT01597596|473267339|FG000|Overall Study|Physician Decision|0|||
131446614|NCT01597596|473267340|FG001|Overall Study|Physician Decision|1|||
131446615|NCT02141295|473267353|FG000|Overall Study|Adverse Event|1|||
131446616|NCT02141295|473267354|FG001|Overall Study|Adverse Event|18|||
131446617|NCT02141295|473267355|FG002|Overall Study|Adverse Event|11|||
131446618|NCT02141295|473267353|FG000|Overall Study|Physician Decision|2|||
131446619|NCT02141295|473267354|FG001|Overall Study|Physician Decision|19|||
131446620|NCT02141295|473267355|FG002|Overall Study|Physician Decision|14|||
131446621|NCT02141295|473267353|FG000|Overall Study|Study terminated by sponsor|0|||
131446622|NCT02141295|473267354|FG001|Overall Study|Study terminated by sponsor|6|||
131446623|NCT02141295|473267355|FG002|Overall Study|Study terminated by sponsor|6|||
131446624|NCT02141295|473267353|FG000|Overall Study|Non-compliance|0|||
131446625|NCT02141295|473267354|FG001|Overall Study|Non-compliance|1|||
131446626|NCT02141295|473267355|FG002|Overall Study|Non-compliance|0|||
131446627|NCT02141295|473267353|FG000|Overall Study|Progressive disease|3|||
131446628|NCT02141295|473267354|FG001|Overall Study|Progressive disease|32|||
131446629|NCT02141295|473267355|FG002|Overall Study|Progressive disease|50|||
131446630|NCT02141295|473267353|FG000|Overall Study|Reason not specified|0|||
131446631|NCT02141295|473267354|FG001|Overall Study|Reason not specified|9|||
131446632|NCT02141295|473267355|FG002|Overall Study|Reason not specified|10|||
131446633|NCT02141295|473267353|FG000|Overall Study|Withdrawal by Subject|0|||
131446634|NCT02141295|473267354|FG001|Overall Study|Withdrawal by Subject|9|||
131446635|NCT02141295|473267355|FG002|Overall Study|Withdrawal by Subject|4|||
131446636|NCT01710501|473267356|FG000|Overall Study|Lost to Follow-up|2|||
131446637|NCT01710501|473267357|FG001|Overall Study|Lost to Follow-up|0|||
131446638|NCT01710501|473267358|FG002|Overall Study|Lost to Follow-up|0|||
131446639|NCT02536976|473267359|FG000|Overall Study|Physician Decision|0|||
131446640|NCT02536976|473267360|FG001|Overall Study|Physician Decision|1|||
131446641|NCT01281124|473267383|FG000|Overall Study|Death|1|||
131446642|NCT02038933|473267384|FG000|Overall Study|Disease progression|104|||
131446643|NCT02038933|473267384|FG000|Overall Study|Study drug toxicity|6|||
131446644|NCT02038933|473267384|FG000|Overall Study|Adverse event unrelated to study drug|6|||
131446645|NCT02038933|473267384|FG000|Overall Study|Participant request to discontinue treatment|2|||
131446646|NCT02038933|473267384|FG000|Overall Study|Lost to Follow-up|1|||
131446647|NCT02038933|473267384|FG000|Overall Study|Other reasons|2|||
131446648|NCT03250273|473267385|FG000|Overall Study|Disease Progression|2|||
131446649|NCT03250273|473267386|FG001|Overall Study|Disease Progression|11|||
131446650|NCT03250273|473267385|FG000|Overall Study|Death|0|||
131446651|NCT03250273|473267386|FG001|Overall Study|Death|1|||
131446652|NCT02392624|473267387|FG000|Overall Study|Withdrawal by Subject|15|||
131446653|NCT02392624|473267388|FG001|Overall Study|Withdrawal by Subject|12|||
131446654|NCT02392624|473267389|FG002|Overall Study|Withdrawal by Subject|9|||
131446655|NCT02392624|473267387|FG000|Overall Study|Adverse Event|4|||
131446656|NCT02392624|473267388|FG001|Overall Study|Adverse Event|1|||
131446657|NCT02392624|473267389|FG002|Overall Study|Adverse Event|2|||
131446658|NCT02392624|473267387|FG000|Overall Study|Pregnancy|1|||
131446659|NCT02392624|473267388|FG001|Overall Study|Pregnancy|0|||
131446660|NCT02392624|473267389|FG002|Overall Study|Pregnancy|0|||
131446661|NCT02392624|473267387|FG000|Overall Study|Protocol Violation|0|||
131446662|NCT02392624|473267388|FG001|Overall Study|Protocol Violation|0|||
131446663|NCT02392624|473267389|FG002|Overall Study|Protocol Violation|1|||
131446664|NCT02392624|473267387|FG000|Overall Study|Sponsor/Investigator Decision|2|||
131446665|NCT02392624|473267388|FG001|Overall Study|Sponsor/Investigator Decision|1|||
131446666|NCT02392624|473267389|FG002|Overall Study|Sponsor/Investigator Decision|0|||
131446667|NCT02392624|473267387|FG000|Overall Study|Other|49|||
131446668|NCT02392624|473267388|FG001|Overall Study|Other|1|||
131446669|NCT02392624|473267389|FG002|Overall Study|Other|1|||
131645303|NCT02229578|473989178|FG000|Overall Study|Protocol Violation|2|||
131645304|NCT02229578|473989179|FG001|Overall Study|Protocol Violation|0|||
131645305|NCT00943787|473989180|FG000|Overall Study|Physician Decision|4|||
131645306|NCT00943787|473989180|FG000|Overall Study|Withdrawal by Subject|3|||
131645307|NCT02706951|473989182|FG000|Period 1|Adverse Event|1|||
131645308|NCT02706951|473989183|FG001|Period 1|Adverse Event|5|||
131645309|NCT02706951|473989184|FG002|Period 1|Adverse Event|3|||
131645310|NCT02706951|473989185|FG003|Period 1|Adverse Event|0|||
131446670|NCT02113982|473267392|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
131446671|NCT02113982|473267393|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
131446672|NCT02113982|473267394|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
131802068|NCT04977336|474559170|FG003|Overall Study|Lost to Follow-up|0|||
131446673|NCT02113982|473267395|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
131446674|NCT02113982|473267396|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
131446675|NCT02113982|473267397|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
131645311|NCT02706951|473989186|FG004|Period 1|Adverse Event|0|||
131645312|NCT02706951|473989182|FG000|Period 1|Withdrawal by Subject|10|||
131645313|NCT02706951|473989183|FG001|Period 1|Withdrawal by Subject|6|||
131446676|NCT02113982|473267398|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
131446677|NCT02113982|473267399|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
131446678|NCT02113982|473267400|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
131446679|NCT02113982|473267401|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
131446680|NCT02113982|473267402|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
131446681|NCT02113982|473267403|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
131446682|NCT02113982|473267404|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
131446683|NCT02113982|473267405|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
131446684|NCT02113982|473267392|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
131446685|NCT02113982|473267393|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
131446686|NCT02113982|473267394|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
131446687|NCT02113982|473267395|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
131446688|NCT02113982|473267396|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
131446689|NCT02113982|473267397|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
131446690|NCT02113982|473267398|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
131645314|NCT02706951|473989184|FG002|Period 1|Withdrawal by Subject|6|||
131446691|NCT02113982|473267399|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
131446692|NCT02113982|473267400|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
131645315|NCT02706951|473989185|FG003|Period 1|Withdrawal by Subject|0|||
131645316|NCT02706951|473989186|FG004|Period 1|Withdrawal by Subject|0|||
131645317|NCT02706951|473989182|FG000|Period 1|Lost to Follow-up|0|||
131645318|NCT02706951|473989183|FG001|Period 1|Lost to Follow-up|4|||
131645319|NCT02706951|473989184|FG002|Period 1|Lost to Follow-up|1|||
131645320|NCT02706951|473989185|FG003|Period 1|Lost to Follow-up|0|||
131645321|NCT02706951|473989186|FG004|Period 1|Lost to Follow-up|0|||
131645322|NCT02706951|473989182|FG000|Period 1|Other|2|||
131802069|NCT04977336|474559171|FG004|Overall Study|Lost to Follow-up|0|||
131802070|NCT01759290|474559172|FG000|Overall Study|Subjects withdrawn consent|5|||
131446693|NCT02113982|473267401|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
131446694|NCT02113982|473267402|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
131446695|NCT02113982|473267403|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
131645323|NCT02706951|473989183|FG001|Period 1|Other|1|||
131645324|NCT02706951|473989184|FG002|Period 1|Other|0|||
131446696|NCT02113982|473267404|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
131446697|NCT02113982|473267405|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
131645325|NCT02706951|473989185|FG003|Period 1|Other|0|||
131446698|NCT02113982|473267392|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446699|NCT02113982|473267393|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446700|NCT02113982|473267394|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446701|NCT02113982|473267395|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446702|NCT02113982|473267396|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446703|NCT02113982|473267397|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131645326|NCT02706951|473989186|FG004|Period 1|Other|0|||
131645327|NCT02706951|473989182|FG000|Period 2|Adverse Event|0|||
131645328|NCT02706951|473989183|FG001|Period 2|Adverse Event|0|||
131645329|NCT02706951|473989184|FG002|Period 2|Adverse Event|0|||
131645330|NCT02706951|473989185|FG003|Period 2|Adverse Event|25|||
131645331|NCT02706951|473989186|FG004|Period 2|Adverse Event|34|||
131645332|NCT02706951|473989182|FG000|Period 2|Withdrawal by Subject|0|||
131645333|NCT02706951|473989183|FG001|Period 2|Withdrawal by Subject|0|||
131645334|NCT02706951|473989184|FG002|Period 2|Withdrawal by Subject|0|||
131645335|NCT02706951|473989185|FG003|Period 2|Withdrawal by Subject|38|||
131645336|NCT02706951|473989186|FG004|Period 2|Withdrawal by Subject|44|||
131645337|NCT02706951|473989182|FG000|Period 2|Lost to Follow-up|0|||
131645338|NCT02706951|473989183|FG001|Period 2|Lost to Follow-up|0|||
131645339|NCT02706951|473989184|FG002|Period 2|Lost to Follow-up|0|||
131645340|NCT02706951|473989185|FG003|Period 2|Lost to Follow-up|17|||
131645341|NCT02706951|473989186|FG004|Period 2|Lost to Follow-up|9|||
131645342|NCT02706951|473989182|FG000|Period 2|COVID-19 Related|0|||
131645343|NCT02706951|473989183|FG001|Period 2|COVID-19 Related|0|||
131645344|NCT02706951|473989184|FG002|Period 2|COVID-19 Related|0|||
131645345|NCT02706951|473989185|FG003|Period 2|COVID-19 Related|1|||
131645346|NCT02706951|473989186|FG004|Period 2|COVID-19 Related|2|||
131645347|NCT02706951|473989182|FG000|Period 2|Other|0|||
131645348|NCT02706951|473989183|FG001|Period 2|Other|0|||
131645349|NCT02706951|473989184|FG002|Period 2|Other|0|||
131645350|NCT02706951|473989185|FG003|Period 2|Other|37|||
131645351|NCT02706951|473989186|FG004|Period 2|Other|31|||
131645352|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
131446704|NCT02113982|473267398|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
131446705|NCT02113982|473267399|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446706|NCT02113982|473267400|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446707|NCT02113982|473267401|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446708|NCT02113982|473267402|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446709|NCT02113982|473267403|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446710|NCT02113982|473267404|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446711|NCT02113982|473267405|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
131446712|NCT02113982|473267392|FG000|Stage 1: Dose Escalation|Transplant|0|||
131446713|NCT02113982|473267393|FG001|Stage 1: Dose Escalation|Transplant|1|||
131645353|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
131645354|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
131446714|NCT02113982|473267394|FG002|Stage 1: Dose Escalation|Transplant|0|||
131446715|NCT02113982|473267395|FG003|Stage 1: Dose Escalation|Transplant|0|||
131645355|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
131446716|NCT02113982|473267396|FG004|Stage 1: Dose Escalation|Transplant|0|||
131446717|NCT02113982|473267397|FG005|Stage 1: Dose Escalation|Transplant|1|||
131446718|NCT02113982|473267398|FG006|Stage 1: Dose Escalation|Transplant|0|||
131446719|NCT02113982|473267399|FG007|Stage 1: Dose Escalation|Transplant|0|||
131446720|NCT02113982|473267400|FG008|Stage 1: Dose Escalation|Transplant|0|||
131446721|NCT02113982|473267401|FG009|Stage 1: Dose Escalation|Transplant|0|||
131446722|NCT02113982|473267402|FG010|Stage 1: Dose Escalation|Transplant|0|||
131446723|NCT02113982|473267403|FG011|Stage 1: Dose Escalation|Transplant|0|||
131446724|NCT02113982|473267404|FG012|Stage 1: Dose Escalation|Transplant|0|||
131446725|NCT02113982|473267405|FG013|Stage 1: Dose Escalation|Transplant|0|||
131446726|NCT02113982|473267392|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
131446727|NCT02113982|473267393|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
131446728|NCT02113982|473267394|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
131446729|NCT02113982|473267395|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
131446730|NCT02113982|473267396|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
131446731|NCT02113982|473267397|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
131446732|NCT02113982|473267398|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
131645356|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
131645357|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
131645358|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
131645359|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
131802071|NCT01759290|474559172|FG000|Overall Study|Physician Decision|2|||
131446733|NCT02113982|473267399|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
131645360|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
131645361|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
131645362|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
131645363|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
131645364|NCT01216072|473989187|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
131645365|NCT01216072|473989188|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
131645366|NCT01216072|473989187|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
131645367|NCT01216072|473989188|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
131645368|NCT01216072|473989187|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
131446734|NCT02113982|473267400|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
131446735|NCT02113982|473267401|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
131446736|NCT02113982|473267402|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
131446737|NCT02113982|473267403|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
131446738|NCT02113982|473267404|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
131446739|NCT02113982|473267405|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
131446740|NCT02113982|473267392|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
131446741|NCT02113982|473267393|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
131446742|NCT02113982|473267394|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
131446743|NCT02113982|473267395|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
131446744|NCT02113982|473267396|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
131446745|NCT02113982|473267397|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
131446746|NCT02113982|473267398|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
131645369|NCT01216072|473989188|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
131446747|NCT02113982|473267399|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
131446748|NCT02113982|473267400|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
131446749|NCT02113982|473267401|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
131446750|NCT02113982|473267402|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
131446751|NCT02113982|473267403|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
131446752|NCT02113982|473267404|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
131446753|NCT02113982|473267405|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
131446754|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
131446755|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
131446756|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
131446757|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
131446758|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
131446759|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
131446760|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
131446761|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
131446762|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
131446763|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
131446764|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
131446765|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
131446766|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
131446767|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
131446768|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
131446769|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
131446770|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
131446771|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
131446772|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
131446773|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
131446774|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
131446775|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
131446776|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
131446777|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
131446778|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
131446779|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
131446780|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
131446781|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
131446782|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446783|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446784|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446785|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446786|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446787|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446788|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446789|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
131446790|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446791|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
131446792|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
131446793|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446794|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
131645370|NCT01216072|473989187|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
131645371|NCT01216072|473989188|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
131446795|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
131446796|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446797|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446798|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446799|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446800|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446801|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446802|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446803|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
131446804|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446805|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
131446806|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446807|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446808|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446809|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
131446810|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446811|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446812|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446813|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446814|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446815|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446816|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446817|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
131446818|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446819|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446820|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446821|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446822|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446823|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
131446824|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Transplant|0|||
131446825|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Transplant|0|||
131446826|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Transplant|0|||
131446827|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Transplant|0|||
131446828|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Transplant|0|||
131446829|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Transplant|0|||
131446830|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Transplant|0|||
131446831|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Transplant|0|||
131446832|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Transplant|0|||
131446833|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Transplant|4|||
131446834|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Transplant|2|||
131446835|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Transplant|0|||
131446836|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Transplant|0|||
131446837|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Transplant|0|||
131446838|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
131446839|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
131446840|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
131446841|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
131446842|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
131446843|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
131446844|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
131446845|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
131446846|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
131446847|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
131446848|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
131446849|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
131446850|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
131446851|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
131446852|NCT02113982|473267392|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
131446853|NCT02113982|473267393|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
131446854|NCT02113982|473267394|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
131446855|NCT02113982|473267395|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
131446856|NCT02113982|473267396|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
131446857|NCT02113982|473267397|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
131446858|NCT02113982|473267398|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
131446859|NCT02113982|473267399|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
131645372|NCT04294667|473989190|FG000|Overall Study|Lack of Efficacy|4|||
131645373|NCT04294667|473989191|FG001|Overall Study|Lack of Efficacy|4|||
131446860|NCT02113982|473267400|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
131446861|NCT02113982|473267401|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
131446862|NCT02113982|473267402|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
131446863|NCT02113982|473267403|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
131446864|NCT02113982|473267404|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
131645374|NCT04294667|473989190|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
131446865|NCT02113982|473267405|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
131446866|NCT02113982|473267392|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446867|NCT02113982|473267393|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446868|NCT02113982|473267394|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446869|NCT02113982|473267395|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446870|NCT02113982|473267396|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446871|NCT02113982|473267397|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446872|NCT02113982|473267398|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446873|NCT02113982|473267399|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446874|NCT02113982|473267400|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446875|NCT02113982|473267401|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446876|NCT02113982|473267402|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446877|NCT02113982|473267403|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
131446878|NCT02113982|473267404|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446879|NCT02113982|473267405|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
131446880|NCT02113982|473267392|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446881|NCT02113982|473267393|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446882|NCT02113982|473267394|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446883|NCT02113982|473267395|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446884|NCT02113982|473267396|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446885|NCT02113982|473267397|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446886|NCT02113982|473267398|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446887|NCT02113982|473267399|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446888|NCT02113982|473267400|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446889|NCT02113982|473267401|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446890|NCT02113982|473267402|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446891|NCT02113982|473267403|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
131446892|NCT02113982|473267404|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
131446893|NCT02113982|473267405|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
131645375|NCT04294667|473989191|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
131645376|NCT04294667|473989190|FG000|Overall Study|Patient has a Renal Flare|1|||
131645377|NCT04294667|473989191|FG001|Overall Study|Patient has a Renal Flare|0|||
131645378|NCT04294667|473989190|FG000|Overall Study|SLE Worsening|0|||
131446894|NCT02113982|473267392|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446895|NCT02113982|473267393|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446896|NCT02113982|473267394|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446897|NCT02113982|473267395|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446898|NCT02113982|473267396|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446899|NCT02113982|473267397|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446900|NCT02113982|473267398|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446901|NCT02113982|473267399|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446902|NCT02113982|473267400|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446903|NCT02113982|473267401|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446904|NCT02113982|473267402|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446905|NCT02113982|473267403|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
131446906|NCT02113982|473267404|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446907|NCT02113982|473267405|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
131446908|NCT02113982|473267392|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
131446909|NCT02113982|473267393|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
131446910|NCT02113982|473267394|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
131446911|NCT02113982|473267395|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
131446912|NCT02113982|473267396|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
131446913|NCT02113982|473267397|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
131446914|NCT02113982|473267398|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
131446915|NCT02113982|473267399|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
131446916|NCT02113982|473267400|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
131446917|NCT02113982|473267401|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
131446918|NCT02113982|473267402|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
131446919|NCT02113982|473267403|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
131446920|NCT02113982|473267404|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
131446921|NCT02113982|473267405|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
131446922|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446923|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446924|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446925|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446926|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446927|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446928|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446929|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446930|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446931|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131645379|NCT04294667|473989191|FG001|Overall Study|SLE Worsening|1|||
131446932|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446933|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446934|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
131446935|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
131446936|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446937|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446938|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446939|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446940|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446941|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446942|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446943|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446944|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446945|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446946|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446947|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
131446948|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
131446949|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
131446950|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446951|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446952|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446953|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446954|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446955|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446956|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446957|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446958|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446959|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446960|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446961|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
131446962|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
131446963|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
131446964|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446965|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446966|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446967|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446968|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446969|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446970|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446971|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446972|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446973|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446974|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446975|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
131446976|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
131446977|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
131446978|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446979|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446980|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446981|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446982|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446983|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446984|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446985|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446986|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446987|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446988|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446989|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446990|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
131446991|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
131446992|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131446993|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131446994|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131446995|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131446996|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131645380|NCT04294667|473989190|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
131645381|NCT04294667|473989191|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
131446997|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131446998|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131446999|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131447000|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131447001|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131447002|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131447003|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131447004|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
131447005|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
131447006|NCT02113982|473267392|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447007|NCT02113982|473267393|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447008|NCT02113982|473267394|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447009|NCT02113982|473267395|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447010|NCT02113982|473267396|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447011|NCT02113982|473267397|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447012|NCT02113982|473267398|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447013|NCT02113982|473267399|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447014|NCT02113982|473267400|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447015|NCT02113982|473267401|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447016|NCT02113982|473267402|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447017|NCT02113982|473267403|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447018|NCT02113982|473267404|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
131447019|NCT02113982|473267405|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
131447020|NCT02085161|473267406|FG000|Overall Study|Not Treated|1|||
131447021|NCT02085161|473267407|FG001|Overall Study|Not Treated|0|||
131447022|NCT02085161|473267408|FG002|Overall Study|Not Treated|0|||
131447023|NCT02085161|473267409|FG003|Overall Study|Not Treated|0|||
131447024|NCT02085161|473267406|FG000|Overall Study|Adverse Event|8|||
131447025|NCT02085161|473267407|FG001|Overall Study|Adverse Event|5|||
131447026|NCT02085161|473267408|FG002|Overall Study|Adverse Event|4|||
131447027|NCT02085161|473267409|FG003|Overall Study|Adverse Event|5|||
131447028|NCT02085161|473267406|FG000|Overall Study|Protocol Violation|0|||
131447029|NCT02085161|473267407|FG001|Overall Study|Protocol Violation|1|||
131447030|NCT02085161|473267408|FG002|Overall Study|Protocol Violation|0|||
131447031|NCT02085161|473267409|FG003|Overall Study|Protocol Violation|1|||
131447032|NCT02085161|473267406|FG000|Overall Study|Withdrawal by Subject|2|||
131447033|NCT02085161|473267407|FG001|Overall Study|Withdrawal by Subject|4|||
131447034|NCT02085161|473267408|FG002|Overall Study|Withdrawal by Subject|0|||
131447035|NCT02085161|473267409|FG003|Overall Study|Withdrawal by Subject|3|||
131447036|NCT02085161|473267406|FG000|Overall Study|Other Reason|1|||
131447037|NCT02085161|473267407|FG001|Overall Study|Other Reason|0|||
131447038|NCT02085161|473267408|FG002|Overall Study|Other Reason|1|||
131447039|NCT02085161|473267409|FG003|Overall Study|Other Reason|1|||
131447040|NCT01936870|473267412|FG000|Overall Study|No Visit After Treatment|176|||
131447041|NCT01936870|473267412|FG000|Overall Study|Protocol Violation|12|||
131447042|NCT01936870|473267412|FG000|Overall Study|No Drug Administration|1|||
131447043|NCT00628108|473267421|FG000|Overall Study|Adverse Event|0|||
131447044|NCT00628108|473267422|FG001|Overall Study|Adverse Event|3|||
131447045|NCT00628108|473267421|FG000|Overall Study|Withdrawal by Subject|1|||
131447046|NCT00628108|473267422|FG001|Overall Study|Withdrawal by Subject|0|||
131447047|NCT02399163|473267425|FG000|Overall Study|Adverse Event|2|||
131447048|NCT02399163|473267425|FG000|Overall Study|Protocol Deviation|2|||
131447049|NCT02399163|473267425|FG000|Overall Study|Withdrawal by Participant|5|||
131447050|NCT03910244|473267427|FG000|Overall Study|Adverse Event|14|||
131447051|NCT03910244|473267428|FG001|Overall Study|Adverse Event|0|||
131447052|NCT03910244|473267427|FG000|Overall Study|Death|1|||
131447053|NCT03910244|473267428|FG001|Overall Study|Death|0|||
131447054|NCT03910244|473267427|FG000|Overall Study|Lost to Follow-up|0|||
131447055|NCT03910244|473267428|FG001|Overall Study|Lost to Follow-up|2|||
131447056|NCT03910244|473267427|FG000|Overall Study|Joint withdrawal decision|1|||
131447057|NCT03910244|473267428|FG001|Overall Study|Joint withdrawal decision|0|||
131447058|NCT03910244|473267427|FG000|Overall Study|Study Terminated by Sponsor|7|||
131447059|NCT03910244|473267428|FG001|Overall Study|Study Terminated by Sponsor|4|||
131447060|NCT03910244|473267427|FG000|Overall Study|Physician Decision|1|||
131447061|NCT03910244|473267428|FG001|Overall Study|Physician Decision|0|||
131447062|NCT03910244|473267427|FG000|Overall Study|Protocol Violation|1|||
131447063|NCT03910244|473267428|FG001|Overall Study|Protocol Violation|0|||
131447064|NCT03910244|473267427|FG000|Overall Study|Withdrawal by Subject|7|||
131447065|NCT03910244|473267428|FG001|Overall Study|Withdrawal by Subject|2|||
131447066|NCT02085460|473267432|FG000|Overall Study|Adverse Event|2|||
131447067|NCT02085460|473267433|FG001|Overall Study|Adverse Event|2|||
131447068|NCT02085460|473267434|FG002|Overall Study|Adverse Event|1|||
131447069|NCT02085460|473267432|FG000|Overall Study|Physician Decision|1|||
131447070|NCT02085460|473267433|FG001|Overall Study|Physician Decision|1|||
131447071|NCT02085460|473267434|FG002|Overall Study|Physician Decision|2|||
131447072|NCT02085460|473267432|FG000|Overall Study|Withdrawal by Subject|11|||
131447073|NCT02085460|473267433|FG001|Overall Study|Withdrawal by Subject|5|||
131447074|NCT02085460|473267434|FG002|Overall Study|Withdrawal by Subject|7|||
131447075|NCT01285323|473267435|FG000|Overall Study|Adverse Event|9|||
131645382|NCT04294667|473989190|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
131645383|NCT04294667|473989191|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
131645384|NCT04294667|473989190|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
131645385|NCT04294667|473989191|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
131645386|NCT04294667|473989190|FG000|Overall Study|Subject Moved to Another State|0|||
131645387|NCT04294667|473989191|FG001|Overall Study|Subject Moved to Another State|1|||
131645388|NCT04294667|473989190|FG000|Overall Study|Adverse event, serious fatal|0|||
131645389|NCT04294667|473989191|FG001|Overall Study|Adverse event, serious fatal|1|||
131645390|NCT04294667|473989190|FG000|Overall Study|Adverse event, non-fatal|3|||
131645391|NCT04294667|473989191|FG001|Overall Study|Adverse event, non-fatal|4|||
131645392|NCT02599688|473989194|FG000|Overall Study|Lack of Efficacy|1|||
131645393|NCT02599688|473989194|FG000|Overall Study|Withdrawal by Subject|1|||
131645394|NCT02599688|473989194|FG000|Overall Study|Termination by Sponsor|2|||
131645395|NCT01841697|473989195|FG000|Overall Study|Death|0|||
131645396|NCT01841697|473989196|FG001|Overall Study|Death|1|||
131645397|NCT01841697|473989195|FG000|Overall Study|Lost to Follow-up|4|||
131645398|NCT01841697|473989196|FG001|Overall Study|Lost to Follow-up|1|||
131645399|NCT01841697|473989195|FG000|Overall Study|Withdrawal by Subject|16|||
131645400|NCT01841697|473989196|FG001|Overall Study|Withdrawal by Subject|16|||
131645401|NCT00756457|473989197|FG000|Overall Study|Lost to Follow-up|1|||
131645402|NCT00756457|473989198|FG001|Overall Study|Lost to Follow-up|2|||
131645403|NCT01777490|473989201|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
131645404|NCT01777490|473989202|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
131645405|NCT01777490|473989203|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
131645406|NCT01777490|473989204|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
131645407|NCT02818998|473989207|FG000|Overall Study|Adverse Event|3|||
131645408|NCT02818998|473989208|FG001|Overall Study|Adverse Event|2|||
131802072|NCT01759290|474559172|FG000|Overall Study|Death|17|||
131447076|NCT01285323|473267436|FG001|Overall Study|Adverse Event|8|||
131447077|NCT01285323|473267435|FG000|Overall Study|Lack of Efficacy|4|||
131447078|NCT01285323|473267436|FG001|Overall Study|Lack of Efficacy|2|||
131447079|NCT01285323|473267435|FG000|Overall Study|Withdrawal by Subject|15|||
131447080|NCT01285323|473267436|FG001|Overall Study|Withdrawal by Subject|11|||
131447081|NCT01285323|473267435|FG000|Overall Study|Protocol Violation|1|||
131447082|NCT01285323|473267436|FG001|Overall Study|Protocol Violation|2|||
131447083|NCT01285323|473267435|FG000|Overall Study|Non-compliance with study procedures|2|||
131447084|NCT01285323|473267436|FG001|Overall Study|Non-compliance with study procedures|3|||
131447085|NCT01285323|473267435|FG000|Overall Study|Lost to Follow-up|1|||
131447086|NCT01285323|473267436|FG001|Overall Study|Lost to Follow-up|1|||
131645409|NCT02818998|473989209|FG002|Overall Study|Adverse Event|1|||
131645410|NCT02818998|473989207|FG000|Overall Study|Lost to Follow-up|4|||
131645411|NCT02818998|473989208|FG001|Overall Study|Lost to Follow-up|1|||
131645412|NCT02818998|473989209|FG002|Overall Study|Lost to Follow-up|2|||
131645413|NCT02818998|473989207|FG000|Overall Study|Withdrawal by sponsor|0|||
131645414|NCT02818998|473989208|FG001|Overall Study|Withdrawal by sponsor|1|||
131645415|NCT02818998|473989209|FG002|Overall Study|Withdrawal by sponsor|1|||
131645416|NCT02818998|473989207|FG000|Overall Study|Death|3|||
131645417|NCT02818998|473989208|FG001|Overall Study|Death|6|||
131802073|NCT01759290|474559172|FG000|Overall Study|Lost to Follow-up|53|||
131447087|NCT01285323|473267435|FG000|Overall Study|Other|1|||
131645418|NCT02818998|473989209|FG002|Overall Study|Death|8|||
131645419|NCT02818998|473989207|FG000|Overall Study|Withdrawal by Subject|7|||
131645420|NCT02818998|473989208|FG001|Overall Study|Withdrawal by Subject|6|||
131645421|NCT02818998|473989209|FG002|Overall Study|Withdrawal by Subject|6|||
131645422|NCT02818998|473989207|FG000|Overall Study|Physician Decision|1|||
131645423|NCT02818998|473989208|FG001|Overall Study|Physician Decision|0|||
131645424|NCT02818998|473989209|FG002|Overall Study|Physician Decision|0|||
131645425|NCT00632021|473989213|FG000|Overall Study|Withdrawal/death|4|||
131645426|NCT00632021|473989214|FG001|Overall Study|Withdrawal/death|7|||
131447088|NCT01285323|473267436|FG001|Overall Study|Other|3|||
131447089|NCT00763035|473267437|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
131447090|NCT00763035|473267438|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
131447091|NCT00763035|473267437|FG000|First Intervention|Adverse Event|0|||
131447092|NCT00763035|473267438|FG001|First Intervention|Adverse Event|1|||
131447093|NCT00763035|473267437|FG000|Second Intervention|Adverse Event|1|||
131447094|NCT00763035|473267438|FG001|Second Intervention|Adverse Event|0|||
131447095|NCT00763035|473267437|FG000|Second Intervention|Physician Decision|2|||
131447096|NCT00763035|473267438|FG001|Second Intervention|Physician Decision|0|||
131447097|NCT02606643|473267439|FG000|Overall Study|did not meet inclusion criteria|1|||
131447098|NCT02606643|473267440|FG001|Overall Study|did not meet inclusion criteria|3|||
131447099|NCT00803569|473267442|FG000|Overall Study|Progressive Disease|3|||
131447100|NCT00803569|473267442|FG000|Overall Study|Noncompliance|1|||
131447101|NCT04313244|473267447|FG000|Overall Study|Withdrawal of Consent|3|||
131447102|NCT04313244|473267448|FG001|Overall Study|Withdrawal of Consent|3|||
131447103|NCT04313244|473267447|FG000|Overall Study|Met Exclusion Criteria|1|||
131447104|NCT04313244|473267448|FG001|Overall Study|Met Exclusion Criteria|0|||
131447105|NCT04313244|473267447|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
131447106|NCT04313244|473267448|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
131447107|NCT00907335|473267449|FG000|Overall Study|Withdrawal by Subject|2|||
131447108|NCT00907335|473267450|FG001|Overall Study|Withdrawal by Subject|0|||
131447109|NCT00907335|473267449|FG000|Overall Study|Adverse Event|4|||
131447110|NCT00907335|473267450|FG001|Overall Study|Adverse Event|1|||
131447111|NCT00907335|473267449|FG000|Overall Study|Lost to Follow-up|2|||
131447112|NCT00907335|473267450|FG001|Overall Study|Lost to Follow-up|0|||
131447113|NCT04004988|473267451|FG000|Period 1|Physician Decision|2|||
131447114|NCT04004988|473267452|FG001|Period 1|Physician Decision|0|||
131447115|NCT04004988|473267451|FG000|Period 1|Withdrawal by Subject|0|||
131447116|NCT04004988|473267452|FG001|Period 1|Withdrawal by Subject|1|||
131447117|NCT04004988|473267451|FG000|Period 1|Adverse Event|1|||
131447118|NCT04004988|473267452|FG001|Period 1|Adverse Event|2|||
131447119|NCT02161016|473267453|FG000|Overall Study|withdrawn by IRB|1|||
131447120|NCT03755934|473267457|FG000|Overall Study|Adverse Event|4|||
131447121|NCT03755934|473267458|FG001|Overall Study|Adverse Event|1|||
131447122|NCT03755934|473267459|FG002|Overall Study|Adverse Event|1|||
131447123|NCT03755934|473267460|FG003|Overall Study|Adverse Event|3|||
131447124|NCT03755934|473267457|FG000|Overall Study|Physician Decision|2|||
131447125|NCT03755934|473267458|FG001|Overall Study|Physician Decision|0|||
131447126|NCT03755934|473267459|FG002|Overall Study|Physician Decision|0|||
131447127|NCT03755934|473267460|FG003|Overall Study|Physician Decision|1|||
131447128|NCT03755934|473267457|FG000|Overall Study|Withdrawal by Subject|5|||
131447129|NCT03755934|473267458|FG001|Overall Study|Withdrawal by Subject|0|||
131447130|NCT03755934|473267459|FG002|Overall Study|Withdrawal by Subject|0|||
131447131|NCT03755934|473267460|FG003|Overall Study|Withdrawal by Subject|1|||
131447132|NCT03755934|473267457|FG000|Overall Study|Other|3|||
131447133|NCT03755934|473267458|FG001|Overall Study|Other|1|||
131447134|NCT03755934|473267459|FG002|Overall Study|Other|3|||
131447135|NCT03755934|473267460|FG003|Overall Study|Other|1|||
131447136|NCT00361296|473267464|FG000|Overall Study|Physician Decision|1|||
131447137|NCT00361296|473267464|FG000|Overall Study|Lack of Efficacy|2|||
131447138|NCT00198822|473267465|FG000|Overall Study|Lost to Follow-up|14|||
131447139|NCT00198822|473267466|FG001|Overall Study|Lost to Follow-up|20|||
131447140|NCT00198822|473267467|FG002|Overall Study|Lost to Follow-up|21|||
131447141|NCT02668653|473267468|FG000|Overall Study|Refractory disease|41|||
131447142|NCT02668653|473267469|FG001|Overall Study|Refractory disease|70|||
131645427|NCT00952848|473989217|FG000|Overall Study|Withdrawal by Subject|4|||
131645428|NCT00458393|473989218|FG000|Overall Study|Withdrawal by Subject|67|||
131645429|NCT00458393|473989219|FG001|Overall Study|Withdrawal by Subject|80|||
131447143|NCT02668653|473267468|FG000|Overall Study|Relapse|44|||
131447144|NCT02668653|473267469|FG001|Overall Study|Relapse|65|||
131447145|NCT02668653|473267468|FG000|Overall Study|Adverse Event|58|||
131447146|NCT02668653|473267469|FG001|Overall Study|Adverse Event|23|||
131447147|NCT02668653|473267468|FG000|Overall Study|Subject decision to stop study drug|25|||
131447148|NCT02668653|473267469|FG001|Overall Study|Subject decision to stop study drug|23|||
131447149|NCT02668653|473267468|FG000|Overall Study|Other reasons not specified|16|||
131645430|NCT00458393|473989218|FG000|Overall Study|Physician Decision|31|||
131645431|NCT00458393|473989219|FG001|Overall Study|Physician Decision|22|||
131645432|NCT00458393|473989218|FG000|Overall Study|Relocated|77|||
131645433|NCT00458393|473989219|FG001|Overall Study|Relocated|81|||
131447150|NCT02668653|473267469|FG001|Overall Study|Other reasons not specified|11|||
131447151|NCT02668653|473267468|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
131447152|NCT02668653|473267469|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
131645434|NCT00458393|473989218|FG000|Overall Study|Lost to Follow-up|115|||
131645435|NCT00458393|473989219|FG001|Overall Study|Lost to Follow-up|92|||
131645436|NCT00458393|473989218|FG000|Overall Study|Sites marked other on the form.|19|||
131645437|NCT00458393|473989219|FG001|Overall Study|Sites marked other on the form.|20|||
131645438|NCT00857233|473989222|FG000|Overall Study|Adverse Event|24|||
131645439|NCT00857233|473989222|FG000|Overall Study|Lack of Efficacy|1|||
131645440|NCT00857233|473989222|FG000|Overall Study|Non-compliance|1|||
131645441|NCT00857233|473989222|FG000|Overall Study|Withdrawal of Consent|9|||
131645442|NCT00857233|473989222|FG000|Overall Study|Lost to Follow-up|4|||
131645443|NCT00857233|473989222|FG000|Overall Study|Nursing Home Placement|14|||
131645444|NCT00857233|473989222|FG000|Overall Study|Other Reasons|2|||
131645445|NCT05043883|473989223|FG000|Overall Study|Minimum required measurements could not be taken|4|||
131645446|NCT01587118|473989224|FG000|Overall Study|Adverse Event|3|||
131645447|NCT01587118|473989224|FG000|Overall Study|Lost to Follow-up|2|||
131645448|NCT01587118|473989224|FG000|Overall Study|Relocation|1|||
131645449|NCT01587118|473989224|FG000|Overall Study|nonresponse|1|||
131645450|NCT00537329|473989225|FG000|Overall Study|Death|10|||
131645451|NCT00537329|473989225|FG000|Overall Study|Adverse Event|3|||
131645452|NCT00537329|473989225|FG000|Overall Study|Lack of Efficacy|2|||
131645453|NCT00537329|473989225|FG000|Overall Study|Lost to Follow-up|6|||
131645454|NCT00537329|473989225|FG000|Overall Study|Withdrawal by Subject|4|||
131645455|NCT00537329|473989225|FG000|Overall Study|Other|1|||
131645456|NCT02049515|473989226|FG000|Overall Study|Adverse Event|46|||
131645457|NCT02049515|473989227|FG001|Overall Study|Adverse Event|2|||
131645458|NCT02049515|473989226|FG000|Overall Study|Protocol-specified Disease Progression|23|||
131645459|NCT02049515|473989227|FG001|Overall Study|Protocol-specified Disease Progression|2|||
131715509|NCT02793544|474235524|FG000|Overall Study|Withdrawal by Subject|1|||
131645460|NCT02049515|473989226|FG000|Overall Study|Death|6|||
131645461|NCT02049515|473989227|FG001|Overall Study|Death|0|||
131645462|NCT02049515|473989226|FG000|Overall Study|Physician Decision|5|||
131645463|NCT02049515|473989227|FG001|Overall Study|Physician Decision|1|||
131645464|NCT02049515|473989226|FG000|Overall Study|Withdrawal by Subject|3|||
131645465|NCT02049515|473989227|FG001|Overall Study|Withdrawal by Subject|0|||
131645466|NCT02049515|473989226|FG000|Overall Study|Termination of the Study by Sponsor|2|||
131645467|NCT02049515|473989227|FG001|Overall Study|Termination of the Study by Sponsor|0|||
131645468|NCT02049515|473989226|FG000|Overall Study|Protocol Violation|1|||
131645469|NCT02049515|473989227|FG001|Overall Study|Protocol Violation|1|||
131645470|NCT02049515|473989226|FG000|Overall Study|Clinical Deterioration|1|||
131645471|NCT02049515|473989227|FG001|Overall Study|Clinical Deterioration|0|||
131645472|NCT02049515|473989226|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
131645473|NCT02049515|473989227|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
131645474|NCT02049515|473989226|FG000|Overall Study|Treatment Interruption >42 Days|1|||
131447153|NCT02668653|473267468|FG000|Overall Study|Investigator decision|10|||
131447154|NCT02668653|473267469|FG001|Overall Study|Investigator decision|7|||
131447155|NCT02668653|473267468|FG000|Overall Study|Failure to meet continuation criteria|5|||
131447156|NCT02668653|473267469|FG001|Overall Study|Failure to meet continuation criteria|12|||
131447157|NCT02668653|473267468|FG000|Overall Study|Lost to Follow-up|1|||
131447158|NCT02668653|473267469|FG001|Overall Study|Lost to Follow-up|0|||
131645475|NCT02049515|473989227|FG001|Overall Study|Treatment Interruption >42 Days|0|||
131645476|NCT02049515|473989226|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
131645477|NCT02049515|473989227|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
131645478|NCT00224029|473989229|FG000|Overall Study|Lost to Follow-up|1|||
131645479|NCT00224029|473989229|FG000|Overall Study|Withdrawal by Subject|4|||
131645480|NCT00224029|473989229|FG000|Overall Study|Other|1|||
131645481|NCT01390441|473989230|FG000|Treatment Period|Protocol Violation|0|||
131645482|NCT01390441|473989231|FG001|Treatment Period|Protocol Violation|1|||
131645483|NCT01390441|473989232|FG002|Treatment Period|Protocol Violation|0|||
131645484|NCT01390441|473989233|FG003|Treatment Period|Protocol Violation|0|||
131645485|NCT01390441|473989234|FG004|Treatment Period|Protocol Violation|0|||
131645486|NCT01390441|473989230|FG000|Treatment Period|Physician Decision|0|||
131645487|NCT01390441|473989231|FG001|Treatment Period|Physician Decision|0|||
131645488|NCT01390441|473989232|FG002|Treatment Period|Physician Decision|0|||
131645489|NCT01390441|473989233|FG003|Treatment Period|Physician Decision|1|||
131645490|NCT01390441|473989234|FG004|Treatment Period|Physician Decision|0|||
131645491|NCT01390441|473989230|FG000|Treatment Period|Lack of Efficacy|0|||
131645492|NCT01390441|473989231|FG001|Treatment Period|Lack of Efficacy|0|||
131645493|NCT01390441|473989232|FG002|Treatment Period|Lack of Efficacy|0|||
131645494|NCT01390441|473989233|FG003|Treatment Period|Lack of Efficacy|0|||
131645495|NCT01390441|473989234|FG004|Treatment Period|Lack of Efficacy|1|||
131645496|NCT01390441|473989230|FG000|Treatment Period|Unknown due to early stopping of study|0|||
131645497|NCT01390441|473989231|FG001|Treatment Period|Unknown due to early stopping of study|0|||
131645498|NCT01390441|473989232|FG002|Treatment Period|Unknown due to early stopping of study|8|||
131645499|NCT01390441|473989233|FG003|Treatment Period|Unknown due to early stopping of study|11|||
131645500|NCT01390441|473989234|FG004|Treatment Period|Unknown due to early stopping of study|7|||
131645501|NCT01390441|473989230|FG000|Treatment Period|Adverse Event|0|||
131645502|NCT01390441|473989231|FG001|Treatment Period|Adverse Event|0|||
131645503|NCT01390441|473989232|FG002|Treatment Period|Adverse Event|1|||
131645504|NCT01390441|473989233|FG003|Treatment Period|Adverse Event|1|||
131645505|NCT01390441|473989234|FG004|Treatment Period|Adverse Event|2|||
131645506|NCT01390441|473989230|FG000|Treatment Period|Withdrawal by Subject|0|||
131447159|NCT02668653|473267468|FG000|Overall Study|Pregnancy|0|||
131447160|NCT02668653|473267469|FG001|Overall Study|Pregnancy|1|||
131447161|NCT02668653|473267468|FG000|Overall Study|Death|0|||
131447162|NCT02668653|473267469|FG001|Overall Study|Death|1|||
131447163|NCT02420821|473267470|FG000|Overall Study|Lost to Follow-up|6|||
131447164|NCT02420821|473267471|FG001|Overall Study|Lost to Follow-up|6|||
131447165|NCT02420821|473267470|FG000|Overall Study|Non-compliance|0|||
131447166|NCT02420821|473267471|FG001|Overall Study|Non-compliance|2|||
131447167|NCT02420821|473267470|FG000|Overall Study|Physician Decision|6|||
131447168|NCT02420821|473267471|FG001|Overall Study|Physician Decision|2|||
131447169|NCT02420821|473267470|FG000|Overall Study|Withdrawal by Subject|32|||
131447170|NCT02420821|473267471|FG001|Overall Study|Withdrawal by Subject|25|||
131447171|NCT02420821|473267470|FG000|Overall Study|Death|270|||
131447172|NCT02420821|473267471|FG001|Overall Study|Death|263|||
131447173|NCT02420821|473267470|FG000|Overall Study|Study Terminated By Sponsor|145|||
131447174|NCT02420821|473267471|FG001|Overall Study|Study Terminated By Sponsor|149|||
131447175|NCT02420821|473267470|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
131447176|NCT02420821|473267471|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
131447177|NCT02420821|473267470|FG000|Overall Study|Adverse Event|0|||
131645507|NCT01390441|473989231|FG001|Treatment Period|Withdrawal by Subject|0|||
131645508|NCT01390441|473989232|FG002|Treatment Period|Withdrawal by Subject|1|||
131447178|NCT02420821|473267471|FG001|Overall Study|Adverse Event|1|||
131447179|NCT02420821|473267470|FG000|Overall Study|Protinuria|0|||
131447180|NCT02420821|473267471|FG001|Overall Study|Protinuria|1|||
131447181|NCT02420821|473267470|FG000|Overall Study|Progressive Disease|1|||
131447182|NCT02420821|473267471|FG001|Overall Study|Progressive Disease|1|||
131645509|NCT01390441|473989233|FG003|Treatment Period|Withdrawal by Subject|0|||
131645510|NCT01390441|473989234|FG004|Treatment Period|Withdrawal by Subject|1|||
131447183|NCT02420821|473267470|FG000|Overall Study|Disease Progression|0|||
131447184|NCT02420821|473267471|FG001|Overall Study|Disease Progression|1|||
131645511|NCT01390441|473989230|FG000|Treatment Period|Lost to Follow-up|1|||
131645512|NCT01390441|473989231|FG001|Treatment Period|Lost to Follow-up|0|||
131645513|NCT01390441|473989232|FG002|Treatment Period|Lost to Follow-up|0|||
131645514|NCT01390441|473989233|FG003|Treatment Period|Lost to Follow-up|0|||
131645515|NCT01390441|473989234|FG004|Treatment Period|Lost to Follow-up|0|||
131645516|NCT01390441|473989230|FG000|Extension Period|Protocol Violation|3|||
131645517|NCT01390441|473989231|FG001|Extension Period|Protocol Violation|1|||
131645518|NCT01390441|473989232|FG002|Extension Period|Protocol Violation|0|||
131645519|NCT01390441|473989233|FG003|Extension Period|Protocol Violation|1|||
131645520|NCT01390441|473989234|FG004|Extension Period|Protocol Violation|0|||
131645521|NCT01407276|473989235|FG000|Overall Study|Withdrawal by Subject|0|||
131447185|NCT02420821|473267470|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
131645522|NCT01407276|473989236|FG001|Overall Study|Withdrawal by Subject|0|||
131447186|NCT02420821|473267471|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
131447187|NCT01409707|473267472|FG000|Overall Study|Withdrawal by Subject|5|||
131447188|NCT01409707|473267473|FG001|Overall Study|Withdrawal by Subject|17|||
131447189|NCT01409707|473267474|FG002|Overall Study|Withdrawal by Subject|16|||
131447190|NCT01929317|473267475|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
131447191|NCT01929317|473267476|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
131447192|NCT01929317|473267475|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
131447193|NCT01929317|473267476|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
131447194|NCT01929317|473267475|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
131447195|NCT01929317|473267476|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
131447196|NCT01929317|473267475|FG000|Long-term Phase|Adverse Event|5|||
131447197|NCT01929317|473267476|FG001|Long-term Phase|Adverse Event|1|||
131447198|NCT01929317|473267475|FG000|Long-term Phase|Physician Decision|3|||
131447199|NCT01929317|473267476|FG001|Long-term Phase|Physician Decision|0|||
131447200|NCT01929317|473267475|FG000|Long-term Phase|Withdrawal by Subject|4|||
131447201|NCT01929317|473267476|FG001|Long-term Phase|Withdrawal by Subject|0|||
131447202|NCT01929317|473267475|FG000|Long-term Phase|Protocol Violation|1|||
131447203|NCT01929317|473267476|FG001|Long-term Phase|Protocol Violation|0|||
131447204|NCT01929317|473267475|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
131447205|NCT01929317|473267476|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
131447206|NCT01929317|473267475|FG000|Long-term Phase|Study Closed/Terminated|5|||
131447207|NCT01929317|473267476|FG001|Long-term Phase|Study Closed/Terminated|3|||
131447208|NCT00577889|473267477|FG000|Overall Study|Withdrawal by Subject|1|||
131447209|NCT00577889|473267478|FG001|Overall Study|Withdrawal by Subject|0|||
131447210|NCT00577889|473267479|FG002|Overall Study|Withdrawal by Subject|0|||
131447211|NCT04322526|473267480|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
131447212|NCT04322526|473267481|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
131447213|NCT04322526|473267480|FG000|Washout (1 Week)|Lost to Follow-up|1|||
131447214|NCT04322526|473267481|FG001|Washout (1 Week)|Lost to Follow-up|2|||
131447215|NCT00993967|473267482|FG000|Overall Study|Adverse Event|8|||
131447216|NCT00993967|473267482|FG000|Overall Study|Death|1|||
131447217|NCT00993967|473267482|FG000|Overall Study|Lost to Follow-up|14|||
131447218|NCT00993967|473267482|FG000|Overall Study|Withdrawal by Subject|36|||
131447219|NCT00993967|473267482|FG000|Overall Study|Protocol Violation|2|||
131447220|NCT02760498|473267485|FG000|Overall Study|Adverse Event|3|||
131447221|NCT02760498|473267486|FG001|Overall Study|Adverse Event|3|||
131447222|NCT02760498|473267487|FG002|Overall Study|Adverse Event|1|||
131447223|NCT02760498|473267488|FG003|Overall Study|Adverse Event|1|||
131447224|NCT02760498|473267489|FG004|Overall Study|Adverse Event|0|||
131645523|NCT01407276|473989237|FG002|Overall Study|Withdrawal by Subject|0|||
131645524|NCT01407276|473989238|FG003|Overall Study|Withdrawal by Subject|0|||
131645525|NCT01407276|473989239|FG004|Overall Study|Withdrawal by Subject|0|||
131645526|NCT01407276|473989240|FG005|Overall Study|Withdrawal by Subject|0|||
131645527|NCT01407276|473989241|FG006|Overall Study|Withdrawal by Subject|0|||
131645528|NCT01407276|473989242|FG007|Overall Study|Withdrawal by Subject|1|||
131645529|NCT02635386|473989243|FG000|Overall Study|Pregnancy|2|||
131645530|NCT02635386|473989244|FG001|Overall Study|Pregnancy|0|||
131645531|NCT02635386|473989245|FG002|Overall Study|Pregnancy|0|||
131645532|NCT02635386|473989246|FG003|Overall Study|Pregnancy|0|||
131645533|NCT02635386|473989247|FG004|Overall Study|Pregnancy|2|||
131645534|NCT02635386|473989243|FG000|Overall Study|Withdrawal by Subject|1|||
131645535|NCT02635386|473989244|FG001|Overall Study|Withdrawal by Subject|1|||
131645536|NCT02635386|473989245|FG002|Overall Study|Withdrawal by Subject|0|||
131645537|NCT02635386|473989246|FG003|Overall Study|Withdrawal by Subject|1|||
131645538|NCT02635386|473989247|FG004|Overall Study|Withdrawal by Subject|0|||
131645539|NCT02635386|473989243|FG000|Overall Study|Physician Decision|0|||
131645540|NCT02635386|473989244|FG001|Overall Study|Physician Decision|1|||
131645541|NCT02635386|473989245|FG002|Overall Study|Physician Decision|0|||
131645542|NCT02635386|473989246|FG003|Overall Study|Physician Decision|0|||
131645543|NCT02635386|473989247|FG004|Overall Study|Physician Decision|0|||
131645544|NCT02635386|473989243|FG000|Overall Study|Moved Out of State|0|||
131645545|NCT02635386|473989244|FG001|Overall Study|Moved Out of State|1|||
131447225|NCT02760498|473267490|FG005|Overall Study|Adverse Event|6|||
131645546|NCT02635386|473989245|FG002|Overall Study|Moved Out of State|0|||
131645547|NCT02635386|473989246|FG003|Overall Study|Moved Out of State|0|||
131447226|NCT02760498|473267485|FG000|Overall Study|Death|7|||
131447227|NCT02760498|473267486|FG001|Overall Study|Death|5|||
131447228|NCT02760498|473267487|FG002|Overall Study|Death|5|||
131447229|NCT02760498|473267488|FG003|Overall Study|Death|7|||
131645548|NCT02635386|473989247|FG004|Overall Study|Moved Out of State|0|||
131645549|NCT02635386|473989243|FG000|Overall Study|Noncompliant|0|||
131645550|NCT02635386|473989244|FG001|Overall Study|Noncompliant|2|||
131645551|NCT02635386|473989245|FG002|Overall Study|Noncompliant|1|||
131645552|NCT02635386|473989246|FG003|Overall Study|Noncompliant|1|||
131645553|NCT02635386|473989247|FG004|Overall Study|Noncompliant|1|||
131645554|NCT02635386|473989243|FG000|Overall Study|side effects|0|||
131645555|NCT02635386|473989244|FG001|Overall Study|side effects|0|||
131645556|NCT02635386|473989245|FG002|Overall Study|side effects|1|||
131645557|NCT02635386|473989246|FG003|Overall Study|side effects|4|||
131645558|NCT02635386|473989247|FG004|Overall Study|side effects|6|||
131645559|NCT02635386|473989243|FG000|Overall Study|needed other major surgery|0|||
131645560|NCT02635386|473989244|FG001|Overall Study|needed other major surgery|1|||
131645561|NCT02635386|473989245|FG002|Overall Study|needed other major surgery|0|||
131645562|NCT02635386|473989246|FG003|Overall Study|needed other major surgery|0|||
131645563|NCT02635386|473989247|FG004|Overall Study|needed other major surgery|0|||
131645564|NCT02635386|473989243|FG000|Overall Study|Other medical problems not drug related|0|||
131645565|NCT02635386|473989244|FG001|Overall Study|Other medical problems not drug related|0|||
131645566|NCT02635386|473989245|FG002|Overall Study|Other medical problems not drug related|0|||
131645567|NCT02635386|473989246|FG003|Overall Study|Other medical problems not drug related|1|||
131645568|NCT02635386|473989247|FG004|Overall Study|Other medical problems not drug related|0|||
131645569|NCT02287233|473989251|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
131645570|NCT02287233|473989252|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
131645571|NCT02287233|473989253|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
131645572|NCT02287233|473989251|FG000|Overall Study|Adverse Event Related to Progression|0|||
131645573|NCT02287233|473989252|FG001|Overall Study|Adverse Event Related to Progression|2|||
131645574|NCT02287233|473989253|FG002|Overall Study|Adverse Event Related to Progression|8|||
131645575|NCT02287233|473989251|FG000|Overall Study|Physician Decision|1|||
131447230|NCT02760498|473267489|FG004|Overall Study|Death|0|||
131645576|NCT02287233|473989252|FG001|Overall Study|Physician Decision|2|||
131645577|NCT02287233|473989253|FG002|Overall Study|Physician Decision|4|||
131645578|NCT02287233|473989251|FG000|Overall Study|Progressive Disease with Death|0|||
131645579|NCT02287233|473989252|FG001|Overall Study|Progressive Disease with Death|0|||
131645580|NCT02287233|473989253|FG002|Overall Study|Progressive Disease with Death|10|||
131645581|NCT02287233|473989251|FG000|Overall Study|Progressive Disease Without Death|2|||
131645582|NCT02287233|473989252|FG001|Overall Study|Progressive Disease Without Death|3|||
131645583|NCT02287233|473989253|FG002|Overall Study|Progressive Disease Without Death|20|||
131645584|NCT02287233|473989251|FG000|Overall Study|Withdrawal by Subject|1|||
131645585|NCT02287233|473989252|FG001|Overall Study|Withdrawal by Subject|1|||
131645586|NCT02287233|473989253|FG002|Overall Study|Withdrawal by Subject|7|||
131645587|NCT02287233|473989251|FG000|Overall Study|Other|3|||
131645588|NCT02287233|473989252|FG001|Overall Study|Other|0|||
131645589|NCT02287233|473989253|FG002|Overall Study|Other|15|||
131645590|NCT02287233|473989251|FG000|Overall Study|Did Not Receive Treatment|0|||
131645591|NCT02287233|473989252|FG001|Overall Study|Did Not Receive Treatment|0|||
131645592|NCT02287233|473989253|FG002|Overall Study|Did Not Receive Treatment|2|||
131645593|NCT00085566|473989254|FG000|Overall Study|Adverse Event|0|||
131645594|NCT00085566|473989255|FG001|Overall Study|Adverse Event|0|||
131645595|NCT00085566|473989256|FG002|Overall Study|Adverse Event|10|||
131645596|NCT00085566|473989254|FG000|Overall Study|Patient Not treated|0|||
131645597|NCT00085566|473989255|FG001|Overall Study|Patient Not treated|0|||
131645598|NCT00085566|473989256|FG002|Overall Study|Patient Not treated|3|||
131645599|NCT00085566|473989254|FG000|Overall Study|Clinical progression|0|||
131645600|NCT00085566|473989255|FG001|Overall Study|Clinical progression|0|||
131645601|NCT00085566|473989256|FG002|Overall Study|Clinical progression|1|||
131645602|NCT03174782|473989257|FG000|Overall Study|Protocol Violation|1|||
131645603|NCT03174782|473989258|FG001|Overall Study|Protocol Violation|0|||
131645604|NCT03174782|473989257|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
131645605|NCT03174782|473989258|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
131447231|NCT02760498|473267490|FG005|Overall Study|Death|23|||
131447232|NCT02760498|473267485|FG000|Overall Study|Lost to Follow-up|0|||
131447233|NCT02760498|473267486|FG001|Overall Study|Lost to Follow-up|0|||
131645606|NCT03178045|473989259|FG000|Overall Study|Withdrawal by Subject|5|||
131645607|NCT03178045|473989260|FG001|Overall Study|Withdrawal by Subject|7|||
131645608|NCT03178045|473989259|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
131645609|NCT03178045|473989260|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
131645610|NCT03178045|473989259|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
131645611|NCT03178045|473989260|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
131645612|NCT00267098|473989262|FG000|Overall Study|Death|0|||
131645613|NCT00267098|473989263|FG001|Overall Study|Death|0|||
131645614|NCT00267098|473989264|FG002|Overall Study|Death|57|||
131645615|NCT00267098|473989265|FG003|Overall Study|Death|66|||
131645616|NCT00267098|473989266|FG004|Overall Study|Death|14|||
131645617|NCT00267098|473989267|FG005|Overall Study|Death|23|||
131645618|NCT00267098|473989268|FG006|Overall Study|Death|28|||
131645619|NCT00267098|473989269|FG007|Overall Study|Death|9|||
131645620|NCT00267098|473989262|FG000|Overall Study|Lost to Follow-up|0|||
131645621|NCT00267098|473989263|FG001|Overall Study|Lost to Follow-up|0|||
131645622|NCT00267098|473989264|FG002|Overall Study|Lost to Follow-up|6|||
131645623|NCT00267098|473989265|FG003|Overall Study|Lost to Follow-up|5|||
131645624|NCT00267098|473989266|FG004|Overall Study|Lost to Follow-up|2|||
131645625|NCT00267098|473989267|FG005|Overall Study|Lost to Follow-up|3|||
131645626|NCT00267098|473989268|FG006|Overall Study|Lost to Follow-up|1|||
131447234|NCT02760498|473267487|FG002|Overall Study|Lost to Follow-up|0|||
131447235|NCT02760498|473267488|FG003|Overall Study|Lost to Follow-up|0|||
131447236|NCT02760498|473267489|FG004|Overall Study|Lost to Follow-up|0|||
131447237|NCT02760498|473267490|FG005|Overall Study|Lost to Follow-up|3|||
131447238|NCT02760498|473267485|FG000|Overall Study|Non-compliance with study drug|0|||
131447239|NCT02760498|473267486|FG001|Overall Study|Non-compliance with study drug|2|||
131447240|NCT02760498|473267487|FG002|Overall Study|Non-compliance with study drug|0|||
131447241|NCT02760498|473267488|FG003|Overall Study|Non-compliance with study drug|0|||
131447242|NCT02760498|473267489|FG004|Overall Study|Non-compliance with study drug|0|||
131447243|NCT02760498|473267490|FG005|Overall Study|Non-compliance with study drug|0|||
131447244|NCT02760498|473267485|FG000|Overall Study|Participant decision|1|||
131447245|NCT02760498|473267486|FG001|Overall Study|Participant decision|4|||
131447246|NCT02760498|473267487|FG002|Overall Study|Participant decision|2|||
131447247|NCT02760498|473267488|FG003|Overall Study|Participant decision|2|||
131447248|NCT02760498|473267489|FG004|Overall Study|Participant decision|1|||
131447249|NCT02760498|473267490|FG005|Overall Study|Participant decision|6|||
131447250|NCT02760498|473267485|FG000|Overall Study|Sponsor decision|0|||
131447251|NCT02760498|473267486|FG001|Overall Study|Sponsor decision|0|||
131447252|NCT02760498|473267487|FG002|Overall Study|Sponsor decision|0|||
131447253|NCT02760498|473267488|FG003|Overall Study|Sponsor decision|3|||
131447254|NCT02760498|473267489|FG004|Overall Study|Sponsor decision|0|||
131447255|NCT02760498|473267490|FG005|Overall Study|Sponsor decision|0|||
131447256|NCT02760498|473267485|FG000|Overall Study|Physician Decision|3|||
131447257|NCT02760498|473267486|FG001|Overall Study|Physician Decision|4|||
131447258|NCT02760498|473267487|FG002|Overall Study|Physician Decision|1|||
131447259|NCT02760498|473267488|FG003|Overall Study|Physician Decision|4|||
131447260|NCT02760498|473267489|FG004|Overall Study|Physician Decision|0|||
131447261|NCT02760498|473267490|FG005|Overall Study|Physician Decision|2|||
131447262|NCT02760498|473267485|FG000|Overall Study|Disease progression|21|||
131447263|NCT02760498|473267486|FG001|Overall Study|Disease progression|19|||
131645627|NCT00267098|473989269|FG007|Overall Study|Lost to Follow-up|1|||
131645628|NCT00267098|473989262|FG000|Overall Study|Withdrawal by Subject|8|||
131645629|NCT00267098|473989263|FG001|Overall Study|Withdrawal by Subject|0|||
131645630|NCT00267098|473989264|FG002|Overall Study|Withdrawal by Subject|24|||
131645631|NCT00267098|473989265|FG003|Overall Study|Withdrawal by Subject|21|||
131645632|NCT00267098|473989266|FG004|Overall Study|Withdrawal by Subject|12|||
131645633|NCT00267098|473989267|FG005|Overall Study|Withdrawal by Subject|9|||
131645634|NCT00267098|473989268|FG006|Overall Study|Withdrawal by Subject|12|||
131645635|NCT00267098|473989269|FG007|Overall Study|Withdrawal by Subject|5|||
131645636|NCT00267098|473989262|FG000|Overall Study|Physician Decision|5|||
131645637|NCT00267098|473989263|FG001|Overall Study|Physician Decision|0|||
131645638|NCT00267098|473989264|FG002|Overall Study|Physician Decision|7|||
131645639|NCT00267098|473989265|FG003|Overall Study|Physician Decision|11|||
131645640|NCT00267098|473989266|FG004|Overall Study|Physician Decision|5|||
131645641|NCT00267098|473989267|FG005|Overall Study|Physician Decision|4|||
131645642|NCT00267098|473989268|FG006|Overall Study|Physician Decision|3|||
131645643|NCT00267098|473989269|FG007|Overall Study|Physician Decision|0|||
131645644|NCT00267098|473989262|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
131645645|NCT00267098|473989263|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131645646|NCT00267098|473989264|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131645647|NCT00267098|473989265|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131645648|NCT00267098|473989266|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
131645649|NCT00267098|473989267|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131645650|NCT00267098|473989268|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131645651|NCT00267098|473989269|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131645652|NCT00267098|473989262|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645653|NCT00267098|473989263|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
131645654|NCT00267098|473989264|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645655|NCT00267098|473989265|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645656|NCT00267098|473989266|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645657|NCT00267098|473989267|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645658|NCT00267098|473989268|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645659|NCT00267098|473989269|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131645660|NCT00267098|473989262|FG000|Overall Study|Site closure|0|||
131645661|NCT00267098|473989263|FG001|Overall Study|Site closure|0|||
131903139|NCT01435759|474931417|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131903140|NCT01435759|474931418|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131447264|NCT02760498|473267487|FG002|Overall Study|Disease progression|20|||
131447265|NCT02760498|473267488|FG003|Overall Study|Disease progression|18|||
131447266|NCT02760498|473267489|FG004|Overall Study|Disease progression|4|||
131447267|NCT02760498|473267490|FG005|Overall Study|Disease progression|55|||
131447268|NCT02760498|473267485|FG000|Overall Study|Withdrawal by Subject|4|||
131447269|NCT02760498|473267486|FG001|Overall Study|Withdrawal by Subject|7|||
131645662|NCT00267098|473989264|FG002|Overall Study|Site closure|0|||
131645663|NCT00267098|473989265|FG003|Overall Study|Site closure|1|||
131447270|NCT02760498|473267487|FG002|Overall Study|Withdrawal by Subject|5|||
131645664|NCT00267098|473989266|FG004|Overall Study|Site closure|0|||
131645665|NCT00267098|473989267|FG005|Overall Study|Site closure|1|||
131645666|NCT00267098|473989268|FG006|Overall Study|Site closure|1|||
131645667|NCT00267098|473989269|FG007|Overall Study|Site closure|0|||
131645668|NCT00267098|473989262|FG000|Overall Study|Explanted Medtronic device|0|||
131645669|NCT00267098|473989263|FG001|Overall Study|Explanted Medtronic device|0|||
131645670|NCT00267098|473989264|FG002|Overall Study|Explanted Medtronic device|0|||
131645671|NCT00267098|473989265|FG003|Overall Study|Explanted Medtronic device|1|||
131645672|NCT00267098|473989266|FG004|Overall Study|Explanted Medtronic device|0|||
131645673|NCT00267098|473989267|FG005|Overall Study|Explanted Medtronic device|0|||
131645674|NCT00267098|473989268|FG006|Overall Study|Explanted Medtronic device|0|||
131645675|NCT00267098|473989269|FG007|Overall Study|Explanted Medtronic device|0|||
131645676|NCT00267098|473989262|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645677|NCT00267098|473989263|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645678|NCT00267098|473989264|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645679|NCT00267098|473989265|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645680|NCT00267098|473989266|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
131645681|NCT00267098|473989267|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645682|NCT00267098|473989268|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645683|NCT00267098|473989269|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131645684|NCT00267098|473989262|FG000|Overall Study|Subject listed for heart transplant|0|||
131645685|NCT00267098|473989263|FG001|Overall Study|Subject listed for heart transplant|0|||
131645686|NCT00267098|473989264|FG002|Overall Study|Subject listed for heart transplant|0|||
131645687|NCT00267098|473989265|FG003|Overall Study|Subject listed for heart transplant|0|||
131645688|NCT00267098|473989266|FG004|Overall Study|Subject listed for heart transplant|0|||
131645689|NCT00267098|473989267|FG005|Overall Study|Subject listed for heart transplant|0|||
131645690|NCT00267098|473989268|FG006|Overall Study|Subject listed for heart transplant|1|||
131645691|NCT00267098|473989269|FG007|Overall Study|Subject listed for heart transplant|0|||
131645692|NCT00267098|473989262|FG000|Overall Study|Sponsor withdrew subject|0|||
131645693|NCT00267098|473989263|FG001|Overall Study|Sponsor withdrew subject|0|||
131645694|NCT00267098|473989264|FG002|Overall Study|Sponsor withdrew subject|0|||
131645695|NCT00267098|473989265|FG003|Overall Study|Sponsor withdrew subject|1|||
131645696|NCT00267098|473989266|FG004|Overall Study|Sponsor withdrew subject|0|||
131645697|NCT00267098|473989267|FG005|Overall Study|Sponsor withdrew subject|0|||
131645698|NCT00267098|473989268|FG006|Overall Study|Sponsor withdrew subject|0|||
131645699|NCT00267098|473989269|FG007|Overall Study|Sponsor withdrew subject|0|||
131645700|NCT02689453|473989273|FG000|Overall Study|Progressive disease|0|||
131645701|NCT02689453|473989274|FG001|Overall Study|Progressive disease|1|||
131645702|NCT02689453|473989275|FG002|Overall Study|Progressive disease|1|||
131645703|NCT02688530|473989276|FG000|Overall Study|Withdrawal by Subject|0|||
131645704|NCT02688530|473989277|FG001|Overall Study|Withdrawal by Subject|1|||
131645705|NCT02688530|473989278|FG002|Overall Study|Withdrawal by Subject|0|||
131645706|NCT02688530|473989279|FG003|Overall Study|Withdrawal by Subject|0|||
131645707|NCT02688530|473989276|FG000|Overall Study|Lost to Follow-up|0|||
131645708|NCT02688530|473989277|FG001|Overall Study|Lost to Follow-up|0|||
131645709|NCT02688530|473989278|FG002|Overall Study|Lost to Follow-up|2|||
131645710|NCT02688530|473989279|FG003|Overall Study|Lost to Follow-up|0|||
131645711|NCT01658020|473989280|FG000|Overall Study|Adverse Event|3|||
131645712|NCT01658020|473989281|FG001|Overall Study|Adverse Event|3|||
131645713|NCT01658020|473989280|FG000|Overall Study|Lost to Follow-up|1|||
131645714|NCT01658020|473989281|FG001|Overall Study|Lost to Follow-up|0|||
131645715|NCT01658020|473989280|FG000|Overall Study|Withdrawal by Subject|4|||
131645716|NCT01658020|473989281|FG001|Overall Study|Withdrawal by Subject|5|||
131645717|NCT01658020|473989280|FG000|Overall Study|Protocol Violation|0|||
131645718|NCT01658020|473989281|FG001|Overall Study|Protocol Violation|1|||
131645719|NCT03778294|473991045|FG000|Overall Study|Death|1|||
131645720|NCT03778294|473991045|FG000|Overall Study|Issues with insurance|1|||
131645721|NCT03778294|473991045|FG000|Overall Study|disease progression before treatment|2|||
131645722|NCT03023722|473991052|FG000|Overall Study|No follow-up assessment|4|||
131645723|NCT04836559|473991053|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131645724|NCT04836559|473991054|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
131645725|NCT04836559|473991055|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
131645726|NCT04836559|473991056|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
131645727|NCT04836559|473991057|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131645728|NCT04836559|473991058|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131645729|NCT04836559|473991059|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131645730|NCT04836559|473991060|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131645731|NCT04836559|473991053|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131645732|NCT04836559|473991054|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
131645733|NCT04836559|473991055|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
131645734|NCT04836559|473991056|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
131645735|NCT04836559|473991057|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131645736|NCT04836559|473991058|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131645737|NCT04836559|473991059|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131645738|NCT04836559|473991060|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131645739|NCT04836559|473991053|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
131645740|NCT04836559|473991054|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645741|NCT04836559|473991055|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645742|NCT04836559|473991056|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645743|NCT04836559|473991057|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645744|NCT04836559|473991058|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645745|NCT04836559|473991059|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645746|NCT04836559|473991060|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131645747|NCT04836559|473991053|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
131645748|NCT04836559|473991054|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645749|NCT04836559|473991055|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645750|NCT04836559|473991056|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645751|NCT04836559|473991057|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645752|NCT04836559|473991058|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645753|NCT04836559|473991059|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645754|NCT04836559|473991060|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
131645755|NCT04836559|473991053|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645756|NCT04836559|473991054|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645757|NCT04836559|473991055|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645758|NCT04836559|473991056|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
131645759|NCT04836559|473991057|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645760|NCT04836559|473991058|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645761|NCT04836559|473991059|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645762|NCT04836559|473991060|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131645763|NCT04836559|473991053|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131645764|NCT04836559|473991054|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131645765|NCT04836559|473991055|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131645766|NCT04836559|473991056|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131645767|NCT04836559|473991057|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
131645768|NCT04836559|473991058|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
131645769|NCT04836559|473991059|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
131645770|NCT04836559|473991060|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
131645771|NCT04836559|473991053|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131645772|NCT04836559|473991054|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131645773|NCT04836559|473991055|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131645774|NCT04836559|473991056|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131645775|NCT04836559|473991057|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
131645776|NCT04836559|473991058|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
131645777|NCT04836559|473991059|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
131645778|NCT04836559|473991060|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
131447271|NCT02760498|473267488|FG003|Overall Study|Withdrawal by Subject|1|||
131447272|NCT02760498|473267489|FG004|Overall Study|Withdrawal by Subject|0|||
131447273|NCT02760498|473267490|FG005|Overall Study|Withdrawal by Subject|6|||
131447274|NCT02760498|473267485|FG000|Overall Study|Other than specified|1|||
131447275|NCT02760498|473267486|FG001|Overall Study|Other than specified|6|||
131447276|NCT02760498|473267487|FG002|Overall Study|Other than specified|0|||
131447277|NCT02760498|473267488|FG003|Overall Study|Other than specified|3|||
131447278|NCT02760498|473267489|FG004|Overall Study|Other than specified|1|||
131447279|NCT02760498|473267490|FG005|Overall Study|Other than specified|0|||
131447280|NCT02760498|473267485|FG000|Overall Study|Not treated|0|||
131447281|NCT02760498|473267486|FG001|Overall Study|Not treated|0|||
131447282|NCT02760498|473267487|FG002|Overall Study|Not treated|0|||
131447283|NCT02760498|473267488|FG003|Overall Study|Not treated|0|||
131645779|NCT04836559|473991053|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131645780|NCT04836559|473991054|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131645781|NCT04836559|473991055|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131645782|NCT04836559|473991056|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131645783|NCT04836559|473991057|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
131645784|NCT04836559|473991058|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
131645785|NCT04836559|473991059|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131645786|NCT04836559|473991060|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
131447284|NCT02760498|473267489|FG004|Overall Study|Not treated|0|||
131447285|NCT02760498|473267490|FG005|Overall Study|Not treated|2|||
131447286|NCT02059278|473267492|FG000|Overall Study|Adverse Event|1|||
131447287|NCT02059278|473267493|FG001|Overall Study|Adverse Event|1|||
131447288|NCT02059278|473267492|FG000|Overall Study|Lost to Follow-up|1|||
131447289|NCT02059278|473267493|FG001|Overall Study|Lost to Follow-up|0|||
131447290|NCT02059278|473267492|FG000|Overall Study|Withdrawal by Subject|0|||
131447291|NCT02059278|473267493|FG001|Overall Study|Withdrawal by Subject|3|||
131447292|NCT02059278|473267492|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
131447293|NCT02059278|473267493|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
131447294|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
131447295|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
131447296|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
131645787|NCT04836559|473991053|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645788|NCT04836559|473991054|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645789|NCT04836559|473991055|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645790|NCT04836559|473991056|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645791|NCT04836559|473991057|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645792|NCT04836559|473991058|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645793|NCT04836559|473991059|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131645794|NCT04836559|473991060|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
131645795|NCT00730015|473991061|FG000|Overall Study|Adverse Event|11|||
131645796|NCT00730015|473991062|FG001|Overall Study|Adverse Event|10|||
131447297|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
131447298|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Adverse Event|2|||
131447299|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Adverse Event|5|||
131447300|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Adverse Event|1|||
131447301|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Adverse Event|2|||
131447302|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Death|13|||
131447303|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Death|17|||
131447304|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Death|1|||
131447305|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Death|0|||
131447306|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
131447307|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
131447308|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
131447309|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
131447310|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Disease Progression|2|||
131447311|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Disease Progression|0|||
131447312|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Disease Progression|0|||
131447313|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Disease Progression|0|||
131447314|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
131447315|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
131447316|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
131447317|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
131447318|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
131447319|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
131447320|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
131447321|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
131447322|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
131447323|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
131447324|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
131447325|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
131447326|NCT03955146|473267496|FG000|DB Period (48 Weeks)|Participant Decision|9|||
131447327|NCT03955146|473267497|FG001|DB Period (48 Weeks)|Participant Decision|12|||
131447328|NCT03955146|473267498|FG002|DB Period (48 Weeks)|Participant Decision|1|||
131447329|NCT03955146|473267499|FG003|DB Period (48 Weeks)|Participant Decision|1|||
131447330|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
131447331|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
131447332|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
131447333|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
131447334|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
131447335|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
131447336|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
131447337|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
131447338|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
131447339|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
131447340|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
131715510|NCT02793544|474235525|FG001|Overall Study|Withdrawal by Subject|0|||
131715511|NCT03929250|474235528|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
131447341|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
131447342|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
131447343|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
131715512|NCT03929250|474235529|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
131645797|NCT00730015|473991063|FG002|Overall Study|Adverse Event|8|||
131645798|NCT00730015|473991061|FG000|Overall Study|Protocol Violation|2|||
131645799|NCT00730015|473991062|FG001|Overall Study|Protocol Violation|6|||
131645800|NCT00730015|473991063|FG002|Overall Study|Protocol Violation|4|||
131645801|NCT00730015|473991061|FG000|Overall Study|Withdrawal by Subject|12|||
131645802|NCT00730015|473991062|FG001|Overall Study|Withdrawal by Subject|12|||
131645803|NCT00730015|473991063|FG002|Overall Study|Withdrawal by Subject|8|||
131645804|NCT00730015|473991061|FG000|Overall Study|Lost to Follow-up|4|||
131645805|NCT00730015|473991062|FG001|Overall Study|Lost to Follow-up|10|||
131645806|NCT00730015|473991063|FG002|Overall Study|Lost to Follow-up|3|||
131645807|NCT00730015|473991061|FG000|Overall Study|Lack of Efficacy|1|||
131645808|NCT00730015|473991062|FG001|Overall Study|Lack of Efficacy|2|||
131645809|NCT00730015|473991063|FG002|Overall Study|Lack of Efficacy|8|||
131645810|NCT00730015|473991061|FG000|Overall Study|Other Reason|1|||
131645811|NCT00730015|473991062|FG001|Overall Study|Other Reason|0|||
131645812|NCT00730015|473991063|FG002|Overall Study|Other Reason|1|||
131645813|NCT02370251|473991064|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
131645814|NCT02370251|473991064|FG000|Overall Study|Death|4|||
131447344|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
131645815|NCT01150045|473991065|FG000|Overall Study|Protocol Violation|0|||
131645816|NCT01150045|473991066|FG001|Overall Study|Protocol Violation|1|||
131645817|NCT01150045|473991067|FG002|Overall Study|Protocol Violation|0|||
131645818|NCT01150045|473991068|FG003|Overall Study|Protocol Violation|1|||
131645819|NCT01663506|473991070|FG000|Overall Study|Lack of Efficacy|3|||
131645820|NCT01663506|473991070|FG000|Overall Study|Consent Withdrawal by Subject|1|||
131447345|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
131447346|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
131447347|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
131645821|NCT01663506|473991070|FG000|Overall Study|Lost to Follow-up|1|||
131645822|NCT01663506|473991070|FG000|Overall Study|Adverse Event|1|||
131645823|NCT01663506|473991070|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
131645824|NCT02094898|473991071|FG000|Overall Study|Clinical Worsening|2|||
131645825|NCT02094898|473991071|FG000|Overall Study|Adverse Event|2|||
131645826|NCT02094898|473991071|FG000|Overall Study|Lack of Efficacy|1|||
131645827|NCT01432626|473991072|FG000|Overall Study|LV function recovered|2|||
131645828|NCT01432626|473991072|FG000|Overall Study|Withdrawal by Subject|2|||
131645829|NCT01432626|473991072|FG000|Overall Study|Only 1 image competed|2|||
131645830|NCT01432626|473991072|FG000|Overall Study|Imaging agent not available|1|||
131645831|NCT05382039|473991073|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
131645832|NCT05382039|473991074|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
131645833|NCT05382039|473991075|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
131645834|NCT05382039|473991073|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
131645835|NCT05382039|473991074|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
131645836|NCT05382039|473991075|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
131645837|NCT05382039|473991073|FG000|Overall Study|waiting for confirmation|0|||
131645838|NCT05382039|473991074|FG001|Overall Study|waiting for confirmation|0|||
131645839|NCT05382039|473991075|FG002|Overall Study|waiting for confirmation|1|||
131645840|NCT03210519|473991076|FG000|Overall Study|Adverse Event|2|||
131645841|NCT03210519|473991077|FG001|Overall Study|Adverse Event|0|||
131645842|NCT04351269|473991078|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
131645843|NCT04351269|473991079|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
131645844|NCT04351269|473991080|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
131645845|NCT04351269|473991078|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
131645846|NCT04351269|473991079|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
131645847|NCT04351269|473991080|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
131447348|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
131447349|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
131447350|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
131645848|NCT04351269|473991078|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
131645849|NCT04351269|473991079|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
131645850|NCT04351269|473991080|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
131645851|NCT04351269|473991078|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
131645852|NCT04351269|473991079|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
131645853|NCT04351269|473991080|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
131645854|NCT04351269|473991078|FG000|Overall Study|Lost to Follow-up|1|||
131645855|NCT04351269|473991079|FG001|Overall Study|Lost to Follow-up|3|||
131645856|NCT04351269|473991080|FG002|Overall Study|Lost to Follow-up|0|||
131645857|NCT02270671|473991083|FG000|Overall Study|Withdrawal by Subject|1|||
131645858|NCT02270671|473991084|FG001|Overall Study|Withdrawal by Subject|1|||
131645859|NCT02270671|473991083|FG000|Overall Study|Protocol Violation|0|||
131645860|NCT02270671|473991084|FG001|Overall Study|Protocol Violation|1|||
131645861|NCT02270671|473991083|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
131645862|NCT02270671|473991084|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
131645863|NCT02270671|473991083|FG000|Overall Study|Lost to Follow-up|2|||
131645864|NCT02270671|473991084|FG001|Overall Study|Lost to Follow-up|1|||
131645865|NCT05878873|473991089|FG000|Overall Study|Lost to Follow-up|2|||
131645866|NCT05878873|473991090|FG001|Overall Study|Lost to Follow-up|0|||
131645867|NCT00882115|473991092|FG000|Overall Study|Withdrawal by Subject|3|||
131645868|NCT00882115|473991092|FG000|Overall Study|did not respond to DEP challe|6|||
131645869|NCT01547598|473991093|FG000|Overall Study|Withdrew consent|1|||
131645870|NCT01547598|473991094|FG001|Overall Study|Withdrew consent|1|||
131645871|NCT01547598|473991093|FG000|Overall Study|Lost to Follow-up|1|||
131645872|NCT01547598|473991094|FG001|Overall Study|Lost to Follow-up|1|||
131645873|NCT01547598|473991093|FG000|Overall Study|Adverse Event|1|||
131645874|NCT01547598|473991094|FG001|Overall Study|Adverse Event|1|||
131645875|NCT01547598|473991093|FG000|Overall Study|Protocol Violation|1|||
131645876|NCT01547598|473991094|FG001|Overall Study|Protocol Violation|1|||
131645877|NCT01547598|473991093|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131645878|NCT01547598|473991094|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131645879|NCT02125279|473991095|FG000|Overall Study|Lack of Efficacy|2|||
131645880|NCT02125279|473991095|FG000|Overall Study|Withdrawal by Subject|6|||
131645881|NCT02125279|473991095|FG000|Overall Study|Protocol Violation|1|||
131645882|NCT02125279|473991095|FG000|Overall Study|Lost to Follow-up|4|||
131645883|NCT01790295|473991102|FG000|Overall Study|Adverse Event|1|||
131645884|NCT01790295|473991102|FG000|Overall Study|Death|4|||
131645885|NCT01790295|473991102|FG000|Overall Study|Lack of Efficacy|2|||
131645886|NCT01790295|473991102|FG000|Overall Study|Study closure|4|||
131645887|NCT03721172|473991103|FG000|Placebo-controlled Phase|Adverse Event|7|||
131645888|NCT03721172|473991104|FG001|Placebo-controlled Phase|Adverse Event|7|||
131645889|NCT03721172|473991105|FG002|Placebo-controlled Phase|Adverse Event|0|||
131645890|NCT03721172|473991103|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
131645891|NCT03721172|473991104|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
131645892|NCT03721172|473991105|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
131645893|NCT03721172|473991103|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
131645894|NCT03721172|473991104|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
131645895|NCT03721172|473991105|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
131645896|NCT03721172|473991103|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
131645897|NCT03721172|473991104|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
131645898|NCT03721172|473991105|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
131645899|NCT03721172|473991103|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
131645900|NCT03721172|473991104|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
131645901|NCT03721172|473991105|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
131645902|NCT03721172|473991103|FG000|Placebo-controlled Phase|Other|3|||
131645903|NCT03721172|473991104|FG001|Placebo-controlled Phase|Other|0|||
131645904|NCT03721172|473991105|FG002|Placebo-controlled Phase|Other|0|||
131645905|NCT03721172|473991103|FG000|Apremilast Extension Phase|Adverse Event|0|||
131645906|NCT03721172|473991104|FG001|Apremilast Extension Phase|Adverse Event|0|||
131645907|NCT03721172|473991105|FG002|Apremilast Extension Phase|Adverse Event|10|||
131645908|NCT03721172|473991103|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
131645909|NCT03721172|473991104|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
131645910|NCT03721172|473991105|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
131645911|NCT03721172|473991103|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
131645912|NCT03721172|473991104|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
131645913|NCT03721172|473991105|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
131645914|NCT03721172|473991103|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
131645915|NCT03721172|473991104|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
131645916|NCT03721172|473991105|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
131645917|NCT03721172|473991103|FG000|Apremilast Extension Phase|Protocol Violation|0|||
131645918|NCT03721172|473991104|FG001|Apremilast Extension Phase|Protocol Violation|0|||
131645919|NCT03721172|473991105|FG002|Apremilast Extension Phase|Protocol Violation|1|||
131645920|NCT03721172|473991103|FG000|Apremilast Extension Phase|Physician Decision|0|||
131645921|NCT03721172|473991104|FG001|Apremilast Extension Phase|Physician Decision|0|||
131645922|NCT03721172|473991105|FG002|Apremilast Extension Phase|Physician Decision|1|||
131645923|NCT03721172|473991103|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
131645924|NCT03721172|473991104|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
131645925|NCT03721172|473991105|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
131645926|NCT03721172|473991103|FG000|Apremilast Extension Phase|Other|0|||
131645927|NCT03721172|473991104|FG001|Apremilast Extension Phase|Other|0|||
131645928|NCT03721172|473991105|FG002|Apremilast Extension Phase|Other|3|||
131645929|NCT03721172|473991103|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
131645930|NCT03721172|473991104|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
131645931|NCT03721172|473991105|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
131645932|NCT00420784|473991106|FG000|Overall Study|Adverse Event|11|||
131645933|NCT00420784|473991107|FG001|Overall Study|Adverse Event|29|||
131645934|NCT00420784|473991108|FG002|Overall Study|Adverse Event|10|||
131645935|NCT00420784|473991109|FG003|Overall Study|Adverse Event|5|||
131645936|NCT00420784|473991106|FG000|Overall Study|Withdrawal by Subject|0|||
131645937|NCT00420784|473991107|FG001|Overall Study|Withdrawal by Subject|1|||
131645938|NCT00420784|473991108|FG002|Overall Study|Withdrawal by Subject|0|||
131645939|NCT00420784|473991109|FG003|Overall Study|Withdrawal by Subject|0|||
131645940|NCT00420784|473991106|FG000|Overall Study|Lost to Follow-up|0|||
131645941|NCT00420784|473991107|FG001|Overall Study|Lost to Follow-up|0|||
131645942|NCT00420784|473991108|FG002|Overall Study|Lost to Follow-up|2|||
131645943|NCT00420784|473991109|FG003|Overall Study|Lost to Follow-up|1|||
131645944|NCT00420784|473991106|FG000|Overall Study|Virologic Stopping Rule|17|||
131645945|NCT00420784|473991107|FG001|Overall Study|Virologic Stopping Rule|26|||
131645946|NCT00420784|473991108|FG002|Overall Study|Virologic Stopping Rule|41|||
131645947|NCT00420784|473991109|FG003|Overall Study|Virologic Stopping Rule|67|||
131645948|NCT00420784|473991106|FG000|Overall Study|Other|1|||
131645949|NCT00420784|473991107|FG001|Overall Study|Other|2|||
131645950|NCT00420784|473991108|FG002|Overall Study|Other|0|||
131645951|NCT00420784|473991109|FG003|Overall Study|Other|5|||
131645952|NCT02472145|473991112|FG000|Overall Study|Death|10|||
131645953|NCT02472145|473991113|FG001|Overall Study|Death|101|||
131645954|NCT02472145|473991114|FG002|Overall Study|Death|99|||
131645955|NCT02472145|473991112|FG000|Overall Study|Lost to Follow-up|0|||
131645956|NCT02472145|473991113|FG001|Overall Study|Lost to Follow-up|1|||
131645957|NCT02472145|473991114|FG002|Overall Study|Lost to Follow-up|0|||
131645958|NCT02472145|473991112|FG000|Overall Study|Withdrawal by Subject|0|||
131645959|NCT02472145|473991113|FG001|Overall Study|Withdrawal by Subject|9|||
131903141|NCT01435759|474931413|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
131645960|NCT02472145|473991114|FG002|Overall Study|Withdrawal by Subject|13|||
131645961|NCT02472145|473991112|FG000|Overall Study|Sponsor decision|0|||
131645962|NCT02472145|473991113|FG001|Overall Study|Sponsor decision|3|||
131645963|NCT02472145|473991114|FG002|Overall Study|Sponsor decision|2|||
131645964|NCT02472145|473991112|FG000|Overall Study|Other|0|||
131645965|NCT02472145|473991113|FG001|Overall Study|Other|45|||
131903142|NCT01435759|474931414|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131645966|NCT02472145|473991114|FG002|Overall Study|Other|43|||
131645967|NCT01296555|473991115|FG000|Overall Study|Adverse Event|0|||
131645968|NCT01296555|473991116|FG001|Overall Study|Adverse Event|0|||
131645969|NCT01296555|473991117|FG002|Overall Study|Adverse Event|1|||
131645970|NCT01296555|473991118|FG003|Overall Study|Adverse Event|1|||
131645971|NCT01296555|473991119|FG004|Overall Study|Adverse Event|2|||
131645972|NCT01296555|473991120|FG005|Overall Study|Adverse Event|4|||
131645973|NCT01296555|473991121|FG006|Overall Study|Adverse Event|1|||
131645974|NCT01296555|473991122|FG007|Overall Study|Adverse Event|4|||
131645975|NCT01296555|473991123|FG008|Overall Study|Adverse Event|3|||
131645976|NCT01296555|473991124|FG009|Overall Study|Adverse Event|1|||
131645977|NCT01296555|473991125|FG010|Overall Study|Adverse Event|0|||
131645978|NCT01296555|473991126|FG011|Overall Study|Adverse Event|4|||
131645979|NCT01296555|473991127|FG012|Overall Study|Adverse Event|1|||
131645980|NCT01296555|473991128|FG013|Overall Study|Adverse Event|4|||
131645981|NCT01296555|473991129|FG014|Overall Study|Adverse Event|0|||
131645982|NCT01296555|473991130|FG015|Overall Study|Adverse Event|0|||
131645983|NCT01296555|473991131|FG016|Overall Study|Adverse Event|0|||
131645984|NCT01296555|473991132|FG017|Overall Study|Adverse Event|0|||
131645985|NCT01296555|473991133|FG018|Overall Study|Adverse Event|0|||
131645986|NCT01296555|473991134|FG019|Overall Study|Adverse Event|1|||
131645987|NCT01296555|473991135|FG020|Overall Study|Adverse Event|0|||
131645988|NCT01296555|473991136|FG021|Overall Study|Adverse Event|0|||
131645989|NCT01296555|473991137|FG022|Overall Study|Adverse Event|0|||
131645990|NCT01296555|473991138|FG023|Overall Study|Adverse Event|0|||
131645991|NCT01296555|473991139|FG024|Overall Study|Adverse Event|0|||
131645992|NCT01296555|473991140|FG025|Overall Study|Adverse Event|0|||
131645993|NCT01296555|473991141|FG026|Overall Study|Adverse Event|0|||
131645994|NCT01296555|473991142|FG027|Overall Study|Adverse Event|0|||
131645995|NCT01296555|473991143|FG028|Overall Study|Adverse Event|0|||
131645996|NCT01296555|473991115|FG000|Overall Study|Reason Not Specified|0|||
131645997|NCT01296555|473991116|FG001|Overall Study|Reason Not Specified|0|||
131645998|NCT01296555|473991117|FG002|Overall Study|Reason Not Specified|0|||
131645999|NCT01296555|473991118|FG003|Overall Study|Reason Not Specified|0|||
131646000|NCT01296555|473991119|FG004|Overall Study|Reason Not Specified|0|||
131646001|NCT01296555|473991120|FG005|Overall Study|Reason Not Specified|0|||
131646002|NCT01296555|473991121|FG006|Overall Study|Reason Not Specified|0|||
131646003|NCT01296555|473991122|FG007|Overall Study|Reason Not Specified|0|||
131646004|NCT01296555|473991123|FG008|Overall Study|Reason Not Specified|0|||
131646005|NCT01296555|473991124|FG009|Overall Study|Reason Not Specified|0|||
131646006|NCT01296555|473991125|FG010|Overall Study|Reason Not Specified|0|||
131646007|NCT01296555|473991126|FG011|Overall Study|Reason Not Specified|0|||
131646008|NCT01296555|473991127|FG012|Overall Study|Reason Not Specified|0|||
131646009|NCT01296555|473991128|FG013|Overall Study|Reason Not Specified|1|||
131646010|NCT01296555|473991129|FG014|Overall Study|Reason Not Specified|2|||
131646011|NCT01296555|473991130|FG015|Overall Study|Reason Not Specified|3|||
131646012|NCT01296555|473991131|FG016|Overall Study|Reason Not Specified|7|||
131646013|NCT01296555|473991132|FG017|Overall Study|Reason Not Specified|4|||
131646014|NCT01296555|473991133|FG018|Overall Study|Reason Not Specified|3|||
131646015|NCT01296555|473991134|FG019|Overall Study|Reason Not Specified|7|||
131646016|NCT01296555|473991135|FG020|Overall Study|Reason Not Specified|11|||
131646017|NCT01296555|473991136|FG021|Overall Study|Reason Not Specified|5|||
131646018|NCT01296555|473991137|FG022|Overall Study|Reason Not Specified|5|||
131646019|NCT01296555|473991138|FG023|Overall Study|Reason Not Specified|7|||
131646020|NCT01296555|473991139|FG024|Overall Study|Reason Not Specified|2|||
131646021|NCT01296555|473991140|FG025|Overall Study|Reason Not Specified|2|||
131646022|NCT01296555|473991141|FG026|Overall Study|Reason Not Specified|19|||
131447351|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
131447352|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
131447353|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
131447354|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
131447355|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
131447356|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
131447357|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
131447358|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
131447359|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
131646023|NCT01296555|473991142|FG027|Overall Study|Reason Not Specified|11|||
131646024|NCT01296555|473991143|FG028|Overall Study|Reason Not Specified|9|||
131646025|NCT01296555|473991115|FG000|Overall Study|Physician Decision|0|||
131646026|NCT01296555|473991116|FG001|Overall Study|Physician Decision|0|||
131646027|NCT01296555|473991117|FG002|Overall Study|Physician Decision|0|||
131646028|NCT01296555|473991118|FG003|Overall Study|Physician Decision|0|||
131646029|NCT01296555|473991119|FG004|Overall Study|Physician Decision|1|||
131646030|NCT01296555|473991120|FG005|Overall Study|Physician Decision|0|||
131646031|NCT01296555|473991121|FG006|Overall Study|Physician Decision|0|||
131646032|NCT01296555|473991122|FG007|Overall Study|Physician Decision|0|||
131646033|NCT01296555|473991123|FG008|Overall Study|Physician Decision|0|||
131646034|NCT01296555|473991124|FG009|Overall Study|Physician Decision|0|||
131646035|NCT01296555|473991125|FG010|Overall Study|Physician Decision|0|||
131646036|NCT01296555|473991126|FG011|Overall Study|Physician Decision|0|||
131646037|NCT01296555|473991127|FG012|Overall Study|Physician Decision|0|||
131646038|NCT01296555|473991128|FG013|Overall Study|Physician Decision|1|||
131646039|NCT01296555|473991129|FG014|Overall Study|Physician Decision|0|||
131646040|NCT01296555|473991130|FG015|Overall Study|Physician Decision|0|||
131646041|NCT01296555|473991131|FG016|Overall Study|Physician Decision|0|||
131646042|NCT01296555|473991132|FG017|Overall Study|Physician Decision|0|||
131646043|NCT01296555|473991133|FG018|Overall Study|Physician Decision|0|||
131646044|NCT01296555|473991134|FG019|Overall Study|Physician Decision|1|||
131646045|NCT01296555|473991135|FG020|Overall Study|Physician Decision|0|||
131646046|NCT01296555|473991136|FG021|Overall Study|Physician Decision|0|||
131646047|NCT01296555|473991137|FG022|Overall Study|Physician Decision|0|||
131646048|NCT01296555|473991138|FG023|Overall Study|Physician Decision|0|||
131646049|NCT01296555|473991139|FG024|Overall Study|Physician Decision|0|||
131646050|NCT01296555|473991140|FG025|Overall Study|Physician Decision|0|||
131646051|NCT01296555|473991141|FG026|Overall Study|Physician Decision|0|||
131646052|NCT01296555|473991142|FG027|Overall Study|Physician Decision|0|||
131646053|NCT01296555|473991143|FG028|Overall Study|Physician Decision|0|||
131646054|NCT01296555|473991115|FG000|Overall Study|Progressive Disease|6|||
131646055|NCT01296555|473991116|FG001|Overall Study|Progressive Disease|3|||
131646056|NCT01296555|473991117|FG002|Overall Study|Progressive Disease|3|||
131646057|NCT01296555|473991118|FG003|Overall Study|Progressive Disease|7|||
131646058|NCT01296555|473991119|FG004|Overall Study|Progressive Disease|6|||
131802074|NCT01759290|474559172|FG000|Overall Study|Unknown reason|4|||
131802075|NCT00406848|474559175|FG000|Overall Study|Withdrawal by Subject|27|||
131802076|NCT00406848|474559176|FG001|Overall Study|Withdrawal by Subject|22|||
131646059|NCT01296555|473991120|FG005|Overall Study|Progressive Disease|16|||
131646060|NCT01296555|473991121|FG006|Overall Study|Progressive Disease|16|||
131646061|NCT01296555|473991122|FG007|Overall Study|Progressive Disease|8|||
131646062|NCT01296555|473991123|FG008|Overall Study|Progressive Disease|7|||
131646063|NCT01296555|473991124|FG009|Overall Study|Progressive Disease|18|||
131646064|NCT01296555|473991125|FG010|Overall Study|Progressive Disease|7|||
131646065|NCT01296555|473991126|FG011|Overall Study|Progressive Disease|14|||
131646066|NCT01296555|473991127|FG012|Overall Study|Progressive Disease|5|||
131646067|NCT01296555|473991128|FG013|Overall Study|Progressive Disease|12|||
131646068|NCT01296555|473991129|FG014|Overall Study|Progressive Disease|1|||
131646069|NCT01296555|473991130|FG015|Overall Study|Progressive Disease|1|||
131646070|NCT01296555|473991131|FG016|Overall Study|Progressive Disease|0|||
131646071|NCT01296555|473991132|FG017|Overall Study|Progressive Disease|0|||
131646072|NCT01296555|473991133|FG018|Overall Study|Progressive Disease|0|||
131646073|NCT01296555|473991134|FG019|Overall Study|Progressive Disease|1|||
131646074|NCT01296555|473991135|FG020|Overall Study|Progressive Disease|0|||
131646075|NCT01296555|473991136|FG021|Overall Study|Progressive Disease|0|||
131646076|NCT01296555|473991137|FG022|Overall Study|Progressive Disease|0|||
131646077|NCT01296555|473991138|FG023|Overall Study|Progressive Disease|0|||
131646078|NCT01296555|473991139|FG024|Overall Study|Progressive Disease|1|||
131646079|NCT01296555|473991140|FG025|Overall Study|Progressive Disease|0|||
131646080|NCT01296555|473991141|FG026|Overall Study|Progressive Disease|5|||
131646081|NCT01296555|473991142|FG027|Overall Study|Progressive Disease|1|||
131646082|NCT01296555|473991143|FG028|Overall Study|Progressive Disease|0|||
131646083|NCT01296555|473991115|FG000|Overall Study|Protocol Violation|0|||
131646084|NCT01296555|473991116|FG001|Overall Study|Protocol Violation|0|||
131646085|NCT01296555|473991117|FG002|Overall Study|Protocol Violation|0|||
131646086|NCT01296555|473991118|FG003|Overall Study|Protocol Violation|0|||
131646087|NCT01296555|473991119|FG004|Overall Study|Protocol Violation|0|||
131646088|NCT01296555|473991120|FG005|Overall Study|Protocol Violation|0|||
131646089|NCT01296555|473991121|FG006|Overall Study|Protocol Violation|0|||
131646090|NCT01296555|473991122|FG007|Overall Study|Protocol Violation|0|||
131646091|NCT01296555|473991123|FG008|Overall Study|Protocol Violation|0|||
131646092|NCT01296555|473991124|FG009|Overall Study|Protocol Violation|0|||
131646093|NCT01296555|473991125|FG010|Overall Study|Protocol Violation|0|||
131646094|NCT01296555|473991126|FG011|Overall Study|Protocol Violation|0|||
131646095|NCT01296555|473991127|FG012|Overall Study|Protocol Violation|0|||
131646096|NCT01296555|473991128|FG013|Overall Study|Protocol Violation|1|||
131646097|NCT01296555|473991129|FG014|Overall Study|Protocol Violation|0|||
131646098|NCT01296555|473991130|FG015|Overall Study|Protocol Violation|0|||
131646099|NCT01296555|473991131|FG016|Overall Study|Protocol Violation|0|||
131646100|NCT01296555|473991132|FG017|Overall Study|Protocol Violation|0|||
131646101|NCT01296555|473991133|FG018|Overall Study|Protocol Violation|0|||
131646102|NCT01296555|473991134|FG019|Overall Study|Protocol Violation|0|||
131646103|NCT01296555|473991135|FG020|Overall Study|Protocol Violation|0|||
131646104|NCT01296555|473991136|FG021|Overall Study|Protocol Violation|0|||
131646105|NCT01296555|473991137|FG022|Overall Study|Protocol Violation|0|||
131646106|NCT01296555|473991138|FG023|Overall Study|Protocol Violation|0|||
131646107|NCT01296555|473991139|FG024|Overall Study|Protocol Violation|0|||
131646108|NCT01296555|473991140|FG025|Overall Study|Protocol Violation|0|||
131646109|NCT01296555|473991141|FG026|Overall Study|Protocol Violation|0|||
131646110|NCT01296555|473991142|FG027|Overall Study|Protocol Violation|0|||
131646111|NCT01296555|473991143|FG028|Overall Study|Protocol Violation|0|||
131646112|NCT01296555|473991115|FG000|Overall Study|Study Terminated By Sponsor|0|||
131646113|NCT01296555|473991116|FG001|Overall Study|Study Terminated By Sponsor|0|||
131646114|NCT01296555|473991117|FG002|Overall Study|Study Terminated By Sponsor|0|||
131646115|NCT01296555|473991118|FG003|Overall Study|Study Terminated By Sponsor|0|||
131646116|NCT01296555|473991119|FG004|Overall Study|Study Terminated By Sponsor|0|||
131646117|NCT01296555|473991120|FG005|Overall Study|Study Terminated By Sponsor|0|||
131646118|NCT01296555|473991121|FG006|Overall Study|Study Terminated By Sponsor|0|||
131646119|NCT01296555|473991122|FG007|Overall Study|Study Terminated By Sponsor|0|||
131646120|NCT01296555|473991123|FG008|Overall Study|Study Terminated By Sponsor|0|||
131646121|NCT01296555|473991124|FG009|Overall Study|Study Terminated By Sponsor|0|||
131646122|NCT01296555|473991125|FG010|Overall Study|Study Terminated By Sponsor|0|||
131646123|NCT01296555|473991126|FG011|Overall Study|Study Terminated By Sponsor|0|||
131646124|NCT01296555|473991127|FG012|Overall Study|Study Terminated By Sponsor|0|||
131646125|NCT01296555|473991128|FG013|Overall Study|Study Terminated By Sponsor|0|||
131646126|NCT01296555|473991129|FG014|Overall Study|Study Terminated By Sponsor|0|||
131646127|NCT01296555|473991130|FG015|Overall Study|Study Terminated By Sponsor|0|||
131646128|NCT01296555|473991131|FG016|Overall Study|Study Terminated By Sponsor|0|||
131646129|NCT01296555|473991132|FG017|Overall Study|Study Terminated By Sponsor|0|||
131646130|NCT01296555|473991133|FG018|Overall Study|Study Terminated By Sponsor|0|||
131646131|NCT01296555|473991134|FG019|Overall Study|Study Terminated By Sponsor|0|||
131646132|NCT01296555|473991135|FG020|Overall Study|Study Terminated By Sponsor|0|||
131646133|NCT01296555|473991136|FG021|Overall Study|Study Terminated By Sponsor|0|||
131646134|NCT01296555|473991137|FG022|Overall Study|Study Terminated By Sponsor|0|||
131646135|NCT01296555|473991138|FG023|Overall Study|Study Terminated By Sponsor|0|||
131646136|NCT01296555|473991139|FG024|Overall Study|Study Terminated By Sponsor|0|||
131646137|NCT01296555|473991140|FG025|Overall Study|Study Terminated By Sponsor|1|||
131646138|NCT01296555|473991141|FG026|Overall Study|Study Terminated By Sponsor|0|||
131802077|NCT00406848|474559175|FG000|Overall Study|Adverse Event|38|||
131447360|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
131447361|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
131447362|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
131447363|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
131447364|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
131447365|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
131447366|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
131646139|NCT01296555|473991142|FG027|Overall Study|Study Terminated By Sponsor|0|||
131447367|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
131447368|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
131447369|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
131646140|NCT01296555|473991143|FG028|Overall Study|Study Terminated By Sponsor|0|||
131646141|NCT01296555|473991115|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646142|NCT01296555|473991116|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646143|NCT01296555|473991117|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646144|NCT01296555|473991118|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646145|NCT01296555|473991119|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646146|NCT01296555|473991120|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646147|NCT01296555|473991121|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646148|NCT01296555|473991122|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646149|NCT01296555|473991123|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646150|NCT01296555|473991124|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646151|NCT01296555|473991125|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646152|NCT01296555|473991126|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646153|NCT01296555|473991127|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646154|NCT01296555|473991128|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646155|NCT01296555|473991129|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646156|NCT01296555|473991130|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646157|NCT01296555|473991131|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646158|NCT01296555|473991132|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646159|NCT01296555|473991133|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646160|NCT01296555|473991134|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
131646161|NCT01296555|473991135|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646162|NCT01296555|473991136|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646163|NCT01296555|473991137|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646164|NCT01296555|473991138|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646165|NCT01296555|473991139|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646166|NCT01296555|473991140|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646167|NCT01296555|473991141|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646168|NCT01296555|473991142|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646169|NCT01296555|473991143|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131646170|NCT01296555|473991115|FG000|Overall Study|Death|0|||
131646171|NCT01296555|473991116|FG001|Overall Study|Death|0|||
131646172|NCT01296555|473991117|FG002|Overall Study|Death|0|||
131646173|NCT01296555|473991118|FG003|Overall Study|Death|2|||
131646174|NCT01296555|473991119|FG004|Overall Study|Death|1|||
131646175|NCT01296555|473991120|FG005|Overall Study|Death|0|||
131646176|NCT01296555|473991121|FG006|Overall Study|Death|2|||
131646177|NCT01296555|473991122|FG007|Overall Study|Death|0|||
131646178|NCT01296555|473991123|FG008|Overall Study|Death|0|||
131646179|NCT01296555|473991124|FG009|Overall Study|Death|1|||
131646180|NCT01296555|473991125|FG010|Overall Study|Death|0|||
131646181|NCT01296555|473991126|FG011|Overall Study|Death|1|||
131646182|NCT01296555|473991127|FG012|Overall Study|Death|0|||
131646183|NCT01296555|473991128|FG013|Overall Study|Death|2|||
131646184|NCT01296555|473991129|FG014|Overall Study|Death|27|||
131646185|NCT01296555|473991130|FG015|Overall Study|Death|15|||
131646186|NCT01296555|473991131|FG016|Overall Study|Death|11|||
131646187|NCT01296555|473991132|FG017|Overall Study|Death|11|||
131646188|NCT01296555|473991133|FG018|Overall Study|Death|17|||
131646189|NCT01296555|473991134|FG019|Overall Study|Death|12|||
131646190|NCT01296555|473991135|FG020|Overall Study|Death|13|||
131646191|NCT01296555|473991136|FG021|Overall Study|Death|12|||
131802078|NCT00406848|474559176|FG001|Overall Study|Adverse Event|7|||
131802079|NCT00406848|474559175|FG000|Overall Study|Lack of Efficacy|9|||
131646192|NCT01296555|473991137|FG022|Overall Study|Death|12|||
131646193|NCT01296555|473991138|FG023|Overall Study|Death|13|||
131646194|NCT01296555|473991139|FG024|Overall Study|Death|7|||
131646195|NCT01296555|473991140|FG025|Overall Study|Death|7|||
131802080|NCT00406848|474559176|FG001|Overall Study|Lack of Efficacy|14|||
131646196|NCT01296555|473991141|FG026|Overall Study|Death|35|||
131646197|NCT01296555|473991142|FG027|Overall Study|Death|92|||
131646198|NCT01296555|473991143|FG028|Overall Study|Death|44|||
131646199|NCT01296555|473991115|FG000|Overall Study|Lost to Follow-up|0|||
131646200|NCT01296555|473991116|FG001|Overall Study|Lost to Follow-up|0|||
131646201|NCT01296555|473991117|FG002|Overall Study|Lost to Follow-up|0|||
131646202|NCT01296555|473991118|FG003|Overall Study|Lost to Follow-up|0|||
131646203|NCT01296555|473991119|FG004|Overall Study|Lost to Follow-up|0|||
131646204|NCT01296555|473991120|FG005|Overall Study|Lost to Follow-up|0|||
131646205|NCT01296555|473991121|FG006|Overall Study|Lost to Follow-up|0|||
131646206|NCT01296555|473991122|FG007|Overall Study|Lost to Follow-up|0|||
131646207|NCT01296555|473991123|FG008|Overall Study|Lost to Follow-up|0|||
131802081|NCT00406848|474559175|FG000|Overall Study|Protocol Violation|10|||
131802082|NCT00406848|474559176|FG001|Overall Study|Protocol Violation|6|||
131802083|NCT00406848|474559175|FG000|Overall Study|Lost to Follow-up|6|||
131802084|NCT00406848|474559176|FG001|Overall Study|Lost to Follow-up|2|||
131802085|NCT00406848|474559175|FG000|Overall Study|Physician Decision|2|||
131802086|NCT00406848|474559176|FG001|Overall Study|Physician Decision|2|||
131802087|NCT00406848|474559175|FG000|Overall Study|Sponsor Decision|1|||
131802088|NCT00406848|474559176|FG001|Overall Study|Sponsor Decision|1|||
131802089|NCT03629249|474559177|FG000|Overall Study|Study terminated by sponsor|197|||
131802090|NCT03629249|474559178|FG001|Overall Study|Study terminated by sponsor|197|||
131802091|NCT03629249|474559179|FG002|Overall Study|Study terminated by sponsor|194|||
131802092|NCT03629249|474559177|FG000|Overall Study|Protocol deviation|0|||
131802093|NCT03629249|474559178|FG001|Overall Study|Protocol deviation|2|||
131646208|NCT01296555|473991124|FG009|Overall Study|Lost to Follow-up|0|||
131646209|NCT01296555|473991125|FG010|Overall Study|Lost to Follow-up|0|||
131646210|NCT01296555|473991126|FG011|Overall Study|Lost to Follow-up|0|||
131646211|NCT01296555|473991127|FG012|Overall Study|Lost to Follow-up|0|||
131646212|NCT01296555|473991128|FG013|Overall Study|Lost to Follow-up|0|||
131646213|NCT01296555|473991129|FG014|Overall Study|Lost to Follow-up|2|||
131646214|NCT01296555|473991130|FG015|Overall Study|Lost to Follow-up|1|||
131646215|NCT01296555|473991131|FG016|Overall Study|Lost to Follow-up|0|||
131646216|NCT01296555|473991132|FG017|Overall Study|Lost to Follow-up|2|||
131646217|NCT01296555|473991133|FG018|Overall Study|Lost to Follow-up|0|||
131646218|NCT01296555|473991134|FG019|Overall Study|Lost to Follow-up|2|||
131646219|NCT01296555|473991135|FG020|Overall Study|Lost to Follow-up|3|||
131646220|NCT01296555|473991136|FG021|Overall Study|Lost to Follow-up|2|||
131646221|NCT01296555|473991137|FG022|Overall Study|Lost to Follow-up|0|||
131646222|NCT01296555|473991138|FG023|Overall Study|Lost to Follow-up|0|||
131646223|NCT01296555|473991139|FG024|Overall Study|Lost to Follow-up|0|||
131646224|NCT01296555|473991140|FG025|Overall Study|Lost to Follow-up|0|||
131646225|NCT01296555|473991141|FG026|Overall Study|Lost to Follow-up|3|||
131646226|NCT01296555|473991142|FG027|Overall Study|Lost to Follow-up|13|||
131646227|NCT01296555|473991143|FG028|Overall Study|Lost to Follow-up|5|||
131646228|NCT01296555|473991115|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131646229|NCT01296555|473991116|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131646230|NCT01296555|473991117|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131646231|NCT01296555|473991118|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131646232|NCT01296555|473991119|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131646233|NCT01296555|473991120|FG005|Overall Study|Non-Compliance With Study Drug|0|||
131646234|NCT01296555|473991121|FG006|Overall Study|Non-Compliance With Study Drug|0|||
131646235|NCT01296555|473991122|FG007|Overall Study|Non-Compliance With Study Drug|1|||
131646236|NCT01296555|473991123|FG008|Overall Study|Non-Compliance With Study Drug|0|||
131646237|NCT01296555|473991124|FG009|Overall Study|Non-Compliance With Study Drug|0|||
131646238|NCT01296555|473991125|FG010|Overall Study|Non-Compliance With Study Drug|0|||
131646239|NCT01296555|473991126|FG011|Overall Study|Non-Compliance With Study Drug|0|||
131646240|NCT01296555|473991127|FG012|Overall Study|Non-Compliance With Study Drug|0|||
131646241|NCT01296555|473991128|FG013|Overall Study|Non-Compliance With Study Drug|0|||
131646242|NCT01296555|473991129|FG014|Overall Study|Non-Compliance With Study Drug|0|||
131646243|NCT01296555|473991130|FG015|Overall Study|Non-Compliance With Study Drug|0|||
131646244|NCT01296555|473991131|FG016|Overall Study|Non-Compliance With Study Drug|0|||
131646245|NCT01296555|473991132|FG017|Overall Study|Non-Compliance With Study Drug|0|||
131646246|NCT01296555|473991133|FG018|Overall Study|Non-Compliance With Study Drug|0|||
131802094|NCT03629249|474559179|FG002|Overall Study|Protocol deviation|5|||
131802095|NCT03629249|474559177|FG000|Overall Study|Subject decision|1|||
131646247|NCT01296555|473991134|FG019|Overall Study|Non-Compliance With Study Drug|0|||
131646248|NCT01296555|473991135|FG020|Overall Study|Non-Compliance With Study Drug|0|||
131646249|NCT01296555|473991136|FG021|Overall Study|Non-Compliance With Study Drug|0|||
131802096|NCT03629249|474559178|FG001|Overall Study|Subject decision|1|||
131646250|NCT01296555|473991137|FG022|Overall Study|Non-Compliance With Study Drug|0|||
131646251|NCT01296555|473991138|FG023|Overall Study|Non-Compliance With Study Drug|0|||
131646252|NCT01296555|473991139|FG024|Overall Study|Non-Compliance With Study Drug|0|||
131646253|NCT01296555|473991140|FG025|Overall Study|Non-Compliance With Study Drug|0|||
131646254|NCT01296555|473991141|FG026|Overall Study|Non-Compliance With Study Drug|0|||
131646255|NCT01296555|473991142|FG027|Overall Study|Non-Compliance With Study Drug|0|||
131802097|NCT03629249|474559179|FG002|Overall Study|Subject decision|3|||
131802098|NCT03629249|474559177|FG000|Overall Study|Adverse Event|1|||
131646256|NCT01296555|473991143|FG028|Overall Study|Non-Compliance With Study Drug|0|||
131802099|NCT03629249|474559178|FG001|Overall Study|Adverse Event|1|||
131802100|NCT03629249|474559179|FG002|Overall Study|Adverse Event|0|||
131447370|NCT03955146|473267496|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
131447371|NCT03955146|473267497|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
131447372|NCT03955146|473267498|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
131447373|NCT03955146|473267499|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
131447374|NCT02002598|473267502|FG000|Dose Level 1|Withdrawal by Subject|1|||
131447375|NCT02002598|473267503|FG001|Dose Level 1|Withdrawal by Subject|0|||
131447376|NCT02002598|473267504|FG002|Dose Level 1|Withdrawal by Subject|0|||
131447377|NCT02002598|473267505|FG003|Dose Level 1|Withdrawal by Subject|0|||
131447378|NCT02002598|473267506|FG004|Dose Level 1|Withdrawal by Subject|0|||
131447379|NCT02195518|473267507|FG000|Overall Study|Adverse Event|1|||
131447380|NCT02195518|473267507|FG000|Overall Study|Protocol Violation|4|||
131447381|NCT02195518|473267507|FG000|Overall Study|Pregnancy|2|||
131447382|NCT02195518|473267507|FG000|Overall Study|Withdrawal by Subject|1|||
131447383|NCT02195518|473267507|FG000|Overall Study|Lost to Follow-up|1|||
131447384|NCT03312634|473268710|FG000|Overall Study|Adverse Event|11|||
131447385|NCT03312634|473268711|FG001|Overall Study|Adverse Event|0|||
131447386|NCT03312634|473268710|FG000|Overall Study|Sponsor request|2|||
131447387|NCT03312634|473268711|FG001|Overall Study|Sponsor request|0|||
131447388|NCT03312634|473268710|FG000|Overall Study|Withdrawal by Subject|31|||
131447389|NCT03312634|473268711|FG001|Overall Study|Withdrawal by Subject|9|||
131447390|NCT03312634|473268710|FG000|Overall Study|Enrolled in an interventional study|0|||
131447391|NCT03312634|473268711|FG001|Overall Study|Enrolled in an interventional study|52|||
131447392|NCT03312634|473268710|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
131447393|NCT03312634|473268711|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
131447394|NCT03312634|473268710|FG000|Overall Study|Death|0|||
131447395|NCT03312634|473268711|FG001|Overall Study|Death|1|||
131447396|NCT03312634|473268710|FG000|Overall Study|Non-compliance|0|||
131447397|NCT03312634|473268711|FG001|Overall Study|Non-compliance|2|||
131447398|NCT03312634|473268710|FG000|Overall Study|Lost to Follow-up|0|||
131447399|NCT03312634|473268711|FG001|Overall Study|Lost to Follow-up|1|||
131447400|NCT03312634|473268710|FG000|Overall Study|Enrolled into non-interventional study|0|||
131447401|NCT03312634|473268711|FG001|Overall Study|Enrolled into non-interventional study|5|||
131447402|NCT03312634|473268710|FG000|Overall Study|Worsening clinical condition|0|||
131447403|NCT03312634|473268711|FG001|Overall Study|Worsening clinical condition|1|||
131447404|NCT03312634|473268710|FG000|Overall Study|Participant did not want to travel|0|||
131447405|NCT03312634|473268711|FG001|Overall Study|Participant did not want to travel|1|||
131447406|NCT03312634|473268710|FG000|Overall Study|Physician Decision|1|||
131447407|NCT03312634|473268711|FG001|Overall Study|Physician Decision|0|||
131447408|NCT03312634|473268710|FG000|Overall Study|Other|13|||
131447409|NCT03312634|473268711|FG001|Overall Study|Other|0|||
131447410|NCT01399372|473268716|FG000|Overall Study|Protocol Violation|3|||
131447411|NCT01399372|473268717|FG001|Overall Study|Protocol Violation|1|||
131447412|NCT00463567|473268720|FG000|Overall Study|Adverse Event|29|||
131447413|NCT00463567|473268721|FG001|Overall Study|Adverse Event|26|||
131447414|NCT00463567|473268722|FG002|Overall Study|Adverse Event|17|||
131447415|NCT00463567|473268723|FG003|Overall Study|Adverse Event|46|||
131447416|NCT00463567|473268724|FG004|Overall Study|Adverse Event|10|||
131447417|NCT00463567|473268725|FG005|Overall Study|Adverse Event|10|||
131447418|NCT00463567|473268726|FG006|Overall Study|Adverse Event|4|||
131447419|NCT00463567|473268720|FG000|Overall Study|Withdrawal by Subject|29|||
131447420|NCT00463567|473268721|FG001|Overall Study|Withdrawal by Subject|22|||
131447421|NCT00463567|473268722|FG002|Overall Study|Withdrawal by Subject|20|||
131447422|NCT00463567|473268723|FG003|Overall Study|Withdrawal by Subject|37|||
131447423|NCT00463567|473268724|FG004|Overall Study|Withdrawal by Subject|6|||
131646257|NCT01296555|473991115|FG000|Overall Study|Withdrawal by Subject|0|||
131646258|NCT01296555|473991116|FG001|Overall Study|Withdrawal by Subject|0|||
131646259|NCT01296555|473991117|FG002|Overall Study|Withdrawal by Subject|0|||
131646260|NCT01296555|473991118|FG003|Overall Study|Withdrawal by Subject|0|||
131646261|NCT01296555|473991119|FG004|Overall Study|Withdrawal by Subject|1|||
131646262|NCT01296555|473991120|FG005|Overall Study|Withdrawal by Subject|0|||
131646263|NCT01296555|473991121|FG006|Overall Study|Withdrawal by Subject|1|||
131646264|NCT01296555|473991122|FG007|Overall Study|Withdrawal by Subject|0|||
131646265|NCT01296555|473991123|FG008|Overall Study|Withdrawal by Subject|0|||
131646266|NCT01296555|473991124|FG009|Overall Study|Withdrawal by Subject|0|||
131715513|NCT02582658|474235537|FG000|Overall Study|Failure to Return|10|||
131715514|NCT02582658|474235537|FG000|Overall Study|Insufficient Virological Response|2|||
131715515|NCT02582658|474235537|FG000|Overall Study|Withdrawn Consent|1|||
131715516|NCT02582658|474235537|FG000|Overall Study|Death|1|||
131715517|NCT02582658|474235537|FG000|Overall Study|Not further specified|11|||
131715518|NCT01024244|474236905|FG000|Overall Study|Adverse Event|1|||
131715519|NCT01024244|474236906|FG001|Overall Study|Adverse Event|2|||
131715520|NCT01024244|474236907|FG002|Overall Study|Adverse Event|0|||
131715521|NCT01024244|474236908|FG003|Overall Study|Adverse Event|1|||
131715522|NCT01024244|474236909|FG004|Overall Study|Adverse Event|2|||
131715523|NCT01024244|474236905|FG000|Overall Study|Entry Criteria Not Met|0|||
131715524|NCT01024244|474236906|FG001|Overall Study|Entry Criteria Not Met|1|||
131802101|NCT03629249|474559177|FG000|Overall Study|Death|1|||
131802102|NCT03629249|474559178|FG001|Overall Study|Death|0|||
131646267|NCT01296555|473991125|FG010|Overall Study|Withdrawal by Subject|1|||
131646268|NCT01296555|473991126|FG011|Overall Study|Withdrawal by Subject|1|||
131646269|NCT01296555|473991127|FG012|Overall Study|Withdrawal by Subject|0|||
131646270|NCT01296555|473991128|FG013|Overall Study|Withdrawal by Subject|0|||
131646271|NCT01296555|473991129|FG014|Overall Study|Withdrawal by Subject|3|||
131646272|NCT01296555|473991130|FG015|Overall Study|Withdrawal by Subject|0|||
131646273|NCT01296555|473991131|FG016|Overall Study|Withdrawal by Subject|2|||
131646274|NCT01296555|473991132|FG017|Overall Study|Withdrawal by Subject|1|||
131646275|NCT01296555|473991133|FG018|Overall Study|Withdrawal by Subject|0|||
131646276|NCT01296555|473991134|FG019|Overall Study|Withdrawal by Subject|1|||
131646277|NCT01296555|473991135|FG020|Overall Study|Withdrawal by Subject|1|||
131646278|NCT01296555|473991136|FG021|Overall Study|Withdrawal by Subject|1|||
131646279|NCT01296555|473991137|FG022|Overall Study|Withdrawal by Subject|3|||
131646280|NCT01296555|473991138|FG023|Overall Study|Withdrawal by Subject|0|||
131646281|NCT01296555|473991139|FG024|Overall Study|Withdrawal by Subject|0|||
131646282|NCT01296555|473991140|FG025|Overall Study|Withdrawal by Subject|0|||
131646283|NCT01296555|473991141|FG026|Overall Study|Withdrawal by Subject|8|||
131646284|NCT01296555|473991142|FG027|Overall Study|Withdrawal by Subject|4|||
131646285|NCT01296555|473991143|FG028|Overall Study|Withdrawal by Subject|2|||
131646286|NCT01101061|473991144|FG000|Overall Study|Adverse Event|0|||
131646287|NCT01101061|473991145|FG001|Overall Study|Adverse Event|0|||
131646288|NCT01101061|473991146|FG002|Overall Study|Adverse Event|1|||
131646289|NCT01101061|473991147|FG003|Overall Study|Adverse Event|0|||
131646290|NCT01101061|473991148|FG004|Overall Study|Adverse Event|0|||
131646291|NCT01101061|473991149|FG005|Overall Study|Adverse Event|0|||
131646292|NCT03000348|473991150|FG000|Overall Study|Adverse Event|1|||
131646293|NCT03000348|473991151|FG001|Overall Study|Adverse Event|1|||
131646294|NCT03000348|473991152|FG002|Overall Study|Adverse Event|1|||
131646295|NCT03000348|473991153|FG003|Overall Study|Adverse Event|1|||
131646296|NCT03000348|473991154|FG004|Overall Study|Adverse Event|1|||
131646297|NCT03000348|473991155|FG005|Overall Study|Adverse Event|1|||
131646298|NCT03000348|473991150|FG000|Overall Study|Lost to Follow-up|0|||
131646299|NCT03000348|473991151|FG001|Overall Study|Lost to Follow-up|0|||
131646300|NCT03000348|473991152|FG002|Overall Study|Lost to Follow-up|1|||
131646301|NCT03000348|473991153|FG003|Overall Study|Lost to Follow-up|0|||
131646302|NCT03000348|473991154|FG004|Overall Study|Lost to Follow-up|0|||
131646303|NCT03000348|473991155|FG005|Overall Study|Lost to Follow-up|0|||
131646304|NCT03000348|473991150|FG000|Overall Study|Withdrawal by Subject|0|||
131646305|NCT03000348|473991151|FG001|Overall Study|Withdrawal by Subject|1|||
131646306|NCT03000348|473991152|FG002|Overall Study|Withdrawal by Subject|0|||
131646307|NCT03000348|473991153|FG003|Overall Study|Withdrawal by Subject|0|||
131646308|NCT03000348|473991154|FG004|Overall Study|Withdrawal by Subject|0|||
131646309|NCT03000348|473991155|FG005|Overall Study|Withdrawal by Subject|0|||
131646310|NCT03000348|473991150|FG000|Overall Study|Consent|0|||
131646311|NCT03000348|473991151|FG001|Overall Study|Consent|0|||
131646312|NCT03000348|473991152|FG002|Overall Study|Consent|0|||
131646313|NCT03000348|473991153|FG003|Overall Study|Consent|0|||
131646314|NCT03000348|473991154|FG004|Overall Study|Consent|1|||
131646315|NCT03000348|473991155|FG005|Overall Study|Consent|0|||
131802103|NCT03629249|474559179|FG002|Overall Study|Death|0|||
131646316|NCT03000348|473991150|FG000|Overall Study|Failure to expectorate sputum|1|||
131646317|NCT03000348|473991151|FG001|Overall Study|Failure to expectorate sputum|0|||
131646318|NCT03000348|473991152|FG002|Overall Study|Failure to expectorate sputum|1|||
131646319|NCT03000348|473991153|FG003|Overall Study|Failure to expectorate sputum|0|||
131646320|NCT03000348|473991154|FG004|Overall Study|Failure to expectorate sputum|1|||
131646321|NCT03000348|473991155|FG005|Overall Study|Failure to expectorate sputum|0|||
131646322|NCT03000348|473991150|FG000|Overall Study|No gram negative|1|||
131646323|NCT03000348|473991151|FG001|Overall Study|No gram negative|2|||
131646324|NCT03000348|473991152|FG002|Overall Study|No gram negative|1|||
131646325|NCT03000348|473991153|FG003|Overall Study|No gram negative|1|||
131646326|NCT03000348|473991154|FG004|Overall Study|No gram negative|1|||
131646327|NCT03000348|473991155|FG005|Overall Study|No gram negative|1|||
131646328|NCT03000348|473991150|FG000|Overall Study|Patient had no transport|0|||
131646329|NCT03000348|473991151|FG001|Overall Study|Patient had no transport|0|||
131646330|NCT03000348|473991152|FG002|Overall Study|Patient had no transport|0|||
131646331|NCT03000348|473991153|FG003|Overall Study|Patient had no transport|1|||
131646332|NCT03000348|473991154|FG004|Overall Study|Patient had no transport|0|||
131646333|NCT03000348|473991155|FG005|Overall Study|Patient had no transport|0|||
131646334|NCT03000348|473991150|FG000|Overall Study|Dosing|0|||
131646335|NCT03000348|473991151|FG001|Overall Study|Dosing|0|||
131646336|NCT03000348|473991152|FG002|Overall Study|Dosing|0|||
131646337|NCT03000348|473991153|FG003|Overall Study|Dosing|0|||
131646338|NCT03000348|473991154|FG004|Overall Study|Dosing|1|||
131646339|NCT03000348|473991155|FG005|Overall Study|Dosing|0|||
131646340|NCT00745498|473991157|FG000|Overall Study|Lost to Follow-up|1|||
131646341|NCT00745498|473991158|FG001|Overall Study|Lost to Follow-up|1|||
131802104|NCT03629249|474559177|FG000|Overall Study|Physician Decision|1|||
131802105|NCT03629249|474559178|FG001|Overall Study|Physician Decision|0|||
131802106|NCT03629249|474559179|FG002|Overall Study|Physician Decision|0|||
131802107|NCT00352690|474559180|FG000|Overall Study|Determined to be ineligible|2|||
131802108|NCT00352690|474559181|FG001|Overall Study|Determined to be ineligible|0|||
131802109|NCT02719522|474559188|FG000|Overall Study|Implant Failure|4|||
131802110|NCT02719522|474559188|FG000|Overall Study|Death|2|||
131802111|NCT02719522|474559188|FG000|Overall Study|Lost to Follow-up|5|||
131802112|NCT01030965|474559190|FG000|Overall Study|Lack of Efficacy|3|||
131802113|NCT01030965|474559191|FG001|Overall Study|Lack of Efficacy|2|||
131802114|NCT01030965|474559192|FG002|Overall Study|Lack of Efficacy|0|||
131802115|NCT01030965|474559193|FG003|Overall Study|Lack of Efficacy|3|||
131802116|NCT01030965|474559190|FG000|Overall Study|Protocol Violation|1|||
131802117|NCT01030965|474559191|FG001|Overall Study|Protocol Violation|1|||
131802118|NCT01030965|474559192|FG002|Overall Study|Protocol Violation|1|||
131802119|NCT01030965|474559193|FG003|Overall Study|Protocol Violation|1|||
131802120|NCT01030965|474559190|FG000|Overall Study|Adverse Event|0|||
131802121|NCT01030965|474559191|FG001|Overall Study|Adverse Event|1|||
131802122|NCT01030965|474559192|FG002|Overall Study|Adverse Event|2|||
131802123|NCT01030965|474559193|FG003|Overall Study|Adverse Event|1|||
131802124|NCT01030965|474559190|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
131802125|NCT01030965|474559191|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
131802126|NCT01030965|474559192|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
131802127|NCT01030965|474559193|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
131802128|NCT01030965|474559190|FG000|Overall Study|Withdrawal by Subject|0|||
131802129|NCT01030965|474559191|FG001|Overall Study|Withdrawal by Subject|1|||
131802130|NCT01030965|474559192|FG002|Overall Study|Withdrawal by Subject|0|||
131802131|NCT01030965|474559193|FG003|Overall Study|Withdrawal by Subject|2|||
131802132|NCT02097290|474559194|FG000|Overall Study|Death|6|||
131802133|NCT02097290|474559194|FG000|Overall Study|Total Withdrawals|3|||
131802134|NCT02097290|474559194|FG000|Overall Study|Attempt|8|||
131802135|NCT05277389|474559195|FG000|Overall Study|Lost to Follow-up|1|||
131802136|NCT05277389|474559196|FG001|Overall Study|Lost to Follow-up|4|||
131802137|NCT06096168|474559197|FG000|Overall Study|Death|30|||
131802138|NCT06096168|474559197|FG000|Overall Study|Revision|2|||
131802139|NCT01411332|474559202|FG000|Enrollment|Protocol Violation|0|||
131802140|NCT01411332|474559203|FG001|Enrollment|Protocol Violation|1|||
131802141|NCT01411332|474559202|FG000|Enrollment|Withdrawal by Subject|0|||
131802142|NCT01411332|474559203|FG001|Enrollment|Withdrawal by Subject|1|||
131802143|NCT01411332|474559202|FG000|Treatment|Lost to Follow-up|1|||
131447424|NCT00463567|473268725|FG005|Overall Study|Withdrawal by Subject|5|||
131447425|NCT00463567|473268726|FG006|Overall Study|Withdrawal by Subject|1|||
131646342|NCT00745498|473991159|FG002|Overall Study|Lost to Follow-up|3|||
131646343|NCT00745498|473991157|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
131646344|NCT00745498|473991158|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
131646345|NCT00745498|473991159|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
131646346|NCT00745498|473991157|FG000|Overall Study|Non-PDR related VH|0|||
131646347|NCT00745498|473991158|FG001|Overall Study|Non-PDR related VH|1|||
131646348|NCT00745498|473991159|FG002|Overall Study|Non-PDR related VH|1|||
131646349|NCT00745498|473991157|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
131646350|NCT00745498|473991158|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
131646351|NCT00745498|473991159|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
131646352|NCT00778921|473991160|FG000|Overall Study|Adverse Event|9|||
131646353|NCT00778921|473991161|FG001|Overall Study|Adverse Event|10|||
131646354|NCT00778921|473991162|FG002|Overall Study|Adverse Event|14|||
131646355|NCT00778921|473991160|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
131646356|NCT00778921|473991161|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
131646357|NCT00778921|473991162|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131646358|NCT00778921|473991160|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
131646359|NCT00778921|473991161|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
131802144|NCT01411332|474559203|FG001|Treatment|Lost to Follow-up|0|||
131903143|NCT01435759|474931415|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131903144|NCT01435759|474931416|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131646360|NCT00778921|473991162|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
131802145|NCT02170688|474559204|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
131802146|NCT02170688|474559205|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
131903145|NCT01435759|474931417|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131802147|NCT02170688|474559206|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
131802148|NCT02170688|474559207|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
131903146|NCT01435759|474931418|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131646361|NCT00778921|473991160|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
131646362|NCT00778921|473991161|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
131646363|NCT00778921|473991162|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
131802149|NCT02170688|474559208|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
131802150|NCT02170688|474559204|FG000|Overall Study|Full dose not received|0|||
131802151|NCT02170688|474559205|FG001|Overall Study|Full dose not received|1|||
131802152|NCT02170688|474559206|FG002|Overall Study|Full dose not received|0|||
131646364|NCT00778921|473991160|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
131646365|NCT00778921|473991161|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
131646366|NCT00778921|473991162|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
131646367|NCT00778921|473991160|FG000|Overall Study|Patient withdrew request|3|||
131646368|NCT00778921|473991161|FG001|Overall Study|Patient withdrew request|1|||
131646369|NCT00778921|473991162|FG002|Overall Study|Patient withdrew request|6|||
131646370|NCT00778921|473991160|FG000|Overall Study|Lost to Follow-up|0|||
131646371|NCT00778921|473991161|FG001|Overall Study|Lost to Follow-up|2|||
131646372|NCT00778921|473991162|FG002|Overall Study|Lost to Follow-up|1|||
131646373|NCT00778921|473991160|FG000|Overall Study|Administrative Problems|1|||
131646374|NCT00778921|473991161|FG001|Overall Study|Administrative Problems|2|||
131646375|NCT00778921|473991162|FG002|Overall Study|Administrative Problems|0|||
131646376|NCT00778921|473991160|FG000|Overall Study|Protocol Violation|3|||
131646377|NCT00778921|473991161|FG001|Overall Study|Protocol Violation|0|||
131646378|NCT00778921|473991162|FG002|Overall Study|Protocol Violation|2|||
131646379|NCT00778921|473991160|FG000|Overall Study|Not treated|0|||
131646380|NCT00778921|473991161|FG001|Overall Study|Not treated|2|||
131646381|NCT00778921|473991162|FG002|Overall Study|Not treated|2|||
131646382|NCT04805073|473991163|FG000|Overall Study|study personnel not available|2|||
131646383|NCT04805073|473991164|FG001|Overall Study|study personnel not available|0|||
131646384|NCT04805073|473991163|FG000|Overall Study|spinal anesthesia failure|0|||
131646385|NCT04805073|473991164|FG001|Overall Study|spinal anesthesia failure|1|||
131646386|NCT04805073|473991163|FG000|Overall Study|Lost to Follow-up|0|||
131646387|NCT04805073|473991164|FG001|Overall Study|Lost to Follow-up|2|||
131646388|NCT01163474|473991165|FG000|Overall Study|Withdrawal by Subject|1|||
131646389|NCT01163474|473991165|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
131646390|NCT01163474|473991165|FG000|Overall Study|Lost to Follow-up|3|||
131646391|NCT01078922|473991174|FG000|Overall Study|Adverse Event|1|||
131646392|NCT02706847|473991177|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
131646393|NCT02706847|473991178|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
131646394|NCT02706847|473991179|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
131646395|NCT02706847|473991180|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
131646396|NCT02706847|473991177|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
131646397|NCT02706847|473991178|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
131646398|NCT02706847|473991179|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
131646399|NCT02706847|473991180|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
131646400|NCT02706847|473991177|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
131646401|NCT02706847|473991178|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
131646402|NCT02706847|473991179|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
131646403|NCT02706847|473991180|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
131646404|NCT02706847|473991177|FG000|Period 1: Day 1 to Week 12|Other|4|||
131646405|NCT02706847|473991178|FG001|Period 1: Day 1 to Week 12|Other|4|||
131646406|NCT02706847|473991179|FG002|Period 1: Day 1 to Week 12|Other|2|||
131646407|NCT02706847|473991180|FG003|Period 1: Day 1 to Week 12|Other|2|||
131646408|NCT02706847|473991177|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
131646409|NCT02706847|473991178|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
131646410|NCT02706847|473991179|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
131646411|NCT02706847|473991180|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
131646412|NCT02706847|473991177|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
131646413|NCT02706847|473991178|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
131646414|NCT02706847|473991179|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
131646415|NCT02706847|473991180|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
131646416|NCT02706847|473991177|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
131646417|NCT02706847|473991178|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
131646418|NCT02706847|473991179|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
131646419|NCT02706847|473991180|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
131646420|NCT02706847|473991177|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
131802153|NCT02170688|474559207|FG003|Overall Study|Full dose not received|0|||
131802154|NCT02170688|474559208|FG004|Overall Study|Full dose not received|0|||
131802155|NCT02170688|474559204|FG000|Overall Study|Physician Decision|0|||
131646421|NCT02706847|473991178|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
131646422|NCT02706847|473991179|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
131646423|NCT02706847|473991180|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
131646424|NCT02706847|473991177|FG000|Period 1: Week 12 to Week 24|Other|1|||
131646425|NCT02706847|473991178|FG001|Period 1: Week 12 to Week 24|Other|0|||
131646426|NCT02706847|473991179|FG002|Period 1: Week 12 to Week 24|Other|1|||
131646427|NCT02706847|473991180|FG003|Period 1: Week 12 to Week 24|Other|4|||
131802156|NCT02170688|474559205|FG001|Overall Study|Physician Decision|0|||
131646428|NCT02706847|473991177|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
131646429|NCT02706847|473991178|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
131646430|NCT02706847|473991179|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
131646431|NCT02706847|473991180|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
131646432|NCT02706847|473991177|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
131802157|NCT02170688|474559206|FG002|Overall Study|Physician Decision|1|||
131802158|NCT02170688|474559207|FG003|Overall Study|Physician Decision|0|||
131802159|NCT02170688|474559208|FG004|Overall Study|Physician Decision|0|||
131802160|NCT01471522|474559212|FG000|Overall Study|Withdrawal by Subject|28|||
131802161|NCT01471522|474559213|FG001|Overall Study|Withdrawal by Subject|22|||
131802162|NCT01471522|474559212|FG000|Overall Study|Lost to Follow-up|36|||
131802163|NCT01471522|474559213|FG001|Overall Study|Lost to Follow-up|26|||
131802164|NCT00444145|474560552|FG000|Overall Study|Withdrawal by Subject|2|||
131802165|NCT00444145|474560552|FG000|Overall Study|Lost to Follow-up|1|||
131802166|NCT00444145|474560552|FG000|Overall Study|non-compliant|11|||
131802167|NCT00444145|474560552|FG000|Overall Study|Screen Failures|5|||
131802168|NCT03805438|474560553|FG000|Overall Study|Lack of Efficacy|1|||
131802169|NCT03805438|474560553|FG000|Overall Study|Protocol Violation|1|||
131802170|NCT00366899|474560554|FG000|Infant Series|Withdrawal by Subject|4|||
131802171|NCT00366899|474560555|FG001|Infant Series|Withdrawal by Subject|7|||
131802172|NCT00366899|474560554|FG000|Infant Series|Protocol Violation|2|||
131802173|NCT00366899|474560555|FG001|Infant Series|Protocol Violation|1|||
131802174|NCT00366899|474560554|FG000|Infant Series|Failed to return|1|||
131802175|NCT00366899|474560555|FG001|Infant Series|Failed to return|1|||
131802176|NCT00366899|474560554|FG000|Infant Series|Lost to Follow-up|0|||
131802177|NCT00366899|474560555|FG001|Infant Series|Lost to Follow-up|2|||
131802178|NCT00366899|474560554|FG000|Infant Series|Adverse Event|0|||
131802179|NCT00366899|474560555|FG001|Infant Series|Adverse Event|1|||
131802180|NCT00366899|474560554|FG000|Infant Series|Physician Decision|1|||
131802181|NCT00366899|474560555|FG001|Infant Series|Physician Decision|0|||
131802182|NCT00366899|474560554|FG000|Infant Series|Randomized but not consented|1|||
131802183|NCT00366899|474560555|FG001|Infant Series|Randomized but not consented|0|||
131802184|NCT00366899|474560554|FG000|After Infant Series|Lost to Follow-up|4|||
131802185|NCT00366899|474560555|FG001|After Infant Series|Lost to Follow-up|3|||
131802186|NCT00366899|474560554|FG000|After Infant Series|Withdrawal by Subject|1|||
131802187|NCT00366899|474560555|FG001|After Infant Series|Withdrawal by Subject|4|||
131802188|NCT00366899|474560554|FG000|After Infant Series|Adverse Event|1|||
131903147|NCT01435759|474931413|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
131903148|NCT01435759|474931414|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131646433|NCT02706847|473991178|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
131646434|NCT02706847|473991179|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
131646435|NCT02706847|473991180|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
131646436|NCT02706847|473991177|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
131646437|NCT02706847|473991178|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
131646438|NCT02706847|473991179|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
131646439|NCT02706847|473991180|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
131646440|NCT02706847|473991177|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
131646441|NCT02706847|473991178|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
131646442|NCT02706847|473991179|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
131646443|NCT02706847|473991180|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
131646444|NCT02706847|473991177|FG000|Period 2: Week 24 to Week 260|Other|8|||
131646445|NCT02706847|473991178|FG001|Period 2: Week 24 to Week 260|Other|5|||
131646446|NCT02706847|473991179|FG002|Period 2: Week 24 to Week 260|Other|15|||
131646447|NCT02706847|473991180|FG003|Period 2: Week 24 to Week 260|Other|15|||
131646448|NCT01174264|473991183|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
131646449|NCT01174264|473991184|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
131646450|NCT01174264|473991185|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
131646451|NCT01174264|473991183|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
131646452|NCT01174264|473991184|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
131646453|NCT01174264|473991185|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
131646454|NCT01174264|473991183|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
131646455|NCT01174264|473991184|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
131646456|NCT01174264|473991185|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
131646457|NCT02031536|473991188|FG000|Overall Study|ineligible|1|||
131646458|NCT02031536|473991189|FG001|Overall Study|ineligible|0|||
131646459|NCT02353871|473991190|FG000|Overall Study|Protocol deviation|0|||
131646460|NCT02353871|473991191|FG001|Overall Study|Protocol deviation|1|||
131646461|NCT02353871|473991190|FG000|Overall Study|Consent withdrawn|1|||
131646462|NCT02353871|473991191|FG001|Overall Study|Consent withdrawn|8|||
131646463|NCT02353871|473991190|FG000|Overall Study|Lost to Follow-up|2|||
131646464|NCT02353871|473991191|FG001|Overall Study|Lost to Follow-up|0|||
131802189|NCT00366899|474560555|FG001|After Infant Series|Adverse Event|2|||
131802190|NCT00366899|474560554|FG000|After Infant Series|Protocol Violation|1|||
131903149|NCT01435759|474931415|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131802191|NCT00366899|474560555|FG001|After Infant Series|Protocol Violation|0|||
131802192|NCT00366899|474560554|FG000|Toddler Dose|Withdrawal by Subject|1|||
131802193|NCT00366899|474560555|FG001|Toddler Dose|Withdrawal by Subject|1|||
131802194|NCT00366899|474560554|FG000|Toddler Dose|Protocol Violation|1|||
131802195|NCT00366899|474560555|FG001|Toddler Dose|Protocol Violation|0|||
131802196|NCT00630305|474560556|FG000|Overall Study|Withdrawal by Subject|1|||
131802197|NCT00630305|474560556|FG000|Overall Study|Inability to insert contact lens|1|||
131802198|NCT01494506|474560557|FG000|Overall Study|Lack of Efficacy|77|||
131802199|NCT01494506|474560558|FG001|Overall Study|Lack of Efficacy|83|||
131802200|NCT01494506|474560559|FG002|Overall Study|Lack of Efficacy|57|||
131802201|NCT01494506|474560557|FG000|Overall Study|Adverse Event|17|||
131802202|NCT01494506|474560558|FG001|Overall Study|Adverse Event|10|||
131646465|NCT00115336|473991192|FG000|Overall Study|Hospital discharge before study drug|0|||
131646466|NCT00115336|473991193|FG001|Overall Study|Hospital discharge before study drug|1|||
131646467|NCT01191008|473991209|FG000|Overall Study|Protocol Violation|7|||
131646468|NCT01191008|473991209|FG000|Overall Study|Lost to Follow-up|8|||
131646469|NCT04905849|473991212|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
131646470|NCT04905849|473991213|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
131646471|NCT04913948|473991221|FG000|Overall Study|Withdrawal by Subject|2|||
131646472|NCT04913948|473991221|FG000|Overall Study|Sample processing issues|1|||
131646473|NCT04913948|473991221|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
131646474|NCT04199052|473991222|FG000|Overall Study|Lost to Follow-up|11|||
131646475|NCT04199052|473991223|FG001|Overall Study|Lost to Follow-up|18|||
131646476|NCT00699842|473991224|FG000|Overall Study|Death|0|||
131646477|NCT00699842|473991225|FG001|Overall Study|Death|1|||
131646478|NCT00699842|473991226|FG002|Overall Study|Death|0|||
131646479|NCT03522389|473991227|FG000|Overall Study|Lost to Follow-up|1|||
131646480|NCT03522389|473991228|FG001|Overall Study|Lost to Follow-up|1|||
131646481|NCT03522389|473991229|FG002|Overall Study|Lost to Follow-up|2|||
131646482|NCT03522389|473991227|FG000|Overall Study|had herniated nucleus pulposus|0|||
131646483|NCT03522389|473991228|FG001|Overall Study|had herniated nucleus pulposus|1|||
131646484|NCT03522389|473991229|FG002|Overall Study|had herniated nucleus pulposus|0|||
131646485|NCT03522389|473991227|FG000|Overall Study|go to work in other province|1|||
131646486|NCT03522389|473991228|FG001|Overall Study|go to work in other province|0|||
131646487|NCT03522389|473991229|FG002|Overall Study|go to work in other province|0|||
131646488|NCT04750577|473991230|FG000|Overall Study|Adverse Event|2|||
131646489|NCT04750577|473991231|FG001|Overall Study|Adverse Event|10|||
131646490|NCT04750577|473991232|FG002|Overall Study|Adverse Event|8|||
131646491|NCT04750577|473991233|FG003|Overall Study|Adverse Event|1|||
131646492|NCT04750577|473991230|FG000|Overall Study|Change of residence|0|||
131646493|NCT04750577|473991231|FG001|Overall Study|Change of residence|0|||
131646494|NCT04750577|473991232|FG002|Overall Study|Change of residence|1|||
131646495|NCT04750577|473991233|FG003|Overall Study|Change of residence|0|||
131646496|NCT04750577|473991230|FG000|Overall Study|Burden of study procedures|0|||
131646497|NCT04750577|473991231|FG001|Overall Study|Burden of study procedures|2|||
131646498|NCT04750577|473991232|FG002|Overall Study|Burden of study procedures|2|||
131646499|NCT04750577|473991233|FG003|Overall Study|Burden of study procedures|0|||
131646500|NCT04750577|473991230|FG000|Overall Study|Prematurely discontinued|0|||
131646501|NCT04750577|473991231|FG001|Overall Study|Prematurely discontinued|0|||
131646502|NCT04750577|473991232|FG002|Overall Study|Prematurely discontinued|0|||
131646503|NCT04750577|473991233|FG003|Overall Study|Prematurely discontinued|2|||
131646504|NCT04750577|473991230|FG000|Overall Study|Protocol deviation|1|||
131646505|NCT04750577|473991231|FG001|Overall Study|Protocol deviation|1|||
131646506|NCT04750577|473991232|FG002|Overall Study|Protocol deviation|1|||
131646507|NCT04750577|473991233|FG003|Overall Study|Protocol deviation|1|||
131646508|NCT04750577|473991230|FG000|Overall Study|Other than listed|3|||
131646509|NCT04750577|473991231|FG001|Overall Study|Other than listed|2|||
131646510|NCT04750577|473991232|FG002|Overall Study|Other than listed|2|||
131646511|NCT04750577|473991233|FG003|Overall Study|Other than listed|1|||
131646512|NCT04750577|473991230|FG000|Overall Study|Not treated|0|||
131646513|NCT04750577|473991231|FG001|Overall Study|Not treated|0|||
131646514|NCT04750577|473991232|FG002|Overall Study|Not treated|0|||
131646515|NCT04750577|473991233|FG003|Overall Study|Not treated|2|||
131646516|NCT04599907|473991236|FG000|Overall Study|Withdrawal by Subject|1|||
131646517|NCT04599907|473991237|FG001|Overall Study|Withdrawal by Subject|7|||
131646518|NCT04599907|473991238|FG002|Overall Study|Withdrawal by Subject|6|||
131646519|NCT04599907|473991236|FG000|Overall Study|Lost to Follow-up|0|||
131646520|NCT04599907|473991237|FG001|Overall Study|Lost to Follow-up|1|||
131646521|NCT04599907|473991238|FG002|Overall Study|Lost to Follow-up|0|||
131646522|NCT01466790|473991240|FG000|Overall Study|Adverse Event|1|||
131646523|NCT01466790|473991241|FG001|Overall Study|Adverse Event|0|||
131646524|NCT01466790|473991242|FG002|Overall Study|Adverse Event|0|||
131646525|NCT01466790|473991243|FG003|Overall Study|Adverse Event|0|||
131802203|NCT01494506|474560559|FG002|Overall Study|Adverse Event|11|||
131802204|NCT01494506|474560557|FG000|Overall Study|Death|9|||
131646526|NCT01466790|473991244|FG004|Overall Study|Adverse Event|2|||
131646527|NCT01466790|473991245|FG005|Overall Study|Adverse Event|0|||
131646528|NCT01466790|473991246|FG006|Overall Study|Adverse Event|0|||
131646529|NCT01466790|473991247|FG007|Overall Study|Adverse Event|0|||
131646530|NCT01466790|473991240|FG000|Overall Study|Lost to Follow-up|2|||
131802205|NCT01494506|474560558|FG001|Overall Study|Death|5|||
131802206|NCT01494506|474560559|FG002|Overall Study|Death|2|||
131646531|NCT01466790|473991241|FG001|Overall Study|Lost to Follow-up|0|||
131447426|NCT00463567|473268720|FG000|Overall Study|Protocol Deviation|13|||
131447427|NCT00463567|473268721|FG001|Overall Study|Protocol Deviation|9|||
131447428|NCT00463567|473268722|FG002|Overall Study|Protocol Deviation|14|||
131447429|NCT00463567|473268723|FG003|Overall Study|Protocol Deviation|11|||
131447430|NCT00463567|473268724|FG004|Overall Study|Protocol Deviation|1|||
131447431|NCT00463567|473268725|FG005|Overall Study|Protocol Deviation|1|||
131802207|NCT01494506|474560557|FG000|Overall Study|Physician Decision|7|||
131447432|NCT00463567|473268726|FG006|Overall Study|Protocol Deviation|2|||
131447433|NCT00463567|473268720|FG000|Overall Study|Lost to Follow-up|12|||
131447434|NCT00463567|473268721|FG001|Overall Study|Lost to Follow-up|6|||
131447435|NCT00463567|473268722|FG002|Overall Study|Lost to Follow-up|13|||
131447436|NCT00463567|473268723|FG003|Overall Study|Lost to Follow-up|8|||
131447437|NCT00463567|473268724|FG004|Overall Study|Lost to Follow-up|1|||
131447438|NCT00463567|473268725|FG005|Overall Study|Lost to Follow-up|1|||
131447439|NCT00463567|473268726|FG006|Overall Study|Lost to Follow-up|1|||
131447440|NCT00463567|473268720|FG000|Overall Study|Administrative problems|5|||
131447441|NCT00463567|473268721|FG001|Overall Study|Administrative problems|3|||
131447442|NCT00463567|473268722|FG002|Overall Study|Administrative problems|6|||
131447443|NCT00463567|473268723|FG003|Overall Study|Administrative problems|9|||
131447444|NCT00463567|473268724|FG004|Overall Study|Administrative problems|3|||
131447445|NCT00463567|473268725|FG005|Overall Study|Administrative problems|2|||
131447446|NCT00463567|473268726|FG006|Overall Study|Administrative problems|2|||
131447447|NCT00463567|473268720|FG000|Overall Study|Lack of Efficacy|4|||
131447448|NCT00463567|473268721|FG001|Overall Study|Lack of Efficacy|9|||
131447449|NCT00463567|473268722|FG002|Overall Study|Lack of Efficacy|9|||
131447450|NCT00463567|473268723|FG003|Overall Study|Lack of Efficacy|17|||
131447451|NCT00463567|473268724|FG004|Overall Study|Lack of Efficacy|1|||
131447452|NCT00463567|473268725|FG005|Overall Study|Lack of Efficacy|0|||
131447453|NCT00463567|473268726|FG006|Overall Study|Lack of Efficacy|1|||
131447454|NCT00463567|473268720|FG000|Overall Study|Abnormal lab value(s)|1|||
131447455|NCT00463567|473268721|FG001|Overall Study|Abnormal lab value(s)|1|||
131447456|NCT00463567|473268722|FG002|Overall Study|Abnormal lab value(s)|2|||
131447457|NCT00463567|473268723|FG003|Overall Study|Abnormal lab value(s)|1|||
131447458|NCT00463567|473268724|FG004|Overall Study|Abnormal lab value(s)|1|||
131447459|NCT00463567|473268725|FG005|Overall Study|Abnormal lab value(s)|0|||
131447460|NCT00463567|473268726|FG006|Overall Study|Abnormal lab value(s)|0|||
131447461|NCT00463567|473268720|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131802208|NCT01494506|474560558|FG001|Overall Study|Physician Decision|5|||
131802209|NCT01494506|474560559|FG002|Overall Study|Physician Decision|4|||
131802210|NCT01494506|474560557|FG000|Overall Study|Withdrawal by Subject|17|||
131802211|NCT01494506|474560558|FG001|Overall Study|Withdrawal by Subject|20|||
131802212|NCT01494506|474560559|FG002|Overall Study|Withdrawal by Subject|14|||
131802213|NCT01494506|474560557|FG000|Overall Study|Clinical Deterioration|21|||
131802214|NCT01494506|474560558|FG001|Overall Study|Clinical Deterioration|17|||
131802215|NCT01494506|474560559|FG002|Overall Study|Clinical Deterioration|13|||
131802216|NCT01494506|474560557|FG000|Overall Study|Sponsor Decision|0|||
131802217|NCT01494506|474560558|FG001|Overall Study|Sponsor Decision|0|||
131802218|NCT01494506|474560559|FG002|Overall Study|Sponsor Decision|1|||
131802219|NCT01494506|474560557|FG000|Overall Study|Other|0|||
131802220|NCT01494506|474560558|FG001|Overall Study|Other|3|||
131802221|NCT01494506|474560559|FG002|Overall Study|Other|1|||
131802222|NCT02473640|474560568|FG000|Treatment Period 1|Adverse Event|1|||
131802223|NCT02395822|474560571|FG000|Overall Study|Withdrawal by Subject|1|||
131802224|NCT02395822|474560571|FG000|Overall Study|Death|1|||
131802225|NCT02777528|474560572|FG000|Overall Study|Still in study|24|||
131802226|NCT02777528|474560573|FG001|Overall Study|Still in study|10|||
131802227|NCT02777528|474560574|FG002|Overall Study|Still in study|1|||
131802228|NCT02777528|474560572|FG000|Overall Study|Study Device Explanted|1|||
131802229|NCT02777528|474560573|FG001|Overall Study|Study Device Explanted|0|||
131802230|NCT02777528|474560574|FG002|Overall Study|Study Device Explanted|0|||
131802231|NCT02777528|474560572|FG000|Overall Study|Death|14|||
131447462|NCT00463567|473268721|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131447463|NCT00463567|473268722|FG002|Overall Study|Abnormal test procedure result(s)|6|||
131802232|NCT02777528|474560573|FG001|Overall Study|Death|7|||
131802233|NCT02777528|474560574|FG002|Overall Study|Death|1|||
131447464|NCT00463567|473268723|FG003|Overall Study|Abnormal test procedure result(s)|2|||
131447465|NCT00463567|473268724|FG004|Overall Study|Abnormal test procedure result(s)|0|||
131802234|NCT02777528|474560572|FG000|Overall Study|Withdrawal by Subject|2|||
131802235|NCT02777528|474560573|FG001|Overall Study|Withdrawal by Subject|2|||
131802236|NCT02777528|474560574|FG002|Overall Study|Withdrawal by Subject|1|||
131802237|NCT02777528|474560572|FG000|Overall Study|Physician Decision|2|||
131802238|NCT02777528|474560573|FG001|Overall Study|Physician Decision|1|||
131447466|NCT00463567|473268725|FG005|Overall Study|Abnormal test procedure result(s)|2|||
131447467|NCT00463567|473268726|FG006|Overall Study|Abnormal test procedure result(s)|0|||
131447468|NCT00463567|473268720|FG000|Overall Study|Death|1|||
131447469|NCT00463567|473268721|FG001|Overall Study|Death|0|||
131802239|NCT02777528|474560574|FG002|Overall Study|Physician Decision|0|||
131802240|NCT02777528|474560572|FG000|Overall Study|Lost to Follow-up|2|||
131802241|NCT02777528|474560573|FG001|Overall Study|Lost to Follow-up|0|||
131802242|NCT02777528|474560574|FG002|Overall Study|Lost to Follow-up|0|||
131802243|NCT02777528|474560572|FG000|Overall Study|Discontinued due to Other|1|||
131802244|NCT02777528|474560573|FG001|Overall Study|Discontinued due to Other|0|||
131802245|NCT02777528|474560574|FG002|Overall Study|Discontinued due to Other|0|||
131802246|NCT02937701|474560575|FG000|Day 1 to Week 22|Adverse Event|11|||
131802247|NCT02937701|474560576|FG001|Day 1 to Week 22|Adverse Event|14|||
131802248|NCT02937701|474560577|FG002|Day 1 to Week 22|Adverse Event|0|||
131802249|NCT02937701|474560578|FG003|Day 1 to Week 22|Adverse Event|0|||
131802250|NCT02937701|474560579|FG004|Day 1 to Week 22|Adverse Event|0|||
131802251|NCT02937701|474560575|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
131802252|NCT02937701|474560576|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
131802253|NCT02937701|474560577|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
131802254|NCT02937701|474560578|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
131802255|NCT02937701|474560579|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
131802256|NCT02937701|474560575|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
131802257|NCT02937701|474560576|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
131802258|NCT02937701|474560577|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
131802259|NCT02937701|474560578|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
131802260|NCT02937701|474560579|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
131802261|NCT02937701|474560575|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
131802262|NCT02937701|474560576|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
131802263|NCT02937701|474560577|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
131802264|NCT02937701|474560578|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
131802265|NCT02937701|474560579|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
131802266|NCT02937701|474560575|FG000|Day 1 to Week 22|Death|1|||
131802267|NCT02937701|474560576|FG001|Day 1 to Week 22|Death|1|||
131802268|NCT02937701|474560577|FG002|Day 1 to Week 22|Death|0|||
131802269|NCT02937701|474560578|FG003|Day 1 to Week 22|Death|0|||
131802270|NCT02937701|474560579|FG004|Day 1 to Week 22|Death|0|||
131802271|NCT02937701|474560575|FG000|Day 1 to Week 22|Protocol Violation|1|||
131802272|NCT02937701|474560576|FG001|Day 1 to Week 22|Protocol Violation|1|||
131802273|NCT02937701|474560577|FG002|Day 1 to Week 22|Protocol Violation|0|||
131802274|NCT02937701|474560578|FG003|Day 1 to Week 22|Protocol Violation|0|||
131802275|NCT02937701|474560579|FG004|Day 1 to Week 22|Protocol Violation|0|||
131802276|NCT02937701|474560575|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
131802277|NCT02937701|474560576|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
131802278|NCT02937701|474560577|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
131802279|NCT02937701|474560578|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
131802280|NCT02937701|474560579|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
131802281|NCT02937701|474560575|FG000|Day 1 to Week 22|Physician Decision|2|||
131802282|NCT02937701|474560576|FG001|Day 1 to Week 22|Physician Decision|0|||
131802283|NCT02937701|474560577|FG002|Day 1 to Week 22|Physician Decision|0|||
131802284|NCT02937701|474560578|FG003|Day 1 to Week 22|Physician Decision|0|||
131802285|NCT02937701|474560579|FG004|Day 1 to Week 22|Physician Decision|0|||
131802286|NCT02937701|474560575|FG000|Day 1 to Week 22|Other|1|||
131802287|NCT02937701|474560576|FG001|Day 1 to Week 22|Other|0|||
131802288|NCT02937701|474560577|FG002|Day 1 to Week 22|Other|0|||
131802289|NCT02937701|474560578|FG003|Day 1 to Week 22|Other|0|||
131802290|NCT02937701|474560579|FG004|Day 1 to Week 22|Other|0|||
131802291|NCT02937701|474560575|FG000|Week 22 to Week 50|Adverse Event|0|||
131802292|NCT02937701|474560576|FG001|Week 22 to Week 50|Adverse Event|0|||
131802293|NCT02937701|474560577|FG002|Week 22 to Week 50|Adverse Event|10|||
131802294|NCT02937701|474560578|FG003|Week 22 to Week 50|Adverse Event|3|||
131802295|NCT02937701|474560579|FG004|Week 22 to Week 50|Adverse Event|3|||
131646532|NCT01466790|473991242|FG002|Overall Study|Lost to Follow-up|0|||
131646533|NCT01466790|473991243|FG003|Overall Study|Lost to Follow-up|0|||
131646534|NCT01466790|473991244|FG004|Overall Study|Lost to Follow-up|0|||
131646535|NCT01466790|473991245|FG005|Overall Study|Lost to Follow-up|0|||
131646536|NCT01466790|473991246|FG006|Overall Study|Lost to Follow-up|0|||
131646537|NCT01466790|473991247|FG007|Overall Study|Lost to Follow-up|0|||
131646538|NCT01466790|473991240|FG000|Overall Study|Withdrawal by Subject|1|||
131646539|NCT01466790|473991241|FG001|Overall Study|Withdrawal by Subject|1|||
131646540|NCT01466790|473991242|FG002|Overall Study|Withdrawal by Subject|0|||
131646541|NCT01466790|473991243|FG003|Overall Study|Withdrawal by Subject|0|||
131802296|NCT02937701|474560575|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
131802297|NCT02937701|474560576|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
131802298|NCT02937701|474560577|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
131802299|NCT02937701|474560578|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
131802300|NCT02937701|474560579|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
131802301|NCT02937701|474560575|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
131802302|NCT02937701|474560576|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
131802303|NCT02937701|474560577|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
131802304|NCT02937701|474560578|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
131646542|NCT01466790|473991244|FG004|Overall Study|Withdrawal by Subject|1|||
131646543|NCT01466790|473991245|FG005|Overall Study|Withdrawal by Subject|0|||
131646544|NCT01466790|473991246|FG006|Overall Study|Withdrawal by Subject|1|||
131646545|NCT01466790|473991247|FG007|Overall Study|Withdrawal by Subject|1|||
131646546|NCT01251887|473991248|FG000|Overall Study|Scheduling conflict|1|||
131802305|NCT02937701|474560579|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
131802306|NCT02937701|474560575|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
131802307|NCT02937701|474560576|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
131802308|NCT02937701|474560577|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
131802309|NCT02937701|474560578|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
131802310|NCT02937701|474560579|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
131802311|NCT02937701|474560575|FG000|Week 22 to Week 50|Physician Decision|0|||
131802312|NCT02937701|474560576|FG001|Week 22 to Week 50|Physician Decision|0|||
131802313|NCT02937701|474560577|FG002|Week 22 to Week 50|Physician Decision|2|||
131802314|NCT02937701|474560578|FG003|Week 22 to Week 50|Physician Decision|0|||
131802315|NCT02937701|474560579|FG004|Week 22 to Week 50|Physician Decision|1|||
131802316|NCT02937701|474560575|FG000|Week 22 to Week 50|Other|0|||
131802317|NCT02937701|474560576|FG001|Week 22 to Week 50|Other|0|||
131802318|NCT02937701|474560577|FG002|Week 22 to Week 50|Other|0|||
131802319|NCT02937701|474560578|FG003|Week 22 to Week 50|Other|0|||
131802320|NCT02937701|474560579|FG004|Week 22 to Week 50|Other|1|||
131802321|NCT04720664|474560580|FG000|Overall Study|Adverse Event|2|||
131802322|NCT04720664|474560580|FG000|Overall Study|Lack of Efficacy|9|||
131802323|NCT03952143|474560584|FG000|Lead-In Period|Adverse Event|2|||
131802324|NCT03952143|474560585|FG001|Lead-In Period|Adverse Event|0|||
131802325|NCT03952143|474560586|FG002|Lead-In Period|Adverse Event|0|||
131802326|NCT03952143|474560584|FG000|Lead-In Period|Lack of Efficacy|2|||
131802327|NCT03952143|474560585|FG001|Lead-In Period|Lack of Efficacy|0|||
131802328|NCT03952143|474560586|FG002|Lead-In Period|Lack of Efficacy|0|||
131802329|NCT03952143|474560584|FG000|Lead-In Period|Physician Decision|5|||
131802330|NCT03952143|474560585|FG001|Lead-In Period|Physician Decision|0|||
131802331|NCT03952143|474560586|FG002|Lead-In Period|Physician Decision|0|||
131802332|NCT03952143|474560584|FG000|Lead-In Period|Protocol Violation|5|||
131802333|NCT03952143|474560585|FG001|Lead-In Period|Protocol Violation|0|||
131802334|NCT03952143|474560586|FG002|Lead-In Period|Protocol Violation|0|||
131802335|NCT03952143|474560584|FG000|Lead-In Period|Withdrawal by Subject|19|||
131802336|NCT03952143|474560585|FG001|Lead-In Period|Withdrawal by Subject|0|||
131802337|NCT03952143|474560586|FG002|Lead-In Period|Withdrawal by Subject|0|||
131802338|NCT03952143|474560584|FG000|Treatment Period|Adverse Event|0|||
131802339|NCT03952143|474560585|FG001|Treatment Period|Adverse Event|0|||
131802340|NCT03952143|474560586|FG002|Treatment Period|Adverse Event|1|||
131802341|NCT03952143|474560584|FG000|Treatment Period|Lost to Follow-up|0|||
131903150|NCT01435759|474931416|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131903151|NCT01435759|474931417|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131903152|NCT01435759|474931418|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131802342|NCT03952143|474560585|FG001|Treatment Period|Lost to Follow-up|2|||
131802343|NCT03952143|474560586|FG002|Treatment Period|Lost to Follow-up|0|||
131802344|NCT03952143|474560584|FG000|Treatment Period|Physician Decision|0|||
131802345|NCT03952143|474560585|FG001|Treatment Period|Physician Decision|0|||
131802346|NCT03952143|474560586|FG002|Treatment Period|Physician Decision|2|||
131802347|NCT03952143|474560584|FG000|Treatment Period|Protocol Violation|0|||
131802348|NCT03952143|474560585|FG001|Treatment Period|Protocol Violation|0|||
131802349|NCT03952143|474560586|FG002|Treatment Period|Protocol Violation|1|||
131715525|NCT01024244|474236907|FG002|Overall Study|Entry Criteria Not Met|0|||
131715526|NCT01024244|474236908|FG003|Overall Study|Entry Criteria Not Met|0|||
131715527|NCT01024244|474236909|FG004|Overall Study|Entry Criteria Not Met|0|||
131715528|NCT01024244|474236905|FG000|Overall Study|Lack of Efficacy|1|||
131715529|NCT01024244|474236906|FG001|Overall Study|Lack of Efficacy|0|||
131715530|NCT01024244|474236907|FG002|Overall Study|Lack of Efficacy|0|||
131715531|NCT01024244|474236908|FG003|Overall Study|Lack of Efficacy|0|||
131715532|NCT01024244|474236909|FG004|Overall Study|Lack of Efficacy|0|||
131715533|NCT01024244|474236905|FG000|Overall Study|Protocol Violation|1|||
131715534|NCT01024244|474236906|FG001|Overall Study|Protocol Violation|0|||
131715535|NCT01024244|474236907|FG002|Overall Study|Protocol Violation|0|||
131715536|NCT01024244|474236908|FG003|Overall Study|Protocol Violation|0|||
131715537|NCT01024244|474236909|FG004|Overall Study|Protocol Violation|2|||
131715538|NCT01024244|474236905|FG000|Overall Study|Sponsor Decision|14|||
131715539|NCT01024244|474236906|FG001|Overall Study|Sponsor Decision|7|||
131903153|NCT01435759|474931413|FG000|Antidepressant Lead-in Phase|Other|119|||
131447470|NCT00463567|473268722|FG002|Overall Study|Death|2|||
131447471|NCT00463567|473268723|FG003|Overall Study|Death|0|||
131715540|NCT01024244|474236907|FG002|Overall Study|Sponsor Decision|14|||
131715541|NCT01024244|474236908|FG003|Overall Study|Sponsor Decision|12|||
131715542|NCT01024244|474236909|FG004|Overall Study|Sponsor Decision|10|||
131715543|NCT01024244|474236905|FG000|Overall Study|Withdrawal by Subject|0|||
131715544|NCT01024244|474236906|FG001|Overall Study|Withdrawal by Subject|1|||
131715545|NCT01024244|474236907|FG002|Overall Study|Withdrawal by Subject|0|||
131715546|NCT01024244|474236908|FG003|Overall Study|Withdrawal by Subject|0|||
131715547|NCT01024244|474236909|FG004|Overall Study|Withdrawal by Subject|0|||
131715548|NCT04645797|474236919|FG000|Overall Study|Disease Progression|3|||
131447472|NCT00463567|473268724|FG004|Overall Study|Death|0|||
131715549|NCT04645797|474236920|FG001|Overall Study|Disease Progression|3|||
131715550|NCT04645797|474236921|FG002|Overall Study|Disease Progression|1|||
131715551|NCT04645797|474236922|FG003|Overall Study|Disease Progression|0|||
131715552|NCT04645797|474236923|FG004|Overall Study|Disease Progression|0|||
131715553|NCT04645797|474236924|FG005|Overall Study|Disease Progression|0|||
131715554|NCT04645797|474236925|FG006|Overall Study|Disease Progression|0|||
131715555|NCT04645797|474236919|FG000|Overall Study|Death|3|||
131715556|NCT04645797|474236920|FG001|Overall Study|Death|1|||
131715557|NCT04645797|474236921|FG002|Overall Study|Death|0|||
131715558|NCT04645797|474236922|FG003|Overall Study|Death|0|||
131715559|NCT04645797|474236923|FG004|Overall Study|Death|0|||
131715560|NCT04645797|474236924|FG005|Overall Study|Death|0|||
131715561|NCT04645797|474236925|FG006|Overall Study|Death|0|||
131715562|NCT00733902|474236927|FG000|Overall Study|Death|0|||
131715563|NCT00733902|474236928|FG001|Overall Study|Death|0|||
131715564|NCT00733902|474236929|FG002|Overall Study|Death|0|||
131715565|NCT00733902|474236930|FG003|Overall Study|Death|1|||
131715566|NCT00733902|474236927|FG000|Overall Study|Adverse Event|3|||
131715567|NCT00733902|474236928|FG001|Overall Study|Adverse Event|4|||
131715568|NCT00733902|474236929|FG002|Overall Study|Adverse Event|7|||
131715569|NCT00733902|474236930|FG003|Overall Study|Adverse Event|11|||
131715570|NCT00733902|474236927|FG000|Overall Study|Lack of Efficacy|56|||
131715571|NCT00733902|474236928|FG001|Overall Study|Lack of Efficacy|21|||
131715572|NCT00733902|474236929|FG002|Overall Study|Lack of Efficacy|34|||
131715573|NCT00733902|474236930|FG003|Overall Study|Lack of Efficacy|23|||
131715574|NCT00733902|474236927|FG000|Overall Study|Protocol Violation|4|||
131715575|NCT00733902|474236928|FG001|Overall Study|Protocol Violation|6|||
131715576|NCT00733902|474236929|FG002|Overall Study|Protocol Violation|3|||
131715577|NCT00733902|474236930|FG003|Overall Study|Protocol Violation|3|||
131715578|NCT00733902|474236927|FG000|Overall Study|Withdrawal by Subject|10|||
131715579|NCT00733902|474236928|FG001|Overall Study|Withdrawal by Subject|5|||
131715580|NCT00733902|474236929|FG002|Overall Study|Withdrawal by Subject|4|||
131715581|NCT00733902|474236930|FG003|Overall Study|Withdrawal by Subject|16|||
131715582|NCT00733902|474236927|FG000|Overall Study|Entered extension study|89|||
131715583|NCT00733902|474236928|FG001|Overall Study|Entered extension study|124|||
131715584|NCT00733902|474236929|FG002|Overall Study|Entered extension study|111|||
131715585|NCT00733902|474236930|FG003|Overall Study|Entered extension study|109|||
131715586|NCT00733902|474236927|FG000|Overall Study|Randomized but not treated|2|||
131715587|NCT00733902|474236928|FG001|Overall Study|Randomized but not treated|2|||
131715588|NCT00733902|474236929|FG002|Overall Study|Randomized but not treated|2|||
131715589|NCT00733902|474236930|FG003|Overall Study|Randomized but not treated|1|||
131715590|NCT03812510|474236937|FG000|Overall Study|Lost to Follow-up|39|||
131715591|NCT03812510|474236937|FG000|Overall Study|Withdrawal by Subject|42|||
131715592|NCT03812510|474236937|FG000|Overall Study|Physician Decision|2|||
131715593|NCT03812510|474236937|FG000|Overall Study|Study Terminated by Sponsor|9|||
131715594|NCT03812510|474236937|FG000|Overall Study|Did Not Start Study Medication|55|||
131715595|NCT03812510|474236937|FG000|Overall Study|Adverse Event|5|||
131715596|NCT00117312|474236938|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
131715597|NCT00117312|474236939|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
131715598|NCT00117312|474236940|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
131715599|NCT00117312|474236941|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
131715600|NCT00117312|474236938|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
131715601|NCT00117312|474236939|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
131715602|NCT00117312|474236940|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
131447473|NCT00463567|473268725|FG005|Overall Study|Death|0|||
131447474|NCT00463567|473268726|FG006|Overall Study|Death|0|||
131447475|NCT01432730|473268727|FG000|Period 1|Adverse Event|2|||
131447476|NCT01432730|473268728|FG001|Period 1|Adverse Event|0|||
131447477|NCT01432730|473268727|FG000|Period 2|Adverse Event|0|||
131447478|NCT01432730|473268728|FG001|Period 2|Adverse Event|4|||
131447479|NCT01421719|473268729|FG000|Overall Study|Withdrawal by Subject|4|||
131447480|NCT01124006|473268730|FG000|Overall Study|Withdrawal by Subject|2|||
131447481|NCT01124006|473268731|FG001|Overall Study|Withdrawal by Subject|2|||
131447482|NCT01124006|473268732|FG002|Overall Study|Withdrawal by Subject|0|||
131447483|NCT01124006|473268730|FG000|Overall Study|Lost to Follow-up|1|||
131447484|NCT01124006|473268731|FG001|Overall Study|Lost to Follow-up|0|||
131447485|NCT01124006|473268732|FG002|Overall Study|Lost to Follow-up|1|||
131447486|NCT01124006|473268730|FG000|Overall Study|Other|0|||
131447487|NCT01124006|473268731|FG001|Overall Study|Other|0|||
131447488|NCT01124006|473268732|FG002|Overall Study|Other|1|||
131447489|NCT01712399|473268738|FG000|Overall Study|Lost to Follow-up|1|||
131447490|NCT01712399|473268738|FG000|Overall Study|Withdrawal by Subject|39|||
131447491|NCT01712399|473268738|FG000|Overall Study|Death|1|||
131447492|NCT01712399|473268738|FG000|Overall Study|Adverse Event|11|||
131447493|NCT01712399|473268738|FG000|Overall Study|Study closure|345|||
131447494|NCT01942837|473268739|FG000|Overall Study|Death|1|||
131447495|NCT01942837|473268739|FG000|Overall Study|Symptomatic or radiographic progression|49|||
131447496|NCT01942837|473268739|FG000|Overall Study|Adverse Event|6|||
131447497|NCT01942837|473268739|FG000|Overall Study|Physician Decision|3|||
131447498|NCT01942837|473268739|FG000|Overall Study|Withdrawal by Subject|2|||
131447499|NCT01942837|473268739|FG000|Overall Study|Intercurrent Illness|1|||
131447500|NCT01942837|473268739|FG000|Overall Study|On treatment|3|||
131447501|NCT01942837|473268739|FG000|Overall Study|Never initiate the treatment|2|||
131447502|NCT01298648|473268740|FG000|Overall Study|Withdrawal by Subject|2|||
131447503|NCT01298648|473268740|FG000|Overall Study|Lost to Follow-up|21|||
131447504|NCT01803607|473268743|FG000|Overall Study|Adverse Event|5|||
131447505|NCT01803607|473268744|FG001|Overall Study|Adverse Event|3|||
131447506|NCT01803607|473268743|FG000|Overall Study|Lack of Efficacy|0|||
131447507|NCT01803607|473268744|FG001|Overall Study|Lack of Efficacy|1|||
131447508|NCT01803607|473268743|FG000|Overall Study|Protocol Violation|3|||
131447509|NCT01803607|473268744|FG001|Overall Study|Protocol Violation|2|||
131447510|NCT01803607|473268743|FG000|Overall Study|Study terminated by sponsor|54|||
131447511|NCT01803607|473268744|FG001|Overall Study|Study terminated by sponsor|56|||
131447512|NCT01803607|473268743|FG000|Overall Study|Withdrawal by Subject|6|||
131447513|NCT01803607|473268744|FG001|Overall Study|Withdrawal by Subject|5|||
131447514|NCT03038100|473268747|FG000|Overall Study|Death|289|||
131447515|NCT03038100|473268748|FG001|Overall Study|Death|272|||
131447516|NCT03038100|473268747|FG000|Overall Study|Lost to Follow-up|9|||
131447517|NCT03038100|473268748|FG001|Overall Study|Lost to Follow-up|10|||
131447518|NCT03038100|473268747|FG000|Overall Study|Protocol Deviation|1|||
131447519|NCT03038100|473268748|FG001|Overall Study|Protocol Deviation|4|||
131447520|NCT03038100|473268747|FG000|Overall Study|Withdrawal by Subject|45|||
131447521|NCT03038100|473268748|FG001|Overall Study|Withdrawal by Subject|51|||
131447522|NCT03038100|473268747|FG000|Overall Study|Study Terminated By Sponsor|305|||
131447523|NCT03038100|473268748|FG001|Overall Study|Study Terminated By Sponsor|311|||
131447524|NCT03038100|473268747|FG000|Overall Study|Physician Decision|1|||
131447525|NCT03038100|473268748|FG001|Overall Study|Physician Decision|3|||
131447526|NCT00706238|473268749|FG000|Overall Study|Disease progression|4|||
131447527|NCT00706238|473268749|FG000|Overall Study|Other|1|||
131447528|NCT03841604|473268752|FG000|Overall Study|Withdrawal by Subject|3|||
131447529|NCT03841604|473268753|FG001|Overall Study|Withdrawal by Subject|1|||
131447530|NCT03841604|473268752|FG000|Overall Study|Adverse Event|4|||
131447531|NCT03841604|473268753|FG001|Overall Study|Adverse Event|2|||
131447532|NCT03841604|473268752|FG000|Overall Study|Physician Decision|1|||
131447533|NCT03841604|473268753|FG001|Overall Study|Physician Decision|0|||
131447534|NCT03877510|473268756|FG000|Overall Study|Death|6|||
131447535|NCT03877510|473268756|FG000|Overall Study|Lost to Follow-up|2|||
131447536|NCT03877510|473268756|FG000|Overall Study|Non-compliance with study drug|2|||
131447537|NCT03877510|473268756|FG000|Overall Study|Lack of Efficacy|14|||
131447538|NCT03877510|473268756|FG000|Overall Study|Adverse Event|20|||
131447539|NCT03877510|473268756|FG000|Overall Study|Withdrawal by Subject|22|||
131447540|NCT03877510|473268756|FG000|Overall Study|Miscellaneous|1|||
131447541|NCT01417377|473268757|FG000|Overall Study|Lost to Follow-up|12|||
131447542|NCT01417377|473268757|FG000|Overall Study|Enrolled, but not treated|1|||
131447543|NCT01774721|473268761|FG000|Overall Study|Death|133|||
131447544|NCT01774721|473268762|FG001|Overall Study|Death|152|||
131447545|NCT01774721|473268761|FG000|Overall Study|Withdrawal by Subject|20|||
131447546|NCT01774721|473268762|FG001|Overall Study|Withdrawal by Subject|14|||
131447547|NCT01774721|473268761|FG000|Overall Study|Lost to Follow-up|6|||
131447548|NCT01774721|473268762|FG001|Overall Study|Lost to Follow-up|7|||
131447549|NCT01774721|473268761|FG000|Overall Study|Did not meet eligibility criteria|0|||
131447550|NCT01774721|473268762|FG001|Overall Study|Did not meet eligibility criteria|3|||
131448278|NCT02079246|473272631|FG000|OLEX|Other: Worsening of condition|1|||
131802350|NCT03952143|474560584|FG000|Treatment Period|Withdrawal by Subject|0|||
131802351|NCT03952143|474560585|FG001|Treatment Period|Withdrawal by Subject|5|||
131802352|NCT03952143|474560586|FG002|Treatment Period|Withdrawal by Subject|26|||
131802353|NCT03952143|474560584|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
131802354|NCT03952143|474560585|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
131802355|NCT03952143|474560586|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
131802356|NCT03952143|474560584|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
131802357|NCT03952143|474560585|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
131802358|NCT03952143|474560586|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
131802359|NCT00874237|474560594|FG000|Overall Study|Physician Decision|0|||
131802360|NCT00874237|474560595|FG001|Overall Study|Physician Decision|1|||
131447551|NCT01774721|473268761|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
131447552|NCT01774721|473268762|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
131447553|NCT01774721|473268761|FG000|Overall Study|Study terminated by sponsor|5|||
131447554|NCT01774721|473268762|FG001|Overall Study|Study terminated by sponsor|0|||
131447555|NCT01774721|473268761|FG000|Overall Study|Disease progression|5|||
131447556|NCT01774721|473268762|FG001|Overall Study|Disease progression|0|||
131802361|NCT00874237|474560596|FG002|Overall Study|Physician Decision|0|||
131802362|NCT00874237|474560597|FG003|Overall Study|Physician Decision|0|||
131802363|NCT00874237|474560598|FG004|Overall Study|Physician Decision|0|||
131802364|NCT00874237|474560599|FG005|Overall Study|Physician Decision|0|||
131447557|NCT03848832|473268764|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
131646547|NCT01251887|473991249|FG001|Overall Study|Scheduling conflict|2|||
131802365|NCT00874237|474560594|FG000|Overall Study|Withdrawal by Subject|0|||
131802366|NCT00874237|474560595|FG001|Overall Study|Withdrawal by Subject|0|||
131802367|NCT00874237|474560596|FG002|Overall Study|Withdrawal by Subject|1|||
131802368|NCT00874237|474560597|FG003|Overall Study|Withdrawal by Subject|0|||
131802369|NCT00874237|474560598|FG004|Overall Study|Withdrawal by Subject|0|||
131802370|NCT00874237|474560599|FG005|Overall Study|Withdrawal by Subject|0|||
131802371|NCT03912337|474560600|FG000|Overall Study|Withdrawal of Consent From Study|1|||
131802372|NCT03912337|474560601|FG001|Overall Study|Withdrawal of Consent From Study|0|||
131802373|NCT03912337|474560600|FG000|Overall Study|Lost to Follow-up|1|||
131802374|NCT03912337|474560601|FG001|Overall Study|Lost to Follow-up|1|||
131802375|NCT03752528|474560602|FG000|Part A|Lost to Follow-up|1|||
131802376|NCT03752528|474560602|FG000|Part A|Protocol Violation|1|||
131802377|NCT03752528|474560602|FG000|Part B|Protocol Violation|1|||
131802378|NCT03752528|474560602|FG000|Part B|Study terminated by sponsor|3|||
131802379|NCT02458469|474560603|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131802380|NCT02458469|474560604|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131802381|NCT02458469|474560605|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
131802382|NCT02458469|474560606|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131903154|NCT01435759|474931414|FG001|Antidepressant Lead-in Phase|Other|0|||
131903155|NCT01435759|474931415|FG002|Antidepressant Lead-in Phase|Other|0|||
131646548|NCT01251887|473991250|FG002|Overall Study|Scheduling conflict|2|||
131646549|NCT01251887|473991248|FG000|Overall Study|Physician Decision|0|||
131646550|NCT01251887|473991249|FG001|Overall Study|Physician Decision|1|||
131646551|NCT01251887|473991250|FG002|Overall Study|Physician Decision|0|||
131646552|NCT03668223|473991251|FG000|Overall Study|Death|10|||
131646553|NCT03668223|473991252|FG001|Overall Study|Death|5|||
131646554|NCT03668223|473991251|FG000|Overall Study|Lost to Follow-up|12|||
131646555|NCT03668223|473991252|FG001|Overall Study|Lost to Follow-up|12|||
131646556|NCT03668223|473991251|FG000|Overall Study|Withdrawal by Subject|8|||
131646557|NCT03668223|473991252|FG001|Overall Study|Withdrawal by Subject|3|||
131646558|NCT01103232|473991253|FG000|Overall Study|Withdrawal by Subject|1|||
131646559|NCT01103232|473991254|FG001|Overall Study|Withdrawal by Subject|1|||
131646560|NCT01103232|473991253|FG000|Overall Study|Protocol Violation|0|||
131646561|NCT01103232|473991254|FG001|Overall Study|Protocol Violation|1|||
131646562|NCT05347485|473991255|FG000|Overall Study|Death|14|||
131646563|NCT05347485|473991255|FG000|Overall Study|Lost to Follow-up|2|||
131646564|NCT05347485|473991255|FG000|Overall Study|Withdrawal by Subject|13|||
131646565|NCT05347485|473991255|FG000|Overall Study|Progressive Disease|1|||
131646566|NCT05347485|473991255|FG000|Overall Study|Study Terminated by Sponsor|49|||
131646567|NCT05347485|473991255|FG000|Overall Study|Other|1|||
131646568|NCT05347485|473991255|FG000|Overall Study|Enrolled (consented) but not treated|4|||
131802383|NCT02458469|474560607|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131802384|NCT02458469|474560608|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131903156|NCT01435759|474931416|FG003|Antidepressant Lead-in Phase|Other|0|||
131802385|NCT02458469|474560603|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
131802386|NCT02458469|474560604|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
131447558|NCT03848832|473268765|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
131646569|NCT05347485|473991255|FG000|Overall Study|Disease Relapse|2|||
131646570|NCT03733899|473991256|FG000|Period 1|Protocol Violation|0|||
131646571|NCT03733899|473991257|FG001|Period 1|Protocol Violation|0|||
131646572|NCT03733899|473991258|FG002|Period 1|Protocol Violation|0|||
131802387|NCT02458469|474560605|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
131802388|NCT02458469|474560606|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
131802389|NCT02458469|474560607|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
131802390|NCT02458469|474560608|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
131802391|NCT02458469|474560603|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
131802392|NCT02458469|474560604|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
131802393|NCT02458469|474560605|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
131802394|NCT02458469|474560606|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
131802395|NCT02458469|474560607|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
131802396|NCT02458469|474560608|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
131802397|NCT03561883|474560609|FG000|Overall Study|Adverse Event|10|||
131802398|NCT03561883|474560610|FG001|Overall Study|Adverse Event|13|||
131802399|NCT03561883|474560609|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131802400|NCT03561883|474560610|FG001|Overall Study|Non-Compliance With Study Drug|2|||
131802401|NCT03561883|474560609|FG000|Overall Study|Protocol Violation|2|||
131802402|NCT03561883|474560610|FG001|Overall Study|Protocol Violation|3|||
131802403|NCT03561883|474560609|FG000|Overall Study|Withdrawal by Subject|14|||
131802404|NCT03561883|474560610|FG001|Overall Study|Withdrawal by Subject|6|||
131802405|NCT03561883|474560609|FG000|Overall Study|Lost to Follow-up|2|||
131802406|NCT03561883|474560610|FG001|Overall Study|Lost to Follow-up|6|||
131646573|NCT03733899|473991259|FG003|Period 1|Protocol Violation|0|||
131646574|NCT03733899|473991260|FG004|Period 1|Protocol Violation|0|||
131646575|NCT03733899|473991261|FG005|Period 1|Protocol Violation|1|||
131646576|NCT03733899|473991256|FG000|Period 2|Unscuccessful Treatment|0|||
131646577|NCT03733899|473991257|FG001|Period 2|Unscuccessful Treatment|1|||
131646578|NCT03733899|473991258|FG002|Period 2|Unscuccessful Treatment|0|||
131646579|NCT03733899|473991259|FG003|Period 2|Unscuccessful Treatment|0|||
131646580|NCT03733899|473991260|FG004|Period 2|Unscuccessful Treatment|0|||
131646581|NCT03733899|473991261|FG005|Period 2|Unscuccessful Treatment|0|||
131646582|NCT03733899|473991256|FG000|Period 3|Withdrawal by Subject|1|||
131646583|NCT03733899|473991257|FG001|Period 3|Withdrawal by Subject|0|||
131646584|NCT03733899|473991258|FG002|Period 3|Withdrawal by Subject|0|||
131646585|NCT03733899|473991259|FG003|Period 3|Withdrawal by Subject|0|||
131646586|NCT03733899|473991260|FG004|Period 3|Withdrawal by Subject|0|||
131646587|NCT03733899|473991261|FG005|Period 3|Withdrawal by Subject|0|||
131646588|NCT02035696|473992620|FG000|Overall Study|Lost to Follow-up|0|||
131646589|NCT02035696|473992621|FG001|Overall Study|Lost to Follow-up|3|||
131646590|NCT02035696|473992622|FG002|Overall Study|Lost to Follow-up|1|||
131646591|NCT02035696|473992623|FG003|Overall Study|Lost to Follow-up|2|||
131646592|NCT02035696|473992620|FG000|Overall Study|Withdrawal by Subject|3|||
131646593|NCT02035696|473992621|FG001|Overall Study|Withdrawal by Subject|0|||
131646594|NCT02035696|473992622|FG002|Overall Study|Withdrawal by Subject|2|||
131646595|NCT02035696|473992623|FG003|Overall Study|Withdrawal by Subject|1|||
131646596|NCT04650698|473992624|FG000|Overall Study|Protocol Violation|2|||
131646597|NCT04650698|473992625|FG001|Overall Study|Protocol Violation|1|||
131646598|NCT04650698|473992624|FG000|Overall Study|Withdrawal by Subject|0|||
131646599|NCT04650698|473992625|FG001|Overall Study|Withdrawal by Subject|1|||
131646600|NCT00321685|473992628|FG000|Overall Study|Adverse Event|18|||
131646601|NCT00321685|473992628|FG000|Overall Study|Death|2|||
131646602|NCT00321685|473992628|FG000|Overall Study|Withdrawal by Subject|8|||
131646603|NCT00321685|473992628|FG000|Overall Study|Alternative therapy|1|||
131646604|NCT00321685|473992628|FG000|Overall Study|Complicating disese|1|||
131646605|NCT00321685|473992628|FG000|Overall Study|Other|5|||
131802407|NCT03561883|474560609|FG000|Overall Study|Study Terminated by Sponsor|12|||
131802408|NCT03561883|474560610|FG001|Overall Study|Study Terminated by Sponsor|11|||
131646606|NCT00321685|473992628|FG000|Overall Study|Not start protocol therapy|2|||
131646607|NCT00321685|473992628|FG000|Overall Study|Ineligible|2|||
131646608|NCT00127842|473992629|FG000|Overall Study|Adverse Event|15|||
131646609|NCT00127842|473992629|FG000|Overall Study|Withdrawal by Subject|3|||
131646610|NCT00127842|473992629|FG000|Overall Study|Lost to Follow-up|1|||
131802409|NCT03561883|474560609|FG000|Overall Study|Physician Decision|1|||
131646611|NCT00127842|473992629|FG000|Overall Study|Lack of Efficacy|12|||
131646612|NCT00127842|473992629|FG000|Overall Study|Noncompliance|2|||
131646613|NCT00127842|473992629|FG000|Overall Study|Protocol Violation|1|||
131646614|NCT00127842|473992629|FG000|Overall Study|Other|5|||
131646615|NCT00589303|473992636|FG000|Overall Study|Withdrawal by Subject|2|||
131646616|NCT00589303|473992637|FG001|Overall Study|Withdrawal by Subject|1|||
131646617|NCT01131104|473992638|FG000|Overall Study|Withdrawal by Subject|3|||
131646618|NCT01131104|473992638|FG000|Overall Study|Physician Decision|4|||
131646619|NCT01131104|473992638|FG000|Overall Study|Information Not Available|5|||
131646620|NCT01131104|473992638|FG000|Overall Study|No Information on Index Date of Onset|1|||
131646621|NCT01245140|473992641|FG000|Overall Study|Adverse Event|1|||
131646622|NCT01245140|473992642|FG001|Overall Study|Adverse Event|3|||
131646623|NCT01245140|473992641|FG000|Overall Study|Lack of Efficacy|2|||
131646624|NCT01245140|473992642|FG001|Overall Study|Lack of Efficacy|4|||
131646625|NCT01245140|473992641|FG000|Overall Study|Protocol Violation|0|||
131646626|NCT01245140|473992642|FG001|Overall Study|Protocol Violation|1|||
131646627|NCT01245140|473992641|FG000|Overall Study|Withdrawal by Subject|0|||
131646628|NCT01245140|473992642|FG001|Overall Study|Withdrawal by Subject|1|||
131646629|NCT01245140|473992641|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
131646630|NCT01245140|473992642|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
131646631|NCT00013611|473992643|FG000|Overall Study|Lost to Follow-up|91|||
131646632|NCT00013611|473992644|FG001|Overall Study|Lost to Follow-up|100|||
131646633|NCT01234883|473992650|FG000|Overall Study|Early treatment release|8|||
131646634|NCT01234883|473992651|FG001|Overall Study|Early treatment release|10|||
131646635|NCT01234883|473992650|FG000|Overall Study|Parent/guardian withdrew consent|1|||
131646636|NCT01234883|473992651|FG001|Overall Study|Parent/guardian withdrew consent|2|||
131646637|NCT01234883|473992650|FG000|Overall Study|Technical difficulties with IV infusion|0|||
131646638|NCT01234883|473992651|FG001|Overall Study|Technical difficulties with IV infusion|1|||
131646639|NCT01234883|473992650|FG000|Overall Study|Inclusion/exclusion failure|1|||
131646640|NCT01234883|473992651|FG001|Overall Study|Inclusion/exclusion failure|0|||
131646641|NCT02552147|473992657|FG000|First Intervention (7 Days)|Protocol Violation|1|||
131646642|NCT02552147|473992658|FG001|First Intervention (7 Days)|Protocol Violation|0|||
131646643|NCT02552147|473992657|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
131646644|NCT02552147|473992658|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
131646645|NCT02229227|473992659|FG000|Overall Study|Adverse Event|14|||
131646646|NCT02229227|473992660|FG001|Overall Study|Adverse Event|9|||
131646647|NCT02229227|473992659|FG000|Overall Study|Lack of Efficacy|3|||
131646648|NCT02229227|473992660|FG001|Overall Study|Lack of Efficacy|3|||
131646649|NCT02229227|473992659|FG000|Overall Study|Protocol Violation|6|||
131646650|NCT02229227|473992660|FG001|Overall Study|Protocol Violation|8|||
131646651|NCT02229227|473992659|FG000|Overall Study|Protocol defined stopping criteria|1|||
131646652|NCT02229227|473992660|FG001|Overall Study|Protocol defined stopping criteria|3|||
131646653|NCT02229227|473992659|FG000|Overall Study|Lost to Follow-up|3|||
131646654|NCT02229227|473992660|FG001|Overall Study|Lost to Follow-up|3|||
131646655|NCT02229227|473992659|FG000|Overall Study|Study terminated by sponsor|11|||
131646656|NCT02229227|473992660|FG001|Overall Study|Study terminated by sponsor|11|||
131646657|NCT02229227|473992659|FG000|Overall Study|Withdrawal by Subject|8|||
131646658|NCT02229227|473992660|FG001|Overall Study|Withdrawal by Subject|12|||
131646659|NCT02229227|473992659|FG000|Overall Study|Other|0|||
131646660|NCT02229227|473992660|FG001|Overall Study|Other|1|||
131646661|NCT02229227|473992659|FG000|Overall Study|Physician Decision|5|||
131646662|NCT02229227|473992660|FG001|Overall Study|Physician Decision|12|||
131646663|NCT04071301|473992661|FG000|Overall Study|Withdrawal by Subject|6|||
131646664|NCT04071301|473992661|FG000|Overall Study|Death|1|||
131646665|NCT01850589|473992662|FG000|Overall Study|Withdrawal by Subject|8|||
131646666|NCT01850589|473992663|FG001|Overall Study|Withdrawal by Subject|0|||
131646667|NCT04468230|473992667|FG000|Overall Study|Adverse Event|2|||
131646668|NCT03721705|473992670|FG000|Overall Study|Adverse Event|2|||
131646669|NCT03721705|473992671|FG001|Overall Study|Adverse Event|0|||
131646670|NCT03721705|473992670|FG000|Overall Study|Withdrawal by Subject|4|||
131646671|NCT03721705|473992671|FG001|Overall Study|Withdrawal by Subject|10|||
131646672|NCT03721705|473992670|FG000|Overall Study|No Suitable Study Partner|1|||
131802410|NCT03561883|474560610|FG001|Overall Study|Physician Decision|0|||
131802411|NCT03561883|474560609|FG000|Overall Study|Randomized by Mistake|1|||
131646673|NCT03721705|473992671|FG001|Overall Study|No Suitable Study Partner|0|||
131646674|NCT03721705|473992670|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
131646675|NCT03721705|473992671|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
131646676|NCT03721705|473992670|FG000|Overall Study|Death|0|||
131646677|NCT03721705|473992671|FG001|Overall Study|Death|1|||
131646678|NCT00822770|473992674|FG000|Overall Study|Not treated|1|||
131646679|NCT00822770|473992675|FG001|Overall Study|Not treated|0|||
131646680|NCT00822770|473992674|FG000|Overall Study|Complication/Incomplete treatment|1|||
131646681|NCT00822770|473992675|FG001|Overall Study|Complication/Incomplete treatment|0|||
131802412|NCT03561883|474560610|FG001|Overall Study|Randomized by Mistake|0|||
131646682|NCT00822770|473992674|FG000|Overall Study|Death|1|||
131646683|NCT00822770|473992675|FG001|Overall Study|Death|1|||
131646684|NCT02402322|473992676|FG000|Pretreatment|Withdrawal by Subject|3|||
131646685|NCT02402322|473992677|FG001|Pretreatment|Withdrawal by Subject|1|||
131646686|NCT02402322|473992678|FG002|Pretreatment|Withdrawal by Subject|1|||
131646687|NCT02402322|473992676|FG000|Follow-up|Withdrawal by Subject|6|||
131646688|NCT02402322|473992677|FG001|Follow-up|Withdrawal by Subject|3|||
131646689|NCT02402322|473992678|FG002|Follow-up|Withdrawal by Subject|24|||
131646690|NCT04593823|473992679|FG000|Overall Study|Withdrawal by Subject|1|||
131646691|NCT04593823|473992680|FG001|Overall Study|Withdrawal by Subject|1|||
131646692|NCT04593823|473992679|FG000|Overall Study|Lost to Follow-up|0|||
131646693|NCT04593823|473992680|FG001|Overall Study|Lost to Follow-up|1|||
131646694|NCT04042077|473992685|FG000|Overall Study|Adverse Event|0|||
131646695|NCT04042077|473992686|FG001|Overall Study|Adverse Event|1|||
131646696|NCT04042077|473992685|FG000|Overall Study|Death|2|||
131646697|NCT04042077|473992686|FG001|Overall Study|Death|1|||
131646698|NCT04042077|473992685|FG000|Overall Study|Physician Decision|2|||
131646699|NCT04042077|473992686|FG001|Overall Study|Physician Decision|0|||
131646700|NCT04042077|473992685|FG000|Overall Study|Withdrawal by Subject|3|||
131646701|NCT04042077|473992686|FG001|Overall Study|Withdrawal by Subject|2|||
131646702|NCT04042077|473992685|FG000|Overall Study|Lack of Efficacy|0|||
131646703|NCT04042077|473992686|FG001|Overall Study|Lack of Efficacy|1|||
131646704|NCT00838929|473992688|FG000|Overall Study|Protocol Violation|0|||
131646705|NCT00838929|473992689|FG001|Overall Study|Protocol Violation|1|||
131646706|NCT00838929|473992690|FG002|Overall Study|Protocol Violation|0|||
131646707|NCT00838929|473992688|FG000|Overall Study|Disease progression|0|||
131646708|NCT00838929|473992689|FG001|Overall Study|Disease progression|2|||
131646709|NCT00838929|473992690|FG002|Overall Study|Disease progression|1|||
131646710|NCT05990387|473992691|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
131646711|NCT05990387|473992692|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
131646712|NCT02257918|473992693|FG000|Overall Study|Lost to Follow-up|4|||
131646713|NCT02257918|473992694|FG001|Overall Study|Lost to Follow-up|1|||
131646714|NCT02257918|473992695|FG002|Overall Study|Lost to Follow-up|0|||
131646715|NCT02257918|473992693|FG000|Overall Study|Withdrawal by Subject|0|||
131646716|NCT02257918|473992694|FG001|Overall Study|Withdrawal by Subject|0|||
131646717|NCT02257918|473992695|FG002|Overall Study|Withdrawal by Subject|1|||
131715603|NCT00117312|474236941|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
131715604|NCT00117312|474236938|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
131715605|NCT00117312|474236939|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
131715606|NCT00117312|474236940|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
131715607|NCT00117312|474236941|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
131715608|NCT00117312|474236938|FG000|Overall Study|Other|0|||
131715609|NCT00117312|474236939|FG001|Overall Study|Other|1|||
131715610|NCT00117312|474236940|FG002|Overall Study|Other|3|||
131715611|NCT00117312|474236941|FG003|Overall Study|Other|1|||
131715612|NCT00117312|474236938|FG000|Overall Study|Patient choice|0|||
131715613|NCT00117312|474236939|FG001|Overall Study|Patient choice|0|||
131715614|NCT00117312|474236940|FG002|Overall Study|Patient choice|2|||
131715615|NCT00117312|474236941|FG003|Overall Study|Patient choice|1|||
131715616|NCT00117312|474236938|FG000|Overall Study|Adverse Event|0|||
131715617|NCT00117312|474236939|FG001|Overall Study|Adverse Event|2|||
131715618|NCT00117312|474236940|FG002|Overall Study|Adverse Event|0|||
131715619|NCT00117312|474236941|FG003|Overall Study|Adverse Event|0|||
131715620|NCT00117312|474236938|FG000|Overall Study|Protocol Violation|0|||
131715621|NCT00117312|474236939|FG001|Overall Study|Protocol Violation|1|||
131715622|NCT00117312|474236940|FG002|Overall Study|Protocol Violation|3|||
131715623|NCT00117312|474236941|FG003|Overall Study|Protocol Violation|0|||
131715624|NCT00117312|474236938|FG000|Overall Study|PSA decrease <=50%|0|||
131715625|NCT00117312|474236939|FG001|Overall Study|PSA decrease <=50%|2|||
131715626|NCT00117312|474236940|FG002|Overall Study|PSA decrease <=50%|2|||
131715627|NCT00117312|474236941|FG003|Overall Study|PSA decrease <=50%|4|||
131715628|NCT00117312|474236938|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
131715629|NCT00117312|474236939|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
131715630|NCT00117312|474236940|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
131715631|NCT00117312|474236941|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
131715632|NCT00117312|474236938|FG000|Overall Study|Hepatic abnormality|0|||
131715633|NCT00117312|474236939|FG001|Overall Study|Hepatic abnormality|1|||
131646718|NCT02257918|473992693|FG000|Overall Study|Pregnancy|0|||
131646719|NCT02257918|473992694|FG001|Overall Study|Pregnancy|0|||
131715634|NCT00117312|474236940|FG002|Overall Study|Hepatic abnormality|0|||
131715635|NCT00117312|474236941|FG003|Overall Study|Hepatic abnormality|1|||
131715636|NCT00117312|474236938|FG000|Overall Study|Withdrawal by Subject|0|||
131715637|NCT00117312|474236939|FG001|Overall Study|Withdrawal by Subject|2|||
131715638|NCT00117312|474236940|FG002|Overall Study|Withdrawal by Subject|0|||
131646720|NCT02257918|473992695|FG002|Overall Study|Pregnancy|1|||
131715639|NCT00117312|474236941|FG003|Overall Study|Withdrawal by Subject|0|||
131903157|NCT01435759|474931417|FG004|Antidepressant Lead-in Phase|Other|0|||
131646721|NCT01806389|473992697|FG000|Overall Study|Withdrawal by Subject|4|||
131646722|NCT03371823|473992704|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
131646723|NCT03371823|473992705|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
131646724|NCT01263054|473992709|FG000|Overall Study|Death|1|||
131646725|NCT01263054|473992710|FG001|Overall Study|Death|0|||
131646726|NCT01263054|473992709|FG000|Overall Study|Lost to Follow-up|2|||
131646727|NCT01263054|473992710|FG001|Overall Study|Lost to Follow-up|2|||
131646728|NCT01263054|473992709|FG000|Overall Study|Withdrawal by Subject|1|||
131646729|NCT01263054|473992710|FG001|Overall Study|Withdrawal by Subject|3|||
131646730|NCT01263054|473992709|FG000|Overall Study|Qualification Violation|1|||
131646731|NCT01263054|473992710|FG001|Overall Study|Qualification Violation|0|||
131646732|NCT01263054|473992709|FG000|Overall Study|Other|0|||
131646733|NCT01263054|473992710|FG001|Overall Study|Other|1|||
131646734|NCT00936598|473992711|FG000|Overall Study|Withdrawal by Subject|1|||
131646735|NCT00936598|473992712|FG001|Overall Study|Withdrawal by Subject|0|||
131646736|NCT00936598|473992711|FG000|Overall Study|Ineligible after consent|1|||
131646737|NCT00936598|473992712|FG001|Overall Study|Ineligible after consent|0|||
131646738|NCT01310699|473992713|FG000|Overall Study|Patients did not complete tandem.|4|||
131646739|NCT01310699|473992714|FG001|Overall Study|Patients did not complete tandem.|6|||
131646740|NCT00926575|473992715|FG000|Overall Study|Adverse Event|1|||
131646741|NCT00926575|473992716|FG001|Overall Study|Adverse Event|1|||
131646742|NCT00926575|473992715|FG000|Overall Study|Death|4|||
131646743|NCT00926575|473992716|FG001|Overall Study|Death|4|||
131646744|NCT00926575|473992715|FG000|Overall Study|Lost to Follow-up|1|||
131646745|NCT00926575|473992716|FG001|Overall Study|Lost to Follow-up|1|||
131646746|NCT00926575|473992715|FG000|Overall Study|Physician Decision|1|||
131646747|NCT00926575|473992716|FG001|Overall Study|Physician Decision|2|||
131646748|NCT00926575|473992715|FG000|Overall Study|Protocol Violation|1|||
131646749|NCT00926575|473992716|FG001|Overall Study|Protocol Violation|0|||
131646750|NCT00926575|473992715|FG000|Overall Study|Withdrawal by Subject|8|||
131646751|NCT00926575|473992716|FG001|Overall Study|Withdrawal by Subject|9|||
131646752|NCT02201901|473992719|FG000|Overall Study|Randomized but never treated|0|||
131646753|NCT02201901|473992720|FG001|Overall Study|Randomized but never treated|1|||
131646754|NCT02201901|473992721|FG002|Overall Study|Randomized but never treated|0|||
131646755|NCT02201901|473992719|FG000|Overall Study|Lack of Efficacy|7|||
131646756|NCT02201901|473992720|FG001|Overall Study|Lack of Efficacy|1|||
131646757|NCT02201901|473992721|FG002|Overall Study|Lack of Efficacy|6|||
131646758|NCT02201901|473992719|FG000|Overall Study|Death|3|||
131646759|NCT02201901|473992720|FG001|Overall Study|Death|3|||
131646760|NCT02201901|473992721|FG002|Overall Study|Death|3|||
131646761|NCT02201901|473992719|FG000|Overall Study|Lost to Follow-up|2|||
131646762|NCT02201901|473992720|FG001|Overall Study|Lost to Follow-up|3|||
131646763|NCT02201901|473992721|FG002|Overall Study|Lost to Follow-up|2|||
131646764|NCT02201901|473992719|FG000|Overall Study|Withdrew Consent|2|||
131646765|NCT02201901|473992720|FG001|Overall Study|Withdrew Consent|0|||
131646766|NCT02201901|473992721|FG002|Overall Study|Withdrew Consent|2|||
131646767|NCT02201901|473992719|FG000|Overall Study|Adverse Event|1|||
131646768|NCT02201901|473992720|FG001|Overall Study|Adverse Event|1|||
131646769|NCT02201901|473992721|FG002|Overall Study|Adverse Event|0|||
131646770|NCT02242643|473992722|FG000|Overall Study|Protocol Violation|1|||
131646771|NCT02242643|473992723|FG001|Overall Study|Protocol Violation|2|||
131646772|NCT02242643|473992722|FG000|Overall Study|Withdrawal by Subject|15|||
131646773|NCT02242643|473992723|FG001|Overall Study|Withdrawal by Subject|10|||
131646774|NCT02242643|473992722|FG000|Overall Study|Migrated/moved from study area|1|||
131646775|NCT02242643|473992723|FG001|Overall Study|Migrated/moved from study area|3|||
131646776|NCT02242643|473992722|FG000|Overall Study|Lost to Follow-up|54|||
131715640|NCT02635204|474236942|FG000|Overall Study|Adverse Event|1|||
131715641|NCT02635204|474236943|FG001|Overall Study|Adverse Event|0|||
131715642|NCT02635204|474236942|FG000|Overall Study|Lost to Follow-up|1|||
131715643|NCT02635204|474236943|FG001|Overall Study|Lost to Follow-up|1|||
131715644|NCT00389207|474236944|FG000|Overall Study|Adverse Event|26|||
131715645|NCT00389207|474236945|FG001|Overall Study|Adverse Event|32|||
131715646|NCT00389207|474236946|FG002|Overall Study|Adverse Event|10|||
131715647|NCT00389207|474236944|FG000|Overall Study|Protocol Violation|3|||
131715648|NCT00389207|474236945|FG001|Overall Study|Protocol Violation|1|||
131715649|NCT00389207|474236946|FG002|Overall Study|Protocol Violation|4|||
131715650|NCT00389207|474236944|FG000|Overall Study|Lost to Follow-up|12|||
131715651|NCT00389207|474236945|FG001|Overall Study|Lost to Follow-up|9|||
131715652|NCT00389207|474236946|FG002|Overall Study|Lost to Follow-up|7|||
131715653|NCT00389207|474236944|FG000|Overall Study|Withdrawal by Subject|5|||
131903158|NCT01435759|474931418|FG005|Antidepressant Lead-in Phase|Other|0|||
131646777|NCT02242643|473992723|FG001|Overall Study|Lost to Follow-up|61|||
131646778|NCT02242643|473992722|FG000|Overall Study|Child placed in foster care by family|0|||
131646779|NCT02242643|473992723|FG001|Overall Study|Child placed in foster care by family|1|||
131646780|NCT02242643|473992722|FG000|Overall Study|Non-compliance|1|||
131646781|NCT02242643|473992723|FG001|Overall Study|Non-compliance|0|||
131646782|NCT02242643|473992722|FG000|Overall Study|Consent withdrawal by parent|1|||
131646783|NCT02242643|473992723|FG001|Overall Study|Consent withdrawal by parent|0|||
131646784|NCT02242643|473992722|FG000|Overall Study|Protocol requirements not followed|1|||
131646785|NCT02242643|473992723|FG001|Overall Study|Protocol requirements not followed|0|||
131646786|NCT02242643|473992722|FG000|Overall Study|Language barrier|1|||
131646787|NCT02242643|473992723|FG001|Overall Study|Language barrier|0|||
131646788|NCT02242643|473992722|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
131646789|NCT02242643|473992723|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
131646790|NCT02633397|473992731|FG000|Overall Study|Adverse Event|8|||
131646791|NCT02633397|473992732|FG001|Overall Study|Adverse Event|8|||
131646792|NCT02633397|473992731|FG000|Overall Study|Study Burden|4|||
131646793|NCT02633397|473992732|FG001|Overall Study|Study Burden|1|||
131646794|NCT02633397|473992731|FG000|Overall Study|Treatment interruption|2|||
131646795|NCT02633397|473992732|FG001|Overall Study|Treatment interruption|5|||
131646796|NCT02633397|473992731|FG000|Overall Study|Death|2|||
131646797|NCT02633397|473992732|FG001|Overall Study|Death|2|||
131646798|NCT02633397|473992731|FG000|Overall Study|Physician Decision|0|||
131646799|NCT02633397|473992732|FG001|Overall Study|Physician Decision|1|||
131646800|NCT03595878|473992733|FG000|Overall Study|Death|2|||
131646801|NCT03595878|473992734|FG001|Overall Study|Death|1|||
131646802|NCT03595878|473992735|FG002|Overall Study|Death|0|||
131646803|NCT03595878|473992733|FG000|Overall Study|Disease progression|2|||
131646804|NCT03595878|473992734|FG001|Overall Study|Disease progression|1|||
131646805|NCT03595878|473992735|FG002|Overall Study|Disease progression|2|||
131646806|NCT03494985|473992736|FG000|Overall Study|Adverse Event|3|||
131646807|NCT03494985|473992737|FG001|Overall Study|Adverse Event|2|||
131646808|NCT03494985|473992738|FG002|Overall Study|Adverse Event|3|||
131646809|NCT03494985|473992739|FG003|Overall Study|Adverse Event|0|||
131646810|NCT03494985|473992736|FG000|Overall Study|Other (Withdrawal of consent)|2|||
131646811|NCT03494985|473992737|FG001|Overall Study|Other (Withdrawal of consent)|3|||
131646812|NCT03494985|473992738|FG002|Overall Study|Other (Withdrawal of consent)|2|||
131646813|NCT03494985|473992739|FG003|Overall Study|Other (Withdrawal of consent)|5|||
131646814|NCT03494985|473992736|FG000|Overall Study|Other (Not specified)|0|||
131646815|NCT03494985|473992737|FG001|Overall Study|Other (Not specified)|1|||
131646816|NCT03494985|473992738|FG002|Overall Study|Other (Not specified)|1|||
131646817|NCT03494985|473992739|FG003|Overall Study|Other (Not specified)|0|||
131646818|NCT03036124|473992740|FG000|Overall Study|Lost to Follow-up|0|||
131646819|NCT03036124|473992741|FG001|Overall Study|Lost to Follow-up|2|||
131646820|NCT03036124|473992740|FG000|Overall Study|Withdrawal by Subject|5|||
131646821|NCT03036124|473992741|FG001|Overall Study|Withdrawal by Subject|4|||
131646822|NCT02282059|473992742|FG000|Overall Study|Other|15|||
131646823|NCT02282059|473992743|FG001|Overall Study|Other|3|||
131646824|NCT02282059|473992742|FG000|Overall Study|Participant refused further follow-up|8|||
131646825|NCT02282059|473992743|FG001|Overall Study|Participant refused further follow-up|4|||
131646826|NCT02282059|473992742|FG000|Overall Study|Lost to Follow-up|19|||
131646827|NCT02282059|473992743|FG001|Overall Study|Lost to Follow-up|3|||
131646828|NCT02282059|473992742|FG000|Overall Study|Death|40|||
131646829|NCT02282059|473992743|FG001|Overall Study|Death|8|||
131646830|NCT05093504|473992744|FG000|Overall Study|Death|0|||
131646831|NCT05093504|473992745|FG001|Overall Study|Death|1|||
131646832|NCT02394925|473992746|FG000|Overall Study|Adverse Event|1|||
131646833|NCT02394925|473992746|FG000|Overall Study|Lens Discomfort|3|||
131646834|NCT02394925|473992746|FG000|Overall Study|Lens handling difficulities|5|||
131646835|NCT02394925|473992746|FG000|Overall Study|Lost to Follow-up|9|||
131646836|NCT02394925|473992746|FG000|Overall Study|Protocol Violation|5|||
131646837|NCT02394925|473992746|FG000|Overall Study|No longer meet eligibility criteria|1|||
131646838|NCT02394925|473992746|FG000|Overall Study|Unsatisfactory Visual Response|5|||
131646839|NCT04886518|473992756|FG000|Overall Study|Noncompliance with study drug|1|||
131646840|NCT04886518|473992757|FG001|Overall Study|Noncompliance with study drug|0|||
131646841|NCT04886518|473992758|FG002|Overall Study|Noncompliance with study drug|0|||
131646842|NCT04886518|473992756|FG000|Overall Study|Adverse Event|0|||
131646843|NCT04886518|473992757|FG001|Overall Study|Adverse Event|1|||
131646844|NCT04886518|473992758|FG002|Overall Study|Adverse Event|0|||
131646845|NCT04886518|473992756|FG000|Overall Study|Withdrawal by Subject|1|||
131646846|NCT04886518|473992757|FG001|Overall Study|Withdrawal by Subject|0|||
131646847|NCT04886518|473992758|FG002|Overall Study|Withdrawal by Subject|0|||
131802413|NCT03561883|474560609|FG000|Overall Study|Other, Not Specified|3|||
131646848|NCT00966264|473994816|FG000|Overall Study|Lost to Follow-up|4|||
131646849|NCT00966264|473994817|FG001|Overall Study|Lost to Follow-up|3|||
131646850|NCT01867047|473994818|FG000|Overall Study|Lost to Follow-up|3|||
131646851|NCT01867047|473994819|FG001|Overall Study|Lost to Follow-up|3|||
131646852|NCT01867047|473994818|FG000|Overall Study|Withdrawal by Subject|2|||
131646853|NCT01867047|473994819|FG001|Overall Study|Withdrawal by Subject|0|||
131646854|NCT01867047|473994818|FG000|Overall Study|Physician Decision|2|||
131646855|NCT01867047|473994819|FG001|Overall Study|Physician Decision|0|||
131646856|NCT01867047|473994818|FG000|Overall Study|surgery not indicated in protocol|1|||
131802414|NCT03561883|474560610|FG001|Overall Study|Other, Not Specified|2|||
131802415|NCT06354270|474560611|FG000|Overall Study|Withdrawal by Subject|1|||
131802416|NCT06354270|474560612|FG001|Overall Study|Withdrawal by Subject|0|||
131802417|NCT01939197|474560613|FG000|Overall Study|Withdrawal by Subject|1|||
131802418|NCT01939197|474560614|FG001|Overall Study|Withdrawal by Subject|0|||
131802419|NCT01939197|474560615|FG002|Overall Study|Withdrawal by Subject|0|||
131802420|NCT01939197|474560616|FG003|Overall Study|Withdrawal by Subject|0|||
131802421|NCT01939197|474560617|FG004|Overall Study|Withdrawal by Subject|1|||
131802422|NCT01939197|474560618|FG005|Overall Study|Withdrawal by Subject|0|||
131802423|NCT01939197|474560619|FG006|Overall Study|Withdrawal by Subject|0|||
131646857|NCT01867047|473994819|FG001|Overall Study|surgery not indicated in protocol|2|||
131646858|NCT01090011|473994820|FG000|Overall Study|Progressive disease|128|||
131646859|NCT01090011|473994820|FG000|Overall Study|Adverse Event|32|||
131646860|NCT01090011|473994820|FG000|Overall Study|Protocol Violation|1|||
131646861|NCT01090011|473994820|FG000|Overall Study|Refusal to start/continue medication|5|||
131646862|NCT01090011|473994820|FG000|Overall Study|Other reason not defined above|5|||
131646863|NCT00379769|473994821|FG000|Main Study|Death|57|||
131646864|NCT00379769|473994822|FG001|Main Study|Death|67|||
131646865|NCT00379769|473994823|FG002|Main Study|Death|54|||
131646866|NCT00379769|473994824|FG003|Main Study|Death|72|||
131646867|NCT00379769|473994825|FG004|Main Study|Death|0|||
131646868|NCT00379769|473994826|FG005|Main Study|Death|0|||
131646869|NCT00379769|473994821|FG000|Main Study|Adverse Event|5|||
131646870|NCT00379769|473994822|FG001|Main Study|Adverse Event|8|||
131646871|NCT00379769|473994823|FG002|Main Study|Adverse Event|10|||
131646872|NCT00379769|473994824|FG003|Main Study|Adverse Event|11|||
131646873|NCT00379769|473994825|FG004|Main Study|Adverse Event|0|||
131646874|NCT00379769|473994826|FG005|Main Study|Adverse Event|0|||
131646875|NCT00379769|473994821|FG000|Main Study|Lost to Follow-up|29|||
131646876|NCT00379769|473994822|FG001|Main Study|Lost to Follow-up|29|||
131646877|NCT00379769|473994823|FG002|Main Study|Lost to Follow-up|25|||
131646878|NCT00379769|473994824|FG003|Main Study|Lost to Follow-up|26|||
131646879|NCT00379769|473994825|FG004|Main Study|Lost to Follow-up|0|||
131646880|NCT00379769|473994826|FG005|Main Study|Lost to Follow-up|0|||
131646881|NCT00379769|473994821|FG000|Main Study|Withdrawal by Subject|46|||
131646882|NCT00379769|473994822|FG001|Main Study|Withdrawal by Subject|56|||
131646883|NCT00379769|473994823|FG002|Main Study|Withdrawal by Subject|72|||
131646884|NCT00379769|473994824|FG003|Main Study|Withdrawal by Subject|70|||
131646885|NCT00379769|473994825|FG004|Main Study|Withdrawal by Subject|0|||
131646886|NCT00379769|473994826|FG005|Main Study|Withdrawal by Subject|0|||
131646887|NCT00379769|473994821|FG000|Main Study|Moved to survival status follow-up only|27|||
131646888|NCT00379769|473994822|FG001|Main Study|Moved to survival status follow-up only|25|||
131646889|NCT00379769|473994823|FG002|Main Study|Moved to survival status follow-up only|32|||
131646890|NCT00379769|473994824|FG003|Main Study|Moved to survival status follow-up only|36|||
131646891|NCT00379769|473994825|FG004|Main Study|Moved to survival status follow-up only|0|||
131646892|NCT00379769|473994826|FG005|Main Study|Moved to survival status follow-up only|0|||
131646893|NCT00379769|473994821|FG000|Main Study|Participant moved|3|||
131646894|NCT00379769|473994822|FG001|Main Study|Participant moved|2|||
131646895|NCT00379769|473994823|FG002|Main Study|Participant moved|3|||
131646896|NCT00379769|473994824|FG003|Main Study|Participant moved|3|||
131646897|NCT00379769|473994825|FG004|Main Study|Participant moved|0|||
131646898|NCT00379769|473994826|FG005|Main Study|Participant moved|0|||
131646899|NCT00379769|473994821|FG000|Main Study|Poor compliance|3|||
131646900|NCT00379769|473994822|FG001|Main Study|Poor compliance|2|||
131646901|NCT00379769|473994823|FG002|Main Study|Poor compliance|2|||
131646902|NCT00379769|473994824|FG003|Main Study|Poor compliance|1|||
131646903|NCT00379769|473994825|FG004|Main Study|Poor compliance|0|||
131646904|NCT00379769|473994826|FG005|Main Study|Poor compliance|0|||
131646905|NCT00379769|473994821|FG000|Main Study|Prohibited glucose lowering medication|0|||
131646906|NCT00379769|473994822|FG001|Main Study|Prohibited glucose lowering medication|3|||
131802424|NCT01939197|474560613|FG000|Overall Study|Lost to Follow-up|0|||
131646907|NCT00379769|473994823|FG002|Main Study|Prohibited glucose lowering medication|0|||
131646908|NCT00379769|473994824|FG003|Main Study|Prohibited glucose lowering medication|1|||
131646909|NCT00379769|473994825|FG004|Main Study|Prohibited glucose lowering medication|0|||
131646910|NCT00379769|473994826|FG005|Main Study|Prohibited glucose lowering medication|0|||
131646911|NCT00379769|473994821|FG000|Main Study|Site closed|4|||
131646912|NCT00379769|473994822|FG001|Main Study|Site closed|4|||
131646913|NCT00379769|473994823|FG002|Main Study|Site closed|4|||
131646914|NCT00379769|473994824|FG003|Main Study|Site closed|8|||
131646915|NCT00379769|473994825|FG004|Main Study|Site closed|0|||
131646916|NCT00379769|473994826|FG005|Main Study|Site closed|0|||
131646917|NCT00379769|473994821|FG000|Main Study|Entry criteria violation|0|||
131646918|NCT00379769|473994822|FG001|Main Study|Entry criteria violation|0|||
131646919|NCT00379769|473994823|FG002|Main Study|Entry criteria violation|1|||
131802425|NCT01939197|474560614|FG001|Overall Study|Lost to Follow-up|1|||
131646920|NCT00379769|473994824|FG003|Main Study|Entry criteria violation|1|||
131646921|NCT00379769|473994825|FG004|Main Study|Entry criteria violation|0|||
131646922|NCT00379769|473994826|FG005|Main Study|Entry criteria violation|0|||
131802426|NCT01939197|474560615|FG002|Overall Study|Lost to Follow-up|0|||
131646923|NCT00379769|473994821|FG000|Main Study|Participant did not take study drug|0|||
131646924|NCT00379769|473994822|FG001|Main Study|Participant did not take study drug|0|||
131646925|NCT00379769|473994823|FG002|Main Study|Participant did not take study drug|1|||
131646926|NCT00379769|473994824|FG003|Main Study|Participant did not take study drug|0|||
131646927|NCT00379769|473994825|FG004|Main Study|Participant did not take study drug|0|||
131646928|NCT00379769|473994826|FG005|Main Study|Participant did not take study drug|0|||
131646929|NCT00379769|473994821|FG000|Main Study|Physician Decision|2|||
131646930|NCT00379769|473994822|FG001|Main Study|Physician Decision|2|||
131646931|NCT00379769|473994823|FG002|Main Study|Physician Decision|1|||
131646932|NCT00379769|473994824|FG003|Main Study|Physician Decision|1|||
131646933|NCT00379769|473994825|FG004|Main Study|Physician Decision|0|||
131646934|NCT00379769|473994826|FG005|Main Study|Physician Decision|0|||
131646935|NCT00379769|473994821|FG000|Main Study|Participant completed study at visit 27|1|||
131646936|NCT00379769|473994822|FG001|Main Study|Participant completed study at visit 27|0|||
131646937|NCT00379769|473994823|FG002|Main Study|Participant completed study at visit 27|0|||
131646938|NCT00379769|473994824|FG003|Main Study|Participant completed study at visit 27|0|||
131646939|NCT00379769|473994825|FG004|Main Study|Participant completed study at visit 27|0|||
131646940|NCT00379769|473994826|FG005|Main Study|Participant completed study at visit 27|0|||
131646941|NCT00379769|473994821|FG000|Main Study|Personal reasons|1|||
131646942|NCT00379769|473994822|FG001|Main Study|Personal reasons|0|||
131646943|NCT00379769|473994823|FG002|Main Study|Personal reasons|0|||
131646944|NCT00379769|473994824|FG003|Main Study|Personal reasons|0|||
131646945|NCT00379769|473994825|FG004|Main Study|Personal reasons|0|||
131646946|NCT00379769|473994826|FG005|Main Study|Personal reasons|0|||
131646947|NCT00379769|473994821|FG000|Main Study|Risk of heart failure|0|||
131646948|NCT00379769|473994822|FG001|Main Study|Risk of heart failure|1|||
131646949|NCT00379769|473994823|FG002|Main Study|Risk of heart failure|0|||
131646950|NCT00379769|473994824|FG003|Main Study|Risk of heart failure|0|||
131646951|NCT00379769|473994825|FG004|Main Study|Risk of heart failure|0|||
131646952|NCT00379769|473994826|FG005|Main Study|Risk of heart failure|0|||
131646953|NCT00379769|473994821|FG000|Main Study|Investigator refused to log temperature|0|||
131646954|NCT00379769|473994822|FG001|Main Study|Investigator refused to log temperature|0|||
131646955|NCT00379769|473994823|FG002|Main Study|Investigator refused to log temperature|1|||
131646956|NCT00379769|473994824|FG003|Main Study|Investigator refused to log temperature|0|||
131646957|NCT00379769|473994825|FG004|Main Study|Investigator refused to log temperature|0|||
131646958|NCT00379769|473994826|FG005|Main Study|Investigator refused to log temperature|0|||
131646959|NCT00379769|473994821|FG000|Main Study|Reason unspecified|0|||
131646960|NCT00379769|473994822|FG001|Main Study|Reason unspecified|0|||
131646961|NCT00379769|473994823|FG002|Main Study|Reason unspecified|1|||
131646962|NCT00379769|473994824|FG003|Main Study|Reason unspecified|0|||
131646963|NCT00379769|473994825|FG004|Main Study|Reason unspecified|0|||
131646964|NCT00379769|473994826|FG005|Main Study|Reason unspecified|0|||
131646965|NCT00379769|473994821|FG000|Observational Follow-up|Death|0|||
131646966|NCT00379769|473994822|FG001|Observational Follow-up|Death|0|||
131646967|NCT00379769|473994823|FG002|Observational Follow-up|Death|0|||
131646968|NCT00379769|473994824|FG003|Observational Follow-up|Death|0|||
131646969|NCT00379769|473994825|FG004|Observational Follow-up|Death|78|||
131715654|NCT00389207|474236945|FG001|Overall Study|Withdrawal by Subject|7|||
131715655|NCT00389207|474236946|FG002|Overall Study|Withdrawal by Subject|11|||
131715656|NCT00389207|474236944|FG000|Overall Study|Other|17|||
131715657|NCT00389207|474236945|FG001|Overall Study|Other|23|||
131715658|NCT00389207|474236946|FG002|Overall Study|Other|9|||
131715659|NCT03527043|474236947|FG000|Overall Study|Withdrawal by Subject|1|||
131715660|NCT03527043|474236948|FG001|Overall Study|Withdrawal by Subject|0|||
131715661|NCT02120417|474236949|FG000|Overall Study|Death|5|||
131715662|NCT02120417|474236950|FG001|Overall Study|Death|1|||
131715663|NCT02120417|474236949|FG000|Overall Study|Adverse Event|3|||
131715664|NCT02120417|474236950|FG001|Overall Study|Adverse Event|9|||
131715665|NCT02120417|474236949|FG000|Overall Study|Participant decision|4|||
131715666|NCT02120417|474236950|FG001|Overall Study|Participant decision|4|||
131715667|NCT02120417|474236949|FG000|Overall Study|Disease progression|41|||
131715668|NCT02120417|474236950|FG001|Overall Study|Disease progression|45|||
131715669|NCT02120417|474236949|FG000|Overall Study|Noncompliance with study treatment|0|||
131646970|NCT00379769|473994826|FG005|Observational Follow-up|Death|70|||
131715670|NCT02120417|474236950|FG001|Overall Study|Noncompliance with study treatment|2|||
131715671|NCT02120417|474236949|FG000|Overall Study|Physician Decision|2|||
131646971|NCT00379769|473994821|FG000|Observational Follow-up|Adverse Event|0|||
131646972|NCT00379769|473994822|FG001|Observational Follow-up|Adverse Event|0|||
131646973|NCT00379769|473994823|FG002|Observational Follow-up|Adverse Event|0|||
131646974|NCT00379769|473994824|FG003|Observational Follow-up|Adverse Event|0|||
131646975|NCT00379769|473994825|FG004|Observational Follow-up|Adverse Event|1|||
131646976|NCT00379769|473994826|FG005|Observational Follow-up|Adverse Event|0|||
131646977|NCT00379769|473994821|FG000|Observational Follow-up|Lost to Follow-up|0|||
131715672|NCT02120417|474236950|FG001|Overall Study|Physician Decision|3|||
131715673|NCT02120417|474236949|FG000|Overall Study|Other unspecified|5|||
131646978|NCT00379769|473994822|FG001|Observational Follow-up|Lost to Follow-up|0|||
131646979|NCT00379769|473994823|FG002|Observational Follow-up|Lost to Follow-up|0|||
131646980|NCT00379769|473994824|FG003|Observational Follow-up|Lost to Follow-up|0|||
131646981|NCT00379769|473994825|FG004|Observational Follow-up|Lost to Follow-up|25|||
131646982|NCT00379769|473994826|FG005|Observational Follow-up|Lost to Follow-up|27|||
131646983|NCT00379769|473994821|FG000|Observational Follow-up|Withdrawal by Subject|0|||
131646984|NCT00379769|473994822|FG001|Observational Follow-up|Withdrawal by Subject|0|||
131646985|NCT00379769|473994823|FG002|Observational Follow-up|Withdrawal by Subject|0|||
131646986|NCT00379769|473994824|FG003|Observational Follow-up|Withdrawal by Subject|0|||
131646987|NCT00379769|473994825|FG004|Observational Follow-up|Withdrawal by Subject|12|||
131646988|NCT00379769|473994826|FG005|Observational Follow-up|Withdrawal by Subject|12|||
131646989|NCT00379769|473994821|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
131646990|NCT00379769|473994822|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
131646991|NCT00379769|473994823|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
131646992|NCT00379769|473994824|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
131646993|NCT00379769|473994825|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
131646994|NCT00379769|473994826|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
131646995|NCT00379769|473994821|FG000|Observational Follow-up|Physician Decision|0|||
131646996|NCT00379769|473994822|FG001|Observational Follow-up|Physician Decision|0|||
131646997|NCT00379769|473994823|FG002|Observational Follow-up|Physician Decision|0|||
131646998|NCT00379769|473994824|FG003|Observational Follow-up|Physician Decision|0|||
131646999|NCT00379769|473994825|FG004|Observational Follow-up|Physician Decision|8|||
131647000|NCT00379769|473994826|FG005|Observational Follow-up|Physician Decision|8|||
131647001|NCT00379769|473994821|FG000|Observational Follow-up|Site Closed Early|0|||
131647002|NCT00379769|473994822|FG001|Observational Follow-up|Site Closed Early|0|||
131647003|NCT00379769|473994823|FG002|Observational Follow-up|Site Closed Early|0|||
131647004|NCT00379769|473994824|FG003|Observational Follow-up|Site Closed Early|0|||
131647005|NCT00379769|473994825|FG004|Observational Follow-up|Site Closed Early|6|||
131647006|NCT00379769|473994826|FG005|Observational Follow-up|Site Closed Early|7|||
131647007|NCT00379769|473994821|FG000|Observational Follow-up|Participant Moved|0|||
131647008|NCT00379769|473994822|FG001|Observational Follow-up|Participant Moved|0|||
131647009|NCT00379769|473994823|FG002|Observational Follow-up|Participant Moved|0|||
131647010|NCT00379769|473994824|FG003|Observational Follow-up|Participant Moved|0|||
131647011|NCT00379769|473994825|FG004|Observational Follow-up|Participant Moved|0|||
131647012|NCT00379769|473994826|FG005|Observational Follow-up|Participant Moved|1|||
131647013|NCT00379769|473994821|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
131647014|NCT00379769|473994822|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
131647015|NCT00379769|473994823|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
131647016|NCT00379769|473994824|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
131647017|NCT00379769|473994825|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
131647018|NCT00379769|473994826|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
131647019|NCT01689363|473994834|FG000|Overall Study|Protocol Violation|0|||
131647020|NCT01689363|473994835|FG001|Overall Study|Protocol Violation|1|||
131647021|NCT01689363|473994836|FG002|Overall Study|Protocol Violation|0|||
131647022|NCT01689363|473994837|FG003|Overall Study|Protocol Violation|0|||
131647023|NCT01689363|473994838|FG004|Overall Study|Protocol Violation|0|||
131647024|NCT01689363|473994839|FG005|Overall Study|Protocol Violation|0|||
131647025|NCT01689363|473994840|FG006|Overall Study|Protocol Violation|0|||
131647026|NCT01689363|473994841|FG007|Overall Study|Protocol Violation|0|||
131647027|NCT02859064|473994842|FG000|Overall Study|Progressive Disease|3|||
131647028|NCT02859064|473994842|FG000|Overall Study|Physician Decision|1|||
131647029|NCT02859064|473994842|FG000|Overall Study|Withdrawal by Subject|1|||
131647030|NCT02859064|473994842|FG000|Overall Study|Death|1|||
131647031|NCT01638390|473994843|FG000|Overall Study|screening failures|21|||
131647032|NCT01536587|473994844|FG000|Overall Study|Adverse Event|2|||
131647033|NCT04596995|473994845|FG000|Overall Study|Lack of Efficacy|8|||
131647034|NCT04596995|473994845|FG000|Overall Study|Lost to Follow-up|3|||
131647035|NCT04596995|473994845|FG000|Overall Study|Withdrawal by Subject|12|||
131647036|NCT04596995|473994845|FG000|Overall Study|Sponsor decision|3|||
131647037|NCT04596995|473994845|FG000|Overall Study|Enrolled in managed access program|3|||
131647038|NCT02354651|473994846|FG000|Overall Study|Withdrawal by Subject|2|||
131647039|NCT02354651|473994846|FG000|Overall Study|Physician Decision|1|||
131647040|NCT00590564|473994848|FG000|Overall Study|Withdrawal by Subject|4|||
131647041|NCT00590564|473994848|FG000|Overall Study|Lost to Follow-up|6|||
131647042|NCT00590564|473994848|FG000|Overall Study|Protocol Violation|1|||
131647043|NCT00590564|473994848|FG000|Overall Study|Patient Found to be Ineligible|1|||
131647044|NCT00590564|473994848|FG000|Overall Study|Patient Non-compliance|6|||
131647045|NCT01377389|473994849|FG000|Overall Study|Withdrawal by Subject|1|||
131647046|NCT01377389|473994849|FG000|Overall Study|Screen failure|2|||
131647047|NCT01434680|473994850|FG000|Overall Study|Withdrawal by Subject|1|||
131647048|NCT01434680|473994851|FG001|Overall Study|Withdrawal by Subject|0|||
131647049|NCT01434680|473994852|FG002|Overall Study|Withdrawal by Subject|2|||
131647050|NCT01434680|473994853|FG003|Overall Study|Withdrawal by Subject|0|||
131647051|NCT01434680|473994850|FG000|Overall Study|Lost to Follow-up|1|||
131647052|NCT01434680|473994851|FG001|Overall Study|Lost to Follow-up|1|||
131647053|NCT01434680|473994852|FG002|Overall Study|Lost to Follow-up|0|||
131647054|NCT01434680|473994853|FG003|Overall Study|Lost to Follow-up|0|||
131647055|NCT01434680|473994850|FG000|Overall Study|Protocol Violation|1|||
131647056|NCT01434680|473994851|FG001|Overall Study|Protocol Violation|1|||
131647057|NCT01434680|473994852|FG002|Overall Study|Protocol Violation|0|||
131647058|NCT01434680|473994853|FG003|Overall Study|Protocol Violation|0|||
131647059|NCT03020069|473994857|FG000|Overall Study|Lost to Follow-up|0|||
131647060|NCT03020069|473994858|FG001|Overall Study|Lost to Follow-up|1|||
131647061|NCT03382561|473994860|FG000|Overall Study|Disease progression|47|||
131647062|NCT03382561|473994861|FG001|Overall Study|Disease progression|6|||
131647063|NCT03382561|473994860|FG000|Overall Study|Adverse Event|10|||
131647064|NCT03382561|473994861|FG001|Overall Study|Adverse Event|2|||
131647065|NCT03382561|473994860|FG000|Overall Study|Death|8|||
131647066|NCT03382561|473994861|FG001|Overall Study|Death|3|||
131647067|NCT03382561|473994860|FG000|Overall Study|Withdrawal by Subject|6|||
131647068|NCT03382561|473994861|FG001|Overall Study|Withdrawal by Subject|5|||
131647069|NCT03382561|473994860|FG000|Overall Study|Alternative therapy|2|||
131647070|NCT03382561|473994861|FG001|Overall Study|Alternative therapy|8|||
131647071|NCT03382561|473994860|FG000|Overall Study|Never started treatment|3|||
131647072|NCT03382561|473994861|FG001|Overall Study|Never started treatment|6|||
131647073|NCT03382561|473994860|FG000|Overall Study|Lack of Efficacy|0|||
131647074|NCT03382561|473994861|FG001|Overall Study|Lack of Efficacy|1|||
131647075|NCT03382561|473994860|FG000|Overall Study|Physician Decision|0|||
131647076|NCT03382561|473994861|FG001|Overall Study|Physician Decision|1|||
131647077|NCT03382561|473994860|FG000|Overall Study|Other complicating disease|0|||
131647078|NCT03382561|473994861|FG001|Overall Study|Other complicating disease|1|||
131647079|NCT00334542|473994864|FG000|Overall Study|Adverse Event|3|||
131647080|NCT00334542|473994864|FG000|Overall Study|Withdrawal by Subject|1|||
131647081|NCT00334542|473994864|FG000|Overall Study|New cancer diagnosis|1|||
131647082|NCT05765435|473994867|FG000|Overall Study|Lost to Follow-up|0|||
131647083|NCT05765435|473994868|FG001|Overall Study|Lost to Follow-up|1|||
131647084|NCT05765435|473994869|FG002|Overall Study|Lost to Follow-up|0|||
131647085|NCT05765435|473994867|FG000|Overall Study|Withdrawal by Subject|0|||
131647086|NCT05765435|473994868|FG001|Overall Study|Withdrawal by Subject|0|||
131647087|NCT05765435|473994869|FG002|Overall Study|Withdrawal by Subject|1|||
131647088|NCT01907906|473994875|FG000|Overall Study|Withdrawal by Subject|1|||
131647089|NCT01907906|473994876|FG001|Overall Study|Withdrawal by Subject|0|||
131647090|NCT01907906|473994875|FG000|Overall Study|Physician Decision|3|||
131647091|NCT01907906|473994876|FG001|Overall Study|Physician Decision|1|||
131647092|NCT02786004|473994877|FG000|Overall Study|Withdrawal by Subject|0|||
131647093|NCT02786004|473994878|FG001|Overall Study|Withdrawal by Subject|1|||
131647094|NCT00126659|473994884|FG000|Overall Study|Adverse Event|0|||
131647095|NCT00126659|473994885|FG001|Overall Study|Adverse Event|0|||
131647096|NCT00126659|473994886|FG002|Overall Study|Adverse Event|2|||
131647097|NCT02367352|473994887|FG000|Overall Study|Progressive disease|7|||
131647098|NCT02367352|473994888|FG001|Overall Study|Progressive disease|0|||
131647099|NCT02367352|473994889|FG002|Overall Study|Progressive disease|0|||
131647100|NCT02367352|473994887|FG000|Overall Study|Participant Received Alternative Therapy|1|||
131647101|NCT02367352|473994888|FG001|Overall Study|Participant Received Alternative Therapy|0|||
131647102|NCT02367352|473994889|FG002|Overall Study|Participant Received Alternative Therapy|0|||
131647103|NCT02367352|473994887|FG000|Overall Study|Adverse Event|1|||
131647104|NCT02367352|473994888|FG001|Overall Study|Adverse Event|0|||
131647105|NCT02367352|473994889|FG002|Overall Study|Adverse Event|0|||
131647106|NCT01013961|473994890|FG000|Overall Study|Adverse Event|2|||
131647107|NCT01013961|473994891|FG001|Overall Study|Adverse Event|2|||
131647108|NCT01013961|473994890|FG000|Overall Study|Withdrawal by Subject|1|||
131647109|NCT01013961|473994891|FG001|Overall Study|Withdrawal by Subject|0|||
131647110|NCT01013961|473994890|FG000|Overall Study|Physician Decision|0|||
131647111|NCT01013961|473994891|FG001|Overall Study|Physician Decision|1|||
131647112|NCT01375751|473994896|FG000|Overall Study|Other|0|||
131647113|NCT01375751|473994897|FG001|Overall Study|Other|1|||
131647114|NCT01375751|473994898|FG002|Overall Study|Other|0|||
131647115|NCT02980523|473994899|FG000|Overall Study|Lost to Follow-up|1|||
131647116|NCT02980523|473994900|FG001|Overall Study|Lost to Follow-up|4|||
131647117|NCT02980523|473994901|FG002|Overall Study|Lost to Follow-up|1|||
131647118|NCT02980523|473994902|FG003|Overall Study|Lost to Follow-up|2|||
131647119|NCT02980523|473994903|FG004|Overall Study|Lost to Follow-up|1|||
131715674|NCT02120417|474236950|FG001|Overall Study|Other unspecified|4|||
131715675|NCT02286102|474236951|FG000|Overall Study|Screen Failure|1|||
131715676|NCT02286102|474236952|FG001|Overall Study|Screen Failure|1|||
131715677|NCT00749203|474236956|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
131715678|NCT00749203|474236957|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
131647120|NCT02980523|473994899|FG000|Overall Study|Excluded from analysis|1|||
131647121|NCT02980523|473994900|FG001|Overall Study|Excluded from analysis|3|||
131647122|NCT02980523|473994901|FG002|Overall Study|Excluded from analysis|1|||
131647123|NCT02980523|473994902|FG003|Overall Study|Excluded from analysis|1|||
131647124|NCT02980523|473994903|FG004|Overall Study|Excluded from analysis|1|||
131647125|NCT02980523|473994899|FG000|Overall Study|Lack of Efficacy|1|||
131647126|NCT02980523|473994900|FG001|Overall Study|Lack of Efficacy|4|||
131647127|NCT02980523|473994901|FG002|Overall Study|Lack of Efficacy|4|||
131647128|NCT02980523|473994902|FG003|Overall Study|Lack of Efficacy|5|||
131647129|NCT02980523|473994903|FG004|Overall Study|Lack of Efficacy|8|||
131647130|NCT02980523|473994899|FG000|Overall Study|Did not receive intervention|0|||
131647131|NCT02980523|473994900|FG001|Overall Study|Did not receive intervention|0|||
131647132|NCT02980523|473994901|FG002|Overall Study|Did not receive intervention|0|||
131647133|NCT02980523|473994902|FG003|Overall Study|Did not receive intervention|1|||
131647134|NCT02980523|473994903|FG004|Overall Study|Did not receive intervention|0|||
131647135|NCT02375347|473994904|FG000|Overall Study|Protocol Violation|1|||
131647136|NCT00559377|473994905|FG000|Overall Study|Withdrawal by Subject|9|||
131647137|NCT00940875|473994906|FG000|Treatment Phase|Adverse Event|9|||
131647138|NCT00940875|473994907|FG001|Treatment Phase|Adverse Event|3|||
131647139|NCT00940875|473994906|FG000|Treatment Phase|Death|3|||
131647140|NCT00940875|473994907|FG001|Treatment Phase|Death|5|||
131647141|NCT00940875|473994906|FG000|Treatment Phase|Lack of Efficacy|1|||
131647142|NCT00940875|473994907|FG001|Treatment Phase|Lack of Efficacy|0|||
131647143|NCT00940875|473994906|FG000|Treatment Phase|Withdrawal by Subject|3|||
131647144|NCT00940875|473994907|FG001|Treatment Phase|Withdrawal by Subject|0|||
131647145|NCT00940875|473994906|FG000|Treatment Phase|Disease progression|9|||
131647146|NCT00940875|473994907|FG001|Treatment Phase|Disease progression|11|||
131647147|NCT00940875|473994906|FG000|Treatment Phase|Physician Decision|1|||
131647148|NCT00940875|473994907|FG001|Treatment Phase|Physician Decision|0|||
131647149|NCT00940875|473994906|FG000|Post-Study Treatment|Death|0|||
131647150|NCT00940875|473994907|FG001|Post-Study Treatment|Death|1|||
131647151|NCT00940875|473994906|FG000|Post-Study Treatment|Disease Progression|0|||
131647152|NCT00940875|473994907|FG001|Post-Study Treatment|Disease Progression|2|||
131647153|NCT00490945|473994908|FG000|Overall Study|Adverse Event|0|||
131647154|NCT00490945|473994909|FG001|Overall Study|Adverse Event|1|||
131647155|NCT00490945|473994910|FG002|Overall Study|Adverse Event|0|||
131647156|NCT00490945|473994911|FG003|Overall Study|Adverse Event|0|||
131647157|NCT00490945|473994912|FG004|Overall Study|Adverse Event|0|||
131647158|NCT01080326|473994913|FG000|Overall Study|Patient deterioration prior to procedure|3|||
131647159|NCT01080326|473994913|FG000|Overall Study|Surgeon decision|1|||
131647160|NCT01318876|473994914|FG000|Day 8 Survey|email address invalid|96|||
131647161|NCT01318876|473994914|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
131647162|NCT01318876|473994914|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
131647163|NCT00723125|473994916|FG000|Overall Study|Met Dx|1|||
131647164|NCT00723125|473994917|FG001|Overall Study|Met Dx|0|||
131647165|NCT00723125|473994916|FG000|Overall Study|Withdrawal by Subject|15|||
131647166|NCT00723125|473994917|FG001|Overall Study|Withdrawal by Subject|6|||
131647167|NCT00723125|473994916|FG000|Overall Study|Adverse Event|2|||
131647168|NCT00723125|473994917|FG001|Overall Study|Adverse Event|0|||
131647169|NCT00478205|473994918|FG000|Overall Study|Adverse Event|182|||
131647170|NCT00478205|473994919|FG001|Overall Study|Adverse Event|39|||
131647171|NCT00478205|473994918|FG000|Overall Study|Medication Non-compliance|9|||
131647172|NCT00478205|473994919|FG001|Overall Study|Medication Non-compliance|4|||
131647173|NCT00478205|473994918|FG000|Overall Study|Protocol Violation|15|||
131647174|NCT00478205|473994919|FG001|Overall Study|Protocol Violation|5|||
131647175|NCT00478205|473994918|FG000|Overall Study|Request of Investigator or Sponsor|4|||
131647176|NCT00478205|473994919|FG001|Overall Study|Request of Investigator or Sponsor|5|||
131647177|NCT00478205|473994918|FG000|Overall Study|Withdrawal by Subject|61|||
131802427|NCT01939197|474560616|FG003|Overall Study|Lost to Follow-up|1|||
131802428|NCT01939197|474560617|FG004|Overall Study|Lost to Follow-up|3|||
131802429|NCT01939197|474560618|FG005|Overall Study|Lost to Follow-up|1|||
131802430|NCT01939197|474560619|FG006|Overall Study|Lost to Follow-up|2|||
131802431|NCT02343120|474560627|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
131802432|NCT02343120|474560628|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
131647178|NCT00478205|473994919|FG001|Overall Study|Withdrawal by Subject|22|||
131647179|NCT00478205|473994918|FG000|Overall Study|Lack of Efficacy|1|||
131802433|NCT02343120|474560629|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
131647180|NCT00478205|473994919|FG001|Overall Study|Lack of Efficacy|0|||
131647181|NCT00478205|473994918|FG000|Overall Study|Other|24|||
131647182|NCT00478205|473994919|FG001|Overall Study|Other|12|||
131647183|NCT00825305|473994930|FG000|Overall Study|Adverse Event|1|||
131647184|NCT00825305|473994931|FG001|Overall Study|Adverse Event|1|||
131647185|NCT00825305|473994930|FG000|Overall Study|Withdrawal by Subject|6|||
131647186|NCT00825305|473994931|FG001|Overall Study|Withdrawal by Subject|12|||
131647187|NCT00825305|473994930|FG000|Overall Study|Inappropriate inclusion|1|||
131802434|NCT02343120|474560630|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
131647188|NCT00825305|473994931|FG001|Overall Study|Inappropriate inclusion|0|||
131903159|NCT01435759|474931413|FG000|Double-blind Phase|Adverse Event|7|||
131647189|NCT00825305|473994930|FG000|Overall Study|Protocol Violation|9|||
131647190|NCT00825305|473994931|FG001|Overall Study|Protocol Violation|9|||
131647191|NCT00825305|473994930|FG000|Overall Study|Can not be classified|0|||
131647192|NCT00825305|473994931|FG001|Overall Study|Can not be classified|1|||
131647193|NCT00003477|473994934|FG000|Overall Study|Not evalauable|4|||
131647194|NCT01236352|473994935|FG000|Overall Study|Death|0|||
131647195|NCT01236352|473994936|FG001|Overall Study|Death|0|||
131647196|NCT01236352|473994937|FG002|Overall Study|Death|0|||
131647197|NCT01236352|473994938|FG003|Overall Study|Death|0|||
131647198|NCT01236352|473994939|FG004|Overall Study|Death|0|||
131647199|NCT01236352|473994940|FG005|Overall Study|Death|0|||
131647200|NCT01236352|473994941|FG006|Overall Study|Death|0|||
131647201|NCT01236352|473994942|FG007|Overall Study|Death|1|||
131647202|NCT01236352|473994943|FG008|Overall Study|Death|0|||
131647203|NCT01236352|473994944|FG009|Overall Study|Death|0|||
131647204|NCT01236352|473994945|FG010|Overall Study|Death|0|||
131647205|NCT01236352|473994935|FG000|Overall Study|Withdrawal by Subject|0|||
131647206|NCT01236352|473994936|FG001|Overall Study|Withdrawal by Subject|0|||
131647207|NCT01236352|473994937|FG002|Overall Study|Withdrawal by Subject|0|||
131647208|NCT01236352|473994938|FG003|Overall Study|Withdrawal by Subject|0|||
131647209|NCT01236352|473994939|FG004|Overall Study|Withdrawal by Subject|0|||
131647210|NCT01236352|473994940|FG005|Overall Study|Withdrawal by Subject|0|||
131647211|NCT01236352|473994941|FG006|Overall Study|Withdrawal by Subject|0|||
131647212|NCT01236352|473994942|FG007|Overall Study|Withdrawal by Subject|0|||
131647213|NCT01236352|473994943|FG008|Overall Study|Withdrawal by Subject|0|||
131647214|NCT01236352|473994944|FG009|Overall Study|Withdrawal by Subject|2|||
131647215|NCT01236352|473994945|FG010|Overall Study|Withdrawal by Subject|1|||
131647216|NCT01236352|473994935|FG000|Overall Study|Adverse Event|0|||
131647217|NCT01236352|473994936|FG001|Overall Study|Adverse Event|0|||
131647218|NCT01236352|473994937|FG002|Overall Study|Adverse Event|0|||
131647219|NCT01236352|473994938|FG003|Overall Study|Adverse Event|0|||
131647220|NCT01236352|473994939|FG004|Overall Study|Adverse Event|0|||
131647221|NCT01236352|473994940|FG005|Overall Study|Adverse Event|0|||
131647222|NCT01236352|473994941|FG006|Overall Study|Adverse Event|2|||
131647223|NCT01236352|473994942|FG007|Overall Study|Adverse Event|0|||
131647224|NCT01236352|473994943|FG008|Overall Study|Adverse Event|0|||
131647225|NCT01236352|473994944|FG009|Overall Study|Adverse Event|4|||
131647226|NCT01236352|473994945|FG010|Overall Study|Adverse Event|1|||
131647227|NCT01236352|473994935|FG000|Overall Study|Study drug toxicity|0|||
131647228|NCT01236352|473994936|FG001|Overall Study|Study drug toxicity|0|||
131647229|NCT01236352|473994937|FG002|Overall Study|Study drug toxicity|0|||
131647230|NCT01236352|473994938|FG003|Overall Study|Study drug toxicity|0|||
131647231|NCT01236352|473994939|FG004|Overall Study|Study drug toxicity|0|||
131647232|NCT01236352|473994940|FG005|Overall Study|Study drug toxicity|1|||
131647233|NCT01236352|473994941|FG006|Overall Study|Study drug toxicity|1|||
131647234|NCT01236352|473994942|FG007|Overall Study|Study drug toxicity|0|||
131647235|NCT01236352|473994943|FG008|Overall Study|Study drug toxicity|0|||
131647236|NCT01236352|473994944|FG009|Overall Study|Study drug toxicity|2|||
131647237|NCT01236352|473994945|FG010|Overall Study|Study drug toxicity|2|||
131647238|NCT01236352|473994935|FG000|Overall Study|Disease progression|1|||
131647239|NCT01236352|473994936|FG001|Overall Study|Disease progression|2|||
131647240|NCT01236352|473994937|FG002|Overall Study|Disease progression|1|||
131647241|NCT01236352|473994938|FG003|Overall Study|Disease progression|2|||
131647242|NCT01236352|473994939|FG004|Overall Study|Disease progression|2|||
131647243|NCT01236352|473994940|FG005|Overall Study|Disease progression|2|||
131647244|NCT01236352|473994941|FG006|Overall Study|Disease progression|1|||
131647245|NCT01236352|473994942|FG007|Overall Study|Disease progression|3|||
131647246|NCT01236352|473994943|FG008|Overall Study|Disease progression|2|||
131647247|NCT01236352|473994944|FG009|Overall Study|Disease progression|2|||
131647248|NCT01236352|473994945|FG010|Overall Study|Disease progression|2|||
131647249|NCT01236352|473994935|FG000|Overall Study|Poor/Non-compliance|1|||
131647250|NCT01236352|473994936|FG001|Overall Study|Poor/Non-compliance|0|||
131647251|NCT01236352|473994937|FG002|Overall Study|Poor/Non-compliance|0|||
131647252|NCT01236352|473994938|FG003|Overall Study|Poor/Non-compliance|0|||
131647253|NCT01236352|473994939|FG004|Overall Study|Poor/Non-compliance|0|||
131647254|NCT01236352|473994940|FG005|Overall Study|Poor/Non-compliance|0|||
131647255|NCT01236352|473994941|FG006|Overall Study|Poor/Non-compliance|0|||
131647256|NCT01236352|473994942|FG007|Overall Study|Poor/Non-compliance|0|||
131647257|NCT01236352|473994943|FG008|Overall Study|Poor/Non-compliance|0|||
131647258|NCT01236352|473994944|FG009|Overall Study|Poor/Non-compliance|0|||
131647259|NCT01236352|473994945|FG010|Overall Study|Poor/Non-compliance|0|||
131647260|NCT01236352|473994935|FG000|Overall Study|Maximum clinical benefit|1|||
131647261|NCT01236352|473994936|FG001|Overall Study|Maximum clinical benefit|1|||
131647262|NCT01236352|473994937|FG002|Overall Study|Maximum clinical benefit|1|||
131715679|NCT00749203|474236956|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
131715680|NCT00749203|474236957|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
131715681|NCT00749203|474236956|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
131715682|NCT00749203|474236957|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
131715683|NCT00749203|474236956|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
131715684|NCT00749203|474236957|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
131715685|NCT00749203|474236956|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
131715686|NCT00749203|474236957|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
131715687|NCT00749203|474236956|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
131715688|NCT00749203|474236957|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
131715689|NCT02853760|474236958|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
131715690|NCT02853760|474236959|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
131715691|NCT02853760|474236960|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
131715692|NCT02853760|474236961|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
131715693|NCT02853760|474236962|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
131715694|NCT02853760|474236963|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
131715695|NCT03577990|474236964|FG000|Overall Study|Lost to Follow-up|4|||
131715696|NCT03577990|474236965|FG001|Overall Study|Lost to Follow-up|6|||
131715697|NCT03577990|474236964|FG000|Overall Study|Withdrawal by Subject|4|||
131715698|NCT03577990|474236965|FG001|Overall Study|Withdrawal by Subject|7|||
131715699|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
131715700|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131715701|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131715702|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131715703|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131715704|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
131715705|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
131715706|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
131715707|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
131715708|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
131715709|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
131715710|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
131715711|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
131715712|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
131715713|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
131715714|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
131715715|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
131715716|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
131715717|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
131715718|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
131715719|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
131715720|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
131715721|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
131715722|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
131715723|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
131715724|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
131715725|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
131715726|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
131715727|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
131715728|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
131715729|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
131715730|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
131715731|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
131715732|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
131715733|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
131715734|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
131715735|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
131715736|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
131715737|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
131715738|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
131715739|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
131715740|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
131715741|NCT00100048|474236966|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131802435|NCT02343120|474560631|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
131647263|NCT01236352|473994938|FG003|Overall Study|Maximum clinical benefit|0|||
131647264|NCT01236352|473994939|FG004|Overall Study|Maximum clinical benefit|2|||
131647265|NCT01236352|473994940|FG005|Overall Study|Maximum clinical benefit|0|||
131647266|NCT01236352|473994941|FG006|Overall Study|Maximum clinical benefit|3|||
131647267|NCT01236352|473994942|FG007|Overall Study|Maximum clinical benefit|1|||
131647268|NCT01236352|473994943|FG008|Overall Study|Maximum clinical benefit|1|||
131647269|NCT01236352|473994944|FG009|Overall Study|Maximum clinical benefit|4|||
131647270|NCT01236352|473994945|FG010|Overall Study|Maximum clinical benefit|2|||
131647271|NCT01236352|473994935|FG000|Overall Study|Subject request to discontinue treatment|0|||
131647272|NCT01236352|473994936|FG001|Overall Study|Subject request to discontinue treatment|0|||
131647273|NCT01236352|473994937|FG002|Overall Study|Subject request to discontinue treatment|1|||
131647274|NCT01236352|473994938|FG003|Overall Study|Subject request to discontinue treatment|1|||
131647275|NCT01236352|473994939|FG004|Overall Study|Subject request to discontinue treatment|0|||
131647276|NCT01236352|473994940|FG005|Overall Study|Subject request to discontinue treatment|1|||
131647277|NCT01236352|473994941|FG006|Overall Study|Subject request to discontinue treatment|0|||
131647278|NCT01236352|473994942|FG007|Overall Study|Subject request to discontinue treatment|0|||
131647279|NCT01236352|473994943|FG008|Overall Study|Subject request to discontinue treatment|0|||
131647280|NCT01236352|473994944|FG009|Overall Study|Subject request to discontinue treatment|1|||
131647281|NCT01236352|473994945|FG010|Overall Study|Subject request to discontinue treatment|4|||
131647282|NCT01236352|473994935|FG000|Overall Study|Subject to receive drug via EAP|1|||
131647283|NCT01236352|473994936|FG001|Overall Study|Subject to receive drug via EAP|1|||
131647284|NCT01236352|473994937|FG002|Overall Study|Subject to receive drug via EAP|1|||
131647285|NCT01236352|473994938|FG003|Overall Study|Subject to receive drug via EAP|0|||
131647286|NCT01236352|473994939|FG004|Overall Study|Subject to receive drug via EAP|0|||
131647287|NCT01236352|473994940|FG005|Overall Study|Subject to receive drug via EAP|0|||
131647288|NCT01236352|473994941|FG006|Overall Study|Subject to receive drug via EAP|0|||
131647289|NCT01236352|473994942|FG007|Overall Study|Subject to receive drug via EAP|2|||
131647290|NCT01236352|473994943|FG008|Overall Study|Subject to receive drug via EAP|0|||
131647291|NCT01236352|473994944|FG009|Overall Study|Subject to receive drug via EAP|4|||
131647292|NCT01236352|473994945|FG010|Overall Study|Subject to receive drug via EAP|0|||
131647293|NCT01236352|473994935|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
131647294|NCT01236352|473994936|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
131647295|NCT01236352|473994937|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
131647296|NCT01236352|473994938|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
131647297|NCT01236352|473994939|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
131647298|NCT01236352|473994940|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
131647299|NCT01236352|473994941|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
131647300|NCT01236352|473994942|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
131647301|NCT01236352|473994943|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
131647302|NCT01236352|473994944|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
131647303|NCT01236352|473994945|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
131647304|NCT01236352|473994935|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647305|NCT01236352|473994936|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647306|NCT01236352|473994937|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647307|NCT01236352|473994938|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647308|NCT01236352|473994939|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647309|NCT01236352|473994940|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647310|NCT01236352|473994941|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647311|NCT01236352|473994942|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647312|NCT01236352|473994943|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647313|NCT01236352|473994944|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131647314|NCT01236352|473994945|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
131647315|NCT01236352|473994935|FG000|Overall Study|Lack of response to drug|0|||
131647316|NCT01236352|473994936|FG001|Overall Study|Lack of response to drug|0|||
131647317|NCT01236352|473994937|FG002|Overall Study|Lack of response to drug|0|||
131647318|NCT01236352|473994938|FG003|Overall Study|Lack of response to drug|0|||
131647319|NCT01236352|473994939|FG004|Overall Study|Lack of response to drug|0|||
131647320|NCT01236352|473994940|FG005|Overall Study|Lack of response to drug|0|||
131647321|NCT01236352|473994941|FG006|Overall Study|Lack of response to drug|0|||
131647322|NCT01236352|473994942|FG007|Overall Study|Lack of response to drug|0|||
131647323|NCT01236352|473994943|FG008|Overall Study|Lack of response to drug|0|||
131647324|NCT01236352|473994944|FG009|Overall Study|Lack of response to drug|1|||
131647325|NCT01236352|473994945|FG010|Overall Study|Lack of response to drug|1|||
131647326|NCT01236352|473994935|FG000|Overall Study|Patient transferred to IST|0|||
131647327|NCT01236352|473994936|FG001|Overall Study|Patient transferred to IST|0|||
131802436|NCT02343120|474560627|FG000|Part 1: Dose Escalation|Death|1|||
131647328|NCT01236352|473994937|FG002|Overall Study|Patient transferred to IST|0|||
131802437|NCT02343120|474560628|FG001|Part 1: Dose Escalation|Death|2|||
131802438|NCT02343120|474560629|FG002|Part 1: Dose Escalation|Death|2|||
131802439|NCT02343120|474560630|FG003|Part 1: Dose Escalation|Death|2|||
131802440|NCT02343120|474560631|FG004|Part 1: Dose Escalation|Death|1|||
131802441|NCT02343120|474560627|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
131802442|NCT02343120|474560628|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
131802443|NCT02343120|474560629|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
131802444|NCT02343120|474560630|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
131647329|NCT01236352|473994938|FG003|Overall Study|Patient transferred to IST|0|||
131647330|NCT01236352|473994939|FG004|Overall Study|Patient transferred to IST|0|||
131647331|NCT01236352|473994940|FG005|Overall Study|Patient transferred to IST|0|||
131647332|NCT01236352|473994941|FG006|Overall Study|Patient transferred to IST|0|||
131647333|NCT01236352|473994942|FG007|Overall Study|Patient transferred to IST|0|||
131647334|NCT01236352|473994943|FG008|Overall Study|Patient transferred to IST|0|||
131647335|NCT01236352|473994944|FG009|Overall Study|Patient transferred to IST|2|||
131647336|NCT01236352|473994945|FG010|Overall Study|Patient transferred to IST|6|||
131647337|NCT01575873|473994946|FG000|Overall Study|Withdrawal by Subject|15|||
131647338|NCT01575873|473994947|FG001|Overall Study|Withdrawal by Subject|20|||
131647339|NCT01575873|473994948|FG002|Overall Study|Withdrawal by Subject|34|||
131647340|NCT01575873|473994949|FG003|Overall Study|Withdrawal by Subject|34|||
131647341|NCT01575873|473994946|FG000|Overall Study|Adverse Event|7|||
131647342|NCT01575873|473994947|FG001|Overall Study|Adverse Event|7|||
131647343|NCT01575873|473994948|FG002|Overall Study|Adverse Event|9|||
131647344|NCT01575873|473994949|FG003|Overall Study|Adverse Event|12|||
131647345|NCT01575873|473994946|FG000|Overall Study|Lost to Follow-up|1|||
131647346|NCT01575873|473994947|FG001|Overall Study|Lost to Follow-up|3|||
131647347|NCT01575873|473994948|FG002|Overall Study|Lost to Follow-up|13|||
131647348|NCT01575873|473994949|FG003|Overall Study|Lost to Follow-up|5|||
131647349|NCT01575873|473994946|FG000|Overall Study|Death|3|||
131647350|NCT01575873|473994947|FG001|Overall Study|Death|2|||
131647351|NCT01575873|473994948|FG002|Overall Study|Death|8|||
131647352|NCT01575873|473994949|FG003|Overall Study|Death|9|||
131647353|NCT01575873|473994946|FG000|Overall Study|Noncompliance|1|||
131647354|NCT01575873|473994947|FG001|Overall Study|Noncompliance|2|||
131647355|NCT01575873|473994948|FG002|Overall Study|Noncompliance|4|||
131647356|NCT01575873|473994949|FG003|Overall Study|Noncompliance|3|||
131647357|NCT01575873|473994946|FG000|Overall Study|Administrative decision|1|||
131647358|NCT01575873|473994947|FG001|Overall Study|Administrative decision|1|||
131647359|NCT01575873|473994948|FG002|Overall Study|Administrative decision|1|||
131647360|NCT01575873|473994949|FG003|Overall Study|Administrative decision|0|||
131647361|NCT01575873|473994946|FG000|Overall Study|Protocol deviation|0|||
131647362|NCT01575873|473994947|FG001|Overall Study|Protocol deviation|1|||
131647363|NCT01575873|473994948|FG002|Overall Study|Protocol deviation|0|||
131647364|NCT01575873|473994949|FG003|Overall Study|Protocol deviation|1|||
131647365|NCT01575873|473994946|FG000|Overall Study|Requirement for Alternative Therapy|0|||
131647366|NCT01575873|473994947|FG001|Overall Study|Requirement for Alternative Therapy|0|||
131647367|NCT01575873|473994948|FG002|Overall Study|Requirement for Alternative Therapy|1|||
131647368|NCT01575873|473994949|FG003|Overall Study|Requirement for Alternative Therapy|1|||
131647369|NCT01575873|473994946|FG000|Overall Study|Other|0|||
131647370|NCT01575873|473994947|FG001|Overall Study|Other|0|||
131647371|NCT01575873|473994948|FG002|Overall Study|Other|4|||
131647372|NCT01575873|473994949|FG003|Overall Study|Other|2|||
131647373|NCT01850030|473994950|FG000|Overall Study|Adverse Event|64|||
131647374|NCT01850030|473994951|FG001|Overall Study|Adverse Event|82|||
131647375|NCT01850030|473994950|FG000|Overall Study|Lack of Efficacy|3|||
131647376|NCT01850030|473994951|FG001|Overall Study|Lack of Efficacy|1|||
131802445|NCT02343120|474560631|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
131802446|NCT02343120|474560627|FG000|Part 2: Expansion|Sponsor decision|0|||
131802447|NCT02343120|474560628|FG001|Part 2: Expansion|Sponsor decision|0|||
131802448|NCT02343120|474560629|FG002|Part 2: Expansion|Sponsor decision|0|||
131647377|NCT01850030|473994950|FG000|Overall Study|Lost to Follow-up|5|||
131802449|NCT02343120|474560630|FG003|Part 2: Expansion|Sponsor decision|165|||
131802450|NCT02343120|474560631|FG004|Part 2: Expansion|Sponsor decision|67|||
131802451|NCT02343120|474560627|FG000|Part 2: Expansion|Death|0|||
131647378|NCT01850030|473994951|FG001|Overall Study|Lost to Follow-up|5|||
131647379|NCT01850030|473994950|FG000|Overall Study|Withdrawal by Subject|3|||
131647380|NCT01850030|473994951|FG001|Overall Study|Withdrawal by Subject|4|||
131647381|NCT01850030|473994950|FG000|Overall Study|Protocol Violation|24|||
131647382|NCT01850030|473994951|FG001|Overall Study|Protocol Violation|28|||
131647383|NCT01850030|473994950|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
131802452|NCT02343120|474560628|FG001|Part 2: Expansion|Death|0|||
131647384|NCT01850030|473994951|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
131802453|NCT02343120|474560629|FG002|Part 2: Expansion|Death|0|||
131802454|NCT02343120|474560630|FG003|Part 2: Expansion|Death|74|||
131647385|NCT00965497|473994953|FG000|Overall Study|Physician Decision|1|||
131647386|NCT02638103|473994954|FG000|Overall Study|Adverse Event|13|||
131647387|NCT02638103|473994955|FG001|Overall Study|Adverse Event|12|||
131715742|NCT00100048|474236967|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131715743|NCT00100048|474236968|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131715744|NCT00100048|474236969|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
131715745|NCT00100048|474236970|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131715746|NCT00100048|474236971|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131715747|NCT01624142|474236973|FG000|Overall Study|Withdrawal by Subject|14|||
131715748|NCT01624142|474236974|FG001|Overall Study|Withdrawal by Subject|4|||
131715749|NCT01624142|474236973|FG000|Overall Study|Death|3|||
131715750|NCT01624142|474236974|FG001|Overall Study|Death|6|||
131447559|NCT03848832|473268766|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
131447560|NCT03848832|473268764|FG000|Overall Study|Withdrawal by Subject|0|||
131447561|NCT03848832|473268765|FG001|Overall Study|Withdrawal by Subject|0|||
131447562|NCT03848832|473268766|FG002|Overall Study|Withdrawal by Subject|1|||
131447563|NCT03848832|473268764|FG000|Overall Study|Withdrawal (Covid-19)|0|||
131447564|NCT03848832|473268765|FG001|Overall Study|Withdrawal (Covid-19)|2|||
131715751|NCT01624142|474236973|FG000|Overall Study|Study Closure|12|||
131715752|NCT01624142|474236974|FG001|Overall Study|Study Closure|6|||
131715753|NCT01624142|474236973|FG000|Overall Study|Lost to Follow-up|2|||
131447565|NCT03848832|473268766|FG002|Overall Study|Withdrawal (Covid-19)|0|||
131447566|NCT03848832|473268764|FG000|Overall Study|Physician Decision|2|||
131447567|NCT03848832|473268765|FG001|Overall Study|Physician Decision|1|||
131447568|NCT03848832|473268766|FG002|Overall Study|Physician Decision|3|||
131447569|NCT03848832|473268764|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
131447570|NCT03848832|473268765|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
131447571|NCT03848832|473268766|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
131447572|NCT03848832|473268764|FG000|Overall Study|Adverse Event|1|||
131447573|NCT03848832|473268765|FG001|Overall Study|Adverse Event|0|||
131447574|NCT03848832|473268766|FG002|Overall Study|Adverse Event|0|||
131447575|NCT01760733|473268768|FG000|Waiting List|Death|18|||
131447576|NCT01760733|473268768|FG000|Waiting List|Removed from waiting list|41|||
131447577|NCT01760733|473268768|FG000|Waiting List|Not received a transplant yet|13|||
131447578|NCT01760733|473268768|FG000|Transplanted|Not reached 10 years post transplant|184|||
131447579|NCT01760733|473268768|FG000|Transplanted|Death|26|||
131447580|NCT01760733|473268768|FG000|Transplanted|Graft loss|7|||
131447581|NCT04646044|473268769|FG000|Overall Study|Lost to Follow-up|0|||
131447582|NCT04646044|473268770|FG001|Overall Study|Lost to Follow-up|0|||
131447583|NCT04646044|473268771|FG002|Overall Study|Lost to Follow-up|1|||
131447584|NCT04646044|473268772|FG003|Overall Study|Lost to Follow-up|0|||
131447585|NCT04646044|473268769|FG000|Overall Study|Withdrawal by Subject|0|||
131447586|NCT04646044|473268770|FG001|Overall Study|Withdrawal by Subject|1|||
131447587|NCT04646044|473268771|FG002|Overall Study|Withdrawal by Subject|0|||
131715754|NCT01624142|474236974|FG001|Overall Study|Lost to Follow-up|0|||
131715755|NCT01624142|474236973|FG000|Overall Study|Other|1|||
131715756|NCT01624142|474236974|FG001|Overall Study|Other|0|||
131715757|NCT01822561|474236975|FG000|Overall Study|Withdrawal by Subject|2|||
131715758|NCT02597062|474236978|FG000|Overall Study|Ineligible|1|||
131715759|NCT03372941|474236979|FG000|Overall Study|Lost to Follow-up|2|||
131715760|NCT03372941|474236980|FG001|Overall Study|Lost to Follow-up|4|||
131715761|NCT00741819|474236981|FG000|Overall Study|Adverse Event|3|||
131715762|NCT00741819|474236981|FG000|Overall Study|Withdrawal by Subject|3|||
131715763|NCT00741819|474236981|FG000|Overall Study|Death|1|||
131715764|NCT00741819|474236981|FG000|Overall Study|Disease progression|1|||
131715765|NCT01126580|474236982|FG000|Overall Study|Adverse Event|14|||
131447588|NCT04646044|473268772|FG003|Overall Study|Withdrawal by Subject|0|||
131447589|NCT01523756|473268773|FG000|Baseline Period|Adverse Event|0|||
131447590|NCT01523756|473268774|FG001|Baseline Period|Adverse Event|1|||
131447591|NCT01523756|473268773|FG000|Test Period 1|Adverse Event|1|||
131447592|NCT01523756|473268774|FG001|Test Period 1|Adverse Event|0|||
131447593|NCT01523756|473268773|FG000|Test Period 2|Withdrawal by Subject|0|||
131447594|NCT01523756|473268774|FG001|Test Period 2|Withdrawal by Subject|1|||
131447595|NCT01467960|473268775|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
131447596|NCT01467960|473268776|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
131447597|NCT01467960|473268777|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
131447598|NCT01467960|473268778|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
131447599|NCT01467960|473268779|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
131715766|NCT01126580|474236983|FG001|Overall Study|Adverse Event|8|||
131715767|NCT01126580|474236984|FG002|Overall Study|Adverse Event|12|||
131715768|NCT01126580|474236982|FG000|Overall Study|Withdrawal by Subject|11|||
131715769|NCT01126580|474236983|FG001|Overall Study|Withdrawal by Subject|19|||
131447600|NCT01467960|473268780|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
131447601|NCT04986904|473268781|FG000|Overall Study|Lost to Follow-up|11|||
131447602|NCT04986904|473268781|FG000|Overall Study|Withdrawal by Subject|1|||
131715770|NCT01126580|474236984|FG002|Overall Study|Withdrawal by Subject|14|||
131715771|NCT01126580|474236982|FG000|Overall Study|Sponsor Decision|5|||
131715772|NCT01126580|474236983|FG001|Overall Study|Sponsor Decision|4|||
131715773|NCT01126580|474236984|FG002|Overall Study|Sponsor Decision|7|||
131647388|NCT02638103|473994956|FG002|Overall Study|Adverse Event|19|||
131647389|NCT02638103|473994957|FG003|Overall Study|Adverse Event|12|||
131647390|NCT02638103|473994954|FG000|Overall Study|Withdrawal by Subject|43|||
131903160|NCT01435759|474931414|FG001|Double-blind Phase|Adverse Event|0|||
131903161|NCT01435759|474931415|FG002|Double-blind Phase|Adverse Event|1|||
131903162|NCT01435759|474931416|FG003|Double-blind Phase|Adverse Event|1|||
131903163|NCT01435759|474931417|FG004|Double-blind Phase|Adverse Event|1|||
131903164|NCT01435759|474931418|FG005|Double-blind Phase|Adverse Event|3|||
131903165|NCT01435759|474931413|FG000|Double-blind Phase|Protocol Violation|2|||
131647391|NCT02638103|473994955|FG001|Overall Study|Withdrawal by Subject|53|||
131647392|NCT02638103|473994956|FG002|Overall Study|Withdrawal by Subject|30|||
131647393|NCT02638103|473994957|FG003|Overall Study|Withdrawal by Subject|61|||
131647394|NCT02638103|473994954|FG000|Overall Study|Protocol Violation|1|||
131647395|NCT02638103|473994955|FG001|Overall Study|Protocol Violation|2|||
131647396|NCT02638103|473994956|FG002|Overall Study|Protocol Violation|1|||
131647397|NCT02638103|473994957|FG003|Overall Study|Protocol Violation|4|||
131647398|NCT02638103|473994954|FG000|Overall Study|Pregnancy|2|||
131647399|NCT02638103|473994955|FG001|Overall Study|Pregnancy|3|||
131647400|NCT02638103|473994956|FG002|Overall Study|Pregnancy|0|||
131647401|NCT02638103|473994957|FG003|Overall Study|Pregnancy|1|||
131647402|NCT02638103|473994954|FG000|Overall Study|Non-compliance to Study Procedures|2|||
131647403|NCT02638103|473994955|FG001|Overall Study|Non-compliance to Study Procedures|1|||
131647404|NCT02638103|473994956|FG002|Overall Study|Non-compliance to Study Procedures|1|||
131647405|NCT02638103|473994957|FG003|Overall Study|Non-compliance to Study Procedures|1|||
131647406|NCT02638103|473994954|FG000|Overall Study|Lost to Follow-up|26|||
131647407|NCT02638103|473994955|FG001|Overall Study|Lost to Follow-up|33|||
131647408|NCT02638103|473994956|FG002|Overall Study|Lost to Follow-up|20|||
131647409|NCT02638103|473994957|FG003|Overall Study|Lost to Follow-up|37|||
131647410|NCT02638103|473994954|FG000|Overall Study|Lack of Efficacy|14|||
131647411|NCT02638103|473994955|FG001|Overall Study|Lack of Efficacy|10|||
131715774|NCT01126580|474236982|FG000|Overall Study|Physician Decision|1|||
131715775|NCT01126580|474236983|FG001|Overall Study|Physician Decision|1|||
131715776|NCT01126580|474236984|FG002|Overall Study|Physician Decision|2|||
131715777|NCT01126580|474236982|FG000|Overall Study|Entry Criteria Not Met|1|||
131715778|NCT01126580|474236983|FG001|Overall Study|Entry Criteria Not Met|1|||
131715779|NCT01126580|474236984|FG002|Overall Study|Entry Criteria Not Met|2|||
131715780|NCT01126580|474236982|FG000|Overall Study|Lack of Efficacy|2|||
131715781|NCT01126580|474236983|FG001|Overall Study|Lack of Efficacy|3|||
131715782|NCT01126580|474236984|FG002|Overall Study|Lack of Efficacy|4|||
131715783|NCT01126580|474236982|FG000|Overall Study|Protocol Violation|0|||
131715784|NCT01126580|474236983|FG001|Overall Study|Protocol Violation|1|||
131715785|NCT01126580|474236984|FG002|Overall Study|Protocol Violation|2|||
131715786|NCT01126580|474236982|FG000|Overall Study|Lost to Follow-up|15|||
131715787|NCT01126580|474236983|FG001|Overall Study|Lost to Follow-up|13|||
131903166|NCT01435759|474931414|FG001|Double-blind Phase|Protocol Violation|0|||
131903167|NCT01435759|474931415|FG002|Double-blind Phase|Protocol Violation|1|||
131647412|NCT02638103|473994956|FG002|Overall Study|Lack of Efficacy|12|||
131903168|NCT01435759|474931416|FG003|Double-blind Phase|Protocol Violation|2|||
131715788|NCT01126580|474236984|FG002|Overall Study|Lost to Follow-up|9|||
131903169|NCT01435759|474931417|FG004|Double-blind Phase|Protocol Violation|0|||
131447603|NCT01588522|473268786|FG000|Overall Study|Withdrawal by Subject|1|||
131447604|NCT01588522|473268787|FG001|Overall Study|Withdrawal by Subject|5|||
131447605|NCT01588522|473268788|FG002|Overall Study|Withdrawal by Subject|3|||
131447606|NCT01588522|473268789|FG003|Overall Study|Withdrawal by Subject|1|||
131447607|NCT01588522|473268790|FG004|Overall Study|Withdrawal by Subject|2|||
131447608|NCT01588522|473268791|FG005|Overall Study|Withdrawal by Subject|0|||
131447609|NCT01588522|473268786|FG000|Overall Study|Lack of Efficacy|0|||
131447610|NCT01588522|473268787|FG001|Overall Study|Lack of Efficacy|0|||
131447611|NCT01588522|473268788|FG002|Overall Study|Lack of Efficacy|0|||
131447612|NCT01588522|473268789|FG003|Overall Study|Lack of Efficacy|0|||
131447613|NCT01588522|473268790|FG004|Overall Study|Lack of Efficacy|1|||
131447614|NCT01588522|473268791|FG005|Overall Study|Lack of Efficacy|0|||
131447615|NCT01588522|473268786|FG000|Overall Study|Adverse Event|0|||
131447616|NCT01588522|473268787|FG001|Overall Study|Adverse Event|0|||
131447617|NCT01588522|473268788|FG002|Overall Study|Adverse Event|0|||
131447618|NCT01588522|473268789|FG003|Overall Study|Adverse Event|1|||
131447619|NCT01588522|473268790|FG004|Overall Study|Adverse Event|0|||
131447620|NCT01588522|473268791|FG005|Overall Study|Adverse Event|0|||
131447621|NCT01588522|473268786|FG000|Overall Study|Grade 2 alopecia|1|||
131447622|NCT01588522|473268787|FG001|Overall Study|Grade 2 alopecia|0|||
131447623|NCT01588522|473268788|FG002|Overall Study|Grade 2 alopecia|0|||
131447624|NCT01588522|473268789|FG003|Overall Study|Grade 2 alopecia|0|||
131447625|NCT01588522|473268790|FG004|Overall Study|Grade 2 alopecia|0|||
131447626|NCT01588522|473268791|FG005|Overall Study|Grade 2 alopecia|0|||
131802455|NCT02343120|474560631|FG004|Part 2: Expansion|Death|17|||
131802456|NCT02343120|474560627|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
131447627|NCT01588522|473268786|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
131447628|NCT01588522|473268787|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
131447629|NCT01588522|473268788|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
131447630|NCT01588522|473268789|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
131802457|NCT02343120|474560628|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
131447631|NCT01588522|473268790|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
131802458|NCT02343120|474560629|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
131802459|NCT02343120|474560630|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
131715789|NCT01126580|474236982|FG000|Overall Study|Treatment Non-compliance|0|||
131715790|NCT01126580|474236983|FG001|Overall Study|Treatment Non-compliance|2|||
131715791|NCT01126580|474236984|FG002|Overall Study|Treatment Non-compliance|3|||
131715792|NCT01708057|474236985|FG000|Overall Study|Withdrawal due to study termination.|1|||
131715793|NCT01708057|474236986|FG001|Overall Study|Withdrawal due to study termination.|1|||
131715794|NCT01708057|474236987|FG002|Overall Study|Withdrawal due to study termination.|1|||
131715795|NCT00538681|474236988|FG000|Overall Study|Progressive Disease|7|||
131715796|NCT00538681|474236989|FG001|Overall Study|Progressive Disease|0|||
131715797|NCT00538681|474236990|FG002|Overall Study|Progressive Disease|1|||
131715798|NCT00538681|474236991|FG003|Overall Study|Progressive Disease|0|||
131715799|NCT00538681|474236988|FG000|Overall Study|Sponsor Decision|1|||
131715800|NCT00538681|474236989|FG001|Overall Study|Sponsor Decision|3|||
131715801|NCT00538681|474236990|FG002|Overall Study|Sponsor Decision|8|||
131715802|NCT00538681|474236991|FG003|Overall Study|Sponsor Decision|9|||
131715803|NCT00538681|474236988|FG000|Overall Study|Adverse Event|1|||
131715804|NCT00538681|474236989|FG001|Overall Study|Adverse Event|1|||
131715805|NCT00538681|474236990|FG002|Overall Study|Adverse Event|1|||
131715806|NCT00538681|474236991|FG003|Overall Study|Adverse Event|0|||
131715807|NCT00538681|474236988|FG000|Overall Study|Death|0|||
131715808|NCT00538681|474236989|FG001|Overall Study|Death|0|||
131715809|NCT00538681|474236990|FG002|Overall Study|Death|1|||
131715810|NCT00538681|474236991|FG003|Overall Study|Death|1|||
131715811|NCT00538681|474236988|FG000|Overall Study|Investigator Decision|0|||
131715812|NCT00538681|474236989|FG001|Overall Study|Investigator Decision|0|||
131715813|NCT00538681|474236990|FG002|Overall Study|Investigator Decision|0|||
131715814|NCT00538681|474236991|FG003|Overall Study|Investigator Decision|1|||
131715815|NCT02970929|474236992|FG000|Overall Study|Adverse Event|18|||
131715816|NCT02970929|474236992|FG000|Overall Study|Lack of Efficacy|8|||
131715817|NCT02970929|474236992|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
131715818|NCT02970929|474236992|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
131802460|NCT02343120|474560631|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
131715819|NCT02970929|474236992|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
131715820|NCT02970929|474236992|FG000|Overall Study|LOST TO FOLLOWUP|6|||
131715821|NCT02970929|474236992|FG000|Overall Study|MOVED OUT OF STATE|1|||
131715822|NCT02970929|474236992|FG000|Overall Study|Withdrawal by Subject|16|||
131802461|NCT02343120|474560627|FG000|Part 2: Expansion|Lost to Follow-up|0|||
131715823|NCT05369806|474236995|FG000|Overall Study|Lost to Follow-up|1|||
131447632|NCT01588522|473268791|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
131447633|NCT01588522|473268786|FG000|Overall Study|Taken off taxane-based regimen|0|||
131447634|NCT01588522|473268787|FG001|Overall Study|Taken off taxane-based regimen|0|||
131447635|NCT01588522|473268788|FG002|Overall Study|Taken off taxane-based regimen|0|||
131447636|NCT01588522|473268789|FG003|Overall Study|Taken off taxane-based regimen|1|||
131802462|NCT02343120|474560628|FG001|Part 2: Expansion|Lost to Follow-up|0|||
131802463|NCT02343120|474560629|FG002|Part 2: Expansion|Lost to Follow-up|0|||
131802464|NCT02343120|474560630|FG003|Part 2: Expansion|Lost to Follow-up|5|||
131802465|NCT02343120|474560631|FG004|Part 2: Expansion|Lost to Follow-up|2|||
131802466|NCT02343120|474560627|FG000|Part 2: Expansion|Other|0|||
131802467|NCT02343120|474560628|FG001|Part 2: Expansion|Other|0|||
131802468|NCT02343120|474560629|FG002|Part 2: Expansion|Other|0|||
131802469|NCT02343120|474560630|FG003|Part 2: Expansion|Other|1|||
131802470|NCT02343120|474560631|FG004|Part 2: Expansion|Other|5|||
131802471|NCT02343120|474560627|FG000|Part 2: Expansion|Adverse Event|0|||
131802472|NCT02343120|474560628|FG001|Part 2: Expansion|Adverse Event|0|||
131802473|NCT02343120|474560629|FG002|Part 2: Expansion|Adverse Event|0|||
131802474|NCT02343120|474560630|FG003|Part 2: Expansion|Adverse Event|1|||
131802475|NCT02343120|474560631|FG004|Part 2: Expansion|Adverse Event|1|||
131802476|NCT02534493|474560634|FG000|Overall Study|Lost to Follow-up|1|||
131802477|NCT02534493|474560634|FG000|Overall Study|Withdrawal by Subject|1|||
131802478|NCT03544138|474560637|FG000|Overall Study|Lost to Follow-up|29|||
131802479|NCT01766778|474560638|FG000|Overall Study|Adverse Event|4|||
131802480|NCT01766778|474560639|FG001|Overall Study|Adverse Event|4|||
131802481|NCT01766778|474560638|FG000|Overall Study|Withdrawal by Subject|1|||
131802482|NCT01766778|474560639|FG001|Overall Study|Withdrawal by Subject|0|||
131802483|NCT03144687|474560640|FG000|Overall Study|Death|0|||
131802484|NCT03144687|474560641|FG001|Overall Study|Death|2|||
131802485|NCT03144687|474560640|FG000|Overall Study|Lost to Follow-up|0|||
131802486|NCT03144687|474560641|FG001|Overall Study|Lost to Follow-up|1|||
131802487|NCT03144687|474560640|FG000|Overall Study|Physician Decision|0|||
131802488|NCT03144687|474560641|FG001|Overall Study|Physician Decision|1|||
131802489|NCT03144687|474560640|FG000|Overall Study|Withdrawal by Subject|1|||
131802490|NCT03144687|474560641|FG001|Overall Study|Withdrawal by Subject|3|||
131802491|NCT03144687|474560640|FG000|Overall Study|Not Reported|2|||
131802492|NCT03144687|474560641|FG001|Overall Study|Not Reported|0|||
131802493|NCT01054599|474560642|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
131802494|NCT01054599|474560643|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
131802495|NCT01054599|474560642|FG000|Overall Study|Protocol Violation|1|||
131802496|NCT01054599|474560643|FG001|Overall Study|Protocol Violation|0|||
131802497|NCT01054599|474560642|FG000|Overall Study|Spells/seizure-like episodes|1|||
131802498|NCT01054599|474560643|FG001|Overall Study|Spells/seizure-like episodes|1|||
131802499|NCT01054599|474560642|FG000|Overall Study|Timing/scheduling difficulties|1|||
131802500|NCT01054599|474560643|FG001|Overall Study|Timing/scheduling difficulties|1|||
131802501|NCT01054599|474560642|FG000|Overall Study|Visual impairment, WTAR <80|0|||
131647413|NCT02638103|473994957|FG003|Overall Study|Lack of Efficacy|22|||
131647414|NCT02638103|473994954|FG000|Overall Study|Other than specified|5|||
131647415|NCT02638103|473994955|FG001|Overall Study|Other than specified|4|||
131647416|NCT02638103|473994956|FG002|Overall Study|Other than specified|2|||
131647417|NCT02638103|473994957|FG003|Overall Study|Other than specified|4|||
131647418|NCT00246090|473994962|FG000|Overall Study|Adverse Event|25|||
131647419|NCT00246090|473994962|FG000|Overall Study|Withdrawal by Subject|7|||
131647420|NCT00246090|473994962|FG000|Overall Study|Progressive Disease|212|||
131647421|NCT00246090|473994962|FG000|Overall Study|Clinical Progression|30|||
131647422|NCT00246090|473994962|FG000|Overall Study|Physician Decision|11|||
131647423|NCT00246090|473994962|FG000|Overall Study|Not Otherwise Specified|10|||
131647424|NCT01827046|473994967|FG000|Overall Study|Lost to Follow-up|1|||
131647425|NCT01827046|473994968|FG001|Overall Study|Lost to Follow-up|5|||
131647426|NCT01827046|473994967|FG000|Overall Study|Withdrawal by Subject|0|||
131647427|NCT01827046|473994968|FG001|Overall Study|Withdrawal by Subject|4|||
131647428|NCT02734004|473994969|FG000|Overall Study|Death|36|||
131647429|NCT02734004|473994970|FG001|Overall Study|Death|24|||
131647430|NCT02734004|473994971|FG002|Overall Study|Death|26|||
131647431|NCT02734004|473994972|FG003|Overall Study|Death|35|||
131647432|NCT02734004|473994973|FG004|Overall Study|Death|13|||
131647433|NCT02734004|473994974|FG005|Overall Study|Death|17|||
131802502|NCT01054599|474560643|FG001|Overall Study|Visual impairment, WTAR <80|1|||
131802503|NCT01054599|474560642|FG000|Overall Study|Lost to Follow-up|0|||
131802504|NCT01054599|474560643|FG001|Overall Study|Lost to Follow-up|2|||
131802505|NCT01054599|474560642|FG000|Overall Study|Adverse Event|0|||
131802506|NCT01054599|474560643|FG001|Overall Study|Adverse Event|1|||
131802507|NCT01054599|474560642|FG000|Overall Study|Withdrawal by Subject|0|||
131802508|NCT01054599|474560643|FG001|Overall Study|Withdrawal by Subject|1|||
131802509|NCT00743197|474560644|FG000|Overall Study|Study terminated due to departure of PI.|1|||
131802510|NCT00743197|474560645|FG001|Overall Study|Study terminated due to departure of PI.|2|||
131647434|NCT02734004|473994975|FG006|Overall Study|Death|20|||
131802511|NCT01478620|474560646|FG000|Overall Study|Lost to Follow-up|6|||
131802512|NCT02888171|474560651|FG000|Overall Study|Lost to Follow-up|2|||
131802513|NCT02888171|474560652|FG001|Overall Study|Lost to Follow-up|1|||
131647435|NCT02734004|473994969|FG000|Overall Study|Lost to Follow-up|1|||
131647436|NCT02734004|473994970|FG001|Overall Study|Lost to Follow-up|1|||
131647437|NCT02734004|473994971|FG002|Overall Study|Lost to Follow-up|0|||
131647438|NCT02734004|473994972|FG003|Overall Study|Lost to Follow-up|0|||
131647439|NCT02734004|473994973|FG004|Overall Study|Lost to Follow-up|1|||
131647440|NCT02734004|473994974|FG005|Overall Study|Lost to Follow-up|0|||
131647441|NCT02734004|473994975|FG006|Overall Study|Lost to Follow-up|0|||
131647442|NCT02734004|473994969|FG000|Overall Study|Withdrawal by Subject|3|||
131647443|NCT02734004|473994970|FG001|Overall Study|Withdrawal by Subject|1|||
131647444|NCT02734004|473994971|FG002|Overall Study|Withdrawal by Subject|1|||
131647445|NCT02734004|473994972|FG003|Overall Study|Withdrawal by Subject|1|||
131647446|NCT02734004|473994973|FG004|Overall Study|Withdrawal by Subject|3|||
131647447|NCT02734004|473994974|FG005|Overall Study|Withdrawal by Subject|0|||
131647448|NCT02734004|473994975|FG006|Overall Study|Withdrawal by Subject|2|||
131647449|NCT02734004|473994969|FG000|Overall Study|Other|0|||
131647450|NCT02734004|473994970|FG001|Overall Study|Other|8|||
131647451|NCT02734004|473994971|FG002|Overall Study|Other|7|||
131647452|NCT02734004|473994972|FG003|Overall Study|Other|4|||
131647453|NCT02734004|473994973|FG004|Overall Study|Other|34|||
131647454|NCT02734004|473994974|FG005|Overall Study|Other|14|||
131647455|NCT02734004|473994975|FG006|Overall Study|Other|10|||
131647456|NCT01294436|473994976|FG000|Overall Study|Adverse Event|10|||
131647457|NCT01294436|473994977|FG001|Overall Study|Adverse Event|17|||
131647458|NCT01294436|473994976|FG000|Overall Study|Withdrawal by Subject|11|||
131647459|NCT01294436|473994977|FG001|Overall Study|Withdrawal by Subject|28|||
131647460|NCT01294436|473994976|FG000|Overall Study|subject no longer meets study criteria|5|||
131647461|NCT01294436|473994977|FG001|Overall Study|subject no longer meets study criteria|20|||
131647462|NCT01294436|473994976|FG000|Overall Study|poor/non-compliance|2|||
131647463|NCT01294436|473994977|FG001|Overall Study|poor/non-compliance|5|||
131647464|NCT01536171|473994986|FG000|Overall Study|Withdrawal by Subject|1|||
131647465|NCT00585078|473994987|FG000|Overall Study|Withdrawal by Subject|4|||
131647466|NCT00585078|473994987|FG000|Overall Study|Poor performance status|1|||
131647467|NCT00585078|473994987|FG000|Overall Study|Disease Progression|24|||
131647468|NCT00585078|473994987|FG000|Overall Study|Adverse Event|10|||
131647469|NCT00585078|473994987|FG000|Overall Study|Death|1|||
131647470|NCT01018732|473994988|FG000|Overall Study|Lost to Follow-up|0|||
131647471|NCT01018732|473994989|FG001|Overall Study|Lost to Follow-up|0|||
131647472|NCT01018732|473994990|FG002|Overall Study|Lost to Follow-up|3|||
131647473|NCT01018732|473994988|FG000|Overall Study|Protocol Violation|1|||
131647474|NCT01018732|473994989|FG001|Overall Study|Protocol Violation|1|||
131647475|NCT01018732|473994990|FG002|Overall Study|Protocol Violation|0|||
131647476|NCT01018732|473994988|FG000|Overall Study|Inappropriate Enrollment|0|||
131647477|NCT01018732|473994989|FG001|Overall Study|Inappropriate Enrollment|1|||
131647478|NCT01018732|473994990|FG002|Overall Study|Inappropriate Enrollment|0|||
131647479|NCT01018732|473994988|FG000|Overall Study|Unable to Classify|0|||
131647480|NCT01018732|473994989|FG001|Overall Study|Unable to Classify|0|||
131647481|NCT01018732|473994990|FG002|Overall Study|Unable to Classify|1|||
131647482|NCT02781311|473994993|FG000|Overall Study|Adverse Event|2|||
131647483|NCT02781311|473994994|FG001|Overall Study|Adverse Event|6|||
131647484|NCT02781311|473994995|FG002|Overall Study|Adverse Event|1|||
131647485|NCT02781311|473994993|FG000|Overall Study|Withdrawal of Consent|11|||
131647486|NCT02781311|473994994|FG001|Overall Study|Withdrawal of Consent|12|||
131647487|NCT02781311|473994995|FG002|Overall Study|Withdrawal of Consent|2|||
131715824|NCT04321343|474236998|FG000|Overall Study|Adverse Event|0|||
131647488|NCT02781311|473994993|FG000|Overall Study|Lost to Follow-up|11|||
131647489|NCT02781311|473994994|FG001|Overall Study|Lost to Follow-up|8|||
131647490|NCT02781311|473994995|FG002|Overall Study|Lost to Follow-up|1|||
131715825|NCT04321343|474236999|FG001|Overall Study|Adverse Event|0|||
131715826|NCT04321343|474237000|FG002|Overall Study|Adverse Event|1|||
131715827|NCT04321343|474237001|FG003|Overall Study|Adverse Event|0|||
131715828|NCT04321343|474236998|FG000|Overall Study|Death|0|||
131715829|NCT04321343|474236999|FG001|Overall Study|Death|0|||
131715830|NCT04321343|474237000|FG002|Overall Study|Death|0|||
131715831|NCT04321343|474237001|FG003|Overall Study|Death|1|||
131715832|NCT04321343|474236998|FG000|Overall Study|Pregnancy|1|||
131715833|NCT04321343|474236999|FG001|Overall Study|Pregnancy|0|||
131715834|NCT04321343|474237000|FG002|Overall Study|Pregnancy|0|||
131715835|NCT04321343|474237001|FG003|Overall Study|Pregnancy|0|||
131715836|NCT04321343|474236998|FG000|Overall Study|Protocol Violation|1|||
131647491|NCT02781311|473994993|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131715837|NCT04321343|474236999|FG001|Overall Study|Protocol Violation|1|||
131715838|NCT04321343|474237000|FG002|Overall Study|Protocol Violation|1|||
131903170|NCT01435759|474931418|FG005|Double-blind Phase|Protocol Violation|1|||
131715839|NCT04321343|474237001|FG003|Overall Study|Protocol Violation|1|||
131647492|NCT02781311|473994994|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131647493|NCT02781311|473994995|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131647494|NCT02165826|473994996|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
131647495|NCT02165826|473994997|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
131715840|NCT04321343|474236998|FG000|Overall Study|Withdrawal by Subject|0|||
131647496|NCT02165826|473994998|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
131647497|NCT02165826|473994996|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
131647498|NCT02165826|473994997|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
131647499|NCT02165826|473994998|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
131647500|NCT02165826|473994996|FG000|Main Treatment Period|Lost to Follow-up|4|||
131647501|NCT02165826|473994997|FG001|Main Treatment Period|Lost to Follow-up|2|||
131647502|NCT02165826|473994998|FG002|Main Treatment Period|Lost to Follow-up|1|||
131647503|NCT02165826|473994996|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
131647504|NCT02165826|473994997|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
131647505|NCT02165826|473994998|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
131647506|NCT02165826|473994996|FG000|Main Treatment Period|Lack of Efficacy|2|||
131647507|NCT02165826|473994997|FG001|Main Treatment Period|Lack of Efficacy|0|||
131647508|NCT02165826|473994998|FG002|Main Treatment Period|Lack of Efficacy|0|||
131647509|NCT02165826|473994996|FG000|Main Treatment Period|Reason Not Specified|8|||
131647510|NCT02165826|473994997|FG001|Main Treatment Period|Reason Not Specified|5|||
131647511|NCT02165826|473994998|FG002|Main Treatment Period|Reason Not Specified|16|||
131647512|NCT02165826|473994996|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
131647513|NCT02165826|473994997|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
131647514|NCT02165826|473994998|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
131647515|NCT02165826|473994996|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
131647516|NCT02165826|473994997|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
131647517|NCT02165826|473994998|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
131647518|NCT02165826|473994996|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
131647519|NCT02165826|473994997|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
131647520|NCT02165826|473994998|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
131647521|NCT02165826|473994996|FG000|Down-Titration Period|Reason Not Specified|1|||
131647522|NCT02165826|473994997|FG001|Down-Titration Period|Reason Not Specified|0|||
131647523|NCT02165826|473994998|FG002|Down-Titration Period|Reason Not Specified|2|||
131647524|NCT01056263|473995003|FG000|Overall Study|Adverse Event|12|||
131647525|NCT01056263|473995003|FG000|Overall Study|Death|1|||
131647526|NCT01056263|473995003|FG000|Overall Study|Withdrawal by Subject|1|||
131647527|NCT01056263|473995003|FG000|Overall Study|Lack of Efficacy|29|||
131647528|NCT01056263|473995003|FG000|Overall Study|Progressive disease|2|||
131647529|NCT01056263|473995003|FG000|Overall Study|Neoplasm progression|1|||
131647530|NCT01056263|473995003|FG000|Overall Study|Objective progression or relapse|1|||
131647531|NCT01056263|473995003|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
131647532|NCT01068210|473995010|FG000|Overall Study|Lost to Follow-up|1|||
131647533|NCT01068210|473995011|FG001|Overall Study|Lost to Follow-up|2|||
131647534|NCT01068210|473995012|FG002|Overall Study|Lost to Follow-up|2|||
131647535|NCT01068210|473995013|FG003|Overall Study|Lost to Follow-up|1|||
131647536|NCT01068210|473995010|FG000|Overall Study|Second cancer|0|||
131647537|NCT01068210|473995011|FG001|Overall Study|Second cancer|1|||
131647538|NCT01068210|473995012|FG002|Overall Study|Second cancer|0|||
131647539|NCT01068210|473995013|FG003|Overall Study|Second cancer|0|||
131647540|NCT01068210|473995010|FG000|Overall Study|Disease progression|0|||
131647541|NCT01068210|473995011|FG001|Overall Study|Disease progression|0|||
131647542|NCT01068210|473995012|FG002|Overall Study|Disease progression|0|||
131647543|NCT01068210|473995013|FG003|Overall Study|Disease progression|2|||
131647544|NCT02037477|473997048|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
131647545|NCT02037477|473997049|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
131647546|NCT02037477|473997050|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
131647547|NCT02037477|473997051|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
131647548|NCT04978350|473997052|FG000|Overall Study|Lost to Follow-up|6|||
131647549|NCT00983749|473997055|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
131647550|NCT00983749|473997056|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
131647551|NCT01952847|473997057|FG000|Overall Study|Ineligible|1|||
131647552|NCT01952847|473997058|FG001|Overall Study|Ineligible|0|||
131647553|NCT01952847|473997059|FG002|Overall Study|Ineligible|0|||
131647554|NCT01952847|473997060|FG003|Overall Study|Ineligible|0|||
131647555|NCT01952847|473997057|FG000|Overall Study|Lack of Insurance Coverage|0|||
131647556|NCT01952847|473997058|FG001|Overall Study|Lack of Insurance Coverage|1|||
131647557|NCT01952847|473997059|FG002|Overall Study|Lack of Insurance Coverage|0|||
131647558|NCT01952847|473997060|FG003|Overall Study|Lack of Insurance Coverage|0|||
131647559|NCT01952847|473997057|FG000|Overall Study|Withdrawal by Subject|1|||
131647560|NCT01952847|473997058|FG001|Overall Study|Withdrawal by Subject|1|||
131647561|NCT01952847|473997059|FG002|Overall Study|Withdrawal by Subject|0|||
131715841|NCT04321343|474236999|FG001|Overall Study|Withdrawal by Subject|6|||
131715842|NCT04321343|474237000|FG002|Overall Study|Withdrawal by Subject|0|||
131715843|NCT04321343|474237001|FG003|Overall Study|Withdrawal by Subject|2|||
131647562|NCT01952847|473997060|FG003|Overall Study|Withdrawal by Subject|1|||
131647563|NCT00781937|473997064|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
131715844|NCT04321343|474236998|FG000|Overall Study|Lost to Follow-up|2|||
131715845|NCT04321343|474236999|FG001|Overall Study|Lost to Follow-up|2|||
131802514|NCT02888171|474560651|FG000|Overall Study|Withdrawal by Subject|3|||
131802515|NCT02888171|474560652|FG001|Overall Study|Withdrawal by Subject|2|||
131802516|NCT02888171|474560651|FG000|Overall Study|Adverse Event|0|||
131447637|NCT01588522|473268790|FG004|Overall Study|Taken off taxane-based regimen|0|||
131447638|NCT01588522|473268791|FG005|Overall Study|Taken off taxane-based regimen|0|||
131447639|NCT01588522|473268786|FG000|Overall Study|Did not initiate chemotherapy|0|||
131647564|NCT00781937|473997065|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
131647565|NCT00781937|473997064|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
131802517|NCT02888171|474560652|FG001|Overall Study|Adverse Event|1|||
131802518|NCT02079532|474560653|FG000|Overall Study|Adverse Event|7|||
131647566|NCT00781937|473997065|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
131647567|NCT00781937|473997064|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
131647568|NCT00781937|473997065|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
131647569|NCT00781937|473997064|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
131447640|NCT01588522|473268787|FG001|Overall Study|Did not initiate chemotherapy|0|||
131447641|NCT01588522|473268788|FG002|Overall Study|Did not initiate chemotherapy|0|||
131447642|NCT01588522|473268789|FG003|Overall Study|Did not initiate chemotherapy|0|||
131447643|NCT01588522|473268790|FG004|Overall Study|Did not initiate chemotherapy|1|||
131447644|NCT01588522|473268791|FG005|Overall Study|Did not initiate chemotherapy|0|||
131447645|NCT05673876|473268792|FG000|Overall Study|Death|3|||
131447646|NCT05673876|473268793|FG001|Overall Study|Death|1|||
131447647|NCT05673876|473268792|FG000|Overall Study|Study Terminated by Sponsor|0|||
131447648|NCT05673876|473268793|FG001|Overall Study|Study Terminated by Sponsor|1|||
131447649|NCT05673876|473268792|FG000|Overall Study|Physician Decision|0|||
131447650|NCT05673876|473268793|FG001|Overall Study|Physician Decision|1|||
131447651|NCT03205423|473268798|FG000|Overall Study|Personal|1|||
131447652|NCT03205423|473268799|FG001|Overall Study|Personal|1|||
131447653|NCT03205423|473268798|FG000|Overall Study|Physician Decision|0|||
131447654|NCT03205423|473268799|FG001|Overall Study|Physician Decision|2|||
131447655|NCT02749422|473268802|FG000|Overall Study|Lost to Follow-up|0|||
131447656|NCT02749422|473268803|FG001|Overall Study|Lost to Follow-up|2|||
131447657|NCT02749422|473268802|FG000|Overall Study|Ineligible|0|||
131447658|NCT02749422|473268803|FG001|Overall Study|Ineligible|1|||
131447659|NCT05786651|473268806|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
131447660|NCT04949490|473268810|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
131447661|NCT04949490|473268811|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
131447662|NCT04949490|473268812|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
131447663|NCT04949490|473268813|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
131447664|NCT04949490|473268814|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
131447665|NCT04949490|473268815|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
131447666|NCT04949490|473268810|FG000|Group A and Group B|Withdrawal by Subject|0|||
131447667|NCT04949490|473268811|FG001|Group A and Group B|Withdrawal by Subject|0|||
131447668|NCT04949490|473268812|FG002|Group A and Group B|Withdrawal by Subject|1|||
131447669|NCT04949490|473268813|FG003|Group A and Group B|Withdrawal by Subject|0|||
131447670|NCT04949490|473268814|FG004|Group A and Group B|Withdrawal by Subject|0|||
131447671|NCT04949490|473268815|FG005|Group A and Group B|Withdrawal by Subject|0|||
131647570|NCT00781937|473997065|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
131647571|NCT00781937|473997064|FG000|Main Trial Period Through Week 56|Unclassified|10|||
131647572|NCT00781937|473997065|FG001|Main Trial Period Through Week 56|Unclassified|15|||
131647573|NCT00781937|473997064|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
131647574|NCT00781937|473997065|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
131647575|NCT00781937|473997064|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
131647576|NCT00781937|473997065|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
131647577|NCT04698915|473997066|FG000|Overall Study|Adverse Event|2|||
131647578|NCT04698915|473997067|FG001|Overall Study|Adverse Event|0|||
131647579|NCT04698915|473997066|FG000|Overall Study|Death|23|||
131647580|NCT04698915|473997067|FG001|Overall Study|Death|20|||
131647581|NCT04698915|473997066|FG000|Overall Study|Physician Decision|1|||
131647582|NCT04698915|473997067|FG001|Overall Study|Physician Decision|1|||
131647583|NCT04698915|473997066|FG000|Overall Study|Lost to Follow-up|1|||
131647584|NCT04698915|473997067|FG001|Overall Study|Lost to Follow-up|0|||
131802519|NCT02079532|474560653|FG000|Overall Study|Additional or changed therapy|2|||
131802520|NCT02079532|474560653|FG000|Overall Study|Lack of Efficacy|9|||
131647585|NCT04698915|473997066|FG000|Overall Study|Study Terminated by Sponsor|55|||
131802521|NCT02079532|474560653|FG000|Overall Study|Protocol Violation|3|||
131447672|NCT04949490|473268810|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
131447673|NCT04949490|473268811|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
131447674|NCT04949490|473268812|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
131447675|NCT04949490|473268813|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
131647586|NCT04698915|473997067|FG001|Overall Study|Study Terminated by Sponsor|60|||
131647587|NCT04698915|473997066|FG000|Overall Study|Withdrawal by Subject|2|||
131802522|NCT02079532|474560653|FG000|Overall Study|Withdrawal by Subject|1|||
131448279|NCT02079246|473272632|FG001|OLEX|Other: Worsening of condition|0|||
131802523|NCT02079532|474560653|FG000|Overall Study|Administrative problems|1|||
131802524|NCT02079532|474560653|FG000|Overall Study|Inclusion into ReFIRST|3|||
131802525|NCT02079532|474560653|FG000|Overall Study|Other|3|||
131802526|NCT02507375|474560656|FG000|Overall Study|Progressive Disease|4|||
131802527|NCT02507375|474560657|FG001|Overall Study|Progressive Disease|5|||
131647588|NCT04698915|473997067|FG001|Overall Study|Withdrawal by Subject|3|||
131647589|NCT03520075|473997068|FG000|Phase 1 (Dose Escalation)|Death|2|||
131647590|NCT03520075|473997069|FG001|Phase 1 (Dose Escalation)|Death|2|||
131647591|NCT03520075|473997070|FG002|Phase 1 (Dose Escalation)|Death|3|||
131647592|NCT03520075|473997071|FG003|Phase 1 (Dose Escalation)|Death|2|||
131802528|NCT02507375|474560656|FG000|Overall Study|Death|0|||
131802529|NCT02507375|474560657|FG001|Overall Study|Death|1|||
131802530|NCT02507375|474560656|FG000|Overall Study|Refused treatment|0|||
131802531|NCT02507375|474560657|FG001|Overall Study|Refused treatment|1|||
131802532|NCT02507375|474560656|FG000|Overall Study|Adverse Event|0|||
131802533|NCT02507375|474560657|FG001|Overall Study|Adverse Event|1|||
131447676|NCT04949490|473268814|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
131647593|NCT03520075|473997072|FG004|Phase 1 (Dose Escalation)|Death|6|||
131647594|NCT03520075|473997073|FG005|Phase 1 (Dose Escalation)|Death|5|||
131647595|NCT03520075|473997074|FG006|Phase 1 (Dose Escalation)|Death|3|||
131802534|NCT02158936|474560658|FG000|Overall Study|Study closed/ terminated|57|||
131802535|NCT02158936|474560659|FG001|Overall Study|Study closed/ terminated|77|||
131802536|NCT02158936|474560658|FG000|Overall Study|Azacitidine tx discontinued|53|||
131802537|NCT02158936|474560659|FG001|Overall Study|Azacitidine tx discontinued|46|||
131448280|NCT02079246|473272631|FG000|OLEX|Other: Moved to nursing home|1|||
131647596|NCT03520075|473997075|FG007|Phase 1 (Dose Escalation)|Death|2|||
131647597|NCT03520075|473997076|FG008|Phase 1 (Dose Escalation)|Death|3|||
131802538|NCT02158936|474560658|FG000|Overall Study|Adverse Event|39|||
131802539|NCT02158936|474560659|FG001|Overall Study|Adverse Event|24|||
131802540|NCT02158936|474560658|FG000|Overall Study|Withdrawal by Subject|15|||
131647598|NCT03520075|473997077|FG009|Phase 1 (Dose Escalation)|Death|1|||
131647599|NCT03520075|473997078|FG010|Phase 1 (Dose Escalation)|Death|5|||
131647600|NCT03520075|473997079|FG011|Phase 1 (Dose Escalation)|Death|7|||
131647601|NCT03520075|473997080|FG012|Phase 1 (Dose Escalation)|Death|11|||
131647602|NCT03520075|473997081|FG013|Phase 1 (Dose Escalation)|Death|0|||
131647603|NCT03520075|473997082|FG014|Phase 1 (Dose Escalation)|Death|0|||
131647604|NCT03520075|473997083|FG015|Phase 1 (Dose Escalation)|Death|0|||
131647605|NCT03520075|473997084|FG016|Phase 1 (Dose Escalation)|Death|0|||
131647606|NCT03520075|473997085|FG017|Phase 1 (Dose Escalation)|Death|0|||
131647607|NCT03520075|473997086|FG018|Phase 1 (Dose Escalation)|Death|0|||
131647608|NCT03520075|473997068|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
131647609|NCT03520075|473997069|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647610|NCT03520075|473997070|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647611|NCT03520075|473997071|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
131647612|NCT03520075|473997072|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
131647613|NCT03520075|473997073|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
131647614|NCT03520075|473997074|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647615|NCT03520075|473997075|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
131647616|NCT03520075|473997076|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647617|NCT03520075|473997077|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
131647618|NCT03520075|473997078|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647619|NCT03520075|473997079|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647620|NCT03520075|473997080|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
131647621|NCT03520075|473997081|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647622|NCT03520075|473997082|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647623|NCT03520075|473997083|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647624|NCT03520075|473997084|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647625|NCT03520075|473997085|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647626|NCT03520075|473997086|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131647627|NCT03520075|473997068|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647628|NCT03520075|473997069|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131647629|NCT03520075|473997070|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647630|NCT03520075|473997071|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131647631|NCT03520075|473997072|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131647632|NCT03520075|473997073|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647633|NCT03520075|473997074|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647634|NCT03520075|473997075|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647635|NCT03520075|473997076|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647636|NCT03520075|473997077|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647637|NCT03520075|473997078|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131647638|NCT03520075|473997079|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647639|NCT03520075|473997080|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131647640|NCT03520075|473997081|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647641|NCT03520075|473997082|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647642|NCT03520075|473997083|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647643|NCT03520075|473997084|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647644|NCT03520075|473997085|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647645|NCT03520075|473997086|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131647646|NCT03520075|473997068|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647647|NCT03520075|473997069|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647648|NCT03520075|473997070|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647649|NCT03520075|473997071|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647650|NCT03520075|473997072|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647651|NCT03520075|473997073|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647652|NCT03520075|473997074|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647653|NCT03520075|473997075|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647654|NCT03520075|473997076|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647655|NCT03520075|473997077|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
131647656|NCT03520075|473997078|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647657|NCT03520075|473997079|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647658|NCT03520075|473997080|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
131647659|NCT03520075|473997081|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647660|NCT03520075|473997082|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131802541|NCT02158936|474560659|FG001|Overall Study|Withdrawal by Subject|16|||
131802542|NCT02158936|474560658|FG000|Overall Study|Physician Decision|15|||
131802543|NCT02158936|474560659|FG001|Overall Study|Physician Decision|13|||
131802544|NCT02158936|474560658|FG000|Overall Study|Lost to Follow-up|0|||
131802545|NCT02158936|474560659|FG001|Overall Study|Lost to Follow-up|1|||
131802546|NCT00522457|474560660|FG000|Overall Study|Due to disease progression|16|||
131802547|NCT00522457|474560660|FG000|Overall Study|Adverse Event|2|||
131647661|NCT03520075|473997083|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647662|NCT03520075|473997084|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647663|NCT03520075|473997085|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647664|NCT03520075|473997086|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131647665|NCT03520075|473997068|FG000|Phase 2 (Dose Expansion)|Death|0|||
131647666|NCT03520075|473997069|FG001|Phase 2 (Dose Expansion)|Death|0|||
131647667|NCT03520075|473997070|FG002|Phase 2 (Dose Expansion)|Death|0|||
131647668|NCT03520075|473997071|FG003|Phase 2 (Dose Expansion)|Death|0|||
131647669|NCT03520075|473997072|FG004|Phase 2 (Dose Expansion)|Death|0|||
131647670|NCT03520075|473997073|FG005|Phase 2 (Dose Expansion)|Death|0|||
131647671|NCT03520075|473997074|FG006|Phase 2 (Dose Expansion)|Death|0|||
131647672|NCT03520075|473997075|FG007|Phase 2 (Dose Expansion)|Death|0|||
131647673|NCT03520075|473997076|FG008|Phase 2 (Dose Expansion)|Death|0|||
131647674|NCT03520075|473997077|FG009|Phase 2 (Dose Expansion)|Death|0|||
131647675|NCT03520075|473997078|FG010|Phase 2 (Dose Expansion)|Death|0|||
131647676|NCT03520075|473997079|FG011|Phase 2 (Dose Expansion)|Death|0|||
131647677|NCT03520075|473997080|FG012|Phase 2 (Dose Expansion)|Death|0|||
131647678|NCT03520075|473997081|FG013|Phase 2 (Dose Expansion)|Death|20|||
131647679|NCT03520075|473997082|FG014|Phase 2 (Dose Expansion)|Death|13|||
131647680|NCT03520075|473997083|FG015|Phase 2 (Dose Expansion)|Death|9|||
131647681|NCT03520075|473997084|FG016|Phase 2 (Dose Expansion)|Death|5|||
131647682|NCT03520075|473997085|FG017|Phase 2 (Dose Expansion)|Death|14|||
131647683|NCT03520075|473997086|FG018|Phase 2 (Dose Expansion)|Death|12|||
131647684|NCT03520075|473997068|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647685|NCT03520075|473997069|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647686|NCT03520075|473997070|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647687|NCT03520075|473997071|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647688|NCT03520075|473997072|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647689|NCT03520075|473997073|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647690|NCT03520075|473997074|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647691|NCT03520075|473997075|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647692|NCT03520075|473997076|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647693|NCT03520075|473997077|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647694|NCT03520075|473997078|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647695|NCT03520075|473997079|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647696|NCT03520075|473997080|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647697|NCT03520075|473997081|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131647698|NCT03520075|473997082|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
131647699|NCT03520075|473997083|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
131647700|NCT03520075|473997084|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
131647701|NCT03520075|473997085|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
131647702|NCT03520075|473997086|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
131647703|NCT03520075|473997068|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647704|NCT03520075|473997069|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647705|NCT03520075|473997070|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647706|NCT03520075|473997071|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647707|NCT03520075|473997072|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647708|NCT03520075|473997073|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647709|NCT03520075|473997074|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647710|NCT03520075|473997075|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647711|NCT03520075|473997076|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647712|NCT03520075|473997077|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647713|NCT03520075|473997078|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647714|NCT03520075|473997079|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647715|NCT03520075|473997080|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647716|NCT03520075|473997081|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647717|NCT03520075|473997082|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
131647718|NCT03520075|473997083|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
131647719|NCT03520075|473997084|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647720|NCT03520075|473997085|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131647721|NCT03520075|473997086|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
131647722|NCT03520075|473997068|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647723|NCT03520075|473997069|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647724|NCT03520075|473997070|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647725|NCT03520075|473997071|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647726|NCT03520075|473997072|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647727|NCT03520075|473997073|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647728|NCT03520075|473997074|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647729|NCT03520075|473997075|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131715846|NCT04321343|474237000|FG002|Overall Study|Lost to Follow-up|1|||
131802548|NCT01691248|474560661|FG000|Overall Study|Protocol Violation|43|||
131802549|NCT01691248|474560662|FG001|Overall Study|Protocol Violation|27|||
131802550|NCT01691248|474560661|FG000|Overall Study|Adverse Event|24|||
131447677|NCT04949490|473268815|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
131447678|NCT04949490|473268810|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
131447679|NCT04949490|473268811|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
131447680|NCT04949490|473268812|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
131647730|NCT03520075|473997076|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647731|NCT03520075|473997077|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647732|NCT03520075|473997078|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647733|NCT03520075|473997079|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647734|NCT03520075|473997080|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647735|NCT03520075|473997081|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
131647736|NCT03520075|473997082|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647737|NCT03520075|473997083|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647738|NCT03520075|473997084|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
131647739|NCT03520075|473997085|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
131647740|NCT03520075|473997086|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131647741|NCT02577003|473997089|FG000|Overall Study|Adverse Event|2|||
131647742|NCT02577003|473997090|FG001|Overall Study|Adverse Event|4|||
131647743|NCT02577003|473997089|FG000|Overall Study|Withdrawal by Subject|0|||
131647744|NCT02577003|473997090|FG001|Overall Study|Withdrawal by Subject|1|||
131647745|NCT00203047|473997098|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
131647746|NCT00203047|473997099|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
131647747|NCT00203047|473997098|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
131647748|NCT00203047|473997099|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
131647749|NCT00203047|473997098|FG000|Overall Study|Withdrawal by Subject|13|||
131647750|NCT00203047|473997099|FG001|Overall Study|Withdrawal by Subject|47|||
131647751|NCT00203047|473997098|FG000|Overall Study|Teva requested participant withdrawal|1|||
131647752|NCT00203047|473997099|FG001|Overall Study|Teva requested participant withdrawal|1|||
131647753|NCT00203047|473997098|FG000|Overall Study|Physician Decision|8|||
131647754|NCT00203047|473997099|FG001|Overall Study|Physician Decision|7|||
131647755|NCT00203047|473997098|FG000|Overall Study|Non-compliance|4|||
131647756|NCT00203047|473997099|FG001|Overall Study|Non-compliance|8|||
131647757|NCT00203047|473997098|FG000|Overall Study|Protocol Violation|1|||
131647758|NCT00203047|473997099|FG001|Overall Study|Protocol Violation|0|||
131647759|NCT00203047|473997098|FG000|Overall Study|Lost to Follow-up|11|||
131647760|NCT00203047|473997099|FG001|Overall Study|Lost to Follow-up|5|||
131647761|NCT00203047|473997098|FG000|Overall Study|Adverse Event|8|||
131647762|NCT00203047|473997099|FG001|Overall Study|Adverse Event|18|||
131647763|NCT00203047|473997098|FG000|Overall Study|Death|1|||
131647764|NCT00203047|473997099|FG001|Overall Study|Death|2|||
131647765|NCT00203047|473997098|FG000|Overall Study|Pregnancy|3|||
131715847|NCT04321343|474237001|FG003|Overall Study|Lost to Follow-up|3|||
131715848|NCT01097044|474237002|FG000|Overall Study|Withdrawal by Subject|4|||
131715849|NCT01097044|474237003|FG001|Overall Study|Withdrawal by Subject|4|||
131715850|NCT01097044|474237002|FG000|Overall Study|Lost to Follow-up|1|||
131715851|NCT01097044|474237003|FG001|Overall Study|Lost to Follow-up|0|||
131715852|NCT01097044|474237002|FG000|Overall Study|Withdrawal by Sponsor|0|||
131715853|NCT01097044|474237003|FG001|Overall Study|Withdrawal by Sponsor|1|||
131715854|NCT01331161|474237004|FG000|Overall Study|Physician Decision|1|||
131715855|NCT01331161|474237005|FG001|Overall Study|Physician Decision|0|||
131715856|NCT01331161|474237004|FG000|Overall Study|Lost to Follow-up|0|||
131715857|NCT01331161|474237005|FG001|Overall Study|Lost to Follow-up|1|||
131715858|NCT01331161|474237004|FG000|Overall Study|Pregnancy|0|||
131715859|NCT01331161|474237005|FG001|Overall Study|Pregnancy|1|||
131715860|NCT02581995|474237008|FG000|Overall Study|Unspecified other|3|||
131715861|NCT02581995|474237008|FG000|Overall Study|Adverse Event|6|||
131715862|NCT02581995|474237008|FG000|Overall Study|Lost to Follow-up|5|||
131715863|NCT02581995|474237008|FG000|Overall Study|Withdrawal by participant|12|||
131715864|NCT02581995|474237008|FG000|Overall Study|Physician Decision|1|||
131715865|NCT02581995|474237008|FG000|Overall Study|Death|4|||
131715866|NCT03874234|474238839|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715867|NCT03874234|474238840|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715868|NCT03874234|474238841|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715869|NCT03874234|474238842|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
131715870|NCT03874234|474238843|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715871|NCT03874234|474238844|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715872|NCT03874234|474238845|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715873|NCT03874234|474238846|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715874|NCT03874234|474238847|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715875|NCT03874234|474238848|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131802551|NCT01691248|474560662|FG001|Overall Study|Adverse Event|22|||
131802552|NCT01691248|474560661|FG000|Overall Study|Withdrawal by Subject|20|||
131802553|NCT01691248|474560662|FG001|Overall Study|Withdrawal by Subject|18|||
131647766|NCT00203047|473997099|FG001|Overall Study|Pregnancy|0|||
131647767|NCT00203047|473997098|FG000|Overall Study|Other|5|||
131647768|NCT00203047|473997099|FG001|Overall Study|Other|5|||
131647769|NCT00340704|473997104|FG000|PK Study|Adverse Event|0|||
131647770|NCT00340704|473997105|FG001|PK Study|Adverse Event|1|||
131647771|NCT00340704|473997106|FG002|PK Study|Adverse Event|0|||
131647772|NCT00340704|473997107|FG003|PK Study|Adverse Event|0|||
131647773|NCT00340704|473997108|FG004|PK Study|Adverse Event|0|||
131647774|NCT00340704|473997109|FG005|PK Study|Adverse Event|0|||
131647775|NCT00340704|473997110|FG006|PK Study|Adverse Event|0|||
131647776|NCT00340704|473997111|FG007|PK Study|Adverse Event|0|||
131647777|NCT00340704|473997112|FG008|PK Study|Adverse Event|0|||
131647778|NCT00340704|473997104|FG000|PK Study|Not treated|0|||
131647779|NCT00340704|473997105|FG001|PK Study|Not treated|0|||
131647780|NCT00340704|473997106|FG002|PK Study|Not treated|1|||
131647781|NCT00340704|473997107|FG003|PK Study|Not treated|0|||
131647782|NCT00340704|473997108|FG004|PK Study|Not treated|0|||
131647783|NCT00340704|473997109|FG005|PK Study|Not treated|0|||
131647784|NCT00340704|473997110|FG006|PK Study|Not treated|0|||
131647785|NCT00340704|473997111|FG007|PK Study|Not treated|0|||
131647786|NCT00340704|473997112|FG008|PK Study|Not treated|0|||
131647787|NCT00340704|473997104|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131647788|NCT00340704|473997105|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131647789|NCT00340704|473997106|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131647790|NCT00340704|473997107|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
131647791|NCT00340704|473997108|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
131647792|NCT00340704|473997109|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131647793|NCT00340704|473997110|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131647794|NCT00340704|473997111|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
131647795|NCT00340704|473997112|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
131647796|NCT00340704|473997104|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647797|NCT00340704|473997105|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647798|NCT00340704|473997106|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647799|NCT00340704|473997107|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647800|NCT00340704|473997108|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647801|NCT00340704|473997109|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
131647802|NCT00340704|473997110|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647803|NCT00340704|473997111|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647804|NCT00340704|473997112|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131647805|NCT00340704|473997104|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647806|NCT00340704|473997105|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647807|NCT00340704|473997106|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647808|NCT00340704|473997107|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647809|NCT00340704|473997108|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
131647810|NCT00340704|473997109|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
131647811|NCT00340704|473997110|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647812|NCT00340704|473997111|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647813|NCT00340704|473997112|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131647814|NCT00340704|473997104|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131647815|NCT00340704|473997105|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131802554|NCT01691248|474560661|FG000|Overall Study|Confirmed CDAD|14|||
131802555|NCT01691248|474560662|FG001|Overall Study|Confirmed CDAD|31|||
131802556|NCT01691248|474560661|FG000|Overall Study|Lost to Follow-up|2|||
131802557|NCT01691248|474560662|FG001|Overall Study|Lost to Follow-up|5|||
131802558|NCT01691248|474560661|FG000|Overall Study|Reason not provided|4|||
131802559|NCT01691248|474560662|FG001|Overall Study|Reason not provided|4|||
131802560|NCT01691248|474560661|FG000|Overall Study|Not Treated|4|||
131802561|NCT01691248|474560662|FG001|Overall Study|Not Treated|7|||
131802562|NCT01432171|474560663|FG000|Overall Study|Death|1|||
131647816|NCT00340704|473997106|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131657864|NCT01156376|474032918|FG000|Overall Study|Withdrawal by Subject|0|||
131802563|NCT01432171|474560664|FG001|Overall Study|Death|2|||
131802564|NCT01432171|474560663|FG000|Overall Study|Lost to Follow-up|6|||
131802565|NCT01432171|474560664|FG001|Overall Study|Lost to Follow-up|5|||
131715876|NCT03874234|474238849|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715877|NCT03874234|474238850|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715878|NCT03874234|474238851|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131715879|NCT03874234|474238839|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
131715880|NCT03874234|474238840|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715881|NCT03874234|474238841|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715882|NCT03874234|474238842|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715883|NCT03874234|474238843|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715884|NCT03874234|474238844|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715885|NCT03874234|474238845|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715886|NCT03874234|474238846|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715887|NCT03874234|474238847|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715888|NCT03874234|474238848|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715889|NCT03874234|474238849|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715890|NCT03874234|474238850|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715891|NCT03874234|474238851|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131715892|NCT03874234|474238839|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715893|NCT03874234|474238840|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715894|NCT03874234|474238841|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715895|NCT03874234|474238842|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
131715896|NCT03874234|474238843|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715897|NCT03874234|474238844|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715898|NCT03874234|474238845|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715899|NCT03874234|474238846|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715900|NCT03874234|474238847|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715901|NCT03874234|474238848|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715902|NCT03874234|474238849|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715903|NCT03874234|474238850|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715904|NCT03874234|474238851|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131715905|NCT03874234|474238839|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715906|NCT03874234|474238840|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715907|NCT03874234|474238841|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715908|NCT03874234|474238842|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715909|NCT03874234|474238843|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
131715910|NCT03874234|474238844|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715911|NCT03874234|474238845|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715912|NCT03874234|474238846|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715913|NCT03874234|474238847|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715914|NCT03874234|474238848|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715915|NCT03874234|474238849|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715916|NCT03874234|474238850|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715917|NCT03874234|474238851|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131715918|NCT03874234|474238839|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715919|NCT03874234|474238840|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715920|NCT03874234|474238841|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715921|NCT03874234|474238842|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715922|NCT03874234|474238843|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715923|NCT03874234|474238844|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715924|NCT03874234|474238845|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715925|NCT03874234|474238846|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
131715926|NCT03874234|474238847|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715927|NCT03874234|474238848|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715928|NCT03874234|474238849|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715929|NCT03874234|474238850|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715930|NCT03874234|474238851|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131715931|NCT03874234|474238839|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715932|NCT03874234|474238840|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715933|NCT03874234|474238841|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715934|NCT03874234|474238842|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715935|NCT03874234|474238843|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
131715936|NCT03874234|474238844|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
131715937|NCT03874234|474238845|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715938|NCT03874234|474238846|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715939|NCT03874234|474238847|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715940|NCT03874234|474238848|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715941|NCT03874234|474238849|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131647817|NCT00340704|473997107|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131647818|NCT00340704|473997108|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131647819|NCT00340704|473997109|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
131647820|NCT00340704|473997110|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
131647821|NCT00340704|473997111|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
131647822|NCT00340704|473997112|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
131647823|NCT00121667|473997113|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
131647824|NCT00121667|473997114|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
131647825|NCT00121667|473997115|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
131647826|NCT00121667|473997116|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
131647827|NCT00121667|473997113|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
131647828|NCT00121667|473997114|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
131647829|NCT00121667|473997115|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
131647830|NCT00121667|473997116|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
131647831|NCT00121667|473997113|FG000|Short Term (ST) Period|Adverse Event|5|||
131647832|NCT00121667|473997114|FG001|Short Term (ST) Period|Adverse Event|6|||
131647833|NCT00121667|473997115|FG002|Short Term (ST) Period|Adverse Event|5|||
131647834|NCT00121667|473997116|FG003|Short Term (ST) Period|Adverse Event|3|||
131647835|NCT00121667|473997113|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
131447681|NCT04949490|473268813|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
131447682|NCT04949490|473268814|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
131447683|NCT04949490|473268815|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
131447684|NCT02017405|473268816|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
131447685|NCT02017405|473268817|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
131447686|NCT02017405|473268818|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
131447687|NCT02017405|473268819|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
131447688|NCT02017405|473268820|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
131447689|NCT02017405|473268821|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
131447690|NCT02017405|473268816|FG000|Open-label Phase|Adverse Event|1|||
131447691|NCT02017405|473268817|FG001|Open-label Phase|Adverse Event|1|||
131447692|NCT02017405|473268818|FG002|Open-label Phase|Adverse Event|0|||
131447693|NCT02017405|473268819|FG003|Open-label Phase|Adverse Event|0|||
131447694|NCT02017405|473268820|FG004|Open-label Phase|Adverse Event|0|||
131447695|NCT02017405|473268821|FG005|Open-label Phase|Adverse Event|0|||
131447696|NCT02864394|473268823|FG000|Overall Study|Death|184|||
131447697|NCT02864394|473268824|FG001|Overall Study|Death|189|||
131447698|NCT02864394|473268823|FG000|Overall Study|Lost to Follow-up|0|||
131447699|NCT02864394|473268824|FG001|Overall Study|Lost to Follow-up|2|||
131447700|NCT02864394|473268823|FG000|Overall Study|Sponsor Decision|26|||
131447701|NCT02864394|473268824|FG001|Overall Study|Sponsor Decision|11|||
131447702|NCT02864394|473268823|FG000|Overall Study|Withdrawal by Subject|3|||
131447703|NCT02864394|473268824|FG001|Overall Study|Withdrawal by Subject|10|||
131447704|NCT04730804|473268829|FG000|Overall Study|Physician Decision|0|||
131447705|NCT04730804|473268830|FG001|Overall Study|Physician Decision|0|||
131447706|NCT04730804|473268831|FG002|Overall Study|Physician Decision|0|||
131447707|NCT04730804|473268832|FG003|Overall Study|Physician Decision|0|||
131447708|NCT04730804|473268833|FG004|Overall Study|Physician Decision|0|||
131447709|NCT04730804|473268834|FG005|Overall Study|Physician Decision|1|||
131447710|NCT04730804|473268829|FG000|Overall Study|Withdrawal by Subject|0|||
131447711|NCT04730804|473268830|FG001|Overall Study|Withdrawal by Subject|0|||
131447712|NCT04730804|473268831|FG002|Overall Study|Withdrawal by Subject|0|||
131447713|NCT04730804|473268832|FG003|Overall Study|Withdrawal by Subject|0|||
131447714|NCT04730804|473268833|FG004|Overall Study|Withdrawal by Subject|1|||
131447715|NCT04730804|473268834|FG005|Overall Study|Withdrawal by Subject|2|||
131447716|NCT02404025|473270716|FG000|Overall Study|Adverse Event|1|||
131447717|NCT02404025|473270716|FG000|Overall Study|Lack of Efficacy|3|||
131447718|NCT01524796|473270717|FG000|Overall Study|Adverse Event|13|||
131447719|NCT01524796|473270717|FG000|Overall Study|Lack of Efficacy|3|||
131447720|NCT01524796|473270717|FG000|Overall Study|Lost to Follow-up|1|||
131447721|NCT01524796|473270717|FG000|Overall Study|The price|1|||
131447722|NCT01524796|473270717|FG000|Overall Study|Withdrawal by Subject|4|||
131447723|NCT01524796|473270717|FG000|Overall Study|Move|1|||
131447724|NCT01524796|473270717|FG000|Overall Study|Deterioration of pains|1|||
131447725|NCT01524796|473270717|FG000|Overall Study|Gall stone surgery|1|||
131447726|NCT01524796|473270717|FG000|Overall Study|Nervous about confidentiality|1|||
131447727|NCT01524796|473270717|FG000|Overall Study|Switch to carbamazapine|1|||
131447728|NCT01524796|473270717|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
131447729|NCT03938259|473270721|FG000|Overall Study|unable to establish baseline for ventilation|1|||
131447730|NCT03938259|473270722|FG001|Overall Study|unable to establish baseline for ventilation|1|||
131647836|NCT00121667|473997114|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
131647837|NCT00121667|473997115|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
131647838|NCT00121667|473997116|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
131647839|NCT00121667|473997113|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
131647840|NCT00121667|473997114|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
131647841|NCT00121667|473997115|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
131647842|NCT00121667|473997116|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
131447731|NCT00956007|473270725|FG000|Overall Study|Protocol Violation|27|||
131447732|NCT00956007|473270726|FG001|Overall Study|Protocol Violation|23|||
131447733|NCT03774576|473270727|FG000|Period 2|Adverse Event|1|||
131447734|NCT01746901|473270728|FG000|Naloxone Challenge Phase|Adverse Event|2|||
131447735|NCT01746901|473270729|FG001|Naloxone Challenge Phase|Adverse Event|0|||
131447736|NCT01746901|473270730|FG002|Naloxone Challenge Phase|Adverse Event|0|||
131447737|NCT01746901|473270731|FG003|Naloxone Challenge Phase|Adverse Event|0|||
131447738|NCT01746901|473270732|FG004|Naloxone Challenge Phase|Adverse Event|0|||
131447739|NCT01746901|473270733|FG005|Naloxone Challenge Phase|Adverse Event|0|||
131447740|NCT01746901|473270734|FG006|Naloxone Challenge Phase|Adverse Event|0|||
131447741|NCT01746901|473270735|FG007|Naloxone Challenge Phase|Adverse Event|0|||
131447742|NCT01746901|473270736|FG008|Naloxone Challenge Phase|Adverse Event|0|||
131447743|NCT01746901|473270728|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
131447744|NCT01746901|473270729|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447745|NCT01746901|473270730|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131647843|NCT00121667|473997113|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
131647844|NCT00121667|473997114|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
131647845|NCT00121667|473997115|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
131647846|NCT00121667|473997116|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
131647847|NCT00121667|473997113|FG000|Short Term (ST) Period|Other Reason|3|||
131647848|NCT00121667|473997114|FG001|Short Term (ST) Period|Other Reason|0|||
131647849|NCT00121667|473997115|FG002|Short Term (ST) Period|Other Reason|0|||
131647850|NCT00121667|473997116|FG003|Short Term (ST) Period|Other Reason|0|||
131647851|NCT00121667|473997113|FG000|Short Term (ST) Period|Death|0|||
131647852|NCT00121667|473997114|FG001|Short Term (ST) Period|Death|0|||
131647853|NCT00121667|473997115|FG002|Short Term (ST) Period|Death|0|||
131647854|NCT00121667|473997116|FG003|Short Term (ST) Period|Death|1|||
131647855|NCT00121667|473997113|FG000|Short Term (ST) Period|Pregnancy|0|||
131647856|NCT00121667|473997114|FG001|Short Term (ST) Period|Pregnancy|0|||
131647857|NCT00121667|473997115|FG002|Short Term (ST) Period|Pregnancy|0|||
131647858|NCT00121667|473997116|FG003|Short Term (ST) Period|Pregnancy|1|||
131647859|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
131647860|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
131647861|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
131647862|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
131647863|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
131647864|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
131647865|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
131647866|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
131647867|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
131647868|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
131647869|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
131647870|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
131647871|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
131647872|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
131647873|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
131647874|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
131647875|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
131647876|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
131647877|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
131647878|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
131647879|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
131647880|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
131647881|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
131647882|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
131647883|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
131647884|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
131447746|NCT01746901|473270731|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447747|NCT01746901|473270732|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447748|NCT01746901|473270733|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447749|NCT01746901|473270734|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447750|NCT01746901|473270735|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447751|NCT01746901|473270736|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
131447752|NCT01746901|473270728|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447753|NCT01746901|473270729|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
131447754|NCT01746901|473270730|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447755|NCT01746901|473270731|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447756|NCT01746901|473270732|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447757|NCT01746901|473270733|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447758|NCT01746901|473270734|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447759|NCT01746901|473270735|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447760|NCT01746901|473270736|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131447761|NCT01746901|473270728|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131447762|NCT01746901|473270729|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
131447763|NCT01746901|473270730|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
131447764|NCT01746901|473270731|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131447765|NCT01746901|473270732|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131447766|NCT01746901|473270733|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131447767|NCT01746901|473270734|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131647885|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
131647886|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
131647887|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
131647888|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
131658614|NCT02003222|474035395|FG000|Induction|Death|0|||
131903171|NCT01435759|474931413|FG000|Double-blind Phase|Withdrawal by Subject|17|||
131658615|NCT02003222|474035396|FG001|Induction|Death|0|||
131802566|NCT01432171|474560663|FG000|Overall Study|Withdrawal by Subject|3|||
131802567|NCT01432171|474560664|FG001|Overall Study|Withdrawal by Subject|1|||
131802568|NCT01432171|474560663|FG000|Overall Study|Noncompliance|2|||
131802569|NCT01432171|474560664|FG001|Overall Study|Noncompliance|3|||
131802570|NCT01432171|474560663|FG000|Overall Study|Insurance denial trial coverage|1|||
131802571|NCT01432171|474560664|FG001|Overall Study|Insurance denial trial coverage|0|||
131802572|NCT01432171|474560663|FG000|Overall Study|Patient moved to palliative care|1|||
131802573|NCT01432171|474560664|FG001|Overall Study|Patient moved to palliative care|0|||
131802574|NCT02863575|474560665|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
131802575|NCT02863575|474560666|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
131802576|NCT02863575|474560667|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
131802577|NCT02863575|474560665|FG000|Overall Study|Withdrawal by Subject|0|||
131802578|NCT02863575|474560666|FG001|Overall Study|Withdrawal by Subject|1|||
131802579|NCT02863575|474560667|FG002|Overall Study|Withdrawal by Subject|1|||
131802580|NCT02863575|474560665|FG000|Overall Study|Adverse Event|0|||
131802581|NCT02863575|474560666|FG001|Overall Study|Adverse Event|1|||
131802582|NCT02863575|474560667|FG002|Overall Study|Adverse Event|0|||
131802583|NCT01619800|474561935|FG000|Overall Study|study terminated|2|||
131802584|NCT01619800|474561936|FG001|Overall Study|study terminated|0|||
131802585|NCT00419770|474561938|FG000|Overall Study|Withdrawal by Subject|5|||
131802586|NCT00419770|474561939|FG001|Overall Study|Withdrawal by Subject|1|||
131802587|NCT02848326|474561940|FG000|Treatment Period|Adverse Event|5|||
131802588|NCT02848326|474561941|FG001|Treatment Period|Adverse Event|4|||
131802589|NCT02848326|474561942|FG002|Treatment Period|Adverse Event|11|||
131802590|NCT02848326|474561943|FG003|Treatment Period|Adverse Event|6|||
131802591|NCT02848326|474561944|FG004|Treatment Period|Adverse Event|5|||
131802592|NCT02848326|474561945|FG005|Treatment Period|Adverse Event|7|||
131802593|NCT02848326|474561940|FG000|Treatment Period|Withdrawal of Consent|20|||
131802594|NCT02848326|474561941|FG001|Treatment Period|Withdrawal of Consent|6|||
131802595|NCT02848326|474561942|FG002|Treatment Period|Withdrawal of Consent|9|||
131802596|NCT02848326|474561943|FG003|Treatment Period|Withdrawal of Consent|6|||
131802597|NCT02848326|474561944|FG004|Treatment Period|Withdrawal of Consent|9|||
131802598|NCT02848326|474561945|FG005|Treatment Period|Withdrawal of Consent|6|||
131802599|NCT02848326|474561940|FG000|Treatment Period|Lost to Follow-up|5|||
131802600|NCT02848326|474561941|FG001|Treatment Period|Lost to Follow-up|1|||
131447768|NCT01746901|473270735|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131447769|NCT01746901|473270736|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
131447770|NCT01746901|473270728|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447771|NCT01746901|473270729|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
131802601|NCT02848326|474561942|FG002|Treatment Period|Lost to Follow-up|11|||
131802602|NCT02848326|474561943|FG003|Treatment Period|Lost to Follow-up|7|||
131447772|NCT01746901|473270730|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
131447773|NCT01746901|473270731|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447774|NCT01746901|473270732|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447775|NCT01746901|473270733|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447776|NCT01746901|473270734|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447777|NCT01746901|473270735|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447778|NCT01746901|473270736|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
131447779|NCT01746901|473270728|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447780|NCT01746901|473270729|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
131447781|NCT01746901|473270730|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
131447782|NCT01746901|473270731|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447783|NCT01746901|473270732|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447784|NCT01746901|473270733|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447785|NCT01746901|473270734|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447786|NCT01746901|473270735|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447787|NCT01746901|473270736|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131447788|NCT01746901|473270728|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
131447789|NCT01746901|473270729|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
131447790|NCT01746901|473270730|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
131447791|NCT01746901|473270731|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
131448281|NCT02079246|473272632|FG001|OLEX|Other: Moved to nursing home|0|||
131647889|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
131647890|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
131802603|NCT02848326|474561944|FG004|Treatment Period|Lost to Follow-up|2|||
131802604|NCT02848326|474561945|FG005|Treatment Period|Lost to Follow-up|3|||
131802605|NCT02848326|474561940|FG000|Treatment Period|Pregnancy|0|||
131802606|NCT02848326|474561941|FG001|Treatment Period|Pregnancy|0|||
131802607|NCT02848326|474561942|FG002|Treatment Period|Pregnancy|1|||
131802608|NCT02848326|474561943|FG003|Treatment Period|Pregnancy|1|||
131802609|NCT02848326|474561944|FG004|Treatment Period|Pregnancy|0|||
131802610|NCT02848326|474561945|FG005|Treatment Period|Pregnancy|1|||
131802611|NCT02848326|474561940|FG000|Treatment Period|Protocol Violation|4|||
131802612|NCT02848326|474561941|FG001|Treatment Period|Protocol Violation|3|||
131802613|NCT02848326|474561942|FG002|Treatment Period|Protocol Violation|4|||
131647891|NCT00121667|473997113|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
131647892|NCT00121667|473997114|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
131647893|NCT00121667|473997115|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
131647894|NCT00121667|473997116|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
131647895|NCT01453023|473997117|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
131647896|NCT01453023|473997118|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
131647897|NCT01453023|473997117|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
131647898|NCT01453023|473997118|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
131647899|NCT01453023|473997117|FG000|Treatment Period 2|Protocol Violation|0|||
131647900|NCT01453023|473997118|FG001|Treatment Period 2|Protocol Violation|1|||
131802614|NCT02848326|474561943|FG003|Treatment Period|Protocol Violation|2|||
131802615|NCT02848326|474561944|FG004|Treatment Period|Protocol Violation|3|||
131802616|NCT02848326|474561945|FG005|Treatment Period|Protocol Violation|3|||
131802617|NCT02848326|474561940|FG000|Treatment Period|Non-compliance with Study Drug|4|||
131802618|NCT02848326|474561941|FG001|Treatment Period|Non-compliance with Study Drug|0|||
131447792|NCT01746901|473270732|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
131647901|NCT05186311|473997119|FG000|Part A: Serum|Withdrawal by Subject|1|||
131447793|NCT01746901|473270733|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
131647902|NCT02879383|473997120|FG000|First 24 Weeks|Physician Decision|0|||
131647903|NCT02879383|473997121|FG001|First 24 Weeks|Physician Decision|1|||
131647904|NCT02879383|473997122|FG002|First 24 Weeks|Physician Decision|0|||
131647905|NCT02879383|473997123|FG003|First 24 Weeks|Physician Decision|0|||
131647906|NCT02417441|473997140|FG000|Overall Study|Inconclusive due to missing data|52|||
131647907|NCT02417441|473997141|FG001|Overall Study|Inconclusive due to missing data|19|||
131647908|NCT00983853|473997144|FG000|Overall Study|Lost to Follow-up|1|||
131647909|NCT00983853|473997145|FG001|Overall Study|Lost to Follow-up|1|||
131647910|NCT00983853|473997146|FG002|Overall Study|Lost to Follow-up|2|||
131647911|NCT00983853|473997147|FG003|Overall Study|Lost to Follow-up|2|||
131647912|NCT00983853|473997148|FG004|Overall Study|Lost to Follow-up|2|||
131647913|NCT00983853|473997149|FG005|Overall Study|Lost to Follow-up|1|||
131647914|NCT00983853|473997144|FG000|Overall Study|Withdrawal by Subject|0|||
131647915|NCT00983853|473997145|FG001|Overall Study|Withdrawal by Subject|0|||
131647916|NCT00983853|473997146|FG002|Overall Study|Withdrawal by Subject|1|||
131647917|NCT00983853|473997147|FG003|Overall Study|Withdrawal by Subject|0|||
131647918|NCT00983853|473997148|FG004|Overall Study|Withdrawal by Subject|1|||
131647919|NCT00983853|473997149|FG005|Overall Study|Withdrawal by Subject|0|||
131647920|NCT00983853|473997144|FG000|Overall Study|Unable to come to study follow-up visits|0|||
131647921|NCT00983853|473997145|FG001|Overall Study|Unable to come to study follow-up visits|1|||
131647922|NCT00983853|473997146|FG002|Overall Study|Unable to come to study follow-up visits|0|||
131647923|NCT00983853|473997147|FG003|Overall Study|Unable to come to study follow-up visits|0|||
131647924|NCT00983853|473997148|FG004|Overall Study|Unable to come to study follow-up visits|0|||
131647925|NCT00983853|473997149|FG005|Overall Study|Unable to come to study follow-up visits|0|||
131647926|NCT03603639|473997150|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131647927|NCT03603639|473997151|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131647928|NCT03603639|473997152|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131647929|NCT03603639|473997153|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
131647930|NCT03603639|473997154|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131647931|NCT03603639|473997155|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131647932|NCT03603639|473997150|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
131647933|NCT03603639|473997151|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
131647934|NCT03603639|473997152|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
131647935|NCT03603639|473997153|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
131647936|NCT03603639|473997154|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
131647937|NCT03603639|473997155|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
131647938|NCT03016598|473997163|FG000|Overall Study|Lost to Follow-up|0|||
131647939|NCT03016598|473997164|FG001|Overall Study|Lost to Follow-up|2|||
131647940|NCT02947100|473997166|FG000|Overall Study|study terminated early|3|||
131647941|NCT02947100|473997166|FG000|Overall Study|did not meet inclusion criteria|1|||
131647942|NCT00742326|473997169|FG000|Overall Study|Physician Decision|0|||
131647943|NCT00742326|473997170|FG001|Overall Study|Physician Decision|1|||
131647944|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
131647945|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
131647946|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
131647947|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
131647948|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
131647949|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
131647950|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
131647951|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
131647952|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
131647953|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
131647954|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
131647955|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
131647956|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
131647957|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
131647958|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
131647959|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
131647960|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
131647961|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
131647962|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Missing|2|||
131647963|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Missing|1|||
131647964|NCT00443209|473997172|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
131647965|NCT00443209|473997173|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
131647966|NCT00443209|473997172|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
131647967|NCT00443209|473997173|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
131647968|NCT00443209|473997172|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
131447794|NCT01746901|473270734|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
131447795|NCT01746901|473270735|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
131647969|NCT00443209|473997173|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
131647970|NCT00443209|473997172|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
131647971|NCT00443209|473997173|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
131647972|NCT00443209|473997172|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
131647973|NCT00443209|473997173|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
131647974|NCT00443209|473997172|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
131647975|NCT00443209|473997173|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
131647976|NCT00443209|473997172|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
131647977|NCT00443209|473997173|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
131647978|NCT01628692|473997174|FG000|Overall Study|Lack of Efficacy|4|||
131647979|NCT01628692|473997175|FG001|Overall Study|Lack of Efficacy|4|||
131647980|NCT01628692|473997176|FG002|Overall Study|Lack of Efficacy|5|||
131647981|NCT01628692|473997177|FG003|Overall Study|Lack of Efficacy|1|||
131647982|NCT01628692|473997178|FG004|Overall Study|Lack of Efficacy|4|||
131647983|NCT01628692|473997179|FG005|Overall Study|Lack of Efficacy|7|||
131647984|NCT01628692|473997174|FG000|Overall Study|Adverse Event|2|||
131647985|NCT01628692|473997175|FG001|Overall Study|Adverse Event|0|||
131647986|NCT01628692|473997176|FG002|Overall Study|Adverse Event|2|||
131647987|NCT01628692|473997177|FG003|Overall Study|Adverse Event|0|||
131647988|NCT01628692|473997178|FG004|Overall Study|Adverse Event|0|||
131647989|NCT01628692|473997179|FG005|Overall Study|Adverse Event|0|||
131647990|NCT01628692|473997174|FG000|Overall Study|Withdrawal by Subject|0|||
131647991|NCT01628692|473997175|FG001|Overall Study|Withdrawal by Subject|1|||
131647992|NCT01628692|473997176|FG002|Overall Study|Withdrawal by Subject|1|||
131647993|NCT01628692|473997177|FG003|Overall Study|Withdrawal by Subject|0|||
131647994|NCT01628692|473997178|FG004|Overall Study|Withdrawal by Subject|0|||
131647995|NCT01628692|473997179|FG005|Overall Study|Withdrawal by Subject|0|||
131647996|NCT01628692|473997174|FG000|Overall Study|Death|0|||
131647997|NCT01628692|473997175|FG001|Overall Study|Death|1|||
131647998|NCT01628692|473997176|FG002|Overall Study|Death|0|||
131647999|NCT01628692|473997177|FG003|Overall Study|Death|0|||
131648000|NCT01628692|473997178|FG004|Overall Study|Death|0|||
131648001|NCT01628692|473997179|FG005|Overall Study|Death|0|||
131648002|NCT01628692|473997174|FG000|Overall Study|Poor compliance/noncompliance|1|||
131648003|NCT01628692|473997175|FG001|Overall Study|Poor compliance/noncompliance|0|||
131648004|NCT01628692|473997176|FG002|Overall Study|Poor compliance/noncompliance|0|||
131648005|NCT01628692|473997177|FG003|Overall Study|Poor compliance/noncompliance|0|||
131648006|NCT01628692|473997178|FG004|Overall Study|Poor compliance/noncompliance|0|||
131648007|NCT01628692|473997179|FG005|Overall Study|Poor compliance/noncompliance|0|||
131648008|NCT01628692|473997174|FG000|Overall Study|Administrative reason by sponsor|0|||
131648009|NCT01628692|473997175|FG001|Overall Study|Administrative reason by sponsor|0|||
131648010|NCT01628692|473997176|FG002|Overall Study|Administrative reason by sponsor|0|||
131648011|NCT01628692|473997177|FG003|Overall Study|Administrative reason by sponsor|0|||
131648012|NCT01628692|473997178|FG004|Overall Study|Administrative reason by sponsor|0|||
131648013|NCT01628692|473997179|FG005|Overall Study|Administrative reason by sponsor|1|||
131648014|NCT01628692|473997174|FG000|Overall Study|Completed 12 Week only|0|||
131648015|NCT01628692|473997175|FG001|Overall Study|Completed 12 Week only|0|||
131648016|NCT01628692|473997176|FG002|Overall Study|Completed 12 Week only|0|||
131648017|NCT01628692|473997177|FG003|Overall Study|Completed 12 Week only|0|||
131648018|NCT01628692|473997178|FG004|Overall Study|Completed 12 Week only|0|||
131648019|NCT01628692|473997179|FG005|Overall Study|Completed 12 Week only|1|||
131648020|NCT00409409|473997180|FG000|Overall Study|Adverse Event|7|||
131648021|NCT00409409|473997181|FG001|Overall Study|Adverse Event|2|||
131648022|NCT00409409|473997180|FG000|Overall Study|Withdrawal by Subject|1|||
131648023|NCT00409409|473997181|FG001|Overall Study|Withdrawal by Subject|1|||
131648024|NCT00409409|473997180|FG000|Overall Study|Any other reason not above-mentioned|0|||
131648025|NCT00409409|473997181|FG001|Overall Study|Any other reason not above-mentioned|1|||
131715942|NCT03874234|474238850|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715943|NCT03874234|474238851|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131715944|NCT03874234|474238839|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715945|NCT03874234|474238840|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715946|NCT03874234|474238841|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715947|NCT03874234|474238842|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715948|NCT03874234|474238843|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715949|NCT03874234|474238844|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715950|NCT03874234|474238845|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
131715951|NCT03874234|474238846|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715952|NCT03874234|474238847|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715953|NCT03874234|474238848|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715954|NCT03874234|474238849|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131648026|NCT03635086|473997185|FG000|Overall Study|Withdrawal of consent|0|||
131648027|NCT03635086|473997186|FG001|Overall Study|Withdrawal of consent|0|||
131648028|NCT03635086|473997187|FG002|Overall Study|Withdrawal of consent|1|||
131648029|NCT03635086|473997188|FG003|Overall Study|Withdrawal of consent|0|||
131648030|NCT03635086|473997189|FG004|Overall Study|Withdrawal of consent|0|||
131648031|NCT03635086|473997185|FG000|Overall Study|Adverse Event|0|||
131648032|NCT03635086|473997186|FG001|Overall Study|Adverse Event|1|||
131648033|NCT03635086|473997187|FG002|Overall Study|Adverse Event|0|||
131648034|NCT03635086|473997188|FG003|Overall Study|Adverse Event|0|||
131648035|NCT03635086|473997189|FG004|Overall Study|Adverse Event|0|||
131648036|NCT03635086|473997185|FG000|Overall Study|Lost to Follow-up|1|||
131648037|NCT03635086|473997186|FG001|Overall Study|Lost to Follow-up|0|||
131648038|NCT03635086|473997187|FG002|Overall Study|Lost to Follow-up|0|||
131648039|NCT03635086|473997188|FG003|Overall Study|Lost to Follow-up|0|||
131648040|NCT03635086|473997189|FG004|Overall Study|Lost to Follow-up|0|||
131648041|NCT02196077|473997190|FG000|Overall Study|Adverse Event|4|||
131648042|NCT02196077|473997190|FG000|Overall Study|Lack of Efficacy|1|||
131648043|NCT02196077|473997190|FG000|Overall Study|Withdrawal by Subject|14|||
131648044|NCT02196077|473997190|FG000|Overall Study|Physician Decision|1|||
131648045|NCT02196077|473997190|FG000|Overall Study|Lost to Follow-up|3|||
131648046|NCT02196077|473997190|FG000|Overall Study|Protocol Violation|24|||
131648047|NCT03513068|473997195|FG000|Overall Study|Death|1|||
131648048|NCT03513068|473997196|FG001|Overall Study|Death|0|||
131648049|NCT03513068|473997195|FG000|Overall Study|Withdrawal by Subject|4|||
131648050|NCT03513068|473997196|FG001|Overall Study|Withdrawal by Subject|6|||
131648051|NCT01012947|473997197|FG000|Overall Study|Lost to Follow-up|131|||
131648052|NCT01012947|473997198|FG001|Overall Study|Lost to Follow-up|135|||
131648053|NCT01012947|473997199|FG002|Overall Study|Lost to Follow-up|130|||
131648054|NCT01012947|473997200|FG003|Overall Study|Lost to Follow-up|118|||
131648055|NCT01012947|473997201|FG004|Overall Study|Lost to Follow-up|142|||
131648056|NCT04016272|473997204|FG000|Overall Study|Withdrawal by Subject|1|||
131648057|NCT04016272|473997205|FG001|Overall Study|Withdrawal by Subject|2|||
131648058|NCT04547023|473997206|FG000|Overall Study|Did Not Receive Intervention|3|||
131648059|NCT04547023|473997207|FG001|Overall Study|Did Not Receive Intervention|2|||
131648060|NCT04547023|473997206|FG000|Overall Study|Lost to Follow-up|1|||
131648061|NCT04547023|473997207|FG001|Overall Study|Lost to Follow-up|1|||
131648062|NCT01262092|473997208|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
131715955|NCT03874234|474238850|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715956|NCT03874234|474238851|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131715957|NCT03874234|474238839|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715958|NCT03874234|474238840|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715959|NCT03874234|474238841|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715960|NCT03874234|474238842|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715961|NCT03874234|474238843|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
131715962|NCT03874234|474238844|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131903172|NCT01435759|474931414|FG001|Double-blind Phase|Withdrawal by Subject|4|||
131903173|NCT01435759|474931415|FG002|Double-blind Phase|Withdrawal by Subject|3|||
131648063|NCT01262092|473997209|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
131648064|NCT01262092|473997208|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
131648065|NCT01262092|473997209|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
131648066|NCT01262092|473997208|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
131648067|NCT01262092|473997209|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
131648068|NCT01262092|473997208|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
131648069|NCT01262092|473997209|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
131648070|NCT03784820|473997210|FG000|Overall Study|Lost to Follow-up|5|||
131648071|NCT03784820|473997211|FG001|Overall Study|Lost to Follow-up|5|||
131648072|NCT03784820|473997212|FG002|Overall Study|Lost to Follow-up|3|||
131648073|NCT03784820|473997213|FG003|Overall Study|Lost to Follow-up|3|||
131648074|NCT04147858|473997214|FG000|Overall Study|Adverse Event|6|||
131648075|NCT04147858|473997215|FG001|Overall Study|Adverse Event|6|||
131648076|NCT04147858|473997216|FG002|Overall Study|Adverse Event|6|||
131648077|NCT04147858|473997214|FG000|Overall Study|Lack of Efficacy|3|||
131648078|NCT04147858|473997215|FG001|Overall Study|Lack of Efficacy|3|||
131648079|NCT04147858|473997216|FG002|Overall Study|Lack of Efficacy|1|||
131648080|NCT04147858|473997214|FG000|Overall Study|Lost to Follow-up|1|||
131648081|NCT04147858|473997215|FG001|Overall Study|Lost to Follow-up|6|||
131648082|NCT04147858|473997216|FG002|Overall Study|Lost to Follow-up|2|||
131648083|NCT04147858|473997214|FG000|Overall Study|Withdrawal by Subject|3|||
131648084|NCT04147858|473997215|FG001|Overall Study|Withdrawal by Subject|4|||
131648085|NCT04147858|473997216|FG002|Overall Study|Withdrawal by Subject|10|||
131648086|NCT04147858|473997214|FG000|Overall Study|Subject Noncompliance, Other|4|||
131648087|NCT04147858|473997215|FG001|Overall Study|Subject Noncompliance, Other|3|||
131648088|NCT04147858|473997216|FG002|Overall Study|Subject Noncompliance, Other|1|||
131648089|NCT00658606|473997219|FG000|Overall Study|Adverse Event|2|||
131648090|NCT00658606|473997220|FG001|Overall Study|Adverse Event|1|||
131648091|NCT00658606|473997219|FG000|Overall Study|Lack of Efficacy|6|||
131715963|NCT03874234|474238845|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715964|NCT03874234|474238846|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715965|NCT03874234|474238847|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715966|NCT03874234|474238848|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715967|NCT03874234|474238849|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715968|NCT03874234|474238850|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715969|NCT03874234|474238851|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131715970|NCT00686205|474238855|FG000|Overall Study|Protocol Violation|127|||
131715971|NCT00686205|474238856|FG001|Overall Study|Protocol Violation|0|||
131715972|NCT00686205|474238855|FG000|Overall Study|Withdrawal by Subject|2|||
131715973|NCT00686205|474238856|FG001|Overall Study|Withdrawal by Subject|0|||
131715974|NCT00686205|474238855|FG000|Overall Study|Specimen handling procedure altered|5878|||
131715975|NCT00686205|474238856|FG001|Overall Study|Specimen handling procedure altered|0|||
131715976|NCT00686205|474238855|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
131715977|NCT00686205|474238856|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
131715978|NCT00265941|474238857|FG000|Overall Study|Protocol Violation|22|||
131715979|NCT00265941|474238858|FG001|Overall Study|Protocol Violation|25|||
131715980|NCT00265941|474238857|FG000|Overall Study|Lost to Follow-up|1|||
131715981|NCT00265941|474238858|FG001|Overall Study|Lost to Follow-up|1|||
131715982|NCT03816995|474238861|FG000|Overall Study|Withdrawal by Subject|3|||
131715983|NCT03816995|474238862|FG001|Overall Study|Withdrawal by Subject|1|||
131715984|NCT03816995|474238861|FG000|Overall Study|Cancelled Surgery|8|||
131715985|NCT03816995|474238862|FG001|Overall Study|Cancelled Surgery|12|||
131715986|NCT03816995|474238861|FG000|Overall Study|No wound protector used|11|||
131715987|NCT03816995|474238862|FG001|Overall Study|No wound protector used|17|||
131715988|NCT03816995|474238861|FG000|Overall Study|Protocol Violation|2|||
131715989|NCT03816995|474238862|FG001|Overall Study|Protocol Violation|3|||
131715990|NCT01324830|474238864|FG000|Overall Study|Progressive Disease|3|||
131715991|NCT01324830|474238865|FG001|Overall Study|Progressive Disease|2|||
131715992|NCT01324830|474238866|FG002|Overall Study|Progressive Disease|3|||
131715993|NCT01324830|474238867|FG003|Overall Study|Progressive Disease|3|||
131715994|NCT01324830|474238868|FG004|Overall Study|Progressive Disease|6|||
131715995|NCT01324830|474238869|FG005|Overall Study|Progressive Disease|6|||
131648092|NCT00658606|473997220|FG001|Overall Study|Lack of Efficacy|3|||
131648093|NCT00658606|473997219|FG000|Overall Study|Lost to Follow-up|1|||
131648094|NCT00658606|473997220|FG001|Overall Study|Lost to Follow-up|0|||
131648095|NCT00658606|473997219|FG000|Overall Study|Withdrawal by Subject|7|||
131648096|NCT00658606|473997220|FG001|Overall Study|Withdrawal by Subject|16|||
131648097|NCT00658606|473997219|FG000|Overall Study|Lack of Compliance|0|||
131715996|NCT01324830|474238870|FG006|Overall Study|Progressive Disease|3|||
131715997|NCT01324830|474238871|FG007|Overall Study|Progressive Disease|3|||
131715998|NCT01324830|474238872|FG008|Overall Study|Progressive Disease|3|||
131447796|NCT01746901|473270736|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
131447797|NCT01746901|473270728|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447798|NCT01746901|473270729|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447799|NCT01746901|473270730|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447800|NCT01746901|473270731|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447801|NCT01746901|473270732|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447802|NCT01746901|473270733|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447803|NCT01746901|473270734|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447804|NCT01746901|473270735|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
131447805|NCT01746901|473270736|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
131447806|NCT01746901|473270728|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447807|NCT01746901|473270729|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447808|NCT01746901|473270730|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447809|NCT01746901|473270731|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447810|NCT01746901|473270732|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447811|NCT01746901|473270733|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
131447812|NCT01746901|473270734|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
131447813|NCT01746901|473270735|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447814|NCT01746901|473270736|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
131447815|NCT01746901|473270728|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447816|NCT01746901|473270729|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447817|NCT01746901|473270730|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447818|NCT01746901|473270731|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
131447819|NCT01746901|473270732|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447820|NCT01746901|473270733|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447821|NCT01746901|473270734|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447822|NCT01746901|473270735|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447823|NCT01746901|473270736|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
131447824|NCT01746901|473270728|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447825|NCT01746901|473270729|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447826|NCT01746901|473270730|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447827|NCT01746901|473270731|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447828|NCT01746901|473270732|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447829|NCT01746901|473270733|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
131447830|NCT01746901|473270734|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447831|NCT01746901|473270735|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
131447832|NCT01746901|473270736|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
131447833|NCT01746901|473270728|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447834|NCT01746901|473270729|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447835|NCT01746901|473270730|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447836|NCT01746901|473270731|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447837|NCT01746901|473270732|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447838|NCT01746901|473270733|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447839|NCT01746901|473270734|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
131447840|NCT01746901|473270735|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
131447841|NCT01746901|473270736|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
131447842|NCT03594110|473270740|FG000|Interventional Part|Participant concerned about study treatment|23|||
131447843|NCT03594110|473270741|FG001|Interventional Part|Participant concerned about study treatment|28|||
131447844|NCT03594110|473270740|FG000|Interventional Part|Doctor advice|38|||
131447845|NCT03594110|473270741|FG001|Interventional Part|Doctor advice|40|||
131447846|NCT03594110|473270740|FG000|Interventional Part|Participants' wish|89|||
131447847|NCT03594110|473270741|FG001|Interventional Part|Participants' wish|68|||
131447848|NCT03594110|473270740|FG000|Interventional Part|Adverse event-non-fatal events|119|||
131802619|NCT02848326|474561942|FG002|Treatment Period|Non-compliance with Study Drug|0|||
131802620|NCT02848326|474561943|FG003|Treatment Period|Non-compliance with Study Drug|1|||
131802621|NCT02848326|474561944|FG004|Treatment Period|Non-compliance with Study Drug|0|||
131802622|NCT02848326|474561945|FG005|Treatment Period|Non-compliance with Study Drug|0|||
131802623|NCT02848326|474561940|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
131802624|NCT02848326|474561941|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
131802625|NCT02848326|474561942|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
131802626|NCT02848326|474561943|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
131802627|NCT02848326|474561944|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
131802628|NCT02848326|474561945|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
131802629|NCT02848326|474561940|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
131802630|NCT02848326|474561941|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
131802631|NCT02848326|474561942|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
131802632|NCT02848326|474561943|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
131802633|NCT02848326|474561944|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
131802634|NCT02848326|474561945|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
131802635|NCT00414466|474561952|FG000|Overall Study|Adverse Event|0|||
131802636|NCT00414466|474561953|FG001|Overall Study|Adverse Event|0|||
131802637|NCT00414466|474561954|FG002|Overall Study|Adverse Event|1|||
131802638|NCT00414466|474561955|FG003|Overall Study|Adverse Event|1|||
131802639|NCT00414466|474561952|FG000|Overall Study|Lack of Efficacy|1|||
131802640|NCT00414466|474561953|FG001|Overall Study|Lack of Efficacy|0|||
131802641|NCT00414466|474561954|FG002|Overall Study|Lack of Efficacy|0|||
131802642|NCT00414466|474561955|FG003|Overall Study|Lack of Efficacy|0|||
131802643|NCT00414466|474561952|FG000|Overall Study|Withdrawn by Sponsor|1|||
131802644|NCT00414466|474561953|FG001|Overall Study|Withdrawn by Sponsor|0|||
131802645|NCT00414466|474561954|FG002|Overall Study|Withdrawn by Sponsor|0|||
131802646|NCT00414466|474561955|FG003|Overall Study|Withdrawn by Sponsor|0|||
131802647|NCT04526210|474561956|FG000|Overall Study|Sponsor decision|7|||
131802648|NCT04526210|474561957|FG001|Overall Study|Sponsor decision|5|||
131802649|NCT04526210|474561956|FG000|Overall Study|Withdrawal by Subject|3|||
131802650|NCT04526210|474561957|FG001|Overall Study|Withdrawal by Subject|2|||
131802651|NCT02637232|474561958|FG000|Overall Study|Lost to Follow-up|42|||
131648098|NCT00658606|473997220|FG001|Overall Study|Lack of Compliance|3|||
131648099|NCT02520310|473997221|FG000|At 6 Months Clinical Follow-up|Death|1|||
131648100|NCT02520310|473997221|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
131648101|NCT02520310|473997221|FG000|AT 3 Year Clinical Follow-up|Death|2|||
131648102|NCT02520310|473997221|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
131648103|NCT02520310|473997221|FG000|AT 4 Year Clinical Follow-up|Death|1|||
131648104|NCT02520310|473997221|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
131648105|NCT04535544|473997222|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
131648106|NCT04535544|473997223|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
131648107|NCT04535544|473997224|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
131648108|NCT04535544|473997225|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
131648109|NCT04535544|473997222|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
131648110|NCT04535544|473997223|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
131648111|NCT04535544|473997224|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
131648112|NCT04535544|473997225|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
131648113|NCT04535544|473997222|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
131648114|NCT04535544|473997223|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
131648115|NCT04535544|473997224|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
131648116|NCT04535544|473997225|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
131648117|NCT04535544|473997222|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
131648118|NCT04535544|473997223|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
131648119|NCT04535544|473997224|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
131648120|NCT04535544|473997225|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
131648121|NCT04535544|473997222|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
131648122|NCT04535544|473997223|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
131648123|NCT04535544|473997224|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
131648124|NCT04535544|473997225|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
131648125|NCT04535544|473997222|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
131648126|NCT04535544|473997223|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
131648127|NCT04535544|473997224|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
131648128|NCT04535544|473997225|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
131648129|NCT04535544|473997222|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
131648130|NCT04535544|473997223|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
131648131|NCT04535544|473997224|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
131648132|NCT04535544|473997225|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
131648133|NCT04535544|473997222|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
131903174|NCT01435759|474931416|FG003|Double-blind Phase|Withdrawal by Subject|4|||
131903175|NCT01435759|474931417|FG004|Double-blind Phase|Withdrawal by Subject|2|||
131903176|NCT01435759|474931418|FG005|Double-blind Phase|Withdrawal by Subject|2|||
131648134|NCT04535544|473997223|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
131648135|NCT04535544|473997224|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
131648136|NCT04535544|473997225|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
131903177|NCT01435759|474931413|FG000|Double-blind Phase|Lost to Follow-up|31|||
131903178|NCT01435759|474931414|FG001|Double-blind Phase|Lost to Follow-up|1|||
131648137|NCT05992922|473997228|FG000|Overall Study|Adverse Event|6|||
131802652|NCT02637232|474561958|FG000|Overall Study|Adverse Event|11|||
131802653|NCT02637232|474561958|FG000|Overall Study|patient 's decision|2|||
131802654|NCT01781637|474561959|FG000|Overall Study|Adverse Event|1|||
131802655|NCT01781637|474561960|FG001|Overall Study|Adverse Event|0|||
131802656|NCT01781637|474561959|FG000|Overall Study|Lack of Efficacy|2|||
131802657|NCT01781637|474561960|FG001|Overall Study|Lack of Efficacy|6|||
131802658|NCT01781637|474561959|FG000|Overall Study|Withdrawal by Subject|1|||
131802659|NCT01781637|474561960|FG001|Overall Study|Withdrawal by Subject|0|||
131802660|NCT02999178|474561961|FG000|Overall Study|Adverse Event|85|||
131802661|NCT02999178|474561962|FG001|Overall Study|Adverse Event|62|||
131802662|NCT02999178|474561961|FG000|Overall Study|Protocol Violation|1|||
131802663|NCT02999178|474561962|FG001|Overall Study|Protocol Violation|2|||
131802664|NCT02999178|474561961|FG000|Overall Study|Lost to Follow-up|0|||
131802665|NCT02999178|474561962|FG001|Overall Study|Lost to Follow-up|2|||
131802666|NCT02999178|474561961|FG000|Overall Study|Withdrawal by Subject|21|||
131802667|NCT02999178|474561962|FG001|Overall Study|Withdrawal by Subject|21|||
131802668|NCT02999178|474561961|FG000|Overall Study|Other reason not defined above|7|||
131802669|NCT02999178|474561962|FG001|Overall Study|Other reason not defined above|13|||
131802670|NCT00090857|474561964|FG000|Overall Study|Lost to Follow-up|0|||
131802671|NCT00090857|474561965|FG001|Overall Study|Lost to Follow-up|1|||
131648138|NCT05992922|473997229|FG001|Overall Study|Adverse Event|0|||
131648139|NCT05992922|473997228|FG000|Overall Study|Sponsor Termination of Study|14|||
131648140|NCT05992922|473997229|FG001|Overall Study|Sponsor Termination of Study|20|||
131648141|NCT01246999|473998549|FG000|Overall Study|Lost to Follow-up|0|||
131648142|NCT01246999|473998550|FG001|Overall Study|Lost to Follow-up|1|||
131648143|NCT01246999|473998551|FG002|Overall Study|Lost to Follow-up|0|||
131648144|NCT01246999|473998552|FG003|Overall Study|Lost to Follow-up|0|||
131648145|NCT01246999|473998549|FG000|Overall Study|Withdrawal by Subject|0|||
131648146|NCT01246999|473998550|FG001|Overall Study|Withdrawal by Subject|0|||
131648147|NCT01246999|473998551|FG002|Overall Study|Withdrawal by Subject|0|||
131648148|NCT01246999|473998552|FG003|Overall Study|Withdrawal by Subject|2|||
131648149|NCT02172911|473998566|FG000|Overall Study|Serious Adverse Event|0|||
131648150|NCT02172911|473998567|FG001|Overall Study|Serious Adverse Event|1|||
131648151|NCT02172911|473998566|FG000|Overall Study|Progression of Disease|0|||
131648152|NCT02172911|473998567|FG001|Overall Study|Progression of Disease|1|||
131648153|NCT02172911|473998566|FG000|Overall Study|Loss of insurance coverage|1|||
131648154|NCT02172911|473998567|FG001|Overall Study|Loss of insurance coverage|0|||
131648155|NCT00129935|473998570|FG000|Overall Study|Adverse Event|18|||
131648156|NCT00129935|473998571|FG001|Overall Study|Adverse Event|56|||
131648157|NCT00129935|473998570|FG000|Overall Study|Death|1|||
131648158|NCT00129935|473998571|FG001|Overall Study|Death|1|||
131648159|NCT00129935|473998570|FG000|Overall Study|Withdrawal by Subject|7|||
131648160|NCT00129935|473998571|FG001|Overall Study|Withdrawal by Subject|20|||
131648161|NCT00129935|473998570|FG000|Overall Study|Protocol Violation|0|||
131648162|NCT00129935|473998571|FG001|Overall Study|Protocol Violation|4|||
131648163|NCT00129935|473998570|FG000|Overall Study|Physician Decision|3|||
131648164|NCT00129935|473998571|FG001|Overall Study|Physician Decision|4|||
131648165|NCT00129935|473998570|FG000|Overall Study|Recurrence|1|||
131648166|NCT00129935|473998571|FG001|Overall Study|Recurrence|3|||
131648167|NCT00129935|473998570|FG000|Overall Study|Second primary|0|||
131648168|NCT00129935|473998571|FG001|Overall Study|Second primary|1|||
131648169|NCT00129935|473998570|FG000|Overall Study|Other|3|||
131648170|NCT00129935|473998571|FG001|Overall Study|Other|2|||
131648171|NCT00129935|473998570|FG000|Overall Study|Crossed to the other arm|2|||
131648172|NCT00129935|473998571|FG001|Overall Study|Crossed to the other arm|1|||
131648173|NCT00129935|473998570|FG000|Overall Study|Incorrect study treatment|1|||
131648174|NCT00129935|473998571|FG001|Overall Study|Incorrect study treatment|0|||
131648175|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
131648176|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
131648177|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
131648178|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Death|4|||
131648179|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Death|2|||
131648180|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Death|3|||
131648181|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
131648182|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
131648183|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
131648184|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
131648185|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
131648186|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
131648187|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
131648188|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
131648189|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
131648190|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
131648191|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
131802672|NCT00090857|474561964|FG000|Overall Study|Withdrawal by Subject|2|||
131802673|NCT00090857|474561965|FG001|Overall Study|Withdrawal by Subject|0|||
131802674|NCT00090857|474561964|FG000|Overall Study|Adverse Event|2|||
131802675|NCT00090857|474561965|FG001|Overall Study|Adverse Event|2|||
131802676|NCT05097326|474561966|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
131802677|NCT05097326|474561967|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
131447849|NCT03594110|473270741|FG001|Interventional Part|Adverse event-non-fatal events|116|||
131447850|NCT03594110|473270740|FG000|Interventional Part|Study drug stopped, reason missing|336|||
131447851|NCT03594110|473270741|FG001|Interventional Part|Study drug stopped, reason missing|294|||
131447852|NCT03594110|473270740|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
131447853|NCT03594110|473270741|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
131447854|NCT03594110|473270740|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
131447855|NCT03594110|473270741|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
131447856|NCT03594110|473270740|FG000|Interventional Part|Contraindicated drug started|32|||
131447857|NCT03594110|473270741|FG001|Interventional Part|Contraindicated drug started|18|||
131447858|NCT03594110|473270740|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
131447859|NCT03594110|473270741|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
131447860|NCT03594110|473270740|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
131447861|NCT03594110|473270741|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
131447862|NCT03594110|473270740|FG000|Non-interventional Part|Withdrawal by Subject|3|||
131447863|NCT03594110|473270741|FG001|Non-interventional Part|Withdrawal by Subject|4|||
131447864|NCT03594110|473270740|FG000|Non-interventional Part|Lost to Follow-up|45|||
131447865|NCT03594110|473270741|FG001|Non-interventional Part|Lost to Follow-up|41|||
131447866|NCT05029362|473270742|FG000|Overall Study|Lost to Follow-up|9|||
131447867|NCT00684021|473270748|FG000|Overall Study|MRI Contraindicated|1|||
131447868|NCT00684021|473270749|FG001|Overall Study|MRI Contraindicated|1|||
131447869|NCT00684021|473270750|FG002|Overall Study|MRI Contraindicated|1|||
131447870|NCT00684021|473270751|FG003|Overall Study|MRI Contraindicated|0|||
131447871|NCT00684021|473270748|FG000|Overall Study|MRI not performed|0|||
131715999|NCT01324830|474238873|FG009|Overall Study|Progressive Disease|6|||
131716000|NCT01324830|474238874|FG010|Overall Study|Progressive Disease|2|||
131903179|NCT01435759|474931415|FG002|Double-blind Phase|Lost to Follow-up|2|||
131447872|NCT00684021|473270749|FG001|Overall Study|MRI not performed|1|||
131447873|NCT00684021|473270750|FG002|Overall Study|MRI not performed|1|||
131447874|NCT00684021|473270751|FG003|Overall Study|MRI not performed|2|||
131447875|NCT00684021|473270748|FG000|Overall Study|Death|1|||
131447876|NCT00684021|473270749|FG001|Overall Study|Death|0|||
131447877|NCT00684021|473270750|FG002|Overall Study|Death|0|||
131447878|NCT00684021|473270751|FG003|Overall Study|Death|0|||
131447879|NCT00927953|473270752|FG000|Overall Study|Death|2|||
131447880|NCT00927953|473270753|FG001|Overall Study|Death|1|||
131447881|NCT04041414|473270754|FG000|Overall Study|Lost to Follow-up|1|||
131447882|NCT04041414|473270755|FG001|Overall Study|Lost to Follow-up|2|||
131447883|NCT02900378|473270756|FG000|Randomization (Visit 2)|Adverse Event|14|||
131447884|NCT02900378|473270757|FG001|Randomization (Visit 2)|Adverse Event|11|||
131447885|NCT02900378|473270756|FG000|Randomization (Visit 2)|Death|1|||
131447886|NCT02900378|473270757|FG001|Randomization (Visit 2)|Death|4|||
131447887|NCT02900378|473270756|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
131447888|NCT02900378|473270757|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
131447889|NCT02900378|473270756|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
131447890|NCT02900378|473270757|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
131447891|NCT02900378|473270756|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
131447892|NCT02900378|473270757|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
131447893|NCT02900378|473270756|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
131447894|NCT02900378|473270757|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
131447895|NCT02900378|473270756|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
131447896|NCT02900378|473270757|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
131447897|NCT01249261|473270771|FG000|Overall Study|Withdrawal by Subject|1|||
131447898|NCT01249261|473270772|FG001|Overall Study|Withdrawal by Subject|0|||
131447899|NCT00482053|473270776|FG000|Inter-treatment Period|Disease progression|1|||
131447900|NCT01055197|473270783|FG000|Overall Study|Protocol Violation|7|||
131447901|NCT01055197|473270784|FG001|Overall Study|Protocol Violation|2|||
131716001|NCT01324830|474238875|FG011|Overall Study|Progressive Disease|1|||
131716002|NCT01324830|474238876|FG012|Overall Study|Progressive Disease|1|||
131716003|NCT01324830|474238877|FG013|Overall Study|Progressive Disease|1|||
131716004|NCT01324830|474238878|FG014|Overall Study|Progressive Disease|1|||
131716005|NCT01324830|474238879|FG015|Overall Study|Progressive Disease|3|||
131716006|NCT01324830|474238880|FG016|Overall Study|Progressive Disease|2|||
131716007|NCT01324830|474238881|FG017|Overall Study|Progressive Disease|3|||
131716008|NCT01324830|474238882|FG018|Overall Study|Progressive Disease|4|||
131716009|NCT01324830|474238864|FG000|Overall Study|Dose limiting toxicity|0|||
131716010|NCT01324830|474238865|FG001|Overall Study|Dose limiting toxicity|0|||
131447902|NCT01055197|473270783|FG000|Overall Study|Withdrawal by Subject|2|||
131447903|NCT01055197|473270784|FG001|Overall Study|Withdrawal by Subject|0|||
131447904|NCT00389610|473270785|FG000|Overall Study|Disease Progression|0|||
131447905|NCT00389610|473270786|FG001|Overall Study|Disease Progression|19|||
131447906|NCT00389610|473270785|FG000|Overall Study|Death|0|||
131447907|NCT00389610|473270786|FG001|Overall Study|Death|1|||
131447908|NCT00389610|473270785|FG000|Overall Study|Physician Decision|0|||
131716011|NCT01324830|474238866|FG002|Overall Study|Dose limiting toxicity|0|||
131716012|NCT01324830|474238867|FG003|Overall Study|Dose limiting toxicity|0|||
131648192|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
131648193|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
131648194|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
131648195|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
131648196|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
131648197|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
131648198|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
131648199|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
131648200|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
131903180|NCT01435759|474931416|FG003|Double-blind Phase|Lost to Follow-up|0|||
131903181|NCT01435759|474931417|FG004|Double-blind Phase|Lost to Follow-up|3|||
131903182|NCT01435759|474931418|FG005|Double-blind Phase|Lost to Follow-up|3|||
131903183|NCT01435759|474931413|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
131903184|NCT01435759|474931414|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
131903185|NCT01435759|474931415|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
131447909|NCT00389610|473270786|FG001|Overall Study|Physician Decision|1|||
131447910|NCT00389610|473270785|FG000|Overall Study|Withdrawal by Subject|0|||
131447911|NCT00389610|473270786|FG001|Overall Study|Withdrawal by Subject|1|||
131648201|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
131648202|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
131648203|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
131648204|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
131648205|NCT02783573|473998572|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
131648206|NCT02783573|473998573|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
131648207|NCT02783573|473998574|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
131648208|NCT02783573|473998572|FG000|Delayed-Start Period|Sponsor Decision|0|||
131648209|NCT02783573|473998573|FG001|Delayed-Start Period|Sponsor Decision|17|||
131648210|NCT02783573|473998574|FG002|Delayed-Start Period|Sponsor Decision|12|||
131648211|NCT00725712|473998582|FG000|Overall Study|Withdrawal by Subject|2|||
131648212|NCT00725712|473998583|FG001|Overall Study|Withdrawal by Subject|1|||
131648213|NCT00725712|473998582|FG000|Overall Study|Protocol Violation|1|||
131648214|NCT00725712|473998583|FG001|Overall Study|Protocol Violation|0|||
131447912|NCT00538902|473270787|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
131447913|NCT00538902|473270788|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
131447914|NCT00538902|473270789|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
131447915|NCT00538902|473270787|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
131447916|NCT00538902|473270788|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
131447917|NCT00538902|473270789|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
131447918|NCT00538902|473270787|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
131447919|NCT00538902|473270788|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
131447920|NCT00538902|473270789|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
131648215|NCT00725712|473998582|FG000|Overall Study|Progressive disease|37|||
131648216|NCT00725712|473998583|FG001|Overall Study|Progressive disease|16|||
131648217|NCT00725712|473998582|FG000|Overall Study|Clinical progression not based on RECIST|0|||
131648218|NCT00725712|473998583|FG001|Overall Study|Clinical progression not based on RECIST|3|||
131648219|NCT00725712|473998582|FG000|Overall Study|Adverse Event|5|||
131648220|NCT00725712|473998583|FG001|Overall Study|Adverse Event|5|||
131648221|NCT00725712|473998582|FG000|Overall Study|Death|2|||
131648222|NCT00725712|473998583|FG001|Overall Study|Death|0|||
131648223|NCT00725712|473998582|FG000|Overall Study|Other: Death|1|||
131648224|NCT00725712|473998583|FG001|Overall Study|Other: Death|0|||
131648225|NCT00725712|473998582|FG000|Overall Study|Hospitalized, unable to continue|0|||
131648226|NCT00725712|473998583|FG001|Overall Study|Hospitalized, unable to continue|1|||
131648227|NCT01439867|473998584|FG000|Overall Study|Non-compliance|0|||
131648228|NCT01439867|473998585|FG001|Overall Study|Non-compliance|1|||
131648229|NCT01439867|473998584|FG000|Overall Study|Withdrawal by Subject|1|||
131716013|NCT01324830|474238868|FG004|Overall Study|Dose limiting toxicity|1|||
131716014|NCT01324830|474238869|FG005|Overall Study|Dose limiting toxicity|0|||
131716015|NCT01324830|474238870|FG006|Overall Study|Dose limiting toxicity|0|||
131716016|NCT01324830|474238871|FG007|Overall Study|Dose limiting toxicity|0|||
131716017|NCT01324830|474238872|FG008|Overall Study|Dose limiting toxicity|0|||
131716018|NCT01324830|474238873|FG009|Overall Study|Dose limiting toxicity|0|||
131716019|NCT01324830|474238874|FG010|Overall Study|Dose limiting toxicity|0|||
131716020|NCT01324830|474238875|FG011|Overall Study|Dose limiting toxicity|0|||
131716021|NCT01324830|474238876|FG012|Overall Study|Dose limiting toxicity|0|||
131716022|NCT01324830|474238877|FG013|Overall Study|Dose limiting toxicity|0|||
131716023|NCT01324830|474238878|FG014|Overall Study|Dose limiting toxicity|0|||
131716024|NCT01324830|474238879|FG015|Overall Study|Dose limiting toxicity|0|||
131716025|NCT01324830|474238880|FG016|Overall Study|Dose limiting toxicity|1|||
131716026|NCT01324830|474238881|FG017|Overall Study|Dose limiting toxicity|1|||
131716027|NCT01324830|474238882|FG018|Overall Study|Dose limiting toxicity|1|||
131716028|NCT01324830|474238864|FG000|Overall Study|Reason not mentioned above|0|||
131716029|NCT01324830|474238865|FG001|Overall Study|Reason not mentioned above|0|||
131716030|NCT01324830|474238866|FG002|Overall Study|Reason not mentioned above|0|||
131716031|NCT01324830|474238867|FG003|Overall Study|Reason not mentioned above|0|||
131716032|NCT01324830|474238868|FG004|Overall Study|Reason not mentioned above|0|||
131716033|NCT01324830|474238869|FG005|Overall Study|Reason not mentioned above|0|||
131716034|NCT01324830|474238870|FG006|Overall Study|Reason not mentioned above|0|||
131716035|NCT01324830|474238871|FG007|Overall Study|Reason not mentioned above|0|||
131716036|NCT01324830|474238872|FG008|Overall Study|Reason not mentioned above|0|||
131903186|NCT01435759|474931416|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
131903187|NCT01435759|474931417|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
131903188|NCT01435759|474931418|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
131903189|NCT01435759|474931413|FG000|Double-blind Phase|Other|8|||
131903190|NCT01435759|474931414|FG001|Double-blind Phase|Other|2|||
131903191|NCT01435759|474931415|FG002|Double-blind Phase|Other|0|||
131903192|NCT01435759|474931416|FG003|Double-blind Phase|Other|2|||
131648230|NCT01439867|473998585|FG001|Overall Study|Withdrawal by Subject|2|||
131648231|NCT01439867|473998584|FG000|Overall Study|Administrative Decision|4|||
131648232|NCT01439867|473998585|FG001|Overall Study|Administrative Decision|5|||
131648233|NCT01439867|473998584|FG000|Overall Study|Protocol-specified Criteria|1|||
131648234|NCT01439867|473998585|FG001|Overall Study|Protocol-specified Criteria|0|||
131648235|NCT02056626|473998586|FG000|Overall Study|patient did not follow directions|3|||
131648236|NCT02056626|473998587|FG001|Overall Study|patient did not follow directions|1|||
131648237|NCT02056626|473998588|FG002|Overall Study|patient did not follow directions|0|||
131648238|NCT02056626|473998589|FG003|Overall Study|patient did not follow directions|0|||
131648239|NCT00863512|473998590|FG000|Overall Study|Adverse Event|2|||
131648240|NCT00863512|473998591|FG001|Overall Study|Adverse Event|0|||
131648241|NCT00863512|473998590|FG000|Overall Study|Withdrawal by Subject|11|||
131648242|NCT00863512|473998591|FG001|Overall Study|Withdrawal by Subject|0|||
131648243|NCT00863512|473998590|FG000|Overall Study|Physician Decision|1|||
131648244|NCT00863512|473998591|FG001|Overall Study|Physician Decision|0|||
131648245|NCT02635360|473998592|FG000|Overall Study|Adverse Event|0|||
131648246|NCT02635360|473998593|FG001|Overall Study|Adverse Event|3|||
131648247|NCT02635360|473998592|FG000|Overall Study|Withdrawal by Subject|2|||
131648248|NCT02635360|473998593|FG001|Overall Study|Withdrawal by Subject|0|||
131648249|NCT02635360|473998592|FG000|Overall Study|Non-Compliance|3|||
131648250|NCT02635360|473998593|FG001|Overall Study|Non-Compliance|1|||
131648251|NCT02635360|473998592|FG000|Overall Study|Disease Progression|0|||
131648252|NCT02635360|473998593|FG001|Overall Study|Disease Progression|2|||
131648253|NCT02635360|473998592|FG000|Overall Study|Lost to Follow-up|1|||
131648254|NCT02635360|473998593|FG001|Overall Study|Lost to Follow-up|1|||
131648255|NCT01454739|473998597|FG000|Overall Study|Protocol Violation|2|||
131648256|NCT01454739|473998598|FG001|Overall Study|Protocol Violation|3|||
131648257|NCT01454739|473998597|FG000|Overall Study|Withdrawal by Subject|2|||
131648258|NCT01454739|473998598|FG001|Overall Study|Withdrawal by Subject|6|||
131648259|NCT01454739|473998597|FG000|Overall Study|Other|3|||
131648260|NCT01454739|473998598|FG001|Overall Study|Other|5|||
131648261|NCT01454739|473998597|FG000|Overall Study|Physician Decision|0|||
131648262|NCT01454739|473998598|FG001|Overall Study|Physician Decision|5|||
131648263|NCT01454739|473998597|FG000|Overall Study|Lost to Follow-up|0|||
131648264|NCT01454739|473998598|FG001|Overall Study|Lost to Follow-up|1|||
131648265|NCT01454739|473998597|FG000|Overall Study|Adverse Event|0|||
131648266|NCT01454739|473998598|FG001|Overall Study|Adverse Event|1|||
131648267|NCT01784523|473998601|FG000|Overall Study|Study closed early|7|||
131648268|NCT01784523|473998602|FG001|Overall Study|Study closed early|4|||
131648269|NCT04340947|473998603|FG000|7-day Washout Period|Lost to Follow-up|5|||
131648270|NCT04340947|473998604|FG001|7-day Washout Period|Lost to Follow-up|4|||
131648271|NCT01124097|473998608|FG000|Overall Study|Withdrawal by Subject|4|||
131648272|NCT01124097|473998609|FG001|Overall Study|Withdrawal by Subject|3|||
131648273|NCT01124097|473998610|FG002|Overall Study|Withdrawal by Subject|2|||
131648274|NCT01124097|473998611|FG003|Overall Study|Withdrawal by Subject|3|||
131648275|NCT01124097|473998608|FG000|Overall Study|Lack of Efficacy|2|||
131648276|NCT01124097|473998609|FG001|Overall Study|Lack of Efficacy|3|||
131648277|NCT01124097|473998610|FG002|Overall Study|Lack of Efficacy|1|||
131648278|NCT01124097|473998611|FG003|Overall Study|Lack of Efficacy|3|||
131648279|NCT01124097|473998608|FG000|Overall Study|Adverse Event|24|||
131648280|NCT01124097|473998609|FG001|Overall Study|Adverse Event|15|||
131648281|NCT01124097|473998610|FG002|Overall Study|Adverse Event|15|||
131648282|NCT01124097|473998611|FG003|Overall Study|Adverse Event|7|||
131648283|NCT01124097|473998608|FG000|Overall Study|Protocol Violation|2|||
131648284|NCT01124097|473998609|FG001|Overall Study|Protocol Violation|0|||
131648285|NCT01124097|473998610|FG002|Overall Study|Protocol Violation|2|||
131648286|NCT01124097|473998611|FG003|Overall Study|Protocol Violation|1|||
131648287|NCT01124097|473998608|FG000|Overall Study|Physician Decision|2|||
131648288|NCT01124097|473998609|FG001|Overall Study|Physician Decision|1|||
131648289|NCT01124097|473998610|FG002|Overall Study|Physician Decision|0|||
131648290|NCT01124097|473998611|FG003|Overall Study|Physician Decision|0|||
131903193|NCT01435759|474931417|FG004|Double-blind Phase|Other|0|||
131648291|NCT01677299|473998612|FG000|Overall Study|Adverse Event|0|||
131648292|NCT01677299|473998613|FG001|Overall Study|Adverse Event|2|||
131648293|NCT01677299|473998614|FG002|Overall Study|Adverse Event|1|||
131648294|NCT01677299|473998615|FG003|Overall Study|Adverse Event|0|||
131648295|NCT01677299|473998612|FG000|Overall Study|Withdrawal by Subject|0|||
131648296|NCT01677299|473998613|FG001|Overall Study|Withdrawal by Subject|1|||
131648297|NCT01677299|473998614|FG002|Overall Study|Withdrawal by Subject|0|||
131648298|NCT01677299|473998615|FG003|Overall Study|Withdrawal by Subject|1|||
131648299|NCT00193479|473998616|FG000|Induction Chemotherapy|Adverse Event|2|||
131648300|NCT00193479|473998616|FG000|Induction Chemotherapy|Disease Progression|1|||
131648301|NCT00193479|473998616|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
131648302|NCT00193479|473998616|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
131648303|NCT03334253|473998618|FG000|Overall Study|Withdrawal by Subject|1|||
131648304|NCT03334253|473998619|FG001|Overall Study|Withdrawal by Subject|0|||
131648305|NCT03334253|473998618|FG000|Overall Study|Lost to Follow-up|4|||
131648306|NCT03334253|473998619|FG001|Overall Study|Lost to Follow-up|3|||
131648307|NCT03334253|473998618|FG000|Overall Study|Moved residence|2|||
131716037|NCT01324830|474238873|FG009|Overall Study|Reason not mentioned above|0|||
131716038|NCT01324830|474238874|FG010|Overall Study|Reason not mentioned above|0|||
131716039|NCT01324830|474238875|FG011|Overall Study|Reason not mentioned above|0|||
131716040|NCT01324830|474238876|FG012|Overall Study|Reason not mentioned above|0|||
131716041|NCT01324830|474238877|FG013|Overall Study|Reason not mentioned above|0|||
131716042|NCT01324830|474238878|FG014|Overall Study|Reason not mentioned above|0|||
131716043|NCT01324830|474238879|FG015|Overall Study|Reason not mentioned above|0|||
131716044|NCT01324830|474238880|FG016|Overall Study|Reason not mentioned above|0|||
131716045|NCT01324830|474238881|FG017|Overall Study|Reason not mentioned above|1|||
131716046|NCT01324830|474238882|FG018|Overall Study|Reason not mentioned above|0|||
131716047|NCT01324830|474238864|FG000|Overall Study|Adverse Event, serious fatal|0|||
131716048|NCT01324830|474238865|FG001|Overall Study|Adverse Event, serious fatal|1|||
131716049|NCT01324830|474238866|FG002|Overall Study|Adverse Event, serious fatal|0|||
131716050|NCT01324830|474238867|FG003|Overall Study|Adverse Event, serious fatal|0|||
131716051|NCT01324830|474238868|FG004|Overall Study|Adverse Event, serious fatal|0|||
131716052|NCT01324830|474238869|FG005|Overall Study|Adverse Event, serious fatal|0|||
131716053|NCT01324830|474238870|FG006|Overall Study|Adverse Event, serious fatal|0|||
131716054|NCT01324830|474238871|FG007|Overall Study|Adverse Event, serious fatal|0|||
131716055|NCT01324830|474238872|FG008|Overall Study|Adverse Event, serious fatal|0|||
131716056|NCT01324830|474238873|FG009|Overall Study|Adverse Event, serious fatal|0|||
131903194|NCT01435759|474931418|FG005|Double-blind Phase|Other|0|||
131903195|NCT02849587|474931421|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
131903196|NCT02849587|474931422|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
131903197|NCT02849587|474931423|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
131903198|NCT02849587|474931421|FG000|Overall Study|Withdrawal by Subject|0|||
131903199|NCT02849587|474931422|FG001|Overall Study|Withdrawal by Subject|1|||
131903200|NCT02849587|474931423|FG002|Overall Study|Withdrawal by Subject|0|||
131903201|NCT02421419|474931427|FG000|Overall Study|Physician Decision|0|||
131903202|NCT02421419|474931428|FG001|Overall Study|Physician Decision|0|||
131903203|NCT02421419|474931429|FG002|Overall Study|Physician Decision|1|||
131903204|NCT01275144|474931437|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
131903205|NCT01275144|474931438|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
131903206|NCT01365130|474931439|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
131903207|NCT05607576|474931441|FG000|Overall Study|immediate sensor error|2|||
131903208|NCT05607576|474931441|FG000|Overall Study|Physician Decision|2|||
131903209|NCT01091246|474931442|FG000|Overall Study|Lost to Follow-up|23|||
131903210|NCT01091246|474931443|FG001|Overall Study|Lost to Follow-up|11|||
131903211|NCT01091246|474931444|FG002|Overall Study|Lost to Follow-up|7|||
131903212|NCT01091246|474931442|FG000|Overall Study|Adverse Event|1|||
131903213|NCT01091246|474931443|FG001|Overall Study|Adverse Event|0|||
131903214|NCT01091246|474931444|FG002|Overall Study|Adverse Event|1|||
131903215|NCT01091246|474931442|FG000|Overall Study|Withdrawal by Subject|9|||
131903216|NCT01091246|474931443|FG001|Overall Study|Withdrawal by Subject|5|||
131903217|NCT01091246|474931444|FG002|Overall Study|Withdrawal by Subject|4|||
131903218|NCT01091246|474931442|FG000|Overall Study|Subject not dosed|2|||
131903219|NCT01091246|474931443|FG001|Overall Study|Subject not dosed|0|||
131903220|NCT01091246|474931444|FG002|Overall Study|Subject not dosed|1|||
131648308|NCT03334253|473998619|FG001|Overall Study|Moved residence|2|||
131648309|NCT00872001|473998620|FG000|Overall Study|Adverse Event|34|||
131648310|NCT00872001|473998621|FG001|Overall Study|Adverse Event|23|||
131648311|NCT00872001|473998620|FG000|Overall Study|Protocol Defined Clinical Event|5|||
131648312|NCT00872001|473998621|FG001|Overall Study|Protocol Defined Clinical Event|7|||
131648313|NCT00872001|473998620|FG000|Overall Study|Lost to Follow-up|13|||
131716057|NCT01324830|474238874|FG010|Overall Study|Adverse Event, serious fatal|0|||
131903221|NCT01819727|474931445|FG000|Overall Study|Adverse Event|8|||
131716058|NCT01324830|474238875|FG011|Overall Study|Adverse Event, serious fatal|0|||
131716059|NCT01324830|474238876|FG012|Overall Study|Adverse Event, serious fatal|0|||
131802678|NCT02684344|474561969|FG000|Overall Study|Withdrawal by Subject|0|||
131802679|NCT02684344|474561970|FG001|Overall Study|Withdrawal by Subject|1|||
131648314|NCT00872001|473998621|FG001|Overall Study|Lost to Follow-up|12|||
131648315|NCT00872001|473998620|FG000|Overall Study|Withdrawal by Subject|18|||
131648316|NCT00872001|473998621|FG001|Overall Study|Withdrawal by Subject|30|||
131648317|NCT00872001|473998620|FG000|Overall Study|Protocol Violation|5|||
131648318|NCT00872001|473998621|FG001|Overall Study|Protocol Violation|8|||
131648319|NCT00872001|473998620|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
131648320|NCT00872001|473998621|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
131648321|NCT00872001|473998620|FG000|Overall Study|Administrative|23|||
131648322|NCT00872001|473998621|FG001|Overall Study|Administrative|15|||
131648323|NCT02030002|473998622|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
131648324|NCT02030002|473998622|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
131648325|NCT02030002|473998622|FG000|Follow-up|Lost to Follow-up|2|||
131648326|NCT02413593|473998632|FG000|Overall Study|Lost to Follow-up|3|||
131648327|NCT02413593|473998632|FG000|Overall Study|Adverse Event|1|||
131648328|NCT01807182|473998633|FG000|Overall Study|Death|1|||
131648329|NCT01807182|473998633|FG000|Overall Study|New therapy|1|||
131648330|NCT01807182|473998633|FG000|Overall Study|Moved to hospice care|1|||
131648331|NCT00150618|473998636|FG000|Overall Study|Adverse Event|2|||
131802680|NCT03480425|474561971|FG000|Overall Study|Force transducer technical failure|1|||
131802681|NCT02424188|474561973|FG000|Overall Study|Death|2|||
131802682|NCT02424188|474561974|FG001|Overall Study|Death|2|||
131802683|NCT02424188|474561973|FG000|Overall Study|Lost to Follow-up|1|||
131802684|NCT02424188|474561974|FG001|Overall Study|Lost to Follow-up|3|||
131802685|NCT02424188|474561973|FG000|Overall Study|Incarceration|1|||
131802686|NCT02424188|474561974|FG001|Overall Study|Incarceration|0|||
131802687|NCT01085045|474561975|FG000|Part A|Withdrawal by Subject|4|||
131802688|NCT01085045|474561975|FG000|Part A|Adverse Event|6|||
131802689|NCT01085045|474561975|FG000|Part A|Protocol Violation|1|||
131802690|NCT01085045|474561975|FG000|Part A|Protocol Specified Criteria|7|||
131802691|NCT01085045|474561975|FG000|Part B|Withdrawal by Subject|2|||
131802692|NCT01085045|474561975|FG000|Part B|Protocol Specified Criteria|6|||
131802693|NCT01085045|474561975|FG000|Part B|Lost to Follow-up|1|||
131802694|NCT01085045|474561975|FG000|Part B|Adverse Event|6|||
131802695|NCT00416520|474561981|FG000|Open-label Period|Adverse Event|28|||
131802696|NCT00416520|474561982|FG001|Open-label Period|Adverse Event|10|||
131802697|NCT00416520|474561983|FG002|Open-label Period|Adverse Event|0|||
131802698|NCT00416520|474561984|FG003|Open-label Period|Adverse Event|0|||
131802699|NCT00416520|474561981|FG000|Open-label Period|Death|2|||
131802700|NCT00416520|474561982|FG001|Open-label Period|Death|1|||
131802701|NCT00416520|474561983|FG002|Open-label Period|Death|0|||
131648332|NCT00150618|473998637|FG001|Overall Study|Adverse Event|2|||
131802702|NCT00416520|474561984|FG003|Open-label Period|Death|0|||
131802703|NCT00416520|474561981|FG000|Open-label Period|Lack of Efficacy|8|||
131802704|NCT00416520|474561982|FG001|Open-label Period|Lack of Efficacy|1|||
131802705|NCT00416520|474561983|FG002|Open-label Period|Lack of Efficacy|0|||
131802706|NCT00416520|474561984|FG003|Open-label Period|Lack of Efficacy|0|||
131802707|NCT00416520|474561981|FG000|Open-label Period|Protocol Violation|3|||
131648333|NCT00150618|473998638|FG002|Overall Study|Adverse Event|6|||
131648334|NCT00150618|473998639|FG003|Overall Study|Adverse Event|9|||
131802708|NCT00416520|474561982|FG001|Open-label Period|Protocol Violation|3|||
131802709|NCT00416520|474561983|FG002|Open-label Period|Protocol Violation|0|||
131802710|NCT00416520|474561984|FG003|Open-label Period|Protocol Violation|0|||
131802711|NCT00416520|474561981|FG000|Open-label Period|Withdrawal by Subject|16|||
131802712|NCT00416520|474561982|FG001|Open-label Period|Withdrawal by Subject|5|||
131802713|NCT00416520|474561983|FG002|Open-label Period|Withdrawal by Subject|0|||
131802714|NCT00416520|474561984|FG003|Open-label Period|Withdrawal by Subject|0|||
131802715|NCT00416520|474561981|FG000|Open-label Period|Other Reasons|3|||
131802716|NCT00416520|474561982|FG001|Open-label Period|Other Reasons|12|||
131802717|NCT00416520|474561983|FG002|Open-label Period|Other Reasons|0|||
131802718|NCT00416520|474561984|FG003|Open-label Period|Other Reasons|0|||
131802719|NCT00416520|474561981|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
131802720|NCT00416520|474561982|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
131802721|NCT00416520|474561983|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
131802722|NCT00416520|474561984|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
131802723|NCT00416520|474561981|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
131802724|NCT00416520|474561982|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
131802725|NCT00416520|474561983|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
131802726|NCT00416520|474561984|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
131802727|NCT00416520|474561981|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
131802728|NCT00416520|474561982|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
131802729|NCT00416520|474561983|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
131648335|NCT00150618|473998640|FG004|Overall Study|Adverse Event|5|||
131648336|NCT00150618|473998636|FG000|Overall Study|Withdrawal by Subject|6|||
131648337|NCT00150618|473998637|FG001|Overall Study|Withdrawal by Subject|8|||
131648338|NCT00150618|473998638|FG002|Overall Study|Withdrawal by Subject|8|||
131648339|NCT00150618|473998639|FG003|Overall Study|Withdrawal by Subject|4|||
131648340|NCT00150618|473998640|FG004|Overall Study|Withdrawal by Subject|5|||
131648341|NCT00150618|473998636|FG000|Overall Study|Lost to Follow-up|4|||
131648342|NCT00150618|473998637|FG001|Overall Study|Lost to Follow-up|1|||
131648343|NCT00150618|473998638|FG002|Overall Study|Lost to Follow-up|5|||
131648344|NCT00150618|473998639|FG003|Overall Study|Lost to Follow-up|8|||
131648345|NCT00150618|473998640|FG004|Overall Study|Lost to Follow-up|4|||
131648346|NCT00150618|473998636|FG000|Overall Study|Protocol Violation|1|||
131648347|NCT00150618|473998637|FG001|Overall Study|Protocol Violation|0|||
131648348|NCT00150618|473998638|FG002|Overall Study|Protocol Violation|0|||
131648349|NCT00150618|473998639|FG003|Overall Study|Protocol Violation|0|||
131648350|NCT00150618|473998640|FG004|Overall Study|Protocol Violation|1|||
131648351|NCT00150618|473998636|FG000|Overall Study|Lack of Efficacy|1|||
131648352|NCT00150618|473998637|FG001|Overall Study|Lack of Efficacy|4|||
131648353|NCT00150618|473998638|FG002|Overall Study|Lack of Efficacy|7|||
131648354|NCT00150618|473998639|FG003|Overall Study|Lack of Efficacy|4|||
131648355|NCT00150618|473998640|FG004|Overall Study|Lack of Efficacy|6|||
131648356|NCT00150618|473998636|FG000|Overall Study|No study meds|0|||
131648357|NCT00150618|473998637|FG001|Overall Study|No study meds|0|||
131648358|NCT00150618|473998638|FG002|Overall Study|No study meds|0|||
131648359|NCT00150618|473998639|FG003|Overall Study|No study meds|0|||
131648360|NCT00150618|473998640|FG004|Overall Study|No study meds|2|||
131648361|NCT00150618|473998636|FG000|Overall Study|Physician Decision|0|||
131648362|NCT00150618|473998637|FG001|Overall Study|Physician Decision|2|||
131648363|NCT00150618|473998638|FG002|Overall Study|Physician Decision|0|||
131648364|NCT00150618|473998639|FG003|Overall Study|Physician Decision|0|||
131648365|NCT00150618|473998640|FG004|Overall Study|Physician Decision|1|||
131648366|NCT00150618|473998636|FG000|Overall Study|Lack of compliance|2|||
131648367|NCT00150618|473998637|FG001|Overall Study|Lack of compliance|1|||
131648368|NCT00150618|473998638|FG002|Overall Study|Lack of compliance|1|||
131648369|NCT00150618|473998639|FG003|Overall Study|Lack of compliance|0|||
131648370|NCT00150618|473998640|FG004|Overall Study|Lack of compliance|1|||
131648371|NCT00150618|473998636|FG000|Overall Study|Abnormal ECG|1|||
131648372|NCT00150618|473998637|FG001|Overall Study|Abnormal ECG|0|||
131648373|NCT00150618|473998638|FG002|Overall Study|Abnormal ECG|0|||
131648374|NCT00150618|473998639|FG003|Overall Study|Abnormal ECG|0|||
131648375|NCT00150618|473998640|FG004|Overall Study|Abnormal ECG|0|||
131648376|NCT00150618|473998636|FG000|Overall Study|Sponsor's decision|0|||
131648377|NCT00150618|473998637|FG001|Overall Study|Sponsor's decision|0|||
131648378|NCT00150618|473998638|FG002|Overall Study|Sponsor's decision|0|||
131648379|NCT00150618|473998639|FG003|Overall Study|Sponsor's decision|1|||
131648380|NCT00150618|473998640|FG004|Overall Study|Sponsor's decision|0|||
131648381|NCT01791413|473998641|FG000|Overall Study|Lost to Follow-up|5|||
131648382|NCT01791413|473998642|FG001|Overall Study|Lost to Follow-up|1|||
131648383|NCT00250432|473998644|FG000|Overall Study|Adverse Event|25|||
131648384|NCT00250432|473998645|FG001|Overall Study|Adverse Event|29|||
131648385|NCT00250432|473998644|FG000|Overall Study|Lack of Efficacy|2|||
131648386|NCT00250432|473998645|FG001|Overall Study|Lack of Efficacy|1|||
131648387|NCT00250432|473998644|FG000|Overall Study|Lost to Follow-up|6|||
131648388|NCT00250432|473998645|FG001|Overall Study|Lost to Follow-up|5|||
131648389|NCT00250432|473998644|FG000|Overall Study|Patient Moved|0|||
131648390|NCT00250432|473998645|FG001|Overall Study|Patient Moved|1|||
131648391|NCT00250432|473998644|FG000|Overall Study|Protocol Violation|0|||
131648392|NCT00250432|473998645|FG001|Overall Study|Protocol Violation|3|||
131648393|NCT00250432|473998644|FG000|Overall Study|Withdrawal by Subject|6|||
131648394|NCT00250432|473998645|FG001|Overall Study|Withdrawal by Subject|2|||
131648395|NCT00250432|473998644|FG000|Overall Study|Pt died out of posttherapy report period|6|||
131802730|NCT00416520|474561984|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
131802731|NCT00883090|474561988|FG000|Overall Study|Sponsor's decision|1|||
131802732|NCT00883090|474561988|FG000|Overall Study|Withdrawal by Subject|1|||
131802733|NCT01492361|474561989|FG000|Overall Study|Withdrawal by Subject|281|||
131648396|NCT00250432|473998645|FG001|Overall Study|Pt died out of posttherapy report period|5|||
131648397|NCT00250432|473998644|FG000|Overall Study|Pt was considered untreatable|0|||
131648398|NCT00250432|473998645|FG001|Overall Study|Pt was considered untreatable|1|||
131648399|NCT04946942|473998648|FG000|Overall Study|Lost to Follow-up|6|||
131648400|NCT04946942|473998649|FG001|Overall Study|Lost to Follow-up|2|||
131648401|NCT04946942|473998650|FG002|Overall Study|Lost to Follow-up|0|||
131648402|NCT04907357|473998653|FG000|Overall Study|Death|0|||
131648403|NCT04907357|473998654|FG001|Overall Study|Death|1|||
131648404|NCT04907357|473998653|FG000|Overall Study|Lost to Follow-up|9|||
131648405|NCT04907357|473998654|FG001|Overall Study|Lost to Follow-up|18|||
131648406|NCT04907357|473998653|FG000|Overall Study|Physician Decision|1|||
131648407|NCT04907357|473998654|FG001|Overall Study|Physician Decision|0|||
131648408|NCT04907357|473998653|FG000|Overall Study|Withdrawal by Subject|0|||
131648409|NCT04907357|473998654|FG001|Overall Study|Withdrawal by Subject|1|||
131648410|NCT04907357|473998653|FG000|Overall Study|Unable to attend visits|1|||
131648411|NCT04907357|473998654|FG001|Overall Study|Unable to attend visits|0|||
131648412|NCT04907357|473998653|FG000|Overall Study|Incarcerated|1|||
131648413|NCT04907357|473998654|FG001|Overall Study|Incarcerated|1|||
131648414|NCT00365547|473998655|FG000|Overall Study|Insurance did not cover Avastin|1|||
131447921|NCT00538902|473270787|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
131447922|NCT00538902|473270788|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
131648415|NCT00365547|473998655|FG000|Overall Study|Screen failure|1|||
131802734|NCT01492361|474561990|FG001|Overall Study|Withdrawal by Subject|297|||
131648416|NCT00365547|473998655|FG000|Overall Study|Withdrawal by Subject|1|||
131648417|NCT03170518|473998656|FG000|Overall Study|Lost to Follow-up|4|||
131648418|NCT03170518|473998657|FG001|Overall Study|Lost to Follow-up|1|||
131648419|NCT03170518|473998658|FG002|Overall Study|Lost to Follow-up|0|||
131648420|NCT03170518|473998656|FG000|Overall Study|Physician Decision|1|||
131648421|NCT03170518|473998657|FG001|Overall Study|Physician Decision|0|||
131802735|NCT01492361|474561989|FG000|Overall Study|Physician Decision|12|||
131447923|NCT00538902|473270789|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
131447924|NCT00538902|473270787|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
131447925|NCT00538902|473270788|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
131447926|NCT00538902|473270789|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
131447927|NCT00538902|473270787|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
131447928|NCT00538902|473270788|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
131447929|NCT00538902|473270789|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
131447930|NCT00538902|473270787|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
131447931|NCT00538902|473270788|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
131447932|NCT00538902|473270789|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
131447933|NCT00538902|473270787|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
131447934|NCT00538902|473270788|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
131447935|NCT00538902|473270789|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
131447936|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
131447937|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
131447938|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
131447939|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
131447940|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131447941|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
131447942|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
131447943|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
131447944|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
131447945|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
131447946|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
131447947|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
131447948|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
131447949|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
131447950|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
131447951|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
131447952|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
131447953|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
131447954|NCT03739203|473270790|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
131447955|NCT03739203|473270791|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
131447956|NCT03739203|473270792|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
131447957|NCT03739203|473270790|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
131447958|NCT03739203|473270791|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
131447959|NCT03739203|473270792|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
131447960|NCT03739203|473270790|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
131447961|NCT03739203|473270791|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
131447962|NCT03739203|473270792|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
131447963|NCT03739203|473270790|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
131447964|NCT03739203|473270791|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
131447965|NCT03739203|473270792|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
131447966|NCT03739203|473270790|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
131447967|NCT03739203|473270791|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
131447968|NCT03739203|473270792|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
131447969|NCT03131570|473270793|FG000|Overall Study|Adverse Event|1|||
131447970|NCT03131570|473270794|FG001|Overall Study|Adverse Event|0|||
131447971|NCT00830440|473270795|FG000|Overall Study|Protocol Violation|1|||
131447972|NCT00830440|473270796|FG001|Overall Study|Protocol Violation|0|||
131447973|NCT00830440|473270795|FG000|Overall Study|Withdrawal by Subject|1|||
131447974|NCT00830440|473270796|FG001|Overall Study|Withdrawal by Subject|0|||
131447975|NCT00830440|473270795|FG000|Overall Study|unsuccessful procedure|4|||
131802736|NCT01492361|474561990|FG001|Overall Study|Physician Decision|12|||
131447976|NCT00830440|473270796|FG001|Overall Study|unsuccessful procedure|0|||
131447977|NCT00830440|473270795|FG000|Overall Study|Adverse Event|2|||
131447978|NCT00830440|473270796|FG001|Overall Study|Adverse Event|0|||
131447979|NCT01967940|473270801|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
131447980|NCT01967940|473270802|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
131447981|NCT01967940|473270803|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
131447982|NCT01967940|473270804|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
131447983|NCT01967940|473270801|FG000|Part 2|Adverse Event|0|||
131447984|NCT01967940|473270802|FG001|Part 2|Adverse Event|0|||
131447985|NCT01967940|473270803|FG002|Part 2|Adverse Event|0|||
131802737|NCT01492361|474561989|FG000|Overall Study|Lost to Follow-up|6|||
131447986|NCT01967940|473270804|FG003|Part 2|Adverse Event|1|||
131447987|NCT01967940|473270801|FG000|Part 2|Unknown Reason|0|||
131447988|NCT01967940|473270802|FG001|Part 2|Unknown Reason|0|||
131447989|NCT01967940|473270803|FG002|Part 2|Unknown Reason|0|||
131447990|NCT01967940|473270804|FG003|Part 2|Unknown Reason|1|||
131447991|NCT00942604|473270806|FG000|Overall Study|Protocol Violation|1|||
131447992|NCT00942604|473270807|FG001|Overall Study|Protocol Violation|1|||
131447993|NCT00942604|473270806|FG000|Overall Study|Adverse Event|0|||
131447994|NCT00942604|473270807|FG001|Overall Study|Adverse Event|1|||
131447995|NCT00942604|473270806|FG000|Overall Study|Withdrawal by Subject|0|||
131447996|NCT00942604|473270807|FG001|Overall Study|Withdrawal by Subject|1|||
131447997|NCT00942604|473270806|FG000|Overall Study|Patient relocation|1|||
131447998|NCT00942604|473270807|FG001|Overall Study|Patient relocation|1|||
131447999|NCT01188343|473270808|FG000|Overall Study|Not vaccinated|0|||
131448000|NCT01188343|473270809|FG001|Overall Study|Not vaccinated|2|||
131448001|NCT01188343|473270810|FG002|Overall Study|Not vaccinated|1|||
131448002|NCT01188343|473270808|FG000|Overall Study|Withdrawal by Subject|1|||
131448003|NCT01188343|473270809|FG001|Overall Study|Withdrawal by Subject|24|||
131448004|NCT01188343|473270810|FG002|Overall Study|Withdrawal by Subject|0|||
131448005|NCT01143246|473270811|FG000|Overall Study|Adverse Event|24|||
131448006|NCT01143246|473270812|FG001|Overall Study|Adverse Event|28|||
131448007|NCT01143246|473270811|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
131448008|NCT01143246|473270812|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
131448009|NCT01143246|473270811|FG000|Overall Study|Lost to Follow-up|0|||
131448010|NCT01143246|473270812|FG001|Overall Study|Lost to Follow-up|1|||
131448011|NCT01143246|473270811|FG000|Overall Study|Death|16|||
131448012|NCT01143246|473270812|FG001|Overall Study|Death|15|||
131448013|NCT01143246|473270811|FG000|Overall Study|Reason not Specified|3|||
131903222|NCT01819727|474931446|FG001|Overall Study|Adverse Event|9|||
131903223|NCT01819727|474931445|FG000|Overall Study|Death|1|||
131903224|NCT01819727|474931446|FG001|Overall Study|Death|0|||
131903225|NCT01819727|474931445|FG000|Overall Study|Lost to Follow-up|1|||
131903226|NCT01819727|474931446|FG001|Overall Study|Lost to Follow-up|1|||
131903227|NCT01819727|474931445|FG000|Overall Study|Physician Decision|3|||
131903228|NCT01819727|474931446|FG001|Overall Study|Physician Decision|2|||
131903229|NCT01819727|474931445|FG000|Overall Study|Pregnancy|1|||
131903230|NCT01819727|474931446|FG001|Overall Study|Pregnancy|0|||
131903231|NCT01819727|474931445|FG000|Overall Study|Protocol Violation|0|||
131903232|NCT01819727|474931446|FG001|Overall Study|Protocol Violation|2|||
131903233|NCT01819727|474931445|FG000|Overall Study|Study Terminated by Sponsor|0|||
131903234|NCT01819727|474931446|FG001|Overall Study|Study Terminated by Sponsor|1|||
131903235|NCT01819727|474931445|FG000|Overall Study|Withdrawal by Subject|6|||
131903236|NCT01819727|474931446|FG001|Overall Study|Withdrawal by Subject|11|||
131903237|NCT01819727|474931445|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
131903238|NCT01819727|474931446|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
131903239|NCT01819727|474931445|FG000|Overall Study|Quit due to lack of health benifits|0|||
131903240|NCT01819727|474931446|FG001|Overall Study|Quit due to lack of health benifits|1|||
131903241|NCT01628848|474931450|FG000|Overall Study|Adverse Event|9|||
131903242|NCT01628848|474931451|FG001|Overall Study|Adverse Event|7|||
131903243|NCT01628848|474931450|FG000|Overall Study|Lack of Efficacy|0|||
131903244|NCT01628848|474931451|FG001|Overall Study|Lack of Efficacy|4|||
131903245|NCT01628848|474931450|FG000|Overall Study|Withdrawal by Subject|0|||
131903246|NCT01628848|474931451|FG001|Overall Study|Withdrawal by Subject|2|||
131903247|NCT01628848|474931450|FG000|Overall Study|Physician Decision|3|||
131648422|NCT03170518|473998658|FG002|Overall Study|Physician Decision|0|||
131648423|NCT03170518|473998656|FG000|Overall Study|Withdrawal by Subject|4|||
131903248|NCT01628848|474931451|FG001|Overall Study|Physician Decision|1|||
131903249|NCT03839394|474931452|FG000|Overall Study|Lost to Follow-up|6|||
131448014|NCT01143246|473270812|FG001|Overall Study|Reason not Specified|5|||
131448015|NCT01663103|473270813|FG000|Overall Study|Withdrawal by Subject|1|||
131448016|NCT01663103|473270814|FG001|Overall Study|Withdrawal by Subject|2|||
131448017|NCT01663103|473270813|FG000|Overall Study|Adverse Event|1|||
131448018|NCT01663103|473270814|FG001|Overall Study|Adverse Event|0|||
131448019|NCT01663103|473270813|FG000|Overall Study|dog bite|1|||
131448020|NCT01663103|473270814|FG001|Overall Study|dog bite|0|||
131658616|NCT02003222|474035397|FG002|Induction|Death|0|||
131903250|NCT03839394|474931453|FG001|Overall Study|Lost to Follow-up|8|||
131903251|NCT03839394|474931452|FG000|Overall Study|Withdrawal by Subject|0|||
131903252|NCT03839394|474931453|FG001|Overall Study|Withdrawal by Subject|2|||
131903253|NCT02895295|474931456|FG000|Overall Study|Survey Non-response|71|||
131648424|NCT03170518|473998657|FG001|Overall Study|Withdrawal by Subject|5|||
131648425|NCT03170518|473998658|FG002|Overall Study|Withdrawal by Subject|2|||
131648426|NCT03170518|473998656|FG000|Overall Study|Site terminated by sponsor|0|||
131648427|NCT03170518|473998657|FG001|Overall Study|Site terminated by sponsor|1|||
131648428|NCT03170518|473998658|FG002|Overall Study|Site terminated by sponsor|0|||
131648429|NCT03170518|473998656|FG000|Overall Study|Non-compliance with study drug|1|||
131648430|NCT03170518|473998657|FG001|Overall Study|Non-compliance with study drug|0|||
131648431|NCT03170518|473998658|FG002|Overall Study|Non-compliance with study drug|1|||
131648432|NCT03170518|473998656|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131648433|NCT03170518|473998657|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131648434|NCT03170518|473998658|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131648435|NCT04428476|473998659|FG000|Overall Study|Withdrawal by Subject|1|||
131648436|NCT04428476|473998659|FG000|Overall Study|Still on treatment|12|||
131648437|NCT00546078|473998660|FG000|Overall Study|Lost to Follow-up|1|||
131648438|NCT00546078|473998661|FG001|Overall Study|Lost to Follow-up|3|||
131648439|NCT00546078|473998660|FG000|Overall Study|Withdrawal by Subject|2|||
131648440|NCT00546078|473998661|FG001|Overall Study|Withdrawal by Subject|3|||
131648441|NCT00546078|473998660|FG000|Overall Study|Other reason|1|||
131648442|NCT00546078|473998661|FG001|Overall Study|Other reason|1|||
131648443|NCT03023423|473998664|FG000|Overall Study|Death|5|||
131648444|NCT03023423|473998665|FG001|Overall Study|Death|12|||
131648445|NCT03023423|473998666|FG002|Overall Study|Death|20|||
131648446|NCT03023423|473998664|FG000|Overall Study|Other|0|||
131648447|NCT03023423|473998665|FG001|Overall Study|Other|2|||
131903254|NCT02895295|474931457|FG001|Overall Study|Survey Non-response|94|||
131648448|NCT03023423|473998666|FG002|Overall Study|Other|2|||
131648449|NCT03023423|473998664|FG000|Overall Study|Ongoing|2|||
131648450|NCT03023423|473998665|FG001|Overall Study|Ongoing|32|||
131903255|NCT02895295|474931458|FG002|Overall Study|Survey Non-response|92|||
131648451|NCT03023423|473998666|FG002|Overall Study|Ongoing|24|||
131648452|NCT03512197|473998667|FG000|Overall Study|Guardian decision|1|||
131448021|NCT05567783|473270819|FG000|Overall Study|Death|2|||
131448022|NCT05567783|473270820|FG001|Overall Study|Death|3|||
131448023|NCT05567783|473270821|FG002|Overall Study|Death|0|||
131648453|NCT03512197|473998668|FG001|Overall Study|Guardian decision|1|||
131648454|NCT03512197|473998667|FG000|Overall Study|Lack of Efficacy|19|||
131648455|NCT03512197|473998668|FG001|Overall Study|Lack of Efficacy|11|||
131648456|NCT03512197|473998667|FG000|Overall Study|New Therapy for Study Indication|16|||
131648457|NCT03512197|473998668|FG001|Overall Study|New Therapy for Study Indication|16|||
131648458|NCT03512197|473998667|FG000|Overall Study|Physician Decision|60|||
131648459|NCT03512197|473998668|FG001|Overall Study|Physician Decision|60|||
131648460|NCT03512197|473998667|FG000|Overall Study|Protocol Violation|0|||
131648461|NCT03512197|473998668|FG001|Overall Study|Protocol Violation|2|||
131648462|NCT03512197|473998667|FG000|Overall Study|Terminated by Sponsored|46|||
131648463|NCT03512197|473998668|FG001|Overall Study|Terminated by Sponsored|50|||
131648464|NCT03512197|473998667|FG000|Overall Study|Subject Decision|15|||
131648465|NCT03512197|473998668|FG001|Overall Study|Subject Decision|12|||
131648466|NCT03512197|473998667|FG000|Overall Study|Withdrawal of informed consent|20|||
131648467|NCT03512197|473998668|FG001|Overall Study|Withdrawal of informed consent|14|||
131648468|NCT03512197|473998667|FG000|Overall Study|Adverse Event|30|||
131648469|NCT03512197|473998668|FG001|Overall Study|Adverse Event|34|||
131648470|NCT03512197|473998667|FG000|Overall Study|Death|14|||
131648471|NCT03512197|473998668|FG001|Overall Study|Death|9|||
131648472|NCT03512197|473998667|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
131648473|NCT03512197|473998668|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
131648474|NCT03512197|473998667|FG000|Overall Study|Missing|3|||
131648475|NCT03512197|473998668|FG001|Overall Study|Missing|13|||
131648476|NCT03842436|473998669|FG000|Overall Study|Lost to Follow-up|1|||
131648477|NCT00490698|473998672|FG000|Overall Study|Withdrawal by Subject|1|||
131648478|NCT00490698|473998672|FG000|Overall Study|Disease Progression|7|||
131648479|NCT00490698|473998672|FG000|Overall Study|Physician Decision|2|||
131648480|NCT03358238|473998674|FG000|Overall Study|Withdrawal by Subject|0|||
131648481|NCT03358238|473998675|FG001|Overall Study|Withdrawal by Subject|1|||
131648482|NCT01431950|473998678|FG000|Overall Study|Study Site Closed/Terminated|7|||
131648483|NCT01431950|473998679|FG001|Overall Study|Study Site Closed/Terminated|3|||
131648484|NCT01431950|473998678|FG000|Overall Study|Withdrawal by Subject|4|||
131648485|NCT01431950|473998679|FG001|Overall Study|Withdrawal by Subject|3|||
131648486|NCT01431950|473998678|FG000|Overall Study|Protocol Violation|2|||
131648487|NCT01431950|473998679|FG001|Overall Study|Protocol Violation|3|||
131648488|NCT01431950|473998678|FG000|Overall Study|Adverse Event|2|||
131648489|NCT01431950|473998679|FG001|Overall Study|Adverse Event|2|||
131648490|NCT01431950|473998678|FG000|Overall Study|Physician Decision|2|||
131648491|NCT01431950|473998679|FG001|Overall Study|Physician Decision|1|||
131648492|NCT01431950|473998678|FG000|Overall Study|Lack of Efficacy|2|||
131648493|NCT01431950|473998679|FG001|Overall Study|Lack of Efficacy|1|||
131648494|NCT01431950|473998678|FG000|Overall Study|Lost to Follow-up|0|||
131648495|NCT01431950|473998679|FG001|Overall Study|Lost to Follow-up|1|||
131648496|NCT01431950|473998678|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131648497|NCT01431950|473998679|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131648498|NCT00583947|473998680|FG000|Cross-over Period|Adverse Event|2|||
131648499|NCT00583947|473998681|FG001|Cross-over Period|Adverse Event|0|||
131648500|NCT00583947|473998680|FG000|Cross-over Period|Withdrawal by Subject|2|||
131648501|NCT00583947|473998681|FG001|Cross-over Period|Withdrawal by Subject|0|||
131648502|NCT00583947|473998680|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
131648503|NCT00583947|473998681|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
131648504|NCT00583947|473998680|FG000|Cross-over Period|Other|1|||
131648505|NCT00583947|473998681|FG001|Cross-over Period|Other|1|||
131648506|NCT01740154|473998683|FG000|Overall Study|Adverse Event|1|||
131448024|NCT05567783|473270819|FG000|Overall Study|Lost to Follow-up|25|||
131448025|NCT05567783|473270820|FG001|Overall Study|Lost to Follow-up|19|||
131448026|NCT05567783|473270821|FG002|Overall Study|Lost to Follow-up|17|||
131448027|NCT05567783|473270819|FG000|Overall Study|Physician Decision|10|||
131448028|NCT05567783|473270820|FG001|Overall Study|Physician Decision|7|||
131648507|NCT05226130|473998684|FG000|Overall Study|Lost to Follow-up|0|||
131648508|NCT05226130|473998685|FG001|Overall Study|Lost to Follow-up|1|||
131648509|NCT05226130|473998684|FG000|Overall Study|Not treatment adherent|0|||
131648510|NCT05226130|473998685|FG001|Overall Study|Not treatment adherent|2|||
131648511|NCT03358472|473998686|FG000|Overall Study|Death|6|||
131648512|NCT03358472|473998687|FG001|Overall Study|Death|3|||
131648513|NCT03358472|473998688|FG002|Overall Study|Death|10|||
131648514|NCT03358472|473998686|FG000|Overall Study|Physician Decision|0|||
131648515|NCT03358472|473998687|FG001|Overall Study|Physician Decision|1|||
131648516|NCT03358472|473998688|FG002|Overall Study|Physician Decision|0|||
131648517|NCT03358472|473998686|FG000|Overall Study|Withdrawal by Subject|0|||
131448029|NCT05567783|473270821|FG002|Overall Study|Physician Decision|9|||
131648518|NCT03358472|473998687|FG001|Overall Study|Withdrawal by Subject|0|||
131648519|NCT03358472|473998688|FG002|Overall Study|Withdrawal by Subject|1|||
131648520|NCT03358472|473998686|FG000|Overall Study|On-going at clinical cut off date|9|||
131448030|NCT05567783|473270819|FG000|Overall Study|Study Terminated by Sponsor|924|||
131448031|NCT05567783|473270820|FG001|Overall Study|Study Terminated by Sponsor|937|||
131448032|NCT05567783|473270821|FG002|Overall Study|Study Terminated by Sponsor|941|||
131448033|NCT05567783|473270819|FG000|Overall Study|Withdrawal by Subject|23|||
131448034|NCT05567783|473270820|FG001|Overall Study|Withdrawal by Subject|27|||
131448035|NCT05567783|473270821|FG002|Overall Study|Withdrawal by Subject|24|||
131448036|NCT05567783|473270819|FG000|Overall Study|Incarcerated|1|||
131448037|NCT05567783|473270820|FG001|Overall Study|Incarcerated|0|||
131448038|NCT05567783|473270821|FG002|Overall Study|Incarcerated|0|||
131448039|NCT05567783|473270819|FG000|Overall Study|Participant randomized in error|4|||
131448040|NCT05567783|473270820|FG001|Overall Study|Participant randomized in error|2|||
131903256|NCT04821830|474931461|FG000|Overall Study|Withdrawal by Subject|1|||
131448041|NCT05567783|473270821|FG002|Overall Study|Participant randomized in error|2|||
131448042|NCT01690143|473270822|FG000|Overall Study|Withdrawal by Subject|1|||
131448043|NCT03113487|473270825|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
131448044|NCT03777982|473270826|FG000|Overall Study|Physician Decision|0|||
131448045|NCT03777982|473270827|FG001|Overall Study|Physician Decision|1|||
131448046|NCT03944577|473270835|FG000|Overall Study|Adverse Event|3|||
131448047|NCT00391586|473270837|FG000|Overall Study|Progressive disease|13|||
131448048|NCT00391586|473270837|FG000|Overall Study|Adverse Event|5|||
131903257|NCT04821830|474931462|FG001|Overall Study|Withdrawal by Subject|0|||
131903258|NCT00960804|474931464|FG000|Overall Study|Adverse Event|1|||
131903259|NCT00960804|474931465|FG001|Overall Study|Adverse Event|0|||
131903260|NCT00960804|474931466|FG002|Overall Study|Adverse Event|0|||
131903261|NCT00960804|474931464|FG000|Overall Study|Withdrawal by Subject|1|||
131448049|NCT00391586|473270837|FG000|Overall Study|Physician Decision|2|||
131448050|NCT00391586|473270837|FG000|Overall Study|Death|4|||
131448051|NCT00904982|473270839|FG000|Overall Study|Withdrawal by Subject|2|||
131448052|NCT00904982|473270840|FG001|Overall Study|Withdrawal by Subject|0|||
131903262|NCT00960804|474931465|FG001|Overall Study|Withdrawal by Subject|0|||
131448053|NCT00904982|473270841|FG002|Overall Study|Withdrawal by Subject|0|||
131448054|NCT00904982|473270842|FG003|Overall Study|Withdrawal by Subject|0|||
131448055|NCT02072668|473270846|FG000|Second Intervention|Lost to Follow-up|1|||
131903263|NCT00960804|474931466|FG002|Overall Study|Withdrawal by Subject|0|||
131448056|NCT02072668|473270847|FG001|Second Intervention|Lost to Follow-up|0|||
131448057|NCT01658436|473270852|FG000|Overall Study|Adverse Event|6|||
131448058|NCT01658436|473270853|FG001|Overall Study|Adverse Event|5|||
131448059|NCT01658436|473270852|FG000|Overall Study|Physician Decision|1|||
131448060|NCT01658436|473270853|FG001|Overall Study|Physician Decision|0|||
131448061|NCT01658436|473270852|FG000|Overall Study|Progressive disease|12|||
131448062|NCT01658436|473270853|FG001|Overall Study|Progressive disease|4|||
131448063|NCT01658436|473270852|FG000|Overall Study|Study terminated by sponsor|0|||
131448064|NCT01658436|473270853|FG001|Overall Study|Study terminated by sponsor|1|||
131448065|NCT01658436|473270852|FG000|Overall Study|Subject/guardian decision|0|||
131448066|NCT01658436|473270853|FG001|Overall Study|Subject/guardian decision|1|||
131448067|NCT01658436|473270852|FG000|Overall Study|Death|1|||
131448068|NCT01658436|473270853|FG001|Overall Study|Death|0|||
131448069|NCT00686712|473270854|FG000|Overall Study|Protocol Violation|8|||
131448070|NCT00686712|473270855|FG001|Overall Study|Protocol Violation|8|||
131448071|NCT00686712|473270856|FG002|Overall Study|Protocol Violation|10|||
131448072|NCT00686712|473270854|FG000|Overall Study|Lost to Follow-up|1|||
131448073|NCT00686712|473270855|FG001|Overall Study|Lost to Follow-up|2|||
131448074|NCT00686712|473270856|FG002|Overall Study|Lost to Follow-up|3|||
131448075|NCT00686712|473270854|FG000|Overall Study|Adverse Event|1|||
131448076|NCT00686712|473270855|FG001|Overall Study|Adverse Event|1|||
131448077|NCT00686712|473270856|FG002|Overall Study|Adverse Event|0|||
131448078|NCT03987503|473270857|FG000|Overall Study|Lost to Follow-up|20|||
131448079|NCT03987503|473270857|FG000|Overall Study|Withdrawal by Subject|2|||
131448080|NCT04119414|473270858|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
131448081|NCT03058146|473270859|FG000|Overall Study|Withdrawal by Subject|4|||
131448082|NCT03058146|473270860|FG001|Overall Study|Withdrawal by Subject|1|||
131448083|NCT03058146|473270859|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
131448084|NCT03058146|473270860|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
131448085|NCT01352793|473270868|FG000|Overall Study|Lost to Follow-up|289|||
131448086|NCT01352793|473270869|FG001|Overall Study|Lost to Follow-up|125|||
131448087|NCT01352793|473270868|FG000|Overall Study|Withdrawal by Subject|120|||
131448088|NCT01352793|473270869|FG001|Overall Study|Withdrawal by Subject|55|||
131448089|NCT01352793|473270868|FG000|Overall Study|Protocol Violation|44|||
131448090|NCT01352793|473270869|FG001|Overall Study|Protocol Violation|23|||
131448091|NCT01352793|473270868|FG000|Overall Study|Adverse Event|44|||
131448092|NCT01352793|473270869|FG001|Overall Study|Adverse Event|10|||
131448093|NCT01352793|473270868|FG000|Overall Study|Physician Decision|1|||
131448094|NCT01352793|473270869|FG001|Overall Study|Physician Decision|0|||
131448095|NCT01352793|473270868|FG000|Overall Study|Pregnancy|26|||
131448096|NCT01352793|473270869|FG001|Overall Study|Pregnancy|8|||
131448097|NCT01352793|473270868|FG000|Overall Study|Other|25|||
131448098|NCT01352793|473270869|FG001|Overall Study|Other|7|||
131448099|NCT01352793|473270868|FG000|Overall Study|Medication error|2|||
131448100|NCT01352793|473270869|FG001|Overall Study|Medication error|2|||
131448101|NCT01352793|473270868|FG000|Overall Study|Death|1|||
131448102|NCT01352793|473270869|FG001|Overall Study|Death|0|||
131448103|NCT01352793|473270868|FG000|Overall Study|Randomized but not vaccinated|8|||
131448104|NCT01352793|473270869|FG001|Overall Study|Randomized but not vaccinated|0|||
131448105|NCT01352793|473270868|FG000|Overall Study|No longer meets eligibility criteria|25|||
131448106|NCT01352793|473270869|FG001|Overall Study|No longer meets eligibility criteria|15|||
131448107|NCT01716234|473270874|FG000|Overall Study|Protocol Violation|0|||
131448108|NCT01716234|473270875|FG001|Overall Study|Protocol Violation|0|||
131802738|NCT01492361|474561990|FG001|Overall Study|Lost to Follow-up|13|||
131802739|NCT01492361|474561989|FG000|Overall Study|Other than specified above|106|||
131802740|NCT01492361|474561990|FG001|Overall Study|Other than specified above|138|||
131802741|NCT01475838|474561991|FG000|Randomized Phase|Randomized but Not Treated|0|||
131802742|NCT01475838|474561992|FG001|Randomized Phase|Randomized but Not Treated|5|||
131802743|NCT01475838|474561991|FG000|Randomized Phase|Adverse Event|6|||
131802744|NCT01475838|474561992|FG001|Randomized Phase|Adverse Event|1|||
131802745|NCT01475838|474561991|FG000|Randomized Phase|Pregnancy|0|||
131802746|NCT01475838|474561992|FG001|Randomized Phase|Pregnancy|1|||
131802747|NCT01475838|474561991|FG000|Randomized Phase|Investigators Discretion|1|||
131448109|NCT01716234|473270876|FG002|Overall Study|Protocol Violation|0|||
131448110|NCT01716234|473270877|FG003|Overall Study|Protocol Violation|1|||
131448111|NCT01716234|473270878|FG004|Overall Study|Protocol Violation|1|||
131648521|NCT03358472|473998687|FG001|Overall Study|On-going at clinical cut off date|6|||
131648522|NCT03358472|473998688|FG002|Overall Study|On-going at clinical cut off date|5|||
131648523|NCT01124838|473998689|FG000|Overall Study|Miscellaneous|4|||
131648524|NCT01124838|473998690|FG001|Overall Study|Miscellaneous|2|||
131648525|NCT01124838|473998689|FG000|Overall Study|Adverse Event|7|||
131648526|NCT01124838|473998690|FG001|Overall Study|Adverse Event|11|||
131648527|NCT01124838|473998689|FG000|Overall Study|Lack of Efficacy|2|||
131648528|NCT01124838|473998690|FG001|Overall Study|Lack of Efficacy|0|||
131648529|NCT01124838|473998689|FG000|Overall Study|Withdrawal by Subject|3|||
131648530|NCT01124838|473998690|FG001|Overall Study|Withdrawal by Subject|2|||
131648531|NCT01124838|473998689|FG000|Overall Study|Lost to Follow-up|2|||
131648532|NCT01124838|473998690|FG001|Overall Study|Lost to Follow-up|0|||
131648533|NCT02726945|473998691|FG000|Overall Study|Withdrawal by Subject|0|||
131648534|NCT02726945|473998692|FG001|Overall Study|Withdrawal by Subject|0|||
131648535|NCT02726945|473998693|FG002|Overall Study|Withdrawal by Subject|1|||
131648536|NCT02726945|473998691|FG000|Overall Study|Elected to have total knee replacement|0|||
131648537|NCT02726945|473998692|FG001|Overall Study|Elected to have total knee replacement|1|||
131648538|NCT02726945|473998693|FG002|Overall Study|Elected to have total knee replacement|0|||
131648539|NCT02797522|474000756|FG000|Overall Study|Study Terminated by Sponsor|0|||
131648540|NCT02797522|474000757|FG001|Overall Study|Study Terminated by Sponsor|0|||
131648541|NCT02797522|474000758|FG002|Overall Study|Study Terminated by Sponsor|0|||
131648542|NCT02797522|474000759|FG003|Overall Study|Study Terminated by Sponsor|0|||
131648543|NCT02797522|474000760|FG004|Overall Study|Study Terminated by Sponsor|0|||
131648544|NCT02797522|474000761|FG005|Overall Study|Study Terminated by Sponsor|0|||
131648545|NCT02797522|474000762|FG006|Overall Study|Study Terminated by Sponsor|0|||
131648546|NCT02797522|474000763|FG007|Overall Study|Study Terminated by Sponsor|4|||
131648547|NCT02797522|474000764|FG008|Overall Study|Study Terminated by Sponsor|2|||
131648548|NCT02797522|474000765|FG009|Overall Study|Study Terminated by Sponsor|4|||
131648549|NCT02797522|474000766|FG010|Overall Study|Study Terminated by Sponsor|1|||
131648550|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
131648551|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
131648552|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
131648553|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
131648554|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
131648555|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
131648556|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
131648557|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
131648558|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
131648559|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
131648560|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
131648561|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
131802748|NCT01475838|474561992|FG001|Randomized Phase|Investigators Discretion|2|||
131802749|NCT01475838|474561991|FG000|Randomized Phase|Withdrew Consent|10|||
131802750|NCT01475838|474561992|FG001|Randomized Phase|Withdrew Consent|14|||
131802751|NCT01475838|474561991|FG000|Randomized Phase|Lost to Follow-up|3|||
131802752|NCT01475838|474561992|FG001|Randomized Phase|Lost to Follow-up|4|||
131802753|NCT01475838|474561991|FG000|Randomized Phase|Participant Noncompliance|1|||
131802754|NCT01475838|474561992|FG001|Randomized Phase|Participant Noncompliance|5|||
131802755|NCT01475838|474561991|FG000|Randomized Phase|Protocol Violation|9|||
131802756|NCT01475838|474561992|FG001|Randomized Phase|Protocol Violation|4|||
131802757|NCT01475838|474561991|FG000|Extension Phase|Participant Noncompliance|1|||
131802758|NCT01475838|474561992|FG001|Extension Phase|Participant Noncompliance|0|||
131802759|NCT00560235|474561998|FG000|Phase 1|Discontinued|8|||
131802760|NCT00560235|474561999|FG001|Phase 1|Discontinued|0|||
131802761|NCT00560235|474562000|FG002|Phase 1|Discontinued|0|||
131802762|NCT00560235|474561998|FG000|Phase 1B|Discontinued|0|||
131802763|NCT00560235|474561999|FG001|Phase 1B|Discontinued|19|||
131802764|NCT00560235|474562000|FG002|Phase 1B|Discontinued|0|||
131802765|NCT00560235|474561998|FG000|Phase 2|Discontinued|0|||
131802766|NCT00560235|474561999|FG001|Phase 2|Discontinued|0|||
131802767|NCT00560235|474562000|FG002|Phase 2|Discontinued|96|||
131802768|NCT00560235|474561998|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
131802769|NCT00560235|474561999|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
131802770|NCT00560235|474562000|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
131802771|NCT01996033|474562003|FG000|Overall Study|Death|1|||
131648562|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
131648563|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
131648564|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
131802772|NCT01996033|474562003|FG000|Overall Study|Physician Decision|1|||
131648565|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
131648566|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
131648567|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
131802773|NCT01996033|474562003|FG000|Overall Study|Withdrawal by Subject|4|||
131448112|NCT01716234|473270879|FG005|Overall Study|Protocol Violation|1|||
131802774|NCT01996033|474562003|FG000|Overall Study|Lost to Follow-up|3|||
131802775|NCT03227445|474562006|FG000|Period 1 (28 Days)|Adverse Event|1|||
131802776|NCT03227445|474562007|FG001|Period 1 (28 Days)|Adverse Event|2|||
131648568|NCT00132678|474000767|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
131648569|NCT00132678|474000768|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
131648570|NCT00132678|474000769|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
131648571|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Death|2|||
131648572|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Death|0|||
131648573|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Death|0|||
131648574|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
131648575|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
131648576|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
131648577|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
131648578|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
131648579|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
131648580|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
131648581|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
131648582|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
131648583|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
131648584|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
131648585|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
131648586|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
131648587|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
131648588|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
131648589|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
131648590|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
131648591|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
131648592|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
131648593|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
131648594|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
131648595|NCT00132678|474000767|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
131648596|NCT00132678|474000768|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
131648597|NCT00132678|474000769|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
131648598|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
131648599|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
131648600|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
131648601|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
131648602|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
131648603|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
131648604|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
131648605|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
131648606|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
131648607|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
131648608|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
131648609|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
131648610|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
131648611|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
131648612|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
131648613|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
131648614|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
131648615|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
131648616|NCT00132678|474000767|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
131648617|NCT00132678|474000768|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
131648618|NCT00132678|474000769|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
131648619|NCT01367847|474000770|FG000|Overall Study|Withdrawal by Subject|2|||
131648620|NCT01367847|474000771|FG001|Overall Study|Withdrawal by Subject|2|||
131648621|NCT01606319|474000772|FG000|Overall Study|Lost to Follow-up|17|||
131648622|NCT01606319|474000773|FG001|Overall Study|Lost to Follow-up|14|||
131648623|NCT01606319|474000772|FG000|Overall Study|Withdrawal by Subject|9|||
131648624|NCT01606319|474000773|FG001|Overall Study|Withdrawal by Subject|12|||
131802777|NCT03227445|474562008|FG002|Period 1 (28 Days)|Adverse Event|0|||
131648625|NCT01606319|474000772|FG000|Overall Study|Physician Decision|1|||
131648626|NCT01606319|474000773|FG001|Overall Study|Physician Decision|2|||
131648627|NCT01606319|474000772|FG000|Overall Study|Lack of Efficacy|6|||
131648628|NCT01606319|474000773|FG001|Overall Study|Lack of Efficacy|8|||
131648629|NCT01606319|474000772|FG000|Overall Study|Adverse Event|1|||
131802778|NCT03227445|474562009|FG003|Period 1 (28 Days)|Adverse Event|1|||
131802779|NCT03227445|474562006|FG000|Period 1 (28 Days)|Protocol Violation|1|||
131648630|NCT01606319|474000773|FG001|Overall Study|Adverse Event|4|||
131648631|NCT01594827|474000774|FG000|Overall Study|Adverse Event|1|||
131648632|NCT01594827|474000775|FG001|Overall Study|Adverse Event|0|||
131648633|NCT01594827|474000774|FG000|Overall Study|Physician Decision|3|||
131648634|NCT01594827|474000775|FG001|Overall Study|Physician Decision|0|||
131648635|NCT02406248|474000777|FG000|Overall Study|Death|7|||
131648636|NCT02406248|474000777|FG000|Overall Study|Withdrawal by Subject|2|||
131648637|NCT02878603|474000778|FG000|Overall Study|Lost to Follow-up|4|||
131648638|NCT02878603|474000779|FG001|Overall Study|Lost to Follow-up|1|||
131648639|NCT02878603|474000778|FG000|Overall Study|Withdrawal by Subject|1|||
131648640|NCT02878603|474000779|FG001|Overall Study|Withdrawal by Subject|1|||
131648641|NCT02878603|474000778|FG000|Overall Study|Death|1|||
131648642|NCT02878603|474000779|FG001|Overall Study|Death|0|||
131648643|NCT02878603|474000778|FG000|Overall Study|Physician Decision|0|||
131648644|NCT02878603|474000779|FG001|Overall Study|Physician Decision|3|||
131648645|NCT02838134|474000780|FG000|Overall Study|Lost to Follow-up|1|||
131648646|NCT02838134|474000781|FG001|Overall Study|Lost to Follow-up|2|||
131648647|NCT02838134|474000780|FG000|Overall Study|logistic problems|1|||
131648648|NCT02838134|474000781|FG001|Overall Study|logistic problems|1|||
131648649|NCT04674189|474000782|FG000|Overall Study|Adverse Event|0|||
131648650|NCT04674189|474000783|FG001|Overall Study|Adverse Event|0|||
131648651|NCT04674189|474000784|FG002|Overall Study|Adverse Event|1|||
131648652|NCT04674189|474000782|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
131648653|NCT04674189|474000783|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
131648654|NCT04674189|474000784|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
131648655|NCT04674189|474000782|FG000|Overall Study|Physician Decision|1|||
131648656|NCT04674189|474000783|FG001|Overall Study|Physician Decision|0|||
131648657|NCT04674189|474000784|FG002|Overall Study|Physician Decision|0|||
131648658|NCT04674189|474000782|FG000|Overall Study|Withdrawal by Participant|83|||
131648659|NCT04674189|474000783|FG001|Overall Study|Withdrawal by Participant|71|||
131648660|NCT04674189|474000784|FG002|Overall Study|Withdrawal by Participant|142|||
131648661|NCT04674189|474000782|FG000|Overall Study|Lost to Follow-up|55|||
131648662|NCT04674189|474000783|FG001|Overall Study|Lost to Follow-up|53|||
131648663|NCT04674189|474000784|FG002|Overall Study|Lost to Follow-up|44|||
131648664|NCT04674189|474000782|FG000|Overall Study|Miscellaneous|27|||
131648665|NCT04674189|474000783|FG001|Overall Study|Miscellaneous|23|||
131648666|NCT04674189|474000784|FG002|Overall Study|Miscellaneous|207|||
131648667|NCT04674189|474000782|FG000|Overall Study|Did Not Receive Treatment|3|||
131648668|NCT04674189|474000783|FG001|Overall Study|Did Not Receive Treatment|1|||
131648669|NCT04674189|474000784|FG002|Overall Study|Did Not Receive Treatment|2|||
131648670|NCT00794924|474000785|FG000|Overall Study|Lost to Follow-up|6|||
131648671|NCT00794924|474000786|FG001|Overall Study|Lost to Follow-up|8|||
131648672|NCT00794924|474000785|FG000|Overall Study|Withdrawal by Subject|48|||
131648673|NCT00794924|474000786|FG001|Overall Study|Withdrawal by Subject|60|||
131648674|NCT00794924|474000785|FG000|Overall Study|Adverse Event|6|||
131648675|NCT00794924|474000786|FG001|Overall Study|Adverse Event|2|||
131648676|NCT00953615|474000787|FG000|Overall Study|Adverse Event|1|||
131648677|NCT01969851|474000795|FG000|Overall Study|Adverse Event|0|||
131648678|NCT01969851|474000796|FG001|Overall Study|Adverse Event|0|||
131648679|NCT01969851|474000797|FG002|Overall Study|Adverse Event|3|||
131648680|NCT01969851|474000795|FG000|Overall Study|Lack of Efficacy|0|||
131648681|NCT01969851|474000796|FG001|Overall Study|Lack of Efficacy|3|||
131648682|NCT01969851|474000797|FG002|Overall Study|Lack of Efficacy|1|||
131648683|NCT01969851|474000795|FG000|Overall Study|Withdrawal by Subject|1|||
131648684|NCT01969851|474000796|FG001|Overall Study|Withdrawal by Subject|0|||
131648685|NCT01969851|474000797|FG002|Overall Study|Withdrawal by Subject|1|||
131648686|NCT01969851|474000795|FG000|Overall Study|No effective dose in Titration period|0|||
131648687|NCT01969851|474000796|FG001|Overall Study|No effective dose in Titration period|0|||
131648688|NCT01969851|474000797|FG002|Overall Study|No effective dose in Titration period|1|||
131648689|NCT01969851|474000795|FG000|Overall Study|Sponsor decision|0|||
131648690|NCT01969851|474000796|FG001|Overall Study|Sponsor decision|0|||
131648691|NCT01969851|474000797|FG002|Overall Study|Sponsor decision|1|||
131648692|NCT02389764|474000803|FG000|Overall Study|Lack of Efficacy|9|||
131648693|NCT02498236|474000804|FG000|Overall Study|Did not show for testing|1|||
131648694|NCT02498236|474000805|FG001|Overall Study|Did not show for testing|0|||
131648695|NCT02498236|474000806|FG002|Overall Study|Did not show for testing|0|||
131648696|NCT02498236|474000807|FG003|Overall Study|Did not show for testing|0|||
131648697|NCT02498236|474000808|FG004|Overall Study|Did not show for testing|0|||
131648698|NCT02498236|474000809|FG005|Overall Study|Did not show for testing|0|||
131648699|NCT02498236|474000810|FG006|Overall Study|Did not show for testing|0|||
131648700|NCT02498236|474000811|FG007|Overall Study|Did not show for testing|1|||
131648701|NCT02498236|474000804|FG000|Overall Study|Equipment failure|0|||
131648702|NCT02498236|474000805|FG001|Overall Study|Equipment failure|0|||
131648703|NCT02498236|474000806|FG002|Overall Study|Equipment failure|0|||
131648704|NCT02498236|474000807|FG003|Overall Study|Equipment failure|0|||
131648705|NCT02498236|474000808|FG004|Overall Study|Equipment failure|0|||
131648706|NCT02498236|474000809|FG005|Overall Study|Equipment failure|0|||
131648707|NCT02498236|474000810|FG006|Overall Study|Equipment failure|1|||
131903264|NCT00960804|474931464|FG000|Overall Study|Study terminated by the sponsor|5|||
131903265|NCT00960804|474931465|FG001|Overall Study|Study terminated by the sponsor|4|||
131903266|NCT00960804|474931466|FG002|Overall Study|Study terminated by the sponsor|10|||
131903267|NCT03810456|474931467|FG000|Treatment|Urgent Family Matters|3|||
131903268|NCT03810456|474931468|FG001|Treatment|Urgent Family Matters|0|||
131903269|NCT03810456|474931469|FG002|Treatment|Urgent Family Matters|0|||
131903270|NCT03810456|474931467|FG000|Treatment|Scheduling Conflicts|0|||
131903271|NCT03810456|474931468|FG001|Treatment|Scheduling Conflicts|11|||
131903272|NCT03810456|474931469|FG002|Treatment|Scheduling Conflicts|0|||
131903273|NCT03810456|474931467|FG000|Treatment|No Longer Interested|0|||
131903274|NCT03810456|474931468|FG001|Treatment|No Longer Interested|12|||
131903275|NCT03810456|474931469|FG002|Treatment|No Longer Interested|0|||
131903276|NCT03810456|474931467|FG000|Treatment|Transportation Issues|0|||
131903277|NCT03810456|474931468|FG001|Treatment|Transportation Issues|1|||
131903278|NCT03810456|474931469|FG002|Treatment|Transportation Issues|0|||
131903279|NCT03810456|474931467|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
131903280|NCT03810456|474931468|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
131903281|NCT03810456|474931469|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
131903282|NCT03810456|474931467|FG000|1 Month Follow-Up|Relocated to Different State|1|||
131903283|NCT03810456|474931468|FG001|1 Month Follow-Up|Relocated to Different State|0|||
131903284|NCT03810456|474931469|FG002|1 Month Follow-Up|Relocated to Different State|1|||
131903285|NCT03810456|474931467|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
131903286|NCT03810456|474931468|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
131903287|NCT03810456|474931469|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
131903288|NCT03810456|474931467|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
131903289|NCT03810456|474931468|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
131903290|NCT03810456|474931469|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
131903291|NCT03810456|474931467|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
131903292|NCT03810456|474931468|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
131903293|NCT03810456|474931469|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
131903294|NCT03810456|474931467|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
131903295|NCT03810456|474931468|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
131903296|NCT03810456|474931469|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
131903297|NCT03810456|474931467|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
131903298|NCT03810456|474931468|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
131903299|NCT03810456|474931469|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
131903300|NCT00490919|474931470|FG000|Open-label Run-in Period|Adverse Event|239|||
131903301|NCT00490919|474931471|FG001|Open-label Run-in Period|Adverse Event|0|||
131903302|NCT00490919|474931472|FG002|Open-label Run-in Period|Adverse Event|0|||
131903303|NCT00490919|474931470|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
131903304|NCT00490919|474931471|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
131903305|NCT00490919|474931472|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
131903306|NCT00490919|474931470|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
131903307|NCT00490919|474931471|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
131903308|NCT00490919|474931472|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
131903309|NCT00490919|474931470|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
131903310|NCT00490919|474931471|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
131903311|NCT00490919|474931472|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
131903312|NCT00490919|474931470|FG000|Open-label Run-in Period|Administrative|40|||
131903313|NCT00490919|474931471|FG001|Open-label Run-in Period|Administrative|0|||
131903314|NCT00490919|474931472|FG002|Open-label Run-in Period|Administrative|0|||
131903315|NCT00490919|474931470|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
131903316|NCT00490919|474931471|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
131903317|NCT00490919|474931472|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
131903318|NCT00490919|474931470|FG000|Double-blind Phase|Adverse Event|0|||
131903319|NCT00490919|474931471|FG001|Double-blind Phase|Adverse Event|40|||
131903320|NCT00490919|474931472|FG002|Double-blind Phase|Adverse Event|20|||
131903321|NCT00490919|474931470|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131903322|NCT00490919|474931471|FG001|Double-blind Phase|Withdrawal by Subject|10|||
131903323|NCT00490919|474931472|FG002|Double-blind Phase|Withdrawal by Subject|11|||
131903324|NCT00490919|474931470|FG000|Double-blind Phase|Lost to Follow-up|0|||
131903325|NCT00490919|474931471|FG001|Double-blind Phase|Lost to Follow-up|8|||
131903326|NCT00490919|474931472|FG002|Double-blind Phase|Lost to Follow-up|11|||
131903327|NCT00490919|474931470|FG000|Double-blind Phase|Lack of Efficacy|0|||
131903328|NCT00490919|474931471|FG001|Double-blind Phase|Lack of Efficacy|22|||
131903329|NCT00490919|474931472|FG002|Double-blind Phase|Lack of Efficacy|36|||
131903330|NCT00490919|474931470|FG000|Double-blind Phase|Administrative|0|||
131903331|NCT00490919|474931471|FG001|Double-blind Phase|Administrative|6|||
131903332|NCT00490919|474931472|FG002|Double-blind Phase|Administrative|6|||
131903333|NCT00116688|474933211|FG000|Overall Study|Protocol deviation|1|||
131903334|NCT00116688|474933212|FG001|Overall Study|Protocol deviation|0|||
131903335|NCT00116688|474933211|FG000|Overall Study|Noncompliance|3|||
131903336|NCT00116688|474933212|FG001|Overall Study|Noncompliance|1|||
131903337|NCT00116688|474933211|FG000|Overall Study|Adverse Event|11|||
131903338|NCT00116688|474933212|FG001|Overall Study|Adverse Event|0|||
131903339|NCT00116688|474933211|FG000|Overall Study|Withdrawal by Subject|26|||
131903340|NCT00116688|474933212|FG001|Overall Study|Withdrawal by Subject|2|||
131903341|NCT00116688|474933211|FG000|Overall Study|Requirement for alternative therapy|11|||
131903342|NCT00116688|474933212|FG001|Overall Study|Requirement for alternative therapy|1|||
131903343|NCT00116688|474933211|FG000|Overall Study|Physician Decision|7|||
131903344|NCT00116688|474933212|FG001|Overall Study|Physician Decision|0|||
131802780|NCT03227445|474562007|FG001|Period 1 (28 Days)|Protocol Violation|0|||
131802781|NCT03227445|474562008|FG002|Period 1 (28 Days)|Protocol Violation|0|||
131802782|NCT03227445|474562009|FG003|Period 1 (28 Days)|Protocol Violation|0|||
131802783|NCT03227445|474562006|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
131802784|NCT03227445|474562007|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
131802785|NCT03227445|474562008|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
131802786|NCT03227445|474562009|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
131802787|NCT03227445|474562006|FG000|Period 2 (28 Days)|Adverse Event|1|||
131802788|NCT03227445|474562007|FG001|Period 2 (28 Days)|Adverse Event|0|||
131802789|NCT03227445|474562008|FG002|Period 2 (28 Days)|Adverse Event|2|||
131802790|NCT03227445|474562009|FG003|Period 2 (28 Days)|Adverse Event|1|||
131802791|NCT03227445|474562006|FG000|Period 2 (28 Days)|Protocol Violation|0|||
131802792|NCT03227445|474562007|FG001|Period 2 (28 Days)|Protocol Violation|0|||
131903345|NCT00116688|474933211|FG000|Overall Study|Lost to Follow-up|3|||
131903346|NCT00116688|474933212|FG001|Overall Study|Lost to Follow-up|0|||
131903347|NCT00116688|474933211|FG000|Overall Study|Death|15|||
131648708|NCT02498236|474000811|FG007|Overall Study|Equipment failure|0|||
131648709|NCT02498236|474000804|FG000|Overall Study|Withdrawal by Subject|0|||
131648710|NCT02498236|474000805|FG001|Overall Study|Withdrawal by Subject|0|||
131802793|NCT03227445|474562008|FG002|Period 2 (28 Days)|Protocol Violation|0|||
131802794|NCT03227445|474562009|FG003|Period 2 (28 Days)|Protocol Violation|1|||
131802795|NCT03227445|474562006|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
131903348|NCT00116688|474933212|FG001|Overall Study|Death|0|||
131903349|NCT00116688|474933211|FG000|Overall Study|Protocol-specified criteria|3|||
131903350|NCT00116688|474933212|FG001|Overall Study|Protocol-specified criteria|0|||
131903351|NCT00116688|474933211|FG000|Overall Study|Pregnancy|1|||
131903352|NCT00116688|474933212|FG001|Overall Study|Pregnancy|0|||
131903353|NCT00116688|474933211|FG000|Overall Study|Other|11|||
131903354|NCT00116688|474933212|FG001|Overall Study|Other|0|||
131903355|NCT01775670|474933216|FG000|Overall Study|Lost to Follow-up|1|||
131903356|NCT01775670|474933217|FG001|Overall Study|Lost to Follow-up|1|||
131903357|NCT01298700|474933219|FG000|Overall Study|Adverse Event|50|||
131903358|NCT01298700|474933220|FG001|Overall Study|Adverse Event|51|||
131903359|NCT01298700|474933219|FG000|Overall Study|Lack of Efficacy|9|||
131903360|NCT01298700|474933220|FG001|Overall Study|Lack of Efficacy|14|||
131903361|NCT01298700|474933219|FG000|Overall Study|Lost to Follow-up|5|||
131903362|NCT01298700|474933220|FG001|Overall Study|Lost to Follow-up|2|||
131903363|NCT01298700|474933219|FG000|Overall Study|Withdrawal by Subject|12|||
131903364|NCT01298700|474933220|FG001|Overall Study|Withdrawal by Subject|9|||
131658617|NCT02003222|474035398|FG003|Induction|Death|0|||
131802796|NCT03227445|474562007|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
131802797|NCT03227445|474562008|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
131802798|NCT03227445|474562009|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
131802799|NCT00755196|474562010|FG000|Overall Study|Lost to Follow-up|1|||
131802800|NCT00755196|474562010|FG000|Overall Study|Lack of Efficiency|1|||
131802801|NCT01703832|474562011|FG000|Overall Study|Withdrawal by Subject|1|||
131802802|NCT01703832|474562012|FG001|Overall Study|Withdrawal by Subject|0|||
131802803|NCT01991470|474562013|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
131802804|NCT01991470|474562013|FG000|Enlite 1 Period|Adverse Event|1|||
131802805|NCT01991470|474562013|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
131802806|NCT01991470|474562013|FG000|Enlite 3 Period|Lost to Follow-up|1|||
131802807|NCT01991470|474562013|FG000|Enlite 3 Period|Physician Decision|2|||
131802808|NCT01991470|474562013|FG000|Enlite 3 Period|Physician Decision|8|||
131802809|NCT01991470|474562013|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
131802810|NCT00243932|474562014|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
131802811|NCT00243932|474562015|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
131802812|NCT00243932|474562016|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
131802813|NCT02143102|474562019|FG000|Overall Study|Lost to Follow-up|11|||
131802814|NCT02143102|474562020|FG001|Overall Study|Lost to Follow-up|0|||
131802815|NCT04538170|474562021|FG000|Overall Study|Withdrawal by Subject|104|||
131802816|NCT04538170|474562022|FG001|Overall Study|Withdrawal by Subject|210|||
131802817|NCT03247556|474562025|FG000|Overall Study|Adverse Event|1|||
131802818|NCT03247556|474562026|FG001|Overall Study|Adverse Event|4|||
131802819|NCT03247556|474562027|FG002|Overall Study|Adverse Event|5|||
131802820|NCT03247556|474562025|FG000|Overall Study|Lost to Follow-up|5|||
131802821|NCT03247556|474562026|FG001|Overall Study|Lost to Follow-up|5|||
131802822|NCT03247556|474562027|FG002|Overall Study|Lost to Follow-up|4|||
131802823|NCT03247556|474562025|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
131802824|NCT03247556|474562026|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
131802825|NCT03247556|474562027|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
131802826|NCT03247556|474562025|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
131802827|NCT03247556|474562026|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
131802828|NCT03247556|474562027|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
131802829|NCT03247556|474562025|FG000|Overall Study|Protocol Violation|2|||
131802830|NCT03247556|474562026|FG001|Overall Study|Protocol Violation|0|||
131802831|NCT03247556|474562027|FG002|Overall Study|Protocol Violation|1|||
131802832|NCT03247556|474562025|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
131802833|NCT03247556|474562026|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
131802834|NCT03247556|474562027|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
131802835|NCT02731157|474562029|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
131802836|NCT00760266|474562030|FG000|Overall Study|Adverse Event|13|||
131802837|NCT00760266|474562031|FG001|Overall Study|Adverse Event|7|||
131802838|NCT00760266|474562030|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131802839|NCT00760266|474562031|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131802840|NCT00760266|474562030|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131802841|NCT00760266|474562031|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131802842|NCT00760266|474562030|FG000|Overall Study|Lack of Efficacy|2|||
131802843|NCT00760266|474562031|FG001|Overall Study|Lack of Efficacy|2|||
131802844|NCT00760266|474562030|FG000|Overall Study|Protocol deviation|2|||
131802845|NCT00760266|474562031|FG001|Overall Study|Protocol deviation|4|||
131802846|NCT00760266|474562030|FG000|Overall Study|Patient withdrew consent|3|||
131802847|NCT00760266|474562031|FG001|Overall Study|Patient withdrew consent|3|||
131802848|NCT00760266|474562030|FG000|Overall Study|Lost to Follow-up|2|||
131802849|NCT00760266|474562031|FG001|Overall Study|Lost to Follow-up|1|||
131802850|NCT00760266|474562030|FG000|Overall Study|Administrative Problems|0|||
131802851|NCT00760266|474562031|FG001|Overall Study|Administrative Problems|1|||
131802852|NCT05150964|474562032|FG000|Overall Study|Lost to Follow-up|2|||
131802853|NCT01856309|474562033|FG000|Overall Study|Death|4|||
131802854|NCT01856309|474562034|FG001|Overall Study|Death|6|||
131903365|NCT01298700|474933219|FG000|Overall Study|Protocol Violation|6|||
131903366|NCT01298700|474933220|FG001|Overall Study|Protocol Violation|4|||
131903367|NCT01298700|474933219|FG000|Overall Study|Other Miscellaneous Reasons|16|||
131903368|NCT01298700|474933220|FG001|Overall Study|Other Miscellaneous Reasons|15|||
131648711|NCT02498236|474000806|FG002|Overall Study|Withdrawal by Subject|0|||
131648712|NCT02498236|474000807|FG003|Overall Study|Withdrawal by Subject|0|||
131648713|NCT02498236|474000808|FG004|Overall Study|Withdrawal by Subject|1|||
131648714|NCT02498236|474000809|FG005|Overall Study|Withdrawal by Subject|0|||
131648715|NCT02498236|474000810|FG006|Overall Study|Withdrawal by Subject|0|||
131648716|NCT02498236|474000811|FG007|Overall Study|Withdrawal by Subject|0|||
131648717|NCT02296892|474000812|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
131648718|NCT02296892|474000813|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
131648719|NCT02296892|474000814|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
131648720|NCT02296892|474000812|FG000|Overall Study|Lost to Follow-up|5|||
131648721|NCT02296892|474000813|FG001|Overall Study|Lost to Follow-up|0|||
131648722|NCT02296892|474000814|FG002|Overall Study|Lost to Follow-up|1|||
131648723|NCT01814072|474000815|FG000|Overall Study|Lost to Follow-up|2|||
131648724|NCT01814072|474000816|FG001|Overall Study|Lost to Follow-up|2|||
131648725|NCT01814072|474000817|FG002|Overall Study|Lost to Follow-up|2|||
131648726|NCT01814072|474000818|FG003|Overall Study|Lost to Follow-up|0|||
131648727|NCT01814072|474000819|FG004|Overall Study|Lost to Follow-up|2|||
131648728|NCT01814072|474000820|FG005|Overall Study|Lost to Follow-up|3|||
131648729|NCT01814072|474000821|FG006|Overall Study|Lost to Follow-up|3|||
131648730|NCT01814072|474000822|FG007|Overall Study|Lost to Follow-up|1|||
131648731|NCT01814072|474000823|FG008|Overall Study|Lost to Follow-up|2|||
131648732|NCT01814072|474000824|FG009|Overall Study|Lost to Follow-up|3|||
131648733|NCT01814072|474000825|FG010|Overall Study|Lost to Follow-up|1|||
131648734|NCT01814072|474000826|FG011|Overall Study|Lost to Follow-up|2|||
131648735|NCT01814072|474000827|FG012|Overall Study|Lost to Follow-up|2|||
131648736|NCT01814072|474000828|FG013|Overall Study|Lost to Follow-up|1|||
131648737|NCT01814072|474000829|FG014|Overall Study|Lost to Follow-up|2|||
131648738|NCT01814072|474000830|FG015|Overall Study|Lost to Follow-up|1|||
131648739|NCT01814072|474000831|FG016|Overall Study|Lost to Follow-up|3|||
131648740|NCT01814072|474000832|FG017|Overall Study|Lost to Follow-up|1|||
131648741|NCT01814072|474000833|FG018|Overall Study|Lost to Follow-up|3|||
131648742|NCT01814072|474000834|FG019|Overall Study|Lost to Follow-up|3|||
131648743|NCT01814072|474000835|FG020|Overall Study|Lost to Follow-up|2|||
131648744|NCT01814072|474000836|FG021|Overall Study|Lost to Follow-up|1|||
131648745|NCT01814072|474000837|FG022|Overall Study|Lost to Follow-up|3|||
131648746|NCT01814072|474000838|FG023|Overall Study|Lost to Follow-up|1|||
131648747|NCT01814072|474000839|FG024|Overall Study|Lost to Follow-up|4|||
131648748|NCT01814072|474000840|FG025|Overall Study|Lost to Follow-up|1|||
131648749|NCT01814072|474000841|FG026|Overall Study|Lost to Follow-up|1|||
131648750|NCT01814072|474000842|FG027|Overall Study|Lost to Follow-up|2|||
131648751|NCT01814072|474000843|FG028|Overall Study|Lost to Follow-up|3|||
131648752|NCT01814072|474000844|FG029|Overall Study|Lost to Follow-up|3|||
131648753|NCT01814072|474000845|FG030|Overall Study|Lost to Follow-up|2|||
131648754|NCT01814072|474000846|FG031|Overall Study|Lost to Follow-up|0|||
131648755|NCT01814072|474000815|FG000|Overall Study|Withdrawal by Subject|2|||
131648756|NCT01814072|474000816|FG001|Overall Study|Withdrawal by Subject|0|||
131648757|NCT01814072|474000817|FG002|Overall Study|Withdrawal by Subject|1|||
131648758|NCT01814072|474000818|FG003|Overall Study|Withdrawal by Subject|0|||
131648759|NCT01814072|474000819|FG004|Overall Study|Withdrawal by Subject|2|||
131648760|NCT01814072|474000820|FG005|Overall Study|Withdrawal by Subject|3|||
131648761|NCT01814072|474000821|FG006|Overall Study|Withdrawal by Subject|1|||
131648762|NCT01814072|474000822|FG007|Overall Study|Withdrawal by Subject|0|||
131648763|NCT01814072|474000823|FG008|Overall Study|Withdrawal by Subject|1|||
131648764|NCT01814072|474000824|FG009|Overall Study|Withdrawal by Subject|2|||
131648765|NCT01814072|474000825|FG010|Overall Study|Withdrawal by Subject|0|||
131648766|NCT01814072|474000826|FG011|Overall Study|Withdrawal by Subject|0|||
131903369|NCT01298700|474933219|FG000|Overall Study|Did not Receive Study Drug|3|||
131903370|NCT01298700|474933220|FG001|Overall Study|Did not Receive Study Drug|5|||
131903371|NCT04006145|474933223|FG000|Overall Study|Lost to Follow-up|0|||
131903372|NCT04006145|474933224|FG001|Overall Study|Lost to Follow-up|1|||
131903373|NCT04006145|474933223|FG000|Overall Study|Other|1|||
131648767|NCT01814072|474000827|FG012|Overall Study|Withdrawal by Subject|1|||
131648768|NCT01814072|474000828|FG013|Overall Study|Withdrawal by Subject|1|||
131648769|NCT01814072|474000829|FG014|Overall Study|Withdrawal by Subject|1|||
131648770|NCT01814072|474000830|FG015|Overall Study|Withdrawal by Subject|1|||
131648771|NCT01814072|474000831|FG016|Overall Study|Withdrawal by Subject|0|||
131648772|NCT01814072|474000832|FG017|Overall Study|Withdrawal by Subject|0|||
131648773|NCT01814072|474000833|FG018|Overall Study|Withdrawal by Subject|0|||
131648774|NCT01814072|474000834|FG019|Overall Study|Withdrawal by Subject|2|||
131648775|NCT01814072|474000835|FG020|Overall Study|Withdrawal by Subject|0|||
131648776|NCT01814072|474000836|FG021|Overall Study|Withdrawal by Subject|0|||
131648777|NCT01814072|474000837|FG022|Overall Study|Withdrawal by Subject|1|||
131648778|NCT01814072|474000838|FG023|Overall Study|Withdrawal by Subject|0|||
131648779|NCT01814072|474000839|FG024|Overall Study|Withdrawal by Subject|2|||
131648780|NCT01814072|474000840|FG025|Overall Study|Withdrawal by Subject|1|||
131648781|NCT01814072|474000841|FG026|Overall Study|Withdrawal by Subject|1|||
131648782|NCT01814072|474000842|FG027|Overall Study|Withdrawal by Subject|2|||
131903374|NCT04006145|474933224|FG001|Overall Study|Other|2|||
131648783|NCT01814072|474000843|FG028|Overall Study|Withdrawal by Subject|1|||
131648784|NCT01814072|474000844|FG029|Overall Study|Withdrawal by Subject|0|||
131648785|NCT01814072|474000845|FG030|Overall Study|Withdrawal by Subject|0|||
131648786|NCT01814072|474000846|FG031|Overall Study|Withdrawal by Subject|0|||
131648787|NCT00383123|474000847|FG000|Overall Study|Adverse Event|1|||
131648788|NCT00383123|474000848|FG001|Overall Study|Adverse Event|0|||
131648789|NCT00383123|474000847|FG000|Overall Study|Lost to Follow-up|68|||
131648790|NCT00383123|474000848|FG001|Overall Study|Lost to Follow-up|61|||
131648791|NCT00383123|474000847|FG000|Overall Study|Protocol Violation|5|||
131648792|NCT00383123|474000848|FG001|Overall Study|Protocol Violation|1|||
131648793|NCT00383123|474000847|FG000|Overall Study|Withdrawal by Subject|27|||
131648794|NCT00383123|474000848|FG001|Overall Study|Withdrawal by Subject|18|||
131648795|NCT00383123|474000847|FG000|Overall Study|Other reason|10|||
131648796|NCT00383123|474000848|FG001|Overall Study|Other reason|6|||
131648797|NCT03566979|474000849|FG000|Overall Study|Withdrawal by Subject|2|||
131648798|NCT03566979|474000850|FG001|Overall Study|Withdrawal by Subject|0|||
131648799|NCT03566979|474000851|FG002|Overall Study|Withdrawal by Subject|1|||
131648800|NCT03566979|474000852|FG003|Overall Study|Withdrawal by Subject|1|||
131648801|NCT03566979|474000849|FG000|Overall Study|Lost to Follow-up|2|||
131648802|NCT03566979|474000850|FG001|Overall Study|Lost to Follow-up|7|||
131648803|NCT03566979|474000851|FG002|Overall Study|Lost to Follow-up|9|||
131648804|NCT03566979|474000852|FG003|Overall Study|Lost to Follow-up|5|||
131648805|NCT03566979|474000849|FG000|Overall Study|Adverse Event|1|||
131648806|NCT03566979|474000850|FG001|Overall Study|Adverse Event|0|||
131648807|NCT03566979|474000851|FG002|Overall Study|Adverse Event|0|||
131648808|NCT03566979|474000852|FG003|Overall Study|Adverse Event|0|||
131648809|NCT01011868|474000855|FG000|After Week 18 Follow-up|Adverse Event|8|||
131648810|NCT01011868|474000856|FG001|After Week 18 Follow-up|Adverse Event|6|||
131648811|NCT01011868|474000857|FG002|After Week 18 Follow-up|Adverse Event|13|||
131648812|NCT01011868|474000855|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
131648813|NCT01011868|474000856|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
131648814|NCT01011868|474000857|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
131648815|NCT01011868|474000855|FG000|After Week 18 Follow-up|Protocol Violation|1|||
131648816|NCT01011868|474000856|FG001|After Week 18 Follow-up|Protocol Violation|1|||
131648817|NCT01011868|474000857|FG002|After Week 18 Follow-up|Protocol Violation|1|||
131648818|NCT01011868|474000855|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
131648819|NCT01011868|474000856|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
131448113|NCT01716234|473270880|FG006|Overall Study|Protocol Violation|0|||
131648820|NCT01011868|474000857|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
131648821|NCT01011868|474000855|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
131648822|NCT01011868|474000856|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
131648823|NCT01011868|474000857|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
131903375|NCT00010257|474933227|FG000|Overall Study|Withdrawal by Subject|1|||
131648824|NCT01011868|474000855|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
131648825|NCT01011868|474000856|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
131648826|NCT01011868|474000857|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
131648827|NCT01011868|474000855|FG000|After Week 78 Follow-up|Adverse Event|14|||
131648828|NCT01011868|474000856|FG001|After Week 78 Follow-up|Adverse Event|18|||
131648829|NCT01011868|474000857|FG002|After Week 78 Follow-up|Adverse Event|21|||
131648830|NCT01011868|474000855|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
131648831|NCT01011868|474000856|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
131648832|NCT01011868|474000857|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
131648833|NCT01011868|474000855|FG000|After Week 78 Follow-up|Protocol Violation|9|||
131648834|NCT01011868|474000856|FG001|After Week 78 Follow-up|Protocol Violation|1|||
131648835|NCT01011868|474000857|FG002|After Week 78 Follow-up|Protocol Violation|2|||
131648836|NCT01011868|474000855|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
131648837|NCT01011868|474000856|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
131648838|NCT01011868|474000857|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
131648839|NCT01011868|474000855|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
131648840|NCT01011868|474000856|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
131648841|NCT01011868|474000857|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
131648842|NCT01011868|474000855|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
131648843|NCT01011868|474000856|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
131648844|NCT01011868|474000857|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
131648845|NCT02336425|474000858|FG000|Overall Study|Study terminated.|2|||
131648846|NCT02336425|474000859|FG001|Overall Study|Study terminated.|2|||
131648847|NCT02336425|474000860|FG002|Overall Study|Study terminated.|3|||
131648848|NCT02336425|474000861|FG003|Overall Study|Study terminated.|3|||
131648849|NCT00978562|474000862|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
131648850|NCT01782690|474000863|FG000|Overall Study|Not reported|7|||
131648851|NCT01782690|474000863|FG000|Overall Study|Toxicity of gemcitabine|1|||
131648852|NCT01782690|474000863|FG000|Overall Study|Toxicity of erlotinib|1|||
131648853|NCT01782690|474000863|FG000|Overall Study|Lost to Follow-up|31|||
131648854|NCT01782690|474000863|FG000|Overall Study|Withdrawal of informed consent|2|||
131648855|NCT01782690|474000863|FG000|Overall Study|Absent rash|9|||
131648856|NCT01782690|474000863|FG000|Overall Study|Physician Decision|13|||
131648857|NCT01782690|474000863|FG000|Overall Study|Patient's wish|21|||
131648858|NCT01782690|474000863|FG000|Overall Study|Tumor progression|74|||
131648859|NCT01782690|474000863|FG000|Overall Study|Death|133|||
131648860|NCT01782690|474000863|FG000|Overall Study|Study completion unknown|7|||
131648861|NCT01948076|474000865|FG000|Overall Study|Withdrawal by Subject|0|||
131648862|NCT01948076|474000866|FG001|Overall Study|Withdrawal by Subject|1|||
131648863|NCT04277507|474000868|FG000|Overall Study|Lost to Follow-up|17|||
131648864|NCT04277507|474000868|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
131648865|NCT04277507|474000868|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
131648866|NCT04277507|474000868|FG000|Overall Study|Withdrawal by Subject|3|||
131648867|NCT04277507|474000868|FG000|Overall Study|Death due to COVID-19|1|||
131648868|NCT04277507|474000868|FG000|Overall Study|Data missing for full evaluation|5|||
131648869|NCT00738283|474000874|FG000|Overall Study|Death|1|||
131648870|NCT00738283|474000874|FG000|Overall Study|Transfer to another facility|2|||
131648871|NCT00738283|474000874|FG000|Overall Study|Discharge home prior to end of study|1|||
131648872|NCT00486252|474000875|FG000|Overall Study|Adverse Event|7|||
131802855|NCT01856309|474562035|FG002|Overall Study|Death|11|||
131648873|NCT00486252|474000875|FG000|Overall Study|Lack of Efficacy|9|||
131648874|NCT00486252|474000875|FG000|Overall Study|Lost to Follow-up|24|||
131648875|NCT00486252|474000875|FG000|Overall Study|Other|18|||
131648876|NCT01210651|474000878|FG000|Overall Study|Lost to Follow-up|1|||
131648877|NCT01210651|474000879|FG001|Overall Study|Lost to Follow-up|1|||
131802856|NCT01856309|474562036|FG003|Overall Study|Death|6|||
131802857|NCT01856309|474562033|FG000|Overall Study|Lost to Follow-up|6|||
131802858|NCT01856309|474562034|FG001|Overall Study|Lost to Follow-up|2|||
131802859|NCT01856309|474562035|FG002|Overall Study|Lost to Follow-up|4|||
131802860|NCT01856309|474562036|FG003|Overall Study|Lost to Follow-up|8|||
131802861|NCT01856309|474562033|FG000|Overall Study|Withdrawal by Subject|11|||
131802862|NCT01856309|474562034|FG001|Overall Study|Withdrawal by Subject|13|||
131802863|NCT01856309|474562035|FG002|Overall Study|Withdrawal by Subject|28|||
131802864|NCT01856309|474562036|FG003|Overall Study|Withdrawal by Subject|26|||
131802865|NCT01856309|474562033|FG000|Overall Study|Other|227|||
131802866|NCT01856309|474562034|FG001|Overall Study|Other|225|||
131802867|NCT01856309|474562035|FG002|Overall Study|Other|447|||
131802868|NCT01856309|474562036|FG003|Overall Study|Other|469|||
131802869|NCT01856309|474562033|FG000|Overall Study|Lack of Efficacy|14|||
131802870|NCT01856309|474562034|FG001|Overall Study|Lack of Efficacy|9|||
131802871|NCT01856309|474562035|FG002|Overall Study|Lack of Efficacy|40|||
131802872|NCT01856309|474562036|FG003|Overall Study|Lack of Efficacy|25|||
131802873|NCT01856309|474562033|FG000|Overall Study|Adverse Event|31|||
131802874|NCT01856309|474562034|FG001|Overall Study|Adverse Event|31|||
131648878|NCT01210651|474000878|FG000|Overall Study|schedule conflicts|1|||
131648879|NCT01210651|474000879|FG001|Overall Study|schedule conflicts|5|||
131648880|NCT01210651|474000878|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
131648881|NCT01210651|474000879|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
131648882|NCT01210651|474000878|FG000|Overall Study|Withdrawal by Subject|1|||
131648883|NCT01210651|474000879|FG001|Overall Study|Withdrawal by Subject|1|||
131648884|NCT01210651|474000878|FG000|Overall Study|Injury outside study|2|||
131648885|NCT01210651|474000879|FG001|Overall Study|Injury outside study|0|||
131648886|NCT01261247|474000880|FG000|Overall Study|Ineligible|2|||
131648887|NCT02559310|474000884|FG000|Overall Study|Death|4|||
131648888|NCT02559310|474000885|FG001|Overall Study|Death|3|||
131648889|NCT02559310|474000884|FG000|Overall Study|Lost to Follow-up|5|||
131648890|NCT02559310|474000885|FG001|Overall Study|Lost to Follow-up|3|||
131648891|NCT02559310|474000884|FG000|Overall Study|Physician Decision|2|||
131648892|NCT02559310|474000885|FG001|Overall Study|Physician Decision|1|||
131648893|NCT02559310|474000884|FG000|Overall Study|Withdrawal by Subject|13|||
131648894|NCT02559310|474000885|FG001|Overall Study|Withdrawal by Subject|9|||
131648895|NCT02559310|474000884|FG000|Overall Study|Sponsor Decision|0|||
131648896|NCT02559310|474000885|FG001|Overall Study|Sponsor Decision|1|||
131648897|NCT02559310|474000884|FG000|Overall Study|Randomized but not treated|3|||
131648898|NCT02559310|474000885|FG001|Overall Study|Randomized but not treated|2|||
131648899|NCT02592707|474000886|FG000|Overall Study|Consent Withdrawn|0|||
131648900|NCT02592707|474000887|FG001|Overall Study|Consent Withdrawn|1|||
131648901|NCT02592707|474000888|FG002|Overall Study|Consent Withdrawn|2|||
131648902|NCT02592707|474000889|FG003|Overall Study|Consent Withdrawn|0|||
131648903|NCT02592707|474000886|FG000|Overall Study|Death|1|||
131648904|NCT02592707|474000887|FG001|Overall Study|Death|0|||
131648905|NCT02592707|474000888|FG002|Overall Study|Death|0|||
131648906|NCT02592707|474000889|FG003|Overall Study|Death|0|||
131648907|NCT02592707|474000886|FG000|Overall Study|Progressive Disease|4|||
131648908|NCT02592707|474000887|FG001|Overall Study|Progressive Disease|4|||
131648909|NCT02592707|474000888|FG002|Overall Study|Progressive Disease|3|||
131648910|NCT02592707|474000889|FG003|Overall Study|Progressive Disease|3|||
131648911|NCT02592707|474000886|FG000|Overall Study|Other|0|||
131648912|NCT02592707|474000887|FG001|Overall Study|Other|0|||
131648913|NCT02592707|474000888|FG002|Overall Study|Other|1|||
131648914|NCT02592707|474000889|FG003|Overall Study|Other|2|||
131648915|NCT02592707|474000886|FG000|Overall Study|Never entered LTFU period|1|||
131648916|NCT02592707|474000887|FG001|Overall Study|Never entered LTFU period|0|||
131648917|NCT02592707|474000888|FG002|Overall Study|Never entered LTFU period|0|||
131648918|NCT02592707|474000889|FG003|Overall Study|Never entered LTFU period|2|||
131648919|NCT00469859|474000890|FG000|Overall Study|Inevaluable|0|||
131648920|NCT00469859|474000891|FG001|Overall Study|Inevaluable|2|||
131648921|NCT04124471|474000892|FG000|Overall Study|screen failure|1|||
131648922|NCT04855734|474000893|FG000|Overall Study|Lost to Follow-up|2|||
131648923|NCT04855734|474000894|FG001|Overall Study|Lost to Follow-up|2|||
131648924|NCT03732677|474000895|FG000|Overall Study|Terminated the study|154|||
131648925|NCT03732677|474000896|FG001|Overall Study|Terminated the study|197|||
131648926|NCT03732677|474000895|FG000|Overall Study|Continuing study off treatment|379|||
131648927|NCT03732677|474000896|FG001|Overall Study|Continuing study off treatment|333|||
131648928|NCT04013971|474000897|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
131648929|NCT04013971|474000898|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
131648930|NCT04013971|474000897|FG000|Overall Study|Missing biomechanical data|0|||
131648931|NCT04013971|474000898|FG001|Overall Study|Missing biomechanical data|1|||
131648932|NCT01340014|474000901|FG000|Period 1, First 7 Days|Adverse Event|1|||
131648933|NCT01340014|474000902|FG001|Period 1, First 7 Days|Adverse Event|0|||
131648934|NCT01340014|474000901|FG000|Period 1, First 7 Days|Personal Reasons|1|||
131648935|NCT01340014|474000902|FG001|Period 1, First 7 Days|Personal Reasons|0|||
131648936|NCT01340014|474000901|FG000|Period 2, Second 7 Days|Adverse Event|0|||
131648937|NCT01340014|474000902|FG001|Period 2, Second 7 Days|Adverse Event|1|||
131648938|NCT00344032|474000907|FG000|Overall Study|Adverse Event|0|||
131648939|NCT00344032|474000908|FG001|Overall Study|Adverse Event|1|||
131648940|NCT00344032|474000907|FG000|Overall Study|Withdrawal by Subject|6|||
131648941|NCT00344032|474000908|FG001|Overall Study|Withdrawal by Subject|2|||
131648942|NCT00344032|474000907|FG000|Overall Study|Lost to Follow-up|4|||
131648943|NCT00344032|474000908|FG001|Overall Study|Lost to Follow-up|6|||
131648944|NCT00344032|474000907|FG000|Overall Study|Physician Decision|4|||
131648945|NCT00344032|474000908|FG001|Overall Study|Physician Decision|1|||
131648946|NCT05131477|474000913|FG000|PART 1|Withdrawal by Subject|2|||
131648947|NCT05131477|474000914|FG001|PART 1|Withdrawal by Subject|9|||
131648948|NCT05131477|474000915|FG002|PART 1|Withdrawal by Subject|6|||
131648949|NCT05131477|474000916|FG003|PART 1|Withdrawal by Subject|2|||
131648950|NCT05131477|474000917|FG004|PART 1|Withdrawal by Subject|8|||
131648951|NCT05131477|474000918|FG005|PART 1|Withdrawal by Subject|0|||
131648952|NCT05131477|474000919|FG006|PART 1|Withdrawal by Subject|0|||
131648953|NCT05131477|474000920|FG007|PART 1|Withdrawal by Subject|0|||
131648954|NCT05131477|474000921|FG008|PART 1|Withdrawal by Subject|0|||
131648955|NCT05131477|474000922|FG009|PART 1|Withdrawal by Subject|0|||
131648956|NCT05131477|474000923|FG010|PART 1|Withdrawal by Subject|0|||
131648957|NCT05131477|474000924|FG011|PART 1|Withdrawal by Subject|0|||
131648958|NCT05131477|474000925|FG012|PART 1|Withdrawal by Subject|0|||
131648959|NCT05131477|474000926|FG013|PART 1|Withdrawal by Subject|0|||
131648960|NCT05131477|474000913|FG000|PART 1|Physician Decision|1|||
131648961|NCT05131477|474000914|FG001|PART 1|Physician Decision|0|||
131648962|NCT05131477|474000915|FG002|PART 1|Physician Decision|0|||
131648963|NCT05131477|474000916|FG003|PART 1|Physician Decision|0|||
131648964|NCT05131477|474000917|FG004|PART 1|Physician Decision|0|||
131648965|NCT05131477|474000918|FG005|PART 1|Physician Decision|0|||
131648966|NCT05131477|474000919|FG006|PART 1|Physician Decision|0|||
131648967|NCT05131477|474000920|FG007|PART 1|Physician Decision|0|||
131648968|NCT05131477|474000921|FG008|PART 1|Physician Decision|0|||
131648969|NCT05131477|474000922|FG009|PART 1|Physician Decision|0|||
131648970|NCT05131477|474000923|FG010|PART 1|Physician Decision|0|||
131648971|NCT05131477|474000924|FG011|PART 1|Physician Decision|0|||
131648972|NCT05131477|474000925|FG012|PART 1|Physician Decision|0|||
131648973|NCT05131477|474000926|FG013|PART 1|Physician Decision|0|||
131648974|NCT05131477|474000913|FG000|PART 1|Adverse Event|3|||
131648975|NCT05131477|474000914|FG001|PART 1|Adverse Event|5|||
131648976|NCT05131477|474000915|FG002|PART 1|Adverse Event|1|||
131648977|NCT05131477|474000916|FG003|PART 1|Adverse Event|6|||
131648978|NCT05131477|474000917|FG004|PART 1|Adverse Event|4|||
131648979|NCT05131477|474000918|FG005|PART 1|Adverse Event|0|||
131648980|NCT05131477|474000919|FG006|PART 1|Adverse Event|0|||
131648981|NCT05131477|474000920|FG007|PART 1|Adverse Event|0|||
131648982|NCT05131477|474000921|FG008|PART 1|Adverse Event|0|||
131648983|NCT05131477|474000922|FG009|PART 1|Adverse Event|0|||
131648984|NCT05131477|474000923|FG010|PART 1|Adverse Event|0|||
131648985|NCT05131477|474000924|FG011|PART 1|Adverse Event|0|||
131648986|NCT05131477|474000925|FG012|PART 1|Adverse Event|0|||
131648987|NCT05131477|474000926|FG013|PART 1|Adverse Event|0|||
131648988|NCT05131477|474000913|FG000|PART 1|unclassified|1|||
131648989|NCT05131477|474000914|FG001|PART 1|unclassified|1|||
131648990|NCT05131477|474000915|FG002|PART 1|unclassified|0|||
131648991|NCT05131477|474000916|FG003|PART 1|unclassified|0|||
131648992|NCT05131477|474000917|FG004|PART 1|unclassified|4|||
131648993|NCT05131477|474000918|FG005|PART 1|unclassified|0|||
131648994|NCT05131477|474000919|FG006|PART 1|unclassified|0|||
131648995|NCT05131477|474000920|FG007|PART 1|unclassified|0|||
131648996|NCT05131477|474000921|FG008|PART 1|unclassified|0|||
131648997|NCT05131477|474000922|FG009|PART 1|unclassified|0|||
131648998|NCT05131477|474000923|FG010|PART 1|unclassified|0|||
131648999|NCT05131477|474000924|FG011|PART 1|unclassified|0|||
131649000|NCT05131477|474000925|FG012|PART 1|unclassified|0|||
131649001|NCT05131477|474000926|FG013|PART 1|unclassified|0|||
131649002|NCT05131477|474000913|FG000|PART 1|Randomized and not treated|0|||
131649003|NCT05131477|474000914|FG001|PART 1|Randomized and not treated|0|||
131649004|NCT05131477|474000915|FG002|PART 1|Randomized and not treated|0|||
131649005|NCT05131477|474000916|FG003|PART 1|Randomized and not treated|1|||
131649006|NCT05131477|474000917|FG004|PART 1|Randomized and not treated|1|||
131649007|NCT05131477|474000918|FG005|PART 1|Randomized and not treated|0|||
131649008|NCT05131477|474000919|FG006|PART 1|Randomized and not treated|0|||
131649009|NCT05131477|474000920|FG007|PART 1|Randomized and not treated|0|||
131649010|NCT05131477|474000921|FG008|PART 1|Randomized and not treated|0|||
131649011|NCT05131477|474000922|FG009|PART 1|Randomized and not treated|0|||
131649012|NCT05131477|474000923|FG010|PART 1|Randomized and not treated|0|||
131649013|NCT05131477|474000924|FG011|PART 1|Randomized and not treated|0|||
131649014|NCT05131477|474000925|FG012|PART 1|Randomized and not treated|0|||
131649015|NCT05131477|474000926|FG013|PART 1|Randomized and not treated|0|||
131903376|NCT00010257|474933228|FG001|Overall Study|Withdrawal by Subject|0|||
131903377|NCT00643760|474933229|FG000|Overall Study|Adverse Event|11|||
131903378|NCT00643760|474933230|FG001|Overall Study|Adverse Event|5|||
131903379|NCT00643760|474933231|FG002|Overall Study|Adverse Event|12|||
131903380|NCT00643760|474933232|FG003|Overall Study|Adverse Event|21|||
131903381|NCT00643760|474933233|FG004|Overall Study|Adverse Event|6|||
131649016|NCT05131477|474000913|FG000|PART 1|Protocol Violation|2|||
131649017|NCT05131477|474000914|FG001|PART 1|Protocol Violation|0|||
131649018|NCT05131477|474000915|FG002|PART 1|Protocol Violation|0|||
131649019|NCT05131477|474000916|FG003|PART 1|Protocol Violation|1|||
131649020|NCT05131477|474000917|FG004|PART 1|Protocol Violation|0|||
131649021|NCT05131477|474000918|FG005|PART 1|Protocol Violation|0|||
131649022|NCT05131477|474000919|FG006|PART 1|Protocol Violation|0|||
131716060|NCT01324830|474238877|FG013|Overall Study|Adverse Event, serious fatal|0|||
131903382|NCT00643760|474933229|FG000|Overall Study|Lack of Efficacy|3|||
131649023|NCT05131477|474000920|FG007|PART 1|Protocol Violation|0|||
131649024|NCT05131477|474000921|FG008|PART 1|Protocol Violation|0|||
131649025|NCT05131477|474000922|FG009|PART 1|Protocol Violation|0|||
131649026|NCT05131477|474000923|FG010|PART 1|Protocol Violation|0|||
131649027|NCT05131477|474000924|FG011|PART 1|Protocol Violation|0|||
131649028|NCT05131477|474000925|FG012|PART 1|Protocol Violation|0|||
131649029|NCT05131477|474000926|FG013|PART 1|Protocol Violation|0|||
131649030|NCT05131477|474000913|FG000|PART 1|Lack of Efficacy|0|||
131649031|NCT05131477|474000914|FG001|PART 1|Lack of Efficacy|1|||
131649032|NCT05131477|474000915|FG002|PART 1|Lack of Efficacy|1|||
131903383|NCT00643760|474933230|FG001|Overall Study|Lack of Efficacy|1|||
131649033|NCT05131477|474000916|FG003|PART 1|Lack of Efficacy|2|||
131649034|NCT05131477|474000917|FG004|PART 1|Lack of Efficacy|5|||
131649035|NCT05131477|474000918|FG005|PART 1|Lack of Efficacy|0|||
131649036|NCT05131477|474000919|FG006|PART 1|Lack of Efficacy|0|||
131649037|NCT05131477|474000920|FG007|PART 1|Lack of Efficacy|0|||
131649038|NCT05131477|474000921|FG008|PART 1|Lack of Efficacy|0|||
131649039|NCT05131477|474000922|FG009|PART 1|Lack of Efficacy|0|||
131649040|NCT05131477|474000923|FG010|PART 1|Lack of Efficacy|0|||
131649041|NCT05131477|474000924|FG011|PART 1|Lack of Efficacy|0|||
131649042|NCT05131477|474000925|FG012|PART 1|Lack of Efficacy|0|||
131649043|NCT05131477|474000926|FG013|PART 1|Lack of Efficacy|0|||
131649044|NCT05131477|474000913|FG000|PART 2|Withdrawal by Subject|0|||
131649045|NCT05131477|474000914|FG001|PART 2|Withdrawal by Subject|0|||
131649046|NCT05131477|474000915|FG002|PART 2|Withdrawal by Subject|0|||
131649047|NCT05131477|474000916|FG003|PART 2|Withdrawal by Subject|0|||
131649048|NCT05131477|474000917|FG004|PART 2|Withdrawal by Subject|0|||
131649049|NCT05131477|474000918|FG005|PART 2|Withdrawal by Subject|0|||
131649050|NCT05131477|474000919|FG006|PART 2|Withdrawal by Subject|2|||
131649051|NCT05131477|474000920|FG007|PART 2|Withdrawal by Subject|0|||
131649052|NCT05131477|474000921|FG008|PART 2|Withdrawal by Subject|0|||
131649053|NCT05131477|474000922|FG009|PART 2|Withdrawal by Subject|0|||
131649054|NCT05131477|474000923|FG010|PART 2|Withdrawal by Subject|2|||
131649055|NCT05131477|474000924|FG011|PART 2|Withdrawal by Subject|0|||
131649056|NCT05131477|474000925|FG012|PART 2|Withdrawal by Subject|2|||
131649057|NCT05131477|474000926|FG013|PART 2|Withdrawal by Subject|2|||
131649058|NCT05131477|474000913|FG000|PART 2|Other|0|||
131649059|NCT05131477|474000914|FG001|PART 2|Other|0|||
131649060|NCT05131477|474000915|FG002|PART 2|Other|0|||
131649061|NCT05131477|474000916|FG003|PART 2|Other|0|||
131649062|NCT05131477|474000917|FG004|PART 2|Other|0|||
131649063|NCT05131477|474000918|FG005|PART 2|Other|0|||
131649064|NCT05131477|474000919|FG006|PART 2|Other|0|||
131649065|NCT05131477|474000920|FG007|PART 2|Other|0|||
131649066|NCT05131477|474000921|FG008|PART 2|Other|1|||
131649067|NCT05131477|474000922|FG009|PART 2|Other|1|||
131649068|NCT05131477|474000923|FG010|PART 2|Other|0|||
131649069|NCT05131477|474000924|FG011|PART 2|Other|0|||
131649070|NCT05131477|474000925|FG012|PART 2|Other|1|||
131649071|NCT05131477|474000926|FG013|PART 2|Other|0|||
131649072|NCT05131477|474000913|FG000|PART 2|Lack of Efficacy|0|||
131649073|NCT05131477|474000914|FG001|PART 2|Lack of Efficacy|0|||
131649074|NCT05131477|474000915|FG002|PART 2|Lack of Efficacy|0|||
131649075|NCT05131477|474000916|FG003|PART 2|Lack of Efficacy|0|||
131649076|NCT05131477|474000917|FG004|PART 2|Lack of Efficacy|0|||
131649077|NCT05131477|474000918|FG005|PART 2|Lack of Efficacy|1|||
131649078|NCT05131477|474000919|FG006|PART 2|Lack of Efficacy|1|||
131649079|NCT05131477|474000920|FG007|PART 2|Lack of Efficacy|0|||
131649080|NCT05131477|474000921|FG008|PART 2|Lack of Efficacy|3|||
131649081|NCT05131477|474000922|FG009|PART 2|Lack of Efficacy|0|||
131649082|NCT05131477|474000923|FG010|PART 2|Lack of Efficacy|1|||
131649083|NCT05131477|474000924|FG011|PART 2|Lack of Efficacy|0|||
131649084|NCT05131477|474000925|FG012|PART 2|Lack of Efficacy|2|||
131649085|NCT05131477|474000926|FG013|PART 2|Lack of Efficacy|0|||
131649086|NCT05131477|474000913|FG000|PART 2|Unclassified|0|||
131649087|NCT05131477|474000914|FG001|PART 2|Unclassified|0|||
131649088|NCT05131477|474000915|FG002|PART 2|Unclassified|0|||
131802875|NCT01856309|474562035|FG002|Overall Study|Adverse Event|55|||
131802876|NCT01856309|474562036|FG003|Overall Study|Adverse Event|65|||
131802877|NCT01856309|474562033|FG000|Overall Study|Pregnancy|0|||
131802878|NCT01856309|474562034|FG001|Overall Study|Pregnancy|0|||
131649089|NCT05131477|474000916|FG003|PART 2|Unclassified|0|||
131649090|NCT05131477|474000917|FG004|PART 2|Unclassified|0|||
131649091|NCT05131477|474000918|FG005|PART 2|Unclassified|0|||
131802879|NCT01856309|474562035|FG002|Overall Study|Pregnancy|0|||
131649092|NCT05131477|474000919|FG006|PART 2|Unclassified|0|||
131649093|NCT05131477|474000920|FG007|PART 2|Unclassified|0|||
131649094|NCT05131477|474000921|FG008|PART 2|Unclassified|0|||
131649095|NCT05131477|474000922|FG009|PART 2|Unclassified|0|||
131649096|NCT05131477|474000923|FG010|PART 2|Unclassified|1|||
131649097|NCT05131477|474000924|FG011|PART 2|Unclassified|0|||
131649098|NCT05131477|474000925|FG012|PART 2|Unclassified|0|||
131649099|NCT05131477|474000926|FG013|PART 2|Unclassified|0|||
131649100|NCT05131477|474000913|FG000|PART 2|Re-randomized and not treated|0|||
131649101|NCT05131477|474000914|FG001|PART 2|Re-randomized and not treated|0|||
131649102|NCT05131477|474000915|FG002|PART 2|Re-randomized and not treated|0|||
131649103|NCT05131477|474000916|FG003|PART 2|Re-randomized and not treated|0|||
131649104|NCT05131477|474000917|FG004|PART 2|Re-randomized and not treated|0|||
131649105|NCT05131477|474000918|FG005|PART 2|Re-randomized and not treated|0|||
131649106|NCT05131477|474000919|FG006|PART 2|Re-randomized and not treated|0|||
131649107|NCT05131477|474000920|FG007|PART 2|Re-randomized and not treated|1|||
131649108|NCT05131477|474000921|FG008|PART 2|Re-randomized and not treated|0|||
131649109|NCT05131477|474000922|FG009|PART 2|Re-randomized and not treated|0|||
131649110|NCT05131477|474000923|FG010|PART 2|Re-randomized and not treated|1|||
131649111|NCT05131477|474000924|FG011|PART 2|Re-randomized and not treated|0|||
131649112|NCT05131477|474000925|FG012|PART 2|Re-randomized and not treated|1|||
131649113|NCT05131477|474000926|FG013|PART 2|Re-randomized and not treated|1|||
131649114|NCT02194829|474000927|FG000|Overall Study|Adverse Event|2|||
131649115|NCT02194829|474000928|FG001|Overall Study|Adverse Event|2|||
131649116|NCT02194829|474000927|FG000|Overall Study|Death|0|||
131802880|NCT01856309|474562036|FG003|Overall Study|Pregnancy|1|||
131802881|NCT01856309|474562033|FG000|Overall Study|Physician Decision|6|||
131802882|NCT01856309|474562034|FG001|Overall Study|Physician Decision|1|||
131802883|NCT01856309|474562035|FG002|Overall Study|Physician Decision|6|||
131802884|NCT01856309|474562036|FG003|Overall Study|Physician Decision|8|||
131649117|NCT02194829|474000928|FG001|Overall Study|Death|1|||
131649118|NCT02194829|474000927|FG000|Overall Study|Disease progression|0|||
131649119|NCT02194829|474000928|FG001|Overall Study|Disease progression|1|||
131649120|NCT02194829|474000927|FG000|Overall Study|Withdrawal by Subject|0|||
131649121|NCT02194829|474000928|FG001|Overall Study|Withdrawal by Subject|1|||
131649122|NCT02194829|474000927|FG000|Overall Study|Never started protocol therapy|0|||
131649123|NCT02194829|474000928|FG001|Overall Study|Never started protocol therapy|1|||
131649124|NCT05101993|474000933|FG000|Overall Study|Withdrawal by Subject|1|||
131649125|NCT04577573|474000934|FG000|Overall Study|Technical - invalid protocol|0|||
131649126|NCT04577573|474000935|FG001|Overall Study|Technical - invalid protocol|2|||
131649127|NCT04577573|474000936|FG002|Overall Study|Technical - invalid protocol|0|||
131649128|NCT04297618|474000937|FG000|Overall Study|Adverse Event|1|||
131649129|NCT04297618|474000937|FG000|Overall Study|Withdrawal by Subject|1|||
131649130|NCT02065882|474000938|FG000|Part I: PK/PD|Screening failure|5|||
131649131|NCT02065882|474000938|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
131649132|NCT02065882|474000938|FG000|Part I: PK/PD|Adverse Event|1|||
131649133|NCT02065882|474000938|FG000|Part II: Clinical Efficacy|Screening failure|7|||
131649134|NCT02065882|474000938|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
131649135|NCT02065882|474000938|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
131649136|NCT02065882|474000938|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
131649137|NCT02065882|474000938|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
131649138|NCT02065882|474000938|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
131649139|NCT06719986|474000939|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
131649140|NCT06719986|474000940|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
131649141|NCT06719986|474000941|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
131649142|NCT06719986|474000939|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
131802885|NCT01856309|474562033|FG000|Overall Study|Noncompliance With Study Drug|0|||
131802886|NCT01856309|474562034|FG001|Overall Study|Noncompliance With Study Drug|1|||
131802887|NCT01856309|474562035|FG002|Overall Study|Noncompliance With Study Drug|4|||
131802888|NCT01856309|474562036|FG003|Overall Study|Noncompliance With Study Drug|1|||
131802889|NCT01273181|474562037|FG000|Phase I, Dose 1|Study termination|1|||
131802890|NCT01273181|474562038|FG001|Phase I, Dose 1|Study termination|0|||
131649143|NCT06719986|474000940|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
131649144|NCT06719986|474000941|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
131802891|NCT01273181|474562039|FG002|Phase I, Dose 1|Study termination|0|||
131802892|NCT01273181|474562040|FG003|Phase I, Dose 1|Study termination|0|||
131802893|NCT01273181|474562037|FG000|Phase I, Dose 2|Death during treatment|0|||
131802894|NCT01273181|474562038|FG001|Phase I, Dose 2|Death during treatment|1|||
131802895|NCT01273181|474562039|FG002|Phase I, Dose 2|Death during treatment|0|||
131903384|NCT00643760|474933231|FG002|Overall Study|Lack of Efficacy|0|||
131649145|NCT02600897|474000943|FG000|Overall Study|Death|1|||
131802896|NCT01273181|474562040|FG003|Phase I, Dose 2|Death during treatment|0|||
131802897|NCT01273181|474562037|FG000|Phase 2, Dose 1|Study termination|0|||
131649146|NCT02600897|474000944|FG001|Overall Study|Death|2|||
131649147|NCT02600897|474000945|FG002|Overall Study|Death|1|||
131649148|NCT02600897|474000946|FG003|Overall Study|Death|2|||
131649149|NCT02600897|474000947|FG004|Overall Study|Death|3|||
131649150|NCT02600897|474000948|FG005|Overall Study|Death|2|||
131649151|NCT02600897|474000949|FG006|Overall Study|Death|10|||
131649152|NCT02600897|474000950|FG007|Overall Study|Death|7|||
131649153|NCT02600897|474000951|FG008|Overall Study|Death|20|||
131649154|NCT02600897|474000943|FG000|Overall Study|Lost to Follow-up|1|||
131649155|NCT02600897|474000944|FG001|Overall Study|Lost to Follow-up|0|||
131649156|NCT02600897|474000945|FG002|Overall Study|Lost to Follow-up|0|||
131649157|NCT02600897|474000946|FG003|Overall Study|Lost to Follow-up|0|||
131649158|NCT02600897|474000947|FG004|Overall Study|Lost to Follow-up|0|||
131649159|NCT02600897|474000948|FG005|Overall Study|Lost to Follow-up|0|||
131649160|NCT02600897|474000949|FG006|Overall Study|Lost to Follow-up|0|||
131649161|NCT02600897|474000950|FG007|Overall Study|Lost to Follow-up|1|||
131649162|NCT02600897|474000951|FG008|Overall Study|Lost to Follow-up|0|||
131649163|NCT02600897|474000943|FG000|Overall Study|Withdrawal by Subject|0|||
131649164|NCT02600897|474000944|FG001|Overall Study|Withdrawal by Subject|0|||
131649165|NCT02600897|474000945|FG002|Overall Study|Withdrawal by Subject|0|||
131649166|NCT02600897|474000946|FG003|Overall Study|Withdrawal by Subject|0|||
131649167|NCT02600897|474000947|FG004|Overall Study|Withdrawal by Subject|0|||
131649168|NCT02600897|474000948|FG005|Overall Study|Withdrawal by Subject|0|||
131649169|NCT02600897|474000949|FG006|Overall Study|Withdrawal by Subject|0|||
131649170|NCT02600897|474000950|FG007|Overall Study|Withdrawal by Subject|4|||
131649171|NCT02600897|474000951|FG008|Overall Study|Withdrawal by Subject|2|||
131649172|NCT02600897|474000943|FG000|Overall Study|Reason Not Specified|0|||
131649173|NCT02600897|474000944|FG001|Overall Study|Reason Not Specified|0|||
131649174|NCT02600897|474000945|FG002|Overall Study|Reason Not Specified|0|||
131649175|NCT02600897|474000946|FG003|Overall Study|Reason Not Specified|0|||
131649176|NCT02600897|474000947|FG004|Overall Study|Reason Not Specified|0|||
131649177|NCT02600897|474000948|FG005|Overall Study|Reason Not Specified|0|||
131649178|NCT02600897|474000949|FG006|Overall Study|Reason Not Specified|0|||
131649179|NCT02600897|474000950|FG007|Overall Study|Reason Not Specified|0|||
131649180|NCT02600897|474000951|FG008|Overall Study|Reason Not Specified|1|||
131649181|NCT06840769|474000952|FG000|Overall Study|Withdrawal by Subject|1|||
131649182|NCT06840769|474000953|FG001|Overall Study|Withdrawal by Subject|0|||
131649183|NCT06840769|474000954|FG002|Overall Study|Withdrawal by Subject|0|||
131649184|NCT06840769|474000955|FG003|Overall Study|Withdrawal by Subject|0|||
131649185|NCT06840769|474000956|FG004|Overall Study|Withdrawal by Subject|0|||
131649186|NCT02473965|474002733|FG000|Overall Study|Adverse Event|6|||
131649187|NCT02473965|474002734|FG001|Overall Study|Adverse Event|4|||
131649188|NCT02473965|474002733|FG000|Overall Study|MG worsening|4|||
131649189|NCT02473965|474002734|FG001|Overall Study|MG worsening|1|||
131649190|NCT02473965|474002733|FG000|Overall Study|Withdrawal by Subject|2|||
131649191|NCT02473965|474002734|FG001|Overall Study|Withdrawal by Subject|3|||
131649192|NCT02473965|474002733|FG000|Overall Study|Physician Decision|0|||
131649193|NCT02473965|474002734|FG001|Overall Study|Physician Decision|2|||
131649194|NCT03192462|474002735|FG000|Overall Study|Death|13|||
131649195|NCT03192462|474002736|FG001|Overall Study|Death|11|||
131649196|NCT03192462|474002737|FG002|Overall Study|Death|9|||
131649197|NCT03192462|474002735|FG000|Overall Study|Lost to Follow-up|0|||
131649198|NCT03192462|474002736|FG001|Overall Study|Lost to Follow-up|1|||
131649199|NCT03192462|474002737|FG002|Overall Study|Lost to Follow-up|0|||
131649200|NCT03192462|474002735|FG000|Overall Study|On follow up|0|||
131649201|NCT03192462|474002736|FG001|Overall Study|On follow up|0|||
131649202|NCT03192462|474002737|FG002|Overall Study|On follow up|3|||
131649203|NCT02737826|474002738|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
131649204|NCT02737826|474002739|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
131649205|NCT02737826|474002740|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
131649206|NCT00078377|474002741|FG000|Overall Study|Adverse Event|2|||
131649207|NCT00078377|474002742|FG001|Overall Study|Adverse Event|5|||
131649208|NCT00078377|474002743|FG002|Overall Study|Adverse Event|1|||
131649209|NCT00078377|474002741|FG000|Overall Study|Lack of Efficacy|2|||
131649210|NCT00078377|474002742|FG001|Overall Study|Lack of Efficacy|0|||
131649211|NCT00078377|474002743|FG002|Overall Study|Lack of Efficacy|2|||
131649212|NCT00078377|474002741|FG000|Overall Study|Lost to Follow-up|0|||
131649213|NCT00078377|474002742|FG001|Overall Study|Lost to Follow-up|1|||
131649214|NCT00078377|474002743|FG002|Overall Study|Lost to Follow-up|1|||
131649215|NCT00078377|474002741|FG000|Overall Study|Physician Decision|2|||
131649216|NCT00078377|474002742|FG001|Overall Study|Physician Decision|0|||
131649217|NCT00078377|474002743|FG002|Overall Study|Physician Decision|0|||
131802898|NCT01273181|474562038|FG001|Phase 2, Dose 1|Study termination|0|||
131802899|NCT01273181|474562039|FG002|Phase 2, Dose 1|Study termination|1|||
131802900|NCT01273181|474562040|FG003|Phase 2, Dose 1|Study termination|0|||
131802901|NCT01273181|474562037|FG000|Phase 2, Dose 2|Death during treatment|0|||
131802902|NCT01273181|474562038|FG001|Phase 2, Dose 2|Death during treatment|0|||
131649218|NCT00078377|474002741|FG000|Overall Study|Withdrawal by Subject|3|||
131649219|NCT00078377|474002742|FG001|Overall Study|Withdrawal by Subject|4|||
131649220|NCT00078377|474002743|FG002|Overall Study|Withdrawal by Subject|4|||
131649221|NCT00078377|474002741|FG000|Overall Study|Miscellaneous|2|||
131649222|NCT00078377|474002742|FG001|Overall Study|Miscellaneous|6|||
131649223|NCT00078377|474002743|FG002|Overall Study|Miscellaneous|1|||
131649224|NCT00581893|474002744|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
131649225|NCT00581893|474002745|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
131649226|NCT00233480|474002746|FG000|Overall Study|Underwent status II heart transplant|0|||
131649227|NCT00233480|474002747|FG001|Overall Study|Underwent status II heart transplant|1|||
131649228|NCT01484431|474002750|FG000|Period 1: High Dose|Physician Decision|0|||
131649229|NCT01484431|474002751|FG001|Period 1: High Dose|Physician Decision|1|||
131649230|NCT01484431|474002752|FG002|Period 1: High Dose|Physician Decision|0|||
131649231|NCT01484431|474002750|FG000|Period 2|Death|0|||
131649232|NCT01484431|474002751|FG001|Period 2|Death|1|||
131649233|NCT01484431|474002752|FG002|Period 2|Death|1|||
131649234|NCT01484431|474002750|FG000|Period 2|Physician Decision|0|||
131649235|NCT01484431|474002751|FG001|Period 2|Physician Decision|0|||
131649236|NCT01484431|474002752|FG002|Period 2|Physician Decision|1|||
131649237|NCT01484431|474002750|FG000|Period 2|Non-Compliance with Study Drug|1|||
131649238|NCT01484431|474002751|FG001|Period 2|Non-Compliance with Study Drug|0|||
131649239|NCT01484431|474002752|FG002|Period 2|Non-Compliance with Study Drug|0|||
131649240|NCT00475644|474002755|FG000|Overall Study|Protocol Violation|13|||
131649241|NCT01411241|474002756|FG000|Overall Study|Protocol Violation|0|||
131649242|NCT01411241|474002757|FG001|Overall Study|Protocol Violation|5|||
131649243|NCT01411241|474002756|FG000|Overall Study|Withdrawal by Subject|9|||
131649244|NCT01411241|474002757|FG001|Overall Study|Withdrawal by Subject|10|||
131649245|NCT01411241|474002756|FG000|Overall Study|Serious Adverse Event|0|||
131649246|NCT01411241|474002757|FG001|Overall Study|Serious Adverse Event|3|||
131649247|NCT01411241|474002756|FG000|Overall Study|Lost to Follow-up|2|||
131649248|NCT01411241|474002757|FG001|Overall Study|Lost to Follow-up|4|||
131649249|NCT02980042|474002760|FG000|Overall Study|Lost to Follow-up|5|||
131802903|NCT01273181|474562039|FG002|Phase 2, Dose 2|Death during treatment|0|||
131802904|NCT01273181|474562040|FG003|Phase 2, Dose 2|Death during treatment|1|||
131802905|NCT03657160|474562041|FG000|Overall Study|Adverse Event|5|||
131802906|NCT03657160|474562042|FG001|Overall Study|Adverse Event|6|||
131802907|NCT03657160|474562041|FG000|Overall Study|Protocol Deviation|3|||
131802908|NCT03657160|474562042|FG001|Overall Study|Protocol Deviation|0|||
131802909|NCT03657160|474562041|FG000|Overall Study|Withdrawal by Subject|18|||
131802910|NCT03657160|474562042|FG001|Overall Study|Withdrawal by Subject|16|||
131802911|NCT03657160|474562041|FG000|Overall Study|Site Termination|1|||
131802912|NCT03657160|474562042|FG001|Overall Study|Site Termination|0|||
131802913|NCT03657160|474562041|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
131802914|NCT03657160|474562042|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
131802915|NCT03657160|474562041|FG000|Overall Study|Death|33|||
131802916|NCT03657160|474562042|FG001|Overall Study|Death|26|||
131802917|NCT03657160|474562041|FG000|Overall Study|Death (COVID-19-Related)|1|||
131802918|NCT03657160|474562042|FG001|Overall Study|Death (COVID-19-Related)|0|||
131802919|NCT03657160|474562041|FG000|Overall Study|Reason Not Specified|5|||
131802920|NCT03657160|474562042|FG001|Overall Study|Reason Not Specified|5|||
131802921|NCT03657160|474562041|FG000|Overall Study|Other (COVID-19-Related)|0|||
131802922|NCT03657160|474562042|FG001|Overall Study|Other (COVID-19-Related)|1|||
131802923|NCT04638153|474562043|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131802924|NCT04638153|474562044|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131802925|NCT04638153|474562045|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131802926|NCT04638153|474562043|FG000|Overall Study|Study terminated by sponsor|4|||
131802927|NCT04638153|474562044|FG001|Overall Study|Study terminated by sponsor|2|||
131802928|NCT04638153|474562045|FG002|Overall Study|Study terminated by sponsor|14|||
131802929|NCT01434693|474562046|FG000|Overall Study|Adverse Event|1|||
131802930|NCT01434693|474562047|FG001|Overall Study|Adverse Event|0|||
131802931|NCT01434693|474562048|FG002|Overall Study|Adverse Event|0|||
131802932|NCT01434693|474562049|FG003|Overall Study|Adverse Event|0|||
131802933|NCT01434693|474562046|FG000|Overall Study|Withdrawal by Subject|1|||
131802934|NCT01434693|474562047|FG001|Overall Study|Withdrawal by Subject|0|||
131802935|NCT01434693|474562048|FG002|Overall Study|Withdrawal by Subject|1|||
131802936|NCT01434693|474562049|FG003|Overall Study|Withdrawal by Subject|1|||
131802937|NCT01434693|474562046|FG000|Overall Study|Lost to Follow-up|1|||
131802938|NCT01434693|474562047|FG001|Overall Study|Lost to Follow-up|0|||
131802939|NCT01434693|474562048|FG002|Overall Study|Lost to Follow-up|0|||
131802940|NCT01434693|474562049|FG003|Overall Study|Lost to Follow-up|0|||
131802941|NCT04006171|474562050|FG000|Overall Study|Withdrawal by Subject|8|||
131802942|NCT04006171|474562051|FG001|Overall Study|Withdrawal by Subject|7|||
131802943|NCT04006171|474562050|FG000|Overall Study|missing serum samples|2|||
131802944|NCT04006171|474562051|FG001|Overall Study|missing serum samples|2|||
131802945|NCT04006171|474562050|FG000|Overall Study|insufficient sample volume|2|||
131802946|NCT04006171|474562051|FG001|Overall Study|insufficient sample volume|3|||
131802947|NCT00537030|474562052|FG000|Overall Study|Physician Decision|2|||
131802948|NCT00537030|474562052|FG000|Overall Study|Withdrawal by Subject|2|||
131802949|NCT00537030|474562052|FG000|Overall Study|≥ Grade 2 allergy|7|||
131802950|NCT00537030|474562052|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
131802951|NCT00537030|474562052|FG000|Overall Study|Ineligible|2|||
131649250|NCT02980042|474002761|FG001|Overall Study|Lost to Follow-up|0|||
131802952|NCT00537030|474562052|FG000|Overall Study|Inevaluable|2|||
131802953|NCT00162123|474562055|FG000|Overall Study|Disease progression|27|||
131802954|NCT00162123|474562056|FG001|Overall Study|Disease progression|19|||
131802955|NCT00162123|474562057|FG002|Overall Study|Disease progression|10|||
131649251|NCT02980042|474002760|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
131649252|NCT02980042|474002761|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
131649253|NCT01020877|474002764|FG000|Second Intervention|Withdrawal by Subject|1|||
131649254|NCT01020877|474002765|FG001|Second Intervention|Withdrawal by Subject|0|||
131649255|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
131649256|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
131649257|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
131649258|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
131649259|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
131649260|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
131649261|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
131649262|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
131649263|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
131649264|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
131649265|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
131649266|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
131649267|NCT00790400|474002766|FG000|Double-blind Period (Core Phase)|Death|1|||
131649268|NCT00790400|474002767|FG001|Double-blind Period (Core Phase)|Death|0|||
131649269|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
131649270|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
131649271|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
131649272|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
131649273|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
131649274|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
131649275|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
131649276|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
131649277|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
131649278|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
131649279|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Death|1|||
131649280|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Death|0|||
131649281|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
131649282|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
131649283|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
131649284|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
131649285|NCT00790400|474002766|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
131649286|NCT00790400|474002767|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
131649287|NCT00078338|474002768|FG000|Overall Study|Adverse Event|31|||
131649288|NCT00078338|474002769|FG001|Overall Study|Adverse Event|24|||
131649289|NCT00078338|474002768|FG000|Overall Study|Lost to Follow-up|17|||
131649290|NCT00078338|474002769|FG001|Overall Study|Lost to Follow-up|2|||
131649291|NCT00078338|474002768|FG000|Overall Study|Protocol Violation|2|||
131649292|NCT00078338|474002769|FG001|Overall Study|Protocol Violation|2|||
131649293|NCT00078338|474002768|FG000|Overall Study|Disease Progression|4|||
131649294|NCT00078338|474002769|FG001|Overall Study|Disease Progression|7|||
131649295|NCT00078338|474002768|FG000|Overall Study|Other|28|||
131649296|NCT00078338|474002769|FG001|Overall Study|Other|16|||
131649297|NCT00078338|474002768|FG000|Overall Study|Subjects randomized, but not treated|3|||
131649298|NCT00078338|474002769|FG001|Overall Study|Subjects randomized, but not treated|3|||
131649299|NCT00592293|474002770|FG000|Overall Study|Withdrawal by Subject|1|||
131649300|NCT04292470|474002771|FG000|Overall Study|Withdrawal by Subject|0|||
131649301|NCT04292470|474002772|FG001|Overall Study|Withdrawal by Subject|1|||
131649302|NCT02906020|474002786|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
131649303|NCT02906020|474002787|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
131649304|NCT02906020|474002788|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
131649305|NCT02906020|474002789|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
131649306|NCT02906020|474002790|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
131649307|NCT02906020|474002791|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
131649308|NCT02906020|474002792|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
131802956|NCT00162123|474562058|FG003|Overall Study|Disease progression|4|||
131802957|NCT00162123|474562059|FG004|Overall Study|Disease progression|8|||
131802958|NCT00162123|474562060|FG005|Overall Study|Disease progression|3|||
131649309|NCT02906020|474002793|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
131649310|NCT02906020|474002794|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
131649311|NCT02906020|474002795|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
131649312|NCT02906020|474002796|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
131802959|NCT00162123|474562061|FG006|Overall Study|Disease progression|1|||
131802960|NCT00162123|474562062|FG007|Overall Study|Disease progression|0|||
131903385|NCT00643760|474933232|FG003|Overall Study|Lack of Efficacy|4|||
131903386|NCT00643760|474933233|FG004|Overall Study|Lack of Efficacy|3|||
131903387|NCT00643760|474933229|FG000|Overall Study|Protocol Violation|7|||
131903388|NCT00643760|474933230|FG001|Overall Study|Protocol Violation|6|||
131903389|NCT00643760|474933231|FG002|Overall Study|Protocol Violation|4|||
131903390|NCT00643760|474933232|FG003|Overall Study|Protocol Violation|4|||
131903391|NCT00643760|474933233|FG004|Overall Study|Protocol Violation|6|||
131903392|NCT00643760|474933229|FG000|Overall Study|Lost to Follow-up|6|||
131903393|NCT00643760|474933230|FG001|Overall Study|Lost to Follow-up|2|||
131903394|NCT00643760|474933231|FG002|Overall Study|Lost to Follow-up|1|||
131903395|NCT00643760|474933232|FG003|Overall Study|Lost to Follow-up|3|||
131903396|NCT00643760|474933233|FG004|Overall Study|Lost to Follow-up|3|||
131903397|NCT00643760|474933229|FG000|Overall Study|Investigator Discretion|0|||
131903398|NCT00643760|474933230|FG001|Overall Study|Investigator Discretion|0|||
131903399|NCT00643760|474933231|FG002|Overall Study|Investigator Discretion|0|||
131903400|NCT00643760|474933232|FG003|Overall Study|Investigator Discretion|2|||
131903401|NCT00643760|474933233|FG004|Overall Study|Investigator Discretion|0|||
131903402|NCT00643760|474933229|FG000|Overall Study|Withdrawal by Subject|3|||
131903403|NCT00643760|474933230|FG001|Overall Study|Withdrawal by Subject|1|||
131903404|NCT00643760|474933231|FG002|Overall Study|Withdrawal by Subject|2|||
131903405|NCT00643760|474933232|FG003|Overall Study|Withdrawal by Subject|4|||
131903406|NCT00643760|474933233|FG004|Overall Study|Withdrawal by Subject|1|||
131903407|NCT00104052|474933237|FG000|Overall Study|Adverse Event|1|||
131903408|NCT00104052|474933237|FG000|Overall Study|Lack of Efficacy|26|||
131903409|NCT00104052|474933237|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
131903410|NCT01241279|474933242|FG000|Overall Study|Lost to Follow-up|0|||
131903411|NCT01241279|474933243|FG001|Overall Study|Lost to Follow-up|1|||
131802961|NCT00162123|474562055|FG000|Overall Study|Study drug toxicity|6|||
131802962|NCT00162123|474562056|FG001|Overall Study|Study drug toxicity|1|||
131802963|NCT00162123|474562057|FG002|Overall Study|Study drug toxicity|5|||
131802964|NCT00162123|474562058|FG003|Overall Study|Study drug toxicity|0|||
131802965|NCT00162123|474562059|FG004|Overall Study|Study drug toxicity|4|||
131802966|NCT00162123|474562060|FG005|Overall Study|Study drug toxicity|1|||
131802967|NCT00162123|474562061|FG006|Overall Study|Study drug toxicity|1|||
131802968|NCT00162123|474562062|FG007|Overall Study|Study drug toxicity|0|||
131802969|NCT00162123|474562055|FG000|Overall Study|Death|3|||
131802970|NCT00162123|474562056|FG001|Overall Study|Death|3|||
131903412|NCT00239720|474933244|FG000|Overall Study|Adverse Event|1|||
131903413|NCT00239720|474933245|FG001|Overall Study|Adverse Event|0|||
131903414|NCT00239720|474933244|FG000|Overall Study|Lost to Follow-up|0|||
131903415|NCT00239720|474933245|FG001|Overall Study|Lost to Follow-up|1|||
131903416|NCT01145482|474933246|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
131903417|NCT01145482|474933247|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
131903418|NCT01405560|474933250|FG000|Overall Study|Physician Decision|1|||
131903419|NCT02059239|474933252|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
131903420|NCT02059239|474933253|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
131903421|NCT02059239|474933252|FG000|Overall Study|Physician Decision|1|||
131903422|NCT02059239|474933253|FG001|Overall Study|Physician Decision|0|||
131903423|NCT01268267|474933254|FG000|Overall Study|Protocol Violation|1|||
131903424|NCT04176939|474933255|FG000|Overall Study|Withdrawal by Subject|5|||
131903425|NCT04176939|474933255|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
131903426|NCT04176939|474933255|FG000|Overall Study|Lost to Follow-up|2|||
131903427|NCT04176939|474933255|FG000|Overall Study|Unspecified reason|4|||
131903428|NCT04176939|474933255|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
131448114|NCT01716234|473270874|FG000|Overall Study|Lack of Efficacy|0|||
131649313|NCT02906020|474002797|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
131649314|NCT02906020|474002798|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
131649315|NCT02906020|474002799|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
131649316|NCT02906020|474002800|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
131802971|NCT00162123|474562057|FG002|Overall Study|Death|1|||
131649317|NCT02906020|474002801|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
131649318|NCT02906020|474002786|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649319|NCT02906020|474002787|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131658618|NCT02003222|474035399|FG004|Induction|Death|3|||
131802972|NCT00162123|474562058|FG003|Overall Study|Death|1|||
131903429|NCT04919317|474933262|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
131903430|NCT04919317|474933263|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
131903431|NCT04919317|474933262|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
131903432|NCT04919317|474933263|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
131903433|NCT02869789|474933264|FG000|Overall Study|Disease progression|184|||
131448115|NCT01716234|473270875|FG001|Overall Study|Lack of Efficacy|0|||
131802973|NCT00162123|474562059|FG004|Overall Study|Death|1|||
131802974|NCT00162123|474562060|FG005|Overall Study|Death|1|||
131802975|NCT00162123|474562061|FG006|Overall Study|Death|0|||
131903434|NCT02869789|474933265|FG001|Overall Study|Disease progression|109|||
131903435|NCT02869789|474933266|FG002|Overall Study|Disease progression|260|||
131903436|NCT02869789|474933267|FG003|Overall Study|Disease progression|19|||
131649320|NCT02906020|474002788|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649321|NCT02906020|474002789|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649322|NCT02906020|474002790|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649323|NCT02906020|474002791|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649324|NCT02906020|474002792|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649325|NCT02906020|474002793|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649326|NCT02906020|474002794|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
131649327|NCT02906020|474002795|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
131649328|NCT02906020|474002796|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649329|NCT02906020|474002797|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649330|NCT02906020|474002798|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649331|NCT02906020|474002799|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649332|NCT02906020|474002800|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649333|NCT02906020|474002801|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131649334|NCT02906020|474002786|FG000|Part 2: Double-blind Treatment Period|Other|0|||
131649335|NCT02906020|474002787|FG001|Part 2: Double-blind Treatment Period|Other|0|||
131649336|NCT02906020|474002788|FG002|Part 2: Double-blind Treatment Period|Other|0|||
131649337|NCT02906020|474002789|FG003|Part 2: Double-blind Treatment Period|Other|0|||
131649338|NCT02906020|474002790|FG004|Part 2: Double-blind Treatment Period|Other|0|||
131649339|NCT02906020|474002791|FG005|Part 2: Double-blind Treatment Period|Other|0|||
131649340|NCT02906020|474002792|FG006|Part 2: Double-blind Treatment Period|Other|0|||
131649341|NCT02906020|474002793|FG007|Part 2: Double-blind Treatment Period|Other|0|||
131649342|NCT02906020|474002794|FG008|Part 2: Double-blind Treatment Period|Other|6|||
131649343|NCT02906020|474002795|FG009|Part 2: Double-blind Treatment Period|Other|10|||
131649344|NCT02906020|474002796|FG010|Part 2: Double-blind Treatment Period|Other|0|||
131649345|NCT02906020|474002797|FG011|Part 2: Double-blind Treatment Period|Other|0|||
131649346|NCT02906020|474002798|FG012|Part 2: Double-blind Treatment Period|Other|0|||
131649347|NCT02906020|474002799|FG013|Part 2: Double-blind Treatment Period|Other|0|||
131649348|NCT02906020|474002800|FG014|Part 2: Double-blind Treatment Period|Other|0|||
131649349|NCT02906020|474002801|FG015|Part 2: Double-blind Treatment Period|Other|0|||
131649350|NCT02906020|474002786|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649351|NCT02906020|474002787|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649352|NCT02906020|474002788|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649353|NCT02906020|474002789|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649354|NCT02906020|474002790|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649355|NCT02906020|474002791|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649356|NCT02906020|474002792|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649357|NCT02906020|474002793|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649358|NCT02906020|474002794|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649359|NCT02906020|474002795|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649360|NCT02906020|474002796|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649361|NCT02906020|474002797|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649362|NCT02906020|474002798|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
131649363|NCT02906020|474002799|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
131649364|NCT02906020|474002800|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649365|NCT02906020|474002801|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131649366|NCT02906020|474002786|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649367|NCT02906020|474002787|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649368|NCT02906020|474002788|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649369|NCT02906020|474002789|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649370|NCT02906020|474002790|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649371|NCT02906020|474002791|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649372|NCT02906020|474002792|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649373|NCT02906020|474002793|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649374|NCT02906020|474002794|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649375|NCT02906020|474002795|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649376|NCT02906020|474002796|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649377|NCT02906020|474002797|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649378|NCT02906020|474002798|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
131649379|NCT02906020|474002799|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
131649380|NCT02906020|474002800|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131649381|NCT02906020|474002801|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
131649382|NCT02906020|474002786|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649383|NCT02906020|474002787|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649384|NCT02906020|474002788|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649385|NCT02906020|474002789|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649386|NCT02906020|474002790|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131658619|NCT02003222|474035395|FG000|Induction|Withdrawal by Subject|0|||
131649387|NCT02906020|474002791|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649388|NCT02906020|474002792|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649389|NCT02906020|474002793|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649390|NCT02906020|474002794|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649391|NCT02906020|474002795|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649392|NCT02906020|474002796|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649393|NCT02906020|474002797|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649394|NCT02906020|474002798|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
131649395|NCT02906020|474002799|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
131649396|NCT02906020|474002800|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649397|NCT02906020|474002801|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131649398|NCT02906020|474002786|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649399|NCT02906020|474002787|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649400|NCT02906020|474002788|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649401|NCT02906020|474002789|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649402|NCT02906020|474002790|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649403|NCT02906020|474002791|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649404|NCT02906020|474002792|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649405|NCT02906020|474002793|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649406|NCT02906020|474002794|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649407|NCT02906020|474002795|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649408|NCT02906020|474002796|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649409|NCT02906020|474002797|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649410|NCT02906020|474002798|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
131649411|NCT02906020|474002799|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
131649412|NCT02906020|474002800|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649413|NCT02906020|474002801|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131649414|NCT02906020|474002786|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649415|NCT02906020|474002787|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649416|NCT02906020|474002788|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649417|NCT02906020|474002789|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649418|NCT02906020|474002790|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649419|NCT02906020|474002791|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649420|NCT02906020|474002792|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649421|NCT02906020|474002793|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649422|NCT02906020|474002794|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649423|NCT02906020|474002795|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649424|NCT02906020|474002796|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649425|NCT02906020|474002797|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131649426|NCT02906020|474002798|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
131649427|NCT02906020|474002799|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
131716061|NCT01324830|474238878|FG014|Overall Study|Adverse Event, serious fatal|0|||
131716062|NCT01324830|474238879|FG015|Overall Study|Adverse Event, serious fatal|0|||
131716063|NCT01324830|474238880|FG016|Overall Study|Adverse Event, serious fatal|0|||
131716064|NCT01324830|474238881|FG017|Overall Study|Adverse Event, serious fatal|0|||
131716065|NCT01324830|474238882|FG018|Overall Study|Adverse Event, serious fatal|0|||
131716066|NCT01324830|474238864|FG000|Overall Study|Adverse Event, non-fatal|0|||
131716067|NCT01324830|474238865|FG001|Overall Study|Adverse Event, non-fatal|0|||
131716068|NCT01324830|474238866|FG002|Overall Study|Adverse Event, non-fatal|0|||
131716069|NCT01324830|474238867|FG003|Overall Study|Adverse Event, non-fatal|0|||
131716070|NCT01324830|474238868|FG004|Overall Study|Adverse Event, non-fatal|0|||
131716071|NCT01324830|474238869|FG005|Overall Study|Adverse Event, non-fatal|0|||
131716072|NCT01324830|474238870|FG006|Overall Study|Adverse Event, non-fatal|0|||
131716073|NCT01324830|474238871|FG007|Overall Study|Adverse Event, non-fatal|0|||
131716074|NCT01324830|474238872|FG008|Overall Study|Adverse Event, non-fatal|2|||
131716075|NCT01324830|474238873|FG009|Overall Study|Adverse Event, non-fatal|0|||
131716076|NCT01324830|474238874|FG010|Overall Study|Adverse Event, non-fatal|1|||
131716077|NCT01324830|474238875|FG011|Overall Study|Adverse Event, non-fatal|0|||
131716078|NCT01324830|474238876|FG012|Overall Study|Adverse Event, non-fatal|0|||
131716079|NCT01324830|474238877|FG013|Overall Study|Adverse Event, non-fatal|0|||
131716080|NCT01324830|474238878|FG014|Overall Study|Adverse Event, non-fatal|0|||
131716081|NCT01324830|474238879|FG015|Overall Study|Adverse Event, non-fatal|0|||
131716082|NCT01324830|474238880|FG016|Overall Study|Adverse Event, non-fatal|0|||
131716083|NCT01324830|474238881|FG017|Overall Study|Adverse Event, non-fatal|1|||
131903437|NCT02869789|474933264|FG000|Overall Study|Study drug toxicity|90|||
131903438|NCT02869789|474933265|FG001|Overall Study|Study drug toxicity|32|||
131903439|NCT02869789|474933266|FG002|Overall Study|Study drug toxicity|55|||
131903440|NCT02869789|474933267|FG003|Overall Study|Study drug toxicity|14|||
131903441|NCT02869789|474933264|FG000|Overall Study|Death|7|||
131903442|NCT02869789|474933265|FG001|Overall Study|Death|3|||
131903443|NCT02869789|474933266|FG002|Overall Study|Death|5|||
131903444|NCT02869789|474933267|FG003|Overall Study|Death|1|||
131903445|NCT02869789|474933264|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
131903446|NCT02869789|474933265|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
131903447|NCT02869789|474933266|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
131903448|NCT02869789|474933267|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
131903449|NCT02869789|474933264|FG000|Overall Study|Participant request to discontinue study treatment|10|||
131903450|NCT02869789|474933265|FG001|Overall Study|Participant request to discontinue study treatment|5|||
131903451|NCT02869789|474933266|FG002|Overall Study|Participant request to discontinue study treatment|5|||
131903452|NCT02869789|474933267|FG003|Overall Study|Participant request to discontinue study treatment|3|||
131903453|NCT02869789|474933264|FG000|Overall Study|Withdrawal by Subject|5|||
131903454|NCT02869789|474933265|FG001|Overall Study|Withdrawal by Subject|2|||
131903455|NCT02869789|474933266|FG002|Overall Study|Withdrawal by Subject|7|||
131903456|NCT02869789|474933267|FG003|Overall Study|Withdrawal by Subject|2|||
131903457|NCT02869789|474933264|FG000|Overall Study|Lost to Follow-up|0|||
131903458|NCT02869789|474933265|FG001|Overall Study|Lost to Follow-up|0|||
131903459|NCT02869789|474933266|FG002|Overall Study|Lost to Follow-up|2|||
131903460|NCT02869789|474933267|FG003|Overall Study|Lost to Follow-up|0|||
131903461|NCT02869789|474933264|FG000|Overall Study|Maximum clinical benefit|5|||
131903462|NCT02869789|474933265|FG001|Overall Study|Maximum clinical benefit|2|||
131903463|NCT02869789|474933266|FG002|Overall Study|Maximum clinical benefit|1|||
131903464|NCT02869789|474933267|FG003|Overall Study|Maximum clinical benefit|0|||
131903465|NCT02869789|474933264|FG000|Overall Study|Poor/Non-compliance|0|||
131903466|NCT02869789|474933265|FG001|Overall Study|Poor/Non-compliance|2|||
131903467|NCT02869789|474933266|FG002|Overall Study|Poor/Non-compliance|1|||
131903468|NCT02869789|474933267|FG003|Overall Study|Poor/Non-compliance|0|||
131903469|NCT02869789|474933264|FG000|Overall Study|Participant no longer meets study criteria|0|||
131903470|NCT02869789|474933265|FG001|Overall Study|Participant no longer meets study criteria|1|||
131903471|NCT02869789|474933266|FG002|Overall Study|Participant no longer meets study criteria|1|||
131903472|NCT02869789|474933267|FG003|Overall Study|Participant no longer meets study criteria|0|||
131903473|NCT02869789|474933264|FG000|Overall Study|Administrative reason by sponsor|0|||
131903474|NCT02869789|474933265|FG001|Overall Study|Administrative reason by sponsor|0|||
131903475|NCT02869789|474933266|FG002|Overall Study|Administrative reason by sponsor|1|||
131903476|NCT02869789|474933267|FG003|Overall Study|Administrative reason by sponsor|0|||
131903477|NCT02869789|474933264|FG000|Overall Study|Other reasons|4|||
131903478|NCT02869789|474933265|FG001|Overall Study|Other reasons|8|||
131903479|NCT02869789|474933266|FG002|Overall Study|Other reasons|6|||
131903480|NCT02869789|474933267|FG003|Overall Study|Other reasons|0|||
131903481|NCT01529606|474933274|FG000|Overall Study|Lost to Follow-up|21|||
131903482|NCT01529606|474933275|FG001|Overall Study|Lost to Follow-up|18|||
131903483|NCT01900444|474933282|FG000|Overall Study|Protocol Violation|2|||
131903484|NCT01900444|474933282|FG000|Overall Study|Lost to Follow-up|1|||
131903485|NCT00072384|474933285|FG000|Overall Study|Physician Decision|1|||
131903486|NCT00072384|474933285|FG000|Overall Study|Ineligible|8|||
131903487|NCT01825200|474933286|FG000|Overall Study|Lost to Follow-up|5|||
131903488|NCT01825200|474933287|FG001|Overall Study|Lost to Follow-up|6|||
131903489|NCT01825200|474933286|FG000|Overall Study|Withdrawal by Subject|0|||
131903490|NCT01825200|474933287|FG001|Overall Study|Withdrawal by Subject|1|||
131903491|NCT00731822|474933299|FG000|Overall Study|Adverse Event|2|||
131903492|NCT00731822|474933300|FG001|Overall Study|Adverse Event|1|||
131903493|NCT00731822|474933299|FG000|Overall Study|Protocol Violation|1|||
131903494|NCT00731822|474933300|FG001|Overall Study|Protocol Violation|0|||
131802976|NCT00162123|474562062|FG007|Overall Study|Death|0|||
131802977|NCT00162123|474562055|FG000|Overall Study|Withdrawal by Subject|2|||
131802978|NCT00162123|474562056|FG001|Overall Study|Withdrawal by Subject|0|||
131802979|NCT00162123|474562057|FG002|Overall Study|Withdrawal by Subject|2|||
131802980|NCT00162123|474562058|FG003|Overall Study|Withdrawal by Subject|1|||
131802981|NCT00162123|474562059|FG004|Overall Study|Withdrawal by Subject|1|||
131802982|NCT00162123|474562060|FG005|Overall Study|Withdrawal by Subject|2|||
131802983|NCT00162123|474562061|FG006|Overall Study|Withdrawal by Subject|1|||
131802984|NCT00162123|474562062|FG007|Overall Study|Withdrawal by Subject|0|||
131903495|NCT00731822|474933299|FG000|Overall Study|Lost to Follow-up|1|||
131802985|NCT00162123|474562055|FG000|Overall Study|Deterioration without progression|2|||
131802986|NCT00162123|474562056|FG001|Overall Study|Deterioration without progression|2|||
131903496|NCT00731822|474933300|FG001|Overall Study|Lost to Follow-up|0|||
131903497|NCT05209880|474933304|FG000|1-Month Follow-up|Spoke with Doctor|5|||
131903498|NCT05209880|474933305|FG001|1-Month Follow-up|Spoke with Doctor|5|||
131903499|NCT05209880|474933304|FG000|1-Month Follow-up|Lost to Follow-up|7|||
131903500|NCT05209880|474933305|FG001|1-Month Follow-up|Lost to Follow-up|9|||
131903501|NCT05209880|474933304|FG000|1-Month Follow-up|Discontinued|0|||
131903502|NCT05209880|474933305|FG001|1-Month Follow-up|Discontinued|1|||
131903503|NCT05209880|474933304|FG000|3-Month Follow-up|Spoke with Doctor|17|||
131903504|NCT05209880|474933305|FG001|3-Month Follow-up|Spoke with Doctor|7|||
131903505|NCT05209880|474933304|FG000|3-Month Follow-up|Lost to Follow-up|8|||
131903506|NCT05209880|474933305|FG001|3-Month Follow-up|Lost to Follow-up|10|||
131903507|NCT05209880|474933304|FG000|3-Month Follow-up|Discontinued|1|||
131903508|NCT05209880|474933305|FG001|3-Month Follow-up|Discontinued|3|||
131903509|NCT05209880|474933304|FG000|6-Month Follow-up|Spoke with Doctor|25|||
131903510|NCT05209880|474933305|FG001|6-Month Follow-up|Spoke with Doctor|14|||
131903511|NCT05209880|474933304|FG000|6-Month Follow-up|Lost to Follow-up|9|||
131903512|NCT05209880|474933305|FG001|6-Month Follow-up|Lost to Follow-up|14|||
131903513|NCT05209880|474933304|FG000|6-Month Follow-up|Discontinued|1|||
131903514|NCT05209880|474933305|FG001|6-Month Follow-up|Discontinued|3|||
131903515|NCT02127658|474933306|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
131903516|NCT02127658|474933307|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
131903517|NCT02127658|474933306|FG000|Overall Study|Withdrawal by Subject|0|||
131903518|NCT02127658|474933307|FG001|Overall Study|Withdrawal by Subject|2|||
131903519|NCT02127658|474933306|FG000|Overall Study|Physician Decision|0|||
131903520|NCT02127658|474933307|FG001|Overall Study|Physician Decision|1|||
131903521|NCT01443858|474933308|FG000|Overall Study|Withdrawal by Subject|9|||
131903522|NCT01443858|474933309|FG001|Overall Study|Withdrawal by Subject|8|||
131903523|NCT01443858|474933310|FG002|Overall Study|Withdrawal by Subject|5|||
131903524|NCT01443858|474933308|FG000|Overall Study|Lack of Efficacy|1|||
131903525|NCT01443858|474933309|FG001|Overall Study|Lack of Efficacy|0|||
131903526|NCT01443858|474933310|FG002|Overall Study|Lack of Efficacy|0|||
131903527|NCT01443858|474933308|FG000|Overall Study|Lost to Follow-up|5|||
131903528|NCT01443858|474933309|FG001|Overall Study|Lost to Follow-up|5|||
131903529|NCT01443858|474933310|FG002|Overall Study|Lost to Follow-up|2|||
131903530|NCT01867008|474933311|FG000|Overall Study|Withdrawal by Subject|1|||
131903531|NCT01534273|474933312|FG000|Period 1|Physician Decision|0|||
131903532|NCT01534273|474933313|FG001|Period 1|Physician Decision|0|||
131903533|NCT01534273|474933314|FG002|Period 1|Physician Decision|0|||
131903534|NCT01534273|474933315|FG003|Period 1|Physician Decision|1|||
131903535|NCT01534273|474933316|FG004|Period 1|Physician Decision|0|||
131903536|NCT01534273|474933317|FG005|Period 1|Physician Decision|0|||
131903537|NCT01534273|474933318|FG006|Period 1|Physician Decision|0|||
131903538|NCT03586050|474933319|FG000|Overall Study|Death|3|||
131903539|NCT03586050|474933319|FG000|Overall Study|Withdrawal by Subject|2|||
131903540|NCT01211145|474933320|FG000|Overall Study|Reason not specified|3|||
131903541|NCT01211145|474933321|FG001|Overall Study|Reason not specified|2|||
131903542|NCT01211145|474933322|FG002|Overall Study|Reason not specified|2|||
131903543|NCT01211145|474933323|FG003|Overall Study|Reason not specified|1|||
131903544|NCT01211145|474933320|FG000|Overall Study|Lost to Follow-up|3|||
131903545|NCT01211145|474933321|FG001|Overall Study|Lost to Follow-up|2|||
131903546|NCT01211145|474933322|FG002|Overall Study|Lost to Follow-up|1|||
131903547|NCT01211145|474933323|FG003|Overall Study|Lost to Follow-up|2|||
131903548|NCT01211145|474933320|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131903549|NCT01211145|474933321|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131903550|NCT01211145|474933322|FG002|Overall Study|Study-specific withdrawal criteria|0|||
131903551|NCT01211145|474933323|FG003|Overall Study|Study-specific withdrawal criteria|0|||
131903552|NCT01211145|474933320|FG000|Overall Study|Severe noncompliance to protocol|1|||
131903553|NCT01211145|474933321|FG001|Overall Study|Severe noncompliance to protocol|0|||
131716084|NCT01324830|474238882|FG018|Overall Study|Adverse Event, non-fatal|0|||
131716085|NCT01324830|474238864|FG000|Overall Study|Withdrawal by Subject|0|||
131716086|NCT01324830|474238865|FG001|Overall Study|Withdrawal by Subject|0|||
131716087|NCT01324830|474238866|FG002|Overall Study|Withdrawal by Subject|0|||
131716088|NCT01324830|474238867|FG003|Overall Study|Withdrawal by Subject|0|||
131716089|NCT01324830|474238868|FG004|Overall Study|Withdrawal by Subject|0|||
131716090|NCT01324830|474238869|FG005|Overall Study|Withdrawal by Subject|1|||
131716091|NCT01324830|474238870|FG006|Overall Study|Withdrawal by Subject|0|||
131716092|NCT01324830|474238871|FG007|Overall Study|Withdrawal by Subject|0|||
131716093|NCT01324830|474238872|FG008|Overall Study|Withdrawal by Subject|0|||
131716094|NCT01324830|474238873|FG009|Overall Study|Withdrawal by Subject|0|||
131716095|NCT01324830|474238874|FG010|Overall Study|Withdrawal by Subject|1|||
131716096|NCT01324830|474238875|FG011|Overall Study|Withdrawal by Subject|0|||
131716097|NCT01324830|474238876|FG012|Overall Study|Withdrawal by Subject|0|||
131716098|NCT01324830|474238877|FG013|Overall Study|Withdrawal by Subject|0|||
131716099|NCT01324830|474238878|FG014|Overall Study|Withdrawal by Subject|0|||
131716100|NCT01324830|474238879|FG015|Overall Study|Withdrawal by Subject|0|||
131716101|NCT01324830|474238880|FG016|Overall Study|Withdrawal by Subject|0|||
131716102|NCT01324830|474238881|FG017|Overall Study|Withdrawal by Subject|0|||
131716103|NCT01324830|474238882|FG018|Overall Study|Withdrawal by Subject|1|||
131716104|NCT01485614|474238883|FG000|Randomization|Not Treated|1|||
131716105|NCT01485614|474238884|FG001|Randomization|Not Treated|0|||
131716106|NCT01485614|474238885|FG002|Randomization|Not Treated|0|||
131649428|NCT02906020|474002800|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
131649429|NCT02906020|474002801|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
131649430|NCT02906020|474002786|FG000|Part 2: Long-term Follow-up Period|Other|0|||
131649431|NCT02906020|474002787|FG001|Part 2: Long-term Follow-up Period|Other|0|||
131649432|NCT02906020|474002788|FG002|Part 2: Long-term Follow-up Period|Other|0|||
131649433|NCT02906020|474002789|FG003|Part 2: Long-term Follow-up Period|Other|0|||
131649434|NCT02906020|474002790|FG004|Part 2: Long-term Follow-up Period|Other|0|||
131649435|NCT02906020|474002791|FG005|Part 2: Long-term Follow-up Period|Other|0|||
131649436|NCT02906020|474002792|FG006|Part 2: Long-term Follow-up Period|Other|0|||
131649437|NCT02906020|474002793|FG007|Part 2: Long-term Follow-up Period|Other|0|||
131649438|NCT02906020|474002794|FG008|Part 2: Long-term Follow-up Period|Other|0|||
131649439|NCT02906020|474002795|FG009|Part 2: Long-term Follow-up Period|Other|0|||
131649440|NCT02906020|474002796|FG010|Part 2: Long-term Follow-up Period|Other|0|||
131649441|NCT02906020|474002797|FG011|Part 2: Long-term Follow-up Period|Other|0|||
131649442|NCT02906020|474002798|FG012|Part 2: Long-term Follow-up Period|Other|13|||
131649443|NCT02906020|474002799|FG013|Part 2: Long-term Follow-up Period|Other|8|||
131649444|NCT02906020|474002800|FG014|Part 2: Long-term Follow-up Period|Other|3|||
131649445|NCT02906020|474002801|FG015|Part 2: Long-term Follow-up Period|Other|2|||
131649446|NCT02179177|474002802|FG000|Overall Study|Lost to Follow-up|1|||
131649447|NCT02179177|474002803|FG001|Overall Study|Lost to Follow-up|1|||
131649448|NCT02179177|474002802|FG000|Overall Study|Withdrawal by Subject|1|||
131649449|NCT02179177|474002803|FG001|Overall Study|Withdrawal by Subject|1|||
131649450|NCT01821937|474002807|FG000|Overall Study|Adverse Event|0|||
131649451|NCT01821937|474002808|FG001|Overall Study|Adverse Event|3|||
131649452|NCT02153905|474002809|FG000|Overall Study|Death|1|||
131649453|NCT02153905|474002810|FG001|Overall Study|Death|0|||
131649454|NCT00351377|474002815|FG000|Overall Study|Adverse Event|5|||
131649455|NCT00351377|474002815|FG000|Overall Study|Death|1|||
131649456|NCT00351377|474002815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131649457|NCT01516749|474002816|FG000|Active Therapy|Lost to Follow-up|1|||
131649458|NCT01516749|474002816|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
131649459|NCT01607879|474002817|FG000|Overall Study|Death|1|||
131649460|NCT01607879|474002818|FG001|Overall Study|Death|0|||
131649461|NCT03994731|474002824|FG000|Pegloticase + IMM Period|Death|2|||
131649462|NCT03994731|474002825|FG001|Pegloticase + IMM Period|Death|0|||
131649463|NCT03994731|474002824|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
131649464|NCT03994731|474002825|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
131649465|NCT03994731|474002824|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
131649466|NCT03994731|474002825|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
131649467|NCT00609947|474002830|FG000|Overall Study|Death|1|||
131649468|NCT00790205|474002831|FG000|Overall Study|Lost to Follow-up|61|||
131649469|NCT00790205|474002832|FG001|Overall Study|Lost to Follow-up|71|||
131649470|NCT00790205|474002831|FG000|Overall Study|Withdrawal by Subject|299|||
131649471|NCT00790205|474002832|FG001|Overall Study|Withdrawal by Subject|363|||
131649472|NCT01304498|474002833|FG000|Overall Study|Adverse Event|1|||
131649473|NCT01304498|474002834|FG001|Overall Study|Adverse Event|1|||
131649474|NCT01304498|474002833|FG000|Overall Study|Withdrawal by Subject|2|||
131649475|NCT01304498|474002834|FG001|Overall Study|Withdrawal by Subject|3|||
131649476|NCT01304498|474002833|FG000|Overall Study|Protocol Violation|1|||
131649477|NCT01304498|474002834|FG001|Overall Study|Protocol Violation|0|||
131649478|NCT01304498|474002833|FG000|Overall Study|Lost to Follow-up|2|||
131649479|NCT01304498|474002834|FG001|Overall Study|Lost to Follow-up|1|||
131649480|NCT02643628|474002835|FG000|Overall Study|Lost to Follow-up|1|||
131649481|NCT02643628|474002836|FG001|Overall Study|Lost to Follow-up|4|||
131649482|NCT02643628|474002835|FG000|Overall Study|Withdrawal by Subject|0|||
131649483|NCT02643628|474002836|FG001|Overall Study|Withdrawal by Subject|1|||
131649484|NCT02643628|474002835|FG000|Overall Study|Relocated out of state|0|||
131649485|NCT02643628|474002836|FG001|Overall Study|Relocated out of state|1|||
131649486|NCT01834586|474002845|FG000|Overall Study|Adverse Event|1|||
131649487|NCT01667549|474002849|FG000|Overall Study|Withdrawal by Subject|3|||
131649488|NCT01667549|474002850|FG001|Overall Study|Withdrawal by Subject|5|||
131649489|NCT01667549|474002851|FG002|Overall Study|Withdrawal by Subject|7|||
131649490|NCT01667549|474002852|FG003|Overall Study|Withdrawal by Subject|6|||
131903554|NCT01211145|474933322|FG002|Overall Study|Severe noncompliance to protocol|0|||
131903555|NCT01211145|474933323|FG003|Overall Study|Severe noncompliance to protocol|0|||
131903556|NCT01211145|474933320|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
131649491|NCT01667549|474002853|FG004|Overall Study|Withdrawal by Subject|1|||
131649492|NCT03482752|474002854|FG000|Overall Study|Withdrawal by Subject|2|||
131649493|NCT03482752|474002854|FG000|Overall Study|Lost to Follow-up|1|||
131649494|NCT03482752|474002854|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
131649495|NCT01080300|474002855|FG000|Overall Study|Adverse Event|49|||
131649496|NCT01080300|474002856|FG001|Overall Study|Adverse Event|35|||
131649497|NCT01080300|474002855|FG000|Overall Study|Lack of Efficacy|12|||
131649498|NCT01080300|474002856|FG001|Overall Study|Lack of Efficacy|15|||
131649499|NCT01080300|474002855|FG000|Overall Study|Protocol Violation|7|||
131649500|NCT01080300|474002856|FG001|Overall Study|Protocol Violation|13|||
131649501|NCT01080300|474002855|FG000|Overall Study|Lost to Follow-up|10|||
131649502|NCT01080300|474002856|FG001|Overall Study|Lost to Follow-up|6|||
131649503|NCT01080300|474002855|FG000|Overall Study|Death|0|||
131649504|NCT01080300|474002856|FG001|Overall Study|Death|1|||
131649505|NCT01080300|474002855|FG000|Overall Study|Withdrawal by Subject|12|||
131649506|NCT01080300|474002856|FG001|Overall Study|Withdrawal by Subject|28|||
131649507|NCT01080300|474002855|FG000|Overall Study|Reasons not specified|4|||
131649508|NCT01080300|474002856|FG001|Overall Study|Reasons not specified|6|||
131649509|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
131649510|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
131649511|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
131649512|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
131649513|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
131649514|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131649515|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
131649516|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
131649517|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
131649518|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
131649519|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
131649520|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
131649521|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
131649522|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
131649523|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
131649524|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
131649525|NCT04210843|474002858|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
131649526|NCT04210843|474002859|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
131649527|NCT04210843|474002858|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
131649528|NCT04210843|474002859|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
131649529|NCT04210843|474002858|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
131649530|NCT04210843|474002859|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
131649531|NCT04210843|474002858|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
131649532|NCT04210843|474002859|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131649533|NCT04210843|474002858|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
131649534|NCT04210843|474002859|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
131649535|NCT04210843|474002858|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
131649536|NCT04210843|474002859|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
131649537|NCT04210843|474002858|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
131649538|NCT04210843|474002859|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
131649539|NCT04210843|474002858|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
131649540|NCT04210843|474002859|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
131649541|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
131649542|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
131649543|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
131649544|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
131649545|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
131649546|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
131649547|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
131649548|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
131649549|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
131649550|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
131649551|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
131649552|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
131649553|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
131649554|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
131649555|NCT04210843|474002858|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
131649556|NCT04210843|474002859|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
131649557|NCT02844777|474002860|FG000|Overall Study|Withdrawal by Subject|2|||
131903557|NCT01211145|474933321|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
131903558|NCT01211145|474933322|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
131903559|NCT01211145|474933323|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
131903560|NCT01211145|474933320|FG000|Overall Study|Patient decision|2|||
131903561|NCT01211145|474933321|FG001|Overall Study|Patient decision|1|||
131649558|NCT02844777|474002861|FG001|Overall Study|Withdrawal by Subject|0|||
131649559|NCT02844777|474002862|FG002|Overall Study|Withdrawal by Subject|0|||
131649560|NCT01776008|474002863|FG000|Overall Study|ineligible|2|||
131649561|NCT04092452|474002864|FG000|Overall Study|Adverse Event|1|||
131649562|NCT04092452|474002865|FG001|Overall Study|Adverse Event|3|||
131649563|NCT04092452|474002866|FG002|Overall Study|Adverse Event|3|||
131903562|NCT01211145|474933322|FG002|Overall Study|Patient decision|0|||
131903563|NCT01211145|474933323|FG003|Overall Study|Patient decision|2|||
131903564|NCT00570401|474933324|FG000|Overall Study|Adverse Event|2|||
131903565|NCT00385918|474933327|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
131903566|NCT00385918|474933328|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
131903567|NCT00385918|474933329|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
131903568|NCT00385918|474933327|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
131903569|NCT00385918|474933328|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
131903570|NCT00385918|474933329|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
131903571|NCT00385918|474933327|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
131903572|NCT00385918|474933328|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
131903573|NCT00385918|474933329|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
131903574|NCT00385918|474933327|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
131649564|NCT04092452|474002867|FG003|Overall Study|Adverse Event|7|||
131649565|NCT04092452|474002864|FG000|Overall Study|Lack of Efficacy|1|||
131649566|NCT04092452|474002865|FG001|Overall Study|Lack of Efficacy|1|||
131649567|NCT04092452|474002866|FG002|Overall Study|Lack of Efficacy|1|||
131649568|NCT04092452|474002867|FG003|Overall Study|Lack of Efficacy|0|||
131649569|NCT04092452|474002864|FG000|Overall Study|Lost to Follow-up|4|||
131649570|NCT04092452|474002865|FG001|Overall Study|Lost to Follow-up|3|||
131649571|NCT04092452|474002866|FG002|Overall Study|Lost to Follow-up|5|||
131649572|NCT04092452|474002867|FG003|Overall Study|Lost to Follow-up|1|||
131649573|NCT04092452|474002864|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131649574|NCT04092452|474002865|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131649575|NCT04092452|474002866|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131649576|NCT04092452|474002867|FG003|Overall Study|Non-Compliance With Study Drug|1|||
131649577|NCT04092452|474002864|FG000|Overall Study|Physician Decision|1|||
131649578|NCT04092452|474002865|FG001|Overall Study|Physician Decision|0|||
131649579|NCT04092452|474002866|FG002|Overall Study|Physician Decision|1|||
131649580|NCT04092452|474002867|FG003|Overall Study|Physician Decision|0|||
131649581|NCT04092452|474002864|FG000|Overall Study|Pregnancy|2|||
131649582|NCT04092452|474002865|FG001|Overall Study|Pregnancy|0|||
131649583|NCT04092452|474002866|FG002|Overall Study|Pregnancy|0|||
131649584|NCT04092452|474002867|FG003|Overall Study|Pregnancy|0|||
131649585|NCT04092452|474002864|FG000|Overall Study|Protocol Deviation|1|||
131649586|NCT04092452|474002865|FG001|Overall Study|Protocol Deviation|0|||
131649587|NCT04092452|474002866|FG002|Overall Study|Protocol Deviation|0|||
131649588|NCT04092452|474002867|FG003|Overall Study|Protocol Deviation|0|||
131649589|NCT04092452|474002864|FG000|Overall Study|Withdrawal by Subject|3|||
131649590|NCT04092452|474002865|FG001|Overall Study|Withdrawal by Subject|10|||
131649591|NCT04092452|474002866|FG002|Overall Study|Withdrawal by Subject|3|||
131649592|NCT04092452|474002867|FG003|Overall Study|Withdrawal by Subject|5|||
131649593|NCT04092452|474002864|FG000|Overall Study|Other|0|||
131649594|NCT04092452|474002865|FG001|Overall Study|Other|0|||
131649595|NCT04092452|474002866|FG002|Overall Study|Other|1|||
131649596|NCT04092452|474002867|FG003|Overall Study|Other|2|||
131649597|NCT02127125|474002868|FG000|Overall Study|Lost to Follow-up|0|||
131649598|NCT02127125|474002869|FG001|Overall Study|Lost to Follow-up|0|||
131649599|NCT02127125|474002870|FG002|Overall Study|Lost to Follow-up|0|||
131649600|NCT02127125|474002871|FG003|Overall Study|Lost to Follow-up|0|||
131649601|NCT02127125|474002872|FG004|Overall Study|Lost to Follow-up|2|||
131649602|NCT02127125|474002873|FG005|Overall Study|Lost to Follow-up|1|||
131649603|NCT02127125|474002874|FG006|Overall Study|Lost to Follow-up|0|||
131649604|NCT02127125|474002875|FG007|Overall Study|Lost to Follow-up|0|||
131649605|NCT02127125|474002876|FG008|Overall Study|Lost to Follow-up|0|||
131649606|NCT02127125|474002868|FG000|Overall Study|Withdrawal by Subject|0|||
131649607|NCT02127125|474002869|FG001|Overall Study|Withdrawal by Subject|0|||
131649608|NCT02127125|474002870|FG002|Overall Study|Withdrawal by Subject|0|||
131649609|NCT02127125|474002871|FG003|Overall Study|Withdrawal by Subject|1|||
131649610|NCT02127125|474002872|FG004|Overall Study|Withdrawal by Subject|0|||
131649611|NCT02127125|474002873|FG005|Overall Study|Withdrawal by Subject|0|||
131903575|NCT00385918|474933328|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
131649612|NCT02127125|474002874|FG006|Overall Study|Withdrawal by Subject|0|||
131649613|NCT02127125|474002875|FG007|Overall Study|Withdrawal by Subject|0|||
131649614|NCT02127125|474002876|FG008|Overall Study|Withdrawal by Subject|0|||
131649615|NCT02127125|474002868|FG000|Overall Study|Physician Decision|0|||
131649616|NCT02127125|474002869|FG001|Overall Study|Physician Decision|0|||
131649617|NCT02127125|474002870|FG002|Overall Study|Physician Decision|1|||
131649618|NCT02127125|474002871|FG003|Overall Study|Physician Decision|0|||
131649619|NCT02127125|474002872|FG004|Overall Study|Physician Decision|1|||
131649620|NCT02127125|474002873|FG005|Overall Study|Physician Decision|2|||
131649621|NCT02127125|474002874|FG006|Overall Study|Physician Decision|0|||
131649622|NCT02127125|474002875|FG007|Overall Study|Physician Decision|0|||
131649623|NCT02127125|474002876|FG008|Overall Study|Physician Decision|0|||
131649624|NCT02353468|474002878|FG000|Overall Study|Study terminated|3|||
131649625|NCT02493946|474002879|FG000|DB Period|Withdrawal by Subject|8|||
131649626|NCT02493946|474002880|FG001|DB Period|Withdrawal by Subject|5|||
131649627|NCT02493946|474002881|FG002|DB Period|Withdrawal by Subject|0|||
131649628|NCT02493946|474002879|FG000|Open Label Period|Withdrawal by Subject|0|||
131649629|NCT02493946|474002880|FG001|Open Label Period|Withdrawal by Subject|0|||
131649630|NCT02493946|474002881|FG002|Open Label Period|Withdrawal by Subject|74|||
131649631|NCT02493946|474002879|FG000|Open Label Period|Adverse Event|0|||
131649632|NCT02493946|474002880|FG001|Open Label Period|Adverse Event|0|||
131649633|NCT02493946|474002881|FG002|Open Label Period|Adverse Event|4|||
131649634|NCT02493946|474002879|FG000|Open Label Period|Lost to Follow-up|0|||
131649635|NCT02493946|474002880|FG001|Open Label Period|Lost to Follow-up|0|||
131649636|NCT02493946|474002881|FG002|Open Label Period|Lost to Follow-up|1|||
131649637|NCT02493946|474002879|FG000|Open Label Period|Investigator decision, non-compliance|0|||
131649638|NCT02493946|474002880|FG001|Open Label Period|Investigator decision, non-compliance|0|||
131649639|NCT02493946|474002881|FG002|Open Label Period|Investigator decision, non-compliance|2|||
131649640|NCT02493946|474002879|FG000|Open Label Period|Investigator decision, non-availability|0|||
131649641|NCT02493946|474002880|FG001|Open Label Period|Investigator decision, non-availability|0|||
131649642|NCT02493946|474002881|FG002|Open Label Period|Investigator decision, non-availability|1|||
131649643|NCT02493946|474002879|FG000|Open Label Period|Pregnancy|0|||
131649644|NCT02493946|474002880|FG001|Open Label Period|Pregnancy|0|||
131649645|NCT02493946|474002881|FG002|Open Label Period|Pregnancy|3|||
131649646|NCT02493946|474002879|FG000|Open Label Period|Site error|0|||
131649647|NCT02493946|474002880|FG001|Open Label Period|Site error|0|||
131649648|NCT02493946|474002881|FG002|Open Label Period|Site error|1|||
131649649|NCT00848484|474002882|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
131649650|NCT00848484|474002883|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
131649651|NCT00848484|474002882|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
131649652|NCT00848484|474002883|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
131649653|NCT00848484|474002882|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
131649654|NCT00848484|474002883|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
131649655|NCT00848484|474002882|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
131649656|NCT00848484|474002883|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
131649657|NCT00848484|474002882|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
131649658|NCT00848484|474002883|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
131649659|NCT02975102|474002891|FG000|Overall Study|Adverse Event|2|||
131649660|NCT02975102|474002892|FG001|Overall Study|Adverse Event|1|||
131649661|NCT03017742|474002893|FG000|Overall Study|Protocol Violation|36|||
131649662|NCT03017742|474002893|FG000|Overall Study|Withdrawal by Subject|37|||
131649663|NCT00762476|474002895|FG000|Overall Study|Adverse Event|7|||
131649664|NCT00762476|474002896|FG001|Overall Study|Adverse Event|1|||
131649665|NCT00762476|474002895|FG000|Overall Study|Lost to Follow-up|2|||
131649666|NCT00762476|474002896|FG001|Overall Study|Lost to Follow-up|0|||
131649667|NCT00762476|474002895|FG000|Overall Study|Protocol Violation|5|||
131649668|NCT00762476|474002896|FG001|Overall Study|Protocol Violation|6|||
131649669|NCT00762476|474002895|FG000|Overall Study|Physician Decision|2|||
131649670|NCT00762476|474002896|FG001|Overall Study|Physician Decision|14|||
131649671|NCT00762476|474002895|FG000|Overall Study|Withdrawal by Subject|6|||
131649672|NCT00762476|474002896|FG001|Overall Study|Withdrawal by Subject|12|||
131649673|NCT00762476|474002895|FG000|Overall Study|antibiotic use|0|||
131649674|NCT00762476|474002896|FG001|Overall Study|antibiotic use|1|||
131649675|NCT00762476|474002895|FG000|Overall Study|non-compliance with study visits|0|||
131649676|NCT00762476|474002896|FG001|Overall Study|non-compliance with study visits|2|||
131649677|NCT00762476|474002895|FG000|Overall Study|Seasonal allergies|1|||
131649678|NCT00762476|474002896|FG001|Overall Study|Seasonal allergies|0|||
131649679|NCT01358331|474002897|FG000|Overall Study|Lost to Follow-up|0|||
131649680|NCT01358331|474002898|FG001|Overall Study|Lost to Follow-up|0|||
131649681|NCT01358331|474002899|FG002|Overall Study|Lost to Follow-up|0|||
131649682|NCT01358331|474002900|FG003|Overall Study|Lost to Follow-up|1|||
131649683|NCT01358331|474002901|FG004|Overall Study|Lost to Follow-up|0|||
131649684|NCT01358331|474002902|FG005|Overall Study|Lost to Follow-up|0|||
131649685|NCT01358331|474002897|FG000|Overall Study|Withdrawal by Subject|0|||
131649686|NCT01358331|474002898|FG001|Overall Study|Withdrawal by Subject|0|||
131649687|NCT01358331|474002899|FG002|Overall Study|Withdrawal by Subject|0|||
131649688|NCT01358331|474002900|FG003|Overall Study|Withdrawal by Subject|1|||
131649689|NCT01358331|474002901|FG004|Overall Study|Withdrawal by Subject|1|||
131649690|NCT01358331|474002902|FG005|Overall Study|Withdrawal by Subject|1|||
131903576|NCT00385918|474933329|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
131903577|NCT00385918|474933327|FG000|Intervention Phase After Randomization|Physician Decision|1|||
131649691|NCT01358331|474002897|FG000|Overall Study|Adverse Events|1|||
131649692|NCT01358331|474002898|FG001|Overall Study|Adverse Events|1|||
131649693|NCT01358331|474002899|FG002|Overall Study|Adverse Events|1|||
131649694|NCT01358331|474002900|FG003|Overall Study|Adverse Events|0|||
131649695|NCT01358331|474002901|FG004|Overall Study|Adverse Events|1|||
131649696|NCT01358331|474002902|FG005|Overall Study|Adverse Events|5|||
131649697|NCT01358331|474002897|FG000|Overall Study|Symptomatic Deterioration|0|||
131649698|NCT01358331|474002898|FG001|Overall Study|Symptomatic Deterioration|0|||
131649699|NCT01358331|474002899|FG002|Overall Study|Symptomatic Deterioration|0|||
131649700|NCT01358331|474002900|FG003|Overall Study|Symptomatic Deterioration|0|||
131649701|NCT01358331|474002901|FG004|Overall Study|Symptomatic Deterioration|1|||
131649702|NCT01358331|474002902|FG005|Overall Study|Symptomatic Deterioration|0|||
131649703|NCT01358331|474002897|FG000|Overall Study|Participants did not wish to continue|0|||
131649704|NCT01358331|474002898|FG001|Overall Study|Participants did not wish to continue|0|||
131649705|NCT01358331|474002899|FG002|Overall Study|Participants did not wish to continue|0|||
131649706|NCT01358331|474002900|FG003|Overall Study|Participants did not wish to continue|0|||
131649707|NCT01358331|474002901|FG004|Overall Study|Participants did not wish to continue|1|||
131649708|NCT01358331|474002902|FG005|Overall Study|Participants did not wish to continue|0|||
131649709|NCT01358331|474002897|FG000|Overall Study|Progress of disease under investigation|1|||
131649710|NCT01358331|474002898|FG001|Overall Study|Progress of disease under investigation|2|||
131802987|NCT00162123|474562057|FG002|Overall Study|Deterioration without progression|3|||
131802988|NCT00162123|474562058|FG003|Overall Study|Deterioration without progression|0|||
131802989|NCT00162123|474562059|FG004|Overall Study|Deterioration without progression|1|||
131802990|NCT00162123|474562060|FG005|Overall Study|Deterioration without progression|0|||
131802991|NCT00162123|474562061|FG006|Overall Study|Deterioration without progression|0|||
131802992|NCT00162123|474562062|FG007|Overall Study|Deterioration without progression|0|||
131802993|NCT00162123|474562055|FG000|Overall Study|Adverse Event|1|||
131802994|NCT00162123|474562056|FG001|Overall Study|Adverse Event|2|||
131802995|NCT00162123|474562057|FG002|Overall Study|Adverse Event|0|||
131802996|NCT00162123|474562058|FG003|Overall Study|Adverse Event|2|||
131802997|NCT00162123|474562059|FG004|Overall Study|Adverse Event|1|||
131802998|NCT00162123|474562060|FG005|Overall Study|Adverse Event|0|||
131802999|NCT00162123|474562061|FG006|Overall Study|Adverse Event|0|||
131803000|NCT00162123|474562062|FG007|Overall Study|Adverse Event|0|||
131803001|NCT00162123|474562055|FG000|Overall Study|Not specified (before treatment)|2|||
131803002|NCT00162123|474562056|FG001|Overall Study|Not specified (before treatment)|0|||
131803003|NCT00162123|474562057|FG002|Overall Study|Not specified (before treatment)|0|||
131803004|NCT00162123|474562058|FG003|Overall Study|Not specified (before treatment)|0|||
131803005|NCT00162123|474562059|FG004|Overall Study|Not specified (before treatment)|12|||
131803006|NCT00162123|474562060|FG005|Overall Study|Not specified (before treatment)|1|||
131803007|NCT00162123|474562061|FG006|Overall Study|Not specified (before treatment)|0|||
131803008|NCT00162123|474562062|FG007|Overall Study|Not specified (before treatment)|0|||
131803009|NCT00162123|474562055|FG000|Overall Study|Not specified (after start of treatment)|0|||
131903578|NCT00385918|474933328|FG001|Intervention Phase After Randomization|Physician Decision|0|||
131903579|NCT00385918|474933329|FG002|Intervention Phase After Randomization|Physician Decision|0|||
131649711|NCT01358331|474002899|FG002|Overall Study|Progress of disease under investigation|3|||
131649712|NCT01358331|474002900|FG003|Overall Study|Progress of disease under investigation|1|||
131649713|NCT01358331|474002901|FG004|Overall Study|Progress of disease under investigation|3|||
131903580|NCT00385918|474933327|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
131903581|NCT00385918|474933328|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
131903582|NCT00385918|474933329|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
131903583|NCT01676701|474933330|FG000|Overall Study|Protocol Violation|1|||
131903584|NCT01676701|474933331|FG001|Overall Study|Protocol Violation|0|||
131903585|NCT01676701|474933330|FG000|Overall Study|Sponsor Decision|3|||
131903586|NCT01676701|474933331|FG001|Overall Study|Sponsor Decision|4|||
131903587|NCT02115607|474933342|FG000|Overall Study|Withdrawal by Subject|1|||
131903588|NCT00549549|474933344|FG000|Overall Study|Adverse Event|5|||
131903589|NCT00549549|474933345|FG001|Overall Study|Adverse Event|3|||
131448116|NCT01716234|473270876|FG002|Overall Study|Lack of Efficacy|0|||
131649714|NCT01358331|474002902|FG005|Overall Study|Progress of disease under investigation|0|||
131649715|NCT01564277|474002903|FG000|Overall Study|Protocol Violation|0|||
131803010|NCT00162123|474562056|FG001|Overall Study|Not specified (after start of treatment)|0|||
131803011|NCT00162123|474562057|FG002|Overall Study|Not specified (after start of treatment)|0|||
131649716|NCT01564277|474002904|FG001|Overall Study|Protocol Violation|1|||
131649717|NCT01564277|474002903|FG000|Overall Study|Physician Decision|1|||
131649718|NCT01564277|474002904|FG001|Overall Study|Physician Decision|0|||
131649719|NCT01637077|474002905|FG000|Overall Study|Cancel|1|||
131649720|NCT01637077|474002906|FG001|Overall Study|Cancel|1|||
131649721|NCT01637077|474002905|FG000|Overall Study|Withdrawal by Subject|1|||
131649722|NCT01637077|474002906|FG001|Overall Study|Withdrawal by Subject|0|||
131649723|NCT01637077|474002905|FG000|Overall Study|No cycle 1 questionnaire data|2|||
131649724|NCT01637077|474002906|FG001|Overall Study|No cycle 1 questionnaire data|0|||
131649725|NCT02595372|474002907|FG000|Overall Study|Adverse Event|6|||
131649726|NCT02595372|474002907|FG000|Overall Study|Physician Decision|2|||
131649727|NCT02595372|474002907|FG000|Overall Study|Disease Progression|1|||
131649728|NCT01594970|474002908|FG000|Overall Study|Non-Adverse Event Related|4|||
131649729|NCT01594970|474002909|FG001|Overall Study|Non-Adverse Event Related|5|||
131649730|NCT01594970|474002910|FG002|Overall Study|Non-Adverse Event Related|6|||
131649731|NCT01594970|474002908|FG000|Overall Study|Adverse Event|17|||
131649732|NCT01594970|474002909|FG001|Overall Study|Adverse Event|23|||
131649733|NCT01594970|474002910|FG002|Overall Study|Adverse Event|23|||
131649734|NCT01594970|474002908|FG000|Overall Study|Lost to Follow-up|54|||
131649735|NCT01594970|474002909|FG001|Overall Study|Lost to Follow-up|54|||
131649736|NCT01594970|474002910|FG002|Overall Study|Lost to Follow-up|37|||
131649737|NCT01299480|474002912|FG000|Overall Study|No longer willing to participate|19|||
131649738|NCT01299480|474002913|FG001|Overall Study|No longer willing to participate|17|||
131649739|NCT01299480|474002914|FG002|Overall Study|No longer willing to participate|14|||
131649740|NCT01299480|474002915|FG003|Overall Study|No longer willing to participate|13|||
131649741|NCT01299480|474002916|FG004|Overall Study|No longer willing to participate|10|||
131649742|NCT01299480|474002912|FG000|Overall Study|Protocol Violation|7|||
131649743|NCT01299480|474002913|FG001|Overall Study|Protocol Violation|5|||
131649744|NCT01299480|474002914|FG002|Overall Study|Protocol Violation|8|||
131649745|NCT01299480|474002915|FG003|Overall Study|Protocol Violation|1|||
131649746|NCT01299480|474002916|FG004|Overall Study|Protocol Violation|1|||
131649747|NCT01299480|474002912|FG000|Overall Study|Withdrawal by Subject|3|||
131649748|NCT01299480|474002913|FG001|Overall Study|Withdrawal by Subject|4|||
131649749|NCT01299480|474002914|FG002|Overall Study|Withdrawal by Subject|7|||
131649750|NCT01299480|474002915|FG003|Overall Study|Withdrawal by Subject|3|||
131649751|NCT01299480|474002916|FG004|Overall Study|Withdrawal by Subject|4|||
131649752|NCT01299480|474002912|FG000|Overall Study|Adverse Event|6|||
131649753|NCT01299480|474002913|FG001|Overall Study|Adverse Event|4|||
131649754|NCT01299480|474002914|FG002|Overall Study|Adverse Event|5|||
131649755|NCT01299480|474002915|FG003|Overall Study|Adverse Event|4|||
131649756|NCT01299480|474002916|FG004|Overall Study|Adverse Event|0|||
131649757|NCT01299480|474002912|FG000|Overall Study|Withdrawal due to pregnancy|0|||
131649758|NCT01299480|474002913|FG001|Overall Study|Withdrawal due to pregnancy|1|||
131649759|NCT01299480|474002914|FG002|Overall Study|Withdrawal due to pregnancy|1|||
131649760|NCT01299480|474002915|FG003|Overall Study|Withdrawal due to pregnancy|0|||
131649761|NCT01299480|474002916|FG004|Overall Study|Withdrawal due to pregnancy|0|||
131649762|NCT01299480|474002912|FG000|Overall Study|Physician Decision|1|||
131649763|NCT01299480|474002913|FG001|Overall Study|Physician Decision|1|||
131649764|NCT01299480|474002914|FG002|Overall Study|Physician Decision|0|||
131649765|NCT01299480|474002915|FG003|Overall Study|Physician Decision|2|||
131649766|NCT01299480|474002916|FG004|Overall Study|Physician Decision|0|||
131649767|NCT01299480|474002912|FG000|Overall Study|Lost to Follow-up|3|||
131903590|NCT00549549|474933346|FG002|Overall Study|Adverse Event|1|||
131903591|NCT00549549|474933347|FG003|Overall Study|Adverse Event|9|||
131903592|NCT00549549|474933344|FG000|Overall Study|Lack of Efficacy|9|||
131649768|NCT01299480|474002913|FG001|Overall Study|Lost to Follow-up|1|||
131649769|NCT01299480|474002914|FG002|Overall Study|Lost to Follow-up|2|||
131649770|NCT01299480|474002915|FG003|Overall Study|Lost to Follow-up|1|||
131649771|NCT01299480|474002916|FG004|Overall Study|Lost to Follow-up|2|||
131649772|NCT01299480|474002912|FG000|Overall Study|Other|3|||
131649773|NCT01299480|474002913|FG001|Overall Study|Other|2|||
131649774|NCT01299480|474002914|FG002|Overall Study|Other|3|||
131649775|NCT01299480|474002915|FG003|Overall Study|Other|0|||
131649776|NCT01299480|474002916|FG004|Overall Study|Other|3|||
131903593|NCT00549549|474933345|FG001|Overall Study|Lack of Efficacy|6|||
131649777|NCT01299480|474002912|FG000|Overall Study|Started, but not vaccinated|0|||
131649778|NCT01299480|474002913|FG001|Overall Study|Started, but not vaccinated|0|||
131649779|NCT01299480|474002914|FG002|Overall Study|Started, but not vaccinated|1|||
131649780|NCT01299480|474002915|FG003|Overall Study|Started, but not vaccinated|1|||
131649781|NCT01299480|474002916|FG004|Overall Study|Started, but not vaccinated|0|||
131649782|NCT00617929|474002922|FG000|Overall Study|Physician Decision|1|||
131649783|NCT04949802|474005348|FG000|Overall Study|Lost to Follow-up|3|||
131649784|NCT03816761|474005349|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131649785|NCT03816761|474005350|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131649786|NCT03816761|474005351|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131649787|NCT03816761|474005352|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131649788|NCT03816761|474005353|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131649789|NCT03816761|474005354|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
131649790|NCT03816761|474005349|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
131649791|NCT03816761|474005350|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
131649792|NCT03816761|474005351|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
131649793|NCT03816761|474005352|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
131649794|NCT03816761|474005353|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
131649795|NCT03816761|474005354|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
131649796|NCT02419417|474005355|FG000|Overall Study|Disease progression|5|||
131649797|NCT02419417|474005356|FG001|Overall Study|Disease progression|4|||
131649798|NCT02419417|474005357|FG002|Overall Study|Disease progression|13|||
131649799|NCT02419417|474005358|FG003|Overall Study|Disease progression|10|||
131649800|NCT02419417|474005359|FG004|Overall Study|Disease progression|10|||
131803012|NCT00162123|474562058|FG003|Overall Study|Not specified (after start of treatment)|0|||
131803013|NCT00162123|474562059|FG004|Overall Study|Not specified (after start of treatment)|3|||
131803014|NCT00162123|474562060|FG005|Overall Study|Not specified (after start of treatment)|0|||
131803015|NCT00162123|474562061|FG006|Overall Study|Not specified (after start of treatment)|0|||
131803016|NCT00162123|474562062|FG007|Overall Study|Not specified (after start of treatment)|0|||
131803017|NCT00162123|474562055|FG000|Overall Study|Physician Decision|1|||
131803018|NCT00162123|474562056|FG001|Overall Study|Physician Decision|2|||
131803019|NCT00162123|474562057|FG002|Overall Study|Physician Decision|0|||
131803020|NCT00162123|474562058|FG003|Overall Study|Physician Decision|0|||
131803021|NCT00162123|474562059|FG004|Overall Study|Physician Decision|0|||
131803022|NCT00162123|474562060|FG005|Overall Study|Physician Decision|1|||
131803023|NCT00162123|474562061|FG006|Overall Study|Physician Decision|1|||
131803024|NCT00162123|474562062|FG007|Overall Study|Physician Decision|0|||
131803025|NCT00162123|474562055|FG000|Overall Study|Tumor assessment only (not treated)|0|||
131803026|NCT00162123|474562056|FG001|Overall Study|Tumor assessment only (not treated)|0|||
131803027|NCT00162123|474562057|FG002|Overall Study|Tumor assessment only (not treated)|0|||
131803028|NCT00162123|474562058|FG003|Overall Study|Tumor assessment only (not treated)|0|||
131803029|NCT00162123|474562059|FG004|Overall Study|Tumor assessment only (not treated)|0|||
131803030|NCT00162123|474562060|FG005|Overall Study|Tumor assessment only (not treated)|0|||
131803031|NCT00162123|474562061|FG006|Overall Study|Tumor assessment only (not treated)|0|||
131803032|NCT00162123|474562062|FG007|Overall Study|Tumor assessment only (not treated)|1|||
131803033|NCT00162123|474562055|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
131803034|NCT00162123|474562056|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
131803035|NCT00162123|474562057|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
131803036|NCT00162123|474562058|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
131803037|NCT00162123|474562059|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
131803038|NCT00162123|474562060|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
131803039|NCT00162123|474562061|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
131803040|NCT00162123|474562062|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
131803041|NCT02016170|474562063|FG000|Overall Study|Adverse Event|1|||
131803042|NCT02016170|474562064|FG001|Overall Study|Adverse Event|1|||
131803043|NCT02016170|474562065|FG002|Overall Study|Adverse Event|0|||
131803044|NCT02016170|474562063|FG000|Overall Study|Protocol Violation|1|||
131803045|NCT02016170|474562064|FG001|Overall Study|Protocol Violation|0|||
131803046|NCT02016170|474562065|FG002|Overall Study|Protocol Violation|0|||
131803047|NCT02327130|474562066|FG000|Overall Study|Discharged in less than 5 days|5|||
131803048|NCT02327130|474562066|FG000|Overall Study|Physician Decision|2|||
131803049|NCT02327130|474562066|FG000|Overall Study|Unable to provide breath sample|1|||
131803050|NCT02327130|474562066|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
131803051|NCT02327130|474562066|FG000|Overall Study|Met exclusion criteria|3|||
131803052|NCT01104662|474562067|FG000|Overall Study|Adverse Event|2|||
131803053|NCT01104662|474562068|FG001|Overall Study|Adverse Event|2|||
131803054|NCT01104662|474562069|FG002|Overall Study|Adverse Event|0|||
131803055|NCT01104662|474562070|FG003|Overall Study|Adverse Event|1|||
131803056|NCT01104662|474562071|FG004|Overall Study|Adverse Event|1|||
131803057|NCT01104662|474562072|FG005|Overall Study|Adverse Event|1|||
131803058|NCT01104662|474562073|FG006|Overall Study|Adverse Event|0|||
131803059|NCT01104662|474562074|FG007|Overall Study|Adverse Event|0|||
131803060|NCT01104662|474562067|FG000|Overall Study|Clinical Failure|1|||
131803061|NCT01104662|474562068|FG001|Overall Study|Clinical Failure|0|||
131803062|NCT01104662|474562069|FG002|Overall Study|Clinical Failure|0|||
131803063|NCT01104662|474562070|FG003|Overall Study|Clinical Failure|0|||
131803064|NCT01104662|474562071|FG004|Overall Study|Clinical Failure|0|||
131803065|NCT01104662|474562072|FG005|Overall Study|Clinical Failure|1|||
131649801|NCT02419417|474005360|FG005|Overall Study|Disease progression|3|||
131649802|NCT02419417|474005361|FG006|Overall Study|Disease progression|4|||
131649803|NCT02419417|474005362|FG007|Overall Study|Disease progression|5|||
131649804|NCT02419417|474005363|FG008|Overall Study|Disease progression|13|||
131803066|NCT01104662|474562073|FG006|Overall Study|Clinical Failure|0|||
131803067|NCT01104662|474562074|FG007|Overall Study|Clinical Failure|0|||
131649805|NCT02419417|474005364|FG009|Overall Study|Disease progression|9|||
131803068|NCT01104662|474562067|FG000|Overall Study|Participant left investigator's care|1|||
131803069|NCT01104662|474562068|FG001|Overall Study|Participant left investigator's care|1|||
131903594|NCT00549549|474933346|FG002|Overall Study|Lack of Efficacy|4|||
131903595|NCT00549549|474933347|FG003|Overall Study|Lack of Efficacy|2|||
131903596|NCT00549549|474933344|FG000|Overall Study|Lost to Follow-up|1|||
131903597|NCT00549549|474933345|FG001|Overall Study|Lost to Follow-up|0|||
131903598|NCT00549549|474933346|FG002|Overall Study|Lost to Follow-up|1|||
131903599|NCT00549549|474933347|FG003|Overall Study|Lost to Follow-up|2|||
131903600|NCT00549549|474933344|FG000|Overall Study|Withdrawal by Subject|0|||
131903601|NCT00549549|474933345|FG001|Overall Study|Withdrawal by Subject|4|||
131903602|NCT00549549|474933346|FG002|Overall Study|Withdrawal by Subject|1|||
131903603|NCT00549549|474933347|FG003|Overall Study|Withdrawal by Subject|0|||
131903604|NCT00549549|474933344|FG000|Overall Study|Other|9|||
131903605|NCT00549549|474933345|FG001|Overall Study|Other|9|||
131903606|NCT00549549|474933346|FG002|Overall Study|Other|9|||
131903607|NCT00549549|474933347|FG003|Overall Study|Other|11|||
131903608|NCT00549549|474933344|FG000|Overall Study|Randomized but not treated|0|||
131903609|NCT00549549|474933345|FG001|Overall Study|Randomized but not treated|0|||
131716107|NCT01485614|474238886|FG003|Randomization|Not Treated|0|||
131716108|NCT01485614|474238883|FG000|Weeks 0-20|Lost to Follow-up|2|||
131903610|NCT00549549|474933346|FG002|Overall Study|Randomized but not treated|1|||
131903611|NCT00549549|474933347|FG003|Overall Study|Randomized but not treated|1|||
131903612|NCT02227784|474933351|FG000|Double-Blind Phase|Adverse Event|3|||
131716109|NCT01485614|474238884|FG001|Weeks 0-20|Lost to Follow-up|0|||
131716110|NCT01485614|474238885|FG002|Weeks 0-20|Lost to Follow-up|0|||
131716111|NCT01485614|474238886|FG003|Weeks 0-20|Lost to Follow-up|0|||
131716112|NCT01485614|474238883|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
131716113|NCT01485614|474238884|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
131716114|NCT01485614|474238885|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
131716115|NCT01485614|474238886|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
131716116|NCT01485614|474238883|FG000|Weeks 0-20|Withdrawal by Subject|3|||
131716117|NCT01485614|474238884|FG001|Weeks 0-20|Withdrawal by Subject|2|||
131716118|NCT01485614|474238885|FG002|Weeks 0-20|Withdrawal by Subject|1|||
131716119|NCT01485614|474238886|FG003|Weeks 0-20|Withdrawal by Subject|0|||
131716120|NCT01485614|474238883|FG000|Weeks 20-54|Lost to Follow-up|4|||
131716121|NCT01485614|474238884|FG001|Weeks 20-54|Lost to Follow-up|3|||
131716122|NCT01485614|474238885|FG002|Weeks 20-54|Lost to Follow-up|1|||
131716123|NCT01485614|474238886|FG003|Weeks 20-54|Lost to Follow-up|0|||
131716124|NCT01485614|474238883|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
131716125|NCT01485614|474238884|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
131803070|NCT01104662|474562069|FG002|Overall Study|Participant left investigator's care|0|||
131803071|NCT01104662|474562070|FG003|Overall Study|Participant left investigator's care|0|||
131803072|NCT01104662|474562071|FG004|Overall Study|Participant left investigator's care|0|||
131803073|NCT01104662|474562072|FG005|Overall Study|Participant left investigator's care|0|||
131803074|NCT01104662|474562073|FG006|Overall Study|Participant left investigator's care|0|||
131716126|NCT01485614|474238885|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
131716127|NCT01485614|474238886|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
131649806|NCT02419417|474005365|FG010|Overall Study|Disease progression|0|||
131649807|NCT02419417|474005355|FG000|Overall Study|Study drug toxicity|0|||
131649808|NCT02419417|474005356|FG001|Overall Study|Study drug toxicity|0|||
131649809|NCT02419417|474005357|FG002|Overall Study|Study drug toxicity|0|||
131649810|NCT02419417|474005358|FG003|Overall Study|Study drug toxicity|0|||
131649811|NCT02419417|474005359|FG004|Overall Study|Study drug toxicity|1|||
131649812|NCT02419417|474005360|FG005|Overall Study|Study drug toxicity|0|||
131649813|NCT02419417|474005361|FG006|Overall Study|Study drug toxicity|0|||
131649814|NCT02419417|474005362|FG007|Overall Study|Study drug toxicity|0|||
131649815|NCT02419417|474005363|FG008|Overall Study|Study drug toxicity|0|||
131649816|NCT02419417|474005364|FG009|Overall Study|Study drug toxicity|0|||
131649817|NCT02419417|474005365|FG010|Overall Study|Study drug toxicity|0|||
131649818|NCT02419417|474005355|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131649819|NCT02419417|474005356|FG001|Overall Study|Adverse event unrelated to study drug|0|||
131649820|NCT02419417|474005357|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131649821|NCT02419417|474005358|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131649822|NCT02419417|474005359|FG004|Overall Study|Adverse event unrelated to study drug|2|||
131649823|NCT02419417|474005360|FG005|Overall Study|Adverse event unrelated to study drug|1|||
131649824|NCT02419417|474005361|FG006|Overall Study|Adverse event unrelated to study drug|0|||
131649825|NCT02419417|474005362|FG007|Overall Study|Adverse event unrelated to study drug|1|||
131649826|NCT02419417|474005363|FG008|Overall Study|Adverse event unrelated to study drug|0|||
131649827|NCT02419417|474005364|FG009|Overall Study|Adverse event unrelated to study drug|0|||
131649828|NCT02419417|474005365|FG010|Overall Study|Adverse event unrelated to study drug|0|||
131649829|NCT02419417|474005355|FG000|Overall Study|Participant request to discontinue|0|||
131649830|NCT02419417|474005356|FG001|Overall Study|Participant request to discontinue|0|||
131649831|NCT02419417|474005357|FG002|Overall Study|Participant request to discontinue|0|||
131649832|NCT02419417|474005358|FG003|Overall Study|Participant request to discontinue|0|||
131649833|NCT02419417|474005359|FG004|Overall Study|Participant request to discontinue|0|||
131649834|NCT02419417|474005360|FG005|Overall Study|Participant request to discontinue|0|||
131649835|NCT02419417|474005361|FG006|Overall Study|Participant request to discontinue|0|||
131649836|NCT02419417|474005362|FG007|Overall Study|Participant request to discontinue|0|||
131649837|NCT02419417|474005363|FG008|Overall Study|Participant request to discontinue|0|||
131649838|NCT02419417|474005364|FG009|Overall Study|Participant request to discontinue|1|||
131649839|NCT02419417|474005365|FG010|Overall Study|Participant request to discontinue|0|||
131649840|NCT02419417|474005355|FG000|Overall Study|Withdrawal by Subject|0|||
131649841|NCT02419417|474005356|FG001|Overall Study|Withdrawal by Subject|0|||
131649842|NCT02419417|474005357|FG002|Overall Study|Withdrawal by Subject|0|||
131649843|NCT02419417|474005358|FG003|Overall Study|Withdrawal by Subject|0|||
131649844|NCT02419417|474005359|FG004|Overall Study|Withdrawal by Subject|0|||
131649845|NCT02419417|474005360|FG005|Overall Study|Withdrawal by Subject|0|||
131649846|NCT02419417|474005361|FG006|Overall Study|Withdrawal by Subject|0|||
131649847|NCT02419417|474005362|FG007|Overall Study|Withdrawal by Subject|0|||
131649848|NCT02419417|474005363|FG008|Overall Study|Withdrawal by Subject|0|||
131649849|NCT02419417|474005364|FG009|Overall Study|Withdrawal by Subject|0|||
131649850|NCT02419417|474005365|FG010|Overall Study|Withdrawal by Subject|1|||
131649851|NCT01240551|474005366|FG000|Overall Study|Refused further treatment|3|||
131649852|NCT01240551|474005367|FG001|Overall Study|Refused further treatment|2|||
131649853|NCT01240551|474005366|FG000|Overall Study|Lost to Follow-up|1|||
131649854|NCT01240551|474005367|FG001|Overall Study|Lost to Follow-up|1|||
131649855|NCT02568397|474005371|FG000|Period 2|Withdrawal by Subject|0|||
131649856|NCT02568397|474005372|FG001|Period 2|Withdrawal by Subject|1|||
131649857|NCT02568397|474005371|FG000|Period 2|Physician Decision|0|||
131649858|NCT02568397|474005372|FG001|Period 2|Physician Decision|1|||
131649859|NCT01317875|474005373|FG000|Overall Study|Other|0|||
131649860|NCT01317875|474005374|FG001|Overall Study|Other|0|||
131649861|NCT01317875|474005375|FG002|Overall Study|Other|1|||
131649862|NCT01317875|474005376|FG003|Overall Study|Other|0|||
131649863|NCT01317875|474005377|FG004|Overall Study|Other|0|||
131649864|NCT01317875|474005378|FG005|Overall Study|Other|0|||
131649865|NCT01317875|474005379|FG006|Overall Study|Other|0|||
131649866|NCT01317875|474005380|FG007|Overall Study|Other|0|||
131649867|NCT01317875|474005381|FG008|Overall Study|Other|0|||
131649868|NCT01317875|474005382|FG009|Overall Study|Other|0|||
131649869|NCT01317875|474005373|FG000|Overall Study|Noncompliance with study drug|0|||
131649870|NCT01317875|474005374|FG001|Overall Study|Noncompliance with study drug|0|||
131649871|NCT01317875|474005375|FG002|Overall Study|Noncompliance with study drug|1|||
131649872|NCT01317875|474005376|FG003|Overall Study|Noncompliance with study drug|0|||
131649873|NCT01317875|474005377|FG004|Overall Study|Noncompliance with study drug|0|||
131649874|NCT01317875|474005378|FG005|Overall Study|Noncompliance with study drug|0|||
131649875|NCT01317875|474005379|FG006|Overall Study|Noncompliance with study drug|0|||
131649876|NCT01317875|474005380|FG007|Overall Study|Noncompliance with study drug|0|||
131649877|NCT01317875|474005381|FG008|Overall Study|Noncompliance with study drug|0|||
131649878|NCT01317875|474005382|FG009|Overall Study|Noncompliance with study drug|0|||
131649879|NCT01317875|474005373|FG000|Overall Study|Progressive Disease|1|||
131649880|NCT01317875|474005374|FG001|Overall Study|Progressive Disease|0|||
131903613|NCT02227784|474933352|FG001|Double-Blind Phase|Adverse Event|2|||
131903614|NCT02227784|474933353|FG002|Double-Blind Phase|Adverse Event|1|||
131903615|NCT02227784|474933354|FG003|Double-Blind Phase|Adverse Event|3|||
131903616|NCT02227784|474933355|FG004|Double-Blind Phase|Adverse Event|0|||
131903617|NCT02227784|474933351|FG000|Double-Blind Phase|Physician Decision|1|||
131903618|NCT02227784|474933352|FG001|Double-Blind Phase|Physician Decision|0|||
131903619|NCT02227784|474933353|FG002|Double-Blind Phase|Physician Decision|0|||
131903620|NCT02227784|474933354|FG003|Double-Blind Phase|Physician Decision|1|||
131903621|NCT02227784|474933355|FG004|Double-Blind Phase|Physician Decision|0|||
131903622|NCT02227784|474933351|FG000|Double-Blind Phase|Protocol Violation|0|||
131903623|NCT02227784|474933352|FG001|Double-Blind Phase|Protocol Violation|0|||
131903624|NCT02227784|474933353|FG002|Double-Blind Phase|Protocol Violation|1|||
131903625|NCT02227784|474933354|FG003|Double-Blind Phase|Protocol Violation|1|||
131903626|NCT02227784|474933355|FG004|Double-Blind Phase|Protocol Violation|0|||
131903627|NCT02227784|474933351|FG000|Double-Blind Phase|Sponsor Decision|34|||
131903628|NCT02227784|474933352|FG001|Double-Blind Phase|Sponsor Decision|15|||
131903629|NCT02227784|474933353|FG002|Double-Blind Phase|Sponsor Decision|14|||
131903630|NCT02227784|474933354|FG003|Double-Blind Phase|Sponsor Decision|32|||
131903631|NCT02227784|474933355|FG004|Double-Blind Phase|Sponsor Decision|0|||
131903632|NCT02227784|474933351|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
131903633|NCT02227784|474933352|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
131903634|NCT02227784|474933353|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
131903635|NCT02227784|474933354|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
131903636|NCT02227784|474933355|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
131903637|NCT02227784|474933351|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
131649881|NCT01317875|474005375|FG002|Overall Study|Progressive Disease|2|||
131649882|NCT01317875|474005376|FG003|Overall Study|Progressive Disease|0|||
131649883|NCT01317875|474005377|FG004|Overall Study|Progressive Disease|1|||
131649884|NCT01317875|474005378|FG005|Overall Study|Progressive Disease|0|||
131649885|NCT01317875|474005379|FG006|Overall Study|Progressive Disease|0|||
131649886|NCT01317875|474005380|FG007|Overall Study|Progressive Disease|1|||
131649887|NCT01317875|474005381|FG008|Overall Study|Progressive Disease|0|||
131649888|NCT01317875|474005382|FG009|Overall Study|Progressive Disease|0|||
131649889|NCT01317875|474005373|FG000|Overall Study|Withdrawal by Subject|0|||
131649890|NCT01317875|474005374|FG001|Overall Study|Withdrawal by Subject|0|||
131649891|NCT01317875|474005375|FG002|Overall Study|Withdrawal by Subject|0|||
131649892|NCT01317875|474005376|FG003|Overall Study|Withdrawal by Subject|0|||
131649893|NCT01317875|474005377|FG004|Overall Study|Withdrawal by Subject|1|||
131649894|NCT01317875|474005378|FG005|Overall Study|Withdrawal by Subject|0|||
131649895|NCT01317875|474005379|FG006|Overall Study|Withdrawal by Subject|0|||
131649896|NCT01317875|474005380|FG007|Overall Study|Withdrawal by Subject|3|||
131649897|NCT01317875|474005381|FG008|Overall Study|Withdrawal by Subject|0|||
131649898|NCT01317875|474005382|FG009|Overall Study|Withdrawal by Subject|0|||
131649899|NCT01317875|474005373|FG000|Overall Study|Physician Decision|0|||
131649900|NCT01317875|474005374|FG001|Overall Study|Physician Decision|1|||
131649901|NCT01317875|474005375|FG002|Overall Study|Physician Decision|1|||
131649902|NCT01317875|474005376|FG003|Overall Study|Physician Decision|0|||
131649903|NCT01317875|474005377|FG004|Overall Study|Physician Decision|2|||
131649904|NCT01317875|474005378|FG005|Overall Study|Physician Decision|0|||
131649905|NCT01317875|474005379|FG006|Overall Study|Physician Decision|0|||
131649906|NCT01317875|474005380|FG007|Overall Study|Physician Decision|2|||
131649907|NCT01317875|474005381|FG008|Overall Study|Physician Decision|0|||
131649908|NCT01317875|474005382|FG009|Overall Study|Physician Decision|0|||
131649909|NCT01317875|474005373|FG000|Overall Study|Death|0|||
131649910|NCT01317875|474005374|FG001|Overall Study|Death|0|||
131649911|NCT01317875|474005375|FG002|Overall Study|Death|2|||
131649912|NCT01317875|474005376|FG003|Overall Study|Death|1|||
131649913|NCT01317875|474005377|FG004|Overall Study|Death|0|||
131649914|NCT01317875|474005378|FG005|Overall Study|Death|1|||
131649915|NCT01317875|474005379|FG006|Overall Study|Death|0|||
131649916|NCT01317875|474005380|FG007|Overall Study|Death|4|||
131649917|NCT01317875|474005381|FG008|Overall Study|Death|0|||
131903638|NCT02227784|474933352|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
131649918|NCT01317875|474005382|FG009|Overall Study|Death|0|||
131649919|NCT01317875|474005373|FG000|Overall Study|Adverse Event|2|||
131649920|NCT01317875|474005374|FG001|Overall Study|Adverse Event|1|||
131649921|NCT01317875|474005375|FG002|Overall Study|Adverse Event|2|||
131903639|NCT02227784|474933353|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
131903640|NCT02227784|474933354|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
131903641|NCT02227784|474933355|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
131903642|NCT02227784|474933351|FG000|Open-Label Extension Phase (OLE)|Death|0|||
131649922|NCT01317875|474005376|FG003|Overall Study|Adverse Event|1|||
131649923|NCT01317875|474005377|FG004|Overall Study|Adverse Event|5|||
131649924|NCT01317875|474005378|FG005|Overall Study|Adverse Event|1|||
131649925|NCT01317875|474005379|FG006|Overall Study|Adverse Event|2|||
131649926|NCT01317875|474005380|FG007|Overall Study|Adverse Event|5|||
131903643|NCT02227784|474933352|FG001|Open-Label Extension Phase (OLE)|Death|0|||
131903644|NCT02227784|474933353|FG002|Open-Label Extension Phase (OLE)|Death|0|||
131803075|NCT01104662|474562074|FG007|Overall Study|Participant left investigator's care|0|||
131803076|NCT01104662|474562067|FG000|Overall Study|Reason not specified|3|||
131803077|NCT01104662|474562068|FG001|Overall Study|Reason not specified|3|||
131803078|NCT01104662|474562069|FG002|Overall Study|Reason not specified|0|||
131803079|NCT01104662|474562070|FG003|Overall Study|Reason not specified|0|||
131803080|NCT01104662|474562071|FG004|Overall Study|Reason not specified|0|||
131803081|NCT01104662|474562072|FG005|Overall Study|Reason not specified|1|||
131803082|NCT01104662|474562073|FG006|Overall Study|Reason not specified|0|||
131803083|NCT01104662|474562074|FG007|Overall Study|Reason not specified|0|||
131803084|NCT01104662|474562067|FG000|Overall Study|Randomized but not treated|3|||
131803085|NCT01104662|474562068|FG001|Overall Study|Randomized but not treated|4|||
131649927|NCT01317875|474005381|FG008|Overall Study|Adverse Event|0|||
131649928|NCT01317875|474005382|FG009|Overall Study|Adverse Event|0|||
131649929|NCT01200342|474005383|FG000|Overall Study|Disease Progression|1|||
131649930|NCT00953147|474005384|FG000|Overall Study|Adverse Event|8|||
131649931|NCT00953147|474005385|FG001|Overall Study|Adverse Event|16|||
131649932|NCT00953147|474005386|FG002|Overall Study|Adverse Event|6|||
131649933|NCT00953147|474005384|FG000|Overall Study|Protocol Violation|2|||
131649934|NCT00953147|474005385|FG001|Overall Study|Protocol Violation|8|||
131649935|NCT00953147|474005386|FG002|Overall Study|Protocol Violation|4|||
131649936|NCT00953147|474005384|FG000|Overall Study|Withdrawal by Subject|13|||
131649937|NCT00953147|474005385|FG001|Overall Study|Withdrawal by Subject|15|||
131649938|NCT00953147|474005386|FG002|Overall Study|Withdrawal by Subject|12|||
131649939|NCT00953147|474005384|FG000|Overall Study|Lost to Follow-up|8|||
131649940|NCT00953147|474005385|FG001|Overall Study|Lost to Follow-up|9|||
131649941|NCT00953147|474005386|FG002|Overall Study|Lost to Follow-up|4|||
131649942|NCT00953147|474005384|FG000|Overall Study|Physician Decision|2|||
131649943|NCT00953147|474005385|FG001|Overall Study|Physician Decision|7|||
131649944|NCT00953147|474005386|FG002|Overall Study|Physician Decision|3|||
131649945|NCT00953147|474005384|FG000|Overall Study|Other|4|||
131649946|NCT00953147|474005385|FG001|Overall Study|Other|11|||
131649947|NCT00953147|474005386|FG002|Overall Study|Other|13|||
131649948|NCT02514239|474005387|FG000|Overall Study|Refused to continue trial medication|0|||
131649949|NCT02514239|474005388|FG001|Overall Study|Refused to continue trial medication|0|||
131649950|NCT02514239|474005389|FG002|Overall Study|Refused to continue trial medication|0|||
131649951|NCT02514239|474005390|FG003|Overall Study|Refused to continue trial medication|0|||
131649952|NCT02514239|474005391|FG004|Overall Study|Refused to continue trial medication|0|||
131649953|NCT02514239|474005392|FG005|Overall Study|Refused to continue trial medication|0|||
131649954|NCT02514239|474005393|FG006|Overall Study|Refused to continue trial medication|0|||
131649955|NCT02514239|474005394|FG007|Overall Study|Refused to continue trial medication|0|||
131649956|NCT02514239|474005395|FG008|Overall Study|Refused to continue trial medication|0|||
131649957|NCT02514239|474005396|FG009|Overall Study|Refused to continue trial medication|1|||
131649958|NCT02514239|474005387|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649959|NCT02514239|474005388|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649960|NCT02514239|474005389|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649961|NCT02514239|474005390|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649962|NCT02514239|474005391|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649963|NCT02514239|474005392|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649964|NCT02514239|474005393|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649965|NCT02514239|474005394|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
131649966|NCT02514239|474005395|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
131649967|NCT02514239|474005396|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
131649968|NCT02514239|474005387|FG000|Overall Study|Not treated|0|||
131649969|NCT02514239|474005388|FG001|Overall Study|Not treated|1|||
131649970|NCT02514239|474005389|FG002|Overall Study|Not treated|0|||
131649971|NCT02514239|474005390|FG003|Overall Study|Not treated|0|||
131649972|NCT02514239|474005391|FG004|Overall Study|Not treated|0|||
131649973|NCT02514239|474005392|FG005|Overall Study|Not treated|0|||
131649974|NCT02514239|474005393|FG006|Overall Study|Not treated|0|||
131649975|NCT02514239|474005394|FG007|Overall Study|Not treated|0|||
131649976|NCT02514239|474005395|FG008|Overall Study|Not treated|0|||
131649977|NCT02514239|474005396|FG009|Overall Study|Not treated|0|||
131649978|NCT02514239|474005387|FG000|Overall Study|Other Adverse Events|2|||
131649979|NCT02514239|474005388|FG001|Overall Study|Other Adverse Events|0|||
131649980|NCT02514239|474005389|FG002|Overall Study|Other Adverse Events|0|||
131649981|NCT02514239|474005390|FG003|Overall Study|Other Adverse Events|1|||
131649982|NCT02514239|474005391|FG004|Overall Study|Other Adverse Events|0|||
131649983|NCT02514239|474005392|FG005|Overall Study|Other Adverse Events|1|||
131649984|NCT02514239|474005393|FG006|Overall Study|Other Adverse Events|0|||
131649985|NCT02514239|474005394|FG007|Overall Study|Other Adverse Events|1|||
131803086|NCT01104662|474562069|FG002|Overall Study|Randomized but not treated|1|||
131803087|NCT01104662|474562070|FG003|Overall Study|Randomized but not treated|0|||
131649986|NCT02514239|474005395|FG008|Overall Study|Other Adverse Events|2|||
131649987|NCT02514239|474005396|FG009|Overall Study|Other Adverse Events|0|||
131649988|NCT02514239|474005387|FG000|Overall Study|Progressive disease|3|||
131649989|NCT02514239|474005388|FG001|Overall Study|Progressive disease|3|||
131649990|NCT02514239|474005389|FG002|Overall Study|Progressive disease|2|||
131649991|NCT02514239|474005390|FG003|Overall Study|Progressive disease|2|||
131649992|NCT02514239|474005391|FG004|Overall Study|Progressive disease|3|||
131649993|NCT02514239|474005392|FG005|Overall Study|Progressive disease|3|||
131649994|NCT02514239|474005393|FG006|Overall Study|Progressive disease|4|||
131649995|NCT02514239|474005394|FG007|Overall Study|Progressive disease|2|||
131649996|NCT02514239|474005395|FG008|Overall Study|Progressive disease|5|||
131649997|NCT02514239|474005396|FG009|Overall Study|Progressive disease|0|||
131649998|NCT02763215|474005397|FG000|Overall Study|Participants withdrew from study|3|||
131649999|NCT02763215|474005397|FG000|Overall Study|Missed visit|1|||
131650000|NCT02763215|474005397|FG000|Overall Study|Visit outside visit-window|1|||
131650001|NCT02763215|474005397|FG000|Overall Study|Death|1|||
131650002|NCT02763215|474005397|FG000|Overall Study|Lost to Follow-up|1|||
131650003|NCT01483144|474005401|FG000|Overall Study|Adverse Event|9|||
131650004|NCT01483144|474005402|FG001|Overall Study|Adverse Event|4|||
131650005|NCT01483144|474005403|FG002|Overall Study|Adverse Event|6|||
131650006|NCT01483144|474005401|FG000|Overall Study|Withdrawal by Subject|0|||
131650007|NCT01483144|474005402|FG001|Overall Study|Withdrawal by Subject|2|||
131650008|NCT01483144|474005403|FG002|Overall Study|Withdrawal by Subject|5|||
131650009|NCT01483144|474005401|FG000|Overall Study|Physician Decision|1|||
131650010|NCT01483144|474005402|FG001|Overall Study|Physician Decision|0|||
131650011|NCT01483144|474005403|FG002|Overall Study|Physician Decision|0|||
131650012|NCT01483144|474005401|FG000|Overall Study|Lost to Follow-up|2|||
131650013|NCT01483144|474005402|FG001|Overall Study|Lost to Follow-up|4|||
131650014|NCT01483144|474005403|FG002|Overall Study|Lost to Follow-up|1|||
131650015|NCT01483144|474005401|FG000|Overall Study|Protocol Violation|3|||
131650016|NCT01483144|474005402|FG001|Overall Study|Protocol Violation|3|||
131650017|NCT01483144|474005403|FG002|Overall Study|Protocol Violation|3|||
131650018|NCT01375673|474005410|FG000|Overall Study|Withdrawal by Subject|0|||
131650019|NCT01375673|474005411|FG001|Overall Study|Withdrawal by Subject|1|||
131650020|NCT00079339|474005416|FG000|Overall Study|Adverse Event|1|||
131650021|NCT00079339|474005417|FG001|Overall Study|Adverse Event|7|||
131650022|NCT00079339|474005418|FG002|Overall Study|Adverse Event|2|||
131650023|NCT00079339|474005416|FG000|Overall Study|Death|1|||
131650024|NCT00079339|474005417|FG001|Overall Study|Death|0|||
131650025|NCT00079339|474005418|FG002|Overall Study|Death|0|||
131650026|NCT00079339|474005416|FG000|Overall Study|Non-compliance|0|||
131650027|NCT00079339|474005417|FG001|Overall Study|Non-compliance|0|||
131716128|NCT01485614|474238883|FG000|Weeks 20-54|Withdrawal by Subject|5|||
131716129|NCT01485614|474238884|FG001|Weeks 20-54|Withdrawal by Subject|3|||
131716130|NCT01485614|474238885|FG002|Weeks 20-54|Withdrawal by Subject|0|||
131716131|NCT01485614|474238886|FG003|Weeks 20-54|Withdrawal by Subject|0|||
131716132|NCT02210780|474238887|FG000|Overall Study|Adverse Event|0|||
131716133|NCT02210780|474238888|FG001|Overall Study|Adverse Event|5|||
131716134|NCT02210780|474238887|FG000|Overall Study|Lost to Follow-up|2|||
131716135|NCT02210780|474238888|FG001|Overall Study|Lost to Follow-up|1|||
131716136|NCT02210780|474238887|FG000|Overall Study|Withdrawal by Subject|1|||
131716137|NCT02210780|474238888|FG001|Overall Study|Withdrawal by Subject|1|||
131716138|NCT02210780|474238887|FG000|Overall Study|Physician Decision|1|||
131716139|NCT02210780|474238888|FG001|Overall Study|Physician Decision|0|||
131716140|NCT02210780|474238887|FG000|Overall Study|Protocol Violation|1|||
131716141|NCT02210780|474238888|FG001|Overall Study|Protocol Violation|0|||
131716142|NCT02210780|474238887|FG000|Overall Study|Other than specified above|0|||
131716143|NCT02210780|474238888|FG001|Overall Study|Other than specified above|1|||
131716144|NCT00942409|474238889|FG000|Overall Study|Lack of Efficacy|1|||
131716145|NCT00942409|474238889|FG000|Overall Study|study drug unavailable|2|||
131716146|NCT01486264|474238896|FG000|Overall Study|Death|1|||
131716147|NCT01486264|474238897|FG001|Overall Study|Death|1|||
131716148|NCT01486264|474238896|FG000|Overall Study|Adverse Event|3|||
131716149|NCT01486264|474238897|FG001|Overall Study|Adverse Event|3|||
131716150|NCT01486264|474238896|FG000|Overall Study|Lack of Efficacy|6|||
131716151|NCT01486264|474238897|FG001|Overall Study|Lack of Efficacy|10|||
131716152|NCT01486264|474238896|FG000|Overall Study|Withdrawal by Subject|7|||
131650028|NCT00079339|474005418|FG002|Overall Study|Non-compliance|1|||
131650029|NCT00079339|474005416|FG000|Overall Study|Withdrawal by Subject|0|||
131650030|NCT00079339|474005417|FG001|Overall Study|Withdrawal by Subject|4|||
131650031|NCT00079339|474005418|FG002|Overall Study|Withdrawal by Subject|1|||
131650032|NCT00079339|474005416|FG000|Overall Study|Disease progression|3|||
131650033|NCT00079339|474005417|FG001|Overall Study|Disease progression|28|||
131650034|NCT00079339|474005418|FG002|Overall Study|Disease progression|2|||
131716153|NCT01486264|474238897|FG001|Overall Study|Withdrawal by Subject|18|||
131716154|NCT01486264|474238896|FG000|Overall Study|Physician Decision|1|||
131716155|NCT01486264|474238897|FG001|Overall Study|Physician Decision|1|||
131716156|NCT01486264|474238896|FG000|Overall Study|Protocol Violation|3|||
131716157|NCT01486264|474238897|FG001|Overall Study|Protocol Violation|0|||
131650035|NCT00520845|474005419|FG000|Overall Study|Death|3|||
131650036|NCT00520845|474005419|FG000|Overall Study|Adverse Event|4|||
131903645|NCT02227784|474933354|FG003|Open-Label Extension Phase (OLE)|Death|0|||
131903646|NCT02227784|474933355|FG004|Open-Label Extension Phase (OLE)|Death|1|||
131903647|NCT02227784|474933351|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
131903648|NCT02227784|474933352|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
131903649|NCT02227784|474933353|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
131903650|NCT02227784|474933354|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
131903651|NCT02227784|474933355|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
131903652|NCT02227784|474933351|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
131903653|NCT02227784|474933352|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
131903654|NCT02227784|474933353|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
131903655|NCT02227784|474933354|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
131903656|NCT02227784|474933355|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
131903657|NCT02155699|474933356|FG000|Overall Study|Withdrawal by Subject|0|||
131903658|NCT02155699|474933357|FG001|Overall Study|Withdrawal by Subject|3|||
131903659|NCT02155699|474933358|FG002|Overall Study|Withdrawal by Subject|6|||
131903660|NCT02155699|474933359|FG003|Overall Study|Withdrawal by Subject|1|||
131903661|NCT02155699|474933356|FG000|Overall Study|Lost to Follow-up|0|||
131903662|NCT02155699|474933357|FG001|Overall Study|Lost to Follow-up|0|||
131903663|NCT02155699|474933358|FG002|Overall Study|Lost to Follow-up|0|||
131903664|NCT02155699|474933359|FG003|Overall Study|Lost to Follow-up|3|||
131903665|NCT02155699|474933356|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
131903666|NCT02155699|474933357|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
131903667|NCT02155699|474933358|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
131903668|NCT02155699|474933359|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
131903669|NCT00102596|474933360|FG000|Part A|Screen failures|6|||
131903670|NCT00102596|474933361|FG001|Part A|Screen failures|0|||
131903671|NCT00102596|474933360|FG000|Part A|Adverse Event|1|||
131650037|NCT00520845|474005419|FG000|Overall Study|Disease Progression, relapse|13|||
131650038|NCT00520845|474005419|FG000|Overall Study|Withdrawal by Subject|1|||
131650039|NCT00520845|474005419|FG000|Overall Study|Alternative Therapy|1|||
131650040|NCT03274453|474005420|FG000|Overall Study|Lost to Follow-up|2|||
131650041|NCT03274453|474005421|FG001|Overall Study|Lost to Follow-up|5|||
131650042|NCT03274453|474005422|FG002|Overall Study|Lost to Follow-up|4|||
131650043|NCT03274453|474005423|FG003|Overall Study|Lost to Follow-up|1|||
131650044|NCT03274453|474005420|FG000|Overall Study|Physician Decision|2|||
131650045|NCT03274453|474005421|FG001|Overall Study|Physician Decision|0|||
131650046|NCT03274453|474005422|FG002|Overall Study|Physician Decision|0|||
131650047|NCT03274453|474005423|FG003|Overall Study|Physician Decision|3|||
131650048|NCT03274453|474005420|FG000|Overall Study|Surgery Cancelled|0|||
131650049|NCT03274453|474005421|FG001|Overall Study|Surgery Cancelled|1|||
131650050|NCT03274453|474005422|FG002|Overall Study|Surgery Cancelled|0|||
131650051|NCT03274453|474005423|FG003|Overall Study|Surgery Cancelled|0|||
131650052|NCT00945672|474005426|FG000|Overall Study|Withdrawal by Subject|0|||
131650053|NCT00945672|474005427|FG001|Overall Study|Withdrawal by Subject|0|||
131650054|NCT00945672|474005428|FG002|Overall Study|Withdrawal by Subject|0|||
131650055|NCT00945672|474005429|FG003|Overall Study|Withdrawal by Subject|1|||
131650056|NCT03845140|474005432|FG000|Overall Study|Participant travelled outside study area|0|||
131650057|NCT03845140|474005433|FG001|Overall Study|Participant travelled outside study area|1|||
131650058|NCT03845140|474005434|FG002|Overall Study|Participant travelled outside study area|0|||
131650059|NCT03845140|474005435|FG003|Overall Study|Participant travelled outside study area|0|||
131650060|NCT03845140|474005436|FG004|Overall Study|Participant travelled outside study area|0|||
131650061|NCT03845140|474005437|FG005|Overall Study|Participant travelled outside study area|0|||
131650062|NCT01592045|474005438|FG000|Overall Study|Disease Progression|1|||
131650063|NCT01592045|474005439|FG001|Overall Study|Disease Progression|1|||
131650064|NCT01592045|474005438|FG000|Overall Study|Adverse Event|1|||
131650065|NCT01592045|474005439|FG001|Overall Study|Adverse Event|1|||
131650066|NCT01592045|474005438|FG000|Overall Study|Withdrawal by Subject|1|||
131650067|NCT01592045|474005439|FG001|Overall Study|Withdrawal by Subject|0|||
131650068|NCT01592045|474005438|FG000|Overall Study|Moved out of country|2|||
131650069|NCT01592045|474005439|FG001|Overall Study|Moved out of country|0|||
131650070|NCT01681992|474005442|FG000|Overall Study|Adverse Event|3|||
131650071|NCT01681992|474005443|FG001|Overall Study|Adverse Event|2|||
131650072|NCT01681992|474005444|FG002|Overall Study|Adverse Event|3|||
131650073|NCT01681992|474005442|FG000|Overall Study|Lost to Follow-up|36|||
131650074|NCT01681992|474005443|FG001|Overall Study|Lost to Follow-up|38|||
131650075|NCT01681992|474005444|FG002|Overall Study|Lost to Follow-up|53|||
131650076|NCT01681992|474005442|FG000|Overall Study|As Per Sponsor Decision|0|||
131650077|NCT01681992|474005443|FG001|Overall Study|As Per Sponsor Decision|0|||
131650078|NCT01681992|474005444|FG002|Overall Study|As Per Sponsor Decision|1|||
131650079|NCT01681992|474005442|FG000|Overall Study|Protocol Violation|0|||
131650080|NCT01681992|474005443|FG001|Overall Study|Protocol Violation|0|||
131650081|NCT01681992|474005444|FG002|Overall Study|Protocol Violation|1|||
131650082|NCT01681992|474005442|FG000|Overall Study|Withdrawal by Subject|27|||
131650083|NCT01681992|474005443|FG001|Overall Study|Withdrawal by Subject|30|||
131650084|NCT01681992|474005444|FG002|Overall Study|Withdrawal by Subject|25|||
131650085|NCT01661205|474005449|FG000|Overall Study|Physician Decision|2|||
131650086|NCT03111095|474005452|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
131650087|NCT03111095|474005453|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
131650088|NCT03111095|474005452|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
131650089|NCT03111095|474005453|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
131650090|NCT00504075|474005454|FG000|Overall Study|Adverse Event|1|||
131650091|NCT00504075|474005454|FG000|Overall Study|Lost to Follow-up|5|||
131650092|NCT00504075|474005454|FG000|Overall Study|Withdrawal by Subject|1|||
131650093|NCT00504075|474005454|FG000|Overall Study|Required other therapeutic intervention|1|||
131650094|NCT03812029|474005461|FG000|Overall Study|Protocol Violation|1|||
131650095|NCT03812029|474005462|FG001|Overall Study|Protocol Violation|0|||
131650096|NCT03812029|474005463|FG002|Overall Study|Protocol Violation|0|||
131650097|NCT03812029|474005464|FG003|Overall Study|Protocol Violation|1|||
131650098|NCT03812029|474005465|FG004|Overall Study|Protocol Violation|0|||
131650099|NCT03812029|474005461|FG000|Overall Study|Withdrawal by Subject|1|||
131650100|NCT03812029|474005462|FG001|Overall Study|Withdrawal by Subject|0|||
131650101|NCT03812029|474005463|FG002|Overall Study|Withdrawal by Subject|0|||
131650102|NCT03812029|474005464|FG003|Overall Study|Withdrawal by Subject|2|||
131650103|NCT03812029|474005465|FG004|Overall Study|Withdrawal by Subject|2|||
131650104|NCT03812029|474005461|FG000|Overall Study|Stopping rules|0|||
131650105|NCT03812029|474005462|FG001|Overall Study|Stopping rules|1|||
131650106|NCT03812029|474005463|FG002|Overall Study|Stopping rules|0|||
131650107|NCT03812029|474005464|FG003|Overall Study|Stopping rules|0|||
131650108|NCT03812029|474005465|FG004|Overall Study|Stopping rules|0|||
131650109|NCT03812029|474005461|FG000|Overall Study|Adverse Event|0|||
131650110|NCT03812029|474005462|FG001|Overall Study|Adverse Event|9|||
131650111|NCT03812029|474005463|FG002|Overall Study|Adverse Event|0|||
131650112|NCT03812029|474005464|FG003|Overall Study|Adverse Event|3|||
131650113|NCT03812029|474005465|FG004|Overall Study|Adverse Event|5|||
131650114|NCT03812029|474005461|FG000|Overall Study|Lost to Follow-up|0|||
131650115|NCT03812029|474005462|FG001|Overall Study|Lost to Follow-up|0|||
131650116|NCT03812029|474005463|FG002|Overall Study|Lost to Follow-up|0|||
131650117|NCT03812029|474005464|FG003|Overall Study|Lost to Follow-up|0|||
131650118|NCT03812029|474005465|FG004|Overall Study|Lost to Follow-up|3|||
131650119|NCT03149042|474005466|FG000|Overall Study|Invasive FFR not performed|21|||
131650120|NCT03149042|474005466|FG000|Overall Study|Poor CT Image Quality|1|||
131650121|NCT03149042|474005466|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
131650122|NCT00732992|474005475|FG000|Overall Study|Adverse Event|1|||
131650123|NCT00732992|474005476|FG001|Overall Study|Adverse Event|1|||
131650124|NCT00732992|474005475|FG000|Overall Study|Objective Progression or Relapse|3|||
131650125|NCT00732992|474005476|FG001|Overall Study|Objective Progression or Relapse|5|||
131650126|NCT00732992|474005475|FG000|Overall Study|Global Deterioration of Health Status|1|||
131650127|NCT00732992|474005476|FG001|Overall Study|Global Deterioration of Health Status|0|||
131650128|NCT00732992|474005475|FG000|Overall Study|Withdrawal by Subject|1|||
131650129|NCT00732992|474005476|FG001|Overall Study|Withdrawal by Subject|0|||
131650130|NCT02344342|474005477|FG000|Overall Study|Industry partner dropped out|11|||
131650131|NCT02344342|474005478|FG001|Overall Study|Industry partner dropped out|9|||
131650132|NCT02344342|474005479|FG002|Overall Study|Industry partner dropped out|14|||
131650133|NCT02344342|474005480|FG003|Overall Study|Industry partner dropped out|10|||
131650134|NCT03690427|474005484|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
131650135|NCT03690427|474005485|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
131650136|NCT02609672|474005489|FG000|Overall Study|Lost to Follow-up|3|||
131650137|NCT02609672|474005490|FG001|Overall Study|Lost to Follow-up|1|||
131650138|NCT02956837|474005492|FG000|Overall Study|Serious Adverse Events|0|||
131650139|NCT02956837|474005493|FG001|Overall Study|Serious Adverse Events|1|||
131650140|NCT02956837|474005494|FG002|Overall Study|Serious Adverse Events|0|||
131650141|NCT02956837|474005495|FG003|Overall Study|Serious Adverse Events|0|||
131650142|NCT02956837|474005492|FG000|Overall Study|Withdrawal by Subject|0|||
131650143|NCT02956837|474005493|FG001|Overall Study|Withdrawal by Subject|1|||
131650144|NCT02956837|474005494|FG002|Overall Study|Withdrawal by Subject|0|||
131650145|NCT02956837|474005495|FG003|Overall Study|Withdrawal by Subject|3|||
131650146|NCT02956837|474005492|FG000|Overall Study|Lost to Follow-up|0|||
131650147|NCT02956837|474005493|FG001|Overall Study|Lost to Follow-up|1|||
131803088|NCT01104662|474562071|FG004|Overall Study|Randomized but not treated|0|||
131448117|NCT01716234|473270877|FG003|Overall Study|Lack of Efficacy|1|||
131650148|NCT02956837|474005494|FG002|Overall Study|Lost to Follow-up|2|||
131650149|NCT02956837|474005495|FG003|Overall Study|Lost to Follow-up|0|||
131650150|NCT02597712|474005496|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
131650151|NCT02597712|474005497|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
131650152|NCT02597712|474005496|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
131650153|NCT02597712|474005497|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
131650154|NCT02597712|474005496|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
131650155|NCT02597712|474005497|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
131716158|NCT01486264|474238896|FG000|Overall Study|Lost to Follow-up|3|||
131716159|NCT01486264|474238897|FG001|Overall Study|Lost to Follow-up|2|||
131716160|NCT01486264|474238896|FG000|Overall Study|Other|5|||
131716161|NCT01486264|474238897|FG001|Overall Study|Other|11|||
131716162|NCT01486264|474238896|FG000|Overall Study|Not treated|0|||
131716163|NCT01486264|474238897|FG001|Overall Study|Not treated|1|||
131716164|NCT03584009|474238898|FG000|Overall Study|Death|25|||
131716165|NCT03584009|474238899|FG001|Overall Study|Death|18|||
131716166|NCT03584009|474238898|FG000|Overall Study|Lost to Follow-up|0|||
131716167|NCT03584009|474238899|FG001|Overall Study|Lost to Follow-up|1|||
131716168|NCT03584009|474238898|FG000|Overall Study|Physician Decision|1|||
131716169|NCT03584009|474238899|FG001|Overall Study|Physician Decision|1|||
131716170|NCT03584009|474238898|FG000|Overall Study|Study Terminated by Sponsor|22|||
131716171|NCT03584009|474238899|FG001|Overall Study|Study Terminated by Sponsor|30|||
131716172|NCT03584009|474238898|FG000|Overall Study|Withdrawal by Subject|3|||
131716173|NCT03584009|474238899|FG001|Overall Study|Withdrawal by Subject|2|||
131716174|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
131716175|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
131716176|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
131716177|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
131803089|NCT01104662|474562072|FG005|Overall Study|Randomized but not treated|1|||
131803090|NCT01104662|474562073|FG006|Overall Study|Randomized but not treated|0|||
131803091|NCT01104662|474562074|FG007|Overall Study|Randomized but not treated|0|||
131803092|NCT01706926|474562075|FG000|Overall Study|Lost to Follow-up|0|||
131803093|NCT01706926|474562076|FG001|Overall Study|Lost to Follow-up|0|||
131803094|NCT01706926|474562077|FG002|Overall Study|Lost to Follow-up|1|||
131803095|NCT01706926|474562078|FG003|Overall Study|Lost to Follow-up|0|||
131803096|NCT01706926|474562075|FG000|Overall Study|Withdrawal by Subject|2|||
131803097|NCT01706926|474562076|FG001|Overall Study|Withdrawal by Subject|0|||
131803098|NCT01706926|474562077|FG002|Overall Study|Withdrawal by Subject|1|||
131803099|NCT01706926|474562078|FG003|Overall Study|Withdrawal by Subject|2|||
131803100|NCT01706926|474562075|FG000|Overall Study|Other|4|||
131803101|NCT01706926|474562076|FG001|Overall Study|Other|4|||
131803102|NCT01706926|474562077|FG002|Overall Study|Other|4|||
131803103|NCT01706926|474562078|FG003|Overall Study|Other|3|||
131803104|NCT01108094|474563597|FG000|Overall Study|Adverse Event|2|||
131803105|NCT01108094|474563598|FG001|Overall Study|Adverse Event|0|||
131803106|NCT01108094|474563599|FG002|Overall Study|Adverse Event|0|||
131803107|NCT01108094|474563600|FG003|Overall Study|Adverse Event|0|||
131803108|NCT01108094|474563597|FG000|Overall Study|Withdrawal by Subject|1|||
131803109|NCT01108094|474563598|FG001|Overall Study|Withdrawal by Subject|0|||
131803110|NCT01108094|474563599|FG002|Overall Study|Withdrawal by Subject|0|||
131803111|NCT01108094|474563600|FG003|Overall Study|Withdrawal by Subject|0|||
131803112|NCT01519661|474563607|FG000|Overall Study|Protocol deviation|6|||
131803113|NCT01519661|474563607|FG000|Overall Study|Lost to Follow-up|3|||
131803114|NCT01519661|474563607|FG000|Overall Study|Withdrawal by Subject|17|||
131803115|NCT01519661|474563607|FG000|Overall Study|Lack of Efficacy|6|||
131803116|NCT01519661|474563607|FG000|Overall Study|Adverse Event|29|||
131803117|NCT01139047|474563608|FG000|Overall Study|Withdrawal by Subject|1|||
131803118|NCT05628675|474563609|FG000|Overall Study|Lost to Follow-up|2|||
131803119|NCT05628675|474563609|FG000|Overall Study|Withdrawal by Subject|1|||
131803120|NCT01941095|474563610|FG000|Overall Study|Insufficient therapeutic response|13|||
131803121|NCT01941095|474563610|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
131803122|NCT01941095|474563610|FG000|Overall Study|Adverse Event|11|||
131803123|NCT01941095|474563610|FG000|Overall Study|Physician Decision|3|||
131803124|NCT01941095|474563610|FG000|Overall Study|Withdrawal by Subject|17|||
131803125|NCT01941095|474563610|FG000|Overall Study|Lost to Follow-up|10|||
131803126|NCT02918877|474563613|FG000|Overall Study|Withdrawal by Subject|2|||
131803127|NCT02918877|474563614|FG001|Overall Study|Withdrawal by Subject|2|||
131803128|NCT02918877|474563613|FG000|Overall Study|Surgery cancelled|1|||
131803129|NCT02918877|474563614|FG001|Overall Study|Surgery cancelled|0|||
131803130|NCT02918877|474563613|FG000|Overall Study|Physician Decision|1|||
131803131|NCT02918877|474563614|FG001|Overall Study|Physician Decision|0|||
131803132|NCT02918877|474563613|FG000|Overall Study|Received intraoperative steroids|1|||
131803133|NCT02918877|474563614|FG001|Overall Study|Received intraoperative steroids|0|||
131803134|NCT02918877|474563613|FG000|Overall Study|Unable to obtain lab samples|1|||
131803135|NCT02918877|474563614|FG001|Overall Study|Unable to obtain lab samples|0|||
131803136|NCT02918877|474563613|FG000|Overall Study|Unsafe to perform BAL|0|||
131803137|NCT02918877|474563614|FG001|Overall Study|Unsafe to perform BAL|1|||
131803138|NCT05818137|474563615|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
131803139|NCT05818137|474563615|FG000|Extension Treatment Period|Ongoing participants|44|||
131803140|NCT00048568|474563618|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
131803141|NCT00048568|474563619|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
131803142|NCT00048568|474563620|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
131803143|NCT00048568|474563618|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
131803144|NCT00048568|474563619|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
131803145|NCT00048568|474563620|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
131803146|NCT00048568|474563618|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
131803147|NCT00048568|474563619|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
131803148|NCT00048568|474563620|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
131803149|NCT00048568|474563618|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
131803150|NCT00048568|474563619|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
131803151|NCT00048568|474563620|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
131650156|NCT01727505|474005498|FG000|First 24 Hours|Adverse Event|0|||
131650157|NCT01727505|474005499|FG001|First 24 Hours|Adverse Event|1|||
131650158|NCT01727505|474005498|FG000|Second 24 Hours|Missing data|0|||
131650159|NCT01727505|474005499|FG001|Second 24 Hours|Missing data|1|||
131650160|NCT01441635|474005503|FG000|Overall Study|Adverse Event|4|||
131650161|NCT01441635|474005504|FG001|Overall Study|Adverse Event|3|||
131650162|NCT01441635|474005505|FG002|Overall Study|Adverse Event|1|||
131650163|NCT01441635|474005506|FG003|Overall Study|Adverse Event|5|||
131650164|NCT01441635|474005507|FG004|Overall Study|Adverse Event|1|||
131650165|NCT01441635|474005508|FG005|Overall Study|Adverse Event|2|||
131650166|NCT01441635|474005509|FG006|Overall Study|Adverse Event|2|||
131650167|NCT01441635|474005510|FG007|Overall Study|Adverse Event|2|||
131650168|NCT01441635|474005511|FG008|Overall Study|Adverse Event|1|||
131650169|NCT01441635|474005512|FG009|Overall Study|Adverse Event|0|||
131650170|NCT01441635|474005503|FG000|Overall Study|Withdrawal by Subject|1|||
131650171|NCT01441635|474005504|FG001|Overall Study|Withdrawal by Subject|1|||
131650172|NCT01441635|474005505|FG002|Overall Study|Withdrawal by Subject|0|||
131650173|NCT01441635|474005506|FG003|Overall Study|Withdrawal by Subject|1|||
131650174|NCT01441635|474005507|FG004|Overall Study|Withdrawal by Subject|0|||
131650175|NCT01441635|474005508|FG005|Overall Study|Withdrawal by Subject|0|||
131650176|NCT01441635|474005509|FG006|Overall Study|Withdrawal by Subject|2|||
131650177|NCT01441635|474005510|FG007|Overall Study|Withdrawal by Subject|0|||
131650178|NCT01441635|474005511|FG008|Overall Study|Withdrawal by Subject|1|||
131650179|NCT01441635|474005512|FG009|Overall Study|Withdrawal by Subject|1|||
131650180|NCT01441635|474005503|FG000|Overall Study|Lost to Follow-up|0|||
131650181|NCT01441635|474005504|FG001|Overall Study|Lost to Follow-up|1|||
131650182|NCT01441635|474005505|FG002|Overall Study|Lost to Follow-up|1|||
131650183|NCT01441635|474005506|FG003|Overall Study|Lost to Follow-up|1|||
131650184|NCT01441635|474005507|FG004|Overall Study|Lost to Follow-up|1|||
131650185|NCT01441635|474005508|FG005|Overall Study|Lost to Follow-up|3|||
131650186|NCT01441635|474005509|FG006|Overall Study|Lost to Follow-up|1|||
131650187|NCT01441635|474005510|FG007|Overall Study|Lost to Follow-up|1|||
131650188|NCT01441635|474005511|FG008|Overall Study|Lost to Follow-up|0|||
131650189|NCT01441635|474005512|FG009|Overall Study|Lost to Follow-up|1|||
131650190|NCT01441635|474005503|FG000|Overall Study|Noncompliance|0|||
131650191|NCT01441635|474005504|FG001|Overall Study|Noncompliance|1|||
131650192|NCT01441635|474005505|FG002|Overall Study|Noncompliance|0|||
131650193|NCT01441635|474005506|FG003|Overall Study|Noncompliance|0|||
131650194|NCT01441635|474005507|FG004|Overall Study|Noncompliance|0|||
131650195|NCT01441635|474005508|FG005|Overall Study|Noncompliance|0|||
131650196|NCT01441635|474005509|FG006|Overall Study|Noncompliance|1|||
131650197|NCT01441635|474005510|FG007|Overall Study|Noncompliance|0|||
131650198|NCT01441635|474005511|FG008|Overall Study|Noncompliance|0|||
131650199|NCT01441635|474005512|FG009|Overall Study|Noncompliance|0|||
131650200|NCT01441635|474005503|FG000|Overall Study|Surgery or Invasive Intervention|0|||
131650201|NCT01441635|474005504|FG001|Overall Study|Surgery or Invasive Intervention|0|||
131650202|NCT01441635|474005505|FG002|Overall Study|Surgery or Invasive Intervention|1|||
131650203|NCT01441635|474005506|FG003|Overall Study|Surgery or Invasive Intervention|0|||
131650204|NCT01441635|474005507|FG004|Overall Study|Surgery or Invasive Intervention|0|||
131650205|NCT01441635|474005508|FG005|Overall Study|Surgery or Invasive Intervention|0|||
131650206|NCT01441635|474005509|FG006|Overall Study|Surgery or Invasive Intervention|0|||
131650207|NCT01441635|474005510|FG007|Overall Study|Surgery or Invasive Intervention|0|||
131650208|NCT01441635|474005511|FG008|Overall Study|Surgery or Invasive Intervention|0|||
131448118|NCT01716234|473270878|FG004|Overall Study|Lack of Efficacy|0|||
131650209|NCT01441635|474005512|FG009|Overall Study|Surgery or Invasive Intervention|0|||
131650210|NCT01441635|474005503|FG000|Overall Study|Received Exclusionary Medication|1|||
131650211|NCT01441635|474005504|FG001|Overall Study|Received Exclusionary Medication|0|||
131650212|NCT01441635|474005505|FG002|Overall Study|Received Exclusionary Medication|0|||
131650213|NCT01441635|474005506|FG003|Overall Study|Received Exclusionary Medication|0|||
131650214|NCT01441635|474005507|FG004|Overall Study|Received Exclusionary Medication|0|||
131650215|NCT01441635|474005508|FG005|Overall Study|Received Exclusionary Medication|0|||
131650216|NCT01441635|474005509|FG006|Overall Study|Received Exclusionary Medication|0|||
131650217|NCT01441635|474005510|FG007|Overall Study|Received Exclusionary Medication|0|||
131650218|NCT01441635|474005511|FG008|Overall Study|Received Exclusionary Medication|0|||
131650219|NCT01441635|474005512|FG009|Overall Study|Received Exclusionary Medication|0|||
131650220|NCT01441635|474005503|FG000|Overall Study|Other|0|||
131650221|NCT01441635|474005504|FG001|Overall Study|Other|0|||
131650222|NCT01441635|474005505|FG002|Overall Study|Other|0|||
131650223|NCT01441635|474005506|FG003|Overall Study|Other|0|||
131650224|NCT01441635|474005507|FG004|Overall Study|Other|0|||
131650225|NCT01441635|474005508|FG005|Overall Study|Other|0|||
131448119|NCT01716234|473270879|FG005|Overall Study|Lack of Efficacy|0|||
131650226|NCT01441635|474005509|FG006|Overall Study|Other|0|||
131650227|NCT01441635|474005510|FG007|Overall Study|Other|1|||
131650228|NCT01441635|474005511|FG008|Overall Study|Other|0|||
131650229|NCT01441635|474005512|FG009|Overall Study|Other|0|||
131650230|NCT02637323|474005513|FG000|Overall Study|Lost to Follow-up|2|||
131650231|NCT02637323|474005514|FG001|Overall Study|Lost to Follow-up|0|||
131650232|NCT02637323|474005513|FG000|Overall Study|Protocol Violation|0|||
131650233|NCT02637323|474005514|FG001|Overall Study|Protocol Violation|1|||
131650234|NCT01825577|474005515|FG000|Overall Study|Physician Decision|2|||
131650235|NCT01825577|474005515|FG000|Overall Study|Withdrawal by Subject|1|||
131650236|NCT01825577|474005515|FG000|Overall Study|Withdrawn by family members|2|||
131650237|NCT01825577|474005515|FG000|Overall Study|Lack of Efficacy|3|||
131650238|NCT03274895|474005516|FG000|Overall Study|Lack of Efficacy|1|||
131650239|NCT03274895|474005517|FG001|Overall Study|Lack of Efficacy|0|||
131650240|NCT03274895|474005516|FG000|Overall Study|Adverse Event|8|||
131650241|NCT03274895|474005517|FG001|Overall Study|Adverse Event|7|||
131650242|NCT03274895|474005516|FG000|Overall Study|Lost to Follow-up|1|||
131650243|NCT03274895|474005517|FG001|Overall Study|Lost to Follow-up|0|||
131650244|NCT03274895|474005516|FG000|Overall Study|Diagnosis not confirmed|3|||
131650245|NCT03274895|474005517|FG001|Overall Study|Diagnosis not confirmed|4|||
131650246|NCT01245374|474005529|FG000|Overall Study|Protocol Violation|1|||
131650247|NCT01245374|474005529|FG000|Overall Study|Withdrawal by Subject|3|||
131650248|NCT04954326|474005530|FG000|Overall Study|Protocol Violation|0|||
131650249|NCT04954326|474005531|FG001|Overall Study|Protocol Violation|1|||
131650250|NCT04954326|474005530|FG000|Overall Study|Death|0|||
131650251|NCT04954326|474005531|FG001|Overall Study|Death|2|||
131650252|NCT04954326|474005530|FG000|Overall Study|Physician Decision|0|||
131650253|NCT04954326|474005531|FG001|Overall Study|Physician Decision|1|||
131650254|NCT04982575|474005532|FG000|Overall Study|Withdrawal by Subject|2|||
131650255|NCT04982575|474005533|FG001|Overall Study|Withdrawal by Subject|0|||
131650256|NCT04982575|474005534|FG002|Overall Study|Withdrawal by Subject|2|||
131650257|NCT01151423|474005535|FG000|Overall Study|Study terminated by Sponsor|9|||
131650258|NCT01151423|474005536|FG001|Overall Study|Study terminated by Sponsor|10|||
131650259|NCT01151423|474005535|FG000|Overall Study|Protocol Violation|0|||
131650260|NCT01151423|474005536|FG001|Overall Study|Protocol Violation|1|||
131650261|NCT01151423|474005535|FG000|Overall Study|Physician Decision|1|||
131650262|NCT01151423|474005536|FG001|Overall Study|Physician Decision|1|||
131650263|NCT01151423|474005535|FG000|Overall Study|Pregnancy|0|||
131650264|NCT01151423|474005536|FG001|Overall Study|Pregnancy|1|||
131650265|NCT01151423|474005535|FG000|Overall Study|Death|0|||
131650266|NCT01151423|474005536|FG001|Overall Study|Death|1|||
131650267|NCT01151423|474005535|FG000|Overall Study|Adverse Event|3|||
131650268|NCT01151423|474005536|FG001|Overall Study|Adverse Event|0|||
131650269|NCT01151423|474005535|FG000|Overall Study|Withdrawal by Subject|1|||
131650270|NCT01151423|474005536|FG001|Overall Study|Withdrawal by Subject|3|||
131650271|NCT01151423|474005535|FG000|Overall Study|Lost to Follow-up|1|||
131650272|NCT01151423|474005536|FG001|Overall Study|Lost to Follow-up|0|||
131650273|NCT01151423|474005535|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
131650274|NCT01151423|474005536|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
131650275|NCT01151423|474005535|FG000|Overall Study|Participated in other clinical trial|1|||
131650276|NCT01151423|474005536|FG001|Overall Study|Participated in other clinical trial|0|||
131650277|NCT00475228|474005537|FG000|Overall Study|Lost to Follow-up|17|||
131650278|NCT00475228|474005538|FG001|Overall Study|Lost to Follow-up|17|||
131650279|NCT01183390|474007666|FG000|First Intervention|Adverse Event|0|||
131650280|NCT01183390|474007667|FG001|First Intervention|Adverse Event|1|||
131650281|NCT02358668|474007668|FG000|Overall Study|Adverse Event|2|||
131650282|NCT02358668|474007669|FG001|Overall Study|Adverse Event|0|||
131650283|NCT02358668|474007670|FG002|Overall Study|Adverse Event|0|||
131650284|NCT02358668|474007668|FG000|Overall Study|Withdrawal by Subject|0|||
131650285|NCT02358668|474007669|FG001|Overall Study|Withdrawal by Subject|1|||
131650286|NCT02358668|474007670|FG002|Overall Study|Withdrawal by Subject|0|||
131650287|NCT01730950|474007673|FG000|Overall Study|Protocol Violation|6|||
131650288|NCT01730950|474007674|FG001|Overall Study|Protocol Violation|6|||
131716178|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
131716179|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
131716180|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
131716181|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
131716182|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
131716183|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
131716184|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
131716185|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
131650289|NCT03258723|474007677|FG000|Overall Study|COVID Interruption of study|54|||
131650290|NCT03258723|474007677|FG000|Overall Study|Lost to Follow-up|8|||
131650291|NCT01107899|474007681|FG000|Overall Study|Physician Decision|5|||
131650292|NCT01107899|474007682|FG001|Overall Study|Physician Decision|0|||
131650293|NCT01107899|474007683|FG002|Overall Study|Physician Decision|3|||
131650294|NCT01107899|474007681|FG000|Overall Study|Withdrawal by Subject|0|||
131650295|NCT01107899|474007682|FG001|Overall Study|Withdrawal by Subject|0|||
131650296|NCT01107899|474007683|FG002|Overall Study|Withdrawal by Subject|1|||
131650297|NCT00953771|474007684|FG000|Overall Study|Death|1|||
131650298|NCT00953771|474007685|FG001|Overall Study|Death|0|||
131650299|NCT00974259|474007686|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
131650300|NCT00974259|474007687|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
131650301|NCT00944229|474007690|FG000|Overall Study|Withdrawal by Subject|11|||
131650302|NCT00944229|474007690|FG000|Overall Study|Physician Decision|14|||
131650303|NCT01810939|474007691|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
131650304|NCT01810939|474007692|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
131650305|NCT01810939|474007693|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
131650306|NCT01810939|474007691|FG000|Part A Treatment Period|Protocol Violation|2|||
131650307|NCT01810939|474007692|FG001|Part A Treatment Period|Protocol Violation|0|||
131650308|NCT01810939|474007693|FG002|Part A Treatment Period|Protocol Violation|0|||
131650309|NCT01810939|474007691|FG000|Part A Treatment Period|Adverse Event|10|||
131650310|NCT01810939|474007692|FG001|Part A Treatment Period|Adverse Event|0|||
131650311|NCT01810939|474007693|FG002|Part A Treatment Period|Adverse Event|0|||
131650312|NCT01810939|474007691|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
131650313|NCT01810939|474007692|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
131650314|NCT01810939|474007693|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
131650315|NCT01810939|474007691|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
131650316|NCT01810939|474007692|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
131650317|NCT01810939|474007693|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
131650318|NCT01810939|474007691|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
131650319|NCT01810939|474007692|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
131650320|NCT01810939|474007693|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
131650321|NCT01810939|474007691|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
131650322|NCT01810939|474007692|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
131650323|NCT01810939|474007693|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
131650324|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
131650325|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
131650326|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
131650327|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
131650328|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
131650329|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
131650330|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
131650331|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
131650332|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
131650333|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
131650334|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
131650335|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
131650336|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
131650337|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
131650338|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
131650339|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
131650340|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
131650341|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
131650342|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
131650343|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
131650344|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
131650345|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
131650346|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
131650347|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
131650348|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
131650349|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
131650350|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
131650351|NCT01810939|474007691|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
131650352|NCT01810939|474007692|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
131650353|NCT01810939|474007693|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
131650354|NCT00884650|474007696|FG000|Overall Study|Did not return complete pain diaries|7|||
131650355|NCT00884650|474007697|FG001|Overall Study|Did not return complete pain diaries|7|||
131650356|NCT00884650|474007696|FG000|Overall Study|Admitted Post-Op|1|||
131650357|NCT00884650|474007697|FG001|Overall Study|Admitted Post-Op|0|||
131650358|NCT00884650|474007696|FG000|Overall Study|Femoral Stress Fracture|1|||
131650359|NCT00884650|474007697|FG001|Overall Study|Femoral Stress Fracture|0|||
131650360|NCT00884650|474007696|FG000|Overall Study|Pain Pump Complication|0|||
131650361|NCT00884650|474007697|FG001|Overall Study|Pain Pump Complication|1|||
131650362|NCT01732549|474007700|FG000|Overall Study|Adverse Event|13|||
131650363|NCT01732549|474007701|FG001|Overall Study|Adverse Event|3|||
131650364|NCT01732549|474007700|FG000|Overall Study|Consent withdrawn|13|||
131650365|NCT01732549|474007701|FG001|Overall Study|Consent withdrawn|6|||
131650366|NCT01732549|474007700|FG000|Overall Study|Disease progression|37|||
131448120|NCT01716234|473270880|FG006|Overall Study|Lack of Efficacy|0|||
131448121|NCT01716234|473270874|FG000|Overall Study|Did not meet protocol eligibility|0|||
131650367|NCT01732549|474007701|FG001|Overall Study|Disease progression|50|||
131650368|NCT01732549|474007700|FG000|Overall Study|Other|8|||
131650369|NCT01732549|474007701|FG001|Overall Study|Other|14|||
131650370|NCT00447590|474007704|FG000|Overall Study|Withdrawal by Subject|26|||
131650371|NCT00447590|474007704|FG000|Overall Study|Lost to Follow-up|24|||
131650372|NCT00447590|474007704|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
131650373|NCT01967069|474007705|FG000|Overall Study|Adverse Event|2|||
131650374|NCT01967069|474007706|FG001|Overall Study|Adverse Event|2|||
131650375|NCT01967069|474007705|FG000|Overall Study|Lost to Follow-up|5|||
131650376|NCT01967069|474007706|FG001|Overall Study|Lost to Follow-up|2|||
131650377|NCT01967069|474007705|FG000|Overall Study|Withdrawal by Subject|1|||
131650378|NCT01967069|474007706|FG001|Overall Study|Withdrawal by Subject|3|||
131650379|NCT01967069|474007705|FG000|Overall Study|Lack of Efficacy|0|||
131650380|NCT01967069|474007706|FG001|Overall Study|Lack of Efficacy|1|||
131650381|NCT03933462|474007709|FG000|Overall Study|Adverse Event|2|||
131650382|NCT03933462|474007710|FG001|Overall Study|Adverse Event|0|||
131650383|NCT00358644|474007716|FG000|Overall Study|Progressive Disease|21|||
131650384|NCT00358644|474007716|FG000|Overall Study|Adverse Event|7|||
131650385|NCT00358644|474007716|FG000|Overall Study|Death|11|||
131650386|NCT00358644|474007716|FG000|Overall Study|Withdrawal by Subject|4|||
131650387|NCT00358644|474007716|FG000|Overall Study|Physician Decision|6|||
131650388|NCT00358644|474007716|FG000|Overall Study|Patient not eligible for study|1|||
131650389|NCT00513708|474007717|FG000|Overall Study|Lost to Follow-up|4|||
131650390|NCT00513708|474007718|FG001|Overall Study|Lost to Follow-up|4|||
131650391|NCT00513708|474007719|FG002|Overall Study|Lost to Follow-up|4|||
131650392|NCT00368875|474007720|FG000|Overall Study|Adverse Event|0|||
131650393|NCT00368875|474007721|FG001|Overall Study|Adverse Event|12|||
131650394|NCT00368875|474007720|FG000|Overall Study|Progressive disease|3|||
131650395|NCT00368875|474007721|FG001|Overall Study|Progressive disease|27|||
131650396|NCT00368875|474007720|FG000|Overall Study|Withdrawal by Subject|2|||
131650397|NCT00368875|474007721|FG001|Overall Study|Withdrawal by Subject|6|||
131650398|NCT00368875|474007720|FG000|Overall Study|Other Reason|0|||
131650399|NCT00368875|474007721|FG001|Overall Study|Other Reason|2|||
131650400|NCT00368875|474007720|FG000|Overall Study|Alternative Therapy|1|||
131650401|NCT00368875|474007721|FG001|Overall Study|Alternative Therapy|1|||
131650402|NCT03327831|474007722|FG000|Overall Study|Lost to Follow-up|2|||
131650403|NCT01162486|474007723|FG000|Overall Study|low ANC|1|||
131650404|NCT01162486|474007724|FG001|Overall Study|low ANC|0|||
131650405|NCT01162486|474007725|FG002|Overall Study|low ANC|0|||
131650406|NCT01162486|474007726|FG003|Overall Study|low ANC|0|||
131650407|NCT01162486|474007727|FG004|Overall Study|low ANC|0|||
131650408|NCT01162486|474007723|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
131650409|NCT01162486|474007724|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131650410|NCT01162486|474007725|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131650411|NCT01162486|474007726|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131650412|NCT01162486|474007727|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131650413|NCT01162486|474007723|FG000|Overall Study|elevated LFTs|0|||
131650414|NCT01162486|474007724|FG001|Overall Study|elevated LFTs|0|||
131650415|NCT01162486|474007725|FG002|Overall Study|elevated LFTs|1|||
131650416|NCT01162486|474007726|FG003|Overall Study|elevated LFTs|0|||
131650417|NCT01162486|474007727|FG004|Overall Study|elevated LFTs|0|||
131650418|NCT01162486|474007723|FG000|Overall Study|Pregnancy|0|||
131650419|NCT01162486|474007724|FG001|Overall Study|Pregnancy|0|||
131650420|NCT01162486|474007725|FG002|Overall Study|Pregnancy|0|||
131650421|NCT01162486|474007726|FG003|Overall Study|Pregnancy|1|||
131650422|NCT01162486|474007727|FG004|Overall Study|Pregnancy|0|||
131650423|NCT03332784|474007730|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650424|NCT03332784|474007731|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
131650425|NCT03332784|474007732|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650426|NCT03332784|474007733|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650427|NCT03332784|474007734|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650428|NCT03332784|474007735|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650429|NCT03332784|474007736|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650430|NCT03332784|474007737|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650431|NCT03332784|474007738|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650432|NCT03332784|474007739|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650433|NCT03332784|474007740|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650434|NCT03332784|474007741|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650435|NCT03332784|474007742|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650436|NCT03332784|474007743|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650437|NCT03332784|474007744|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
131650438|NCT03332784|474007745|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650439|NCT03332784|474007746|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650440|NCT03332784|474007747|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650441|NCT03332784|474007748|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131650442|NCT03332784|474007749|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131803152|NCT00048568|474563618|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
131903672|NCT00102596|474933361|FG001|Part A|Adverse Event|0|||
131903673|NCT00248651|474933366|FG000|Overall Study|Withdrawal by Subject|28|||
131903674|NCT00248651|474933367|FG001|Overall Study|Withdrawal by Subject|40|||
131903675|NCT00248651|474933368|FG002|Overall Study|Withdrawal by Subject|32|||
131903676|NCT02688933|474933369|FG000|Overall Study|Adverse Event|3|||
131903677|NCT02688933|474933370|FG001|Overall Study|Adverse Event|1|||
131903678|NCT02688933|474933369|FG000|Overall Study|Lack of Efficacy|2|||
131903679|NCT02688933|474933370|FG001|Overall Study|Lack of Efficacy|2|||
131903680|NCT02688933|474933369|FG000|Overall Study|Poor compliance to protocol|7|||
131903681|NCT02688933|474933370|FG001|Overall Study|Poor compliance to protocol|4|||
131716186|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
131716187|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
131716188|NCT00446030|474238900|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
131716189|NCT00446030|474238901|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
131716190|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
131716191|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
131716192|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
131650443|NCT00401258|474007750|FG000|Overall Study|Adverse Event|7|||
131650444|NCT01430468|474007751|FG000|Overall Study|Physician Decision|2|||
131650445|NCT01430468|474007752|FG001|Overall Study|Physician Decision|1|||
131650446|NCT01430468|474007751|FG000|Overall Study|Withdrawal by Subject|5|||
131650447|NCT01430468|474007752|FG001|Overall Study|Withdrawal by Subject|5|||
131650448|NCT01305239|474007753|FG000|Overall Study|Adverse Event|22|||
131650449|NCT01305239|474007753|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
131650450|NCT03229486|474007754|FG000|Overall Study|Protocol Violation|0|||
131650451|NCT03229486|474007755|FG001|Overall Study|Protocol Violation|1|||
131650452|NCT00760747|474007762|FG000|Study Period II|Adverse Event|3|||
131650453|NCT00760747|474007763|FG001|Study Period II|Adverse Event|4|||
131650454|NCT00760747|474007762|FG000|Study Period II|Lack of Efficacy|0|||
131650455|NCT00760747|474007763|FG001|Study Period II|Lack of Efficacy|6|||
131650456|NCT00760747|474007762|FG000|Study Period II|Parent/Caregiver Decision|3|||
131650457|NCT00760747|474007763|FG001|Study Period II|Parent/Caregiver Decision|0|||
131650458|NCT00760747|474007762|FG000|Study Period II|Protocol Violation|6|||
131650459|NCT00760747|474007763|FG001|Study Period II|Protocol Violation|3|||
131650460|NCT00760747|474007762|FG000|Study Period II|Withdrawal by Subject|1|||
131650461|NCT00760747|474007763|FG001|Study Period II|Withdrawal by Subject|0|||
131650462|NCT00760747|474007762|FG000|Study Period II|No drug administered|0|||
131650463|NCT00760747|474007763|FG001|Study Period II|No drug administered|1|||
131650464|NCT00760747|474007762|FG000|Study Period III|Adverse Event|1|||
131716193|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
131716194|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
131716195|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
131716196|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
131650465|NCT00760747|474007763|FG001|Study Period III|Adverse Event|0|||
131650466|NCT00760747|474007762|FG000|Study Period III|Lack of Efficacy|1|||
131716197|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
131650467|NCT00760747|474007763|FG001|Study Period III|Lack of Efficacy|0|||
131650468|NCT00760747|474007762|FG000|Study Period III|Parent/Caregiver Decision|0|||
131903682|NCT02688933|474933369|FG000|Overall Study|Hypoglycemia|2|||
131903683|NCT02688933|474933370|FG001|Overall Study|Hypoglycemia|0|||
131650469|NCT00760747|474007763|FG001|Study Period III|Parent/Caregiver Decision|1|||
131803153|NCT00048568|474563619|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
131803154|NCT00048568|474563620|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
131803155|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|Death|1|||
131803156|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|Death|1|||
131650470|NCT00760747|474007762|FG000|Study Period III|Protocol Violation|1|||
131650471|NCT00760747|474007763|FG001|Study Period III|Protocol Violation|1|||
131650472|NCT00760747|474007762|FG000|Study Period III|Physician Decision|0|||
131650473|NCT00760747|474007763|FG001|Study Period III|Physician Decision|1|||
131650474|NCT01443923|474007764|FG000|Overall Study|Adverse Event|1|||
131650475|NCT01443923|474007765|FG001|Overall Study|Adverse Event|0|||
131650476|NCT00844597|474007768|FG000|Overall Study|Adverse Event|0|||
131650477|NCT00844597|474007769|FG001|Overall Study|Adverse Event|0|||
131650478|NCT00844597|474007770|FG002|Overall Study|Adverse Event|0|||
131650479|NCT00844597|474007771|FG003|Overall Study|Adverse Event|1|||
131650480|NCT00844597|474007772|FG004|Overall Study|Adverse Event|0|||
131650481|NCT00844597|474007773|FG005|Overall Study|Adverse Event|0|||
131650482|NCT04160988|474007774|FG000|Overall Study|poor image quality|28|||
131650483|NCT02670122|474007775|FG000|Overall Study|Lost to Follow-up|4|||
131650484|NCT02762903|474007781|FG000|Overall Study|Lost to Follow-up|0|||
131650485|NCT02762903|474007782|FG001|Overall Study|Lost to Follow-up|1|||
131650486|NCT01228175|474007783|FG000|Overall Study|Lost to Follow-up|64|||
131650487|NCT01228175|474007784|FG001|Overall Study|Lost to Follow-up|50|||
131650488|NCT01228175|474007783|FG000|Overall Study|Withdrawal by Subject|1|||
131650489|NCT01228175|474007784|FG001|Overall Study|Withdrawal by Subject|2|||
131650490|NCT01228175|474007783|FG000|Overall Study|Physician Decision|1|||
131650491|NCT01228175|474007784|FG001|Overall Study|Physician Decision|1|||
131650492|NCT01889069|474007785|FG000|Overall Study|Death|18|||
131650493|NCT01889069|474007785|FG000|Overall Study|Progression of Disease|14|||
131650494|NCT01889069|474007785|FG000|Overall Study|Lost to Follow-up|6|||
131650495|NCT01889069|474007785|FG000|Overall Study|Other|4|||
131650496|NCT01889069|474007785|FG000|Overall Study|Consent Withdrawal|3|||
131650497|NCT00108745|474007786|FG000|Overall Study|Withdrawal by Subject|19|||
131650498|NCT00108745|474007787|FG001|Overall Study|Withdrawal by Subject|12|||
131650499|NCT00108745|474007788|FG002|Overall Study|Withdrawal by Subject|12|||
131650500|NCT00108745|474007786|FG000|Overall Study|Never Treated|8|||
131650501|NCT00108745|474007787|FG001|Overall Study|Never Treated|10|||
131650502|NCT00108745|474007788|FG002|Overall Study|Never Treated|12|||
131650503|NCT00108745|474007786|FG000|Overall Study|Ineligible|7|||
131650504|NCT00108745|474007787|FG001|Overall Study|Ineligible|13|||
131650505|NCT00108745|474007788|FG002|Overall Study|Ineligible|13|||
131650506|NCT01426347|474007790|FG000|Overall Study|Lost to Follow-up|0|||
131650507|NCT01426347|474007791|FG001|Overall Study|Lost to Follow-up|3|||
131650508|NCT01426347|474007790|FG000|Overall Study|Protocol Violation|2|||
131650509|NCT01426347|474007791|FG001|Overall Study|Protocol Violation|0|||
131650510|NCT01426347|474007790|FG000|Overall Study|Withdrawal by Subject|5|||
131650511|NCT01426347|474007791|FG001|Overall Study|Withdrawal by Subject|0|||
131650512|NCT00455741|474007792|FG000|Overall Study|Physician Decision|0|||
131650513|NCT00455741|474007793|FG001|Overall Study|Physician Decision|1|||
131803157|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|Death|0|||
131803158|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
131803159|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
131803160|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
131650514|NCT04978090|474007798|FG000|Overall Study|unable to adequately fit device|2|||
131650515|NCT00935532|474007799|FG000|Overall Study|Adverse Event|11|||
131650516|NCT00935532|474007800|FG001|Overall Study|Adverse Event|6|||
131650517|NCT00935532|474007799|FG000|Overall Study|Death|1|||
131650518|NCT00935532|474007800|FG001|Overall Study|Death|0|||
131650519|NCT00935532|474007799|FG000|Overall Study|Lost to Follow-up|1|||
131650520|NCT00935532|474007800|FG001|Overall Study|Lost to Follow-up|0|||
131650521|NCT00935532|474007799|FG000|Overall Study|Physician Decision|1|||
131650522|NCT00935532|474007800|FG001|Overall Study|Physician Decision|2|||
131650523|NCT00935532|474007799|FG000|Overall Study|Protocol Violation|2|||
131650524|NCT00935532|474007800|FG001|Overall Study|Protocol Violation|1|||
131650525|NCT00935532|474007799|FG000|Overall Study|Subject Decision|2|||
131650526|NCT00935532|474007800|FG001|Overall Study|Subject Decision|1|||
131650527|NCT00935532|474007799|FG000|Overall Study|Sponsor Decision|0|||
131650528|NCT00935532|474007800|FG001|Overall Study|Sponsor Decision|1|||
131650529|NCT00935532|474007799|FG000|Overall Study|Loss Glucose Control|4|||
131650530|NCT00935532|474007800|FG001|Overall Study|Loss Glucose Control|0|||
131803161|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
131650531|NCT00996606|474007803|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
131650532|NCT00996606|474007803|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131650533|NCT00996606|474007803|FG000|Overall Study|Protocol Violation|1|||
131650534|NCT00996606|474007803|FG000|Overall Study|Withdrawal by Subject|3|||
131650535|NCT00632502|474007805|FG000|Overall Study|Adverse Event|0|||
131650536|NCT00632502|474007806|FG001|Overall Study|Adverse Event|1|||
131650537|NCT00632502|474007805|FG000|Overall Study|Randomized not treated|3|||
131650538|NCT00632502|474007806|FG001|Overall Study|Randomized not treated|0|||
131650539|NCT00681668|474007807|FG000|Overall Study|Protocol Violation|1|||
131650540|NCT00681668|474007807|FG000|Overall Study|Withdrawal by Subject|1|||
131650541|NCT02209181|474007808|FG000|Overall Study|Adverse Event|1|||
131650542|NCT02209181|474007809|FG001|Overall Study|Adverse Event|0|||
131650543|NCT02209181|474007810|FG002|Overall Study|Adverse Event|1|||
131650544|NCT02209181|474007811|FG003|Overall Study|Adverse Event|0|||
131650545|NCT02209181|474007808|FG000|Overall Study|Withdrawal by Subject|0|||
131650546|NCT02209181|474007809|FG001|Overall Study|Withdrawal by Subject|1|||
131650547|NCT02209181|474007810|FG002|Overall Study|Withdrawal by Subject|0|||
131650548|NCT02209181|474007811|FG003|Overall Study|Withdrawal by Subject|0|||
131650549|NCT06926673|474007812|FG000|Overall Study|Lost to Follow-up|0|||
131650550|NCT06926673|474007813|FG001|Overall Study|Lost to Follow-up|0|||
131650551|NCT06926673|474007814|FG002|Overall Study|Lost to Follow-up|0|||
131650552|NCT06926673|474007815|FG003|Overall Study|Lost to Follow-up|1|||
131650553|NCT06926673|474007816|FG004|Overall Study|Lost to Follow-up|0|||
131650554|NCT06926673|474007817|FG005|Overall Study|Lost to Follow-up|0|||
131650555|NCT06926673|474007818|FG006|Overall Study|Lost to Follow-up|0|||
131650556|NCT06926673|474007812|FG000|Overall Study|Physician Decision|0|||
131650557|NCT06926673|474007813|FG001|Overall Study|Physician Decision|0|||
131650558|NCT06926673|474007814|FG002|Overall Study|Physician Decision|0|||
131650559|NCT06926673|474007815|FG003|Overall Study|Physician Decision|0|||
131650560|NCT06926673|474007816|FG004|Overall Study|Physician Decision|0|||
131650561|NCT06926673|474007817|FG005|Overall Study|Physician Decision|0|||
131650562|NCT06926673|474007818|FG006|Overall Study|Physician Decision|1|||
131650563|NCT06926673|474007812|FG000|Overall Study|Withdrawal by Subject|0|||
131650564|NCT06926673|474007813|FG001|Overall Study|Withdrawal by Subject|3|||
131650565|NCT06926673|474007814|FG002|Overall Study|Withdrawal by Subject|2|||
131650566|NCT06926673|474007815|FG003|Overall Study|Withdrawal by Subject|1|||
131650567|NCT06926673|474007816|FG004|Overall Study|Withdrawal by Subject|0|||
131650568|NCT06926673|474007817|FG005|Overall Study|Withdrawal by Subject|2|||
131650569|NCT06926673|474007818|FG006|Overall Study|Withdrawal by Subject|0|||
131650570|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Adverse Event|2|||
131650571|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Adverse Event|0|||
131650572|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Adverse Event|0|||
131650573|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Adverse Event|0|||
131650574|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
131650575|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
131650576|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
131650577|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
131650578|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
131650579|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
131650580|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
131650581|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
131650582|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Physician Decision|1|||
131650583|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Physician Decision|0|||
131650584|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Physician Decision|0|||
131650585|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Physician Decision|0|||
131650586|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Pregnancy|1|||
131650587|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Pregnancy|0|||
131650588|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Pregnancy|0|||
131650589|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Pregnancy|0|||
131650590|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
131650591|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
131650592|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
131650593|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
131650594|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
131650595|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
131650596|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
131650597|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
131803162|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
131650598|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
131448122|NCT01716234|473270875|FG001|Overall Study|Did not meet protocol eligibility|0|||
131650599|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
131650600|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
131650601|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
131650602|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
131658620|NCT02003222|474035396|FG001|Induction|Withdrawal by Subject|0|||
131650603|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
131650604|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
131650605|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
131650606|NCT04057573|474010208|FG000|24-Week Double-Blind Period|Not Treated|1|||
131650607|NCT04057573|474010209|FG001|24-Week Double-Blind Period|Not Treated|0|||
131650608|NCT04057573|474010210|FG002|24-Week Double-Blind Period|Not Treated|0|||
131650609|NCT04057573|474010211|FG003|24-Week Double-Blind Period|Not Treated|0|||
131650610|NCT04057573|474010208|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
131650611|NCT04057573|474010209|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
131650612|NCT04057573|474010210|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
131650613|NCT04057573|474010211|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
131650614|NCT04057573|474010208|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
131650615|NCT04057573|474010209|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
131650616|NCT04057573|474010210|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
131650617|NCT04057573|474010211|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
131650618|NCT04057573|474010208|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
131650619|NCT04057573|474010209|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
131650620|NCT04057573|474010210|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
131650621|NCT04057573|474010211|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
131650622|NCT04057573|474010208|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
131650623|NCT04057573|474010209|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
131650624|NCT04057573|474010210|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
131650625|NCT04057573|474010211|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
131650626|NCT04057573|474010208|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
131650627|NCT04057573|474010209|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
131650628|NCT04057573|474010210|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
131650629|NCT04057573|474010211|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
131650630|NCT00667459|474010214|FG000|Overall Study|Death|0|||
131650631|NCT00667459|474010215|FG001|Overall Study|Death|2|||
131650632|NCT00667459|474010214|FG000|Overall Study|Lost to Follow-up|8|||
131650633|NCT00667459|474010215|FG001|Overall Study|Lost to Follow-up|43|||
131650634|NCT01381575|474010216|FG000|Overall Study|Serious Adverse Event|1|||
131650635|NCT01381575|474010217|FG001|Overall Study|Serious Adverse Event|0|||
131650636|NCT01381575|474010218|FG002|Overall Study|Serious Adverse Event|0|||
131650637|NCT01381575|474010216|FG000|Overall Study|Non-Serious Adverse Event|0|||
131650638|NCT01381575|474010217|FG001|Overall Study|Non-Serious Adverse Event|0|||
131650639|NCT01381575|474010218|FG002|Overall Study|Non-Serious Adverse Event|1|||
131650640|NCT01381575|474010216|FG000|Overall Study|Protocol Violation|0|||
131650641|NCT01381575|474010217|FG001|Overall Study|Protocol Violation|1|||
131650642|NCT01381575|474010218|FG002|Overall Study|Protocol Violation|1|||
131650643|NCT01381575|474010216|FG000|Overall Study|Withdrawal by Subject|15|||
131650644|NCT01381575|474010217|FG001|Overall Study|Withdrawal by Subject|9|||
131650645|NCT01381575|474010218|FG002|Overall Study|Withdrawal by Subject|7|||
131650646|NCT01381575|474010216|FG000|Overall Study|Migrated/moved from study area|2|||
131650647|NCT01381575|474010217|FG001|Overall Study|Migrated/moved from study area|12|||
131650648|NCT01381575|474010218|FG002|Overall Study|Migrated/moved from study area|2|||
131650649|NCT01381575|474010216|FG000|Overall Study|Lost to Follow-up|8|||
131650650|NCT01381575|474010217|FG001|Overall Study|Lost to Follow-up|17|||
131650651|NCT01381575|474010218|FG002|Overall Study|Lost to Follow-up|9|||
131650652|NCT01443403|474010219|FG000|Overall Study|Adverse Event|1|||
131650653|NCT01443403|474010220|FG001|Overall Study|Adverse Event|1|||
131650654|NCT01443403|474010221|FG002|Overall Study|Adverse Event|4|||
131650655|NCT01443403|474010222|FG003|Overall Study|Adverse Event|5|||
131650656|NCT01443403|474010219|FG000|Overall Study|Withdrawal by Subject|0|||
131716198|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
131716199|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
131716200|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
131716201|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
131716202|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
131716203|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
131716204|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
131716205|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
131803163|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
131803164|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
131650657|NCT01443403|474010220|FG001|Overall Study|Withdrawal by Subject|1|||
131650658|NCT01443403|474010221|FG002|Overall Study|Withdrawal by Subject|2|||
131650659|NCT01443403|474010222|FG003|Overall Study|Withdrawal by Subject|1|||
131650660|NCT01443403|474010219|FG000|Overall Study|Lost to Follow-up|0|||
131650661|NCT01443403|474010220|FG001|Overall Study|Lost to Follow-up|0|||
131650662|NCT01443403|474010221|FG002|Overall Study|Lost to Follow-up|0|||
131650663|NCT01443403|474010222|FG003|Overall Study|Lost to Follow-up|1|||
131650664|NCT01443403|474010219|FG000|Overall Study|Protocol Violation|2|||
131650665|NCT01443403|474010220|FG001|Overall Study|Protocol Violation|1|||
131650666|NCT01443403|474010221|FG002|Overall Study|Protocol Violation|1|||
131650667|NCT01443403|474010222|FG003|Overall Study|Protocol Violation|1|||
131650668|NCT01443403|474010219|FG000|Overall Study|Use of Prohibited Treatment|2|||
131650669|NCT01443403|474010220|FG001|Overall Study|Use of Prohibited Treatment|3|||
131650670|NCT01443403|474010221|FG002|Overall Study|Use of Prohibited Treatment|0|||
131650671|NCT01443403|474010222|FG003|Overall Study|Use of Prohibited Treatment|0|||
131650672|NCT01443403|474010219|FG000|Overall Study|Other - Miscellaneous|1|||
131650673|NCT01443403|474010220|FG001|Overall Study|Other - Miscellaneous|0|||
131650674|NCT01443403|474010221|FG002|Overall Study|Other - Miscellaneous|0|||
131650675|NCT01443403|474010222|FG003|Overall Study|Other - Miscellaneous|1|||
131650676|NCT00474526|474010223|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
131650677|NCT00474526|474010224|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
131650678|NCT00474526|474010225|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
131650679|NCT00474526|474010226|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
131650680|NCT00474526|474010227|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
131650681|NCT00474526|474010228|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
131650682|NCT00474526|474010229|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
131650683|NCT00474526|474010230|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
131650684|NCT00474526|474010231|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
131650685|NCT00474526|474010232|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
131650686|NCT00474526|474010233|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
131650687|NCT00474526|474010234|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
131650688|NCT00474526|474010235|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
131650689|NCT00474526|474010236|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
131650690|NCT00474526|474010237|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
131650691|NCT00474526|474010238|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
131650692|NCT00474526|474010239|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
131650693|NCT00474526|474010223|FG000|Overall Study|Adverse Event|2|||
131650694|NCT00474526|474010224|FG001|Overall Study|Adverse Event|0|||
131650695|NCT00474526|474010225|FG002|Overall Study|Adverse Event|2|||
131650696|NCT00474526|474010226|FG003|Overall Study|Adverse Event|4|||
131650697|NCT00474526|474010227|FG004|Overall Study|Adverse Event|2|||
131650698|NCT00474526|474010228|FG005|Overall Study|Adverse Event|1|||
131650699|NCT00474526|474010229|FG006|Overall Study|Adverse Event|1|||
131650700|NCT00474526|474010230|FG007|Overall Study|Adverse Event|0|||
131650701|NCT00474526|474010231|FG008|Overall Study|Adverse Event|0|||
131650702|NCT00474526|474010232|FG009|Overall Study|Adverse Event|0|||
131650703|NCT00474526|474010233|FG010|Overall Study|Adverse Event|0|||
131650704|NCT00474526|474010234|FG011|Overall Study|Adverse Event|0|||
131650705|NCT00474526|474010235|FG012|Overall Study|Adverse Event|0|||
131650706|NCT00474526|474010236|FG013|Overall Study|Adverse Event|0|||
131650707|NCT00474526|474010237|FG014|Overall Study|Adverse Event|1|||
131650708|NCT00474526|474010238|FG015|Overall Study|Adverse Event|1|||
131650709|NCT00474526|474010239|FG016|Overall Study|Adverse Event|0|||
131650710|NCT00474526|474010223|FG000|Overall Study|Death|0|||
131650711|NCT00474526|474010224|FG001|Overall Study|Death|0|||
131650712|NCT00474526|474010225|FG002|Overall Study|Death|0|||
131650713|NCT00474526|474010226|FG003|Overall Study|Death|0|||
131650714|NCT00474526|474010227|FG004|Overall Study|Death|0|||
131650715|NCT00474526|474010228|FG005|Overall Study|Death|0|||
131650716|NCT00474526|474010229|FG006|Overall Study|Death|0|||
131650717|NCT00474526|474010230|FG007|Overall Study|Death|0|||
131650718|NCT00474526|474010231|FG008|Overall Study|Death|0|||
131650719|NCT00474526|474010232|FG009|Overall Study|Death|0|||
131650720|NCT00474526|474010233|FG010|Overall Study|Death|0|||
131650721|NCT00474526|474010234|FG011|Overall Study|Death|0|||
131650722|NCT00474526|474010235|FG012|Overall Study|Death|0|||
131650723|NCT00474526|474010236|FG013|Overall Study|Death|3|||
131650724|NCT00474526|474010237|FG014|Overall Study|Death|0|||
131650725|NCT00474526|474010238|FG015|Overall Study|Death|0|||
131650726|NCT00474526|474010239|FG016|Overall Study|Death|0|||
131650727|NCT00474526|474010223|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650728|NCT00474526|474010224|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
131650729|NCT00474526|474010225|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650730|NCT00474526|474010226|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
131650731|NCT00474526|474010227|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
131650732|NCT00474526|474010228|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650733|NCT00474526|474010229|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650734|NCT00474526|474010230|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650735|NCT00474526|474010231|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650736|NCT00474526|474010232|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650737|NCT00474526|474010233|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650738|NCT00474526|474010234|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650739|NCT00474526|474010235|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650740|NCT00474526|474010236|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
131650741|NCT00474526|474010237|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
131650742|NCT00474526|474010238|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650743|NCT00474526|474010239|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131650744|NCT00474526|474010223|FG000|Overall Study|Lost to Follow-up|8|||
131650745|NCT00474526|474010224|FG001|Overall Study|Lost to Follow-up|6|||
131650746|NCT00474526|474010225|FG002|Overall Study|Lost to Follow-up|13|||
131650747|NCT00474526|474010226|FG003|Overall Study|Lost to Follow-up|29|||
131650748|NCT00474526|474010227|FG004|Overall Study|Lost to Follow-up|11|||
131650749|NCT00474526|474010228|FG005|Overall Study|Lost to Follow-up|5|||
131650750|NCT00474526|474010229|FG006|Overall Study|Lost to Follow-up|8|||
131650751|NCT00474526|474010230|FG007|Overall Study|Lost to Follow-up|1|||
131650752|NCT00474526|474010231|FG008|Overall Study|Lost to Follow-up|0|||
131650753|NCT00474526|474010232|FG009|Overall Study|Lost to Follow-up|6|||
131650754|NCT00474526|474010233|FG010|Overall Study|Lost to Follow-up|2|||
131650755|NCT00474526|474010234|FG011|Overall Study|Lost to Follow-up|4|||
131650756|NCT00474526|474010235|FG012|Overall Study|Lost to Follow-up|6|||
131650757|NCT00474526|474010236|FG013|Overall Study|Lost to Follow-up|74|||
131650758|NCT00474526|474010237|FG014|Overall Study|Lost to Follow-up|29|||
131650759|NCT00474526|474010238|FG015|Overall Study|Lost to Follow-up|4|||
131650760|NCT00474526|474010239|FG016|Overall Study|Lost to Follow-up|5|||
131650761|NCT00474526|474010223|FG000|Overall Study|Protocol Violation|2|||
131650762|NCT00474526|474010224|FG001|Overall Study|Protocol Violation|6|||
131650763|NCT00474526|474010225|FG002|Overall Study|Protocol Violation|4|||
131650764|NCT00474526|474010226|FG003|Overall Study|Protocol Violation|12|||
131650765|NCT00474526|474010227|FG004|Overall Study|Protocol Violation|3|||
131650766|NCT00474526|474010228|FG005|Overall Study|Protocol Violation|1|||
131650767|NCT00474526|474010229|FG006|Overall Study|Protocol Violation|3|||
131650768|NCT00474526|474010230|FG007|Overall Study|Protocol Violation|0|||
131650769|NCT00474526|474010231|FG008|Overall Study|Protocol Violation|0|||
131650770|NCT00474526|474010232|FG009|Overall Study|Protocol Violation|4|||
131650771|NCT00474526|474010233|FG010|Overall Study|Protocol Violation|2|||
131650772|NCT00474526|474010234|FG011|Overall Study|Protocol Violation|2|||
131650773|NCT00474526|474010235|FG012|Overall Study|Protocol Violation|4|||
131650774|NCT00474526|474010236|FG013|Overall Study|Protocol Violation|19|||
131650775|NCT00474526|474010237|FG014|Overall Study|Protocol Violation|9|||
131650776|NCT00474526|474010238|FG015|Overall Study|Protocol Violation|6|||
131650777|NCT00474526|474010239|FG016|Overall Study|Protocol Violation|2|||
131650778|NCT00474526|474010223|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
131650779|NCT00474526|474010224|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
131650780|NCT00474526|474010225|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
131650781|NCT00474526|474010226|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
131650782|NCT00474526|474010227|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
131650783|NCT00474526|474010228|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
131650784|NCT00474526|474010229|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
131650785|NCT00474526|474010230|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
131650786|NCT00474526|474010231|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
131650787|NCT00474526|474010232|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
131650788|NCT00474526|474010233|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
131650789|NCT00474526|474010234|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
131650790|NCT00474526|474010235|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
131650791|NCT00474526|474010236|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
131650792|NCT00474526|474010237|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
131650793|NCT00474526|474010238|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
131650794|NCT00474526|474010239|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
131650795|NCT00474526|474010223|FG000|Overall Study|Withdrawal by Subject|9|||
131650796|NCT00474526|474010224|FG001|Overall Study|Withdrawal by Subject|24|||
131650797|NCT00474526|474010225|FG002|Overall Study|Withdrawal by Subject|21|||
131650798|NCT00474526|474010226|FG003|Overall Study|Withdrawal by Subject|52|||
131716206|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
131716207|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
131716208|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
131716209|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
131716210|NCT00446030|474238900|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
131716211|NCT00446030|474238901|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
131716212|NCT02886715|474238902|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131716213|NCT02886715|474238903|FG001|Overall Study|Non-Compliance With Study Drug|2|||
131716214|NCT02886715|474238904|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131803165|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
131650799|NCT00474526|474010227|FG004|Overall Study|Withdrawal by Subject|38|||
131650800|NCT00474526|474010228|FG005|Overall Study|Withdrawal by Subject|6|||
131650801|NCT00474526|474010229|FG006|Overall Study|Withdrawal by Subject|12|||
131650802|NCT00474526|474010230|FG007|Overall Study|Withdrawal by Subject|4|||
131650803|NCT00474526|474010231|FG008|Overall Study|Withdrawal by Subject|4|||
131650804|NCT00474526|474010232|FG009|Overall Study|Withdrawal by Subject|13|||
131650805|NCT00474526|474010233|FG010|Overall Study|Withdrawal by Subject|5|||
131650806|NCT00474526|474010234|FG011|Overall Study|Withdrawal by Subject|4|||
131650807|NCT00474526|474010235|FG012|Overall Study|Withdrawal by Subject|4|||
131650808|NCT00474526|474010236|FG013|Overall Study|Withdrawal by Subject|37|||
131448123|NCT01716234|473270876|FG002|Overall Study|Did not meet protocol eligibility|1|||
131650809|NCT00474526|474010237|FG014|Overall Study|Withdrawal by Subject|22|||
131650810|NCT00474526|474010238|FG015|Overall Study|Withdrawal by Subject|1|||
131650811|NCT00474526|474010239|FG016|Overall Study|Withdrawal by Subject|1|||
131650812|NCT04546217|474010242|FG000|Overall Study|Withdrawal by Subject|2|||
131650813|NCT04546217|474010243|FG001|Overall Study|Withdrawal by Subject|0|||
131650814|NCT04546217|474010242|FG000|Overall Study|Uncontrolled hypertension|1|||
131650815|NCT04546217|474010243|FG001|Overall Study|Uncontrolled hypertension|0|||
131650816|NCT02550938|474010244|FG000|Overall Study|Lost to Follow-up|8|||
131650817|NCT02550938|474010245|FG001|Overall Study|Lost to Follow-up|7|||
131650818|NCT02550938|474010246|FG002|Overall Study|Lost to Follow-up|12|||
131650819|NCT02550938|474010247|FG003|Overall Study|Lost to Follow-up|11|||
131650820|NCT01251770|474010248|FG000|Overall Study|Protocol Violation|13|||
131650821|NCT01251770|474010249|FG001|Overall Study|Protocol Violation|7|||
131650822|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131650823|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131650824|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
131650825|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
131650826|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
131650827|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
131650828|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
131650829|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
131650830|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
131650831|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
131650832|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
131650833|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
131650834|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
131650835|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
131650836|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131650837|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131650838|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131650839|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131650840|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131650841|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131650842|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
131650843|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131650844|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
131650845|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
131650846|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
131650847|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
131650848|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
131650849|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131650850|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131650851|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131650852|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131650853|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131650854|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
131650855|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131650856|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131650857|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131650858|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
131650859|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131650860|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131650861|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131650862|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131650863|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131658621|NCT02003222|474035397|FG002|Induction|Withdrawal by Subject|0|||
131658622|NCT02003222|474035398|FG003|Induction|Withdrawal by Subject|0|||
131658623|NCT02003222|474035399|FG004|Induction|Withdrawal by Subject|8|||
131658624|NCT02003222|474035395|FG000|Induction|Other reasons|0|||
131658625|NCT02003222|474035396|FG001|Induction|Other reasons|0|||
131658626|NCT02003222|474035397|FG002|Induction|Other reasons|0|||
131658627|NCT02003222|474035398|FG003|Induction|Other reasons|0|||
131658628|NCT02003222|474035399|FG004|Induction|Other reasons|22|||
131658629|NCT02003222|474035395|FG000|Intensification|Never started treatment|0|||
131658630|NCT02003222|474035396|FG001|Intensification|Never started treatment|0|||
131658631|NCT02003222|474035397|FG002|Intensification|Never started treatment|0|||
131658632|NCT02003222|474035398|FG003|Intensification|Never started treatment|0|||
131658633|NCT02003222|474035399|FG004|Intensification|Never started treatment|2|||
131650864|NCT01888874|474010253|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131650865|NCT01888874|474010254|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
131650866|NCT01888874|474010255|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131650867|NCT01888874|474010256|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131650868|NCT01888874|474010257|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131650869|NCT01888874|474010258|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
131650870|NCT01888874|474010259|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131650871|NCT01888874|474010253|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
131650872|NCT01888874|474010254|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
131650873|NCT01888874|474010255|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
131650874|NCT01888874|474010256|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131650875|NCT01888874|474010257|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
131650876|NCT01888874|474010258|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131650877|NCT01888874|474010259|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131650878|NCT01888874|474010253|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131650879|NCT01888874|474010254|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131650880|NCT01888874|474010255|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131650881|NCT01888874|474010256|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131650882|NCT01888874|474010257|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
131650883|NCT01888874|474010258|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131650884|NCT01888874|474010259|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131650885|NCT01888874|474010253|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131650886|NCT01888874|474010254|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131650887|NCT01888874|474010255|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
131650888|NCT01888874|474010256|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131650889|NCT01888874|474010257|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131650890|NCT01888874|474010258|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
131650891|NCT01888874|474010259|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131650892|NCT01888874|474010253|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131650893|NCT01888874|474010254|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131650894|NCT01888874|474010255|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
131650895|NCT01888874|474010256|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131650896|NCT01888874|474010257|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131650897|NCT01888874|474010258|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131650898|NCT01888874|474010259|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131650899|NCT01888874|474010253|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
131650900|NCT01888874|474010254|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
131650901|NCT01888874|474010255|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
131650902|NCT01888874|474010256|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
131650903|NCT01888874|474010257|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
131650904|NCT01888874|474010258|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
131650905|NCT01888874|474010259|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
131650906|NCT01888874|474010253|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131650907|NCT01888874|474010254|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
131650908|NCT01888874|474010255|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131650909|NCT01888874|474010256|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131650910|NCT01888874|474010257|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131650911|NCT01888874|474010258|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
131650912|NCT01888874|474010259|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131650913|NCT04307940|474010261|FG000|Overall Study|Adverse Event|1|||
131650914|NCT04307940|474010262|FG001|Overall Study|Adverse Event|0|||
131650915|NCT04307940|474010263|FG002|Overall Study|Adverse Event|0|||
131650916|NCT04307940|474010261|FG000|Overall Study|Withdrawal by Subject|2|||
131650917|NCT04307940|474010262|FG001|Overall Study|Withdrawal by Subject|3|||
131650918|NCT04307940|474010263|FG002|Overall Study|Withdrawal by Subject|1|||
131650919|NCT04307940|474010261|FG000|Overall Study|Lost to Follow-up|2|||
131650920|NCT04307940|474010262|FG001|Overall Study|Lost to Follow-up|0|||
131650921|NCT04307940|474010263|FG002|Overall Study|Lost to Follow-up|1|||
131650922|NCT00979953|474010266|FG000|Overall Study|Adverse Event|5|||
131650923|NCT00979953|474010267|FG001|Overall Study|Adverse Event|2|||
131650924|NCT00979953|474010268|FG002|Overall Study|Adverse Event|17|||
131650925|NCT00979953|474010269|FG003|Overall Study|Adverse Event|4|||
131650926|NCT00979953|474010266|FG000|Overall Study|Lack of Efficacy|1|||
131650927|NCT00979953|474010267|FG001|Overall Study|Lack of Efficacy|2|||
131650928|NCT00979953|474010268|FG002|Overall Study|Lack of Efficacy|0|||
131650929|NCT00979953|474010269|FG003|Overall Study|Lack of Efficacy|0|||
131650930|NCT00979953|474010266|FG000|Overall Study|Lost to Follow-up|1|||
131650931|NCT00979953|474010267|FG001|Overall Study|Lost to Follow-up|1|||
131650932|NCT00979953|474010268|FG002|Overall Study|Lost to Follow-up|1|||
131650933|NCT00979953|474010269|FG003|Overall Study|Lost to Follow-up|0|||
131650934|NCT00979953|474010266|FG000|Overall Study|Withdrawal by Subject|0|||
131650935|NCT00979953|474010267|FG001|Overall Study|Withdrawal by Subject|0|||
131650936|NCT00979953|474010268|FG002|Overall Study|Withdrawal by Subject|2|||
131650937|NCT00979953|474010269|FG003|Overall Study|Withdrawal by Subject|1|||
131650938|NCT00979953|474010266|FG000|Overall Study|Protocol Violation|1|||
131650939|NCT00979953|474010267|FG001|Overall Study|Protocol Violation|0|||
131650940|NCT00979953|474010268|FG002|Overall Study|Protocol Violation|2|||
131650941|NCT00979953|474010269|FG003|Overall Study|Protocol Violation|2|||
131650942|NCT04052425|474010272|FG000|24-Week Double-blind Period|Adverse Event|0|||
131650943|NCT04052425|474010273|FG001|24-Week Double-blind Period|Adverse Event|1|||
131650944|NCT04052425|474010274|FG002|24-Week Double-blind Period|Adverse Event|0|||
131650945|NCT04052425|474010275|FG003|24-Week Double-blind Period|Adverse Event|0|||
131650946|NCT04052425|474010272|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
131650947|NCT04052425|474010273|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
131650948|NCT04052425|474010274|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
131650949|NCT04052425|474010275|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
131650950|NCT04052425|474010272|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
131650951|NCT04052425|474010273|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
131650952|NCT04052425|474010274|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
131650953|NCT04052425|474010275|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
131650954|NCT04052425|474010272|FG000|24-Week Double-blind Period|Physician Decision|1|||
131650955|NCT04052425|474010273|FG001|24-Week Double-blind Period|Physician Decision|0|||
131650956|NCT04052425|474010274|FG002|24-Week Double-blind Period|Physician Decision|0|||
131650957|NCT04052425|474010275|FG003|24-Week Double-blind Period|Physician Decision|0|||
131650958|NCT04052425|474010272|FG000|24-Week Double-blind Period|Protocol Violation|1|||
131650959|NCT04052425|474010273|FG001|24-Week Double-blind Period|Protocol Violation|0|||
131650960|NCT04052425|474010274|FG002|24-Week Double-blind Period|Protocol Violation|0|||
131650961|NCT04052425|474010275|FG003|24-Week Double-blind Period|Protocol Violation|0|||
131650962|NCT04052425|474010272|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
131650963|NCT04052425|474010273|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
131650964|NCT04052425|474010274|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
131650965|NCT04052425|474010275|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
131650966|NCT04052425|474010272|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
131650967|NCT04052425|474010273|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
131650968|NCT04052425|474010274|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
131650969|NCT04052425|474010275|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
131650970|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
131650971|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
131650972|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
131650973|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
131650974|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
131650975|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
131650976|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
131650977|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
131650978|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
131650979|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
131650980|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
131650981|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
131650982|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
131650983|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
131650984|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
131650985|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
131650986|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
131650987|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
131650988|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
131716215|NCT02886715|474238902|FG000|Overall Study|Adverse Event|4|||
131716216|NCT02886715|474238903|FG001|Overall Study|Adverse Event|2|||
131716217|NCT02886715|474238904|FG002|Overall Study|Adverse Event|0|||
131716218|NCT02886715|474238902|FG000|Overall Study|Lack of Efficacy|0|||
131716219|NCT02886715|474238903|FG001|Overall Study|Lack of Efficacy|2|||
131716220|NCT02886715|474238904|FG002|Overall Study|Lack of Efficacy|1|||
131716221|NCT02886715|474238902|FG000|Overall Study|Lost to Follow-up|29|||
131716222|NCT02886715|474238903|FG001|Overall Study|Lost to Follow-up|26|||
131716223|NCT02886715|474238904|FG002|Overall Study|Lost to Follow-up|10|||
131716224|NCT02886715|474238902|FG000|Overall Study|Pregnancy|1|||
131716225|NCT02886715|474238903|FG001|Overall Study|Pregnancy|1|||
131716226|NCT02886715|474238904|FG002|Overall Study|Pregnancy|1|||
131716227|NCT02886715|474238902|FG000|Overall Study|Protocol Violation|3|||
131650989|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
131650990|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
131650991|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
131650992|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
131650993|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
131650994|NCT04052425|474010272|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
131650995|NCT04052425|474010273|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
131650996|NCT04052425|474010274|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
131650997|NCT04052425|474010275|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
131650998|NCT04334278|474010276|FG000|Overall Study|Lost to Follow-up|0|||
131650999|NCT04334278|474010277|FG001|Overall Study|Lost to Follow-up|3|||
131651000|NCT04334278|474010276|FG000|Overall Study|Withdrawal by Subject|4|||
131651001|NCT04334278|474010277|FG001|Overall Study|Withdrawal by Subject|2|||
131651002|NCT04829747|474010280|FG000|Overall Study|Protocol Violation|1|||
131651003|NCT02615509|474010281|FG000|Overall Study|Lost to Follow-up|134|||
131651004|NCT02615509|474010281|FG000|Overall Study|Death|4|||
131651005|NCT02615509|474010281|FG000|Overall Study|Withdrawal by Subject|8|||
131651006|NCT00425607|474010282|FG000|Overall Study|Death|1|||
131651007|NCT00425607|474010282|FG000|Overall Study|Withdrawal by Subject|1|||
131651008|NCT02563548|474010283|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
131651009|NCT02563548|474010284|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131651010|NCT02563548|474010285|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131651011|NCT02563548|474010286|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
131651012|NCT02563548|474010287|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131651013|NCT02563548|474010288|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131651014|NCT02563548|474010283|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
131651015|NCT02563548|474010284|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
131651016|NCT02563548|474010285|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
131651017|NCT02563548|474010286|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
131651018|NCT02563548|474010287|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
131651019|NCT02563548|474010288|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
131651020|NCT02563548|474010283|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131651021|NCT02563548|474010284|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131651022|NCT02563548|474010285|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
131651023|NCT02563548|474010286|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131651024|NCT02563548|474010287|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131651025|NCT02563548|474010288|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131651026|NCT02563548|474010283|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131651027|NCT02563548|474010284|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131651028|NCT02563548|474010285|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
131651029|NCT02563548|474010286|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
131651030|NCT02563548|474010287|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131651031|NCT02563548|474010288|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131651032|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131651033|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131651034|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131651035|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131651036|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
131651037|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
131651038|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131651039|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131651040|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131651041|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131651042|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
131651043|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
131651044|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131651045|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131651046|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131651047|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131651048|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
131651049|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131651050|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131651051|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131651052|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131651053|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131651054|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
131651055|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
131658634|NCT02003222|474035395|FG000|Intensification|Adverse Event|0|||
131651056|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131651057|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131651058|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131651059|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131651060|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131651061|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
131651062|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131651063|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131651064|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131651065|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131651066|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131651067|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
131651068|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131651069|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131651070|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131651071|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131651072|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131651073|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
131651074|NCT02563548|474010283|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131651075|NCT02563548|474010284|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131651076|NCT02563548|474010285|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131651077|NCT02563548|474010286|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131651078|NCT02563548|474010287|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
131651079|NCT02563548|474010288|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131651080|NCT00968526|474010289|FG000|Overall Study|Adverse Event|2|||
131651081|NCT00968526|474010290|FG001|Overall Study|Adverse Event|0|||
131651082|NCT00968526|474010289|FG000|Overall Study|Migrated/moved from study area|1|||
131651083|NCT00968526|474010290|FG001|Overall Study|Migrated/moved from study area|0|||
131651084|NCT03926195|474010294|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
131651085|NCT03926195|474010295|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
131651086|NCT03926195|474010294|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
131651087|NCT03926195|474010295|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
131651088|NCT03926195|474010294|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
131651089|NCT03926195|474010295|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
131651090|NCT03926195|474010294|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
131651091|NCT03926195|474010295|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
131651092|NCT03926195|474010294|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
131651093|NCT03926195|474010295|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
131651094|NCT03926195|474010294|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
131651095|NCT03926195|474010295|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
131651096|NCT03054337|474010296|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
131651097|NCT03054337|474010297|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
131651098|NCT03054337|474010298|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
131651099|NCT03054337|474010299|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
131651100|NCT03054337|474010300|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
131651101|NCT03054337|474010301|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
131651102|NCT03738475|474010305|FG000|Overall Study|Participant Non-Compliance|1|||
131651103|NCT03738475|474010306|FG001|Overall Study|Participant Non-Compliance|0|||
131651104|NCT00737477|474010307|FG000|Overall Study|Adverse Event|9|||
131716228|NCT02886715|474238903|FG001|Overall Study|Protocol Violation|2|||
131716229|NCT02886715|474238904|FG002|Overall Study|Protocol Violation|1|||
131716230|NCT02886715|474238902|FG000|Overall Study|Withdrawal by Subject|20|||
131716231|NCT02886715|474238903|FG001|Overall Study|Withdrawal by Subject|18|||
131716232|NCT02886715|474238904|FG002|Overall Study|Withdrawal by Subject|5|||
131716233|NCT02886715|474238902|FG000|Overall Study|missing|7|||
131716234|NCT02886715|474238903|FG001|Overall Study|missing|2|||
131716235|NCT02886715|474238904|FG002|Overall Study|missing|2|||
131716236|NCT00222105|474238905|FG000|Overall Study|Removed due to wrong diagnosis|1|||
131716237|NCT00222105|474238905|FG000|Overall Study|Withdrawal by Subject|1|||
131716238|NCT00222105|474238905|FG000|Overall Study|Adverse Event|8|||
131716239|NCT00222105|474238905|FG000|Overall Study|Treatment delays|2|||
131716240|NCT00222105|474238905|FG000|Overall Study|Death|2|||
131716241|NCT00503399|474238906|FG000|Overall Study|Death|2|||
131716242|NCT00503399|474238907|FG001|Overall Study|Death|1|||
131716243|NCT00503399|474238906|FG000|Overall Study|Protocol Violation|1|||
131716244|NCT00503399|474238907|FG001|Overall Study|Protocol Violation|0|||
131716245|NCT00503399|474238906|FG000|Overall Study|Withdrawal by Subject|4|||
131716246|NCT00503399|474238907|FG001|Overall Study|Withdrawal by Subject|2|||
131716247|NCT00503399|474238906|FG000|Overall Study|Adverse Event|0|||
131716248|NCT00503399|474238907|FG001|Overall Study|Adverse Event|3|||
131651105|NCT00737477|474010307|FG000|Overall Study|Death|9|||
131651106|NCT00737477|474010307|FG000|Overall Study|Treatment Refusal|1|||
131651107|NCT00737477|474010307|FG000|Overall Study|Withdrawal by Subject|1|||
131651108|NCT00737477|474010307|FG000|Overall Study|Renal Transplantation|10|||
131651109|NCT00737477|474010307|FG000|Overall Study|Other|4|||
131651110|NCT00581477|474010308|FG000|Overall Study|Physician Decision|2|||
131651111|NCT03106753|474010309|FG000|Overall Study|Withdrawal by Subject|0|||
131651112|NCT03106753|474010310|FG001|Overall Study|Withdrawal by Subject|1|||
131651113|NCT01853475|474010317|FG000|Overall Study|Withdrawal by Subject|0|||
131651114|NCT01853475|474010318|FG001|Overall Study|Withdrawal by Subject|1|||
131651115|NCT01853475|474010319|FG002|Overall Study|Withdrawal by Subject|0|||
131651116|NCT01023958|474010326|FG000|Overall Study|Progressive disease|48|||
131651117|NCT01023958|474010326|FG000|Overall Study|Other adverse event|1|||
131651118|NCT01023958|474010326|FG000|Overall Study|Refused to continue medication|1|||
131651119|NCT02159040|474010327|FG000|Overall Study|Death|1|||
131651120|NCT03080493|474010328|FG000|Overall Study|Did not provide NRS pain results|1|||
131651121|NCT03080493|474010329|FG001|Overall Study|Did not provide NRS pain results|0|||
131651122|NCT03080493|474010328|FG000|Overall Study|Adverse Event|0|||
131651123|NCT03080493|474010329|FG001|Overall Study|Adverse Event|1|||
131651124|NCT03080493|474010328|FG000|Overall Study|Randomization error (parity group)|0|||
131651125|NCT03080493|474010329|FG001|Overall Study|Randomization error (parity group)|1|||
131651126|NCT00755417|474010330|FG000|Overall Study|Adverse Event|28|||
131651127|NCT00755417|474010331|FG001|Overall Study|Adverse Event|20|||
131651128|NCT00755417|474010332|FG002|Overall Study|Adverse Event|7|||
131651129|NCT00755417|474010330|FG000|Overall Study|Lack of Efficacy|8|||
131651130|NCT00755417|474010331|FG001|Overall Study|Lack of Efficacy|4|||
131651131|NCT00755417|474010332|FG002|Overall Study|Lack of Efficacy|9|||
131651132|NCT00755417|474010330|FG000|Overall Study|Protocol Violation|2|||
131651133|NCT00755417|474010331|FG001|Overall Study|Protocol Violation|1|||
131651134|NCT00755417|474010332|FG002|Overall Study|Protocol Violation|1|||
131651135|NCT00755417|474010330|FG000|Overall Study|Lost to Follow-up|3|||
131651136|NCT00755417|474010331|FG001|Overall Study|Lost to Follow-up|0|||
131651137|NCT00755417|474010332|FG002|Overall Study|Lost to Follow-up|1|||
131651138|NCT00755417|474010330|FG000|Overall Study|Withdrawal by Subject|12|||
131651139|NCT00755417|474010331|FG001|Overall Study|Withdrawal by Subject|12|||
131651140|NCT00755417|474010332|FG002|Overall Study|Withdrawal by Subject|12|||
131651141|NCT00755417|474010330|FG000|Overall Study|Not specified or missing data|9|||
131651142|NCT00755417|474010331|FG001|Overall Study|Not specified or missing data|18|||
131651143|NCT00755417|474010332|FG002|Overall Study|Not specified or missing data|12|||
131651144|NCT02362503|474010334|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
131651145|NCT02362503|474010335|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
131651146|NCT02362503|474010336|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
131651147|NCT02362503|474010334|FG000|Double-blind Period-Up to 8 Days|Death|1|||
131651148|NCT02362503|474010335|FG001|Double-blind Period-Up to 8 Days|Death|0|||
131651149|NCT02362503|474010336|FG002|Double-blind Period-Up to 8 Days|Death|0|||
131651150|NCT02362503|474010334|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
131651151|NCT02362503|474010335|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
131651152|NCT02362503|474010336|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
131651153|NCT02362503|474010334|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
131651154|NCT02362503|474010335|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
131651155|NCT02362503|474010336|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
131651156|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
131651157|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
131651158|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
131651159|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
131651160|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
131651161|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
131651162|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
131651163|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
131651164|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
131651165|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
131651166|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
131651167|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
131651168|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
131651169|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
131651170|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
131651171|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
131903684|NCT02688933|474933369|FG000|Overall Study|Other than Specified|14|||
131651172|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
131651173|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
131651174|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
131903685|NCT02688933|474933370|FG001|Overall Study|Other than Specified|25|||
131651175|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
131651176|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
131651177|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
131651178|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
131651179|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
131651180|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
131651181|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
131651182|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
131651183|NCT02362503|474010334|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
131651184|NCT02362503|474010335|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
131651185|NCT02362503|474010336|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
131651186|NCT02803593|474010337|FG000|Overall Study|Lost to Follow-up|17|||
131651187|NCT02803593|474010338|FG001|Overall Study|Lost to Follow-up|35|||
131651188|NCT05143138|474010339|FG000|Overall Study|Death|5|||
131651189|NCT05143138|474010340|FG001|Overall Study|Death|35|||
131651190|NCT05143138|474010341|FG002|Overall Study|Death|1|||
131651191|NCT05143138|474010339|FG000|Overall Study|Lost to Follow-up|2|||
131651192|NCT05143138|474010340|FG001|Overall Study|Lost to Follow-up|4|||
131651193|NCT05143138|474010341|FG002|Overall Study|Lost to Follow-up|0|||
131651194|NCT05143138|474010339|FG000|Overall Study|withdrawal|1|||
131651195|NCT05143138|474010340|FG001|Overall Study|withdrawal|1|||
131651196|NCT05143138|474010341|FG002|Overall Study|withdrawal|0|||
131651197|NCT04245345|474010342|FG000|Overall Study|Death|1|||
131651198|NCT04245345|474010342|FG000|Overall Study|Exited prior to implant|5|||
131651199|NCT04245345|474010342|FG000|Overall Study|Exited prior to 1-month|9|||
131651200|NCT04245345|474010342|FG000|Overall Study|Missed 1-month visit|3|||
131651201|NCT04245345|474010342|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
131651202|NCT04245345|474010342|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
131651203|NCT03004404|474010345|FG000|Period 2|Adverse Event|0|||
131651204|NCT03004404|474010346|FG001|Period 2|Adverse Event|0|||
131651205|NCT03004404|474010347|FG002|Period 2|Adverse Event|0|||
131651206|NCT03004404|474010348|FG003|Period 2|Adverse Event|0|||
131651207|NCT03004404|474010349|FG004|Period 2|Adverse Event|0|||
131651208|NCT03004404|474010350|FG005|Period 2|Adverse Event|0|||
131651209|NCT03004404|474010351|FG006|Period 2|Adverse Event|0|||
131651210|NCT03004404|474010352|FG007|Period 2|Adverse Event|0|||
131651211|NCT03004404|474010353|FG008|Period 2|Adverse Event|1|||
131651212|NCT03004404|474010354|FG009|Period 2|Adverse Event|0|||
131651213|NCT03004404|474010355|FG010|Period 2|Adverse Event|0|||
131651214|NCT03004404|474010356|FG011|Period 2|Adverse Event|0|||
131651215|NCT03004404|474010357|FG012|Period 2|Adverse Event|0|||
131651216|NCT03004404|474010358|FG013|Period 2|Adverse Event|0|||
131651217|NCT03004404|474010359|FG014|Period 2|Adverse Event|0|||
131651218|NCT03004404|474010360|FG015|Period 2|Adverse Event|1|||
131651219|NCT01099917|474010363|FG000|Overall Study|Adverse Event|3|||
131651220|NCT01099917|474010363|FG000|Overall Study|Not Treated|24|||
131651221|NCT00422734|474010369|FG000|Overall Study|Physician Decision|1|||
131651222|NCT00422734|474010370|FG001|Overall Study|Physician Decision|1|||
131651223|NCT00422734|474010369|FG000|Overall Study|Protocol Violation|1|||
131651224|NCT00422734|474010370|FG001|Overall Study|Protocol Violation|6|||
131651225|NCT00422734|474010369|FG000|Overall Study|Withdrawal by Subject|12|||
131651226|NCT00422734|474010370|FG001|Overall Study|Withdrawal by Subject|8|||
131651227|NCT00422734|474010369|FG000|Overall Study|Adverse Event|0|||
131651228|NCT00422734|474010370|FG001|Overall Study|Adverse Event|3|||
131651229|NCT00422734|474010369|FG000|Overall Study|Partner Decision|0|||
131651230|NCT00422734|474010370|FG001|Overall Study|Partner Decision|3|||
131651231|NCT03355209|474010371|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
131651232|NCT03355209|474010372|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
131651233|NCT03355209|474010373|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
131651234|NCT03355209|474010374|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
131651235|NCT03355209|474010375|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
131651236|NCT03355209|474010376|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
131651237|NCT03355209|474010371|FG000|Part 1: Double-Blind Period|Death|0|||
131651238|NCT03355209|474010372|FG001|Part 1: Double-Blind Period|Death|0|||
131651239|NCT03355209|474010373|FG002|Part 1: Double-Blind Period|Death|1|||
131651240|NCT03355209|474010374|FG003|Part 1: Double-Blind Period|Death|0|||
131651241|NCT03355209|474010375|FG004|Part 1: Double-Blind Period|Death|0|||
131651242|NCT03355209|474010376|FG005|Part 1: Double-Blind Period|Death|0|||
131651243|NCT03355209|474010371|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
131651244|NCT03355209|474010372|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
131651245|NCT03355209|474010373|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
131803166|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
131803167|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
131803168|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
131651246|NCT03355209|474010374|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
131651247|NCT03355209|474010375|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
131903686|NCT02688933|474933369|FG000|Overall Study|Lost to Follow-up|1|||
131903687|NCT02688933|474933370|FG001|Overall Study|Lost to Follow-up|5|||
131903688|NCT00828113|474933371|FG000|Overall Study|Withdrawal by Subject|27|||
131903689|NCT00828113|474933372|FG001|Overall Study|Withdrawal by Subject|26|||
131903690|NCT00828113|474933371|FG000|Overall Study|Lost to Follow-up|3|||
131903691|NCT00828113|474933372|FG001|Overall Study|Lost to Follow-up|5|||
131903692|NCT00810199|474933373|FG000|Overall Study|Adverse Event|24|||
131903693|NCT00810199|474933374|FG001|Overall Study|Adverse Event|26|||
131903694|NCT00810199|474933373|FG000|Overall Study|Death|4|||
131903695|NCT00810199|474933374|FG001|Overall Study|Death|6|||
131903696|NCT00810199|474933373|FG000|Overall Study|Withdrew consent|9|||
131903697|NCT00810199|474933374|FG001|Overall Study|Withdrew consent|12|||
131903698|NCT00810199|474933373|FG000|Overall Study|Insufficient therapeutic response|5|||
131903699|NCT00810199|474933374|FG001|Overall Study|Insufficient therapeutic response|14|||
131903700|NCT00810199|474933373|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
131903701|NCT00810199|474933374|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
131903702|NCT00810199|474933373|FG000|Overall Study|Administrative/Other|5|||
131903703|NCT00810199|474933374|FG001|Overall Study|Administrative/Other|6|||
131903704|NCT00810199|474933373|FG000|Overall Study|Protocol Violation|2|||
131903705|NCT00810199|474933374|FG001|Overall Study|Protocol Violation|6|||
131903706|NCT00810199|474933373|FG000|Overall Study|Failure to return|1|||
131903707|NCT00810199|474933374|FG001|Overall Study|Failure to return|4|||
131903708|NCT00810199|474933373|FG000|Overall Study|Did not receive study drug|2|||
131903709|NCT00810199|474933374|FG001|Overall Study|Did not receive study drug|1|||
131903710|NCT02287038|474933375|FG000|Overall Study|Stopped attending appointments|3|||
131903711|NCT02287038|474933376|FG001|Overall Study|Stopped attending appointments|2|||
131903712|NCT02287038|474933375|FG000|Overall Study|Anxiety after starting medication|0|||
131903713|NCT02287038|474933376|FG001|Overall Study|Anxiety after starting medication|1|||
131903714|NCT02287038|474933375|FG000|Overall Study|Nausea after starting medication|1|||
131903715|NCT02287038|474933376|FG001|Overall Study|Nausea after starting medication|0|||
131903716|NCT02287038|474933375|FG000|Overall Study|Abnormal ECG after starting medication|1|||
131903717|NCT02287038|474933376|FG001|Overall Study|Abnormal ECG after starting medication|0|||
131903718|NCT05502302|474933386|FG000|Overall Study|Lost to Follow-up|6|||
131903719|NCT05502302|474933386|FG000|Overall Study|Death|2|||
131903720|NCT00003471|474933390|FG000|Overall Study|Not evaluable|4|||
131903721|NCT02104895|474933391|FG000|Overall Study|Withdrawal by Subject|0|||
131903722|NCT02104895|474933392|FG001|Overall Study|Withdrawal by Subject|14|||
131903723|NCT02668640|474933393|FG000|Overall Study|Lost to Follow-up|13|||
131903724|NCT02668640|474933393|FG000|Overall Study|Other, not specified|1|||
131903725|NCT01107925|474933395|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
131903726|NCT01107925|474933396|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
131903727|NCT01107925|474933397|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
131903728|NCT01107925|474933398|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
131903729|NCT01107925|474933399|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
131903730|NCT01107925|474933400|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
131903731|NCT01107925|474933395|FG000|Period 2|Withdrawal by Subject|0|||
131903732|NCT01107925|474933396|FG001|Period 2|Withdrawal by Subject|1|||
131903733|NCT01107925|474933397|FG002|Period 2|Withdrawal by Subject|0|||
131903734|NCT01107925|474933398|FG003|Period 2|Withdrawal by Subject|0|||
131903735|NCT01107925|474933399|FG004|Period 2|Withdrawal by Subject|0|||
131903736|NCT01107925|474933400|FG005|Period 2|Withdrawal by Subject|1|||
131903737|NCT03311945|474933401|FG000|Overall Study|Adverse Event|2|||
131716249|NCT00503399|474238906|FG000|Overall Study|Lost to Follow-up|0|||
131716250|NCT00503399|474238907|FG001|Overall Study|Lost to Follow-up|2|||
131716251|NCT01120626|474238910|FG000|Overall Study|Withdrawal by Subject|1|||
131716252|NCT01120626|474238911|FG001|Overall Study|Withdrawal by Subject|0|||
131716253|NCT00488631|474238927|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
131716254|NCT00488631|474238928|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
131903738|NCT03311945|474933401|FG000|Overall Study|Lack of Efficacy|1|||
131903739|NCT04877990|474933402|FG000|Treatment|Other reasons|3|||
131903740|NCT04877990|474933403|FG001|Treatment|Other reasons|1|||
131903741|NCT04877990|474933402|FG000|Treatment|Administrative reasons by sponsor|17|||
131903742|NCT04877990|474933403|FG001|Treatment|Administrative reasons by sponsor|33|||
131903743|NCT04877990|474933402|FG000|Treatment|Withdrawal by Subject|2|||
131903744|NCT04877990|474933403|FG001|Treatment|Withdrawal by Subject|6|||
131903745|NCT04877990|474933402|FG000|Treatment|Adverse Event|2|||
131903746|NCT04877990|474933403|FG001|Treatment|Adverse Event|1|||
131903747|NCT01619878|474933404|FG000|6 Week Follow-up Phase|Adverse Event|1|||
131903748|NCT01619878|474933404|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
131716255|NCT00488631|474238929|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
131716256|NCT00488631|474238930|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
131716257|NCT00488631|474238931|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
131716258|NCT00488631|474238932|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
131716259|NCT00488631|474238933|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
131716260|NCT00488631|474238934|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
131903749|NCT01619878|474933404|FG000|Follow-up at 12 Months of Age|Death|2|||
131903750|NCT01386606|474935315|FG000|Overall Study|Adverse Event|0|||
131903751|NCT01386606|474935316|FG001|Overall Study|Adverse Event|1|||
131903752|NCT01386606|474935317|FG002|Overall Study|Adverse Event|0|||
131903753|NCT01386606|474935318|FG003|Overall Study|Adverse Event|0|||
131716261|NCT00488631|474238935|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
131716262|NCT00488631|474238936|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
131716263|NCT00488631|474238927|FG000|Double Blind Period (Week 0-54)|Death|0|||
131716264|NCT00488631|474238928|FG001|Double Blind Period (Week 0-54)|Death|0|||
131716265|NCT00488631|474238929|FG002|Double Blind Period (Week 0-54)|Death|0|||
131716266|NCT00488631|474238930|FG003|Double Blind Period (Week 0-54)|Death|0|||
131716267|NCT00488631|474238931|FG004|Double Blind Period (Week 0-54)|Death|0|||
131716268|NCT00488631|474238932|FG005|Double Blind Period (Week 0-54)|Death|1|||
131803169|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
131803170|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
131803171|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
131803172|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
131803173|NCT00048568|474563618|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
131803174|NCT00048568|474563619|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
131803175|NCT00048568|474563620|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
131803176|NCT00048568|474563618|FG000|Open-Label Period|Death|0|||
131803177|NCT00048568|474563619|FG001|Open-Label Period|Death|0|||
131803178|NCT00048568|474563620|FG002|Open-Label Period|Death|13|||
131803179|NCT00048568|474563618|FG000|Open-Label Period|Adverse Event|0|||
131803180|NCT00048568|474563619|FG001|Open-Label Period|Adverse Event|0|||
131803181|NCT00048568|474563620|FG002|Open-Label Period|Adverse Event|49|||
131803182|NCT00048568|474563618|FG000|Open-Label Period|Lack of Efficacy|0|||
131803183|NCT00048568|474563619|FG001|Open-Label Period|Lack of Efficacy|0|||
131803184|NCT00048568|474563620|FG002|Open-Label Period|Lack of Efficacy|32|||
131803185|NCT00048568|474563618|FG000|Open-Label Period|Withdrawal by Subject|0|||
131803186|NCT00048568|474563619|FG001|Open-Label Period|Withdrawal by Subject|0|||
131803187|NCT00048568|474563620|FG002|Open-Label Period|Withdrawal by Subject|26|||
131803188|NCT00048568|474563618|FG000|Open-Label Period|Pregnancy|0|||
131803189|NCT00048568|474563619|FG001|Open-Label Period|Pregnancy|0|||
131803190|NCT00048568|474563620|FG002|Open-Label Period|Pregnancy|5|||
131803191|NCT00048568|474563618|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
131803192|NCT00048568|474563619|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
131803193|NCT00048568|474563620|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
131803194|NCT00048568|474563618|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
131803195|NCT00048568|474563619|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
131803196|NCT00048568|474563620|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
131803197|NCT00048568|474563618|FG000|Open-Label Period|Unknown Reasons|0|||
131803198|NCT00048568|474563619|FG001|Open-Label Period|Unknown Reasons|0|||
131803199|NCT00048568|474563620|FG002|Open-Label Period|Unknown Reasons|25|||
131803200|NCT00048568|474563618|FG000|Open-Label Period|Lost to Follow-up|0|||
131803201|NCT00048568|474563619|FG001|Open-Label Period|Lost to Follow-up|0|||
131803202|NCT00048568|474563620|FG002|Open-Label Period|Lost to Follow-up|7|||
131803203|NCT01717976|474563621|FG000|Overall Study|Protocol Violation|0|||
131803204|NCT01717976|474563622|FG001|Overall Study|Protocol Violation|1|||
131803205|NCT03831048|474563623|FG000|Overall Study|Protocol Violation|9|||
131803206|NCT03831048|474563624|FG001|Overall Study|Protocol Violation|3|||
131803207|NCT03831048|474563623|FG000|Overall Study|Death|4|||
131803208|NCT03831048|474563624|FG001|Overall Study|Death|9|||
131803209|NCT03831048|474563623|FG000|Overall Study|Re-transplant|0|||
131803210|NCT03831048|474563624|FG001|Overall Study|Re-transplant|2|||
131803211|NCT03831048|474563623|FG000|Overall Study|Protocol violation and death|1|||
131803212|NCT03831048|474563624|FG001|Overall Study|Protocol violation and death|1|||
131803213|NCT01315249|474563630|FG000|Overall Study|Adverse Event|22|||
131803214|NCT01315249|474563631|FG001|Overall Study|Adverse Event|26|||
131803215|NCT01315249|474563630|FG000|Overall Study|Withdrawal by Subject|11|||
131803216|NCT01315249|474563631|FG001|Overall Study|Withdrawal by Subject|10|||
131903754|NCT01386606|474935315|FG000|Overall Study|Withdrawal by Subject|0|||
131448124|NCT01716234|473270877|FG003|Overall Study|Did not meet protocol eligibility|0|||
131803217|NCT01315249|474563630|FG000|Overall Study|Protocol Violation|8|||
131803218|NCT01315249|474563631|FG001|Overall Study|Protocol Violation|5|||
131803219|NCT01315249|474563630|FG000|Overall Study|Abnormal test results|1|||
131803220|NCT01315249|474563631|FG001|Overall Study|Abnormal test results|2|||
131803221|NCT01315249|474563630|FG000|Overall Study|Administrative problems|1|||
131716269|NCT00488631|474238933|FG006|Double Blind Period (Week 0-54)|Death|0|||
131716270|NCT00488631|474238934|FG007|Double Blind Period (Week 0-54)|Death|0|||
131716271|NCT00488631|474238935|FG008|Double Blind Period (Week 0-54)|Death|0|||
131803222|NCT01315249|474563631|FG001|Overall Study|Administrative problems|0|||
131716272|NCT00488631|474238936|FG009|Double Blind Period (Week 0-54)|Death|0|||
131716273|NCT00488631|474238927|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
131903755|NCT01386606|474935316|FG001|Overall Study|Withdrawal by Subject|1|||
131903756|NCT01386606|474935317|FG002|Overall Study|Withdrawal by Subject|1|||
131903757|NCT01386606|474935318|FG003|Overall Study|Withdrawal by Subject|0|||
131903758|NCT01386606|474935315|FG000|Overall Study|Protocol Violation|1|||
131903759|NCT01386606|474935316|FG001|Overall Study|Protocol Violation|0|||
131903760|NCT01386606|474935317|FG002|Overall Study|Protocol Violation|1|||
131903761|NCT01386606|474935318|FG003|Overall Study|Protocol Violation|1|||
131903762|NCT01386606|474935315|FG000|Overall Study|Lost to Follow-up|2|||
131903763|NCT01386606|474935316|FG001|Overall Study|Lost to Follow-up|0|||
131903764|NCT01386606|474935317|FG002|Overall Study|Lost to Follow-up|0|||
131903765|NCT01386606|474935318|FG003|Overall Study|Lost to Follow-up|0|||
131903766|NCT01386606|474935315|FG000|Overall Study|Subject incarcerated|0|||
131903767|NCT01386606|474935316|FG001|Overall Study|Subject incarcerated|1|||
131903768|NCT01386606|474935317|FG002|Overall Study|Subject incarcerated|0|||
131903769|NCT01386606|474935318|FG003|Overall Study|Subject incarcerated|0|||
131903770|NCT01386606|474935315|FG000|Overall Study|Unable to draw PK|1|||
131903771|NCT01386606|474935316|FG001|Overall Study|Unable to draw PK|0|||
131903772|NCT01386606|474935317|FG002|Overall Study|Unable to draw PK|0|||
131903773|NCT01386606|474935318|FG003|Overall Study|Unable to draw PK|0|||
131903774|NCT01386606|474935315|FG000|Overall Study|T levels too high|0|||
131903775|NCT01386606|474935316|FG001|Overall Study|T levels too high|1|||
131903776|NCT01386606|474935317|FG002|Overall Study|T levels too high|1|||
131903777|NCT01386606|474935318|FG003|Overall Study|T levels too high|0|||
131903778|NCT02188160|474935319|FG000|Overall Study|Adverse Event|1|||
131903779|NCT02188160|474935320|FG001|Overall Study|Adverse Event|0|||
131903780|NCT02188160|474935319|FG000|Overall Study|Use of an excluded medication|0|||
131903781|NCT02188160|474935320|FG001|Overall Study|Use of an excluded medication|1|||
131903782|NCT04113694|474935321|FG000|Overall Study|Adverse Event|2|||
131903783|NCT04113694|474935321|FG000|Overall Study|Lost to Follow-up|2|||
131903784|NCT04113694|474935321|FG000|Overall Study|Withdrawal by Subject|6|||
131903785|NCT04113694|474935321|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
131903786|NCT01228591|474935328|FG000|Baseline|Lack of Efficacy|1|||
131903787|NCT01228591|474935329|FG001|Baseline|Lack of Efficacy|2|||
131903788|NCT04980014|474935330|FG000|Overall Study|Participants who are Duplicated|1|||
131903789|NCT04980014|474935330|FG000|Overall Study|Follow-up Failure|13|||
131903790|NCT04980014|474935330|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
131903791|NCT04980014|474935330|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
131903792|NCT04980014|474935330|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
131903793|NCT01921517|474935331|FG000|Overall Study|Lost to Follow-up|5|||
131903794|NCT01921517|474935332|FG001|Overall Study|Lost to Follow-up|0|||
131903795|NCT01921517|474935331|FG000|Overall Study|Newly diagnosed health concern|2|||
131903796|NCT01921517|474935332|FG001|Overall Study|Newly diagnosed health concern|0|||
131903797|NCT01921517|474935331|FG000|Overall Study|Physician Decision|0|||
131903798|NCT01921517|474935332|FG001|Overall Study|Physician Decision|2|||
131903799|NCT01921517|474935331|FG000|Overall Study|Withdrawal by Subject|7|||
131903800|NCT01921517|474935332|FG001|Overall Study|Withdrawal by Subject|3|||
131903801|NCT01921517|474935331|FG000|Overall Study|Subject missed final imaging|1|||
131903802|NCT01921517|474935332|FG001|Overall Study|Subject missed final imaging|4|||
131903803|NCT01095835|474935335|FG000|Overall Study|Adverse Event|8|||
131903804|NCT01095835|474935336|FG001|Overall Study|Adverse Event|6|||
131903805|NCT01095835|474935337|FG002|Overall Study|Adverse Event|6|||
131903806|NCT01095835|474935335|FG000|Overall Study|Lack of Efficacy|0|||
131903807|NCT01095835|474935336|FG001|Overall Study|Lack of Efficacy|1|||
131903808|NCT01095835|474935337|FG002|Overall Study|Lack of Efficacy|0|||
131903809|NCT01095835|474935335|FG000|Overall Study|Physician Decision|0|||
131903810|NCT01095835|474935336|FG001|Overall Study|Physician Decision|0|||
131903811|NCT01095835|474935337|FG002|Overall Study|Physician Decision|1|||
131716274|NCT00488631|474238928|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
131716275|NCT00488631|474238929|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
131716276|NCT00488631|474238930|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
131716277|NCT00488631|474238931|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
131716278|NCT00488631|474238932|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
131716279|NCT00488631|474238933|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131716280|NCT00488631|474238934|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131903812|NCT01095835|474935335|FG000|Overall Study|Withdrawal by Subject|1|||
131903813|NCT01095835|474935336|FG001|Overall Study|Withdrawal by Subject|3|||
131903814|NCT01095835|474935337|FG002|Overall Study|Withdrawal by Subject|0|||
131903815|NCT01095835|474935335|FG000|Overall Study|Non study compliance|0|||
131903816|NCT01095835|474935336|FG001|Overall Study|Non study compliance|0|||
131903817|NCT01095835|474935337|FG002|Overall Study|Non study compliance|1|||
131903818|NCT01095835|474935335|FG000|Overall Study|Protocol Violation|1|||
131903819|NCT01095835|474935336|FG001|Overall Study|Protocol Violation|2|||
131651248|NCT03355209|474010376|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
131651249|NCT03355209|474010371|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
131651250|NCT03355209|474010372|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
131651251|NCT03355209|474010373|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
131651252|NCT03355209|474010374|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131651253|NCT03355209|474010375|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131651254|NCT03355209|474010376|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131651255|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
131651256|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
131651257|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
131651258|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
131651259|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
131651260|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
131651261|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131651262|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
131651263|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131651264|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131651265|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131651266|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131651267|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
131651268|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
131651269|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
131651270|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
131651271|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
131651272|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
131651273|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
131651274|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
131651275|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
131651276|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
131651277|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
131651278|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
131651279|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
131651280|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
131651281|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
131651282|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131651283|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
131651284|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131651285|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131651286|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131651287|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131651288|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
131651289|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131651290|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
131651291|NCT03355209|474010371|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
131651292|NCT03355209|474010372|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131651293|NCT03355209|474010373|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
131651294|NCT03355209|474010374|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131651295|NCT03355209|474010375|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131651296|NCT03355209|474010376|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131651297|NCT02567708|474010377|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
131651298|NCT02567708|474010378|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
131651299|NCT02567708|474010377|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
131651300|NCT02567708|474010378|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
131651301|NCT02567708|474010377|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
131651302|NCT02567708|474010378|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
131651303|NCT02567708|474010377|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
131716281|NCT00488631|474238935|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131716282|NCT00488631|474238936|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131716283|NCT00488631|474238927|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
131716284|NCT00488631|474238928|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
131716285|NCT00488631|474238929|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
131716286|NCT00488631|474238930|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131716287|NCT00488631|474238931|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
131716288|NCT00488631|474238932|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
131803223|NCT01315249|474563630|FG000|Overall Study|inability to use device|1|||
131803224|NCT01315249|474563631|FG001|Overall Study|inability to use device|0|||
131803225|NCT01315249|474563630|FG000|Overall Study|Lack of Efficacy|0|||
131803226|NCT01315249|474563631|FG001|Overall Study|Lack of Efficacy|1|||
131803227|NCT01315249|474563630|FG000|Overall Study|Lost to Follow-up|0|||
131803228|NCT01315249|474563631|FG001|Overall Study|Lost to Follow-up|2|||
131651304|NCT02567708|474010378|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
131651305|NCT00706654|474010379|FG000|Conversion Phase|Lost to Follow-up|4|||
131651306|NCT00706654|474010380|FG001|Conversion Phase|Lost to Follow-up|0|||
131651307|NCT00706654|474010381|FG002|Conversion Phase|Lost to Follow-up|0|||
131651308|NCT00706654|474010382|FG003|Conversion Phase|Lost to Follow-up|0|||
131651309|NCT00706654|474010379|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
131651310|NCT00706654|474010380|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
131651311|NCT00706654|474010381|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
131651312|NCT00706654|474010382|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
131651313|NCT00706654|474010379|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
131651314|NCT00706654|474010380|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
131651315|NCT00706654|474010381|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
131651316|NCT00706654|474010382|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
131651317|NCT00706654|474010379|FG000|Conversion Phase|Withdrawn by Investigator|14|||
131651318|NCT00706654|474010380|FG001|Conversion Phase|Withdrawn by Investigator|0|||
131651319|NCT00706654|474010381|FG002|Conversion Phase|Withdrawn by Investigator|0|||
131651320|NCT00706654|474010382|FG003|Conversion Phase|Withdrawn by Investigator|0|||
131651321|NCT00706654|474010379|FG000|Conversion Phase|Withdrew Consent|38|||
131651322|NCT00706654|474010380|FG001|Conversion Phase|Withdrew Consent|0|||
131651323|NCT00706654|474010381|FG002|Conversion Phase|Withdrew Consent|0|||
131651324|NCT00706654|474010382|FG003|Conversion Phase|Withdrew Consent|0|||
131651325|NCT00706654|474010379|FG000|Conversion Phase|Adverse Event|18|||
131651326|NCT00706654|474010380|FG001|Conversion Phase|Adverse Event|0|||
131651327|NCT00706654|474010381|FG002|Conversion Phase|Adverse Event|0|||
131651328|NCT00706654|474010382|FG003|Conversion Phase|Adverse Event|0|||
131651329|NCT00706654|474010379|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
131651330|NCT00706654|474010380|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131448125|NCT01716234|473270878|FG004|Overall Study|Did not meet protocol eligibility|0|||
131651331|NCT00706654|474010381|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131651332|NCT00706654|474010382|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131651333|NCT00706654|474010379|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
131651334|NCT00706654|474010380|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131803229|NCT01315249|474563630|FG000|Overall Study|Death|0|||
131651335|NCT00706654|474010381|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131651336|NCT00706654|474010382|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131651337|NCT00706654|474010379|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
131651338|NCT00706654|474010380|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
131651339|NCT00706654|474010381|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
131651340|NCT00706654|474010382|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
131651341|NCT00706654|474010379|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
131651342|NCT00706654|474010380|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
131651343|NCT00706654|474010381|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
131651344|NCT00706654|474010382|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
131651345|NCT00706654|474010379|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
131651346|NCT00706654|474010380|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131651347|NCT00706654|474010381|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131651348|NCT00706654|474010382|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131651349|NCT00706654|474010379|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
131651350|NCT00706654|474010380|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131651351|NCT00706654|474010381|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131651352|NCT00706654|474010382|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131651353|NCT00706654|474010379|FG000|Oral Stabilization Phase|Withdrew consent|55|||
131651354|NCT00706654|474010380|FG001|Oral Stabilization Phase|Withdrew consent|0|||
131651355|NCT00706654|474010381|FG002|Oral Stabilization Phase|Withdrew consent|0|||
131651356|NCT00706654|474010382|FG003|Oral Stabilization Phase|Withdrew consent|0|||
131651357|NCT00706654|474010379|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
131651358|NCT00706654|474010380|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
131651359|NCT00706654|474010381|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
131651360|NCT00706654|474010382|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
131651361|NCT00706654|474010379|FG000|Oral Stabilization Phase|Adverse Event|21|||
131651362|NCT00706654|474010380|FG001|Oral Stabilization Phase|Adverse Event|0|||
131651363|NCT00706654|474010381|FG002|Oral Stabilization Phase|Adverse Event|0|||
131651364|NCT00706654|474010382|FG003|Oral Stabilization Phase|Adverse Event|0|||
131651365|NCT00706654|474010379|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
131651366|NCT00706654|474010380|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131651367|NCT00706654|474010381|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131651368|NCT00706654|474010382|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131651369|NCT00706654|474010379|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
131651370|NCT00706654|474010380|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131651371|NCT00706654|474010381|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131651372|NCT00706654|474010382|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131651373|NCT00706654|474010379|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
131651374|NCT00706654|474010380|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
131651375|NCT00706654|474010381|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
131651376|NCT00706654|474010382|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
131651377|NCT00706654|474010379|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
131651378|NCT00706654|474010380|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
131651379|NCT00706654|474010381|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
131651380|NCT00706654|474010382|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
131651381|NCT00706654|474010379|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
131651382|NCT00706654|474010380|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
131651383|NCT00706654|474010381|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
131651384|NCT00706654|474010382|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
131651385|NCT00706654|474010379|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
131651386|NCT00706654|474010380|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
131651387|NCT00706654|474010381|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
131651388|NCT00706654|474010382|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
131651389|NCT00706654|474010379|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
131651390|NCT00706654|474010380|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
131651391|NCT00706654|474010381|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
131651392|NCT00706654|474010382|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
131651393|NCT00706654|474010379|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
131651394|NCT00706654|474010380|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
131651395|NCT00706654|474010381|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
131651396|NCT00706654|474010382|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
131651397|NCT00706654|474010379|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
131651398|NCT00706654|474010380|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
131651399|NCT00706654|474010381|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
131651400|NCT00706654|474010382|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
131651401|NCT00706654|474010379|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
131651402|NCT00706654|474010380|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
131903820|NCT01095835|474935337|FG002|Overall Study|Protocol Violation|0|||
131903821|NCT03110354|474935341|FG000|Overall Study|Death|1|||
131903822|NCT03110354|474935342|FG001|Overall Study|Death|0|||
131903823|NCT03110354|474935343|FG002|Overall Study|Death|0|||
131903824|NCT03110354|474935344|FG003|Overall Study|Death|1|||
131903825|NCT03110354|474935345|FG004|Overall Study|Death|0|||
131903826|NCT03110354|474935341|FG000|Overall Study|Start of new therapy|0|||
131903827|NCT03110354|474935342|FG001|Overall Study|Start of new therapy|0|||
131903828|NCT03110354|474935343|FG002|Overall Study|Start of new therapy|0|||
131903829|NCT03110354|474935344|FG003|Overall Study|Start of new therapy|0|||
131903830|NCT03110354|474935345|FG004|Overall Study|Start of new therapy|1|||
131903831|NCT03110354|474935341|FG000|Overall Study|Failure to achieve response|2|||
131716289|NCT00488631|474238933|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131716290|NCT00488631|474238934|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131716291|NCT00488631|474238935|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131716292|NCT00488631|474238936|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131716293|NCT00488631|474238927|FG000|Double Blind Period (Week 0-54)|Other|6|||
131716294|NCT00488631|474238928|FG001|Double Blind Period (Week 0-54)|Other|12|||
131716295|NCT00488631|474238929|FG002|Double Blind Period (Week 0-54)|Other|10|||
131716296|NCT00488631|474238930|FG003|Double Blind Period (Week 0-54)|Other|11|||
131716297|NCT00488631|474238931|FG004|Double Blind Period (Week 0-54)|Other|14|||
131716298|NCT00488631|474238932|FG005|Double Blind Period (Week 0-54)|Other|34|||
131716299|NCT00488631|474238933|FG006|Double Blind Period (Week 0-54)|Other|0|||
131716300|NCT00488631|474238934|FG007|Double Blind Period (Week 0-54)|Other|0|||
131716301|NCT00488631|474238935|FG008|Double Blind Period (Week 0-54)|Other|0|||
131716302|NCT00488631|474238936|FG009|Double Blind Period (Week 0-54)|Other|0|||
131716303|NCT00488631|474238927|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131716304|NCT00488631|474238928|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131903832|NCT03110354|474935342|FG001|Overall Study|Failure to achieve response|3|||
131903833|NCT03110354|474935343|FG002|Overall Study|Failure to achieve response|0|||
131903834|NCT03110354|474935344|FG003|Overall Study|Failure to achieve response|2|||
131903835|NCT03110354|474935345|FG004|Overall Study|Failure to achieve response|1|||
131903836|NCT03110354|474935341|FG000|Overall Study|Progressive disease|1|||
131716305|NCT00488631|474238929|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131716306|NCT00488631|474238930|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131903837|NCT03110354|474935342|FG001|Overall Study|Progressive disease|1|||
131903838|NCT03110354|474935343|FG002|Overall Study|Progressive disease|3|||
131903839|NCT03110354|474935344|FG003|Overall Study|Progressive disease|4|||
131903840|NCT03110354|474935345|FG004|Overall Study|Progressive disease|2|||
131716307|NCT00488631|474238931|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131716308|NCT00488631|474238932|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131716309|NCT00488631|474238933|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
131903841|NCT03110354|474935341|FG000|Overall Study|Adverse Event|0|||
131903842|NCT03110354|474935342|FG001|Overall Study|Adverse Event|0|||
131903843|NCT03110354|474935343|FG002|Overall Study|Adverse Event|0|||
131903844|NCT03110354|474935344|FG003|Overall Study|Adverse Event|2|||
131903845|NCT03110354|474935345|FG004|Overall Study|Adverse Event|2|||
131903846|NCT03110354|474935341|FG000|Overall Study|Other|0|||
131903847|NCT03110354|474935342|FG001|Overall Study|Other|0|||
131903848|NCT03110354|474935343|FG002|Overall Study|Other|0|||
131903849|NCT03110354|474935344|FG003|Overall Study|Other|1|||
131903850|NCT03110354|474935345|FG004|Overall Study|Other|1|||
131903851|NCT01965327|474935351|FG000|Overall Study|Physician Decision|2|||
131903852|NCT01294423|474935352|FG000|Overall Study|Adverse Event|1|||
131903853|NCT01294423|474935353|FG001|Overall Study|Adverse Event|2|||
131903854|NCT01294423|474935354|FG002|Overall Study|Adverse Event|3|||
131903855|NCT01294423|474935352|FG000|Overall Study|Withdrawal by Subject|1|||
131903856|NCT01294423|474935353|FG001|Overall Study|Withdrawal by Subject|2|||
131903857|NCT01294423|474935354|FG002|Overall Study|Withdrawal by Subject|2|||
131903858|NCT01294423|474935352|FG000|Overall Study|subject no longer meets study criteria|2|||
131903859|NCT01294423|474935353|FG001|Overall Study|subject no longer meets study criteria|5|||
131903860|NCT01294423|474935354|FG002|Overall Study|subject no longer meets study criteria|2|||
131716310|NCT00488631|474238934|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
131716311|NCT00488631|474238935|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
131903861|NCT01294423|474935352|FG000|Overall Study|poor/non-compliance|1|||
131903862|NCT01294423|474935353|FG001|Overall Study|poor/non-compliance|0|||
131903863|NCT01294423|474935354|FG002|Overall Study|poor/non-compliance|1|||
131903864|NCT01699750|474935357|FG000|Overall Study|Withdrew Consent|0|||
131903865|NCT01699750|474935358|FG001|Overall Study|Withdrew Consent|1|||
131903866|NCT01699750|474935357|FG000|Overall Study|Other|0|||
131903867|NCT01699750|474935358|FG001|Overall Study|Other|2|||
131903868|NCT01484951|474935359|FG000|Overall Study|Adverse Event|3|||
131903869|NCT01484951|474935359|FG000|Overall Study|Personal Reasons|1|||
131903870|NCT01484951|474935359|FG000|Overall Study|Non-Compliance|1|||
131903871|NCT02119299|474935360|FG000|Overall Study|Withdrawal by Subject|7|||
131903872|NCT02119299|474935360|FG000|Overall Study|Lack of Efficacy|1|||
131903873|NCT02119299|474935360|FG000|Overall Study|Pregnancy|1|||
131903874|NCT02452047|474935361|FG000|Overall Study|Adverse Event|0|||
131903875|NCT02452047|474935362|FG001|Overall Study|Adverse Event|1|||
131903876|NCT02452047|474935363|FG002|Overall Study|Adverse Event|1|||
131903877|NCT02452047|474935361|FG000|Overall Study|Death|1|||
131903878|NCT02452047|474935362|FG001|Overall Study|Death|3|||
131903879|NCT02452047|474935363|FG002|Overall Study|Death|1|||
131903880|NCT02452047|474935361|FG000|Overall Study|Physician Decision|1|||
131903881|NCT02452047|474935362|FG001|Overall Study|Physician Decision|0|||
131903882|NCT02452047|474935363|FG002|Overall Study|Physician Decision|0|||
131903883|NCT02452047|474935361|FG000|Overall Study|Lost to Follow-up|1|||
131903884|NCT02452047|474935362|FG001|Overall Study|Lost to Follow-up|1|||
131903885|NCT02452047|474935363|FG002|Overall Study|Lost to Follow-up|0|||
131903886|NCT02452047|474935361|FG000|Overall Study|Withdrawal by Subject|1|||
131903887|NCT02452047|474935362|FG001|Overall Study|Withdrawal by Subject|0|||
131903888|NCT02452047|474935363|FG002|Overall Study|Withdrawal by Subject|0|||
131903889|NCT01249417|474935364|FG000|Randomised Population|Study treatment not received|0|||
131903890|NCT01249417|474935365|FG001|Randomised Population|Study treatment not received|0|||
131903891|NCT01249417|474935366|FG002|Randomised Population|Study treatment not received|2|||
131903892|NCT01249417|474935364|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
131903893|NCT01249417|474935365|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
131903894|NCT01249417|474935366|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
131903895|NCT01249417|474935364|FG000|Treatment Phase - ITT Population|Other|0|||
131903896|NCT01249417|474935365|FG001|Treatment Phase - ITT Population|Other|0|||
131903897|NCT01249417|474935366|FG002|Treatment Phase - ITT Population|Other|1|||
131903898|NCT01249417|474935364|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
131903899|NCT01249417|474935365|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
131903900|NCT01249417|474935366|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
131803230|NCT01315249|474563631|FG001|Overall Study|Death|1|||
131803231|NCT01604850|474563632|FG000|Overall Study|Enrolled but never treated|0|||
131803232|NCT01604850|474563633|FG001|Overall Study|Enrolled but never treated|1|||
131803233|NCT01604850|474563632|FG000|Overall Study|Efficacy Failure|50|||
131803234|NCT01604850|474563633|FG001|Overall Study|Efficacy Failure|29|||
131651403|NCT00706654|474010381|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
131651404|NCT00706654|474010382|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
131651405|NCT04148651|474010386|FG000|Overall Study|Lost to Follow-up|2|||
131651406|NCT05262751|474010389|FG000|Washout Period 2|Adverse Event|1|||
131651407|NCT05262751|474010390|FG001|Washout Period 2|Adverse Event|0|||
131803235|NCT01604850|474563632|FG000|Overall Study|Lost to Follow-up|1|||
131803236|NCT01604850|474563633|FG001|Overall Study|Lost to Follow-up|0|||
131803237|NCT01604850|474563632|FG000|Overall Study|Subject withdrew consent|1|||
131803238|NCT01604850|474563633|FG001|Overall Study|Subject withdrew consent|0|||
131803239|NCT04099888|474563654|FG000|Overall Study|Study terminated by sponsor|9|||
131803240|NCT04099888|474563655|FG001|Overall Study|Study terminated by sponsor|11|||
131803241|NCT04099888|474563654|FG000|Overall Study|Lost to Follow-up|1|||
131803242|NCT04099888|474563655|FG001|Overall Study|Lost to Follow-up|1|||
131803243|NCT04099888|474563654|FG000|Overall Study|Withdrawal by Subject|5|||
131803244|NCT04099888|474563655|FG001|Overall Study|Withdrawal by Subject|6|||
131803245|NCT04099888|474563654|FG000|Overall Study|Death|5|||
131803246|NCT04099888|474563655|FG001|Overall Study|Death|2|||
131803247|NCT04099888|474563654|FG000|Overall Study|Other|1|||
131803248|NCT04099888|474563655|FG001|Overall Study|Other|0|||
131803249|NCT01203878|474563656|FG000|Overall Study|Withdrawal by Subject|0|||
131803250|NCT01203878|474563657|FG001|Overall Study|Withdrawal by Subject|0|||
131803251|NCT01203878|474563658|FG002|Overall Study|Withdrawal by Subject|1|||
131803252|NCT01203878|474563656|FG000|Overall Study|Adverse Event|0|||
131803253|NCT01203878|474563657|FG001|Overall Study|Adverse Event|0|||
131803254|NCT01203878|474563658|FG002|Overall Study|Adverse Event|2|||
131803255|NCT00274937|474563659|FG000|Overall Study|Physician Decision|10|||
131803256|NCT00274937|474563659|FG000|Overall Study|Withdrawal by Subject|6|||
131803257|NCT00274937|474563659|FG000|Overall Study|Progressive Disease|4|||
131803258|NCT01471093|474563661|FG000|Overall Study|Adverse Event|1|||
131803259|NCT01471093|474563662|FG001|Overall Study|Adverse Event|0|||
131803260|NCT01471093|474563663|FG002|Overall Study|Adverse Event|0|||
131803261|NCT01471093|474563664|FG003|Overall Study|Adverse Event|0|||
131651408|NCT05262751|474010391|FG002|Washout Period 2|Adverse Event|0|||
131803262|NCT02932878|474563667|FG000|Overall Study|Due to Lab Results|2|||
131803263|NCT02932878|474563668|FG001|Overall Study|Due to Lab Results|1|||
131803264|NCT00864097|474563669|FG000|Overall Study|Death|0|||
131803265|NCT00864097|474563670|FG001|Overall Study|Death|1|||
131803266|NCT00864097|474563671|FG002|Overall Study|Death|0|||
131903901|NCT01249417|474935364|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
131903902|NCT01249417|474935365|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
131903903|NCT01249417|474935366|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
131903904|NCT01249417|474935364|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
131903905|NCT01249417|474935365|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
131716312|NCT00488631|474238936|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131716313|NCT00488631|474238927|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
131716314|NCT00488631|474238928|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
131716315|NCT00488631|474238929|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
131716316|NCT00488631|474238930|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
131716317|NCT00488631|474238931|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
131716318|NCT00488631|474238932|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
131716319|NCT00488631|474238933|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
131716320|NCT00488631|474238934|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
131716321|NCT00488631|474238935|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
131716322|NCT00488631|474238936|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
131716323|NCT00488631|474238927|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131716324|NCT00488631|474238928|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131716325|NCT00488631|474238929|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131716326|NCT00488631|474238930|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131716327|NCT00488631|474238931|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131716328|NCT00488631|474238932|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131716329|NCT00488631|474238933|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
131716330|NCT00488631|474238934|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
131716331|NCT00488631|474238935|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
131716332|NCT00488631|474238936|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
131716333|NCT00488631|474238927|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131803267|NCT00864097|474563672|FG003|Overall Study|Death|0|||
131803268|NCT00864097|474563669|FG000|Overall Study|Adverse Event|6|||
131803269|NCT00864097|474563670|FG001|Overall Study|Adverse Event|8|||
131803270|NCT00864097|474563671|FG002|Overall Study|Adverse Event|11|||
131803271|NCT00864097|474563672|FG003|Overall Study|Adverse Event|9|||
131803272|NCT00864097|474563669|FG000|Overall Study|Lack of Efficacy|9|||
131803273|NCT00864097|474563670|FG001|Overall Study|Lack of Efficacy|3|||
131803274|NCT00864097|474563671|FG002|Overall Study|Lack of Efficacy|7|||
131803275|NCT00864097|474563672|FG003|Overall Study|Lack of Efficacy|2|||
131803276|NCT00864097|474563669|FG000|Overall Study|Lost to Follow-up|0|||
131803277|NCT00864097|474563670|FG001|Overall Study|Lost to Follow-up|1|||
131803278|NCT00864097|474563671|FG002|Overall Study|Lost to Follow-up|0|||
131803279|NCT00864097|474563672|FG003|Overall Study|Lost to Follow-up|1|||
131803280|NCT00864097|474563669|FG000|Overall Study|Withdrawal by Subject|15|||
131803281|NCT00864097|474563670|FG001|Overall Study|Withdrawal by Subject|11|||
131803282|NCT00864097|474563671|FG002|Overall Study|Withdrawal by Subject|11|||
131803283|NCT00864097|474563672|FG003|Overall Study|Withdrawal by Subject|12|||
131803284|NCT00864097|474563669|FG000|Overall Study|Protocol Violation|2|||
131803285|NCT00864097|474563670|FG001|Overall Study|Protocol Violation|1|||
131803286|NCT00864097|474563671|FG002|Overall Study|Protocol Violation|0|||
131803287|NCT00864097|474563672|FG003|Overall Study|Protocol Violation|1|||
131803288|NCT00864097|474563669|FG000|Overall Study|Terminated by sponsor|105|||
131803289|NCT00864097|474563670|FG001|Overall Study|Terminated by sponsor|112|||
131803290|NCT00864097|474563671|FG002|Overall Study|Terminated by sponsor|102|||
131803291|NCT00864097|474563672|FG003|Overall Study|Terminated by sponsor|99|||
131803292|NCT00864097|474563669|FG000|Overall Study|Randomized but not treated|2|||
131803293|NCT00864097|474563670|FG001|Overall Study|Randomized but not treated|0|||
131803294|NCT00864097|474563671|FG002|Overall Study|Randomized but not treated|1|||
131803295|NCT00864097|474563672|FG003|Overall Study|Randomized but not treated|0|||
131803296|NCT00864097|474563669|FG000|Overall Study|Other|0|||
131803297|NCT00864097|474563670|FG001|Overall Study|Other|0|||
131803298|NCT00864097|474563671|FG002|Overall Study|Other|0|||
131803299|NCT00864097|474563672|FG003|Overall Study|Other|1|||
131803300|NCT00880568|474563673|FG000|Overall Study|Disease progression|3|||
131803301|NCT00880568|474563674|FG001|Overall Study|Disease progression|3|||
131803302|NCT00880568|474563675|FG002|Overall Study|Disease progression|3|||
131803303|NCT00880568|474563676|FG003|Overall Study|Disease progression|1|||
131803304|NCT00880568|474563677|FG004|Overall Study|Disease progression|3|||
131803305|NCT00880568|474563678|FG005|Overall Study|Disease progression|3|||
131803306|NCT00880568|474563679|FG006|Overall Study|Disease progression|5|||
131803307|NCT00880568|474563680|FG007|Overall Study|Disease progression|0|||
131803308|NCT00880568|474563681|FG008|Overall Study|Disease progression|3|||
131803309|NCT00880568|474563673|FG000|Overall Study|Adverse Event|0|||
131803310|NCT00880568|474563674|FG001|Overall Study|Adverse Event|0|||
131803311|NCT00880568|474563675|FG002|Overall Study|Adverse Event|0|||
131803312|NCT00880568|474563676|FG003|Overall Study|Adverse Event|0|||
131803313|NCT00880568|474563677|FG004|Overall Study|Adverse Event|0|||
131803314|NCT00880568|474563678|FG005|Overall Study|Adverse Event|0|||
131803315|NCT00880568|474563679|FG006|Overall Study|Adverse Event|1|||
131803316|NCT00880568|474563680|FG007|Overall Study|Adverse Event|1|||
131803317|NCT00880568|474563681|FG008|Overall Study|Adverse Event|0|||
131803318|NCT00880568|474563673|FG000|Overall Study|Withdrawal by Subject|0|||
131803319|NCT00880568|474563674|FG001|Overall Study|Withdrawal by Subject|0|||
131803320|NCT00880568|474563675|FG002|Overall Study|Withdrawal by Subject|0|||
131803321|NCT00880568|474563676|FG003|Overall Study|Withdrawal by Subject|0|||
131803322|NCT00880568|474563677|FG004|Overall Study|Withdrawal by Subject|0|||
131803323|NCT00880568|474563678|FG005|Overall Study|Withdrawal by Subject|0|||
131803324|NCT00880568|474563679|FG006|Overall Study|Withdrawal by Subject|0|||
131803325|NCT00880568|474563680|FG007|Overall Study|Withdrawal by Subject|1|||
131803326|NCT00880568|474563681|FG008|Overall Study|Withdrawal by Subject|0|||
131803327|NCT00620022|474563685|FG000|Treatment Period 1|Adverse Event|4|||
131803328|NCT00620022|474563686|FG001|Treatment Period 1|Adverse Event|6|||
131803329|NCT00620022|474563685|FG000|Treatment Period 1|Subject withdrew consent|1|||
131803330|NCT00620022|474563686|FG001|Treatment Period 1|Subject withdrew consent|0|||
131803331|NCT00620022|474563685|FG000|Treatment Period 2|Adverse Event|2|||
131651409|NCT05262751|474010392|FG003|Washout Period 2|Adverse Event|0|||
131651410|NCT05262751|474010393|FG004|Washout Period 2|Adverse Event|0|||
131651411|NCT05262751|474010394|FG005|Washout Period 2|Adverse Event|0|||
131651412|NCT05262751|474010389|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
131651413|NCT05262751|474010390|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
131651414|NCT05262751|474010391|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
131651415|NCT05262751|474010392|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
131651416|NCT05262751|474010393|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
131651417|NCT05262751|474010394|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
131651418|NCT01001390|474010395|FG000|Overall Study|Failure to wear AFO device|2|||
131651419|NCT01001390|474010396|FG001|Overall Study|Failure to wear AFO device|0|||
131651420|NCT01151215|474010397|FG000|Overall Study|Worsening of condition under study|1|||
131651421|NCT01151215|474010398|FG001|Overall Study|Worsening of condition under study|1|||
131651422|NCT01151215|474010399|FG002|Overall Study|Worsening of condition under study|1|||
131651423|NCT01151215|474010397|FG000|Overall Study|Death|16|||
131651424|NCT01151215|474010398|FG001|Overall Study|Death|20|||
131651425|NCT01151215|474010399|FG002|Overall Study|Death|11|||
131651426|NCT01151215|474010397|FG000|Overall Study|Lost to Follow-up|0|||
131651427|NCT01151215|474010398|FG001|Overall Study|Lost to Follow-up|0|||
131651428|NCT01151215|474010399|FG002|Overall Study|Lost to Follow-up|3|||
131651429|NCT01151215|474010397|FG000|Overall Study|Withdrawal by Subject|3|||
131651430|NCT01151215|474010398|FG001|Overall Study|Withdrawal by Subject|1|||
131651431|NCT01151215|474010399|FG002|Overall Study|Withdrawal by Subject|2|||
131651432|NCT01151215|474010397|FG000|Overall Study|Disease progression|0|||
131651433|NCT01151215|474010398|FG001|Overall Study|Disease progression|1|||
131651434|NCT01151215|474010399|FG002|Overall Study|Disease progression|1|||
131651435|NCT01151215|474010397|FG000|Overall Study|Safety as judged by the investigator|0|||
131651436|NCT01151215|474010398|FG001|Overall Study|Safety as judged by the investigator|0|||
131651437|NCT01151215|474010399|FG002|Overall Study|Safety as judged by the investigator|1|||
131651438|NCT01721954|474010400|FG000|Overall Study|Death|58|||
131651439|NCT01721954|474010401|FG001|Overall Study|Death|64|||
131651440|NCT01721954|474010400|FG000|Overall Study|Withdrawal by Subject|8|||
131651441|NCT01721954|474010401|FG001|Overall Study|Withdrawal by Subject|4|||
131651442|NCT01721954|474010400|FG000|Overall Study|Adverse Event|2|||
131651443|NCT01721954|474010401|FG001|Overall Study|Adverse Event|0|||
131651444|NCT01721954|474010400|FG000|Overall Study|Lost to Follow-up|2|||
131803332|NCT00620022|474563686|FG001|Treatment Period 2|Adverse Event|2|||
131803333|NCT00849901|474563687|FG000|Acute Treatment Phase|Adverse Event|9|||
131803334|NCT00849901|474563688|FG001|Acute Treatment Phase|Adverse Event|1|||
131803335|NCT00849901|474563689|FG002|Acute Treatment Phase|Adverse Event|3|||
131651445|NCT01721954|474010401|FG001|Overall Study|Lost to Follow-up|1|||
131651446|NCT03392168|474010402|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
131651447|NCT03392168|474010403|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
131651448|NCT03392168|474010404|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
131651449|NCT03392168|474010405|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
131651450|NCT03392168|474010402|FG000|Period 2: Cohort 2|Other|0|||
131651451|NCT03392168|474010403|FG001|Period 2: Cohort 2|Other|1|||
131651452|NCT03392168|474010404|FG002|Period 2: Cohort 2|Other|0|||
131651453|NCT03392168|474010405|FG003|Period 2: Cohort 2|Other|0|||
131651454|NCT00243074|474010412|FG000|Overall Study|Ineligible|6|||
131651455|NCT00243074|474010412|FG000|Overall Study|Adverse Event|6|||
131651456|NCT00243074|474010412|FG000|Overall Study|Withdrawal by Subject|2|||
131651457|NCT00243074|474010412|FG000|Overall Study|Lack of Efficacy|36|||
131803336|NCT00849901|474563687|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
131651458|NCT00243074|474010412|FG000|Overall Study|Death|2|||
131651459|NCT00243074|474010412|FG000|Overall Study|not protocol specified|1|||
131651460|NCT00243074|474010412|FG000|Overall Study|Did not receive any treatment|1|||
131803337|NCT00849901|474563688|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
131651461|NCT03041792|474010413|FG000|Overall Study|Adverse Event|4|||
131716334|NCT00488631|474238928|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716335|NCT00488631|474238929|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716336|NCT00488631|474238930|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716337|NCT00488631|474238931|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716338|NCT00488631|474238932|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716339|NCT00488631|474238933|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
131716340|NCT00488631|474238934|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716341|NCT00488631|474238935|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
131716342|NCT00488631|474238936|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131716343|NCT00488631|474238927|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716344|NCT00488631|474238928|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716345|NCT00488631|474238929|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716346|NCT00488631|474238930|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716347|NCT00488631|474238931|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716348|NCT00488631|474238932|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716349|NCT00488631|474238933|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
131716350|NCT00488631|474238934|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
131716351|NCT00488631|474238935|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
131716352|NCT00488631|474238936|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131716353|NCT01073943|474238942|FG000|Overall Study|Withdrawal by Subject|8|||
131716354|NCT01073943|474238943|FG001|Overall Study|Withdrawal by Subject|2|||
131716355|NCT01073943|474238942|FG000|Overall Study|Protocol Violation|2|||
131716356|NCT01073943|474238943|FG001|Overall Study|Protocol Violation|1|||
131716357|NCT01073943|474238942|FG000|Overall Study|Adverse Event|1|||
131716358|NCT01073943|474238943|FG001|Overall Study|Adverse Event|1|||
131716359|NCT01073943|474238942|FG000|Overall Study|Lost to Follow-up|0|||
131716360|NCT01073943|474238943|FG001|Overall Study|Lost to Follow-up|2|||
131716361|NCT01073943|474238942|FG000|Overall Study|Power outage; colonoscopy not done|1|||
131716362|NCT01073943|474238943|FG001|Overall Study|Power outage; colonoscopy not done|0|||
131716363|NCT01073943|474238942|FG000|Overall Study|Subject forgot|0|||
131716364|NCT01073943|474238943|FG001|Overall Study|Subject forgot|1|||
131903906|NCT01249417|474935366|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
131903907|NCT00917124|474935367|FG000|Overall Study|Protocol Violation|4|||
131903908|NCT00917124|474935368|FG001|Overall Study|Protocol Violation|6|||
131716365|NCT01073943|474238942|FG000|Overall Study|Unable to return for follow-up|0|||
131716366|NCT01073943|474238943|FG001|Overall Study|Unable to return for follow-up|1|||
131716367|NCT01073943|474238942|FG000|Overall Study|Could not tolerate prep|1|||
131716368|NCT01073943|474238943|FG001|Overall Study|Could not tolerate prep|0|||
131716369|NCT00824421|474238947|FG000|Overall Study|Adverse Event|6|||
131716370|NCT00824421|474238948|FG001|Overall Study|Adverse Event|6|||
131716371|NCT00824421|474238949|FG002|Overall Study|Adverse Event|6|||
131716372|NCT00824421|474238947|FG000|Overall Study|Death|0|||
131716373|NCT00824421|474238948|FG001|Overall Study|Death|1|||
131716374|NCT00824421|474238949|FG002|Overall Study|Death|0|||
131716375|NCT00824421|474238947|FG000|Overall Study|Lack of Efficacy|5|||
131716376|NCT00824421|474238948|FG001|Overall Study|Lack of Efficacy|7|||
131716377|NCT00824421|474238949|FG002|Overall Study|Lack of Efficacy|4|||
131716378|NCT00824421|474238947|FG000|Overall Study|Lost to Follow-up|2|||
131716379|NCT00824421|474238948|FG001|Overall Study|Lost to Follow-up|3|||
131716380|NCT00824421|474238949|FG002|Overall Study|Lost to Follow-up|0|||
131716381|NCT00824421|474238947|FG000|Overall Study|Pregnancy|1|||
131716382|NCT00824421|474238948|FG001|Overall Study|Pregnancy|0|||
131716383|NCT00824421|474238949|FG002|Overall Study|Pregnancy|1|||
131716384|NCT00824421|474238947|FG000|Overall Study|Withdrawal by Subject|2|||
131716385|NCT00824421|474238948|FG001|Overall Study|Withdrawal by Subject|3|||
131716386|NCT00824421|474238949|FG002|Overall Study|Withdrawal by Subject|3|||
131716387|NCT00824421|474238947|FG000|Overall Study|Randomized but not Treated|1|||
131716388|NCT00824421|474238948|FG001|Overall Study|Randomized but not Treated|1|||
131716389|NCT00824421|474238949|FG002|Overall Study|Randomized but not Treated|0|||
131716390|NCT00824421|474238947|FG000|Overall Study|Other|0|||
131716391|NCT00824421|474238948|FG001|Overall Study|Other|1|||
131716392|NCT00824421|474238949|FG002|Overall Study|Other|0|||
131716393|NCT02469246|474238952|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
131716394|NCT02469246|474238953|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
131903909|NCT02771275|474935370|FG000|Overall Study|Reoperation|3|||
131903910|NCT02771275|474935370|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
131448126|NCT01716234|473270879|FG005|Overall Study|Did not meet protocol eligibility|4|||
131716395|NCT02469246|474238952|FG000|Double-Blind Phase|Adverse Event|12|||
131716396|NCT02469246|474238953|FG001|Double-Blind Phase|Adverse Event|9|||
131716397|NCT02469246|474238952|FG000|Double-Blind Phase|Death|2|||
131716398|NCT02469246|474238953|FG001|Double-Blind Phase|Death|0|||
131716399|NCT02469246|474238952|FG000|Double-Blind Phase|Lack of Efficacy|2|||
131716400|NCT02469246|474238953|FG001|Double-Blind Phase|Lack of Efficacy|1|||
131651462|NCT03041792|474010414|FG001|Overall Study|Adverse Event|0|||
131651463|NCT03041792|474010413|FG000|Overall Study|Death in the family|0|||
131651464|NCT03041792|474010414|FG001|Overall Study|Death in the family|2|||
131651465|NCT03041792|474010413|FG000|Overall Study|Randomized but not treated|0|||
131651466|NCT03041792|474010414|FG001|Overall Study|Randomized but not treated|1|||
131651467|NCT02227992|474010417|FG000|Overall Study|Lost to Follow-up|1|||
131651468|NCT02227992|474010418|FG001|Overall Study|Lost to Follow-up|1|||
131651469|NCT03075527|474010419|FG000|Overall Study|Death|1|||
131651470|NCT03075527|474010419|FG000|Overall Study|Withdrawal by Subject|1|||
131651471|NCT03075527|474010419|FG000|Overall Study|Physician Decision|3|||
131651472|NCT03075527|474010419|FG000|Overall Study|Progression/Relapse|14|||
131651473|NCT04641962|474010425|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
131651474|NCT04641962|474010426|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
131651475|NCT04641962|474010427|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
131651476|NCT04641962|474010428|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
131651477|NCT04641962|474010429|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
131651478|NCT04641962|474010425|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131651479|NCT04641962|474010426|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131651480|NCT04641962|474010427|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131651481|NCT04641962|474010428|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
131651482|NCT04641962|474010429|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131651483|NCT04641962|474010425|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
131651484|NCT04641962|474010426|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
131651485|NCT04641962|474010427|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
131651486|NCT04641962|474010428|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
131651487|NCT04641962|474010429|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
131651488|NCT04641962|474010425|FG000|DBT Period: Up to 52 Weeks|Death|1|||
131651489|NCT04641962|474010426|FG001|DBT Period: Up to 52 Weeks|Death|0|||
131651490|NCT04641962|474010427|FG002|DBT Period: Up to 52 Weeks|Death|0|||
131651491|NCT04641962|474010428|FG003|DBT Period: Up to 52 Weeks|Death|0|||
131651492|NCT04641962|474010429|FG004|DBT Period: Up to 52 Weeks|Death|0|||
131651493|NCT04641962|474010425|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
131803338|NCT00849901|474563689|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
131803339|NCT00849901|474563687|FG000|Acute Treatment Phase|Protocol Violation|0|||
131803340|NCT00849901|474563688|FG001|Acute Treatment Phase|Protocol Violation|2|||
131803341|NCT00849901|474563689|FG002|Acute Treatment Phase|Protocol Violation|1|||
131803342|NCT00849901|474563687|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
131803343|NCT00849901|474563688|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
131803344|NCT00849901|474563689|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
131803345|NCT00849901|474563687|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
131803346|NCT00849901|474563688|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
131803347|NCT00849901|474563689|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
131803348|NCT00849901|474563687|FG000|Acute Treatment Phase|Physician Decision|1|||
131803349|NCT00849901|474563688|FG001|Acute Treatment Phase|Physician Decision|1|||
131803350|NCT00849901|474563689|FG002|Acute Treatment Phase|Physician Decision|1|||
131803351|NCT00849901|474563687|FG000|Acute Treatment Phase|Sponsor Decision|1|||
131803352|NCT00849901|474563688|FG001|Acute Treatment Phase|Sponsor Decision|0|||
131803353|NCT00849901|474563689|FG002|Acute Treatment Phase|Sponsor Decision|0|||
131803354|NCT00849901|474563687|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
131803355|NCT00849901|474563688|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
131803356|NCT00849901|474563689|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
131803357|NCT00849901|474563687|FG000|Extension Phase|Adverse Event|2|||
131803358|NCT00849901|474563688|FG001|Extension Phase|Adverse Event|8|||
131803359|NCT00849901|474563689|FG002|Extension Phase|Adverse Event|4|||
131803360|NCT00849901|474563687|FG000|Extension Phase|Lost to Follow-up|3|||
131803361|NCT00849901|474563688|FG001|Extension Phase|Lost to Follow-up|0|||
131803362|NCT00849901|474563689|FG002|Extension Phase|Lost to Follow-up|1|||
131803363|NCT00849901|474563687|FG000|Extension Phase|Protocol Violation|2|||
131803364|NCT00849901|474563688|FG001|Extension Phase|Protocol Violation|2|||
131803365|NCT00849901|474563689|FG002|Extension Phase|Protocol Violation|4|||
131803366|NCT00849901|474563687|FG000|Extension Phase|Withdrawal by Subject|7|||
131803367|NCT00849901|474563688|FG001|Extension Phase|Withdrawal by Subject|6|||
131803368|NCT00849901|474563689|FG002|Extension Phase|Withdrawal by Subject|3|||
131803369|NCT00849901|474563687|FG000|Extension Phase|Parent or Caregiver Decision|10|||
131803370|NCT00849901|474563688|FG001|Extension Phase|Parent or Caregiver Decision|4|||
131803371|NCT00849901|474563689|FG002|Extension Phase|Parent or Caregiver Decision|4|||
131803372|NCT00849901|474563687|FG000|Extension Phase|Physician Decision|1|||
131803373|NCT00849901|474563688|FG001|Extension Phase|Physician Decision|2|||
131803374|NCT00849901|474563689|FG002|Extension Phase|Physician Decision|0|||
131803375|NCT00849901|474563687|FG000|Extension Phase|Lack of Efficacy|2|||
131803376|NCT00849901|474563688|FG001|Extension Phase|Lack of Efficacy|4|||
131903911|NCT00126594|474935371|FG000|Overall Study|Ineligible|2|||
131651494|NCT04641962|474010426|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
131651495|NCT04641962|474010427|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
131651496|NCT04641962|474010428|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
131803377|NCT00849901|474563689|FG002|Extension Phase|Lack of Efficacy|1|||
131803378|NCT00262223|474563692|FG000|Treatment Phase|Withdrawal by Subject|3|||
131651497|NCT04641962|474010429|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
131651498|NCT04641962|474010425|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
131651499|NCT04641962|474010426|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
131651500|NCT04641962|474010427|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
131651501|NCT04641962|474010428|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
131651502|NCT04641962|474010429|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
131651503|NCT04641962|474010425|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131651504|NCT04641962|474010426|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131651505|NCT04641962|474010427|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
131651506|NCT04641962|474010428|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131651507|NCT04641962|474010429|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131651508|NCT00862836|474010430|FG000|Overall Study|Withdrawal by Subject|1|||
131651509|NCT02460575|474012526|FG000|Overall Study|Lost to Follow-up|1|||
131651510|NCT02460575|474012527|FG001|Overall Study|Lost to Follow-up|0|||
131651511|NCT02521363|474012528|FG000|Overall Study|Withdrawal by Subject|1|||
131651512|NCT02521363|474012529|FG001|Overall Study|Withdrawal by Subject|2|||
131651513|NCT05543174|474012530|FG000|Overall Study|Ongoing|7|||
131651514|NCT03374488|474012531|FG000|Overall Study|Death|13|||
131651515|NCT03374488|474012532|FG001|Overall Study|Death|13|||
131651516|NCT03374488|474012531|FG000|Overall Study|Withdrawal by Subject|3|||
131651517|NCT03374488|474012532|FG001|Overall Study|Withdrawal by Subject|1|||
131651518|NCT03374488|474012531|FG000|Overall Study|Physician Decision|3|||
131651519|NCT03374488|474012532|FG001|Overall Study|Physician Decision|0|||
131651520|NCT03104075|474012533|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
131651521|NCT03104075|474012534|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
131651522|NCT04024462|474012535|FG000|Overall Study|Withdrawal by Subject|6|||
131651523|NCT04024462|474012536|FG001|Overall Study|Withdrawal by Subject|7|||
131651524|NCT04024462|474012535|FG000|Overall Study|Progressive Disease|0|||
131651525|NCT04024462|474012536|FG001|Overall Study|Progressive Disease|1|||
131651526|NCT04024462|474012535|FG000|Overall Study|Adverse Event|0|||
131651527|NCT04024462|474012536|FG001|Overall Study|Adverse Event|1|||
131651528|NCT04024462|474012535|FG000|Overall Study|Death|0|||
131651529|NCT04024462|474012536|FG001|Overall Study|Death|1|||
131651530|NCT04024462|474012535|FG000|Overall Study|Lost to Follow-up|1|||
131803379|NCT00262223|474563693|FG001|Treatment Phase|Withdrawal by Subject|6|||
131803380|NCT00262223|474563692|FG000|Treatment Phase|Adverse Event|1|||
131803381|NCT00262223|474563693|FG001|Treatment Phase|Adverse Event|2|||
131803382|NCT00262223|474563692|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
131803383|NCT00262223|474563693|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
131651531|NCT04024462|474012536|FG001|Overall Study|Lost to Follow-up|0|||
131651532|NCT04024462|474012535|FG000|Overall Study|Ongoing in the Study|94|||
131651533|NCT04024462|474012536|FG001|Overall Study|Ongoing in the Study|89|||
131651534|NCT04896008|474012537|FG000|Overall Study|Ongoing|70|||
131651535|NCT04896008|474012538|FG001|Overall Study|Ongoing|38|||
131651536|NCT04896008|474012537|FG000|Overall Study|Adverse Event|0|||
131651537|NCT04896008|474012538|FG001|Overall Study|Adverse Event|2|||
131651538|NCT04896008|474012537|FG000|Overall Study|Death|5|||
131651539|NCT04896008|474012538|FG001|Overall Study|Death|10|||
131651540|NCT04896008|474012537|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
131651541|NCT04896008|474012538|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
131651542|NCT04896008|474012537|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
131651543|NCT04896008|474012538|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
131651544|NCT04896008|474012537|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
131651545|NCT04896008|474012538|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
131651546|NCT04896008|474012537|FG000|Overall Study|Withdrawal by Subject|1|||
131651547|NCT04896008|474012538|FG001|Overall Study|Withdrawal by Subject|4|||
131651548|NCT04896008|474012537|FG000|Overall Study|Investigator Decision|2|||
131651549|NCT04896008|474012538|FG001|Overall Study|Investigator Decision|0|||
131651550|NCT04896008|474012537|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
131651551|NCT04896008|474012538|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
131651552|NCT01270828|474012543|FG000|Pregabalin CR SB|Reason Unspecified|0|||
131651553|NCT01270828|474012544|FG001|Pregabalin CR SB|Reason Unspecified|0|||
131651554|NCT01270828|474012545|FG002|Pregabalin CR SB|Reason Unspecified|8|||
131651555|NCT01270828|474012543|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
131651556|NCT01270828|474012544|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
131651557|NCT01270828|474012545|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
131651558|NCT01270828|474012543|FG000|Pregabalin CR SB|Related adverse event|0|||
131651559|NCT01270828|474012544|FG001|Pregabalin CR SB|Related adverse event|0|||
131651560|NCT01270828|474012545|FG002|Pregabalin CR SB|Related adverse event|46|||
131651561|NCT01270828|474012543|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
131651562|NCT01270828|474012544|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
131651563|NCT01270828|474012545|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
131651564|NCT01270828|474012543|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
131651565|NCT01270828|474012544|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
131651566|NCT01270828|474012545|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
131651567|NCT01270828|474012543|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
131651568|NCT01270828|474012544|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
131651569|NCT01270828|474012545|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
131651570|NCT01270828|474012543|FG000|Pregabalin CR SB|Unrelated AE|0|||
131651571|NCT01270828|474012544|FG001|Pregabalin CR SB|Unrelated AE|0|||
131651572|NCT01270828|474012545|FG002|Pregabalin CR SB|Unrelated AE|8|||
131651573|NCT01270828|474012543|FG000|Pregabalin CR SB|Protocol Violation|0|||
131651574|NCT01270828|474012544|FG001|Pregabalin CR SB|Protocol Violation|0|||
131651575|NCT01270828|474012545|FG002|Pregabalin CR SB|Protocol Violation|8|||
131651576|NCT01270828|474012543|FG000|Double Blind Phase|Death|0|||
131651577|NCT01270828|474012544|FG001|Double Blind Phase|Death|1|||
131651578|NCT01270828|474012545|FG002|Double Blind Phase|Death|0|||
131651579|NCT01270828|474012543|FG000|Double Blind Phase|Protocol Violation|0|||
131651580|NCT01270828|474012544|FG001|Double Blind Phase|Protocol Violation|1|||
131651581|NCT01270828|474012545|FG002|Double Blind Phase|Protocol Violation|0|||
131651582|NCT01270828|474012543|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
131651583|NCT01270828|474012544|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
131651584|NCT01270828|474012545|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
131651585|NCT01270828|474012543|FG000|Double Blind Phase|Reason Unspecified|7|||
131651586|NCT01270828|474012544|FG001|Double Blind Phase|Reason Unspecified|4|||
131651587|NCT01270828|474012545|FG002|Double Blind Phase|Reason Unspecified|0|||
131651588|NCT01270828|474012543|FG000|Double Blind Phase|Withdrawal by Subject|6|||
131651589|NCT01270828|474012544|FG001|Double Blind Phase|Withdrawal by Subject|15|||
131651590|NCT01270828|474012545|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131651591|NCT01270828|474012543|FG000|Double Blind Phase|Lost to Follow-up|1|||
131651592|NCT01270828|474012544|FG001|Double Blind Phase|Lost to Follow-up|2|||
131803384|NCT00262223|474563692|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
131803385|NCT00262223|474563693|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
131803386|NCT00262223|474563692|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
131803387|NCT00262223|474563693|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
131803388|NCT01804270|474563694|FG000|Overall Study|Withdrawal by Subject|1|||
131803389|NCT01804270|474563695|FG001|Overall Study|Withdrawal by Subject|1|||
131803390|NCT00437658|474563697|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
131803391|NCT00437658|474563698|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
131803392|NCT00437658|474563699|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
131803393|NCT00437658|474563697|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
131803394|NCT00437658|474563698|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
131448127|NCT01716234|473270880|FG006|Overall Study|Did not meet protocol eligibility|0|||
131651593|NCT01270828|474012545|FG002|Double Blind Phase|Lost to Follow-up|0|||
131651594|NCT01270828|474012543|FG000|Double Blind Phase|Lack of Efficacy|2|||
131651595|NCT01270828|474012544|FG001|Double Blind Phase|Lack of Efficacy|11|||
131716401|NCT02469246|474238952|FG000|Double-Blind Phase|Investigator's Discretion|8|||
131716402|NCT02469246|474238953|FG001|Double-Blind Phase|Investigator's Discretion|8|||
131716403|NCT02469246|474238952|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
131716404|NCT02469246|474238953|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
131716405|NCT02469246|474238952|FG000|Double-Blind Phase|Protocol Violation|1|||
131716406|NCT02469246|474238953|FG001|Double-Blind Phase|Protocol Violation|1|||
131716407|NCT02469246|474238952|FG000|Double-Blind Phase|Withdrew Consent|25|||
131716408|NCT02469246|474238953|FG001|Double-Blind Phase|Withdrew Consent|25|||
131716409|NCT02469246|474238952|FG000|Double-Blind Phase|Lost to Follow-up|9|||
131716410|NCT02469246|474238953|FG001|Double-Blind Phase|Lost to Follow-up|5|||
131716411|NCT03293680|474238954|FG000|Overall Study|Death|1|||
131716412|NCT03293680|474238954|FG000|Overall Study|Did not meet inclusion criteria|8|||
131716413|NCT02690701|474238957|FG000|Treatment Period 1|Adverse Event|2|||
131716414|NCT02690701|474238958|FG001|Treatment Period 1|Adverse Event|2|||
131716415|NCT02690701|474238957|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131716416|NCT02690701|474238958|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131716417|NCT02690701|474238957|FG000|Treatment Period 2|Adverse Event|2|||
131716418|NCT02690701|474238958|FG001|Treatment Period 2|Adverse Event|0|||
131716419|NCT02690701|474238957|FG000|Treatment Period 2|Lack of Efficacy|1|||
131716420|NCT02690701|474238958|FG001|Treatment Period 2|Lack of Efficacy|0|||
131716421|NCT02690701|474238957|FG000|Treatment Period 2|Lost to Follow-up|0|||
131716422|NCT02690701|474238958|FG001|Treatment Period 2|Lost to Follow-up|2|||
131716423|NCT02690701|474238957|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131716424|NCT02690701|474238958|FG001|Treatment Period 2|Withdrawal by Subject|2|||
131716425|NCT02690701|474238957|FG000|Treatment Period 2|Protocol Violation|0|||
131651596|NCT01270828|474012545|FG002|Double Blind Phase|Lack of Efficacy|0|||
131651597|NCT01270828|474012543|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
131651598|NCT01270828|474012544|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
131651599|NCT01270828|474012545|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
131651600|NCT01270828|474012543|FG000|Double Blind Phase|Adverse event related to study drug|5|||
131651601|NCT01270828|474012544|FG001|Double Blind Phase|Adverse event related to study drug|7|||
131651602|NCT01270828|474012545|FG002|Double Blind Phase|Adverse event related to study drug|0|||
131651603|NCT02963090|474012546|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
131651604|NCT02963090|474012547|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
131651605|NCT00709228|474012553|FG000|Overall Study|Not treated|14|||
131651606|NCT00709228|474012553|FG000|Overall Study|Eligibility criteria not met|281|||
131651607|NCT00709228|474012553|FG000|Overall Study|Adverse events|2|||
131651608|NCT00709228|474012553|FG000|Overall Study|Discontinued treatment|14|||
131651609|NCT00709228|474012553|FG000|Overall Study|Did not enter follow-up|4|||
131651610|NCT00709228|474012553|FG000|Overall Study|Discontinued follow-up|5|||
131651611|NCT00709228|474012553|FG000|Overall Study|Disease progression|1|||
131651612|NCT00709228|474012553|FG000|Overall Study|Lost to Follow-up|6|||
131651613|NCT00709228|474012553|FG000|Overall Study|Non-compliance|5|||
131651614|NCT02870972|474012554|FG000|Overall Study|Adverse Event|1|||
131651615|NCT02870972|474012555|FG001|Overall Study|Adverse Event|0|||
131651616|NCT02870972|474012556|FG002|Overall Study|Adverse Event|0|||
131651617|NCT02870972|474012557|FG003|Overall Study|Adverse Event|0|||
131651618|NCT02870972|474012558|FG004|Overall Study|Adverse Event|0|||
131651619|NCT04497389|474012559|FG000|Overall Study|Withdrawal by Subject|1|||
131651620|NCT04497389|474012560|FG001|Overall Study|Withdrawal by Subject|0|||
131651621|NCT00789360|474012563|FG000|Overall Study|Protocol Violation|3|||
131651622|NCT00789360|474012564|FG001|Overall Study|Protocol Violation|1|||
131651623|NCT04400487|474012565|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131651624|NCT04400487|474012565|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
131651625|NCT04400487|474012565|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
131716426|NCT02690701|474238958|FG001|Treatment Period 2|Protocol Violation|1|||
131651626|NCT03559062|474012566|FG000|Overall Study|Other|0|||
131651627|NCT03559062|474012567|FG001|Overall Study|Other|1|||
131651628|NCT03559062|474012568|FG002|Overall Study|Other|0|||
131651629|NCT00022659|474012569|FG000|Overall Study|Ineligible: wrong primary|1|||
131716427|NCT01642212|474238959|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
131716428|NCT01642212|474238960|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131716429|NCT01642212|474238961|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131716430|NCT01642212|474238962|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131716431|NCT01642212|474238963|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131716432|NCT01642212|474238959|FG000|Double-blind Treatment|Other|0|||
131716433|NCT01642212|474238960|FG001|Double-blind Treatment|Other|2|||
131651630|NCT00022659|474012569|FG000|Overall Study|Never treated|1|||
131651631|NCT03322540|474012571|FG000|Overall Study|Death|21|||
131651632|NCT03322540|474012572|FG001|Overall Study|Death|28|||
131651633|NCT03322540|474012571|FG000|Overall Study|Lost to Follow-up|0|||
131651634|NCT03322540|474012572|FG001|Overall Study|Lost to Follow-up|1|||
131651635|NCT03322540|474012571|FG000|Overall Study|Physician Decision|7|||
131651636|NCT03322540|474012572|FG001|Overall Study|Physician Decision|6|||
131651637|NCT03322540|474012571|FG000|Overall Study|Withdrawal by Subject|3|||
131651638|NCT03322540|474012572|FG001|Overall Study|Withdrawal by Subject|1|||
131651639|NCT03322540|474012571|FG000|Overall Study|Study terminated by sponsor|0|||
131651640|NCT03322540|474012572|FG001|Overall Study|Study terminated by sponsor|1|||
131651641|NCT03445533|474012573|FG000|Overall Study|Progressive Disease|48|||
131651642|NCT03445533|474012574|FG001|Overall Study|Progressive Disease|81|||
131651643|NCT03445533|474012573|FG000|Overall Study|Adverse Event|60|||
131651644|NCT03445533|474012574|FG001|Overall Study|Adverse Event|64|||
131651645|NCT03445533|474012573|FG000|Overall Study|Death|9|||
131651646|NCT03445533|474012574|FG001|Overall Study|Death|19|||
131651647|NCT03445533|474012573|FG000|Overall Study|Miscellaneous|0|||
131651648|NCT03445533|474012574|FG001|Overall Study|Miscellaneous|16|||
131651649|NCT03445533|474012573|FG000|Overall Study|Withdrawal by Subject|3|||
131651650|NCT03445533|474012574|FG001|Overall Study|Withdrawal by Subject|4|||
131651651|NCT03445533|474012573|FG000|Overall Study|Physician Decision|1|||
131651652|NCT03445533|474012574|FG001|Overall Study|Physician Decision|3|||
131651653|NCT03445533|474012573|FG000|Overall Study|Sponsor Decision|0|||
131651654|NCT03445533|474012574|FG001|Overall Study|Sponsor Decision|1|||
131651655|NCT03445533|474012573|FG000|Overall Study|Lost to Follow-up|0|||
131651656|NCT03445533|474012574|FG001|Overall Study|Lost to Follow-up|1|||
131651657|NCT03445533|474012573|FG000|Overall Study|Never Received any Study Treatment|7|||
131651658|NCT03445533|474012574|FG001|Overall Study|Never Received any Study Treatment|4|||
131651659|NCT02493062|474012575|FG000|Overall Study|Physician Decision|12|||
131651660|NCT01327612|474012577|FG000|Overall Study|Withdrawal by Subject|0|||
131651661|NCT01327612|474012578|FG001|Overall Study|Withdrawal by Subject|0|||
131651662|NCT01327612|474012579|FG002|Overall Study|Withdrawal by Subject|0|||
131651663|NCT01327612|474012580|FG003|Overall Study|Withdrawal by Subject|0|||
131651664|NCT01327612|474012581|FG004|Overall Study|Withdrawal by Subject|0|||
131651665|NCT01327612|474012582|FG005|Overall Study|Withdrawal by Subject|1|||
131651666|NCT01327612|474012583|FG006|Overall Study|Withdrawal by Subject|0|||
131651667|NCT01327612|474012577|FG000|Overall Study|Disease Progression|1|||
131651668|NCT01327612|474012578|FG001|Overall Study|Disease Progression|1|||
131651669|NCT01327612|474012579|FG002|Overall Study|Disease Progression|1|||
131651670|NCT01327612|474012580|FG003|Overall Study|Disease Progression|0|||
131651671|NCT01327612|474012581|FG004|Overall Study|Disease Progression|1|||
131651672|NCT01327612|474012582|FG005|Overall Study|Disease Progression|2|||
131651673|NCT01327612|474012583|FG006|Overall Study|Disease Progression|2|||
131651674|NCT01327612|474012577|FG000|Overall Study|Administrative Decision|0|||
131651675|NCT01327612|474012578|FG001|Overall Study|Administrative Decision|0|||
131651676|NCT01327612|474012579|FG002|Overall Study|Administrative Decision|0|||
131651677|NCT01327612|474012580|FG003|Overall Study|Administrative Decision|1|||
131651678|NCT01327612|474012581|FG004|Overall Study|Administrative Decision|0|||
131651679|NCT01327612|474012582|FG005|Overall Study|Administrative Decision|0|||
131651680|NCT01327612|474012583|FG006|Overall Study|Administrative Decision|0|||
131651681|NCT01327612|474012577|FG000|Overall Study|Death|0|||
131651682|NCT01327612|474012578|FG001|Overall Study|Death|0|||
131651683|NCT01327612|474012579|FG002|Overall Study|Death|0|||
131651684|NCT01327612|474012580|FG003|Overall Study|Death|0|||
131651685|NCT01327612|474012581|FG004|Overall Study|Death|1|||
131651686|NCT01327612|474012582|FG005|Overall Study|Death|0|||
131651687|NCT01327612|474012583|FG006|Overall Study|Death|0|||
131716434|NCT01642212|474238961|FG002|Double-blind Treatment|Other|1|||
131716435|NCT01642212|474238962|FG003|Double-blind Treatment|Other|0|||
131716436|NCT01642212|474238963|FG004|Double-blind Treatment|Other|0|||
131903912|NCT00126594|474935372|FG001|Overall Study|Ineligible|0|||
131651688|NCT00426127|474012584|FG000|Overall Study|Adverse Event|1|||
131651689|NCT00426127|474012584|FG000|Overall Study|Removed due to disease progression|1|||
131651690|NCT05569421|474012585|FG000|Overall Study|Withdrawal by Subject|1|||
131651691|NCT05569421|474012586|FG001|Overall Study|Withdrawal by Subject|0|||
131651692|NCT05569421|474012587|FG002|Overall Study|Withdrawal by Subject|0|||
131651693|NCT01689857|474012588|FG000|Overall Study|Lost to Follow-up|5|||
131651694|NCT01689857|474012589|FG001|Overall Study|Lost to Follow-up|2|||
131651695|NCT01730378|474012590|FG000|Overall Study|Lost to Follow-up|1|||
131651696|NCT01730378|474012591|FG001|Overall Study|Lost to Follow-up|0|||
131651697|NCT00874731|474012593|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
131651698|NCT00874731|474012594|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
131651699|NCT00874731|474012595|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
131651700|NCT00874731|474012593|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
131651701|NCT00874731|474012594|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
131651702|NCT00874731|474012595|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
131651703|NCT00874731|474012593|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
131716437|NCT01642212|474238959|FG000|Double-blind Treatment|Non-compliance|0|||
131651704|NCT00874731|474012594|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
131651705|NCT00874731|474012595|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
131651706|NCT00955708|474012596|FG000|Overall Study|Death|269|||
131651707|NCT00955708|474012596|FG000|Overall Study|Lost to Follow-up|72|||
131651708|NCT00955708|474012596|FG000|Overall Study|Physician Decision|36|||
131651709|NCT00955708|474012596|FG000|Overall Study|Protocol Violation|134|||
131651710|NCT00955708|474012596|FG000|Overall Study|Registry Conclusion|186|||
131651711|NCT00955708|474012596|FG000|Overall Study|Product removed from service|94|||
131651712|NCT00955708|474012596|FG000|Overall Study|Patient Refused to participate further|116|||
131651713|NCT00955708|474012596|FG000|Overall Study|Closure of study location|60|||
131651714|NCT00955708|474012596|FG000|Overall Study|Patient changed care provider/moved|91|||
131651715|NCT05105087|474012597|FG000|Overall Study|Withdrawal by Subject|2|||
131651716|NCT05105087|474012597|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
131651717|NCT01016262|474012600|FG000|Double-blind Phase|Adverse Event|0|||
131651718|NCT01016262|474012601|FG001|Double-blind Phase|Adverse Event|0|||
131651719|NCT01016262|474012602|FG002|Double-blind Phase|Adverse Event|1|||
131651720|NCT01016262|474012603|FG003|Double-blind Phase|Adverse Event|0|||
131651721|NCT01016262|474012604|FG004|Double-blind Phase|Adverse Event|0|||
131651722|NCT01016262|474012605|FG005|Double-blind Phase|Adverse Event|0|||
131651723|NCT01016262|474012600|FG000|Double-blind Phase|Lack of Efficacy|1|||
131651724|NCT01016262|474012601|FG001|Double-blind Phase|Lack of Efficacy|0|||
131651725|NCT01016262|474012602|FG002|Double-blind Phase|Lack of Efficacy|5|||
131651726|NCT01016262|474012603|FG003|Double-blind Phase|Lack of Efficacy|0|||
131651727|NCT01016262|474012604|FG004|Double-blind Phase|Lack of Efficacy|0|||
131651728|NCT01016262|474012605|FG005|Double-blind Phase|Lack of Efficacy|0|||
131651729|NCT01016262|474012600|FG000|Double-blind Phase|Disease Progression|0|||
131651730|NCT01016262|474012601|FG001|Double-blind Phase|Disease Progression|1|||
131651731|NCT01016262|474012602|FG002|Double-blind Phase|Disease Progression|2|||
131651732|NCT01016262|474012603|FG003|Double-blind Phase|Disease Progression|0|||
131651733|NCT01016262|474012604|FG004|Double-blind Phase|Disease Progression|0|||
131651734|NCT01016262|474012605|FG005|Double-blind Phase|Disease Progression|0|||
131651735|NCT01016262|474012600|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
131651736|NCT01016262|474012601|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
131651737|NCT01016262|474012602|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
131651738|NCT01016262|474012603|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
131651739|NCT01016262|474012604|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
131651740|NCT01016262|474012605|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
131651741|NCT01016262|474012600|FG000|Open-Label Phase|Adverse Event|0|||
131651742|NCT01016262|474012601|FG001|Open-Label Phase|Adverse Event|0|||
131651743|NCT01016262|474012602|FG002|Open-Label Phase|Adverse Event|0|||
131651744|NCT01016262|474012603|FG003|Open-Label Phase|Adverse Event|1|||
131651745|NCT01016262|474012604|FG004|Open-Label Phase|Adverse Event|0|||
131651746|NCT01016262|474012605|FG005|Open-Label Phase|Adverse Event|0|||
131651747|NCT01016262|474012600|FG000|Open-Label Phase|Lost to Follow-up|0|||
131651748|NCT01016262|474012601|FG001|Open-Label Phase|Lost to Follow-up|0|||
131651749|NCT01016262|474012602|FG002|Open-Label Phase|Lost to Follow-up|0|||
131651750|NCT01016262|474012603|FG003|Open-Label Phase|Lost to Follow-up|0|||
131651751|NCT01016262|474012604|FG004|Open-Label Phase|Lost to Follow-up|1|||
131651752|NCT01016262|474012605|FG005|Open-Label Phase|Lost to Follow-up|0|||
131651753|NCT01016262|474012600|FG000|Open-Label Phase|Lack of Efficacy|0|||
131651754|NCT01016262|474012601|FG001|Open-Label Phase|Lack of Efficacy|0|||
131651755|NCT01016262|474012602|FG002|Open-Label Phase|Lack of Efficacy|0|||
131651756|NCT01016262|474012603|FG003|Open-Label Phase|Lack of Efficacy|1|||
131651757|NCT01016262|474012604|FG004|Open-Label Phase|Lack of Efficacy|0|||
131651758|NCT01016262|474012605|FG005|Open-Label Phase|Lack of Efficacy|0|||
131716438|NCT01642212|474238960|FG001|Double-blind Treatment|Non-compliance|1|||
131716439|NCT01642212|474238961|FG002|Double-blind Treatment|Non-compliance|0|||
131716440|NCT01642212|474238962|FG003|Double-blind Treatment|Non-compliance|0|||
131716441|NCT01642212|474238963|FG004|Double-blind Treatment|Non-compliance|0|||
131651759|NCT01016262|474012600|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
131651760|NCT01016262|474012601|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
131651761|NCT01016262|474012602|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
131716442|NCT01642212|474238959|FG000|Double-blind Treatment|Adverse Event|0|||
131651762|NCT01016262|474012603|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
131651763|NCT01016262|474012604|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
131651764|NCT01016262|474012605|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
131651765|NCT01736540|474012606|FG000|Overall Study|Did not complete scan within 45 days|2|||
131651766|NCT01736540|474012606|FG000|Overall Study|Death|1|||
131651767|NCT01736540|474012606|FG000|Overall Study|Abnormal test procedure|1|||
131651768|NCT01736540|474012606|FG000|Overall Study|Withdrawal by Subject|5|||
131651769|NCT01736540|474012606|FG000|Overall Study|Protocol Violation|1|||
131651770|NCT01736540|474012606|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
131716443|NCT01642212|474238960|FG001|Double-blind Treatment|Adverse Event|0|||
131716444|NCT01642212|474238961|FG002|Double-blind Treatment|Adverse Event|1|||
131716445|NCT01642212|474238962|FG003|Double-blind Treatment|Adverse Event|0|||
131716446|NCT01642212|474238963|FG004|Double-blind Treatment|Adverse Event|0|||
131716447|NCT01642212|474238959|FG000|Open-label Extension|Adverse Event|0|||
131716448|NCT01642212|474238960|FG001|Open-label Extension|Adverse Event|0|||
131716449|NCT01642212|474238961|FG002|Open-label Extension|Adverse Event|0|||
131716450|NCT01642212|474238962|FG003|Open-label Extension|Adverse Event|3|||
131716451|NCT01642212|474238963|FG004|Open-label Extension|Adverse Event|0|||
131716452|NCT01642212|474238959|FG000|Open-label Extension|Sponsor Decision|0|||
131716453|NCT01642212|474238960|FG001|Open-label Extension|Sponsor Decision|0|||
131716454|NCT01642212|474238961|FG002|Open-label Extension|Sponsor Decision|0|||
131716455|NCT01642212|474238962|FG003|Open-label Extension|Sponsor Decision|7|||
131716456|NCT01642212|474238963|FG004|Open-label Extension|Sponsor Decision|4|||
131716457|NCT01642212|474238959|FG000|Open-label Extension|Consent Withdrawn|0|||
131716458|NCT01642212|474238960|FG001|Open-label Extension|Consent Withdrawn|0|||
131716459|NCT01642212|474238961|FG002|Open-label Extension|Consent Withdrawn|0|||
131716460|NCT01642212|474238962|FG003|Open-label Extension|Consent Withdrawn|0|||
131716461|NCT01642212|474238963|FG004|Open-label Extension|Consent Withdrawn|2|||
131716462|NCT01642212|474238959|FG000|Open-label Extension|Lost to Follow-up|0|||
131716463|NCT01642212|474238960|FG001|Open-label Extension|Lost to Follow-up|0|||
131716464|NCT01642212|474238961|FG002|Open-label Extension|Lost to Follow-up|0|||
131716465|NCT01642212|474238962|FG003|Open-label Extension|Lost to Follow-up|0|||
131716466|NCT01642212|474238963|FG004|Open-label Extension|Lost to Follow-up|1|||
131716467|NCT01642212|474238959|FG000|Open-label Extension|Other|0|||
131716468|NCT01642212|474238960|FG001|Open-label Extension|Other|0|||
131716469|NCT01642212|474238961|FG002|Open-label Extension|Other|0|||
131716470|NCT01642212|474238962|FG003|Open-label Extension|Other|0|||
131716471|NCT01642212|474238963|FG004|Open-label Extension|Other|1|||
131716472|NCT00947349|474238969|FG000|Triple Treatment Combination Period|Adverse Event|0|||
131716473|NCT00947349|474238970|FG001|Triple Treatment Combination Period|Adverse Event|1|||
131716474|NCT00947349|474238971|FG002|Triple Treatment Combination Period|Adverse Event|0|||
131716475|NCT00947349|474238972|FG003|Triple Treatment Combination Period|Adverse Event|0|||
131716476|NCT00947349|474238969|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
131716477|NCT00947349|474238970|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
131716478|NCT00947349|474238971|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
131716479|NCT00947349|474238972|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
131716480|NCT00947349|474238969|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
131716481|NCT00947349|474238970|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
131716482|NCT00947349|474238971|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
131716483|NCT00947349|474238972|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
131716484|NCT00947349|474238969|FG000|Overall Study Standard of Care|Other|0|||
131716485|NCT00947349|474238970|FG001|Overall Study Standard of Care|Other|0|||
131716486|NCT00947349|474238971|FG002|Overall Study Standard of Care|Other|0|||
131716487|NCT00947349|474238972|FG003|Overall Study Standard of Care|Other|1|||
131716488|NCT01697345|474238973|FG000|Overall Study|Withdrawal by Subject|1|||
131716489|NCT00140855|474238974|FG000|Overall Study|Progressive disease|2|||
131716490|NCT05262764|474238984|FG000|Overall Study|Case report form not collected|9|||
131716491|NCT05262764|474238984|FG000|Overall Study|No patient visits after entry|23|||
131716492|NCT05262764|474238984|FG000|Overall Study|Registration rule not followed|2|||
131716493|NCT05262764|474238984|FG000|Overall Study|Patient of non-chronic heart failure|1|||
131716494|NCT01392183|474238985|FG000|First Drug Administration|Adverse Event|3|||
131716495|NCT01392183|474238986|FG001|First Drug Administration|Adverse Event|2|||
131716496|NCT01392183|474238985|FG000|First Drug Administration|Death|1|||
131716497|NCT01392183|474238986|FG001|First Drug Administration|Death|0|||
131716498|NCT01392183|474238985|FG000|First Drug Administration|Withdrawal by Subject|10|||
131716499|NCT01392183|474238986|FG001|First Drug Administration|Withdrawal by Subject|17|||
131716500|NCT03430310|474238987|FG000|Overall Study|Protocol Violation|2|||
131716501|NCT03430310|474238988|FG001|Overall Study|Protocol Violation|0|||
131716502|NCT03430310|474238987|FG000|Overall Study|Withdrawal by Subject|3|||
131716503|NCT03430310|474238988|FG001|Overall Study|Withdrawal by Subject|2|||
131716504|NCT03430310|474238987|FG000|Overall Study|COVID shutdown March 2020|0|||
131716505|NCT03430310|474238988|FG001|Overall Study|COVID shutdown March 2020|1|||
131716506|NCT03972488|474238990|FG000|Overall Study|Progressive disease|42|||
131716507|NCT03972488|474238991|FG001|Overall Study|Progressive disease|44|||
131716508|NCT03972488|474238990|FG000|Overall Study|Physician Decision|13|||
131716509|NCT03972488|474238991|FG001|Overall Study|Physician Decision|7|||
131716510|NCT03972488|474238990|FG000|Overall Study|Adverse Event|8|||
131716511|NCT03972488|474238991|FG001|Overall Study|Adverse Event|1|||
131716512|NCT03972488|474238990|FG000|Overall Study|Death|4|||
131716513|NCT03972488|474238991|FG001|Overall Study|Death|4|||
131716514|NCT03972488|474238990|FG000|Overall Study|Withdrawal by Subject|3|||
131716515|NCT03972488|474238991|FG001|Overall Study|Withdrawal by Subject|4|||
131716516|NCT03972488|474238990|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
131716517|NCT03972488|474238991|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
131651771|NCT01736540|474012606|FG000|Overall Study|No show for MRI appointment|1|||
131651772|NCT01736540|474012606|FG000|Overall Study|Unable to make MRI appointment|3|||
131651773|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
131651774|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
131651775|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
131651776|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
131651777|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
131651778|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
131651779|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
131651780|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
131651781|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
131651782|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
131651783|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
131651784|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
131651785|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
131651786|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
131651787|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
131651788|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
131651789|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
131651790|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
131651791|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
131651792|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
131651793|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
131651794|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
131651795|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
131651796|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
131651797|NCT00479882|474012607|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
131651798|NCT00479882|474012608|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
131651799|NCT00479882|474012609|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
131651800|NCT00479882|474012610|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
131651801|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
131651802|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
131651803|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
131651804|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
131651805|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
131651806|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
131651807|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
131651808|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
131651809|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
131651810|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
131651811|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
131651812|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
131651813|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
131651814|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
131651815|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
131651816|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
131651817|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
131651818|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
131651819|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
131651820|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
131651821|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
131651822|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
131651823|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
131651824|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
131651825|NCT00479882|474012607|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
131651826|NCT00479882|474012608|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
131651827|NCT00479882|474012609|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
131651828|NCT00479882|474012610|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
131651829|NCT01132820|474012611|FG000|Overall Study|Ineligible: wrong cell type|1|||
131651830|NCT01132820|474012611|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
131651831|NCT01132820|474012611|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
131448128|NCT01716234|473270874|FG000|Overall Study|Adverse Event|7|||
131448129|NCT01716234|473270875|FG001|Overall Study|Adverse Event|10|||
131651832|NCT01132820|474012611|FG000|Overall Study|Never treated|1|||
131651833|NCT01132820|474012611|FG000|Overall Study|Inadequate data|1|||
131448130|NCT01716234|473270876|FG002|Overall Study|Adverse Event|2|||
131651834|NCT01370655|474012614|FG000|Period 1|Adverse Event|2|||
131651835|NCT01370655|474012615|FG001|Period 1|Adverse Event|0|||
131651836|NCT01370655|474012616|FG002|Period 1|Adverse Event|0|||
131651837|NCT01370655|474012617|FG003|Period 1|Adverse Event|0|||
131651838|NCT01370655|474012618|FG004|Period 1|Adverse Event|0|||
131651839|NCT01370655|474012619|FG005|Period 1|Adverse Event|0|||
131651840|NCT01370655|474012620|FG006|Period 1|Adverse Event|1|||
131651841|NCT01370655|474012621|FG007|Period 1|Adverse Event|0|||
131651842|NCT01370655|474012622|FG008|Period 1|Adverse Event|0|||
131651843|NCT01370655|474012623|FG009|Period 1|Adverse Event|0|||
131651844|NCT01370655|474012624|FG010|Period 1|Adverse Event|0|||
131651845|NCT01370655|474012625|FG011|Period 1|Adverse Event|0|||
131651846|NCT01370655|474012614|FG000|Period 2|Adverse Event|0|||
131651847|NCT01370655|474012615|FG001|Period 2|Adverse Event|0|||
131651848|NCT01370655|474012616|FG002|Period 2|Adverse Event|1|||
131651849|NCT01370655|474012617|FG003|Period 2|Adverse Event|0|||
131651850|NCT01370655|474012618|FG004|Period 2|Adverse Event|1|||
131651851|NCT01370655|474012619|FG005|Period 2|Adverse Event|0|||
131651852|NCT01370655|474012620|FG006|Period 2|Adverse Event|0|||
131651853|NCT01370655|474012621|FG007|Period 2|Adverse Event|1|||
131651854|NCT01370655|474012622|FG008|Period 2|Adverse Event|0|||
131651855|NCT01370655|474012623|FG009|Period 2|Adverse Event|0|||
131651856|NCT01370655|474012624|FG010|Period 2|Adverse Event|0|||
131651857|NCT01370655|474012625|FG011|Period 2|Adverse Event|0|||
131651858|NCT01370655|474012614|FG000|Period 2|met protocol specified stopping criteria|0|||
131651859|NCT01370655|474012615|FG001|Period 2|met protocol specified stopping criteria|0|||
131651860|NCT01370655|474012616|FG002|Period 2|met protocol specified stopping criteria|1|||
131651861|NCT01370655|474012617|FG003|Period 2|met protocol specified stopping criteria|0|||
131651862|NCT01370655|474012618|FG004|Period 2|met protocol specified stopping criteria|0|||
131651863|NCT01370655|474012619|FG005|Period 2|met protocol specified stopping criteria|0|||
131651864|NCT01370655|474012620|FG006|Period 2|met protocol specified stopping criteria|1|||
131651865|NCT01370655|474012621|FG007|Period 2|met protocol specified stopping criteria|0|||
131651866|NCT01370655|474012622|FG008|Period 2|met protocol specified stopping criteria|1|||
131651867|NCT01370655|474012623|FG009|Period 2|met protocol specified stopping criteria|0|||
131651868|NCT01370655|474012624|FG010|Period 2|met protocol specified stopping criteria|1|||
131651869|NCT01370655|474012625|FG011|Period 2|met protocol specified stopping criteria|0|||
131651870|NCT01370655|474012614|FG000|Period 2|Withdrawal by Subject|0|||
131651871|NCT01370655|474012615|FG001|Period 2|Withdrawal by Subject|0|||
131651872|NCT01370655|474012616|FG002|Period 2|Withdrawal by Subject|0|||
131651873|NCT01370655|474012617|FG003|Period 2|Withdrawal by Subject|0|||
131651874|NCT01370655|474012618|FG004|Period 2|Withdrawal by Subject|0|||
131651875|NCT01370655|474012619|FG005|Period 2|Withdrawal by Subject|0|||
131651876|NCT01370655|474012620|FG006|Period 2|Withdrawal by Subject|0|||
131651877|NCT01370655|474012621|FG007|Period 2|Withdrawal by Subject|0|||
131651878|NCT01370655|474012622|FG008|Period 2|Withdrawal by Subject|1|||
131651879|NCT01370655|474012623|FG009|Period 2|Withdrawal by Subject|0|||
131651880|NCT01370655|474012624|FG010|Period 2|Withdrawal by Subject|0|||
131651881|NCT01370655|474012625|FG011|Period 2|Withdrawal by Subject|0|||
131651882|NCT05000216|474012627|FG000|Stage 1|Lost to Follow-up|0|||
131651883|NCT05000216|474012628|FG001|Stage 1|Lost to Follow-up|0|||
131651884|NCT05000216|474012629|FG002|Stage 1|Lost to Follow-up|0|||
131651885|NCT05000216|474012630|FG003|Stage 1|Lost to Follow-up|0|||
131651886|NCT05000216|474012631|FG004|Stage 1|Lost to Follow-up|0|||
131651887|NCT05000216|474012632|FG005|Stage 1|Lost to Follow-up|0|||
131651888|NCT05000216|474012633|FG006|Stage 1|Lost to Follow-up|1|||
131716518|NCT02770807|474238996|FG000|Overall Study|Adverse Event|3|||
131716519|NCT02770807|474238997|FG001|Overall Study|Adverse Event|3|||
131716520|NCT02770807|474238998|FG002|Overall Study|Adverse Event|1|||
131716521|NCT02770807|474238996|FG000|Overall Study|Withdrawal by Subject|7|||
131716522|NCT02770807|474238997|FG001|Overall Study|Withdrawal by Subject|3|||
131716523|NCT02770807|474238998|FG002|Overall Study|Withdrawal by Subject|4|||
131716524|NCT02770807|474238996|FG000|Overall Study|Other|0|||
131716525|NCT02770807|474238997|FG001|Overall Study|Other|1|||
131716526|NCT02770807|474238998|FG002|Overall Study|Other|0|||
131803395|NCT00437658|474563699|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
131651889|NCT05000216|474012634|FG007|Stage 1|Lost to Follow-up|1|||
131651890|NCT05000216|474012635|FG008|Stage 1|Lost to Follow-up|0|||
131651891|NCT05000216|474012636|FG009|Stage 1|Lost to Follow-up|2|||
131651892|NCT05000216|474012637|FG010|Stage 1|Lost to Follow-up|3|||
131651893|NCT05000216|474012638|FG011|Stage 1|Lost to Follow-up|0|||
131651894|NCT05000216|474012639|FG012|Stage 1|Lost to Follow-up|0|||
131651895|NCT05000216|474012640|FG013|Stage 1|Lost to Follow-up|0|||
131651896|NCT05000216|474012641|FG014|Stage 1|Lost to Follow-up|0|||
131651897|NCT05000216|474012642|FG015|Stage 1|Lost to Follow-up|0|||
131651898|NCT05000216|474012643|FG016|Stage 1|Lost to Follow-up|0|||
131651899|NCT05000216|474012644|FG017|Stage 1|Lost to Follow-up|0|||
131651900|NCT05000216|474012645|FG018|Stage 1|Lost to Follow-up|0|||
131651901|NCT05000216|474012646|FG019|Stage 1|Lost to Follow-up|0|||
131651902|NCT05000216|474012647|FG020|Stage 1|Lost to Follow-up|0|||
131651903|NCT05000216|474012648|FG021|Stage 1|Lost to Follow-up|0|||
131716527|NCT02770807|474238996|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
131651904|NCT05000216|474012627|FG000|Stage 1|Physician Decision|0|||
131651905|NCT05000216|474012628|FG001|Stage 1|Physician Decision|0|||
131651906|NCT05000216|474012629|FG002|Stage 1|Physician Decision|0|||
131651907|NCT05000216|474012630|FG003|Stage 1|Physician Decision|0|||
131651908|NCT05000216|474012631|FG004|Stage 1|Physician Decision|0|||
131651909|NCT05000216|474012632|FG005|Stage 1|Physician Decision|0|||
131651910|NCT05000216|474012633|FG006|Stage 1|Physician Decision|0|||
131651911|NCT05000216|474012634|FG007|Stage 1|Physician Decision|1|||
131651912|NCT05000216|474012635|FG008|Stage 1|Physician Decision|1|||
131651913|NCT05000216|474012636|FG009|Stage 1|Physician Decision|0|||
131651914|NCT05000216|474012637|FG010|Stage 1|Physician Decision|0|||
131651915|NCT05000216|474012638|FG011|Stage 1|Physician Decision|0|||
131651916|NCT05000216|474012639|FG012|Stage 1|Physician Decision|0|||
131651917|NCT05000216|474012640|FG013|Stage 1|Physician Decision|0|||
131651918|NCT05000216|474012641|FG014|Stage 1|Physician Decision|0|||
131651919|NCT05000216|474012642|FG015|Stage 1|Physician Decision|0|||
131651920|NCT05000216|474012643|FG016|Stage 1|Physician Decision|0|||
131651921|NCT05000216|474012644|FG017|Stage 1|Physician Decision|0|||
131651922|NCT05000216|474012645|FG018|Stage 1|Physician Decision|0|||
131651923|NCT05000216|474012646|FG019|Stage 1|Physician Decision|0|||
131651924|NCT05000216|474012647|FG020|Stage 1|Physician Decision|0|||
131651925|NCT05000216|474012648|FG021|Stage 1|Physician Decision|0|||
131651926|NCT05000216|474012627|FG000|Stage 1|Withdrawal by Subject|0|||
131651927|NCT05000216|474012628|FG001|Stage 1|Withdrawal by Subject|1|||
131651928|NCT05000216|474012629|FG002|Stage 1|Withdrawal by Subject|0|||
131651929|NCT05000216|474012630|FG003|Stage 1|Withdrawal by Subject|0|||
131651930|NCT05000216|474012631|FG004|Stage 1|Withdrawal by Subject|0|||
131651931|NCT05000216|474012632|FG005|Stage 1|Withdrawal by Subject|0|||
131651932|NCT05000216|474012633|FG006|Stage 1|Withdrawal by Subject|0|||
131651933|NCT05000216|474012634|FG007|Stage 1|Withdrawal by Subject|0|||
131651934|NCT05000216|474012635|FG008|Stage 1|Withdrawal by Subject|0|||
131651935|NCT05000216|474012636|FG009|Stage 1|Withdrawal by Subject|3|||
131651936|NCT05000216|474012637|FG010|Stage 1|Withdrawal by Subject|10|||
131651937|NCT05000216|474012638|FG011|Stage 1|Withdrawal by Subject|0|||
131651938|NCT05000216|474012639|FG012|Stage 1|Withdrawal by Subject|0|||
131651939|NCT05000216|474012640|FG013|Stage 1|Withdrawal by Subject|0|||
131651940|NCT05000216|474012641|FG014|Stage 1|Withdrawal by Subject|0|||
131651941|NCT05000216|474012642|FG015|Stage 1|Withdrawal by Subject|0|||
131651942|NCT05000216|474012643|FG016|Stage 1|Withdrawal by Subject|0|||
131651943|NCT05000216|474012644|FG017|Stage 1|Withdrawal by Subject|0|||
131651944|NCT05000216|474012645|FG018|Stage 1|Withdrawal by Subject|0|||
131651945|NCT05000216|474012646|FG019|Stage 1|Withdrawal by Subject|0|||
131651946|NCT05000216|474012647|FG020|Stage 1|Withdrawal by Subject|0|||
131651947|NCT05000216|474012648|FG021|Stage 1|Withdrawal by Subject|0|||
131651948|NCT05000216|474012627|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
131651949|NCT05000216|474012628|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
131651950|NCT05000216|474012629|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
131651951|NCT05000216|474012630|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
131651952|NCT05000216|474012631|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
131651953|NCT05000216|474012632|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
131651954|NCT05000216|474012633|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
131651955|NCT05000216|474012634|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
131651956|NCT05000216|474012635|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
131651957|NCT05000216|474012636|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
131651958|NCT05000216|474012637|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
131651959|NCT05000216|474012638|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
131651960|NCT05000216|474012639|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
131651961|NCT05000216|474012640|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
131651962|NCT05000216|474012641|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
131651963|NCT05000216|474012642|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
131651964|NCT05000216|474012643|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
131651965|NCT05000216|474012644|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
131651966|NCT05000216|474012645|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
131651967|NCT05000216|474012646|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
131651968|NCT05000216|474012647|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
131651969|NCT05000216|474012648|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
131651970|NCT05000216|474012627|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651971|NCT05000216|474012628|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651972|NCT05000216|474012629|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651973|NCT05000216|474012630|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651974|NCT05000216|474012631|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651975|NCT05000216|474012632|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651976|NCT05000216|474012633|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651977|NCT05000216|474012634|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651978|NCT05000216|474012635|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
131651979|NCT05000216|474012636|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651980|NCT05000216|474012637|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651981|NCT05000216|474012638|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651982|NCT05000216|474012639|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651983|NCT05000216|474012640|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651984|NCT05000216|474012641|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651985|NCT05000216|474012642|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651986|NCT05000216|474012643|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651987|NCT05000216|474012644|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651988|NCT05000216|474012645|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651989|NCT05000216|474012646|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651990|NCT05000216|474012647|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651991|NCT05000216|474012648|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131651992|NCT05000216|474012627|FG000|Stage 1|Other|0|||
131651993|NCT05000216|474012628|FG001|Stage 1|Other|0|||
131651994|NCT05000216|474012629|FG002|Stage 1|Other|0|||
131651995|NCT05000216|474012630|FG003|Stage 1|Other|0|||
131651996|NCT05000216|474012631|FG004|Stage 1|Other|1|||
131651997|NCT05000216|474012632|FG005|Stage 1|Other|0|||
131651998|NCT05000216|474012633|FG006|Stage 1|Other|0|||
131651999|NCT05000216|474012634|FG007|Stage 1|Other|2|||
131652000|NCT05000216|474012635|FG008|Stage 1|Other|0|||
131652001|NCT05000216|474012636|FG009|Stage 1|Other|0|||
131652002|NCT05000216|474012637|FG010|Stage 1|Other|1|||
131652003|NCT05000216|474012638|FG011|Stage 1|Other|1|||
131652004|NCT05000216|474012639|FG012|Stage 1|Other|0|||
131652005|NCT05000216|474012640|FG013|Stage 1|Other|0|||
131652006|NCT05000216|474012641|FG014|Stage 1|Other|0|||
131652007|NCT05000216|474012642|FG015|Stage 1|Other|0|||
131652008|NCT05000216|474012643|FG016|Stage 1|Other|0|||
131652009|NCT05000216|474012644|FG017|Stage 1|Other|0|||
131652010|NCT05000216|474012645|FG018|Stage 1|Other|0|||
131652011|NCT05000216|474012646|FG019|Stage 1|Other|0|||
131652012|NCT05000216|474012647|FG020|Stage 1|Other|0|||
131652013|NCT05000216|474012648|FG021|Stage 1|Other|0|||
131652014|NCT05000216|474012627|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
131652015|NCT05000216|474012628|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
131652016|NCT05000216|474012629|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
131652017|NCT05000216|474012630|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
131652018|NCT05000216|474012631|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
131652019|NCT05000216|474012632|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
131652020|NCT05000216|474012633|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
131652021|NCT05000216|474012634|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
131652022|NCT05000216|474012635|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
131652023|NCT05000216|474012636|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
131652024|NCT05000216|474012637|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
131652025|NCT05000216|474012638|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
131652026|NCT05000216|474012639|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
131652027|NCT05000216|474012640|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
131652028|NCT05000216|474012641|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
131652029|NCT05000216|474012642|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
131652030|NCT05000216|474012643|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
131652031|NCT05000216|474012644|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
131652032|NCT05000216|474012645|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
131652033|NCT05000216|474012646|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
131652034|NCT05000216|474012647|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
131652035|NCT05000216|474012648|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
131652036|NCT05000216|474012627|FG000|Stage 2|Lost to Follow-up|0|||
131652037|NCT05000216|474012628|FG001|Stage 2|Lost to Follow-up|0|||
131652038|NCT05000216|474012629|FG002|Stage 2|Lost to Follow-up|0|||
131652039|NCT05000216|474012630|FG003|Stage 2|Lost to Follow-up|0|||
131903913|NCT00126594|474935371|FG000|Overall Study|Withdrawal by Subject|0|||
131903914|NCT00126594|474935372|FG001|Overall Study|Withdrawal by Subject|4|||
131903915|NCT00126594|474935371|FG000|Overall Study|Physician Decision|1|||
131903916|NCT00126594|474935372|FG001|Overall Study|Physician Decision|3|||
131903917|NCT00126594|474935371|FG000|Overall Study|Adverse Event|7|||
131903918|NCT00126594|474935372|FG001|Overall Study|Adverse Event|5|||
131652040|NCT05000216|474012631|FG004|Stage 2|Lost to Follow-up|0|||
131652041|NCT05000216|474012632|FG005|Stage 2|Lost to Follow-up|0|||
131652042|NCT05000216|474012633|FG006|Stage 2|Lost to Follow-up|0|||
131652043|NCT05000216|474012634|FG007|Stage 2|Lost to Follow-up|0|||
131652044|NCT05000216|474012635|FG008|Stage 2|Lost to Follow-up|0|||
131652045|NCT05000216|474012636|FG009|Stage 2|Lost to Follow-up|0|||
131652046|NCT05000216|474012637|FG010|Stage 2|Lost to Follow-up|0|||
131652047|NCT05000216|474012638|FG011|Stage 2|Lost to Follow-up|0|||
131652048|NCT05000216|474012639|FG012|Stage 2|Lost to Follow-up|0|||
131652049|NCT05000216|474012640|FG013|Stage 2|Lost to Follow-up|0|||
131652050|NCT05000216|474012641|FG014|Stage 2|Lost to Follow-up|0|||
131652051|NCT05000216|474012642|FG015|Stage 2|Lost to Follow-up|0|||
131652052|NCT05000216|474012643|FG016|Stage 2|Lost to Follow-up|4|||
131903919|NCT00126594|474935371|FG000|Overall Study|Non-compliance|0|||
131652053|NCT05000216|474012644|FG017|Stage 2|Lost to Follow-up|0|||
131652054|NCT05000216|474012645|FG018|Stage 2|Lost to Follow-up|0|||
131652055|NCT05000216|474012646|FG019|Stage 2|Lost to Follow-up|0|||
131652056|NCT05000216|474012647|FG020|Stage 2|Lost to Follow-up|0|||
131652057|NCT05000216|474012648|FG021|Stage 2|Lost to Follow-up|0|||
131652058|NCT05000216|474012627|FG000|Stage 2|Physician Decision|0|||
131652059|NCT05000216|474012628|FG001|Stage 2|Physician Decision|0|||
131652060|NCT05000216|474012629|FG002|Stage 2|Physician Decision|0|||
131652061|NCT05000216|474012630|FG003|Stage 2|Physician Decision|0|||
131652062|NCT05000216|474012631|FG004|Stage 2|Physician Decision|0|||
131652063|NCT05000216|474012632|FG005|Stage 2|Physician Decision|0|||
131652064|NCT05000216|474012633|FG006|Stage 2|Physician Decision|0|||
131652065|NCT05000216|474012634|FG007|Stage 2|Physician Decision|0|||
131652066|NCT05000216|474012635|FG008|Stage 2|Physician Decision|0|||
131652067|NCT05000216|474012636|FG009|Stage 2|Physician Decision|0|||
131652068|NCT05000216|474012637|FG010|Stage 2|Physician Decision|0|||
131652069|NCT05000216|474012638|FG011|Stage 2|Physician Decision|0|||
131652070|NCT05000216|474012639|FG012|Stage 2|Physician Decision|1|||
131652071|NCT05000216|474012640|FG013|Stage 2|Physician Decision|0|||
131652072|NCT05000216|474012641|FG014|Stage 2|Physician Decision|0|||
131652073|NCT05000216|474012642|FG015|Stage 2|Physician Decision|0|||
131652074|NCT05000216|474012643|FG016|Stage 2|Physician Decision|0|||
131652075|NCT05000216|474012644|FG017|Stage 2|Physician Decision|0|||
131652076|NCT05000216|474012645|FG018|Stage 2|Physician Decision|0|||
131652077|NCT05000216|474012646|FG019|Stage 2|Physician Decision|0|||
131652078|NCT05000216|474012647|FG020|Stage 2|Physician Decision|0|||
131652079|NCT05000216|474012648|FG021|Stage 2|Physician Decision|0|||
131652080|NCT05000216|474012627|FG000|Stage 2|Withdrawal by Subject|0|||
131652081|NCT05000216|474012628|FG001|Stage 2|Withdrawal by Subject|0|||
131652082|NCT05000216|474012629|FG002|Stage 2|Withdrawal by Subject|0|||
131652083|NCT05000216|474012630|FG003|Stage 2|Withdrawal by Subject|0|||
131652084|NCT05000216|474012631|FG004|Stage 2|Withdrawal by Subject|0|||
131652085|NCT05000216|474012632|FG005|Stage 2|Withdrawal by Subject|0|||
131652086|NCT05000216|474012633|FG006|Stage 2|Withdrawal by Subject|0|||
131652087|NCT05000216|474012634|FG007|Stage 2|Withdrawal by Subject|0|||
131803396|NCT00437658|474563697|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
131803397|NCT00437658|474563698|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
131652088|NCT05000216|474012635|FG008|Stage 2|Withdrawal by Subject|0|||
131652089|NCT05000216|474012636|FG009|Stage 2|Withdrawal by Subject|0|||
131652090|NCT05000216|474012637|FG010|Stage 2|Withdrawal by Subject|0|||
131652091|NCT05000216|474012638|FG011|Stage 2|Withdrawal by Subject|0|||
131652092|NCT05000216|474012639|FG012|Stage 2|Withdrawal by Subject|0|||
131652093|NCT05000216|474012640|FG013|Stage 2|Withdrawal by Subject|0|||
131716528|NCT02770807|474238997|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
131716529|NCT02770807|474238998|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
131716530|NCT02770807|474238996|FG000|Overall Study|Physician Decision|0|||
131716531|NCT02770807|474238997|FG001|Overall Study|Physician Decision|0|||
131716532|NCT02770807|474238998|FG002|Overall Study|Physician Decision|1|||
131716533|NCT03277196|474238999|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
131716534|NCT03277196|474238999|FG000|Overall Study|Lost to Follow-up|3|||
131716535|NCT03277196|474238999|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
131652094|NCT05000216|474012641|FG014|Stage 2|Withdrawal by Subject|2|||
131652095|NCT05000216|474012642|FG015|Stage 2|Withdrawal by Subject|0|||
131652096|NCT05000216|474012643|FG016|Stage 2|Withdrawal by Subject|9|||
131652097|NCT05000216|474012644|FG017|Stage 2|Withdrawal by Subject|0|||
131652098|NCT05000216|474012645|FG018|Stage 2|Withdrawal by Subject|0|||
131652099|NCT05000216|474012646|FG019|Stage 2|Withdrawal by Subject|0|||
131652100|NCT05000216|474012647|FG020|Stage 2|Withdrawal by Subject|0|||
131652101|NCT05000216|474012648|FG021|Stage 2|Withdrawal by Subject|0|||
131652102|NCT05000216|474012627|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
131652103|NCT05000216|474012628|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
131652104|NCT05000216|474012629|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
131652105|NCT05000216|474012630|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
131652106|NCT05000216|474012631|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
131652107|NCT05000216|474012632|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
131652108|NCT05000216|474012633|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
131652109|NCT05000216|474012634|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
131652110|NCT05000216|474012635|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
131652111|NCT05000216|474012636|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
131652112|NCT05000216|474012637|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
131652113|NCT05000216|474012638|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
131652114|NCT05000216|474012639|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
131652115|NCT05000216|474012640|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
131652116|NCT05000216|474012641|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
131652117|NCT05000216|474012642|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
131652118|NCT05000216|474012643|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
131652119|NCT05000216|474012644|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
131652120|NCT05000216|474012645|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
131652121|NCT05000216|474012646|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
131652122|NCT05000216|474012647|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
131652123|NCT05000216|474012648|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
131652124|NCT05000216|474012627|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652125|NCT05000216|474012628|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652126|NCT05000216|474012629|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652127|NCT05000216|474012630|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652128|NCT05000216|474012631|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652129|NCT05000216|474012632|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652130|NCT05000216|474012633|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652131|NCT05000216|474012634|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652132|NCT05000216|474012635|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652133|NCT05000216|474012636|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652134|NCT05000216|474012637|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652135|NCT05000216|474012638|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652136|NCT05000216|474012639|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652137|NCT05000216|474012640|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652138|NCT05000216|474012641|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
131652139|NCT05000216|474012642|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652140|NCT05000216|474012643|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
131716536|NCT03277196|474238999|FG000|Overall Study|Other|2|||
131716537|NCT01056107|474241026|FG000|Overall Study|Withdrawal by Subject|0|||
131716538|NCT01056107|474241027|FG001|Overall Study|Withdrawal by Subject|1|||
131716539|NCT01056107|474241028|FG002|Overall Study|Withdrawal by Subject|3|||
131716540|NCT01056107|474241029|FG003|Overall Study|Withdrawal by Subject|0|||
131716541|NCT02017444|474241030|FG000|Overall Study|Physician Decision|1|||
131716542|NCT02017444|474241031|FG001|Overall Study|Physician Decision|0|||
131716543|NCT02017444|474241030|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
131716544|NCT02017444|474241031|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
131716545|NCT00374556|474241032|FG000|Overall Study|Lost to Follow-up|1|||
131716546|NCT00374556|474241033|FG001|Overall Study|Lost to Follow-up|0|||
131716547|NCT00374556|474241032|FG000|Overall Study|Removed at baseline due to medical cond|0|||
131716548|NCT00374556|474241033|FG001|Overall Study|Removed at baseline due to medical cond|1|||
131716549|NCT01821963|474241040|FG000|Overall Study|Adverse Event|1|||
131716550|NCT00783289|474241041|FG000|Overall Study|Protocol Violation|0|||
131716551|NCT00783289|474241042|FG001|Overall Study|Protocol Violation|1|||
131716552|NCT00783289|474241043|FG002|Overall Study|Protocol Violation|0|||
131716553|NCT00783289|474241044|FG003|Overall Study|Protocol Violation|0|||
131652141|NCT05000216|474012644|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652142|NCT05000216|474012645|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652143|NCT05000216|474012646|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652144|NCT05000216|474012647|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652145|NCT05000216|474012648|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131652146|NCT05000216|474012627|FG000|Stage 2|Other reason|0|||
131652147|NCT05000216|474012628|FG001|Stage 2|Other reason|0|||
131652148|NCT05000216|474012629|FG002|Stage 2|Other reason|0|||
131652149|NCT05000216|474012630|FG003|Stage 2|Other reason|0|||
131652150|NCT05000216|474012631|FG004|Stage 2|Other reason|0|||
131652151|NCT05000216|474012632|FG005|Stage 2|Other reason|0|||
131652152|NCT05000216|474012633|FG006|Stage 2|Other reason|0|||
131652153|NCT05000216|474012634|FG007|Stage 2|Other reason|0|||
131652154|NCT05000216|474012635|FG008|Stage 2|Other reason|0|||
131652155|NCT05000216|474012636|FG009|Stage 2|Other reason|0|||
131652156|NCT05000216|474012637|FG010|Stage 2|Other reason|0|||
131652157|NCT05000216|474012638|FG011|Stage 2|Other reason|0|||
131652158|NCT05000216|474012639|FG012|Stage 2|Other reason|0|||
131652159|NCT05000216|474012640|FG013|Stage 2|Other reason|0|||
131652160|NCT05000216|474012641|FG014|Stage 2|Other reason|0|||
131652161|NCT05000216|474012642|FG015|Stage 2|Other reason|0|||
131652162|NCT05000216|474012643|FG016|Stage 2|Other reason|1|||
131652163|NCT05000216|474012644|FG017|Stage 2|Other reason|0|||
131652164|NCT05000216|474012645|FG018|Stage 2|Other reason|0|||
131652165|NCT05000216|474012646|FG019|Stage 2|Other reason|0|||
131652166|NCT05000216|474012647|FG020|Stage 2|Other reason|0|||
131652167|NCT05000216|474012648|FG021|Stage 2|Other reason|0|||
131652168|NCT05000216|474012627|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
131652169|NCT05000216|474012628|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
131652170|NCT05000216|474012629|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
131652171|NCT05000216|474012630|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
131652172|NCT05000216|474012631|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
131652173|NCT05000216|474012632|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
131652174|NCT05000216|474012633|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
131652175|NCT05000216|474012634|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
131652176|NCT05000216|474012635|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
131652177|NCT05000216|474012636|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
131652178|NCT05000216|474012637|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
131652179|NCT05000216|474012638|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
131652180|NCT05000216|474012639|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
131652181|NCT05000216|474012640|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
131652182|NCT05000216|474012641|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
131652183|NCT05000216|474012642|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
131652184|NCT05000216|474012643|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
131652185|NCT05000216|474012644|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
131652186|NCT05000216|474012645|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
131652187|NCT05000216|474012646|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
131652188|NCT05000216|474012647|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
131652189|NCT05000216|474012648|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
131652190|NCT05000216|474012627|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652191|NCT05000216|474012628|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652192|NCT05000216|474012629|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652193|NCT05000216|474012630|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652194|NCT05000216|474012631|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652195|NCT05000216|474012632|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652196|NCT05000216|474012633|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652197|NCT05000216|474012634|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652198|NCT05000216|474012635|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652199|NCT05000216|474012636|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652200|NCT05000216|474012637|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652201|NCT05000216|474012638|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652202|NCT05000216|474012639|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652203|NCT05000216|474012640|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
131716554|NCT01896232|474241045|FG000|Overall Study|Death|6|||
131716555|NCT01896232|474241046|FG001|Overall Study|Death|10|||
131652204|NCT05000216|474012641|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652205|NCT05000216|474012642|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
131652206|NCT05000216|474012643|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652207|NCT05000216|474012644|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652208|NCT05000216|474012645|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652209|NCT05000216|474012646|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652210|NCT05000216|474012647|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652211|NCT05000216|474012648|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
131652212|NCT05000216|474012627|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652213|NCT05000216|474012628|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652214|NCT05000216|474012629|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652215|NCT05000216|474012630|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652216|NCT05000216|474012631|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131716556|NCT01896232|474241045|FG000|Overall Study|Withdrawal by Subject|32|||
131716557|NCT01896232|474241046|FG001|Overall Study|Withdrawal by Subject|31|||
131716558|NCT01896232|474241045|FG000|Overall Study|Sponsor Decision|2|||
131716559|NCT01896232|474241046|FG001|Overall Study|Sponsor Decision|0|||
131716560|NCT01896232|474241045|FG000|Overall Study|Lost to Follow-up|9|||
131716561|NCT01896232|474241046|FG001|Overall Study|Lost to Follow-up|12|||
131716562|NCT01217606|474241049|FG000|Initial Treatment Phase|Other Reasons|0|||
131716563|NCT01217606|474241050|FG001|Initial Treatment Phase|Other Reasons|2|||
131716564|NCT01217606|474241049|FG000|Initial Treatment Phase|Protocol Violation|3|||
131716565|NCT01217606|474241050|FG001|Initial Treatment Phase|Protocol Violation|2|||
131716566|NCT01217606|474241049|FG000|Initial Treatment Phase|Personal Reasons|0|||
131716567|NCT01217606|474241050|FG001|Initial Treatment Phase|Personal Reasons|2|||
131716568|NCT01217606|474241049|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
131716569|NCT01217606|474241050|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
131716570|NCT01217606|474241049|FG000|Initial Treatment Phase|Adverse Event|10|||
131716571|NCT01217606|474241050|FG001|Initial Treatment Phase|Adverse Event|6|||
131716572|NCT01217606|474241049|FG000|9-Month Masked Extension|Adverse Event|3|||
131716573|NCT01217606|474241050|FG001|9-Month Masked Extension|Adverse Event|6|||
131716574|NCT01217606|474241049|FG000|9-Month Masked Extension|Other Reasons|4|||
131716575|NCT01217606|474241050|FG001|9-Month Masked Extension|Other Reasons|4|||
131716576|NCT01217606|474241049|FG000|9-Month Masked Extension|Personal Reasons|2|||
131716577|NCT01217606|474241050|FG001|9-Month Masked Extension|Personal Reasons|1|||
131716578|NCT01217606|474241049|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
131716579|NCT01217606|474241050|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
131716580|NCT01217606|474241049|FG000|9-Month Masked Extension|Pregnancy|1|||
131716581|NCT01217606|474241050|FG001|9-Month Masked Extension|Pregnancy|0|||
131716582|NCT01217606|474241049|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
131716583|NCT01217606|474241050|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
131716584|NCT04419506|474241053|FG000|Overall Study|Adverse Event|0|||
131716585|NCT04419506|474241054|FG001|Overall Study|Adverse Event|10|||
131716586|NCT04419506|474241055|FG002|Overall Study|Adverse Event|0|||
131716587|NCT04419506|474241056|FG003|Overall Study|Adverse Event|3|||
131716588|NCT04419506|474241053|FG000|Overall Study|Withdrawal by Subject|0|||
131716589|NCT04419506|474241054|FG001|Overall Study|Withdrawal by Subject|0|||
131716590|NCT04419506|474241055|FG002|Overall Study|Withdrawal by Subject|0|||
131716591|NCT04419506|474241056|FG003|Overall Study|Withdrawal by Subject|1|||
131716592|NCT04419506|474241053|FG000|Overall Study|poor-compliance|0|||
131716593|NCT04419506|474241054|FG001|Overall Study|poor-compliance|0|||
131716594|NCT04419506|474241055|FG002|Overall Study|poor-compliance|0|||
131716595|NCT04419506|474241056|FG003|Overall Study|poor-compliance|1|||
131716596|NCT03976401|474241063|FG000|Overall Study|Adverse Event|2|||
131716597|NCT03976401|474241064|FG001|Overall Study|Adverse Event|0|||
131716598|NCT03976401|474241065|FG002|Overall Study|Adverse Event|4|||
131716599|NCT03976401|474241066|FG003|Overall Study|Adverse Event|1|||
131716600|NCT03976401|474241067|FG004|Overall Study|Adverse Event|1|||
131716601|NCT03976401|474241068|FG005|Overall Study|Adverse Event|0|||
131716602|NCT03976401|474241063|FG000|Overall Study|Withdrawal by Subject|0|||
131716603|NCT03976401|474241064|FG001|Overall Study|Withdrawal by Subject|1|||
131716604|NCT03976401|474241065|FG002|Overall Study|Withdrawal by Subject|0|||
131716605|NCT03976401|474241066|FG003|Overall Study|Withdrawal by Subject|0|||
131716606|NCT03976401|474241067|FG004|Overall Study|Withdrawal by Subject|0|||
131903920|NCT00126594|474935372|FG001|Overall Study|Non-compliance|1|||
131716607|NCT03976401|474241068|FG005|Overall Study|Withdrawal by Subject|1|||
131716608|NCT03976401|474241063|FG000|Overall Study|Physician Decision|0|||
131716609|NCT03976401|474241064|FG001|Overall Study|Physician Decision|0|||
131716610|NCT03976401|474241065|FG002|Overall Study|Physician Decision|1|||
131716611|NCT03976401|474241066|FG003|Overall Study|Physician Decision|0|||
131716612|NCT03976401|474241067|FG004|Overall Study|Physician Decision|0|||
131716613|NCT03976401|474241068|FG005|Overall Study|Physician Decision|0|||
131716614|NCT03976401|474241063|FG000|Overall Study|Lost to Follow-up|1|||
131716615|NCT03976401|474241064|FG001|Overall Study|Lost to Follow-up|2|||
131716616|NCT03976401|474241065|FG002|Overall Study|Lost to Follow-up|0|||
131716617|NCT03976401|474241066|FG003|Overall Study|Lost to Follow-up|0|||
131716618|NCT03976401|474241067|FG004|Overall Study|Lost to Follow-up|0|||
131716619|NCT03976401|474241068|FG005|Overall Study|Lost to Follow-up|0|||
131716620|NCT03976401|474241063|FG000|Overall Study|Protocol Violation|0|||
131716621|NCT03976401|474241064|FG001|Overall Study|Protocol Violation|1|||
131716622|NCT03976401|474241065|FG002|Overall Study|Protocol Violation|0|||
131716623|NCT03976401|474241066|FG003|Overall Study|Protocol Violation|0|||
131716624|NCT03976401|474241067|FG004|Overall Study|Protocol Violation|0|||
131716625|NCT03976401|474241068|FG005|Overall Study|Protocol Violation|0|||
131716626|NCT03976401|474241063|FG000|Overall Study|Withdrew Consent|0|||
131716627|NCT03976401|474241064|FG001|Overall Study|Withdrew Consent|0|||
131903921|NCT00126594|474935371|FG000|Overall Study|Disease Progression|29|||
131716628|NCT03976401|474241065|FG002|Overall Study|Withdrew Consent|0|||
131716629|NCT03976401|474241066|FG003|Overall Study|Withdrew Consent|1|||
131716630|NCT03976401|474241067|FG004|Overall Study|Withdrew Consent|0|||
131716631|NCT03976401|474241068|FG005|Overall Study|Withdrew Consent|0|||
131716632|NCT01503021|474241070|FG000|Overall Study|Adverse Event|7|||
131803398|NCT00437658|474563699|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
131803399|NCT00437658|474563697|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
131803400|NCT00437658|474563698|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
131803401|NCT00437658|474563699|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
131652217|NCT05000216|474012632|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652218|NCT05000216|474012633|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652219|NCT05000216|474012634|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652220|NCT05000216|474012635|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652221|NCT05000216|474012636|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652222|NCT05000216|474012637|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652223|NCT05000216|474012638|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652224|NCT05000216|474012639|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652225|NCT05000216|474012640|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
131652226|NCT05000216|474012641|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652227|NCT05000216|474012642|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
131652228|NCT05000216|474012643|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652229|NCT05000216|474012644|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652230|NCT05000216|474012645|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
131652231|NCT05000216|474012646|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652232|NCT05000216|474012647|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652233|NCT05000216|474012648|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131652234|NCT02057575|474012650|FG000|Overall Study|Adverse Event|0|||
131652235|NCT02057575|474012651|FG001|Overall Study|Adverse Event|2|||
131652236|NCT02057575|474012652|FG002|Overall Study|Adverse Event|0|||
131652237|NCT02057575|474012653|FG003|Overall Study|Adverse Event|1|||
131652238|NCT02057575|474012650|FG000|Overall Study|Withdrawal by Subject|1|||
131652239|NCT02057575|474012651|FG001|Overall Study|Withdrawal by Subject|0|||
131652240|NCT02057575|474012652|FG002|Overall Study|Withdrawal by Subject|0|||
131652241|NCT02057575|474012653|FG003|Overall Study|Withdrawal by Subject|0|||
131652242|NCT02057575|474012650|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
131652243|NCT02057575|474012651|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
131652244|NCT02057575|474012652|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
131652245|NCT02057575|474012653|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
131652246|NCT02057575|474012650|FG000|Overall Study|Protocol Violation|0|||
131652247|NCT02057575|474012651|FG001|Overall Study|Protocol Violation|1|||
131652248|NCT02057575|474012652|FG002|Overall Study|Protocol Violation|0|||
131652249|NCT02057575|474012653|FG003|Overall Study|Protocol Violation|0|||
131652250|NCT00332462|474012654|FG000|Overall Study|Adverse Event|5|||
131652251|NCT00332462|474012654|FG000|Overall Study|Abnormal Lab Value|1|||
131652252|NCT00332462|474012654|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131652253|NCT00332462|474012654|FG000|Overall Study|no longer requires study drug|1|||
131652254|NCT00332462|474012654|FG000|Overall Study|Death|3|||
131652255|NCT00332462|474012654|FG000|Overall Study|Graft Loss|2|||
131652256|NCT01643044|474012655|FG000|Overall Study|Lost to Follow-up|1|||
131652257|NCT01643044|474012656|FG001|Overall Study|Lost to Follow-up|1|||
131652258|NCT01643044|474012655|FG000|Overall Study|Miscarried baby|2|||
131652259|NCT01643044|474012656|FG001|Overall Study|Miscarried baby|2|||
131803402|NCT00437658|474563697|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
131803403|NCT00437658|474563698|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
131803404|NCT00437658|474563699|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
131803405|NCT00437658|474563697|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
131803406|NCT00437658|474563698|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
131803407|NCT00437658|474563699|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
131803408|NCT00437658|474563697|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
131803409|NCT00437658|474563698|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
131803410|NCT00437658|474563699|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
131803411|NCT00437658|474563697|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
131903922|NCT00126594|474935372|FG001|Overall Study|Disease Progression|24|||
131652260|NCT01643044|474012655|FG000|Overall Study|Delivered outside of hospital|1|||
131652261|NCT01643044|474012656|FG001|Overall Study|Delivered outside of hospital|2|||
131652262|NCT01735175|474012657|FG000|Overall Study|Withdrawal by Subject|9|||
131652263|NCT01735175|474012658|FG001|Overall Study|Withdrawal by Subject|2|||
131652264|NCT01735175|474012657|FG000|Overall Study|Lost to Follow-up|4|||
131652265|NCT01735175|474012658|FG001|Overall Study|Lost to Follow-up|2|||
131903923|NCT03769649|474935373|FG000|Overall Study|Lost to Follow-up|4|||
131448131|NCT01716234|473270877|FG003|Overall Study|Adverse Event|8|||
131448132|NCT01716234|473270878|FG004|Overall Study|Adverse Event|3|||
131652266|NCT01735175|474012657|FG000|Overall Study|Death|3|||
131652267|NCT01735175|474012658|FG001|Overall Study|Death|2|||
131652268|NCT01735175|474012657|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
131652269|NCT01735175|474012658|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
131652270|NCT00659880|474012659|FG000|Overall Study|Lost to Follow-up|5|||
131652271|NCT01031628|474012660|FG000|Overall Study|Study terminated early|0|||
131652272|NCT01031628|474012661|FG001|Overall Study|Study terminated early|1|||
131652273|NCT01031628|474012662|FG002|Overall Study|Study terminated early|3|||
131652274|NCT01031628|474012663|FG003|Overall Study|Study terminated early|0|||
131652275|NCT02195479|474012665|FG000|Overall Study|Lost to Follow-up|18|||
131652276|NCT02195479|474012666|FG001|Overall Study|Lost to Follow-up|15|||
131652277|NCT02195479|474012665|FG000|Overall Study|Death|217|||
131652278|NCT02195479|474012666|FG001|Overall Study|Death|171|||
131652279|NCT02195479|474012665|FG000|Overall Study|Physician Decision|1|||
131652280|NCT02195479|474012666|FG001|Overall Study|Physician Decision|0|||
131652281|NCT02195479|474012665|FG000|Overall Study|Withdrawal by Subject|30|||
131652282|NCT02195479|474012666|FG001|Overall Study|Withdrawal by Subject|30|||
131652283|NCT02195479|474012665|FG000|Overall Study|Other|3|||
131652284|NCT02195479|474012666|FG001|Overall Study|Other|4|||
131652285|NCT02195479|474012665|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
131652286|NCT02195479|474012666|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
131652287|NCT03443414|474012667|FG000|Overall Study|Adverse Event|6|||
131652288|NCT03443414|474012668|FG001|Overall Study|Adverse Event|0|||
131652289|NCT03443414|474012669|FG002|Overall Study|Adverse Event|4|||
131652290|NCT03443414|474012670|FG003|Overall Study|Adverse Event|2|||
131652291|NCT03443414|474012671|FG004|Overall Study|Adverse Event|3|||
131652292|NCT03443414|474012667|FG000|Overall Study|Withdrawal by Subject|3|||
131652293|NCT03443414|474012668|FG001|Overall Study|Withdrawal by Subject|2|||
131652294|NCT03443414|474012669|FG002|Overall Study|Withdrawal by Subject|2|||
131652295|NCT03443414|474012670|FG003|Overall Study|Withdrawal by Subject|2|||
131652296|NCT03443414|474012671|FG004|Overall Study|Withdrawal by Subject|1|||
131652297|NCT03443414|474012667|FG000|Overall Study|Death|0|||
131652298|NCT03443414|474012668|FG001|Overall Study|Death|1|||
131652299|NCT03443414|474012669|FG002|Overall Study|Death|0|||
131652300|NCT03443414|474012670|FG003|Overall Study|Death|1|||
131652301|NCT03443414|474012671|FG004|Overall Study|Death|0|||
131652302|NCT03443414|474012667|FG000|Overall Study|Reason not specified|2|||
131803412|NCT00437658|474563698|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
131803413|NCT00437658|474563699|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
131803414|NCT00437658|474563697|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
131803415|NCT00437658|474563698|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
131803416|NCT00437658|474563699|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
131803417|NCT00437658|474563697|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
131803418|NCT00437658|474563698|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
131803419|NCT00437658|474563699|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
131803420|NCT00437658|474563697|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
131803421|NCT00437658|474563698|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
131803422|NCT00437658|474563699|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
131803423|NCT00437658|474563697|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
131803424|NCT00437658|474563698|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
131803425|NCT00437658|474563699|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
131803426|NCT02152566|474563700|FG000|Overall Study|Lost to Follow-up|1|||
131803427|NCT02152566|474563700|FG000|Overall Study|Withdrawal by Subject|2|||
131803428|NCT04407806|474563701|FG000|Overall Study|Withdrawal by Subject|1|||
131803429|NCT04407806|474563702|FG001|Overall Study|Withdrawal by Subject|2|||
131803430|NCT01440283|474563707|FG000|Overall Study|Death|3|||
131803431|NCT01440283|474563707|FG000|Overall Study|Withdrawal by Subject|4|||
131803432|NCT01440283|474563707|FG000|Overall Study|Physician Decision|3|||
131803433|NCT01735630|474563713|FG000|Overall Study|Adverse Event|8|||
131803434|NCT01735630|474563714|FG001|Overall Study|Adverse Event|7|||
131803435|NCT01735630|474563713|FG000|Overall Study|Lost to Follow-up|1|||
131803436|NCT01735630|474563714|FG001|Overall Study|Lost to Follow-up|0|||
131803437|NCT01735630|474563713|FG000|Overall Study|Physician Decision|0|||
131803438|NCT01735630|474563714|FG001|Overall Study|Physician Decision|1|||
131803439|NCT01735630|474563713|FG000|Overall Study|Sponsor Decision|2|||
131803440|NCT01735630|474563714|FG001|Overall Study|Sponsor Decision|1|||
131803441|NCT01735630|474563713|FG000|Overall Study|Withdrawal by Subject|7|||
131652303|NCT03443414|474012668|FG001|Overall Study|Reason not specified|0|||
131652304|NCT03443414|474012669|FG002|Overall Study|Reason not specified|0|||
131652305|NCT03443414|474012670|FG003|Overall Study|Reason not specified|0|||
131652306|NCT03443414|474012671|FG004|Overall Study|Reason not specified|1|||
131652307|NCT01436305|474012676|FG000|Overall Study|Death|1|||
131652308|NCT01436305|474012677|FG001|Overall Study|Death|0|||
131652309|NCT01436305|474012678|FG002|Overall Study|Death|0|||
131652310|NCT01436305|474012676|FG000|Overall Study|Lost to Follow-up|0|||
131652311|NCT01436305|474012677|FG001|Overall Study|Lost to Follow-up|1|||
131652312|NCT01436305|474012678|FG002|Overall Study|Lost to Follow-up|0|||
131652313|NCT01436305|474012676|FG000|Overall Study|Withdrawal by Subject|1|||
131652314|NCT01436305|474012677|FG001|Overall Study|Withdrawal by Subject|3|||
131652315|NCT01436305|474012678|FG002|Overall Study|Withdrawal by Subject|0|||
131652316|NCT01154140|474012680|FG000|Overall Study|Death|71|||
131716633|NCT01503021|474241071|FG001|Overall Study|Adverse Event|6|||
131716634|NCT01503021|474241070|FG000|Overall Study|Death|0|||
131716635|NCT01503021|474241071|FG001|Overall Study|Death|2|||
131716636|NCT01503021|474241070|FG000|Overall Study|Lost to Follow-up|2|||
131716637|NCT01503021|474241071|FG001|Overall Study|Lost to Follow-up|0|||
131716638|NCT01503021|474241070|FG000|Overall Study|Physician Decision|3|||
131716639|NCT01503021|474241071|FG001|Overall Study|Physician Decision|0|||
131716640|NCT01503021|474241070|FG000|Overall Study|Protocol Violation|1|||
131716641|NCT01503021|474241071|FG001|Overall Study|Protocol Violation|3|||
131716642|NCT01503021|474241070|FG000|Overall Study|Withdrawal by Subject|9|||
131716643|NCT01503021|474241071|FG001|Overall Study|Withdrawal by Subject|8|||
131716644|NCT01503021|474241070|FG000|Overall Study|Moved, received transplant, etc.|5|||
131716645|NCT01503021|474241071|FG001|Overall Study|Moved, received transplant, etc.|7|||
131716646|NCT00817414|474241072|FG000|Overall Study|Adverse Event|1|||
131716647|NCT00817414|474241073|FG001|Overall Study|Adverse Event|1|||
131716648|NCT00817414|474241074|FG002|Overall Study|Adverse Event|1|||
131716649|NCT00817414|474241075|FG003|Overall Study|Adverse Event|0|||
131716650|NCT00817414|474241076|FG004|Overall Study|Adverse Event|0|||
131716651|NCT00817414|474241072|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
131716652|NCT00817414|474241073|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
131716653|NCT00817414|474241074|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
131716654|NCT00817414|474241075|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
131716655|NCT00817414|474241076|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
131716656|NCT00817414|474241072|FG000|Overall Study|Withdrawal by Subject|1|||
131716657|NCT00817414|474241073|FG001|Overall Study|Withdrawal by Subject|1|||
131716658|NCT00817414|474241074|FG002|Overall Study|Withdrawal by Subject|0|||
131716659|NCT00817414|474241075|FG003|Overall Study|Withdrawal by Subject|0|||
131716660|NCT00817414|474241076|FG004|Overall Study|Withdrawal by Subject|0|||
131716661|NCT00817414|474241072|FG000|Overall Study|Lost to Follow-up|0|||
131716662|NCT00817414|474241073|FG001|Overall Study|Lost to Follow-up|0|||
131716663|NCT00817414|474241074|FG002|Overall Study|Lost to Follow-up|1|||
131716664|NCT00817414|474241075|FG003|Overall Study|Lost to Follow-up|1|||
131716665|NCT00817414|474241076|FG004|Overall Study|Lost to Follow-up|1|||
131716666|NCT00817414|474241072|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131716667|NCT00817414|474241073|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131716668|NCT00817414|474241074|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131716669|NCT00817414|474241075|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
131716670|NCT00817414|474241076|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131716671|NCT00817414|474241072|FG000|Overall Study|Protocol Violation|0|||
131716672|NCT00817414|474241073|FG001|Overall Study|Protocol Violation|0|||
131716673|NCT00817414|474241074|FG002|Overall Study|Protocol Violation|0|||
131716674|NCT00817414|474241075|FG003|Overall Study|Protocol Violation|0|||
131716675|NCT00817414|474241076|FG004|Overall Study|Protocol Violation|1|||
131716676|NCT00097539|474241077|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
131716677|NCT00097539|474241078|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
131716678|NCT00097539|474241079|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
131716679|NCT00097539|474241080|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
131716680|NCT00097539|474241081|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
131716681|NCT00097539|474241082|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
131716682|NCT00097539|474241083|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
131716683|NCT00097539|474241077|FG000|Overall Study|Withdrawal by Subject|925|||
131716684|NCT00097539|474241078|FG001|Overall Study|Withdrawal by Subject|323|||
131716685|NCT00097539|474241079|FG002|Overall Study|Withdrawal by Subject|346|||
131716686|NCT00097539|474241080|FG003|Overall Study|Withdrawal by Subject|217|||
131716687|NCT00097539|474241081|FG004|Overall Study|Withdrawal by Subject|68|||
131716688|NCT00097539|474241082|FG005|Overall Study|Withdrawal by Subject|229|||
131716689|NCT00097539|474241083|FG006|Overall Study|Withdrawal by Subject|3|||
131716690|NCT00097539|474241077|FG000|Overall Study|Participant Non-compliant|2140|||
131716691|NCT00097539|474241078|FG001|Overall Study|Participant Non-compliant|567|||
131716692|NCT00097539|474241079|FG002|Overall Study|Participant Non-compliant|1067|||
131716693|NCT00097539|474241080|FG003|Overall Study|Participant Non-compliant|353|||
131716694|NCT00097539|474241081|FG004|Overall Study|Participant Non-compliant|136|||
131716695|NCT00097539|474241082|FG005|Overall Study|Participant Non-compliant|543|||
131716696|NCT00097539|474241083|FG006|Overall Study|Participant Non-compliant|18|||
131716697|NCT00097539|474241077|FG000|Overall Study|Lack of Efficacy|249|||
131716698|NCT00097539|474241078|FG001|Overall Study|Lack of Efficacy|122|||
131716699|NCT00097539|474241079|FG002|Overall Study|Lack of Efficacy|202|||
131716700|NCT00097539|474241080|FG003|Overall Study|Lack of Efficacy|105|||
131716701|NCT00097539|474241081|FG004|Overall Study|Lack of Efficacy|45|||
131716702|NCT00097539|474241082|FG005|Overall Study|Lack of Efficacy|228|||
131716703|NCT00097539|474241083|FG006|Overall Study|Lack of Efficacy|5|||
131716704|NCT00097539|474241077|FG000|Overall Study|Adverse Event|78|||
131716705|NCT00097539|474241078|FG001|Overall Study|Adverse Event|133|||
131716706|NCT00097539|474241079|FG002|Overall Study|Adverse Event|37|||
131803442|NCT01735630|474563714|FG001|Overall Study|Withdrawal by Subject|9|||
131803443|NCT03099538|474563715|FG000|Overall Study|Lack of Efficacy|3|||
131803444|NCT00440557|474563716|FG000|Overall Study|Withdrawal by Subject|10|||
131803445|NCT00440557|474563717|FG001|Overall Study|Withdrawal by Subject|5|||
131803446|NCT00440557|474563718|FG002|Overall Study|Withdrawal by Subject|11|||
131803447|NCT00440557|474563716|FG000|Overall Study|Lost to Follow-up|1|||
131803448|NCT00440557|474563717|FG001|Overall Study|Lost to Follow-up|2|||
131803449|NCT00440557|474563718|FG002|Overall Study|Lost to Follow-up|6|||
131803450|NCT00440557|474563716|FG000|Overall Study|Adverse Event|3|||
131803451|NCT00440557|474563717|FG001|Overall Study|Adverse Event|3|||
131803452|NCT00440557|474563718|FG002|Overall Study|Adverse Event|5|||
131803453|NCT00440557|474563716|FG000|Overall Study|Death|2|||
131803454|NCT00440557|474563717|FG001|Overall Study|Death|6|||
131803455|NCT00440557|474563718|FG002|Overall Study|Death|3|||
131803456|NCT00440557|474563716|FG000|Overall Study|Began Dialysis|4|||
131803457|NCT00440557|474563717|FG001|Overall Study|Began Dialysis|1|||
131803458|NCT00440557|474563718|FG002|Overall Study|Began Dialysis|4|||
131803459|NCT00440557|474563716|FG000|Overall Study|Principal Investigator decision|0|||
131803460|NCT00440557|474563717|FG001|Overall Study|Principal Investigator decision|3|||
131803461|NCT00440557|474563718|FG002|Overall Study|Principal Investigator decision|1|||
131803462|NCT00440557|474563716|FG000|Overall Study|Patient moved|1|||
131803463|NCT00440557|474563717|FG001|Overall Study|Patient moved|2|||
131803464|NCT00440557|474563718|FG002|Overall Study|Patient moved|1|||
131803465|NCT00440557|474563716|FG000|Overall Study|Principal Investigator's office closed|3|||
131803466|NCT00440557|474563717|FG001|Overall Study|Principal Investigator's office closed|6|||
131803467|NCT00440557|474563718|FG002|Overall Study|Principal Investigator's office closed|4|||
131803468|NCT00440557|474563716|FG000|Overall Study|Patient transferred to nursing home|0|||
131803469|NCT00440557|474563717|FG001|Overall Study|Patient transferred to nursing home|1|||
131803470|NCT00440557|474563718|FG002|Overall Study|Patient transferred to nursing home|0|||
131803471|NCT00440557|474563716|FG000|Overall Study|Patient had surgery|1|||
131803472|NCT00440557|474563717|FG001|Overall Study|Patient had surgery|0|||
131803473|NCT00440557|474563718|FG002|Overall Study|Patient had surgery|0|||
131803474|NCT01720264|474563719|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
131803475|NCT01720264|474563719|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
131803476|NCT01720264|474563719|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
131803477|NCT00615069|474563729|FG000|Overall Study|Death|10|||
131803478|NCT00615069|474563729|FG000|Overall Study|Physician Decision|2|||
131803479|NCT00615069|474563729|FG000|Overall Study|Withdrawal by Subject|4|||
131803480|NCT00669942|474563731|FG000|Parts 2 and 3|Adverse Event|0|||
131803481|NCT00669942|474563732|FG001|Parts 2 and 3|Adverse Event|0|||
131803482|NCT00669942|474563733|FG002|Parts 2 and 3|Adverse Event|0|||
131803483|NCT00669942|474563734|FG003|Parts 2 and 3|Adverse Event|0|||
131803484|NCT00669942|474563735|FG004|Parts 2 and 3|Adverse Event|0|||
131803485|NCT00669942|474563736|FG005|Parts 2 and 3|Adverse Event|0|||
131803486|NCT00669942|474563737|FG006|Parts 2 and 3|Adverse Event|0|||
131803487|NCT00669942|474563738|FG007|Parts 2 and 3|Adverse Event|2|||
131803488|NCT00669942|474563739|FG008|Parts 2 and 3|Adverse Event|1|||
131803489|NCT00669942|474563740|FG009|Parts 2 and 3|Adverse Event|0|||
131803490|NCT00669942|474563741|FG010|Parts 2 and 3|Adverse Event|0|||
131803491|NCT00669942|474563742|FG011|Parts 2 and 3|Adverse Event|0|||
131803492|NCT00669942|474563731|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
131803493|NCT00669942|474563732|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
131803494|NCT00669942|474563733|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
131803495|NCT00669942|474563734|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
131803496|NCT00669942|474563735|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
131803497|NCT00669942|474563736|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
131803498|NCT00669942|474563737|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
131803499|NCT00669942|474563738|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
131803500|NCT00669942|474563739|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
131803501|NCT00669942|474563740|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
131803502|NCT00669942|474563741|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
131803503|NCT00669942|474563742|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
131803504|NCT00669942|474563731|FG000|Parts 2 and 3|Protocol Violation|0|||
131803505|NCT00669942|474563732|FG001|Parts 2 and 3|Protocol Violation|0|||
131803506|NCT00669942|474563733|FG002|Parts 2 and 3|Protocol Violation|0|||
131803507|NCT00669942|474563734|FG003|Parts 2 and 3|Protocol Violation|0|||
131803508|NCT00669942|474563735|FG004|Parts 2 and 3|Protocol Violation|0|||
131803509|NCT00669942|474563736|FG005|Parts 2 and 3|Protocol Violation|1|||
131803510|NCT00669942|474563737|FG006|Parts 2 and 3|Protocol Violation|0|||
131803511|NCT00669942|474563738|FG007|Parts 2 and 3|Protocol Violation|0|||
131803512|NCT00669942|474563739|FG008|Parts 2 and 3|Protocol Violation|0|||
131803513|NCT00669942|474563740|FG009|Parts 2 and 3|Protocol Violation|0|||
131803514|NCT00669942|474563741|FG010|Parts 2 and 3|Protocol Violation|0|||
131803515|NCT00669942|474563742|FG011|Parts 2 and 3|Protocol Violation|0|||
131803516|NCT00259012|474563744|FG000|Overall Study|Adverse Event|0|||
131803517|NCT00259012|474563745|FG001|Overall Study|Adverse Event|1|||
131803518|NCT00259012|474563744|FG000|Overall Study|Withdrawal by Subject|1|||
131803519|NCT00259012|474563745|FG001|Overall Study|Withdrawal by Subject|0|||
131652317|NCT01154140|474012681|FG001|Overall Study|Death|81|||
131652318|NCT01154140|474012680|FG000|Overall Study|Lost to Follow-up|4|||
131652319|NCT01154140|474012681|FG001|Overall Study|Lost to Follow-up|5|||
131652320|NCT01154140|474012680|FG000|Overall Study|Withdrawal by Subject|12|||
131652321|NCT01154140|474012681|FG001|Overall Study|Withdrawal by Subject|13|||
131652322|NCT01154140|474012680|FG000|Overall Study|Other|3|||
131652323|NCT01154140|474012681|FG001|Overall Study|Other|1|||
131652324|NCT01154140|474012680|FG000|Overall Study|Randomized but not treated|1|||
131652325|NCT01154140|474012681|FG001|Overall Study|Randomized but not treated|2|||
131652326|NCT02992691|474012683|FG000|Overall Study|Adverse Event|2|||
131652327|NCT02992691|474012683|FG000|Overall Study|Withdrawal by Subject|1|||
131652328|NCT04276051|474012684|FG000|Overall Study|Lost to Follow-up|0|||
131652329|NCT04276051|474012685|FG001|Overall Study|Lost to Follow-up|1|||
131652330|NCT04276051|474012684|FG000|Overall Study|Physician Decision|0|||
131652331|NCT04276051|474012685|FG001|Overall Study|Physician Decision|1|||
131652332|NCT04276051|474012684|FG000|Overall Study|Withdrawal by Subject|1|||
131652333|NCT04276051|474012685|FG001|Overall Study|Withdrawal by Subject|1|||
131652334|NCT00392925|474012686|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
131652335|NCT00392925|474012687|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
131652336|NCT00392925|474012688|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
131652337|NCT00392925|474012689|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
131652338|NCT00392925|474012686|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
131652339|NCT00392925|474012687|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
131652340|NCT00392925|474012688|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
131652341|NCT00392925|474012689|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
131652342|NCT00392925|474012686|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
131652343|NCT00392925|474012687|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
131652344|NCT00392925|474012688|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
131652345|NCT00392925|474012689|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
131652346|NCT00392925|474012686|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
131652347|NCT00392925|474012687|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
131652348|NCT00392925|474012688|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
131652349|NCT00392925|474012689|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
131652350|NCT00392925|474012686|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
131652351|NCT00392925|474012687|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
131652352|NCT00392925|474012688|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
131652353|NCT00392925|474012689|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
131652354|NCT00392925|474012686|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
131652355|NCT00392925|474012687|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
131652356|NCT00392925|474012688|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
131652357|NCT00392925|474012689|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
131803520|NCT00259012|474563744|FG000|Overall Study|Physician Decision|0|||
131803521|NCT00259012|474563745|FG001|Overall Study|Physician Decision|1|||
131803522|NCT00259012|474563744|FG000|Overall Study|Lost to Follow-up|0|||
131803523|NCT00259012|474563745|FG001|Overall Study|Lost to Follow-up|1|||
131803524|NCT00259012|474563744|FG000|Overall Study|Protocol Violation|1|||
131803525|NCT00259012|474563745|FG001|Overall Study|Protocol Violation|1|||
131803526|NCT01941030|474563761|FG000|Overall Study|Death|3|||
131803527|NCT01941030|474563762|FG001|Overall Study|Death|2|||
131803528|NCT01941030|474563761|FG000|Overall Study|Lost to Follow-up|6|||
131803529|NCT01941030|474563762|FG001|Overall Study|Lost to Follow-up|5|||
131803530|NCT01941030|474563761|FG000|Overall Study|Withdrawal by Subject|4|||
131803531|NCT01941030|474563762|FG001|Overall Study|Withdrawal by Subject|6|||
131803532|NCT01479439|474563766|FG000|Overall Study|Adverse Event|1|||
131803533|NCT01479439|474563767|FG001|Overall Study|Adverse Event|0|||
131803534|NCT01479439|474563768|FG002|Overall Study|Adverse Event|0|||
131803535|NCT01479439|474563766|FG000|Overall Study|Lost to Follow-up|0|||
131803536|NCT01479439|474563767|FG001|Overall Study|Lost to Follow-up|1|||
131803537|NCT01479439|474563768|FG002|Overall Study|Lost to Follow-up|0|||
131803538|NCT01479439|474563766|FG000|Overall Study|Protocol Violation|0|||
131803539|NCT01479439|474563767|FG001|Overall Study|Protocol Violation|0|||
131803540|NCT01479439|474563768|FG002|Overall Study|Protocol Violation|2|||
131803541|NCT02365207|474563769|FG000|Overall Study|Withdrawal by Subject|1|||
131803542|NCT02365207|474563769|FG000|Overall Study|Physician Decision|1|||
131803543|NCT01936948|474563770|FG000|Overall Study|no 30-day follow-up data|0|||
131803544|NCT01936948|474563771|FG001|Overall Study|no 30-day follow-up data|3|||
131803545|NCT01936948|474563772|FG002|Overall Study|no 30-day follow-up data|3|||
131803546|NCT01936948|474563773|FG003|Overall Study|no 30-day follow-up data|3|||
131803547|NCT02924038|474565154|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
131803548|NCT02924038|474565155|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
131803549|NCT01101022|474565163|FG000|Overall Study|Adverse Event|6|||
131803550|NCT01101022|474565164|FG001|Overall Study|Adverse Event|2|||
131803551|NCT01101022|474565163|FG000|Overall Study|Protocol Violation|4|||
131803552|NCT01101022|474565164|FG001|Overall Study|Protocol Violation|3|||
131803553|NCT01101022|474565163|FG000|Overall Study|Withdrawal by Subject|3|||
131803554|NCT01101022|474565164|FG001|Overall Study|Withdrawal by Subject|8|||
131803555|NCT01101022|474565163|FG000|Overall Study|Lost to Follow-up|1|||
131803556|NCT01101022|474565164|FG001|Overall Study|Lost to Follow-up|4|||
131803557|NCT01101022|474565163|FG000|Overall Study|Lack of Efficacy|0|||
131803558|NCT01101022|474565164|FG001|Overall Study|Lack of Efficacy|7|||
131803559|NCT01101022|474565163|FG000|Overall Study|Sponsor decision|1|||
131803560|NCT01101022|474565164|FG001|Overall Study|Sponsor decision|1|||
131803561|NCT01101022|474565163|FG000|Overall Study|Non-compliance|1|||
131803562|NCT01101022|474565164|FG001|Overall Study|Non-compliance|0|||
131803563|NCT01101022|474565163|FG000|Overall Study|Work schedule|1|||
131803564|NCT01101022|474565164|FG001|Overall Study|Work schedule|1|||
131803565|NCT01101022|474565163|FG000|Overall Study|Vacation|0|||
131803566|NCT01101022|474565164|FG001|Overall Study|Vacation|1|||
131803567|NCT01648166|474565167|FG000|Overall Study|inadequate toenail samples|53|||
131803568|NCT01648166|474565168|FG001|Overall Study|inadequate toenail samples|100|||
131803569|NCT02532764|474565169|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803570|NCT02532764|474565170|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803571|NCT02532764|474565171|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803572|NCT02532764|474565172|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803573|NCT02532764|474565173|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803574|NCT02532764|474565174|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803575|NCT02532764|474565175|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
131803576|NCT02532764|474565176|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
131803577|NCT02532764|474565177|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
131803578|NCT02532764|474565178|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
131652358|NCT00392925|474012686|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
131652359|NCT00392925|474012687|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
131652360|NCT00392925|474012688|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
131803579|NCT03527745|474565179|FG000|Overall Study|Lost to Follow-up|3|||
131803580|NCT03527745|474565180|FG001|Overall Study|Lost to Follow-up|6|||
131652361|NCT00392925|474012689|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
131803581|NCT03527745|474565181|FG002|Overall Study|Lost to Follow-up|7|||
131803582|NCT03527745|474565182|FG003|Overall Study|Lost to Follow-up|9|||
131803583|NCT03527745|474565183|FG004|Overall Study|Lost to Follow-up|0|||
131803584|NCT03527745|474565184|FG005|Overall Study|Lost to Follow-up|2|||
131803585|NCT03527745|474565185|FG006|Overall Study|Lost to Follow-up|3|||
131803586|NCT03527745|474565186|FG007|Overall Study|Lost to Follow-up|2|||
131803587|NCT03527745|474565187|FG008|Overall Study|Lost to Follow-up|3|||
131803588|NCT03527745|474565188|FG009|Overall Study|Lost to Follow-up|2|||
131803589|NCT03527745|474565189|FG010|Overall Study|Lost to Follow-up|1|||
131803590|NCT03527745|474565190|FG011|Overall Study|Lost to Follow-up|1|||
131803591|NCT03527745|474565191|FG012|Overall Study|Lost to Follow-up|0|||
131803592|NCT03527745|474565192|FG013|Overall Study|Lost to Follow-up|0|||
131803593|NCT03527745|474565193|FG014|Overall Study|Lost to Follow-up|0|||
131803594|NCT03527745|474565194|FG015|Overall Study|Lost to Follow-up|0|||
131803595|NCT03527745|474565195|FG016|Overall Study|Lost to Follow-up|1|||
131803596|NCT03527745|474565196|FG017|Overall Study|Lost to Follow-up|0|||
131803597|NCT03527745|474565197|FG018|Overall Study|Lost to Follow-up|0|||
131803598|NCT03527745|474565198|FG019|Overall Study|Lost to Follow-up|1|||
131803599|NCT03527745|474565199|FG020|Overall Study|Lost to Follow-up|1|||
131803600|NCT03527745|474565200|FG021|Overall Study|Lost to Follow-up|5|||
131803601|NCT03527745|474565201|FG022|Overall Study|Lost to Follow-up|6|||
131803602|NCT03527745|474565202|FG023|Overall Study|Lost to Follow-up|8|||
131803603|NCT03527745|474565203|FG024|Overall Study|Lost to Follow-up|1|||
131803604|NCT03527745|474565204|FG025|Overall Study|Lost to Follow-up|3|||
131803605|NCT02475954|474565205|FG000|Overall Study|Withdrawal by Subject|2|||
131803606|NCT02475954|474565206|FG001|Overall Study|Withdrawal by Subject|2|||
131803607|NCT02475954|474565205|FG000|Overall Study|Lost to Follow-up|11|||
131803608|NCT02475954|474565206|FG001|Overall Study|Lost to Follow-up|9|||
131803609|NCT02475954|474565205|FG000|Overall Study|Death|1|||
131803610|NCT02475954|474565206|FG001|Overall Study|Death|1|||
131803611|NCT01918397|474565207|FG000|Overall Study|Never started treatment|2|||
131803612|NCT01918397|474565208|FG001|Overall Study|Never started treatment|1|||
131803613|NCT01918397|474565209|FG002|Overall Study|Never started treatment|0|||
131803614|NCT01918397|474565210|FG003|Overall Study|Never started treatment|0|||
131803615|NCT01918397|474565207|FG000|Overall Study|Adverse Event|1|||
131803616|NCT01918397|474565208|FG001|Overall Study|Adverse Event|1|||
131803617|NCT01918397|474565209|FG002|Overall Study|Adverse Event|1|||
131803618|NCT01918397|474565210|FG003|Overall Study|Adverse Event|0|||
131803619|NCT01918397|474565207|FG000|Overall Study|Lack of compliance|2|||
131803620|NCT01918397|474565208|FG001|Overall Study|Lack of compliance|2|||
131803621|NCT01918397|474565209|FG002|Overall Study|Lack of compliance|3|||
131803622|NCT01918397|474565210|FG003|Overall Study|Lack of compliance|0|||
131803623|NCT01918397|474565207|FG000|Overall Study|Pregnancy|0|||
131803624|NCT01918397|474565208|FG001|Overall Study|Pregnancy|1|||
131803625|NCT01918397|474565209|FG002|Overall Study|Pregnancy|0|||
131803626|NCT01918397|474565210|FG003|Overall Study|Pregnancy|0|||
131803627|NCT01918397|474565207|FG000|Overall Study|Rifampin susceptible|0|||
131803628|NCT01918397|474565208|FG001|Overall Study|Rifampin susceptible|0|||
131803629|NCT01918397|474565209|FG002|Overall Study|Rifampin susceptible|0|||
131803630|NCT01918397|474565210|FG003|Overall Study|Rifampin susceptible|2|||
131803631|NCT01918397|474565207|FG000|Overall Study|Treatment failure|0|||
131803632|NCT01918397|474565208|FG001|Overall Study|Treatment failure|0|||
131803633|NCT01918397|474565209|FG002|Overall Study|Treatment failure|0|||
131803634|NCT01918397|474565210|FG003|Overall Study|Treatment failure|1|||
131803635|NCT01918397|474565207|FG000|Overall Study|Withdrawal by Subject|3|||
131803636|NCT01918397|474565208|FG001|Overall Study|Withdrawal by Subject|2|||
131803637|NCT01918397|474565209|FG002|Overall Study|Withdrawal by Subject|1|||
131803638|NCT01918397|474565210|FG003|Overall Study|Withdrawal by Subject|1|||
131803639|NCT01918397|474565207|FG000|Overall Study|XDR at baseline|0|||
131803640|NCT01918397|474565208|FG001|Overall Study|XDR at baseline|0|||
131803641|NCT01918397|474565209|FG002|Overall Study|XDR at baseline|1|||
131803642|NCT01918397|474565210|FG003|Overall Study|XDR at baseline|0|||
131803643|NCT01918397|474565207|FG000|Overall Study|Lost to Follow-up|2|||
131803644|NCT01918397|474565208|FG001|Overall Study|Lost to Follow-up|1|||
131803645|NCT01918397|474565209|FG002|Overall Study|Lost to Follow-up|1|||
131803646|NCT01918397|474565210|FG003|Overall Study|Lost to Follow-up|1|||
131803647|NCT01918397|474565207|FG000|Overall Study|Increased QTc|1|||
131803648|NCT01918397|474565208|FG001|Overall Study|Increased QTc|0|||
131803649|NCT01918397|474565209|FG002|Overall Study|Increased QTc|0|||
131803650|NCT01918397|474565210|FG003|Overall Study|Increased QTc|1|||
131803651|NCT01918397|474565207|FG000|Overall Study|Death|0|||
131803652|NCT01918397|474565208|FG001|Overall Study|Death|0|||
131803653|NCT01918397|474565209|FG002|Overall Study|Death|1|||
131803654|NCT01918397|474565210|FG003|Overall Study|Death|0|||
131803655|NCT01918397|474565207|FG000|Overall Study|Involved in another investigative trial|0|||
131803656|NCT01918397|474565208|FG001|Overall Study|Involved in another investigative trial|0|||
131803657|NCT01918397|474565209|FG002|Overall Study|Involved in another investigative trial|0|||
131803658|NCT01918397|474565210|FG003|Overall Study|Involved in another investigative trial|1|||
131803659|NCT02942264|474565214|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803660|NCT02942264|474565215|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
131803661|NCT02942264|474565216|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803662|NCT02942264|474565217|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803663|NCT02942264|474565218|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803664|NCT02942264|474565219|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803665|NCT02942264|474565220|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
131803666|NCT02942264|474565221|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803667|NCT02942264|474565222|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
131803668|NCT02942264|474565214|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803669|NCT02942264|474565215|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803670|NCT02942264|474565216|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803671|NCT02942264|474565217|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803672|NCT02942264|474565218|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803673|NCT02942264|474565219|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803674|NCT02942264|474565220|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803675|NCT02942264|474565221|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
131803676|NCT02942264|474565222|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
131803677|NCT01328093|474565223|FG000|Double-Blind Phase|Adverse Event|78|||
131803678|NCT01328093|474565224|FG001|Double-Blind Phase|Adverse Event|15|||
131803679|NCT01328093|474565223|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
131803680|NCT01328093|474565224|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
131803681|NCT01328093|474565223|FG000|Double-Blind Phase|Lost to Follow-up|39|||
131803682|NCT01328093|474565224|FG001|Double-Blind Phase|Lost to Follow-up|14|||
131803683|NCT01328093|474565223|FG000|Double-Blind Phase|Protocol Violation|30|||
131803684|NCT01328093|474565224|FG001|Double-Blind Phase|Protocol Violation|10|||
131803685|NCT01328093|474565223|FG000|Double-Blind Phase|Lack of Efficacy|55|||
131803686|NCT01328093|474565224|FG001|Double-Blind Phase|Lack of Efficacy|13|||
131803687|NCT01328093|474565223|FG000|Double-Blind Phase|Sponsor Decision|17|||
131803688|NCT01328093|474565224|FG001|Double-Blind Phase|Sponsor Decision|3|||
131803689|NCT01328093|474565223|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
131803690|NCT01328093|474565224|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
131803691|NCT01328093|474565223|FG000|Double-Blind Phase|Scheduling conflict|8|||
131803692|NCT01328093|474565224|FG001|Double-Blind Phase|Scheduling conflict|3|||
131803693|NCT01328093|474565223|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
131803694|NCT01328093|474565224|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
131803695|NCT01328093|474565223|FG000|Double-Blind Phase|Death|1|||
131803696|NCT01328093|474565224|FG001|Double-Blind Phase|Death|0|||
131803697|NCT01328093|474565223|FG000|Open-Label Phase|Sponsor Decision|98|||
131803698|NCT01328093|474565224|FG001|Open-Label Phase|Sponsor Decision|34|||
131803699|NCT01328093|474565223|FG000|Open-Label Phase|Protocol Violation|8|||
131803700|NCT01328093|474565224|FG001|Open-Label Phase|Protocol Violation|3|||
131803701|NCT01328093|474565223|FG000|Open-Label Phase|Lost to Follow-up|10|||
131803702|NCT01328093|474565224|FG001|Open-Label Phase|Lost to Follow-up|1|||
131803703|NCT01328093|474565223|FG000|Open-Label Phase|Adverse Event|10|||
131803704|NCT01328093|474565224|FG001|Open-Label Phase|Adverse Event|4|||
131803705|NCT01328093|474565223|FG000|Open-Label Phase|Lack of Efficacy|5|||
131803706|NCT01328093|474565224|FG001|Open-Label Phase|Lack of Efficacy|6|||
131803707|NCT01328093|474565223|FG000|Open-Label Phase|Withdrawal by Subject|4|||
131803708|NCT01328093|474565224|FG001|Open-Label Phase|Withdrawal by Subject|1|||
131803709|NCT01328093|474565223|FG000|Open-Label Phase|Scheduling conflict|2|||
131803710|NCT01328093|474565224|FG001|Open-Label Phase|Scheduling conflict|1|||
131803711|NCT01328093|474565223|FG000|Open-Label Phase|Subject is moving or has moved|2|||
131803712|NCT01328093|474565224|FG001|Open-Label Phase|Subject is moving or has moved|0|||
131803713|NCT01328093|474565223|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
131803714|NCT01328093|474565224|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
131803715|NCT02334722|474565225|FG000|Overall Study|Lost to Follow-up|4|||
131803716|NCT02334722|474565226|FG001|Overall Study|Lost to Follow-up|0|||
131803717|NCT02334722|474565225|FG000|Overall Study|6 week questionnaire not completed|2|||
131803718|NCT02334722|474565226|FG001|Overall Study|6 week questionnaire not completed|0|||
131803719|NCT02334722|474565225|FG000|Overall Study|Unable to obtain medication|1|||
131803720|NCT02334722|474565226|FG001|Overall Study|Unable to obtain medication|1|||
131803721|NCT02334722|474565225|FG000|Overall Study|Withdrawal by Subject|0|||
131803722|NCT02334722|474565226|FG001|Overall Study|Withdrawal by Subject|3|||
131803723|NCT02334722|474565225|FG000|Overall Study|Adverse Event|0|||
131803724|NCT02334722|474565226|FG001|Overall Study|Adverse Event|2|||
131803725|NCT02334722|474565225|FG000|Overall Study|Physician Decision|0|||
131803726|NCT02334722|474565226|FG001|Overall Study|Physician Decision|1|||
131803727|NCT00856388|474565227|FG000|Overall Study|Other|1|||
131803728|NCT00832377|474565228|FG000|Overall Study|Protocol Violation|1|||
131803729|NCT03661528|474565229|FG000|Overall Study|Death|1|||
131803730|NCT03661528|474565230|FG001|Overall Study|Death|0|||
131803731|NCT03661528|474565229|FG000|Overall Study|Physician Decision|3|||
131803732|NCT03661528|474565230|FG001|Overall Study|Physician Decision|1|||
131803733|NCT03661528|474565229|FG000|Overall Study|Other than Specified|5|||
131803734|NCT03661528|474565230|FG001|Overall Study|Other than Specified|2|||
131803735|NCT03661528|474565229|FG000|Overall Study|Withdrawal by Subject|5|||
131803736|NCT03661528|474565230|FG001|Overall Study|Withdrawal by Subject|3|||
131803737|NCT03661528|474565229|FG000|Overall Study|Disease Progression|8|||
131803738|NCT03661528|474565230|FG001|Overall Study|Disease Progression|13|||
131803739|NCT03661528|474565229|FG000|Overall Study|Adverse Event|61|||
131803740|NCT03661528|474565230|FG001|Overall Study|Adverse Event|55|||
131803741|NCT00925769|474565232|FG000|Overall Study|Major toxicity|1|||
131803742|NCT00925769|474565233|FG001|Overall Study|Major toxicity|0|||
131803743|NCT00925769|474565234|FG002|Overall Study|Major toxicity|1|||
131803744|NCT00925769|474565235|FG003|Overall Study|Major toxicity|1|||
131803745|NCT00925769|474565236|FG004|Overall Study|Major toxicity|0|||
131803746|NCT00925769|474565237|FG005|Overall Study|Major toxicity|0|||
131803747|NCT00925769|474565232|FG000|Overall Study|Disease progression|4|||
131803748|NCT00925769|474565233|FG001|Overall Study|Disease progression|5|||
131803749|NCT00925769|474565234|FG002|Overall Study|Disease progression|3|||
131803750|NCT00925769|474565235|FG003|Overall Study|Disease progression|4|||
131803751|NCT00925769|474565236|FG004|Overall Study|Disease progression|2|||
131803752|NCT00925769|474565237|FG005|Overall Study|Disease progression|3|||
131803753|NCT00925769|474565232|FG000|Overall Study|Death|0|||
131803754|NCT00925769|474565233|FG001|Overall Study|Death|0|||
131803755|NCT00925769|474565234|FG002|Overall Study|Death|1|||
131803756|NCT00925769|474565235|FG003|Overall Study|Death|0|||
131803757|NCT00925769|474565236|FG004|Overall Study|Death|0|||
131803758|NCT00925769|474565237|FG005|Overall Study|Death|0|||
131803759|NCT00925769|474565232|FG000|Overall Study|Physician Decision|1|||
131803760|NCT00925769|474565233|FG001|Overall Study|Physician Decision|0|||
131803761|NCT00925769|474565234|FG002|Overall Study|Physician Decision|0|||
131803762|NCT00925769|474565235|FG003|Overall Study|Physician Decision|0|||
131803763|NCT00925769|474565236|FG004|Overall Study|Physician Decision|0|||
131803764|NCT00925769|474565237|FG005|Overall Study|Physician Decision|0|||
131803765|NCT00925769|474565232|FG000|Overall Study|Missing documentation|0|||
131803766|NCT00925769|474565233|FG001|Overall Study|Missing documentation|1|||
131803767|NCT00925769|474565234|FG002|Overall Study|Missing documentation|0|||
131803768|NCT00925769|474565235|FG003|Overall Study|Missing documentation|0|||
131803769|NCT00925769|474565236|FG004|Overall Study|Missing documentation|0|||
131803770|NCT00925769|474565237|FG005|Overall Study|Missing documentation|0|||
131803771|NCT00925769|474565232|FG000|Overall Study|End of study visit not done|0|||
131803772|NCT00925769|474565233|FG001|Overall Study|End of study visit not done|0|||
131803773|NCT00925769|474565234|FG002|Overall Study|End of study visit not done|1|||
131803774|NCT00925769|474565235|FG003|Overall Study|End of study visit not done|0|||
131803775|NCT00925769|474565236|FG004|Overall Study|End of study visit not done|0|||
131803776|NCT00925769|474565237|FG005|Overall Study|End of study visit not done|0|||
131803777|NCT00925769|474565232|FG000|Overall Study|Participant is unable to swallow drug|0|||
131803778|NCT00925769|474565233|FG001|Overall Study|Participant is unable to swallow drug|0|||
131803779|NCT00925769|474565234|FG002|Overall Study|Participant is unable to swallow drug|0|||
131803780|NCT00925769|474565235|FG003|Overall Study|Participant is unable to swallow drug|1|||
131803781|NCT00925769|474565236|FG004|Overall Study|Participant is unable to swallow drug|0|||
131803782|NCT00925769|474565237|FG005|Overall Study|Participant is unable to swallow drug|0|||
131803783|NCT00925769|474565232|FG000|Overall Study|Adverse Event|0|||
131803784|NCT00925769|474565233|FG001|Overall Study|Adverse Event|0|||
131803785|NCT00925769|474565234|FG002|Overall Study|Adverse Event|0|||
131803786|NCT00925769|474565235|FG003|Overall Study|Adverse Event|0|||
131803787|NCT00925769|474565236|FG004|Overall Study|Adverse Event|1|||
131803788|NCT00925769|474565237|FG005|Overall Study|Adverse Event|0|||
131652362|NCT00392925|474012686|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
131652363|NCT00392925|474012687|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
131652364|NCT00392925|474012688|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
131652365|NCT00392925|474012689|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
131652366|NCT00392925|474012686|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
131652367|NCT00392925|474012687|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
131652368|NCT00392925|474012688|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
131652369|NCT00392925|474012689|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
131652370|NCT01461005|474012693|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
131652371|NCT00664534|474012694|FG000|Overall Study|Adverse Event|2|||
131652372|NCT00664534|474012695|FG001|Overall Study|Adverse Event|3|||
131652373|NCT00664534|474012694|FG000|Overall Study|Lost to Follow-up|6|||
131652374|NCT00664534|474012695|FG001|Overall Study|Lost to Follow-up|10|||
131652375|NCT00664534|474012694|FG000|Overall Study|Protocol Violation|10|||
131652376|NCT00664534|474012695|FG001|Overall Study|Protocol Violation|8|||
131652377|NCT00664534|474012694|FG000|Overall Study|Withdrawal by Subject|7|||
131652378|NCT00664534|474012695|FG001|Overall Study|Withdrawal by Subject|6|||
131652379|NCT00664534|474012694|FG000|Overall Study|Physician Decision|8|||
131652380|NCT00664534|474012695|FG001|Overall Study|Physician Decision|0|||
131652381|NCT00664534|474012694|FG000|Overall Study|Sponsor decision|8|||
131652382|NCT00664534|474012695|FG001|Overall Study|Sponsor decision|6|||
131652383|NCT02579772|474012696|FG000|Overall Study|Withdrawal by Subject|0|||
131803789|NCT02017964|474565238|FG000|Overall Study|Patient deemed ineligible|1|||
131652384|NCT02579772|474012697|FG001|Overall Study|Withdrawal by Subject|1|||
131803790|NCT00569374|474565240|FG000|Overall Study|Withdrawal by Subject|4|||
131803791|NCT00912288|474565243|FG000|Overall Study|Death|0|||
131803792|NCT00912288|474565244|FG001|Overall Study|Death|1|||
131803793|NCT00912288|474565243|FG000|Overall Study|Adverse Event|1|||
131803794|NCT00912288|474565244|FG001|Overall Study|Adverse Event|1|||
131803795|NCT00912288|474565243|FG000|Overall Study|Lost to Follow-up|1|||
131803796|NCT00912288|474565244|FG001|Overall Study|Lost to Follow-up|0|||
131803797|NCT00912288|474565243|FG000|Overall Study|Protocol Violation|1|||
131803798|NCT00912288|474565244|FG001|Overall Study|Protocol Violation|0|||
131803799|NCT00912288|474565243|FG000|Overall Study|Withdrawal by Subject|3|||
131803800|NCT00912288|474565244|FG001|Overall Study|Withdrawal by Subject|3|||
131803801|NCT00912288|474565243|FG000|Overall Study|Study terminated by sponsor|34|||
131803802|NCT00912288|474565244|FG001|Overall Study|Study terminated by sponsor|35|||
131803803|NCT00912288|474565243|FG000|Overall Study|Other|1|||
131803804|NCT00912288|474565244|FG001|Overall Study|Other|0|||
131803805|NCT01449630|474565247|FG000|Period 1|Physician Decision|1|||
131803806|NCT01449630|474565248|FG001|Period 1|Physician Decision|0|||
131803807|NCT01449630|474565249|FG002|Period 1|Physician Decision|0|||
131803808|NCT01449630|474565250|FG003|Period 1|Physician Decision|1|||
131803809|NCT01449630|474565251|FG004|Period 1|Physician Decision|0|||
131803810|NCT01449630|474565252|FG005|Period 1|Physician Decision|0|||
131803811|NCT01449630|474565253|FG006|Period 1|Physician Decision|0|||
131803812|NCT01449630|474565254|FG007|Period 1|Physician Decision|0|||
131803813|NCT01449630|474565255|FG008|Period 1|Physician Decision|0|||
131803814|NCT01449630|474565247|FG000|Period 1|Sponsor Decision|0|||
131803815|NCT01449630|474565248|FG001|Period 1|Sponsor Decision|0|||
131803816|NCT01449630|474565249|FG002|Period 1|Sponsor Decision|0|||
131803817|NCT01449630|474565250|FG003|Period 1|Sponsor Decision|0|||
131803818|NCT01449630|474565251|FG004|Period 1|Sponsor Decision|0|||
131803819|NCT01449630|474565252|FG005|Period 1|Sponsor Decision|1|||
131803820|NCT01449630|474565253|FG006|Period 1|Sponsor Decision|0|||
131803821|NCT01449630|474565254|FG007|Period 1|Sponsor Decision|0|||
131803822|NCT01449630|474565255|FG008|Period 1|Sponsor Decision|0|||
131803823|NCT01449630|474565247|FG000|Period 2|Sponsor Decision|0|||
131803824|NCT01449630|474565248|FG001|Period 2|Sponsor Decision|0|||
131652385|NCT02579772|474012696|FG000|Overall Study|Usage of additional antioxidants|1|||
131652386|NCT02579772|474012697|FG001|Overall Study|Usage of additional antioxidants|0|||
131652387|NCT02579772|474012696|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
131652388|NCT02579772|474012697|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
131652389|NCT04463680|474012698|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
131652390|NCT04463680|474012698|FG000|Overall Study|Not eligible due to implant duration of use|1|||
131652391|NCT04463680|474012698|FG000|Overall Study|Withdrawal by Subject|3|||
131652392|NCT04147195|474012699|FG000|Overall Study|Adverse Event|0|||
131652393|NCT04147195|474012700|FG001|Overall Study|Adverse Event|3|||
131652394|NCT04147195|474012699|FG000|Overall Study|Study Terminated by Sponsor|4|||
131652395|NCT04147195|474012700|FG001|Overall Study|Study Terminated by Sponsor|2|||
131652396|NCT04147195|474012699|FG000|Overall Study|Withdrawal by Subject|0|||
131652397|NCT04147195|474012700|FG001|Overall Study|Withdrawal by Subject|1|||
131652398|NCT05823012|474012701|FG000|Titration Period|Adverse Event|1|||
131652399|NCT05823012|474012701|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
131652400|NCT05823012|474012701|FG000|Maintenance Period|Adverse Event|1|||
131652401|NCT05823012|474012701|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
131803825|NCT01449630|474565249|FG002|Period 2|Sponsor Decision|0|||
131803826|NCT01449630|474565250|FG003|Period 2|Sponsor Decision|0|||
131803827|NCT01449630|474565251|FG004|Period 2|Sponsor Decision|0|||
131803828|NCT01449630|474565252|FG005|Period 2|Sponsor Decision|0|||
131803829|NCT01449630|474565253|FG006|Period 2|Sponsor Decision|1|||
131803830|NCT01449630|474565254|FG007|Period 2|Sponsor Decision|0|||
131803831|NCT01449630|474565255|FG008|Period 2|Sponsor Decision|0|||
131803832|NCT00877032|474565256|FG000|Overall Study|Did not meet entrance criteria|0|||
131803833|NCT00877032|474565257|FG001|Overall Study|Did not meet entrance criteria|0|||
131803834|NCT00877032|474565258|FG002|Overall Study|Did not meet entrance criteria|0|||
131803835|NCT00877032|474565259|FG003|Overall Study|Did not meet entrance criteria|1|||
131803836|NCT00877032|474565260|FG004|Overall Study|Did not meet entrance criteria|0|||
131803837|NCT00877032|474565261|FG005|Overall Study|Did not meet entrance criteria|0|||
131803838|NCT00877032|474565262|FG006|Overall Study|Did not meet entrance criteria|2|||
131803839|NCT01496183|474565268|FG000|Overall Study|Physician Decision|3|||
131803840|NCT01496183|474565269|FG001|Overall Study|Physician Decision|1|||
131803841|NCT01496183|474565268|FG000|Overall Study|Withdrawal by Subject|0|||
131803842|NCT01496183|474565269|FG001|Overall Study|Withdrawal by Subject|1|||
131803843|NCT03002077|474565270|FG000|Overall Study|Non-compliance with Study Drug|4|||
131803844|NCT03002077|474565270|FG000|Overall Study|Non-compliance w/Background ADT|1|||
131803845|NCT03002077|474565270|FG000|Overall Study|Study Terminated by Sponsor|257|||
131803846|NCT03002077|474565270|FG000|Overall Study|Site Terminated by Sponsor|5|||
131803847|NCT03002077|474565270|FG000|Overall Study|Miscellaneous Reasons|10|||
131803848|NCT03002077|474565270|FG000|Overall Study|Adverse Event|23|||
131803849|NCT03002077|474565270|FG000|Overall Study|Lack of Efficacy|20|||
131803850|NCT03002077|474565270|FG000|Overall Study|Withdrawal by Subject|72|||
131803851|NCT03002077|474565270|FG000|Overall Study|Lost to Follow-up|21|||
131803852|NCT03002077|474565270|FG000|Overall Study|Pregnancy|4|||
131803853|NCT03002077|474565270|FG000|Overall Study|Protocol Violation|21|||
131903924|NCT01290718|474935376|FG000|Overall Study|Early termination of the study|4|||
131903925|NCT00473655|474935377|FG000|Overall Study|Lost to Follow-up|9|||
131903926|NCT00473655|474935378|FG001|Overall Study|Lost to Follow-up|5|||
131903927|NCT00473655|474935379|FG002|Overall Study|Lost to Follow-up|8|||
131903928|NCT05081388|474935380|FG000|Overall Study|Adverse Event|1|||
131903929|NCT05081388|474935381|FG001|Overall Study|Adverse Event|0|||
131903930|NCT05081388|474935382|FG002|Overall Study|Adverse Event|0|||
131903931|NCT05081388|474935383|FG003|Overall Study|Adverse Event|0|||
131652402|NCT05823012|474012701|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
131652403|NCT04991753|474013999|FG000|Overall Study|Withdrawal by Subject|0|||
131652404|NCT04991753|474014000|FG001|Overall Study|Withdrawal by Subject|1|||
131803854|NCT04625114|474565271|FG000|Overall Study|Adverse Event|3|||
131803855|NCT04625114|474565272|FG001|Overall Study|Adverse Event|1|||
131803856|NCT04625114|474565271|FG000|Overall Study|Withdrawal by Subject|2|||
131803857|NCT04625114|474565272|FG001|Overall Study|Withdrawal by Subject|0|||
131903932|NCT05081388|474935384|FG004|Overall Study|Adverse Event|0|||
131903933|NCT05081388|474935380|FG000|Overall Study|Lost to Follow-up|0|||
131903934|NCT05081388|474935381|FG001|Overall Study|Lost to Follow-up|1|||
131652405|NCT01920477|474014001|FG000|Overall Study|Adverse Event|0|||
131803858|NCT02849652|474565275|FG000|Overall Study|Lost to Follow-up|104|||
131803859|NCT02849652|474565276|FG001|Overall Study|Lost to Follow-up|35|||
131803860|NCT02849652|474565277|FG002|Overall Study|Lost to Follow-up|116|||
131803861|NCT02849652|474565278|FG003|Overall Study|Lost to Follow-up|22|||
131803862|NCT02849652|474565275|FG000|Overall Study|Withdrawal by Subject|10|||
131903935|NCT05081388|474935382|FG002|Overall Study|Lost to Follow-up|0|||
131803863|NCT02849652|474565276|FG001|Overall Study|Withdrawal by Subject|2|||
131803864|NCT02849652|474565277|FG002|Overall Study|Withdrawal by Subject|8|||
131652406|NCT01920477|474014002|FG001|Overall Study|Adverse Event|1|||
131652407|NCT01920477|474014001|FG000|Overall Study|Lack of Efficacy|1|||
131652408|NCT01920477|474014002|FG001|Overall Study|Lack of Efficacy|0|||
131652409|NCT01920477|474014001|FG000|Overall Study|Study closed/terminated|14|||
131803865|NCT02849652|474565278|FG003|Overall Study|Withdrawal by Subject|4|||
131803866|NCT01863745|474565279|FG000|Overall Study|Disease Progression|9|||
131803867|NCT01863745|474565279|FG000|Overall Study|Adverse Event|2|||
131803868|NCT01863745|474565279|FG000|Overall Study|Death|1|||
131803869|NCT01863745|474565279|FG000|Overall Study|Withdrawal by Subject|1|||
131803870|NCT00472290|474565280|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
131803871|NCT00472290|474565280|FG000|Overall Study|Protocol Specified Criteria|7|||
131803872|NCT00472290|474565280|FG000|Overall Study|Administrative Decision|37|||
131803873|NCT00472290|474565280|FG000|Overall Study|Death|3|||
131803874|NCT00472290|474565280|FG000|Overall Study|Lost to Follow-up|1|||
131803875|NCT00472290|474565280|FG000|Overall Study|Lack of Efficacy|1|||
131803876|NCT00472290|474565280|FG000|Overall Study|Disease Progression|4|||
131803877|NCT00472290|474565280|FG000|Overall Study|Withdrawal by Subject|5|||
131803878|NCT00472290|474565280|FG000|Overall Study|Adverse Event|6|||
131803879|NCT00472290|474565280|FG000|Overall Study|Requirement for alternative therapy|7|||
131803880|NCT00777829|474565281|FG000|Overall Study|Withdrawal by Subject|0|||
131803881|NCT00777829|474565282|FG001|Overall Study|Withdrawal by Subject|2|||
131803882|NCT01395030|474565295|FG000|Overall Study|Did not complete FCH PET/CT|7|||
131803883|NCT02079766|474565296|FG000|Overall Study|Physician Decision|1|||
131803884|NCT02079766|474565297|FG001|Overall Study|Physician Decision|0|||
131803885|NCT02079766|474565296|FG000|Overall Study|Withdrawal by Subject|1|||
131803886|NCT02079766|474565297|FG001|Overall Study|Withdrawal by Subject|0|||
131803887|NCT02930005|474565298|FG000|Overall Study|Lost to Follow-up|1|||
131652410|NCT01920477|474014002|FG001|Overall Study|Study closed/terminated|15|||
131652411|NCT01920477|474014001|FG000|Overall Study|Withdrawal by Subject|0|||
131652412|NCT01920477|474014002|FG001|Overall Study|Withdrawal by Subject|1|||
131652413|NCT01681277|474014005|FG000|Overall Study|Adverse Event|1|||
131652414|NCT01681277|474014006|FG001|Overall Study|Adverse Event|0|||
131652415|NCT01681277|474014007|FG002|Overall Study|Adverse Event|0|||
131652416|NCT01681277|474014008|FG003|Overall Study|Adverse Event|0|||
131652417|NCT01681277|474014009|FG004|Overall Study|Adverse Event|0|||
131652418|NCT02113124|474014010|FG000|Overall Study|Unable to retrieve blood sample|1|||
131652419|NCT02113124|474014011|FG001|Overall Study|Unable to retrieve blood sample|1|||
131652420|NCT03299049|474014012|FG000|Overall Study|On-going|486|||
131652421|NCT03299049|474014013|FG001|Overall Study|On-going|481|||
131652422|NCT03299049|474014012|FG000|Overall Study|Withdrawal by Subject|6|||
131652423|NCT03299049|474014013|FG001|Overall Study|Withdrawal by Subject|21|||
131652424|NCT03299049|474014012|FG000|Overall Study|Physician Decision|5|||
131652425|NCT03299049|474014013|FG001|Overall Study|Physician Decision|1|||
131652426|NCT03299049|474014012|FG000|Overall Study|Lost to Follow-up|2|||
131652427|NCT03299049|474014013|FG001|Overall Study|Lost to Follow-up|0|||
131652428|NCT03299049|474014012|FG000|Overall Study|Pregnancy|1|||
131652429|NCT03299049|474014013|FG001|Overall Study|Pregnancy|3|||
131652430|NCT03299049|474014012|FG000|Overall Study|Protocol Violation|1|||
131652431|NCT03299049|474014013|FG001|Overall Study|Protocol Violation|1|||
131652432|NCT03299049|474014012|FG000|Overall Study|Lack of Efficacy|9|||
131652433|NCT03299049|474014013|FG001|Overall Study|Lack of Efficacy|3|||
131652434|NCT03299049|474014012|FG000|Overall Study|Adverse Event|12|||
131652435|NCT03299049|474014013|FG001|Overall Study|Adverse Event|13|||
131803888|NCT02930005|474565299|FG001|Overall Study|Lost to Follow-up|5|||
131448133|NCT01716234|473270879|FG005|Overall Study|Adverse Event|6|||
131652436|NCT01901419|474014014|FG000|Overall Study|Protocol Violation|2|||
131652437|NCT01901419|474014015|FG001|Overall Study|Protocol Violation|6|||
131652438|NCT01901419|474014014|FG000|Overall Study|unavailable researchers|6|||
131652439|NCT01901419|474014015|FG001|Overall Study|unavailable researchers|3|||
131652440|NCT01667926|474014016|FG000|Overall Study|Withdrawal by Subject|1|||
131652441|NCT01667926|474014017|FG001|Overall Study|Withdrawal by Subject|2|||
131652442|NCT01667926|474014018|FG002|Overall Study|Withdrawal by Subject|2|||
131652443|NCT01667926|474014016|FG000|Overall Study|Physician Decision|0|||
131652444|NCT01667926|474014017|FG001|Overall Study|Physician Decision|0|||
131652445|NCT01667926|474014018|FG002|Overall Study|Physician Decision|1|||
131652446|NCT01667926|474014016|FG000|Overall Study|Time committment|0|||
131652447|NCT01667926|474014017|FG001|Overall Study|Time committment|0|||
131652448|NCT01667926|474014018|FG002|Overall Study|Time committment|2|||
131652449|NCT01667926|474014016|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
131803889|NCT05067647|474565303|FG000|Overall Study|Lost to Follow-up|1|||
131803890|NCT02781727|474565306|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
131803891|NCT02781727|474565307|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
131803892|NCT02781727|474565306|FG000|Treatment Period|Withdrawal by Subject|1|||
131803893|NCT02781727|474565307|FG001|Treatment Period|Withdrawal by Subject|0|||
131803894|NCT02781727|474565306|FG000|Treatment Period|Lost to Follow-up|0|||
131803895|NCT02781727|474565307|FG001|Treatment Period|Lost to Follow-up|1|||
131803896|NCT05214560|474565309|FG000|Overall Study|Screening Failure|1|||
131652450|NCT01667926|474014017|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
131652451|NCT01667926|474014018|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
131652452|NCT01667926|474014016|FG000|Overall Study|Lost to Follow-up|1|||
131652453|NCT01667926|474014017|FG001|Overall Study|Lost to Follow-up|2|||
131652454|NCT01667926|474014018|FG002|Overall Study|Lost to Follow-up|1|||
131652455|NCT01667926|474014016|FG000|Overall Study|Side effects|3|||
131652456|NCT01667926|474014017|FG001|Overall Study|Side effects|0|||
131652457|NCT01667926|474014018|FG002|Overall Study|Side effects|0|||
131652458|NCT02271984|474014021|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652459|NCT02271984|474014022|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652460|NCT02271984|474014023|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652461|NCT02271984|474014024|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652462|NCT02271984|474014025|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652463|NCT02271984|474014026|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
131652464|NCT02271984|474014027|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652465|NCT02271984|474014028|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
131652466|NCT02271984|474014029|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652467|NCT02271984|474014030|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652468|NCT02271984|474014031|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652469|NCT02271984|474014032|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131652470|NCT02412735|474014033|FG000|Overall Study|Adverse Event|0|||
131652471|NCT02412735|474014034|FG001|Overall Study|Adverse Event|1|||
131652472|NCT02412735|474014035|FG002|Overall Study|Adverse Event|2|||
131652473|NCT02412735|474014033|FG000|Overall Study|Withdrawal by Subject|23|||
131652474|NCT02412735|474014034|FG001|Overall Study|Withdrawal by Subject|27|||
131652475|NCT02412735|474014035|FG002|Overall Study|Withdrawal by Subject|22|||
131652476|NCT02412735|474014033|FG000|Overall Study|Investigator Decision|3|||
131652477|NCT02412735|474014034|FG001|Overall Study|Investigator Decision|3|||
131652478|NCT02412735|474014035|FG002|Overall Study|Investigator Decision|2|||
131652479|NCT02412735|474014033|FG000|Overall Study|Lost to Follow-up|17|||
131652480|NCT02412735|474014034|FG001|Overall Study|Lost to Follow-up|11|||
131652481|NCT02412735|474014035|FG002|Overall Study|Lost to Follow-up|18|||
131652482|NCT02412735|474014033|FG000|Overall Study|Reason not Specified|3|||
131652483|NCT02412735|474014034|FG001|Overall Study|Reason not Specified|2|||
131652484|NCT02412735|474014035|FG002|Overall Study|Reason not Specified|2|||
131652485|NCT04043143|474014036|FG000|Overall Study|Lost to Follow-up|5|||
131652486|NCT04043143|474014037|FG001|Overall Study|Lost to Follow-up|5|||
131652487|NCT04043143|474014036|FG000|Overall Study|screen failure|1|||
131652488|NCT04043143|474014037|FG001|Overall Study|screen failure|0|||
131652489|NCT03480932|474014038|FG000|Overall Study|Death|1|||
131652490|NCT03480932|474014039|FG001|Overall Study|Death|1|||
131652491|NCT03480932|474014040|FG002|Overall Study|Death|0|||
131652492|NCT03480932|474014038|FG000|Overall Study|Lost to Follow-up|0|||
131652493|NCT03480932|474014039|FG001|Overall Study|Lost to Follow-up|2|||
131652494|NCT03480932|474014040|FG002|Overall Study|Lost to Follow-up|3|||
131652495|NCT03480932|474014038|FG000|Overall Study|Incarcerated|2|||
131652496|NCT03480932|474014039|FG001|Overall Study|Incarcerated|2|||
131652497|NCT03480932|474014040|FG002|Overall Study|Incarcerated|2|||
131652498|NCT04624243|474014041|FG000|Overall Study|Death|0|||
131652499|NCT04624243|474014042|FG001|Overall Study|Death|1|||
131652500|NCT04624243|474014043|FG002|Overall Study|Death|0|||
131652501|NCT04624243|474014044|FG003|Overall Study|Death|0|||
131652502|NCT04624243|474014045|FG004|Overall Study|Death|0|||
131652503|NCT04624243|474014041|FG000|Overall Study|Lost to Follow-up|2|||
131652504|NCT04624243|474014042|FG001|Overall Study|Lost to Follow-up|3|||
131652505|NCT04624243|474014043|FG002|Overall Study|Lost to Follow-up|7|||
131652506|NCT04624243|474014044|FG003|Overall Study|Lost to Follow-up|1|||
131652507|NCT04624243|474014045|FG004|Overall Study|Lost to Follow-up|3|||
131652508|NCT04624243|474014041|FG000|Overall Study|Physician Decision|3|||
131652509|NCT04624243|474014042|FG001|Overall Study|Physician Decision|8|||
131652510|NCT04624243|474014043|FG002|Overall Study|Physician Decision|15|||
131652511|NCT04624243|474014044|FG003|Overall Study|Physician Decision|2|||
131652512|NCT04624243|474014045|FG004|Overall Study|Physician Decision|11|||
131652513|NCT04624243|474014041|FG000|Overall Study|Withdrawal by Subject|19|||
131652514|NCT04624243|474014042|FG001|Overall Study|Withdrawal by Subject|44|||
131652515|NCT04624243|474014043|FG002|Overall Study|Withdrawal by Subject|40|||
131652516|NCT04624243|474014044|FG003|Overall Study|Withdrawal by Subject|21|||
131652517|NCT04624243|474014045|FG004|Overall Study|Withdrawal by Subject|39|||
131652518|NCT04624243|474014041|FG000|Overall Study|Miscellaneous|3|||
131652519|NCT04624243|474014042|FG001|Overall Study|Miscellaneous|12|||
131652520|NCT04624243|474014043|FG002|Overall Study|Miscellaneous|9|||
131652521|NCT04624243|474014044|FG003|Overall Study|Miscellaneous|4|||
131652522|NCT04624243|474014045|FG004|Overall Study|Miscellaneous|6|||
131652523|NCT03325777|474014048|FG000|Overall Study|Lost to Follow-up|9|||
131652524|NCT03325777|474014049|FG001|Overall Study|Lost to Follow-up|12|||
131652525|NCT02522728|474014050|FG000|Overall Study|Withdrawal by Subject|6|||
131652526|NCT02522728|474014051|FG001|Overall Study|Withdrawal by Subject|6|||
131652527|NCT02522728|474014050|FG000|Overall Study|Death|4|||
131652528|NCT02522728|474014051|FG001|Overall Study|Death|3|||
131652529|NCT02522728|474014050|FG000|Overall Study|Adverse Event|2|||
131652530|NCT02522728|474014051|FG001|Overall Study|Adverse Event|1|||
131652531|NCT02522728|474014050|FG000|Overall Study|Did not receive randomized study device|0|||
131652532|NCT02522728|474014051|FG001|Overall Study|Did not receive randomized study device|1|||
131652533|NCT01266161|474014058|FG000|Overall Study|Ineligible|1|||
131652534|NCT01266161|474014059|FG001|Overall Study|Ineligible|0|||
131652535|NCT01266161|474014058|FG000|Overall Study|Lack of Efficacy|0|||
131652536|NCT01266161|474014059|FG001|Overall Study|Lack of Efficacy|1|||
131652537|NCT01266161|474014058|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
131652538|NCT01266161|474014059|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
131652539|NCT02990468|474014060|FG000|Phase 2: MTD|Change in treatment|0|||
131652540|NCT02990468|474014061|FG001|Phase 2: MTD|Change in treatment|0|||
131652541|NCT02990468|474014062|FG002|Phase 2: MTD|Change in treatment|1|||
131652542|NCT01485120|474014066|FG000|Overall Study|Withdrawal by Subject|2|||
131652543|NCT01081886|474014067|FG000|Overall Study|Study termination|11|||
131652544|NCT01081886|474014068|FG001|Overall Study|Study termination|13|||
131652545|NCT00402051|474014073|FG000|Overall Study|Progressive Disease|13|||
131652546|NCT00402051|474014074|FG001|Overall Study|Progressive Disease|20|||
131652547|NCT00402051|474014073|FG000|Overall Study|Adverse Event|11|||
131652548|NCT00402051|474014074|FG001|Overall Study|Adverse Event|4|||
131652549|NCT00402051|474014073|FG000|Overall Study|Physician Decision|7|||
131652550|NCT00402051|474014074|FG001|Overall Study|Physician Decision|3|||
131652551|NCT00402051|474014073|FG000|Overall Study|Withdrawal by Subject|3|||
131652552|NCT00402051|474014074|FG001|Overall Study|Withdrawal by Subject|3|||
131652553|NCT00402051|474014073|FG000|Overall Study|Death - Related to Study Drug|1|||
131652554|NCT00402051|474014074|FG001|Overall Study|Death - Related to Study Drug|2|||
131652555|NCT00402051|474014073|FG000|Overall Study|Death Due to Study Disease|2|||
131652556|NCT00402051|474014074|FG001|Overall Study|Death Due to Study Disease|1|||
131652557|NCT00402051|474014073|FG000|Overall Study|Death Due to Adverse Event|0|||
131652558|NCT00402051|474014074|FG001|Overall Study|Death Due to Adverse Event|2|||
131652559|NCT00402051|474014073|FG000|Overall Study|Lost to Follow-up|1|||
131652560|NCT00402051|474014074|FG001|Overall Study|Lost to Follow-up|0|||
131652561|NCT00975676|474014078|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
131716707|NCT00097539|474241080|FG003|Overall Study|Adverse Event|27|||
131716708|NCT00097539|474241081|FG004|Overall Study|Adverse Event|30|||
131716709|NCT00097539|474241082|FG005|Overall Study|Adverse Event|59|||
131716710|NCT00097539|474241083|FG006|Overall Study|Adverse Event|1|||
131716711|NCT00097539|474241077|FG000|Overall Study|Death|2|||
131716712|NCT00097539|474241078|FG001|Overall Study|Death|7|||
131716713|NCT00097539|474241079|FG002|Overall Study|Death|0|||
131716714|NCT00097539|474241080|FG003|Overall Study|Death|0|||
131716715|NCT00097539|474241081|FG004|Overall Study|Death|1|||
131716716|NCT00097539|474241082|FG005|Overall Study|Death|3|||
131716717|NCT00097539|474241083|FG006|Overall Study|Death|0|||
131716718|NCT00097539|474241077|FG000|Overall Study|Reasons Other Than Above|3602|||
131716719|NCT00097539|474241078|FG001|Overall Study|Reasons Other Than Above|1382|||
131716720|NCT00097539|474241079|FG002|Overall Study|Reasons Other Than Above|1757|||
131716721|NCT00097539|474241080|FG003|Overall Study|Reasons Other Than Above|692|||
131716722|NCT00097539|474241081|FG004|Overall Study|Reasons Other Than Above|361|||
131716723|NCT00097539|474241082|FG005|Overall Study|Reasons Other Than Above|1244|||
131716724|NCT00097539|474241083|FG006|Overall Study|Reasons Other Than Above|34|||
131716725|NCT00097539|474241077|FG000|Overall Study|Reason not Specified|111|||
131716726|NCT00097539|474241078|FG001|Overall Study|Reason not Specified|49|||
131716727|NCT00097539|474241079|FG002|Overall Study|Reason not Specified|53|||
131716728|NCT00097539|474241080|FG003|Overall Study|Reason not Specified|21|||
131716729|NCT00097539|474241081|FG004|Overall Study|Reason not Specified|11|||
131716730|NCT00097539|474241082|FG005|Overall Study|Reason not Specified|40|||
131716731|NCT00097539|474241083|FG006|Overall Study|Reason not Specified|2|||
131716732|NCT02966314|474241084|FG000|Overall Study|Lost to Follow-up|1|||
131716733|NCT02966314|474241085|FG001|Overall Study|Lost to Follow-up|0|||
131716734|NCT03941548|474241086|FG000|Overall Study|Adverse Event|0|||
131716735|NCT03941548|474241087|FG001|Overall Study|Adverse Event|1|||
131652562|NCT00975676|474014079|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
131652563|NCT02548078|474014080|FG000|Overall Study|Serious adverse event/Adverse event|1|||
131652564|NCT02548078|474014081|FG001|Overall Study|Serious adverse event/Adverse event|0|||
131652565|NCT02548078|474014080|FG000|Overall Study|Moved from study area|3|||
131652566|NCT02548078|474014081|FG001|Overall Study|Moved from study area|3|||
131652567|NCT02548078|474014080|FG000|Overall Study|Lost to Follow-up|1|||
131652568|NCT02548078|474014081|FG001|Overall Study|Lost to Follow-up|3|||
131716736|NCT03941548|474241086|FG000|Overall Study|Lost to Follow-up|0|||
131716737|NCT03941548|474241087|FG001|Overall Study|Lost to Follow-up|1|||
131716738|NCT03941548|474241086|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
131716739|NCT03941548|474241087|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
131716740|NCT01242111|474241090|FG000|Overall Study|Adverse Event|1|||
131716741|NCT01242111|474241090|FG000|Overall Study|Withdrawal by Subject|1|||
131803897|NCT05214560|474565309|FG000|Overall Study|Physician Decision|4|||
131652569|NCT03128671|474014082|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
131652570|NCT03128671|474014083|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
131652571|NCT03128671|474014082|FG000|Allocation|Death|1|||
131652572|NCT03128671|474014083|FG001|Allocation|Death|0|||
131652573|NCT03128671|474014082|FG000|Allocation|Withdrawal by Subject|4|||
131652574|NCT03128671|474014083|FG001|Allocation|Withdrawal by Subject|0|||
131652575|NCT03128671|474014082|FG000|Intervention|Withdrawal by Subject|11|||
131652576|NCT03128671|474014083|FG001|Intervention|Withdrawal by Subject|10|||
131803898|NCT05214560|474565309|FG000|Overall Study|Withdrawal by Subject|1|||
131803899|NCT05214560|474565309|FG000|Overall Study|Lost to Follow-up|2|||
131803900|NCT05214560|474565309|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
131803901|NCT05214560|474565309|FG000|Overall Study|Study physician not available for the anesthesia|3|||
131803902|NCT05214560|474565309|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
131803903|NCT05214560|474565309|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
131803904|NCT05214560|474565309|FG000|Overall Study|Surgery not performed|3|||
131803905|NCT00870870|474565311|FG000|Overall Study|Withdrawal by Subject|0|||
131803906|NCT00870870|474565312|FG001|Overall Study|Withdrawal by Subject|1|||
131803907|NCT00870870|474565313|FG002|Overall Study|Withdrawal by Subject|1|||
131803908|NCT00870870|474565314|FG003|Overall Study|Withdrawal by Subject|3|||
131803909|NCT00870870|474565311|FG000|Overall Study|Adverse Event|0|||
131803910|NCT00870870|474565312|FG001|Overall Study|Adverse Event|0|||
131803911|NCT00870870|474565313|FG002|Overall Study|Adverse Event|2|||
131803912|NCT00870870|474565314|FG003|Overall Study|Adverse Event|2|||
131652577|NCT03128671|474014082|FG000|Intervention|Palliative/hospice care initiated|9|||
131652578|NCT03128671|474014083|FG001|Intervention|Palliative/hospice care initiated|10|||
131652579|NCT03128671|474014082|FG000|Intervention|Death|13|||
131652580|NCT03128671|474014083|FG001|Intervention|Death|11|||
131652581|NCT03128671|474014082|FG000|Intervention|Interrupted by hurricane|1|||
131652582|NCT03128671|474014083|FG001|Intervention|Interrupted by hurricane|0|||
131652583|NCT03128671|474014082|FG000|Intervention|Physician Decision|2|||
131652584|NCT03128671|474014083|FG001|Intervention|Physician Decision|3|||
131652585|NCT05239598|474014088|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
131652586|NCT05239598|474014089|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
131652587|NCT05239598|474014088|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
131652588|NCT05239598|474014089|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
131652589|NCT02998476|474014096|FG000|Overall Study|Lost to Follow-up|1|||
131652590|NCT02998476|474014097|FG001|Overall Study|Lost to Follow-up|0|||
131652591|NCT02998476|474014096|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
131652592|NCT02998476|474014097|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
131652593|NCT02998476|474014096|FG000|Overall Study|Withdrawal by Subject|1|||
131652594|NCT02998476|474014097|FG001|Overall Study|Withdrawal by Subject|2|||
131652595|NCT02998476|474014096|FG000|Overall Study|Death|45|||
131652596|NCT02998476|474014097|FG001|Overall Study|Death|2|||
131652597|NCT02998476|474014096|FG000|Overall Study|Other|6|||
131652598|NCT02998476|474014097|FG001|Overall Study|Other|1|||
131652599|NCT03277352|474014098|FG000|Overall Study|Study Terminated By Sponsor|2|||
131652600|NCT03277352|474014098|FG000|Overall Study|Withdrawal by Subject|4|||
131652601|NCT03277352|474014098|FG000|Overall Study|Death|4|||
131903936|NCT05081388|474935383|FG003|Overall Study|Lost to Follow-up|0|||
131903937|NCT05081388|474935384|FG004|Overall Study|Lost to Follow-up|0|||
131903938|NCT05081388|474935380|FG000|Overall Study|Subject decision|0|||
131903939|NCT05081388|474935381|FG001|Overall Study|Subject decision|0|||
131903940|NCT05081388|474935382|FG002|Overall Study|Subject decision|0|||
131903941|NCT05081388|474935383|FG003|Overall Study|Subject decision|1|||
131903942|NCT05081388|474935384|FG004|Overall Study|Subject decision|0|||
131903943|NCT00243919|474935385|FG000|Overall Study|Death|3|||
131903944|NCT00243919|474935386|FG001|Overall Study|Death|4|||
131903945|NCT00243919|474935387|FG002|Overall Study|Death|6|||
131903946|NCT00243919|474935385|FG000|Overall Study|Withdrawal by Subject|6|||
131903947|NCT00243919|474935386|FG001|Overall Study|Withdrawal by Subject|6|||
131903948|NCT00243919|474935387|FG002|Overall Study|Withdrawal by Subject|2|||
131652602|NCT01435772|474014099|FG000|Overall Study|Adverse Event|1|||
131652603|NCT01435772|474014100|FG001|Overall Study|Adverse Event|0|||
131803913|NCT00822926|474565320|FG000|Second Injection Visit|Lost to Follow-up|1|||
131803914|NCT00822926|474565321|FG001|Second Injection Visit|Lost to Follow-up|0|||
131803915|NCT00822926|474565320|FG000|Second Injection Visit|Withdrawal by Subject|0|||
131903949|NCT00243919|474935385|FG000|Overall Study|Lost to Follow-up|6|||
131652604|NCT01435772|474014101|FG002|Overall Study|Adverse Event|2|||
131652605|NCT01435772|474014099|FG000|Overall Study|Withdrawal by Subject|0|||
131652606|NCT01435772|474014100|FG001|Overall Study|Withdrawal by Subject|1|||
131652607|NCT01435772|474014101|FG002|Overall Study|Withdrawal by Subject|3|||
131652608|NCT01435772|474014099|FG000|Overall Study|Other - study termination|2|||
131803916|NCT00822926|474565321|FG001|Second Injection Visit|Withdrawal by Subject|1|||
131803917|NCT03018249|474565322|FG000|Overall Study|Withdrawal by Subject|2|||
131903950|NCT00243919|474935386|FG001|Overall Study|Lost to Follow-up|7|||
131903951|NCT00243919|474935387|FG002|Overall Study|Lost to Follow-up|3|||
131652609|NCT01435772|474014100|FG001|Overall Study|Other - study termination|2|||
131652610|NCT01435772|474014101|FG002|Overall Study|Other - study termination|10|||
131652611|NCT03238963|474014102|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
131652612|NCT03238963|474014103|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
131652613|NCT03238963|474014102|FG000|Overall Study|Withdrawal by Subject|1|||
131652614|NCT03238963|474014103|FG001|Overall Study|Withdrawal by Subject|1|||
131652615|NCT03238963|474014102|FG000|Overall Study|Lost to Follow-up|1|||
131652616|NCT03238963|474014103|FG001|Overall Study|Lost to Follow-up|0|||
131652617|NCT03238963|474014102|FG000|Overall Study|Protocol Violation|1|||
131652618|NCT03238963|474014103|FG001|Overall Study|Protocol Violation|1|||
131652619|NCT03238963|474014102|FG000|Overall Study|Adverse Event|1|||
131652620|NCT03238963|474014103|FG001|Overall Study|Adverse Event|0|||
131652621|NCT01424813|474014106|FG000|Overall Study|Withdrawal by Subject|3|||
131903952|NCT00243919|474935385|FG000|Overall Study|Administrative Error|1|||
131903953|NCT00243919|474935386|FG001|Overall Study|Administrative Error|0|||
131903954|NCT00243919|474935387|FG002|Overall Study|Administrative Error|0|||
131903955|NCT00243919|474935385|FG000|Overall Study|Physician Decision|1|||
131903956|NCT00243919|474935386|FG001|Overall Study|Physician Decision|1|||
131903957|NCT00243919|474935387|FG002|Overall Study|Physician Decision|0|||
131903958|NCT04202497|474935388|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
131903959|NCT04202497|474935389|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
131903960|NCT04202497|474935390|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
131903961|NCT04202497|474935391|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
131652622|NCT01424813|474014107|FG001|Overall Study|Withdrawal by Subject|0|||
131652623|NCT01424813|474014106|FG000|Overall Study|Protocol Violation|1|||
131652624|NCT01424813|474014107|FG001|Overall Study|Protocol Violation|0|||
131652625|NCT01424813|474014106|FG000|Overall Study|Other|1|||
131652626|NCT01424813|474014107|FG001|Overall Study|Other|2|||
131652627|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Adverse Event|10|||
131652628|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Adverse Event|9|||
131652629|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Adverse Event|7|||
131652630|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
131652631|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
131652632|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
131652633|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
131652634|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
131652635|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
131652636|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Physician Decision|7|||
131652637|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Physician Decision|3|||
131652638|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Physician Decision|2|||
131652639|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Pregnancy|2|||
131652640|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Pregnancy|1|||
131652641|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Pregnancy|3|||
131652642|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
131716742|NCT01242111|474241090|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
131903962|NCT05547386|474935392|FG000|Overall Study|Withdrawal by Subject|7|||
131903963|NCT04622969|474935393|FG000|Overall Study|Withdrawal by Subject|2|||
131903964|NCT04622969|474935394|FG001|Overall Study|Withdrawal by Subject|3|||
131903965|NCT05616013|474935395|FG000|Overall Study|Adverse Event|6|||
131716743|NCT02015819|474241091|FG000|Overall Study|Rickham catheter was misaligned|0|||
131716744|NCT02015819|474241092|FG001|Overall Study|Rickham catheter was misaligned|0|||
131716745|NCT02015819|474241093|FG002|Overall Study|Rickham catheter was misaligned|0|||
131716746|NCT02015819|474241094|FG003|Overall Study|Rickham catheter was misaligned|1|||
131716747|NCT02945657|474241095|FG000|Overall Study|Adverse Event|1|||
131716748|NCT02945657|474241095|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
131716749|NCT00466505|474241104|FG000|Overall Study|disease progression|13|||
131716750|NCT00466505|474241104|FG000|Overall Study|Adverse Event|4|||
131716751|NCT00811252|474241105|FG000|Overall Study|Adverse Event|6|||
131716752|NCT00811252|474241106|FG001|Overall Study|Adverse Event|10|||
131716753|NCT00811252|474241107|FG002|Overall Study|Adverse Event|15|||
131716754|NCT00811252|474241105|FG000|Overall Study|Lack of Efficacy|7|||
131716755|NCT00811252|474241106|FG001|Overall Study|Lack of Efficacy|2|||
131716756|NCT00811252|474241107|FG002|Overall Study|Lack of Efficacy|0|||
131716757|NCT00811252|474241105|FG000|Overall Study|Protocol Violation|3|||
131716758|NCT00811252|474241106|FG001|Overall Study|Protocol Violation|3|||
131716759|NCT00811252|474241107|FG002|Overall Study|Protocol Violation|2|||
131716760|NCT00811252|474241105|FG000|Overall Study|Withdrawal of Consent|1|||
131903966|NCT05616013|474935396|FG001|Overall Study|Adverse Event|12|||
131716761|NCT00811252|474241106|FG001|Overall Study|Withdrawal of Consent|2|||
131652643|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
131652644|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
131652645|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
131652646|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
131652647|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
131652648|NCT02614183|474014108|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
131652649|NCT02614183|474014109|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
131652650|NCT02614183|474014110|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
131652651|NCT02614183|474014108|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
131652652|NCT02614183|474014109|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
131652653|NCT02614183|474014110|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
131652654|NCT02614183|474014108|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
131652655|NCT02614183|474014109|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
131652656|NCT02614183|474014110|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
131652657|NCT02614183|474014108|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
131652658|NCT02614183|474014109|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
131652659|NCT02614183|474014110|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
131652660|NCT02614183|474014108|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
131652661|NCT02614183|474014109|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
131652662|NCT02614183|474014110|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
131652663|NCT03838731|474015573|FG000|Overall Study|Pregnancy|0|||
131652664|NCT03838731|474015574|FG001|Overall Study|Pregnancy|1|||
131652665|NCT03838731|474015573|FG000|Overall Study|Withdrawal of consent|1|||
131652666|NCT03838731|474015574|FG001|Overall Study|Withdrawal of consent|0|||
131652667|NCT01088984|474015575|FG000|Phase 1|Death|2|||
131652668|NCT01088984|474015576|FG001|Phase 1|Death|1|||
131652669|NCT01088984|474015575|FG000|Phase 1|Disease Progression|2|||
131652670|NCT01088984|474015576|FG001|Phase 1|Disease Progression|4|||
131652671|NCT01088984|474015575|FG000|Phase 1|Other|1|||
131652672|NCT01088984|474015576|FG001|Phase 1|Other|1|||
131652673|NCT01088984|474015575|FG000|Phase 2|Death|0|||
131652674|NCT01088984|474015576|FG001|Phase 2|Death|5|||
131652675|NCT01088984|474015575|FG000|Phase 2|Withdrawal by Subject|0|||
131652676|NCT01088984|474015576|FG001|Phase 2|Withdrawal by Subject|1|||
131652677|NCT01088984|474015575|FG000|Phase 2|DIsease Progression|0|||
131652678|NCT01088984|474015576|FG001|Phase 2|DIsease Progression|25|||
131652679|NCT01088984|474015575|FG000|Phase 2|Other|0|||
131652680|NCT01088984|474015576|FG001|Phase 2|Other|1|||
131652681|NCT04707664|474015577|FG000|Overall Study|Adverse Event|2|||
131652682|NCT04707664|474015578|FG001|Overall Study|Adverse Event|0|||
131652683|NCT04707664|474015577|FG000|Overall Study|Death|1|||
131652684|NCT04707664|474015578|FG001|Overall Study|Death|2|||
131652685|NCT04707664|474015577|FG000|Overall Study|Withdrawal by Subject|13|||
131652686|NCT04707664|474015578|FG001|Overall Study|Withdrawal by Subject|21|||
131652687|NCT04707664|474015577|FG000|Overall Study|Lost to Follow-up|11|||
131652688|NCT04707664|474015578|FG001|Overall Study|Lost to Follow-up|13|||
131652689|NCT04707664|474015577|FG000|Overall Study|Not treated|2|||
131652690|NCT04707664|474015578|FG001|Overall Study|Not treated|0|||
131652691|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
131652692|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
131652693|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131652694|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
131652695|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131652696|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131652697|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
131652698|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
131652699|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131652700|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131652701|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
131652702|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131652703|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131716762|NCT00811252|474241107|FG002|Overall Study|Withdrawal of Consent|2|||
131716763|NCT00811252|474241105|FG000|Overall Study|Lost to Follow-up|0|||
131716764|NCT00811252|474241106|FG001|Overall Study|Lost to Follow-up|0|||
131716765|NCT00811252|474241107|FG002|Overall Study|Lost to Follow-up|2|||
131716766|NCT00811252|474241105|FG000|Overall Study|Administrative or Other Reasons|0|||
131716767|NCT00811252|474241106|FG001|Overall Study|Administrative or Other Reasons|3|||
131716768|NCT00811252|474241107|FG002|Overall Study|Administrative or Other Reasons|2|||
131716769|NCT00813748|474241108|FG000|Skin Test Substudy|Physician Decision|0|||
131716770|NCT00813748|474241109|FG001|Skin Test Substudy|Physician Decision|1|||
131716771|NCT00728416|474241116|FG000|Overall Study|Adverse Event|1|||
131448134|NCT01716234|473270880|FG006|Overall Study|Adverse Event|0|||
131652704|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
131652705|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131716772|NCT00728416|474241117|FG001|Overall Study|Adverse Event|1|||
131652706|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
131652707|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
131652708|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
131652709|NCT00603525|474015579|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
131652710|NCT00603525|474015580|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
131652711|NCT00603525|474015581|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
131652712|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131652713|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
131652714|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131652715|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131652716|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
131652717|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131652718|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131652719|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
131652720|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131652721|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131652722|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
131652723|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131652724|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131652725|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
131652726|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131652727|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131652728|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
131652729|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131652730|NCT00603525|474015579|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131652731|NCT00603525|474015580|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
131652732|NCT00603525|474015581|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131652733|NCT00603525|474015579|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
131652734|NCT00603525|474015580|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
131652735|NCT00603525|474015581|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
131652736|NCT01939353|474015585|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
131652737|NCT01939353|474015585|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
131652738|NCT01939353|474015585|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
131652739|NCT01939353|474015585|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
131652740|NCT01939353|474015585|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
131652741|NCT05048238|474015593|FG000|Overall Study|Withdrawal by Subject|1|||
131652742|NCT01886287|474015602|FG000|Overall Study|Radiographic disease progression|1|||
131652743|NCT01886287|474015602|FG000|Overall Study|Clinical progression due to disease|1|||
131652744|NCT05071053|474015603|FG000|Overall Study|Progressive disease|30|||
131652745|NCT05071053|474015603|FG000|Overall Study|Adverse Event|5|||
131652746|NCT01602510|474015608|FG000|Open Label Phase|Adverse Event|46|||
131652747|NCT01602510|474015609|FG001|Open Label Phase|Adverse Event|0|||
131652748|NCT01602510|474015610|FG002|Open Label Phase|Adverse Event|0|||
131652749|NCT01602510|474015608|FG000|Open Label Phase|Lack of Efficacy|22|||
131652750|NCT01602510|474015609|FG001|Open Label Phase|Lack of Efficacy|0|||
131652751|NCT01602510|474015610|FG002|Open Label Phase|Lack of Efficacy|0|||
131652752|NCT01602510|474015608|FG000|Open Label Phase|Protocol Violation|15|||
131652753|NCT01602510|474015609|FG001|Open Label Phase|Protocol Violation|0|||
131652754|NCT01602510|474015610|FG002|Open Label Phase|Protocol Violation|0|||
131652755|NCT01602510|474015608|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
131652756|NCT01602510|474015609|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
131652757|NCT01602510|474015610|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
131652758|NCT01602510|474015608|FG000|Open Label Phase|Lost to Follow-up|22|||
131803918|NCT03018249|474565323|FG001|Overall Study|Withdrawal by Subject|2|||
131803919|NCT01378975|474565324|FG000|Overall Study|Death|77|||
131803920|NCT01378975|474565325|FG001|Overall Study|Death|46|||
131803921|NCT01378975|474565324|FG000|Overall Study|Investigator Request|1|||
131803922|NCT01378975|474565325|FG001|Overall Study|Investigator Request|0|||
131803923|NCT01378975|474565324|FG000|Overall Study|Lost to Follow-up|4|||
131803924|NCT01378975|474565325|FG001|Overall Study|Lost to Follow-up|1|||
131652759|NCT01602510|474015609|FG001|Open Label Phase|Lost to Follow-up|0|||
131803925|NCT01378975|474565324|FG000|Overall Study|Withdrew Consent|4|||
131803926|NCT01378975|474565325|FG001|Overall Study|Withdrew Consent|3|||
131803927|NCT03991494|474565328|FG000|Overall Study|Progressive Disease|4|||
131803928|NCT03601637|474566936|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
131652760|NCT01602510|474015610|FG002|Open Label Phase|Lost to Follow-up|0|||
131652761|NCT01602510|474015608|FG000|Open Label Phase|Physician Decision|19|||
131652762|NCT01602510|474015609|FG001|Open Label Phase|Physician Decision|0|||
131652763|NCT01602510|474015610|FG002|Open Label Phase|Physician Decision|0|||
131652764|NCT01602510|474015608|FG000|Open Label Phase|Withdrawal by Subject|57|||
131652765|NCT01602510|474015609|FG001|Open Label Phase|Withdrawal by Subject|0|||
131652766|NCT01602510|474015610|FG002|Open Label Phase|Withdrawal by Subject|0|||
131652767|NCT01602510|474015608|FG000|Randomized Phase|Adverse Event|0|||
131652768|NCT01602510|474015609|FG001|Randomized Phase|Adverse Event|2|||
131652769|NCT01602510|474015610|FG002|Randomized Phase|Adverse Event|6|||
131652770|NCT01602510|474015608|FG000|Randomized Phase|Lack of Efficacy|0|||
131652771|NCT01602510|474015609|FG001|Randomized Phase|Lack of Efficacy|4|||
131652772|NCT01602510|474015610|FG002|Randomized Phase|Lack of Efficacy|4|||
131652773|NCT01602510|474015608|FG000|Randomized Phase|Protocol Violation|0|||
131652774|NCT01602510|474015609|FG001|Randomized Phase|Protocol Violation|3|||
131652775|NCT01602510|474015610|FG002|Randomized Phase|Protocol Violation|3|||
131652776|NCT01602510|474015608|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
131652777|NCT01602510|474015609|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
131652778|NCT01602510|474015610|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
131652779|NCT01602510|474015608|FG000|Randomized Phase|Lost to Follow-up|0|||
131652780|NCT01602510|474015609|FG001|Randomized Phase|Lost to Follow-up|1|||
131652781|NCT01602510|474015610|FG002|Randomized Phase|Lost to Follow-up|3|||
131652782|NCT01602510|474015608|FG000|Randomized Phase|Physician Decision|0|||
131652783|NCT01602510|474015609|FG001|Randomized Phase|Physician Decision|0|||
131652784|NCT01602510|474015610|FG002|Randomized Phase|Physician Decision|2|||
131652785|NCT01602510|474015608|FG000|Randomized Phase|Withdrawal by Subject|0|||
131652786|NCT01602510|474015609|FG001|Randomized Phase|Withdrawal by Subject|6|||
131652787|NCT01602510|474015610|FG002|Randomized Phase|Withdrawal by Subject|7|||
131652788|NCT01261000|474015611|FG000|Overall Study|Screen failure|1|||
131652789|NCT03519204|474015612|FG000|Overall Study|Lost to Follow-up|3|||
131652790|NCT03519204|474015613|FG001|Overall Study|Lost to Follow-up|8|||
131652791|NCT03519204|474015612|FG000|Overall Study|Withdrawal by Subject|9|||
131652792|NCT03519204|474015613|FG001|Overall Study|Withdrawal by Subject|7|||
131652793|NCT03519204|474015612|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131652794|NCT03519204|474015613|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131652795|NCT01289210|474015614|FG000|Overall Study|Adverse Event|1|||
131652796|NCT01818531|474015618|FG000|Overall Study|Withdrawn for case delay after block|1|||
131652797|NCT01818531|474015619|FG001|Overall Study|Withdrawn for case delay after block|0|||
131652798|NCT01818531|474015618|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
131652799|NCT01818531|474015619|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
131652800|NCT01818531|474015618|FG000|Overall Study|Withdrawn for failure to place block|0|||
131652801|NCT01818531|474015619|FG001|Overall Study|Withdrawn for failure to place block|1|||
131652802|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
131652803|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
131652804|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
131652805|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
131652806|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
131652807|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
131652808|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
131652809|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
131652810|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
131652811|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
131652812|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131652813|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131652814|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
131652815|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
131652816|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131652817|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131652818|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131652819|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131652820|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
131652821|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652822|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652823|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652824|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
131652825|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652826|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652827|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652828|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
131652829|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
131652830|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
131652831|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
131716773|NCT00728416|474241116|FG000|Overall Study|Treatment Failure|0|||
131903967|NCT05616013|474935397|FG002|Overall Study|Adverse Event|8|||
131903968|NCT05616013|474935398|FG003|Overall Study|Adverse Event|4|||
131903969|NCT05616013|474935399|FG004|Overall Study|Adverse Event|6|||
131903970|NCT05616013|474935400|FG005|Overall Study|Adverse Event|8|||
131903971|NCT05616013|474935401|FG006|Overall Study|Adverse Event|3|||
131903972|NCT05616013|474935402|FG007|Overall Study|Adverse Event|6|||
131903973|NCT05616013|474935403|FG008|Overall Study|Adverse Event|1|||
131903974|NCT05616013|474935395|FG000|Overall Study|Lost to Follow-up|5|||
131903975|NCT05616013|474935396|FG001|Overall Study|Lost to Follow-up|4|||
131903976|NCT05616013|474935397|FG002|Overall Study|Lost to Follow-up|3|||
131903977|NCT05616013|474935398|FG003|Overall Study|Lost to Follow-up|2|||
131903978|NCT05616013|474935399|FG004|Overall Study|Lost to Follow-up|0|||
131903979|NCT05616013|474935400|FG005|Overall Study|Lost to Follow-up|5|||
131903980|NCT05616013|474935401|FG006|Overall Study|Lost to Follow-up|2|||
131903981|NCT05616013|474935402|FG007|Overall Study|Lost to Follow-up|1|||
131903982|NCT05616013|474935403|FG008|Overall Study|Lost to Follow-up|2|||
131903983|NCT05616013|474935395|FG000|Overall Study|Non-compliance with study requirements|2|||
131903984|NCT05616013|474935396|FG001|Overall Study|Non-compliance with study requirements|2|||
131903985|NCT05616013|474935397|FG002|Overall Study|Non-compliance with study requirements|2|||
131903986|NCT05616013|474935398|FG003|Overall Study|Non-compliance with study requirements|3|||
131903987|NCT05616013|474935399|FG004|Overall Study|Non-compliance with study requirements|0|||
131903988|NCT05616013|474935400|FG005|Overall Study|Non-compliance with study requirements|2|||
131903989|NCT05616013|474935401|FG006|Overall Study|Non-compliance with study requirements|1|||
131903990|NCT05616013|474935402|FG007|Overall Study|Non-compliance with study requirements|1|||
131903991|NCT05616013|474935403|FG008|Overall Study|Non-compliance with study requirements|4|||
131903992|NCT05616013|474935395|FG000|Overall Study|Withdrawal by Subject|11|||
131903993|NCT05616013|474935396|FG001|Overall Study|Withdrawal by Subject|9|||
131903994|NCT05616013|474935397|FG002|Overall Study|Withdrawal by Subject|8|||
131903995|NCT05616013|474935398|FG003|Overall Study|Withdrawal by Subject|6|||
131903996|NCT05616013|474935399|FG004|Overall Study|Withdrawal by Subject|3|||
131903997|NCT05616013|474935400|FG005|Overall Study|Withdrawal by Subject|4|||
131903998|NCT05616013|474935401|FG006|Overall Study|Withdrawal by Subject|6|||
131903999|NCT05616013|474935402|FG007|Overall Study|Withdrawal by Subject|5|||
131904000|NCT05616013|474935403|FG008|Overall Study|Withdrawal by Subject|4|||
131904001|NCT05616013|474935395|FG000|Overall Study|Physician Decision|0|||
131904002|NCT05616013|474935396|FG001|Overall Study|Physician Decision|0|||
131904003|NCT05616013|474935397|FG002|Overall Study|Physician Decision|1|||
131904004|NCT05616013|474935398|FG003|Overall Study|Physician Decision|0|||
131904005|NCT05616013|474935399|FG004|Overall Study|Physician Decision|0|||
131904006|NCT05616013|474935400|FG005|Overall Study|Physician Decision|1|||
131904007|NCT05616013|474935401|FG006|Overall Study|Physician Decision|3|||
131904008|NCT05616013|474935402|FG007|Overall Study|Physician Decision|0|||
131652832|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
131652833|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
131652834|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131652835|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131652836|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131652837|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131652838|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
131652839|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
131652840|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
131652841|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
131652842|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
131652843|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131904009|NCT05616013|474935403|FG008|Overall Study|Physician Decision|0|||
131652844|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131904010|NCT05616013|474935395|FG000|Overall Study|Protocol Violation|0|||
131904011|NCT05616013|474935396|FG001|Overall Study|Protocol Violation|0|||
131904012|NCT05616013|474935397|FG002|Overall Study|Protocol Violation|0|||
131904013|NCT05616013|474935398|FG003|Overall Study|Protocol Violation|0|||
131904014|NCT05616013|474935399|FG004|Overall Study|Protocol Violation|0|||
131904015|NCT05616013|474935400|FG005|Overall Study|Protocol Violation|0|||
131904016|NCT05616013|474935401|FG006|Overall Study|Protocol Violation|1|||
131904017|NCT05616013|474935402|FG007|Overall Study|Protocol Violation|0|||
131652845|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131904018|NCT05616013|474935403|FG008|Overall Study|Protocol Violation|2|||
131904019|NCT05616013|474935395|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
131904020|NCT05616013|474935396|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
131904021|NCT05616013|474935397|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
131904022|NCT05616013|474935398|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
131904023|NCT05616013|474935399|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
131652846|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131904024|NCT05616013|474935400|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
131904025|NCT05616013|474935401|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
131904026|NCT05616013|474935402|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
131652847|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
131652848|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
131652849|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
131652850|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
131652851|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
131652852|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
131652853|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
131652854|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
131652855|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
131652856|NCT00477490|474015620|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
131652857|NCT00477490|474015621|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
131652858|NCT00477490|474015622|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
131652859|NCT00477490|474015623|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
131652860|NCT00477490|474015624|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
131652861|NCT00477490|474015625|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
131652862|NCT00477490|474015626|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
131652863|NCT00477490|474015627|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
131716774|NCT00728416|474241117|FG001|Overall Study|Treatment Failure|1|||
131716775|NCT00728416|474241116|FG000|Overall Study|Withdrawal by Subject|1|||
131716776|NCT00728416|474241117|FG001|Overall Study|Withdrawal by Subject|0|||
131716777|NCT00509106|474241120|FG000|Overall Study|Adverse Event|3|||
131716778|NCT00509106|474241121|FG001|Overall Study|Adverse Event|2|||
131652864|NCT00477490|474015628|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
131652865|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
131652866|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
131716779|NCT00509106|474241120|FG000|Overall Study|Noncompliance|0|||
131716780|NCT00509106|474241121|FG001|Overall Study|Noncompliance|1|||
131716781|NCT00509106|474241120|FG000|Overall Study|At the request of sponsor/investigator|1|||
131716782|NCT00509106|474241121|FG001|Overall Study|At the request of sponsor/investigator|2|||
131716783|NCT00509106|474241120|FG000|Overall Study|Withdrew consent|4|||
131716784|NCT00509106|474241121|FG001|Overall Study|Withdrew consent|8|||
131716785|NCT00509106|474241120|FG000|Overall Study|Lost to Follow-up|16|||
131716786|NCT00509106|474241121|FG001|Overall Study|Lost to Follow-up|10|||
131716787|NCT00509106|474241120|FG000|Overall Study|Other|1|||
131716788|NCT00509106|474241121|FG001|Overall Study|Other|0|||
131716789|NCT00509106|474241120|FG000|Overall Study|Death|6|||
131716790|NCT00509106|474241121|FG001|Overall Study|Death|6|||
131716791|NCT00927485|474241122|FG000|Overall Study|Adverse Event|4|||
131716792|NCT00927485|474241123|FG001|Overall Study|Adverse Event|2|||
131716793|NCT00927485|474241122|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
131716794|NCT00927485|474241123|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
131716795|NCT03830281|474241124|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
131716796|NCT03830281|474241125|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
131716797|NCT03830281|474241124|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
131716798|NCT03830281|474241125|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
131803929|NCT03601637|474566937|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
131652867|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
131716799|NCT03830281|474241124|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
131716800|NCT03830281|474241125|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
131716801|NCT03830281|474241124|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
131716802|NCT03830281|474241125|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
131652868|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
131652869|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
131652870|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
131652871|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
131652872|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
131652873|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
131652874|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
131652875|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
131652876|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
131652877|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131652878|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131652879|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131652880|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131652881|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131652882|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
131652883|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131652884|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
131652885|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
131652886|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131652887|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
131652888|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131652889|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
131652890|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131652891|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131652892|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131652893|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131652894|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131652895|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131652896|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
131652897|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131716803|NCT03830281|474241124|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
131716804|NCT03830281|474241125|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
131716805|NCT03830281|474241124|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
131716806|NCT03830281|474241125|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
131716807|NCT03830281|474241124|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
131716808|NCT03830281|474241125|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
131716809|NCT03830281|474241124|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
131716810|NCT03830281|474241125|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
131716811|NCT03830281|474241124|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
131716812|NCT03830281|474241125|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
131716813|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
131716814|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
131716815|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
131716816|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
131716817|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
131716818|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
131904027|NCT05616013|474935403|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
131904028|NCT05616013|474935395|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
131904029|NCT05616013|474935396|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904030|NCT05616013|474935397|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904031|NCT05616013|474935398|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131652898|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131652899|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
131652900|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
131652901|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131652902|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
131652903|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131652904|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131652905|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131904032|NCT05616013|474935399|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904033|NCT05616013|474935400|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904034|NCT05616013|474935401|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904035|NCT05616013|474935402|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904036|NCT05616013|474935403|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
131904037|NCT05616013|474935395|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
131904038|NCT05616013|474935396|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904039|NCT05616013|474935397|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904040|NCT05616013|474935398|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904041|NCT05616013|474935399|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904042|NCT05616013|474935400|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904043|NCT05616013|474935401|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904044|NCT05616013|474935402|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904045|NCT05616013|474935403|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
131904046|NCT05616013|474935395|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904047|NCT05616013|474935396|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
131904048|NCT05616013|474935397|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904049|NCT05616013|474935398|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904050|NCT05616013|474935399|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904051|NCT05616013|474935400|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131652906|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131652907|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131904052|NCT05616013|474935401|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904053|NCT05616013|474935402|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904054|NCT05616013|474935403|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131904055|NCT05616013|474935395|FG000|Overall Study|Participant Decision, Time Constraints|0|||
131904056|NCT05616013|474935396|FG001|Overall Study|Participant Decision, Time Constraints|1|||
131904057|NCT05616013|474935397|FG002|Overall Study|Participant Decision, Time Constraints|0|||
131904058|NCT05616013|474935398|FG003|Overall Study|Participant Decision, Time Constraints|0|||
131904059|NCT05616013|474935399|FG004|Overall Study|Participant Decision, Time Constraints|0|||
131904060|NCT05616013|474935400|FG005|Overall Study|Participant Decision, Time Constraints|0|||
131904061|NCT05616013|474935401|FG006|Overall Study|Participant Decision, Time Constraints|0|||
131904062|NCT05616013|474935402|FG007|Overall Study|Participant Decision, Time Constraints|0|||
131904063|NCT05616013|474935403|FG008|Overall Study|Participant Decision, Time Constraints|0|||
131904064|NCT05616013|474935395|FG000|Overall Study|Prohibited Concomitant Medication|0|||
131904065|NCT05616013|474935396|FG001|Overall Study|Prohibited Concomitant Medication|0|||
131904066|NCT05616013|474935397|FG002|Overall Study|Prohibited Concomitant Medication|1|||
131904067|NCT05616013|474935398|FG003|Overall Study|Prohibited Concomitant Medication|0|||
131652908|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131652909|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131652910|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
131652911|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
131652912|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
131652913|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
131652914|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
131652915|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
131652916|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
131904068|NCT05616013|474935399|FG004|Overall Study|Prohibited Concomitant Medication|0|||
131904069|NCT05616013|474935400|FG005|Overall Study|Prohibited Concomitant Medication|0|||
131904070|NCT05616013|474935401|FG006|Overall Study|Prohibited Concomitant Medication|0|||
131904071|NCT05616013|474935402|FG007|Overall Study|Prohibited Concomitant Medication|0|||
131904072|NCT05616013|474935403|FG008|Overall Study|Prohibited Concomitant Medication|0|||
131904073|NCT05616013|474935395|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904074|NCT05616013|474935396|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904075|NCT05616013|474935397|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
131904076|NCT05616013|474935398|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904077|NCT05616013|474935399|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904078|NCT05616013|474935400|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904079|NCT05616013|474935401|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904080|NCT05616013|474935402|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904081|NCT05616013|474935403|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
131904082|NCT05616013|474935395|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904083|NCT05616013|474935396|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131652917|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
131652918|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
131652919|NCT00477490|474015620|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131652920|NCT00477490|474015621|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
131652921|NCT00477490|474015622|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
131652922|NCT00477490|474015623|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131652923|NCT00477490|474015624|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
131652924|NCT00477490|474015625|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131904084|NCT05616013|474935397|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904085|NCT05616013|474935398|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
131904086|NCT05616013|474935399|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904087|NCT05616013|474935400|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904088|NCT05616013|474935401|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904089|NCT05616013|474935402|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904090|NCT05616013|474935403|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
131904091|NCT05616013|474935395|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904092|NCT05616013|474935396|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904093|NCT05616013|474935397|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904094|NCT05616013|474935398|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904095|NCT05616013|474935399|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904096|NCT05616013|474935400|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904097|NCT05616013|474935401|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
131652925|NCT00477490|474015626|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131652926|NCT00477490|474015627|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131652927|NCT00477490|474015628|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131652928|NCT01110408|474015629|FG000|Overall Study|Protocol Violation|1|||
131904098|NCT05616013|474935402|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904099|NCT05616013|474935403|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
131904100|NCT05616013|474935395|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131652929|NCT01110408|474015630|FG001|Overall Study|Protocol Violation|0|||
131652930|NCT00669877|474015631|FG000|Overall Study|Disease Progression/Death|4|||
131652931|NCT01646177|474015632|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
131652932|NCT01646177|474015633|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
131652933|NCT01646177|474015634|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
131716819|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Personal issues|2|||
131716820|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Personal issues|0|||
131716821|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Personal issues|0|||
131716822|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Too busy|7|||
131716823|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Too busy|1|||
131716824|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Too busy|0|||
131716825|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Pain|2|||
131716826|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Pain|0|||
131716827|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Pain|0|||
131716828|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Moved|1|||
131716829|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Moved|0|||
131716830|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Moved|0|||
131716831|NCT00594399|474241126|FG000|Initial 3 Month Counseling|Family illness|1|||
131716832|NCT00594399|474241127|FG001|Initial 3 Month Counseling|Family illness|0|||
131716833|NCT00594399|474241128|FG002|Initial 3 Month Counseling|Family illness|0|||
131716834|NCT00594399|474241126|FG000|Rerandomization Arm 1 Only|Death|2|||
131716835|NCT00594399|474241127|FG001|Rerandomization Arm 1 Only|Death|1|||
131716836|NCT00594399|474241128|FG002|Rerandomization Arm 1 Only|Death|0|||
131716837|NCT00594399|474241126|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
131716838|NCT00594399|474241127|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
131716839|NCT00594399|474241128|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
131716840|NCT01985321|474241130|FG000|Overall Study|Protocol Violation|4|||
131716841|NCT01985321|474241131|FG001|Overall Study|Protocol Violation|3|||
131716842|NCT01985321|474241130|FG000|Overall Study|Withdrawal by Subject|1|||
131716843|NCT01985321|474241131|FG001|Overall Study|Withdrawal by Subject|0|||
131716844|NCT01985321|474241130|FG000|Overall Study|Lost to Follow-up|5|||
131716845|NCT01985321|474241131|FG001|Overall Study|Lost to Follow-up|2|||
131716846|NCT01985321|474241130|FG000|Overall Study|Subject treated wrong type of sore|1|||
131716847|NCT01985321|474241131|FG001|Overall Study|Subject treated wrong type of sore|0|||
131716848|NCT00659438|474241132|FG000|Overall Study|Withdrawal by Subject|2|||
131716849|NCT00659438|474241133|FG001|Overall Study|Withdrawal by Subject|2|||
131716850|NCT00659438|474241132|FG000|Overall Study|Death|11|||
131716851|NCT00659438|474241133|FG001|Overall Study|Death|6|||
131716852|NCT00659438|474241132|FG000|Overall Study|Lost to Follow-up|1|||
131716853|NCT00659438|474241133|FG001|Overall Study|Lost to Follow-up|0|||
131716854|NCT02201940|474241135|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
131652934|NCT01646177|474015635|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
131716855|NCT02201940|474241136|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
131716856|NCT02201940|474241135|FG000|Overall Study|Lack of Efficacy|2|||
131716857|NCT02201940|474241136|FG001|Overall Study|Lack of Efficacy|113|||
131716858|NCT02201940|474241135|FG000|Overall Study|Lost to Follow-up|5|||
131716859|NCT02201940|474241136|FG001|Overall Study|Lost to Follow-up|0|||
131716860|NCT02201940|474241135|FG000|Overall Study|Withdrew Consent|2|||
131716861|NCT02201940|474241136|FG001|Overall Study|Withdrew Consent|1|||
131716862|NCT02201940|474241135|FG000|Overall Study|Investigator's Discretion|1|||
131716863|NCT02201940|474241136|FG001|Overall Study|Investigator's Discretion|1|||
131716864|NCT02201940|474241135|FG000|Overall Study|Death|1|||
131803930|NCT03601637|474566936|FG000|Overall Study|Adverse Event|1|||
131803931|NCT03601637|474566937|FG001|Overall Study|Adverse Event|1|||
131803932|NCT03601637|474566936|FG000|Overall Study|Other|0|||
131803933|NCT03601637|474566937|FG001|Overall Study|Other|1|||
131803934|NCT01507051|474566941|FG000|Overall Study|Withdrawal by Subject|1|||
131803935|NCT01507051|474566942|FG001|Overall Study|Withdrawal by Subject|3|||
131803936|NCT01507051|474566943|FG002|Overall Study|Withdrawal by Subject|1|||
131803937|NCT01507051|474566944|FG003|Overall Study|Withdrawal by Subject|6|||
131803938|NCT01507051|474566941|FG000|Overall Study|Physician Decision|0|||
131803939|NCT01507051|474566942|FG001|Overall Study|Physician Decision|0|||
131803940|NCT01507051|474566943|FG002|Overall Study|Physician Decision|0|||
131803941|NCT01507051|474566944|FG003|Overall Study|Physician Decision|1|||
131803942|NCT01507051|474566941|FG000|Overall Study|Adverse Event|1|||
131803943|NCT01507051|474566942|FG001|Overall Study|Adverse Event|0|||
131803944|NCT01507051|474566943|FG002|Overall Study|Adverse Event|0|||
131803945|NCT01507051|474566944|FG003|Overall Study|Adverse Event|0|||
131803946|NCT00420303|474566945|FG000|Overall Study|Serious Adverse Event|1|||
131803947|NCT00420303|474566946|FG001|Overall Study|Serious Adverse Event|0|||
131803948|NCT00420303|474566945|FG000|Overall Study|Lack of Efficacy|0|||
131803949|NCT00420303|474566946|FG001|Overall Study|Lack of Efficacy|3|||
131803950|NCT00420303|474566945|FG000|Overall Study|Physician Decision|0|||
131803951|NCT00420303|474566946|FG001|Overall Study|Physician Decision|1|||
131803952|NCT00745420|474566948|FG000|Overall Study|Ineligible|1|||
131803953|NCT00088829|474566953|FG000|Overall Study|PI left institution and study was close|22|||
131803954|NCT04455633|474566954|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
131803955|NCT04455633|474566955|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
131803956|NCT04455633|474566956|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
131803957|NCT04455633|474566954|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
131803958|NCT04455633|474566955|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
131803959|NCT04455633|474566956|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
131803960|NCT04455633|474566954|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
131803961|NCT04455633|474566955|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
131803962|NCT04455633|474566956|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
131803963|NCT04455633|474566954|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
131803964|NCT04455633|474566955|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
131803965|NCT04455633|474566956|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
131803966|NCT03478397|474566957|FG000|Overall Study|Refused to participate|31|||
131803967|NCT03478397|474566958|FG001|Overall Study|Refused to participate|7|||
131803968|NCT01617668|474566961|FG000|Overall Study|Adverse Event|7|||
131803969|NCT01617668|474566962|FG001|Overall Study|Adverse Event|0|||
131803970|NCT01617668|474566963|FG002|Overall Study|Adverse Event|12|||
131803971|NCT01617668|474566964|FG003|Overall Study|Adverse Event|5|||
131803972|NCT01617668|474566961|FG000|Overall Study|Physician Decision|1|||
131803973|NCT01617668|474566962|FG001|Overall Study|Physician Decision|2|||
131803974|NCT01617668|474566963|FG002|Overall Study|Physician Decision|3|||
131803975|NCT01617668|474566964|FG003|Overall Study|Physician Decision|0|||
131803976|NCT01617668|474566961|FG000|Overall Study|Progressive Disease|4|||
131803977|NCT01617668|474566962|FG001|Overall Study|Progressive Disease|4|||
131803978|NCT01617668|474566963|FG002|Overall Study|Progressive Disease|6|||
131803979|NCT01617668|474566964|FG003|Overall Study|Progressive Disease|9|||
131803980|NCT01617668|474566961|FG000|Overall Study|Subject/guardian decision|1|||
131803981|NCT01617668|474566962|FG001|Overall Study|Subject/guardian decision|3|||
131803982|NCT01617668|474566963|FG002|Overall Study|Subject/guardian decision|2|||
131803983|NCT01617668|474566964|FG003|Overall Study|Subject/guardian decision|1|||
131803984|NCT00686959|474566965|FG000|Overall Study|Participants censored (no death events)|124|||
131803985|NCT00686959|474566966|FG001|Overall Study|Participants censored (no death events)|117|||
131716865|NCT02201940|474241136|FG001|Overall Study|Death|0|||
131716866|NCT02201940|474241135|FG000|Overall Study|Adverse Event|0|||
131716867|NCT02201940|474241136|FG001|Overall Study|Adverse Event|1|||
131716868|NCT02604264|474241138|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
131716869|NCT02604264|474241139|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
131803986|NCT00150462|474566969|FG000|Overall Study|Disease Progression or Relapse|3|||
131803987|NCT00150462|474566970|FG001|Overall Study|Disease Progression or Relapse|1|||
131803988|NCT00150462|474566971|FG002|Overall Study|Disease Progression or Relapse|2|||
131803989|NCT00150462|474566972|FG003|Overall Study|Disease Progression or Relapse|1|||
131803990|NCT00150462|474566973|FG004|Overall Study|Disease Progression or Relapse|2|||
131803991|NCT00150462|474566974|FG005|Overall Study|Disease Progression or Relapse|2|||
131803992|NCT00150462|474566975|FG006|Overall Study|Disease Progression or Relapse|3|||
131904101|NCT05616013|474935396|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904102|NCT05616013|474935397|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904103|NCT05616013|474935398|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904104|NCT05616013|474935399|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904105|NCT05616013|474935400|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904106|NCT05616013|474935401|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904107|NCT05616013|474935402|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131904108|NCT05616013|474935403|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
131904109|NCT05616013|474935395|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904110|NCT05616013|474935396|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904111|NCT05616013|474935397|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904112|NCT05616013|474935398|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904113|NCT05616013|474935399|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904114|NCT05616013|474935400|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904115|NCT05616013|474935401|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904116|NCT05616013|474935402|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
131904117|NCT05616013|474935403|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
131904118|NCT05116202|474935404|FG000|Overall Study|Study Terminated by Sponsor|21|||
131904119|NCT05116202|474935405|FG001|Overall Study|Study Terminated by Sponsor|38|||
131904120|NCT05116202|474935406|FG002|Overall Study|Study Terminated by Sponsor|17|||
131904121|NCT05116202|474935407|FG003|Overall Study|Study Terminated by Sponsor|18|||
131904122|NCT05116202|474935408|FG004|Overall Study|Study Terminated by Sponsor|0|||
131904123|NCT05116202|474935404|FG000|Overall Study|Withdrawal by Subject|0|||
131652935|NCT01646177|474015636|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652936|NCT01646177|474015637|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652937|NCT01646177|474015638|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131904124|NCT05116202|474935405|FG001|Overall Study|Withdrawal by Subject|1|||
131904125|NCT05116202|474935406|FG002|Overall Study|Withdrawal by Subject|1|||
131904126|NCT05116202|474935407|FG003|Overall Study|Withdrawal by Subject|1|||
131652938|NCT01646177|474015639|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652939|NCT01646177|474015640|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652940|NCT01646177|474015641|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652941|NCT01646177|474015642|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652942|NCT01646177|474015643|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131652943|NCT01646177|474015632|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
131652944|NCT01646177|474015633|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
131652945|NCT01646177|474015634|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
131652946|NCT01646177|474015635|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
131652947|NCT01646177|474015636|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652948|NCT01646177|474015637|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652949|NCT01646177|474015638|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652950|NCT01646177|474015639|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652951|NCT01646177|474015640|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652952|NCT01646177|474015641|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652953|NCT01646177|474015642|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652954|NCT01646177|474015643|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131652955|NCT01646177|474015632|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
131652956|NCT01646177|474015633|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
131652957|NCT01646177|474015634|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
131652958|NCT01646177|474015635|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
131652959|NCT01646177|474015636|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652960|NCT01646177|474015637|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652961|NCT01646177|474015638|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652962|NCT01646177|474015639|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652963|NCT01646177|474015640|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652964|NCT01646177|474015641|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652965|NCT01646177|474015642|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652966|NCT01646177|474015643|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131652967|NCT01646177|474015632|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
131652968|NCT01646177|474015633|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
131904127|NCT05116202|474935408|FG004|Overall Study|Withdrawal by Subject|1|||
131904128|NCT05116202|474935404|FG000|Overall Study|Lost to Follow-up|0|||
131652969|NCT01646177|474015634|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
131652970|NCT01646177|474015635|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
131652971|NCT01646177|474015636|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652972|NCT01646177|474015637|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652973|NCT01646177|474015638|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652974|NCT01646177|474015639|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652975|NCT01646177|474015640|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652976|NCT01646177|474015641|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652977|NCT01646177|474015642|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131803993|NCT00150462|474566976|FG007|Overall Study|Disease Progression or Relapse|5|||
131803994|NCT00150462|474566977|FG008|Overall Study|Disease Progression or Relapse|5|||
131803995|NCT00150462|474566978|FG009|Overall Study|Disease Progression or Relapse|3|||
131803996|NCT00150462|474566979|FG010|Overall Study|Disease Progression or Relapse|2|||
131803997|NCT00150462|474566969|FG000|Overall Study|Withdrawal by Subject|0|||
131803998|NCT00150462|474566970|FG001|Overall Study|Withdrawal by Subject|1|||
131803999|NCT00150462|474566971|FG002|Overall Study|Withdrawal by Subject|1|||
131804000|NCT00150462|474566972|FG003|Overall Study|Withdrawal by Subject|0|||
131804001|NCT00150462|474566973|FG004|Overall Study|Withdrawal by Subject|1|||
131804002|NCT00150462|474566974|FG005|Overall Study|Withdrawal by Subject|2|||
131804003|NCT00150462|474566975|FG006|Overall Study|Withdrawal by Subject|0|||
131804004|NCT00150462|474566976|FG007|Overall Study|Withdrawal by Subject|1|||
131804005|NCT00150462|474566977|FG008|Overall Study|Withdrawal by Subject|0|||
131804006|NCT00150462|474566978|FG009|Overall Study|Withdrawal by Subject|1|||
131804007|NCT00150462|474566979|FG010|Overall Study|Withdrawal by Subject|0|||
131804008|NCT00150462|474566969|FG000|Overall Study|Death|0|||
131652978|NCT01646177|474015643|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131652979|NCT01646177|474015632|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652980|NCT01646177|474015633|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131716870|NCT03192904|474241140|FG000|Overall Study|Physician Decision|3|||
131716871|NCT03192904|474241141|FG001|Overall Study|Physician Decision|1|||
131716872|NCT03192904|474241140|FG000|Overall Study|Lost to Follow-up|0|||
131716873|NCT03192904|474241141|FG001|Overall Study|Lost to Follow-up|1|||
131716874|NCT00424398|474241142|FG000|Overall Study|Withdrawal by Subject|2|||
131716875|NCT00424398|474241143|FG001|Overall Study|Withdrawal by Subject|1|||
131716876|NCT00424398|474241144|FG002|Overall Study|Withdrawal by Subject|0|||
131716877|NCT00424398|474241142|FG000|Overall Study|Subject met exclusion criteria|1|||
131716878|NCT00424398|474241143|FG001|Overall Study|Subject met exclusion criteria|0|||
131716879|NCT00424398|474241144|FG002|Overall Study|Subject met exclusion criteria|0|||
131716880|NCT01023789|474241145|FG000|3 - Year Visit|Death|29|||
131716881|NCT01023789|474241145|FG000|3 - Year Visit|Withdrawal of consent|1|||
131716882|NCT01023789|474241145|FG000|3 - Year Visit|Lost to Follow-up|13|||
131716883|NCT01309737|474241149|FG000|Week 0 to 16|Death|1|||
131716884|NCT01309737|474241150|FG001|Week 0 to 16|Death|0|||
131716885|NCT01309737|474241151|FG002|Week 0 to 16|Death|1|||
131716886|NCT01309737|474241152|FG003|Week 0 to 16|Death|0|||
131716887|NCT01309737|474241153|FG004|Week 0 to 16|Death|0|||
131716888|NCT01309737|474241149|FG000|Week 0 to 16|Adverse Event|11|||
131716889|NCT01309737|474241150|FG001|Week 0 to 16|Adverse Event|10|||
131716890|NCT01309737|474241151|FG002|Week 0 to 16|Adverse Event|5|||
131716891|NCT01309737|474241152|FG003|Week 0 to 16|Adverse Event|0|||
131716892|NCT01309737|474241153|FG004|Week 0 to 16|Adverse Event|0|||
131716893|NCT01309737|474241149|FG000|Week 0 to 16|Lack of Efficacy|15|||
131716894|NCT01309737|474241150|FG001|Week 0 to 16|Lack of Efficacy|2|||
131716895|NCT01309737|474241151|FG002|Week 0 to 16|Lack of Efficacy|24|||
131716896|NCT01309737|474241152|FG003|Week 0 to 16|Lack of Efficacy|0|||
131716897|NCT01309737|474241153|FG004|Week 0 to 16|Lack of Efficacy|0|||
131716898|NCT01309737|474241149|FG000|Week 0 to 16|Lost to Follow-up|7|||
131716899|NCT01309737|474241150|FG001|Week 0 to 16|Lost to Follow-up|8|||
131716900|NCT01309737|474241151|FG002|Week 0 to 16|Lost to Follow-up|3|||
131716901|NCT01309737|474241152|FG003|Week 0 to 16|Lost to Follow-up|0|||
131716902|NCT01309737|474241153|FG004|Week 0 to 16|Lost to Follow-up|0|||
131716903|NCT01309737|474241149|FG000|Week 0 to 16|Withdrawal by Subject|7|||
131716904|NCT01309737|474241150|FG001|Week 0 to 16|Withdrawal by Subject|6|||
131716905|NCT01309737|474241151|FG002|Week 0 to 16|Withdrawal by Subject|7|||
131716906|NCT01309737|474241152|FG003|Week 0 to 16|Withdrawal by Subject|0|||
131716907|NCT01309737|474241153|FG004|Week 0 to 16|Withdrawal by Subject|0|||
131716908|NCT01309737|474241149|FG000|Week 0 to 16|Other|10|||
131716909|NCT01309737|474241150|FG001|Week 0 to 16|Other|14|||
131716910|NCT01309737|474241151|FG002|Week 0 to 16|Other|4|||
131716911|NCT01309737|474241152|FG003|Week 0 to 16|Other|0|||
131716912|NCT01309737|474241153|FG004|Week 0 to 16|Other|0|||
131716913|NCT01309737|474241149|FG000|Week 0 to 16|Randomized, but not treated|1|||
131716914|NCT01309737|474241150|FG001|Week 0 to 16|Randomized, but not treated|0|||
131716915|NCT01309737|474241151|FG002|Week 0 to 16|Randomized, but not treated|0|||
131716916|NCT01309737|474241152|FG003|Week 0 to 16|Randomized, but not treated|0|||
131716917|NCT01309737|474241153|FG004|Week 0 to 16|Randomized, but not treated|0|||
131716918|NCT01309737|474241149|FG000|Week 16 to 52|Death|0|||
131652981|NCT01646177|474015634|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
131904129|NCT05116202|474935405|FG001|Overall Study|Lost to Follow-up|0|||
131904130|NCT05116202|474935406|FG002|Overall Study|Lost to Follow-up|0|||
131904131|NCT05116202|474935407|FG003|Overall Study|Lost to Follow-up|0|||
131904132|NCT05116202|474935408|FG004|Overall Study|Lost to Follow-up|2|||
131904133|NCT05116202|474935404|FG000|Overall Study|Death|1|||
131904134|NCT05116202|474935405|FG001|Overall Study|Death|1|||
131904135|NCT05116202|474935406|FG002|Overall Study|Death|2|||
131904136|NCT05116202|474935407|FG003|Overall Study|Death|1|||
131904137|NCT05116202|474935408|FG004|Overall Study|Death|5|||
131904138|NCT05067972|474935409|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
131904139|NCT05067972|474935410|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
131904140|NCT05067972|474935411|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
131904141|NCT05067972|474935412|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
131904142|NCT05067972|474935413|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
131904143|NCT05067972|474935414|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
131904144|NCT05067972|474935415|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
131904145|NCT05067972|474935409|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
131904146|NCT05067972|474935410|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
131904147|NCT05067972|474935411|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
131904148|NCT05067972|474935412|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
131904149|NCT05067972|474935413|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
131904150|NCT05067972|474935414|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
131904151|NCT05067972|474935415|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
131904152|NCT05067972|474935409|FG000|Part 1: Treatment|Progressive Disease|3|||
131904153|NCT05067972|474935410|FG001|Part 1: Treatment|Progressive Disease|3|||
131904154|NCT05067972|474935411|FG002|Part 1: Treatment|Progressive Disease|4|||
131904155|NCT05067972|474935412|FG003|Part 1: Treatment|Progressive Disease|2|||
131904156|NCT05067972|474935413|FG004|Part 1: Treatment|Progressive Disease|3|||
131904157|NCT05067972|474935414|FG005|Part 1: Treatment|Progressive Disease|0|||
131904158|NCT05067972|474935415|FG006|Part 1: Treatment|Progressive Disease|2|||
131904159|NCT05067972|474935409|FG000|Part 1: Treatment|Physician Decision|0|||
131904160|NCT05067972|474935410|FG001|Part 1: Treatment|Physician Decision|0|||
131904161|NCT05067972|474935411|FG002|Part 1: Treatment|Physician Decision|0|||
131904162|NCT05067972|474935412|FG003|Part 1: Treatment|Physician Decision|1|||
131904163|NCT05067972|474935413|FG004|Part 1: Treatment|Physician Decision|0|||
131904164|NCT05067972|474935414|FG005|Part 1: Treatment|Physician Decision|0|||
131904165|NCT05067972|474935415|FG006|Part 1: Treatment|Physician Decision|0|||
131904166|NCT05067972|474935409|FG000|Part 1: Treatment|Death|0|||
131904167|NCT05067972|474935410|FG001|Part 1: Treatment|Death|0|||
131904168|NCT05067972|474935411|FG002|Part 1: Treatment|Death|0|||
131904169|NCT05067972|474935412|FG003|Part 1: Treatment|Death|2|||
131904170|NCT05067972|474935413|FG004|Part 1: Treatment|Death|0|||
131904171|NCT05067972|474935414|FG005|Part 1: Treatment|Death|0|||
131904172|NCT05067972|474935415|FG006|Part 1: Treatment|Death|0|||
131652982|NCT01646177|474015635|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
131652983|NCT01646177|474015636|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131904173|NCT05067972|474935409|FG000|Part 1: Treatment|Adverse Event|0|||
131904174|NCT05067972|474935410|FG001|Part 1: Treatment|Adverse Event|0|||
131904175|NCT05067972|474935411|FG002|Part 1: Treatment|Adverse Event|0|||
131904176|NCT05067972|474935412|FG003|Part 1: Treatment|Adverse Event|0|||
131904177|NCT05067972|474935413|FG004|Part 1: Treatment|Adverse Event|0|||
131904178|NCT05067972|474935414|FG005|Part 1: Treatment|Adverse Event|2|||
131904179|NCT05067972|474935415|FG006|Part 1: Treatment|Adverse Event|1|||
131448135|NCT01716234|473270874|FG000|Overall Study|Withdrawal by Subject|3|||
131652984|NCT01646177|474015637|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652985|NCT01646177|474015638|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652986|NCT01646177|474015639|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652987|NCT01646177|474015640|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652988|NCT01646177|474015641|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652989|NCT01646177|474015642|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652990|NCT01646177|474015643|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131652991|NCT01646177|474015632|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
131652992|NCT01646177|474015633|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
131652993|NCT01646177|474015634|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
131652994|NCT01646177|474015635|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131652995|NCT01646177|474015636|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131652996|NCT01646177|474015637|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131652997|NCT01646177|474015638|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131652998|NCT01646177|474015639|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131652999|NCT01646177|474015640|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131653000|NCT01646177|474015641|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131653001|NCT01646177|474015642|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131658635|NCT02003222|474035396|FG001|Intensification|Adverse Event|0|||
131904180|NCT05067972|474935409|FG000|Part 1: Follow-up|Adverse Event|0|||
131904181|NCT05067972|474935410|FG001|Part 1: Follow-up|Adverse Event|0|||
131904182|NCT05067972|474935411|FG002|Part 1: Follow-up|Adverse Event|0|||
131904183|NCT05067972|474935412|FG003|Part 1: Follow-up|Adverse Event|0|||
131904184|NCT05067972|474935413|FG004|Part 1: Follow-up|Adverse Event|0|||
131904185|NCT05067972|474935414|FG005|Part 1: Follow-up|Adverse Event|1|||
131904186|NCT05067972|474935415|FG006|Part 1: Follow-up|Adverse Event|0|||
131904187|NCT05067972|474935409|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
131904188|NCT05067972|474935410|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
131904189|NCT05067972|474935411|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
131904190|NCT05067972|474935412|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
131904191|NCT05067972|474935413|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
131904192|NCT05067972|474935414|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
131904193|NCT05067972|474935415|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
131904194|NCT05067972|474935409|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
131904195|NCT05067972|474935410|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
131904196|NCT05067972|474935411|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
131904197|NCT05067972|474935412|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
131904198|NCT05067972|474935413|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
131904199|NCT05067972|474935414|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
131904200|NCT05067972|474935415|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
131904201|NCT05067972|474935409|FG000|Part 1: Follow-up|Physician Decision|0|||
131904202|NCT05067972|474935410|FG001|Part 1: Follow-up|Physician Decision|0|||
131904203|NCT05067972|474935411|FG002|Part 1: Follow-up|Physician Decision|0|||
131904204|NCT05067972|474935412|FG003|Part 1: Follow-up|Physician Decision|1|||
131904205|NCT05067972|474935413|FG004|Part 1: Follow-up|Physician Decision|0|||
131904206|NCT05067972|474935414|FG005|Part 1: Follow-up|Physician Decision|0|||
131904207|NCT05067972|474935415|FG006|Part 1: Follow-up|Physician Decision|0|||
131904208|NCT05067972|474935409|FG000|Part 1: Follow-up|Death|1|||
131904209|NCT05067972|474935410|FG001|Part 1: Follow-up|Death|2|||
131904210|NCT05067972|474935411|FG002|Part 1: Follow-up|Death|1|||
131904211|NCT05067972|474935412|FG003|Part 1: Follow-up|Death|0|||
131904212|NCT05067972|474935413|FG004|Part 1: Follow-up|Death|1|||
131904213|NCT05067972|474935414|FG005|Part 1: Follow-up|Death|0|||
131904214|NCT05067972|474935415|FG006|Part 1: Follow-up|Death|1|||
131904215|NCT04391842|474935416|FG000|Overall Study|Withdrawal by Subject|2|||
131904216|NCT01676012|474935417|FG000|Overall Study|Adverse Event|2|||
131904217|NCT01676012|474935417|FG000|Overall Study|incomplete set of videos|1|||
131904218|NCT02667301|474935436|FG000|Overall Study|Adverse Event|1|||
131904219|NCT02667301|474935436|FG000|Overall Study|Lack of Efficacy|1|||
131904220|NCT02283658|474935437|FG000|Overall Study|Withdrawal by Subject|1|||
131904221|NCT03528551|474935439|FG000|Overall Study|Lost to Follow-up|0|||
131904222|NCT03528551|474935440|FG001|Overall Study|Lost to Follow-up|1|||
131904223|NCT03528551|474935441|FG002|Overall Study|Lost to Follow-up|0|||
131904224|NCT03528551|474935439|FG000|Overall Study|Transferred to other arm/group|2|||
131904225|NCT03528551|474935440|FG001|Overall Study|Transferred to other arm/group|3|||
131904226|NCT03528551|474935441|FG002|Overall Study|Transferred to other arm/group|0|||
131904227|NCT03528551|474935439|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131904228|NCT03528551|474935440|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131904229|NCT03528551|474935441|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131904230|NCT03528551|474935439|FG000|Overall Study|Protocol Violation|0|||
131904231|NCT03528551|474935440|FG001|Overall Study|Protocol Violation|3|||
131904232|NCT03528551|474935441|FG002|Overall Study|Protocol Violation|0|||
131904233|NCT03528551|474935439|FG000|Overall Study|Withdrawal by Subject|0|||
131904234|NCT03528551|474935440|FG001|Overall Study|Withdrawal by Subject|7|||
131904235|NCT03528551|474935441|FG002|Overall Study|Withdrawal by Subject|0|||
131904236|NCT00846586|474935442|FG000|Overall Study|Adverse Event|20|||
131904237|NCT00846586|474935443|FG001|Overall Study|Adverse Event|10|||
131904238|NCT00846586|474935442|FG000|Overall Study|Subject withdrew consent|8|||
131904239|NCT00846586|474935443|FG001|Overall Study|Subject withdrew consent|10|||
131904240|NCT00846586|474935442|FG000|Overall Study|Administrative problems|5|||
131904241|NCT00846586|474935443|FG001|Overall Study|Administrative problems|4|||
131904242|NCT00846586|474935442|FG000|Overall Study|Death|2|||
131904243|NCT00846586|474935443|FG001|Overall Study|Death|0|||
131904244|NCT00846586|474935442|FG000|Overall Study|Protocol deviation|2|||
131904245|NCT00846586|474935443|FG001|Overall Study|Protocol deviation|6|||
131904246|NCT00846586|474935442|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131904247|NCT00846586|474935443|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131904248|NCT00846586|474935442|FG000|Overall Study|Lost to Follow-up|1|||
131904249|NCT00846586|474935443|FG001|Overall Study|Lost to Follow-up|4|||
131904250|NCT00846586|474935442|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131904251|NCT00846586|474935443|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131904252|NCT00689338|474935444|FG000|Overall Study|Death|65|||
131904253|NCT00689338|474935444|FG000|Overall Study|Adverse Event|13|||
131904254|NCT00689338|474935444|FG000|Overall Study|Insufficient Clinical Response|1|||
131904255|NCT00689338|474935444|FG000|Overall Study|Lack of Efficacy|6|||
131658636|NCT02003222|474035397|FG002|Intensification|Adverse Event|0|||
131804009|NCT00150462|474566970|FG001|Overall Study|Death|1|||
131804010|NCT00150462|474566971|FG002|Overall Study|Death|0|||
131804011|NCT00150462|474566972|FG003|Overall Study|Death|0|||
131804012|NCT00150462|474566973|FG004|Overall Study|Death|0|||
131804013|NCT00150462|474566974|FG005|Overall Study|Death|0|||
131804014|NCT00150462|474566975|FG006|Overall Study|Death|0|||
131804015|NCT00150462|474566976|FG007|Overall Study|Death|0|||
131804016|NCT00150462|474566977|FG008|Overall Study|Death|1|||
131804017|NCT00150462|474566978|FG009|Overall Study|Death|0|||
131804018|NCT00150462|474566979|FG010|Overall Study|Death|0|||
131804019|NCT00150462|474566969|FG000|Overall Study|Adverse Event|0|||
131804020|NCT00150462|474566970|FG001|Overall Study|Adverse Event|0|||
131804021|NCT00150462|474566971|FG002|Overall Study|Adverse Event|0|||
131804022|NCT00150462|474566972|FG003|Overall Study|Adverse Event|1|||
131804023|NCT00150462|474566973|FG004|Overall Study|Adverse Event|0|||
131804024|NCT00150462|474566974|FG005|Overall Study|Adverse Event|0|||
131804025|NCT00150462|474566975|FG006|Overall Study|Adverse Event|0|||
131804026|NCT00150462|474566976|FG007|Overall Study|Adverse Event|2|||
131804027|NCT00150462|474566977|FG008|Overall Study|Adverse Event|0|||
131804028|NCT00150462|474566978|FG009|Overall Study|Adverse Event|1|||
131804029|NCT00150462|474566979|FG010|Overall Study|Adverse Event|0|||
131804030|NCT00150462|474566969|FG000|Overall Study|Physician Decision|0|||
131804031|NCT00150462|474566970|FG001|Overall Study|Physician Decision|0|||
131804032|NCT00150462|474566971|FG002|Overall Study|Physician Decision|1|||
131804033|NCT00150462|474566972|FG003|Overall Study|Physician Decision|1|||
131804034|NCT00150462|474566973|FG004|Overall Study|Physician Decision|0|||
131804035|NCT00150462|474566974|FG005|Overall Study|Physician Decision|0|||
131804036|NCT00150462|474566975|FG006|Overall Study|Physician Decision|0|||
131804037|NCT00150462|474566976|FG007|Overall Study|Physician Decision|0|||
131804038|NCT00150462|474566977|FG008|Overall Study|Physician Decision|0|||
131804039|NCT00150462|474566978|FG009|Overall Study|Physician Decision|0|||
131804040|NCT00150462|474566979|FG010|Overall Study|Physician Decision|0|||
131804041|NCT00150462|474566969|FG000|Overall Study|Other|0|||
131804042|NCT00150462|474566970|FG001|Overall Study|Other|0|||
131804043|NCT00150462|474566971|FG002|Overall Study|Other|0|||
131804044|NCT00150462|474566972|FG003|Overall Study|Other|0|||
131804045|NCT00150462|474566973|FG004|Overall Study|Other|0|||
131804046|NCT00150462|474566974|FG005|Overall Study|Other|0|||
131804047|NCT00150462|474566975|FG006|Overall Study|Other|0|||
131804048|NCT00150462|474566976|FG007|Overall Study|Other|0|||
131804049|NCT00150462|474566977|FG008|Overall Study|Other|0|||
131804050|NCT00150462|474566978|FG009|Overall Study|Other|1|||
131804051|NCT00150462|474566979|FG010|Overall Study|Other|1|||
131804052|NCT00678639|474566980|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
131804053|NCT00678639|474566981|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
131804054|NCT00986245|474566984|FG000|First Intervention|Poor compliance|8|||
131804055|NCT00986245|474566985|FG001|First Intervention|Poor compliance|4|||
131804056|NCT00986245|474566984|FG000|First Intervention|Lack of Efficacy|1|||
131804057|NCT00986245|474566985|FG001|First Intervention|Lack of Efficacy|2|||
131804058|NCT00986245|474566984|FG000|First Intervention|Withdrawal by Subject|0|||
131804059|NCT00986245|474566985|FG001|First Intervention|Withdrawal by Subject|1|||
131804060|NCT00986245|474566984|FG000|First Intervention|Protocol Violation|0|||
131804061|NCT00986245|474566985|FG001|First Intervention|Protocol Violation|1|||
131804062|NCT00986245|474566984|FG000|First Intervention|Out of indication|1|||
131804063|NCT00986245|474566985|FG001|First Intervention|Out of indication|0|||
131804064|NCT00986245|474566984|FG000|Second Intervention|Poor compliance|1|||
131804065|NCT00986245|474566985|FG001|Second Intervention|Poor compliance|0|||
131804066|NCT00986245|474566984|FG000|Second Intervention|Lost to Follow-up|1|||
131804067|NCT00986245|474566985|FG001|Second Intervention|Lost to Follow-up|0|||
131804068|NCT00986245|474566984|FG000|Second Intervention|Protocol Violation|0|||
131804069|NCT00986245|474566985|FG001|Second Intervention|Protocol Violation|1|||
131804070|NCT01214850|474566988|FG000|Overall Study|Withdrawal by Subject|38|||
131804071|NCT01214850|474566989|FG001|Overall Study|Withdrawal by Subject|31|||
131804072|NCT01214850|474566990|FG002|Overall Study|Withdrawal by Subject|28|||
131658637|NCT02003222|474035398|FG003|Intensification|Adverse Event|0|||
131804073|NCT01214850|474566988|FG000|Overall Study|Lost to Follow-up|124|||
131804074|NCT01214850|474566989|FG001|Overall Study|Lost to Follow-up|98|||
131804075|NCT01214850|474566990|FG002|Overall Study|Lost to Follow-up|123|||
131804076|NCT01214850|474566988|FG000|Overall Study|Protocol Violation|5|||
131804077|NCT01214850|474566989|FG001|Overall Study|Protocol Violation|5|||
131804078|NCT01214850|474566990|FG002|Overall Study|Protocol Violation|6|||
131804079|NCT01214850|474566988|FG000|Overall Study|Adverse event or death|11|||
131804080|NCT01214850|474566989|FG001|Overall Study|Adverse event or death|8|||
131804081|NCT01214850|474566990|FG002|Overall Study|Adverse event or death|3|||
131804082|NCT01214850|474566988|FG000|Overall Study|Inappropriate enrollment|2|||
131804083|NCT01214850|474566989|FG001|Overall Study|Inappropriate enrollment|1|||
131804084|NCT01214850|474566990|FG002|Overall Study|Inappropriate enrollment|0|||
131804085|NCT01214850|474566988|FG000|Overall Study|Administrative reason|1|||
131804086|NCT01214850|474566989|FG001|Overall Study|Administrative reason|0|||
131804087|NCT01214850|474566990|FG002|Overall Study|Administrative reason|0|||
131653002|NCT01646177|474015643|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131653003|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653004|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653005|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653006|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653007|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
131653008|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
131653009|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
131653010|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
131653011|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653012|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653013|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653014|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131653015|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653016|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653017|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653018|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653019|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
131653020|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
131653021|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
131653022|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
131653023|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653024|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653025|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653026|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131653027|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653028|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653029|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653030|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653031|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
131653032|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
131653033|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
131653034|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
131653035|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653036|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653037|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653038|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131653039|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653040|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653041|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653042|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653043|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
131653044|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
131653045|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
131653046|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
131653047|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653048|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653049|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653050|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131653051|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653052|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653053|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653054|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653055|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
131653056|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
131653057|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
131653058|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
131653059|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653060|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653061|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131716919|NCT01309737|474241150|FG001|Week 16 to 52|Death|0|||
131716920|NCT01309737|474241151|FG002|Week 16 to 52|Death|0|||
131716921|NCT01309737|474241152|FG003|Week 16 to 52|Death|0|||
131804088|NCT01214850|474566988|FG000|Overall Study|Unable to classify|2|||
131804089|NCT01214850|474566989|FG001|Overall Study|Unable to classify|1|||
131804090|NCT01214850|474566990|FG002|Overall Study|Unable to classify|1|||
131804091|NCT00565448|474566994|FG000|Overall Study|Adverse Event|1|||
131653062|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131653063|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653064|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653065|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131448136|NCT01716234|473270875|FG001|Overall Study|Withdrawal by Subject|0|||
131653066|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653067|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
131653068|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
131653069|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653070|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
131653071|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653072|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653073|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653074|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131653075|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131653076|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131653077|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131804092|NCT00565448|474566995|FG001|Overall Study|Adverse Event|2|||
131804093|NCT00565448|474566994|FG000|Overall Study|Disease progression|1|||
131804094|NCT00565448|474566995|FG001|Overall Study|Disease progression|0|||
131804095|NCT00565448|474566994|FG000|Overall Study|Withdrawal by Subject|1|||
131804096|NCT00565448|474566995|FG001|Overall Study|Withdrawal by Subject|0|||
131804097|NCT00193609|474566996|FG000|Overall Study|Lack of Efficacy|2|||
131804098|NCT00193609|474566996|FG000|Overall Study|Adverse Event|2|||
131804099|NCT00336479|474567000|FG000|Overall Study|Adverse Event|8|||
131804100|NCT00336479|474567001|FG001|Overall Study|Adverse Event|11|||
131804101|NCT00336479|474567002|FG002|Overall Study|Adverse Event|18|||
131804102|NCT00336479|474567003|FG003|Overall Study|Adverse Event|4|||
131804103|NCT00336479|474567000|FG000|Overall Study|Noncompliant|1|||
131804104|NCT00336479|474567001|FG001|Overall Study|Noncompliant|7|||
131804105|NCT00336479|474567002|FG002|Overall Study|Noncompliant|3|||
131804106|NCT00336479|474567003|FG003|Overall Study|Noncompliant|0|||
131804107|NCT00336479|474567000|FG000|Overall Study|Physician Decision|2|||
131804108|NCT00336479|474567001|FG001|Overall Study|Physician Decision|3|||
131804109|NCT00336479|474567002|FG002|Overall Study|Physician Decision|1|||
131804110|NCT00336479|474567003|FG003|Overall Study|Physician Decision|0|||
131804111|NCT00336479|474567000|FG000|Overall Study|Lost to Follow-up|3|||
131804112|NCT00336479|474567001|FG001|Overall Study|Lost to Follow-up|2|||
131804113|NCT00336479|474567002|FG002|Overall Study|Lost to Follow-up|0|||
131804114|NCT00336479|474567003|FG003|Overall Study|Lost to Follow-up|0|||
131804115|NCT00336479|474567000|FG000|Overall Study|Withdrawal by Subject|3|||
131804116|NCT00336479|474567001|FG001|Overall Study|Withdrawal by Subject|2|||
131804117|NCT00336479|474567002|FG002|Overall Study|Withdrawal by Subject|3|||
131804118|NCT00336479|474567003|FG003|Overall Study|Withdrawal by Subject|0|||
131804119|NCT00336479|474567000|FG000|Overall Study|Other|0|||
131804120|NCT00336479|474567001|FG001|Overall Study|Other|0|||
131804121|NCT00336479|474567002|FG002|Overall Study|Other|1|||
131804122|NCT00336479|474567003|FG003|Overall Study|Other|0|||
131804123|NCT00336479|474567000|FG000|Overall Study|Virologic Stopping Rule|20|||
131804124|NCT00336479|474567001|FG001|Overall Study|Virologic Stopping Rule|0|||
131804125|NCT00336479|474567002|FG002|Overall Study|Virologic Stopping Rule|0|||
131653078|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131653079|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
131653080|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
131653081|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
131653082|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
131653083|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131653084|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131904256|NCT00689338|474935444|FG000|Overall Study|Other|8|||
131653085|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131658638|NCT02003222|474035399|FG004|Intensification|Adverse Event|6|||
131804126|NCT00336479|474567003|FG003|Overall Study|Virologic Stopping Rule|0|||
131804127|NCT01722877|474567004|FG000|Overall Study|Death|1|||
131804128|NCT01722877|474567004|FG000|Overall Study|Lost to Follow-up|1|||
131804129|NCT02373098|474567005|FG000|Overall Study|Lost to Follow-up|1|||
131804130|NCT02373098|474567006|FG001|Overall Study|Lost to Follow-up|0|||
131804131|NCT02373098|474567005|FG000|Overall Study|Protocol Violation|3|||
131804132|NCT02373098|474567006|FG001|Overall Study|Protocol Violation|0|||
131804133|NCT02373098|474567005|FG000|Overall Study|Withdrawal by Subject|5|||
131804134|NCT02373098|474567006|FG001|Overall Study|Withdrawal by Subject|0|||
131804135|NCT02373098|474567005|FG000|Overall Study|Adverse Event|3|||
131804136|NCT02373098|474567006|FG001|Overall Study|Adverse Event|0|||
131804137|NCT03639311|474567009|FG000|Maintenance Phase|Lost to Follow-up|1|||
131804138|NCT03639311|474567010|FG001|Maintenance Phase|Lost to Follow-up|0|||
131804139|NCT03639311|474567011|FG002|Maintenance Phase|Lost to Follow-up|0|||
131804140|NCT03639311|474567009|FG000|Maintenance Phase|Adverse Event|1|||
131904257|NCT00689338|474935444|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
131904258|NCT00689338|474935444|FG000|Overall Study|Lost to Follow-up|5|||
131904259|NCT00689338|474935444|FG000|Overall Study|Withdrawal by Subject|3|||
131904260|NCT00689338|474935444|FG000|Overall Study|Protocol Violation|15|||
131804141|NCT03639311|474567010|FG001|Maintenance Phase|Adverse Event|0|||
131804142|NCT03639311|474567011|FG002|Maintenance Phase|Adverse Event|0|||
131804143|NCT03639311|474567009|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
131804144|NCT03639311|474567010|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
131904261|NCT01061606|474935445|FG000|Overall Study|Adverse Event|1|||
131653086|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131653087|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
131653088|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
131653089|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
131653090|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
131653091|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
131653092|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
131653093|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
131653094|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
131653095|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
131653096|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
131653097|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
131653098|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
131653099|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653100|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653101|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653102|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653103|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
131653104|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
131653105|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
131653106|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
131653107|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653108|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653109|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653110|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131653111|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653112|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653113|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653114|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653115|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653116|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653117|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653118|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
131653119|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653120|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653121|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653122|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131653123|NCT01646177|474015632|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653124|NCT01646177|474015633|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653125|NCT01646177|474015634|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653126|NCT01646177|474015635|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653127|NCT01646177|474015636|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653128|NCT01646177|474015637|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
131653129|NCT01646177|474015638|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
131653130|NCT01646177|474015639|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
131653131|NCT01646177|474015640|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653132|NCT01646177|474015641|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653133|NCT01646177|474015642|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653134|NCT01646177|474015643|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131653135|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653136|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653137|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653138|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653139|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653140|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653141|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653142|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131653143|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
131653144|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
131653145|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
131653146|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
131653147|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653148|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653149|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653150|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653151|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653152|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653153|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653154|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131653155|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
131653156|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
131653157|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
131653158|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
131653159|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131716922|NCT01309737|474241153|FG004|Week 16 to 52|Death|1|||
131716923|NCT01309737|474241149|FG000|Week 16 to 52|Adverse Event|7|||
131653160|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653161|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653162|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653163|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653164|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653165|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653166|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131653167|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
131653168|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
131653169|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
131653170|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
131653171|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653172|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653173|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653174|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653175|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653176|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653177|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653178|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131653179|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
131653180|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
131653181|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
131653182|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
131653183|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653184|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653185|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653186|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653187|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653188|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653189|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653190|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131653191|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
131804145|NCT03639311|474567011|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
131804146|NCT03639311|474567009|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
131804147|NCT03639311|474567010|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
131804148|NCT03639311|474567011|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
131804149|NCT03639311|474567009|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
131804150|NCT03639311|474567010|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
131804151|NCT03639311|474567011|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
131804152|NCT03639311|474567009|FG000|Maintenance Phase|Lack of Efficacy|1|||
131653192|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
131653193|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
131653194|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
131653195|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653196|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653197|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653198|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653199|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653200|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653201|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653202|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131653203|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
131653204|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
131653205|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
131653206|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
131653207|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653208|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653209|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653210|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653211|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653212|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653213|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653214|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131804153|NCT03639311|474567010|FG001|Maintenance Phase|Lack of Efficacy|0|||
131653215|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131653216|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
131653217|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
131653218|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
131653219|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653220|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653221|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653222|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653223|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653224|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653225|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653226|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653227|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131653228|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
131653229|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
131653230|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
131653231|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653232|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653233|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653234|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653235|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653236|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653237|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653238|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653239|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
131653240|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131653241|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
131653242|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
131653243|NCT01646177|474015632|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653244|NCT01646177|474015633|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653245|NCT01646177|474015634|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131658789|NCT01283516|474035434|FG003|Overall Study|Disease Progression|3|||
131658790|NCT01283516|474035435|FG004|Overall Study|Disease Progression|13|||
131658791|NCT01283516|474035436|FG005|Overall Study|Disease Progression|8|||
131658792|NCT01283516|474035437|FG006|Overall Study|Disease Progression|6|||
131716924|NCT01309737|474241150|FG001|Week 16 to 52|Adverse Event|7|||
131716925|NCT01309737|474241151|FG002|Week 16 to 52|Adverse Event|0|||
131658793|NCT01283516|474035438|FG007|Overall Study|Disease Progression|3|||
131658794|NCT01283516|474035439|FG008|Overall Study|Disease Progression|139|||
131658795|NCT01283516|474035431|FG000|Overall Study|Withdrawal by Subject|0|||
131658796|NCT01283516|474035432|FG001|Overall Study|Withdrawal by Subject|0|||
131658797|NCT01283516|474035433|FG002|Overall Study|Withdrawal by Subject|0|||
131658798|NCT01283516|474035434|FG003|Overall Study|Withdrawal by Subject|0|||
131658799|NCT01283516|474035435|FG004|Overall Study|Withdrawal by Subject|1|||
131658800|NCT01283516|474035436|FG005|Overall Study|Withdrawal by Subject|0|||
131658801|NCT01283516|474035437|FG006|Overall Study|Withdrawal by Subject|1|||
131658802|NCT01283516|474035438|FG007|Overall Study|Withdrawal by Subject|0|||
131658803|NCT01283516|474035439|FG008|Overall Study|Withdrawal by Subject|36|||
131658804|NCT01283516|474035431|FG000|Overall Study|Administrative problems|0|||
131653246|NCT01646177|474015635|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653247|NCT01646177|474015636|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653248|NCT01646177|474015637|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653249|NCT01646177|474015638|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653250|NCT01646177|474015639|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653251|NCT01646177|474015640|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653252|NCT01646177|474015641|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131653253|NCT01646177|474015642|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
131653254|NCT01646177|474015643|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
131653255|NCT02920970|474015644|FG000|First Intervention|Protocol Violation|0|||
131653256|NCT02920970|474015645|FG001|First Intervention|Protocol Violation|1|||
131653257|NCT02920970|474015644|FG000|First Intervention|Adverse Event|0|||
131653258|NCT02920970|474015645|FG001|First Intervention|Adverse Event|1|||
131653259|NCT02920970|474015644|FG000|Second Intervention|Poor Lens Fit|1|||
131653260|NCT02920970|474015645|FG001|Second Intervention|Poor Lens Fit|0|||
131653261|NCT02269423|474015651|FG000|Overall Study|Discontinued due to change in residence|0|||
131653262|NCT02269423|474015652|FG001|Overall Study|Discontinued due to change in residence|1|||
131653263|NCT02269423|474015653|FG002|Overall Study|Discontinued due to change in residence|0|||
131653264|NCT02269423|474015654|FG003|Overall Study|Discontinued due to change in residence|1|||
131653265|NCT00755105|474015657|FG000|Overall Study|Withdrawal by Subject|9|||
131653266|NCT00755105|474015658|FG001|Overall Study|Withdrawal by Subject|11|||
131653267|NCT00755105|474015659|FG002|Overall Study|Withdrawal by Subject|4|||
131653268|NCT01281839|474015661|FG000|Overall Study|Lost to Follow-up|6|||
131653269|NCT01281839|474015662|FG001|Overall Study|Lost to Follow-up|3|||
131653270|NCT01281839|474015661|FG000|Overall Study|Withdrawal by Subject|4|||
131653271|NCT01281839|474015662|FG001|Overall Study|Withdrawal by Subject|10|||
131653272|NCT01281839|474015661|FG000|Overall Study|Reason not specified|0|||
131653273|NCT01281839|474015662|FG001|Overall Study|Reason not specified|1|||
131653274|NCT01277887|474015663|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
131653275|NCT01277887|474015664|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
131804154|NCT03639311|474567011|FG002|Maintenance Phase|Lack of Efficacy|0|||
131804155|NCT03125200|474567021|FG000|Overall Study|Study Termination|0|||
131804156|NCT03125200|474567022|FG001|Overall Study|Study Termination|0|||
131804157|NCT03125200|474567023|FG002|Overall Study|Study Termination|0|||
131804158|NCT03125200|474567024|FG003|Overall Study|Study Termination|1|||
131804159|NCT03125200|474567025|FG004|Overall Study|Study Termination|1|||
131804160|NCT03125200|474567026|FG005|Overall Study|Study Termination|2|||
131804161|NCT03125200|474567027|FG006|Overall Study|Study Termination|1|||
131804162|NCT03125200|474567021|FG000|Overall Study|Clinical Progression|0|||
131804163|NCT03125200|474567022|FG001|Overall Study|Clinical Progression|0|||
131804164|NCT03125200|474567023|FG002|Overall Study|Clinical Progression|0|||
131804165|NCT03125200|474567024|FG003|Overall Study|Clinical Progression|1|||
131804166|NCT03125200|474567025|FG004|Overall Study|Clinical Progression|0|||
131804167|NCT03125200|474567026|FG005|Overall Study|Clinical Progression|1|||
131804168|NCT03125200|474567027|FG006|Overall Study|Clinical Progression|0|||
131804169|NCT03125200|474567021|FG000|Overall Study|Progressive Disease|2|||
131804170|NCT03125200|474567022|FG001|Overall Study|Progressive Disease|1|||
131804171|NCT03125200|474567023|FG002|Overall Study|Progressive Disease|2|||
131804172|NCT03125200|474567024|FG003|Overall Study|Progressive Disease|1|||
131804173|NCT03125200|474567025|FG004|Overall Study|Progressive Disease|2|||
131804174|NCT03125200|474567026|FG005|Overall Study|Progressive Disease|0|||
131804175|NCT03125200|474567027|FG006|Overall Study|Progressive Disease|1|||
131804176|NCT03125200|474567021|FG000|Overall Study|Lack of Efficacy|0|||
131804177|NCT03125200|474567022|FG001|Overall Study|Lack of Efficacy|0|||
131804178|NCT03125200|474567023|FG002|Overall Study|Lack of Efficacy|0|||
131804179|NCT03125200|474567024|FG003|Overall Study|Lack of Efficacy|1|||
131804180|NCT03125200|474567025|FG004|Overall Study|Lack of Efficacy|0|||
131804181|NCT03125200|474567026|FG005|Overall Study|Lack of Efficacy|0|||
131804182|NCT03125200|474567027|FG006|Overall Study|Lack of Efficacy|0|||
131804183|NCT03125200|474567021|FG000|Overall Study|Toxicity|0|||
131804184|NCT03125200|474567022|FG001|Overall Study|Toxicity|0|||
131804185|NCT03125200|474567023|FG002|Overall Study|Toxicity|0|||
131804186|NCT03125200|474567024|FG003|Overall Study|Toxicity|1|||
131804187|NCT03125200|474567025|FG004|Overall Study|Toxicity|0|||
131804188|NCT03125200|474567026|FG005|Overall Study|Toxicity|0|||
131804189|NCT03125200|474567027|FG006|Overall Study|Toxicity|0|||
131804190|NCT03125200|474567021|FG000|Overall Study|Consent Withdrawn by Subject|0|||
131804191|NCT03125200|474567022|FG001|Overall Study|Consent Withdrawn by Subject|1|||
131804192|NCT03125200|474567023|FG002|Overall Study|Consent Withdrawn by Subject|0|||
131804193|NCT03125200|474567024|FG003|Overall Study|Consent Withdrawn by Subject|0|||
131804194|NCT03125200|474567025|FG004|Overall Study|Consent Withdrawn by Subject|1|||
131653276|NCT01277887|474015663|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
131653277|NCT01277887|474015664|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
131658879|NCT00384397|474035455|FG000|Overall Study|Lost to Follow-up|11|||
131658880|NCT00384397|474035456|FG001|Overall Study|Lost to Follow-up|13|||
131653278|NCT01277887|474015663|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
131653279|NCT01277887|474015664|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
131653280|NCT00415051|474015665|FG000|Overall Study|Protocol Violation|1|||
131653281|NCT01518153|474015670|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
131653282|NCT01518153|474015671|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
131653283|NCT01518153|474015672|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
131653284|NCT01518153|474015670|FG000|Stem Cell Transplant|Death|2|||
131653285|NCT01518153|474015671|FG001|Stem Cell Transplant|Death|0|||
131653286|NCT01518153|474015672|FG002|Stem Cell Transplant|Death|0|||
131653287|NCT01518153|474015670|FG000|Stem Cell Transplant|Secondary graft failure|1|||
131653288|NCT01518153|474015671|FG001|Stem Cell Transplant|Secondary graft failure|0|||
131653289|NCT01518153|474015672|FG002|Stem Cell Transplant|Secondary graft failure|0|||
131653290|NCT01518153|474015670|FG000|Stem Cell Transplant|Adverse Event|1|||
131653291|NCT01518153|474015671|FG001|Stem Cell Transplant|Adverse Event|0|||
131716926|NCT01309737|474241152|FG003|Week 16 to 52|Adverse Event|6|||
131716927|NCT01309737|474241153|FG004|Week 16 to 52|Adverse Event|5|||
131716928|NCT01309737|474241149|FG000|Week 16 to 52|Lack of Efficacy|107|||
131653292|NCT01518153|474015672|FG002|Stem Cell Transplant|Adverse Event|0|||
131653293|NCT01518153|474015670|FG000|Donor Lymphocyte Infusion|Death|0|||
131716929|NCT01309737|474241150|FG001|Week 16 to 52|Lack of Efficacy|76|||
131716930|NCT01309737|474241151|FG002|Week 16 to 52|Lack of Efficacy|0|||
131716931|NCT01309737|474241152|FG003|Week 16 to 52|Lack of Efficacy|25|||
131716932|NCT01309737|474241153|FG004|Week 16 to 52|Lack of Efficacy|21|||
131716933|NCT01309737|474241149|FG000|Week 16 to 52|Lost to Follow-up|4|||
131716934|NCT01309737|474241150|FG001|Week 16 to 52|Lost to Follow-up|2|||
131716935|NCT01309737|474241151|FG002|Week 16 to 52|Lost to Follow-up|0|||
131716936|NCT01309737|474241152|FG003|Week 16 to 52|Lost to Follow-up|1|||
131716937|NCT01309737|474241153|FG004|Week 16 to 52|Lost to Follow-up|4|||
131716938|NCT01309737|474241149|FG000|Week 16 to 52|Withdrawal by Subject|5|||
131716939|NCT01309737|474241150|FG001|Week 16 to 52|Withdrawal by Subject|6|||
131716940|NCT01309737|474241151|FG002|Week 16 to 52|Withdrawal by Subject|0|||
131716941|NCT01309737|474241152|FG003|Week 16 to 52|Withdrawal by Subject|0|||
131716942|NCT01309737|474241153|FG004|Week 16 to 52|Withdrawal by Subject|2|||
131716943|NCT01309737|474241149|FG000|Week 16 to 52|Other|10|||
131716944|NCT01309737|474241150|FG001|Week 16 to 52|Other|12|||
131716945|NCT01309737|474241151|FG002|Week 16 to 52|Other|0|||
131716946|NCT01309737|474241152|FG003|Week 16 to 52|Other|2|||
131716947|NCT01309737|474241153|FG004|Week 16 to 52|Other|0|||
131716948|NCT01442181|474241155|FG000|Overall Study|patient refused surgery|1|||
131716949|NCT01442181|474241156|FG001|Overall Study|patient refused surgery|0|||
131716950|NCT01442181|474241155|FG000|Overall Study|no insurance for surgery|1|||
131716951|NCT01442181|474241156|FG001|Overall Study|no insurance for surgery|0|||
131716952|NCT01442181|474241155|FG000|Overall Study|low ejection factor|0|||
131716953|NCT01442181|474241156|FG001|Overall Study|low ejection factor|1|||
131716954|NCT01442181|474241155|FG000|Overall Study|Lost to Follow-up|1|||
131716955|NCT01442181|474241156|FG001|Overall Study|Lost to Follow-up|1|||
131716956|NCT01442181|474241155|FG000|Overall Study|patient in an additional study|1|||
131716957|NCT01442181|474241156|FG001|Overall Study|patient in an additional study|0|||
131716958|NCT01442181|474241155|FG000|Overall Study|atrial fibrillation not noted|0|||
131716959|NCT01442181|474241156|FG001|Overall Study|atrial fibrillation not noted|1|||
131716960|NCT02034123|474241157|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131653294|NCT01518153|474015671|FG001|Donor Lymphocyte Infusion|Death|2|||
131653295|NCT01518153|474015672|FG002|Donor Lymphocyte Infusion|Death|1|||
131653296|NCT01754753|474015673|FG000|Overall Study|Study close|43|||
131653297|NCT01754753|474015674|FG001|Overall Study|Study close|44|||
131653298|NCT01754753|474015673|FG000|Overall Study|Lost to Follow-up|9|||
131653299|NCT01754753|474015674|FG001|Overall Study|Lost to Follow-up|5|||
131448137|NCT01716234|473270876|FG002|Overall Study|Withdrawal by Subject|2|||
131448138|NCT01716234|473270877|FG003|Overall Study|Withdrawal by Subject|2|||
131448139|NCT01716234|473270878|FG004|Overall Study|Withdrawal by Subject|1|||
131653300|NCT00856245|474015676|FG000|Overall Study|Was not transplanted|5|||
131653301|NCT01250509|474015677|FG000|Overall Study|Lost to Follow-up|5|||
131653302|NCT01250509|474015678|FG001|Overall Study|Lost to Follow-up|2|||
131653303|NCT00600613|474015682|FG000|Overall Study|Protocol Deviation|1|||
131804195|NCT03125200|474567026|FG005|Overall Study|Consent Withdrawn by Subject|0|||
131904262|NCT01061606|474935445|FG000|Overall Study|Death|1|||
131904263|NCT01061606|474935445|FG000|Overall Study|Disease Progression|4|||
131904264|NCT01061606|474935445|FG000|Overall Study|alternative therapy|2|||
131904265|NCT00735007|474935446|FG000|Overall Study|Adverse Event|4|||
131904266|NCT00735007|474935446|FG000|Overall Study|Protocol Violation|1|||
131904267|NCT01789047|474935447|FG000|Overall Study|Adverse Event|3|||
131904268|NCT01789047|474935448|FG001|Overall Study|Adverse Event|2|||
131904269|NCT01789047|474935447|FG000|Overall Study|Withdrawal by Subject|1|||
131904270|NCT01789047|474935448|FG001|Overall Study|Withdrawal by Subject|2|||
131904271|NCT00715403|474935449|FG000|Overall Study|Progressive disease|0|||
131904272|NCT00715403|474935450|FG001|Overall Study|Progressive disease|1|||
131904273|NCT00715403|474935451|FG002|Overall Study|Progressive disease|3|||
131904274|NCT00715403|474935452|FG003|Overall Study|Progressive disease|9|||
131904275|NCT00715403|474935453|FG004|Overall Study|Progressive disease|5|||
131904276|NCT00715403|474935454|FG005|Overall Study|Progressive disease|14|||
131904277|NCT00715403|474935455|FG006|Overall Study|Progressive disease|1|||
131904278|NCT00715403|474935449|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
131904279|NCT00715403|474935450|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
131904280|NCT00715403|474935451|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
131904281|NCT00715403|474935452|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
131904282|NCT00715403|474935453|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
131904283|NCT00715403|474935454|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
131904284|NCT00715403|474935455|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
131904285|NCT00715403|474935449|FG000|Overall Study|Other Adverse Event than DLT|1|||
131904286|NCT00715403|474935450|FG001|Overall Study|Other Adverse Event than DLT|0|||
131904287|NCT00715403|474935451|FG002|Overall Study|Other Adverse Event than DLT|0|||
131904288|NCT00715403|474935452|FG003|Overall Study|Other Adverse Event than DLT|0|||
131904289|NCT00715403|474935453|FG004|Overall Study|Other Adverse Event than DLT|0|||
131904290|NCT00715403|474935454|FG005|Overall Study|Other Adverse Event than DLT|2|||
131904291|NCT00715403|474935455|FG006|Overall Study|Other Adverse Event than DLT|0|||
131653304|NCT01509547|474015687|FG000|Overall Study|Lost to Follow-up|24|||
131653305|NCT01509547|474015688|FG001|Overall Study|Lost to Follow-up|14|||
131653306|NCT01509547|474015687|FG000|Overall Study|Withdrawal by Subject|11|||
131448140|NCT01716234|473270879|FG005|Overall Study|Withdrawal by Subject|3|||
131448141|NCT01716234|473270880|FG006|Overall Study|Withdrawal by Subject|0|||
131448142|NCT00515619|473270882|FG000|Overall Study|Adverse Event|34|||
131448143|NCT00515619|473270882|FG000|Overall Study|Lack of Efficacy|92|||
131448144|NCT00515619|473270882|FG000|Overall Study|Withdrawal by Subject|66|||
131448145|NCT00515619|473270882|FG000|Overall Study|Protocol Violation|3|||
131448146|NCT00515619|473270882|FG000|Overall Study|Lost to Follow-up|4|||
131448147|NCT00515619|473270882|FG000|Overall Study|Unsatisfactory compliance|6|||
131448148|NCT00515619|473270882|FG000|Overall Study|Other: Site discontinuing trials|2|||
131448149|NCT00515619|473270882|FG000|Overall Study|Other: Subject cannot attend visits|2|||
131448150|NCT00515619|473270882|FG000|Overall Study|Other: Subject required surgery|1|||
131448151|NCT00515619|473270882|FG000|Overall Study|Other: Subject moved to another country|1|||
131653307|NCT01509547|474015688|FG001|Overall Study|Withdrawal by Subject|24|||
131653308|NCT01509547|474015687|FG000|Overall Study|Physician Decision|0|||
131653309|NCT01509547|474015688|FG001|Overall Study|Physician Decision|1|||
131904292|NCT00715403|474935449|FG000|Overall Study|Protocol Violation|0|||
131904293|NCT00715403|474935450|FG001|Overall Study|Protocol Violation|0|||
131904294|NCT00715403|474935451|FG002|Overall Study|Protocol Violation|0|||
131904295|NCT00715403|474935452|FG003|Overall Study|Protocol Violation|0|||
131904296|NCT00715403|474935453|FG004|Overall Study|Protocol Violation|0|||
131448152|NCT00515619|473270882|FG000|Overall Study|Other: Investigator decision|1|||
131448153|NCT00515619|473270882|FG000|Overall Study|Other: Subject became pregnant|1|||
131448154|NCT00515619|473270882|FG000|Overall Study|Other: Request from sponsor|1|||
131904297|NCT00715403|474935454|FG005|Overall Study|Protocol Violation|1|||
131904298|NCT00715403|474935455|FG006|Overall Study|Protocol Violation|0|||
131904299|NCT00715403|474935449|FG000|Overall Study|Other reason not defined above|0|||
131904300|NCT00715403|474935450|FG001|Overall Study|Other reason not defined above|0|||
131904301|NCT00715403|474935451|FG002|Overall Study|Other reason not defined above|1|||
131904302|NCT00715403|474935452|FG003|Overall Study|Other reason not defined above|0|||
131904303|NCT00715403|474935453|FG004|Overall Study|Other reason not defined above|1|||
131904304|NCT00715403|474935454|FG005|Overall Study|Other reason not defined above|1|||
131904305|NCT00715403|474935455|FG006|Overall Study|Other reason not defined above|0|||
131904306|NCT03644017|474935456|FG000|Overall Study|Access Abandonment|5|||
131904307|NCT03644017|474935456|FG000|Overall Study|Kidney Transplant|2|||
131904308|NCT02700048|474935457|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
131904309|NCT02700048|474935458|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
131904310|NCT02175225|474935461|FG000|Overall Study|Withdrawal by Subject|1|||
131904311|NCT02175225|474935462|FG001|Overall Study|Withdrawal by Subject|2|||
131904312|NCT02175225|474935461|FG000|Overall Study|Lost to Follow-up|6|||
131904313|NCT02175225|474935462|FG001|Overall Study|Lost to Follow-up|7|||
131904314|NCT02175225|474935461|FG000|Overall Study|Study drug not administered|1|||
131904315|NCT02175225|474935462|FG001|Overall Study|Study drug not administered|2|||
131904316|NCT02340000|474935463|FG000|Time Period 1|Withdrawal by Subject|6|||
131904317|NCT02340000|474935464|FG001|Time Period 1|Withdrawal by Subject|8|||
131904318|NCT02340000|474935463|FG000|Time Period 1|Lost to Follow-up|6|||
131904319|NCT02340000|474935464|FG001|Time Period 1|Lost to Follow-up|7|||
131904320|NCT02340000|474935463|FG000|Time Period 2|Withdrawal by Subject|9|||
131904321|NCT02340000|474935464|FG001|Time Period 2|Withdrawal by Subject|7|||
131904322|NCT02340000|474935463|FG000|Time Period 2|Lost to Follow-up|10|||
131904323|NCT02340000|474935464|FG001|Time Period 2|Lost to Follow-up|8|||
131904324|NCT01883895|474935469|FG000|Overall Study|Lost to Follow-up|2|||
131904325|NCT00073918|474935470|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
131904326|NCT00073918|474935470|FG000|Overall Study|Rapid disease progression|2|||
131904327|NCT00073918|474935470|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
131904328|NCT00919633|474935473|FG000|Overall Study|Adverse Event|1|||
131904329|NCT00919633|474935474|FG001|Overall Study|Adverse Event|9|||
131904330|NCT00919633|474935475|FG002|Overall Study|Adverse Event|12|||
131904331|NCT00919633|474935476|FG003|Overall Study|Adverse Event|10|||
131904332|NCT00919633|474935473|FG000|Overall Study|Death|0|||
131904333|NCT00919633|474935474|FG001|Overall Study|Death|0|||
131904334|NCT00919633|474935475|FG002|Overall Study|Death|2|||
131904335|NCT00919633|474935476|FG003|Overall Study|Death|0|||
131904336|NCT00919633|474935473|FG000|Overall Study|Lack of Efficacy|17|||
131904337|NCT00919633|474935474|FG001|Overall Study|Lack of Efficacy|3|||
131904338|NCT00919633|474935475|FG002|Overall Study|Lack of Efficacy|2|||
131904339|NCT00919633|474935476|FG003|Overall Study|Lack of Efficacy|3|||
131904340|NCT00919633|474935473|FG000|Overall Study|Withdrawal by Subject|1|||
131653310|NCT01371708|474015691|FG000|Overall Study|Insufficient clinical response|3|||
131653311|NCT01371708|474015692|FG001|Overall Study|Insufficient clinical response|2|||
131653312|NCT01371708|474015693|FG002|Overall Study|Insufficient clinical response|0|||
131904341|NCT00919633|474935474|FG001|Overall Study|Withdrawal by Subject|2|||
131904342|NCT00919633|474935475|FG002|Overall Study|Withdrawal by Subject|4|||
131904343|NCT00919633|474935476|FG003|Overall Study|Withdrawal by Subject|3|||
131653313|NCT01371708|474015691|FG000|Overall Study|Lost to Follow-up|5|||
131653314|NCT01371708|474015692|FG001|Overall Study|Lost to Follow-up|9|||
131653315|NCT01371708|474015693|FG002|Overall Study|Lost to Follow-up|7|||
131904344|NCT00919633|474935473|FG000|Overall Study|Lost to Follow-up|3|||
131904345|NCT00919633|474935474|FG001|Overall Study|Lost to Follow-up|1|||
131904346|NCT00919633|474935475|FG002|Overall Study|Lost to Follow-up|0|||
131904347|NCT00919633|474935476|FG003|Overall Study|Lost to Follow-up|2|||
131716961|NCT02034123|474241158|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716962|NCT02034123|474241159|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716963|NCT02034123|474241160|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716964|NCT02034123|474241161|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
131716965|NCT02034123|474241162|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716966|NCT02034123|474241163|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716967|NCT02034123|474241164|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
131716968|NCT02034123|474241165|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
131716969|NCT02034123|474241166|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716970|NCT02034123|474241167|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716971|NCT02034123|474241168|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716972|NCT02034123|474241169|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716973|NCT02034123|474241170|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716974|NCT02034123|474241171|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716975|NCT02034123|474241172|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716976|NCT02034123|474241173|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716977|NCT02034123|474241174|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131716978|NCT02034123|474241157|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716979|NCT02034123|474241158|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716980|NCT02034123|474241159|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716981|NCT02034123|474241160|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
131716982|NCT02034123|474241161|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716983|NCT02034123|474241162|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716984|NCT02034123|474241163|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716985|NCT02034123|474241164|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716986|NCT02034123|474241165|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716987|NCT02034123|474241166|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716988|NCT02034123|474241167|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716989|NCT02034123|474241168|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716990|NCT02034123|474241169|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716991|NCT02034123|474241170|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716992|NCT02034123|474241171|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716993|NCT02034123|474241172|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716994|NCT02034123|474241173|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716995|NCT02034123|474241174|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131716996|NCT02034123|474241157|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131716997|NCT02034123|474241158|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131716998|NCT02034123|474241159|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131716999|NCT02034123|474241160|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717000|NCT02034123|474241161|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717001|NCT02034123|474241162|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717002|NCT02034123|474241163|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717003|NCT02034123|474241164|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131804196|NCT03125200|474567027|FG006|Overall Study|Consent Withdrawn by Subject|1|||
131653316|NCT01371708|474015691|FG000|Overall Study|Protocol Violation|2|||
131653317|NCT01371708|474015692|FG001|Overall Study|Protocol Violation|1|||
131653318|NCT01371708|474015693|FG002|Overall Study|Protocol Violation|2|||
131653319|NCT01371708|474015691|FG000|Overall Study|No longer willing to participate|7|||
131653320|NCT01371708|474015692|FG001|Overall Study|No longer willing to participate|7|||
131653321|NCT01371708|474015693|FG002|Overall Study|No longer willing to participate|13|||
131653322|NCT01371708|474015691|FG000|Overall Study|Medication error/not related to AE|0|||
131653323|NCT01371708|474015692|FG001|Overall Study|Medication error/not related to AE|1|||
131653324|NCT01371708|474015693|FG002|Overall Study|Medication error/not related to AE|0|||
131653325|NCT01371708|474015691|FG000|Overall Study|Other|3|||
131653326|NCT01371708|474015692|FG001|Overall Study|Other|2|||
131653327|NCT01371708|474015693|FG002|Overall Study|Other|4|||
131904348|NCT00919633|474935473|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
131904349|NCT00919633|474935474|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
131904350|NCT00919633|474935475|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
131904351|NCT00919633|474935476|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
131904352|NCT00919633|474935473|FG000|Overall Study|Protocol Violation|0|||
131904353|NCT00919633|474935474|FG001|Overall Study|Protocol Violation|0|||
131904354|NCT00919633|474935475|FG002|Overall Study|Protocol Violation|0|||
131904355|NCT00919633|474935476|FG003|Overall Study|Protocol Violation|1|||
131904356|NCT00919633|474935473|FG000|Overall Study|Physician Decision|0|||
131904357|NCT00919633|474935474|FG001|Overall Study|Physician Decision|0|||
131904358|NCT00919633|474935475|FG002|Overall Study|Physician Decision|0|||
131904359|NCT00919633|474935476|FG003|Overall Study|Physician Decision|1|||
131904360|NCT00919633|474935473|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
131904361|NCT00919633|474935474|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
131904362|NCT00919633|474935475|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
131904363|NCT00919633|474935476|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
131904364|NCT00919633|474935473|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
131904365|NCT00919633|474935474|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
131904366|NCT00919633|474935475|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
131904367|NCT00919633|474935476|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
131904368|NCT01121263|474935477|FG000|Overall Study|Death|3|||
131904369|NCT01121263|474935478|FG001|Overall Study|Death|2|||
131904370|NCT01121263|474935477|FG000|Overall Study|Lost to Follow-up|22|||
131904371|NCT01121263|474935478|FG001|Overall Study|Lost to Follow-up|12|||
131904372|NCT01121263|474935477|FG000|Overall Study|Withdrawal by Subject|0|||
131904373|NCT01121263|474935478|FG001|Overall Study|Withdrawal by Subject|1|||
131904374|NCT02007720|474935479|FG000|Overall Study|Withdrawal by Subject|9|||
131904375|NCT02007720|474935480|FG001|Overall Study|Withdrawal by Subject|11|||
131904376|NCT02007720|474935479|FG000|Overall Study|study terminated by sponsor|58|||
131904377|NCT02007720|474935480|FG001|Overall Study|study terminated by sponsor|54|||
131904378|NCT02007720|474935479|FG000|Overall Study|technical problem|4|||
131904379|NCT02007720|474935480|FG001|Overall Study|technical problem|2|||
131904380|NCT02007720|474935479|FG000|Overall Study|patient followd less than 165 days|11|||
131904381|NCT02007720|474935480|FG001|Overall Study|patient followd less than 165 days|5|||
131904382|NCT02481050|474936952|FG000|Overall Study|Adverse Event|1|||
131904383|NCT02481050|474936952|FG000|Overall Study|Disease Progression|47|||
131904384|NCT02481050|474936952|FG000|Overall Study|Withdrawal by Subject|7|||
131904385|NCT02481050|474936952|FG000|Overall Study|Other|3|||
131904386|NCT03246347|474936955|FG000|Overall Study|On Study|23|||
131904387|NCT01022203|474936956|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
131904388|NCT01022203|474936957|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
131904389|NCT01022203|474936956|FG000|Post Treatment Assessment|Physician Decision|2|||
131904390|NCT01022203|474936957|FG001|Post Treatment Assessment|Physician Decision|0|||
131904391|NCT01022203|474936956|FG000|Post Treatment Assessment|Adverse Event|0|||
131904392|NCT01022203|474936957|FG001|Post Treatment Assessment|Adverse Event|2|||
131904393|NCT01022203|474936956|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
131904394|NCT01022203|474936957|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
131904395|NCT03638128|474936960|FG000|Overall Study|Withdrawal by Subject|1|||
131904396|NCT03638128|474936961|FG001|Overall Study|Withdrawal by Subject|7|||
131904397|NCT03638128|474936962|FG002|Overall Study|Withdrawal by Subject|6|||
131904398|NCT03638128|474936960|FG000|Overall Study|Sponsor Decision|15|||
131804197|NCT00119379|474567031|FG000|Overall Study|Adverse Event|4|||
131804198|NCT00119379|474567032|FG001|Overall Study|Adverse Event|1|||
131804199|NCT00694551|474567033|FG000|Overall Study|Disease Progression|1|||
131804200|NCT00694551|474567034|FG001|Overall Study|Disease Progression|0|||
131804201|NCT00694551|474567035|FG002|Overall Study|Disease Progression|1|||
131804202|NCT01937390|474567043|FG000|Overall Study|Death|2|||
131804203|NCT01937390|474567043|FG000|Overall Study|Lost to Follow-up|7|||
131904399|NCT03638128|474936961|FG001|Overall Study|Sponsor Decision|12|||
131804204|NCT01937390|474567043|FG000|Overall Study|Withdrawal by Subject|5|||
131804205|NCT01937390|474567043|FG000|Overall Study|Fail to return|21|||
131904400|NCT03638128|474936962|FG002|Overall Study|Sponsor Decision|19|||
131904401|NCT03638128|474936960|FG000|Overall Study|Lost to Follow-up|0|||
131904402|NCT03638128|474936961|FG001|Overall Study|Lost to Follow-up|0|||
131904403|NCT03638128|474936962|FG002|Overall Study|Lost to Follow-up|1|||
131904404|NCT00329108|474936964|FG000|Overall Study|Adverse Event|2|||
131904405|NCT00329108|474936965|FG001|Overall Study|Adverse Event|2|||
131904406|NCT00329108|474936964|FG000|Overall Study|Lack of Efficacy|3|||
131904407|NCT00329108|474936965|FG001|Overall Study|Lack of Efficacy|3|||
131904408|NCT00329108|474936964|FG000|Overall Study|Withdrawal by Subject|0|||
131904409|NCT00329108|474936965|FG001|Overall Study|Withdrawal by Subject|2|||
131904410|NCT00329108|474936964|FG000|Overall Study|symptomatic deterioration|1|||
131904411|NCT00329108|474936965|FG001|Overall Study|symptomatic deterioration|1|||
131653328|NCT01371708|474015691|FG000|Overall Study|Adverse Event|5|||
131653329|NCT01371708|474015692|FG001|Overall Study|Adverse Event|8|||
131653330|NCT01371708|474015693|FG002|Overall Study|Adverse Event|12|||
131653331|NCT01371708|474015691|FG000|Overall Study|Started but did not receive treatment|1|||
131653332|NCT01371708|474015692|FG001|Overall Study|Started but did not receive treatment|0|||
131653333|NCT01371708|474015693|FG002|Overall Study|Started but did not receive treatment|1|||
131653334|NCT02514551|474015694|FG000|Overall Study|Lost to Follow-up|0|||
131653335|NCT02514551|474015695|FG001|Overall Study|Lost to Follow-up|1|||
131904412|NCT00329108|474936964|FG000|Overall Study|Subject no longer willing to participate|2|||
131653336|NCT02514551|474015694|FG000|Overall Study|Participant Never Treated|0|||
131653337|NCT02514551|474015695|FG001|Overall Study|Participant Never Treated|2|||
131653338|NCT00570908|474015707|FG000|Overall Study|Adverse Event|5|||
131653339|NCT00570908|474015707|FG000|Overall Study|Withdrawal by Subject|2|||
131653340|NCT01213524|474015708|FG000|Baseline|Withdrawal by Subject|5|||
131653341|NCT01213524|474015708|FG000|Baseline|high breath alcohol levels|1|||
131653342|NCT01213524|474015708|FG000|Baseline|Physician Decision|1|||
131653343|NCT01213524|474015708|FG000|Session 2|Withdrawal by Subject|5|||
131653344|NCT01213524|474015708|FG000|Session 3|Withdrawal by Subject|4|||
131653345|NCT01213524|474015708|FG000|Session 4|Physician Decision|1|||
131653346|NCT01213524|474015708|FG000|Session 4|Withdrawal by Subject|2|||
131653347|NCT05415748|474015717|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
131653348|NCT05415748|474015718|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
131653349|NCT05415748|474015719|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
131653350|NCT05415748|474015720|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
131653351|NCT05415748|474015717|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
131904413|NCT00329108|474936965|FG001|Overall Study|Subject no longer willing to participate|2|||
131904414|NCT00329108|474936964|FG000|Overall Study|study terminated by sponsor|1|||
131904415|NCT00329108|474936965|FG001|Overall Study|study terminated by sponsor|0|||
131904416|NCT00329108|474936964|FG000|Overall Study|withdrew patient after SAE resolved|1|||
131904417|NCT00329108|474936965|FG001|Overall Study|withdrew patient after SAE resolved|0|||
131904418|NCT00329108|474936964|FG000|Overall Study|Protocol Violation|0|||
131904419|NCT00329108|474936965|FG001|Overall Study|Protocol Violation|2|||
131904420|NCT00903201|474936966|FG000|Overall Study|Adverse Event|1|||
131904421|NCT00903201|474936967|FG001|Overall Study|Adverse Event|4|||
131904422|NCT00903201|474936968|FG002|Overall Study|Adverse Event|0|||
131904423|NCT00903201|474936966|FG000|Overall Study|Protocol Violation|2|||
131904424|NCT00903201|474936967|FG001|Overall Study|Protocol Violation|1|||
131904425|NCT00903201|474936968|FG002|Overall Study|Protocol Violation|0|||
131904426|NCT00903201|474936966|FG000|Overall Study|Lost to Follow-up|0|||
131904427|NCT00903201|474936967|FG001|Overall Study|Lost to Follow-up|1|||
131904428|NCT00903201|474936968|FG002|Overall Study|Lost to Follow-up|0|||
131904429|NCT00903201|474936966|FG000|Overall Study|Physician Decision|1|||
131904430|NCT00903201|474936967|FG001|Overall Study|Physician Decision|0|||
131904431|NCT00903201|474936968|FG002|Overall Study|Physician Decision|1|||
131904432|NCT00903201|474936966|FG000|Overall Study|Withdrawal by Subject|1|||
131904433|NCT00903201|474936967|FG001|Overall Study|Withdrawal by Subject|0|||
131904434|NCT00903201|474936968|FG002|Overall Study|Withdrawal by Subject|1|||
131904435|NCT01094288|474936971|FG000|Overall Study|Adverse Event|0|||
131904436|NCT01094288|474936972|FG001|Overall Study|Adverse Event|3|||
131904437|NCT01094288|474936973|FG002|Overall Study|Adverse Event|1|||
131904438|NCT01094288|474936974|FG003|Overall Study|Adverse Event|1|||
131904439|NCT01094288|474936975|FG004|Overall Study|Adverse Event|0|||
131904440|NCT01094288|474936976|FG005|Overall Study|Adverse Event|0|||
131904441|NCT01094288|474936977|FG006|Overall Study|Adverse Event|0|||
131904442|NCT01094288|474936978|FG007|Overall Study|Adverse Event|0|||
131904443|NCT01094288|474936971|FG000|Overall Study|Withdrawal by Subject|0|||
131904444|NCT01094288|474936972|FG001|Overall Study|Withdrawal by Subject|1|||
131904445|NCT01094288|474936973|FG002|Overall Study|Withdrawal by Subject|2|||
131904446|NCT01094288|474936974|FG003|Overall Study|Withdrawal by Subject|0|||
131904447|NCT01094288|474936975|FG004|Overall Study|Withdrawal by Subject|0|||
131904448|NCT01094288|474936976|FG005|Overall Study|Withdrawal by Subject|0|||
131904449|NCT01094288|474936977|FG006|Overall Study|Withdrawal by Subject|0|||
131904450|NCT01094288|474936978|FG007|Overall Study|Withdrawal by Subject|2|||
131904451|NCT01094288|474936971|FG000|Overall Study|Initiation of Alternative Therapy|0|||
131904452|NCT01094288|474936972|FG001|Overall Study|Initiation of Alternative Therapy|0|||
131904453|NCT01094288|474936973|FG002|Overall Study|Initiation of Alternative Therapy|1|||
131904454|NCT01094288|474936974|FG003|Overall Study|Initiation of Alternative Therapy|0|||
131904455|NCT01094288|474936975|FG004|Overall Study|Initiation of Alternative Therapy|0|||
131904456|NCT01094288|474936976|FG005|Overall Study|Initiation of Alternative Therapy|0|||
131904457|NCT01094288|474936977|FG006|Overall Study|Initiation of Alternative Therapy|0|||
131904458|NCT01094288|474936978|FG007|Overall Study|Initiation of Alternative Therapy|0|||
131904459|NCT01094288|474936971|FG000|Overall Study|Reason not Specified|2|||
131904460|NCT01094288|474936972|FG001|Overall Study|Reason not Specified|3|||
131904461|NCT01094288|474936973|FG002|Overall Study|Reason not Specified|0|||
131904462|NCT01094288|474936974|FG003|Overall Study|Reason not Specified|1|||
131904463|NCT01094288|474936975|FG004|Overall Study|Reason not Specified|0|||
131904464|NCT01094288|474936976|FG005|Overall Study|Reason not Specified|0|||
131904465|NCT01094288|474936977|FG006|Overall Study|Reason not Specified|0|||
131904466|NCT01094288|474936978|FG007|Overall Study|Reason not Specified|0|||
131904467|NCT01094288|474936971|FG000|Overall Study|Ongoing Participants|0|||
131904468|NCT01094288|474936972|FG001|Overall Study|Ongoing Participants|3|||
131904469|NCT01094288|474936973|FG002|Overall Study|Ongoing Participants|0|||
131904470|NCT01094288|474936974|FG003|Overall Study|Ongoing Participants|0|||
131904471|NCT01094288|474936975|FG004|Overall Study|Ongoing Participants|0|||
131904472|NCT01094288|474936976|FG005|Overall Study|Ongoing Participants|0|||
131904473|NCT01094288|474936977|FG006|Overall Study|Ongoing Participants|0|||
131904474|NCT01094288|474936978|FG007|Overall Study|Ongoing Participants|0|||
131904475|NCT02611882|474936979|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
131904476|NCT02611882|474936980|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
131904477|NCT02611882|474936981|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
131904478|NCT01389232|474936982|FG000|Overall Study|Had scaffold removed|15|||
131904479|NCT01389232|474936982|FG000|Overall Study|Personal reasons|2|||
131904480|NCT01389232|474936982|FG000|Overall Study|Adverse Event|1|||
131904481|NCT01389232|474936982|FG000|Overall Study|Death|1|||
131904482|NCT01317940|474936983|FG000|Overall Study|Death|1|||
131904483|NCT01317940|474936984|FG001|Overall Study|Death|0|||
131904484|NCT01317940|474936985|FG002|Overall Study|Death|1|||
131904485|NCT01317940|474936986|FG003|Overall Study|Death|0|||
131904486|NCT01317940|474936987|FG004|Overall Study|Death|0|||
131904487|NCT01317940|474936988|FG005|Overall Study|Death|0|||
131904488|NCT01317940|474936983|FG000|Overall Study|Lost to Follow-up|0|||
131904489|NCT01317940|474936984|FG001|Overall Study|Lost to Follow-up|0|||
131904490|NCT01317940|474936985|FG002|Overall Study|Lost to Follow-up|1|||
131904491|NCT01317940|474936986|FG003|Overall Study|Lost to Follow-up|1|||
131904492|NCT01317940|474936987|FG004|Overall Study|Lost to Follow-up|1|||
131904493|NCT01317940|474936988|FG005|Overall Study|Lost to Follow-up|0|||
131904494|NCT01317940|474936983|FG000|Overall Study|Change in therapy plan|0|||
131904495|NCT01317940|474936984|FG001|Overall Study|Change in therapy plan|0|||
131904496|NCT01317940|474936985|FG002|Overall Study|Change in therapy plan|3|||
131904497|NCT01317940|474936986|FG003|Overall Study|Change in therapy plan|0|||
131904498|NCT01317940|474936987|FG004|Overall Study|Change in therapy plan|0|||
131904499|NCT01317940|474936988|FG005|Overall Study|Change in therapy plan|0|||
131904500|NCT02371616|474936990|FG000|Overall Study|Protocol Violation|2|||
131904501|NCT02371616|474936991|FG001|Overall Study|Protocol Violation|1|||
131904502|NCT02371616|474936990|FG000|Overall Study|Adverse Event|0|||
131904503|NCT02371616|474936991|FG001|Overall Study|Adverse Event|1|||
131904504|NCT02371616|474936990|FG000|Overall Study|Withdrawal of Consent|1|||
131904505|NCT02371616|474936991|FG001|Overall Study|Withdrawal of Consent|0|||
131904506|NCT02371616|474936990|FG000|Overall Study|Other (Not specified)|1|||
131904507|NCT02371616|474936991|FG001|Overall Study|Other (Not specified)|5|||
131904508|NCT00754741|474936992|FG000|Overall Study|Died or disenrolled|57|||
131904509|NCT00754741|474936993|FG001|Overall Study|Died or disenrolled|69|||
131904510|NCT00754741|474936994|FG002|Overall Study|Died or disenrolled|54|||
131904511|NCT04152200|474936996|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
131653352|NCT05415748|474015718|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
131653353|NCT05415748|474015719|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
131904512|NCT04152200|474936997|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
131904513|NCT00593814|474936998|FG000|Overall Study|Death|7|||
131904514|NCT00593814|474936999|FG001|Overall Study|Death|0|||
131904515|NCT00593814|474936998|FG000|Overall Study|Withdrawal by Subject|7|||
131653354|NCT05415748|474015720|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
131653355|NCT02819024|474015723|FG000|Overall Study|Withdrawal by Subject|1|||
131904516|NCT00593814|474936999|FG001|Overall Study|Withdrawal by Subject|0|||
131904517|NCT00593814|474936998|FG000|Overall Study|Lost to Follow-up|7|||
131904518|NCT00593814|474936999|FG001|Overall Study|Lost to Follow-up|0|||
131904519|NCT00593814|474936998|FG000|Overall Study|Physician Decision|3|||
131904520|NCT00593814|474936999|FG001|Overall Study|Physician Decision|0|||
131448155|NCT00515619|473270882|FG000|Overall Study|Other: Drug available on license|1|||
131448156|NCT00515619|473270882|FG000|Overall Study|Other: Subject interested in other AED|1|||
131448157|NCT03067077|473270883|FG000|Overall Study|Did not receive surgery|4|||
131804206|NCT01706536|474567044|FG000|Overall Study|Withdrawal by Subject|1|||
131804207|NCT01706536|474567045|FG001|Overall Study|Withdrawal by Subject|0|||
131804208|NCT01706536|474567046|FG002|Overall Study|Withdrawal by Subject|1|||
131653356|NCT00792948|474015724|FG000|Overall Study|Adverse Event|6|||
131653357|NCT00792948|474015724|FG000|Overall Study|Death|4|||
131653358|NCT00792948|474015724|FG000|Overall Study|Withdrawal by Subject|3|||
131653359|NCT00792948|474015724|FG000|Overall Study|Ineligible|2|||
131653360|NCT00792948|474015724|FG000|Overall Study|Insurance denial - not treated|1|||
131653361|NCT00792948|474015724|FG000|Overall Study|Physician Decision|11|||
131653362|NCT00792948|474015724|FG000|Overall Study|Protocol Violation|1|||
131653363|NCT00281320|474015725|FG000|Overall Study|Adverse Event|12|||
131653364|NCT00281320|474015726|FG001|Overall Study|Adverse Event|9|||
131653365|NCT00281320|474015725|FG000|Overall Study|Lack of Efficacy|4|||
131653366|NCT00281320|474015726|FG001|Overall Study|Lack of Efficacy|3|||
131804209|NCT01706536|474567047|FG003|Overall Study|Withdrawal by Subject|0|||
131653367|NCT00281320|474015725|FG000|Overall Study|Withdrawal by Subject|5|||
131653368|NCT00281320|474015726|FG001|Overall Study|Withdrawal by Subject|6|||
131653369|NCT00281320|474015725|FG000|Overall Study|Lost to Follow-up|1|||
131653370|NCT00281320|474015726|FG001|Overall Study|Lost to Follow-up|2|||
131653371|NCT00281320|474015725|FG000|Overall Study|Other|3|||
131653372|NCT00281320|474015726|FG001|Overall Study|Other|1|||
131653373|NCT01447576|474015737|FG000|Overall Study|Lost to Follow-up|52|||
131653374|NCT01447576|474015737|FG000|Overall Study|Adverse Event|127|||
131653375|NCT01447576|474015737|FG000|Overall Study|Participant met withdrawal criteria|40|||
131653376|NCT01447576|474015737|FG000|Overall Study|Withdrawal by Subject|100|||
131653377|NCT01447576|474015737|FG000|Overall Study|Protocol deviation|83|||
131653378|NCT01447576|474015737|FG000|Overall Study|Lack of Efficacy|68|||
131653379|NCT01447576|474015737|FG000|Overall Study|Physician Decision|6|||
131653380|NCT03832595|474015743|FG000|Overall Study|Death|142|||
131653381|NCT03832595|474015744|FG001|Overall Study|Death|130|||
131653382|NCT03832595|474015743|FG000|Overall Study|Medical management without dialysis|37|||
131653383|NCT03832595|474015744|FG001|Overall Study|Medical management without dialysis|1|||
131653384|NCT02397447|474015745|FG000|Overall Study|Lost to Follow-up|2|||
131653385|NCT02397447|474015746|FG001|Overall Study|Lost to Follow-up|2|||
131653386|NCT00699153|474018347|FG000|Overall Study|Lost to Follow-up|1|||
131653387|NCT00699153|474018348|FG001|Overall Study|Lost to Follow-up|0|||
131653388|NCT00699153|474018347|FG000|Overall Study|Adverse Event|0|||
131653389|NCT00699153|474018348|FG001|Overall Study|Adverse Event|2|||
131653390|NCT00699153|474018347|FG000|Overall Study|Protocol Violation|1|||
131653391|NCT00699153|474018348|FG001|Overall Study|Protocol Violation|0|||
131653392|NCT00699153|474018347|FG000|Overall Study|Travel Problem|1|||
131717004|NCT02034123|474241165|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
131717005|NCT02034123|474241166|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131653393|NCT00699153|474018348|FG001|Overall Study|Travel Problem|0|||
131717006|NCT02034123|474241167|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717007|NCT02034123|474241168|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717008|NCT02034123|474241169|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717009|NCT02034123|474241170|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717010|NCT02034123|474241171|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717011|NCT02034123|474241172|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131653394|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
131653395|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
131653396|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
131653397|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
131653398|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Death|13|||
131653399|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Death|12|||
131653400|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Progression|257|||
131717012|NCT02034123|474241173|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717013|NCT02034123|474241174|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131717014|NCT02034123|474241157|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717015|NCT02034123|474241158|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717016|NCT02034123|474241159|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717017|NCT02034123|474241160|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
131717018|NCT02034123|474241161|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
131717019|NCT02034123|474241162|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717020|NCT02034123|474241163|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717021|NCT02034123|474241164|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717022|NCT02034123|474241165|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717023|NCT02034123|474241166|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717024|NCT02034123|474241167|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717025|NCT02034123|474241168|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717026|NCT02034123|474241169|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717027|NCT02034123|474241170|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717028|NCT02034123|474241171|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717029|NCT02034123|474241172|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717030|NCT02034123|474241173|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717031|NCT02034123|474241174|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131717032|NCT00246259|474241175|FG000|Overall Study|Other|3|||
131717033|NCT00246259|474241176|FG001|Overall Study|Other|3|||
131717034|NCT00246259|474241175|FG000|Overall Study|Not stable by Week 18|2|||
131717035|NCT00246259|474241176|FG001|Overall Study|Not stable by Week 18|1|||
131717036|NCT00246259|474241175|FG000|Overall Study|Participant non-compliant|4|||
131717037|NCT00246259|474241176|FG001|Overall Study|Participant non-compliant|9|||
131717038|NCT00246259|474241175|FG000|Overall Study|Lack of Efficacy|2|||
131717039|NCT00246259|474241176|FG001|Overall Study|Lack of Efficacy|2|||
131717040|NCT00246259|474241175|FG000|Overall Study|Investigator withdrew participant|2|||
131717041|NCT00246259|474241176|FG001|Overall Study|Investigator withdrew participant|0|||
131717042|NCT00246259|474241175|FG000|Overall Study|Adverse Event|5|||
131717043|NCT00246259|474241176|FG001|Overall Study|Adverse Event|0|||
131717044|NCT00246259|474241175|FG000|Overall Study|Lost to Follow-up|3|||
131717045|NCT00246259|474241176|FG001|Overall Study|Lost to Follow-up|4|||
131717046|NCT00246259|474241175|FG000|Overall Study|Withdrawal by Subject|5|||
131717047|NCT00246259|474241176|FG001|Overall Study|Withdrawal by Subject|1|||
131717048|NCT00246259|474241175|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
131717049|NCT00246259|474241176|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
131717050|NCT00709202|474241177|FG000|Overall Study|Withdrawal by Subject|6|||
131717051|NCT00709202|474241178|FG001|Overall Study|Withdrawal by Subject|6|||
131717052|NCT03133767|474241180|FG000|Overall Study|Lost to Follow-up|38|||
131717053|NCT03133767|474241181|FG001|Overall Study|Lost to Follow-up|24|||
131717054|NCT03133767|474241180|FG000|Overall Study|Protocol Violation|0|||
131717055|NCT03133767|474241181|FG001|Overall Study|Protocol Violation|1|||
131717056|NCT02240706|474241184|FG000|Overall Study|Lack of Efficacy|2|||
131717057|NCT02240706|474241185|FG001|Overall Study|Lack of Efficacy|2|||
131717058|NCT02240706|474241186|FG002|Overall Study|Lack of Efficacy|2|||
131717059|NCT02240706|474241187|FG003|Overall Study|Lack of Efficacy|2|||
131717060|NCT02240706|474241188|FG004|Overall Study|Lack of Efficacy|5|||
131717061|NCT02240706|474241189|FG005|Overall Study|Lack of Efficacy|0|||
131717062|NCT02240706|474241190|FG006|Overall Study|Lack of Efficacy|0|||
131717063|NCT02240706|474241184|FG000|Overall Study|Adverse Event|1|||
131717064|NCT02240706|474241185|FG001|Overall Study|Adverse Event|0|||
131804210|NCT01706536|474567048|FG004|Overall Study|Withdrawal by Subject|0|||
131804211|NCT01706536|474567044|FG000|Overall Study|Adverse Event|2|||
131804212|NCT01706536|474567045|FG001|Overall Study|Adverse Event|3|||
131804213|NCT01706536|474567046|FG002|Overall Study|Adverse Event|4|||
131804214|NCT01706536|474567047|FG003|Overall Study|Adverse Event|3|||
131804215|NCT01706536|474567048|FG004|Overall Study|Adverse Event|2|||
131804216|NCT01706536|474567044|FG000|Overall Study|Lack of Efficacy|1|||
131804217|NCT01706536|474567045|FG001|Overall Study|Lack of Efficacy|0|||
131804218|NCT01706536|474567046|FG002|Overall Study|Lack of Efficacy|0|||
131717065|NCT02240706|474241186|FG002|Overall Study|Adverse Event|1|||
131717066|NCT02240706|474241187|FG003|Overall Study|Adverse Event|0|||
131717067|NCT02240706|474241188|FG004|Overall Study|Adverse Event|2|||
131804219|NCT01706536|474567047|FG003|Overall Study|Lack of Efficacy|1|||
131804220|NCT01706536|474567048|FG004|Overall Study|Lack of Efficacy|0|||
131804221|NCT01706536|474567044|FG000|Overall Study|non compliance|0|||
131804222|NCT01706536|474567045|FG001|Overall Study|non compliance|1|||
131804223|NCT01706536|474567046|FG002|Overall Study|non compliance|0|||
131804224|NCT01706536|474567047|FG003|Overall Study|non compliance|0|||
131804225|NCT01706536|474567048|FG004|Overall Study|non compliance|0|||
131804226|NCT00683293|474567060|FG000|Overall Study|Withdrawal by Subject|2|||
131804227|NCT00683293|474567061|FG001|Overall Study|Withdrawal by Subject|3|||
131804228|NCT03262012|474567062|FG000|Overall Study|Withdrawal by Subject|15|||
131804229|NCT03262012|474567063|FG001|Overall Study|Withdrawal by Subject|13|||
131804230|NCT03262012|474567064|FG002|Overall Study|Withdrawal by Subject|8|||
131804231|NCT03262012|474567065|FG003|Overall Study|Withdrawal by Subject|7|||
131904521|NCT02699996|474937000|FG000|Overall Study|Withdrawal by Subject|5|||
131904522|NCT02699996|474937001|FG001|Overall Study|Withdrawal by Subject|2|||
131904523|NCT04069715|474937002|FG000|Overall Study|Lost to Follow-up|1|||
131904524|NCT04069715|474937003|FG001|Overall Study|Lost to Follow-up|1|||
131904525|NCT04069715|474937002|FG000|Overall Study|Physician Decision|1|||
131904526|NCT04069715|474937003|FG001|Overall Study|Physician Decision|1|||
131904527|NCT04069715|474937002|FG000|Overall Study|Withdrawal by Subject|3|||
131904528|NCT04069715|474937003|FG001|Overall Study|Withdrawal by Subject|3|||
131904529|NCT03205150|474937004|FG000|Overall Study|Protocol deviation|1|||
131904530|NCT03205150|474937005|FG001|Overall Study|Protocol deviation|3|||
131904531|NCT03205150|474937006|FG002|Overall Study|Protocol deviation|0|||
131904532|NCT03205150|474937004|FG000|Overall Study|Patient/guardian decision|0|||
131904533|NCT03205150|474937005|FG001|Overall Study|Patient/guardian decision|3|||
131904534|NCT03205150|474937006|FG002|Overall Study|Patient/guardian decision|0|||
131904535|NCT03205150|474937004|FG000|Overall Study|Adverse Event|1|||
131904536|NCT03205150|474937005|FG001|Overall Study|Adverse Event|1|||
131904537|NCT03205150|474937006|FG002|Overall Study|Adverse Event|1|||
131904538|NCT03205150|474937004|FG000|Overall Study|Lost to Follow-up|0|||
131904539|NCT03205150|474937005|FG001|Overall Study|Lost to Follow-up|0|||
131904540|NCT03205150|474937006|FG002|Overall Study|Lost to Follow-up|1|||
131804232|NCT03262012|474567062|FG000|Overall Study|Adverse Event|10|||
131804233|NCT03262012|474567063|FG001|Overall Study|Adverse Event|12|||
131804234|NCT03262012|474567064|FG002|Overall Study|Adverse Event|4|||
131804235|NCT03262012|474567065|FG003|Overall Study|Adverse Event|6|||
131804236|NCT03262012|474567062|FG000|Overall Study|Physician Decision|2|||
131804237|NCT03262012|474567063|FG001|Overall Study|Physician Decision|5|||
131804238|NCT03262012|474567064|FG002|Overall Study|Physician Decision|1|||
131804239|NCT03262012|474567065|FG003|Overall Study|Physician Decision|0|||
131804240|NCT03262012|474567062|FG000|Overall Study|Lack of Efficacy|0|||
131804241|NCT03262012|474567063|FG001|Overall Study|Lack of Efficacy|5|||
131804242|NCT03262012|474567064|FG002|Overall Study|Lack of Efficacy|1|||
131804243|NCT03262012|474567065|FG003|Overall Study|Lack of Efficacy|2|||
131804244|NCT03262012|474567062|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
131804245|NCT03262012|474567063|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
131904541|NCT02723188|474937007|FG000|Overall Study|Withdrawal by Subject|1|||
131904542|NCT02723188|474937008|FG001|Overall Study|Withdrawal by Subject|0|||
131904543|NCT02723188|474937009|FG002|Overall Study|Withdrawal by Subject|0|||
131904544|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
131658881|NCT00384397|474035457|FG002|Overall Study|Lost to Follow-up|3|||
131658882|NCT00384397|474035455|FG000|Overall Study|Withdrawal by Subject|14|||
131658883|NCT00384397|474035456|FG001|Overall Study|Withdrawal by Subject|17|||
131658884|NCT00384397|474035457|FG002|Overall Study|Withdrawal by Subject|15|||
131658885|NCT01214642|474035458|FG000|Overall Study|Progressive Disease|3|||
131658886|NCT01214642|474035459|FG001|Overall Study|Progressive Disease|2|||
131658887|NCT01214642|474035460|FG002|Overall Study|Progressive Disease|3|||
131658888|NCT01214642|474035461|FG003|Overall Study|Progressive Disease|5|||
131658889|NCT01214642|474035462|FG004|Overall Study|Progressive Disease|5|||
131658890|NCT01214642|474035463|FG005|Overall Study|Progressive Disease|3|||
131658891|NCT01214642|474035464|FG006|Overall Study|Progressive Disease|5|||
131658892|NCT01214642|474035465|FG007|Overall Study|Progressive Disease|3|||
131658893|NCT01214642|474035466|FG008|Overall Study|Progressive Disease|10|||
131658894|NCT01214642|474035467|FG009|Overall Study|Progressive Disease|2|||
131658895|NCT01214642|474035468|FG010|Overall Study|Progressive Disease|1|||
131658896|NCT01214642|474035469|FG011|Overall Study|Progressive Disease|4|||
131658897|NCT01214642|474035458|FG000|Overall Study|Adverse Event|0|||
131658898|NCT01214642|474035459|FG001|Overall Study|Adverse Event|1|||
131658899|NCT01214642|474035460|FG002|Overall Study|Adverse Event|0|||
131658900|NCT01214642|474035461|FG003|Overall Study|Adverse Event|0|||
131658901|NCT01214642|474035462|FG004|Overall Study|Adverse Event|0|||
131658902|NCT01214642|474035463|FG005|Overall Study|Adverse Event|0|||
131658903|NCT01214642|474035464|FG006|Overall Study|Adverse Event|1|||
131658904|NCT01214642|474035465|FG007|Overall Study|Adverse Event|0|||
131658905|NCT01214642|474035466|FG008|Overall Study|Adverse Event|0|||
131658906|NCT01214642|474035467|FG009|Overall Study|Adverse Event|1|||
131658907|NCT01214642|474035468|FG010|Overall Study|Adverse Event|1|||
131658908|NCT01214642|474035469|FG011|Overall Study|Adverse Event|0|||
131658909|NCT01214642|474035458|FG000|Overall Study|Death|0|||
131653401|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Progression|218|||
131717068|NCT02240706|474241189|FG005|Overall Study|Adverse Event|0|||
131653402|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
131653403|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
131653404|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
131653405|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
131653406|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
131653407|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
131653408|NCT01006980|474018352|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
131653409|NCT01006980|474018353|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
131653410|NCT01006980|474018352|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
131653411|NCT01006980|474018353|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
131653412|NCT01006980|474018352|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
131653413|NCT01006980|474018353|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
131653414|NCT01006980|474018352|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
131653415|NCT01006980|474018353|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
131653416|NCT01006980|474018352|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
131653417|NCT01006980|474018353|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
131653418|NCT01006980|474018352|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
131653419|NCT01006980|474018353|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
131653420|NCT02706405|474018362|FG000|Overall Study|Death|3|||
131653421|NCT02706405|474018363|FG001|Overall Study|Death|2|||
131653422|NCT02706405|474018364|FG002|Overall Study|Death|0|||
131653423|NCT02706405|474018365|FG003|Overall Study|Death|1|||
131653424|NCT02706405|474018366|FG004|Overall Study|Death|0|||
131653425|NCT02706405|474018367|FG005|Overall Study|Death|0|||
131653426|NCT02706405|474018368|FG006|Overall Study|Death|3|||
131653427|NCT02706405|474018369|FG007|Overall Study|Death|4|||
131653428|NCT02706405|474018362|FG000|Overall Study|Disease progression|0|||
131653429|NCT02706405|474018363|FG001|Overall Study|Disease progression|0|||
131653430|NCT02706405|474018364|FG002|Overall Study|Disease progression|0|||
131653431|NCT02706405|474018365|FG003|Overall Study|Disease progression|0|||
131653432|NCT02706405|474018366|FG004|Overall Study|Disease progression|0|||
131653433|NCT02706405|474018367|FG005|Overall Study|Disease progression|0|||
131653434|NCT02706405|474018368|FG006|Overall Study|Disease progression|0|||
131653435|NCT02706405|474018369|FG007|Overall Study|Disease progression|1|||
131653436|NCT02706405|474018362|FG000|Overall Study|Pt moved to new therapy|0|||
131653437|NCT02706405|474018363|FG001|Overall Study|Pt moved to new therapy|0|||
131653438|NCT02706405|474018364|FG002|Overall Study|Pt moved to new therapy|0|||
131653439|NCT02706405|474018365|FG003|Overall Study|Pt moved to new therapy|0|||
131653440|NCT02706405|474018366|FG004|Overall Study|Pt moved to new therapy|0|||
131653441|NCT02706405|474018367|FG005|Overall Study|Pt moved to new therapy|1|||
131653442|NCT02706405|474018368|FG006|Overall Study|Pt moved to new therapy|0|||
131653443|NCT02706405|474018369|FG007|Overall Study|Pt moved to new therapy|1|||
131653444|NCT02706405|474018362|FG000|Overall Study|Physician Decision|1|||
131653445|NCT02706405|474018363|FG001|Overall Study|Physician Decision|0|||
131653446|NCT02706405|474018364|FG002|Overall Study|Physician Decision|0|||
131653447|NCT02706405|474018365|FG003|Overall Study|Physician Decision|0|||
131653448|NCT02706405|474018366|FG004|Overall Study|Physician Decision|0|||
131653449|NCT02706405|474018367|FG005|Overall Study|Physician Decision|0|||
131653450|NCT02706405|474018368|FG006|Overall Study|Physician Decision|0|||
131653451|NCT02706405|474018369|FG007|Overall Study|Physician Decision|0|||
131653452|NCT01228318|474018370|FG000|Overall Study|Clinic no show to receive intervention|1|||
131653453|NCT01228318|474018371|FG001|Overall Study|Clinic no show to receive intervention|0|||
131653454|NCT01228318|474018370|FG000|Overall Study|Unable to contact|2|||
131653455|NCT01228318|474018371|FG001|Overall Study|Unable to contact|5|||
131653456|NCT01228318|474018370|FG000|Overall Study|Moved|0|||
131653457|NCT01228318|474018371|FG001|Overall Study|Moved|2|||
131653458|NCT01228318|474018370|FG000|Overall Study|Incarcerated|1|||
131653459|NCT01228318|474018371|FG001|Overall Study|Incarcerated|0|||
131653460|NCT01182441|474018372|FG000|Overall Study|Patient Still in Follow-up|152|||
131653461|NCT01182441|474018373|FG001|Overall Study|Patient Still in Follow-up|72|||
131653462|NCT01182441|474018372|FG000|Overall Study|Death|37|||
131653463|NCT01182441|474018373|FG001|Overall Study|Death|25|||
131717069|NCT02240706|474241190|FG006|Overall Study|Adverse Event|0|||
131717070|NCT02240706|474241184|FG000|Overall Study|Progressive disease|0|||
131717071|NCT02240706|474241185|FG001|Overall Study|Progressive disease|0|||
131717072|NCT02240706|474241186|FG002|Overall Study|Progressive disease|0|||
131717073|NCT02240706|474241187|FG003|Overall Study|Progressive disease|0|||
131717074|NCT02240706|474241188|FG004|Overall Study|Progressive disease|1|||
131717075|NCT02240706|474241189|FG005|Overall Study|Progressive disease|0|||
131717076|NCT02240706|474241190|FG006|Overall Study|Progressive disease|0|||
131717077|NCT02240706|474241184|FG000|Overall Study|Dose limiting toxicity|0|||
131717078|NCT02240706|474241185|FG001|Overall Study|Dose limiting toxicity|0|||
131717079|NCT02240706|474241186|FG002|Overall Study|Dose limiting toxicity|0|||
131717080|NCT02240706|474241187|FG003|Overall Study|Dose limiting toxicity|0|||
131717081|NCT02240706|474241188|FG004|Overall Study|Dose limiting toxicity|1|||
131653464|NCT01182441|474018372|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
131653465|NCT01182441|474018373|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
131653466|NCT01182441|474018372|FG000|Overall Study|Lost to Follow-up|5|||
131653467|NCT01182441|474018373|FG001|Overall Study|Lost to Follow-up|8|||
131717082|NCT02240706|474241189|FG005|Overall Study|Dose limiting toxicity|0|||
131653468|NCT01182441|474018372|FG000|Overall Study|Withdrawal by Subject|6|||
131653469|NCT01182441|474018373|FG001|Overall Study|Withdrawal by Subject|13|||
131653470|NCT01182441|474018372|FG000|Overall Study|Implant Not Attempted|4|||
131653471|NCT01182441|474018373|FG001|Overall Study|Implant Not Attempted|0|||
131653472|NCT01182441|474018372|FG000|Overall Study|Adverse Event|2|||
131653473|NCT01182441|474018373|FG001|Overall Study|Adverse Event|0|||
131653474|NCT01182441|474018372|FG000|Overall Study|Physician Decision|1|||
131653475|NCT01182441|474018373|FG001|Overall Study|Physician Decision|1|||
131653476|NCT04079868|474018374|FG000|Overall Study|Lost to Follow-up|100|||
131653477|NCT04079868|474018375|FG001|Overall Study|Lost to Follow-up|200|||
131653478|NCT04079868|474018374|FG000|Overall Study|Physician Decision|100|||
131653479|NCT04079868|474018375|FG001|Overall Study|Physician Decision|0|||
131653480|NCT05620108|474018380|FG000|Overall Study|Physician Decision|1|||
131653481|NCT05620108|474018381|FG001|Overall Study|Physician Decision|2|||
131653482|NCT04201288|474018385|FG000|Overall Study|Death|1|||
131653483|NCT04201288|474018386|FG001|Overall Study|Death|1|||
131653484|NCT04201288|474018385|FG000|Overall Study|Lost to Follow-up|5|||
131653485|NCT04201288|474018386|FG001|Overall Study|Lost to Follow-up|3|||
131653486|NCT04201288|474018385|FG000|Overall Study|Withdrawal by Subject|1|||
131653487|NCT04201288|474018386|FG001|Overall Study|Withdrawal by Subject|0|||
131653488|NCT02038842|474018387|FG000|Overall Study|Withdrawal by Subject|2|||
131717083|NCT02240706|474241190|FG006|Overall Study|Dose limiting toxicity|0|||
131717084|NCT02240706|474241184|FG000|Overall Study|Refused to continue taking medication|0|||
131717085|NCT02240706|474241185|FG001|Overall Study|Refused to continue taking medication|1|||
131717086|NCT02240706|474241186|FG002|Overall Study|Refused to continue taking medication|3|||
131717087|NCT02240706|474241187|FG003|Overall Study|Refused to continue taking medication|1|||
131717088|NCT02240706|474241188|FG004|Overall Study|Refused to continue taking medication|2|||
131717089|NCT02240706|474241189|FG005|Overall Study|Refused to continue taking medication|0|||
131717090|NCT02240706|474241190|FG006|Overall Study|Refused to continue taking medication|0|||
131717091|NCT02240706|474241184|FG000|Overall Study|Insurance billing concerns|0|||
131717092|NCT02240706|474241185|FG001|Overall Study|Insurance billing concerns|0|||
131717093|NCT02240706|474241186|FG002|Overall Study|Insurance billing concerns|0|||
131717094|NCT02240706|474241187|FG003|Overall Study|Insurance billing concerns|1|||
131717095|NCT02240706|474241188|FG004|Overall Study|Insurance billing concerns|0|||
131717096|NCT02240706|474241189|FG005|Overall Study|Insurance billing concerns|0|||
131717097|NCT02240706|474241190|FG006|Overall Study|Insurance billing concerns|0|||
131717098|NCT00613626|474241192|FG000|Overall Study|Ineligible|0|||
131717099|NCT00613626|474241193|FG001|Overall Study|Ineligible|1|||
131717100|NCT00613626|474241194|FG002|Overall Study|Ineligible|0|||
131717101|NCT02333227|474241195|FG000|Overall Study|Lost to Follow-up|137|||
131717102|NCT02333227|474241196|FG001|Overall Study|Lost to Follow-up|106|||
131717103|NCT02333227|474241195|FG000|Overall Study|Pregnancy Interrupted|42|||
131717104|NCT02333227|474241196|FG001|Overall Study|Pregnancy Interrupted|89|||
131717105|NCT02333227|474241195|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
131717106|NCT02333227|474241196|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
131717107|NCT03934684|474241197|FG000|Overall Study|Participants continuing in study|11|||
131717108|NCT03934684|474241198|FG001|Overall Study|Participants continuing in study|4|||
131717109|NCT03934684|474241197|FG000|Overall Study|Discontinuation of carfilzomib|20|||
131717110|NCT03934684|474241198|FG001|Overall Study|Discontinuation of carfilzomib|30|||
131717111|NCT03934684|474241197|FG000|Overall Study|Death|2|||
131717112|NCT03934684|474241198|FG001|Overall Study|Death|2|||
131717113|NCT03934684|474241197|FG000|Overall Study|Lost to Follow-up|2|||
131717114|NCT03934684|474241198|FG001|Overall Study|Lost to Follow-up|5|||
131717115|NCT03934684|474241197|FG000|Overall Study|Withdrawal by Subject|7|||
131717116|NCT03934684|474241198|FG001|Overall Study|Withdrawal by Subject|8|||
131717117|NCT01731002|474241199|FG000|Overall Study|Adverse Event|0|||
131717118|NCT01731002|474241200|FG001|Overall Study|Adverse Event|2|||
131717119|NCT01731002|474241201|FG002|Overall Study|Adverse Event|2|||
131717120|NCT01731002|474241199|FG000|Overall Study|Non-Compliant|0|||
131717121|NCT01731002|474241200|FG001|Overall Study|Non-Compliant|1|||
131717122|NCT01731002|474241201|FG002|Overall Study|Non-Compliant|0|||
131717123|NCT01731002|474241199|FG000|Overall Study|Lost to Follow-up|1|||
131717124|NCT01731002|474241200|FG001|Overall Study|Lost to Follow-up|0|||
131717125|NCT01731002|474241201|FG002|Overall Study|Lost to Follow-up|0|||
131717126|NCT01731002|474241199|FG000|Overall Study|Test Agent Discontinuation|0|||
131717127|NCT01731002|474241200|FG001|Overall Study|Test Agent Discontinuation|1|||
131717128|NCT01731002|474241201|FG002|Overall Study|Test Agent Discontinuation|0|||
131717129|NCT01731002|474241199|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
131448158|NCT03067077|473270884|FG001|Overall Study|Did not receive surgery|5|||
131717130|NCT01731002|474241200|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
131717131|NCT01731002|474241201|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
131717132|NCT01731002|474241199|FG000|Overall Study|Elevated IOP|1|||
131717133|NCT01731002|474241200|FG001|Overall Study|Elevated IOP|0|||
131717134|NCT01731002|474241201|FG002|Overall Study|Elevated IOP|0|||
131717135|NCT01731002|474241199|FG000|Overall Study|Inappropriate use of study medications|0|||
131717136|NCT01731002|474241200|FG001|Overall Study|Inappropriate use of study medications|0|||
131717137|NCT01731002|474241201|FG002|Overall Study|Inappropriate use of study medications|1|||
131717138|NCT03476239|474241202|FG000|Overall Study|Withdrawal by Subject|10|||
131717139|NCT03476239|474241202|FG000|Overall Study|Death|80|||
131717140|NCT03476239|474241202|FG000|Overall Study|Lost to Follow-up|8|||
131717141|NCT01446809|474241206|FG000|Overall Study|Adverse Event|0|||
131717142|NCT01446809|474241207|FG001|Overall Study|Adverse Event|0|||
131717143|NCT01446809|474241208|FG002|Overall Study|Adverse Event|1|||
131717144|NCT01446809|474241206|FG000|Overall Study|Failure to complete study procedures|0|||
131717145|NCT01446809|474241207|FG001|Overall Study|Failure to complete study procedures|0|||
131717146|NCT01446809|474241208|FG002|Overall Study|Failure to complete study procedures|1|||
131717147|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
131717148|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
131717149|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
131717150|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
131717151|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
131717152|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131717153|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131448159|NCT03067077|473270883|FG000|Overall Study|Lost to Follow-up|3|||
131717154|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131717155|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131717156|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
131717157|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131717158|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131717159|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131717160|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
131717161|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131717162|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
131717163|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
131717164|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
131717165|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
131717166|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
131717167|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
131717168|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
131717169|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
131717170|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
131717171|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
131717172|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
131717173|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
131717174|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
131717175|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
131717176|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
131717177|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
131717178|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
131717179|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
131717180|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
131717181|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
131717182|NCT00785577|474241209|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
131717183|NCT00785577|474241210|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
131717184|NCT00785577|474241211|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
131717185|NCT00785577|474241212|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
131717186|NCT00785577|474241213|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
131717187|NCT00785577|474241209|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131717188|NCT00785577|474241210|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131717189|NCT00785577|474241211|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131717190|NCT00785577|474241212|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
131717191|NCT00785577|474241213|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131717192|NCT00785577|474241209|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
131717193|NCT00785577|474241210|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
131717194|NCT00785577|474241211|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
131717195|NCT00785577|474241212|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
131717196|NCT00785577|474241213|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
131717197|NCT01682044|474241214|FG000|Overall Study|Death|1|||
131717198|NCT01682044|474241214|FG000|Overall Study|Progression|3|||
131717199|NCT01826214|474242130|FG000|Overall Study|Adverse Event|7|||
131717200|NCT01826214|474242131|FG001|Overall Study|Adverse Event|6|||
131717201|NCT01826214|474242130|FG000|Overall Study|Death|3|||
131717202|NCT01826214|474242131|FG001|Overall Study|Death|1|||
131717203|NCT01826214|474242130|FG000|Overall Study|Lost to Follow-up|1|||
131717204|NCT01826214|474242131|FG001|Overall Study|Lost to Follow-up|0|||
131717205|NCT01826214|474242130|FG000|Overall Study|Physician Decision|0|||
131717206|NCT01826214|474242131|FG001|Overall Study|Physician Decision|2|||
131717207|NCT01826214|474242130|FG000|Overall Study|Progressive disease|22|||
131717208|NCT01826214|474242131|FG001|Overall Study|Progressive disease|21|||
131804246|NCT03262012|474567064|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
131717209|NCT01826214|474242130|FG000|Overall Study|Study terminated by Sponsor|0|||
131717210|NCT01826214|474242131|FG001|Overall Study|Study terminated by Sponsor|1|||
131717211|NCT01826214|474242130|FG000|Overall Study|Subject/guardian decision|2|||
131717212|NCT01826214|474242131|FG001|Overall Study|Subject/guardian decision|3|||
131717213|NCT01614457|474242139|FG000|Overall Study|Non-Compliance|1|||
131717214|NCT01614457|474242140|FG001|Overall Study|Non-Compliance|0|||
131717215|NCT01614457|474242139|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
131717216|NCT01614457|474242140|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
131717217|NCT01756157|474242148|FG000|First Intervention Period|Withdrawal by Subject|1|||
131717218|NCT01756157|474242149|FG001|First Intervention Period|Withdrawal by Subject|0|||
131717219|NCT01756157|474242148|FG000|First Intervention Period|Lost to Follow-up|0|||
131717220|NCT01756157|474242149|FG001|First Intervention Period|Lost to Follow-up|2|||
131717221|NCT02799381|474242152|FG000|Overall Study|Withdrew consent|3|||
131717222|NCT02799381|474242153|FG001|Overall Study|Withdrew consent|2|||
131717223|NCT02799381|474242152|FG000|Overall Study|Adverse Event|0|||
131717224|NCT02799381|474242153|FG001|Overall Study|Adverse Event|1|||
131717225|NCT02799381|474242152|FG000|Overall Study|Participant did not take any study drug|1|||
131717226|NCT02799381|474242153|FG001|Overall Study|Participant did not take any study drug|0|||
131717227|NCT03368859|474242154|FG000|Overall Study|Withdrew Consent|5|||
131717228|NCT03368859|474242155|FG001|Overall Study|Withdrew Consent|4|||
131717229|NCT03368859|474242154|FG000|Overall Study|Death|12|||
131717230|NCT03368859|474242155|FG001|Overall Study|Death|6|||
131717231|NCT03368859|474242154|FG000|Overall Study|Study terminated by Sponsor|18|||
131717232|NCT03368859|474242155|FG001|Overall Study|Study terminated by Sponsor|23|||
131717233|NCT03368859|474242154|FG000|Overall Study|Other|1|||
131717234|NCT03368859|474242155|FG001|Overall Study|Other|1|||
131717235|NCT03952130|474242156|FG000|Overall Study|Adverse Event|0|||
131717236|NCT03952130|474242157|FG001|Overall Study|Adverse Event|1|||
131717237|NCT03952130|474242156|FG000|Overall Study|Lost to Follow-up|1|||
131717238|NCT03952130|474242157|FG001|Overall Study|Lost to Follow-up|0|||
131717239|NCT03952130|474242156|FG000|Overall Study|Withdrawal by Subject|1|||
131717240|NCT03952130|474242157|FG001|Overall Study|Withdrawal by Subject|5|||
131717241|NCT01713348|474242158|FG000|Overall Study|Withdrawal by Subject|3|||
131717242|NCT01713348|474242159|FG001|Overall Study|Withdrawal by Subject|2|||
131717243|NCT01713348|474242160|FG002|Overall Study|Withdrawal by Subject|2|||
131717244|NCT01713348|474242161|FG003|Overall Study|Withdrawal by Subject|0|||
131717245|NCT01713348|474242158|FG000|Overall Study|Lost to Follow-up|1|||
131717246|NCT01713348|474242159|FG001|Overall Study|Lost to Follow-up|0|||
131717247|NCT01713348|474242160|FG002|Overall Study|Lost to Follow-up|0|||
131717248|NCT01713348|474242161|FG003|Overall Study|Lost to Follow-up|0|||
131717249|NCT05882890|474242164|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
131717250|NCT01584024|474242165|FG000|Overall Study|Lost to Follow-up|10|||
131717251|NCT01584024|474242165|FG000|Overall Study|Withdrawal by Subject|3|||
131717252|NCT00613314|474242166|FG000|Overall Study|Adverse Event|5|||
131717253|NCT00613314|474242166|FG000|Overall Study|Protocol Violation|14|||
131717254|NCT00613314|474242166|FG000|Overall Study|Lost to Follow-up|46|||
131717255|NCT00613314|474242166|FG000|Overall Study|Other reason not defined above|90|||
131717256|NCT04723537|474242168|FG000|Overall Study|Withdrawal by Subject|3|||
131717257|NCT04723537|474242169|FG001|Overall Study|Withdrawal by Subject|0|||
131717258|NCT04723537|474242170|FG002|Overall Study|Withdrawal by Subject|0|||
131717259|NCT04723537|474242168|FG000|Overall Study|Physician Decision|0|||
131717260|NCT04723537|474242169|FG001|Overall Study|Physician Decision|0|||
131717261|NCT04723537|474242170|FG002|Overall Study|Physician Decision|1|||
131717262|NCT04723537|474242168|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
131717263|NCT04723537|474242169|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
131717264|NCT04723537|474242170|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
131717265|NCT02432807|474242171|FG000|Overall Study|Adverse Event|0|||
131717266|NCT02432807|474242172|FG001|Overall Study|Adverse Event|2|||
131717267|NCT02432807|474242171|FG000|Overall Study|Lost to Follow-up|1|||
131717268|NCT02432807|474242172|FG001|Overall Study|Lost to Follow-up|0|||
131717269|NCT02432807|474242171|FG000|Overall Study|Withdrawal by Subject|1|||
131717270|NCT02432807|474242172|FG001|Overall Study|Withdrawal by Subject|1|||
131717271|NCT02432807|474242171|FG000|Overall Study|Other|1|||
131717272|NCT02432807|474242172|FG001|Overall Study|Other|1|||
131717273|NCT01845025|474242173|FG000|Overall Study|Adverse Event|6|||
131717274|NCT01845025|474242174|FG001|Overall Study|Adverse Event|3|||
131717275|NCT01845025|474242173|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131717276|NCT01845025|474242174|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131717277|NCT01845025|474242173|FG000|Overall Study|Withdrawal by Subject|48|||
131717278|NCT01845025|474242174|FG001|Overall Study|Withdrawal by Subject|44|||
131717279|NCT01845025|474242173|FG000|Overall Study|Lost to Follow-up|13|||
131717280|NCT01845025|474242174|FG001|Overall Study|Lost to Follow-up|13|||
131717281|NCT01845025|474242173|FG000|Overall Study|Administrative problems|8|||
131717282|NCT01845025|474242174|FG001|Overall Study|Administrative problems|8|||
131717283|NCT01845025|474242173|FG000|Overall Study|Death|2|||
131717284|NCT01845025|474242174|FG001|Overall Study|Death|0|||
131717285|NCT01845025|474242173|FG000|Overall Study|Protocol deviation|3|||
131717286|NCT01845025|474242174|FG001|Overall Study|Protocol deviation|6|||
131717287|NCT01845025|474242173|FG000|Overall Study|Missing|1|||
131717288|NCT01845025|474242174|FG001|Overall Study|Missing|1|||
131717289|NCT01929083|474242180|FG000|Intervention 1|Lost to Follow-up|2|||
131717290|NCT01929083|474242181|FG001|Intervention 1|Lost to Follow-up|0|||
131717291|NCT01929083|474242180|FG000|Intervention 1|Nonadherent to study medications|1|||
131717292|NCT01929083|474242181|FG001|Intervention 1|Nonadherent to study medications|0|||
131717293|NCT01929083|474242180|FG000|Intervention 2|Adverse Event|0|||
131717294|NCT01929083|474242181|FG001|Intervention 2|Adverse Event|1|||
131717295|NCT00087438|474242183|FG000|Overall Study|Ineligible / No protocol treatment|4|||
131717296|NCT01931865|474242184|FG000|Overall Study|Lost to Follow-up|2|||
131717297|NCT01931865|474242184|FG000|Overall Study|Withdrawal by Subject|2|||
131717298|NCT00283387|474242185|FG000|First Intervention|Subject non-compliant|1|||
131717299|NCT00283387|474242186|FG001|First Intervention|Subject non-compliant|1|||
131717300|NCT00283387|474242185|FG000|First Intervention|Withdrawal by Subject|0|||
131717301|NCT00283387|474242186|FG001|First Intervention|Withdrawal by Subject|1|||
131717302|NCT00356915|474242194|FG000|Overall Study|Non compliance|1|||
131717303|NCT00356915|474242195|FG001|Overall Study|Non compliance|2|||
131717304|NCT00356915|474242196|FG002|Overall Study|Non compliance|1|||
131717305|NCT00356915|474242194|FG000|Overall Study|Protocol Violation|2|||
131717306|NCT00356915|474242195|FG001|Overall Study|Protocol Violation|3|||
131717307|NCT00356915|474242196|FG002|Overall Study|Protocol Violation|2|||
131717308|NCT00356915|474242194|FG000|Overall Study|Withdrawal by Subject|14|||
131717309|NCT00356915|474242195|FG001|Overall Study|Withdrawal by Subject|14|||
131717310|NCT00356915|474242196|FG002|Overall Study|Withdrawal by Subject|10|||
131717311|NCT00356915|474242194|FG000|Overall Study|Lack of Efficacy|0|||
131717312|NCT00356915|474242195|FG001|Overall Study|Lack of Efficacy|0|||
131717313|NCT00356915|474242196|FG002|Overall Study|Lack of Efficacy|3|||
131717314|NCT00356915|474242194|FG000|Overall Study|Lost to Follow-up|27|||
131717315|NCT00356915|474242195|FG001|Overall Study|Lost to Follow-up|34|||
131717316|NCT00356915|474242196|FG002|Overall Study|Lost to Follow-up|14|||
131717317|NCT00356915|474242194|FG000|Overall Study|Administrative Decision|0|||
131717318|NCT00356915|474242195|FG001|Overall Study|Administrative Decision|0|||
131717319|NCT00356915|474242196|FG002|Overall Study|Administrative Decision|1|||
131717320|NCT00356915|474242194|FG000|Overall Study|Physician Decision|0|||
131717321|NCT00356915|474242195|FG001|Overall Study|Physician Decision|2|||
131717322|NCT00356915|474242196|FG002|Overall Study|Physician Decision|0|||
131717323|NCT00356915|474242194|FG000|Overall Study|Adverse Event|21|||
131717324|NCT00356915|474242195|FG001|Overall Study|Adverse Event|31|||
131717325|NCT00356915|474242196|FG002|Overall Study|Adverse Event|8|||
131717326|NCT00356915|474242194|FG000|Overall Study|Miscellaneous reasons|11|||
131717327|NCT00356915|474242195|FG001|Overall Study|Miscellaneous reasons|8|||
131717328|NCT00356915|474242196|FG002|Overall Study|Miscellaneous reasons|3|||
131717329|NCT03953118|474242197|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
131717330|NCT03953118|474242198|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
131717331|NCT04003610|474242199|FG000|Overall Study|Lost to Follow-up|0|||
131717332|NCT04003610|474242200|FG001|Overall Study|Lost to Follow-up|1|||
131717333|NCT04003610|474242201|FG002|Overall Study|Lost to Follow-up|0|||
131717334|NCT04003610|474242199|FG000|Overall Study|Death|0|||
131717335|NCT04003610|474242200|FG001|Overall Study|Death|0|||
131717336|NCT04003610|474242201|FG002|Overall Study|Death|3|||
131717337|NCT04003610|474242199|FG000|Overall Study|Study Terminated by Sponsor|0|||
131717338|NCT04003610|474242200|FG001|Overall Study|Study Terminated by Sponsor|0|||
131717339|NCT04003610|474242201|FG002|Overall Study|Study Terminated by Sponsor|3|||
131717340|NCT03022461|474242204|FG000|Overall Study|Death|3|||
131717341|NCT00816036|474242205|FG000|Overall Study|Death|47|||
131717342|NCT00816036|474242206|FG001|Overall Study|Death|28|||
131804247|NCT03262012|474567065|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
131804248|NCT01469546|474567066|FG000|Received 5 mg Dose|Adverse Event|13|||
131804249|NCT01469546|474567066|FG000|Received 5 mg Dose|Death|2|||
131804250|NCT01469546|474567066|FG000|Received 5 mg Dose|Protocol Violation|2|||
131804251|NCT01469546|474567066|FG000|Received 5 mg Dose|Progressive Disease|3|||
131804252|NCT01469546|474567066|FG000|Received 5 mg Dose|Physician Decision|3|||
131804253|NCT02801877|474567069|FG000|Overall Study|Lost to Follow-up|1|||
131804254|NCT02801877|474567070|FG001|Overall Study|Lost to Follow-up|1|||
131804255|NCT02801877|474567071|FG002|Overall Study|Lost to Follow-up|2|||
131804256|NCT02801877|474567072|FG003|Overall Study|Lost to Follow-up|0|||
131804257|NCT02801877|474567069|FG000|Overall Study|Never Started Treatment|2|||
131804258|NCT02801877|474567070|FG001|Overall Study|Never Started Treatment|0|||
131804259|NCT02801877|474567071|FG002|Overall Study|Never Started Treatment|4|||
131804260|NCT02801877|474567072|FG003|Overall Study|Never Started Treatment|0|||
131804261|NCT00591630|474567073|FG000|Overall Study|Death|0|||
131717343|NCT00816036|474242205|FG000|Overall Study|Lost to Follow-up|75|||
131804262|NCT00591630|474567074|FG001|Overall Study|Death|0|||
131804263|NCT00591630|474567075|FG002|Overall Study|Death|1|||
131804264|NCT00591630|474567076|FG003|Overall Study|Death|0|||
131804265|NCT00154102|474567077|FG000|Overall Study|investigational study phase ongoing|7|||
131717344|NCT00816036|474242206|FG001|Overall Study|Lost to Follow-up|57|||
131717345|NCT00816036|474242205|FG000|Overall Study|Withdrawal by Subject|54|||
131717346|NCT00816036|474242206|FG001|Overall Study|Withdrawal by Subject|23|||
131717347|NCT01299025|474242207|FG000|Overall Study|Withdrawal by Subject|2|||
131717348|NCT01299025|474242208|FG001|Overall Study|Withdrawal by Subject|1|||
131717349|NCT01299025|474242207|FG000|Overall Study|Lost to Follow-up|1|||
131717350|NCT01299025|474242208|FG001|Overall Study|Lost to Follow-up|0|||
131717351|NCT01624194|474242209|FG000|Overall Study|Lost to Follow-up|1|||
131717352|NCT01624194|474242210|FG001|Overall Study|Lost to Follow-up|0|||
131717353|NCT01624194|474242209|FG000|Overall Study|Withdrawal by Subject|1|||
131717354|NCT01624194|474242210|FG001|Overall Study|Withdrawal by Subject|0|||
131717355|NCT03212261|474242211|FG000|Overall Study|Became ineligible d/t tech|2|||
131717356|NCT03212261|474242211|FG000|Overall Study|Tech Trouble- No first study visit|1|||
131717357|NCT03212261|474242211|FG000|Overall Study|Lost to Follow-up|7|||
131717358|NCT03212261|474242211|FG000|Overall Study|Family Emergency|1|||
131717359|NCT03212261|474242211|FG000|Overall Study|Too busy/ No time|5|||
131717360|NCT01076179|474242212|FG000|Overall Study|Withdrawal by Subject|1|||
131717361|NCT05480514|474242213|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
131717362|NCT05480514|474242214|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
131717363|NCT05480514|474242213|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
131717364|NCT05480514|474242214|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
131717365|NCT05480514|474242213|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131717366|NCT05480514|474242214|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
131717367|NCT05480514|474242213|FG000|Period 1|Covid-19 Related|1|||
131717368|NCT05480514|474242214|FG001|Period 1|Covid-19 Related|0|||
131717369|NCT05480514|474242213|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
131717370|NCT05480514|474242214|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
131717371|NCT04091217|474242215|FG000|Overall Study|Lost to Follow-up|2|||
131717372|NCT05662332|474242216|FG000|Overall Study|Death|3|||
131717373|NCT05662332|474242217|FG001|Overall Study|Death|3|||
131717374|NCT05662332|474242216|FG000|Overall Study|Lost to Follow-up|3|||
131717375|NCT05662332|474242217|FG001|Overall Study|Lost to Follow-up|8|||
131717376|NCT05662332|474242216|FG000|Overall Study|Physician Decision|1|||
131717377|NCT05662332|474242217|FG001|Overall Study|Physician Decision|2|||
131717378|NCT05662332|474242216|FG000|Overall Study|Protocol Deviation|2|||
131717379|NCT05662332|474242217|FG001|Overall Study|Protocol Deviation|1|||
131717380|NCT05662332|474242216|FG000|Overall Study|Withdrawal by Subject|14|||
131717381|NCT05662332|474242217|FG001|Overall Study|Withdrawal by Subject|14|||
131717382|NCT05662332|474242216|FG000|Overall Study|Assigned Treatment by Mistake|5|||
131717383|NCT05662332|474242217|FG001|Overall Study|Assigned Treatment by Mistake|7|||
131717384|NCT05662332|474242216|FG000|Overall Study|Non-compliance with study drug|4|||
131717385|NCT05662332|474242217|FG001|Overall Study|Non-compliance with study drug|1|||
131717386|NCT05662332|474242216|FG000|Overall Study|Due to Bariatric surgery|1|||
131717387|NCT05662332|474242217|FG001|Overall Study|Due to Bariatric surgery|0|||
131717388|NCT05662332|474242216|FG000|Overall Study|Subject Moving out of State|0|||
131717389|NCT05662332|474242217|FG001|Overall Study|Subject Moving out of State|1|||
131717390|NCT05662332|474242216|FG000|Overall Study|Subject Missed the Schedule|1|||
131717391|NCT05662332|474242217|FG001|Overall Study|Subject Missed the Schedule|0|||
131717392|NCT05662332|474242216|FG000|Overall Study|The Patient Moved to Another City|1|||
131717393|NCT05662332|474242217|FG001|Overall Study|The Patient Moved to Another City|0|||
131717394|NCT04885257|474242218|FG000|Overall Study|Withdrawal by Subject|1|||
131717395|NCT04885257|474242219|FG001|Overall Study|Withdrawal by Subject|0|||
131717396|NCT00256295|474242220|FG000|Overall Study|Withdrawal by Subject|3|||
131717397|NCT00256295|474242220|FG000|Overall Study|Death|1|||
131717398|NCT00628355|474242234|FG000|Overall Study|Withdrawal by Subject|1|||
131717399|NCT00628355|474242235|FG001|Overall Study|Withdrawal by Subject|1|||
131717400|NCT03542682|474242236|FG000|Overall Study|COVID-19 Protocol|0|||
131717401|NCT03542682|474242237|FG001|Overall Study|COVID-19 Protocol|1|||
131717402|NCT01659151|474242241|FG000|Overall Study|Inadequate TIL growth|1|||
131717403|NCT01901328|474242242|FG000|Overall Study|Lost to Follow-up|1|||
131904545|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
131717404|NCT01901328|474242243|FG001|Overall Study|Lost to Follow-up|0|||
131717405|NCT01901328|474242242|FG000|Overall Study|Physician Decision|0|||
131717406|NCT01901328|474242243|FG001|Overall Study|Physician Decision|1|||
131717407|NCT01901328|474242242|FG000|Overall Study|Protocol Violation|1|||
131904546|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
131904547|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
131717408|NCT01901328|474242243|FG001|Overall Study|Protocol Violation|1|||
131717409|NCT01901328|474242242|FG000|Overall Study|Study Terminated by Sponsor|19|||
131717410|NCT01901328|474242243|FG001|Overall Study|Study Terminated by Sponsor|16|||
131717411|NCT01901328|474242242|FG000|Overall Study|Withdrawal by Subject|1|||
131717412|NCT01901328|474242243|FG001|Overall Study|Withdrawal by Subject|2|||
131717413|NCT01901328|474242242|FG000|Overall Study|Lack of Efficacy|0|||
131717414|NCT01901328|474242243|FG001|Overall Study|Lack of Efficacy|1|||
131717415|NCT04865731|474242244|FG000|Overall Study|Physician Decision|2|||
131717416|NCT04865731|474242245|FG001|Overall Study|Physician Decision|1|||
131717417|NCT04865731|474242244|FG000|Overall Study|Adverse Event|1|||
131717418|NCT04865731|474242245|FG001|Overall Study|Adverse Event|0|||
131717419|NCT04865731|474242244|FG000|Overall Study|Withdrawal by Subject|0|||
131717420|NCT04865731|474242245|FG001|Overall Study|Withdrawal by Subject|1|||
131717421|NCT01672892|474243665|FG000|Overall Study|Protocol Violation|7|||
131717422|NCT01672892|474243666|FG001|Overall Study|Protocol Violation|3|||
131717423|NCT00942162|474243679|FG000|Overall Study|Death|45|||
131717424|NCT00942162|474243680|FG001|Overall Study|Death|35|||
131717425|NCT00942162|474243681|FG002|Overall Study|Death|0|||
131717426|NCT00942162|474243679|FG000|Overall Study|Withdrawal by Subject|7|||
131717427|NCT00942162|474243680|FG001|Overall Study|Withdrawal by Subject|2|||
131717428|NCT00942162|474243681|FG002|Overall Study|Withdrawal by Subject|0|||
131717429|NCT00942162|474243679|FG000|Overall Study|Lost to Follow-up|4|||
131717430|NCT00942162|474243680|FG001|Overall Study|Lost to Follow-up|0|||
131717431|NCT00942162|474243681|FG002|Overall Study|Lost to Follow-up|0|||
131717432|NCT00942162|474243679|FG000|Overall Study|Other|14|||
131717433|NCT00942162|474243680|FG001|Overall Study|Other|13|||
131717434|NCT00942162|474243681|FG002|Overall Study|Other|2|||
131717435|NCT01006356|474243682|FG000|Overall Study|Adverse Event|6|||
131717436|NCT01006356|474243682|FG000|Overall Study|Physician Decision|1|||
131717437|NCT01006356|474243682|FG000|Overall Study|Paticipants did not cooperate|6|||
131717438|NCT01006356|474243682|FG000|Overall Study|Withdrawal by Subject|1|||
131717439|NCT01006356|474243682|FG000|Overall Study|Choice by participants|2|||
131717440|NCT01006356|474243682|FG000|Overall Study|Protocol Violation|3|||
131717441|NCT01006356|474243682|FG000|Overall Study|Other|23|||
131717442|NCT02424539|474243690|FG000|Overall Study|Adverse Event|0|||
131717443|NCT02424539|474243691|FG001|Overall Study|Adverse Event|0|||
131717444|NCT02424539|474243692|FG002|Overall Study|Adverse Event|1|||
131717445|NCT02424539|474243690|FG000|Overall Study|Physician Decision|0|||
131717446|NCT02424539|474243691|FG001|Overall Study|Physician Decision|0|||
131717447|NCT02424539|474243692|FG002|Overall Study|Physician Decision|1|||
131717448|NCT02424539|474243690|FG000|Overall Study|Withdrawal by Subject|3|||
131717449|NCT02424539|474243691|FG001|Overall Study|Withdrawal by Subject|1|||
131804266|NCT00154102|474567078|FG001|Overall Study|investigational study phase ongoing|2|||
131804267|NCT01248247|474568473|FG000|Overall Study|Adverse Event|2|||
131804268|NCT01248247|474568474|FG001|Overall Study|Adverse Event|4|||
131804269|NCT01248247|474568475|FG002|Overall Study|Adverse Event|4|||
131804270|NCT01248247|474568476|FG003|Overall Study|Adverse Event|2|||
131804271|NCT01248247|474568473|FG000|Overall Study|Death|0|||
131804272|NCT01248247|474568474|FG001|Overall Study|Death|1|||
131804273|NCT01248247|474568475|FG002|Overall Study|Death|4|||
131904548|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
131904549|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
131904550|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
131717450|NCT02424539|474243692|FG002|Overall Study|Withdrawal by Subject|0|||
131717451|NCT02424539|474243690|FG000|Overall Study|Other: Reached stopping criteria|11|||
131717452|NCT02424539|474243691|FG001|Overall Study|Other: Reached stopping criteria|7|||
131717453|NCT02424539|474243692|FG002|Overall Study|Other: Reached stopping criteria|6|||
131717454|NCT04893265|474243693|FG000|Overall Study|Withdrawal by Subject|2|||
131717455|NCT04893265|474243694|FG001|Overall Study|Withdrawal by Subject|5|||
131717456|NCT04893265|474243693|FG000|Overall Study|Lost to Follow-up|0|||
131717457|NCT04893265|474243694|FG001|Overall Study|Lost to Follow-up|4|||
131717458|NCT03090191|474243699|FG000|Overall Study|Adverse Event|90|||
131717459|NCT03090191|474243700|FG001|Overall Study|Adverse Event|72|||
131717460|NCT03090191|474243699|FG000|Overall Study|Death|365|||
131717461|NCT03090191|474243700|FG001|Overall Study|Death|358|||
131717462|NCT03090191|474243699|FG000|Overall Study|Lost to Follow-up|382|||
131717463|NCT03090191|474243700|FG001|Overall Study|Lost to Follow-up|394|||
131717464|NCT03090191|474243699|FG000|Overall Study|Physician Decision|77|||
131717465|NCT03090191|474243700|FG001|Overall Study|Physician Decision|66|||
131717466|NCT03090191|474243699|FG000|Overall Study|Protocol Violation|43|||
131717467|NCT03090191|474243700|FG001|Overall Study|Protocol Violation|52|||
131717468|NCT03090191|474243699|FG000|Overall Study|Withdrawal by Subject|2160|||
131717469|NCT03090191|474243700|FG001|Overall Study|Withdrawal by Subject|2133|||
131804274|NCT01248247|474568476|FG003|Overall Study|Death|7|||
131804275|NCT01248247|474568473|FG000|Overall Study|Lost to Follow-up|0|||
131804276|NCT01248247|474568474|FG001|Overall Study|Lost to Follow-up|1|||
131904551|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
131904552|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
131904553|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
131904554|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
131904555|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
131904556|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
131904557|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
131904558|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
131904559|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
131904560|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
131904561|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
131904562|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
131904563|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
131904564|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
131904565|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
131904566|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
131904567|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
131904568|NCT01198002|474937012|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
131904569|NCT01198002|474937013|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
131717470|NCT03090191|474243699|FG000|Overall Study|Site terminated|7|||
131717471|NCT03090191|474243700|FG001|Overall Study|Site terminated|8|||
131717472|NCT03090191|474243699|FG000|Overall Study|Other|66|||
131717473|NCT03090191|474243700|FG001|Overall Study|Other|60|||
131717474|NCT03090191|474243699|FG000|Overall Study|Withdrawn before any study vaccination|43|||
131717475|NCT03090191|474243700|FG001|Overall Study|Withdrawn before any study vaccination|52|||
131717476|NCT01021007|474243706|FG000|Overall Study|Lost to Follow-up|1|||
131717477|NCT01021007|474243707|FG001|Overall Study|Lost to Follow-up|1|||
131904570|NCT01198002|474937014|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
131904571|NCT01198002|474937012|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
131904572|NCT01198002|474937013|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
131904573|NCT01198002|474937014|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
131904574|NCT01198002|474937012|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
131904575|NCT01198002|474937013|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
131904576|NCT01198002|474937014|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
131904577|NCT01198002|474937012|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
131904578|NCT01198002|474937013|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
131904579|NCT01198002|474937014|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
131904580|NCT01198002|474937012|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
131904581|NCT01198002|474937013|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
131904582|NCT01198002|474937014|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
131904583|NCT01198002|474937012|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
131904584|NCT01198002|474937013|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
131904585|NCT01198002|474937014|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
131904586|NCT01198002|474937012|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
131904587|NCT01198002|474937013|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
131904588|NCT01198002|474937014|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
131904589|NCT00789321|474937021|FG000|Overall Study|Adverse Event|0|||
131904590|NCT00789321|474937022|FG001|Overall Study|Adverse Event|1|||
131904591|NCT03652818|474937027|FG000|Overall Study|Adverse Event|1|||
131904592|NCT03652818|474937028|FG001|Overall Study|Adverse Event|0|||
131904593|NCT03652818|474937029|FG002|Overall Study|Adverse Event|0|||
131717478|NCT01021007|474243706|FG000|Overall Study|Adverse Event|1|||
131717479|NCT01021007|474243707|FG001|Overall Study|Adverse Event|3|||
131717480|NCT01697215|474243710|FG000|Overall Study|Physician Decision|5|||
131717481|NCT01697215|474243710|FG000|Overall Study|Malfunction|9|||
131717482|NCT01697215|474243710|FG000|Overall Study|CXR not available|9|||
131717483|NCT00900796|474243713|FG000|Phase 1|Lacked sufficient information|4|||
131717484|NCT00900796|474243713|FG000|Phase 1|Missing information at Week 16|7|||
131717485|NCT00900796|474243713|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
131717486|NCT00900796|474243713|FG000|Phase 2|Lost to Follow-up|5|||
131717487|NCT01829048|474243718|FG000|Overall Study|Withdrawal by Subject|0|||
131717488|NCT01829048|474243719|FG001|Overall Study|Withdrawal by Subject|0|||
131717489|NCT01829048|474243720|FG002|Overall Study|Withdrawal by Subject|0|||
131717490|NCT01829048|474243721|FG003|Overall Study|Withdrawal by Subject|2|||
131717491|NCT01829048|474243722|FG004|Overall Study|Withdrawal by Subject|0|||
131717492|NCT01121406|474243723|FG000|Overall Study|Progressive disease RECIST|44|||
131717493|NCT01121406|474243724|FG001|Overall Study|Progressive disease RECIST|28|||
131717494|NCT01121406|474243723|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
131717495|NCT01121406|474243724|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
131717496|NCT01121406|474243723|FG000|Overall Study|Other AE|3|||
131717497|NCT01121406|474243724|FG001|Overall Study|Other AE|10|||
131717498|NCT01121406|474243723|FG000|Overall Study|Non-compliant with protocol|0|||
131717499|NCT01121406|474243724|FG001|Overall Study|Non-compliant with protocol|2|||
131717500|NCT01121406|474243723|FG000|Overall Study|Lost to Follow-up|0|||
131717501|NCT01121406|474243724|FG001|Overall Study|Lost to Follow-up|1|||
131717502|NCT01121406|474243723|FG000|Overall Study|Refused continuation of study med.|1|||
131717503|NCT01121406|474243724|FG001|Overall Study|Refused continuation of study med.|2|||
131717504|NCT01121406|474243723|FG000|Overall Study|Reason other than specified above|2|||
131717505|NCT01121406|474243724|FG001|Overall Study|Reason other than specified above|6|||
131717506|NCT01121406|474243723|FG000|Overall Study|Not treated|1|||
131717507|NCT01121406|474243724|FG001|Overall Study|Not treated|0|||
131717508|NCT02504541|474243726|FG000|Overall Study|Adverse Event|4|||
131717509|NCT02504541|474243726|FG000|Overall Study|Withdrawal by Subject|4|||
131717510|NCT02504541|474243726|FG000|Overall Study|Lost to Follow-up|1|||
131717511|NCT02504541|474243726|FG000|Overall Study|Met Stopping Criteria|1|||
131717512|NCT02504541|474243726|FG000|Overall Study|Protocol Violation|2|||
131717513|NCT02504541|474243726|FG000|Overall Study|Termination by Sponsor|1|||
131717514|NCT02504541|474243726|FG000|Overall Study|Other|2|||
131717515|NCT02504541|474243726|FG000|Overall Study|Multiple|5|||
131717516|NCT00500071|474243727|FG000|Screening and Washout Phase|Protocol Violation|1|||
131717517|NCT00500071|474243727|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
131717518|NCT00500071|474243727|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
131717519|NCT00500071|474243727|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
131717520|NCT00500071|474243727|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
131717521|NCT00500071|474243727|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
131717522|NCT00500071|474243727|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
131717523|NCT03182738|474243736|FG000|Overall Study|Lost to Follow-up|9|||
131717524|NCT03182738|474243737|FG001|Overall Study|Lost to Follow-up|3|||
131717525|NCT03182738|474243736|FG000|Overall Study|Pregnancy|0|||
131717526|NCT03182738|474243737|FG001|Overall Study|Pregnancy|1|||
131717527|NCT03182738|474243736|FG000|Overall Study|Withdrawal by Subject|0|||
131717528|NCT03182738|474243737|FG001|Overall Study|Withdrawal by Subject|1|||
131717529|NCT01244737|474243738|FG000|Overall Study|Physician Decision|2|||
131717530|NCT01244737|474243739|FG001|Overall Study|Physician Decision|18|||
131717531|NCT01244737|474243740|FG002|Overall Study|Physician Decision|5|||
131717532|NCT01244737|474243738|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
131717533|NCT01244737|474243739|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
131717534|NCT01244737|474243740|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
131717535|NCT01244737|474243738|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
131717536|NCT01244737|474243739|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
131717537|NCT01244737|474243740|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
131717538|NCT01244737|474243738|FG000|Overall Study|MIB immunopathology results not available|3|||
131717539|NCT01244737|474243739|FG001|Overall Study|MIB immunopathology results not available|2|||
131717540|NCT01244737|474243740|FG002|Overall Study|MIB immunopathology results not available|0|||
131717541|NCT01244737|474243738|FG000|Overall Study|PET data failure|0|||
131717542|NCT01244737|474243739|FG001|Overall Study|PET data failure|1|||
131717543|NCT01244737|474243740|FG002|Overall Study|PET data failure|0|||
131717544|NCT01244737|474243738|FG000|Overall Study|Withdrawal by Subject|0|||
131717545|NCT01244737|474243739|FG001|Overall Study|Withdrawal by Subject|0|||
131717546|NCT01244737|474243740|FG002|Overall Study|Withdrawal by Subject|1|||
131717547|NCT02835495|474243742|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
131717548|NCT02835495|474243743|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
131717549|NCT02835495|474243742|FG000|Overall Study|Declined in-person follow-up visit|4|||
131717550|NCT02835495|474243743|FG001|Overall Study|Declined in-person follow-up visit|2|||
131717551|NCT00730236|474243744|FG000|Overall Study|Adverse Event|4|||
131717552|NCT00730236|474243744|FG000|Overall Study|Withdrawal by Subject|1|||
131717553|NCT00730236|474243744|FG000|Overall Study|Non-compliance|1|||
131717554|NCT01772134|474243749|FG000|Overall Study|Adverse Event|6|||
131717555|NCT01772134|474243750|FG001|Overall Study|Adverse Event|5|||
131717556|NCT01772134|474243751|FG002|Overall Study|Adverse Event|10|||
131717557|NCT01772134|474243749|FG000|Overall Study|Withdrew Consent|3|||
131804277|NCT01248247|474568475|FG002|Overall Study|Lost to Follow-up|1|||
131804278|NCT01248247|474568476|FG003|Overall Study|Lost to Follow-up|0|||
131804279|NCT01248247|474568473|FG000|Overall Study|Alternative treatment|0|||
131804280|NCT01248247|474568474|FG001|Overall Study|Alternative treatment|1|||
131717558|NCT01772134|474243750|FG001|Overall Study|Withdrew Consent|1|||
131717559|NCT01772134|474243751|FG002|Overall Study|Withdrew Consent|5|||
131717560|NCT01772134|474243749|FG000|Overall Study|Lost to Follow-up|2|||
131717561|NCT01772134|474243750|FG001|Overall Study|Lost to Follow-up|0|||
131717562|NCT01772134|474243751|FG002|Overall Study|Lost to Follow-up|0|||
131717563|NCT01772134|474243749|FG000|Overall Study|Protocol Deviation|4|||
131717564|NCT01772134|474243750|FG001|Overall Study|Protocol Deviation|3|||
131717565|NCT01772134|474243751|FG002|Overall Study|Protocol Deviation|3|||
131804281|NCT01248247|474568475|FG002|Overall Study|Alternative treatment|0|||
131717566|NCT01772134|474243749|FG000|Overall Study|Lack of Efficacy|11|||
131717567|NCT01772134|474243750|FG001|Overall Study|Lack of Efficacy|5|||
131717568|NCT01772134|474243751|FG002|Overall Study|Lack of Efficacy|3|||
131717569|NCT01772134|474243749|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
131717570|NCT01772134|474243750|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
131717571|NCT01772134|474243751|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
131717572|NCT01772134|474243749|FG000|Overall Study|Randomized Study Medication Not Received|2|||
131717573|NCT01772134|474243750|FG001|Overall Study|Randomized Study Medication Not Received|0|||
131717574|NCT01772134|474243751|FG002|Overall Study|Randomized Study Medication Not Received|1|||
131717575|NCT03486314|474243756|FG000|Part A|Adverse Event|1|||
131717576|NCT03486314|474243757|FG001|Part A|Adverse Event|0|||
131717577|NCT03486314|474243758|FG002|Part A|Adverse Event|0|||
131717578|NCT03486314|474243756|FG000|Part A|Symptomatic Deterioration|2|||
131717579|NCT03486314|474243757|FG001|Part A|Symptomatic Deterioration|0|||
131717580|NCT03486314|474243758|FG002|Part A|Symptomatic Deterioration|0|||
131717581|NCT03301857|474243760|FG000|Overall Study|Death|0|||
131717582|NCT03301857|474243761|FG001|Overall Study|Death|2|||
131717583|NCT03301857|474243760|FG000|Overall Study|Lost to Follow-up|4|||
131717584|NCT03301857|474243761|FG001|Overall Study|Lost to Follow-up|2|||
131717585|NCT03301857|474243760|FG000|Overall Study|Decision by Sponsor|6|||
131717586|NCT03301857|474243761|FG001|Overall Study|Decision by Sponsor|0|||
131717587|NCT03301857|474243760|FG000|Overall Study|Withdrawal by Subject|12|||
131717588|NCT03301857|474243761|FG001|Overall Study|Withdrawal by Subject|4|||
131717589|NCT00855439|474243766|FG000|Overall Study|Withdrawal by Subject|2|||
131717590|NCT00855439|474243767|FG001|Overall Study|Withdrawal by Subject|0|||
131717591|NCT00855439|474243766|FG000|Overall Study|Pregnancy|1|||
131717592|NCT00855439|474243767|FG001|Overall Study|Pregnancy|0|||
131717593|NCT05502289|474243768|FG000|Period 1|Out Of Window|1|||
131717594|NCT05502289|474243769|FG001|Period 1|Out Of Window|0|||
131717595|NCT00986349|474243780|FG000|Overall Study|Unsuccessful implant procedure|3|||
131717596|NCT00986349|474243780|FG000|Overall Study|Adverse Event|2|||
131717597|NCT00986349|474243780|FG000|Overall Study|Physician Decision|1|||
131717598|NCT00986349|474243780|FG000|Overall Study|device migration|1|||
131717599|NCT02299934|474243781|FG000|Overall Study|Termination of study|13|||
131717600|NCT00561353|474243782|FG000|Overall Study|Subject reached a virologic endpoint|2|||
131717601|NCT00561353|474243783|FG001|Overall Study|Subject reached a virologic endpoint|1|||
131717602|NCT00561353|474243784|FG002|Overall Study|Subject reached a virologic endpoint|1|||
131717603|NCT00561353|474243785|FG003|Overall Study|Subject reached a virologic endpoint|4|||
131717604|NCT00561353|474243786|FG004|Overall Study|Subject reached a virologic endpoint|1|||
131717605|NCT00561353|474243787|FG005|Overall Study|Subject reached a virologic endpoint|3|||
131717606|NCT00561353|474243788|FG006|Overall Study|Subject reached a virologic endpoint|4|||
131717607|NCT00561353|474243789|FG007|Overall Study|Subject reached a virologic endpoint|4|||
131717608|NCT00561353|474243790|FG008|Overall Study|Subject reached a virologic endpoint|5|||
131717609|NCT00561353|474243791|FG009|Overall Study|Subject reached a virologic endpoint|0|||
131717610|NCT00561353|474243782|FG000|Overall Study|Subject ineligible to continue the trial|0|||
131717611|NCT00561353|474243783|FG001|Overall Study|Subject ineligible to continue the trial|0|||
131717612|NCT00561353|474243784|FG002|Overall Study|Subject ineligible to continue the trial|0|||
131717613|NCT00561353|474243785|FG003|Overall Study|Subject ineligible to continue the trial|0|||
131717614|NCT00561353|474243786|FG004|Overall Study|Subject ineligible to continue the trial|0|||
131717615|NCT00561353|474243787|FG005|Overall Study|Subject ineligible to continue the trial|1|||
131717616|NCT00561353|474243788|FG006|Overall Study|Subject ineligible to continue the trial|1|||
131717617|NCT00561353|474243789|FG007|Overall Study|Subject ineligible to continue the trial|0|||
131717618|NCT00561353|474243790|FG008|Overall Study|Subject ineligible to continue the trial|2|||
131717619|NCT00561353|474243791|FG009|Overall Study|Subject ineligible to continue the trial|1|||
131717620|NCT00561353|474243782|FG000|Overall Study|Other|1|||
131717621|NCT00561353|474243783|FG001|Overall Study|Other|0|||
131717622|NCT00561353|474243784|FG002|Overall Study|Other|1|||
131717623|NCT00561353|474243785|FG003|Overall Study|Other|0|||
131717624|NCT00561353|474243786|FG004|Overall Study|Other|0|||
131717625|NCT00561353|474243787|FG005|Overall Study|Other|2|||
131717626|NCT00561353|474243788|FG006|Overall Study|Other|0|||
131717627|NCT00561353|474243789|FG007|Overall Study|Other|0|||
131717628|NCT00561353|474243790|FG008|Overall Study|Other|0|||
131717629|NCT00561353|474243791|FG009|Overall Study|Other|0|||
131717630|NCT00561353|474243782|FG000|Overall Study|Adverse Event|0|||
131717631|NCT00561353|474243783|FG001|Overall Study|Adverse Event|0|||
131717632|NCT00561353|474243784|FG002|Overall Study|Adverse Event|0|||
131717633|NCT00561353|474243785|FG003|Overall Study|Adverse Event|2|||
131717634|NCT00561353|474243786|FG004|Overall Study|Adverse Event|0|||
131717635|NCT00561353|474243787|FG005|Overall Study|Adverse Event|0|||
131448160|NCT03067077|473270884|FG001|Overall Study|Lost to Follow-up|2|||
131717636|NCT00561353|474243788|FG006|Overall Study|Adverse Event|1|||
131717637|NCT00561353|474243789|FG007|Overall Study|Adverse Event|0|||
131717638|NCT00561353|474243790|FG008|Overall Study|Adverse Event|0|||
131717639|NCT00561353|474243791|FG009|Overall Study|Adverse Event|1|||
131717640|NCT00561353|474243782|FG000|Overall Study|Lost to Follow-up|2|||
131717641|NCT00561353|474243783|FG001|Overall Study|Lost to Follow-up|0|||
131717642|NCT00561353|474243784|FG002|Overall Study|Lost to Follow-up|1|||
131717643|NCT00561353|474243785|FG003|Overall Study|Lost to Follow-up|0|||
131717644|NCT00561353|474243786|FG004|Overall Study|Lost to Follow-up|0|||
131717645|NCT00561353|474243787|FG005|Overall Study|Lost to Follow-up|0|||
131717646|NCT00561353|474243788|FG006|Overall Study|Lost to Follow-up|0|||
131717647|NCT00561353|474243789|FG007|Overall Study|Lost to Follow-up|0|||
131717648|NCT00561353|474243790|FG008|Overall Study|Lost to Follow-up|0|||
131717649|NCT00561353|474243791|FG009|Overall Study|Lost to Follow-up|0|||
131717650|NCT00561353|474243782|FG000|Overall Study|Withdrawal by Subject|0|||
131717651|NCT00561353|474243783|FG001|Overall Study|Withdrawal by Subject|2|||
131717652|NCT00561353|474243784|FG002|Overall Study|Withdrawal by Subject|0|||
131717653|NCT00561353|474243785|FG003|Overall Study|Withdrawal by Subject|0|||
131717654|NCT00561353|474243786|FG004|Overall Study|Withdrawal by Subject|0|||
131717655|NCT00561353|474243787|FG005|Overall Study|Withdrawal by Subject|0|||
131717656|NCT00561353|474243788|FG006|Overall Study|Withdrawal by Subject|0|||
131717657|NCT00561353|474243789|FG007|Overall Study|Withdrawal by Subject|0|||
131717658|NCT00561353|474243790|FG008|Overall Study|Withdrawal by Subject|0|||
131717659|NCT00561353|474243791|FG009|Overall Study|Withdrawal by Subject|0|||
131717660|NCT02117687|474243792|FG000|Overall Study|Lost to Follow-up|0|||
131717661|NCT02117687|474243793|FG001|Overall Study|Lost to Follow-up|1|||
131717662|NCT02117687|474243792|FG000|Overall Study|Adverse Event|0|||
131717663|NCT02117687|474243793|FG001|Overall Study|Adverse Event|2|||
131717664|NCT02117687|474243792|FG000|Overall Study|Other Reasons|1|||
131717665|NCT02117687|474243793|FG001|Overall Study|Other Reasons|1|||
131717666|NCT03232073|474243794|FG000|Overall Study|Death|1|||
131717667|NCT03232073|474243795|FG001|Overall Study|Death|0|||
131717668|NCT03232073|474243794|FG000|Overall Study|Adverse Event|7|||
131717669|NCT03232073|474243795|FG001|Overall Study|Adverse Event|12|||
131717670|NCT03232073|474243794|FG000|Overall Study|Lost to Follow-up|6|||
131717671|NCT03232073|474243795|FG001|Overall Study|Lost to Follow-up|6|||
131717672|NCT03232073|474243794|FG000|Overall Study|Lack of Efficacy|10|||
131717673|NCT03232073|474243795|FG001|Overall Study|Lack of Efficacy|8|||
131717674|NCT03232073|474243794|FG000|Overall Study|Physician Decision|9|||
131717675|NCT03232073|474243795|FG001|Overall Study|Physician Decision|2|||
131717676|NCT03232073|474243794|FG000|Overall Study|Withdrawal by Subject|54|||
131717677|NCT03232073|474243795|FG001|Overall Study|Withdrawal by Subject|39|||
131717678|NCT04909463|474245708|FG000|Overall Study|Withdrawal by Subject|0|||
131717679|NCT04909463|474245709|FG001|Overall Study|Withdrawal by Subject|1|||
131717680|NCT04909463|474245710|FG002|Overall Study|Withdrawal by Subject|0|||
131717681|NCT04909463|474245711|FG003|Overall Study|Withdrawal by Subject|0|||
131717682|NCT04909463|474245708|FG000|Overall Study|Lost to Follow-up|2|||
131717683|NCT04909463|474245709|FG001|Overall Study|Lost to Follow-up|1|||
131717684|NCT04909463|474245710|FG002|Overall Study|Lost to Follow-up|1|||
131717685|NCT04909463|474245711|FG003|Overall Study|Lost to Follow-up|0|||
131717686|NCT00853632|474245712|FG000|Overall Study|Death|88|||
131717687|NCT00853632|474245712|FG000|Overall Study|Withdrawal by Subject|45|||
131717688|NCT00853632|474245712|FG000|Overall Study|Lost to Follow-up|30|||
131717689|NCT00853632|474245712|FG000|Overall Study|Reoperation/Explant|17|||
131717690|NCT00853632|474245712|FG000|Overall Study|Exit with other reason|22|||
131717691|NCT00886821|474245713|FG000|Stage 2|Adverse Event|0|||
131717692|NCT00886821|474245714|FG001|Stage 2|Adverse Event|0|||
131717693|NCT00886821|474245715|FG002|Stage 2|Adverse Event|0|||
131717694|NCT00886821|474245716|FG003|Stage 2|Adverse Event|0|||
131717695|NCT00886821|474245717|FG004|Stage 2|Adverse Event|0|||
131717696|NCT00886821|474245718|FG005|Stage 2|Adverse Event|0|||
131717697|NCT00886821|474245719|FG006|Stage 2|Adverse Event|0|||
131717698|NCT00886821|474245720|FG007|Stage 2|Adverse Event|0|||
131717699|NCT00886821|474245721|FG008|Stage 2|Adverse Event|0|||
131717700|NCT00886821|474245722|FG009|Stage 2|Adverse Event|0|||
131717701|NCT00886821|474245723|FG010|Stage 2|Adverse Event|0|||
131717702|NCT00886821|474245724|FG011|Stage 2|Adverse Event|1|||
131717703|NCT00886821|474245725|FG012|Stage 2|Adverse Event|3|||
131717704|NCT00886821|474245726|FG013|Stage 2|Adverse Event|0|||
131717705|NCT00886821|474245713|FG000|Stage 2|Lost to Follow-up|0|||
131717706|NCT00886821|474245714|FG001|Stage 2|Lost to Follow-up|0|||
131717707|NCT00886821|474245715|FG002|Stage 2|Lost to Follow-up|0|||
131717708|NCT00886821|474245716|FG003|Stage 2|Lost to Follow-up|0|||
131717709|NCT00886821|474245717|FG004|Stage 2|Lost to Follow-up|0|||
131717710|NCT00886821|474245718|FG005|Stage 2|Lost to Follow-up|0|||
131717711|NCT00886821|474245719|FG006|Stage 2|Lost to Follow-up|0|||
131717712|NCT00886821|474245720|FG007|Stage 2|Lost to Follow-up|0|||
131717713|NCT00886821|474245721|FG008|Stage 2|Lost to Follow-up|0|||
131717714|NCT00886821|474245722|FG009|Stage 2|Lost to Follow-up|0|||
131717715|NCT00886821|474245723|FG010|Stage 2|Lost to Follow-up|0|||
131717716|NCT00886821|474245724|FG011|Stage 2|Lost to Follow-up|0|||
131717717|NCT00886821|474245725|FG012|Stage 2|Lost to Follow-up|2|||
131717718|NCT00886821|474245726|FG013|Stage 2|Lost to Follow-up|1|||
131717719|NCT00914628|474245727|FG000|Overall Study|Death|35|||
131717720|NCT00914628|474245728|FG001|Overall Study|Death|17|||
131717721|NCT00914628|474245727|FG000|Overall Study|Medical decision|4|||
131717722|NCT00914628|474245728|FG001|Overall Study|Medical decision|0|||
131717723|NCT00914628|474245727|FG000|Overall Study|Protocol Violation|1|||
131717724|NCT00914628|474245728|FG001|Overall Study|Protocol Violation|0|||
131717725|NCT00914628|474245727|FG000|Overall Study|Lack of Efficacy|1|||
131717726|NCT00914628|474245728|FG001|Overall Study|Lack of Efficacy|0|||
131717727|NCT00914628|474245727|FG000|Overall Study|non-randomized|1|||
131717728|NCT00914628|474245728|FG001|Overall Study|non-randomized|0|||
131717729|NCT00914628|474245727|FG000|Overall Study|Relapse|1|||
131717730|NCT00914628|474245728|FG001|Overall Study|Relapse|2|||
131717731|NCT00914628|474245727|FG000|Overall Study|Study terminated by Sponsor|14|||
131717732|NCT00914628|474245728|FG001|Overall Study|Study terminated by Sponsor|8|||
131717733|NCT00914628|474245727|FG000|Overall Study|Patients who did not receive a single dose|7|||
131717734|NCT00914628|474245728|FG001|Overall Study|Patients who did not receive a single dose|1|||
131904594|NCT03652818|474937030|FG003|Overall Study|Adverse Event|0|||
131717735|NCT03311126|474245729|FG000|Induction|Death|1|||
131904595|NCT03652818|474937031|FG004|Overall Study|Adverse Event|0|||
131717736|NCT03311126|474245729|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
131717737|NCT02579603|474245730|FG000|Overall Study|Not treated|1|||
131717738|NCT02579603|474245731|FG001|Overall Study|Not treated|0|||
131717739|NCT02579603|474245730|FG000|Overall Study|Adverse Event|2|||
131717740|NCT02579603|474245731|FG001|Overall Study|Adverse Event|2|||
131717741|NCT02579603|474245730|FG000|Overall Study|Other than stated|1|||
131717742|NCT02579603|474245731|FG001|Overall Study|Other than stated|0|||
131717743|NCT00469079|474245732|FG000|Overall Study|Lack of Efficacy|3|||
131717744|NCT00469079|474245733|FG001|Overall Study|Lack of Efficacy|8|||
131717745|NCT00469079|474245734|FG002|Overall Study|Lack of Efficacy|5|||
131717746|NCT00469079|474245732|FG000|Overall Study|Adverse Event|1|||
131717747|NCT00469079|474245733|FG001|Overall Study|Adverse Event|3|||
131717748|NCT00469079|474245734|FG002|Overall Study|Adverse Event|2|||
131717749|NCT00469079|474245732|FG000|Overall Study|Lost to Follow-up|4|||
131717750|NCT00469079|474245733|FG001|Overall Study|Lost to Follow-up|8|||
131717751|NCT00469079|474245734|FG002|Overall Study|Lost to Follow-up|10|||
131717752|NCT00469079|474245732|FG000|Overall Study|Withdrawal by Subject|1|||
131717753|NCT00469079|474245733|FG001|Overall Study|Withdrawal by Subject|2|||
131717754|NCT00469079|474245734|FG002|Overall Study|Withdrawal by Subject|2|||
131717755|NCT00469079|474245732|FG000|Overall Study|Ineligible|0|||
131717756|NCT00469079|474245733|FG001|Overall Study|Ineligible|1|||
131717757|NCT00469079|474245734|FG002|Overall Study|Ineligible|0|||
131717758|NCT01416181|474245735|FG000|Part 1|Other|10|||
131717759|NCT01416181|474245736|FG001|Part 1|Other|24|||
131717760|NCT01416181|474245735|FG000|Part 1|Death|0|||
131717761|NCT01416181|474245736|FG001|Part 1|Death|1|||
131717762|NCT01416181|474245735|FG000|Part 1|Investigator Decision|7|||
131717763|NCT01416181|474245736|FG001|Part 1|Investigator Decision|6|||
131717764|NCT01416181|474245735|FG000|Part 1|Withdrawal by Subject|74|||
131717765|NCT01416181|474245736|FG001|Part 1|Withdrawal by Subject|48|||
131717766|NCT01416181|474245735|FG000|Part 1|Lack of Efficacy|16|||
131717767|NCT01416181|474245736|FG001|Part 1|Lack of Efficacy|8|||
131717768|NCT01416181|474245735|FG000|Part 1|Lost to Follow-up|1|||
131717769|NCT01416181|474245736|FG001|Part 1|Lost to Follow-up|1|||
131717770|NCT01416181|474245735|FG000|Part 1|Adverse Event|15|||
131717771|NCT01416181|474245736|FG001|Part 1|Adverse Event|18|||
131717772|NCT01416181|474245735|FG000|Part 1|Ongoing in Follow-Up|14|||
131717773|NCT01416181|474245736|FG001|Part 1|Ongoing in Follow-Up|8|||
131717774|NCT01416181|474245735|FG000|Part 2|Adverse Event|11|||
131717775|NCT01416181|474245736|FG001|Part 2|Adverse Event|4|||
131717776|NCT01416181|474245735|FG000|Part 2|Other|234|||
131717777|NCT01416181|474245736|FG001|Part 2|Other|267|||
131717778|NCT01416181|474245735|FG000|Part 2|Investigator Decision|6|||
131717779|NCT01416181|474245736|FG001|Part 2|Investigator Decision|7|||
131717780|NCT01416181|474245735|FG000|Part 2|Withdrawal by Subject|14|||
131717781|NCT01416181|474245736|FG001|Part 2|Withdrawal by Subject|5|||
131717782|NCT01416181|474245735|FG000|Part 2|Lack of Efficacy|4|||
131717783|NCT01416181|474245736|FG001|Part 2|Lack of Efficacy|1|||
131717784|NCT01416181|474245735|FG000|Part 2|Lost to Follow-up|2|||
131717785|NCT01416181|474245736|FG001|Part 2|Lost to Follow-up|2|||
131717786|NCT02981472|474245737|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
131717787|NCT02981472|474245738|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
131717788|NCT02981472|474245737|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131717789|NCT02981472|474245738|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131717790|NCT02981472|474245737|FG000|Treatment Period|Adverse Event|6|||
131717791|NCT02981472|474245738|FG001|Treatment Period|Adverse Event|1|||
131717792|NCT02981472|474245737|FG000|Treatment Period|Participant withdrew consent|1|||
131717793|NCT02981472|474245738|FG001|Treatment Period|Participant withdrew consent|0|||
131904596|NCT03652818|474937027|FG000|Overall Study|Physician Decision|1|||
131904597|NCT03652818|474937028|FG001|Overall Study|Physician Decision|0|||
131904598|NCT03652818|474937029|FG002|Overall Study|Physician Decision|0|||
131904599|NCT03652818|474937030|FG003|Overall Study|Physician Decision|0|||
131904600|NCT03652818|474937031|FG004|Overall Study|Physician Decision|0|||
131904601|NCT03652818|474937027|FG000|Overall Study|Lost to Follow-up|0|||
131904602|NCT03652818|474937028|FG001|Overall Study|Lost to Follow-up|1|||
131904603|NCT03652818|474937029|FG002|Overall Study|Lost to Follow-up|2|||
131904604|NCT03652818|474937030|FG003|Overall Study|Lost to Follow-up|1|||
131904605|NCT03652818|474937031|FG004|Overall Study|Lost to Follow-up|1|||
131904606|NCT03964207|474937032|FG000|First Treatment|Withdrawal by Subject|1|||
131904607|NCT03964207|474937033|FG001|First Treatment|Withdrawal by Subject|2|||
131904608|NCT03964207|474937032|FG000|First Treatment|Protocol Violation|1|||
131717794|NCT02981472|474245737|FG000|Treatment Period|Lost to Follow-up|0|||
131717795|NCT02981472|474245738|FG001|Treatment Period|Lost to Follow-up|1|||
131717796|NCT02698410|474245739|FG000|Overall Study|Adverse Event|2|||
131717797|NCT02698410|474245739|FG000|Overall Study|Withdrawal by Subject|1|||
131717798|NCT02698410|474245739|FG000|Overall Study|Other|1|||
131717799|NCT00621023|474245741|FG000|Overall Study|Death|5|||
131717800|NCT00621023|474245741|FG000|Overall Study|Follow up discontinued|1|||
131717801|NCT04430348|474245752|FG000|Overall Study|Death|3|||
131717802|NCT04430348|474245753|FG001|Overall Study|Death|2|||
131717803|NCT04430348|474245754|FG002|Overall Study|Death|2|||
131717804|NCT04430348|474245755|FG003|Overall Study|Death|2|||
131717805|NCT04430348|474245756|FG004|Overall Study|Death|2|||
131717806|NCT04430348|474245757|FG005|Overall Study|Death|3|||
131717807|NCT04430348|474245752|FG000|Overall Study|Lost to Follow-up|0|||
131717808|NCT04430348|474245753|FG001|Overall Study|Lost to Follow-up|0|||
131717809|NCT04430348|474245754|FG002|Overall Study|Lost to Follow-up|0|||
131717810|NCT04430348|474245755|FG003|Overall Study|Lost to Follow-up|1|||
131717811|NCT04430348|474245756|FG004|Overall Study|Lost to Follow-up|0|||
131717812|NCT04430348|474245757|FG005|Overall Study|Lost to Follow-up|0|||
131717813|NCT04430348|474245752|FG000|Overall Study|Adverse Event|0|||
131717814|NCT04430348|474245753|FG001|Overall Study|Adverse Event|0|||
131717815|NCT04430348|474245754|FG002|Overall Study|Adverse Event|0|||
131717816|NCT04430348|474245755|FG003|Overall Study|Adverse Event|0|||
131717817|NCT04430348|474245756|FG004|Overall Study|Adverse Event|0|||
131717818|NCT04430348|474245757|FG005|Overall Study|Adverse Event|1|||
131717819|NCT04430348|474245752|FG000|Overall Study|Withdrawal by Subject|0|||
131717820|NCT04430348|474245753|FG001|Overall Study|Withdrawal by Subject|1|||
131717821|NCT04430348|474245754|FG002|Overall Study|Withdrawal by Subject|0|||
131717822|NCT04430348|474245755|FG003|Overall Study|Withdrawal by Subject|0|||
131717823|NCT04430348|474245756|FG004|Overall Study|Withdrawal by Subject|0|||
131717824|NCT04430348|474245757|FG005|Overall Study|Withdrawal by Subject|1|||
131717825|NCT04430348|474245752|FG000|Overall Study|Study Terminated by Sponsor|0|||
131717826|NCT04430348|474245753|FG001|Overall Study|Study Terminated by Sponsor|0|||
131717827|NCT04430348|474245754|FG002|Overall Study|Study Terminated by Sponsor|2|||
131717828|NCT04430348|474245755|FG003|Overall Study|Study Terminated by Sponsor|0|||
131717829|NCT04430348|474245756|FG004|Overall Study|Study Terminated by Sponsor|1|||
131717830|NCT04430348|474245757|FG005|Overall Study|Study Terminated by Sponsor|1|||
131717831|NCT02559505|474245758|FG000|Overall Study|Lost to Follow-up|23|||
131717832|NCT02559505|474245759|FG001|Overall Study|Lost to Follow-up|20|||
131717833|NCT02559505|474245758|FG000|Overall Study|Withdrawal by Subject|4|||
131717834|NCT02559505|474245759|FG001|Overall Study|Withdrawal by Subject|2|||
131717835|NCT00698516|474245760|FG000|Overall Study|Study Termination|2|||
131904609|NCT03964207|474937033|FG001|First Treatment|Protocol Violation|0|||
131904610|NCT03964207|474937032|FG000|First Treatment|Lost to Follow-up|1|||
131904611|NCT03964207|474937033|FG001|First Treatment|Lost to Follow-up|0|||
131717836|NCT00698516|474245760|FG000|Overall Study|Withdrawal by Subject|3|||
131717837|NCT04331899|474245770|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
131717838|NCT04331899|474245771|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
131717839|NCT00719810|474245774|FG000|Overall Study|Adverse Event|0|||
131717840|NCT00719810|474245775|FG001|Overall Study|Adverse Event|2|||
131717841|NCT00719810|474245776|FG002|Overall Study|Adverse Event|3|||
131717842|NCT00719810|474245774|FG000|Overall Study|Lost to Follow-up|2|||
131717843|NCT00719810|474245775|FG001|Overall Study|Lost to Follow-up|0|||
131804282|NCT01248247|474568476|FG003|Overall Study|Alternative treatment|0|||
131804283|NCT01248247|474568473|FG000|Overall Study|Other|2|||
131804284|NCT01248247|474568474|FG001|Overall Study|Other|8|||
131804285|NCT01248247|474568475|FG002|Overall Study|Other|8|||
131804286|NCT01248247|474568476|FG003|Overall Study|Other|5|||
131804287|NCT01248247|474568473|FG000|Overall Study|Progression|18|||
131804288|NCT01248247|474568474|FG001|Overall Study|Progression|27|||
131804289|NCT01248247|474568475|FG002|Overall Study|Progression|56|||
131804290|NCT01248247|474568476|FG003|Overall Study|Progression|44|||
131804291|NCT01248247|474568473|FG000|Overall Study|Refuse further treatment|0|||
131804292|NCT01248247|474568474|FG001|Overall Study|Refuse further treatment|0|||
131717844|NCT00719810|474245776|FG002|Overall Study|Lost to Follow-up|3|||
131717845|NCT00719810|474245774|FG000|Overall Study|Physician Decision|0|||
131717846|NCT00719810|474245775|FG001|Overall Study|Physician Decision|1|||
131717847|NCT00719810|474245776|FG002|Overall Study|Physician Decision|0|||
131717848|NCT00719810|474245774|FG000|Overall Study|Withdrawal by Subject|1|||
131717849|NCT00719810|474245775|FG001|Overall Study|Withdrawal by Subject|1|||
131717850|NCT00719810|474245776|FG002|Overall Study|Withdrawal by Subject|2|||
131717851|NCT00573131|474245779|FG000|Overall Study|Withdrawal by Subject|10|||
131717852|NCT00573131|474245780|FG001|Overall Study|Withdrawal by Subject|8|||
131717853|NCT00893789|474245781|FG000|Overall Study|Withdrawal by Subject|3|||
131717854|NCT00893789|474245782|FG001|Overall Study|Withdrawal by Subject|1|||
131717855|NCT00893789|474245783|FG002|Overall Study|Withdrawal by Subject|3|||
131717856|NCT00893789|474245784|FG003|Overall Study|Withdrawal by Subject|1|||
131717857|NCT00893789|474245781|FG000|Overall Study|Noncompliance With Study Drug|1|||
131717858|NCT00893789|474245782|FG001|Overall Study|Noncompliance With Study Drug|0|||
131717859|NCT00893789|474245783|FG002|Overall Study|Noncompliance With Study Drug|1|||
131717860|NCT00893789|474245784|FG003|Overall Study|Noncompliance With Study Drug|2|||
131717861|NCT00893789|474245781|FG000|Overall Study|Noncompliance With Study Procedures|1|||
131717862|NCT00893789|474245782|FG001|Overall Study|Noncompliance With Study Procedures|0|||
131717863|NCT00893789|474245783|FG002|Overall Study|Noncompliance With Study Procedures|0|||
131717864|NCT00893789|474245784|FG003|Overall Study|Noncompliance With Study Procedures|0|||
131717865|NCT00893789|474245781|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
131717866|NCT00893789|474245782|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
131717867|NCT00893789|474245783|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
131717868|NCT00893789|474245784|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
131717869|NCT00893789|474245781|FG000|Overall Study|Adverse Event|0|||
131717870|NCT00893789|474245782|FG001|Overall Study|Adverse Event|2|||
131717871|NCT00893789|474245783|FG002|Overall Study|Adverse Event|1|||
131717872|NCT00893789|474245784|FG003|Overall Study|Adverse Event|5|||
131717873|NCT00893789|474245781|FG000|Overall Study|Protocol Violation|0|||
131717874|NCT00893789|474245782|FG001|Overall Study|Protocol Violation|1|||
131717875|NCT00893789|474245783|FG002|Overall Study|Protocol Violation|1|||
131717876|NCT00893789|474245784|FG003|Overall Study|Protocol Violation|4|||
131717877|NCT00893789|474245781|FG000|Overall Study|Lost to Follow-up|0|||
131717878|NCT00893789|474245782|FG001|Overall Study|Lost to Follow-up|0|||
131717879|NCT00893789|474245783|FG002|Overall Study|Lost to Follow-up|0|||
131717880|NCT00893789|474245784|FG003|Overall Study|Lost to Follow-up|1|||
131717881|NCT02024464|474245785|FG000|Overall Study|Discontinued|5|||
131717882|NCT02024464|474245786|FG001|Overall Study|Discontinued|4|||
131717883|NCT02024464|474245785|FG000|Overall Study|Missed Visits|1|||
131717884|NCT02024464|474245786|FG001|Overall Study|Missed Visits|0|||
131717885|NCT02024464|474245785|FG000|Overall Study|Lost to Follow-up|4|||
131717886|NCT02024464|474245786|FG001|Overall Study|Lost to Follow-up|7|||
131804293|NCT01248247|474568475|FG002|Overall Study|Refuse further treatment|1|||
131804294|NCT01248247|474568476|FG003|Overall Study|Refuse further treatment|2|||
131804295|NCT01248247|474568473|FG000|Overall Study|Complicating disease|0|||
131804296|NCT01248247|474568474|FG001|Overall Study|Complicating disease|0|||
131804297|NCT01248247|474568475|FG002|Overall Study|Complicating disease|1|||
131804298|NCT01248247|474568476|FG003|Overall Study|Complicating disease|1|||
131804299|NCT04349917|474568479|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
131804300|NCT04349917|474568480|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
131804301|NCT04349917|474568479|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
131804302|NCT04349917|474568480|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
131717887|NCT05408858|474245791|FG000|Overall Study|no longer met eligibility criteria|1|||
131717888|NCT02037919|474245793|FG000|Overall Study|Lost to Follow-up|30|||
131717889|NCT02037919|474245794|FG001|Overall Study|Lost to Follow-up|45|||
131717890|NCT01973283|474245797|FG000|Overall Study|Lost to Follow-up|4|||
131717891|NCT03717922|474245805|FG000|Overall Study|Lost to Follow-up|2|||
131717892|NCT03717922|474245806|FG001|Overall Study|Lost to Follow-up|2|||
131717893|NCT02586805|474245812|FG000|Overall Study|Withdrawal by Subject|3|||
131804303|NCT00441467|474568481|FG000|Overall Study|Adverse Event|6|||
131804304|NCT00441467|474568481|FG000|Overall Study|Withdrawal by Subject|3|||
131804305|NCT00441467|474568481|FG000|Overall Study|Progressive disease|9|||
131717894|NCT02586805|474245813|FG001|Overall Study|Withdrawal by Subject|1|||
131717895|NCT02586805|474245814|FG002|Overall Study|Withdrawal by Subject|1|||
131717896|NCT02586805|474245815|FG003|Overall Study|Withdrawal by Subject|2|||
131717897|NCT02586805|474245812|FG000|Overall Study|Adverse Event|2|||
131717898|NCT02586805|474245813|FG001|Overall Study|Adverse Event|0|||
131717899|NCT02586805|474245814|FG002|Overall Study|Adverse Event|1|||
131717900|NCT02586805|474245815|FG003|Overall Study|Adverse Event|0|||
131717901|NCT02586805|474245812|FG000|Overall Study|Lost to Follow-up|0|||
131717902|NCT02586805|474245813|FG001|Overall Study|Lost to Follow-up|0|||
131717903|NCT02586805|474245814|FG002|Overall Study|Lost to Follow-up|1|||
131717904|NCT02586805|474245815|FG003|Overall Study|Lost to Follow-up|0|||
131717905|NCT02586805|474245812|FG000|Overall Study|Physician Decision|1|||
131717906|NCT02586805|474245813|FG001|Overall Study|Physician Decision|0|||
131717907|NCT02586805|474245814|FG002|Overall Study|Physician Decision|0|||
131717908|NCT02586805|474245815|FG003|Overall Study|Physician Decision|0|||
131717909|NCT01859403|474245816|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
131717910|NCT01859403|474245817|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
131717911|NCT01859403|474245816|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
131717912|NCT01859403|474245817|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
131717913|NCT01859403|474245816|FG000|Primary Endpoint Measure|Physician Decision|0|||
131717914|NCT01859403|474245817|FG001|Primary Endpoint Measure|Physician Decision|1|||
131717915|NCT01859403|474245816|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
131717916|NCT01859403|474245817|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
131717917|NCT01531725|474245819|FG000|Overall Study|Protocol Violation|5|||
131717918|NCT00472303|474245820|FG000|Titration Phase|Adverse Event|22|||
131717919|NCT00472303|474245821|FG001|Titration Phase|Adverse Event|12|||
131717920|NCT00472303|474245822|FG002|Titration Phase|Adverse Event|0|||
131717921|NCT00472303|474245820|FG000|Titration Phase|Death|4|||
131717922|NCT00472303|474245821|FG001|Titration Phase|Death|2|||
131717923|NCT00472303|474245822|FG002|Titration Phase|Death|0|||
131717924|NCT00472303|474245820|FG000|Titration Phase|Lack of Efficacy|10|||
131717925|NCT00472303|474245821|FG001|Titration Phase|Lack of Efficacy|0|||
131717926|NCT00472303|474245822|FG002|Titration Phase|Lack of Efficacy|0|||
131717927|NCT00472303|474245820|FG000|Titration Phase|Withdrawal by Subject|16|||
131717928|NCT00472303|474245821|FG001|Titration Phase|Withdrawal by Subject|13|||
131717929|NCT00472303|474245822|FG002|Titration Phase|Withdrawal by Subject|0|||
131717930|NCT00472303|474245820|FG000|Titration Phase|Trial Medication non-compliant|4|||
131717931|NCT00472303|474245821|FG001|Titration Phase|Trial Medication non-compliant|1|||
131717932|NCT00472303|474245822|FG002|Titration Phase|Trial Medication non-compliant|0|||
131717933|NCT00472303|474245820|FG000|Titration Phase|Other|3|||
131717934|NCT00472303|474245821|FG001|Titration Phase|Other|1|||
131717935|NCT00472303|474245822|FG002|Titration Phase|Other|0|||
131717936|NCT00472303|474245820|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
131717937|NCT00472303|474245821|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
131717938|NCT00472303|474245822|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
131717939|NCT00472303|474245820|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
131717940|NCT00472303|474245821|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
131717941|NCT00472303|474245822|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
131717942|NCT00472303|474245820|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
131717943|NCT00472303|474245821|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
131717944|NCT00472303|474245822|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
131653489|NCT02038842|474018388|FG001|Overall Study|Withdrawal by Subject|2|||
131653490|NCT02038842|474018389|FG002|Overall Study|Withdrawal by Subject|0|||
131653491|NCT02038842|474018390|FG003|Overall Study|Withdrawal by Subject|0|||
131653492|NCT02038842|474018387|FG000|Overall Study|Participant decision|0|||
131717945|NCT00472303|474245820|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
131717946|NCT00472303|474245821|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
131717947|NCT00472303|474245822|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
131717948|NCT00472303|474245820|FG000|Discontinuations After Titration Phase|Other|5|||
131717949|NCT00472303|474245821|FG001|Discontinuations After Titration Phase|Other|0|||
131717950|NCT00472303|474245822|FG002|Discontinuations After Titration Phase|Other|0|||
131717951|NCT00472303|474245820|FG000|Maintenance Phase|Adverse Event|5|||
131717952|NCT00472303|474245821|FG001|Maintenance Phase|Adverse Event|6|||
131717953|NCT00472303|474245822|FG002|Maintenance Phase|Adverse Event|6|||
131717954|NCT00472303|474245820|FG000|Maintenance Phase|Death|3|||
131717955|NCT00472303|474245821|FG001|Maintenance Phase|Death|0|||
131804306|NCT01042522|474568482|FG000|Overall Study|Adverse Event|1|||
131804307|NCT01042522|474568483|FG001|Overall Study|Adverse Event|2|||
131804308|NCT01042522|474568482|FG000|Overall Study|Disease Progression|5|||
131653493|NCT02038842|474018388|FG001|Overall Study|Participant decision|0|||
131653494|NCT02038842|474018389|FG002|Overall Study|Participant decision|2|||
131653495|NCT02038842|474018390|FG003|Overall Study|Participant decision|1|||
131653496|NCT02038842|474018387|FG000|Overall Study|Adverse Event|0|||
131653497|NCT02038842|474018388|FG001|Overall Study|Adverse Event|0|||
131717956|NCT00472303|474245822|FG002|Maintenance Phase|Death|2|||
131653498|NCT02038842|474018389|FG002|Overall Study|Adverse Event|3|||
131653499|NCT02038842|474018390|FG003|Overall Study|Adverse Event|1|||
131653500|NCT02038842|474018387|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
131653501|NCT02038842|474018388|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
131653502|NCT02038842|474018389|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
131653503|NCT02038842|474018390|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
131653504|NCT03412773|474018391|FG000|Overall Study|Lost to Follow-up|0|||
131653505|NCT03412773|474018392|FG001|Overall Study|Lost to Follow-up|7|||
131717957|NCT00472303|474245820|FG000|Maintenance Phase|Lack of Efficacy|2|||
131717958|NCT00472303|474245821|FG001|Maintenance Phase|Lack of Efficacy|2|||
131653506|NCT03412773|474018393|FG002|Overall Study|Lost to Follow-up|6|||
131653507|NCT03412773|474018391|FG000|Overall Study|Withdrawal by Subject|0|||
131653508|NCT03412773|474018392|FG001|Overall Study|Withdrawal by Subject|15|||
131717959|NCT00472303|474245822|FG002|Maintenance Phase|Lack of Efficacy|4|||
131717960|NCT00472303|474245820|FG000|Maintenance Phase|Withdrawal by Subject|6|||
131717961|NCT00472303|474245821|FG001|Maintenance Phase|Withdrawal by Subject|7|||
131717962|NCT00472303|474245822|FG002|Maintenance Phase|Withdrawal by Subject|3|||
131717963|NCT00472303|474245820|FG000|Maintenance Phase|Trial medication non-compliant|0|||
131717964|NCT00472303|474245821|FG001|Maintenance Phase|Trial medication non-compliant|0|||
131717965|NCT00472303|474245822|FG002|Maintenance Phase|Trial medication non-compliant|1|||
131717966|NCT00472303|474245820|FG000|Maintenance Phase|Resolution of pain|0|||
131717967|NCT00472303|474245821|FG001|Maintenance Phase|Resolution of pain|0|||
131717968|NCT00472303|474245822|FG002|Maintenance Phase|Resolution of pain|1|||
131717969|NCT00472303|474245820|FG000|Maintenance Phase|Other|1|||
131717970|NCT00472303|474245821|FG001|Maintenance Phase|Other|1|||
131717971|NCT00472303|474245822|FG002|Maintenance Phase|Other|0|||
131717972|NCT03459040|474245832|FG000|Overall Study|Death|8|||
131717973|NCT03459040|474245832|FG000|Overall Study|Withdrawal by Subject|1|||
131717974|NCT01273818|474245833|FG000|Overall Study|Physician Decision|13|||
131717975|NCT01273818|474245834|FG001|Overall Study|Physician Decision|2|||
131717976|NCT01273818|474245835|FG002|Overall Study|Physician Decision|9|||
131717977|NCT03815175|474245836|FG000|Overall Study|Subject Lost to Follow-up|6|||
131717978|NCT03815175|474245836|FG000|Overall Study|Subject Withdrew Consent|48|||
131717979|NCT03815175|474245836|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
131717980|NCT03815175|474245836|FG000|Overall Study|Death|86|||
131717981|NCT03815175|474245836|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
131717982|NCT03815175|474245836|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
131717983|NCT03815175|474245836|FG000|Overall Study|Other Status Change Reason|1|||
131717984|NCT03815175|474245836|FG000|Overall Study|Missed Visit|12|||
131717985|NCT01259466|474245839|FG000|Overall Study|Withdrawal by Subject|1|||
131717986|NCT01259466|474245840|FG001|Overall Study|Withdrawal by Subject|9|||
131717987|NCT05300087|474245843|FG000|Overall Study|Withdrawal by Subject|0|||
131717988|NCT05300087|474245844|FG001|Overall Study|Withdrawal by Subject|1|||
131717989|NCT03248128|474245845|FG000|Overall Study|Lost to Follow-up|1|||
131717990|NCT03248128|474245846|FG001|Overall Study|Lost to Follow-up|0|||
131717991|NCT03248128|474245845|FG000|Overall Study|Withdrawal by Subject|16|||
131717992|NCT03248128|474245846|FG001|Overall Study|Withdrawal by Subject|14|||
131717993|NCT03248128|474245845|FG000|Overall Study|Site Closed|4|||
131717994|NCT03248128|474245846|FG001|Overall Study|Site Closed|3|||
131717995|NCT03248128|474245845|FG000|Overall Study|Randomized, but did not receive treatment|1|||
131717996|NCT03248128|474245846|FG001|Overall Study|Randomized, but did not receive treatment|3|||
131717997|NCT01914679|474245847|FG000|Overall Study|Lack of Efficacy|1|||
131717998|NCT01914679|474245847|FG000|Overall Study|Sponsor terminated study|4|||
131717999|NCT02722044|474245848|FG000|Overall Study|Adverse Event|2|||
131718000|NCT02722044|474245848|FG000|Overall Study|Physician Decision|1|||
131718001|NCT02722044|474245848|FG000|Overall Study|Withdrawal by Subject|1|||
131718002|NCT02722044|474245848|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
131718003|NCT00457639|474245849|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
131718004|NCT00457639|474245850|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
131718005|NCT00457639|474245849|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
131718006|NCT00457639|474245850|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
131718007|NCT00457639|474245849|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
131718008|NCT00457639|474245850|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
131718009|NCT00002850|474245851|FG000|Overall Study|Death|4|||
131718010|NCT00002850|474245852|FG001|Overall Study|Death|1|||
131718011|NCT00002850|474245853|FG002|Overall Study|Death|3|||
131718012|NCT00002850|474245851|FG000|Overall Study|Protocol Violation|1|||
131718013|NCT00002850|474245852|FG001|Overall Study|Protocol Violation|0|||
131718014|NCT00002850|474245853|FG002|Overall Study|Protocol Violation|1|||
131718015|NCT00002850|474245851|FG000|Overall Study|Withdrawal by Subject|0|||
131718016|NCT00002850|474245852|FG001|Overall Study|Withdrawal by Subject|1|||
131718017|NCT00002850|474245853|FG002|Overall Study|Withdrawal by Subject|0|||
131718018|NCT03528681|474247575|FG000|Open-Label Phase|Physician Decision|2|||
131718019|NCT03528681|474247576|FG001|Open-Label Phase|Physician Decision|0|||
131718020|NCT03528681|474247577|FG002|Open-Label Phase|Physician Decision|0|||
131718021|NCT03528681|474247578|FG003|Open-Label Phase|Physician Decision|0|||
131718022|NCT03528681|474247575|FG000|Open-Label Phase|Withdrawal by Subject|8|||
131718023|NCT03528681|474247576|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131718024|NCT03528681|474247577|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131718025|NCT03528681|474247578|FG003|Open-Label Phase|Withdrawal by Subject|0|||
131718026|NCT03528681|474247575|FG000|Open-Label Phase|(Not collected)|4|||
131718027|NCT03528681|474247576|FG001|Open-Label Phase|(Not collected)|0|||
131718028|NCT03528681|474247577|FG002|Open-Label Phase|(Not collected)|0|||
131718029|NCT03528681|474247578|FG003|Open-Label Phase|(Not collected)|0|||
131718030|NCT03528681|474247575|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
131718031|NCT03528681|474247576|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
131718032|NCT03528681|474247577|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
131718033|NCT03528681|474247578|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
131718034|NCT03528681|474247575|FG000|Randomized Treatment Phase|Physician Decision|0|||
131718035|NCT03528681|474247576|FG001|Randomized Treatment Phase|Physician Decision|5|||
131718036|NCT03528681|474247577|FG002|Randomized Treatment Phase|Physician Decision|1|||
131718037|NCT03528681|474247578|FG003|Randomized Treatment Phase|Physician Decision|2|||
131718038|NCT03528681|474247575|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
131718039|NCT03528681|474247576|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
131718040|NCT03528681|474247577|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
131718041|NCT03528681|474247578|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
131718042|NCT03528681|474247575|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
131718043|NCT03528681|474247576|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
131718044|NCT03528681|474247577|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
131718045|NCT03528681|474247578|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
131718046|NCT03528681|474247575|FG000|Randomized Treatment Phase|(Not collected)|0|||
131718047|NCT03528681|474247576|FG001|Randomized Treatment Phase|(Not collected)|4|||
131718048|NCT03528681|474247577|FG002|Randomized Treatment Phase|(Not collected)|6|||
131718049|NCT03528681|474247578|FG003|Randomized Treatment Phase|(Not collected)|5|||
131718050|NCT00955110|474247579|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
131718051|NCT00955110|474247579|FG000|Treatment Phase|Adverse Event|2|||
131718052|NCT00955110|474247579|FG000|Treatment Phase|Administrative reasons|2|||
131718053|NCT00955110|474247579|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
131718054|NCT00955110|474247579|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
131718055|NCT00504257|474247590|FG000|Overall Study|Withdrawal by Subject|2|||
131718056|NCT00504257|474247590|FG000|Overall Study|ineligible histology|2|||
131718057|NCT02750410|474247591|FG000|Double-Blind Treatment Period|Adverse Event|2|||
131718058|NCT02750410|474247592|FG001|Double-Blind Treatment Period|Adverse Event|2|||
131718059|NCT02750410|474247591|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131718060|NCT02750410|474247592|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131718061|NCT02750410|474247591|FG000|Open-Label Extension Period|Adverse Event|5|||
131718062|NCT02750410|474247592|FG001|Open-Label Extension Period|Adverse Event|3|||
131718063|NCT02750410|474247591|FG000|Open-Label Extension Period|Protocol Violation|0|||
131718064|NCT02750410|474247592|FG001|Open-Label Extension Period|Protocol Violation|1|||
131718065|NCT02750410|474247591|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
131718066|NCT02750410|474247592|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
131718067|NCT02317510|474247593|FG000|Overall Study|Adverse Event|0|||
131718068|NCT02317510|474247594|FG001|Overall Study|Adverse Event|1|||
131718069|NCT01238120|474247595|FG000|Overall Study|Withdrawal by Subject|4|||
131718070|NCT01238120|474247596|FG001|Overall Study|Withdrawal by Subject|1|||
131718071|NCT01238120|474247597|FG002|Overall Study|Withdrawal by Subject|2|||
131718072|NCT01238120|474247598|FG003|Overall Study|Withdrawal by Subject|5|||
131718073|NCT01238120|474247595|FG000|Overall Study|Lost to Follow-up|2|||
131718074|NCT01238120|474247596|FG001|Overall Study|Lost to Follow-up|0|||
131718075|NCT01238120|474247597|FG002|Overall Study|Lost to Follow-up|1|||
131718076|NCT01238120|474247598|FG003|Overall Study|Lost to Follow-up|1|||
131718077|NCT01238120|474247595|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
131718078|NCT01238120|474247596|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
131718079|NCT01238120|474247597|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
131718080|NCT01238120|474247598|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
131718081|NCT03596164|474247600|FG000|Overall Study|Adverse Event|0|||
131718082|NCT03596164|474247601|FG001|Overall Study|Adverse Event|1|||
131718083|NCT03596164|474247600|FG000|Overall Study|Death|1|||
131718084|NCT03596164|474247601|FG001|Overall Study|Death|0|||
131718085|NCT04112914|474247602|FG000|Overall Study|Lost to Follow-up|13|||
131718086|NCT04112914|474247603|FG001|Overall Study|Lost to Follow-up|9|||
131718087|NCT04112914|474247602|FG000|Overall Study|Withdrawal by Subject|1|||
131718088|NCT04112914|474247603|FG001|Overall Study|Withdrawal by Subject|0|||
131718089|NCT03427073|474247604|FG000|Overall Study|Disease Progression|1|||
131718090|NCT03427073|474247605|FG001|Overall Study|Disease Progression|1|||
131718091|NCT03427073|474247606|FG002|Overall Study|Disease Progression|1|||
131718092|NCT03427073|474247607|FG003|Overall Study|Disease Progression|3|||
131718093|NCT03427073|474247608|FG004|Overall Study|Disease Progression|3|||
131718094|NCT03427073|474247609|FG005|Overall Study|Disease Progression|4|||
131718095|NCT03427073|474247610|FG006|Overall Study|Disease Progression|2|||
131718096|NCT03427073|474247611|FG007|Overall Study|Disease Progression|3|||
131718097|NCT03427073|474247604|FG000|Overall Study|Physician Decision|0|||
131718098|NCT03427073|474247605|FG001|Overall Study|Physician Decision|0|||
131718099|NCT03427073|474247606|FG002|Overall Study|Physician Decision|0|||
131718100|NCT03427073|474247607|FG003|Overall Study|Physician Decision|0|||
131718101|NCT03427073|474247608|FG004|Overall Study|Physician Decision|0|||
131718102|NCT03427073|474247609|FG005|Overall Study|Physician Decision|0|||
131718103|NCT03427073|474247610|FG006|Overall Study|Physician Decision|1|||
131718104|NCT03427073|474247611|FG007|Overall Study|Physician Decision|1|||
131718105|NCT01486238|474247614|FG000|Overall Study|Death|0|||
131718106|NCT01486238|474247615|FG001|Overall Study|Death|2|||
131718107|NCT01486238|474247614|FG000|Overall Study|Withdrawal by Subject|2|||
131718108|NCT01486238|474247615|FG001|Overall Study|Withdrawal by Subject|1|||
131718109|NCT01486238|474247614|FG000|Overall Study|Lost to Follow-up|0|||
131718110|NCT01486238|474247615|FG001|Overall Study|Lost to Follow-up|3|||
131718111|NCT02318602|474247618|FG000|Overall Study|Adverse Event|0|||
131718112|NCT02318602|474247619|FG001|Overall Study|Adverse Event|1|||
131718113|NCT02318602|474247620|FG002|Overall Study|Adverse Event|1|||
131718114|NCT02318602|474247618|FG000|Overall Study|Withdrawal by Subject|0|||
131718115|NCT02318602|474247619|FG001|Overall Study|Withdrawal by Subject|3|||
131718116|NCT02318602|474247620|FG002|Overall Study|Withdrawal by Subject|0|||
131718117|NCT02318602|474247618|FG000|Overall Study|Death|1|||
131718118|NCT02318602|474247619|FG001|Overall Study|Death|0|||
131718119|NCT02318602|474247620|FG002|Overall Study|Death|0|||
131718120|NCT02318602|474247618|FG000|Overall Study|Guardian decision to withdraw|0|||
131718121|NCT02318602|474247619|FG001|Overall Study|Guardian decision to withdraw|0|||
131718122|NCT02318602|474247620|FG002|Overall Study|Guardian decision to withdraw|1|||
131718123|NCT00693706|474247621|FG000|Overall Study|Protocol Violation|0|||
131718124|NCT00693706|474247622|FG001|Overall Study|Protocol Violation|1|||
131718125|NCT01873950|474247623|FG000|Period 5|Withdrawal by Subject|0|||
131718126|NCT01873950|474247624|FG001|Period 5|Withdrawal by Subject|0|||
131718127|NCT01873950|474247625|FG002|Period 5|Withdrawal by Subject|0|||
131718128|NCT01873950|474247626|FG003|Period 5|Withdrawal by Subject|1|||
131718129|NCT01873950|474247627|FG004|Period 5|Withdrawal by Subject|0|||
131718130|NCT05421754|474247628|FG000|Overall Study|Technical issue with sensor|1|||
131718131|NCT02580058|474247630|FG000|Overall Study|Adverse Event|16|||
131718132|NCT02580058|474247631|FG001|Overall Study|Adverse Event|30|||
131718133|NCT02580058|474247632|FG002|Overall Study|Adverse Event|20|||
131718134|NCT02580058|474247630|FG000|Overall Study|Death|4|||
131718135|NCT02580058|474247631|FG001|Overall Study|Death|4|||
131718136|NCT02580058|474247632|FG002|Overall Study|Death|5|||
131718137|NCT02580058|474247630|FG000|Overall Study|Physician Decision|1|||
131718138|NCT02580058|474247631|FG001|Overall Study|Physician Decision|3|||
131718139|NCT02580058|474247632|FG002|Overall Study|Physician Decision|11|||
131718140|NCT02580058|474247630|FG000|Overall Study|Other|5|||
131718141|NCT02580058|474247631|FG001|Overall Study|Other|1|||
131718142|NCT02580058|474247632|FG002|Overall Study|Other|3|||
131718143|NCT02580058|474247630|FG000|Overall Study|Withdrawal by Subject|4|||
131718144|NCT02580058|474247631|FG001|Overall Study|Withdrawal by Subject|7|||
131718145|NCT02580058|474247632|FG002|Overall Study|Withdrawal by Subject|31|||
131718146|NCT02580058|474247630|FG000|Overall Study|Global Deterioration of Health Status|19|||
131718147|NCT02580058|474247631|FG001|Overall Study|Global Deterioration of Health Status|18|||
131718148|NCT02580058|474247632|FG002|Overall Study|Global Deterioration of Health Status|24|||
131718149|NCT02580058|474247630|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
131718150|NCT02580058|474247631|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131718151|NCT02580058|474247632|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
131718152|NCT02580058|474247630|FG000|Overall Study|Progressive Disease|137|||
131718153|NCT02580058|474247631|FG001|Overall Study|Progressive Disease|125|||
131718154|NCT02580058|474247632|FG002|Overall Study|Progressive Disease|94|||
131718155|NCT02580058|474247630|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131718156|NCT02580058|474247631|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131718157|NCT02580058|474247632|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131718158|NCT02498652|474247633|FG000|Overall Study|Protocol Violation|0|||
131718159|NCT02498652|474247634|FG001|Overall Study|Protocol Violation|1|||
131718160|NCT01193335|474247635|FG000|After Infant Series|Lost to Follow-up|1|||
131718161|NCT01193335|474247636|FG001|After Infant Series|Lost to Follow-up|2|||
131718162|NCT01193335|474247635|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
131718163|NCT01193335|474247636|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
131718164|NCT01193335|474247635|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
131718165|NCT01193335|474247636|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
131718166|NCT01193335|474247635|FG000|1-Year Follow-up|Lost to Follow-up|4|||
131718167|NCT01193335|474247636|FG001|1-Year Follow-up|Lost to Follow-up|0|||
131718168|NCT01193335|474247635|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
131718169|NCT01193335|474247636|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
131718170|NCT01193335|474247635|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
131718171|NCT01193335|474247636|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
131718172|NCT01733329|474247638|FG000|Overall Study|Protocol Violation|1|||
131718173|NCT01733329|474247639|FG001|Overall Study|Protocol Violation|1|||
131718174|NCT01733329|474247638|FG000|Overall Study|Uterine artery injury|1|||
131718175|NCT01733329|474247639|FG001|Overall Study|Uterine artery injury|0|||
131718176|NCT02500550|474247646|FG000|Overall Study|Death|7|||
131718177|NCT02388776|474247648|FG000|Overall Study|Death|1|||
131718178|NCT02388776|474247648|FG000|Overall Study|Lost to Follow-up|1|||
131718179|NCT03826914|474247649|FG000|Overall Study|Withdrawal by Subject|1|||
131718180|NCT03826914|474247650|FG001|Overall Study|Withdrawal by Subject|1|||
131718181|NCT04334148|474247651|FG000|Overall Study|positive nasal swab at baseline|0|||
131718182|NCT04334148|474247652|FG001|Overall Study|positive nasal swab at baseline|1|||
131718183|NCT00922935|474247655|FG000|Overall Study|Protocol Violation|0|||
131718184|NCT00922935|474247656|FG001|Overall Study|Protocol Violation|3|||
131718185|NCT00922935|474247657|FG002|Overall Study|Protocol Violation|0|||
131718186|NCT00922935|474247655|FG000|Overall Study|Physician Decision|1|||
131718187|NCT00922935|474247656|FG001|Overall Study|Physician Decision|1|||
131718188|NCT00922935|474247657|FG002|Overall Study|Physician Decision|0|||
131718189|NCT00922935|474247655|FG000|Overall Study|Lost to Follow-up|0|||
131718190|NCT00922935|474247656|FG001|Overall Study|Lost to Follow-up|1|||
131718191|NCT00922935|474247657|FG002|Overall Study|Lost to Follow-up|0|||
131718192|NCT00542828|474247658|FG000|Overall Study|Physician Decision|1|||
131718193|NCT00542828|474247658|FG000|Overall Study|Need for Prohibited Treatment|3|||
131718194|NCT00542828|474247658|FG000|Overall Study|Study Prematurely Discontinued|7|||
131718195|NCT00542828|474247658|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
131718196|NCT01499576|474247661|FG000|Overall Study|Physician Decision|12|||
131718197|NCT01499576|474247661|FG000|Overall Study|Withdrawal by Subject|9|||
131718198|NCT03228186|474247662|FG000|Overall Study|Patient never started treatment|1|||
131718199|NCT04283461|474247663|FG000|Overall Study|Enrolled in separate trial|0|||
131718200|NCT04283461|474247664|FG001|Overall Study|Enrolled in separate trial|0|||
131718201|NCT04283461|474247665|FG002|Overall Study|Enrolled in separate trial|8|||
131718202|NCT04283461|474247666|FG003|Overall Study|Enrolled in separate trial|13|||
131718203|NCT04283461|474247667|FG004|Overall Study|Enrolled in separate trial|12|||
131718204|NCT04283461|474247668|FG005|Overall Study|Enrolled in separate trial|0|||
131718205|NCT04283461|474247669|FG006|Overall Study|Enrolled in separate trial|0|||
131718206|NCT04283461|474247670|FG007|Overall Study|Enrolled in separate trial|8|||
131718207|NCT04283461|474247671|FG008|Overall Study|Enrolled in separate trial|0|||
131718208|NCT04283461|474247672|FG009|Overall Study|Enrolled in separate trial|0|||
131718209|NCT04283461|474247673|FG010|Overall Study|Enrolled in separate trial|0|||
131718210|NCT04283461|474247674|FG011|Overall Study|Enrolled in separate trial|7|||
131718211|NCT04283461|474247675|FG012|Overall Study|Enrolled in separate trial|0|||
131718212|NCT04246047|474247676|FG000|Overall Study|Death|50|||
131718213|NCT04246047|474247677|FG001|Overall Study|Death|77|||
131718214|NCT04246047|474247676|FG000|Overall Study|Lost to Follow-up|1|||
131718215|NCT04246047|474247677|FG001|Overall Study|Lost to Follow-up|3|||
131718216|NCT04246047|474247676|FG000|Overall Study|Physician Decision|4|||
131718217|NCT04246047|474247677|FG001|Overall Study|Physician Decision|10|||
131718218|NCT04246047|474247676|FG000|Overall Study|Withdrawal by Subject|19|||
131718219|NCT04246047|474247677|FG001|Overall Study|Withdrawal by Subject|26|||
131718220|NCT04246047|474247676|FG000|Overall Study|Ongoing|169|||
131718221|NCT04246047|474247677|FG001|Overall Study|Ongoing|135|||
131718222|NCT04233424|474247687|FG000|Overall Study|Death|15|||
131718223|NCT04233424|474247688|FG001|Overall Study|Death|16|||
131718224|NCT04233424|474247687|FG000|Overall Study|Withdrawal by Subject|2|||
131718225|NCT04233424|474247688|FG001|Overall Study|Withdrawal by Subject|8|||
131718226|NCT04233424|474247687|FG000|Overall Study|Physician Decision|1|||
131718227|NCT04233424|474247688|FG001|Overall Study|Physician Decision|3|||
131718228|NCT04233424|474247687|FG000|Overall Study|Protocol Violation|3|||
131718229|NCT04233424|474247688|FG001|Overall Study|Protocol Violation|1|||
131718230|NCT04233424|474247687|FG000|Overall Study|Lost to Follow-up|1|||
131718231|NCT04233424|474247688|FG001|Overall Study|Lost to Follow-up|3|||
131718232|NCT04233424|474247687|FG000|Overall Study|subject refuse to visit site|2|||
131718233|NCT04233424|474247688|FG001|Overall Study|subject refuse to visit site|0|||
131718234|NCT03517436|474247689|FG000|Overall Study|Death|3|||
131718235|NCT03517436|474247689|FG000|Overall Study|Withdrawal by Subject|4|||
131718236|NCT03517436|474247689|FG000|Overall Study|Did not receive study valve.|1|||
131718237|NCT02698189|474247690|FG000|Overall Study|Physician Decision|3|||
131718238|NCT02698189|474247691|FG001|Overall Study|Physician Decision|0|||
131718239|NCT02698189|474247690|FG000|Overall Study|Progressive disease|0|||
131804309|NCT01042522|474568483|FG001|Overall Study|Disease Progression|0|||
131804310|NCT01042522|474568482|FG000|Overall Study|Death|1|||
131804311|NCT01042522|474568483|FG001|Overall Study|Death|0|||
131804312|NCT01042522|474568482|FG000|Overall Study|Patient Refused|0|||
131804313|NCT01042522|474568483|FG001|Overall Study|Patient Refused|3|||
131804314|NCT01042522|474568482|FG000|Overall Study|Withdrawal by Subject|1|||
131804315|NCT01042522|474568483|FG001|Overall Study|Withdrawal by Subject|1|||
131718240|NCT02698189|474247691|FG001|Overall Study|Progressive disease|5|||
131718241|NCT02698189|474247690|FG000|Overall Study|Study terminated by sponsor|0|||
131718242|NCT02698189|474247691|FG001|Overall Study|Study terminated by sponsor|1|||
131718243|NCT04375878|474247696|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
131718244|NCT04375878|474247697|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
131718245|NCT04375878|474247698|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131718246|NCT04375878|474247699|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131718247|NCT04375878|474247700|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131718248|NCT04375878|474247701|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131718249|NCT04375878|474247696|FG000|Crossover First and Second Interventions|Adverse Event|0|||
131718250|NCT04375878|474247697|FG001|Crossover First and Second Interventions|Adverse Event|0|||
131718251|NCT04375878|474247698|FG002|Crossover First and Second Interventions|Adverse Event|1|||
131718252|NCT04375878|474247699|FG003|Crossover First and Second Interventions|Adverse Event|0|||
131718253|NCT04375878|474247700|FG004|Crossover First and Second Interventions|Adverse Event|0|||
131718254|NCT04375878|474247701|FG005|Crossover First and Second Interventions|Adverse Event|0|||
131718255|NCT04375878|474247696|FG000|Extension Phase|Withdrawal by Subject|0|||
131718256|NCT04375878|474247697|FG001|Extension Phase|Withdrawal by Subject|0|||
131718257|NCT04375878|474247698|FG002|Extension Phase|Withdrawal by Subject|0|||
131718258|NCT04375878|474247699|FG003|Extension Phase|Withdrawal by Subject|0|||
131718259|NCT04375878|474247700|FG004|Extension Phase|Withdrawal by Subject|1|||
131718260|NCT04375878|474247701|FG005|Extension Phase|Withdrawal by Subject|0|||
131718261|NCT01254344|474247702|FG000|Overall Study|Adverse Event|2|||
131718262|NCT01254344|474247703|FG001|Overall Study|Adverse Event|5|||
131718263|NCT01254344|474247702|FG000|Overall Study|Physician Decision|7|||
131718264|NCT01254344|474247703|FG001|Overall Study|Physician Decision|4|||
131718265|NCT01254344|474247702|FG000|Overall Study|Protocol Violation|1|||
131718266|NCT01254344|474247703|FG001|Overall Study|Protocol Violation|4|||
131718267|NCT01254344|474247702|FG000|Overall Study|Withdrawal by Subject|3|||
131718268|NCT01254344|474247703|FG001|Overall Study|Withdrawal by Subject|6|||
131718269|NCT01982630|474247704|FG000|Overall Study|Adverse Event|2|||
131718270|NCT01982630|474247705|FG001|Overall Study|Adverse Event|0|||
131718271|NCT01982630|474247706|FG002|Overall Study|Adverse Event|1|||
131718272|NCT01982630|474247707|FG003|Overall Study|Adverse Event|0|||
131718273|NCT01982630|474247708|FG004|Overall Study|Adverse Event|1|||
131718274|NCT01982630|474247709|FG005|Overall Study|Adverse Event|2|||
131718275|NCT01982630|474247710|FG006|Overall Study|Adverse Event|1|||
131718276|NCT01982630|474247711|FG007|Overall Study|Adverse Event|0|||
131718277|NCT01982630|474247704|FG000|Overall Study|Physician Decision|1|||
131718278|NCT01982630|474247705|FG001|Overall Study|Physician Decision|0|||
131718279|NCT01982630|474247706|FG002|Overall Study|Physician Decision|2|||
131718280|NCT01982630|474247707|FG003|Overall Study|Physician Decision|1|||
131718281|NCT01982630|474247708|FG004|Overall Study|Physician Decision|2|||
131718282|NCT01982630|474247709|FG005|Overall Study|Physician Decision|0|||
131718283|NCT01982630|474247710|FG006|Overall Study|Physician Decision|0|||
131718284|NCT01982630|474247711|FG007|Overall Study|Physician Decision|0|||
131718285|NCT01982630|474247704|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718286|NCT01982630|474247705|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718287|NCT01982630|474247706|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
131718288|NCT01982630|474247707|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718289|NCT01982630|474247708|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718290|NCT01982630|474247709|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718291|NCT01982630|474247710|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718292|NCT01982630|474247711|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131718293|NCT01982630|474247704|FG000|Overall Study|Withdrawal by Subject|0|||
131718294|NCT01982630|474247705|FG001|Overall Study|Withdrawal by Subject|0|||
131718295|NCT01982630|474247706|FG002|Overall Study|Withdrawal by Subject|0|||
131718296|NCT01982630|474247707|FG003|Overall Study|Withdrawal by Subject|0|||
131718297|NCT01982630|474247708|FG004|Overall Study|Withdrawal by Subject|0|||
131718298|NCT01982630|474247709|FG005|Overall Study|Withdrawal by Subject|1|||
131718299|NCT01982630|474247710|FG006|Overall Study|Withdrawal by Subject|0|||
131718300|NCT01982630|474247711|FG007|Overall Study|Withdrawal by Subject|0|||
131718301|NCT00820040|474247714|FG000|Overall Study|Death|1|||
131718302|NCT00820040|474247714|FG000|Overall Study|Sponsor terminated study|1|||
131804316|NCT00485472|474568484|FG000|Overall Study|Adverse Event|8|||
131718303|NCT00820040|474247714|FG000|Overall Study|Screen failure|1|||
131718304|NCT01824602|474247717|FG000|Overall Study|Withdrawal by Subject|0|||
131804317|NCT00485472|474568485|FG001|Overall Study|Adverse Event|5|||
131718305|NCT01824602|474247718|FG001|Overall Study|Withdrawal by Subject|0|||
131718306|NCT01824602|474247719|FG002|Overall Study|Withdrawal by Subject|1|||
131718307|NCT01824602|474247720|FG003|Overall Study|Withdrawal by Subject|2|||
131718308|NCT01824602|474247717|FG000|Overall Study|Patient non-compliance|0|||
131718309|NCT01824602|474247718|FG001|Overall Study|Patient non-compliance|0|||
131718310|NCT01824602|474247719|FG002|Overall Study|Patient non-compliance|1|||
131718311|NCT01824602|474247720|FG003|Overall Study|Patient non-compliance|0|||
131718312|NCT01824602|474247717|FG000|Overall Study|Adverse Event|1|||
131718313|NCT01824602|474247718|FG001|Overall Study|Adverse Event|0|||
131718314|NCT01824602|474247719|FG002|Overall Study|Adverse Event|2|||
131718315|NCT01824602|474247720|FG003|Overall Study|Adverse Event|2|||
131718316|NCT01824602|474247717|FG000|Overall Study|Treatment failure|0|||
131718317|NCT01824602|474247718|FG001|Overall Study|Treatment failure|0|||
131718318|NCT01824602|474247719|FG002|Overall Study|Treatment failure|0|||
131718319|NCT01824602|474247720|FG003|Overall Study|Treatment failure|1|||
131718320|NCT00618956|474247722|FG000|Overall Study|Adverse Event|10|||
131718321|NCT00618956|474247723|FG001|Overall Study|Adverse Event|34|||
131718322|NCT00618956|474247722|FG000|Overall Study|Lack of Efficacy|2|||
131718323|NCT00618956|474247723|FG001|Overall Study|Lack of Efficacy|1|||
131718324|NCT00618956|474247722|FG000|Overall Study|Withdrawal by Subject|5|||
131718325|NCT00618956|474247723|FG001|Overall Study|Withdrawal by Subject|7|||
131718326|NCT00618956|474247722|FG000|Overall Study|Lost to Follow-up|4|||
131718327|NCT00618956|474247723|FG001|Overall Study|Lost to Follow-up|5|||
131718328|NCT00618956|474247722|FG000|Overall Study|Protocol Violation|2|||
131718329|NCT00618956|474247723|FG001|Overall Study|Protocol Violation|2|||
131718330|NCT00618956|474247722|FG000|Overall Study|did not meet criteria, non-compliance|2|||
131718331|NCT00618956|474247723|FG001|Overall Study|did not meet criteria, non-compliance|1|||
131718332|NCT02006576|474247725|FG000|Overall Study|Withdrawal by Subject|4|||
131718333|NCT02006576|474247726|FG001|Overall Study|Withdrawal by Subject|6|||
131718334|NCT02006576|474247727|FG002|Overall Study|Withdrawal by Subject|2|||
131718335|NCT02006576|474247725|FG000|Overall Study|Death|0|||
131718336|NCT02006576|474247726|FG001|Overall Study|Death|0|||
131718337|NCT02006576|474247727|FG002|Overall Study|Death|1|||
131718338|NCT02006576|474247725|FG000|Overall Study|Lost to Follow-up|1|||
131718339|NCT02006576|474247726|FG001|Overall Study|Lost to Follow-up|0|||
131718340|NCT02006576|474247727|FG002|Overall Study|Lost to Follow-up|1|||
131718341|NCT02006576|474247725|FG000|Overall Study|Screen Failure, too sick, other|13|||
131718342|NCT02006576|474247726|FG001|Overall Study|Screen Failure, too sick, other|1|||
131718343|NCT02006576|474247727|FG002|Overall Study|Screen Failure, too sick, other|13|||
131718344|NCT03478683|474247728|FG000|Overall Study|Adverse Event|5|||
131718345|NCT03478683|474247729|FG001|Overall Study|Adverse Event|3|||
131718346|NCT03478683|474247728|FG000|Overall Study|Lost to Follow-up|0|||
131718347|NCT03478683|474247729|FG001|Overall Study|Lost to Follow-up|5|||
131718348|NCT03478683|474247728|FG000|Overall Study|Physician Decision|1|||
131718349|NCT03478683|474247729|FG001|Overall Study|Physician Decision|3|||
131718350|NCT03478683|474247728|FG000|Overall Study|Withdrawal by Subject|7|||
131718351|NCT03478683|474247729|FG001|Overall Study|Withdrawal by Subject|7|||
131718352|NCT02332915|474247736|FG000|Overall Study|Moved out of region|3|||
131718353|NCT02332915|474247737|FG001|Overall Study|Moved out of region|0|||
131718354|NCT02332915|474247736|FG000|Overall Study|Unrelated illness|1|||
131718355|NCT02332915|474247737|FG001|Overall Study|Unrelated illness|1|||
131718356|NCT02332915|474247736|FG000|Overall Study|Travel distance prohibitive|0|||
131718357|NCT02332915|474247737|FG001|Overall Study|Travel distance prohibitive|1|||
131718358|NCT02332915|474247736|FG000|Overall Study|did not meet inclusion criteria|2|||
131718359|NCT02332915|474247737|FG001|Overall Study|did not meet inclusion criteria|4|||
131718360|NCT05847881|474247738|FG000|Overall Study|Principal Investigator Decision|8|||
131718361|NCT05847881|474247738|FG000|Overall Study|Withdrawal by Subject|2|||
131718362|NCT01084252|474249239|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718363|NCT01084252|474249240|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718364|NCT01084252|474249241|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718365|NCT01084252|474249242|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718366|NCT01084252|474249243|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718367|NCT01084252|474249244|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718368|NCT01084252|474249245|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718369|NCT01084252|474249246|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718370|NCT01084252|474249247|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718371|NCT01084252|474249248|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718372|NCT01084252|474249249|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718373|NCT01084252|474249250|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718374|NCT01084252|474249251|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
131718375|NCT01084252|474249252|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131718376|NCT04493619|474249254|FG000|Overall Study|Death|4|||
131718377|NCT04493619|474249255|FG001|Overall Study|Death|3|||
131718378|NCT04493619|474249256|FG002|Overall Study|Death|3|||
131718379|NCT04493619|474249257|FG003|Overall Study|Death|4|||
131718380|NCT04493619|474249254|FG000|Overall Study|Study discontinued early|10|||
131718381|NCT04493619|474249255|FG001|Overall Study|Study discontinued early|0|||
131718382|NCT04493619|474249256|FG002|Overall Study|Study discontinued early|4|||
131718383|NCT04493619|474249257|FG003|Overall Study|Study discontinued early|8|||
131718384|NCT04493619|474249254|FG000|Overall Study|Lost to Follow-up|0|||
131718385|NCT04493619|474249255|FG001|Overall Study|Lost to Follow-up|0|||
131718386|NCT04493619|474249256|FG002|Overall Study|Lost to Follow-up|0|||
131718387|NCT04493619|474249257|FG003|Overall Study|Lost to Follow-up|1|||
131718388|NCT00756002|474249266|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
131718389|NCT00756002|474249267|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
131718390|NCT00756002|474249266|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131718391|NCT00756002|474249267|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131718392|NCT00756002|474249266|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
131718393|NCT00756002|474249267|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
131718394|NCT00756002|474249266|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
131718395|NCT00756002|474249267|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
131718396|NCT00756002|474249266|FG000|Double-Blind Treatment Period|Other|2|||
131718397|NCT00756002|474249267|FG001|Double-Blind Treatment Period|Other|2|||
131718398|NCT01451515|474249268|FG000|Overall Study|Death|0|||
131718399|NCT01451515|474249269|FG001|Overall Study|Death|1|||
131718400|NCT01451515|474249270|FG002|Overall Study|Death|0|||
131718401|NCT01451515|474249268|FG000|Overall Study|Withdrawal by Subject|0|||
131718402|NCT01451515|474249269|FG001|Overall Study|Withdrawal by Subject|1|||
131718403|NCT01451515|474249270|FG002|Overall Study|Withdrawal by Subject|0|||
131718404|NCT01451515|474249268|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
131718405|NCT01451515|474249269|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
131718406|NCT01451515|474249270|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
131718407|NCT01451515|474249268|FG000|Overall Study|Relapse (except CNS)|1|||
131718408|NCT01451515|474249269|FG001|Overall Study|Relapse (except CNS)|1|||
131718409|NCT01451515|474249270|FG002|Overall Study|Relapse (except CNS)|0|||
131718410|NCT00174941|474249271|FG000|Overall Study|Adverse Event|1|||
131718411|NCT00174941|474249272|FG001|Overall Study|Adverse Event|10|||
131718412|NCT00174941|474249273|FG002|Overall Study|Adverse Event|2|||
131718413|NCT00174941|474249274|FG003|Overall Study|Adverse Event|13|||
131718414|NCT00174941|474249271|FG000|Overall Study|Protocol Violation|0|||
131718415|NCT00174941|474249272|FG001|Overall Study|Protocol Violation|1|||
131718416|NCT00174941|474249273|FG002|Overall Study|Protocol Violation|0|||
131718417|NCT00174941|474249274|FG003|Overall Study|Protocol Violation|1|||
131718418|NCT00174941|474249271|FG000|Overall Study|Lost to Follow-up|0|||
131718419|NCT00174941|474249272|FG001|Overall Study|Lost to Follow-up|3|||
131718420|NCT00174941|474249273|FG002|Overall Study|Lost to Follow-up|2|||
131718421|NCT00174941|474249274|FG003|Overall Study|Lost to Follow-up|5|||
131718422|NCT00174941|474249271|FG000|Overall Study|Personal Reason(s)|0|||
131718423|NCT00174941|474249272|FG001|Overall Study|Personal Reason(s)|14|||
131718424|NCT00174941|474249273|FG002|Overall Study|Personal Reason(s)|8|||
131718425|NCT00174941|474249274|FG003|Overall Study|Personal Reason(s)|22|||
131718426|NCT00174941|474249271|FG000|Overall Study|Gout Flare|0|||
131718427|NCT00174941|474249272|FG001|Overall Study|Gout Flare|4|||
131718428|NCT00174941|474249273|FG002|Overall Study|Gout Flare|4|||
131718429|NCT00174941|474249274|FG003|Overall Study|Gout Flare|8|||
131718430|NCT00174941|474249271|FG000|Overall Study|Reason Not Specified|1|||
131718431|NCT00174941|474249272|FG001|Overall Study|Reason Not Specified|6|||
131718432|NCT00174941|474249273|FG002|Overall Study|Reason Not Specified|2|||
131718433|NCT00174941|474249274|FG003|Overall Study|Reason Not Specified|9|||
131718434|NCT01458340|474249275|FG000|Overall Study|Adverse Event|5|||
131718435|NCT01458340|474249276|FG001|Overall Study|Adverse Event|4|||
131718436|NCT01458340|474249277|FG002|Overall Study|Adverse Event|2|||
131718437|NCT01458340|474249275|FG000|Overall Study|Lost to Follow-up|3|||
131718438|NCT01458340|474249276|FG001|Overall Study|Lost to Follow-up|3|||
131718439|NCT01458340|474249277|FG002|Overall Study|Lost to Follow-up|10|||
131718440|NCT01458340|474249275|FG000|Overall Study|Miscellaneous|0|||
131718441|NCT01458340|474249276|FG001|Overall Study|Miscellaneous|1|||
131718442|NCT01458340|474249277|FG002|Overall Study|Miscellaneous|0|||
131718443|NCT01458340|474249275|FG000|Overall Study|Physician Decision|1|||
131718444|NCT01458340|474249276|FG001|Overall Study|Physician Decision|1|||
131718445|NCT01458340|474249277|FG002|Overall Study|Physician Decision|2|||
131718446|NCT01458340|474249275|FG000|Overall Study|Protocol Violation|6|||
131718447|NCT01458340|474249276|FG001|Overall Study|Protocol Violation|6|||
131804318|NCT00485472|474568484|FG000|Overall Study|Lack of Efficacy|5|||
131718448|NCT01458340|474249277|FG002|Overall Study|Protocol Violation|5|||
131718449|NCT01458340|474249275|FG000|Overall Study|Withdrawal by Subject|12|||
131718450|NCT01458340|474249276|FG001|Overall Study|Withdrawal by Subject|6|||
131718451|NCT01458340|474249277|FG002|Overall Study|Withdrawal by Subject|4|||
131718452|NCT03126227|474249278|FG000|Overall Study|Adverse Event|43|||
131718453|NCT03126227|474249279|FG001|Overall Study|Adverse Event|4|||
131718454|NCT03126227|474249278|FG000|Overall Study|Death|0|||
131718455|NCT03126227|474249279|FG001|Overall Study|Death|1|||
131718456|NCT03126227|474249278|FG000|Overall Study|Lost to Follow-up|0|||
131718457|NCT03126227|474249279|FG001|Overall Study|Lost to Follow-up|1|||
131718458|NCT03126227|474249278|FG000|Overall Study|Physician Decision|2|||
131718459|NCT03126227|474249279|FG001|Overall Study|Physician Decision|0|||
131718460|NCT03126227|474249278|FG000|Overall Study|Protocol Violation|1|||
131718461|NCT03126227|474249279|FG001|Overall Study|Protocol Violation|0|||
131718462|NCT03126227|474249278|FG000|Overall Study|Withdrawal by Subject|19|||
131718463|NCT03126227|474249279|FG001|Overall Study|Withdrawal by Subject|3|||
131718464|NCT03126227|474249278|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
131718465|NCT03126227|474249279|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
131718466|NCT03126227|474249278|FG000|Overall Study|Lack of dosing compliance|2|||
131718467|NCT03126227|474249279|FG001|Overall Study|Lack of dosing compliance|0|||
131718468|NCT03126227|474249278|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
131718469|NCT03126227|474249279|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
131718470|NCT03126227|474249278|FG000|Overall Study|Scheduling conflict|1|||
131718471|NCT03126227|474249279|FG001|Overall Study|Scheduling conflict|0|||
131718472|NCT01126619|474249284|FG000|Overall Study|Not eligible for the study|2|||
131718473|NCT01126619|474249284|FG000|Overall Study|Investigator decision|4|||
131718474|NCT01126619|474249284|FG000|Overall Study|Serious adverse event|1|||
131718475|NCT01126619|474249284|FG000|Overall Study|Withdrawal by Subject|9|||
131718476|NCT01126619|474249284|FG000|Overall Study|Non-compliance|1|||
131718477|NCT03351244|474249285|FG000|Overall Study|Adverse Event|7|||
131718478|NCT03351244|474249286|FG001|Overall Study|Adverse Event|11|||
131718479|NCT03351244|474249287|FG002|Overall Study|Adverse Event|12|||
131718480|NCT03351244|474249285|FG000|Overall Study|Investigator's decision|0|||
131718481|NCT03351244|474249286|FG001|Overall Study|Investigator's decision|0|||
131718482|NCT03351244|474249287|FG002|Overall Study|Investigator's decision|2|||
131718483|NCT03351244|474249285|FG000|Overall Study|System error|0|||
131718484|NCT03351244|474249286|FG001|Overall Study|System error|0|||
131718485|NCT03351244|474249287|FG002|Overall Study|System error|2|||
131718486|NCT03351244|474249285|FG000|Overall Study|COVID-19 restrictions|3|||
131718487|NCT03351244|474249286|FG001|Overall Study|COVID-19 restrictions|0|||
131718488|NCT03351244|474249287|FG002|Overall Study|COVID-19 restrictions|1|||
131718489|NCT03351244|474249285|FG000|Overall Study|Non-compliance|2|||
131718490|NCT03351244|474249286|FG001|Overall Study|Non-compliance|5|||
131718491|NCT03351244|474249287|FG002|Overall Study|Non-compliance|0|||
131718492|NCT03351244|474249285|FG000|Overall Study|Withdrawal by Subject|11|||
131718493|NCT03351244|474249286|FG001|Overall Study|Withdrawal by Subject|16|||
131718494|NCT03351244|474249287|FG002|Overall Study|Withdrawal by Subject|13|||
131718495|NCT03351244|474249285|FG000|Overall Study|Lost to Follow-up|2|||
131718496|NCT03351244|474249286|FG001|Overall Study|Lost to Follow-up|6|||
131718497|NCT03351244|474249287|FG002|Overall Study|Lost to Follow-up|4|||
131718498|NCT03351244|474249285|FG000|Overall Study|Protocol Violation|2|||
131718499|NCT03351244|474249286|FG001|Overall Study|Protocol Violation|2|||
131718500|NCT03351244|474249287|FG002|Overall Study|Protocol Violation|0|||
131718501|NCT04899271|474249288|FG000|Overall Study|Lost to Follow-up|1|||
131718502|NCT04899271|474249289|FG001|Overall Study|Lost to Follow-up|0|||
131718503|NCT04899271|474249288|FG000|Overall Study|Subject request/consent withdrawal|2|||
131718504|NCT04899271|474249289|FG001|Overall Study|Subject request/consent withdrawal|0|||
131718505|NCT00892437|474249298|FG000|Randomized Phase|Randomized but not treated|6|||
131718506|NCT00892437|474249299|FG001|Randomized Phase|Randomized but not treated|0|||
131718507|NCT00892437|474249298|FG000|Randomized Phase|Adverse Event|2|||
131718508|NCT00892437|474249299|FG001|Randomized Phase|Adverse Event|2|||
131718509|NCT00892437|474249298|FG000|Randomized Phase|Lost to Follow-up|1|||
131804319|NCT00485472|474568485|FG001|Overall Study|Lack of Efficacy|4|||
131804320|NCT00485472|474568484|FG000|Overall Study|Withdrawal by Subject|1|||
131718510|NCT00892437|474249299|FG001|Randomized Phase|Lost to Follow-up|3|||
131718511|NCT00892437|474249298|FG000|Randomized Phase|Investigator's Discretion|1|||
131718512|NCT00892437|474249299|FG001|Randomized Phase|Investigator's Discretion|0|||
131718513|NCT00892437|474249298|FG000|Randomized Phase|Withdrew Consent|1|||
131718514|NCT00892437|474249299|FG001|Randomized Phase|Withdrew Consent|0|||
131718515|NCT00892437|474249298|FG000|Open-Label Extension Phase|Adverse Event|4|||
131718516|NCT00892437|474249299|FG001|Open-Label Extension Phase|Adverse Event|2|||
131718517|NCT00892437|474249298|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
131718518|NCT00892437|474249299|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
131718519|NCT00892437|474249298|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
131718520|NCT00892437|474249299|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
131718521|NCT00892437|474249298|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
131718522|NCT00892437|474249299|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
131718523|NCT00892437|474249298|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
131718524|NCT00892437|474249299|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
131718525|NCT03185130|474249300|FG000|Overall Study|Withdrawal by Subject|0|||
131718526|NCT03185130|474249301|FG001|Overall Study|Withdrawal by Subject|2|||
131718527|NCT01925703|474249302|FG000|Overall Study|Physician Decision|1|||
131718528|NCT01925703|474249302|FG000|Overall Study|Lost to Follow-up|2|||
131718529|NCT01925703|474249302|FG000|Overall Study|Discharge prior to full iron repletion|1|||
131718530|NCT03215277|474249307|FG000|Overall Study|Adverse Event|2|||
131718531|NCT03215277|474249308|FG001|Overall Study|Adverse Event|3|||
131718532|NCT03215277|474249307|FG000|Overall Study|Death|1|||
131718533|NCT03215277|474249308|FG001|Overall Study|Death|0|||
131804321|NCT00485472|474568485|FG001|Overall Study|Withdrawal by Subject|0|||
131718534|NCT03215277|474249307|FG000|Overall Study|Lost to Follow-up|0|||
131718535|NCT03215277|474249308|FG001|Overall Study|Lost to Follow-up|1|||
131448161|NCT03435211|473270885|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
131718536|NCT03215277|474249307|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
131718537|NCT03215277|474249308|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
131718538|NCT04786210|474249313|FG000|Overall Study|Lost to Follow-up|2|||
131718539|NCT04786210|474249313|FG000|Overall Study|Withdrawal by Subject|4|||
131804322|NCT00485472|474568484|FG000|Overall Study|Protocol Violation|0|||
131718540|NCT00095303|474249314|FG000|Main Study|Lost to Follow-up|91|||
131718541|NCT00095303|474249315|FG001|Main Study|Lost to Follow-up|87|||
131718542|NCT00095303|474249314|FG000|Follow Up Study|Lost to Follow-up|59|||
131718543|NCT00095303|474249315|FG001|Follow Up Study|Lost to Follow-up|58|||
131718544|NCT01364467|474249316|FG000|Overall Study|Lost to Follow-up|1|||
131718545|NCT01364467|474249317|FG001|Overall Study|Lost to Follow-up|2|||
131718546|NCT05139030|474249320|FG000|Overall Study|Withdrawal by Subject|1|||
131718547|NCT05139030|474249321|FG001|Overall Study|Withdrawal by Subject|3|||
131718548|NCT05139030|474249320|FG000|Overall Study|Adverse Event|0|||
131718549|NCT05139030|474249321|FG001|Overall Study|Adverse Event|1|||
131718550|NCT05139030|474249320|FG000|Overall Study|Failure to meet continuation criteria|0|||
131718551|NCT05139030|474249321|FG001|Overall Study|Failure to meet continuation criteria|1|||
131718552|NCT02502864|474249329|FG000|Overall Study|Withdrawal by Subject|1|||
131718553|NCT03772327|474249330|FG000|Overall Study|Lost to Follow-up|3|||
131718554|NCT03772327|474249331|FG001|Overall Study|Lost to Follow-up|4|||
131718555|NCT03772327|474249330|FG000|Overall Study|Withdrawal by Subject|2|||
131718556|NCT03772327|474249331|FG001|Overall Study|Withdrawal by Subject|3|||
131718557|NCT00845429|474249342|FG000|Overall Study|Protocol Violation|5|||
131718558|NCT00845429|474249343|FG001|Overall Study|Protocol Violation|4|||
131718559|NCT00845429|474249344|FG002|Overall Study|Protocol Violation|7|||
131718560|NCT00845429|474249342|FG000|Overall Study|Lost to Follow-up|7|||
131718561|NCT00845429|474249343|FG001|Overall Study|Lost to Follow-up|9|||
131718562|NCT00845429|474249344|FG002|Overall Study|Lost to Follow-up|10|||
131718563|NCT00845429|474249342|FG000|Overall Study|Withdrawal by Subject|2|||
131718564|NCT00845429|474249343|FG001|Overall Study|Withdrawal by Subject|2|||
131718565|NCT00845429|474249344|FG002|Overall Study|Withdrawal by Subject|2|||
131718566|NCT00845429|474249342|FG000|Overall Study|Serious adverse event|0|||
131718567|NCT00845429|474249343|FG001|Overall Study|Serious adverse event|0|||
131718568|NCT00845429|474249344|FG002|Overall Study|Serious adverse event|1|||
131718569|NCT00587223|474249345|FG000|Overall Study|Adverse Event|1|||
131718570|NCT00195351|474249346|FG000|Overall Study|Lost to Follow-up|9|||
131718571|NCT00195351|474249347|FG001|Overall Study|Lost to Follow-up|9|||
131718572|NCT00195351|474249346|FG000|Overall Study|Withdrawal by Subject|6|||
131718573|NCT00195351|474249347|FG001|Overall Study|Withdrawal by Subject|3|||
131718574|NCT00195351|474249346|FG000|Overall Study|Protocol Deviation|3|||
131718575|NCT00195351|474249347|FG001|Overall Study|Protocol Deviation|2|||
131718576|NCT00195351|474249346|FG000|Overall Study|Death|3|||
131718577|NCT00195351|474249347|FG001|Overall Study|Death|1|||
131718578|NCT00195351|474249346|FG000|Overall Study|Lack of Efficacy|0|||
131718579|NCT00195351|474249347|FG001|Overall Study|Lack of Efficacy|1|||
131718580|NCT02493751|474249350|FG000|Overall Study|Withdrawal by Subject|2|||
131718581|NCT02493751|474249351|FG001|Overall Study|Withdrawal by Subject|8|||
131718582|NCT02493751|474249350|FG000|Overall Study|Death|6|||
131718583|NCT02493751|474249351|FG001|Overall Study|Death|13|||
131718584|NCT02493751|474249350|FG000|Overall Study|Lost to Follow-up|2|||
131718585|NCT02493751|474249351|FG001|Overall Study|Lost to Follow-up|3|||
131718586|NCT02493751|474249350|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
131718587|NCT02493751|474249351|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
131718588|NCT02296840|474249354|FG000|Overall Study|Adverse Event|1|||
131718589|NCT02296840|474249355|FG001|Overall Study|Adverse Event|1|||
131718590|NCT02296840|474249354|FG000|Overall Study|Protocol Violation|2|||
131718591|NCT02296840|474249355|FG001|Overall Study|Protocol Violation|1|||
131718592|NCT02296840|474249354|FG000|Overall Study|Lost to Follow-up|6|||
131718593|NCT02296840|474249355|FG001|Overall Study|Lost to Follow-up|17|||
131718594|NCT00104871|474249356|FG000|Overall Study|Not evaluable|1|||
131718595|NCT00761215|474249359|FG000|Overall Study|Randomized but didn't receive drug|1|||
131718596|NCT00761215|474249360|FG001|Overall Study|Randomized but didn't receive drug|1|||
131718597|NCT00761215|474249361|FG002|Overall Study|Randomized but didn't receive drug|2|||
131718598|NCT00761215|474249359|FG000|Overall Study|Lost to Follow-up|6|||
131718599|NCT00761215|474249360|FG001|Overall Study|Lost to Follow-up|3|||
131718600|NCT00761215|474249361|FG002|Overall Study|Lost to Follow-up|6|||
131718601|NCT00761215|474249359|FG000|Overall Study|Withdrawal by Subject|1|||
131718602|NCT00761215|474249360|FG001|Overall Study|Withdrawal by Subject|0|||
131718603|NCT00761215|474249361|FG002|Overall Study|Withdrawal by Subject|0|||
131718604|NCT00761215|474249359|FG000|Overall Study|Bacteremia|1|||
131718605|NCT00761215|474249360|FG001|Overall Study|Bacteremia|0|||
131718606|NCT00761215|474249361|FG002|Overall Study|Bacteremia|0|||
131718607|NCT01450137|474249372|FG000|Up to Week 12|Adverse Event|2|||
131718608|NCT01450137|474249373|FG001|Up to Week 12|Adverse Event|1|||
131718609|NCT01450137|474249372|FG000|Up to Week 12|Withdrawal by Subject|0|||
131718610|NCT01450137|474249373|FG001|Up to Week 12|Withdrawal by Subject|2|||
131718611|NCT01450137|474249372|FG000|Week 12 to Study End|Death|0|||
131718612|NCT01450137|474249373|FG001|Week 12 to Study End|Death|1|||
131718613|NCT01450137|474249372|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
131718614|NCT01450137|474249373|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
131718615|NCT01687673|474249386|FG000|Overall Study|Physician Decision|1|||
131718616|NCT02128490|474251463|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131718617|NCT02128490|474251464|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131718618|NCT02128490|474251465|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
131718619|NCT02128490|474251466|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
131718620|NCT02128490|474251467|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131718621|NCT02128490|474251463|FG000|Overall Study|Major Protocol Deviation|1|||
131718622|NCT02128490|474251464|FG001|Overall Study|Major Protocol Deviation|2|||
131718623|NCT02128490|474251465|FG002|Overall Study|Major Protocol Deviation|0|||
131718624|NCT02128490|474251466|FG003|Overall Study|Major Protocol Deviation|2|||
131718625|NCT02128490|474251467|FG004|Overall Study|Major Protocol Deviation|2|||
131718626|NCT02128490|474251463|FG000|Overall Study|Lost to Follow-up|0|||
131718627|NCT02128490|474251464|FG001|Overall Study|Lost to Follow-up|0|||
131718628|NCT02128490|474251465|FG002|Overall Study|Lost to Follow-up|1|||
131718629|NCT02128490|474251466|FG003|Overall Study|Lost to Follow-up|1|||
131718630|NCT02128490|474251467|FG004|Overall Study|Lost to Follow-up|1|||
131718631|NCT02128490|474251463|FG000|Overall Study|Voluntary Withdrawal|3|||
131718632|NCT02128490|474251464|FG001|Overall Study|Voluntary Withdrawal|3|||
131718633|NCT02128490|474251465|FG002|Overall Study|Voluntary Withdrawal|1|||
131718634|NCT02128490|474251466|FG003|Overall Study|Voluntary Withdrawal|1|||
131718635|NCT02128490|474251467|FG004|Overall Study|Voluntary Withdrawal|2|||
131718636|NCT02128490|474251463|FG000|Overall Study|Lack of Efficacy|0|||
131718637|NCT02128490|474251464|FG001|Overall Study|Lack of Efficacy|1|||
131718638|NCT02128490|474251465|FG002|Overall Study|Lack of Efficacy|0|||
131718639|NCT02128490|474251466|FG003|Overall Study|Lack of Efficacy|0|||
131718640|NCT02128490|474251467|FG004|Overall Study|Lack of Efficacy|0|||
131718641|NCT02128490|474251463|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131718642|NCT02128490|474251464|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131718643|NCT02128490|474251465|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131718644|NCT02128490|474251466|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131718645|NCT02128490|474251467|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
131718646|NCT02128490|474251463|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131718647|NCT02128490|474251464|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131718648|NCT02128490|474251465|FG002|Overall Study|Other Miscellaneous Reasons|2|||
131718649|NCT02128490|474251466|FG003|Overall Study|Other Miscellaneous Reasons|1|||
131718650|NCT02128490|474251467|FG004|Overall Study|Other Miscellaneous Reasons|1|||
131718651|NCT02243176|474251468|FG000|Overall Study|Other reason|1|||
131718652|NCT02243176|474251469|FG001|Overall Study|Other reason|2|||
131718653|NCT02243176|474251468|FG000|Overall Study|protocol specified withdrawal critera|1|||
131718654|NCT02243176|474251469|FG001|Overall Study|protocol specified withdrawal critera|3|||
131718655|NCT02243176|474251468|FG000|Overall Study|Protocol Violation|2|||
131718656|NCT02243176|474251469|FG001|Overall Study|Protocol Violation|1|||
131718657|NCT02243176|474251468|FG000|Overall Study|Withdrawal by Subject|8|||
131718658|NCT02243176|474251469|FG001|Overall Study|Withdrawal by Subject|7|||
131718659|NCT02243176|474251468|FG000|Overall Study|Adverse Event|2|||
131718660|NCT02243176|474251469|FG001|Overall Study|Adverse Event|2|||
131718661|NCT02342171|474251473|FG000|Overall Study|Death|4|||
131718662|NCT02342171|474251474|FG001|Overall Study|Death|87|||
131718663|NCT02342171|474251473|FG000|Overall Study|Received favipiravir|10|||
131718664|NCT02342171|474251474|FG001|Overall Study|Received favipiravir|0|||
131718665|NCT02342171|474251473|FG000|Overall Study|Missing cycle treshold value|1|||
131804323|NCT00485472|474568485|FG001|Overall Study|Protocol Violation|1|||
131718666|NCT02342171|474251474|FG001|Overall Study|Missing cycle treshold value|0|||
131718667|NCT02342171|474251473|FG000|Overall Study|Unknown outcome|0|||
131718668|NCT02342171|474251474|FG001|Overall Study|Unknown outcome|1|||
131718669|NCT02342171|474251473|FG000|Overall Study|Missing age data|0|||
131718670|NCT02342171|474251474|FG001|Overall Study|Missing age data|1|||
131718671|NCT03518840|474251477|FG000|Overall Study|Lost to Follow-up|6|||
131718672|NCT00875420|474251480|FG000|Overall Study|Adverse Event|0|||
131718673|NCT00875420|474251481|FG001|Overall Study|Adverse Event|1|||
131718674|NCT00875420|474251482|FG002|Overall Study|Adverse Event|1|||
131718675|NCT00875420|474251483|FG003|Overall Study|Adverse Event|0|||
131718676|NCT00875420|474251484|FG004|Overall Study|Adverse Event|0|||
131718677|NCT00875420|474251480|FG000|Overall Study|Inability to complete study procedures|1|||
131718678|NCT00875420|474251481|FG001|Overall Study|Inability to complete study procedures|0|||
131718679|NCT00875420|474251482|FG002|Overall Study|Inability to complete study procedures|1|||
131718680|NCT00875420|474251483|FG003|Overall Study|Inability to complete study procedures|1|||
131718681|NCT00875420|474251484|FG004|Overall Study|Inability to complete study procedures|1|||
131718682|NCT00875420|474251480|FG000|Overall Study|Lost to Follow-up|1|||
131718683|NCT00875420|474251481|FG001|Overall Study|Lost to Follow-up|0|||
131718684|NCT00875420|474251482|FG002|Overall Study|Lost to Follow-up|0|||
131718685|NCT00875420|474251483|FG003|Overall Study|Lost to Follow-up|0|||
131718686|NCT00875420|474251484|FG004|Overall Study|Lost to Follow-up|0|||
131718687|NCT00875420|474251480|FG000|Overall Study|Personal reason|0|||
131718688|NCT00875420|474251481|FG001|Overall Study|Personal reason|0|||
131718689|NCT00875420|474251482|FG002|Overall Study|Personal reason|0|||
131718690|NCT00875420|474251483|FG003|Overall Study|Personal reason|0|||
131718691|NCT00875420|474251484|FG004|Overall Study|Personal reason|1|||
131718692|NCT00875420|474251480|FG000|Overall Study|Prohibited medication|0|||
131718693|NCT00875420|474251481|FG001|Overall Study|Prohibited medication|0|||
131718694|NCT00875420|474251482|FG002|Overall Study|Prohibited medication|0|||
131718695|NCT00875420|474251483|FG003|Overall Study|Prohibited medication|1|||
131718696|NCT00875420|474251484|FG004|Overall Study|Prohibited medication|0|||
131718697|NCT00875420|474251480|FG000|Overall Study|Sponsor decision|0|||
131718698|NCT00875420|474251481|FG001|Overall Study|Sponsor decision|1|||
131718699|NCT00875420|474251482|FG002|Overall Study|Sponsor decision|0|||
131718700|NCT00875420|474251483|FG003|Overall Study|Sponsor decision|0|||
131718701|NCT00875420|474251484|FG004|Overall Study|Sponsor decision|0|||
131718702|NCT00875420|474251480|FG000|Overall Study|Withdrawal by Subject|0|||
131718703|NCT00875420|474251481|FG001|Overall Study|Withdrawal by Subject|0|||
131718704|NCT00875420|474251482|FG002|Overall Study|Withdrawal by Subject|1|||
131718705|NCT00875420|474251483|FG003|Overall Study|Withdrawal by Subject|0|||
131718706|NCT00875420|474251484|FG004|Overall Study|Withdrawal by Subject|0|||
131718707|NCT03704051|474251485|FG000|Overall Study|Withdrawal by Subject|4|||
131718708|NCT03704051|474251486|FG001|Overall Study|Withdrawal by Subject|0|||
131718709|NCT02517515|474251487|FG000|Overall Study|Adverse Event|0|||
131718710|NCT02517515|474251488|FG001|Overall Study|Adverse Event|1|||
131718711|NCT02517515|474251487|FG000|Overall Study|Withdrew Consent|0|||
131718712|NCT02517515|474251488|FG001|Overall Study|Withdrew Consent|1|||
131718713|NCT02517515|474251487|FG000|Overall Study|Lost to Follow-up|1|||
131718714|NCT02517515|474251488|FG001|Overall Study|Lost to Follow-up|0|||
131718715|NCT02517515|474251487|FG000|Overall Study|Other|1|||
131718716|NCT02517515|474251488|FG001|Overall Study|Other|0|||
131718717|NCT03716726|474251491|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
131718718|NCT03716726|474251492|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
131718719|NCT03716726|474251491|FG000|12 Months Followup|Lost to Follow-up|10|||
131718720|NCT03716726|474251492|FG001|12 Months Followup|Lost to Follow-up|17|||
131718721|NCT02786537|474251495|FG000|As Randomized|Adverse Event|0|||
131718722|NCT02786537|474251496|FG001|As Randomized|Adverse Event|11|||
131718723|NCT02786537|474251497|FG002|As Randomized|Adverse Event|0|||
131718724|NCT02786537|474251498|FG003|As Randomized|Adverse Event|4|||
131718725|NCT02786537|474251499|FG004|As Randomized|Adverse Event|6|||
131718726|NCT02786537|474251500|FG005|As Randomized|Adverse Event|2|||
131718727|NCT02786537|474251495|FG000|As Randomized|Lack of Efficacy|0|||
131718728|NCT02786537|474251496|FG001|As Randomized|Lack of Efficacy|0|||
131718729|NCT02786537|474251497|FG002|As Randomized|Lack of Efficacy|0|||
131718730|NCT02786537|474251498|FG003|As Randomized|Lack of Efficacy|1|||
131718731|NCT02786537|474251499|FG004|As Randomized|Lack of Efficacy|0|||
131718732|NCT02786537|474251500|FG005|As Randomized|Lack of Efficacy|0|||
131718733|NCT02786537|474251495|FG000|As Randomized|Withdrawal by Subject|1|||
131718734|NCT02786537|474251496|FG001|As Randomized|Withdrawal by Subject|2|||
131718735|NCT02786537|474251497|FG002|As Randomized|Withdrawal by Subject|0|||
131718736|NCT02786537|474251498|FG003|As Randomized|Withdrawal by Subject|1|||
131718737|NCT02786537|474251499|FG004|As Randomized|Withdrawal by Subject|1|||
131718738|NCT02786537|474251500|FG005|As Randomized|Withdrawal by Subject|0|||
131718739|NCT02786537|474251495|FG000|As Randomized|Death|0|||
131718740|NCT02786537|474251496|FG001|As Randomized|Death|2|||
131718741|NCT02786537|474251497|FG002|As Randomized|Death|0|||
131718742|NCT02786537|474251498|FG003|As Randomized|Death|3|||
131718743|NCT02786537|474251499|FG004|As Randomized|Death|1|||
131718744|NCT02786537|474251500|FG005|As Randomized|Death|0|||
131718745|NCT02786537|474251495|FG000|As Randomized|Non-compliance with study drug|1|||
131718746|NCT02786537|474251496|FG001|As Randomized|Non-compliance with study drug|11|||
131718747|NCT02786537|474251497|FG002|As Randomized|Non-compliance with study drug|0|||
131718748|NCT02786537|474251498|FG003|As Randomized|Non-compliance with study drug|1|||
131718749|NCT02786537|474251499|FG004|As Randomized|Non-compliance with study drug|0|||
131718750|NCT02786537|474251500|FG005|As Randomized|Non-compliance with study drug|1|||
131718751|NCT02786537|474251495|FG000|As Randomized|Lost to treatment follow-up|4|||
131718752|NCT02786537|474251496|FG001|As Randomized|Lost to treatment follow-up|32|||
131718753|NCT02786537|474251497|FG002|As Randomized|Lost to treatment follow-up|0|||
131718754|NCT02786537|474251498|FG003|As Randomized|Lost to treatment follow-up|24|||
131718755|NCT02786537|474251499|FG004|As Randomized|Lost to treatment follow-up|4|||
131718756|NCT02786537|474251500|FG005|As Randomized|Lost to treatment follow-up|4|||
131718757|NCT02786537|474251495|FG000|As Randomized|Incarceration|0|||
131718758|NCT02786537|474251496|FG001|As Randomized|Incarceration|1|||
131718759|NCT02786537|474251497|FG002|As Randomized|Incarceration|0|||
131718760|NCT02786537|474251498|FG003|As Randomized|Incarceration|0|||
131718761|NCT02786537|474251499|FG004|As Randomized|Incarceration|0|||
131718762|NCT02786537|474251500|FG005|As Randomized|Incarceration|0|||
131718763|NCT02786537|474251495|FG000|As Randomized|Opiate Dependency Relapse|0|||
131718764|NCT02786537|474251496|FG001|As Randomized|Opiate Dependency Relapse|1|||
131718765|NCT02786537|474251497|FG002|As Randomized|Opiate Dependency Relapse|0|||
131718766|NCT02786537|474251498|FG003|As Randomized|Opiate Dependency Relapse|0|||
131718767|NCT02786537|474251499|FG004|As Randomized|Opiate Dependency Relapse|0|||
131718768|NCT02786537|474251500|FG005|As Randomized|Opiate Dependency Relapse|0|||
131718769|NCT02786537|474251495|FG000|As Randomized|HCV drugs stolen from pt|0|||
131718770|NCT02786537|474251496|FG001|As Randomized|HCV drugs stolen from pt|1|||
131718771|NCT02786537|474251497|FG002|As Randomized|HCV drugs stolen from pt|0|||
131718772|NCT02786537|474251498|FG003|As Randomized|HCV drugs stolen from pt|0|||
131718773|NCT02786537|474251499|FG004|As Randomized|HCV drugs stolen from pt|0|||
131718774|NCT02786537|474251500|FG005|As Randomized|HCV drugs stolen from pt|0|||
131718775|NCT02786537|474251495|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
131718776|NCT02786537|474251496|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
131718777|NCT02786537|474251497|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
131718778|NCT02786537|474251498|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
131718779|NCT02786537|474251499|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
131718780|NCT02786537|474251500|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
131718781|NCT02786537|474251495|FG000|As Randomized|Subject lost insurance|0|||
131718782|NCT02786537|474251496|FG001|As Randomized|Subject lost insurance|0|||
131718783|NCT02786537|474251497|FG002|As Randomized|Subject lost insurance|0|||
131718784|NCT02786537|474251498|FG003|As Randomized|Subject lost insurance|1|||
131718785|NCT02786537|474251499|FG004|As Randomized|Subject lost insurance|0|||
131718786|NCT02786537|474251500|FG005|As Randomized|Subject lost insurance|0|||
131718787|NCT02786537|474251495|FG000|As Treated|Adverse Event|0|||
131718788|NCT02786537|474251496|FG001|As Treated|Adverse Event|11|||
131718789|NCT02786537|474251497|FG002|As Treated|Adverse Event|0|||
131718790|NCT02786537|474251498|FG003|As Treated|Adverse Event|4|||
131718791|NCT02786537|474251499|FG004|As Treated|Adverse Event|6|||
131718792|NCT02786537|474251500|FG005|As Treated|Adverse Event|2|||
131718793|NCT02786537|474251495|FG000|As Treated|Death|0|||
131718794|NCT02786537|474251496|FG001|As Treated|Death|2|||
131718795|NCT02786537|474251497|FG002|As Treated|Death|0|||
131718796|NCT02786537|474251498|FG003|As Treated|Death|3|||
131718797|NCT02786537|474251499|FG004|As Treated|Death|1|||
131718798|NCT02786537|474251500|FG005|As Treated|Death|0|||
131718799|NCT02786537|474251495|FG000|As Treated|Lack of Efficacy|0|||
131718800|NCT02786537|474251496|FG001|As Treated|Lack of Efficacy|0|||
131718801|NCT02786537|474251497|FG002|As Treated|Lack of Efficacy|0|||
131718802|NCT02786537|474251498|FG003|As Treated|Lack of Efficacy|1|||
131718803|NCT02786537|474251499|FG004|As Treated|Lack of Efficacy|0|||
131718804|NCT02786537|474251500|FG005|As Treated|Lack of Efficacy|0|||
131718805|NCT02786537|474251495|FG000|As Treated|Lost to Follow-up|4|||
131718806|NCT02786537|474251496|FG001|As Treated|Lost to Follow-up|32|||
131718807|NCT02786537|474251497|FG002|As Treated|Lost to Follow-up|0|||
131718808|NCT02786537|474251498|FG003|As Treated|Lost to Follow-up|25|||
131718809|NCT02786537|474251499|FG004|As Treated|Lost to Follow-up|4|||
131718810|NCT02786537|474251500|FG005|As Treated|Lost to Follow-up|4|||
131718811|NCT02786537|474251495|FG000|As Treated|Non-compliance with study drug|1|||
131718812|NCT02786537|474251496|FG001|As Treated|Non-compliance with study drug|11|||
131718813|NCT02786537|474251497|FG002|As Treated|Non-compliance with study drug|0|||
131718814|NCT02786537|474251498|FG003|As Treated|Non-compliance with study drug|1|||
131718815|NCT02786537|474251499|FG004|As Treated|Non-compliance with study drug|0|||
131718816|NCT02786537|474251500|FG005|As Treated|Non-compliance with study drug|1|||
131718817|NCT02786537|474251495|FG000|As Treated|Lost insurance|0|||
131718818|NCT02786537|474251496|FG001|As Treated|Lost insurance|0|||
131718819|NCT02786537|474251497|FG002|As Treated|Lost insurance|0|||
131718820|NCT02786537|474251498|FG003|As Treated|Lost insurance|1|||
131718821|NCT02786537|474251499|FG004|As Treated|Lost insurance|0|||
131718822|NCT02786537|474251500|FG005|As Treated|Lost insurance|0|||
131718823|NCT02786537|474251495|FG000|As Treated|Withdrawal by Subject|1|||
131718824|NCT02786537|474251496|FG001|As Treated|Withdrawal by Subject|2|||
131718825|NCT02786537|474251497|FG002|As Treated|Withdrawal by Subject|0|||
131718826|NCT02786537|474251498|FG003|As Treated|Withdrawal by Subject|0|||
131718827|NCT02786537|474251499|FG004|As Treated|Withdrawal by Subject|1|||
131718828|NCT02786537|474251500|FG005|As Treated|Withdrawal by Subject|0|||
131718829|NCT02786537|474251495|FG000|As Treated|Incarceration|0|||
131718830|NCT02786537|474251496|FG001|As Treated|Incarceration|1|||
131718831|NCT02786537|474251497|FG002|As Treated|Incarceration|0|||
131718832|NCT02786537|474251498|FG003|As Treated|Incarceration|0|||
131718833|NCT02786537|474251499|FG004|As Treated|Incarceration|0|||
131718834|NCT02786537|474251500|FG005|As Treated|Incarceration|0|||
131718835|NCT02786537|474251495|FG000|As Treated|Opiate dependency relapse|0|||
131718836|NCT02786537|474251496|FG001|As Treated|Opiate dependency relapse|1|||
131718837|NCT02786537|474251497|FG002|As Treated|Opiate dependency relapse|0|||
131718838|NCT02786537|474251498|FG003|As Treated|Opiate dependency relapse|0|||
131718839|NCT02786537|474251499|FG004|As Treated|Opiate dependency relapse|0|||
131718840|NCT02786537|474251500|FG005|As Treated|Opiate dependency relapse|0|||
131718841|NCT02786537|474251495|FG000|As Treated|Drugs stolen from patient|0|||
131718842|NCT02786537|474251496|FG001|As Treated|Drugs stolen from patient|1|||
131718843|NCT02786537|474251497|FG002|As Treated|Drugs stolen from patient|0|||
131718844|NCT02786537|474251498|FG003|As Treated|Drugs stolen from patient|0|||
131718845|NCT02786537|474251499|FG004|As Treated|Drugs stolen from patient|0|||
131718846|NCT02786537|474251500|FG005|As Treated|Drugs stolen from patient|0|||
131718847|NCT02786537|474251495|FG000|As Treated|Advised to stop tx after loss of meds|0|||
131718848|NCT02786537|474251496|FG001|As Treated|Advised to stop tx after loss of meds|1|||
131718849|NCT02786537|474251497|FG002|As Treated|Advised to stop tx after loss of meds|0|||
131718850|NCT02786537|474251498|FG003|As Treated|Advised to stop tx after loss of meds|0|||
131718851|NCT02786537|474251499|FG004|As Treated|Advised to stop tx after loss of meds|0|||
131718852|NCT02786537|474251500|FG005|As Treated|Advised to stop tx after loss of meds|0|||
131718853|NCT01981187|474251501|FG000|Overall Study|Participant/guardian decision|2|||
131718854|NCT01981187|474251501|FG000|Overall Study|Physician Decision|1|||
131718855|NCT01981187|474251501|FG000|Overall Study|Disease progression|2|||
131718856|NCT01981187|474251501|FG000|Overall Study|Adverse Event|7|||
131718857|NCT02638012|474251502|FG000|Overall Study|Lost to Follow-up|1|||
131718858|NCT00443560|474251506|FG000|Overall Study|No intrathecal dose|58|||
131718859|NCT00443560|474251507|FG001|Overall Study|No intrathecal dose|26|||
131718860|NCT00443560|474251506|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
131718861|NCT00443560|474251507|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
131718862|NCT01362322|474251512|FG000|Overall Study|Withdrawal by Subject|3|||
131718863|NCT01362322|474251513|FG001|Overall Study|Withdrawal by Subject|1|||
131718864|NCT01362322|474251512|FG000|Overall Study|Lost to Follow-up|2|||
131718865|NCT01362322|474251513|FG001|Overall Study|Lost to Follow-up|6|||
131718866|NCT01943539|474251514|FG000|Overall Study|Non-compliance with at-home intervention|4|||
131718867|NCT01943539|474251515|FG001|Overall Study|Non-compliance with at-home intervention|0|||
131718868|NCT01009463|474251516|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
131718869|NCT01009463|474251517|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131718870|NCT01009463|474251518|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131718871|NCT01009463|474251519|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131718872|NCT01009463|474251520|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131718873|NCT01009463|474251516|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
131718874|NCT01009463|474251517|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
131718875|NCT01009463|474251518|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
131718876|NCT01009463|474251519|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
131718877|NCT01009463|474251520|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
131718878|NCT01009463|474251516|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
131718879|NCT01009463|474251517|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131718880|NCT01009463|474251518|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131718881|NCT01009463|474251519|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131718882|NCT01009463|474251520|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131718883|NCT01009463|474251516|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
131718884|NCT01009463|474251517|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
131718885|NCT01009463|474251518|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
131718886|NCT01009463|474251519|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
131804324|NCT00485472|474568484|FG000|Overall Study|Other|2|||
131804325|NCT00485472|474568485|FG001|Overall Study|Other|1|||
131718887|NCT01009463|474251520|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
131718888|NCT01009463|474251516|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
131718889|NCT01009463|474251517|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131718890|NCT01009463|474251518|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131718891|NCT01009463|474251519|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131718892|NCT01009463|474251520|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131718893|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
131718894|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
131718895|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
131718896|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
131718897|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
131718898|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131718899|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
131718900|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
131718901|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
131718902|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
131718903|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131718904|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
131718905|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
131718906|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
131718907|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
131718908|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
131718909|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
131718910|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
131718911|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
131718912|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
131718913|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131718914|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
131718915|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
131718916|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
131718917|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
131718918|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131718919|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
131718920|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131718921|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
131718922|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131718923|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131718924|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
131718925|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
131718926|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
131718927|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
131718928|NCT01009463|474251516|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
131718929|NCT01009463|474251517|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
131718930|NCT01009463|474251518|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
131718931|NCT01009463|474251519|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
131718932|NCT01009463|474251520|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
131718933|NCT03199911|474251521|FG000|Overall Study|Lost to Follow-up|5|||
131718934|NCT03199911|474251522|FG001|Overall Study|Lost to Follow-up|5|||
131718935|NCT03199911|474251521|FG000|Overall Study|Did not proceed with surgery|2|||
131718936|NCT03199911|474251522|FG001|Overall Study|Did not proceed with surgery|1|||
131718937|NCT02413255|474251523|FG000|Overall Study|Voluntary Withdrawal|0|||
131718938|NCT02413255|474251524|FG001|Overall Study|Voluntary Withdrawal|0|||
131718939|NCT02413255|474251525|FG002|Overall Study|Voluntary Withdrawal|0|||
131718940|NCT02413255|474251526|FG003|Overall Study|Voluntary Withdrawal|0|||
131718941|NCT02413255|474251527|FG004|Overall Study|Voluntary Withdrawal|0|||
131718942|NCT02413255|474251528|FG005|Overall Study|Voluntary Withdrawal|0|||
131718943|NCT02413255|474251529|FG006|Overall Study|Voluntary Withdrawal|0|||
131718944|NCT02413255|474251530|FG007|Overall Study|Voluntary Withdrawal|0|||
131718945|NCT02413255|474251531|FG008|Overall Study|Voluntary Withdrawal|0|||
131718946|NCT02413255|474251532|FG009|Overall Study|Voluntary Withdrawal|0|||
131718947|NCT02413255|474251533|FG010|Overall Study|Voluntary Withdrawal|0|||
131718948|NCT02413255|474251534|FG011|Overall Study|Voluntary Withdrawal|0|||
131718949|NCT02413255|474251535|FG012|Overall Study|Voluntary Withdrawal|0|||
131718950|NCT02413255|474251536|FG013|Overall Study|Voluntary Withdrawal|0|||
131718951|NCT02413255|474251537|FG014|Overall Study|Voluntary Withdrawal|1|||
131718952|NCT02413255|474251538|FG015|Overall Study|Voluntary Withdrawal|0|||
131718953|NCT02413255|474251539|FG016|Overall Study|Voluntary Withdrawal|0|||
131804326|NCT00485472|474568484|FG000|Overall Study|Lost to Follow-up|0|||
131804327|NCT00485472|474568485|FG001|Overall Study|Lost to Follow-up|1|||
131804328|NCT04015232|474568487|FG000|Overall Study|Withdrawal by Subject|7|||
131804329|NCT04015232|474568488|FG001|Overall Study|Withdrawal by Subject|4|||
131718954|NCT03715465|474251540|FG000|Overall Study|Withdrawal by Subject|1|||
131718955|NCT03715465|474251541|FG001|Overall Study|Withdrawal by Subject|2|||
131718956|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
131718957|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
131718958|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
131718959|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
131718960|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
131718961|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
131718962|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
131718963|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
131718964|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
131718965|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
131718966|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
131718967|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
131804330|NCT04015232|474568487|FG000|Overall Study|Protocol Violation|1|||
131718968|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
131718969|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
131718970|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
131718971|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
131718972|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
131718973|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
131718974|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Death|0|||
131718975|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Death|1|||
131718976|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Death|0|||
131718977|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
131718978|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
131718979|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
131718980|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
131718981|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
131718982|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
131718983|NCT00430781|474251551|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
131718984|NCT00430781|474251552|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
131718985|NCT00430781|474251553|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
131718986|NCT00430781|474251551|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
131718987|NCT00430781|474251552|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
131718988|NCT00430781|474251553|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
131718989|NCT00430781|474251551|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
131718990|NCT00430781|474251552|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
131718991|NCT00430781|474251553|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
131718992|NCT00430781|474251551|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
131718993|NCT00430781|474251552|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
131718994|NCT00430781|474251553|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
131718995|NCT00430781|474251551|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
131718996|NCT00430781|474251552|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
131718997|NCT00430781|474251553|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
131718998|NCT00430781|474251551|FG000|Final Analysis; 31 July 2008|Other|0|||
131718999|NCT00430781|474251552|FG001|Final Analysis; 31 July 2008|Other|1|||
131719000|NCT00430781|474251553|FG002|Final Analysis; 31 July 2008|Other|0|||
131719001|NCT00430781|474251551|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
131719002|NCT00430781|474251552|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
131719003|NCT00430781|474251553|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
131719004|NCT00430781|474251551|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
131719005|NCT00430781|474251552|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
131719006|NCT00430781|474251553|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
131719007|NCT00430781|474251551|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
131719008|NCT00430781|474251552|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
131719009|NCT00430781|474251553|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
131719010|NCT00430781|474251551|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
131719011|NCT00430781|474251552|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
131719012|NCT00430781|474251553|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
131719013|NCT00430781|474251551|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
131719014|NCT00430781|474251552|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
131719015|NCT00430781|474251553|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
131719016|NCT00430781|474251551|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
131719017|NCT00430781|474251552|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
131719018|NCT00430781|474251553|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
131719019|NCT00430781|474251551|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
131719020|NCT00430781|474251552|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
131719021|NCT00430781|474251553|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
131719022|NCT02158533|474251554|FG000|Stage 1|Adverse Event|6|||
131719023|NCT02158533|474251555|FG001|Stage 1|Adverse Event|4|||
131719024|NCT02158533|474251556|FG002|Stage 1|Adverse Event|7|||
131719025|NCT02158533|474251557|FG003|Stage 1|Adverse Event|0|||
131719026|NCT02158533|474251558|FG004|Stage 1|Adverse Event|0|||
131719027|NCT02158533|474251559|FG005|Stage 1|Adverse Event|0|||
131719028|NCT02158533|474251554|FG000|Stage 1|Withdrawal by Subject|3|||
131719029|NCT02158533|474251555|FG001|Stage 1|Withdrawal by Subject|2|||
131719030|NCT02158533|474251556|FG002|Stage 1|Withdrawal by Subject|1|||
131719031|NCT02158533|474251557|FG003|Stage 1|Withdrawal by Subject|0|||
131719032|NCT02158533|474251558|FG004|Stage 1|Withdrawal by Subject|0|||
131719033|NCT02158533|474251559|FG005|Stage 1|Withdrawal by Subject|0|||
131719034|NCT02158533|474251554|FG000|Stage 1|Lack of Efficacy|1|||
131719035|NCT02158533|474251555|FG001|Stage 1|Lack of Efficacy|0|||
131719036|NCT02158533|474251556|FG002|Stage 1|Lack of Efficacy|0|||
131719037|NCT02158533|474251557|FG003|Stage 1|Lack of Efficacy|0|||
131719038|NCT02158533|474251558|FG004|Stage 1|Lack of Efficacy|0|||
131719039|NCT02158533|474251559|FG005|Stage 1|Lack of Efficacy|0|||
131719040|NCT02158533|474251554|FG000|Stage 1|Lost to Follow-up|3|||
131719041|NCT02158533|474251555|FG001|Stage 1|Lost to Follow-up|1|||
131719042|NCT02158533|474251556|FG002|Stage 1|Lost to Follow-up|0|||
131719043|NCT02158533|474251557|FG003|Stage 1|Lost to Follow-up|0|||
131719044|NCT02158533|474251558|FG004|Stage 1|Lost to Follow-up|0|||
131719045|NCT02158533|474251559|FG005|Stage 1|Lost to Follow-up|0|||
131719046|NCT02158533|474251554|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
131719047|NCT02158533|474251555|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
131719048|NCT02158533|474251556|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
131719049|NCT02158533|474251557|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
131719050|NCT02158533|474251558|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
131719051|NCT02158533|474251559|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
131719052|NCT02158533|474251554|FG000|Stage 1|Non-compliance with study visits|1|||
131719053|NCT02158533|474251555|FG001|Stage 1|Non-compliance with study visits|0|||
131719054|NCT02158533|474251556|FG002|Stage 1|Non-compliance with study visits|0|||
131719055|NCT02158533|474251557|FG003|Stage 1|Non-compliance with study visits|0|||
131719056|NCT02158533|474251558|FG004|Stage 1|Non-compliance with study visits|0|||
131719057|NCT02158533|474251559|FG005|Stage 1|Non-compliance with study visits|0|||
131719058|NCT02158533|474251554|FG000|Stage 2|Adverse Event|0|||
131719059|NCT02158533|474251555|FG001|Stage 2|Adverse Event|0|||
131719060|NCT02158533|474251556|FG002|Stage 2|Adverse Event|0|||
131719061|NCT02158533|474251557|FG003|Stage 2|Adverse Event|0|||
131719062|NCT02158533|474251558|FG004|Stage 2|Adverse Event|0|||
131719063|NCT02158533|474251559|FG005|Stage 2|Adverse Event|1|||
131719064|NCT02158533|474251554|FG000|Stage 2|Lack of Efficacy|0|||
131719065|NCT02158533|474251555|FG001|Stage 2|Lack of Efficacy|0|||
131719066|NCT02158533|474251556|FG002|Stage 2|Lack of Efficacy|0|||
131719067|NCT02158533|474251557|FG003|Stage 2|Lack of Efficacy|0|||
131719068|NCT02158533|474251558|FG004|Stage 2|Lack of Efficacy|1|||
131719069|NCT02158533|474251559|FG005|Stage 2|Lack of Efficacy|0|||
131719070|NCT02158533|474251554|FG000|Stage 2|Lost to Follow-up|0|||
131719071|NCT02158533|474251555|FG001|Stage 2|Lost to Follow-up|0|||
131719072|NCT02158533|474251556|FG002|Stage 2|Lost to Follow-up|0|||
131719073|NCT02158533|474251557|FG003|Stage 2|Lost to Follow-up|1|||
131719074|NCT02158533|474251558|FG004|Stage 2|Lost to Follow-up|1|||
131719075|NCT02158533|474251559|FG005|Stage 2|Lost to Follow-up|2|||
131719076|NCT02158533|474251554|FG000|Stage 2|Withdrawal by Subject|0|||
131719077|NCT02158533|474251555|FG001|Stage 2|Withdrawal by Subject|0|||
131719078|NCT02158533|474251556|FG002|Stage 2|Withdrawal by Subject|0|||
131719079|NCT02158533|474251557|FG003|Stage 2|Withdrawal by Subject|0|||
131719080|NCT02158533|474251558|FG004|Stage 2|Withdrawal by Subject|1|||
131719081|NCT02158533|474251559|FG005|Stage 2|Withdrawal by Subject|2|||
131719082|NCT02158533|474251554|FG000|Stage 2|Physician Decision|0|||
131719083|NCT02158533|474251555|FG001|Stage 2|Physician Decision|0|||
131719084|NCT02158533|474251556|FG002|Stage 2|Physician Decision|0|||
131719085|NCT02158533|474251557|FG003|Stage 2|Physician Decision|0|||
131719086|NCT02158533|474251558|FG004|Stage 2|Physician Decision|1|||
131719087|NCT02158533|474251559|FG005|Stage 2|Physician Decision|0|||
131719088|NCT02158533|474251554|FG000|Stage 2|Pregnancy|0|||
131719089|NCT02158533|474251555|FG001|Stage 2|Pregnancy|0|||
131719090|NCT02158533|474251556|FG002|Stage 2|Pregnancy|0|||
131719091|NCT02158533|474251557|FG003|Stage 2|Pregnancy|1|||
131719092|NCT02158533|474251558|FG004|Stage 2|Pregnancy|0|||
131719093|NCT02158533|474251559|FG005|Stage 2|Pregnancy|0|||
131719094|NCT02158533|474251554|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
131719095|NCT02158533|474251555|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
131719096|NCT02158533|474251556|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
131719097|NCT02158533|474251557|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
131719098|NCT02158533|474251558|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
131719099|NCT02158533|474251559|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
131719100|NCT02158533|474251554|FG000|Stage 2|Non-adherence with study visits|0|||
131719101|NCT02158533|474251555|FG001|Stage 2|Non-adherence with study visits|0|||
131719102|NCT02158533|474251556|FG002|Stage 2|Non-adherence with study visits|0|||
131719103|NCT02158533|474251557|FG003|Stage 2|Non-adherence with study visits|0|||
131719104|NCT02158533|474251558|FG004|Stage 2|Non-adherence with study visits|0|||
131719105|NCT02158533|474251559|FG005|Stage 2|Non-adherence with study visits|1|||
131719106|NCT04329949|474251562|FG000|Overall Study|Death|36|||
131719107|NCT04329949|474251562|FG000|Overall Study|Withdrawal by Subject|4|||
131719108|NCT04329949|474251562|FG000|Overall Study|Termination of study by sponsor|3|||
131719109|NCT01335971|474251567|FG000|Overall Study|Withdrawal by Subject|1|||
131719110|NCT01335971|474251568|FG001|Overall Study|Withdrawal by Subject|0|||
131719111|NCT01335971|474251569|FG002|Overall Study|Withdrawal by Subject|0|||
131719112|NCT01335971|474251567|FG000|Overall Study|Did not complete bronchoscopy|1|||
131719113|NCT01335971|474251568|FG001|Overall Study|Did not complete bronchoscopy|1|||
131719114|NCT01335971|474251569|FG002|Overall Study|Did not complete bronchoscopy|1|||
131719115|NCT00384956|474251570|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
131719116|NCT00917384|474251571|FG000|Overall Study|Lost to Follow-up|4|||
131719117|NCT00917384|474251572|FG001|Overall Study|Lost to Follow-up|2|||
131719118|NCT00917384|474251571|FG000|Overall Study|Withdrawal by Subject|10|||
131719119|NCT00917384|474251572|FG001|Overall Study|Withdrawal by Subject|2|||
131719120|NCT00149214|474251577|FG000|Overall Study|Adverse Event|12|||
131719121|NCT00149214|474251578|FG001|Overall Study|Adverse Event|9|||
131719122|NCT00149214|474251577|FG000|Overall Study|Withdrawal by Subject|4|||
131719123|NCT00149214|474251578|FG001|Overall Study|Withdrawal by Subject|1|||
131719124|NCT00149214|474251577|FG000|Overall Study|Physician Decision|3|||
131719125|NCT00149214|474251578|FG001|Overall Study|Physician Decision|3|||
131719126|NCT00149214|474251577|FG000|Overall Study|Sponsor Decision|0|||
131719127|NCT00149214|474251578|FG001|Overall Study|Sponsor Decision|1|||
131719128|NCT00149214|474251577|FG000|Overall Study|Progressive Disease|7|||
131719129|NCT00149214|474251578|FG001|Overall Study|Progressive Disease|3|||
131719130|NCT00947154|474251579|FG000|Overall Study|Lost to Follow-up|1|||
131719131|NCT03794986|474251580|FG000|Overall Study|0 Sessions Attended|34|||
131719132|NCT03794986|474251581|FG001|Overall Study|0 Sessions Attended|37|||
131719133|NCT03794986|474251580|FG000|Overall Study|Withdrawal by Subject|4|||
131719134|NCT03794986|474251581|FG001|Overall Study|Withdrawal by Subject|6|||
131719135|NCT03794986|474251580|FG000|Overall Study|Protocol Violation|1|||
131719136|NCT03794986|474251581|FG001|Overall Study|Protocol Violation|0|||
131719137|NCT05309083|474251582|FG000|Overall Study|Withdrawal by Subject|2|||
131719138|NCT01165229|474251583|FG000|Overall Study|Serious Adverse Event|456|||
131719139|NCT01165229|474251584|FG001|Overall Study|Serious Adverse Event|487|||
131719140|NCT01165229|474251583|FG000|Overall Study|Non-Serious Adverse Event|47|||
131719141|NCT01165229|474251584|FG001|Overall Study|Non-Serious Adverse Event|15|||
131719142|NCT01165229|474251583|FG000|Overall Study|Protocol Violation|6|||
131719143|NCT01165229|474251584|FG001|Overall Study|Protocol Violation|8|||
131719144|NCT01165229|474251583|FG000|Overall Study|Withdrawal by Subject|387|||
131719145|NCT01165229|474251584|FG001|Overall Study|Withdrawal by Subject|396|||
131719146|NCT01165229|474251583|FG000|Overall Study|Migrated/moved from study area|51|||
131719147|NCT01165229|474251584|FG001|Overall Study|Migrated/moved from study area|46|||
131719148|NCT01165229|474251583|FG000|Overall Study|Lost to Follow-up|123|||
131719149|NCT01165229|474251584|FG001|Overall Study|Lost to Follow-up|133|||
131719150|NCT01165229|474251583|FG000|Overall Study|Suspected HZ Episode|2|||
131719151|NCT01165229|474251584|FG001|Overall Study|Suspected HZ Episode|2|||
131719152|NCT01165229|474251583|FG000|Overall Study|No reason from the subject|108|||
131719153|NCT01165229|474251584|FG001|Overall Study|No reason from the subject|102|||
131719154|NCT01165229|474251583|FG000|Overall Study|Unknown completion status|0|||
131719155|NCT01165229|474251584|FG001|Overall Study|Unknown completion status|1|||
131719156|NCT00881205|474251588|FG000|Overall Study|Adverse Event|8|||
131719157|NCT00881205|474251589|FG001|Overall Study|Adverse Event|3|||
131719158|NCT00881205|474251588|FG000|Overall Study|Withdrawal by Subject|1|||
131719159|NCT00881205|474251589|FG001|Overall Study|Withdrawal by Subject|2|||
131719160|NCT00881205|474251588|FG000|Overall Study|Lost to Follow-up|0|||
131719161|NCT00881205|474251589|FG001|Overall Study|Lost to Follow-up|1|||
131719162|NCT00881205|474251588|FG000|Overall Study|Administrative problems|1|||
131719163|NCT00881205|474251589|FG001|Overall Study|Administrative problems|1|||
131719164|NCT00881205|474251588|FG000|Overall Study|Condition no longer requires drug|1|||
131719165|NCT00881205|474251589|FG001|Overall Study|Condition no longer requires drug|0|||
131719166|NCT00465569|474251590|FG000|Overall Study|persistent eczema during dose escalation|1|||
131719167|NCT00465569|474251591|FG001|Overall Study|persistent eczema during dose escalation|0|||
131719168|NCT00849212|474251592|FG000|Overall Study|Lack of Efficacy|1|||
131719169|NCT00849212|474251592|FG000|Overall Study|Withdrawal by Subject|3|||
131719170|NCT00849212|474251592|FG000|Overall Study|Adverse Event|2|||
131719171|NCT00849212|474251592|FG000|Overall Study|Miscellaneous|1|||
131719172|NCT01634243|474251593|FG000|Overall Study|Adverse Event|5|||
131719173|NCT01634243|474251594|FG001|Overall Study|Adverse Event|5|||
131719174|NCT01634243|474251593|FG000|Overall Study|Lack of Efficacy|1|||
131719175|NCT01634243|474251594|FG001|Overall Study|Lack of Efficacy|0|||
131719176|NCT02111369|474251602|FG000|Overall Study|Lost to Follow-up|2|||
131719177|NCT02111369|474251602|FG000|Overall Study|Withdrawal by Subject|1|||
131719178|NCT00971321|474251606|FG000|Up to Month 7|Withdrawal by Subject|1|||
131719179|NCT00971321|474251607|FG001|Up to Month 7|Withdrawal by Subject|0|||
131719180|NCT00971321|474251606|FG000|Up to Month 7|Migrated/moved from study area|3|||
131719181|NCT00971321|474251607|FG001|Up to Month 7|Migrated/moved from study area|2|||
131719182|NCT00971321|474251606|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
131719183|NCT00971321|474251607|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
131719184|NCT00971321|474251606|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
131719185|NCT00971321|474251607|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
131719186|NCT00971321|474251606|FG000|Up to Month 11-12|Lost to Follow-up|1|||
131719187|NCT00971321|474251607|FG001|Up to Month 11-12|Lost to Follow-up|0|||
131719188|NCT00519623|474251610|FG000|Overall Study|Adverse Event|1|||
131719189|NCT02485717|474251614|FG000|Overall Study|Lost to Follow-up|6|||
131719190|NCT02485717|474251615|FG001|Overall Study|Lost to Follow-up|0|||
131719191|NCT02485717|474251616|FG002|Overall Study|Lost to Follow-up|0|||
131719192|NCT02485717|474251614|FG000|Overall Study|Withdrawal by Subject|0|||
131719193|NCT02485717|474251615|FG001|Overall Study|Withdrawal by Subject|0|||
131719194|NCT02485717|474251616|FG002|Overall Study|Withdrawal by Subject|1|||
131719195|NCT02485717|474251614|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
131719196|NCT02485717|474251615|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
131719197|NCT02485717|474251616|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
131719198|NCT02485717|474251614|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
131719199|NCT02485717|474251615|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
131719200|NCT02485717|474251616|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
131719201|NCT01476787|474251617|FG000|Treatment|Progression|64|||
131719202|NCT01476787|474251618|FG001|Treatment|Progression|71|||
131719203|NCT01476787|474251617|FG000|Treatment|Toxicity|44|||
131719204|NCT01476787|474251618|FG001|Treatment|Toxicity|16|||
131719205|NCT01476787|474251617|FG000|Treatment|Death|0|||
131719206|NCT01476787|474251618|FG001|Treatment|Death|1|||
131719207|NCT01476787|474251617|FG000|Treatment|Withdrawal by Subject|3|||
131719208|NCT01476787|474251618|FG001|Treatment|Withdrawal by Subject|14|||
131719209|NCT01476787|474251617|FG000|Treatment|Major protocol violation|1|||
131719210|NCT01476787|474251618|FG001|Treatment|Major protocol violation|6|||
131719211|NCT01476787|474251617|FG000|Treatment|Other reasons|10|||
131719212|NCT01476787|474251618|FG001|Treatment|Other reasons|22|||
131719213|NCT01476787|474251617|FG000|Treatment|Concurrent illness|12|||
131719214|NCT01476787|474251618|FG001|Treatment|Concurrent illness|9|||
131719215|NCT01476787|474251617|FG000|Treatment|Insufficient response|15|||
131719216|NCT01476787|474251618|FG001|Treatment|Insufficient response|3|||
131719217|NCT01476787|474251617|FG000|Treatment|Voluntary treatment discontinuation|8|||
131719218|NCT01476787|474251618|FG001|Treatment|Voluntary treatment discontinuation|4|||
131719219|NCT01450540|474251619|FG000|Overall Study|Withdrawal by Subject|19|||
131719220|NCT01450540|474251620|FG001|Overall Study|Withdrawal by Subject|13|||
131719221|NCT01450540|474251619|FG000|Overall Study|protocol deviation|3|||
131719222|NCT01450540|474251620|FG001|Overall Study|protocol deviation|23|||
131719223|NCT01926886|474251621|FG000|Overall Study|Administrative/other|1|||
131719224|NCT01926886|474251622|FG001|Overall Study|Administrative/other|0|||
131719225|NCT01926886|474251621|FG000|Overall Study|Adverse event/intercurrent illness|4|||
131719226|NCT01926886|474251622|FG001|Overall Study|Adverse event/intercurrent illness|0|||
131719227|NCT01926886|474251621|FG000|Overall Study|Disease progression/recurrence|4|||
131719228|NCT01926886|474251622|FG001|Overall Study|Disease progression/recurrence|0|||
131719229|NCT01926886|474251621|FG000|Overall Study|Withdrawal by Subject|15|||
131719230|NCT01926886|474251622|FG001|Overall Study|Withdrawal by Subject|0|||
131719231|NCT01926886|474251621|FG000|Overall Study|Failure to return|3|||
131719232|NCT01926886|474251622|FG001|Overall Study|Failure to return|0|||
131719233|NCT01926886|474251621|FG000|Overall Study|Recurrence of disease|1|||
131719234|NCT01926886|474251622|FG001|Overall Study|Recurrence of disease|0|||
131719235|NCT01926886|474251621|FG000|Overall Study|Progression of disease|2|||
131719236|NCT01926886|474251622|FG001|Overall Study|Progression of disease|0|||
131719237|NCT01926886|474251621|FG000|Overall Study|Death|1|||
131719238|NCT01926886|474251622|FG001|Overall Study|Death|0|||
131719239|NCT01926886|474251621|FG000|Overall Study|Did not cooperate|1|||
131719240|NCT01926886|474251622|FG001|Overall Study|Did not cooperate|0|||
131719241|NCT01662999|474251631|FG000|Period 3|Withdrawal by Subject|0|||
131719242|NCT01662999|474251632|FG001|Period 3|Withdrawal by Subject|1|||
131804331|NCT04015232|474568488|FG001|Overall Study|Protocol Violation|0|||
131804332|NCT04015232|474568487|FG000|Overall Study|Medical Grounds|3|||
131804333|NCT04015232|474568488|FG001|Overall Study|Medical Grounds|3|||
131804334|NCT00727571|474568490|FG000|Overall Study|Ineligibility determined|1|||
131804335|NCT00727571|474568491|FG001|Overall Study|Ineligibility determined|1|||
131804336|NCT00727571|474568492|FG002|Overall Study|Ineligibility determined|1|||
131804337|NCT00727571|474568493|FG003|Overall Study|Ineligibility determined|0|||
131804338|NCT00727571|474568490|FG000|Overall Study|Death|0|||
131804339|NCT00727571|474568491|FG001|Overall Study|Death|19|||
131804340|NCT00727571|474568492|FG002|Overall Study|Death|5|||
131804341|NCT00727571|474568493|FG003|Overall Study|Death|1|||
131804342|NCT00727571|474568490|FG000|Overall Study|Physician Decision|0|||
131804343|NCT00727571|474568491|FG001|Overall Study|Physician Decision|5|||
131804344|NCT00727571|474568492|FG002|Overall Study|Physician Decision|0|||
131804345|NCT00727571|474568493|FG003|Overall Study|Physician Decision|0|||
131804346|NCT00727571|474568490|FG000|Overall Study|Withdrawal by Subject|0|||
131804347|NCT00727571|474568491|FG001|Overall Study|Withdrawal by Subject|10|||
131804348|NCT00727571|474568492|FG002|Overall Study|Withdrawal by Subject|11|||
131804349|NCT00727571|474568493|FG003|Overall Study|Withdrawal by Subject|0|||
131804350|NCT00727571|474568490|FG000|Overall Study|Subject Non Compliance|0|||
131804351|NCT00727571|474568491|FG001|Overall Study|Subject Non Compliance|6|||
131804352|NCT00727571|474568492|FG002|Overall Study|Subject Non Compliance|0|||
131804353|NCT00727571|474568493|FG003|Overall Study|Subject Non Compliance|4|||
131804354|NCT00727571|474568490|FG000|Overall Study|Dismissed from nursing home|0|||
131804355|NCT00727571|474568491|FG001|Overall Study|Dismissed from nursing home|9|||
131804356|NCT00727571|474568492|FG002|Overall Study|Dismissed from nursing home|5|||
131804357|NCT00727571|474568493|FG003|Overall Study|Dismissed from nursing home|0|||
131804358|NCT00727571|474568490|FG000|Overall Study|Hospitalization|0|||
131804359|NCT00727571|474568491|FG001|Overall Study|Hospitalization|1|||
131804360|NCT00727571|474568492|FG002|Overall Study|Hospitalization|0|||
131804361|NCT00727571|474568493|FG003|Overall Study|Hospitalization|1|||
131804362|NCT00727571|474568490|FG000|Overall Study|AE not leading to hospitalization|0|||
131804363|NCT00727571|474568491|FG001|Overall Study|AE not leading to hospitalization|0|||
131804364|NCT00727571|474568492|FG002|Overall Study|AE not leading to hospitalization|2|||
131804365|NCT00727571|474568493|FG003|Overall Study|AE not leading to hospitalization|0|||
131804366|NCT00727571|474568490|FG000|Overall Study|Other|0|||
131804367|NCT00727571|474568491|FG001|Overall Study|Other|4|||
131804368|NCT00727571|474568492|FG002|Overall Study|Other|6|||
131804369|NCT00727571|474568493|FG003|Overall Study|Other|0|||
131804370|NCT03164772|474568495|FG000|Overall Study|Death|4|||
131719243|NCT01662999|474251633|FG002|Period 3|Withdrawal by Subject|0|||
131719244|NCT01662999|474251634|FG003|Period 3|Withdrawal by Subject|0|||
131719245|NCT01662999|474251635|FG004|Period 3|Withdrawal by Subject|0|||
131719246|NCT01662999|474251636|FG005|Period 3|Withdrawal by Subject|0|||
131719247|NCT02234622|474251637|FG000|Overall Study|Withdrawal by Subject|16|||
131719248|NCT02234622|474251638|FG001|Overall Study|Withdrawal by Subject|22|||
131719249|NCT02234622|474251637|FG000|Overall Study|Lost to Follow-up|27|||
131719250|NCT02234622|474251638|FG001|Overall Study|Lost to Follow-up|14|||
131719251|NCT04090164|474251639|FG000|Overall Study|incomplete data on file|245|||
131719252|NCT04090164|474251640|FG001|Overall Study|incomplete data on file|0|||
131719253|NCT01877655|474251645|FG000|Overall Study|Death|57|||
131719254|NCT01877655|474251646|FG001|Overall Study|Death|52|||
131719255|NCT01877655|474251645|FG000|Overall Study|Withdrawal by Subject|18|||
131719256|NCT01877655|474251646|FG001|Overall Study|Withdrawal by Subject|26|||
131719257|NCT01877655|474251645|FG000|Overall Study|Physician Decision|11|||
131804371|NCT03164772|474568496|FG001|Overall Study|Death|2|||
131804372|NCT03164772|474568495|FG000|Overall Study|Adverse Event|1|||
131804373|NCT03164772|474568496|FG001|Overall Study|Adverse Event|4|||
131804374|NCT03164772|474568495|FG000|Overall Study|Progressive Disease|11|||
131804375|NCT03164772|474568496|FG001|Overall Study|Progressive Disease|21|||
131804376|NCT03164772|474568495|FG000|Overall Study|Physician Decision|2|||
131804377|NCT03164772|474568496|FG001|Overall Study|Physician Decision|0|||
131804378|NCT03164772|474568495|FG000|Overall Study|Withdrawal by Subject|0|||
131804379|NCT03164772|474568496|FG001|Overall Study|Withdrawal by Subject|4|||
131804380|NCT01029353|474568498|FG000|Overall Study|Lost to Follow-up|4|||
131804381|NCT01029353|474568499|FG001|Overall Study|Lost to Follow-up|5|||
131804382|NCT01029353|474568500|FG002|Overall Study|Lost to Follow-up|5|||
131719258|NCT01877655|474251646|FG001|Overall Study|Physician Decision|10|||
131719259|NCT01877655|474251645|FG000|Overall Study|Miscellaneous|4|||
131719260|NCT01877655|474251646|FG001|Overall Study|Miscellaneous|4|||
131719261|NCT01877655|474251645|FG000|Overall Study|Randomized but Never Received Drug|8|||
131719262|NCT01877655|474251646|FG001|Overall Study|Randomized but Never Received Drug|5|||
131719263|NCT03497689|474251647|FG000|Overall Study|Adverse Event|2|||
131719264|NCT03497689|474251647|FG000|Overall Study|Death|1|||
131719265|NCT03497689|474251647|FG000|Overall Study|Physician Decision|1|||
131719266|NCT03497689|474251647|FG000|Overall Study|Withdrawal by Subject|1|||
131719267|NCT03497689|474251647|FG000|Overall Study|Protocol Violation|2|||
131719268|NCT03191786|474251648|FG000|Overall Study|Death|236|||
131719269|NCT03191786|474251649|FG001|Overall Study|Death|127|||
131719270|NCT03191786|474251648|FG000|Overall Study|Lost to Follow-up|9|||
131719271|NCT03191786|474251649|FG001|Overall Study|Lost to Follow-up|3|||
131719272|NCT03191786|474251648|FG000|Overall Study|Physician Decision|1|||
131719273|NCT03191786|474251649|FG001|Overall Study|Physician Decision|0|||
131719274|NCT03191786|474251648|FG000|Overall Study|Moved to Post Trial Access Program|30|||
131719275|NCT03191786|474251649|FG001|Overall Study|Moved to Post Trial Access Program|5|||
131719276|NCT03191786|474251648|FG000|Overall Study|Withdrawal by Subject|26|||
131719277|NCT03191786|474251649|FG001|Overall Study|Withdrawal by Subject|16|||
131719278|NCT04513158|474251652|FG000|Overall Study|Screen Failure|1|||
131719279|NCT03439345|474253242|FG000|Overall Study|Lost to Follow-up|0|||
131719280|NCT03439345|474253243|FG001|Overall Study|Lost to Follow-up|1|||
131719281|NCT03439345|474253242|FG000|Overall Study|Consent withdrawn|0|||
131719282|NCT03439345|474253243|FG001|Overall Study|Consent withdrawn|1|||
131719283|NCT02333331|474253246|FG000|Overall Study|Adverse Event|1|||
131719284|NCT02333331|474253247|FG001|Overall Study|Adverse Event|0|||
131719285|NCT02333331|474253248|FG002|Overall Study|Adverse Event|4|||
131719286|NCT02333331|474253249|FG003|Overall Study|Adverse Event|1|||
131719287|NCT02333331|474253246|FG000|Overall Study|Death|0|||
131719288|NCT02333331|474253247|FG001|Overall Study|Death|0|||
131719289|NCT02333331|474253248|FG002|Overall Study|Death|2|||
131719290|NCT02333331|474253249|FG003|Overall Study|Death|0|||
131719291|NCT02333331|474253246|FG000|Overall Study|Lost to Follow-up|0|||
131719292|NCT02333331|474253247|FG001|Overall Study|Lost to Follow-up|0|||
131719293|NCT02333331|474253248|FG002|Overall Study|Lost to Follow-up|1|||
131719294|NCT02333331|474253249|FG003|Overall Study|Lost to Follow-up|0|||
131719295|NCT02333331|474253246|FG000|Overall Study|Physician Decision|0|||
131719296|NCT02333331|474253247|FG001|Overall Study|Physician Decision|1|||
131719297|NCT02333331|474253248|FG002|Overall Study|Physician Decision|0|||
131719298|NCT02333331|474253249|FG003|Overall Study|Physician Decision|0|||
131719299|NCT02333331|474253246|FG000|Overall Study|Protocol Deviation|0|||
131719300|NCT02333331|474253247|FG001|Overall Study|Protocol Deviation|3|||
131719301|NCT02333331|474253248|FG002|Overall Study|Protocol Deviation|2|||
131719302|NCT02333331|474253249|FG003|Overall Study|Protocol Deviation|1|||
131719303|NCT02333331|474253246|FG000|Overall Study|Patient/Guardian Decision|1|||
131719304|NCT02333331|474253247|FG001|Overall Study|Patient/Guardian Decision|2|||
131719305|NCT02333331|474253248|FG002|Overall Study|Patient/Guardian Decision|9|||
131719306|NCT02333331|474253249|FG003|Overall Study|Patient/Guardian Decision|1|||
131719307|NCT02413398|474253250|FG000|Overall Study|Lost to Follow-up|2|||
131719308|NCT02413398|474253251|FG001|Overall Study|Lost to Follow-up|4|||
131719309|NCT02413398|474253250|FG000|Overall Study|Withdrawal by Subject|1|||
131719310|NCT02413398|474253251|FG001|Overall Study|Withdrawal by Subject|1|||
131719311|NCT02413398|474253250|FG000|Overall Study|Other Eligibility criteria|1|||
131719312|NCT02413398|474253251|FG001|Overall Study|Other Eligibility criteria|2|||
131719313|NCT01494038|474253254|FG000|Overall Study|Protocol Violation|1|||
131719314|NCT01494038|474253255|FG001|Overall Study|Protocol Violation|1|||
131719315|NCT01494038|474253254|FG000|Overall Study|Lost to Follow-up|18|||
131719316|NCT01494038|474253255|FG001|Overall Study|Lost to Follow-up|20|||
131719317|NCT01494038|474253254|FG000|Overall Study|Withdrawal by Subject|44|||
131719318|NCT01494038|474253255|FG001|Overall Study|Withdrawal by Subject|34|||
131804383|NCT01029353|474568501|FG003|Overall Study|Lost to Follow-up|4|||
131804384|NCT01029353|474568498|FG000|Overall Study|Consent Withdrawn|2|||
131804385|NCT01029353|474568499|FG001|Overall Study|Consent Withdrawn|0|||
131804386|NCT01029353|474568500|FG002|Overall Study|Consent Withdrawn|0|||
131719319|NCT01494038|474253254|FG000|Overall Study|Not able to get to clinic|21|||
131719320|NCT01494038|474253255|FG001|Overall Study|Not able to get to clinic|15|||
131719321|NCT01494038|474253254|FG000|Overall Study|Not willing to adhere to reqs|2|||
131719322|NCT01494038|474253255|FG001|Overall Study|Not willing to adhere to reqs|9|||
131719323|NCT01494038|474253254|FG000|Overall Study|Death|2|||
131719324|NCT01494038|474253255|FG001|Overall Study|Death|4|||
131804387|NCT01029353|474568501|FG003|Overall Study|Consent Withdrawn|0|||
131719325|NCT02874794|474253256|FG000|Overall Study|Physician Decision|3|||
131719326|NCT02874794|474253257|FG001|Overall Study|Physician Decision|2|||
131719327|NCT02874794|474253256|FG000|Overall Study|Withdrawal by Subject|2|||
131719328|NCT02874794|474253257|FG001|Overall Study|Withdrawal by Subject|8|||
131719329|NCT02874794|474253256|FG000|Overall Study|Death|2|||
131719330|NCT02874794|474253257|FG001|Overall Study|Death|1|||
131719331|NCT00537940|474253258|FG000|Overall Study|Adverse Event|20|||
131719332|NCT00537940|474253259|FG001|Overall Study|Adverse Event|19|||
131719333|NCT00537940|474253258|FG000|Overall Study|Lack of Efficacy|8|||
131719334|NCT00537940|474253259|FG001|Overall Study|Lack of Efficacy|16|||
131719335|NCT00537940|474253258|FG000|Overall Study|Lost to Follow-up|23|||
131719336|NCT00537940|474253259|FG001|Overall Study|Lost to Follow-up|29|||
131719337|NCT00537940|474253258|FG000|Overall Study|Withdrawal by Subject|113|||
131719338|NCT00537940|474253259|FG001|Overall Study|Withdrawal by Subject|95|||
131719339|NCT00537940|474253258|FG000|Overall Study|Protocol Violation|6|||
131719340|NCT00537940|474253259|FG001|Overall Study|Protocol Violation|4|||
131719341|NCT00537940|474253258|FG000|Overall Study|Pregnancy|1|||
131719342|NCT00537940|474253259|FG001|Overall Study|Pregnancy|1|||
131719343|NCT00537940|474253258|FG000|Overall Study|Study terminated by sponsor|2|||
131719344|NCT00537940|474253259|FG001|Overall Study|Study terminated by sponsor|3|||
131804388|NCT01029353|474568498|FG000|Overall Study|Primary Outcome Indeterminate|1|||
131804389|NCT01029353|474568499|FG001|Overall Study|Primary Outcome Indeterminate|3|||
131448162|NCT03863080|473270886|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
131719345|NCT00537940|474253258|FG000|Overall Study|Other|10|||
131719346|NCT00537940|474253259|FG001|Overall Study|Other|12|||
131719604|NCT03443024|474253359|FG002|Overall Study|Withdrawal by Subject|9|||
131719605|NCT03443024|474253360|FG003|Overall Study|Withdrawal by Subject|23|||
131719606|NCT03443024|474253357|FG000|Overall Study|Physician Decision|1|||
131719607|NCT03443024|474253358|FG001|Overall Study|Physician Decision|2|||
131719608|NCT03443024|474253359|FG002|Overall Study|Physician Decision|0|||
131719609|NCT03443024|474253360|FG003|Overall Study|Physician Decision|1|||
131719610|NCT03443024|474253357|FG000|Overall Study|Sponsor Decision|1|||
131719611|NCT03443024|474253358|FG001|Overall Study|Sponsor Decision|1|||
131719612|NCT03443024|474253359|FG002|Overall Study|Sponsor Decision|0|||
131719613|NCT03443024|474253360|FG003|Overall Study|Sponsor Decision|0|||
131719614|NCT03443024|474253357|FG000|Overall Study|Protocol Deviation|0|||
131719615|NCT03443024|474253358|FG001|Overall Study|Protocol Deviation|0|||
131719616|NCT03443024|474253359|FG002|Overall Study|Protocol Deviation|0|||
131719617|NCT03443024|474253360|FG003|Overall Study|Protocol Deviation|2|||
131719618|NCT01919411|474253362|FG000|Overall Study|Lost to Follow-up|2|||
131719619|NCT01919411|474253363|FG001|Overall Study|Lost to Follow-up|4|||
131719620|NCT01919411|474253362|FG000|Overall Study|Physician Decision|1|||
131719621|NCT01919411|474253363|FG001|Overall Study|Physician Decision|0|||
131719622|NCT01919411|474253362|FG000|Overall Study|Protocol Violation|2|||
131719623|NCT01919411|474253363|FG001|Overall Study|Protocol Violation|1|||
131719624|NCT01650805|474253364|FG000|Overall Study|Withdrawal by Subject|1|||
131719625|NCT01650805|474253365|FG001|Overall Study|Withdrawal by Subject|0|||
131719626|NCT01887210|474253366|FG000|Overall Study|Withdrawal by Subject|1|||
131719627|NCT01887210|474253367|FG001|Overall Study|Withdrawal by Subject|3|||
131719628|NCT01887210|474253366|FG000|Overall Study|Lost to Follow-up|0|||
131719629|NCT01887210|474253367|FG001|Overall Study|Lost to Follow-up|1|||
131719630|NCT02452359|474253368|FG000|Overall Study|Adverse Event|1|||
131719631|NCT02452359|474253368|FG000|Overall Study|Lost to Follow-up|15|||
131719632|NCT02452359|474253368|FG000|Overall Study|Pregnancy|1|||
131719633|NCT02452359|474253368|FG000|Overall Study|Withdrawal by Subject|4|||
131719634|NCT00840463|474253369|FG000|Overall Study|Adverse Event|1|||
131719635|NCT00840463|474253370|FG001|Overall Study|Adverse Event|0|||
131719636|NCT02515669|474253375|FG000|228 Week Open-Label Phase|Other|0|||
131719637|NCT02515669|474253376|FG001|228 Week Open-Label Phase|Other|0|||
131719638|NCT02515669|474253377|FG002|228 Week Open-Label Phase|Other|1|||
131719639|NCT02515669|474253378|FG003|228 Week Open-Label Phase|Other|4|||
131719640|NCT02515669|474253375|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
131719641|NCT02515669|474253376|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
131719642|NCT02515669|474253377|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
131719643|NCT02515669|474253378|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
131719644|NCT02515669|474253375|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
131719645|NCT02515669|474253376|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
131719646|NCT02515669|474253377|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
131719647|NCT02515669|474253378|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
131719648|NCT02515669|474253375|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
131719649|NCT02515669|474253376|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
131719650|NCT02515669|474253377|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
131719651|NCT02515669|474253378|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
131719652|NCT02515669|474253375|FG000|228 Week Open-Label Phase|Missing|0|||
131719653|NCT02515669|474253376|FG001|228 Week Open-Label Phase|Missing|2|||
131719654|NCT02515669|474253377|FG002|228 Week Open-Label Phase|Missing|2|||
131719655|NCT02515669|474253378|FG003|228 Week Open-Label Phase|Missing|2|||
131719656|NCT03750838|474253379|FG000|Overall Study|Lost to Follow-up|10|||
131719657|NCT03750838|474253380|FG001|Overall Study|Lost to Follow-up|6|||
131719658|NCT00630032|474253384|FG000|Overall Study|Death|55|||
131719659|NCT00630032|474253385|FG001|Overall Study|Death|49|||
131719660|NCT00630032|474253384|FG000|Overall Study|Withdrawal by Subject|3|||
131719661|NCT00630032|474253385|FG001|Overall Study|Withdrawal by Subject|2|||
131719662|NCT00630032|474253384|FG000|Overall Study|Lost to Follow-up|18|||
131719663|NCT00630032|474253385|FG001|Overall Study|Lost to Follow-up|31|||
131719664|NCT00630032|474253384|FG000|Overall Study|Protocol Violation|1|||
131719665|NCT00630032|474253385|FG001|Overall Study|Protocol Violation|0|||
131719666|NCT00630032|474253384|FG000|Overall Study|Patient has moved|1|||
131719667|NCT00630032|474253385|FG001|Overall Study|Patient has moved|1|||
131719668|NCT00630032|474253384|FG000|Overall Study|Disease progression|1|||
131719669|NCT00630032|474253385|FG001|Overall Study|Disease progression|1|||
131719670|NCT00630032|474253384|FG000|Overall Study|End of monitoring in US centers|11|||
131719671|NCT00630032|474253385|FG001|Overall Study|End of monitoring in US centers|11|||
131719672|NCT05635838|474255185|FG000|16-Week DBVC Period|Adverse Event|2|||
131719673|NCT05635838|474255186|FG001|16-Week DBVC Period|Adverse Event|0|||
131719674|NCT05635838|474255187|FG002|16-Week DBVC Period|Adverse Event|0|||
131719675|NCT05635838|474255188|FG003|16-Week DBVC Period|Adverse Event|0|||
131719676|NCT05635838|474255185|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
131719677|NCT05635838|474255186|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
131719678|NCT05635838|474255187|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
131719679|NCT05635838|474255188|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
131719680|NCT05635838|474255185|FG000|16-Week DBVC Period|Physician Decision|0|||
131719681|NCT05635838|474255186|FG001|16-Week DBVC Period|Physician Decision|1|||
131719682|NCT05635838|474255187|FG002|16-Week DBVC Period|Physician Decision|0|||
131719683|NCT05635838|474255188|FG003|16-Week DBVC Period|Physician Decision|0|||
131719684|NCT05635838|474255185|FG000|16-Week DBVC Period|Protocol Violation|1|||
131719685|NCT05635838|474255186|FG001|16-Week DBVC Period|Protocol Violation|0|||
131719686|NCT05635838|474255187|FG002|16-Week DBVC Period|Protocol Violation|0|||
131719687|NCT05635838|474255188|FG003|16-Week DBVC Period|Protocol Violation|0|||
131719688|NCT05635838|474255185|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
131719689|NCT05635838|474255186|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
131719690|NCT05635838|474255187|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
131719691|NCT05635838|474255188|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
131719692|NCT05635838|474255185|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
131719693|NCT05635838|474255186|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
131719694|NCT05635838|474255187|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
131719695|NCT05635838|474255188|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
131719696|NCT05635838|474255185|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
131719697|NCT05635838|474255186|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
131719698|NCT05635838|474255187|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
131719699|NCT05635838|474255188|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
131719700|NCT05635838|474255185|FG000|16-Week OLE Period|Adverse Event|0|||
131719701|NCT05635838|474255186|FG001|16-Week OLE Period|Adverse Event|0|||
131719702|NCT05635838|474255187|FG002|16-Week OLE Period|Adverse Event|0|||
131719703|NCT05635838|474255188|FG003|16-Week OLE Period|Adverse Event|2|||
131719704|NCT05635838|474255185|FG000|16-Week OLE Period|Lost to Follow-up|0|||
131719705|NCT05635838|474255186|FG001|16-Week OLE Period|Lost to Follow-up|0|||
131719706|NCT05635838|474255187|FG002|16-Week OLE Period|Lost to Follow-up|1|||
131719707|NCT05635838|474255188|FG003|16-Week OLE Period|Lost to Follow-up|3|||
131719708|NCT05635838|474255185|FG000|16-Week OLE Period|Physician Decision|0|||
131719709|NCT05635838|474255186|FG001|16-Week OLE Period|Physician Decision|0|||
131719710|NCT05635838|474255187|FG002|16-Week OLE Period|Physician Decision|0|||
131719711|NCT05635838|474255188|FG003|16-Week OLE Period|Physician Decision|1|||
131719712|NCT05635838|474255185|FG000|16-Week OLE Period|Protocol Violation|0|||
131719713|NCT05635838|474255186|FG001|16-Week OLE Period|Protocol Violation|0|||
131719714|NCT05635838|474255187|FG002|16-Week OLE Period|Protocol Violation|1|||
131719715|NCT05635838|474255188|FG003|16-Week OLE Period|Protocol Violation|1|||
131719716|NCT05635838|474255185|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
131719717|NCT05635838|474255186|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
131719718|NCT05635838|474255187|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
131719719|NCT05635838|474255188|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
131719720|NCT05635838|474255185|FG000|16-Week OLE Period|Pregnancy|0|||
131719721|NCT05635838|474255186|FG001|16-Week OLE Period|Pregnancy|0|||
131719722|NCT05635838|474255187|FG002|16-Week OLE Period|Pregnancy|1|||
131719723|NCT05635838|474255188|FG003|16-Week OLE Period|Pregnancy|0|||
131719724|NCT05165394|474255190|FG000|Overall Study|Withdrawal by Subject|5|||
131719725|NCT05165394|474255191|FG001|Overall Study|Withdrawal by Subject|1|||
131719726|NCT05165394|474255190|FG000|Overall Study|Lost to Follow-up|1|||
131719727|NCT05165394|474255191|FG001|Overall Study|Lost to Follow-up|2|||
131719728|NCT05165394|474255190|FG000|Overall Study|Other Than Specified|0|||
131719729|NCT05165394|474255191|FG001|Overall Study|Other Than Specified|1|||
131719730|NCT00001259|474255193|FG000|Study 2|Adverse Event|0|||
131719731|NCT00001259|474255194|FG001|Study 2|Adverse Event|0|||
131719732|NCT00001259|474255195|FG002|Study 2|Adverse Event|0|||
131719733|NCT00001259|474255196|FG003|Study 2|Adverse Event|0|||
131719734|NCT00001259|474255197|FG004|Study 2|Adverse Event|2|||
131719735|NCT00001259|474255198|FG005|Study 2|Adverse Event|0|||
131719736|NCT00001259|474255199|FG006|Study 2|Adverse Event|0|||
131719737|NCT03705494|474255200|FG000|Overall Study|Lost to Follow-up|2|||
131719738|NCT03705494|474255201|FG001|Overall Study|Lost to Follow-up|1|||
131719739|NCT03705494|474255200|FG000|Overall Study|Withdrawal by Subject|5|||
131719740|NCT03705494|474255201|FG001|Overall Study|Withdrawal by Subject|2|||
131719741|NCT02629393|474255207|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
131719742|NCT02629393|474255207|FG000|Overall Study|Physician Decision|1|||
131719743|NCT02089737|474255209|FG000|Overall Study|Survey form not completed|5|||
131719744|NCT02089737|474255209|FG000|Overall Study|Not treated|1|||
131719745|NCT01062399|474255213|FG000|Overall Study|Protocol Violation|0|||
131719746|NCT01062399|474255214|FG001|Overall Study|Protocol Violation|1|||
131719747|NCT01062399|474255215|FG002|Overall Study|Protocol Violation|0|||
131719748|NCT01062399|474255216|FG003|Overall Study|Protocol Violation|6|||
131719749|NCT01062399|474255217|FG004|Overall Study|Protocol Violation|4|||
131719750|NCT03133481|474255224|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
131719751|NCT03133481|474255225|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
131719752|NCT00779038|474255232|FG000|Overall Study|Study Prematurely Terminated|13|||
131719753|NCT01184989|474255233|FG000|Overall Study|Adverse Event|11|||
131719754|NCT01184989|474255233|FG000|Overall Study|Withdrawal by Subject|1|||
131719755|NCT01570491|474255234|FG000|Overall Study|Lost to Follow-up|3|||
131719756|NCT01570491|474255235|FG001|Overall Study|Lost to Follow-up|1|||
131719757|NCT01570491|474255234|FG000|Overall Study|treatment: not given or discontinued|2|||
131719758|NCT01570491|474255235|FG001|Overall Study|treatment: not given or discontinued|0|||
131719759|NCT05370157|474255238|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
131719760|NCT05370157|474255239|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
131719761|NCT05370157|474255238|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
131719762|NCT05370157|474255239|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
131719763|NCT04407507|474255240|FG000|Overall Study|Withdrawal by Subject|0|||
131719764|NCT04407507|474255241|FG001|Overall Study|Withdrawal by Subject|1|||
131719765|NCT00847613|474255249|FG000|Overall Study|Ongoing at cut-off date|250|||
131719766|NCT00847613|474255250|FG001|Overall Study|Ongoing at cut-off date|265|||
131719767|NCT00847613|474255251|FG002|Overall Study|Ongoing at cut-off date|64|||
131719768|NCT00847613|474255252|FG003|Overall Study|Ongoing at cut-off date|64|||
131719769|NCT00847613|474255249|FG000|Overall Study|Death|1|||
131719770|NCT00847613|474255250|FG001|Overall Study|Death|1|||
131719771|NCT00847613|474255251|FG002|Overall Study|Death|0|||
131719772|NCT00847613|474255252|FG003|Overall Study|Death|0|||
131719773|NCT00847613|474255249|FG000|Overall Study|Adverse Event|36|||
131719774|NCT00847613|474255250|FG001|Overall Study|Adverse Event|26|||
131719775|NCT00847613|474255251|FG002|Overall Study|Adverse Event|5|||
131719776|NCT00847613|474255252|FG003|Overall Study|Adverse Event|6|||
131719777|NCT00847613|474255249|FG000|Overall Study|Lack of Efficacy|7|||
131719778|NCT00847613|474255250|FG001|Overall Study|Lack of Efficacy|3|||
131719779|NCT00847613|474255251|FG002|Overall Study|Lack of Efficacy|3|||
131719780|NCT00847613|474255252|FG003|Overall Study|Lack of Efficacy|1|||
131719781|NCT00847613|474255249|FG000|Overall Study|Study terminated by Sponsor|1|||
131719782|NCT00847613|474255250|FG001|Overall Study|Study terminated by Sponsor|0|||
131719783|NCT00847613|474255251|FG002|Overall Study|Study terminated by Sponsor|2|||
131719784|NCT00847613|474255252|FG003|Overall Study|Study terminated by Sponsor|1|||
131719785|NCT00847613|474255249|FG000|Overall Study|Lost to Follow-up|5|||
131719786|NCT00847613|474255250|FG001|Overall Study|Lost to Follow-up|0|||
131719787|NCT00847613|474255251|FG002|Overall Study|Lost to Follow-up|0|||
131719788|NCT00847613|474255252|FG003|Overall Study|Lost to Follow-up|3|||
131719789|NCT00847613|474255249|FG000|Overall Study|Protocol Violation|6|||
131719790|NCT00847613|474255250|FG001|Overall Study|Protocol Violation|6|||
131719791|NCT00847613|474255251|FG002|Overall Study|Protocol Violation|3|||
131719792|NCT00847613|474255252|FG003|Overall Study|Protocol Violation|1|||
131719793|NCT00847613|474255249|FG000|Overall Study|Pregnancy|1|||
131719794|NCT00847613|474255250|FG001|Overall Study|Pregnancy|1|||
131719795|NCT00847613|474255251|FG002|Overall Study|Pregnancy|0|||
131719796|NCT00847613|474255252|FG003|Overall Study|Pregnancy|0|||
131719797|NCT00847613|474255249|FG000|Overall Study|Site closure|1|||
131719798|NCT00847613|474255250|FG001|Overall Study|Site closure|0|||
131719799|NCT00847613|474255251|FG002|Overall Study|Site closure|0|||
131719800|NCT00847613|474255252|FG003|Overall Study|Site closure|1|||
131719801|NCT00847613|474255249|FG000|Overall Study|Withdrawal by Subject|8|||
131719802|NCT00847613|474255250|FG001|Overall Study|Withdrawal by Subject|11|||
131719803|NCT00847613|474255251|FG002|Overall Study|Withdrawal by Subject|2|||
131719804|NCT00847613|474255252|FG003|Overall Study|Withdrawal by Subject|2|||
131719805|NCT00847613|474255249|FG000|Overall Study|Participant moved|4|||
131719806|NCT00847613|474255250|FG001|Overall Study|Participant moved|1|||
131719807|NCT00847613|474255251|FG002|Overall Study|Participant moved|0|||
131719808|NCT00847613|474255252|FG003|Overall Study|Participant moved|0|||
131719809|NCT00847613|474255249|FG000|Overall Study|Sponsor request|0|||
131719810|NCT00847613|474255250|FG001|Overall Study|Sponsor request|1|||
131719811|NCT00847613|474255251|FG002|Overall Study|Sponsor request|0|||
131719812|NCT00847613|474255252|FG003|Overall Study|Sponsor request|0|||
131719813|NCT00847613|474255249|FG000|Overall Study|Randomized, but not treated|0|||
131719814|NCT00847613|474255250|FG001|Overall Study|Randomized, but not treated|3|||
131719815|NCT00847613|474255251|FG002|Overall Study|Randomized, but not treated|0|||
131719816|NCT00847613|474255252|FG003|Overall Study|Randomized, but not treated|0|||
131719817|NCT00847613|474255249|FG000|Overall Study|Other|1|||
131719818|NCT00847613|474255250|FG001|Overall Study|Other|1|||
131719819|NCT00847613|474255251|FG002|Overall Study|Other|2|||
131719820|NCT00847613|474255252|FG003|Overall Study|Other|0|||
131719821|NCT00754390|474255253|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
131719822|NCT00754390|474255253|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
131719823|NCT00754390|474255253|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
131719824|NCT00754390|474255253|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
131719825|NCT01009294|474255254|FG000|Overall Study|Study discontinued by Sponsor|6|||
131719826|NCT04332419|474255255|FG000|Overall Study|Withdrawal by Subject|1|||
131719827|NCT04222725|474255258|FG000|Overall Study|Adverse Event|0|||
131719828|NCT04222725|474255259|FG001|Overall Study|Adverse Event|1|||
131719829|NCT04222725|474255260|FG002|Overall Study|Adverse Event|0|||
131719830|NCT04222725|474255261|FG003|Overall Study|Adverse Event|0|||
131719831|NCT04925570|474255262|FG000|Overall Study|Protocol Violation|24|||
131719832|NCT04925570|474255263|FG001|Overall Study|Protocol Violation|30|||
131719833|NCT04925570|474255262|FG000|Overall Study|Withdrawal by Subject|0|||
131719834|NCT04925570|474255263|FG001|Overall Study|Withdrawal by Subject|2|||
131719835|NCT00658333|474255264|FG000|Overall Study|Adverse Event|2|||
131719836|NCT00658333|474255265|FG001|Overall Study|Adverse Event|1|||
131719837|NCT00828451|474255266|FG000|Overall Study|Death|2|||
131719838|NCT00828451|474255266|FG000|Overall Study|Lack of intravenous line|7|||
131719839|NCT00828451|474255266|FG000|Overall Study|Withdrawal by Subject|1|||
131719840|NCT00828451|474255266|FG000|Overall Study|Deterioration in clinical status|1|||
131719841|NCT00667277|474255269|FG000|Overall Study|Withdrawal by Subject|2|||
131719842|NCT00519532|474255270|FG000|Overall Study|Adverse Event|11|||
131719843|NCT00519532|474255270|FG000|Overall Study|Withdrawal by Subject|5|||
131719844|NCT00519532|474255270|FG000|Overall Study|Lost to Follow-up|2|||
131719845|NCT03138564|474255271|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
131719846|NCT03138564|474255272|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
131719847|NCT03138564|474255271|FG000|Overall Study|Lost to Follow-up|16|||
131719848|NCT03138564|474255272|FG001|Overall Study|Lost to Follow-up|2|||
131719849|NCT03138564|474255271|FG000|Overall Study|Withdrawal by Subject|48|||
131719850|NCT03138564|474255272|FG001|Overall Study|Withdrawal by Subject|4|||
131719851|NCT03138564|474255271|FG000|Overall Study|No longer met eligibility criteria|2|||
131719852|NCT03138564|474255272|FG001|Overall Study|No longer met eligibility criteria|0|||
131719853|NCT03138564|474255271|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
131719854|NCT03138564|474255272|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
131719855|NCT03138564|474255271|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
131719856|NCT03138564|474255272|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
131719857|NCT03138564|474255271|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
131719858|NCT03138564|474255272|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
131719859|NCT03138564|474255271|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
131719860|NCT03138564|474255272|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
131719861|NCT00624338|474255273|FG000|Overall Study|Adverse Event|14|||
131719862|NCT00624338|474255274|FG001|Overall Study|Adverse Event|14|||
131719863|NCT00624338|474255275|FG002|Overall Study|Adverse Event|18|||
131719864|NCT00624338|474255273|FG000|Overall Study|Lost to Follow-up|1|||
131719865|NCT00624338|474255274|FG001|Overall Study|Lost to Follow-up|0|||
131719866|NCT00624338|474255275|FG002|Overall Study|Lost to Follow-up|0|||
131719867|NCT00624338|474255273|FG000|Overall Study|Lack of Efficacy|11|||
131719868|NCT00624338|474255274|FG001|Overall Study|Lack of Efficacy|3|||
131719869|NCT00624338|474255275|FG002|Overall Study|Lack of Efficacy|14|||
131719870|NCT00624338|474255273|FG000|Overall Study|Protocol Violation|3|||
131719871|NCT00624338|474255274|FG001|Overall Study|Protocol Violation|3|||
131719872|NCT00624338|474255275|FG002|Overall Study|Protocol Violation|2|||
131719873|NCT00624338|474255273|FG000|Overall Study|Death|0|||
131719874|NCT00624338|474255274|FG001|Overall Study|Death|2|||
131719875|NCT00624338|474255275|FG002|Overall Study|Death|0|||
131719876|NCT00624338|474255273|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
131719877|NCT00624338|474255274|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
131719878|NCT00624338|474255275|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
131719879|NCT00624338|474255273|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
131719880|NCT00624338|474255274|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
131719881|NCT00624338|474255275|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
131719882|NCT00624338|474255273|FG000|Overall Study|Other|15|||
131719883|NCT00624338|474255274|FG001|Overall Study|Other|5|||
131719884|NCT00624338|474255275|FG002|Overall Study|Other|9|||
131719885|NCT00624338|474255273|FG000|Overall Study|Randomized but not treated|2|||
131719886|NCT00624338|474255274|FG001|Overall Study|Randomized but not treated|1|||
131719887|NCT00624338|474255275|FG002|Overall Study|Randomized but not treated|3|||
131719888|NCT01548638|474255276|FG000|Overall Study|Protocol Violation|3|||
131719889|NCT01548638|474255276|FG000|Overall Study|Withdrawal by Subject|1|||
131719890|NCT05593432|474255277|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
131719891|NCT05593432|474255278|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
131719892|NCT05593432|474255279|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
131719893|NCT05593432|474255280|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
131719894|NCT05593432|474255277|FG000|16-Week OLE Period|Lack of Efficacy|0|||
131719895|NCT05593432|474255278|FG001|16-Week OLE Period|Lack of Efficacy|0|||
131719896|NCT05593432|474255279|FG002|16-Week OLE Period|Lack of Efficacy|0|||
131719897|NCT05593432|474255280|FG003|16-Week OLE Period|Lack of Efficacy|1|||
131719898|NCT05593432|474255277|FG000|16-Week OLE Period|Lost to Follow-up|0|||
131719899|NCT05593432|474255278|FG001|16-Week OLE Period|Lost to Follow-up|0|||
131719900|NCT05593432|474255279|FG002|16-Week OLE Period|Lost to Follow-up|1|||
131719901|NCT05593432|474255280|FG003|16-Week OLE Period|Lost to Follow-up|2|||
131719902|NCT05593432|474255277|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
131719903|NCT05593432|474255278|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
131719904|NCT05593432|474255279|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
131719905|NCT05593432|474255280|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
131719906|NCT03885284|474255281|FG000|Overall Study|Disease Progression|1|||
131719907|NCT03885284|474255282|FG001|Overall Study|Disease Progression|3|||
131719908|NCT03885284|474255281|FG000|Overall Study|Physician Decision|0|||
131719909|NCT03885284|474255282|FG001|Overall Study|Physician Decision|1|||
131719910|NCT05897853|474255285|FG000|Overall Study|Lost to Follow-up|2|||
131719911|NCT05897853|474255286|FG001|Overall Study|Lost to Follow-up|0|||
131719912|NCT05897853|474255285|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
131719913|NCT05897853|474255286|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
131719914|NCT01591330|474255290|FG000|Period 1|Adverse Event|1|||
131719915|NCT01591330|474255291|FG001|Period 1|Adverse Event|0|||
131719916|NCT01591330|474255292|FG002|Period 1|Adverse Event|0|||
131719917|NCT01591330|474255293|FG003|Period 1|Adverse Event|0|||
131719918|NCT01591330|474255290|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
131719919|NCT01591330|474255291|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
131719920|NCT01591330|474255292|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
131719921|NCT01591330|474255293|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
131719922|NCT01591330|474255290|FG000|Period 2|Adverse Event|1|||
131719923|NCT01591330|474255291|FG001|Period 2|Adverse Event|0|||
131719924|NCT01591330|474255292|FG002|Period 2|Adverse Event|0|||
131719925|NCT01591330|474255293|FG003|Period 2|Adverse Event|0|||
131719926|NCT04458857|474255296|FG000|Overall Study|Adverse Event|0|||
131719927|NCT04458857|474255297|FG001|Overall Study|Adverse Event|1|||
131719928|NCT04458857|474255298|FG002|Overall Study|Adverse Event|0|||
131719929|NCT04458857|474255296|FG000|Overall Study|Withdrawal by Subject|2|||
131719930|NCT04458857|474255297|FG001|Overall Study|Withdrawal by Subject|0|||
131719931|NCT04458857|474255298|FG002|Overall Study|Withdrawal by Subject|0|||
131719932|NCT04458857|474255296|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131719933|NCT04458857|474255297|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131804544|NCT02914600|474568556|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
131804545|NCT02914600|474568557|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
131804546|NCT02914600|474568558|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
131804547|NCT02914600|474568556|FG000|Overall Study|Enrolled but not treated|1|||
131804548|NCT02914600|474568557|FG001|Overall Study|Enrolled but not treated|0|||
131804549|NCT02914600|474568558|FG002|Overall Study|Enrolled but not treated|0|||
131804550|NCT00454909|474568559|FG000|Overall Study|Withdrawal by Subject|1|||
131804551|NCT00454909|474568560|FG001|Overall Study|Withdrawal by Subject|0|||
131804552|NCT00454909|474568561|FG002|Overall Study|Withdrawal by Subject|0|||
131804553|NCT00454909|474568559|FG000|Overall Study|Migrated/moved from study area|0|||
131804554|NCT00454909|474568560|FG001|Overall Study|Migrated/moved from study area|0|||
131804555|NCT00454909|474568561|FG002|Overall Study|Migrated/moved from study area|1|||
131804556|NCT00454909|474568559|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
131804557|NCT00454909|474568560|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
131804558|NCT00454909|474568561|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
131804559|NCT00454909|474568559|FG000|Overall Study|Others|1|||
131804560|NCT00454909|474568560|FG001|Overall Study|Others|0|||
131804561|NCT00454909|474568561|FG002|Overall Study|Others|0|||
131804562|NCT02996682|474568562|FG000|Overall Study|Death|0|||
131804563|NCT02996682|474568563|FG001|Overall Study|Death|3|||
131804564|NCT02457520|474568564|FG000|Active Treatment Phase|Adverse Event|10|||
131804565|NCT02457520|474568564|FG000|Active Treatment Phase|Lost to Follow-up|8|||
131804566|NCT02457520|474568564|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
131804567|NCT02457520|474568564|FG000|Active Treatment Phase|other|4|||
131719934|NCT04458857|474255298|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131719935|NCT04458857|474255296|FG000|Overall Study|Non-compliance with study drug|0|||
131804568|NCT02457520|474568564|FG000|Active Treatment Phase|Physician Decision|1|||
131719936|NCT04458857|474255297|FG001|Overall Study|Non-compliance with study drug|1|||
131719937|NCT04458857|474255298|FG002|Overall Study|Non-compliance with study drug|0|||
131719938|NCT04458857|474255296|FG000|Overall Study|Lost to Follow-up|4|||
131719939|NCT04458857|474255297|FG001|Overall Study|Lost to Follow-up|1|||
131719940|NCT04458857|474255298|FG002|Overall Study|Lost to Follow-up|0|||
131719941|NCT02609399|474255299|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
131904619|NCT00830219|474937041|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
131904620|NCT00301834|474937042|FG000|Overall Study|Death|1|||
131719942|NCT02609399|474255300|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
131719943|NCT02609399|474255299|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
131719944|NCT02609399|474255300|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
131719945|NCT02609399|474255299|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
131719946|NCT02609399|474255300|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
131719947|NCT02986373|474255304|FG000|Overall Study|Adverse Event|4|||
131719948|NCT02986373|474255304|FG000|Overall Study|Lost to Follow-up|1|||
131719949|NCT02986373|474255304|FG000|Overall Study|Withdrawal by Subject|10|||
131719950|NCT02986373|474255304|FG000|Overall Study|Other|24|||
131719951|NCT04800315|474255305|FG000|Randomization|Did not receive study treatment|1|||
131719952|NCT04800315|474255306|FG001|Randomization|Did not receive study treatment|0|||
131719953|NCT04800315|474255307|FG002|Randomization|Did not receive study treatment|0|||
131719954|NCT04800315|474255308|FG003|Randomization|Did not receive study treatment|0|||
131719955|NCT04800315|474255305|FG000|Treatment Period|Adverse Event|4|||
131719956|NCT04800315|474255306|FG001|Treatment Period|Adverse Event|2|||
131719957|NCT04800315|474255307|FG002|Treatment Period|Adverse Event|1|||
131719958|NCT04800315|474255308|FG003|Treatment Period|Adverse Event|2|||
131719959|NCT04800315|474255305|FG000|Treatment Period|Lack of Efficacy|1|||
131719960|NCT04800315|474255306|FG001|Treatment Period|Lack of Efficacy|0|||
131719961|NCT04800315|474255307|FG002|Treatment Period|Lack of Efficacy|0|||
131719962|NCT04800315|474255308|FG003|Treatment Period|Lack of Efficacy|3|||
131719963|NCT04800315|474255305|FG000|Treatment Period|Lost to Follow-up|0|||
131719964|NCT04800315|474255306|FG001|Treatment Period|Lost to Follow-up|1|||
131719965|NCT04800315|474255307|FG002|Treatment Period|Lost to Follow-up|2|||
131719966|NCT04800315|474255308|FG003|Treatment Period|Lost to Follow-up|2|||
131719967|NCT04800315|474255305|FG000|Treatment Period|Withdrawal by participant|0|||
131719968|NCT04800315|474255306|FG001|Treatment Period|Withdrawal by participant|0|||
131719969|NCT04800315|474255307|FG002|Treatment Period|Withdrawal by participant|0|||
131719970|NCT04800315|474255308|FG003|Treatment Period|Withdrawal by participant|4|||
131719971|NCT04800315|474255305|FG000|Treatment Period|Other Reasons|0|||
131719972|NCT04800315|474255306|FG001|Treatment Period|Other Reasons|2|||
131719973|NCT04800315|474255307|FG002|Treatment Period|Other Reasons|0|||
131719974|NCT04800315|474255308|FG003|Treatment Period|Other Reasons|1|||
131719975|NCT00753922|474255309|FG000|Overall Study|Lost to Follow-up|155|||
131719976|NCT00753922|474255310|FG001|Overall Study|Lost to Follow-up|24|||
131719977|NCT00753922|474255311|FG002|Overall Study|Lost to Follow-up|28|||
131904621|NCT01811732|474937043|FG000|Overall Study|Lost to Follow-up|24|||
131904622|NCT01811732|474937044|FG001|Overall Study|Lost to Follow-up|30|||
131719978|NCT00753922|474255312|FG003|Overall Study|Lost to Follow-up|5|||
131719979|NCT00753922|474255309|FG000|Overall Study|Withdrawal by Subject|9|||
131719980|NCT00753922|474255310|FG001|Overall Study|Withdrawal by Subject|11|||
131719981|NCT00753922|474255311|FG002|Overall Study|Withdrawal by Subject|4|||
131804569|NCT02457520|474568564|FG000|Active Treatment Phase|Protocol Violation|1|||
131804570|NCT02457520|474568564|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
131804571|NCT02457520|474568564|FG000|Post-treatment Period|Other: Retreatment Required|7|||
131804572|NCT02457520|474568564|FG000|Post-treatment Period|Lost to Follow-up|23|||
131804573|NCT02457520|474568564|FG000|Post-treatment Period|Other|3|||
131804574|NCT02457520|474568564|FG000|Post-treatment Period|Physician Decision|1|||
131804575|NCT02457520|474568564|FG000|Post-treatment Period|Withdrawal by Subject|14|||
131804576|NCT00282048|474568565|FG000|Overall Study|Lack of Efficacy|30|||
131804577|NCT00282048|474568565|FG000|Overall Study|Adverse Event|22|||
131804578|NCT00282048|474568565|FG000|Overall Study|Withdrawal by Subject|1|||
131804579|NCT00282048|474568565|FG000|Overall Study|Other|8|||
131804580|NCT00282048|474568565|FG000|Overall Study|Ongoing|1|||
131804581|NCT02107092|474568566|FG000|Overall Study|Miscellaneous|3|||
131804582|NCT02107092|474568566|FG000|Overall Study|Subject compliance|3|||
131804583|NCT02107092|474568566|FG000|Overall Study|Hypo-or hyperkalemia|2|||
131804584|NCT02107092|474568566|FG000|Overall Study|Met ECG withdrawal criteria|3|||
131804585|NCT02107092|474568566|FG000|Overall Study|Physician Decision|3|||
131804586|NCT02107092|474568566|FG000|Overall Study|Lost to Follow-up|2|||
131804587|NCT02107092|474568566|FG000|Overall Study|Withdrawal by Subject|9|||
131719982|NCT00753922|474255312|FG003|Overall Study|Withdrawal by Subject|2|||
131719983|NCT00753922|474255309|FG000|Overall Study|Patient Non-compliance|55|||
131804588|NCT02107092|474568566|FG000|Overall Study|Adverse Event|7|||
131804589|NCT02107092|474568566|FG000|Overall Study|Expected progression of CKD|12|||
131804590|NCT03522675|474568568|FG000|Overall Study|Screen fail|1|||
131719984|NCT00753922|474255310|FG001|Overall Study|Patient Non-compliance|22|||
131719985|NCT00753922|474255311|FG002|Overall Study|Patient Non-compliance|14|||
131719986|NCT00753922|474255312|FG003|Overall Study|Patient Non-compliance|11|||
131719987|NCT00753922|474255309|FG000|Overall Study|Patients Not Completing Visit|11|||
131719988|NCT00753922|474255310|FG001|Overall Study|Patients Not Completing Visit|0|||
131719989|NCT00753922|474255311|FG002|Overall Study|Patients Not Completing Visit|1|||
131719990|NCT00753922|474255312|FG003|Overall Study|Patients Not Completing Visit|0|||
131804591|NCT03522675|474568568|FG000|Overall Study|Non-reactive to histamine|1|||
131719991|NCT00753922|474255309|FG000|Overall Study|Death|2|||
131719992|NCT00753922|474255310|FG001|Overall Study|Death|23|||
131719993|NCT00753922|474255311|FG002|Overall Study|Death|2|||
131719994|NCT00753922|474255312|FG003|Overall Study|Death|1|||
131719995|NCT00753922|474255309|FG000|Overall Study|Discontinuation Due to Explantation|14|||
131719996|NCT00753922|474255310|FG001|Overall Study|Discontinuation Due to Explantation|14|||
131719997|NCT00753922|474255311|FG002|Overall Study|Discontinuation Due to Explantation|14|||
131719998|NCT00753922|474255312|FG003|Overall Study|Discontinuation Due to Explantation|4|||
131719999|NCT02932267|474255315|FG000|Overall Study|Withdrawal by Subject|3|||
131720000|NCT02932267|474255315|FG000|Overall Study|Lost to Follow-up|4|||
131720001|NCT02932267|474255315|FG000|Overall Study|Pregnancy|1|||
131720002|NCT02453841|474255318|FG000|Overall Study|Protocol Violation|1|||
131720003|NCT02453841|474255318|FG000|Overall Study|Unable to obtain blood samples|2|||
131720004|NCT02190591|474255319|FG000|Overall Study|Withdrawal by Subject|1|||
131720005|NCT02190591|474255320|FG001|Overall Study|Withdrawal by Subject|8|||
131720006|NCT02190591|474255319|FG000|Overall Study|Protocol Violation|1|||
131720007|NCT02190591|474255320|FG001|Overall Study|Protocol Violation|0|||
131720008|NCT02190591|474255319|FG000|Overall Study|did not use peanut ball as instructed|0|||
131720009|NCT02190591|474255320|FG001|Overall Study|did not use peanut ball as instructed|2|||
131720010|NCT02190591|474255319|FG000|Overall Study|face presentation so she was ineligible|0|||
131720011|NCT02190591|474255320|FG001|Overall Study|face presentation so she was ineligible|1|||
131720012|NCT03851510|474255321|FG000|Overall Study|Screen Fail|1|||
131720013|NCT03851510|474255321|FG000|Overall Study|Adverse Event|1|||
131720014|NCT03851510|474255321|FG000|Overall Study|Withdrawal by Subject|1|||
131720015|NCT03598777|474255322|FG000|Overall Study|Study Terminated by Sponsor|3|||
131720016|NCT03598777|474255323|FG001|Overall Study|Study Terminated by Sponsor|0|||
131720017|NCT03598777|474255324|FG002|Overall Study|Study Terminated by Sponsor|0|||
131720018|NCT03598777|474255325|FG003|Overall Study|Study Terminated by Sponsor|0|||
131720019|NCT03598777|474255326|FG004|Overall Study|Study Terminated by Sponsor|15|||
131720020|NCT03598777|474255322|FG000|Overall Study|Withdrawal by Subject|1|||
131720021|NCT03598777|474255323|FG001|Overall Study|Withdrawal by Subject|1|||
131720022|NCT03598777|474255324|FG002|Overall Study|Withdrawal by Subject|0|||
131720023|NCT03598777|474255325|FG003|Overall Study|Withdrawal by Subject|0|||
131720024|NCT03598777|474255326|FG004|Overall Study|Withdrawal by Subject|0|||
131720025|NCT03598777|474255322|FG000|Overall Study|Adverse Event|1|||
131720026|NCT03598777|474255323|FG001|Overall Study|Adverse Event|0|||
131720027|NCT03598777|474255324|FG002|Overall Study|Adverse Event|0|||
131720028|NCT03598777|474255325|FG003|Overall Study|Adverse Event|0|||
131720029|NCT03598777|474255326|FG004|Overall Study|Adverse Event|0|||
131720030|NCT03598777|474255322|FG000|Overall Study|Lost to Follow-up|1|||
131720031|NCT03598777|474255323|FG001|Overall Study|Lost to Follow-up|0|||
131720032|NCT03598777|474255324|FG002|Overall Study|Lost to Follow-up|0|||
131720033|NCT03598777|474255325|FG003|Overall Study|Lost to Follow-up|0|||
131720034|NCT03598777|474255326|FG004|Overall Study|Lost to Follow-up|0|||
131720035|NCT01151137|474255327|FG000|Overall Study|Death|15|||
131720036|NCT01151137|474255328|FG001|Overall Study|Death|27|||
131720037|NCT01151137|474255327|FG000|Overall Study|Lost to Follow-up|1|||
131720038|NCT01151137|474255328|FG001|Overall Study|Lost to Follow-up|1|||
131720039|NCT00072189|474255329|FG000|Overall Study|Withdrawal by Subject|1|||
131720040|NCT00144300|474255330|FG000|Overall Study|Adverse Event|18|||
131720041|NCT00144300|474255331|FG001|Overall Study|Adverse Event|16|||
131720042|NCT00144300|474255330|FG000|Overall Study|Protocol Violation|1|||
131720043|NCT00144300|474255331|FG001|Overall Study|Protocol Violation|3|||
131720044|NCT00144300|474255330|FG000|Overall Study|Lost to Follow-up|3|||
131720045|NCT00144300|474255331|FG001|Overall Study|Lost to Follow-up|0|||
131720046|NCT00144300|474255330|FG000|Overall Study|Withdrawal by Subject|6|||
131720047|NCT00144300|474255331|FG001|Overall Study|Withdrawal by Subject|6|||
131720048|NCT00144300|474255330|FG000|Overall Study|Other reason (not specified)|1|||
131720049|NCT00144300|474255331|FG001|Overall Study|Other reason (not specified)|3|||
131720050|NCT01933672|474255332|FG000|Metformin Run-in Period|Adverse Event|1|||
131720051|NCT01933672|474255333|FG001|Metformin Run-in Period|Adverse Event|0|||
131720052|NCT01933672|474255334|FG002|Metformin Run-in Period|Adverse Event|0|||
131720053|NCT01933672|474255335|FG003|Metformin Run-in Period|Adverse Event|0|||
131720054|NCT01933672|474255336|FG004|Metformin Run-in Period|Adverse Event|0|||
131720055|NCT01933672|474255337|FG005|Metformin Run-in Period|Adverse Event|0|||
131720056|NCT01933672|474255338|FG006|Metformin Run-in Period|Adverse Event|0|||
131720057|NCT01933672|474255332|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
131720058|NCT01933672|474255333|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131720059|NCT01933672|474255334|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131720060|NCT01933672|474255335|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131720061|NCT01933672|474255336|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131720062|NCT01933672|474255337|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131720063|NCT01933672|474255338|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131720064|NCT01933672|474255332|FG000|Metformin Run-in Period|Other|5|||
131720065|NCT01933672|474255333|FG001|Metformin Run-in Period|Other|0|||
131720066|NCT01933672|474255334|FG002|Metformin Run-in Period|Other|0|||
131720067|NCT01933672|474255335|FG003|Metformin Run-in Period|Other|0|||
131720068|NCT01933672|474255336|FG004|Metformin Run-in Period|Other|0|||
131720069|NCT01933672|474255337|FG005|Metformin Run-in Period|Other|0|||
131720070|NCT01933672|474255338|FG006|Metformin Run-in Period|Other|0|||
131720071|NCT01933672|474255332|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720072|NCT01933672|474255333|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720073|NCT01933672|474255334|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720074|NCT01933672|474255335|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720075|NCT01933672|474255336|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
131720076|NCT01933672|474255337|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720077|NCT01933672|474255338|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720078|NCT01933672|474255332|FG000|First Intervention Period (12-16 Days)|Other|0|||
131720079|NCT01933672|474255333|FG001|First Intervention Period (12-16 Days)|Other|0|||
131720080|NCT01933672|474255334|FG002|First Intervention Period (12-16 Days)|Other|1|||
131720081|NCT01933672|474255335|FG003|First Intervention Period (12-16 Days)|Other|0|||
131720082|NCT01933672|474255336|FG004|First Intervention Period (12-16 Days)|Other|0|||
131720083|NCT01933672|474255337|FG005|First Intervention Period (12-16 Days)|Other|1|||
131720084|NCT01933672|474255338|FG006|First Intervention Period (12-16 Days)|Other|0|||
131720085|NCT01933672|474255332|FG000|Second Intervention Period (12-16 Days)|Other|0|||
131720086|NCT01933672|474255333|FG001|Second Intervention Period (12-16 Days)|Other|1|||
131720087|NCT01933672|474255334|FG002|Second Intervention Period (12-16 Days)|Other|1|||
131720088|NCT01933672|474255335|FG003|Second Intervention Period (12-16 Days)|Other|0|||
131720089|NCT01933672|474255336|FG004|Second Intervention Period (12-16 Days)|Other|0|||
131720090|NCT01933672|474255337|FG005|Second Intervention Period (12-16 Days)|Other|0|||
131720091|NCT01933672|474255338|FG006|Second Intervention Period (12-16 Days)|Other|0|||
131720092|NCT01933672|474255332|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720093|NCT01933672|474255333|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720094|NCT01933672|474255334|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720095|NCT01933672|474255335|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
131720096|NCT01933672|474255336|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720097|NCT01933672|474255337|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720098|NCT01933672|474255338|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131720099|NCT01933672|474255332|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131720100|NCT01933672|474255333|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
131720101|NCT01933672|474255334|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131720102|NCT01933672|474255335|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131720103|NCT01933672|474255336|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131720104|NCT01933672|474255337|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131720105|NCT01933672|474255338|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131720106|NCT02426086|474255342|FG000|Overall Study|Death|33|||
131720107|NCT02426086|474255343|FG001|Overall Study|Death|36|||
131720108|NCT02426086|474255342|FG000|Overall Study|Lost to Follow-up|2|||
131720109|NCT02426086|474255343|FG001|Overall Study|Lost to Follow-up|0|||
131720110|NCT02426086|474255342|FG000|Overall Study|Study Terminated by Sponsor|5|||
131720111|NCT02426086|474255343|FG001|Overall Study|Study Terminated by Sponsor|14|||
131720112|NCT02426086|474255342|FG000|Overall Study|Withdrawal by Subject|8|||
131720113|NCT02426086|474255343|FG001|Overall Study|Withdrawal by Subject|9|||
131720114|NCT00524303|474255344|FG000|Overall Study|Lost to Follow-up|6|||
131720115|NCT00524303|474255345|FG001|Overall Study|Lost to Follow-up|0|||
131720116|NCT00524303|474255346|FG002|Overall Study|Lost to Follow-up|3|||
131720117|NCT00524303|474255344|FG000|Overall Study|Protocol Violation|0|||
131904623|NCT01811732|474937043|FG000|Overall Study|Withdrawal by Subject|16|||
131904624|NCT01811732|474937044|FG001|Overall Study|Withdrawal by Subject|10|||
131904625|NCT01811732|474937043|FG000|Overall Study|Adverse Event|3|||
131720118|NCT00524303|474255345|FG001|Overall Study|Protocol Violation|1|||
131720119|NCT00524303|474255346|FG002|Overall Study|Protocol Violation|1|||
131720120|NCT00524303|474255344|FG000|Overall Study|Withdrawal by Subject|3|||
131720121|NCT00524303|474255345|FG001|Overall Study|Withdrawal by Subject|0|||
131904626|NCT01811732|474937044|FG001|Overall Study|Adverse Event|9|||
131720122|NCT00524303|474255346|FG002|Overall Study|Withdrawal by Subject|4|||
131720123|NCT00524303|474255344|FG000|Overall Study|Death|0|||
131904627|NCT01811732|474937043|FG000|Overall Study|Lack of Efficacy|3|||
131904628|NCT01811732|474937044|FG001|Overall Study|Lack of Efficacy|1|||
131720124|NCT00524303|474255345|FG001|Overall Study|Death|2|||
131720125|NCT00524303|474255346|FG002|Overall Study|Death|3|||
131720126|NCT00524303|474255344|FG000|Overall Study|Adverse Event|1|||
131720127|NCT00524303|474255345|FG001|Overall Study|Adverse Event|2|||
131720128|NCT00524303|474255346|FG002|Overall Study|Adverse Event|3|||
131720129|NCT00524303|474255344|FG000|Overall Study|Did not Complete Study Dosing|1|||
131720130|NCT00524303|474255345|FG001|Overall Study|Did not Complete Study Dosing|0|||
131720131|NCT00524303|474255346|FG002|Overall Study|Did not Complete Study Dosing|0|||
131720132|NCT00524303|474255344|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
131720133|NCT00524303|474255345|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
131720134|NCT00524303|474255346|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
131720135|NCT00524303|474255344|FG000|Overall Study|Disease Progression|0|||
131720136|NCT00524303|474255345|FG001|Overall Study|Disease Progression|4|||
131720137|NCT00524303|474255346|FG002|Overall Study|Disease Progression|1|||
131720138|NCT00524303|474255344|FG000|Overall Study|Disease Recurrence|0|||
131720139|NCT00524303|474255345|FG001|Overall Study|Disease Recurrence|1|||
131720140|NCT00524303|474255346|FG002|Overall Study|Disease Recurrence|0|||
131720141|NCT00524303|474255344|FG000|Overall Study|Sponsor Request|0|||
131720142|NCT00524303|474255345|FG001|Overall Study|Sponsor Request|0|||
131720143|NCT00524303|474255346|FG002|Overall Study|Sponsor Request|1|||
131720144|NCT00524303|474255344|FG000|Overall Study|Physician Decision|0|||
131720145|NCT00524303|474255345|FG001|Overall Study|Physician Decision|0|||
131720146|NCT00524303|474255346|FG002|Overall Study|Physician Decision|1|||
131720147|NCT00524303|474255344|FG000|Overall Study|Completed 5 years|0|||
131720148|NCT00524303|474255345|FG001|Overall Study|Completed 5 years|0|||
131720149|NCT00524303|474255346|FG002|Overall Study|Completed 5 years|1|||
131720150|NCT01769404|474255355|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
131720151|NCT01769404|474255356|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
131720152|NCT01769404|474255355|FG000|Treatment Period 1|Withdrawal by Subject|3|||
131720153|NCT01769404|474255356|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131720154|NCT01769404|474255355|FG000|Treatment Period 1|Sponsor decision|1|||
131720155|NCT01769404|474255356|FG001|Treatment Period 1|Sponsor decision|0|||
131720156|NCT01769404|474255355|FG000|Treatment Period 2|Sponsor decision|7|||
131720157|NCT01769404|474255356|FG001|Treatment Period 2|Sponsor decision|0|||
131720158|NCT00538733|474255357|FG000|Overall Study|Adverse Event|8|||
131720159|NCT00538733|474255357|FG000|Overall Study|Death|1|||
131720160|NCT00538733|474255357|FG000|Overall Study|declined to participate|2|||
131720161|NCT00538733|474255357|FG000|Overall Study|still on therapy|1|||
131720162|NCT00095121|474255360|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
131720163|NCT00095121|474255361|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
131720164|NCT00095121|474255360|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
131720165|NCT00095121|474255361|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
131720166|NCT01266148|474257077|FG000|Overall Study|Adverse Event|2|||
131720167|NCT01266148|474257078|FG001|Overall Study|Adverse Event|0|||
131720168|NCT01266148|474257077|FG000|Overall Study|Ongoing rejection|1|||
131720169|NCT01266148|474257078|FG001|Overall Study|Ongoing rejection|0|||
131720170|NCT01266148|474257077|FG000|Overall Study|2 2R rejections|1|||
131720171|NCT01266148|474257078|FG001|Overall Study|2 2R rejections|0|||
131720172|NCT01266148|474257077|FG000|Overall Study|Death|2|||
131720173|NCT01266148|474257078|FG001|Overall Study|Death|3|||
131720174|NCT01266148|474257077|FG000|Overall Study|missing mGFR value + AE|1|||
131720175|NCT01266148|474257078|FG001|Overall Study|missing mGFR value + AE|0|||
131720176|NCT01853228|474257079|FG000|Phase 1|Lack of Efficacy|8|||
131720177|NCT01853228|474257080|FG001|Phase 1|Lack of Efficacy|0|||
131720178|NCT01853228|474257079|FG000|Phase 1|Other|1|||
131720179|NCT01853228|474257080|FG001|Phase 1|Other|0|||
131720180|NCT01853228|474257079|FG000|Phase 2|Physician Decision|0|||
131720181|NCT01853228|474257080|FG001|Phase 2|Physician Decision|1|||
131720182|NCT01853228|474257079|FG000|Phase 2|Proceed To Transplant|0|||
131720183|NCT01853228|474257080|FG001|Phase 2|Proceed To Transplant|3|||
131720184|NCT01853228|474257079|FG000|Phase 2|Lack of Efficacy|0|||
131720185|NCT01853228|474257080|FG001|Phase 2|Lack of Efficacy|4|||
131720186|NCT03167619|474257081|FG000|Overall Study|Death|11|||
131720187|NCT03167619|474257082|FG001|Overall Study|Death|8|||
131720188|NCT03167619|474257081|FG000|Overall Study|Withdrawal by Subject|1|||
131720189|NCT03167619|474257082|FG001|Overall Study|Withdrawal by Subject|2|||
131720190|NCT03167619|474257081|FG000|Overall Study|Physician Decision|0|||
131720191|NCT03167619|474257082|FG001|Overall Study|Physician Decision|1|||
131720192|NCT01348919|474257084|FG000|Overall Study|Adverse Event|3|||
131720193|NCT01348919|474257085|FG001|Overall Study|Adverse Event|1|||
131720194|NCT01348919|474257086|FG002|Overall Study|Adverse Event|0|||
131720195|NCT01348919|474257084|FG000|Overall Study|Withdrawal by Subject|0|||
131720196|NCT01348919|474257085|FG001|Overall Study|Withdrawal by Subject|1|||
131720197|NCT01348919|474257086|FG002|Overall Study|Withdrawal by Subject|0|||
131720198|NCT01348919|474257084|FG000|Overall Study|Disease progression|0|||
131720199|NCT01348919|474257085|FG001|Overall Study|Disease progression|1|||
131720200|NCT01348919|474257086|FG002|Overall Study|Disease progression|1|||
131720201|NCT04426630|474257087|FG000|Overall Study|Death|4|||
131720202|NCT04426630|474257087|FG000|Overall Study|Lost to Follow-up|2|||
131720203|NCT02082184|474257093|FG000|Overall Study|Adverse Event|1|||
131720204|NCT02082184|474257094|FG001|Overall Study|Adverse Event|0|||
131720205|NCT02082184|474257093|FG000|Overall Study|Medical diagnosis|1|||
131720206|NCT02082184|474257094|FG001|Overall Study|Medical diagnosis|2|||
131720207|NCT02082184|474257093|FG000|Overall Study|Device associated symptoms|5|||
131720208|NCT02082184|474257094|FG001|Overall Study|Device associated symptoms|0|||
131720209|NCT02082184|474257093|FG000|Overall Study|Withdrawal by Subject|3|||
131720210|NCT02082184|474257094|FG001|Overall Study|Withdrawal by Subject|2|||
131720211|NCT02082184|474257093|FG000|Overall Study|Protocol Violation|0|||
131720212|NCT02082184|474257094|FG001|Overall Study|Protocol Violation|6|||
131720213|NCT02082184|474257093|FG000|Overall Study|Lost to Follow-up|0|||
131720214|NCT02082184|474257094|FG001|Overall Study|Lost to Follow-up|2|||
131720215|NCT02082184|474257093|FG000|Overall Study|Subject non-compliance|0|||
131720216|NCT02082184|474257094|FG001|Overall Study|Subject non-compliance|1|||
131720217|NCT04328623|474257103|FG000|Overall Study|Protocol Violation|0|||
131720218|NCT04328623|474257104|FG001|Overall Study|Protocol Violation|1|||
131720219|NCT00849693|474257105|FG000|Acute Treatment Phase|Adverse Event|12|||
131720220|NCT00849693|474257106|FG001|Acute Treatment Phase|Adverse Event|7|||
131720221|NCT00849693|474257107|FG002|Acute Treatment Phase|Adverse Event|6|||
131720222|NCT00849693|474257108|FG003|Acute Treatment Phase|Adverse Event|4|||
131720223|NCT00849693|474257105|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
131720224|NCT00849693|474257106|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
131720225|NCT00849693|474257107|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
131720226|NCT00849693|474257108|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
131720227|NCT00849693|474257105|FG000|Acute Treatment Phase|Protocol Violation|1|||
131720228|NCT00849693|474257106|FG001|Acute Treatment Phase|Protocol Violation|5|||
131720229|NCT00849693|474257107|FG002|Acute Treatment Phase|Protocol Violation|2|||
131720230|NCT00849693|474257108|FG003|Acute Treatment Phase|Protocol Violation|6|||
131720231|NCT00849693|474257105|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
131720232|NCT00849693|474257106|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
131720233|NCT00849693|474257107|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
131720234|NCT00849693|474257108|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
131720235|NCT00849693|474257105|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
131720236|NCT00849693|474257106|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
131720237|NCT00849693|474257107|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
131720238|NCT00849693|474257108|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
131720239|NCT00849693|474257105|FG000|Acute Treatment Phase|Physician Decision|2|||
131720240|NCT00849693|474257106|FG001|Acute Treatment Phase|Physician Decision|1|||
131720241|NCT00849693|474257107|FG002|Acute Treatment Phase|Physician Decision|2|||
131720242|NCT00849693|474257108|FG003|Acute Treatment Phase|Physician Decision|1|||
131720243|NCT00849693|474257105|FG000|Acute Treatment Phase|Sponsor decision|0|||
131720244|NCT00849693|474257106|FG001|Acute Treatment Phase|Sponsor decision|0|||
131720245|NCT00849693|474257107|FG002|Acute Treatment Phase|Sponsor decision|1|||
131720246|NCT00849693|474257108|FG003|Acute Treatment Phase|Sponsor decision|0|||
131720247|NCT00849693|474257105|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
131720248|NCT00849693|474257106|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
131720249|NCT00849693|474257107|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
131720250|NCT00849693|474257108|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
131720251|NCT00849693|474257105|FG000|Extension Phase|Adverse Event|4|||
131720252|NCT00849693|474257106|FG001|Extension Phase|Adverse Event|6|||
131720253|NCT00849693|474257107|FG002|Extension Phase|Adverse Event|3|||
131904629|NCT01811732|474937043|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
131904630|NCT01811732|474937044|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
131904631|NCT01811732|474937043|FG000|Overall Study|Physician Decision|2|||
131904632|NCT01811732|474937044|FG001|Overall Study|Physician Decision|0|||
131904633|NCT01811732|474937043|FG000|Overall Study|Death|1|||
131904634|NCT01811732|474937044|FG001|Overall Study|Death|1|||
131904635|NCT01811732|474937043|FG000|Overall Study|Insufficient venous access|0|||
131904636|NCT01811732|474937044|FG001|Overall Study|Insufficient venous access|1|||
131904637|NCT01811732|474937043|FG000|Overall Study|Protocol Violation|0|||
131904638|NCT01811732|474937044|FG001|Overall Study|Protocol Violation|1|||
131720254|NCT00849693|474257108|FG003|Extension Phase|Adverse Event|7|||
131720255|NCT00849693|474257105|FG000|Extension Phase|Lost to Follow-up|7|||
131720256|NCT00849693|474257106|FG001|Extension Phase|Lost to Follow-up|5|||
131720257|NCT00849693|474257107|FG002|Extension Phase|Lost to Follow-up|6|||
131720258|NCT00849693|474257108|FG003|Extension Phase|Lost to Follow-up|6|||
131904639|NCT01811732|474937043|FG000|Overall Study|Subject incarcerated|1|||
131904640|NCT01811732|474937044|FG001|Overall Study|Subject incarcerated|2|||
131720259|NCT00849693|474257105|FG000|Extension Phase|Protocol Violation|0|||
131720260|NCT00849693|474257106|FG001|Extension Phase|Protocol Violation|3|||
131720261|NCT00849693|474257107|FG002|Extension Phase|Protocol Violation|2|||
131720262|NCT00849693|474257108|FG003|Extension Phase|Protocol Violation|3|||
131720263|NCT00849693|474257105|FG000|Extension Phase|Withdrawal by Subject|6|||
131904641|NCT01811732|474937043|FG000|Overall Study|Admitted to another facility|1|||
131720264|NCT00849693|474257106|FG001|Extension Phase|Withdrawal by Subject|9|||
131720265|NCT00849693|474257107|FG002|Extension Phase|Withdrawal by Subject|10|||
131720266|NCT00849693|474257108|FG003|Extension Phase|Withdrawal by Subject|15|||
131720267|NCT00849693|474257105|FG000|Extension Phase|Parent or caregiver decision|9|||
131720268|NCT00849693|474257106|FG001|Extension Phase|Parent or caregiver decision|4|||
131720269|NCT00849693|474257107|FG002|Extension Phase|Parent or caregiver decision|10|||
131720270|NCT00849693|474257108|FG003|Extension Phase|Parent or caregiver decision|5|||
131720271|NCT00849693|474257105|FG000|Extension Phase|Physician Decision|1|||
131720272|NCT00849693|474257106|FG001|Extension Phase|Physician Decision|1|||
131720273|NCT00849693|474257107|FG002|Extension Phase|Physician Decision|2|||
131720274|NCT00849693|474257108|FG003|Extension Phase|Physician Decision|0|||
131720275|NCT00849693|474257105|FG000|Extension Phase|Sponsor decision|1|||
131720276|NCT00849693|474257106|FG001|Extension Phase|Sponsor decision|0|||
131720277|NCT00849693|474257107|FG002|Extension Phase|Sponsor decision|0|||
131720278|NCT00849693|474257108|FG003|Extension Phase|Sponsor decision|1|||
131720279|NCT00849693|474257105|FG000|Extension Phase|Lack of Efficacy|2|||
131720280|NCT00849693|474257106|FG001|Extension Phase|Lack of Efficacy|2|||
131720281|NCT00849693|474257107|FG002|Extension Phase|Lack of Efficacy|2|||
131720282|NCT00849693|474257108|FG003|Extension Phase|Lack of Efficacy|1|||
131720283|NCT00634543|474257109|FG000|Overall Study|Other|1|||
131720284|NCT00634543|474257110|FG001|Overall Study|Other|2|||
131720285|NCT00634543|474257109|FG000|Overall Study|Protocol Violation|3|||
131720286|NCT00634543|474257110|FG001|Overall Study|Protocol Violation|3|||
131720287|NCT00634543|474257109|FG000|Overall Study|Adverse Event|11|||
131720288|NCT00634543|474257110|FG001|Overall Study|Adverse Event|11|||
131720289|NCT00634543|474257109|FG000|Overall Study|Withdrawal by Subject|4|||
131904642|NCT01811732|474937044|FG001|Overall Study|Admitted to another facility|0|||
131904643|NCT01811732|474937043|FG000|Overall Study|Correct study drug not available on site|1|||
131720290|NCT00634543|474257110|FG001|Overall Study|Withdrawal by Subject|4|||
131720291|NCT00634543|474257109|FG000|Overall Study|Lost to Follow-up|0|||
131720292|NCT00634543|474257110|FG001|Overall Study|Lost to Follow-up|1|||
131720293|NCT00077623|474257113|FG000|Overall Study|Adverse Event|1|||
131720294|NCT00077623|474257114|FG001|Overall Study|Adverse Event|0|||
131720295|NCT00077623|474257115|FG002|Overall Study|Adverse Event|1|||
131720296|NCT00077623|474257113|FG000|Overall Study|Withdrawal by Subject|2|||
131720297|NCT00077623|474257114|FG001|Overall Study|Withdrawal by Subject|10|||
131720298|NCT00077623|474257115|FG002|Overall Study|Withdrawal by Subject|1|||
131720299|NCT00077623|474257113|FG000|Overall Study|Other-Non safety reason|18|||
131720300|NCT00077623|474257114|FG001|Overall Study|Other-Non safety reason|15|||
131720301|NCT00077623|474257115|FG002|Overall Study|Other-Non safety reason|19|||
131720302|NCT00077623|474257113|FG000|Overall Study|Insufficient therapeutic response|2|||
131720303|NCT00077623|474257114|FG001|Overall Study|Insufficient therapeutic response|0|||
131720304|NCT00077623|474257115|FG002|Overall Study|Insufficient therapeutic response|0|||
131720305|NCT00077623|474257113|FG000|Overall Study|Death|12|||
131720306|NCT00077623|474257114|FG001|Overall Study|Death|18|||
131720307|NCT00077623|474257115|FG002|Overall Study|Death|11|||
131720308|NCT00077623|474257113|FG000|Overall Study|Failure to return|1|||
131720309|NCT00077623|474257114|FG001|Overall Study|Failure to return|0|||
131720310|NCT00077623|474257115|FG002|Overall Study|Failure to return|0|||
131720311|NCT02465034|474257116|FG000|Overall Study|Withdrawal by Subject|1|||
131720312|NCT02465034|474257117|FG001|Overall Study|Withdrawal by Subject|1|||
131720313|NCT02465034|474257116|FG000|Overall Study|Screen fail|2|||
131904644|NCT01811732|474937044|FG001|Overall Study|Correct study drug not available on site|0|||
131904645|NCT00288912|474937047|FG000|Overall Study|Developed exclusion criterion|4|||
131904646|NCT00288912|474937048|FG001|Overall Study|Developed exclusion criterion|6|||
131904647|NCT00288912|474937049|FG002|Overall Study|Developed exclusion criterion|7|||
131904648|NCT00288912|474937047|FG000|Overall Study|Lost to Follow-up|9|||
131904649|NCT00288912|474937048|FG001|Overall Study|Lost to Follow-up|6|||
131904650|NCT00288912|474937049|FG002|Overall Study|Lost to Follow-up|9|||
131904651|NCT00288912|474937047|FG000|Overall Study|Withdrawal by Subject|4|||
131904652|NCT00288912|474937048|FG001|Overall Study|Withdrawal by Subject|5|||
131904653|NCT00288912|474937049|FG002|Overall Study|Withdrawal by Subject|12|||
131904654|NCT01868646|474937051|FG000|Overall Study|Do not meet inclusion criteria|3|||
131904655|NCT01868646|474937052|FG001|Overall Study|Do not meet inclusion criteria|5|||
131904656|NCT02026141|474937053|FG000|Overall Study|Protocol Violation|0|||
131904657|NCT02026141|474937054|FG001|Overall Study|Protocol Violation|1|||
131904658|NCT01783743|474937059|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
131904659|NCT01783743|474937060|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
131904660|NCT01783743|474937059|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
131904661|NCT01783743|474937060|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
131904662|NCT01783743|474937059|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
131904663|NCT01783743|474937060|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
131904664|NCT01607593|474937061|FG000|Overall Study|Adverse Event|15|||
131904665|NCT01607593|474937061|FG000|Overall Study|Lack of Efficacy|16|||
131904666|NCT01607593|474937061|FG000|Overall Study|Lost to Follow-up|25|||
131720314|NCT02465034|474257117|FG001|Overall Study|Screen fail|0|||
131720315|NCT02465034|474257116|FG000|Overall Study|Could not be scheduled for study visit|0|||
131720316|NCT02465034|474257117|FG001|Overall Study|Could not be scheduled for study visit|5|||
131720317|NCT02138110|474257121|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
131720318|NCT02138110|474257121|FG000|Overall Scaffold Implantation|Death|3|||
131720319|NCT00882713|474257124|FG000|Overall Study|Adverse Event|2|||
131720320|NCT00882713|474257124|FG000|Overall Study|Death|3|||
131720321|NCT00882713|474257124|FG000|Overall Study|Administrative reasons|4|||
131720322|NCT00882713|474257124|FG000|Overall Study|refused treatment/withdrew consent|4|||
131720323|NCT00882713|474257124|FG000|Overall Study|Blood transfusion|2|||
131720324|NCT00882713|474257124|FG000|Overall Study|Insufficient therapeutic response|3|||
131720325|NCT00882713|474257124|FG000|Overall Study|Failure to return|2|||
131720326|NCT00882713|474257124|FG000|Overall Study|Other - Reasons|2|||
131720327|NCT02760602|474257127|FG000|Overall Study|Withdrawal by Subject|1|||
131720328|NCT02760602|474257128|FG001|Overall Study|Withdrawal by Subject|0|||
131720329|NCT02760602|474257127|FG000|Overall Study|Terminated by sponsor|12|||
131720330|NCT02760602|474257128|FG001|Overall Study|Terminated by sponsor|13|||
131720331|NCT05299892|474257138|FG000|Overall Study|Withdrawal by Subject|2|||
131720332|NCT02397655|474257139|FG000|Overall Study|data not completed|1301|||
131720333|NCT03334214|474257141|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
131720334|NCT03334214|474257142|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
131720335|NCT03334214|474257141|FG000|Overall Study|Withdrawal by Subject|0|||
131720336|NCT03334214|474257142|FG001|Overall Study|Withdrawal by Subject|1|||
131720337|NCT03334214|474257141|FG000|Overall Study|Other|1|||
131720338|NCT03334214|474257142|FG001|Overall Study|Other|0|||
131720339|NCT01588197|474257145|FG000|Overall Study|Lack of Efficacy|0|||
131720340|NCT01588197|474257146|FG001|Overall Study|Lack of Efficacy|1|||
131720341|NCT01588197|474257145|FG000|Overall Study|No MRI|1|||
131720342|NCT01588197|474257146|FG001|Overall Study|No MRI|0|||
131720343|NCT01937312|474257147|FG000|Overall Study|Adverse Event|10|||
131720344|NCT01937312|474257148|FG001|Overall Study|Adverse Event|1|||
131720345|NCT01937312|474257147|FG000|Overall Study|Lack of Efficacy|0|||
131720346|NCT01937312|474257148|FG001|Overall Study|Lack of Efficacy|1|||
131720347|NCT01937312|474257147|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
131720348|NCT01937312|474257148|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
131720349|NCT01025336|474257152|FG000|Overall Study|Protocol Violation|0|||
131720350|NCT01025336|474257153|FG001|Overall Study|Protocol Violation|0|||
131720351|NCT01025336|474257154|FG002|Overall Study|Protocol Violation|0|||
131720352|NCT01025336|474257155|FG003|Overall Study|Protocol Violation|2|||
131720353|NCT01025336|474257156|FG004|Overall Study|Protocol Violation|0|||
131720354|NCT00474253|474257157|FG000|Overall Study|Withdrew consent|2|||
131720355|NCT00474253|474257158|FG001|Overall Study|Withdrew consent|0|||
131720356|NCT00474253|474257157|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
131720357|NCT00474253|474257158|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
131720358|NCT00474253|474257157|FG000|Overall Study|Lost to Follow-up|1|||
131720359|NCT00474253|474257158|FG001|Overall Study|Lost to Follow-up|0|||
131720360|NCT00474253|474257157|FG000|Overall Study|Discharged prior to study completion|0|||
131720361|NCT00474253|474257158|FG001|Overall Study|Discharged prior to study completion|1|||
131720362|NCT03414359|474257163|FG000|Overall Study|Lack of Efficacy|1|||
131720363|NCT03414359|474257164|FG001|Overall Study|Lack of Efficacy|1|||
131720364|NCT03414359|474257163|FG000|Overall Study|Protocol Violation|0|||
131720365|NCT03414359|474257164|FG001|Overall Study|Protocol Violation|1|||
131720366|NCT02273973|474257167|FG000|Overall Study|Adverse Event|4|||
131720367|NCT02273973|474257168|FG001|Overall Study|Adverse Event|0|||
131720368|NCT02273973|474257167|FG000|Overall Study|Withdrawal by Subject|2|||
131720369|NCT02273973|474257168|FG001|Overall Study|Withdrawal by Subject|3|||
131720370|NCT02273973|474257167|FG000|Overall Study|Death|1|||
131720371|NCT02273973|474257168|FG001|Overall Study|Death|0|||
131720372|NCT02273973|474257167|FG000|Overall Study|Non-compliance|1|||
131720373|NCT02273973|474257168|FG001|Overall Study|Non-compliance|0|||
131720374|NCT02273973|474257167|FG000|Overall Study|Protocol Violation|1|||
131720375|NCT02273973|474257168|FG001|Overall Study|Protocol Violation|0|||
131804592|NCT00707161|474568569|FG000|Overall Study|Physician Decision|6|||
131804593|NCT01498120|474568585|FG000|Overall Study|Lost to Follow-up|1|||
131804594|NCT01498120|474568585|FG000|Overall Study|Withdrawal by Subject|5|||
131804595|NCT01498120|474568585|FG000|Overall Study|AE, non-serious non-fatal|3|||
131804596|NCT01498120|474568585|FG000|Overall Study|Other|4|||
131804597|NCT01173692|474568586|FG000|Overall Study|Adverse Event|1|||
131804598|NCT01173692|474568587|FG001|Overall Study|Adverse Event|2|||
131904667|NCT01607593|474937061|FG000|Overall Study|Continuation|33|||
131904668|NCT01607593|474937061|FG000|Overall Study|Other|4|||
131904669|NCT00728494|474937074|FG000|Overall Study|Adverse Event|7|||
131720376|NCT02273973|474257167|FG000|Overall Study|Progression of disease|0|||
131720377|NCT02273973|474257168|FG001|Overall Study|Progression of disease|2|||
131720378|NCT02273973|474257167|FG000|Overall Study|Lost to Follow-up|0|||
131720379|NCT02273973|474257168|FG001|Overall Study|Lost to Follow-up|1|||
131720380|NCT02273973|474257167|FG000|Overall Study|Physician Decision|0|||
131804599|NCT01173692|474568586|FG000|Overall Study|Withdrawal by Subject|1|||
131720381|NCT02273973|474257168|FG001|Overall Study|Physician Decision|1|||
131720382|NCT02273973|474257167|FG000|Overall Study|Reason not specified|0|||
131720383|NCT02273973|474257168|FG001|Overall Study|Reason not specified|1|||
131720384|NCT01739595|474257170|FG000|Overall Study|Adverse Event|3|||
131720385|NCT01739595|474257171|FG001|Overall Study|Adverse Event|0|||
131720386|NCT01739595|474257172|FG002|Overall Study|Adverse Event|0|||
131720387|NCT01739595|474257170|FG000|Overall Study|Lost to Follow-up|2|||
131720388|NCT01739595|474257171|FG001|Overall Study|Lost to Follow-up|0|||
131720389|NCT01739595|474257172|FG002|Overall Study|Lost to Follow-up|0|||
131720390|NCT01739595|474257170|FG000|Overall Study|Withdrawal by Subject|2|||
131720391|NCT01739595|474257171|FG001|Overall Study|Withdrawal by Subject|1|||
131720392|NCT01739595|474257172|FG002|Overall Study|Withdrawal by Subject|2|||
131720393|NCT01739595|474257170|FG000|Overall Study|Eligibility issue|3|||
131720394|NCT01739595|474257171|FG001|Overall Study|Eligibility issue|0|||
131720395|NCT01739595|474257172|FG002|Overall Study|Eligibility issue|0|||
131720396|NCT01739595|474257170|FG000|Overall Study|Protocol Violation|1|||
131720397|NCT01739595|474257171|FG001|Overall Study|Protocol Violation|0|||
131720398|NCT01739595|474257172|FG002|Overall Study|Protocol Violation|0|||
131720399|NCT01739595|474257170|FG000|Overall Study|Lab assessment|1|||
131720400|NCT01739595|474257171|FG001|Overall Study|Lab assessment|0|||
131720401|NCT01739595|474257172|FG002|Overall Study|Lab assessment|0|||
131720402|NCT01739595|474257170|FG000|Overall Study|Drug discrepancy|1|||
131720403|NCT01739595|474257171|FG001|Overall Study|Drug discrepancy|0|||
131720404|NCT01739595|474257172|FG002|Overall Study|Drug discrepancy|0|||
131720405|NCT01282814|474257173|FG000|First Intervention|Emesis During Dosing Interval|0|||
131720406|NCT01282814|474257174|FG001|First Intervention|Emesis During Dosing Interval|3|||
131720407|NCT01282814|474257173|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
131720408|NCT01282814|474257174|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131720409|NCT02403206|474257175|FG000|Overall Study|Lost to Follow-up|4|||
131720410|NCT02403206|474257176|FG001|Overall Study|Lost to Follow-up|3|||
131720411|NCT02403206|474257175|FG000|Overall Study|Physician Decision|2|||
131720412|NCT02403206|474257176|FG001|Overall Study|Physician Decision|0|||
131720413|NCT02403206|474257175|FG000|Overall Study|Withdrawal by Subject|3|||
131720414|NCT02403206|474257176|FG001|Overall Study|Withdrawal by Subject|3|||
131720415|NCT02403206|474257175|FG000|Overall Study|Reason not given|2|||
131720416|NCT02403206|474257176|FG001|Overall Study|Reason not given|4|||
131720417|NCT00957372|474257177|FG000|PART I|Lost to Follow-up|0|||
131720418|NCT00957372|474257178|FG001|PART I|Lost to Follow-up|0|||
131720419|NCT00957372|474257179|FG002|PART I|Lost to Follow-up|1|||
131720420|NCT00957372|474257180|FG003|PART I|Lost to Follow-up|0|||
131720421|NCT00957372|474257177|FG000|PART II|Withdrawal by Subject|0|||
131720422|NCT00957372|474257178|FG001|PART II|Withdrawal by Subject|0|||
131720423|NCT00957372|474257179|FG002|PART II|Withdrawal by Subject|0|||
131720424|NCT00957372|474257180|FG003|PART II|Withdrawal by Subject|8|||
131720425|NCT00957372|474257177|FG000|PART II|Physician Decision|0|||
131720426|NCT00957372|474257178|FG001|PART II|Physician Decision|0|||
131720427|NCT00957372|474257179|FG002|PART II|Physician Decision|0|||
131720428|NCT00957372|474257180|FG003|PART II|Physician Decision|1|||
131720429|NCT00957372|474257177|FG000|PART II|Pregnancy|0|||
131720430|NCT00957372|474257178|FG001|PART II|Pregnancy|0|||
131720431|NCT00957372|474257179|FG002|PART II|Pregnancy|0|||
131720432|NCT00957372|474257180|FG003|PART II|Pregnancy|1|||
131720433|NCT00957372|474257177|FG000|PART II|Not Know|0|||
131720434|NCT00957372|474257178|FG001|PART II|Not Know|0|||
131720435|NCT00957372|474257179|FG002|PART II|Not Know|0|||
131720436|NCT00957372|474257180|FG003|PART II|Not Know|20|||
131720437|NCT00957372|474257177|FG000|PART II|Adverse Event|0|||
131720438|NCT00957372|474257178|FG001|PART II|Adverse Event|0|||
131720439|NCT00957372|474257179|FG002|PART II|Adverse Event|0|||
131720440|NCT00957372|474257180|FG003|PART II|Adverse Event|10|||
131720441|NCT00957372|474257177|FG000|PART II|Patient non-compliance|0|||
131720442|NCT00957372|474257178|FG001|PART II|Patient non-compliance|0|||
131720443|NCT00957372|474257179|FG002|PART II|Patient non-compliance|0|||
131720444|NCT00957372|474257180|FG003|PART II|Patient non-compliance|4|||
131720445|NCT01676116|474257183|FG000|Overall Study|Withdrawal criteria|2|||
131720446|NCT01676116|474257184|FG001|Overall Study|Withdrawal criteria|14|||
131720447|NCT01676116|474257183|FG000|Overall Study|Adverse Event|1|||
131720448|NCT01676116|474257184|FG001|Overall Study|Adverse Event|2|||
131720449|NCT01676116|474257183|FG000|Overall Study|Unclassified|4|||
131720450|NCT01676116|474257184|FG001|Overall Study|Unclassified|10|||
131720451|NCT01676116|474257183|FG000|Overall Study|Protocol Violation|9|||
131804600|NCT01173692|474568587|FG001|Overall Study|Withdrawal by Subject|3|||
131804601|NCT00304083|474568595|FG000|Overall Study|Withdrawal by Subject|4|||
131804602|NCT00304083|474568596|FG001|Overall Study|Withdrawal by Subject|2|||
131720452|NCT01676116|474257184|FG001|Overall Study|Protocol Violation|3|||
131804603|NCT00304083|474568595|FG000|Overall Study|Physician Decision|8|||
131720453|NCT01287117|474257185|FG000|Overall Study|Adverse Event|2|||
131720454|NCT01287117|474257186|FG001|Overall Study|Adverse Event|1|||
131720455|NCT01287117|474257187|FG002|Overall Study|Adverse Event|1|||
131720456|NCT01287117|474257188|FG003|Overall Study|Adverse Event|1|||
131720457|NCT01287117|474257185|FG000|Overall Study|Lost to Follow-up|1|||
131804604|NCT00304083|474568596|FG001|Overall Study|Physician Decision|3|||
131804605|NCT00304083|474568595|FG000|Overall Study|Disease Progression|5|||
131804606|NCT00304083|474568596|FG001|Overall Study|Disease Progression|1|||
131804607|NCT00304083|474568595|FG000|Overall Study|Other|5|||
131804608|NCT00304083|474568596|FG001|Overall Study|Other|2|||
131804609|NCT03966365|474568599|FG000|Overall Study|Protocol Violation|1|||
131804610|NCT03966365|474568600|FG001|Overall Study|Protocol Violation|0|||
131720458|NCT01287117|474257186|FG001|Overall Study|Lost to Follow-up|1|||
131720459|NCT01287117|474257187|FG002|Overall Study|Lost to Follow-up|0|||
131720460|NCT01287117|474257188|FG003|Overall Study|Lost to Follow-up|0|||
131720461|NCT01287117|474257185|FG000|Overall Study|Physician Decision|0|||
131720462|NCT01287117|474257186|FG001|Overall Study|Physician Decision|1|||
131720463|NCT01287117|474257187|FG002|Overall Study|Physician Decision|1|||
131720464|NCT01287117|474257188|FG003|Overall Study|Physician Decision|1|||
131720465|NCT01287117|474257185|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
131720466|NCT01287117|474257186|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
131720467|NCT01287117|474257187|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
131720468|NCT01287117|474257188|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
131720469|NCT01287117|474257185|FG000|Overall Study|Disease Progression|10|||
131720470|NCT01287117|474257186|FG001|Overall Study|Disease Progression|5|||
131720471|NCT01287117|474257187|FG002|Overall Study|Disease Progression|6|||
131720472|NCT01287117|474257188|FG003|Overall Study|Disease Progression|5|||
131720473|NCT00778999|474257195|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
131720474|NCT00778999|474257196|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
131720475|NCT00778999|474257195|FG000|Overall Study|Did not receive recFSH|14|||
131720476|NCT00778999|474257196|FG001|Overall Study|Did not receive recFSH|20|||
131720477|NCT02032524|474257197|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
131720478|NCT02032524|474257198|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
131720479|NCT02032524|474257199|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
131720480|NCT02032524|474257200|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
131720481|NCT02032524|474257201|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
131720482|NCT02032524|474257202|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
131720483|NCT02032524|474257197|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131720484|NCT02032524|474257198|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131720485|NCT02032524|474257199|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131720486|NCT02032524|474257200|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
131720487|NCT02032524|474257201|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131720488|NCT02032524|474257202|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
131720489|NCT02032524|474257197|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
131720490|NCT02032524|474257198|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
131720491|NCT02032524|474257199|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
131720492|NCT02032524|474257200|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
131720493|NCT02032524|474257201|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
131720494|NCT02032524|474257202|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
131720495|NCT02032524|474257197|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131720496|NCT02032524|474257198|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
131720497|NCT02032524|474257199|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131720498|NCT02032524|474257200|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131720499|NCT02032524|474257201|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
131720500|NCT02032524|474257202|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131720501|NCT02032524|474257197|FG000|Period 2: LTS13769 Study|Other|0|||
131720502|NCT02032524|474257198|FG001|Period 2: LTS13769 Study|Other|0|||
131720503|NCT02032524|474257199|FG002|Period 2: LTS13769 Study|Other|0|||
131720504|NCT02032524|474257200|FG003|Period 2: LTS13769 Study|Other|0|||
131720505|NCT02032524|474257201|FG004|Period 2: LTS13769 Study|Other|0|||
131720506|NCT02032524|474257202|FG005|Period 2: LTS13769 Study|Other|1|||
131720507|NCT02975349|474257203|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131720508|NCT02975349|474257204|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131720509|NCT02975349|474257205|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131720510|NCT02975349|474257206|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131720511|NCT02975349|474257207|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131720512|NCT02975349|474257208|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131720513|NCT02975349|474257209|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131720514|NCT02975349|474257203|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131720515|NCT02975349|474257204|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131720516|NCT02975349|474257205|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131720517|NCT02975349|474257206|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131720518|NCT02975349|474257207|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131720519|NCT02975349|474257208|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131720520|NCT02975349|474257209|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131720521|NCT02975349|474257203|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
131720522|NCT02975349|474257204|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
131720523|NCT02975349|474257205|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
131804611|NCT01044732|474568601|FG000|Overall Study|Lost to Follow-up|2|||
131720524|NCT02975349|474257206|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
131720525|NCT02975349|474257207|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
131720526|NCT02975349|474257208|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
131720527|NCT02975349|474257209|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
131720528|NCT02975349|474257203|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
131720529|NCT02975349|474257204|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
131720530|NCT02975349|474257205|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
131720531|NCT02975349|474257206|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
131720532|NCT02975349|474257207|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
131720533|NCT02975349|474257208|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
131720534|NCT02975349|474257209|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
131720535|NCT02975349|474257203|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
131720536|NCT02975349|474257204|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
131720537|NCT02975349|474257205|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
131720538|NCT02975349|474257206|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
131720539|NCT02975349|474257207|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
131720540|NCT02975349|474257208|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
131720541|NCT02975349|474257209|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
131720542|NCT02975349|474257203|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131720543|NCT02975349|474257204|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131720544|NCT02975349|474257205|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131720545|NCT02975349|474257206|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
131720546|NCT02975349|474257207|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131720547|NCT02975349|474257208|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131720548|NCT02975349|474257209|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131720549|NCT02975349|474257203|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131720550|NCT02975349|474257204|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
131720551|NCT02975349|474257205|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131720552|NCT02975349|474257206|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131720553|NCT02975349|474257207|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131720554|NCT02975349|474257208|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131720555|NCT02975349|474257209|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131720556|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
131720557|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
131720558|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
131720559|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
131720560|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
131720561|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
131720562|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
131720563|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131720564|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131720565|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131720566|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131720567|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
131720568|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131720569|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131720570|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131720571|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131720572|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131720573|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131720574|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
131720575|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131720576|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
131720577|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
131720578|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
131804612|NCT01044732|474568602|FG001|Overall Study|Lost to Follow-up|1|||
131804613|NCT01044732|474568601|FG000|Overall Study|Physician Decision|5|||
131433994|NCT04276233|473214590|FG000|Overall Study|Adverse Event|1|||
131720579|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
131720580|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
131720581|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
131720582|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
131904670|NCT00728494|474937075|FG001|Overall Study|Adverse Event|0|||
131904671|NCT00728494|474937074|FG000|Overall Study|Withdrawal by Subject|0|||
131904672|NCT00728494|474937075|FG001|Overall Study|Withdrawal by Subject|2|||
131904673|NCT00728494|474937074|FG000|Overall Study|Lack of Efficacy|2|||
131904674|NCT00728494|474937075|FG001|Overall Study|Lack of Efficacy|4|||
131904675|NCT00728494|474937074|FG000|Overall Study|No data available|0|||
131904676|NCT00728494|474937075|FG001|Overall Study|No data available|1|||
131904677|NCT03439137|474937076|FG000|Overall Study|Adverse Event|16|||
131904678|NCT03439137|474937077|FG001|Overall Study|Adverse Event|12|||
131904679|NCT03439137|474937076|FG000|Overall Study|Physician Decision|0|||
131904680|NCT03439137|474937077|FG001|Overall Study|Physician Decision|5|||
131904681|NCT03439137|474937076|FG000|Overall Study|Withdrawal by Subject|14|||
131904682|NCT03439137|474937077|FG001|Overall Study|Withdrawal by Subject|4|||
131904683|NCT03439137|474937076|FG000|Overall Study|Conducting rescue therapy|2|||
131904684|NCT03439137|474937077|FG001|Overall Study|Conducting rescue therapy|1|||
131904685|NCT03439137|474937076|FG000|Overall Study|Difficult to control Hb|10|||
131904686|NCT03439137|474937077|FG001|Overall Study|Difficult to control Hb|2|||
131904687|NCT03439137|474937076|FG000|Overall Study|Initiation of a renal transplant|0|||
131904688|NCT03439137|474937077|FG001|Overall Study|Initiation of a renal transplant|2|||
131904689|NCT02219685|474937079|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
131904690|NCT02219685|474937080|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
131904691|NCT02219685|474937079|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
131904692|NCT02219685|474937080|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
131904693|NCT00427908|474937081|FG000|Primary Phase|Lost to Follow-up|4|||
131904694|NCT00427908|474937082|FG001|Primary Phase|Lost to Follow-up|0|||
131904695|NCT00427908|474937083|FG002|Primary Phase|Lost to Follow-up|2|||
131904696|NCT00427908|474937084|FG003|Primary Phase|Lost to Follow-up|0|||
131904697|NCT00427908|474937081|FG000|Primary Phase|Withdrawal by Subject|1|||
131904698|NCT00427908|474937082|FG001|Primary Phase|Withdrawal by Subject|2|||
131904699|NCT00427908|474937083|FG002|Primary Phase|Withdrawal by Subject|1|||
131904700|NCT00427908|474937084|FG003|Primary Phase|Withdrawal by Subject|0|||
131904701|NCT00427908|474937081|FG000|Primary Phase|Adverse Event|0|||
131904702|NCT00427908|474937082|FG001|Primary Phase|Adverse Event|1|||
131904703|NCT00427908|474937083|FG002|Primary Phase|Adverse Event|0|||
131904704|NCT00427908|474937084|FG003|Primary Phase|Adverse Event|0|||
131904705|NCT00069264|474937086|FG000|Overall Study|Adverse Event|3|||
131904706|NCT00069264|474937086|FG000|Overall Study|Progressive Disease|23|||
131720583|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
131720584|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
131720585|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
131720586|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
131720587|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
131720588|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
131720589|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
131720590|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
131720591|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131720592|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131720593|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
131720594|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131720595|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131720596|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
131720597|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131720598|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
131720599|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
131720600|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
131720601|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
131720602|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
131720603|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
131720604|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
131720605|NCT02975349|474257203|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
131904707|NCT00069264|474937086|FG000|Overall Study|Withdrawal by Subject|3|||
131904708|NCT00069264|474937086|FG000|Overall Study|Discon Therapy|3|||
131904709|NCT04467515|474937087|FG000|Overall Study|Lost to Follow-up|1|||
131904710|NCT04467515|474937088|FG001|Overall Study|Lost to Follow-up|0|||
131904711|NCT04467515|474937089|FG002|Overall Study|Lost to Follow-up|0|||
131904712|NCT04467515|474937087|FG000|Overall Study|Withdrawal by Subject|1|||
131904713|NCT04467515|474937088|FG001|Overall Study|Withdrawal by Subject|0|||
131904714|NCT04467515|474937089|FG002|Overall Study|Withdrawal by Subject|1|||
131904715|NCT04467515|474937087|FG000|Overall Study|Progressive Disease|0|||
131904716|NCT04467515|474937088|FG001|Overall Study|Progressive Disease|1|||
131720606|NCT02975349|474257204|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
131720607|NCT02975349|474257205|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
131720608|NCT02975349|474257206|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
131720609|NCT02975349|474257207|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
131720610|NCT02975349|474257208|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
131720611|NCT02975349|474257209|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
131720612|NCT03567187|474257212|FG000|Overall Study|Lost to Follow-up|18|||
131720613|NCT02032875|474257215|FG000|Treatment Period|Adverse Event|1|||
131720614|NCT02032875|474257216|FG001|Treatment Period|Adverse Event|0|||
131720615|NCT02032875|474257215|FG000|Treatment Period|Liver transplant, No extension needed|0|||
131720616|NCT02032875|474257216|FG001|Treatment Period|Liver transplant, No extension needed|1|||
131720617|NCT02032875|474257215|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
131720618|NCT02032875|474257216|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
131720619|NCT02032875|474257215|FG000|Follow-up Period|Death|0|||
131720620|NCT02032875|474257216|FG001|Follow-up Period|Death|1|||
131720621|NCT02032875|474257215|FG000|Follow-up Period|Virologic Relapse|3|||
131720622|NCT02032875|474257216|FG001|Follow-up Period|Virologic Relapse|10|||
131720623|NCT04358458|474257217|FG000|Overall Study|Death|1|||
131720624|NCT04358458|474257218|FG001|Overall Study|Death|1|||
131720625|NCT04358458|474257219|FG002|Overall Study|Death|3|||
131720626|NCT04358458|474257220|FG003|Overall Study|Death|8|||
131720627|NCT04358458|474257221|FG004|Overall Study|Death|1|||
131720628|NCT04358458|474257222|FG005|Overall Study|Death|6|||
131720629|NCT04358458|474257223|FG006|Overall Study|Death|2|||
131720630|NCT04358458|474257224|FG007|Overall Study|Death|3|||
131720631|NCT04358458|474257217|FG000|Overall Study|Lost to Follow-up|0|||
131720632|NCT04358458|474257218|FG001|Overall Study|Lost to Follow-up|0|||
131720633|NCT04358458|474257219|FG002|Overall Study|Lost to Follow-up|0|||
131720634|NCT04358458|474257220|FG003|Overall Study|Lost to Follow-up|0|||
131720635|NCT04358458|474257221|FG004|Overall Study|Lost to Follow-up|0|||
131720636|NCT04358458|474257222|FG005|Overall Study|Lost to Follow-up|0|||
131720637|NCT04358458|474257223|FG006|Overall Study|Lost to Follow-up|0|||
131720638|NCT04358458|474257224|FG007|Overall Study|Lost to Follow-up|1|||
131720639|NCT04358458|474257217|FG000|Overall Study|Site is closing study participation|0|||
131720640|NCT04358458|474257218|FG001|Overall Study|Site is closing study participation|0|||
131720641|NCT04358458|474257219|FG002|Overall Study|Site is closing study participation|0|||
131720642|NCT04358458|474257220|FG003|Overall Study|Site is closing study participation|1|||
131720643|NCT04358458|474257221|FG004|Overall Study|Site is closing study participation|0|||
131720644|NCT04358458|474257222|FG005|Overall Study|Site is closing study participation|0|||
131720645|NCT04358458|474257223|FG006|Overall Study|Site is closing study participation|0|||
131720646|NCT04358458|474257224|FG007|Overall Study|Site is closing study participation|0|||
131720647|NCT04358458|474257217|FG000|Overall Study|Sponsor request|2|||
131720648|NCT04358458|474257218|FG001|Overall Study|Sponsor request|3|||
131720649|NCT04358458|474257219|FG002|Overall Study|Sponsor request|3|||
131720650|NCT04358458|474257220|FG003|Overall Study|Sponsor request|0|||
131720651|NCT04358458|474257221|FG004|Overall Study|Sponsor request|2|||
131720652|NCT04358458|474257222|FG005|Overall Study|Sponsor request|3|||
131720653|NCT04358458|474257223|FG006|Overall Study|Sponsor request|1|||
131720654|NCT04358458|474257224|FG007|Overall Study|Sponsor request|1|||
131720655|NCT04358458|474257217|FG000|Overall Study|Withdrawal by Subject|0|||
131720656|NCT04358458|474257218|FG001|Overall Study|Withdrawal by Subject|0|||
131720657|NCT04358458|474257219|FG002|Overall Study|Withdrawal by Subject|1|||
131720658|NCT04358458|474257220|FG003|Overall Study|Withdrawal by Subject|1|||
131720659|NCT04358458|474257221|FG004|Overall Study|Withdrawal by Subject|0|||
131720660|NCT04358458|474257222|FG005|Overall Study|Withdrawal by Subject|1|||
131720661|NCT04358458|474257223|FG006|Overall Study|Withdrawal by Subject|0|||
131720662|NCT04358458|474257224|FG007|Overall Study|Withdrawal by Subject|1|||
131720663|NCT02031146|474258731|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
131720664|NCT02031146|474258732|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
131720665|NCT02031146|474258733|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
131720666|NCT02031146|474258734|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
131720667|NCT02031146|474258735|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
131720668|NCT02031146|474258736|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
131720669|NCT02031146|474258737|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
131720670|NCT02495077|474258738|FG000|Overall Study|Adverse Event|0|||
131720671|NCT02495077|474258739|FG001|Overall Study|Adverse Event|1|||
131720672|NCT02495077|474258740|FG002|Overall Study|Adverse Event|1|||
131720673|NCT02495077|474258741|FG003|Overall Study|Adverse Event|0|||
131720674|NCT02495077|474258738|FG000|Overall Study|Death|3|||
131720675|NCT02495077|474258739|FG001|Overall Study|Death|5|||
131904717|NCT04467515|474937089|FG002|Overall Study|Progressive Disease|3|||
131904718|NCT04467515|474937087|FG000|Overall Study|Death|0|||
131904719|NCT04467515|474937088|FG001|Overall Study|Death|1|||
131904720|NCT04467515|474937089|FG002|Overall Study|Death|0|||
131904721|NCT03834506|474937092|FG000|Overall Study|Death|336|||
131904722|NCT03834506|474937093|FG001|Overall Study|Death|326|||
131904723|NCT03834506|474937092|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131720676|NCT02495077|474258740|FG002|Overall Study|Death|0|||
131720677|NCT02495077|474258741|FG003|Overall Study|Death|0|||
131720678|NCT02495077|474258738|FG000|Overall Study|Lost to Follow-up|6|||
131720679|NCT02495077|474258739|FG001|Overall Study|Lost to Follow-up|4|||
131720680|NCT02495077|474258740|FG002|Overall Study|Lost to Follow-up|0|||
131720681|NCT02495077|474258741|FG003|Overall Study|Lost to Follow-up|0|||
131720682|NCT02495077|474258738|FG000|Overall Study|Physician Decision|2|||
131720683|NCT02495077|474258739|FG001|Overall Study|Physician Decision|1|||
131720684|NCT02495077|474258740|FG002|Overall Study|Physician Decision|4|||
131720685|NCT02495077|474258741|FG003|Overall Study|Physician Decision|0|||
131720686|NCT02495077|474258738|FG000|Overall Study|Protocol Violation|0|||
131720687|NCT02495077|474258739|FG001|Overall Study|Protocol Violation|1|||
131720688|NCT02495077|474258740|FG002|Overall Study|Protocol Violation|0|||
131720689|NCT02495077|474258741|FG003|Overall Study|Protocol Violation|0|||
131720690|NCT02495077|474258738|FG000|Overall Study|Screen Failure|0|||
131720691|NCT02495077|474258739|FG001|Overall Study|Screen Failure|0|||
131720692|NCT02495077|474258740|FG002|Overall Study|Screen Failure|0|||
131720693|NCT02495077|474258741|FG003|Overall Study|Screen Failure|48|||
131720694|NCT02495077|474258738|FG000|Overall Study|Withdrawal by Subject|7|||
131720695|NCT02495077|474258739|FG001|Overall Study|Withdrawal by Subject|7|||
131720696|NCT02495077|474258740|FG002|Overall Study|Withdrawal by Subject|7|||
131720697|NCT02495077|474258741|FG003|Overall Study|Withdrawal by Subject|0|||
131720698|NCT02495077|474258738|FG000|Overall Study|Covid-19 research restrictions|1|||
131720699|NCT02495077|474258739|FG001|Overall Study|Covid-19 research restrictions|0|||
131720700|NCT02495077|474258740|FG002|Overall Study|Covid-19 research restrictions|0|||
131720701|NCT02495077|474258741|FG003|Overall Study|Covid-19 research restrictions|0|||
131720702|NCT02495077|474258738|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
131720703|NCT02495077|474258739|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
131720704|NCT02495077|474258740|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
131720705|NCT02495077|474258741|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
131720706|NCT02495077|474258738|FG000|Overall Study|Incarcerated|0|||
131720707|NCT02495077|474258739|FG001|Overall Study|Incarcerated|1|||
131720708|NCT02495077|474258740|FG002|Overall Study|Incarcerated|0|||
131720709|NCT02495077|474258741|FG003|Overall Study|Incarcerated|0|||
131720710|NCT02495077|474258738|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
131720711|NCT02495077|474258739|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
131720712|NCT02495077|474258740|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
131720713|NCT02495077|474258741|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
131720714|NCT02495077|474258738|FG000|Overall Study|Timing of transplant and randomization|0|||
131720715|NCT02495077|474258739|FG001|Overall Study|Timing of transplant and randomization|0|||
131720716|NCT02495077|474258740|FG002|Overall Study|Timing of transplant and randomization|5|||
131720717|NCT02495077|474258741|FG003|Overall Study|Timing of transplant and randomization|0|||
131720718|NCT02742649|474258742|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
131720719|NCT02742649|474258743|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131720720|NCT02742649|474258744|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131720721|NCT02742649|474258745|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131720722|NCT02742649|474258746|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131720723|NCT02742649|474258742|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131720724|NCT02742649|474258743|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131720725|NCT02742649|474258744|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131720726|NCT02742649|474258745|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131720727|NCT02742649|474258746|FG004|Double-Blind Treatment Period|Adverse Event|0|||
131720728|NCT02742649|474258742|FG000|Open-Label Period|Lost to Follow-up|0|||
131720729|NCT02742649|474258743|FG001|Open-Label Period|Lost to Follow-up|0|||
131720730|NCT02742649|474258744|FG002|Open-Label Period|Lost to Follow-up|0|||
131720731|NCT02742649|474258745|FG003|Open-Label Period|Lost to Follow-up|0|||
131720732|NCT02742649|474258746|FG004|Open-Label Period|Lost to Follow-up|1|||
131720733|NCT03937986|474258749|FG000|Overall Study|COVID-19 Pandemic|1|||
131720734|NCT01712438|474258752|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
131904724|NCT03834506|474937093|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131720735|NCT01712438|474258752|FG000|Overall Study|Ongoing ITI treatment|6|||
131720736|NCT01712438|474258752|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
131720737|NCT01712438|474258752|FG000|Overall Study|Prematurely Discontinued|25|||
131720738|NCT01123889|474258753|FG000|Overall Study|Lost to Follow-up|3|||
131720739|NCT01123889|474258754|FG001|Overall Study|Lost to Follow-up|1|||
131720740|NCT00685178|474258755|FG000|Overall Study|Adverse Event|1|||
131720741|NCT00685178|474258756|FG001|Overall Study|Adverse Event|5|||
131720742|NCT00685178|474258757|FG002|Overall Study|Adverse Event|2|||
131720743|NCT00685178|474258758|FG003|Overall Study|Adverse Event|4|||
131720744|NCT00685178|474258755|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
131720745|NCT00685178|474258756|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
131720746|NCT00685178|474258757|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
131720747|NCT00685178|474258758|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
131720748|NCT00685178|474258755|FG000|Overall Study|voluntary study discharge|4|||
131720749|NCT00685178|474258756|FG001|Overall Study|voluntary study discharge|5|||
131720750|NCT00685178|474258757|FG002|Overall Study|voluntary study discharge|1|||
131720751|NCT00685178|474258758|FG003|Overall Study|voluntary study discharge|1|||
131720752|NCT00685178|474258755|FG000|Overall Study|incarcerated|1|||
131720753|NCT00685178|474258756|FG001|Overall Study|incarcerated|3|||
131720754|NCT00685178|474258757|FG002|Overall Study|incarcerated|7|||
131720755|NCT00685178|474258758|FG003|Overall Study|incarcerated|0|||
131720756|NCT00685178|474258755|FG000|Overall Study|administrative (disciplinary) discharge|0|||
131720757|NCT00685178|474258756|FG001|Overall Study|administrative (disciplinary) discharge|1|||
131720758|NCT00685178|474258757|FG002|Overall Study|administrative (disciplinary) discharge|0|||
131720759|NCT00685178|474258758|FG003|Overall Study|administrative (disciplinary) discharge|2|||
131720760|NCT00685178|474258755|FG000|Overall Study|Pregnancy|0|||
131720761|NCT00685178|474258756|FG001|Overall Study|Pregnancy|0|||
131720762|NCT00685178|474258757|FG002|Overall Study|Pregnancy|0|||
131720763|NCT00685178|474258758|FG003|Overall Study|Pregnancy|1|||
131720764|NCT01736683|474258760|FG000|Overall Study|Disease Relapse|0|||
131720765|NCT01736683|474258761|FG001|Overall Study|Disease Relapse|0|||
131720766|NCT01736683|474258762|FG002|Overall Study|Disease Relapse|2|||
131720767|NCT01736683|474258763|FG003|Overall Study|Disease Relapse|1|||
131720768|NCT01736683|474258764|FG004|Overall Study|Disease Relapse|0|||
131720769|NCT01736683|474258760|FG000|Overall Study|Adverse Event|0|||
131720770|NCT01736683|474258761|FG001|Overall Study|Adverse Event|2|||
131720771|NCT01736683|474258762|FG002|Overall Study|Adverse Event|2|||
131720772|NCT01736683|474258763|FG003|Overall Study|Adverse Event|3|||
131720773|NCT01736683|474258764|FG004|Overall Study|Adverse Event|2|||
131720774|NCT01736683|474258760|FG000|Overall Study|Withdrawal by Subject|0|||
131720775|NCT01736683|474258761|FG001|Overall Study|Withdrawal by Subject|0|||
131720776|NCT01736683|474258762|FG002|Overall Study|Withdrawal by Subject|3|||
131720777|NCT01736683|474258763|FG003|Overall Study|Withdrawal by Subject|1|||
131720778|NCT01736683|474258764|FG004|Overall Study|Withdrawal by Subject|1|||
131720779|NCT01736683|474258760|FG000|Overall Study|Lack of Therapeutic Effect|7|||
131720780|NCT01736683|474258761|FG001|Overall Study|Lack of Therapeutic Effect|4|||
131720781|NCT01736683|474258762|FG002|Overall Study|Lack of Therapeutic Effect|13|||
131720782|NCT01736683|474258763|FG003|Overall Study|Lack of Therapeutic Effect|20|||
131720783|NCT01736683|474258764|FG004|Overall Study|Lack of Therapeutic Effect|1|||
131720784|NCT01736683|474258760|FG000|Overall Study|Progressive Disease|0|||
131720785|NCT01736683|474258761|FG001|Overall Study|Progressive Disease|0|||
131720786|NCT01736683|474258762|FG002|Overall Study|Progressive Disease|0|||
131720787|NCT01736683|474258763|FG003|Overall Study|Progressive Disease|1|||
131720788|NCT01736683|474258764|FG004|Overall Study|Progressive Disease|0|||
131720789|NCT01736683|474258760|FG000|Overall Study|Other|0|||
131720790|NCT01736683|474258761|FG001|Overall Study|Other|0|||
131720791|NCT01736683|474258762|FG002|Overall Study|Other|1|||
131720792|NCT01736683|474258763|FG003|Overall Study|Other|9|||
131720793|NCT01736683|474258764|FG004|Overall Study|Other|1|||
131720794|NCT02046564|474258765|FG000|Overall Study|Adverse Event|6|||
131720795|NCT02046564|474258766|FG001|Overall Study|Adverse Event|3|||
131720796|NCT02046564|474258765|FG000|Overall Study|Physician Decision|0|||
131720797|NCT02046564|474258766|FG001|Overall Study|Physician Decision|1|||
131720798|NCT02046564|474258765|FG000|Overall Study|Protocol Violation|3|||
131720799|NCT02046564|474258766|FG001|Overall Study|Protocol Violation|1|||
131720800|NCT02046564|474258765|FG000|Overall Study|Withdrawal by Subject|4|||
131720801|NCT02046564|474258766|FG001|Overall Study|Withdrawal by Subject|10|||
131720802|NCT02046564|474258765|FG000|Overall Study|Subject met withdrawal criteria|2|||
131720803|NCT02046564|474258766|FG001|Overall Study|Subject met withdrawal criteria|5|||
131720804|NCT01260181|474258767|FG000|Overall Study|Decision of Investigator|1|||
131720805|NCT01844076|474258770|FG000|Overall Study|Adverse Event|1|||
131804614|NCT01044732|474568602|FG001|Overall Study|Physician Decision|3|||
131804615|NCT01044732|474568601|FG000|Overall Study|Protocol Violation|11|||
131804616|NCT01044732|474568602|FG001|Overall Study|Protocol Violation|12|||
131804617|NCT01044732|474568601|FG000|Overall Study|Withdrawal by Subject|0|||
131804618|NCT01044732|474568602|FG001|Overall Study|Withdrawal by Subject|1|||
131804619|NCT01044732|474568601|FG000|Overall Study|Inadequate bowel preparation|11|||
131804620|NCT01044732|474568602|FG001|Overall Study|Inadequate bowel preparation|17|||
131804621|NCT01044732|474568601|FG000|Overall Study|Inability to reach cecum|5|||
131804622|NCT01044732|474568602|FG001|Overall Study|Inability to reach cecum|2|||
131804623|NCT01044732|474568601|FG000|Overall Study|Technical error or malfunction|15|||
131804624|NCT01044732|474568602|FG001|Overall Study|Technical error or malfunction|14|||
131804625|NCT01569152|474568603|FG000|Phase IIa, Period 1|Early Escape|5|||
131804626|NCT01569152|474568604|FG001|Phase IIa, Period 1|Early Escape|22|||
131804627|NCT01569152|474568605|FG002|Phase IIa, Period 1|Early Escape|0|||
131804628|NCT01569152|474568603|FG000|Phase IIa, Period 1|Adverse Event|4|||
131804629|NCT01569152|474568604|FG001|Phase IIa, Period 1|Adverse Event|0|||
131804630|NCT01569152|474568605|FG002|Phase IIa, Period 1|Adverse Event|0|||
131804631|NCT01569152|474568603|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
131804632|NCT01569152|474568604|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
131804633|NCT01569152|474568605|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
131804634|NCT01569152|474568603|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
131804635|NCT01569152|474568604|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
131804636|NCT01569152|474568605|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
131804637|NCT01569152|474568603|FG000|Phase IIa, Period 1|Protocol Violation|0|||
131804638|NCT01569152|474568604|FG001|Phase IIa, Period 1|Protocol Violation|1|||
131804639|NCT01569152|474568605|FG002|Phase IIa, Period 1|Protocol Violation|0|||
131804640|NCT01569152|474568603|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
131804641|NCT01569152|474568604|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
131804642|NCT01569152|474568605|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
131804643|NCT01569152|474568603|FG000|Safety Extension, Period 3|Adverse Event|0|||
131804644|NCT01569152|474568604|FG001|Safety Extension, Period 3|Adverse Event|0|||
131804645|NCT01569152|474568605|FG002|Safety Extension, Period 3|Adverse Event|4|||
131804646|NCT01569152|474568603|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
131804647|NCT01569152|474568604|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
131804648|NCT01569152|474568605|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
131720806|NCT01844076|474258771|FG001|Overall Study|Adverse Event|0|||
131720807|NCT01844076|474258772|FG002|Overall Study|Adverse Event|0|||
131720808|NCT01844076|474258773|FG003|Overall Study|Adverse Event|0|||
131720809|NCT01844076|474258770|FG000|Overall Study|Withdrawal by Subject|1|||
131720810|NCT01844076|474258771|FG001|Overall Study|Withdrawal by Subject|0|||
131720811|NCT01844076|474258772|FG002|Overall Study|Withdrawal by Subject|0|||
131720812|NCT01844076|474258773|FG003|Overall Study|Withdrawal by Subject|0|||
131804649|NCT01569152|474568603|FG000|Safety Extension, Period 3|Physician Decision|0|||
131804650|NCT01569152|474568604|FG001|Safety Extension, Period 3|Physician Decision|0|||
131804651|NCT01569152|474568605|FG002|Safety Extension, Period 3|Physician Decision|2|||
131720813|NCT00635102|474258776|FG000|Overall Study|Withdrawal by Subject|7|||
131804652|NCT01569152|474568603|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
131804653|NCT01569152|474568604|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
131804654|NCT01569152|474568605|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
131804655|NCT00824265|474568614|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
131804656|NCT00824265|474568615|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
131804657|NCT00824265|474568614|FG000|Treatment Phase|Protocol Violation|1|||
131804658|NCT00824265|474568615|FG001|Treatment Phase|Protocol Violation|0|||
131804659|NCT00824265|474568614|FG000|Treatment Phase|Lost to Follow-up|1|||
131804660|NCT00824265|474568615|FG001|Treatment Phase|Lost to Follow-up|1|||
131804661|NCT00824265|474568614|FG000|Treatment Phase|Physician Decision|6|||
131804662|NCT00824265|474568615|FG001|Treatment Phase|Physician Decision|12|||
131804663|NCT00824265|474568614|FG000|Treatment Phase|Withdrawal by Subject|6|||
131804664|NCT00824265|474568615|FG001|Treatment Phase|Withdrawal by Subject|15|||
131804665|NCT00824265|474568614|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
131804666|NCT00824265|474568615|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
131804667|NCT00824265|474568614|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
131804668|NCT00824265|474568615|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
131804669|NCT02920996|474568616|FG000|Overall Study|Adverse Event|8|||
131804670|NCT02920996|474568617|FG001|Overall Study|Adverse Event|0|||
131804671|NCT02920996|474568616|FG000|Overall Study|Physician Decision|1|||
131804672|NCT02920996|474568617|FG001|Overall Study|Physician Decision|0|||
131804673|NCT02920996|474568616|FG000|Overall Study|Death|1|||
131804674|NCT02920996|474568617|FG001|Overall Study|Death|0|||
131804675|NCT02920996|474568616|FG000|Overall Study|Missing|1|||
131804676|NCT02920996|474568617|FG001|Overall Study|Missing|0|||
131804677|NCT02920996|474568616|FG000|Overall Study|Subject Non-Compliance|1|||
131804678|NCT02920996|474568617|FG001|Overall Study|Subject Non-Compliance|0|||
131804679|NCT01402947|474568620|FG000|First Intervention|Adverse Event|0|||
131804680|NCT01402947|474568621|FG001|First Intervention|Adverse Event|1|||
131804681|NCT00385684|474568622|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
131720814|NCT00635102|474258777|FG001|Overall Study|Withdrawal by Subject|8|||
131804682|NCT00385684|474568623|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
131804683|NCT00385684|474568622|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
131804684|NCT00385684|474568623|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
131804685|NCT00385684|474568622|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
131804686|NCT00385684|474568623|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
131720815|NCT01938625|474258779|FG000|Overall Study|Withdrawal by Subject|0|||
131720816|NCT01938625|474258780|FG001|Overall Study|Withdrawal by Subject|1|||
131720817|NCT01938625|474258779|FG000|Overall Study|Adverse Event|0|||
131720818|NCT01938625|474258780|FG001|Overall Study|Adverse Event|1|||
131720819|NCT02088034|474258781|FG000|Overall Study|Lost to Follow-up|1|||
131720820|NCT02088034|474258782|FG001|Overall Study|Lost to Follow-up|1|||
131720821|NCT02088034|474258783|FG002|Overall Study|Lost to Follow-up|0|||
131720822|NCT02088034|474258781|FG000|Overall Study|Pregnancy|2|||
131720823|NCT02088034|474258782|FG001|Overall Study|Pregnancy|1|||
131720824|NCT02088034|474258783|FG002|Overall Study|Pregnancy|2|||
131720825|NCT00308620|474258784|FG000|Overall Study|Death|1|||
131720826|NCT00308620|474258785|FG001|Overall Study|Death|1|||
131720827|NCT00308620|474258786|FG002|Overall Study|Death|0|||
131720828|NCT00308620|474258784|FG000|Overall Study|Lost to Follow-up|0|||
131720829|NCT00308620|474258785|FG001|Overall Study|Lost to Follow-up|0|||
131720830|NCT00308620|474258786|FG002|Overall Study|Lost to Follow-up|1|||
131720831|NCT00593112|474258789|FG000|Overall Study|Scan Anxiety|3|||
131720832|NCT00593112|474258790|FG001|Overall Study|Scan Anxiety|0|||
131720833|NCT00593112|474258789|FG000|Overall Study|Abnormal Scan|1|||
131720834|NCT00593112|474258790|FG001|Overall Study|Abnormal Scan|0|||
131720835|NCT00593112|474258789|FG000|Overall Study|Unreadable Scan|1|||
131720836|NCT00593112|474258790|FG001|Overall Study|Unreadable Scan|0|||
131720837|NCT00593112|474258789|FG000|Overall Study|Withdrawal by Subject|5|||
131720838|NCT00593112|474258790|FG001|Overall Study|Withdrawal by Subject|0|||
131720839|NCT03043365|474258791|FG000|Weeks 0 to Week 8|Adverse Event|1|||
131720840|NCT03043365|474258792|FG001|Weeks 0 to Week 8|Adverse Event|3|||
131720841|NCT03043365|474258791|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
131720842|NCT03043365|474258792|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
131720843|NCT03043365|474258791|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
131720844|NCT03043365|474258792|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
131720845|NCT05372315|474258793|FG000|Overall Study|Withdrawal by Subject|1|||
131720846|NCT05372315|474258794|FG001|Overall Study|Withdrawal by Subject|0|||
131720847|NCT00650585|474258795|FG000|Overall Study|Lost to Follow-up|505|||
131720848|NCT00650585|474258796|FG001|Overall Study|Lost to Follow-up|482|||
131720849|NCT00650585|474258795|FG000|Overall Study|No parental consent|935|||
131720850|NCT00650585|474258796|FG001|Overall Study|No parental consent|866|||
131720851|NCT00650585|474258795|FG000|Overall Study|Excluded/ruled ineligible|357|||
131720852|NCT00650585|474258796|FG001|Overall Study|Excluded/ruled ineligible|129|||
131720853|NCT02532543|474258798|FG000|Overall Study|Lost to Follow-up|0|||
131720854|NCT02532543|474258799|FG001|Overall Study|Lost to Follow-up|0|||
131720855|NCT02532543|474258800|FG002|Overall Study|Lost to Follow-up|1|||
131720856|NCT02532543|474258801|FG003|Overall Study|Lost to Follow-up|0|||
131720857|NCT00923091|474258806|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
131720858|NCT00923091|474258807|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
131720859|NCT00923091|474258808|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
131720860|NCT00923091|474258809|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
131720861|NCT00923091|474258810|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
131720862|NCT00923091|474258811|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
131720863|NCT00923091|474258812|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
131720864|NCT00923091|474258813|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
131720865|NCT00923091|474258814|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131720866|NCT00923091|474258815|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131720867|NCT00923091|474258816|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131720868|NCT00923091|474258817|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131720869|NCT00923091|474258818|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131720870|NCT00923091|474258806|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
131720871|NCT00923091|474258807|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
131720872|NCT00923091|474258808|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
131720873|NCT00923091|474258809|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
131720874|NCT00923091|474258810|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
131720875|NCT00923091|474258811|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
131720876|NCT00923091|474258812|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
131720877|NCT00923091|474258813|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
131720878|NCT00923091|474258814|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131720879|NCT00923091|474258815|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131904725|NCT03834506|474937092|FG000|Overall Study|Withdrawal by Subject|10|||
131720880|NCT00923091|474258816|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131720881|NCT00923091|474258817|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131720882|NCT00923091|474258818|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131720883|NCT00923091|474258806|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
131720884|NCT00923091|474258807|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
131720885|NCT00923091|474258808|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
131720886|NCT00923091|474258809|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
131720887|NCT00923091|474258810|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
131720888|NCT00923091|474258811|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
131720889|NCT00923091|474258812|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
131720890|NCT00923091|474258813|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
131720891|NCT00923091|474258814|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131720892|NCT00923091|474258815|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131720893|NCT00923091|474258816|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131720894|NCT00923091|474258817|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131720895|NCT00923091|474258818|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131720896|NCT00923091|474258806|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720897|NCT00923091|474258807|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720898|NCT00923091|474258808|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720899|NCT00923091|474258809|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720900|NCT00923091|474258810|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720901|NCT00923091|474258811|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
131720902|NCT00923091|474258812|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720903|NCT00923091|474258813|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720904|NCT00923091|474258814|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720905|NCT00923091|474258815|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720906|NCT00923091|474258816|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720907|NCT00923091|474258817|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720908|NCT00923091|474258818|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131720909|NCT00923091|474258806|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720910|NCT00923091|474258807|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
131720911|NCT00923091|474258808|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720912|NCT00923091|474258809|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
131720913|NCT00923091|474258810|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720914|NCT00923091|474258811|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
131720915|NCT00923091|474258812|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720916|NCT00923091|474258813|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720917|NCT00923091|474258814|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720918|NCT00923091|474258815|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720919|NCT00923091|474258816|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720920|NCT00923091|474258817|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720921|NCT00923091|474258818|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131720922|NCT00923091|474258806|FG000|Period III (Single-Blind)|Adverse Event|5|||
131720923|NCT00923091|474258807|FG001|Period III (Single-Blind)|Adverse Event|0|||
131720924|NCT00923091|474258808|FG002|Period III (Single-Blind)|Adverse Event|0|||
131720925|NCT00923091|474258809|FG003|Period III (Single-Blind)|Adverse Event|0|||
131720926|NCT00923091|474258810|FG004|Period III (Single-Blind)|Adverse Event|0|||
131720927|NCT00923091|474258811|FG005|Period III (Single-Blind)|Adverse Event|0|||
131720928|NCT00923091|474258812|FG006|Period III (Single-Blind)|Adverse Event|0|||
131720929|NCT00923091|474258813|FG007|Period III (Single-Blind)|Adverse Event|0|||
131720930|NCT00923091|474258814|FG008|Period III (Single-Blind)|Adverse Event|0|||
131720931|NCT00923091|474258815|FG009|Period III (Single-Blind)|Adverse Event|0|||
131720932|NCT00923091|474258816|FG010|Period III (Single-Blind)|Adverse Event|0|||
131720933|NCT00923091|474258817|FG011|Period III (Single-Blind)|Adverse Event|0|||
131720934|NCT00923091|474258818|FG012|Period III (Single-Blind)|Adverse Event|0|||
131720935|NCT00923091|474258806|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
131720936|NCT00923091|474258807|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720937|NCT00923091|474258808|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720938|NCT00923091|474258809|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720939|NCT00923091|474258810|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720940|NCT00923091|474258811|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720941|NCT00923091|474258812|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720942|NCT00923091|474258813|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720943|NCT00923091|474258814|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720944|NCT00923091|474258815|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720945|NCT00923091|474258816|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720946|NCT00923091|474258817|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720947|NCT00923091|474258818|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
131720948|NCT00923091|474258806|FG000|Period III (Single-Blind)|Protocol Violation|3|||
131720949|NCT00923091|474258807|FG001|Period III (Single-Blind)|Protocol Violation|0|||
131720950|NCT00923091|474258808|FG002|Period III (Single-Blind)|Protocol Violation|0|||
131720951|NCT00923091|474258809|FG003|Period III (Single-Blind)|Protocol Violation|0|||
131720952|NCT00923091|474258810|FG004|Period III (Single-Blind)|Protocol Violation|0|||
131904726|NCT03834506|474937093|FG001|Overall Study|Withdrawal by Subject|8|||
131904727|NCT03834506|474937092|FG000|Overall Study|Sponsor decision|165|||
131720953|NCT00923091|474258811|FG005|Period III (Single-Blind)|Protocol Violation|0|||
131720954|NCT00923091|474258812|FG006|Period III (Single-Blind)|Protocol Violation|0|||
131720955|NCT00923091|474258813|FG007|Period III (Single-Blind)|Protocol Violation|0|||
131720956|NCT00923091|474258814|FG008|Period III (Single-Blind)|Protocol Violation|0|||
131720957|NCT00923091|474258815|FG009|Period III (Single-Blind)|Protocol Violation|0|||
131720958|NCT00923091|474258816|FG010|Period III (Single-Blind)|Protocol Violation|0|||
131720959|NCT00923091|474258817|FG011|Period III (Single-Blind)|Protocol Violation|0|||
131720960|NCT00923091|474258818|FG012|Period III (Single-Blind)|Protocol Violation|0|||
131720961|NCT00923091|474258806|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
131720962|NCT00923091|474258807|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
131720963|NCT00923091|474258808|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
131720964|NCT00923091|474258809|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
131720965|NCT00923091|474258810|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
131720966|NCT00923091|474258811|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
131720967|NCT00923091|474258812|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
131720968|NCT00923091|474258813|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
131720969|NCT00923091|474258814|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
131720970|NCT00923091|474258815|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
131720971|NCT00923091|474258816|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
131720972|NCT00923091|474258817|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
131720973|NCT00923091|474258818|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
131720974|NCT00923091|474258806|FG000|Period IV (Double-Blind)|Adverse Event|2|||
131720975|NCT00923091|474258807|FG001|Period IV (Double-Blind)|Adverse Event|0|||
131720976|NCT00923091|474258808|FG002|Period IV (Double-Blind)|Adverse Event|0|||
131720977|NCT00923091|474258809|FG003|Period IV (Double-Blind)|Adverse Event|0|||
131720978|NCT00923091|474258810|FG004|Period IV (Double-Blind)|Adverse Event|0|||
131720979|NCT00923091|474258811|FG005|Period IV (Double-Blind)|Adverse Event|0|||
131720980|NCT00923091|474258812|FG006|Period IV (Double-Blind)|Adverse Event|0|||
131720981|NCT00923091|474258813|FG007|Period IV (Double-Blind)|Adverse Event|0|||
131720982|NCT00923091|474258814|FG008|Period IV (Double-Blind)|Adverse Event|0|||
131720983|NCT00923091|474258815|FG009|Period IV (Double-Blind)|Adverse Event|0|||
131720984|NCT00923091|474258816|FG010|Period IV (Double-Blind)|Adverse Event|0|||
131720985|NCT00923091|474258817|FG011|Period IV (Double-Blind)|Adverse Event|0|||
131720986|NCT00923091|474258818|FG012|Period IV (Double-Blind)|Adverse Event|0|||
131720987|NCT00923091|474258806|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720988|NCT00923091|474258807|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
131720989|NCT00923091|474258808|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720990|NCT00923091|474258809|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720991|NCT00923091|474258810|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720992|NCT00923091|474258811|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720993|NCT00923091|474258812|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720994|NCT00923091|474258813|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720995|NCT00923091|474258814|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720996|NCT00923091|474258815|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720997|NCT00923091|474258816|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720998|NCT00923091|474258817|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131720999|NCT00923091|474258818|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131721000|NCT00923091|474258806|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
131721001|NCT00923091|474258807|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
131721002|NCT00923091|474258808|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
131721003|NCT00923091|474258809|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
131721004|NCT00923091|474258810|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
131721005|NCT00923091|474258811|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
131721006|NCT00923091|474258812|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
131721007|NCT00923091|474258813|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
131721008|NCT00923091|474258814|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
131721009|NCT00923091|474258815|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
131721010|NCT00923091|474258816|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
131721011|NCT00923091|474258817|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
131804687|NCT02682602|474568625|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
131804688|NCT02682602|474568626|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
131804689|NCT02682602|474568625|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
131804690|NCT02682602|474568626|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
131804691|NCT00705536|474570501|FG000|Start Period 1|Withdrawal by Subject|0|||
131804692|NCT00705536|474570502|FG001|Start Period 1|Withdrawal by Subject|0|||
131804693|NCT00705536|474570503|FG002|Start Period 1|Withdrawal by Subject|0|||
131804694|NCT00705536|474570504|FG003|Start Period 1|Withdrawal by Subject|1|||
131804695|NCT04188106|474570505|FG000|Overall Study|Lost to Follow-up|5|||
131804696|NCT04188106|474570505|FG000|Overall Study|Non-Compliance|1|||
131804697|NCT02289963|474570506|FG000|Overall Study|Adverse Event|1|||
131804698|NCT02289963|474570507|FG001|Overall Study|Adverse Event|2|||
131804699|NCT02289963|474570506|FG000|Overall Study|Poor compliance to protocol|1|||
131804700|NCT02289963|474570507|FG001|Overall Study|Poor compliance to protocol|0|||
131804701|NCT02289963|474570506|FG000|Overall Study|Withdrawal by Subject|1|||
131804702|NCT02289963|474570507|FG001|Overall Study|Withdrawal by Subject|0|||
131804703|NCT02289963|474570506|FG000|Overall Study|Last injection missed|2|||
131804704|NCT02289963|474570507|FG001|Overall Study|Last injection missed|2|||
131804705|NCT02289963|474570506|FG000|Overall Study|End treatment visit outside visit window|0|||
131804706|NCT02289963|474570507|FG001|Overall Study|End treatment visit outside visit window|4|||
131804707|NCT02289963|474570506|FG000|Overall Study|Other than specified above|0|||
131804708|NCT02289963|474570507|FG001|Overall Study|Other than specified above|2|||
131804709|NCT02311361|474570508|FG000|Overall Study|Did not receive treatment|0|||
131804710|NCT02311361|474570509|FG001|Overall Study|Did not receive treatment|1|||
131804711|NCT02311361|474570510|FG002|Overall Study|Did not receive treatment|0|||
131804712|NCT02311361|474570511|FG003|Overall Study|Did not receive treatment|1|||
131804713|NCT00365300|474570512|FG000|Open-label Phase|Adverse Event|4|||
131804714|NCT00365300|474570513|FG001|Open-label Phase|Adverse Event|0|||
131804715|NCT00365300|474570512|FG000|Open-label Phase|Failed to Return|1|||
131804716|NCT00365300|474570513|FG001|Open-label Phase|Failed to Return|0|||
131804717|NCT00365300|474570512|FG000|Open-label Phase|Physician Decision|1|||
131804718|NCT00365300|474570513|FG001|Open-label Phase|Physician Decision|0|||
131804719|NCT00365300|474570512|FG000|Open-label Phase|Noncompliance|9|||
131804720|NCT00365300|474570513|FG001|Open-label Phase|Noncompliance|0|||
131804721|NCT00365300|474570512|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
131804722|NCT00365300|474570513|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
131804723|NCT00365300|474570512|FG000|Open-label Phase|Protocol Violation|1|||
131721012|NCT00923091|474258818|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
131721013|NCT00923091|474258806|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721014|NCT00923091|474258807|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721015|NCT00923091|474258808|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721016|NCT00923091|474258809|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721017|NCT00923091|474258810|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721018|NCT00923091|474258811|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721019|NCT00923091|474258812|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721020|NCT00923091|474258813|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721021|NCT00923091|474258814|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
131721022|NCT00923091|474258815|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721023|NCT00923091|474258816|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721024|NCT00923091|474258817|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
131721025|NCT00923091|474258818|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
131448282|NCT02079246|473272631|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
131496710|NCT02289690|473446368|FG009|Overall Study|Lost to Follow-up|2|||
131721026|NCT00923091|474258806|FG000|Period V (Double -Blind)|Protocol Violation|0|||
131721027|NCT00923091|474258807|FG001|Period V (Double -Blind)|Protocol Violation|0|||
131721028|NCT00923091|474258808|FG002|Period V (Double -Blind)|Protocol Violation|0|||
131804724|NCT00365300|474570513|FG001|Open-label Phase|Protocol Violation|0|||
131804725|NCT00365300|474570512|FG000|Open-label Phase|Lack of Efficacy|1|||
131804726|NCT00365300|474570513|FG001|Open-label Phase|Lack of Efficacy|0|||
131804727|NCT00365300|474570512|FG000|Open-label Phase|Patient skipped open label phase|1|||
131804728|NCT00365300|474570513|FG001|Open-label Phase|Patient skipped open label phase|0|||
131804729|NCT00365300|474570512|FG000|Double-blind Phase|Failed to return|1|||
131721029|NCT00923091|474258809|FG003|Period V (Double -Blind)|Protocol Violation|0|||
131721030|NCT00923091|474258810|FG004|Period V (Double -Blind)|Protocol Violation|0|||
131721031|NCT00923091|474258811|FG005|Period V (Double -Blind)|Protocol Violation|0|||
131721032|NCT00923091|474258812|FG006|Period V (Double -Blind)|Protocol Violation|0|||
131721033|NCT00923091|474258813|FG007|Period V (Double -Blind)|Protocol Violation|0|||
131721034|NCT00923091|474258814|FG008|Period V (Double -Blind)|Protocol Violation|0|||
131721035|NCT00923091|474258815|FG009|Period V (Double -Blind)|Protocol Violation|0|||
131721036|NCT00923091|474258816|FG010|Period V (Double -Blind)|Protocol Violation|0|||
131721037|NCT00923091|474258817|FG011|Period V (Double -Blind)|Protocol Violation|0|||
131721038|NCT00923091|474258818|FG012|Period V (Double -Blind)|Protocol Violation|1|||
131721039|NCT00923091|474258806|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
131721040|NCT00923091|474258807|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
131721041|NCT00923091|474258808|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
131721042|NCT00923091|474258809|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
131721043|NCT00923091|474258810|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
131721044|NCT00923091|474258811|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
131721045|NCT00923091|474258812|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
131721046|NCT00923091|474258813|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
131721047|NCT00923091|474258814|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
131721048|NCT00923091|474258815|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
131721049|NCT00923091|474258816|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
131721050|NCT00923091|474258817|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
131721051|NCT00923091|474258818|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
131721052|NCT00923091|474258806|FG000|Period VI (Open-Label)|Adverse Event|17|||
131721053|NCT00923091|474258807|FG001|Period VI (Open-Label)|Adverse Event|0|||
131721054|NCT00923091|474258808|FG002|Period VI (Open-Label)|Adverse Event|4|||
131721055|NCT00923091|474258809|FG003|Period VI (Open-Label)|Adverse Event|1|||
131721056|NCT00923091|474258810|FG004|Period VI (Open-Label)|Adverse Event|1|||
131721057|NCT00923091|474258811|FG005|Period VI (Open-Label)|Adverse Event|0|||
131721058|NCT00923091|474258812|FG006|Period VI (Open-Label)|Adverse Event|0|||
131721059|NCT00923091|474258813|FG007|Period VI (Open-Label)|Adverse Event|0|||
131721060|NCT00923091|474258814|FG008|Period VI (Open-Label)|Adverse Event|0|||
131721061|NCT00923091|474258815|FG009|Period VI (Open-Label)|Adverse Event|0|||
131721062|NCT00923091|474258816|FG010|Period VI (Open-Label)|Adverse Event|0|||
131721063|NCT00923091|474258817|FG011|Period VI (Open-Label)|Adverse Event|0|||
131721064|NCT00923091|474258818|FG012|Period VI (Open-Label)|Adverse Event|0|||
131721065|NCT00923091|474258806|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
131721066|NCT00923091|474258807|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
131721067|NCT00923091|474258808|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
131721068|NCT00923091|474258809|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721069|NCT00923091|474258810|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
131721070|NCT00923091|474258811|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721071|NCT00923091|474258812|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721072|NCT00923091|474258813|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721073|NCT00923091|474258814|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721074|NCT00923091|474258815|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721075|NCT00923091|474258816|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721076|NCT00923091|474258817|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721077|NCT00923091|474258818|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
131721078|NCT00923091|474258806|FG000|Period VI (Open-Label)|Protocol Violation|6|||
131721079|NCT00923091|474258807|FG001|Period VI (Open-Label)|Protocol Violation|1|||
131721080|NCT00923091|474258808|FG002|Period VI (Open-Label)|Protocol Violation|3|||
131721081|NCT00923091|474258809|FG003|Period VI (Open-Label)|Protocol Violation|1|||
131721082|NCT00923091|474258810|FG004|Period VI (Open-Label)|Protocol Violation|4|||
131721083|NCT00923091|474258811|FG005|Period VI (Open-Label)|Protocol Violation|0|||
131721084|NCT00923091|474258812|FG006|Period VI (Open-Label)|Protocol Violation|0|||
131721085|NCT00923091|474258813|FG007|Period VI (Open-Label)|Protocol Violation|0|||
131721086|NCT00923091|474258814|FG008|Period VI (Open-Label)|Protocol Violation|0|||
131721087|NCT00923091|474258815|FG009|Period VI (Open-Label)|Protocol Violation|0|||
131721088|NCT00923091|474258816|FG010|Period VI (Open-Label)|Protocol Violation|0|||
131721089|NCT00923091|474258817|FG011|Period VI (Open-Label)|Protocol Violation|0|||
131721090|NCT00923091|474258818|FG012|Period VI (Open-Label)|Protocol Violation|0|||
131721091|NCT00923091|474258806|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
131721092|NCT00923091|474258807|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
131721093|NCT00923091|474258808|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
131721094|NCT00923091|474258809|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
131804730|NCT00365300|474570513|FG001|Double-blind Phase|Failed to return|0|||
131804731|NCT00365300|474570512|FG000|Double-blind Phase|Noncompliance|1|||
131804732|NCT00365300|474570513|FG001|Double-blind Phase|Noncompliance|1|||
131721095|NCT00923091|474258810|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
131721096|NCT00923091|474258811|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
131721097|NCT00923091|474258812|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
131721098|NCT00923091|474258813|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
131721099|NCT00923091|474258814|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
131721100|NCT00923091|474258815|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
131721101|NCT00923091|474258816|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
131721102|NCT00923091|474258817|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
131721103|NCT00923091|474258818|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
131721104|NCT00923091|474258806|FG000|Period VI (Open-Label)|Other Reason|0|||
131721105|NCT00923091|474258807|FG001|Period VI (Open-Label)|Other Reason|0|||
131721106|NCT00923091|474258808|FG002|Period VI (Open-Label)|Other Reason|0|||
131721107|NCT00923091|474258809|FG003|Period VI (Open-Label)|Other Reason|1|||
131721108|NCT00923091|474258810|FG004|Period VI (Open-Label)|Other Reason|1|||
131721109|NCT00923091|474258811|FG005|Period VI (Open-Label)|Other Reason|0|||
131721110|NCT00923091|474258812|FG006|Period VI (Open-Label)|Other Reason|0|||
131721111|NCT00923091|474258813|FG007|Period VI (Open-Label)|Other Reason|0|||
131721112|NCT00923091|474258814|FG008|Period VI (Open-Label)|Other Reason|0|||
131721113|NCT00923091|474258815|FG009|Period VI (Open-Label)|Other Reason|0|||
131721114|NCT00923091|474258816|FG010|Period VI (Open-Label)|Other Reason|0|||
131721115|NCT00923091|474258817|FG011|Period VI (Open-Label)|Other Reason|0|||
131721116|NCT00923091|474258818|FG012|Period VI (Open-Label)|Other Reason|0|||
131721117|NCT00467649|474258819|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
131721118|NCT00467649|474258820|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
131721119|NCT00467649|474258821|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
131721120|NCT00467649|474258822|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
131721121|NCT00467649|474258823|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
131721122|NCT00467649|474258824|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
131721123|NCT00467649|474258819|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
131721124|NCT00467649|474258820|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
131721125|NCT00467649|474258821|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
131721126|NCT00467649|474258822|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
131721127|NCT00467649|474258823|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
131721128|NCT00467649|474258824|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
131721129|NCT00467649|474258819|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
131721130|NCT00467649|474258820|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
131721131|NCT00467649|474258821|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131721132|NCT00467649|474258822|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131721133|NCT00467649|474258823|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131721134|NCT00467649|474258824|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131721135|NCT00467649|474258819|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
131721136|NCT00467649|474258820|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
131721137|NCT00467649|474258821|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131721138|NCT00467649|474258822|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131721139|NCT00467649|474258823|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131721140|NCT00467649|474258824|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131721141|NCT00467649|474258819|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131721142|NCT00467649|474258820|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131721143|NCT00467649|474258821|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131721144|NCT00467649|474258822|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
131721145|NCT00467649|474258823|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131721146|NCT00467649|474258824|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131721147|NCT00467649|474258819|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131721148|NCT00467649|474258820|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131721149|NCT00467649|474258821|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131721150|NCT00467649|474258822|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
131721151|NCT00467649|474258823|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131721152|NCT00467649|474258824|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131721153|NCT00467649|474258819|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131721154|NCT00467649|474258820|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131721155|NCT00467649|474258821|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131721156|NCT00467649|474258822|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131721157|NCT00467649|474258823|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131721158|NCT00467649|474258824|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
131721159|NCT03633331|474258827|FG000|Overall Study|Withdrawal by Subject|1|||
131721160|NCT03233048|474258828|FG000|Overall Study|Withdrawal by Subject|1|||
131721161|NCT01396525|474258831|FG000|Overall Study|Withdrawal by Subject|8|||
131721162|NCT01396525|474258831|FG000|Overall Study|Death|14|||
131721163|NCT01396525|474258831|FG000|Overall Study|Lost to Follow-up|4|||
131721164|NCT03114969|474258832|FG000|Overall Study|Lost to Follow-up|0|||
131721165|NCT03114969|474258833|FG001|Overall Study|Lost to Follow-up|0|||
131721166|NCT03114969|474258834|FG002|Overall Study|Lost to Follow-up|3|||
131721167|NCT03114969|474258835|FG003|Overall Study|Lost to Follow-up|2|||
131721168|NCT03114969|474258836|FG004|Overall Study|Lost to Follow-up|0|||
131721169|NCT03114969|474258837|FG005|Overall Study|Lost to Follow-up|0|||
131721170|NCT03114969|474258838|FG006|Overall Study|Lost to Follow-up|0|||
131721171|NCT03114969|474258839|FG007|Overall Study|Lost to Follow-up|0|||
131721172|NCT03114969|474258840|FG008|Overall Study|Lost to Follow-up|0|||
131721173|NCT03114969|474258832|FG000|Overall Study|Adverse Event|0|||
131721174|NCT03114969|474258833|FG001|Overall Study|Adverse Event|0|||
131721175|NCT03114969|474258834|FG002|Overall Study|Adverse Event|1|||
131721176|NCT03114969|474258835|FG003|Overall Study|Adverse Event|0|||
131721177|NCT03114969|474258836|FG004|Overall Study|Adverse Event|0|||
131721178|NCT03114969|474258837|FG005|Overall Study|Adverse Event|1|||
131721179|NCT03114969|474258838|FG006|Overall Study|Adverse Event|1|||
131721180|NCT03114969|474258839|FG007|Overall Study|Adverse Event|0|||
131721181|NCT03114969|474258840|FG008|Overall Study|Adverse Event|2|||
131721182|NCT00949650|474258841|FG000|Overall Study|Progressive disease|188|||
131721183|NCT00949650|474258842|FG001|Overall Study|Progressive disease|19|||
131721184|NCT00949650|474258841|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
131721185|NCT00949650|474258842|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
131721186|NCT00949650|474258841|FG000|Overall Study|Other Adverse Event (AE)|28|||
131721187|NCT00949650|474258842|FG001|Overall Study|Other Adverse Event (AE)|17|||
131721188|NCT00949650|474258841|FG000|Overall Study|Protocol Violation|1|||
131721189|NCT00949650|474258842|FG001|Overall Study|Protocol Violation|4|||
131721190|NCT00949650|474258841|FG000|Overall Study|Refusal to continue medication|7|||
131721191|NCT00949650|474258842|FG001|Overall Study|Refusal to continue medication|11|||
131721192|NCT00949650|474258841|FG000|Overall Study|Not treated|1|||
131721193|NCT00949650|474258842|FG001|Overall Study|Not treated|4|||
131721194|NCT00949650|474258841|FG000|Overall Study|Other not specified above|5|||
131721195|NCT00949650|474258842|FG001|Overall Study|Other not specified above|0|||
131721196|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Adverse Event|12|||
131721197|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Adverse Event|3|||
131721198|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Adverse Event|4|||
131721199|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Adverse Event|2|||
131721200|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
131721201|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
131721202|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
131721203|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
131721204|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
131721205|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
131721206|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
131721207|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
131721208|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
131721209|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
131721210|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
131721211|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
131721212|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
131721213|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
131721214|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
131721215|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
131721216|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
131721217|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
131721218|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
131721219|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
131721220|NCT02436239|474258843|FG000|Open-Lable Treatment Period|Other Reason|1|||
131804733|NCT00365300|474570512|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131433995|NCT04276233|473214590|FG000|Overall Study|Lost to Follow-up|3|||
131721221|NCT02436239|474258844|FG001|Open-Lable Treatment Period|Other Reason|1|||
131721222|NCT02436239|474258845|FG002|Open-Lable Treatment Period|Other Reason|0|||
131721223|NCT02436239|474258846|FG003|Open-Lable Treatment Period|Other Reason|0|||
131721224|NCT02436239|474258843|FG000|Down-Taper Period|Withdrawal by Subject|4|||
131721225|NCT02436239|474258844|FG001|Down-Taper Period|Withdrawal by Subject|4|||
131721226|NCT02436239|474258845|FG002|Down-Taper Period|Withdrawal by Subject|1|||
131804734|NCT00365300|474570513|FG001|Double-blind Phase|Withdrawal by Subject|1|||
131804735|NCT00365300|474570512|FG000|Double-blind Phase|Protocol Violation|3|||
131721227|NCT02436239|474258846|FG003|Down-Taper Period|Withdrawal by Subject|2|||
131721228|NCT02782715|474258860|FG000|Overall Study|Withdrawal by Subject|1|||
131721229|NCT03368404|474258868|FG000|Overall Study|Adverse Event|2|||
131721230|NCT03368404|474258869|FG001|Overall Study|Adverse Event|1|||
131804736|NCT00365300|474570513|FG001|Double-blind Phase|Protocol Violation|1|||
131804737|NCT00365300|474570512|FG000|Double-blind Phase|Lack of Efficacy|6|||
131721231|NCT03368404|474258868|FG000|Overall Study|Withdrawal by Subject|1|||
131721232|NCT03368404|474258869|FG001|Overall Study|Withdrawal by Subject|1|||
131721233|NCT00995371|474258870|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
131721234|NCT00995371|474258871|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
131721235|NCT02983292|474258872|FG000|Overall Study|Participant unwell & cannot travel|2|||
131721236|NCT02983292|474258872|FG000|Overall Study|Lost to Follow-up|3|||
131721237|NCT02983292|474258872|FG000|Overall Study|Participant withdrew consent|2|||
131721238|NCT02983292|474258872|FG000|Overall Study|Revision|7|||
131721239|NCT02983292|474258872|FG000|Overall Study|Death|1|||
131721240|NCT02983292|474258872|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
131721241|NCT02983292|474258872|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
131721242|NCT02983292|474258872|FG000|Overall Study|Participant relocation|1|||
131721243|NCT04725682|474258873|FG000|Overall Study|Withdrawal by Subject|7|||
131721244|NCT04725682|474258874|FG001|Overall Study|Withdrawal by Subject|5|||
131721245|NCT04725682|474258873|FG000|Overall Study|Failed to comply with the requirements|2|||
131721246|NCT04725682|474258874|FG001|Overall Study|Failed to comply with the requirements|1|||
131721247|NCT04725682|474258873|FG000|Overall Study|Adverse Event|1|||
131721248|NCT04725682|474258874|FG001|Overall Study|Adverse Event|1|||
131721249|NCT04725682|474258873|FG000|Overall Study|Death|0|||
131721250|NCT04725682|474258874|FG001|Overall Study|Death|1|||
131721251|NCT00964795|474258875|FG000|Overall Study|Withdrawal by Subject|79|||
131721252|NCT00964795|474258875|FG000|Overall Study|Adverse Event|12|||
131721253|NCT00964795|474258875|FG000|Overall Study|Death|14|||
131721254|NCT00964795|474258875|FG000|Overall Study|Lost to Follow-up|7|||
131721255|NCT00964795|474258875|FG000|Overall Study|Termination of Study by Sponsor|169|||
131721256|NCT00964795|474258875|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
131721257|NCT00964795|474258875|FG000|Overall Study|Other|23|||
131721258|NCT00586690|474258880|FG000|Overall Study|Death|2|||
131721259|NCT00586690|474258881|FG001|Overall Study|Death|0|||
131721260|NCT00586690|474258880|FG000|Overall Study|Disease Progression|10|||
131721261|NCT00586690|474258881|FG001|Overall Study|Disease Progression|0|||
131721262|NCT00586690|474258880|FG000|Overall Study|Adverse Event|1|||
131721263|NCT00586690|474258881|FG001|Overall Study|Adverse Event|0|||
131721264|NCT00586690|474258880|FG000|Overall Study|Lack of Efficacy|2|||
131721265|NCT00586690|474258881|FG001|Overall Study|Lack of Efficacy|0|||
131721266|NCT00586690|474258880|FG000|Overall Study|Lab can't accommodate|1|||
131721267|NCT00586690|474258881|FG001|Overall Study|Lab can't accommodate|0|||
131721268|NCT00857246|474258882|FG000|Induction Regimen|Adverse Event|1|||
131721269|NCT00857246|474258882|FG000|Induction Regimen|disease-related complications|1|||
131721270|NCT00857246|474258882|FG000|Induction Regimen|Withdrawal by Subject|1|||
131721271|NCT00857246|474258882|FG000|Surgery (Curative)|disease progression|6|||
131721272|NCT00857246|474258882|FG000|ChemoRT|Withdrawal by Subject|1|||
131721273|NCT00857246|474258882|FG000|ChemoRT|Adverse Event|2|||
131721274|NCT01607892|474258884|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
131721275|NCT01607892|474258885|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
131721276|NCT01607892|474258886|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
131721277|NCT01607892|474258887|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
131721278|NCT01607892|474258888|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
131721279|NCT01607892|474258884|FG000|Overall Study|Death|4|||
131721280|NCT01607892|474258885|FG001|Overall Study|Death|2|||
131721281|NCT01607892|474258886|FG002|Overall Study|Death|8|||
131721282|NCT01607892|474258887|FG003|Overall Study|Death|10|||
131721283|NCT01607892|474258888|FG004|Overall Study|Death|3|||
131721284|NCT01607892|474258884|FG000|Overall Study|Investigator discretion|2|||
131721285|NCT01607892|474258885|FG001|Overall Study|Investigator discretion|4|||
131721286|NCT01607892|474258886|FG002|Overall Study|Investigator discretion|4|||
131721287|NCT01607892|474258887|FG003|Overall Study|Investigator discretion|8|||
131721288|NCT01607892|474258888|FG004|Overall Study|Investigator discretion|0|||
131721289|NCT01607892|474258884|FG000|Overall Study|Other treatments became available|1|||
131721290|NCT01607892|474258885|FG001|Overall Study|Other treatments became available|1|||
131721291|NCT01607892|474258886|FG002|Overall Study|Other treatments became available|0|||
131721292|NCT01607892|474258887|FG003|Overall Study|Other treatments became available|0|||
131721293|NCT01607892|474258888|FG004|Overall Study|Other treatments became available|2|||
131904728|NCT03834506|474937093|FG001|Overall Study|Sponsor decision|178|||
131904729|NCT03834506|474937092|FG000|Overall Study|Physician Decision|3|||
131904730|NCT03834506|474937093|FG001|Overall Study|Physician Decision|1|||
131904731|NCT03834506|474937092|FG000|Overall Study|Lost to Follow-up|0|||
131904732|NCT03834506|474937093|FG001|Overall Study|Lost to Follow-up|1|||
131904733|NCT00916578|474938906|FG000|Overall Study|Physician Decision|2|||
131904734|NCT00916578|474938906|FG000|Overall Study|Withdrawal by Subject|3|||
131721294|NCT01607892|474258884|FG000|Overall Study|Intercurrent illness|1|||
131721295|NCT01607892|474258885|FG001|Overall Study|Intercurrent illness|0|||
131721296|NCT01607892|474258886|FG002|Overall Study|Intercurrent illness|0|||
131721297|NCT01607892|474258887|FG003|Overall Study|Intercurrent illness|3|||
131904735|NCT00916578|474938906|FG000|Overall Study|Insurance Denial|2|||
131904736|NCT02737358|474938909|FG000|Overall Study|Withdrawal by Subject|7|||
131721298|NCT01607892|474258888|FG004|Overall Study|Intercurrent illness|0|||
131721299|NCT01607892|474258884|FG000|Overall Study|Non-Compliance with study procedures|0|||
131721300|NCT01607892|474258885|FG001|Overall Study|Non-Compliance with study procedures|0|||
131721301|NCT01607892|474258886|FG002|Overall Study|Non-Compliance with study procedures|1|||
131721302|NCT01607892|474258887|FG003|Overall Study|Non-Compliance with study procedures|0|||
131721303|NCT01607892|474258888|FG004|Overall Study|Non-Compliance with study procedures|0|||
131721304|NCT01607892|474258884|FG000|Overall Study|Consent withdrawn by participant|9|||
131721305|NCT01607892|474258885|FG001|Overall Study|Consent withdrawn by participant|4|||
131721306|NCT01607892|474258886|FG002|Overall Study|Consent withdrawn by participant|24|||
131721307|NCT01607892|474258887|FG003|Overall Study|Consent withdrawn by participant|14|||
131721308|NCT01607892|474258888|FG004|Overall Study|Consent withdrawn by participant|4|||
131448283|NCT02079246|473272632|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
131448284|NCT02079246|473272631|FG000|OLEX-MEM|Adverse Event|0|||
131448285|NCT02079246|473272632|FG001|OLEX-MEM|Adverse Event|6|||
131721309|NCT01607892|474258884|FG000|Overall Study|Disease progression|38|||
131721310|NCT01607892|474258885|FG001|Overall Study|Disease progression|13|||
131448286|NCT02079246|473272631|FG000|OLEX-MEM|Withdrawal by Subject|0|||
131448287|NCT02079246|473272632|FG001|OLEX-MEM|Withdrawal by Subject|7|||
131721311|NCT01607892|474258886|FG002|Overall Study|Disease progression|37|||
131721312|NCT01607892|474258887|FG003|Overall Study|Disease progression|57|||
131721313|NCT01607892|474258888|FG004|Overall Study|Disease progression|9|||
131721314|NCT01607892|474258884|FG000|Overall Study|Incidence or severity of Adverse events|3|||
131721315|NCT01607892|474258885|FG001|Overall Study|Incidence or severity of Adverse events|3|||
131721316|NCT01607892|474258886|FG002|Overall Study|Incidence or severity of Adverse events|7|||
131721317|NCT01607892|474258887|FG003|Overall Study|Incidence or severity of Adverse events|2|||
131721318|NCT01607892|474258888|FG004|Overall Study|Incidence or severity of Adverse events|6|||
131721319|NCT03022422|474258889|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
131721320|NCT03022422|474258890|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
131721321|NCT03022422|474258891|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
131721322|NCT03022422|474258892|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
131721323|NCT03022422|474258893|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
131721324|NCT03022422|474258894|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
131721325|NCT01444391|474258895|FG000|Overall Study|Death|1|||
131721326|NCT01582282|474260337|FG000|Overall Study|Adverse Event|1|||
131721327|NCT01582282|474260338|FG001|Overall Study|Adverse Event|1|||
131721328|NCT01582282|474260339|FG002|Overall Study|Adverse Event|0|||
131721329|NCT01582282|474260337|FG000|Overall Study|Lost to Follow-up|1|||
131721330|NCT01582282|474260338|FG001|Overall Study|Lost to Follow-up|0|||
131721331|NCT01582282|474260339|FG002|Overall Study|Lost to Follow-up|0|||
131721332|NCT01582282|474260337|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
131904737|NCT02737358|474938910|FG001|Overall Study|Withdrawal by Subject|12|||
131904738|NCT02737358|474938909|FG000|Overall Study|Lost to Follow-up|2|||
131904739|NCT02737358|474938910|FG001|Overall Study|Lost to Follow-up|3|||
131904740|NCT03191799|474938916|FG000|Overall Study|Withdrawal by Subject|4|||
131904741|NCT03191799|474938916|FG000|Overall Study|Physician Decision|2|||
131904742|NCT03191799|474938916|FG000|Overall Study|Lost to Follow-up|1|||
131904743|NCT03191799|474938916|FG000|Overall Study|Death|2|||
131904744|NCT00748241|474938922|FG000|Overall Study|Implant failure|1|||
131904745|NCT00748241|474938922|FG000|Overall Study|Lost to Follow-up|5|||
131904746|NCT00748241|474938922|FG000|Overall Study|Death|2|||
131904747|NCT01240382|474938923|FG000|Overall Study|Adverse Event|2|||
131904748|NCT01240382|474938924|FG001|Overall Study|Adverse Event|1|||
131904749|NCT01240382|474938923|FG000|Overall Study|Lack of Efficacy|0|||
131904750|NCT01240382|474938924|FG001|Overall Study|Lack of Efficacy|2|||
131904751|NCT01240382|474938923|FG000|Overall Study|Fear of adverse events|0|||
131904752|NCT01240382|474938924|FG001|Overall Study|Fear of adverse events|1|||
131904753|NCT02456727|474938932|FG000|Overall Study|Lost to Follow-up|63|||
131904754|NCT02456727|474938933|FG001|Overall Study|Lost to Follow-up|65|||
131904755|NCT02456727|474938932|FG000|Overall Study|Death|2|||
131904756|NCT02456727|474938933|FG001|Overall Study|Death|1|||
131904757|NCT02456727|474938932|FG000|Overall Study|Withdrawal by Subject|1|||
131904758|NCT02456727|474938933|FG001|Overall Study|Withdrawal by Subject|10|||
131904759|NCT02456727|474938932|FG000|Overall Study|Never Initiated Treatment|43|||
131904760|NCT02456727|474938933|FG001|Overall Study|Never Initiated Treatment|30|||
131904761|NCT02643693|474938934|FG000|Overall Study|Physician Decision|0|||
131904762|NCT02643693|474938935|FG001|Overall Study|Physician Decision|1|||
131904763|NCT02643693|474938936|FG002|Overall Study|Physician Decision|0|||
131904764|NCT02643693|474938937|FG003|Overall Study|Physician Decision|0|||
131904765|NCT02643693|474938938|FG004|Overall Study|Physician Decision|0|||
131904766|NCT02643693|474938939|FG005|Overall Study|Physician Decision|0|||
131904767|NCT02643693|474938934|FG000|Overall Study|Withdrawal by Subject|0|||
131904768|NCT02643693|474938935|FG001|Overall Study|Withdrawal by Subject|1|||
131904769|NCT02643693|474938936|FG002|Overall Study|Withdrawal by Subject|0|||
131904770|NCT02643693|474938937|FG003|Overall Study|Withdrawal by Subject|0|||
131448288|NCT02079246|473272631|FG000|OLEX-MEM|Protocol Violation|0|||
131448289|NCT02079246|473272632|FG001|OLEX-MEM|Protocol Violation|2|||
131721333|NCT01582282|474260338|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
131721334|NCT01582282|474260339|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
131721335|NCT01486316|474260340|FG000|Overall Study|Device explanted with/without re-implant|3|||
131448290|NCT02079246|473272631|FG000|OLEX-MEM|Lost to Follow-up|0|||
131448291|NCT02079246|473272632|FG001|OLEX-MEM|Lost to Follow-up|1|||
131448292|NCT02079246|473272631|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
131448293|NCT02079246|473272632|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
131721336|NCT01486316|474260341|FG001|Overall Study|Device explanted with/without re-implant|2|||
131721337|NCT01486316|474260342|FG002|Overall Study|Device explanted with/without re-implant|0|||
131721338|NCT01486316|474260343|FG003|Overall Study|Device explanted with/without re-implant|2|||
131721339|NCT01486316|474260340|FG000|Overall Study|Not meeting eligibility criteria|0|||
131721340|NCT01486316|474260341|FG001|Overall Study|Not meeting eligibility criteria|0|||
131721341|NCT01486316|474260342|FG002|Overall Study|Not meeting eligibility criteria|1|||
131721342|NCT01486316|474260343|FG003|Overall Study|Not meeting eligibility criteria|0|||
131721343|NCT01486316|474260340|FG000|Overall Study|Withdrawal by Subject|1|||
131721344|NCT01486316|474260341|FG001|Overall Study|Withdrawal by Subject|0|||
131721345|NCT01486316|474260342|FG002|Overall Study|Withdrawal by Subject|3|||
131721346|NCT01486316|474260343|FG003|Overall Study|Withdrawal by Subject|0|||
131721347|NCT01486316|474260340|FG000|Overall Study|Physician Decision|0|||
131721348|NCT01486316|474260341|FG001|Overall Study|Physician Decision|0|||
131721349|NCT01486316|474260342|FG002|Overall Study|Physician Decision|1|||
131721350|NCT01486316|474260343|FG003|Overall Study|Physician Decision|0|||
131721351|NCT01486316|474260340|FG000|Overall Study|Death|0|||
131721352|NCT01486316|474260341|FG001|Overall Study|Death|1|||
131721353|NCT01486316|474260342|FG002|Overall Study|Death|0|||
131721354|NCT01486316|474260343|FG003|Overall Study|Death|0|||
131448294|NCT00775190|473272637|FG000|Overall Study|Lost to Follow-up|2|||
131448295|NCT00775190|473272638|FG001|Overall Study|Lost to Follow-up|3|||
131496711|NCT02289690|473446359|FG000|Overall Study|Death|0|||
131721355|NCT02114203|474260368|FG000|Overall Study|Adverse Event|0|||
131721356|NCT02114203|474260369|FG001|Overall Study|Adverse Event|1|||
131721357|NCT02114203|474260370|FG002|Overall Study|Adverse Event|0|||
131721358|NCT02114203|474260368|FG000|Overall Study|Withdrawal by Subject|0|||
131721359|NCT02114203|474260369|FG001|Overall Study|Withdrawal by Subject|1|||
131721360|NCT02114203|474260370|FG002|Overall Study|Withdrawal by Subject|0|||
131721361|NCT01518699|474260372|FG000|Period 2|Protocol Violation|1|||
131721362|NCT01518699|474260373|FG001|Period 2|Protocol Violation|1|||
131721363|NCT01518699|474260374|FG002|Period 2|Protocol Violation|0|||
131721364|NCT01518699|474260375|FG003|Period 2|Protocol Violation|0|||
131721365|NCT01518699|474260376|FG004|Period 2|Protocol Violation|0|||
131721366|NCT01518699|474260377|FG005|Period 2|Protocol Violation|0|||
131721367|NCT01518699|474260372|FG000|Period 2|Lost to Follow-up|0|||
131721368|NCT01518699|474260373|FG001|Period 2|Lost to Follow-up|1|||
131721369|NCT01518699|474260374|FG002|Period 2|Lost to Follow-up|0|||
131721370|NCT01518699|474260375|FG003|Period 2|Lost to Follow-up|0|||
131721371|NCT01518699|474260376|FG004|Period 2|Lost to Follow-up|0|||
131721372|NCT01518699|474260377|FG005|Period 2|Lost to Follow-up|0|||
131721373|NCT01518699|474260372|FG000|Period 2|Adverse Event|1|||
131721374|NCT01518699|474260373|FG001|Period 2|Adverse Event|0|||
131721375|NCT01518699|474260374|FG002|Period 2|Adverse Event|0|||
131721376|NCT01518699|474260375|FG003|Period 2|Adverse Event|0|||
131721377|NCT01518699|474260376|FG004|Period 2|Adverse Event|0|||
131721378|NCT01518699|474260377|FG005|Period 2|Adverse Event|0|||
131721379|NCT02839746|474260379|FG000|Overall Study|Not met selection criteria|12|||
131721380|NCT00744055|474260380|FG000|Overall Study|Withdrawal by Subject|6|||
131721381|NCT00744055|474260381|FG001|Overall Study|Withdrawal by Subject|9|||
131721382|NCT00744055|474260380|FG000|Overall Study|Lack of Efficacy|0|||
131721383|NCT00744055|474260381|FG001|Overall Study|Lack of Efficacy|1|||
131721384|NCT00744055|474260380|FG000|Overall Study|Physician Decision|0|||
131721385|NCT00744055|474260381|FG001|Overall Study|Physician Decision|2|||
131721386|NCT00744055|474260380|FG000|Overall Study|Protocol Violation|1|||
131721387|NCT00744055|474260381|FG001|Overall Study|Protocol Violation|1|||
131721388|NCT00744055|474260380|FG000|Overall Study|Lost to Follow-up|0|||
131721389|NCT00744055|474260381|FG001|Overall Study|Lost to Follow-up|1|||
131721390|NCT02767570|474260384|FG000|Overall Study|Lost to Follow-up|3|||
131721391|NCT02767570|474260385|FG001|Overall Study|Lost to Follow-up|0|||
131721392|NCT02767570|474260384|FG000|Overall Study|COVID shutdown|2|||
131721393|NCT02767570|474260385|FG001|Overall Study|COVID shutdown|5|||
131721394|NCT02767570|474260384|FG000|Overall Study|Increased pain|2|||
131721395|NCT02767570|474260385|FG001|Overall Study|Increased pain|0|||
131721396|NCT02767570|474260384|FG000|Overall Study|Withdrawal by Subject|1|||
131721397|NCT02767570|474260385|FG001|Overall Study|Withdrawal by Subject|3|||
131721398|NCT02767570|474260384|FG000|Overall Study|Unrelated medical issue|1|||
131721399|NCT02767570|474260385|FG001|Overall Study|Unrelated medical issue|1|||
131721400|NCT02767570|474260384|FG000|Overall Study|Received intra-articular injection|0|||
131721401|NCT02767570|474260385|FG001|Overall Study|Received intra-articular injection|1|||
131721402|NCT00151411|474260386|FG000|Overall Study|Lost to Follow-up|15|||
131721403|NCT00151411|474260387|FG001|Overall Study|Lost to Follow-up|19|||
131721404|NCT00151411|474260386|FG000|Overall Study|Withdrawal by Subject|12|||
131721405|NCT00151411|474260387|FG001|Overall Study|Withdrawal by Subject|20|||
131721406|NCT00151411|474260386|FG000|Overall Study|Adverse Event|6|||
131721407|NCT00151411|474260387|FG001|Overall Study|Adverse Event|0|||
131721408|NCT00151411|474260386|FG000|Overall Study|Pregnancy|0|||
131721409|NCT00151411|474260387|FG001|Overall Study|Pregnancy|4|||
131721410|NCT00417612|474260388|FG000|Overall Study|Errant diagnosis|0|||
131721411|NCT00417612|474260389|FG001|Overall Study|Errant diagnosis|1|||
131721412|NCT00417612|474260388|FG000|Overall Study|Adverse Event|2|||
131721413|NCT00417612|474260389|FG001|Overall Study|Adverse Event|0|||
131721414|NCT00417612|474260388|FG000|Overall Study|Protocol Violation|0|||
131721415|NCT00417612|474260389|FG001|Overall Study|Protocol Violation|2|||
131721416|NCT00417612|474260388|FG000|Overall Study|Lost to Follow-up|1|||
131721417|NCT00417612|474260389|FG001|Overall Study|Lost to Follow-up|0|||
131904771|NCT02643693|474938938|FG004|Overall Study|Withdrawal by Subject|0|||
131904772|NCT02643693|474938939|FG005|Overall Study|Withdrawal by Subject|0|||
131904773|NCT02643693|474938934|FG000|Overall Study|Protocol Adherence Issues|2|||
131904774|NCT02643693|474938935|FG001|Overall Study|Protocol Adherence Issues|0|||
131904775|NCT02643693|474938936|FG002|Overall Study|Protocol Adherence Issues|1|||
131904776|NCT02643693|474938937|FG003|Overall Study|Protocol Adherence Issues|0|||
131721418|NCT01157169|474260392|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
131721419|NCT01157169|474260393|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
131721420|NCT01157169|474260392|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
131721421|NCT01157169|474260393|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
131721422|NCT01330381|474260396|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
131721423|NCT01330381|474260397|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
131721424|NCT01330381|474260398|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
131721425|NCT01330381|474260396|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
131721426|NCT01330381|474260397|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
131721427|NCT01330381|474260398|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
131721428|NCT01330381|474260396|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
131721429|NCT01330381|474260397|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
131721430|NCT01330381|474260398|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
131721431|NCT01330381|474260396|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
131721432|NCT01330381|474260397|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
131721433|NCT01330381|474260398|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
131721434|NCT01330381|474260396|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
131721435|NCT01330381|474260397|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
131721436|NCT01330381|474260398|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
131721437|NCT01330381|474260396|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
131721438|NCT01330381|474260397|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
131721439|NCT01330381|474260398|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
131721440|NCT01330381|474260396|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
131721441|NCT01330381|474260397|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
131721442|NCT01330381|474260398|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
131721443|NCT01330381|474260396|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
131721444|NCT01330381|474260397|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
131721445|NCT01330381|474260398|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
131721446|NCT01330381|474260396|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
131721447|NCT01330381|474260397|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
131721448|NCT01330381|474260398|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
131721449|NCT01330381|474260396|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
131721450|NCT01330381|474260397|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
131721451|NCT01330381|474260398|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
131721452|NCT03846947|474260399|FG000|Overall Study|technical issues with imaging sequence|2|||
131721453|NCT01978912|474260400|FG000|Overall Study|Adverse Event|0|||
131721454|NCT01978912|474260401|FG001|Overall Study|Adverse Event|1|||
131721455|NCT01978912|474260402|FG002|Overall Study|Adverse Event|0|||
131721456|NCT01978912|474260403|FG003|Overall Study|Adverse Event|0|||
131721457|NCT01978912|474260400|FG000|Overall Study|Lost to Follow-up|1|||
131721458|NCT01978912|474260401|FG001|Overall Study|Lost to Follow-up|1|||
131721459|NCT01978912|474260402|FG002|Overall Study|Lost to Follow-up|0|||
131721460|NCT01978912|474260403|FG003|Overall Study|Lost to Follow-up|1|||
131904777|NCT02643693|474938938|FG004|Overall Study|Protocol Adherence Issues|0|||
131721461|NCT01978912|474260400|FG000|Overall Study|Withdrawal by Subject|1|||
131721462|NCT01978912|474260401|FG001|Overall Study|Withdrawal by Subject|0|||
131721463|NCT01978912|474260402|FG002|Overall Study|Withdrawal by Subject|2|||
131721464|NCT01978912|474260403|FG003|Overall Study|Withdrawal by Subject|2|||
131721465|NCT01978912|474260400|FG000|Overall Study|Lumbar Surgery|1|||
131721466|NCT01978912|474260401|FG001|Overall Study|Lumbar Surgery|0|||
131721467|NCT01978912|474260402|FG002|Overall Study|Lumbar Surgery|1|||
131721468|NCT01978912|474260403|FG003|Overall Study|Lumbar Surgery|0|||
131721469|NCT01978912|474260400|FG000|Overall Study|Intradiscal Steroid Injection|0|||
131721470|NCT01978912|474260401|FG001|Overall Study|Intradiscal Steroid Injection|1|||
131721471|NCT01978912|474260402|FG002|Overall Study|Intradiscal Steroid Injection|0|||
131721472|NCT01978912|474260403|FG003|Overall Study|Intradiscal Steroid Injection|0|||
131721473|NCT00224107|474260404|FG000|Overall Study|Adverse Event|20|||
131804738|NCT00365300|474570513|FG001|Double-blind Phase|Lack of Efficacy|6|||
131804739|NCT02896361|474570514|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
131804740|NCT02896361|474570515|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
131804741|NCT02896361|474570516|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
131804742|NCT02896361|474570514|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
131721474|NCT00224107|474260405|FG001|Overall Study|Adverse Event|6|||
131721475|NCT00224107|474260404|FG000|Overall Study|Protocol Violation|2|||
131721476|NCT00224107|474260405|FG001|Overall Study|Protocol Violation|3|||
131721477|NCT00224107|474260404|FG000|Overall Study|Withdrawal by Subject|1|||
131721478|NCT00224107|474260405|FG001|Overall Study|Withdrawal by Subject|4|||
131721479|NCT00224107|474260404|FG000|Overall Study|Lack of Efficacy|2|||
131721480|NCT00224107|474260405|FG001|Overall Study|Lack of Efficacy|0|||
131721481|NCT00224107|474260404|FG000|Overall Study|Lost to Follow-up|4|||
131721482|NCT00224107|474260405|FG001|Overall Study|Lost to Follow-up|0|||
131721483|NCT00224107|474260404|FG000|Overall Study|Physician Decision|1|||
131721484|NCT00224107|474260405|FG001|Overall Study|Physician Decision|0|||
131804743|NCT02896361|474570515|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
131804744|NCT02896361|474570516|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
131804745|NCT01179048|474570518|FG000|Overall Study|Withdrawn - does not allow contact|4|||
131804746|NCT01179048|474570519|FG001|Overall Study|Withdrawn - does not allow contact|8|||
131804747|NCT01179048|474570518|FG000|Overall Study|Lost to Follow-up|8|||
131804748|NCT01179048|474570519|FG001|Overall Study|Lost to Follow-up|9|||
131804749|NCT01179048|474570518|FG000|Overall Study|Alive|127|||
131804750|NCT01179048|474570519|FG001|Overall Study|Alive|142|||
131804751|NCT00358449|474570527|FG000|Overall Study|Adverse Event|1|||
131804752|NCT00358449|474570528|FG001|Overall Study|Adverse Event|0|||
131804753|NCT00358449|474570529|FG002|Overall Study|Adverse Event|1|||
131721485|NCT00224107|474260404|FG000|Overall Study|Other|1|||
131721486|NCT00224107|474260405|FG001|Overall Study|Other|1|||
131721487|NCT04220866|474260406|FG000|Overall Study|Death|4|||
131721488|NCT04220866|474260407|FG001|Overall Study|Death|5|||
131721489|NCT04220866|474260406|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
131721490|NCT04220866|474260407|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
131721491|NCT04220866|474260406|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
131721492|NCT04220866|474260407|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
131721493|NCT04220866|474260406|FG000|Overall Study|Withdrawal by Subject|0|||
131721494|NCT04220866|474260407|FG001|Overall Study|Withdrawal by Subject|1|||
131721495|NCT01408537|474260410|FG000|Overall Study|Withdrawal by Subject|2|||
131721496|NCT01408537|474260410|FG000|Overall Study|Protocol Violation|3|||
131721497|NCT01408537|474260410|FG000|Overall Study|Lost to Follow-up|3|||
131721498|NCT03842709|474260417|FG000|Overall Study|Withdrawal by Subject|3|||
131721499|NCT03842709|474260418|FG001|Overall Study|Withdrawal by Subject|3|||
131721500|NCT03842709|474260417|FG000|Overall Study|Lost to Follow-up|1|||
131721501|NCT03842709|474260418|FG001|Overall Study|Lost to Follow-up|0|||
131721502|NCT00984659|474260419|FG000|2-week Run-in Period|Adverse Event|8|||
131721503|NCT00984659|474260420|FG001|2-week Run-in Period|Adverse Event|0|||
131721504|NCT00984659|474260421|FG002|2-week Run-in Period|Adverse Event|0|||
131721505|NCT00984659|474260422|FG003|2-week Run-in Period|Adverse Event|0|||
131721506|NCT00984659|474260419|FG000|2-week Run-in Period|Protocol Violation|5|||
131904778|NCT02643693|474938939|FG005|Overall Study|Protocol Adherence Issues|1|||
131904779|NCT00888654|474938940|FG000|Overall Study|Problems swallowing oral meds.|1|||
131904780|NCT00888654|474938940|FG000|Overall Study|Not enough oral meds before surgery|3|||
131904781|NCT00888654|474938940|FG000|Overall Study|Surgery aborted|2|||
131904782|NCT00888654|474938940|FG000|Overall Study|Withdrawal by Subject|1|||
131904783|NCT00888654|474938940|FG000|Overall Study|Inelig. due to contraindication of med|1|||
131904784|NCT00888654|474938940|FG000|Overall Study|Change in surg date|1|||
131904785|NCT00888654|474938940|FG000|Overall Study|Stopped meds due to headaches|1|||
131904786|NCT02974868|474938943|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
131904787|NCT02974868|474938944|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
131904788|NCT02974868|474938945|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
131904789|NCT02974868|474938946|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
131904790|NCT02974868|474938943|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
131904791|NCT02974868|474938944|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
131904792|NCT02974868|474938945|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
131904793|NCT02974868|474938946|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
131904794|NCT02974868|474938943|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
131904795|NCT02974868|474938944|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
131904796|NCT02974868|474938945|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
131904797|NCT02974868|474938946|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
131904798|NCT02974868|474938943|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
131904799|NCT02974868|474938944|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
131904800|NCT02974868|474938945|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
131904801|NCT02974868|474938946|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
131904802|NCT00706004|474938947|FG000|Overall Study|Did not meet eligibility criteria|2|||
131904803|NCT00297648|474938950|FG000|Overall Study|Adverse Event|13|||
131904804|NCT00297648|474938950|FG000|Overall Study|Lack of Efficacy|18|||
131904805|NCT00297648|474938950|FG000|Overall Study|Lost to Follow-up|1|||
131904806|NCT00297648|474938950|FG000|Overall Study|Withdrawal by Subject|3|||
131904807|NCT00297648|474938950|FG000|Overall Study|Other: Incompliance|1|||
131433996|NCT04276233|473214590|FG000|Overall Study|Physician Decision|4|||
131804754|NCT00358449|474570527|FG000|Overall Study|Lost to Follow-up|1|||
131804755|NCT00358449|474570528|FG001|Overall Study|Lost to Follow-up|0|||
131804756|NCT00358449|474570529|FG002|Overall Study|Lost to Follow-up|0|||
131448296|NCT00775190|473272637|FG000|Overall Study|Withdrawal by Subject|1|||
131448297|NCT00775190|473272638|FG001|Overall Study|Withdrawal by Subject|2|||
131448298|NCT00775190|473272637|FG000|Overall Study|Protocol Violation|1|||
131448299|NCT00775190|473272638|FG001|Overall Study|Protocol Violation|0|||
131448300|NCT04610281|473272643|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
131448301|NCT04610281|473272644|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
131448302|NCT03077412|473272645|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
131448303|NCT03077412|473272646|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
131448304|NCT03077412|473272647|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
131448305|NCT03077412|473272645|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
131448306|NCT03077412|473272646|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
131448307|NCT03077412|473272647|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
131448308|NCT03077412|473272645|FG000|Overall Study|Adverse Event|1|||
131448309|NCT03077412|473272646|FG001|Overall Study|Adverse Event|2|||
131448310|NCT03077412|473272647|FG002|Overall Study|Adverse Event|2|||
131448311|NCT03077412|473272645|FG000|Overall Study|Investigator's Discretion|0|||
131448312|NCT03077412|473272646|FG001|Overall Study|Investigator's Discretion|1|||
131448313|NCT03077412|473272647|FG002|Overall Study|Investigator's Discretion|1|||
131721507|NCT00984659|474260420|FG001|2-week Run-in Period|Protocol Violation|0|||
131448314|NCT03077412|473272645|FG000|Overall Study|Withdrew Consent|0|||
131448315|NCT03077412|473272646|FG001|Overall Study|Withdrew Consent|2|||
131448316|NCT03077412|473272647|FG002|Overall Study|Withdrew Consent|0|||
131448317|NCT02266888|473272649|FG000|Overall Study|Death|2|||
131448318|NCT02266888|473272650|FG001|Overall Study|Death|2|||
131448319|NCT02266888|473272651|FG002|Overall Study|Death|4|||
131721508|NCT00984659|474260421|FG002|2-week Run-in Period|Protocol Violation|0|||
131721509|NCT00984659|474260422|FG003|2-week Run-in Period|Protocol Violation|0|||
131721510|NCT00984659|474260419|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
131721511|NCT00984659|474260420|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
131721512|NCT00984659|474260421|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
131448320|NCT02266888|473272652|FG003|Overall Study|Death|2|||
131448321|NCT02266888|473272649|FG000|Overall Study|Physician Decision|0|||
131448322|NCT02266888|473272650|FG001|Overall Study|Physician Decision|1|||
131448323|NCT02266888|473272651|FG002|Overall Study|Physician Decision|2|||
131448324|NCT02266888|473272652|FG003|Overall Study|Physician Decision|2|||
131448325|NCT02266888|473272649|FG000|Overall Study|Study Terminated|5|||
131448326|NCT02266888|473272650|FG001|Overall Study|Study Terminated|1|||
131448327|NCT02266888|473272651|FG002|Overall Study|Study Terminated|0|||
131448328|NCT02266888|473272652|FG003|Overall Study|Study Terminated|0|||
131448329|NCT02266888|473272649|FG000|Overall Study|No Longer Eligible|0|||
131448330|NCT02266888|473272650|FG001|Overall Study|No Longer Eligible|0|||
131448331|NCT02266888|473272651|FG002|Overall Study|No Longer Eligible|0|||
131448332|NCT02266888|473272652|FG003|Overall Study|No Longer Eligible|2|||
131448333|NCT02266888|473272649|FG000|Overall Study|Randomization Closed|0|||
131448334|NCT02266888|473272650|FG001|Overall Study|Randomization Closed|0|||
131448335|NCT02266888|473272651|FG002|Overall Study|Randomization Closed|4|||
131448336|NCT02266888|473272652|FG003|Overall Study|Randomization Closed|0|||
131448337|NCT02266888|473272649|FG000|Overall Study|Personnel unavailable at transplant|0|||
131448338|NCT02266888|473272650|FG001|Overall Study|Personnel unavailable at transplant|0|||
131448339|NCT02266888|473272651|FG002|Overall Study|Personnel unavailable at transplant|0|||
131448340|NCT02266888|473272652|FG003|Overall Study|Personnel unavailable at transplant|1|||
131448341|NCT02266888|473272649|FG000|Overall Study|Transfer of care|0|||
131448342|NCT02266888|473272650|FG001|Overall Study|Transfer of care|0|||
131448343|NCT02266888|473272651|FG002|Overall Study|Transfer of care|1|||
131448344|NCT02266888|473272652|FG003|Overall Study|Transfer of care|0|||
131448345|NCT02351856|473272653|FG000|Overall Study|Adverse Event|2|||
131448346|NCT02351856|473272653|FG000|Overall Study|Physician Decision|5|||
131448347|NCT02351856|473272653|FG000|Overall Study|Study terminated by sponsor|1|||
131448348|NCT01458392|473272654|FG000|Overall Study|Death|2|||
131448349|NCT01458392|473272655|FG001|Overall Study|Death|11|||
131448350|NCT01458392|473272656|FG002|Overall Study|Death|22|||
131448351|NCT01458392|473272654|FG000|Overall Study|At the discretion of the sponsor|0|||
131448352|NCT01458392|473272655|FG001|Overall Study|At the discretion of the sponsor|2|||
131448353|NCT01458392|473272656|FG002|Overall Study|At the discretion of the sponsor|7|||
131448354|NCT01458392|473272654|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
131448355|NCT01458392|473272655|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
131448356|NCT01458392|473272656|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
131448357|NCT00918255|473272659|FG000|Overall Study|Adverse Event|1|||
131448358|NCT00918255|473272660|FG001|Overall Study|Adverse Event|0|||
131448359|NCT00918255|473272661|FG002|Overall Study|Adverse Event|0|||
131448360|NCT00918255|473272659|FG000|Overall Study|Withdrawal by Subject|1|||
131448361|NCT00918255|473272660|FG001|Overall Study|Withdrawal by Subject|0|||
131448362|NCT00918255|473272661|FG002|Overall Study|Withdrawal by Subject|2|||
131448363|NCT00918255|473272659|FG000|Overall Study|Lack of Efficacy|1|||
131448364|NCT00918255|473272660|FG001|Overall Study|Lack of Efficacy|0|||
131448365|NCT00918255|473272661|FG002|Overall Study|Lack of Efficacy|0|||
131448366|NCT00918255|473272659|FG000|Overall Study|Lost to Follow-up|1|||
131448367|NCT00918255|473272660|FG001|Overall Study|Lost to Follow-up|0|||
131448368|NCT00918255|473272661|FG002|Overall Study|Lost to Follow-up|2|||
131448369|NCT00918255|473272659|FG000|Overall Study|Exceeded allowed number of interventions|0|||
131448370|NCT00918255|473272660|FG001|Overall Study|Exceeded allowed number of interventions|0|||
131448371|NCT00918255|473272661|FG002|Overall Study|Exceeded allowed number of interventions|1|||
131448372|NCT00918255|473272659|FG000|Overall Study|Non-compliance|1|||
131448373|NCT00918255|473272660|FG001|Overall Study|Non-compliance|0|||
131448374|NCT00918255|473272661|FG002|Overall Study|Non-compliance|0|||
131448375|NCT00918255|473272659|FG000|Overall Study|Investigator discretion|1|||
131448376|NCT00918255|473272660|FG001|Overall Study|Investigator discretion|0|||
131721513|NCT00984659|474260422|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
131721514|NCT00984659|474260419|FG000|2-week Run-in Period|Lost to Follow-up|3|||
131721515|NCT00984659|474260420|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131721516|NCT00984659|474260421|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131721517|NCT00984659|474260422|FG003|2-week Run-in Period|Lost to Follow-up|0|||
131721518|NCT00984659|474260419|FG000|2-week Run-in Period|Physician Decision|10|||
131721519|NCT00984659|474260420|FG001|2-week Run-in Period|Physician Decision|0|||
131721520|NCT00984659|474260421|FG002|2-week Run-in Period|Physician Decision|0|||
131721521|NCT00984659|474260422|FG003|2-week Run-in Period|Physician Decision|0|||
131721522|NCT00984659|474260419|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
131721523|NCT00984659|474260420|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131721524|NCT00984659|474260421|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131721525|NCT00984659|474260422|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
131721526|NCT00984659|474260419|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
131721527|NCT00984659|474260420|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131721528|NCT00984659|474260421|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131721529|NCT00984659|474260422|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131721530|NCT00984659|474260419|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
131721531|NCT00984659|474260420|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
131721532|NCT00984659|474260421|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
131721533|NCT00984659|474260422|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
131721534|NCT00984659|474260419|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
131721535|NCT00984659|474260420|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
131721536|NCT00984659|474260421|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
131721537|NCT00984659|474260422|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
131721538|NCT00984659|474260419|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
131721539|NCT00984659|474260420|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
131721540|NCT00984659|474260421|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
131721541|NCT00984659|474260422|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
131721542|NCT00984659|474260419|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
131721543|NCT00984659|474260420|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
131721544|NCT00984659|474260421|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
131721545|NCT00984659|474260422|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
131721546|NCT00984659|474260419|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131721547|NCT00984659|474260420|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
131721548|NCT00984659|474260421|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
131721549|NCT00984659|474260422|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
131721550|NCT03894540|474260426|FG000|Overall Study|Adverse Event|0|||
131721551|NCT03894540|474260427|FG001|Overall Study|Adverse Event|0|||
131721552|NCT03894540|474260428|FG002|Overall Study|Adverse Event|0|||
131721553|NCT03894540|474260429|FG003|Overall Study|Adverse Event|0|||
131721554|NCT03894540|474260430|FG004|Overall Study|Adverse Event|1|||
131721555|NCT03894540|474260431|FG005|Overall Study|Adverse Event|0|||
131721556|NCT03894540|474260426|FG000|Overall Study|Withdrawal by Subject|0|||
131721557|NCT03894540|474260427|FG001|Overall Study|Withdrawal by Subject|0|||
131721558|NCT03894540|474260428|FG002|Overall Study|Withdrawal by Subject|0|||
131721559|NCT03894540|474260429|FG003|Overall Study|Withdrawal by Subject|0|||
131721560|NCT03894540|474260430|FG004|Overall Study|Withdrawal by Subject|1|||
131721561|NCT03894540|474260431|FG005|Overall Study|Withdrawal by Subject|0|||
131721562|NCT03894540|474260426|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
131721563|NCT03894540|474260427|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
131904808|NCT03575702|474938951|FG000|Overall Study|Withdrawal by Subject|1|||
131448377|NCT00918255|473272661|FG002|Overall Study|Investigator discretion|0|||
131721564|NCT03894540|474260428|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
131448378|NCT01193244|473272662|FG000|Overall Study|Withdrawal by Subject|79|||
131448379|NCT01193244|473272663|FG001|Overall Study|Withdrawal by Subject|97|||
131721565|NCT03894540|474260429|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
131721566|NCT03894540|474260430|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
131721567|NCT03894540|474260431|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
131721568|NCT03894540|474260426|FG000|Overall Study|Progressive Disease Clinical|1|||
131721569|NCT03894540|474260427|FG001|Overall Study|Progressive Disease Clinical|1|||
131721570|NCT03894540|474260428|FG002|Overall Study|Progressive Disease Clinical|0|||
131721571|NCT03894540|474260429|FG003|Overall Study|Progressive Disease Clinical|1|||
131721572|NCT03894540|474260430|FG004|Overall Study|Progressive Disease Clinical|5|||
131804757|NCT00358449|474570527|FG000|Overall Study|Withdrawal by Subject|2|||
131448380|NCT01193244|473272662|FG000|Overall Study|Other|303|||
131448381|NCT01193244|473272663|FG001|Overall Study|Other|278|||
131448382|NCT01193244|473272662|FG000|Overall Study|Lost to Follow-up|6|||
131448383|NCT01193244|473272663|FG001|Overall Study|Lost to Follow-up|15|||
131448384|NCT03763877|473272673|FG000|Overall Study|Withdrawal by Subject|3|||
131448385|NCT03763877|473272674|FG001|Overall Study|Withdrawal by Subject|1|||
131448386|NCT03763877|473272675|FG002|Overall Study|Withdrawal by Subject|3|||
131448387|NCT03763877|473272676|FG003|Overall Study|Withdrawal by Subject|4|||
131448388|NCT03763877|473272673|FG000|Overall Study|Adverse Event|1|||
131448389|NCT03763877|473272674|FG001|Overall Study|Adverse Event|1|||
131448390|NCT03763877|473272675|FG002|Overall Study|Adverse Event|3|||
131448391|NCT03763877|473272676|FG003|Overall Study|Adverse Event|1|||
131448392|NCT03763877|473272673|FG000|Overall Study|Protocol Violation|1|||
131721573|NCT03894540|474260431|FG005|Overall Study|Progressive Disease Clinical|1|||
131721574|NCT03894540|474260426|FG000|Overall Study|Study termination by sponsor|0|||
131721575|NCT03894540|474260427|FG001|Overall Study|Study termination by sponsor|0|||
131804758|NCT00358449|474570528|FG001|Overall Study|Withdrawal by Subject|0|||
131448393|NCT03763877|473272674|FG001|Overall Study|Protocol Violation|1|||
131448394|NCT03763877|473272675|FG002|Overall Study|Protocol Violation|0|||
131448395|NCT03763877|473272676|FG003|Overall Study|Protocol Violation|0|||
131448396|NCT03763877|473272673|FG000|Overall Study|Lost to Follow-up|0|||
131448397|NCT03763877|473272674|FG001|Overall Study|Lost to Follow-up|1|||
131448398|NCT03763877|473272675|FG002|Overall Study|Lost to Follow-up|1|||
131448399|NCT03763877|473272676|FG003|Overall Study|Lost to Follow-up|0|||
131448400|NCT03040336|473272677|FG000|Overall Study|Death|1|||
131448401|NCT03040336|473272678|FG001|Overall Study|Death|0|||
131448402|NCT03040336|473272677|FG000|Overall Study|Withdrawal by Subject|2|||
131448403|NCT03040336|473272678|FG001|Overall Study|Withdrawal by Subject|3|||
131448404|NCT00068692|473272683|FG000|Step 1: Registration|Disese progression/relapse|5|||
131448405|NCT00068692|473272684|FG001|Step 1: Registration|Disese progression/relapse|0|||
131448406|NCT00068692|473272685|FG002|Step 1: Registration|Disese progression/relapse|0|||
131448407|NCT00068692|473272686|FG003|Step 1: Registration|Disese progression/relapse|0|||
131448408|NCT00068692|473272687|FG004|Step 1: Registration|Disese progression/relapse|0|||
131448409|NCT00068692|473272688|FG005|Step 1: Registration|Disese progression/relapse|0|||
131448410|NCT00068692|473272689|FG006|Step 1: Registration|Disese progression/relapse|0|||
131448411|NCT00068692|473272690|FG007|Step 1: Registration|Disese progression/relapse|0|||
131448412|NCT00068692|473272683|FG000|Step 1: Registration|Adverse Event|7|||
131804759|NCT00358449|474570529|FG002|Overall Study|Withdrawal by Subject|0|||
131804760|NCT00358449|474570527|FG000|Overall Study|Lack of Efficacy|0|||
131804761|NCT00358449|474570528|FG001|Overall Study|Lack of Efficacy|1|||
131804762|NCT00358449|474570529|FG002|Overall Study|Lack of Efficacy|0|||
131804763|NCT00358449|474570527|FG000|Overall Study|Steriod Inhaler was Increased|0|||
131721576|NCT03894540|474260428|FG002|Overall Study|Study termination by sponsor|0|||
131721577|NCT03894540|474260429|FG003|Overall Study|Study termination by sponsor|0|||
131721578|NCT03894540|474260430|FG004|Overall Study|Study termination by sponsor|2|||
131721579|NCT03894540|474260431|FG005|Overall Study|Study termination by sponsor|0|||
131721580|NCT01508676|474260434|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
131721581|NCT01508676|474260435|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
131721582|NCT01508676|474260434|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
131721583|NCT01508676|474260435|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
131721584|NCT01508676|474260434|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
131721585|NCT01508676|474260435|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
131721586|NCT01508676|474260434|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
131721587|NCT01508676|474260435|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
131721588|NCT01508676|474260434|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
131721589|NCT01508676|474260435|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
131721590|NCT02052960|474260437|FG000|Overall Study|Adverse Event|19|||
131721591|NCT02052960|474260438|FG001|Overall Study|Adverse Event|17|||
131721592|NCT02052960|474260437|FG000|Overall Study|Protocol Violation|4|||
131804764|NCT00358449|474570528|FG001|Overall Study|Steriod Inhaler was Increased|0|||
131804765|NCT00358449|474570529|FG002|Overall Study|Steriod Inhaler was Increased|1|||
131448413|NCT00068692|473272684|FG001|Step 1: Registration|Adverse Event|0|||
131448414|NCT00068692|473272685|FG002|Step 1: Registration|Adverse Event|0|||
131448415|NCT00068692|473272686|FG003|Step 1: Registration|Adverse Event|0|||
131448416|NCT00068692|473272687|FG004|Step 1: Registration|Adverse Event|0|||
131721593|NCT02052960|474260438|FG001|Overall Study|Protocol Violation|3|||
131721594|NCT02052960|474260437|FG000|Overall Study|Withdrawal by Subject|6|||
131721595|NCT02052960|474260438|FG001|Overall Study|Withdrawal by Subject|11|||
131721596|NCT02052960|474260437|FG000|Overall Study|Other|25|||
131721597|NCT02052960|474260438|FG001|Overall Study|Other|15|||
131721598|NCT02460822|474260439|FG000|Overall Study|Withdrawal by Subject|1|||
131721599|NCT03849560|474260440|FG000|Overall Study|Withdrawal by Subject|1|||
131721600|NCT03849560|474260441|FG001|Overall Study|Withdrawal by Subject|0|||
131721601|NCT03849560|474260442|FG002|Overall Study|Withdrawal by Subject|0|||
131721602|NCT04045613|474260443|FG000|Overall Study|Adverse Event|2|||
131721603|NCT04045613|474260444|FG001|Overall Study|Adverse Event|2|||
131804766|NCT01367457|474570532|FG000|Overall Study|Death|2|||
131804767|NCT01367457|474570533|FG001|Overall Study|Death|0|||
131721604|NCT04045613|474260445|FG002|Overall Study|Adverse Event|1|||
131721605|NCT04045613|474260446|FG003|Overall Study|Adverse Event|1|||
131721606|NCT04045613|474260447|FG004|Overall Study|Adverse Event|0|||
131721607|NCT04045613|474260448|FG005|Overall Study|Adverse Event|0|||
131721608|NCT04045613|474260449|FG006|Overall Study|Adverse Event|1|||
131804768|NCT01367457|474570534|FG002|Overall Study|Death|0|||
131721609|NCT04045613|474260443|FG000|Overall Study|Withdrawal by Subject|0|||
131804769|NCT01367457|474570532|FG000|Overall Study|Investigator's decision|2|||
131721610|NCT04045613|474260444|FG001|Overall Study|Withdrawal by Subject|5|||
131721611|NCT04045613|474260445|FG002|Overall Study|Withdrawal by Subject|0|||
131721612|NCT04045613|474260446|FG003|Overall Study|Withdrawal by Subject|0|||
131721613|NCT04045613|474260447|FG004|Overall Study|Withdrawal by Subject|0|||
131721614|NCT04045613|474260448|FG005|Overall Study|Withdrawal by Subject|1|||
131721615|NCT04045613|474260449|FG006|Overall Study|Withdrawal by Subject|0|||
131721616|NCT04045613|474260443|FG000|Overall Study|Physician Decision|2|||
131721617|NCT04045613|474260444|FG001|Overall Study|Physician Decision|0|||
131721618|NCT04045613|474260445|FG002|Overall Study|Physician Decision|0|||
131721619|NCT04045613|474260446|FG003|Overall Study|Physician Decision|0|||
131721620|NCT04045613|474260447|FG004|Overall Study|Physician Decision|1|||
131721621|NCT04045613|474260448|FG005|Overall Study|Physician Decision|0|||
131721622|NCT04045613|474260449|FG006|Overall Study|Physician Decision|0|||
131721623|NCT04045613|474260443|FG000|Overall Study|Death|3|||
131721624|NCT04045613|474260444|FG001|Overall Study|Death|0|||
131721625|NCT04045613|474260445|FG002|Overall Study|Death|0|||
131721626|NCT04045613|474260446|FG003|Overall Study|Death|0|||
131721627|NCT04045613|474260447|FG004|Overall Study|Death|0|||
131721628|NCT04045613|474260448|FG005|Overall Study|Death|0|||
131721629|NCT04045613|474260449|FG006|Overall Study|Death|1|||
131721630|NCT04045613|474260443|FG000|Overall Study|Other reasons|0|||
131721631|NCT04045613|474260444|FG001|Overall Study|Other reasons|1|||
131721632|NCT04045613|474260445|FG002|Overall Study|Other reasons|0|||
131721633|NCT04045613|474260446|FG003|Overall Study|Other reasons|0|||
131721634|NCT04045613|474260447|FG004|Overall Study|Other reasons|0|||
131721635|NCT04045613|474260448|FG005|Overall Study|Other reasons|0|||
131721636|NCT04045613|474260449|FG006|Overall Study|Other reasons|1|||
131721637|NCT04045613|474260443|FG000|Overall Study|Progressive disease: Clinical progression|1|||
131721638|NCT04045613|474260444|FG001|Overall Study|Progressive disease: Clinical progression|0|||
131721639|NCT04045613|474260445|FG002|Overall Study|Progressive disease: Clinical progression|3|||
131721640|NCT04045613|474260446|FG003|Overall Study|Progressive disease: Clinical progression|1|||
131721641|NCT04045613|474260447|FG004|Overall Study|Progressive disease: Clinical progression|1|||
131721642|NCT04045613|474260448|FG005|Overall Study|Progressive disease: Clinical progression|3|||
131721643|NCT04045613|474260449|FG006|Overall Study|Progressive disease: Clinical progression|3|||
131721644|NCT04045613|474260443|FG000|Overall Study|Progressive disease: Radiological progression|24|||
131721645|NCT04045613|474260444|FG001|Overall Study|Progressive disease: Radiological progression|6|||
131721646|NCT04045613|474260445|FG002|Overall Study|Progressive disease: Radiological progression|8|||
131721647|NCT04045613|474260446|FG003|Overall Study|Progressive disease: Radiological progression|0|||
131721648|NCT04045613|474260447|FG004|Overall Study|Progressive disease: Radiological progression|6|||
131721649|NCT04045613|474260448|FG005|Overall Study|Progressive disease: Radiological progression|6|||
131721650|NCT04045613|474260449|FG006|Overall Study|Progressive disease: Radiological progression|11|||
131721651|NCT00450866|474260456|FG000|Overall Study|Adverse Event|0|||
131721652|NCT00450866|474260457|FG001|Overall Study|Adverse Event|1|||
131721653|NCT00450866|474260456|FG000|Overall Study|Withdrawal by Subject|5|||
131721654|NCT00450866|474260457|FG001|Overall Study|Withdrawal by Subject|2|||
131721655|NCT00450866|474260456|FG000|Overall Study|Death|1|||
131721656|NCT00450866|474260457|FG001|Overall Study|Death|0|||
131721657|NCT00450866|474260456|FG000|Overall Study|Physician Decision|1|||
131721658|NCT00450866|474260457|FG001|Overall Study|Physician Decision|0|||
131721659|NCT01743027|474260458|FG000|Overall Study|Adverse Event|2|||
131804770|NCT01367457|474570533|FG001|Overall Study|Investigator's decision|0|||
131448417|NCT00068692|473272688|FG005|Step 1: Registration|Adverse Event|0|||
131448418|NCT00068692|473272689|FG006|Step 1: Registration|Adverse Event|0|||
131448419|NCT00068692|473272690|FG007|Step 1: Registration|Adverse Event|0|||
131448420|NCT00068692|473272683|FG000|Step 1: Registration|Death|1|||
131448421|NCT00068692|473272684|FG001|Step 1: Registration|Death|0|||
131448422|NCT00068692|473272685|FG002|Step 1: Registration|Death|0|||
131448423|NCT00068692|473272686|FG003|Step 1: Registration|Death|0|||
131448424|NCT00068692|473272687|FG004|Step 1: Registration|Death|0|||
131448425|NCT00068692|473272688|FG005|Step 1: Registration|Death|0|||
131448426|NCT00068692|473272689|FG006|Step 1: Registration|Death|0|||
131448427|NCT00068692|473272690|FG007|Step 1: Registration|Death|0|||
131448428|NCT00068692|473272683|FG000|Step 1: Registration|Withdrawal by Subject|11|||
131448429|NCT00068692|473272684|FG001|Step 1: Registration|Withdrawal by Subject|0|||
131448430|NCT00068692|473272685|FG002|Step 1: Registration|Withdrawal by Subject|0|||
131448431|NCT00068692|473272686|FG003|Step 1: Registration|Withdrawal by Subject|0|||
131448432|NCT00068692|473272687|FG004|Step 1: Registration|Withdrawal by Subject|0|||
131448433|NCT00068692|473272688|FG005|Step 1: Registration|Withdrawal by Subject|0|||
131448434|NCT00068692|473272689|FG006|Step 1: Registration|Withdrawal by Subject|0|||
131448435|NCT00068692|473272690|FG007|Step 1: Registration|Withdrawal by Subject|0|||
131448436|NCT00068692|473272683|FG000|Step 1: Registration|Alternative therapy|2|||
131448437|NCT00068692|473272684|FG001|Step 1: Registration|Alternative therapy|0|||
131448438|NCT00068692|473272685|FG002|Step 1: Registration|Alternative therapy|0|||
131448439|NCT00068692|473272686|FG003|Step 1: Registration|Alternative therapy|0|||
131448440|NCT00068692|473272687|FG004|Step 1: Registration|Alternative therapy|0|||
131448441|NCT00068692|473272688|FG005|Step 1: Registration|Alternative therapy|0|||
131448442|NCT00068692|473272689|FG006|Step 1: Registration|Alternative therapy|0|||
131448443|NCT00068692|473272690|FG007|Step 1: Registration|Alternative therapy|0|||
131448444|NCT00068692|473272683|FG000|Step 1: Registration|Complicating disease|2|||
131448445|NCT00068692|473272684|FG001|Step 1: Registration|Complicating disease|0|||
131448446|NCT00068692|473272685|FG002|Step 1: Registration|Complicating disease|0|||
131448447|NCT00068692|473272686|FG003|Step 1: Registration|Complicating disease|0|||
131448448|NCT00068692|473272687|FG004|Step 1: Registration|Complicating disease|0|||
131448449|NCT00068692|473272688|FG005|Step 1: Registration|Complicating disease|0|||
131448450|NCT00068692|473272689|FG006|Step 1: Registration|Complicating disease|0|||
131448451|NCT00068692|473272690|FG007|Step 1: Registration|Complicating disease|0|||
131448452|NCT00068692|473272683|FG000|Step 1: Registration|Protocol Violation|1|||
131448453|NCT00068692|473272684|FG001|Step 1: Registration|Protocol Violation|0|||
131448454|NCT00068692|473272685|FG002|Step 1: Registration|Protocol Violation|0|||
131448455|NCT00068692|473272686|FG003|Step 1: Registration|Protocol Violation|0|||
131448456|NCT00068692|473272687|FG004|Step 1: Registration|Protocol Violation|0|||
131448457|NCT00068692|473272688|FG005|Step 1: Registration|Protocol Violation|0|||
131448458|NCT00068692|473272689|FG006|Step 1: Registration|Protocol Violation|0|||
131448459|NCT00068692|473272690|FG007|Step 1: Registration|Protocol Violation|0|||
131721660|NCT01743027|474260459|FG001|Overall Study|Adverse Event|0|||
131448460|NCT00068692|473272683|FG000|Step 1: Registration|Not eligible|6|||
131448461|NCT00068692|473272684|FG001|Step 1: Registration|Not eligible|0|||
131448462|NCT00068692|473272685|FG002|Step 1: Registration|Not eligible|0|||
131448463|NCT00068692|473272686|FG003|Step 1: Registration|Not eligible|0|||
131448464|NCT00068692|473272687|FG004|Step 1: Registration|Not eligible|0|||
131448465|NCT00068692|473272688|FG005|Step 1: Registration|Not eligible|0|||
131448466|NCT00068692|473272689|FG006|Step 1: Registration|Not eligible|0|||
131448467|NCT00068692|473272690|FG007|Step 1: Registration|Not eligible|0|||
131448468|NCT00068692|473272683|FG000|Step 1: Registration|Other|2|||
131448469|NCT00068692|473272684|FG001|Step 1: Registration|Other|0|||
131448470|NCT00068692|473272685|FG002|Step 1: Registration|Other|0|||
131448471|NCT00068692|473272686|FG003|Step 1: Registration|Other|0|||
131448472|NCT00068692|473272687|FG004|Step 1: Registration|Other|0|||
131448473|NCT00068692|473272688|FG005|Step 1: Registration|Other|0|||
131448474|NCT00068692|473272689|FG006|Step 1: Registration|Other|0|||
131448475|NCT00068692|473272690|FG007|Step 1: Registration|Other|0|||
131448476|NCT00068692|473272683|FG000|Step 1: Registration|Not start protocol therapy|3|||
131448477|NCT00068692|473272684|FG001|Step 1: Registration|Not start protocol therapy|0|||
131448478|NCT00068692|473272685|FG002|Step 1: Registration|Not start protocol therapy|0|||
131448479|NCT00068692|473272686|FG003|Step 1: Registration|Not start protocol therapy|0|||
131448480|NCT00068692|473272687|FG004|Step 1: Registration|Not start protocol therapy|0|||
131448481|NCT00068692|473272688|FG005|Step 1: Registration|Not start protocol therapy|0|||
131448482|NCT00068692|473272689|FG006|Step 1: Registration|Not start protocol therapy|0|||
131448483|NCT00068692|473272690|FG007|Step 1: Registration|Not start protocol therapy|0|||
131448484|NCT00068692|473272683|FG000|Step 1: Registration|Registered but not randomized|0|||
131448485|NCT00068692|473272684|FG001|Step 1: Registration|Registered but not randomized|1|||
131448486|NCT00068692|473272685|FG002|Step 1: Registration|Registered but not randomized|0|||
131448487|NCT00068692|473272686|FG003|Step 1: Registration|Registered but not randomized|0|||
131448488|NCT00068692|473272687|FG004|Step 1: Registration|Registered but not randomized|0|||
131448489|NCT00068692|473272688|FG005|Step 1: Registration|Registered but not randomized|0|||
131448490|NCT00068692|473272689|FG006|Step 1: Registration|Registered but not randomized|0|||
131448491|NCT00068692|473272690|FG007|Step 1: Registration|Registered but not randomized|0|||
131448492|NCT00068692|473272683|FG000|Step 2: Randomization|Disesae progression/replase|0|||
131448493|NCT00068692|473272684|FG001|Step 2: Randomization|Disesae progression/replase|0|||
131448494|NCT00068692|473272685|FG002|Step 2: Randomization|Disesae progression/replase|1|||
131448495|NCT00068692|473272686|FG003|Step 2: Randomization|Disesae progression/replase|1|||
131448496|NCT00068692|473272687|FG004|Step 2: Randomization|Disesae progression/replase|0|||
131448497|NCT00068692|473272688|FG005|Step 2: Randomization|Disesae progression/replase|0|||
131448498|NCT00068692|473272689|FG006|Step 2: Randomization|Disesae progression/replase|0|||
131448499|NCT00068692|473272690|FG007|Step 2: Randomization|Disesae progression/replase|0|||
131448500|NCT00068692|473272683|FG000|Step 2: Randomization|Adverse Event|0|||
131448501|NCT00068692|473272684|FG001|Step 2: Randomization|Adverse Event|0|||
131448502|NCT00068692|473272685|FG002|Step 2: Randomization|Adverse Event|4|||
131448503|NCT00068692|473272686|FG003|Step 2: Randomization|Adverse Event|2|||
131448504|NCT00068692|473272687|FG004|Step 2: Randomization|Adverse Event|2|||
131448505|NCT00068692|473272688|FG005|Step 2: Randomization|Adverse Event|3|||
131448506|NCT00068692|473272689|FG006|Step 2: Randomization|Adverse Event|4|||
131448507|NCT00068692|473272690|FG007|Step 2: Randomization|Adverse Event|4|||
131448508|NCT00068692|473272683|FG000|Step 2: Randomization|Death|0|||
131448509|NCT00068692|473272684|FG001|Step 2: Randomization|Death|0|||
131448510|NCT00068692|473272685|FG002|Step 2: Randomization|Death|0|||
131448511|NCT00068692|473272686|FG003|Step 2: Randomization|Death|0|||
131448512|NCT00068692|473272687|FG004|Step 2: Randomization|Death|1|||
131448513|NCT00068692|473272688|FG005|Step 2: Randomization|Death|0|||
131448514|NCT00068692|473272689|FG006|Step 2: Randomization|Death|0|||
131448515|NCT00068692|473272690|FG007|Step 2: Randomization|Death|1|||
131448516|NCT00068692|473272683|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
131448517|NCT00068692|473272684|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
131448518|NCT00068692|473272685|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
131448519|NCT00068692|473272686|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
131448520|NCT00068692|473272687|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
131448521|NCT00068692|473272688|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
131448522|NCT00068692|473272689|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
131448523|NCT00068692|473272690|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
131448524|NCT00068692|473272683|FG000|Step 2: Randomization|alternative therapy|0|||
131448525|NCT00068692|473272684|FG001|Step 2: Randomization|alternative therapy|0|||
131448526|NCT00068692|473272685|FG002|Step 2: Randomization|alternative therapy|0|||
131448527|NCT00068692|473272686|FG003|Step 2: Randomization|alternative therapy|1|||
131448528|NCT00068692|473272687|FG004|Step 2: Randomization|alternative therapy|1|||
131448529|NCT00068692|473272688|FG005|Step 2: Randomization|alternative therapy|0|||
131448530|NCT00068692|473272689|FG006|Step 2: Randomization|alternative therapy|0|||
131448531|NCT00068692|473272690|FG007|Step 2: Randomization|alternative therapy|0|||
131448532|NCT00068692|473272683|FG000|Step 2: Randomization|Physician Decision|0|||
131448533|NCT00068692|473272684|FG001|Step 2: Randomization|Physician Decision|0|||
131448534|NCT00068692|473272685|FG002|Step 2: Randomization|Physician Decision|0|||
131448535|NCT00068692|473272686|FG003|Step 2: Randomization|Physician Decision|1|||
131448536|NCT00068692|473272687|FG004|Step 2: Randomization|Physician Decision|1|||
131804771|NCT01367457|474570534|FG002|Overall Study|Investigator's decision|0|||
131804772|NCT01367457|474570532|FG000|Overall Study|Clinical decline (CD)|2|||
131804773|NCT01367457|474570533|FG001|Overall Study|Clinical decline (CD)|0|||
131448537|NCT00068692|473272688|FG005|Step 2: Randomization|Physician Decision|0|||
131448538|NCT00068692|473272689|FG006|Step 2: Randomization|Physician Decision|0|||
131448539|NCT00068692|473272690|FG007|Step 2: Randomization|Physician Decision|0|||
131448540|NCT00068692|473272683|FG000|Step 2: Randomization|Other|0|||
131448541|NCT00068692|473272684|FG001|Step 2: Randomization|Other|0|||
131804774|NCT01367457|474570534|FG002|Overall Study|Clinical decline (CD)|0|||
131804775|NCT01367457|474570532|FG000|Overall Study|Progression and death|8|||
131804776|NCT01367457|474570533|FG001|Overall Study|Progression and death|0|||
131804777|NCT01367457|474570534|FG002|Overall Study|Progression and death|0|||
131804778|NCT01367457|474570532|FG000|Overall Study|Toxicity|16|||
131804779|NCT01367457|474570533|FG001|Overall Study|Toxicity|0|||
131804780|NCT01367457|474570534|FG002|Overall Study|Toxicity|0|||
131804781|NCT01367457|474570532|FG000|Overall Study|Progression|137|||
131804782|NCT01367457|474570533|FG001|Overall Study|Progression|0|||
131804783|NCT01367457|474570534|FG002|Overall Study|Progression|0|||
131804784|NCT01367457|474570532|FG000|Overall Study|Patient asks for rest + slow progression|1|||
131804785|NCT01367457|474570533|FG001|Overall Study|Patient asks for rest + slow progression|0|||
131804786|NCT01367457|474570534|FG002|Overall Study|Patient asks for rest + slow progression|0|||
131804787|NCT01367457|474570532|FG000|Overall Study|Investigator's opinion, stable disease|1|||
131804788|NCT01367457|474570533|FG001|Overall Study|Investigator's opinion, stable disease|0|||
131804789|NCT01367457|474570534|FG002|Overall Study|Investigator's opinion, stable disease|0|||
131804790|NCT01367457|474570532|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
131804791|NCT01367457|474570533|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
131804792|NCT01367457|474570534|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
131804793|NCT01367457|474570532|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
131804794|NCT01367457|474570533|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
131804795|NCT01367457|474570534|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
131804796|NCT01367457|474570532|FG000|Overall Study|low grade toxicities + stable disease|1|||
131804797|NCT01367457|474570533|FG001|Overall Study|low grade toxicities + stable disease|0|||
131804798|NCT01367457|474570534|FG002|Overall Study|low grade toxicities + stable disease|0|||
131804799|NCT01367457|474570532|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
131804800|NCT01367457|474570533|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
131804801|NCT01367457|474570534|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
131804802|NCT01367457|474570532|FG000|Overall Study|Withdrawal by Subject|1|||
131804803|NCT01367457|474570533|FG001|Overall Study|Withdrawal by Subject|0|||
131804804|NCT01367457|474570534|FG002|Overall Study|Withdrawal by Subject|0|||
131804805|NCT01367457|474570532|FG000|Overall Study|CD, associated leukaemia|1|||
131804806|NCT01367457|474570533|FG001|Overall Study|CD, associated leukaemia|0|||
131804807|NCT01367457|474570534|FG002|Overall Study|CD, associated leukaemia|0|||
131804808|NCT01367457|474570532|FG000|Overall Study|Uncontrolled pain|1|||
131804809|NCT01367457|474570533|FG001|Overall Study|Uncontrolled pain|0|||
131804810|NCT01367457|474570534|FG002|Overall Study|Uncontrolled pain|0|||
131804811|NCT01367457|474570532|FG000|Overall Study|Overall status worsens to grade 4|1|||
131904809|NCT03575702|474938952|FG001|Overall Study|Withdrawal by Subject|1|||
131904810|NCT03575702|474938951|FG000|Overall Study|Lost to Follow-up|1|||
131721661|NCT01743027|474260460|FG002|Overall Study|Adverse Event|0|||
131721662|NCT01743027|474260461|FG003|Overall Study|Adverse Event|0|||
131721663|NCT01743027|474260458|FG000|Overall Study|Lost to Follow-up|0|||
131721664|NCT01743027|474260459|FG001|Overall Study|Lost to Follow-up|0|||
131721665|NCT01743027|474260460|FG002|Overall Study|Lost to Follow-up|2|||
131721666|NCT01743027|474260461|FG003|Overall Study|Lost to Follow-up|0|||
131721667|NCT01743027|474260458|FG000|Overall Study|Progressive Disease|1|||
131721668|NCT01743027|474260459|FG001|Overall Study|Progressive Disease|4|||
131721669|NCT01743027|474260460|FG002|Overall Study|Progressive Disease|3|||
131721670|NCT01743027|474260461|FG003|Overall Study|Progressive Disease|0|||
131721671|NCT01743027|474260458|FG000|Overall Study|Protocol Violation|1|||
131721672|NCT01743027|474260459|FG001|Overall Study|Protocol Violation|1|||
131721673|NCT01743027|474260460|FG002|Overall Study|Protocol Violation|1|||
131721674|NCT01743027|474260461|FG003|Overall Study|Protocol Violation|0|||
131721675|NCT01743027|474260458|FG000|Overall Study|Withdrawal by Subject|1|||
131721676|NCT01743027|474260459|FG001|Overall Study|Withdrawal by Subject|0|||
131721677|NCT01743027|474260460|FG002|Overall Study|Withdrawal by Subject|3|||
131721678|NCT01743027|474260461|FG003|Overall Study|Withdrawal by Subject|1|||
131721679|NCT02111811|474260464|FG000|Treatment Phase|Lost to Follow-up|22|||
131721680|NCT02111811|474260465|FG001|Treatment Phase|Lost to Follow-up|18|||
131721681|NCT02111811|474260464|FG000|Treatment Phase|Death|2|||
131721682|NCT02111811|474260465|FG001|Treatment Phase|Death|0|||
131721683|NCT02111811|474260464|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
131721684|NCT02111811|474260465|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
131721685|NCT02111811|474260464|FG000|Follow up Period (Aim 2)|Death|2|||
131721686|NCT02111811|474260465|FG001|Follow up Period (Aim 2)|Death|0|||
131721687|NCT01524289|474260476|FG000|Overall Study|Lost to Follow-up|0|||
131721688|NCT01524289|474260477|FG001|Overall Study|Lost to Follow-up|1|||
131448542|NCT00068692|473272685|FG002|Step 2: Randomization|Other|0|||
131448543|NCT00068692|473272686|FG003|Step 2: Randomization|Other|1|||
131448544|NCT00068692|473272687|FG004|Step 2: Randomization|Other|0|||
131448545|NCT00068692|473272688|FG005|Step 2: Randomization|Other|1|||
131448546|NCT00068692|473272689|FG006|Step 2: Randomization|Other|0|||
131448547|NCT00068692|473272690|FG007|Step 2: Randomization|Other|0|||
131448548|NCT00068692|473272683|FG000|Step 2: Randomization|never start protocol therapy|0|||
131448549|NCT00068692|473272684|FG001|Step 2: Randomization|never start protocol therapy|0|||
131721689|NCT01524289|474260476|FG000|Overall Study|Physician Decision|1|||
131721690|NCT01524289|474260477|FG001|Overall Study|Physician Decision|0|||
131721691|NCT01524289|474260476|FG000|Overall Study|Protocol Violation|5|||
131721692|NCT01524289|474260477|FG001|Overall Study|Protocol Violation|1|||
131721693|NCT01524289|474260476|FG000|Overall Study|Withdrawal by Subject|11|||
131721694|NCT01524289|474260477|FG001|Overall Study|Withdrawal by Subject|7|||
131721695|NCT01524289|474260476|FG000|Overall Study|Adverse Event|12|||
131721696|NCT01524289|474260477|FG001|Overall Study|Adverse Event|5|||
131721697|NCT01524289|474260476|FG000|Overall Study|Did not take study medication|1|||
131721698|NCT01524289|474260477|FG001|Overall Study|Did not take study medication|0|||
131721699|NCT02104180|474260478|FG000|Overall Study|Protocol Violation|1|||
131721700|NCT02104180|474260479|FG001|Overall Study|Protocol Violation|0|||
131721701|NCT02704429|474260483|FG000|Part A: 24 Weeks|Adverse Event|3|||
131721702|NCT02704429|474260484|FG001|Part A: 24 Weeks|Adverse Event|0|||
131721703|NCT02704429|474260483|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
131721704|NCT02704429|474260484|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
131721705|NCT02209597|474260488|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
131721706|NCT02209597|474260488|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
131721707|NCT02209597|474260488|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
131721708|NCT02209597|474260488|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
131721709|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Adverse Event|37|||
131721710|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Adverse Event|0|||
131721711|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Adverse Event|0|||
131721712|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Adverse Event|0|||
131721713|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Death|2|||
131721714|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Death|0|||
131721715|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Death|0|||
131721716|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Death|0|||
131721717|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
131721718|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
131721719|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
131721720|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
131721721|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
131804812|NCT01367457|474570533|FG001|Overall Study|Overall status worsens to grade 4|0|||
131804813|NCT01367457|474570534|FG002|Overall Study|Overall status worsens to grade 4|0|||
131804814|NCT01367457|474570532|FG000|Overall Study|Stabilisation + frequent infections|1|||
131804815|NCT01367457|474570533|FG001|Overall Study|Stabilisation + frequent infections|0|||
131804816|NCT01367457|474570534|FG002|Overall Study|Stabilisation + frequent infections|0|||
131804817|NCT01367457|474570532|FG000|Overall Study|No clinical benefit|1|||
131804818|NCT01367457|474570533|FG001|Overall Study|No clinical benefit|0|||
131804819|NCT01367457|474570534|FG002|Overall Study|No clinical benefit|0|||
131804820|NCT01367457|474570532|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
131804821|NCT01367457|474570533|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
131804822|NCT01367457|474570534|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
131804823|NCT01367457|474570532|FG000|Overall Study|Overall decline|1|||
131804824|NCT01367457|474570533|FG001|Overall Study|Overall decline|0|||
131804825|NCT01367457|474570534|FG002|Overall Study|Overall decline|0|||
131804826|NCT01367457|474570532|FG000|Overall Study|Rejection of treatment|1|||
131721722|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
131804827|NCT01367457|474570533|FG001|Overall Study|Rejection of treatment|0|||
131721723|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
131721724|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
131721725|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
131721726|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
131721727|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
131721728|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
131721729|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
131804828|NCT01367457|474570534|FG002|Overall Study|Rejection of treatment|0|||
131804829|NCT01367457|474570532|FG000|Overall Study|Lost to Follow-up|1|||
131721730|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
131721731|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
131721732|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
131721733|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Physician Decision|4|||
131721734|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Physician Decision|0|||
131721735|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Physician Decision|0|||
131804830|NCT01367457|474570533|FG001|Overall Study|Lost to Follow-up|0|||
131804831|NCT01367457|474570534|FG002|Overall Study|Lost to Follow-up|0|||
131804832|NCT01367457|474570532|FG000|Overall Study|Death from septic shock|1|||
131804833|NCT01367457|474570533|FG001|Overall Study|Death from septic shock|0|||
131804834|NCT01367457|474570534|FG002|Overall Study|Death from septic shock|0|||
131804835|NCT01367457|474570532|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
131804836|NCT01367457|474570533|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
131804837|NCT01367457|474570534|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
131804838|NCT01367457|474570532|FG000|Overall Study|Patient's Wish|1|||
131804839|NCT01367457|474570533|FG001|Overall Study|Patient's Wish|0|||
131804840|NCT01367457|474570534|FG002|Overall Study|Patient's Wish|0|||
131804841|NCT01367457|474570532|FG000|Overall Study|Palliative. Overall decline|1|||
131804842|NCT01367457|474570533|FG001|Overall Study|Palliative. Overall decline|0|||
131804843|NCT01367457|474570534|FG002|Overall Study|Palliative. Overall decline|0|||
131721736|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Physician Decision|0|||
131721737|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Pregnancy|1|||
131721738|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Pregnancy|0|||
131721739|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Pregnancy|0|||
131721740|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Pregnancy|0|||
131721741|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
131721742|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
131721743|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
131804844|NCT01367457|474570532|FG000|Overall Study|Suspected DP/suspected active infection|1|||
131804845|NCT01367457|474570533|FG001|Overall Study|Suspected DP/suspected active infection|0|||
131721744|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
131721745|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
131721746|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
131721747|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
131721748|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
131721749|NCT01855789|474260490|FG000|1) Baseline up to Week 24|Other|4|||
131721750|NCT01855789|474260491|FG001|1) Baseline up to Week 24|Other|0|||
131721751|NCT01855789|474260492|FG002|1) Baseline up to Week 24|Other|0|||
131721752|NCT01855789|474260493|FG003|1) Baseline up to Week 24|Other|0|||
131721753|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
131721754|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
131721755|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
131721756|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
131721757|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
131721758|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
131721759|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
131721760|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
131721761|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
131721762|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
131721763|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
131721764|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
131721765|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
131804846|NCT01367457|474570534|FG002|Overall Study|Suspected DP/suspected active infection|0|||
131804847|NCT01520909|474570535|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
131804848|NCT01520909|474570536|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
131804849|NCT01520909|474570537|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
131804850|NCT01520909|474570535|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
131804851|NCT01520909|474570536|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
131804852|NCT01520909|474570537|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
131804853|NCT01520909|474570535|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
131804854|NCT01520909|474570536|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
131804855|NCT01520909|474570537|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
131804856|NCT01520909|474570535|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
131804857|NCT01520909|474570536|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
131804858|NCT01520909|474570537|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
131904811|NCT03575702|474938952|FG001|Overall Study|Lost to Follow-up|2|||
131904812|NCT03575702|474938951|FG000|Overall Study|Protocol Violation|0|||
131904813|NCT03575702|474938952|FG001|Overall Study|Protocol Violation|1|||
131904814|NCT03575702|474938951|FG000|Overall Study|Patient non compliance|4|||
131904815|NCT03575702|474938952|FG001|Overall Study|Patient non compliance|0|||
131904816|NCT03903172|474938953|FG000|Overall Study|screen fail|4|||
131904817|NCT03903172|474938954|FG001|Overall Study|screen fail|1|||
131904818|NCT01545388|474938955|FG000|Overall Study|Adverse Event|2|||
131904819|NCT01545388|474938956|FG001|Overall Study|Adverse Event|4|||
131904820|NCT01545388|474938957|FG002|Overall Study|Adverse Event|1|||
131904821|NCT01545388|474938955|FG000|Overall Study|Lack of Efficacy|3|||
131904822|NCT01545388|474938956|FG001|Overall Study|Lack of Efficacy|2|||
131904823|NCT01545388|474938957|FG002|Overall Study|Lack of Efficacy|5|||
131904824|NCT01545388|474938955|FG000|Overall Study|Participant moved or relocated|1|||
131904825|NCT01545388|474938956|FG001|Overall Study|Participant moved or relocated|0|||
131904826|NCT01545388|474938957|FG002|Overall Study|Participant moved or relocated|0|||
131904827|NCT01545388|474938955|FG000|Overall Study|Withdrawal by Subject|1|||
131904828|NCT01545388|474938956|FG001|Overall Study|Withdrawal by Subject|4|||
131904829|NCT01545388|474938957|FG002|Overall Study|Withdrawal by Subject|2|||
131904830|NCT01545388|474938955|FG000|Overall Study|Other|1|||
131904831|NCT01545388|474938956|FG001|Overall Study|Other|1|||
131904832|NCT01545388|474938957|FG002|Overall Study|Other|0|||
131904833|NCT01255163|474938958|FG000|Overall Study|Withdrawal by Subject|1|||
131904834|NCT01255163|474938959|FG001|Overall Study|Withdrawal by Subject|0|||
131904835|NCT01255163|474938958|FG000|Overall Study|Lost to Follow-up|2|||
131904836|NCT01255163|474938959|FG001|Overall Study|Lost to Follow-up|0|||
131904837|NCT01255163|474938958|FG000|Overall Study|Adverse Event|0|||
131904838|NCT01255163|474938959|FG001|Overall Study|Adverse Event|2|||
131904839|NCT01255163|474938958|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
131904840|NCT01255163|474938959|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
131904841|NCT02495389|474938960|FG000|Overall Study|Withdrawal by Subject|40|||
131904842|NCT01802385|474938964|FG000|Overall Study|Death|106|||
131904843|NCT01802385|474938965|FG001|Overall Study|Death|120|||
131904844|NCT03834493|474938966|FG000|Overall Study|Participants Ongoing|311|||
131904845|NCT03834493|474938967|FG001|Overall Study|Participants Ongoing|324|||
131904846|NCT03834493|474938966|FG000|Overall Study|Withdrawal by Subject|20|||
131904847|NCT03834493|474938967|FG001|Overall Study|Withdrawal by Subject|17|||
131904848|NCT03834493|474938966|FG000|Overall Study|Physician Decision|1|||
131721766|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
131721767|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
131721768|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
131721769|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
131721770|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
131721771|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
131721772|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
131721773|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
131721774|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
131721775|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
131721776|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
131721777|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
131721778|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
131721779|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
131721780|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
131721781|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
131721782|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
131721783|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
131721784|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
131721785|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
131721786|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
131721787|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
131721788|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
131721789|NCT01855789|474260490|FG000|2) Week 24 up to End of Study|Other|0|||
131721790|NCT01855789|474260491|FG001|2) Week 24 up to End of Study|Other|0|||
131721791|NCT01855789|474260492|FG002|2) Week 24 up to End of Study|Other|0|||
131721792|NCT01855789|474260493|FG003|2) Week 24 up to End of Study|Other|1|||
131721793|NCT03067311|474260494|FG000|Overall Study|Lost to Follow-up|1|||
131721794|NCT03067311|474260495|FG001|Overall Study|Lost to Follow-up|1|||
131721795|NCT03067311|474260494|FG000|Overall Study|Moved away|1|||
131721796|NCT03067311|474260495|FG001|Overall Study|Moved away|1|||
131721797|NCT00907738|474260496|FG000|Overall Study|Adverse Event|2|||
131721798|NCT00907738|474260497|FG001|Overall Study|Adverse Event|0|||
131721799|NCT00907738|474260498|FG002|Overall Study|Adverse Event|1|||
131721800|NCT00907738|474260499|FG003|Overall Study|Adverse Event|0|||
131721801|NCT00907738|474260500|FG004|Overall Study|Adverse Event|0|||
131721802|NCT00907738|474260496|FG000|Overall Study|not specified or withdrew consent|3|||
131721803|NCT00907738|474260497|FG001|Overall Study|not specified or withdrew consent|0|||
131721804|NCT00907738|474260498|FG002|Overall Study|not specified or withdrew consent|0|||
131721805|NCT00907738|474260499|FG003|Overall Study|not specified or withdrew consent|0|||
131721806|NCT00907738|474260500|FG004|Overall Study|not specified or withdrew consent|0|||
131721807|NCT00907738|474260496|FG000|Overall Study|Disease progression|8|||
131721808|NCT00907738|474260497|FG001|Overall Study|Disease progression|1|||
131721809|NCT00907738|474260498|FG002|Overall Study|Disease progression|6|||
131721810|NCT00907738|474260499|FG003|Overall Study|Disease progression|4|||
131721811|NCT00907738|474260500|FG004|Overall Study|Disease progression|2|||
131721812|NCT01089725|474260501|FG000|Overall Study|Adverse Event|1|||
131721813|NCT01089725|474260502|FG001|Overall Study|Adverse Event|1|||
131721814|NCT01089725|474260503|FG002|Overall Study|Adverse Event|0|||
131721815|NCT01089725|474260504|FG003|Overall Study|Adverse Event|0|||
131721816|NCT01089725|474260505|FG004|Overall Study|Adverse Event|2|||
131721817|NCT01089725|474260501|FG000|Overall Study|Lack of Efficacy|4|||
131721818|NCT01089725|474260502|FG001|Overall Study|Lack of Efficacy|3|||
131721819|NCT01089725|474260503|FG002|Overall Study|Lack of Efficacy|1|||
131721820|NCT01089725|474260504|FG003|Overall Study|Lack of Efficacy|0|||
131721821|NCT01089725|474260505|FG004|Overall Study|Lack of Efficacy|4|||
131721822|NCT01089725|474260501|FG000|Overall Study|Lost to Follow-up|2|||
131721823|NCT01089725|474260502|FG001|Overall Study|Lost to Follow-up|2|||
131721824|NCT01089725|474260503|FG002|Overall Study|Lost to Follow-up|0|||
131721825|NCT01089725|474260504|FG003|Overall Study|Lost to Follow-up|3|||
131721826|NCT01089725|474260505|FG004|Overall Study|Lost to Follow-up|0|||
131721827|NCT01089725|474260501|FG000|Overall Study|Protocol Violation|0|||
131721828|NCT01089725|474260502|FG001|Overall Study|Protocol Violation|0|||
131721829|NCT01089725|474260503|FG002|Overall Study|Protocol Violation|1|||
131721830|NCT01089725|474260504|FG003|Overall Study|Protocol Violation|1|||
131721831|NCT01089725|474260505|FG004|Overall Study|Protocol Violation|0|||
131721832|NCT01089725|474260501|FG000|Overall Study|Withdrawal by Subject|5|||
131721833|NCT01089725|474260502|FG001|Overall Study|Withdrawal by Subject|5|||
131804859|NCT02188303|474570538|FG000|Overall Study|Adverse Event|0|||
131721834|NCT01089725|474260503|FG002|Overall Study|Withdrawal by Subject|4|||
131721835|NCT01089725|474260504|FG003|Overall Study|Withdrawal by Subject|5|||
131721836|NCT01089725|474260505|FG004|Overall Study|Withdrawal by Subject|4|||
131721837|NCT01089725|474260501|FG000|Overall Study|Study Terminated by Sponsor|51|||
131721838|NCT01089725|474260502|FG001|Overall Study|Study Terminated by Sponsor|56|||
131721839|NCT01089725|474260503|FG002|Overall Study|Study Terminated by Sponsor|53|||
131721840|NCT01089725|474260504|FG003|Overall Study|Study Terminated by Sponsor|68|||
131721841|NCT01089725|474260505|FG004|Overall Study|Study Terminated by Sponsor|68|||
131721842|NCT01089725|474260501|FG000|Overall Study|Randomized, but not treated|0|||
131721843|NCT01089725|474260502|FG001|Overall Study|Randomized, but not treated|1|||
131721844|NCT01089725|474260503|FG002|Overall Study|Randomized, but not treated|2|||
131721845|NCT01089725|474260504|FG003|Overall Study|Randomized, but not treated|1|||
131721846|NCT01089725|474260505|FG004|Overall Study|Randomized, but not treated|2|||
131721847|NCT01089725|474260501|FG000|Overall Study|Other|3|||
131721848|NCT01089725|474260502|FG001|Overall Study|Other|0|||
131721849|NCT01089725|474260503|FG002|Overall Study|Other|0|||
131721850|NCT01089725|474260504|FG003|Overall Study|Other|1|||
131721851|NCT01089725|474260505|FG004|Overall Study|Other|0|||
131721852|NCT03692910|474262190|FG000|Overall Study|Lost to Follow-up|4|||
131721853|NCT03692910|474262191|FG001|Overall Study|Lost to Follow-up|0|||
131721854|NCT03692910|474262192|FG002|Overall Study|Lost to Follow-up|0|||
131721855|NCT03692910|474262190|FG000|Overall Study|Withdrawal by Subject|2|||
131721856|NCT03692910|474262191|FG001|Overall Study|Withdrawal by Subject|0|||
131721857|NCT03692910|474262192|FG002|Overall Study|Withdrawal by Subject|0|||
131721858|NCT01981122|474262193|FG000|Overall Study|Withdrawal by Subject|0|||
131721859|NCT01981122|474262194|FG001|Overall Study|Withdrawal by Subject|2|||
131721860|NCT01981122|474262193|FG000|Overall Study|Protocol Violation|0|||
131721861|NCT01981122|474262194|FG001|Overall Study|Protocol Violation|1|||
131721862|NCT01981122|474262193|FG000|Overall Study|Lost to Follow-up|0|||
131721863|NCT01981122|474262194|FG001|Overall Study|Lost to Follow-up|1|||
131721864|NCT01981122|474262193|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
131721865|NCT01981122|474262194|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
131721866|NCT01981122|474262193|FG000|Overall Study|Death|14|||
131721867|NCT01981122|474262194|FG001|Overall Study|Death|15|||
131721868|NCT03216265|474262195|FG000|Overall Study|Adverse Event|2|||
131721869|NCT03216265|474262196|FG001|Overall Study|Adverse Event|0|||
131721870|NCT03216265|474262197|FG002|Overall Study|Adverse Event|2|||
131721871|NCT03216265|474262195|FG000|Overall Study|Lost to Follow-up|0|||
131721872|NCT03216265|474262196|FG001|Overall Study|Lost to Follow-up|1|||
131721873|NCT03216265|474262197|FG002|Overall Study|Lost to Follow-up|0|||
131721874|NCT03216265|474262195|FG000|Overall Study|Withdrawal by Subject|0|||
131721875|NCT03216265|474262196|FG001|Overall Study|Withdrawal by Subject|0|||
131721876|NCT03216265|474262197|FG002|Overall Study|Withdrawal by Subject|1|||
131721877|NCT01334125|474262201|FG000|Overall Study|Lost to Follow-up|3|||
131721878|NCT01334125|474262202|FG001|Overall Study|Lost to Follow-up|3|||
131721879|NCT00401973|474262205|FG000|Overall Study|Adverse Event|2|||
131721880|NCT00401973|474262206|FG001|Overall Study|Adverse Event|8|||
131721881|NCT00401973|474262207|FG002|Overall Study|Adverse Event|4|||
131721882|NCT00401973|474262205|FG000|Overall Study|Clinical Relapse|0|||
131721883|NCT00401973|474262206|FG001|Overall Study|Clinical Relapse|1|||
131721884|NCT00401973|474262207|FG002|Overall Study|Clinical Relapse|1|||
131721885|NCT00401973|474262205|FG000|Overall Study|Lack of Efficacy|0|||
131721886|NCT00401973|474262206|FG001|Overall Study|Lack of Efficacy|0|||
131721887|NCT00401973|474262207|FG002|Overall Study|Lack of Efficacy|3|||
131721888|NCT00401973|474262205|FG000|Overall Study|Lost to Follow-up|2|||
131721889|NCT00401973|474262206|FG001|Overall Study|Lost to Follow-up|2|||
131721890|NCT00401973|474262207|FG002|Overall Study|Lost to Follow-up|2|||
131721891|NCT00401973|474262205|FG000|Overall Study|Physician Decision|2|||
131721892|NCT00401973|474262206|FG001|Overall Study|Physician Decision|0|||
131721893|NCT00401973|474262207|FG002|Overall Study|Physician Decision|1|||
131721894|NCT00401973|474262205|FG000|Overall Study|Protocol Violation|1|||
131721895|NCT00401973|474262206|FG001|Overall Study|Protocol Violation|2|||
131721896|NCT00401973|474262207|FG002|Overall Study|Protocol Violation|3|||
131721897|NCT00401973|474262205|FG000|Overall Study|Sponsor Decision|0|||
131721898|NCT00401973|474262206|FG001|Overall Study|Sponsor Decision|1|||
131721899|NCT00401973|474262207|FG002|Overall Study|Sponsor Decision|0|||
131721900|NCT00401973|474262205|FG000|Overall Study|Withdrawal by Subject|4|||
131721901|NCT00401973|474262206|FG001|Overall Study|Withdrawal by Subject|12|||
131804860|NCT02188303|474570539|FG001|Overall Study|Adverse Event|0|||
131721902|NCT00401973|474262207|FG002|Overall Study|Withdrawal by Subject|9|||
131721903|NCT05523362|474262208|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
131721904|NCT05523362|474262208|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
131721905|NCT05523362|474262208|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
131721906|NCT05523362|474262208|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
131721907|NCT03515538|474262209|FG000|Overall Study|Lack of Efficacy|2|||
131721908|NCT03515538|474262210|FG001|Overall Study|Lack of Efficacy|0|||
131721909|NCT03515538|474262211|FG002|Overall Study|Lack of Efficacy|2|||
131721910|NCT03515538|474262212|FG003|Overall Study|Lack of Efficacy|0|||
131721911|NCT03515538|474262209|FG000|Overall Study|Death|0|||
131721912|NCT03515538|474262210|FG001|Overall Study|Death|0|||
131721913|NCT03515538|474262211|FG002|Overall Study|Death|1|||
131721914|NCT03515538|474262212|FG003|Overall Study|Death|0|||
131721915|NCT03515538|474262209|FG000|Overall Study|Protocol Violation|0|||
131721916|NCT03515538|474262210|FG001|Overall Study|Protocol Violation|0|||
131721917|NCT03515538|474262211|FG002|Overall Study|Protocol Violation|0|||
131721918|NCT03515538|474262212|FG003|Overall Study|Protocol Violation|1|||
131721919|NCT03515538|474262209|FG000|Overall Study|Screen failure (baseline dropout)|0|||
131721920|NCT03515538|474262210|FG001|Overall Study|Screen failure (baseline dropout)|1|||
131721921|NCT03515538|474262211|FG002|Overall Study|Screen failure (baseline dropout)|0|||
131721922|NCT03515538|474262212|FG003|Overall Study|Screen failure (baseline dropout)|0|||
131721923|NCT03515538|474262209|FG000|Overall Study|Withdrawal by Subject|2|||
131721924|NCT03515538|474262210|FG001|Overall Study|Withdrawal by Subject|2|||
131721925|NCT03515538|474262211|FG002|Overall Study|Withdrawal by Subject|1|||
131721926|NCT03515538|474262212|FG003|Overall Study|Withdrawal by Subject|3|||
131721927|NCT03515538|474262209|FG000|Overall Study|Physician Decision|1|||
131721928|NCT03515538|474262210|FG001|Overall Study|Physician Decision|0|||
131721929|NCT03515538|474262211|FG002|Overall Study|Physician Decision|0|||
131721930|NCT03515538|474262212|FG003|Overall Study|Physician Decision|1|||
131721931|NCT04075604|474262213|FG000|Overall Study|Adverse Event|0|||
131721932|NCT04075604|474262214|FG001|Overall Study|Adverse Event|0|||
131721933|NCT04075604|474262215|FG002|Overall Study|Adverse Event|3|||
131721934|NCT04075604|474262213|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131721935|NCT04075604|474262214|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131721936|NCT04075604|474262215|FG002|Overall Study|Participant request to discontinue study treatment|1|||
131721937|NCT04075604|474262213|FG000|Overall Study|Participant withdrew consent|0|||
131721938|NCT04075604|474262214|FG001|Overall Study|Participant withdrew consent|0|||
131721939|NCT04075604|474262215|FG002|Overall Study|Participant withdrew consent|1|||
131721940|NCT04075604|474262213|FG000|Overall Study|Other reasons|1|||
131721941|NCT04075604|474262214|FG001|Overall Study|Other reasons|0|||
131721942|NCT04075604|474262215|FG002|Overall Study|Other reasons|0|||
131721943|NCT04075604|474262213|FG000|Overall Study|Disease progression|0|||
131721944|NCT04075604|474262214|FG001|Overall Study|Disease progression|1|||
131721945|NCT04075604|474262215|FG002|Overall Study|Disease progression|0|||
131721946|NCT04075604|474262213|FG000|Overall Study|Study drug toxicity|0|||
131721947|NCT04075604|474262214|FG001|Overall Study|Study drug toxicity|5|||
131721948|NCT04075604|474262215|FG002|Overall Study|Study drug toxicity|1|||
131721949|NCT01650779|474262218|FG000|Overall Study|Withdrawal by Subject|1|||
131721950|NCT04329923|474262221|FG000|Overall Study|Withdrawal by Subject|1|||
131721951|NCT04329923|474262222|FG001|Overall Study|Withdrawal by Subject|4|||
131721952|NCT04329923|474262223|FG002|Overall Study|Withdrawal by Subject|1|||
131721953|NCT04329923|474262224|FG003|Overall Study|Withdrawal by Subject|1|||
131721954|NCT04329923|474262225|FG004|Overall Study|Withdrawal by Subject|1|||
131721955|NCT04329923|474262226|FG005|Overall Study|Withdrawal by Subject|1|||
131721956|NCT04329923|474262221|FG000|Overall Study|early termination of study|0|||
131721957|NCT04329923|474262222|FG001|Overall Study|early termination of study|0|||
131721958|NCT04329923|474262223|FG002|Overall Study|early termination of study|0|||
131721959|NCT04329923|474262224|FG003|Overall Study|early termination of study|0|||
131721960|NCT04329923|474262225|FG004|Overall Study|early termination of study|1|||
131721961|NCT04329923|474262226|FG005|Overall Study|early termination of study|2|||
131721962|NCT04329923|474262221|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131721963|NCT04329923|474262222|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131721964|NCT04329923|474262223|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131721965|NCT04329923|474262224|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131721966|NCT04329923|474262225|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131721967|NCT04329923|474262226|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
131721968|NCT01272180|474262227|FG000|Overall Study|Adverse Event|0|||
131721969|NCT01272180|474262228|FG001|Overall Study|Adverse Event|0|||
131721970|NCT01272180|474262229|FG002|Overall Study|Adverse Event|1|||
131721971|NCT01272180|474262230|FG003|Overall Study|Adverse Event|0|||
131721972|NCT01272180|474262227|FG000|Overall Study|Withdrawal by Subject|2|||
131721973|NCT01272180|474262228|FG001|Overall Study|Withdrawal by Subject|6|||
131721974|NCT01272180|474262229|FG002|Overall Study|Withdrawal by Subject|3|||
131721975|NCT01272180|474262230|FG003|Overall Study|Withdrawal by Subject|2|||
131721976|NCT01272180|474262227|FG000|Overall Study|Lost to Follow-up|15|||
131721977|NCT01272180|474262228|FG001|Overall Study|Lost to Follow-up|14|||
131721978|NCT01272180|474262229|FG002|Overall Study|Lost to Follow-up|8|||
131721979|NCT01272180|474262230|FG003|Overall Study|Lost to Follow-up|10|||
131721980|NCT01272180|474262227|FG000|Overall Study|Inappropriate enrollment|0|||
131721981|NCT01272180|474262228|FG001|Overall Study|Inappropriate enrollment|0|||
131721982|NCT01272180|474262229|FG002|Overall Study|Inappropriate enrollment|1|||
131721983|NCT01272180|474262230|FG003|Overall Study|Inappropriate enrollment|1|||
131721984|NCT01272180|474262227|FG000|Overall Study|Protocol Violation|0|||
131721985|NCT01272180|474262228|FG001|Overall Study|Protocol Violation|1|||
131721986|NCT01272180|474262229|FG002|Overall Study|Protocol Violation|0|||
131721987|NCT01272180|474262230|FG003|Overall Study|Protocol Violation|1|||
131721988|NCT01183858|474262231|FG000|Overall Study|Death not related to Progressive Disease|5|||
131721989|NCT01183858|474262232|FG001|Overall Study|Death not related to Progressive Disease|6|||
131721990|NCT01183858|474262231|FG000|Overall Study|Adverse Event|14|||
131721991|NCT01183858|474262232|FG001|Overall Study|Adverse Event|11|||
131721992|NCT01183858|474262231|FG000|Overall Study|Investigator's Decision|0|||
131721993|NCT01183858|474262232|FG001|Overall Study|Investigator's Decision|3|||
131721994|NCT01183858|474262231|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131721995|NCT01183858|474262232|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131721996|NCT01183858|474262231|FG000|Overall Study|Refused Treatment|1|||
131721997|NCT01183858|474262232|FG001|Overall Study|Refused Treatment|4|||
131721998|NCT01183858|474262231|FG000|Overall Study|Withdrew Consent|4|||
131721999|NCT01183858|474262232|FG001|Overall Study|Withdrew Consent|4|||
131722000|NCT01183858|474262231|FG000|Overall Study|Discontinued Smoking|3|||
131722001|NCT01183858|474262232|FG001|Overall Study|Discontinued Smoking|1|||
131722002|NCT01183858|474262231|FG000|Overall Study|Protocol Violation|1|||
131722003|NCT01183858|474262232|FG001|Overall Study|Protocol Violation|0|||
131722004|NCT01183858|474262231|FG000|Overall Study|Administrative/Other|6|||
131722005|NCT01183858|474262232|FG001|Overall Study|Administrative/Other|6|||
131722006|NCT01183858|474262231|FG000|Overall Study|Progressive Disease|112|||
131722007|NCT01183858|474262232|FG001|Overall Study|Progressive Disease|115|||
131722008|NCT01183858|474262231|FG000|Overall Study|Death related to Progressive Disease|4|||
131722009|NCT01183858|474262232|FG001|Overall Study|Death related to Progressive Disease|5|||
131722010|NCT01183858|474262231|FG000|Overall Study|Lost to Follow-up|1|||
131722011|NCT01183858|474262232|FG001|Overall Study|Lost to Follow-up|1|||
131722012|NCT00641147|474262233|FG000|Completed 4 Months.|Physician Decision|1|||
131722013|NCT00641147|474262234|FG001|Completed 4 Months.|Physician Decision|0|||
131722014|NCT00641147|474262233|FG000|Completed 4 Months.|Adverse Event|1|||
131722015|NCT00641147|474262234|FG001|Completed 4 Months.|Adverse Event|0|||
131722016|NCT00641147|474262233|FG000|Completed 8 Months.|Physician Decision|2|||
131722017|NCT00641147|474262234|FG001|Completed 8 Months.|Physician Decision|1|||
131722018|NCT00641147|474262233|FG000|Completed 8 Months.|non compliance|1|||
131722019|NCT00641147|474262234|FG001|Completed 8 Months.|non compliance|0|||
131722020|NCT00641147|474262233|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
131722021|NCT00641147|474262234|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
131722022|NCT00641147|474262233|FG000|Completed 12 Months.|Physician Decision|1|||
131722023|NCT00641147|474262234|FG001|Completed 12 Months.|Physician Decision|1|||
131722024|NCT00641147|474262233|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
131722025|NCT00641147|474262234|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
131722026|NCT00641147|474262233|FG000|Completed 16 Months.|Physician Decision|1|||
131722027|NCT00641147|474262234|FG001|Completed 16 Months.|Physician Decision|0|||
131722028|NCT00641147|474262233|FG000|Completed 16 Months.|Lost to Follow-up|1|||
131722029|NCT00641147|474262234|FG001|Completed 16 Months.|Lost to Follow-up|0|||
131722030|NCT00791128|474262235|FG000|Overall Study|Adverse Event|4|||
131722031|NCT00791128|474262235|FG000|Overall Study|Device migration|2|||
131722032|NCT00791128|474262235|FG000|Overall Study|non-compliance by subject|2|||
131722033|NCT00791128|474262235|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
131722034|NCT01629667|474262236|FG000|Overall Study|Lost to Follow-up|0|||
131722035|NCT01629667|474262237|FG001|Overall Study|Lost to Follow-up|1|||
131722036|NCT01629667|474262238|FG002|Overall Study|Lost to Follow-up|1|||
131722037|NCT01629667|474262236|FG000|Overall Study|Withdrawal by Subject|31|||
131804861|NCT02188303|474570540|FG002|Overall Study|Adverse Event|0|||
131804862|NCT02188303|474570541|FG003|Overall Study|Adverse Event|0|||
131804863|NCT02188303|474570542|FG004|Overall Study|Adverse Event|0|||
131804864|NCT02188303|474570543|FG005|Overall Study|Adverse Event|2|||
131804865|NCT02188303|474570544|FG006|Overall Study|Adverse Event|0|||
131804866|NCT02188303|474570545|FG007|Overall Study|Adverse Event|2|||
131804867|NCT02188303|474570538|FG000|Overall Study|Dose Termination Criteria Met|0|||
131804868|NCT02188303|474570539|FG001|Overall Study|Dose Termination Criteria Met|0|||
131804869|NCT02188303|474570540|FG002|Overall Study|Dose Termination Criteria Met|0|||
131804870|NCT02188303|474570541|FG003|Overall Study|Dose Termination Criteria Met|0|||
131804871|NCT02188303|474570542|FG004|Overall Study|Dose Termination Criteria Met|0|||
131804872|NCT02188303|474570543|FG005|Overall Study|Dose Termination Criteria Met|0|||
131804873|NCT02188303|474570544|FG006|Overall Study|Dose Termination Criteria Met|2|||
131804874|NCT02188303|474570545|FG007|Overall Study|Dose Termination Criteria Met|4|||
131804875|NCT04206332|474570547|FG000|Part A|Lost to Follow-up|0|||
131804876|NCT04206332|474570548|FG001|Part A|Lost to Follow-up|1|||
131804877|NCT04206332|474570549|FG002|Part A|Lost to Follow-up|0|||
131804878|NCT04206332|474570550|FG003|Part A|Lost to Follow-up|0|||
131804879|NCT04206332|474570551|FG004|Part A|Lost to Follow-up|0|||
131804880|NCT04206332|474570552|FG005|Part A|Lost to Follow-up|0|||
131804881|NCT04206332|474570553|FG006|Part A|Lost to Follow-up|0|||
131722038|NCT01629667|474262237|FG001|Overall Study|Withdrawal by Subject|20|||
131722039|NCT01629667|474262238|FG002|Overall Study|Withdrawal by Subject|28|||
131722040|NCT01629667|474262236|FG000|Overall Study|Death|1|||
131722041|NCT01629667|474262237|FG001|Overall Study|Death|5|||
131722042|NCT01629667|474262238|FG002|Overall Study|Death|3|||
131722043|NCT01629667|474262236|FG000|Overall Study|Randomized, not treated|2|||
131722044|NCT01629667|474262237|FG001|Overall Study|Randomized, not treated|1|||
131722045|NCT01629667|474262238|FG002|Overall Study|Randomized, not treated|0|||
131722046|NCT01629667|474262236|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
131722047|NCT01629667|474262237|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
131722048|NCT01629667|474262238|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
131722049|NCT01629667|474262236|FG000|Overall Study|Requiring lung transplant|2|||
131722050|NCT01629667|474262237|FG001|Overall Study|Requiring lung transplant|1|||
131722051|NCT01629667|474262238|FG002|Overall Study|Requiring lung transplant|3|||
131722052|NCT01629667|474262236|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
131722053|NCT01629667|474262237|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
131722054|NCT01629667|474262238|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
131722055|NCT01629667|474262236|FG000|Overall Study|Started other medicine|1|||
131722056|NCT01629667|474262237|FG001|Overall Study|Started other medicine|0|||
131722057|NCT01629667|474262238|FG002|Overall Study|Started other medicine|1|||
131722058|NCT01629667|474262236|FG000|Overall Study|Site error in safety follow-up|0|||
131722059|NCT01629667|474262237|FG001|Overall Study|Site error in safety follow-up|0|||
131722060|NCT01629667|474262238|FG002|Overall Study|Site error in safety follow-up|1|||
131722061|NCT01629667|474262236|FG000|Overall Study|Enrolled in another clinical study|0|||
131722062|NCT01629667|474262237|FG001|Overall Study|Enrolled in another clinical study|1|||
131722063|NCT01629667|474262238|FG002|Overall Study|Enrolled in another clinical study|0|||
131722064|NCT01629667|474262236|FG000|Overall Study|Code break|1|||
131722065|NCT01629667|474262237|FG001|Overall Study|Code break|0|||
131722066|NCT01629667|474262238|FG002|Overall Study|Code break|0|||
131722067|NCT00546351|474262239|FG000|Overall Study|Adverse Event|76|||
131722068|NCT00546351|474262239|FG000|Overall Study|Lack of Efficacy|15|||
131722069|NCT00546351|474262239|FG000|Overall Study|Withdrawal by Subject|109|||
131722070|NCT00546351|474262239|FG000|Overall Study|Lost to Follow-up|9|||
131722071|NCT00546351|474262239|FG000|Overall Study|Protocol Deviation|1|||
131804882|NCT04206332|474570554|FG007|Part A|Lost to Follow-up|0|||
131804883|NCT04206332|474570555|FG008|Part A|Lost to Follow-up|0|||
131804884|NCT04206332|474570556|FG009|Part A|Lost to Follow-up|0|||
131804885|NCT04206332|474570557|FG010|Part A|Lost to Follow-up|0|||
131804886|NCT04206332|474570558|FG011|Part A|Lost to Follow-up|0|||
131804887|NCT04206332|474570559|FG012|Part A|Lost to Follow-up|0|||
131904849|NCT03834493|474938967|FG001|Overall Study|Physician Decision|0|||
131722072|NCT00546351|474262239|FG000|Overall Study|Unsatisfactory compliance|9|||
131722073|NCT00546351|474262239|FG000|Overall Study|Other reasons for premature termination|17|||
131722074|NCT03952650|474262240|FG000|Overall Study|TRAVEL|0|||
131722075|NCT03952650|474262241|FG001|Overall Study|TRAVEL|4|||
131722076|NCT03952650|474262242|FG002|Overall Study|TRAVEL|0|||
131722077|NCT03952650|474262243|FG003|Overall Study|TRAVEL|4|||
131722078|NCT03952650|474262244|FG004|Overall Study|TRAVEL|0|||
131722079|NCT03952650|474262245|FG005|Overall Study|TRAVEL|3|||
131722080|NCT03952650|474262246|FG006|Overall Study|TRAVEL|2|||
131722081|NCT03952650|474262240|FG000|Overall Study|Withdrawal by Subject|0|||
131722082|NCT03952650|474262241|FG001|Overall Study|Withdrawal by Subject|2|||
131722083|NCT03952650|474262242|FG002|Overall Study|Withdrawal by Subject|0|||
131722084|NCT03952650|474262243|FG003|Overall Study|Withdrawal by Subject|3|||
131722085|NCT03952650|474262244|FG004|Overall Study|Withdrawal by Subject|0|||
131722086|NCT03952650|474262245|FG005|Overall Study|Withdrawal by Subject|1|||
131722087|NCT03952650|474262246|FG006|Overall Study|Withdrawal by Subject|1|||
131722088|NCT03952650|474262240|FG000|Overall Study|Lost to Follow-up|0|||
131722089|NCT03952650|474262241|FG001|Overall Study|Lost to Follow-up|1|||
131722090|NCT03952650|474262242|FG002|Overall Study|Lost to Follow-up|0|||
131722091|NCT03952650|474262243|FG003|Overall Study|Lost to Follow-up|0|||
131722092|NCT03952650|474262244|FG004|Overall Study|Lost to Follow-up|0|||
131722093|NCT03952650|474262245|FG005|Overall Study|Lost to Follow-up|1|||
131722094|NCT03952650|474262246|FG006|Overall Study|Lost to Follow-up|1|||
131722095|NCT03952650|474262240|FG000|Overall Study|Received wrong vaccine and travelled|0|||
131722096|NCT03952650|474262241|FG001|Overall Study|Received wrong vaccine and travelled|0|||
131722097|NCT03952650|474262242|FG002|Overall Study|Received wrong vaccine and travelled|0|||
131722098|NCT03952650|474262243|FG003|Overall Study|Received wrong vaccine and travelled|0|||
131722099|NCT03952650|474262244|FG004|Overall Study|Received wrong vaccine and travelled|0|||
131722100|NCT03952650|474262245|FG005|Overall Study|Received wrong vaccine and travelled|1|||
131722101|NCT03952650|474262246|FG006|Overall Study|Received wrong vaccine and travelled|0|||
131722102|NCT03952650|474262240|FG000|Overall Study|Unable to make study visit|0|||
131722103|NCT03952650|474262241|FG001|Overall Study|Unable to make study visit|0|||
131722104|NCT03952650|474262242|FG002|Overall Study|Unable to make study visit|0|||
131722105|NCT03952650|474262243|FG003|Overall Study|Unable to make study visit|0|||
131722106|NCT03952650|474262244|FG004|Overall Study|Unable to make study visit|0|||
131722107|NCT03952650|474262245|FG005|Overall Study|Unable to make study visit|1|||
131722108|NCT03952650|474262246|FG006|Overall Study|Unable to make study visit|0|||
131722109|NCT02424149|474262247|FG000|Overall Study|surgery cancelled|2|||
131722110|NCT02424149|474262248|FG001|Overall Study|surgery cancelled|0|||
131722111|NCT02424149|474262247|FG000|Overall Study|Withdrawal by Subject|0|||
131722112|NCT02424149|474262248|FG001|Overall Study|Withdrawal by Subject|1|||
131722113|NCT00592683|474262249|FG000|Overall Study|Found ineligible|0|||
131722114|NCT00592683|474262250|FG001|Overall Study|Found ineligible|1|||
131722115|NCT00592683|474262249|FG000|Overall Study|Withdrawal by Subject|1|||
131722116|NCT00592683|474262250|FG001|Overall Study|Withdrawal by Subject|0|||
131722117|NCT00592683|474262249|FG000|Overall Study|Adverse Event|0|||
131722118|NCT00592683|474262250|FG001|Overall Study|Adverse Event|2|||
131722119|NCT00592683|474262249|FG000|Overall Study|Protocol Violation|1|||
131722120|NCT00592683|474262250|FG001|Overall Study|Protocol Violation|0|||
131722121|NCT00592683|474262249|FG000|Overall Study|Study drug expired|1|||
131722122|NCT00592683|474262250|FG001|Overall Study|Study drug expired|0|||
131722123|NCT00592683|474262249|FG000|Overall Study|Other|1|||
131722124|NCT00592683|474262250|FG001|Overall Study|Other|0|||
131722125|NCT00592683|474262249|FG000|Overall Study|Lost to Follow-up|0|||
131722126|NCT00592683|474262250|FG001|Overall Study|Lost to Follow-up|1|||
131722127|NCT01357239|474262256|FG000|Stratum: All Patients|Adverse Event|0|||
131722128|NCT01357239|474262257|FG001|Stratum: All Patients|Adverse Event|0|||
131722129|NCT01357239|474262258|FG002|Stratum: All Patients|Adverse Event|1|||
131722130|NCT01357239|474262259|FG003|Stratum: All Patients|Adverse Event|1|||
131722131|NCT01357239|474262256|FG000|Stratum: All Patients|Subject withdrew consent|0|||
131722132|NCT01357239|474262257|FG001|Stratum: All Patients|Subject withdrew consent|0|||
131722133|NCT01357239|474262258|FG002|Stratum: All Patients|Subject withdrew consent|1|||
131722134|NCT01357239|474262259|FG003|Stratum: All Patients|Subject withdrew consent|1|||
131722135|NCT01357239|474262256|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
131722136|NCT01357239|474262257|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
131722137|NCT01357239|474262258|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
131722138|NCT01357239|474262259|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
131722139|NCT01357239|474262256|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
131722140|NCT01357239|474262257|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
131722141|NCT01357239|474262258|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
131722142|NCT01357239|474262259|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
131804888|NCT04206332|474570560|FG013|Part A|Lost to Follow-up|0|||
131804889|NCT04206332|474570561|FG014|Part A|Lost to Follow-up|0|||
131804890|NCT04206332|474570562|FG015|Part A|Lost to Follow-up|0|||
131804891|NCT04206332|474570563|FG016|Part A|Lost to Follow-up|0|||
131804892|NCT04206332|474570547|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804893|NCT04206332|474570548|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804894|NCT04206332|474570549|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804895|NCT04206332|474570550|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804896|NCT04206332|474570551|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804897|NCT04206332|474570552|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
131804898|NCT04206332|474570553|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804899|NCT04206332|474570554|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804900|NCT04206332|474570555|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804901|NCT04206332|474570556|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804902|NCT04206332|474570557|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804903|NCT04206332|474570558|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131722143|NCT01357239|474262256|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
131722144|NCT01357239|474262257|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
131722145|NCT01357239|474262258|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
131722146|NCT01357239|474262259|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
131722147|NCT00545818|474262265|FG000|Overall Study|Protocol Violation|1|||
131722148|NCT00545818|474262266|FG001|Overall Study|Protocol Violation|0|||
131722149|NCT00545818|474262265|FG000|Overall Study|Adverse Event|1|||
131722150|NCT00545818|474262266|FG001|Overall Study|Adverse Event|1|||
131722151|NCT00545818|474262265|FG000|Overall Study|Lost to Follow-up|1|||
131722152|NCT00545818|474262266|FG001|Overall Study|Lost to Follow-up|6|||
131722153|NCT00609609|474262267|FG000|Overall Study|Withdrawal by Subject|2|||
131722154|NCT00609609|474262268|FG001|Overall Study|Withdrawal by Subject|0|||
131722155|NCT00609609|474262267|FG000|Overall Study|Progression|4|||
131722156|NCT00609609|474262268|FG001|Overall Study|Progression|2|||
131722157|NCT01050062|474262269|FG000|Overall Study|Adverse Event|75|||
131722158|NCT01050062|474262270|FG001|Overall Study|Adverse Event|22|||
131722159|NCT01050062|474262269|FG000|Overall Study|Lost to Follow-up|83|||
131722160|NCT01050062|474262270|FG001|Overall Study|Lost to Follow-up|35|||
131722161|NCT01050062|474262269|FG000|Overall Study|Lack of Efficacy|22|||
131722162|NCT01050062|474262270|FG001|Overall Study|Lack of Efficacy|35|||
131722163|NCT01050062|474262269|FG000|Overall Study|Physician Decision|74|||
131722164|NCT01050062|474262270|FG001|Overall Study|Physician Decision|9|||
131722165|NCT01050062|474262269|FG000|Overall Study|Others|17|||
131722166|NCT01050062|474262270|FG001|Overall Study|Others|11|||
131804904|NCT04206332|474570559|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131904850|NCT03834493|474938966|FG000|Overall Study|Death|289|||
131722167|NCT00670111|474262273|FG000|Enrollment to One Month|Testing Failure|0|||
131722168|NCT00670111|474262274|FG001|Enrollment to One Month|Testing Failure|0|||
131722169|NCT00670111|474262275|FG002|Enrollment to One Month|Testing Failure|13|||
131722170|NCT00670111|474262273|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
131722171|NCT00670111|474262274|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
131722172|NCT00670111|474262275|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
131722173|NCT00670111|474262273|FG000|Enrollment to One Month|Physician Decision|1|||
131722174|NCT00670111|474262274|FG001|Enrollment to One Month|Physician Decision|0|||
131722175|NCT00670111|474262275|FG002|Enrollment to One Month|Physician Decision|0|||
131448550|NCT00068692|473272685|FG002|Step 2: Randomization|never start protocol therapy|1|||
131448551|NCT00068692|473272686|FG003|Step 2: Randomization|never start protocol therapy|0|||
131448552|NCT00068692|473272687|FG004|Step 2: Randomization|never start protocol therapy|1|||
131448553|NCT00068692|473272688|FG005|Step 2: Randomization|never start protocol therapy|0|||
131448554|NCT00068692|473272689|FG006|Step 2: Randomization|never start protocol therapy|0|||
131448555|NCT00068692|473272690|FG007|Step 2: Randomization|never start protocol therapy|0|||
131448556|NCT00248040|473272695|FG000|Overall Study|transplantectomy|2|||
131448557|NCT00248040|473272696|FG001|Overall Study|transplantectomy|1|||
131448558|NCT00248040|473272697|FG002|Overall Study|transplantectomy|3|||
131448559|NCT00248040|473272695|FG000|Overall Study|transplant cancelled post treat start|1|||
131448560|NCT00248040|473272696|FG001|Overall Study|transplant cancelled post treat start|0|||
131448561|NCT00248040|473272697|FG002|Overall Study|transplant cancelled post treat start|0|||
131448562|NCT00248040|473272695|FG000|Overall Study|Death|0|||
131448563|NCT00248040|473272696|FG001|Overall Study|Death|0|||
131448564|NCT00248040|473272697|FG002|Overall Study|Death|1|||
131448565|NCT03557034|473272700|FG000|Overall Study|Withdrawal by Subject|1|||
131448566|NCT03557034|473272701|FG001|Overall Study|Withdrawal by Subject|0|||
131448567|NCT00719472|473272704|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
131448568|NCT00719472|473272704|FG000|Enrolled in Study|Subject decision to withdraw|8|||
131448569|NCT00719472|473272704|FG000|Enrolled in Study|Various Reasons|17|||
131448570|NCT00719472|473272704|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
131448571|NCT00719472|473272704|FG000|Received Cycle 1 Treatment|Death|5|||
131448572|NCT00719472|473272704|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
131448573|NCT00719472|473272704|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
131448574|NCT00719472|473272704|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
131448575|NCT00719472|473272704|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
131448576|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
131448577|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Death|6|||
131448578|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Disease progression|3|||
131448579|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
131448580|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
131448581|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
131448582|NCT00719472|473272704|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
131448583|NCT01244893|473272705|FG000|Baseline|Protocol Violation|0|||
131448584|NCT01244893|473272706|FG001|Baseline|Protocol Violation|1|||
131448585|NCT01244893|473272705|FG000|1-Week Follow Up|Lost to Follow-up|1|||
131448586|NCT01244893|473272706|FG001|1-Week Follow Up|Lost to Follow-up|0|||
131448587|NCT00357552|473272707|FG000|Screening|Did not meet eligibility criteria|84|||
131448588|NCT00357552|473272707|FG000|Weeks 0 to 24|Death|1|||
131448589|NCT00357552|473272707|FG000|Weeks 24 to 104|Death|3|||
131448590|NCT00357552|473272707|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
131448591|NCT00882557|473272710|FG000|Overall Study|Withdrawal by Subject|1|||
131448592|NCT00882557|473272711|FG001|Overall Study|Withdrawal by Subject|0|||
131448593|NCT00882557|473272710|FG000|Overall Study|Trouble with Vein Access|1|||
131448594|NCT00882557|473272711|FG001|Overall Study|Trouble with Vein Access|0|||
131448595|NCT00882557|473272710|FG000|Overall Study|Randomized Not Treated|0|||
131448596|NCT00882557|473272711|FG001|Overall Study|Randomized Not Treated|1|||
131448597|NCT00711191|473272717|FG000|Overall Study|Adverse Event|1|||
131448598|NCT00711191|473272718|FG001|Overall Study|Adverse Event|1|||
131448599|NCT00711191|473272719|FG002|Overall Study|Adverse Event|2|||
131448600|NCT00711191|473272717|FG000|Overall Study|Objective progression or relapse|2|||
131448601|NCT00711191|473272718|FG001|Overall Study|Objective progression or relapse|3|||
131448602|NCT00711191|473272719|FG002|Overall Study|Objective progression or relapse|7|||
131448603|NCT00711191|473272717|FG000|Overall Study|Withdrawal by Subject|0|||
131448604|NCT00711191|473272718|FG001|Overall Study|Withdrawal by Subject|1|||
131448605|NCT00711191|473272719|FG002|Overall Study|Withdrawal by Subject|3|||
131448606|NCT00790842|473272720|FG000|Dose Level 1|Adverse Event|1|||
131448607|NCT00790842|473272721|FG001|Dose Level 1|Adverse Event|0|||
131448608|NCT00790842|473272722|FG002|Dose Level 1|Adverse Event|0|||
131448609|NCT00790842|473272723|FG003|Dose Level 1|Adverse Event|2|||
131722176|NCT03988751|474262276|FG000|Overall Study|Withdrawal by Subject|1|||
131448610|NCT00790842|473272724|FG004|Dose Level 1|Adverse Event|0|||
131448611|NCT00790842|473272725|FG005|Dose Level 1|Adverse Event|0|||
131448612|NCT00790842|473272726|FG006|Dose Level 1|Adverse Event|0|||
131722177|NCT03988751|474262277|FG001|Overall Study|Withdrawal by Subject|0|||
131448613|NCT00790842|473272727|FG007|Dose Level 1|Adverse Event|1|||
131448614|NCT00790842|473272728|FG008|Dose Level 1|Adverse Event|0|||
131448615|NCT00790842|473272729|FG009|Dose Level 1|Adverse Event|0|||
131448616|NCT00790842|473272730|FG010|Dose Level 1|Adverse Event|0|||
131448617|NCT00790842|473272720|FG000|Dose Level 1|Physician Decision|1|||
131448618|NCT00790842|473272721|FG001|Dose Level 1|Physician Decision|0|||
131448619|NCT00790842|473272722|FG002|Dose Level 1|Physician Decision|0|||
131722178|NCT03988751|474262276|FG000|Overall Study|Protocol Violation|0|||
131448620|NCT00790842|473272723|FG003|Dose Level 1|Physician Decision|0|||
131448621|NCT00790842|473272724|FG004|Dose Level 1|Physician Decision|0|||
131722179|NCT03988751|474262277|FG001|Overall Study|Protocol Violation|1|||
131722180|NCT00844883|474262280|FG000|Overall Study|Bridged to liver transplant|3|||
131722181|NCT00844883|474262280|FG000|Overall Study|Bridged to resection|1|||
131722182|NCT02623361|474262281|FG000|Overall Study|Protocol Violation|0|||
131722183|NCT02623361|474262282|FG001|Overall Study|Protocol Violation|1|||
131722184|NCT02623361|474262281|FG000|Overall Study|Withdrawal by Subject|0|||
131722185|NCT02623361|474262282|FG001|Overall Study|Withdrawal by Subject|1|||
131722186|NCT02441803|474262284|FG000|Overall Study|Physician Decision|0|||
131722187|NCT02441803|474262285|FG001|Overall Study|Physician Decision|2|||
131722188|NCT02441803|474262286|FG002|Overall Study|Physician Decision|2|||
131722189|NCT03000452|474262288|FG000|Treatment Period|Death|1|||
131722190|NCT03000452|474262288|FG000|Treatment Period|Progressive Disease (PD)|14|||
131722191|NCT03000452|474262288|FG000|Treatment Period|Physician Decision|1|||
131722192|NCT03000452|474262288|FG000|Treatment Period|Miscellaneous|2|||
131722193|NCT03000452|474262288|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
131722194|NCT03000452|474262288|FG000|Follow-Up Period|Death|3|||
131722195|NCT03000452|474262288|FG000|Follow-Up Period|Withdrawal by Subject|3|||
131722196|NCT00537823|474262293|FG000|Overall Study|Adverse Event|2|||
131722197|NCT00537823|474262294|FG001|Overall Study|Adverse Event|0|||
131722198|NCT03065530|474262295|FG000|Overall Study|Lack of Efficacy|1|||
131722199|NCT03065530|474262296|FG001|Overall Study|Lack of Efficacy|1|||
131722200|NCT03065530|474262297|FG002|Overall Study|Lack of Efficacy|0|||
131722201|NCT03065530|474262298|FG003|Overall Study|Lack of Efficacy|1|||
131722202|NCT03065530|474262295|FG000|Overall Study|Protocol Violation|1|||
131722203|NCT03065530|474262296|FG001|Overall Study|Protocol Violation|0|||
131722204|NCT03065530|474262297|FG002|Overall Study|Protocol Violation|1|||
131722205|NCT03065530|474262298|FG003|Overall Study|Protocol Violation|1|||
131722206|NCT03455543|474262299|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
131722207|NCT03455543|474262300|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
131722208|NCT03455543|474262301|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
131722209|NCT03455543|474262299|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
131722210|NCT03455543|474262300|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
131722211|NCT03455543|474262301|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
131722212|NCT03455543|474262299|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
131722213|NCT03455543|474262300|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
131722214|NCT03455543|474262301|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
131722215|NCT03455543|474262299|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
131722216|NCT03455543|474262300|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
131722217|NCT03455543|474262301|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
131722218|NCT03455543|474262299|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
131722219|NCT03455543|474262300|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
131722220|NCT03455543|474262301|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
131722221|NCT03455543|474262299|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
131722222|NCT03455543|474262300|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
131722223|NCT03455543|474262301|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
131722224|NCT03455543|474262299|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
131722225|NCT03455543|474262300|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
131722226|NCT03455543|474262301|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
131722227|NCT03455543|474262299|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
131722228|NCT03455543|474262300|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
131722229|NCT03455543|474262301|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
131722230|NCT03455543|474262299|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
131722231|NCT03455543|474262300|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
131722232|NCT03455543|474262301|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
131722233|NCT02873221|474262302|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
131722234|NCT02873221|474262303|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
131722235|NCT02873221|474262304|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
131722236|NCT02873221|474262302|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
131722237|NCT02873221|474262303|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
131722238|NCT02873221|474262304|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
131722239|NCT02873221|474262302|FG000|Treatment Period|Protocol Violation|2|||
131722240|NCT02873221|474262303|FG001|Treatment Period|Protocol Violation|5|||
131904851|NCT03834493|474938967|FG001|Overall Study|Death|282|||
131722241|NCT02873221|474262304|FG002|Treatment Period|Protocol Violation|8|||
131722242|NCT02873221|474262302|FG000|Treatment Period|Pregnancy|4|||
131722243|NCT02873221|474262303|FG001|Treatment Period|Pregnancy|6|||
131722244|NCT02873221|474262304|FG002|Treatment Period|Pregnancy|3|||
131722245|NCT02873221|474262302|FG000|Treatment Period|Lack of Qualifying Event|0|||
131722246|NCT02873221|474262303|FG001|Treatment Period|Lack of Qualifying Event|3|||
131722247|NCT02873221|474262304|FG002|Treatment Period|Lack of Qualifying Event|1|||
131722248|NCT02873221|474262302|FG000|Treatment Period|Withdrawal of Consent|52|||
131722249|NCT02873221|474262303|FG001|Treatment Period|Withdrawal of Consent|51|||
131722250|NCT02873221|474262304|FG002|Treatment Period|Withdrawal of Consent|41|||
131722251|NCT02873221|474262302|FG000|Treatment Period|Lack of Efficacy|0|||
131722252|NCT02873221|474262303|FG001|Treatment Period|Lack of Efficacy|17|||
131722253|NCT02873221|474262304|FG002|Treatment Period|Lack of Efficacy|12|||
131722254|NCT02873221|474262302|FG000|Treatment Period|Adverse Event|4|||
131722255|NCT02873221|474262303|FG001|Treatment Period|Adverse Event|9|||
131722256|NCT02873221|474262304|FG002|Treatment Period|Adverse Event|11|||
131722257|NCT02873221|474262302|FG000|Treatment Period|Lost to Follow-up|26|||
131722258|NCT02873221|474262303|FG001|Treatment Period|Lost to Follow-up|30|||
131722259|NCT02873221|474262304|FG002|Treatment Period|Lost to Follow-up|26|||
131722260|NCT02873221|474262302|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
131722261|NCT02873221|474262303|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
131722262|NCT02873221|474262304|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
131722263|NCT02873221|474262302|FG000|Safety Follow-up Period|Protocol Violation|0|||
131722264|NCT02873221|474262303|FG001|Safety Follow-up Period|Protocol Violation|0|||
131722265|NCT02873221|474262304|FG002|Safety Follow-up Period|Protocol Violation|1|||
131722266|NCT02873221|474262302|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
131722267|NCT02873221|474262303|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
131722268|NCT02873221|474262304|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
131722269|NCT02873221|474262302|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
131722270|NCT02873221|474262303|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
131722271|NCT02873221|474262304|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
131722272|NCT00852930|474262307|FG000|Overall Study|Withdrawal by Subject|1|||
131722273|NCT00852930|474262308|FG001|Overall Study|Withdrawal by Subject|1|||
131722274|NCT00852930|474262309|FG002|Overall Study|Withdrawal by Subject|1|||
131722275|NCT00852930|474262307|FG000|Overall Study|Physician Decision|0|||
131722276|NCT00852930|474262308|FG001|Overall Study|Physician Decision|0|||
131722277|NCT00852930|474262309|FG002|Overall Study|Physician Decision|1|||
131722278|NCT00479466|474262310|FG000|Overall Study|Adverse Event|5|||
131722279|NCT00479466|474262311|FG001|Overall Study|Adverse Event|1|||
131722280|NCT00479466|474262312|FG002|Overall Study|Adverse Event|0|||
131722281|NCT00479466|474262313|FG003|Overall Study|Adverse Event|1|||
131722282|NCT00479466|474262314|FG004|Overall Study|Adverse Event|2|||
131722283|NCT00479466|474262315|FG005|Overall Study|Adverse Event|0|||
131722284|NCT00479466|474262310|FG000|Overall Study|Hyperglycemia|0|||
131722285|NCT00479466|474262311|FG001|Overall Study|Hyperglycemia|0|||
131722286|NCT00479466|474262312|FG002|Overall Study|Hyperglycemia|0|||
131722287|NCT00479466|474262313|FG003|Overall Study|Hyperglycemia|0|||
131722288|NCT00479466|474262314|FG004|Overall Study|Hyperglycemia|0|||
131722289|NCT00479466|474262315|FG005|Overall Study|Hyperglycemia|1|||
131722290|NCT00479466|474262310|FG000|Overall Study|Lack of Efficacy|2|||
131722291|NCT00479466|474262311|FG001|Overall Study|Lack of Efficacy|0|||
131722292|NCT00479466|474262312|FG002|Overall Study|Lack of Efficacy|1|||
131722293|NCT00479466|474262313|FG003|Overall Study|Lack of Efficacy|0|||
131722294|NCT00479466|474262314|FG004|Overall Study|Lack of Efficacy|0|||
131722295|NCT00479466|474262315|FG005|Overall Study|Lack of Efficacy|0|||
131722296|NCT00479466|474262310|FG000|Overall Study|Lost to Follow-up|0|||
131722297|NCT00479466|474262311|FG001|Overall Study|Lost to Follow-up|1|||
131722298|NCT00479466|474262312|FG002|Overall Study|Lost to Follow-up|1|||
131722299|NCT00479466|474262313|FG003|Overall Study|Lost to Follow-up|0|||
131722300|NCT00479466|474262314|FG004|Overall Study|Lost to Follow-up|2|||
131722301|NCT00479466|474262315|FG005|Overall Study|Lost to Follow-up|2|||
131722302|NCT00479466|474262310|FG000|Overall Study|Physician Decision|2|||
131722303|NCT00479466|474262311|FG001|Overall Study|Physician Decision|1|||
131722304|NCT00479466|474262312|FG002|Overall Study|Physician Decision|1|||
131722305|NCT00479466|474262313|FG003|Overall Study|Physician Decision|0|||
131722306|NCT00479466|474262314|FG004|Overall Study|Physician Decision|0|||
131722307|NCT00479466|474262315|FG005|Overall Study|Physician Decision|0|||
131722308|NCT00479466|474262310|FG000|Overall Study|Pregnancy|0|||
131722309|NCT00479466|474262311|FG001|Overall Study|Pregnancy|0|||
131722310|NCT00479466|474262312|FG002|Overall Study|Pregnancy|0|||
131722311|NCT00479466|474262313|FG003|Overall Study|Pregnancy|0|||
131722312|NCT00479466|474262314|FG004|Overall Study|Pregnancy|1|||
131722313|NCT00479466|474262315|FG005|Overall Study|Pregnancy|0|||
131722314|NCT00479466|474262310|FG000|Overall Study|Protocol Violation|1|||
131722315|NCT00479466|474262311|FG001|Overall Study|Protocol Violation|0|||
131722316|NCT00479466|474262312|FG002|Overall Study|Protocol Violation|0|||
131722317|NCT00479466|474262313|FG003|Overall Study|Protocol Violation|0|||
131722318|NCT00479466|474262314|FG004|Overall Study|Protocol Violation|0|||
131722319|NCT00479466|474262315|FG005|Overall Study|Protocol Violation|0|||
131722320|NCT00479466|474262310|FG000|Overall Study|Withdrawal by Subject|3|||
131722321|NCT00479466|474262311|FG001|Overall Study|Withdrawal by Subject|5|||
131722322|NCT00479466|474262312|FG002|Overall Study|Withdrawal by Subject|0|||
131722323|NCT00479466|474262313|FG003|Overall Study|Withdrawal by Subject|2|||
131722324|NCT00479466|474262314|FG004|Overall Study|Withdrawal by Subject|3|||
131722325|NCT00479466|474262315|FG005|Overall Study|Withdrawal by Subject|1|||
131722326|NCT01325493|474262316|FG000|Overall Study|Protocol Violation|0|||
131722327|NCT01325493|474262317|FG001|Overall Study|Protocol Violation|1|||
131722328|NCT01325493|474262316|FG000|Overall Study|loss of neuromonitoring signals|0|||
131722329|NCT01325493|474262317|FG001|Overall Study|loss of neuromonitoring signals|2|||
131722330|NCT01325493|474262316|FG000|Overall Study|Allergy|1|||
131722331|NCT01325493|474262317|FG001|Overall Study|Allergy|0|||
131722332|NCT01512368|474262323|FG000|Overall Study|Protocol Violation|3|||
131722333|NCT00328198|474262324|FG000|Treatment|Adverse Event|21|||
131722334|NCT00328198|474262324|FG000|Treatment|Death|1|||
131722335|NCT00328198|474262324|FG000|Treatment|Physician Decision|5|||
131722336|NCT00328198|474262324|FG000|Treatment|Withdrawal by Subject|5|||
131722337|NCT00328198|474262324|FG000|Treatment|Evidence of disease progression|2|||
131722338|NCT00328198|474262324|FG000|Treatment|Non-compliance|1|||
131722339|NCT00328198|474262324|FG000|Treatment|Confirmed complete response, MRD -|3|||
131722340|NCT00328198|474262324|FG000|Follow-up|Lost to Follow-up|4|||
131722341|NCT00328198|474262324|FG000|Follow-up|Death|31|||
131722342|NCT02717546|474262329|FG000|Overall Study|Lost to Follow-up|12|||
131722343|NCT02614794|474262334|FG000|Overall Study|Death|258|||
131722344|NCT02614794|474262335|FG001|Overall Study|Death|151|||
131722345|NCT02614794|474262334|FG000|Overall Study|Study closure by Sponsor|119|||
131722346|NCT02614794|474262335|FG001|Overall Study|Study closure by Sponsor|45|||
131722347|NCT02614794|474262334|FG000|Overall Study|Withdrawal by Subject|24|||
131722348|NCT02614794|474262335|FG001|Overall Study|Withdrawal by Subject|5|||
131722349|NCT02614794|474262334|FG000|Overall Study|Lost to Follow-up|7|||
131722350|NCT02614794|474262335|FG001|Overall Study|Lost to Follow-up|0|||
131722351|NCT02614794|474262334|FG000|Overall Study|Physician Decision|1|||
131722352|NCT02614794|474262335|FG001|Overall Study|Physician Decision|1|||
131722353|NCT02614794|474262334|FG000|Overall Study|Hospital closure|1|||
131722354|NCT02614794|474262335|FG001|Overall Study|Hospital closure|0|||
131722355|NCT00234104|474262340|FG000|Overall Study|Adverse Event|4|||
131722356|NCT00234104|474262341|FG001|Overall Study|Adverse Event|0|||
131722357|NCT00234104|474262342|FG002|Overall Study|Adverse Event|3|||
131722358|NCT00234104|474262343|FG003|Overall Study|Adverse Event|5|||
131722359|NCT00234104|474262340|FG000|Overall Study|Protocol Violation|0|||
131722360|NCT00234104|474262341|FG001|Overall Study|Protocol Violation|0|||
131722361|NCT00234104|474262342|FG002|Overall Study|Protocol Violation|0|||
131722362|NCT00234104|474262343|FG003|Overall Study|Protocol Violation|1|||
131722363|NCT00234104|474262340|FG000|Overall Study|Physician Decision|0|||
131722364|NCT00234104|474262341|FG001|Overall Study|Physician Decision|1|||
131722365|NCT00234104|474262342|FG002|Overall Study|Physician Decision|2|||
131722366|NCT00234104|474262343|FG003|Overall Study|Physician Decision|2|||
131804905|NCT04206332|474570560|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131722367|NCT01633060|474262344|FG000|Randomization Phase|Protocol deviation|1|||
131722368|NCT01633060|474262345|FG001|Randomization Phase|Protocol deviation|2|||
131722369|NCT01633060|474262344|FG000|Randomization Phase|Technical problem|0|||
131722370|NCT01633060|474262345|FG001|Randomization Phase|Technical problem|1|||
131722371|NCT01633060|474262344|FG000|Treatment Phase|Adverse Event|24|||
131722372|NCT01633060|474262345|FG001|Treatment Phase|Adverse Event|3|||
131722373|NCT01633060|474262344|FG000|Treatment Phase|Lost to Follow-up|1|||
131722374|NCT01633060|474262345|FG001|Treatment Phase|Lost to Follow-up|0|||
131722375|NCT01633060|474262344|FG000|Treatment Phase|Physician Decision|16|||
131904852|NCT05559905|474938968|FG000|Overall Study|Withdrawal by Subject|1|||
131722376|NCT01633060|474262345|FG001|Treatment Phase|Physician Decision|7|||
131722377|NCT01633060|474262344|FG000|Treatment Phase|Progressive Disease|210|||
131722378|NCT01633060|474262345|FG001|Treatment Phase|Progressive Disease|120|||
131722379|NCT01633060|474262344|FG000|Treatment Phase|Protocol Deviation|1|||
131722380|NCT01633060|474262345|FG001|Treatment Phase|Protocol Deviation|0|||
131722381|NCT01633060|474262344|FG000|Treatment Phase|Study Terminated by sponsor|7|||
131448622|NCT00790842|473272725|FG005|Dose Level 1|Physician Decision|0|||
131448623|NCT00790842|473272726|FG006|Dose Level 1|Physician Decision|0|||
131448624|NCT00790842|473272727|FG007|Dose Level 1|Physician Decision|1|||
131448625|NCT00790842|473272728|FG008|Dose Level 1|Physician Decision|0|||
131448626|NCT00790842|473272729|FG009|Dose Level 1|Physician Decision|0|||
131448627|NCT00790842|473272730|FG010|Dose Level 1|Physician Decision|0|||
131448628|NCT00790842|473272720|FG000|Dose Level 1|Withdrawal by Subject|1|||
131448629|NCT00790842|473272721|FG001|Dose Level 1|Withdrawal by Subject|0|||
131448630|NCT00790842|473272722|FG002|Dose Level 1|Withdrawal by Subject|0|||
131448631|NCT00790842|473272723|FG003|Dose Level 1|Withdrawal by Subject|0|||
131448632|NCT00790842|473272724|FG004|Dose Level 1|Withdrawal by Subject|0|||
131448633|NCT00790842|473272725|FG005|Dose Level 1|Withdrawal by Subject|0|||
131448634|NCT00790842|473272726|FG006|Dose Level 1|Withdrawal by Subject|0|||
131448635|NCT00790842|473272727|FG007|Dose Level 1|Withdrawal by Subject|0|||
131448636|NCT00790842|473272728|FG008|Dose Level 1|Withdrawal by Subject|0|||
131448637|NCT00790842|473272729|FG009|Dose Level 1|Withdrawal by Subject|0|||
131448638|NCT00790842|473272730|FG010|Dose Level 1|Withdrawal by Subject|0|||
131448639|NCT00790842|473272720|FG000|Dose Level 2|Death|0|||
131448640|NCT00790842|473272721|FG001|Dose Level 2|Death|1|||
131448641|NCT00790842|473272722|FG002|Dose Level 2|Death|0|||
131448642|NCT00790842|473272723|FG003|Dose Level 2|Death|0|||
131722382|NCT01633060|474262345|FG001|Treatment Phase|Study Terminated by sponsor|3|||
131722383|NCT01633060|474262344|FG000|Treatment Phase|Subject/guardian decision|25|||
131722384|NCT01633060|474262345|FG001|Treatment Phase|Subject/guardian decision|4|||
131722385|NCT01633060|474262344|FG000|Treatment Phase|Death|4|||
131722386|NCT01633060|474262345|FG001|Treatment Phase|Death|3|||
131722387|NCT01633060|474262344|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
131722388|NCT01633060|474262345|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131722389|NCT01633060|474262344|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
131722390|NCT01633060|474262345|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
131722391|NCT01633060|474262344|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
131722392|NCT01633060|474262345|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
131722393|NCT01633060|474262344|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
131722394|NCT01633060|474262345|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
131722395|NCT01633060|474262344|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
131722396|NCT01633060|474262345|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
131722397|NCT01633060|474262344|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
131722398|NCT01633060|474262345|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
131722399|NCT00069121|474262346|FG000|Overall Study|Death|286|||
131722400|NCT00069121|474262347|FG001|Overall Study|Death|242|||
131722401|NCT00069121|474262346|FG000|Overall Study|Withdrawal by Subject|18|||
131722402|NCT00069121|474262347|FG001|Overall Study|Withdrawal by Subject|20|||
131722403|NCT00069121|474262346|FG000|Overall Study|Lost to Follow-up|63|||
131722404|NCT00069121|474262347|FG001|Overall Study|Lost to Follow-up|63|||
131722405|NCT00231478|474262353|FG000|Overall Study|Protocol Violation|3|||
131722406|NCT00231478|474262354|FG001|Overall Study|Protocol Violation|2|||
131722407|NCT00231478|474262353|FG000|Overall Study|Refused Treatment|1|||
131722408|NCT00231478|474262354|FG001|Overall Study|Refused Treatment|1|||
131722409|NCT00231478|474262353|FG000|Overall Study|Withdrawal by Subject|1|||
131722410|NCT00231478|474262354|FG001|Overall Study|Withdrawal by Subject|0|||
131722411|NCT00231478|474262353|FG000|Overall Study|Adverse Event|0|||
131722412|NCT00231478|474262354|FG001|Overall Study|Adverse Event|1|||
131722413|NCT00231478|474262353|FG000|Overall Study|Administrative|3|||
131722414|NCT00231478|474262354|FG001|Overall Study|Administrative|2|||
131722415|NCT00393458|474262365|FG000|Overall Study|Adverse Event|35|||
131722416|NCT00393458|474262366|FG001|Overall Study|Adverse Event|24|||
131722417|NCT00393458|474262367|FG002|Overall Study|Adverse Event|40|||
131722418|NCT00393458|474262368|FG003|Overall Study|Adverse Event|35|||
131722419|NCT00393458|474262365|FG000|Overall Study|Subject withdrew consent|27|||
131722420|NCT00393458|474262366|FG001|Overall Study|Subject withdrew consent|40|||
131722421|NCT00393458|474262367|FG002|Overall Study|Subject withdrew consent|33|||
131722422|NCT00393458|474262368|FG003|Overall Study|Subject withdrew consent|50|||
131722423|NCT00393458|474262365|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
131722424|NCT00393458|474262366|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
131722425|NCT00393458|474262367|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
131448643|NCT00790842|473272724|FG004|Dose Level 2|Death|1|||
131448644|NCT00790842|473272725|FG005|Dose Level 2|Death|0|||
131448645|NCT00790842|473272726|FG006|Dose Level 2|Death|0|||
131722426|NCT00393458|474262368|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
131722427|NCT00393458|474262365|FG000|Overall Study|Protocol deviation|11|||
131722428|NCT00393458|474262366|FG001|Overall Study|Protocol deviation|11|||
131722429|NCT00393458|474262367|FG002|Overall Study|Protocol deviation|11|||
131722430|NCT00393458|474262368|FG003|Overall Study|Protocol deviation|10|||
131448646|NCT00790842|473272727|FG007|Dose Level 2|Death|0|||
131804906|NCT04206332|474570561|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804907|NCT04206332|474570562|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804908|NCT04206332|474570563|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131804909|NCT04206332|474570547|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804910|NCT04206332|474570548|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804911|NCT04206332|474570549|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804912|NCT04206332|474570550|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804913|NCT04206332|474570551|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804914|NCT04206332|474570552|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804915|NCT04206332|474570553|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804916|NCT04206332|474570554|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
131804917|NCT04206332|474570555|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804918|NCT04206332|474570556|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804919|NCT04206332|474570557|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
131804920|NCT04206332|474570558|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804921|NCT04206332|474570559|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804922|NCT04206332|474570560|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804923|NCT04206332|474570561|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131904853|NCT05559905|474938969|FG001|Overall Study|Withdrawal by Subject|0|||
131904854|NCT05559905|474938970|FG002|Overall Study|Withdrawal by Subject|0|||
131904855|NCT05559905|474938968|FG000|Overall Study|Not Reported|1|||
131904856|NCT05559905|474938969|FG001|Overall Study|Not Reported|0|||
131904857|NCT05559905|474938970|FG002|Overall Study|Not Reported|0|||
131722431|NCT00393458|474262365|FG000|Overall Study|Administrative problems|7|||
131722432|NCT00393458|474262366|FG001|Overall Study|Administrative problems|8|||
131722433|NCT00393458|474262367|FG002|Overall Study|Administrative problems|5|||
131722434|NCT00393458|474262368|FG003|Overall Study|Administrative problems|2|||
131722435|NCT00393458|474262365|FG000|Overall Study|Lost to Follow-up|5|||
131722436|NCT00393458|474262366|FG001|Overall Study|Lost to Follow-up|6|||
131722437|NCT00393458|474262367|FG002|Overall Study|Lost to Follow-up|5|||
131722438|NCT00393458|474262368|FG003|Overall Study|Lost to Follow-up|3|||
131722439|NCT00393458|474262365|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131722440|NCT00393458|474262366|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131722441|NCT00393458|474262367|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131722442|NCT00393458|474262368|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131722443|NCT00393458|474262365|FG000|Overall Study|Death|1|||
131722444|NCT00393458|474262366|FG001|Overall Study|Death|1|||
131722445|NCT00393458|474262367|FG002|Overall Study|Death|5|||
131722446|NCT00393458|474262368|FG003|Overall Study|Death|5|||
131722447|NCT00393458|474262365|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131722448|NCT00393458|474262366|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131722449|NCT00393458|474262367|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131722450|NCT00393458|474262368|FG003|Overall Study|Abnormal test procedure result(s)|2|||
131722451|NCT00393458|474262365|FG000|Overall Study|Subject no longer requires study drug|0|||
131722452|NCT00393458|474262366|FG001|Overall Study|Subject no longer requires study drug|1|||
131722453|NCT00393458|474262367|FG002|Overall Study|Subject no longer requires study drug|0|||
131722454|NCT00393458|474262368|FG003|Overall Study|Subject no longer requires study drug|0|||
131722455|NCT00104104|474262371|FG000|Overall Study|Adverse Event|8|||
131722456|NCT00104104|474262372|FG001|Overall Study|Adverse Event|8|||
131722457|NCT00104104|474262371|FG000|Overall Study|Abnormal laboratory value(s)|20|||
131722458|NCT00104104|474262372|FG001|Overall Study|Abnormal laboratory value(s)|14|||
131722459|NCT00104104|474262371|FG000|Overall Study|Lack of Efficacy|0|||
131722460|NCT00104104|474262372|FG001|Overall Study|Lack of Efficacy|3|||
131904858|NCT04003103|474938971|FG000|Overall Study|Death|1|||
131904859|NCT04003103|474938972|FG001|Overall Study|Death|0|||
131904860|NCT04003103|474938973|FG002|Overall Study|Death|0|||
131904861|NCT04003103|474938971|FG000|Overall Study|Lost to Follow-up|4|||
131904862|NCT04003103|474938972|FG001|Overall Study|Lost to Follow-up|3|||
131904863|NCT04003103|474938973|FG002|Overall Study|Lost to Follow-up|2|||
131904864|NCT04003103|474938971|FG000|Overall Study|Withdrawal by Subject|10|||
131904865|NCT04003103|474938972|FG001|Overall Study|Withdrawal by Subject|1|||
131904866|NCT04003103|474938973|FG002|Overall Study|Withdrawal by Subject|1|||
131904867|NCT04003103|474938971|FG000|Overall Study|Status not recorded|0|||
131904868|NCT04003103|474938972|FG001|Overall Study|Status not recorded|2|||
131904869|NCT04003103|474938973|FG002|Overall Study|Status not recorded|0|||
131904870|NCT03829462|474938978|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
131722461|NCT00104104|474262371|FG000|Overall Study|Condition no longer requires study drug|7|||
131722462|NCT00104104|474262372|FG001|Overall Study|Condition no longer requires study drug|4|||
131722463|NCT00104104|474262371|FG000|Overall Study|Protocol Violation|5|||
131722464|NCT00104104|474262372|FG001|Overall Study|Protocol Violation|2|||
131722465|NCT00104104|474262371|FG000|Overall Study|Withdrawal by Subject|11|||
131722466|NCT00104104|474262372|FG001|Overall Study|Withdrawal by Subject|15|||
131722467|NCT00104104|474262371|FG000|Overall Study|Lost to Follow-up|3|||
131722468|NCT00104104|474262372|FG001|Overall Study|Lost to Follow-up|7|||
131722469|NCT00104104|474262371|FG000|Overall Study|Administrative problems|12|||
131722470|NCT00104104|474262372|FG001|Overall Study|Administrative problems|13|||
131722471|NCT00104104|474262371|FG000|Overall Study|Death|9|||
131722472|NCT00104104|474262372|FG001|Overall Study|Death|6|||
131722473|NCT01821677|474262373|FG000|Overall Study|Adverse Event|4|||
131722474|NCT01821677|474262374|FG001|Overall Study|Adverse Event|6|||
131722475|NCT01821677|474262375|FG002|Overall Study|Adverse Event|5|||
131722476|NCT01821677|474262373|FG000|Overall Study|Physician Decision|1|||
131722477|NCT01821677|474262374|FG001|Overall Study|Physician Decision|4|||
131722478|NCT01821677|474262375|FG002|Overall Study|Physician Decision|1|||
131722479|NCT01821677|474262373|FG000|Overall Study|Non-compliance|0|||
131722480|NCT01821677|474262374|FG001|Overall Study|Non-compliance|1|||
131722481|NCT01821677|474262375|FG002|Overall Study|Non-compliance|2|||
131722482|NCT01821677|474262373|FG000|Overall Study|Lost to Follow-up|2|||
131722483|NCT01821677|474262374|FG001|Overall Study|Lost to Follow-up|1|||
131722484|NCT01821677|474262375|FG002|Overall Study|Lost to Follow-up|3|||
131722485|NCT01821677|474262373|FG000|Overall Study|Protocol Violation|0|||
131722486|NCT01821677|474262374|FG001|Overall Study|Protocol Violation|0|||
131722487|NCT01821677|474262375|FG002|Overall Study|Protocol Violation|2|||
131722488|NCT01821677|474262373|FG000|Overall Study|Withdrawal by Subject|7|||
131722489|NCT01821677|474262374|FG001|Overall Study|Withdrawal by Subject|3|||
131722490|NCT01821677|474262375|FG002|Overall Study|Withdrawal by Subject|2|||
131722491|NCT01821677|474262373|FG000|Overall Study|Other|9|||
131722492|NCT01821677|474262374|FG001|Overall Study|Other|0|||
131722493|NCT01821677|474262375|FG002|Overall Study|Other|0|||
131722494|NCT02903511|474262381|FG000|Overall Study|Withdrawal by Subject|1|||
131722495|NCT02903511|474262382|FG001|Overall Study|Withdrawal by Subject|0|||
131722496|NCT02903511|474262381|FG000|Overall Study|Lost to Follow-up|3|||
131722497|NCT02903511|474262382|FG001|Overall Study|Lost to Follow-up|2|||
131722498|NCT05363293|474262387|FG000|Overall Study|Withdrawal by Subject|1|||
131722499|NCT05363293|474262388|FG001|Overall Study|Withdrawal by Subject|0|||
131722500|NCT05363293|474262389|FG002|Overall Study|Withdrawal by Subject|0|||
131722501|NCT05363293|474262390|FG003|Overall Study|Withdrawal by Subject|0|||
131722502|NCT05363293|474262391|FG004|Overall Study|Withdrawal by Subject|0|||
131722503|NCT05363293|474262392|FG005|Overall Study|Withdrawal by Subject|0|||
131722504|NCT05363293|474262393|FG006|Overall Study|Withdrawal by Subject|0|||
131722505|NCT05363293|474262394|FG007|Overall Study|Withdrawal by Subject|0|||
131722506|NCT05363293|474262395|FG008|Overall Study|Withdrawal by Subject|0|||
131722507|NCT05363293|474262396|FG009|Overall Study|Withdrawal by Subject|0|||
131722508|NCT01894516|474263846|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
131722509|NCT01894516|474263847|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
131722510|NCT01894516|474263848|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
131722511|NCT01894516|474263849|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
131722512|NCT01894516|474263846|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
131722513|NCT01894516|474263847|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131722514|NCT01894516|474263848|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131722515|NCT01894516|474263849|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131722516|NCT01894516|474263846|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
131722517|NCT01894516|474263847|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
131722518|NCT01894516|474263848|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
131722519|NCT01894516|474263849|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
131722520|NCT01894516|474263846|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
131722521|NCT01894516|474263847|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
131722522|NCT01894516|474263848|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
131722523|NCT01894516|474263849|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
131722524|NCT01894516|474263846|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
131722525|NCT01894516|474263847|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131722526|NCT01894516|474263848|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131722527|NCT01894516|474263849|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
131804924|NCT04206332|474570562|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131722528|NCT01894516|474263846|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131722529|NCT01894516|474263847|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
131722530|NCT01894516|474263848|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
131722531|NCT01894516|474263849|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131722532|NCT01894516|474263846|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
131722533|NCT01894516|474263847|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
131722534|NCT01894516|474263848|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
131722535|NCT01894516|474263849|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
131722536|NCT01894516|474263846|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131722537|NCT01894516|474263847|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131722538|NCT01894516|474263848|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
131722539|NCT01894516|474263849|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131722540|NCT03635190|474263850|FG000|Overall Study|Lost to Follow-up|4|||
131722541|NCT03635190|474263850|FG000|Overall Study|Death|3|||
131722542|NCT03635190|474263850|FG000|Overall Study|Withdrawal by Subject|1|||
131722543|NCT03635190|474263850|FG000|Overall Study|Patient moved and did not return for follow up|1|||
131722544|NCT01277289|474263851|FG000|Overall Study|fragile vein|1|||
131722545|NCT01277289|474263852|FG001|Overall Study|fragile vein|0|||
131722546|NCT01277289|474263851|FG000|Overall Study|Physician Decision|1|||
131722547|NCT01277289|474263852|FG001|Overall Study|Physician Decision|0|||
131722548|NCT01277289|474263851|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
131722549|NCT01277289|474263852|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
131722550|NCT01277289|474263851|FG000|Overall Study|Protocol Violation|1|||
131722551|NCT01277289|474263852|FG001|Overall Study|Protocol Violation|1|||
131722552|NCT01277289|474263851|FG000|Overall Study|Adverse Event|2|||
131722553|NCT01277289|474263852|FG001|Overall Study|Adverse Event|1|||
131722554|NCT01277289|474263851|FG000|Overall Study|consent withdrawn|1|||
131722555|NCT01277289|474263852|FG001|Overall Study|consent withdrawn|1|||
131722556|NCT01277289|474263851|FG000|Overall Study|premature closure of the study|4|||
131722557|NCT01277289|474263852|FG001|Overall Study|premature closure of the study|2|||
131722558|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
131722559|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
131722560|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
131722561|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
131722562|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
131722563|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
131722564|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
131722565|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
131722566|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
131722567|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
131722568|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
131722569|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
131722570|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
131722571|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
131722572|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
131722573|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
131722574|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
131722575|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
131722576|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
131722577|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
131722578|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
131722579|NCT00092547|474263853|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
131722580|NCT00092547|474263854|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
131722581|NCT00092547|474263855|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
131722582|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
131722583|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
131722584|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
131722585|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
131722586|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
131722587|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
131722588|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
131722589|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
131722590|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
131722591|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
131722592|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
131722593|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
131722594|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
131722595|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
131722596|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
131722597|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
131722598|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
131448647|NCT00790842|473272728|FG008|Dose Level 2|Death|0|||
131448648|NCT00790842|473272729|FG009|Dose Level 2|Death|0|||
131448649|NCT00790842|473272730|FG010|Dose Level 2|Death|0|||
131448650|NCT00790842|473272720|FG000|Dose Level 2|Physician Decision|0|||
131448651|NCT00790842|473272721|FG001|Dose Level 2|Physician Decision|1|||
131448652|NCT00790842|473272722|FG002|Dose Level 2|Physician Decision|0|||
131448653|NCT00790842|473272723|FG003|Dose Level 2|Physician Decision|0|||
131448654|NCT00790842|473272724|FG004|Dose Level 2|Physician Decision|0|||
131448655|NCT00790842|473272725|FG005|Dose Level 2|Physician Decision|0|||
131448656|NCT00790842|473272726|FG006|Dose Level 2|Physician Decision|0|||
131448657|NCT00790842|473272727|FG007|Dose Level 2|Physician Decision|0|||
131448658|NCT00790842|473272728|FG008|Dose Level 2|Physician Decision|0|||
131448659|NCT00790842|473272729|FG009|Dose Level 2|Physician Decision|0|||
131448660|NCT00790842|473272730|FG010|Dose Level 2|Physician Decision|0|||
131448661|NCT00790842|473272720|FG000|Dose Level 2|Withdrawal by Subject|0|||
131448662|NCT00790842|473272721|FG001|Dose Level 2|Withdrawal by Subject|1|||
131448663|NCT00790842|473272722|FG002|Dose Level 2|Withdrawal by Subject|0|||
131448664|NCT00790842|473272723|FG003|Dose Level 2|Withdrawal by Subject|0|||
131448665|NCT00790842|473272724|FG004|Dose Level 2|Withdrawal by Subject|0|||
131448666|NCT00790842|473272725|FG005|Dose Level 2|Withdrawal by Subject|0|||
131448667|NCT00790842|473272726|FG006|Dose Level 2|Withdrawal by Subject|0|||
131448668|NCT00790842|473272727|FG007|Dose Level 2|Withdrawal by Subject|0|||
131448669|NCT00790842|473272728|FG008|Dose Level 2|Withdrawal by Subject|0|||
131448670|NCT00790842|473272729|FG009|Dose Level 2|Withdrawal by Subject|0|||
131448671|NCT00790842|473272730|FG010|Dose Level 2|Withdrawal by Subject|0|||
131448672|NCT00790842|473272720|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448673|NCT00790842|473272721|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448674|NCT00790842|473272722|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448675|NCT00790842|473272723|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448676|NCT00790842|473272724|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448677|NCT00790842|473272725|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448678|NCT00790842|473272726|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448679|NCT00790842|473272727|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448680|NCT00790842|473272728|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
131448681|NCT00790842|473272729|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448682|NCT00790842|473272730|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131448683|NCT00790842|473272720|FG000|Dose Level 3|Adverse Event|0|||
131448684|NCT00790842|473272721|FG001|Dose Level 3|Adverse Event|0|||
131448685|NCT00790842|473272722|FG002|Dose Level 3|Adverse Event|1|||
131448686|NCT00790842|473272723|FG003|Dose Level 3|Adverse Event|0|||
131448687|NCT00790842|473272724|FG004|Dose Level 3|Adverse Event|0|||
131448688|NCT00790842|473272725|FG005|Dose Level 3|Adverse Event|0|||
131448689|NCT00790842|473272726|FG006|Dose Level 3|Adverse Event|0|||
131448690|NCT00790842|473272727|FG007|Dose Level 3|Adverse Event|0|||
131448691|NCT00790842|473272728|FG008|Dose Level 3|Adverse Event|0|||
131448692|NCT00790842|473272729|FG009|Dose Level 3|Adverse Event|0|||
131448693|NCT00790842|473272730|FG010|Dose Level 3|Adverse Event|0|||
131448694|NCT00790842|473272720|FG000|Dose Level 3|Withdrawal by Subject|0|||
131722599|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
131722600|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
131722601|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
131722602|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
131904871|NCT03829462|474938979|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
131904872|NCT03829462|474938978|FG000|Overall Study|No treatment due to progression disease|0|||
131904873|NCT03829462|474938979|FG001|Overall Study|No treatment due to progression disease|1|||
131904874|NCT02277028|474938981|FG000|Overall Study|Lost to Follow-up|1|||
131904875|NCT02277028|474938982|FG001|Overall Study|Lost to Follow-up|0|||
131904876|NCT02277028|474938981|FG000|Overall Study|Withdrawal by Subject|0|||
131904877|NCT02277028|474938982|FG001|Overall Study|Withdrawal by Subject|1|||
131904878|NCT02718911|474938983|FG000|Overall Study|Adverse Event|0|||
131904879|NCT02718911|474938984|FG001|Overall Study|Adverse Event|0|||
131904880|NCT02718911|474938985|FG002|Overall Study|Adverse Event|0|||
131448695|NCT00790842|473272721|FG001|Dose Level 3|Withdrawal by Subject|0|||
131448696|NCT00790842|473272722|FG002|Dose Level 3|Withdrawal by Subject|3|||
131722603|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
131722604|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
131722605|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
131448697|NCT00790842|473272723|FG003|Dose Level 3|Withdrawal by Subject|0|||
131722606|NCT00092547|474263853|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
131722607|NCT00092547|474263854|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
131448698|NCT00790842|473272724|FG004|Dose Level 3|Withdrawal by Subject|0|||
131448699|NCT00790842|473272725|FG005|Dose Level 3|Withdrawal by Subject|0|||
131448700|NCT00790842|473272726|FG006|Dose Level 3|Withdrawal by Subject|0|||
131448701|NCT00790842|473272727|FG007|Dose Level 3|Withdrawal by Subject|0|||
131448702|NCT00790842|473272728|FG008|Dose Level 3|Withdrawal by Subject|0|||
131722608|NCT00092547|474263855|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
131722609|NCT00092547|474263853|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
131722610|NCT00092547|474263854|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
131722611|NCT00092547|474263855|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
131722612|NCT00092547|474263853|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
131722613|NCT00092547|474263854|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
131722614|NCT00092547|474263855|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
131722615|NCT00092547|474263853|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
131722616|NCT00092547|474263854|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
131722617|NCT00092547|474263855|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
131722618|NCT00092547|474263853|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
131722619|NCT00092547|474263854|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
131722620|NCT00092547|474263855|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
131722621|NCT01539837|474263856|FG000|Overall Study|reduce neutrophil level|0|||
131722622|NCT01539837|474263857|FG001|Overall Study|reduce neutrophil level|1|||
131722623|NCT01539837|474263858|FG002|Overall Study|reduce neutrophil level|1|||
131722624|NCT01539837|474263856|FG000|Overall Study|bad compliance|0|||
131722625|NCT01539837|474263857|FG001|Overall Study|bad compliance|0|||
131722626|NCT01539837|474263858|FG002|Overall Study|bad compliance|1|||
131722627|NCT01295905|474263867|FG000|Overall Study|Did not meet inclusion criteria|1|||
131722628|NCT01295905|474263868|FG001|Overall Study|Did not meet inclusion criteria|0|||
131722629|NCT01295905|474263867|FG000|Overall Study|Met exclusion criteria|1|||
131722630|NCT01295905|474263868|FG001|Overall Study|Met exclusion criteria|0|||
131722631|NCT03707977|474263870|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
131722632|NCT03707977|474263871|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
131722633|NCT03707977|474263872|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
131722634|NCT03707977|474263870|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
131722635|NCT03707977|474263871|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
131722636|NCT03707977|474263872|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
131722637|NCT02640612|474263873|FG000|Overall Study|Adverse Event|6|||
131722638|NCT02640612|474263874|FG001|Overall Study|Adverse Event|7|||
131722639|NCT02640612|474263875|FG002|Overall Study|Adverse Event|2|||
131722640|NCT02640612|474263873|FG000|Overall Study|Death|1|||
131722641|NCT02640612|474263874|FG001|Overall Study|Death|0|||
131722642|NCT02640612|474263875|FG002|Overall Study|Death|0|||
131722643|NCT02640612|474263873|FG000|Overall Study|Withdrawal by Subject|10|||
131722644|NCT02640612|474263874|FG001|Overall Study|Withdrawal by Subject|3|||
131804925|NCT04206332|474570563|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804926|NCT04206332|474570547|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804927|NCT04206332|474570548|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804928|NCT04206332|474570549|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804929|NCT04206332|474570550|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804930|NCT04206332|474570551|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804931|NCT04206332|474570552|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804932|NCT04206332|474570553|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804933|NCT04206332|474570554|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131904881|NCT02718911|474938986|FG003|Overall Study|Adverse Event|0|||
131722645|NCT02640612|474263875|FG002|Overall Study|Withdrawal by Subject|3|||
131722646|NCT02640612|474263873|FG000|Overall Study|Lost to Follow-up|4|||
131722647|NCT02640612|474263874|FG001|Overall Study|Lost to Follow-up|1|||
131804934|NCT04206332|474570555|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804935|NCT04206332|474570556|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804936|NCT04206332|474570557|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804937|NCT04206332|474570558|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131448703|NCT00790842|473272729|FG009|Dose Level 3|Withdrawal by Subject|2|||
131448704|NCT00790842|473272730|FG010|Dose Level 3|Withdrawal by Subject|0|||
131448705|NCT00790842|473272720|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131722648|NCT02640612|474263875|FG002|Overall Study|Lost to Follow-up|1|||
131804938|NCT04206332|474570559|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131722649|NCT02640612|474263873|FG000|Overall Study|Protocol Violation|0|||
131722650|NCT02640612|474263874|FG001|Overall Study|Protocol Violation|2|||
131722651|NCT02640612|474263875|FG002|Overall Study|Protocol Violation|0|||
131722652|NCT02640612|474263873|FG000|Overall Study|Lack of Efficacy|1|||
131722653|NCT02640612|474263874|FG001|Overall Study|Lack of Efficacy|1|||
131722654|NCT02640612|474263875|FG002|Overall Study|Lack of Efficacy|0|||
131722655|NCT01720667|474263876|FG000|Overall Study|Adverse Event|1|||
131722656|NCT01720667|474263877|FG001|Overall Study|Adverse Event|1|||
131722657|NCT01720667|474263876|FG000|Overall Study|Withdrawal by Subject|3|||
131722658|NCT01720667|474263877|FG001|Overall Study|Withdrawal by Subject|0|||
131722659|NCT03472534|474263878|FG000|Overall Study|Withdrawal by Subject|9|||
131722660|NCT03472534|474263878|FG000|Overall Study|Adverse Event|2|||
131722661|NCT03396471|474263882|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
131722662|NCT03396471|474263882|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
131722663|NCT03396471|474263882|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
131722664|NCT03396471|474263882|FG000|Study Treatment - Up to 22 Months|Death|2|||
131722665|NCT03396471|474263882|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
131722666|NCT03396471|474263882|FG000|Follow up - Up to 2 Years|Death|9|||
131722667|NCT03396471|474263882|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
131722668|NCT03396471|474263882|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
131722669|NCT03396471|474263882|FG000|Follow up - Up to 2 Years|study terminated|1|||
131722670|NCT03396471|474263882|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
131722671|NCT03396471|474263882|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
131804939|NCT04206332|474570560|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804940|NCT04206332|474570561|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131804941|NCT04206332|474570562|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131722672|NCT01319929|474263886|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
131722673|NCT01319929|474263887|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
131722674|NCT01319929|474263886|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
131722675|NCT01319929|474263887|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
131722676|NCT01319929|474263886|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
131722677|NCT01319929|474263887|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
131722678|NCT01319929|474263886|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
131722679|NCT01319929|474263887|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
131722680|NCT01319929|474263886|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
131722681|NCT01319929|474263887|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
131722682|NCT03237845|474263888|FG000|Overall Study|Adverse Event|0|||
131722683|NCT03237845|474263889|FG001|Overall Study|Adverse Event|1|||
131722684|NCT03237845|474263888|FG000|Overall Study|Lost to Follow-up|13|||
131722685|NCT03237845|474263889|FG001|Overall Study|Lost to Follow-up|10|||
131722686|NCT03237845|474263888|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
131722687|NCT03237845|474263889|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
131904882|NCT02718911|474938987|FG004|Overall Study|Adverse Event|0|||
131904883|NCT02718911|474938988|FG005|Overall Study|Adverse Event|0|||
131904884|NCT02718911|474938989|FG006|Overall Study|Adverse Event|0|||
131904885|NCT02718911|474938990|FG007|Overall Study|Adverse Event|0|||
131904886|NCT02718911|474938991|FG008|Overall Study|Adverse Event|0|||
131904887|NCT02718911|474938992|FG009|Overall Study|Adverse Event|2|||
131904888|NCT02718911|474938983|FG000|Overall Study|Death|2|||
131904889|NCT02718911|474938984|FG001|Overall Study|Death|3|||
131904890|NCT02718911|474938985|FG002|Overall Study|Death|1|||
131904891|NCT02718911|474938986|FG003|Overall Study|Death|0|||
131904892|NCT02718911|474938987|FG004|Overall Study|Death|1|||
131904893|NCT02718911|474938988|FG005|Overall Study|Death|3|||
131904894|NCT02718911|474938989|FG006|Overall Study|Death|1|||
131904895|NCT02718911|474938990|FG007|Overall Study|Death|1|||
131904896|NCT02718911|474938991|FG008|Overall Study|Death|4|||
131904897|NCT02718911|474938992|FG009|Overall Study|Death|3|||
131904898|NCT02718911|474938983|FG000|Overall Study|Lost to Follow-up|0|||
131904899|NCT02718911|474938984|FG001|Overall Study|Lost to Follow-up|0|||
131904900|NCT02718911|474938985|FG002|Overall Study|Lost to Follow-up|0|||
131904901|NCT02718911|474938986|FG003|Overall Study|Lost to Follow-up|0|||
131904902|NCT02718911|474938987|FG004|Overall Study|Lost to Follow-up|0|||
131904903|NCT02718911|474938988|FG005|Overall Study|Lost to Follow-up|0|||
131904904|NCT02718911|474938989|FG006|Overall Study|Lost to Follow-up|0|||
131904905|NCT02718911|474938990|FG007|Overall Study|Lost to Follow-up|0|||
131904906|NCT02718911|474938991|FG008|Overall Study|Lost to Follow-up|1|||
131904907|NCT02718911|474938992|FG009|Overall Study|Lost to Follow-up|0|||
131904908|NCT02718911|474938983|FG000|Overall Study|Physician Decision|2|||
131904909|NCT02718911|474938984|FG001|Overall Study|Physician Decision|0|||
131904910|NCT02718911|474938985|FG002|Overall Study|Physician Decision|1|||
131722688|NCT03237845|474263888|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
131722689|NCT03237845|474263889|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
131722690|NCT03237845|474263888|FG000|Overall Study|Physician Decision|1|||
131722691|NCT03237845|474263889|FG001|Overall Study|Physician Decision|2|||
131722692|NCT03237845|474263888|FG000|Overall Study|Pregnancy|1|||
131722693|NCT03237845|474263889|FG001|Overall Study|Pregnancy|0|||
131722694|NCT03237845|474263888|FG000|Overall Study|Protocol Deviation|0|||
131722695|NCT03237845|474263889|FG001|Overall Study|Protocol Deviation|1|||
131722696|NCT03237845|474263888|FG000|Overall Study|Technical Problems|8|||
131722697|NCT03237845|474263889|FG001|Overall Study|Technical Problems|1|||
131722698|NCT03237845|474263888|FG000|Overall Study|Withdrawal by Subject|3|||
131722699|NCT03237845|474263889|FG001|Overall Study|Withdrawal by Subject|3|||
131722700|NCT03237845|474263888|FG000|Overall Study|Other Reasons|4|||
131722701|NCT03237845|474263889|FG001|Overall Study|Other Reasons|0|||
131722702|NCT01221233|474263890|FG000|Overall Study|Withdrawal by Subject|3|||
131722703|NCT01221233|474263891|FG001|Overall Study|Withdrawal by Subject|1|||
131722704|NCT03865407|474263895|FG000|Overall Study|Adverse Event|1|||
131722705|NCT03865407|474263896|FG001|Overall Study|Adverse Event|0|||
131722706|NCT03865407|474263895|FG000|Overall Study|Withdrawal by Subject|1|||
131722707|NCT03865407|474263896|FG001|Overall Study|Withdrawal by Subject|0|||
131722708|NCT03865407|474263895|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
131722709|NCT03865407|474263896|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
131722710|NCT02117050|474263897|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
131722711|NCT01645280|474263899|FG000|Overall Study|Death|0|||
131722712|NCT01645280|474263900|FG001|Overall Study|Death|1|||
131722713|NCT01645280|474263901|FG002|Overall Study|Death|0|||
131722714|NCT01645280|474263902|FG003|Overall Study|Death|0|||
131722715|NCT01645280|474263903|FG004|Overall Study|Death|0|||
131722716|NCT01645280|474263899|FG000|Overall Study|Withdrawal by Subject|4|||
131722717|NCT01645280|474263900|FG001|Overall Study|Withdrawal by Subject|0|||
131722718|NCT01645280|474263901|FG002|Overall Study|Withdrawal by Subject|2|||
131722719|NCT01645280|474263902|FG003|Overall Study|Withdrawal by Subject|4|||
131722720|NCT01645280|474263903|FG004|Overall Study|Withdrawal by Subject|5|||
131722721|NCT01645280|474263899|FG000|Overall Study|Lost to Follow-up|0|||
131722722|NCT01645280|474263900|FG001|Overall Study|Lost to Follow-up|0|||
131722723|NCT01645280|474263901|FG002|Overall Study|Lost to Follow-up|0|||
131722724|NCT01645280|474263902|FG003|Overall Study|Lost to Follow-up|2|||
131722725|NCT01645280|474263903|FG004|Overall Study|Lost to Follow-up|1|||
131722726|NCT01645280|474263899|FG000|Overall Study|Other|1|||
131722727|NCT01645280|474263900|FG001|Overall Study|Other|1|||
131722728|NCT01645280|474263901|FG002|Overall Study|Other|2|||
131722729|NCT01645280|474263902|FG003|Overall Study|Other|0|||
131722730|NCT01645280|474263903|FG004|Overall Study|Other|0|||
131722731|NCT01645280|474263899|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
131722732|NCT01645280|474263900|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
131722733|NCT01645280|474263901|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
131722734|NCT01645280|474263902|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
131722735|NCT01645280|474263903|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
131722736|NCT00546819|474263910|FG000|Overall Study|Adverse Event|2|||
131722737|NCT00546819|474263911|FG001|Overall Study|Adverse Event|3|||
131722738|NCT00546819|474263910|FG000|Overall Study|Lost to Follow-up|2|||
131722739|NCT00546819|474263911|FG001|Overall Study|Lost to Follow-up|1|||
131722740|NCT00546819|474263910|FG000|Overall Study|Withdrawal by Subject|4|||
131722741|NCT00546819|474263911|FG001|Overall Study|Withdrawal by Subject|2|||
131722742|NCT00491530|474263920|FG000|Overall Study|Adverse Event|6|||
131722743|NCT00491530|474263921|FG001|Overall Study|Adverse Event|1|||
131722744|NCT00491530|474263922|FG002|Overall Study|Adverse Event|2|||
131804942|NCT04206332|474570563|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
131804943|NCT04206332|474570547|FG000|Part C|Withdrawal by Subject|0|||
131804944|NCT04206332|474570548|FG001|Part C|Withdrawal by Subject|0|||
131804945|NCT04206332|474570549|FG002|Part C|Withdrawal by Subject|0|||
131804946|NCT04206332|474570550|FG003|Part C|Withdrawal by Subject|0|||
131804947|NCT04206332|474570551|FG004|Part C|Withdrawal by Subject|0|||
131722745|NCT00491530|474263920|FG000|Overall Study|Withdrawal by Subject|3|||
131722746|NCT00491530|474263921|FG001|Overall Study|Withdrawal by Subject|0|||
131722747|NCT00491530|474263922|FG002|Overall Study|Withdrawal by Subject|0|||
131722748|NCT00491530|474263920|FG000|Overall Study|Lost to Follow-up|3|||
131804948|NCT04206332|474570552|FG005|Part C|Withdrawal by Subject|0|||
131722749|NCT00491530|474263921|FG001|Overall Study|Lost to Follow-up|2|||
131722750|NCT00491530|474263922|FG002|Overall Study|Lost to Follow-up|2|||
131722751|NCT00491530|474263920|FG000|Overall Study|Lack of Efficacy|0|||
131722752|NCT00491530|474263921|FG001|Overall Study|Lack of Efficacy|1|||
131722753|NCT00491530|474263922|FG002|Overall Study|Lack of Efficacy|0|||
131722754|NCT00491530|474263920|FG000|Overall Study|Investigator Discretion|0|||
131722755|NCT00491530|474263921|FG001|Overall Study|Investigator Discretion|1|||
131722756|NCT00491530|474263922|FG002|Overall Study|Investigator Discretion|0|||
131804949|NCT04206332|474570553|FG006|Part C|Withdrawal by Subject|0|||
131722757|NCT00491530|474263920|FG000|Overall Study|Patient Request|0|||
131722758|NCT00491530|474263921|FG001|Overall Study|Patient Request|1|||
131722759|NCT00491530|474263922|FG002|Overall Study|Patient Request|0|||
131722760|NCT00491530|474263920|FG000|Overall Study|Use of Prohibited Medication|0|||
131722761|NCT00491530|474263921|FG001|Overall Study|Use of Prohibited Medication|0|||
131722762|NCT00491530|474263922|FG002|Overall Study|Use of Prohibited Medication|1|||
131722763|NCT02859415|474263923|FG000|Overall Study|Physician Decision|1|||
131722764|NCT02859415|474263924|FG001|Overall Study|Physician Decision|0|||
131722765|NCT02859415|474263923|FG000|Overall Study|Off treatment due to cardiac event|0|||
131722766|NCT02859415|474263924|FG001|Overall Study|Off treatment due to cardiac event|1|||
131722767|NCT01174784|474263925|FG000|Overall Study|Screen fails|4|||
131722768|NCT04601272|474263929|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
131722769|NCT04601272|474263930|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
131722770|NCT04601272|474263931|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
131722771|NCT00414440|474263932|FG000|Core Period|Withdrawal by Subject|70|||
131722772|NCT00414440|474263933|FG001|Core Period|Withdrawal by Subject|32|||
131722773|NCT00414440|474263932|FG000|Extension Period|Lost to Follow-up|44|||
131722774|NCT00414440|474263933|FG001|Extension Period|Lost to Follow-up|52|||
131722775|NCT00414440|474263932|FG000|Extension Period|Did not consent to continue follow up|61|||
131722776|NCT00414440|474263933|FG001|Extension Period|Did not consent to continue follow up|54|||
131722777|NCT00414440|474263932|FG000|Extension Period|Other|1|||
131722778|NCT00414440|474263933|FG001|Extension Period|Other|1|||
131722779|NCT00414440|474263932|FG000|Extension Period|Administrative|16|||
131722780|NCT00414440|474263933|FG001|Extension Period|Administrative|16|||
131722781|NCT00414440|474263932|FG000|Extension Period|Death|1|||
131722782|NCT00414440|474263933|FG001|Extension Period|Death|2|||
131722783|NCT00414440|474263932|FG000|Extension Period|Withdrawal by Subject|9|||
131722784|NCT00414440|474263933|FG001|Extension Period|Withdrawal by Subject|7|||
131722785|NCT00414440|474263932|FG000|Extension Period|Not included in follow up period|18|||
131722786|NCT00414440|474263933|FG001|Extension Period|Not included in follow up period|8|||
131722787|NCT02168946|474263934|FG000|Overall Study|Adverse Event|8|||
131722788|NCT02168946|474263935|FG001|Overall Study|Adverse Event|5|||
131722789|NCT02168946|474263934|FG000|Overall Study|Lost to Follow-up|3|||
131722790|NCT02168946|474263935|FG001|Overall Study|Lost to Follow-up|0|||
131722791|NCT02168946|474263934|FG000|Overall Study|Subject unable to come back for visits|1|||
131722792|NCT02168946|474263935|FG001|Overall Study|Subject unable to come back for visits|0|||
131722793|NCT01971476|474263937|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
131722794|NCT01971476|474263938|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
131722795|NCT01971476|474263939|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
131722796|NCT01971476|474263937|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
131722797|NCT01971476|474263938|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
131722798|NCT01971476|474263939|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
131722799|NCT01971476|474263937|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
131722800|NCT01971476|474263938|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
131722801|NCT01971476|474263939|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
131722802|NCT02498821|474263940|FG000|Overall Study|Screen failure|3|||
131722803|NCT02498821|474263941|FG001|Overall Study|Screen failure|5|||
131722804|NCT01716169|474263942|FG000|Overall Study|Adverse Event|1|||
131722805|NCT01716169|474263942|FG000|Overall Study|Lost to Follow-up|1|||
131722806|NCT01716169|474263942|FG000|Overall Study|Withdrawal by Subject|1|||
131722807|NCT01716169|474263942|FG000|Overall Study|inconsistent dressing application|1|||
131722808|NCT00553787|474263943|FG000|Overall Study|Adverse Event|34|||
131722809|NCT00553787|474263944|FG001|Overall Study|Adverse Event|21|||
131722810|NCT00553787|474263945|FG002|Overall Study|Adverse Event|67|||
131722811|NCT00553787|474263943|FG000|Overall Study|Lost to Follow-up|132|||
131722812|NCT00553787|474263944|FG001|Overall Study|Lost to Follow-up|44|||
131722813|NCT00553787|474263945|FG002|Overall Study|Lost to Follow-up|78|||
131722814|NCT00553787|474263943|FG000|Overall Study|Withdrawal by Subject|151|||
131722815|NCT00553787|474263944|FG001|Overall Study|Withdrawal by Subject|40|||
131722816|NCT00553787|474263945|FG002|Overall Study|Withdrawal by Subject|83|||
131722817|NCT00553787|474263943|FG000|Overall Study|Lack of Efficacy|31|||
131722818|NCT00553787|474263944|FG001|Overall Study|Lack of Efficacy|1|||
131722819|NCT00553787|474263945|FG002|Overall Study|Lack of Efficacy|3|||
131722820|NCT00553787|474263943|FG000|Overall Study|Pregnancy|0|||
131722821|NCT00553787|474263944|FG001|Overall Study|Pregnancy|1|||
131722822|NCT00553787|474263945|FG002|Overall Study|Pregnancy|2|||
131722823|NCT00553787|474263943|FG000|Overall Study|non compliance|4|||
131722824|NCT00553787|474263944|FG001|Overall Study|non compliance|0|||
131722825|NCT00553787|474263945|FG002|Overall Study|non compliance|11|||
131722826|NCT00553787|474263943|FG000|Overall Study|Requirement for restricted medication|8|||
131722827|NCT00553787|474263944|FG001|Overall Study|Requirement for restricted medication|7|||
131722828|NCT00553787|474263945|FG002|Overall Study|Requirement for restricted medication|5|||
131722829|NCT00553787|474263943|FG000|Overall Study|Other|18|||
131722830|NCT00553787|474263944|FG001|Overall Study|Other|10|||
131722831|NCT00553787|474263945|FG002|Overall Study|Other|13|||
131722832|NCT04542291|474263962|FG000|Overall Study|Adverse Event|1|||
131722833|NCT04542291|474263962|FG000|Overall Study|Physician Decision|2|||
131722834|NCT05258058|474263967|FG000|Overall Study|Withdrawal by Subject|2|||
131722835|NCT04579393|474263968|FG000|Overall Study|Withdrawal by Subject|2|||
131722836|NCT04579393|474263969|FG001|Overall Study|Withdrawal by Subject|2|||
131722837|NCT04579393|474263968|FG000|Overall Study|Death|1|||
131722838|NCT04579393|474263969|FG001|Overall Study|Death|3|||
131722839|NCT02725177|474263975|FG000|Overall Study|Physician Decision|4|||
131722840|NCT02725177|474263975|FG000|Overall Study|Adverse Event|1|||
131722841|NCT00793585|474263978|FG000|Overall Study|Adverse Event|1|||
131722842|NCT00793585|474263979|FG001|Overall Study|Adverse Event|1|||
131722843|NCT00793585|474263978|FG000|Overall Study|Protocol Violation|1|||
131722844|NCT00793585|474263979|FG001|Overall Study|Protocol Violation|2|||
131722845|NCT00377299|474263980|FG000|Overall Study|Lost to Follow-up|14|||
131722846|NCT00377299|474263981|FG001|Overall Study|Lost to Follow-up|19|||
131722847|NCT00377299|474263980|FG000|Overall Study|Adverse Event|0|||
131722848|NCT00377299|474263981|FG001|Overall Study|Adverse Event|1|||
131722849|NCT00377299|474263980|FG000|Overall Study|Withdrawal by Subject|5|||
131722850|NCT00377299|474263981|FG001|Overall Study|Withdrawal by Subject|4|||
131722851|NCT00035815|474263985|FG000|Overall Study|Withdrawal by Subject|17|||
131722852|NCT00035815|474263986|FG001|Overall Study|Withdrawal by Subject|11|||
131722853|NCT02699515|474265931|FG000|Overall Study|Death|3|||
131722854|NCT02699515|474265932|FG001|Overall Study|Death|3|||
131722855|NCT02699515|474265933|FG002|Overall Study|Death|3|||
131722856|NCT02699515|474265934|FG003|Overall Study|Death|23|||
131722857|NCT02699515|474265935|FG004|Overall Study|Death|22|||
131722858|NCT02699515|474265936|FG005|Overall Study|Death|23|||
131722859|NCT02699515|474265937|FG006|Overall Study|Death|3|||
131722860|NCT02699515|474265938|FG007|Overall Study|Death|5|||
131722861|NCT02699515|474265931|FG000|Overall Study|Withdrawal by Subject|0|||
131722862|NCT02699515|474265932|FG001|Overall Study|Withdrawal by Subject|0|||
131722863|NCT02699515|474265933|FG002|Overall Study|Withdrawal by Subject|3|||
131722864|NCT02699515|474265934|FG003|Overall Study|Withdrawal by Subject|1|||
131722865|NCT02699515|474265935|FG004|Overall Study|Withdrawal by Subject|5|||
131722866|NCT02699515|474265936|FG005|Overall Study|Withdrawal by Subject|3|||
131722867|NCT02699515|474265937|FG006|Overall Study|Withdrawal by Subject|0|||
131722868|NCT02699515|474265938|FG007|Overall Study|Withdrawal by Subject|1|||
131722869|NCT02699515|474265931|FG000|Overall Study|Other|1|||
131722870|NCT02699515|474265932|FG001|Overall Study|Other|0|||
131722871|NCT02699515|474265933|FG002|Overall Study|Other|1|||
131722872|NCT02699515|474265934|FG003|Overall Study|Other|6|||
131722873|NCT02699515|474265935|FG004|Overall Study|Other|4|||
131722874|NCT02699515|474265936|FG005|Overall Study|Other|3|||
131722875|NCT02699515|474265937|FG006|Overall Study|Other|0|||
131722876|NCT02699515|474265938|FG007|Overall Study|Other|0|||
131722877|NCT00375934|474265940|FG000|Overall Study|Adverse Event|1|||
131722878|NCT00375934|474265941|FG001|Overall Study|Adverse Event|1|||
131722879|NCT00375934|474265940|FG000|Overall Study|Withdrawal by Subject|2|||
131722880|NCT00375934|474265941|FG001|Overall Study|Withdrawal by Subject|2|||
131722881|NCT00375934|474265940|FG000|Overall Study|Lack of Efficacy|0|||
131722882|NCT00375934|474265941|FG001|Overall Study|Lack of Efficacy|2|||
131722883|NCT00375934|474265940|FG000|Overall Study|Physician Decision|0|||
131722884|NCT00375934|474265941|FG001|Overall Study|Physician Decision|1|||
131722885|NCT03191396|474265942|FG000|Overall Study|Lost to Follow-up|0|||
131722886|NCT03191396|474265943|FG001|Overall Study|Lost to Follow-up|3|||
131722887|NCT03191396|474265942|FG000|Overall Study|Withdrawal by Subject|3|||
131722888|NCT03191396|474265943|FG001|Overall Study|Withdrawal by Subject|2|||
131722889|NCT02452970|474265946|FG000|Overall Study|Adverse Event|1|||
131722890|NCT01300286|474265947|FG000|Overall Study|did not get dosed|1|||
131722891|NCT01283581|474265950|FG000|Overall Study|Lost to Follow-up|8|||
131722892|NCT01283581|474265951|FG001|Overall Study|Lost to Follow-up|6|||
131722893|NCT01283581|474265952|FG002|Overall Study|Lost to Follow-up|8|||
131722894|NCT01283581|474265950|FG000|Overall Study|Withdrawal by Subject|2|||
131722895|NCT01283581|474265951|FG001|Overall Study|Withdrawal by Subject|5|||
131722896|NCT01283581|474265952|FG002|Overall Study|Withdrawal by Subject|2|||
131722897|NCT01283581|474265950|FG000|Overall Study|Adverse Event|1|||
131722898|NCT01283581|474265951|FG001|Overall Study|Adverse Event|1|||
131722899|NCT01283581|474265952|FG002|Overall Study|Adverse Event|4|||
131722900|NCT01283581|474265950|FG000|Overall Study|Physician Decision|0|||
131722901|NCT01283581|474265951|FG001|Overall Study|Physician Decision|1|||
131722902|NCT01283581|474265952|FG002|Overall Study|Physician Decision|2|||
131722903|NCT01283581|474265950|FG000|Overall Study|Protocol Violation|0|||
131722904|NCT01283581|474265951|FG001|Overall Study|Protocol Violation|1|||
131722905|NCT01283581|474265952|FG002|Overall Study|Protocol Violation|2|||
131722906|NCT01283581|474265950|FG000|Overall Study|Noncompliance|1|||
131722907|NCT01283581|474265951|FG001|Overall Study|Noncompliance|0|||
131722908|NCT01283581|474265952|FG002|Overall Study|Noncompliance|0|||
131722909|NCT01283581|474265950|FG000|Overall Study|Investigator unblinded|0|||
131722910|NCT01283581|474265951|FG001|Overall Study|Investigator unblinded|0|||
131722911|NCT01283581|474265952|FG002|Overall Study|Investigator unblinded|1|||
131722912|NCT01283581|474265950|FG000|Overall Study|"Early termination"|0|||
131722913|NCT01283581|474265951|FG001|Overall Study|"Early termination"|0|||
131722914|NCT01283581|474265952|FG002|Overall Study|"Early termination"|1|||
131722915|NCT00486226|474265953|FG000|Overall Study|Death|3|||
131722916|NCT00486226|474265953|FG000|Overall Study|Adverse Event|1|||
131722917|NCT00486226|474265953|FG000|Overall Study|Withdrawal by Subject|1|||
131722918|NCT00486226|474265953|FG000|Overall Study|Lost to Follow-up|8|||
131722919|NCT01259492|474265954|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
131722920|NCT01259492|474265955|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
131722921|NCT01259492|474265956|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
131722922|NCT01259492|474265957|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
131722923|NCT01259492|474265954|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
131722924|NCT01259492|474265955|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
131722925|NCT01259492|474265956|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
131722926|NCT01259492|474265957|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
131722927|NCT01259492|474265954|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
131722928|NCT01259492|474265955|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
131722929|NCT01259492|474265956|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
131722930|NCT01259492|474265957|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
131722931|NCT01259492|474265954|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
131722932|NCT01259492|474265955|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
131722933|NCT01259492|474265956|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
131722934|NCT01259492|474265957|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
131722935|NCT01259492|474265954|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
131722936|NCT01259492|474265955|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
131722937|NCT01259492|474265956|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
131722938|NCT01259492|474265957|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
131722939|NCT01259492|474265954|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
131722940|NCT01259492|474265955|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
131722941|NCT01259492|474265956|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
131722942|NCT01259492|474265957|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
131722943|NCT01259492|474265954|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
131722944|NCT01259492|474265955|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
131722945|NCT01259492|474265956|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
131722946|NCT01259492|474265957|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
131722947|NCT01259492|474265954|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
131722948|NCT01259492|474265955|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
131722949|NCT01259492|474265956|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
131722950|NCT01259492|474265957|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
131722951|NCT01259492|474265954|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
131722952|NCT01259492|474265955|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
131722953|NCT01259492|474265956|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
131722954|NCT01259492|474265957|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
131722955|NCT01259492|474265954|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
131722956|NCT01259492|474265955|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
131722957|NCT01259492|474265956|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
131722958|NCT01259492|474265957|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
131722959|NCT01259492|474265954|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
131722960|NCT01259492|474265955|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
131722961|NCT01259492|474265956|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
131722962|NCT01259492|474265957|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
131722963|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
131722964|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
131722965|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
131722966|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
131722967|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
131722968|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
131722969|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
131722970|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
131722971|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
131904911|NCT02718911|474938986|FG003|Overall Study|Physician Decision|1|||
131722972|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
131722973|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
131722974|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
131722975|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
131722976|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
131722977|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
131722978|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
131722979|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
131722980|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
131722981|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
131722982|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
131722983|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
131722984|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
131722985|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
131722986|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
131722987|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
131722988|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
131722989|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
131722990|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
131722991|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
131722992|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
131722993|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
131722994|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
131722995|NCT01259492|474265954|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
131722996|NCT01259492|474265955|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
131722997|NCT01259492|474265956|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
131722998|NCT01259492|474265957|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
131722999|NCT01058369|474265960|FG000|Overall Study|Adverse Event|1|||
131723000|NCT01058369|474265960|FG000|Overall Study|Early termination study|1|||
131723001|NCT00663858|474265961|FG000|Overall Study|Adverse Event|9|||
131723002|NCT00663858|474265962|FG001|Overall Study|Adverse Event|1|||
131723003|NCT00663858|474265963|FG002|Overall Study|Adverse Event|6|||
131723004|NCT00663858|474265961|FG000|Overall Study|Lack of Efficacy|5|||
131723005|NCT00663858|474265962|FG001|Overall Study|Lack of Efficacy|1|||
131723006|NCT00663858|474265963|FG002|Overall Study|Lack of Efficacy|3|||
131723007|NCT00663858|474265961|FG000|Overall Study|Withdrawal by Subject|7|||
131723008|NCT00663858|474265962|FG001|Overall Study|Withdrawal by Subject|3|||
131723009|NCT00663858|474265963|FG002|Overall Study|Withdrawal by Subject|3|||
131723010|NCT00663858|474265961|FG000|Overall Study|Protocol Violation|5|||
131723011|NCT00663858|474265962|FG001|Overall Study|Protocol Violation|3|||
131723012|NCT00663858|474265963|FG002|Overall Study|Protocol Violation|4|||
131723013|NCT00663858|474265961|FG000|Overall Study|Other|8|||
131723014|NCT00663858|474265962|FG001|Overall Study|Other|2|||
131723015|NCT00663858|474265963|FG002|Overall Study|Other|4|||
131723016|NCT03060577|474265964|FG000|Overall Study|Withdrawal by Subject|25|||
131723017|NCT03060577|474265965|FG001|Overall Study|Withdrawal by Subject|5|||
131723018|NCT03060577|474265964|FG000|Overall Study|Physician Decision|4|||
131723019|NCT03060577|474265965|FG001|Overall Study|Physician Decision|3|||
131723020|NCT03060577|474265964|FG000|Overall Study|Lost to Follow-up|3|||
131723021|NCT03060577|474265965|FG001|Overall Study|Lost to Follow-up|0|||
131723022|NCT03060577|474265964|FG000|Overall Study|Death|7|||
131723023|NCT03060577|474265965|FG001|Overall Study|Death|1|||
131723024|NCT03060577|474265964|FG000|Overall Study|Adverse Event|9|||
131723025|NCT03060577|474265965|FG001|Overall Study|Adverse Event|1|||
131723026|NCT03060577|474265964|FG000|Overall Study|Inclusion/Exclusion|1|||
131723027|NCT03060577|474265965|FG001|Overall Study|Inclusion/Exclusion|0|||
131723028|NCT03060577|474265964|FG000|Overall Study|Other|8|||
131723029|NCT03060577|474265965|FG001|Overall Study|Other|2|||
131804950|NCT04206332|474570554|FG007|Part C|Withdrawal by Subject|0|||
131804951|NCT04206332|474570555|FG008|Part C|Withdrawal by Subject|0|||
131804952|NCT04206332|474570556|FG009|Part C|Withdrawal by Subject|0|||
131804953|NCT04206332|474570557|FG010|Part C|Withdrawal by Subject|0|||
131804954|NCT04206332|474570558|FG011|Part C|Withdrawal by Subject|0|||
131804955|NCT04206332|474570559|FG012|Part C|Withdrawal by Subject|0|||
131804956|NCT04206332|474570560|FG013|Part C|Withdrawal by Subject|0|||
131804957|NCT04206332|474570561|FG014|Part C|Withdrawal by Subject|2|||
131723030|NCT02940886|474265969|FG000|Overall Study|Adverse Event|7|||
131723031|NCT02940886|474265970|FG001|Overall Study|Adverse Event|3|||
131723032|NCT02940886|474265969|FG000|Overall Study|Protocol Violation|0|||
131723033|NCT02940886|474265970|FG001|Overall Study|Protocol Violation|2|||
131723034|NCT02940886|474265969|FG000|Overall Study|Withdrawal by Subject|28|||
131723035|NCT02940886|474265970|FG001|Overall Study|Withdrawal by Subject|20|||
131723036|NCT02940886|474265969|FG000|Overall Study|Death|1|||
131723037|NCT02940886|474265970|FG001|Overall Study|Death|0|||
131804958|NCT04206332|474570562|FG015|Part C|Withdrawal by Subject|0|||
131804959|NCT04206332|474570563|FG016|Part C|Withdrawal by Subject|0|||
131804960|NCT01038856|474570571|FG000|Overall Study|Adverse Event|2|||
131723038|NCT02940886|474265969|FG000|Overall Study|Lack of Efficacy|1|||
131723039|NCT02940886|474265970|FG001|Overall Study|Lack of Efficacy|0|||
131723040|NCT02940886|474265969|FG000|Overall Study|Lost to Follow-up|49|||
131723041|NCT02940886|474265970|FG001|Overall Study|Lost to Follow-up|21|||
131723042|NCT02940886|474265969|FG000|Overall Study|Physician Decision|9|||
131723043|NCT02940886|474265970|FG001|Overall Study|Physician Decision|4|||
131723044|NCT02940886|474265969|FG000|Overall Study|Sponsor decision|0|||
131723045|NCT02940886|474265970|FG001|Overall Study|Sponsor decision|1|||
131723046|NCT02940886|474265969|FG000|Overall Study|No treatment|7|||
131723047|NCT02940886|474265970|FG001|Overall Study|No treatment|2|||
131723048|NCT02940886|474265969|FG000|Overall Study|Enrolment error|0|||
131723049|NCT02940886|474265970|FG001|Overall Study|Enrolment error|1|||
131723050|NCT01306058|474265974|FG000|Overall Study|Death|1|||
131723051|NCT01306058|474265974|FG000|Overall Study|Enrolled but did not get treatment|1|||
131723052|NCT01666444|474265975|FG000|Overall Study|Did not initiate treatment|2|||
131723053|NCT01666444|474265976|FG001|Overall Study|Did not initiate treatment|1|||
131723054|NCT00084682|474265981|FG000|Overall Study|Withdrawal by Subject|1|||
131723055|NCT03238248|474265984|FG000|Overall Study|Death|5|||
131723056|NCT03238248|474265984|FG000|Overall Study|Withdrawal by Subject|7|||
131723057|NCT03238248|474265984|FG000|Overall Study|Participant proceeding to transplant|10|||
131723058|NCT03238248|474265984|FG000|Overall Study|Lack of Efficacy|4|||
131723059|NCT03238248|474265984|FG000|Overall Study|Physician Decision|3|||
131723060|NCT03238248|474265984|FG000|Overall Study|Transitioning to another study|1|||
131723061|NCT03238248|474265984|FG000|Overall Study|No longer benefiting|1|||
131723062|NCT03238248|474265984|FG000|Overall Study|Other complicating disease|1|||
131723063|NCT03238248|474265984|FG000|Overall Study|Adverse Event|5|||
131723064|NCT03238248|474265984|FG000|Overall Study|Disease progression|26|||
131723065|NCT03238248|474265984|FG000|Overall Study|N/A participant is still on treatment|1|||
131723066|NCT03238248|474265984|FG000|Overall Study|Decline in condition|1|||
131723067|NCT03238248|474265984|FG000|Overall Study|Alternative therapy|2|||
131723068|NCT01013883|474265985|FG000|Overall Study|Lost to Follow-up|2|||
131723069|NCT01013883|474265986|FG001|Overall Study|Lost to Follow-up|2|||
131723070|NCT02241512|474265991|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
131723071|NCT02241512|474265992|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
131723072|NCT00641043|474265993|FG000|Overall Study|Adverse Event|6|||
131723073|NCT00641043|474265994|FG001|Overall Study|Adverse Event|4|||
131723074|NCT00641043|474265993|FG000|Overall Study|Protocol Violation|2|||
131723075|NCT00641043|474265994|FG001|Overall Study|Protocol Violation|3|||
131723076|NCT00641043|474265993|FG000|Overall Study|Lost to Follow-up|3|||
131723077|NCT00641043|474265994|FG001|Overall Study|Lost to Follow-up|2|||
131723078|NCT00641043|474265993|FG000|Overall Study|Withdrawal by Subject|4|||
131723079|NCT00641043|474265994|FG001|Overall Study|Withdrawal by Subject|4|||
131723080|NCT00641043|474265993|FG000|Overall Study|Other incl. lack of efficacy|4|||
131723081|NCT00641043|474265994|FG001|Overall Study|Other incl. lack of efficacy|2|||
131723082|NCT02584634|474265995|FG000|Overall Study|Adverse Event|3|||
131723083|NCT02584634|474265996|FG001|Overall Study|Adverse Event|5|||
131723084|NCT02584634|474265995|FG000|Overall Study|Death|0|||
131723085|NCT02584634|474265996|FG001|Overall Study|Death|1|||
131723086|NCT02584634|474265995|FG000|Overall Study|Lost to Follow-up|0|||
131723087|NCT02584634|474265996|FG001|Overall Study|Lost to Follow-up|1|||
131723088|NCT02584634|474265995|FG000|Overall Study|Physician Decision|1|||
131723089|NCT02584634|474265996|FG001|Overall Study|Physician Decision|2|||
131723090|NCT02584634|474265995|FG000|Overall Study|Progressive disease|7|||
131723091|NCT02584634|474265996|FG001|Overall Study|Progressive disease|15|||
131723092|NCT02584634|474265995|FG000|Overall Study|Withdrawal by Subject|1|||
131723093|NCT02584634|474265996|FG001|Overall Study|Withdrawal by Subject|1|||
131723094|NCT02584634|474265995|FG000|Overall Study|Other|0|||
131723095|NCT02584634|474265996|FG001|Overall Study|Other|6|||
131723096|NCT00474630|474265997|FG000|Overall Study|Adverse Event|98|||
131723097|NCT00474630|474265998|FG001|Overall Study|Adverse Event|26|||
131723098|NCT00474630|474265997|FG000|Overall Study|Lost to Follow-up|22|||
131723099|NCT00474630|474265998|FG001|Overall Study|Lost to Follow-up|15|||
131723100|NCT00474630|474265997|FG000|Overall Study|Withdrawal by Subject|21|||
131723101|NCT00474630|474265998|FG001|Overall Study|Withdrawal by Subject|15|||
131723102|NCT00474630|474265997|FG000|Overall Study|Protocol Violation|3|||
131723103|NCT00474630|474265998|FG001|Overall Study|Protocol Violation|4|||
131804961|NCT01666730|474570572|FG000|Overall Study|Adverse Event|16|||
131804962|NCT01666730|474570572|FG000|Overall Study|Death|2|||
131723104|NCT00474630|474265997|FG000|Overall Study|Lack of Efficacy|5|||
131723105|NCT00474630|474265998|FG001|Overall Study|Lack of Efficacy|6|||
131723106|NCT00474630|474265997|FG000|Overall Study|Drug noncompliance, other|11|||
131723107|NCT00474630|474265998|FG001|Overall Study|Drug noncompliance, other|4|||
131723108|NCT03088605|474265999|FG000|Overall Study|Withdrawal by Subject|1|||
131723109|NCT03088605|474266000|FG001|Overall Study|Withdrawal by Subject|0|||
131723110|NCT03666143|474266001|FG000|Overall Study|Death|158|||
131723111|NCT03666143|474266001|FG000|Overall Study|Sponsor Decision|31|||
131723112|NCT03666143|474266001|FG000|Overall Study|Withdrawal by Subject|11|||
131723113|NCT03666143|474266001|FG000|Overall Study|Lost to Follow-up|5|||
131723114|NCT03666143|474266001|FG000|Overall Study|Physician Decision|1|||
131448706|NCT00790842|473272721|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131723115|NCT03666143|474266001|FG000|Overall Study|Rolled into extension study|9|||
131723116|NCT03666143|474266001|FG000|Overall Study|Progressive Disease|1|||
131723117|NCT02747043|474266004|FG000|Overall Study|Other|1|||
131723118|NCT02747043|474266005|FG001|Overall Study|Other|1|||
131723119|NCT02747043|474266004|FG000|Overall Study|Adverse Event|3|||
131723120|NCT02747043|474266005|FG001|Overall Study|Adverse Event|1|||
131723121|NCT02747043|474266004|FG000|Overall Study|Withdrawal by Subject|1|||
131723122|NCT02747043|474266005|FG001|Overall Study|Withdrawal by Subject|1|||
131723123|NCT02747043|474266004|FG000|Overall Study|Physician Decision|1|||
131723124|NCT02747043|474266005|FG001|Overall Study|Physician Decision|1|||
131723125|NCT02747043|474266004|FG000|Overall Study|Protocol Violation|0|||
131723126|NCT02747043|474266005|FG001|Overall Study|Protocol Violation|1|||
131723127|NCT02747043|474266004|FG000|Overall Study|Disease progression|4|||
131723128|NCT02747043|474266005|FG001|Overall Study|Disease progression|0|||
131723129|NCT01749735|474266014|FG000|Overall Study|Withdrawal by Subject|1|||
131723130|NCT01749735|474266015|FG001|Overall Study|Withdrawal by Subject|0|||
131723131|NCT01873742|474266016|FG000|Overall Study|Lost to Follow-up|68|||
131723132|NCT01873742|474266017|FG001|Overall Study|Lost to Follow-up|76|||
131723133|NCT00790296|474266019|FG000|Overall Study|Did not meet study eligibility criteria|1|||
131723134|NCT00790296|474266020|FG001|Overall Study|Did not meet study eligibility criteria|1|||
131723135|NCT00790296|474266019|FG000|Overall Study|Adverse Event|0|||
131723136|NCT00790296|474266020|FG001|Overall Study|Adverse Event|1|||
131723137|NCT02612077|474266021|FG000|Overall Study|Adverse Event|3|||
131723138|NCT02612077|474266021|FG000|Overall Study|Withdrawal by Subject|9|||
131723139|NCT02612077|474266021|FG000|Overall Study|Protocol Violation|28|||
131723140|NCT02612077|474266021|FG000|Overall Study|Lost to Follow-up|20|||
131723141|NCT02612077|474266021|FG000|Overall Study|Death|377|||
131723142|NCT02612077|474266021|FG000|Overall Study|Moved or Changed Medical Team|23|||
131723143|NCT02612077|474266021|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
131723144|NCT02612077|474266021|FG000|Overall Study|Disease Progression|3|||
131723145|NCT02612077|474266021|FG000|Overall Study|Unknown reason|2|||
131723146|NCT02075255|474266022|FG000|Overall Study|Study specific withdrawal criteria|0|||
131723147|NCT02075255|474266023|FG001|Overall Study|Study specific withdrawal criteria|1|||
131723148|NCT02075255|474266024|FG002|Overall Study|Study specific withdrawal criteria|1|||
131723149|NCT02075255|474266022|FG000|Overall Study|Withdrawal by Subject|4|||
131723150|NCT02075255|474266023|FG001|Overall Study|Withdrawal by Subject|1|||
131723151|NCT02075255|474266024|FG002|Overall Study|Withdrawal by Subject|0|||
131723152|NCT02075255|474266022|FG000|Overall Study|Lost to Follow-up|0|||
131723153|NCT02075255|474266023|FG001|Overall Study|Lost to Follow-up|0|||
131723154|NCT02075255|474266024|FG002|Overall Study|Lost to Follow-up|1|||
131723155|NCT02075255|474266022|FG000|Overall Study|Adverse Event|0|||
131723156|NCT02075255|474266023|FG001|Overall Study|Adverse Event|0|||
131723157|NCT02075255|474266024|FG002|Overall Study|Adverse Event|1|||
131723158|NCT02075255|474266022|FG000|Overall Study|Death|0|||
131723159|NCT02075255|474266023|FG001|Overall Study|Death|2|||
131723160|NCT02075255|474266024|FG002|Overall Study|Death|0|||
131723161|NCT01088412|474266025|FG000|Overall Study|Adverse Event|38|||
131723162|NCT01088412|474266026|FG001|Overall Study|Adverse Event|0|||
131723163|NCT01088412|474266027|FG002|Overall Study|Adverse Event|0|||
131723164|NCT01088412|474266025|FG000|Overall Study|Death|42|||
131723165|NCT01088412|474266026|FG001|Overall Study|Death|6|||
131723166|NCT01088412|474266027|FG002|Overall Study|Death|0|||
131723167|NCT01088412|474266025|FG000|Overall Study|Other Reason per Case Report Form|2089|||
131723168|NCT01088412|474266026|FG001|Overall Study|Other Reason per Case Report Form|103|||
131723169|NCT01088412|474266027|FG002|Overall Study|Other Reason per Case Report Form|9|||
131723170|NCT01088412|474266025|FG000|Overall Study|Withdrawal by Subject|1761|||
131723171|NCT01088412|474266026|FG001|Overall Study|Withdrawal by Subject|25|||
131723172|NCT01088412|474266027|FG002|Overall Study|Withdrawal by Subject|1|||
131723173|NCT01088412|474266025|FG000|Overall Study|Received Another GH Product|79|||
131723174|NCT01088412|474266026|FG001|Overall Study|Received Another GH Product|0|||
131723175|NCT01088412|474266027|FG002|Overall Study|Received Another GH Product|0|||
131723176|NCT01088412|474266025|FG000|Overall Study|Participant Moved|601|||
131723177|NCT01088412|474266026|FG001|Overall Study|Participant Moved|21|||
131723178|NCT01088412|474266027|FG002|Overall Study|Participant Moved|2|||
131723179|NCT01088412|474266025|FG000|Overall Study|Physician Decision|1041|||
131723180|NCT01088412|474266026|FG001|Overall Study|Physician Decision|8|||
131723181|NCT01088412|474266027|FG002|Overall Study|Physician Decision|4|||
131723182|NCT01088412|474266025|FG000|Overall Study|Sponsor Decision|4467|||
131723183|NCT01088412|474266026|FG001|Overall Study|Sponsor Decision|79|||
131723184|NCT01088412|474266027|FG002|Overall Study|Sponsor Decision|23|||
131723185|NCT01088412|474266025|FG000|Overall Study|Third Party Required to Change Brand|487|||
131723186|NCT01088412|474266026|FG001|Overall Study|Third Party Required to Change Brand|0|||
131804963|NCT01666730|474570572|FG000|Overall Study|Physician Decision|5|||
131723187|NCT01088412|474266027|FG002|Overall Study|Third Party Required to Change Brand|0|||
131723188|NCT01088412|474266025|FG000|Overall Study|Lost to Follow-up|3052|||
131723189|NCT01088412|474266026|FG001|Overall Study|Lost to Follow-up|130|||
131723190|NCT01088412|474266027|FG002|Overall Study|Lost to Follow-up|11|||
131723191|NCT01088412|474266025|FG000|Overall Study|Study Summary Not Completed|4360|||
131723192|NCT01088412|474266026|FG001|Overall Study|Study Summary Not Completed|64|||
131723193|NCT01088412|474266027|FG002|Overall Study|Study Summary Not Completed|22|||
131723194|NCT02285010|474266028|FG000|Overall Study|not abdominal hysterectomy|2|||
131723195|NCT02285010|474266029|FG001|Overall Study|not abdominal hysterectomy|0|||
131723196|NCT02285010|474266028|FG000|Overall Study|Not spinal anesthesia|3|||
131723197|NCT02285010|474266029|FG001|Overall Study|Not spinal anesthesia|1|||
131723198|NCT00301067|474266032|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
131723199|NCT00301067|474266033|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
131723200|NCT00301067|474266034|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
131723201|NCT00301067|474266035|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
131723202|NCT00301067|474266032|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
131723203|NCT00301067|474266033|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
131723204|NCT00301067|474266034|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
131723205|NCT00301067|474266035|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
131723206|NCT00301067|474266032|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
131723207|NCT00301067|474266033|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
131723208|NCT00301067|474266034|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
131723209|NCT00301067|474266035|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
131723210|NCT00301067|474266032|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
131723211|NCT00301067|474266033|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
131723212|NCT00301067|474266034|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
131723213|NCT00301067|474266035|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
131723214|NCT00301067|474266032|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
131723215|NCT00301067|474266033|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
131723216|NCT00301067|474266034|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
131723217|NCT00301067|474266035|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
131723218|NCT00301067|474266032|FG000|Follow up Until Death|Alive at last data cut point|1|||
131723219|NCT00301067|474266033|FG001|Follow up Until Death|Alive at last data cut point|0|||
131723220|NCT00301067|474266034|FG002|Follow up Until Death|Alive at last data cut point|0|||
131723221|NCT00301067|474266035|FG003|Follow up Until Death|Alive at last data cut point|1|||
131723222|NCT01208181|474266037|FG000|Part 1|Withdrawal by Subject|11|||
131723223|NCT01208181|474266038|FG001|Part 1|Withdrawal by Subject|10|||
131723224|NCT01208181|474266039|FG002|Part 1|Withdrawal by Subject|0|||
131723225|NCT01208181|474266040|FG003|Part 1|Withdrawal by Subject|0|||
131723226|NCT01208181|474266041|FG004|Part 1|Withdrawal by Subject|0|||
131723227|NCT01208181|474266037|FG000|Part 1|Technical problem|5|||
131723228|NCT01208181|474266038|FG001|Part 1|Technical problem|0|||
131723229|NCT01208181|474266039|FG002|Part 1|Technical problem|0|||
131723230|NCT01208181|474266040|FG003|Part 1|Technical problem|0|||
131723231|NCT01208181|474266041|FG004|Part 1|Technical problem|0|||
131723232|NCT01208181|474266037|FG000|Part 1|Protocol Violation|10|||
131723233|NCT01208181|474266038|FG001|Part 1|Protocol Violation|5|||
131723234|NCT01208181|474266039|FG002|Part 1|Protocol Violation|0|||
131723235|NCT01208181|474266040|FG003|Part 1|Protocol Violation|0|||
131723236|NCT01208181|474266041|FG004|Part 1|Protocol Violation|0|||
131723237|NCT01208181|474266037|FG000|Part 1|Physician Decision|4|||
131723238|NCT01208181|474266038|FG001|Part 1|Physician Decision|0|||
131723239|NCT01208181|474266039|FG002|Part 1|Physician Decision|0|||
131723240|NCT01208181|474266040|FG003|Part 1|Physician Decision|0|||
131723241|NCT01208181|474266041|FG004|Part 1|Physician Decision|0|||
131723242|NCT01208181|474266037|FG000|Part 1|Non-compliance with study drug|1|||
131723243|NCT01208181|474266038|FG001|Part 1|Non-compliance with study drug|1|||
131723244|NCT01208181|474266039|FG002|Part 1|Non-compliance with study drug|0|||
131723245|NCT01208181|474266040|FG003|Part 1|Non-compliance with study drug|0|||
131723246|NCT01208181|474266041|FG004|Part 1|Non-compliance with study drug|0|||
131723247|NCT01208181|474266037|FG000|Part 1|Lost to Follow-up|5|||
131723248|NCT01208181|474266038|FG001|Part 1|Lost to Follow-up|3|||
131723249|NCT01208181|474266039|FG002|Part 1|Lost to Follow-up|0|||
131723250|NCT01208181|474266040|FG003|Part 1|Lost to Follow-up|0|||
131723251|NCT01208181|474266041|FG004|Part 1|Lost to Follow-up|1|||
131723252|NCT01208181|474266037|FG000|Part 1|Lack of Efficacy|37|||
131723253|NCT01208181|474266038|FG001|Part 1|Lack of Efficacy|12|||
131723254|NCT01208181|474266039|FG002|Part 1|Lack of Efficacy|0|||
131723255|NCT01208181|474266040|FG003|Part 1|Lack of Efficacy|0|||
131723256|NCT01208181|474266041|FG004|Part 1|Lack of Efficacy|17|||
131723257|NCT01208181|474266037|FG000|Part 1|Adverse Event|26|||
131723258|NCT01208181|474266038|FG001|Part 1|Adverse Event|24|||
131723259|NCT01208181|474266039|FG002|Part 1|Adverse Event|0|||
131723260|NCT01208181|474266040|FG003|Part 1|Adverse Event|0|||
131723261|NCT01208181|474266041|FG004|Part 1|Adverse Event|4|||
131723262|NCT01208181|474266037|FG000|Part 2|Adverse Event|0|||
131723263|NCT01208181|474266038|FG001|Part 2|Adverse Event|0|||
131723264|NCT01208181|474266039|FG002|Part 2|Adverse Event|6|||
131723265|NCT01208181|474266040|FG003|Part 2|Adverse Event|7|||
131723266|NCT01208181|474266041|FG004|Part 2|Adverse Event|0|||
131723267|NCT01208181|474266037|FG000|Part 2|Withdrawal by Subject|0|||
131723268|NCT01208181|474266038|FG001|Part 2|Withdrawal by Subject|0|||
131723269|NCT01208181|474266039|FG002|Part 2|Withdrawal by Subject|1|||
131723270|NCT01208181|474266040|FG003|Part 2|Withdrawal by Subject|1|||
131723271|NCT01208181|474266041|FG004|Part 2|Withdrawal by Subject|0|||
131723272|NCT01208181|474266037|FG000|Part 2|Protocol Violation|0|||
131723273|NCT01208181|474266038|FG001|Part 2|Protocol Violation|0|||
131723274|NCT01208181|474266039|FG002|Part 2|Protocol Violation|1|||
131723275|NCT01208181|474266040|FG003|Part 2|Protocol Violation|0|||
131723276|NCT01208181|474266041|FG004|Part 2|Protocol Violation|0|||
131723277|NCT01208181|474266037|FG000|Part 2|Physician Decision|0|||
131723278|NCT01208181|474266038|FG001|Part 2|Physician Decision|0|||
131723279|NCT01208181|474266039|FG002|Part 2|Physician Decision|1|||
131723280|NCT01208181|474266040|FG003|Part 2|Physician Decision|2|||
131723281|NCT01208181|474266041|FG004|Part 2|Physician Decision|0|||
131723282|NCT01208181|474266037|FG000|Part 2|Non-compliance with study drug|0|||
131723283|NCT01208181|474266038|FG001|Part 2|Non-compliance with study drug|0|||
131723284|NCT01208181|474266039|FG002|Part 2|Non-compliance with study drug|1|||
131723285|NCT01208181|474266040|FG003|Part 2|Non-compliance with study drug|1|||
131723286|NCT01208181|474266041|FG004|Part 2|Non-compliance with study drug|0|||
131723287|NCT01208181|474266037|FG000|Part 2|Lost to Follow-up|0|||
131723288|NCT01208181|474266038|FG001|Part 2|Lost to Follow-up|0|||
131723289|NCT01208181|474266039|FG002|Part 2|Lost to Follow-up|1|||
131723290|NCT01208181|474266040|FG003|Part 2|Lost to Follow-up|2|||
131723291|NCT01208181|474266041|FG004|Part 2|Lost to Follow-up|0|||
131723292|NCT01208181|474266037|FG000|Part 2|Lack of Efficacy|0|||
131723293|NCT01208181|474266038|FG001|Part 2|Lack of Efficacy|0|||
131723294|NCT01208181|474266039|FG002|Part 2|Lack of Efficacy|5|||
131723295|NCT01208181|474266040|FG003|Part 2|Lack of Efficacy|7|||
131723296|NCT01208181|474266041|FG004|Part 2|Lack of Efficacy|0|||
131723297|NCT01457339|474266042|FG000|Period 3 (100 mg)|Adverse Event|0|||
131723298|NCT01457339|474266043|FG001|Period 3 (100 mg)|Adverse Event|1|||
131723299|NCT01457339|474266042|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
131723300|NCT01457339|474266043|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
131723301|NCT01457339|474266042|FG000|Period 6 (250 mg)|Family Emergency|1|||
131723302|NCT01457339|474266043|FG001|Period 6 (250 mg)|Family Emergency|0|||
131723303|NCT01457339|474266042|FG000|Period 6 (250 mg)|Personal appointment|0|||
131723304|NCT01457339|474266043|FG001|Period 6 (250 mg)|Personal appointment|1|||
131723305|NCT01478347|474266044|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
131723306|NCT01478347|474266044|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
131723307|NCT01478347|474266044|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
131723308|NCT00196937|474266045|FG000|Overall Study|Serious Adverse Event|1|||
131723309|NCT00196937|474266046|FG001|Overall Study|Serious Adverse Event|0|||
131723310|NCT00196937|474266047|FG002|Overall Study|Serious Adverse Event|0|||
131723311|NCT00196937|474266045|FG000|Overall Study|Non-serious adverse event|1|||
131723312|NCT00196937|474266046|FG001|Overall Study|Non-serious adverse event|1|||
131723313|NCT00196937|474266047|FG002|Overall Study|Non-serious adverse event|1|||
131723314|NCT00196937|474266045|FG000|Overall Study|Withdrawal by Subject|0|||
131723315|NCT00196937|474266046|FG001|Overall Study|Withdrawal by Subject|0|||
131723316|NCT00196937|474266047|FG002|Overall Study|Withdrawal by Subject|2|||
131723317|NCT00196937|474266045|FG000|Overall Study|Lost to Follow-up|4|||
131723318|NCT00196937|474266046|FG001|Overall Study|Lost to Follow-up|3|||
131723319|NCT00196937|474266047|FG002|Overall Study|Lost to Follow-up|3|||
131723320|NCT00196937|474266045|FG000|Overall Study|Other|3|||
131723321|NCT00196937|474266046|FG001|Overall Study|Other|1|||
131723322|NCT00196937|474266047|FG002|Overall Study|Other|1|||
131723323|NCT01751646|474266050|FG000|Overall Study|Lost to Follow-up|5|||
131723324|NCT01751646|474266051|FG001|Overall Study|Lost to Follow-up|1|||
131723325|NCT01751646|474266050|FG000|Overall Study|Withdrawal by Subject|0|||
131723326|NCT01751646|474266051|FG001|Overall Study|Withdrawal by Subject|4|||
131723327|NCT01751646|474266050|FG000|Overall Study|Starting hormone therapy|1|||
131723328|NCT01751646|474266051|FG001|Overall Study|Starting hormone therapy|0|||
131723329|NCT01751646|474266050|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
131723330|NCT01751646|474266051|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
131723331|NCT01751646|474266050|FG000|Overall Study|Inadvertent enrollment|1|||
131723332|NCT01751646|474266051|FG001|Overall Study|Inadvertent enrollment|1|||
131723333|NCT01751646|474266050|FG000|Overall Study|Moved out of the area|1|||
131723334|NCT01751646|474266051|FG001|Overall Study|Moved out of the area|5|||
131723335|NCT01751646|474266050|FG000|Overall Study|Inability to attend required visits|0|||
131723336|NCT01751646|474266051|FG001|Overall Study|Inability to attend required visits|1|||
131723337|NCT01751646|474266050|FG000|Overall Study|Off study due to multiple obligations|0|||
131723338|NCT01751646|474266051|FG001|Overall Study|Off study due to multiple obligations|1|||
131723339|NCT01751646|474266050|FG000|Overall Study|Fails to comply with study requirements|0|||
131723340|NCT01751646|474266051|FG001|Overall Study|Fails to comply with study requirements|1|||
131723341|NCT01751646|474266050|FG000|Overall Study|Childcare issues|1|||
131723342|NCT01751646|474266051|FG001|Overall Study|Childcare issues|1|||
131723343|NCT02335450|474266052|FG000|Overall Study|Pregnancy|1|||
131723344|NCT02973815|474266053|FG000|Post Intervention|Death|1|||
131723345|NCT02973815|474266054|FG001|Post Intervention|Death|0|||
131723346|NCT02973815|474266053|FG000|Post Intervention|Lost to Follow-up|7|||
131723347|NCT02973815|474266054|FG001|Post Intervention|Lost to Follow-up|24|||
131723348|NCT02973815|474266053|FG000|Follow-up|Lost to Follow-up|2|||
131723349|NCT02973815|474266054|FG001|Follow-up|Lost to Follow-up|0|||
131723350|NCT02613572|474266055|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
131723351|NCT02613572|474266056|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
131723352|NCT02613572|474266057|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
131723353|NCT02613572|474266055|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
131723354|NCT02613572|474266056|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
131723355|NCT02613572|474266057|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
131723356|NCT01056523|474266062|FG000|Overall Study|Death|1|||
131723357|NCT01056523|474266063|FG001|Overall Study|Death|0|||
131723358|NCT01056523|474266064|FG002|Overall Study|Death|2|||
131723359|NCT01056523|474266065|FG003|Overall Study|Death|3|||
131723360|NCT01056523|474266066|FG004|Overall Study|Death|0|||
131723361|NCT01056523|474266067|FG005|Overall Study|Death|0|||
131723362|NCT01056523|474266068|FG006|Overall Study|Death|1|||
131723363|NCT03429556|474266069|FG000|Overall Study|Lost to Follow-up|0|||
131723364|NCT03429556|474266070|FG001|Overall Study|Lost to Follow-up|1|||
131723365|NCT03429556|474266071|FG002|Overall Study|Lost to Follow-up|0|||
131723366|NCT03429556|474266072|FG003|Overall Study|Lost to Follow-up|0|||
131723367|NCT01863758|474266077|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
131723368|NCT01863758|474266077|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
131723369|NCT02369510|474266078|FG000|Overall Study|Spilled Medication|1|||
131723370|NCT02369510|474266079|FG001|Overall Study|Spilled Medication|2|||
131723371|NCT02369510|474266080|FG002|Overall Study|Spilled Medication|1|||
131723372|NCT02369510|474266078|FG000|Overall Study|Epidural Activation|1|||
131723373|NCT02369510|474266079|FG001|Overall Study|Epidural Activation|1|||
131723374|NCT02369510|474266080|FG002|Overall Study|Epidural Activation|5|||
131723375|NCT04952389|474266086|FG000|Overall Study|Withdrawal by Subject|8|||
131723376|NCT04952389|474266087|FG001|Overall Study|Withdrawal by Subject|4|||
131723377|NCT02050048|474266088|FG000|Overall Study|Lost to Follow-up|0|||
131723378|NCT02050048|474266089|FG001|Overall Study|Lost to Follow-up|1|||
131723379|NCT02050048|474266088|FG000|Overall Study|Death|1|||
131723380|NCT02050048|474266089|FG001|Overall Study|Death|0|||
131723381|NCT02050048|474266088|FG000|Overall Study|Ineligible after ERCP|4|||
131723382|NCT02050048|474266089|FG001|Overall Study|Ineligible after ERCP|1|||
131723383|NCT04285723|474266095|FG000|Overall Study|Subject decision|1|||
131723384|NCT04285723|474266096|FG001|Overall Study|Subject decision|2|||
131723385|NCT04285723|474266095|FG000|Overall Study|Physician Decision|1|||
131723386|NCT04285723|474266096|FG001|Overall Study|Physician Decision|0|||
131723387|NCT04285723|474266095|FG000|Overall Study|No efficiency|1|||
131723388|NCT04285723|474266096|FG001|Overall Study|No efficiency|0|||
131723389|NCT01507246|474266097|FG000|Overall Study|Required different surgical procedures|2|||
131723390|NCT01507246|474266098|FG001|Overall Study|Required different surgical procedures|1|||
131723391|NCT00969618|474266101|FG000|Overall Study|Adverse Event|29|||
131723392|NCT00969618|474266101|FG000|Overall Study|Entry Criteria Not Met|3|||
131723393|NCT00969618|474266101|FG000|Overall Study|Lack of Efficacy|2|||
131723394|NCT00969618|474266101|FG000|Overall Study|Lost to Follow-up|7|||
131723395|NCT00969618|474266101|FG000|Overall Study|Physician Decision|1|||
131723396|NCT00969618|474266101|FG000|Overall Study|Protocol Violation|9|||
131723397|NCT00969618|474266101|FG000|Overall Study|Withdrawal by Subject|27|||
131723398|NCT03270085|474267985|FG000|Overall Study|Withdrawal by Subject|1|||
131723399|NCT03270085|474267986|FG001|Overall Study|Withdrawal by Subject|0|||
131723400|NCT02400346|474267987|FG000|Overall Study|Adverse Event|24|||
131723401|NCT02400346|474267987|FG000|Overall Study|Lack of Efficacy|9|||
131723402|NCT02400346|474267987|FG000|Overall Study|Non-compliance with IMP|1|||
131804964|NCT01666730|474570572|FG000|Overall Study|Withdrawal by Subject|9|||
131804965|NCT01666730|474570572|FG000|Overall Study|Disease progression/relapse|18|||
131804966|NCT04466111|474570573|FG000|Prior to Trial Phase|Physician Decision|1|||
131804967|NCT02087904|474570576|FG000|Overall Study|Did Not Receive Study Drug|0|||
131804968|NCT02087904|474570577|FG001|Overall Study|Did Not Receive Study Drug|0|||
131804969|NCT02087904|474570578|FG002|Overall Study|Did Not Receive Study Drug|2|||
131496712|NCT02289690|473446360|FG001|Overall Study|Death|0|||
131723403|NCT02400346|474267987|FG000|Overall Study|Withdrawal by Subject|7|||
131723404|NCT02400346|474267987|FG000|Overall Study|Administrative or other reason(s)|2|||
131723405|NCT02400346|474267987|FG000|Overall Study|Lost to Follow-up|1|||
131723406|NCT00283712|474267994|FG000|Overall Study|Death|0|||
131723407|NCT00283712|474267995|FG001|Overall Study|Death|1|||
131723408|NCT00098345|474267997|FG000|Overall Study|Adverse Event|7|||
131723409|NCT00098345|474267997|FG000|Overall Study|Withdrawal by Subject|2|||
131723410|NCT00098345|474267997|FG000|Overall Study|progression|4|||
131723411|NCT02564120|474268000|FG000|Overall Study|Did not return release forms|160|||
131723412|NCT02564120|474268000|FG000|Overall Study|Death|58|||
131723413|NCT02564120|474268000|FG000|Overall Study|Withdrawal by Subject|204|||
131723414|NCT02564120|474268000|FG000|Overall Study|Other medical condition|24|||
131723415|NCT01966731|474268003|FG000|Overall Study|Death|2|||
131723416|NCT01966731|474268003|FG000|Overall Study|Lost to Follow-up|1|||
131723417|NCT01966731|474268003|FG000|Overall Study|Physician Decision|2|||
131723418|NCT01966731|474268003|FG000|Overall Study|Follow up is not complete|600|||
131723419|NCT01966731|474268003|FG000|Overall Study|Screening Failure|29|||
131723420|NCT01966731|474268003|FG000|Overall Study|Found to be ineligible|1|||
131723421|NCT01380093|474268005|FG000|Naloxone Challenge Phase|Screen failures|21|||
131723422|NCT01380093|474268006|FG001|Naloxone Challenge Phase|Screen failures|0|||
131723423|NCT01380093|474268007|FG002|Naloxone Challenge Phase|Screen failures|0|||
131723424|NCT01380093|474268008|FG003|Naloxone Challenge Phase|Screen failures|0|||
131723425|NCT01380093|474268009|FG004|Naloxone Challenge Phase|Screen failures|0|||
131723426|NCT01380093|474268010|FG005|Naloxone Challenge Phase|Screen failures|0|||
131723427|NCT01380093|474268011|FG006|Naloxone Challenge Phase|Screen failures|0|||
131723428|NCT01380093|474268012|FG007|Naloxone Challenge Phase|Screen failures|0|||
131723429|NCT01380093|474268013|FG008|Naloxone Challenge Phase|Screen failures|0|||
131723430|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723431|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
131723432|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723433|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723434|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723435|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723436|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723437|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723438|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131723439|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723440|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
131723441|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
131723442|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723443|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723444|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723445|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723446|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723447|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131723448|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723449|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
131723450|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723451|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723452|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723453|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723454|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723455|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723456|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131723457|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131723458|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
131723459|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
131723460|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131723461|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131723462|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131723463|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131723464|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131723465|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131804970|NCT02087904|474570579|FG003|Overall Study|Did Not Receive Study Drug|1|||
131723466|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723467|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
131723468|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
131723469|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723470|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723471|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723472|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723473|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723474|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131723475|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723476|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723477|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
131723478|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723479|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723480|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723481|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723482|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723483|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
131723484|NCT01380093|474268005|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723485|NCT01380093|474268006|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723486|NCT01380093|474268007|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
131723487|NCT01380093|474268008|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723488|NCT01380093|474268009|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723489|NCT01380093|474268010|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723490|NCT01380093|474268011|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723491|NCT01380093|474268012|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723492|NCT01380093|474268013|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131723493|NCT01380093|474268005|FG000|Treatment Phase: Second Intervention|Other|0|||
131723494|NCT01380093|474268006|FG001|Treatment Phase: Second Intervention|Other|0|||
131723495|NCT01380093|474268007|FG002|Treatment Phase: Second Intervention|Other|0|||
131723496|NCT01380093|474268008|FG003|Treatment Phase: Second Intervention|Other|1|||
131723497|NCT01380093|474268009|FG004|Treatment Phase: Second Intervention|Other|0|||
131723498|NCT01380093|474268010|FG005|Treatment Phase: Second Intervention|Other|0|||
131723499|NCT01380093|474268011|FG006|Treatment Phase: Second Intervention|Other|0|||
131723500|NCT01380093|474268012|FG007|Treatment Phase: Second Intervention|Other|0|||
131723501|NCT01380093|474268013|FG008|Treatment Phase: Second Intervention|Other|0|||
131723502|NCT01380093|474268005|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
131723503|NCT01380093|474268006|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
131723504|NCT01380093|474268007|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
131723505|NCT01380093|474268008|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
131723506|NCT01380093|474268009|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
131723507|NCT01380093|474268010|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
131904912|NCT02718911|474938987|FG004|Overall Study|Physician Decision|0|||
131904913|NCT02718911|474938988|FG005|Overall Study|Physician Decision|0|||
131904914|NCT02718911|474938989|FG006|Overall Study|Physician Decision|0|||
131723508|NCT01380093|474268011|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
131723509|NCT01380093|474268012|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
131723510|NCT01380093|474268013|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
131723511|NCT01380093|474268005|FG000|Treatment Phase: Third Intervention|Other|0|||
131723512|NCT01380093|474268006|FG001|Treatment Phase: Third Intervention|Other|0|||
131723513|NCT01380093|474268007|FG002|Treatment Phase: Third Intervention|Other|0|||
131723514|NCT01380093|474268008|FG003|Treatment Phase: Third Intervention|Other|0|||
131723515|NCT01380093|474268009|FG004|Treatment Phase: Third Intervention|Other|0|||
131723516|NCT01380093|474268010|FG005|Treatment Phase: Third Intervention|Other|0|||
131723517|NCT01380093|474268011|FG006|Treatment Phase: Third Intervention|Other|0|||
131723518|NCT01380093|474268012|FG007|Treatment Phase: Third Intervention|Other|0|||
131723519|NCT01380093|474268013|FG008|Treatment Phase: Third Intervention|Other|1|||
131723520|NCT04734873|474268014|FG000|Overall Study|Lost to Follow-up|1|||
131723521|NCT04734873|474268015|FG001|Overall Study|Lost to Follow-up|3|||
131723522|NCT04734873|474268016|FG002|Overall Study|Lost to Follow-up|2|||
131723523|NCT04734873|474268014|FG000|Overall Study|Randomized but not dosed|1|||
131723524|NCT04734873|474268015|FG001|Overall Study|Randomized but not dosed|0|||
131723525|NCT04734873|474268016|FG002|Overall Study|Randomized but not dosed|1|||
131723526|NCT00201201|474268017|FG000|Overall Study|Death|0|||
131723527|NCT00201201|474268018|FG001|Overall Study|Death|2|||
131723528|NCT00201201|474268017|FG000|Overall Study|Withdrawal by Subject|5|||
131723529|NCT00201201|474268018|FG001|Overall Study|Withdrawal by Subject|5|||
131723530|NCT01342640|474268020|FG000|Overall Study|Adverse Event|3|||
131904915|NCT02718911|474938990|FG007|Overall Study|Physician Decision|1|||
131723531|NCT01342640|474268020|FG000|Overall Study|Protocol Violation|16|||
131723532|NCT01342640|474268020|FG000|Overall Study|Lost to Follow-up|21|||
131723533|NCT01342640|474268020|FG000|Overall Study|Other|1|||
131723534|NCT04101422|474268022|FG000|Overall Study|Ineligible|1|||
131723535|NCT04101422|474268023|FG001|Overall Study|Ineligible|0|||
131723536|NCT04101422|474268024|FG002|Overall Study|Ineligible|9|||
131723537|NCT04101422|474268025|FG003|Overall Study|Ineligible|0|||
131723538|NCT04101422|474268022|FG000|Overall Study|Withdrawal by Subject|0|||
131723539|NCT04101422|474268023|FG001|Overall Study|Withdrawal by Subject|0|||
131723540|NCT04101422|474268024|FG002|Overall Study|Withdrawal by Subject|1|||
131723541|NCT04101422|474268025|FG003|Overall Study|Withdrawal by Subject|0|||
131723542|NCT04101422|474268022|FG000|Overall Study|Not attending to the stimuli|0|||
131723543|NCT04101422|474268023|FG001|Overall Study|Not attending to the stimuli|0|||
131723544|NCT04101422|474268024|FG002|Overall Study|Not attending to the stimuli|4|||
131723545|NCT04101422|474268025|FG003|Overall Study|Not attending to the stimuli|0|||
131723546|NCT04101422|474268022|FG000|Overall Study|Did not download app|0|||
131723547|NCT04101422|474268023|FG001|Overall Study|Did not download app|0|||
131723548|NCT04101422|474268024|FG002|Overall Study|Did not download app|0|||
131723549|NCT04101422|474268025|FG003|Overall Study|Did not download app|17|||
131804971|NCT02087904|474570576|FG000|Overall Study|Adverse Event|8|||
131723550|NCT04101422|474268022|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
131723551|NCT04101422|474268023|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
131804972|NCT02087904|474570577|FG001|Overall Study|Adverse Event|4|||
131804973|NCT02087904|474570578|FG002|Overall Study|Adverse Event|4|||
131804974|NCT02087904|474570579|FG003|Overall Study|Adverse Event|12|||
131804975|NCT02087904|474570576|FG000|Overall Study|Lack of Efficacy|3|||
131804976|NCT02087904|474570577|FG001|Overall Study|Lack of Efficacy|6|||
131804977|NCT02087904|474570578|FG002|Overall Study|Lack of Efficacy|3|||
131804978|NCT02087904|474570579|FG003|Overall Study|Lack of Efficacy|2|||
131804979|NCT02087904|474570576|FG000|Overall Study|Other|6|||
131804980|NCT02087904|474570577|FG001|Overall Study|Other|2|||
131804981|NCT02087904|474570578|FG002|Overall Study|Other|4|||
131804982|NCT02087904|474570579|FG003|Overall Study|Other|4|||
131804983|NCT02087904|474570576|FG000|Overall Study|Withdrawal by Subject|8|||
131804984|NCT02087904|474570577|FG001|Overall Study|Withdrawal by Subject|3|||
131804985|NCT02087904|474570578|FG002|Overall Study|Withdrawal by Subject|7|||
131804986|NCT02087904|474570579|FG003|Overall Study|Withdrawal by Subject|4|||
131804987|NCT02087904|474570576|FG000|Overall Study|Lost to Follow-up|0|||
131804988|NCT02087904|474570577|FG001|Overall Study|Lost to Follow-up|4|||
131804989|NCT02087904|474570578|FG002|Overall Study|Lost to Follow-up|2|||
131804990|NCT02087904|474570579|FG003|Overall Study|Lost to Follow-up|2|||
131804991|NCT00050778|474570581|FG000|Overall Study|Adverse Event|13|||
131804992|NCT00050778|474570582|FG001|Overall Study|Adverse Event|3|||
131804993|NCT00050778|474570583|FG002|Overall Study|Adverse Event|2|||
131804994|NCT00050778|474570581|FG000|Overall Study|Death|0|||
131723552|NCT04101422|474268024|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
131723553|NCT04101422|474268025|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
131723554|NCT00718861|474268026|FG000|Overall Study|Withdrawal by Subject|15|||
131723555|NCT00718861|474268027|FG001|Overall Study|Withdrawal by Subject|10|||
131804995|NCT00050778|474570582|FG001|Overall Study|Death|1|||
131723556|NCT00718861|474268026|FG000|Overall Study|Adverse Event|2|||
131723557|NCT00718861|474268027|FG001|Overall Study|Adverse Event|1|||
131723558|NCT00718861|474268026|FG000|Overall Study|Lost to Follow-up|2|||
131723559|NCT00718861|474268027|FG001|Overall Study|Lost to Follow-up|1|||
131723560|NCT00718861|474268026|FG000|Overall Study|Administrative Problems|1|||
131723561|NCT00718861|474268027|FG001|Overall Study|Administrative Problems|1|||
131723562|NCT00718861|474268026|FG000|Overall Study|Death|1|||
131723563|NCT00718861|474268027|FG001|Overall Study|Death|5|||
131804996|NCT00050778|474570583|FG002|Overall Study|Death|1|||
131804997|NCT00050778|474570581|FG000|Overall Study|Lack of Efficacy|16|||
131804998|NCT00050778|474570582|FG001|Overall Study|Lack of Efficacy|2|||
131804999|NCT00050778|474570583|FG002|Overall Study|Lack of Efficacy|2|||
131723564|NCT04983901|474268029|FG000|Overall Study|Death|1|||
131723565|NCT04983901|474268030|FG001|Overall Study|Death|4|||
131723566|NCT04983901|474268029|FG000|Overall Study|Lost to Follow-up|3|||
131723567|NCT04983901|474268030|FG001|Overall Study|Lost to Follow-up|0|||
131723568|NCT04983901|474268029|FG000|Overall Study|Protocol Violation|1|||
131723569|NCT04983901|474268030|FG001|Overall Study|Protocol Violation|0|||
131723570|NCT04983901|474268029|FG000|Overall Study|Withdrawal by Subject|1|||
131723571|NCT04983901|474268030|FG001|Overall Study|Withdrawal by Subject|2|||
131723572|NCT03671369|474268035|FG000|Overall Study|Other|1|||
131723573|NCT03671369|474268035|FG000|Overall Study|Withdrawal by Subject|289|||
131723574|NCT03671369|474268035|FG000|Overall Study|Not willing to be vaccinated|1|||
131723575|NCT04382651|474268036|FG000|Overall Study|Death|26|||
131723576|NCT04382651|474268037|FG001|Overall Study|Death|23|||
131723577|NCT04382651|474268036|FG000|Overall Study|Lost to Follow-up|3|||
131723578|NCT04382651|474268037|FG001|Overall Study|Lost to Follow-up|4|||
131723579|NCT04382651|474268036|FG000|Overall Study|Withdrawal by Subject|2|||
131723580|NCT04382651|474268037|FG001|Overall Study|Withdrawal by Subject|0|||
131723581|NCT04382651|474268036|FG000|Overall Study|Physician Decision|0|||
131723582|NCT04382651|474268037|FG001|Overall Study|Physician Decision|1|||
131723583|NCT02732912|474268038|FG000|Overall Study|Discharged before night|2|||
131723584|NCT02732912|474268039|FG001|Overall Study|Discharged before night|6|||
131723585|NCT02732912|474268038|FG000|Overall Study|Incomplete completion of questionnaire|2|||
131723586|NCT02732912|474268039|FG001|Overall Study|Incomplete completion of questionnaire|3|||
131723587|NCT02732912|474268038|FG000|Overall Study|No outcome; discharged or refused|6|||
131723588|NCT02732912|474268039|FG001|Overall Study|No outcome; discharged or refused|9|||
131723589|NCT01507545|474268044|FG000|Overall Study|Withdrawal by Subject|6|||
131723590|NCT01507545|474268045|FG001|Overall Study|Withdrawal by Subject|2|||
131723591|NCT01507545|474268044|FG000|Overall Study|Lost to Follow-up|1|||
131723592|NCT01507545|474268045|FG001|Overall Study|Lost to Follow-up|0|||
131723593|NCT01507545|474268044|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
131723594|NCT01507545|474268045|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
131723595|NCT01507545|474268044|FG000|Overall Study|Progressive disease|60|||
131723596|NCT01507545|474268045|FG001|Overall Study|Progressive disease|27|||
131723597|NCT01507545|474268044|FG000|Overall Study|Other|6|||
131723598|NCT01507545|474268045|FG001|Overall Study|Other|4|||
131723599|NCT01671488|474268046|FG000|Overall Study|Withdrawal by Subject|1|||
131723600|NCT01022853|474268047|FG000|Overall Study|Progressive disease|2|||
131723601|NCT01022853|474268048|FG001|Overall Study|Progressive disease|3|||
131723602|NCT01022853|474268049|FG002|Overall Study|Progressive disease|11|||
131723603|NCT01022853|474268050|FG003|Overall Study|Progressive disease|7|||
131723604|NCT01022853|474268051|FG004|Overall Study|Progressive disease|1|||
131723605|NCT01022853|474268047|FG000|Overall Study|Dose-limiting toxicity|0|||
131723606|NCT01022853|474268048|FG001|Overall Study|Dose-limiting toxicity|0|||
131723607|NCT01022853|474268049|FG002|Overall Study|Dose-limiting toxicity|0|||
131723608|NCT01022853|474268050|FG003|Overall Study|Dose-limiting toxicity|0|||
131723609|NCT01022853|474268051|FG004|Overall Study|Dose-limiting toxicity|1|||
131723610|NCT01022853|474268047|FG000|Overall Study|Withdrawal by Subject|0|||
131723611|NCT01022853|474268048|FG001|Overall Study|Withdrawal by Subject|1|||
131723612|NCT01022853|474268049|FG002|Overall Study|Withdrawal by Subject|1|||
131723613|NCT01022853|474268050|FG003|Overall Study|Withdrawal by Subject|1|||
131723614|NCT01022853|474268051|FG004|Overall Study|Withdrawal by Subject|0|||
131723615|NCT01022853|474268047|FG000|Overall Study|Other not stated above|1|||
131723616|NCT01022853|474268048|FG001|Overall Study|Other not stated above|0|||
131805000|NCT00050778|474570581|FG000|Overall Study|Lost to Follow-up|0|||
131723617|NCT01022853|474268049|FG002|Overall Study|Other not stated above|1|||
131723618|NCT01022853|474268050|FG003|Overall Study|Other not stated above|0|||
131723619|NCT01022853|474268051|FG004|Overall Study|Other not stated above|0|||
131723620|NCT01753518|474268052|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
131723621|NCT01753518|474268053|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
131723622|NCT01753518|474268052|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
131723623|NCT01753518|474268053|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
131805001|NCT00050778|474570582|FG001|Overall Study|Lost to Follow-up|2|||
131723624|NCT01753518|474268052|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
131723625|NCT01753518|474268053|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
131723626|NCT01753518|474268052|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
131723627|NCT01753518|474268053|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
131723628|NCT01214434|474268054|FG000|Overall Study|Withdrawal by Subject|1|||
131723629|NCT01214434|474268055|FG001|Overall Study|Withdrawal by Subject|0|||
131723630|NCT01214434|474268054|FG000|Overall Study|Lost to Follow-up|2|||
131723631|NCT01214434|474268055|FG001|Overall Study|Lost to Follow-up|2|||
131723632|NCT01214434|474268054|FG000|Overall Study|Site error|1|||
131723633|NCT01214434|474268055|FG001|Overall Study|Site error|0|||
131723634|NCT00138151|474268056|FG000|Overall Study|Withdrawal by Subject|3|||
131723635|NCT00138151|474268056|FG000|Overall Study|Physician Decision|1|||
131723636|NCT03503773|474268057|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
131723637|NCT03503773|474268058|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
131723638|NCT03503773|474268057|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
131723639|NCT03503773|474268058|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
131723640|NCT03503773|474268057|FG000|Overall Study|Not completing the primary ABPM|3|||
131723641|NCT03503773|474268058|FG001|Overall Study|Not completing the primary ABPM|1|||
131723642|NCT03503773|474268057|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131723643|NCT03503773|474268058|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131723644|NCT02675517|474268064|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
131723645|NCT02675517|474268064|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
131723646|NCT00425438|474268065|FG000|Overall Study|Termination by Sponsor|25|||
131723647|NCT00425438|474268066|FG001|Overall Study|Termination by Sponsor|27|||
131723648|NCT03494725|474268067|FG000|Overall Study|Withdrawal by Subject|0|||
131723649|NCT03494725|474268068|FG001|Overall Study|Withdrawal by Subject|2|||
131723650|NCT03494725|474268067|FG000|Overall Study|Antibiotic use|1|||
131723651|NCT03494725|474268068|FG001|Overall Study|Antibiotic use|0|||
131723652|NCT02619253|474268069|FG000|Overall Study|Adverse Event|0|||
131723653|NCT02619253|474268070|FG001|Overall Study|Adverse Event|0|||
131723654|NCT02619253|474268071|FG002|Overall Study|Adverse Event|1|||
131723655|NCT02619253|474268072|FG003|Overall Study|Adverse Event|1|||
131723656|NCT02619253|474268073|FG004|Overall Study|Adverse Event|3|||
131723657|NCT02619253|474268069|FG000|Overall Study|Alternative Therapy|0|||
131723658|NCT02619253|474268070|FG001|Overall Study|Alternative Therapy|0|||
131723659|NCT02619253|474268071|FG002|Overall Study|Alternative Therapy|1|||
131723660|NCT02619253|474268072|FG003|Overall Study|Alternative Therapy|0|||
131723661|NCT02619253|474268073|FG004|Overall Study|Alternative Therapy|0|||
131723662|NCT02619253|474268069|FG000|Overall Study|Death|0|||
131723663|NCT02619253|474268070|FG001|Overall Study|Death|0|||
131723664|NCT02619253|474268071|FG002|Overall Study|Death|0|||
131723665|NCT02619253|474268072|FG003|Overall Study|Death|1|||
131723666|NCT02619253|474268073|FG004|Overall Study|Death|0|||
131723667|NCT02619253|474268069|FG000|Overall Study|Disease Progression|4|||
131723668|NCT02619253|474268070|FG001|Overall Study|Disease Progression|2|||
131723669|NCT02619253|474268071|FG002|Overall Study|Disease Progression|8|||
131723670|NCT02619253|474268072|FG003|Overall Study|Disease Progression|9|||
131723671|NCT02619253|474268073|FG004|Overall Study|Disease Progression|10|||
131723672|NCT02619253|474268069|FG000|Overall Study|Needed a disqualifying therapy|0|||
131723673|NCT02619253|474268070|FG001|Overall Study|Needed a disqualifying therapy|0|||
131723674|NCT02619253|474268071|FG002|Overall Study|Needed a disqualifying therapy|1|||
131723675|NCT02619253|474268072|FG003|Overall Study|Needed a disqualifying therapy|0|||
131723676|NCT02619253|474268073|FG004|Overall Study|Needed a disqualifying therapy|0|||
131723677|NCT02619253|474268069|FG000|Overall Study|Transferred to hospice|0|||
131723678|NCT02619253|474268070|FG001|Overall Study|Transferred to hospice|0|||
131723679|NCT02619253|474268071|FG002|Overall Study|Transferred to hospice|1|||
131723680|NCT02619253|474268072|FG003|Overall Study|Transferred to hospice|0|||
131723681|NCT02619253|474268073|FG004|Overall Study|Transferred to hospice|0|||
131723682|NCT02619253|474268069|FG000|Overall Study|Physician Decision|0|||
131723683|NCT02619253|474268070|FG001|Overall Study|Physician Decision|1|||
131723684|NCT02619253|474268071|FG002|Overall Study|Physician Decision|2|||
131723685|NCT02619253|474268072|FG003|Overall Study|Physician Decision|3|||
131723686|NCT02619253|474268073|FG004|Overall Study|Physician Decision|0|||
131723687|NCT02619253|474268069|FG000|Overall Study|Withdrawal by Subject|0|||
131723688|NCT02619253|474268070|FG001|Overall Study|Withdrawal by Subject|1|||
131723689|NCT02619253|474268071|FG002|Overall Study|Withdrawal by Subject|0|||
131723690|NCT02619253|474268072|FG003|Overall Study|Withdrawal by Subject|0|||
131723691|NCT02619253|474268073|FG004|Overall Study|Withdrawal by Subject|2|||
131723692|NCT00514449|474268074|FG000|Overall Study|Withdrawal by Subject|1|||
131723693|NCT00514449|474268075|FG001|Overall Study|Withdrawal by Subject|2|||
131723694|NCT00514449|474268074|FG000|Overall Study|Protocol Violation|1|||
131723695|NCT00514449|474268075|FG001|Overall Study|Protocol Violation|2|||
131723696|NCT00514449|474268074|FG000|Overall Study|Lost to Follow-up|1|||
131723697|NCT00514449|474268075|FG001|Overall Study|Lost to Follow-up|0|||
131723698|NCT00149825|474268079|FG000|Overall Study|Intolerance to medication side effects|1|||
131723699|NCT00149825|474268080|FG001|Overall Study|Intolerance to medication side effects|2|||
131723700|NCT00149825|474268079|FG000|Overall Study|Time commitments|2|||
131723701|NCT00149825|474268080|FG001|Overall Study|Time commitments|1|||
131723702|NCT00149825|474268079|FG000|Overall Study|Not liking insomnia therapy|1|||
131723703|NCT00149825|474268080|FG001|Overall Study|Not liking insomnia therapy|0|||
131723704|NCT00149825|474268079|FG000|Overall Study|Other|1|||
131723705|NCT00149825|474268080|FG001|Overall Study|Other|0|||
131723706|NCT01359982|474268081|FG000|Overall Study|Adverse Event|2|||
131723707|NCT01359982|474268082|FG001|Overall Study|Adverse Event|0|||
131723708|NCT01359982|474268083|FG002|Overall Study|Adverse Event|0|||
131723709|NCT01359982|474268084|FG003|Overall Study|Adverse Event|1|||
131723710|NCT01359982|474268085|FG004|Overall Study|Adverse Event|0|||
131723711|NCT01359982|474268086|FG005|Overall Study|Adverse Event|0|||
131723712|NCT01359982|474268081|FG000|Overall Study|Death|1|||
131723713|NCT01359982|474268082|FG001|Overall Study|Death|0|||
131723714|NCT01359982|474268083|FG002|Overall Study|Death|0|||
131723715|NCT01359982|474268084|FG003|Overall Study|Death|0|||
131723716|NCT01359982|474268085|FG004|Overall Study|Death|0|||
131723717|NCT01359982|474268086|FG005|Overall Study|Death|0|||
131723718|NCT00942708|474268087|FG000|Overall Study|Withdrawal by Subject|1|||
131723719|NCT01426386|474268092|FG000|Overall Study|Adverse Event|0|||
131723720|NCT01426386|474268093|FG001|Overall Study|Adverse Event|1|||
131723721|NCT01426386|474268094|FG002|Overall Study|Adverse Event|0|||
131723722|NCT01426386|474268095|FG003|Overall Study|Adverse Event|0|||
131723723|NCT01426386|474268096|FG004|Overall Study|Adverse Event|0|||
131723724|NCT01426386|474268097|FG005|Overall Study|Adverse Event|0|||
131723725|NCT01426386|474268092|FG000|Overall Study|Did not attend scheduled visit|1|||
131723726|NCT01426386|474268093|FG001|Overall Study|Did not attend scheduled visit|4|||
131723727|NCT01426386|474268094|FG002|Overall Study|Did not attend scheduled visit|0|||
131723728|NCT01426386|474268095|FG003|Overall Study|Did not attend scheduled visit|0|||
131723729|NCT01426386|474268096|FG004|Overall Study|Did not attend scheduled visit|2|||
131723730|NCT01426386|474268097|FG005|Overall Study|Did not attend scheduled visit|1|||
131723731|NCT01426386|474268092|FG000|Overall Study|Poor response|2|||
131723732|NCT01426386|474268093|FG001|Overall Study|Poor response|1|||
131723733|NCT01426386|474268094|FG002|Overall Study|Poor response|2|||
131723734|NCT01426386|474268095|FG003|Overall Study|Poor response|0|||
131723735|NCT01426386|474268096|FG004|Overall Study|Poor response|1|||
131723736|NCT01426386|474268097|FG005|Overall Study|Poor response|0|||
131723737|NCT01426386|474268092|FG000|Overall Study|Personal reasons|0|||
131723738|NCT01426386|474268093|FG001|Overall Study|Personal reasons|0|||
131723739|NCT01426386|474268094|FG002|Overall Study|Personal reasons|0|||
131723740|NCT01426386|474268095|FG003|Overall Study|Personal reasons|0|||
131723741|NCT01426386|474268096|FG004|Overall Study|Personal reasons|1|||
131723742|NCT01426386|474268097|FG005|Overall Study|Personal reasons|0|||
131723743|NCT01096667|474268098|FG000|Overall Study|Lost to Follow-up|1|||
131723744|NCT01096667|474268099|FG001|Overall Study|Lost to Follow-up|1|||
131723745|NCT01096667|474268100|FG002|Overall Study|Lost to Follow-up|1|||
131723746|NCT01096667|474268101|FG003|Overall Study|Lost to Follow-up|0|||
131723747|NCT01096667|474268102|FG004|Overall Study|Lost to Follow-up|0|||
131723748|NCT01096667|474268098|FG000|Overall Study|Withdrawal by Subject|1|||
131723749|NCT01096667|474268099|FG001|Overall Study|Withdrawal by Subject|0|||
131723750|NCT01096667|474268100|FG002|Overall Study|Withdrawal by Subject|0|||
131723751|NCT01096667|474268101|FG003|Overall Study|Withdrawal by Subject|1|||
131723752|NCT01096667|474268102|FG004|Overall Study|Withdrawal by Subject|0|||
131723753|NCT01096667|474268098|FG000|Overall Study|Reason not available|0|||
131723754|NCT01096667|474268099|FG001|Overall Study|Reason not available|1|||
131723755|NCT01096667|474268100|FG002|Overall Study|Reason not available|1|||
131723756|NCT01096667|474268101|FG003|Overall Study|Reason not available|1|||
131723757|NCT01096667|474268102|FG004|Overall Study|Reason not available|0|||
131723758|NCT01096667|474268098|FG000|Overall Study|Protocol Violation|0|||
131723759|NCT01096667|474268099|FG001|Overall Study|Protocol Violation|0|||
131723760|NCT01096667|474268100|FG002|Overall Study|Protocol Violation|0|||
131723761|NCT01096667|474268101|FG003|Overall Study|Protocol Violation|1|||
131723762|NCT01096667|474268102|FG004|Overall Study|Protocol Violation|0|||
131723763|NCT01096667|474268098|FG000|Overall Study|Not treated|1|||
131723764|NCT01096667|474268099|FG001|Overall Study|Not treated|0|||
131723765|NCT01096667|474268100|FG002|Overall Study|Not treated|0|||
131723766|NCT01096667|474268101|FG003|Overall Study|Not treated|0|||
131723767|NCT01096667|474268102|FG004|Overall Study|Not treated|0|||
131723768|NCT00306891|474268103|FG000|Part A|Withdrawal by Subject|1|||
131723769|NCT00306891|474268104|FG001|Part A|Withdrawal by Subject|1|||
131723770|NCT00306891|474268105|FG002|Part A|Withdrawal by Subject|0|||
131723771|NCT00306891|474268106|FG003|Part A|Withdrawal by Subject|0|||
131723772|NCT00306891|474268103|FG000|Part A|Condition under investigation worsened|2|||
131723773|NCT00306891|474268104|FG001|Part A|Condition under investigation worsened|2|||
131723774|NCT00306891|474268105|FG002|Part A|Condition under investigation worsened|0|||
131805002|NCT00050778|474570583|FG002|Overall Study|Lost to Follow-up|4|||
131723775|NCT00306891|474268106|FG003|Part A|Condition under investigation worsened|0|||
131723776|NCT00306891|474268103|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
131723777|NCT00306891|474268104|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
131723778|NCT00306891|474268105|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
131723779|NCT00306891|474268106|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
131723780|NCT00306891|474268103|FG000|Part A|Partial bowel obstruction|1|||
131723781|NCT00306891|474268104|FG001|Part A|Partial bowel obstruction|0|||
131723782|NCT00306891|474268105|FG002|Part A|Partial bowel obstruction|0|||
131723783|NCT00306891|474268106|FG003|Part A|Partial bowel obstruction|0|||
131723784|NCT00306891|474268103|FG000|Part A|Reaccumul. of ascites following drainage|0|||
131723785|NCT00306891|474268104|FG001|Part A|Reaccumul. of ascites following drainage|1|||
131723786|NCT00306891|474268105|FG002|Part A|Reaccumul. of ascites following drainage|0|||
131723787|NCT00306891|474268106|FG003|Part A|Reaccumul. of ascites following drainage|0|||
131723788|NCT00306891|474268103|FG000|Part A|Suspicion of second malignancy|0|||
131723789|NCT00306891|474268104|FG001|Part A|Suspicion of second malignancy|1|||
131723790|NCT00306891|474268105|FG002|Part A|Suspicion of second malignancy|0|||
131723791|NCT00306891|474268106|FG003|Part A|Suspicion of second malignancy|0|||
131723792|NCT00306891|474268103|FG000|Part A|QTC interval outwith elig. criteria|1|||
131723793|NCT00306891|474268104|FG001|Part A|QTC interval outwith elig. criteria|0|||
131723794|NCT00306891|474268105|FG002|Part A|QTC interval outwith elig. criteria|0|||
131723795|NCT00306891|474268106|FG003|Part A|QTC interval outwith elig. criteria|0|||
131723796|NCT00306891|474268103|FG000|Part B|Death|0|||
131723797|NCT00306891|474268104|FG001|Part B|Death|0|||
131723798|NCT00306891|474268105|FG002|Part B|Death|1|||
131723799|NCT00306891|474268106|FG003|Part B|Death|2|||
131723800|NCT00306891|474268103|FG000|Part B|Adverse Event|0|||
131723801|NCT00306891|474268104|FG001|Part B|Adverse Event|0|||
131723802|NCT00306891|474268105|FG002|Part B|Adverse Event|5|||
131723803|NCT00306891|474268106|FG003|Part B|Adverse Event|5|||
131723804|NCT00306891|474268103|FG000|Part B|Withdrawal by Subject|0|||
131723805|NCT00306891|474268104|FG001|Part B|Withdrawal by Subject|0|||
131723806|NCT00306891|474268105|FG002|Part B|Withdrawal by Subject|3|||
131723807|NCT00306891|474268106|FG003|Part B|Withdrawal by Subject|1|||
131723808|NCT00306891|474268103|FG000|Part B|Condition under investigation worsened|0|||
131723809|NCT00306891|474268104|FG001|Part B|Condition under investigation worsened|0|||
131723810|NCT00306891|474268105|FG002|Part B|Condition under investigation worsened|2|||
131723811|NCT00306891|474268106|FG003|Part B|Condition under investigation worsened|8|||
131723812|NCT00306891|474268103|FG000|Part B|Development of study specific disc crit.|0|||
131723813|NCT00306891|474268104|FG001|Part B|Development of study specific disc crit.|0|||
131723814|NCT00306891|474268105|FG002|Part B|Development of study specific disc crit.|0|||
131723815|NCT00306891|474268106|FG003|Part B|Development of study specific disc crit.|1|||
131723816|NCT00673673|474268107|FG000|Overall Study|Progressive disease|27|||
131723817|NCT00673673|474268107|FG000|Overall Study|Adverse Event|4|||
131723818|NCT00673673|474268107|FG000|Overall Study|Withdrawal by Subject|3|||
131723819|NCT00673673|474268107|FG000|Overall Study|Investigators' discretion|2|||
131723820|NCT00853905|474268108|FG000|Overall Study|Lost to Follow-up|1|||
131723821|NCT00853905|474268109|FG001|Overall Study|Lost to Follow-up|3|||
131723822|NCT00853905|474268108|FG000|Overall Study|Withdrawal by Subject|0|||
131723823|NCT00853905|474268109|FG001|Overall Study|Withdrawal by Subject|1|||
131723824|NCT00853905|474268108|FG000|Overall Study|never had surgery|1|||
131723825|NCT00853905|474268109|FG001|Overall Study|never had surgery|0|||
131723826|NCT04538950|474268110|FG000|Overall Study|Pulmonary Issues|2|||
131723827|NCT04538950|474268110|FG000|Overall Study|illness|2|||
131723828|NCT00970294|474268113|FG000|Overall Study|Physician Decision|4|||
131723829|NCT00970294|474268113|FG000|Overall Study|Withdrawal by Subject|1|||
131723830|NCT00847561|474268114|FG000|Overall Study|Withdrawal by Subject|4|||
131723831|NCT00847561|474268115|FG001|Overall Study|Withdrawal by Subject|3|||
131723832|NCT00847561|474268114|FG000|Overall Study|Unable to schedule|9|||
131723833|NCT00847561|474268115|FG001|Overall Study|Unable to schedule|1|||
131723834|NCT01333189|474268116|FG000|Overall Study|Time constraints|1|||
131723835|NCT01333189|474268117|FG001|Overall Study|Time constraints|0|||
131723836|NCT01333189|474268116|FG000|Overall Study|Adverse Event|1|||
131723837|NCT01333189|474268117|FG001|Overall Study|Adverse Event|0|||
131723838|NCT01333189|474268116|FG000|Overall Study|Transportation difficulties|0|||
131723839|NCT01333189|474268117|FG001|Overall Study|Transportation difficulties|1|||
131723840|NCT01333189|474268116|FG000|Overall Study|Moved from region|0|||
131723841|NCT01333189|474268117|FG001|Overall Study|Moved from region|1|||
131723842|NCT01787591|474268119|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
131723843|NCT01787591|474268120|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
131723844|NCT01787591|474268121|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
131723845|NCT01787591|474268122|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
131723846|NCT02489630|474268123|FG000|Overall Study|Oversedation|1|||
131723847|NCT02489630|474268124|FG001|Overall Study|Oversedation|1|||
131723848|NCT02489630|474268123|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
131723849|NCT02489630|474268124|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
131723850|NCT01326962|474268126|FG000|Overall Study|Adverse Event|1|||
131723851|NCT01326962|474268126|FG000|Overall Study|Withdrawal by Subject|1|||
131723852|NCT01326962|474268126|FG000|Overall Study|Lost to Follow-up|3|||
131723853|NCT01326962|474268126|FG000|Overall Study|Other|2|||
131723854|NCT04799782|474268128|FG000|Washout|Physician Decision|2|||
131723855|NCT04799782|474268129|FG001|Washout|Physician Decision|0|||
131723856|NCT04799782|474268128|FG000|Washout|Withdrawal by Subject|0|||
131723857|NCT04799782|474268129|FG001|Washout|Withdrawal by Subject|2|||
131723858|NCT04799782|474268128|FG000|Washout|Lost to Follow-up|0|||
131723859|NCT04799782|474268129|FG001|Washout|Lost to Follow-up|1|||
131723860|NCT02606877|474268130|FG000|Overall Study|Adverse Event|3|||
131723861|NCT02606877|474268131|FG001|Overall Study|Adverse Event|0|||
131723862|NCT02606877|474268130|FG000|Overall Study|Non-compliance with protocol|0|||
131723863|NCT02606877|474268131|FG001|Overall Study|Non-compliance with protocol|1|||
131723864|NCT02606877|474268130|FG000|Overall Study|Other than listed above|1|||
131723865|NCT02606877|474268131|FG001|Overall Study|Other than listed above|0|||
131723866|NCT01318902|474268136|FG000|Overall Study|Symptomatic Deterioration|0|||
131723867|NCT01318902|474268137|FG001|Overall Study|Symptomatic Deterioration|1|||
131723868|NCT01318902|474268138|FG002|Overall Study|Symptomatic Deterioration|1|||
131723869|NCT01318902|474268139|FG003|Overall Study|Symptomatic Deterioration|2|||
131723870|NCT01318902|474268136|FG000|Overall Study|Withdrawal by Patient|0|||
131723871|NCT01318902|474268137|FG001|Overall Study|Withdrawal by Patient|1|||
131723872|NCT01318902|474268138|FG002|Overall Study|Withdrawal by Patient|0|||
131723873|NCT01318902|474268139|FG003|Overall Study|Withdrawal by Patient|3|||
131723874|NCT01318902|474268136|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
131723875|NCT01318902|474268137|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
131723876|NCT01318902|474268138|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
131723877|NCT01318902|474268139|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
131723878|NCT01318902|474268136|FG000|Overall Study|Adverse Event|0|||
131723879|NCT01318902|474268137|FG001|Overall Study|Adverse Event|1|||
131723880|NCT01318902|474268138|FG002|Overall Study|Adverse Event|0|||
131723881|NCT01318902|474268139|FG003|Overall Study|Adverse Event|0|||
131723882|NCT01318902|474268136|FG000|Overall Study|Terminated by Sponsor|0|||
131723883|NCT01318902|474268137|FG001|Overall Study|Terminated by Sponsor|0|||
131723884|NCT01318902|474268138|FG002|Overall Study|Terminated by Sponsor|1|||
131723885|NCT01318902|474268139|FG003|Overall Study|Terminated by Sponsor|0|||
131723886|NCT05243550|474269507|FG000|Overall Study|Ongoing in the Study|171|||
131723887|NCT05243550|474269507|FG000|Overall Study|Withdrawal by Subject|10|||
131723888|NCT05243550|474269507|FG000|Overall Study|Lost to Follow-up|7|||
131723889|NCT05243550|474269507|FG000|Overall Study|Adverse Event|3|||
131723890|NCT05243550|474269507|FG000|Overall Study|Noncompliance|1|||
131723891|NCT05243550|474269507|FG000|Overall Study|Physician Decision|1|||
131723892|NCT05243550|474269507|FG000|Overall Study|Other Reason|4|||
131723893|NCT00893113|474269512|FG000|Overall Study|Lost to Follow-up|4|||
131723894|NCT00893113|474269513|FG001|Overall Study|Lost to Follow-up|8|||
131723895|NCT00893113|474269512|FG000|Overall Study|Early Termination|1|||
131723896|NCT00893113|474269513|FG001|Overall Study|Early Termination|1|||
131723897|NCT00893113|474269512|FG000|Overall Study|Withdrew Consent|8|||
131723898|NCT00893113|474269513|FG001|Overall Study|Withdrew Consent|7|||
131723899|NCT00128206|474269520|FG000|Overall Study|Lost to Follow-up|137|||
131723900|NCT00128206|474269521|FG001|Overall Study|Lost to Follow-up|118|||
131723901|NCT00128206|474269520|FG000|Overall Study|Adverse Event|0|||
131723902|NCT00128206|474269521|FG001|Overall Study|Adverse Event|2|||
131723903|NCT03032068|474269522|FG000|Overall Study|Adverse Event|1|||
131805003|NCT00050778|474570581|FG000|Overall Study|Physician Decision|3|||
131805004|NCT00050778|474570582|FG001|Overall Study|Physician Decision|0|||
131805005|NCT00050778|474570583|FG002|Overall Study|Physician Decision|2|||
131805006|NCT00050778|474570581|FG000|Overall Study|Protocol Violation|2|||
131805007|NCT00050778|474570582|FG001|Overall Study|Protocol Violation|0|||
131805008|NCT00050778|474570583|FG002|Overall Study|Protocol Violation|1|||
131805009|NCT00050778|474570581|FG000|Overall Study|Withdrawal by Subject|6|||
131805010|NCT00050778|474570582|FG001|Overall Study|Withdrawal by Subject|8|||
131805011|NCT00050778|474570583|FG002|Overall Study|Withdrawal by Subject|4|||
131805012|NCT00050778|474570581|FG000|Overall Study|Randomized but not treated|4|||
131723904|NCT01269125|474269523|FG000|Overall Study|Adverse Event|3|||
131723905|NCT01269125|474269524|FG001|Overall Study|Adverse Event|5|||
131723906|NCT01269125|474269525|FG002|Overall Study|Adverse Event|0|||
131723907|NCT01269125|474269523|FG000|Overall Study|Lost to Follow-up|4|||
131723908|NCT01269125|474269524|FG001|Overall Study|Lost to Follow-up|0|||
131723909|NCT01269125|474269525|FG002|Overall Study|Lost to Follow-up|0|||
131723910|NCT01040832|474269527|FG000|Overall Study|Adverse Event|4|||
131805013|NCT00050778|474570582|FG001|Overall Study|Randomized but not treated|5|||
131723911|NCT01040832|474269528|FG001|Overall Study|Adverse Event|5|||
131723912|NCT01040832|474269527|FG000|Overall Study|Death|4|||
131723913|NCT01040832|474269528|FG001|Overall Study|Death|6|||
131723914|NCT01040832|474269527|FG000|Overall Study|Withdrawal by Subject|2|||
131723915|NCT01040832|474269528|FG001|Overall Study|Withdrawal by Subject|3|||
131448707|NCT00790842|473272722|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131723916|NCT01040832|474269527|FG000|Overall Study|Progressive disease|32|||
131723917|NCT01040832|474269528|FG001|Overall Study|Progressive disease|17|||
131723918|NCT01040832|474269527|FG000|Overall Study|Symptomatic deterioration|2|||
131723919|NCT01040832|474269528|FG001|Overall Study|Symptomatic deterioration|5|||
131723920|NCT01040832|474269527|FG000|Overall Study|Other|2|||
131723921|NCT01040832|474269528|FG001|Overall Study|Other|1|||
131723922|NCT00500149|474269529|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
131723923|NCT00500149|474269530|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
131723924|NCT00500149|474269529|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
131723925|NCT00500149|474269530|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
131723926|NCT00500149|474269529|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
131723927|NCT00500149|474269530|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
131723928|NCT00500149|474269529|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
131723929|NCT00500149|474269530|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
131723930|NCT00500149|474269529|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
131723931|NCT00500149|474269530|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
131723932|NCT00500149|474269529|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
131723933|NCT00500149|474269530|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
131723934|NCT00500149|474269529|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
131723935|NCT00500149|474269530|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
131723936|NCT00089843|474269531|FG000|Overall Study|Withdrawal by Subject|1|||
131723937|NCT00089843|474269532|FG001|Overall Study|Withdrawal by Subject|4|||
131723938|NCT00089843|474269533|FG002|Overall Study|Withdrawal by Subject|5|||
131723939|NCT00089843|474269534|FG003|Overall Study|Withdrawal by Subject|6|||
131723940|NCT00089843|474269531|FG000|Overall Study|Physician Decision|1|||
131723941|NCT00089843|474269532|FG001|Overall Study|Physician Decision|0|||
131723942|NCT00089843|474269533|FG002|Overall Study|Physician Decision|0|||
131723943|NCT00089843|474269534|FG003|Overall Study|Physician Decision|1|||
131723944|NCT03042611|474269535|FG000|Core Phase|Withdrawal by Subject|13|||
131723945|NCT03042611|474269536|FG001|Core Phase|Withdrawal by Subject|4|||
131723946|NCT03042611|474269537|FG002|Core Phase|Withdrawal by Subject|0|||
131723947|NCT03042611|474269538|FG003|Core Phase|Withdrawal by Subject|0|||
131723948|NCT03042611|474269535|FG000|Core Phase|Death|232|||
131723949|NCT03042611|474269536|FG001|Core Phase|Death|110|||
131723950|NCT03042611|474269537|FG002|Core Phase|Death|0|||
131723951|NCT03042611|474269538|FG003|Core Phase|Death|0|||
131723952|NCT03042611|474269535|FG000|Core Phase|Lost to Follow-up|4|||
131723953|NCT03042611|474269536|FG001|Core Phase|Lost to Follow-up|7|||
131723954|NCT03042611|474269537|FG002|Core Phase|Lost to Follow-up|0|||
131723955|NCT03042611|474269538|FG003|Core Phase|Lost to Follow-up|0|||
131723956|NCT03042611|474269535|FG000|Core Phase|Physician Decision|7|||
131723957|NCT03042611|474269536|FG001|Core Phase|Physician Decision|2|||
131723958|NCT03042611|474269537|FG002|Core Phase|Physician Decision|0|||
131723959|NCT03042611|474269538|FG003|Core Phase|Physician Decision|0|||
131723960|NCT03042611|474269535|FG000|Core Phase|Study Closed|0|||
131723961|NCT03042611|474269536|FG001|Core Phase|Study Closed|1|||
131723962|NCT03042611|474269537|FG002|Core Phase|Study Closed|0|||
131723963|NCT03042611|474269538|FG003|Core Phase|Study Closed|0|||
131723964|NCT03042611|474269535|FG000|Extension Phase|Death|0|||
131723965|NCT03042611|474269536|FG001|Extension Phase|Death|0|||
131723966|NCT03042611|474269537|FG002|Extension Phase|Death|34|||
131723967|NCT03042611|474269538|FG003|Extension Phase|Death|16|||
131723968|NCT03042611|474269535|FG000|Extension Phase|Lost to Follow-up|0|||
131723969|NCT03042611|474269536|FG001|Extension Phase|Lost to Follow-up|0|||
131723970|NCT03042611|474269537|FG002|Extension Phase|Lost to Follow-up|1|||
131723971|NCT03042611|474269538|FG003|Extension Phase|Lost to Follow-up|1|||
131723972|NCT03042611|474269535|FG000|Extension Phase|Study Closed|0|||
131723973|NCT03042611|474269536|FG001|Extension Phase|Study Closed|0|||
131723974|NCT03042611|474269537|FG002|Extension Phase|Study Closed|17|||
131723975|NCT03042611|474269538|FG003|Extension Phase|Study Closed|11|||
131723976|NCT00592358|474269541|FG000|Overall Study|Withdrawal by Subject|2|||
131723977|NCT00592358|474269541|FG000|Overall Study|Adverse Event|1|||
131723978|NCT00592358|474269541|FG000|Overall Study|Lack of Efficacy|2|||
131723979|NCT00592358|474269541|FG000|Overall Study|Inability to swallow pills|1|||
131723980|NCT01166659|474269542|FG000|Overall Study|Subject Decision|8|||
131723981|NCT01166659|474269542|FG000|Overall Study|Investigator Decision|2|||
131723982|NCT01166659|474269542|FG000|Overall Study|Death|1|||
131723983|NCT01166659|474269542|FG000|Overall Study|Lost to Follow-up|1|||
131723984|NCT01166659|474269542|FG000|Overall Study|Study Closed at Site|1|||
131723985|NCT01371838|474269557|FG000|Overall Study|Withdrawal by Subject|27|||
131723986|NCT01371838|474269558|FG001|Overall Study|Withdrawal by Subject|33|||
131496713|NCT02289690|473446361|FG002|Overall Study|Death|0|||
131723987|NCT01371838|474269557|FG000|Overall Study|Lost to Follow-up|10|||
131723988|NCT01371838|474269558|FG001|Overall Study|Lost to Follow-up|20|||
131723989|NCT01371838|474269557|FG000|Overall Study|Death|3|||
131723990|NCT01371838|474269558|FG001|Overall Study|Death|4|||
131723991|NCT01371838|474269557|FG000|Overall Study|Protocol Violation|3|||
131723992|NCT01371838|474269558|FG001|Overall Study|Protocol Violation|0|||
131723993|NCT01371838|474269557|FG000|Overall Study|Investigator Decision|3|||
131723994|NCT01371838|474269558|FG001|Overall Study|Investigator Decision|8|||
131723995|NCT01371838|474269557|FG000|Overall Study|Last follow-up visit not conducted|2|||
131723996|NCT01371838|474269558|FG001|Overall Study|Last follow-up visit not conducted|0|||
131723997|NCT01371838|474269557|FG000|Overall Study|Lack of therapeutic response|0|||
131723998|NCT01371838|474269558|FG001|Overall Study|Lack of therapeutic response|1|||
131723999|NCT01371838|474269557|FG000|Overall Study|Surgery|1|||
131724000|NCT01371838|474269558|FG001|Overall Study|Surgery|0|||
131724001|NCT04275310|474269561|FG000|Overall Study|Non-randomized due to running out of funding|4|||
131724002|NCT04275310|474269562|FG001|Overall Study|Non-randomized due to running out of funding|0|||
131724003|NCT02225223|474269563|FG000|Overall Study|Death|10|||
131724004|NCT02225223|474269564|FG001|Overall Study|Death|1|||
131724005|NCT02225223|474269563|FG000|Overall Study|Lost to Follow-up|5|||
131724006|NCT02225223|474269564|FG001|Overall Study|Lost to Follow-up|0|||
131724007|NCT02225223|474269563|FG000|Overall Study|Other|1|||
131724008|NCT02225223|474269564|FG001|Overall Study|Other|2|||
131724009|NCT02225223|474269563|FG000|Overall Study|Physician Decision|1|||
131724010|NCT02225223|474269564|FG001|Overall Study|Physician Decision|0|||
131724011|NCT02225223|474269563|FG000|Overall Study|Withdrawal by Subject|2|||
131724012|NCT02225223|474269564|FG001|Overall Study|Withdrawal by Subject|2|||
131724013|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
131724014|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
131724015|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
131724016|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
131724017|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
131724018|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
131724019|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
131724020|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
131724021|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
131724022|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
131724023|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
131724024|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
131724025|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
131724026|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
131724027|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
131724028|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
131724029|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
131724030|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
131724031|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
131724032|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
131724033|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
131724034|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
131724035|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
131724036|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
131724037|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
131724038|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
131724039|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
131724040|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
131724041|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
131724042|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
131724043|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
131724044|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
131724045|NCT00958568|474269566|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
131724046|NCT00958568|474269567|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
131724047|NCT00958568|474269568|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
131724048|NCT00958568|474269569|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
131724049|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
131724050|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
131724051|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
131724052|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
131724053|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
131904916|NCT02718911|474938991|FG008|Overall Study|Physician Decision|2|||
131724054|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
131724055|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
131724056|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
131724057|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
131724058|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
131724059|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
131724060|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
131724061|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
131724062|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
131724063|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
131724064|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
131724065|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
131724066|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
131724067|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
131724068|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
131724069|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
131724070|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
131724071|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
131724072|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
131724073|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
131724074|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
131724075|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
131724076|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
131724077|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
131724078|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
131724079|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
131724080|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
131724081|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
131724082|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
131724083|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
131724084|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
131724085|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
131724086|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
131724087|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
131724088|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
131724089|NCT00958568|474269566|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
131724090|NCT00958568|474269567|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
131724091|NCT00958568|474269568|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
131724092|NCT00958568|474269569|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
131724093|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
131724094|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
131724095|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
131724096|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
131724097|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
131724098|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
131724099|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
131724100|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
131724101|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
131724102|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
131724103|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
131724104|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
131724105|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
131724106|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
131724107|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
131724108|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
131724109|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
131724110|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
131724111|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
131724112|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
131724113|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
131724114|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
131904917|NCT02718911|474938992|FG009|Overall Study|Physician Decision|1|||
131724115|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
131724116|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
131724117|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
131724118|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
131724119|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
131724120|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
131724121|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
131724122|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
131724123|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
131724124|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
131724125|NCT00958568|474269566|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
131724126|NCT00958568|474269567|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
131724127|NCT00958568|474269568|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
131724128|NCT00958568|474269569|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
131724129|NCT01936649|474269580|FG000|Overall Study|Withdrawal by Subject|4|||
131724130|NCT01936649|474269580|FG000|Overall Study|Physician Decision|2|||
131724131|NCT01936649|474269580|FG000|Overall Study|Protocol Violation|2|||
131724132|NCT01936649|474269580|FG000|Overall Study|Other than specified above|5|||
131724133|NCT04655586|474269589|FG000|Overall Study|Physician Decision|1|||
131724134|NCT04655586|474269590|FG001|Overall Study|Physician Decision|3|||
131724135|NCT04655586|474269591|FG002|Overall Study|Physician Decision|4|||
131724136|NCT04655586|474269589|FG000|Overall Study|Withdrawal by Subject|1|||
131724137|NCT04655586|474269590|FG001|Overall Study|Withdrawal by Subject|3|||
131724138|NCT04655586|474269591|FG002|Overall Study|Withdrawal by Subject|1|||
131724139|NCT00891657|474269596|FG000|Overall Study|Withdrawal by Subject|1|||
131724140|NCT00891657|474269597|FG001|Overall Study|Withdrawal by Subject|1|||
131724141|NCT02927171|474269602|FG000|Overall Study|Lost to Follow-up|0|||
131724142|NCT02927171|474269603|FG001|Overall Study|Lost to Follow-up|1|||
131724143|NCT04530825|474269608|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
131724144|NCT04530825|474269609|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
131724145|NCT04530825|474269610|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
131724146|NCT04530825|474269611|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
131724147|NCT04530825|474269608|FG000|Overall Study|Did not complete follow-up|3|||
131724148|NCT04530825|474269609|FG001|Overall Study|Did not complete follow-up|0|||
131724149|NCT04530825|474269610|FG002|Overall Study|Did not complete follow-up|0|||
131724150|NCT04530825|474269611|FG003|Overall Study|Did not complete follow-up|0|||
131724151|NCT00850499|474269613|FG000|Overall Study|Adverse Event|3|||
131724152|NCT00850499|474269614|FG001|Overall Study|Adverse Event|1|||
131724153|NCT00850499|474269613|FG000|Overall Study|Lack of Efficacy|0|||
131724154|NCT00850499|474269614|FG001|Overall Study|Lack of Efficacy|1|||
131724155|NCT04498910|474269615|FG000|Overall Study|Lost to Follow-up|0|||
131724156|NCT04498910|474269616|FG001|Overall Study|Lost to Follow-up|1|||
131724157|NCT04498910|474269615|FG000|Overall Study|Withdrawal by Subject|2|||
131724158|NCT04498910|474269616|FG001|Overall Study|Withdrawal by Subject|1|||
131724159|NCT04498910|474269615|FG000|Overall Study|Adverse Event|1|||
131724160|NCT04498910|474269616|FG001|Overall Study|Adverse Event|0|||
131724161|NCT00909090|474269617|FG000|Overall Study|Lost to Follow-up|17|||
131724162|NCT00909090|474269618|FG001|Overall Study|Lost to Follow-up|17|||
131724163|NCT00611455|474269622|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
131724164|NCT00611455|474269623|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
131724165|NCT00611455|474269624|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131724166|NCT00611455|474269622|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
131724167|NCT00611455|474269623|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131724168|NCT00611455|474269624|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131805014|NCT00050778|474570583|FG002|Overall Study|Randomized but not treated|2|||
131805015|NCT00050778|474570581|FG000|Overall Study|Familial and personal reasons|1|||
131805016|NCT00050778|474570582|FG001|Overall Study|Familial and personal reasons|0|||
131805017|NCT00050778|474570583|FG002|Overall Study|Familial and personal reasons|0|||
131805018|NCT01126736|474570585|FG000|Overall Study|Death|2|||
131805019|NCT01126736|474570586|FG001|Overall Study|Death|2|||
131805020|NCT01126736|474570587|FG002|Overall Study|Death|1|||
131805021|NCT01126736|474570588|FG003|Overall Study|Death|19|||
131805022|NCT01126736|474570589|FG004|Overall Study|Death|19|||
131805023|NCT01126736|474570585|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
131805024|NCT01126736|474570586|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
131805025|NCT01126736|474570587|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
131805026|NCT01126736|474570588|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
131805027|NCT01126736|474570589|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
131805028|NCT01126736|474570585|FG000|Overall Study|Lost to Follow-up|0|||
131805029|NCT01126736|474570586|FG001|Overall Study|Lost to Follow-up|0|||
131805030|NCT01126736|474570587|FG002|Overall Study|Lost to Follow-up|0|||
131805031|NCT01126736|474570588|FG003|Overall Study|Lost to Follow-up|1|||
131805032|NCT01126736|474570589|FG004|Overall Study|Lost to Follow-up|1|||
131805033|NCT01126736|474570585|FG000|Overall Study|Administrative reasons|0|||
131805034|NCT01126736|474570586|FG001|Overall Study|Administrative reasons|0|||
131805035|NCT01126736|474570587|FG002|Overall Study|Administrative reasons|0|||
131805036|NCT01126736|474570588|FG003|Overall Study|Administrative reasons|0|||
131805037|NCT01126736|474570589|FG004|Overall Study|Administrative reasons|1|||
131805038|NCT01126736|474570585|FG000|Overall Study|Progressive disease|0|||
131805039|NCT01126736|474570586|FG001|Overall Study|Progressive disease|0|||
131805040|NCT01126736|474570587|FG002|Overall Study|Progressive disease|0|||
131805041|NCT01126736|474570588|FG003|Overall Study|Progressive disease|2|||
131805042|NCT01126736|474570589|FG004|Overall Study|Progressive disease|1|||
131805043|NCT01126736|474570585|FG000|Overall Study|Withdrawal by Subject|0|||
131805044|NCT01126736|474570586|FG001|Overall Study|Withdrawal by Subject|0|||
131805045|NCT01126736|474570587|FG002|Overall Study|Withdrawal by Subject|0|||
131805046|NCT01126736|474570588|FG003|Overall Study|Withdrawal by Subject|1|||
131805047|NCT01126736|474570589|FG004|Overall Study|Withdrawal by Subject|1|||
131805048|NCT01126736|474570585|FG000|Overall Study|Other|2|||
131805049|NCT01126736|474570586|FG001|Overall Study|Other|4|||
131805050|NCT01126736|474570587|FG002|Overall Study|Other|4|||
131805051|NCT01126736|474570588|FG003|Overall Study|Other|16|||
131805052|NCT01126736|474570589|FG004|Overall Study|Other|15|||
131805053|NCT02015390|474570590|FG000|Overall Study|Lost to Follow-up|1|||
131805054|NCT02015390|474570591|FG001|Overall Study|Lost to Follow-up|0|||
131805055|NCT02015390|474570590|FG000|Overall Study|Adverse Event|0|||
131805056|NCT02015390|474570591|FG001|Overall Study|Adverse Event|3|||
131805057|NCT02015390|474570590|FG000|Overall Study|Physician Decision|0|||
131805058|NCT02015390|474570591|FG001|Overall Study|Physician Decision|1|||
131805059|NCT00064753|474570592|FG000|Overall Study|Death|251|||
131805060|NCT00064753|474570593|FG001|Overall Study|Death|242|||
131805061|NCT00064753|474570592|FG000|Overall Study|Withdrawal by Subject|198|||
131805062|NCT00064753|474570593|FG001|Overall Study|Withdrawal by Subject|171|||
131805063|NCT00064753|474570592|FG000|Overall Study|Lost to Follow-up|225|||
131805064|NCT00064753|474570593|FG001|Overall Study|Lost to Follow-up|235|||
131805065|NCT02193880|474570596|FG000|Overall Study|patients did not collect enough HPC|3|||
131805066|NCT03136380|474570597|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131805067|NCT03136380|474570598|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
131805068|NCT03136380|474570599|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131805069|NCT03136380|474570600|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131805070|NCT03136380|474570601|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131805071|NCT01661686|474570605|FG000|Overall Study|Lost to Follow-up|2|||
131805072|NCT01661686|474570606|FG001|Overall Study|Lost to Follow-up|1|||
131805073|NCT01661686|474570605|FG000|Overall Study|did not receive allocated intervention|0|||
131805074|NCT01661686|474570606|FG001|Overall Study|did not receive allocated intervention|1|||
131805075|NCT04869787|474570613|FG000|Screening|Physician Decision|1|||
131805076|NCT04869787|474570613|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
131805077|NCT00813293|474570615|FG000|Overall Study|Intercurrent illness|1|||
131805078|NCT00813293|474570616|FG001|Overall Study|Intercurrent illness|0|||
131805079|NCT00813293|474570615|FG000|Overall Study|Adverse Event|0|||
131805080|NCT00813293|474570616|FG001|Overall Study|Adverse Event|1|||
131805081|NCT02419937|474570617|FG000|Overall Study|Lost to Follow-up|1|||
131805082|NCT02419937|474570618|FG001|Overall Study|Lost to Follow-up|0|||
131805083|NCT00553280|474570620|FG000|Overall Study|Adverse Event|19|||
131805084|NCT00553280|474570620|FG000|Overall Study|Lack of Efficacy|3|||
131805085|NCT00553280|474570620|FG000|Overall Study|Withdrawal by Subject|3|||
131805086|NCT00553280|474570620|FG000|Overall Study|Physician Decision|1|||
131805087|NCT01544127|474570621|FG000|Overall Study|Lost to Follow-up|4|||
131805088|NCT01544127|474570622|FG001|Overall Study|Lost to Follow-up|2|||
131805089|NCT01544127|474570623|FG002|Overall Study|Lost to Follow-up|9|||
131805090|NCT01544127|474570621|FG000|Overall Study|Withdrawal by Subject|2|||
131805091|NCT01544127|474570622|FG001|Overall Study|Withdrawal by Subject|2|||
131805092|NCT01544127|474570623|FG002|Overall Study|Withdrawal by Subject|1|||
131805093|NCT01544127|474570621|FG000|Overall Study|Discharged out of catchment area|1|||
131904918|NCT02718911|474938983|FG000|Overall Study|Withdrawal by Subject|0|||
131904919|NCT02718911|474938984|FG001|Overall Study|Withdrawal by Subject|0|||
131904920|NCT02718911|474938985|FG002|Overall Study|Withdrawal by Subject|0|||
131904921|NCT02718911|474938986|FG003|Overall Study|Withdrawal by Subject|0|||
131904922|NCT02718911|474938987|FG004|Overall Study|Withdrawal by Subject|1|||
131904923|NCT02718911|474938988|FG005|Overall Study|Withdrawal by Subject|0|||
131904924|NCT02718911|474938989|FG006|Overall Study|Withdrawal by Subject|0|||
131904925|NCT02718911|474938990|FG007|Overall Study|Withdrawal by Subject|0|||
131904926|NCT02718911|474938991|FG008|Overall Study|Withdrawal by Subject|1|||
131724169|NCT00611455|474269622|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
131724170|NCT00611455|474269623|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
131724171|NCT00611455|474269624|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131724172|NCT00611455|474269622|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131724173|NCT00611455|474269623|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131724174|NCT00611455|474269624|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131724175|NCT00611455|474269622|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
131724176|NCT00611455|474269623|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
131724177|NCT00611455|474269624|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
131724178|NCT00611455|474269622|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
131724179|NCT00611455|474269623|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
131724180|NCT00611455|474269624|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
131724181|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131724182|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
131724183|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131724184|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131724185|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
131724186|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131724187|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131724188|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
131724189|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131724190|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131724191|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
131724192|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131724193|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131724194|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
131724195|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131724196|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
131724197|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
131724198|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
131724199|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131724200|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
131724201|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131724202|NCT00611455|474269622|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131724203|NCT00611455|474269623|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
131724204|NCT00611455|474269624|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131724205|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
131724206|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
131724207|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
131724208|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
131724209|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
131724210|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
131724211|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
131724212|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
131724213|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
131724214|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
131724215|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
131724216|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
131724217|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
131724218|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
131724219|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
131724220|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
131724221|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
131724222|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
131724223|NCT00611455|474269622|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
131724224|NCT00611455|474269623|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
131724225|NCT00611455|474269624|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
131724226|NCT01839188|474269625|FG000|Overall Study|Withdrawal by Subject|1|||
131724227|NCT00206518|474269626|FG000|Overall Study|Lack of Efficacy|6|||
131724228|NCT00206518|474269627|FG001|Overall Study|Lack of Efficacy|4|||
131724229|NCT00206518|474269626|FG000|Overall Study|Adverse Event|2|||
131724230|NCT00206518|474269627|FG001|Overall Study|Adverse Event|1|||
131724231|NCT00206518|474269626|FG000|Overall Study|Physician Decision|1|||
131724232|NCT00206518|474269627|FG001|Overall Study|Physician Decision|0|||
131904927|NCT02718911|474938992|FG009|Overall Study|Withdrawal by Subject|4|||
131904928|NCT02718911|474938983|FG000|Overall Study|Reason Not Collected|0|||
131724233|NCT00206518|474269626|FG000|Overall Study|Protocol Violation|1|||
131724234|NCT00206518|474269627|FG001|Overall Study|Protocol Violation|1|||
131724235|NCT00465738|474269629|FG000|Overall Study|Lost to Follow-up|2|||
131724236|NCT00465738|474269630|FG001|Overall Study|Lost to Follow-up|0|||
131724237|NCT00465738|474269629|FG000|Overall Study|Adverse Event|0|||
131724238|NCT00465738|474269630|FG001|Overall Study|Adverse Event|1|||
131724239|NCT00465738|474269629|FG000|Overall Study|Withdrawal by Subject|2|||
131724240|NCT00465738|474269630|FG001|Overall Study|Withdrawal by Subject|0|||
131805094|NCT01544127|474570622|FG001|Overall Study|Discharged out of catchment area|1|||
131805095|NCT01544127|474570623|FG002|Overall Study|Discharged out of catchment area|1|||
131805096|NCT01544127|474570621|FG000|Overall Study|Death|1|||
131805097|NCT01544127|474570622|FG001|Overall Study|Death|0|||
131805098|NCT01544127|474570623|FG002|Overall Study|Death|0|||
131805099|NCT01544127|474570621|FG000|Overall Study|Jail or Prison|1|||
131805100|NCT01544127|474570622|FG001|Overall Study|Jail or Prison|1|||
131805101|NCT01544127|474570623|FG002|Overall Study|Jail or Prison|2|||
131805102|NCT01544127|474570621|FG000|Overall Study|Became Psychotic|1|||
131805103|NCT01544127|474570622|FG001|Overall Study|Became Psychotic|0|||
131805104|NCT01544127|474570623|FG002|Overall Study|Became Psychotic|0|||
131805105|NCT01544127|474570621|FG000|Overall Study|Researcher withdrew|1|||
131805106|NCT01544127|474570622|FG001|Overall Study|Researcher withdrew|0|||
131805107|NCT01544127|474570623|FG002|Overall Study|Researcher withdrew|0|||
131805108|NCT01544127|474570621|FG000|Overall Study|Went active duty|0|||
131805109|NCT01544127|474570622|FG001|Overall Study|Went active duty|0|||
131805110|NCT01544127|474570623|FG002|Overall Study|Went active duty|1|||
131805111|NCT02661295|474570624|FG000|Overall Study|Death|1|||
131805112|NCT02661295|474570624|FG000|Overall Study|Transferred Out|1|||
131805113|NCT02661295|474570624|FG000|Overall Study|Kidney Transplant|1|||
131805114|NCT02661295|474570624|FG000|Overall Study|Withdrawn due to side effects|8|||
131805115|NCT02661295|474570624|FG000|Overall Study|Withdrawn due to access type|1|||
131805116|NCT02661295|474570624|FG000|Overall Study|Withdrawn due to allergies|1|||
131805117|NCT02661295|474570624|FG000|Overall Study|Withdrawn due to non-compliance|1|||
131805118|NCT02661295|474570624|FG000|Overall Study|Withdrawal by Subject|3|||
131805119|NCT02661295|474570624|FG000|Overall Study|Failed screening|2|||
131805120|NCT04213326|474570625|FG000|Overall Study|Consent withdrawn|51|||
131805121|NCT04213326|474570626|FG001|Overall Study|Consent withdrawn|241|||
131805122|NCT04213326|474570625|FG000|Overall Study|Lost to Follow-up|50|||
131805123|NCT04213326|474570626|FG001|Overall Study|Lost to Follow-up|902|||
131805124|NCT04213326|474570625|FG000|Overall Study|Protocol Violation|3|||
131805125|NCT04213326|474570626|FG001|Overall Study|Protocol Violation|25|||
131805126|NCT04213326|474570625|FG000|Overall Study|Participant eligibility changed|106|||
131805127|NCT04213326|474570626|FG001|Overall Study|Participant eligibility changed|19|||
131805128|NCT04213326|474570625|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
131805129|NCT04213326|474570626|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
131805130|NCT04213326|474570625|FG000|Overall Study|Incomplete study visit|0|||
131805131|NCT04213326|474570626|FG001|Overall Study|Incomplete study visit|367|||
131805132|NCT02549092|474570627|FG000|Treatment Period|Adverse Event|2|||
131805133|NCT02549092|474570628|FG001|Treatment Period|Adverse Event|2|||
131805134|NCT02549092|474570627|FG000|Treatment Period|Withdrawal by Subject|1|||
131805135|NCT02549092|474570628|FG001|Treatment Period|Withdrawal by Subject|3|||
131805136|NCT02549092|474570627|FG000|Treatment Period|Lack of Efficacy|0|||
131805137|NCT02549092|474570628|FG001|Treatment Period|Lack of Efficacy|2|||
131805138|NCT02549092|474570627|FG000|Extension/Transition Period|Adverse Event|1|||
131805139|NCT02549092|474570628|FG001|Extension/Transition Period|Adverse Event|1|||
131805140|NCT02549092|474570627|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
131805141|NCT02549092|474570628|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
131805142|NCT02549092|474570627|FG000|Extension/Transition Period|Other, Not Specified|4|||
131805143|NCT02549092|474570628|FG001|Extension/Transition Period|Other, Not Specified|2|||
131805144|NCT03627091|474570629|FG000|Overall Study|Adverse Event|0|||
131805145|NCT03627091|474570630|FG001|Overall Study|Adverse Event|0|||
131805146|NCT03627091|474570631|FG002|Overall Study|Adverse Event|2|||
131805147|NCT03627091|474570629|FG000|Overall Study|Withdrawal by Subject|2|||
131805148|NCT03627091|474570630|FG001|Overall Study|Withdrawal by Subject|0|||
131805149|NCT03627091|474570631|FG002|Overall Study|Withdrawal by Subject|2|||
131805150|NCT03627091|474570629|FG000|Overall Study|Physician Decision|2|||
131805151|NCT03627091|474570630|FG001|Overall Study|Physician Decision|0|||
131805152|NCT03627091|474570631|FG002|Overall Study|Physician Decision|0|||
131805153|NCT03627091|474570629|FG000|Overall Study|Site terminated by sponsor|0|||
131805154|NCT03627091|474570630|FG001|Overall Study|Site terminated by sponsor|1|||
131805155|NCT03627091|474570631|FG002|Overall Study|Site terminated by sponsor|0|||
131805156|NCT03627091|474570629|FG000|Overall Study|Disease relapse|7|||
131805157|NCT03627091|474570630|FG001|Overall Study|Disease relapse|5|||
131805158|NCT03627091|474570631|FG002|Overall Study|Disease relapse|1|||
131805159|NCT03627091|474570629|FG000|Overall Study|Other|1|||
131805160|NCT03627091|474570630|FG001|Overall Study|Other|0|||
131805161|NCT03627091|474570631|FG002|Overall Study|Other|0|||
131805162|NCT02193165|474570636|FG000|4 Week Product Use|Lost to Follow-up|1|||
131724241|NCT00465738|474269629|FG000|Overall Study|Other|2|||
131724242|NCT00465738|474269630|FG001|Overall Study|Other|5|||
131724243|NCT02792777|474269631|FG000|Overall Study|Withdrawal by Subject|2|||
131724244|NCT02792777|474269632|FG001|Overall Study|Withdrawal by Subject|0|||
131724245|NCT02792777|474269631|FG000|Overall Study|Recording malfunction|2|||
131724246|NCT02792777|474269632|FG001|Overall Study|Recording malfunction|0|||
131724247|NCT02792777|474269631|FG000|Overall Study|Later determined to be ineligible|2|||
131724248|NCT02792777|474269632|FG001|Overall Study|Later determined to be ineligible|0|||
131724249|NCT02792777|474269631|FG000|Overall Study|Participant interviewed twice|1|||
131724250|NCT02792777|474269632|FG001|Overall Study|Participant interviewed twice|0|||
131724251|NCT01171521|474269635|FG000|Overall Study|Lost to Follow-up|5|||
131724252|NCT01171521|474269635|FG000|Overall Study|screen failure|1|||
131724253|NCT00515463|474269642|FG000|Overall Study|Physician Decision|4|||
131724254|NCT00515463|474269643|FG001|Overall Study|Physician Decision|2|||
131724255|NCT00515463|474269642|FG000|Overall Study|Adverse Event|1|||
131724256|NCT00515463|474269643|FG001|Overall Study|Adverse Event|2|||
131724257|NCT00515463|474269642|FG000|Overall Study|Withdrawal by Subject|3|||
131724258|NCT00515463|474269643|FG001|Overall Study|Withdrawal by Subject|4|||
131724259|NCT00515463|474269642|FG000|Overall Study|Lost to Follow-up|6|||
131724260|NCT00515463|474269643|FG001|Overall Study|Lost to Follow-up|5|||
131724261|NCT00515463|474269642|FG000|Overall Study|Other|0|||
131724262|NCT00515463|474269643|FG001|Overall Study|Other|1|||
131724263|NCT02269319|474269644|FG000|Overall Study|Lost to Follow-up|4|||
131724264|NCT02269319|474269645|FG001|Overall Study|Lost to Follow-up|3|||
131724265|NCT02269319|474269644|FG000|Overall Study|Adverse Event|0|||
131724266|NCT02269319|474269645|FG001|Overall Study|Adverse Event|1|||
131724267|NCT02269319|474269644|FG000|Overall Study|Instructions not followed|1|||
131724268|NCT02269319|474269645|FG001|Overall Study|Instructions not followed|0|||
131724269|NCT01589094|474269646|FG000|Overall Study|Did not receive treatment|2|||
131724270|NCT03575468|474269647|FG000|Overall Study|Withdrawal by Subject|3|||
131724271|NCT03575468|474269648|FG001|Overall Study|Withdrawal by Subject|0|||
131724272|NCT03575468|474269647|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
131724273|NCT03575468|474269648|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
131724274|NCT03575468|474269647|FG000|Overall Study|Lost to Follow-up|13|||
131724275|NCT03575468|474269648|FG001|Overall Study|Lost to Follow-up|17|||
131724276|NCT02240628|474271115|FG000|Overall Study|Physician Decision|6|||
131724277|NCT02240628|474271116|FG001|Overall Study|Physician Decision|5|||
131724278|NCT02385123|474271117|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
131724279|NCT00552305|474271121|FG000|Overall Study|Adverse Event|43|||
131724280|NCT00552305|474271121|FG000|Overall Study|Lack of Efficacy|120|||
131724281|NCT00552305|474271121|FG000|Overall Study|Lost to Follow-up|4|||
131724282|NCT00552305|474271121|FG000|Overall Study|Protocol Violation|3|||
131724283|NCT00552305|474271121|FG000|Overall Study|Withdrawal by Subject|44|||
131724284|NCT00552305|474271121|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
131724285|NCT00552305|474271121|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
131724286|NCT00552305|474271121|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
131724287|NCT00552305|474271121|FG000|Overall Study|Unsatisfactory compliance|11|||
131724288|NCT00552305|474271121|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
131724289|NCT00552305|474271121|FG000|Overall Study|AE/Other: prohibited drug required|1|||
131724290|NCT00552305|474271121|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
131724291|NCT00552305|474271121|FG000|Overall Study|Other: Site closed|4|||
131724292|NCT00552305|474271121|FG000|Overall Study|Other: Personal problems|1|||
131724293|NCT00552305|474271121|FG000|Overall Study|Other: Unable to attend visits|1|||
131724294|NCT00552305|474271121|FG000|Overall Study|Other: Subject underwent surgery|4|||
131724295|NCT00552305|474271121|FG000|Overall Study|Other: Subject became pregnant|1|||
131724296|NCT00552305|474271121|FG000|Overall Study|Other: Health problems, not drug related|1|||
131724297|NCT00552305|474271121|FG000|Overall Study|Other: Subject moved from area|2|||
131724298|NCT00552305|474271121|FG000|Overall Study|Other: Subject incarcerated|1|||
131724299|NCT00552305|474271121|FG000|Overall Study|Other: Subject went to rehab|1|||
131724300|NCT01849848|474271122|FG000|Overall Study|Physician Decision|1|||
131724301|NCT01849848|474271122|FG000|Overall Study|Progression of the primary disease|3|||
131724302|NCT01070303|474271123|FG000|Overall Study|Adverse Event|39|||
131724303|NCT01070303|474271123|FG000|Overall Study|Withdrawal by Subject|20|||
131724304|NCT01070303|474271123|FG000|Overall Study|Lost to Follow-up|9|||
131724305|NCT01070303|474271123|FG000|Overall Study|Protocol Violation|0|||
131724306|NCT01070303|474271123|FG000|Overall Study|Lack of Efficacy|2|||
131724307|NCT01070303|474271123|FG000|Overall Study|Administrative Reason|1|||
131724308|NCT01070303|474271123|FG000|Overall Study|Other|18|||
131724309|NCT02345434|474271124|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
131724310|NCT02345434|474271125|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
131724311|NCT02926573|474271126|FG000|Overall Study|Nausea|1|||
131724312|NCT02926573|474271127|FG001|Overall Study|Nausea|0|||
131724313|NCT02926573|474271126|FG000|Overall Study|Remain intubated|2|||
131724314|NCT02926573|474271127|FG001|Overall Study|Remain intubated|2|||
131724315|NCT02926573|474271126|FG000|Overall Study|Change in surgery plan|3|||
131724316|NCT02926573|474271127|FG001|Overall Study|Change in surgery plan|1|||
131724317|NCT02926573|474271126|FG000|Overall Study|Change to outpatient status|5|||
131724318|NCT02926573|474271127|FG001|Overall Study|Change to outpatient status|1|||
131724319|NCT02926573|474271126|FG000|Overall Study|Withdrawal by Subject|0|||
131724320|NCT02926573|474271127|FG001|Overall Study|Withdrawal by Subject|2|||
131724321|NCT02926573|474271126|FG000|Overall Study|Return to operating room|0|||
131724322|NCT02926573|474271127|FG001|Overall Study|Return to operating room|2|||
131724323|NCT02926573|474271126|FG000|Overall Study|Delirium|0|||
131724324|NCT02926573|474271127|FG001|Overall Study|Delirium|1|||
131724325|NCT00858702|474271130|FG000|Overall Study|Lack of Efficacy|1|||
131724326|NCT00858702|474271131|FG001|Overall Study|Lack of Efficacy|0|||
131724327|NCT00858702|474271130|FG000|Overall Study|Protocol Violation|1|||
131724328|NCT00858702|474271131|FG001|Overall Study|Protocol Violation|1|||
131724329|NCT00858702|474271130|FG000|Overall Study|Other|2|||
131724330|NCT00858702|474271131|FG001|Overall Study|Other|1|||
131724331|NCT00858702|474271130|FG000|Overall Study|Withdrawal by Subject|1|||
131724332|NCT00858702|474271131|FG001|Overall Study|Withdrawal by Subject|0|||
131724333|NCT00771030|474271132|FG000|Overall Study|Adverse Event|0|||
131724334|NCT00771030|474271133|FG001|Overall Study|Adverse Event|1|||
131724335|NCT00771030|474271134|FG002|Overall Study|Adverse Event|0|||
131724336|NCT00771030|474271135|FG003|Overall Study|Adverse Event|0|||
131724337|NCT00771030|474271136|FG004|Overall Study|Adverse Event|0|||
131724338|NCT00771030|474271137|FG005|Overall Study|Adverse Event|0|||
131724339|NCT00771030|474271138|FG006|Overall Study|Adverse Event|0|||
131724340|NCT02416908|474271144|FG000|Dose Escalation Phase|Adverse Event|0|||
131724341|NCT02416908|474271145|FG001|Dose Escalation Phase|Adverse Event|0|||
131724342|NCT02416908|474271146|FG002|Dose Escalation Phase|Adverse Event|3|||
131724343|NCT02416908|474271147|FG003|Dose Escalation Phase|Adverse Event|0|||
131724344|NCT02416908|474271144|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131724345|NCT02416908|474271145|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131724346|NCT02416908|474271146|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
131724347|NCT02416908|474271147|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131724348|NCT00940342|474271150|FG000|Overall Study|Adverse Event|0|||
131724349|NCT00940342|474271151|FG001|Overall Study|Adverse Event|2|||
131724350|NCT00940342|474271152|FG002|Overall Study|Adverse Event|1|||
131724351|NCT03792750|474271154|FG000|Overall Study|Death|3|||
131724352|NCT01172288|474271155|FG000|Overall Study|Adverse Event|1|||
131724353|NCT01172288|474271156|FG001|Overall Study|Adverse Event|0|||
131724354|NCT01172288|474271155|FG000|Overall Study|Protocol Violation|0|||
131724355|NCT01172288|474271156|FG001|Overall Study|Protocol Violation|1|||
131724356|NCT02902809|474271159|FG000|Overall Study|Discontinuation of asthma program|28|||
131724357|NCT00532259|474271160|FG000|Overall Study|Withdrawal by Subject|2|||
131724358|NCT00532259|474271160|FG000|Overall Study|Adverse Event|1|||
131724359|NCT00532259|474271160|FG000|Overall Study|Death|1|||
131724360|NCT00532259|474271160|FG000|Overall Study|Lack of Efficacy|21|||
131724361|NCT00532259|474271160|FG000|Overall Study|Lost to Follow-up|3|||
131724362|NCT00532259|474271160|FG000|Overall Study|Physician Decision|3|||
131724363|NCT00532259|474271160|FG000|Overall Study|Protocol Violation|1|||
131724364|NCT00793104|474271161|FG000|Overall Study|Lost to Follow-up|1|||
131724365|NCT03694522|474271167|FG000|Overall Study|Withdrawal by Subject|8|||
131724366|NCT03694522|474271168|FG001|Overall Study|Withdrawal by Subject|10|||
131724367|NCT03694522|474271167|FG000|Overall Study|Physician Decision|53|||
131724368|NCT03694522|474271168|FG001|Overall Study|Physician Decision|54|||
131724369|NCT03694522|474271167|FG000|Overall Study|Other|1|||
131724370|NCT03694522|474271168|FG001|Overall Study|Other|1|||
131724371|NCT03694522|474271167|FG000|Overall Study|Lost to Follow-up|0|||
131724372|NCT03694522|474271168|FG001|Overall Study|Lost to Follow-up|1|||
131724373|NCT02760407|474271169|FG000|Overall Study|Death|2|||
131724374|NCT02760407|474271170|FG001|Overall Study|Death|3|||
131724375|NCT02760407|474271171|FG002|Overall Study|Death|1|||
131724376|NCT02760407|474271172|FG003|Overall Study|Death|1|||
131724377|NCT02760407|474271169|FG000|Overall Study|Lost to Follow-up|1|||
131724378|NCT02760407|474271170|FG001|Overall Study|Lost to Follow-up|7|||
131724379|NCT02760407|474271171|FG002|Overall Study|Lost to Follow-up|4|||
131724380|NCT02760407|474271172|FG003|Overall Study|Lost to Follow-up|6|||
131724381|NCT02760407|474271169|FG000|Overall Study|Withdrawal by Subject|25|||
131724382|NCT02760407|474271170|FG001|Overall Study|Withdrawal by Subject|31|||
131724383|NCT02760407|474271171|FG002|Overall Study|Withdrawal by Subject|37|||
131724384|NCT02760407|474271172|FG003|Overall Study|Withdrawal by Subject|25|||
131724385|NCT02760407|474271169|FG000|Overall Study|Violation of Eligibility criteria|0|||
131724386|NCT02760407|474271170|FG001|Overall Study|Violation of Eligibility criteria|0|||
131724387|NCT02760407|474271171|FG002|Overall Study|Violation of Eligibility criteria|1|||
131724388|NCT02760407|474271172|FG003|Overall Study|Violation of Eligibility criteria|1|||
131724389|NCT02760407|474271169|FG000|Overall Study|Personal reasons|0|||
131724390|NCT02760407|474271170|FG001|Overall Study|Personal reasons|0|||
131724391|NCT02760407|474271171|FG002|Overall Study|Personal reasons|0|||
131724392|NCT02760407|474271172|FG003|Overall Study|Personal reasons|1|||
131724393|NCT02760407|474271169|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
131724394|NCT02760407|474271170|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
131724395|NCT02760407|474271171|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
131724396|NCT02760407|474271172|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
131724397|NCT02760407|474271169|FG000|Overall Study|Use of prohibited Medication|0|||
131724398|NCT02760407|474271170|FG001|Overall Study|Use of prohibited Medication|0|||
131724399|NCT02760407|474271171|FG002|Overall Study|Use of prohibited Medication|1|||
131724400|NCT02760407|474271172|FG003|Overall Study|Use of prohibited Medication|0|||
131724401|NCT02760407|474271169|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
131724402|NCT02760407|474271170|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
131724403|NCT02760407|474271171|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
131724404|NCT02760407|474271172|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
131724405|NCT02760407|474271169|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
131724406|NCT02760407|474271170|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
131724407|NCT02760407|474271171|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
131724408|NCT02760407|474271172|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
131724409|NCT02760407|474271169|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
131724410|NCT02760407|474271170|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
131724411|NCT02760407|474271171|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
131724412|NCT02760407|474271172|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
131724413|NCT02760407|474271169|FG000|Overall Study|Inadequately Enrolled|0|||
131724414|NCT02760407|474271170|FG001|Overall Study|Inadequately Enrolled|0|||
131724415|NCT02760407|474271171|FG002|Overall Study|Inadequately Enrolled|0|||
131724416|NCT02760407|474271172|FG003|Overall Study|Inadequately Enrolled|1|||
131724417|NCT02760407|474271169|FG000|Overall Study|Withdrawal By PI's Decision|0|||
131724418|NCT02760407|474271170|FG001|Overall Study|Withdrawal By PI's Decision|1|||
131724419|NCT02760407|474271171|FG002|Overall Study|Withdrawal By PI's Decision|0|||
131724420|NCT02760407|474271172|FG003|Overall Study|Withdrawal By PI's Decision|0|||
131724421|NCT02760407|474271169|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
131724422|NCT02760407|474271170|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
131724423|NCT02760407|474271171|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
131724424|NCT02760407|474271172|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
131724425|NCT02760407|474271169|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
131724426|NCT02760407|474271170|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
131724427|NCT02760407|474271171|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
131724428|NCT02760407|474271172|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
131724429|NCT02760407|474271169|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
131724430|NCT02760407|474271170|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
131724431|NCT02760407|474271171|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
131724432|NCT02760407|474271172|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
131724433|NCT02760407|474271169|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
131724434|NCT02760407|474271170|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
131724435|NCT02760407|474271171|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
131724436|NCT02760407|474271172|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
131724437|NCT02760407|474271169|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
131724438|NCT02760407|474271170|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
131724439|NCT02760407|474271171|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
131724440|NCT02760407|474271172|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
131805163|NCT02193165|474570637|FG001|4 Week Product Use|Lost to Follow-up|1|||
131805164|NCT02193165|474570638|FG002|4 Week Product Use|Lost to Follow-up|1|||
131805165|NCT02193165|474570636|FG000|6 Week Product Use|Lost to Follow-up|0|||
131805166|NCT02193165|474570637|FG001|6 Week Product Use|Lost to Follow-up|1|||
131805167|NCT02193165|474570638|FG002|6 Week Product Use|Lost to Follow-up|0|||
131805168|NCT00854308|474570639|FG000|Overall Study|Disease progression|42|||
131805169|NCT00854308|474570640|FG001|Overall Study|Disease progression|50|||
131805170|NCT00854308|474570639|FG000|Overall Study|Adverse Event|8|||
131805171|NCT00854308|474570640|FG001|Overall Study|Adverse Event|3|||
131805172|NCT00854308|474570639|FG000|Overall Study|Death|2|||
131805173|NCT00854308|474570640|FG001|Overall Study|Death|5|||
131805174|NCT00854308|474570639|FG000|Overall Study|Physician Decision|6|||
131448708|NCT00790842|473272723|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131724441|NCT02760407|474271169|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
131724442|NCT02760407|474271170|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
131724443|NCT02760407|474271171|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
131724444|NCT02760407|474271172|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
131724445|NCT02760407|474271169|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
131724446|NCT02760407|474271170|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
131724447|NCT02760407|474271171|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
131724448|NCT02760407|474271172|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
131724449|NCT02760407|474271169|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
131724450|NCT02760407|474271170|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
131724451|NCT02760407|474271171|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
131724452|NCT02760407|474271172|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
131724453|NCT02760407|474271169|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
131724454|NCT02760407|474271170|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
131724455|NCT02760407|474271171|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
131724456|NCT02760407|474271172|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
131724457|NCT01748760|474271173|FG000|Overall Study|Withdrawal by Subject|1|||
131724458|NCT01748760|474271174|FG001|Overall Study|Withdrawal by Subject|1|||
131724459|NCT01748760|474271173|FG000|Overall Study|Lost to Follow-up|5|||
131724460|NCT01748760|474271174|FG001|Overall Study|Lost to Follow-up|1|||
131724461|NCT03245814|474271175|FG000|Overall Study|Lost to Follow-up|5|||
131724462|NCT03245814|474271176|FG001|Overall Study|Lost to Follow-up|8|||
131724463|NCT03245814|474271175|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
131724464|NCT03245814|474271176|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
131724465|NCT01164501|474271177|FG000|Overall Study|Not treated|2|||
131724466|NCT01164501|474271178|FG001|Overall Study|Not treated|0|||
131724467|NCT01164501|474271179|FG002|Overall Study|Not treated|1|||
131724468|NCT01164501|474271177|FG000|Overall Study|Adverse Event|18|||
131724469|NCT01164501|474271178|FG001|Overall Study|Adverse Event|4|||
131724470|NCT01164501|474271179|FG002|Overall Study|Adverse Event|21|||
131724471|NCT01164501|474271177|FG000|Overall Study|Lack of Efficacy|0|||
131724472|NCT01164501|474271178|FG001|Overall Study|Lack of Efficacy|0|||
131724473|NCT01164501|474271179|FG002|Overall Study|Lack of Efficacy|1|||
131724474|NCT01164501|474271177|FG000|Overall Study|Non compliant with protocol|1|||
131724475|NCT01164501|474271178|FG001|Overall Study|Non compliant with protocol|1|||
131724476|NCT01164501|474271179|FG002|Overall Study|Non compliant with protocol|4|||
131724477|NCT01164501|474271177|FG000|Overall Study|Lost to Follow-up|3|||
131724478|NCT01164501|474271178|FG001|Overall Study|Lost to Follow-up|0|||
131724479|NCT01164501|474271179|FG002|Overall Study|Lost to Follow-up|3|||
131724480|NCT01164501|474271177|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
131724481|NCT01164501|474271178|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
131724482|NCT01164501|474271179|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
131724483|NCT01164501|474271177|FG000|Overall Study|Other reason not defined above|9|||
131724484|NCT01164501|474271178|FG001|Overall Study|Other reason not defined above|1|||
131724485|NCT01164501|474271179|FG002|Overall Study|Other reason not defined above|4|||
131724486|NCT00945191|474271180|FG000|Overall Study|Did not achieve a complete response|18|||
131724487|NCT00945191|474271180|FG000|Overall Study|Participant relocated to another state|1|||
131724488|NCT00945191|474271180|FG000|Overall Study|Disease progression|3|||
131724489|NCT00945191|474271180|FG000|Overall Study|Serious adverse event or adverse event|1|||
131724490|NCT00945191|474271180|FG000|Overall Study|Investigator's discretion|1|||
131724491|NCT00394914|474271183|FG000|Treatment Period|Adverse Event|0|||
131724492|NCT00394914|474271184|FG001|Treatment Period|Adverse Event|3|||
131724493|NCT00394914|474271185|FG002|Treatment Period|Adverse Event|1|||
131724494|NCT00394914|474271183|FG000|Treatment Period|Lost to Follow-up|0|||
131724495|NCT00394914|474271184|FG001|Treatment Period|Lost to Follow-up|1|||
131724496|NCT00394914|474271185|FG002|Treatment Period|Lost to Follow-up|0|||
131724497|NCT00394914|474271183|FG000|Treatment Period|Withdrawal by Subject|0|||
131724498|NCT00394914|474271184|FG001|Treatment Period|Withdrawal by Subject|2|||
131724499|NCT00394914|474271185|FG002|Treatment Period|Withdrawal by Subject|2|||
131724500|NCT00394914|474271183|FG000|Treatment Period|Noncompliance with protocol|0|||
131724501|NCT00394914|474271184|FG001|Treatment Period|Noncompliance with protocol|3|||
131724502|NCT00394914|474271185|FG002|Treatment Period|Noncompliance with protocol|2|||
131724503|NCT00394914|474271183|FG000|Treatment Period|Did not meet protocol eligibility|0|||
131724504|NCT00394914|474271184|FG001|Treatment Period|Did not meet protocol eligibility|1|||
131724505|NCT00394914|474271185|FG002|Treatment Period|Did not meet protocol eligibility|1|||
131724506|NCT00312377|474271190|FG000|Overall Study|Death|403|||
131805175|NCT00854308|474570640|FG001|Overall Study|Physician Decision|6|||
131805176|NCT00854308|474570639|FG000|Overall Study|Withdrawal by Subject|4|||
131805177|NCT00854308|474570640|FG001|Overall Study|Withdrawal by Subject|2|||
131805178|NCT00854308|474570639|FG000|Overall Study|Sponsor's decision to terminate study|0|||
131724507|NCT00312377|474271191|FG001|Overall Study|Death|418|||
131724508|NCT00312377|474271190|FG000|Overall Study|Withdrawal by Subject|23|||
131724509|NCT00312377|474271191|FG001|Overall Study|Withdrawal by Subject|30|||
131724510|NCT00312377|474271190|FG000|Overall Study|Lost to Follow-up|9|||
131724511|NCT00312377|474271191|FG001|Overall Study|Lost to Follow-up|12|||
131724512|NCT00312377|474271190|FG000|Overall Study|Non-compliance|0|||
131724513|NCT00312377|474271191|FG001|Overall Study|Non-compliance|2|||
131724514|NCT00312377|474271190|FG000|Overall Study|Randomised but never received treatment|6|||
131724515|NCT00312377|474271191|FG001|Overall Study|Randomised but never received treatment|6|||
131724516|NCT00312377|474271190|FG000|Overall Study|Discontinue treatment survival follow up|202|||
131724517|NCT00312377|474271191|FG001|Overall Study|Discontinue treatment survival follow up|200|||
131724518|NCT00312377|474271190|FG000|Overall Study|Site ended participation in study|1|||
131724519|NCT00312377|474271191|FG001|Overall Study|Site ended participation in study|0|||
131724520|NCT00872898|474271192|FG000|Part Two - Double Blind|Adverse Event|4|||
131724521|NCT00872898|474271193|FG001|Part Two - Double Blind|Adverse Event|3|||
131724522|NCT00872898|474271192|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
131724523|NCT00872898|474271193|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
131724524|NCT00872898|474271192|FG000|Part Two - Double Blind|Protocol Violation|1|||
131724525|NCT00872898|474271193|FG001|Part Two - Double Blind|Protocol Violation|0|||
131724526|NCT00872898|474271192|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
131724527|NCT00872898|474271193|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
131724528|NCT00872898|474271192|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
131724529|NCT00872898|474271193|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
131724530|NCT00872898|474271192|FG000|Part Two - Double Blind|Other reasons|2|||
131724531|NCT00872898|474271193|FG001|Part Two - Double Blind|Other reasons|0|||
131724532|NCT01004146|474271199|FG000|Overall Study|Withdrawal by Subject|4|||
131724533|NCT01004146|474271200|FG001|Overall Study|Withdrawal by Subject|5|||
131724534|NCT01001494|474271207|FG000|Overall Study|Adverse Event|8|||
131724535|NCT01001494|474271208|FG001|Overall Study|Adverse Event|4|||
131724536|NCT01001494|474271209|FG002|Overall Study|Adverse Event|6|||
131724537|NCT01001494|474271207|FG000|Overall Study|Protocol Violation|0|||
131724538|NCT01001494|474271208|FG001|Overall Study|Protocol Violation|1|||
131724539|NCT01001494|474271209|FG002|Overall Study|Protocol Violation|1|||
131724540|NCT01001494|474271207|FG000|Overall Study|Lost to Follow-up|2|||
131724541|NCT01001494|474271208|FG001|Overall Study|Lost to Follow-up|0|||
131724542|NCT01001494|474271209|FG002|Overall Study|Lost to Follow-up|1|||
131724543|NCT01001494|474271207|FG000|Overall Study|Withdrawal by Subject|9|||
131724544|NCT01001494|474271208|FG001|Overall Study|Withdrawal by Subject|7|||
131724545|NCT01001494|474271209|FG002|Overall Study|Withdrawal by Subject|17|||
131724546|NCT01001494|474271207|FG000|Overall Study|COPD exacerbation|3|||
131724547|NCT01001494|474271208|FG001|Overall Study|COPD exacerbation|4|||
131724548|NCT01001494|474271209|FG002|Overall Study|COPD exacerbation|5|||
131724549|NCT01001494|474271207|FG000|Overall Study|Lack of Efficacy|2|||
131724550|NCT01001494|474271208|FG001|Overall Study|Lack of Efficacy|0|||
131724551|NCT01001494|474271209|FG002|Overall Study|Lack of Efficacy|8|||
131724552|NCT01001494|474271207|FG000|Overall Study|Other|0|||
131724553|NCT01001494|474271208|FG001|Overall Study|Other|1|||
131724554|NCT01001494|474271209|FG002|Overall Study|Other|3|||
131724555|NCT02179398|474271210|FG000|Overall Study|Lack of obligatory data|3|||
131724556|NCT02179398|474271211|FG001|Overall Study|Lack of obligatory data|3|||
131805179|NCT00854308|474570640|FG001|Overall Study|Sponsor's decision to terminate study|1|||
131805180|NCT00610363|474570641|FG000|Overall Study|Non-compliance with protocol|0|||
131805181|NCT00610363|474570642|FG001|Overall Study|Non-compliance with protocol|1|||
131805182|NCT00610363|474570641|FG000|Overall Study|Adverse Event|3|||
131805183|NCT00610363|474570642|FG001|Overall Study|Adverse Event|1|||
131805184|NCT00610363|474570641|FG000|Overall Study|Lack of Efficacy|2|||
131805185|NCT00610363|474570642|FG001|Overall Study|Lack of Efficacy|0|||
131805186|NCT00610363|474570641|FG000|Overall Study|Lost to Follow-up|4|||
131904929|NCT02718911|474938984|FG001|Overall Study|Reason Not Collected|0|||
131448709|NCT00790842|473272724|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131448710|NCT00790842|473272725|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
131448711|NCT00790842|473272726|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131448712|NCT00790842|473272727|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131448713|NCT00790842|473272728|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131724557|NCT02179398|474271210|FG000|Overall Study|Lost to Follow-up|0|||
131724558|NCT02179398|474271211|FG001|Overall Study|Lost to Follow-up|1|||
131724559|NCT00408681|474271215|FG000|Overall Study|Lack of Efficacy|2|||
131724560|NCT00408681|474271215|FG000|Overall Study|Adverse Event|7|||
131724561|NCT02519231|474271221|FG000|Overall Study|Lost to Follow-up|2|||
131724562|NCT02519231|474271222|FG001|Overall Study|Lost to Follow-up|5|||
131724563|NCT02519231|474271221|FG000|Overall Study|Withdrawal by Subject|0|||
131724564|NCT02519231|474271222|FG001|Overall Study|Withdrawal by Subject|1|||
131805187|NCT00610363|474570642|FG001|Overall Study|Lost to Follow-up|0|||
131805188|NCT00610363|474570641|FG000|Overall Study|Withdrawal by Subject|1|||
131805189|NCT00610363|474570642|FG001|Overall Study|Withdrawal by Subject|0|||
131805190|NCT00610363|474570641|FG000|Overall Study|Other than specified above|1|||
131724565|NCT00447421|474271223|FG000|Overall Study|Lack of Efficacy|1|||
131724566|NCT00447421|474271223|FG000|Overall Study|Adverse Event|3|||
131724567|NCT00447421|474271223|FG000|Overall Study|Sponsor Decision|2|||
131724568|NCT02124798|474271224|FG000|Overall Study|Adverse Event|3|||
131724569|NCT02124798|474271224|FG000|Overall Study|Lost to Follow-up|1|||
131724570|NCT01707147|474271228|FG000|Overall Study|Administered Trajenta prior to contract|5|||
131724571|NCT01707147|474271228|FG000|Overall Study|Patients who have not taken Trajenta|1|||
131724572|NCT01707147|474271228|FG000|Overall Study|Follow-up failure|17|||
131724573|NCT01707147|474271228|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
131724574|NCT02053246|474271229|FG000|Overall Study|Withdrawal by Subject|3|||
131724575|NCT02053246|474271229|FG000|Overall Study|Physician Decision|1|||
131724576|NCT02795156|474271230|FG000|Overall Study|Progressive Disease|22|||
131724577|NCT02795156|474271231|FG001|Overall Study|Progressive Disease|7|||
131724578|NCT02795156|474271232|FG002|Overall Study|Progressive Disease|34|||
131724579|NCT02795156|474271233|FG003|Overall Study|Progressive Disease|7|||
131724580|NCT02795156|474271230|FG000|Overall Study|Adverse Event|13|||
131724581|NCT02795156|474271231|FG001|Overall Study|Adverse Event|2|||
131724582|NCT02795156|474271232|FG002|Overall Study|Adverse Event|3|||
131724583|NCT02795156|474271233|FG003|Overall Study|Adverse Event|2|||
131724584|NCT02795156|474271230|FG000|Overall Study|Death|1|||
131724585|NCT02795156|474271231|FG001|Overall Study|Death|1|||
131724586|NCT02795156|474271232|FG002|Overall Study|Death|1|||
131724587|NCT02795156|474271233|FG003|Overall Study|Death|0|||
131724588|NCT02795156|474271230|FG000|Overall Study|Physician Decision|1|||
131724589|NCT02795156|474271231|FG001|Overall Study|Physician Decision|0|||
131724590|NCT02795156|474271232|FG002|Overall Study|Physician Decision|1|||
131724591|NCT02795156|474271233|FG003|Overall Study|Physician Decision|0|||
131724592|NCT02795156|474271230|FG000|Overall Study|Withdrawal by Subject|2|||
131724593|NCT02795156|474271231|FG001|Overall Study|Withdrawal by Subject|0|||
131724594|NCT02795156|474271232|FG002|Overall Study|Withdrawal by Subject|3|||
131724595|NCT02795156|474271233|FG003|Overall Study|Withdrawal by Subject|0|||
131724596|NCT02707757|474271234|FG000|Overall Study|Protocol Violation|3|||
131724597|NCT02707757|474271235|FG001|Overall Study|Protocol Violation|2|||
131724598|NCT02707757|474271234|FG000|Overall Study|Withdrawal by Subject|2|||
131724599|NCT02707757|474271235|FG001|Overall Study|Withdrawal by Subject|0|||
131724600|NCT02707757|474271234|FG000|Overall Study|Death|0|||
131724601|NCT02707757|474271235|FG001|Overall Study|Death|1|||
131724602|NCT02707757|474271234|FG000|Overall Study|Adverse Event|6|||
131724603|NCT02707757|474271235|FG001|Overall Study|Adverse Event|4|||
131724604|NCT02707757|474271234|FG000|Overall Study|Renal transplant/elective operation|1|||
131724605|NCT02707757|474271235|FG001|Overall Study|Renal transplant/elective operation|5|||
131724606|NCT00815308|474271236|FG000|Overall Study|Adverse Event|4|||
131724607|NCT00815308|474271236|FG000|Overall Study|Withdrawal by Subject|0|||
131724608|NCT00815308|474271236|FG000|Overall Study|Protocol Violation|6|||
131724609|NCT00638846|474271240|FG000|Overall Study|Adverse Event|0|||
131724610|NCT00638846|474271241|FG001|Overall Study|Adverse Event|1|||
131724611|NCT00638846|474271240|FG000|Overall Study|Lost to Follow-up|3|||
131724612|NCT00638846|474271241|FG001|Overall Study|Lost to Follow-up|2|||
131724613|NCT00638846|474271240|FG000|Overall Study|lens issue|1|||
131724614|NCT00638846|474271241|FG001|Overall Study|lens issue|3|||
131724615|NCT00652093|474271242|FG000|Overall Study|Withdrawal by Subject|0|||
131724616|NCT00652093|474271243|FG001|Overall Study|Withdrawal by Subject|0|||
131724617|NCT00652093|474271244|FG002|Overall Study|Withdrawal by Subject|1|||
131724618|NCT00652093|474271245|FG003|Overall Study|Withdrawal by Subject|0|||
131724619|NCT00652093|474271246|FG004|Overall Study|Withdrawal by Subject|1|||
131724620|NCT00652093|474271247|FG005|Overall Study|Withdrawal by Subject|0|||
131724621|NCT00652093|474271242|FG000|Overall Study|Physician Decision|0|||
131724622|NCT00652093|474271243|FG001|Overall Study|Physician Decision|0|||
131724623|NCT00652093|474271244|FG002|Overall Study|Physician Decision|0|||
131724624|NCT00652093|474271245|FG003|Overall Study|Physician Decision|0|||
131724625|NCT00652093|474271246|FG004|Overall Study|Physician Decision|1|||
131724626|NCT00652093|474271247|FG005|Overall Study|Physician Decision|0|||
131724627|NCT02961764|474271250|FG000|Overall Study|Protocol Violation|0|||
131724628|NCT02961764|474271251|FG001|Overall Study|Protocol Violation|1|||
131724629|NCT02961764|474271250|FG000|Overall Study|Death|2|||
131724630|NCT02961764|474271251|FG001|Overall Study|Death|0|||
131724631|NCT02961764|474271250|FG000|Overall Study|Lost to Follow-up|35|||
131724632|NCT02961764|474271251|FG001|Overall Study|Lost to Follow-up|24|||
131724633|NCT02961764|474271250|FG000|Overall Study|Withdrawal by Subject|2|||
131724634|NCT02961764|474271251|FG001|Overall Study|Withdrawal by Subject|0|||
131724635|NCT01422304|474271252|FG000|Overall Study|Adverse Event|0|||
131724636|NCT01422304|474271253|FG001|Overall Study|Adverse Event|1|||
131724637|NCT01422304|474271252|FG000|Overall Study|Lost to Follow-up|14|||
131724638|NCT01422304|474271253|FG001|Overall Study|Lost to Follow-up|20|||
131724639|NCT01422304|474271252|FG000|Overall Study|Never Entered Follow-up|2|||
131724640|NCT01422304|474271253|FG001|Overall Study|Never Entered Follow-up|1|||
131724641|NCT01422304|474271252|FG000|Overall Study|Protocol Violation|1|||
131724642|NCT01422304|474271253|FG001|Overall Study|Protocol Violation|0|||
131724643|NCT01422304|474271252|FG000|Overall Study|Withdrawal by Subject|4|||
131724644|NCT01422304|474271253|FG001|Overall Study|Withdrawal by Subject|2|||
131724645|NCT01422304|474271252|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131724646|NCT01422304|474271253|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
131724647|NCT01422304|474271252|FG000|Overall Study|Not Treated|3|||
131724648|NCT01422304|474271253|FG001|Overall Study|Not Treated|11|||
131724649|NCT00916721|474271254|FG000|Overall Study|Lost to Follow-up|0|||
131724650|NCT00916721|474271255|FG001|Overall Study|Lost to Follow-up|1|||
131724651|NCT00916721|474271254|FG000|Overall Study|Adverse Event|6|||
131724652|NCT00916721|474271255|FG001|Overall Study|Adverse Event|3|||
131724653|NCT00916721|474271254|FG000|Overall Study|Withdrawal by Subject|2|||
131724654|NCT00916721|474271255|FG001|Overall Study|Withdrawal by Subject|2|||
131724655|NCT00916721|474271254|FG000|Overall Study|Protocol Violation|2|||
131724656|NCT00916721|474271255|FG001|Overall Study|Protocol Violation|4|||
131724657|NCT01469052|474271258|FG000|Overall Study|Adverse Event|2|||
131724658|NCT01469052|474271259|FG001|Overall Study|Adverse Event|3|||
131724659|NCT01469052|474271260|FG002|Overall Study|Adverse Event|0|||
131724660|NCT01469052|474271261|FG003|Overall Study|Adverse Event|2|||
131724661|NCT01469052|474271262|FG004|Overall Study|Adverse Event|0|||
131724662|NCT01469052|474271263|FG005|Overall Study|Adverse Event|1|||
131724663|NCT01469052|474271258|FG000|Overall Study|Progressive disease|3|||
131724664|NCT01469052|474271259|FG001|Overall Study|Progressive disease|0|||
131724665|NCT01469052|474271260|FG002|Overall Study|Progressive disease|5|||
131724666|NCT01469052|474271261|FG003|Overall Study|Progressive disease|3|||
131724667|NCT01469052|474271262|FG004|Overall Study|Progressive disease|7|||
131724668|NCT01469052|474271263|FG005|Overall Study|Progressive disease|2|||
131724669|NCT01469052|474271258|FG000|Overall Study|Lack of Efficacy|0|||
131724670|NCT01469052|474271259|FG001|Overall Study|Lack of Efficacy|0|||
131724671|NCT01469052|474271260|FG002|Overall Study|Lack of Efficacy|0|||
131724672|NCT01469052|474271261|FG003|Overall Study|Lack of Efficacy|0|||
131724673|NCT01469052|474271262|FG004|Overall Study|Lack of Efficacy|0|||
131724674|NCT01469052|474271263|FG005|Overall Study|Lack of Efficacy|2|||
131724675|NCT01469052|474271258|FG000|Overall Study|Moved to rollover protocol|1|||
131724676|NCT01469052|474271259|FG001|Overall Study|Moved to rollover protocol|0|||
131724677|NCT01469052|474271260|FG002|Overall Study|Moved to rollover protocol|1|||
131724678|NCT01469052|474271261|FG003|Overall Study|Moved to rollover protocol|0|||
131724679|NCT01469052|474271262|FG004|Overall Study|Moved to rollover protocol|0|||
131724680|NCT01469052|474271263|FG005|Overall Study|Moved to rollover protocol|1|||
131724681|NCT01469052|474271258|FG000|Overall Study|Other|0|||
131724682|NCT01469052|474271259|FG001|Overall Study|Other|1|||
131724683|NCT01469052|474271260|FG002|Overall Study|Other|0|||
131724684|NCT01469052|474271261|FG003|Overall Study|Other|0|||
131724685|NCT01469052|474271262|FG004|Overall Study|Other|1|||
131724686|NCT01469052|474271263|FG005|Overall Study|Other|0|||
131724687|NCT01519427|474271265|FG000|Overall Study|disease progression|2|||
131724688|NCT03894904|474271266|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
131724689|NCT03894904|474271267|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
131724690|NCT03894904|474271266|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
131724691|NCT03894904|474271267|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
131724692|NCT02190435|474271268|FG000|Overall Study|First 12 patients were lead-ins|12|||
131724693|NCT02190435|474271269|FG001|Overall Study|First 12 patients were lead-ins|0|||
131724694|NCT02190435|474271268|FG000|Overall Study|3 consented screen fails|3|||
131724695|NCT02190435|474271269|FG001|Overall Study|3 consented screen fails|0|||
131724696|NCT01781026|474271270|FG000|Overall Study|Lack of Efficacy|2|||
131724697|NCT05094154|474272583|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
131724698|NCT05094154|474272584|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
131724699|NCT05094154|474272583|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
131724700|NCT05094154|474272584|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
131724701|NCT02531035|474272593|FG000|Overall Study|Death|0|||
131724702|NCT02531035|474272594|FG001|Overall Study|Death|1|||
131724703|NCT02531035|474272593|FG000|Overall Study|Protocol Violation|1|||
131724704|NCT02531035|474272594|FG001|Overall Study|Protocol Violation|1|||
131724705|NCT02531035|474272593|FG000|Overall Study|Noncompliance with study drug|8|||
131724706|NCT02531035|474272594|FG001|Overall Study|Noncompliance with study drug|3|||
131724707|NCT02531035|474272593|FG000|Overall Study|Physician Decision|1|||
131724708|NCT02531035|474272594|FG001|Overall Study|Physician Decision|0|||
131724709|NCT02531035|474272593|FG000|Overall Study|Adverse Event|16|||
131724710|NCT02531035|474272594|FG001|Overall Study|Adverse Event|45|||
131724711|NCT02531035|474272593|FG000|Overall Study|Other|3|||
131724712|NCT02531035|474272594|FG001|Overall Study|Other|2|||
131724713|NCT02531035|474272593|FG000|Overall Study|Withdrawal by Subject|42|||
131724714|NCT02531035|474272594|FG001|Overall Study|Withdrawal by Subject|32|||
131724715|NCT02531035|474272593|FG000|Overall Study|Lost to Follow-up|8|||
131724716|NCT02531035|474272594|FG001|Overall Study|Lost to Follow-up|10|||
131724717|NCT02531035|474272593|FG000|Overall Study|Randomized, not treated|2|||
131724718|NCT02531035|474272594|FG001|Overall Study|Randomized, not treated|1|||
131724719|NCT01240811|474272601|FG000|Overall Study|Physician Decision|0|||
131724720|NCT01240811|474272602|FG001|Overall Study|Physician Decision|1|||
131724721|NCT01240811|474272603|FG002|Overall Study|Physician Decision|0|||
131724722|NCT01240811|474272601|FG000|Overall Study|Withdrawal by Subject|0|||
131724723|NCT01240811|474272602|FG001|Overall Study|Withdrawal by Subject|0|||
131724724|NCT01240811|474272603|FG002|Overall Study|Withdrawal by Subject|1|||
131724725|NCT01597622|474272607|FG000|Overall Study|Adverse Event|7|||
131724726|NCT01597622|474272607|FG000|Overall Study|Lack of Efficacy|3|||
131724727|NCT01597622|474272607|FG000|Overall Study|Protocol Violation|1|||
131724728|NCT01597622|474272607|FG000|Overall Study|Lost to Follow-up|1|||
131724729|NCT01597622|474272607|FG000|Overall Study|Investigator Discretion|5|||
131724730|NCT01597622|474272607|FG000|Overall Study|Withdrawal by Subject|20|||
131724731|NCT01597622|474272607|FG000|Overall Study|Death|1|||
131724732|NCT00521339|474272611|FG000|Treatment Phase|Adverse Event|2|||
131724733|NCT00521339|474272612|FG001|Treatment Phase|Adverse Event|0|||
131724734|NCT00521339|474272613|FG002|Treatment Phase|Adverse Event|0|||
131724735|NCT00521339|474272611|FG000|Treatment Phase|Intolerability to study drug|2|||
131724736|NCT00521339|474272612|FG001|Treatment Phase|Intolerability to study drug|0|||
131724737|NCT00521339|474272613|FG002|Treatment Phase|Intolerability to study drug|0|||
131724738|NCT00521339|474272611|FG000|Treatment Phase|Lack of Efficacy|3|||
131724739|NCT00521339|474272612|FG001|Treatment Phase|Lack of Efficacy|0|||
131724740|NCT00521339|474272613|FG002|Treatment Phase|Lack of Efficacy|0|||
131724741|NCT00521339|474272611|FG000|Treatment Phase|Withdrawal by Subject|3|||
131724742|NCT00521339|474272612|FG001|Treatment Phase|Withdrawal by Subject|0|||
131724743|NCT00521339|474272613|FG002|Treatment Phase|Withdrawal by Subject|0|||
131724744|NCT00521339|474272611|FG000|Treatment Phase|Lost to Follow-up|1|||
131724745|NCT00521339|474272612|FG001|Treatment Phase|Lost to Follow-up|0|||
131724746|NCT00521339|474272613|FG002|Treatment Phase|Lost to Follow-up|0|||
131724747|NCT00521339|474272611|FG000|Treatment Phase|Protocol Violation|1|||
131724748|NCT00521339|474272612|FG001|Treatment Phase|Protocol Violation|0|||
131724749|NCT00521339|474272613|FG002|Treatment Phase|Protocol Violation|0|||
131724750|NCT00521339|474272611|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
131724751|NCT00521339|474272612|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
131724752|NCT00521339|474272613|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
131724753|NCT00521339|474272611|FG000|Treatment Extension Phase|Death|0|||
131724754|NCT00521339|474272612|FG001|Treatment Extension Phase|Death|0|||
131724755|NCT00521339|474272613|FG002|Treatment Extension Phase|Death|1|||
131724756|NCT03314519|474272614|FG000|Overall Study|Protocol Violation|3|||
131724757|NCT03314519|474272615|FG001|Overall Study|Protocol Violation|2|||
131724758|NCT00950690|474272618|FG000|Overall Study|Death|4|||
131724759|NCT00950690|474272618|FG000|Overall Study|Adverse Event|15|||
131724760|NCT00950690|474272618|FG000|Overall Study|Lack of Efficacy|22|||
131724761|NCT00950690|474272618|FG000|Overall Study|Lost to Follow-up|40|||
131724762|NCT00950690|474272618|FG000|Overall Study|Other|163|||
131724763|NCT01713036|474272619|FG000|Overall Study|Death|1|||
131724764|NCT03567291|474272622|FG000|Period I|Adverse Event|14|||
131724765|NCT03567291|474272623|FG001|Period I|Adverse Event|0|||
131724766|NCT03567291|474272624|FG002|Period I|Adverse Event|0|||
131724767|NCT03567291|474272625|FG003|Period I|Adverse Event|0|||
131724768|NCT03567291|474272622|FG000|Period I|Protocol Violation|1|||
131724769|NCT03567291|474272623|FG001|Period I|Protocol Violation|0|||
131724770|NCT03567291|474272624|FG002|Period I|Protocol Violation|0|||
131724771|NCT03567291|474272625|FG003|Period I|Protocol Violation|0|||
131724772|NCT03567291|474272622|FG000|Period I|Withdrawal by Subject|23|||
131724773|NCT03567291|474272623|FG001|Period I|Withdrawal by Subject|0|||
131724774|NCT03567291|474272624|FG002|Period I|Withdrawal by Subject|0|||
131724775|NCT03567291|474272625|FG003|Period I|Withdrawal by Subject|0|||
131724776|NCT03567291|474272622|FG000|Period I|Lost to Follow-up|2|||
131724777|NCT03567291|474272623|FG001|Period I|Lost to Follow-up|0|||
131724778|NCT03567291|474272624|FG002|Period I|Lost to Follow-up|0|||
131724779|NCT03567291|474272625|FG003|Period I|Lost to Follow-up|0|||
131724780|NCT03567291|474272622|FG000|Period I|Terminated by sponsor|44|||
131724781|NCT03567291|474272623|FG001|Period I|Terminated by sponsor|0|||
131724782|NCT03567291|474272624|FG002|Period I|Terminated by sponsor|0|||
131724783|NCT03567291|474272625|FG003|Period I|Terminated by sponsor|0|||
131724784|NCT03567291|474272622|FG000|Period I|Missing or unknown|7|||
131724785|NCT03567291|474272623|FG001|Period I|Missing or unknown|0|||
131724786|NCT03567291|474272624|FG002|Period I|Missing or unknown|0|||
131724787|NCT03567291|474272625|FG003|Period I|Missing or unknown|0|||
131724788|NCT03567291|474272622|FG000|Period II|Adverse Event|0|||
131724789|NCT03567291|474272623|FG001|Period II|Adverse Event|1|||
131724790|NCT03567291|474272624|FG002|Period II|Adverse Event|0|||
131724791|NCT03567291|474272625|FG003|Period II|Adverse Event|0|||
131724792|NCT03567291|474272622|FG000|Period II|Missing or unknown|0|||
131724793|NCT03567291|474272623|FG001|Period II|Missing or unknown|2|||
131724794|NCT03567291|474272624|FG002|Period II|Missing or unknown|1|||
131724795|NCT03567291|474272625|FG003|Period II|Missing or unknown|0|||
131724796|NCT03567291|474272622|FG000|Period III|Adverse Event|0|||
131724797|NCT03567291|474272623|FG001|Period III|Adverse Event|0|||
131724798|NCT03567291|474272624|FG002|Period III|Adverse Event|0|||
131724799|NCT03567291|474272625|FG003|Period III|Adverse Event|4|||
131724800|NCT03567291|474272622|FG000|Period III|Withdrawal by Subject|0|||
131724801|NCT03567291|474272623|FG001|Period III|Withdrawal by Subject|0|||
131724802|NCT03567291|474272624|FG002|Period III|Withdrawal by Subject|0|||
131724803|NCT03567291|474272625|FG003|Period III|Withdrawal by Subject|4|||
131724804|NCT03567291|474272622|FG000|Period III|Lost to Follow-up|0|||
131724805|NCT03567291|474272623|FG001|Period III|Lost to Follow-up|0|||
131724806|NCT03567291|474272624|FG002|Period III|Lost to Follow-up|0|||
131724807|NCT03567291|474272625|FG003|Period III|Lost to Follow-up|1|||
131724808|NCT03567291|474272622|FG000|Period III|Terminated by sponsor|0|||
131724809|NCT03567291|474272623|FG001|Period III|Terminated by sponsor|0|||
131724810|NCT03567291|474272624|FG002|Period III|Terminated by sponsor|0|||
131724811|NCT03567291|474272625|FG003|Period III|Terminated by sponsor|68|||
131724812|NCT03567291|474272622|FG000|Period III|Missing or unknown|0|||
131724813|NCT03567291|474272623|FG001|Period III|Missing or unknown|0|||
131724814|NCT03567291|474272624|FG002|Period III|Missing or unknown|0|||
131724815|NCT03567291|474272625|FG003|Period III|Missing or unknown|8|||
131724816|NCT01103349|474272626|FG000|Overall Study|Adverse Event|8|||
131724817|NCT01103349|474272627|FG001|Overall Study|Adverse Event|5|||
131724818|NCT01103349|474272628|FG002|Overall Study|Adverse Event|3|||
131724819|NCT01103349|474272626|FG000|Overall Study|Consent withdrawn|1|||
131724820|NCT01103349|474272627|FG001|Overall Study|Consent withdrawn|0|||
131724821|NCT01103349|474272628|FG002|Overall Study|Consent withdrawn|0|||
131724822|NCT01103349|474272626|FG000|Overall Study|Incorrectly included in the trial|1|||
131724823|NCT01103349|474272627|FG001|Overall Study|Incorrectly included in the trial|0|||
131724824|NCT01103349|474272628|FG002|Overall Study|Incorrectly included in the trial|0|||
131724825|NCT01103349|474272626|FG000|Overall Study|Withdrawal by Subject|1|||
131724826|NCT01103349|474272627|FG001|Overall Study|Withdrawal by Subject|1|||
131724827|NCT01103349|474272628|FG002|Overall Study|Withdrawal by Subject|0|||
131724828|NCT01103349|474272626|FG000|Overall Study|did not want to take trial medication|0|||
131724829|NCT01103349|474272627|FG001|Overall Study|did not want to take trial medication|1|||
131724830|NCT01103349|474272628|FG002|Overall Study|did not want to take trial medication|0|||
131805191|NCT00610363|474570642|FG001|Overall Study|Other than specified above|1|||
131805192|NCT03048500|474570643|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
131805193|NCT03048500|474570643|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
131805194|NCT03048500|474570643|FG000|Reached 1st Response/Continued Treatment|Death|1|||
131805195|NCT03048500|474570643|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
131805196|NCT03048500|474570643|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
131805197|NCT03048500|474570643|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
131805198|NCT03048500|474570643|FG000|Follow up for 3 Years|Death|12|||
131805199|NCT00302952|474570644|FG000|Overall Study|Physician Decision|1|||
131805200|NCT00302952|474570645|FG001|Overall Study|Physician Decision|1|||
131805201|NCT00302952|474570644|FG000|Overall Study|Withdrawal by Subject|2|||
131805202|NCT00302952|474570645|FG001|Overall Study|Withdrawal by Subject|3|||
131805203|NCT00302952|474570644|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
131805204|NCT00302952|474570645|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
131805205|NCT02008565|474570654|FG000|Overall Study|Protocol Violation|1|||
131904930|NCT02718911|474938985|FG002|Overall Study|Reason Not Collected|1|||
131904931|NCT02718911|474938986|FG003|Overall Study|Reason Not Collected|0|||
131904932|NCT02718911|474938987|FG004|Overall Study|Reason Not Collected|0|||
131904933|NCT02718911|474938988|FG005|Overall Study|Reason Not Collected|0|||
131904934|NCT02718911|474938989|FG006|Overall Study|Reason Not Collected|2|||
131805206|NCT02008565|474570655|FG001|Overall Study|Protocol Violation|1|||
131904935|NCT02718911|474938990|FG007|Overall Study|Reason Not Collected|1|||
131805207|NCT02008565|474570656|FG002|Overall Study|Protocol Violation|2|||
131805208|NCT02008565|474570657|FG003|Overall Study|Protocol Violation|0|||
131805209|NCT00857623|474570658|FG000|Overall Study|Adverse Event|5|||
131805210|NCT00857623|474570659|FG001|Overall Study|Adverse Event|2|||
131805211|NCT00857623|474570658|FG000|Overall Study|Study-specific discontinuation criteria|5|||
131805212|NCT00857623|474570659|FG001|Overall Study|Study-specific discontinuation criteria|3|||
131904936|NCT02718911|474938991|FG008|Overall Study|Reason Not Collected|4|||
131724831|NCT01103349|474272626|FG000|Overall Study|forgot to take medication|0|||
131724832|NCT01103349|474272627|FG001|Overall Study|forgot to take medication|0|||
131724833|NCT01103349|474272628|FG002|Overall Study|forgot to take medication|1|||
131724834|NCT00090285|474272629|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
131805213|NCT00857623|474570658|FG000|Overall Study|Withdrawal by Subject|2|||
131805214|NCT00857623|474570659|FG001|Overall Study|Withdrawal by Subject|1|||
131805215|NCT00857623|474570658|FG000|Overall Study|Lack of Efficacy|1|||
131805216|NCT00857623|474570659|FG001|Overall Study|Lack of Efficacy|1|||
131805217|NCT00857623|474570658|FG000|Overall Study|Severe non-compliance to protocol|1|||
131805218|NCT00857623|474570659|FG001|Overall Study|Severe non-compliance to protocol|1|||
131805219|NCT00857623|474570658|FG000|Overall Study|Intake of prohibited medication|0|||
131805220|NCT00857623|474570659|FG001|Overall Study|Intake of prohibited medication|1|||
131805221|NCT00857623|474570658|FG000|Overall Study|Positive for HEP C|0|||
131805222|NCT00857623|474570659|FG001|Overall Study|Positive for HEP C|1|||
131805223|NCT03435081|474570660|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
131805224|NCT03435081|474570661|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
131805225|NCT03435081|474570662|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
131805226|NCT03435081|474570660|FG000|Week 0 to Week 16|Adverse Event|2|||
131805227|NCT03435081|474570661|FG001|Week 0 to Week 16|Adverse Event|2|||
131805228|NCT03435081|474570662|FG002|Week 0 to Week 16|Adverse Event|2|||
131805229|NCT03435081|474570660|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
131805230|NCT03435081|474570661|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
131805231|NCT03435081|474570662|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
131805232|NCT03435081|474570660|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
131805233|NCT03435081|474570661|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
131805234|NCT03435081|474570662|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
131805235|NCT03435081|474570660|FG000|Week 0 to Week 16|Pregnancy|1|||
131805236|NCT03435081|474570661|FG001|Week 0 to Week 16|Pregnancy|0|||
131805237|NCT03435081|474570662|FG002|Week 0 to Week 16|Pregnancy|0|||
131805238|NCT03435081|474570660|FG000|Week 0 to Week 16|Non-compliance|1|||
131805239|NCT03435081|474570661|FG001|Week 0 to Week 16|Non-compliance|0|||
131805240|NCT03435081|474570662|FG002|Week 0 to Week 16|Non-compliance|2|||
131805241|NCT03435081|474570660|FG000|Week 0 to Week 16|Inadequate Response|0|||
131805242|NCT03435081|474570661|FG001|Week 0 to Week 16|Inadequate Response|1|||
131805243|NCT03435081|474570662|FG002|Week 0 to Week 16|Inadequate Response|0|||
131805244|NCT03435081|474570660|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
131805245|NCT03435081|474570661|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
131805246|NCT03435081|474570662|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
131805247|NCT03435081|474570660|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
131805248|NCT03435081|474570661|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
131805249|NCT03435081|474570662|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
131805250|NCT03435081|474570660|FG000|Week 16 to Week 104|Adverse Event|1|||
131805251|NCT03435081|474570661|FG001|Week 16 to Week 104|Adverse Event|0|||
131805252|NCT03435081|474570662|FG002|Week 16 to Week 104|Adverse Event|2|||
131805253|NCT03435081|474570660|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
131805254|NCT03435081|474570661|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
131805255|NCT03435081|474570662|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
131805256|NCT03435081|474570660|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
131805257|NCT03435081|474570661|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
131805258|NCT03435081|474570662|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
131805259|NCT03435081|474570660|FG000|Week 16 to Week 104|Non--Compliance|0|||
131805260|NCT03435081|474570661|FG001|Week 16 to Week 104|Non--Compliance|0|||
131805261|NCT03435081|474570662|FG002|Week 16 to Week 104|Non--Compliance|1|||
131805262|NCT00420238|474570663|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
131805263|NCT00420238|474570664|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
131805264|NCT00420238|474570663|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
131805265|NCT00420238|474570664|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
131805266|NCT00420238|474570663|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
131805267|NCT00420238|474570664|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
131805268|NCT00420238|474570663|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
131805269|NCT00420238|474570664|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
131805270|NCT00420238|474570663|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
131805271|NCT00420238|474570664|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
131448714|NCT00790842|473272729|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131448715|NCT00790842|473272730|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
131448716|NCT00790842|473272720|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131805272|NCT00420238|474570663|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
131805273|NCT00420238|474570664|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
131805274|NCT00463606|474570665|FG000|Overall Study|Adverse Event|21|||
131805275|NCT00463606|474570666|FG001|Overall Study|Adverse Event|18|||
131805276|NCT00463606|474570667|FG002|Overall Study|Adverse Event|11|||
131805277|NCT00463606|474570665|FG000|Overall Study|Withdrawal by Subject|11|||
131805278|NCT00463606|474570666|FG001|Overall Study|Withdrawal by Subject|11|||
131805279|NCT00463606|474570667|FG002|Overall Study|Withdrawal by Subject|5|||
131805280|NCT00463606|474570665|FG000|Overall Study|Lost to Follow-up|2|||
131805281|NCT00463606|474570666|FG001|Overall Study|Lost to Follow-up|2|||
131904937|NCT02718911|474938992|FG009|Overall Study|Reason Not Collected|9|||
131724835|NCT00090285|474272630|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
131724836|NCT00090285|474272631|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131724837|NCT00090285|474272632|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131724838|NCT00090285|474272633|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131724839|NCT00090285|474272634|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131724840|NCT00090285|474272629|FG000|Base Study Vaccination Period|Adverse Event|2|||
131724841|NCT00090285|474272630|FG001|Base Study Vaccination Period|Adverse Event|4|||
131724842|NCT00090285|474272631|FG002|Base Study Vaccination Period|Adverse Event|0|||
131724843|NCT00090285|474272632|FG003|Base Study Vaccination Period|Adverse Event|0|||
131724844|NCT00090285|474272633|FG004|Base Study Vaccination Period|Adverse Event|0|||
131724845|NCT00090285|474272634|FG005|Base Study Vaccination Period|Adverse Event|0|||
131724846|NCT00090285|474272629|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
131724847|NCT00090285|474272630|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
131724848|NCT00090285|474272631|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
131724849|NCT00090285|474272632|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
131724850|NCT00090285|474272633|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131724851|NCT00090285|474272634|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
131724852|NCT00090285|474272629|FG000|Base Study Vaccination Period|Protocol Violation|2|||
131724853|NCT00090285|474272630|FG001|Base Study Vaccination Period|Protocol Violation|3|||
131724854|NCT00090285|474272631|FG002|Base Study Vaccination Period|Protocol Violation|0|||
131724855|NCT00090285|474272632|FG003|Base Study Vaccination Period|Protocol Violation|0|||
131724856|NCT00090285|474272633|FG004|Base Study Vaccination Period|Protocol Violation|0|||
131724857|NCT00090285|474272634|FG005|Base Study Vaccination Period|Protocol Violation|0|||
131724858|NCT00090285|474272629|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
131724859|NCT00090285|474272630|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
131724860|NCT00090285|474272631|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
131724861|NCT00090285|474272632|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
131724862|NCT00090285|474272633|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131724863|NCT00090285|474272634|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
131724864|NCT00090285|474272629|FG000|Base Study Vaccination Period|Uncooperative|2|||
131724865|NCT00090285|474272630|FG001|Base Study Vaccination Period|Uncooperative|2|||
131724866|NCT00090285|474272631|FG002|Base Study Vaccination Period|Uncooperative|0|||
131724867|NCT00090285|474272632|FG003|Base Study Vaccination Period|Uncooperative|0|||
131724868|NCT00090285|474272633|FG004|Base Study Vaccination Period|Uncooperative|0|||
131724869|NCT00090285|474272634|FG005|Base Study Vaccination Period|Uncooperative|0|||
131724870|NCT00090285|474272629|FG000|Base Study Vaccination Period|Moved|20|||
131724871|NCT00090285|474272630|FG001|Base Study Vaccination Period|Moved|21|||
131724872|NCT00090285|474272631|FG002|Base Study Vaccination Period|Moved|0|||
131724873|NCT00090285|474272632|FG003|Base Study Vaccination Period|Moved|0|||
131724874|NCT00090285|474272633|FG004|Base Study Vaccination Period|Moved|0|||
131724875|NCT00090285|474272634|FG005|Base Study Vaccination Period|Moved|0|||
131724876|NCT00090285|474272629|FG000|Base Study Vaccination Period|Site Terminated|1|||
131724877|NCT00090285|474272630|FG001|Base Study Vaccination Period|Site Terminated|0|||
131724878|NCT00090285|474272631|FG002|Base Study Vaccination Period|Site Terminated|0|||
131724879|NCT00090285|474272632|FG003|Base Study Vaccination Period|Site Terminated|0|||
131724880|NCT00090285|474272633|FG004|Base Study Vaccination Period|Site Terminated|0|||
131724881|NCT00090285|474272634|FG005|Base Study Vaccination Period|Site Terminated|0|||
131724882|NCT00090285|474272629|FG000|Base Study Vaccination Period|Other|2|||
131724883|NCT00090285|474272630|FG001|Base Study Vaccination Period|Other|2|||
131724884|NCT00090285|474272631|FG002|Base Study Vaccination Period|Other|0|||
131724885|NCT00090285|474272632|FG003|Base Study Vaccination Period|Other|0|||
131724886|NCT00090285|474272633|FG004|Base Study Vaccination Period|Other|0|||
131724887|NCT00090285|474272634|FG005|Base Study Vaccination Period|Other|0|||
131724888|NCT00090285|474272629|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
131724889|NCT00090285|474272630|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
131724890|NCT00090285|474272631|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
131724891|NCT00090285|474272632|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
131724892|NCT00090285|474272633|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
131724893|NCT00090285|474272634|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
131724894|NCT00090285|474272629|FG000|Base Study Vaccination Period|HIV positive|1|||
131724895|NCT00090285|474272630|FG001|Base Study Vaccination Period|HIV positive|1|||
131724896|NCT00090285|474272631|FG002|Base Study Vaccination Period|HIV positive|0|||
131724897|NCT00090285|474272632|FG003|Base Study Vaccination Period|HIV positive|0|||
131805282|NCT00463606|474570667|FG002|Overall Study|Lost to Follow-up|3|||
131805283|NCT00463606|474570665|FG000|Overall Study|Subject noncompliance|1|||
131724898|NCT00090285|474272633|FG004|Base Study Vaccination Period|HIV positive|0|||
131724899|NCT00090285|474272634|FG005|Base Study Vaccination Period|HIV positive|0|||
131724900|NCT00090285|474272629|FG000|Base Study Follow-up Period|Adverse Event|3|||
131724901|NCT00090285|474272630|FG001|Base Study Follow-up Period|Adverse Event|10|||
131805284|NCT00463606|474570666|FG001|Overall Study|Subject noncompliance|1|||
131724902|NCT00090285|474272631|FG002|Base Study Follow-up Period|Adverse Event|0|||
131724903|NCT00090285|474272632|FG003|Base Study Follow-up Period|Adverse Event|0|||
131724904|NCT00090285|474272633|FG004|Base Study Follow-up Period|Adverse Event|0|||
131724905|NCT00090285|474272634|FG005|Base Study Follow-up Period|Adverse Event|0|||
131724906|NCT00090285|474272629|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
131724907|NCT00090285|474272630|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
131724908|NCT00090285|474272631|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
131724909|NCT00090285|474272632|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
131724910|NCT00090285|474272633|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
131724911|NCT00090285|474272634|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
131724912|NCT00090285|474272629|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
131724913|NCT00090285|474272630|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
131724914|NCT00090285|474272631|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
131724915|NCT00090285|474272632|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
131724916|NCT00090285|474272633|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
131724917|NCT00090285|474272634|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
131724918|NCT00090285|474272629|FG000|Base Study Follow-up Period|Moved|41|||
131724919|NCT00090285|474272630|FG001|Base Study Follow-up Period|Moved|36|||
131724920|NCT00090285|474272631|FG002|Base Study Follow-up Period|Moved|0|||
131724921|NCT00090285|474272632|FG003|Base Study Follow-up Period|Moved|0|||
131724922|NCT00090285|474272633|FG004|Base Study Follow-up Period|Moved|0|||
131724923|NCT00090285|474272634|FG005|Base Study Follow-up Period|Moved|0|||
131724924|NCT00090285|474272629|FG000|Base Study Follow-up Period|Other|2|||
131724925|NCT00090285|474272630|FG001|Base Study Follow-up Period|Other|0|||
131724926|NCT00090285|474272631|FG002|Base Study Follow-up Period|Other|0|||
131724927|NCT00090285|474272632|FG003|Base Study Follow-up Period|Other|0|||
131724928|NCT00090285|474272633|FG004|Base Study Follow-up Period|Other|0|||
131724929|NCT00090285|474272634|FG005|Base Study Follow-up Period|Other|0|||
131724930|NCT00090285|474272629|FG000|Base Study Follow-up Period|Protocol Violation|1|||
131724931|NCT00090285|474272630|FG001|Base Study Follow-up Period|Protocol Violation|0|||
131724932|NCT00090285|474272631|FG002|Base Study Follow-up Period|Protocol Violation|0|||
131724933|NCT00090285|474272632|FG003|Base Study Follow-up Period|Protocol Violation|0|||
131724934|NCT00090285|474272633|FG004|Base Study Follow-up Period|Protocol Violation|0|||
131724935|NCT00090285|474272634|FG005|Base Study Follow-up Period|Protocol Violation|0|||
131724936|NCT00090285|474272629|FG000|Base Study Follow-up Period|Uncooperative|3|||
131724937|NCT00090285|474272630|FG001|Base Study Follow-up Period|Uncooperative|4|||
131724938|NCT00090285|474272631|FG002|Base Study Follow-up Period|Uncooperative|0|||
131724939|NCT00090285|474272632|FG003|Base Study Follow-up Period|Uncooperative|0|||
131724940|NCT00090285|474272633|FG004|Base Study Follow-up Period|Uncooperative|0|||
131724941|NCT00090285|474272634|FG005|Base Study Follow-up Period|Uncooperative|0|||
131724942|NCT00090285|474272629|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
131724943|NCT00090285|474272630|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
131724944|NCT00090285|474272631|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
131724945|NCT00090285|474272632|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
131724946|NCT00090285|474272633|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
131724947|NCT00090285|474272634|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
131724948|NCT00090285|474272629|FG000|Extension 1|Adverse Event|0|||
131724949|NCT00090285|474272630|FG001|Extension 1|Adverse Event|0|||
131724950|NCT00090285|474272631|FG002|Extension 1|Adverse Event|2|||
131724951|NCT00090285|474272632|FG003|Extension 1|Adverse Event|0|||
131724952|NCT00090285|474272633|FG004|Extension 1|Adverse Event|0|||
131724953|NCT00090285|474272634|FG005|Extension 1|Adverse Event|0|||
131724954|NCT00090285|474272629|FG000|Extension 1|Lost to Follow-up|0|||
131724955|NCT00090285|474272630|FG001|Extension 1|Lost to Follow-up|0|||
131724956|NCT00090285|474272631|FG002|Extension 1|Lost to Follow-up|35|||
131724957|NCT00090285|474272632|FG003|Extension 1|Lost to Follow-up|0|||
131724958|NCT00090285|474272633|FG004|Extension 1|Lost to Follow-up|0|||
131724959|NCT00090285|474272634|FG005|Extension 1|Lost to Follow-up|0|||
131724960|NCT00090285|474272629|FG000|Extension 1|Withdrawal by Subject|0|||
131724961|NCT00090285|474272630|FG001|Extension 1|Withdrawal by Subject|0|||
131724962|NCT00090285|474272631|FG002|Extension 1|Withdrawal by Subject|13|||
131724963|NCT00090285|474272632|FG003|Extension 1|Withdrawal by Subject|1|||
131724964|NCT00090285|474272633|FG004|Extension 1|Withdrawal by Subject|0|||
131724965|NCT00090285|474272634|FG005|Extension 1|Withdrawal by Subject|0|||
131724966|NCT00090285|474272629|FG000|Extension 1|Other|0|||
131724967|NCT00090285|474272630|FG001|Extension 1|Other|0|||
131724968|NCT00090285|474272631|FG002|Extension 1|Other|4|||
131724969|NCT00090285|474272632|FG003|Extension 1|Other|0|||
131724970|NCT00090285|474272633|FG004|Extension 1|Other|0|||
131724971|NCT00090285|474272634|FG005|Extension 1|Other|0|||
131724972|NCT00090285|474272629|FG000|Extension 1|Moved|0|||
131724973|NCT00090285|474272630|FG001|Extension 1|Moved|0|||
131724974|NCT00090285|474272631|FG002|Extension 1|Moved|3|||
131724975|NCT00090285|474272632|FG003|Extension 1|Moved|0|||
131724976|NCT00090285|474272633|FG004|Extension 1|Moved|0|||
131724977|NCT00090285|474272634|FG005|Extension 1|Moved|0|||
131724978|NCT00090285|474272629|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
131724979|NCT00090285|474272630|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
131724980|NCT00090285|474272631|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
131724981|NCT00090285|474272632|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
131724982|NCT00090285|474272633|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
131724983|NCT00090285|474272634|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
131724984|NCT00090285|474272629|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131724985|NCT00090285|474272630|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131724986|NCT00090285|474272631|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131724987|NCT00090285|474272632|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131724988|NCT00090285|474272633|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
131724989|NCT00090285|474272634|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
131724990|NCT00090285|474272629|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131724991|NCT00090285|474272630|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131724992|NCT00090285|474272631|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131724993|NCT00090285|474272632|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131724994|NCT00090285|474272633|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
131724995|NCT00090285|474272634|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
131724996|NCT00090285|474272629|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
131724997|NCT00090285|474272630|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
131724998|NCT00090285|474272631|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
131724999|NCT00090285|474272632|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
131725000|NCT00090285|474272633|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
131725001|NCT00090285|474272634|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
131725002|NCT00907478|474272635|FG000|Overall Study|Ineligibility determined|0|||
131725003|NCT00907478|474272636|FG001|Overall Study|Ineligibility determined|0|||
131725004|NCT00907478|474272637|FG002|Overall Study|Ineligibility determined|1|||
131725005|NCT00907478|474272635|FG000|Overall Study|Noncompliance|0|||
131725006|NCT00907478|474272636|FG001|Overall Study|Noncompliance|0|||
131725007|NCT00907478|474272637|FG002|Overall Study|Noncompliance|1|||
131725008|NCT00907478|474272635|FG000|Overall Study|Adverse Event|3|||
131725009|NCT00907478|474272636|FG001|Overall Study|Adverse Event|1|||
131725010|NCT00907478|474272637|FG002|Overall Study|Adverse Event|2|||
131725011|NCT00907478|474272635|FG000|Overall Study|Withdrawal by Subject|8|||
131725012|NCT00907478|474272636|FG001|Overall Study|Withdrawal by Subject|9|||
131725013|NCT00907478|474272637|FG002|Overall Study|Withdrawal by Subject|6|||
131725014|NCT00907478|474272635|FG000|Overall Study|Requirement for alternative therapy|1|||
131725015|NCT00907478|474272636|FG001|Overall Study|Requirement for alternative therapy|2|||
131725016|NCT00907478|474272637|FG002|Overall Study|Requirement for alternative therapy|3|||
131725017|NCT00907478|474272635|FG000|Overall Study|Physician Decision|2|||
131725018|NCT00907478|474272636|FG001|Overall Study|Physician Decision|0|||
131725019|NCT00907478|474272637|FG002|Overall Study|Physician Decision|3|||
131725020|NCT00907478|474272635|FG000|Overall Study|Death|4|||
131725021|NCT00907478|474272636|FG001|Overall Study|Death|2|||
131725022|NCT00907478|474272637|FG002|Overall Study|Death|1|||
131725023|NCT00907478|474272635|FG000|Overall Study|Protocol-specified criteria|5|||
131725024|NCT00907478|474272636|FG001|Overall Study|Protocol-specified criteria|2|||
131725025|NCT00907478|474272637|FG002|Overall Study|Protocol-specified criteria|3|||
131725026|NCT00907478|474272635|FG000|Overall Study|Pregnancy|0|||
131725027|NCT00907478|474272636|FG001|Overall Study|Pregnancy|1|||
131725028|NCT00907478|474272637|FG002|Overall Study|Pregnancy|1|||
131725029|NCT00907478|474272635|FG000|Overall Study|Lost to Follow-up|1|||
131725030|NCT00907478|474272636|FG001|Overall Study|Lost to Follow-up|0|||
131725031|NCT00907478|474272637|FG002|Overall Study|Lost to Follow-up|0|||
131725032|NCT00907478|474272635|FG000|Overall Study|Other|3|||
131725033|NCT00907478|474272636|FG001|Overall Study|Other|0|||
131725034|NCT00907478|474272637|FG002|Overall Study|Other|1|||
131725035|NCT02639182|474272638|FG000|Overall Study|Disease Progression|50|||
131725036|NCT02639182|474272639|FG001|Overall Study|Disease Progression|49|||
131725037|NCT02639182|474272638|FG000|Overall Study|Adverse Event|7|||
131725038|NCT02639182|474272639|FG001|Overall Study|Adverse Event|5|||
131725039|NCT02639182|474272638|FG000|Overall Study|Physician Decision|3|||
131725040|NCT02639182|474272639|FG001|Overall Study|Physician Decision|3|||
131725041|NCT02639182|474272638|FG000|Overall Study|Withdrew Consent|5|||
131725042|NCT02639182|474272639|FG001|Overall Study|Withdrew Consent|4|||
131725043|NCT02639182|474272638|FG000|Overall Study|Lost to Follow-up|0|||
131725044|NCT02639182|474272639|FG001|Overall Study|Lost to Follow-up|1|||
131725045|NCT02639182|474272638|FG000|Overall Study|Study Closure|1|||
131725046|NCT02639182|474272639|FG001|Overall Study|Study Closure|2|||
131725047|NCT02639182|474272638|FG000|Overall Study|Sponsor Ended Study|0|||
131725048|NCT02639182|474272639|FG001|Overall Study|Sponsor Ended Study|1|||
131725049|NCT02639182|474272638|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
131725050|NCT02639182|474272639|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
131725051|NCT03069690|474272640|FG000|Pregnancy Intervention|Pregnancy loss|9|||
131725052|NCT03069690|474272641|FG001|Pregnancy Intervention|Pregnancy loss|4|||
131725053|NCT03069690|474272642|FG002|Pregnancy Intervention|Pregnancy loss|0|||
131805285|NCT00463606|474570667|FG002|Overall Study|Subject noncompliance|0|||
131805286|NCT00463606|474570665|FG000|Overall Study|Subject moved out of town|1|||
131805287|NCT00463606|474570666|FG001|Overall Study|Subject moved out of town|0|||
131805288|NCT00463606|474570667|FG002|Overall Study|Subject moved out of town|0|||
131805289|NCT00463606|474570665|FG000|Overall Study|Physician Decision|0|||
131805290|NCT00463606|474570666|FG001|Overall Study|Physician Decision|1|||
131805291|NCT00463606|474570667|FG002|Overall Study|Physician Decision|0|||
131805292|NCT00463606|474570665|FG000|Overall Study|Sponsor request|0|||
131805293|NCT00463606|474570666|FG001|Overall Study|Sponsor request|1|||
131805294|NCT00463606|474570667|FG002|Overall Study|Sponsor request|0|||
131805295|NCT00463606|474570665|FG000|Overall Study|Exclusion criteria violation|2|||
131805296|NCT00463606|474570666|FG001|Overall Study|Exclusion criteria violation|0|||
131805297|NCT00463606|474570667|FG002|Overall Study|Exclusion criteria violation|0|||
131805298|NCT00463606|474570665|FG000|Overall Study|Coordinator error|1|||
131725054|NCT03069690|474272643|FG003|Pregnancy Intervention|Pregnancy loss|0|||
131725055|NCT03069690|474272644|FG004|Pregnancy Intervention|Pregnancy loss|0|||
131725056|NCT03069690|474272645|FG005|Pregnancy Intervention|Pregnancy loss|0|||
131725057|NCT03069690|474272640|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
131725058|NCT03069690|474272641|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
131725059|NCT03069690|474272642|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
131805299|NCT00463606|474570666|FG001|Overall Study|Coordinator error|0|||
131805300|NCT00463606|474570667|FG002|Overall Study|Coordinator error|0|||
131805301|NCT00463606|474570665|FG000|Overall Study|Patient randomized in error|1|||
131805302|NCT00463606|474570666|FG001|Overall Study|Patient randomized in error|0|||
131805303|NCT00463606|474570667|FG002|Overall Study|Patient randomized in error|0|||
131805304|NCT00463606|474570665|FG000|Overall Study|Participation in another ABT-335 trial|1|||
131805305|NCT00463606|474570666|FG001|Overall Study|Participation in another ABT-335 trial|0|||
131805306|NCT00463606|474570667|FG002|Overall Study|Participation in another ABT-335 trial|0|||
131805307|NCT00463606|474570665|FG000|Overall Study|Protocol Violation|0|||
131805308|NCT00463606|474570666|FG001|Overall Study|Protocol Violation|0|||
131805309|NCT00463606|474570667|FG002|Overall Study|Protocol Violation|1|||
131725060|NCT03069690|474272643|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
131725061|NCT03069690|474272644|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
131725062|NCT03069690|474272645|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
131725063|NCT03069690|474272640|FG000|Postpartum Intervention|Lost to Follow-up|0|||
131725064|NCT03069690|474272641|FG001|Postpartum Intervention|Lost to Follow-up|0|||
131725065|NCT03069690|474272642|FG002|Postpartum Intervention|Lost to Follow-up|5|||
131725066|NCT03069690|474272643|FG003|Postpartum Intervention|Lost to Follow-up|5|||
131725067|NCT03069690|474272644|FG004|Postpartum Intervention|Lost to Follow-up|2|||
131725068|NCT03069690|474272645|FG005|Postpartum Intervention|Lost to Follow-up|4|||
131725069|NCT03268746|474272650|FG000|Overall Study|Withdrawal by Subject|1|||
131725070|NCT00553059|474272651|FG000|Overall Study|Deemed ineligible|1|||
131725071|NCT00553059|474272652|FG001|Overall Study|Deemed ineligible|1|||
131725072|NCT00553059|474272651|FG000|Overall Study|Drug supply not available|0|||
131725073|NCT00553059|474272652|FG001|Overall Study|Drug supply not available|1|||
131725074|NCT01372878|474272653|FG000|Overall Study|Withdrawal by Subject|63|||
131725075|NCT01372878|474272653|FG000|Overall Study|Protocol Violation|17|||
131725076|NCT01372878|474272653|FG000|Overall Study|incomplete study procedure|104|||
131725077|NCT00117338|474272654|FG000|Overall Study|Adverse Event|0|||
131725078|NCT00117338|474272655|FG001|Overall Study|Adverse Event|1|||
131725079|NCT00117338|474272654|FG000|Overall Study|Protocol Violation|3|||
131725080|NCT00117338|474272655|FG001|Overall Study|Protocol Violation|2|||
131725081|NCT00117338|474272654|FG000|Overall Study|Withdrawal by Subject|1|||
131725082|NCT00117338|474272655|FG001|Overall Study|Withdrawal by Subject|0|||
131725083|NCT00117338|474272654|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
131725084|NCT00117338|474272655|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
131725085|NCT00117338|474272654|FG000|Overall Study|Lack of Efficacy|0|||
131725086|NCT00117338|474272655|FG001|Overall Study|Lack of Efficacy|1|||
131725087|NCT00859898|474272660|FG000|Overall Study|Lack of Efficacy|0|||
131725088|NCT00859898|474272661|FG001|Overall Study|Lack of Efficacy|1|||
131725089|NCT00859898|474272662|FG002|Overall Study|Lack of Efficacy|1|||
131725090|NCT00859898|474272660|FG000|Overall Study|Adverse Event|4|||
131725091|NCT00859898|474272661|FG001|Overall Study|Adverse Event|9|||
131725092|NCT00859898|474272662|FG002|Overall Study|Adverse Event|8|||
131725093|NCT00859898|474272660|FG000|Overall Study|Withdrawal by Subject|11|||
131805310|NCT00549718|474572527|FG000|Overall Study|Insufficient clinical response|20|||
131805311|NCT00549718|474572528|FG001|Overall Study|Insufficient clinical response|7|||
131805312|NCT00549718|474572529|FG002|Overall Study|Insufficient clinical response|18|||
131805313|NCT00549718|474572530|FG003|Overall Study|Insufficient clinical response|32|||
131725094|NCT00859898|474272661|FG001|Overall Study|Withdrawal by Subject|8|||
131725095|NCT00859898|474272662|FG002|Overall Study|Withdrawal by Subject|11|||
131805314|NCT00549718|474572527|FG000|Overall Study|Adverse Event|6|||
131904938|NCT05002972|474938993|FG000|Overall Study|Withdrawal by Subject|2|||
131904939|NCT01172873|474938997|FG000|Overall Study|Withdrawal by Subject|3|||
131904940|NCT01172873|474938998|FG001|Overall Study|Withdrawal by Subject|2|||
131904941|NCT00983372|474938999|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
131725096|NCT00859898|474272660|FG000|Overall Study|Death|0|||
131725097|NCT00859898|474272661|FG001|Overall Study|Death|0|||
131725098|NCT00859898|474272662|FG002|Overall Study|Death|1|||
131725099|NCT00859898|474272660|FG000|Overall Study|Lost to Follow-up|10|||
131725100|NCT00859898|474272661|FG001|Overall Study|Lost to Follow-up|11|||
131725101|NCT00859898|474272662|FG002|Overall Study|Lost to Follow-up|5|||
131725102|NCT00859898|474272660|FG000|Overall Study|poor/non-compliance|2|||
131725103|NCT00859898|474272661|FG001|Overall Study|poor/non-compliance|0|||
131725104|NCT00859898|474272662|FG002|Overall Study|poor/non-compliance|0|||
131725105|NCT00859898|474272660|FG000|Overall Study|No longer meets criteria|0|||
131725106|NCT00859898|474272661|FG001|Overall Study|No longer meets criteria|1|||
131725107|NCT00859898|474272662|FG002|Overall Study|No longer meets criteria|0|||
131725108|NCT00859898|474272660|FG000|Overall Study|non-specified|1|||
131725109|NCT00859898|474272661|FG001|Overall Study|non-specified|1|||
131725110|NCT00859898|474272662|FG002|Overall Study|non-specified|1|||
131725111|NCT01302041|474272663|FG000|Overall Study|Death|5|||
131725112|NCT01302041|474272663|FG000|Overall Study|Withdrawal by Subject|4|||
131805315|NCT00549718|474572528|FG001|Overall Study|Adverse Event|8|||
131805316|NCT00549718|474572529|FG002|Overall Study|Adverse Event|7|||
131805317|NCT00549718|474572530|FG003|Overall Study|Adverse Event|3|||
131805318|NCT00549718|474572527|FG000|Overall Study|Lost to Follow-up|4|||
131805319|NCT00549718|474572528|FG001|Overall Study|Lost to Follow-up|2|||
131805320|NCT00549718|474572529|FG002|Overall Study|Lost to Follow-up|0|||
131805321|NCT00549718|474572530|FG003|Overall Study|Lost to Follow-up|6|||
131805322|NCT00549718|474572527|FG000|Overall Study|Withdrawal by Subject|9|||
131805323|NCT00549718|474572528|FG001|Overall Study|Withdrawal by Subject|18|||
131805324|NCT00549718|474572529|FG002|Overall Study|Withdrawal by Subject|12|||
131805325|NCT00549718|474572530|FG003|Overall Study|Withdrawal by Subject|13|||
131805326|NCT00549718|474572527|FG000|Overall Study|Administrative|2|||
131805327|NCT00549718|474572528|FG001|Overall Study|Administrative|2|||
131805328|NCT00549718|474572529|FG002|Overall Study|Administrative|2|||
131805329|NCT00549718|474572530|FG003|Overall Study|Administrative|1|||
131805330|NCT01675622|474572533|FG000|Overall Study|Withdrawal by Subject|2|||
131805331|NCT01675622|474572534|FG001|Overall Study|Withdrawal by Subject|2|||
131805332|NCT01675622|474572533|FG000|Overall Study|Adverse Event|12|||
131805333|NCT01675622|474572534|FG001|Overall Study|Adverse Event|10|||
131805334|NCT01675622|474572533|FG000|Overall Study|Protocol Violation|4|||
131805335|NCT01675622|474572534|FG001|Overall Study|Protocol Violation|1|||
131805336|NCT01675622|474572533|FG000|Overall Study|Lack of Efficacy|2|||
131805337|NCT01675622|474572534|FG001|Overall Study|Lack of Efficacy|4|||
131805338|NCT01675622|474572533|FG000|Overall Study|Lost to Follow-up|1|||
131805339|NCT01675622|474572534|FG001|Overall Study|Lost to Follow-up|3|||
131805340|NCT01675622|474572533|FG000|Overall Study|Other|5|||
131805341|NCT01675622|474572534|FG001|Overall Study|Other|4|||
131805342|NCT04032977|474572535|FG000|Overall Study|Withdrawal by Subject|6|||
131805343|NCT04032977|474572536|FG001|Overall Study|Withdrawal by Subject|1|||
131805344|NCT04032977|474572535|FG000|Overall Study|Lost to Follow-up|2|||
131805345|NCT04032977|474572536|FG001|Overall Study|Lost to Follow-up|7|||
131805346|NCT04032977|474572535|FG000|Overall Study|Pregnancy|1|||
131805347|NCT04032977|474572536|FG001|Overall Study|Pregnancy|0|||
131805348|NCT03075761|474572538|FG000|Overall Study|Lost to Follow-up|1|||
131805349|NCT03075761|474572539|FG001|Overall Study|Lost to Follow-up|6|||
131805350|NCT02880761|474572540|FG000|Overall Study|Death|6|||
131725113|NCT01302041|474272663|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
131725114|NCT01302041|474272663|FG000|Overall Study|Other-Miscellaneous Reason|2|||
131725115|NCT04504032|474272664|FG000|Overall Study|Adverse Event|1|||
131725116|NCT04504032|474272665|FG001|Overall Study|Adverse Event|2|||
131725117|NCT04504032|474272664|FG000|Overall Study|Lost to Follow-up|6|||
131496714|NCT02289690|473446362|FG003|Overall Study|Death|0|||
131725118|NCT04504032|474272665|FG001|Overall Study|Lost to Follow-up|9|||
131725119|NCT04504032|474272664|FG000|Overall Study|Protocol Violation|2|||
131725120|NCT04504032|474272665|FG001|Overall Study|Protocol Violation|0|||
131725121|NCT04504032|474272664|FG000|Overall Study|Study terminated by sponsor|1|||
131725122|NCT04504032|474272665|FG001|Overall Study|Study terminated by sponsor|2|||
131725123|NCT04504032|474272664|FG000|Overall Study|Withdrawal by Subject|9|||
131725124|NCT04504032|474272665|FG001|Overall Study|Withdrawal by Subject|11|||
131725125|NCT04504032|474272664|FG000|Overall Study|Disease progression prior to dosing|15|||
131725126|NCT04504032|474272665|FG001|Overall Study|Disease progression prior to dosing|3|||
131725127|NCT04504032|474272664|FG000|Overall Study|Drug supply issues|1|||
131725128|NCT04504032|474272665|FG001|Overall Study|Drug supply issues|1|||
131725129|NCT04504032|474272664|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
131725130|NCT04504032|474272665|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
131725131|NCT01327339|474272669|FG000|Overall Study|Protocol Violation|8|||
131725132|NCT00700752|474272670|FG000|First Intervention|Withdrawal by Subject|0|||
131805351|NCT02880761|474572541|FG001|Overall Study|Death|8|||
131805352|NCT02880761|474572540|FG000|Overall Study|Withdrawal by Subject|3|||
131805353|NCT02880761|474572541|FG001|Overall Study|Withdrawal by Subject|6|||
131725133|NCT00700752|474272671|FG001|First Intervention|Withdrawal by Subject|2|||
131725134|NCT01302769|474272672|FG000|Overall Study|Lost to Follow-up|1|||
131725135|NCT01302769|474272673|FG001|Overall Study|Lost to Follow-up|1|||
131725136|NCT04983940|474272674|FG000|Overall Study|Lost to Follow-up|14|||
131725137|NCT04983940|474272674|FG000|Overall Study|Lack of Efficacy|2|||
131725138|NCT01645930|474272675|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
131725139|NCT01645930|474272675|FG000|Overall Study|Progressive Disease|12|||
131725140|NCT01645930|474272675|FG000|Overall Study|Adverse Event|4|||
131725141|NCT01645930|474272675|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
131725142|NCT01645930|474272675|FG000|Overall Study|Withdrawal by Participant|2|||
131725143|NCT01645930|474272675|FG000|Overall Study|Reason not Defined|1|||
131725144|NCT02522377|474272679|FG000|Overall Study|Withdrawal by Subject|1|||
131725145|NCT02522377|474272680|FG001|Overall Study|Withdrawal by Subject|0|||
131725146|NCT02522377|474272679|FG000|Overall Study|Remission Achieved|3|||
131725147|NCT02522377|474272680|FG001|Overall Study|Remission Achieved|0|||
131725148|NCT02263365|474272681|FG000|Overall Study|Physician Decision|22|||
131725149|NCT02263365|474272682|FG001|Overall Study|Physician Decision|18|||
131725150|NCT01797432|474272688|FG000|Overall Study|Lost to Follow-up|1|||
131725151|NCT01797432|474272688|FG000|Overall Study|Adverse Event|1|||
131725152|NCT01797432|474272688|FG000|Overall Study|Withdrawal by Subject|1|||
131725153|NCT01797432|474272688|FG000|Overall Study|lived too far from study site|1|||
131725154|NCT00492921|474272691|FG000|Overall Study|Death|1|||
131725155|NCT00492921|474272692|FG001|Overall Study|Death|0|||
131725156|NCT00492921|474272693|FG002|Overall Study|Death|1|||
131725157|NCT00734929|474272694|FG000|Overall Study|Lost to Follow-up|1|||
131725158|NCT00734929|474272695|FG001|Overall Study|Lost to Follow-up|2|||
131725159|NCT00734929|474272694|FG000|Overall Study|No intervention/ screen fail|5|||
131725160|NCT00734929|474272695|FG001|Overall Study|No intervention/ screen fail|3|||
131725161|NCT03176966|474272699|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
131725162|NCT03176966|474272700|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
131725163|NCT03176966|474272699|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
131725164|NCT03176966|474272700|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
131725165|NCT03176966|474272699|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
131725166|NCT03176966|474272700|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
131725167|NCT03176966|474272699|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
131725168|NCT03176966|474272700|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
131725169|NCT03176966|474272699|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
131725170|NCT03176966|474272700|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
131725171|NCT03176966|474272699|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
131725172|NCT03176966|474272700|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
131725173|NCT03176966|474272699|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
131725174|NCT03176966|474272700|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
131725175|NCT01520922|474272701|FG000|Treatment Phase|Physician Decision|2|||
131725176|NCT01520922|474272702|FG001|Treatment Phase|Physician Decision|1|||
131725177|NCT01520922|474272701|FG000|Treatment Phase|Progression|0|||
131725178|NCT01520922|474272702|FG001|Treatment Phase|Progression|2|||
131725179|NCT01520922|474272701|FG000|Treatment Phase|Adverse Event|3|||
131725180|NCT01520922|474272702|FG001|Treatment Phase|Adverse Event|5|||
131725181|NCT01520922|474272701|FG000|Follow up|Lost to Follow-up|0|||
131725182|NCT01520922|474272702|FG001|Follow up|Lost to Follow-up|1|||
131805354|NCT02880761|474572540|FG000|Overall Study|Protocol Violation|4|||
131805355|NCT02880761|474572541|FG001|Overall Study|Protocol Violation|3|||
131805356|NCT02880761|474572540|FG000|Overall Study|Lost to Follow-up|3|||
131805357|NCT02880761|474572541|FG001|Overall Study|Lost to Follow-up|4|||
131805358|NCT03597256|474572542|FG000|Overall Study|Lost to Follow-up|3|||
131805359|NCT03597256|474572543|FG001|Overall Study|Lost to Follow-up|1|||
131805360|NCT03597256|474572542|FG000|Overall Study|Withdrawal by Subject|0|||
131805361|NCT03597256|474572543|FG001|Overall Study|Withdrawal by Subject|1|||
131805362|NCT03597256|474572542|FG000|Overall Study|Could not return for treatment|0|||
131805363|NCT03597256|474572543|FG001|Overall Study|Could not return for treatment|1|||
131805364|NCT03597256|474572542|FG000|Overall Study|Moved from location|0|||
131805365|NCT03597256|474572543|FG001|Overall Study|Moved from location|1|||
131805366|NCT03597256|474572542|FG000|Overall Study|Not accepted the treatment|0|||
131805367|NCT03597256|474572543|FG001|Overall Study|Not accepted the treatment|1|||
131805368|NCT02106156|474572544|FG000|Overall Study|Patient Died|19|||
131805369|NCT02106156|474572545|FG001|Overall Study|Patient Died|0|||
131805370|NCT02106156|474572546|FG002|Overall Study|Patient Died|0|||
131805371|NCT02106156|474572544|FG000|Overall Study|Lack of Tolerability|305|||
131805372|NCT02106156|474572545|FG001|Overall Study|Lack of Tolerability|3|||
131805373|NCT02106156|474572546|FG002|Overall Study|Lack of Tolerability|0|||
131725183|NCT01520922|474272701|FG000|Survival Follow-up|Withdrawal by Subject|1|||
131725184|NCT01520922|474272702|FG001|Survival Follow-up|Withdrawal by Subject|0|||
131725185|NCT01696877|474272703|FG000|Overall Study|Adverse Event|0|||
131725186|NCT01696877|474272704|FG001|Overall Study|Adverse Event|1|||
131725187|NCT00469014|474272705|FG000|Initial Phase Randomization|Disease Progression|0|||
131725188|NCT00469014|474272706|FG001|Initial Phase Randomization|Disease Progression|1|||
131725189|NCT00469014|474272707|FG002|Initial Phase Randomization|Disease Progression|1|||
131725190|NCT00469014|474272708|FG003|Initial Phase Randomization|Disease Progression|0|||
131725191|NCT00469014|474272705|FG000|Initial Phase Randomization|No Response|1|||
131725192|NCT00469014|474272706|FG001|Initial Phase Randomization|No Response|0|||
131725193|NCT00469014|474272707|FG002|Initial Phase Randomization|No Response|0|||
131725194|NCT00469014|474272708|FG003|Initial Phase Randomization|No Response|1|||
131725195|NCT00469014|474272705|FG000|Adaptive Randomization|Not Evaluable|1|||
131725196|NCT00469014|474272706|FG001|Adaptive Randomization|Not Evaluable|0|||
131725197|NCT00469014|474272707|FG002|Adaptive Randomization|Not Evaluable|0|||
131725198|NCT00469014|474272708|FG003|Adaptive Randomization|Not Evaluable|1|||
131725199|NCT00469014|474272705|FG000|Adaptive Randomization|No Response|0|||
131725200|NCT00469014|474272706|FG001|Adaptive Randomization|No Response|1|||
131725201|NCT00469014|474272707|FG002|Adaptive Randomization|No Response|0|||
131725202|NCT00469014|474272708|FG003|Adaptive Randomization|No Response|0|||
131725203|NCT00469014|474272705|FG000|Adaptive Randomization|Death|0|||
131725204|NCT00469014|474272706|FG001|Adaptive Randomization|Death|0|||
131725205|NCT00469014|474272707|FG002|Adaptive Randomization|Death|1|||
131725206|NCT00469014|474272708|FG003|Adaptive Randomization|Death|0|||
131725207|NCT03461289|474272710|FG000|Overall Study|Death|1|||
131725208|NCT00866294|474272711|FG000|Overall Study|Adverse Event|12|||
131725209|NCT00866294|474272712|FG001|Overall Study|Adverse Event|13|||
131725210|NCT00866294|474272713|FG002|Overall Study|Adverse Event|9|||
131725211|NCT00866294|474272711|FG000|Overall Study|Lack of Efficacy|7|||
131725212|NCT00866294|474272712|FG001|Overall Study|Lack of Efficacy|1|||
131725213|NCT00866294|474272713|FG002|Overall Study|Lack of Efficacy|0|||
131725214|NCT00866294|474272711|FG000|Overall Study|Protocol Violation|2|||
131725215|NCT00866294|474272712|FG001|Overall Study|Protocol Violation|0|||
131725216|NCT00866294|474272713|FG002|Overall Study|Protocol Violation|0|||
131725217|NCT00866294|474272711|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
131725218|NCT00866294|474272712|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131725219|NCT00866294|474272713|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131725220|NCT00866294|474272711|FG000|Overall Study|Lost to Follow-up|1|||
131725221|NCT00866294|474272712|FG001|Overall Study|Lost to Follow-up|3|||
131725222|NCT00866294|474272713|FG002|Overall Study|Lost to Follow-up|0|||
131725223|NCT00866294|474272711|FG000|Overall Study|Physician Decision|6|||
131725224|NCT00866294|474272712|FG001|Overall Study|Physician Decision|2|||
131725225|NCT00866294|474272713|FG002|Overall Study|Physician Decision|1|||
131725226|NCT00081289|474272714|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
131725227|NCT00081289|474272715|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
131725228|NCT00081289|474272714|FG000|Overall Study|Ineligible / no protocol treatment|3|||
131725229|NCT00081289|474272715|FG001|Overall Study|Ineligible / no protocol treatment|4|||
131725230|NCT01903434|474272719|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
131725231|NCT01903434|474272720|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
131725232|NCT01903434|474272719|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
131725233|NCT01903434|474272720|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
131725234|NCT02749370|474272721|FG000|Overall Study|Withdrawal by Subject|11|||
131725235|NCT02749370|474272721|FG000|Overall Study|Lost to Follow-up|3|||
131725236|NCT03242759|474272725|FG000|Overall Study|Adverse Event|5|||
131725237|NCT03242759|474272726|FG001|Overall Study|Adverse Event|1|||
131725238|NCT03242759|474272725|FG000|Overall Study|Withdrawal by Subject|4|||
131725239|NCT03242759|474272726|FG001|Overall Study|Withdrawal by Subject|3|||
131725240|NCT03242759|474272725|FG000|Overall Study|Lost to Follow-up|3|||
131725241|NCT03242759|474272726|FG001|Overall Study|Lost to Follow-up|1|||
131725242|NCT03242759|474272725|FG000|Overall Study|Administrative problems|1|||
131496715|NCT02289690|473446363|FG004|Overall Study|Death|0|||
131725243|NCT03242759|474272726|FG001|Overall Study|Administrative problems|1|||
131725244|NCT03242759|474272725|FG000|Overall Study|Death|22|||
131725245|NCT03242759|474272726|FG001|Overall Study|Death|0|||
131725246|NCT03242759|474272725|FG000|Overall Study|Change visit schedule|0|||
131725247|NCT03242759|474272726|FG001|Overall Study|Change visit schedule|1|||
131725248|NCT00404768|474272729|FG000|Part A and B|Withdrawn due to labor progression|1|||
131725249|NCT00404768|474272730|FG001|Part A and B|Withdrawn due to labor progression|0|||
131725250|NCT00404768|474272731|FG002|Part A and B|Withdrawn due to labor progression|0|||
131725251|NCT00404768|474272732|FG003|Part A and B|Withdrawn due to labor progression|0|||
131725252|NCT00404768|474272729|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
131725253|NCT00404768|474272730|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
131725254|NCT00404768|474272731|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
131725255|NCT00404768|474272732|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
131725256|NCT00404768|474272729|FG000|Part C|Adverse Event|0|||
131725257|NCT00404768|474272730|FG001|Part C|Adverse Event|0|||
131725258|NCT00404768|474272731|FG002|Part C|Adverse Event|0|||
131725259|NCT00404768|474272732|FG003|Part C|Adverse Event|3|||
131805374|NCT02106156|474572544|FG000|Overall Study|Lack of Virological Response|1044|||
131725260|NCT00404768|474272729|FG000|Part C|Lost to Follow-up|0|||
131448717|NCT00790842|473272721|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131725261|NCT00404768|474272730|FG001|Part C|Lost to Follow-up|0|||
131725262|NCT00404768|474272731|FG002|Part C|Lost to Follow-up|3|||
131725263|NCT00404768|474272732|FG003|Part C|Lost to Follow-up|1|||
131725264|NCT00404768|474272729|FG000|Part C|Withdrawal by Subject|0|||
131725265|NCT00404768|474272730|FG001|Part C|Withdrawal by Subject|0|||
131725266|NCT00404768|474272731|FG002|Part C|Withdrawal by Subject|2|||
131725267|NCT00404768|474272732|FG003|Part C|Withdrawal by Subject|1|||
131725268|NCT00404768|474272729|FG000|Part C|Early withdrawal from study medication|0|||
131725269|NCT00404768|474272730|FG001|Part C|Early withdrawal from study medication|0|||
131725270|NCT00404768|474272731|FG002|Part C|Early withdrawal from study medication|1|||
131725271|NCT00404768|474272732|FG003|Part C|Early withdrawal from study medication|0|||
131725272|NCT00404768|474272729|FG000|Part C|Participant did not respond to therapy|0|||
131725273|NCT00404768|474272730|FG001|Part C|Participant did not respond to therapy|0|||
131725274|NCT00404768|474272731|FG002|Part C|Participant did not respond to therapy|1|||
131725275|NCT00404768|474272732|FG003|Part C|Participant did not respond to therapy|1|||
131725276|NCT00404768|474272729|FG000|Part C|Physician withdrew the study medication|0|||
131725277|NCT00404768|474272730|FG001|Part C|Physician withdrew the study medication|0|||
131725278|NCT00404768|474272731|FG002|Part C|Physician withdrew the study medication|1|||
131725279|NCT00404768|474272732|FG003|Part C|Physician withdrew the study medication|0|||
131805375|NCT02106156|474572545|FG001|Overall Study|Lack of Virological Response|8|||
131805376|NCT02106156|474572546|FG002|Overall Study|Lack of Virological Response|0|||
131805377|NCT02106156|474572544|FG000|Overall Study|Concomitant Disease|74|||
131805378|NCT02106156|474572545|FG001|Overall Study|Concomitant Disease|2|||
131805379|NCT02106156|474572546|FG002|Overall Study|Concomitant Disease|0|||
131805380|NCT02106156|474572544|FG000|Overall Study|Lack of Compliance|211|||
131805381|NCT02106156|474572545|FG001|Overall Study|Lack of Compliance|7|||
131805382|NCT02106156|474572546|FG002|Overall Study|Lack of Compliance|0|||
131805383|NCT02106156|474572544|FG000|Overall Study|Patients Request|307|||
131805384|NCT02106156|474572545|FG001|Overall Study|Patients Request|9|||
131725280|NCT00404768|474272729|FG000|Part C|Participant delivered baby|0|||
131725281|NCT00404768|474272730|FG001|Part C|Participant delivered baby|0|||
131725282|NCT00404768|474272731|FG002|Part C|Participant delivered baby|0|||
131725283|NCT00404768|474272732|FG003|Part C|Participant delivered baby|1|||
131725284|NCT00404768|474272729|FG000|Part C|Unsatisfactory uterine response to IP|0|||
131725285|NCT00404768|474272730|FG001|Part C|Unsatisfactory uterine response to IP|0|||
131725286|NCT00404768|474272731|FG002|Part C|Unsatisfactory uterine response to IP|0|||
131725287|NCT00404768|474272732|FG003|Part C|Unsatisfactory uterine response to IP|1|||
131725288|NCT00404768|474272729|FG000|Part C|Active labor|0|||
131725289|NCT00404768|474272730|FG001|Part C|Active labor|0|||
131725290|NCT00404768|474272731|FG002|Part C|Active labor|0|||
131725291|NCT00404768|474272732|FG003|Part C|Active labor|1|||
131725292|NCT00404768|474272729|FG000|Part C|Lack of Efficacy|0|||
131725293|NCT00404768|474272730|FG001|Part C|Lack of Efficacy|0|||
131725294|NCT00404768|474272731|FG002|Part C|Lack of Efficacy|0|||
131725295|NCT00404768|474272732|FG003|Part C|Lack of Efficacy|2|||
131725296|NCT00404768|474272729|FG000|Part C|Treatment failure|0|||
131805385|NCT02106156|474572546|FG002|Overall Study|Patients Request|0|||
131805386|NCT02106156|474572544|FG000|Overall Study|Lost to Follow-up|451|||
131805387|NCT02106156|474572545|FG001|Overall Study|Lost to Follow-up|8|||
131805388|NCT02106156|474572546|FG002|Overall Study|Lost to Follow-up|0|||
131805389|NCT02106156|474572544|FG000|Overall Study|Unplanned Event|82|||
131805390|NCT02106156|474572545|FG001|Overall Study|Unplanned Event|2|||
131805391|NCT02106156|474572546|FG002|Overall Study|Unplanned Event|0|||
131805392|NCT02106156|474572544|FG000|Overall Study|Change of Laboratory Parameter|10|||
131805393|NCT02106156|474572545|FG001|Overall Study|Change of Laboratory Parameter|0|||
131805394|NCT02106156|474572546|FG002|Overall Study|Change of Laboratory Parameter|0|||
131805395|NCT02106156|474572544|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
131805396|NCT02106156|474572545|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
131805397|NCT02106156|474572546|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
131805398|NCT02106156|474572544|FG000|Overall Study|Relocation/Change of Physician|40|||
131805399|NCT02106156|474572545|FG001|Overall Study|Relocation/Change of Physician|1|||
131805400|NCT02106156|474572546|FG002|Overall Study|Relocation/Change of Physician|0|||
131805401|NCT05017480|474572556|FG000|Stage 1 Study|Withdrawal by Subject|8|||
131805402|NCT05017480|474572557|FG001|Stage 1 Study|Withdrawal by Subject|6|||
131805403|NCT05017480|474572558|FG002|Stage 1 Study|Withdrawal by Subject|0|||
131805404|NCT05017480|474572559|FG003|Stage 1 Study|Withdrawal by Subject|0|||
131805405|NCT05017480|474572560|FG004|Stage 1 Study|Withdrawal by Subject|0|||
131805406|NCT05017480|474572556|FG000|Stage 1 Study|Adverse Event|1|||
131805407|NCT05017480|474572557|FG001|Stage 1 Study|Adverse Event|1|||
131805408|NCT05017480|474572558|FG002|Stage 1 Study|Adverse Event|0|||
131725297|NCT00404768|474272730|FG001|Part C|Treatment failure|0|||
131725298|NCT00404768|474272731|FG002|Part C|Treatment failure|0|||
131725299|NCT00404768|474272732|FG003|Part C|Treatment failure|1|||
131725300|NCT00404768|474272729|FG000|Part C|Investigator discretion|0|||
131725301|NCT00404768|474272730|FG001|Part C|Investigator discretion|0|||
131725302|NCT00404768|474272731|FG002|Part C|Investigator discretion|0|||
131448718|NCT00790842|473272722|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
131725303|NCT00404768|474272732|FG003|Part C|Investigator discretion|1|||
131725304|NCT00404768|474272729|FG000|Part C|Researcher suspended study medication|0|||
131725305|NCT00404768|474272730|FG001|Part C|Researcher suspended study medication|0|||
131725306|NCT00404768|474272731|FG002|Part C|Researcher suspended study medication|0|||
131725307|NCT00404768|474272732|FG003|Part C|Researcher suspended study medication|1|||
131725308|NCT04773041|474272733|FG000|Overall Study|Unable to data match|1|||
131725309|NCT04773041|474272734|FG001|Overall Study|Unable to data match|0|||
131725310|NCT04773041|474272735|FG002|Overall Study|Unable to data match|0|||
131725311|NCT05270694|474274132|FG000|Overall Study|Death|1|||
131725312|NCT05270694|474274132|FG000|Overall Study|Medical issues impacted ability to participate|2|||
131725313|NCT05270694|474274132|FG000|Overall Study|Lost to Follow-up|3|||
131725314|NCT05270694|474274132|FG000|Overall Study|Withdrawal by Subject|3|||
131725315|NCT02100657|474274133|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
131725316|NCT02100657|474274134|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
131725317|NCT02100657|474274135|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
131725318|NCT02100657|474274133|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
131725319|NCT02100657|474274134|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
131725320|NCT02100657|474274135|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
131725321|NCT02100657|474274133|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
131725322|NCT02100657|474274134|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
131725323|NCT02100657|474274135|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
131725324|NCT02100657|474274133|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
131725325|NCT02100657|474274134|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
131725326|NCT02100657|474274135|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
131805409|NCT05017480|474572559|FG003|Stage 1 Study|Adverse Event|0|||
131805410|NCT05017480|474572560|FG004|Stage 1 Study|Adverse Event|0|||
131805411|NCT05017480|474572556|FG000|Stage 1 Study|Poor Compliance|1|||
131805412|NCT05017480|474572557|FG001|Stage 1 Study|Poor Compliance|1|||
131805413|NCT05017480|474572558|FG002|Stage 1 Study|Poor Compliance|0|||
131805414|NCT05017480|474572559|FG003|Stage 1 Study|Poor Compliance|0|||
131805415|NCT05017480|474572560|FG004|Stage 1 Study|Poor Compliance|0|||
131805416|NCT05017480|474572556|FG000|Stage 1 Study|Physician Decision|0|||
131805417|NCT05017480|474572557|FG001|Stage 1 Study|Physician Decision|1|||
131805418|NCT05017480|474572558|FG002|Stage 1 Study|Physician Decision|0|||
131805419|NCT05017480|474572559|FG003|Stage 1 Study|Physician Decision|0|||
131805420|NCT05017480|474572560|FG004|Stage 1 Study|Physician Decision|0|||
131805421|NCT05017480|474572556|FG000|Stage 2 Study|Withdrawal by Subject|0|||
131805422|NCT05017480|474572557|FG001|Stage 2 Study|Withdrawal by Subject|0|||
131805423|NCT05017480|474572558|FG002|Stage 2 Study|Withdrawal by Subject|6|||
131805424|NCT05017480|474572559|FG003|Stage 2 Study|Withdrawal by Subject|9|||
131805425|NCT05017480|474572560|FG004|Stage 2 Study|Withdrawal by Subject|11|||
131805426|NCT05017480|474572556|FG000|Stage 2 Study|Lost to Follow-up|0|||
131805427|NCT05017480|474572557|FG001|Stage 2 Study|Lost to Follow-up|0|||
131805428|NCT05017480|474572558|FG002|Stage 2 Study|Lost to Follow-up|0|||
131805429|NCT05017480|474572559|FG003|Stage 2 Study|Lost to Follow-up|2|||
131805430|NCT05017480|474572560|FG004|Stage 2 Study|Lost to Follow-up|1|||
131805431|NCT05017480|474572556|FG000|Stage 2 Study|Adverse Event|0|||
131805432|NCT05017480|474572557|FG001|Stage 2 Study|Adverse Event|0|||
131805433|NCT05017480|474572558|FG002|Stage 2 Study|Adverse Event|0|||
131805434|NCT05017480|474572559|FG003|Stage 2 Study|Adverse Event|1|||
131805435|NCT05017480|474572560|FG004|Stage 2 Study|Adverse Event|0|||
131805436|NCT05017480|474572556|FG000|Stage 2 Study|COVID-19|0|||
131805437|NCT05017480|474572557|FG001|Stage 2 Study|COVID-19|0|||
131805438|NCT05017480|474572558|FG002|Stage 2 Study|COVID-19|0|||
131805439|NCT05017480|474572559|FG003|Stage 2 Study|COVID-19|1|||
131805440|NCT05017480|474572560|FG004|Stage 2 Study|COVID-19|0|||
131805441|NCT05017480|474572556|FG000|Stage 2 Study|Pregnancy|0|||
131448719|NCT00790842|473272723|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448720|NCT00790842|473272724|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448721|NCT00790842|473272725|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131725327|NCT02100657|474274133|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
131725328|NCT02100657|474274134|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
131725329|NCT02100657|474274135|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
131725330|NCT02100657|474274133|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
131725331|NCT02100657|474274134|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
131805442|NCT05017480|474572557|FG001|Stage 2 Study|Pregnancy|0|||
131725332|NCT02100657|474274135|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
131805443|NCT05017480|474572558|FG002|Stage 2 Study|Pregnancy|0|||
131805444|NCT05017480|474572559|FG003|Stage 2 Study|Pregnancy|0|||
131805445|NCT05017480|474572560|FG004|Stage 2 Study|Pregnancy|1|||
131805446|NCT01136382|474572561|FG000|Overall Study|Other|8|||
131805447|NCT01136382|474572562|FG001|Overall Study|Other|3|||
131805448|NCT01136382|474572561|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
131805449|NCT01136382|474572562|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
131805450|NCT01136382|474572561|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
131725333|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
131725334|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
131725335|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
131725336|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Death|0|||
131725337|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Death|0|||
131725338|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Death|1|||
131725339|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
131725340|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
131725341|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
131725342|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
131725343|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
131725344|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
131725345|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
131725346|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
131725347|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
131725348|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
131725349|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
131725350|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
131725351|NCT02100657|474274133|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
131725352|NCT02100657|474274134|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
131725353|NCT02100657|474274135|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
131725354|NCT01543490|474274139|FG000|Overall Study|Adverse Event|4|||
131725355|NCT01543490|474274140|FG001|Overall Study|Adverse Event|0|||
131725356|NCT01543490|474274139|FG000|Overall Study|Physician Decision|1|||
131725357|NCT01543490|474274140|FG001|Overall Study|Physician Decision|0|||
131725358|NCT01543490|474274139|FG000|Overall Study|Lack of Efficacy|3|||
131725359|NCT01543490|474274140|FG001|Overall Study|Lack of Efficacy|3|||
131725360|NCT01543490|474274139|FG000|Overall Study|Lost to Follow-up|5|||
131725361|NCT01543490|474274140|FG001|Overall Study|Lost to Follow-up|0|||
131725362|NCT01543490|474274139|FG000|Overall Study|Withdrawal by Subject|2|||
131725363|NCT01543490|474274140|FG001|Overall Study|Withdrawal by Subject|0|||
131725364|NCT01543490|474274139|FG000|Overall Study|Other-Various Administrative Reasons|1|||
131725365|NCT01543490|474274140|FG001|Overall Study|Other-Various Administrative Reasons|2|||
131725366|NCT04168645|474274142|FG000|Overall Study|Lost to Follow-up|23|||
131725367|NCT04168645|474274143|FG001|Overall Study|Lost to Follow-up|28|||
131725368|NCT04168645|474274144|FG002|Overall Study|Lost to Follow-up|15|||
131725369|NCT04168645|474274145|FG003|Overall Study|Lost to Follow-up|12|||
131725370|NCT04168645|474274142|FG000|Overall Study|Death|1|||
131725371|NCT04168645|474274143|FG001|Overall Study|Death|1|||
131725372|NCT04168645|474274144|FG002|Overall Study|Death|0|||
131725373|NCT04168645|474274145|FG003|Overall Study|Death|0|||
131725374|NCT04168645|474274142|FG000|Overall Study|Withdrawal by Subject|5|||
131725375|NCT04168645|474274143|FG001|Overall Study|Withdrawal by Subject|2|||
131725376|NCT04168645|474274144|FG002|Overall Study|Withdrawal by Subject|2|||
131725377|NCT04168645|474274145|FG003|Overall Study|Withdrawal by Subject|2|||
131725378|NCT04168645|474274142|FG000|Overall Study|Administrative Withdrawal|3|||
131725379|NCT04168645|474274143|FG001|Overall Study|Administrative Withdrawal|1|||
131725380|NCT04168645|474274144|FG002|Overall Study|Administrative Withdrawal|1|||
131725381|NCT04168645|474274145|FG003|Overall Study|Administrative Withdrawal|3|||
131725382|NCT03132805|474274148|FG000|Overall Study|Lost to Follow-up|142|||
131725383|NCT03132805|474274149|FG001|Overall Study|Lost to Follow-up|141|||
131725384|NCT03132805|474274150|FG002|Overall Study|Lost to Follow-up|113|||
131725385|NCT03918642|474274152|FG000|Overall Study|Lost to Follow-up|12|||
131725386|NCT03918642|474274153|FG001|Overall Study|Lost to Follow-up|10|||
131805451|NCT01136382|474572562|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
131805452|NCT01136382|474572561|FG000|Overall Study|Withdrawal by Subject|4|||
131805453|NCT01136382|474572562|FG001|Overall Study|Withdrawal by Subject|1|||
131725387|NCT03825042|474274154|FG000|Overall Study|Adverse Event|1|||
131725388|NCT03825042|474274155|FG001|Overall Study|Adverse Event|0|||
131725389|NCT03825042|474274154|FG000|Overall Study|Withdrawal by Subject|1|||
131725390|NCT03825042|474274155|FG001|Overall Study|Withdrawal by Subject|0|||
131725391|NCT01158534|474274162|FG000|Overall Study|Withdrawal by Subject|1|||
131805454|NCT02653664|474572567|FG000|Post-Treatment|Withdrawal by Subject|6|||
131805455|NCT02653664|474572568|FG001|Post-Treatment|Withdrawal by Subject|5|||
131805456|NCT02653664|474572569|FG002|Post-Treatment|Withdrawal by Subject|7|||
131805457|NCT02653664|474572567|FG000|Post-Treatment|Lost to Follow-up|8|||
131805458|NCT02653664|474572568|FG001|Post-Treatment|Lost to Follow-up|1|||
131805459|NCT02653664|474572569|FG002|Post-Treatment|Lost to Follow-up|7|||
131805460|NCT02653664|474572567|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
131805461|NCT02653664|474572568|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
131805462|NCT02653664|474572569|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
131805463|NCT02653664|474572567|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
131805464|NCT02653664|474572568|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
131805465|NCT02653664|474572569|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
131725392|NCT01158534|474274162|FG000|Overall Study|Death|1|||
131725393|NCT01158534|474274162|FG000|Overall Study|Other|1|||
131725394|NCT01988012|474274163|FG000|Overall Study|Adverse Event|5|||
131725395|NCT01988012|474274163|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131725396|NCT01988012|474274163|FG000|Overall Study|Patient Withdrawal of Consent|4|||
131725397|NCT01988012|474274163|FG000|Overall Study|Lost to Follow-up|1|||
131725398|NCT01988012|474274163|FG000|Overall Study|Physician Decision|1|||
131725399|NCT01988012|474274163|FG000|Overall Study|Protocol Violation|1|||
131725400|NCT02115815|474274164|FG000|Overall Study|Withdrawal by Subject|2|||
131725401|NCT02115815|474274165|FG001|Overall Study|Withdrawal by Subject|0|||
131725402|NCT02115815|474274166|FG002|Overall Study|Withdrawal by Subject|0|||
131725403|NCT02115815|474274167|FG003|Overall Study|Withdrawal by Subject|0|||
131725404|NCT02115815|474274168|FG004|Overall Study|Withdrawal by Subject|0|||
131725405|NCT02115815|474274169|FG005|Overall Study|Withdrawal by Subject|0|||
131725406|NCT02115815|474274170|FG006|Overall Study|Withdrawal by Subject|0|||
131725407|NCT02115815|474274164|FG000|Overall Study|Not enough drug to dose participant|0|||
131725408|NCT02115815|474274165|FG001|Overall Study|Not enough drug to dose participant|0|||
131725409|NCT02115815|474274166|FG002|Overall Study|Not enough drug to dose participant|0|||
131725410|NCT02115815|474274167|FG003|Overall Study|Not enough drug to dose participant|0|||
131725411|NCT02115815|474274168|FG004|Overall Study|Not enough drug to dose participant|0|||
131725412|NCT02115815|474274169|FG005|Overall Study|Not enough drug to dose participant|1|||
131725413|NCT02115815|474274170|FG006|Overall Study|Not enough drug to dose participant|0|||
131725414|NCT02115815|474274164|FG000|Overall Study|Missed appointment, randomized in error|0|||
131725415|NCT02115815|474274165|FG001|Overall Study|Missed appointment, randomized in error|0|||
131725416|NCT02115815|474274166|FG002|Overall Study|Missed appointment, randomized in error|0|||
131725417|NCT02115815|474274167|FG003|Overall Study|Missed appointment, randomized in error|0|||
131725418|NCT02115815|474274168|FG004|Overall Study|Missed appointment, randomized in error|0|||
131725419|NCT02115815|474274169|FG005|Overall Study|Missed appointment, randomized in error|1|||
131725420|NCT02115815|474274170|FG006|Overall Study|Missed appointment, randomized in error|0|||
131725421|NCT01228071|474274171|FG000|Overall Study|Protocol Violation|1|||
131725422|NCT01228071|474274171|FG000|Overall Study|Withdrawal by Subject|1|||
131725423|NCT04003155|474274172|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
131725424|NCT04003155|474274173|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
131725425|NCT04003155|474274174|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
131725426|NCT04003155|474274175|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
131725427|NCT04003155|474274176|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
131725428|NCT04003155|474274172|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
131725429|NCT04003155|474274173|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
131725430|NCT04003155|474274174|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
131725431|NCT04003155|474274175|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
131725432|NCT04003155|474274176|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
131725433|NCT04003155|474274172|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
131725434|NCT04003155|474274173|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
131725435|NCT04003155|474274174|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
131725436|NCT04003155|474274175|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
131725437|NCT04003155|474274176|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
131725438|NCT04003155|474274172|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
131725439|NCT04003155|474274173|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
131725440|NCT04003155|474274174|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
131725441|NCT04003155|474274175|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
131725442|NCT04003155|474274176|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
131725443|NCT04003155|474274172|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
131725444|NCT04003155|474274173|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
131725445|NCT04003155|474274174|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
131725446|NCT04003155|474274175|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
131448722|NCT00790842|473272726|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448723|NCT00790842|473272727|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448724|NCT00790842|473272728|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448725|NCT00790842|473272729|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448726|NCT00790842|473272730|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
131448727|NCT00790842|473272720|FG000|Dose Level 4|Adverse Event|0|||
131448728|NCT00790842|473272721|FG001|Dose Level 4|Adverse Event|0|||
131448729|NCT00790842|473272722|FG002|Dose Level 4|Adverse Event|0|||
131448730|NCT00790842|473272723|FG003|Dose Level 4|Adverse Event|0|||
131448731|NCT00790842|473272724|FG004|Dose Level 4|Adverse Event|0|||
131448732|NCT00790842|473272725|FG005|Dose Level 4|Adverse Event|0|||
131448733|NCT00790842|473272726|FG006|Dose Level 4|Adverse Event|1|||
131448734|NCT00790842|473272727|FG007|Dose Level 4|Adverse Event|0|||
131725447|NCT04003155|474274176|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
131725448|NCT04003155|474274172|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
131725449|NCT04003155|474274173|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
131448735|NCT00790842|473272728|FG008|Dose Level 4|Adverse Event|0|||
131448736|NCT00790842|473272729|FG009|Dose Level 4|Adverse Event|0|||
131805466|NCT02653664|474572567|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
131805467|NCT02653664|474572568|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
131805468|NCT02653664|474572569|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
131805469|NCT02653664|474572567|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
131805470|NCT02653664|474572568|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
131805471|NCT02653664|474572569|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
131805472|NCT02653664|474572567|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
131725450|NCT04003155|474274174|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
131725451|NCT04003155|474274175|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
131725452|NCT04003155|474274176|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
131725453|NCT04003155|474274172|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
131725454|NCT04003155|474274173|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
131725455|NCT04003155|474274174|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
131725456|NCT04003155|474274175|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
131725457|NCT04003155|474274176|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
131725458|NCT04003155|474274172|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
131725459|NCT04003155|474274173|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
131805473|NCT02653664|474572568|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
131725460|NCT04003155|474274174|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
131725461|NCT04003155|474274175|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
131725462|NCT04003155|474274176|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
131725463|NCT04003155|474274172|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
131725464|NCT04003155|474274173|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
131725465|NCT04003155|474274174|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
131725466|NCT04003155|474274175|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
131725467|NCT04003155|474274176|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
131725468|NCT01912872|474274177|FG000|Overall Study|Lost to Follow-up|2|||
131725469|NCT01912872|474274178|FG001|Overall Study|Lost to Follow-up|3|||
131725470|NCT01912872|474274179|FG002|Overall Study|Lost to Follow-up|5|||
131725471|NCT01912872|474274180|FG003|Overall Study|Lost to Follow-up|5|||
131725472|NCT01912872|474274177|FG000|Overall Study|Other unspecified|3|||
131725473|NCT01912872|474274178|FG001|Overall Study|Other unspecified|1|||
131725474|NCT01912872|474274179|FG002|Overall Study|Other unspecified|3|||
131725475|NCT01912872|474274180|FG003|Overall Study|Other unspecified|0|||
131725476|NCT01912872|474274177|FG000|Overall Study|Informed consent withdrawn|0|||
131725477|NCT01912872|474274178|FG001|Overall Study|Informed consent withdrawn|0|||
131725478|NCT01912872|474274179|FG002|Overall Study|Informed consent withdrawn|1|||
131725479|NCT01912872|474274180|FG003|Overall Study|Informed consent withdrawn|1|||
131725480|NCT01912872|474274177|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
131725481|NCT01912872|474274178|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
131725482|NCT01912872|474274179|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
131725483|NCT01912872|474274180|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
131725484|NCT01912872|474274177|FG000|Overall Study|Protocol Violation|0|||
131725485|NCT01912872|474274178|FG001|Overall Study|Protocol Violation|0|||
131725486|NCT01912872|474274179|FG002|Overall Study|Protocol Violation|1|||
131725487|NCT01912872|474274180|FG003|Overall Study|Protocol Violation|0|||
131725488|NCT01912872|474274177|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131725489|NCT01912872|474274178|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131725490|NCT01912872|474274179|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131725491|NCT01912872|474274180|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131725492|NCT01912872|474274177|FG000|Overall Study|Withdrawal of study medication|0|||
131725493|NCT01912872|474274178|FG001|Overall Study|Withdrawal of study medication|0|||
131725494|NCT01912872|474274179|FG002|Overall Study|Withdrawal of study medication|0|||
131725495|NCT01912872|474274180|FG003|Overall Study|Withdrawal of study medication|2|||
131725496|NCT01912872|474274177|FG000|Overall Study|Missing|0|||
131725497|NCT01912872|474274178|FG001|Overall Study|Missing|0|||
131805474|NCT02653664|474572569|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
131805475|NCT02653664|474572567|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
131725498|NCT01912872|474274179|FG002|Overall Study|Missing|0|||
131725499|NCT01912872|474274180|FG003|Overall Study|Missing|1|||
131725500|NCT02778867|474274181|FG000|Phase 1|Withdrawal by Subject|2|||
131725501|NCT02778867|474274182|FG001|Phase 1|Withdrawal by Subject|3|||
131725502|NCT02778867|474274183|FG002|Phase 1|Withdrawal by Subject|0|||
131725503|NCT02778867|474274184|FG003|Phase 1|Withdrawal by Subject|0|||
131725504|NCT02778867|474274181|FG000|Phase 2|Withdrawal by Subject|0|||
131725505|NCT02778867|474274182|FG001|Phase 2|Withdrawal by Subject|0|||
131725506|NCT02778867|474274183|FG002|Phase 2|Withdrawal by Subject|1|||
131725507|NCT02778867|474274184|FG003|Phase 2|Withdrawal by Subject|0|||
131725508|NCT02778867|474274181|FG000|Phase 2|Physician Decision|0|||
131725509|NCT02778867|474274182|FG001|Phase 2|Physician Decision|0|||
131725510|NCT02778867|474274183|FG002|Phase 2|Physician Decision|0|||
131725511|NCT02778867|474274184|FG003|Phase 2|Physician Decision|1|||
131725512|NCT02778867|474274181|FG000|Phase 2|Adverse Event|0|||
131725513|NCT02778867|474274182|FG001|Phase 2|Adverse Event|0|||
131725514|NCT02778867|474274183|FG002|Phase 2|Adverse Event|0|||
131725515|NCT02778867|474274184|FG003|Phase 2|Adverse Event|1|||
131725516|NCT05232097|474274200|FG000|Overall Study|Physician Decision|1|||
131725517|NCT03662334|474274203|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
131725518|NCT03662334|474274204|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
131725519|NCT01158950|474274206|FG000|1st Intervention (1 Day)|Physician Decision|1|||
131725520|NCT01158950|474274207|FG001|1st Intervention (1 Day)|Physician Decision|2|||
131725521|NCT00510692|474274208|FG000|Overall Study|Adverse Event|1|||
131725522|NCT00510692|474274209|FG001|Overall Study|Adverse Event|3|||
131725523|NCT00510692|474274208|FG000|Overall Study|Withdrawal by Subject|1|||
131725524|NCT00510692|474274209|FG001|Overall Study|Withdrawal by Subject|0|||
131725525|NCT01845077|474274210|FG000|Washout Period|Lost to Follow-up|0|||
131725526|NCT01845077|474274211|FG001|Washout Period|Lost to Follow-up|1|||
131725527|NCT01845077|474274212|FG002|Washout Period|Lost to Follow-up|0|||
131725528|NCT01845077|474274213|FG003|Washout Period|Lost to Follow-up|1|||
131725529|NCT01845077|474274214|FG004|Washout Period|Lost to Follow-up|0|||
131725530|NCT01845077|474274215|FG005|Washout Period|Lost to Follow-up|1|||
131725531|NCT01845077|474274210|FG000|Washout Period|Adverse Event|1|||
131725532|NCT01845077|474274211|FG001|Washout Period|Adverse Event|0|||
131725533|NCT01845077|474274212|FG002|Washout Period|Adverse Event|0|||
131725534|NCT01845077|474274213|FG003|Washout Period|Adverse Event|0|||
131725535|NCT01845077|474274214|FG004|Washout Period|Adverse Event|0|||
131725536|NCT01845077|474274215|FG005|Washout Period|Adverse Event|0|||
131725537|NCT01845077|474274210|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
131725538|NCT01845077|474274211|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
131725539|NCT01845077|474274212|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
131725540|NCT01845077|474274213|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
131725541|NCT01845077|474274214|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
131725542|NCT01845077|474274215|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
131725543|NCT01845077|474274210|FG000|Washout Period|Protocol Violation|0|||
131725544|NCT01845077|474274211|FG001|Washout Period|Protocol Violation|0|||
131725545|NCT01845077|474274212|FG002|Washout Period|Protocol Violation|0|||
131725546|NCT01845077|474274213|FG003|Washout Period|Protocol Violation|1|||
131725547|NCT01845077|474274214|FG004|Washout Period|Protocol Violation|1|||
131725548|NCT01845077|474274215|FG005|Washout Period|Protocol Violation|0|||
131725549|NCT03290300|474274216|FG000|Overall Study|Lost to Follow-up|3|||
131725550|NCT01137435|474274219|FG000|Overall Study|Lost to Follow-up|24|||
131725551|NCT01137435|474274219|FG000|Overall Study|Off label usage|4|||
131725552|NCT02746679|474274225|FG000|Overall Study|Lost to Follow-up|4|||
131725553|NCT02746679|474274226|FG001|Overall Study|Lost to Follow-up|6|||
131725554|NCT00487279|474274227|FG000|Overall Study|Death|1|||
131725555|NCT00487279|474274228|FG001|Overall Study|Death|0|||
131725556|NCT00487279|474274227|FG000|Overall Study|Withdrawal by Subject|0|||
131725557|NCT00487279|474274228|FG001|Overall Study|Withdrawal by Subject|2|||
131725558|NCT00501852|474274229|FG000|Overall Study|Adverse Event|3|||
131725559|NCT00501852|474274229|FG000|Overall Study|Withdrawal by Subject|2|||
131725560|NCT01416610|474274232|FG000|Overall Study|Adverse Event|4|||
131725561|NCT01416610|474274232|FG000|Overall Study|Adverse Event -Patient decision|3|||
131725562|NCT01416610|474274232|FG000|Overall Study|Lack of Efficacy|4|||
131725563|NCT01416610|474274232|FG000|Overall Study|No reason given|5|||
131725564|NCT01416610|474274232|FG000|Overall Study|Withdrawal by Subject|13|||
131725565|NCT01416610|474274232|FG000|Overall Study|Lost to Follow-up|7|||
131725566|NCT01416610|474274232|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
131725567|NCT01927562|474274233|FG000|Overall Study|Lost to Follow-up|30|||
131725568|NCT01927562|474274233|FG000|Overall Study|Withdrawal by Subject|3|||
131725569|NCT01927562|474274233|FG000|Overall Study|Physician Decision|5|||
131725570|NCT00642616|474274234|FG000|Overall Study|Adverse Event|2|||
131725571|NCT00642616|474274235|FG001|Overall Study|Adverse Event|0|||
131725572|NCT00642616|474274236|FG002|Overall Study|Adverse Event|1|||
131725573|NCT00642616|474274237|FG003|Overall Study|Adverse Event|0|||
131805476|NCT02653664|474572568|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
131805477|NCT02653664|474572569|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
131805478|NCT02653664|474572567|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
131805479|NCT02653664|474572568|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
131805480|NCT02653664|474572569|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
131805481|NCT02653664|474572567|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
131805482|NCT02653664|474572568|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
131805483|NCT02653664|474572569|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
131805484|NCT00324168|474572570|FG000|Overall Study|Lost to Follow-up|19|||
131805485|NCT00324168|474572571|FG001|Overall Study|Lost to Follow-up|18|||
131805486|NCT00324168|474572570|FG000|Overall Study|Death|3|||
131805487|NCT00324168|474572571|FG001|Overall Study|Death|3|||
131805488|NCT00324168|474572570|FG000|Overall Study|Patient did not visit in f/u window|6|||
131805489|NCT00324168|474572571|FG001|Overall Study|Patient did not visit in f/u window|9|||
131805490|NCT02300103|474572576|FG000|Overall Study|Lack of Efficacy|3|||
131805491|NCT02300103|474572576|FG000|Overall Study|Protocol Violation|1|||
131805492|NCT02300103|474572576|FG000|Overall Study|Withdrew Consent|2|||
131805493|NCT04091971|474572577|FG000|Overall Study|Withdrawal by Subject|1|||
131805494|NCT04091971|474572577|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
131805495|NCT04091971|474572577|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
131805496|NCT00893464|474572580|FG000|Overall Study|Did not complete therapy/experience PD|0|||
131805497|NCT00893464|474572581|FG001|Overall Study|Did not complete therapy/experience PD|0|||
131805498|NCT00893464|474572582|FG002|Overall Study|Did not complete therapy/experience PD|0|||
131805499|NCT00893464|474572583|FG003|Overall Study|Did not complete therapy/experience PD|0|||
131805500|NCT00893464|474572584|FG004|Overall Study|Did not complete therapy/experience PD|0|||
131805501|NCT00893464|474572585|FG005|Overall Study|Did not complete therapy/experience PD|0|||
131805502|NCT00893464|474572586|FG006|Overall Study|Did not complete therapy/experience PD|2|||
131805503|NCT00893464|474572587|FG007|Overall Study|Did not complete therapy/experience PD|2|||
131805504|NCT01389102|474572588|FG000|Overall Study|Adverse Event|1|||
131805505|NCT01389102|474572589|FG001|Overall Study|Adverse Event|3|||
131805506|NCT01389102|474572590|FG002|Overall Study|Adverse Event|2|||
131805507|NCT01389102|474572591|FG003|Overall Study|Adverse Event|2|||
131805508|NCT01389102|474572592|FG004|Overall Study|Adverse Event|2|||
131805509|NCT01389102|474572593|FG005|Overall Study|Adverse Event|2|||
131805510|NCT01389102|474572588|FG000|Overall Study|Hurricane Katrina|4|||
131805511|NCT01389102|474572589|FG001|Overall Study|Hurricane Katrina|2|||
131805512|NCT01389102|474572590|FG002|Overall Study|Hurricane Katrina|3|||
131805513|NCT01389102|474572591|FG003|Overall Study|Hurricane Katrina|0|||
131805514|NCT01389102|474572592|FG004|Overall Study|Hurricane Katrina|3|||
131805515|NCT01389102|474572593|FG005|Overall Study|Hurricane Katrina|1|||
131805516|NCT01389102|474572588|FG000|Overall Study|Lost to Follow-up|4|||
131805517|NCT01389102|474572589|FG001|Overall Study|Lost to Follow-up|1|||
131805518|NCT01389102|474572590|FG002|Overall Study|Lost to Follow-up|1|||
131805519|NCT01389102|474572591|FG003|Overall Study|Lost to Follow-up|2|||
131805520|NCT01389102|474572592|FG004|Overall Study|Lost to Follow-up|4|||
131805521|NCT01389102|474572593|FG005|Overall Study|Lost to Follow-up|1|||
131805522|NCT01389102|474572588|FG000|Overall Study|Protocol Violation|0|||
131805523|NCT01389102|474572589|FG001|Overall Study|Protocol Violation|0|||
131725574|NCT00642616|474274234|FG000|Overall Study|Study Terminated by Sponsor|7|||
131725575|NCT00642616|474274235|FG001|Overall Study|Study Terminated by Sponsor|6|||
131725576|NCT00642616|474274236|FG002|Overall Study|Study Terminated by Sponsor|4|||
131725577|NCT00642616|474274237|FG003|Overall Study|Study Terminated by Sponsor|5|||
131805524|NCT01389102|474572590|FG002|Overall Study|Protocol Violation|3|||
131805525|NCT01389102|474572591|FG003|Overall Study|Protocol Violation|0|||
131725578|NCT00642616|474274234|FG000|Overall Study|Withdrawal by Subject|0|||
131805526|NCT01389102|474572592|FG004|Overall Study|Protocol Violation|1|||
131725579|NCT00642616|474274235|FG001|Overall Study|Withdrawal by Subject|1|||
131725580|NCT00642616|474274236|FG002|Overall Study|Withdrawal by Subject|1|||
131725581|NCT00642616|474274237|FG003|Overall Study|Withdrawal by Subject|1|||
131805527|NCT01389102|474572593|FG005|Overall Study|Protocol Violation|1|||
131805528|NCT01389102|474572588|FG000|Overall Study|Withdrawal by Subject|7|||
131805529|NCT01389102|474572589|FG001|Overall Study|Withdrawal by Subject|4|||
131805530|NCT01389102|474572590|FG002|Overall Study|Withdrawal by Subject|9|||
131805531|NCT01389102|474572591|FG003|Overall Study|Withdrawal by Subject|2|||
131805532|NCT01389102|474572592|FG004|Overall Study|Withdrawal by Subject|3|||
131725582|NCT00642616|474274234|FG000|Overall Study|Protocol Violation|0|||
131725583|NCT00642616|474274235|FG001|Overall Study|Protocol Violation|0|||
131725584|NCT00642616|474274236|FG002|Overall Study|Protocol Violation|2|||
131725585|NCT00642616|474274237|FG003|Overall Study|Protocol Violation|0|||
131725586|NCT00642616|474274234|FG000|Overall Study|Physician Decision|0|||
131725587|NCT00642616|474274235|FG001|Overall Study|Physician Decision|0|||
131725588|NCT00642616|474274236|FG002|Overall Study|Physician Decision|1|||
131725589|NCT00642616|474274237|FG003|Overall Study|Physician Decision|1|||
131725590|NCT00399802|474274238|FG000|Overall Study|Adverse Event|0|||
131725591|NCT00399802|474274239|FG001|Overall Study|Adverse Event|2|||
131725592|NCT00399802|474274238|FG000|Overall Study|Participant discontinued by mistake|0|||
131725593|NCT00399802|474274239|FG001|Overall Study|Participant discontinued by mistake|1|||
131725594|NCT00542815|474274240|FG000|Overall Study|Adverse Event|19|||
131725595|NCT00542815|474274241|FG001|Overall Study|Adverse Event|6|||
131725596|NCT00542815|474274242|FG002|Overall Study|Adverse Event|9|||
131725597|NCT00542815|474274240|FG000|Overall Study|Death|10|||
131725598|NCT00542815|474274241|FG001|Overall Study|Death|7|||
131725599|NCT00542815|474274242|FG002|Overall Study|Death|3|||
131725600|NCT00542815|474274240|FG000|Overall Study|Lack of Efficacy|9|||
131725601|NCT00542815|474274241|FG001|Overall Study|Lack of Efficacy|2|||
131725602|NCT00542815|474274242|FG002|Overall Study|Lack of Efficacy|0|||
131725603|NCT00542815|474274240|FG000|Overall Study|Physician Decision|2|||
131725604|NCT00542815|474274241|FG001|Overall Study|Physician Decision|1|||
131725605|NCT00542815|474274242|FG002|Overall Study|Physician Decision|0|||
131725606|NCT00542815|474274240|FG000|Overall Study|Protocol Violation|1|||
131725607|NCT00542815|474274241|FG001|Overall Study|Protocol Violation|1|||
131725608|NCT00542815|474274242|FG002|Overall Study|Protocol Violation|2|||
131725609|NCT00542815|474274240|FG000|Overall Study|Withdrawal by Subject|41|||
131725610|NCT00542815|474274241|FG001|Overall Study|Withdrawal by Subject|5|||
131725611|NCT00542815|474274242|FG002|Overall Study|Withdrawal by Subject|8|||
131725612|NCT00542815|474274240|FG000|Overall Study|Other reasons|24|||
131725613|NCT00542815|474274241|FG001|Overall Study|Other reasons|10|||
131725614|NCT00542815|474274242|FG002|Overall Study|Other reasons|10|||
131725615|NCT02955186|474274243|FG000|Overall Study|Withdrawal by Subject|6|||
131725616|NCT02955186|474274244|FG001|Overall Study|Withdrawal by Subject|2|||
131725617|NCT02955186|474274243|FG000|Overall Study|Protocol Violation|1|||
131725618|NCT02955186|474274244|FG001|Overall Study|Protocol Violation|0|||
131725619|NCT01618656|474274245|FG000|Overall Study|Withdrawal by Subject|7|||
131725620|NCT01618656|474274246|FG001|Overall Study|Withdrawal by Subject|3|||
131725621|NCT01618656|474274245|FG000|Overall Study|Physician Decision|1|||
131725622|NCT01618656|474274246|FG001|Overall Study|Physician Decision|1|||
131725623|NCT01899144|474274247|FG000|Treatment Period 2|Other|1|||
131725624|NCT01899144|474274247|FG000|Treatment Period 3|Other|2|||
131725625|NCT01899144|474274247|FG000|Treatment Period 5|Other|1|||
131725626|NCT00751881|474274252|FG000|Core Treatment Period|Not treated|1|||
131725627|NCT00751881|474274253|FG001|Core Treatment Period|Not treated|1|||
131725628|NCT00751881|474274254|FG002|Core Treatment Period|Not treated|2|||
131725629|NCT00751881|474274252|FG000|Core Treatment Period|Adverse Event|26|||
131725630|NCT00751881|474274253|FG001|Core Treatment Period|Adverse Event|54|||
131725631|NCT00751881|474274254|FG002|Core Treatment Period|Adverse Event|58|||
131725632|NCT00751881|474274252|FG000|Core Treatment Period|Lack of Efficacy|37|||
131725633|NCT00751881|474274253|FG001|Core Treatment Period|Lack of Efficacy|30|||
131725634|NCT00751881|474274254|FG002|Core Treatment Period|Lack of Efficacy|20|||
131725635|NCT00751881|474274252|FG000|Core Treatment Period|Poor compliance to protocol|15|||
131725636|NCT00751881|474274253|FG001|Core Treatment Period|Poor compliance to protocol|3|||
131725637|NCT00751881|474274254|FG002|Core Treatment Period|Poor compliance to protocol|4|||
131725638|NCT00751881|474274252|FG000|Core Treatment Period|Lost to Follow-up|6|||
131725639|NCT00751881|474274253|FG001|Core Treatment Period|Lost to Follow-up|4|||
131725640|NCT00751881|474274254|FG002|Core Treatment Period|Lost to Follow-up|3|||
131725641|NCT00751881|474274252|FG000|Core Treatment Period|Other: protocol deviation|3|||
131725642|NCT00751881|474274253|FG001|Core Treatment Period|Other: protocol deviation|3|||
131725643|NCT00751881|474274254|FG002|Core Treatment Period|Other: protocol deviation|7|||
131725644|NCT00751881|474274252|FG000|Core Treatment Period|Other: wish to parent|5|||
131725645|NCT00751881|474274253|FG001|Core Treatment Period|Other: wish to parent|7|||
131725646|NCT00751881|474274254|FG002|Core Treatment Period|Other: wish to parent|4|||
131725647|NCT00751881|474274252|FG000|Core Treatment Period|Other: personal/family constraints|6|||
131725648|NCT00751881|474274253|FG001|Core Treatment Period|Other: personal/family constraints|7|||
131725649|NCT00751881|474274254|FG002|Core Treatment Period|Other: personal/family constraints|10|||
131725650|NCT00751881|474274252|FG000|Core Treatment Period|Other: MS treatment change|6|||
131725651|NCT00751881|474274253|FG001|Core Treatment Period|Other: MS treatment change|4|||
131725652|NCT00751881|474274254|FG002|Core Treatment Period|Other: MS treatment change|4|||
131725653|NCT00751881|474274252|FG000|Core Treatment Period|Other: tolerability complaints|2|||
131725654|NCT00751881|474274253|FG001|Core Treatment Period|Other: tolerability complaints|0|||
131725655|NCT00751881|474274254|FG002|Core Treatment Period|Other: tolerability complaints|0|||
131805533|NCT01389102|474572593|FG005|Overall Study|Withdrawal by Subject|3|||
131725656|NCT00751881|474274252|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
131725657|NCT00751881|474274253|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
131725658|NCT00751881|474274254|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
131725659|NCT00751881|474274252|FG000|Extension Study Period|Adverse Event|18|||
131725660|NCT00751881|474274253|FG001|Extension Study Period|Adverse Event|20|||
131725661|NCT00751881|474274254|FG002|Extension Study Period|Adverse Event|21|||
131725662|NCT00751881|474274252|FG000|Extension Study Period|Lack of Efficacy|14|||
131725663|NCT00751881|474274253|FG001|Extension Study Period|Lack of Efficacy|10|||
131725664|NCT00751881|474274254|FG002|Extension Study Period|Lack of Efficacy|20|||
131725665|NCT00751881|474274252|FG000|Extension Study Period|Lost to Follow-up|4|||
131725666|NCT00751881|474274253|FG001|Extension Study Period|Lost to Follow-up|9|||
131725667|NCT00751881|474274254|FG002|Extension Study Period|Lost to Follow-up|6|||
131725668|NCT00751881|474274252|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
131725669|NCT00751881|474274253|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
131725670|NCT00751881|474274254|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
131725671|NCT00751881|474274252|FG000|Extension Study Period|Other than specified above|26|||
131725672|NCT00751881|474274253|FG001|Extension Study Period|Other than specified above|30|||
131725673|NCT00751881|474274254|FG002|Extension Study Period|Other than specified above|18|||
131725674|NCT04770155|474274257|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725675|NCT04770155|474274258|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725676|NCT04770155|474274259|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725677|NCT04770155|474274260|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725678|NCT04770155|474274261|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725679|NCT04770155|474274262|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725680|NCT04770155|474274263|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725681|NCT04770155|474274264|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131725682|NCT00864227|474274265|FG000|Overall Study|Withdrawal by Subject|1|||
131725683|NCT00864227|474274265|FG000|Overall Study|Disease Relapse/Progression|3|||
131725684|NCT01632878|474274268|FG000|Screening|Physician Decision|268|||
131725685|NCT01632878|474274268|FG000|Treatment|Lost to Follow-up|41|||
131725686|NCT01632878|474274268|FG000|Treatment|Withdrawal by Subject|36|||
131725687|NCT01632878|474274268|FG000|Treatment|Physician Decision|34|||
131725688|NCT01632878|474274268|FG000|Treatment|missing information|4|||
131725689|NCT01632878|474274268|FG000|Treatment|no information on study completion|43|||
131725690|NCT02522481|474274273|FG000|Overall Study|discontinued|1|||
131725691|NCT02522481|474274273|FG000|Overall Study|Not dosed|2|||
131725692|NCT03123939|474274274|FG000|Overall Study|Lack of Efficacy|6|||
131725693|NCT03123939|474274274|FG000|Overall Study|Death|5|||
131725694|NCT03123939|474274274|FG000|Overall Study|Physician Decision|2|||
131725695|NCT03123939|474274274|FG000|Overall Study|Subject/guardian decision|2|||
131725696|NCT03123939|474274274|FG000|Overall Study|Lost to Follow-up|1|||
131725697|NCT03123939|474274274|FG000|Overall Study|New therapy for study indication|1|||
131725698|NCT03123939|474274274|FG000|Overall Study|Protocol deviation|1|||
131725699|NCT03123939|474274274|FG000|Overall Study|Progressive disease|18|||
131725700|NCT03123939|474274274|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
131725701|NCT03123939|474274274|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
131725702|NCT01118143|474274275|FG000|Overall Study|Withdrawal by Subject|2|||
131725703|NCT01118143|474274276|FG001|Overall Study|Withdrawal by Subject|5|||
131725704|NCT02112448|474274277|FG000|Overall Study|lab values precluding use of ketorolac|2|||
131725705|NCT02112448|474274278|FG001|Overall Study|lab values precluding use of ketorolac|2|||
131725706|NCT02112448|474274277|FG000|Overall Study|Protocol Violation|1|||
131725707|NCT02112448|474274278|FG001|Overall Study|Protocol Violation|2|||
131725708|NCT02112448|474274277|FG000|Overall Study|Physician Decision|4|||
131725709|NCT02112448|474274278|FG001|Overall Study|Physician Decision|6|||
131725710|NCT02112448|474274277|FG000|Overall Study|required heparin so could not use ketoro|1|||
131725711|NCT02112448|474274278|FG001|Overall Study|required heparin so could not use ketoro|0|||
131725712|NCT03504774|474275931|FG000|Overall Study|Adverse Event|2|||
131725713|NCT03504774|474275932|FG001|Overall Study|Adverse Event|0|||
131725714|NCT03504774|474275931|FG000|Overall Study|Lost to Follow-up|0|||
131725715|NCT03504774|474275932|FG001|Overall Study|Lost to Follow-up|1|||
131725716|NCT03504774|474275931|FG000|Overall Study|Protocol Violation|11|||
131725717|NCT03504774|474275932|FG001|Overall Study|Protocol Violation|3|||
131725718|NCT03504774|474275931|FG000|Overall Study|failed wk 52 DBPCFC|1|||
131725719|NCT03504774|474275932|FG001|Overall Study|failed wk 52 DBPCFC|0|||
131725720|NCT00915005|474275938|FG000|Overall Study|Withdrawal by Subject|4|||
131725721|NCT00915005|474275939|FG001|Overall Study|Withdrawal by Subject|4|||
131725722|NCT00915005|474275938|FG000|Overall Study|Patient preferred protons therapy|6|||
131725723|NCT00915005|474275939|FG001|Overall Study|Patient preferred protons therapy|0|||
131725724|NCT00915005|474275938|FG000|Overall Study|Insurance denial|3|||
131725725|NCT00915005|474275939|FG001|Overall Study|Insurance denial|15|||
131725726|NCT03554005|474275942|FG000|Overall Study|Not in participant's best interest|0|||
131725727|NCT03554005|474275943|FG001|Overall Study|Not in participant's best interest|0|||
131725728|NCT03554005|474275944|FG002|Overall Study|Not in participant's best interest|0|||
131725729|NCT03554005|474275945|FG003|Overall Study|Not in participant's best interest|0|||
131725730|NCT03554005|474275946|FG004|Overall Study|Not in participant's best interest|0|||
131725731|NCT03554005|474275947|FG005|Overall Study|Not in participant's best interest|1|||
131725732|NCT03554005|474275942|FG000|Overall Study|Disease Progression|1|||
131725733|NCT03554005|474275943|FG001|Overall Study|Disease Progression|1|||
131725734|NCT03554005|474275944|FG002|Overall Study|Disease Progression|1|||
131725735|NCT03554005|474275945|FG003|Overall Study|Disease Progression|1|||
131725736|NCT03554005|474275946|FG004|Overall Study|Disease Progression|5|||
131725737|NCT03554005|474275947|FG005|Overall Study|Disease Progression|6|||
131725738|NCT03554005|474275942|FG000|Overall Study|Adverse Event|0|||
131725739|NCT03554005|474275943|FG001|Overall Study|Adverse Event|0|||
131725740|NCT03554005|474275944|FG002|Overall Study|Adverse Event|0|||
131725741|NCT03554005|474275945|FG003|Overall Study|Adverse Event|0|||
131725742|NCT03554005|474275946|FG004|Overall Study|Adverse Event|0|||
131725743|NCT03554005|474275947|FG005|Overall Study|Adverse Event|3|||
131725744|NCT03554005|474275942|FG000|Overall Study|Physician Decision|0|||
131725745|NCT03554005|474275943|FG001|Overall Study|Physician Decision|0|||
131725746|NCT03554005|474275944|FG002|Overall Study|Physician Decision|0|||
131725747|NCT03554005|474275945|FG003|Overall Study|Physician Decision|0|||
131725748|NCT03554005|474275946|FG004|Overall Study|Physician Decision|1|||
131725749|NCT03554005|474275947|FG005|Overall Study|Physician Decision|0|||
131725750|NCT03554005|474275942|FG000|Overall Study|Other|0|||
131725751|NCT03554005|474275943|FG001|Overall Study|Other|0|||
131725752|NCT03554005|474275944|FG002|Overall Study|Other|0|||
131725753|NCT03554005|474275945|FG003|Overall Study|Other|0|||
131725754|NCT03554005|474275946|FG004|Overall Study|Other|0|||
131725755|NCT03554005|474275947|FG005|Overall Study|Other|1|||
131725756|NCT00631488|474275948|FG000|Overall Study|Adverse Event|1|||
131725757|NCT00631488|474275949|FG001|Overall Study|Adverse Event|0|||
131725758|NCT00631488|474275950|FG002|Overall Study|Adverse Event|0|||
131725759|NCT00631488|474275948|FG000|Overall Study|Lost to Follow-up|2|||
131725760|NCT00631488|474275949|FG001|Overall Study|Lost to Follow-up|2|||
131725761|NCT00631488|474275950|FG002|Overall Study|Lost to Follow-up|0|||
131725762|NCT00631488|474275948|FG000|Overall Study|Physician Decision|1|||
131725763|NCT00631488|474275949|FG001|Overall Study|Physician Decision|0|||
131725764|NCT00631488|474275950|FG002|Overall Study|Physician Decision|1|||
131725765|NCT00631488|474275948|FG000|Overall Study|Protocol Violation|0|||
131725766|NCT00631488|474275949|FG001|Overall Study|Protocol Violation|0|||
131725767|NCT00631488|474275950|FG002|Overall Study|Protocol Violation|1|||
131725768|NCT03648476|474275951|FG000|Overall Study|Withdrawal by Subject|2|||
131725769|NCT03648476|474275952|FG001|Overall Study|Withdrawal by Subject|1|||
131725770|NCT02855411|474275954|FG000|Overall Study|Study terminated by sponsor|21|||
131725771|NCT02855411|474275954|FG000|Overall Study|Does not meet entrance criteria|14|||
131725772|NCT02546856|474275955|FG000|4 Months Evaluation|Death|2|||
131725773|NCT02546856|474275956|FG001|4 Months Evaluation|Death|3|||
131725774|NCT02546856|474275955|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
131725775|NCT02546856|474275956|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
131725776|NCT02546856|474275955|FG000|4 Months Evaluation|Lost to Follow-up|3|||
131725777|NCT02546856|474275956|FG001|4 Months Evaluation|Lost to Follow-up|3|||
131805534|NCT01389102|474572588|FG000|Overall Study|Subject Traveling Out of Country|0|||
131805535|NCT01389102|474572589|FG001|Overall Study|Subject Traveling Out of Country|0|||
131805536|NCT01389102|474572590|FG002|Overall Study|Subject Traveling Out of Country|0|||
131805537|NCT01389102|474572591|FG003|Overall Study|Subject Traveling Out of Country|1|||
131805538|NCT01389102|474572592|FG004|Overall Study|Subject Traveling Out of Country|0|||
131805539|NCT01389102|474572593|FG005|Overall Study|Subject Traveling Out of Country|0|||
131805540|NCT01389102|474572588|FG000|Overall Study|Subject Moved|2|||
131725778|NCT02546856|474275955|FG000|4 Months Evaluation|Physician Decision|3|||
131725779|NCT02546856|474275956|FG001|4 Months Evaluation|Physician Decision|0|||
131725780|NCT02546856|474275955|FG000|4 Months Evaluation|Working or living abroad|5|||
131725781|NCT02546856|474275956|FG001|4 Months Evaluation|Working or living abroad|1|||
131725782|NCT02546856|474275955|FG000|4 Months Evaluation|reasons not due to titration|4|||
131725783|NCT02546856|474275956|FG001|4 Months Evaluation|reasons not due to titration|1|||
131725784|NCT02546856|474275955|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
131725785|NCT02546856|474275956|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
131725786|NCT02546856|474275955|FG000|6 Months Evaluation|Death|1|||
131725787|NCT02546856|474275956|FG001|6 Months Evaluation|Death|1|||
131725788|NCT02546856|474275955|FG000|6 Months Evaluation|Lost to Follow-up|1|||
131725789|NCT02546856|474275956|FG001|6 Months Evaluation|Lost to Follow-up|1|||
131725790|NCT02546856|474275955|FG000|6 Months Evaluation|Working or living abroad|6|||
131725791|NCT02546856|474275956|FG001|6 Months Evaluation|Working or living abroad|4|||
131725792|NCT02546856|474275955|FG000|6 Months Evaluation|reasons not due to titration|0|||
131725793|NCT02546856|474275956|FG001|6 Months Evaluation|reasons not due to titration|1|||
131805541|NCT01389102|474572589|FG001|Overall Study|Subject Moved|0|||
131805542|NCT01389102|474572590|FG002|Overall Study|Subject Moved|1|||
131805543|NCT01389102|474572591|FG003|Overall Study|Subject Moved|0|||
131805544|NCT01389102|474572592|FG004|Overall Study|Subject Moved|0|||
131805545|NCT01389102|474572593|FG005|Overall Study|Subject Moved|0|||
131805546|NCT01389102|474572588|FG000|Overall Study|Unavailable due to husband's illness|0|||
131805547|NCT01389102|474572589|FG001|Overall Study|Unavailable due to husband's illness|1|||
131805548|NCT01389102|474572590|FG002|Overall Study|Unavailable due to husband's illness|0|||
131805549|NCT01389102|474572591|FG003|Overall Study|Unavailable due to husband's illness|0|||
131805550|NCT01389102|474572592|FG004|Overall Study|Unavailable due to husband's illness|0|||
131805551|NCT01389102|474572593|FG005|Overall Study|Unavailable due to husband's illness|0|||
131805552|NCT01389102|474572588|FG000|Overall Study|Investigator Judgement|0|||
131805553|NCT01389102|474572589|FG001|Overall Study|Investigator Judgement|1|||
131805554|NCT01389102|474572590|FG002|Overall Study|Investigator Judgement|0|||
131805555|NCT01389102|474572591|FG003|Overall Study|Investigator Judgement|0|||
131805556|NCT01389102|474572592|FG004|Overall Study|Investigator Judgement|0|||
131805557|NCT01389102|474572593|FG005|Overall Study|Investigator Judgement|0|||
131805558|NCT02910037|474572594|FG000|Overall Study|Withdrawal by Subject|4|||
131805559|NCT02910037|474572594|FG000|Overall Study|Lost to Follow-up|6|||
131805560|NCT00436553|474572595|FG000|Overall Study|Adverse Event|4|||
131725794|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
131725795|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
131725796|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
131725797|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131725798|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131725799|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131725800|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131725801|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131725802|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
131725803|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
131725804|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
131725805|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131725806|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131725807|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131725808|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131725809|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131725810|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
131725811|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
131725812|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
131725813|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131725814|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131725815|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131725816|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131725817|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131725818|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
131725819|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
131725820|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131725821|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131725822|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131725823|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131725824|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131725825|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131725826|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
131725827|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
131725828|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
131725829|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131725830|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131805561|NCT00436553|474572596|FG001|Overall Study|Adverse Event|3|||
131805562|NCT00436553|474572597|FG002|Overall Study|Adverse Event|4|||
131805563|NCT00436553|474572595|FG000|Overall Study|Death|3|||
131805564|NCT00436553|474572596|FG001|Overall Study|Death|1|||
131805565|NCT00436553|474572597|FG002|Overall Study|Death|3|||
131805566|NCT00436553|474572595|FG000|Overall Study|Lost to Follow-up|0|||
131805567|NCT00436553|474572596|FG001|Overall Study|Lost to Follow-up|2|||
131805568|NCT00436553|474572597|FG002|Overall Study|Lost to Follow-up|0|||
131805569|NCT00436553|474572595|FG000|Overall Study|Protocol Violation|1|||
131805570|NCT00436553|474572596|FG001|Overall Study|Protocol Violation|0|||
131805571|NCT00436553|474572597|FG002|Overall Study|Protocol Violation|0|||
131805572|NCT00436553|474572595|FG000|Overall Study|Withdrawal by Subject|5|||
131805573|NCT00436553|474572596|FG001|Overall Study|Withdrawal by Subject|6|||
131805574|NCT00436553|474572597|FG002|Overall Study|Withdrawal by Subject|3|||
131805575|NCT01035060|474572602|FG000|Overall Study|Lost to Follow-up|0|||
131805576|NCT01035060|474572603|FG001|Overall Study|Lost to Follow-up|7|||
131805577|NCT01035060|474572602|FG000|Overall Study|Did not quality after 2nd screening|14|||
131805578|NCT01035060|474572603|FG001|Overall Study|Did not quality after 2nd screening|1|||
131805579|NCT01035060|474572602|FG000|Overall Study|Withdrawal by Subject|8|||
131805580|NCT01035060|474572603|FG001|Overall Study|Withdrawal by Subject|6|||
131805581|NCT01035060|474572602|FG000|Overall Study|Physician Decision|2|||
131805582|NCT01035060|474572603|FG001|Overall Study|Physician Decision|0|||
131805583|NCT01981720|474572614|FG000|Overall Study|Adverse Event|1|||
131805584|NCT01981720|474572614|FG000|Overall Study|Withdrawal by Subject|3|||
131805585|NCT01981720|474572614|FG000|Overall Study|Pregnancy|1|||
131805586|NCT02674477|474572615|FG000|Overall Study|Protocol Violation|8|||
131805587|NCT02674477|474572616|FG001|Overall Study|Protocol Violation|2|||
131805588|NCT00696020|474572617|FG000|Overall Study|Adverse Event|3|||
131805589|NCT00696020|474572618|FG001|Overall Study|Adverse Event|1|||
131805590|NCT00696020|474572619|FG002|Overall Study|Adverse Event|2|||
131805591|NCT00696020|474572620|FG003|Overall Study|Adverse Event|1|||
131805592|NCT00696020|474572617|FG000|Overall Study|Lack of Efficacy|1|||
131805593|NCT00696020|474572618|FG001|Overall Study|Lack of Efficacy|0|||
131805594|NCT00696020|474572619|FG002|Overall Study|Lack of Efficacy|0|||
131805595|NCT00696020|474572620|FG003|Overall Study|Lack of Efficacy|0|||
131805596|NCT00696020|474572617|FG000|Overall Study|Protocol Violation|0|||
131805597|NCT00696020|474572618|FG001|Overall Study|Protocol Violation|0|||
131805598|NCT00696020|474572619|FG002|Overall Study|Protocol Violation|0|||
131805599|NCT00696020|474572620|FG003|Overall Study|Protocol Violation|1|||
131805600|NCT00696020|474572617|FG000|Overall Study|Withdrawal by Subject|0|||
131805601|NCT00696020|474572618|FG001|Overall Study|Withdrawal by Subject|1|||
131805602|NCT00696020|474572619|FG002|Overall Study|Withdrawal by Subject|0|||
131805603|NCT00696020|474572620|FG003|Overall Study|Withdrawal by Subject|1|||
131805604|NCT00696020|474572617|FG000|Overall Study|Other not stated above|0|||
131805605|NCT00696020|474572618|FG001|Overall Study|Other not stated above|0|||
131805606|NCT00696020|474572619|FG002|Overall Study|Other not stated above|1|||
131805607|NCT00696020|474572620|FG003|Overall Study|Other not stated above|1|||
131805608|NCT00624065|474572621|FG000|Overall Study|Adverse Event|5|||
131805609|NCT00624065|474572622|FG001|Overall Study|Adverse Event|6|||
131805610|NCT00624065|474572621|FG000|Overall Study|Lost to Follow-up|4|||
131805611|NCT00624065|474572622|FG001|Overall Study|Lost to Follow-up|1|||
131805612|NCT00624065|474572621|FG000|Overall Study|Consent withdrawn|6|||
131805613|NCT00624065|474572622|FG001|Overall Study|Consent withdrawn|5|||
131805614|NCT00624065|474572621|FG000|Overall Study|Lack of Efficacy|0|||
131805615|NCT00624065|474572622|FG001|Overall Study|Lack of Efficacy|3|||
131805616|NCT00624065|474572621|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
131805617|NCT00624065|474572622|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
131805618|NCT01387022|474572623|FG000|Overall Study|Death|1|||
131805619|NCT01387022|474572624|FG001|Overall Study|Death|1|||
131805620|NCT01387022|474572623|FG000|Overall Study|Lost to Follow-up|0|||
131805621|NCT01387022|474572624|FG001|Overall Study|Lost to Follow-up|3|||
131805622|NCT02076022|474572625|FG000|Overall Study|Withdrawal by Subject|2|||
131805623|NCT02076022|474572626|FG001|Overall Study|Withdrawal by Subject|0|||
131805624|NCT00312663|474572627|FG000|Immunization Phase|Adverse Event|0|||
131805625|NCT00312663|474572628|FG001|Immunization Phase|Adverse Event|1|||
131805626|NCT00312663|474572629|FG002|Immunization Phase|Adverse Event|0|||
131805627|NCT01536405|474572632|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
131805628|NCT01536405|474572633|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
131805629|NCT01536405|474572632|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
131805630|NCT01536405|474572633|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
131805631|NCT01536405|474572632|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
131805632|NCT01536405|474572633|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
131805633|NCT01536405|474572632|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
131805634|NCT01536405|474572633|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
131805635|NCT01536405|474572632|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
131805636|NCT01536405|474572633|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
131805637|NCT01536405|474572632|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
131805638|NCT01536405|474572633|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
131805639|NCT01536405|474572632|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
131805640|NCT01536405|474572633|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
131725831|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131725832|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131725833|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131725834|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
131725835|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
131725836|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131725837|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131725838|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131725839|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131725840|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131725841|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131725842|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
131725843|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
131725844|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131725845|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131725846|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131725847|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131725848|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131725849|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131725850|NCT01097616|474275957|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725851|NCT01097616|474275958|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725852|NCT01097616|474275959|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
131725853|NCT01097616|474275960|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725854|NCT01097616|474275961|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725855|NCT01097616|474275962|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725856|NCT01097616|474275963|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725857|NCT01097616|474275964|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131725858|NCT01097616|474275957|FG000|Optional DB EXT Phase|Adverse Event|0|||
131725859|NCT01097616|474275958|FG001|Optional DB EXT Phase|Adverse Event|7|||
131725860|NCT01097616|474275959|FG002|Optional DB EXT Phase|Adverse Event|2|||
131725861|NCT01097616|474275960|FG003|Optional DB EXT Phase|Adverse Event|0|||
131725862|NCT01097616|474275961|FG004|Optional DB EXT Phase|Adverse Event|0|||
131725863|NCT01097616|474275962|FG005|Optional DB EXT Phase|Adverse Event|0|||
131725864|NCT01097616|474275963|FG006|Optional DB EXT Phase|Adverse Event|0|||
131725865|NCT01097616|474275964|FG007|Optional DB EXT Phase|Adverse Event|0|||
131725866|NCT01097616|474275957|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
131725867|NCT01097616|474275958|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
131725868|NCT01097616|474275959|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
131725869|NCT01097616|474275960|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
131725870|NCT01097616|474275961|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
131725871|NCT01097616|474275962|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
131725872|NCT01097616|474275963|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
131725873|NCT01097616|474275964|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
131725874|NCT01097616|474275957|FG000|Optional DB EXT Phase|Protocol Violation|0|||
131725875|NCT01097616|474275958|FG001|Optional DB EXT Phase|Protocol Violation|2|||
131725876|NCT01097616|474275959|FG002|Optional DB EXT Phase|Protocol Violation|3|||
131725877|NCT01097616|474275960|FG003|Optional DB EXT Phase|Protocol Violation|0|||
131725878|NCT01097616|474275961|FG004|Optional DB EXT Phase|Protocol Violation|0|||
131725879|NCT01097616|474275962|FG005|Optional DB EXT Phase|Protocol Violation|0|||
131725880|NCT01097616|474275963|FG006|Optional DB EXT Phase|Protocol Violation|0|||
131725881|NCT01097616|474275964|FG007|Optional DB EXT Phase|Protocol Violation|0|||
131725882|NCT01097616|474275957|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
131725883|NCT01097616|474275958|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
131725884|NCT01097616|474275959|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
131725885|NCT01097616|474275960|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
131725886|NCT01097616|474275961|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
131725887|NCT01097616|474275962|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
131725888|NCT01097616|474275963|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
131725889|NCT01097616|474275964|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
131725890|NCT01097616|474275957|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
131725891|NCT01097616|474275958|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
131725892|NCT01097616|474275959|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
131725893|NCT01097616|474275960|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
131725894|NCT01097616|474275961|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
131725895|NCT01097616|474275962|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
131805641|NCT01536405|474572632|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
131805642|NCT01536405|474572633|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
131725896|NCT01097616|474275963|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
131805643|NCT01536405|474572632|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
131805644|NCT01536405|474572633|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
131805645|NCT01536405|474572632|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
131805646|NCT01536405|474572633|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
131805647|NCT01536405|474572632|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
131805648|NCT01536405|474572633|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
131805649|NCT01536405|474572632|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
131805650|NCT01536405|474572633|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
131805651|NCT01536405|474572632|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
131805652|NCT01536405|474572633|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
131805653|NCT00301366|474572634|FG000|Overall Study|Adverse Event|1|||
131805654|NCT02726581|474572637|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
131805655|NCT02726581|474572638|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
131805656|NCT02726581|474572639|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
131805657|NCT02726581|474572637|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
131805658|NCT02726581|474572638|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
131805659|NCT02726581|474572639|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
131805660|NCT02726581|474572637|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131805661|NCT02726581|474572638|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131805662|NCT02726581|474572639|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131805663|NCT02726581|474572637|FG000|Treatment Period|Disease progression|47|||
131805664|NCT02726581|474572638|FG001|Treatment Period|Disease progression|50|||
131805665|NCT02726581|474572639|FG002|Treatment Period|Disease progression|16|||
131805666|NCT02726581|474572637|FG000|Treatment Period|Other reasons|9|||
131805667|NCT02726581|474572638|FG001|Treatment Period|Other reasons|8|||
131805668|NCT02726581|474572639|FG002|Treatment Period|Other reasons|2|||
131805669|NCT02726581|474572637|FG000|Treatment Period|Study drug toxicity|6|||
131805670|NCT02726581|474572638|FG001|Treatment Period|Study drug toxicity|3|||
131805671|NCT02726581|474572639|FG002|Treatment Period|Study drug toxicity|2|||
131805672|NCT02726581|474572637|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
131805673|NCT02726581|474572638|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
131805674|NCT02726581|474572639|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
131805675|NCT02726581|474572637|FG000|Treatment Period|Participant withdrew consent|3|||
131805676|NCT02726581|474572638|FG001|Treatment Period|Participant withdrew consent|1|||
131805677|NCT02726581|474572639|FG002|Treatment Period|Participant withdrew consent|1|||
131805678|NCT02726581|474572637|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
131805679|NCT02726581|474572638|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
131805680|NCT02726581|474572639|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
131805681|NCT02726581|474572637|FG000|Treatment Period|Maximum clinical benefit|0|||
131805682|NCT02726581|474572638|FG001|Treatment Period|Maximum clinical benefit|2|||
131805683|NCT02726581|474572639|FG002|Treatment Period|Maximum clinical benefit|0|||
131805684|NCT02726581|474572637|FG000|Treatment Period|Death|1|||
131805685|NCT02726581|474572638|FG001|Treatment Period|Death|0|||
131805686|NCT02726581|474572639|FG002|Treatment Period|Death|0|||
131725897|NCT01097616|474275964|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
131725898|NCT01097616|474275957|FG000|Optional DB EXT Phase|Physician Decision|1|||
131725899|NCT01097616|474275958|FG001|Optional DB EXT Phase|Physician Decision|0|||
131725900|NCT01097616|474275959|FG002|Optional DB EXT Phase|Physician Decision|0|||
131725901|NCT01097616|474275960|FG003|Optional DB EXT Phase|Physician Decision|0|||
131725902|NCT01097616|474275961|FG004|Optional DB EXT Phase|Physician Decision|0|||
131725903|NCT01097616|474275962|FG005|Optional DB EXT Phase|Physician Decision|0|||
131725904|NCT01097616|474275963|FG006|Optional DB EXT Phase|Physician Decision|0|||
131725905|NCT01097616|474275964|FG007|Optional DB EXT Phase|Physician Decision|0|||
131725906|NCT01097616|474275957|FG000|DB RO Phase|Adverse Event|0|||
131725907|NCT01097616|474275958|FG001|DB RO Phase|Adverse Event|0|||
131725908|NCT01097616|474275959|FG002|DB RO Phase|Adverse Event|0|||
131725909|NCT01097616|474275960|FG003|DB RO Phase|Adverse Event|0|||
131725910|NCT01097616|474275961|FG004|DB RO Phase|Adverse Event|0|||
131725911|NCT01097616|474275962|FG005|DB RO Phase|Adverse Event|0|||
131725912|NCT01097616|474275963|FG006|DB RO Phase|Adverse Event|1|||
131725913|NCT01097616|474275964|FG007|DB RO Phase|Adverse Event|0|||
131725914|NCT01097616|474275957|FG000|DB RO Phase|Withdrawal by Subject|0|||
131725915|NCT01097616|474275958|FG001|DB RO Phase|Withdrawal by Subject|0|||
131725916|NCT01097616|474275959|FG002|DB RO Phase|Withdrawal by Subject|0|||
131725917|NCT01097616|474275960|FG003|DB RO Phase|Withdrawal by Subject|0|||
131725918|NCT01097616|474275961|FG004|DB RO Phase|Withdrawal by Subject|0|||
131725919|NCT01097616|474275962|FG005|DB RO Phase|Withdrawal by Subject|1|||
131725920|NCT01097616|474275963|FG006|DB RO Phase|Withdrawal by Subject|0|||
131725921|NCT01097616|474275964|FG007|DB RO Phase|Withdrawal by Subject|0|||
131725922|NCT01097616|474275957|FG000|DB RO Phase|Lost to Follow-up|0|||
131725923|NCT01097616|474275958|FG001|DB RO Phase|Lost to Follow-up|0|||
131725924|NCT01097616|474275959|FG002|DB RO Phase|Lost to Follow-up|0|||
131725925|NCT01097616|474275960|FG003|DB RO Phase|Lost to Follow-up|1|||
131725926|NCT01097616|474275961|FG004|DB RO Phase|Lost to Follow-up|1|||
131805687|NCT02726581|474572637|FG000|Treatment Period|Poor/non-compliance|1|||
131805688|NCT02726581|474572638|FG001|Treatment Period|Poor/non-compliance|0|||
131805689|NCT02726581|474572639|FG002|Treatment Period|Poor/non-compliance|0|||
131805690|NCT02726581|474572637|FG000|Treatment Period|Participant no longer meets study criteria|0|||
131805691|NCT02726581|474572638|FG001|Treatment Period|Participant no longer meets study criteria|1|||
131805692|NCT02726581|474572639|FG002|Treatment Period|Participant no longer meets study criteria|0|||
131805693|NCT02511782|474572640|FG000|Overall Study|Withdrawal by Subject|1|||
131805694|NCT02511782|474572641|FG001|Overall Study|Withdrawal by Subject|0|||
131805695|NCT02511782|474572642|FG002|Overall Study|Withdrawal by Subject|0|||
131805696|NCT00450190|474572643|FG000|Overall Study|Withdrawal by Subject|2|||
131805697|NCT01536574|474572644|FG000|Overall Study|Adverse Event|4|||
131805698|NCT01536574|474572645|FG001|Overall Study|Adverse Event|5|||
131805699|NCT01536574|474572644|FG000|Overall Study|Withdrawal by Subject|1|||
131805700|NCT01536574|474572645|FG001|Overall Study|Withdrawal by Subject|2|||
131805701|NCT01536574|474572644|FG000|Overall Study|Lack of Efficacy|1|||
131805702|NCT01536574|474572645|FG001|Overall Study|Lack of Efficacy|0|||
131805703|NCT01376167|474572646|FG000|Overall Study|Lost to Follow-up|2|||
131805704|NCT01376167|474572647|FG001|Overall Study|Lost to Follow-up|4|||
131805705|NCT01376167|474572648|FG002|Overall Study|Lost to Follow-up|2|||
131805706|NCT01376167|474572646|FG000|Overall Study|Physician Decision|1|||
131805707|NCT01376167|474572647|FG001|Overall Study|Physician Decision|1|||
131805708|NCT01376167|474572648|FG002|Overall Study|Physician Decision|0|||
131805709|NCT01376167|474572646|FG000|Overall Study|Withdrawal by Subject|1|||
131725927|NCT01097616|474275962|FG005|DB RO Phase|Lost to Follow-up|0|||
131805710|NCT01376167|474572647|FG001|Overall Study|Withdrawal by Subject|5|||
131805711|NCT01376167|474572648|FG002|Overall Study|Withdrawal by Subject|4|||
131805712|NCT02514122|474572649|FG000|Overall Study|Withdrawal by Subject|2|||
131805713|NCT02514122|474572650|FG001|Overall Study|Withdrawal by Subject|0|||
131805714|NCT01472341|474572651|FG000|Overall Study|Started insulin therapy|55|||
131805715|NCT01472341|474572651|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
131805716|NCT01472341|474572651|FG000|Overall Study|Withdrawal by Subject|39|||
131805717|NCT01472341|474572651|FG000|Overall Study|Lost to Follow-up|52|||
131805718|NCT01472341|474572651|FG000|Overall Study|Laboratory parameters unavailable|25|||
131805719|NCT01472341|474572651|FG000|Overall Study|Death|9|||
131805720|NCT00112463|474572654|FG000|Overall Study|Physician Decision|1|||
131805721|NCT00112463|474572654|FG000|Overall Study|Progression|30|||
131805722|NCT00112463|474572654|FG000|Overall Study|Second Primary|1|||
131805723|NCT00112463|474572654|FG000|Overall Study|Toxicity|3|||
131805724|NCT00112463|474572654|FG000|Overall Study|Withdrawal by Subject|2|||
131725928|NCT01097616|474275963|FG006|DB RO Phase|Lost to Follow-up|0|||
131725929|NCT01097616|474275964|FG007|DB RO Phase|Lost to Follow-up|1|||
131725930|NCT01097616|474275957|FG000|DB RO Phase|Not Treated in RO|0|||
131725931|NCT01097616|474275958|FG001|DB RO Phase|Not Treated in RO|0|||
131725932|NCT01097616|474275959|FG002|DB RO Phase|Not Treated in RO|0|||
131725933|NCT01097616|474275960|FG003|DB RO Phase|Not Treated in RO|0|||
131725934|NCT01097616|474275961|FG004|DB RO Phase|Not Treated in RO|0|||
131725935|NCT01097616|474275962|FG005|DB RO Phase|Not Treated in RO|1|||
131725936|NCT01097616|474275963|FG006|DB RO Phase|Not Treated in RO|0|||
131725937|NCT01097616|474275964|FG007|DB RO Phase|Not Treated in RO|0|||
131725938|NCT00130208|474275965|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
131725939|NCT00130208|474275966|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
131725940|NCT00130208|474275965|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
131725941|NCT00130208|474275966|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
131725942|NCT00130208|474275965|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
131725943|NCT00130208|474275966|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
131725944|NCT00130208|474275965|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
131725945|NCT00130208|474275966|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
131725946|NCT00130208|474275965|FG000|Maintenance Period (26 Weeks)|Other|1|||
131725947|NCT00130208|474275966|FG001|Maintenance Period (26 Weeks)|Other|1|||
131725948|NCT00130208|474275965|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
131805725|NCT00112463|474572654|FG000|Overall Study|Never started treatment|2|||
131805726|NCT01118312|474572661|FG000|Overall Study|Lost to Follow-up|33|||
131805727|NCT01118312|474572662|FG001|Overall Study|Lost to Follow-up|32|||
131805728|NCT01118312|474572661|FG000|Overall Study|Withdrawal by Subject|1|||
131725949|NCT00130208|474275966|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
131805729|NCT01118312|474572662|FG001|Overall Study|Withdrawal by Subject|3|||
131805730|NCT00296647|474572663|FG000|Overall Study|Death|4|||
131805731|NCT00296647|474572664|FG001|Overall Study|Death|1|||
131805732|NCT00296647|474572665|FG002|Overall Study|Death|2|||
131805733|NCT00296647|474572666|FG003|Overall Study|Death|1|||
131805734|NCT00296647|474572667|FG004|Overall Study|Death|1|||
131805735|NCT00296647|474572663|FG000|Overall Study|Withdrawal by Subject|28|||
131805736|NCT00296647|474572664|FG001|Overall Study|Withdrawal by Subject|27|||
131725950|NCT00130208|474275965|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
131725951|NCT00130208|474275966|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
131725952|NCT00130208|474275965|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
131725953|NCT00130208|474275966|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
131725954|NCT00130208|474275965|FG000|Washout Period (8 Weeks)|Other|1|||
131725955|NCT00130208|474275966|FG001|Washout Period (8 Weeks)|Other|1|||
131725956|NCT00589472|474275968|FG000|Overall Study|Adverse Event|1|||
131725957|NCT01703819|474275971|FG000|Overall Study|Adverse Event|0|||
131725958|NCT01703819|474275972|FG001|Overall Study|Adverse Event|1|||
131725959|NCT01703819|474275971|FG000|Overall Study|Withdrawal by Subject|0|||
131725960|NCT01703819|474275972|FG001|Overall Study|Withdrawal by Subject|1|||
131805737|NCT00296647|474572665|FG002|Overall Study|Withdrawal by Subject|32|||
131805738|NCT00296647|474572666|FG003|Overall Study|Withdrawal by Subject|16|||
131805739|NCT00296647|474572667|FG004|Overall Study|Withdrawal by Subject|19|||
131805740|NCT01629381|474572668|FG000|Overall Study|Withdrawal by Subject|2|||
131805741|NCT01629381|474572669|FG001|Overall Study|Withdrawal by Subject|5|||
131805742|NCT00735904|474572670|FG000|Overall Study|Adverse Event|3|||
131805743|NCT00735904|474572670|FG000|Overall Study|Death|20|||
131805744|NCT00735904|474572670|FG000|Overall Study|Protocol Violation|1|||
131805745|NCT00735904|474572670|FG000|Overall Study|Withdrawal by Subject|1|||
131805746|NCT00735904|474572670|FG000|Overall Study|Study Terminated by Sponsor|5|||
131805747|NCT00735904|474572670|FG000|Overall Study|Other|8|||
131805748|NCT01390844|474572674|FG000|Treatment Phase|Adverse Event|12|||
131805749|NCT01390844|474572675|FG001|Treatment Phase|Adverse Event|2|||
131805750|NCT01390844|474572676|FG002|Treatment Phase|Adverse Event|3|||
131805751|NCT01390844|474572677|FG003|Treatment Phase|Adverse Event|2|||
131805752|NCT01390844|474572674|FG000|Treatment Phase|Treatment Failure|23|||
131805753|NCT01390844|474572675|FG001|Treatment Phase|Treatment Failure|25|||
131805754|NCT01390844|474572676|FG002|Treatment Phase|Treatment Failure|10|||
131805755|NCT01390844|474572677|FG003|Treatment Phase|Treatment Failure|13|||
131805756|NCT01390844|474572674|FG000|Treatment Phase|Non-Medical Reasons|5|||
131805757|NCT01390844|474572675|FG001|Treatment Phase|Non-Medical Reasons|1|||
131805758|NCT01390844|474572676|FG002|Treatment Phase|Non-Medical Reasons|8|||
131805759|NCT01390844|474572677|FG003|Treatment Phase|Non-Medical Reasons|1|||
131805760|NCT01390844|474572674|FG000|Treatment Phase|Non-GCP Compliant|0|||
131805761|NCT01390844|474572675|FG001|Treatment Phase|Non-GCP Compliant|0|||
131805762|NCT01390844|474572676|FG002|Treatment Phase|Non-GCP Compliant|10|||
131805763|NCT01390844|474572677|FG003|Treatment Phase|Non-GCP Compliant|3|||
131805764|NCT01390844|474572674|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
131805765|NCT01390844|474572675|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
131805766|NCT01390844|474572676|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
131805767|NCT01390844|474572677|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
131805768|NCT03204539|474572680|FG000|Overall Study|Loss of funding|0|||
131805769|NCT03204539|474572681|FG001|Overall Study|Loss of funding|1|||
131805770|NCT03361228|474572683|FG000|Overall Study|Other|1|||
131805771|NCT03361228|474572684|FG001|Overall Study|Other|1|||
131805772|NCT03361228|474572683|FG000|Overall Study|Death|3|||
131805773|NCT03361228|474572684|FG001|Overall Study|Death|0|||
131805774|NCT02193178|474572691|FG000|Overall Study|Lost to Follow-up|1|||
131805775|NCT02193178|474572691|FG000|Overall Study|Dry eyes|1|||
131805776|NCT04320849|474572694|FG000|Overall Study|Withdrawal by Subject|4|||
131805777|NCT04320849|474572694|FG000|Overall Study|Imaging data unavailable|2|||
131805778|NCT04320849|474572694|FG000|Overall Study|Incomplete imaging|2|||
131805779|NCT00214422|474572695|FG000|Overall Study|Physician Decision|2|||
131805780|NCT00214422|474572696|FG001|Overall Study|Physician Decision|0|||
131805781|NCT00214422|474572697|FG002|Overall Study|Physician Decision|0|||
131805782|NCT00214422|474572695|FG000|Overall Study|Developed esophageal ca|1|||
131805783|NCT00214422|474572696|FG001|Overall Study|Developed esophageal ca|0|||
131805784|NCT00214422|474572697|FG002|Overall Study|Developed esophageal ca|0|||
131805785|NCT00214422|474572695|FG000|Overall Study|Pt taken off study|1|||
131805786|NCT00214422|474572696|FG001|Overall Study|Pt taken off study|1|||
131805787|NCT00214422|474572697|FG002|Overall Study|Pt taken off study|0|||
131805788|NCT00214422|474572695|FG000|Overall Study|Disease progression on study|1|||
131805789|NCT00214422|474572696|FG001|Overall Study|Disease progression on study|0|||
131805790|NCT00214422|474572697|FG002|Overall Study|Disease progression on study|0|||
131805791|NCT00214422|474572695|FG000|Overall Study|Unable to make a radiation treatment|0|||
131805792|NCT00214422|474572696|FG001|Overall Study|Unable to make a radiation treatment|0|||
131805793|NCT00214422|474572697|FG002|Overall Study|Unable to make a radiation treatment|1|||
131805794|NCT03929393|474572698|FG000|Overall Study|Death|1|||
131805795|NCT03929393|474572699|FG001|Overall Study|Death|0|||
131805796|NCT03929393|474572698|FG000|Overall Study|Time Commitment|2|||
131805797|NCT03929393|474572699|FG001|Overall Study|Time Commitment|5|||
131805798|NCT03929393|474572698|FG000|Overall Study|Motor Vehicle Accident|0|||
131805799|NCT03929393|474572699|FG001|Overall Study|Motor Vehicle Accident|1|||
131805800|NCT03929393|474572698|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
131805801|NCT03929393|474572699|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
131805802|NCT03929393|474572698|FG000|Overall Study|Other|1|||
131805803|NCT03929393|474572699|FG001|Overall Study|Other|3|||
131805804|NCT02817841|474574333|FG000|Overall Study|Lost to Follow-up|287|||
131805805|NCT02817841|474574333|FG000|Overall Study|Withdrawal by Subject|183|||
131725961|NCT04230486|474275973|FG000|Overall Study|Screen Failure|1|||
131805806|NCT02817841|474574333|FG000|Overall Study|Adverse event not related to bleeding|131|||
131805807|NCT02817841|474574333|FG000|Overall Study|Adverse event related to bleeding|51|||
131805808|NCT02817841|474574333|FG000|Overall Study|Pregnancy|32|||
131805809|NCT02817841|474574333|FG000|Overall Study|Pregnancy wish|17|||
131805810|NCT02817841|474574333|FG000|Overall Study|Other reasons|53|||
131805811|NCT02817841|474574333|FG000|Overall Study|Protocol Violation|94|||
131805812|NCT01746017|474574336|FG000|Period 1|Withdrawal by Subject|0|||
131805813|NCT01746017|474574337|FG001|Period 1|Withdrawal by Subject|0|||
131805814|NCT01746017|474574338|FG002|Period 1|Withdrawal by Subject|0|||
131805815|NCT01746017|474574339|FG003|Period 1|Withdrawal by Subject|0|||
131805816|NCT01746017|474574340|FG004|Period 1|Withdrawal by Subject|0|||
131805817|NCT01746017|474574341|FG005|Period 1|Withdrawal by Subject|0|||
131805818|NCT01746017|474574342|FG006|Period 1|Withdrawal by Subject|1|||
131805819|NCT01746017|474574343|FG007|Period 1|Withdrawal by Subject|0|||
131805820|NCT01746017|474574344|FG008|Period 1|Withdrawal by Subject|0|||
131805821|NCT01746017|474574345|FG009|Period 1|Withdrawal by Subject|0|||
131805822|NCT01746017|474574346|FG010|Period 1|Withdrawal by Subject|0|||
131805823|NCT01746017|474574336|FG000|Period 3|Withdrawal by Subject|0|||
131805824|NCT01746017|474574337|FG001|Period 3|Withdrawal by Subject|0|||
131805825|NCT01746017|474574338|FG002|Period 3|Withdrawal by Subject|0|||
131805826|NCT01746017|474574339|FG003|Period 3|Withdrawal by Subject|0|||
131805827|NCT01746017|474574340|FG004|Period 3|Withdrawal by Subject|0|||
131805828|NCT01746017|474574341|FG005|Period 3|Withdrawal by Subject|1|||
131805829|NCT01746017|474574342|FG006|Period 3|Withdrawal by Subject|0|||
131805830|NCT01746017|474574343|FG007|Period 3|Withdrawal by Subject|0|||
131805831|NCT01746017|474574344|FG008|Period 3|Withdrawal by Subject|0|||
131805832|NCT01746017|474574345|FG009|Period 3|Withdrawal by Subject|0|||
131805833|NCT01746017|474574346|FG010|Period 3|Withdrawal by Subject|0|||
131805834|NCT00397488|474574347|FG000|Overall Study|Withdrawal by Subject|3|||
131805835|NCT00397488|474574347|FG000|Overall Study|Adverse Event|3|||
131805836|NCT00397488|474574347|FG000|Overall Study|Death|1|||
131805837|NCT02424097|474574348|FG000|Overall Study|Lost to Follow-up|1|||
131805838|NCT02424097|474574349|FG001|Overall Study|Lost to Follow-up|2|||
131805839|NCT02943447|474574350|FG000|Blinded Study Phase|Withdrew Consent|1|||
131805840|NCT02943447|474574351|FG001|Blinded Study Phase|Withdrew Consent|2|||
131805841|NCT02943447|474574352|FG002|Blinded Study Phase|Withdrew Consent|1|||
131805842|NCT02943447|474574350|FG000|Blinded Study Phase|Adverse Event|3|||
131805843|NCT02943447|474574351|FG001|Blinded Study Phase|Adverse Event|0|||
131805844|NCT02943447|474574352|FG002|Blinded Study Phase|Adverse Event|0|||
131805845|NCT02943447|474574350|FG000|Blinded Study Phase|Investigator's discretion|1|||
131805846|NCT02943447|474574351|FG001|Blinded Study Phase|Investigator's discretion|0|||
131805847|NCT02943447|474574352|FG002|Blinded Study Phase|Investigator's discretion|0|||
131805848|NCT02943447|474574350|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
131805849|NCT02943447|474574351|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
131805850|NCT02943447|474574352|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
131805851|NCT02943447|474574350|FG000|Open-Label Extension Phase|Adverse Event|4|||
131805852|NCT02943447|474574351|FG001|Open-Label Extension Phase|Adverse Event|7|||
131805853|NCT02943447|474574352|FG002|Open-Label Extension Phase|Adverse Event|3|||
131805854|NCT02943447|474574350|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
131805855|NCT02943447|474574351|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
131805856|NCT02943447|474574352|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
131805857|NCT02943447|474574350|FG000|Open-Label Extension Phase|Withdrew consent|1|||
131805858|NCT02943447|474574351|FG001|Open-Label Extension Phase|Withdrew consent|1|||
131805859|NCT02943447|474574352|FG002|Open-Label Extension Phase|Withdrew consent|1|||
131805860|NCT02943447|474574350|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
131805861|NCT02943447|474574351|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
131805862|NCT02943447|474574352|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
131805863|NCT04657770|474574360|FG000|Overall Study|Withdrawal by Subject|3|||
131805864|NCT04657770|474574360|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
131805865|NCT00746798|474574361|FG000|Overall Study|Protocol Violation|0|||
131805866|NCT00746798|474574362|FG001|Overall Study|Protocol Violation|1|||
131805867|NCT00746798|474574363|FG002|Overall Study|Protocol Violation|0|||
131805868|NCT00746798|474574364|FG003|Overall Study|Protocol Violation|0|||
131805869|NCT00746798|474574361|FG000|Overall Study|Withdrawal by Subject|0|||
131805870|NCT00746798|474574362|FG001|Overall Study|Withdrawal by Subject|1|||
131805871|NCT00746798|474574363|FG002|Overall Study|Withdrawal by Subject|1|||
131448737|NCT00790842|473272730|FG010|Dose Level 4|Adverse Event|0|||
131805872|NCT00746798|474574364|FG003|Overall Study|Withdrawal by Subject|0|||
131805873|NCT00746798|474574361|FG000|Overall Study|Death|0|||
131448738|NCT00790842|473272720|FG000|Dose Level 4|Physician Decision|0|||
131448739|NCT00790842|473272721|FG001|Dose Level 4|Physician Decision|0|||
131448740|NCT00790842|473272722|FG002|Dose Level 4|Physician Decision|0|||
131448741|NCT00790842|473272723|FG003|Dose Level 4|Physician Decision|0|||
131448742|NCT00790842|473272724|FG004|Dose Level 4|Physician Decision|0|||
131448743|NCT00790842|473272725|FG005|Dose Level 4|Physician Decision|0|||
131805874|NCT00746798|474574362|FG001|Overall Study|Death|0|||
131448744|NCT00790842|473272726|FG006|Dose Level 4|Physician Decision|1|||
131725962|NCT03215264|474275974|FG000|Dose Level 2|Adverse Event|0|||
131725963|NCT03215264|474275975|FG001|Dose Level 2|Adverse Event|1|||
131725964|NCT03215264|474275976|FG002|Dose Level 2|Adverse Event|0|||
131725965|NCT03215264|474275974|FG000|Dose Level 3|Withdrawal by Subject|0|||
131725966|NCT03215264|474275975|FG001|Dose Level 3|Withdrawal by Subject|0|||
131725967|NCT03215264|474275976|FG002|Dose Level 3|Withdrawal by Subject|1|||
131725968|NCT02145156|474275977|FG000|Overall Study|No match to vaccination records|60|||
131725969|NCT02145156|474275978|FG001|Overall Study|No match to vaccination records|52|||
131725970|NCT02145156|474275979|FG002|Overall Study|No match to vaccination records|41|||
131725971|NCT02234583|474275982|FG000|Overall Study|Adverse Event|172|||
131725972|NCT02234583|474275983|FG001|Overall Study|Adverse Event|156|||
131725973|NCT02234583|474275982|FG000|Overall Study|Withdrawal by Subject|109|||
131725974|NCT02234583|474275983|FG001|Overall Study|Withdrawal by Subject|157|||
131725975|NCT02234583|474275982|FG000|Overall Study|Lost to Follow-up|0|||
131725976|NCT02234583|474275983|FG001|Overall Study|Lost to Follow-up|1|||
131725977|NCT02234583|474275982|FG000|Overall Study|Lack of Efficacy|58|||
131725978|NCT02234583|474275983|FG001|Overall Study|Lack of Efficacy|103|||
131725979|NCT02234583|474275982|FG000|Overall Study|Protocol Violation|35|||
131725980|NCT02234583|474275983|FG001|Overall Study|Protocol Violation|42|||
131725981|NCT02234583|474275982|FG000|Overall Study|Other|39|||
131725982|NCT02234583|474275983|FG001|Overall Study|Other|97|||
131725983|NCT02805907|474275984|FG000|Overall Study|Lost to Follow-up|3|||
131725984|NCT02805907|474275985|FG001|Overall Study|Lost to Follow-up|3|||
131725985|NCT01651052|474275988|FG000|Overall Study|Death|21|||
131725986|NCT01651052|474275988|FG000|Overall Study|Explant|1|||
131725987|NCT01651052|474275988|FG000|Overall Study|Withdrawal by Subject|1|||
131725988|NCT01651052|474275988|FG000|Overall Study|Lost to Follow-up|3|||
131725989|NCT00871858|474275991|FG000|Overall Study|Protocol Violation|3|||
131725990|NCT00871858|474275992|FG001|Overall Study|Protocol Violation|4|||
131725991|NCT00871858|474275991|FG000|Overall Study|Adverse Event|1|||
131725992|NCT00871858|474275992|FG001|Overall Study|Adverse Event|1|||
131725993|NCT00871858|474275991|FG000|Overall Study|Withdrawal by Subject|1|||
131725994|NCT00871858|474275992|FG001|Overall Study|Withdrawal by Subject|1|||
131725995|NCT00871858|474275991|FG000|Overall Study|Lost to Follow-up|0|||
131725996|NCT00871858|474275992|FG001|Overall Study|Lost to Follow-up|1|||
131725997|NCT01188798|474275993|FG000|Overall Study|Death|0|||
131725998|NCT01188798|474275994|FG001|Overall Study|Death|1|||
131725999|NCT01188798|474275993|FG000|Overall Study|Required additional transplant|1|||
131726000|NCT01188798|474275994|FG001|Overall Study|Required additional transplant|1|||
131726001|NCT01188798|474275993|FG000|Overall Study|Protocol closure|1|||
131726002|NCT01188798|474275994|FG001|Overall Study|Protocol closure|1|||
131726003|NCT02795767|474275995|FG000|Overall Study|Received Commercial Emicizumab|1|||
131726004|NCT02795767|474275996|FG001|Overall Study|Received Commercial Emicizumab|0|||
131726005|NCT02795767|474275997|FG002|Overall Study|Received Commercial Emicizumab|0|||
131726006|NCT01097330|474276013|FG000|Overall Study|Study terminated early|7|||
131726007|NCT01097330|474276014|FG001|Overall Study|Study terminated early|5|||
131726008|NCT01400971|474276015|FG000|Overall Study|Death|82|||
131726009|NCT01400971|474276015|FG000|Overall Study|Lost to Follow-up|196|||
131726010|NCT01400971|474276015|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
131726011|NCT01400971|474276015|FG000|Overall Study|Physician Decision|57|||
131726012|NCT01400971|474276015|FG000|Overall Study|Withdrawal by Subject|158|||
131726013|NCT01400971|474276015|FG000|Overall Study|Other|422|||
131726014|NCT01765764|474276018|FG000|Treatment Period|Adverse Event|1|||
131726015|NCT01765764|474276019|FG001|Treatment Period|Adverse Event|2|||
131726016|NCT01765764|474276020|FG002|Treatment Period|Adverse Event|1|||
131726017|NCT01765764|474276018|FG000|Treatment Period|Lost to Follow-up|0|||
131726018|NCT01765764|474276019|FG001|Treatment Period|Lost to Follow-up|3|||
131726019|NCT01765764|474276020|FG002|Treatment Period|Lost to Follow-up|2|||
131726020|NCT01765764|474276018|FG000|Treatment Period|Personal Reasons|1|||
131726021|NCT01765764|474276019|FG001|Treatment Period|Personal Reasons|2|||
131726022|NCT01765764|474276020|FG002|Treatment Period|Personal Reasons|1|||
131726023|NCT01765764|474276018|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
131726024|NCT01765764|474276019|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
131726025|NCT01765764|474276020|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
131726026|NCT01558089|474276021|FG000|Overall Study|Adverse Event|1|||
131726027|NCT01558089|474276021|FG000|Overall Study|Lack of Efficacy|1|||
131726028|NCT01558089|474276021|FG000|Overall Study|Lost to Follow-up|5|||
131448745|NCT00790842|473272727|FG007|Dose Level 4|Physician Decision|0|||
131726029|NCT01558089|474276021|FG000|Overall Study|Withdrawal by Subject|6|||
131726030|NCT03117049|474276034|FG000|Overall Study|Continued the follow-up period|109|||
131726031|NCT03117049|474276035|FG001|Overall Study|Continued the follow-up period|129|||
131726032|NCT03117049|474276034|FG000|Overall Study|Died|82|||
131726033|NCT03117049|474276035|FG001|Overall Study|Died|93|||
131726034|NCT03117049|474276034|FG000|Overall Study|Consent withdrawal|7|||
131726035|NCT03117049|474276035|FG001|Overall Study|Consent withdrawal|6|||
131726036|NCT03117049|474276034|FG000|Overall Study|Missing contact|3|||
131726037|NCT03117049|474276035|FG001|Overall Study|Missing contact|3|||
131726038|NCT00651118|474276036|FG000|Overall Study|Adverse Event|4|||
131726039|NCT00651118|474276037|FG001|Overall Study|Adverse Event|0|||
131726040|NCT00651118|474276038|FG002|Overall Study|Adverse Event|1|||
131726041|NCT00651118|474276039|FG003|Overall Study|Adverse Event|1|||
131726042|NCT00651118|474276036|FG000|Overall Study|Protocol Violation|2|||
131726043|NCT00651118|474276037|FG001|Overall Study|Protocol Violation|2|||
131726044|NCT00651118|474276038|FG002|Overall Study|Protocol Violation|6|||
131726045|NCT00651118|474276039|FG003|Overall Study|Protocol Violation|2|||
131726046|NCT00651118|474276036|FG000|Overall Study|Lost to Follow-up|2|||
131726047|NCT00651118|474276037|FG001|Overall Study|Lost to Follow-up|0|||
131726048|NCT00651118|474276038|FG002|Overall Study|Lost to Follow-up|1|||
131726049|NCT00651118|474276039|FG003|Overall Study|Lost to Follow-up|2|||
131726050|NCT00651118|474276036|FG000|Overall Study|administrative|1|||
131726051|NCT00651118|474276037|FG001|Overall Study|administrative|4|||
131726052|NCT00651118|474276038|FG002|Overall Study|administrative|2|||
131726053|NCT00651118|474276039|FG003|Overall Study|administrative|1|||
131726054|NCT00651118|474276036|FG000|Overall Study|Withdrawal by Subject|0|||
131726055|NCT00651118|474276037|FG001|Overall Study|Withdrawal by Subject|1|||
131726056|NCT00651118|474276038|FG002|Overall Study|Withdrawal by Subject|1|||
131726057|NCT00651118|474276039|FG003|Overall Study|Withdrawal by Subject|1|||
131726058|NCT00839098|474276040|FG000|Overall Study|Withdrawal by Subject|2|||
131726059|NCT00839098|474276041|FG001|Overall Study|Withdrawal by Subject|1|||
131726060|NCT00839098|474276042|FG002|Overall Study|Withdrawal by Subject|7|||
131726061|NCT00365976|474276045|FG000|Overall Study|Withdrawal by Subject|1|||
131726062|NCT00365976|474276046|FG001|Overall Study|Withdrawal by Subject|5|||
131726063|NCT02260193|474276053|FG000|Overall Study|Lack of Efficacy|0|||
131726064|NCT02260193|474276054|FG001|Overall Study|Lack of Efficacy|1|||
131726065|NCT02260193|474276055|FG002|Overall Study|Lack of Efficacy|6|||
131726066|NCT02260193|474276053|FG000|Overall Study|Adverse Event|3|||
131726067|NCT02260193|474276054|FG001|Overall Study|Adverse Event|4|||
131726068|NCT02260193|474276055|FG002|Overall Study|Adverse Event|1|||
131726069|NCT02260193|474276053|FG000|Overall Study|Protocol Violation|0|||
131726070|NCT02260193|474276054|FG001|Overall Study|Protocol Violation|4|||
131726071|NCT02260193|474276055|FG002|Overall Study|Protocol Violation|0|||
131726072|NCT02260193|474276053|FG000|Overall Study|Withdrawal by Subject|3|||
131726073|NCT02260193|474276054|FG001|Overall Study|Withdrawal by Subject|0|||
131726074|NCT02260193|474276055|FG002|Overall Study|Withdrawal by Subject|2|||
131726075|NCT02260193|474276053|FG000|Overall Study|Kidney Transplantation|0|||
131726076|NCT02260193|474276054|FG001|Overall Study|Kidney Transplantation|0|||
131726077|NCT02260193|474276055|FG002|Overall Study|Kidney Transplantation|1|||
131726078|NCT00935220|474276056|FG000|Overall Study|Adverse Event|1|||
131726079|NCT00935220|474276056|FG000|Overall Study|Other reason (not specified)|1|||
131726080|NCT00798967|474276057|FG000|Overall Study|Adverse Event|2|||
131805875|NCT00746798|474574363|FG002|Overall Study|Death|2|||
131805876|NCT00746798|474574364|FG003|Overall Study|Death|0|||
131805877|NCT00746798|474574361|FG000|Overall Study|Participant unable to return for visit|1|||
131805878|NCT00746798|474574362|FG001|Overall Study|Participant unable to return for visit|0|||
131805879|NCT00746798|474574363|FG002|Overall Study|Participant unable to return for visit|0|||
131805880|NCT00746798|474574364|FG003|Overall Study|Participant unable to return for visit|0|||
131805881|NCT00633594|474574365|FG000|Overall Study|Adverse Event|0|||
131805882|NCT00633594|474574366|FG001|Overall Study|Adverse Event|4|||
131805883|NCT00633594|474574367|FG002|Overall Study|Adverse Event|7|||
131805884|NCT00633594|474574365|FG000|Overall Study|Death|0|||
131805885|NCT00633594|474574366|FG001|Overall Study|Death|1|||
131805886|NCT00633594|474574367|FG002|Overall Study|Death|2|||
131805887|NCT00633594|474574365|FG000|Overall Study|Disease Progression|0|||
131805888|NCT00633594|474574366|FG001|Overall Study|Disease Progression|0|||
131805889|NCT00633594|474574367|FG002|Overall Study|Disease Progression|1|||
131726081|NCT00798967|474276058|FG001|Overall Study|Adverse Event|3|||
131726082|NCT00798967|474276057|FG000|Overall Study|Withdrawal by Subject|0|||
131726083|NCT00798967|474276058|FG001|Overall Study|Withdrawal by Subject|1|||
131726084|NCT00798967|474276057|FG000|Overall Study|Physician Decision|1|||
131726085|NCT00798967|474276058|FG001|Overall Study|Physician Decision|0|||
131805890|NCT03655106|474574368|FG000|Overall Study|Withdrawal by Subject|3|||
131805891|NCT03655106|474574369|FG001|Overall Study|Withdrawal by Subject|2|||
131805892|NCT03655106|474574368|FG000|Overall Study|Lost to Follow-up|2|||
131726086|NCT00798967|474276057|FG000|Overall Study|Randomized in error by site|1|||
131726087|NCT00798967|474276058|FG001|Overall Study|Randomized in error by site|0|||
131726088|NCT00336492|474276061|FG000|Overall Study|Adverse Event|4|||
131726089|NCT00336492|474276062|FG001|Overall Study|Adverse Event|3|||
131726090|NCT00336492|474276063|FG002|Overall Study|Adverse Event|6|||
131726091|NCT00336492|474276061|FG000|Overall Study|Lack of Efficacy|6|||
131726092|NCT00336492|474276062|FG001|Overall Study|Lack of Efficacy|1|||
131726093|NCT00336492|474276063|FG002|Overall Study|Lack of Efficacy|4|||
131726094|NCT00336492|474276061|FG000|Overall Study|Other|5|||
131726095|NCT00336492|474276062|FG001|Overall Study|Other|0|||
131726096|NCT00336492|474276063|FG002|Overall Study|Other|1|||
131726097|NCT01415440|474276064|FG000|Overall Study|Lost to Follow-up|0|||
131726098|NCT01415440|474276065|FG001|Overall Study|Lost to Follow-up|1|||
131726099|NCT01415440|474276066|FG002|Overall Study|Lost to Follow-up|2|||
131726100|NCT01415440|474276064|FG000|Overall Study|Physician Decision|3|||
131726101|NCT01415440|474276065|FG001|Overall Study|Physician Decision|0|||
131726102|NCT01415440|474276066|FG002|Overall Study|Physician Decision|0|||
131726103|NCT01415440|474276064|FG000|Overall Study|Withdrawal by Subject|1|||
131726104|NCT01415440|474276065|FG001|Overall Study|Withdrawal by Subject|0|||
131726105|NCT01415440|474276066|FG002|Overall Study|Withdrawal by Subject|0|||
131726106|NCT00227877|474276067|FG000|Pre-visit Assessment|Technical difficulties|7|||
131726107|NCT00227877|474276068|FG001|Pre-visit Assessment|Technical difficulties|3|||
131726108|NCT00227877|474276069|FG002|Pre-visit Assessment|Technical difficulties|0|||
131726109|NCT00227877|474276070|FG003|Pre-visit Assessment|Technical difficulties|0|||
131726110|NCT00227877|474276067|FG000|Post-visit Checklist|Lost to Follow-up|24|||
131726111|NCT00227877|474276068|FG001|Post-visit Checklist|Lost to Follow-up|13|||
131726112|NCT00227877|474276069|FG002|Post-visit Checklist|Lost to Follow-up|1|||
131726113|NCT00227877|474276070|FG003|Post-visit Checklist|Lost to Follow-up|0|||
131726114|NCT00227877|474276067|FG000|3-months Follow-up|Completed late|135|||
131726115|NCT00227877|474276068|FG001|3-months Follow-up|Completed late|128|||
131726116|NCT00227877|474276069|FG002|3-months Follow-up|Completed late|34|||
131726117|NCT00227877|474276070|FG003|3-months Follow-up|Completed late|8|||
131726118|NCT00227877|474276067|FG000|3-months Follow-up|Lost to Follow-up|178|||
131726119|NCT00227877|474276068|FG001|3-months Follow-up|Lost to Follow-up|139|||
131726120|NCT00227877|474276069|FG002|3-months Follow-up|Lost to Follow-up|18|||
131726121|NCT00227877|474276070|FG003|3-months Follow-up|Lost to Follow-up|13|||
131726122|NCT00227877|474276067|FG000|12-months Follow-up|Completed late|78|||
131726123|NCT00227877|474276068|FG001|12-months Follow-up|Completed late|74|||
131726124|NCT00227877|474276069|FG002|12-months Follow-up|Completed late|1|||
131726125|NCT00227877|474276070|FG003|12-months Follow-up|Completed late|0|||
131726126|NCT00227877|474276067|FG000|12-months Follow-up|Lost to Follow-up|232|||
131726127|NCT00227877|474276068|FG001|12-months Follow-up|Lost to Follow-up|189|||
131726128|NCT00227877|474276069|FG002|12-months Follow-up|Lost to Follow-up|30|||
131726129|NCT00227877|474276070|FG003|12-months Follow-up|Lost to Follow-up|26|||
131726130|NCT00633139|474276072|FG000|Overall Study|Non compliance|0|||
131726131|NCT00633139|474276073|FG001|Overall Study|Non compliance|0|||
131726132|NCT00633139|474276074|FG002|Overall Study|Non compliance|1|||
131726133|NCT00633139|474276072|FG000|Overall Study|Withdrawal by Subject|0|||
131726134|NCT00633139|474276073|FG001|Overall Study|Withdrawal by Subject|1|||
131726135|NCT00633139|474276074|FG002|Overall Study|Withdrawal by Subject|0|||
131726136|NCT02160977|474276076|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
131726137|NCT02160977|474276077|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
131726138|NCT02160977|474276076|FG000|Three Months After Surgery|Lost to Follow-up|0|||
131726139|NCT02160977|474276077|FG001|Three Months After Surgery|Lost to Follow-up|2|||
131726140|NCT02160977|474276076|FG000|Six Months After Surgery|Lost to Follow-up|2|||
131726141|NCT02160977|474276077|FG001|Six Months After Surgery|Lost to Follow-up|1|||
131726142|NCT01522651|474276081|FG000|Overall Study|Adverse Event|3|||
131726143|NCT01522651|474276082|FG001|Overall Study|Adverse Event|4|||
131726144|NCT01522651|474276083|FG002|Overall Study|Adverse Event|4|||
131726145|NCT01522651|474276084|FG003|Overall Study|Adverse Event|5|||
131726146|NCT01522651|474276085|FG004|Overall Study|Adverse Event|4|||
131726147|NCT01522651|474276081|FG000|Overall Study|Cardioversion|1|||
131726148|NCT01522651|474276082|FG001|Overall Study|Cardioversion|0|||
131726149|NCT01522651|474276083|FG002|Overall Study|Cardioversion|0|||
131726150|NCT01522651|474276084|FG003|Overall Study|Cardioversion|0|||
131726151|NCT01522651|474276085|FG004|Overall Study|Cardioversion|0|||
131726152|NCT01522651|474276081|FG000|Overall Study|Device Malfunction|0|||
131726153|NCT01522651|474276082|FG001|Overall Study|Device Malfunction|1|||
131726154|NCT01522651|474276083|FG002|Overall Study|Device Malfunction|0|||
131726155|NCT01522651|474276084|FG003|Overall Study|Device Malfunction|0|||
131448746|NCT00790842|473272728|FG008|Dose Level 4|Physician Decision|0|||
131726156|NCT01522651|474276085|FG004|Overall Study|Device Malfunction|0|||
131726157|NCT01522651|474276081|FG000|Overall Study|Investigator's Discretion|0|||
131726158|NCT01522651|474276082|FG001|Overall Study|Investigator's Discretion|1|||
131726159|NCT01522651|474276083|FG002|Overall Study|Investigator's Discretion|0|||
131726160|NCT01522651|474276084|FG003|Overall Study|Investigator's Discretion|0|||
131726161|NCT01522651|474276085|FG004|Overall Study|Investigator's Discretion|0|||
131726162|NCT01522651|474276081|FG000|Overall Study|Protocol Violation|3|||
131726163|NCT01522651|474276082|FG001|Overall Study|Protocol Violation|0|||
131726164|NCT01522651|474276083|FG002|Overall Study|Protocol Violation|0|||
131726165|NCT01522651|474276084|FG003|Overall Study|Protocol Violation|0|||
131726166|NCT01522651|474276085|FG004|Overall Study|Protocol Violation|0|||
131726167|NCT01522651|474276081|FG000|Overall Study|Reason Not Specified|0|||
131726168|NCT01522651|474276082|FG001|Overall Study|Reason Not Specified|0|||
131726169|NCT01522651|474276083|FG002|Overall Study|Reason Not Specified|0|||
131726170|NCT01522651|474276084|FG003|Overall Study|Reason Not Specified|1|||
131726171|NCT01522651|474276085|FG004|Overall Study|Reason Not Specified|0|||
131726172|NCT01522651|474276081|FG000|Overall Study|Participant Non-Compliance|1|||
131726173|NCT01522651|474276082|FG001|Overall Study|Participant Non-Compliance|0|||
131726174|NCT01522651|474276083|FG002|Overall Study|Participant Non-Compliance|0|||
131726175|NCT01522651|474276084|FG003|Overall Study|Participant Non-Compliance|0|||
131726176|NCT01522651|474276085|FG004|Overall Study|Participant Non-Compliance|0|||
131726177|NCT01522651|474276081|FG000|Overall Study|Withdrew Consent|1|||
131726178|NCT01522651|474276082|FG001|Overall Study|Withdrew Consent|1|||
131726179|NCT01522651|474276083|FG002|Overall Study|Withdrew Consent|0|||
131726180|NCT01522651|474276084|FG003|Overall Study|Withdrew Consent|1|||
131726181|NCT01522651|474276085|FG004|Overall Study|Withdrew Consent|1|||
131726182|NCT01522651|474276081|FG000|Overall Study|Randomized but Never Treated|0|||
131726183|NCT01522651|474276082|FG001|Overall Study|Randomized but Never Treated|1|||
131726184|NCT01522651|474276083|FG002|Overall Study|Randomized but Never Treated|0|||
131726185|NCT01522651|474276084|FG003|Overall Study|Randomized but Never Treated|1|||
131726186|NCT01522651|474276085|FG004|Overall Study|Randomized but Never Treated|1|||
131726187|NCT02658656|474276086|FG000|Screening|Failed eligibility criteria|0|||
131726188|NCT02658656|474276087|FG001|Screening|Failed eligibility criteria|0|||
131726189|NCT02658656|474276088|FG002|Screening|Failed eligibility criteria|263|||
131726190|NCT02658656|474276086|FG000|Randomization|Withdrawal by Subject|8|||
131726191|NCT02658656|474276087|FG001|Randomization|Withdrawal by Subject|7|||
131726192|NCT02658656|474276088|FG002|Randomization|Withdrawal by Subject|0|||
131726193|NCT02658656|474276086|FG000|Randomization|Lost to Follow-up|1|||
131726194|NCT02658656|474276087|FG001|Randomization|Lost to Follow-up|3|||
131726195|NCT02658656|474276088|FG002|Randomization|Lost to Follow-up|0|||
131726196|NCT02658656|474276086|FG000|Randomization|Adverse Event|4|||
131726197|NCT02658656|474276087|FG001|Randomization|Adverse Event|0|||
131726198|NCT02658656|474276088|FG002|Randomization|Adverse Event|0|||
131726199|NCT02658656|474276086|FG000|Randomization|Administrative Termination|3|||
131726200|NCT02658656|474276087|FG001|Randomization|Administrative Termination|1|||
131726201|NCT02658656|474276088|FG002|Randomization|Administrative Termination|0|||
131726202|NCT02658656|474276086|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
131726203|NCT02658656|474276087|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
131726204|NCT02658656|474276088|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
131726205|NCT02658656|474276086|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
131726206|NCT02658656|474276087|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
131726207|NCT02658656|474276088|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
131726208|NCT02658656|474276086|FG000|Randomization|Not eligible for Randomization|1|||
131726209|NCT02658656|474276087|FG001|Randomization|Not eligible for Randomization|0|||
131726210|NCT02658656|474276088|FG002|Randomization|Not eligible for Randomization|0|||
131726211|NCT02658656|474276086|FG000|Randomization|Protocol Violation|1|||
131726212|NCT02658656|474276087|FG001|Randomization|Protocol Violation|0|||
131726213|NCT02658656|474276088|FG002|Randomization|Protocol Violation|0|||
131726214|NCT01937130|474277603|FG000|Overall Study|Withdrawal by Subject|0|||
131726215|NCT01937130|474277604|FG001|Overall Study|Withdrawal by Subject|0|||
131726216|NCT01937130|474277605|FG002|Overall Study|Withdrawal by Subject|0|||
131726217|NCT01937130|474277606|FG003|Overall Study|Withdrawal by Subject|1|||
131726218|NCT01937130|474277603|FG000|Overall Study|Adverse Event|0|||
131726219|NCT01937130|474277604|FG001|Overall Study|Adverse Event|1|||
131726220|NCT01937130|474277605|FG002|Overall Study|Adverse Event|0|||
131726221|NCT01937130|474277606|FG003|Overall Study|Adverse Event|1|||
131726222|NCT01937130|474277603|FG000|Overall Study|Death|1|||
131726223|NCT01937130|474277604|FG001|Overall Study|Death|1|||
131726224|NCT01937130|474277605|FG002|Overall Study|Death|1|||
131726225|NCT01937130|474277606|FG003|Overall Study|Death|0|||
131726226|NCT01937130|474277603|FG000|Overall Study|Lost to Follow-up|2|||
131726227|NCT01937130|474277604|FG001|Overall Study|Lost to Follow-up|0|||
131726228|NCT01937130|474277605|FG002|Overall Study|Lost to Follow-up|2|||
131726229|NCT01937130|474277606|FG003|Overall Study|Lost to Follow-up|0|||
131726230|NCT01937130|474277603|FG000|Overall Study|Physician Decision|0|||
131726231|NCT01937130|474277604|FG001|Overall Study|Physician Decision|1|||
131726232|NCT01937130|474277605|FG002|Overall Study|Physician Decision|0|||
131726233|NCT01937130|474277606|FG003|Overall Study|Physician Decision|0|||
131726234|NCT01937130|474277603|FG000|Overall Study|Patients unable to swallow|0|||
131726235|NCT01937130|474277604|FG001|Overall Study|Patients unable to swallow|1|||
131726236|NCT01937130|474277605|FG002|Overall Study|Patients unable to swallow|0|||
131726237|NCT01937130|474277606|FG003|Overall Study|Patients unable to swallow|0|||
131726238|NCT01937130|474277603|FG000|Overall Study|Patient lost to FU due to death|2|||
131726239|NCT01937130|474277604|FG001|Overall Study|Patient lost to FU due to death|0|||
131726240|NCT01937130|474277605|FG002|Overall Study|Patient lost to FU due to death|0|||
131726241|NCT01937130|474277606|FG003|Overall Study|Patient lost to FU due to death|0|||
131726242|NCT03009539|474277609|FG000|Overall Study|Lost to Follow-up|132|||
131726243|NCT03009539|474277610|FG001|Overall Study|Lost to Follow-up|113|||
131726244|NCT03009539|474277611|FG002|Overall Study|Lost to Follow-up|132|||
131726245|NCT03009539|474277612|FG003|Overall Study|Lost to Follow-up|113|||
131726246|NCT03151148|474277613|FG000|Overall Study|Lost to Follow-up|1|||
131726247|NCT03151148|474277614|FG001|Overall Study|Lost to Follow-up|0|||
131726248|NCT03151148|474277613|FG000|Overall Study|Withdrawal by Subject|1|||
131726249|NCT03151148|474277614|FG001|Overall Study|Withdrawal by Subject|0|||
131726250|NCT00710034|474277615|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
131726251|NCT00710034|474277616|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
131726252|NCT00710034|474277615|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
131726253|NCT00710034|474277616|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
131726254|NCT00710034|474277615|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
131726255|NCT00710034|474277616|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
131726256|NCT00710034|474277615|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
131726257|NCT00710034|474277616|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
131726258|NCT00710034|474277615|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
131726259|NCT00710034|474277616|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
131726260|NCT00710034|474277615|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
131726261|NCT00710034|474277616|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
131726262|NCT00710034|474277615|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
131726263|NCT00710034|474277616|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
131726264|NCT00710034|474277615|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
131726265|NCT00710034|474277616|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
131726266|NCT00710034|474277615|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
131805893|NCT03655106|474574369|FG001|Overall Study|Lost to Follow-up|1|||
131805894|NCT03655106|474574368|FG000|Overall Study|Duplicate Enrollment|1|||
131805895|NCT03655106|474574369|FG001|Overall Study|Duplicate Enrollment|1|||
131805896|NCT03655106|474574368|FG000|Overall Study|Protocol Violation|3|||
131805897|NCT03655106|474574369|FG001|Overall Study|Protocol Violation|0|||
131805898|NCT01045096|474574373|FG000|Overall Study|Withdrawal by Subject|2|||
131805899|NCT01045096|474574374|FG001|Overall Study|Withdrawal by Subject|0|||
131805900|NCT01045096|474574375|FG002|Overall Study|Withdrawal by Subject|0|||
131805901|NCT01045096|474574373|FG000|Overall Study|Other|1|||
131805902|NCT01045096|474574374|FG001|Overall Study|Other|0|||
131805903|NCT01045096|474574375|FG002|Overall Study|Other|0|||
131805904|NCT01511939|474574377|FG000|Overall Study|Withdrawal by Subject|2|||
131805905|NCT01511939|474574378|FG001|Overall Study|Withdrawal by Subject|1|||
131805906|NCT01511939|474574379|FG002|Overall Study|Withdrawal by Subject|0|||
131805907|NCT03497897|474574384|FG000|Overall Study|Adverse Event|1|||
131805908|NCT03497897|474574385|FG001|Overall Study|Adverse Event|1|||
131805909|NCT03497897|474574386|FG002|Overall Study|Adverse Event|1|||
131805910|NCT03497897|474574384|FG000|Overall Study|Lost to Follow-up|2|||
131805911|NCT03497897|474574385|FG001|Overall Study|Lost to Follow-up|0|||
131805912|NCT03497897|474574386|FG002|Overall Study|Lost to Follow-up|2|||
131805913|NCT03497897|474574384|FG000|Overall Study|Physician Decision|1|||
131805914|NCT03497897|474574385|FG001|Overall Study|Physician Decision|0|||
131805915|NCT03497897|474574386|FG002|Overall Study|Physician Decision|0|||
131805916|NCT03497897|474574384|FG000|Overall Study|Subject/Guardian Decision|2|||
131805917|NCT03497897|474574385|FG001|Overall Study|Subject/Guardian Decision|1|||
131904942|NCT00983372|474938999|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
131904943|NCT00983372|474938999|FG000|Diltiazem ER Alone|Adverse Event|1|||
131904944|NCT05518539|474939002|FG000|Overall Study|Lost to Follow-up|6|||
131904945|NCT02053493|474939007|FG000|Overall Study|Withdrawal by Subject|1|||
131904946|NCT02053493|474939008|FG001|Overall Study|Withdrawal by Subject|1|||
131904947|NCT04613518|474939011|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
131904948|NCT04613518|474939012|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
131904949|NCT04613518|474939013|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
131904950|NCT04613518|474939011|FG000|Double-Blind Treatment Period|Adverse Event|2|||
131904951|NCT04613518|474939012|FG001|Double-Blind Treatment Period|Adverse Event|0|||
131904952|NCT04613518|474939013|FG002|Double-Blind Treatment Period|Adverse Event|1|||
131904953|NCT04613518|474939011|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
131904954|NCT04613518|474939012|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
131904955|NCT04613518|474939013|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
131904956|NCT04613518|474939011|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
131904957|NCT04613518|474939012|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
131726267|NCT00710034|474277616|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
131726268|NCT00710034|474277615|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
131726269|NCT00710034|474277616|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
131726270|NCT00710034|474277615|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
131726271|NCT00710034|474277616|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
131726272|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
131726273|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
131726274|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
131726275|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
131726276|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Death|8|||
131726277|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Death|3|||
131726278|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
131726279|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
131726280|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
131726281|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
131726282|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
131726283|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
131726284|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
131726285|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
131726286|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
131726287|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
131726288|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
131726289|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
131726290|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
131726291|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
131726292|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
131726293|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
131726294|NCT00494871|474277617|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
131726295|NCT00494871|474277618|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
131726296|NCT00494871|474277617|FG000|Follow-up (FU) Period|Adverse Event|1|||
131726297|NCT00494871|474277618|FG001|Follow-up (FU) Period|Adverse Event|1|||
131726298|NCT00494871|474277617|FG000|Follow-up (FU) Period|Death|13|||
131726299|NCT00494871|474277618|FG001|Follow-up (FU) Period|Death|12|||
131726300|NCT00494871|474277617|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
131726301|NCT00494871|474277618|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
131726302|NCT00494871|474277617|FG000|Follow-up (FU) Period|Physician Decision|0|||
131726303|NCT00494871|474277618|FG001|Follow-up (FU) Period|Physician Decision|1|||
131726304|NCT00494871|474277617|FG000|Follow-up (FU) Period|Protocol Violation|1|||
131726305|NCT00494871|474277618|FG001|Follow-up (FU) Period|Protocol Violation|0|||
131805918|NCT03497897|474574386|FG002|Overall Study|Subject/Guardian Decision|3|||
131805919|NCT01049334|474574391|FG000|Overall Study|Withdrawal by Subject|5|||
131805920|NCT01049334|474574392|FG001|Overall Study|Withdrawal by Subject|3|||
131805921|NCT01049334|474574391|FG000|Overall Study|Adverse Event|2|||
131805922|NCT01049334|474574392|FG001|Overall Study|Adverse Event|3|||
131805923|NCT01049334|474574391|FG000|Overall Study|Physician Decision|2|||
131805924|NCT01049334|474574392|FG001|Overall Study|Physician Decision|0|||
131805925|NCT01049334|474574391|FG000|Overall Study|Protocol Violation|0|||
131805926|NCT01049334|474574392|FG001|Overall Study|Protocol Violation|1|||
131805927|NCT03447262|474574396|FG000|Overall Study|Adverse Event|7|||
131805928|NCT03447262|474574396|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
131805929|NCT03447262|474574396|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
131805930|NCT03447262|474574396|FG000|Overall Study|Death|2|||
131805931|NCT03447262|474574396|FG000|Overall Study|Study Termination by Sponsor|455|||
131805932|NCT03447262|474574396|FG000|Overall Study|Other|4|||
131805933|NCT00496964|474574402|FG000|Overall Study|Withdrawal by Subject|0|||
131805934|NCT00496964|474574403|FG001|Overall Study|Withdrawal by Subject|1|||
131805935|NCT02058498|474574404|FG000|Overall Study|Withdrawal by Subject|4|||
131805936|NCT03351335|474574406|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
131805937|NCT03351335|474574407|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
131805938|NCT03351335|474574408|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
131805939|NCT05327491|474574409|FG000|Periods 1 & 2|Miscellaneous|0|||
131805940|NCT05327491|474574410|FG001|Periods 1 & 2|Miscellaneous|1|||
131805941|NCT05327491|474574411|FG002|Periods 1 & 2|Miscellaneous|0|||
131805942|NCT05327491|474574412|FG003|Periods 1 & 2|Miscellaneous|0|||
131805943|NCT05327491|474574409|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
131805944|NCT05327491|474574410|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
131805945|NCT05327491|474574411|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
131805946|NCT05327491|474574412|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
131805947|NCT05038293|474574413|FG000|Overall Study|device was not operating properly for one subject.|1|||
131805948|NCT05038293|474574414|FG001|Overall Study|device was not operating properly for one subject.|0|||
131805949|NCT05038293|474574413|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
131805950|NCT05038293|474574414|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
131805951|NCT01171989|474574415|FG000|Overall Study|Lost to Follow-up|0|||
131805952|NCT01171989|474574416|FG001|Overall Study|Lost to Follow-up|0|||
131805953|NCT01171989|474574417|FG002|Overall Study|Lost to Follow-up|1|||
131805954|NCT01247701|474574420|FG000|Overall Study|Death|2|||
131805955|NCT01247701|474574420|FG000|Overall Study|Relapsed|8|||
131805956|NCT04166630|474574421|FG000|Overall Study|Withdrawal by Subject|0|||
131805957|NCT04166630|474574422|FG001|Overall Study|Withdrawal by Subject|1|||
131726306|NCT00494871|474277617|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
131726307|NCT00494871|474277618|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
131805958|NCT00096447|474574423|FG000|Overall Study|Never treated|1|||
131805959|NCT01171963|474574424|FG000|Overall Study|Adverse Event|10|||
131805960|NCT01171963|474574425|FG001|Overall Study|Adverse Event|15|||
131805961|NCT01171963|474574424|FG000|Overall Study|Lost to Follow-up|23|||
131805962|NCT01171963|474574425|FG001|Overall Study|Lost to Follow-up|24|||
131805963|NCT01171963|474574424|FG000|Overall Study|Other - diarrhoea|1|||
131805964|NCT01171963|474574425|FG001|Overall Study|Other - diarrhoea|0|||
131805965|NCT01171963|474574424|FG000|Overall Study|Withdrawal by Subject|114|||
131805966|NCT01171963|474574425|FG001|Overall Study|Withdrawal by Subject|129|||
131726308|NCT00494871|474277617|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
131726309|NCT00494871|474277618|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
131805967|NCT05093205|474574426|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
131805968|NCT05093205|474574427|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
131805969|NCT05093205|474574428|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
131805970|NCT05093205|474574429|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
131805971|NCT05093205|474574430|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
131805972|NCT05093205|474574431|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
131805973|NCT05093205|474574432|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
131805974|NCT05093205|474574433|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
131805975|NCT05093205|474574434|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
131726310|NCT04543955|474277619|FG000|Overall Study|Company cancelled study|1|||
131726311|NCT04543955|474277620|FG001|Overall Study|Company cancelled study|0|||
131726312|NCT01614769|474277631|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
131726313|NCT01614769|474277632|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
131726314|NCT01614769|474277633|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
131726315|NCT01614769|474277634|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
131726316|NCT01614769|474277635|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
131726317|NCT01614769|474277636|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
131726318|NCT01614769|474277631|FG000|Period 1|Protocol Violation|0|||
131726319|NCT01614769|474277632|FG001|Period 1|Protocol Violation|0|||
131726320|NCT01614769|474277633|FG002|Period 1|Protocol Violation|0|||
131726321|NCT01614769|474277634|FG003|Period 1|Protocol Violation|1|||
131726322|NCT01614769|474277635|FG004|Period 1|Protocol Violation|0|||
131726323|NCT01614769|474277636|FG005|Period 1|Protocol Violation|0|||
131726324|NCT01614769|474277631|FG000|Period 1|Withdrawal by Subject|1|||
131726325|NCT01614769|474277632|FG001|Period 1|Withdrawal by Subject|0|||
131726326|NCT01614769|474277633|FG002|Period 1|Withdrawal by Subject|0|||
131726327|NCT01614769|474277634|FG003|Period 1|Withdrawal by Subject|0|||
131726328|NCT01614769|474277635|FG004|Period 1|Withdrawal by Subject|0|||
131726329|NCT01614769|474277636|FG005|Period 1|Withdrawal by Subject|0|||
131726330|NCT01614769|474277631|FG000|Period 3|Withdrawal by Subject|0|||
131726331|NCT01614769|474277632|FG001|Period 3|Withdrawal by Subject|0|||
131726332|NCT01614769|474277633|FG002|Period 3|Withdrawal by Subject|1|||
131805976|NCT05093205|474574435|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
131805977|NCT05093205|474574436|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
131805978|NCT05093205|474574437|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
131805979|NCT05093205|474574438|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
131805980|NCT05093205|474574426|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131726333|NCT01614769|474277634|FG003|Period 3|Withdrawal by Subject|0|||
131726334|NCT01614769|474277635|FG004|Period 3|Withdrawal by Subject|0|||
131726335|NCT01614769|474277636|FG005|Period 3|Withdrawal by Subject|0|||
131726336|NCT03123354|474277639|FG000|Overall Study|Physician Decision|6|||
131805981|NCT05093205|474574427|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805982|NCT05093205|474574428|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
131805983|NCT05093205|474574429|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131726337|NCT04760314|474277640|FG000|Induction Period|Withdrawal by Subject|0|||
131726338|NCT04760314|474277641|FG001|Induction Period|Withdrawal by Subject|1|||
131726339|NCT04760314|474277642|FG002|Induction Period|Withdrawal by Subject|1|||
131726340|NCT04760314|474277643|FG003|Induction Period|Withdrawal by Subject|0|||
131726341|NCT04760314|474277644|FG004|Induction Period|Withdrawal by Subject|0|||
131726342|NCT04760314|474277645|FG005|Induction Period|Withdrawal by Subject|0|||
131726343|NCT04760314|474277646|FG006|Induction Period|Withdrawal by Subject|0|||
131726344|NCT04760314|474277647|FG007|Induction Period|Withdrawal by Subject|0|||
131726345|NCT04760314|474277648|FG008|Induction Period|Withdrawal by Subject|0|||
131726346|NCT04760314|474277649|FG009|Induction Period|Withdrawal by Subject|0|||
131726347|NCT04760314|474277650|FG010|Induction Period|Withdrawal by Subject|0|||
131726348|NCT04760314|474277640|FG000|Induction Period|Adverse Event|0|||
131726349|NCT04760314|474277641|FG001|Induction Period|Adverse Event|0|||
131726350|NCT04760314|474277642|FG002|Induction Period|Adverse Event|2|||
131726351|NCT04760314|474277643|FG003|Induction Period|Adverse Event|0|||
131726352|NCT04760314|474277644|FG004|Induction Period|Adverse Event|0|||
131726353|NCT04760314|474277645|FG005|Induction Period|Adverse Event|0|||
131726354|NCT04760314|474277646|FG006|Induction Period|Adverse Event|0|||
131726355|NCT04760314|474277647|FG007|Induction Period|Adverse Event|0|||
131726356|NCT04760314|474277648|FG008|Induction Period|Adverse Event|0|||
131726357|NCT04760314|474277649|FG009|Induction Period|Adverse Event|0|||
131726358|NCT04760314|474277650|FG010|Induction Period|Adverse Event|0|||
131726359|NCT04760314|474277640|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726360|NCT04760314|474277641|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726361|NCT04760314|474277642|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726362|NCT04760314|474277643|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
131726363|NCT04760314|474277644|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
131726364|NCT04760314|474277645|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
131726365|NCT04760314|474277646|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
131726366|NCT04760314|474277647|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726367|NCT04760314|474277648|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726368|NCT04760314|474277649|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726369|NCT04760314|474277650|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
131726370|NCT04760314|474277640|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726371|NCT04760314|474277641|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726372|NCT04760314|474277642|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726373|NCT04760314|474277643|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
131726374|NCT04760314|474277644|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726375|NCT04760314|474277645|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
131726376|NCT04760314|474277646|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
131726377|NCT04760314|474277647|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726378|NCT04760314|474277648|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726379|NCT04760314|474277649|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726380|NCT04760314|474277650|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131726381|NCT04760314|474277640|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726382|NCT04760314|474277641|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726383|NCT04760314|474277642|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726384|NCT04760314|474277643|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726385|NCT04760314|474277644|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
131726386|NCT04760314|474277645|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726387|NCT04760314|474277646|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726388|NCT04760314|474277647|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726389|NCT04760314|474277648|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726390|NCT04760314|474277649|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726391|NCT04760314|474277650|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131726392|NCT04760314|474277640|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
131726393|NCT04760314|474277641|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
131726394|NCT04760314|474277642|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
131726395|NCT04760314|474277643|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
131726396|NCT04760314|474277644|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
131726397|NCT04760314|474277645|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
131726398|NCT04760314|474277646|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
131726399|NCT04760314|474277647|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
131726400|NCT04760314|474277648|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
131726401|NCT04760314|474277649|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
131726402|NCT04760314|474277650|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
131726403|NCT04760314|474277640|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726404|NCT04760314|474277641|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726405|NCT04760314|474277642|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726406|NCT04760314|474277643|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726407|NCT04760314|474277644|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726408|NCT04760314|474277645|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726409|NCT04760314|474277646|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726410|NCT04760314|474277647|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131726411|NCT04760314|474277648|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131726412|NCT04760314|474277649|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131726413|NCT04760314|474277650|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131726414|NCT04760314|474277640|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726415|NCT04760314|474277641|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726416|NCT04760314|474277642|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726417|NCT04760314|474277643|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726418|NCT04760314|474277644|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726419|NCT04760314|474277645|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726420|NCT04760314|474277646|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726421|NCT04760314|474277647|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
131726422|NCT04760314|474277648|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
131726423|NCT04760314|474277649|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
131726424|NCT04760314|474277650|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131726425|NCT04760314|474277640|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726426|NCT04760314|474277641|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726427|NCT04760314|474277642|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726428|NCT04760314|474277643|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726429|NCT04760314|474277644|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726430|NCT04760314|474277645|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726431|NCT04760314|474277646|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726432|NCT04760314|474277647|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
131726433|NCT04760314|474277648|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726434|NCT04760314|474277649|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726435|NCT04760314|474277650|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131726436|NCT04760314|474277640|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726437|NCT04760314|474277641|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726438|NCT04760314|474277642|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726439|NCT04760314|474277643|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726440|NCT04760314|474277644|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726441|NCT04760314|474277645|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726442|NCT04760314|474277646|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726443|NCT04760314|474277647|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
131726444|NCT04760314|474277648|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
131726445|NCT04760314|474277649|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
131726446|NCT04760314|474277650|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
131805984|NCT05093205|474574430|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805985|NCT05093205|474574431|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805986|NCT05093205|474574432|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805987|NCT05093205|474574433|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131726447|NCT00960440|474277651|FG000|Overall Study|Death|0|||
131726448|NCT00960440|474277652|FG001|Overall Study|Death|0|||
131726449|NCT00960440|474277653|FG002|Overall Study|Death|0|||
131726450|NCT00960440|474277654|FG003|Overall Study|Death|1|||
131726451|NCT00960440|474277651|FG000|Overall Study|Adverse Event|12|||
131726452|NCT00960440|474277652|FG001|Overall Study|Adverse Event|12|||
131726453|NCT00960440|474277653|FG002|Overall Study|Adverse Event|4|||
131726454|NCT00960440|474277654|FG003|Overall Study|Adverse Event|4|||
131726455|NCT00960440|474277651|FG000|Overall Study|Lack of Efficacy|2|||
131726456|NCT00960440|474277652|FG001|Overall Study|Lack of Efficacy|5|||
131726457|NCT00960440|474277653|FG002|Overall Study|Lack of Efficacy|3|||
131726458|NCT00960440|474277654|FG003|Overall Study|Lack of Efficacy|8|||
131726459|NCT00960440|474277651|FG000|Overall Study|Protocol Violation|2|||
131726460|NCT00960440|474277652|FG001|Overall Study|Protocol Violation|8|||
131726461|NCT00960440|474277653|FG002|Overall Study|Protocol Violation|3|||
131726462|NCT00960440|474277654|FG003|Overall Study|Protocol Violation|4|||
131726463|NCT00960440|474277651|FG000|Overall Study|Withdrawal by Subject|9|||
131726464|NCT00960440|474277652|FG001|Overall Study|Withdrawal by Subject|5|||
131726465|NCT00960440|474277653|FG002|Overall Study|Withdrawal by Subject|2|||
131726466|NCT00960440|474277654|FG003|Overall Study|Withdrawal by Subject|1|||
131726467|NCT00960440|474277651|FG000|Overall Study|Other|1|||
131726468|NCT00960440|474277652|FG001|Overall Study|Other|1|||
131726469|NCT00960440|474277653|FG002|Overall Study|Other|1|||
131726470|NCT00960440|474277654|FG003|Overall Study|Other|0|||
131726471|NCT02616029|474277656|FG000|Overall Study|Adverse Event|1|||
131726472|NCT02616029|474277657|FG001|Overall Study|Adverse Event|0|||
131726473|NCT02616029|474277656|FG000|Overall Study|Death|0|||
131726474|NCT02616029|474277657|FG001|Overall Study|Death|1|||
131726475|NCT02616029|474277656|FG000|Overall Study|Protocol Violation|1|||
131726476|NCT02616029|474277657|FG001|Overall Study|Protocol Violation|0|||
131726477|NCT02616029|474277656|FG000|Overall Study|Withdrew Consent|1|||
131726478|NCT02616029|474277657|FG001|Overall Study|Withdrew Consent|0|||
131726479|NCT02616029|474277656|FG000|Overall Study|Enrolled and Never Treated|1|||
131726480|NCT02616029|474277657|FG001|Overall Study|Enrolled and Never Treated|1|||
131726481|NCT03408873|474277664|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
131726482|NCT03408873|474277664|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
131726483|NCT03408873|474277664|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
131726484|NCT03408873|474277664|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
131726485|NCT03408873|474277664|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
131726486|NCT03408873|474277664|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
131726487|NCT01264965|474277665|FG000|Overall Study|Withdrawal by Subject|10|||
131726488|NCT00532883|474277668|FG000|Overall Study|Adverse Event|1|||
131726489|NCT00532883|474277669|FG001|Overall Study|Adverse Event|0|||
131726490|NCT00532883|474277670|FG002|Overall Study|Adverse Event|0|||
131726491|NCT00532883|474277671|FG003|Overall Study|Adverse Event|1|||
131726492|NCT00532883|474277668|FG000|Overall Study|Lost to Follow-up|1|||
131726493|NCT00532883|474277669|FG001|Overall Study|Lost to Follow-up|1|||
131726494|NCT00532883|474277670|FG002|Overall Study|Lost to Follow-up|1|||
131726495|NCT00532883|474277671|FG003|Overall Study|Lost to Follow-up|0|||
131726496|NCT00532883|474277668|FG000|Overall Study|Withdrawal by Subject|0|||
131726497|NCT00532883|474277669|FG001|Overall Study|Withdrawal by Subject|1|||
131726498|NCT00532883|474277670|FG002|Overall Study|Withdrawal by Subject|1|||
131726499|NCT00532883|474277671|FG003|Overall Study|Withdrawal by Subject|0|||
131726500|NCT00532883|474277668|FG000|Overall Study|Subject was Nonadherent|0|||
131726501|NCT00532883|474277669|FG001|Overall Study|Subject was Nonadherent|1|||
131726502|NCT00532883|474277670|FG002|Overall Study|Subject was Nonadherent|1|||
131726503|NCT00532883|474277671|FG003|Overall Study|Subject was Nonadherent|0|||
131726504|NCT00532883|474277668|FG000|Overall Study|Early Study Termination|4|||
131726505|NCT00532883|474277669|FG001|Overall Study|Early Study Termination|4|||
131726506|NCT00532883|474277670|FG002|Overall Study|Early Study Termination|1|||
131726507|NCT00532883|474277671|FG003|Overall Study|Early Study Termination|4|||
131726508|NCT01797783|474277672|FG000|Overall Study|Adverse Event|1|||
131726509|NCT01797783|474277673|FG001|Overall Study|Adverse Event|1|||
131726510|NCT01797783|474277672|FG000|Overall Study|Withdrawal by Subject|1|||
131726511|NCT01797783|474277673|FG001|Overall Study|Withdrawal by Subject|0|||
131726512|NCT03799718|474277674|FG000|Overall Study|Adverse Event|2|||
131726513|NCT02202031|474277675|FG000|Overall Study|Lost to Follow-up|1|||
131726514|NCT02202031|474277676|FG001|Overall Study|Lost to Follow-up|0|||
131726515|NCT02202031|474277675|FG000|Overall Study|Too Busy|1|||
131726516|NCT02202031|474277676|FG001|Overall Study|Too Busy|3|||
131726517|NCT02202031|474277675|FG000|Overall Study|Illness/Medical Reason|0|||
131726518|NCT02202031|474277676|FG001|Overall Study|Illness/Medical Reason|2|||
131726519|NCT02202031|474277675|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
131726520|NCT02202031|474277676|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
131726521|NCT02214186|474277680|FG000|Overall Study|Lost to Follow-up|1|||
131726522|NCT02214186|474277681|FG001|Overall Study|Lost to Follow-up|1|||
131726523|NCT02214186|474277680|FG000|Overall Study|Protocol Violation|1|||
131726524|NCT02214186|474277681|FG001|Overall Study|Protocol Violation|1|||
131726525|NCT01525849|474277682|FG000|Overall Study|Lost to Follow-up|3|||
131726526|NCT01525849|474277683|FG001|Overall Study|Lost to Follow-up|2|||
131726527|NCT01525849|474277682|FG000|Overall Study|Withdrawal by Subject|1|||
131726528|NCT01525849|474277683|FG001|Overall Study|Withdrawal by Subject|9|||
131726529|NCT01525849|474277682|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
131726530|NCT01525849|474277683|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
131726531|NCT01525849|474277682|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
131726532|NCT01525849|474277683|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
131726533|NCT03964415|474277693|FG000|Overall Study|Sponsor's decision|1563|||
131726534|NCT03964415|474277694|FG001|Overall Study|Sponsor's decision|1528|||
131726535|NCT03964415|474277693|FG000|Overall Study|Lost to Follow-up|139|||
131726536|NCT03964415|474277694|FG001|Overall Study|Lost to Follow-up|146|||
131726537|NCT03964415|474277693|FG000|Overall Study|Withdrawal by Subject|68|||
131726538|NCT03964415|474277694|FG001|Overall Study|Withdrawal by Subject|72|||
131726539|NCT03964415|474277693|FG000|Overall Study|Physician Decision|34|||
131726540|NCT03964415|474277694|FG001|Overall Study|Physician Decision|48|||
131726541|NCT03964415|474277693|FG000|Overall Study|Adverse Event|3|||
131726542|NCT03964415|474277694|FG001|Overall Study|Adverse Event|0|||
131726543|NCT03964415|474277693|FG000|Overall Study|Death|4|||
131726544|NCT03964415|474277694|FG001|Overall Study|Death|6|||
131726545|NCT03964415|474277693|FG000|Overall Study|Protocol Violation|1|||
131904958|NCT04613518|474939013|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
131904959|NCT04613518|474939011|FG000|Double-Blind Treatment Period|Other Reasons|2|||
131904960|NCT04613518|474939012|FG001|Double-Blind Treatment Period|Other Reasons|0|||
131904961|NCT04613518|474939013|FG002|Double-Blind Treatment Period|Other Reasons|0|||
131726546|NCT03964415|474277694|FG001|Overall Study|Protocol Violation|4|||
131726547|NCT03964415|474277693|FG000|Overall Study|Other|35|||
131726548|NCT03964415|474277694|FG001|Overall Study|Other|38|||
131726549|NCT03964415|474277693|FG000|Overall Study|Randomized but not treated|6|||
131726550|NCT03964415|474277694|FG001|Overall Study|Randomized but not treated|7|||
131726551|NCT01734993|474277695|FG000|Overall Study|Adverse Event|1|||
131726552|NCT01734993|474277695|FG000|Overall Study|Lack of Efficacy|1|||
131726553|NCT01024465|474277696|FG000|Overall Study|Adverse Event|2|||
131726554|NCT01024465|474277696|FG000|Overall Study|Physician Decision|1|||
131726555|NCT03078608|474277700|FG000|Overall Study|Death|1|||
131726556|NCT03078608|474277701|FG001|Overall Study|Death|2|||
131726557|NCT03078608|474277702|FG002|Overall Study|Death|0|||
131726558|NCT03078608|474277703|FG003|Overall Study|Death|0|||
131726559|NCT03078608|474277700|FG000|Overall Study|Withdrawal by Subject|8|||
131726560|NCT03078608|474277701|FG001|Overall Study|Withdrawal by Subject|1|||
131726561|NCT03078608|474277702|FG002|Overall Study|Withdrawal by Subject|0|||
131726562|NCT03078608|474277703|FG003|Overall Study|Withdrawal by Subject|0|||
131726563|NCT03078608|474277700|FG000|Overall Study|Lost to Follow-up|5|||
131726564|NCT03078608|474277701|FG001|Overall Study|Lost to Follow-up|8|||
131726565|NCT03078608|474277702|FG002|Overall Study|Lost to Follow-up|4|||
131726566|NCT03078608|474277703|FG003|Overall Study|Lost to Follow-up|1|||
131726567|NCT00723840|474277704|FG000|Overall Study|Lost to Follow-up|2|||
131726568|NCT00723840|474277704|FG000|Overall Study|Failure to return|18|||
131726569|NCT00723840|474277704|FG000|Overall Study|Withdrawal by Subject|55|||
131726570|NCT00723840|474277704|FG000|Overall Study|Serious Adverse Events|3|||
131726571|NCT00723840|474277704|FG000|Overall Study|Other Medical Event|2|||
131726572|NCT00723840|474277704|FG000|Overall Study|Unspecified reason|2|||
131805988|NCT05093205|474574434|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805989|NCT05093205|474574435|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805990|NCT05093205|474574436|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805991|NCT05093205|474574437|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805992|NCT05093205|474574438|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131805993|NCT05093205|474574426|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
131805994|NCT05093205|474574427|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
131805995|NCT05093205|474574428|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
131805996|NCT05093205|474574429|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
131805997|NCT05093205|474574430|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
131805998|NCT05093205|474574431|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
131805999|NCT05093205|474574432|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
131806000|NCT05093205|474574433|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
131806001|NCT05093205|474574434|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
131726573|NCT02853331|474277710|FG000|Overall Study|Death|59|||
131726574|NCT02853331|474277711|FG001|Overall Study|Death|95|||
131726575|NCT02853331|474277710|FG000|Overall Study|Withdrawal by Subject|5|||
131726576|NCT02853331|474277711|FG001|Overall Study|Withdrawal by Subject|9|||
131726577|NCT02853331|474277710|FG000|Overall Study|Ongoing in study|368|||
131904962|NCT04613518|474939011|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
131726578|NCT02853331|474277711|FG001|Overall Study|Ongoing in study|325|||
131726579|NCT04156646|474277714|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
131726580|NCT04156646|474277715|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
131726581|NCT02086565|474277723|FG000|Overall Study|Lost to Follow-up|9|||
131726582|NCT02086565|474277724|FG001|Overall Study|Lost to Follow-up|7|||
131726583|NCT02086565|474277723|FG000|Overall Study|Withdrawal by Subject|2|||
131904963|NCT04613518|474939012|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
131806002|NCT05093205|474574435|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
131806003|NCT05093205|474574436|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
131806004|NCT05093205|474574437|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
131806005|NCT05093205|474574438|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
131806006|NCT05093205|474574426|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
131806007|NCT05093205|474574427|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
131806008|NCT05093205|474574428|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
131806009|NCT05093205|474574429|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
131726584|NCT02086565|474277724|FG001|Overall Study|Withdrawal by Subject|1|||
131726585|NCT02086565|474277723|FG000|Overall Study|Death|3|||
131726586|NCT02086565|474277724|FG001|Overall Study|Death|2|||
131726587|NCT02086565|474277723|FG000|Overall Study|withdrawn by research team|2|||
131726588|NCT02086565|474277724|FG001|Overall Study|withdrawn by research team|2|||
131726589|NCT02116972|474277727|FG000|Overall Study|Adverse Event|4|||
131726590|NCT02116972|474277728|FG001|Overall Study|Adverse Event|4|||
131726591|NCT02116972|474277729|FG002|Overall Study|Adverse Event|1|||
131726592|NCT02116972|474277727|FG000|Overall Study|Withdrawal by Subject|1|||
131726593|NCT02116972|474277728|FG001|Overall Study|Withdrawal by Subject|1|||
131726594|NCT02116972|474277729|FG002|Overall Study|Withdrawal by Subject|5|||
131726595|NCT02116972|474277727|FG000|Overall Study|Protocol Violation|1|||
131726596|NCT02116972|474277728|FG001|Overall Study|Protocol Violation|0|||
131726597|NCT02116972|474277729|FG002|Overall Study|Protocol Violation|1|||
131726598|NCT02116972|474277727|FG000|Overall Study|Lost to Follow-up|4|||
131726599|NCT02116972|474277728|FG001|Overall Study|Lost to Follow-up|3|||
131726600|NCT02116972|474277729|FG002|Overall Study|Lost to Follow-up|1|||
131726601|NCT02116972|474277727|FG000|Overall Study|Lack of Efficacy|6|||
131726602|NCT02116972|474277728|FG001|Overall Study|Lack of Efficacy|6|||
131726603|NCT02116972|474277729|FG002|Overall Study|Lack of Efficacy|5|||
131726604|NCT02116972|474277727|FG000|Overall Study|scheduling conflicts and relocation|3|||
131726605|NCT02116972|474277728|FG001|Overall Study|scheduling conflicts and relocation|3|||
131726606|NCT02116972|474277729|FG002|Overall Study|scheduling conflicts and relocation|6|||
131726607|NCT00784784|474277730|FG000|Overall Study|Withdrawal by Subject|2|||
131726608|NCT00784784|474277731|FG001|Overall Study|Withdrawal by Subject|2|||
131726609|NCT00863928|474277732|FG000|Overall Study|Protocol Violation|26|||
131726610|NCT00863928|474277733|FG001|Overall Study|Protocol Violation|0|||
131726611|NCT00863928|474277732|FG000|Overall Study|Withdrawal by Subject|3|||
131726612|NCT00863928|474277733|FG001|Overall Study|Withdrawal by Subject|0|||
131726613|NCT00863928|474277732|FG000|Overall Study|surgery cancellation|4|||
131726614|NCT00863928|474277733|FG001|Overall Study|surgery cancellation|0|||
131726615|NCT00863928|474277732|FG000|Overall Study|medication allergy|3|||
131726616|NCT00863928|474277733|FG001|Overall Study|medication allergy|0|||
131726617|NCT01041573|474277739|FG000|Overall Study|Withdrawal by Subject|2|||
131726618|NCT01041573|474277740|FG001|Overall Study|Withdrawal by Subject|5|||
131726619|NCT01041573|474277741|FG002|Overall Study|Withdrawal by Subject|2|||
131726620|NCT01041573|474277742|FG003|Overall Study|Withdrawal by Subject|0|||
131726621|NCT01041573|474277739|FG000|Overall Study|Death|1|||
131726622|NCT01041573|474277740|FG001|Overall Study|Death|0|||
131726623|NCT01041573|474277741|FG002|Overall Study|Death|0|||
131726624|NCT01041573|474277742|FG003|Overall Study|Death|0|||
131726625|NCT01041573|474277739|FG000|Overall Study|Lost to Follow-up|0|||
131726626|NCT01041573|474277740|FG001|Overall Study|Lost to Follow-up|1|||
131726627|NCT01041573|474277741|FG002|Overall Study|Lost to Follow-up|2|||
131726628|NCT01041573|474277742|FG003|Overall Study|Lost to Follow-up|1|||
131726629|NCT01041573|474277739|FG000|Overall Study|Adverse Event|0|||
131726630|NCT01041573|474277740|FG001|Overall Study|Adverse Event|2|||
131726631|NCT01041573|474277741|FG002|Overall Study|Adverse Event|0|||
131726632|NCT01041573|474277742|FG003|Overall Study|Adverse Event|0|||
131726633|NCT01041573|474277739|FG000|Overall Study|relocation|1|||
131726634|NCT01041573|474277740|FG001|Overall Study|relocation|4|||
131448747|NCT00790842|473272729|FG009|Dose Level 4|Physician Decision|0|||
131448748|NCT00790842|473272730|FG010|Dose Level 4|Physician Decision|1|||
131448749|NCT00790842|473272720|FG000|Dose Level 4|Withdrawal by Subject|0|||
131726635|NCT01041573|474277741|FG002|Overall Study|relocation|3|||
131726636|NCT01041573|474277742|FG003|Overall Study|relocation|1|||
131726637|NCT01041573|474277739|FG000|Overall Study|further blood extraction|0|||
131726638|NCT01041573|474277740|FG001|Overall Study|further blood extraction|1|||
131726639|NCT01041573|474277741|FG002|Overall Study|further blood extraction|0|||
131726640|NCT01041573|474277742|FG003|Overall Study|further blood extraction|0|||
131726641|NCT01041573|474277739|FG000|Overall Study|positive to anti-HCV|1|||
131726642|NCT01041573|474277740|FG001|Overall Study|positive to anti-HCV|0|||
131726643|NCT01041573|474277741|FG002|Overall Study|positive to anti-HCV|0|||
131806010|NCT05093205|474574430|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
131806011|NCT05093205|474574431|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
131806012|NCT05093205|474574432|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
131806013|NCT05093205|474574433|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
131806014|NCT05093205|474574434|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
131806015|NCT05093205|474574435|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
131806016|NCT05093205|474574436|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
131806017|NCT05093205|474574437|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
131806018|NCT05093205|474574438|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
131806019|NCT05093205|474574426|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
131806020|NCT05093205|474574427|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
131806021|NCT05093205|474574428|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
131806022|NCT05093205|474574429|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
131806023|NCT05093205|474574430|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
131806024|NCT05093205|474574431|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
131806025|NCT05093205|474574432|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
131806026|NCT05093205|474574433|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
131806027|NCT05093205|474574434|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
131726644|NCT01041573|474277742|FG003|Overall Study|positive to anti-HCV|0|||
131726645|NCT04172831|474277743|FG000|Overall Study|Adverse Event|21|||
131726646|NCT04172831|474277744|FG001|Overall Study|Adverse Event|9|||
131726647|NCT04172831|474277743|FG000|Overall Study|Lack of Efficacy|2|||
131726648|NCT04172831|474277744|FG001|Overall Study|Lack of Efficacy|8|||
131726649|NCT04172831|474277743|FG000|Overall Study|Physician Decision|0|||
131726650|NCT04172831|474277744|FG001|Overall Study|Physician Decision|1|||
131726651|NCT04172831|474277743|FG000|Overall Study|Withdrawal by Subject|12|||
131726652|NCT04172831|474277744|FG001|Overall Study|Withdrawal by Subject|11|||
131726653|NCT04172831|474277743|FG000|Overall Study|Lost to Follow-up|4|||
131726654|NCT04172831|474277744|FG001|Overall Study|Lost to Follow-up|9|||
131726655|NCT04172831|474277743|FG000|Overall Study|COVID-19 related crisis|3|||
131726656|NCT04172831|474277744|FG001|Overall Study|COVID-19 related crisis|3|||
131726657|NCT04172831|474277743|FG000|Overall Study|Subject non-compliance|1|||
131726658|NCT04172831|474277744|FG001|Overall Study|Subject non-compliance|1|||
131726659|NCT04172831|474277743|FG000|Overall Study|Family emergency|1|||
131726660|NCT04172831|474277744|FG001|Overall Study|Family emergency|0|||
131726661|NCT00530712|474277747|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
131726662|NCT00530712|474277747|FG000|30 Day Follow-up Visit|Missed Visit|5|||
131726663|NCT00530712|474277747|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
131726664|NCT00530712|474277747|FG000|6 Month Follow-up Visit|Missed Visit|3|||
131726665|NCT00530712|474277747|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
131726666|NCT00530712|474277747|FG000|6 Month Follow-up Visit|Death|2|||
131726667|NCT00530712|474277747|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
131726668|NCT00530712|474277747|FG000|12 Month Follow-up Visit|Missed Visit|3|||
131726669|NCT00530712|474277747|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
131726670|NCT00530712|474277747|FG000|12 Month Follow-up Visit|Death|9|||
131726671|NCT02399475|474277748|FG000|Overall Study|Physician Decision|1|||
131726672|NCT02399475|474277749|FG001|Overall Study|Physician Decision|0|||
131726673|NCT00408421|474279093|FG000|Treatment Initial Randomization|Adverse Event|5|||
131726674|NCT00408421|474279094|FG001|Treatment Initial Randomization|Adverse Event|9|||
131726675|NCT00408421|474279095|FG002|Treatment Initial Randomization|Adverse Event|0|||
131726676|NCT00408421|474279093|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
131726677|NCT00408421|474279094|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
131726678|NCT00408421|474279095|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
131726679|NCT00408421|474279093|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
131726680|NCT00408421|474279094|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
131726681|NCT00408421|474279095|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
131726682|NCT00408421|474279093|FG000|Treatment Initial Randomization|Physician Decision|1|||
131726683|NCT00408421|474279094|FG001|Treatment Initial Randomization|Physician Decision|0|||
131726684|NCT00408421|474279095|FG002|Treatment Initial Randomization|Physician Decision|0|||
131726685|NCT00408421|474279093|FG000|Treatment Initial Randomization|Protocol Violation|0|||
131726686|NCT00408421|474279094|FG001|Treatment Initial Randomization|Protocol Violation|1|||
131726687|NCT00408421|474279095|FG002|Treatment Initial Randomization|Protocol Violation|0|||
131726688|NCT00408421|474279093|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
131726689|NCT00408421|474279094|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
131726690|NCT00408421|474279095|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
131726691|NCT00408421|474279093|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
131726692|NCT00408421|474279094|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
131726693|NCT00408421|474279095|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
131726694|NCT00408421|474279093|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
131726695|NCT00408421|474279094|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
131726696|NCT00408421|474279095|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
131726697|NCT00408421|474279093|FG000|Treatment Re-Randomization|Adverse Event|2|||
131726698|NCT00408421|474279094|FG001|Treatment Re-Randomization|Adverse Event|2|||
131726699|NCT00408421|474279095|FG002|Treatment Re-Randomization|Adverse Event|4|||
131726700|NCT00408421|474279093|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
131726701|NCT00408421|474279094|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
131726702|NCT00408421|474279095|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
131726703|NCT00408421|474279093|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
131726704|NCT00408421|474279094|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
131726705|NCT00408421|474279095|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
131726706|NCT00408421|474279093|FG000|Treatment Re-Randomization|Physician Decision|1|||
131726707|NCT00408421|474279094|FG001|Treatment Re-Randomization|Physician Decision|3|||
131726708|NCT00408421|474279095|FG002|Treatment Re-Randomization|Physician Decision|0|||
131726709|NCT00408421|474279093|FG000|Treatment Re-Randomization|Protocol Violation|1|||
131726710|NCT00408421|474279094|FG001|Treatment Re-Randomization|Protocol Violation|1|||
131726711|NCT00408421|474279095|FG002|Treatment Re-Randomization|Protocol Violation|0|||
131726712|NCT00408421|474279093|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
131726713|NCT00408421|474279094|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
131726714|NCT00408421|474279095|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
131726715|NCT02322892|474279098|FG000|Overall Study|Surgery cancelled|1|||
131726716|NCT02322892|474279099|FG001|Overall Study|Surgery cancelled|2|||
131726717|NCT02322892|474279098|FG000|Overall Study|Met exclusion criteria|0|||
131726718|NCT02322892|474279099|FG001|Overall Study|Met exclusion criteria|1|||
131726719|NCT02322892|474279098|FG000|Overall Study|Protocol Violation|1|||
131726720|NCT02322892|474279099|FG001|Overall Study|Protocol Violation|0|||
131726721|NCT02125331|474279102|FG000|Overall Study|Protocol Violation|1|||
131726722|NCT02125331|474279103|FG001|Overall Study|Protocol Violation|0|||
131726723|NCT02125331|474279102|FG000|Overall Study|technical problem|2|||
131726724|NCT02125331|474279103|FG001|Overall Study|technical problem|0|||
131726725|NCT02125331|474279102|FG000|Overall Study|screen failure|2|||
131726726|NCT02125331|474279103|FG001|Overall Study|screen failure|0|||
131726727|NCT02601001|474279104|FG000|Dosing Period 2|Adverse Event|0|||
131726728|NCT02601001|474279105|FG001|Dosing Period 2|Adverse Event|0|||
131726729|NCT02601001|474279106|FG002|Dosing Period 2|Adverse Event|0|||
131726730|NCT02601001|474279107|FG003|Dosing Period 2|Adverse Event|0|||
131726731|NCT02601001|474279108|FG004|Dosing Period 2|Adverse Event|0|||
131726732|NCT02601001|474279109|FG005|Dosing Period 2|Adverse Event|0|||
131726733|NCT02601001|474279110|FG006|Dosing Period 2|Adverse Event|1|||
131726734|NCT02433210|474279112|FG000|Overall Study|Physician Decision|1|||
131726735|NCT02433210|474279113|FG001|Overall Study|Physician Decision|0|||
131726736|NCT02433210|474279114|FG002|Overall Study|Physician Decision|0|||
131726737|NCT01989546|474279115|FG000|Overall Study|Clinical Progression|1|||
131726738|NCT01989546|474279115|FG000|Overall Study|Disease progression on study|8|||
131726739|NCT01958671|474279116|FG000|Overall Study|Adverse Event|1|||
131726740|NCT01958671|474279117|FG001|Overall Study|Adverse Event|1|||
131726741|NCT01958671|474279118|FG002|Overall Study|Adverse Event|5|||
131726742|NCT01958671|474279116|FG000|Overall Study|Death|1|||
131726743|NCT01958671|474279117|FG001|Overall Study|Death|0|||
131726744|NCT01958671|474279118|FG002|Overall Study|Death|0|||
131726745|NCT01958671|474279116|FG000|Overall Study|Excluded medication|0|||
131726746|NCT01958671|474279117|FG001|Overall Study|Excluded medication|0|||
131726747|NCT01958671|474279118|FG002|Overall Study|Excluded medication|1|||
131726748|NCT01958671|474279116|FG000|Overall Study|Hyperglycemia|0|||
131726749|NCT01958671|474279117|FG001|Overall Study|Hyperglycemia|0|||
131726750|NCT01958671|474279118|FG002|Overall Study|Hyperglycemia|2|||
131726751|NCT01958671|474279116|FG000|Overall Study|Lost to Follow-up|7|||
131726752|NCT01958671|474279117|FG001|Overall Study|Lost to Follow-up|11|||
131726753|NCT01958671|474279118|FG002|Overall Study|Lost to Follow-up|7|||
131726754|NCT01958671|474279116|FG000|Overall Study|Non-compliance with study drug|1|||
131726755|NCT01958671|474279117|FG001|Overall Study|Non-compliance with study drug|1|||
131726756|NCT01958671|474279118|FG002|Overall Study|Non-compliance with study drug|1|||
131726757|NCT01958671|474279116|FG000|Overall Study|Pregnancy|0|||
131726758|NCT01958671|474279117|FG001|Overall Study|Pregnancy|0|||
131806028|NCT05093205|474574435|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
131806029|NCT05093205|474574436|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
131726759|NCT01958671|474279118|FG002|Overall Study|Pregnancy|1|||
131726760|NCT01958671|474279116|FG000|Overall Study|Protocol Violation|0|||
131726761|NCT01958671|474279117|FG001|Overall Study|Protocol Violation|1|||
131726762|NCT01958671|474279118|FG002|Overall Study|Protocol Violation|0|||
131726763|NCT01958671|474279116|FG000|Overall Study|Study site terminated by sponsor|1|||
131726764|NCT01958671|474279117|FG001|Overall Study|Study site terminated by sponsor|0|||
131726765|NCT01958671|474279118|FG002|Overall Study|Study site terminated by sponsor|1|||
131726766|NCT01958671|474279116|FG000|Overall Study|Participant moved|0|||
131726767|NCT01958671|474279117|FG001|Overall Study|Participant moved|0|||
131726768|NCT01958671|474279118|FG002|Overall Study|Participant moved|1|||
131726769|NCT01958671|474279116|FG000|Overall Study|Withdrawal by Subject|8|||
131726770|NCT01958671|474279117|FG001|Overall Study|Withdrawal by Subject|10|||
131726771|NCT01958671|474279118|FG002|Overall Study|Withdrawal by Subject|13|||
131726772|NCT02421120|474279120|FG000|Overall Study|Adverse Event|1|||
131726773|NCT02207530|474279121|FG000|Overall Study|Worsening condition under investigation|78|||
131726774|NCT02207530|474279121|FG000|Overall Study|Patient decision to stop study treatment|5|||
131726775|NCT02207530|474279121|FG000|Overall Study|Adverse Event|8|||
131726776|NCT02345161|474279122|FG000|Overall Study|Withdrawal by Subject|25|||
131726777|NCT02345161|474279123|FG001|Overall Study|Withdrawal by Subject|33|||
131726778|NCT02345161|474279122|FG000|Overall Study|Adverse Event|16|||
131726779|NCT02345161|474279123|FG001|Overall Study|Adverse Event|19|||
131726780|NCT02345161|474279122|FG000|Overall Study|Physician Decision|4|||
131726781|NCT02345161|474279123|FG001|Overall Study|Physician Decision|4|||
131726782|NCT02345161|474279122|FG000|Overall Study|Lost to Follow-up|0|||
131726783|NCT02345161|474279123|FG001|Overall Study|Lost to Follow-up|1|||
131726784|NCT00305006|474279130|FG000|Overall Study|Withdrawal by Subject|1|||
131726785|NCT00305006|474279131|FG001|Overall Study|Withdrawal by Subject|0|||
131726786|NCT00305006|474279130|FG000|Overall Study|Failure to complete pretest|0|||
131726787|NCT00305006|474279131|FG001|Overall Study|Failure to complete pretest|1|||
131726788|NCT02606045|474279135|FG000|Overall Study|Study closed before treament could begin|1|||
131726789|NCT02606045|474279136|FG001|Overall Study|Study closed before treament could begin|2|||
131726790|NCT00907881|474279137|FG000|Overall Study|Lost to Follow-up|59|||
131726791|NCT00907881|474279137|FG000|Overall Study|Noncompliance|5|||
131726792|NCT00907881|474279137|FG000|Overall Study|Withdrawal by Subject|5|||
131726793|NCT00907881|474279137|FG000|Overall Study|Protocol Violation|1|||
131726794|NCT00907881|474279137|FG000|Overall Study|Missing discontinuation information|15|||
131726795|NCT01996319|474279140|FG000|Overall Study|Protocol Violation|1|||
131726796|NCT01996319|474279141|FG001|Overall Study|Protocol Violation|0|||
131726797|NCT01996319|474279140|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
131726798|NCT01996319|474279141|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
131726799|NCT01996319|474279140|FG000|Overall Study|Adverse Event|2|||
131726800|NCT01996319|474279141|FG001|Overall Study|Adverse Event|2|||
131726801|NCT01671085|474279144|FG000|Overall Study|Withdrawal by Subject|1|||
131726802|NCT01671085|474279145|FG001|Overall Study|Withdrawal by Subject|0|||
131726803|NCT00637273|474279146|FG000|Overall Study|Adverse Event|11|||
131726804|NCT00637273|474279147|FG001|Overall Study|Adverse Event|5|||
131726805|NCT00637273|474279148|FG002|Overall Study|Adverse Event|7|||
131726806|NCT00637273|474279146|FG000|Overall Study|Lost to Follow-up|8|||
131726807|NCT00637273|474279147|FG001|Overall Study|Lost to Follow-up|9|||
131726808|NCT00637273|474279148|FG002|Overall Study|Lost to Follow-up|13|||
131726809|NCT00637273|474279146|FG000|Overall Study|Protocol Violation|2|||
131726810|NCT00637273|474279147|FG001|Overall Study|Protocol Violation|4|||
131726811|NCT00637273|474279148|FG002|Overall Study|Protocol Violation|1|||
131726812|NCT00637273|474279146|FG000|Overall Study|Withdrawal of Consent|18|||
131726813|NCT00637273|474279147|FG001|Overall Study|Withdrawal of Consent|6|||
131726814|NCT00637273|474279148|FG002|Overall Study|Withdrawal of Consent|18|||
131726815|NCT00637273|474279146|FG000|Overall Study|Investigator Decision|1|||
131726816|NCT00637273|474279147|FG001|Overall Study|Investigator Decision|3|||
131726817|NCT00637273|474279148|FG002|Overall Study|Investigator Decision|1|||
131726818|NCT00637273|474279146|FG000|Overall Study|Administrative|2|||
131726819|NCT00637273|474279147|FG001|Overall Study|Administrative|0|||
131726820|NCT00637273|474279148|FG002|Overall Study|Administrative|0|||
131806030|NCT05093205|474574437|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
131806031|NCT05093205|474574438|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
131806032|NCT05093205|474574426|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
131806033|NCT05093205|474574427|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
131806034|NCT05093205|474574428|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
131806035|NCT05093205|474574429|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
131806036|NCT05093205|474574430|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
131726821|NCT00637273|474279146|FG000|Overall Study|Loss of Glucose Control|1|||
131726822|NCT00637273|474279147|FG001|Overall Study|Loss of Glucose Control|1|||
131726823|NCT00637273|474279148|FG002|Overall Study|Loss of Glucose Control|1|||
131726824|NCT00986258|474279149|FG000|Observation Period|Not eligible to be dosed|11|||
131726825|NCT00986258|474279149|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
131726826|NCT00986258|474279149|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
131806037|NCT05093205|474574431|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
131806038|NCT05093205|474574432|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
131806039|NCT05093205|474574433|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
131806040|NCT05093205|474574434|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
131806041|NCT05093205|474574435|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
131806042|NCT05093205|474574436|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
131726827|NCT00986258|474279149|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
131726828|NCT00986258|474279149|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
131806043|NCT05093205|474574437|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
131806044|NCT05093205|474574438|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
131806045|NCT05093205|474574426|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
131806046|NCT05093205|474574427|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
131726829|NCT00986258|474279149|FG000|Titration and Optimal Dose Period|Other|1|||
131726830|NCT00986258|474279149|FG000|Maintenance Period|Adverse Event|5|||
131726831|NCT00986258|474279149|FG000|Maintenance Period|Lack of Efficacy|2|||
131726832|NCT00986258|474279149|FG000|Maintenance Period|Withdrawal by Subject|2|||
131726833|NCT01740440|474279151|FG000|Overall Study|Lost to Follow-up|3|||
131726834|NCT01063751|474279152|FG000|Overall Study|Censored from analyses|42|||
131726835|NCT01063751|474279152|FG000|Overall Study|Withdrawal by Subject|34|||
131726836|NCT01063751|474279152|FG000|Overall Study|Lost to Follow-up|30|||
131726837|NCT01063751|474279152|FG000|Overall Study|Death|13|||
131726838|NCT01063751|474279152|FG000|Overall Study|Sponsored Terminated Study|60|||
131726839|NCT01063751|474279152|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
131726840|NCT01063751|474279152|FG000|Overall Study|Investigator site closed|10|||
131726841|NCT01063751|474279152|FG000|Overall Study|Revision|6|||
131726842|NCT01063751|474279152|FG000|Overall Study|Physician Decision|4|||
131726843|NCT00793819|474279158|FG000|Overall Study|Adverse Event|8|||
131726844|NCT00793819|474279159|FG001|Overall Study|Adverse Event|4|||
131726845|NCT00793819|474279158|FG000|Overall Study|Lack of Efficacy|1|||
131726846|NCT00793819|474279159|FG001|Overall Study|Lack of Efficacy|1|||
131726847|NCT00793819|474279158|FG000|Overall Study|Withdrawal by Subject|4|||
131726848|NCT00793819|474279159|FG001|Overall Study|Withdrawal by Subject|3|||
131726849|NCT00793819|474279158|FG000|Overall Study|Lost to Follow-up|1|||
131726850|NCT00793819|474279159|FG001|Overall Study|Lost to Follow-up|1|||
131726851|NCT00611130|474279160|FG000|Overall Study|Lost to Follow-up|25|||
131726852|NCT00611130|474279161|FG001|Overall Study|Lost to Follow-up|29|||
131726853|NCT00611130|474279160|FG000|Overall Study|Protocol noncompliance|7|||
131726854|NCT00611130|474279161|FG001|Overall Study|Protocol noncompliance|6|||
131726855|NCT00611130|474279160|FG000|Overall Study|Withdrawal by Subject|6|||
131726856|NCT00611130|474279161|FG001|Overall Study|Withdrawal by Subject|5|||
131726857|NCT00611130|474279160|FG000|Overall Study|Other|5|||
131726858|NCT00611130|474279161|FG001|Overall Study|Other|4|||
131726859|NCT00611130|474279160|FG000|Overall Study|Incarceration|3|||
131448750|NCT00790842|473272721|FG001|Dose Level 4|Withdrawal by Subject|0|||
131448751|NCT00790842|473272722|FG002|Dose Level 4|Withdrawal by Subject|0|||
131448752|NCT00790842|473272723|FG003|Dose Level 4|Withdrawal by Subject|0|||
131448753|NCT00790842|473272724|FG004|Dose Level 4|Withdrawal by Subject|0|||
131448754|NCT00790842|473272725|FG005|Dose Level 4|Withdrawal by Subject|0|||
131448755|NCT00790842|473272726|FG006|Dose Level 4|Withdrawal by Subject|0|||
131448756|NCT00790842|473272727|FG007|Dose Level 4|Withdrawal by Subject|0|||
131448757|NCT00790842|473272728|FG008|Dose Level 4|Withdrawal by Subject|0|||
131448758|NCT00790842|473272729|FG009|Dose Level 4|Withdrawal by Subject|0|||
131448759|NCT00790842|473272730|FG010|Dose Level 4|Withdrawal by Subject|1|||
131448760|NCT00790842|473272720|FG000|Expansion Cohort|Adverse Event|0|||
131726860|NCT00611130|474279161|FG001|Overall Study|Incarceration|2|||
131726861|NCT00611130|474279160|FG000|Overall Study|Administrative|1|||
131726862|NCT00611130|474279161|FG001|Overall Study|Administrative|1|||
131726863|NCT00611130|474279160|FG000|Overall Study|Adverse Event|1|||
131448761|NCT00790842|473272721|FG001|Expansion Cohort|Adverse Event|0|||
131726864|NCT00611130|474279161|FG001|Overall Study|Adverse Event|0|||
131726865|NCT00611130|474279160|FG000|Overall Study|Death|1|||
131448762|NCT00790842|473272722|FG002|Expansion Cohort|Adverse Event|0|||
131726866|NCT00611130|474279161|FG001|Overall Study|Death|0|||
131726867|NCT02062151|474279164|FG000|Overall Study|screen failure|1|||
131726868|NCT00751101|474279167|FG000|Overall Study|Withdrawal by Subject|1|||
131726869|NCT00751101|474279168|FG001|Overall Study|Withdrawal by Subject|0|||
131726870|NCT00751101|474279167|FG000|Overall Study|No HFS / Never Started Patch/|0|||
131726871|NCT00751101|474279168|FG001|Overall Study|No HFS / Never Started Patch/|4|||
131726872|NCT00751101|474279167|FG000|Overall Study|Never began capecitabine|1|||
131726873|NCT00751101|474279168|FG001|Overall Study|Never began capecitabine|0|||
131726874|NCT00751101|474279167|FG000|Overall Study|Physician Decision|0|||
131726875|NCT00751101|474279168|FG001|Overall Study|Physician Decision|1|||
131726876|NCT01905397|474279171|FG000|Overall Study|Death|0|||
131726877|NCT01905397|474279172|FG001|Overall Study|Death|1|||
131726878|NCT01905397|474279171|FG000|Overall Study|Withdrawal by Subject|2|||
131726879|NCT01905397|474279172|FG001|Overall Study|Withdrawal by Subject|0|||
131726880|NCT01905397|474279171|FG000|Overall Study|Surgery canceled/aborted|9|||
131726881|NCT01905397|474279172|FG001|Overall Study|Surgery canceled/aborted|5|||
131726882|NCT01905397|474279171|FG000|Overall Study|Incision < 7 cm|2|||
131726883|NCT01905397|474279172|FG001|Overall Study|Incision < 7 cm|0|||
131726884|NCT01905397|474279171|FG000|Overall Study|Wrong treatment|1|||
131726885|NCT01905397|474279172|FG001|Overall Study|Wrong treatment|1|||
131726886|NCT01905397|474279171|FG000|Overall Study|Device not applied|3|||
131726887|NCT01905397|474279172|FG001|Overall Study|Device not applied|0|||
131726888|NCT01905397|474279171|FG000|Overall Study|Dressing not applied in operating room|1|||
131726889|NCT01905397|474279172|FG001|Overall Study|Dressing not applied in operating room|0|||
131726890|NCT01905397|474279171|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
131726891|NCT01905397|474279172|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
131726892|NCT00455858|474279176|FG000|Overall Study|Lost to Follow-up|2|||
131726893|NCT00455858|474279176|FG000|Overall Study|Protocol Violation|1|||
131726894|NCT00455858|474279176|FG000|Overall Study|Lack of Efficacy|1|||
131726895|NCT00455858|474279176|FG000|Overall Study|Well controlled FPG without insulin|1|||
131726896|NCT00455858|474279176|FG000|Overall Study|Withdrawal|1|||
131726897|NCT02092389|474279178|FG000|Overall Study|Adverse Event|1|||
131726898|NCT02092389|474279178|FG000|Overall Study|Other|5|||
131726899|NCT01242020|474279179|FG000|Overall Study|Withdrawal by Subject|2|||
131726900|NCT01242020|474279180|FG001|Overall Study|Withdrawal by Subject|0|||
131726901|NCT01242020|474279179|FG000|Overall Study|Failed screening|1|||
131726902|NCT01242020|474279180|FG001|Overall Study|Failed screening|0|||
131726903|NCT01276847|474279188|FG000|Overall Study|Withdrawal by Subject|1|||
131726904|NCT01276847|474279189|FG001|Overall Study|Withdrawal by Subject|0|||
131726905|NCT01276847|474279190|FG002|Overall Study|Withdrawal by Subject|0|||
131726906|NCT03321929|474279191|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
131726907|NCT02119104|474279195|FG000|Overall Study|Protocol Violation|16|||
131726908|NCT02698423|474279197|FG000|Overall Study|Lost to Follow-up|19|||
131806047|NCT05093205|474574428|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
131806048|NCT05093205|474574429|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
131806049|NCT05093205|474574430|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
131806050|NCT05093205|474574431|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
131806051|NCT05093205|474574432|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
131806052|NCT05093205|474574433|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
131806053|NCT05093205|474574434|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
131806054|NCT05093205|474574435|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
131806055|NCT05093205|474574436|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
131806056|NCT05093205|474574437|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
131806057|NCT05093205|474574438|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
131806058|NCT05093205|474574426|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
131806059|NCT05093205|474574427|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
131806060|NCT05093205|474574428|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
131806061|NCT05093205|474574429|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
131806062|NCT05093205|474574430|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
131806063|NCT05093205|474574431|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
131448763|NCT00790842|473272723|FG003|Expansion Cohort|Adverse Event|0|||
131448764|NCT00790842|473272724|FG004|Expansion Cohort|Adverse Event|0|||
131448765|NCT00790842|473272725|FG005|Expansion Cohort|Adverse Event|0|||
131726909|NCT02698423|474279198|FG001|Overall Study|Lost to Follow-up|24|||
131726910|NCT03634072|474279199|FG000|Overall Study|Early termination of overall study|1|||
131726911|NCT03634072|474279200|FG001|Overall Study|Early termination of overall study|0|||
131726912|NCT02144220|474279205|FG000|Overall Study|technology incompatibility|9|||
131726913|NCT02144220|474279205|FG000|Overall Study|Lack of Efficacy|4|||
131726914|NCT02144220|474279205|FG000|Overall Study|Physician Decision|3|||
131726915|NCT02144220|474279205|FG000|Overall Study|Withdrawal by Subject|2|||
131726916|NCT02144220|474279205|FG000|Overall Study|Protocol Violation|1|||
131726917|NCT01952015|474279206|FG000|Induction|Protocol Violation|1|||
131726918|NCT01952015|474279206|FG000|Maintenance|Adverse Event|2|||
131726919|NCT01952015|474279206|FG000|Treatment Period 3|Physician Decision|9|||
131726920|NCT02508701|474279207|FG000|Overall Study|Lost to Follow-up|9|||
131726921|NCT02508701|474279208|FG001|Overall Study|Lost to Follow-up|5|||
131726922|NCT02508701|474279209|FG002|Overall Study|Lost to Follow-up|5|||
131726923|NCT02508701|474279210|FG003|Overall Study|Lost to Follow-up|3|||
131726924|NCT03184701|474279211|FG000|Overall Study|Death|3|||
131726925|NCT03184701|474279211|FG000|Overall Study|Physician Decision|3|||
131726926|NCT03184701|474279211|FG000|Overall Study|Withdrawal by Subject|6|||
131726927|NCT03184701|474279211|FG000|Overall Study|Lost to Follow-up|5|||
131726928|NCT01259297|474279217|FG000|Double Blind Randomized Period|Death|1|||
131726929|NCT01259297|474279218|FG001|Double Blind Randomized Period|Death|1|||
131726930|NCT01259297|474279219|FG002|Double Blind Randomized Period|Death|1|||
131726931|NCT01259297|474279220|FG003|Double Blind Randomized Period|Death|2|||
131726932|NCT01259297|474279221|FG004|Double Blind Randomized Period|Death|1|||
131726933|NCT01259297|474279222|FG005|Double Blind Randomized Period|Death|5|||
131726934|NCT01259297|474279223|FG006|Double Blind Randomized Period|Death|2|||
131726935|NCT01259297|474279224|FG007|Double Blind Randomized Period|Death|1|||
131726936|NCT01259297|474279217|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131726937|NCT01259297|474279218|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131726938|NCT01259297|474279219|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
131726939|NCT01259297|474279220|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
131726940|NCT01259297|474279221|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
131726941|NCT01259297|474279222|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131726942|NCT01259297|474279223|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131726943|NCT01259297|474279224|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131726944|NCT01259297|474279217|FG000|Double Blind Randomized Period|Other reasons|0|||
131726945|NCT01259297|474279218|FG001|Double Blind Randomized Period|Other reasons|1|||
131726946|NCT01259297|474279219|FG002|Double Blind Randomized Period|Other reasons|0|||
131726947|NCT01259297|474279220|FG003|Double Blind Randomized Period|Other reasons|0|||
131726948|NCT01259297|474279221|FG004|Double Blind Randomized Period|Other reasons|1|||
131726949|NCT01259297|474279222|FG005|Double Blind Randomized Period|Other reasons|2|||
131726950|NCT01259297|474279223|FG006|Double Blind Randomized Period|Other reasons|3|||
131726951|NCT01259297|474279224|FG007|Double Blind Randomized Period|Other reasons|1|||
131726952|NCT00592501|474279225|FG000|Overall Study|Withdrawal by Subject|1|||
131726953|NCT00592501|474279225|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
131726954|NCT01345786|474279227|FG000|Overall Study|Adverse Event|0|||
131726955|NCT01345786|474279228|FG001|Overall Study|Adverse Event|1|||
131726956|NCT01345786|474279229|FG002|Overall Study|Adverse Event|3|||
131726957|NCT01345786|474279230|FG003|Overall Study|Adverse Event|1|||
131726958|NCT01345786|474279227|FG000|Overall Study|Subject withdrew consent|2|||
131726959|NCT01345786|474279228|FG001|Overall Study|Subject withdrew consent|2|||
131726960|NCT01345786|474279229|FG002|Overall Study|Subject withdrew consent|1|||
131726961|NCT01345786|474279230|FG003|Overall Study|Subject withdrew consent|0|||
131806064|NCT05093205|474574432|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
131806065|NCT05093205|474574433|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
131806066|NCT05093205|474574434|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
131806067|NCT05093205|474574435|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
131806068|NCT05093205|474574436|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
131806069|NCT05093205|474574437|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
131806070|NCT05093205|474574438|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
131806071|NCT05093205|474574426|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806072|NCT05093205|474574427|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806073|NCT05093205|474574428|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806074|NCT05093205|474574429|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806075|NCT05093205|474574430|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806076|NCT05093205|474574431|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806077|NCT05093205|474574432|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806078|NCT05093205|474574433|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806079|NCT05093205|474574434|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806080|NCT05093205|474574435|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
131806081|NCT05093205|474574436|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806082|NCT05093205|474574437|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806083|NCT05093205|474574438|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
131806084|NCT05093205|474574426|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
131806085|NCT05093205|474574427|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
131904964|NCT04613518|474939013|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131904965|NCT04613518|474939011|FG000|Open-Label Treatment Period|Adverse Event|1|||
131904966|NCT04613518|474939012|FG001|Open-Label Treatment Period|Adverse Event|0|||
131904967|NCT04613518|474939013|FG002|Open-Label Treatment Period|Adverse Event|3|||
131904968|NCT04613518|474939011|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
131904969|NCT04613518|474939012|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
131806086|NCT05093205|474574428|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
131806087|NCT05093205|474574429|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
131806088|NCT05093205|474574430|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
131806089|NCT05093205|474574431|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
131806090|NCT05093205|474574432|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
131806091|NCT05093205|474574433|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
131806092|NCT05093205|474574434|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
131806093|NCT05093205|474574435|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
131806094|NCT05093205|474574436|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
131806095|NCT05093205|474574437|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
131806096|NCT05093205|474574438|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
131806097|NCT05093205|474574426|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806098|NCT05093205|474574427|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806099|NCT05093205|474574428|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806100|NCT05093205|474574429|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806101|NCT05093205|474574430|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806102|NCT05093205|474574431|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806103|NCT05093205|474574432|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806104|NCT05093205|474574433|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806105|NCT05093205|474574434|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131448766|NCT00790842|473272726|FG006|Expansion Cohort|Adverse Event|1|||
131806106|NCT05093205|474574435|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806107|NCT05093205|474574436|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
131806108|NCT05093205|474574437|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806109|NCT05093205|474574438|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
131806110|NCT05093205|474574426|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806111|NCT05093205|474574427|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806112|NCT05093205|474574428|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806113|NCT05093205|474574429|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806114|NCT05093205|474574430|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806115|NCT05093205|474574431|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806116|NCT05093205|474574432|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806117|NCT05093205|474574433|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806118|NCT05093205|474574434|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806119|NCT05093205|474574435|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806120|NCT05093205|474574436|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806121|NCT05093205|474574437|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
131806122|NCT05093205|474574438|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
131806123|NCT05093205|474574426|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
131806124|NCT05093205|474574427|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
131806125|NCT05093205|474574428|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
131806126|NCT05093205|474574429|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
131806127|NCT05093205|474574430|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
131806128|NCT05093205|474574431|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
131806129|NCT05093205|474574432|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
131806130|NCT05093205|474574433|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
131806131|NCT05093205|474574434|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
131806132|NCT05093205|474574435|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
131806133|NCT05093205|474574436|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
131806134|NCT05093205|474574437|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
131806135|NCT05093205|474574438|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
131806136|NCT05093205|474574426|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806137|NCT05093205|474574427|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806138|NCT05093205|474574428|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806139|NCT05093205|474574429|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131904970|NCT04613518|474939013|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
131904971|NCT04613518|474939011|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
131904972|NCT04613518|474939012|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
131726962|NCT01345786|474279227|FG000|Overall Study|Noncompliance with protocol|1|||
131726963|NCT01345786|474279228|FG001|Overall Study|Noncompliance with protocol|0|||
131726964|NCT01345786|474279229|FG002|Overall Study|Noncompliance with protocol|1|||
131726965|NCT01345786|474279230|FG003|Overall Study|Noncompliance with protocol|0|||
131726966|NCT01345786|474279227|FG000|Overall Study|Administrative|3|||
131726967|NCT01345786|474279228|FG001|Overall Study|Administrative|5|||
131726968|NCT01345786|474279229|FG002|Overall Study|Administrative|0|||
131726969|NCT01345786|474279230|FG003|Overall Study|Administrative|0|||
131726970|NCT01345786|474279227|FG000|Overall Study|Lost to Follow-up|0|||
131726971|NCT01345786|474279228|FG001|Overall Study|Lost to Follow-up|0|||
131726972|NCT01345786|474279229|FG002|Overall Study|Lost to Follow-up|0|||
131726973|NCT01345786|474279230|FG003|Overall Study|Lost to Follow-up|2|||
131726974|NCT01963117|474279240|FG000|Overall Study|Death|1|||
131726975|NCT04430582|474279241|FG000|Overall Study|Found to meet exclusionary criteria|1|||
131726976|NCT04430582|474279242|FG001|Overall Study|Found to meet exclusionary criteria|0|||
131726977|NCT04430582|474279241|FG000|Overall Study|Withdrawal by Subject|0|||
131726978|NCT04430582|474279242|FG001|Overall Study|Withdrawal by Subject|1|||
131726979|NCT04267562|474281614|FG000|Assessed for Eligibility|Screen Failure|64|||
131726980|NCT04267562|474281614|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
131726981|NCT04267562|474281614|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
131726982|NCT04267562|474281614|FG000|Assessed for Eligibility|Site closure|6|||
131726983|NCT04267562|474281614|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
131726984|NCT04267562|474281614|FG000|Assessed for Eligibility|Physician Decision|1|||
131726985|NCT04267562|474281614|FG000|Month 24|Elective hysterectomy|1|||
131726986|NCT04267562|474281614|FG000|Month 24|Lost to Follow-up|1|||
131726987|NCT04267562|474281614|FG000|Month 36|Elective hysterectomy|2|||
131726988|NCT04267562|474281614|FG000|Month 36|Lost to Follow-up|3|||
131726989|NCT04359823|474281615|FG000|Overall Study|Lost to Follow-up|0|||
131806140|NCT05093205|474574430|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131726990|NCT04359823|474281616|FG001|Overall Study|Lost to Follow-up|1|||
131806141|NCT05093205|474574431|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131726991|NCT04359823|474281615|FG000|Overall Study|Withdrawal by Subject|0|||
131726992|NCT04359823|474281616|FG001|Overall Study|Withdrawal by Subject|1|||
131726993|NCT01850563|474281617|FG000|Overall Study|Not eligible|3|||
131806142|NCT05093205|474574432|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131726994|NCT01850563|474281618|FG001|Overall Study|Not eligible|0|||
131806143|NCT05093205|474574433|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806144|NCT05093205|474574434|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806145|NCT05093205|474574435|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806146|NCT05093205|474574436|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806147|NCT05093205|474574437|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
131806148|NCT05093205|474574438|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131806149|NCT00585689|474574439|FG000|Overall Study|Received different ABI-007 schedule|3|||
131806150|NCT00585689|474574439|FG000|Overall Study|Adverse Event|1|||
131806151|NCT00585689|474574439|FG000|Overall Study|Patient Declined Surgery|1|||
131806152|NCT00585689|474574439|FG000|Overall Study|Patient had unresectable disease|1|||
131806153|NCT00585689|474574439|FG000|Overall Study|Death|1|||
131806154|NCT04185909|474574440|FG000|Overall Study|Lost to Follow-up|1|||
131806155|NCT01417078|474574441|FG000|Overall Study|Withdrawal by Subject|1|||
131806156|NCT00626548|474574442|FG000|Overall Study|Adverse Event|164|||
131806157|NCT00626548|474574443|FG001|Overall Study|Adverse Event|44|||
131806158|NCT00626548|474574442|FG000|Overall Study|Withdrawal by Subject|42|||
131806159|NCT00626548|474574443|FG001|Overall Study|Withdrawal by Subject|46|||
131806160|NCT00626548|474574442|FG000|Overall Study|Protocol Violation|4|||
131806161|NCT00626548|474574443|FG001|Overall Study|Protocol Violation|11|||
131806162|NCT00626548|474574442|FG000|Overall Study|Lost to Follow-up|2|||
131806163|NCT00626548|474574443|FG001|Overall Study|Lost to Follow-up|2|||
131806164|NCT00626548|474574442|FG000|Overall Study|Other termination reason|493|||
131806165|NCT00626548|474574443|FG001|Overall Study|Other termination reason|613|||
131806166|NCT00048581|474574444|FG000|Double-Blind Period|Adverse Event|9|||
131806167|NCT00048581|474574445|FG001|Double-Blind Period|Adverse Event|5|||
131806168|NCT00048581|474574446|FG002|Double-Blind Period|Adverse Event|0|||
131806169|NCT00048581|474574444|FG000|Double-Blind Period|Lack of Efficacy|14|||
131806170|NCT00048581|474574445|FG001|Double-Blind Period|Lack of Efficacy|27|||
131806171|NCT00048581|474574446|FG002|Double-Blind Period|Lack of Efficacy|0|||
131806172|NCT00048581|474574444|FG000|Double-Blind Period|Lost to Follow-up|5|||
131806173|NCT00048581|474574445|FG001|Double-Blind Period|Lost to Follow-up|0|||
131806174|NCT00048581|474574446|FG002|Double-Blind Period|Lost to Follow-up|0|||
131806175|NCT00048581|474574444|FG000|Double-Blind Period|Withdrawal by Subject|5|||
131806176|NCT00048581|474574445|FG001|Double-Blind Period|Withdrawal by Subject|2|||
131806177|NCT00048581|474574446|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131806178|NCT00048581|474574444|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
131806179|NCT00048581|474574445|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
131806180|NCT00048581|474574446|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
131806181|NCT00048581|474574444|FG000|Double-Blind Period|Investigator Decision|1|||
131806182|NCT00048581|474574445|FG001|Double-Blind Period|Investigator Decision|0|||
131806183|NCT00048581|474574446|FG002|Double-Blind Period|Investigator Decision|0|||
131806184|NCT00048581|474574444|FG000|Open-Label Period|Death|0|||
131806185|NCT00048581|474574445|FG001|Open-Label Period|Death|0|||
131806186|NCT00048581|474574446|FG002|Open-Label Period|Death|4|||
131806187|NCT00048581|474574444|FG000|Open-Label Period|Adverse Event|0|||
131806188|NCT00048581|474574445|FG001|Open-Label Period|Adverse Event|0|||
131806189|NCT00048581|474574446|FG002|Open-Label Period|Adverse Event|37|||
131806190|NCT00048581|474574444|FG000|Open-Label Period|Lack of Efficacy|0|||
131806191|NCT00048581|474574445|FG001|Open-Label Period|Lack of Efficacy|0|||
131806192|NCT00048581|474574446|FG002|Open-Label Period|Lack of Efficacy|69|||
131806193|NCT00048581|474574444|FG000|Open-Label Period|Lost to Follow-up|0|||
131806194|NCT00048581|474574445|FG001|Open-Label Period|Lost to Follow-up|0|||
131806195|NCT00048581|474574446|FG002|Open-Label Period|Lost to Follow-up|14|||
131806196|NCT00048581|474574444|FG000|Open-Label Period|Withdrawal by Subject|0|||
131806197|NCT00048581|474574445|FG001|Open-Label Period|Withdrawal by Subject|0|||
131806198|NCT00048581|474574446|FG002|Open-Label Period|Withdrawal by Subject|20|||
131806199|NCT00048581|474574444|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
131726995|NCT02078713|474281621|FG000|Overall Study|Lost to Follow-up|49|||
131726996|NCT02078713|474281622|FG001|Overall Study|Lost to Follow-up|55|||
131726997|NCT02078713|474281623|FG002|Overall Study|Lost to Follow-up|0|||
131726998|NCT02078713|474281624|FG003|Overall Study|Lost to Follow-up|0|||
131726999|NCT02078713|474281621|FG000|Overall Study|Pregnant at baseline|3|||
131727000|NCT02078713|474281622|FG001|Overall Study|Pregnant at baseline|5|||
131727001|NCT02078713|474281623|FG002|Overall Study|Pregnant at baseline|0|||
131727002|NCT02078713|474281624|FG003|Overall Study|Pregnant at baseline|0|||
131727003|NCT02078713|474281621|FG000|Overall Study|Enrolled twice|0|||
131727004|NCT02078713|474281622|FG001|Overall Study|Enrolled twice|1|||
131727005|NCT02078713|474281623|FG002|Overall Study|Enrolled twice|0|||
131727006|NCT02078713|474281624|FG003|Overall Study|Enrolled twice|0|||
131727007|NCT00696657|474281629|FG000|Overall Study|Protocol Violation|0|||
131806200|NCT00048581|474574445|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
131806201|NCT00048581|474574446|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
131806202|NCT00048581|474574444|FG000|Open-Label Period|Poor/Non-compliance|0|||
131806203|NCT00048581|474574445|FG001|Open-Label Period|Poor/Non-compliance|0|||
131904973|NCT04613518|474939013|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
131806204|NCT00048581|474574446|FG002|Open-Label Period|Poor/Non-compliance|5|||
131727008|NCT00696657|474281630|FG001|Overall Study|Protocol Violation|0|||
131727009|NCT00696657|474281631|FG002|Overall Study|Protocol Violation|0|||
131727010|NCT00696657|474281632|FG003|Overall Study|Protocol Violation|0|||
131727011|NCT00696657|474281633|FG004|Overall Study|Protocol Violation|0|||
131727012|NCT00696657|474281634|FG005|Overall Study|Protocol Violation|1|||
131727013|NCT00696657|474281635|FG006|Overall Study|Protocol Violation|0|||
131727014|NCT00696657|474281636|FG007|Overall Study|Protocol Violation|0|||
131727015|NCT00696657|474281637|FG008|Overall Study|Protocol Violation|1|||
131727016|NCT00696657|474281629|FG000|Overall Study|Lack of Efficacy|0|||
131727017|NCT00696657|474281630|FG001|Overall Study|Lack of Efficacy|1|||
131727018|NCT00696657|474281631|FG002|Overall Study|Lack of Efficacy|0|||
131727019|NCT00696657|474281632|FG003|Overall Study|Lack of Efficacy|0|||
131727020|NCT00696657|474281633|FG004|Overall Study|Lack of Efficacy|0|||
131727021|NCT00696657|474281634|FG005|Overall Study|Lack of Efficacy|0|||
131727022|NCT00696657|474281635|FG006|Overall Study|Lack of Efficacy|0|||
131727023|NCT00696657|474281636|FG007|Overall Study|Lack of Efficacy|0|||
131727024|NCT00696657|474281637|FG008|Overall Study|Lack of Efficacy|0|||
131727025|NCT00696657|474281629|FG000|Overall Study|Withdrawal criteria|1|||
131727026|NCT00696657|474281630|FG001|Overall Study|Withdrawal criteria|3|||
131727027|NCT00696657|474281631|FG002|Overall Study|Withdrawal criteria|2|||
131727028|NCT00696657|474281632|FG003|Overall Study|Withdrawal criteria|2|||
131727029|NCT00696657|474281633|FG004|Overall Study|Withdrawal criteria|0|||
131727030|NCT00696657|474281634|FG005|Overall Study|Withdrawal criteria|0|||
131727031|NCT00696657|474281635|FG006|Overall Study|Withdrawal criteria|1|||
131727032|NCT00696657|474281636|FG007|Overall Study|Withdrawal criteria|1|||
131727033|NCT00696657|474281637|FG008|Overall Study|Withdrawal criteria|2|||
131727034|NCT00696657|474281629|FG000|Overall Study|Unclassified|0|||
131727035|NCT00696657|474281630|FG001|Overall Study|Unclassified|1|||
131806205|NCT00048581|474574444|FG000|Open-Label Period|Pregnancy|0|||
131806206|NCT00048581|474574445|FG001|Open-Label Period|Pregnancy|0|||
131806207|NCT00048581|474574446|FG002|Open-Label Period|Pregnancy|7|||
131806208|NCT00048581|474574444|FG000|Open-Label Period|Study Site Closure|0|||
131806209|NCT00048581|474574445|FG001|Open-Label Period|Study Site Closure|0|||
131806210|NCT00048581|474574446|FG002|Open-Label Period|Study Site Closure|2|||
131806211|NCT00048581|474574444|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
131806212|NCT00048581|474574445|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
131806213|NCT00048581|474574446|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
131806214|NCT00048581|474574444|FG000|Open-Label Period|Problem With Transportation To Site|0|||
131806215|NCT00048581|474574445|FG001|Open-Label Period|Problem With Transportation To Site|0|||
131806216|NCT00048581|474574446|FG002|Open-Label Period|Problem With Transportation To Site|1|||
131806217|NCT00048581|474574444|FG000|Open-Label Period|Primary Investigator Retired|0|||
131806218|NCT00048581|474574445|FG001|Open-Label Period|Primary Investigator Retired|0|||
131806219|NCT00048581|474574446|FG002|Open-Label Period|Primary Investigator Retired|2|||
131806220|NCT00048581|474574444|FG000|Open-Label Period|Study Ended By Sponsor|0|||
131806221|NCT00048581|474574445|FG001|Open-Label Period|Study Ended By Sponsor|0|||
131806222|NCT00048581|474574446|FG002|Open-Label Period|Study Ended By Sponsor|1|||
131806223|NCT01059903|474574448|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
131806224|NCT01059903|474574449|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
131806225|NCT00385593|474574456|FG000|Overall Study|Adverse Event|3|||
131806226|NCT00385593|474574457|FG001|Overall Study|Adverse Event|2|||
131806227|NCT00385593|474574456|FG000|Overall Study|Withdrawal by Subject|17|||
131806228|NCT00385593|474574457|FG001|Overall Study|Withdrawal by Subject|7|||
131806229|NCT00385593|474574456|FG000|Overall Study|Lost to Follow-up|12|||
131806230|NCT00385593|474574457|FG001|Overall Study|Lost to Follow-up|8|||
131806231|NCT00385593|474574456|FG000|Overall Study|Protocol Violation|7|||
131806232|NCT00385593|474574457|FG001|Overall Study|Protocol Violation|4|||
131806233|NCT00385593|474574456|FG000|Overall Study|Several reasons|17|||
131806234|NCT00385593|474574457|FG001|Overall Study|Several reasons|15|||
131806235|NCT00385593|474574456|FG000|Overall Study|Incorrect inclusion|2|||
131806236|NCT00385593|474574457|FG001|Overall Study|Incorrect inclusion|0|||
131806237|NCT00385593|474574456|FG000|Overall Study|Incorrect randomization|0|||
131806238|NCT00385593|474574457|FG001|Overall Study|Incorrect randomization|1|||
131806239|NCT02100228|474574458|FG000|Overall Study|Other|19|||
131806240|NCT02100228|474574459|FG001|Overall Study|Other|19|||
131806241|NCT02100228|474574458|FG000|Overall Study|Administrative reason|0|||
131806242|NCT02100228|474574459|FG001|Overall Study|Administrative reason|1|||
131806243|NCT02100228|474574458|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
131806244|NCT02100228|474574459|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
131806245|NCT02100228|474574458|FG000|Overall Study|Non-compliance|0|||
131806246|NCT02100228|474574459|FG001|Overall Study|Non-compliance|3|||
131806247|NCT02100228|474574458|FG000|Overall Study|Lost to Follow-up|0|||
131727036|NCT00696657|474281631|FG002|Overall Study|Unclassified|3|||
131727037|NCT00696657|474281632|FG003|Overall Study|Unclassified|2|||
131727038|NCT00696657|474281633|FG004|Overall Study|Unclassified|4|||
131806248|NCT02100228|474574459|FG001|Overall Study|Lost to Follow-up|1|||
131727039|NCT00696657|474281634|FG005|Overall Study|Unclassified|2|||
131727040|NCT00696657|474281635|FG006|Overall Study|Unclassified|0|||
131727041|NCT00696657|474281636|FG007|Overall Study|Unclassified|0|||
131727042|NCT00696657|474281637|FG008|Overall Study|Unclassified|1|||
131727043|NCT00696657|474281629|FG000|Overall Study|Adverse Event|0|||
131727044|NCT00696657|474281630|FG001|Overall Study|Adverse Event|0|||
131727045|NCT00696657|474281631|FG002|Overall Study|Adverse Event|3|||
131727046|NCT00696657|474281632|FG003|Overall Study|Adverse Event|7|||
131727047|NCT00696657|474281633|FG004|Overall Study|Adverse Event|6|||
131727048|NCT00696657|474281634|FG005|Overall Study|Adverse Event|9|||
131727049|NCT00696657|474281635|FG006|Overall Study|Adverse Event|14|||
131727050|NCT00696657|474281636|FG007|Overall Study|Adverse Event|2|||
131727051|NCT00696657|474281637|FG008|Overall Study|Adverse Event|5|||
131727052|NCT01790438|474281638|FG000|Overall Study|Adverse Event|3|||
131727053|NCT01790438|474281639|FG001|Overall Study|Adverse Event|2|||
131727054|NCT01790438|474281638|FG000|Overall Study|Death|4|||
131727055|NCT01790438|474281639|FG001|Overall Study|Death|0|||
131727056|NCT01790438|474281638|FG000|Overall Study|Lost to Follow-up|5|||
131727057|NCT01790438|474281639|FG001|Overall Study|Lost to Follow-up|2|||
131727058|NCT01790438|474281638|FG000|Overall Study|Withdrawal by Subject|13|||
131727059|NCT01790438|474281639|FG001|Overall Study|Withdrawal by Subject|2|||
131727060|NCT01790438|474281638|FG000|Overall Study|Physician Decision|3|||
131727061|NCT01790438|474281639|FG001|Overall Study|Physician Decision|1|||
131727062|NCT01790438|474281638|FG000|Overall Study|Sponsor Decision|0|||
131727063|NCT01790438|474281639|FG001|Overall Study|Sponsor Decision|3|||
131727064|NCT01790438|474281638|FG000|Overall Study|Protocol Required Discontinuation|7|||
131727065|NCT01790438|474281639|FG001|Overall Study|Protocol Required Discontinuation|1|||
131727066|NCT02090114|474281643|FG000|Overall Study|Withdrawal by Subject|3|||
131727067|NCT02090114|474281644|FG001|Overall Study|Withdrawal by Subject|6|||
131727068|NCT02090114|474281645|FG002|Overall Study|Withdrawal by Subject|2|||
131727069|NCT02090114|474281646|FG003|Overall Study|Withdrawal by Subject|1|||
131727070|NCT02090114|474281643|FG000|Overall Study|Physician Decision|5|||
131727071|NCT02090114|474281644|FG001|Overall Study|Physician Decision|0|||
131727072|NCT02090114|474281645|FG002|Overall Study|Physician Decision|1|||
131727073|NCT02090114|474281646|FG003|Overall Study|Physician Decision|1|||
131727074|NCT02090114|474281643|FG000|Overall Study|Adverse Event|1|||
131727075|NCT02090114|474281644|FG001|Overall Study|Adverse Event|2|||
131727076|NCT02090114|474281645|FG002|Overall Study|Adverse Event|2|||
131727077|NCT02090114|474281646|FG003|Overall Study|Adverse Event|0|||
131727078|NCT02090114|474281643|FG000|Overall Study|Progressive Disease|20|||
131727079|NCT02090114|474281644|FG001|Overall Study|Progressive Disease|21|||
131727080|NCT02090114|474281645|FG002|Overall Study|Progressive Disease|23|||
131727081|NCT02090114|474281646|FG003|Overall Study|Progressive Disease|6|||
131727082|NCT02090114|474281643|FG000|Overall Study|Death|1|||
131727083|NCT02090114|474281644|FG001|Overall Study|Death|0|||
131727084|NCT02090114|474281645|FG002|Overall Study|Death|1|||
131727085|NCT02090114|474281646|FG003|Overall Study|Death|0|||
131727086|NCT00059215|474281649|FG000|Overall Study|Adverse Event|5|||
131727087|NCT00059215|474281650|FG001|Overall Study|Adverse Event|5|||
131727088|NCT00059215|474281651|FG002|Overall Study|Adverse Event|9|||
131727089|NCT00059215|474281652|FG003|Overall Study|Adverse Event|9|||
131727090|NCT00059215|474281649|FG000|Overall Study|Death|0|||
131727091|NCT00059215|474281650|FG001|Overall Study|Death|0|||
131727092|NCT00059215|474281651|FG002|Overall Study|Death|3|||
131727093|NCT00059215|474281652|FG003|Overall Study|Death|0|||
131727094|NCT00059215|474281649|FG000|Overall Study|Lost to Follow-up|1|||
131727095|NCT00059215|474281650|FG001|Overall Study|Lost to Follow-up|2|||
131727096|NCT00059215|474281651|FG002|Overall Study|Lost to Follow-up|0|||
131727097|NCT00059215|474281652|FG003|Overall Study|Lost to Follow-up|0|||
131727098|NCT00059215|474281649|FG000|Overall Study|Withdrawal by Subject|4|||
131727099|NCT00059215|474281650|FG001|Overall Study|Withdrawal by Subject|4|||
131727100|NCT00059215|474281651|FG002|Overall Study|Withdrawal by Subject|1|||
131727101|NCT00059215|474281652|FG003|Overall Study|Withdrawal by Subject|3|||
131727102|NCT00059215|474281649|FG000|Overall Study|Protocol Violation|1|||
131727103|NCT00059215|474281650|FG001|Overall Study|Protocol Violation|0|||
131727104|NCT00059215|474281651|FG002|Overall Study|Protocol Violation|1|||
131727105|NCT00059215|474281652|FG003|Overall Study|Protocol Violation|0|||
131727106|NCT00059215|474281649|FG000|Overall Study|Protocol entry criteria not met|1|||
131727107|NCT00059215|474281650|FG001|Overall Study|Protocol entry criteria not met|1|||
131727108|NCT00059215|474281651|FG002|Overall Study|Protocol entry criteria not met|0|||
131727109|NCT00059215|474281652|FG003|Overall Study|Protocol entry criteria not met|2|||
131727110|NCT00059215|474281649|FG000|Overall Study|Physician Decision|1|||
131727111|NCT00059215|474281650|FG001|Overall Study|Physician Decision|2|||
131727112|NCT00059215|474281651|FG002|Overall Study|Physician Decision|1|||
131727113|NCT00059215|474281652|FG003|Overall Study|Physician Decision|1|||
131727114|NCT04439838|474281653|FG000|Overall Study|Withdrawal by Subject|0|||
131727115|NCT04439838|474281654|FG001|Overall Study|Withdrawal by Subject|0|||
131727116|NCT04439838|474281655|FG002|Overall Study|Withdrawal by Subject|0|||
131727117|NCT04439838|474281656|FG003|Overall Study|Withdrawal by Subject|0|||
131727118|NCT04439838|474281657|FG004|Overall Study|Withdrawal by Subject|0|||
131727119|NCT04439838|474281658|FG005|Overall Study|Withdrawal by Subject|0|||
131727120|NCT04439838|474281659|FG006|Overall Study|Withdrawal by Subject|0|||
131727121|NCT04439838|474281660|FG007|Overall Study|Withdrawal by Subject|0|||
131727122|NCT04439838|474281661|FG008|Overall Study|Withdrawal by Subject|1|||
131727123|NCT04494633|474281662|FG000|Overall Study|Lost to Follow-up|5|||
131727124|NCT04494633|474281663|FG001|Overall Study|Lost to Follow-up|3|||
131727125|NCT04494633|474281662|FG000|Overall Study|Protocol Violation|1|||
131727126|NCT04494633|474281663|FG001|Overall Study|Protocol Violation|1|||
131904974|NCT04613518|474939011|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
131904975|NCT04613518|474939012|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
131904976|NCT04613518|474939013|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
131904977|NCT04613518|474939011|FG000|Open-Label Treatment Period|Other reasons|1|||
131904978|NCT04613518|474939012|FG001|Open-Label Treatment Period|Other reasons|0|||
131904979|NCT04613518|474939013|FG002|Open-Label Treatment Period|Other reasons|0|||
131904980|NCT01619865|474939014|FG000|Overall Study|Adverse Event|1|||
131904981|NCT01619865|474939014|FG000|Overall Study|Death|2|||
131727127|NCT00414310|474281664|FG000|Overall Study|Not treated|1|||
131727128|NCT00414310|474281665|FG001|Overall Study|Not treated|0|||
131727129|NCT01781429|474281666|FG000|Overall Study|Death|0|||
131727130|NCT01781429|474281667|FG001|Overall Study|Death|0|||
131727131|NCT01781429|474281668|FG002|Overall Study|Death|0|||
131727132|NCT01781429|474281669|FG003|Overall Study|Death|0|||
131727133|NCT01781429|474281670|FG004|Overall Study|Death|0|||
131727134|NCT01781429|474281671|FG005|Overall Study|Death|0|||
131727135|NCT01781429|474281672|FG006|Overall Study|Death|0|||
131727136|NCT01781429|474281673|FG007|Overall Study|Death|0|||
131727137|NCT01781429|474281674|FG008|Overall Study|Death|0|||
131727138|NCT01781429|474281675|FG009|Overall Study|Death|1|||
131727139|NCT01781429|474281676|FG010|Overall Study|Death|0|||
131727140|NCT01781429|474281677|FG011|Overall Study|Death|0|||
131727141|NCT01781429|474281678|FG012|Overall Study|Death|1|||
131727142|NCT01781429|474281679|FG013|Overall Study|Death|0|||
131727143|NCT01781429|474281680|FG014|Overall Study|Death|1|||
131727144|NCT01781429|474281681|FG015|Overall Study|Death|0|||
131727145|NCT01781429|474281666|FG000|Overall Study|Withdrawal by Subject|0|||
131727146|NCT01781429|474281667|FG001|Overall Study|Withdrawal by Subject|0|||
131727147|NCT01781429|474281668|FG002|Overall Study|Withdrawal by Subject|0|||
131727148|NCT01781429|474281669|FG003|Overall Study|Withdrawal by Subject|0|||
131727149|NCT01781429|474281670|FG004|Overall Study|Withdrawal by Subject|0|||
131727150|NCT01781429|474281671|FG005|Overall Study|Withdrawal by Subject|0|||
131727151|NCT01781429|474281672|FG006|Overall Study|Withdrawal by Subject|0|||
131727152|NCT01781429|474281673|FG007|Overall Study|Withdrawal by Subject|0|||
131727153|NCT01781429|474281674|FG008|Overall Study|Withdrawal by Subject|1|||
131727154|NCT01781429|474281675|FG009|Overall Study|Withdrawal by Subject|3|||
131727155|NCT01781429|474281676|FG010|Overall Study|Withdrawal by Subject|1|||
131727156|NCT01781429|474281677|FG011|Overall Study|Withdrawal by Subject|1|||
131727157|NCT01781429|474281678|FG012|Overall Study|Withdrawal by Subject|5|||
131727158|NCT01781429|474281679|FG013|Overall Study|Withdrawal by Subject|2|||
131727159|NCT01781429|474281680|FG014|Overall Study|Withdrawal by Subject|3|||
131727160|NCT01781429|474281681|FG015|Overall Study|Withdrawal by Subject|0|||
131727161|NCT01781429|474281666|FG000|Overall Study|Disease Progression|1|||
131727162|NCT01781429|474281667|FG001|Overall Study|Disease Progression|0|||
131727163|NCT01781429|474281668|FG002|Overall Study|Disease Progression|1|||
131727164|NCT01781429|474281669|FG003|Overall Study|Disease Progression|1|||
131727165|NCT01781429|474281670|FG004|Overall Study|Disease Progression|1|||
131727166|NCT01781429|474281671|FG005|Overall Study|Disease Progression|4|||
131727167|NCT01781429|474281672|FG006|Overall Study|Disease Progression|7|||
131727168|NCT01781429|474281673|FG007|Overall Study|Disease Progression|4|||
131904982|NCT01619865|474939014|FG000|Overall Study|subject not able to comply|1|||
131904983|NCT01494818|474939015|FG000|Overall Study|Relocation|1|||
131904984|NCT01494818|474939016|FG001|Overall Study|Relocation|2|||
131727169|NCT01781429|474281674|FG008|Overall Study|Disease Progression|6|||
131727170|NCT01781429|474281675|FG009|Overall Study|Disease Progression|15|||
131727171|NCT01781429|474281676|FG010|Overall Study|Disease Progression|15|||
131727172|NCT01781429|474281677|FG011|Overall Study|Disease Progression|15|||
131727173|NCT01781429|474281678|FG012|Overall Study|Disease Progression|15|||
131727174|NCT01781429|474281679|FG013|Overall Study|Disease Progression|4|||
131727175|NCT01781429|474281680|FG014|Overall Study|Disease Progression|11|||
131727176|NCT01781429|474281681|FG015|Overall Study|Disease Progression|0|||
131727177|NCT01781429|474281666|FG000|Overall Study|Unacceptable Toxicity|0|||
131904985|NCT01494818|474939015|FG000|Overall Study|Lost to Follow-up|1|||
131727178|NCT01781429|474281667|FG001|Overall Study|Unacceptable Toxicity|0|||
131727179|NCT01781429|474281668|FG002|Overall Study|Unacceptable Toxicity|0|||
131727180|NCT01781429|474281669|FG003|Overall Study|Unacceptable Toxicity|0|||
131727181|NCT01781429|474281670|FG004|Overall Study|Unacceptable Toxicity|0|||
131727182|NCT01781429|474281671|FG005|Overall Study|Unacceptable Toxicity|0|||
131904986|NCT01494818|474939016|FG001|Overall Study|Lost to Follow-up|0|||
131904987|NCT00791999|474939017|FG000|Overall Study|Protocol planed withdrawal|14|||
131904988|NCT00791999|474939018|FG001|Overall Study|Protocol planed withdrawal|11|||
131904989|NCT00791999|474939019|FG002|Overall Study|Protocol planed withdrawal|11|||
131904990|NCT00791999|474939020|FG003|Overall Study|Protocol planed withdrawal|45|||
131904991|NCT00791999|474939017|FG000|Overall Study|Withdrawal by Subject|0|||
131904992|NCT00791999|474939018|FG001|Overall Study|Withdrawal by Subject|1|||
131904993|NCT00791999|474939019|FG002|Overall Study|Withdrawal by Subject|0|||
131904994|NCT00791999|474939020|FG003|Overall Study|Withdrawal by Subject|2|||
131904995|NCT00791999|474939017|FG000|Overall Study|Protocol Violation|3|||
131904996|NCT00791999|474939018|FG001|Overall Study|Protocol Violation|0|||
131904997|NCT00791999|474939019|FG002|Overall Study|Protocol Violation|1|||
131904998|NCT00791999|474939020|FG003|Overall Study|Protocol Violation|0|||
131904999|NCT00791999|474939017|FG000|Overall Study|Adverse Event|3|||
131905000|NCT00791999|474939018|FG001|Overall Study|Adverse Event|3|||
131905001|NCT00791999|474939019|FG002|Overall Study|Adverse Event|7|||
131905002|NCT00791999|474939020|FG003|Overall Study|Adverse Event|3|||
131905003|NCT00791999|474939017|FG000|Overall Study|Lack of Efficacy|0|||
131905004|NCT00791999|474939018|FG001|Overall Study|Lack of Efficacy|1|||
131905005|NCT00791999|474939019|FG002|Overall Study|Lack of Efficacy|0|||
131905006|NCT00791999|474939020|FG003|Overall Study|Lack of Efficacy|2|||
131905007|NCT00791999|474939017|FG000|Overall Study|Reason other than those above|1|||
131905008|NCT00791999|474939018|FG001|Overall Study|Reason other than those above|0|||
131905009|NCT00791999|474939019|FG002|Overall Study|Reason other than those above|1|||
131905010|NCT00791999|474939020|FG003|Overall Study|Reason other than those above|0|||
131905011|NCT01077323|474939021|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
131905012|NCT01077323|474939022|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
131905013|NCT01077323|474939023|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
131905014|NCT01077323|474939021|FG000|Overall Study|Dispensing of drug in baseline period|0|||
131905015|NCT01077323|474939022|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
131905016|NCT01077323|474939023|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
131905017|NCT01077323|474939021|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
131905018|NCT01077323|474939022|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
131905019|NCT01077323|474939023|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
131905020|NCT00617357|474939024|FG000|Overall Study|Lost to Follow-up|7|||
131905021|NCT00617357|474939024|FG000|Overall Study|Death|5|||
131905022|NCT00617357|474939024|FG000|Overall Study|insurance concerns|2|||
131905023|NCT00617357|474939024|FG000|Overall Study|Withdrawal by Subject|1|||
131905024|NCT00617357|474939024|FG000|Overall Study|Physician Decision|1|||
131905025|NCT01710020|474939025|FG000|Period 1|Protocol Violation|1|||
131905026|NCT02153918|474939026|FG000|Overall Study|Refused further treatment|1|||
131905027|NCT01764841|474939027|FG000|Overall Study|Logistical Difficulties|0|||
131905028|NCT01764841|474939028|FG001|Overall Study|Logistical Difficulties|1|||
131905029|NCT01764841|474939029|FG002|Overall Study|Logistical Difficulties|0|||
131905030|NCT01764841|474939030|FG003|Overall Study|Logistical Difficulties|0|||
131905031|NCT01764841|474939027|FG000|Overall Study|Death|3|||
131905032|NCT01764841|474939028|FG001|Overall Study|Death|0|||
131905033|NCT01764841|474939029|FG002|Overall Study|Death|1|||
131905034|NCT01764841|474939030|FG003|Overall Study|Death|4|||
131905035|NCT01764841|474939027|FG000|Overall Study|No Follow Up|1|||
131905036|NCT01764841|474939028|FG001|Overall Study|No Follow Up|0|||
131905037|NCT01764841|474939029|FG002|Overall Study|No Follow Up|1|||
131727183|NCT01781429|474281672|FG006|Overall Study|Unacceptable Toxicity|0|||
131727184|NCT01781429|474281673|FG007|Overall Study|Unacceptable Toxicity|0|||
131727185|NCT01781429|474281674|FG008|Overall Study|Unacceptable Toxicity|0|||
131727186|NCT01781429|474281675|FG009|Overall Study|Unacceptable Toxicity|0|||
131727187|NCT01781429|474281676|FG010|Overall Study|Unacceptable Toxicity|0|||
131727188|NCT01781429|474281677|FG011|Overall Study|Unacceptable Toxicity|2|||
131727189|NCT01781429|474281678|FG012|Overall Study|Unacceptable Toxicity|0|||
131727190|NCT01781429|474281679|FG013|Overall Study|Unacceptable Toxicity|0|||
131727191|NCT01781429|474281680|FG014|Overall Study|Unacceptable Toxicity|0|||
131727192|NCT01781429|474281681|FG015|Overall Study|Unacceptable Toxicity|0|||
131727193|NCT01781429|474281666|FG000|Overall Study|Patient Condition Changed|0|||
131727194|NCT01781429|474281667|FG001|Overall Study|Patient Condition Changed|0|||
131905038|NCT01764841|474939030|FG003|Overall Study|No Follow Up|0|||
131905039|NCT01764841|474939027|FG000|Overall Study|Protocol Violation|0|||
131905040|NCT01764841|474939028|FG001|Overall Study|Protocol Violation|1|||
131905041|NCT01764841|474939029|FG002|Overall Study|Protocol Violation|0|||
131905042|NCT01764841|474939030|FG003|Overall Study|Protocol Violation|0|||
131905043|NCT01764841|474939027|FG000|Overall Study|Withdrawal by Subject|16|||
131905044|NCT01764841|474939028|FG001|Overall Study|Withdrawal by Subject|24|||
131905045|NCT01764841|474939029|FG002|Overall Study|Withdrawal by Subject|11|||
131905046|NCT01764841|474939030|FG003|Overall Study|Withdrawal by Subject|15|||
131905047|NCT01764841|474939027|FG000|Overall Study|Lost to Follow-up|3|||
131727195|NCT01781429|474281668|FG002|Overall Study|Patient Condition Changed|0|||
131727196|NCT01781429|474281669|FG003|Overall Study|Patient Condition Changed|0|||
131727197|NCT01781429|474281670|FG004|Overall Study|Patient Condition Changed|0|||
131727198|NCT01781429|474281671|FG005|Overall Study|Patient Condition Changed|0|||
131727199|NCT01781429|474281672|FG006|Overall Study|Patient Condition Changed|0|||
131727200|NCT01781429|474281673|FG007|Overall Study|Patient Condition Changed|0|||
131727201|NCT01781429|474281674|FG008|Overall Study|Patient Condition Changed|0|||
131727202|NCT01781429|474281675|FG009|Overall Study|Patient Condition Changed|4|||
131727203|NCT01781429|474281676|FG010|Overall Study|Patient Condition Changed|0|||
131727204|NCT01781429|474281677|FG011|Overall Study|Patient Condition Changed|1|||
131727205|NCT01781429|474281678|FG012|Overall Study|Patient Condition Changed|0|||
131727206|NCT01781429|474281679|FG013|Overall Study|Patient Condition Changed|1|||
131727207|NCT01781429|474281680|FG014|Overall Study|Patient Condition Changed|0|||
131727208|NCT01781429|474281681|FG015|Overall Study|Patient Condition Changed|0|||
131727209|NCT01781429|474281666|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
131727210|NCT01781429|474281667|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
131727211|NCT01781429|474281668|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
131727212|NCT01781429|474281669|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
131727213|NCT01781429|474281670|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
131727214|NCT01781429|474281671|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
131727215|NCT01781429|474281672|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
131727216|NCT01781429|474281673|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
131727217|NCT01781429|474281674|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
131727218|NCT01781429|474281675|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
131727219|NCT01781429|474281676|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
131727220|NCT01781429|474281677|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
131727221|NCT01781429|474281678|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
131727222|NCT01781429|474281679|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
131727223|NCT01781429|474281680|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
131727224|NCT01781429|474281681|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
131727225|NCT01781429|474281666|FG000|Overall Study|Enrolled, but not treated|0|||
131727226|NCT01781429|474281667|FG001|Overall Study|Enrolled, but not treated|0|||
131727227|NCT01781429|474281668|FG002|Overall Study|Enrolled, but not treated|0|||
131727228|NCT01781429|474281669|FG003|Overall Study|Enrolled, but not treated|0|||
131727229|NCT01781429|474281670|FG004|Overall Study|Enrolled, but not treated|0|||
131727230|NCT01781429|474281671|FG005|Overall Study|Enrolled, but not treated|0|||
131727231|NCT01781429|474281672|FG006|Overall Study|Enrolled, but not treated|0|||
131727232|NCT01781429|474281673|FG007|Overall Study|Enrolled, but not treated|0|||
131727233|NCT01781429|474281674|FG008|Overall Study|Enrolled, but not treated|0|||
131727234|NCT01781429|474281675|FG009|Overall Study|Enrolled, but not treated|0|||
131727235|NCT01781429|474281676|FG010|Overall Study|Enrolled, but not treated|1|||
131727236|NCT01781429|474281677|FG011|Overall Study|Enrolled, but not treated|0|||
131727237|NCT01781429|474281678|FG012|Overall Study|Enrolled, but not treated|0|||
131727238|NCT01781429|474281679|FG013|Overall Study|Enrolled, but not treated|0|||
131727239|NCT01781429|474281680|FG014|Overall Study|Enrolled, but not treated|0|||
131727240|NCT01781429|474281681|FG015|Overall Study|Enrolled, but not treated|0|||
131727241|NCT00931892|474281682|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
131727242|NCT00931892|474281683|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
131727243|NCT00390780|474281684|FG000|Overall Study|Not completed|10|||
131727244|NCT00390780|474281685|FG001|Overall Study|Not completed|4|||
131727245|NCT00390780|474281684|FG000|Overall Study|Protocol Violation|6|||
131727246|NCT00390780|474281685|FG001|Overall Study|Protocol Violation|4|||
131727247|NCT00390780|474281684|FG000|Overall Study|Lost to Follow-up|3|||
131727248|NCT00390780|474281685|FG001|Overall Study|Lost to Follow-up|6|||
131727249|NCT00390780|474281684|FG000|Overall Study|Adverse Event|2|||
131727250|NCT00390780|474281685|FG001|Overall Study|Adverse Event|3|||
131727251|NCT00390780|474281684|FG000|Overall Study|Death|1|||
131727252|NCT00390780|474281685|FG001|Overall Study|Death|3|||
131727253|NCT00390780|474281684|FG000|Overall Study|Withdrawal by Subject|1|||
131806249|NCT02100228|474574458|FG000|Overall Study|Withdrawal by Subject|27|||
131727254|NCT00390780|474281685|FG001|Overall Study|Withdrawal by Subject|2|||
131727255|NCT00390780|474281684|FG000|Overall Study|Inclusion criteria not satisfied|0|||
131727256|NCT00390780|474281685|FG001|Overall Study|Inclusion criteria not satisfied|2|||
131727257|NCT00390780|474281684|FG000|Overall Study|Lost to follow up and other reasons|0|||
131727258|NCT00390780|474281685|FG001|Overall Study|Lost to follow up and other reasons|1|||
131727259|NCT00390780|474281684|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
131727260|NCT00390780|474281685|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
131727261|NCT00390780|474281684|FG000|Overall Study|SAE, death|0|||
131727262|NCT00390780|474281685|FG001|Overall Study|SAE, death|1|||
131727263|NCT01070550|474281686|FG000|Overall Study|Adverse Event|43|||
131727264|NCT01070550|474281687|FG001|Overall Study|Adverse Event|1|||
131727265|NCT01070550|474281688|FG002|Overall Study|Adverse Event|3|||
131727266|NCT01070550|474281689|FG003|Overall Study|Adverse Event|0|||
131727267|NCT01070550|474281690|FG004|Overall Study|Adverse Event|0|||
131727268|NCT01070550|474281691|FG005|Overall Study|Adverse Event|0|||
131727269|NCT01070550|474281686|FG000|Overall Study|Death|20|||
131727270|NCT01070550|474281687|FG001|Overall Study|Death|4|||
131727271|NCT01070550|474281688|FG002|Overall Study|Death|3|||
131727272|NCT01070550|474281689|FG003|Overall Study|Death|0|||
131727273|NCT01070550|474281690|FG004|Overall Study|Death|0|||
131727274|NCT01070550|474281691|FG005|Overall Study|Death|0|||
131727275|NCT01070550|474281686|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
131727276|NCT01070550|474281687|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131727277|NCT01070550|474281688|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131727278|NCT01070550|474281689|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131727279|NCT01070550|474281690|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131727280|NCT01070550|474281691|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131727281|NCT01070550|474281686|FG000|Overall Study|Early termination|3|||
131727282|NCT01070550|474281687|FG001|Overall Study|Early termination|0|||
131727283|NCT01070550|474281688|FG002|Overall Study|Early termination|0|||
131727284|NCT01070550|474281689|FG003|Overall Study|Early termination|0|||
131727285|NCT01070550|474281690|FG004|Overall Study|Early termination|0|||
131727286|NCT01070550|474281691|FG005|Overall Study|Early termination|0|||
131727287|NCT01070550|474281686|FG000|Overall Study|Failed to return|450|||
131727288|NCT01070550|474281687|FG001|Overall Study|Failed to return|33|||
131727289|NCT01070550|474281688|FG002|Overall Study|Failed to return|144|||
131727290|NCT01070550|474281689|FG003|Overall Study|Failed to return|40|||
131727291|NCT01070550|474281690|FG004|Overall Study|Failed to return|1|||
131727292|NCT01070550|474281691|FG005|Overall Study|Failed to return|2|||
131727293|NCT01070550|474281686|FG000|Overall Study|Incomplete treatment|2|||
131727294|NCT01070550|474281687|FG001|Overall Study|Incomplete treatment|0|||
131727295|NCT01070550|474281688|FG002|Overall Study|Incomplete treatment|0|||
131727296|NCT01070550|474281689|FG003|Overall Study|Incomplete treatment|0|||
131727297|NCT01070550|474281690|FG004|Overall Study|Incomplete treatment|0|||
131727298|NCT01070550|474281691|FG005|Overall Study|Incomplete treatment|0|||
131727299|NCT01070550|474281686|FG000|Overall Study|Lab test not done|22|||
131727300|NCT01070550|474281687|FG001|Overall Study|Lab test not done|3|||
131727301|NCT01070550|474281688|FG002|Overall Study|Lab test not done|4|||
131727302|NCT01070550|474281689|FG003|Overall Study|Lab test not done|1|||
131727303|NCT01070550|474281690|FG004|Overall Study|Lab test not done|0|||
131727304|NCT01070550|474281691|FG005|Overall Study|Lab test not done|1|||
131727305|NCT01070550|474281686|FG000|Overall Study|Lack of Efficacy|65|||
131727306|NCT01070550|474281687|FG001|Overall Study|Lack of Efficacy|1|||
131727307|NCT01070550|474281688|FG002|Overall Study|Lack of Efficacy|5|||
131727308|NCT01070550|474281689|FG003|Overall Study|Lack of Efficacy|5|||
131727309|NCT01070550|474281690|FG004|Overall Study|Lack of Efficacy|0|||
131727310|NCT01070550|474281691|FG005|Overall Study|Lack of Efficacy|1|||
131727311|NCT01070550|474281686|FG000|Overall Study|Miscellaneous|12|||
131727312|NCT01070550|474281687|FG001|Overall Study|Miscellaneous|2|||
131727313|NCT01070550|474281688|FG002|Overall Study|Miscellaneous|3|||
131727314|NCT01070550|474281689|FG003|Overall Study|Miscellaneous|1|||
131727315|NCT01070550|474281690|FG004|Overall Study|Miscellaneous|0|||
131727316|NCT01070550|474281691|FG005|Overall Study|Miscellaneous|0|||
131727317|NCT01070550|474281686|FG000|Overall Study|New treatment started|3|||
131727318|NCT01070550|474281687|FG001|Overall Study|New treatment started|1|||
131727319|NCT01070550|474281688|FG002|Overall Study|New treatment started|0|||
131727320|NCT01070550|474281689|FG003|Overall Study|New treatment started|2|||
131727321|NCT01070550|474281690|FG004|Overall Study|New treatment started|0|||
131727322|NCT01070550|474281691|FG005|Overall Study|New treatment started|0|||
131727323|NCT01070550|474281686|FG000|Overall Study|Non-responders|493|||
131727324|NCT01070550|474281687|FG001|Overall Study|Non-responders|4|||
131727325|NCT01070550|474281688|FG002|Overall Study|Non-responders|21|||
131727326|NCT01070550|474281689|FG003|Overall Study|Non-responders|20|||
131727327|NCT01070550|474281690|FG004|Overall Study|Non-responders|0|||
131727328|NCT01070550|474281691|FG005|Overall Study|Non-responders|2|||
131727329|NCT01070550|474281686|FG000|Overall Study|Not categorized|33|||
131727330|NCT01070550|474281687|FG001|Overall Study|Not categorized|2|||
131727331|NCT01070550|474281688|FG002|Overall Study|Not categorized|6|||
131727332|NCT01070550|474281689|FG003|Overall Study|Not categorized|1|||
131727333|NCT01070550|474281690|FG004|Overall Study|Not categorized|0|||
131727334|NCT01070550|474281691|FG005|Overall Study|Not categorized|1|||
131727335|NCT01070550|474281686|FG000|Overall Study|Protocol Violation|15|||
131727336|NCT01070550|474281687|FG001|Overall Study|Protocol Violation|1|||
131727337|NCT01070550|474281688|FG002|Overall Study|Protocol Violation|1|||
131727338|NCT01070550|474281689|FG003|Overall Study|Protocol Violation|1|||
131727339|NCT01070550|474281690|FG004|Overall Study|Protocol Violation|0|||
131727340|NCT01070550|474281691|FG005|Overall Study|Protocol Violation|0|||
131727341|NCT01070550|474281686|FG000|Overall Study|Relapse|44|||
131727342|NCT01070550|474281687|FG001|Overall Study|Relapse|5|||
131727343|NCT01070550|474281688|FG002|Overall Study|Relapse|14|||
131727344|NCT01070550|474281689|FG003|Overall Study|Relapse|4|||
131727345|NCT01070550|474281690|FG004|Overall Study|Relapse|0|||
131727346|NCT01070550|474281691|FG005|Overall Study|Relapse|0|||
131727347|NCT01070550|474281686|FG000|Overall Study|Result not available|3|||
131727348|NCT01070550|474281687|FG001|Overall Study|Result not available|1|||
131727349|NCT01070550|474281688|FG002|Overall Study|Result not available|3|||
131727350|NCT01070550|474281689|FG003|Overall Study|Result not available|0|||
131727351|NCT01070550|474281690|FG004|Overall Study|Result not available|0|||
131727352|NCT01070550|474281691|FG005|Overall Study|Result not available|0|||
131727353|NCT01070550|474281686|FG000|Overall Study|Screen failure|1|||
131727354|NCT01070550|474281687|FG001|Overall Study|Screen failure|0|||
131727355|NCT01070550|474281688|FG002|Overall Study|Screen failure|0|||
131727356|NCT01070550|474281689|FG003|Overall Study|Screen failure|0|||
131727357|NCT01070550|474281690|FG004|Overall Study|Screen failure|0|||
131727358|NCT01070550|474281691|FG005|Overall Study|Screen failure|0|||
131727359|NCT01070550|474281686|FG000|Overall Study|Sponsor decision|1|||
131727360|NCT01070550|474281687|FG001|Overall Study|Sponsor decision|0|||
131727361|NCT01070550|474281688|FG002|Overall Study|Sponsor decision|0|||
131727362|NCT01070550|474281689|FG003|Overall Study|Sponsor decision|0|||
131727363|NCT01070550|474281690|FG004|Overall Study|Sponsor decision|0|||
131727364|NCT01070550|474281691|FG005|Overall Study|Sponsor decision|0|||
131727365|NCT01070550|474281686|FG000|Overall Study|Treatment duration shortened|1|||
131727366|NCT01070550|474281687|FG001|Overall Study|Treatment duration shortened|0|||
131727367|NCT01070550|474281688|FG002|Overall Study|Treatment duration shortened|0|||
131727368|NCT01070550|474281689|FG003|Overall Study|Treatment duration shortened|0|||
131727369|NCT01070550|474281690|FG004|Overall Study|Treatment duration shortened|0|||
131727370|NCT01070550|474281691|FG005|Overall Study|Treatment duration shortened|0|||
131727371|NCT01070550|474281686|FG000|Overall Study|Treatment interrupted|7|||
131727372|NCT01070550|474281687|FG001|Overall Study|Treatment interrupted|0|||
131727373|NCT01070550|474281688|FG002|Overall Study|Treatment interrupted|1|||
131727374|NCT01070550|474281689|FG003|Overall Study|Treatment interrupted|1|||
131727375|NCT01070550|474281690|FG004|Overall Study|Treatment interrupted|0|||
131727376|NCT01070550|474281691|FG005|Overall Study|Treatment interrupted|0|||
131727377|NCT01070550|474281686|FG000|Overall Study|Treatment not started|14|||
131727378|NCT01070550|474281687|FG001|Overall Study|Treatment not started|2|||
131727379|NCT01070550|474281688|FG002|Overall Study|Treatment not started|4|||
131727380|NCT01070550|474281689|FG003|Overall Study|Treatment not started|0|||
131727381|NCT01070550|474281690|FG004|Overall Study|Treatment not started|0|||
131727382|NCT01070550|474281691|FG005|Overall Study|Treatment not started|0|||
131727383|NCT01070550|474281686|FG000|Overall Study|Treatment restarted|0|||
131727384|NCT01070550|474281687|FG001|Overall Study|Treatment restarted|1|||
131727385|NCT01070550|474281688|FG002|Overall Study|Treatment restarted|0|||
131727386|NCT01070550|474281689|FG003|Overall Study|Treatment restarted|0|||
131727387|NCT01070550|474281690|FG004|Overall Study|Treatment restarted|0|||
131727388|NCT01070550|474281691|FG005|Overall Study|Treatment restarted|0|||
131727389|NCT01070550|474281686|FG000|Overall Study|Treatment stopped|3|||
131727390|NCT01070550|474281687|FG001|Overall Study|Treatment stopped|0|||
131727391|NCT01070550|474281688|FG002|Overall Study|Treatment stopped|0|||
131727392|NCT01070550|474281689|FG003|Overall Study|Treatment stopped|0|||
131727393|NCT01070550|474281690|FG004|Overall Study|Treatment stopped|0|||
131727394|NCT01070550|474281691|FG005|Overall Study|Treatment stopped|0|||
131727395|NCT01070550|474281686|FG000|Overall Study|Treatment unavailable|1|||
131727396|NCT01070550|474281687|FG001|Overall Study|Treatment unavailable|0|||
131727397|NCT01070550|474281688|FG002|Overall Study|Treatment unavailable|0|||
131727398|NCT01070550|474281689|FG003|Overall Study|Treatment unavailable|0|||
131727399|NCT01070550|474281690|FG004|Overall Study|Treatment unavailable|0|||
131727400|NCT01070550|474281691|FG005|Overall Study|Treatment unavailable|0|||
131727401|NCT01070550|474281686|FG000|Overall Study|Treatment was stopped early|7|||
131727402|NCT01070550|474281687|FG001|Overall Study|Treatment was stopped early|0|||
131727403|NCT01070550|474281688|FG002|Overall Study|Treatment was stopped early|0|||
131727404|NCT01070550|474281689|FG003|Overall Study|Treatment was stopped early|0|||
131727405|NCT01070550|474281690|FG004|Overall Study|Treatment was stopped early|0|||
131727406|NCT01070550|474281691|FG005|Overall Study|Treatment was stopped early|0|||
131727407|NCT01070550|474281686|FG000|Overall Study|Other|5|||
131727408|NCT01070550|474281687|FG001|Overall Study|Other|0|||
131727409|NCT01070550|474281688|FG002|Overall Study|Other|0|||
131727410|NCT01070550|474281689|FG003|Overall Study|Other|1|||
131727411|NCT01070550|474281690|FG004|Overall Study|Other|0|||
131727412|NCT01070550|474281691|FG005|Overall Study|Other|0|||
131727413|NCT01070550|474281686|FG000|Overall Study|Withdrawal by Subject|35|||
131806250|NCT02100228|474574459|FG001|Overall Study|Withdrawal by Subject|37|||
131806251|NCT02100228|474574458|FG000|Overall Study|Adverse Event|16|||
131806252|NCT02100228|474574459|FG001|Overall Study|Adverse Event|12|||
131806253|NCT02100228|474574458|FG000|Overall Study|Death|1|||
131806254|NCT02100228|474574459|FG001|Overall Study|Death|1|||
131806255|NCT02421952|474574460|FG000|Overall Study|Diary Not Returned|93|||
131806256|NCT02421952|474574460|FG000|Overall Study|Failed seriation task|13|||
131806257|NCT02421952|474574460|FG000|Overall Study|Subject uncooperative for baseline test|2|||
131806258|NCT02421952|474574460|FG000|Overall Study|Surgery cancelled|1|||
131806259|NCT00389064|474574470|FG000|Overall Study|Adverse Event|11|||
131806260|NCT00389064|474574471|FG001|Overall Study|Adverse Event|3|||
131806261|NCT00389064|474574470|FG000|Overall Study|Lack of Efficacy|3|||
131806262|NCT00389064|474574471|FG001|Overall Study|Lack of Efficacy|14|||
131806263|NCT00389064|474574470|FG000|Overall Study|Withdrawal by Subject|17|||
131806264|NCT00389064|474574471|FG001|Overall Study|Withdrawal by Subject|27|||
131806265|NCT00389064|474574470|FG000|Overall Study|Physician Decision|2|||
131806266|NCT00389064|474574471|FG001|Overall Study|Physician Decision|2|||
131806267|NCT00389064|474574470|FG000|Overall Study|Lost to Follow-up|1|||
131727414|NCT01070550|474281687|FG001|Overall Study|Withdrawal by Subject|0|||
131727415|NCT01070550|474281688|FG002|Overall Study|Withdrawal by Subject|3|||
131727416|NCT01070550|474281689|FG003|Overall Study|Withdrawal by Subject|0|||
131727417|NCT01070550|474281690|FG004|Overall Study|Withdrawal by Subject|0|||
131727418|NCT01070550|474281691|FG005|Overall Study|Withdrawal by Subject|0|||
131727419|NCT01585961|474281692|FG000|Overall Study|Death|6|||
131727420|NCT01585961|474281692|FG000|Overall Study|Physician Decision|1|||
131727421|NCT01585961|474281692|FG000|Overall Study|Decision to use non-study catheter|1|||
131727422|NCT01585961|474281692|FG000|Overall Study|Withdrawal by Subject|1|||
131727423|NCT01585961|474281692|FG000|Overall Study|Lost to Follow-up|23|||
131727424|NCT01585961|474281692|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
131727425|NCT00109733|474281693|FG000|Overall Study|Protocol Violation|0|||
131727426|NCT00109733|474281694|FG001|Overall Study|Protocol Violation|1|||
131727427|NCT00109733|474281693|FG000|Overall Study|Stopped taking study drug|1|||
131727428|NCT00109733|474281694|FG001|Overall Study|Stopped taking study drug|1|||
131727429|NCT00109733|474281693|FG000|Overall Study|Non-compliant|0|||
131727430|NCT00109733|474281694|FG001|Overall Study|Non-compliant|1|||
131727431|NCT00109733|474281693|FG000|Overall Study|Could not commit time for study|1|||
131727432|NCT00109733|474281694|FG001|Overall Study|Could not commit time for study|1|||
131727433|NCT06094296|474281699|FG000|Overall Study|Progressive Disease|1|||
131727434|NCT06094296|474281700|FG001|Overall Study|Progressive Disease|0|||
131727435|NCT06094296|474281701|FG002|Overall Study|Progressive Disease|0|||
131727436|NCT06094296|474281702|FG003|Overall Study|Progressive Disease|0|||
131727437|NCT03332667|474281703|FG000|Overall Study|Adverse Event|0|||
131727438|NCT03332667|474281704|FG001|Overall Study|Adverse Event|0|||
131727439|NCT03332667|474281705|FG002|Overall Study|Adverse Event|2|||
131727440|NCT03332667|474281706|FG003|Overall Study|Adverse Event|1|||
131727441|NCT03332667|474281703|FG000|Overall Study|Withdrawal by Subject|2|||
131727442|NCT03332667|474281704|FG001|Overall Study|Withdrawal by Subject|1|||
131727443|NCT03332667|474281705|FG002|Overall Study|Withdrawal by Subject|5|||
131727444|NCT03332667|474281706|FG003|Overall Study|Withdrawal by Subject|1|||
131727445|NCT03332667|474281703|FG000|Overall Study|Disease Progression or Relapse|2|||
131727446|NCT03332667|474281704|FG001|Overall Study|Disease Progression or Relapse|1|||
131727447|NCT03332667|474281705|FG002|Overall Study|Disease Progression or Relapse|3|||
131727448|NCT03332667|474281706|FG003|Overall Study|Disease Progression or Relapse|0|||
131727449|NCT03332667|474281703|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
131727450|NCT03332667|474281704|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
131727451|NCT03332667|474281705|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
131727452|NCT03332667|474281706|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
131727453|NCT03332667|474281703|FG000|Overall Study|No Treatment Received|0|||
131727454|NCT03332667|474281704|FG001|Overall Study|No Treatment Received|0|||
131727455|NCT03332667|474281705|FG002|Overall Study|No Treatment Received|1|||
131727456|NCT03332667|474281706|FG003|Overall Study|No Treatment Received|0|||
131727457|NCT04964063|474281707|FG000|Overall Study|Adverse Event|4|||
131727458|NCT04964063|474281707|FG000|Overall Study|Lost to Follow-up|47|||
131727459|NCT04964063|474281707|FG000|Overall Study|Withdrawal by Subject|5|||
131727460|NCT04964063|474281707|FG000|Overall Study|Baseline Tasks Expired|41|||
131727461|NCT04964063|474281707|FG000|Overall Study|Participant withdrawn in error|1|||
131806268|NCT00389064|474574471|FG001|Overall Study|Lost to Follow-up|2|||
131727462|NCT01035606|474281708|FG000|Overall Study|change in health, job demands,family|3|||
131727463|NCT01035606|474281709|FG001|Overall Study|change in health, job demands,family|3|||
131727464|NCT01035606|474281710|FG002|Overall Study|change in health, job demands,family|4|||
131727465|NCT01809262|474281711|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727466|NCT01809262|474281712|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727467|NCT01809262|474281713|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727468|NCT01809262|474281714|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
131806269|NCT00389064|474574470|FG000|Overall Study|Protocol Violation|2|||
131806270|NCT00389064|474574471|FG001|Overall Study|Protocol Violation|0|||
131806271|NCT00389064|474574470|FG000|Overall Study|Multiple Reasons|9|||
131806272|NCT00389064|474574471|FG001|Overall Study|Multiple Reasons|11|||
131806273|NCT04149964|474574472|FG000|Overall Study|Lost to Follow-up|19|||
131806274|NCT04149964|474574473|FG001|Overall Study|Lost to Follow-up|18|||
131806275|NCT04753437|474574474|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131806276|NCT04753437|474574475|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131806277|NCT04753437|474574474|FG000|Overall Study|Liver Function Test Abnormalities|2|||
131806278|NCT04753437|474574475|FG001|Overall Study|Liver Function Test Abnormalities|4|||
131806279|NCT01223365|474574476|FG000|Open-label Titration Period|Enrolled but not treated|1|||
131806280|NCT01223365|474574476|FG000|Open-label Titration Period|Adverse Event|23|||
131806281|NCT01223365|474574476|FG000|Open-label Titration Period|Lack of Efficacy|3|||
131806282|NCT01223365|474574476|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
131806283|NCT01223365|474574476|FG000|Open-label Titration Period|Protocol Violation|1|||
131806284|NCT01223365|474574476|FG000|Open-label Titration Period|Lost to Follow-up|2|||
131806285|NCT01223365|474574476|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
131806286|NCT01223365|474574476|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
131806287|NCT01223365|474574476|FG000|Open-label Titration Period|Starting physical therapy|1|||
131806288|NCT01223365|474574476|FG000|Open-label Treatment Period|Adverse Event|39|||
131806289|NCT01223365|474574476|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
131806290|NCT01223365|474574476|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
131806291|NCT01223365|474574476|FG000|Open-label Treatment Period|Protocol Violation|15|||
131806292|NCT01223365|474574476|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
131806293|NCT01223365|474574476|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
131806294|NCT01223365|474574476|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
131806295|NCT01223365|474574476|FG000|Open-label Treatment Period|Moved out of area|2|||
131806296|NCT01223365|474574476|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
131806297|NCT01223365|474574476|FG000|Open-label Treatment Period|"Out of window"|1|||
131806298|NCT01223365|474574476|FG000|Open-label Treatment Period|Starting physical therapy|1|||
131806299|NCT01223365|474574476|FG000|Open-label Treatment Period|Physician Decision|2|||
131806300|NCT03567174|474574477|FG000|Overall Study|Death|24|||
131806301|NCT03567174|474574478|FG001|Overall Study|Death|31|||
131806302|NCT03567174|474574477|FG000|Overall Study|Lost to Follow-up|165|||
131806303|NCT03567174|474574478|FG001|Overall Study|Lost to Follow-up|174|||
131806304|NCT03243630|474574479|FG000|Overall Study|Protocol Violation|1|||
131806305|NCT03243630|474574479|FG000|Overall Study|Physician Decision|1|||
131806306|NCT02140060|474574480|FG000|Overall Study|Adverse Event|0|||
131806307|NCT02140060|474574481|FG001|Overall Study|Adverse Event|0|||
131806308|NCT02140060|474574482|FG002|Overall Study|Adverse Event|0|||
131806309|NCT02140060|474574483|FG003|Overall Study|Adverse Event|1|||
131806310|NCT02140060|474574484|FG004|Overall Study|Adverse Event|1|||
131806311|NCT02140060|474574485|FG005|Overall Study|Adverse Event|1|||
131806312|NCT02140060|474574480|FG000|Overall Study|Lack of Efficacy|0|||
131806313|NCT02140060|474574481|FG001|Overall Study|Lack of Efficacy|0|||
131806314|NCT02140060|474574482|FG002|Overall Study|Lack of Efficacy|0|||
131806315|NCT02140060|474574483|FG003|Overall Study|Lack of Efficacy|1|||
131806316|NCT02140060|474574484|FG004|Overall Study|Lack of Efficacy|0|||
131806317|NCT02140060|474574485|FG005|Overall Study|Lack of Efficacy|0|||
131806318|NCT01387737|474576098|FG000|Overall Study|Adverse Event|20|||
131806319|NCT01387737|474576099|FG001|Overall Study|Adverse Event|30|||
131806320|NCT01387737|474576098|FG000|Overall Study|Lack of Efficacy|1|||
131806321|NCT01387737|474576099|FG001|Overall Study|Lack of Efficacy|0|||
131806322|NCT01387737|474576098|FG000|Overall Study|Physician Decision|3|||
131806323|NCT01387737|474576099|FG001|Overall Study|Physician Decision|10|||
131806324|NCT01387737|474576098|FG000|Overall Study|Withdrawal by Subject|27|||
131806325|NCT01387737|474576099|FG001|Overall Study|Withdrawal by Subject|31|||
131806326|NCT01387737|474576098|FG000|Overall Study|Clearly not eligible for the study|1|||
131806327|NCT01387737|474576099|FG001|Overall Study|Clearly not eligible for the study|3|||
131806328|NCT01215981|474576102|FG000|Overall Study|Physician Decision|0|||
131806329|NCT01215981|474576103|FG001|Overall Study|Physician Decision|1|||
131806330|NCT01215981|474576102|FG000|Overall Study|Protocol Violation|1|||
131806331|NCT01215981|474576103|FG001|Overall Study|Protocol Violation|0|||
131806332|NCT01215981|474576102|FG000|Overall Study|Withdrawal by Subject|1|||
131806333|NCT01215981|474576103|FG001|Overall Study|Withdrawal by Subject|0|||
131806334|NCT00840632|474576109|FG000|First Intervention|Withdrawal by Subject|0|||
131806335|NCT00840632|474576110|FG001|First Intervention|Withdrawal by Subject|1|||
131806336|NCT00840632|474576109|FG000|Washout|Withdrawal by Subject|1|||
131806337|NCT00840632|474576110|FG001|Washout|Withdrawal by Subject|1|||
131806338|NCT01294787|474576111|FG000|Period 1|Adverse Event|0|||
131806339|NCT01294787|474576112|FG001|Period 1|Adverse Event|0|||
131806340|NCT01294787|474576113|FG002|Period 1|Adverse Event|0|||
131806341|NCT01294787|474576114|FG003|Period 1|Adverse Event|0|||
131905048|NCT01764841|474939028|FG001|Overall Study|Lost to Follow-up|0|||
131806342|NCT01294787|474576115|FG004|Period 1|Adverse Event|1|||
131806343|NCT01294787|474576116|FG005|Period 1|Adverse Event|0|||
131806344|NCT01294787|474576111|FG000|Period 1|Withdrawal by Subject|0|||
131727469|NCT01809262|474281715|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
131727470|NCT01809262|474281716|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727471|NCT01809262|474281717|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727472|NCT01809262|474281718|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727473|NCT01809262|474281719|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727474|NCT01809262|474281720|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
131727475|NCT01809262|474281711|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727476|NCT01809262|474281712|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
131727477|NCT01809262|474281713|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727478|NCT01809262|474281714|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727479|NCT01809262|474281715|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727480|NCT01809262|474281716|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727481|NCT01809262|474281717|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727482|NCT01809262|474281718|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727483|NCT01809262|474281719|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727484|NCT01809262|474281720|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131727485|NCT01505491|474281721|FG000|Overall Study|Other reason not listed|1|||
131727486|NCT01505491|474281722|FG001|Overall Study|Other reason not listed|0|||
131727487|NCT01505491|474281723|FG002|Overall Study|Other reason not listed|0|||
131727488|NCT01505491|474281721|FG000|Overall Study|Withdrawal by Subject|1|||
131727489|NCT01505491|474281722|FG001|Overall Study|Withdrawal by Subject|1|||
131727490|NCT01505491|474281723|FG002|Overall Study|Withdrawal by Subject|4|||
131727491|NCT01505491|474281721|FG000|Overall Study|Lost to Follow-up|0|||
131727492|NCT01505491|474281722|FG001|Overall Study|Lost to Follow-up|0|||
131727493|NCT01505491|474281723|FG002|Overall Study|Lost to Follow-up|1|||
131727494|NCT00367640|474281732|FG000|Overall Study|Adverse Event|3|||
131727495|NCT00367640|474281733|FG001|Overall Study|Adverse Event|6|||
131727496|NCT00367640|474281734|FG002|Overall Study|Adverse Event|8|||
131727497|NCT00367640|474281735|FG003|Overall Study|Adverse Event|0|||
131727498|NCT00367640|474281732|FG000|Overall Study|Withdrawal by Subject|8|||
131727499|NCT00367640|474281733|FG001|Overall Study|Withdrawal by Subject|11|||
131727500|NCT00367640|474281734|FG002|Overall Study|Withdrawal by Subject|8|||
131727501|NCT00367640|474281735|FG003|Overall Study|Withdrawal by Subject|6|||
131727502|NCT00367640|474281732|FG000|Overall Study|Any other reason not above-mentioned|7|||
131727503|NCT00367640|474281733|FG001|Overall Study|Any other reason not above-mentioned|5|||
131727504|NCT00367640|474281734|FG002|Overall Study|Any other reason not above-mentioned|3|||
131727505|NCT00367640|474281735|FG003|Overall Study|Any other reason not above-mentioned|4|||
131727506|NCT00406315|474281739|FG000|Overall Study|Death|1|||
131727507|NCT00406315|474281739|FG000|Overall Study|Adverse Event|39|||
131727508|NCT00406315|474281739|FG000|Overall Study|Laboratory Abnormality|4|||
131727509|NCT00406315|474281739|FG000|Overall Study|Lack of Efficacy|13|||
131727510|NCT00406315|474281739|FG000|Overall Study|Other|33|||
131727511|NCT00406315|474281739|FG000|Overall Study|Lost to Follow-up|21|||
131727512|NCT00406315|474281739|FG000|Overall Study|Withdrawal by Subject|30|||
131727513|NCT01312428|474281740|FG000|Overall Study|Study Termination|3|||
131727514|NCT01312428|474281741|FG001|Overall Study|Study Termination|4|||
131727515|NCT00339183|474281743|FG000|Overall Study|Adverse Event|5|||
131727516|NCT00339183|474281744|FG001|Overall Study|Adverse Event|3|||
131727517|NCT00339183|474281743|FG000|Overall Study|Withdrawal by Subject|16|||
131727518|NCT00339183|474281744|FG001|Overall Study|Withdrawal by Subject|19|||
131727519|NCT00339183|474281743|FG000|Overall Study|Physician Decision|2|||
131727520|NCT00339183|474281744|FG001|Overall Study|Physician Decision|4|||
131727521|NCT00339183|474281743|FG000|Overall Study|Lost to Follow-up|17|||
131727522|NCT00339183|474281744|FG001|Overall Study|Lost to Follow-up|17|||
131727523|NCT00339183|474281743|FG000|Overall Study|Protocol-specified criteria|12|||
131727524|NCT00339183|474281744|FG001|Overall Study|Protocol-specified criteria|8|||
131727525|NCT00339183|474281743|FG000|Overall Study|Missing reason|3|||
131727526|NCT00339183|474281744|FG001|Overall Study|Missing reason|1|||
131727527|NCT00339183|474281743|FG000|Overall Study|Other|46|||
131727528|NCT00339183|474281744|FG001|Overall Study|Other|40|||
131727529|NCT00339183|474281743|FG000|Overall Study|Ongoing|20|||
131727530|NCT00339183|474281744|FG001|Overall Study|Ongoing|13|||
131727531|NCT00446446|474281745|FG000|Overall Study|Death|10|||
131727532|NCT00446446|474281745|FG000|Overall Study|Withdrawal by Subject|6|||
131727533|NCT00446446|474281745|FG000|Overall Study|Other|4|||
131727534|NCT00446446|474281745|FG000|Overall Study|Disease Progession|2|||
131727535|NCT00446446|474281745|FG000|Overall Study|Adverse Event|1|||
131806345|NCT01294787|474576112|FG001|Period 1|Withdrawal by Subject|0|||
131806346|NCT01294787|474576113|FG002|Period 1|Withdrawal by Subject|0|||
131727536|NCT00446446|474281745|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
131727537|NCT01455428|474281746|FG000|Overall Study|Protocol Violation|2|||
131727538|NCT01455428|474281747|FG001|Overall Study|Protocol Violation|1|||
131727539|NCT01455428|474281746|FG000|Overall Study|Adverse Event|6|||
131727540|NCT01455428|474281747|FG001|Overall Study|Adverse Event|2|||
131727541|NCT01455428|474281746|FG000|Overall Study|Lost to Follow-up|1|||
131806347|NCT01294787|474576114|FG003|Period 1|Withdrawal by Subject|1|||
131806348|NCT01294787|474576115|FG004|Period 1|Withdrawal by Subject|1|||
131806349|NCT01294787|474576116|FG005|Period 1|Withdrawal by Subject|1|||
131806350|NCT01294787|474576111|FG000|Period 1|Administrative problem|0|||
131806351|NCT01294787|474576112|FG001|Period 1|Administrative problem|0|||
131806352|NCT01294787|474576113|FG002|Period 1|Administrative problem|1|||
131806353|NCT01294787|474576114|FG003|Period 1|Administrative problem|0|||
131806354|NCT01294787|474576115|FG004|Period 1|Administrative problem|0|||
131806355|NCT01294787|474576116|FG005|Period 1|Administrative problem|1|||
131806356|NCT01294787|474576111|FG000|Period 2|Adverse Event|0|||
131806357|NCT01294787|474576112|FG001|Period 2|Adverse Event|3|||
131806358|NCT01294787|474576113|FG002|Period 2|Adverse Event|0|||
131806359|NCT01294787|474576114|FG003|Period 2|Adverse Event|1|||
131806360|NCT01294787|474576115|FG004|Period 2|Adverse Event|0|||
131806361|NCT01294787|474576116|FG005|Period 2|Adverse Event|0|||
131806362|NCT01294787|474576111|FG000|Period 2|No longer needs study drug|0|||
131806363|NCT01294787|474576112|FG001|Period 2|No longer needs study drug|0|||
131806364|NCT01294787|474576113|FG002|Period 2|No longer needs study drug|0|||
131806365|NCT01294787|474576114|FG003|Period 2|No longer needs study drug|1|||
131806366|NCT01294787|474576115|FG004|Period 2|No longer needs study drug|0|||
131806367|NCT01294787|474576116|FG005|Period 2|No longer needs study drug|0|||
131806368|NCT01294787|474576111|FG000|Period 3|Adverse Event|0|||
131806369|NCT01294787|474576112|FG001|Period 3|Adverse Event|0|||
131806370|NCT01294787|474576113|FG002|Period 3|Adverse Event|0|||
131806371|NCT01294787|474576114|FG003|Period 3|Adverse Event|0|||
131806372|NCT01294787|474576115|FG004|Period 3|Adverse Event|1|||
131806373|NCT01294787|474576116|FG005|Period 3|Adverse Event|0|||
131806374|NCT01725529|474576119|FG000|Overall Study|Adverse Event|1|||
131727542|NCT01455428|474281747|FG001|Overall Study|Lost to Follow-up|1|||
131727543|NCT01455428|474281746|FG000|Overall Study|Withdrawal by Subject|2|||
131727544|NCT01455428|474281747|FG001|Overall Study|Withdrawal by Subject|5|||
131727545|NCT01455428|474281746|FG000|Overall Study|Did not meet entrance criteria|0|||
131727546|NCT01455428|474281747|FG001|Overall Study|Did not meet entrance criteria|2|||
131727547|NCT01455428|474281746|FG000|Overall Study|Insufficient clinical response|0|||
131727548|NCT01455428|474281747|FG001|Overall Study|Insufficient clinical response|2|||
131727549|NCT01455428|474281746|FG000|Overall Study|Did not receive treatment|1|||
131727550|NCT01455428|474281747|FG001|Overall Study|Did not receive treatment|1|||
131727551|NCT01455428|474281746|FG000|Overall Study|Other|2|||
131727552|NCT01455428|474281747|FG001|Overall Study|Other|4|||
131727553|NCT03303339|474281748|FG000|Overall Study|Death|2|||
131727554|NCT03303339|474281749|FG001|Overall Study|Death|2|||
131727555|NCT03303339|474281750|FG002|Overall Study|Death|2|||
131727556|NCT03303339|474281751|FG003|Overall Study|Death|1|||
131727557|NCT03303339|474281752|FG004|Overall Study|Death|4|||
131727558|NCT03303339|474281753|FG005|Overall Study|Death|2|||
131727559|NCT03303339|474281754|FG006|Overall Study|Death|2|||
131727560|NCT03303339|474281755|FG007|Overall Study|Death|2|||
131727561|NCT03303339|474281756|FG008|Overall Study|Death|3|||
131727562|NCT03303339|474281757|FG009|Overall Study|Death|3|||
131727563|NCT03303339|474281758|FG010|Overall Study|Death|4|||
131727564|NCT03303339|474281759|FG011|Overall Study|Death|24|||
131727565|NCT03303339|474281748|FG000|Overall Study|Study Terminated by Sponsor|0|||
131806375|NCT01725529|474576120|FG001|Overall Study|Adverse Event|0|||
131806376|NCT01725529|474576121|FG002|Overall Study|Adverse Event|0|||
131806377|NCT01725529|474576119|FG000|Overall Study|Lost to Follow-up|2|||
131806378|NCT01725529|474576120|FG001|Overall Study|Lost to Follow-up|1|||
131806379|NCT01725529|474576121|FG002|Overall Study|Lost to Follow-up|1|||
131806380|NCT01725529|474576119|FG000|Overall Study|Protocol Violation|0|||
131806381|NCT01725529|474576120|FG001|Overall Study|Protocol Violation|1|||
131806382|NCT01725529|474576121|FG002|Overall Study|Protocol Violation|1|||
131806383|NCT01725529|474576119|FG000|Overall Study|Withdrawal by Subject|12|||
131727566|NCT03303339|474281749|FG001|Overall Study|Study Terminated by Sponsor|0|||
131727567|NCT03303339|474281750|FG002|Overall Study|Study Terminated by Sponsor|0|||
131727568|NCT03303339|474281751|FG003|Overall Study|Study Terminated by Sponsor|0|||
131727569|NCT03303339|474281752|FG004|Overall Study|Study Terminated by Sponsor|0|||
131806384|NCT01725529|474576120|FG001|Overall Study|Withdrawal by Subject|14|||
131806385|NCT01725529|474576121|FG002|Overall Study|Withdrawal by Subject|8|||
131806386|NCT01948258|474576123|FG000|Overall Study|Pregnancy|41|||
131806387|NCT01948258|474576123|FG000|Overall Study|Did not complete by cut-off date|35|||
131806388|NCT01948258|474576123|FG000|Overall Study|Lost to Follow-up|27|||
131806389|NCT01948258|474576123|FG000|Overall Study|Withdrawal by SPD|8|||
131806390|NCT01948258|474576123|FG000|Overall Study|Withdrawal by Subject|6|||
131727570|NCT03303339|474281753|FG005|Overall Study|Study Terminated by Sponsor|0|||
131727571|NCT03303339|474281754|FG006|Overall Study|Study Terminated by Sponsor|0|||
131727572|NCT03303339|474281755|FG007|Overall Study|Study Terminated by Sponsor|0|||
131727573|NCT03303339|474281756|FG008|Overall Study|Study Terminated by Sponsor|1|||
131727574|NCT03303339|474281757|FG009|Overall Study|Study Terminated by Sponsor|0|||
131727575|NCT03303339|474281758|FG010|Overall Study|Study Terminated by Sponsor|1|||
131727576|NCT03303339|474281759|FG011|Overall Study|Study Terminated by Sponsor|1|||
131806391|NCT01948258|474576123|FG000|Overall Study|Health Care Professional|43|||
131806392|NCT01948258|474576123|FG000|Overall Study|Removed from statistical analysis|2|||
131806393|NCT00723528|474576127|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
131806394|NCT00723528|474576128|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
131806395|NCT00723528|474576129|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
131806396|NCT00723528|474576130|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
131806397|NCT00723528|474576131|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
131806398|NCT00723528|474576132|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
131806399|NCT00723528|474576133|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
131806400|NCT00723528|474576127|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
131806401|NCT00723528|474576128|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131806402|NCT00723528|474576129|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131806403|NCT00723528|474576130|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131806404|NCT00723528|474576131|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131806405|NCT00723528|474576132|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131806406|NCT00723528|474576133|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131806407|NCT00723528|474576127|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
131806408|NCT00723528|474576128|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
131806409|NCT00723528|474576129|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
131806410|NCT00723528|474576130|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
131806411|NCT00723528|474576131|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
131806412|NCT00723528|474576132|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
131806413|NCT00723528|474576133|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
131806414|NCT00723528|474576127|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
131806415|NCT00723528|474576128|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
131727577|NCT03303339|474281748|FG000|Overall Study|Withdrawal by Subject|1|||
131727578|NCT03303339|474281749|FG001|Overall Study|Withdrawal by Subject|0|||
131727579|NCT03303339|474281750|FG002|Overall Study|Withdrawal by Subject|0|||
131727580|NCT03303339|474281751|FG003|Overall Study|Withdrawal by Subject|0|||
131727581|NCT03303339|474281752|FG004|Overall Study|Withdrawal by Subject|0|||
131727582|NCT03303339|474281753|FG005|Overall Study|Withdrawal by Subject|1|||
131727583|NCT03303339|474281754|FG006|Overall Study|Withdrawal by Subject|1|||
131727584|NCT03303339|474281755|FG007|Overall Study|Withdrawal by Subject|0|||
131727585|NCT03303339|474281756|FG008|Overall Study|Withdrawal by Subject|0|||
131727586|NCT03303339|474281757|FG009|Overall Study|Withdrawal by Subject|0|||
131727587|NCT03303339|474281758|FG010|Overall Study|Withdrawal by Subject|0|||
131727588|NCT03303339|474281759|FG011|Overall Study|Withdrawal by Subject|2|||
131727589|NCT03303339|474281748|FG000|Overall Study|Physician Decision|0|||
131727590|NCT03303339|474281749|FG001|Overall Study|Physician Decision|0|||
131727591|NCT03303339|474281750|FG002|Overall Study|Physician Decision|0|||
131727592|NCT03303339|474281751|FG003|Overall Study|Physician Decision|0|||
131727593|NCT03303339|474281752|FG004|Overall Study|Physician Decision|1|||
131727594|NCT03303339|474281753|FG005|Overall Study|Physician Decision|0|||
131727595|NCT03303339|474281754|FG006|Overall Study|Physician Decision|0|||
131727596|NCT03303339|474281755|FG007|Overall Study|Physician Decision|0|||
131727597|NCT03303339|474281756|FG008|Overall Study|Physician Decision|0|||
131727598|NCT03303339|474281757|FG009|Overall Study|Physician Decision|0|||
131727599|NCT03303339|474281758|FG010|Overall Study|Physician Decision|0|||
131806416|NCT00723528|474576129|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
131806417|NCT00723528|474576130|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
131806418|NCT00723528|474576131|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
131806419|NCT00723528|474576132|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
131806420|NCT00723528|474576133|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
131806421|NCT00723528|474576127|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
131806422|NCT00723528|474576128|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131806423|NCT00723528|474576129|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
131806424|NCT00723528|474576130|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131806425|NCT00723528|474576131|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131727600|NCT03303339|474281759|FG011|Overall Study|Physician Decision|0|||
131727601|NCT03303339|474281748|FG000|Overall Study|Safety/Non-compliance|0|||
131727602|NCT03303339|474281749|FG001|Overall Study|Safety/Non-compliance|0|||
131727603|NCT03303339|474281750|FG002|Overall Study|Safety/Non-compliance|0|||
131727604|NCT03303339|474281751|FG003|Overall Study|Safety/Non-compliance|0|||
131727605|NCT03303339|474281752|FG004|Overall Study|Safety/Non-compliance|0|||
131727606|NCT03303339|474281753|FG005|Overall Study|Safety/Non-compliance|0|||
131727607|NCT03303339|474281754|FG006|Overall Study|Safety/Non-compliance|0|||
131727608|NCT03303339|474281755|FG007|Overall Study|Safety/Non-compliance|0|||
131727609|NCT03303339|474281756|FG008|Overall Study|Safety/Non-compliance|0|||
131727610|NCT03303339|474281757|FG009|Overall Study|Safety/Non-compliance|0|||
131727611|NCT03303339|474281758|FG010|Overall Study|Safety/Non-compliance|0|||
131727612|NCT03303339|474281759|FG011|Overall Study|Safety/Non-compliance|1|||
131727613|NCT00231062|474281760|FG000|Overall Study|Physician Decision|6|||
131727614|NCT01052012|474281761|FG000|Overall Study|Not treated|2|||
131727615|NCT01052012|474281762|FG001|Overall Study|Not treated|5|||
131727616|NCT01052012|474281763|FG002|Overall Study|Not treated|0|||
131727617|NCT01052012|474281764|FG003|Overall Study|Not treated|0|||
131727618|NCT01052012|474281765|FG004|Overall Study|Not treated|11|||
131727619|NCT01052012|474281766|FG005|Overall Study|Not treated|8|||
131727620|NCT01052012|474281761|FG000|Overall Study|Adverse Event|1|||
131727621|NCT01052012|474281762|FG001|Overall Study|Adverse Event|0|||
131727622|NCT01052012|474281763|FG002|Overall Study|Adverse Event|0|||
131727623|NCT01052012|474281764|FG003|Overall Study|Adverse Event|1|||
131727624|NCT01052012|474281765|FG004|Overall Study|Adverse Event|0|||
131727625|NCT01052012|474281766|FG005|Overall Study|Adverse Event|0|||
131727626|NCT01052012|474281761|FG000|Overall Study|Lost to Follow-up|0|||
131727627|NCT01052012|474281762|FG001|Overall Study|Lost to Follow-up|0|||
131727628|NCT01052012|474281763|FG002|Overall Study|Lost to Follow-up|0|||
131727629|NCT01052012|474281764|FG003|Overall Study|Lost to Follow-up|0|||
131727630|NCT01052012|474281765|FG004|Overall Study|Lost to Follow-up|1|||
131727631|NCT01052012|474281766|FG005|Overall Study|Lost to Follow-up|0|||
131727632|NCT01052012|474281761|FG000|Overall Study|Withdrawal by Subject|1|||
131727633|NCT01052012|474281762|FG001|Overall Study|Withdrawal by Subject|1|||
131806426|NCT00723528|474576132|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131806427|NCT00723528|474576133|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131806428|NCT00723528|474576127|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
131806429|NCT00723528|474576128|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
131806430|NCT00723528|474576129|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
131727634|NCT01052012|474281763|FG002|Overall Study|Withdrawal by Subject|0|||
131727635|NCT01052012|474281764|FG003|Overall Study|Withdrawal by Subject|0|||
131727636|NCT01052012|474281765|FG004|Overall Study|Withdrawal by Subject|3|||
131727637|NCT01052012|474281766|FG005|Overall Study|Withdrawal by Subject|1|||
131727638|NCT01052012|474281761|FG000|Overall Study|Physician Decision|0|||
131727639|NCT01052012|474281762|FG001|Overall Study|Physician Decision|0|||
131727640|NCT01052012|474281763|FG002|Overall Study|Physician Decision|0|||
131727641|NCT01052012|474281764|FG003|Overall Study|Physician Decision|0|||
131727642|NCT01052012|474281765|FG004|Overall Study|Physician Decision|0|||
131727643|NCT01052012|474281766|FG005|Overall Study|Physician Decision|1|||
131727644|NCT01052012|474281761|FG000|Overall Study|Other|0|||
131727645|NCT01052012|474281762|FG001|Overall Study|Other|0|||
131727646|NCT01052012|474281763|FG002|Overall Study|Other|0|||
131727647|NCT01052012|474281764|FG003|Overall Study|Other|0|||
131727648|NCT01052012|474281765|FG004|Overall Study|Other|1|||
131727649|NCT01052012|474281766|FG005|Overall Study|Other|0|||
131727650|NCT01651260|474281767|FG000|Overall Study|unable to apply product|3|||
131727651|NCT02239094|474281770|FG000|Overall Study|Withdrawal by Subject|1|||
131727652|NCT02239094|474281770|FG000|Overall Study|Remitted before started|1|||
131727653|NCT01597193|474281771|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
131727654|NCT01597193|474281772|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
131727655|NCT01597193|474281773|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131727656|NCT01597193|474281774|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131727657|NCT01597193|474281775|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131727658|NCT01597193|474281776|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131727659|NCT01597193|474281777|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131727660|NCT01597193|474281771|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131727661|NCT01597193|474281772|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131806431|NCT00723528|474576130|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
131806432|NCT00723528|474576131|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
131806433|NCT00723528|474576132|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
131806434|NCT00723528|474576133|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
131727662|NCT01597193|474281773|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131727663|NCT01597193|474281774|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
131727664|NCT01597193|474281775|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
131727665|NCT01597193|474281776|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
131905049|NCT01764841|474939029|FG002|Overall Study|Lost to Follow-up|1|||
131727666|NCT01597193|474281777|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131727667|NCT01597193|474281771|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
131727668|NCT01597193|474281772|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
131727669|NCT01597193|474281773|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
131727670|NCT01597193|474281774|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
131727671|NCT01597193|474281775|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
131727672|NCT01597193|474281776|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
131727673|NCT01597193|474281777|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
131727674|NCT01597193|474281771|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131727675|NCT01597193|474281772|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131727676|NCT01597193|474281773|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131727677|NCT01597193|474281774|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131727678|NCT01597193|474281775|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131727679|NCT01597193|474281776|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
131727680|NCT01597193|474281777|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131727681|NCT01597193|474281771|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131727682|NCT01597193|474281772|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131727683|NCT01597193|474281773|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131727684|NCT01597193|474281774|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
131727685|NCT01597193|474281775|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131727686|NCT01597193|474281776|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
131727687|NCT01597193|474281777|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131727688|NCT00053846|474281778|FG000|Overall Study|Changed mind|8|||
131727689|NCT00053846|474281779|FG001|Overall Study|Changed mind|13|||
131727690|NCT00053846|474281778|FG000|Overall Study|Became too ill|8|||
131727691|NCT00053846|474281779|FG001|Overall Study|Became too ill|7|||
131727692|NCT00053846|474281778|FG000|Overall Study|Expired|5|||
131727693|NCT00053846|474281779|FG001|Overall Study|Expired|0|||
131727694|NCT00053846|474281778|FG000|Overall Study|Became ineligible|3|||
131727695|NCT00053846|474281779|FG001|Overall Study|Became ineligible|1|||
131727696|NCT00053846|474281778|FG000|Overall Study|Did not return data|1|||
131727697|NCT00053846|474281779|FG001|Overall Study|Did not return data|2|||
131727698|NCT00053846|474281778|FG000|Overall Study|Quit due to side effects|1|||
131727699|NCT00053846|474281779|FG001|Overall Study|Quit due to side effects|3|||
131727700|NCT00053846|474281778|FG000|Overall Study|Pills too large|0|||
131727701|NCT00053846|474281779|FG001|Overall Study|Pills too large|1|||
131727702|NCT03880227|474281784|FG000|First Visit|Withdrawal by Subject|1|||
131727703|NCT03880227|474281785|FG001|First Visit|Withdrawal by Subject|0|||
131727704|NCT03880227|474281786|FG002|First Visit|Withdrawal by Subject|0|||
131727705|NCT03880227|474281787|FG003|First Visit|Withdrawal by Subject|0|||
131727706|NCT03880227|474281784|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
131727707|NCT03880227|474281785|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
131727708|NCT03880227|474281786|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
131727709|NCT03880227|474281787|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
131727710|NCT03880227|474281784|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
131727711|NCT03880227|474281785|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
131727712|NCT03880227|474281786|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
131727713|NCT03880227|474281787|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
131727714|NCT03880227|474281784|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
131727715|NCT03880227|474281785|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
131727716|NCT03880227|474281786|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
131727717|NCT03880227|474281787|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
131727718|NCT02229864|474281788|FG000|Overall Study|Death|2|||
131727719|NCT02229864|474281788|FG000|Overall Study|Lost to Follow-up|1|||
131727720|NCT01929044|474281792|FG000|Overall Study|Adverse Event|1|||
131727721|NCT01929044|474281793|FG001|Overall Study|Adverse Event|0|||
131727722|NCT01929044|474281792|FG000|Overall Study|Protocol Violation|9|||
131727723|NCT01929044|474281793|FG001|Overall Study|Protocol Violation|14|||
131727724|NCT01929044|474281792|FG000|Overall Study|Not Treated|1|||
131727725|NCT01929044|474281793|FG001|Overall Study|Not Treated|3|||
131727726|NCT01070784|474281794|FG000|Overall Study|Withdrawal by Subject|6|||
131727727|NCT01070784|474281795|FG001|Overall Study|Withdrawal by Subject|9|||
131727728|NCT01070784|474281794|FG000|Overall Study|Adverse Event|14|||
131727729|NCT01070784|474281795|FG001|Overall Study|Adverse Event|9|||
131727730|NCT01000064|474281797|FG000|Overall Study|Withdrawal by Subject|1|||
131727731|NCT01000064|474281798|FG001|Overall Study|Withdrawal by Subject|1|||
131727732|NCT02518620|474281799|FG000|Overall Study|Adverse Event|23|||
131727733|NCT02518620|474281800|FG001|Overall Study|Adverse Event|11|||
131727734|NCT02518620|474281799|FG000|Overall Study|Lack of Efficacy|2|||
131727735|NCT02518620|474281800|FG001|Overall Study|Lack of Efficacy|0|||
131727736|NCT02518620|474281799|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131727737|NCT02518620|474281800|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131727738|NCT02518620|474281799|FG000|Overall Study|Physician Decision|1|||
131727739|NCT02518620|474281800|FG001|Overall Study|Physician Decision|1|||
131727740|NCT02518620|474281799|FG000|Overall Study|Sponsor's Decision|0|||
131727741|NCT02518620|474281800|FG001|Overall Study|Sponsor's Decision|3|||
131727742|NCT02518620|474281799|FG000|Overall Study|Lost to Follow-up|1|||
131727743|NCT02518620|474281800|FG001|Overall Study|Lost to Follow-up|1|||
131727744|NCT02518620|474281799|FG000|Overall Study|Withdrawal by Subject|17|||
131727745|NCT02518620|474281800|FG001|Overall Study|Withdrawal by Subject|9|||
131727746|NCT02518620|474281799|FG000|Overall Study|Death|1|||
131727747|NCT02518620|474281800|FG001|Overall Study|Death|0|||
131727748|NCT02518620|474281799|FG000|Overall Study|Pregnancy Wish|3|||
131727749|NCT02518620|474281800|FG001|Overall Study|Pregnancy Wish|0|||
131727750|NCT02518620|474281799|FG000|Overall Study|Pregnancy|1|||
131727751|NCT02518620|474281800|FG001|Overall Study|Pregnancy|0|||
131727752|NCT02518620|474281799|FG000|Overall Study|Relocation|2|||
131727753|NCT02518620|474281800|FG001|Overall Study|Relocation|1|||
131727754|NCT00085540|474281803|FG000|Overall Study|Withdrawal by Subject|0|||
131727755|NCT00085540|474281804|FG001|Overall Study|Withdrawal by Subject|1|||
131727756|NCT00085540|474281803|FG000|Overall Study|Protocol Violation|0|||
131727757|NCT00085540|474281804|FG001|Overall Study|Protocol Violation|1|||
131727758|NCT01518192|474281805|FG000|Overall Study|Lost to Follow-up|29|||
131727759|NCT01518192|474281806|FG001|Overall Study|Lost to Follow-up|26|||
131727760|NCT01518192|474281807|FG002|Overall Study|Lost to Follow-up|35|||
131727761|NCT01605396|474281808|FG000|Overall Study|Adverse Event|5|||
131727762|NCT01605396|474281809|FG001|Overall Study|Adverse Event|3|||
131727763|NCT01605396|474281808|FG000|Overall Study|Lost to Follow-up|1|||
131727764|NCT01605396|474281809|FG001|Overall Study|Lost to Follow-up|0|||
131727765|NCT01605396|474281808|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131727766|NCT01605396|474281809|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131727767|NCT01605396|474281808|FG000|Overall Study|Physician Decision|2|||
131727768|NCT01605396|474281809|FG001|Overall Study|Physician Decision|2|||
131727769|NCT01605396|474281808|FG000|Overall Study|Progressive Disease|23|||
131727770|NCT01605396|474281809|FG001|Overall Study|Progressive Disease|27|||
131727771|NCT01605396|474281808|FG000|Overall Study|Withdrawal by Subject|4|||
131727772|NCT01605396|474281809|FG001|Overall Study|Withdrawal by Subject|2|||
131727773|NCT01605396|474281808|FG000|Overall Study|Transfer Off Study|4|||
131727774|NCT01605396|474281809|FG001|Overall Study|Transfer Off Study|5|||
131727775|NCT03090737|474281812|FG000|Overall Study|Other reasons|1|||
131727776|NCT03090737|474281812|FG000|Overall Study|Completed treatment as per protocol|17|||
131727777|NCT03090737|474281812|FG000|Overall Study|Maximum clinical benefit|2|||
131727778|NCT03090737|474281812|FG000|Overall Study|Adverse event unrelated to study drug|7|||
131727779|NCT03090737|474281812|FG000|Overall Study|Study drug toxicity|4|||
131727780|NCT03090737|474281812|FG000|Overall Study|Disease progression|98|||
131727781|NCT03141307|474281813|FG000|In-Hospital|Withdrawal by Subject|0|||
131727782|NCT03141307|474281814|FG001|In-Hospital|Withdrawal by Subject|2|||
131727783|NCT03141307|474281813|FG000|In-Hospital|Protocol Violation|4|||
131727784|NCT03141307|474281814|FG001|In-Hospital|Protocol Violation|0|||
131727785|NCT03141307|474281813|FG000|Follow-Up|Lost to Follow-up|97|||
131727786|NCT03141307|474281814|FG001|Follow-Up|Lost to Follow-up|54|||
131727787|NCT01770353|474281817|FG000|Overall Study|Progressive disease|2|||
131727788|NCT01770353|474281818|FG001|Overall Study|Progressive disease|1|||
131727789|NCT01770353|474281817|FG000|Overall Study|Adverse Event|0|||
131727790|NCT01770353|474281818|FG001|Overall Study|Adverse Event|1|||
131727791|NCT01770353|474281817|FG000|Overall Study|Protocol Violation|1|||
131727792|NCT01770353|474281818|FG001|Overall Study|Protocol Violation|0|||
131727793|NCT01770353|474281817|FG000|Overall Study|Physician Decision|0|||
131727794|NCT01770353|474281818|FG001|Overall Study|Physician Decision|3|||
131727795|NCT01770353|474281817|FG000|Overall Study|Clinical deterioration|3|||
131727796|NCT01770353|474281818|FG001|Overall Study|Clinical deterioration|6|||
131727797|NCT01770353|474281817|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
131727798|NCT01770353|474281818|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
131727799|NCT02574312|474281819|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
131727800|NCT02574312|474281820|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
131727801|NCT01254604|474283428|FG000|Overall Study|Lost to Follow-up|1|||
131727802|NCT01254604|474283429|FG001|Overall Study|Lost to Follow-up|1|||
131727803|NCT01254604|474283428|FG000|Overall Study|Protocol Violation|2|||
131727804|NCT01254604|474283429|FG001|Overall Study|Protocol Violation|2|||
131727805|NCT01254604|474283428|FG000|Overall Study|Withdrawal by Subject|2|||
131727806|NCT01254604|474283429|FG001|Overall Study|Withdrawal by Subject|4|||
131727807|NCT01254604|474283428|FG000|Overall Study|Adverse Event|3|||
131727808|NCT01254604|474283429|FG001|Overall Study|Adverse Event|2|||
131727809|NCT03074162|474283430|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131727810|NCT03074162|474283431|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131727811|NCT03074162|474283432|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
131727812|NCT03074162|474283433|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131727813|NCT03074162|474283434|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131727814|NCT03074162|474283435|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131727815|NCT03074162|474283430|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131727816|NCT03074162|474283431|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131727817|NCT03074162|474283432|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
131727818|NCT03074162|474283433|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131727819|NCT03074162|474283434|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131727820|NCT03074162|474283435|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
131727821|NCT03074162|474283430|FG000|Period 3|Withdrawal by Subject|1|||
131727822|NCT03074162|474283431|FG001|Period 3|Withdrawal by Subject|0|||
131727823|NCT03074162|474283432|FG002|Period 3|Withdrawal by Subject|0|||
131727824|NCT03074162|474283433|FG003|Period 3|Withdrawal by Subject|0|||
131727825|NCT03074162|474283434|FG004|Period 3|Withdrawal by Subject|1|||
131727826|NCT03074162|474283435|FG005|Period 3|Withdrawal by Subject|0|||
131727827|NCT02948777|474283436|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
131727828|NCT05070429|474283437|FG000|Overall Study|Death|0|||
131727829|NCT05070429|474283438|FG001|Overall Study|Death|4|||
131727830|NCT05070429|474283437|FG000|Overall Study|Withdrawal by Subject|2|||
131727831|NCT05070429|474283438|FG001|Overall Study|Withdrawal by Subject|1|||
131727832|NCT05070429|474283437|FG000|Overall Study|Other|15|||
131727833|NCT05070429|474283438|FG001|Overall Study|Other|5|||
131727834|NCT03703375|474283439|FG000|Randomization Period|Withdrawal by Subject|0|||
131727835|NCT03703375|474283440|FG001|Randomization Period|Withdrawal by Subject|0|||
131727836|NCT03703375|474283441|FG002|Randomization Period|Withdrawal by Subject|0|||
131727837|NCT03703375|474283442|FG003|Randomization Period|Withdrawal by Subject|1|||
131727838|NCT03703375|474283439|FG000|Randomization Period|Completed safety run-in treatment|7|||
131727839|NCT03703375|474283440|FG001|Randomization Period|Completed safety run-in treatment|0|||
131727840|NCT03703375|474283441|FG002|Randomization Period|Completed safety run-in treatment|0|||
131727841|NCT03703375|474283442|FG003|Randomization Period|Completed safety run-in treatment|0|||
131727842|NCT03703375|474283439|FG000|Treatment Period|Other Reasons|0|||
131727843|NCT03703375|474283440|FG001|Treatment Period|Other Reasons|1|||
131727844|NCT03703375|474283441|FG002|Treatment Period|Other Reasons|0|||
131727845|NCT03703375|474283442|FG003|Treatment Period|Other Reasons|3|||
131727846|NCT03703375|474283439|FG000|Treatment Period|Consent Withdrawal|0|||
131727847|NCT03703375|474283440|FG001|Treatment Period|Consent Withdrawal|0|||
131727848|NCT03703375|474283441|FG002|Treatment Period|Consent Withdrawal|0|||
131727849|NCT03703375|474283442|FG003|Treatment Period|Consent Withdrawal|1|||
131727850|NCT03703375|474283439|FG000|Treatment Period|Death|1|||
131727851|NCT03703375|474283440|FG001|Treatment Period|Death|0|||
131727852|NCT03703375|474283441|FG002|Treatment Period|Death|1|||
131727853|NCT03703375|474283442|FG003|Treatment Period|Death|2|||
131727854|NCT03703375|474283439|FG000|Treatment Period|Toxicity of Study Treatment|2|||
131727855|NCT03703375|474283440|FG001|Treatment Period|Toxicity of Study Treatment|0|||
131727856|NCT03703375|474283441|FG002|Treatment Period|Toxicity of Study Treatment|4|||
131727857|NCT03703375|474283442|FG003|Treatment Period|Toxicity of Study Treatment|1|||
131727858|NCT03703375|474283439|FG000|Treatment Period|Progression|32|||
131727859|NCT03703375|474283440|FG001|Treatment Period|Progression|1|||
131727860|NCT03703375|474283441|FG002|Treatment Period|Progression|7|||
131727861|NCT03703375|474283442|FG003|Treatment Period|Progression|11|||
131727862|NCT03703375|474283439|FG000|Treatment Period|Completed treatment|7|||
131727863|NCT03703375|474283440|FG001|Treatment Period|Completed treatment|2|||
131727864|NCT03703375|474283441|FG002|Treatment Period|Completed treatment|0|||
131727865|NCT03703375|474283442|FG003|Treatment Period|Completed treatment|0|||
131727866|NCT00623467|474283443|FG000|Overall Study|Lost to Follow-up|1|||
131727867|NCT00623467|474283443|FG000|Overall Study|Protocol Violation|4|||
131727868|NCT00623467|474283443|FG000|Overall Study|Withdrawal by Subject|2|||
131905050|NCT01764841|474939030|FG003|Overall Study|Lost to Follow-up|0|||
131727869|NCT02834403|474283444|FG000|Overall Study|Physician Decision|2|||
131727870|NCT02834403|474283445|FG001|Overall Study|Physician Decision|1|||
131727871|NCT02834403|474283446|FG002|Overall Study|Physician Decision|2|||
131727872|NCT02834403|474283447|FG003|Overall Study|Physician Decision|1|||
131727873|NCT02834403|474283448|FG004|Overall Study|Physician Decision|1|||
131727874|NCT02834403|474283449|FG005|Overall Study|Physician Decision|2|||
131727875|NCT02834403|474283450|FG006|Overall Study|Physician Decision|12|||
131727876|NCT02834403|474283444|FG000|Overall Study|Adverse Event|0|||
131727877|NCT02834403|474283445|FG001|Overall Study|Adverse Event|0|||
131727878|NCT02834403|474283446|FG002|Overall Study|Adverse Event|0|||
131727879|NCT02834403|474283447|FG003|Overall Study|Adverse Event|0|||
131727880|NCT02834403|474283448|FG004|Overall Study|Adverse Event|1|||
131727881|NCT02834403|474283449|FG005|Overall Study|Adverse Event|1|||
131727882|NCT02834403|474283450|FG006|Overall Study|Adverse Event|3|||
131727883|NCT02834403|474283444|FG000|Overall Study|Withdrawal by Subject|0|||
131727884|NCT02834403|474283445|FG001|Overall Study|Withdrawal by Subject|1|||
131727885|NCT02834403|474283446|FG002|Overall Study|Withdrawal by Subject|0|||
131727886|NCT02834403|474283447|FG003|Overall Study|Withdrawal by Subject|0|||
131727887|NCT02834403|474283448|FG004|Overall Study|Withdrawal by Subject|1|||
131727888|NCT02834403|474283449|FG005|Overall Study|Withdrawal by Subject|0|||
131727889|NCT02834403|474283450|FG006|Overall Study|Withdrawal by Subject|0|||
131727890|NCT02834403|474283444|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
131727891|NCT02834403|474283445|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
131727892|NCT02834403|474283446|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
131727893|NCT02834403|474283447|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
131727894|NCT02834403|474283448|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
131727895|NCT02834403|474283449|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
131727896|NCT02834403|474283450|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
131727897|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
131727898|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
131727899|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
131727900|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
131727901|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
131727902|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
131727903|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
131727904|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
131727905|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
131727906|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
131727907|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
131727908|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
131727909|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
131727910|NCT02232516|474283456|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
131727911|NCT02232516|474283456|FG000|Survival Follow-up|Death|15|||
131727912|NCT02232516|474283456|FG000|Survival Follow-up|Withdrawal by Subject|3|||
131727913|NCT02232516|474283456|FG000|Survival Follow-up|Lost to Follow-up|1|||
131727914|NCT02232516|474283456|FG000|Survival Follow-up|Still in follow-up|5|||
131727915|NCT00972244|474283457|FG000|Overall Study|Incorrect Enrolment|1|||
131727916|NCT00972244|474283458|FG001|Overall Study|Incorrect Enrolment|0|||
131727917|NCT00972244|474283459|FG002|Overall Study|Incorrect Enrolment|0|||
131727918|NCT00972244|474283460|FG003|Overall Study|Incorrect Enrolment|0|||
131727919|NCT00972244|474283461|FG004|Overall Study|Incorrect Enrolment|0|||
131727920|NCT00972244|474283457|FG000|Overall Study|Adverse Event|0|||
131727921|NCT00972244|474283458|FG001|Overall Study|Adverse Event|1|||
131727922|NCT00972244|474283459|FG002|Overall Study|Adverse Event|1|||
131727923|NCT00972244|474283460|FG003|Overall Study|Adverse Event|0|||
131727924|NCT00972244|474283461|FG004|Overall Study|Adverse Event|0|||
131727925|NCT00972244|474283457|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
131727926|NCT00972244|474283458|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
131727927|NCT00972244|474283459|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
131727928|NCT00972244|474283460|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
131727929|NCT00972244|474283461|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
131727930|NCT00972244|474283457|FG000|Overall Study|Withdrawal by Subject|1|||
131727931|NCT00972244|474283458|FG001|Overall Study|Withdrawal by Subject|2|||
131727932|NCT00972244|474283459|FG002|Overall Study|Withdrawal by Subject|1|||
131727933|NCT00972244|474283460|FG003|Overall Study|Withdrawal by Subject|0|||
131727934|NCT00972244|474283461|FG004|Overall Study|Withdrawal by Subject|1|||
131806435|NCT00723528|474576127|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
131806436|NCT00723528|474576128|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
131806437|NCT00723528|474576129|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
131806438|NCT00723528|474576130|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
131806439|NCT00723528|474576131|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
131806440|NCT00723528|474576132|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
131806441|NCT00723528|474576133|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
131806442|NCT00723528|474576127|FG000|Period 2: After Controlled Period|Other|0|||
131806443|NCT00723528|474576128|FG001|Period 2: After Controlled Period|Other|0|||
131806444|NCT00723528|474576129|FG002|Period 2: After Controlled Period|Other|0|||
131806445|NCT00723528|474576130|FG003|Period 2: After Controlled Period|Other|0|||
131806446|NCT00723528|474576131|FG004|Period 2: After Controlled Period|Other|1|||
131806447|NCT00723528|474576132|FG005|Period 2: After Controlled Period|Other|4|||
131806448|NCT00723528|474576133|FG006|Period 2: After Controlled Period|Other|0|||
131806449|NCT00723528|474576127|FG000|Period 2: After Controlled Period|Adverse Event|0|||
131806450|NCT00723528|474576128|FG001|Period 2: After Controlled Period|Adverse Event|0|||
131806451|NCT00723528|474576129|FG002|Period 2: After Controlled Period|Adverse Event|0|||
131806452|NCT00723528|474576130|FG003|Period 2: After Controlled Period|Adverse Event|0|||
131806453|NCT00723528|474576131|FG004|Period 2: After Controlled Period|Adverse Event|1|||
131806454|NCT00723528|474576132|FG005|Period 2: After Controlled Period|Adverse Event|0|||
131727935|NCT00972244|474283457|FG000|Overall Study|Safety|0|||
131727936|NCT00972244|474283458|FG001|Overall Study|Safety|0|||
131727937|NCT00972244|474283459|FG002|Overall Study|Safety|0|||
131727938|NCT00972244|474283460|FG003|Overall Study|Safety|0|||
131727939|NCT00972244|474283461|FG004|Overall Study|Safety|1|||
131727940|NCT00972244|474283457|FG000|Overall Study|Death|1|||
131727941|NCT00972244|474283458|FG001|Overall Study|Death|0|||
131727942|NCT00972244|474283459|FG002|Overall Study|Death|0|||
131727943|NCT00972244|474283460|FG003|Overall Study|Death|0|||
131727944|NCT00972244|474283461|FG004|Overall Study|Death|0|||
131727945|NCT00972244|474283457|FG000|Overall Study|Various|0|||
131727946|NCT00972244|474283458|FG001|Overall Study|Various|0|||
131727947|NCT00972244|474283459|FG002|Overall Study|Various|0|||
131727948|NCT00972244|474283460|FG003|Overall Study|Various|0|||
131727949|NCT00972244|474283461|FG004|Overall Study|Various|2|||
131727950|NCT02064439|474283463|FG000|Overall Study|Adverse Event|51|||
131727951|NCT02064439|474283464|FG001|Overall Study|Adverse Event|47|||
131727952|NCT02064439|474283465|FG002|Overall Study|Adverse Event|46|||
131727953|NCT02064439|474283463|FG000|Overall Study|Death|0|||
131727954|NCT02064439|474283464|FG001|Overall Study|Death|2|||
131727955|NCT02064439|474283465|FG002|Overall Study|Death|3|||
131727956|NCT02064439|474283463|FG000|Overall Study|Withdrawal by Subject|29|||
131727957|NCT02064439|474283464|FG001|Overall Study|Withdrawal by Subject|18|||
131727958|NCT02064439|474283465|FG002|Overall Study|Withdrawal by Subject|26|||
131727959|NCT02064439|474283463|FG000|Overall Study|Protocol Violation|3|||
131727960|NCT02064439|474283464|FG001|Overall Study|Protocol Violation|5|||
131727961|NCT02064439|474283465|FG002|Overall Study|Protocol Violation|3|||
131727962|NCT02064439|474283463|FG000|Overall Study|Lost to Follow-up|1|||
131727963|NCT02064439|474283464|FG001|Overall Study|Lost to Follow-up|3|||
131727964|NCT02064439|474283465|FG002|Overall Study|Lost to Follow-up|4|||
131727965|NCT02064439|474283463|FG000|Overall Study|Non-compliance with study medication|21|||
131727966|NCT02064439|474283464|FG001|Overall Study|Non-compliance with study medication|19|||
131727967|NCT02064439|474283465|FG002|Overall Study|Non-compliance with study medication|23|||
131727968|NCT02064439|474283463|FG000|Overall Study|Physician Decision|0|||
131727969|NCT02064439|474283464|FG001|Overall Study|Physician Decision|1|||
131727970|NCT02064439|474283465|FG002|Overall Study|Physician Decision|1|||
131727971|NCT02064439|474283463|FG000|Overall Study|Logistical difficulties|6|||
131727972|NCT02064439|474283464|FG001|Overall Study|Logistical difficulties|5|||
131727973|NCT02064439|474283465|FG002|Overall Study|Logistical difficulties|2|||
131727974|NCT02064439|474283463|FG000|Overall Study|Efficacy outcome reached|18|||
131727975|NCT02064439|474283464|FG001|Overall Study|Efficacy outcome reached|16|||
131727976|NCT02064439|474283465|FG002|Overall Study|Efficacy outcome reached|57|||
131727977|NCT02064439|474283463|FG000|Overall Study|Safety outcome reached|12|||
131727978|NCT02064439|474283464|FG001|Overall Study|Safety outcome reached|20|||
131727979|NCT02064439|474283465|FG002|Overall Study|Safety outcome reached|10|||
131727980|NCT02064439|474283463|FG000|Overall Study|Other|2|||
131905051|NCT02616783|474939032|FG000|Overall Study|Randomized but Not Treated|1|||
131448767|NCT00790842|473272727|FG007|Expansion Cohort|Adverse Event|0|||
131727981|NCT02064439|474283464|FG001|Overall Study|Other|2|||
131727982|NCT02064439|474283465|FG002|Overall Study|Other|7|||
131727983|NCT02433288|474283466|FG000|Overall Study|Severe non-compliance to protocol|13|||
131806455|NCT00723528|474576133|FG006|Period 2: After Controlled Period|Adverse Event|1|||
131806456|NCT00723528|474576127|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
131806457|NCT00723528|474576128|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
131806458|NCT00723528|474576129|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
131806459|NCT00723528|474576130|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
131806460|NCT00723528|474576131|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
131806461|NCT00723528|474576132|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
131806462|NCT00723528|474576133|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
131806463|NCT00723528|474576127|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
131727984|NCT02433288|474283467|FG001|Overall Study|Severe non-compliance to protocol|7|||
131727985|NCT02433288|474283466|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
131727986|NCT02433288|474283467|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
131727987|NCT02433288|474283466|FG000|Overall Study|Withdrawal by Subject|101|||
131727988|NCT02433288|474283467|FG001|Overall Study|Withdrawal by Subject|99|||
131727989|NCT02433288|474283466|FG000|Overall Study|Lost to Follow-up|2|||
131727990|NCT02433288|474283467|FG001|Overall Study|Lost to Follow-up|14|||
131727991|NCT02433288|474283466|FG000|Overall Study|Death|0|||
131727992|NCT02433288|474283467|FG001|Overall Study|Death|3|||
131727993|NCT03350750|474283468|FG000|Overall Study|Death|1|||
131727994|NCT03350750|474283469|FG001|Overall Study|Death|1|||
131727995|NCT01120093|474283474|FG000|Treatment Period 1|Adverse Event|0|||
131727996|NCT01120093|474283475|FG001|Treatment Period 1|Adverse Event|0|||
131727997|NCT01120093|474283476|FG002|Treatment Period 1|Adverse Event|1|||
131727998|NCT01120093|474283477|FG003|Treatment Period 1|Adverse Event|0|||
131727999|NCT01120093|474283478|FG004|Treatment Period 1|Adverse Event|1|||
131728000|NCT01120093|474283474|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131728001|NCT01120093|474283475|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131728002|NCT01120093|474283476|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131728003|NCT01120093|474283477|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131728004|NCT01120093|474283478|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131728005|NCT01120093|474283474|FG000|Treatment Period 2|Adverse Event|0|||
131806464|NCT00723528|474576128|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
131806465|NCT00723528|474576129|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
131806466|NCT00723528|474576130|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
131806467|NCT00723528|474576131|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
131806468|NCT00723528|474576132|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
131806469|NCT00723528|474576133|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
131806470|NCT03785548|474576134|FG000|Overall Study|age > 80|1|||
131806471|NCT03785548|474576135|FG001|Overall Study|age > 80|0|||
131806472|NCT03785548|474576134|FG000|Overall Study|no Postop queries|1|||
131806473|NCT03785548|474576135|FG001|Overall Study|no Postop queries|0|||
131806474|NCT01993030|474576136|FG000|Overall Study|Adverse Event|0|||
131806475|NCT01993030|474576137|FG001|Overall Study|Adverse Event|4|||
131806476|NCT01710657|474576138|FG000|Overall Study|Lost to Follow-up|2|||
131806477|NCT01710657|474576139|FG001|Overall Study|Lost to Follow-up|0|||
131806478|NCT01710657|474576140|FG002|Overall Study|Lost to Follow-up|1|||
131806479|NCT01710657|474576138|FG000|Overall Study|Protocol Violation|2|||
131806480|NCT01710657|474576139|FG001|Overall Study|Protocol Violation|2|||
131806481|NCT01710657|474576140|FG002|Overall Study|Protocol Violation|0|||
131806482|NCT01710657|474576138|FG000|Overall Study|Adverse Event|14|||
131806483|NCT01710657|474576139|FG001|Overall Study|Adverse Event|8|||
131806484|NCT01710657|474576140|FG002|Overall Study|Adverse Event|28|||
131806485|NCT01710657|474576138|FG000|Overall Study|Withdrawal by Subject|0|||
131806486|NCT01710657|474576139|FG001|Overall Study|Withdrawal by Subject|1|||
131806487|NCT01710657|474576140|FG002|Overall Study|Withdrawal by Subject|2|||
131806488|NCT01710657|474576138|FG000|Overall Study|Lack of Efficacy|0|||
131806489|NCT01710657|474576139|FG001|Overall Study|Lack of Efficacy|1|||
131806490|NCT01710657|474576140|FG002|Overall Study|Lack of Efficacy|1|||
131806491|NCT00667862|474576143|FG000|Overall Study|Adverse Event|9|||
131806492|NCT00667862|474576143|FG000|Overall Study|Death|1|||
131806493|NCT00667862|474576143|FG000|Overall Study|Disease Progression|22|||
131806494|NCT00667862|474576143|FG000|Overall Study|Withdrawal by Subject|3|||
131806495|NCT00667095|474576156|FG000|Overall Study|Withdrawal by Subject|0|||
131728006|NCT01120093|474283475|FG001|Treatment Period 2|Adverse Event|0|||
131728007|NCT01120093|474283476|FG002|Treatment Period 2|Adverse Event|0|||
131806496|NCT00667095|474576157|FG001|Overall Study|Withdrawal by Subject|1|||
131806497|NCT01882257|474576159|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
131806498|NCT01882257|474576160|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
131905052|NCT02616783|474939033|FG001|Overall Study|Randomized but Not Treated|0|||
131905053|NCT02616783|474939032|FG000|Overall Study|Adverse Event|1|||
131728008|NCT01120093|474283477|FG003|Treatment Period 2|Adverse Event|1|||
131728009|NCT01120093|474283478|FG004|Treatment Period 2|Adverse Event|0|||
131728010|NCT01120093|474283474|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131728011|NCT01120093|474283475|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131728012|NCT01120093|474283476|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131728013|NCT01120093|474283477|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131728014|NCT01120093|474283478|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131728015|NCT01120093|474283474|FG000|Treatment Period 3|Lack of Efficacy|0|||
131728016|NCT01120093|474283475|FG001|Treatment Period 3|Lack of Efficacy|0|||
131728017|NCT01120093|474283476|FG002|Treatment Period 3|Lack of Efficacy|0|||
131728018|NCT01120093|474283477|FG003|Treatment Period 3|Lack of Efficacy|1|||
131728019|NCT01120093|474283478|FG004|Treatment Period 3|Lack of Efficacy|0|||
131728020|NCT01120093|474283474|FG000|Treatment Period 3|Adverse Event|0|||
131728021|NCT01120093|474283475|FG001|Treatment Period 3|Adverse Event|0|||
131728022|NCT01120093|474283476|FG002|Treatment Period 3|Adverse Event|0|||
131728023|NCT01120093|474283477|FG003|Treatment Period 3|Adverse Event|0|||
131728024|NCT01120093|474283478|FG004|Treatment Period 3|Adverse Event|1|||
131728025|NCT01120093|474283474|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131728026|NCT01120093|474283475|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131728027|NCT01120093|474283476|FG002|Treatment Period 3|Withdrawal by Subject|1|||
131728028|NCT01120093|474283477|FG003|Treatment Period 3|Withdrawal by Subject|0|||
131728029|NCT01120093|474283478|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131728030|NCT01120093|474283474|FG000|Treatment Period 4|Adverse Event|1|||
131728031|NCT01120093|474283475|FG001|Treatment Period 4|Adverse Event|0|||
131728032|NCT01120093|474283476|FG002|Treatment Period 4|Adverse Event|0|||
131728033|NCT01120093|474283477|FG003|Treatment Period 4|Adverse Event|0|||
131728034|NCT01120093|474283478|FG004|Treatment Period 4|Adverse Event|0|||
131728035|NCT01120093|474283474|FG000|Treatment Period 5|Adverse Event|0|||
131728036|NCT01120093|474283475|FG001|Treatment Period 5|Adverse Event|1|||
131728037|NCT01120093|474283476|FG002|Treatment Period 5|Adverse Event|0|||
131728038|NCT01120093|474283477|FG003|Treatment Period 5|Adverse Event|1|||
131728039|NCT01120093|474283478|FG004|Treatment Period 5|Adverse Event|0|||
131728040|NCT01849250|474283479|FG000|Overall Study|Withdrawal by Subject|1|||
131728041|NCT01849250|474283480|FG001|Overall Study|Withdrawal by Subject|0|||
131728042|NCT01849250|474283479|FG000|Overall Study|Not Evaluable|5|||
131728043|NCT01849250|474283480|FG001|Overall Study|Not Evaluable|3|||
131728044|NCT01849250|474283479|FG000|Overall Study|Screen Failure|1|||
131728045|NCT01849250|474283480|FG001|Overall Study|Screen Failure|0|||
131728046|NCT02184143|474283485|FG000|Overall Study|Withdrawal by Subject|4|||
131728047|NCT02184143|474283486|FG001|Overall Study|Withdrawal by Subject|4|||
131728048|NCT02184143|474283485|FG000|Overall Study|Lost to Follow-up|5|||
131728049|NCT02184143|474283486|FG001|Overall Study|Lost to Follow-up|3|||
131728050|NCT02184143|474283485|FG000|Overall Study|Death|1|||
131728051|NCT02184143|474283486|FG001|Overall Study|Death|0|||
131728052|NCT00257192|474283487|FG000|Overall Study|Adverse Event|21|||
131728053|NCT00257192|474283488|FG001|Overall Study|Adverse Event|10|||
131728054|NCT00257192|474283487|FG000|Overall Study|Laboratory abnormality|1|||
131728055|NCT00257192|474283488|FG001|Overall Study|Laboratory abnormality|1|||
131728056|NCT00257192|474283487|FG000|Overall Study|Lost to Follow-up|3|||
131728057|NCT00257192|474283488|FG001|Overall Study|Lost to Follow-up|3|||
131728058|NCT00257192|474283487|FG000|Overall Study|Insufficient clinical response|18|||
131728059|NCT00257192|474283488|FG001|Overall Study|Insufficient clinical response|18|||
131728060|NCT00257192|474283487|FG000|Overall Study|Withdrawal by Subject|14|||
131728061|NCT00257192|474283488|FG001|Overall Study|Withdrawal by Subject|2|||
131728062|NCT00257192|474283487|FG000|Overall Study|Randomized but not treated|0|||
131728063|NCT00257192|474283488|FG001|Overall Study|Randomized but not treated|1|||
131728064|NCT00257192|474283487|FG000|Overall Study|Study terminated by sponsor|1|||
131728065|NCT00257192|474283488|FG001|Overall Study|Study terminated by sponsor|0|||
131728066|NCT00257192|474283487|FG000|Overall Study|Miscellaneous|0|||
131728067|NCT00257192|474283488|FG001|Overall Study|Miscellaneous|4|||
131728068|NCT00570739|474283489|FG000|Overall Study|Adverse Event|8|||
131728069|NCT00570739|474283490|FG001|Overall Study|Adverse Event|6|||
131728070|NCT00570739|474283491|FG002|Overall Study|Adverse Event|2|||
131728071|NCT00570739|474283492|FG003|Overall Study|Adverse Event|2|||
131728072|NCT00570739|474283489|FG000|Overall Study|Lost to Follow-up|4|||
131728073|NCT00570739|474283490|FG001|Overall Study|Lost to Follow-up|5|||
131728074|NCT00570739|474283491|FG002|Overall Study|Lost to Follow-up|4|||
131728075|NCT00570739|474283492|FG003|Overall Study|Lost to Follow-up|1|||
131728076|NCT00570739|474283489|FG000|Overall Study|Physician Decision|1|||
131728077|NCT00570739|474283490|FG001|Overall Study|Physician Decision|1|||
131728078|NCT00570739|474283491|FG002|Overall Study|Physician Decision|0|||
131728079|NCT00570739|474283492|FG003|Overall Study|Physician Decision|0|||
131728080|NCT00570739|474283489|FG000|Overall Study|Withdrawal by Subject|7|||
131728081|NCT00570739|474283490|FG001|Overall Study|Withdrawal by Subject|7|||
131728082|NCT00570739|474283491|FG002|Overall Study|Withdrawal by Subject|3|||
131728083|NCT00570739|474283492|FG003|Overall Study|Withdrawal by Subject|5|||
131728084|NCT00570739|474283489|FG000|Overall Study|Required restricted medication|0|||
131728085|NCT00570739|474283490|FG001|Overall Study|Required restricted medication|0|||
131728086|NCT00570739|474283491|FG002|Overall Study|Required restricted medication|1|||
131728087|NCT00570739|474283492|FG003|Overall Study|Required restricted medication|0|||
131728088|NCT00570739|474283489|FG000|Overall Study|Met discontinuation criteria|1|||
131728089|NCT00570739|474283490|FG001|Overall Study|Met discontinuation criteria|0|||
131728090|NCT00570739|474283491|FG002|Overall Study|Met discontinuation criteria|1|||
131728091|NCT00570739|474283492|FG003|Overall Study|Met discontinuation criteria|1|||
131728092|NCT00570739|474283489|FG000|Overall Study|Other|0|||
131728093|NCT00570739|474283490|FG001|Overall Study|Other|2|||
131728094|NCT00570739|474283491|FG002|Overall Study|Other|5|||
131728095|NCT00570739|474283492|FG003|Overall Study|Other|3|||
131728096|NCT01921270|474283497|FG000|Overall Study|Withdrawal by Subject|1|||
131728097|NCT00844428|474283498|FG000|Screening Period|Screen Failure|3|||
131728098|NCT00844428|474283498|FG000|Extension Treatment Period|Death|1|||
131728099|NCT00844428|474283498|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
131728100|NCT00789477|474283499|FG000|Overall Study|Withdrawal by Subject|2|||
131728101|NCT00789477|474283500|FG001|Overall Study|Withdrawal by Subject|1|||
131728102|NCT00789477|474283501|FG002|Overall Study|Withdrawal by Subject|3|||
131728103|NCT00789477|474283502|FG003|Overall Study|Withdrawal by Subject|2|||
131728104|NCT00789477|474283503|FG004|Overall Study|Withdrawal by Subject|3|||
131728105|NCT00789477|474283499|FG000|Overall Study|Protocol Violation|1|||
131728106|NCT00789477|474283500|FG001|Overall Study|Protocol Violation|0|||
131728107|NCT00789477|474283501|FG002|Overall Study|Protocol Violation|0|||
131728108|NCT00789477|474283502|FG003|Overall Study|Protocol Violation|1|||
131728109|NCT00789477|474283503|FG004|Overall Study|Protocol Violation|0|||
131728110|NCT00789477|474283499|FG000|Overall Study|Adverse Event|3|||
131728111|NCT00789477|474283500|FG001|Overall Study|Adverse Event|3|||
131728112|NCT00789477|474283501|FG002|Overall Study|Adverse Event|1|||
131728113|NCT00789477|474283502|FG003|Overall Study|Adverse Event|0|||
131728114|NCT00789477|474283503|FG004|Overall Study|Adverse Event|0|||
131728115|NCT00789477|474283499|FG000|Overall Study|Death|1|||
131728116|NCT00789477|474283500|FG001|Overall Study|Death|1|||
131728117|NCT00789477|474283501|FG002|Overall Study|Death|2|||
131728118|NCT00789477|474283502|FG003|Overall Study|Death|2|||
131728119|NCT00789477|474283503|FG004|Overall Study|Death|0|||
131728120|NCT00789477|474283499|FG000|Overall Study|Lost to Follow-up|0|||
131728121|NCT00789477|474283500|FG001|Overall Study|Lost to Follow-up|1|||
131728122|NCT00789477|474283501|FG002|Overall Study|Lost to Follow-up|4|||
131728123|NCT00789477|474283502|FG003|Overall Study|Lost to Follow-up|2|||
131728124|NCT00789477|474283503|FG004|Overall Study|Lost to Follow-up|4|||
131728125|NCT00789477|474283499|FG000|Overall Study|Lack of Efficacy|2|||
131728126|NCT00789477|474283500|FG001|Overall Study|Lack of Efficacy|0|||
131728127|NCT00789477|474283501|FG002|Overall Study|Lack of Efficacy|0|||
131728128|NCT00789477|474283502|FG003|Overall Study|Lack of Efficacy|0|||
131728129|NCT00789477|474283503|FG004|Overall Study|Lack of Efficacy|0|||
131728130|NCT00789477|474283499|FG000|Overall Study|Other|2|||
131728131|NCT00789477|474283500|FG001|Overall Study|Other|0|||
131728132|NCT00789477|474283501|FG002|Overall Study|Other|1|||
131728133|NCT00789477|474283502|FG003|Overall Study|Other|3|||
131728134|NCT00789477|474283503|FG004|Overall Study|Other|0|||
131728135|NCT01844700|474283504|FG000|Overall Study|Lack of Efficacy|1|||
131728136|NCT01844700|474283505|FG001|Overall Study|Lack of Efficacy|0|||
131728137|NCT01844700|474283504|FG000|Overall Study|refused medication switch|1|||
131728138|NCT01844700|474283505|FG001|Overall Study|refused medication switch|0|||
131728139|NCT01844700|474283504|FG000|Overall Study|Withdrawal by Subject|1|||
131728140|NCT01844700|474283505|FG001|Overall Study|Withdrawal by Subject|0|||
131728141|NCT01844700|474283504|FG000|Overall Study|stopped taking meds|0|||
131728142|NCT01844700|474283505|FG001|Overall Study|stopped taking meds|1|||
131728143|NCT02680847|474283506|FG000|Overall Study|Other|2|||
131728144|NCT02680847|474283507|FG001|Overall Study|Other|0|||
131728145|NCT02680847|474283508|FG002|Overall Study|Other|0|||
131728146|NCT02680847|474283506|FG000|Overall Study|No longer met eligibility criteria|2|||
131728147|NCT02680847|474283507|FG001|Overall Study|No longer met eligibility criteria|2|||
131728148|NCT02680847|474283508|FG002|Overall Study|No longer met eligibility criteria|0|||
131728149|NCT02680847|474283506|FG000|Overall Study|Unwilling to participate in study|1|||
131728150|NCT02680847|474283507|FG001|Overall Study|Unwilling to participate in study|1|||
131728151|NCT02680847|474283508|FG002|Overall Study|Unwilling to participate in study|0|||
131728152|NCT02680847|474283506|FG000|Overall Study|Lack of Efficacy|0|||
131728153|NCT02680847|474283507|FG001|Overall Study|Lack of Efficacy|0|||
131728154|NCT02680847|474283508|FG002|Overall Study|Lack of Efficacy|2|||
131728155|NCT02680847|474283506|FG000|Overall Study|Adverse Event|0|||
131728156|NCT02680847|474283507|FG001|Overall Study|Adverse Event|0|||
131728157|NCT02680847|474283508|FG002|Overall Study|Adverse Event|1|||
131806499|NCT01882257|474576161|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
131728158|NCT02375698|474283509|FG000|Overall Study|Withdrawal by Subject|0|||
131728159|NCT02375698|474283510|FG001|Overall Study|Withdrawal by Subject|2|||
131728160|NCT02375698|474283509|FG000|Overall Study|Physician Decision|2|||
131728161|NCT02375698|474283510|FG001|Overall Study|Physician Decision|0|||
131728162|NCT00772967|474283513|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
131728163|NCT00772967|474283514|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
131728164|NCT00772967|474283515|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
131728165|NCT00772967|474283516|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
131728166|NCT00772967|474283517|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
131728167|NCT00772967|474283518|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
131728168|NCT00772967|474283513|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131728169|NCT00772967|474283514|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
131728170|NCT00772967|474283515|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131728171|NCT00772967|474283516|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131728172|NCT00772967|474283517|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131728173|NCT00772967|474283518|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131728174|NCT00772967|474283513|FG000|Crossover Treatment 3|Adverse Event|0|||
131728175|NCT00772967|474283514|FG001|Crossover Treatment 3|Adverse Event|0|||
131728176|NCT00772967|474283515|FG002|Crossover Treatment 3|Adverse Event|0|||
131728177|NCT00772967|474283516|FG003|Crossover Treatment 3|Adverse Event|0|||
131728178|NCT00772967|474283517|FG004|Crossover Treatment 3|Adverse Event|1|||
131728179|NCT00772967|474283518|FG005|Crossover Treatment 3|Adverse Event|0|||
131728180|NCT01595646|474283519|FG000|Overall Study|Withdrawal by Subject|1|||
131728181|NCT01595646|474283520|FG001|Overall Study|Withdrawal by Subject|0|||
131728182|NCT01595646|474283521|FG002|Overall Study|Withdrawal by Subject|0|||
131728183|NCT01161524|474283524|FG000|Core Study (23 Weeks)|Adverse Event|3|||
131728184|NCT01161524|474283525|FG001|Core Study (23 Weeks)|Adverse Event|0|||
131728185|NCT01161524|474283526|FG002|Core Study (23 Weeks)|Adverse Event|0|||
131728186|NCT01161524|474283524|FG000|Core Study (23 Weeks)|Other|1|||
131728187|NCT01161524|474283525|FG001|Core Study (23 Weeks)|Other|0|||
131728188|NCT01161524|474283526|FG002|Core Study (23 Weeks)|Other|0|||
131728189|NCT01161524|474283524|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
131728190|NCT01161524|474283525|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
131728191|NCT01161524|474283526|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
131728192|NCT01161524|474283524|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
131728193|NCT01161524|474283525|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
131728194|NCT01161524|474283526|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
131728195|NCT01161524|474283524|FG000|Core Study (23 Weeks)|Subject Choice|3|||
131728196|NCT01161524|474283525|FG001|Core Study (23 Weeks)|Subject Choice|2|||
131728197|NCT01161524|474283526|FG002|Core Study (23 Weeks)|Subject Choice|0|||
131728198|NCT01161524|474283524|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
131728199|NCT01161524|474283525|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
131728200|NCT01161524|474283526|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
131728201|NCT01161524|474283524|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
131728202|NCT01161524|474283525|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
131728203|NCT01161524|474283526|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
131728204|NCT01161524|474283524|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
131728205|NCT01161524|474283525|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
131728206|NCT01161524|474283526|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
131728207|NCT01161524|474283524|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
131728208|NCT01161524|474283525|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
131728209|NCT01161524|474283526|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
131728210|NCT01161524|474283524|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
131728211|NCT01161524|474283525|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
131728212|NCT01161524|474283526|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
131728213|NCT02021812|474283531|FG000|Overall Study|Death|8|||
131728214|NCT02021812|474283531|FG000|Overall Study|Withdrawal by Subject|3|||
131728215|NCT02021812|474283531|FG000|Overall Study|Lost to Follow-up|2|||
131728216|NCT02021812|474283531|FG000|Overall Study|Refuse to return, COVD 19|2|||
131728217|NCT00504166|474283532|FG000|Overall Study|Adverse Event|1|||
131728218|NCT00504166|474283533|FG001|Overall Study|Adverse Event|4|||
131728219|NCT00504166|474283532|FG000|Overall Study|Withdrawal by Subject|3|||
131728220|NCT00504166|474283533|FG001|Overall Study|Withdrawal by Subject|6|||
131728221|NCT00504166|474283532|FG000|Overall Study|Physician Decision|1|||
131728222|NCT00504166|474283533|FG001|Overall Study|Physician Decision|1|||
131728223|NCT00504166|474283532|FG000|Overall Study|Lost to Follow-up|1|||
131728224|NCT00504166|474283533|FG001|Overall Study|Lost to Follow-up|3|||
131728225|NCT02807454|474283542|FG000|Overall Study|Adverse Event|1|||
131728226|NCT02807454|474283543|FG001|Overall Study|Adverse Event|0|||
131728227|NCT02807454|474283542|FG000|Overall Study|Withdrawal by Subject|0|||
131728228|NCT02807454|474283543|FG001|Overall Study|Withdrawal by Subject|1|||
131728229|NCT02807454|474283542|FG000|Overall Study|Progressive Disease|30|||
131728230|NCT02807454|474283543|FG001|Overall Study|Progressive Disease|3|||
131728231|NCT02807454|474283542|FG000|Overall Study|Other Reasons|1|||
131728232|NCT02807454|474283543|FG001|Overall Study|Other Reasons|1|||
131728233|NCT00374907|474283544|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
131728234|NCT00374907|474283545|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
131728235|NCT00374907|474283544|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
131728236|NCT00374907|474283545|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
131728237|NCT00374907|474283544|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
131728238|NCT00374907|474283545|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
131728239|NCT00374907|474283544|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
131728240|NCT00374907|474283545|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
131728241|NCT00374907|474283544|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
131728242|NCT00374907|474283545|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
131728243|NCT01780389|474283550|FG000|Overall Study|Adverse Event|1|||
131728244|NCT02582749|474283552|FG000|Overall Study|Study terminated by funder|5|||
131728245|NCT02582749|474283553|FG001|Overall Study|Study terminated by funder|10|||
131728246|NCT02582749|474283552|FG000|Overall Study|Withdrawal by Subject|0|||
131728247|NCT02582749|474283553|FG001|Overall Study|Withdrawal by Subject|1|||
131728248|NCT02815397|474283556|FG000|Overall Study|Physician Decision|2|||
131728249|NCT01323673|474283557|FG000|Overall Study|Adverse Event|0|||
131728250|NCT01323673|474283558|FG001|Overall Study|Adverse Event|1|||
131728251|NCT01323673|474283557|FG000|Overall Study|Lost to Follow-up|0|||
131728252|NCT01323673|474283558|FG001|Overall Study|Lost to Follow-up|1|||
131728253|NCT01323673|474283557|FG000|Overall Study|Protocol Violation|1|||
131728254|NCT01323673|474283558|FG001|Overall Study|Protocol Violation|0|||
131728255|NCT01323673|474283557|FG000|Overall Study|Withdrawal by Subject|2|||
131728256|NCT01323673|474283558|FG001|Overall Study|Withdrawal by Subject|3|||
131728257|NCT04598165|474283559|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
131728258|NCT04598165|474283560|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
131728259|NCT04598165|474283559|FG000|Completed 6-week Follow-up|Death|2|||
131728260|NCT04598165|474283560|FG001|Completed 6-week Follow-up|Death|1|||
131728261|NCT04598165|474283559|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
131728262|NCT04598165|474283560|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
131728263|NCT04598165|474283559|FG000|Completed 6-week Follow-up|Ineligible|4|||
131728264|NCT04598165|474283560|FG001|Completed 6-week Follow-up|Ineligible|3|||
131728265|NCT04598165|474283559|FG000|Completed 6-week Follow-up|Partner refusal|0|||
131728266|NCT04598165|474283560|FG001|Completed 6-week Follow-up|Partner refusal|1|||
131728267|NCT04598165|474283559|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
131728268|NCT04598165|474283560|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
131728269|NCT01200511|474283561|FG000|Overall Study|Lost to Follow-up|3|||
131728270|NCT01200511|474283561|FG000|Overall Study|Withdrawal by Subject|1|||
131728271|NCT01200511|474283561|FG000|Overall Study|Adverse Event|1|||
131728272|NCT04229446|474283565|FG000|Overall Study|Death|12|||
131728273|NCT04229446|474283566|FG001|Overall Study|Death|10|||
131728274|NCT04229446|474283565|FG000|Overall Study|Lost to Follow-up|5|||
131728275|NCT04229446|474283566|FG001|Overall Study|Lost to Follow-up|8|||
131728276|NCT02566525|474283567|FG000|Overall Study|Protocol Violation|3|||
131728277|NCT02566525|474283568|FG001|Overall Study|Protocol Violation|5|||
131728278|NCT00337467|474283569|FG000|Overall Study|Adverse Event|3|||
131728279|NCT00337467|474283569|FG000|Overall Study|Subject Withdrew Consent|2|||
131728280|NCT00337467|474283569|FG000|Overall Study|Pregnancy|1|||
131728281|NCT00337467|474283569|FG000|Overall Study|Lost to Follow-up|2|||
131728282|NCT00337467|474283569|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
131728283|NCT04083222|474283570|FG000|Overall Study|Voluntary Withdrawal|0|||
131728284|NCT04083222|474283571|FG001|Overall Study|Voluntary Withdrawal|1|||
131728285|NCT04083222|474283570|FG000|Overall Study|Reason not Specified|0|||
131728286|NCT04083222|474283571|FG001|Overall Study|Reason not Specified|1|||
131728287|NCT03103750|474283572|FG000|Overall Study|Adverse Event|1|||
131728288|NCT03103750|474283573|FG001|Overall Study|Adverse Event|0|||
131728289|NCT03103750|474283572|FG000|Overall Study|Lost to Follow-up|1|||
131728290|NCT03103750|474283573|FG001|Overall Study|Lost to Follow-up|0|||
131728291|NCT03103750|474283572|FG000|Overall Study|PET Equipment Related|2|||
131728292|NCT03103750|474283573|FG001|Overall Study|PET Equipment Related|2|||
131728293|NCT03607682|474283574|FG000|Overall Study|Withdrawal by Subject|1|||
131728294|NCT03607682|474283574|FG000|Overall Study|Disease progression|1|||
131728295|NCT00376688|474283575|FG000|Overall Study|Adverse Event|3|||
131728296|NCT00376688|474283575|FG000|Overall Study|Death|1|||
131728297|NCT04400318|474285247|FG000|Overall Study|Adverse Event|1|||
131728298|NCT04400318|474285248|FG001|Overall Study|Adverse Event|0|||
131728299|NCT04400318|474285247|FG000|Overall Study|Withdrawal by Subject|1|||
131728300|NCT04400318|474285248|FG001|Overall Study|Withdrawal by Subject|1|||
131728301|NCT04400318|474285247|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
131728302|NCT04400318|474285248|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
131728303|NCT04191967|474285249|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
131728304|NCT04191967|474285249|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
131728305|NCT02410902|474285252|FG000|Overall Study|Adverse Event|2|||
131728306|NCT02410902|474285253|FG001|Overall Study|Adverse Event|3|||
131728307|NCT02410902|474285252|FG000|Overall Study|Lost to Follow-up|4|||
131728308|NCT02410902|474285253|FG001|Overall Study|Lost to Follow-up|1|||
131806500|NCT01882257|474576159|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
131806501|NCT01882257|474576160|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
131806502|NCT01882257|474576161|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
131806503|NCT00905346|474576162|FG000|Period 1|Withdrawal by Subject|1|||
131806504|NCT00905346|474576163|FG001|Period 1|Withdrawal by Subject|0|||
131806505|NCT01435265|474576164|FG000|Overall Study|Lost to Follow-up|0|||
131806506|NCT01435265|474576165|FG001|Overall Study|Lost to Follow-up|1|||
131806507|NCT00469417|474576166|FG000|Overall Study|Treatment failure all lesions|18|||
131806508|NCT00469417|474576167|FG001|Overall Study|Treatment failure all lesions|11|||
131806509|NCT00469417|474576166|FG000|Overall Study|Consent withdrawn|1|||
131806510|NCT00469417|474576167|FG001|Overall Study|Consent withdrawn|1|||
131806511|NCT00469417|474576166|FG000|Overall Study|Adverse Event|8|||
131806512|NCT00469417|474576167|FG001|Overall Study|Adverse Event|2|||
131806513|NCT00469417|474576166|FG000|Overall Study|Lost to Follow-up|1|||
131806514|NCT00469417|474576167|FG001|Overall Study|Lost to Follow-up|2|||
131806515|NCT00469417|474576166|FG000|Overall Study|Intercurrent disease|0|||
131806516|NCT00469417|474576167|FG001|Overall Study|Intercurrent disease|1|||
131806517|NCT00469417|474576166|FG000|Overall Study|Randomized but not treated|2|||
131806518|NCT00469417|474576167|FG001|Overall Study|Randomized but not treated|0|||
131806519|NCT04088760|474576170|FG000|Overall Study|Physician Decision|1|||
131806520|NCT01391793|474576171|FG000|Overall Study|Ineligible|3|||
131806521|NCT01391793|474576172|FG001|Overall Study|Ineligible|0|||
131806522|NCT01391793|474576171|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
131806523|NCT01391793|474576172|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
131806524|NCT01391793|474576171|FG000|Overall Study|No DMSA|73|||
131806525|NCT01391793|474576172|FG001|Overall Study|No DMSA|57|||
131806526|NCT00105196|474576173|FG000|Overall Study|Lack of Efficacy|2|||
131806527|NCT00105196|474576174|FG001|Overall Study|Lack of Efficacy|3|||
131806528|NCT00105196|474576173|FG000|Overall Study|Adverse Event|11|||
131806529|NCT00105196|474576174|FG001|Overall Study|Adverse Event|3|||
131806530|NCT00105196|474576173|FG000|Overall Study|Withdrawal by Subject|6|||
131806531|NCT00105196|474576174|FG001|Overall Study|Withdrawal by Subject|6|||
131806532|NCT00105196|474576173|FG000|Overall Study|Lost to Follow-up|3|||
131806533|NCT00105196|474576174|FG001|Overall Study|Lost to Follow-up|2|||
131806534|NCT00105196|474576173|FG000|Overall Study|Poor/noncompliance|3|||
131806535|NCT00105196|474576174|FG001|Overall Study|Poor/noncompliance|4|||
131806536|NCT00105196|474576173|FG000|Overall Study|Protocol Violation|5|||
131806537|NCT00105196|474576174|FG001|Overall Study|Protocol Violation|2|||
131806538|NCT00105196|474576173|FG000|Overall Study|pending surgery|0|||
131806539|NCT00105196|474576174|FG001|Overall Study|pending surgery|1|||
131806540|NCT00105196|474576173|FG000|Overall Study|marijuana use|0|||
131806541|NCT00105196|474576174|FG001|Overall Study|marijuana use|1|||
131806542|NCT00105196|474576173|FG000|Overall Study|Subject became unblinded|0|||
131806543|NCT00105196|474576174|FG001|Overall Study|Subject became unblinded|1|||
131806544|NCT03025880|474576175|FG000|Overall Study|Adverse Event|1|||
131806545|NCT03025880|474576176|FG001|Overall Study|Adverse Event|0|||
131806546|NCT03025880|474576175|FG000|Overall Study|Death|1|||
131806547|NCT03025880|474576176|FG001|Overall Study|Death|1|||
131806548|NCT03025880|474576175|FG000|Overall Study|Withdrawal by Subject|0|||
131806549|NCT03025880|474576176|FG001|Overall Study|Withdrawal by Subject|1|||
131806550|NCT03025880|474576175|FG000|Overall Study|Physician Decision|0|||
131806551|NCT03025880|474576176|FG001|Overall Study|Physician Decision|1|||
131728309|NCT02410902|474285252|FG000|Overall Study|Protocol Violation|1|||
131728310|NCT02410902|474285253|FG001|Overall Study|Protocol Violation|4|||
131806552|NCT03025880|474576175|FG000|Overall Study|Progressive Disease|12|||
131806553|NCT03025880|474576176|FG001|Overall Study|Progressive Disease|19|||
131806554|NCT00184600|474576177|FG000|Overall Study|Adverse Event|9|||
131806555|NCT00184600|474576178|FG001|Overall Study|Adverse Event|0|||
131806556|NCT00184600|474576179|FG002|Overall Study|Adverse Event|5|||
131806557|NCT00184600|474576177|FG000|Overall Study|Death|3|||
131806558|NCT00184600|474576178|FG001|Overall Study|Death|9|||
131806559|NCT00184600|474576179|FG002|Overall Study|Death|7|||
131806560|NCT00184600|474576177|FG000|Overall Study|Lack of Efficacy|3|||
131806561|NCT00184600|474576178|FG001|Overall Study|Lack of Efficacy|1|||
131728311|NCT02410902|474285252|FG000|Overall Study|Withdrawal by Subject|6|||
131728312|NCT02410902|474285253|FG001|Overall Study|Withdrawal by Subject|8|||
131728313|NCT02410902|474285252|FG000|Overall Study|Non-Compliance|8|||
131728314|NCT02410902|474285253|FG001|Overall Study|Non-Compliance|2|||
131728315|NCT00747617|474285254|FG000|Overall Study|Lost to Follow-up|3|||
131728316|NCT00747617|474285255|FG001|Overall Study|Lost to Follow-up|1|||
131728317|NCT01746732|474285256|FG000|Lead-In Period|Withdrawal by Subject|1|||
131728318|NCT01746732|474285257|FG001|Lead-In Period|Withdrawal by Subject|0|||
131728319|NCT01746732|474285258|FG002|Lead-In Period|Withdrawal by Subject|0|||
131728320|NCT01746732|474285256|FG000|Period 1|Physician Decision|0|||
131728321|NCT01746732|474285257|FG001|Period 1|Physician Decision|1|||
131728322|NCT01746732|474285258|FG002|Period 1|Physician Decision|0|||
131728323|NCT01746732|474285256|FG000|Period 2|Withdrawal by Subject|0|||
131728324|NCT01746732|474285257|FG001|Period 2|Withdrawal by Subject|0|||
131728325|NCT01746732|474285258|FG002|Period 2|Withdrawal by Subject|2|||
131728326|NCT01746732|474285256|FG000|Period 2|Adverse Event|0|||
131728327|NCT01746732|474285257|FG001|Period 2|Adverse Event|0|||
131728328|NCT01746732|474285258|FG002|Period 2|Adverse Event|1|||
131728329|NCT01746732|474285256|FG000|Period 2|Lost to Follow-up|0|||
131728330|NCT01746732|474285257|FG001|Period 2|Lost to Follow-up|0|||
131728331|NCT01746732|474285258|FG002|Period 2|Lost to Follow-up|1|||
131728332|NCT02279524|474285259|FG000|Overall Study|Withdrawal by Subject|3|||
131728333|NCT02279524|474285260|FG001|Overall Study|Withdrawal by Subject|6|||
131728334|NCT02279524|474285261|FG002|Overall Study|Withdrawal by Subject|3|||
131728335|NCT02279524|474285259|FG000|Overall Study|Adverse Event|4|||
131728336|NCT02279524|474285260|FG001|Overall Study|Adverse Event|3|||
131728337|NCT02279524|474285261|FG002|Overall Study|Adverse Event|2|||
131728338|NCT02279524|474285259|FG000|Overall Study|Lost to Follow-up|1|||
131728339|NCT02279524|474285260|FG001|Overall Study|Lost to Follow-up|1|||
131728340|NCT02279524|474285261|FG002|Overall Study|Lost to Follow-up|0|||
131728341|NCT02279524|474285259|FG000|Overall Study|Disallowed medication|1|||
131728342|NCT02279524|474285260|FG001|Overall Study|Disallowed medication|1|||
131728343|NCT02279524|474285261|FG002|Overall Study|Disallowed medication|2|||
131728344|NCT02279524|474285259|FG000|Overall Study|Bariatric surgery|1|||
131728345|NCT02279524|474285260|FG001|Overall Study|Bariatric surgery|0|||
131728346|NCT02279524|474285261|FG002|Overall Study|Bariatric surgery|0|||
131728347|NCT03509207|474285262|FG000|Overall Study|Death|2|||
131728348|NCT02817555|474285263|FG000|Overall Study|Death|1|||
131728349|NCT02817555|474285264|FG001|Overall Study|Death|3|||
131728350|NCT02817555|474285263|FG000|Overall Study|moved away|1|||
131728351|NCT02817555|474285264|FG001|Overall Study|moved away|0|||
131728352|NCT02817555|474285263|FG000|Overall Study|transplant|1|||
131728353|NCT02817555|474285264|FG001|Overall Study|transplant|1|||
131728354|NCT02817555|474285263|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
131728355|NCT02817555|474285264|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
131728356|NCT00137436|474285265|FG000|Overall Study|Adverse Event|13|||
131728357|NCT00137436|474285265|FG000|Overall Study|Death|2|||
131728358|NCT00137436|474285265|FG000|Overall Study|Lack of Efficacy|17|||
131728359|NCT00137436|474285265|FG000|Overall Study|Withdrawal by Subject|6|||
131728360|NCT00137436|474285265|FG000|Overall Study|Other|5|||
131728361|NCT04657016|474285266|FG000|Overall Study|Adverse Event|2|||
131728362|NCT04657016|474285267|FG001|Overall Study|Adverse Event|4|||
131728363|NCT04657016|474285266|FG000|Overall Study|Death|1|||
131728364|NCT04657016|474285267|FG001|Overall Study|Death|1|||
131806562|NCT00184600|474576179|FG002|Overall Study|Lack of Efficacy|3|||
131806563|NCT00184600|474576177|FG000|Overall Study|Lost to Follow-up|4|||
131728365|NCT04657016|474285266|FG000|Overall Study|Lost to Follow-up|24|||
131728366|NCT04657016|474285267|FG001|Overall Study|Lost to Follow-up|12|||
131728367|NCT04657016|474285266|FG000|Overall Study|Physician Decision|1|||
131806564|NCT00184600|474576178|FG001|Overall Study|Lost to Follow-up|6|||
131806565|NCT00184600|474576179|FG002|Overall Study|Lost to Follow-up|1|||
131728368|NCT04657016|474285267|FG001|Overall Study|Physician Decision|2|||
131728369|NCT04657016|474285266|FG000|Overall Study|Pregnancy|2|||
131806566|NCT00184600|474576177|FG000|Overall Study|Protocol Violation|2|||
131806567|NCT00184600|474576178|FG001|Overall Study|Protocol Violation|2|||
131728370|NCT04657016|474285267|FG001|Overall Study|Pregnancy|2|||
131728371|NCT04657016|474285266|FG000|Overall Study|Protocol Deviation|1|||
131728372|NCT04657016|474285267|FG001|Overall Study|Protocol Deviation|0|||
131728373|NCT04657016|474285266|FG000|Overall Study|Withdrawal by Subject|28|||
131728374|NCT04657016|474285267|FG001|Overall Study|Withdrawal by Subject|14|||
131728375|NCT04657016|474285266|FG000|Overall Study|Other - as reported by the investigator|6|||
131728376|NCT04657016|474285267|FG001|Overall Study|Other - as reported by the investigator|0|||
131728377|NCT00912015|474285271|FG000|Overall Study|Lack of Efficacy|1|||
131728378|NCT00912015|474285272|FG001|Overall Study|Lack of Efficacy|0|||
131728379|NCT00912015|474285273|FG002|Overall Study|Lack of Efficacy|0|||
131728380|NCT00912015|474285274|FG003|Overall Study|Lack of Efficacy|0|||
131806568|NCT00184600|474576179|FG002|Overall Study|Protocol Violation|3|||
131905054|NCT02616783|474939033|FG001|Overall Study|Adverse Event|0|||
131728381|NCT00912015|474285271|FG000|Overall Study|Withdrawal by Subject|8|||
131728382|NCT00912015|474285272|FG001|Overall Study|Withdrawal by Subject|8|||
131728383|NCT00912015|474285273|FG002|Overall Study|Withdrawal by Subject|3|||
131728384|NCT00912015|474285274|FG003|Overall Study|Withdrawal by Subject|0|||
131728385|NCT00912015|474285271|FG000|Overall Study|Protocol Violation|1|||
131728386|NCT00912015|474285272|FG001|Overall Study|Protocol Violation|0|||
131728387|NCT00912015|474285273|FG002|Overall Study|Protocol Violation|0|||
131728388|NCT00912015|474285274|FG003|Overall Study|Protocol Violation|1|||
131728389|NCT00912015|474285271|FG000|Overall Study|Adverse Event|6|||
131728390|NCT00912015|474285272|FG001|Overall Study|Adverse Event|0|||
131728391|NCT00912015|474285273|FG002|Overall Study|Adverse Event|0|||
131728392|NCT00912015|474285274|FG003|Overall Study|Adverse Event|1|||
131728393|NCT01356602|474285275|FG000|Overall Study|Protocol Deviation|0|||
131728394|NCT01356602|474285276|FG001|Overall Study|Protocol Deviation|1|||
131728395|NCT01356602|474285277|FG002|Overall Study|Protocol Deviation|1|||
131728396|NCT01356602|474285275|FG000|Overall Study|Administrative Problems|1|||
131728397|NCT01356602|474285276|FG001|Overall Study|Administrative Problems|4|||
131728398|NCT01356602|474285277|FG002|Overall Study|Administrative Problems|5|||
131728399|NCT01356602|474285275|FG000|Overall Study|Lost to Follow-up|4|||
131728400|NCT01356602|474285276|FG001|Overall Study|Lost to Follow-up|5|||
131728401|NCT01356602|474285277|FG002|Overall Study|Lost to Follow-up|6|||
131728402|NCT01356602|474285275|FG000|Overall Study|Withdrawal by Subject|4|||
131728403|NCT01356602|474285276|FG001|Overall Study|Withdrawal by Subject|3|||
131728404|NCT01356602|474285277|FG002|Overall Study|Withdrawal by Subject|7|||
131728405|NCT01356602|474285275|FG000|Overall Study|Lack of Efficacy|0|||
131728406|NCT01356602|474285276|FG001|Overall Study|Lack of Efficacy|1|||
131728407|NCT01356602|474285277|FG002|Overall Study|Lack of Efficacy|4|||
131728408|NCT01356602|474285275|FG000|Overall Study|Adverse Event|0|||
131728409|NCT01356602|474285276|FG001|Overall Study|Adverse Event|1|||
131728410|NCT01356602|474285277|FG002|Overall Study|Adverse Event|1|||
131728411|NCT01115569|474285278|FG000|Conversion/Titration Phase|Adverse Event|59|||
131728412|NCT01115569|474285279|FG001|Conversion/Titration Phase|Adverse Event|0|||
131728413|NCT01115569|474285278|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
131728414|NCT01115569|474285279|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
131728415|NCT01115569|474285278|FG000|Conversion/Titration Phase|Physician Decision|5|||
131728416|NCT01115569|474285279|FG001|Conversion/Titration Phase|Physician Decision|0|||
131728417|NCT01115569|474285278|FG000|Conversion/Titration Phase|Protocol Violation|68|||
131728418|NCT01115569|474285279|FG001|Conversion/Titration Phase|Protocol Violation|0|||
131728419|NCT01115569|474285278|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
131728420|NCT01115569|474285279|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
131728421|NCT01115569|474285278|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
131728422|NCT01115569|474285279|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
131728423|NCT01115569|474285278|FG000|Maintenance Phase|Adverse Event|0|||
131728424|NCT01115569|474285279|FG001|Maintenance Phase|Adverse Event|43|||
131728425|NCT01115569|474285278|FG000|Maintenance Phase|Lost to Follow-up|0|||
131728426|NCT01115569|474285279|FG001|Maintenance Phase|Lost to Follow-up|8|||
131728427|NCT01115569|474285278|FG000|Maintenance Phase|Physician Decision|0|||
131728428|NCT01115569|474285279|FG001|Maintenance Phase|Physician Decision|3|||
131728429|NCT01115569|474285278|FG000|Maintenance Phase|Protocol Violation|0|||
131728430|NCT01115569|474285279|FG001|Maintenance Phase|Protocol Violation|9|||
131728431|NCT01115569|474285278|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131728432|NCT01115569|474285279|FG001|Maintenance Phase|Withdrawal by Subject|27|||
131728433|NCT01115569|474285278|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
131728434|NCT01115569|474285279|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
131728435|NCT01115569|474285278|FG000|Maintenance Phase|Administrative|0|||
131728436|NCT01115569|474285279|FG001|Maintenance Phase|Administrative|1|||
131728437|NCT01993329|474285281|FG000|Period 2|Adverse Event|0|||
131806569|NCT00184600|474576177|FG000|Overall Study|Withdrawal by Subject|20|||
131806570|NCT00184600|474576178|FG001|Overall Study|Withdrawal by Subject|28|||
131728438|NCT01993329|474285282|FG001|Period 2|Adverse Event|0|||
131728439|NCT01993329|474285283|FG002|Period 2|Adverse Event|0|||
131728440|NCT01993329|474285284|FG003|Period 2|Adverse Event|0|||
131728441|NCT01993329|474285285|FG004|Period 2|Adverse Event|0|||
131728442|NCT01993329|474285286|FG005|Period 2|Adverse Event|1|||
131728443|NCT01993329|474285281|FG000|Wash-out|Personal reasons|0|||
131728444|NCT01993329|474285282|FG001|Wash-out|Personal reasons|1|||
131806571|NCT00184600|474576179|FG002|Overall Study|Withdrawal by Subject|12|||
131806572|NCT00184600|474576177|FG000|Overall Study|Unclassified|4|||
131728445|NCT01993329|474285283|FG002|Wash-out|Personal reasons|0|||
131728446|NCT01993329|474285284|FG003|Wash-out|Personal reasons|0|||
131728447|NCT01993329|474285285|FG004|Wash-out|Personal reasons|0|||
131728448|NCT01993329|474285286|FG005|Wash-out|Personal reasons|0|||
131728449|NCT02311478|474285287|FG000|Overall Study|Withdrawal by Subject|1|||
131728450|NCT02311478|474285287|FG000|Overall Study|Lost to Follow-up|5|||
131728451|NCT02311478|474285287|FG000|Overall Study|Failed IUD Insertion|1|||
131728452|NCT03242928|474285288|FG000|Overall Study|Adverse Event|2|||
131728453|NCT03242928|474285289|FG001|Overall Study|Adverse Event|1|||
131806573|NCT00184600|474576178|FG001|Overall Study|Unclassified|5|||
131806574|NCT00184600|474576179|FG002|Overall Study|Unclassified|3|||
131806575|NCT00286754|474576180|FG000|Overall Study|Adverse Event|2|||
131806576|NCT00286754|474576181|FG001|Overall Study|Adverse Event|2|||
131806577|NCT00286754|474576182|FG002|Overall Study|Adverse Event|3|||
131806578|NCT00286754|474576180|FG000|Overall Study|Withdrawal by Subject|6|||
131806579|NCT00286754|474576181|FG001|Overall Study|Withdrawal by Subject|2|||
131806580|NCT00286754|474576182|FG002|Overall Study|Withdrawal by Subject|0|||
131806581|NCT00286754|474576180|FG000|Overall Study|Lost to Follow-up|12|||
131806582|NCT00286754|474576181|FG001|Overall Study|Lost to Follow-up|14|||
131806583|NCT00286754|474576182|FG002|Overall Study|Lost to Follow-up|6|||
131806584|NCT00286754|474576180|FG000|Overall Study|Moved out of state|0|||
131806585|NCT00286754|474576181|FG001|Overall Study|Moved out of state|0|||
131806586|NCT00286754|474576182|FG002|Overall Study|Moved out of state|1|||
131806587|NCT02336165|474576183|FG000|Overall Study|Death|3|||
131806588|NCT02336165|474576184|FG001|Overall Study|Death|0|||
131806589|NCT02336165|474576185|FG002|Overall Study|Death|0|||
131806590|NCT02336165|474576186|FG003|Overall Study|Death|0|||
131728454|NCT03242928|474285288|FG000|Overall Study|Lost to Follow-up|2|||
131728455|NCT03242928|474285289|FG001|Overall Study|Lost to Follow-up|0|||
131728456|NCT03242928|474285288|FG000|Overall Study|Physician Decision|0|||
131728457|NCT03242928|474285289|FG001|Overall Study|Physician Decision|1|||
131728458|NCT03242928|474285288|FG000|Overall Study|Withdrawal by Subject|5|||
131728459|NCT03242928|474285289|FG001|Overall Study|Withdrawal by Subject|3|||
131728460|NCT03276936|474285290|FG000|Overall Study|Adverse Event|4|||
131728461|NCT03276936|474285291|FG001|Overall Study|Adverse Event|2|||
131728462|NCT03276936|474285290|FG000|Overall Study|Lost to Follow-up|16|||
131728463|NCT03276936|474285291|FG001|Overall Study|Lost to Follow-up|13|||
131728464|NCT03276936|474285290|FG000|Overall Study|Withdrawal by Subject|30|||
131728465|NCT03276936|474285291|FG001|Overall Study|Withdrawal by Subject|20|||
131728466|NCT03276936|474285290|FG000|Overall Study|Not mentioned|6|||
131728467|NCT03276936|474285291|FG001|Overall Study|Not mentioned|3|||
131728468|NCT03041116|474285292|FG000|Double-blind|Death|0|||
131728469|NCT03041116|474285293|FG001|Double-blind|Death|2|||
131728470|NCT03041116|474285292|FG000|Double-blind|Withdrawal by Subject|0|||
131728471|NCT03041116|474285293|FG001|Double-blind|Withdrawal by Subject|4|||
131728472|NCT03041116|474285292|FG000|Open-label|Death|1|||
131728473|NCT03041116|474285293|FG001|Open-label|Death|0|||
131728474|NCT03041116|474285292|FG000|Open-label|Termination of the study by Sponsor|39|||
131728475|NCT03041116|474285293|FG001|Open-label|Termination of the study by Sponsor|37|||
131728476|NCT03041116|474285292|FG000|Open-label|Withdrawal by Subject|1|||
131728477|NCT03041116|474285293|FG001|Open-label|Withdrawal by Subject|0|||
131728478|NCT00943319|474285294|FG000|Overall Study|Death|1|||
131728479|NCT02043301|474285295|FG000|Overall Study|Discontinued|0|||
131728480|NCT02043301|474285296|FG001|Overall Study|Discontinued|1|||
131728481|NCT02043301|474285297|FG002|Overall Study|Discontinued|0|||
131728482|NCT03097328|474285298|FG000|Overall Study|Still on Therapy|2|||
131728483|NCT03097328|474285298|FG000|Overall Study|Progressive Disease|29|||
131806591|NCT02336165|474576187|FG004|Overall Study|Death|1|||
131806592|NCT02336165|474576183|FG000|Overall Study|Physician Decision|2|||
131806593|NCT02336165|474576184|FG001|Overall Study|Physician Decision|2|||
131806594|NCT02336165|474576185|FG002|Overall Study|Physician Decision|1|||
131806595|NCT02336165|474576186|FG003|Overall Study|Physician Decision|1|||
131806596|NCT02336165|474576187|FG004|Overall Study|Physician Decision|0|||
131806597|NCT02336165|474576183|FG000|Overall Study|Withdrawal by Subject|0|||
131806598|NCT02336165|474576184|FG001|Overall Study|Withdrawal by Subject|0|||
131806599|NCT02336165|474576185|FG002|Overall Study|Withdrawal by Subject|1|||
131806600|NCT02336165|474576186|FG003|Overall Study|Withdrawal by Subject|0|||
131806601|NCT02336165|474576187|FG004|Overall Study|Withdrawal by Subject|1|||
131905055|NCT02616783|474939032|FG000|Overall Study|Death|1|||
131728484|NCT03097328|474285298|FG000|Overall Study|Adverse Event|4|||
131728485|NCT03097328|474285298|FG000|Overall Study|Withdrawal by Subject|1|||
131728486|NCT03097328|474285298|FG000|Overall Study|Physician Decision|1|||
131905056|NCT02616783|474939033|FG001|Overall Study|Death|0|||
131728487|NCT03097328|474285298|FG000|Overall Study|Patient Decision|1|||
131728488|NCT03097328|474285298|FG000|Overall Study|Ineligible for Study Drug|1|||
131728489|NCT01798134|474285299|FG000|Overall Study|Lost to Follow-up|1|||
131806602|NCT02336165|474576183|FG000|Overall Study|Adverse Event|4|||
131806603|NCT02336165|474576184|FG001|Overall Study|Adverse Event|1|||
131728490|NCT01798134|474285299|FG000|Overall Study|Withdrawal by Subject|3|||
131806604|NCT02336165|474576185|FG002|Overall Study|Adverse Event|2|||
131806605|NCT02336165|474576186|FG003|Overall Study|Adverse Event|4|||
131806606|NCT02336165|474576187|FG004|Overall Study|Adverse Event|1|||
131806607|NCT02336165|474576183|FG000|Overall Study|Progressive disease|23|||
131806608|NCT02336165|474576184|FG001|Overall Study|Progressive disease|22|||
131728491|NCT01798134|474285299|FG000|Overall Study|Death|2|||
131728492|NCT01798134|474285299|FG000|Overall Study|Adverse Event|3|||
131728493|NCT01798134|474285299|FG000|Overall Study|Physician Decision|3|||
131728494|NCT01798134|474285299|FG000|Overall Study|Liver transplant/surgery|4|||
131728495|NCT02653976|474285300|FG000|Overall Study|Withdrawal by Subject|5|||
131728496|NCT02653976|474285300|FG000|Overall Study|Death|4|||
131728497|NCT02023164|474285301|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
131728498|NCT02023164|474285302|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
131728499|NCT00883558|474285303|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
131728500|NCT00883558|474285304|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
131728501|NCT00883558|474285305|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
131728502|NCT00883558|474285303|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
131728503|NCT00883558|474285304|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
131728504|NCT00883558|474285305|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
131728505|NCT00883558|474285303|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
131728506|NCT00883558|474285304|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
131728507|NCT00883558|474285305|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
131728508|NCT00883558|474285303|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
131728509|NCT00883558|474285304|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
131728510|NCT00883558|474285305|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
131728511|NCT00883558|474285303|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
131728512|NCT00883558|474285304|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
131728513|NCT00883558|474285305|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
131728514|NCT02436577|474285306|FG000|Overall Study|Protocol Deviation|0|||
131728515|NCT02436577|474285307|FG001|Overall Study|Protocol Deviation|1|||
131728516|NCT02436577|474285308|FG002|Overall Study|Protocol Deviation|0|||
131728517|NCT02436577|474285309|FG003|Overall Study|Protocol Deviation|0|||
131728518|NCT02436577|474285310|FG004|Overall Study|Protocol Deviation|0|||
131728519|NCT02436577|474285311|FG005|Overall Study|Protocol Deviation|0|||
131728520|NCT00625365|474285316|FG000|Overall Study|Withdrawal by Subject|1|||
131728521|NCT00625365|474285316|FG000|Overall Study|No IV access|5|||
131728522|NCT00625365|474285316|FG000|Overall Study|VSD|1|||
131728523|NCT02678741|474285318|FG000|Overall Study|Death|4|||
131728524|NCT02678741|474285318|FG000|Overall Study|Withdrawal by Subject|1|||
131728525|NCT02678741|474285318|FG000|Overall Study|ineligible|3|||
131728526|NCT02678741|474285318|FG000|Overall Study|Not RECIST Measurable|2|||
131728527|NCT02678741|474285318|FG000|Overall Study|Lack of Efficacy|10|||
131728528|NCT00903032|474285319|FG000|Overall Study|Withdrawal by Subject|5|||
131728529|NCT00903032|474285320|FG001|Overall Study|Withdrawal by Subject|3|||
131728530|NCT00903032|474285319|FG000|Overall Study|Lost to Follow-up|2|||
131728531|NCT00903032|474285320|FG001|Overall Study|Lost to Follow-up|2|||
131728532|NCT01876732|474285333|FG000|Overall Study|MMA was not over 800mg/dL|75|||
131728533|NCT02341014|474285338|FG000|Overall Study|Adverse Event|0|||
131728534|NCT02341014|474285339|FG001|Overall Study|Adverse Event|1|||
131728535|NCT02341014|474285340|FG002|Overall Study|Adverse Event|0|||
131728536|NCT02341014|474285341|FG003|Overall Study|Adverse Event|0|||
131728537|NCT02341014|474285342|FG004|Overall Study|Adverse Event|2|||
131728538|NCT04705597|474285343|FG000|Overall Study|Death|16|||
131728539|NCT04705597|474285344|FG001|Overall Study|Death|9|||
131728540|NCT04705597|474285343|FG000|Overall Study|Lost to Follow-up|1|||
131728541|NCT04705597|474285344|FG001|Overall Study|Lost to Follow-up|0|||
131728542|NCT04705597|474285343|FG000|Overall Study|Withdrawal by Subject|1|||
131728543|NCT04705597|474285344|FG001|Overall Study|Withdrawal by Subject|2|||
131728544|NCT00273858|474285351|FG000|Overall Study|Not completed 24 month observation time|334|||
131728545|NCT00273858|474285351|FG000|Overall Study|Lost to Follow-up|101|||
131728546|NCT00273858|474285351|FG000|Overall Study|Withdrawal by Subject|21|||
131728547|NCT00273858|474285351|FG000|Overall Study|Adverse Event|81|||
131728548|NCT01258348|474285352|FG000|Overall Study|Adverse Event|1|||
131728549|NCT01258348|474285353|FG001|Overall Study|Adverse Event|1|||
131728550|NCT01258348|474285354|FG002|Overall Study|Adverse Event|3|||
131728551|NCT01258348|474285355|FG003|Overall Study|Adverse Event|2|||
131728552|NCT01258348|474285356|FG004|Overall Study|Adverse Event|4|||
131728553|NCT01258348|474285352|FG000|Overall Study|Progressive Disease|0|||
131728554|NCT01258348|474285353|FG001|Overall Study|Progressive Disease|3|||
131448768|NCT00790842|473272728|FG008|Expansion Cohort|Adverse Event|0|||
131728555|NCT01258348|474285354|FG002|Overall Study|Progressive Disease|0|||
131728556|NCT01258348|474285355|FG003|Overall Study|Progressive Disease|2|||
131728557|NCT01258348|474285356|FG004|Overall Study|Progressive Disease|2|||
131728558|NCT01258348|474285352|FG000|Overall Study|Physician Decision|0|||
131728559|NCT01258348|474285353|FG001|Overall Study|Physician Decision|0|||
131728560|NCT01258348|474285354|FG002|Overall Study|Physician Decision|0|||
131728561|NCT01258348|474285355|FG003|Overall Study|Physician Decision|2|||
131728562|NCT01258348|474285356|FG004|Overall Study|Physician Decision|0|||
131728563|NCT01258348|474285352|FG000|Overall Study|Withdrawal by Subject|0|||
131728564|NCT01258348|474285353|FG001|Overall Study|Withdrawal by Subject|1|||
131728565|NCT01258348|474285354|FG002|Overall Study|Withdrawal by Subject|0|||
131728566|NCT01258348|474285355|FG003|Overall Study|Withdrawal by Subject|0|||
131728567|NCT01258348|474285356|FG004|Overall Study|Withdrawal by Subject|0|||
131728568|NCT01234402|474285362|FG000|Overall Study|Lost to Follow-up|0|||
131728569|NCT01234402|474285363|FG001|Overall Study|Lost to Follow-up|1|||
131728570|NCT01234402|474285364|FG002|Overall Study|Lost to Follow-up|3|||
131728571|NCT01234402|474285362|FG000|Overall Study|Withdrawal by Subject|1|||
131728572|NCT01234402|474285363|FG001|Overall Study|Withdrawal by Subject|3|||
131728573|NCT01234402|474285364|FG002|Overall Study|Withdrawal by Subject|4|||
131728574|NCT01234402|474285362|FG000|Overall Study|Never treated: Death|0|||
131728575|NCT01234402|474285363|FG001|Overall Study|Never treated: Death|0|||
131728576|NCT01234402|474285364|FG002|Overall Study|Never treated: Death|1|||
131728577|NCT01234402|474285362|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
131728578|NCT01234402|474285363|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
131728579|NCT01234402|474285364|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
131728580|NCT01234402|474285362|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
131728581|NCT01234402|474285363|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
131728582|NCT01234402|474285364|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
131728583|NCT02417233|474285366|FG000|Overall Study|Death|4|||
131728584|NCT02417233|474285367|FG001|Overall Study|Death|10|||
131728585|NCT02417233|474285368|FG002|Overall Study|Death|14|||
131728586|NCT02417233|474285366|FG000|Overall Study|Lost to Follow-up|27|||
131728587|NCT02417233|474285367|FG001|Overall Study|Lost to Follow-up|39|||
131728588|NCT02417233|474285368|FG002|Overall Study|Lost to Follow-up|34|||
131728589|NCT02417233|474285366|FG000|Overall Study|Protocol Violation|2|||
131728590|NCT02417233|474285367|FG001|Overall Study|Protocol Violation|0|||
131728591|NCT02417233|474285368|FG002|Overall Study|Protocol Violation|2|||
131728592|NCT02417233|474285366|FG000|Overall Study|Withdrawal by Subject|2|||
131728593|NCT02417233|474285367|FG001|Overall Study|Withdrawal by Subject|1|||
131728594|NCT02417233|474285368|FG002|Overall Study|Withdrawal by Subject|8|||
131728595|NCT02417233|474285366|FG000|Overall Study|Relocation out of study area|1|||
131728596|NCT02417233|474285367|FG001|Overall Study|Relocation out of study area|0|||
131728597|NCT02417233|474285368|FG002|Overall Study|Relocation out of study area|1|||
131728598|NCT02417233|474285366|FG000|Overall Study|Mentally unstable|0|||
131728599|NCT02417233|474285367|FG001|Overall Study|Mentally unstable|1|||
131728600|NCT02417233|474285368|FG002|Overall Study|Mentally unstable|0|||
131728601|NCT03649321|474285369|FG000|Overall Study|Withdrawal by Subject|1|||
131728602|NCT03649321|474285370|FG001|Overall Study|Withdrawal by Subject|0|||
131728603|NCT03649321|474285369|FG000|Overall Study|Death|1|||
131728604|NCT03649321|474285370|FG001|Overall Study|Death|0|||
131728605|NCT00321984|474285371|FG000|Overall Study|Adverse Event|9|||
131728606|NCT00321984|474285372|FG001|Overall Study|Adverse Event|6|||
131728607|NCT00321984|474285373|FG002|Overall Study|Adverse Event|8|||
131728608|NCT00321984|474285371|FG000|Overall Study|Protocol Violation|0|||
131728609|NCT00321984|474285372|FG001|Overall Study|Protocol Violation|1|||
131728610|NCT00321984|474285373|FG002|Overall Study|Protocol Violation|1|||
131728611|NCT00321984|474285371|FG000|Overall Study|Lost to Follow-up|2|||
131728612|NCT00321984|474285372|FG001|Overall Study|Lost to Follow-up|4|||
131728613|NCT00321984|474285373|FG002|Overall Study|Lost to Follow-up|2|||
131728614|NCT00321984|474285371|FG000|Overall Study|Withdrawal by Subject|8|||
131728615|NCT00321984|474285372|FG001|Overall Study|Withdrawal by Subject|6|||
131728616|NCT00321984|474285373|FG002|Overall Study|Withdrawal by Subject|5|||
131728617|NCT00321984|474285371|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
131728618|NCT00321984|474285372|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
131728619|NCT00321984|474285373|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
131728620|NCT00321984|474285371|FG000|Overall Study|Lack of Efficacy|3|||
131728621|NCT00321984|474285372|FG001|Overall Study|Lack of Efficacy|1|||
131728622|NCT00321984|474285373|FG002|Overall Study|Lack of Efficacy|3|||
131728623|NCT00321984|474285371|FG000|Overall Study|Noncompliant|0|||
131728624|NCT00321984|474285372|FG001|Overall Study|Noncompliant|0|||
131728625|NCT00321984|474285373|FG002|Overall Study|Noncompliant|2|||
131728626|NCT00321984|474285371|FG000|Overall Study|Pregnancy|0|||
131728627|NCT00321984|474285372|FG001|Overall Study|Pregnancy|1|||
131728628|NCT00321984|474285373|FG002|Overall Study|Pregnancy|0|||
131728629|NCT00321984|474285371|FG000|Overall Study|Per Subject Request|1|||
131728630|NCT00321984|474285372|FG001|Overall Study|Per Subject Request|0|||
131728631|NCT00321984|474285373|FG002|Overall Study|Per Subject Request|0|||
131728632|NCT00321984|474285371|FG000|Overall Study|Per Investigator Request|1|||
131728633|NCT00321984|474285372|FG001|Overall Study|Per Investigator Request|0|||
131728634|NCT00321984|474285373|FG002|Overall Study|Per Investigator Request|0|||
131728635|NCT00321984|474285371|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
131728636|NCT00321984|474285372|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
131728637|NCT00321984|474285373|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
131728638|NCT02137772|474285375|FG000|Overall Study|Adverse Event|6|||
131728639|NCT02137772|474285376|FG001|Overall Study|Adverse Event|3|||
131728640|NCT02137772|474285375|FG000|Overall Study|Death|71|||
131728641|NCT02137772|474285376|FG001|Overall Study|Death|44|||
131728642|NCT02137772|474285375|FG000|Overall Study|Lost to Follow-up|8|||
131728643|NCT02137772|474285376|FG001|Overall Study|Lost to Follow-up|4|||
131728644|NCT02137772|474285375|FG000|Overall Study|Physician Decision|15|||
131728645|NCT02137772|474285376|FG001|Overall Study|Physician Decision|5|||
131728646|NCT02137772|474285375|FG000|Overall Study|Withdrawal by Subject|28|||
131728647|NCT02137772|474285376|FG001|Overall Study|Withdrawal by Subject|17|||
131728648|NCT02137772|474285375|FG000|Overall Study|Non-compliance with study drug|1|||
131728649|NCT02137772|474285376|FG001|Overall Study|Non-compliance with study drug|0|||
131728650|NCT02137772|474285375|FG000|Overall Study|Not treated|3|||
131728651|NCT02137772|474285376|FG001|Overall Study|Not treated|2|||
131728652|NCT00803244|474285377|FG000|Overall Study|Adverse Event|1|||
131728653|NCT00803244|474285378|FG001|Overall Study|Adverse Event|2|||
131728654|NCT00803244|474285377|FG000|Overall Study|Withdrawal by Subject|2|||
131728655|NCT00803244|474285378|FG001|Overall Study|Withdrawal by Subject|3|||
131728656|NCT00803244|474285377|FG000|Overall Study|Any other reason not above-mentioned|4|||
131728657|NCT00803244|474285378|FG001|Overall Study|Any other reason not above-mentioned|10|||
131728658|NCT00616239|474285380|FG000|Overall Study|Withdrawal by Subject|2|||
131728659|NCT02873715|474285381|FG000|Overall Study|Lost to Follow-up|84|||
131728660|NCT02873715|474285382|FG001|Overall Study|Lost to Follow-up|94|||
131728661|NCT02873715|474285381|FG000|Overall Study|Withdrawal by Subject|7|||
131728662|NCT02873715|474285382|FG001|Overall Study|Withdrawal by Subject|26|||
131728663|NCT03241173|474285386|FG000|Overall Study|Death|3|||
131728664|NCT03241173|474285387|FG001|Overall Study|Death|2|||
131728665|NCT03241173|474285388|FG002|Overall Study|Death|4|||
131728666|NCT03241173|474285389|FG003|Overall Study|Death|4|||
131728667|NCT03241173|474285390|FG004|Overall Study|Death|2|||
131728668|NCT03241173|474285391|FG005|Overall Study|Death|2|||
131728669|NCT03241173|474285392|FG006|Overall Study|Death|3|||
131728670|NCT03241173|474285393|FG007|Overall Study|Death|1|||
131728671|NCT03241173|474285394|FG008|Overall Study|Death|0|||
131728672|NCT03241173|474285395|FG009|Overall Study|Death|5|||
131728673|NCT03241173|474285396|FG010|Overall Study|Death|4|||
131728674|NCT03241173|474285397|FG011|Overall Study|Death|3|||
131728675|NCT03241173|474285398|FG012|Overall Study|Death|0|||
131728676|NCT03241173|474285399|FG013|Overall Study|Death|0|||
131728677|NCT03241173|474285400|FG014|Overall Study|Death|0|||
131728678|NCT03241173|474285386|FG000|Overall Study|Withdrawal by Subject|0|||
131728679|NCT03241173|474285387|FG001|Overall Study|Withdrawal by Subject|0|||
131728680|NCT03241173|474285388|FG002|Overall Study|Withdrawal by Subject|1|||
131728681|NCT03241173|474285389|FG003|Overall Study|Withdrawal by Subject|0|||
131728682|NCT03241173|474285390|FG004|Overall Study|Withdrawal by Subject|0|||
131728683|NCT03241173|474285391|FG005|Overall Study|Withdrawal by Subject|1|||
131728684|NCT03241173|474285392|FG006|Overall Study|Withdrawal by Subject|0|||
131728685|NCT03241173|474285393|FG007|Overall Study|Withdrawal by Subject|0|||
131728686|NCT03241173|474285394|FG008|Overall Study|Withdrawal by Subject|0|||
131728687|NCT03241173|474285395|FG009|Overall Study|Withdrawal by Subject|0|||
131728688|NCT03241173|474285396|FG010|Overall Study|Withdrawal by Subject|0|||
131728689|NCT03241173|474285397|FG011|Overall Study|Withdrawal by Subject|0|||
131728690|NCT03241173|474285398|FG012|Overall Study|Withdrawal by Subject|0|||
131728691|NCT03241173|474285399|FG013|Overall Study|Withdrawal by Subject|0|||
131728692|NCT03241173|474285400|FG014|Overall Study|Withdrawal by Subject|0|||
131728693|NCT03241173|474285386|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131728694|NCT03241173|474285387|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131728695|NCT03241173|474285388|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131728696|NCT03241173|474285389|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131806609|NCT02336165|474576185|FG002|Overall Study|Progressive disease|27|||
131448769|NCT00790842|473272729|FG009|Expansion Cohort|Adverse Event|0|||
131728697|NCT03241173|474285390|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131728698|NCT03241173|474285391|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131806610|NCT02336165|474576186|FG003|Overall Study|Progressive disease|24|||
131728699|NCT03241173|474285392|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131728700|NCT03241173|474285393|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131728701|NCT03241173|474285394|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131728702|NCT03241173|474285395|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131728703|NCT03241173|474285396|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131728704|NCT03241173|474285397|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
131728705|NCT03241173|474285398|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131728706|NCT03241173|474285399|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131728707|NCT03241173|474285400|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131728708|NCT03241173|474285386|FG000|Overall Study|Lost to Follow-up|0|||
131728709|NCT03241173|474285387|FG001|Overall Study|Lost to Follow-up|0|||
131728710|NCT03241173|474285388|FG002|Overall Study|Lost to Follow-up|0|||
131728711|NCT03241173|474285389|FG003|Overall Study|Lost to Follow-up|0|||
131728712|NCT03241173|474285390|FG004|Overall Study|Lost to Follow-up|1|||
131728713|NCT03241173|474285391|FG005|Overall Study|Lost to Follow-up|0|||
131728714|NCT03241173|474285392|FG006|Overall Study|Lost to Follow-up|0|||
131728715|NCT03241173|474285393|FG007|Overall Study|Lost to Follow-up|0|||
131728716|NCT03241173|474285394|FG008|Overall Study|Lost to Follow-up|0|||
131728717|NCT03241173|474285395|FG009|Overall Study|Lost to Follow-up|1|||
131728718|NCT03241173|474285396|FG010|Overall Study|Lost to Follow-up|0|||
131728719|NCT03241173|474285397|FG011|Overall Study|Lost to Follow-up|0|||
131728720|NCT03241173|474285398|FG012|Overall Study|Lost to Follow-up|0|||
131728721|NCT03241173|474285399|FG013|Overall Study|Lost to Follow-up|0|||
131728722|NCT03241173|474285400|FG014|Overall Study|Lost to Follow-up|0|||
131728723|NCT00564629|474285401|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
131728724|NCT00564629|474285402|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
131728725|NCT03648996|474285403|FG000|Overall Study|Withdrawal by Subject|0|||
131728726|NCT03648996|474285404|FG001|Overall Study|Withdrawal by Subject|2|||
131728727|NCT03648996|474285405|FG002|Overall Study|Withdrawal by Subject|2|||
131728728|NCT03648996|474285403|FG000|Overall Study|Physician Decision|2|||
131728729|NCT03648996|474285404|FG001|Overall Study|Physician Decision|0|||
131728730|NCT03648996|474285405|FG002|Overall Study|Physician Decision|0|||
131728731|NCT00590681|474285406|FG000|Overall Study|Withdrawal by Subject|7|||
131728732|NCT00590681|474285406|FG000|Overall Study|Adverse Event|8|||
131728733|NCT00590681|474285406|FG000|Overall Study|Death|3|||
131728734|NCT00590681|474285406|FG000|Overall Study|Lost to Follow-up|1|||
131728735|NCT00590681|474285406|FG000|Overall Study|disease progression|1|||
131728736|NCT00443430|474285412|FG000|Overall Study|Lack of Efficacy|3|||
131728737|NCT00443430|474285413|FG001|Overall Study|Lack of Efficacy|3|||
131728738|NCT00443430|474285412|FG000|Overall Study|Adverse Event|1|||
131728739|NCT00443430|474285413|FG001|Overall Study|Adverse Event|1|||
131728740|NCT00064662|474285414|FG000|Overall Study|Death|1|||
131728741|NCT00064662|474285415|FG001|Overall Study|Death|1|||
131728742|NCT00064662|474285414|FG000|Overall Study|Lost to Follow-up|57|||
131728743|NCT00064662|474285415|FG001|Overall Study|Lost to Follow-up|44|||
131728744|NCT00064662|474285414|FG000|Overall Study|Withdrawal by Subject|14|||
131728745|NCT00064662|474285415|FG001|Overall Study|Withdrawal by Subject|14|||
131728746|NCT00064662|474285414|FG000|Overall Study|Administratively withdrawn|2|||
131728747|NCT00064662|474285415|FG001|Overall Study|Administratively withdrawn|2|||
131728748|NCT02650284|474285419|FG000|Overall Study|Lost to Follow-up|3|||
131728749|NCT02650284|474285420|FG001|Overall Study|Lost to Follow-up|3|||
131728750|NCT02650284|474285419|FG000|Overall Study|Consent incorrectly taken|0|||
131728751|NCT02650284|474285420|FG001|Overall Study|Consent incorrectly taken|1|||
131728752|NCT01165203|474285421|FG000|Active Phase|Serious Adverse Event|1|||
131728753|NCT01165203|474285422|FG001|Active Phase|Serious Adverse Event|0|||
131728754|NCT01165203|474285421|FG000|Active Phase|Withdrawal by Subject|2|||
131728755|NCT01165203|474285422|FG001|Active Phase|Withdrawal by Subject|1|||
131728756|NCT01165203|474285421|FG000|Active Phase|Migrated/moved from study area|0|||
131728757|NCT01165203|474285422|FG001|Active Phase|Migrated/moved from study area|1|||
131728758|NCT01165203|474285421|FG000|Active Phase|Lost to Follow-up|2|||
131728759|NCT01165203|474285422|FG001|Active Phase|Lost to Follow-up|0|||
131728760|NCT01165203|474285421|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
131728761|NCT01165203|474285422|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
131728762|NCT01165203|474285421|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
131728763|NCT01165203|474285422|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
131728764|NCT01165203|474285421|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
131728765|NCT01165203|474285422|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
131728766|NCT01165203|474285421|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
131728767|NCT01165203|474285422|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
131728768|NCT01165203|474285421|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
131728769|NCT01165203|474285422|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
131728770|NCT01663740|474285430|FG000|Overall Study|Lost to Follow-up|1|||
131728771|NCT01663740|474285431|FG001|Overall Study|Lost to Follow-up|4|||
131728772|NCT01663740|474285430|FG000|Overall Study|Other|9|||
131728773|NCT01663740|474285431|FG001|Overall Study|Other|2|||
131728774|NCT01663740|474285430|FG000|Overall Study|Inclusion/Exclusion not met|1|||
131728775|NCT01663740|474285431|FG001|Overall Study|Inclusion/Exclusion not met|0|||
131728776|NCT01663740|474285430|FG000|Overall Study|Death|0|||
131728777|NCT01663740|474285431|FG001|Overall Study|Death|1|||
131728778|NCT01663740|474285430|FG000|Overall Study|Withdrawal by Subject|2|||
131728779|NCT01663740|474285431|FG001|Overall Study|Withdrawal by Subject|1|||
131728780|NCT01663740|474285430|FG000|Overall Study|No end of study status|3|||
131728781|NCT01663740|474285431|FG001|Overall Study|No end of study status|0|||
131728782|NCT01931462|474286984|FG000|Overall Study|Withdrawal by Subject|1|||
131728783|NCT01881620|474286992|FG000|Overall Study|Protocol Violation|4|||
131728784|NCT01675011|474287003|FG000|Overall Study|Trial terminated by Sponsor|3|||
131728785|NCT01675011|474287004|FG001|Overall Study|Trial terminated by Sponsor|1|||
131728786|NCT00615290|474287005|FG000|Overall Study|Adverse Event|2|||
131728787|NCT00615290|474287005|FG000|Overall Study|Lost to Follow-up|3|||
131728788|NCT00615290|474287005|FG000|Overall Study|Withdrawal by Subject|1|||
131728789|NCT00615290|474287005|FG000|Overall Study|Other|2|||
131728790|NCT01252134|474287006|FG000|Period 1, 8 Hours|Personal Reasons|0|||
131728791|NCT01252134|474287007|FG001|Period 1, 8 Hours|Personal Reasons|1|||
131728792|NCT01252134|474287008|FG002|Period 1, 8 Hours|Personal Reasons|1|||
131728793|NCT01252134|474287009|FG003|Period 1, 8 Hours|Personal Reasons|0|||
131728794|NCT01252134|474287010|FG004|Period 1, 8 Hours|Personal Reasons|0|||
131728795|NCT01252134|474287011|FG005|Period 1, 8 Hours|Personal Reasons|0|||
131728796|NCT03650452|474287012|FG000|Overall Study|Physician Decision|1|||
131728797|NCT03650452|474287013|FG001|Overall Study|Physician Decision|0|||
131728798|NCT03650452|474287012|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
131728799|NCT03650452|474287013|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131728800|NCT03650452|474287012|FG000|Overall Study|Adverse Event|3|||
131728801|NCT03650452|474287013|FG001|Overall Study|Adverse Event|4|||
131728802|NCT03650452|474287012|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
131728803|NCT03650452|474287013|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
131728804|NCT02273050|474287014|FG000|Overall Study|Adverse Event|4|||
131728805|NCT02273050|474287015|FG001|Overall Study|Adverse Event|3|||
131728806|NCT02273050|474287016|FG002|Overall Study|Adverse Event|3|||
131728807|NCT02273050|474287014|FG000|Overall Study|Death|0|||
131728808|NCT02273050|474287015|FG001|Overall Study|Death|0|||
131728809|NCT02273050|474287016|FG002|Overall Study|Death|1|||
131728810|NCT02273050|474287014|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
131728811|NCT02273050|474287015|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
131728812|NCT02273050|474287016|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
131728813|NCT02273050|474287014|FG000|Overall Study|Lack of Efficacy|0|||
131728814|NCT02273050|474287015|FG001|Overall Study|Lack of Efficacy|1|||
131728815|NCT02273050|474287016|FG002|Overall Study|Lack of Efficacy|1|||
131728816|NCT02273050|474287014|FG000|Overall Study|Withdrawal by Subject|17|||
131728817|NCT02273050|474287015|FG001|Overall Study|Withdrawal by Subject|14|||
131728818|NCT02273050|474287016|FG002|Overall Study|Withdrawal by Subject|16|||
131728819|NCT02273050|474287014|FG000|Overall Study|Lost to Follow-up|0|||
131728820|NCT02273050|474287015|FG001|Overall Study|Lost to Follow-up|2|||
131728821|NCT02273050|474287016|FG002|Overall Study|Lost to Follow-up|3|||
131728822|NCT02273050|474287014|FG000|Overall Study|Protocol Violation|3|||
131806611|NCT02336165|474576187|FG004|Overall Study|Progressive disease|19|||
131806612|NCT02336165|474576183|FG000|Overall Study|Non-compliance|1|||
131806613|NCT02336165|474576184|FG001|Overall Study|Non-compliance|0|||
131806614|NCT02336165|474576185|FG002|Overall Study|Non-compliance|0|||
131806615|NCT02336165|474576186|FG003|Overall Study|Non-compliance|1|||
131806616|NCT02336165|474576187|FG004|Overall Study|Non-compliance|0|||
131806617|NCT02336165|474576183|FG000|Overall Study|Other|1|||
131806618|NCT02336165|474576184|FG001|Overall Study|Other|0|||
131806619|NCT02336165|474576185|FG002|Overall Study|Other|0|||
131806620|NCT02336165|474576186|FG003|Overall Study|Other|1|||
131806621|NCT02336165|474576187|FG004|Overall Study|Other|0|||
131728823|NCT02273050|474287015|FG001|Overall Study|Protocol Violation|1|||
131728824|NCT02273050|474287016|FG002|Overall Study|Protocol Violation|4|||
131728825|NCT01795898|474287018|FG000|Overall Study|Adverse Event|27|||
131728826|NCT01795898|474287018|FG000|Overall Study|Lost to Follow-up|20|||
131728827|NCT01795898|474287018|FG000|Overall Study|Withdrawal of consent|6|||
131728828|NCT01795898|474287018|FG000|Overall Study|Diagnosed with metastasis|1|||
131728829|NCT01795898|474287018|FG000|Overall Study|No pain|1|||
131728830|NCT01795898|474287018|FG000|Overall Study|Death|1|||
131905057|NCT02616783|474939032|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131728831|NCT01795898|474287018|FG000|Overall Study|Withdrew consent & had adverse events|3|||
131728832|NCT01795898|474287018|FG000|Overall Study|Physician Decision|1|||
131728833|NCT03539458|474287019|FG000|Overall Study|Death|1|||
131806622|NCT00552669|474576193|FG000|Overall Study|Death|3|||
131806623|NCT00552669|474576194|FG001|Overall Study|Death|7|||
131806624|NCT01844375|474576195|FG000|Overall Study|Protocol Violation|1|||
131728834|NCT01703286|474287022|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
131728835|NCT01703286|474287023|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
131728836|NCT01703286|474287024|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
131728837|NCT01703286|474287025|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
131728838|NCT01703286|474287026|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
131728839|NCT01703286|474287027|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
131728840|NCT01703286|474287022|FG000|Period 2 Including Washout|Adverse Event|0|||
131728841|NCT01703286|474287023|FG001|Period 2 Including Washout|Adverse Event|0|||
131728842|NCT01703286|474287024|FG002|Period 2 Including Washout|Adverse Event|0|||
131728843|NCT01703286|474287025|FG003|Period 2 Including Washout|Adverse Event|1|||
131728844|NCT01703286|474287026|FG004|Period 2 Including Washout|Adverse Event|0|||
131728845|NCT01703286|474287027|FG005|Period 2 Including Washout|Adverse Event|0|||
131728846|NCT02531373|474287030|FG000|Overall Study|Lack of Efficacy|0|||
131728847|NCT02531373|474287031|FG001|Overall Study|Lack of Efficacy|0|||
131728848|NCT02531373|474287032|FG002|Overall Study|Lack of Efficacy|0|||
131728849|NCT02531373|474287033|FG003|Overall Study|Lack of Efficacy|0|||
131728850|NCT02531373|474287034|FG004|Overall Study|Lack of Efficacy|3|||
131728851|NCT02531373|474287035|FG005|Overall Study|Lack of Efficacy|2|||
131728852|NCT02531373|474287036|FG006|Overall Study|Lack of Efficacy|4|||
131728853|NCT02531373|474287037|FG007|Overall Study|Lack of Efficacy|8|||
131728854|NCT02531373|474287038|FG008|Overall Study|Lack of Efficacy|5|||
131728855|NCT02531373|474287030|FG000|Overall Study|Lost to Follow-up|0|||
131728856|NCT02531373|474287031|FG001|Overall Study|Lost to Follow-up|0|||
131728857|NCT02531373|474287032|FG002|Overall Study|Lost to Follow-up|0|||
131728858|NCT02531373|474287033|FG003|Overall Study|Lost to Follow-up|0|||
131728859|NCT02531373|474287034|FG004|Overall Study|Lost to Follow-up|0|||
131728860|NCT02531373|474287035|FG005|Overall Study|Lost to Follow-up|2|||
131728861|NCT02531373|474287036|FG006|Overall Study|Lost to Follow-up|2|||
131728862|NCT02531373|474287037|FG007|Overall Study|Lost to Follow-up|0|||
131728863|NCT02531373|474287038|FG008|Overall Study|Lost to Follow-up|0|||
131728864|NCT02531373|474287030|FG000|Overall Study|Physician Decision|0|||
131728865|NCT02531373|474287031|FG001|Overall Study|Physician Decision|0|||
131728866|NCT02531373|474287032|FG002|Overall Study|Physician Decision|0|||
131728867|NCT02531373|474287033|FG003|Overall Study|Physician Decision|0|||
131728868|NCT02531373|474287034|FG004|Overall Study|Physician Decision|2|||
131728869|NCT02531373|474287035|FG005|Overall Study|Physician Decision|1|||
131728870|NCT02531373|474287036|FG006|Overall Study|Physician Decision|0|||
131728871|NCT02531373|474287037|FG007|Overall Study|Physician Decision|0|||
131728872|NCT02531373|474287038|FG008|Overall Study|Physician Decision|0|||
131728873|NCT02531373|474287030|FG000|Overall Study|Protocol Violation|0|||
131728874|NCT02531373|474287031|FG001|Overall Study|Protocol Violation|0|||
131728875|NCT02531373|474287032|FG002|Overall Study|Protocol Violation|0|||
131728876|NCT02531373|474287033|FG003|Overall Study|Protocol Violation|0|||
131728877|NCT02531373|474287034|FG004|Overall Study|Protocol Violation|0|||
131728878|NCT02531373|474287035|FG005|Overall Study|Protocol Violation|1|||
131728879|NCT02531373|474287036|FG006|Overall Study|Protocol Violation|1|||
131728880|NCT02531373|474287037|FG007|Overall Study|Protocol Violation|0|||
131728881|NCT02531373|474287038|FG008|Overall Study|Protocol Violation|1|||
131728882|NCT02531373|474287030|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131728883|NCT02531373|474287031|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131728884|NCT02531373|474287032|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131728885|NCT02531373|474287033|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131728886|NCT02531373|474287034|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131728887|NCT02531373|474287035|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
131806625|NCT01844375|474576196|FG001|Overall Study|Protocol Violation|1|||
131806626|NCT03020615|474576197|FG000|Overall Study|Physician Decision|3|||
131806627|NCT03020615|474576198|FG001|Overall Study|Physician Decision|1|||
131806628|NCT03020615|474576199|FG002|Overall Study|Physician Decision|2|||
131806629|NCT03020615|474576197|FG000|Overall Study|Parent/guardian/patient choice|3|||
131806630|NCT03020615|474576198|FG001|Overall Study|Parent/guardian/patient choice|0|||
131806631|NCT03020615|474576199|FG002|Overall Study|Parent/guardian/patient choice|4|||
131728888|NCT02531373|474287036|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
131806632|NCT03020615|474576197|FG000|Overall Study|Screen failure|0|||
131905058|NCT02616783|474939033|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131728889|NCT02531373|474287037|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
131728890|NCT02531373|474287038|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
131728891|NCT02531373|474287030|FG000|Overall Study|Withdrawal by Subject|0|||
131728892|NCT02531373|474287031|FG001|Overall Study|Withdrawal by Subject|0|||
131728893|NCT02531373|474287032|FG002|Overall Study|Withdrawal by Subject|0|||
131806633|NCT03020615|474576198|FG001|Overall Study|Screen failure|0|||
131728894|NCT02531373|474287033|FG003|Overall Study|Withdrawal by Subject|0|||
131728895|NCT02531373|474287034|FG004|Overall Study|Withdrawal by Subject|3|||
131728896|NCT02531373|474287035|FG005|Overall Study|Withdrawal by Subject|0|||
131728897|NCT02531373|474287036|FG006|Overall Study|Withdrawal by Subject|0|||
131728898|NCT02531373|474287037|FG007|Overall Study|Withdrawal by Subject|0|||
131728899|NCT02531373|474287038|FG008|Overall Study|Withdrawal by Subject|0|||
131806634|NCT03020615|474576199|FG002|Overall Study|Screen failure|1|||
131806635|NCT03020615|474576197|FG000|Overall Study|Death|1|||
131806636|NCT03020615|474576198|FG001|Overall Study|Death|0|||
131728900|NCT00536731|474287039|FG000|Overall Study|Adverse Event|3|||
131728901|NCT00536731|474287040|FG001|Overall Study|Adverse Event|2|||
131728902|NCT00536731|474287041|FG002|Overall Study|Adverse Event|3|||
131728903|NCT00536731|474287039|FG000|Overall Study|Withdrawal by Subject|0|||
131728904|NCT00536731|474287040|FG001|Overall Study|Withdrawal by Subject|2|||
131728905|NCT00536731|474287041|FG002|Overall Study|Withdrawal by Subject|0|||
131728906|NCT00536731|474287039|FG000|Overall Study|Intake of prohibited conc. medication|0|||
131728907|NCT00536731|474287040|FG001|Overall Study|Intake of prohibited conc. medication|0|||
131728908|NCT00536731|474287041|FG002|Overall Study|Intake of prohibited conc. medication|1|||
131728909|NCT00536731|474287039|FG000|Overall Study|Safety reasons|0|||
131728910|NCT00536731|474287040|FG001|Overall Study|Safety reasons|0|||
131728911|NCT00536731|474287041|FG002|Overall Study|Safety reasons|1|||
131728912|NCT00536731|474287039|FG000|Overall Study|Other|1|||
131728913|NCT00536731|474287040|FG001|Overall Study|Other|1|||
131728914|NCT00536731|474287041|FG002|Overall Study|Other|0|||
131728915|NCT01675531|474287042|FG000|Overall Study|Adverse Event|9|||
131728916|NCT01675531|474287042|FG000|Overall Study|Withdrawal by Subject|7|||
131728917|NCT01675531|474287042|FG000|Overall Study|Lack of Efficacy|1|||
131728918|NCT01675531|474287042|FG000|Overall Study|Protocol Violation|8|||
131728919|NCT02795988|474287047|FG000|Phase 1b|Withdrawal by Subject|0|||
131728920|NCT02795988|474287048|FG001|Phase 1b|Withdrawal by Subject|1|||
131728921|NCT02795988|474287049|FG002|Phase 1b|Withdrawal by Subject|0|||
131728922|NCT02795988|474287050|FG003|Phase 1b|Withdrawal by Subject|0|||
131728923|NCT02795988|474287051|FG004|Phase 1b|Withdrawal by Subject|0|||
131728924|NCT02795988|474287052|FG005|Phase 1b|Withdrawal by Subject|0|||
131728925|NCT02795988|474287053|FG006|Phase 1b|Withdrawal by Subject|0|||
131728926|NCT02795988|474287047|FG000|Phase 1b|Death|1|||
131728927|NCT02795988|474287048|FG001|Phase 1b|Death|2|||
131728928|NCT02795988|474287049|FG002|Phase 1b|Death|1|||
131728929|NCT02795988|474287050|FG003|Phase 1b|Death|0|||
131728930|NCT02795988|474287051|FG004|Phase 1b|Death|0|||
131728931|NCT02795988|474287052|FG005|Phase 1b|Death|0|||
131728932|NCT02795988|474287053|FG006|Phase 1b|Death|0|||
131728933|NCT02795988|474287047|FG000|Phase 1b|Physician Decision|0|||
131728934|NCT02795988|474287048|FG001|Phase 1b|Physician Decision|0|||
131728935|NCT02795988|474287049|FG002|Phase 1b|Physician Decision|1|||
131728936|NCT02795988|474287050|FG003|Phase 1b|Physician Decision|0|||
131728937|NCT02795988|474287051|FG004|Phase 1b|Physician Decision|0|||
131728938|NCT02795988|474287052|FG005|Phase 1b|Physician Decision|0|||
131728939|NCT02795988|474287053|FG006|Phase 1b|Physician Decision|0|||
131728940|NCT02795988|474287047|FG000|Phase 1b|Progressive Disease|2|||
131728941|NCT02795988|474287048|FG001|Phase 1b|Progressive Disease|2|||
131728942|NCT02795988|474287049|FG002|Phase 1b|Progressive Disease|0|||
131728943|NCT02795988|474287050|FG003|Phase 1b|Progressive Disease|0|||
131728944|NCT02795988|474287051|FG004|Phase 1b|Progressive Disease|0|||
131728945|NCT02795988|474287052|FG005|Phase 1b|Progressive Disease|0|||
131728946|NCT02795988|474287053|FG006|Phase 1b|Progressive Disease|0|||
131728947|NCT02795988|474287047|FG000|Phase 2|Withdrawal by Subject|0|||
131806637|NCT03020615|474576199|FG002|Overall Study|Death|0|||
131806638|NCT03020615|474576197|FG000|Overall Study|Lost to Follow-up|0|||
131728948|NCT02795988|474287048|FG001|Phase 2|Withdrawal by Subject|0|||
131728949|NCT02795988|474287049|FG002|Phase 2|Withdrawal by Subject|0|||
131728950|NCT02795988|474287050|FG003|Phase 2|Withdrawal by Subject|1|||
131728951|NCT02795988|474287051|FG004|Phase 2|Withdrawal by Subject|0|||
131728952|NCT02795988|474287052|FG005|Phase 2|Withdrawal by Subject|0|||
131728953|NCT02795988|474287053|FG006|Phase 2|Withdrawal by Subject|0|||
131728954|NCT02795988|474287047|FG000|Phase 2|Death|0|||
131728955|NCT02795988|474287048|FG001|Phase 2|Death|0|||
131806639|NCT03020615|474576198|FG001|Overall Study|Lost to Follow-up|1|||
131806640|NCT03020615|474576199|FG002|Overall Study|Lost to Follow-up|0|||
131806641|NCT00252720|474576201|FG000|Overall Study|Withdrawal by Subject|95|||
131806642|NCT00252720|474576202|FG001|Overall Study|Withdrawal by Subject|97|||
131728956|NCT02795988|474287049|FG002|Phase 2|Death|0|||
131728957|NCT02795988|474287050|FG003|Phase 2|Death|17|||
131728958|NCT02795988|474287051|FG004|Phase 2|Death|17|||
131728959|NCT02795988|474287052|FG005|Phase 2|Death|0|||
131728960|NCT02795988|474287053|FG006|Phase 2|Death|0|||
131806643|NCT00252720|474576201|FG000|Overall Study|Death|7|||
131806644|NCT00252720|474576202|FG001|Overall Study|Death|8|||
131728961|NCT02795988|474287047|FG000|Phase 2|Other|0|||
131806645|NCT00252720|474576201|FG000|Overall Study|Moving|23|||
131728962|NCT02795988|474287048|FG001|Phase 2|Other|0|||
131728963|NCT02795988|474287049|FG002|Phase 2|Other|0|||
131728964|NCT02795988|474287050|FG003|Phase 2|Other|1|||
131728965|NCT02795988|474287051|FG004|Phase 2|Other|0|||
131728966|NCT02795988|474287052|FG005|Phase 2|Other|0|||
131728967|NCT02795988|474287053|FG006|Phase 2|Other|0|||
131728968|NCT02795988|474287047|FG000|Phase 2 Extension|Death|0|||
131728969|NCT02795988|474287048|FG001|Phase 2 Extension|Death|0|||
131728970|NCT02795988|474287049|FG002|Phase 2 Extension|Death|0|||
131728971|NCT02795988|474287050|FG003|Phase 2 Extension|Death|0|||
131728972|NCT02795988|474287051|FG004|Phase 2 Extension|Death|0|||
131806646|NCT00252720|474576202|FG001|Overall Study|Moving|42|||
131728973|NCT02795988|474287052|FG005|Phase 2 Extension|Death|5|||
131728974|NCT02795988|474287053|FG006|Phase 2 Extension|Death|6|||
131728975|NCT02795988|474287047|FG000|Phase 2 Extension|Other reasons|0|||
131728976|NCT02795988|474287048|FG001|Phase 2 Extension|Other reasons|0|||
131728977|NCT02795988|474287049|FG002|Phase 2 Extension|Other reasons|0|||
131728978|NCT02795988|474287050|FG003|Phase 2 Extension|Other reasons|0|||
131728979|NCT02795988|474287051|FG004|Phase 2 Extension|Other reasons|0|||
131728980|NCT02795988|474287052|FG005|Phase 2 Extension|Other reasons|2|||
131728981|NCT02795988|474287053|FG006|Phase 2 Extension|Other reasons|1|||
131728982|NCT05058664|474287056|FG000|Overall Study|No follow-up data provided|4|||
131728983|NCT05058664|474287057|FG001|Overall Study|No follow-up data provided|0|||
131728984|NCT05058664|474287058|FG002|Overall Study|No follow-up data provided|2|||
131728985|NCT05058664|474287056|FG000|Overall Study|Withdrawal by Subject|0|||
131728986|NCT05058664|474287057|FG001|Overall Study|Withdrawal by Subject|0|||
131728987|NCT05058664|474287058|FG002|Overall Study|Withdrawal by Subject|1|||
131728988|NCT01597557|474287059|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
131728989|NCT01597557|474287060|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
131728990|NCT01702363|474287063|FG000|Overall Study|Adverse Event|14|||
131728991|NCT01702363|474287063|FG000|Overall Study|Lack of Efficacy|4|||
131728992|NCT01702363|474287063|FG000|Overall Study|Withdrawal by Subject|2|||
131728993|NCT01293032|474287064|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
131728994|NCT01293032|474287065|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
131728995|NCT01293032|474287066|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
131728996|NCT01293032|474287067|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
131728997|NCT01293032|474287064|FG000|Treatment|Adverse Event|0|||
131728998|NCT01293032|474287065|FG001|Treatment|Adverse Event|0|||
131728999|NCT01293032|474287066|FG002|Treatment|Adverse Event|1|||
131729000|NCT01293032|474287067|FG003|Treatment|Adverse Event|1|||
131729001|NCT01293032|474287064|FG000|Treatment|Withdrawal by Subject|2|||
131729002|NCT01293032|474287065|FG001|Treatment|Withdrawal by Subject|4|||
131729003|NCT01293032|474287066|FG002|Treatment|Withdrawal by Subject|0|||
131729004|NCT01293032|474287067|FG003|Treatment|Withdrawal by Subject|0|||
131729005|NCT01293032|474287064|FG000|Treatment|Disease Progression, relapse|0|||
131729006|NCT01293032|474287065|FG001|Treatment|Disease Progression, relapse|1|||
131729007|NCT01293032|474287066|FG002|Treatment|Disease Progression, relapse|0|||
131729008|NCT01293032|474287067|FG003|Treatment|Disease Progression, relapse|0|||
131729009|NCT02985450|474287077|FG000|Overall Study|Lost to Follow-up|7|||
131729010|NCT00431847|474287080|FG000|Overall Study|completion of less than two study visits|6|||
131729011|NCT00431847|474287081|FG001|Overall Study|completion of less than two study visits|3|||
131729012|NCT00431847|474287082|FG002|Overall Study|completion of less than two study visits|4|||
131729013|NCT00431847|474287083|FG003|Overall Study|completion of less than two study visits|14|||
131729014|NCT00431847|474287084|FG004|Overall Study|completion of less than two study visits|0|||
131729015|NCT00431847|474287080|FG000|Overall Study|Protocol Violation|0|||
131729016|NCT00431847|474287081|FG001|Overall Study|Protocol Violation|0|||
131729017|NCT00431847|474287082|FG002|Overall Study|Protocol Violation|0|||
131729018|NCT00431847|474287083|FG003|Overall Study|Protocol Violation|0|||
131729019|NCT00431847|474287084|FG004|Overall Study|Protocol Violation|1|||
131729020|NCT01469013|474287085|FG000|Part A (Treatment Period)|Adverse Event|1|||
131729021|NCT01469013|474287086|FG001|Part A (Treatment Period)|Adverse Event|0|||
131729022|NCT01469013|474287087|FG002|Part A (Treatment Period)|Adverse Event|0|||
131729023|NCT01469013|474287088|FG003|Part A (Treatment Period)|Adverse Event|0|||
131729024|NCT01469013|474287089|FG004|Part A (Treatment Period)|Adverse Event|1|||
131729025|NCT01469013|474287090|FG005|Part A (Treatment Period)|Adverse Event|0|||
131729026|NCT01469013|474287091|FG006|Part A (Treatment Period)|Adverse Event|0|||
131729027|NCT01469013|474287092|FG007|Part A (Treatment Period)|Adverse Event|0|||
131729028|NCT01469013|474287093|FG008|Part A (Treatment Period)|Adverse Event|0|||
131729029|NCT01469013|474287094|FG009|Part A (Treatment Period)|Adverse Event|0|||
131729030|NCT01469013|474287095|FG010|Part A (Treatment Period)|Adverse Event|0|||
131729031|NCT01469013|474287096|FG011|Part A (Treatment Period)|Adverse Event|0|||
131729032|NCT01469013|474287097|FG012|Part A (Treatment Period)|Adverse Event|0|||
131729033|NCT01469013|474287085|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729034|NCT01469013|474287086|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729035|NCT01469013|474287087|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
131729036|NCT01469013|474287088|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729037|NCT01469013|474287089|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729038|NCT01469013|474287090|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729039|NCT01469013|474287091|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729040|NCT01469013|474287092|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729041|NCT01469013|474287093|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729042|NCT01469013|474287094|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729043|NCT01469013|474287095|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729044|NCT01469013|474287096|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729045|NCT01469013|474287097|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
131729046|NCT01469013|474287085|FG000|Part B (Extension Period)|Adverse Event|0|||
131729047|NCT01469013|474287086|FG001|Part B (Extension Period)|Adverse Event|0|||
131806647|NCT00252720|474576201|FG000|Overall Study|Mainly patients lost to follow-up|7|||
131806648|NCT00252720|474576202|FG001|Overall Study|Mainly patients lost to follow-up|18|||
131806649|NCT04239872|474576208|FG000|Overall Study|Lost to Follow-up|0|||
131806650|NCT04239872|474576209|FG001|Overall Study|Lost to Follow-up|1|||
131806651|NCT01185821|474576215|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131806652|NCT01185821|474576216|FG001|Overall Study|Abnormal laboratory value(s)|2|||
131806653|NCT01185821|474576217|FG002|Overall Study|Abnormal laboratory value(s)|1|||
131806654|NCT01185821|474576218|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131806655|NCT01185821|474576219|FG004|Overall Study|Abnormal laboratory value(s)|0|||
131806656|NCT01185821|474576215|FG000|Overall Study|Protocol Violation|0|||
131806657|NCT01185821|474576216|FG001|Overall Study|Protocol Violation|0|||
131806658|NCT01185821|474576217|FG002|Overall Study|Protocol Violation|0|||
131806659|NCT01185821|474576218|FG003|Overall Study|Protocol Violation|1|||
131806660|NCT01185821|474576219|FG004|Overall Study|Protocol Violation|1|||
131806661|NCT01185821|474576215|FG000|Overall Study|Abnormal test procedure result|0|||
131806662|NCT01185821|474576216|FG001|Overall Study|Abnormal test procedure result|0|||
131806663|NCT01185821|474576217|FG002|Overall Study|Abnormal test procedure result|0|||
131806664|NCT01185821|474576218|FG003|Overall Study|Abnormal test procedure result|0|||
131806665|NCT01185821|474576219|FG004|Overall Study|Abnormal test procedure result|1|||
131806666|NCT01185821|474576215|FG000|Overall Study|Death|0|||
131806667|NCT01185821|474576216|FG001|Overall Study|Death|1|||
131806668|NCT01185821|474576217|FG002|Overall Study|Death|0|||
131806669|NCT01185821|474576218|FG003|Overall Study|Death|0|||
131806670|NCT01185821|474576219|FG004|Overall Study|Death|0|||
131806671|NCT01185821|474576215|FG000|Overall Study|Condition no longer required study drug|0|||
131806672|NCT01185821|474576216|FG001|Overall Study|Condition no longer required study drug|0|||
131806673|NCT01185821|474576217|FG002|Overall Study|Condition no longer required study drug|0|||
131806674|NCT01185821|474576218|FG003|Overall Study|Condition no longer required study drug|0|||
131806675|NCT01185821|474576219|FG004|Overall Study|Condition no longer required study drug|1|||
131806676|NCT01185821|474576215|FG000|Overall Study|Adverse Event|2|||
131806677|NCT01185821|474576216|FG001|Overall Study|Adverse Event|3|||
131806678|NCT01185821|474576217|FG002|Overall Study|Adverse Event|1|||
131806679|NCT01185821|474576218|FG003|Overall Study|Adverse Event|2|||
131806680|NCT01185821|474576219|FG004|Overall Study|Adverse Event|5|||
131806681|NCT01185821|474576215|FG000|Overall Study|Lack of Efficacy|0|||
131806682|NCT01185821|474576216|FG001|Overall Study|Lack of Efficacy|0|||
131806683|NCT01185821|474576217|FG002|Overall Study|Lack of Efficacy|3|||
131806684|NCT01185821|474576218|FG003|Overall Study|Lack of Efficacy|0|||
131806685|NCT01185821|474576219|FG004|Overall Study|Lack of Efficacy|9|||
131806686|NCT01185821|474576215|FG000|Overall Study|Withdrawal by Subject|3|||
131806687|NCT01185821|474576216|FG001|Overall Study|Withdrawal by Subject|2|||
131806688|NCT01185821|474576217|FG002|Overall Study|Withdrawal by Subject|2|||
131806689|NCT01185821|474576218|FG003|Overall Study|Withdrawal by Subject|1|||
131729048|NCT01469013|474287087|FG002|Part B (Extension Period)|Adverse Event|0|||
131729049|NCT01469013|474287088|FG003|Part B (Extension Period)|Adverse Event|0|||
131729050|NCT01469013|474287089|FG004|Part B (Extension Period)|Adverse Event|0|||
131729051|NCT01469013|474287090|FG005|Part B (Extension Period)|Adverse Event|2|||
131729052|NCT01469013|474287091|FG006|Part B (Extension Period)|Adverse Event|5|||
131729053|NCT01469013|474287092|FG007|Part B (Extension Period)|Adverse Event|5|||
131729054|NCT01469013|474287093|FG008|Part B (Extension Period)|Adverse Event|3|||
131729055|NCT01469013|474287094|FG009|Part B (Extension Period)|Adverse Event|3|||
131729056|NCT01469013|474287095|FG010|Part B (Extension Period)|Adverse Event|1|||
131729057|NCT01469013|474287096|FG011|Part B (Extension Period)|Adverse Event|6|||
131729058|NCT01469013|474287097|FG012|Part B (Extension Period)|Adverse Event|3|||
131729059|NCT01469013|474287085|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
131729060|NCT01469013|474287086|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
131729061|NCT01469013|474287087|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
131729062|NCT01469013|474287088|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
131729063|NCT01469013|474287089|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
131729064|NCT01469013|474287090|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
131729065|NCT01469013|474287091|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
131729066|NCT01469013|474287092|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
131806690|NCT01185821|474576219|FG004|Overall Study|Withdrawal by Subject|3|||
131806691|NCT01185821|474576215|FG000|Overall Study|Lost to Follow-up|1|||
131806692|NCT01185821|474576216|FG001|Overall Study|Lost to Follow-up|1|||
131729067|NCT01469013|474287093|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
131729068|NCT01469013|474287094|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
131806693|NCT01185821|474576217|FG002|Overall Study|Lost to Follow-up|2|||
131806694|NCT01185821|474576218|FG003|Overall Study|Lost to Follow-up|1|||
131806695|NCT01185821|474576219|FG004|Overall Study|Lost to Follow-up|2|||
131806696|NCT01185821|474576215|FG000|Overall Study|Administrative problems|0|||
131729069|NCT01469013|474287095|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
131729070|NCT01469013|474287096|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
131729071|NCT01469013|474287097|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
131729072|NCT00002663|474287098|FG000|Overall Study|Death|4|||
131729073|NCT00002663|474287099|FG001|Overall Study|Death|1|||
131729074|NCT00002663|474287100|FG002|Overall Study|Death|1|||
131729075|NCT00002663|474287101|FG003|Overall Study|Death|0|||
131729076|NCT00002663|474287102|FG004|Overall Study|Death|0|||
131729077|NCT00002663|474287103|FG005|Overall Study|Death|13|||
131729078|NCT00002663|474287104|FG006|Overall Study|Death|0|||
131729079|NCT00002663|474287105|FG007|Overall Study|Death|1|||
131448770|NCT00790842|473272730|FG010|Expansion Cohort|Adverse Event|0|||
131448771|NCT00790842|473272720|FG000|Expansion Cohort|Death|0|||
131448772|NCT00790842|473272721|FG001|Expansion Cohort|Death|0|||
131448773|NCT00790842|473272722|FG002|Expansion Cohort|Death|2|||
131448774|NCT00790842|473272723|FG003|Expansion Cohort|Death|0|||
131729080|NCT00002663|474287106|FG008|Overall Study|Death|1|||
131729081|NCT00002663|474287107|FG009|Overall Study|Death|1|||
131729082|NCT00002663|474287098|FG000|Overall Study|Lost to Follow-up|3|||
131729083|NCT00002663|474287099|FG001|Overall Study|Lost to Follow-up|0|||
131729084|NCT00002663|474287100|FG002|Overall Study|Lost to Follow-up|0|||
131729085|NCT00002663|474287101|FG003|Overall Study|Lost to Follow-up|1|||
131729086|NCT00002663|474287102|FG004|Overall Study|Lost to Follow-up|0|||
131729087|NCT00002663|474287103|FG005|Overall Study|Lost to Follow-up|1|||
131729088|NCT00002663|474287104|FG006|Overall Study|Lost to Follow-up|0|||
131729089|NCT00002663|474287105|FG007|Overall Study|Lost to Follow-up|0|||
131729090|NCT00002663|474287106|FG008|Overall Study|Lost to Follow-up|0|||
131729091|NCT00002663|474287107|FG009|Overall Study|Lost to Follow-up|0|||
131729092|NCT00002663|474287098|FG000|Overall Study|Other|0|||
131729093|NCT00002663|474287099|FG001|Overall Study|Other|1|||
131729094|NCT00002663|474287100|FG002|Overall Study|Other|0|||
131729095|NCT00002663|474287101|FG003|Overall Study|Other|0|||
131729096|NCT00002663|474287102|FG004|Overall Study|Other|0|||
131729097|NCT00002663|474287103|FG005|Overall Study|Other|1|||
131729098|NCT00002663|474287104|FG006|Overall Study|Other|1|||
131729099|NCT00002663|474287105|FG007|Overall Study|Other|0|||
131729100|NCT00002663|474287106|FG008|Overall Study|Other|0|||
131729101|NCT00002663|474287107|FG009|Overall Study|Other|0|||
131729102|NCT00002663|474287098|FG000|Overall Study|Physician Decision|0|||
131729103|NCT00002663|474287099|FG001|Overall Study|Physician Decision|0|||
131729104|NCT00002663|474287100|FG002|Overall Study|Physician Decision|0|||
131729105|NCT00002663|474287101|FG003|Overall Study|Physician Decision|0|||
131729106|NCT00002663|474287102|FG004|Overall Study|Physician Decision|1|||
131729107|NCT00002663|474287103|FG005|Overall Study|Physician Decision|0|||
131729108|NCT00002663|474287104|FG006|Overall Study|Physician Decision|0|||
131729109|NCT00002663|474287105|FG007|Overall Study|Physician Decision|0|||
131729110|NCT00002663|474287106|FG008|Overall Study|Physician Decision|1|||
131729111|NCT00002663|474287107|FG009|Overall Study|Physician Decision|1|||
131729112|NCT00002663|474287098|FG000|Overall Study|Adverse Event|0|||
131448775|NCT00790842|473272724|FG004|Expansion Cohort|Death|0|||
131448776|NCT00790842|473272725|FG005|Expansion Cohort|Death|0|||
131448777|NCT00790842|473272726|FG006|Expansion Cohort|Death|0|||
131448778|NCT00790842|473272727|FG007|Expansion Cohort|Death|0|||
131448779|NCT00790842|473272728|FG008|Expansion Cohort|Death|0|||
131448780|NCT00790842|473272729|FG009|Expansion Cohort|Death|0|||
131448781|NCT00790842|473272730|FG010|Expansion Cohort|Death|0|||
131448782|NCT00790842|473272720|FG000|Expansion Cohort|Physician Decision|0|||
131448783|NCT00790842|473272721|FG001|Expansion Cohort|Physician Decision|0|||
131448784|NCT00790842|473272722|FG002|Expansion Cohort|Physician Decision|1|||
131448785|NCT00790842|473272723|FG003|Expansion Cohort|Physician Decision|0|||
131729113|NCT00002663|474287099|FG001|Overall Study|Adverse Event|0|||
131729114|NCT00002663|474287100|FG002|Overall Study|Adverse Event|0|||
131729115|NCT00002663|474287101|FG003|Overall Study|Adverse Event|1|||
131448786|NCT00790842|473272724|FG004|Expansion Cohort|Physician Decision|0|||
131448787|NCT00790842|473272725|FG005|Expansion Cohort|Physician Decision|0|||
131729116|NCT00002663|474287102|FG004|Overall Study|Adverse Event|0|||
131729117|NCT00002663|474287103|FG005|Overall Study|Adverse Event|0|||
131729118|NCT00002663|474287104|FG006|Overall Study|Adverse Event|0|||
131729119|NCT00002663|474287105|FG007|Overall Study|Adverse Event|1|||
131729120|NCT00002663|474287106|FG008|Overall Study|Adverse Event|0|||
131729121|NCT00002663|474287107|FG009|Overall Study|Adverse Event|0|||
131729122|NCT02142894|474287109|FG000|Overall Study|Protocol Violation|8|||
131729123|NCT00739297|474287110|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
131729124|NCT00739297|474287111|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
131448788|NCT00790842|473272726|FG006|Expansion Cohort|Physician Decision|0|||
131448789|NCT00790842|473272727|FG007|Expansion Cohort|Physician Decision|0|||
131448790|NCT00790842|473272728|FG008|Expansion Cohort|Physician Decision|0|||
131496716|NCT02289690|473446364|FG005|Overall Study|Death|0|||
131729125|NCT00739297|474287112|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
131729126|NCT00739297|474287113|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
131729127|NCT00739297|474287114|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
131729128|NCT00739297|474287115|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
131729129|NCT00739297|474287116|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
131729130|NCT00739297|474287110|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131729131|NCT00739297|474287111|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131729132|NCT00739297|474287112|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131729133|NCT00739297|474287113|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131729134|NCT00739297|474287114|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131806697|NCT01185821|474576216|FG001|Overall Study|Administrative problems|0|||
131806698|NCT01185821|474576217|FG002|Overall Study|Administrative problems|1|||
131806699|NCT01185821|474576218|FG003|Overall Study|Administrative problems|1|||
131806700|NCT01185821|474576219|FG004|Overall Study|Administrative problems|2|||
131806701|NCT01546545|474576220|FG000|Overall Study|Withdrawal by Subject|1|||
131806702|NCT04060147|474576221|FG000|Overall Study|Withdrew consent|1|||
131806703|NCT02057458|474576225|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
131729135|NCT00739297|474287115|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
131729136|NCT00739297|474287116|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
131729137|NCT02552355|474287120|FG000|Overall Study|Adverse Event|0|||
131729138|NCT02552355|474287121|FG001|Overall Study|Adverse Event|2|||
131806704|NCT02057458|474576226|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
131806705|NCT02057458|474576227|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
131806706|NCT02057458|474576225|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
131806707|NCT02057458|474576226|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
131806708|NCT02057458|474576227|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
131806709|NCT02057458|474576225|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
131806710|NCT02057458|474576226|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
131806711|NCT02057458|474576227|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
131806712|NCT03693430|474576228|FG000|Overall Study|Lost to Follow-up|3|||
131806713|NCT03693430|474576229|FG001|Overall Study|Lost to Follow-up|14|||
131806714|NCT03693430|474576228|FG000|Overall Study|Death|1|||
131806715|NCT03693430|474576229|FG001|Overall Study|Death|0|||
131806716|NCT03693430|474576228|FG000|Overall Study|Withdrawal by Subject|0|||
131806717|NCT03693430|474576229|FG001|Overall Study|Withdrawal by Subject|4|||
131806718|NCT04510285|474576230|FG000|Overall Study|Death|1|||
131496717|NCT02289690|473446365|FG006|Overall Study|Death|0|||
131729139|NCT02552355|474287122|FG002|Overall Study|Adverse Event|2|||
131729140|NCT02552355|474287123|FG003|Overall Study|Adverse Event|0|||
131729141|NCT02552355|474287120|FG000|Overall Study|Withdrawal by Subject|0|||
131729142|NCT02552355|474287121|FG001|Overall Study|Withdrawal by Subject|0|||
131729143|NCT02552355|474287122|FG002|Overall Study|Withdrawal by Subject|0|||
131729144|NCT02552355|474287123|FG003|Overall Study|Withdrawal by Subject|1|||
131729145|NCT01519245|474287124|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
131729146|NCT01519245|474287125|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
131729147|NCT00933335|474287128|FG000|Overall Study|Lost to Follow-up|1|||
131729148|NCT00933335|474287129|FG001|Overall Study|Lost to Follow-up|3|||
131729149|NCT00933335|474287128|FG000|Overall Study|Withdrawal by Subject|0|||
131729150|NCT00933335|474287129|FG001|Overall Study|Withdrawal by Subject|1|||
131729151|NCT00933335|474287128|FG000|Overall Study|Progressive Disease|0|||
131729152|NCT00933335|474287129|FG001|Overall Study|Progressive Disease|11|||
131729153|NCT00933335|474287128|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
131729154|NCT00933335|474287129|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
131729155|NCT00933335|474287128|FG000|Overall Study|Co-morbid Illness|1|||
131729156|NCT00933335|474287129|FG001|Overall Study|Co-morbid Illness|0|||
131806719|NCT01406795|474576231|FG000|Overall Study|Withdrawal by Subject|1|||
131806720|NCT03897088|474576232|FG000|Overall Study|Withdrawal by Subject|12|||
131806721|NCT03897088|474576233|FG001|Overall Study|Withdrawal by Subject|12|||
131806722|NCT03897088|474576232|FG000|Overall Study|Lost to Follow-up|7|||
131806723|NCT03897088|474576233|FG001|Overall Study|Lost to Follow-up|15|||
131806724|NCT03897088|474576232|FG000|Overall Study|Sponsor Decision|1|||
131806725|NCT03897088|474576233|FG001|Overall Study|Sponsor Decision|2|||
131806726|NCT03897088|474576232|FG000|Overall Study|COVID-19|2|||
131806727|NCT03897088|474576233|FG001|Overall Study|COVID-19|0|||
131806728|NCT03897088|474576232|FG000|Overall Study|Other|3|||
131729157|NCT02084134|474287130|FG000|Overall Study|Protocol Violation|4|||
131729158|NCT02084134|474287131|FG001|Overall Study|Protocol Violation|2|||
131729159|NCT02084134|474287130|FG000|Overall Study|Death|0|||
131729160|NCT02084134|474287131|FG001|Overall Study|Death|1|||
131729161|NCT02379923|474287132|FG000|Overall Study|Death|5|||
131806729|NCT03897088|474576233|FG001|Overall Study|Other|0|||
131729162|NCT00426751|474287133|FG000|Overall Study|Adverse Event|8|||
131729163|NCT00426751|474287134|FG001|Overall Study|Adverse Event|1|||
131729164|NCT00426751|474287133|FG000|Overall Study|Lost to Follow-up|7|||
131729165|NCT00426751|474287134|FG001|Overall Study|Lost to Follow-up|6|||
131729166|NCT00426751|474287133|FG000|Overall Study|Consent Withdrawn|0|||
131729167|NCT00426751|474287134|FG001|Overall Study|Consent Withdrawn|1|||
131729168|NCT00426751|474287133|FG000|Overall Study|Other Reasons|7|||
131729169|NCT00426751|474287134|FG001|Overall Study|Other Reasons|12|||
131729170|NCT01617434|474287137|FG000|Overall Study|Adverse Event|12|||
131729171|NCT01617434|474287138|FG001|Overall Study|Adverse Event|3|||
131729172|NCT01617434|474287137|FG000|Overall Study|Protocol Violation|8|||
131729173|NCT01617434|474287138|FG001|Overall Study|Protocol Violation|7|||
131729174|NCT01617434|474287137|FG000|Overall Study|Withdrawal Criteria|12|||
131729175|NCT01617434|474287138|FG001|Overall Study|Withdrawal Criteria|37|||
131729176|NCT01617434|474287137|FG000|Overall Study|Unclassified|3|||
131729177|NCT01617434|474287138|FG001|Overall Study|Unclassified|4|||
131729178|NCT00705224|474287139|FG000|Overall Study|Adverse Event|1|||
131729179|NCT00705224|474287139|FG000|Overall Study|Lack of Efficacy|2|||
131729180|NCT00705224|474287139|FG000|Overall Study|Withdrawal by Subject|3|||
131729181|NCT00705224|474287139|FG000|Overall Study|Lost to Follow-up|5|||
131729182|NCT03283163|474287140|FG000|Overall Study|Lost to Follow-up|1|||
131729183|NCT03283163|474287140|FG000|Overall Study|other life commitments|6|||
131729184|NCT03283163|474287140|FG000|Overall Study|COVID-19 institution wide halting|1|||
131729185|NCT03283163|474287140|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
131729186|NCT03283163|474287140|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
131729187|NCT00237796|474287141|FG000|Overall Study|Baseline and one other ILSS required|10|||
131729188|NCT00237796|474287142|FG001|Overall Study|Baseline and one other ILSS required|5|||
131729189|NCT00968253|474287144|FG000|Overall Study|Death|0|||
131729190|NCT00968253|474287145|FG001|Overall Study|Death|0|||
131729191|NCT00968253|474287146|FG002|Overall Study|Death|2|||
131729192|NCT00968253|474287144|FG000|Overall Study|Withdrawal by Subject|0|||
131729193|NCT00968253|474287145|FG001|Overall Study|Withdrawal by Subject|0|||
131729194|NCT00968253|474287146|FG002|Overall Study|Withdrawal by Subject|1|||
131729195|NCT00968253|474287144|FG000|Overall Study|Disease Progression|0|||
131729196|NCT00968253|474287145|FG001|Overall Study|Disease Progression|3|||
131729197|NCT00968253|474287146|FG002|Overall Study|Disease Progression|3|||
131729198|NCT00968253|474287144|FG000|Overall Study|Adverse Event|0|||
131729199|NCT00968253|474287145|FG001|Overall Study|Adverse Event|0|||
131729200|NCT00968253|474287146|FG002|Overall Study|Adverse Event|1|||
131729201|NCT03596177|474287147|FG000|Single Blind Period|Withdrawal by Subject|1|||
131729202|NCT03596177|474287148|FG001|Single Blind Period|Withdrawal by Subject|1|||
131729203|NCT03596177|474287147|FG000|Single Blind Period|Other|1|||
131729204|NCT03596177|474287148|FG001|Single Blind Period|Other|0|||
131729205|NCT03596177|474287147|FG000|Double Blind Period|Withdrawal by Subject|0|||
131729206|NCT03596177|474287148|FG001|Double Blind Period|Withdrawal by Subject|1|||
131729207|NCT03596177|474287147|FG000|Double Blind Period|Other|0|||
131729208|NCT03596177|474287148|FG001|Double Blind Period|Other|4|||
131729209|NCT03596177|474287147|FG000|Double Blind Period|Death during safety follow-up|0|||
131729210|NCT03596177|474287148|FG001|Double Blind Period|Death during safety follow-up|1|||
131806730|NCT03897088|474576232|FG000|Overall Study|Non-compliance with Study Drug|1|||
131806731|NCT03897088|474576233|FG001|Overall Study|Non-compliance with Study Drug|1|||
131806732|NCT03897088|474576232|FG000|Overall Study|Pregnancy|0|||
131806733|NCT03897088|474576233|FG001|Overall Study|Pregnancy|1|||
131806734|NCT00319735|474576234|FG000|Overall Study|Death|2|||
131806735|NCT00854100|474576241|FG000|Overall Study|Inability to complete the study visits|0|||
131729211|NCT03141086|474287151|FG000|Overall Study|Study Terminated By Sponsor|1|||
131729212|NCT03141086|474287152|FG001|Overall Study|Study Terminated By Sponsor|1|||
131729213|NCT03141086|474287151|FG000|Overall Study|Withdrawal by Subject|0|||
131729214|NCT03141086|474287152|FG001|Overall Study|Withdrawal by Subject|1|||
131729215|NCT03141086|474287151|FG000|Overall Study|Protocol Violation|0|||
131729216|NCT03141086|474287152|FG001|Overall Study|Protocol Violation|1|||
131729217|NCT03141086|474287151|FG000|Overall Study|Adverse Event|0|||
131729218|NCT03141086|474287152|FG001|Overall Study|Adverse Event|2|||
131729219|NCT02488759|474287155|FG000|Overall Study|Disease progression|73|||
131729220|NCT02488759|474287156|FG001|Overall Study|Disease progression|111|||
131729221|NCT02488759|474287157|FG002|Overall Study|Disease progression|62|||
131729222|NCT02488759|474287158|FG003|Overall Study|Disease progression|7|||
131729223|NCT02488759|474287159|FG004|Overall Study|Disease progression|4|||
131806736|NCT00854100|474576242|FG001|Overall Study|Inability to complete the study visits|0|||
131806737|NCT00854100|474576243|FG002|Overall Study|Inability to complete the study visits|1|||
131806738|NCT00854100|474576241|FG000|Overall Study|Lost to Follow-up|2|||
131806739|NCT00854100|474576242|FG001|Overall Study|Lost to Follow-up|0|||
131806740|NCT00854100|474576243|FG002|Overall Study|Lost to Follow-up|3|||
131806741|NCT00854100|474576241|FG000|Overall Study|Withdrawal by Subject|3|||
131806742|NCT00854100|474576242|FG001|Overall Study|Withdrawal by Subject|1|||
131806743|NCT00854100|474576243|FG002|Overall Study|Withdrawal by Subject|2|||
131806744|NCT00854100|474576241|FG000|Overall Study|Protocol Violation|2|||
131496718|NCT02289690|473446366|FG007|Overall Study|Death|49|||
131806745|NCT00854100|474576242|FG001|Overall Study|Protocol Violation|4|||
131806746|NCT00854100|474576243|FG002|Overall Study|Protocol Violation|3|||
131806747|NCT00854100|474576241|FG000|Overall Study|Adverse Event|2|||
131806748|NCT00854100|474576242|FG001|Overall Study|Adverse Event|1|||
131806749|NCT00854100|474576243|FG002|Overall Study|Adverse Event|2|||
131806750|NCT02216071|474576246|FG000|Overall Study|Withdrawal by Subject|7|||
131806751|NCT02216071|474576247|FG001|Overall Study|Withdrawal by Subject|2|||
131806752|NCT02216071|474576246|FG000|Overall Study|Lost to Follow-up|3|||
131729224|NCT02488759|474287160|FG005|Overall Study|Disease progression|2|||
131729225|NCT02488759|474287155|FG000|Overall Study|Study drug toxicity|11|||
131729226|NCT02488759|474287156|FG001|Overall Study|Study drug toxicity|33|||
131729227|NCT02488759|474287157|FG002|Overall Study|Study drug toxicity|31|||
131729228|NCT02488759|474287158|FG003|Overall Study|Study drug toxicity|0|||
131729229|NCT02488759|474287159|FG004|Overall Study|Study drug toxicity|0|||
131729230|NCT02488759|474287160|FG005|Overall Study|Study drug toxicity|2|||
131729231|NCT02488759|474287155|FG000|Overall Study|Adverse event unrelated to study drug|9|||
131729232|NCT02488759|474287156|FG001|Overall Study|Adverse event unrelated to study drug|11|||
131729233|NCT02488759|474287157|FG002|Overall Study|Adverse event unrelated to study drug|7|||
131729234|NCT02488759|474287158|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131729235|NCT02488759|474287159|FG004|Overall Study|Adverse event unrelated to study drug|1|||
131729236|NCT02488759|474287160|FG005|Overall Study|Adverse event unrelated to study drug|0|||
131729237|NCT02488759|474287155|FG000|Overall Study|Participant request to discontinue study treatment|6|||
131729238|NCT02488759|474287156|FG001|Overall Study|Participant request to discontinue study treatment|8|||
131729239|NCT02488759|474287157|FG002|Overall Study|Participant request to discontinue study treatment|4|||
131729240|NCT02488759|474287158|FG003|Overall Study|Participant request to discontinue study treatment|0|||
131729241|NCT02488759|474287159|FG004|Overall Study|Participant request to discontinue study treatment|0|||
131729242|NCT02488759|474287160|FG005|Overall Study|Participant request to discontinue study treatment|0|||
131729243|NCT02488759|474287155|FG000|Overall Study|Withdrawal by Subject|4|||
131729244|NCT02488759|474287156|FG001|Overall Study|Withdrawal by Subject|0|||
131729245|NCT02488759|474287157|FG002|Overall Study|Withdrawal by Subject|3|||
131729246|NCT02488759|474287158|FG003|Overall Study|Withdrawal by Subject|0|||
131729247|NCT02488759|474287159|FG004|Overall Study|Withdrawal by Subject|0|||
131729248|NCT02488759|474287160|FG005|Overall Study|Withdrawal by Subject|2|||
131729249|NCT02488759|474287155|FG000|Overall Study|Lost to Follow-up|0|||
131729250|NCT02488759|474287156|FG001|Overall Study|Lost to Follow-up|0|||
131729251|NCT02488759|474287157|FG002|Overall Study|Lost to Follow-up|2|||
131729252|NCT02488759|474287158|FG003|Overall Study|Lost to Follow-up|0|||
131729253|NCT02488759|474287159|FG004|Overall Study|Lost to Follow-up|0|||
131729254|NCT02488759|474287160|FG005|Overall Study|Lost to Follow-up|0|||
131729255|NCT02488759|474287155|FG000|Overall Study|Maximum clinical benefit|3|||
131729256|NCT02488759|474287156|FG001|Overall Study|Maximum clinical benefit|0|||
131729257|NCT02488759|474287157|FG002|Overall Study|Maximum clinical benefit|1|||
131729258|NCT02488759|474287158|FG003|Overall Study|Maximum clinical benefit|0|||
131729259|NCT02488759|474287159|FG004|Overall Study|Maximum clinical benefit|0|||
131729260|NCT02488759|474287160|FG005|Overall Study|Maximum clinical benefit|0|||
131729261|NCT02488759|474287155|FG000|Overall Study|Other reasons|7|||
131729262|NCT02488759|474287156|FG001|Overall Study|Other reasons|32|||
131806753|NCT02216071|474576247|FG001|Overall Study|Lost to Follow-up|3|||
131806754|NCT02216071|474576246|FG000|Overall Study|Protocol Violation|3|||
131806755|NCT02216071|474576247|FG001|Overall Study|Protocol Violation|5|||
131806756|NCT02216071|474576246|FG000|Overall Study|Other|2|||
131806757|NCT02216071|474576247|FG001|Overall Study|Other|2|||
131806758|NCT02262377|474577574|FG000|Overall Study|Lost to Follow-up|5|||
131806759|NCT02262377|474577575|FG001|Overall Study|Lost to Follow-up|6|||
131806760|NCT02262377|474577574|FG000|Overall Study|Found ineligible after enrollment|3|||
131806761|NCT02262377|474577575|FG001|Overall Study|Found ineligible after enrollment|0|||
131806762|NCT02262377|474577574|FG000|Overall Study|Withdrawal by Subject|4|||
131806763|NCT02262377|474577575|FG001|Overall Study|Withdrawal by Subject|0|||
131806764|NCT00371839|474577578|FG000|Overall Study|Death|4|||
131806765|NCT00371839|474577579|FG001|Overall Study|Death|0|||
131905059|NCT02616783|474939032|FG000|Overall Study|Protocol Violation|1|||
131729263|NCT02488759|474287157|FG002|Overall Study|Other reasons|23|||
131729264|NCT02488759|474287158|FG003|Overall Study|Other reasons|1|||
131806766|NCT00371839|474577580|FG002|Overall Study|Death|0|||
131806767|NCT00371839|474577578|FG000|Overall Study|Withdrawal by Subject|7|||
131806768|NCT00371839|474577579|FG001|Overall Study|Withdrawal by Subject|4|||
131806769|NCT00371839|474577580|FG002|Overall Study|Withdrawal by Subject|0|||
131806770|NCT00371839|474577578|FG000|Overall Study|Lost to Follow-up|6|||
131905060|NCT02616783|474939033|FG001|Overall Study|Protocol Violation|1|||
131729265|NCT02488759|474287159|FG004|Overall Study|Other reasons|1|||
131729266|NCT02488759|474287160|FG005|Overall Study|Other reasons|1|||
131806771|NCT00371839|474577579|FG001|Overall Study|Lost to Follow-up|3|||
131806772|NCT00371839|474577580|FG002|Overall Study|Lost to Follow-up|2|||
131806773|NCT05612724|474577583|FG000|Overall Study|Lost to Follow-up|4|||
131905061|NCT02616783|474939032|FG000|Overall Study|Withdrew Consent|1|||
131448791|NCT00790842|473272729|FG009|Expansion Cohort|Physician Decision|0|||
131729267|NCT03860844|474287161|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
131729268|NCT03860844|474287162|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
131729269|NCT03860844|474287163|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
131729270|NCT03860844|474287161|FG000|Overall Study|Progressive disease|5|||
131729271|NCT03860844|474287162|FG001|Overall Study|Progressive disease|3|||
131729272|NCT03860844|474287163|FG002|Overall Study|Progressive disease|4|||
131729273|NCT03860844|474287161|FG000|Overall Study|Other, Not related to COVID-19|0|||
131729274|NCT03860844|474287162|FG001|Overall Study|Other, Not related to COVID-19|1|||
131729275|NCT03860844|474287163|FG002|Overall Study|Other, Not related to COVID-19|0|||
131729276|NCT02429427|474287164|FG000|Overall Study|Adverse Event|220|||
131729277|NCT02429427|474287165|FG001|Overall Study|Adverse Event|92|||
131729278|NCT02429427|474287164|FG000|Overall Study|Protocol Violation|10|||
131729279|NCT02429427|474287165|FG001|Overall Study|Protocol Violation|6|||
131729280|NCT02429427|474287164|FG000|Overall Study|Lost to Follow-up|15|||
131729281|NCT02429427|474287165|FG001|Overall Study|Lost to Follow-up|6|||
131729282|NCT02429427|474287164|FG000|Overall Study|Withdrawal by Subject|64|||
131729283|NCT02429427|474287165|FG001|Overall Study|Withdrawal by Subject|34|||
131729284|NCT02429427|474287164|FG000|Overall Study|Other|62|||
131729285|NCT02429427|474287165|FG001|Overall Study|Other|41|||
131729286|NCT00719732|474287166|FG000|Overall Study|Lost to Follow-up|20|||
131729287|NCT00719732|474287166|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
131729288|NCT00719732|474287166|FG000|Overall Study|Illness not associated with device|1|||
131729289|NCT03625986|474288326|FG000|Randomization Period|Lost to Follow-up|7|||
131729290|NCT03625986|474288327|FG001|Randomization Period|Lost to Follow-up|12|||
131729291|NCT03625986|474288326|FG000|Randomization Period|Withdrawal by Subject|10|||
131729292|NCT03625986|474288327|FG001|Randomization Period|Withdrawal by Subject|6|||
131729293|NCT04920084|474288329|FG000|Overall Study|Adverse Event|1|||
131729294|NCT04920084|474288329|FG000|Overall Study|Lost to Follow-up|2|||
131729295|NCT04920084|474288329|FG000|Overall Study|Withdrawal by Subject|2|||
131729296|NCT01096446|474288330|FG000|Overall Study|Death|1|||
131729297|NCT01096446|474288331|FG001|Overall Study|Death|0|||
131729298|NCT01096446|474288330|FG000|Overall Study|Protocol Violation|2|||
131729299|NCT01096446|474288331|FG001|Overall Study|Protocol Violation|0|||
131729300|NCT00620321|474288332|FG000|Overall Study|Adverse Event|1|||
131729301|NCT00620321|474288333|FG001|Overall Study|Adverse Event|1|||
131729302|NCT00620321|474288332|FG000|Overall Study|Death|1|||
131729303|NCT00620321|474288333|FG001|Overall Study|Death|1|||
131729304|NCT00620321|474288332|FG000|Overall Study|Physician Decision|0|||
131729305|NCT00620321|474288333|FG001|Overall Study|Physician Decision|7|||
131729306|NCT00620321|474288332|FG000|Overall Study|Progressive Disease|5|||
131729307|NCT00620321|474288333|FG001|Overall Study|Progressive Disease|5|||
131729308|NCT00620321|474288332|FG000|Overall Study|Sponsor Decision|0|||
131729309|NCT00620321|474288333|FG001|Overall Study|Sponsor Decision|1|||
131729310|NCT00620321|474288332|FG000|Overall Study|Withdrawal by Subject|1|||
131729311|NCT00620321|474288333|FG001|Overall Study|Withdrawal by Subject|1|||
131729312|NCT01431144|474288334|FG000|Overall Study|Implant mobility and removal|2|||
131729313|NCT01431144|474288335|FG001|Overall Study|Implant mobility and removal|0|||
131729314|NCT00953043|474288342|FG000|Overall Study|Withdrawal by Subject|4|||
131729315|NCT00953043|474288343|FG001|Overall Study|Withdrawal by Subject|0|||
131729316|NCT00953043|474288342|FG000|Overall Study|Physician Decision|0|||
131729317|NCT00953043|474288343|FG001|Overall Study|Physician Decision|2|||
131729318|NCT01043185|474288344|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
131729319|NCT01043185|474288345|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
131729320|NCT01043185|474288346|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
131729321|NCT01043185|474288347|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
131729322|NCT01043185|474288348|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
131729323|NCT01043185|474288349|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
131729324|NCT01043185|474288350|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
131729325|NCT01043185|474288351|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
131729326|NCT01043185|474288352|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
131729327|NCT01043185|474288353|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
131448792|NCT00790842|473272730|FG010|Expansion Cohort|Physician Decision|0|||
131448793|NCT00790842|473272720|FG000|Expansion Cohort|Withdrawal by Subject|0|||
131448794|NCT00790842|473272721|FG001|Expansion Cohort|Withdrawal by Subject|0|||
131729328|NCT01432262|474288354|FG000|Overall Study|Withdrawal by Subject|2|||
131729329|NCT01432262|474288355|FG001|Overall Study|Withdrawal by Subject|1|||
131729330|NCT00165646|474288356|FG000|Overall Study|Adverse Event|1|||
131729331|NCT00165646|474288357|FG001|Overall Study|Adverse Event|1|||
131729332|NCT00165646|474288358|FG002|Overall Study|Adverse Event|1|||
131729333|NCT00165646|474288356|FG000|Overall Study|Lack of Efficacy|1|||
131729334|NCT00165646|474288357|FG001|Overall Study|Lack of Efficacy|2|||
131729335|NCT00165646|474288358|FG002|Overall Study|Lack of Efficacy|0|||
131729336|NCT00165646|474288356|FG000|Overall Study|Withdrawal by Subject|0|||
131448795|NCT00790842|473272722|FG002|Expansion Cohort|Withdrawal by Subject|3|||
131729337|NCT00165646|474288357|FG001|Overall Study|Withdrawal by Subject|2|||
131729338|NCT00165646|474288358|FG002|Overall Study|Withdrawal by Subject|1|||
131729339|NCT00165646|474288356|FG000|Overall Study|Physician Decision|2|||
131729340|NCT00165646|474288357|FG001|Overall Study|Physician Decision|0|||
131729341|NCT00165646|474288358|FG002|Overall Study|Physician Decision|2|||
131729342|NCT00165646|474288356|FG000|Overall Study|Protocol Violation|1|||
131729343|NCT00165646|474288357|FG001|Overall Study|Protocol Violation|0|||
131729344|NCT00165646|474288358|FG002|Overall Study|Protocol Violation|0|||
131729345|NCT01104558|474288359|FG000|Overall Study|Protocol Violation|6|||
131729346|NCT01104558|474288359|FG000|Overall Study|Missing of primary efficacy assessment|10|||
131729347|NCT01104558|474288359|FG000|Overall Study|Missing of genetic analysis results|1|||
131729348|NCT01755195|474288360|FG000|Overall Study|Participant noncompliance|2|||
131729349|NCT01755195|474288360|FG000|Overall Study|Switched to alternative treatment|4|||
131729350|NCT01755195|474288360|FG000|Overall Study|Withdrawal by Subject|1|||
131729351|NCT01755195|474288360|FG000|Overall Study|Participant refused to start treatment|1|||
131729352|NCT01755195|474288360|FG000|Overall Study|Participant has been consented for another trial|1|||
131729353|NCT01755195|474288360|FG000|Overall Study|Refused further treatment|3|||
131729354|NCT01755195|474288360|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
131729355|NCT00523341|474288361|FG000|Overall Study|Withdrawal by Subject|399|||
131729356|NCT00523341|474288362|FG001|Overall Study|Withdrawal by Subject|427|||
131729357|NCT00523341|474288361|FG000|Overall Study|Other|181|||
131729358|NCT00523341|474288362|FG001|Overall Study|Other|198|||
131729359|NCT00523341|474288361|FG000|Overall Study|Adverse Event|122|||
131729360|NCT00523341|474288362|FG001|Overall Study|Adverse Event|155|||
131729361|NCT00523341|474288361|FG000|Overall Study|Death|101|||
131729362|NCT00523341|474288362|FG001|Overall Study|Death|110|||
131729363|NCT00523341|474288361|FG000|Overall Study|Lost to Follow-up|73|||
131729364|NCT00523341|474288362|FG001|Overall Study|Lost to Follow-up|61|||
131729365|NCT00523341|474288361|FG000|Overall Study|Non-compliance|20|||
131729366|NCT00523341|474288362|FG001|Overall Study|Non-compliance|13|||
131729367|NCT00523341|474288361|FG000|Overall Study|Physician Decision|14|||
131729368|NCT00523341|474288362|FG001|Overall Study|Physician Decision|13|||
131729369|NCT00523341|474288361|FG000|Overall Study|Requirement for Alternative Therapy|4|||
131729370|NCT00523341|474288362|FG001|Overall Study|Requirement for Alternative Therapy|14|||
131729371|NCT00523341|474288361|FG000|Overall Study|Protocol Deviation|6|||
131729372|NCT00523341|474288362|FG001|Overall Study|Protocol Deviation|5|||
131729373|NCT00523341|474288361|FG000|Overall Study|Ineligibility Determined|3|||
131729374|NCT00523341|474288362|FG001|Overall Study|Ineligibility Determined|4|||
131729375|NCT00523341|474288361|FG000|Overall Study|Disease Progression|1|||
131729376|NCT00523341|474288362|FG001|Overall Study|Disease Progression|0|||
131729377|NCT05137041|474288365|FG000|Overall Study|Lost to Follow-up|1|||
131729378|NCT05137041|474288366|FG001|Overall Study|Lost to Follow-up|1|||
131729379|NCT05137041|474288365|FG000|Overall Study|Withdrawal by Subject|0|||
131729380|NCT05137041|474288366|FG001|Overall Study|Withdrawal by Subject|2|||
131729381|NCT05137041|474288365|FG000|Overall Study|Reason not Specified|0|||
131729382|NCT05137041|474288366|FG001|Overall Study|Reason not Specified|1|||
131729383|NCT02361762|474288368|FG000|Overall Study|Withdrawal by Subject|0|||
131729384|NCT02361762|474288369|FG001|Overall Study|Withdrawal by Subject|1|||
131729385|NCT02361762|474288368|FG000|Overall Study|Lost to Follow-up|0|||
131729386|NCT02361762|474288369|FG001|Overall Study|Lost to Follow-up|1|||
131729387|NCT02819310|474288370|FG000|Overall Study|Withdrawal by Subject|37|||
131729388|NCT02819310|474288370|FG000|Overall Study|Lost to Follow-up|16|||
131729389|NCT02819310|474288370|FG000|Overall Study|Adverse Event|13|||
131729390|NCT02819310|474288370|FG000|Overall Study|Lack of Efficacy|5|||
131729391|NCT02819310|474288370|FG000|Overall Study|Physician Decision|8|||
131729392|NCT02819310|474288370|FG000|Overall Study|Protocol Violation|30|||
131729393|NCT04907539|474288371|FG000|Overall Study|Consent withdrawn|1|||
131729394|NCT04907539|474288372|FG001|Overall Study|Consent withdrawn|0|||
131729395|NCT04907539|474288371|FG000|Overall Study|Death|14|||
131729396|NCT04907539|474288372|FG001|Overall Study|Death|3|||
131729397|NCT00051558|474288373|FG000|Overall Study|Adverse Event|30|||
131729398|NCT00051558|474288374|FG001|Overall Study|Adverse Event|18|||
131729399|NCT00051558|474288373|FG000|Overall Study|Withdrawal by Subject|29|||
131729400|NCT00051558|474288374|FG001|Overall Study|Withdrawal by Subject|42|||
131729401|NCT00051558|474288373|FG000|Overall Study|Death|9|||
131729402|NCT00051558|474288374|FG001|Overall Study|Death|15|||
131806774|NCT04000815|474577584|FG000|Overall Study|Lost to Follow-up|9|||
131729403|NCT00051558|474288373|FG000|Overall Study|Lost to Follow-up|4|||
131729404|NCT00051558|474288374|FG001|Overall Study|Lost to Follow-up|13|||
131729405|NCT00051558|474288373|FG000|Overall Study|Protocol Violation|3|||
131729406|NCT00051558|474288374|FG001|Overall Study|Protocol Violation|4|||
131729407|NCT00051558|474288373|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
131729408|NCT00051558|474288374|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
131729409|NCT00051558|474288373|FG000|Overall Study|Sponsor Decision|6|||
131729410|NCT00051558|474288374|FG001|Overall Study|Sponsor Decision|1|||
131729411|NCT00051558|474288373|FG000|Overall Study|Other|2|||
131729412|NCT00051558|474288374|FG001|Overall Study|Other|1|||
131729413|NCT00051558|474288373|FG000|Overall Study|Significant Lab Value|2|||
131729414|NCT00051558|474288374|FG001|Overall Study|Significant Lab Value|0|||
131729415|NCT00051558|474288373|FG000|Overall Study|Physician Decision|5|||
131729416|NCT00051558|474288374|FG001|Overall Study|Physician Decision|0|||
131729417|NCT01808118|474288378|FG000|Period 1|Adverse Event|15|||
131729418|NCT01808118|474288379|FG001|Period 1|Adverse Event|0|||
131729419|NCT01808118|474288380|FG002|Period 1|Adverse Event|0|||
131729420|NCT01808118|474288378|FG000|Period 1|Withdrew consent|24|||
131729421|NCT01808118|474288379|FG001|Period 1|Withdrew consent|0|||
131729422|NCT01808118|474288380|FG002|Period 1|Withdrew consent|0|||
131729423|NCT01808118|474288378|FG000|Period 1|Lost to Follow-up|9|||
131729424|NCT01808118|474288379|FG001|Period 1|Lost to Follow-up|0|||
131729425|NCT01808118|474288380|FG002|Period 1|Lost to Follow-up|0|||
131729426|NCT01808118|474288378|FG000|Period 1|Did not meet criteria for remission|303|||
131729427|NCT01808118|474288379|FG001|Period 1|Did not meet criteria for remission|0|||
131729428|NCT01808118|474288380|FG002|Period 1|Did not meet criteria for remission|0|||
131729429|NCT01808118|474288378|FG000|Period 1|Enrolled in error|7|||
131729430|NCT01808118|474288379|FG001|Period 1|Enrolled in error|0|||
131729431|NCT01808118|474288380|FG002|Period 1|Enrolled in error|0|||
131729432|NCT01808118|474288378|FG000|Period 1|Did not meet inclusion criteria|3|||
131729433|NCT01808118|474288379|FG001|Period 1|Did not meet inclusion criteria|0|||
131729434|NCT01808118|474288380|FG002|Period 1|Did not meet inclusion criteria|0|||
131729435|NCT01808118|474288378|FG000|Period 1|Non-conformance with inclusion criteria|3|||
131729436|NCT01808118|474288379|FG001|Period 1|Non-conformance with inclusion criteria|0|||
131729437|NCT01808118|474288380|FG002|Period 1|Non-conformance with inclusion criteria|0|||
131729438|NCT01808118|474288378|FG000|Period 1|Investigator decision: site closure|2|||
131729439|NCT01808118|474288379|FG001|Period 1|Investigator decision: site closure|0|||
131729440|NCT01808118|474288380|FG002|Period 1|Investigator decision: site closure|0|||
131729441|NCT01808118|474288378|FG000|Period 1|Non-compliance per sponsor|1|||
131729442|NCT01808118|474288379|FG001|Period 1|Non-compliance per sponsor|0|||
131729443|NCT01808118|474288380|FG002|Period 1|Non-compliance per sponsor|0|||
131729444|NCT01808118|474288378|FG000|Period 1|Lack of Efficacy|1|||
131729445|NCT01808118|474288379|FG001|Period 1|Lack of Efficacy|0|||
131729446|NCT01808118|474288380|FG002|Period 1|Lack of Efficacy|0|||
131729447|NCT01808118|474288378|FG000|Period 2|Adverse Event|0|||
131729448|NCT01808118|474288379|FG001|Period 2|Adverse Event|4|||
131729449|NCT01808118|474288380|FG002|Period 2|Adverse Event|0|||
131729450|NCT01808118|474288378|FG000|Period 2|Withdrew consent|0|||
131729451|NCT01808118|474288379|FG001|Period 2|Withdrew consent|7|||
131729452|NCT01808118|474288380|FG002|Period 2|Withdrew consent|6|||
131729453|NCT01808118|474288378|FG000|Period 2|Lost to Follow-up|0|||
131729454|NCT01808118|474288379|FG001|Period 2|Lost to Follow-up|0|||
131729455|NCT01808118|474288380|FG002|Period 2|Lost to Follow-up|2|||
131729456|NCT01808118|474288378|FG000|Period 2|Investigator no longer conducting trials|0|||
131729457|NCT01808118|474288379|FG001|Period 2|Investigator no longer conducting trials|1|||
131729458|NCT01808118|474288380|FG002|Period 2|Investigator no longer conducting trials|0|||
131729459|NCT01808118|474288378|FG000|Period 2|Switched to other therapy|0|||
131729460|NCT01808118|474288379|FG001|Period 2|Switched to other therapy|1|||
131729461|NCT01808118|474288380|FG002|Period 2|Switched to other therapy|0|||
131729462|NCT04467164|474288381|FG000|Washout (1 Week)|Lost to Follow-up|2|||
131729463|NCT04467164|474288382|FG001|Washout (1 Week)|Lost to Follow-up|0|||
131729464|NCT01984346|474288383|FG000|Overall Study|Physician Decision|4|||
131729465|NCT01984346|474288384|FG001|Overall Study|Physician Decision|2|||
131729466|NCT01984346|474288383|FG000|Overall Study|Withdrawal by Subject|2|||
131729467|NCT01984346|474288384|FG001|Overall Study|Withdrawal by Subject|2|||
131729468|NCT01984346|474288383|FG000|Overall Study|Enrollment Closed|8|||
131729469|NCT01984346|474288384|FG001|Overall Study|Enrollment Closed|1|||
131729470|NCT01984346|474288383|FG000|Overall Study|Insurance Coverage|1|||
131729471|NCT01984346|474288384|FG001|Overall Study|Insurance Coverage|0|||
131729472|NCT01984346|474288383|FG000|Overall Study|Intra-operative Exclusion|2|||
131729473|NCT01984346|474288384|FG001|Overall Study|Intra-operative Exclusion|0|||
131729474|NCT00718419|474288389|FG000|Overall Study|Adverse Event|2|||
131729475|NCT00718419|474288390|FG001|Overall Study|Adverse Event|1|||
131729476|NCT00718419|474288389|FG000|Overall Study|Physician Decision|1|||
131729477|NCT00718419|474288390|FG001|Overall Study|Physician Decision|6|||
131729478|NCT00718419|474288389|FG000|Overall Study|Sponsor decision|0|||
131729479|NCT00718419|474288390|FG001|Overall Study|Sponsor decision|1|||
131729480|NCT00718419|474288389|FG000|Overall Study|Withdrawal by Subject|0|||
131729481|NCT00718419|474288390|FG001|Overall Study|Withdrawal by Subject|5|||
131729482|NCT00718419|474288389|FG000|Overall Study|Progressive Disease|7|||
131729483|NCT00718419|474288390|FG001|Overall Study|Progressive Disease|25|||
131729484|NCT00718419|474288389|FG000|Overall Study|Death Due to Progressive Disease|2|||
131729485|NCT00718419|474288390|FG001|Overall Study|Death Due to Progressive Disease|0|||
131729486|NCT00718419|474288389|FG000|Overall Study|Death Due to Study Drug Related|0|||
131729487|NCT00718419|474288390|FG001|Overall Study|Death Due to Study Drug Related|1|||
131729488|NCT00718419|474288389|FG000|Overall Study|Death Due to Adverse Events|1|||
131729489|NCT00718419|474288390|FG001|Overall Study|Death Due to Adverse Events|0|||
131729490|NCT02389816|474288399|FG000|Overall Study|Randomized but Not Treated|1|||
131729491|NCT02389816|474288400|FG001|Overall Study|Randomized but Not Treated|0|||
131806775|NCT04000815|474577585|FG001|Overall Study|Lost to Follow-up|2|||
131806776|NCT04000815|474577586|FG002|Overall Study|Lost to Follow-up|3|||
131806777|NCT04000815|474577584|FG000|Overall Study|Withdrawal by Subject|4|||
131806778|NCT04000815|474577585|FG001|Overall Study|Withdrawal by Subject|3|||
131806779|NCT04000815|474577586|FG002|Overall Study|Withdrawal by Subject|2|||
131806780|NCT04000815|474577584|FG000|Overall Study|Right ovarian cyst occured|1|||
131806781|NCT04000815|474577585|FG001|Overall Study|Right ovarian cyst occured|0|||
131806782|NCT04000815|474577586|FG002|Overall Study|Right ovarian cyst occured|0|||
131806783|NCT04000815|474577584|FG000|Overall Study|Hypertension occured on follow up|0|||
131806784|NCT04000815|474577585|FG001|Overall Study|Hypertension occured on follow up|0|||
131806785|NCT04000815|474577586|FG002|Overall Study|Hypertension occured on follow up|2|||
131806786|NCT00239577|474577587|FG000|Primary Phase|Adverse Event|0|||
131806787|NCT00239577|474577588|FG001|Primary Phase|Adverse Event|0|||
131806788|NCT00239577|474577589|FG002|Primary Phase|Adverse Event|1|||
131806789|NCT00239577|474577590|FG003|Primary Phase|Adverse Event|0|||
131806790|NCT00239577|474577587|FG000|Primary Phase|Other|5|||
131806791|NCT00239577|474577588|FG001|Primary Phase|Other|3|||
131806792|NCT00239577|474577589|FG002|Primary Phase|Other|2|||
131806793|NCT00239577|474577590|FG003|Primary Phase|Other|0|||
131806794|NCT02736721|474577593|FG000|Overall Study|Adverse Event|8|||
131729492|NCT02389816|474288401|FG002|Overall Study|Randomized but Not Treated|0|||
131729493|NCT02389816|474288399|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
131729494|NCT02389816|474288400|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
131729495|NCT02389816|474288401|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
131729496|NCT02389816|474288399|FG000|Overall Study|Major Protocol Deviation|1|||
131729497|NCT02389816|474288400|FG001|Overall Study|Major Protocol Deviation|0|||
131729498|NCT02389816|474288401|FG002|Overall Study|Major Protocol Deviation|0|||
131729499|NCT02389816|474288399|FG000|Overall Study|Lost to Follow-up|1|||
131729500|NCT02389816|474288400|FG001|Overall Study|Lost to Follow-up|0|||
131729501|NCT02389816|474288401|FG002|Overall Study|Lost to Follow-up|0|||
131729502|NCT02389816|474288399|FG000|Overall Study|Withdrawal of Consent|6|||
131729503|NCT02389816|474288400|FG001|Overall Study|Withdrawal of Consent|4|||
131729504|NCT02389816|474288401|FG002|Overall Study|Withdrawal of Consent|4|||
131729505|NCT02389816|474288399|FG000|Overall Study|Lack of Efficacy|1|||
131729506|NCT02389816|474288400|FG001|Overall Study|Lack of Efficacy|0|||
131729507|NCT02389816|474288401|FG002|Overall Study|Lack of Efficacy|0|||
131729508|NCT02389816|474288399|FG000|Overall Study|Non Compliance with Study Drug|1|||
131729509|NCT02389816|474288400|FG001|Overall Study|Non Compliance with Study Drug|1|||
131729510|NCT02389816|474288401|FG002|Overall Study|Non Compliance with Study Drug|1|||
131729511|NCT02389816|474288399|FG000|Overall Study|Reason not Specified|0|||
131729512|NCT02389816|474288400|FG001|Overall Study|Reason not Specified|2|||
131729513|NCT02389816|474288401|FG002|Overall Study|Reason not Specified|0|||
131729514|NCT01594476|474288402|FG000|Overall Study|Protocol Violation|1|||
131729515|NCT01594476|474288403|FG001|Overall Study|Protocol Violation|3|||
131729516|NCT01106534|474288404|FG000|Overall Study|Withdrawal by Subject|18|||
131729517|NCT01106534|474288404|FG000|Overall Study|Lost to Follow-up|2|||
131729518|NCT01106534|474288404|FG000|Overall Study|Death|16|||
131729519|NCT01106534|474288404|FG000|Overall Study|Physician Decision|1|||
131729520|NCT01603641|474288410|FG000|Overall Study|Did not Receive Treatment|3|||
131729521|NCT01603641|474288410|FG000|Overall Study|Adverse Event|1|||
131729522|NCT01603641|474288410|FG000|Overall Study|Lack of Efficacy|1|||
131729523|NCT01603641|474288410|FG000|Overall Study|Lost to Follow-up|6|||
131729524|NCT01603641|474288410|FG000|Overall Study|Personal Reasons|18|||
131729525|NCT01603641|474288410|FG000|Overall Study|Other Miscellaneous Reasons|6|||
131729526|NCT03161678|474288411|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131729527|NCT03161678|474288412|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131729528|NCT03161678|474288413|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131729529|NCT03161678|474288414|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
131729530|NCT03161678|474288415|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131729531|NCT03161678|474288416|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131729532|NCT03161678|474288411|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
131729533|NCT03161678|474288412|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
131729534|NCT03161678|474288413|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
131729535|NCT03161678|474288414|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
131729536|NCT03161678|474288415|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
131729537|NCT03161678|474288416|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
131806795|NCT02736721|474577593|FG000|Overall Study|Lost to Follow-up|3|||
131806796|NCT02736721|474577593|FG000|Overall Study|Other|5|||
131729538|NCT03161678|474288411|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
131729539|NCT03161678|474288412|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
131729540|NCT03161678|474288413|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
131729541|NCT03161678|474288414|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
131729542|NCT03161678|474288415|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
131806797|NCT03021018|474577594|FG000|Overall Study|Adverse Event|1|||
131806798|NCT03021018|474577595|FG001|Overall Study|Adverse Event|0|||
131905062|NCT02616783|474939033|FG001|Overall Study|Withdrew Consent|1|||
131496719|NCT02289690|473446367|FG008|Overall Study|Death|45|||
131729543|NCT03161678|474288416|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
131729544|NCT03161678|474288411|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131729545|NCT03161678|474288412|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131729546|NCT03161678|474288413|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131729547|NCT03161678|474288414|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
131729548|NCT03161678|474288415|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131729549|NCT03161678|474288416|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131729550|NCT01757704|474288417|FG000|Overall Study|Protocol Violation|1|||
131729551|NCT01757704|474288418|FG001|Overall Study|Protocol Violation|3|||
131729552|NCT01879618|474288419|FG000|Overall Study|Does not meet entrance criteria|1|||
131729553|NCT01879618|474288419|FG000|Overall Study|Withdrawal by Subject|1|||
131729554|NCT01879618|474288419|FG000|Overall Study|Surgery;changed schedule; not available|8|||
131729555|NCT01879618|474288419|FG000|Overall Study|Protocol Violation|6|||
131729556|NCT01879618|474288419|FG000|Overall Study|Adverse Event|5|||
131729557|NCT02890329|474288422|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131729558|NCT02890329|474288423|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
131729559|NCT02890329|474288424|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131729560|NCT02890329|474288425|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131729561|NCT02890329|474288426|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131729562|NCT02890329|474288427|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131729563|NCT02890329|474288422|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
131729564|NCT02890329|474288423|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
131729565|NCT02890329|474288424|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131729566|NCT02890329|474288425|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131729567|NCT02890329|474288426|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131729568|NCT02890329|474288427|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131729569|NCT02890329|474288422|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131729570|NCT02890329|474288423|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131729571|NCT02890329|474288424|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131729572|NCT02890329|474288425|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
131729573|NCT02890329|474288426|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131729574|NCT02890329|474288427|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131729575|NCT02890329|474288422|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131729576|NCT02890329|474288423|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131729577|NCT02890329|474288424|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
131729578|NCT02890329|474288425|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131729579|NCT02890329|474288426|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131729580|NCT02890329|474288427|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131729581|NCT00938327|474288428|FG000|Overall Study|Adverse Event|2|||
131729582|NCT00938327|474288428|FG000|Overall Study|Protocol Violation|1|||
131729583|NCT00938327|474288428|FG000|Overall Study|Withdrawal by Subject|4|||
131729584|NCT00938327|474288428|FG000|Overall Study|Lost to Follow-up|37|||
131729585|NCT00938327|474288428|FG000|Overall Study|2nd dose received outside of the study|7|||
131729586|NCT00938327|474288428|FG000|Overall Study|Vaccine not received as out of stock|9|||
131729587|NCT02749721|474288429|FG000|Screening|Withdrawal by Subject|1|||
131729588|NCT02749721|474288429|FG000|Screening|Lost to Follow-up|2|||
131729589|NCT02749721|474288429|FG000|Screening|Protocol Violation|3|||
131729590|NCT02749721|474288429|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
131729591|NCT02749721|474288429|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
131729592|NCT02691247|474288430|FG000|Overall Study|Withdrawal by Subject|1|||
131729593|NCT02691247|474288431|FG001|Overall Study|Withdrawal by Subject|2|||
131729594|NCT02691247|474288432|FG002|Overall Study|Withdrawal by Subject|2|||
131729595|NCT02691247|474288430|FG000|Overall Study|Lost to Follow-up|2|||
131729596|NCT02691247|474288431|FG001|Overall Study|Lost to Follow-up|0|||
131729597|NCT02691247|474288432|FG002|Overall Study|Lost to Follow-up|1|||
131729598|NCT05468086|474288435|FG000|Overall Study|Withdrawal by Subject|3|||
131729599|NCT05468086|474288435|FG000|Overall Study|Subject was found ineligible after consent|1|||
131729600|NCT01095250|474288438|FG000|Overall Study|administrative reasons|8|||
131729601|NCT01095250|474288439|FG001|Overall Study|administrative reasons|10|||
131729602|NCT01095250|474288440|FG002|Overall Study|administrative reasons|7|||
131729603|NCT01095250|474288441|FG003|Overall Study|administrative reasons|5|||
131729604|NCT01095250|474288438|FG000|Overall Study|Withdrawal by Subject|0|||
131729605|NCT01095250|474288439|FG001|Overall Study|Withdrawal by Subject|0|||
131729606|NCT01095250|474288440|FG002|Overall Study|Withdrawal by Subject|1|||
131729607|NCT01095250|474288441|FG003|Overall Study|Withdrawal by Subject|0|||
131729608|NCT00783705|474288443|FG000|Overall Study|Adverse Event|2|||
131729609|NCT00783705|474288444|FG001|Overall Study|Adverse Event|0|||
131806799|NCT03021018|474577596|FG002|Overall Study|Adverse Event|0|||
131806800|NCT03021018|474577594|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
131729610|NCT00783705|474288443|FG000|Overall Study|Withdrawal by Subject|3|||
131729611|NCT00783705|474288444|FG001|Overall Study|Withdrawal by Subject|2|||
131729612|NCT00783705|474288443|FG000|Overall Study|Lost to Follow-up|1|||
131729613|NCT00783705|474288444|FG001|Overall Study|Lost to Follow-up|3|||
131729614|NCT03643432|474288445|FG000|Overall Study|Lost to Follow-up|1|||
131729615|NCT03643432|474288446|FG001|Overall Study|Lost to Follow-up|0|||
131729616|NCT00701727|474289690|FG000|First Treatment Period|Adverse Event|0|||
131729617|NCT00701727|474289691|FG001|First Treatment Period|Adverse Event|0|||
131729618|NCT00701727|474289690|FG000|First Treatment Period|Withdrawal by Subject|1|||
131729619|NCT00701727|474289691|FG001|First Treatment Period|Withdrawal by Subject|0|||
131729620|NCT00701727|474289690|FG000|First Treatment Period|sponsor decision|0|||
131729621|NCT00701727|474289691|FG001|First Treatment Period|sponsor decision|1|||
131729622|NCT00701727|474289690|FG000|First Treatment Period|Lost to Follow-up|0|||
131729623|NCT00701727|474289691|FG001|First Treatment Period|Lost to Follow-up|1|||
131729624|NCT00701727|474289690|FG000|Second Treatment Period|Withdrawal by Subject|2|||
131806801|NCT03021018|474577595|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
131806802|NCT03021018|474577596|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
131806803|NCT04123548|474577603|FG000|Overall Study|Withdrawal by Subject|1|||
131806804|NCT04123548|474577603|FG000|Overall Study|Lost to Follow-up|8|||
131806805|NCT04123548|474577603|FG000|Overall Study|Death|4|||
131806806|NCT04123548|474577603|FG000|Overall Study|Reason Not Specified|1|||
131806807|NCT00418184|474577604|FG000|Double-blind Phase|Withdrawal by Subject|22|||
131806808|NCT00418184|474577605|FG001|Double-blind Phase|Withdrawal by Subject|9|||
131806809|NCT00418184|474577604|FG000|Double-blind Phase|Adverse Event|2|||
131806810|NCT00418184|474577605|FG001|Double-blind Phase|Adverse Event|1|||
131806811|NCT00418184|474577604|FG000|Double-blind Phase|Poor compliance|3|||
131806812|NCT00418184|474577605|FG001|Double-blind Phase|Poor compliance|1|||
131806813|NCT00620074|474577606|FG000|Overall Study|Adverse Event|1|||
131806814|NCT02822235|474577607|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
131806815|NCT02822235|474577608|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
131806816|NCT02822235|474577607|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
131806817|NCT02822235|474577608|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
131806818|NCT02822235|474577607|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
131806819|NCT02822235|474577608|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
131806820|NCT02822235|474577607|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
131806821|NCT02822235|474577608|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
131806822|NCT02822235|474577607|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
131806823|NCT02822235|474577608|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
131806824|NCT02822235|474577607|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
131806825|NCT02822235|474577608|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
131448796|NCT00790842|473272723|FG003|Expansion Cohort|Withdrawal by Subject|0|||
131729625|NCT00701727|474289691|FG001|Second Treatment Period|Withdrawal by Subject|0|||
131729626|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131729627|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131729628|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131729629|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
131729630|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131729631|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131729632|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131729633|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131729634|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
131729635|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
131729636|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131729637|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131729638|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131729639|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131729640|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
131729641|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131729642|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131729643|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131729644|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131806826|NCT03214952|474577609|FG000|Overall Study|Protocol Deviation|45|||
131806827|NCT03214952|474577609|FG000|Overall Study|Case Report Forms Uncollected|13|||
131806828|NCT00834743|474577610|FG000|Second Intervention|Withdrawal by Subject|1|||
131806829|NCT00834743|474577611|FG001|Second Intervention|Withdrawal by Subject|0|||
131729645|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131729646|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
131729647|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
131806830|NCT04112823|474577614|FG000|Overall Study|Lost to Follow-up|2|||
131806831|NCT04112823|474577615|FG001|Overall Study|Lost to Follow-up|3|||
131806832|NCT02728102|474577616|FG000|Overall Study|Death|3|||
131806833|NCT02728102|474577617|FG001|Overall Study|Death|0|||
131806834|NCT02728102|474577618|FG002|Overall Study|Death|1|||
131806835|NCT02728102|474577616|FG000|Overall Study|Withdrawal by Subject|0|||
131806836|NCT02728102|474577617|FG001|Overall Study|Withdrawal by Subject|2|||
131806837|NCT02728102|474577618|FG002|Overall Study|Withdrawal by Subject|3|||
131806838|NCT02728102|474577616|FG000|Overall Study|Physician Decision|1|||
131806839|NCT02728102|474577617|FG001|Overall Study|Physician Decision|1|||
131806840|NCT02728102|474577618|FG002|Overall Study|Physician Decision|0|||
131729648|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131729649|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131729650|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131729651|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131729652|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
131729653|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
131729654|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131729655|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131729656|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
131729657|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
131729658|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
131729659|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
131729660|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
131729661|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
131729662|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
131729663|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
131729664|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
131729665|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
131729666|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
131729667|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
131729668|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
131729669|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
131729670|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
131729671|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
131729672|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
131729673|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
131729674|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
131729675|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
131729676|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
131729677|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
131729678|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
131729679|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
131729680|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
131729681|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
131729682|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
131729683|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
131729684|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
131729685|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
131729686|NCT03395197|474289694|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
131729687|NCT03395197|474289695|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
131729688|NCT03395197|474289696|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
131729689|NCT03395197|474289697|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
131729690|NCT03395197|474289698|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
131806841|NCT02728102|474577616|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
131806842|NCT02728102|474577617|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
131448797|NCT00790842|473272724|FG004|Expansion Cohort|Withdrawal by Subject|0|||
131806843|NCT02728102|474577618|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
131806844|NCT02728102|474577616|FG000|Overall Study|Covid|0|||
131729691|NCT03395197|474289699|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
131729692|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Death|0|||
131729693|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Death|0|||
131729694|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Death|0|||
131806845|NCT02728102|474577617|FG001|Overall Study|Covid|0|||
131806846|NCT02728102|474577618|FG002|Overall Study|Covid|1|||
131806847|NCT01182415|474577619|FG000|Overall Study|Lost to Follow-up|1|||
131806848|NCT00086996|474577621|FG000|Overall Study|Adverse Event|29|||
131806849|NCT00086996|474577621|FG000|Overall Study|Death|4|||
131806850|NCT00086996|474577621|FG000|Overall Study|progression/relapse|7|||
131806851|NCT00086996|474577621|FG000|Overall Study|Withdrawal by Subject|13|||
131806852|NCT00086996|474577621|FG000|Overall Study|Other|6|||
131806853|NCT00086996|474577621|FG000|Overall Study|not eligible|5|||
131806854|NCT01422538|474577624|FG000|Overall Study|Lost to Follow-up|0|||
131806855|NCT01422538|474577625|FG001|Overall Study|Lost to Follow-up|1|||
131806856|NCT01422538|474577626|FG002|Overall Study|Lost to Follow-up|1|||
131806857|NCT01422538|474577624|FG000|Overall Study|Missed visit|0|||
131806858|NCT01422538|474577625|FG001|Overall Study|Missed visit|1|||
131806859|NCT01422538|474577626|FG002|Overall Study|Missed visit|1|||
131806860|NCT00004562|474577627|FG000|Overall Study|Lost to Follow-up|102|||
131806861|NCT00004562|474577628|FG001|Overall Study|Lost to Follow-up|91|||
131806862|NCT04274686|474577630|FG000|Overall Study|Physician Decision|1|||
131806863|NCT04274686|474577631|FG001|Overall Study|Physician Decision|0|||
131806864|NCT00376623|474577632|FG000|Overall Study|Progressive disease|35|||
131806865|NCT00376623|474577633|FG001|Overall Study|Progressive disease|22|||
131806866|NCT00376623|474577634|FG002|Overall Study|Progressive disease|17|||
131806867|NCT00376623|474577632|FG000|Overall Study|Lost to Follow-up|0|||
131806868|NCT00376623|474577633|FG001|Overall Study|Lost to Follow-up|1|||
131806869|NCT00376623|474577634|FG002|Overall Study|Lost to Follow-up|0|||
131806870|NCT00376623|474577632|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
131806871|NCT00376623|474577633|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
131806872|NCT00376623|474577634|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
131806873|NCT00376623|474577632|FG000|Overall Study|Not treated with BI 2536|1|||
131806874|NCT00376623|474577633|FG001|Overall Study|Not treated with BI 2536|0|||
131806875|NCT00376623|474577634|FG002|Overall Study|Not treated with BI 2536|0|||
131806876|NCT00376623|474577632|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
131806877|NCT00376623|474577633|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
131806878|NCT00376623|474577634|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
131729695|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Death|0|||
131729696|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Death|1|||
131729697|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Death|4|||
131729698|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131729699|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131729700|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131729701|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131729702|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
131729703|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
131729704|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131729705|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131729706|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131729707|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131729708|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
131729709|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131806879|NCT00376623|474577632|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
131806880|NCT00376623|474577633|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
131806881|NCT00376623|474577634|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
131806882|NCT00376623|474577632|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
131806883|NCT00376623|474577633|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
131806884|NCT00376623|474577634|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
131806885|NCT00376623|474577632|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
131806886|NCT00376623|474577633|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
131806887|NCT00376623|474577634|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
131806888|NCT00376623|474577632|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
131806889|NCT00376623|474577633|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
131806890|NCT00376623|474577634|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
131729710|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131729711|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131729712|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131729713|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131729714|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
131729715|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
131729716|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131729717|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131729718|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131729719|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131729720|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
131729721|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
131729722|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131729723|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131729724|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131729725|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131729726|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
131729727|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
131729728|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131729729|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131729730|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131729731|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131729732|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
131729733|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
131729734|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Other|0|||
131729735|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Other|0|||
131729736|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Other|0|||
131729737|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Other|0|||
131729738|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Other|3|||
131729739|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Other|3|||
131729740|NCT03395197|474289694|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
131729741|NCT03395197|474289695|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
131729742|NCT03395197|474289696|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
131729743|NCT03395197|474289697|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
131729744|NCT03395197|474289698|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
131729745|NCT03395197|474289699|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
131729746|NCT00392171|474289700|FG000|Overall Study|Did not meet inclusion criteria|4|||
131729747|NCT00392171|474289700|FG000|Overall Study|Disease progression|101|||
131729748|NCT01605071|474289701|FG000|Overall Study|Withdrawal by Subject|3|||
131729749|NCT01605071|474289702|FG001|Overall Study|Withdrawal by Subject|2|||
131729750|NCT03470922|474289703|FG000|Overall Study|Death|107|||
131729751|NCT03470922|474289704|FG001|Overall Study|Death|118|||
131729752|NCT03470922|474289703|FG000|Overall Study|Lost to Follow-up|5|||
131729753|NCT03470922|474289704|FG001|Overall Study|Lost to Follow-up|5|||
131729754|NCT03470922|474289703|FG000|Overall Study|Participant Withdrew Consent|4|||
131729755|NCT03470922|474289704|FG001|Overall Study|Participant Withdrew Consent|9|||
131729756|NCT03470922|474289703|FG000|Overall Study|Other reasons|1|||
131729757|NCT03470922|474289704|FG001|Overall Study|Other reasons|0|||
131729758|NCT03470922|474289703|FG000|Overall Study|Not reported|1|||
131729759|NCT03470922|474289704|FG001|Overall Study|Not reported|0|||
131729760|NCT02340819|474289705|FG000|Overall Study|Adverse Event|1|||
131729761|NCT02340819|474289705|FG000|Overall Study|Withdrawal by Subject|2|||
131729762|NCT02340819|474289705|FG000|Overall Study|Discontinued with other reason|1|||
131729763|NCT00028002|474289708|FG000|Overall Study|Withdrawal by Subject|3|||
131729764|NCT00028002|474289708|FG000|Overall Study|Ineligible|8|||
131729765|NCT01793051|474289709|FG000|Overall Study|Withdrawal by Subject|6|||
131729766|NCT01793051|474289710|FG001|Overall Study|Withdrawal by Subject|4|||
131729767|NCT01793051|474289709|FG000|Overall Study|Adverse Event|0|||
131729768|NCT01793051|474289710|FG001|Overall Study|Adverse Event|2|||
131729769|NCT01793051|474289709|FG000|Overall Study|Too ill to continue|1|||
131729770|NCT01793051|474289710|FG001|Overall Study|Too ill to continue|0|||
131729771|NCT01793051|474289709|FG000|Overall Study|Switched chemo|1|||
131729772|NCT01793051|474289710|FG001|Overall Study|Switched chemo|1|||
131729773|NCT01793051|474289709|FG000|Overall Study|Lack of compliance|1|||
131729774|NCT01793051|474289710|FG001|Overall Study|Lack of compliance|0|||
131729775|NCT01793051|474289709|FG000|Overall Study|Requested to be removed from the study|1|||
131729776|NCT01793051|474289710|FG001|Overall Study|Requested to be removed from the study|1|||
131729777|NCT03952468|474289713|FG000|Overall Study|Death|0|||
131806891|NCT00376623|474577632|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
131806892|NCT00376623|474577633|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
131806893|NCT00376623|474577634|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
131806894|NCT00376623|474577632|FG000|Overall Study|Increase of tumour markers|0|||
131806895|NCT00376623|474577633|FG001|Overall Study|Increase of tumour markers|1|||
131806896|NCT00376623|474577634|FG002|Overall Study|Increase of tumour markers|0|||
131806897|NCT00376623|474577632|FG000|Overall Study|Bone metastasis|1|||
131806898|NCT00376623|474577633|FG001|Overall Study|Bone metastasis|0|||
131806899|NCT00376623|474577634|FG002|Overall Study|Bone metastasis|0|||
131806900|NCT00910663|474577639|FG000|Period 1|Withdrawal by Subject|0|||
131806901|NCT00910663|474577640|FG001|Period 1|Withdrawal by Subject|1|||
131806902|NCT02865850|474577641|FG000|Overall Study|Death|15|||
131806903|NCT02865850|474577642|FG001|Overall Study|Death|19|||
131806904|NCT02865850|474577641|FG000|Overall Study|Withdrawal by Subject|3|||
131806905|NCT02865850|474577642|FG001|Overall Study|Withdrawal by Subject|2|||
131806906|NCT02865850|474577641|FG000|Overall Study|Lost to Follow-up|3|||
131806907|NCT02865850|474577642|FG001|Overall Study|Lost to Follow-up|2|||
131806908|NCT01772537|474577644|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
131806909|NCT01772537|474577645|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
131806910|NCT01772537|474577646|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
131806911|NCT03195491|474577647|FG000|Overall Study|Study drug toxicity|25|||
131806912|NCT03195491|474577648|FG001|Overall Study|Study drug toxicity|3|||
131806913|NCT03195491|474577647|FG000|Overall Study|Maximum clinical benefit|5|||
131806914|NCT03195491|474577648|FG001|Overall Study|Maximum clinical benefit|0|||
131806915|NCT03195491|474577647|FG000|Overall Study|Lost to Follow-up|1|||
131806916|NCT03195491|474577648|FG001|Overall Study|Lost to Follow-up|0|||
131806917|NCT03195491|474577647|FG000|Overall Study|Death|3|||
131806918|NCT03195491|474577648|FG001|Overall Study|Death|0|||
131806919|NCT03195491|474577647|FG000|Overall Study|Adverse event unrelated to study drug|19|||
131806920|NCT03195491|474577648|FG001|Overall Study|Adverse event unrelated to study drug|2|||
131806921|NCT03195491|474577647|FG000|Overall Study|Disease progression|266|||
131806922|NCT03195491|474577648|FG001|Overall Study|Disease progression|8|||
131729778|NCT03952468|474289714|FG001|Overall Study|Death|1|||
131729779|NCT03952468|474289713|FG000|Overall Study|Adverse Event|0|||
131729780|NCT03952468|474289714|FG001|Overall Study|Adverse Event|1|||
131729781|NCT03952468|474289713|FG000|Overall Study|Physician Decision|1|||
131729782|NCT03952468|474289714|FG001|Overall Study|Physician Decision|0|||
131729783|NCT03952468|474289713|FG000|Overall Study|Lost to Follow-up|3|||
131729784|NCT03952468|474289714|FG001|Overall Study|Lost to Follow-up|4|||
131729785|NCT03952468|474289713|FG000|Overall Study|Withdrawal by Subject|2|||
131729786|NCT03952468|474289714|FG001|Overall Study|Withdrawal by Subject|1|||
131729787|NCT05132569|474289715|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
131729788|NCT05132569|474289716|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
131729789|NCT05132569|474289715|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
131729790|NCT05132569|474289716|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
131729791|NCT05132569|474289715|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
131729792|NCT05132569|474289716|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
131729793|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
131729794|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
131729795|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131806923|NCT03195491|474577647|FG000|Overall Study|Other reasons|10|||
131806924|NCT03195491|474577648|FG001|Overall Study|Other reasons|0|||
131806925|NCT03195491|474577647|FG000|Overall Study|Participant withdrew consent|8|||
131806926|NCT03195491|474577648|FG001|Overall Study|Participant withdrew consent|1|||
131806927|NCT03195491|474577647|FG000|Overall Study|Participant no longer meets study criteria|0|||
131806928|NCT03195491|474577648|FG001|Overall Study|Participant no longer meets study criteria|1|||
131806929|NCT03195491|474577647|FG000|Overall Study|Participant request to discontinue study treatment|10|||
131806930|NCT03195491|474577648|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131806931|NCT01263704|474577649|FG000|Overall Study|Progressive disease|18|||
131806932|NCT01263704|474577649|FG000|Overall Study|Adverse Event|3|||
131806933|NCT01263704|474577649|FG000|Overall Study|Death|2|||
131806934|NCT01263704|474577649|FG000|Overall Study|Patient withdrew consent|2|||
131806935|NCT01263704|474577649|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
131806936|NCT01263704|474577649|FG000|Overall Study|Lost to Follow-up|1|||
131729796|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131806937|NCT01263704|474577649|FG000|Overall Study|Colon metastases|1|||
131806938|NCT01263704|474577649|FG000|Overall Study|Principal Investigator (PI) decision|1|||
131806939|NCT00772941|474577651|FG000|Overall Study|CRFs not available|195|||
131806940|NCT00772941|474577651|FG000|Overall Study|Study not completed|16|||
131729797|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131729798|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131905063|NCT04344301|474939034|FG000|Overall Study|Withdrawal by Subject|1|||
131905064|NCT04344301|474939035|FG001|Overall Study|Withdrawal by Subject|0|||
131905065|NCT04344301|474939034|FG000|Overall Study|Death|0|||
131905066|NCT04344301|474939035|FG001|Overall Study|Death|1|||
131905067|NCT01747499|474939036|FG000|Overall Study|Steroid refractory aGvHD|1|||
131905068|NCT01747499|474939037|FG001|Overall Study|Steroid refractory aGvHD|0|||
131729799|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131729800|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131729801|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
131729802|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131729803|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131729804|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
131729805|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131729806|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131729807|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
131729808|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
131729809|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
131729810|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
131729811|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
131729812|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
131729813|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
131729814|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Other|0|||
131729815|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Other|1|||
131729816|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Other|0|||
131729817|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Other|0|||
131729818|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Other|0|||
131729819|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Other|0|||
131729820|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Other|0|||
131729821|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
131729822|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
131729823|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
131729824|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
131729825|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
131729826|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
131729827|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
131729828|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
131729829|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
131729830|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
131729831|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
131729832|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
131729833|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
131729834|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
131729835|NCT00365716|474289717|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
131729836|NCT00365716|474289718|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
131729837|NCT00365716|474289719|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
131729838|NCT00365716|474289720|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
131729839|NCT00365716|474289721|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
131729840|NCT00365716|474289722|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
131729841|NCT00365716|474289723|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
131729842|NCT00365716|474289717|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
131729843|NCT00365716|474289718|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131729844|NCT00365716|474289719|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131729845|NCT00365716|474289720|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
131729846|NCT00365716|474289721|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
131729847|NCT00365716|474289722|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131729848|NCT00365716|474289723|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131729849|NCT00365716|474289717|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
131729850|NCT00365716|474289718|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
131729851|NCT00365716|474289719|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
131905069|NCT01747499|474939038|FG002|Overall Study|Steroid refractory aGvHD|0|||
131905070|NCT01747499|474939039|FG003|Overall Study|Steroid refractory aGvHD|1|||
131729852|NCT00365716|474289720|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
131729853|NCT00365716|474289721|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
131905071|NCT01747499|474939040|FG004|Overall Study|Steroid refractory aGvHD|4|||
131905072|NCT01747499|474939036|FG000|Overall Study|Physician Decision|0|||
131729854|NCT00365716|474289722|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
131729855|NCT00365716|474289723|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
131729856|NCT00365716|474289717|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
131729857|NCT00365716|474289718|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
131729858|NCT00365716|474289719|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
131729859|NCT00365716|474289720|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
131729860|NCT00365716|474289721|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
131729861|NCT00365716|474289722|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
131729862|NCT00365716|474289723|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
131729863|NCT00365716|474289717|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
131729864|NCT00365716|474289718|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131729865|NCT00365716|474289719|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131729866|NCT00365716|474289720|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131729867|NCT00365716|474289721|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
131729868|NCT00365716|474289722|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131729869|NCT00365716|474289723|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131729870|NCT00365716|474289717|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131729871|NCT00365716|474289718|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
131729872|NCT00365716|474289719|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
131729873|NCT00365716|474289720|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131729874|NCT00365716|474289721|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131729875|NCT00365716|474289722|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131729876|NCT00365716|474289723|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131729877|NCT00365716|474289717|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
131729878|NCT00365716|474289718|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
131729879|NCT00365716|474289719|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
131729880|NCT00365716|474289720|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
131729881|NCT00365716|474289721|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
131729882|NCT00365716|474289722|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
131729883|NCT00365716|474289723|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
131729884|NCT00365716|474289717|FG000|Extension 1|Lost to Follow-up|0|||
131729885|NCT00365716|474289718|FG001|Extension 1|Lost to Follow-up|0|||
131729886|NCT00365716|474289719|FG002|Extension 1|Lost to Follow-up|0|||
131729887|NCT00365716|474289720|FG003|Extension 1|Lost to Follow-up|0|||
131729888|NCT00365716|474289721|FG004|Extension 1|Lost to Follow-up|0|||
131729889|NCT00365716|474289722|FG005|Extension 1|Lost to Follow-up|1|||
131729890|NCT00365716|474289723|FG006|Extension 1|Lost to Follow-up|0|||
131729891|NCT00365716|474289717|FG000|Extension 1|Other|0|||
131729892|NCT00365716|474289718|FG001|Extension 1|Other|0|||
131729893|NCT00365716|474289719|FG002|Extension 1|Other|0|||
131729894|NCT00365716|474289720|FG003|Extension 1|Other|0|||
131729895|NCT00365716|474289721|FG004|Extension 1|Other|0|||
131729896|NCT00365716|474289722|FG005|Extension 1|Other|9|||
131729897|NCT00365716|474289723|FG006|Extension 1|Other|0|||
131729898|NCT00365716|474289717|FG000|Extension 1|Moved|0|||
131729899|NCT00365716|474289718|FG001|Extension 1|Moved|0|||
131729900|NCT00365716|474289719|FG002|Extension 1|Moved|0|||
131729901|NCT00365716|474289720|FG003|Extension 1|Moved|0|||
131729902|NCT00365716|474289721|FG004|Extension 1|Moved|0|||
131729903|NCT00365716|474289722|FG005|Extension 1|Moved|4|||
131729904|NCT00365716|474289723|FG006|Extension 1|Moved|0|||
131729905|NCT00365716|474289717|FG000|Extension 1|Withdrawal by Subject|0|||
131729906|NCT00365716|474289718|FG001|Extension 1|Withdrawal by Subject|0|||
131729907|NCT00365716|474289719|FG002|Extension 1|Withdrawal by Subject|0|||
131806941|NCT00772941|474577651|FG000|Overall Study|Missed Visits|374|||
131806942|NCT00772941|474577651|FG000|Overall Study|Poor Compliance|7|||
131806943|NCT00772941|474577651|FG000|Overall Study|GPSP Violation|90|||
131806944|NCT04786184|474577652|FG000|Overall Study|Adverse Event|4|||
131806945|NCT04786184|474577653|FG001|Overall Study|Adverse Event|0|||
131729908|NCT00365716|474289720|FG003|Extension 1|Withdrawal by Subject|0|||
131729909|NCT00365716|474289721|FG004|Extension 1|Withdrawal by Subject|0|||
131729910|NCT00365716|474289722|FG005|Extension 1|Withdrawal by Subject|3|||
131729911|NCT00365716|474289723|FG006|Extension 1|Withdrawal by Subject|0|||
131729912|NCT00365716|474289717|FG000|Extension 1|Pregnancy|0|||
131729913|NCT00365716|474289718|FG001|Extension 1|Pregnancy|0|||
131729914|NCT00365716|474289719|FG002|Extension 1|Pregnancy|0|||
131729915|NCT00365716|474289720|FG003|Extension 1|Pregnancy|0|||
131905073|NCT01747499|474939037|FG001|Overall Study|Physician Decision|1|||
131729916|NCT00365716|474289721|FG004|Extension 1|Pregnancy|0|||
131729917|NCT00365716|474289722|FG005|Extension 1|Pregnancy|4|||
131729918|NCT00365716|474289723|FG006|Extension 1|Pregnancy|0|||
131729919|NCT00365716|474289717|FG000|Extension 1|Protocol Violation|0|||
131729920|NCT00365716|474289718|FG001|Extension 1|Protocol Violation|0|||
131729921|NCT00365716|474289719|FG002|Extension 1|Protocol Violation|0|||
131729922|NCT00365716|474289720|FG003|Extension 1|Protocol Violation|0|||
131729923|NCT00365716|474289721|FG004|Extension 1|Protocol Violation|0|||
131806946|NCT04786184|474577652|FG000|Overall Study|Withdrawal by Subject|3|||
131806947|NCT04786184|474577653|FG001|Overall Study|Withdrawal by Subject|1|||
131806948|NCT04786184|474577652|FG000|Overall Study|Lost to Follow-up|4|||
131806949|NCT04786184|474577653|FG001|Overall Study|Lost to Follow-up|2|||
131806950|NCT00834756|474577654|FG000|First Intervention|Adverse Event|1|||
131806951|NCT00834756|474577655|FG001|First Intervention|Adverse Event|0|||
131806952|NCT00834756|474577654|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
131806953|NCT00834756|474577655|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
131806954|NCT01534520|474577658|FG000|Overall Study|Adverse Event|0|||
131806955|NCT01534520|474577659|FG001|Overall Study|Adverse Event|1|||
131806956|NCT02979353|474577662|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
131806957|NCT02979353|474577663|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
131806958|NCT02979353|474577662|FG000|Overall Study|Withdrawal by Subject|16|||
131806959|NCT02979353|474577663|FG001|Overall Study|Withdrawal by Subject|12|||
131806960|NCT02979353|474577662|FG000|Overall Study|Death|10|||
131806961|NCT02979353|474577663|FG001|Overall Study|Death|11|||
131806962|NCT02979353|474577662|FG000|Overall Study|Transfer to Hospice Care|19|||
131806963|NCT02979353|474577663|FG001|Overall Study|Transfer to Hospice Care|14|||
131806964|NCT02979353|474577662|FG000|Overall Study|Lost to Follow-up|1|||
131806965|NCT02979353|474577663|FG001|Overall Study|Lost to Follow-up|5|||
131806966|NCT00550537|474577664|FG000|Overall Study|Death|18|||
131806967|NCT00550537|474577664|FG000|Overall Study|Adverse Event|20|||
131806968|NCT00550537|474577664|FG000|Overall Study|Disease progression before|46|||
131806969|NCT00550537|474577664|FG000|Overall Study|Withdrawal by Subject|7|||
131806970|NCT00550537|474577664|FG000|Overall Study|Change in treatment plan|4|||
131806971|NCT00550537|474577664|FG000|Overall Study|Other complicating ilness|3|||
131806972|NCT00550537|474577664|FG000|Overall Study|Declining performance status|2|||
131905074|NCT01747499|474939038|FG002|Overall Study|Physician Decision|0|||
131729924|NCT00365716|474289722|FG005|Extension 1|Protocol Violation|1|||
131729925|NCT00365716|474289723|FG006|Extension 1|Protocol Violation|0|||
131448798|NCT00790842|473272725|FG005|Expansion Cohort|Withdrawal by Subject|0|||
131729926|NCT00365716|474289717|FG000|Extension 2|Lost to Follow-up|0|||
131729927|NCT00365716|474289718|FG001|Extension 2|Lost to Follow-up|0|||
131729928|NCT00365716|474289719|FG002|Extension 2|Lost to Follow-up|0|||
131729929|NCT00365716|474289720|FG003|Extension 2|Lost to Follow-up|0|||
131729930|NCT00365716|474289721|FG004|Extension 2|Lost to Follow-up|0|||
131729931|NCT00365716|474289722|FG005|Extension 2|Lost to Follow-up|0|||
131729932|NCT00365716|474289723|FG006|Extension 2|Lost to Follow-up|2|||
131729933|NCT00365716|474289717|FG000|Extension 2|Other|0|||
131729934|NCT00365716|474289718|FG001|Extension 2|Other|0|||
131729935|NCT00365716|474289719|FG002|Extension 2|Other|0|||
131729936|NCT00365716|474289720|FG003|Extension 2|Other|0|||
131729937|NCT00365716|474289721|FG004|Extension 2|Other|0|||
131729938|NCT00365716|474289722|FG005|Extension 2|Other|0|||
131729939|NCT00365716|474289723|FG006|Extension 2|Other|3|||
131729940|NCT00365716|474289717|FG000|Extension 2|Withdrawal by Subject|0|||
131729941|NCT00365716|474289718|FG001|Extension 2|Withdrawal by Subject|0|||
131729942|NCT00365716|474289719|FG002|Extension 2|Withdrawal by Subject|0|||
131729943|NCT00365716|474289720|FG003|Extension 2|Withdrawal by Subject|0|||
131729944|NCT00365716|474289721|FG004|Extension 2|Withdrawal by Subject|0|||
131729945|NCT00365716|474289722|FG005|Extension 2|Withdrawal by Subject|0|||
131729946|NCT00365716|474289723|FG006|Extension 2|Withdrawal by Subject|5|||
131729947|NCT05761444|474289724|FG000|Overall Study|Protocol Violation|2|||
131729948|NCT05761444|474289725|FG001|Overall Study|Protocol Violation|1|||
131729949|NCT05761444|474289724|FG000|Overall Study|Adverse Event|2|||
131729950|NCT05761444|474289725|FG001|Overall Study|Adverse Event|2|||
131729951|NCT05761444|474289724|FG000|Overall Study|Withdrawal by Subject|3|||
131729952|NCT05761444|474289725|FG001|Overall Study|Withdrawal by Subject|2|||
131729953|NCT05761444|474289724|FG000|Overall Study|Other|1|||
131806973|NCT00550537|474577664|FG000|Overall Study|Treated closer to home|4|||
131806974|NCT00268905|474577665|FG000|Overall Study|Adverse Event|3|||
131806975|NCT00268905|474577666|FG001|Overall Study|Adverse Event|0|||
131806976|NCT00268905|474577667|FG002|Overall Study|Adverse Event|4|||
131905075|NCT01747499|474939039|FG003|Overall Study|Physician Decision|0|||
131496720|NCT02289690|473446368|FG009|Overall Study|Death|41|||
131729954|NCT05761444|474289725|FG001|Overall Study|Other|0|||
131729955|NCT00069576|474289728|FG000|Original Trial|Lost to Follow-up|25|||
131729956|NCT00069576|474289729|FG001|Original Trial|Lost to Follow-up|33|||
131729957|NCT00069576|474289728|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
131729958|NCT00069576|474289729|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
131806977|NCT00268905|474577665|FG000|Overall Study|Lost to Follow-up|0|||
131729959|NCT04430738|474289730|FG000|Phase 1: Dose Escalation|Death|1|||
131729960|NCT04430738|474289731|FG001|Phase 1: Dose Escalation|Death|4|||
131729961|NCT04430738|474289732|FG002|Phase 1: Dose Escalation|Death|4|||
131729962|NCT04430738|474289733|FG003|Phase 1: Dose Escalation|Death|1|||
131729963|NCT04430738|474289734|FG004|Phase 1: Dose Escalation|Death|6|||
131729964|NCT04430738|474289735|FG005|Phase 1: Dose Escalation|Death|0|||
131806978|NCT00268905|474577666|FG001|Overall Study|Lost to Follow-up|1|||
131806979|NCT00268905|474577667|FG002|Overall Study|Lost to Follow-up|0|||
131806980|NCT00268905|474577665|FG000|Overall Study|Withdrawal by Subject|0|||
131806981|NCT00268905|474577666|FG001|Overall Study|Withdrawal by Subject|0|||
131806982|NCT00268905|474577667|FG002|Overall Study|Withdrawal by Subject|3|||
131806983|NCT00268905|474577665|FG000|Overall Study|Progressive Disease|28|||
131806984|NCT00268905|474577666|FG001|Overall Study|Progressive Disease|4|||
131806985|NCT00268905|474577667|FG002|Overall Study|Progressive Disease|3|||
131806986|NCT00268905|474577665|FG000|Overall Study|Physician Decision|3|||
131806987|NCT00268905|474577666|FG001|Overall Study|Physician Decision|0|||
131806988|NCT00268905|474577667|FG002|Overall Study|Physician Decision|1|||
131806989|NCT00268905|474577665|FG000|Overall Study|Clinical Progression|9|||
131806990|NCT00268905|474577666|FG001|Overall Study|Clinical Progression|4|||
131806991|NCT00268905|474577667|FG002|Overall Study|Clinical Progression|1|||
131806992|NCT00617305|474577668|FG000|Overall Study|Adverse Event|4|||
131806993|NCT00617305|474577669|FG001|Overall Study|Adverse Event|0|||
131806994|NCT00617305|474577670|FG002|Overall Study|Adverse Event|0|||
131806995|NCT00617305|474577668|FG000|Overall Study|Death|1|||
131806996|NCT00617305|474577669|FG001|Overall Study|Death|0|||
131806997|NCT00617305|474577670|FG002|Overall Study|Death|0|||
131806998|NCT00617305|474577668|FG000|Overall Study|Physician Decision|1|||
131806999|NCT00617305|474577669|FG001|Overall Study|Physician Decision|0|||
131807000|NCT00617305|474577670|FG002|Overall Study|Physician Decision|0|||
131807001|NCT00617305|474577668|FG000|Overall Study|Protocol Violation|1|||
131807002|NCT00617305|474577669|FG001|Overall Study|Protocol Violation|0|||
131807003|NCT00617305|474577670|FG002|Overall Study|Protocol Violation|1|||
131807004|NCT00617305|474577668|FG000|Overall Study|Withdrawal by Subject|1|||
131807005|NCT00617305|474577669|FG001|Overall Study|Withdrawal by Subject|0|||
131807006|NCT00617305|474577670|FG002|Overall Study|Withdrawal by Subject|0|||
131729965|NCT04430738|474289730|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
131729966|NCT04430738|474289731|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
131729967|NCT04430738|474289732|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
131729968|NCT04430738|474289733|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
131729969|NCT04430738|474289734|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
131729970|NCT04430738|474289735|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
131729971|NCT04430738|474289730|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131729972|NCT04430738|474289731|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
131729973|NCT04430738|474289732|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131729974|NCT04430738|474289733|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
131729975|NCT04430738|474289734|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131729976|NCT04430738|474289735|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131729977|NCT04430738|474289730|FG000|Phase 1: Dose Escalation|Other|1|||
131729978|NCT04430738|474289731|FG001|Phase 1: Dose Escalation|Other|0|||
131729979|NCT04430738|474289732|FG002|Phase 1: Dose Escalation|Other|0|||
131729980|NCT04430738|474289733|FG003|Phase 1: Dose Escalation|Other|0|||
131729981|NCT04430738|474289734|FG004|Phase 1: Dose Escalation|Other|0|||
131729982|NCT04430738|474289735|FG005|Phase 1: Dose Escalation|Other|0|||
131807007|NCT00855738|474577673|FG000|Overall Study|Lost to Follow-up|2|||
131807008|NCT00855738|474577673|FG000|Overall Study|Adverse Event|1|||
131807009|NCT00855738|474577673|FG000|Overall Study|Subject Defaulted|1|||
131807010|NCT00855738|474577673|FG000|Overall Study|Death|1|||
131807011|NCT04384978|474577676|FG000|Overall Study|Withdrawal by Subject|4|||
131807012|NCT04384978|474577677|FG001|Overall Study|Withdrawal by Subject|0|||
131807013|NCT03555305|474577678|FG000|Period 1|Physician Decision|0|||
131807014|NCT03555305|474577679|FG001|Period 1|Physician Decision|1|||
131807015|NCT03555305|474577678|FG000|Period 1|Adverse Event|0|||
131807016|NCT03555305|474577679|FG001|Period 1|Adverse Event|1|||
131807017|NCT03586726|474577687|FG000|Overall Study|Withdrawal by Subject|1|||
131807018|NCT03420300|474577690|FG000|Overall Study|Death|2|||
131807019|NCT03500692|474577705|FG000|Overall Study|Death|163|||
131807020|NCT03500692|474577705|FG000|Overall Study|Lost to Follow-up|75|||
131807021|NCT03500692|474577705|FG000|Overall Study|Termination Reasons|3|||
131807022|NCT01124175|474579449|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
131807023|NCT01124175|474579450|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
131807024|NCT00942968|474579451|FG000|Overall Study|Adverse Event|60|||
131807025|NCT00942968|474579451|FG000|Overall Study|Death|76|||
131807026|NCT00942968|474579451|FG000|Overall Study|Protocol Violation|9|||
131807027|NCT00942968|474579451|FG000|Overall Study|Lost to Follow-up|4|||
131807028|NCT00942968|474579451|FG000|Overall Study|Withdrawal by Subject|44|||
131807029|NCT00942968|474579451|FG000|Overall Study|Sponsor request|5|||
131807030|NCT00942968|474579451|FG000|Overall Study|Physician Decision|11|||
131807031|NCT00942968|474579451|FG000|Overall Study|Progression of disease|12|||
131807032|NCT00942968|474579451|FG000|Overall Study|Inferior vena cava filter placement|4|||
131807033|NCT00942968|474579451|FG000|Overall Study|Pulmonary embolism (PE)|1|||
131807034|NCT00942968|474579451|FG000|Overall Study|Participant required pancreatic biopsy|1|||
131807035|NCT00942968|474579451|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
131807036|NCT01466166|474579455|FG000|Overall Study|Death|1|||
131807037|NCT01466166|474579455|FG000|Overall Study|Lost to Follow-up|7|||
131807038|NCT01466166|474579455|FG000|Overall Study|Infusion Reaction (IR)|27|||
131807039|NCT01466166|474579455|FG000|Overall Study|Adverse Event (Other than IR)|11|||
131729983|NCT04430738|474289730|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131729984|NCT04430738|474289731|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131729985|NCT04430738|474289732|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131729986|NCT04430738|474289733|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131729987|NCT04430738|474289734|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131729988|NCT04430738|474289735|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
131729989|NCT04430738|474289730|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131729990|NCT04430738|474289731|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131729991|NCT04430738|474289732|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131729992|NCT04430738|474289733|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131729993|NCT04430738|474289734|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131729994|NCT04430738|474289735|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
131729995|NCT05590793|474289736|FG000|Overall Study|Withdrawal by Subject|6|||
131729996|NCT05590793|474289736|FG000|Overall Study|Physician Decision|1|||
131729997|NCT05187013|474289737|FG000|Overall Study|Withdrawal by Subject|1|||
131729998|NCT05187013|474289738|FG001|Overall Study|Withdrawal by Subject|1|||
131729999|NCT05187013|474289739|FG002|Overall Study|Withdrawal by Subject|0|||
131730000|NCT05187013|474289737|FG000|Overall Study|Death|0|||
131730001|NCT05187013|474289738|FG001|Overall Study|Death|1|||
131730002|NCT05187013|474289739|FG002|Overall Study|Death|0|||
131730003|NCT05187013|474289737|FG000|Overall Study|Lost to Follow-up|20|||
131730004|NCT05187013|474289738|FG001|Overall Study|Lost to Follow-up|17|||
131730005|NCT05187013|474289739|FG002|Overall Study|Lost to Follow-up|0|||
131730006|NCT05187013|474289737|FG000|Overall Study|Ongoing Participants|3|||
131730007|NCT05187013|474289738|FG001|Overall Study|Ongoing Participants|5|||
131730008|NCT05187013|474289739|FG002|Overall Study|Ongoing Participants|0|||
131730009|NCT04488822|474289740|FG000|Overall Study|Adverse Event|8|||
131730010|NCT04488822|474289740|FG000|Overall Study|Withdrawal by Subject|1|||
131730011|NCT03838367|474289741|FG000|Overall Study|Early termination of study|3|||
131730012|NCT03838367|474289742|FG001|Overall Study|Early termination of study|4|||
131730013|NCT03838367|474289743|FG002|Overall Study|Early termination of study|3|||
131730014|NCT03838367|474289744|FG003|Overall Study|Early termination of study|0|||
131730015|NCT03406104|474289745|FG000|Overall Study|Lost to Follow-up|2|||
131807040|NCT01466166|474579455|FG000|Overall Study|Elevated Serum Uric Acid|78|||
131807041|NCT01466166|474579455|FG000|Overall Study|Withdrawal by Subject|13|||
131807042|NCT01466166|474579455|FG000|Overall Study|Sponsor Decision|4|||
131730016|NCT03406104|474289745|FG000|Overall Study|Withdrawal by Subject|2|||
131730017|NCT03406104|474289745|FG000|Overall Study|due to Covid patient did not want to travel|1|||
131730018|NCT03406104|474289745|FG000|Overall Study|Death|2|||
131730019|NCT03015610|474289751|FG000|Overall Study|Lost to Follow-up|1|||
131730020|NCT03015610|474289752|FG001|Overall Study|Lost to Follow-up|5|||
131730021|NCT02499146|474289761|FG000|Overall Study|Lost to Follow-up|1|||
131730022|NCT02499146|474289761|FG000|Overall Study|Withdrawal by Subject|1|||
131730023|NCT02499146|474289761|FG000|Overall Study|Other|2|||
131730024|NCT02499146|474289761|FG000|Overall Study|Ongoing at date of cut-off|9|||
131730025|NCT02499146|474289761|FG000|Overall Study|Began other treatment/therapy|13|||
131807043|NCT01466166|474579455|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
131807044|NCT01466166|474579455|FG000|Overall Study|Other|20|||
131807045|NCT01340495|474579462|FG000|Overall Study|Withdrawal by Subject|1|||
131807046|NCT01811953|474579463|FG000|Overall Study|Adverse Event|0|||
131807047|NCT01811953|474579464|FG001|Overall Study|Adverse Event|0|||
131807048|NCT01811953|474579465|FG002|Overall Study|Adverse Event|0|||
131807049|NCT01811953|474579466|FG003|Overall Study|Adverse Event|1|||
131905076|NCT01747499|474939040|FG004|Overall Study|Physician Decision|2|||
131807050|NCT01811953|474579467|FG004|Overall Study|Adverse Event|0|||
131807051|NCT01811953|474579468|FG005|Overall Study|Adverse Event|1|||
131807052|NCT01811953|474579463|FG000|Overall Study|Protocol Violation|0|||
131807053|NCT01811953|474579464|FG001|Overall Study|Protocol Violation|0|||
131807054|NCT01811953|474579465|FG002|Overall Study|Protocol Violation|0|||
131730026|NCT05100199|474289762|FG000|Overall Study|Lost to Follow-up|5|||
131730027|NCT05100199|474289763|FG001|Overall Study|Lost to Follow-up|8|||
131730028|NCT05100199|474289764|FG002|Overall Study|Lost to Follow-up|3|||
131730029|NCT05100199|474289765|FG003|Overall Study|Lost to Follow-up|6|||
131730030|NCT05100199|474289762|FG000|Overall Study|Withdrawal by Subject|3|||
131730031|NCT05100199|474289763|FG001|Overall Study|Withdrawal by Subject|3|||
131730032|NCT05100199|474289764|FG002|Overall Study|Withdrawal by Subject|9|||
131730033|NCT05100199|474289765|FG003|Overall Study|Withdrawal by Subject|7|||
131730034|NCT05100199|474289762|FG000|Overall Study|Other|0|||
131730035|NCT05100199|474289763|FG001|Overall Study|Other|0|||
131730036|NCT05100199|474289764|FG002|Overall Study|Other|1|||
131730037|NCT05100199|474289765|FG003|Overall Study|Other|1|||
131730038|NCT00752609|474289766|FG000|Overall Study|Adverse Event|2|||
131730039|NCT00752609|474289767|FG001|Overall Study|Adverse Event|2|||
131730040|NCT00752609|474289766|FG000|Overall Study|Withdrawal by Subject|3|||
131730041|NCT00752609|474289767|FG001|Overall Study|Withdrawal by Subject|0|||
131730042|NCT00752609|474289766|FG000|Overall Study|Physician Decision|1|||
131730043|NCT00752609|474289767|FG001|Overall Study|Physician Decision|0|||
131730044|NCT00752609|474289766|FG000|Overall Study|Death|1|||
131730045|NCT00752609|474289767|FG001|Overall Study|Death|0|||
131730046|NCT00752609|474289766|FG000|Overall Study|Met exclusion criteria|1|||
131730047|NCT00752609|474289767|FG001|Overall Study|Met exclusion criteria|0|||
131730048|NCT00752609|474289766|FG000|Overall Study|Received Aranesp in error|1|||
131730049|NCT00752609|474289767|FG001|Overall Study|Received Aranesp in error|0|||
131730050|NCT00358917|474289770|FG000|Overall Study|Adverse Event|14|||
131730051|NCT00358917|474289771|FG001|Overall Study|Adverse Event|21|||
131730052|NCT00358917|474289770|FG000|Overall Study|Withdrawal by Subject|5|||
131730053|NCT00358917|474289771|FG001|Overall Study|Withdrawal by Subject|7|||
131730054|NCT00358917|474289770|FG000|Overall Study|Lost to Follow-up|20|||
131730055|NCT00358917|474289771|FG001|Overall Study|Lost to Follow-up|17|||
131730056|NCT00358917|474289770|FG000|Overall Study|Noncompliance|12|||
131730057|NCT00358917|474289771|FG001|Overall Study|Noncompliance|11|||
131730058|NCT00358917|474289770|FG000|Overall Study|Death|2|||
131730059|NCT00358917|474289771|FG001|Overall Study|Death|3|||
131730060|NCT00358917|474289770|FG000|Overall Study|Virologic failure|11|||
131730061|NCT00358917|474289771|FG001|Overall Study|Virologic failure|8|||
131730062|NCT00358917|474289770|FG000|Overall Study|Unable to Continue Participation|2|||
131730063|NCT00358917|474289771|FG001|Overall Study|Unable to Continue Participation|2|||
131730064|NCT05692154|474289772|FG000|Overall Study|Adverse Event|0|||
131730065|NCT05692154|474289773|FG001|Overall Study|Adverse Event|1|||
131730066|NCT01379534|474289784|FG000|Treatment Phase|Withdrawal by Subject|2|||
131730067|NCT01379534|474289785|FG001|Treatment Phase|Withdrawal by Subject|2|||
131730068|NCT01379534|474289784|FG000|Treatment Phase|Progressive disease|13|||
131730069|NCT01379534|474289785|FG001|Treatment Phase|Progressive disease|22|||
131730070|NCT01379534|474289784|FG000|Treatment Phase|Adverse Event|7|||
131730071|NCT01379534|474289785|FG001|Treatment Phase|Adverse Event|7|||
131730072|NCT01379534|474289784|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
131730073|NCT01379534|474289785|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
131730074|NCT01379534|474289784|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
131730075|NCT01379534|474289785|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
131730076|NCT01379534|474289784|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
131730077|NCT01379534|474289785|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
131730078|NCT01379534|474289784|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
131730079|NCT01379534|474289785|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
131730080|NCT02275026|474289788|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
131730081|NCT02275026|474289788|FG000|Overall Study|Withdrawal by Subject|4|||
131730082|NCT02275026|474289788|FG000|Overall Study|Ineligible due to medical history|13|||
131730083|NCT02275026|474289788|FG000|Overall Study|MRI malfunction precluded testing|1|||
131730084|NCT02275026|474289788|FG000|Overall Study|Ineligible after MRI findings|1|||
131730085|NCT02275026|474289788|FG000|Overall Study|Lost to Follow-up|2|||
131730086|NCT02275026|474289788|FG000|Overall Study|Scanner failure|1|||
131730087|NCT01108809|474289791|FG000|Overall Study|Adverse Event|3|||
131730088|NCT01108809|474289791|FG000|Overall Study|Lost to Follow-up|1|||
131730089|NCT04238663|474289792|FG000|Overall Study|Lost to Follow-up|0|||
131730090|NCT04238663|474289793|FG001|Overall Study|Lost to Follow-up|1|||
131730091|NCT04238663|474289794|FG002|Overall Study|Lost to Follow-up|0|||
131730092|NCT01193348|474289795|FG000|Screening Period|Screen Failure|5|||
131730093|NCT01193348|474289795|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
131730094|NCT01193348|474289795|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
131730095|NCT01193348|474289795|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
131730096|NCT01193348|474289795|FG000|Extension Treatment Period|Physician Decision|1|||
131807055|NCT01811953|474579466|FG003|Overall Study|Protocol Violation|0|||
131730097|NCT01193348|474289795|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
131730098|NCT04070378|474289796|FG000|Overall Study|Withdrawal by Subject|2|||
131730099|NCT04070378|474289796|FG000|Overall Study|Screen Failure|6|||
131730100|NCT04070378|474289796|FG000|Overall Study|Physician Decision|1|||
131730101|NCT04070378|474289796|FG000|Overall Study|Adverse Event|1|||
131730102|NCT03259334|474289797|FG000|Overall Study|Adverse Event|3|||
131730103|NCT03259334|474289798|FG001|Overall Study|Adverse Event|8|||
131730104|NCT03259334|474289799|FG002|Overall Study|Adverse Event|5|||
131730105|NCT03259334|474289797|FG000|Overall Study|Withdrawal by Subject|4|||
131730106|NCT03259334|474289798|FG001|Overall Study|Withdrawal by Subject|2|||
131730107|NCT03259334|474289799|FG002|Overall Study|Withdrawal by Subject|4|||
131730108|NCT03259334|474289797|FG000|Overall Study|Physician Decision|1|||
131730109|NCT03259334|474289798|FG001|Overall Study|Physician Decision|0|||
131730110|NCT03259334|474289799|FG002|Overall Study|Physician Decision|0|||
131730111|NCT03259334|474289797|FG000|Overall Study|Lost to Follow-up|0|||
131730112|NCT03259334|474289798|FG001|Overall Study|Lost to Follow-up|2|||
131730113|NCT03259334|474289799|FG002|Overall Study|Lost to Follow-up|1|||
131730114|NCT03259334|474289797|FG000|Overall Study|Protocol Deviation|0|||
131730115|NCT03259334|474289798|FG001|Overall Study|Protocol Deviation|3|||
131730116|NCT03259334|474289799|FG002|Overall Study|Protocol Deviation|2|||
131730117|NCT03259334|474289797|FG000|Overall Study|Lack of Efficacy|2|||
131730118|NCT03259334|474289798|FG001|Overall Study|Lack of Efficacy|0|||
131730119|NCT03259334|474289799|FG002|Overall Study|Lack of Efficacy|1|||
131730120|NCT03259334|474289797|FG000|Overall Study|Randomized but never treated|0|||
131730121|NCT03259334|474289798|FG001|Overall Study|Randomized but never treated|2|||
131730122|NCT03259334|474289799|FG002|Overall Study|Randomized but never treated|0|||
131730123|NCT01721408|474289800|FG000|Overall Study|Adverse Event|6|||
131730124|NCT01721408|474289801|FG001|Overall Study|Adverse Event|1|||
131730125|NCT01721408|474289800|FG000|Overall Study|Death|1|||
131730126|NCT01721408|474289801|FG001|Overall Study|Death|0|||
131730127|NCT01721408|474289800|FG000|Overall Study|Insufficient clinical response|15|||
131730128|NCT01721408|474289801|FG001|Overall Study|Insufficient clinical response|6|||
131730129|NCT01721408|474289800|FG000|Overall Study|No longer willing to participate study|9|||
131730130|NCT01721408|474289801|FG001|Overall Study|No longer willing to participate study|10|||
131730131|NCT01721408|474289800|FG000|Overall Study|Protocol Violation|0|||
131730132|NCT01721408|474289801|FG001|Overall Study|Protocol Violation|2|||
131730133|NCT01721408|474289800|FG000|Overall Study|Other|3|||
131730134|NCT01721408|474289801|FG001|Overall Study|Other|3|||
131730135|NCT01721408|474289800|FG000|Overall Study|Lost to Follow-up|1|||
131730136|NCT01721408|474289801|FG001|Overall Study|Lost to Follow-up|2|||
131730137|NCT01721408|474289800|FG000|Overall Study|Does not meet entrance criteria|1|||
131730138|NCT01721408|474289801|FG001|Overall Study|Does not meet entrance criteria|0|||
131730139|NCT03987620|474289804|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
131730140|NCT03987620|474289805|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
131730141|NCT03987620|474289804|FG000|Overall Study|Adverse Event|3|||
131730142|NCT03987620|474289805|FG001|Overall Study|Adverse Event|0|||
131730143|NCT03987620|474289804|FG000|Overall Study|Lost to Follow-up|1|||
131730144|NCT03987620|474289805|FG001|Overall Study|Lost to Follow-up|2|||
131730145|NCT03987620|474289804|FG000|Overall Study|Physician Decision|0|||
131730146|NCT03987620|474289805|FG001|Overall Study|Physician Decision|1|||
131730147|NCT03987620|474289804|FG000|Overall Study|Pregnancy|1|||
131730148|NCT03987620|474289805|FG001|Overall Study|Pregnancy|0|||
131730149|NCT03987620|474289804|FG000|Overall Study|Withdrawal by Subject|7|||
131730150|NCT03987620|474289805|FG001|Overall Study|Withdrawal by Subject|1|||
131730151|NCT03987620|474289804|FG000|Overall Study|Other|2|||
131730152|NCT03987620|474289805|FG001|Overall Study|Other|5|||
131730153|NCT01678807|474289806|FG000|Overall Study|Adverse Event|4|||
131730154|NCT01678807|474289807|FG001|Overall Study|Adverse Event|4|||
131730155|NCT01678807|474289808|FG002|Overall Study|Adverse Event|0|||
131730156|NCT01678807|474289806|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
131730157|NCT01678807|474289807|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
131730158|NCT01678807|474289808|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
131730159|NCT05128162|474289809|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
131730160|NCT05128162|474289809|FG000|Overall Study|Physician Decision|1|||
131730161|NCT00370149|474289810|FG000|Overall Study|Physician Decision|16|||
131730162|NCT00370149|474289811|FG001|Overall Study|Physician Decision|16|||
131730163|NCT00370149|474289810|FG000|Overall Study|Protocol Violation|1|||
131730164|NCT00370149|474289811|FG001|Overall Study|Protocol Violation|0|||
131730165|NCT00370149|474289810|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
131730166|NCT00370149|474289811|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
131730167|NCT00370149|474289810|FG000|Overall Study|Pre-existing infection|0|||
131730168|NCT00370149|474289811|FG001|Overall Study|Pre-existing infection|1|||
131730169|NCT00370149|474289810|FG000|Overall Study|Antibiotic coated dressing placed|0|||
131730170|NCT00370149|474289811|FG001|Overall Study|Antibiotic coated dressing placed|1|||
131730171|NCT05113953|474291203|FG000|Overall Study|Adverse Event|5|||
131730172|NCT05113953|474291204|FG001|Overall Study|Adverse Event|0|||
131730173|NCT05113953|474291205|FG002|Overall Study|Adverse Event|3|||
131730174|NCT05113953|474291203|FG000|Overall Study|Lost to Follow-up|3|||
131730175|NCT05113953|474291204|FG001|Overall Study|Lost to Follow-up|4|||
131730176|NCT05113953|474291205|FG002|Overall Study|Lost to Follow-up|2|||
131730177|NCT05113953|474291203|FG000|Overall Study|Non-compliance with Study Drug|1|||
131730178|NCT05113953|474291204|FG001|Overall Study|Non-compliance with Study Drug|0|||
131730179|NCT05113953|474291205|FG002|Overall Study|Non-compliance with Study Drug|0|||
131730180|NCT05113953|474291203|FG000|Overall Study|Withdrawal by Subject|2|||
131730181|NCT05113953|474291204|FG001|Overall Study|Withdrawal by Subject|6|||
131730182|NCT05113953|474291205|FG002|Overall Study|Withdrawal by Subject|4|||
131730183|NCT05113953|474291203|FG000|Overall Study|Reason not Specified|2|||
131730184|NCT05113953|474291204|FG001|Overall Study|Reason not Specified|0|||
131730185|NCT05113953|474291205|FG002|Overall Study|Reason not Specified|0|||
131730186|NCT00502307|474291208|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
131730187|NCT00502307|474291209|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
131730188|NCT00502307|474291210|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
131730189|NCT00502307|474291208|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
131730190|NCT00502307|474291209|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
131730191|NCT00502307|474291210|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
131730192|NCT00502307|474291208|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
131730193|NCT00502307|474291209|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
131730194|NCT00502307|474291210|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
131730195|NCT00502307|474291208|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
131730196|NCT00502307|474291209|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
131730197|NCT00502307|474291210|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
131730198|NCT00502307|474291208|FG000|Maintenance Period|Progressive disease|80|||
131730199|NCT00502307|474291209|FG001|Maintenance Period|Progressive disease|0|||
131730200|NCT00502307|474291210|FG002|Maintenance Period|Progressive disease|0|||
131730201|NCT00502307|474291208|FG000|Maintenance Period|Discontinued due to other reasons|68|||
131730202|NCT00502307|474291209|FG001|Maintenance Period|Discontinued due to other reasons|0|||
131730203|NCT00502307|474291210|FG002|Maintenance Period|Discontinued due to other reasons|0|||
131730204|NCT01441440|474291211|FG000|Overall Study|Death|1|||
131730205|NCT01441440|474291212|FG001|Overall Study|Death|0|||
131730206|NCT01441440|474291213|FG002|Overall Study|Death|1|||
131730207|NCT01441440|474291211|FG000|Overall Study|Adverse Event|2|||
131730208|NCT01441440|474291212|FG001|Overall Study|Adverse Event|9|||
131730209|NCT01441440|474291213|FG002|Overall Study|Adverse Event|9|||
131730210|NCT01441440|474291211|FG000|Overall Study|Lost to Follow-up|0|||
131730211|NCT01441440|474291212|FG001|Overall Study|Lost to Follow-up|2|||
131730212|NCT01441440|474291213|FG002|Overall Study|Lost to Follow-up|1|||
131730213|NCT01441440|474291211|FG000|Overall Study|Withdrawal by Subject|11|||
131730214|NCT01441440|474291212|FG001|Overall Study|Withdrawal by Subject|9|||
131730215|NCT01441440|474291213|FG002|Overall Study|Withdrawal by Subject|9|||
131730216|NCT01441440|474291211|FG000|Overall Study|Pregnancy|1|||
131730217|NCT01441440|474291212|FG001|Overall Study|Pregnancy|0|||
131730218|NCT01441440|474291213|FG002|Overall Study|Pregnancy|0|||
131730219|NCT01441440|474291211|FG000|Overall Study|Lack of Efficacy|1|||
131730220|NCT01441440|474291212|FG001|Overall Study|Lack of Efficacy|0|||
131730221|NCT01441440|474291213|FG002|Overall Study|Lack of Efficacy|1|||
131730222|NCT01441440|474291211|FG000|Overall Study|Moving|0|||
131730223|NCT01441440|474291212|FG001|Overall Study|Moving|1|||
131730224|NCT01441440|474291213|FG002|Overall Study|Moving|1|||
131730225|NCT01441440|474291211|FG000|Overall Study|Work-related matter|0|||
131730226|NCT01441440|474291212|FG001|Overall Study|Work-related matter|1|||
131730227|NCT01441440|474291213|FG002|Overall Study|Work-related matter|0|||
131730228|NCT01441440|474291211|FG000|Overall Study|Difficllty in keeping the schedule|1|||
131730229|NCT01441440|474291212|FG001|Overall Study|Difficllty in keeping the schedule|1|||
131730230|NCT01441440|474291213|FG002|Overall Study|Difficllty in keeping the schedule|0|||
131730231|NCT02849990|474291216|FG000|Overall Study|Adverse Event|1|||
131730232|NCT02849990|474291216|FG000|Overall Study|Withdrawal by Subject|1|||
131730233|NCT01429792|474291218|FG000|Overall Study|Other Reasons|67|||
131730234|NCT01429792|474291218|FG000|Overall Study|Unknown Disposition|94|||
131730235|NCT01429792|474291218|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
131730236|NCT01429792|474291218|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
131730237|NCT01429792|474291218|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
131730238|NCT01429792|474291218|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
131730239|NCT01429792|474291218|FG000|Overall Study|Withdrawal by Subject|70|||
131730240|NCT01429792|474291218|FG000|Overall Study|Lost to Follow-up|88|||
131730241|NCT00726323|474291219|FG000|Overall Study|Withdrawal by Subject|3|||
131730242|NCT00726323|474291220|FG001|Overall Study|Withdrawal by Subject|1|||
131730243|NCT00726323|474291219|FG000|Overall Study|Physician Decision|1|||
131730244|NCT00726323|474291220|FG001|Overall Study|Physician Decision|0|||
131730245|NCT00726323|474291219|FG000|Overall Study|Progressive disease|23|||
131905077|NCT01747499|474939036|FG000|Overall Study|Death|0|||
131730246|NCT00726323|474291220|FG001|Overall Study|Progressive disease|16|||
131730247|NCT00726323|474291219|FG000|Overall Study|Clinical progression|0|||
131730248|NCT00726323|474291220|FG001|Overall Study|Clinical progression|3|||
131730249|NCT00726323|474291219|FG000|Overall Study|Adverse Event|9|||
131730250|NCT00726323|474291220|FG001|Overall Study|Adverse Event|9|||
131730251|NCT00726323|474291219|FG000|Overall Study|Death|1|||
131730252|NCT00726323|474291220|FG001|Overall Study|Death|0|||
131730253|NCT00726323|474291219|FG000|Overall Study|Participant wished to discontinue|0|||
131730254|NCT00726323|474291220|FG001|Overall Study|Participant wished to discontinue|1|||
131730255|NCT00726323|474291219|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
131730256|NCT00726323|474291220|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
131905078|NCT01747499|474939037|FG001|Overall Study|Death|0|||
131905079|NCT01747499|474939038|FG002|Overall Study|Death|0|||
131905080|NCT01747499|474939039|FG003|Overall Study|Death|1|||
131905081|NCT01747499|474939040|FG004|Overall Study|Death|1|||
131905082|NCT01747499|474939036|FG000|Overall Study|Withdrawal by Subject|0|||
131905083|NCT01747499|474939037|FG001|Overall Study|Withdrawal by Subject|0|||
131905084|NCT01747499|474939038|FG002|Overall Study|Withdrawal by Subject|0|||
131905085|NCT01747499|474939039|FG003|Overall Study|Withdrawal by Subject|0|||
131905086|NCT01747499|474939040|FG004|Overall Study|Withdrawal by Subject|6|||
131905087|NCT01747499|474939036|FG000|Overall Study|Developed AML and death|0|||
131905088|NCT01747499|474939037|FG001|Overall Study|Developed AML and death|0|||
131905089|NCT01747499|474939038|FG002|Overall Study|Developed AML and death|0|||
131905090|NCT01747499|474939039|FG003|Overall Study|Developed AML and death|0|||
131905091|NCT01747499|474939040|FG004|Overall Study|Developed AML and death|1|||
131905092|NCT01747499|474939036|FG000|Overall Study|Determined not to be eligible|0|||
131905093|NCT01747499|474939037|FG001|Overall Study|Determined not to be eligible|0|||
131905094|NCT01747499|474939038|FG002|Overall Study|Determined not to be eligible|0|||
131905095|NCT01747499|474939039|FG003|Overall Study|Determined not to be eligible|0|||
131905096|NCT01747499|474939040|FG004|Overall Study|Determined not to be eligible|1|||
131905097|NCT00072410|474939041|FG000|Overall Study|Progressive disease|0|||
131730257|NCT01522976|474291227|FG000|Overall Study|Ineligible|4|||
131730258|NCT01522976|474291228|FG001|Overall Study|Ineligible|0|||
131730259|NCT01522976|474291229|FG002|Overall Study|Ineligible|1|||
131730260|NCT01522976|474291227|FG000|Overall Study|Death|7|||
131730261|NCT01522976|474291228|FG001|Overall Study|Death|6|||
131730262|NCT01522976|474291229|FG002|Overall Study|Death|2|||
131730263|NCT01522976|474291227|FG000|Overall Study|Still on treatment|9|||
131730264|NCT01522976|474291228|FG001|Overall Study|Still on treatment|9|||
131730265|NCT01522976|474291229|FG002|Overall Study|Still on treatment|6|||
131730266|NCT01522976|474291227|FG000|Overall Study|Disease progression|28|||
131730267|NCT01522976|474291228|FG001|Overall Study|Disease progression|30|||
131730268|NCT01522976|474291229|FG002|Overall Study|Disease progression|25|||
131730269|NCT01522976|474291227|FG000|Overall Study|Adverse Event|17|||
131730270|NCT01522976|474291228|FG001|Overall Study|Adverse Event|7|||
131730271|NCT01522976|474291229|FG002|Overall Study|Adverse Event|18|||
131730272|NCT01522976|474291227|FG000|Overall Study|Refusal unrelated to adverse event|10|||
131730273|NCT01522976|474291228|FG001|Overall Study|Refusal unrelated to adverse event|13|||
131730274|NCT01522976|474291229|FG002|Overall Study|Refusal unrelated to adverse event|14|||
131730275|NCT01522976|474291227|FG000|Overall Study|Not protocol specified|22|||
131730276|NCT01522976|474291228|FG001|Overall Study|Not protocol specified|27|||
131730277|NCT01522976|474291229|FG002|Overall Study|Not protocol specified|27|||
131730278|NCT04075266|474291232|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
131730279|NCT04075266|474291233|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
131730280|NCT04075266|474291232|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
131730281|NCT04075266|474291233|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
131730282|NCT04102098|474291234|FG000|Main Study Period|Ongoing in study|302|||
131730283|NCT04102098|474291235|FG001|Main Study Period|Ongoing in study|291|||
131730284|NCT04102098|474291234|FG000|Main Study Period|Death|20|||
131730285|NCT04102098|474291235|FG001|Main Study Period|Death|27|||
131730286|NCT04102098|474291234|FG000|Main Study Period|Lost to Follow-up|1|||
131730287|NCT04102098|474291235|FG001|Main Study Period|Lost to Follow-up|1|||
131730288|NCT04102098|474291234|FG000|Main Study Period|Physician Decision|0|||
131730289|NCT04102098|474291235|FG001|Main Study Period|Physician Decision|1|||
131730290|NCT04102098|474291234|FG000|Main Study Period|Withdrawal by Subject|11|||
131730291|NCT04102098|474291235|FG001|Main Study Period|Withdrawal by Subject|14|||
131730292|NCT04102098|474291234|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
131730293|NCT04102098|474291235|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
131730294|NCT04102098|474291234|FG000|Crossover: AS Who Crossed Over|Death|11|||
131730295|NCT04102098|474291235|FG001|Crossover: AS Who Crossed Over|Death|0|||
131730296|NCT04102098|474291234|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
131730297|NCT04102098|474291235|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
131730298|NCT04742907|474291236|FG000|Overall Study|Adverse Event|1|||
131730299|NCT04742907|474291237|FG001|Overall Study|Adverse Event|0|||
131730300|NCT04742907|474291238|FG002|Overall Study|Adverse Event|1|||
131730301|NCT04742907|474291236|FG000|Overall Study|Lost to Follow-up|3|||
131730302|NCT04742907|474291237|FG001|Overall Study|Lost to Follow-up|3|||
131730303|NCT04742907|474291238|FG002|Overall Study|Lost to Follow-up|2|||
131730304|NCT04742907|474291236|FG000|Overall Study|Physician Decision|0|||
131730305|NCT04742907|474291237|FG001|Overall Study|Physician Decision|1|||
131730306|NCT04742907|474291238|FG002|Overall Study|Physician Decision|0|||
131730307|NCT04742907|474291236|FG000|Overall Study|Protocol Violation|1|||
131730308|NCT04742907|474291237|FG001|Overall Study|Protocol Violation|1|||
131730309|NCT04742907|474291238|FG002|Overall Study|Protocol Violation|1|||
131730310|NCT04742907|474291236|FG000|Overall Study|Withdrawal by Subject|5|||
131730311|NCT04742907|474291237|FG001|Overall Study|Withdrawal by Subject|6|||
131730312|NCT04742907|474291238|FG002|Overall Study|Withdrawal by Subject|4|||
131730313|NCT04742907|474291236|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
131730314|NCT04742907|474291237|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
131730315|NCT04742907|474291238|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
131730316|NCT04742907|474291236|FG000|Overall Study|Did Not Receive the Study Drug|2|||
131730317|NCT04742907|474291237|FG001|Overall Study|Did Not Receive the Study Drug|4|||
131730318|NCT04742907|474291238|FG002|Overall Study|Did Not Receive the Study Drug|4|||
131730319|NCT02280291|474291239|FG000|Overall Study|Lost to Follow-up|2|||
131730320|NCT02280291|474291240|FG001|Overall Study|Lost to Follow-up|1|||
131730321|NCT02280291|474291241|FG002|Overall Study|Lost to Follow-up|3|||
131730322|NCT02280291|474291242|FG003|Overall Study|Lost to Follow-up|8|||
131730323|NCT02280291|474291239|FG000|Overall Study|Protocol Violation|1|||
131730324|NCT02280291|474291240|FG001|Overall Study|Protocol Violation|0|||
131730325|NCT02280291|474291241|FG002|Overall Study|Protocol Violation|0|||
131730326|NCT02280291|474291242|FG003|Overall Study|Protocol Violation|0|||
131730327|NCT02280291|474291239|FG000|Overall Study|Other|1|||
131730328|NCT02280291|474291240|FG001|Overall Study|Other|1|||
131730329|NCT02280291|474291241|FG002|Overall Study|Other|0|||
131730330|NCT02280291|474291242|FG003|Overall Study|Other|0|||
131730331|NCT06150573|474291243|FG000|Overall Study|Did not meet study criteria|1|||
131730332|NCT06150573|474291244|FG001|Overall Study|Did not meet study criteria|0|||
131730333|NCT06150573|474291243|FG000|Overall Study|Adverse Event|1|||
131730334|NCT06150573|474291244|FG001|Overall Study|Adverse Event|0|||
131730335|NCT06150573|474291243|FG000|Overall Study|Lost to Follow-up|0|||
131730336|NCT06150573|474291244|FG001|Overall Study|Lost to Follow-up|1|||
131730337|NCT06150573|474291243|FG000|Overall Study|Protocol Violation|0|||
131730338|NCT06150573|474291244|FG001|Overall Study|Protocol Violation|1|||
131730339|NCT06150573|474291243|FG000|Overall Study|Withdrawal by Subject|2|||
131730340|NCT06150573|474291244|FG001|Overall Study|Withdrawal by Subject|0|||
131730341|NCT00069095|474291245|FG000|Primary Treatment Phase|Ongoing|0|||
131730342|NCT00069095|474291246|FG001|Primary Treatment Phase|Ongoing|0|||
131730343|NCT00069095|474291247|FG002|Primary Treatment Phase|Ongoing|5|||
131730344|NCT00069095|474291248|FG003|Primary Treatment Phase|Ongoing|7|||
131730345|NCT00069095|474291249|FG004|Primary Treatment Phase|Ongoing|7|||
131730346|NCT00069095|474291250|FG005|Primary Treatment Phase|Ongoing|4|||
131730347|NCT00069095|474291245|FG000|Primary Treatment Phase|Admin/Other|29|||
131730348|NCT00069095|474291246|FG001|Primary Treatment Phase|Admin/Other|38|||
131730349|NCT00069095|474291247|FG002|Primary Treatment Phase|Admin/Other|31|||
131730350|NCT00069095|474291248|FG003|Primary Treatment Phase|Admin/Other|45|||
131730351|NCT00069095|474291249|FG004|Primary Treatment Phase|Admin/Other|48|||
131730352|NCT00069095|474291250|FG005|Primary Treatment Phase|Admin/Other|42|||
131730353|NCT00069095|474291245|FG000|Primary Treatment Phase|Adverse Event|99|||
131730354|NCT00069095|474291246|FG001|Primary Treatment Phase|Adverse Event|92|||
131730355|NCT00069095|474291247|FG002|Primary Treatment Phase|Adverse Event|71|||
131730356|NCT00069095|474291248|FG003|Primary Treatment Phase|Adverse Event|72|||
131730357|NCT00069095|474291249|FG004|Primary Treatment Phase|Adverse Event|109|||
131730358|NCT00069095|474291250|FG005|Primary Treatment Phase|Adverse Event|101|||
131730359|NCT00069095|474291245|FG000|Primary Treatment Phase|Death|14|||
131730360|NCT00069095|474291246|FG001|Primary Treatment Phase|Death|8|||
131730361|NCT00069095|474291247|FG002|Primary Treatment Phase|Death|2|||
131730362|NCT00069095|474291248|FG003|Primary Treatment Phase|Death|5|||
131730363|NCT00069095|474291249|FG004|Primary Treatment Phase|Death|8|||
131730364|NCT00069095|474291250|FG005|Primary Treatment Phase|Death|8|||
131730365|NCT00069095|474291245|FG000|Primary Treatment Phase|Failure to return|5|||
131730366|NCT00069095|474291246|FG001|Primary Treatment Phase|Failure to return|5|||
131730367|NCT00069095|474291247|FG002|Primary Treatment Phase|Failure to return|0|||
131730368|NCT00069095|474291248|FG003|Primary Treatment Phase|Failure to return|0|||
131730369|NCT00069095|474291249|FG004|Primary Treatment Phase|Failure to return|0|||
131730370|NCT00069095|474291250|FG005|Primary Treatment Phase|Failure to return|2|||
131730371|NCT00069095|474291245|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
131730372|NCT00069095|474291246|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
131730373|NCT00069095|474291247|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
131730374|NCT00069095|474291248|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
131730375|NCT00069095|474291249|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
131730376|NCT00069095|474291250|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
131730377|NCT00069095|474291245|FG000|Primary Treatment Phase|Refused treatment|15|||
131730378|NCT00069095|474291246|FG001|Primary Treatment Phase|Refused treatment|26|||
131730379|NCT00069095|474291247|FG002|Primary Treatment Phase|Refused treatment|17|||
131730380|NCT00069095|474291248|FG003|Primary Treatment Phase|Refused treatment|31|||
131730381|NCT00069095|474291249|FG004|Primary Treatment Phase|Refused treatment|24|||
131730382|NCT00069095|474291250|FG005|Primary Treatment Phase|Refused treatment|27|||
131730383|NCT00069095|474291245|FG000|Primary Treatment Phase|Withdrew|2|||
131730384|NCT00069095|474291246|FG001|Primary Treatment Phase|Withdrew|3|||
131730385|NCT00069095|474291247|FG002|Primary Treatment Phase|Withdrew|8|||
131730386|NCT00069095|474291248|FG003|Primary Treatment Phase|Withdrew|2|||
131730387|NCT00069095|474291249|FG004|Primary Treatment Phase|Withdrew|4|||
131730388|NCT00069095|474291250|FG005|Primary Treatment Phase|Withdrew|9|||
131730389|NCT00069095|474291245|FG000|Primary Treatment Phase|Other Violation|0|||
131730390|NCT00069095|474291246|FG001|Primary Treatment Phase|Other Violation|1|||
131730391|NCT00069095|474291247|FG002|Primary Treatment Phase|Other Violation|1|||
131730392|NCT00069095|474291248|FG003|Primary Treatment Phase|Other Violation|1|||
131730393|NCT00069095|474291249|FG004|Primary Treatment Phase|Other Violation|0|||
131730394|NCT00069095|474291250|FG005|Primary Treatment Phase|Other Violation|1|||
131730395|NCT00069095|474291245|FG000|Primary Treatment Phase|Violation criteria|0|||
131730396|NCT00069095|474291246|FG001|Primary Treatment Phase|Violation criteria|2|||
131730397|NCT00069095|474291247|FG002|Primary Treatment Phase|Violation criteria|4|||
131730398|NCT00069095|474291248|FG003|Primary Treatment Phase|Violation criteria|3|||
131730399|NCT00069095|474291249|FG004|Primary Treatment Phase|Violation criteria|1|||
131730400|NCT00069095|474291250|FG005|Primary Treatment Phase|Violation criteria|5|||
131730401|NCT00069095|474291245|FG000|Post-study Treatment Phase|Missing reason|1|||
131730402|NCT00069095|474291246|FG001|Post-study Treatment Phase|Missing reason|3|||
131730403|NCT00069095|474291247|FG002|Post-study Treatment Phase|Missing reason|12|||
131730404|NCT00069095|474291248|FG003|Post-study Treatment Phase|Missing reason|8|||
131730405|NCT00069095|474291249|FG004|Post-study Treatment Phase|Missing reason|18|||
131730406|NCT00069095|474291250|FG005|Post-study Treatment Phase|Missing reason|17|||
131730407|NCT00069095|474291245|FG000|Post-study Treatment Phase|Adverse Event|2|||
131730408|NCT00069095|474291246|FG001|Post-study Treatment Phase|Adverse Event|3|||
131730409|NCT00069095|474291247|FG002|Post-study Treatment Phase|Adverse Event|1|||
131730410|NCT00069095|474291248|FG003|Post-study Treatment Phase|Adverse Event|0|||
131730411|NCT00069095|474291249|FG004|Post-study Treatment Phase|Adverse Event|5|||
131730412|NCT00069095|474291250|FG005|Post-study Treatment Phase|Adverse Event|1|||
131730413|NCT00069095|474291245|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
131730414|NCT00069095|474291246|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
131730415|NCT00069095|474291247|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
131730416|NCT00069095|474291248|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
131730417|NCT00069095|474291249|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
131730418|NCT00069095|474291250|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
131730419|NCT00069095|474291245|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
131730420|NCT00069095|474291246|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
131730421|NCT00069095|474291247|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
131730422|NCT00069095|474291248|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
131730423|NCT00069095|474291249|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
131730424|NCT00069095|474291250|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
131730425|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
131730426|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131730427|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131730428|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131730429|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131730430|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
131730431|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant had complete response|1|||
131730432|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant had complete response|1|||
131730433|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant had complete response|0|||
131730434|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant had complete response|0|||
131730435|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant had complete response|0|||
131730436|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant had complete response|0|||
131730437|NCT00069095|474291245|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131730438|NCT00069095|474291246|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
131730439|NCT00069095|474291247|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131730440|NCT00069095|474291248|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131730441|NCT00069095|474291249|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131730442|NCT00069095|474291250|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131730443|NCT00069095|474291245|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
131730444|NCT00069095|474291246|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
131730445|NCT00069095|474291247|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
131730446|NCT00069095|474291248|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
131730447|NCT00069095|474291249|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
131730448|NCT00069095|474291250|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
131730449|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
131730450|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
131730451|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
131730452|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
131730453|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
131730454|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
131730455|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
131730456|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
131730457|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
131730458|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
131730459|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
131730460|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
131730461|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131730462|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131730463|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131730464|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
131730465|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131730466|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131730467|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
131730468|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
131730469|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
131730470|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
131730471|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
131730472|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
131730473|NCT00069095|474291245|FG000|Post-study Treatment Phase|Surgery|0|||
131730474|NCT00069095|474291246|FG001|Post-study Treatment Phase|Surgery|0|||
131730475|NCT00069095|474291247|FG002|Post-study Treatment Phase|Surgery|0|||
131730476|NCT00069095|474291248|FG003|Post-study Treatment Phase|Surgery|1|||
131730477|NCT00069095|474291249|FG004|Post-study Treatment Phase|Surgery|1|||
131730478|NCT00069095|474291250|FG005|Post-study Treatment Phase|Surgery|0|||
131730479|NCT00069095|474291245|FG000|Post-study Treatment Phase|Death|0|||
131730480|NCT00069095|474291246|FG001|Post-study Treatment Phase|Death|0|||
131730481|NCT00069095|474291247|FG002|Post-study Treatment Phase|Death|0|||
131730482|NCT00069095|474291248|FG003|Post-study Treatment Phase|Death|0|||
131730483|NCT00069095|474291249|FG004|Post-study Treatment Phase|Death|1|||
131730484|NCT00069095|474291250|FG005|Post-study Treatment Phase|Death|0|||
131730485|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
131730486|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
131730487|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
131730488|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
131730489|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
131730490|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
131730491|NCT00069095|474291245|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131730492|NCT00069095|474291246|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131730493|NCT00069095|474291247|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131730494|NCT00069095|474291248|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131730495|NCT00069095|474291249|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
131730496|NCT00069095|474291250|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131730497|NCT00069095|474291245|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131730498|NCT00069095|474291246|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131730499|NCT00069095|474291247|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131730500|NCT00069095|474291248|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131730501|NCT00069095|474291249|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
131730502|NCT00069095|474291250|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131730503|NCT00069095|474291245|FG000|Post-study Treatment Phase|Investigator decision|0|||
131730504|NCT00069095|474291246|FG001|Post-study Treatment Phase|Investigator decision|0|||
131730505|NCT00069095|474291247|FG002|Post-study Treatment Phase|Investigator decision|0|||
131730506|NCT00069095|474291248|FG003|Post-study Treatment Phase|Investigator decision|0|||
131730507|NCT00069095|474291249|FG004|Post-study Treatment Phase|Investigator decision|0|||
131730508|NCT00069095|474291250|FG005|Post-study Treatment Phase|Investigator decision|1|||
131730509|NCT00069095|474291245|FG000|Follow-up Phase|Death|174|||
131730510|NCT00069095|474291246|FG001|Follow-up Phase|Death|206|||
131730511|NCT00069095|474291247|FG002|Follow-up Phase|Death|120|||
131730512|NCT00069095|474291248|FG003|Follow-up Phase|Death|112|||
131730513|NCT00069095|474291249|FG004|Follow-up Phase|Death|92|||
131807056|NCT01811953|474579467|FG004|Overall Study|Protocol Violation|1|||
131807057|NCT01811953|474579468|FG005|Overall Study|Protocol Violation|0|||
131807058|NCT00070291|474579469|FG000|Step 1|Withdrawal by Subject|1|||
131807059|NCT00070291|474579469|FG000|Step 1|Adverse Event|1|||
131730514|NCT00069095|474291250|FG005|Follow-up Phase|Death|101|||
131730515|NCT03508622|474291251|FG000|Overall Study|Protocol Violation|1|||
131730516|NCT03508622|474291252|FG001|Overall Study|Protocol Violation|0|||
131730517|NCT03508622|474291251|FG000|Overall Study|Withdrawal by Subject|1|||
131730518|NCT03508622|474291252|FG001|Overall Study|Withdrawal by Subject|0|||
131730519|NCT03508622|474291251|FG000|Overall Study|Lost to Follow-up|16|||
131730520|NCT03508622|474291252|FG001|Overall Study|Lost to Follow-up|0|||
131807060|NCT00070291|474579469|FG000|Step 2|Adverse Event|1|||
131807061|NCT00520130|474579471|FG000|Overall Study|Disease progression on study|4|||
131807062|NCT00520130|474579472|FG001|Overall Study|Disease progression on study|0|||
131730521|NCT03508622|474291251|FG000|Overall Study|Incomplete data|0|||
131730522|NCT03508622|474291252|FG001|Overall Study|Incomplete data|24|||
131730523|NCT00210158|474291254|FG000|Overall Study|Protocol Violation|0|||
131730524|NCT00210158|474291255|FG001|Overall Study|Protocol Violation|2|||
131730525|NCT04716933|474291256|FG000|Overall Study|Sponsor Decision|36|||
131730526|NCT04716933|474291257|FG001|Overall Study|Sponsor Decision|33|||
131730527|NCT04716933|474291256|FG000|Overall Study|Death|65|||
131807063|NCT00520130|474579471|FG000|Overall Study|Physician Decision|1|||
131807064|NCT00520130|474579472|FG001|Overall Study|Physician Decision|1|||
131730528|NCT04716933|474291257|FG001|Overall Study|Death|67|||
131730529|NCT03196505|474291258|FG000|Overall Study|Physician Decision|26|||
131730530|NCT03196505|474291259|FG001|Overall Study|Physician Decision|26|||
131730531|NCT01005719|474291260|FG000|Period 1|Adverse Event|0|||
131730532|NCT01005719|474291261|FG001|Period 1|Adverse Event|0|||
131730533|NCT01005719|474291262|FG002|Period 1|Adverse Event|0|||
131730534|NCT01005719|474291263|FG003|Period 1|Adverse Event|1|||
131730535|NCT01005719|474291264|FG004|Period 1|Adverse Event|0|||
131730536|NCT01005719|474291265|FG005|Period 1|Adverse Event|0|||
131730537|NCT01005719|474291260|FG000|Period 1|Delay in completing study procedures|0|||
131730538|NCT01005719|474291261|FG001|Period 1|Delay in completing study procedures|0|||
131730539|NCT01005719|474291262|FG002|Period 1|Delay in completing study procedures|0|||
131730540|NCT01005719|474291263|FG003|Period 1|Delay in completing study procedures|0|||
131730541|NCT01005719|474291264|FG004|Period 1|Delay in completing study procedures|0|||
131730542|NCT01005719|474291265|FG005|Period 1|Delay in completing study procedures|1|||
131730543|NCT01005719|474291260|FG000|Period 2|Adverse Event|0|||
131730544|NCT01005719|474291261|FG001|Period 2|Adverse Event|0|||
131730545|NCT01005719|474291262|FG002|Period 2|Adverse Event|0|||
131730546|NCT01005719|474291263|FG003|Period 2|Adverse Event|0|||
131730547|NCT01005719|474291264|FG004|Period 2|Adverse Event|1|||
131730548|NCT01005719|474291265|FG005|Period 2|Adverse Event|1|||
131730549|NCT05114590|474291266|FG000|Overall Study|Adverse Event|1|||
131730550|NCT05114590|474291266|FG000|Overall Study|Investigator decision|1|||
131730551|NCT05114590|474291266|FG000|Overall Study|Lost to Follow-up|5|||
131730552|NCT05114590|474291266|FG000|Overall Study|Withdrawal by Subject|5|||
131730553|NCT05114590|474291266|FG000|Overall Study|Other|2|||
131730554|NCT05372575|474291271|FG000|Overall Study|Protocol Violation|7|||
131730555|NCT05372575|474291272|FG001|Overall Study|Protocol Violation|16|||
131730556|NCT01096550|474291273|FG000|Overall Study|discontinued site|10|||
131730557|NCT01096550|474291274|FG001|Overall Study|discontinued site|11|||
131730558|NCT01096550|474291273|FG000|Overall Study|non-regular treatment track at clinic|1|||
131730559|NCT01096550|474291274|FG001|Overall Study|non-regular treatment track at clinic|1|||
131807065|NCT02028715|474579473|FG000|Overall Study|Adverse Event|2|||
131807066|NCT02028715|474579474|FG001|Overall Study|Adverse Event|2|||
131807067|NCT02028715|474579473|FG000|Overall Study|Physician Decision|1|||
131730560|NCT01096550|474291273|FG000|Overall Study|clinic readmission|1|||
131730561|NCT01096550|474291274|FG001|Overall Study|clinic readmission|1|||
131730562|NCT01096550|474291273|FG000|Overall Study|Withdrawal by Subject|0|||
131730563|NCT01096550|474291274|FG001|Overall Study|Withdrawal by Subject|1|||
131730564|NCT01096550|474291273|FG000|Overall Study|non-African American participant|13|||
131730565|NCT01096550|474291274|FG001|Overall Study|non-African American participant|6|||
131730566|NCT01096550|474291273|FG000|Overall Study|Lost to Follow-up|12|||
131730567|NCT01096550|474291274|FG001|Overall Study|Lost to Follow-up|9|||
131730568|NCT02538666|474291277|FG000|Pre-Treatment|Disease progression|1|||
131730569|NCT02538666|474291278|FG001|Pre-Treatment|Disease progression|0|||
131730570|NCT02538666|474291279|FG002|Pre-Treatment|Disease progression|0|||
131730571|NCT02538666|474291277|FG000|Pre-Treatment|no longer meets study criteria|1|||
131730572|NCT02538666|474291278|FG001|Pre-Treatment|no longer meets study criteria|0|||
131730573|NCT02538666|474291279|FG002|Pre-Treatment|no longer meets study criteria|0|||
131730574|NCT02538666|474291277|FG000|Pre-Treatment|Withdrew Consent|0|||
131730575|NCT02538666|474291278|FG001|Pre-Treatment|Withdrew Consent|1|||
131807068|NCT02028715|474579474|FG001|Overall Study|Physician Decision|0|||
131730576|NCT02538666|474291279|FG002|Pre-Treatment|Withdrew Consent|1|||
131730577|NCT02538666|474291277|FG000|Treatment|Disease progression|270|||
131730578|NCT02538666|474291278|FG001|Treatment|Disease progression|227|||
131730579|NCT02538666|474291279|FG002|Treatment|Disease progression|165|||
131730580|NCT02538666|474291277|FG000|Treatment|Study drug toxicity|1|||
131730581|NCT02538666|474291278|FG001|Treatment|Study drug toxicity|29|||
131730582|NCT02538666|474291279|FG002|Treatment|Study drug toxicity|92|||
131730583|NCT02538666|474291277|FG000|Treatment|Death|0|||
131730584|NCT02538666|474291278|FG001|Treatment|Death|2|||
131730585|NCT02538666|474291279|FG002|Treatment|Death|3|||
131730586|NCT02538666|474291277|FG000|Treatment|Adverse event unrelated to study drug|8|||
131730587|NCT02538666|474291278|FG001|Treatment|Adverse event unrelated to study drug|10|||
131730588|NCT02538666|474291279|FG002|Treatment|Adverse event unrelated to study drug|15|||
131730589|NCT02538666|474291277|FG000|Treatment|Participant request to discontinue study treatment|3|||
131730590|NCT02538666|474291278|FG001|Treatment|Participant request to discontinue study treatment|6|||
131730591|NCT02538666|474291279|FG002|Treatment|Participant request to discontinue study treatment|11|||
131807069|NCT02028715|474579473|FG000|Overall Study|Did not complete satisfaction surveys|2|||
131730592|NCT02538666|474291277|FG000|Treatment|Participant withdrew consent|2|||
131730593|NCT02538666|474291278|FG001|Treatment|Participant withdrew consent|5|||
131730594|NCT02538666|474291279|FG002|Treatment|Participant withdrew consent|3|||
131730595|NCT02538666|474291277|FG000|Treatment|Lost to Follow-up|0|||
131730596|NCT02538666|474291278|FG001|Treatment|Lost to Follow-up|1|||
131730597|NCT02538666|474291279|FG002|Treatment|Lost to Follow-up|1|||
131730598|NCT02538666|474291277|FG000|Treatment|Maximum clinical benefit|4|||
131730599|NCT02538666|474291278|FG001|Treatment|Maximum clinical benefit|3|||
131730600|NCT02538666|474291279|FG002|Treatment|Maximum clinical benefit|4|||
131730601|NCT02538666|474291277|FG000|Treatment|Poor/non-compliance|0|||
131730602|NCT02538666|474291278|FG001|Treatment|Poor/non-compliance|1|||
131730603|NCT02538666|474291279|FG002|Treatment|Poor/non-compliance|0|||
131730604|NCT02538666|474291277|FG000|Treatment|Participant no longer meets study criteria|0|||
131730605|NCT02538666|474291278|FG001|Treatment|Participant no longer meets study criteria|2|||
131730606|NCT02538666|474291279|FG002|Treatment|Participant no longer meets study criteria|0|||
131730607|NCT02538666|474291277|FG000|Treatment|Administrative reason by sponsor|0|||
131730608|NCT02538666|474291278|FG001|Treatment|Administrative reason by sponsor|0|||
131730609|NCT02538666|474291279|FG002|Treatment|Administrative reason by sponsor|1|||
131730610|NCT02538666|474291277|FG000|Treatment|Other reasons|8|||
131730611|NCT02538666|474291278|FG001|Treatment|Other reasons|15|||
131807070|NCT02028715|474579474|FG001|Overall Study|Did not complete satisfaction surveys|2|||
131807071|NCT04915755|474579477|FG000|Overall Study|Physician Decision|3|||
131807072|NCT04915755|474579478|FG001|Overall Study|Physician Decision|2|||
131730612|NCT02538666|474291279|FG002|Treatment|Other reasons|5|||
131730613|NCT02538666|474291277|FG000|Treatment|Not reported|2|||
131730614|NCT02538666|474291278|FG001|Treatment|Not reported|2|||
131730615|NCT02538666|474291279|FG002|Treatment|Not reported|2|||
131730616|NCT04590937|474291280|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
131730617|NCT01544595|474291281|FG000|Status at Week 68|Adverse Event|3|||
131807073|NCT04915755|474579477|FG000|Overall Study|Withdrawal by Subject|1|||
131807074|NCT04915755|474579478|FG001|Overall Study|Withdrawal by Subject|1|||
131807075|NCT04915755|474579477|FG000|Overall Study|Ongoing for PACT|3|||
131807076|NCT04915755|474579478|FG001|Overall Study|Ongoing for PACT|2|||
131448799|NCT00790842|473272726|FG006|Expansion Cohort|Withdrawal by Subject|0|||
131448800|NCT00790842|473272727|FG007|Expansion Cohort|Withdrawal by Subject|0|||
131730618|NCT01544595|474291282|FG001|Status at Week 68|Adverse Event|2|||
131730619|NCT01544595|474291283|FG002|Status at Week 68|Adverse Event|1|||
131730620|NCT01544595|474291284|FG003|Status at Week 68|Adverse Event|0|||
131730621|NCT01544595|474291285|FG004|Status at Week 68|Adverse Event|0|||
131730622|NCT01544595|474291286|FG005|Status at Week 68|Adverse Event|0|||
131730623|NCT01544595|474291281|FG000|Status at Week 68|Lack of Efficacy|1|||
131730624|NCT01544595|474291282|FG001|Status at Week 68|Lack of Efficacy|0|||
131730625|NCT01544595|474291283|FG002|Status at Week 68|Lack of Efficacy|0|||
131730626|NCT01544595|474291284|FG003|Status at Week 68|Lack of Efficacy|0|||
131807077|NCT04915755|474579477|FG000|Overall Study|Other|7|||
131730627|NCT01544595|474291285|FG004|Status at Week 68|Lack of Efficacy|0|||
131730628|NCT01544595|474291286|FG005|Status at Week 68|Lack of Efficacy|0|||
131730629|NCT01544595|474291281|FG000|Status at Week 68|Lost to Follow-up|1|||
131807078|NCT04915755|474579478|FG001|Overall Study|Other|11|||
131807079|NCT02533258|474579479|FG000|Overall Study|Adverse Event|1|||
131807080|NCT02533258|474579479|FG000|Overall Study|Death|2|||
131807081|NCT02533258|474579479|FG000|Overall Study|Other|1|||
131807082|NCT02533258|474579479|FG000|Overall Study|Economic factor|1|||
131807083|NCT02533258|474579479|FG000|Overall Study|Progression of pleural effusion|1|||
131807084|NCT02533258|474579479|FG000|Overall Study|Lack of Efficacy|2|||
131807085|NCT01591785|474579480|FG000|Overall Study|worsening condition|1|||
131807086|NCT01591785|474579481|FG001|Overall Study|worsening condition|2|||
131730630|NCT01544595|474291282|FG001|Status at Week 68|Lost to Follow-up|1|||
131730631|NCT01544595|474291283|FG002|Status at Week 68|Lost to Follow-up|0|||
131730632|NCT01544595|474291284|FG003|Status at Week 68|Lost to Follow-up|0|||
131730633|NCT01544595|474291285|FG004|Status at Week 68|Lost to Follow-up|0|||
131730634|NCT01544595|474291286|FG005|Status at Week 68|Lost to Follow-up|0|||
131730635|NCT01544595|474291281|FG000|Status at Week 68|Non-compliance with study treatment|1|||
131730636|NCT01544595|474291282|FG001|Status at Week 68|Non-compliance with study treatment|0|||
131730637|NCT01544595|474291283|FG002|Status at Week 68|Non-compliance with study treatment|0|||
131730638|NCT01544595|474291284|FG003|Status at Week 68|Non-compliance with study treatment|1|||
131730639|NCT01544595|474291285|FG004|Status at Week 68|Non-compliance with study treatment|0|||
131730640|NCT01544595|474291286|FG005|Status at Week 68|Non-compliance with study treatment|0|||
131730641|NCT01544595|474291281|FG000|Status at Week 68|Protocol Violation|2|||
131730642|NCT01544595|474291282|FG001|Status at Week 68|Protocol Violation|0|||
131730643|NCT01544595|474291283|FG002|Status at Week 68|Protocol Violation|1|||
131730644|NCT01544595|474291284|FG003|Status at Week 68|Protocol Violation|1|||
131730645|NCT01544595|474291285|FG004|Status at Week 68|Protocol Violation|0|||
131730646|NCT01544595|474291286|FG005|Status at Week 68|Protocol Violation|0|||
131730647|NCT01544595|474291281|FG000|Status at Week 68|Technical problems|1|||
131730648|NCT01544595|474291282|FG001|Status at Week 68|Technical problems|0|||
131730649|NCT01544595|474291283|FG002|Status at Week 68|Technical problems|0|||
131730650|NCT01544595|474291284|FG003|Status at Week 68|Technical problems|1|||
131730651|NCT01544595|474291285|FG004|Status at Week 68|Technical problems|0|||
131730652|NCT01544595|474291286|FG005|Status at Week 68|Technical problems|0|||
131730653|NCT01544595|474291281|FG000|Status at Week 68|Withdrawal by Subject|0|||
131730654|NCT01544595|474291282|FG001|Status at Week 68|Withdrawal by Subject|1|||
131730655|NCT01544595|474291283|FG002|Status at Week 68|Withdrawal by Subject|1|||
131730656|NCT01544595|474291284|FG003|Status at Week 68|Withdrawal by Subject|2|||
131730657|NCT01544595|474291285|FG004|Status at Week 68|Withdrawal by Subject|0|||
131730658|NCT01544595|474291286|FG005|Status at Week 68|Withdrawal by Subject|0|||
131730659|NCT01544595|474291281|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
131730660|NCT01544595|474291282|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
131730661|NCT01544595|474291283|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
131730662|NCT01544595|474291284|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
131730663|NCT01544595|474291285|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
131730664|NCT01544595|474291286|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
131730665|NCT01544595|474291281|FG000|Status at Week 156|Withdrawal by Subject|9|||
131730666|NCT01544595|474291282|FG001|Status at Week 156|Withdrawal by Subject|10|||
131730667|NCT01544595|474291283|FG002|Status at Week 156|Withdrawal by Subject|4|||
131730668|NCT01544595|474291284|FG003|Status at Week 156|Withdrawal by Subject|9|||
131730669|NCT01544595|474291285|FG004|Status at Week 156|Withdrawal by Subject|20|||
131730670|NCT01544595|474291286|FG005|Status at Week 156|Withdrawal by Subject|6|||
131730671|NCT01544595|474291281|FG000|Status at Week 156|Adverse Event|9|||
131730672|NCT01544595|474291282|FG001|Status at Week 156|Adverse Event|11|||
131730673|NCT01544595|474291283|FG002|Status at Week 156|Adverse Event|1|||
131730674|NCT01544595|474291284|FG003|Status at Week 156|Adverse Event|3|||
131730675|NCT01544595|474291285|FG004|Status at Week 156|Adverse Event|4|||
131730676|NCT01544595|474291286|FG005|Status at Week 156|Adverse Event|2|||
131730677|NCT01544595|474291281|FG000|Status at Week 156|Lost to Follow-up|4|||
131730678|NCT01544595|474291282|FG001|Status at Week 156|Lost to Follow-up|4|||
131730679|NCT01544595|474291283|FG002|Status at Week 156|Lost to Follow-up|0|||
131730680|NCT01544595|474291284|FG003|Status at Week 156|Lost to Follow-up|1|||
131730681|NCT01544595|474291285|FG004|Status at Week 156|Lost to Follow-up|4|||
131730682|NCT01544595|474291286|FG005|Status at Week 156|Lost to Follow-up|1|||
131730683|NCT01544595|474291281|FG000|Status at Week 156|Non-compliance with study treatement|0|||
131730684|NCT01544595|474291282|FG001|Status at Week 156|Non-compliance with study treatement|1|||
131730685|NCT01544595|474291283|FG002|Status at Week 156|Non-compliance with study treatement|0|||
131730686|NCT01544595|474291284|FG003|Status at Week 156|Non-compliance with study treatement|1|||
131730687|NCT01544595|474291285|FG004|Status at Week 156|Non-compliance with study treatement|0|||
131730688|NCT01544595|474291286|FG005|Status at Week 156|Non-compliance with study treatement|1|||
131730689|NCT01544595|474291281|FG000|Status at Week 156|Physician Decision|0|||
131730690|NCT01544595|474291282|FG001|Status at Week 156|Physician Decision|3|||
131730691|NCT01544595|474291283|FG002|Status at Week 156|Physician Decision|1|||
131730692|NCT01544595|474291284|FG003|Status at Week 156|Physician Decision|0|||
131807087|NCT01591785|474579480|FG000|Overall Study|Protocol Violation|2|||
131807088|NCT01591785|474579481|FG001|Overall Study|Protocol Violation|0|||
131807089|NCT01591785|474579480|FG000|Overall Study|Lost to Follow-up|1|||
131807090|NCT01591785|474579481|FG001|Overall Study|Lost to Follow-up|0|||
131807091|NCT02495857|474579483|FG000|Overall Study|Adverse Event|5|||
131807092|NCT02495857|474579484|FG001|Overall Study|Adverse Event|0|||
131807093|NCT02495857|474579485|FG002|Overall Study|Adverse Event|1|||
131807094|NCT02495857|474579483|FG000|Overall Study|Withdrawal by Subject|9|||
131730693|NCT01544595|474291285|FG004|Status at Week 156|Physician Decision|0|||
131730694|NCT01544595|474291286|FG005|Status at Week 156|Physician Decision|0|||
131905098|NCT00072410|474939042|FG001|Overall Study|Progressive disease|3|||
131730695|NCT01544595|474291281|FG000|Status at Week 156|Pregnancy|2|||
131730696|NCT01544595|474291282|FG001|Status at Week 156|Pregnancy|3|||
131730697|NCT01544595|474291283|FG002|Status at Week 156|Pregnancy|0|||
131730698|NCT01544595|474291284|FG003|Status at Week 156|Pregnancy|0|||
131730699|NCT01544595|474291285|FG004|Status at Week 156|Pregnancy|0|||
131730700|NCT01544595|474291286|FG005|Status at Week 156|Pregnancy|0|||
131730701|NCT01544595|474291281|FG000|Status at Week 156|Protocol Violation|3|||
131730702|NCT01544595|474291282|FG001|Status at Week 156|Protocol Violation|1|||
131730703|NCT01544595|474291283|FG002|Status at Week 156|Protocol Violation|2|||
131730704|NCT01544595|474291284|FG003|Status at Week 156|Protocol Violation|2|||
131730705|NCT01544595|474291285|FG004|Status at Week 156|Protocol Violation|0|||
131730706|NCT01544595|474291286|FG005|Status at Week 156|Protocol Violation|0|||
131730707|NCT01544595|474291281|FG000|Status at Week 156|Technical problems|3|||
131730708|NCT01544595|474291282|FG001|Status at Week 156|Technical problems|1|||
131730709|NCT01544595|474291283|FG002|Status at Week 156|Technical problems|0|||
131730710|NCT01544595|474291284|FG003|Status at Week 156|Technical problems|1|||
131730711|NCT01544595|474291285|FG004|Status at Week 156|Technical problems|0|||
131730712|NCT01544595|474291286|FG005|Status at Week 156|Technical problems|0|||
131730713|NCT01544595|474291281|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
131730714|NCT01544595|474291282|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
131730715|NCT01544595|474291283|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
131730716|NCT01544595|474291284|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
131730717|NCT01544595|474291285|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
131730718|NCT01544595|474291286|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
131730719|NCT01544595|474291281|FG000|Status at Week 156|Lack of Efficacy|1|||
131730720|NCT01544595|474291282|FG001|Status at Week 156|Lack of Efficacy|0|||
131730721|NCT01544595|474291283|FG002|Status at Week 156|Lack of Efficacy|1|||
131730722|NCT01544595|474291284|FG003|Status at Week 156|Lack of Efficacy|4|||
131730723|NCT01544595|474291285|FG004|Status at Week 156|Lack of Efficacy|10|||
131730724|NCT01544595|474291286|FG005|Status at Week 156|Lack of Efficacy|5|||
131730725|NCT04333433|474291295|FG000|Overall Study|Withdrawal by Subject|6|||
131730726|NCT04333433|474291296|FG001|Overall Study|Withdrawal by Subject|3|||
131730727|NCT04333433|474291295|FG000|Overall Study|Death|3|||
131730728|NCT04333433|474291296|FG001|Overall Study|Death|0|||
131730729|NCT04333433|474291295|FG000|Overall Study|Lost to Follow-up|6|||
131730730|NCT04333433|474291296|FG001|Overall Study|Lost to Follow-up|1|||
131730731|NCT04333433|474291295|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
131730732|NCT04333433|474291296|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
131730733|NCT00320385|474291297|FG000|Overall Study|Lost to Follow-up|7|||
131730734|NCT00320385|474291298|FG001|Overall Study|Lost to Follow-up|10|||
131730735|NCT00320385|474291297|FG000|Overall Study|Withdrawal by Subject|6|||
131730736|NCT00320385|474291298|FG001|Overall Study|Withdrawal by Subject|7|||
131730737|NCT00320385|474291297|FG000|Overall Study|Sponsor Terminated Study|2|||
131730738|NCT00320385|474291298|FG001|Overall Study|Sponsor Terminated Study|1|||
131730739|NCT00320385|474291297|FG000|Overall Study|Investigator Decision|0|||
131730740|NCT00320385|474291298|FG001|Overall Study|Investigator Decision|1|||
131730741|NCT00320385|474291297|FG000|Overall Study|Death|1|||
131730742|NCT00320385|474291298|FG001|Overall Study|Death|2|||
131730743|NCT00320385|474291297|FG000|Overall Study|Serious Adverse Event|1|||
131730744|NCT00320385|474291298|FG001|Overall Study|Serious Adverse Event|0|||
131730745|NCT00320385|474291297|FG000|Overall Study|Withdrew Consent|1|||
131730746|NCT00320385|474291298|FG001|Overall Study|Withdrew Consent|0|||
131730747|NCT00320385|474291297|FG000|Overall Study|Adverse Event|0|||
131730748|NCT00320385|474291298|FG001|Overall Study|Adverse Event|1|||
131730749|NCT00001262|474291302|FG000|Overall Study|Death|10|||
131730750|NCT00001262|474291303|FG001|Overall Study|Death|11|||
131730751|NCT00001262|474291304|FG002|Overall Study|Death|0|||
131730752|NCT00001262|474291302|FG000|Overall Study|Withdrawal by Subject|0|||
131730753|NCT00001262|474291303|FG001|Overall Study|Withdrawal by Subject|3|||
131730754|NCT00001262|474291304|FG002|Overall Study|Withdrawal by Subject|0|||
131730755|NCT00878072|474291306|FG000|Overall Study|Withdrew consent|2|||
131730756|NCT01954121|474291316|FG000|Overall Study|Lack of Efficacy|94|||
131730757|NCT01954121|474291317|FG001|Overall Study|Lack of Efficacy|41|||
131730758|NCT01954121|474291316|FG000|Overall Study|Protocol Violation|0|||
131730759|NCT01954121|474291317|FG001|Overall Study|Protocol Violation|2|||
131730760|NCT01954121|474291316|FG000|Overall Study|Lost to Follow-up|5|||
131730761|NCT01954121|474291317|FG001|Overall Study|Lost to Follow-up|6|||
131730762|NCT01954121|474291316|FG000|Overall Study|Withdrawal by Subject|18|||
131730763|NCT01954121|474291317|FG001|Overall Study|Withdrawal by Subject|12|||
131730764|NCT01954121|474291316|FG000|Overall Study|Pregnancy|1|||
131730765|NCT01954121|474291317|FG001|Overall Study|Pregnancy|1|||
131730766|NCT01954121|474291316|FG000|Overall Study|AE, serious fatal|1|||
131730767|NCT01954121|474291317|FG001|Overall Study|AE, serious fatal|0|||
131730768|NCT01954121|474291316|FG000|Overall Study|AE, non-serious non-fatal|5|||
131905099|NCT00372424|474939043|FG000|Overall Study|Adverse Event|2|||
131730769|NCT01954121|474291317|FG001|Overall Study|AE, non-serious non-fatal|22|||
131730770|NCT01954121|474291316|FG000|Overall Study|SAE, non-fatal|1|||
131905100|NCT00372424|474939043|FG000|Overall Study|Withdrawal by Subject|1|||
131905101|NCT00372424|474939043|FG000|Overall Study|Death|1|||
131905102|NCT00372424|474939043|FG000|Overall Study|Objective Progression or Relapse|14|||
131905103|NCT00372424|474939043|FG000|Overall Study|Other|7|||
131905104|NCT00372424|474939043|FG000|Overall Study|Enrolled, Not Treated|1|||
131905105|NCT05214118|474939046|FG000|Overall Study|Lost to Follow-up|0|||
131905106|NCT05214118|474939047|FG001|Overall Study|Lost to Follow-up|2|||
131905107|NCT05214118|474939046|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
131905108|NCT05214118|474939047|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
131905109|NCT05214118|474939046|FG000|Overall Study|moved|1|||
131905110|NCT05214118|474939047|FG001|Overall Study|moved|0|||
131905111|NCT04010461|474939048|FG000|Overall Study|COVID based withdrawal|5|||
131905112|NCT04010461|474939048|FG000|Overall Study|Withdrawal by Subject|5|||
131730771|NCT01954121|474291317|FG001|Overall Study|SAE, non-fatal|4|||
131905113|NCT04010461|474939048|FG000|Overall Study|Adverse Event|1|||
131905114|NCT04010461|474939048|FG000|Overall Study|No Motor Threshold obtainable|1|||
131905115|NCT04010461|474939048|FG000|Overall Study|Physician Decision|1|||
131905116|NCT03797898|474939049|FG000|Overall Study|Lost to Follow-up|60|||
131905117|NCT03797898|474939050|FG001|Overall Study|Lost to Follow-up|69|||
131905118|NCT03797898|474939049|FG000|Overall Study|Withdrawal by Subject|9|||
131730772|NCT01954121|474291316|FG000|Overall Study|Non-compliant with study procedures|1|||
131730773|NCT01954121|474291317|FG001|Overall Study|Non-compliant with study procedures|0|||
131730774|NCT01954121|474291316|FG000|Overall Study|Non-compliant patient|1|||
131730775|NCT01954121|474291317|FG001|Overall Study|Non-compliant patient|1|||
131730776|NCT01954121|474291316|FG000|Overall Study|Subject did not follow instructions|0|||
131730777|NCT01954121|474291317|FG001|Overall Study|Subject did not follow instructions|2|||
131730778|NCT03844633|474291318|FG000|1 Week FU|Lost to Follow-up|0|||
131730779|NCT03844633|474291319|FG001|1 Week FU|Lost to Follow-up|1|||
131730780|NCT03844633|474291320|FG002|1 Week FU|Lost to Follow-up|4|||
131730781|NCT03844633|474291318|FG000|12-month Follow-up|Lost to Follow-up|7|||
131730782|NCT03844633|474291319|FG001|12-month Follow-up|Lost to Follow-up|5|||
131730783|NCT03844633|474291320|FG002|12-month Follow-up|Lost to Follow-up|8|||
131730784|NCT03288779|474291327|FG000|Overall Study|Withdrawal by Subject|3|||
131730785|NCT02588248|474291328|FG000|Overall Study|Physician Decision|4|||
131730786|NCT02588248|474291329|FG001|Overall Study|Physician Decision|3|||
131730787|NCT01355068|474291332|FG000|First Intervention Period|Adverse Event|0|||
131730788|NCT01355068|474291333|FG001|First Intervention Period|Adverse Event|1|||
131730789|NCT01355068|474291332|FG000|First Intervention Period|Withdrawal by Subject|0|||
131730790|NCT01355068|474291333|FG001|First Intervention Period|Withdrawal by Subject|1|||
131730791|NCT00524745|474291334|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
131730792|NCT00524745|474291335|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
131730793|NCT00524745|474291336|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
131730794|NCT00524745|474291337|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
131730795|NCT02504892|474291338|FG000|Overall Study|Adverse event-pneumonitis|2|||
131730796|NCT01413178|474291339|FG000|Overall Study|Toxicity|1|||
131730797|NCT01413178|474291340|FG001|Overall Study|Toxicity|0|||
131730798|NCT01413178|474291339|FG000|Overall Study|Ineligible|0|||
131730799|NCT01413178|474291340|FG001|Overall Study|Ineligible|2|||
131730800|NCT00576693|474291341|FG000|Overall Study|Lost to Follow-up|7|||
131730801|NCT00576693|474291342|FG001|Overall Study|Lost to Follow-up|11|||
131730802|NCT00576693|474291341|FG000|Overall Study|Withdrawal by Subject|3|||
131730803|NCT00576693|474291342|FG001|Overall Study|Withdrawal by Subject|13|||
131730804|NCT00872170|474291343|FG000|Overall Study|Adverse Event|1|||
131730805|NCT00872170|474291344|FG001|Overall Study|Adverse Event|0|||
131730806|NCT00601523|474291345|FG000|Overall Study|Adverse Event|42|||
131730807|NCT00601523|474291346|FG001|Overall Study|Adverse Event|14|||
131730808|NCT00601523|474291345|FG000|Overall Study|Lack of Efficacy|3|||
131730809|NCT00601523|474291346|FG001|Overall Study|Lack of Efficacy|0|||
131730810|NCT00601523|474291345|FG000|Overall Study|Protocol Violation|5|||
131730811|NCT00601523|474291346|FG001|Overall Study|Protocol Violation|1|||
131730812|NCT00601523|474291345|FG000|Overall Study|Lost to Follow-up|0|||
131730813|NCT00601523|474291346|FG001|Overall Study|Lost to Follow-up|1|||
131730814|NCT00601523|474291345|FG000|Overall Study|Withdrawal by Subject|18|||
131730815|NCT00601523|474291346|FG001|Overall Study|Withdrawal by Subject|9|||
131730816|NCT00601523|474291345|FG000|Overall Study|Other|9|||
131730817|NCT00601523|474291346|FG001|Overall Study|Other|1|||
131730818|NCT00804193|474291347|FG000|Overall Study|Lack of baseline fungus|32|||
131730819|NCT00804193|474291348|FG001|Overall Study|Lack of baseline fungus|31|||
131730820|NCT00804193|474291349|FG002|Overall Study|Lack of baseline fungus|19|||
131730821|NCT00804193|474291347|FG000|Overall Study|Adverse Event|0|||
131730822|NCT00804193|474291348|FG001|Overall Study|Adverse Event|0|||
131730823|NCT00804193|474291349|FG002|Overall Study|Adverse Event|2|||
131730824|NCT00804193|474291347|FG000|Overall Study|Lack of Efficacy|1|||
131730825|NCT00804193|474291348|FG001|Overall Study|Lack of Efficacy|1|||
131730826|NCT00804193|474291349|FG002|Overall Study|Lack of Efficacy|3|||
131730827|NCT00804193|474291347|FG000|Overall Study|Protocol Violation|0|||
131730828|NCT00804193|474291348|FG001|Overall Study|Protocol Violation|8|||
131730829|NCT00804193|474291349|FG002|Overall Study|Protocol Violation|2|||
131730830|NCT00804193|474291347|FG000|Overall Study|Lost to Follow-up|3|||
131730831|NCT00804193|474291348|FG001|Overall Study|Lost to Follow-up|3|||
131730832|NCT00804193|474291349|FG002|Overall Study|Lost to Follow-up|4|||
131730833|NCT00804193|474291347|FG000|Overall Study|Withdrawal by Subject|3|||
131730834|NCT00804193|474291348|FG001|Overall Study|Withdrawal by Subject|1|||
131730835|NCT00804193|474291349|FG002|Overall Study|Withdrawal by Subject|2|||
131730836|NCT04072146|474291350|FG000|Overall Study|Adverse Event|0|||
131730837|NCT04072146|474291351|FG001|Overall Study|Adverse Event|1|||
131730838|NCT01987986|474291352|FG000|Overall Study|Lost to Follow-up|1|||
131730839|NCT01987986|474291353|FG001|Overall Study|Lost to Follow-up|0|||
131730840|NCT01987986|474291354|FG002|Overall Study|Lost to Follow-up|0|||
131730841|NCT01987986|474291355|FG003|Overall Study|Lost to Follow-up|0|||
131730842|NCT01987986|474291352|FG000|Overall Study|Adverse Event|1|||
131730843|NCT01987986|474291353|FG001|Overall Study|Adverse Event|0|||
131730844|NCT01987986|474291354|FG002|Overall Study|Adverse Event|2|||
131730845|NCT01987986|474291355|FG003|Overall Study|Adverse Event|0|||
131730846|NCT01064648|474291363|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
131730847|NCT01064648|474291364|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
131730848|NCT01064648|474291365|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
131730849|NCT01064648|474291366|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
131730850|NCT01064648|474291363|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
131730851|NCT01064648|474291364|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
131730852|NCT01064648|474291365|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
131730853|NCT01064648|474291366|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
131730854|NCT01064648|474291363|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
131730855|NCT01064648|474291364|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
131730856|NCT01064648|474291365|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
131730857|NCT01064648|474291366|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
131730858|NCT01064648|474291363|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
131730859|NCT01064648|474291364|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
131730860|NCT01064648|474291365|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
131730861|NCT01064648|474291366|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
131730862|NCT01064648|474291363|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
131730863|NCT01064648|474291364|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
131730864|NCT01064648|474291365|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
131730865|NCT01064648|474291366|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
131730866|NCT01064648|474291363|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
131730867|NCT01064648|474291364|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
131730868|NCT01064648|474291365|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
131730869|NCT01064648|474291366|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
131730870|NCT01064648|474291363|FG000|Phase II|Adverse Event|0|||
131730871|NCT01064648|474291364|FG001|Phase II|Adverse Event|0|||
131730872|NCT01064648|474291365|FG002|Phase II|Adverse Event|15|||
131730873|NCT01064648|474291366|FG003|Phase II|Adverse Event|8|||
131730874|NCT01064648|474291363|FG000|Phase II|Death|0|||
131730875|NCT01064648|474291364|FG001|Phase II|Death|0|||
131730876|NCT01064648|474291365|FG002|Phase II|Death|4|||
131730877|NCT01064648|474291366|FG003|Phase II|Death|5|||
131730878|NCT01064648|474291363|FG000|Phase II|Withdrawal by Subject|0|||
131730879|NCT01064648|474291364|FG001|Phase II|Withdrawal by Subject|0|||
131730880|NCT01064648|474291365|FG002|Phase II|Withdrawal by Subject|2|||
131730881|NCT01064648|474291366|FG003|Phase II|Withdrawal by Subject|5|||
131730882|NCT01064648|474291363|FG000|Phase II|Progression|0|||
131730883|NCT01064648|474291364|FG001|Phase II|Progression|0|||
131730884|NCT01064648|474291365|FG002|Phase II|Progression|21|||
131730885|NCT01064648|474291366|FG003|Phase II|Progression|27|||
131730886|NCT01064648|474291363|FG000|Phase II|Non-protocol specified|0|||
131730887|NCT01064648|474291364|FG001|Phase II|Non-protocol specified|0|||
131730888|NCT01064648|474291365|FG002|Phase II|Non-protocol specified|5|||
131730889|NCT01064648|474291366|FG003|Phase II|Non-protocol specified|3|||
131730890|NCT01064648|474291363|FG000|Phase II|Under Review|0|||
131730891|NCT01064648|474291364|FG001|Phase II|Under Review|0|||
131730892|NCT01064648|474291365|FG002|Phase II|Under Review|2|||
131730893|NCT01064648|474291366|FG003|Phase II|Under Review|0|||
131807095|NCT02495857|474579484|FG001|Overall Study|Withdrawal by Subject|6|||
131730894|NCT00977574|474291367|FG000|Overall Study|Never Treated|4|||
131730895|NCT00977574|474291368|FG001|Overall Study|Never Treated|2|||
131807096|NCT02495857|474579485|FG002|Overall Study|Withdrawal by Subject|10|||
131730896|NCT00977574|474291369|FG002|Overall Study|Never Treated|4|||
131730897|NCT05281523|474291370|FG000|Overall Study|Adverse Event|1|||
131807097|NCT02495857|474579483|FG000|Overall Study|Physician Decision|0|||
131730898|NCT05281523|474291371|FG001|Overall Study|Adverse Event|1|||
131807098|NCT02495857|474579484|FG001|Overall Study|Physician Decision|1|||
131730899|NCT05281523|474291370|FG000|Overall Study|Physician Decision|1|||
131730900|NCT05281523|474291371|FG001|Overall Study|Physician Decision|1|||
131730901|NCT05281523|474291370|FG000|Overall Study|Withdrawal by Subject|5|||
131730902|NCT05281523|474291371|FG001|Overall Study|Withdrawal by Subject|15|||
131730903|NCT05281523|474291370|FG000|Overall Study|GCP violations|3|||
131730904|NCT05281523|474291371|FG001|Overall Study|GCP violations|4|||
131730905|NCT05306873|474293383|FG000|Stage 2|Study stopped|1|||
131807099|NCT02495857|474579485|FG002|Overall Study|Physician Decision|0|||
131807100|NCT02495857|474579483|FG000|Overall Study|Protocol Violation|1|||
131807101|NCT02495857|474579484|FG001|Overall Study|Protocol Violation|1|||
131807102|NCT02495857|474579485|FG002|Overall Study|Protocol Violation|2|||
131807103|NCT02495857|474579483|FG000|Overall Study|Lost to Follow-up|4|||
131807104|NCT02495857|474579484|FG001|Overall Study|Lost to Follow-up|5|||
131807105|NCT02495857|474579485|FG002|Overall Study|Lost to Follow-up|3|||
131807106|NCT02495857|474579483|FG000|Overall Study|Other|3|||
131807107|NCT02495857|474579484|FG001|Overall Study|Other|3|||
131807108|NCT02495857|474579485|FG002|Overall Study|Other|2|||
131807109|NCT00396279|474579486|FG000|Overall Study|Ongoing in study|26|||
131807110|NCT00396279|474579486|FG000|Overall Study|Disease progression|2|||
131807111|NCT00396279|474579486|FG000|Overall Study|Withdrawal by Subject|1|||
131807112|NCT00396279|474579486|FG000|Overall Study|Physician Decision|1|||
131807113|NCT02883452|474579487|FG000|Overall Study|Withdrawal by Subject|1|||
131807114|NCT02883452|474579488|FG001|Overall Study|Withdrawal by Subject|1|||
131807115|NCT02883452|474579489|FG002|Overall Study|Withdrawal by Subject|3|||
131807116|NCT02883452|474579490|FG003|Overall Study|Withdrawal by Subject|0|||
131807117|NCT02883452|474579491|FG004|Overall Study|Withdrawal by Subject|2|||
131807118|NCT02883452|474579492|FG005|Overall Study|Withdrawal by Subject|5|||
131807119|NCT02883452|474579487|FG000|Overall Study|Disease progression|1|||
131807120|NCT02883452|474579488|FG001|Overall Study|Disease progression|0|||
131807121|NCT02883452|474579489|FG002|Overall Study|Disease progression|0|||
131807122|NCT02883452|474579490|FG003|Overall Study|Disease progression|1|||
131807123|NCT02883452|474579491|FG004|Overall Study|Disease progression|4|||
131807124|NCT02883452|474579492|FG005|Overall Study|Disease progression|5|||
131807125|NCT02883452|474579487|FG000|Overall Study|Adverse Event|2|||
131807126|NCT02883452|474579488|FG001|Overall Study|Adverse Event|1|||
131807127|NCT02883452|474579489|FG002|Overall Study|Adverse Event|1|||
131807128|NCT02883452|474579490|FG003|Overall Study|Adverse Event|1|||
131807129|NCT02883452|474579491|FG004|Overall Study|Adverse Event|1|||
131807130|NCT02883452|474579492|FG005|Overall Study|Adverse Event|3|||
131807131|NCT02883452|474579487|FG000|Overall Study|Physician Decision|0|||
131807132|NCT02883452|474579488|FG001|Overall Study|Physician Decision|0|||
131807133|NCT02883452|474579489|FG002|Overall Study|Physician Decision|0|||
131905119|NCT03797898|474939050|FG001|Overall Study|Withdrawal by Subject|7|||
131730906|NCT05306873|474293384|FG001|Stage 2|Study stopped|1|||
131730907|NCT05306873|474293385|FG002|Stage 2|Study stopped|0|||
131730908|NCT05306873|474293386|FG003|Stage 2|Study stopped|0|||
131730909|NCT05306873|474293383|FG000|Stage 2|Stage 2 Treatment Failure|2|||
131730910|NCT05306873|474293384|FG001|Stage 2|Stage 2 Treatment Failure|3|||
131730911|NCT05306873|474293385|FG002|Stage 2|Stage 2 Treatment Failure|0|||
131730912|NCT05306873|474293386|FG003|Stage 2|Stage 2 Treatment Failure|0|||
131730913|NCT05306873|474293383|FG000|Stage 2|Logistical issues due to participant moving|1|||
131730914|NCT05306873|474293384|FG001|Stage 2|Logistical issues due to participant moving|0|||
131730915|NCT05306873|474293385|FG002|Stage 2|Logistical issues due to participant moving|0|||
131730916|NCT05306873|474293386|FG003|Stage 2|Logistical issues due to participant moving|0|||
131730917|NCT05306873|474293383|FG000|Stage 3|Stage 3 Treatment Failure|0|||
131730918|NCT05306873|474293384|FG001|Stage 3|Stage 3 Treatment Failure|0|||
131730919|NCT05306873|474293385|FG002|Stage 3|Stage 3 Treatment Failure|0|||
131730920|NCT05306873|474293386|FG003|Stage 3|Stage 3 Treatment Failure|1|||
131730921|NCT05306873|474293383|FG000|Stage 3|Study Stopped|0|||
131730922|NCT05306873|474293384|FG001|Stage 3|Study Stopped|0|||
131730923|NCT05306873|474293385|FG002|Stage 3|Study Stopped|1|||
131730924|NCT05306873|474293386|FG003|Stage 3|Study Stopped|0|||
131905120|NCT03797898|474939049|FG000|Overall Study|Became ineligible|5|||
131905121|NCT03797898|474939050|FG001|Overall Study|Became ineligible|2|||
131905122|NCT00086190|474939051|FG000|Overall Study|Adverse Event|6|||
131905123|NCT00086190|474939052|FG001|Overall Study|Adverse Event|2|||
131905124|NCT00086190|474939053|FG002|Overall Study|Adverse Event|2|||
131807134|NCT02883452|474579490|FG003|Overall Study|Physician Decision|0|||
131730925|NCT00074412|474293388|FG000|Overall Study|Death|30|||
131730926|NCT00074412|474293389|FG001|Overall Study|Death|26|||
131730927|NCT00074412|474293388|FG000|Overall Study|Lost to Follow-up|52|||
131730928|NCT00074412|474293389|FG001|Overall Study|Lost to Follow-up|58|||
131807135|NCT02883452|474579491|FG004|Overall Study|Physician Decision|4|||
131807136|NCT02883452|474579492|FG005|Overall Study|Physician Decision|1|||
131807137|NCT02883452|474579487|FG000|Overall Study|Death|1|||
131807138|NCT02883452|474579488|FG001|Overall Study|Death|0|||
131807139|NCT02883452|474579489|FG002|Overall Study|Death|1|||
131730929|NCT01953328|474293390|FG000|Overall Study|Withdrawal by Subject|0|||
131807140|NCT02883452|474579490|FG003|Overall Study|Death|0|||
131807141|NCT02883452|474579491|FG004|Overall Study|Death|0|||
131905125|NCT00086190|474939051|FG000|Overall Study|Withdrawal by Subject|0|||
131730930|NCT01953328|474293391|FG001|Overall Study|Withdrawal by Subject|0|||
131730931|NCT01953328|474293392|FG002|Overall Study|Withdrawal by Subject|0|||
131730932|NCT01953328|474293393|FG003|Overall Study|Withdrawal by Subject|0|||
131730933|NCT01953328|474293394|FG004|Overall Study|Withdrawal by Subject|1|||
131730934|NCT01953328|474293395|FG005|Overall Study|Withdrawal by Subject|0|||
131730935|NCT01953328|474293396|FG006|Overall Study|Withdrawal by Subject|0|||
131730936|NCT01953328|474293397|FG007|Overall Study|Withdrawal by Subject|0|||
131730937|NCT01953328|474293390|FG000|Overall Study|Lost to Follow-up|0|||
131730938|NCT01953328|474293391|FG001|Overall Study|Lost to Follow-up|0|||
131730939|NCT01953328|474293392|FG002|Overall Study|Lost to Follow-up|0|||
131730940|NCT01953328|474293393|FG003|Overall Study|Lost to Follow-up|0|||
131730941|NCT01953328|474293394|FG004|Overall Study|Lost to Follow-up|1|||
131730942|NCT01953328|474293395|FG005|Overall Study|Lost to Follow-up|0|||
131730943|NCT01953328|474293396|FG006|Overall Study|Lost to Follow-up|0|||
131730944|NCT01953328|474293397|FG007|Overall Study|Lost to Follow-up|0|||
131730945|NCT02626819|474293400|FG000|Overall Study|Lost to Follow-up|3|||
131730946|NCT02626819|474293401|FG001|Overall Study|Lost to Follow-up|2|||
131730947|NCT02626819|474293400|FG000|Overall Study|Withdrawal by Subject|1|||
131730948|NCT02626819|474293401|FG001|Overall Study|Withdrawal by Subject|0|||
131730949|NCT02626819|474293400|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
131730950|NCT02626819|474293401|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
131730951|NCT02364947|474293403|FG000|Overall Study|Withdrawal by Subject|10|||
131730952|NCT02364947|474293404|FG001|Overall Study|Withdrawal by Subject|8|||
131730953|NCT02364947|474293405|FG002|Overall Study|Withdrawal by Subject|9|||
131730954|NCT02364947|474293403|FG000|Overall Study|Adverse Event|45|||
131730955|NCT02364947|474293404|FG001|Overall Study|Adverse Event|33|||
131730956|NCT02364947|474293405|FG002|Overall Study|Adverse Event|11|||
131730957|NCT02364947|474293403|FG000|Overall Study|Protocol Violation|1|||
131730958|NCT02364947|474293404|FG001|Overall Study|Protocol Violation|1|||
131730959|NCT02364947|474293405|FG002|Overall Study|Protocol Violation|1|||
131730960|NCT02364947|474293403|FG000|Overall Study|Physician Decision|3|||
131730961|NCT02364947|474293404|FG001|Overall Study|Physician Decision|2|||
131730962|NCT02364947|474293405|FG002|Overall Study|Physician Decision|5|||
131730963|NCT02364947|474293403|FG000|Overall Study|Death|0|||
131730964|NCT02364947|474293404|FG001|Overall Study|Death|1|||
131730965|NCT02364947|474293405|FG002|Overall Study|Death|0|||
131730966|NCT02163993|474293406|FG000|Treatment Period|Adverse Event|0|||
131730967|NCT02163993|474293407|FG001|Treatment Period|Adverse Event|1|||
131730968|NCT02163993|474293408|FG002|Treatment Period|Adverse Event|0|||
131730969|NCT02163993|474293409|FG003|Treatment Period|Adverse Event|0|||
131730970|NCT02163993|474293410|FG004|Treatment Period|Adverse Event|1|||
131730971|NCT02163993|474293406|FG000|Treatment Period|Lost to Follow-up|2|||
131730972|NCT02163993|474293407|FG001|Treatment Period|Lost to Follow-up|3|||
131730973|NCT02163993|474293408|FG002|Treatment Period|Lost to Follow-up|1|||
131730974|NCT02163993|474293409|FG003|Treatment Period|Lost to Follow-up|3|||
131730975|NCT02163993|474293410|FG004|Treatment Period|Lost to Follow-up|1|||
131730976|NCT02163993|474293406|FG000|Treatment Period|Physician Decision|1|||
131730977|NCT02163993|474293407|FG001|Treatment Period|Physician Decision|0|||
131730978|NCT02163993|474293408|FG002|Treatment Period|Physician Decision|0|||
131730979|NCT02163993|474293409|FG003|Treatment Period|Physician Decision|0|||
131730980|NCT02163993|474293410|FG004|Treatment Period|Physician Decision|0|||
131730981|NCT02163993|474293406|FG000|Treatment Period|Protocol Violation|2|||
131730982|NCT02163993|474293407|FG001|Treatment Period|Protocol Violation|1|||
131730983|NCT02163993|474293408|FG002|Treatment Period|Protocol Violation|0|||
131730984|NCT02163993|474293409|FG003|Treatment Period|Protocol Violation|1|||
131730985|NCT02163993|474293410|FG004|Treatment Period|Protocol Violation|2|||
131730986|NCT02163993|474293406|FG000|Treatment Period|Withdrawal by Subject|6|||
131730987|NCT02163993|474293407|FG001|Treatment Period|Withdrawal by Subject|4|||
131730988|NCT02163993|474293408|FG002|Treatment Period|Withdrawal by Subject|1|||
131730989|NCT02163993|474293409|FG003|Treatment Period|Withdrawal by Subject|4|||
131730990|NCT02163993|474293410|FG004|Treatment Period|Withdrawal by Subject|1|||
131730991|NCT02163993|474293406|FG000|Treatment Period|Not treated|1|||
131730992|NCT02163993|474293407|FG001|Treatment Period|Not treated|0|||
131730993|NCT02163993|474293408|FG002|Treatment Period|Not treated|0|||
131730994|NCT02163993|474293409|FG003|Treatment Period|Not treated|1|||
131730995|NCT02163993|474293410|FG004|Treatment Period|Not treated|2|||
131730996|NCT02163993|474293406|FG000|Post-treatment Period|Adverse Event|0|||
131730997|NCT02163993|474293407|FG001|Post-treatment Period|Adverse Event|0|||
131730998|NCT02163993|474293408|FG002|Post-treatment Period|Adverse Event|1|||
131730999|NCT02163993|474293409|FG003|Post-treatment Period|Adverse Event|0|||
131807142|NCT02883452|474579492|FG005|Overall Study|Death|0|||
131807143|NCT02883452|474579487|FG000|Overall Study|Other|0|||
131807144|NCT02883452|474579488|FG001|Overall Study|Other|0|||
131807145|NCT02883452|474579489|FG002|Overall Study|Other|0|||
131807146|NCT02883452|474579490|FG003|Overall Study|Other|0|||
131807147|NCT02883452|474579491|FG004|Overall Study|Other|0|||
131807148|NCT02883452|474579492|FG005|Overall Study|Other|1|||
131807149|NCT00830206|474579493|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
131807150|NCT00830206|474579494|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
131807151|NCT04605094|474579496|FG000|Overall Study|Adverse Event|2|||
131807152|NCT04605094|474579497|FG001|Overall Study|Adverse Event|2|||
131807153|NCT04605094|474579496|FG000|Overall Study|Lost to Follow-up|1|||
131905126|NCT00086190|474939052|FG001|Overall Study|Withdrawal by Subject|2|||
131905127|NCT00086190|474939053|FG002|Overall Study|Withdrawal by Subject|2|||
131731000|NCT02163993|474293410|FG004|Post-treatment Period|Adverse Event|0|||
131731001|NCT02163993|474293406|FG000|Post-treatment Period|Lost to Follow-up|2|||
131731002|NCT02163993|474293407|FG001|Post-treatment Period|Lost to Follow-up|2|||
131731003|NCT02163993|474293408|FG002|Post-treatment Period|Lost to Follow-up|3|||
131731004|NCT02163993|474293409|FG003|Post-treatment Period|Lost to Follow-up|1|||
131731005|NCT02163993|474293410|FG004|Post-treatment Period|Lost to Follow-up|0|||
131731006|NCT02163993|474293406|FG000|Post-treatment Period|Protocol Violation|0|||
131731007|NCT02163993|474293407|FG001|Post-treatment Period|Protocol Violation|0|||
131731008|NCT02163993|474293408|FG002|Post-treatment Period|Protocol Violation|0|||
131731009|NCT02163993|474293409|FG003|Post-treatment Period|Protocol Violation|0|||
131731010|NCT02163993|474293410|FG004|Post-treatment Period|Protocol Violation|1|||
131731011|NCT02163993|474293406|FG000|Post-treatment Period|Withdrawal by Subject|2|||
131731012|NCT02163993|474293407|FG001|Post-treatment Period|Withdrawal by Subject|4|||
131731013|NCT02163993|474293408|FG002|Post-treatment Period|Withdrawal by Subject|0|||
131731014|NCT02163993|474293409|FG003|Post-treatment Period|Withdrawal by Subject|1|||
131731015|NCT02163993|474293410|FG004|Post-treatment Period|Withdrawal by Subject|2|||
131731016|NCT00853489|474293411|FG000|Overall Study|Lost to Follow-up|5|||
131731017|NCT00853489|474293412|FG001|Overall Study|Lost to Follow-up|2|||
131731018|NCT05525975|474293413|FG000|Overall Study|Surgery cancellation|4|||
131731019|NCT05525975|474293414|FG001|Overall Study|Surgery cancellation|5|||
131731020|NCT05525975|474293413|FG000|Overall Study|didn't fill prescription|1|||
131731021|NCT05525975|474293414|FG001|Overall Study|didn't fill prescription|0|||
131731022|NCT05525975|474293413|FG000|Overall Study|Withdrawal by Subject|0|||
131731023|NCT05525975|474293414|FG001|Overall Study|Withdrawal by Subject|3|||
131731024|NCT01701583|474293419|FG000|Overall Study|Withdrawal by Subject|2|||
131731025|NCT01701583|474293420|FG001|Overall Study|Withdrawal by Subject|0|||
131731026|NCT02750813|474293421|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
131731027|NCT02750813|474293422|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
131731028|NCT02750813|474293421|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
131731029|NCT02750813|474293422|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
131731030|NCT01998581|474293423|FG000|Overall Study|Refused repeat treatment|20|||
131731031|NCT01998581|474293424|FG001|Overall Study|Refused repeat treatment|4|||
131731032|NCT01998581|474293423|FG000|Overall Study|Protocol Violation|1|||
131731033|NCT01998581|474293424|FG001|Overall Study|Protocol Violation|0|||
131731034|NCT01998581|474293423|FG000|Overall Study|Withdrawal by Subject|8|||
131731035|NCT01998581|474293424|FG001|Overall Study|Withdrawal by Subject|1|||
131731036|NCT01998581|474293423|FG000|Overall Study|Lost to Follow-up|12|||
131731037|NCT01998581|474293424|FG001|Overall Study|Lost to Follow-up|4|||
131731038|NCT01998581|474293423|FG000|Overall Study|Adverse Event|1|||
131731039|NCT01998581|474293424|FG001|Overall Study|Adverse Event|1|||
131731040|NCT01998581|474293423|FG000|Overall Study|Other reasons|3|||
131731041|NCT01998581|474293424|FG001|Overall Study|Other reasons|2|||
131731042|NCT01998581|474293423|FG000|Overall Study|Randomized but withdrew before treatment|1|||
131731043|NCT01998581|474293424|FG001|Overall Study|Randomized but withdrew before treatment|0|||
131731044|NCT01251276|474293425|FG000|Overall Study|Protocol Violation|1|||
131731045|NCT01251276|474293426|FG001|Overall Study|Protocol Violation|0|||
131731046|NCT01251276|474293425|FG000|Overall Study|Lost to Follow-up|0|||
131731047|NCT01251276|474293426|FG001|Overall Study|Lost to Follow-up|1|||
131731048|NCT01345123|474293427|FG000|Overall Study|participants no longer with health plan|79|||
131807154|NCT04605094|474579497|FG001|Overall Study|Lost to Follow-up|4|||
131807155|NCT04605094|474579496|FG000|Overall Study|Physician Decision|2|||
131905128|NCT00086190|474939051|FG000|Overall Study|Protocol Violation|1|||
131905129|NCT00086190|474939052|FG001|Overall Study|Protocol Violation|0|||
131731049|NCT01345123|474293428|FG001|Overall Study|participants no longer with health plan|85|||
131731050|NCT01345123|474293429|FG002|Overall Study|participants no longer with health plan|88|||
131731051|NCT02245568|474293430|FG000|Overall Study|Study terminated by Sponsor|346|||
131731052|NCT02245568|474293430|FG000|Overall Study|Adverse Event|144|||
131905130|NCT00086190|474939053|FG002|Overall Study|Protocol Violation|0|||
131731053|NCT02245568|474293430|FG000|Overall Study|Lack of Efficacy|98|||
131807156|NCT04605094|474579497|FG001|Overall Study|Physician Decision|2|||
131731054|NCT02245568|474293430|FG000|Overall Study|Withdrawal by Caregiver|85|||
131807157|NCT04605094|474579496|FG000|Overall Study|Study terminated by Sponsor|31|||
131905131|NCT00086190|474939051|FG000|Overall Study|Moved|1|||
131731055|NCT02245568|474293430|FG000|Overall Study|Withdrawal by Subject|77|||
131731056|NCT02245568|474293430|FG000|Overall Study|Withdrawal by Legal Representative|31|||
131731057|NCT02245568|474293430|FG000|Overall Study|Missing (Site closure)|16|||
131731058|NCT02245568|474293430|FG000|Overall Study|Physician Decision|14|||
131731059|NCT02245568|474293430|FG000|Overall Study|Non-compliance with study drug|11|||
131731060|NCT02245568|474293430|FG000|Overall Study|Death|9|||
131731061|NCT02245568|474293430|FG000|Overall Study|Blue staining|6|||
131731062|NCT02245568|474293430|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
131731063|NCT02245568|474293430|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
131731064|NCT02245568|474293430|FG000|Overall Study|Lost to Follow-up|5|||
131731065|NCT00366548|474293431|FG000|Infant Series|Adverse Event|1|||
131731066|NCT00366548|474293432|FG001|Infant Series|Adverse Event|3|||
131731067|NCT00366548|474293431|FG000|Infant Series|Protocol Violation|0|||
131731068|NCT00366548|474293432|FG001|Infant Series|Protocol Violation|1|||
131731069|NCT00366548|474293431|FG000|Infant Series|Withdrawal by Subject|3|||
131731070|NCT00366548|474293432|FG001|Infant Series|Withdrawal by Subject|1|||
131731071|NCT00366548|474293431|FG000|After Infant Series|Withdrawal by Subject|3|||
131731072|NCT00366548|474293432|FG001|After Infant Series|Withdrawal by Subject|1|||
131731073|NCT00366548|474293431|FG000|After Infant Series|Adverse Event|2|||
131731074|NCT00366548|474293432|FG001|After Infant Series|Adverse Event|0|||
131731075|NCT00366548|474293431|FG000|After Infant Series|Lost to Follow-up|1|||
131731076|NCT00366548|474293432|FG001|After Infant Series|Lost to Follow-up|0|||
131731077|NCT01051986|474293433|FG000|Overall Study|Death|1|||
131731078|NCT01051986|474293434|FG001|Overall Study|Death|0|||
131731079|NCT01051986|474293433|FG000|Overall Study|Withdrawal by Subject|2|||
131731080|NCT01051986|474293434|FG001|Overall Study|Withdrawal by Subject|1|||
131731081|NCT01051986|474293433|FG000|Overall Study|Protocol Violation|2|||
131731082|NCT01051986|474293434|FG001|Overall Study|Protocol Violation|3|||
131731083|NCT02273752|474293436|FG000|Overall Study|Trial was terminated early|2|||
131731084|NCT01725152|474293437|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
131731085|NCT01725152|474293438|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
131731086|NCT01725152|474293437|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
131731087|NCT01725152|474293438|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
131731088|NCT01725152|474293437|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
131731089|NCT01725152|474293438|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
131731090|NCT01725152|474293437|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
131731091|NCT01725152|474293438|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
131731092|NCT02044159|474293439|FG000|Overall Study|Consent declined (deferred consent)|2|||
131731093|NCT02044159|474293440|FG001|Overall Study|Consent declined (deferred consent)|4|||
131731094|NCT02044159|474293439|FG000|Overall Study|No longer eligible, drug not given|1|||
131731095|NCT02044159|474293440|FG001|Overall Study|No longer eligible, drug not given|0|||
131731096|NCT02044159|474293439|FG000|Overall Study|Nurse declined to give study drug|1|||
131731097|NCT02044159|474293440|FG001|Overall Study|Nurse declined to give study drug|0|||
131731098|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
131731099|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131731100|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131731101|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131731102|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131731103|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
131731104|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131731105|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131731106|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131731107|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131731108|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
131731109|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131731110|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131731111|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131731112|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131731113|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
131731114|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131731115|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131731116|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131731117|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131731118|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
131731119|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131731120|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131731121|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131731122|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131731123|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
131731124|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131731125|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131731126|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131731127|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131731128|NCT01111539|474293441|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
131731129|NCT01111539|474293442|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131731130|NCT01111539|474293443|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131731131|NCT01111539|474293444|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131731132|NCT01111539|474293445|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131731133|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131731134|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131731135|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
131731136|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131731137|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
131731138|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131731139|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131731140|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
131731141|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131731142|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
131731143|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
131731144|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
131731145|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
131731146|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
131731147|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
131731148|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131731149|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131731150|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131731151|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131731152|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
131731153|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131731154|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131731155|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131731156|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
131731157|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131731158|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131731159|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131731160|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131731161|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
131731162|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131731163|NCT01111539|474293441|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131731164|NCT01111539|474293442|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131731165|NCT01111539|474293443|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131731166|NCT01111539|474293444|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131731167|NCT01111539|474293445|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
131731168|NCT02808312|474293446|FG000|Overall Study|Enrolled but Never Treated|0|||
131731169|NCT02808312|474293447|FG001|Overall Study|Enrolled but Never Treated|0|||
131731170|NCT02808312|474293448|FG002|Overall Study|Enrolled but Never Treated|1|||
131731171|NCT02808312|474293449|FG003|Overall Study|Enrolled but Never Treated|0|||
131731172|NCT02808312|474293450|FG004|Overall Study|Enrolled but Never Treated|0|||
131731173|NCT03628417|474293451|FG000|Overall Study|Death|1|||
131448801|NCT00790842|473272728|FG008|Expansion Cohort|Withdrawal by Subject|0|||
131448802|NCT00790842|473272729|FG009|Expansion Cohort|Withdrawal by Subject|0|||
131448803|NCT00790842|473272730|FG010|Expansion Cohort|Withdrawal by Subject|0|||
131448804|NCT00790842|473272720|FG000|Expansion Cohort|Study Closure|0|||
131731174|NCT03628417|474293452|FG001|Overall Study|Death|1|||
131731175|NCT02297438|474293453|FG000|Overall Study|Death|79|||
131731176|NCT02297438|474293454|FG001|Overall Study|Death|86|||
131731177|NCT02297438|474293453|FG000|Overall Study|Lost to Follow-up|9|||
131731178|NCT02297438|474293454|FG001|Overall Study|Lost to Follow-up|7|||
131731179|NCT02297438|474293453|FG000|Overall Study|Withdrawal by Subject|7|||
131731180|NCT02297438|474293454|FG001|Overall Study|Withdrawal by Subject|0|||
131731181|NCT02297438|474293453|FG000|Overall Study|Other|9|||
131731182|NCT02297438|474293454|FG001|Overall Study|Other|5|||
131731183|NCT02297438|474293453|FG000|Overall Study|Ongoing|65|||
131731184|NCT02297438|474293454|FG001|Overall Study|Ongoing|73|||
131731185|NCT02042404|474293460|FG000|Overall Study|Death|1|||
131731186|NCT02042404|474293461|FG001|Overall Study|Death|0|||
131731187|NCT02042404|474293460|FG000|Overall Study|Unrelated Adverse Event|3|||
131731188|NCT02042404|474293461|FG001|Overall Study|Unrelated Adverse Event|0|||
131731189|NCT02042404|474293460|FG000|Overall Study|Inability to meet time requirements|1|||
131731190|NCT02042404|474293461|FG001|Overall Study|Inability to meet time requirements|0|||
131731191|NCT03100942|474293462|FG000|Randomized Treatment Period|Withdrew Consent|4|||
131731192|NCT03100942|474293463|FG001|Randomized Treatment Period|Withdrew Consent|5|||
131731193|NCT03100942|474293464|FG002|Randomized Treatment Period|Withdrew Consent|3|||
131731194|NCT03100942|474293465|FG003|Randomized Treatment Period|Withdrew Consent|3|||
131731195|NCT03100942|474293466|FG004|Randomized Treatment Period|Withdrew Consent|0|||
131731196|NCT03100942|474293467|FG005|Randomized Treatment Period|Withdrew Consent|0|||
131731197|NCT03100942|474293468|FG006|Randomized Treatment Period|Withdrew Consent|0|||
131731198|NCT03100942|474293462|FG000|Randomized Treatment Period|Adverse Event|5|||
131731199|NCT03100942|474293463|FG001|Randomized Treatment Period|Adverse Event|2|||
131731200|NCT03100942|474293464|FG002|Randomized Treatment Period|Adverse Event|1|||
131731201|NCT03100942|474293465|FG003|Randomized Treatment Period|Adverse Event|0|||
131731202|NCT03100942|474293466|FG004|Randomized Treatment Period|Adverse Event|0|||
131731203|NCT03100942|474293467|FG005|Randomized Treatment Period|Adverse Event|0|||
131731204|NCT03100942|474293468|FG006|Randomized Treatment Period|Adverse Event|0|||
131731205|NCT03100942|474293462|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
131731206|NCT03100942|474293463|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
131731207|NCT03100942|474293464|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
131731208|NCT03100942|474293465|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
131731209|NCT03100942|474293466|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
131731210|NCT03100942|474293467|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
131731211|NCT03100942|474293468|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
131731212|NCT03100942|474293462|FG000|Randomized Treatment Period|Protocol Violation|0|||
131731213|NCT03100942|474293463|FG001|Randomized Treatment Period|Protocol Violation|1|||
131731214|NCT03100942|474293464|FG002|Randomized Treatment Period|Protocol Violation|1|||
131731215|NCT03100942|474293465|FG003|Randomized Treatment Period|Protocol Violation|1|||
131731216|NCT03100942|474293466|FG004|Randomized Treatment Period|Protocol Violation|0|||
131731217|NCT03100942|474293467|FG005|Randomized Treatment Period|Protocol Violation|0|||
131731218|NCT03100942|474293468|FG006|Randomized Treatment Period|Protocol Violation|0|||
131731219|NCT03100942|474293462|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
131731220|NCT03100942|474293463|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
131731221|NCT03100942|474293464|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
131731222|NCT03100942|474293465|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
131731223|NCT03100942|474293466|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
131731224|NCT03100942|474293467|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
131731225|NCT03100942|474293468|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
131731226|NCT03100942|474293462|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
131731227|NCT03100942|474293463|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131731228|NCT03100942|474293464|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131731229|NCT03100942|474293465|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
131731230|NCT03100942|474293466|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131731231|NCT03100942|474293467|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131731232|NCT03100942|474293468|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131731233|NCT03100942|474293462|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131731234|NCT03100942|474293463|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131731235|NCT03100942|474293464|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131731236|NCT03100942|474293465|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131731237|NCT03100942|474293466|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131731238|NCT03100942|474293467|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131731239|NCT03100942|474293468|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
131731240|NCT00372190|474293469|FG000|Overall Study|Lost to Follow-up|3|||
131731241|NCT00372190|474293470|FG001|Overall Study|Lost to Follow-up|1|||
131731242|NCT01623531|474293471|FG000|Overall Study|Death|1|||
131731243|NCT01623531|474293472|FG001|Overall Study|Death|0|||
131731244|NCT01623531|474293471|FG000|Overall Study|Protocol Violation|2|||
131731245|NCT01623531|474293472|FG001|Overall Study|Protocol Violation|1|||
131731246|NCT01623531|474293471|FG000|Overall Study|Missing data at primary outcome time poi|1|||
131731247|NCT01623531|474293472|FG001|Overall Study|Missing data at primary outcome time poi|1|||
131731248|NCT04184622|474293474|FG000|Primary Treatment Period|Adverse Event|6|||
131731249|NCT04184622|474293475|FG001|Primary Treatment Period|Adverse Event|4|||
131731250|NCT04184622|474293476|FG002|Primary Treatment Period|Adverse Event|8|||
131731251|NCT04184622|474293477|FG003|Primary Treatment Period|Adverse Event|6|||
131731252|NCT04184622|474293474|FG000|Primary Treatment Period|Death|4|||
131731253|NCT04184622|474293475|FG001|Primary Treatment Period|Death|4|||
131731254|NCT04184622|474293476|FG002|Primary Treatment Period|Death|2|||
131731255|NCT04184622|474293477|FG003|Primary Treatment Period|Death|1|||
131731256|NCT04184622|474293474|FG000|Primary Treatment Period|Lost to Follow-up|41|||
131731257|NCT04184622|474293475|FG001|Primary Treatment Period|Lost to Follow-up|17|||
131731258|NCT04184622|474293476|FG002|Primary Treatment Period|Lost to Follow-up|15|||
131731259|NCT04184622|474293477|FG003|Primary Treatment Period|Lost to Follow-up|13|||
131731260|NCT04184622|474293474|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
131731261|NCT04184622|474293475|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
131731262|NCT04184622|474293476|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
131731263|NCT04184622|474293477|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
131731264|NCT04184622|474293474|FG000|Primary Treatment Period|Physician Decision|0|||
131731265|NCT04184622|474293475|FG001|Primary Treatment Period|Physician Decision|0|||
131731266|NCT04184622|474293476|FG002|Primary Treatment Period|Physician Decision|3|||
131731267|NCT04184622|474293477|FG003|Primary Treatment Period|Physician Decision|1|||
131731268|NCT04184622|474293474|FG000|Primary Treatment Period|Pregnancy|4|||
131731269|NCT04184622|474293475|FG001|Primary Treatment Period|Pregnancy|3|||
131731270|NCT04184622|474293476|FG002|Primary Treatment Period|Pregnancy|4|||
131731271|NCT04184622|474293477|FG003|Primary Treatment Period|Pregnancy|1|||
131731272|NCT04184622|474293474|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
131731273|NCT04184622|474293475|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
131731274|NCT04184622|474293476|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
131731275|NCT04184622|474293477|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
131731276|NCT04184622|474293474|FG000|Additional Treatment Period|Adverse Event|1|||
131731277|NCT04184622|474293475|FG001|Additional Treatment Period|Adverse Event|2|||
131731278|NCT04184622|474293476|FG002|Additional Treatment Period|Adverse Event|1|||
131731279|NCT04184622|474293477|FG003|Additional Treatment Period|Adverse Event|0|||
131731280|NCT04184622|474293474|FG000|Additional Treatment Period|Death|0|||
131731281|NCT04184622|474293475|FG001|Additional Treatment Period|Death|0|||
131731282|NCT04184622|474293476|FG002|Additional Treatment Period|Death|1|||
131731283|NCT04184622|474293477|FG003|Additional Treatment Period|Death|1|||
131731284|NCT04184622|474293474|FG000|Additional Treatment Period|Lost to Follow-up|6|||
131731285|NCT04184622|474293475|FG001|Additional Treatment Period|Lost to Follow-up|4|||
131731286|NCT04184622|474293476|FG002|Additional Treatment Period|Lost to Follow-up|8|||
131731287|NCT04184622|474293477|FG003|Additional Treatment Period|Lost to Follow-up|6|||
131731288|NCT04184622|474293474|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
131731289|NCT04184622|474293475|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
131731290|NCT04184622|474293476|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
131731291|NCT04184622|474293477|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
131731292|NCT04184622|474293474|FG000|Additional Treatment Period|Physician Decision|0|||
131807158|NCT04605094|474579497|FG001|Overall Study|Study terminated by Sponsor|33|||
131807159|NCT04605094|474579496|FG000|Overall Study|Withdrawal by Subject|22|||
131807160|NCT04605094|474579497|FG001|Overall Study|Withdrawal by Subject|19|||
131807161|NCT04605094|474579496|FG000|Overall Study|Other|1|||
131807162|NCT04605094|474579497|FG001|Overall Study|Other|1|||
131807163|NCT02724462|474579498|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
131807164|NCT02724462|474579499|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
131807165|NCT02724462|474579498|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
131807166|NCT02724462|474579499|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
131807167|NCT02724462|474579498|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
131807168|NCT02724462|474579499|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
131731293|NCT04184622|474293475|FG001|Additional Treatment Period|Physician Decision|0|||
131731294|NCT04184622|474293476|FG002|Additional Treatment Period|Physician Decision|1|||
131731295|NCT04184622|474293477|FG003|Additional Treatment Period|Physician Decision|0|||
131731296|NCT04184622|474293474|FG000|Additional Treatment Period|Pregnancy|0|||
131731297|NCT04184622|474293475|FG001|Additional Treatment Period|Pregnancy|0|||
131731298|NCT04184622|474293476|FG002|Additional Treatment Period|Pregnancy|0|||
131731299|NCT04184622|474293477|FG003|Additional Treatment Period|Pregnancy|1|||
131731300|NCT04184622|474293474|FG000|Additional Treatment Period|Protocol deviation|0|||
131731301|NCT04184622|474293475|FG001|Additional Treatment Period|Protocol deviation|0|||
131731302|NCT04184622|474293476|FG002|Additional Treatment Period|Protocol deviation|1|||
131448805|NCT00790842|473272721|FG001|Expansion Cohort|Study Closure|0|||
131731303|NCT04184622|474293477|FG003|Additional Treatment Period|Protocol deviation|0|||
131731304|NCT04184622|474293474|FG000|Additional Treatment Period|Site closed|1|||
131731305|NCT04184622|474293475|FG001|Additional Treatment Period|Site closed|0|||
131731306|NCT04184622|474293476|FG002|Additional Treatment Period|Site closed|1|||
131731307|NCT04184622|474293477|FG003|Additional Treatment Period|Site closed|0|||
131731308|NCT04184622|474293474|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
131731309|NCT04184622|474293475|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
131731310|NCT04184622|474293476|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
131731311|NCT04184622|474293477|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
131731312|NCT04184622|474293474|FG000|Safety Follow-up Period|Adverse Event|6|||
131731313|NCT04184622|474293475|FG001|Safety Follow-up Period|Adverse Event|8|||
131731314|NCT04184622|474293476|FG002|Safety Follow-up Period|Adverse Event|9|||
131731315|NCT04184622|474293477|FG003|Safety Follow-up Period|Adverse Event|16|||
131731316|NCT04184622|474293474|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
131731317|NCT04184622|474293475|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
131731318|NCT04184622|474293476|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
131731319|NCT04184622|474293477|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
131731320|NCT04184622|474293474|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
131731321|NCT04184622|474293475|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
131731322|NCT04184622|474293476|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
131731323|NCT04184622|474293477|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
131731324|NCT04184622|474293474|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
131731325|NCT04184622|474293475|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
131731326|NCT04184622|474293476|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
131731327|NCT04184622|474293477|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
131731328|NCT04184622|474293474|FG000|Safety Follow-up Period|Physician Decision|1|||
131731329|NCT04184622|474293475|FG001|Safety Follow-up Period|Physician Decision|0|||
131731330|NCT04184622|474293476|FG002|Safety Follow-up Period|Physician Decision|0|||
131731331|NCT04184622|474293477|FG003|Safety Follow-up Period|Physician Decision|1|||
131731332|NCT04184622|474293474|FG000|Safety Follow-up Period|Pregnancy|1|||
131731333|NCT04184622|474293475|FG001|Safety Follow-up Period|Pregnancy|3|||
131731334|NCT04184622|474293476|FG002|Safety Follow-up Period|Pregnancy|0|||
131731335|NCT04184622|474293477|FG003|Safety Follow-up Period|Pregnancy|6|||
131731336|NCT04184622|474293474|FG000|Safety Follow-up Period|Protocol deviation|1|||
131731337|NCT04184622|474293475|FG001|Safety Follow-up Period|Protocol deviation|0|||
131731338|NCT04184622|474293476|FG002|Safety Follow-up Period|Protocol deviation|0|||
131731339|NCT04184622|474293477|FG003|Safety Follow-up Period|Protocol deviation|0|||
131731340|NCT04184622|474293474|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
131731341|NCT04184622|474293475|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
131731342|NCT04184622|474293476|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
131731343|NCT04184622|474293477|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
131731344|NCT01617681|474293478|FG000|Period 1 Double Blind|Adverse Event|2|||
131731345|NCT01617681|474293479|FG001|Period 1 Double Blind|Adverse Event|0|||
131731346|NCT01617681|474293480|FG002|Period 1 Double Blind|Adverse Event|0|||
131731347|NCT01617681|474293481|FG003|Period 1 Double Blind|Adverse Event|2|||
131731348|NCT01617681|474293482|FG004|Period 1 Double Blind|Adverse Event|0|||
131731349|NCT01617681|474293478|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
131731350|NCT01617681|474293479|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
131731351|NCT01617681|474293480|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
131731352|NCT01617681|474293481|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
131731353|NCT01617681|474293482|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
131731354|NCT01617681|474293478|FG000|Period 2 Open Label|Adverse Event|0|||
131731355|NCT01617681|474293479|FG001|Period 2 Open Label|Adverse Event|0|||
131731356|NCT01617681|474293480|FG002|Period 2 Open Label|Adverse Event|0|||
131731357|NCT01617681|474293481|FG003|Period 2 Open Label|Adverse Event|0|||
131731358|NCT01617681|474293482|FG004|Period 2 Open Label|Adverse Event|3|||
131731359|NCT01617681|474293478|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
131731360|NCT01617681|474293479|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
131731361|NCT01617681|474293480|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
131731362|NCT01617681|474293481|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
131731363|NCT01617681|474293482|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
131731364|NCT01856595|474293485|FG000|Overall Study|Withdrawal by Subject|0|||
131731365|NCT01856595|474293486|FG001|Overall Study|Withdrawal by Subject|1|||
131731366|NCT01856595|474293487|FG002|Overall Study|Withdrawal by Subject|0|||
131731367|NCT01856595|474293488|FG003|Overall Study|Withdrawal by Subject|0|||
131731368|NCT01856595|474293489|FG004|Overall Study|Withdrawal by Subject|0|||
131731369|NCT01856595|474293490|FG005|Overall Study|Withdrawal by Subject|0|||
131731370|NCT01856595|474293491|FG006|Overall Study|Withdrawal by Subject|1|||
131731371|NCT01856595|474293492|FG007|Overall Study|Withdrawal by Subject|0|||
131731372|NCT01856595|474293493|FG008|Overall Study|Withdrawal by Subject|0|||
131731373|NCT04426825|474293494|FG000|Overall Study|Death|17|||
131731374|NCT04426825|474293494|FG000|Overall Study|Lost to Follow-up|1|||
131807169|NCT02724462|474579498|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
131807170|NCT02724462|474579499|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
131807171|NCT02724462|474579498|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
131807172|NCT02724462|474579499|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
131807173|NCT02724462|474579498|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
131807174|NCT02724462|474579499|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
131807175|NCT01900691|474579500|FG000|Overall Study|Death|7|||
131807176|NCT01900691|474579500|FG000|Overall Study|Lost to Follow-up|4|||
131807177|NCT01900691|474579500|FG000|Overall Study|Study Device Not Placed|3|||
131807178|NCT01900691|474579500|FG000|Overall Study|Non study stent placed|2|||
131807179|NCT01900691|474579500|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
131807180|NCT01900691|474579500|FG000|Overall Study|Complete stent migration through digestive tract|1|||
131807181|NCT01954394|474579505|FG000|Overall Study|Enrolled but not treated|1|||
131807182|NCT01954394|474579506|FG001|Overall Study|Enrolled but not treated|0|||
131807183|NCT01954394|474579505|FG000|Overall Study|Adverse Event|10|||
131905132|NCT00086190|474939052|FG001|Overall Study|Moved|0|||
131905133|NCT00086190|474939053|FG002|Overall Study|Moved|0|||
131905134|NCT00086190|474939051|FG000|Overall Study|Worsening depression|0|||
131905135|NCT00086190|474939052|FG001|Overall Study|Worsening depression|0|||
131731375|NCT04426825|474293494|FG000|Overall Study|Study terminated by sponsor|5|||
131731376|NCT01763905|474293500|FG000|Overall Study|Withdrawal by Subject|1|||
131731377|NCT01763905|474293501|FG001|Overall Study|Withdrawal by Subject|1|||
131731378|NCT01763905|474293502|FG002|Overall Study|Withdrawal by Subject|0|||
131731379|NCT01763905|474293503|FG003|Overall Study|Withdrawal by Subject|1|||
131731380|NCT01763905|474293500|FG000|Overall Study|Decision by sponsor|5|||
131731381|NCT01763905|474293501|FG001|Overall Study|Decision by sponsor|0|||
131731382|NCT01763905|474293502|FG002|Overall Study|Decision by sponsor|8|||
131731383|NCT01763905|474293503|FG003|Overall Study|Decision by sponsor|0|||
131731384|NCT01763905|474293500|FG000|Overall Study|Lost to Follow-up|0|||
131731385|NCT01763905|474293501|FG001|Overall Study|Lost to Follow-up|0|||
131731386|NCT01763905|474293502|FG002|Overall Study|Lost to Follow-up|1|||
131731387|NCT01763905|474293503|FG003|Overall Study|Lost to Follow-up|0|||
131731388|NCT03456713|474293504|FG000|Overall Study|Lost to Follow-up|1|||
131731389|NCT03456713|474293505|FG001|Overall Study|Lost to Follow-up|0|||
131731390|NCT03456713|474293506|FG002|Overall Study|Lost to Follow-up|0|||
131731391|NCT03456713|474293507|FG003|Overall Study|Lost to Follow-up|0|||
131731392|NCT01263691|474293512|FG000|Overall Study|Lost to Follow-up|1|||
131731393|NCT01263691|474293513|FG001|Overall Study|Lost to Follow-up|0|||
131731394|NCT01263691|474293514|FG002|Overall Study|Lost to Follow-up|1|||
131731395|NCT01263691|474293515|FG003|Overall Study|Lost to Follow-up|1|||
131731396|NCT01263691|474293516|FG004|Overall Study|Lost to Follow-up|0|||
131731397|NCT01263691|474293517|FG005|Overall Study|Lost to Follow-up|0|||
131731398|NCT01263691|474293512|FG000|Overall Study|Withdrawal by Subject|1|||
131731399|NCT01263691|474293513|FG001|Overall Study|Withdrawal by Subject|0|||
131731400|NCT01263691|474293514|FG002|Overall Study|Withdrawal by Subject|0|||
131731401|NCT01263691|474293515|FG003|Overall Study|Withdrawal by Subject|0|||
131731402|NCT01263691|474293516|FG004|Overall Study|Withdrawal by Subject|0|||
131731403|NCT01263691|474293517|FG005|Overall Study|Withdrawal by Subject|0|||
131731404|NCT01263691|474293512|FG000|Overall Study|Adverse Event|1|||
131731405|NCT01263691|474293513|FG001|Overall Study|Adverse Event|0|||
131731406|NCT01263691|474293514|FG002|Overall Study|Adverse Event|0|||
131731407|NCT01263691|474293515|FG003|Overall Study|Adverse Event|0|||
131731408|NCT01263691|474293516|FG004|Overall Study|Adverse Event|0|||
131731409|NCT01263691|474293517|FG005|Overall Study|Adverse Event|0|||
131731410|NCT01028651|474293518|FG000|Overall Study|Death|2|||
131731411|NCT01028651|474293518|FG000|Overall Study|Adverse Event|1|||
131731412|NCT00972478|474293522|FG000|Overall Study|Adverse Event|3|||
131731413|NCT00972478|474293523|FG001|Overall Study|Adverse Event|16|||
131731414|NCT00972478|474293522|FG000|Overall Study|Withdrawal by Subject|1|||
131731415|NCT00972478|474293523|FG001|Overall Study|Withdrawal by Subject|8|||
131731416|NCT00972478|474293522|FG000|Overall Study|Progression/Relapse|0|||
131731417|NCT00972478|474293523|FG001|Overall Study|Progression/Relapse|2|||
131731418|NCT00972478|474293522|FG000|Overall Study|Death|0|||
131731419|NCT00972478|474293523|FG001|Overall Study|Death|2|||
131731420|NCT00972478|474293522|FG000|Overall Study|Not protocol specified|1|||
131731421|NCT00972478|474293523|FG001|Overall Study|Not protocol specified|1|||
131731422|NCT00972478|474293522|FG000|Overall Study|Ineligible|1|||
131731423|NCT00972478|474293523|FG001|Overall Study|Ineligible|7|||
131807184|NCT01954394|474579506|FG001|Overall Study|Adverse Event|23|||
131807185|NCT01954394|474579505|FG000|Overall Study|Poor compliance to protocol|7|||
131807186|NCT01954394|474579506|FG001|Overall Study|Poor compliance to protocol|7|||
131731424|NCT00972478|474293522|FG000|Overall Study|Not start protocol treatment|1|||
131731425|NCT00972478|474293523|FG001|Overall Study|Not start protocol treatment|2|||
131731426|NCT02561000|474293524|FG000|Overall Study|Withdrawal by Subject|2|||
131731427|NCT02561000|474293525|FG001|Overall Study|Withdrawal by Subject|3|||
131731428|NCT02561000|474293526|FG002|Overall Study|Withdrawal by Subject|0|||
131731429|NCT02561000|474293524|FG000|Overall Study|Adverse Event|0|||
131807187|NCT01954394|474579505|FG000|Overall Study|Participant Moved|0|||
131807188|NCT01954394|474579506|FG001|Overall Study|Participant Moved|4|||
131807189|NCT01954394|474579505|FG000|Overall Study|Related to Study Drug administration|2|||
131807190|NCT01954394|474579506|FG001|Overall Study|Related to Study Drug administration|2|||
131731430|NCT02561000|474293525|FG001|Overall Study|Adverse Event|1|||
131731431|NCT02561000|474293526|FG002|Overall Study|Adverse Event|0|||
131731432|NCT01554956|474293527|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
131731433|NCT01554956|474293528|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
131731434|NCT01554956|474293529|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
131731435|NCT01554956|474293527|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
131731436|NCT01554956|474293528|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
131731437|NCT01554956|474293529|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
131731438|NCT01554956|474293527|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
131731439|NCT01554956|474293528|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
131731440|NCT01554956|474293529|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
131731441|NCT00114972|474293531|FG000|Overall Study|Withdrawal by Subject|40|||
131731442|NCT00114972|474293532|FG001|Overall Study|Withdrawal by Subject|7|||
131731443|NCT00114972|474293531|FG000|Overall Study|Lost to Follow-up|8|||
131731444|NCT00114972|474293532|FG001|Overall Study|Lost to Follow-up|5|||
131731445|NCT00830037|474293533|FG000|Overall Study|Withdrawal by Subject|2|||
131731446|NCT00830037|474293534|FG001|Overall Study|Withdrawal by Subject|3|||
131731447|NCT00830037|474293533|FG000|Overall Study|Lost to Follow-up|1|||
131731448|NCT00830037|474293534|FG001|Overall Study|Lost to Follow-up|2|||
131731449|NCT00830037|474293533|FG000|Overall Study|Active when terminated by DSMB|15|||
131731450|NCT00830037|474293534|FG001|Overall Study|Active when terminated by DSMB|14|||
131731451|NCT01425190|474293535|FG000|Overall Study|Full dose not consumed.|1|||
131731452|NCT01425190|474293536|FG001|Overall Study|Full dose not consumed.|0|||
131731453|NCT01425190|474293537|FG002|Overall Study|Full dose not consumed.|0|||
131731454|NCT01635933|474293539|FG000|Overall Study|Adverse Event|1|||
131731455|NCT01635933|474293540|FG001|Overall Study|Adverse Event|0|||
131731456|NCT01635933|474293539|FG000|Overall Study|Lost to Follow-up|0|||
131731457|NCT01635933|474293540|FG001|Overall Study|Lost to Follow-up|5|||
131731458|NCT01635933|474293539|FG000|Overall Study|Subject decision|1|||
131731459|NCT01635933|474293540|FG001|Overall Study|Subject decision|1|||
131731460|NCT01635933|474293539|FG000|Overall Study|Noncompliance|0|||
131731461|NCT01635933|474293540|FG001|Overall Study|Noncompliance|1|||
131731462|NCT01635933|474293539|FG000|Overall Study|No longer had transportation|0|||
131731463|NCT01635933|474293540|FG001|Overall Study|No longer had transportation|1|||
131731464|NCT03510663|474293541|FG000|Overall Study|Withdrawal by Subject|0|||
131731465|NCT03510663|474293542|FG001|Overall Study|Withdrawal by Subject|1|||
131731466|NCT03510663|474293543|FG002|Overall Study|Withdrawal by Subject|0|||
131731467|NCT03510663|474293544|FG003|Overall Study|Withdrawal by Subject|0|||
131731468|NCT03510663|474293545|FG004|Overall Study|Withdrawal by Subject|0|||
131731469|NCT03510663|474293546|FG005|Overall Study|Withdrawal by Subject|0|||
131731470|NCT03510663|474293547|FG006|Overall Study|Withdrawal by Subject|0|||
131731471|NCT03510663|474293548|FG007|Overall Study|Withdrawal by Subject|0|||
131731472|NCT01555463|474293549|FG000|Treatment|Adverse Event|6|||
131731473|NCT01555463|474293550|FG001|Treatment|Adverse Event|12|||
131731474|NCT01555463|474293549|FG000|Treatment|Withdrawal by Subject|24|||
131731475|NCT01555463|474293550|FG001|Treatment|Withdrawal by Subject|36|||
131731476|NCT01555463|474293549|FG000|Treatment|Lost to Follow-up|28|||
131731477|NCT01555463|474293550|FG001|Treatment|Lost to Follow-up|23|||
131731478|NCT01555463|474293549|FG000|Treatment|Protocol Violation|4|||
131731479|NCT01555463|474293550|FG001|Treatment|Protocol Violation|5|||
131731480|NCT01555463|474293549|FG000|Treatment|Other reason|2|||
131807191|NCT01954394|474579505|FG000|Overall Study|Other than specified above|10|||
131807192|NCT01954394|474579506|FG001|Overall Study|Other than specified above|21|||
131807193|NCT00909610|474579507|FG000|Period: First Intervention|Adverse Event|0|||
131807194|NCT00909610|474579508|FG001|Period: First Intervention|Adverse Event|1|||
131807195|NCT00909610|474579507|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
131807196|NCT00909610|474579508|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
131807197|NCT00909610|474579507|FG000|Period: Second Intervention|Adverse Event|1|||
131448806|NCT00790842|473272722|FG002|Expansion Cohort|Study Closure|1|||
131448807|NCT00790842|473272723|FG003|Expansion Cohort|Study Closure|0|||
131731481|NCT01555463|474293550|FG001|Treatment|Other reason|3|||
131731482|NCT01555463|474293549|FG000|Follow up|Adverse Event|2|||
131731483|NCT01555463|474293550|FG001|Follow up|Adverse Event|5|||
131731484|NCT01555463|474293549|FG000|Follow up|Death|0|||
131731485|NCT01555463|474293550|FG001|Follow up|Death|1|||
131731486|NCT01555463|474293549|FG000|Follow up|Withdrawal by Subject|22|||
131731487|NCT01555463|474293550|FG001|Follow up|Withdrawal by Subject|22|||
131731488|NCT01555463|474293549|FG000|Follow up|Lost to Follow-up|9|||
131731489|NCT01555463|474293550|FG001|Follow up|Lost to Follow-up|10|||
131731490|NCT01555463|474293549|FG000|Follow up|Protocol Violation|2|||
131448808|NCT00790842|473272724|FG004|Expansion Cohort|Study Closure|0|||
131807198|NCT00909610|474579508|FG001|Period: Second Intervention|Adverse Event|0|||
131807199|NCT02128997|474579518|FG000|Overall Study|Lost to Follow-up|6|||
131807200|NCT02128997|474579519|FG001|Overall Study|Lost to Follow-up|11|||
131807201|NCT02422264|474579530|FG000|Overall Study|Serious Adverse Event|1|||
131807202|NCT02422264|474579531|FG001|Overall Study|Serious Adverse Event|0|||
131807203|NCT02422264|474579530|FG000|Overall Study|Withdrawal by Subject|1|||
131807204|NCT02422264|474579531|FG001|Overall Study|Withdrawal by Subject|2|||
131807205|NCT02422264|474579530|FG000|Overall Study|Migrated/moved from study area|3|||
131807206|NCT02422264|474579531|FG001|Overall Study|Migrated/moved from study area|1|||
131807207|NCT02422264|474579530|FG000|Overall Study|Subject vaccinated outside of the study|0|||
131807208|NCT02422264|474579531|FG001|Overall Study|Subject vaccinated outside of the study|1|||
131807209|NCT03988803|474579532|FG000|Period 2|Prematurely discontinued from medication|2|||
131807210|NCT03988803|474579532|FG000|Period 2|Adverse Event|1|||
131807211|NCT00851877|474579540|FG000|Phase I-1|Death|1|||
131807212|NCT00851877|474579541|FG001|Phase I-1|Death|0|||
131807213|NCT00851877|474579542|FG002|Phase I-1|Death|0|||
131807214|NCT00851877|474579540|FG000|Phase II|Withdrawal by Subject|0|||
131807215|NCT00851877|474579541|FG001|Phase II|Withdrawal by Subject|0|||
131807216|NCT00851877|474579542|FG002|Phase II|Withdrawal by Subject|3|||
131807217|NCT00829673|474579543|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131807218|NCT00829673|474579544|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131807219|NCT01034358|474579545|FG000|Overall Study|Withdrawal by Subject|1|||
131807220|NCT01034358|474579545|FG000|Overall Study|Protocol Violation|1|||
131807221|NCT01838941|474579546|FG000|Overall Study|Adverse Event|1|||
131807222|NCT01838941|474579546|FG000|Overall Study|Withdrawal by Subject|1|||
131807223|NCT00829790|474579549|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
131807224|NCT00829790|474579550|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
131807225|NCT02246166|474579553|FG000|Overall Study|Protocol Violation|1|||
131807226|NCT02246166|474579554|FG001|Overall Study|Protocol Violation|0|||
131807227|NCT03769896|474579555|FG000|Open-label Phase|Lack of Efficacy|5|||
131807228|NCT03769896|474579556|FG001|Open-label Phase|Lack of Efficacy|0|||
131807229|NCT03769896|474579555|FG000|Open-label Phase|Adverse Event|3|||
131807230|NCT03769896|474579556|FG001|Open-label Phase|Adverse Event|0|||
131807231|NCT03769896|474579555|FG000|Open-label Phase|Withdrawal by Subject|1|||
131807232|NCT03769896|474579556|FG001|Open-label Phase|Withdrawal by Subject|0|||
131807233|NCT00829530|474579557|FG000|First Intervention|Adverse Event|0|||
131807234|NCT00829530|474579558|FG001|First Intervention|Adverse Event|1|||
131807235|NCT00829530|474579557|FG000|First Intervention|Intolerance to Venopuncture|0|||
131807236|NCT00829530|474579558|FG001|First Intervention|Intolerance to Venopuncture|1|||
131807237|NCT00829530|474579557|FG000|Second Intervention|Intolerance to Venopuncture|1|||
131807238|NCT00829530|474579558|FG001|Second Intervention|Intolerance to Venopuncture|0|||
131807239|NCT01015625|474579559|FG000|Overall Study|Lost to Follow-up|3|||
131807240|NCT01015625|474579560|FG001|Overall Study|Lost to Follow-up|1|||
131807241|NCT01015625|474579559|FG000|Overall Study|Withdrawal by Subject|2|||
131448809|NCT00790842|473272725|FG005|Expansion Cohort|Study Closure|0|||
131448810|NCT00790842|473272726|FG006|Expansion Cohort|Study Closure|0|||
131448811|NCT00790842|473272727|FG007|Expansion Cohort|Study Closure|0|||
131731491|NCT01555463|474293550|FG001|Follow up|Protocol Violation|4|||
131731492|NCT01555463|474293549|FG000|Follow up|Other reason|3|||
131731493|NCT01555463|474293550|FG001|Follow up|Other reason|3|||
131731494|NCT02026271|474293551|FG000|Overall Study|Adverse Event|2|||
131731495|NCT02026271|474293552|FG001|Overall Study|Adverse Event|3|||
131731496|NCT02026271|474293553|FG002|Overall Study|Adverse Event|2|||
131731497|NCT02026271|474293554|FG003|Overall Study|Adverse Event|3|||
131731498|NCT02026271|474293555|FG004|Overall Study|Adverse Event|0|||
131731499|NCT02026271|474293551|FG000|Overall Study|Withdrawal by Subject|0|||
131731500|NCT02026271|474293552|FG001|Overall Study|Withdrawal by Subject|0|||
131731501|NCT02026271|474293553|FG002|Overall Study|Withdrawal by Subject|0|||
131731502|NCT02026271|474293554|FG003|Overall Study|Withdrawal by Subject|0|||
131731503|NCT02026271|474293555|FG004|Overall Study|Withdrawal by Subject|1|||
131731504|NCT04370028|474293556|FG000|Overall Study|Withdrawal by Subject|695|||
131731505|NCT04370028|474293556|FG000|Overall Study|Protocol Violation|9|||
131731506|NCT04370028|474293556|FG000|Overall Study|Adverse Event|3|||
131731507|NCT00540449|474293557|FG000|Overall Study|Adverse Event|12|||
131731508|NCT00540449|474293558|FG001|Overall Study|Adverse Event|32|||
131731509|NCT00540449|474293557|FG000|Overall Study|Sponsor's Decision|1|||
131731510|NCT00540449|474293558|FG001|Overall Study|Sponsor's Decision|1|||
131448812|NCT00790842|473272728|FG008|Expansion Cohort|Study Closure|0|||
131731511|NCT00540449|474293557|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
131731512|NCT00540449|474293558|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
131807242|NCT01015625|474579560|FG001|Overall Study|Withdrawal by Subject|3|||
131807243|NCT01015625|474579559|FG000|Overall Study|Physician Decision|2|||
131807244|NCT01015625|474579560|FG001|Overall Study|Physician Decision|0|||
131807245|NCT01015625|474579559|FG000|Overall Study|Death|30|||
131807246|NCT01015625|474579560|FG001|Overall Study|Death|22|||
131807247|NCT00625443|474579561|FG000|Overall Study|Adverse Event|1|||
131807248|NCT00625443|474579562|FG001|Overall Study|Adverse Event|4|||
131448813|NCT00790842|473272729|FG009|Expansion Cohort|Study Closure|0|||
131731513|NCT00540449|474293557|FG000|Overall Study|Lost to Follow-up|19|||
131731514|NCT00540449|474293558|FG001|Overall Study|Lost to Follow-up|17|||
131731515|NCT00540449|474293557|FG000|Overall Study|Subject Non-Compliant|7|||
131731516|NCT00540449|474293558|FG001|Overall Study|Subject Non-Compliant|5|||
131731517|NCT00540449|474293557|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
131731518|NCT00540449|474293558|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
131731519|NCT00540449|474293557|FG000|Overall Study|Withdrawal by Subject|10|||
131731520|NCT00540449|474293558|FG001|Overall Study|Withdrawal by Subject|10|||
131731521|NCT00540449|474293557|FG000|Overall Study|Other|1|||
131731522|NCT00540449|474293558|FG001|Overall Study|Other|4|||
131731523|NCT04491877|474295684|FG000|Overall Study|Protocol Deviation|1|||
131731524|NCT04491877|474295685|FG001|Overall Study|Protocol Deviation|0|||
131731525|NCT04491877|474295686|FG002|Overall Study|Protocol Deviation|2|||
131731526|NCT04491877|474295687|FG003|Overall Study|Protocol Deviation|0|||
131731527|NCT04491877|474295688|FG004|Overall Study|Protocol Deviation|0|||
131731528|NCT04491877|474295689|FG005|Overall Study|Protocol Deviation|0|||
131731529|NCT04491877|474295690|FG006|Overall Study|Protocol Deviation|1|||
131731530|NCT04491877|474295691|FG007|Overall Study|Protocol Deviation|1|||
131731531|NCT04491877|474295692|FG008|Overall Study|Protocol Deviation|0|||
131731532|NCT04491877|474295684|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131731533|NCT04491877|474295685|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131731534|NCT04491877|474295686|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131731535|NCT04491877|474295687|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
131731536|NCT04491877|474295688|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131731537|NCT04491877|474295689|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
131731538|NCT04491877|474295690|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
131731539|NCT04491877|474295691|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
131731540|NCT04491877|474295692|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
131731541|NCT04491877|474295684|FG000|Overall Study|Lost to Follow-up|0|||
131731542|NCT04491877|474295685|FG001|Overall Study|Lost to Follow-up|2|||
131731543|NCT04491877|474295686|FG002|Overall Study|Lost to Follow-up|0|||
131731544|NCT04491877|474295687|FG003|Overall Study|Lost to Follow-up|0|||
131731545|NCT04491877|474295688|FG004|Overall Study|Lost to Follow-up|0|||
131731546|NCT04491877|474295689|FG005|Overall Study|Lost to Follow-up|0|||
131731547|NCT04491877|474295690|FG006|Overall Study|Lost to Follow-up|2|||
131731548|NCT04491877|474295691|FG007|Overall Study|Lost to Follow-up|1|||
131731549|NCT04491877|474295692|FG008|Overall Study|Lost to Follow-up|1|||
131731550|NCT00418834|474295700|FG000|Overall Study|Adverse Event|16|||
131731551|NCT00418834|474295701|FG001|Overall Study|Adverse Event|9|||
131731552|NCT00418834|474295700|FG000|Overall Study|Lost to Follow-up|0|||
131731553|NCT00418834|474295701|FG001|Overall Study|Lost to Follow-up|1|||
131731554|NCT00418834|474295700|FG000|Overall Study|Protocol Violation|4|||
131731555|NCT00418834|474295701|FG001|Overall Study|Protocol Violation|3|||
131731556|NCT00418834|474295700|FG000|Overall Study|Withdrawal by Subject|3|||
131731557|NCT00418834|474295701|FG001|Overall Study|Withdrawal by Subject|7|||
131731558|NCT00423085|474295705|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
131731559|NCT00423085|474295706|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
131731560|NCT00423085|474295707|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
131731561|NCT00423085|474295708|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
131731562|NCT00423085|474295705|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
131731563|NCT00423085|474295706|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
131731564|NCT00423085|474295707|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
131731565|NCT00423085|474295708|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131731566|NCT00423085|474295705|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
131731567|NCT00423085|474295706|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
131731568|NCT00423085|474295707|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
131731569|NCT00423085|474295708|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
131731570|NCT00423085|474295705|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
131731571|NCT00423085|474295706|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
131731572|NCT00423085|474295707|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
131731573|NCT00423085|474295708|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
131731574|NCT00423085|474295705|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
131731575|NCT00423085|474295706|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
131731576|NCT00423085|474295707|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
131731577|NCT00423085|474295708|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
131731578|NCT00423085|474295705|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
131731579|NCT00423085|474295706|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
131731580|NCT00423085|474295707|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
131731581|NCT00423085|474295708|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
131731582|NCT00423085|474295705|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
131731583|NCT00423085|474295706|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
131731584|NCT00423085|474295707|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
131905136|NCT00086190|474939053|FG002|Overall Study|Worsening depression|2|||
131905137|NCT03902613|474939054|FG000|Overall Study|Physician Decision|1|||
131905138|NCT02027025|474939058|FG000|Overall Study|Adverse Event|0|||
131905139|NCT02027025|474939059|FG001|Overall Study|Adverse Event|1|||
131731585|NCT00423085|474295708|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
131731586|NCT00423085|474295705|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
131731587|NCT00423085|474295706|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
131731588|NCT00423085|474295707|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
131731589|NCT00423085|474295708|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
131731590|NCT00423085|474295705|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
131731591|NCT00423085|474295706|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
131731592|NCT00423085|474295707|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
131731593|NCT00423085|474295708|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
131731594|NCT00423085|474295705|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
131731595|NCT00423085|474295706|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
131731596|NCT00423085|474295707|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
131731597|NCT00423085|474295708|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
131731598|NCT00423085|474295705|FG000|52-Week Open-Label Extension Phase|Death|0|||
131731599|NCT00423085|474295706|FG001|52-Week Open-Label Extension Phase|Death|0|||
131731600|NCT00423085|474295707|FG002|52-Week Open-Label Extension Phase|Death|0|||
131731601|NCT00423085|474295708|FG003|52-Week Open-Label Extension Phase|Death|2|||
131731602|NCT00769704|474295709|FG000|Overall Study|Lost to Follow-up|3|||
131731603|NCT00769704|474295710|FG001|Overall Study|Lost to Follow-up|2|||
131731604|NCT00769704|474295709|FG000|Overall Study|Death|95|||
131731605|NCT00769704|474295710|FG001|Overall Study|Death|190|||
131731606|NCT00769704|474295709|FG000|Overall Study|Withdrawal by Subject|12|||
131731607|NCT00769704|474295710|FG001|Overall Study|Withdrawal by Subject|5|||
131731608|NCT00769704|474295709|FG000|Overall Study|Other|1|||
131731609|NCT00769704|474295710|FG001|Overall Study|Other|2|||
131731610|NCT05628181|474295711|FG000|Overall Study|Death|2|||
131731611|NCT05628181|474295712|FG001|Overall Study|Death|4|||
131731612|NCT05628181|474295713|FG002|Overall Study|Death|0|||
131731613|NCT01428063|474295714|FG000|Overall Study|Lack of Efficacy|8|||
131731614|NCT01428063|474295715|FG001|Overall Study|Lack of Efficacy|4|||
131731615|NCT01428063|474295716|FG002|Overall Study|Lack of Efficacy|1|||
131731616|NCT01428063|474295714|FG000|Overall Study|Adverse Event|2|||
131731617|NCT01428063|474295715|FG001|Overall Study|Adverse Event|3|||
131731618|NCT01428063|474295716|FG002|Overall Study|Adverse Event|0|||
131731619|NCT01428063|474295714|FG000|Overall Study|Lost to Follow-up|0|||
131731620|NCT01428063|474295715|FG001|Overall Study|Lost to Follow-up|2|||
131731621|NCT01428063|474295716|FG002|Overall Study|Lost to Follow-up|0|||
131731622|NCT01428063|474295714|FG000|Overall Study|No longer meets study criteria|0|||
131731623|NCT01428063|474295715|FG001|Overall Study|No longer meets study criteria|1|||
131731624|NCT01428063|474295716|FG002|Overall Study|No longer meets study criteria|0|||
131731625|NCT00913978|474295717|FG000|Overall Study|Surgeon choice|1|||
131731626|NCT00913978|474295718|FG001|Overall Study|Surgeon choice|3|||
131731627|NCT01327651|474295722|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
131731628|NCT01327651|474295723|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
131731629|NCT01327651|474295724|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
131731630|NCT01327651|474295725|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
131731631|NCT01327651|474295726|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
131731632|NCT01327651|474295727|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
131731633|NCT01327651|474295728|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
131731634|NCT01327651|474295729|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
131731635|NCT01327651|474295730|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
131731636|NCT01327651|474295722|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
131731637|NCT01327651|474295723|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731638|NCT01327651|474295724|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731639|NCT01327651|474295725|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731640|NCT01327651|474295726|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731641|NCT01327651|474295727|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731642|NCT01327651|474295728|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731643|NCT01327651|474295729|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731644|NCT01327651|474295730|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131731645|NCT01327651|474295722|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
131731646|NCT01327651|474295723|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
131731647|NCT01327651|474295724|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
131731648|NCT01327651|474295725|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
131731649|NCT01327651|474295726|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
131905140|NCT02027025|474939060|FG002|Overall Study|Adverse Event|1|||
131905141|NCT02027025|474939058|FG000|Overall Study|Protocol Violation|1|||
131905142|NCT02027025|474939059|FG001|Overall Study|Protocol Violation|0|||
131731650|NCT01327651|474295727|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
131731651|NCT01327651|474295728|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
131731652|NCT01327651|474295729|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
131731653|NCT01327651|474295730|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
131731654|NCT01327651|474295722|FG000|Post Study Follow-up|Lost to Follow-up|0|||
131731655|NCT01327651|474295723|FG001|Post Study Follow-up|Lost to Follow-up|1|||
131731656|NCT01327651|474295724|FG002|Post Study Follow-up|Lost to Follow-up|1|||
131731657|NCT01327651|474295725|FG003|Post Study Follow-up|Lost to Follow-up|0|||
131731658|NCT01327651|474295726|FG004|Post Study Follow-up|Lost to Follow-up|0|||
131731659|NCT01327651|474295727|FG005|Post Study Follow-up|Lost to Follow-up|0|||
131731660|NCT01327651|474295728|FG006|Post Study Follow-up|Lost to Follow-up|4|||
131807249|NCT00625443|474579563|FG002|Overall Study|Adverse Event|0|||
131731661|NCT01327651|474295729|FG007|Post Study Follow-up|Lost to Follow-up|1|||
131731662|NCT01327651|474295730|FG008|Post Study Follow-up|Lost to Follow-up|2|||
131731663|NCT03249792|474295735|FG000|Arms 1, 2, and 4|Death|1|||
131731664|NCT03249792|474295736|FG001|Arms 1, 2, and 4|Death|1|||
131731665|NCT03249792|474295737|FG002|Arms 1, 2, and 4|Death|0|||
131731666|NCT03249792|474295738|FG003|Arms 1, 2, and 4|Death|2|||
131731667|NCT03249792|474295739|FG004|Arms 1, 2, and 4|Death|3|||
131731668|NCT03249792|474295740|FG005|Arms 1, 2, and 4|Death|2|||
131731669|NCT03249792|474295741|FG006|Arms 1, 2, and 4|Death|2|||
131731670|NCT03249792|474295742|FG007|Arms 1, 2, and 4|Death|4|||
131731671|NCT03249792|474295743|FG008|Arms 1, 2, and 4|Death|2|||
131731672|NCT03249792|474295744|FG009|Arms 1, 2, and 4|Death|1|||
131731673|NCT03249792|474295745|FG010|Arms 1, 2, and 4|Death|7|||
131731674|NCT03249792|474295746|FG011|Arms 1, 2, and 4|Death|7|||
131731675|NCT03249792|474295747|FG012|Arms 1, 2, and 4|Death|12|||
131731676|NCT03249792|474295748|FG013|Arms 1, 2, and 4|Death|7|||
131731677|NCT03249792|474295749|FG014|Arms 1, 2, and 4|Death|0|||
131731678|NCT03249792|474295750|FG015|Arms 1, 2, and 4|Death|4|||
131731679|NCT03249792|474295751|FG016|Arms 1, 2, and 4|Death|4|||
131731680|NCT03249792|474295752|FG017|Arms 1, 2, and 4|Death|12|||
131731681|NCT03249792|474295753|FG018|Arms 1, 2, and 4|Death|6|||
131731682|NCT03249792|474295754|FG019|Arms 1, 2, and 4|Death|4|||
131731683|NCT03249792|474295755|FG020|Arms 1, 2, and 4|Death|2|||
131731684|NCT03249792|474295756|FG021|Arms 1, 2, and 4|Death|3|||
131731685|NCT03249792|474295757|FG022|Arms 1, 2, and 4|Death|1|||
131731686|NCT03249792|474295758|FG023|Arms 1, 2, and 4|Death|1|||
131731687|NCT03249792|474295759|FG024|Arms 1, 2, and 4|Death|4|||
131731688|NCT03249792|474295760|FG025|Arms 1, 2, and 4|Death|0|||
131731689|NCT03249792|474295761|FG026|Arms 1, 2, and 4|Death|0|||
131731690|NCT03249792|474295762|FG027|Arms 1, 2, and 4|Death|0|||
131731691|NCT03249792|474295763|FG028|Arms 1, 2, and 4|Death|0|||
131731692|NCT03249792|474295764|FG029|Arms 1, 2, and 4|Death|0|||
131731693|NCT03249792|474295765|FG030|Arms 1, 2, and 4|Death|0|||
131731694|NCT03249792|474295766|FG031|Arms 1, 2, and 4|Death|0|||
131731695|NCT03249792|474295767|FG032|Arms 1, 2, and 4|Death|0|||
131731696|NCT03249792|474295735|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731697|NCT03249792|474295736|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731698|NCT03249792|474295737|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131731699|NCT03249792|474295738|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731700|NCT03249792|474295739|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731701|NCT03249792|474295740|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131731702|NCT03249792|474295741|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
131731703|NCT03249792|474295742|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731704|NCT03249792|474295743|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
131731705|NCT03249792|474295744|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131731706|NCT03249792|474295745|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
131731707|NCT03249792|474295746|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
131731708|NCT03249792|474295747|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
131731709|NCT03249792|474295748|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
131731710|NCT03249792|474295749|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731711|NCT03249792|474295750|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731712|NCT03249792|474295751|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
131731713|NCT03249792|474295752|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731714|NCT03249792|474295753|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131731715|NCT03249792|474295754|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731716|NCT03249792|474295755|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731717|NCT03249792|474295756|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731718|NCT03249792|474295757|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131731719|NCT03249792|474295758|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131731720|NCT03249792|474295759|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731721|NCT03249792|474295760|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731722|NCT03249792|474295761|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731723|NCT03249792|474295762|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731724|NCT03249792|474295763|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731725|NCT03249792|474295764|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731726|NCT03249792|474295765|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731727|NCT03249792|474295766|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731728|NCT03249792|474295767|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131731729|NCT03249792|474295735|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
131731730|NCT03249792|474295736|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
131731731|NCT03249792|474295737|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
131731732|NCT03249792|474295738|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
131731733|NCT03249792|474295739|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
131731734|NCT03249792|474295740|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
131731735|NCT03249792|474295741|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
131731736|NCT03249792|474295742|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
131731737|NCT03249792|474295743|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
131731738|NCT03249792|474295744|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
131731739|NCT03249792|474295745|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
131731740|NCT03249792|474295746|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
131731741|NCT03249792|474295747|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
131731742|NCT03249792|474295748|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
131731743|NCT03249792|474295749|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
131731744|NCT03249792|474295750|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
131731745|NCT03249792|474295751|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
131731746|NCT03249792|474295752|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
131731747|NCT03249792|474295753|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
131731748|NCT03249792|474295754|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
131731749|NCT03249792|474295755|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
131731750|NCT03249792|474295756|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
131731751|NCT03249792|474295757|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
131731752|NCT03249792|474295758|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
131731753|NCT03249792|474295759|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
131731754|NCT03249792|474295760|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
131731755|NCT03249792|474295761|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
131731756|NCT03249792|474295762|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
131731757|NCT03249792|474295763|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
131731758|NCT03249792|474295764|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
131731759|NCT03249792|474295765|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
131731760|NCT03249792|474295766|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
131731761|NCT03249792|474295767|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
131731762|NCT03249792|474295735|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731763|NCT03249792|474295736|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731764|NCT03249792|474295737|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731765|NCT03249792|474295738|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731766|NCT03249792|474295739|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731767|NCT03249792|474295740|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731768|NCT03249792|474295741|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731769|NCT03249792|474295742|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731770|NCT03249792|474295743|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
131731771|NCT03249792|474295744|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731772|NCT03249792|474295745|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731773|NCT03249792|474295746|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731774|NCT03249792|474295747|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731775|NCT03249792|474295748|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731776|NCT03249792|474295749|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731777|NCT03249792|474295750|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731778|NCT03249792|474295751|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
131731779|NCT03249792|474295752|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
131731780|NCT03249792|474295753|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731781|NCT03249792|474295754|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
131731782|NCT03249792|474295755|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731783|NCT03249792|474295756|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731784|NCT03249792|474295757|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731785|NCT03249792|474295758|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731786|NCT03249792|474295759|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731787|NCT03249792|474295760|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731788|NCT03249792|474295761|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731789|NCT03249792|474295762|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731790|NCT03249792|474295763|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731791|NCT03249792|474295764|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731792|NCT03249792|474295765|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731793|NCT03249792|474295766|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731794|NCT03249792|474295767|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
131731795|NCT03249792|474295735|FG000|Switch Over Period|Withdrawal by Subject|0|||
131731796|NCT03249792|474295736|FG001|Switch Over Period|Withdrawal by Subject|0|||
131731797|NCT03249792|474295737|FG002|Switch Over Period|Withdrawal by Subject|0|||
131731798|NCT03249792|474295738|FG003|Switch Over Period|Withdrawal by Subject|0|||
131731799|NCT03249792|474295739|FG004|Switch Over Period|Withdrawal by Subject|0|||
131731800|NCT03249792|474295740|FG005|Switch Over Period|Withdrawal by Subject|0|||
131731801|NCT03249792|474295741|FG006|Switch Over Period|Withdrawal by Subject|0|||
131731802|NCT03249792|474295742|FG007|Switch Over Period|Withdrawal by Subject|0|||
131731803|NCT03249792|474295743|FG008|Switch Over Period|Withdrawal by Subject|0|||
131731804|NCT03249792|474295744|FG009|Switch Over Period|Withdrawal by Subject|0|||
131731805|NCT03249792|474295745|FG010|Switch Over Period|Withdrawal by Subject|0|||
131731806|NCT03249792|474295746|FG011|Switch Over Period|Withdrawal by Subject|0|||
131731807|NCT03249792|474295747|FG012|Switch Over Period|Withdrawal by Subject|0|||
131731808|NCT03249792|474295748|FG013|Switch Over Period|Withdrawal by Subject|0|||
131731809|NCT03249792|474295749|FG014|Switch Over Period|Withdrawal by Subject|0|||
131731810|NCT03249792|474295750|FG015|Switch Over Period|Withdrawal by Subject|0|||
131731811|NCT03249792|474295751|FG016|Switch Over Period|Withdrawal by Subject|0|||
131731812|NCT03249792|474295752|FG017|Switch Over Period|Withdrawal by Subject|0|||
131731813|NCT03249792|474295753|FG018|Switch Over Period|Withdrawal by Subject|0|||
131731814|NCT03249792|474295754|FG019|Switch Over Period|Withdrawal by Subject|0|||
131731815|NCT03249792|474295755|FG020|Switch Over Period|Withdrawal by Subject|0|||
131731816|NCT03249792|474295756|FG021|Switch Over Period|Withdrawal by Subject|0|||
131731817|NCT03249792|474295757|FG022|Switch Over Period|Withdrawal by Subject|0|||
131731818|NCT03249792|474295758|FG023|Switch Over Period|Withdrawal by Subject|0|||
131731819|NCT03249792|474295759|FG024|Switch Over Period|Withdrawal by Subject|0|||
131731820|NCT03249792|474295760|FG025|Switch Over Period|Withdrawal by Subject|0|||
131731821|NCT03249792|474295761|FG026|Switch Over Period|Withdrawal by Subject|0|||
131731822|NCT03249792|474295762|FG027|Switch Over Period|Withdrawal by Subject|0|||
131731823|NCT03249792|474295763|FG028|Switch Over Period|Withdrawal by Subject|0|||
131731824|NCT03249792|474295764|FG029|Switch Over Period|Withdrawal by Subject|0|||
131731825|NCT03249792|474295765|FG030|Switch Over Period|Withdrawal by Subject|0|||
131731826|NCT03249792|474295766|FG031|Switch Over Period|Withdrawal by Subject|1|||
131731827|NCT03249792|474295767|FG032|Switch Over Period|Withdrawal by Subject|0|||
131731828|NCT03249792|474295735|FG000|Switch Over Period|Progressive Disease|0|||
131731829|NCT03249792|474295736|FG001|Switch Over Period|Progressive Disease|0|||
131731830|NCT03249792|474295737|FG002|Switch Over Period|Progressive Disease|0|||
131731831|NCT03249792|474295738|FG003|Switch Over Period|Progressive Disease|0|||
131731832|NCT03249792|474295739|FG004|Switch Over Period|Progressive Disease|0|||
131731833|NCT03249792|474295740|FG005|Switch Over Period|Progressive Disease|0|||
131731834|NCT03249792|474295741|FG006|Switch Over Period|Progressive Disease|0|||
131731835|NCT03249792|474295742|FG007|Switch Over Period|Progressive Disease|0|||
131731836|NCT03249792|474295743|FG008|Switch Over Period|Progressive Disease|0|||
131731837|NCT03249792|474295744|FG009|Switch Over Period|Progressive Disease|0|||
131731838|NCT03249792|474295745|FG010|Switch Over Period|Progressive Disease|0|||
131731839|NCT03249792|474295746|FG011|Switch Over Period|Progressive Disease|0|||
131731840|NCT03249792|474295747|FG012|Switch Over Period|Progressive Disease|0|||
131731841|NCT03249792|474295748|FG013|Switch Over Period|Progressive Disease|0|||
131731842|NCT03249792|474295749|FG014|Switch Over Period|Progressive Disease|0|||
131731843|NCT03249792|474295750|FG015|Switch Over Period|Progressive Disease|0|||
131731844|NCT03249792|474295751|FG016|Switch Over Period|Progressive Disease|0|||
131731845|NCT03249792|474295752|FG017|Switch Over Period|Progressive Disease|0|||
131731846|NCT03249792|474295753|FG018|Switch Over Period|Progressive Disease|0|||
131731847|NCT03249792|474295754|FG019|Switch Over Period|Progressive Disease|0|||
131731848|NCT03249792|474295755|FG020|Switch Over Period|Progressive Disease|0|||
131731849|NCT03249792|474295756|FG021|Switch Over Period|Progressive Disease|0|||
131731850|NCT03249792|474295757|FG022|Switch Over Period|Progressive Disease|0|||
131731851|NCT03249792|474295758|FG023|Switch Over Period|Progressive Disease|0|||
131731852|NCT03249792|474295759|FG024|Switch Over Period|Progressive Disease|0|||
131731853|NCT03249792|474295760|FG025|Switch Over Period|Progressive Disease|0|||
131731854|NCT03249792|474295761|FG026|Switch Over Period|Progressive Disease|1|||
131731855|NCT03249792|474295762|FG027|Switch Over Period|Progressive Disease|0|||
131731856|NCT03249792|474295763|FG028|Switch Over Period|Progressive Disease|1|||
131731857|NCT03249792|474295764|FG029|Switch Over Period|Progressive Disease|2|||
131731858|NCT03249792|474295765|FG030|Switch Over Period|Progressive Disease|1|||
131731859|NCT03249792|474295766|FG031|Switch Over Period|Progressive Disease|0|||
131731860|NCT03249792|474295767|FG032|Switch Over Period|Progressive Disease|1|||
131731861|NCT03249792|474295735|FG000|Switch Over Period|Adverse Event|0|||
131731862|NCT03249792|474295736|FG001|Switch Over Period|Adverse Event|0|||
131731863|NCT03249792|474295737|FG002|Switch Over Period|Adverse Event|0|||
131731864|NCT03249792|474295738|FG003|Switch Over Period|Adverse Event|0|||
131731865|NCT03249792|474295739|FG004|Switch Over Period|Adverse Event|0|||
131731866|NCT03249792|474295740|FG005|Switch Over Period|Adverse Event|0|||
131731867|NCT03249792|474295741|FG006|Switch Over Period|Adverse Event|0|||
131731868|NCT03249792|474295742|FG007|Switch Over Period|Adverse Event|0|||
131731869|NCT03249792|474295743|FG008|Switch Over Period|Adverse Event|0|||
131731870|NCT03249792|474295744|FG009|Switch Over Period|Adverse Event|0|||
131731871|NCT03249792|474295745|FG010|Switch Over Period|Adverse Event|0|||
131731872|NCT03249792|474295746|FG011|Switch Over Period|Adverse Event|0|||
131731873|NCT03249792|474295747|FG012|Switch Over Period|Adverse Event|0|||
131731874|NCT03249792|474295748|FG013|Switch Over Period|Adverse Event|0|||
131731875|NCT03249792|474295749|FG014|Switch Over Period|Adverse Event|0|||
131731876|NCT03249792|474295750|FG015|Switch Over Period|Adverse Event|0|||
131731877|NCT03249792|474295751|FG016|Switch Over Period|Adverse Event|0|||
131731878|NCT03249792|474295752|FG017|Switch Over Period|Adverse Event|0|||
131731879|NCT03249792|474295753|FG018|Switch Over Period|Adverse Event|0|||
131731880|NCT03249792|474295754|FG019|Switch Over Period|Adverse Event|0|||
131731881|NCT03249792|474295755|FG020|Switch Over Period|Adverse Event|0|||
131731882|NCT03249792|474295756|FG021|Switch Over Period|Adverse Event|0|||
131731883|NCT03249792|474295757|FG022|Switch Over Period|Adverse Event|0|||
131731884|NCT03249792|474295758|FG023|Switch Over Period|Adverse Event|0|||
131731885|NCT03249792|474295759|FG024|Switch Over Period|Adverse Event|0|||
131731886|NCT03249792|474295760|FG025|Switch Over Period|Adverse Event|1|||
131731887|NCT03249792|474295761|FG026|Switch Over Period|Adverse Event|0|||
131731888|NCT03249792|474295762|FG027|Switch Over Period|Adverse Event|1|||
131731889|NCT03249792|474295763|FG028|Switch Over Period|Adverse Event|0|||
131731890|NCT03249792|474295764|FG029|Switch Over Period|Adverse Event|0|||
131731891|NCT03249792|474295765|FG030|Switch Over Period|Adverse Event|0|||
131731892|NCT03249792|474295766|FG031|Switch Over Period|Adverse Event|0|||
131731893|NCT03249792|474295767|FG032|Switch Over Period|Adverse Event|0|||
131731894|NCT02284906|474295770|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131807250|NCT00625443|474579561|FG000|Overall Study|Non-compliance with protocol|0|||
131807251|NCT00625443|474579562|FG001|Overall Study|Non-compliance with protocol|1|||
131807252|NCT00625443|474579563|FG002|Overall Study|Non-compliance with protocol|0|||
131807253|NCT00625443|474579561|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
131807254|NCT00625443|474579562|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
131807255|NCT00625443|474579563|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
131807256|NCT00625443|474579561|FG000|Overall Study|Withdrawal by Subject|0|||
131807257|NCT00625443|474579562|FG001|Overall Study|Withdrawal by Subject|1|||
131807258|NCT00625443|474579563|FG002|Overall Study|Withdrawal by Subject|2|||
131807259|NCT00625443|474579561|FG000|Overall Study|Physician Decision|0|||
131807260|NCT00625443|474579562|FG001|Overall Study|Physician Decision|4|||
131807261|NCT00625443|474579563|FG002|Overall Study|Physician Decision|2|||
131807262|NCT00625443|474579561|FG000|Overall Study|Other|0|||
131807263|NCT00625443|474579562|FG001|Overall Study|Other|1|||
131807264|NCT00625443|474579563|FG002|Overall Study|Other|1|||
131807265|NCT02472366|474579564|FG000|Overall Study|Lost to Follow-up|1|||
131807266|NCT02472366|474579565|FG001|Overall Study|Lost to Follow-up|0|||
131807267|NCT02587962|474579567|FG000|Overall Study|Adverse Event|0|||
131905143|NCT02027025|474939060|FG002|Overall Study|Protocol Violation|0|||
131905144|NCT02027025|474939058|FG000|Overall Study|Lost to Follow-up|0|||
131731895|NCT02284906|474295771|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131731896|NCT02284906|474295772|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131731897|NCT02284906|474295770|FG000|Overall Study|Major Protocol Deviation|0|||
131731898|NCT02284906|474295771|FG001|Overall Study|Major Protocol Deviation|1|||
131731899|NCT02284906|474295772|FG002|Overall Study|Major Protocol Deviation|0|||
131731900|NCT02284906|474295770|FG000|Overall Study|Voluntary Withdrawal|2|||
131731901|NCT02284906|474295771|FG001|Overall Study|Voluntary Withdrawal|4|||
131731902|NCT02284906|474295772|FG002|Overall Study|Voluntary Withdrawal|5|||
131731903|NCT02284906|474295770|FG000|Overall Study|Study Termination|0|||
131731904|NCT02284906|474295771|FG001|Overall Study|Study Termination|11|||
131731905|NCT02284906|474295772|FG002|Overall Study|Study Termination|14|||
131731906|NCT02284906|474295770|FG000|Overall Study|Reason not Specified|1|||
131731907|NCT02284906|474295771|FG001|Overall Study|Reason not Specified|1|||
131731908|NCT02284906|474295772|FG002|Overall Study|Reason not Specified|0|||
131905145|NCT02027025|474939059|FG001|Overall Study|Lost to Follow-up|2|||
131905146|NCT02027025|474939060|FG002|Overall Study|Lost to Follow-up|0|||
131905147|NCT02027025|474939058|FG000|Overall Study|Withdrawal by Subject|0|||
131731909|NCT00316303|474295775|FG000|Overall Study|Lost to Follow-up|11|||
131731910|NCT00316303|474295776|FG001|Overall Study|Lost to Follow-up|16|||
131731911|NCT00850759|474295777|FG000|Overall Study|Lost to Follow-up|7|||
131731912|NCT00850759|474295778|FG001|Overall Study|Lost to Follow-up|5|||
131731913|NCT00850759|474295779|FG002|Overall Study|Lost to Follow-up|5|||
131731914|NCT00850759|474295780|FG003|Overall Study|Lost to Follow-up|3|||
131807268|NCT02587962|474579568|FG001|Overall Study|Adverse Event|0|||
131807269|NCT02587962|474579569|FG002|Overall Study|Adverse Event|1|||
131905148|NCT02027025|474939059|FG001|Overall Study|Withdrawal by Subject|1|||
131905149|NCT02027025|474939060|FG002|Overall Study|Withdrawal by Subject|0|||
131731915|NCT00532948|474295781|FG000|Overall Study|Protocol Violation|1|||
131731916|NCT00532948|474295782|FG001|Overall Study|Protocol Violation|0|||
131731917|NCT00532948|474295783|FG002|Overall Study|Protocol Violation|0|||
131731918|NCT00532948|474295781|FG000|Overall Study|Death|3|||
131807270|NCT02587962|474579570|FG003|Overall Study|Adverse Event|0|||
131807271|NCT02587962|474579571|FG004|Overall Study|Adverse Event|0|||
131905150|NCT02027025|474939058|FG000|Overall Study|Sponsor's decision|0|||
131731919|NCT00532948|474295782|FG001|Overall Study|Death|3|||
131807272|NCT02587962|474579567|FG000|Overall Study|Withdrawal by Subject|0|||
131807273|NCT02587962|474579568|FG001|Overall Study|Withdrawal by Subject|0|||
131807274|NCT02587962|474579569|FG002|Overall Study|Withdrawal by Subject|1|||
131807275|NCT02587962|474579570|FG003|Overall Study|Withdrawal by Subject|1|||
131807276|NCT02587962|474579571|FG004|Overall Study|Withdrawal by Subject|4|||
131807277|NCT02587962|474579567|FG000|Overall Study|Radiological progression|2|||
131807278|NCT02587962|474579568|FG001|Overall Study|Radiological progression|2|||
131807279|NCT02587962|474579569|FG002|Overall Study|Radiological progression|2|||
131807280|NCT02587962|474579570|FG003|Overall Study|Radiological progression|5|||
131807281|NCT02587962|474579571|FG004|Overall Study|Radiological progression|10|||
131807282|NCT02587962|474579567|FG000|Overall Study|Clinical progression|0|||
131807283|NCT02587962|474579568|FG001|Overall Study|Clinical progression|1|||
131807284|NCT02587962|474579569|FG002|Overall Study|Clinical progression|2|||
131807285|NCT02587962|474579570|FG003|Overall Study|Clinical progression|0|||
131807286|NCT02587962|474579571|FG004|Overall Study|Clinical progression|1|||
131807287|NCT02770820|474579573|FG000|Overall Study|Death|1|||
131807288|NCT02770820|474579573|FG000|Overall Study|Physician Decision|2|||
131807289|NCT01061866|474579574|FG000|Overall Study|Adverse Event|2|||
131807290|NCT00579670|474579576|FG000|Overall Study|Death|1|||
131807291|NCT00579670|474579577|FG001|Overall Study|Death|0|||
131807292|NCT00579670|474579578|FG002|Overall Study|Death|0|||
131807293|NCT00579670|474579579|FG003|Overall Study|Death|0|||
131807294|NCT00579670|474579580|FG004|Overall Study|Death|0|||
131807295|NCT00579670|474579576|FG000|Overall Study|Adverse Event|1|||
131807296|NCT00579670|474579577|FG001|Overall Study|Adverse Event|0|||
131807297|NCT00579670|474579578|FG002|Overall Study|Adverse Event|1|||
131807298|NCT00579670|474579579|FG003|Overall Study|Adverse Event|2|||
131807299|NCT00579670|474579580|FG004|Overall Study|Adverse Event|0|||
131807300|NCT00579670|474579576|FG000|Overall Study|Lack of Efficacy|0|||
131807301|NCT00579670|474579577|FG001|Overall Study|Lack of Efficacy|0|||
131807302|NCT00579670|474579578|FG002|Overall Study|Lack of Efficacy|1|||
131807303|NCT00579670|474579579|FG003|Overall Study|Lack of Efficacy|14|||
131807304|NCT00579670|474579580|FG004|Overall Study|Lack of Efficacy|0|||
131807305|NCT00579670|474579576|FG000|Overall Study|Lost to Follow-up|0|||
131731920|NCT00532948|474295783|FG002|Overall Study|Death|4|||
131731921|NCT00532948|474295781|FG000|Overall Study|Violation of selection criteria at entry|0|||
131731922|NCT00532948|474295782|FG001|Overall Study|Violation of selection criteria at entry|1|||
131731923|NCT00532948|474295783|FG002|Overall Study|Violation of selection criteria at entry|0|||
131731924|NCT00532948|474295781|FG000|Overall Study|Failure to return|0|||
131731925|NCT00532948|474295782|FG001|Overall Study|Failure to return|1|||
131731926|NCT00532948|474295783|FG002|Overall Study|Failure to return|0|||
131731927|NCT02918266|474295784|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
131731928|NCT02918266|474295785|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731929|NCT02918266|474295786|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731930|NCT02918266|474295787|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731931|NCT02918266|474295788|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731932|NCT02918266|474295789|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731933|NCT02918266|474295790|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
131731934|NCT02918266|474295791|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731935|NCT02918266|474295792|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
131731936|NCT02918266|474295793|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731937|NCT02918266|474295794|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131731938|NCT01259856|474295801|FG000|Overall Study|Adverse Event|12|||
131731939|NCT01259856|474295802|FG001|Overall Study|Adverse Event|9|||
131731940|NCT01259856|474295801|FG000|Overall Study|Death|0|||
131731941|NCT01259856|474295802|FG001|Overall Study|Death|1|||
131731942|NCT01259856|474295801|FG000|Overall Study|Lack of Efficacy|3|||
131731943|NCT01259856|474295802|FG001|Overall Study|Lack of Efficacy|1|||
131731944|NCT01259856|474295801|FG000|Overall Study|Lost to Follow-up|1|||
131731945|NCT01259856|474295802|FG001|Overall Study|Lost to Follow-up|1|||
131731946|NCT01259856|474295801|FG000|Overall Study|Physician Decision|2|||
131731947|NCT01259856|474295802|FG001|Overall Study|Physician Decision|1|||
131807306|NCT00579670|474579577|FG001|Overall Study|Lost to Follow-up|1|||
131807307|NCT00579670|474579578|FG002|Overall Study|Lost to Follow-up|0|||
131807308|NCT00579670|474579579|FG003|Overall Study|Lost to Follow-up|4|||
131807309|NCT00579670|474579580|FG004|Overall Study|Lost to Follow-up|0|||
131731948|NCT01259856|474295801|FG000|Overall Study|Withdrawal by Subject|9|||
131731949|NCT01259856|474295802|FG001|Overall Study|Withdrawal by Subject|10|||
131731950|NCT01259856|474295801|FG000|Overall Study|Treatment never started|0|||
131807310|NCT00579670|474579576|FG000|Overall Study|Other|0|||
131807311|NCT00579670|474579577|FG001|Overall Study|Other|0|||
131807312|NCT00579670|474579578|FG002|Overall Study|Other|1|||
131807313|NCT00579670|474579579|FG003|Overall Study|Other|2|||
131807314|NCT00579670|474579580|FG004|Overall Study|Other|0|||
131807315|NCT00579670|474579576|FG000|Overall Study|Withdrawal by Subject|0|||
131807316|NCT00579670|474579577|FG001|Overall Study|Withdrawal by Subject|0|||
131807317|NCT00579670|474579578|FG002|Overall Study|Withdrawal by Subject|1|||
131448814|NCT00790842|473272730|FG010|Expansion Cohort|Study Closure|0|||
131448815|NCT00419952|473272731|FG000|Overall Study|Adverse Event|8|||
131731951|NCT01259856|474295802|FG001|Overall Study|Treatment never started|6|||
131731952|NCT01259856|474295801|FG000|Overall Study|Study closure by sponsor|40|||
131731953|NCT01259856|474295802|FG001|Overall Study|Study closure by sponsor|41|||
131731954|NCT01259856|474295801|FG000|Overall Study|Patient developed other disease|0|||
131731955|NCT01259856|474295802|FG001|Overall Study|Patient developed other disease|1|||
131731956|NCT01259856|474295801|FG000|Overall Study|Transfer to another study|0|||
131731957|NCT01259856|474295802|FG001|Overall Study|Transfer to another study|1|||
131731958|NCT01259856|474295801|FG000|Overall Study|Unknown/missing|2|||
131731959|NCT01259856|474295802|FG001|Overall Study|Unknown/missing|2|||
131731960|NCT00578864|474295803|FG000|Overall Study|Death|1|||
131731961|NCT00578864|474295804|FG001|Overall Study|Death|0|||
131731962|NCT01253044|474295805|FG000|Overall Study|Lost to Follow-up|38|||
131731963|NCT01253044|474295806|FG001|Overall Study|Lost to Follow-up|29|||
131731964|NCT01087528|474295807|FG000|Overall Study|Withdrawal by Subject|1|||
131731965|NCT01087528|474295807|FG000|Overall Study|Incomplete CE procedure|6|||
131731966|NCT00905307|474295812|FG000|Overall Study|Switched to Open Label Rescue|7|||
131731967|NCT00905307|474295813|FG001|Overall Study|Switched to Open Label Rescue|17|||
131731968|NCT00905307|474295814|FG002|Overall Study|Switched to Open Label Rescue|11|||
131731969|NCT00905307|474295815|FG003|Overall Study|Switched to Open Label Rescue|11|||
131731970|NCT00905307|474295816|FG004|Overall Study|Switched to Open Label Rescue|4|||
131731971|NCT00905307|474295817|FG005|Overall Study|Switched to Open Label Rescue|15|||
131731972|NCT00905307|474295812|FG000|Overall Study|Lost to Follow-up|0|||
131731973|NCT00905307|474295813|FG001|Overall Study|Lost to Follow-up|0|||
131731974|NCT00905307|474295814|FG002|Overall Study|Lost to Follow-up|0|||
131731975|NCT00905307|474295815|FG003|Overall Study|Lost to Follow-up|0|||
131731976|NCT00905307|474295816|FG004|Overall Study|Lost to Follow-up|1|||
131731977|NCT00905307|474295817|FG005|Overall Study|Lost to Follow-up|1|||
131731978|NCT00905307|474295812|FG000|Overall Study|Adverse Event|3|||
131731979|NCT00905307|474295813|FG001|Overall Study|Adverse Event|4|||
131731980|NCT00905307|474295814|FG002|Overall Study|Adverse Event|5|||
131731981|NCT00905307|474295815|FG003|Overall Study|Adverse Event|11|||
131731982|NCT00905307|474295816|FG004|Overall Study|Adverse Event|3|||
131731983|NCT00905307|474295817|FG005|Overall Study|Adverse Event|5|||
131731984|NCT00905307|474295812|FG000|Overall Study|Withdrawal by Subject|5|||
131731985|NCT00905307|474295813|FG001|Overall Study|Withdrawal by Subject|13|||
131731986|NCT00905307|474295814|FG002|Overall Study|Withdrawal by Subject|15|||
131731987|NCT00905307|474295815|FG003|Overall Study|Withdrawal by Subject|11|||
131731988|NCT00905307|474295816|FG004|Overall Study|Withdrawal by Subject|4|||
131731989|NCT00905307|474295817|FG005|Overall Study|Withdrawal by Subject|13|||
131731990|NCT00905307|474295812|FG000|Overall Study|Protocol Violation|1|||
131731991|NCT00905307|474295813|FG001|Overall Study|Protocol Violation|0|||
131731992|NCT00905307|474295814|FG002|Overall Study|Protocol Violation|1|||
131731993|NCT00905307|474295815|FG003|Overall Study|Protocol Violation|0|||
131731994|NCT00905307|474295816|FG004|Overall Study|Protocol Violation|0|||
131731995|NCT00905307|474295817|FG005|Overall Study|Protocol Violation|0|||
131731996|NCT00905307|474295812|FG000|Overall Study|Lack of Efficacy|6|||
131731997|NCT00905307|474295813|FG001|Overall Study|Lack of Efficacy|3|||
131731998|NCT00905307|474295814|FG002|Overall Study|Lack of Efficacy|5|||
131731999|NCT00905307|474295815|FG003|Overall Study|Lack of Efficacy|4|||
131732000|NCT00905307|474295816|FG004|Overall Study|Lack of Efficacy|4|||
131732001|NCT00905307|474295817|FG005|Overall Study|Lack of Efficacy|8|||
131732002|NCT04060667|474295819|FG000|Overall Study|Lost to Follow-up|75|||
131732003|NCT04060667|474295820|FG001|Overall Study|Lost to Follow-up|10|||
131732004|NCT01201798|474295823|FG000|Overall Study|Adverse Event|2|||
131732005|NCT01201798|474295824|FG001|Overall Study|Adverse Event|0|||
131732006|NCT01201798|474295823|FG000|Overall Study|Lost to Follow-up|3|||
131732007|NCT01201798|474295824|FG001|Overall Study|Lost to Follow-up|5|||
131732008|NCT01201798|474295823|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
131732009|NCT01201798|474295824|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
131732010|NCT01201798|474295823|FG000|Overall Study|Noncompliance|1|||
131732011|NCT01201798|474295824|FG001|Overall Study|Noncompliance|0|||
131732012|NCT01201798|474295823|FG000|Overall Study|Protocol Violation|1|||
131732013|NCT01201798|474295824|FG001|Overall Study|Protocol Violation|1|||
131732014|NCT01201798|474295823|FG000|Overall Study|Treatment Failure|1|||
131732015|NCT01201798|474295824|FG001|Overall Study|Treatment Failure|8|||
131448816|NCT00419952|473272732|FG001|Overall Study|Adverse Event|10|||
131732016|NCT00525148|474295830|FG000|Overall Study|Other Adverse Event|3|||
131732017|NCT00525148|474295831|FG001|Overall Study|Other Adverse Event|5|||
131732018|NCT00525148|474295832|FG002|Overall Study|Other Adverse Event|1|||
131732019|NCT00525148|474295833|FG003|Overall Study|Other Adverse Event|8|||
131732020|NCT00525148|474295830|FG000|Overall Study|Progressive disease|18|||
131732021|NCT00525148|474295831|FG001|Overall Study|Progressive disease|30|||
131732022|NCT00525148|474295832|FG002|Overall Study|Progressive disease|6|||
131732023|NCT00525148|474295833|FG003|Overall Study|Progressive disease|49|||
131732024|NCT00525148|474295830|FG000|Overall Study|Refused continuation of study medication|0|||
131732025|NCT00525148|474295831|FG001|Overall Study|Refused continuation of study medication|2|||
131732026|NCT00525148|474295832|FG002|Overall Study|Refused continuation of study medication|0|||
131732027|NCT00525148|474295833|FG003|Overall Study|Refused continuation of study medication|1|||
131732028|NCT00525148|474295830|FG000|Overall Study|Other than stated|2|||
131732029|NCT00525148|474295831|FG001|Overall Study|Other than stated|1|||
131732030|NCT00525148|474295832|FG002|Overall Study|Other than stated|0|||
131732031|NCT00525148|474295833|FG003|Overall Study|Other than stated|3|||
131732032|NCT01035255|474295837|FG000|Overall Study|Death|724|||
131732033|NCT01035255|474295838|FG001|Overall Study|Death|844|||
131732034|NCT01035255|474295837|FG000|Overall Study|Lost to Follow-up|2|||
131732035|NCT01035255|474295838|FG001|Overall Study|Lost to Follow-up|5|||
131732036|NCT01035255|474295837|FG000|Overall Study|patient's request|15|||
131732037|NCT01035255|474295838|FG001|Overall Study|patient's request|13|||
131732038|NCT01912729|474295839|FG000|Overall Study|Withdrawal by Subject|0|||
131732039|NCT01912729|474295840|FG001|Overall Study|Withdrawal by Subject|1|||
131732040|NCT00195260|474295842|FG000|Part 1: Dose Escalation|Adverse Event|0|||
131732041|NCT00195260|474295843|FG001|Part 1: Dose Escalation|Adverse Event|1|||
131732042|NCT00195260|474295844|FG002|Part 1: Dose Escalation|Adverse Event|0|||
131732043|NCT00195260|474295845|FG003|Part 1: Dose Escalation|Adverse Event|1|||
131732044|NCT00195260|474295846|FG004|Part 1: Dose Escalation|Adverse Event|1|||
131732045|NCT00195260|474295847|FG005|Part 1: Dose Escalation|Adverse Event|0|||
131732046|NCT00195260|474295848|FG006|Part 1: Dose Escalation|Adverse Event|3|||
131732047|NCT00195260|474295849|FG007|Part 1: Dose Escalation|Adverse Event|0|||
131732048|NCT00195260|474295850|FG008|Part 1: Dose Escalation|Adverse Event|0|||
131732049|NCT00195260|474295851|FG009|Part 1: Dose Escalation|Adverse Event|0|||
131732050|NCT00195260|474295852|FG010|Part 1: Dose Escalation|Adverse Event|0|||
131732051|NCT00195260|474295842|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732052|NCT00195260|474295843|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732053|NCT00195260|474295844|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732054|NCT00195260|474295845|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732055|NCT00195260|474295846|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131732056|NCT00195260|474295847|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732057|NCT00195260|474295848|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732058|NCT00195260|474295849|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
131732059|NCT00195260|474295850|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732060|NCT00195260|474295851|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732061|NCT00195260|474295852|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131732062|NCT00195260|474295842|FG000|Part 1: Dose Escalation|Death|0|||
131732063|NCT00195260|474295843|FG001|Part 1: Dose Escalation|Death|0|||
131732064|NCT00195260|474295844|FG002|Part 1: Dose Escalation|Death|0|||
131732065|NCT00195260|474295845|FG003|Part 1: Dose Escalation|Death|0|||
131732066|NCT00195260|474295846|FG004|Part 1: Dose Escalation|Death|0|||
131732067|NCT00195260|474295847|FG005|Part 1: Dose Escalation|Death|0|||
131807318|NCT00579670|474579579|FG003|Overall Study|Withdrawal by Subject|0|||
131807319|NCT00579670|474579580|FG004|Overall Study|Withdrawal by Subject|0|||
131807320|NCT00850174|474579587|FG000|Washout: One Week|Withdrawal by Subject|0|||
131807321|NCT00850174|474579588|FG001|Washout: One Week|Withdrawal by Subject|2|||
131807322|NCT00850174|474579587|FG000|Second Intervention|Withdrawal by Subject|1|||
131807323|NCT00850174|474579588|FG001|Second Intervention|Withdrawal by Subject|0|||
131807324|NCT01900626|474579591|FG000|Overall Study|study was closed due to low enrollment|1|||
131807325|NCT01900626|474579592|FG001|Overall Study|study was closed due to low enrollment|1|||
131807326|NCT02682784|474579600|FG000|Overall Study|Withdrawal by Subject|0|||
131807327|NCT02682784|474579601|FG001|Overall Study|Withdrawal by Subject|2|||
131807328|NCT02682784|474579602|FG002|Overall Study|Withdrawal by Subject|1|||
131807329|NCT02682784|474579603|FG003|Overall Study|Withdrawal by Subject|2|||
131807330|NCT02682784|474579600|FG000|Overall Study|Physician Decision|1|||
131807331|NCT02682784|474579601|FG001|Overall Study|Physician Decision|0|||
131807332|NCT02682784|474579602|FG002|Overall Study|Physician Decision|1|||
131807333|NCT02682784|474579603|FG003|Overall Study|Physician Decision|1|||
131807334|NCT01702987|474579604|FG000|Overall Study|Withdrawal by Subject|1|||
131807335|NCT01702987|474579605|FG001|Overall Study|Withdrawal by Subject|0|||
131807336|NCT04533594|474579606|FG000|Overall Study|Death|26|||
131807337|NCT02017223|474579607|FG000|Overall Study|Algorithm problems|2|||
131807338|NCT04263649|474579609|FG000|Overall Study|Adverse Event|53|||
131807339|NCT04263649|474579609|FG000|Overall Study|Lost to Follow-up|3|||
131732068|NCT00195260|474295848|FG006|Part 1: Dose Escalation|Death|0|||
131732069|NCT00195260|474295849|FG007|Part 1: Dose Escalation|Death|1|||
131732070|NCT00195260|474295850|FG008|Part 1: Dose Escalation|Death|0|||
131732071|NCT00195260|474295851|FG009|Part 1: Dose Escalation|Death|0|||
131732072|NCT00195260|474295852|FG010|Part 1: Dose Escalation|Death|0|||
131807340|NCT04263649|474579609|FG000|Overall Study|Death|29|||
131807341|NCT04263649|474579609|FG000|Overall Study|Device deficiency|19|||
131905151|NCT02027025|474939059|FG001|Overall Study|Sponsor's decision|1|||
131807342|NCT04263649|474579609|FG000|Overall Study|other reasons|11|||
131807343|NCT01079988|474579610|FG000|Overall Study|Lost to Follow-up|0|||
131807344|NCT01079988|474579611|FG001|Overall Study|Lost to Follow-up|0|||
131807345|NCT01079988|474579612|FG002|Overall Study|Lost to Follow-up|0|||
131905152|NCT02027025|474939060|FG002|Overall Study|Sponsor's decision|0|||
131732073|NCT00195260|474295842|FG000|Part 1: Dose Escalation|Disease Progression|3|||
131732074|NCT00195260|474295843|FG001|Part 1: Dose Escalation|Disease Progression|2|||
131732075|NCT00195260|474295844|FG002|Part 1: Dose Escalation|Disease Progression|5|||
131732076|NCT00195260|474295845|FG003|Part 1: Dose Escalation|Disease Progression|6|||
131732077|NCT00195260|474295846|FG004|Part 1: Dose Escalation|Disease Progression|4|||
131732078|NCT00195260|474295847|FG005|Part 1: Dose Escalation|Disease Progression|6|||
131732079|NCT00195260|474295848|FG006|Part 1: Dose Escalation|Disease Progression|7|||
131732080|NCT00195260|474295849|FG007|Part 1: Dose Escalation|Disease Progression|4|||
131732081|NCT00195260|474295850|FG008|Part 1: Dose Escalation|Disease Progression|0|||
131732082|NCT00195260|474295851|FG009|Part 1: Dose Escalation|Disease Progression|0|||
131732083|NCT00195260|474295852|FG010|Part 1: Dose Escalation|Disease Progression|0|||
131732084|NCT00195260|474295842|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131732085|NCT00195260|474295843|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131732086|NCT00195260|474295844|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131732087|NCT00195260|474295845|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732088|NCT00195260|474295846|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732089|NCT00195260|474295847|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131732090|NCT00195260|474295848|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732091|NCT00195260|474295849|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732092|NCT00195260|474295850|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732093|NCT00195260|474295851|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732094|NCT00195260|474295852|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131732095|NCT00195260|474295842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732096|NCT00195260|474295843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732097|NCT00195260|474295844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732098|NCT00195260|474295845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732099|NCT00195260|474295846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732100|NCT00195260|474295847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732101|NCT00195260|474295848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732102|NCT00195260|474295849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131732103|NCT00195260|474295850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
131732104|NCT00195260|474295851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
131732105|NCT00195260|474295852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
131732106|NCT00195260|474295842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732107|NCT00195260|474295843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732108|NCT00195260|474295844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732109|NCT00195260|474295845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732110|NCT00195260|474295846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732111|NCT00195260|474295847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732112|NCT00195260|474295848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732113|NCT00195260|474295849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131732114|NCT00195260|474295850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
131732115|NCT00195260|474295851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
131732116|NCT00195260|474295852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
131732117|NCT00195260|474295842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732118|NCT00195260|474295843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732119|NCT00195260|474295844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732120|NCT00195260|474295845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732121|NCT00195260|474295846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732122|NCT00195260|474295847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732123|NCT00195260|474295848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732124|NCT00195260|474295849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131732125|NCT00195260|474295850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
131732126|NCT00195260|474295851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
131732127|NCT00195260|474295852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
131732128|NCT00195260|474295842|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732129|NCT00195260|474295843|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732130|NCT00195260|474295844|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732131|NCT00195260|474295845|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732132|NCT00195260|474295846|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732133|NCT00195260|474295847|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732134|NCT00195260|474295848|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732135|NCT00195260|474295849|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131732136|NCT00195260|474295850|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
131732137|NCT00195260|474295851|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
131732138|NCT00195260|474295852|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
131732139|NCT03007953|474295855|FG000|Overall Study|Withdrawal by Subject|5|||
131732140|NCT03007953|474295856|FG001|Overall Study|Withdrawal by Subject|2|||
131732141|NCT03007953|474295855|FG000|Overall Study|Death|5|||
131732142|NCT03007953|474295856|FG001|Overall Study|Death|7|||
131732143|NCT03007953|474295855|FG000|Overall Study|Lost to Follow-up|3|||
131732144|NCT03007953|474295856|FG001|Overall Study|Lost to Follow-up|2|||
131732145|NCT03007953|474295855|FG000|Overall Study|Enrolled in Hospice|3|||
131732146|NCT03007953|474295856|FG001|Overall Study|Enrolled in Hospice|2|||
131732147|NCT03196297|474295857|FG000|Main Period|Withdrawal by Subject|4|||
131732148|NCT03196297|474295857|FG000|Extension Period|Withdrawal by Subject|1|||
131732149|NCT03196297|474295857|FG000|Extension Period|Lack of Efficacy|2|||
131732150|NCT00829166|474295858|FG000|Overall Study|Death|305|||
131732151|NCT00829166|474295859|FG001|Overall Study|Death|333|||
131732152|NCT00829166|474295858|FG000|Overall Study|Lost to Follow-up|5|||
131732153|NCT00829166|474295859|FG001|Overall Study|Lost to Follow-up|4|||
131732154|NCT00829166|474295858|FG000|Overall Study|Physician's Decision|4|||
131732155|NCT00829166|474295859|FG001|Overall Study|Physician's Decision|3|||
131732156|NCT00829166|474295858|FG000|Overall Study|Subject's Decision|41|||
131732157|NCT00829166|474295859|FG001|Overall Study|Subject's Decision|55|||
131732158|NCT00829166|474295858|FG000|Overall Study|Sponsor's Decision|137|||
131732159|NCT00829166|474295859|FG001|Overall Study|Sponsor's Decision|98|||
131732160|NCT00829166|474295858|FG000|Overall Study|Reason Not Specified|3|||
131732161|NCT00829166|474295859|FG001|Overall Study|Reason Not Specified|3|||
131732162|NCT02213198|474295864|FG000|Baseline|No show for intake|7|||
131732163|NCT02213198|474295865|FG001|Baseline|No show for intake|9|||
131732164|NCT02213198|474295864|FG000|Baseline|Withdrawal by Subject|34|||
131732165|NCT02213198|474295865|FG001|Baseline|Withdrawal by Subject|11|||
131732166|NCT02213198|474295864|FG000|Baseline|transferred out of clinic|7|||
131732167|NCT02213198|474295865|FG001|Baseline|transferred out of clinic|9|||
131732168|NCT02213198|474295864|FG000|Baseline|Lost to Follow-up|40|||
131732169|NCT02213198|474295865|FG001|Baseline|Lost to Follow-up|21|||
131732170|NCT02213198|474295864|FG000|Baseline|incarcerated,violent|0|||
131905153|NCT00732069|474939061|FG000|Washout After First Study Drug|Adverse Event|1|||
131732171|NCT02213198|474295865|FG001|Baseline|incarcerated,violent|1|||
131732172|NCT02213198|474295864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
131732173|NCT02213198|474295865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
131732174|NCT02213198|474295864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
131732175|NCT02213198|474295865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
131732176|NCT02213198|474295864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
131732177|NCT02213198|474295865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
131732178|NCT02213198|474295864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
131732179|NCT02213198|474295865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
131732180|NCT02213198|474295864|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
131732181|NCT02213198|474295865|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
131732182|NCT02213198|474295864|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
131732183|NCT02213198|474295865|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
131732184|NCT04743635|474295866|FG000|Overall Study|Lost to Follow-up|2|||
131732185|NCT04743635|474295867|FG001|Overall Study|Lost to Follow-up|0|||
131732186|NCT03382899|474295868|FG000|Overall Study|Ineligibility Determined|0|||
131732187|NCT03382899|474295869|FG001|Overall Study|Ineligibility Determined|1|||
131732188|NCT03382899|474295868|FG000|Overall Study|Lost to Follow-up|0|||
131732189|NCT03382899|474295869|FG001|Overall Study|Lost to Follow-up|1|||
131732190|NCT03382899|474295868|FG000|Overall Study|Sponsor's decision|31|||
131732191|NCT03382899|474295869|FG001|Overall Study|Sponsor's decision|28|||
131732192|NCT03382899|474295868|FG000|Overall Study|Withdrawal by Subject|0|||
131732193|NCT03382899|474295869|FG001|Overall Study|Withdrawal by Subject|5|||
131732194|NCT02689219|474295870|FG000|Overall Study|Death|1|||
131732195|NCT02689219|474295871|FG001|Overall Study|Death|1|||
131732196|NCT02689219|474295870|FG000|Overall Study|Disease Progression|10|||
131732197|NCT02689219|474295871|FG001|Overall Study|Disease Progression|6|||
131732198|NCT02928406|474295874|FG000|Overall Study|Death|780|||
131732199|NCT02928406|474295874|FG000|Overall Study|Progressive disease|3|||
131732200|NCT02928406|474295874|FG000|Overall Study|Lost to Follow-up|49|||
131732201|NCT02928406|474295874|FG000|Overall Study|Non-compliance|2|||
131732202|NCT02928406|474295874|FG000|Overall Study|Withdrawal by Subject|40|||
131732203|NCT02928406|474295874|FG000|Overall Study|Study terminated by sponsor|57|||
131732204|NCT02928406|474295874|FG000|Overall Study|Physician Decision|1|||
131732205|NCT02928406|474295874|FG000|Overall Study|Various reasons|72|||
131732206|NCT02149836|474295876|FG000|Overall Study|Withdrawal by Subject|1|||
131905154|NCT00732069|474939062|FG001|Washout After First Study Drug|Adverse Event|0|||
131732207|NCT01204658|474295877|FG000|Primary Phase|Adverse Event|0|||
131732208|NCT01204658|474295878|FG001|Primary Phase|Adverse Event|0|||
131732209|NCT01204658|474295879|FG002|Primary Phase|Adverse Event|1|||
131732210|NCT01204658|474295880|FG003|Primary Phase|Adverse Event|0|||
131732211|NCT00786838|474295881|FG000|Overall Study|Physician Decision|4|||
131732212|NCT00786838|474295881|FG000|Overall Study|Death|4|||
131732213|NCT00786838|474295881|FG000|Overall Study|Adverse Event|6|||
131807346|NCT01079988|474579613|FG003|Overall Study|Lost to Follow-up|1|||
131807347|NCT01079988|474579614|FG004|Overall Study|Lost to Follow-up|0|||
131807348|NCT01079988|474579610|FG000|Overall Study|Lack of Efficacy|1|||
131732214|NCT00786838|474295881|FG000|Overall Study|Progressive disease|31|||
131732215|NCT00786838|474295881|FG000|Overall Study|Withdrawal by Subject|4|||
131732216|NCT04937816|474295882|FG000|Overall Study|Study drug stopped, reason missing|5|||
131732217|NCT04937816|474295883|FG001|Overall Study|Study drug stopped, reason missing|3|||
131732218|NCT04937816|474295884|FG002|Overall Study|Study drug stopped, reason missing|4|||
131732219|NCT04937816|474295885|FG003|Overall Study|Study drug stopped, reason missing|6|||
131732220|NCT04937816|474295886|FG004|Overall Study|Study drug stopped, reason missing|1|||
131732221|NCT04937816|474295887|FG005|Overall Study|Study drug stopped, reason missing|0|||
131732222|NCT04937816|474295888|FG006|Overall Study|Study drug stopped, reason missing|0|||
131732223|NCT04937816|474295882|FG000|Overall Study|Other than stated below|173|||
131732224|NCT04937816|474295883|FG001|Overall Study|Other than stated below|143|||
131732225|NCT04937816|474295884|FG002|Overall Study|Other than stated below|125|||
131732226|NCT04937816|474295885|FG003|Overall Study|Other than stated below|44|||
131732227|NCT04937816|474295886|FG004|Overall Study|Other than stated below|45|||
131732228|NCT04937816|474295887|FG005|Overall Study|Other than stated below|28|||
131732229|NCT04937816|474295888|FG006|Overall Study|Other than stated below|31|||
131732230|NCT04937816|474295882|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
131732231|NCT04937816|474295883|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
131732232|NCT04937816|474295884|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
131732233|NCT04937816|474295885|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
131732234|NCT04937816|474295886|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
131732235|NCT04937816|474295887|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
131732236|NCT04937816|474295888|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
131732237|NCT04937816|474295882|FG000|Overall Study|Lost to Follow-up|15|||
131732238|NCT04937816|474295883|FG001|Overall Study|Lost to Follow-up|9|||
131732239|NCT04937816|474295884|FG002|Overall Study|Lost to Follow-up|6|||
131732240|NCT04937816|474295885|FG003|Overall Study|Lost to Follow-up|6|||
131732241|NCT04937816|474295886|FG004|Overall Study|Lost to Follow-up|16|||
131732242|NCT04937816|474295887|FG005|Overall Study|Lost to Follow-up|11|||
131732243|NCT04937816|474295888|FG006|Overall Study|Lost to Follow-up|17|||
131732244|NCT04937816|474295882|FG000|Overall Study|Protocol Violation|15|||
131732245|NCT04937816|474295883|FG001|Overall Study|Protocol Violation|15|||
131732246|NCT04937816|474295884|FG002|Overall Study|Protocol Violation|12|||
131732247|NCT04937816|474295885|FG003|Overall Study|Protocol Violation|30|||
131732248|NCT04937816|474295886|FG004|Overall Study|Protocol Violation|24|||
131732249|NCT04937816|474295887|FG005|Overall Study|Protocol Violation|5|||
131732250|NCT04937816|474295888|FG006|Overall Study|Protocol Violation|5|||
131732251|NCT04937816|474295882|FG000|Overall Study|Adverse Event|303|||
131732252|NCT04937816|474295883|FG001|Overall Study|Adverse Event|267|||
131732253|NCT04937816|474295884|FG002|Overall Study|Adverse Event|273|||
131732254|NCT04937816|474295885|FG003|Overall Study|Adverse Event|553|||
131732255|NCT04937816|474295886|FG004|Overall Study|Adverse Event|575|||
131732256|NCT04937816|474295887|FG005|Overall Study|Adverse Event|343|||
131732257|NCT04937816|474295888|FG006|Overall Study|Adverse Event|337|||
131732258|NCT04937816|474295882|FG000|Overall Study|Not treated|4|||
131732259|NCT04937816|474295883|FG001|Overall Study|Not treated|2|||
131732260|NCT04937816|474295884|FG002|Overall Study|Not treated|2|||
131732261|NCT04937816|474295885|FG003|Overall Study|Not treated|2|||
131732262|NCT04937816|474295886|FG004|Overall Study|Not treated|1|||
131732263|NCT04937816|474295887|FG005|Overall Study|Not treated|4|||
131732264|NCT04937816|474295888|FG006|Overall Study|Not treated|0|||
131732265|NCT04038255|474297641|FG000|Overall Study|Lost to Follow-up|0|||
131732266|NCT04038255|474297642|FG001|Overall Study|Lost to Follow-up|9|||
131732267|NCT04038255|474297643|FG002|Overall Study|Lost to Follow-up|5|||
131732268|NCT04038255|474297641|FG000|Overall Study|Withdrawal by Subject|0|||
131807349|NCT01079988|474579611|FG001|Overall Study|Lack of Efficacy|0|||
131807350|NCT01079988|474579612|FG002|Overall Study|Lack of Efficacy|0|||
131732269|NCT04038255|474297642|FG001|Overall Study|Withdrawal by Subject|0|||
131732270|NCT04038255|474297643|FG002|Overall Study|Withdrawal by Subject|1|||
131732271|NCT05183867|474297644|FG000|Overall Study|Withdrawal by Subject|3|||
131732272|NCT05183867|474297645|FG001|Overall Study|Withdrawal by Subject|2|||
131732273|NCT05183867|474297646|FG002|Overall Study|Withdrawal by Subject|0|||
131732274|NCT01286272|474297647|FG000|Overall Study|Ineligible after beginning treatment|1|||
131732275|NCT01286272|474297648|FG001|Overall Study|Ineligible after beginning treatment|3|||
131732276|NCT03050359|474297649|FG000|Overall Study|Randomized But Not Treated|2|||
131732277|NCT03050359|474297650|FG001|Overall Study|Randomized But Not Treated|0|||
131807351|NCT01079988|474579613|FG003|Overall Study|Lack of Efficacy|0|||
131732278|NCT03050359|474297649|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
131732279|NCT03050359|474297650|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
131807352|NCT01079988|474579614|FG004|Overall Study|Lack of Efficacy|0|||
131807353|NCT01079988|474579610|FG000|Overall Study|Other|0|||
131807354|NCT01079988|474579611|FG001|Overall Study|Other|0|||
131807355|NCT01079988|474579612|FG002|Overall Study|Other|0|||
131807356|NCT01079988|474579613|FG003|Overall Study|Other|2|||
131807357|NCT01079988|474579614|FG004|Overall Study|Other|1|||
131807358|NCT00833937|474579617|FG000|Washout|Withdrawal by Subject|1|||
131807359|NCT00833937|474579618|FG001|Washout|Withdrawal by Subject|0|||
131807360|NCT02392000|474579619|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
131807361|NCT02392000|474579619|FG000|Overall Study|Withdrawal by Subject|1|||
131807362|NCT02392000|474579619|FG000|Overall Study|Lost to Follow-up|8|||
131807363|NCT03725605|474579620|FG000|Overall Study|Unsuccessful TIL expansion|2|||
131807364|NCT03135834|474579621|FG000|Stage 1|Adverse Event|1|||
131807365|NCT03135834|474579622|FG001|Stage 1|Adverse Event|2|||
131807366|NCT03135834|474579623|FG002|Stage 1|Adverse Event|2|||
131807367|NCT03135834|474579624|FG003|Stage 1|Adverse Event|1|||
131807368|NCT03135834|474579621|FG000|Stage 1|Death|1|||
131807369|NCT03135834|474579622|FG001|Stage 1|Death|0|||
131807370|NCT03135834|474579623|FG002|Stage 1|Death|0|||
131807371|NCT03135834|474579624|FG003|Stage 1|Death|0|||
131807372|NCT03135834|474579621|FG000|Stage 1|Lost to Follow-up|17|||
131807373|NCT03135834|474579622|FG001|Stage 1|Lost to Follow-up|24|||
131807374|NCT03135834|474579623|FG002|Stage 1|Lost to Follow-up|21|||
131807375|NCT03135834|474579624|FG003|Stage 1|Lost to Follow-up|38|||
131807376|NCT03135834|474579621|FG000|Stage 1|No longer met eligibility criteria|1|||
131807377|NCT03135834|474579622|FG001|Stage 1|No longer met eligibility criteria|6|||
131807378|NCT03135834|474579623|FG002|Stage 1|No longer met eligibility criteria|2|||
131807379|NCT03135834|474579624|FG003|Stage 1|No longer met eligibility criteria|5|||
131807380|NCT03135834|474579621|FG000|Stage 1|Other|0|||
131807381|NCT03135834|474579622|FG001|Stage 1|Other|2|||
131807382|NCT03135834|474579623|FG002|Stage 1|Other|1|||
131807383|NCT03135834|474579624|FG003|Stage 1|Other|0|||
131807384|NCT03135834|474579621|FG000|Stage 1|Physician Decision|0|||
131807385|NCT03135834|474579622|FG001|Stage 1|Physician Decision|1|||
131807386|NCT03135834|474579623|FG002|Stage 1|Physician Decision|0|||
131807387|NCT03135834|474579624|FG003|Stage 1|Physician Decision|0|||
131807388|NCT03135834|474579621|FG000|Stage 1|Pregnancy|0|||
131807389|NCT03135834|474579622|FG001|Stage 1|Pregnancy|4|||
131807390|NCT03135834|474579623|FG002|Stage 1|Pregnancy|2|||
131905155|NCT00732069|474939063|FG002|Washout After First Study Drug|Adverse Event|0|||
131732280|NCT03050359|474297649|FG000|Overall Study|Significant Protocol Deviation|2|||
131732281|NCT03050359|474297650|FG001|Overall Study|Significant Protocol Deviation|3|||
131732282|NCT03050359|474297649|FG000|Overall Study|Lost to Follow-up|2|||
131732283|NCT03050359|474297650|FG001|Overall Study|Lost to Follow-up|1|||
131732284|NCT03050359|474297649|FG000|Overall Study|Voluntary Withdrawal|4|||
131732285|NCT03050359|474297650|FG001|Overall Study|Voluntary Withdrawal|6|||
131732286|NCT03050359|474297649|FG000|Overall Study|Pregnancy|1|||
131732287|NCT03050359|474297650|FG001|Overall Study|Pregnancy|0|||
131732288|NCT03050359|474297649|FG000|Overall Study|Reason Not Specified|1|||
131732289|NCT03050359|474297650|FG001|Overall Study|Reason Not Specified|0|||
131732290|NCT02614287|474297653|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
131732291|NCT02614287|474297654|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
131732292|NCT02614287|474297653|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
131732293|NCT02614287|474297654|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
131732294|NCT02614287|474297653|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
131732295|NCT02614287|474297654|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
131732296|NCT02614287|474297653|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
131732297|NCT02614287|474297654|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
131732298|NCT02614287|474297653|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
131732299|NCT02614287|474297654|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
131732300|NCT02614287|474297653|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
131732301|NCT02614287|474297654|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
131732302|NCT02614287|474297653|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
131732303|NCT02614287|474297654|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
131732304|NCT02614287|474297653|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
131732305|NCT02614287|474297654|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
131732306|NCT00492856|474297657|FG000|Induction|Adverse Event|2|||
131807391|NCT03135834|474579624|FG003|Stage 1|Pregnancy|4|||
131807392|NCT03135834|474579621|FG000|Stage 1|Protocol Violation|1|||
131807393|NCT03135834|474579622|FG001|Stage 1|Protocol Violation|1|||
131807394|NCT03135834|474579623|FG002|Stage 1|Protocol Violation|2|||
131807395|NCT03135834|474579624|FG003|Stage 1|Protocol Violation|1|||
131807396|NCT03135834|474579621|FG000|Stage 1|Withdrawal by parent/guardian|2|||
131807397|NCT03135834|474579622|FG001|Stage 1|Withdrawal by parent/guardian|10|||
131807398|NCT03135834|474579623|FG002|Stage 1|Withdrawal by parent/guardian|2|||
131807399|NCT03135834|474579624|FG003|Stage 1|Withdrawal by parent/guardian|1|||
131807400|NCT03135834|474579621|FG000|Stage 1|Withdrawal by Subject|16|||
131807401|NCT03135834|474579622|FG001|Stage 1|Withdrawal by Subject|22|||
131807402|NCT03135834|474579623|FG002|Stage 1|Withdrawal by Subject|7|||
131807403|NCT03135834|474579624|FG003|Stage 1|Withdrawal by Subject|10|||
131732307|NCT00492856|474297658|FG001|Induction|Adverse Event|0|||
131732308|NCT00492856|474297659|FG002|Induction|Adverse Event|0|||
131732309|NCT00492856|474297660|FG003|Induction|Adverse Event|0|||
131732310|NCT00492856|474297657|FG000|Induction|Withdrawal by Subject|1|||
131732311|NCT00492856|474297658|FG001|Induction|Withdrawal by Subject|0|||
131732312|NCT00492856|474297659|FG002|Induction|Withdrawal by Subject|0|||
131732313|NCT00492856|474297660|FG003|Induction|Withdrawal by Subject|0|||
131732314|NCT00492856|474297657|FG000|Induction|Death|3|||
131732315|NCT00492856|474297658|FG001|Induction|Death|0|||
131732316|NCT00492856|474297659|FG002|Induction|Death|0|||
131732317|NCT00492856|474297660|FG003|Induction|Death|0|||
131732318|NCT00492856|474297657|FG000|Consolidation|Adverse Event|6|||
131732319|NCT00492856|474297658|FG001|Consolidation|Adverse Event|0|||
131732320|NCT00492856|474297659|FG002|Consolidation|Adverse Event|0|||
131732321|NCT00492856|474297660|FG003|Consolidation|Adverse Event|0|||
131732322|NCT00492856|474297657|FG000|Consolidation|Not protocol specified|2|||
131732323|NCT00492856|474297658|FG001|Consolidation|Not protocol specified|0|||
131732324|NCT00492856|474297659|FG002|Consolidation|Not protocol specified|0|||
131732325|NCT00492856|474297660|FG003|Consolidation|Not protocol specified|0|||
131732326|NCT00492856|474297657|FG000|Consolidation|Lost to Follow-up|1|||
131732327|NCT00492856|474297658|FG001|Consolidation|Lost to Follow-up|0|||
131732328|NCT00492856|474297659|FG002|Consolidation|Lost to Follow-up|0|||
131732329|NCT00492856|474297660|FG003|Consolidation|Lost to Follow-up|0|||
131732330|NCT00492856|474297657|FG000|Post-consolidation|Adverse Event|0|||
131732331|NCT00492856|474297658|FG001|Post-consolidation|Adverse Event|4|||
131732332|NCT00492856|474297659|FG002|Post-consolidation|Adverse Event|0|||
131732333|NCT00492856|474297660|FG003|Post-consolidation|Adverse Event|1|||
131732334|NCT00492856|474297657|FG000|Post-consolidation|Withdrawal by Subject|0|||
131732335|NCT00492856|474297658|FG001|Post-consolidation|Withdrawal by Subject|4|||
131732336|NCT00492856|474297659|FG002|Post-consolidation|Withdrawal by Subject|0|||
131732337|NCT00492856|474297660|FG003|Post-consolidation|Withdrawal by Subject|0|||
131732338|NCT00492856|474297657|FG000|Post-consolidation|Death|0|||
131732339|NCT00492856|474297658|FG001|Post-consolidation|Death|1|||
131732340|NCT00492856|474297659|FG002|Post-consolidation|Death|0|||
131732341|NCT00492856|474297660|FG003|Post-consolidation|Death|0|||
131732342|NCT00492856|474297657|FG000|Post-consolidation|Not protocol specified|0|||
131732343|NCT00492856|474297658|FG001|Post-consolidation|Not protocol specified|1|||
131732344|NCT00492856|474297659|FG002|Post-consolidation|Not protocol specified|0|||
131732345|NCT00492856|474297660|FG003|Post-consolidation|Not protocol specified|0|||
131732346|NCT00492856|474297657|FG000|Post-consolidation|Lost to Follow-up|0|||
131732347|NCT00492856|474297658|FG001|Post-consolidation|Lost to Follow-up|2|||
131732348|NCT00492856|474297659|FG002|Post-consolidation|Lost to Follow-up|0|||
131732349|NCT00492856|474297660|FG003|Post-consolidation|Lost to Follow-up|0|||
131732350|NCT00492856|474297657|FG000|Post-consolidation|Observation Arm|0|||
131732351|NCT00492856|474297658|FG001|Post-consolidation|Observation Arm|0|||
131732352|NCT00492856|474297659|FG002|Post-consolidation|Observation Arm|27|||
131732353|NCT00492856|474297660|FG003|Post-consolidation|Observation Arm|0|||
131732354|NCT01520324|474297661|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
131732355|NCT03488472|474297662|FG000|Overall Study|disease progression additional mets|1|||
131732356|NCT00441441|474297666|FG000|Overall Study|Adverse Event|2|||
131732357|NCT00441441|474297667|FG001|Overall Study|Adverse Event|1|||
131732358|NCT00441441|474297666|FG000|Overall Study|Protocol Violation|4|||
131732359|NCT00441441|474297667|FG001|Overall Study|Protocol Violation|6|||
131732360|NCT00441441|474297666|FG000|Overall Study|Exacerbation of asthma|1|||
131732361|NCT00441441|474297667|FG001|Overall Study|Exacerbation of asthma|2|||
131732362|NCT00441441|474297666|FG000|Overall Study|Withdrawal by Subject|1|||
131732363|NCT00441441|474297667|FG001|Overall Study|Withdrawal by Subject|2|||
131732364|NCT00441441|474297666|FG000|Overall Study|Other|3|||
131732365|NCT00441441|474297667|FG001|Overall Study|Other|3|||
131732366|NCT00262080|474297668|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
131732367|NCT00262080|474297669|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131732368|NCT00262080|474297670|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
131732369|NCT00262080|474297668|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
131732370|NCT00262080|474297669|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
131732371|NCT00262080|474297670|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
131732372|NCT00262080|474297668|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
131732373|NCT00262080|474297669|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
131732374|NCT00262080|474297670|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
131732375|NCT00262080|474297668|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
131732376|NCT00262080|474297669|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
131732377|NCT00262080|474297670|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
131905156|NCT00732069|474939064|FG003|Washout After First Study Drug|Adverse Event|0|||
131732378|NCT00262080|474297668|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
131732379|NCT00262080|474297669|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
131732380|NCT00262080|474297670|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
131807404|NCT03135834|474579621|FG000|Stage 1|Randomized but not Vaccinated|0|||
131807405|NCT03135834|474579622|FG001|Stage 1|Randomized but not Vaccinated|3|||
131807406|NCT03135834|474579623|FG002|Stage 1|Randomized but not Vaccinated|1|||
131807407|NCT03135834|474579624|FG003|Stage 1|Randomized but not Vaccinated|6|||
131807408|NCT03135834|474579621|FG000|Stage 2|Lost to Follow-up|0|||
131807409|NCT03135834|474579622|FG001|Stage 2|Lost to Follow-up|1|||
131807410|NCT03135834|474579623|FG002|Stage 2|Lost to Follow-up|0|||
131807411|NCT03135834|474579624|FG003|Stage 2|Lost to Follow-up|0|||
131807412|NCT03135834|474579621|FG000|Stage 2|Withdrawal by Subject|0|||
131807413|NCT03135834|474579622|FG001|Stage 2|Withdrawal by Subject|1|||
131807414|NCT03135834|474579623|FG002|Stage 2|Withdrawal by Subject|0|||
131807415|NCT03135834|474579624|FG003|Stage 2|Withdrawal by Subject|0|||
131807416|NCT03135834|474579621|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
131807417|NCT03135834|474579622|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
131807418|NCT03135834|474579623|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
131807419|NCT03135834|474579624|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
131807420|NCT03135834|474579621|FG000|Stage 2|Did not receive Booster Vaccination|1|||
131807421|NCT03135834|474579622|FG001|Stage 2|Did not receive Booster Vaccination|1|||
131807422|NCT03135834|474579623|FG002|Stage 2|Did not receive Booster Vaccination|0|||
131807423|NCT03135834|474579624|FG003|Stage 2|Did not receive Booster Vaccination|0|||
131732381|NCT00262080|474297668|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
131732382|NCT00262080|474297669|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
131732383|NCT00262080|474297670|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
131732384|NCT03580382|474297671|FG000|Overall Study|Early Termination of Study|0|||
131732385|NCT03580382|474297672|FG001|Overall Study|Early Termination of Study|3|||
131732386|NCT05619172|474297673|FG000|Safety Cohort 1|Death|7|||
131732387|NCT05619172|474297674|FG001|Safety Cohort 1|Death|0|||
131732388|NCT05619172|474297673|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
131732389|NCT05619172|474297674|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
131732390|NCT05619172|474297673|FG000|Safety Cohort 2|Death|0|||
131732391|NCT05619172|474297674|FG001|Safety Cohort 2|Death|1|||
131732392|NCT05619172|474297673|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
131732393|NCT05619172|474297674|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
131732394|NCT04009096|474297675|FG000|Overall Study|Withdrawal by Subject|0|||
131732395|NCT04009096|474297676|FG001|Overall Study|Withdrawal by Subject|7|||
131732396|NCT04009096|474297677|FG002|Overall Study|Withdrawal by Subject|0|||
131732397|NCT04009096|474297675|FG000|Overall Study|Physician Decision|0|||
131732398|NCT04009096|474297676|FG001|Overall Study|Physician Decision|1|||
131732399|NCT04009096|474297677|FG002|Overall Study|Physician Decision|0|||
131732400|NCT05151471|474297678|FG000|Overall Study|Adverse Event|21|||
131732401|NCT05151471|474297679|FG001|Overall Study|Adverse Event|16|||
131732402|NCT05151471|474297678|FG000|Overall Study|Death|1|||
131732403|NCT05151471|474297679|FG001|Overall Study|Death|0|||
131732404|NCT05151471|474297678|FG000|Overall Study|Lost to Follow-up|0|||
131732405|NCT05151471|474297679|FG001|Overall Study|Lost to Follow-up|1|||
131732406|NCT05151471|474297678|FG000|Overall Study|Withdrawal by Subject|7|||
131732407|NCT05151471|474297679|FG001|Overall Study|Withdrawal by Subject|9|||
131732408|NCT05151471|474297678|FG000|Overall Study|Study terminated by sponsor|49|||
131732409|NCT05151471|474297679|FG001|Overall Study|Study terminated by sponsor|47|||
131732410|NCT05151471|474297678|FG000|Overall Study|Other|2|||
131732411|NCT05151471|474297679|FG001|Overall Study|Other|1|||
131732412|NCT04263142|474297680|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131807424|NCT00965185|474579625|FG000|Overall Study|Lost to Follow-up|2|||
131807425|NCT00965185|474579626|FG001|Overall Study|Lost to Follow-up|0|||
131807426|NCT00965185|474579625|FG000|Overall Study|Withdrawal by Subject|0|||
131807427|NCT00965185|474579626|FG001|Overall Study|Withdrawal by Subject|1|||
131807428|NCT06358820|474581082|FG000|Overall Study|Adverse Event|11|||
131807429|NCT06358820|474581082|FG000|Overall Study|kidney transplantation|3|||
131732413|NCT04263142|474297681|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131732414|NCT04263142|474297682|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131732415|NCT04263142|474297683|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131732416|NCT04263142|474297684|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
131732417|NCT04263142|474297680|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131807430|NCT06358820|474581082|FG000|Overall Study|patient voluntary withdrawal|6|||
131905157|NCT00732069|474939065|FG004|Washout After First Study Drug|Adverse Event|0|||
131732418|NCT04263142|474297681|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131732419|NCT04263142|474297682|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131732420|NCT04263142|474297683|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131732421|NCT04263142|474297684|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
131807431|NCT06358820|474581082|FG000|Overall Study|Physician Decision|1|||
131807432|NCT01066143|474581083|FG000|Overall Study|ineligible for the study|8|||
131807433|NCT05376319|474581084|FG000|Overall Study|Funding termination|2|||
131807434|NCT05376319|474581085|FG001|Overall Study|Funding termination|4|||
131732422|NCT00450372|474297686|FG000|Overall Study|Physician Decision|1|||
131807435|NCT00218257|474581092|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
131807436|NCT00218257|474581093|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
131732423|NCT03010423|474297689|FG000|Overall Study|Study termination|8|||
131732424|NCT04346628|474297692|FG000|Overall Study|Lost to Follow-up|4|||
131732425|NCT04346628|474297693|FG001|Overall Study|Lost to Follow-up|4|||
131732426|NCT04346628|474297692|FG000|Overall Study|Withdrew (had personal reasons)|2|||
131732427|NCT04346628|474297693|FG001|Overall Study|Withdrew (had personal reasons)|5|||
131732428|NCT04346628|474297692|FG000|Overall Study|Withdrew (medication intolerant)|0|||
131732429|NCT04346628|474297693|FG001|Overall Study|Withdrew (medication intolerant)|3|||
131732430|NCT04346628|474297692|FG000|Overall Study|Withdrew (declined intervention)|0|||
131732431|NCT04346628|474297693|FG001|Overall Study|Withdrew (declined intervention)|1|||
131732432|NCT01202227|474297700|FG000|Overall Study|Adverse Event|16|||
131732433|NCT01202227|474297700|FG000|Overall Study|Withdrawal by Subject|2|||
131732434|NCT01202227|474297700|FG000|Overall Study|Lack of Efficacy|1|||
131732435|NCT00643487|474297701|FG000|Overall Study|Technical difficulty|3|||
131732436|NCT04402008|474297704|FG000|Overall Study|Adverse Event|0|||
131732437|NCT04402008|474297705|FG001|Overall Study|Adverse Event|0|||
131732438|NCT04402008|474297706|FG002|Overall Study|Adverse Event|0|||
131732439|NCT04402008|474297707|FG003|Overall Study|Adverse Event|1|||
131732440|NCT04402008|474297708|FG004|Overall Study|Adverse Event|0|||
131732441|NCT04402008|474297709|FG005|Overall Study|Adverse Event|0|||
131732442|NCT04402008|474297710|FG006|Overall Study|Adverse Event|0|||
131732443|NCT04402008|474297704|FG000|Overall Study|Disease Progression|3|||
131732444|NCT04402008|474297705|FG001|Overall Study|Disease Progression|2|||
131732445|NCT04402008|474297706|FG002|Overall Study|Disease Progression|3|||
131732446|NCT04402008|474297707|FG003|Overall Study|Disease Progression|3|||
131732447|NCT04402008|474297708|FG004|Overall Study|Disease Progression|4|||
131732448|NCT04402008|474297709|FG005|Overall Study|Disease Progression|3|||
131732449|NCT04402008|474297710|FG006|Overall Study|Disease Progression|10|||
131732450|NCT04402008|474297704|FG000|Overall Study|Withdrawal by Subject|0|||
131732451|NCT04402008|474297705|FG001|Overall Study|Withdrawal by Subject|1|||
131732452|NCT04402008|474297706|FG002|Overall Study|Withdrawal by Subject|0|||
131732453|NCT04402008|474297707|FG003|Overall Study|Withdrawal by Subject|0|||
131732454|NCT04402008|474297708|FG004|Overall Study|Withdrawal by Subject|1|||
131732455|NCT04402008|474297709|FG005|Overall Study|Withdrawal by Subject|0|||
131732456|NCT04402008|474297710|FG006|Overall Study|Withdrawal by Subject|0|||
131732457|NCT04402008|474297704|FG000|Overall Study|Sponsor Decision|0|||
131732458|NCT04402008|474297705|FG001|Overall Study|Sponsor Decision|0|||
131732459|NCT04402008|474297706|FG002|Overall Study|Sponsor Decision|0|||
131732460|NCT04402008|474297707|FG003|Overall Study|Sponsor Decision|0|||
131732461|NCT04402008|474297708|FG004|Overall Study|Sponsor Decision|0|||
131732462|NCT04402008|474297709|FG005|Overall Study|Sponsor Decision|0|||
131732463|NCT04402008|474297710|FG006|Overall Study|Sponsor Decision|3|||
131732464|NCT04402008|474297704|FG000|Overall Study|Death|0|||
131732465|NCT04402008|474297705|FG001|Overall Study|Death|0|||
131732466|NCT04402008|474297706|FG002|Overall Study|Death|0|||
131732467|NCT04402008|474297707|FG003|Overall Study|Death|0|||
131732468|NCT04402008|474297708|FG004|Overall Study|Death|1|||
131732469|NCT04402008|474297709|FG005|Overall Study|Death|0|||
131732470|NCT04402008|474297710|FG006|Overall Study|Death|2|||
131732471|NCT04402008|474297704|FG000|Overall Study|Other|0|||
131732472|NCT04402008|474297705|FG001|Overall Study|Other|0|||
131732473|NCT04402008|474297706|FG002|Overall Study|Other|0|||
131732474|NCT04402008|474297707|FG003|Overall Study|Other|0|||
131732475|NCT04402008|474297708|FG004|Overall Study|Other|0|||
131807437|NCT00328926|474581094|FG000|Overall Study|Pregnancy|2|||
131807438|NCT00328926|474581095|FG001|Overall Study|Pregnancy|1|||
131807439|NCT00328926|474581096|FG002|Overall Study|Pregnancy|0|||
131732476|NCT04402008|474297709|FG005|Overall Study|Other|0|||
131732477|NCT04402008|474297710|FG006|Overall Study|Other|5|||
131732478|NCT01533935|474297712|FG000|Overall Study|Adverse Event|5|||
131732479|NCT01533935|474297713|FG001|Overall Study|Adverse Event|7|||
131732480|NCT01533935|474297714|FG002|Overall Study|Adverse Event|1|||
131732481|NCT01533935|474297715|FG003|Overall Study|Adverse Event|5|||
131732482|NCT01533935|474297716|FG004|Overall Study|Adverse Event|3|||
131732483|NCT01533935|474297712|FG000|Overall Study|Protocol Violation|0|||
131807440|NCT00328926|474581094|FG000|Overall Study|Lost to Follow-up|0|||
131807441|NCT00328926|474581095|FG001|Overall Study|Lost to Follow-up|1|||
131807442|NCT00328926|474581096|FG002|Overall Study|Lost to Follow-up|0|||
131732484|NCT01533935|474297713|FG001|Overall Study|Protocol Violation|2|||
131732485|NCT01533935|474297714|FG002|Overall Study|Protocol Violation|0|||
131732486|NCT01533935|474297715|FG003|Overall Study|Protocol Violation|0|||
131732487|NCT01533935|474297716|FG004|Overall Study|Protocol Violation|0|||
131732488|NCT01533935|474297712|FG000|Overall Study|Lost to Follow-up|0|||
131807443|NCT00328926|474581094|FG000|Overall Study|Death|0|||
131732489|NCT01533935|474297713|FG001|Overall Study|Lost to Follow-up|0|||
131732490|NCT01533935|474297714|FG002|Overall Study|Lost to Follow-up|1|||
131732491|NCT01533935|474297715|FG003|Overall Study|Lost to Follow-up|0|||
131732492|NCT01533935|474297716|FG004|Overall Study|Lost to Follow-up|0|||
131732493|NCT01533935|474297712|FG000|Overall Study|Withdrawal by Subject|0|||
131732494|NCT01533935|474297713|FG001|Overall Study|Withdrawal by Subject|4|||
131732495|NCT01533935|474297714|FG002|Overall Study|Withdrawal by Subject|5|||
131732496|NCT01533935|474297715|FG003|Overall Study|Withdrawal by Subject|2|||
131732497|NCT01533935|474297716|FG004|Overall Study|Withdrawal by Subject|4|||
131732498|NCT01533935|474297712|FG000|Overall Study|Other reason not defined above|1|||
131732499|NCT01533935|474297713|FG001|Overall Study|Other reason not defined above|0|||
131732500|NCT01533935|474297714|FG002|Overall Study|Other reason not defined above|1|||
131732501|NCT01533935|474297715|FG003|Overall Study|Other reason not defined above|0|||
131732502|NCT01533935|474297716|FG004|Overall Study|Other reason not defined above|1|||
131732503|NCT00879814|474297717|FG000|Overall Study|Adverse Event|0|||
131732504|NCT00879814|474297718|FG001|Overall Study|Adverse Event|1|||
131732505|NCT00879814|474297719|FG002|Overall Study|Adverse Event|0|||
131732506|NCT00879814|474297720|FG003|Overall Study|Adverse Event|0|||
131732507|NCT00879814|474297717|FG000|Overall Study|Lost to Follow-up|1|||
131732508|NCT00879814|474297718|FG001|Overall Study|Lost to Follow-up|0|||
131732509|NCT00879814|474297719|FG002|Overall Study|Lost to Follow-up|0|||
131732510|NCT00879814|474297720|FG003|Overall Study|Lost to Follow-up|2|||
131732511|NCT00879814|474297717|FG000|Overall Study|Participant Failed to Return|0|||
131732512|NCT00879814|474297718|FG001|Overall Study|Participant Failed to Return|0|||
131732513|NCT00879814|474297719|FG002|Overall Study|Participant Failed to Return|0|||
131732514|NCT00879814|474297720|FG003|Overall Study|Participant Failed to Return|1|||
131732515|NCT00879814|474297717|FG000|Overall Study|Withdrawal by Subject|3|||
131732516|NCT00879814|474297718|FG001|Overall Study|Withdrawal by Subject|1|||
131732517|NCT00879814|474297719|FG002|Overall Study|Withdrawal by Subject|1|||
131732518|NCT00879814|474297720|FG003|Overall Study|Withdrawal by Subject|2|||
131732519|NCT00879814|474297717|FG000|Overall Study|Physician Decision|0|||
131732520|NCT00879814|474297718|FG001|Overall Study|Physician Decision|0|||
131732521|NCT00879814|474297719|FG002|Overall Study|Physician Decision|1|||
131732522|NCT00879814|474297720|FG003|Overall Study|Physician Decision|0|||
131732523|NCT00879814|474297717|FG000|Overall Study|Other|0|||
131732524|NCT00879814|474297718|FG001|Overall Study|Other|0|||
131732525|NCT00879814|474297719|FG002|Overall Study|Other|1|||
131732526|NCT00879814|474297720|FG003|Overall Study|Other|0|||
131732527|NCT00630812|474297733|FG000|Randomisation to First Dose|Adverse Event|1|||
131732528|NCT00630812|474297734|FG001|Randomisation to First Dose|Adverse Event|1|||
131732529|NCT00630812|474297733|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
131732530|NCT00630812|474297734|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
131732531|NCT00630812|474297733|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
131732532|NCT00630812|474297734|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
131732533|NCT00630812|474297733|FG000|Randomisation to First Dose|Protocol Violation|4|||
131732534|NCT00630812|474297734|FG001|Randomisation to First Dose|Protocol Violation|1|||
131732535|NCT00630812|474297733|FG000|Double Blind Treatment Period|Adverse Event|13|||
131732536|NCT00630812|474297734|FG001|Double Blind Treatment Period|Adverse Event|5|||
131732537|NCT00630812|474297733|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
131732538|NCT00630812|474297734|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131732539|NCT00630812|474297733|FG000|Double Blind Treatment Period|Physician Decision|2|||
131732540|NCT00630812|474297734|FG001|Double Blind Treatment Period|Physician Decision|1|||
131732541|NCT00630812|474297733|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131732542|NCT00630812|474297734|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131732543|NCT00630812|474297733|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
131732544|NCT00630812|474297734|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
131732545|NCT00630812|474297733|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
131732546|NCT00630812|474297734|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
131732547|NCT00630812|474297733|FG000|Double Blind Treatment Period|Non-compliance|0|||
131732548|NCT00630812|474297734|FG001|Double Blind Treatment Period|Non-compliance|1|||
131732549|NCT03430245|474297735|FG000|Overall Study|Withdrawal by Subject|6|||
131732550|NCT03430245|474297735|FG000|Overall Study|Lost to Follow-up|1|||
131732551|NCT03656926|474297742|FG000|Overall Study|Adverse Event|5|||
131732552|NCT03656926|474297743|FG001|Overall Study|Adverse Event|4|||
131732553|NCT03656926|474297742|FG000|Overall Study|Withdrawal by Subject|7|||
131732554|NCT03656926|474297743|FG001|Overall Study|Withdrawal by Subject|2|||
131732555|NCT03656926|474297742|FG000|Overall Study|Screen fail after randomization|1|||
131732556|NCT03656926|474297743|FG001|Overall Study|Screen fail after randomization|0|||
131732557|NCT03656926|474297742|FG000|Overall Study|PI decision due to patient condition|1|||
131732558|NCT03656926|474297743|FG001|Overall Study|PI decision due to patient condition|0|||
131732559|NCT03656926|474297742|FG000|Overall Study|Patient unresponsiveness|1|||
131732560|NCT03656926|474297743|FG001|Overall Study|Patient unresponsiveness|0|||
131732561|NCT05610176|474297744|FG000|Overall Study|Death|6|||
131732562|NCT00506077|474297745|FG000|Treatment Period 1|Adverse Event|2|||
131732563|NCT00506077|474297746|FG001|Treatment Period 1|Adverse Event|1|||
131732564|NCT00506077|474297745|FG000|Treatment Period 1|Lost to Follow-up|0|||
131732565|NCT00506077|474297746|FG001|Treatment Period 1|Lost to Follow-up|2|||
131732566|NCT00506077|474297745|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131732567|NCT00506077|474297746|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131732568|NCT00506077|474297745|FG000|Treatment Period 2|Adverse Event|0|||
131732569|NCT00506077|474297746|FG001|Treatment Period 2|Adverse Event|1|||
131732570|NCT00506077|474297745|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131732571|NCT00506077|474297746|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131732572|NCT01753076|474297747|FG000|Overall Study|Adverse Event|17|||
131732573|NCT01753076|474297748|FG001|Overall Study|Adverse Event|18|||
131732574|NCT01753076|474297747|FG000|Overall Study|Lack of Efficacy|3|||
131732575|NCT01753076|474297748|FG001|Overall Study|Lack of Efficacy|1|||
131732576|NCT01753076|474297747|FG000|Overall Study|Lost to Follow-up|2|||
131732577|NCT01753076|474297748|FG001|Overall Study|Lost to Follow-up|1|||
131732578|NCT01753076|474297747|FG000|Overall Study|Physician Decision|4|||
131732579|NCT01753076|474297748|FG001|Overall Study|Physician Decision|2|||
131732580|NCT01753076|474297747|FG000|Overall Study|Withdrawal by Subject|14|||
131732581|NCT01753076|474297748|FG001|Overall Study|Withdrawal by Subject|24|||
131732582|NCT01753076|474297747|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
131732583|NCT01753076|474297748|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
131732584|NCT02575079|474297749|FG000|Overall Study|Death|3|||
131732585|NCT02575079|474297750|FG001|Overall Study|Death|0|||
131732586|NCT02575079|474297749|FG000|Overall Study|Withdrawal by Subject|3|||
131732587|NCT02575079|474297750|FG001|Overall Study|Withdrawal by Subject|0|||
131732588|NCT00788775|474297753|FG000|Overall Study|Progressive Disease|8|||
131732589|NCT00788775|474297754|FG001|Overall Study|Progressive Disease|6|||
131732590|NCT00788775|474297753|FG000|Overall Study|Withdrawal by Subject|0|||
131732591|NCT00788775|474297754|FG001|Overall Study|Withdrawal by Subject|2|||
131732592|NCT00788775|474297753|FG000|Overall Study|Patient Non-Compliance|1|||
131732593|NCT00788775|474297754|FG001|Overall Study|Patient Non-Compliance|0|||
131732594|NCT00788775|474297753|FG000|Overall Study|Patient's measurable disease resected.|1|||
131732595|NCT00788775|474297754|FG001|Overall Study|Patient's measurable disease resected.|0|||
131732596|NCT01952834|474297758|FG000|Overall Study|Adverse Event|1|||
131732597|NCT02426658|474297761|FG000|Overall Study|Withdrawal by Subject|1|||
131732598|NCT02426658|474297761|FG000|Overall Study|Patient expired before treatment|2|||
131732599|NCT00524316|474297762|FG000|Overall Study|Withdrawal by Subject|2|||
131732600|NCT00524316|474297762|FG000|Overall Study|Adverse Event|7|||
131732601|NCT00524316|474297762|FG000|Overall Study|Disease Progression|7|||
131732602|NCT01402284|474297763|FG000|Overall Study|Withdrawal consent|2|||
131732603|NCT01402284|474297763|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
131732604|NCT01402284|474297763|FG000|Overall Study|Physician Decision|1|||
131732605|NCT01402284|474297763|FG000|Overall Study|Disease progression on study|10|||
131732606|NCT01199263|474297764|FG000|Overall Study|Ineligible|0|||
131732607|NCT01199263|474297765|FG001|Overall Study|Ineligible|2|||
131732608|NCT01199263|474297764|FG000|Overall Study|Never Treated|6|||
131732609|NCT01199263|474297765|FG001|Overall Study|Never Treated|0|||
131732610|NCT00905021|474297769|FG000|Overall Study|Adverse Event|2|||
131732611|NCT05513391|474297770|FG000|Overall Study|Adverse Event|1|||
131732612|NCT05513391|474297771|FG001|Overall Study|Adverse Event|0|||
131732613|NCT05513391|474297770|FG000|Overall Study|Protocol Deviation|0|||
131732614|NCT05513391|474297771|FG001|Overall Study|Protocol Deviation|1|||
131732615|NCT05513391|474297770|FG000|Overall Study|Withdrawal by Subject|3|||
131732616|NCT05513391|474297771|FG001|Overall Study|Withdrawal by Subject|1|||
131732617|NCT05513391|474297770|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131732618|NCT05513391|474297771|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131732619|NCT05513391|474297770|FG000|Overall Study|Lost to Follow-up|0|||
131732620|NCT05513391|474297771|FG001|Overall Study|Lost to Follow-up|2|||
131732621|NCT00436215|474297772|FG000|Overall Study|Refused further treatment|3|||
131732622|NCT00436215|474297772|FG000|Overall Study|Small bowel obstruction|1|||
131732623|NCT00309777|474297773|FG000|Overall Study|Adverse Event|13|||
131732624|NCT00309777|474297774|FG001|Overall Study|Adverse Event|2|||
131732625|NCT00309777|474297775|FG002|Overall Study|Adverse Event|8|||
131732626|NCT00309777|474297776|FG003|Overall Study|Adverse Event|1|||
131732627|NCT00309777|474297773|FG000|Overall Study|Protocol Violation|4|||
131732628|NCT00309777|474297774|FG001|Overall Study|Protocol Violation|1|||
131732629|NCT00309777|474297775|FG002|Overall Study|Protocol Violation|3|||
131732630|NCT00309777|474297776|FG003|Overall Study|Protocol Violation|1|||
131732631|NCT00309777|474297773|FG000|Overall Study|Withdrawal by Subject|6|||
131732632|NCT00309777|474297774|FG001|Overall Study|Withdrawal by Subject|5|||
131732633|NCT00309777|474297775|FG002|Overall Study|Withdrawal by Subject|7|||
131732634|NCT00309777|474297776|FG003|Overall Study|Withdrawal by Subject|2|||
131732635|NCT00309777|474297773|FG000|Overall Study|Lost to Follow-up|0|||
131732636|NCT00309777|474297774|FG001|Overall Study|Lost to Follow-up|0|||
131732637|NCT00309777|474297775|FG002|Overall Study|Lost to Follow-up|1|||
131732638|NCT00309777|474297776|FG003|Overall Study|Lost to Follow-up|0|||
131732639|NCT00309777|474297773|FG000|Overall Study|Death|0|||
131732640|NCT00309777|474297774|FG001|Overall Study|Death|1|||
131732641|NCT00309777|474297775|FG002|Overall Study|Death|0|||
131732642|NCT00309777|474297776|FG003|Overall Study|Death|0|||
131732643|NCT05513053|474297777|FG000|Overall Study|Lost to Follow-up|9|||
131732644|NCT05513053|474297778|FG001|Overall Study|Lost to Follow-up|11|||
131732645|NCT05513053|474297777|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131732646|NCT05513053|474297778|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131732647|NCT05513053|474297777|FG000|Overall Study|Withdrawal by Subject|2|||
131732648|NCT05513053|474297778|FG001|Overall Study|Withdrawal by Subject|9|||
131732649|NCT05513053|474297777|FG000|Overall Study|Protocol Violation|6|||
131732650|NCT05513053|474297778|FG001|Overall Study|Protocol Violation|3|||
131732651|NCT05513053|474297777|FG000|Overall Study|Adverse Event|0|||
131732652|NCT05513053|474297778|FG001|Overall Study|Adverse Event|2|||
131732653|NCT01575197|474298748|FG000|Overall Study|Migration out of study area|1|||
131732654|NCT01575197|474298749|FG001|Overall Study|Migration out of study area|5|||
131732655|NCT01575197|474298750|FG002|Overall Study|Migration out of study area|4|||
131732656|NCT01575197|474298748|FG000|Overall Study|SAE|0|||
131732657|NCT01575197|474298749|FG001|Overall Study|SAE|1|||
131732658|NCT01575197|474298750|FG002|Overall Study|SAE|0|||
131732659|NCT01575197|474298748|FG000|Overall Study|Lost to Follow-up|0|||
131732660|NCT01575197|474298749|FG001|Overall Study|Lost to Follow-up|1|||
131732661|NCT01575197|474298750|FG002|Overall Study|Lost to Follow-up|0|||
131732662|NCT01575197|474298748|FG000|Overall Study|Withdrawal by Subject|0|||
131732663|NCT01575197|474298749|FG001|Overall Study|Withdrawal by Subject|1|||
131732664|NCT01575197|474298750|FG002|Overall Study|Withdrawal by Subject|1|||
131732665|NCT01575197|474298748|FG000|Overall Study|Protocol Violation|2|||
131732666|NCT01575197|474298749|FG001|Overall Study|Protocol Violation|1|||
131732667|NCT01575197|474298750|FG002|Overall Study|Protocol Violation|1|||
131732668|NCT03885726|474298756|FG000|Overall Study|Staffing issues/lost interest|1|||
131732669|NCT03885726|474298756|FG000|Overall Study|Early discharge from hospital|3|||
131732670|NCT01217190|474298757|FG000|Second Dosing|Withdrawal by Subject|0|||
131732671|NCT01217190|474298758|FG001|Second Dosing|Withdrawal by Subject|2|||
131732672|NCT03116399|474298759|FG000|Overall Study|Death|8|||
131732673|NCT03116399|474298760|FG001|Overall Study|Death|3|||
131732674|NCT03116399|474298759|FG000|Overall Study|Lost to Follow-up|7|||
131732675|NCT03116399|474298760|FG001|Overall Study|Lost to Follow-up|11|||
131732676|NCT03116399|474298759|FG000|Overall Study|Investigator Decision|1|||
131732677|NCT03116399|474298760|FG001|Overall Study|Investigator Decision|1|||
131732678|NCT03116399|474298759|FG000|Overall Study|Withdrawal by Subject|24|||
131732679|NCT03116399|474298760|FG001|Overall Study|Withdrawal by Subject|9|||
131732680|NCT02868216|474298763|FG000|Overall Study|Death|0|||
131732681|NCT02868216|474298764|FG001|Overall Study|Death|1|||
131732682|NCT02868216|474298763|FG000|Overall Study|coronary artery bypass|1|||
131732683|NCT02868216|474298764|FG001|Overall Study|coronary artery bypass|0|||
131732684|NCT02868216|474298763|FG000|Overall Study|Withdrawal by Subject|7|||
131732685|NCT02868216|474298764|FG001|Overall Study|Withdrawal by Subject|5|||
131732686|NCT02702193|474298765|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
131732687|NCT02702193|474298766|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
131732688|NCT02702193|474298765|FG000|4 Month Follow up|Withdrawal by Subject|1|||
131732689|NCT02702193|474298766|FG001|4 Month Follow up|Withdrawal by Subject|0|||
131732690|NCT02702193|474298765|FG000|4 Month Follow up|Lost to Follow-up|17|||
131732691|NCT02702193|474298766|FG001|4 Month Follow up|Lost to Follow-up|18|||
131732692|NCT02702193|474298765|FG000|8 Month Follow up|Withdrawal by Subject|1|||
131732693|NCT02702193|474298766|FG001|8 Month Follow up|Withdrawal by Subject|0|||
131732694|NCT02702193|474298765|FG000|8 Month Follow up|Lost to Follow-up|14|||
131732695|NCT02702193|474298766|FG001|8 Month Follow up|Lost to Follow-up|18|||
131732696|NCT02702193|474298765|FG000|12 Month Follow up|Withdrawal by Subject|1|||
131732697|NCT02702193|474298766|FG001|12 Month Follow up|Withdrawal by Subject|0|||
131732698|NCT02702193|474298765|FG000|12 Month Follow up|Lost to Follow-up|16|||
131732699|NCT02702193|474298766|FG001|12 Month Follow up|Lost to Follow-up|18|||
131732700|NCT00610935|474298771|FG000|Overall Study|Lost to Follow-up|0|||
131732701|NCT00610935|474298772|FG001|Overall Study|Lost to Follow-up|1|||
131732702|NCT00610935|474298771|FG000|Overall Study|Withdrawal by Subject|0|||
131732703|NCT00610935|474298772|FG001|Overall Study|Withdrawal by Subject|2|||
131732704|NCT00610935|474298771|FG000|Overall Study|Sponsor Discontinuation|1|||
131732705|NCT00610935|474298772|FG001|Overall Study|Sponsor Discontinuation|0|||
131732706|NCT00740779|474298773|FG000|Overall Study|Adverse Event|4|||
131732707|NCT00740779|474298774|FG001|Overall Study|Adverse Event|6|||
131732708|NCT00740779|474298775|FG002|Overall Study|Adverse Event|3|||
131732709|NCT00740779|474298773|FG000|Overall Study|Protocol Violation|1|||
131732710|NCT00740779|474298774|FG001|Overall Study|Protocol Violation|1|||
131732711|NCT00740779|474298775|FG002|Overall Study|Protocol Violation|1|||
131732712|NCT00740779|474298773|FG000|Overall Study|Lack of Efficacy|0|||
131732713|NCT00740779|474298774|FG001|Overall Study|Lack of Efficacy|0|||
131732714|NCT00740779|474298775|FG002|Overall Study|Lack of Efficacy|2|||
131732715|NCT00740779|474298773|FG000|Overall Study|Withdrawal by Subject|2|||
131732716|NCT00740779|474298774|FG001|Overall Study|Withdrawal by Subject|4|||
131732717|NCT00740779|474298775|FG002|Overall Study|Withdrawal by Subject|2|||
131732718|NCT00740779|474298773|FG000|Overall Study|Lost to Follow-up|2|||
131732719|NCT00740779|474298774|FG001|Overall Study|Lost to Follow-up|3|||
131732720|NCT00740779|474298775|FG002|Overall Study|Lost to Follow-up|5|||
131732721|NCT00850460|474298778|FG000|Overall Study|Lost to Follow-up|4|||
131732722|NCT00850460|474298779|FG001|Overall Study|Lost to Follow-up|4|||
131732723|NCT02399813|474298785|FG000|Overall Study|Progressive Disease-Radiographic|2|||
131732724|NCT02399813|474298785|FG000|Overall Study|Death|20|||
131732725|NCT02399813|474298785|FG000|Overall Study|Withdrawal by Subject|3|||
131732726|NCT02399813|474298785|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
131732727|NCT02399813|474298785|FG000|Overall Study|Lost to Follow-up|2|||
131732728|NCT02399813|474298785|FG000|Overall Study|Other than specified|5|||
131732729|NCT00988559|474298786|FG000|Overall Study|Withdrawal by Subject|1|||
131732730|NCT00988559|474298787|FG001|Overall Study|Withdrawal by Subject|1|||
131732731|NCT00988559|474298788|FG002|Overall Study|Withdrawal by Subject|0|||
131732732|NCT00988559|474298789|FG003|Overall Study|Withdrawal by Subject|1|||
131732733|NCT00988559|474298786|FG000|Overall Study|Pregnancy|0|||
131732734|NCT00988559|474298787|FG001|Overall Study|Pregnancy|1|||
131732735|NCT00988559|474298788|FG002|Overall Study|Pregnancy|1|||
131732736|NCT00988559|474298789|FG003|Overall Study|Pregnancy|0|||
131732737|NCT00988559|474298786|FG000|Overall Study|Lost to Follow-up|0|||
131732738|NCT00988559|474298787|FG001|Overall Study|Lost to Follow-up|0|||
131732739|NCT00988559|474298788|FG002|Overall Study|Lost to Follow-up|1|||
131732740|NCT00988559|474298789|FG003|Overall Study|Lost to Follow-up|0|||
131732741|NCT02224846|474298790|FG000|Period 1 (Month 3)|Adverse Event|2|||
131732742|NCT02224846|474298791|FG001|Period 1 (Month 3)|Adverse Event|1|||
131732743|NCT02224846|474298790|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
131732744|NCT02224846|474298791|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
131732745|NCT02224846|474298790|FG000|Period 1 (Month 3)|Protocol Violation|4|||
131732746|NCT02224846|474298791|FG001|Period 1 (Month 3)|Protocol Violation|8|||
131732747|NCT02224846|474298790|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
131732748|NCT02224846|474298791|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
131732749|NCT02224846|474298790|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
131732750|NCT02224846|474298791|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
131732751|NCT02224846|474298790|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
131732752|NCT02224846|474298791|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
131732753|NCT02224846|474298790|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
131732754|NCT02224846|474298791|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
131732755|NCT02224846|474298790|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
131732756|NCT02224846|474298791|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
131732757|NCT02224846|474298790|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
131732758|NCT02224846|474298791|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
131732759|NCT02224846|474298790|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
131732760|NCT02224846|474298791|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
131732761|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
131732762|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
131732763|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
131732764|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
131732765|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
131732766|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
131732767|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
131732768|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
131732769|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
131732770|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
131732771|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
131732772|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
131732773|NCT02224846|474298790|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
131732774|NCT02224846|474298791|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
131732775|NCT03280550|474298792|FG000|Overall Study|Withdrawal by Subject|2|||
131732776|NCT03280550|474298793|FG001|Overall Study|Withdrawal by Subject|2|||
131732777|NCT03280550|474298792|FG000|Overall Study|Physician Decision|0|||
131732778|NCT03280550|474298793|FG001|Overall Study|Physician Decision|1|||
131732779|NCT02203838|474298796|FG000|Overall Study|Lack of Efficacy|7|||
131732780|NCT02203838|474298797|FG001|Overall Study|Lack of Efficacy|0|||
131732781|NCT02203838|474298798|FG002|Overall Study|Lack of Efficacy|1|||
131732782|NCT02203838|474298799|FG003|Overall Study|Lack of Efficacy|1|||
131732783|NCT02203838|474298796|FG000|Overall Study|Adverse Event|46|||
131732784|NCT02203838|474298797|FG001|Overall Study|Adverse Event|6|||
131732785|NCT02203838|474298798|FG002|Overall Study|Adverse Event|3|||
131732786|NCT02203838|474298799|FG003|Overall Study|Adverse Event|2|||
131732787|NCT02203838|474298796|FG000|Overall Study|Lost to Follow-up|39|||
131732788|NCT02203838|474298797|FG001|Overall Study|Lost to Follow-up|3|||
131732789|NCT02203838|474298798|FG002|Overall Study|Lost to Follow-up|2|||
131732790|NCT02203838|474298799|FG003|Overall Study|Lost to Follow-up|1|||
131732791|NCT02203838|474298796|FG000|Overall Study|Protocol Violation|7|||
131732792|NCT02203838|474298797|FG001|Overall Study|Protocol Violation|3|||
131732793|NCT02203838|474298798|FG002|Overall Study|Protocol Violation|0|||
131732794|NCT02203838|474298799|FG003|Overall Study|Protocol Violation|0|||
131732795|NCT02203838|474298796|FG000|Overall Study|Withdrawal by Subject|83|||
131732796|NCT02203838|474298797|FG001|Overall Study|Withdrawal by Subject|10|||
131732797|NCT02203838|474298798|FG002|Overall Study|Withdrawal by Subject|8|||
131732798|NCT02203838|474298799|FG003|Overall Study|Withdrawal by Subject|11|||
131732799|NCT02203838|474298796|FG000|Overall Study|Physician Decision|27|||
131732800|NCT02203838|474298797|FG001|Overall Study|Physician Decision|0|||
131732801|NCT02203838|474298798|FG002|Overall Study|Physician Decision|2|||
131732802|NCT02203838|474298799|FG003|Overall Study|Physician Decision|3|||
131732803|NCT02203838|474298796|FG000|Overall Study|Other|1|||
131732804|NCT02203838|474298797|FG001|Overall Study|Other|0|||
131732805|NCT02203838|474298798|FG002|Overall Study|Other|0|||
131732806|NCT02203838|474298799|FG003|Overall Study|Other|0|||
131732807|NCT03345836|474298800|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
131732808|NCT03345836|474298801|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
131732809|NCT03345836|474298802|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
131732810|NCT03345836|474298803|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
131732811|NCT03345836|474298804|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
131732812|NCT03345836|474298805|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
131732813|NCT03345836|474298800|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
131732814|NCT03345836|474298801|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
131732815|NCT03345836|474298802|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
131732816|NCT03345836|474298803|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
131732817|NCT03345836|474298804|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
131732818|NCT03345836|474298805|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
131732819|NCT03345836|474298800|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131732820|NCT03345836|474298801|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
131732821|NCT03345836|474298802|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131732822|NCT03345836|474298803|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131732823|NCT03345836|474298804|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131732824|NCT03345836|474298805|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131732825|NCT03345836|474298800|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
131732826|NCT03345836|474298801|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
131732827|NCT03345836|474298802|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131732828|NCT03345836|474298803|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131732829|NCT03345836|474298804|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131732830|NCT03345836|474298805|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131732831|NCT03345836|474298800|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
131732832|NCT03345836|474298801|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
131732833|NCT03345836|474298802|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
131732834|NCT03345836|474298803|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
131732835|NCT03345836|474298804|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
131732836|NCT03345836|474298805|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
131732837|NCT03345836|474298800|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131732838|NCT03345836|474298801|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131732839|NCT03345836|474298802|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131732840|NCT03345836|474298803|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
131732841|NCT03345836|474298804|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
131807444|NCT00328926|474581095|FG001|Overall Study|Death|0|||
131807445|NCT00328926|474581096|FG002|Overall Study|Death|1|||
131807446|NCT00328926|474581094|FG000|Overall Study|In vitro fertilization treatment|0|||
131807447|NCT00328926|474581095|FG001|Overall Study|In vitro fertilization treatment|0|||
131807448|NCT00328926|474581096|FG002|Overall Study|In vitro fertilization treatment|1|||
131807449|NCT00328926|474581094|FG000|Overall Study|Lack of ovarian response|0|||
131732842|NCT03345836|474298805|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131732843|NCT03345836|474298800|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131807450|NCT00328926|474581095|FG001|Overall Study|Lack of ovarian response|1|||
131732844|NCT03345836|474298801|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131807451|NCT00328926|474581096|FG002|Overall Study|Lack of ovarian response|0|||
131807452|NCT02269657|474581097|FG000|Overall Study|Protocol Violation|3|||
131807453|NCT03450057|474581100|FG000|Overall Study|Death|17|||
131807454|NCT03450057|474581100|FG000|Overall Study|ICF withdrawal|4|||
131732845|NCT03345836|474298802|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131732846|NCT03345836|474298803|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131732847|NCT03345836|474298804|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
131732848|NCT03345836|474298805|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
131732849|NCT03345836|474298800|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131732850|NCT03345836|474298801|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131732851|NCT03345836|474298802|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131732852|NCT03345836|474298803|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131732853|NCT03345836|474298804|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131732854|NCT03345836|474298805|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
131732855|NCT03345836|474298800|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
131732856|NCT03345836|474298801|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
131732857|NCT03345836|474298802|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
131732858|NCT03345836|474298803|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
131732859|NCT03345836|474298804|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
131732860|NCT03345836|474298805|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
131732861|NCT03345836|474298800|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131732862|NCT03345836|474298801|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131732863|NCT03345836|474298802|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131732864|NCT03345836|474298803|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131732865|NCT03345836|474298804|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
131732866|NCT03345836|474298805|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131732867|NCT03345836|474298800|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
131732868|NCT03345836|474298801|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
131732869|NCT03345836|474298802|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
131732870|NCT03345836|474298803|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
131732871|NCT03345836|474298804|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
131732872|NCT03345836|474298805|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
131732873|NCT01915849|474298810|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
131732874|NCT01915849|474298811|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
131732875|NCT01915849|474298812|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
131732876|NCT01915849|474298813|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
131732877|NCT01915849|474298810|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
131905158|NCT00732069|474939066|FG005|Washout After First Study Drug|Adverse Event|0|||
131905159|NCT04460326|474939067|FG000|Completed at Least 4 Meals|Early discharge|5|||
131905160|NCT04460326|474939068|FG001|Completed at Least 4 Meals|Early discharge|5|||
131905161|NCT04460326|474939067|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
131732878|NCT01915849|474298811|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131732879|NCT01915849|474298812|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131905162|NCT04460326|474939068|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
131905163|NCT04460326|474939067|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
131905164|NCT04460326|474939068|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
131905165|NCT04460326|474939067|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
131905166|NCT04460326|474939068|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
131905167|NCT04460326|474939067|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
131905168|NCT04460326|474939068|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
131905169|NCT04460326|474939067|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
131905170|NCT04460326|474939068|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
131905171|NCT00577317|474939069|FG000|Overall Study|Study Terminated|0|||
131905172|NCT00577317|474939070|FG001|Overall Study|Study Terminated|2|||
131905173|NCT04794751|474939073|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
131905174|NCT04794751|474939074|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
131905175|NCT04794751|474939073|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
131732880|NCT01915849|474298813|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131732881|NCT05091060|474298814|FG000|Overall Study|Lost to Follow-up|1|||
131732882|NCT02775864|474298815|FG000|Overall Study|Data ended end of 2010|1764|||
131732883|NCT02775864|474298816|FG001|Overall Study|Data ended end of 2010|2880|||
131732884|NCT02775864|474298817|FG002|Overall Study|Data ended end of 2010|1140|||
131732885|NCT02775864|474298818|FG003|Overall Study|Data ended end of 2010|1194|||
131732886|NCT02775864|474298815|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
131732887|NCT02775864|474298816|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
131732888|NCT02775864|474298817|FG002|Overall Study|Medicaid eligibility discontinued|720|||
131732889|NCT02775864|474298818|FG003|Overall Study|Medicaid eligibility discontinued|890|||
131905176|NCT04794751|474939074|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
131448817|NCT00419952|473272731|FG000|Overall Study|Withdrawal by Subject|44|||
131448818|NCT00419952|473272732|FG001|Overall Study|Withdrawal by Subject|43|||
131732890|NCT01318083|474298819|FG000|Overall Study|Adverse Event|4|||
131732891|NCT01318083|474298820|FG001|Overall Study|Adverse Event|1|||
131732892|NCT01318083|474298821|FG002|Overall Study|Adverse Event|2|||
131732893|NCT01318083|474298819|FG000|Overall Study|Withdrawal by Subject|1|||
131732894|NCT01318083|474298820|FG001|Overall Study|Withdrawal by Subject|0|||
131732895|NCT01318083|474298821|FG002|Overall Study|Withdrawal by Subject|2|||
131732896|NCT01318083|474298819|FG000|Overall Study|Lack of Efficacy|0|||
131732897|NCT01318083|474298820|FG001|Overall Study|Lack of Efficacy|0|||
131732898|NCT01318083|474298821|FG002|Overall Study|Lack of Efficacy|1|||
131732899|NCT01318083|474298819|FG000|Overall Study|Treatment Complications|1|||
131732900|NCT01318083|474298820|FG001|Overall Study|Treatment Complications|0|||
131732901|NCT01318083|474298821|FG002|Overall Study|Treatment Complications|0|||
131732902|NCT01318083|474298819|FG000|Overall Study|Lack of Study Medication Compliance|0|||
131732903|NCT01318083|474298820|FG001|Overall Study|Lack of Study Medication Compliance|1|||
131732904|NCT01318083|474298821|FG002|Overall Study|Lack of Study Medication Compliance|0|||
131732905|NCT03552549|474298823|FG000|Overall Study|Disease progression|25|||
131732906|NCT03552549|474298824|FG001|Overall Study|Disease progression|17|||
131732907|NCT03552549|474298823|FG000|Overall Study|Adverse event in first 12 months|12|||
131732908|NCT03552549|474298824|FG001|Overall Study|Adverse event in first 12 months|8|||
131732909|NCT03552549|474298823|FG000|Overall Study|Withdrawal by Subject|7|||
131732910|NCT03552549|474298824|FG001|Overall Study|Withdrawal by Subject|7|||
131732911|NCT03552549|474298823|FG000|Overall Study|Unknown (no reason provided)|4|||
131732912|NCT03552549|474298824|FG001|Overall Study|Unknown (no reason provided)|2|||
131732913|NCT03552549|474298823|FG000|Overall Study|Not in participant's best interest|2|||
131732914|NCT03552549|474298824|FG001|Overall Study|Not in participant's best interest|1|||
131732915|NCT03552549|474298823|FG000|Overall Study|Did not complete study treatment|2|||
131732916|NCT03552549|474298824|FG001|Overall Study|Did not complete study treatment|3|||
131732917|NCT03552549|474298823|FG000|Overall Study|Did not meet eligibility criteria|1|||
131732918|NCT03552549|474298824|FG001|Overall Study|Did not meet eligibility criteria|0|||
131732919|NCT03552549|474298823|FG000|Overall Study|Administrative|0|||
131732920|NCT03552549|474298824|FG001|Overall Study|Administrative|14|||
131732921|NCT02761993|474298831|FG000|Overall Study|Adverse Event|0|||
131732922|NCT02761993|474298832|FG001|Overall Study|Adverse Event|2|||
131732923|NCT02761993|474298833|FG002|Overall Study|Adverse Event|0|||
131732924|NCT02761993|474298831|FG000|Overall Study|Lost to Follow-up|1|||
131732925|NCT02761993|474298832|FG001|Overall Study|Lost to Follow-up|3|||
131732926|NCT02761993|474298833|FG002|Overall Study|Lost to Follow-up|2|||
131732927|NCT02761993|474298831|FG000|Overall Study|Withdrawal by Subject|1|||
131732928|NCT02761993|474298832|FG001|Overall Study|Withdrawal by Subject|1|||
131732929|NCT02761993|474298833|FG002|Overall Study|Withdrawal by Subject|2|||
131732930|NCT01465178|474298836|FG000|Overall Study|Withdrawal by Subject|1|||
131732931|NCT01465178|474298837|FG001|Overall Study|Withdrawal by Subject|0|||
131732932|NCT03827473|474298840|FG000|Overall Study|Withdrawal by Subject|1|||
131732933|NCT03827473|474298841|FG001|Overall Study|Withdrawal by Subject|0|||
131732934|NCT00875017|474298842|FG000|First Intervention|Withdrawal by Subject|1|||
131732935|NCT00875017|474298843|FG001|First Intervention|Withdrawal by Subject|0|||
131732936|NCT00875017|474298844|FG002|First Intervention|Withdrawal by Subject|1|||
131807455|NCT03450057|474581100|FG000|Overall Study|Lost to Follow-up|2|||
131807456|NCT00573066|474581101|FG000|Overall Study|Exclusion criteria|18|||
131807457|NCT00573066|474581101|FG000|Overall Study|IV malfunction|1|||
131807458|NCT00573066|474581101|FG000|Overall Study|Postoperative bleeding|1|||
131807459|NCT04129346|474581102|FG000|Overall Study|Death|1|||
131732937|NCT00875017|474298845|FG003|First Intervention|Withdrawal by Subject|0|||
131807460|NCT04129346|474581103|FG001|Overall Study|Death|0|||
131732938|NCT00875017|474298846|FG004|First Intervention|Withdrawal by Subject|0|||
131732939|NCT00875017|474298847|FG005|First Intervention|Withdrawal by Subject|0|||
131807461|NCT01534663|474581104|FG000|Overall Study|Lost to Follow-up|0|||
131807462|NCT01534663|474581105|FG001|Overall Study|Lost to Follow-up|2|||
131807463|NCT01534663|474581104|FG000|Overall Study|Adverse Event|2|||
131807464|NCT01534663|474581105|FG001|Overall Study|Adverse Event|1|||
131732940|NCT00875017|474298842|FG000|First Intervention|Adverse Event|0|||
131732941|NCT00875017|474298843|FG001|First Intervention|Adverse Event|0|||
131732942|NCT00875017|474298844|FG002|First Intervention|Adverse Event|0|||
131732943|NCT00875017|474298845|FG003|First Intervention|Adverse Event|1|||
131732944|NCT00875017|474298846|FG004|First Intervention|Adverse Event|0|||
131732945|NCT00875017|474298847|FG005|First Intervention|Adverse Event|0|||
131807465|NCT00627016|474581106|FG000|Overall Study|Adverse Event|1|||
131807466|NCT00627016|474581107|FG001|Overall Study|Adverse Event|1|||
131732946|NCT00875017|474298842|FG000|First Intervention|Problems collecting rectal effluent|1|||
131732947|NCT00875017|474298843|FG001|First Intervention|Problems collecting rectal effluent|0|||
131732948|NCT00875017|474298844|FG002|First Intervention|Problems collecting rectal effluent|0|||
131732949|NCT00875017|474298845|FG003|First Intervention|Problems collecting rectal effluent|0|||
131732950|NCT00875017|474298846|FG004|First Intervention|Problems collecting rectal effluent|0|||
131732951|NCT00875017|474298847|FG005|First Intervention|Problems collecting rectal effluent|0|||
131732952|NCT00875017|474298842|FG000|First Intervention|Intolerance to nasogastric tube|0|||
131732953|NCT00875017|474298843|FG001|First Intervention|Intolerance to nasogastric tube|0|||
131732954|NCT00875017|474298844|FG002|First Intervention|Intolerance to nasogastric tube|0|||
131732955|NCT00875017|474298845|FG003|First Intervention|Intolerance to nasogastric tube|0|||
131732956|NCT00875017|474298846|FG004|First Intervention|Intolerance to nasogastric tube|1|||
131732957|NCT00875017|474298847|FG005|First Intervention|Intolerance to nasogastric tube|0|||
131732958|NCT00875017|474298842|FG000|Washout|Problem collecting rectal effluent|0|||
131732959|NCT00875017|474298843|FG001|Washout|Problem collecting rectal effluent|0|||
131732960|NCT00875017|474298844|FG002|Washout|Problem collecting rectal effluent|1|||
131732961|NCT00875017|474298845|FG003|Washout|Problem collecting rectal effluent|0|||
131732962|NCT00875017|474298846|FG004|Washout|Problem collecting rectal effluent|0|||
131732963|NCT00875017|474298847|FG005|Washout|Problem collecting rectal effluent|0|||
131732964|NCT00875017|474298842|FG000|Second Intervention|Adverse Event|0|||
131732965|NCT00875017|474298843|FG001|Second Intervention|Adverse Event|0|||
131732966|NCT00875017|474298844|FG002|Second Intervention|Adverse Event|0|||
131732967|NCT00875017|474298845|FG003|Second Intervention|Adverse Event|1|||
131732968|NCT00875017|474298846|FG004|Second Intervention|Adverse Event|0|||
131732969|NCT00875017|474298847|FG005|Second Intervention|Adverse Event|0|||
131732970|NCT00875017|474298842|FG000|Washout|Problems collecting rectal effluent|0|||
131732971|NCT00875017|474298843|FG001|Washout|Problems collecting rectal effluent|1|||
131732972|NCT00875017|474298844|FG002|Washout|Problems collecting rectal effluent|0|||
131732973|NCT00875017|474298845|FG003|Washout|Problems collecting rectal effluent|0|||
131732974|NCT00875017|474298846|FG004|Washout|Problems collecting rectal effluent|0|||
131732975|NCT00875017|474298847|FG005|Washout|Problems collecting rectal effluent|0|||
131732976|NCT00875017|474298842|FG000|Third Intervention|Adverse Event|0|||
131732977|NCT00875017|474298843|FG001|Third Intervention|Adverse Event|1|||
131732978|NCT00875017|474298844|FG002|Third Intervention|Adverse Event|1|||
131732979|NCT00875017|474298845|FG003|Third Intervention|Adverse Event|0|||
131732980|NCT00875017|474298846|FG004|Third Intervention|Adverse Event|0|||
131732981|NCT00875017|474298847|FG005|Third Intervention|Adverse Event|0|||
131732982|NCT00875017|474298842|FG000|Washout|Withdrawal by Subject|0|||
131732983|NCT00875017|474298843|FG001|Washout|Withdrawal by Subject|0|||
131732984|NCT00875017|474298844|FG002|Washout|Withdrawal by Subject|0|||
131732985|NCT00875017|474298845|FG003|Washout|Withdrawal by Subject|0|||
131732986|NCT00875017|474298846|FG004|Washout|Withdrawal by Subject|1|||
131732987|NCT00875017|474298847|FG005|Washout|Withdrawal by Subject|0|||
131732988|NCT00875017|474298842|FG000|Fourth Intervention|Inability to comply with fasting|0|||
131732989|NCT00875017|474298843|FG001|Fourth Intervention|Inability to comply with fasting|0|||
131732990|NCT00875017|474298844|FG002|Fourth Intervention|Inability to comply with fasting|0|||
131732991|NCT00875017|474298845|FG003|Fourth Intervention|Inability to comply with fasting|0|||
131732992|NCT00875017|474298846|FG004|Fourth Intervention|Inability to comply with fasting|0|||
131732993|NCT00875017|474298847|FG005|Fourth Intervention|Inability to comply with fasting|1|||
131732994|NCT03342469|474298848|FG000|Overall Study|Withdrawal by Subject|0|||
131732995|NCT03342469|474298849|FG001|Overall Study|Withdrawal by Subject|1|||
131732996|NCT03342469|474298850|FG002|Overall Study|Withdrawal by Subject|0|||
131732997|NCT03342469|474298851|FG003|Overall Study|Withdrawal by Subject|0|||
131732998|NCT01477892|474298852|FG000|Overall Study|Withdrawal by Subject|0|||
131732999|NCT01477892|474298853|FG001|Overall Study|Withdrawal by Subject|2|||
131733000|NCT05515601|474298859|FG000|Overall Study|Withdrawal by Subject|1|||
131733001|NCT05515601|474298860|FG001|Overall Study|Withdrawal by Subject|3|||
131733002|NCT05515601|474298861|FG002|Overall Study|Withdrawal by Subject|2|||
131733003|NCT05515601|474298862|FG003|Overall Study|Withdrawal by Subject|1|||
131733004|NCT05515601|474298863|FG004|Overall Study|Withdrawal by Subject|1|||
131733005|NCT05515601|474298864|FG005|Overall Study|Withdrawal by Subject|1|||
131733006|NCT05515601|474298859|FG000|Overall Study|Lost to Follow-up|0|||
131733007|NCT05515601|474298860|FG001|Overall Study|Lost to Follow-up|0|||
131733008|NCT05515601|474298861|FG002|Overall Study|Lost to Follow-up|0|||
131807467|NCT00627016|474581106|FG000|Overall Study|Protocol Violation|0|||
131733009|NCT05515601|474298862|FG003|Overall Study|Lost to Follow-up|0|||
131733010|NCT05515601|474298863|FG004|Overall Study|Lost to Follow-up|1|||
131733011|NCT05515601|474298864|FG005|Overall Study|Lost to Follow-up|0|||
131733012|NCT00777491|474298865|FG000|Overall Study|Protocol Violation|0|||
131807468|NCT00627016|474581107|FG001|Overall Study|Protocol Violation|2|||
131807469|NCT00627016|474581106|FG000|Overall Study|Lost to Follow-up|0|||
131733013|NCT00777491|474298866|FG001|Overall Study|Protocol Violation|2|||
131733014|NCT00777491|474298865|FG000|Overall Study|Did not receive any protocol treatment|2|||
131733015|NCT00777491|474298866|FG001|Overall Study|Did not receive any protocol treatment|0|||
131807470|NCT00627016|474581107|FG001|Overall Study|Lost to Follow-up|1|||
131807471|NCT00627016|474581106|FG000|Overall Study|Withdrawal by Subject|2|||
131807472|NCT00627016|474581107|FG001|Overall Study|Withdrawal by Subject|1|||
131733016|NCT01912768|474298867|FG000|Overall Study|Adverse Event|2|||
131733017|NCT01912768|474298868|FG001|Overall Study|Adverse Event|0|||
131733018|NCT01912768|474298867|FG000|Overall Study|Lost to Follow-up|2|||
131733019|NCT01912768|474298868|FG001|Overall Study|Lost to Follow-up|1|||
131733020|NCT01912768|474298867|FG000|Overall Study|Withdrawal by Subject|5|||
131733021|NCT01912768|474298868|FG001|Overall Study|Withdrawal by Subject|3|||
131733022|NCT01912768|474298867|FG000|Overall Study|Randomized in error|1|||
131733023|NCT01912768|474298868|FG001|Overall Study|Randomized in error|0|||
131733024|NCT04160468|474298869|FG000|Overall Study|Lost to Follow-up|19|||
131733025|NCT04160468|474298870|FG001|Overall Study|Lost to Follow-up|4|||
131733026|NCT04160468|474298869|FG000|Overall Study|Randomized but not dosed|6|||
131733027|NCT04160468|474298870|FG001|Overall Study|Randomized but not dosed|0|||
131733028|NCT04160468|474298869|FG000|Overall Study|Withdrawal by Subject|4|||
131733029|NCT04160468|474298870|FG001|Overall Study|Withdrawal by Subject|1|||
131733030|NCT04160468|474298869|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
131733031|NCT04160468|474298870|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
131733032|NCT04160468|474298869|FG000|Overall Study|Participant incarcerated|1|||
131733033|NCT04160468|474298870|FG001|Overall Study|Participant incarcerated|0|||
131733034|NCT01187901|474298871|FG000|Overall Study|Protocol Violation|1|||
131733035|NCT01187901|474298872|FG001|Overall Study|Protocol Violation|0|||
131733036|NCT01187901|474298871|FG000|Overall Study|Lost to Follow-up|1|||
131733037|NCT01187901|474298872|FG001|Overall Study|Lost to Follow-up|2|||
131733038|NCT01187901|474298871|FG000|Overall Study|Unrelated Health Reasons|1|||
131733039|NCT01187901|474298872|FG001|Overall Study|Unrelated Health Reasons|2|||
131733040|NCT01187901|474298871|FG000|Overall Study|Suspected Allergic Reaction|1|||
131733041|NCT01187901|474298872|FG001|Overall Study|Suspected Allergic Reaction|1|||
131733042|NCT01187901|474298871|FG000|Overall Study|Adverse Event|3|||
131733043|NCT01187901|474298872|FG001|Overall Study|Adverse Event|0|||
131733044|NCT01187901|474298871|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
131733045|NCT01187901|474298872|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
131733046|NCT01187901|474298871|FG000|Overall Study|Pregnancy|0|||
131733047|NCT01187901|474298872|FG001|Overall Study|Pregnancy|2|||
131733048|NCT00540436|474298875|FG000|First 12-Week Treatment Period|Adverse Event|1|||
131733049|NCT00540436|474298875|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
131733050|NCT00540436|474298875|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
131733051|NCT00540436|474298875|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
131733052|NCT03255291|474298876|FG000|Overall Study|Determined to be ineligible|10|||
131733053|NCT03255291|474298877|FG001|Overall Study|Determined to be ineligible|12|||
131733054|NCT03255291|474298878|FG002|Overall Study|Determined to be ineligible|6|||
131733055|NCT03255291|474298879|FG003|Overall Study|Determined to be ineligible|6|||
131733056|NCT03255291|474298880|FG004|Overall Study|Determined to be ineligible|5|||
131733057|NCT03255291|474298881|FG005|Overall Study|Determined to be ineligible|10|||
131733058|NCT03255291|474298876|FG000|Overall Study|Baseline data collection issues|3|||
131733059|NCT03255291|474298877|FG001|Overall Study|Baseline data collection issues|0|||
131733060|NCT03255291|474298878|FG002|Overall Study|Baseline data collection issues|0|||
131733061|NCT03255291|474298879|FG003|Overall Study|Baseline data collection issues|0|||
131733062|NCT03255291|474298880|FG004|Overall Study|Baseline data collection issues|2|||
131733063|NCT03255291|474298881|FG005|Overall Study|Baseline data collection issues|0|||
131733064|NCT01745393|474298882|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
131733065|NCT01745393|474298883|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
131733066|NCT01745393|474298882|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
131733067|NCT01745393|474298883|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
131733068|NCT01745393|474298882|FG000|12-month Follow-up|Lost to Follow-up|6|||
131733069|NCT01745393|474298883|FG001|12-month Follow-up|Lost to Follow-up|5|||
131733070|NCT00520676|474300569|FG000|Overall Study|Death|84|||
131733071|NCT00520676|474300570|FG001|Overall Study|Death|81|||
131733072|NCT00520676|474300569|FG000|Overall Study|Lost to Follow-up|6|||
131733073|NCT00520676|474300570|FG001|Overall Study|Lost to Follow-up|10|||
131733074|NCT00520676|474300569|FG000|Overall Study|Physician Decision|4|||
131733075|NCT00520676|474300570|FG001|Overall Study|Physician Decision|1|||
131733076|NCT00520676|474300569|FG000|Overall Study|Withdrawal by Subject|7|||
131733077|NCT00520676|474300570|FG001|Overall Study|Withdrawal by Subject|11|||
131733078|NCT02179515|474300571|FG000|Overall Study|switched to alternative treatment|0|||
131733079|NCT02179515|474300572|FG001|Overall Study|switched to alternative treatment|1|||
131733080|NCT02179515|474300573|FG002|Overall Study|switched to alternative treatment|1|||
131733081|NCT02179515|474300571|FG000|Overall Study|Death|0|||
131733082|NCT02179515|474300572|FG001|Overall Study|Death|1|||
131733083|NCT02179515|474300573|FG002|Overall Study|Death|1|||
131733084|NCT02179515|474300571|FG000|Overall Study|refused further treatment|0|||
131733085|NCT02179515|474300572|FG001|Overall Study|refused further treatment|3|||
131733086|NCT02179515|474300573|FG002|Overall Study|refused further treatment|4|||
131733087|NCT02179515|474300571|FG000|Overall Study|Disease progression on study|2|||
131807473|NCT00627016|474581106|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
131733088|NCT02179515|474300572|FG001|Overall Study|Disease progression on study|11|||
131733089|NCT02179515|474300573|FG002|Overall Study|Disease progression on study|8|||
131733090|NCT03484923|474300574|FG000|Overall Study|Adverse Event|3|||
131733091|NCT03484923|474300575|FG001|Overall Study|Adverse Event|3|||
131733092|NCT03484923|474300576|FG002|Overall Study|Adverse Event|5|||
131733093|NCT03484923|474300577|FG003|Overall Study|Adverse Event|11|||
131733094|NCT03484923|474300578|FG004|Overall Study|Adverse Event|1|||
131733095|NCT03484923|474300574|FG000|Overall Study|Death|2|||
131733096|NCT03484923|474300575|FG001|Overall Study|Death|2|||
131733097|NCT03484923|474300576|FG002|Overall Study|Death|3|||
131733098|NCT03484923|474300577|FG003|Overall Study|Death|0|||
131733099|NCT03484923|474300578|FG004|Overall Study|Death|1|||
131733100|NCT03484923|474300574|FG000|Overall Study|Physician Decision|6|||
131733101|NCT03484923|474300575|FG001|Overall Study|Physician Decision|7|||
131733102|NCT03484923|474300576|FG002|Overall Study|Physician Decision|6|||
131733103|NCT03484923|474300577|FG003|Overall Study|Physician Decision|3|||
131733104|NCT03484923|474300578|FG004|Overall Study|Physician Decision|2|||
131733105|NCT03484923|474300574|FG000|Overall Study|Progressive disease|33|||
131733106|NCT03484923|474300575|FG001|Overall Study|Progressive disease|28|||
131733107|NCT03484923|474300576|FG002|Overall Study|Progressive disease|26|||
131733108|NCT03484923|474300577|FG003|Overall Study|Progressive disease|30|||
131733109|NCT03484923|474300578|FG004|Overall Study|Progressive disease|16|||
131733110|NCT03484923|474300574|FG000|Overall Study|Subject Decision|1|||
131733111|NCT03484923|474300575|FG001|Overall Study|Subject Decision|3|||
131733112|NCT03484923|474300576|FG002|Overall Study|Subject Decision|3|||
131733113|NCT03484923|474300577|FG003|Overall Study|Subject Decision|0|||
131733114|NCT03484923|474300578|FG004|Overall Study|Subject Decision|1|||
131733115|NCT03165721|474300583|FG000|Overall Study|Refused further treatment|3|||
131733116|NCT03165721|474300584|FG001|Overall Study|Refused further treatment|0|||
131733117|NCT03165721|474300585|FG002|Overall Study|Refused further treatment|0|||
131733118|NCT03165721|474300583|FG000|Overall Study|Physician Decision|1|||
131733119|NCT03165721|474300584|FG001|Overall Study|Physician Decision|0|||
131733120|NCT03165721|474300585|FG002|Overall Study|Physician Decision|0|||
131733121|NCT01863849|474300586|FG000|Overall Study|Lost to Follow-up|1|||
131733122|NCT01863849|474300587|FG001|Overall Study|Lost to Follow-up|0|||
131733123|NCT01457118|474300588|FG000|Overall Study|Adverse Event|1|||
131733124|NCT01457118|474300589|FG001|Overall Study|Adverse Event|0|||
131733125|NCT01457118|474300590|FG002|Overall Study|Adverse Event|0|||
131733126|NCT01457118|474300591|FG003|Overall Study|Adverse Event|1|||
131733127|NCT01457118|474300588|FG000|Overall Study|Clinical Progression|0|||
131733128|NCT01457118|474300589|FG001|Overall Study|Clinical Progression|1|||
131733129|NCT01457118|474300590|FG002|Overall Study|Clinical Progression|0|||
131733130|NCT01457118|474300591|FG003|Overall Study|Clinical Progression|1|||
131733131|NCT01457118|474300588|FG000|Overall Study|Physician Decision|2|||
131733132|NCT01457118|474300589|FG001|Overall Study|Physician Decision|0|||
131733133|NCT01457118|474300590|FG002|Overall Study|Physician Decision|0|||
131733134|NCT01457118|474300591|FG003|Overall Study|Physician Decision|0|||
131733135|NCT01457118|474300588|FG000|Overall Study|Progressive Disease by RECIST|12|||
131733136|NCT01457118|474300589|FG001|Overall Study|Progressive Disease by RECIST|3|||
131733137|NCT01457118|474300590|FG002|Overall Study|Progressive Disease by RECIST|1|||
131733138|NCT01457118|474300591|FG003|Overall Study|Progressive Disease by RECIST|0|||
131733139|NCT01457118|474300588|FG000|Overall Study|Withdrawal by Subject|5|||
131733140|NCT01457118|474300589|FG001|Overall Study|Withdrawal by Subject|0|||
131733141|NCT01457118|474300590|FG002|Overall Study|Withdrawal by Subject|0|||
131733142|NCT01457118|474300591|FG003|Overall Study|Withdrawal by Subject|0|||
131733143|NCT00115349|474300592|FG000|Overall Study|Study closed due to low enrollment.|11|||
131733144|NCT00115349|474300593|FG001|Overall Study|Study closed due to low enrollment.|9|||
131733145|NCT01718509|474300596|FG000|Overall Study|Lost to Follow-up|18|||
131733146|NCT01718509|474300597|FG001|Overall Study|Lost to Follow-up|15|||
131733147|NCT01718509|474300596|FG000|Overall Study|Withdrawal by Subject|7|||
131733148|NCT01718509|474300597|FG001|Overall Study|Withdrawal by Subject|13|||
131733149|NCT01718509|474300596|FG000|Overall Study|Adverse Event|5|||
131733150|NCT01718509|474300597|FG001|Overall Study|Adverse Event|7|||
131733151|NCT01718509|474300596|FG000|Overall Study|Other|13|||
131733152|NCT01718509|474300597|FG001|Overall Study|Other|11|||
131733153|NCT01718509|474300596|FG000|Overall Study|Protocol Violation|4|||
131733154|NCT01718509|474300597|FG001|Overall Study|Protocol Violation|2|||
131733155|NCT01718509|474300596|FG000|Overall Study|Lack of Efficacy|1|||
131733156|NCT01718509|474300597|FG001|Overall Study|Lack of Efficacy|0|||
131733157|NCT00390416|474300600|FG000|Overall Study|Withdrawal by Subject|1|||
131733158|NCT00390416|474300600|FG000|Overall Study|Not treated|3|||
131733159|NCT01219959|474300601|FG000|Overall Study|Adverse Event|6|||
131733160|NCT01219959|474300602|FG001|Overall Study|Adverse Event|14|||
131733161|NCT01219959|474300601|FG000|Overall Study|Physician Decision|0|||
131733162|NCT01219959|474300602|FG001|Overall Study|Physician Decision|4|||
131733163|NCT01219959|474300601|FG000|Overall Study|Withdrawal by Subject|0|||
131733164|NCT01219959|474300602|FG001|Overall Study|Withdrawal by Subject|2|||
131733165|NCT01219959|474300601|FG000|Overall Study|Renal Transplantation|0|||
131733166|NCT01219959|474300602|FG001|Overall Study|Renal Transplantation|3|||
131733167|NCT01219959|474300601|FG000|Overall Study|Other|1|||
131733168|NCT01219959|474300602|FG001|Overall Study|Other|0|||
131733169|NCT01728584|474300603|FG000|Overall Study|Adverse Event|1|||
131733170|NCT01728584|474300604|FG001|Overall Study|Adverse Event|0|||
131733171|NCT01728584|474300605|FG002|Overall Study|Adverse Event|0|||
131733172|NCT01728584|474300606|FG003|Overall Study|Adverse Event|0|||
131733173|NCT01728584|474300603|FG000|Overall Study|Physician Decision|4|||
131733174|NCT01728584|474300604|FG001|Overall Study|Physician Decision|0|||
131733175|NCT01728584|474300605|FG002|Overall Study|Physician Decision|1|||
131733176|NCT01728584|474300606|FG003|Overall Study|Physician Decision|0|||
131733177|NCT01728584|474300603|FG000|Overall Study|Withdrawal by Subject|1|||
131733178|NCT01728584|474300604|FG001|Overall Study|Withdrawal by Subject|0|||
131733179|NCT01728584|474300605|FG002|Overall Study|Withdrawal by Subject|0|||
131733180|NCT01728584|474300606|FG003|Overall Study|Withdrawal by Subject|0|||
131733181|NCT01728584|474300603|FG000|Overall Study|Screen failure|1|||
131733182|NCT01728584|474300604|FG001|Overall Study|Screen failure|0|||
131733183|NCT01728584|474300605|FG002|Overall Study|Screen failure|0|||
131733184|NCT01728584|474300606|FG003|Overall Study|Screen failure|0|||
131733185|NCT01728584|474300603|FG000|Overall Study|Other reason (not specified)|1|||
131733186|NCT01728584|474300604|FG001|Overall Study|Other reason (not specified)|0|||
131733187|NCT01728584|474300605|FG002|Overall Study|Other reason (not specified)|0|||
131733188|NCT01728584|474300606|FG003|Overall Study|Other reason (not specified)|1|||
131733189|NCT02935634|474300607|FG000|Randomization|Participant withdrew consent|0|||
131733190|NCT02935634|474300608|FG001|Randomization|Participant withdrew consent|1|||
131733191|NCT02935634|474300609|FG002|Randomization|Participant withdrew consent|0|||
131733192|NCT02935634|474300610|FG003|Randomization|Participant withdrew consent|0|||
131733193|NCT02935634|474300611|FG004|Randomization|Participant withdrew consent|0|||
131733194|NCT02935634|474300612|FG005|Randomization|Participant withdrew consent|0|||
131733195|NCT02935634|474300607|FG000|Randomization|Death|2|||
131733196|NCT02935634|474300608|FG001|Randomization|Death|1|||
131733197|NCT02935634|474300609|FG002|Randomization|Death|1|||
131733198|NCT02935634|474300610|FG003|Randomization|Death|0|||
131733199|NCT02935634|474300611|FG004|Randomization|Death|0|||
131733200|NCT02935634|474300612|FG005|Randomization|Death|0|||
131733201|NCT02935634|474300607|FG000|Randomization|Other reasons|0|||
131733202|NCT02935634|474300608|FG001|Randomization|Other reasons|2|||
131733203|NCT02935634|474300609|FG002|Randomization|Other reasons|2|||
131733204|NCT02935634|474300610|FG003|Randomization|Other reasons|0|||
131733205|NCT02935634|474300611|FG004|Randomization|Other reasons|0|||
131733206|NCT02935634|474300612|FG005|Randomization|Other reasons|0|||
131733207|NCT02935634|474300607|FG000|Treatment: Track 1|Disease progression|15|||
131733208|NCT02935634|474300608|FG001|Treatment: Track 1|Disease progression|17|||
131733209|NCT02935634|474300609|FG002|Treatment: Track 1|Disease progression|28|||
131733210|NCT02935634|474300610|FG003|Treatment: Track 1|Disease progression|4|||
131733211|NCT02935634|474300611|FG004|Treatment: Track 1|Disease progression|6|||
131733212|NCT02935634|474300612|FG005|Treatment: Track 1|Disease progression|2|||
131733213|NCT02935634|474300607|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
131733214|NCT02935634|474300608|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
131733215|NCT02935634|474300609|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
131733216|NCT02935634|474300610|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
131733217|NCT02935634|474300611|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
131733218|NCT02935634|474300612|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
131733219|NCT02935634|474300607|FG000|Treatment: Track 1|Lost to Follow-up|1|||
131733220|NCT02935634|474300608|FG001|Treatment: Track 1|Lost to Follow-up|0|||
131733221|NCT02935634|474300609|FG002|Treatment: Track 1|Lost to Follow-up|0|||
131733222|NCT02935634|474300610|FG003|Treatment: Track 1|Lost to Follow-up|0|||
131733223|NCT02935634|474300611|FG004|Treatment: Track 1|Lost to Follow-up|0|||
131733224|NCT02935634|474300612|FG005|Treatment: Track 1|Lost to Follow-up|0|||
131733225|NCT02935634|474300607|FG000|Treatment: Track 1|Study drug toxicity|2|||
131733226|NCT02935634|474300608|FG001|Treatment: Track 1|Study drug toxicity|1|||
131733227|NCT02935634|474300609|FG002|Treatment: Track 1|Study drug toxicity|3|||
131733228|NCT02935634|474300610|FG003|Treatment: Track 1|Study drug toxicity|0|||
131733229|NCT02935634|474300611|FG004|Treatment: Track 1|Study drug toxicity|0|||
131733230|NCT02935634|474300612|FG005|Treatment: Track 1|Study drug toxicity|1|||
131733231|NCT02935634|474300607|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
131905177|NCT04794751|474939073|FG000|Period 1|Protocol Violation|0|||
131807474|NCT00627016|474581107|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
131807475|NCT00627016|474581106|FG000|Overall Study|Lack of Efficacy|1|||
131807476|NCT00627016|474581107|FG001|Overall Study|Lack of Efficacy|0|||
131807477|NCT00627016|474581106|FG000|Overall Study|Placed on Excluded Drugs|1|||
131807478|NCT00627016|474581107|FG001|Overall Study|Placed on Excluded Drugs|0|||
131807479|NCT00627016|474581106|FG000|Overall Study|Pregnancy|1|||
131807480|NCT00627016|474581107|FG001|Overall Study|Pregnancy|0|||
131807481|NCT00377260|474581108|FG000|Overall Study|Lost to Follow-up|0|||
131733232|NCT02935634|474300608|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
131733233|NCT02935634|474300609|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
131733234|NCT02935634|474300610|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
131733235|NCT02935634|474300611|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
131733236|NCT02935634|474300612|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
131733237|NCT02935634|474300607|FG000|Treatment: Track 1|Participant withdrew consent|2|||
131733238|NCT02935634|474300608|FG001|Treatment: Track 1|Participant withdrew consent|0|||
131733239|NCT02935634|474300609|FG002|Treatment: Track 1|Participant withdrew consent|1|||
131733240|NCT02935634|474300610|FG003|Treatment: Track 1|Participant withdrew consent|0|||
131733241|NCT02935634|474300611|FG004|Treatment: Track 1|Participant withdrew consent|1|||
131733242|NCT02935634|474300612|FG005|Treatment: Track 1|Participant withdrew consent|0|||
131733243|NCT02935634|474300607|FG000|Treatment: Track 1|Other reasons|0|||
131733244|NCT02935634|474300608|FG001|Treatment: Track 1|Other reasons|0|||
131733245|NCT02935634|474300609|FG002|Treatment: Track 1|Other reasons|2|||
131733246|NCT02935634|474300610|FG003|Treatment: Track 1|Other reasons|0|||
131733247|NCT02935634|474300611|FG004|Treatment: Track 1|Other reasons|0|||
131733248|NCT02935634|474300612|FG005|Treatment: Track 1|Other reasons|0|||
131733249|NCT02935634|474300607|FG000|Treatment: Track 2|Disease progression|13|||
131733250|NCT02935634|474300608|FG001|Treatment: Track 2|Disease progression|26|||
131733251|NCT02935634|474300609|FG002|Treatment: Track 2|Disease progression|20|||
131733252|NCT02935634|474300610|FG003|Treatment: Track 2|Disease progression|5|||
131733253|NCT02935634|474300611|FG004|Treatment: Track 2|Disease progression|1|||
131733254|NCT02935634|474300612|FG005|Treatment: Track 2|Disease progression|4|||
131733255|NCT02935634|474300607|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
131733256|NCT02935634|474300608|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
131733257|NCT02935634|474300609|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131733258|NCT02935634|474300610|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131733259|NCT02935634|474300611|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131733260|NCT02935634|474300612|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131733261|NCT02935634|474300607|FG000|Treatment: Track 2|Study drug toxicity|7|||
131733262|NCT02935634|474300608|FG001|Treatment: Track 2|Study drug toxicity|3|||
131733263|NCT02935634|474300609|FG002|Treatment: Track 2|Study drug toxicity|0|||
131733264|NCT02935634|474300610|FG003|Treatment: Track 2|Study drug toxicity|0|||
131807482|NCT00377260|474581109|FG001|Overall Study|Lost to Follow-up|1|||
131807483|NCT00377260|474581108|FG000|Overall Study|Withdrawal by Subject|2|||
131807484|NCT00377260|474581109|FG001|Overall Study|Withdrawal by Subject|4|||
131807485|NCT03107091|474581110|FG000|Overall Study|Physician Decision|1|||
131807486|NCT04567186|474581115|FG000|Period 1|COVID-19 related|1|||
131807487|NCT04567186|474581116|FG001|Period 1|COVID-19 related|0|||
131807488|NCT04567186|474581115|FG000|Period 1|Protocol Violation|0|||
131733265|NCT02935634|474300611|FG004|Treatment: Track 2|Study drug toxicity|0|||
131733266|NCT02935634|474300612|FG005|Treatment: Track 2|Study drug toxicity|0|||
131733267|NCT02935634|474300607|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
131733268|NCT02935634|474300608|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
131733269|NCT02935634|474300609|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
131733270|NCT02935634|474300610|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
131733271|NCT02935634|474300611|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
131733272|NCT02935634|474300612|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
131733273|NCT02935634|474300607|FG000|Treatment: Track 2|Participant withdrew consent|0|||
131733274|NCT02935634|474300608|FG001|Treatment: Track 2|Participant withdrew consent|1|||
131807489|NCT04567186|474581116|FG001|Period 1|Protocol Violation|1|||
131807490|NCT04567186|474581115|FG000|Period 1|Adverse Event|0|||
131807491|NCT04567186|474581116|FG001|Period 1|Adverse Event|2|||
131905178|NCT04794751|474939074|FG001|Period 1|Protocol Violation|2|||
131733275|NCT02935634|474300609|FG002|Treatment: Track 2|Participant withdrew consent|1|||
131733276|NCT02935634|474300610|FG003|Treatment: Track 2|Participant withdrew consent|0|||
131733277|NCT02935634|474300611|FG004|Treatment: Track 2|Participant withdrew consent|1|||
131807492|NCT04567186|474581115|FG000|Period 2|COVID-19 Related|0|||
131905179|NCT04794751|474939073|FG000|Period 1|Withdrawal by Subject|0|||
131733278|NCT02935634|474300612|FG005|Treatment: Track 2|Participant withdrew consent|0|||
131733279|NCT05906732|474300613|FG000|Overall Study|Withdrawal by Subject|1|||
131807493|NCT04567186|474581116|FG001|Period 2|COVID-19 Related|1|||
131807494|NCT04567186|474581115|FG000|Period 2|Protocol Violation|0|||
131807495|NCT04567186|474581116|FG001|Period 2|Protocol Violation|1|||
131807496|NCT04567186|474581115|FG000|Period 2|Lost to Follow-up|0|||
131733280|NCT05906732|474300614|FG001|Overall Study|Withdrawal by Subject|0|||
131733281|NCT05906732|474300615|FG002|Overall Study|Withdrawal by Subject|0|||
131733282|NCT05906732|474300616|FG003|Overall Study|Withdrawal by Subject|0|||
131733283|NCT05906732|474300613|FG000|Overall Study|Physician Decision|2|||
131733284|NCT05906732|474300614|FG001|Overall Study|Physician Decision|4|||
131733285|NCT05906732|474300615|FG002|Overall Study|Physician Decision|0|||
131733286|NCT05906732|474300616|FG003|Overall Study|Physician Decision|0|||
131733287|NCT00471536|474300623|FG000|Overall Study|Withdrawal by Subject|1|||
131733288|NCT02651194|474300624|FG000|Overall Study|Lost to Follow-up|3|||
131733289|NCT02651194|474300624|FG000|Overall Study|Other|2|||
131733290|NCT02496585|474300625|FG000|Overall Study|Death|3|||
131733291|NCT02496585|474300626|FG001|Overall Study|Death|0|||
131733292|NCT02496585|474300625|FG000|Overall Study|Lost to Follow-up|2|||
131733293|NCT02496585|474300626|FG001|Overall Study|Lost to Follow-up|0|||
131733294|NCT02496585|474300625|FG000|Overall Study|Withdrawal by Subject|1|||
131733295|NCT02496585|474300626|FG001|Overall Study|Withdrawal by Subject|2|||
131733296|NCT02496585|474300625|FG000|Overall Study|Progression of Malignancy|4|||
131733297|NCT02496585|474300626|FG001|Overall Study|Progression of Malignancy|1|||
131733298|NCT01864018|474300629|FG000|Overall Study|Ineligible|3|||
131733299|NCT01864018|474300630|FG001|Overall Study|Ineligible|1|||
131733300|NCT03609359|474300633|FG000|Overall Study|Progression of primary disease (PD)|25|||
131733301|NCT03609359|474300633|FG000|Overall Study|Patient's refusal|1|||
131733302|NCT03609359|474300633|FG000|Overall Study|Physician Decision|1|||
131733303|NCT03609359|474300633|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
131733304|NCT04285346|474300634|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
131733305|NCT04285346|474300635|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
131733306|NCT04285346|474300634|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
131733307|NCT04285346|474300635|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131733308|NCT04285346|474300634|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
131733309|NCT04285346|474300635|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131733310|NCT01975272|474300636|FG000|Overall Study|Excluded after protocol amendment|1|||
131733311|NCT01975272|474300637|FG001|Overall Study|Excluded after protocol amendment|1|||
131733312|NCT01975272|474300638|FG002|Overall Study|Excluded after protocol amendment|2|||
131733313|NCT02028338|474300640|FG000|Overall Study|Withdrawal by Subject|3|||
131733314|NCT02028338|474300641|FG001|Overall Study|Withdrawal by Subject|1|||
131733315|NCT02028338|474300640|FG000|Overall Study|Unable to contact participant|1|||
131733316|NCT02028338|474300641|FG001|Overall Study|Unable to contact participant|0|||
131733317|NCT01842620|474300645|FG000|Period 1|Withdrawal by Subject|1|||
131733318|NCT01842620|474300646|FG001|Period 1|Withdrawal by Subject|0|||
131448819|NCT00419952|473272731|FG000|Overall Study|Lost to Follow-up|43|||
131733319|NCT00256867|474300647|FG000|Overall Study|Adverse Event|0|||
131733320|NCT00256867|474300648|FG001|Overall Study|Adverse Event|1|||
131733321|NCT00256867|474300649|FG002|Overall Study|Adverse Event|1|||
131733322|NCT00256867|474300650|FG003|Overall Study|Adverse Event|1|||
131733323|NCT00256867|474300651|FG004|Overall Study|Adverse Event|2|||
131733324|NCT00256867|474300652|FG005|Overall Study|Adverse Event|2|||
131733325|NCT00256867|474300653|FG006|Overall Study|Adverse Event|1|||
131733326|NCT00256867|474300654|FG007|Overall Study|Adverse Event|4|||
131733327|NCT00256867|474300647|FG000|Overall Study|Lost to Follow-up|2|||
131733328|NCT00256867|474300648|FG001|Overall Study|Lost to Follow-up|2|||
131733329|NCT00256867|474300649|FG002|Overall Study|Lost to Follow-up|2|||
131733330|NCT00256867|474300650|FG003|Overall Study|Lost to Follow-up|3|||
131733331|NCT00256867|474300651|FG004|Overall Study|Lost to Follow-up|2|||
131733332|NCT00256867|474300652|FG005|Overall Study|Lost to Follow-up|0|||
131733333|NCT00256867|474300653|FG006|Overall Study|Lost to Follow-up|1|||
131733334|NCT00256867|474300654|FG007|Overall Study|Lost to Follow-up|2|||
131733335|NCT00256867|474300647|FG000|Overall Study|Protocol Violation|0|||
131733336|NCT00256867|474300648|FG001|Overall Study|Protocol Violation|0|||
131733337|NCT00256867|474300649|FG002|Overall Study|Protocol Violation|0|||
131733338|NCT00256867|474300650|FG003|Overall Study|Protocol Violation|1|||
131733339|NCT00256867|474300651|FG004|Overall Study|Protocol Violation|0|||
131733340|NCT00256867|474300652|FG005|Overall Study|Protocol Violation|1|||
131733341|NCT00256867|474300653|FG006|Overall Study|Protocol Violation|0|||
131733342|NCT00256867|474300654|FG007|Overall Study|Protocol Violation|1|||
131733343|NCT00256867|474300647|FG000|Overall Study|Withdrawal by Subject|0|||
131733344|NCT00256867|474300648|FG001|Overall Study|Withdrawal by Subject|0|||
131733345|NCT00256867|474300649|FG002|Overall Study|Withdrawal by Subject|1|||
131733346|NCT00256867|474300650|FG003|Overall Study|Withdrawal by Subject|1|||
131733347|NCT00256867|474300651|FG004|Overall Study|Withdrawal by Subject|2|||
131733348|NCT00256867|474300652|FG005|Overall Study|Withdrawal by Subject|2|||
131733349|NCT00256867|474300653|FG006|Overall Study|Withdrawal by Subject|3|||
131733350|NCT00256867|474300654|FG007|Overall Study|Withdrawal by Subject|2|||
131733351|NCT00256867|474300647|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733352|NCT00256867|474300648|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
131733353|NCT00256867|474300649|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733354|NCT00256867|474300650|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733355|NCT00256867|474300651|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733356|NCT00256867|474300652|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733357|NCT00256867|474300653|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733358|NCT00256867|474300654|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131733359|NCT00256867|474300647|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733360|NCT00256867|474300648|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733361|NCT00256867|474300649|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733362|NCT00256867|474300650|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733363|NCT00256867|474300651|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733364|NCT00256867|474300652|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733365|NCT00256867|474300653|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131733366|NCT00256867|474300654|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
131733367|NCT00256867|474300647|FG000|Overall Study|Investigator's Decision|0|||
131733368|NCT00256867|474300648|FG001|Overall Study|Investigator's Decision|0|||
131733369|NCT00256867|474300649|FG002|Overall Study|Investigator's Decision|0|||
131733370|NCT00256867|474300650|FG003|Overall Study|Investigator's Decision|0|||
131733371|NCT00256867|474300651|FG004|Overall Study|Investigator's Decision|1|||
131733372|NCT00256867|474300652|FG005|Overall Study|Investigator's Decision|0|||
131733373|NCT00256867|474300653|FG006|Overall Study|Investigator's Decision|0|||
131733374|NCT00256867|474300654|FG007|Overall Study|Investigator's Decision|0|||
131733375|NCT00256867|474300647|FG000|Overall Study|Non-compliance with study medication|0|||
131733376|NCT00256867|474300648|FG001|Overall Study|Non-compliance with study medication|0|||
131733377|NCT00256867|474300649|FG002|Overall Study|Non-compliance with study medication|0|||
131733378|NCT00256867|474300650|FG003|Overall Study|Non-compliance with study medication|0|||
131733379|NCT00256867|474300651|FG004|Overall Study|Non-compliance with study medication|0|||
131733380|NCT00256867|474300652|FG005|Overall Study|Non-compliance with study medication|0|||
131733381|NCT00256867|474300653|FG006|Overall Study|Non-compliance with study medication|0|||
131733382|NCT00256867|474300654|FG007|Overall Study|Non-compliance with study medication|1|||
131807497|NCT04567186|474581116|FG001|Period 2|Lost to Follow-up|1|||
131733383|NCT00256867|474300647|FG000|Overall Study|Participant travelled Overseas|0|||
131733384|NCT00256867|474300648|FG001|Overall Study|Participant travelled Overseas|1|||
131807498|NCT04567186|474581115|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
131807499|NCT04567186|474581116|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
131733385|NCT00256867|474300649|FG002|Overall Study|Participant travelled Overseas|0|||
131733386|NCT00256867|474300650|FG003|Overall Study|Participant travelled Overseas|0|||
131733387|NCT00256867|474300651|FG004|Overall Study|Participant travelled Overseas|0|||
131733388|NCT00256867|474300652|FG005|Overall Study|Participant travelled Overseas|0|||
131733389|NCT00256867|474300653|FG006|Overall Study|Participant travelled Overseas|0|||
131807500|NCT02924883|474581117|FG000|Overall Study|Death|39|||
131807501|NCT02924883|474581118|FG001|Overall Study|Death|20|||
131448820|NCT00419952|473272732|FG001|Overall Study|Lost to Follow-up|34|||
131448821|NCT00419952|473272731|FG000|Overall Study|Protocol Violation|32|||
131448822|NCT00419952|473272732|FG001|Overall Study|Protocol Violation|24|||
131448823|NCT00419952|473272731|FG000|Overall Study|Pregnancy|4|||
131448824|NCT00419952|473272732|FG001|Overall Study|Pregnancy|2|||
131448825|NCT00419952|473272731|FG000|Overall Study|Physician Decision|1|||
131448826|NCT00419952|473272732|FG001|Overall Study|Physician Decision|3|||
131448827|NCT00419952|473272731|FG000|Overall Study|Incorrectly enrolled|10|||
131448828|NCT00419952|473272732|FG001|Overall Study|Incorrectly enrolled|3|||
131448829|NCT00419952|473272731|FG000|Overall Study|Intake of prohibited medication|2|||
131448830|NCT00419952|473272732|FG001|Overall Study|Intake of prohibited medication|2|||
131448831|NCT00419952|473272731|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
131448832|NCT00419952|473272732|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
131448833|NCT00419952|473272731|FG000|Overall Study|Diary or medication non-compliance|2|||
131448834|NCT00419952|473272732|FG001|Overall Study|Diary or medication non-compliance|4|||
131448835|NCT00419952|473272731|FG000|Overall Study|Abnormal ECG|1|||
131448836|NCT00419952|473272732|FG001|Overall Study|Abnormal ECG|0|||
131733390|NCT00256867|474300654|FG007|Overall Study|Participant travelled Overseas|0|||
131733391|NCT00256867|474300647|FG000|Overall Study|Participant out of assessment window|0|||
131733392|NCT00256867|474300648|FG001|Overall Study|Participant out of assessment window|0|||
131733393|NCT00256867|474300649|FG002|Overall Study|Participant out of assessment window|1|||
131733394|NCT00256867|474300650|FG003|Overall Study|Participant out of assessment window|0|||
131733395|NCT00256867|474300651|FG004|Overall Study|Participant out of assessment window|0|||
131733396|NCT00256867|474300652|FG005|Overall Study|Participant out of assessment window|0|||
131733397|NCT00256867|474300653|FG006|Overall Study|Participant out of assessment window|0|||
131733398|NCT00256867|474300654|FG007|Overall Study|Participant out of assessment window|0|||
131733399|NCT00256867|474300647|FG000|Overall Study|Withdrawal by participant|0|||
131733400|NCT00256867|474300648|FG001|Overall Study|Withdrawal by participant|0|||
131733401|NCT00256867|474300649|FG002|Overall Study|Withdrawal by participant|0|||
131733402|NCT00256867|474300650|FG003|Overall Study|Withdrawal by participant|0|||
131733403|NCT00256867|474300651|FG004|Overall Study|Withdrawal by participant|0|||
131733404|NCT00256867|474300652|FG005|Overall Study|Withdrawal by participant|1|||
131733405|NCT00256867|474300653|FG006|Overall Study|Withdrawal by participant|0|||
131733406|NCT00256867|474300654|FG007|Overall Study|Withdrawal by participant|0|||
131733407|NCT02739594|474300655|FG000|Overall Study|Undesired Event|3|||
131733408|NCT02739594|474300656|FG001|Overall Study|Undesired Event|4|||
131733409|NCT02739594|474300655|FG000|Overall Study|Violation of Eligibility Criteria|1|||
131733410|NCT02739594|474300656|FG001|Overall Study|Violation of Eligibility Criteria|2|||
131733411|NCT02739594|474300655|FG000|Overall Study|Protocol Violation|5|||
131733412|NCT02739594|474300656|FG001|Overall Study|Protocol Violation|6|||
131733413|NCT02739594|474300655|FG000|Overall Study|Death|4|||
131733414|NCT02739594|474300656|FG001|Overall Study|Death|2|||
131733415|NCT02739594|474300655|FG000|Overall Study|Renal Insufficiency|4|||
131733416|NCT02739594|474300656|FG001|Overall Study|Renal Insufficiency|6|||
131733417|NCT02739594|474300655|FG000|Overall Study|Administrative Reasons|1|||
131733418|NCT02739594|474300656|FG001|Overall Study|Administrative Reasons|3|||
131733419|NCT02739594|474300655|FG000|Overall Study|Withdrawal by Subject|1|||
131733420|NCT02739594|474300656|FG001|Overall Study|Withdrawal by Subject|1|||
131733421|NCT02739594|474300655|FG000|Overall Study|Lost to Follow-up|0|||
131733422|NCT02739594|474300656|FG001|Overall Study|Lost to Follow-up|1|||
131733423|NCT02739594|474300655|FG000|Overall Study|Elevated Serum Creatinine|0|||
131733424|NCT02739594|474300656|FG001|Overall Study|Elevated Serum Creatinine|1|||
131733425|NCT02739594|474300655|FG000|Overall Study|Other|6|||
131733426|NCT02739594|474300656|FG001|Overall Study|Other|2|||
131807502|NCT02924883|474581117|FG000|Overall Study|Lost to Follow-up|1|||
131807503|NCT02924883|474581118|FG001|Overall Study|Lost to Follow-up|0|||
131807504|NCT02924883|474581117|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
131807505|NCT02924883|474581118|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
131807506|NCT02924883|474581117|FG000|Overall Study|Protocol Violation|1|||
131807507|NCT02924883|474581118|FG001|Overall Study|Protocol Violation|0|||
131807508|NCT02924883|474581117|FG000|Overall Study|Withdrawal by Subject|22|||
131807509|NCT02924883|474581118|FG001|Overall Study|Withdrawal by Subject|16|||
131448837|NCT02351817|473272733|FG000|Period 1|Adverse Event|1|||
131733427|NCT00527111|474300659|FG000|Overall Study|Adverse Event|14|||
131733428|NCT00527111|474300660|FG001|Overall Study|Adverse Event|13|||
131733429|NCT00527111|474300659|FG000|Overall Study|Death|0|||
131733430|NCT00527111|474300660|FG001|Overall Study|Death|1|||
131448838|NCT02351817|473272734|FG001|Period 1|Adverse Event|2|||
131733431|NCT00527111|474300659|FG000|Overall Study|Investigator Request|2|||
131448839|NCT02351817|473272733|FG000|Period 1|Lack of Efficacy|0|||
131448840|NCT02351817|473272734|FG001|Period 1|Lack of Efficacy|1|||
131448841|NCT02351817|473272733|FG000|Period 2|Adverse Event|0|||
131733432|NCT00527111|474300660|FG001|Overall Study|Investigator Request|1|||
131733433|NCT00527111|474300659|FG000|Overall Study|Patient Request|2|||
131733434|NCT00527111|474300660|FG001|Overall Study|Patient Request|5|||
131807510|NCT02924883|474581117|FG000|Overall Study|Progressive Disease|1|||
131733435|NCT00527111|474300659|FG000|Overall Study|Other|2|||
131733436|NCT00527111|474300660|FG001|Overall Study|Other|2|||
131733437|NCT01930799|474300661|FG000|Overall Study|Withdrawal by Subject|3|||
131733438|NCT01930799|474300661|FG000|Overall Study|Lost to Follow-up|5|||
131733439|NCT00952289|474300665|FG000|All Participants|Death|9|||
131733440|NCT00952289|474300666|FG001|All Participants|Death|9|||
131733441|NCT00952289|474300665|FG000|All Participants|Adverse Event|8|||
131733442|NCT00952289|474300666|FG001|All Participants|Adverse Event|8|||
131733443|NCT00952289|474300665|FG000|All Participants|Disease progression|3|||
131733444|NCT00952289|474300666|FG001|All Participants|Disease progression|12|||
131733445|NCT00952289|474300665|FG000|All Participants|Withdrawal by Subject|1|||
131733446|NCT00952289|474300666|FG001|All Participants|Withdrawal by Subject|10|||
131733447|NCT00952289|474300665|FG000|All Participants|Data lost during site relocation|0|||
131733448|NCT00952289|474300666|FG001|All Participants|Data lost during site relocation|1|||
131733449|NCT00952289|474300665|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
131733450|NCT00952289|474300666|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
131733451|NCT00952289|474300665|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
131733452|NCT00952289|474300666|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
131733453|NCT00952289|474300665|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
131733454|NCT00952289|474300666|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
131733455|NCT00952289|474300665|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
131733456|NCT00952289|474300666|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
131733457|NCT00952289|474300665|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
131733458|NCT00952289|474300666|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
131733459|NCT01921257|474300669|FG000|Overall Study|Adverse Event|1|||
131733460|NCT01921257|474300669|FG000|Overall Study|Protocol Violation|1|||
131733461|NCT01921257|474300669|FG000|Overall Study|Withdrawal by Subject|1|||
131733462|NCT00364845|474300670|FG000|Overall Study|Adverse Event|1|||
131733463|NCT00364845|474300671|FG001|Overall Study|Adverse Event|0|||
131733464|NCT00364845|474300670|FG000|Overall Study|Withdrawal by Subject|2|||
131733465|NCT00364845|474300671|FG001|Overall Study|Withdrawal by Subject|1|||
131733466|NCT00364845|474300670|FG000|Overall Study|Physician Decision|8|||
131733467|NCT00364845|474300671|FG001|Overall Study|Physician Decision|8|||
131733468|NCT00364845|474300670|FG000|Overall Study|Lost to Follow-up|0|||
131733469|NCT00364845|474300671|FG001|Overall Study|Lost to Follow-up|1|||
131733470|NCT00364845|474300670|FG000|Overall Study|Death|0|||
131733471|NCT00364845|474300671|FG001|Overall Study|Death|1|||
131733472|NCT00471445|474300672|FG000|Overall Study|Withdrawal by Subject|1|||
131733473|NCT00471445|474300673|FG001|Overall Study|Withdrawal by Subject|1|||
131733474|NCT00471445|474300672|FG000|Overall Study|Ineligible|1|||
131733475|NCT00471445|474300673|FG001|Overall Study|Ineligible|0|||
131733476|NCT00471445|474300672|FG000|Overall Study|Protocol Violation|0|||
131733477|NCT00471445|474300673|FG001|Overall Study|Protocol Violation|1|||
131733478|NCT03591146|474300674|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131733479|NCT03591146|474300675|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131733480|NCT03591146|474300676|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131733481|NCT03591146|474300677|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131733482|NCT03591146|474300678|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
131733483|NCT03591146|474300674|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131733484|NCT03591146|474300675|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
131733485|NCT03591146|474300676|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131733486|NCT03591146|474300677|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131733487|NCT03591146|474300678|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131733488|NCT03591146|474300674|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131733489|NCT03591146|474300675|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131733490|NCT03591146|474300676|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131733491|NCT03591146|474300677|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131733492|NCT03591146|474300678|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
131807511|NCT02924883|474581118|FG001|Overall Study|Progressive Disease|0|||
131733493|NCT03591146|474300674|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
131733494|NCT03591146|474300675|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
131733495|NCT03591146|474300676|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
131733496|NCT03591146|474300677|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
131733497|NCT03591146|474300678|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
131733498|NCT04737031|474300679|FG000|Overall Study|Patients who did not have a treatment visit|0|||
131733499|NCT04737031|474300680|FG001|Overall Study|Patients who did not have a treatment visit|31|||
131733500|NCT04737031|474300681|FG002|Overall Study|Patients who did not have a treatment visit|93|||
131733501|NCT04737031|474300682|FG003|Overall Study|Patients who did not have a treatment visit|227|||
131733502|NCT01067508|474300685|FG000|Overall Study|Physician Decision|0|||
131733503|NCT01067508|474300686|FG001|Overall Study|Physician Decision|1|||
131733504|NCT01067508|474300685|FG000|Overall Study|Withdrawal by Subject|0|||
131733505|NCT01067508|474300686|FG001|Overall Study|Withdrawal by Subject|1|||
131733506|NCT00444626|474300687|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
131733507|NCT00444626|474300687|FG000|Initial Treatment Period|Adverse Event|1|||
131733508|NCT00444626|474300687|FG000|Initial Treatment Period|Lost to Follow-up|9|||
131733509|NCT04715230|474300690|FG000|Overall Study|Withdrawal by Subject|1|||
131733510|NCT04715230|474300691|FG001|Overall Study|Withdrawal by Subject|0|||
131733511|NCT04715230|474300692|FG002|Overall Study|Withdrawal by Subject|0|||
131733512|NCT04715230|474300690|FG000|Overall Study|Lost to Follow-up|0|||
131733513|NCT04715230|474300691|FG001|Overall Study|Lost to Follow-up|5|||
131733514|NCT04715230|474300692|FG002|Overall Study|Lost to Follow-up|1|||
131733515|NCT03453151|474300693|FG000|Overall Study|Withdrawal by Subject|1|||
131733516|NCT03453151|474300693|FG000|Overall Study|Physician Decision|3|||
131733517|NCT01468909|474300697|FG000|Overall Study|Never Treated|2|||
131733518|NCT01468909|474300698|FG001|Overall Study|Never Treated|2|||
131733519|NCT01511419|474300701|FG000|Dose 2|Physician Decision|1|||
131733520|NCT01511419|474300702|FG001|Dose 2|Physician Decision|0|||
131733521|NCT04594239|474300703|FG000|Overall Study|Withdrawal by Subject|3|||
131733522|NCT04594239|474300704|FG001|Overall Study|Withdrawal by Subject|4|||
131733523|NCT04594239|474300705|FG002|Overall Study|Withdrawal by Subject|2|||
131733524|NCT04594239|474300706|FG003|Overall Study|Withdrawal by Subject|4|||
131733525|NCT04594239|474300703|FG000|Overall Study|Lost to Follow-up|8|||
131733526|NCT04594239|474300704|FG001|Overall Study|Lost to Follow-up|5|||
131733527|NCT04594239|474300705|FG002|Overall Study|Lost to Follow-up|4|||
131733528|NCT04594239|474300706|FG003|Overall Study|Lost to Follow-up|6|||
131733529|NCT04594239|474300703|FG000|Overall Study|Subject relocated|0|||
131733530|NCT04594239|474300704|FG001|Overall Study|Subject relocated|0|||
131733531|NCT04594239|474300705|FG002|Overall Study|Subject relocated|0|||
131733532|NCT04594239|474300706|FG003|Overall Study|Subject relocated|1|||
131733533|NCT02678780|474300707|FG000|Overall Study|Adverse Event|11|||
131733534|NCT02678780|474300708|FG001|Overall Study|Adverse Event|14|||
131733535|NCT02678780|474300707|FG000|Overall Study|Withdrawal by Subject|2|||
131733536|NCT02678780|474300708|FG001|Overall Study|Withdrawal by Subject|1|||
131733537|NCT02678780|474300707|FG000|Overall Study|Sponsor discontinuation|7|||
131733538|NCT02678780|474300708|FG001|Overall Study|Sponsor discontinuation|4|||
131733539|NCT02678780|474300707|FG000|Overall Study|Death|1|||
131733540|NCT02678780|474300708|FG001|Overall Study|Death|1|||
131807512|NCT02924883|474581117|FG000|Overall Study|Study Terminated by Sponsor|69|||
131807513|NCT02924883|474581118|FG001|Overall Study|Study Terminated by Sponsor|32|||
131807514|NCT01256684|474581123|FG000|Overall Study|Adverse Event|1|||
131807515|NCT01256684|474581124|FG001|Overall Study|Adverse Event|4|||
131807516|NCT01256684|474581125|FG002|Overall Study|Adverse Event|2|||
131807517|NCT01256684|474581123|FG000|Overall Study|Withdrawal by Subject|4|||
131807518|NCT01256684|474581124|FG001|Overall Study|Withdrawal by Subject|0|||
131807519|NCT01256684|474581125|FG002|Overall Study|Withdrawal by Subject|2|||
131807520|NCT01256684|474581123|FG000|Overall Study|Physician Decision|0|||
131448842|NCT02351817|473272734|FG001|Period 2|Adverse Event|2|||
131448843|NCT02351817|473272733|FG000|Period 2|Protocol Violation|1|||
131448844|NCT02351817|473272734|FG001|Period 2|Protocol Violation|0|||
131733541|NCT02678780|474300707|FG000|Overall Study|Other|6|||
131448845|NCT02976038|473272735|FG000|Overall Study|Physician Decision|22|||
131733542|NCT02678780|474300708|FG001|Overall Study|Other|8|||
131733543|NCT00091390|474300710|FG000|Overall Study|Protocol Violation|1|||
131733544|NCT00091390|474300710|FG000|Overall Study|No protocol treatment|3|||
131733545|NCT03229759|474300717|FG000|Overall Study|Screen Failure|30|||
131733546|NCT00488618|474300718|FG000|Overall Study|Adverse Event|13|||
131733547|NCT00488618|474300719|FG001|Overall Study|Adverse Event|17|||
131733548|NCT00488618|474300718|FG000|Overall Study|Insufficient Therapeutic Response|18|||
131733549|NCT00488618|474300719|FG001|Overall Study|Insufficient Therapeutic Response|11|||
131733550|NCT00488618|474300718|FG000|Overall Study|Protocol Violation|0|||
131733551|NCT00488618|474300719|FG001|Overall Study|Protocol Violation|2|||
131733552|NCT00488618|474300718|FG000|Overall Study|Withdrawal of Consent|15|||
131733553|NCT00488618|474300719|FG001|Overall Study|Withdrawal of Consent|13|||
131807521|NCT01256684|474581124|FG001|Overall Study|Physician Decision|1|||
131807522|NCT01256684|474581125|FG002|Overall Study|Physician Decision|0|||
131807523|NCT01256684|474581123|FG000|Overall Study|Lack of Efficacy|0|||
131807524|NCT01256684|474581124|FG001|Overall Study|Lack of Efficacy|1|||
131807525|NCT01256684|474581125|FG002|Overall Study|Lack of Efficacy|1|||
131807526|NCT01256684|474581123|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
131807527|NCT01256684|474581124|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
131807528|NCT01256684|474581125|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
131807529|NCT01185548|474581128|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
131807530|NCT02678286|474581129|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
131448846|NCT02976038|473272735|FG000|Overall Study|Withdrawal by Subject|3|||
131448847|NCT02976038|473272735|FG000|Overall Study|Lost to Follow-up|2|||
131448848|NCT02976038|473272735|FG000|Overall Study|Adverse Event|1|||
131448849|NCT01046396|473272736|FG000|Overall Study|Withdrawal by Subject|5|||
131448850|NCT01208207|473272737|FG000|Part I|Adverse Event|19|||
131448851|NCT01208207|473272738|FG001|Part I|Adverse Event|2|||
131448852|NCT01208207|473272739|FG002|Part I|Adverse Event|6|||
131448853|NCT01208207|473272740|FG003|Part I|Adverse Event|0|||
131448854|NCT01208207|473272741|FG004|Part I|Adverse Event|0|||
131448855|NCT01208207|473272742|FG005|Part I|Adverse Event|0|||
131448856|NCT01208207|473272743|FG006|Part I|Adverse Event|0|||
131733554|NCT00488618|474300718|FG000|Overall Study|Lost to Follow-up|1|||
131733555|NCT00488618|474300719|FG001|Overall Study|Lost to Follow-up|0|||
131733556|NCT00948818|474302331|FG000|Overall Study|Adverse Event|10|||
131733557|NCT00948818|474302332|FG001|Overall Study|Adverse Event|32|||
131733558|NCT00948818|474302331|FG000|Overall Study|Protocol Violation|9|||
131733559|NCT00948818|474302332|FG001|Overall Study|Protocol Violation|10|||
131733560|NCT00948818|474302331|FG000|Overall Study|Withdrawal by Subject|25|||
131733561|NCT00948818|474302332|FG001|Overall Study|Withdrawal by Subject|25|||
131733562|NCT00948818|474302331|FG000|Overall Study|Lost to Follow-up|10|||
131733563|NCT00948818|474302332|FG001|Overall Study|Lost to Follow-up|17|||
131733564|NCT00948818|474302331|FG000|Overall Study|Lack of Efficacy|4|||
131733565|NCT00948818|474302332|FG001|Overall Study|Lack of Efficacy|5|||
131733566|NCT00948818|474302331|FG000|Overall Study|Other Reason|4|||
131733567|NCT00948818|474302332|FG001|Overall Study|Other Reason|5|||
131733568|NCT00745368|474302333|FG000|Overall Study|Unable to provide sample|3|||
131733569|NCT02326467|474302334|FG000|Overall Study|Withdrawal by Subject|1|||
131733570|NCT00434512|474302335|FG000|Overall Study|Migrated/moved from study area|0|||
131733571|NCT00434512|474302336|FG001|Overall Study|Migrated/moved from study area|0|||
131733572|NCT00434512|474302337|FG002|Overall Study|Migrated/moved from study area|0|||
131733573|NCT00434512|474302338|FG003|Overall Study|Migrated/moved from study area|1|||
131733574|NCT00434512|474302339|FG004|Overall Study|Migrated/moved from study area|1|||
131733575|NCT00434512|474302340|FG005|Overall Study|Migrated/moved from study area|1|||
131733576|NCT00434512|474302335|FG000|Overall Study|Other|0|||
131733577|NCT00434512|474302336|FG001|Overall Study|Other|1|||
131733578|NCT00434512|474302337|FG002|Overall Study|Other|0|||
131733579|NCT00434512|474302338|FG003|Overall Study|Other|0|||
131733580|NCT00434512|474302339|FG004|Overall Study|Other|0|||
131733581|NCT00434512|474302340|FG005|Overall Study|Other|0|||
131733582|NCT00111475|474302343|FG000|Overall Study|Lost to Follow-up|0|||
131733583|NCT00111475|474302344|FG001|Overall Study|Lost to Follow-up|0|||
131733584|NCT00111475|474302345|FG002|Overall Study|Lost to Follow-up|0|||
131807531|NCT02678286|474581130|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
131807532|NCT02678286|474581129|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
131807533|NCT02678286|474581130|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
131807534|NCT02678286|474581129|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
131807535|NCT02678286|474581130|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
131807536|NCT02678286|474581129|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
131807537|NCT02678286|474581130|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
131448857|NCT01208207|473272737|FG000|Part I|Lack of Efficacy|21|||
131448858|NCT01208207|473272738|FG001|Part I|Lack of Efficacy|3|||
131733585|NCT00111475|474302346|FG003|Overall Study|Lost to Follow-up|0|||
131733586|NCT00111475|474302347|FG004|Overall Study|Lost to Follow-up|0|||
131733587|NCT00111475|474302348|FG005|Overall Study|Lost to Follow-up|1|||
131448859|NCT01208207|473272739|FG002|Part I|Lack of Efficacy|2|||
131448860|NCT01208207|473272740|FG003|Part I|Lack of Efficacy|0|||
131448861|NCT01208207|473272741|FG004|Part I|Lack of Efficacy|0|||
131448862|NCT01208207|473272742|FG005|Part I|Lack of Efficacy|0|||
131733588|NCT00111475|474302349|FG006|Overall Study|Lost to Follow-up|0|||
131733589|NCT00111475|474302350|FG007|Overall Study|Lost to Follow-up|0|||
131733590|NCT00111475|474302351|FG008|Overall Study|Lost to Follow-up|0|||
131733591|NCT00111475|474302352|FG009|Overall Study|Lost to Follow-up|0|||
131733592|NCT03303092|474302353|FG000|Overall Study|Adverse Event|1|||
131733593|NCT03303092|474302354|FG001|Overall Study|Adverse Event|0|||
131733594|NCT03303092|474302355|FG002|Overall Study|Adverse Event|1|||
131733595|NCT03303092|474302353|FG000|Overall Study|Protocol Violation|1|||
131733596|NCT03303092|474302354|FG001|Overall Study|Protocol Violation|5|||
131733597|NCT03303092|474302355|FG002|Overall Study|Protocol Violation|1|||
131733598|NCT03303092|474302353|FG000|Overall Study|Withdrawal by Subject|1|||
131733599|NCT03303092|474302354|FG001|Overall Study|Withdrawal by Subject|1|||
131733600|NCT03303092|474302355|FG002|Overall Study|Withdrawal by Subject|3|||
131733601|NCT00833248|474302361|FG000|Overall Study|Adverse Event|3|||
131733602|NCT00833248|474302362|FG001|Overall Study|Adverse Event|0|||
131733603|NCT00833248|474302361|FG000|Overall Study|Protocol Violation|1|||
131733604|NCT00833248|474302362|FG001|Overall Study|Protocol Violation|2|||
131733605|NCT00833248|474302361|FG000|Overall Study|Withdrawal by Subject|0|||
131733606|NCT00833248|474302362|FG001|Overall Study|Withdrawal by Subject|1|||
131733607|NCT02006667|474302363|FG000|Overall Study|Adverse Event|3|||
131733608|NCT02006667|474302363|FG000|Overall Study|Death|2|||
131733609|NCT02006667|474302363|FG000|Overall Study|Withdrawal by Subject|1|||
131733610|NCT02939937|474302364|FG000|Overall Study|Adverse Event|5|||
131733611|NCT02939937|474302365|FG001|Overall Study|Adverse Event|0|||
131733612|NCT02939937|474302364|FG000|Overall Study|Lost to Follow-up|1|||
131733613|NCT02939937|474302365|FG001|Overall Study|Lost to Follow-up|3|||
131733614|NCT04281030|474302370|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
131733615|NCT04281030|474302371|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
131733616|NCT04281030|474302370|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
131733617|NCT04281030|474302371|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
131733618|NCT01361009|474302372|FG000|Overall Study|Protocol Violation|116|||
131733619|NCT01826422|474302373|FG000|Overall Study|Withdrawal by Subject|1|||
131733620|NCT01826422|474302374|FG001|Overall Study|Withdrawal by Subject|3|||
131733621|NCT03439748|474302381|FG000|Overall Study|Withdrawal by Subject|11|||
131733622|NCT03439748|474302382|FG001|Overall Study|Withdrawal by Subject|17|||
131733623|NCT05131451|474302383|FG000|Overall Study|Protocol Violation|1|||
131733624|NCT05131451|474302384|FG001|Overall Study|Protocol Violation|0|||
131733625|NCT00782418|474302391|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
131733626|NCT00782418|474302392|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131733627|NCT00782418|474302393|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131733628|NCT00782418|474302394|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131733629|NCT00782418|474302395|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131733630|NCT00782418|474302396|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131733631|NCT00782418|474302397|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131733632|NCT00782418|474302391|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
131733633|NCT00782418|474302392|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131733634|NCT00782418|474302393|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131733635|NCT00782418|474302394|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131733636|NCT00782418|474302395|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
131807538|NCT02678286|474581129|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
131807539|NCT02678286|474581130|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
131807540|NCT02331394|474581132|FG000|Overall Study|Disease progression|1|||
131733637|NCT00782418|474302396|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
131807541|NCT01313273|474581133|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
131807542|NCT01313273|474581134|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
131807543|NCT01313273|474581133|FG000|Overall Study|Withdrawal by Subject|1|||
131807544|NCT01313273|474581134|FG001|Overall Study|Withdrawal by Subject|0|||
131807545|NCT01313273|474581133|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
131807546|NCT01313273|474581134|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
131807547|NCT03687736|474581135|FG000|Overall Study|Lost to Follow-up|7|||
131733638|NCT00782418|474302397|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131733639|NCT02324842|474302398|FG000|Overall Study|Lost to Follow-up|1|||
131807548|NCT03687736|474581135|FG000|Overall Study|Withdrawal by Subject|3|||
131448863|NCT01208207|473272743|FG006|Part I|Lack of Efficacy|0|||
131733640|NCT02324842|474302399|FG001|Overall Study|Lost to Follow-up|1|||
131807549|NCT02098876|474581138|FG000|Overall Study|Withdrawal by Subject|5|||
131905180|NCT04794751|474939074|FG001|Period 1|Withdrawal by Subject|1|||
131905181|NCT04794751|474939073|FG000|Period 2|Withdrawal by Subject|0|||
131905182|NCT04794751|474939074|FG001|Period 2|Withdrawal by Subject|1|||
131905183|NCT04794751|474939073|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
131807550|NCT02098876|474581139|FG001|Overall Study|Withdrawal by Subject|5|||
131807551|NCT01270503|474581140|FG000|Overall Study|Lost to Follow-up|1|||
131807552|NCT02459951|474581141|FG000|Overall Study|Unable to meet holding requirement|1|||
131807553|NCT02077465|474581144|FG000|Overall Study|Withdrew Consent|0|||
131807554|NCT02077465|474581145|FG001|Overall Study|Withdrew Consent|1|||
131807555|NCT02077465|474581144|FG000|Overall Study|Lost to Follow-up|1|||
131807556|NCT02077465|474581145|FG001|Overall Study|Lost to Follow-up|0|||
131807557|NCT02481830|474581147|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
131807558|NCT02481830|474581148|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
131807559|NCT02481830|474581147|FG000|Pre-treatment|Withdrawal by Subject|0|||
131807560|NCT02481830|474581148|FG001|Pre-treatment|Withdrawal by Subject|10|||
131807561|NCT02481830|474581147|FG000|Pre-treatment|Disease Progression|1|||
131807562|NCT02481830|474581148|FG001|Pre-treatment|Disease Progression|1|||
131807563|NCT02481830|474581147|FG000|Pre-treatment|Other reasons|0|||
131807564|NCT02481830|474581148|FG001|Pre-treatment|Other reasons|1|||
131807565|NCT02481830|474581147|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
131807566|NCT02481830|474581148|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
131807567|NCT02481830|474581147|FG000|Treatment|Disease Progression|233|||
131807568|NCT02481830|474581148|FG001|Treatment|Disease Progression|171|||
131807569|NCT02481830|474581147|FG000|Treatment|Study drug toxicity|18|||
131807570|NCT02481830|474581148|FG001|Treatment|Study drug toxicity|38|||
131807571|NCT02481830|474581147|FG000|Treatment|Death|1|||
131807572|NCT02481830|474581148|FG001|Treatment|Death|1|||
131807573|NCT02481830|474581147|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
131807574|NCT02481830|474581148|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
131807575|NCT02481830|474581147|FG000|Treatment|Participants request to discontinue Study treatment|6|||
131807576|NCT02481830|474581148|FG001|Treatment|Participants request to discontinue Study treatment|34|||
131807577|NCT02481830|474581147|FG000|Treatment|Withdrawal by Subject|2|||
131807578|NCT02481830|474581148|FG001|Treatment|Withdrawal by Subject|3|||
131807579|NCT02481830|474581147|FG000|Treatment|Lost to Follow-up|1|||
131807580|NCT02481830|474581148|FG001|Treatment|Lost to Follow-up|0|||
131807581|NCT02481830|474581147|FG000|Treatment|Maximum Clinical Benefit|0|||
131807582|NCT02481830|474581148|FG001|Treatment|Maximum Clinical Benefit|5|||
131807583|NCT02481830|474581147|FG000|Treatment|Administrative reason by sponsor|1|||
131807584|NCT02481830|474581148|FG001|Treatment|Administrative reason by sponsor|1|||
131807585|NCT02481830|474581147|FG000|Treatment|Other reasons|6|||
131807586|NCT02481830|474581148|FG001|Treatment|Other reasons|1|||
131807587|NCT00102440|474581149|FG000|Overall Study|Lost to Follow-up|25|||
131807588|NCT00102440|474581150|FG001|Overall Study|Lost to Follow-up|18|||
131807589|NCT00102440|474581151|FG002|Overall Study|Lost to Follow-up|21|||
131733641|NCT02324842|474302400|FG002|Overall Study|Lost to Follow-up|2|||
131733642|NCT02116660|474302401|FG000|Overall Study|Deteriorating renal function|0|||
131733643|NCT02116660|474302402|FG001|Overall Study|Deteriorating renal function|1|||
131733644|NCT02116660|474302401|FG000|Overall Study|Adverse Event|1|||
131733645|NCT02116660|474302402|FG001|Overall Study|Adverse Event|1|||
131733646|NCT02116660|474302401|FG000|Overall Study|Withdrawal by Subject|0|||
131733647|NCT02116660|474302402|FG001|Overall Study|Withdrawal by Subject|2|||
131733648|NCT02116660|474302401|FG000|Overall Study|Organization reason|1|||
131733649|NCT02116660|474302402|FG001|Overall Study|Organization reason|0|||
131733650|NCT02750800|474302403|FG000|Overall Study|Adverse Event|18|||
131733651|NCT02750800|474302403|FG000|Overall Study|Lost to Follow-up|12|||
131733652|NCT02750800|474302403|FG000|Overall Study|Investigator decision|53|||
131733653|NCT02750800|474302403|FG000|Overall Study|Patient request|12|||
131733654|NCT02750800|474302403|FG000|Overall Study|Other, not specified|3|||
131733655|NCT03298412|474302404|FG000|Run-in Period|Other, Not Specified|1|||
131733656|NCT03298412|474302404|FG000|Run-in Period|Disease Progression|1|||
131733657|NCT03298412|474302404|FG000|Run-in Period|Ineligibility Determined|1|||
131733658|NCT03298412|474302404|FG000|Run-in Period|Decision by Sponsor|6|||
131733659|NCT01894477|474302405|FG000|Overall Study|Protocol Violation|0|||
131733660|NCT01894477|474302406|FG001|Overall Study|Protocol Violation|1|||
131807590|NCT00102440|474581149|FG000|Overall Study|Adverse Event|16|||
131807591|NCT00102440|474581150|FG001|Overall Study|Adverse Event|23|||
131807592|NCT00102440|474581151|FG002|Overall Study|Adverse Event|8|||
131807593|NCT00102440|474581149|FG000|Overall Study|Gout Flare|10|||
131905184|NCT04794751|474939074|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
131905185|NCT04794751|474939073|FG000|Period 2|Protocol Violation|1|||
131733661|NCT01894477|474302405|FG000|Overall Study|protocol changed due SC changed to cord|0|||
131733662|NCT01894477|474302406|FG001|Overall Study|protocol changed due SC changed to cord|1|||
131733663|NCT00411788|474302407|FG000|Overall Study|Protocol Violation|1|||
131733664|NCT00411788|474302407|FG000|Overall Study|Adverse Event|1|||
131733665|NCT05631548|474302409|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
131733666|NCT05631548|474302410|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
131733667|NCT01592409|474302411|FG000|Overall Study|Withdrawal by Subject|0|||
131733668|NCT01592409|474302412|FG001|Overall Study|Withdrawal by Subject|1|||
131733669|NCT01409031|474302420|FG000|Overall Study|transferred to other hosp|1|||
131733670|NCT01409031|474302421|FG001|Overall Study|transferred to other hosp|0|||
131733671|NCT01727713|474302422|FG000|Overall Study|Lost to Follow-up|5|||
131733672|NCT01727713|474302422|FG000|Overall Study|Adverse Event|10|||
131733673|NCT01727713|474302422|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
131733674|NCT01727713|474302422|FG000|Overall Study|Withdrawal by Subject|13|||
131733675|NCT01727713|474302422|FG000|Overall Study|Protocol Deviation|2|||
131733676|NCT00995345|474302424|FG000|Overall Study|Withdrawal by Subject|4|||
131733677|NCT00995345|474302425|FG001|Overall Study|Withdrawal by Subject|2|||
131733678|NCT00995345|474302426|FG002|Overall Study|Withdrawal by Subject|1|||
131733679|NCT00995345|474302427|FG003|Overall Study|Withdrawal by Subject|3|||
131733680|NCT00995345|474302428|FG004|Overall Study|Withdrawal by Subject|1|||
131733681|NCT00995345|474302424|FG000|Overall Study|Adverse Event|3|||
131733682|NCT00995345|474302425|FG001|Overall Study|Adverse Event|1|||
131733683|NCT00995345|474302426|FG002|Overall Study|Adverse Event|2|||
131733684|NCT00995345|474302427|FG003|Overall Study|Adverse Event|0|||
131733685|NCT00995345|474302428|FG004|Overall Study|Adverse Event|1|||
131733686|NCT00995345|474302424|FG000|Overall Study|Lost to Follow-up|2|||
131733687|NCT00995345|474302425|FG001|Overall Study|Lost to Follow-up|2|||
131733688|NCT00995345|474302426|FG002|Overall Study|Lost to Follow-up|2|||
131733689|NCT00995345|474302427|FG003|Overall Study|Lost to Follow-up|1|||
131807594|NCT00102440|474581150|FG001|Overall Study|Gout Flare|28|||
131807595|NCT00102440|474581151|FG002|Overall Study|Gout Flare|9|||
131807596|NCT00102440|474581149|FG000|Overall Study|Personal Reason(s)|19|||
131807597|NCT00102440|474581150|FG001|Overall Study|Personal Reason(s)|13|||
131807598|NCT00102440|474581151|FG002|Overall Study|Personal Reason(s)|13|||
131807599|NCT00102440|474581149|FG000|Overall Study|Other|11|||
131807600|NCT00102440|474581150|FG001|Overall Study|Other|14|||
131807601|NCT00102440|474581151|FG002|Overall Study|Other|14|||
131807602|NCT00102440|474581149|FG000|Overall Study|Protocol Violation|7|||
131807603|NCT00102440|474581150|FG001|Overall Study|Protocol Violation|2|||
131807604|NCT00102440|474581151|FG002|Overall Study|Protocol Violation|1|||
131807605|NCT04627038|474581152|FG000|Overall Study|Adverse Event|36|||
131807606|NCT04627038|474581153|FG001|Overall Study|Adverse Event|8|||
131807607|NCT04627038|474581152|FG000|Overall Study|Lost to Follow-up|1|||
131807608|NCT04627038|474581153|FG001|Overall Study|Lost to Follow-up|0|||
131807609|NCT04627038|474581152|FG000|Overall Study|Physician Decision|0|||
131807610|NCT04627038|474581153|FG001|Overall Study|Physician Decision|1|||
131807611|NCT04627038|474581152|FG000|Overall Study|Protocol Violation|3|||
131807612|NCT04627038|474581153|FG001|Overall Study|Protocol Violation|1|||
131807613|NCT04627038|474581152|FG000|Overall Study|Withdrawal by Subject|13|||
131807614|NCT04627038|474581153|FG001|Overall Study|Withdrawal by Subject|3|||
131807615|NCT04627038|474581152|FG000|Overall Study|Non-compliance with study drug|0|||
131807616|NCT04627038|474581153|FG001|Overall Study|Non-compliance with study drug|1|||
131807617|NCT04627038|474581152|FG000|Overall Study|Prohibited Concomitant Medication|1|||
131807618|NCT04627038|474581153|FG001|Overall Study|Prohibited Concomitant Medication|0|||
131807619|NCT02255097|474581154|FG000|Overall Study|Death|151|||
131807620|NCT02255097|474581154|FG000|Overall Study|Lost to Follow-up|5|||
131807621|NCT02255097|474581154|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
131807622|NCT02255097|474581154|FG000|Overall Study|Withdrawal by Subject|7|||
131807623|NCT02255097|474581154|FG000|Overall Study|Allocated but not treated|1|||
131807624|NCT01010542|474581157|FG000|Overall Study|Adverse Event|0|||
131807625|NCT01010542|474581158|FG001|Overall Study|Adverse Event|1|||
131807626|NCT01010542|474581159|FG002|Overall Study|Adverse Event|0|||
131807627|NCT01010542|474581157|FG000|Overall Study|Lost to Follow-up|0|||
131807628|NCT01010542|474581158|FG001|Overall Study|Lost to Follow-up|1|||
131807629|NCT01010542|474581159|FG002|Overall Study|Lost to Follow-up|0|||
131807630|NCT01010542|474581157|FG000|Overall Study|Withdrawal by Subject|0|||
131807631|NCT01010542|474581158|FG001|Overall Study|Withdrawal by Subject|3|||
131807632|NCT01010542|474581159|FG002|Overall Study|Withdrawal by Subject|2|||
131807633|NCT01745120|474581162|FG000|Overall Study|Investigator decision|1|||
131807634|NCT01745120|474581163|FG001|Overall Study|Investigator decision|0|||
131807635|NCT03956862|474581164|FG000|Overall Study|Lost to Follow-up|1|||
131807636|NCT03956862|474581165|FG001|Overall Study|Lost to Follow-up|1|||
131733690|NCT00995345|474302428|FG004|Overall Study|Lost to Follow-up|0|||
131733691|NCT00995345|474302424|FG000|Overall Study|all other reasons combined|2|||
131733692|NCT00995345|474302425|FG001|Overall Study|all other reasons combined|2|||
131733693|NCT00995345|474302426|FG002|Overall Study|all other reasons combined|2|||
131807637|NCT03956862|474581164|FG000|Overall Study|Withdrawal by Subject|1|||
131733694|NCT00995345|474302427|FG003|Overall Study|all other reasons combined|1|||
131733695|NCT00995345|474302428|FG004|Overall Study|all other reasons combined|3|||
131733696|NCT01860534|474302429|FG000|ROP #1|Needed treatment for ROP|0|||
131733697|NCT01860534|474302430|FG001|ROP #1|Needed treatment for ROP|1|||
131733698|NCT01860534|474302429|FG000|ROP #2|discharged prior to ROP #2|1|||
131733699|NCT01860534|474302430|FG001|ROP #2|discharged prior to ROP #2|0|||
131733700|NCT04171037|474302433|FG000|Overall Study|Lost to Follow-up|1|||
131733701|NCT04171037|474302434|FG001|Overall Study|Lost to Follow-up|0|||
131733702|NCT04171037|474302433|FG000|Overall Study|Physician Decision|3|||
131733703|NCT04171037|474302434|FG001|Overall Study|Physician Decision|3|||
131733704|NCT01934894|474302435|FG000|Overall Study|Adverse Event|1|||
131733705|NCT01934894|474302436|FG001|Overall Study|Adverse Event|2|||
131733706|NCT01934894|474302435|FG000|Overall Study|Death|2|||
131733707|NCT01934894|474302436|FG001|Overall Study|Death|0|||
131733708|NCT01934894|474302435|FG000|Overall Study|Withdrawal by Subject|0|||
131733709|NCT01934894|474302436|FG001|Overall Study|Withdrawal by Subject|1|||
131733710|NCT01934894|474302435|FG000|Overall Study|Progressive Disease|3|||
131733711|NCT01934894|474302436|FG001|Overall Study|Progressive Disease|2|||
131733712|NCT01100307|474302442|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
131733713|NCT01100307|474302443|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
131733714|NCT01100307|474302442|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
131733715|NCT01100307|474302443|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
131733716|NCT01100307|474302442|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
131733717|NCT01100307|474302443|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
131733718|NCT01100307|474302442|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
131733719|NCT01100307|474302443|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
131733720|NCT01100307|474302442|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
131733721|NCT01100307|474302443|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
131733722|NCT01100307|474302442|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
131733723|NCT01100307|474302443|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
131733724|NCT04891770|474302444|FG000|Overall Study|Withdrew consent|1|||
131733725|NCT04891770|474302445|FG001|Overall Study|Withdrew consent|3|||
131733726|NCT04891770|474302446|FG002|Overall Study|Withdrew consent|0|||
131733727|NCT04891770|474302444|FG000|Overall Study|Enrolled but never treated|0|||
131733728|NCT04891770|474302445|FG001|Overall Study|Enrolled but never treated|0|||
131807638|NCT03956862|474581165|FG001|Overall Study|Withdrawal by Subject|1|||
131807639|NCT01363765|474581168|FG000|Overall Study|non-diagnostic|2621|||
131807640|NCT01363765|474581169|FG001|Overall Study|non-diagnostic|1124|||
131807641|NCT01363765|474581168|FG000|Overall Study|duplicate records|736|||
131807642|NCT01363765|474581169|FG001|Overall Study|duplicate records|3177|||
131807643|NCT01363765|474581168|FG000|Overall Study|non-resident|156|||
131807644|NCT01363765|474581169|FG001|Overall Study|non-resident|76|||
131807645|NCT01363765|474581168|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
131807646|NCT01363765|474581169|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
131807647|NCT01363765|474581168|FG000|Overall Study|smear during intervention|2170|||
131807648|NCT01363765|474581169|FG001|Overall Study|smear during intervention|0|||
131807649|NCT00635492|474581170|FG000|Overall Study|Death|12|||
131807650|NCT00635492|474581171|FG001|Overall Study|Death|40|||
131807651|NCT00635492|474581170|FG000|Overall Study|Lost to Follow-up|151|||
131807652|NCT00635492|474581171|FG001|Overall Study|Lost to Follow-up|172|||
131807653|NCT00635492|474581170|FG000|Overall Study|Physician Decision|32|||
131807654|NCT00635492|474581171|FG001|Overall Study|Physician Decision|22|||
131807655|NCT00635492|474581170|FG000|Overall Study|Sponsor decision|2|||
131807656|NCT00635492|474581171|FG001|Overall Study|Sponsor decision|3|||
131807657|NCT00635492|474581170|FG000|Overall Study|Withdrawal by Subject|82|||
131807658|NCT00635492|474581171|FG001|Overall Study|Withdrawal by Subject|45|||
131807659|NCT02601560|474581176|FG000|Overall Study|Other|0|||
131807660|NCT02601560|474581177|FG001|Overall Study|Other|0|||
131807661|NCT02601560|474581178|FG002|Overall Study|Other|0|||
131807662|NCT02601560|474581179|FG003|Overall Study|Other|0|||
131807663|NCT02601560|474581180|FG004|Overall Study|Other|0|||
131807664|NCT02601560|474581181|FG005|Overall Study|Other|0|||
131733729|NCT04891770|474302446|FG002|Overall Study|Enrolled but never treated|1|||
131733730|NCT04891770|474302444|FG000|Overall Study|Investigator's discretion|0|||
131733731|NCT04891770|474302445|FG001|Overall Study|Investigator's discretion|1|||
131807665|NCT02601560|474581182|FG006|Overall Study|Other|1|||
131807666|NCT02601560|474581183|FG007|Overall Study|Other|0|||
131807667|NCT03459807|474581187|FG000|Overall Study|Withdrawal due to transplant|0|||
131807668|NCT03459807|474581188|FG001|Overall Study|Withdrawal due to transplant|1|||
131807669|NCT03707912|474581200|FG000|Overall Study|Violation of inclusion criteria|1|||
131807670|NCT03707912|474581201|FG001|Overall Study|Violation of inclusion criteria|0|||
131807671|NCT02865122|474581202|FG000|Overall Study|Adverse Event|1|||
131807672|NCT02865122|474581203|FG001|Overall Study|Adverse Event|0|||
131807673|NCT02865122|474581204|FG002|Overall Study|Adverse Event|0|||
131733732|NCT04891770|474302446|FG002|Overall Study|Investigator's discretion|0|||
131807674|NCT02956460|474582757|FG000|Lens 1|Lost to Follow-up|1|||
131807675|NCT02956460|474582758|FG001|Lens 1|Lost to Follow-up|0|||
131733733|NCT05122650|474302447|FG000|Overall Study|Adverse Event|4|||
131733734|NCT05122650|474302448|FG001|Overall Study|Adverse Event|16|||
131733735|NCT05122650|474302449|FG002|Overall Study|Adverse Event|11|||
131733736|NCT05122650|474302450|FG003|Overall Study|Adverse Event|12|||
131733737|NCT05122650|474302447|FG000|Overall Study|Lack of Efficacy|0|||
131733738|NCT05122650|474302448|FG001|Overall Study|Lack of Efficacy|1|||
131733739|NCT05122650|474302449|FG002|Overall Study|Lack of Efficacy|1|||
131733740|NCT05122650|474302450|FG003|Overall Study|Lack of Efficacy|2|||
131733741|NCT05122650|474302447|FG000|Overall Study|Lost to Follow-up|1|||
131733742|NCT05122650|474302448|FG001|Overall Study|Lost to Follow-up|1|||
131733743|NCT05122650|474302449|FG002|Overall Study|Lost to Follow-up|3|||
131733744|NCT05122650|474302450|FG003|Overall Study|Lost to Follow-up|0|||
131733745|NCT05122650|474302447|FG000|Overall Study|Non-compliance with study intervention|0|||
131733746|NCT05122650|474302448|FG001|Overall Study|Non-compliance with study intervention|0|||
131733747|NCT05122650|474302449|FG002|Overall Study|Non-compliance with study intervention|0|||
131733748|NCT05122650|474302450|FG003|Overall Study|Non-compliance with study intervention|2|||
131733749|NCT05122650|474302447|FG000|Overall Study|Protocol Violation|0|||
131733750|NCT05122650|474302448|FG001|Overall Study|Protocol Violation|1|||
131733751|NCT05122650|474302449|FG002|Overall Study|Protocol Violation|0|||
131733752|NCT05122650|474302450|FG003|Overall Study|Protocol Violation|1|||
131733753|NCT05122650|474302447|FG000|Overall Study|Randomized by mistake|0|||
131733754|NCT05122650|474302448|FG001|Overall Study|Randomized by mistake|0|||
131733755|NCT05122650|474302449|FG002|Overall Study|Randomized by mistake|3|||
131733756|NCT05122650|474302450|FG003|Overall Study|Randomized by mistake|2|||
131733757|NCT05122650|474302447|FG000|Overall Study|Sponsor request|0|||
131733758|NCT05122650|474302448|FG001|Overall Study|Sponsor request|1|||
131733759|NCT05122650|474302449|FG002|Overall Study|Sponsor request|1|||
131733760|NCT05122650|474302450|FG003|Overall Study|Sponsor request|2|||
131733761|NCT05122650|474302447|FG000|Overall Study|Withdrawal by Subject|3|||
131733762|NCT05122650|474302448|FG001|Overall Study|Withdrawal by Subject|7|||
131733763|NCT05122650|474302449|FG002|Overall Study|Withdrawal by Subject|4|||
131733764|NCT05122650|474302450|FG003|Overall Study|Withdrawal by Subject|8|||
131733765|NCT05122650|474302447|FG000|Overall Study|Other|5|||
131733766|NCT05122650|474302448|FG001|Overall Study|Other|0|||
131733767|NCT05122650|474302449|FG002|Overall Study|Other|0|||
131733768|NCT05122650|474302450|FG003|Overall Study|Other|0|||
131733769|NCT04360187|474302461|FG000|Double-Blind Treatment|Adverse Event|9|||
131733770|NCT04360187|474302462|FG001|Double-Blind Treatment|Adverse Event|11|||
131733771|NCT04360187|474302461|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
131733772|NCT04360187|474302462|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
131733773|NCT04360187|474302461|FG000|Double-Blind Treatment|Physician Decision|1|||
131733774|NCT04360187|474302462|FG001|Double-Blind Treatment|Physician Decision|0|||
131733775|NCT04360187|474302461|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
131733776|NCT04360187|474302462|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
131733777|NCT04360187|474302461|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
131733778|NCT04360187|474302462|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
131807676|NCT01827163|474582759|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
131807677|NCT01827163|474582759|FG000|Overall Study|Adverse Event|9|||
131807678|NCT03375463|474582760|FG000|Period 1|Lost to Follow-up|0|||
131807679|NCT03375463|474582761|FG001|Period 1|Lost to Follow-up|0|||
131807680|NCT03375463|474582762|FG002|Period 1|Lost to Follow-up|1|||
131807681|NCT03375463|474582763|FG003|Period 1|Lost to Follow-up|0|||
131807682|NCT03375463|474582764|FG004|Period 1|Lost to Follow-up|0|||
131807683|NCT03375463|474582765|FG005|Period 1|Lost to Follow-up|0|||
131807684|NCT03375463|474582760|FG000|Period 1|Adverse Event|0|||
131807685|NCT03375463|474582761|FG001|Period 1|Adverse Event|0|||
131807686|NCT03375463|474582762|FG002|Period 1|Adverse Event|0|||
131807687|NCT03375463|474582763|FG003|Period 1|Adverse Event|0|||
131807688|NCT03375463|474582764|FG004|Period 1|Adverse Event|1|||
131807689|NCT03375463|474582765|FG005|Period 1|Adverse Event|0|||
131448864|NCT01208207|473272737|FG000|Part I|Lost to Follow-up|6|||
131733779|NCT04360187|474302461|FG000|Follow-Up|Lost to Follow-up|1|||
131733780|NCT04360187|474302462|FG001|Follow-Up|Lost to Follow-up|0|||
131733781|NCT00222729|474302468|FG000|Overall Study|Adverse Event|3|||
131733782|NCT00515008|474302469|FG000|Overall Study|Lost to Follow-up|1|||
131733783|NCT00515008|474302470|FG001|Overall Study|Lost to Follow-up|0|||
131733784|NCT00515008|474302469|FG000|Overall Study|Declined|0|||
131733785|NCT00515008|474302470|FG001|Overall Study|Declined|3|||
131448865|NCT01208207|473272738|FG001|Part I|Lost to Follow-up|1|||
131733786|NCT00515008|474302469|FG000|Overall Study|Left the Boston Area|1|||
131733787|NCT00515008|474302470|FG001|Overall Study|Left the Boston Area|1|||
131733788|NCT00515008|474302469|FG000|Overall Study|Scheduling conflict|1|||
131733789|NCT00515008|474302470|FG001|Overall Study|Scheduling conflict|0|||
131733790|NCT01798706|474302471|FG000|Overall Study|Adverse Event|15|||
131733791|NCT01798706|474302472|FG001|Overall Study|Adverse Event|10|||
131733792|NCT01798706|474302471|FG000|Overall Study|Lack of Efficacy|0|||
131733793|NCT01798706|474302472|FG001|Overall Study|Lack of Efficacy|2|||
131807690|NCT03375463|474582760|FG000|Period 2|Lost to Follow-up|1|||
131807691|NCT03375463|474582761|FG001|Period 2|Lost to Follow-up|1|||
131733794|NCT01798706|474302471|FG000|Overall Study|Poor compliance to protocol|1|||
131733795|NCT01798706|474302472|FG001|Overall Study|Poor compliance to protocol|0|||
131733796|NCT01798706|474302471|FG000|Overall Study|Other than specified above|5|||
131733797|NCT01798706|474302472|FG001|Overall Study|Other than specified above|9|||
131733798|NCT00496873|474302473|FG000|Overall Study|Ineligible|2|||
131733799|NCT00496873|474302473|FG000|Overall Study|Death|2|||
131733800|NCT00496873|474302473|FG000|Overall Study|Withdrawal by Subject|3|||
131733801|NCT03238235|474302474|FG000|Overall Study|Adverse Event|2|||
131733802|NCT03238235|474302475|FG001|Overall Study|Adverse Event|0|||
131733803|NCT03238235|474302474|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
131733804|NCT03238235|474302475|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
131733805|NCT05896761|474302478|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
131733806|NCT05896761|474302479|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
131733807|NCT05896761|474302478|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
131733808|NCT05896761|474302479|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
131733809|NCT00748540|474303503|FG000|Overall Study|Physician Decision|1|||
131733810|NCT02993224|474303504|FG000|Core Phase - Period 1|Adverse Event|4|||
131733811|NCT02993224|474303504|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
131733812|NCT02993224|474303504|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
131733813|NCT02993224|474303504|FG000|Core Phase- Period 2|Adverse Event|1|||
131733814|NCT02993224|474303504|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
131733815|NCT02993224|474303504|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
131733816|NCT02993224|474303504|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
131733817|NCT02993224|474303504|FG000|Extension Phase|Adverse Event|3|||
131733818|NCT02993224|474303504|FG000|Extension Phase|Withdrawal by Subject|3|||
131733819|NCT02993224|474303504|FG000|Extension Phase|Lost to Follow-up|2|||
131733820|NCT02993224|474303504|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
131733821|NCT03136185|474303511|FG000|Overall Study|Adverse Event|0|||
131733822|NCT03136185|474303512|FG001|Overall Study|Adverse Event|1|||
131733823|NCT03136185|474303513|FG002|Overall Study|Adverse Event|3|||
131733824|NCT03136185|474303514|FG003|Overall Study|Adverse Event|1|||
131733825|NCT03136185|474303515|FG004|Overall Study|Adverse Event|2|||
131733826|NCT03136185|474303516|FG005|Overall Study|Adverse Event|2|||
131733827|NCT03136185|474303517|FG006|Overall Study|Adverse Event|5|||
131733828|NCT03136185|474303518|FG007|Overall Study|Adverse Event|1|||
131733829|NCT03136185|474303519|FG008|Overall Study|Adverse Event|1|||
131733830|NCT03136185|474303511|FG000|Overall Study|Death|0|||
131733831|NCT03136185|474303512|FG001|Overall Study|Death|0|||
131733832|NCT03136185|474303513|FG002|Overall Study|Death|0|||
131733833|NCT03136185|474303514|FG003|Overall Study|Death|1|||
131733834|NCT03136185|474303515|FG004|Overall Study|Death|1|||
131733835|NCT03136185|474303516|FG005|Overall Study|Death|0|||
131733836|NCT03136185|474303517|FG006|Overall Study|Death|1|||
131733837|NCT03136185|474303518|FG007|Overall Study|Death|0|||
131733838|NCT03136185|474303519|FG008|Overall Study|Death|0|||
131733839|NCT03136185|474303511|FG000|Overall Study|Physician Decision|3|||
131733840|NCT03136185|474303512|FG001|Overall Study|Physician Decision|1|||
131733841|NCT03136185|474303513|FG002|Overall Study|Physician Decision|1|||
131733842|NCT03136185|474303514|FG003|Overall Study|Physician Decision|2|||
131733843|NCT03136185|474303515|FG004|Overall Study|Physician Decision|1|||
131733844|NCT03136185|474303516|FG005|Overall Study|Physician Decision|2|||
131733845|NCT03136185|474303517|FG006|Overall Study|Physician Decision|1|||
131733846|NCT03136185|474303518|FG007|Overall Study|Physician Decision|0|||
131733847|NCT03136185|474303519|FG008|Overall Study|Physician Decision|1|||
131733848|NCT03136185|474303511|FG000|Overall Study|Protocol Defined Disease Progression|0|||
131733849|NCT03136185|474303512|FG001|Overall Study|Protocol Defined Disease Progression|0|||
131733850|NCT03136185|474303513|FG002|Overall Study|Protocol Defined Disease Progression|1|||
131733851|NCT03136185|474303514|FG003|Overall Study|Protocol Defined Disease Progression|0|||
131733852|NCT03136185|474303515|FG004|Overall Study|Protocol Defined Disease Progression|0|||
131733853|NCT03136185|474303516|FG005|Overall Study|Protocol Defined Disease Progression|1|||
131733854|NCT03136185|474303517|FG006|Overall Study|Protocol Defined Disease Progression|0|||
131733855|NCT03136185|474303518|FG007|Overall Study|Protocol Defined Disease Progression|1|||
131807692|NCT03375463|474582762|FG002|Period 2|Lost to Follow-up|0|||
131807693|NCT03375463|474582763|FG003|Period 2|Lost to Follow-up|0|||
131807694|NCT03375463|474582764|FG004|Period 2|Lost to Follow-up|0|||
131807695|NCT03375463|474582765|FG005|Period 2|Lost to Follow-up|0|||
131807696|NCT01513174|474582767|FG000|Overall Study|Inclusion Error|1|||
131733856|NCT03136185|474303519|FG008|Overall Study|Protocol Defined Disease Progression|1|||
131733857|NCT03136185|474303511|FG000|Overall Study|Withdrawal by Subject|1|||
131733858|NCT03136185|474303512|FG001|Overall Study|Withdrawal by Subject|0|||
131733859|NCT03136185|474303513|FG002|Overall Study|Withdrawal by Subject|1|||
131807697|NCT01513174|474582768|FG001|Overall Study|Inclusion Error|7|||
131807698|NCT01513174|474582767|FG000|Overall Study|Not receive study treatment|3|||
131905186|NCT04794751|474939074|FG001|Period 2|Protocol Violation|0|||
131905187|NCT01190813|474939077|FG000|Overall Study|Lost to Follow-up|1|||
131905188|NCT01190813|474939078|FG001|Overall Study|Lost to Follow-up|2|||
131905189|NCT01190813|474939077|FG000|Overall Study|Withdrawal by Subject|2|||
131905190|NCT01190813|474939078|FG001|Overall Study|Withdrawal by Subject|1|||
131905191|NCT01190813|474939077|FG000|Overall Study|Refused study treatment after randomized|1|||
131905192|NCT01190813|474939078|FG001|Overall Study|Refused study treatment after randomized|0|||
131905193|NCT01190813|474939077|FG000|Overall Study|Adverse Event|0|||
131905194|NCT01190813|474939078|FG001|Overall Study|Adverse Event|1|||
131905195|NCT04414787|474939083|FG000|Overall Study|Patient Death|18|||
131905196|NCT04414787|474939084|FG001|Overall Study|Patient Death|18|||
131905197|NCT04414787|474939085|FG002|Overall Study|Patient Death|15|||
131905198|NCT04414787|474939086|FG003|Overall Study|Patient Death|15|||
131905199|NCT04414787|474939083|FG000|Overall Study|Patient Hospitalization|1|||
131905200|NCT04414787|474939084|FG001|Overall Study|Patient Hospitalization|1|||
131905201|NCT04414787|474939085|FG002|Overall Study|Patient Hospitalization|2|||
131905202|NCT04414787|474939086|FG003|Overall Study|Patient Hospitalization|2|||
131905203|NCT04414787|474939083|FG000|Overall Study|Lost to Follow-up|7|||
131905204|NCT04414787|474939084|FG001|Overall Study|Lost to Follow-up|7|||
131905205|NCT04414787|474939085|FG002|Overall Study|Lost to Follow-up|5|||
131905206|NCT04414787|474939086|FG003|Overall Study|Lost to Follow-up|5|||
131905207|NCT04414787|474939083|FG000|Overall Study|Residence in post-acute care facility|3|||
131905208|NCT04414787|474939084|FG001|Overall Study|Residence in post-acute care facility|3|||
131905209|NCT04414787|474939085|FG002|Overall Study|Residence in post-acute care facility|5|||
131905210|NCT04414787|474939086|FG003|Overall Study|Residence in post-acute care facility|5|||
131905211|NCT04194814|474939089|FG000|Overall Study|Physician Decision|3|||
131733860|NCT03136185|474303514|FG003|Overall Study|Withdrawal by Subject|1|||
131733861|NCT03136185|474303515|FG004|Overall Study|Withdrawal by Subject|1|||
131733862|NCT03136185|474303516|FG005|Overall Study|Withdrawal by Subject|1|||
131733863|NCT03136185|474303517|FG006|Overall Study|Withdrawal by Subject|2|||
131733864|NCT03136185|474303518|FG007|Overall Study|Withdrawal by Subject|3|||
131733865|NCT03136185|474303519|FG008|Overall Study|Withdrawal by Subject|3|||
131733866|NCT03136185|474303511|FG000|Overall Study|Not Reported|4|||
131733867|NCT03136185|474303512|FG001|Overall Study|Not Reported|1|||
131733868|NCT03136185|474303513|FG002|Overall Study|Not Reported|0|||
131733869|NCT03136185|474303514|FG003|Overall Study|Not Reported|1|||
131733870|NCT03136185|474303515|FG004|Overall Study|Not Reported|0|||
131733871|NCT03136185|474303516|FG005|Overall Study|Not Reported|2|||
131733872|NCT03136185|474303517|FG006|Overall Study|Not Reported|1|||
131733873|NCT03136185|474303518|FG007|Overall Study|Not Reported|1|||
131733874|NCT03136185|474303519|FG008|Overall Study|Not Reported|0|||
131733875|NCT00488033|474303527|FG000|Overall Study|Withdrawal by Subject|1|||
131733876|NCT00488033|474303528|FG001|Overall Study|Withdrawal by Subject|0|||
131733877|NCT01423617|474303529|FG000|Overall Study|Lost to Follow-up|0|||
131733878|NCT01423617|474303530|FG001|Overall Study|Lost to Follow-up|1|||
131733879|NCT01515306|474303531|FG000|Overall Study|Adverse Event|3|||
131733880|NCT01515306|474303532|FG001|Overall Study|Adverse Event|2|||
131733881|NCT01515306|474303531|FG000|Overall Study|Progressive Disease|19|||
131733882|NCT01515306|474303532|FG001|Overall Study|Progressive Disease|9|||
131733883|NCT01515306|474303531|FG000|Overall Study|Withdrawal by Subject|1|||
131733884|NCT01515306|474303532|FG001|Overall Study|Withdrawal by Subject|2|||
131733885|NCT01515306|474303531|FG000|Overall Study|Physician Decision|1|||
131733886|NCT01515306|474303532|FG001|Overall Study|Physician Decision|1|||
131733887|NCT00634244|474303536|FG000|Overall Study|Never started treatment|0|||
131733888|NCT00634244|474303537|FG001|Overall Study|Never started treatment|1|||
131733889|NCT00634244|474303538|FG002|Overall Study|Never started treatment|0|||
131905212|NCT04194814|474939090|FG001|Overall Study|Physician Decision|0|||
131905213|NCT04194814|474939089|FG000|Overall Study|Withdrawal by Subject|0|||
131905214|NCT04194814|474939090|FG001|Overall Study|Withdrawal by Subject|2|||
131905215|NCT00945243|474940819|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
131905216|NCT03256578|474940820|FG000|Overall Study|Excluded Post Randomization|66|||
131905217|NCT03256578|474940821|FG001|Overall Study|Excluded Post Randomization|56|||
131905218|NCT04969289|474940824|FG000|Overall Study|Lost to Follow-up|13|||
131905219|NCT04969289|474940825|FG001|Overall Study|Lost to Follow-up|9|||
131905220|NCT03028142|474940826|FG000|Overall Study|Adverse Event|1|||
131905221|NCT03028142|474940827|FG001|Overall Study|Adverse Event|1|||
131905222|NCT03028142|474940828|FG002|Overall Study|Adverse Event|0|||
131905223|NCT03028142|474940829|FG003|Overall Study|Adverse Event|0|||
131905224|NCT03028142|474940830|FG004|Overall Study|Adverse Event|0|||
131905225|NCT03028142|474940831|FG005|Overall Study|Adverse Event|1|||
131905226|NCT03028142|474940826|FG000|Overall Study|Withdrawal by Subject|0|||
131905227|NCT03028142|474940827|FG001|Overall Study|Withdrawal by Subject|0|||
131905228|NCT03028142|474940828|FG002|Overall Study|Withdrawal by Subject|0|||
131905229|NCT03028142|474940829|FG003|Overall Study|Withdrawal by Subject|0|||
131905230|NCT03028142|474940830|FG004|Overall Study|Withdrawal by Subject|1|||
131733890|NCT00634244|474303536|FG000|Overall Study|Death|1|||
131733891|NCT00634244|474303537|FG001|Overall Study|Death|6|||
131733892|NCT00634244|474303538|FG002|Overall Study|Death|0|||
131733893|NCT00634244|474303536|FG000|Overall Study|Adverse Event|0|||
131733894|NCT00634244|474303537|FG001|Overall Study|Adverse Event|2|||
131733895|NCT00634244|474303538|FG002|Overall Study|Adverse Event|0|||
131733896|NCT00634244|474303536|FG000|Overall Study|Withdrawal by Subject|0|||
131733897|NCT00634244|474303537|FG001|Overall Study|Withdrawal by Subject|1|||
131733898|NCT00634244|474303538|FG002|Overall Study|Withdrawal by Subject|0|||
131733899|NCT00634244|474303536|FG000|Overall Study|Physician Decision|0|||
131733900|NCT00634244|474303537|FG001|Overall Study|Physician Decision|1|||
131733901|NCT00634244|474303538|FG002|Overall Study|Physician Decision|0|||
131733902|NCT00634244|474303536|FG000|Overall Study|Disease progression/relapse|0|||
131733903|NCT00634244|474303537|FG001|Overall Study|Disease progression/relapse|1|||
131733904|NCT00634244|474303538|FG002|Overall Study|Disease progression/relapse|0|||
131733905|NCT00634244|474303536|FG000|Overall Study|Other complicating disease|0|||
131733906|NCT00634244|474303537|FG001|Overall Study|Other complicating disease|1|||
131733907|NCT00634244|474303538|FG002|Overall Study|Other complicating disease|0|||
131733908|NCT03855137|474303545|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
131733909|NCT03855137|474303546|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
131733910|NCT03855137|474303547|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
131733911|NCT03855137|474303545|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
131733912|NCT03855137|474303546|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
131733913|NCT03855137|474303547|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
131733914|NCT03855137|474303545|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
131733915|NCT03855137|474303546|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
131733916|NCT03855137|474303547|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
131733917|NCT03855137|474303545|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
131733918|NCT03855137|474303546|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
131733919|NCT03855137|474303547|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
131733920|NCT03855137|474303545|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
131733921|NCT03855137|474303546|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
131733922|NCT03855137|474303547|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
131733923|NCT03855137|474303545|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
131733924|NCT03855137|474303546|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
131733925|NCT03855137|474303547|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
131733926|NCT03855137|474303545|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
131733927|NCT03855137|474303546|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
131733928|NCT03855137|474303547|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
131733929|NCT03855137|474303545|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
131733930|NCT03855137|474303546|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
131733931|NCT03855137|474303547|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
131733932|NCT03855137|474303545|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
131733933|NCT03855137|474303546|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
131733934|NCT03855137|474303547|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
131733935|NCT03855137|474303545|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
131733936|NCT03855137|474303546|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
131733937|NCT03855137|474303547|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
131733938|NCT02427477|474303553|FG000|Period 1|Adverse Event|1|||
131733939|NCT02427477|474303554|FG001|Period 1|Adverse Event|0|||
131733940|NCT04369430|474303558|FG000|Overall Study|Adverse Event|2|||
131733941|NCT04369430|474303559|FG001|Overall Study|Adverse Event|3|||
131733942|NCT04369430|474303558|FG000|Overall Study|Death|1|||
131733943|NCT04369430|474303559|FG001|Overall Study|Death|0|||
131733944|NCT04369430|474303558|FG000|Overall Study|Withdrawal by Subject|4|||
131733945|NCT04369430|474303559|FG001|Overall Study|Withdrawal by Subject|3|||
131733946|NCT04369430|474303558|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
131733947|NCT04369430|474303559|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
131733948|NCT04369430|474303558|FG000|Overall Study|Lost to Follow-up|0|||
131733949|NCT04369430|474303559|FG001|Overall Study|Lost to Follow-up|1|||
131733950|NCT02435277|474303560|FG000|Overall Study|Adverse Event|1|||
131733951|NCT02435277|474303561|FG001|Overall Study|Adverse Event|1|||
131733952|NCT02435277|474303562|FG002|Overall Study|Adverse Event|0|||
131733953|NCT02435277|474303563|FG003|Overall Study|Adverse Event|0|||
131733954|NCT02435277|474303560|FG000|Overall Study|Withdrawal by Subject|1|||
131733955|NCT02435277|474303561|FG001|Overall Study|Withdrawal by Subject|0|||
131733956|NCT02435277|474303562|FG002|Overall Study|Withdrawal by Subject|0|||
131733957|NCT02435277|474303563|FG003|Overall Study|Withdrawal by Subject|0|||
131733958|NCT00008138|474303564|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
131733959|NCT00008138|474303564|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
131733960|NCT00008138|474303564|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
131733961|NCT00008138|474303564|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
131733962|NCT00008138|474303564|FG000|Interval Debulking|Withdrawal by Subject|2|||
131733963|NCT00008138|474303564|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
131733964|NCT00008138|474303564|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
131733965|NCT00008138|474303564|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
131733966|NCT02635737|474303569|FG000|Overall Study|Protocol Violation|1|||
131733967|NCT00937768|474303570|FG000|Overall Study|Refused Further Treatment|3|||
131733968|NCT00937768|474303571|FG001|Overall Study|Refused Further Treatment|2|||
131733969|NCT00937768|474303570|FG000|Overall Study|Disease Progression|1|||
131733970|NCT00937768|474303571|FG001|Overall Study|Disease Progression|1|||
131733971|NCT00937768|474303570|FG000|Overall Study|Alternate Treatment|0|||
131733972|NCT00937768|474303571|FG001|Overall Study|Alternate Treatment|1|||
131733973|NCT00937768|474303570|FG000|Overall Study|No Further Funding|4|||
131733974|NCT00937768|474303571|FG001|Overall Study|No Further Funding|4|||
131733975|NCT02065622|474303572|FG000|Induction Study|Adverse Event|13|||
131733976|NCT02065622|474303573|FG001|Induction Study|Adverse Event|19|||
131733977|NCT02065622|474303574|FG002|Induction Study|Adverse Event|0|||
131733978|NCT02065622|474303575|FG003|Induction Study|Adverse Event|0|||
131733979|NCT02065622|474303576|FG004|Induction Study|Adverse Event|0|||
131733980|NCT02065622|474303572|FG000|Induction Study|Withdrawal by Subject|3|||
131733981|NCT02065622|474303573|FG001|Induction Study|Withdrawal by Subject|5|||
131733982|NCT02065622|474303574|FG002|Induction Study|Withdrawal by Subject|0|||
131733983|NCT02065622|474303575|FG003|Induction Study|Withdrawal by Subject|0|||
131733984|NCT02065622|474303576|FG004|Induction Study|Withdrawal by Subject|0|||
131733985|NCT02065622|474303572|FG000|Induction Study|Lost to Follow-up|1|||
131733986|NCT02065622|474303573|FG001|Induction Study|Lost to Follow-up|0|||
131733987|NCT02065622|474303574|FG002|Induction Study|Lost to Follow-up|0|||
131733988|NCT02065622|474303575|FG003|Induction Study|Lost to Follow-up|0|||
131733989|NCT02065622|474303576|FG004|Induction Study|Lost to Follow-up|0|||
131733990|NCT02065622|474303572|FG000|Induction Study|Lack of Efficacy|22|||
131733991|NCT02065622|474303573|FG001|Induction Study|Lack of Efficacy|27|||
131733992|NCT02065622|474303574|FG002|Induction Study|Lack of Efficacy|0|||
131733993|NCT02065622|474303575|FG003|Induction Study|Lack of Efficacy|0|||
131733994|NCT02065622|474303576|FG004|Induction Study|Lack of Efficacy|0|||
131733995|NCT02065622|474303572|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
131733996|NCT02065622|474303573|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
131733997|NCT02065622|474303574|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
131733998|NCT02065622|474303575|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
131733999|NCT02065622|474303576|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
131734000|NCT02065622|474303572|FG000|Induction Study|Subject Noncompliance|1|||
131734001|NCT02065622|474303573|FG001|Induction Study|Subject Noncompliance|1|||
131734002|NCT02065622|474303574|FG002|Induction Study|Subject Noncompliance|0|||
131734003|NCT02065622|474303575|FG003|Induction Study|Subject Noncompliance|0|||
131734004|NCT02065622|474303576|FG004|Induction Study|Subject Noncompliance|0|||
131734005|NCT02065622|474303572|FG000|Induction Study|Other, Not Specified|3|||
131734006|NCT02065622|474303573|FG001|Induction Study|Other, Not Specified|2|||
131734007|NCT02065622|474303574|FG002|Induction Study|Other, Not Specified|0|||
131734008|NCT02065622|474303575|FG003|Induction Study|Other, Not Specified|0|||
131734009|NCT02065622|474303576|FG004|Induction Study|Other, Not Specified|0|||
131734010|NCT02065622|474303572|FG000|Maintenance Study|Adverse Event|0|||
131734011|NCT02065622|474303573|FG001|Maintenance Study|Adverse Event|0|||
131734012|NCT02065622|474303574|FG002|Maintenance Study|Adverse Event|25|||
131734013|NCT02065622|474303575|FG003|Maintenance Study|Adverse Event|22|||
131734014|NCT02065622|474303576|FG004|Maintenance Study|Adverse Event|11|||
131734015|NCT02065622|474303572|FG000|Maintenance Study|Withdrawal by Subject|0|||
131734016|NCT02065622|474303573|FG001|Maintenance Study|Withdrawal by Subject|0|||
131734017|NCT02065622|474303574|FG002|Maintenance Study|Withdrawal by Subject|11|||
131734018|NCT02065622|474303575|FG003|Maintenance Study|Withdrawal by Subject|5|||
131734019|NCT02065622|474303576|FG004|Maintenance Study|Withdrawal by Subject|7|||
131734020|NCT02065622|474303572|FG000|Maintenance Study|Lost to Follow-up|0|||
131734021|NCT02065622|474303573|FG001|Maintenance Study|Lost to Follow-up|0|||
131734022|NCT02065622|474303574|FG002|Maintenance Study|Lost to Follow-up|4|||
131807699|NCT01513174|474582768|FG001|Overall Study|Not receive study treatment|1|||
131807700|NCT00467363|474582769|FG000|Overall Study|Lost to Follow-up|80|||
131807701|NCT00467363|474582770|FG001|Overall Study|Lost to Follow-up|70|||
131807702|NCT03138967|474582777|FG000|Overall Study|Death|0|||
131807703|NCT03138967|474582778|FG001|Overall Study|Death|1|||
131807704|NCT03138967|474582777|FG000|Overall Study|Physician Decision|1|||
131807705|NCT03138967|474582778|FG001|Overall Study|Physician Decision|3|||
131807706|NCT05169710|474582779|FG000|Overall Study|Adverse Event|1|||
131807707|NCT05169710|474582780|FG001|Overall Study|Adverse Event|2|||
131807708|NCT05169710|474582781|FG002|Overall Study|Adverse Event|2|||
131807709|NCT05169710|474582779|FG000|Overall Study|Lost to Follow-up|0|||
131807710|NCT05169710|474582780|FG001|Overall Study|Lost to Follow-up|0|||
131807711|NCT05169710|474582781|FG002|Overall Study|Lost to Follow-up|1|||
131807712|NCT05169710|474582779|FG000|Overall Study|Withdrawal by Subject|2|||
131807713|NCT05169710|474582780|FG001|Overall Study|Withdrawal by Subject|1|||
131807714|NCT05169710|474582781|FG002|Overall Study|Withdrawal by Subject|0|||
131807715|NCT05169710|474582779|FG000|Overall Study|Other Study Discontinuation Reason|0|||
131807716|NCT05169710|474582780|FG001|Overall Study|Other Study Discontinuation Reason|2|||
131807717|NCT05169710|474582781|FG002|Overall Study|Other Study Discontinuation Reason|0|||
131807718|NCT00836056|474582794|FG000|First Intervention|Adverse Event|1|||
131807719|NCT00836056|474582795|FG001|First Intervention|Adverse Event|0|||
131807720|NCT00846495|474582796|FG000|Overall Study|Lost to Follow-up|1|||
131807721|NCT00846495|474582797|FG001|Overall Study|Lost to Follow-up|0|||
131807722|NCT00846495|474582796|FG000|Overall Study|Adverse Event|5|||
131807723|NCT00846495|474582797|FG001|Overall Study|Adverse Event|1|||
131734023|NCT02065622|474303575|FG003|Maintenance Study|Lost to Follow-up|1|||
131734024|NCT02065622|474303576|FG004|Maintenance Study|Lost to Follow-up|1|||
131734025|NCT02065622|474303572|FG000|Maintenance Study|Lack of Efficacy|0|||
131734026|NCT02065622|474303573|FG001|Maintenance Study|Lack of Efficacy|0|||
131734027|NCT02065622|474303574|FG002|Maintenance Study|Lack of Efficacy|70|||
131734028|NCT02065622|474303575|FG003|Maintenance Study|Lack of Efficacy|55|||
131734029|NCT02065622|474303576|FG004|Maintenance Study|Lack of Efficacy|19|||
131734030|NCT02065622|474303572|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
131734031|NCT02065622|474303573|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
131734032|NCT02065622|474303574|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
131734033|NCT02065622|474303575|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
131734034|NCT02065622|474303576|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
131734035|NCT02065622|474303572|FG000|Maintenance Study|Subject Non-Compliance|0|||
131734036|NCT02065622|474303573|FG001|Maintenance Study|Subject Non-Compliance|0|||
131734037|NCT02065622|474303574|FG002|Maintenance Study|Subject Non-Compliance|1|||
131734038|NCT02065622|474303575|FG003|Maintenance Study|Subject Non-Compliance|3|||
131734039|NCT02065622|474303576|FG004|Maintenance Study|Subject Non-Compliance|2|||
131734040|NCT02065622|474303572|FG000|Maintenance Study|Other, Not Specified|0|||
131734041|NCT02065622|474303573|FG001|Maintenance Study|Other, Not Specified|0|||
131734042|NCT02065622|474303574|FG002|Maintenance Study|Other, Not Specified|6|||
131734043|NCT02065622|474303575|FG003|Maintenance Study|Other, Not Specified|14|||
131734044|NCT02065622|474303576|FG004|Maintenance Study|Other, Not Specified|2|||
131734045|NCT02065622|474303572|FG000|Maintenance Study|Unknown Reason|0|||
131734046|NCT02065622|474303573|FG001|Maintenance Study|Unknown Reason|0|||
131734047|NCT02065622|474303574|FG002|Maintenance Study|Unknown Reason|0|||
131734048|NCT02065622|474303575|FG003|Maintenance Study|Unknown Reason|1|||
131734049|NCT02065622|474303576|FG004|Maintenance Study|Unknown Reason|0|||
131734050|NCT01687413|474303579|FG000|Overall Study|Withdrawal by Subject|0|||
131734051|NCT01687413|474303580|FG001|Overall Study|Withdrawal by Subject|2|||
131734052|NCT01687413|474303579|FG000|Overall Study|Not eligible|0|||
131734053|NCT01687413|474303580|FG001|Overall Study|Not eligible|2|||
131734054|NCT01687413|474303579|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
131807724|NCT00846495|474582796|FG000|Overall Study|Lack of Efficacy|1|||
131905231|NCT03028142|474940831|FG005|Overall Study|Withdrawal by Subject|0|||
131448866|NCT01208207|473272739|FG002|Part I|Lost to Follow-up|0|||
131734055|NCT01687413|474303580|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
131734056|NCT01767194|474303581|FG000|Overall Study|Adverse Event|1|||
131734057|NCT01767194|474303582|FG001|Overall Study|Adverse Event|1|||
131448867|NCT01208207|473272740|FG003|Part I|Lost to Follow-up|0|||
131734058|NCT01767194|474303581|FG000|Overall Study|Death|0|||
131734059|NCT01767194|474303582|FG001|Overall Study|Death|1|||
131734060|NCT01767194|474303581|FG000|Overall Study|Lack of Efficacy|12|||
131734061|NCT01767194|474303582|FG001|Overall Study|Lack of Efficacy|11|||
131807725|NCT00846495|474582797|FG001|Overall Study|Lack of Efficacy|2|||
131807726|NCT00846495|474582796|FG000|Overall Study|Physician Decision|1|||
131807727|NCT00846495|474582797|FG001|Overall Study|Physician Decision|0|||
131807728|NCT01686438|474582798|FG000|Overall Study|Lost to Follow-up|8|||
131807729|NCT01686438|474582799|FG001|Overall Study|Lost to Follow-up|9|||
131807730|NCT01686438|474582800|FG002|Overall Study|Lost to Follow-up|10|||
131448868|NCT01208207|473272741|FG004|Part I|Lost to Follow-up|0|||
131807731|NCT01686438|474582798|FG000|Overall Study|Adverse Event|0|||
131807732|NCT01686438|474582799|FG001|Overall Study|Adverse Event|0|||
131807733|NCT01686438|474582800|FG002|Overall Study|Adverse Event|1|||
131807734|NCT01686438|474582798|FG000|Overall Study|Protocol Violation|0|||
131807735|NCT01686438|474582799|FG001|Overall Study|Protocol Violation|0|||
131734062|NCT01767194|474303581|FG000|Overall Study|Physician Decision|2|||
131734063|NCT01767194|474303582|FG001|Overall Study|Physician Decision|23|||
131734064|NCT01767194|474303581|FG000|Overall Study|Withdrawal by Subject|0|||
131734065|NCT01767194|474303582|FG001|Overall Study|Withdrawal by Subject|1|||
131734066|NCT01767194|474303581|FG000|Overall Study|Ineligible|1|||
131734067|NCT01767194|474303582|FG001|Overall Study|Ineligible|1|||
131734068|NCT01767194|474303581|FG000|Overall Study|Refusal by patient/parent|2|||
131734069|NCT01767194|474303582|FG001|Overall Study|Refusal by patient/parent|4|||
131734070|NCT01767194|474303581|FG000|Overall Study|Criteria not met on time for next cycle|0|||
131734071|NCT01767194|474303582|FG001|Overall Study|Criteria not met on time for next cycle|1|||
131734072|NCT04973228|474303583|FG000|Overall Study|Adverse Event|2|||
131734073|NCT04973228|474303584|FG001|Overall Study|Adverse Event|3|||
131734074|NCT04973228|474303583|FG000|Overall Study|Lack of Efficacy|1|||
131734075|NCT04973228|474303584|FG001|Overall Study|Lack of Efficacy|3|||
131734076|NCT04973228|474303583|FG000|Overall Study|Lost to Follow-up|12|||
131734077|NCT04973228|474303584|FG001|Overall Study|Lost to Follow-up|4|||
131734078|NCT04973228|474303583|FG000|Overall Study|Withdrawal by Subject|11|||
131734079|NCT04973228|474303584|FG001|Overall Study|Withdrawal by Subject|4|||
131734080|NCT04973228|474303583|FG000|Overall Study|Did not tolerate application|1|||
131734081|NCT04973228|474303584|FG001|Overall Study|Did not tolerate application|0|||
131734082|NCT04973228|474303583|FG000|Overall Study|Wanted to early terminate and use own product|0|||
131734083|NCT04973228|474303584|FG001|Overall Study|Wanted to early terminate and use own product|1|||
131734084|NCT04973228|474303583|FG000|Overall Study|Missed visits due to new work schedule|1|||
131734085|NCT04973228|474303584|FG001|Overall Study|Missed visits due to new work schedule|0|||
131734086|NCT00406640|474303602|FG000|Acute Phase|Adverse Event|18|||
131734087|NCT00406640|474303603|FG001|Acute Phase|Adverse Event|13|||
131734088|NCT00406640|474303602|FG000|Acute Phase|Failed to Return|5|||
131734089|NCT00406640|474303603|FG001|Acute Phase|Failed to Return|1|||
131734090|NCT00406640|474303602|FG000|Acute Phase|Physician Decision|0|||
131734091|NCT00406640|474303603|FG001|Acute Phase|Physician Decision|1|||
131734092|NCT00406640|474303602|FG000|Acute Phase|Lost to Follow-up|7|||
131734093|NCT00406640|474303603|FG001|Acute Phase|Lost to Follow-up|4|||
131734094|NCT00406640|474303602|FG000|Acute Phase|Protocol deviation|4|||
131734095|NCT00406640|474303603|FG001|Acute Phase|Protocol deviation|10|||
131734096|NCT00406640|474303602|FG000|Acute Phase|Protocol Violation|3|||
131734097|NCT00406640|474303603|FG001|Acute Phase|Protocol Violation|2|||
131734098|NCT00406640|474303602|FG000|Acute Phase|Withdrawal by Subject|11|||
131734099|NCT00406640|474303603|FG001|Acute Phase|Withdrawal by Subject|9|||
131734100|NCT00406640|474303602|FG000|Acute Phase|Lack of Efficacy|3|||
131734101|NCT00406640|474303603|FG001|Acute Phase|Lack of Efficacy|3|||
131734102|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
131734103|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
131734104|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Death|1|||
131734105|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Death|0|||
131734106|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
131734107|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
131734108|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
131734109|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
131734110|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
131734111|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
131734112|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|non-compliance|7|||
131734113|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|non-compliance|5|||
131734114|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
131734115|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
131734116|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
131734117|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
131734118|NCT00406640|474303602|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
131734119|NCT00406640|474303603|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
131734120|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
131734121|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
131734122|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
131734123|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
131734124|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
131734125|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
131734126|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
131807736|NCT01686438|474582800|FG002|Overall Study|Protocol Violation|1|||
131807737|NCT01686438|474582798|FG000|Overall Study|Withdrawal by Subject|0|||
131807738|NCT01686438|474582799|FG001|Overall Study|Withdrawal by Subject|0|||
131734127|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
131734128|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
131734129|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
131734130|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
131734131|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
131734132|NCT00406640|474303602|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
131734133|NCT00406640|474303603|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
131734134|NCT01454401|474303606|FG000|Overall Study|Death|1|||
131734135|NCT01454401|474303606|FG000|Overall Study|hospitalised|1|||
131734136|NCT01454401|474303606|FG000|Overall Study|osteomyelitis|2|||
131734137|NCT01454401|474303606|FG000|Overall Study|non-adherence|1|||
131734138|NCT00992446|474303612|FG000|Overall Study|Disease Progression|1|||
131734139|NCT00992446|474303612|FG000|Overall Study|Withdrawal by Subject|2|||
131734140|NCT00992446|474303612|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
131734141|NCT03675737|474303615|FG000|Overall Study|Death|593|||
131734142|NCT03675737|474303616|FG001|Overall Study|Death|660|||
131734143|NCT03675737|474303615|FG000|Overall Study|Lost to Follow-up|1|||
131734144|NCT03675737|474303616|FG001|Overall Study|Lost to Follow-up|5|||
131734145|NCT03675737|474303615|FG000|Overall Study|Physician Decision|1|||
131734146|NCT03675737|474303616|FG001|Overall Study|Physician Decision|0|||
131734147|NCT03675737|474303615|FG000|Overall Study|Withdrawal by Subject|14|||
131734148|NCT03675737|474303616|FG001|Overall Study|Withdrawal by Subject|12|||
131734149|NCT03675737|474303615|FG000|Overall Study|Ongoing in Study|181|||
131734150|NCT03675737|474303616|FG001|Overall Study|Ongoing in Study|112|||
131734151|NCT00755846|474305356|FG000|Overall Study|Adverse Event|0|||
131734152|NCT00755846|474305357|FG001|Overall Study|Adverse Event|0|||
131807739|NCT01686438|474582800|FG002|Overall Study|Withdrawal by Subject|1|||
131807740|NCT01029340|474582803|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
131807741|NCT01029340|474582804|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
131807742|NCT01029340|474582805|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
131807743|NCT01029340|474582806|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
131807744|NCT01029340|474582807|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
131734153|NCT00755846|474305358|FG002|Overall Study|Adverse Event|0|||
131734154|NCT00755846|474305359|FG003|Overall Study|Adverse Event|1|||
131734155|NCT00755846|474305360|FG004|Overall Study|Adverse Event|3|||
131734156|NCT00755846|474305361|FG005|Overall Study|Adverse Event|2|||
131734157|NCT00755846|474305356|FG000|Overall Study|Protocol Violation|1|||
131734158|NCT00755846|474305357|FG001|Overall Study|Protocol Violation|1|||
131734159|NCT00755846|474305358|FG002|Overall Study|Protocol Violation|1|||
131734160|NCT00755846|474305359|FG003|Overall Study|Protocol Violation|1|||
131734161|NCT00755846|474305360|FG004|Overall Study|Protocol Violation|1|||
131734162|NCT00755846|474305361|FG005|Overall Study|Protocol Violation|1|||
131734163|NCT00755846|474305356|FG000|Overall Study|Lost to Follow-up|0|||
131734164|NCT00755846|474305357|FG001|Overall Study|Lost to Follow-up|2|||
131734165|NCT00755846|474305358|FG002|Overall Study|Lost to Follow-up|1|||
131734166|NCT00755846|474305359|FG003|Overall Study|Lost to Follow-up|0|||
131734167|NCT00755846|474305360|FG004|Overall Study|Lost to Follow-up|4|||
131734168|NCT00755846|474305361|FG005|Overall Study|Lost to Follow-up|2|||
131734169|NCT00755846|474305356|FG000|Overall Study|Withdrawal by Subject|2|||
131905232|NCT02810418|474940832|FG000|Arm A Dose Escalation|Adverse Event|2|||
131905233|NCT02810418|474940833|FG001|Arm A Dose Escalation|Adverse Event|1|||
131905234|NCT02810418|474940834|FG002|Arm A Dose Escalation|Adverse Event|0|||
131905235|NCT02810418|474940835|FG003|Arm A Dose Escalation|Adverse Event|0|||
131734170|NCT00755846|474305357|FG001|Overall Study|Withdrawal by Subject|3|||
131734171|NCT00755846|474305358|FG002|Overall Study|Withdrawal by Subject|5|||
131734172|NCT00755846|474305359|FG003|Overall Study|Withdrawal by Subject|2|||
131807745|NCT01029340|474582808|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
131807746|NCT01029340|474582803|FG000|Part B Treatment Period|Protocol Violation|0|||
131905236|NCT02810418|474940836|FG004|Arm A Dose Escalation|Adverse Event|0|||
131734173|NCT00755846|474305360|FG004|Overall Study|Withdrawal by Subject|0|||
131734174|NCT00755846|474305361|FG005|Overall Study|Withdrawal by Subject|1|||
131734175|NCT00755846|474305356|FG000|Overall Study|Hyperglycemic Rescue|21|||
131734176|NCT00755846|474305357|FG001|Overall Study|Hyperglycemic Rescue|7|||
131905237|NCT02810418|474940837|FG005|Arm A Dose Escalation|Adverse Event|0|||
131734177|NCT00755846|474305358|FG002|Overall Study|Hyperglycemic Rescue|5|||
131734178|NCT00755846|474305359|FG003|Overall Study|Hyperglycemic Rescue|8|||
131448869|NCT01208207|473272742|FG005|Part I|Lost to Follow-up|0|||
131734179|NCT00755846|474305360|FG004|Overall Study|Hyperglycemic Rescue|8|||
131807747|NCT01029340|474582804|FG001|Part B Treatment Period|Protocol Violation|0|||
131807748|NCT01029340|474582805|FG002|Part B Treatment Period|Protocol Violation|1|||
131734180|NCT00755846|474305361|FG005|Overall Study|Hyperglycemic Rescue|7|||
131734181|NCT00755846|474305356|FG000|Overall Study|Physician Decision|1|||
131734182|NCT00755846|474305357|FG001|Overall Study|Physician Decision|3|||
131734183|NCT00755846|474305358|FG002|Overall Study|Physician Decision|0|||
131734184|NCT00755846|474305359|FG003|Overall Study|Physician Decision|1|||
131734185|NCT00755846|474305360|FG004|Overall Study|Physician Decision|0|||
131734186|NCT00755846|474305361|FG005|Overall Study|Physician Decision|1|||
131734187|NCT00755846|474305356|FG000|Overall Study|Administrative Error|0|||
131734188|NCT00755846|474305357|FG001|Overall Study|Administrative Error|1|||
131734189|NCT00755846|474305358|FG002|Overall Study|Administrative Error|0|||
131734190|NCT00755846|474305359|FG003|Overall Study|Administrative Error|0|||
131734191|NCT00755846|474305360|FG004|Overall Study|Administrative Error|0|||
131734192|NCT00755846|474305361|FG005|Overall Study|Administrative Error|0|||
131734193|NCT00755846|474305356|FG000|Overall Study|Participant Non-compliance|0|||
131734194|NCT00755846|474305357|FG001|Overall Study|Participant Non-compliance|0|||
131734195|NCT00755846|474305358|FG002|Overall Study|Participant Non-compliance|0|||
131734196|NCT00755846|474305359|FG003|Overall Study|Participant Non-compliance|0|||
131734197|NCT00755846|474305360|FG004|Overall Study|Participant Non-compliance|1|||
131734198|NCT00755846|474305361|FG005|Overall Study|Participant Non-compliance|0|||
131734199|NCT02349789|474305363|FG000|Overall Study|Withdrawal by Subject|2|||
131734200|NCT00683475|474305364|FG000|Overall Study|Withdrawal by Subject|1|||
131734201|NCT00683475|474305365|FG001|Overall Study|Withdrawal by Subject|0|||
131734202|NCT00683475|474305364|FG000|Overall Study|Never Treated: Adverse Event|2|||
131734203|NCT00683475|474305365|FG001|Overall Study|Never Treated: Adverse Event|3|||
131734204|NCT00683475|474305364|FG000|Overall Study|Never Treated: Progressive Disease|1|||
131734205|NCT00683475|474305365|FG001|Overall Study|Never Treated: Progressive Disease|0|||
131734206|NCT02922634|474305366|FG000|Overall Study|Withdrawal by Subject|5|||
131734207|NCT02922634|474305366|FG000|Overall Study|Did not have their surgery|5|||
131734208|NCT02723604|474305367|FG000|Overall Study|ineligible|1|||
131734209|NCT02723604|474305367|FG000|Overall Study|never received treatment|1|||
131734210|NCT00352755|474305368|FG000|Overall Study|Physician Decision|1|||
131734211|NCT00352755|474305368|FG000|Overall Study|Adverse Event|1|||
131734212|NCT02429258|474305371|FG000|Overall Study|Withdrawal by Subject|2|||
131734213|NCT02429258|474305372|FG001|Overall Study|Withdrawal by Subject|0|||
131734214|NCT02429258|474305371|FG000|Overall Study|Protocol Violation|0|||
131734215|NCT02429258|474305372|FG001|Overall Study|Protocol Violation|1|||
131734216|NCT02397694|474305373|FG000|Double-Blinded Phase|Adverse Event|1|||
131734217|NCT02397694|474305374|FG001|Double-Blinded Phase|Adverse Event|0|||
131734218|NCT02397694|474305373|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
131734219|NCT02397694|474305374|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
131734220|NCT02397694|474305373|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
131734221|NCT02397694|474305374|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
131734222|NCT02397694|474305373|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
131734223|NCT02397694|474305374|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
131734224|NCT02397694|474305373|FG000|Open Label Extension Phase|Protocol Violation|1|||
131734225|NCT02397694|474305374|FG001|Open Label Extension Phase|Protocol Violation|0|||
131734226|NCT02397694|474305373|FG000|Open Label Extension Phase|Withdrew Consent|3|||
131734227|NCT02397694|474305374|FG001|Open Label Extension Phase|Withdrew Consent|1|||
131734228|NCT02397694|474305373|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
131734229|NCT02397694|474305374|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
131734230|NCT01694420|474305376|FG000|Overall Study|Lost to Follow-up|3|||
131734231|NCT00762372|474305378|FG000|Overall Study|Adverse Event|1|||
131734232|NCT00762372|474305379|FG001|Overall Study|Adverse Event|0|||
131734233|NCT00762372|474305380|FG002|Overall Study|Adverse Event|0|||
131734234|NCT03364335|474305381|FG000|Overall Study|Adverse Event|3|||
131734235|NCT03364335|474305382|FG001|Overall Study|Adverse Event|4|||
131734236|NCT03364335|474305383|FG002|Overall Study|Adverse Event|1|||
131734237|NCT03364335|474305384|FG003|Overall Study|Adverse Event|2|||
131734238|NCT03364335|474305385|FG004|Overall Study|Adverse Event|0|||
131734239|NCT03364335|474305381|FG000|Overall Study|Lost to Follow-up|7|||
131734240|NCT03364335|474305382|FG001|Overall Study|Lost to Follow-up|7|||
131734241|NCT03364335|474305383|FG002|Overall Study|Lost to Follow-up|10|||
131734242|NCT03364335|474305384|FG003|Overall Study|Lost to Follow-up|11|||
131734243|NCT03364335|474305385|FG004|Overall Study|Lost to Follow-up|11|||
131734244|NCT03987919|474305386|FG000|Overall Study|Adverse Event|1|||
131734245|NCT03987919|474305387|FG001|Overall Study|Adverse Event|4|||
131734246|NCT03987919|474305388|FG002|Overall Study|Adverse Event|1|||
131734247|NCT03987919|474305389|FG003|Overall Study|Adverse Event|3|||
131734248|NCT03987919|474305386|FG000|Overall Study|Death|4|||
131734249|NCT03987919|474305387|FG001|Overall Study|Death|4|||
131734250|NCT03987919|474305388|FG002|Overall Study|Death|4|||
131734251|NCT03987919|474305389|FG003|Overall Study|Death|1|||
131734252|NCT03987919|474305386|FG000|Overall Study|Lost to Follow-up|5|||
131807749|NCT01029340|474582806|FG003|Part B Treatment Period|Protocol Violation|0|||
131734253|NCT03987919|474305387|FG001|Overall Study|Lost to Follow-up|6|||
131734254|NCT03987919|474305388|FG002|Overall Study|Lost to Follow-up|8|||
131734255|NCT03987919|474305389|FG003|Overall Study|Lost to Follow-up|12|||
131734256|NCT03987919|474305386|FG000|Overall Study|Physician Decision|0|||
131734257|NCT03987919|474305387|FG001|Overall Study|Physician Decision|2|||
131734258|NCT03987919|474305388|FG002|Overall Study|Physician Decision|0|||
131734259|NCT03987919|474305389|FG003|Overall Study|Physician Decision|4|||
131734260|NCT03987919|474305386|FG000|Overall Study|Pregnancy|1|||
131734261|NCT03987919|474305387|FG001|Overall Study|Pregnancy|0|||
131734262|NCT03987919|474305388|FG002|Overall Study|Pregnancy|1|||
131734263|NCT03987919|474305389|FG003|Overall Study|Pregnancy|1|||
131734264|NCT03987919|474305386|FG000|Overall Study|Protocol Violation|0|||
131734265|NCT03987919|474305387|FG001|Overall Study|Protocol Violation|1|||
131734266|NCT03987919|474305388|FG002|Overall Study|Protocol Violation|0|||
131734267|NCT03987919|474305389|FG003|Overall Study|Protocol Violation|0|||
131734268|NCT03987919|474305386|FG000|Overall Study|Site terminated by Sponsor|0|||
131734269|NCT03987919|474305387|FG001|Overall Study|Site terminated by Sponsor|0|||
131734270|NCT03987919|474305388|FG002|Overall Study|Site terminated by Sponsor|0|||
131734271|NCT03987919|474305389|FG003|Overall Study|Site terminated by Sponsor|1|||
131734272|NCT03987919|474305386|FG000|Overall Study|Withdrawal by Subject|7|||
131734273|NCT03987919|474305387|FG001|Overall Study|Withdrawal by Subject|7|||
131734274|NCT03987919|474305388|FG002|Overall Study|Withdrawal by Subject|8|||
131734275|NCT03987919|474305389|FG003|Overall Study|Withdrawal by Subject|4|||
131734276|NCT03987919|474305386|FG000|Overall Study|Other - as reported by the investigator|1|||
131734277|NCT03987919|474305387|FG001|Overall Study|Other - as reported by the investigator|3|||
131734278|NCT03987919|474305388|FG002|Overall Study|Other - as reported by the investigator|2|||
131734279|NCT03987919|474305389|FG003|Overall Study|Other - as reported by the investigator|0|||
131734280|NCT01194804|474305390|FG000|Overall Study|Withdrawal by Subject|1|||
131734281|NCT01303380|474305391|FG000|Overall Study|Lack of compliance to study procedures|1|||
131734282|NCT03621943|474305392|FG000|First Randomized Intervention|Lost to Follow-up|51|||
131734283|NCT03621943|474305393|FG001|First Randomized Intervention|Lost to Follow-up|54|||
131734284|NCT03621943|474305392|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
131734285|NCT03621943|474305393|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
131734286|NCT03621943|474305392|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
131734287|NCT03621943|474305393|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
131734288|NCT03621943|474305392|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
131734289|NCT03621943|474305393|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
131734290|NCT00748553|474305394|FG000|Overall Study|Adverse Event|0|||
131734291|NCT00748553|474305395|FG001|Overall Study|Adverse Event|1|||
131734292|NCT00748553|474305394|FG000|Overall Study|disease progression|2|||
131734293|NCT00748553|474305395|FG001|Overall Study|disease progression|0|||
131734294|NCT00748553|474305394|FG000|Overall Study|noncompliance|1|||
131734295|NCT00748553|474305395|FG001|Overall Study|noncompliance|0|||
131734296|NCT00315705|474305396|FG000|Phase 1|Refused further treatment|1|||
131734297|NCT00315705|474305396|FG000|Phase 1|Failure to achieve response|8|||
131807750|NCT01029340|474582807|FG004|Part B Treatment Period|Protocol Violation|0|||
131734298|NCT00315705|474305396|FG000|Phase 1|Disease relapse|4|||
131734299|NCT00315705|474305396|FG000|Phase 1|Scheduled for transplant|9|||
131734300|NCT00315705|474305396|FG000|Phase 1|Death|3|||
131734301|NCT00315705|474305396|FG000|Phase 2|Physician Decision|4|||
131734302|NCT00315705|474305396|FG000|Phase 2|Adverse Event|1|||
131734303|NCT00315705|474305396|FG000|Phase 2|Failure to achieve response|3|||
131734304|NCT00315705|474305396|FG000|Phase 2|Disease relapse|1|||
131734305|NCT00315705|474305396|FG000|Phase 2|Scheduled for transplant|8|||
131734306|NCT00315705|474305396|FG000|Phase 2|Other|1|||
131734307|NCT00315705|474305396|FG000|Phase 2|Death|7|||
131734308|NCT01716533|474305397|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
131734309|NCT01716533|474305398|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
131734310|NCT01716533|474305399|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
131734311|NCT01716533|474305400|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
131734312|NCT01716533|474305397|FG000|Overall Study|Withdrawal by Subject|0|||
131734313|NCT01716533|474305398|FG001|Overall Study|Withdrawal by Subject|0|||
131734314|NCT01716533|474305399|FG002|Overall Study|Withdrawal by Subject|0|||
131734315|NCT01716533|474305400|FG003|Overall Study|Withdrawal by Subject|5|||
131734316|NCT01716533|474305397|FG000|Overall Study|Death|0|||
131734317|NCT01716533|474305398|FG001|Overall Study|Death|0|||
131734318|NCT01716533|474305399|FG002|Overall Study|Death|0|||
131734319|NCT01716533|474305400|FG003|Overall Study|Death|2|||
131734320|NCT01716533|474305397|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
131734321|NCT01716533|474305398|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
131734322|NCT01716533|474305399|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
131734323|NCT01716533|474305400|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
131734324|NCT03446651|474305404|FG000|Overall Study|Lost to Follow-up|4|||
131734325|NCT03446651|474305405|FG001|Overall Study|Lost to Follow-up|0|||
131734326|NCT03446651|474305404|FG000|Overall Study|Open Label Participants|5|||
131734327|NCT03446651|474305405|FG001|Overall Study|Open Label Participants|0|||
131734328|NCT01030458|474305409|FG000|Overall Study|Lost to Follow-up|9|||
131734329|NCT01030458|474305410|FG001|Overall Study|Lost to Follow-up|10|||
131734330|NCT01030458|474305409|FG000|Overall Study|Withdrawal by Subject|2|||
131734331|NCT01030458|474305410|FG001|Overall Study|Withdrawal by Subject|3|||
131734332|NCT01030458|474305409|FG000|Overall Study|Logistical reasons|9|||
131734333|NCT01030458|474305410|FG001|Overall Study|Logistical reasons|5|||
131734334|NCT01030458|474305409|FG000|Overall Study|Moved or changed job|6|||
131734335|NCT01030458|474305410|FG001|Overall Study|Moved or changed job|13|||
131734336|NCT01030458|474305409|FG000|Overall Study|Side effect of medication|1|||
131734337|NCT01030458|474305410|FG001|Overall Study|Side effect of medication|1|||
131734338|NCT02420223|474305411|FG000|Overall Study|Adverse Event|1|||
131734339|NCT02420223|474305412|FG001|Overall Study|Adverse Event|0|||
131734340|NCT02420223|474305411|FG000|Overall Study|Physician Decision|0|||
131734341|NCT02420223|474305412|FG001|Overall Study|Physician Decision|2|||
131734342|NCT05142332|474305417|FG000|Overall Study|Withdrawal by Subject|0|||
131734343|NCT05142332|474305418|FG001|Overall Study|Withdrawal by Subject|1|||
131734344|NCT05142332|474305419|FG002|Overall Study|Withdrawal by Subject|2|||
131734345|NCT05142332|474305420|FG003|Overall Study|Withdrawal by Subject|0|||
131734346|NCT05142332|474305421|FG004|Overall Study|Withdrawal by Subject|0|||
131734347|NCT05142332|474305422|FG005|Overall Study|Withdrawal by Subject|2|||
131807751|NCT01029340|474582808|FG005|Part B Treatment Period|Protocol Violation|0|||
131807752|NCT01029340|474582803|FG000|Extension Period|Adverse Event|0|||
131807753|NCT01029340|474582804|FG001|Extension Period|Adverse Event|0|||
131807754|NCT01029340|474582805|FG002|Extension Period|Adverse Event|0|||
131807755|NCT01029340|474582806|FG003|Extension Period|Adverse Event|0|||
131807756|NCT01029340|474582807|FG004|Extension Period|Adverse Event|0|||
131807757|NCT01029340|474582808|FG005|Extension Period|Adverse Event|1|||
131807758|NCT01029340|474582803|FG000|Extension Period|starting another study|0|||
131807759|NCT01029340|474582804|FG001|Extension Period|starting another study|0|||
131807760|NCT01029340|474582805|FG002|Extension Period|starting another study|0|||
131734348|NCT05142332|474305423|FG006|Overall Study|Withdrawal by Subject|6|||
131734349|NCT05142332|474305417|FG000|Overall Study|Left ED|3|||
131734350|NCT05142332|474305418|FG001|Overall Study|Left ED|0|||
131734351|NCT05142332|474305419|FG002|Overall Study|Left ED|4|||
131734352|NCT05142332|474305420|FG003|Overall Study|Left ED|6|||
131734353|NCT05142332|474305421|FG004|Overall Study|Left ED|1|||
131734354|NCT05142332|474305422|FG005|Overall Study|Left ED|2|||
131807761|NCT01029340|474582806|FG003|Extension Period|starting another study|0|||
131807762|NCT01029340|474582807|FG004|Extension Period|starting another study|0|||
131734355|NCT05142332|474305423|FG006|Overall Study|Left ED|6|||
131734356|NCT05142332|474305417|FG000|Overall Study|Physician Decision|0|||
131734357|NCT05142332|474305418|FG001|Overall Study|Physician Decision|0|||
131734358|NCT05142332|474305419|FG002|Overall Study|Physician Decision|2|||
131734359|NCT05142332|474305420|FG003|Overall Study|Physician Decision|1|||
131734360|NCT05142332|474305421|FG004|Overall Study|Physician Decision|0|||
131734361|NCT05142332|474305422|FG005|Overall Study|Physician Decision|0|||
131734362|NCT05142332|474305423|FG006|Overall Study|Physician Decision|3|||
131734363|NCT05142332|474305417|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
131734364|NCT05142332|474305418|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
131734365|NCT05142332|474305419|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
131734366|NCT05142332|474305420|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
131734367|NCT05142332|474305421|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
131734368|NCT05142332|474305422|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
131734369|NCT05142332|474305423|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
131734370|NCT02052778|474305428|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
131734371|NCT02052778|474305429|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
131734372|NCT02052778|474305430|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
131734373|NCT02052778|474305431|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
131734374|NCT02052778|474305432|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
131734375|NCT02052778|474305433|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
131734376|NCT02052778|474305434|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734377|NCT02052778|474305435|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
131734378|NCT02052778|474305436|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
131734379|NCT02052778|474305437|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
131734380|NCT02052778|474305438|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
131734381|NCT02052778|474305439|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
131734382|NCT02052778|474305440|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
131734383|NCT02052778|474305441|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
131734384|NCT02052778|474305442|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734385|NCT02052778|474305443|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734386|NCT02052778|474305444|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734387|NCT02052778|474305445|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734388|NCT02052778|474305446|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734389|NCT02052778|474305447|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734390|NCT02052778|474305448|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734391|NCT02052778|474305449|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734392|NCT02052778|474305450|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131734393|NCT02052778|474305428|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131734394|NCT02052778|474305429|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131734395|NCT02052778|474305430|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131734396|NCT02052778|474305431|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131734397|NCT02052778|474305432|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131734398|NCT02052778|474305433|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131734399|NCT02052778|474305434|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
131734400|NCT02052778|474305435|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131734401|NCT02052778|474305436|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131734402|NCT02052778|474305437|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734403|NCT02052778|474305438|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734404|NCT02052778|474305439|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131734405|NCT02052778|474305440|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131734406|NCT02052778|474305441|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
131734407|NCT02052778|474305442|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734408|NCT02052778|474305443|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734409|NCT02052778|474305444|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734410|NCT02052778|474305445|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734411|NCT02052778|474305446|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734412|NCT02052778|474305447|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734413|NCT02052778|474305448|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131807763|NCT01029340|474582808|FG005|Extension Period|starting another study|8|||
131807764|NCT01029340|474582803|FG000|Extension Period|non-compliance|0|||
131734414|NCT02052778|474305449|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734415|NCT02052778|474305450|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131734416|NCT02052778|474305428|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734417|NCT02052778|474305429|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734418|NCT02052778|474305430|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734419|NCT02052778|474305431|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734420|NCT02052778|474305432|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734421|NCT02052778|474305433|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734422|NCT02052778|474305434|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734423|NCT02052778|474305435|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734424|NCT02052778|474305436|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734425|NCT02052778|474305437|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734426|NCT02052778|474305438|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734427|NCT02052778|474305439|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734428|NCT02052778|474305440|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734429|NCT02052778|474305441|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
131734430|NCT02052778|474305442|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734431|NCT02052778|474305443|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734432|NCT02052778|474305444|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734433|NCT02052778|474305445|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734434|NCT02052778|474305446|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734435|NCT02052778|474305447|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734436|NCT02052778|474305448|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734437|NCT02052778|474305449|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734438|NCT02052778|474305450|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131734439|NCT02052778|474305428|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
131734440|NCT02052778|474305429|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
131734441|NCT02052778|474305430|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
131734442|NCT02052778|474305431|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
131734443|NCT02052778|474305432|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
131734444|NCT02052778|474305433|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
131734445|NCT02052778|474305434|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
131734446|NCT02052778|474305435|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
131734447|NCT02052778|474305436|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
131734448|NCT02052778|474305437|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
131734449|NCT02052778|474305438|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
131734450|NCT02052778|474305439|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
131734451|NCT02052778|474305440|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
131734452|NCT02052778|474305441|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
131734453|NCT02052778|474305442|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
131734454|NCT02052778|474305443|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
131734455|NCT02052778|474305444|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
131734456|NCT02052778|474305445|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
131734457|NCT02052778|474305446|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
131734458|NCT02052778|474305447|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
131734459|NCT02052778|474305448|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
131734460|NCT02052778|474305449|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
131734461|NCT02052778|474305450|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
131734462|NCT02052778|474305428|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734463|NCT02052778|474305429|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734464|NCT02052778|474305430|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734465|NCT02052778|474305431|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734466|NCT02052778|474305432|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734467|NCT02052778|474305433|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734468|NCT02052778|474305434|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734469|NCT02052778|474305435|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734470|NCT02052778|474305436|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
131734471|NCT02052778|474305437|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734472|NCT02052778|474305438|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734473|NCT02052778|474305439|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734474|NCT02052778|474305440|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734475|NCT02052778|474305441|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
131734476|NCT02052778|474305442|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734477|NCT02052778|474305443|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734478|NCT02052778|474305444|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734479|NCT02052778|474305445|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734480|NCT02052778|474305446|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734481|NCT02052778|474305447|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734482|NCT02052778|474305448|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734483|NCT02052778|474305449|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131734484|NCT02052778|474305450|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131448870|NCT01208207|473272743|FG006|Part I|Lost to Follow-up|0|||
131734485|NCT02052778|474305428|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734486|NCT02052778|474305429|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734487|NCT02052778|474305430|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734488|NCT02052778|474305431|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734489|NCT02052778|474305432|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734490|NCT02052778|474305433|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
131734491|NCT02052778|474305434|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734492|NCT02052778|474305435|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734493|NCT02052778|474305436|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734494|NCT02052778|474305437|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734495|NCT02052778|474305438|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734496|NCT02052778|474305439|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734497|NCT02052778|474305440|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
131734498|NCT02052778|474305441|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734499|NCT02052778|474305442|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734500|NCT02052778|474305443|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734501|NCT02052778|474305444|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734502|NCT02052778|474305445|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734503|NCT02052778|474305446|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734504|NCT02052778|474305447|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734505|NCT02052778|474305448|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734506|NCT02052778|474305449|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734507|NCT02052778|474305450|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131734508|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734509|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734510|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734511|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734512|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734513|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734514|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734515|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734516|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734517|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734518|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734519|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734520|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734521|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734522|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
131734523|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
131734524|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
131734525|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
131734526|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
131734527|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
131734528|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
131734529|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
131734530|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131734531|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734532|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734533|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734534|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734535|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734536|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734537|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734538|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734539|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734540|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734541|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734542|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734543|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734544|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131807765|NCT01029340|474582804|FG001|Extension Period|non-compliance|0|||
131807766|NCT01029340|474582805|FG002|Extension Period|non-compliance|0|||
131807767|NCT01029340|474582806|FG003|Extension Period|non-compliance|0|||
131807768|NCT01029340|474582807|FG004|Extension Period|non-compliance|0|||
131807769|NCT01029340|474582808|FG005|Extension Period|non-compliance|1|||
131905238|NCT02810418|474940838|FG006|Arm A Dose Escalation|Adverse Event|0|||
131905239|NCT02810418|474940832|FG000|Dose Expansion|Adverse Event|0|||
131905240|NCT02810418|474940833|FG001|Dose Expansion|Adverse Event|1|||
131905241|NCT02810418|474940834|FG002|Dose Expansion|Adverse Event|1|||
131905242|NCT02810418|474940835|FG003|Dose Expansion|Adverse Event|0|||
131905243|NCT02810418|474940836|FG004|Dose Expansion|Adverse Event|0|||
131905244|NCT02810418|474940837|FG005|Dose Expansion|Adverse Event|0|||
131905245|NCT02810418|474940838|FG006|Dose Expansion|Adverse Event|0|||
131905246|NCT02810418|474940832|FG000|Dose Expansion|Physician Decision|0|||
131734545|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
131734546|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
131734547|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734548|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
131734549|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
131734550|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
131734551|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
131734552|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
131905247|NCT02810418|474940833|FG001|Dose Expansion|Physician Decision|0|||
131905248|NCT02810418|474940834|FG002|Dose Expansion|Physician Decision|2|||
131734553|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131734554|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734555|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734556|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734557|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734558|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734559|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734560|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734561|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734562|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734563|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734564|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734565|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734566|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734567|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734568|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
131734569|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
131734570|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
131734571|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734572|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
131734573|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
131734574|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734575|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734576|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131734577|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734578|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734579|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734580|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734581|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734582|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734583|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734584|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734585|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734586|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734587|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734588|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734589|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734590|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734591|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
131734592|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
131734593|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734594|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734595|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734596|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131905249|NCT02810418|474940835|FG003|Dose Expansion|Physician Decision|0|||
131905250|NCT02810418|474940836|FG004|Dose Expansion|Physician Decision|0|||
131807770|NCT01029340|474582803|FG000|Extension Period|Withdrawal by Subject|0|||
131807771|NCT01029340|474582804|FG001|Extension Period|Withdrawal by Subject|0|||
131807772|NCT01029340|474582805|FG002|Extension Period|Withdrawal by Subject|0|||
131807773|NCT01029340|474582806|FG003|Extension Period|Withdrawal by Subject|0|||
131807774|NCT01029340|474582807|FG004|Extension Period|Withdrawal by Subject|0|||
131807775|NCT01029340|474582808|FG005|Extension Period|Withdrawal by Subject|1|||
131807776|NCT01029340|474582803|FG000|Extension Period|Physician Decision|0|||
131734597|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734598|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734599|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131734600|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734601|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734602|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734603|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734604|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734605|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734606|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734607|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734608|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734609|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734610|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734611|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734612|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734613|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734614|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
131734615|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
131734616|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734617|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734618|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734619|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
131734620|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734621|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734622|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131734623|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
131734624|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
131734625|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
131734626|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
131734627|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
131734628|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
131734629|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
131734630|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
131734631|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
131807777|NCT01029340|474582804|FG001|Extension Period|Physician Decision|0|||
131807778|NCT01029340|474582805|FG002|Extension Period|Physician Decision|0|||
131807779|NCT01029340|474582806|FG003|Extension Period|Physician Decision|0|||
131807780|NCT01029340|474582807|FG004|Extension Period|Physician Decision|0|||
131734632|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
131734633|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
131734634|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
131734635|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
131734636|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
131734637|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
131734638|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
131734639|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
131734640|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
131734641|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
131734642|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
131734643|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
131734644|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
131734645|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
131734646|NCT02052778|474305428|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734647|NCT02052778|474305429|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734648|NCT02052778|474305430|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734649|NCT02052778|474305431|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734650|NCT02052778|474305432|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734651|NCT02052778|474305433|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734652|NCT02052778|474305434|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734653|NCT02052778|474305435|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734654|NCT02052778|474305436|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734655|NCT02052778|474305437|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734656|NCT02052778|474305438|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734657|NCT02052778|474305439|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734658|NCT02052778|474305440|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734659|NCT02052778|474305441|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734660|NCT02052778|474305442|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131734661|NCT02052778|474305443|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131734662|NCT02052778|474305444|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131734663|NCT02052778|474305445|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734664|NCT02052778|474305446|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131734665|NCT02052778|474305447|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734666|NCT02052778|474305448|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734667|NCT02052778|474305449|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734668|NCT02052778|474305450|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131734669|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734670|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734671|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734672|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734673|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734674|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734675|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734676|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734677|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734678|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734679|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734680|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734681|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734682|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734683|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734684|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734685|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734686|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734687|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734688|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734689|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734690|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131734691|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
131734692|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734693|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131905251|NCT02810418|474940837|FG005|Dose Expansion|Physician Decision|0|||
131905252|NCT02810418|474940838|FG006|Dose Expansion|Physician Decision|0|||
131734694|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734695|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734696|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734697|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131807781|NCT01029340|474582808|FG005|Extension Period|Physician Decision|1|||
131807782|NCT02648347|474582809|FG000|Overall Study|Death|174|||
131807783|NCT02648347|474582810|FG001|Overall Study|Death|167|||
131807784|NCT02648347|474582809|FG000|Overall Study|Withdrawal by Subject|16|||
131807785|NCT02648347|474582810|FG001|Overall Study|Withdrawal by Subject|9|||
131807786|NCT02648347|474582809|FG000|Overall Study|Lost to Follow-up|18|||
131807787|NCT02648347|474582810|FG001|Overall Study|Lost to Follow-up|21|||
131807788|NCT02648347|474582809|FG000|Overall Study|Missing|1|||
131807789|NCT02648347|474582810|FG001|Overall Study|Missing|0|||
131807790|NCT02158663|474582814|FG000|Overall Study|Withdrawal by Subject|5|||
131807791|NCT02158663|474582815|FG001|Overall Study|Withdrawal by Subject|4|||
131807792|NCT01265056|474582816|FG000|Initial Study Period|Withdrawal by Subject|1|||
131807793|NCT01265056|474582817|FG001|Initial Study Period|Withdrawal by Subject|1|||
131807794|NCT01265056|474582816|FG000|Initial Study Period|Withdrawal by Subject|1|||
131807795|NCT01265056|474582817|FG001|Initial Study Period|Withdrawal by Subject|1|||
131807796|NCT01265056|474582816|FG000|Follow up|Lost to Follow-up|7|||
131807797|NCT01265056|474582817|FG001|Follow up|Lost to Follow-up|3|||
131807798|NCT02711852|474582819|FG000|Overall Study|Death|5|||
131807799|NCT02711852|474582819|FG000|Overall Study|Lost to Follow-up|1|||
131807800|NCT02711852|474582819|FG000|Overall Study|Completed follow-up|3|||
131807801|NCT02711852|474582819|FG000|Overall Study|Withdrawal by Subject|1|||
131734698|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734699|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734700|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734701|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734702|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734703|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734704|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734705|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734706|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734707|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734708|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734709|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734710|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734711|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734712|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734713|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131734714|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
131734715|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734716|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734717|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734718|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734719|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734720|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734721|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734722|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734723|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734724|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734725|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734726|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734727|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734728|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734729|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734730|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734731|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734732|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734733|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734734|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734735|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734736|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131734737|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
131807802|NCT00537979|474582820|FG000|Overall Study|Adverse Event|2|||
131807803|NCT00537979|474582821|FG001|Overall Study|Adverse Event|2|||
131807804|NCT00537979|474582820|FG000|Overall Study|Withdrawal by Subject|1|||
131807805|NCT00537979|474582821|FG001|Overall Study|Withdrawal by Subject|4|||
131807806|NCT00537979|474582820|FG000|Overall Study|Lost to Follow-up|1|||
131807807|NCT00537979|474582821|FG001|Overall Study|Lost to Follow-up|4|||
131807808|NCT00537979|474582820|FG000|Overall Study|Lack of Efficacy|0|||
131807809|NCT00537979|474582821|FG001|Overall Study|Lack of Efficacy|1|||
131734738|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734739|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734740|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734741|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734742|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734743|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734744|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734745|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734746|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734747|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734748|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734749|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734750|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734751|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734752|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734753|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734754|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734755|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734756|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734757|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734758|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734759|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131734760|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
131734761|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734762|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734763|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734764|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734765|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734766|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734767|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734768|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734769|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734770|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734771|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734772|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734773|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734774|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734775|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734776|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734777|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734778|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131807810|NCT00537979|474582820|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
131807811|NCT00537979|474582821|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
131807812|NCT00537979|474582820|FG000|Overall Study|Death|0|||
131807813|NCT00537979|474582821|FG001|Overall Study|Death|3|||
131807814|NCT00537979|474582820|FG000|Overall Study|Kidney transplant|0|||
131807815|NCT00537979|474582821|FG001|Overall Study|Kidney transplant|3|||
131807816|NCT00537979|474582820|FG000|Overall Study|Heart failure|0|||
131807817|NCT00537979|474582821|FG001|Overall Study|Heart failure|1|||
131807818|NCT02388191|474582823|FG000|Overall Study|Patient did not receive IUD|1|||
131807819|NCT02388191|474582824|FG001|Overall Study|Patient did not receive IUD|0|||
131807820|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
131807821|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
131807822|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
131807823|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
131807824|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
131807825|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
131807826|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
131807827|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
131807828|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
131807829|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
131807830|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
131807831|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
131807832|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
131807833|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
131734779|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734780|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734781|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734782|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131734783|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
131734784|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
131734785|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
131734786|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
131734787|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
131734788|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
131734789|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
131734790|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
131734791|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
131734792|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
131734793|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
131734794|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
131734795|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
131734796|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
131734797|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
131734798|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
131734799|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
131734800|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
131734801|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
131734802|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
131734803|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
131734804|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
131734805|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
131734806|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
131734807|NCT02052778|474305428|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734808|NCT02052778|474305429|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734809|NCT02052778|474305430|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734810|NCT02052778|474305431|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734811|NCT02052778|474305432|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734812|NCT02052778|474305433|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734813|NCT02052778|474305434|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734814|NCT02052778|474305435|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734815|NCT02052778|474305436|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734816|NCT02052778|474305437|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734817|NCT02052778|474305438|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734818|NCT02052778|474305439|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734819|NCT02052778|474305440|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734820|NCT02052778|474305441|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734821|NCT02052778|474305442|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734822|NCT02052778|474305443|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734823|NCT02052778|474305444|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734824|NCT02052778|474305445|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734825|NCT02052778|474305446|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734826|NCT02052778|474305447|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734827|NCT02052778|474305448|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734828|NCT02052778|474305449|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
131734829|NCT02052778|474305450|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
131734830|NCT02345252|474305455|FG000|Double-Blind Phase|Adverse Event|2|||
131734831|NCT02345252|474305456|FG001|Double-Blind Phase|Adverse Event|3|||
131734832|NCT02345252|474305455|FG000|Double-Blind Phase|Death|1|||
131734833|NCT02345252|474305456|FG001|Double-Blind Phase|Death|2|||
131734834|NCT02345252|474305455|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131734835|NCT02345252|474305456|FG001|Double-Blind Phase|Lack of Efficacy|0|||
131734836|NCT02345252|474305455|FG000|Double-Blind Phase|Investigator's Discretion|4|||
131734837|NCT02345252|474305456|FG001|Double-Blind Phase|Investigator's Discretion|6|||
131734838|NCT02345252|474305455|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
131734839|NCT02345252|474305456|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
131734840|NCT02345252|474305455|FG000|Double-Blind Phase|Protocol Violation|2|||
131734841|NCT02345252|474305456|FG001|Double-Blind Phase|Protocol Violation|1|||
131734842|NCT02345252|474305455|FG000|Double-Blind Phase|Withdrew Consent|21|||
131734843|NCT02345252|474305456|FG001|Double-Blind Phase|Withdrew Consent|23|||
131734844|NCT02345252|474305455|FG000|Double-Blind Phase|Lost to Follow-up|8|||
131734845|NCT02345252|474305456|FG001|Double-Blind Phase|Lost to Follow-up|10|||
131734846|NCT02345252|474305455|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
131734847|NCT02345252|474305456|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
131734848|NCT01980706|474305457|FG000|Overall Study|Withdrawal by Subject|9|||
131734849|NCT01980706|474305458|FG001|Overall Study|Withdrawal by Subject|6|||
131734850|NCT01980706|474305459|FG002|Overall Study|Withdrawal by Subject|2|||
131734851|NCT01980706|474305457|FG000|Overall Study|Adverse Event|1|||
131734852|NCT01980706|474305458|FG001|Overall Study|Adverse Event|2|||
131734853|NCT01980706|474305459|FG002|Overall Study|Adverse Event|5|||
131734854|NCT01980706|474305457|FG000|Overall Study|Lost to Follow-up|3|||
131734855|NCT01980706|474305458|FG001|Overall Study|Lost to Follow-up|4|||
131734856|NCT01980706|474305459|FG002|Overall Study|Lost to Follow-up|3|||
131734857|NCT01980706|474305457|FG000|Overall Study|miscellaneous|4|||
131734858|NCT01980706|474305458|FG001|Overall Study|miscellaneous|5|||
131734859|NCT01980706|474305459|FG002|Overall Study|miscellaneous|3|||
131734860|NCT01094730|474305462|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
131734861|NCT01094730|474305463|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
131734862|NCT01094730|474305462|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
131734863|NCT01094730|474305463|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
131734864|NCT01094730|474305462|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
131734865|NCT01094730|474305463|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
131734866|NCT01094730|474305462|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
131734867|NCT01094730|474305463|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
131734868|NCT01094730|474305462|FG000|Period 2 (14 Days)|Protocol Violation|2|||
131734869|NCT01094730|474305463|FG001|Period 2 (14 Days)|Protocol Violation|0|||
131734870|NCT01094730|474305462|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
131734871|NCT01094730|474305463|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
131734872|NCT01094730|474305462|FG000|Period 2 (14 Days)|Adverse Event|0|||
131734873|NCT01094730|474305463|FG001|Period 2 (14 Days)|Adverse Event|1|||
131734874|NCT01094730|474305462|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
131734875|NCT01094730|474305463|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
131734876|NCT01842308|474305464|FG000|Overall Study|Withdrawal by Subject|0|||
131734877|NCT01842308|474305465|FG001|Overall Study|Withdrawal by Subject|0|||
131734878|NCT01842308|474305466|FG002|Overall Study|Withdrawal by Subject|0|||
131734879|NCT01842308|474305467|FG003|Overall Study|Withdrawal by Subject|0|||
131734880|NCT01842308|474305468|FG004|Overall Study|Withdrawal by Subject|1|||
131734881|NCT00987623|474305469|FG000|Overall Study|Lost to Follow-up|2|||
131734882|NCT00987623|474305470|FG001|Overall Study|Lost to Follow-up|1|||
131734883|NCT00987623|474305469|FG000|Overall Study|Time/job conflict|2|||
131734884|NCT00987623|474305470|FG001|Overall Study|Time/job conflict|0|||
131734885|NCT00987623|474305469|FG000|Overall Study|Discomfort|1|||
131734886|NCT00987623|474305470|FG001|Overall Study|Discomfort|0|||
131734887|NCT00987623|474305469|FG000|Overall Study|Biomicroscopy|0|||
131734888|NCT00987623|474305470|FG001|Overall Study|Biomicroscopy|1|||
131734889|NCT00987623|474305469|FG000|Overall Study|Influenza|0|||
131734890|NCT00987623|474305470|FG001|Overall Study|Influenza|1|||
131734891|NCT04056455|474305471|FG000|Overall Study|Adverse Event|1|||
131734892|NCT04056455|474305472|FG001|Overall Study|Adverse Event|0|||
131734893|NCT03521687|474305473|FG000|Overall Study|Adverse Event|4|||
131734894|NCT03521687|474305473|FG000|Overall Study|Physician Decision|1|||
131734895|NCT01151579|474305474|FG000|Overall Study|Physician Decision|3|||
131734896|NCT01151579|474305475|FG001|Overall Study|Physician Decision|1|||
131734897|NCT01151579|474305474|FG000|Overall Study|Withdrawal by Subject|3|||
131734898|NCT01151579|474305475|FG001|Overall Study|Withdrawal by Subject|2|||
131734899|NCT01151579|474305474|FG000|Overall Study|Not meet inclusion criteria|6|||
131734900|NCT01151579|474305475|FG001|Overall Study|Not meet inclusion criteria|4|||
131734901|NCT01276457|474305478|FG000|Core Study|Adverse Event|6|||
131734902|NCT01276457|474305479|FG001|Core Study|Adverse Event|3|||
131734903|NCT01276457|474305478|FG000|Core Study|Lost to Follow-up|1|||
131734904|NCT01276457|474305479|FG001|Core Study|Lost to Follow-up|2|||
131734905|NCT01276457|474305478|FG000|Core Study|Administrative problems|1|||
131734906|NCT01276457|474305479|FG001|Core Study|Administrative problems|1|||
131734907|NCT01276457|474305478|FG000|Core Study|Death|2|||
131734908|NCT01276457|474305479|FG001|Core Study|Death|2|||
131734909|NCT01276457|474305478|FG000|Core Study|Lack of Efficacy|3|||
131734910|NCT01276457|474305479|FG001|Core Study|Lack of Efficacy|12|||
131734911|NCT01276457|474305478|FG000|Extension Study|Lost to Follow-up|3|||
131734912|NCT01276457|474305479|FG001|Extension Study|Lost to Follow-up|0|||
131734913|NCT01276457|474305478|FG000|Extension Study|Death|0|||
131734914|NCT01276457|474305479|FG001|Extension Study|Death|1|||
131734915|NCT01276457|474305478|FG000|Extension Study|Lack of Efficacy|3|||
131734916|NCT01276457|474305479|FG001|Extension Study|Lack of Efficacy|1|||
131734917|NCT01401010|474305485|FG000|Overall Study|Could not interpret assay results|1|||
131734918|NCT01401010|474305486|FG001|Overall Study|Could not interpret assay results|0|||
131734919|NCT03135028|474305487|FG000|Overall Study|Death|6|||
131734920|NCT03135028|474305487|FG000|Overall Study|Study Terminated by Sponsor|2|||
131734921|NCT03135028|474305487|FG000|Overall Study|Withdrew Consent|1|||
131734922|NCT02065869|474305489|FG000|Overall Study|Death|7|||
131734923|NCT02065869|474305489|FG000|Overall Study|Disease relapse|16|||
131734924|NCT02065869|474305489|FG000|Overall Study|Lost to Follow-up|4|||
131734925|NCT02065869|474305489|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
131734926|NCT02065869|474305489|FG000|Overall Study|Withdrawal by Subject|1|||
131734927|NCT01814800|474305490|FG000|Overall Study|Adverse Event|2|||
131734928|NCT01814800|474305490|FG000|Overall Study|Pregnancy|1|||
131734929|NCT01814800|474305490|FG000|Overall Study|Sponsor decision|1|||
131734930|NCT01814800|474305490|FG000|Overall Study|Subject relocation|1|||
131734931|NCT04436822|474305491|FG000|Overall Study|Physician Decision|2|||
131734932|NCT04436822|474305492|FG001|Overall Study|Physician Decision|0|||
131734933|NCT04436822|474305491|FG000|Overall Study|Sponsor request|1|||
131734934|NCT04436822|474305492|FG001|Overall Study|Sponsor request|0|||
131734935|NCT04436822|474305491|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131734936|NCT04436822|474305492|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131734937|NCT04436822|474305491|FG000|Overall Study|Unsuccessful procedure|0|||
131734938|NCT04436822|474305492|FG001|Overall Study|Unsuccessful procedure|1|||
131734939|NCT04436822|474305491|FG000|Overall Study|Withdrawal due to Covid-19|8|||
131734940|NCT04436822|474305492|FG001|Overall Study|Withdrawal due to Covid-19|1|||
131734941|NCT04436822|474305491|FG000|Overall Study|Withdrawal by Subject|1|||
131734942|NCT04436822|474305492|FG001|Overall Study|Withdrawal by Subject|0|||
131734943|NCT04436822|474305491|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
131734944|NCT04436822|474305492|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
131734945|NCT03807739|474305493|FG000|Overall Study|Adverse Event|1|||
131734946|NCT03807739|474305494|FG001|Overall Study|Adverse Event|0|||
131734947|NCT03807739|474305495|FG002|Overall Study|Adverse Event|0|||
131734948|NCT03807739|474305496|FG003|Overall Study|Adverse Event|0|||
131734949|NCT03807739|474305493|FG000|Overall Study|Withdrawal by Subject|1|||
131734950|NCT03807739|474305494|FG001|Overall Study|Withdrawal by Subject|0|||
131734951|NCT03807739|474305495|FG002|Overall Study|Withdrawal by Subject|0|||
131734952|NCT03807739|474305496|FG003|Overall Study|Withdrawal by Subject|0|||
131734953|NCT02371759|474305497|FG000|Overall Study|Protocol Violation|3|||
131734954|NCT02371759|474305498|FG001|Overall Study|Protocol Violation|1|||
131734955|NCT02371759|474305499|FG002|Overall Study|Protocol Violation|1|||
131734956|NCT02371759|474305500|FG003|Overall Study|Protocol Violation|0|||
131734957|NCT02371759|474305501|FG004|Overall Study|Protocol Violation|3|||
131734958|NCT02371759|474305502|FG005|Overall Study|Protocol Violation|1|||
131734959|NCT02371759|474305503|FG006|Overall Study|Protocol Violation|0|||
131734960|NCT02371759|474305504|FG007|Overall Study|Protocol Violation|3|||
131734961|NCT02371759|474305497|FG000|Overall Study|Withdrawal by Subject|0|||
131734962|NCT02371759|474305498|FG001|Overall Study|Withdrawal by Subject|0|||
131734963|NCT02371759|474305499|FG002|Overall Study|Withdrawal by Subject|0|||
131734964|NCT02371759|474305500|FG003|Overall Study|Withdrawal by Subject|0|||
131734965|NCT02371759|474305501|FG004|Overall Study|Withdrawal by Subject|0|||
131734966|NCT02371759|474305502|FG005|Overall Study|Withdrawal by Subject|0|||
131734967|NCT02371759|474305503|FG006|Overall Study|Withdrawal by Subject|0|||
131734968|NCT02371759|474305504|FG007|Overall Study|Withdrawal by Subject|1|||
131734969|NCT03375112|474305505|FG000|Overall Study|Withdrawal by Subject|3|||
131734970|NCT03375112|474305506|FG001|Overall Study|Withdrawal by Subject|0|||
131734971|NCT01689207|474305507|FG000|Overall Study|Adverse Event|0|||
131734972|NCT01689207|474305508|FG001|Overall Study|Adverse Event|1|||
131734973|NCT01689207|474305509|FG002|Overall Study|Adverse Event|0|||
131734974|NCT01689207|474305510|FG003|Overall Study|Adverse Event|0|||
131734975|NCT01689207|474305511|FG004|Overall Study|Adverse Event|2|||
131734976|NCT01689207|474305512|FG005|Overall Study|Adverse Event|1|||
131807834|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
131807835|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
131807836|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
131807837|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
131807838|NCT01045161|474582825|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
131807839|NCT01045161|474582826|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
131807840|NCT01045161|474582827|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
131807841|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
131734977|NCT01689207|474305513|FG006|Overall Study|Adverse Event|0|||
131734978|NCT01689207|474305514|FG007|Overall Study|Adverse Event|0|||
131734979|NCT01689207|474305515|FG008|Overall Study|Adverse Event|1|||
131734980|NCT01689207|474305516|FG009|Overall Study|Adverse Event|0|||
131734981|NCT01689207|474305517|FG010|Overall Study|Adverse Event|0|||
131734982|NCT05118386|474305519|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131734983|NCT05118386|474305520|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131734984|NCT05118386|474305521|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131734985|NCT05118386|474305522|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
131734986|NCT05118386|474305523|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131734987|NCT05118386|474305524|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131807842|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
131807843|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
131734988|NCT05118386|474305519|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131734989|NCT05118386|474305520|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131734990|NCT05118386|474305521|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131734991|NCT05118386|474305522|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131734992|NCT05118386|474305523|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
131734993|NCT05118386|474305524|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131734994|NCT00303108|474305527|FG000|Overall Study|Adverse Event|5|||
131734995|NCT00303108|474305528|FG001|Overall Study|Adverse Event|6|||
131734996|NCT00303108|474305529|FG002|Overall Study|Adverse Event|7|||
131734997|NCT00303108|474305527|FG000|Overall Study|Patient Request|4|||
131734998|NCT00303108|474305528|FG001|Overall Study|Patient Request|2|||
131734999|NCT00303108|474305529|FG002|Overall Study|Patient Request|8|||
131735000|NCT00303108|474305527|FG000|Overall Study|Failed Entry|1|||
131735001|NCT00303108|474305528|FG001|Overall Study|Failed Entry|0|||
131735002|NCT00303108|474305529|FG002|Overall Study|Failed Entry|1|||
131735003|NCT00303108|474305527|FG000|Overall Study|ineligible|2|||
131735004|NCT00303108|474305528|FG001|Overall Study|ineligible|1|||
131735005|NCT00303108|474305529|FG002|Overall Study|ineligible|0|||
131735006|NCT03201198|474305530|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
131735007|NCT03201198|474305531|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
131735008|NCT03201198|474305530|FG000|Overall Study|Withdrawal by Subject|2|||
131735009|NCT03201198|474305531|FG001|Overall Study|Withdrawal by Subject|3|||
131735010|NCT02669862|474307211|FG000|Overall Study|Lost to Follow-up|0|||
131735011|NCT02669862|474307212|FG001|Overall Study|Lost to Follow-up|2|||
131735012|NCT02669862|474307213|FG002|Overall Study|Lost to Follow-up|1|||
131735013|NCT02669862|474307211|FG000|Overall Study|Withdrawal by Subject|2|||
131735014|NCT02669862|474307212|FG001|Overall Study|Withdrawal by Subject|2|||
131735015|NCT02669862|474307213|FG002|Overall Study|Withdrawal by Subject|3|||
131735016|NCT02669862|474307211|FG000|Overall Study|moved|0|||
131735017|NCT02669862|474307212|FG001|Overall Study|moved|1|||
131735018|NCT02669862|474307213|FG002|Overall Study|moved|0|||
131735019|NCT02669862|474307211|FG000|Overall Study|Protocol Violation|0|||
131735020|NCT02669862|474307212|FG001|Overall Study|Protocol Violation|0|||
131735021|NCT02669862|474307213|FG002|Overall Study|Protocol Violation|1|||
131735022|NCT00311181|474307214|FG000|Overall Study|Final DFTs were not obtained|96|||
131735023|NCT02670915|474307216|FG000|Overall Study|Withdrawal by Subject|0|||
131735024|NCT02670915|474307217|FG001|Overall Study|Withdrawal by Subject|1|||
131735025|NCT02670915|474307218|FG002|Overall Study|Withdrawal by Subject|4|||
131735026|NCT02670915|474307216|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131735027|NCT02670915|474307217|FG001|Overall Study|Withdrawal by parent/guardian|4|||
131735028|NCT02670915|474307218|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131735029|NCT02670915|474307216|FG000|Overall Study|Unclassified|0|||
131735030|NCT02670915|474307217|FG001|Overall Study|Unclassified|3|||
131735031|NCT02670915|474307218|FG002|Overall Study|Unclassified|0|||
131735032|NCT00818207|474307219|FG000|Overall Study|Adverse Event|6|||
131735033|NCT00818207|474307220|FG001|Overall Study|Adverse Event|0|||
131735034|NCT00818207|474307219|FG000|Overall Study|Lost to Follow-up|160|||
131735035|NCT00818207|474307220|FG001|Overall Study|Lost to Follow-up|146|||
131735036|NCT00818207|474307219|FG000|Overall Study|Multiple reasons|11|||
131735037|NCT00818207|474307220|FG001|Overall Study|Multiple reasons|12|||
131735038|NCT00818207|474307219|FG000|Overall Study|Withdrawal by Subject|42|||
131735039|NCT00818207|474307220|FG001|Overall Study|Withdrawal by Subject|104|||
131735040|NCT00818207|474307219|FG000|Overall Study|Death|3|||
131735041|NCT00818207|474307220|FG001|Overall Study|Death|5|||
131735042|NCT02494778|474307221|FG000|Overall Study|Death|3|||
131735043|NCT02494778|474307221|FG000|Overall Study|Other|173|||
131807844|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
131735044|NCT02494778|474307221|FG000|Overall Study|Lack of Efficacy|4|||
131735045|NCT02494778|474307221|FG000|Overall Study|Adverse Event|18|||
131735046|NCT02494778|474307221|FG000|Overall Study|Withdrawal by Subject|20|||
131735047|NCT02494778|474307221|FG000|Overall Study|Lost to Follow-up|2|||
131735048|NCT02494778|474307221|FG000|Overall Study|Noncompliant with study drug admin.|1|||
131735049|NCT02616185|474307222|FG000|Overall Study|Death|0|||
131807845|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
131807846|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
131735050|NCT02616185|474307223|FG001|Overall Study|Death|0|||
131735051|NCT02616185|474307224|FG002|Overall Study|Death|0|||
131735052|NCT02616185|474307225|FG003|Overall Study|Death|1|||
131807847|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
131735053|NCT02616185|474307226|FG004|Overall Study|Death|2|||
131735054|NCT02616185|474307227|FG005|Overall Study|Death|0|||
131735055|NCT02616185|474307228|FG006|Overall Study|Death|0|||
131735056|NCT02616185|474307229|FG007|Overall Study|Death|2|||
131735057|NCT02616185|474307230|FG008|Overall Study|Death|1|||
131735058|NCT02616185|474307222|FG000|Overall Study|Study terminated by sponsor|0|||
131735059|NCT02616185|474307223|FG001|Overall Study|Study terminated by sponsor|0|||
131735060|NCT02616185|474307224|FG002|Overall Study|Study terminated by sponsor|1|||
131735061|NCT02616185|474307225|FG003|Overall Study|Study terminated by sponsor|0|||
131735062|NCT02616185|474307226|FG004|Overall Study|Study terminated by sponsor|0|||
131735063|NCT02616185|474307227|FG005|Overall Study|Study terminated by sponsor|0|||
131735064|NCT02616185|474307228|FG006|Overall Study|Study terminated by sponsor|5|||
131735065|NCT02616185|474307229|FG007|Overall Study|Study terminated by sponsor|2|||
131735066|NCT02616185|474307230|FG008|Overall Study|Study terminated by sponsor|0|||
131735067|NCT02616185|474307222|FG000|Overall Study|Participant refused further follow-up|1|||
131735068|NCT02616185|474307223|FG001|Overall Study|Participant refused further follow-up|1|||
131735069|NCT02616185|474307224|FG002|Overall Study|Participant refused further follow-up|2|||
131735070|NCT02616185|474307225|FG003|Overall Study|Participant refused further follow-up|3|||
131735071|NCT02616185|474307226|FG004|Overall Study|Participant refused further follow-up|4|||
131735072|NCT02616185|474307227|FG005|Overall Study|Participant refused further follow-up|0|||
131735073|NCT02616185|474307228|FG006|Overall Study|Participant refused further follow-up|3|||
131735074|NCT02616185|474307229|FG007|Overall Study|Participant refused further follow-up|4|||
131735075|NCT02616185|474307230|FG008|Overall Study|Participant refused further follow-up|3|||
131735076|NCT02616185|474307222|FG000|Overall Study|Not reported|0|||
131735077|NCT02616185|474307223|FG001|Overall Study|Not reported|0|||
131735078|NCT02616185|474307224|FG002|Overall Study|Not reported|0|||
131735079|NCT02616185|474307225|FG003|Overall Study|Not reported|1|||
131735080|NCT02616185|474307226|FG004|Overall Study|Not reported|3|||
131735081|NCT02616185|474307227|FG005|Overall Study|Not reported|1|||
131735082|NCT02616185|474307228|FG006|Overall Study|Not reported|0|||
131735083|NCT02616185|474307229|FG007|Overall Study|Not reported|5|||
131735084|NCT02616185|474307230|FG008|Overall Study|Not reported|2|||
131735085|NCT03725202|474307235|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
131735086|NCT03725202|474307236|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
131735087|NCT03725202|474307237|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
131735088|NCT03725202|474307238|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131735089|NCT03725202|474307239|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131735090|NCT03725202|474307240|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131735091|NCT03725202|474307241|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131735092|NCT03725202|474307242|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131735093|NCT03725202|474307235|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
131735094|NCT03725202|474307236|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
131735095|NCT03725202|474307237|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
131735096|NCT03725202|474307238|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131735097|NCT03725202|474307239|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131735098|NCT03725202|474307240|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131735099|NCT03725202|474307241|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131735100|NCT03725202|474307242|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131735101|NCT03725202|474307235|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
131735102|NCT03725202|474307236|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735103|NCT03725202|474307237|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735104|NCT03725202|474307238|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735105|NCT03725202|474307239|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735106|NCT03725202|474307240|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735107|NCT03725202|474307241|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735108|NCT03725202|474307242|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131735109|NCT03725202|474307235|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
131735110|NCT03725202|474307236|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131735111|NCT03725202|474307237|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131735112|NCT03725202|474307238|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131735113|NCT03725202|474307239|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131735114|NCT03725202|474307240|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131735115|NCT03725202|474307241|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131807848|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
131807849|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
131448871|NCT01208207|473272737|FG000|Part I|Non-Compliance With Study Drug|1|||
131735116|NCT03725202|474307242|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131735117|NCT03725202|474307235|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
131735118|NCT03725202|474307236|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
131735119|NCT03725202|474307237|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
131735120|NCT03725202|474307238|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131807850|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
131735121|NCT03725202|474307239|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131735122|NCT03725202|474307240|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131735123|NCT03725202|474307241|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131735124|NCT03725202|474307242|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131735125|NCT03725202|474307235|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735126|NCT03725202|474307236|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735127|NCT03725202|474307237|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
131735128|NCT03725202|474307238|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735129|NCT03725202|474307239|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735130|NCT03725202|474307240|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735131|NCT03725202|474307241|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735132|NCT03725202|474307242|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131735133|NCT03725202|474307235|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
131735134|NCT03725202|474307236|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
131735135|NCT03725202|474307237|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
131735136|NCT03725202|474307238|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
131735137|NCT03725202|474307239|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
131735138|NCT03725202|474307240|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
131735139|NCT03725202|474307241|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
131735140|NCT03725202|474307242|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
131735141|NCT03725202|474307235|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
131735142|NCT03725202|474307236|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
131735143|NCT03725202|474307237|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
131735144|NCT03725202|474307238|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
131735145|NCT03725202|474307239|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
131735146|NCT03725202|474307240|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
131735147|NCT03725202|474307241|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
131735148|NCT03725202|474307242|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
131735149|NCT03725202|474307235|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131735150|NCT03725202|474307236|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131735151|NCT03725202|474307237|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131735152|NCT03725202|474307238|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
131735153|NCT03725202|474307239|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131735154|NCT03725202|474307240|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131735155|NCT03725202|474307241|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
131735156|NCT03725202|474307242|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
131735157|NCT03725202|474307235|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735158|NCT03725202|474307236|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735159|NCT03725202|474307237|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735160|NCT03725202|474307238|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735161|NCT03725202|474307239|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735162|NCT03725202|474307240|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735163|NCT03725202|474307241|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
131735164|NCT03725202|474307242|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131735165|NCT03725202|474307235|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735166|NCT03725202|474307236|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735167|NCT03725202|474307237|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735168|NCT03725202|474307238|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735169|NCT03725202|474307239|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735170|NCT03725202|474307240|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
131735171|NCT03725202|474307241|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735172|NCT03725202|474307242|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131735173|NCT03725202|474307235|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131735174|NCT03725202|474307236|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131735175|NCT03725202|474307237|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131735176|NCT03725202|474307238|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
131735177|NCT03725202|474307239|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131735178|NCT03725202|474307240|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131735179|NCT03725202|474307241|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
131735180|NCT03725202|474307242|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
131735181|NCT01328249|474307245|FG000|Overall Study|Adverse Event|3|||
131807851|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
131807852|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
131735182|NCT01328249|474307246|FG001|Overall Study|Adverse Event|0|||
131735183|NCT01328249|474307245|FG000|Overall Study|Disease progression|1|||
131807853|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
131735184|NCT01328249|474307246|FG001|Overall Study|Disease progression|0|||
131735185|NCT01328249|474307245|FG000|Overall Study|Withdrawal by Subject|1|||
131735186|NCT01328249|474307246|FG001|Overall Study|Withdrawal by Subject|1|||
131735187|NCT01328249|474307245|FG000|Overall Study|Moved before end of treatment visit|1|||
131735188|NCT01328249|474307246|FG001|Overall Study|Moved before end of treatment visit|0|||
131735189|NCT01328249|474307245|FG000|Overall Study|Subject choice|1|||
131735190|NCT01328249|474307246|FG001|Overall Study|Subject choice|1|||
131735191|NCT01328249|474307245|FG000|Overall Study|Protocol Violation|0|||
131735192|NCT01328249|474307246|FG001|Overall Study|Protocol Violation|1|||
131735193|NCT01215734|474307247|FG000|Overall Study|Death|0|||
131735194|NCT01215734|474307248|FG001|Overall Study|Death|1|||
131735195|NCT01346371|474307249|FG000|Overall Study|Lost to Follow-up|2|||
131735196|NCT01346371|474307250|FG001|Overall Study|Lost to Follow-up|0|||
131735197|NCT02330549|474307252|FG000|Overall Study|Adverse Event|1|||
131735198|NCT02330549|474307253|FG001|Overall Study|Adverse Event|0|||
131735199|NCT02330549|474307252|FG000|Overall Study|Subject withdrew consent|2|||
131735200|NCT02330549|474307253|FG001|Overall Study|Subject withdrew consent|1|||
131735201|NCT02330549|474307252|FG000|Overall Study|Failure to meet randomization criteria|1|||
131735202|NCT02330549|474307253|FG001|Overall Study|Failure to meet randomization criteria|0|||
131735203|NCT00495495|474307259|FG000|Overall Study|Protocol Violation|99|||
131735204|NCT01670656|474307265|FG000|Overall Study|Non-compliance with study drug|0|||
131735205|NCT01670656|474307266|FG001|Overall Study|Non-compliance with study drug|0|||
131735206|NCT01670656|474307267|FG002|Overall Study|Non-compliance with study drug|3|||
131735207|NCT01670656|474307268|FG003|Overall Study|Non-compliance with study drug|0|||
131735208|NCT01670656|474307269|FG004|Overall Study|Non-compliance with study drug|1|||
131735209|NCT01670656|474307265|FG000|Overall Study|Pregnancy|0|||
131735210|NCT01670656|474307266|FG001|Overall Study|Pregnancy|0|||
131735211|NCT01670656|474307267|FG002|Overall Study|Pregnancy|0|||
131735212|NCT01670656|474307268|FG003|Overall Study|Pregnancy|0|||
131735213|NCT01670656|474307269|FG004|Overall Study|Pregnancy|1|||
131735214|NCT01670656|474307265|FG000|Overall Study|Withdrawal by Subject|1|||
131735215|NCT01670656|474307266|FG001|Overall Study|Withdrawal by Subject|1|||
131735216|NCT01670656|474307267|FG002|Overall Study|Withdrawal by Subject|0|||
131735217|NCT01670656|474307268|FG003|Overall Study|Withdrawal by Subject|0|||
131735218|NCT01670656|474307269|FG004|Overall Study|Withdrawal by Subject|0|||
131735219|NCT01670656|474307265|FG000|Overall Study|Non-compliance with protocol|0|||
131735220|NCT01670656|474307266|FG001|Overall Study|Non-compliance with protocol|3|||
131735221|NCT01670656|474307267|FG002|Overall Study|Non-compliance with protocol|1|||
131735222|NCT01670656|474307268|FG003|Overall Study|Non-compliance with protocol|1|||
131735223|NCT01670656|474307269|FG004|Overall Study|Non-compliance with protocol|2|||
131735224|NCT01670656|474307265|FG000|Overall Study|Adverse Event|2|||
131735225|NCT01670656|474307266|FG001|Overall Study|Adverse Event|2|||
131735226|NCT01670656|474307267|FG002|Overall Study|Adverse Event|2|||
131735227|NCT01670656|474307268|FG003|Overall Study|Adverse Event|3|||
131735228|NCT01670656|474307269|FG004|Overall Study|Adverse Event|3|||
131735229|NCT01670656|474307265|FG000|Overall Study|Subject withdrew consent|0|||
131735230|NCT01670656|474307266|FG001|Overall Study|Subject withdrew consent|1|||
131735231|NCT01670656|474307267|FG002|Overall Study|Subject withdrew consent|2|||
131735232|NCT01670656|474307268|FG003|Overall Study|Subject withdrew consent|1|||
131735233|NCT01670656|474307269|FG004|Overall Study|Subject withdrew consent|1|||
131735234|NCT01670656|474307265|FG000|Overall Study|Lost to Follow-up|0|||
131735235|NCT01670656|474307266|FG001|Overall Study|Lost to Follow-up|0|||
131735236|NCT01670656|474307267|FG002|Overall Study|Lost to Follow-up|0|||
131735237|NCT01670656|474307268|FG003|Overall Study|Lost to Follow-up|0|||
131735238|NCT01670656|474307269|FG004|Overall Study|Lost to Follow-up|3|||
131735239|NCT01670656|474307265|FG000|Overall Study|Subject moved|0|||
131735240|NCT01670656|474307266|FG001|Overall Study|Subject moved|0|||
131735241|NCT01670656|474307267|FG002|Overall Study|Subject moved|0|||
131735242|NCT01670656|474307268|FG003|Overall Study|Subject moved|1|||
131735243|NCT01670656|474307269|FG004|Overall Study|Subject moved|0|||
131735244|NCT02702518|474307270|FG000|Overall Study|Lost to Follow-up|3|||
131735245|NCT02702518|474307271|FG001|Overall Study|Lost to Follow-up|4|||
131735246|NCT00789958|474307272|FG000|Overall Study|Adverse Event|3|||
131735247|NCT00789958|474307272|FG000|Overall Study|Withdrawal by Subject|4|||
131735248|NCT00789958|474307272|FG000|Overall Study|Progression|3|||
131735249|NCT00789958|474307272|FG000|Overall Study|not protocol specified|1|||
131735250|NCT00789958|474307272|FG000|Overall Study|Not eligible/not analyzable|26|||
131735251|NCT03331666|474307275|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
131735252|NCT03331666|474307276|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
131735253|NCT01000727|474307278|FG000|Overall Study|Lost to Follow-up|41|||
131735254|NCT01000727|474307279|FG001|Overall Study|Lost to Follow-up|43|||
131735255|NCT01000727|474307278|FG000|Overall Study|Withdrawal by Subject|111|||
131735256|NCT01000727|474307279|FG001|Overall Study|Withdrawal by Subject|109|||
131735257|NCT01000727|474307278|FG000|Overall Study|Study closed/terminated|23|||
131735258|NCT01000727|474307279|FG001|Overall Study|Study closed/terminated|24|||
131735259|NCT03137121|474307280|FG000|Overall Study|Withdrawal by Subject|0|||
131735260|NCT03137121|474307281|FG001|Overall Study|Withdrawal by Subject|1|||
131735261|NCT01026389|474307286|FG000|Overall Study|Withdrawal by Subject|1|||
131735262|NCT01026389|474307287|FG001|Overall Study|Withdrawal by Subject|3|||
131735263|NCT01026389|474307286|FG000|Overall Study|change of treatment, patient moved|4|||
131735264|NCT01026389|474307287|FG001|Overall Study|change of treatment, patient moved|2|||
131735265|NCT00836277|474307288|FG000|Overall Study|Not evaluable for response|6|||
131735266|NCT01995136|474307289|FG000|Overall Study|Change in residence|1|||
131735267|NCT03544268|474307290|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
131735268|NCT03544268|474307291|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
131735269|NCT04410198|474307292|FG000|Overall Study|Death|10|||
131735270|NCT04410198|474307292|FG000|Overall Study|Withdrawal by Subject|7|||
131735271|NCT04410198|474307292|FG000|Overall Study|Transferred/Relocation|4|||
131735272|NCT04410198|474307292|FG000|Overall Study|Kidney Transplant|9|||
131735273|NCT04410198|474307292|FG000|Overall Study|Adverse Event|4|||
131735274|NCT04410198|474307292|FG000|Overall Study|Physician Decision|2|||
131735275|NCT04410198|474307292|FG000|Overall Study|Other than specified|1|||
131735276|NCT01830543|474307295|FG000|Overall Study|Subject Decision|19|||
131735277|NCT01830543|474307296|FG001|Overall Study|Subject Decision|21|||
131735278|NCT01830543|474307297|FG002|Overall Study|Subject Decision|57|||
131735279|NCT01830543|474307295|FG000|Overall Study|Adverse Event|91|||
131735280|NCT01830543|474307296|FG001|Overall Study|Adverse Event|77|||
131735281|NCT01830543|474307297|FG002|Overall Study|Adverse Event|76|||
131735282|NCT01830543|474307295|FG000|Overall Study|Death|20|||
131735283|NCT01830543|474307296|FG001|Overall Study|Death|22|||
131735284|NCT01830543|474307297|FG002|Overall Study|Death|22|||
131735285|NCT01830543|474307295|FG000|Overall Study|Protocol Violation|3|||
131735286|NCT01830543|474307296|FG001|Overall Study|Protocol Violation|7|||
131735287|NCT01830543|474307297|FG002|Overall Study|Protocol Violation|7|||
131735288|NCT01830543|474307295|FG000|Overall Study|Physician Decision|11|||
131735289|NCT01830543|474307296|FG001|Overall Study|Physician Decision|5|||
131735290|NCT01830543|474307297|FG002|Overall Study|Physician Decision|12|||
131735291|NCT01830543|474307295|FG000|Overall Study|Withdrawal by consent|3|||
131735292|NCT01830543|474307296|FG001|Overall Study|Withdrawal by consent|3|||
131735293|NCT01830543|474307297|FG002|Overall Study|Withdrawal by consent|3|||
131735294|NCT01830543|474307295|FG000|Overall Study|Other|12|||
131735295|NCT01830543|474307296|FG001|Overall Study|Other|17|||
131735296|NCT01830543|474307297|FG002|Overall Study|Other|37|||
131735297|NCT03583372|474307300|FG000|Overall Study|Withdrawal by Subject|6|||
131735298|NCT03583372|474307301|FG001|Overall Study|Withdrawal by Subject|11|||
131735299|NCT03583372|474307302|FG002|Overall Study|Withdrawal by Subject|7|||
131735300|NCT03583372|474307303|FG003|Overall Study|Withdrawal by Subject|8|||
131735301|NCT03583372|474307300|FG000|Overall Study|Lost to Follow-up|4|||
131735302|NCT03583372|474307301|FG001|Overall Study|Lost to Follow-up|6|||
131735303|NCT03583372|474307302|FG002|Overall Study|Lost to Follow-up|3|||
131735304|NCT03583372|474307303|FG003|Overall Study|Lost to Follow-up|2|||
131735305|NCT03583372|474307300|FG000|Overall Study|Adverse Event|1|||
131735306|NCT03583372|474307301|FG001|Overall Study|Adverse Event|3|||
131735307|NCT03583372|474307302|FG002|Overall Study|Adverse Event|4|||
131735308|NCT03583372|474307303|FG003|Overall Study|Adverse Event|4|||
131735309|NCT03583372|474307300|FG000|Overall Study|Physician Decision|0|||
131735310|NCT03583372|474307301|FG001|Overall Study|Physician Decision|1|||
131735311|NCT03583372|474307302|FG002|Overall Study|Physician Decision|1|||
131735312|NCT03583372|474307303|FG003|Overall Study|Physician Decision|1|||
131735313|NCT03583372|474307300|FG000|Overall Study|Lack of Efficacy|0|||
131735314|NCT03583372|474307301|FG001|Overall Study|Lack of Efficacy|1|||
131735315|NCT03583372|474307302|FG002|Overall Study|Lack of Efficacy|0|||
131735316|NCT03583372|474307303|FG003|Overall Study|Lack of Efficacy|1|||
131735317|NCT03583372|474307300|FG000|Overall Study|Death|1|||
131735318|NCT03583372|474307301|FG001|Overall Study|Death|0|||
131735319|NCT03583372|474307302|FG002|Overall Study|Death|0|||
131735320|NCT03583372|474307303|FG003|Overall Study|Death|0|||
131735321|NCT03583372|474307300|FG000|Overall Study|Protocol Violation|0|||
131735322|NCT03583372|474307301|FG001|Overall Study|Protocol Violation|1|||
131735323|NCT03583372|474307302|FG002|Overall Study|Protocol Violation|0|||
131735324|NCT03583372|474307303|FG003|Overall Study|Protocol Violation|0|||
131735325|NCT03583372|474307300|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
131735326|NCT03583372|474307301|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
131735327|NCT03583372|474307302|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
131735328|NCT03583372|474307303|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
131735329|NCT03583372|474307300|FG000|Overall Study|Did Not Receive Study Drug|0|||
131735330|NCT03583372|474307301|FG001|Overall Study|Did Not Receive Study Drug|1|||
131735331|NCT03583372|474307302|FG002|Overall Study|Did Not Receive Study Drug|0|||
131735332|NCT03583372|474307303|FG003|Overall Study|Did Not Receive Study Drug|0|||
131735333|NCT03583372|474307300|FG000|Overall Study|Captured as Other in the Database|1|||
131735334|NCT03583372|474307301|FG001|Overall Study|Captured as Other in the Database|2|||
131735335|NCT03583372|474307302|FG002|Overall Study|Captured as Other in the Database|4|||
131735336|NCT03583372|474307303|FG003|Overall Study|Captured as Other in the Database|1|||
131735337|NCT02695524|474307306|FG000|Overall Study|Lost to Follow-up|3|||
131735338|NCT02695524|474307307|FG001|Overall Study|Lost to Follow-up|2|||
131735339|NCT02695524|474307306|FG000|Overall Study|Death|0|||
131735340|NCT02695524|474307307|FG001|Overall Study|Death|1|||
131735341|NCT00377611|474307310|FG000|Overall Study|Adverse Event|2|||
131735342|NCT00377611|474307311|FG001|Overall Study|Adverse Event|9|||
131735343|NCT00377611|474307310|FG000|Overall Study|Protocol Violation|2|||
131735344|NCT00377611|474307311|FG001|Overall Study|Protocol Violation|0|||
131735345|NCT00377611|474307310|FG000|Overall Study|Withdrawal by Subject|0|||
131735346|NCT00377611|474307311|FG001|Overall Study|Withdrawal by Subject|5|||
131735347|NCT00377611|474307310|FG000|Overall Study|Lost to Follow-up|18|||
131735348|NCT00377611|474307311|FG001|Overall Study|Lost to Follow-up|16|||
131735349|NCT00377611|474307310|FG000|Overall Study|Other|0|||
131735350|NCT00377611|474307311|FG001|Overall Study|Other|3|||
131735351|NCT04831515|474307317|FG000|First Intervention|Adverse Event|0|||
131735352|NCT04831515|474307318|FG001|First Intervention|Adverse Event|1|||
131735353|NCT01640925|474307321|FG000|Overall Study|Withdrawal by Subject|1|||
131735354|NCT01640925|474307322|FG001|Overall Study|Withdrawal by Subject|0|||
131735355|NCT01640925|474307321|FG000|Overall Study|Previously enrolled in this trial|13|||
131735356|NCT01640925|474307322|FG001|Overall Study|Previously enrolled in this trial|11|||
131735357|NCT01332019|474307335|FG000|Overall Study|Was Not Dosed|1|||
131735358|NCT01332019|474307336|FG001|Overall Study|Was Not Dosed|0|||
131735359|NCT01332019|474307335|FG000|Overall Study|Other|16|||
131735360|NCT01332019|474307336|FG001|Overall Study|Other|18|||
131735361|NCT01332019|474307335|FG000|Overall Study|Death|2|||
131735362|NCT01332019|474307336|FG001|Overall Study|Death|1|||
131735363|NCT01332019|474307335|FG000|Overall Study|Physician Decision|4|||
131735364|NCT01332019|474307336|FG001|Overall Study|Physician Decision|3|||
131735365|NCT01332019|474307335|FG000|Overall Study|Withdrawal by Subject|73|||
131735366|NCT01332019|474307336|FG001|Overall Study|Withdrawal by Subject|71|||
131735367|NCT01332019|474307335|FG000|Overall Study|Lost to Follow-up|4|||
131735368|NCT01332019|474307336|FG001|Overall Study|Lost to Follow-up|7|||
131735369|NCT01332019|474307335|FG000|Overall Study|Adverse Event|13|||
131735370|NCT01332019|474307336|FG001|Overall Study|Adverse Event|22|||
131735371|NCT00871377|474307337|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131735372|NCT00871377|474307338|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131735373|NCT00871377|474307339|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
131735374|NCT00871377|474307340|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131735375|NCT00871377|474307341|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131735376|NCT00871377|474307342|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131735377|NCT00871377|474307337|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131735378|NCT00871377|474307338|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131735379|NCT00871377|474307339|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131735380|NCT00871377|474307340|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131735381|NCT00871377|474307341|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131735382|NCT00871377|474307342|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
131735383|NCT00871377|474307337|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
131735384|NCT00871377|474307338|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735385|NCT00871377|474307339|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735386|NCT00871377|474307340|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735387|NCT00871377|474307341|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735388|NCT00871377|474307342|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735389|NCT00871377|474307337|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735390|NCT00871377|474307338|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735391|NCT00871377|474307339|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735392|NCT00871377|474307340|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735393|NCT00871377|474307341|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
131735394|NCT00871377|474307342|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
131735395|NCT00871377|474307337|FG000|Third Intervention (10 Weeks)|Death|0|||
131735396|NCT00871377|474307338|FG001|Third Intervention (10 Weeks)|Death|0|||
131735397|NCT00871377|474307339|FG002|Third Intervention (10 Weeks)|Death|0|||
131735398|NCT00871377|474307340|FG003|Third Intervention (10 Weeks)|Death|1|||
131735399|NCT00871377|474307341|FG004|Third Intervention (10 Weeks)|Death|0|||
131735400|NCT00871377|474307342|FG005|Third Intervention (10 Weeks)|Death|0|||
131735401|NCT01395368|474307344|FG000|Overall Study|Physician Decision|14|||
131735402|NCT01395368|474307344|FG000|Overall Study|Withdrawal by Subject|2|||
131735403|NCT00288860|474307351|FG000|Overall Study|Did not complete intake|4|||
131735404|NCT00288860|474307352|FG001|Overall Study|Did not complete intake|8|||
131735405|NCT00288860|474307351|FG000|Overall Study|Death|4|||
131735406|NCT00288860|474307352|FG001|Overall Study|Death|3|||
131735407|NCT00288860|474307351|FG000|Overall Study|Withdrawal by Subject|20|||
131735408|NCT00288860|474307352|FG001|Overall Study|Withdrawal by Subject|15|||
131735409|NCT00288860|474307351|FG000|Overall Study|Lost to Follow-up|74|||
131735410|NCT00288860|474307352|FG001|Overall Study|Lost to Follow-up|71|||
131735411|NCT00243230|474307357|FG000|Double-Blind Period|Adverse Event|0|||
131735412|NCT00243230|474307358|FG001|Double-Blind Period|Adverse Event|2|||
131735413|NCT00243230|474307359|FG002|Double-Blind Period|Adverse Event|2|||
131735414|NCT00243230|474307360|FG003|Double-Blind Period|Adverse Event|0|||
131735415|NCT00243230|474307357|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131735416|NCT00243230|474307358|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131807854|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
131807855|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
131807856|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
131807857|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
131735417|NCT00243230|474307359|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131735418|NCT00243230|474307360|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131735419|NCT00243230|474307357|FG000|Double-Blind Period|Protocol Violation|0|||
131735420|NCT00243230|474307358|FG001|Double-Blind Period|Protocol Violation|0|||
131735421|NCT00243230|474307359|FG002|Double-Blind Period|Protocol Violation|1|||
131735422|NCT00243230|474307360|FG003|Double-Blind Period|Protocol Violation|0|||
131735423|NCT00243230|474307357|FG000|Double-Blind Period|Randomized but Not Treated|0|||
131735424|NCT00243230|474307358|FG001|Double-Blind Period|Randomized but Not Treated|0|||
131735425|NCT00243230|474307359|FG002|Double-Blind Period|Randomized but Not Treated|2|||
131735426|NCT00243230|474307360|FG003|Double-Blind Period|Randomized but Not Treated|0|||
131735427|NCT00243230|474307357|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
131735428|NCT00243230|474307358|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
131735429|NCT00243230|474307359|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
131735430|NCT00243230|474307360|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
131735431|NCT00243230|474307357|FG000|Open Label Period|Adverse Event|0|||
131735432|NCT00243230|474307358|FG001|Open Label Period|Adverse Event|0|||
131735433|NCT00243230|474307359|FG002|Open Label Period|Adverse Event|0|||
131735434|NCT00243230|474307360|FG003|Open Label Period|Adverse Event|2|||
131735435|NCT00243230|474307357|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
131735436|NCT00243230|474307358|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
131735437|NCT00243230|474307359|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
131735438|NCT00243230|474307360|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
131735439|NCT00243230|474307357|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
131735440|NCT00243230|474307358|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
131735441|NCT00243230|474307359|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
131735442|NCT00243230|474307360|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
131735443|NCT00243230|474307357|FG000|Open Label Period|Lost to Follow-up|0|||
131735444|NCT00243230|474307358|FG001|Open Label Period|Lost to Follow-up|0|||
131735445|NCT00243230|474307359|FG002|Open Label Period|Lost to Follow-up|0|||
131735446|NCT00243230|474307360|FG003|Open Label Period|Lost to Follow-up|2|||
131735447|NCT00243230|474307357|FG000|Open Label Period|Withdrawal by Subject|0|||
131735448|NCT00243230|474307358|FG001|Open Label Period|Withdrawal by Subject|0|||
131735449|NCT00243230|474307359|FG002|Open Label Period|Withdrawal by Subject|0|||
131735450|NCT00243230|474307360|FG003|Open Label Period|Withdrawal by Subject|2|||
131735451|NCT00243230|474307357|FG000|Open Label Period|Protocol Violation|0|||
131735452|NCT00243230|474307358|FG001|Open Label Period|Protocol Violation|0|||
131735453|NCT00243230|474307359|FG002|Open Label Period|Protocol Violation|0|||
131735454|NCT00243230|474307360|FG003|Open Label Period|Protocol Violation|2|||
131735455|NCT00243230|474307357|FG000|Open Label Period|Administrative Reason|0|||
131735456|NCT00243230|474307358|FG001|Open Label Period|Administrative Reason|0|||
131735457|NCT00243230|474307359|FG002|Open Label Period|Administrative Reason|0|||
131735458|NCT00243230|474307360|FG003|Open Label Period|Administrative Reason|63|||
131735459|NCT00894413|474307363|FG000|Overall Study|Physician Decision|0|||
131735460|NCT00894413|474307364|FG001|Overall Study|Physician Decision|2|||
131735461|NCT00894413|474307363|FG000|Overall Study|Adverse Event|0|||
131735462|NCT00894413|474307364|FG001|Overall Study|Adverse Event|2|||
131735463|NCT00894413|474307363|FG000|Overall Study|Withdrawal by Subject|0|||
131735464|NCT00894413|474307364|FG001|Overall Study|Withdrawal by Subject|4|||
131735465|NCT02294318|474308790|FG000|Overall Study|Worsening of drinking|3|||
131735466|NCT02294318|474308791|FG001|Overall Study|Worsening of drinking|0|||
131735467|NCT02294318|474308790|FG000|Overall Study|Not exposed to intervention|0|||
131735468|NCT02294318|474308791|FG001|Overall Study|Not exposed to intervention|2|||
131735469|NCT00789191|474308792|FG000|Overall Study|Adverse Event|2|||
131735470|NCT00789191|474308793|FG001|Overall Study|Adverse Event|4|||
131735471|NCT00789191|474308792|FG000|Overall Study|Lack of Efficacy|0|||
131735472|NCT00789191|474308793|FG001|Overall Study|Lack of Efficacy|5|||
131735473|NCT00789191|474308792|FG000|Overall Study|Protocol Violation|5|||
131735474|NCT00789191|474308793|FG001|Overall Study|Protocol Violation|3|||
131807858|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
131807859|NCT01045161|474582825|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
131807860|NCT01045161|474582826|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
131905253|NCT02810418|474940832|FG000|Arm B Dose Escalation|Adverse Event|0|||
131735475|NCT00789191|474308792|FG000|Overall Study|Withdrawal Criteria|2|||
131735476|NCT00789191|474308793|FG001|Overall Study|Withdrawal Criteria|4|||
131735477|NCT00789191|474308792|FG000|Overall Study|Unclassified|5|||
131735478|NCT00789191|474308793|FG001|Overall Study|Unclassified|3|||
131735479|NCT02174861|474308794|FG000|Overall Study|Decision by sponsor|8|||
131735480|NCT02174861|474308794|FG000|Overall Study|Withdrawal by Subject|124|||
131735481|NCT02174861|474308794|FG000|Overall Study|Lost to Follow-up|26|||
131735482|NCT04017442|474308798|FG000|Overall Study|Withdrawal by Subject|0|||
131735483|NCT04017442|474308799|FG001|Overall Study|Withdrawal by Subject|3|||
131735484|NCT04017442|474308798|FG000|Overall Study|Lost to Follow-up|21|||
131735485|NCT04017442|474308799|FG001|Overall Study|Lost to Follow-up|19|||
131735486|NCT02586233|474308800|FG000|Overall Study|Randomized but did not receive treatment|0|||
131735487|NCT02586233|474308801|FG001|Overall Study|Randomized but did not receive treatment|1|||
131735488|NCT02586233|474308802|FG002|Overall Study|Randomized but did not receive treatment|0|||
131735489|NCT02586233|474308803|FG003|Overall Study|Randomized but did not receive treatment|0|||
131735490|NCT02586233|474308804|FG004|Overall Study|Randomized but did not receive treatment|0|||
131735491|NCT02586233|474308805|FG005|Overall Study|Randomized but did not receive treatment|2|||
131735492|NCT02586233|474308806|FG006|Overall Study|Randomized but did not receive treatment|2|||
131735493|NCT02586233|474308800|FG000|Overall Study|Death|0|||
131735494|NCT02586233|474308801|FG001|Overall Study|Death|1|||
131735495|NCT02586233|474308802|FG002|Overall Study|Death|0|||
131735496|NCT02586233|474308803|FG003|Overall Study|Death|0|||
131735497|NCT02586233|474308804|FG004|Overall Study|Death|2|||
131735498|NCT02586233|474308805|FG005|Overall Study|Death|0|||
131735499|NCT02586233|474308806|FG006|Overall Study|Death|0|||
131735500|NCT01757405|474308807|FG000|Overall Study|Lost to Follow-up|1|||
131735501|NCT01757405|474308808|FG001|Overall Study|Lost to Follow-up|1|||
131735502|NCT01757405|474308807|FG000|Overall Study|Withdrawal by Subject|0|||
131735503|NCT01757405|474308808|FG001|Overall Study|Withdrawal by Subject|1|||
131735504|NCT00082758|474308810|FG000|Overall Study|Adverse Event|0|||
131735505|NCT00082758|474308811|FG001|Overall Study|Adverse Event|2|||
131735506|NCT00082758|474308812|FG002|Overall Study|Adverse Event|0|||
131735507|NCT00082758|474308810|FG000|Overall Study|Lack of Efficacy|12|||
131735508|NCT00082758|474308811|FG001|Overall Study|Lack of Efficacy|13|||
131735509|NCT00082758|474308812|FG002|Overall Study|Lack of Efficacy|0|||
131735510|NCT00082758|474308810|FG000|Overall Study|Physician Decision|0|||
131735511|NCT00082758|474308811|FG001|Overall Study|Physician Decision|1|||
131735512|NCT00082758|474308812|FG002|Overall Study|Physician Decision|0|||
131735513|NCT00082758|474308810|FG000|Overall Study|Withdrawal by Subject|3|||
131735514|NCT00082758|474308811|FG001|Overall Study|Withdrawal by Subject|0|||
131735515|NCT00082758|474308812|FG002|Overall Study|Withdrawal by Subject|0|||
131735516|NCT00082758|474308810|FG000|Overall Study|Protocol Violation|0|||
131735517|NCT00082758|474308811|FG001|Overall Study|Protocol Violation|1|||
131735518|NCT00082758|474308812|FG002|Overall Study|Protocol Violation|0|||
131735519|NCT00238303|474308813|FG000|Overall Study|Withdrawal by Subject|11|||
131735520|NCT00238303|474308814|FG001|Overall Study|Withdrawal by Subject|1|||
131735521|NCT00238303|474308815|FG002|Overall Study|Withdrawal by Subject|2|||
131735522|NCT00238303|474308813|FG000|Overall Study|Death|1|||
131735523|NCT00238303|474308814|FG001|Overall Study|Death|0|||
131735524|NCT00238303|474308815|FG002|Overall Study|Death|1|||
131735525|NCT00238303|474308813|FG000|Overall Study|Other Medical Problems|2|||
131735526|NCT00238303|474308814|FG001|Overall Study|Other Medical Problems|0|||
131735527|NCT00238303|474308815|FG002|Overall Study|Other Medical Problems|2|||
131735528|NCT00238303|474308813|FG000|Overall Study|Poor tolerance of study treatment|1|||
131735529|NCT00238303|474308814|FG001|Overall Study|Poor tolerance of study treatment|0|||
131735530|NCT00238303|474308815|FG002|Overall Study|Poor tolerance of study treatment|1|||
131735531|NCT00238303|474308813|FG000|Overall Study|Adverse Event|0|||
131735532|NCT00238303|474308814|FG001|Overall Study|Adverse Event|1|||
131735533|NCT00238303|474308815|FG002|Overall Study|Adverse Event|3|||
131735534|NCT01248130|474308819|FG000|Overall Study|Protocol Violation|1|||
131735535|NCT01248130|474308820|FG001|Overall Study|Protocol Violation|0|||
131735536|NCT01248130|474308819|FG000|Overall Study|Ineligible|1|||
131735537|NCT01248130|474308820|FG001|Overall Study|Ineligible|0|||
131735538|NCT01358877|474308821|FG000|Overall Study|Death|80|||
131735539|NCT01358877|474308822|FG001|Overall Study|Death|89|||
131735540|NCT01358877|474308821|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
131735541|NCT01358877|474308822|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
131735542|NCT01358877|474308821|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
131735543|NCT01358877|474308822|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
131735544|NCT01358877|474308821|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
131735545|NCT01358877|474308822|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
131735546|NCT01358877|474308821|FG000|Overall Study|Other|142|||
131735547|NCT01358877|474308822|FG001|Overall Study|Other|129|||
131735548|NCT01911845|474308827|FG000|Overall Study|Adverse Event|2|||
131735549|NCT01911845|474308827|FG000|Overall Study|Lost to Follow-up|1|||
131735550|NCT01911845|474308827|FG000|Overall Study|Other (not specified)|3|||
131735551|NCT01994226|474308828|FG000|Overall Study|Protocol Violation|13|||
131735552|NCT01994226|474308829|FG001|Overall Study|Protocol Violation|10|||
131735553|NCT01994226|474308828|FG000|Overall Study|Early Cessation of treatment|6|||
131735554|NCT01994226|474308829|FG001|Overall Study|Early Cessation of treatment|11|||
131735555|NCT00436566|474308835|FG000|Overall Study|Withdrawal by Subject|2|||
131735556|NCT00436566|474308835|FG000|Overall Study|Protocol Violation|1|||
131735557|NCT04507867|474308836|FG000|Overall Study|Death|7|||
131735558|NCT04507867|474308837|FG001|Overall Study|Death|1|||
131735559|NCT01188564|474308840|FG000|Double-blind Phase|randomized not treated|1|||
131735560|NCT01188564|474308841|FG001|Double-blind Phase|randomized not treated|0|||
131735561|NCT01954251|474308843|FG000|Overall Study|Adverse Event|5|||
131735562|NCT01954251|474308844|FG001|Overall Study|Adverse Event|7|||
131735563|NCT01954251|474308843|FG000|Overall Study|Lost to Follow-up|6|||
131807861|NCT01045161|474582827|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
131807862|NCT03686033|474582828|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
131807863|NCT03686033|474582829|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
131807864|NCT03686033|474582830|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
131807865|NCT03686033|474582831|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
131807866|NCT03686033|474582832|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
131807867|NCT03686033|474582833|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
131807868|NCT03197883|474582834|FG000|Overall Study|Adverse Event|1|||
131807869|NCT03197883|474582835|FG001|Overall Study|Adverse Event|1|||
131807870|NCT03197883|474582834|FG000|Overall Study|Lost to Follow-up|1|||
131807871|NCT03197883|474582835|FG001|Overall Study|Lost to Follow-up|0|||
131807872|NCT03197883|474582834|FG000|Overall Study|Protocol Violation|1|||
131807873|NCT03197883|474582835|FG001|Overall Study|Protocol Violation|0|||
131807874|NCT03197883|474582834|FG000|Overall Study|Other (Not Specified)|0|||
131807875|NCT03197883|474582835|FG001|Overall Study|Other (Not Specified)|5|||
131807876|NCT00858845|474582837|FG000|Overall Study|Patient underwent heart transplant.|0|||
131735564|NCT01954251|474308844|FG001|Overall Study|Lost to Follow-up|6|||
131735565|NCT01954251|474308843|FG000|Overall Study|Withdrawal by Subject|2|||
131735566|NCT01954251|474308844|FG001|Overall Study|Withdrawal by Subject|6|||
131735567|NCT00779324|474308845|FG000|Overall Study|Lost to Follow-up|2|||
131735568|NCT00779324|474308846|FG001|Overall Study|Lost to Follow-up|1|||
131735569|NCT00779324|474308845|FG000|Overall Study|Withdrawal by Subject|4|||
131735570|NCT00779324|474308846|FG001|Overall Study|Withdrawal by Subject|2|||
131735571|NCT00779324|474308845|FG000|Overall Study|Missed visit|1|||
131735572|NCT00779324|474308846|FG001|Overall Study|Missed visit|1|||
131735573|NCT02207556|474308847|FG000|Overall Study|Physician Decision|1|||
131735574|NCT02207556|474308848|FG001|Overall Study|Physician Decision|0|||
131735575|NCT02207556|474308847|FG000|Overall Study|Withdrawal by Subject|1|||
131735576|NCT02207556|474308848|FG001|Overall Study|Withdrawal by Subject|0|||
131735577|NCT02207556|474308847|FG000|Overall Study|Death|0|||
131735578|NCT02207556|474308848|FG001|Overall Study|Death|5|||
131735579|NCT03558555|474308849|FG000|Overall Study|Lost to Follow-up|2|||
131735580|NCT03558555|474308850|FG001|Overall Study|Lost to Follow-up|1|||
131735581|NCT01958125|474308851|FG000|Overall Study|Missing diary data|2|||
131735582|NCT01958125|474308852|FG001|Overall Study|Missing diary data|6|||
131735583|NCT01958125|474308851|FG000|Overall Study|No headache attacks|0|||
131735584|NCT01958125|474308852|FG001|Overall Study|No headache attacks|2|||
131735585|NCT00617409|474308853|FG000|Overall Study|Withdrawal by Subject|4|||
131735586|NCT00617409|474308854|FG001|Overall Study|Withdrawal by Subject|1|||
131735587|NCT00617409|474308855|FG002|Overall Study|Withdrawal by Subject|2|||
131735588|NCT00617409|474308853|FG000|Overall Study|Adverse Event|0|||
131735589|NCT00617409|474308854|FG001|Overall Study|Adverse Event|2|||
131735590|NCT00617409|474308855|FG002|Overall Study|Adverse Event|3|||
131735591|NCT00617409|474308853|FG000|Overall Study|Disease Progression|8|||
131735592|NCT00617409|474308854|FG001|Overall Study|Disease Progression|8|||
131735593|NCT00617409|474308855|FG002|Overall Study|Disease Progression|18|||
131735594|NCT00617409|474308853|FG000|Overall Study|Death|3|||
131735595|NCT00617409|474308854|FG001|Overall Study|Death|5|||
131735596|NCT00617409|474308855|FG002|Overall Study|Death|4|||
131735597|NCT00617409|474308853|FG000|Overall Study|Alternative Therapy|1|||
131735598|NCT00617409|474308854|FG001|Overall Study|Alternative Therapy|2|||
131735599|NCT00617409|474308855|FG002|Overall Study|Alternative Therapy|0|||
131735600|NCT00781599|474308868|FG000|Overall Study|Lost to Follow-up|7|||
131735601|NCT00781599|474308869|FG001|Overall Study|Lost to Follow-up|4|||
131735602|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
131735603|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
131807877|NCT00858845|474582838|FG001|Overall Study|Patient underwent heart transplant.|1|||
131807878|NCT03031847|474582839|FG000|Overall Study|Death|1|||
131807879|NCT03031847|474582840|FG001|Overall Study|Death|1|||
131807880|NCT03031847|474582841|FG002|Overall Study|Death|2|||
131807881|NCT03031847|474582842|FG003|Overall Study|Death|3|||
131807882|NCT03031847|474582839|FG000|Overall Study|Lost to Follow-up|1|||
131807883|NCT03031847|474582840|FG001|Overall Study|Lost to Follow-up|1|||
131735604|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
131735605|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
131735606|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
131735607|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
131735608|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
131735609|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
131735610|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
131807884|NCT03031847|474582841|FG002|Overall Study|Lost to Follow-up|2|||
131807885|NCT03031847|474582842|FG003|Overall Study|Lost to Follow-up|3|||
131735611|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
131735612|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
131735613|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
131735614|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
131735615|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
131735616|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
131735617|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
131735618|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
131735619|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131735620|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
131735621|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
131735622|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
131735623|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131735624|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131735625|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131735626|NCT01106625|474308873|FG000|Core Period: Baseline to Week 26|Other|8|||
131735627|NCT01106625|474308874|FG001|Core Period: Baseline to Week 26|Other|7|||
131735628|NCT01106625|474308875|FG002|Core Period: Baseline to Week 26|Other|4|||
131735629|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
131735630|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
131735631|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
131735632|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
131735633|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
131735634|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
131735635|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
131735636|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131735637|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
131735638|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131735639|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131735640|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131735641|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
131735642|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131735643|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131735644|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
131735645|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
131735646|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
131735647|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
131735648|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
131735649|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
131735650|NCT01106625|474308873|FG000|Extension Period: Week 26 to Week 52|Other|5|||
131735651|NCT01106625|474308874|FG001|Extension Period: Week 26 to Week 52|Other|5|||
131735652|NCT01106625|474308875|FG002|Extension Period: Week 26 to Week 52|Other|4|||
131735653|NCT00668200|474308881|FG000|Overall Study|Withdrawal by Subject|2|||
131735654|NCT00668200|474308881|FG000|Overall Study|Lost to Follow-up|1|||
131735655|NCT01496430|474308882|FG000|Overall Study|Adverse Event|0|||
131735656|NCT01496430|474308883|FG001|Overall Study|Adverse Event|0|||
131735657|NCT01496430|474308884|FG002|Overall Study|Adverse Event|1|||
131735658|NCT01496430|474308882|FG000|Overall Study|Major Protocol Deviation|0|||
131735659|NCT01496430|474308883|FG001|Overall Study|Major Protocol Deviation|0|||
131735660|NCT01496430|474308884|FG002|Overall Study|Major Protocol Deviation|1|||
131735661|NCT01496430|474308882|FG000|Overall Study|Lost to Follow-up|2|||
131735662|NCT01496430|474308883|FG001|Overall Study|Lost to Follow-up|3|||
131735663|NCT01496430|474308884|FG002|Overall Study|Lost to Follow-up|1|||
131735664|NCT01496430|474308882|FG000|Overall Study|Voluntary Withdrawal|2|||
131735665|NCT01496430|474308883|FG001|Overall Study|Voluntary Withdrawal|1|||
131735666|NCT01496430|474308884|FG002|Overall Study|Voluntary Withdrawal|6|||
131735667|NCT01496430|474308882|FG000|Overall Study|Principal Investigator Discretion|0|||
131735668|NCT01496430|474308883|FG001|Overall Study|Principal Investigator Discretion|1|||
131735669|NCT01496430|474308884|FG002|Overall Study|Principal Investigator Discretion|1|||
131735670|NCT01496430|474308882|FG000|Overall Study|Other|2|||
131735671|NCT01496430|474308883|FG001|Overall Study|Other|0|||
131735672|NCT01496430|474308884|FG002|Overall Study|Other|0|||
131735673|NCT00997321|474308885|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
131735674|NCT00997321|474308886|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
131735675|NCT02509598|474308887|FG000|Overall Study|Withdrawal by Subject|1|||
131735676|NCT02196038|474308888|FG000|Overall Study|Death|16|||
131735677|NCT02196038|474308889|FG001|Overall Study|Death|21|||
131735678|NCT02196038|474308888|FG000|Overall Study|Withdrawal by Subject|0|||
131735679|NCT02196038|474308889|FG001|Overall Study|Withdrawal by Subject|1|||
131735680|NCT02196038|474308888|FG000|Overall Study|Lost to Follow-up|1|||
131735681|NCT02196038|474308889|FG001|Overall Study|Lost to Follow-up|0|||
131735682|NCT02512068|474308894|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
131735683|NCT02512068|474308895|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
131735684|NCT02512068|474308894|FG000|Overall Study|Major Protocol Deviation|1|||
131735685|NCT02512068|474308895|FG001|Overall Study|Major Protocol Deviation|0|||
131735686|NCT02512068|474308894|FG000|Overall Study|Voluntary Withdrawal|0|||
131735687|NCT02512068|474308895|FG001|Overall Study|Voluntary Withdrawal|1|||
131735688|NCT02512068|474308894|FG000|Overall Study|Lack of Efficacy|0|||
131735689|NCT02512068|474308895|FG001|Overall Study|Lack of Efficacy|1|||
131735690|NCT02512068|474308894|FG000|Overall Study|Reason Not Specified|3|||
131735691|NCT02512068|474308895|FG001|Overall Study|Reason Not Specified|5|||
131735692|NCT01098461|474308907|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
131735693|NCT01098461|474308908|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
131735694|NCT01098461|474308909|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
131735695|NCT01098461|474308910|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
131735696|NCT01098461|474308907|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
131735697|NCT01098461|474308908|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
131735698|NCT01098461|474308909|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
131735699|NCT01098461|474308910|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
131735700|NCT01098461|474308907|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
131735701|NCT01098461|474308908|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
131735702|NCT01098461|474308909|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
131735703|NCT01098461|474308910|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
131735704|NCT01098461|474308907|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
131735705|NCT01098461|474308908|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
131735706|NCT01098461|474308909|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
131735707|NCT01098461|474308910|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
131735708|NCT01098461|474308907|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
131735709|NCT01098461|474308908|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
131735710|NCT01098461|474308909|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
131735711|NCT01098461|474308910|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
131735712|NCT01098461|474308907|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
131735713|NCT01098461|474308908|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
131735714|NCT01098461|474308909|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
131735715|NCT01098461|474308910|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
131735716|NCT01098461|474308907|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
131735717|NCT01098461|474308908|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
131735718|NCT01098461|474308909|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
131735719|NCT01098461|474308910|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
131735720|NCT01153763|474308913|FG000|Overall Study|Study Closed|16|||
131735721|NCT01153763|474308913|FG000|Overall Study|Lost to Follow-up|1|||
131735722|NCT01153763|474308913|FG000|Overall Study|Physician Decision|2|||
131735723|NCT01153763|474308913|FG000|Overall Study|Withdrawal by Subject|2|||
131735724|NCT01474746|474308914|FG000|Overall Study|Lost to Follow-up|1|||
131735725|NCT01474746|474308915|FG001|Overall Study|Lost to Follow-up|1|||
131735726|NCT01474746|474308914|FG000|Overall Study|Withdrawal by Subject|2|||
131735727|NCT01474746|474308915|FG001|Overall Study|Withdrawal by Subject|1|||
131735728|NCT01766336|474308917|FG000|Overall Study|Adverse Event|11|||
131735729|NCT01766336|474308918|FG001|Overall Study|Adverse Event|8|||
131735730|NCT01766336|474308917|FG000|Overall Study|Death|4|||
131735731|NCT01766336|474308918|FG001|Overall Study|Death|3|||
131735732|NCT01766336|474308917|FG000|Overall Study|Lost to Follow-up|1|||
131735733|NCT01766336|474308918|FG001|Overall Study|Lost to Follow-up|3|||
131735734|NCT01766336|474308917|FG000|Overall Study|Physician Decision|4|||
131735735|NCT01766336|474308918|FG001|Overall Study|Physician Decision|2|||
131735736|NCT01766336|474308917|FG000|Overall Study|Protocol Violation|0|||
131735737|NCT01766336|474308918|FG001|Overall Study|Protocol Violation|1|||
131735738|NCT01766336|474308917|FG000|Overall Study|Sponsor Decision|52|||
131807886|NCT01353664|474582844|FG000|Overall Study|Other|3|||
131807887|NCT01353664|474582844|FG000|Overall Study|Disease Progression|16|||
131735739|NCT01766336|474308918|FG001|Overall Study|Sponsor Decision|43|||
131735740|NCT01766336|474308917|FG000|Overall Study|Withdrawal by Subject|18|||
131735741|NCT01766336|474308918|FG001|Overall Study|Withdrawal by Subject|15|||
131735742|NCT02605447|474308919|FG000|Overall Study|Death|66|||
131735743|NCT02605447|474308919|FG000|Overall Study|Physician Decision|1|||
131735744|NCT02605447|474308919|FG000|Overall Study|Lost to Follow-up|24|||
131735745|NCT02605447|474308919|FG000|Overall Study|Withdrawal by Subject|10|||
131807888|NCT02612337|474582849|FG000|Overall Study|Lack of Efficacy|1|||
131807889|NCT02612337|474582850|FG001|Overall Study|Lack of Efficacy|0|||
131735746|NCT02605447|474308919|FG000|Overall Study|Not disclosed|1|||
131735747|NCT04544709|474308923|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
131735748|NCT02045212|474308924|FG000|Overall Study|Adverse Event|0|||
131735749|NCT02045212|474308925|FG001|Overall Study|Adverse Event|1|||
131735750|NCT02045212|474308924|FG000|Overall Study|Withdrawal by Subject|1|||
131735751|NCT02045212|474308925|FG001|Overall Study|Withdrawal by Subject|0|||
131735752|NCT02045212|474308924|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
131735753|NCT02045212|474308925|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
131735754|NCT03011840|474308929|FG000|Overall Study|Not received PIL in post PIL phase|0|||
131735755|NCT03011840|474308930|FG001|Overall Study|Not received PIL in post PIL phase|21|||
131735756|NCT00369668|474308932|FG000|Overall Study|Lack of Efficacy|4|||
131735757|NCT00369668|474308933|FG001|Overall Study|Lack of Efficacy|5|||
131735758|NCT00369668|474308934|FG002|Overall Study|Lack of Efficacy|7|||
131735759|NCT03213626|474308937|FG000|Overall Study|Adverse Event|1|||
131735760|NCT03213626|474308937|FG000|Overall Study|Progressive Disease|6|||
131735761|NCT00142519|474308938|FG000|Overall Study|Not Treated|7|||
131735762|NCT00142519|474308939|FG001|Overall Study|Not Treated|9|||
131735763|NCT00142519|474308938|FG000|Overall Study|Protocol Violation|1|||
131735764|NCT00142519|474308939|FG001|Overall Study|Protocol Violation|0|||
131735765|NCT00142519|474308938|FG000|Overall Study|Withdrawal by Subject|10|||
131735766|NCT00142519|474308939|FG001|Overall Study|Withdrawal by Subject|7|||
131735767|NCT02596711|474308940|FG000|Overall Study|Lost to Follow-up|1|||
131735768|NCT02596711|474308941|FG001|Overall Study|Lost to Follow-up|2|||
131735769|NCT02596711|474308942|FG002|Overall Study|Lost to Follow-up|3|||
131735770|NCT01005732|474308943|FG000|Overall Study|Lost to Follow-up|10|||
131735771|NCT01005732|474308943|FG000|Overall Study|Death|1|||
131735772|NCT01552928|474308944|FG000|Period 3|Adverse Event|0|||
131735773|NCT01552928|474308945|FG001|Period 3|Adverse Event|0|||
131735774|NCT01552928|474308946|FG002|Period 3|Adverse Event|1|||
131735775|NCT01552928|474308947|FG003|Period 3|Adverse Event|0|||
131735776|NCT00786032|474311041|FG000|Overall Study|Death|4|||
131735777|NCT00786032|474311041|FG000|Overall Study|Withdrawal by Subject|14|||
131735778|NCT00786032|474311041|FG000|Overall Study|Did not complete in the timeframe|6|||
131735779|NCT02625324|474311042|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
131735780|NCT02625324|474311042|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
131735781|NCT02625324|474311042|FG000|6-Month Follow-up Subject Accountability|Death|5|||
131735782|NCT02625324|474311042|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
131735783|NCT02625324|474311042|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
131735784|NCT02625324|474311042|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
131735785|NCT02625324|474311042|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
131735786|NCT02625324|474311042|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
131735787|NCT02625324|474311042|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
131735788|NCT02625324|474311042|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
131735789|NCT02625324|474311042|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
131735790|NCT02625324|474311042|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
131735791|NCT02625324|474311042|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
131735792|NCT02625324|474311042|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
131735793|NCT02625324|474311042|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
131735794|NCT02625324|474311042|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
131735795|NCT02625324|474311042|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
131735796|NCT02457182|474311043|FG000|Overall Study|Lost to Follow-up|1|||
131735797|NCT02457182|474311044|FG001|Overall Study|Lost to Follow-up|0|||
131735798|NCT01116687|474311045|FG000|Overall Study|Withdrawal by Subject|4|||
131735799|NCT01009983|474311048|FG000|Overall Study|necessary scans not completed|1|||
131735800|NCT03497429|474311049|FG000|Overall Study|Progressive disease|3|||
131735801|NCT03497429|474311050|FG001|Overall Study|Progressive disease|4|||
131735802|NCT03497429|474311049|FG000|Overall Study|Adverse Event|0|||
131735803|NCT03497429|474311050|FG001|Overall Study|Adverse Event|2|||
131735804|NCT00506948|474311051|FG000|Overall Study|Death|4|||
131735805|NCT00506948|474311051|FG000|Overall Study|Adverse Event|5|||
131735806|NCT00506948|474311051|FG000|Overall Study|Physician Decision|1|||
131735807|NCT00165841|474311052|FG000|Overall Study|Adverse Event|2|||
131735808|NCT00165841|474311053|FG001|Overall Study|Adverse Event|3|||
131735809|NCT00165841|474311052|FG000|Overall Study|Lack of Efficacy|6|||
131735810|NCT00165841|474311053|FG001|Overall Study|Lack of Efficacy|33|||
131735811|NCT00165841|474311052|FG000|Overall Study|Lost to Follow-up|4|||
131735812|NCT00165841|474311053|FG001|Overall Study|Lost to Follow-up|4|||
131735813|NCT00165841|474311052|FG000|Overall Study|Withdrawal by Subject|7|||
131735814|NCT00165841|474311053|FG001|Overall Study|Withdrawal by Subject|8|||
131735815|NCT00165841|474311052|FG000|Overall Study|Physician Decision|1|||
131735816|NCT00165841|474311053|FG001|Overall Study|Physician Decision|0|||
131735817|NCT00165841|474311052|FG000|Overall Study|Protocol Violation|6|||
131735818|NCT00165841|474311053|FG001|Overall Study|Protocol Violation|8|||
131735819|NCT00165841|474311052|FG000|Overall Study|Other|3|||
131735820|NCT00165841|474311053|FG001|Overall Study|Other|5|||
131735821|NCT00165841|474311052|FG000|Overall Study|Medication Noncompliance|1|||
131735822|NCT00165841|474311053|FG001|Overall Study|Medication Noncompliance|1|||
131735823|NCT00254293|474311054|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131735824|NCT00254293|474311055|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
131735825|NCT00254293|474311056|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131735826|NCT00254293|474311057|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
131735827|NCT00254293|474311058|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131735828|NCT00254293|474311059|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131735829|NCT00254293|474311060|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131735830|NCT00254293|474311054|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131735831|NCT00254293|474311055|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131735832|NCT00254293|474311056|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
131735833|NCT00254293|474311057|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131735834|NCT00254293|474311058|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131735835|NCT00254293|474311059|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131735836|NCT00254293|474311060|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131735837|NCT00254293|474311054|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131735838|NCT00254293|474311055|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131735839|NCT00254293|474311056|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
131735840|NCT00254293|474311057|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131735841|NCT00254293|474311058|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131735842|NCT00254293|474311059|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131735843|NCT00254293|474311060|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131735844|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Death|0|||
131735845|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Death|0|||
131735846|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Death|1|||
131735847|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Death|0|||
131735848|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Death|0|||
131735849|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Death|0|||
131735850|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Death|0|||
131735851|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
131735852|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131735853|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
131735854|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131735855|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
131735856|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131735857|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131735858|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
131735859|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131735860|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
131735861|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131735862|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
131735863|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131735864|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131735865|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131735866|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131735867|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
131735868|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131735869|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131735870|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131735871|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131735872|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131735873|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131735874|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
131735875|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131735876|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131735877|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131735878|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131735879|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131735880|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131735881|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
131807890|NCT02612337|474582849|FG000|Overall Study|Withdrawal by Subject|2|||
131807891|NCT02612337|474582850|FG001|Overall Study|Withdrawal by Subject|2|||
131807892|NCT02612337|474582849|FG000|Overall Study|Did not receive study drug|0|||
131735882|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131807893|NCT02612337|474582850|FG001|Overall Study|Did not receive study drug|1|||
131807894|NCT02032888|474582855|FG000|Treatment Period|Poor compliance/noncompliance|1|||
131807895|NCT02032888|474582856|FG001|Treatment Period|Poor compliance/noncompliance|1|||
131807896|NCT02032888|474582857|FG002|Treatment Period|Poor compliance/noncompliance|0|||
131807897|NCT02032888|474582855|FG000|Treatment Period|Other|1|||
131807898|NCT02032888|474582856|FG001|Treatment Period|Other|1|||
131807899|NCT02032888|474582857|FG002|Treatment Period|Other|0|||
131807900|NCT02032888|474582855|FG000|Follow-up Period|Lost to Follow-up|1|||
131807901|NCT02032888|474582856|FG001|Follow-up Period|Lost to Follow-up|1|||
131807902|NCT02032888|474582857|FG002|Follow-up Period|Lost to Follow-up|0|||
131807903|NCT02032888|474582855|FG000|Follow-up Period|Death|1|||
131807904|NCT02032888|474582856|FG001|Follow-up Period|Death|1|||
131807905|NCT02032888|474582857|FG002|Follow-up Period|Death|0|||
131807906|NCT02032888|474582855|FG000|Follow-up Period|Other|1|||
131807907|NCT02032888|474582856|FG001|Follow-up Period|Other|0|||
131807908|NCT02032888|474582857|FG002|Follow-up Period|Other|0|||
131807909|NCT01697696|474582858|FG000|Overall Study|Study terminated by sponsor|0|||
131807910|NCT01697696|474582859|FG001|Overall Study|Study terminated by sponsor|3|||
131807911|NCT01697696|474582858|FG000|Overall Study|Protocol deviation|1|||
131807912|NCT01697696|474582859|FG001|Overall Study|Protocol deviation|0|||
131807913|NCT01697696|474582858|FG000|Overall Study|Physician Decision|1|||
131807914|NCT01697696|474582859|FG001|Overall Study|Physician Decision|0|||
131807915|NCT01697696|474582858|FG000|Overall Study|Death|4|||
131807916|NCT01697696|474582859|FG001|Overall Study|Death|2|||
131807917|NCT01697696|474582858|FG000|Overall Study|Lost to Follow-up|10|||
131807918|NCT01697696|474582859|FG001|Overall Study|Lost to Follow-up|7|||
131807919|NCT01697696|474582858|FG000|Overall Study|Subject/guardian decision|31|||
131807920|NCT01697696|474582859|FG001|Overall Study|Subject/guardian decision|35|||
131807921|NCT05593965|474582862|FG000|1st Intervention (1 Day)|Technical error|1|||
131807922|NCT05593965|474582863|FG001|1st Intervention (1 Day)|Technical error|0|||
131807923|NCT03616106|474582864|FG000|Overall Study|Removed by PI|6|||
131807924|NCT03616106|474582865|FG001|Overall Study|Removed by PI|0|||
131807925|NCT03616106|474582864|FG000|Overall Study|Withdrawal by Subject|1|||
131807926|NCT03616106|474582865|FG001|Overall Study|Withdrawal by Subject|1|||
131807927|NCT03616106|474582864|FG000|Overall Study|Lost to Follow-up|7|||
131807928|NCT03616106|474582865|FG001|Overall Study|Lost to Follow-up|0|||
131807929|NCT01880593|474582878|FG000|Overall Study|Adverse Event|1|||
131807930|NCT01880593|474582879|FG001|Overall Study|Adverse Event|0|||
131807931|NCT01880593|474582878|FG000|Overall Study|Lack of Efficacy|1|||
131735883|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131735884|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131735885|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131735886|NCT00254293|474311054|FG000|LTE Open Label Variable SC Dosing|Other|0|||
131735887|NCT00254293|474311055|FG001|LTE Open Label Variable SC Dosing|Other|0|||
131735888|NCT00254293|474311056|FG002|LTE Open Label Variable SC Dosing|Other|2|||
131735889|NCT00254293|474311057|FG003|LTE Open Label Variable SC Dosing|Other|0|||
131735890|NCT00254293|474311058|FG004|LTE Open Label Variable SC Dosing|Other|0|||
131735891|NCT00254293|474311059|FG005|LTE Open Label Variable SC Dosing|Other|0|||
131735892|NCT00254293|474311060|FG006|LTE Open Label Variable SC Dosing|Other|0|||
131735893|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Death|0|||
131735894|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Death|0|||
131735895|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Death|0|||
131735896|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Death|0|||
131735897|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Death|0|||
131735898|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Death|0|||
131735899|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Death|3|||
131735900|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
131735901|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
131735902|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
131735903|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
131735904|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
131735905|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
131735906|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
131735907|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131735908|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131735909|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131735910|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131807932|NCT01880593|474582879|FG001|Overall Study|Lack of Efficacy|5|||
131807933|NCT01880593|474582878|FG000|Overall Study|Withdrawal by Subject|6|||
131807934|NCT01880593|474582879|FG001|Overall Study|Withdrawal by Subject|1|||
131735911|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131735912|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131735913|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
131735914|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131807935|NCT02272777|474582880|FG000|Overall Study|Adverse Event|0|||
131807936|NCT02272777|474582881|FG001|Overall Study|Adverse Event|1|||
131807937|NCT02272777|474582880|FG000|Overall Study|Withdrawal by Subject|0|||
131807938|NCT02272777|474582881|FG001|Overall Study|Withdrawal by Subject|3|||
131735915|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131735916|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131735917|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131735918|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131735919|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131735920|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
131735921|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131735922|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131735923|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131735924|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131735925|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131735926|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131735927|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
131735928|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131735929|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131735930|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131735931|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131735932|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131735933|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131905254|NCT02810418|474940833|FG001|Arm B Dose Escalation|Adverse Event|0|||
131905255|NCT02810418|474940834|FG002|Arm B Dose Escalation|Adverse Event|0|||
131905256|NCT02810418|474940835|FG003|Arm B Dose Escalation|Adverse Event|0|||
131905257|NCT02810418|474940836|FG004|Arm B Dose Escalation|Adverse Event|1|||
131905258|NCT02810418|474940837|FG005|Arm B Dose Escalation|Adverse Event|2|||
131905259|NCT02810418|474940838|FG006|Arm B Dose Escalation|Adverse Event|0|||
131905260|NCT02224625|474940839|FG000|Irritation|Adverse Event|6|||
131905261|NCT02224625|474940839|FG000|Sensitization|Adverse Event|55|||
131905262|NCT01100853|474940848|FG000|Overall Study|Lost to Follow-up|11|||
131905263|NCT01100853|474940849|FG001|Overall Study|Lost to Follow-up|6|||
131905264|NCT01100853|474940848|FG000|Overall Study|Received <4 study injections|10|||
131905265|NCT01100853|474940849|FG001|Overall Study|Received <4 study injections|13|||
131905266|NCT01100853|474940848|FG000|Overall Study|Withdrawal by Subject|6|||
131905267|NCT01100853|474940849|FG001|Overall Study|Withdrawal by Subject|4|||
131905268|NCT01162343|474940850|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
131905269|NCT01162343|474940850|FG000|Overall Study|Refused psychiatrist assessment|12|||
131905270|NCT02579629|474940864|FG000|Overall Study|Withdrawal by Subject|0|||
131905271|NCT02579629|474940865|FG001|Overall Study|Withdrawal by Subject|1|||
131905272|NCT02579629|474940866|FG002|Overall Study|Withdrawal by Subject|0|||
131905273|NCT02579629|474940864|FG000|Overall Study|Screen Failure|2|||
131905274|NCT02579629|474940865|FG001|Overall Study|Screen Failure|0|||
131905275|NCT02579629|474940866|FG002|Overall Study|Screen Failure|2|||
131905276|NCT00266708|474940867|FG000|Overall Study|No renal function|1|||
131905277|NCT00266708|474940868|FG001|Overall Study|No renal function|1|||
131905278|NCT00266708|474940867|FG000|Overall Study|Refused biopsy|3|||
131905279|NCT00266708|474940868|FG001|Overall Study|Refused biopsy|6|||
131905280|NCT00266708|474940867|FG000|Overall Study|Asthma|0|||
131735934|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
131735935|NCT00254293|474311054|FG000|LTE Open Label Fixed Dosing|Other|0|||
131735936|NCT00254293|474311055|FG001|LTE Open Label Fixed Dosing|Other|0|||
131735937|NCT00254293|474311056|FG002|LTE Open Label Fixed Dosing|Other|0|||
131735938|NCT00254293|474311057|FG003|LTE Open Label Fixed Dosing|Other|0|||
131735939|NCT00254293|474311058|FG004|LTE Open Label Fixed Dosing|Other|0|||
131735940|NCT00254293|474311059|FG005|LTE Open Label Fixed Dosing|Other|0|||
131735941|NCT00254293|474311060|FG006|LTE Open Label Fixed Dosing|Other|1|||
131735942|NCT03196193|474311067|FG000|Overall Study|Adverse Event|1|||
131735943|NCT03196193|474311068|FG001|Overall Study|Adverse Event|0|||
131735944|NCT03196193|474311067|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
131735945|NCT03196193|474311068|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
131735946|NCT02709083|474311069|FG000|Overall Study|Original PI left institution|7|||
131735947|NCT01697267|474311070|FG000|Overall Study|Death|3|||
131735948|NCT01697267|474311071|FG001|Overall Study|Death|1|||
131905281|NCT00266708|474940868|FG001|Overall Study|Asthma|2|||
131905282|NCT01926028|474940869|FG000|Overall Study|Lost to Follow-up|7|||
131905283|NCT01926028|474940870|FG001|Overall Study|Lost to Follow-up|6|||
131735949|NCT01697267|474311070|FG000|Overall Study|Withdrawal by Subject|5|||
131735950|NCT01697267|474311071|FG001|Overall Study|Withdrawal by Subject|5|||
131735951|NCT01697267|474311070|FG000|Overall Study|Adverse Event|2|||
131905284|NCT01926028|474940871|FG002|Overall Study|Lost to Follow-up|0|||
131905285|NCT01926028|474940869|FG000|Overall Study|Physician Decision|1|||
131905286|NCT01926028|474940870|FG001|Overall Study|Physician Decision|5|||
131905287|NCT01926028|474940871|FG002|Overall Study|Physician Decision|0|||
131735952|NCT01697267|474311071|FG001|Overall Study|Adverse Event|1|||
131735953|NCT01697267|474311070|FG000|Overall Study|Lost to Follow-up|2|||
131735954|NCT01697267|474311071|FG001|Overall Study|Lost to Follow-up|4|||
131735955|NCT01697267|474311070|FG000|Overall Study|Physician Decision|2|||
131735956|NCT01697267|474311071|FG001|Overall Study|Physician Decision|4|||
131735957|NCT00568958|474311080|FG000|Allocation|Withdrawal by Subject|7|||
131735958|NCT00568958|474311081|FG001|Allocation|Withdrawal by Subject|3|||
131735959|NCT00568958|474311080|FG000|Allocation|Physician Decision|2|||
131735960|NCT00568958|474311081|FG001|Allocation|Physician Decision|0|||
131735961|NCT00568958|474311080|FG000|Follow-Up|Withdrawal by Subject|6|||
131735962|NCT00568958|474311081|FG001|Follow-Up|Withdrawal by Subject|6|||
131735963|NCT00568958|474311080|FG000|Follow-Up|Physician Decision|1|||
131735964|NCT00568958|474311081|FG001|Follow-Up|Physician Decision|1|||
131735965|NCT00568958|474311080|FG000|Follow-Up|Family Emergency|1|||
131735966|NCT00568958|474311081|FG001|Follow-Up|Family Emergency|0|||
131735967|NCT00568958|474311080|FG000|Follow-Up|Adverse Event|1|||
131735968|NCT00568958|474311081|FG001|Follow-Up|Adverse Event|0|||
131735969|NCT01354353|474311086|FG000|Overall Study|Adverse Event|1|||
131735970|NCT01354353|474311087|FG001|Overall Study|Adverse Event|0|||
131735971|NCT01354353|474311088|FG002|Overall Study|Adverse Event|0|||
131735972|NCT01354353|474311089|FG003|Overall Study|Adverse Event|4|||
131735973|NCT01354353|474311090|FG004|Overall Study|Adverse Event|0|||
131735974|NCT01354353|474311091|FG005|Overall Study|Adverse Event|5|||
131735975|NCT01354353|474311086|FG000|Overall Study|Entry Criteria Not Met|0|||
131735976|NCT01354353|474311087|FG001|Overall Study|Entry Criteria Not Met|0|||
131735977|NCT01354353|474311088|FG002|Overall Study|Entry Criteria Not Met|0|||
131735978|NCT01354353|474311089|FG003|Overall Study|Entry Criteria Not Met|1|||
131735979|NCT01354353|474311090|FG004|Overall Study|Entry Criteria Not Met|1|||
131735980|NCT01354353|474311091|FG005|Overall Study|Entry Criteria Not Met|0|||
131735981|NCT01354353|474311086|FG000|Overall Study|Physician Decision|0|||
131735982|NCT01354353|474311087|FG001|Overall Study|Physician Decision|1|||
131735983|NCT01354353|474311088|FG002|Overall Study|Physician Decision|1|||
131735984|NCT01354353|474311089|FG003|Overall Study|Physician Decision|0|||
131735985|NCT01354353|474311090|FG004|Overall Study|Physician Decision|0|||
131735986|NCT01354353|474311091|FG005|Overall Study|Physician Decision|0|||
131735987|NCT01354353|474311086|FG000|Overall Study|Withdrawal by Subject|2|||
131735988|NCT01354353|474311087|FG001|Overall Study|Withdrawal by Subject|0|||
131735989|NCT01354353|474311088|FG002|Overall Study|Withdrawal by Subject|1|||
131735990|NCT01354353|474311089|FG003|Overall Study|Withdrawal by Subject|0|||
131735991|NCT01354353|474311090|FG004|Overall Study|Withdrawal by Subject|0|||
131735992|NCT01354353|474311091|FG005|Overall Study|Withdrawal by Subject|1|||
131735993|NCT02681055|474311092|FG000|Weeks 5-12|Adverse Event|1|||
131735994|NCT02156492|474311095|FG000|Period 1|No Reason Given|0|||
131735995|NCT02156492|474311096|FG001|Period 1|No Reason Given|1|||
131735996|NCT02156492|474311097|FG002|Period 1|No Reason Given|0|||
131735997|NCT02156492|474311095|FG000|Period 3|Adverse Event|0|||
131735998|NCT02156492|474311096|FG001|Period 3|Adverse Event|1|||
131735999|NCT02156492|474311097|FG002|Period 3|Adverse Event|0|||
131736000|NCT00839423|474311098|FG000|Overall Study|Adverse Event|4|||
131736001|NCT00839423|474311099|FG001|Overall Study|Adverse Event|3|||
131736002|NCT00839423|474311100|FG002|Overall Study|Adverse Event|7|||
131736003|NCT00839423|474311101|FG003|Overall Study|Adverse Event|16|||
131736004|NCT00839423|474311098|FG000|Overall Study|Lack of Efficacy|6|||
131736005|NCT00839423|474311099|FG001|Overall Study|Lack of Efficacy|6|||
131736006|NCT00839423|474311100|FG002|Overall Study|Lack of Efficacy|3|||
131736007|NCT00839423|474311101|FG003|Overall Study|Lack of Efficacy|2|||
131736008|NCT00839423|474311098|FG000|Overall Study|Non-compliance|0|||
131736009|NCT00839423|474311099|FG001|Overall Study|Non-compliance|0|||
131736010|NCT00839423|474311100|FG002|Overall Study|Non-compliance|0|||
131736011|NCT00839423|474311101|FG003|Overall Study|Non-compliance|1|||
131736012|NCT00839423|474311098|FG000|Overall Study|Protocol Violation|0|||
131736013|NCT00839423|474311099|FG001|Overall Study|Protocol Violation|1|||
131736014|NCT00839423|474311100|FG002|Overall Study|Protocol Violation|2|||
131736015|NCT00839423|474311101|FG003|Overall Study|Protocol Violation|0|||
131736016|NCT00839423|474311098|FG000|Overall Study|Withdrawal of consent|4|||
131736017|NCT00839423|474311099|FG001|Overall Study|Withdrawal of consent|0|||
131736018|NCT00839423|474311100|FG002|Overall Study|Withdrawal of consent|4|||
131736019|NCT00839423|474311101|FG003|Overall Study|Withdrawal of consent|1|||
131736020|NCT00839423|474311098|FG000|Overall Study|Lost to Follow-up|1|||
131736021|NCT00839423|474311099|FG001|Overall Study|Lost to Follow-up|0|||
131736022|NCT00839423|474311100|FG002|Overall Study|Lost to Follow-up|1|||
131736023|NCT00839423|474311101|FG003|Overall Study|Lost to Follow-up|0|||
131736024|NCT00839423|474311098|FG000|Overall Study|Administrative or other reasons|3|||
131736025|NCT00839423|474311099|FG001|Overall Study|Administrative or other reasons|0|||
131736026|NCT00839423|474311100|FG002|Overall Study|Administrative or other reasons|1|||
131736027|NCT00839423|474311101|FG003|Overall Study|Administrative or other reasons|0|||
131736028|NCT01071096|474311102|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
131736029|NCT01071096|474311103|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
131736030|NCT04348656|474311104|FG000|Overall Study|Withdrawal by Subject|2|||
131736031|NCT04348656|474311105|FG001|Overall Study|Withdrawal by Subject|0|||
131736032|NCT04348656|474311104|FG000|Overall Study|Lost to Follow-up|11|||
131736033|NCT04348656|474311105|FG001|Overall Study|Lost to Follow-up|6|||
131736034|NCT03072719|474311110|FG000|Overall Study|Adverse Event|1|||
131736035|NCT03072719|474311111|FG001|Overall Study|Adverse Event|1|||
131736036|NCT00882999|474311113|FG000|Overall Study|Adverse Event|0|||
131736037|NCT00882999|474311114|FG001|Overall Study|Adverse Event|0|||
131736038|NCT00882999|474311115|FG002|Overall Study|Adverse Event|0|||
131736039|NCT00882999|474311116|FG003|Overall Study|Adverse Event|0|||
131736040|NCT00882999|474311117|FG004|Overall Study|Adverse Event|1|||
131736041|NCT00882999|474311118|FG005|Overall Study|Adverse Event|0|||
131736042|NCT00882999|474311119|FG006|Overall Study|Adverse Event|0|||
131736043|NCT00882999|474311113|FG000|Overall Study|Death|0|||
131736044|NCT00882999|474311114|FG001|Overall Study|Death|1|||
131736045|NCT00882999|474311115|FG002|Overall Study|Death|0|||
131736046|NCT00882999|474311116|FG003|Overall Study|Death|0|||
131736047|NCT00882999|474311117|FG004|Overall Study|Death|0|||
131736048|NCT00882999|474311118|FG005|Overall Study|Death|0|||
131736049|NCT00882999|474311119|FG006|Overall Study|Death|0|||
131736050|NCT00882999|474311113|FG000|Overall Study|Withdrawal by Subject|7|||
131736051|NCT00882999|474311114|FG001|Overall Study|Withdrawal by Subject|6|||
131736052|NCT00882999|474311115|FG002|Overall Study|Withdrawal by Subject|3|||
131736053|NCT00882999|474311116|FG003|Overall Study|Withdrawal by Subject|3|||
131736054|NCT00882999|474311117|FG004|Overall Study|Withdrawal by Subject|6|||
131736055|NCT00882999|474311118|FG005|Overall Study|Withdrawal by Subject|5|||
131736056|NCT00882999|474311119|FG006|Overall Study|Withdrawal by Subject|5|||
131736057|NCT00882999|474311113|FG000|Overall Study|Lost to Follow-up|0|||
131736058|NCT00882999|474311114|FG001|Overall Study|Lost to Follow-up|1|||
131736059|NCT00882999|474311115|FG002|Overall Study|Lost to Follow-up|1|||
131736060|NCT00882999|474311116|FG003|Overall Study|Lost to Follow-up|2|||
131736061|NCT00882999|474311117|FG004|Overall Study|Lost to Follow-up|1|||
131736062|NCT00882999|474311118|FG005|Overall Study|Lost to Follow-up|1|||
131736063|NCT00882999|474311119|FG006|Overall Study|Lost to Follow-up|2|||
131736064|NCT00882999|474311113|FG000|Overall Study|Physician Decision|1|||
131736065|NCT00882999|474311114|FG001|Overall Study|Physician Decision|0|||
131736066|NCT00882999|474311115|FG002|Overall Study|Physician Decision|0|||
131736067|NCT00882999|474311116|FG003|Overall Study|Physician Decision|0|||
131736068|NCT00882999|474311117|FG004|Overall Study|Physician Decision|0|||
131736069|NCT00882999|474311118|FG005|Overall Study|Physician Decision|1|||
131736070|NCT00882999|474311119|FG006|Overall Study|Physician Decision|1|||
131736071|NCT01104584|474311120|FG000|Overall Study|Study drug never administered|21|||
131736072|NCT01104584|474311120|FG000|Overall Study|Study prematurely discontinued|2|||
131736073|NCT02387372|474311123|FG000|Overall Study|Not Treated|1|||
131736074|NCT02387372|474311124|FG001|Overall Study|Not Treated|0|||
131736075|NCT00937560|474311125|FG000|Initial Treatment|Death|6|||
131736076|NCT00937560|474311125|FG000|Initial Treatment|Withdraw consent|3|||
131736077|NCT00937560|474311125|FG000|Initial Treatment|Adverse Event|1|||
131736078|NCT00937560|474311125|FG000|Initial Treatment|Lost to Follow-up|1|||
131736079|NCT00937560|474311125|FG000|Initial Treatment|No end of study page|10|||
131736080|NCT00937560|474311125|FG000|Maintenance Treatment|Death|12|||
131736081|NCT00937560|474311125|FG000|Maintenance Treatment|Withdraw consent|5|||
131736082|NCT00937560|474311125|FG000|Maintenance Treatment|According to protocol|1|||
131736083|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
131736084|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
131736085|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
131736086|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
131736087|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
131736088|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
131736089|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
131736090|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
131736091|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
131736092|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
131736093|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
131736094|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
131736095|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
131736096|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
131736097|NCT00848549|474311126|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
131736098|NCT00848549|474311127|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
131736099|NCT00848549|474311126|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
131736100|NCT00848549|474311127|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
131736101|NCT00848549|474311126|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
131736102|NCT00848549|474311127|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
131736103|NCT00848549|474311126|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
131736104|NCT00848549|474311127|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
131736105|NCT00848549|474311126|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
131736106|NCT00848549|474311127|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
131736107|NCT00848549|474311126|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
131736108|NCT00848549|474311127|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
131736109|NCT00848549|474311126|FG000|E2090-E044-314 (Extension Study)|Other|5|||
131736110|NCT00848549|474311127|FG001|E2090-E044-314 (Extension Study)|Other|6|||
131736111|NCT02561299|474311128|FG000|Overall Study|Death|2|||
131736112|NCT02561299|474311129|FG001|Overall Study|Death|4|||
131736113|NCT02561299|474311128|FG000|Overall Study|Lost to Follow-up|1|||
131736114|NCT02561299|474311129|FG001|Overall Study|Lost to Follow-up|0|||
131736115|NCT02561299|474311128|FG000|Overall Study|Withdrawal by Subject|2|||
131736116|NCT02561299|474311129|FG001|Overall Study|Withdrawal by Subject|2|||
131736117|NCT02106455|474311140|FG000|Overall Study|Case Report Form Uncollected|6|||
131736118|NCT02106455|474311140|FG000|Overall Study|Protocol Deviation|2|||
131736119|NCT00501046|474311141|FG000|Overall Study|Adverse Event|21|||
131736120|NCT00501046|474311142|FG001|Overall Study|Adverse Event|25|||
131736121|NCT00501046|474311141|FG000|Overall Study|Death|23|||
131736122|NCT00501046|474311142|FG001|Overall Study|Death|30|||
131736123|NCT00501046|474311141|FG000|Overall Study|Lost to Follow-up|14|||
131736124|NCT00501046|474311142|FG001|Overall Study|Lost to Follow-up|13|||
131736125|NCT00501046|474311141|FG000|Overall Study|Physician Decision|7|||
131736126|NCT00501046|474311142|FG001|Overall Study|Physician Decision|2|||
131736127|NCT00501046|474311141|FG000|Overall Study|Pregnancy|0|||
131736128|NCT00501046|474311142|FG001|Overall Study|Pregnancy|3|||
131736129|NCT00501046|474311141|FG000|Overall Study|Protocol Violation|2|||
131736130|NCT00501046|474311142|FG001|Overall Study|Protocol Violation|1|||
131736131|NCT00501046|474311141|FG000|Overall Study|Withdrawal by Subject|84|||
131736132|NCT00501046|474311142|FG001|Overall Study|Withdrawal by Subject|83|||
131736133|NCT00501046|474311141|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
131736134|NCT00501046|474311142|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
131736135|NCT01576016|474311146|FG000|Lead Safety|Death|132|||
131736136|NCT01576016|474311147|FG001|Lead Safety|Death|0|||
131736137|NCT01576016|474311146|FG000|Lead Safety|Withdrawal by Subject|81|||
131736138|NCT01576016|474311147|FG001|Lead Safety|Withdrawal by Subject|0|||
131736139|NCT01576016|474311146|FG000|Lead Safety|System Explanted without Replacement|24|||
131736140|NCT01576016|474311147|FG001|Lead Safety|System Explanted without Replacement|0|||
131736141|NCT01576016|474311146|FG000|Lead Safety|Physician Decision|14|||
131736142|NCT01576016|474311147|FG001|Lead Safety|Physician Decision|0|||
131736143|NCT01576016|474311146|FG000|Lead Safety|Lost to Follow-up|13|||
131736144|NCT01576016|474311147|FG001|Lead Safety|Lost to Follow-up|0|||
131736145|NCT01576016|474311146|FG000|Lead Safety|Unsuccessful implant|2|||
131736146|NCT01576016|474311147|FG001|Lead Safety|Unsuccessful implant|0|||
131736147|NCT01576016|474311146|FG000|Lead Safety|Sponsor request|1|||
131736148|NCT01576016|474311147|FG001|Lead Safety|Sponsor request|0|||
131736149|NCT01576016|474311146|FG000|Lead Safety|Device replaced with CRT-D|1|||
131736150|NCT01576016|474311147|FG001|Lead Safety|Device replaced with CRT-D|0|||
131736151|NCT01576016|474311146|FG000|Lead Safety|Patient on Palliative Care|1|||
131736152|NCT01576016|474311147|FG001|Lead Safety|Patient on Palliative Care|0|||
131736153|NCT01576016|474311146|FG000|Lead Safety|Patient noncompliance|1|||
131736154|NCT01576016|474311147|FG001|Lead Safety|Patient noncompliance|0|||
131736155|NCT01576016|474311146|FG000|Lead Safety|Too far from study site|1|||
131807939|NCT02272777|474582880|FG000|Overall Study|Lost to Follow-up|2|||
131736156|NCT01576016|474311147|FG001|Lead Safety|Too far from study site|0|||
131736157|NCT01576016|474311146|FG000|Lead Safety|System deactivated|1|||
131736158|NCT01576016|474311147|FG001|Lead Safety|System deactivated|0|||
131736159|NCT01576016|474311146|FG000|Lead Safety|Patient no longer followed by study PI|1|||
131807940|NCT02272777|474582881|FG001|Overall Study|Lost to Follow-up|0|||
131736160|NCT01576016|474311147|FG001|Lead Safety|Patient no longer followed by study PI|0|||
131736161|NCT01576016|474311146|FG000|MRI Safety|Withdrawal by Subject|0|||
131736162|NCT01576016|474311147|FG001|MRI Safety|Withdrawal by Subject|10|||
131736163|NCT01576016|474311146|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
131736164|NCT01576016|474311147|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
131736165|NCT01576016|474311146|FG000|MRI Safety|Has not yet completed MRI scan|0|||
131736166|NCT01576016|474311147|FG001|MRI Safety|Has not yet completed MRI scan|56|||
131736167|NCT01576016|474311146|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
131736168|NCT01576016|474311147|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
131736169|NCT02488551|474311150|FG000|Overall Study|Lost to Follow-up|4|||
131736170|NCT02488551|474311151|FG001|Overall Study|Lost to Follow-up|7|||
131807941|NCT02272777|474582880|FG000|Overall Study|Other|2|||
131736171|NCT02488551|474311152|FG002|Overall Study|Lost to Follow-up|0|||
131736172|NCT02488551|474311153|FG003|Overall Study|Lost to Follow-up|0|||
131736173|NCT02488551|474311150|FG000|Overall Study|Military Deployment|1|||
131736174|NCT02488551|474311151|FG001|Overall Study|Military Deployment|1|||
131736175|NCT02488551|474311152|FG002|Overall Study|Military Deployment|0|||
131736176|NCT02488551|474311153|FG003|Overall Study|Military Deployment|0|||
131736177|NCT02546674|474311164|FG000|Overall Study|Adverse Event|19|||
131736178|NCT02546674|474311164|FG000|Overall Study|Death|1|||
131736179|NCT02546674|474311164|FG000|Overall Study|Lost to Follow-up|1|||
131736180|NCT02546674|474311164|FG000|Overall Study|Physician Decision|13|||
131736181|NCT02546674|474311164|FG000|Overall Study|Pregnancy|1|||
131736182|NCT02546674|474311164|FG000|Overall Study|Progressive Disease|2|||
131736183|NCT02546674|474311164|FG000|Overall Study|Protocol Deviation|2|||
131736184|NCT02546674|474311164|FG000|Overall Study|Subject/Guardian Decision|6|||
131736185|NCT02546674|474311164|FG000|Overall Study|Withdrawal of Informed Consent|3|||
131736186|NCT02864940|474311169|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
131736187|NCT02864940|474311170|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
131736188|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
131736189|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736190|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736191|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736192|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736193|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736194|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131807942|NCT02272777|474582881|FG001|Overall Study|Other|0|||
131807943|NCT02066922|474582886|FG000|Overall Study|Adverse Event|1|||
131807944|NCT05275205|474582888|FG000|Overall Study|Adverse Event|1|||
131807945|NCT05275205|474582889|FG001|Overall Study|Adverse Event|2|||
131807946|NCT05275205|474582888|FG000|Overall Study|Physician Decision|1|||
131807947|NCT05275205|474582889|FG001|Overall Study|Physician Decision|1|||
131736195|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736196|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131736197|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
131736198|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736199|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736200|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736201|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736202|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736203|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736204|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736205|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131736206|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
131736207|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736208|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736209|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736210|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736211|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736212|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736213|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736214|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131736215|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
131736216|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736217|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736218|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736219|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736220|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736221|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736222|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
131736223|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
131807948|NCT05275205|474582888|FG000|Overall Study|Withdrawal by Subject|2|||
131807949|NCT05275205|474582889|FG001|Overall Study|Withdrawal by Subject|3|||
131807950|NCT05275205|474582888|FG000|Overall Study|Death|1|||
131807951|NCT05275205|474582889|FG001|Overall Study|Death|0|||
131807952|NCT05275205|474582888|FG000|Overall Study|Patient unable to attend visits|1|||
131807953|NCT05275205|474582889|FG001|Overall Study|Patient unable to attend visits|0|||
131736224|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
131736225|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736226|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131807954|NCT00440297|474582890|FG000|Overall Study|Adverse Event|8|||
131807955|NCT00440297|474582891|FG001|Overall Study|Adverse Event|5|||
131736227|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736228|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736229|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736230|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736231|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736232|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131736233|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
131736234|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736235|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736236|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736237|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736238|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736239|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736240|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736241|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131736242|NCT02175771|474311171|FG000|Run-In Period (Pre-assignment)|Other|8|||
131736243|NCT02175771|474311172|FG001|Run-In Period (Pre-assignment)|Other|0|||
131736244|NCT02175771|474311173|FG002|Run-In Period (Pre-assignment)|Other|0|||
131736245|NCT02175771|474311174|FG003|Run-In Period (Pre-assignment)|Other|0|||
131736246|NCT02175771|474311175|FG004|Run-In Period (Pre-assignment)|Other|0|||
131736247|NCT02175771|474311176|FG005|Run-In Period (Pre-assignment)|Other|0|||
131736248|NCT02175771|474311177|FG006|Run-In Period (Pre-assignment)|Other|0|||
131736249|NCT02175771|474311178|FG007|Run-In Period (Pre-assignment)|Other|0|||
131736250|NCT02175771|474311179|FG008|Run-In Period (Pre-assignment)|Other|0|||
131736251|NCT02175771|474311171|FG000|Treatment Period|Adverse Event|0|||
131736252|NCT02175771|474311172|FG001|Treatment Period|Adverse Event|2|||
131736253|NCT02175771|474311173|FG002|Treatment Period|Adverse Event|1|||
131736254|NCT02175771|474311174|FG003|Treatment Period|Adverse Event|1|||
131736255|NCT02175771|474311175|FG004|Treatment Period|Adverse Event|1|||
131736256|NCT02175771|474311176|FG005|Treatment Period|Adverse Event|3|||
131736257|NCT02175771|474311177|FG006|Treatment Period|Adverse Event|2|||
131736258|NCT02175771|474311178|FG007|Treatment Period|Adverse Event|0|||
131736259|NCT02175771|474311179|FG008|Treatment Period|Adverse Event|1|||
131736260|NCT02175771|474311171|FG000|Treatment Period|Withdrawal by Subject|0|||
131736261|NCT02175771|474311172|FG001|Treatment Period|Withdrawal by Subject|9|||
131736262|NCT02175771|474311173|FG002|Treatment Period|Withdrawal by Subject|3|||
131736263|NCT02175771|474311174|FG003|Treatment Period|Withdrawal by Subject|6|||
131736264|NCT02175771|474311175|FG004|Treatment Period|Withdrawal by Subject|2|||
131736265|NCT02175771|474311176|FG005|Treatment Period|Withdrawal by Subject|4|||
131736266|NCT02175771|474311177|FG006|Treatment Period|Withdrawal by Subject|2|||
131736267|NCT02175771|474311178|FG007|Treatment Period|Withdrawal by Subject|9|||
131736268|NCT02175771|474311179|FG008|Treatment Period|Withdrawal by Subject|2|||
131736269|NCT02175771|474311171|FG000|Treatment Period|Noncompliance|0|||
131736270|NCT02175771|474311172|FG001|Treatment Period|Noncompliance|1|||
131736271|NCT02175771|474311173|FG002|Treatment Period|Noncompliance|2|||
131736272|NCT02175771|474311174|FG003|Treatment Period|Noncompliance|0|||
131736273|NCT02175771|474311175|FG004|Treatment Period|Noncompliance|0|||
131736274|NCT02175771|474311176|FG005|Treatment Period|Noncompliance|0|||
131736275|NCT02175771|474311177|FG006|Treatment Period|Noncompliance|0|||
131736276|NCT02175771|474311178|FG007|Treatment Period|Noncompliance|0|||
131736277|NCT02175771|474311179|FG008|Treatment Period|Noncompliance|1|||
131736278|NCT02175771|474311171|FG000|Treatment Period|Protocol Violation|0|||
131736279|NCT02175771|474311172|FG001|Treatment Period|Protocol Violation|0|||
131736280|NCT02175771|474311173|FG002|Treatment Period|Protocol Violation|0|||
131736281|NCT02175771|474311174|FG003|Treatment Period|Protocol Violation|0|||
131736282|NCT02175771|474311175|FG004|Treatment Period|Protocol Violation|0|||
131736283|NCT02175771|474311176|FG005|Treatment Period|Protocol Violation|0|||
131736284|NCT02175771|474311177|FG006|Treatment Period|Protocol Violation|0|||
131736285|NCT02175771|474311178|FG007|Treatment Period|Protocol Violation|1|||
131736286|NCT02175771|474311179|FG008|Treatment Period|Protocol Violation|0|||
131736287|NCT02175771|474311171|FG000|Treatment Period|Disease progression|0|||
131736288|NCT02175771|474311172|FG001|Treatment Period|Disease progression|0|||
131736289|NCT02175771|474311173|FG002|Treatment Period|Disease progression|0|||
131736290|NCT02175771|474311174|FG003|Treatment Period|Disease progression|0|||
131736291|NCT02175771|474311175|FG004|Treatment Period|Disease progression|0|||
131736292|NCT02175771|474311176|FG005|Treatment Period|Disease progression|0|||
131736293|NCT02175771|474311177|FG006|Treatment Period|Disease progression|0|||
131736294|NCT02175771|474311178|FG007|Treatment Period|Disease progression|2|||
131736295|NCT02175771|474311179|FG008|Treatment Period|Disease progression|0|||
131736296|NCT02175771|474311171|FG000|Treatment Period|Lost to Follow-up|0|||
131736297|NCT02175771|474311172|FG001|Treatment Period|Lost to Follow-up|3|||
131736298|NCT02175771|474311173|FG002|Treatment Period|Lost to Follow-up|1|||
131736299|NCT02175771|474311174|FG003|Treatment Period|Lost to Follow-up|3|||
131736300|NCT02175771|474311175|FG004|Treatment Period|Lost to Follow-up|1|||
131736301|NCT02175771|474311176|FG005|Treatment Period|Lost to Follow-up|2|||
131736302|NCT02175771|474311177|FG006|Treatment Period|Lost to Follow-up|1|||
131736303|NCT02175771|474311178|FG007|Treatment Period|Lost to Follow-up|2|||
131736304|NCT02175771|474311179|FG008|Treatment Period|Lost to Follow-up|2|||
131736305|NCT02175771|474311171|FG000|Treatment Period|Lack of Efficacy|0|||
131736306|NCT02175771|474311172|FG001|Treatment Period|Lack of Efficacy|0|||
131736307|NCT02175771|474311173|FG002|Treatment Period|Lack of Efficacy|0|||
131736308|NCT02175771|474311174|FG003|Treatment Period|Lack of Efficacy|0|||
131736309|NCT02175771|474311175|FG004|Treatment Period|Lack of Efficacy|0|||
131736310|NCT02175771|474311176|FG005|Treatment Period|Lack of Efficacy|1|||
131736311|NCT02175771|474311177|FG006|Treatment Period|Lack of Efficacy|0|||
131736312|NCT02175771|474311178|FG007|Treatment Period|Lack of Efficacy|1|||
131736313|NCT02175771|474311179|FG008|Treatment Period|Lack of Efficacy|0|||
131736314|NCT02175771|474311171|FG000|Treatment Period|Other|0|||
131736315|NCT02175771|474311172|FG001|Treatment Period|Other|1|||
131736316|NCT02175771|474311173|FG002|Treatment Period|Other|0|||
131736317|NCT02175771|474311174|FG003|Treatment Period|Other|3|||
131736318|NCT02175771|474311175|FG004|Treatment Period|Other|1|||
131736319|NCT02175771|474311176|FG005|Treatment Period|Other|0|||
131736320|NCT02175771|474311177|FG006|Treatment Period|Other|0|||
131736321|NCT02175771|474311178|FG007|Treatment Period|Other|2|||
131736322|NCT02175771|474311179|FG008|Treatment Period|Other|0|||
131736323|NCT03364673|474311180|FG000|Overall Study|Withdrawal by Subject|2|||
131736324|NCT03364673|474311180|FG000|Overall Study|Injury unrelated to study|3|||
131736325|NCT02232087|474311181|FG000|Overall Study|Withdrawal by Subject|2|||
131736326|NCT02232087|474311182|FG001|Overall Study|Withdrawal by Subject|0|||
131736327|NCT02232087|474311183|FG002|Overall Study|Withdrawal by Subject|0|||
131736328|NCT02232087|474311184|FG003|Overall Study|Withdrawal by Subject|0|||
131736329|NCT02232087|474311185|FG004|Overall Study|Withdrawal by Subject|0|||
131736330|NCT02232087|474311186|FG005|Overall Study|Withdrawal by Subject|1|||
131736331|NCT02232087|474311181|FG000|Overall Study|poor inhalation technique|0|||
131736332|NCT02232087|474311182|FG001|Overall Study|poor inhalation technique|1|||
131736333|NCT02232087|474311183|FG002|Overall Study|poor inhalation technique|0|||
131736334|NCT02232087|474311184|FG003|Overall Study|poor inhalation technique|0|||
131736335|NCT02232087|474311185|FG004|Overall Study|poor inhalation technique|0|||
131736336|NCT02232087|474311186|FG005|Overall Study|poor inhalation technique|2|||
131736337|NCT02232087|474311181|FG000|Overall Study|protocol stop criteria|0|||
131736338|NCT02232087|474311182|FG001|Overall Study|protocol stop criteria|1|||
131736339|NCT02232087|474311183|FG002|Overall Study|protocol stop criteria|0|||
131736340|NCT02232087|474311184|FG003|Overall Study|protocol stop criteria|1|||
131736341|NCT02232087|474311185|FG004|Overall Study|protocol stop criteria|0|||
131736342|NCT02232087|474311186|FG005|Overall Study|protocol stop criteria|0|||
131736343|NCT02232087|474311181|FG000|Overall Study|Adverse Event|0|||
131736344|NCT02232087|474311182|FG001|Overall Study|Adverse Event|0|||
131736345|NCT02232087|474311183|FG002|Overall Study|Adverse Event|0|||
131736346|NCT02232087|474311184|FG003|Overall Study|Adverse Event|0|||
131736347|NCT02232087|474311185|FG004|Overall Study|Adverse Event|1|||
131736348|NCT02232087|474311186|FG005|Overall Study|Adverse Event|0|||
131736349|NCT02208024|474311187|FG000|Overall Study|Withdrawal by Subject|1|||
131736350|NCT04096326|474311188|FG000|Overall Study|Withdrawal by Subject|0|||
131736351|NCT04096326|474311189|FG001|Overall Study|Withdrawal by Subject|0|||
131736352|NCT04096326|474311190|FG002|Overall Study|Withdrawal by Subject|0|||
131736353|NCT04096326|474311191|FG003|Overall Study|Withdrawal by Subject|0|||
131736354|NCT04096326|474311192|FG004|Overall Study|Withdrawal by Subject|0|||
131736355|NCT04096326|474311193|FG005|Overall Study|Withdrawal by Subject|0|||
131736356|NCT04096326|474311194|FG006|Overall Study|Withdrawal by Subject|1|||
131736357|NCT04096326|474311195|FG007|Overall Study|Withdrawal by Subject|0|||
131736358|NCT04096326|474311196|FG008|Overall Study|Withdrawal by Subject|0|||
131736359|NCT04096326|474311197|FG009|Overall Study|Withdrawal by Subject|0|||
131736360|NCT04096326|474311188|FG000|Overall Study|Lost to Follow-up|0|||
131736361|NCT04096326|474311189|FG001|Overall Study|Lost to Follow-up|1|||
131736362|NCT04096326|474311190|FG002|Overall Study|Lost to Follow-up|0|||
131736363|NCT04096326|474311191|FG003|Overall Study|Lost to Follow-up|0|||
131736364|NCT04096326|474311192|FG004|Overall Study|Lost to Follow-up|0|||
131736365|NCT04096326|474311193|FG005|Overall Study|Lost to Follow-up|0|||
131736366|NCT04096326|474311194|FG006|Overall Study|Lost to Follow-up|0|||
131736367|NCT04096326|474311195|FG007|Overall Study|Lost to Follow-up|0|||
131736368|NCT04096326|474311196|FG008|Overall Study|Lost to Follow-up|0|||
131736369|NCT04096326|474311197|FG009|Overall Study|Lost to Follow-up|0|||
131736370|NCT04096326|474311188|FG000|Overall Study|COVID-19-related reasons|0|||
131736371|NCT04096326|474311189|FG001|Overall Study|COVID-19-related reasons|0|||
131736372|NCT04096326|474311190|FG002|Overall Study|COVID-19-related reasons|0|||
131736373|NCT04096326|474311191|FG003|Overall Study|COVID-19-related reasons|0|||
131736374|NCT04096326|474311192|FG004|Overall Study|COVID-19-related reasons|1|||
131736375|NCT04096326|474311193|FG005|Overall Study|COVID-19-related reasons|5|||
131736376|NCT04096326|474311194|FG006|Overall Study|COVID-19-related reasons|0|||
131736377|NCT04096326|474311195|FG007|Overall Study|COVID-19-related reasons|0|||
131736378|NCT04096326|474311196|FG008|Overall Study|COVID-19-related reasons|0|||
131736379|NCT04096326|474311197|FG009|Overall Study|COVID-19-related reasons|0|||
131736380|NCT00194025|474311198|FG000|Overall Study|Adverse Event|1|||
131736381|NCT00194025|474311198|FG000|Overall Study|non-adherence with study medication|4|||
131736382|NCT04804033|474311200|FG000|Period 1: DBT Phase|Adverse Event|1|||
131736383|NCT04804033|474311201|FG001|Period 1: DBT Phase|Adverse Event|5|||
131736384|NCT04804033|474311202|FG002|Period 1: DBT Phase|Adverse Event|3|||
131736385|NCT04804033|474311203|FG003|Period 1: DBT Phase|Adverse Event|4|||
131736386|NCT04804033|474311200|FG000|Period 1: DBT Phase|Death|1|||
131736387|NCT04804033|474311201|FG001|Period 1: DBT Phase|Death|0|||
131736388|NCT04804033|474311202|FG002|Period 1: DBT Phase|Death|0|||
131736389|NCT04804033|474311203|FG003|Period 1: DBT Phase|Death|0|||
131736390|NCT04804033|474311200|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
131736391|NCT04804033|474311201|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
131736392|NCT04804033|474311202|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
131736393|NCT04804033|474311203|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
131736394|NCT04804033|474311200|FG000|Period 1: DBT Phase|Non-compliance|1|||
131736395|NCT04804033|474311201|FG001|Period 1: DBT Phase|Non-compliance|0|||
131736396|NCT04804033|474311202|FG002|Period 1: DBT Phase|Non-compliance|1|||
131736397|NCT04804033|474311203|FG003|Period 1: DBT Phase|Non-compliance|2|||
131736398|NCT04804033|474311200|FG000|Period 1: DBT Phase|Other|0|||
131736399|NCT04804033|474311201|FG001|Period 1: DBT Phase|Other|1|||
131736400|NCT04804033|474311202|FG002|Period 1: DBT Phase|Other|0|||
131736401|NCT04804033|474311203|FG003|Period 1: DBT Phase|Other|0|||
131736402|NCT04804033|474311200|FG000|Period 1: DBT Phase|Pregnancy|2|||
131736403|NCT04804033|474311201|FG001|Period 1: DBT Phase|Pregnancy|0|||
131736404|NCT04804033|474311202|FG002|Period 1: DBT Phase|Pregnancy|0|||
131736405|NCT04804033|474311203|FG003|Period 1: DBT Phase|Pregnancy|0|||
131736406|NCT04804033|474311200|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
131736407|NCT04804033|474311201|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
131736408|NCT04804033|474311202|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
131736409|NCT04804033|474311203|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
131736410|NCT04804033|474311200|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
131736411|NCT04804033|474311201|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
131736412|NCT04804033|474311202|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
131736413|NCT04804033|474311203|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
131736414|NCT04804033|474311200|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
131736415|NCT04804033|474311201|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
131736416|NCT04804033|474311202|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
131736417|NCT04804033|474311203|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
131736418|NCT04804033|474311200|FG000|Period 2: OLE Phase|Adverse Event|3|||
131736419|NCT04804033|474311201|FG001|Period 2: OLE Phase|Adverse Event|4|||
131736420|NCT04804033|474311202|FG002|Period 2: OLE Phase|Adverse Event|2|||
131736421|NCT04804033|474311203|FG003|Period 2: OLE Phase|Adverse Event|0|||
131736422|NCT04804033|474311200|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
131736423|NCT04804033|474311201|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
131736424|NCT04804033|474311202|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
131736425|NCT04804033|474311203|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
131736426|NCT04804033|474311200|FG000|Period 2: OLE Phase|Non-compliance|2|||
131736427|NCT04804033|474311201|FG001|Period 2: OLE Phase|Non-compliance|2|||
131736428|NCT04804033|474311202|FG002|Period 2: OLE Phase|Non-compliance|0|||
131736429|NCT04804033|474311203|FG003|Period 2: OLE Phase|Non-compliance|1|||
131736430|NCT04804033|474311200|FG000|Period 2: OLE Phase|Other|0|||
131736431|NCT04804033|474311201|FG001|Period 2: OLE Phase|Other|2|||
131736432|NCT04804033|474311202|FG002|Period 2: OLE Phase|Other|0|||
131736433|NCT04804033|474311203|FG003|Period 2: OLE Phase|Other|0|||
131736434|NCT04804033|474311200|FG000|Period 2: OLE Phase|Physician Decision|1|||
131736435|NCT04804033|474311201|FG001|Period 2: OLE Phase|Physician Decision|1|||
131736436|NCT04804033|474311202|FG002|Period 2: OLE Phase|Physician Decision|0|||
131736437|NCT04804033|474311203|FG003|Period 2: OLE Phase|Physician Decision|0|||
131736438|NCT04804033|474311200|FG000|Period 2: OLE Phase|Pregnancy|0|||
131736439|NCT04804033|474311201|FG001|Period 2: OLE Phase|Pregnancy|0|||
131736440|NCT04804033|474311202|FG002|Period 2: OLE Phase|Pregnancy|2|||
131807956|NCT00440297|474582890|FG000|Overall Study|Lost to Follow-up|1|||
131807957|NCT00440297|474582891|FG001|Overall Study|Lost to Follow-up|0|||
131736441|NCT04804033|474311203|FG003|Period 2: OLE Phase|Pregnancy|0|||
131736442|NCT04804033|474311200|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
131736443|NCT04804033|474311201|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
131736444|NCT04804033|474311202|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
131807958|NCT00440297|474582890|FG000|Overall Study|Physician Decision|1|||
131807959|NCT00440297|474582891|FG001|Overall Study|Physician Decision|0|||
131807960|NCT00440297|474582890|FG000|Overall Study|Protocol Violation|11|||
131736445|NCT04804033|474311203|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
131736446|NCT04804033|474311200|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
131736447|NCT04804033|474311201|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
131736448|NCT04804033|474311202|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
131736449|NCT04804033|474311203|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
131736450|NCT04804033|474311200|FG000|Period 2: OLE Phase|Not reported|0|||
131736451|NCT04804033|474311201|FG001|Period 2: OLE Phase|Not reported|2|||
131736452|NCT04804033|474311202|FG002|Period 2: OLE Phase|Not reported|0|||
131736453|NCT04804033|474311203|FG003|Period 2: OLE Phase|Not reported|0|||
131736454|NCT04804033|474311200|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
131736455|NCT04804033|474311201|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
131736456|NCT04804033|474311202|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
131736457|NCT04804033|474311203|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
131736458|NCT04804033|474311200|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
131736459|NCT04804033|474311201|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
131736460|NCT04804033|474311202|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
131736461|NCT04804033|474311203|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
131736462|NCT04804033|474311200|FG000|Period 3: Follow-up Phase|Other|0|||
131736463|NCT04804033|474311201|FG001|Period 3: Follow-up Phase|Other|1|||
131736464|NCT04804033|474311202|FG002|Period 3: Follow-up Phase|Other|2|||
131736465|NCT04804033|474311203|FG003|Period 3: Follow-up Phase|Other|1|||
131736466|NCT04804033|474311200|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
131736467|NCT04804033|474311201|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
131736468|NCT04804033|474311202|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
131736469|NCT04804033|474311203|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
131736470|NCT04804033|474311200|FG000|Period 3: Follow-up Phase|Not reported|18|||
131736471|NCT04804033|474311201|FG001|Period 3: Follow-up Phase|Not reported|15|||
131736472|NCT04804033|474311202|FG002|Period 3: Follow-up Phase|Not reported|1|||
131736473|NCT04804033|474311203|FG003|Period 3: Follow-up Phase|Not reported|4|||
131736474|NCT00543569|474311204|FG000|Overall Study|Death|2|||
131736475|NCT00543569|474311205|FG001|Overall Study|Death|2|||
131736476|NCT00543569|474311206|FG002|Overall Study|Death|3|||
131736477|NCT00543569|474311207|FG003|Overall Study|Death|1|||
131736478|NCT00543569|474311204|FG000|Overall Study|Lost to Follow-up|0|||
131736479|NCT00543569|474311205|FG001|Overall Study|Lost to Follow-up|0|||
131736480|NCT00543569|474311206|FG002|Overall Study|Lost to Follow-up|1|||
131736481|NCT00543569|474311207|FG003|Overall Study|Lost to Follow-up|1|||
131736482|NCT00543569|474311204|FG000|Overall Study|Miscellaneous Reasons|7|||
131736483|NCT00543569|474311205|FG001|Overall Study|Miscellaneous Reasons|3|||
131736484|NCT00543569|474311206|FG002|Overall Study|Miscellaneous Reasons|11|||
131736485|NCT00543569|474311207|FG003|Overall Study|Miscellaneous Reasons|4|||
131736486|NCT00543569|474311204|FG000|Overall Study|Randomized but never received study drug|3|||
131736487|NCT00543569|474311205|FG001|Overall Study|Randomized but never received study drug|3|||
131736488|NCT00543569|474311206|FG002|Overall Study|Randomized but never received study drug|5|||
131736489|NCT00543569|474311207|FG003|Overall Study|Randomized but never received study drug|3|||
131736490|NCT04570657|474311212|FG000|Overall Study|Adverse Event|0|||
131736491|NCT04570657|474311213|FG001|Overall Study|Adverse Event|0|||
131736492|NCT04570657|474311214|FG002|Overall Study|Adverse Event|1|||
131736493|NCT04570657|474311212|FG000|Overall Study|Lost to Follow-up|0|||
131736494|NCT04570657|474311213|FG001|Overall Study|Lost to Follow-up|0|||
131736495|NCT04570657|474311214|FG002|Overall Study|Lost to Follow-up|1|||
131736496|NCT04570657|474311212|FG000|Overall Study|Physician Decision|0|||
131736497|NCT04570657|474311213|FG001|Overall Study|Physician Decision|1|||
131736498|NCT04570657|474311214|FG002|Overall Study|Physician Decision|0|||
131736499|NCT04570657|474311212|FG000|Overall Study|Withdrawal by Subject|1|||
131736500|NCT04570657|474311213|FG001|Overall Study|Withdrawal by Subject|2|||
131736501|NCT04570657|474311214|FG002|Overall Study|Withdrawal by Subject|2|||
131736502|NCT02020031|474313363|FG000|Overall Study|Physician Decision|1|||
131736503|NCT02020031|474313364|FG001|Overall Study|Physician Decision|1|||
131736504|NCT00424528|474313372|FG000|Overall Study|Adverse Event|2|||
131736505|NCT00424528|474313373|FG001|Overall Study|Adverse Event|1|||
131736506|NCT00424528|474313374|FG002|Overall Study|Adverse Event|2|||
131736507|NCT00424528|474313372|FG000|Overall Study|Protocol Violation|1|||
131736508|NCT00424528|474313373|FG001|Overall Study|Protocol Violation|1|||
131736509|NCT00424528|474313374|FG002|Overall Study|Protocol Violation|0|||
131736510|NCT00424528|474313372|FG000|Overall Study|Lost to Follow-up|0|||
131736511|NCT00424528|474313373|FG001|Overall Study|Lost to Follow-up|1|||
131736512|NCT00424528|474313374|FG002|Overall Study|Lost to Follow-up|0|||
131736513|NCT00424528|474313372|FG000|Overall Study|noncompliance with study requirements|2|||
131736514|NCT00424528|474313373|FG001|Overall Study|noncompliance with study requirements|1|||
131736515|NCT00424528|474313374|FG002|Overall Study|noncompliance with study requirements|2|||
131736516|NCT00967226|474313376|FG000|Overall Study|Adverse Event|0|||
131736517|NCT00967226|474313377|FG001|Overall Study|Adverse Event|5|||
131736518|NCT00967226|474313376|FG000|Overall Study|Protocol Violation|2|||
131736519|NCT00967226|474313377|FG001|Overall Study|Protocol Violation|0|||
131736520|NCT00967226|474313376|FG000|Overall Study|Physician Decision|0|||
131736521|NCT00967226|474313377|FG001|Overall Study|Physician Decision|1|||
131736522|NCT00605722|474313378|FG000|Overall Study|Adverse Event|6|||
131736523|NCT00605722|474313378|FG000|Overall Study|Insufficient therapeutic response|44|||
131736524|NCT00605722|474313378|FG000|Overall Study|Failure to return|1|||
131736525|NCT04031404|474313382|FG000|Baseline|Lost to Follow-up|0|||
131736526|NCT04031404|474313383|FG001|Baseline|Lost to Follow-up|1|||
131807961|NCT00440297|474582891|FG001|Overall Study|Protocol Violation|7|||
131807962|NCT00440297|474582890|FG000|Overall Study|Withdrawal by Subject|1|||
131807963|NCT00440297|474582891|FG001|Overall Study|Withdrawal by Subject|6|||
131807964|NCT00440297|474582890|FG000|Overall Study|Randomized by mistake|1|||
131807965|NCT00440297|474582891|FG001|Overall Study|Randomized by mistake|0|||
131807966|NCT02024932|474582892|FG000|Overall Study|Adverse Event|2|||
131736527|NCT04031404|474313382|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
131736528|NCT04031404|474313383|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
131736529|NCT04031404|474313382|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
131736530|NCT04031404|474313383|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
131736531|NCT04031404|474313382|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
131736532|NCT04031404|474313383|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
131736533|NCT04031404|474313382|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
131736534|NCT04031404|474313383|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
131736535|NCT01626352|474313384|FG000|Overall Study|Disease Progression|3|||
131736536|NCT01626352|474313384|FG000|Overall Study|Intercurrent Illness|2|||
131736537|NCT01626352|474313384|FG000|Overall Study|Death|2|||
131736538|NCT01626352|474313384|FG000|Overall Study|Withdrawal by Subject|1|||
131736539|NCT01626352|474313384|FG000|Overall Study|Non-Compliance|1|||
131736540|NCT01626352|474313384|FG000|Overall Study|Never Treated|1|||
131736541|NCT02796391|474313385|FG000|Overall Study|Lost to Follow-up|2|||
131736542|NCT02796391|474313386|FG001|Overall Study|Lost to Follow-up|2|||
131736543|NCT02796391|474313387|FG002|Overall Study|Lost to Follow-up|13|||
131736544|NCT02796391|474313388|FG003|Overall Study|Lost to Follow-up|8|||
131736545|NCT02796391|474313389|FG004|Overall Study|Lost to Follow-up|14|||
131736546|NCT02796391|474313390|FG005|Overall Study|Lost to Follow-up|13|||
131736547|NCT02796391|474313385|FG000|Overall Study|COVID|0|||
131736548|NCT02796391|474313386|FG001|Overall Study|COVID|0|||
131736549|NCT02796391|474313387|FG002|Overall Study|COVID|5|||
131736550|NCT02796391|474313388|FG003|Overall Study|COVID|5|||
131736551|NCT02796391|474313389|FG004|Overall Study|COVID|2|||
131736552|NCT02796391|474313390|FG005|Overall Study|COVID|4|||
131736553|NCT02796391|474313385|FG000|Overall Study|Participant did not like study cigarettes|0|||
131736554|NCT02796391|474313386|FG001|Overall Study|Participant did not like study cigarettes|0|||
131736555|NCT02796391|474313387|FG002|Overall Study|Participant did not like study cigarettes|3|||
131736556|NCT02796391|474313388|FG003|Overall Study|Participant did not like study cigarettes|0|||
131736557|NCT02796391|474313389|FG004|Overall Study|Participant did not like study cigarettes|0|||
131736558|NCT02796391|474313390|FG005|Overall Study|Participant did not like study cigarettes|0|||
131736559|NCT02796391|474313385|FG000|Overall Study|Withdrawal by Subject|1|||
131736560|NCT02796391|474313386|FG001|Overall Study|Withdrawal by Subject|1|||
131736561|NCT02796391|474313387|FG002|Overall Study|Withdrawal by Subject|4|||
131736562|NCT02796391|474313388|FG003|Overall Study|Withdrawal by Subject|3|||
131736563|NCT02796391|474313389|FG004|Overall Study|Withdrawal by Subject|4|||
131736564|NCT02796391|474313390|FG005|Overall Study|Withdrawal by Subject|3|||
131736565|NCT02796391|474313385|FG000|Overall Study|Adverse Event|0|||
131736566|NCT02796391|474313386|FG001|Overall Study|Adverse Event|0|||
131736567|NCT02796391|474313387|FG002|Overall Study|Adverse Event|0|||
131736568|NCT02796391|474313388|FG003|Overall Study|Adverse Event|1|||
131736569|NCT02796391|474313389|FG004|Overall Study|Adverse Event|0|||
131736570|NCT02796391|474313390|FG005|Overall Study|Adverse Event|0|||
131736571|NCT02796391|474313385|FG000|Overall Study|Protocol Violation|0|||
131736572|NCT02796391|474313386|FG001|Overall Study|Protocol Violation|0|||
131736573|NCT02796391|474313387|FG002|Overall Study|Protocol Violation|0|||
131736574|NCT02796391|474313388|FG003|Overall Study|Protocol Violation|1|||
131736575|NCT02796391|474313389|FG004|Overall Study|Protocol Violation|0|||
131736576|NCT02796391|474313390|FG005|Overall Study|Protocol Violation|0|||
131736577|NCT00831441|474313391|FG000|Randomized|Death|82|||
131736578|NCT00831441|474313392|FG001|Randomized|Death|81|||
131736579|NCT00831441|474313391|FG000|Randomized|Adverse Event|248|||
131736580|NCT00831441|474313392|FG001|Randomized|Adverse Event|321|||
131736581|NCT00831441|474313391|FG000|Randomized|Emergency procedure|2|||
131736582|NCT00831441|474313392|FG001|Randomized|Emergency procedure|2|||
131736583|NCT00831441|474313391|FG000|Randomized|Elective procedure|26|||
131736584|NCT00831441|474313392|FG001|Randomized|Elective procedure|25|||
131736585|NCT00831441|474313391|FG000|Randomized|Physician Decision|26|||
131736586|NCT00831441|474313392|FG001|Randomized|Physician Decision|35|||
131736587|NCT00831441|474313391|FG000|Randomized|No longer met criteria|13|||
131736588|NCT00831441|474313392|FG001|Randomized|No longer met criteria|19|||
131736589|NCT00831441|474313391|FG000|Randomized|Withdrawal by Subject|178|||
131736590|NCT00831441|474313392|FG001|Randomized|Withdrawal by Subject|212|||
131736591|NCT00831441|474313391|FG000|Randomized|Lost to Follow-up|26|||
131736592|NCT00831441|474313392|FG001|Randomized|Lost to Follow-up|35|||
131736593|NCT00831441|474313391|FG000|Randomized|Administrative reason by sponsor|2780|||
131736594|NCT00831441|474313392|FG001|Randomized|Administrative reason by sponsor|2671|||
131736595|NCT00831441|474313391|FG000|Randomized|poor/non-compliance|30|||
131807967|NCT02024932|474582893|FG001|Overall Study|Adverse Event|3|||
131807968|NCT02024932|474582894|FG002|Overall Study|Adverse Event|0|||
131736596|NCT00831441|474313392|FG001|Randomized|poor/non-compliance|38|||
131736597|NCT00831441|474313391|FG000|Randomized|non-specified|276|||
131736598|NCT00831441|474313392|FG001|Randomized|non-specified|266|||
131736599|NCT00831441|474313391|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
131736600|NCT00831441|474313392|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
131736601|NCT00831441|474313391|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
131736602|NCT00831441|474313392|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
131736603|NCT00831441|474313391|FG000|Follow Up (30 Days)|Death|63|||
131736604|NCT00831441|474313392|FG001|Follow Up (30 Days)|Death|86|||
131736605|NCT00831441|474313391|FG000|Follow Up (30 Days)|non-specified|16|||
131736606|NCT00831441|474313392|FG001|Follow Up (30 Days)|non-specified|26|||
131736607|NCT00831441|474313391|FG000|Follow Up (30 Days)|missing end of study status|0|||
131736608|NCT00831441|474313392|FG001|Follow Up (30 Days)|missing end of study status|1|||
131736609|NCT05674344|474313393|FG000|Overall Study|Screen Fail|21|||
131736610|NCT05674344|474313393|FG000|Overall Study|Incomplete study procedures|3|||
131736611|NCT00111917|474313394|FG000|Overall Study|Withdrawal by Subject|1|||
131736612|NCT00111917|474313395|FG001|Overall Study|Withdrawal by Subject|1|||
131736613|NCT00798655|474313396|FG000|Overall Study|Did not receive at least one dose of pan|2|||
131736614|NCT00343291|474313397|FG000|Overall Study|Adverse Event|13|||
131736615|NCT00343291|474313398|FG001|Overall Study|Adverse Event|13|||
131736616|NCT00343291|474313397|FG000|Overall Study|Death|3|||
131736617|NCT00343291|474313398|FG001|Overall Study|Death|2|||
131736618|NCT00343291|474313397|FG000|Overall Study|Progressive disease|33|||
131736619|NCT00343291|474313398|FG001|Overall Study|Progressive disease|34|||
131736620|NCT00343291|474313397|FG000|Overall Study|Withdrawal by Subject|0|||
131736621|NCT00343291|474313398|FG001|Overall Study|Withdrawal by Subject|2|||
131736622|NCT00343291|474313397|FG000|Overall Study|Other|8|||
131736623|NCT00343291|474313398|FG001|Overall Study|Other|5|||
131736624|NCT00960934|474313401|FG000|Overall Study|Adverse Event|2|||
131736625|NCT00960934|474313402|FG001|Overall Study|Adverse Event|3|||
131736626|NCT00960934|474313403|FG002|Overall Study|Adverse Event|3|||
131736627|NCT00960934|474313404|FG003|Overall Study|Adverse Event|2|||
131736628|NCT00960934|474313405|FG004|Overall Study|Adverse Event|4|||
131736629|NCT00960934|474313406|FG005|Overall Study|Adverse Event|3|||
131736630|NCT00960934|474313401|FG000|Overall Study|Lack of Efficacy|1|||
131448872|NCT01208207|473272738|FG001|Part I|Non-Compliance With Study Drug|0|||
131448873|NCT01208207|473272739|FG002|Part I|Non-Compliance With Study Drug|1|||
131448874|NCT01208207|473272740|FG003|Part I|Non-Compliance With Study Drug|0|||
131736631|NCT00960934|474313402|FG001|Overall Study|Lack of Efficacy|0|||
131736632|NCT00960934|474313403|FG002|Overall Study|Lack of Efficacy|0|||
131736633|NCT00960934|474313404|FG003|Overall Study|Lack of Efficacy|0|||
131736634|NCT00960934|474313405|FG004|Overall Study|Lack of Efficacy|0|||
131736635|NCT00960934|474313406|FG005|Overall Study|Lack of Efficacy|0|||
131736636|NCT00960934|474313401|FG000|Overall Study|Lost to Follow-up|0|||
131736637|NCT00960934|474313402|FG001|Overall Study|Lost to Follow-up|1|||
131736638|NCT00960934|474313403|FG002|Overall Study|Lost to Follow-up|0|||
131736639|NCT00960934|474313404|FG003|Overall Study|Lost to Follow-up|0|||
131736640|NCT00960934|474313405|FG004|Overall Study|Lost to Follow-up|0|||
131736641|NCT00960934|474313406|FG005|Overall Study|Lost to Follow-up|0|||
131736642|NCT00960934|474313401|FG000|Overall Study|Other|2|||
131736643|NCT00960934|474313402|FG001|Overall Study|Other|1|||
131736644|NCT00960934|474313403|FG002|Overall Study|Other|5|||
131736645|NCT00960934|474313404|FG003|Overall Study|Other|4|||
131736646|NCT00960934|474313405|FG004|Overall Study|Other|2|||
131736647|NCT00960934|474313406|FG005|Overall Study|Other|2|||
131736648|NCT00960934|474313401|FG000|Overall Study|Physician Decision|0|||
131736649|NCT00960934|474313402|FG001|Overall Study|Physician Decision|1|||
131736650|NCT00960934|474313403|FG002|Overall Study|Physician Decision|0|||
131736651|NCT00960934|474313404|FG003|Overall Study|Physician Decision|0|||
131736652|NCT00960934|474313405|FG004|Overall Study|Physician Decision|0|||
131736653|NCT00960934|474313406|FG005|Overall Study|Physician Decision|0|||
131736654|NCT00960934|474313401|FG000|Overall Study|Progressive Disease|1|||
131736655|NCT00960934|474313402|FG001|Overall Study|Progressive Disease|1|||
131736656|NCT00960934|474313403|FG002|Overall Study|Progressive Disease|0|||
131736657|NCT00960934|474313404|FG003|Overall Study|Progressive Disease|0|||
131736658|NCT00960934|474313405|FG004|Overall Study|Progressive Disease|1|||
131736659|NCT00960934|474313406|FG005|Overall Study|Progressive Disease|1|||
131736660|NCT00960934|474313401|FG000|Overall Study|Protocol Violation|3|||
131736661|NCT00960934|474313402|FG001|Overall Study|Protocol Violation|4|||
131736662|NCT00960934|474313403|FG002|Overall Study|Protocol Violation|0|||
131736663|NCT00960934|474313404|FG003|Overall Study|Protocol Violation|3|||
131736664|NCT00960934|474313405|FG004|Overall Study|Protocol Violation|3|||
131736665|NCT00960934|474313406|FG005|Overall Study|Protocol Violation|2|||
131448875|NCT01208207|473272741|FG004|Part I|Non-Compliance With Study Drug|0|||
131736666|NCT00960934|474313401|FG000|Overall Study|Withdrawal by Subject|5|||
131736667|NCT00960934|474313402|FG001|Overall Study|Withdrawal by Subject|6|||
131736668|NCT00960934|474313403|FG002|Overall Study|Withdrawal by Subject|4|||
131736669|NCT00960934|474313404|FG003|Overall Study|Withdrawal by Subject|5|||
131736670|NCT00960934|474313405|FG004|Overall Study|Withdrawal by Subject|5|||
131736671|NCT00960934|474313406|FG005|Overall Study|Withdrawal by Subject|7|||
131736672|NCT00960934|474313401|FG000|Overall Study|Study Terminated by Sponsor|50|||
131736673|NCT00960934|474313402|FG001|Overall Study|Study Terminated by Sponsor|46|||
131736674|NCT00960934|474313403|FG002|Overall Study|Study Terminated by Sponsor|52|||
131736675|NCT00960934|474313404|FG003|Overall Study|Study Terminated by Sponsor|50|||
131736676|NCT00960934|474313405|FG004|Overall Study|Study Terminated by Sponsor|49|||
131736677|NCT00960934|474313406|FG005|Overall Study|Study Terminated by Sponsor|49|||
131736678|NCT05254613|474313416|FG000|Overall Study|Lost to Follow-up|0|||
131736679|NCT05254613|474313417|FG001|Overall Study|Lost to Follow-up|0|||
131736680|NCT05254613|474313418|FG002|Overall Study|Lost to Follow-up|1|||
131736681|NCT00718666|474313422|FG000|Booster Phase Year 5|No active participation request|0|||
131736682|NCT00718666|474313423|FG001|Booster Phase Year 5|No active participation request|0|||
131736683|NCT00718666|474313424|FG002|Booster Phase Year 5|No active participation request|1|||
131736684|NCT00718666|474313422|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
131736685|NCT00718666|474313423|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
131736686|NCT00718666|474313424|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
131736687|NCT00718666|474313422|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
131736688|NCT00718666|474313423|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
131736689|NCT00718666|474313424|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
131736690|NCT00718666|474313422|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
131736691|NCT00718666|474313423|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
131736692|NCT00718666|474313424|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
131736693|NCT00421343|474313427|FG000|Overall Study|Death|1|||
131736694|NCT00421343|474313427|FG000|Overall Study|Withdrawal by Subject|2|||
131736695|NCT00421343|474313427|FG000|Overall Study|Lost to Follow-up|3|||
131736696|NCT03471767|474313431|FG000|Overall Study|Withdrawal by Subject|3|||
131736697|NCT03471767|474313432|FG001|Overall Study|Withdrawal by Subject|1|||
131736698|NCT03471767|474313431|FG000|Overall Study|Adverse Event|1|||
131807969|NCT02024932|474582895|FG003|Overall Study|Adverse Event|0|||
131807970|NCT02024932|474582896|FG004|Overall Study|Adverse Event|2|||
131807971|NCT02024932|474582897|FG005|Overall Study|Adverse Event|0|||
131807972|NCT02024932|474582892|FG000|Overall Study|Abnormal laboratory value|0|||
131807973|NCT02024932|474582893|FG001|Overall Study|Abnormal laboratory value|0|||
131807974|NCT02024932|474582894|FG002|Overall Study|Abnormal laboratory value|0|||
131807975|NCT02024932|474582895|FG003|Overall Study|Abnormal laboratory value|2|||
131807976|NCT02024932|474582896|FG004|Overall Study|Abnormal laboratory value|0|||
131807977|NCT02024932|474582897|FG005|Overall Study|Abnormal laboratory value|0|||
131807978|NCT02445339|474582898|FG000|Overall Study|Physician Decision|1|||
131807979|NCT02445339|474582899|FG001|Overall Study|Physician Decision|0|||
131807980|NCT02445339|474582898|FG000|Overall Study|Lost to Follow-up|11|||
131807981|NCT02445339|474582899|FG001|Overall Study|Lost to Follow-up|15|||
131807982|NCT03206177|474582900|FG000|Overall Study|Withdrawal by Subject|1|||
131807983|NCT03020641|474582901|FG000|Overall Study|Lost to Follow-up|0|||
131807984|NCT03020641|474582902|FG001|Overall Study|Lost to Follow-up|1|||
131807985|NCT03020641|474582901|FG000|Overall Study|Converted to open surgery|2|||
131807986|NCT03020641|474582902|FG001|Overall Study|Converted to open surgery|1|||
131807987|NCT03020641|474582901|FG000|Overall Study|for surgery not performed|0|||
131807988|NCT03020641|474582902|FG001|Overall Study|for surgery not performed|1|||
131807989|NCT03041025|474582903|FG000|Overall Study|Adverse Event|0|||
131807990|NCT03041025|474582904|FG001|Overall Study|Adverse Event|0|||
131807991|NCT03041025|474582905|FG002|Overall Study|Adverse Event|1|||
131807992|NCT03041025|474582903|FG000|Overall Study|Lost to Follow-up|1|||
131807993|NCT03041025|474582904|FG001|Overall Study|Lost to Follow-up|0|||
131807994|NCT03041025|474582905|FG002|Overall Study|Lost to Follow-up|0|||
131807995|NCT03041025|474582903|FG000|Overall Study|Withdrawal by Subject|0|||
131807996|NCT03041025|474582904|FG001|Overall Study|Withdrawal by Subject|0|||
131807997|NCT03041025|474582905|FG002|Overall Study|Withdrawal by Subject|1|||
131807998|NCT02963259|474582907|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
131807999|NCT02963259|474582907|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
131808000|NCT02963259|474582907|FG000|Overall Study|Death|1|||
131808001|NCT02963259|474582907|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
131808002|NCT00939003|474582909|FG000|Double-blind Treatment Period|Adverse Event|1|||
131808003|NCT00939003|474582910|FG001|Double-blind Treatment Period|Adverse Event|1|||
131808004|NCT00939003|474582909|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
131808005|NCT00939003|474582910|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
131808006|NCT00939003|474582909|FG000|Double-blind Treatment Period|Pregnancy|0|||
131808007|NCT00939003|474582910|FG001|Double-blind Treatment Period|Pregnancy|1|||
131808008|NCT00939003|474582909|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
131808009|NCT00939003|474582910|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
131808010|NCT00939003|474582909|FG000|Open-label Treatment Period|Adverse Event|4|||
131808011|NCT00939003|474582910|FG001|Open-label Treatment Period|Adverse Event|8|||
131808012|NCT00939003|474582909|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
131808013|NCT00939003|474582910|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
131808014|NCT00939003|474582909|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
131808015|NCT00939003|474582910|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
131808016|NCT00939003|474582909|FG000|Open-label Treatment Period|Pregnancy|1|||
131736699|NCT03471767|474313432|FG001|Overall Study|Adverse Event|0|||
131736700|NCT03471767|474313431|FG000|Overall Study|Lost to Follow-up|1|||
131736701|NCT03471767|474313432|FG001|Overall Study|Lost to Follow-up|0|||
131736702|NCT03471767|474313431|FG000|Overall Study|PI Withdrawal|1|||
131736703|NCT03471767|474313432|FG001|Overall Study|PI Withdrawal|3|||
131736704|NCT01952730|474313433|FG000|Overall Study|FDA shut down core lab used by study|1|||
131736705|NCT05373706|474313434|FG000|Overall Study|Lost to Follow-up|2|||
131736706|NCT05373706|474313435|FG001|Overall Study|Lost to Follow-up|2|||
131736707|NCT01606761|474313439|FG000|Prior to Week 24|Lost to Follow-up|0|||
131736708|NCT01606761|474313440|FG001|Prior to Week 24|Lost to Follow-up|3|||
131736709|NCT01606761|474313441|FG002|Prior to Week 24|Lost to Follow-up|2|||
131736710|NCT01606761|474313442|FG003|Prior to Week 24|Lost to Follow-up|0|||
131736711|NCT01606761|474313443|FG004|Prior to Week 24|Lost to Follow-up|0|||
131736712|NCT01606761|474313439|FG000|Prior to Week 24|Withdrawal by Subject|12|||
131736713|NCT01606761|474313440|FG001|Prior to Week 24|Withdrawal by Subject|10|||
131736714|NCT01606761|474313441|FG002|Prior to Week 24|Withdrawal by Subject|9|||
131736715|NCT01606761|474313442|FG003|Prior to Week 24|Withdrawal by Subject|0|||
131736716|NCT01606761|474313443|FG004|Prior to Week 24|Withdrawal by Subject|0|||
131736717|NCT01606761|474313439|FG000|Prior to Week 24|Adverse Event|11|||
131736718|NCT01606761|474313440|FG001|Prior to Week 24|Adverse Event|18|||
131736719|NCT01606761|474313441|FG002|Prior to Week 24|Adverse Event|22|||
131736720|NCT01606761|474313442|FG003|Prior to Week 24|Adverse Event|0|||
131736721|NCT01606761|474313443|FG004|Prior to Week 24|Adverse Event|0|||
131736722|NCT01606761|474313439|FG000|Prior to Week 24|Lack of Efficacy|15|||
131736723|NCT01606761|474313440|FG001|Prior to Week 24|Lack of Efficacy|14|||
131736724|NCT01606761|474313441|FG002|Prior to Week 24|Lack of Efficacy|8|||
131736725|NCT01606761|474313442|FG003|Prior to Week 24|Lack of Efficacy|0|||
131736726|NCT01606761|474313443|FG004|Prior to Week 24|Lack of Efficacy|0|||
131736727|NCT01606761|474313439|FG000|Prior to Week 24|Physician Decision|0|||
131736728|NCT01606761|474313440|FG001|Prior to Week 24|Physician Decision|3|||
131736729|NCT01606761|474313441|FG002|Prior to Week 24|Physician Decision|1|||
131736730|NCT01606761|474313442|FG003|Prior to Week 24|Physician Decision|0|||
131736731|NCT01606761|474313443|FG004|Prior to Week 24|Physician Decision|0|||
131736732|NCT01606761|474313439|FG000|Prior to Week 24|Other|4|||
131736733|NCT01606761|474313440|FG001|Prior to Week 24|Other|7|||
131736734|NCT01606761|474313441|FG002|Prior to Week 24|Other|5|||
131736735|NCT01606761|474313442|FG003|Prior to Week 24|Other|0|||
131736736|NCT01606761|474313443|FG004|Prior to Week 24|Other|0|||
131736737|NCT01606761|474313439|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
131736738|NCT01606761|474313440|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
131736739|NCT01606761|474313441|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
131736740|NCT01606761|474313442|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
131808017|NCT00939003|474582910|FG001|Open-label Treatment Period|Pregnancy|1|||
131808018|NCT00939003|474582909|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
131808019|NCT00939003|474582910|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
131808020|NCT00939003|474582909|FG000|Open-label Treatment Period|Site Closure|3|||
131808021|NCT00939003|474582910|FG001|Open-label Treatment Period|Site Closure|4|||
131808022|NCT01577381|474582915|FG000|Overall Study|Discontinued|2|||
131808023|NCT01577381|474582916|FG001|Overall Study|Discontinued|1|||
131808024|NCT01577381|474582917|FG002|Overall Study|Discontinued|2|||
131808025|NCT01577381|474582918|FG003|Overall Study|Discontinued|2|||
131808026|NCT01577381|474582915|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
131808027|NCT01577381|474582916|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
131808028|NCT01577381|474582917|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
131808029|NCT01577381|474582918|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
131808030|NCT02186821|474582919|FG000|Overall Study|Adverse Event|9|||
131808031|NCT02186821|474582919|FG000|Overall Study|Death|2|||
131808032|NCT02186821|474582919|FG000|Overall Study|Disease progression|32|||
131808033|NCT02186821|474582919|FG000|Overall Study|Protocol Violation|1|||
131808034|NCT02186821|474582919|FG000|Overall Study|Physician Decision|1|||
131905288|NCT01926028|474940869|FG000|Overall Study|Withdrawal by Subject|9|||
131448876|NCT01208207|473272742|FG005|Part I|Non-Compliance With Study Drug|0|||
131736741|NCT01606761|474313443|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
131736742|NCT01606761|474313439|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
131736743|NCT01606761|474313440|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
131736744|NCT01606761|474313441|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
131736745|NCT01606761|474313442|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
131736746|NCT01606761|474313443|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
131736747|NCT01606761|474313439|FG000|Week 24 to Week 52|Adverse Event|0|||
131736748|NCT01606761|474313440|FG001|Week 24 to Week 52|Adverse Event|11|||
131736749|NCT01606761|474313441|FG002|Week 24 to Week 52|Adverse Event|14|||
131736750|NCT01606761|474313442|FG003|Week 24 to Week 52|Adverse Event|3|||
131736751|NCT01606761|474313443|FG004|Week 24 to Week 52|Adverse Event|15|||
131736752|NCT01606761|474313439|FG000|Week 24 to Week 52|Death|0|||
131808035|NCT02186821|474582919|FG000|Overall Study|Study terminated by sponsor|2|||
131808036|NCT02039908|474582920|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
131808037|NCT02039908|474582921|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
131808038|NCT02039908|474582922|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
131736753|NCT01606761|474313440|FG001|Week 24 to Week 52|Death|0|||
131736754|NCT01606761|474313441|FG002|Week 24 to Week 52|Death|2|||
131736755|NCT01606761|474313442|FG003|Week 24 to Week 52|Death|1|||
131736756|NCT01606761|474313443|FG004|Week 24 to Week 52|Death|0|||
131736757|NCT01606761|474313439|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
131736758|NCT01606761|474313440|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
131736759|NCT01606761|474313441|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
131736760|NCT01606761|474313442|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
131736761|NCT01606761|474313443|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
131736762|NCT01606761|474313439|FG000|Week 24 to Week 52|Physician Decision|0|||
131736763|NCT01606761|474313440|FG001|Week 24 to Week 52|Physician Decision|1|||
131736764|NCT01606761|474313441|FG002|Week 24 to Week 52|Physician Decision|1|||
131736765|NCT01606761|474313442|FG003|Week 24 to Week 52|Physician Decision|0|||
131736766|NCT01606761|474313443|FG004|Week 24 to Week 52|Physician Decision|0|||
131736767|NCT01606761|474313439|FG000|Week 24 to Week 52|Other|0|||
131736768|NCT01606761|474313440|FG001|Week 24 to Week 52|Other|1|||
131736769|NCT01606761|474313441|FG002|Week 24 to Week 52|Other|5|||
131736770|NCT01606761|474313442|FG003|Week 24 to Week 52|Other|2|||
131736771|NCT01606761|474313443|FG004|Week 24 to Week 52|Other|2|||
131736772|NCT01606761|474313439|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
131736773|NCT01606761|474313440|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
131736774|NCT01606761|474313441|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
131736775|NCT01606761|474313442|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
131736776|NCT01606761|474313443|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
131736777|NCT01606761|474313439|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
131736778|NCT01606761|474313440|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
131736779|NCT01606761|474313441|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
131736780|NCT01606761|474313442|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
131736781|NCT01606761|474313443|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
131736782|NCT01606761|474313439|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
131736783|NCT01606761|474313440|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
131736784|NCT01606761|474313441|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
131736785|NCT01606761|474313442|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
131736786|NCT01606761|474313443|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
131736787|NCT01606761|474313439|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
131736788|NCT01606761|474313440|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
131736789|NCT01606761|474313441|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
131736790|NCT01606761|474313442|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
131736791|NCT01606761|474313443|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
131736792|NCT03628508|474313445|FG000|Overall Study|Lost to Follow-up|1|||
131736793|NCT02402218|474313448|FG000|Overall Study|Did not pickup study medication|12|||
131736794|NCT02402218|474313449|FG001|Overall Study|Did not pickup study medication|9|||
131736795|NCT02402218|474313450|FG002|Overall Study|Did not pickup study medication|13|||
131736796|NCT02402218|474313448|FG000|Overall Study|Lack of Efficacy|0|||
131736797|NCT02402218|474313449|FG001|Overall Study|Lack of Efficacy|1|||
131736798|NCT02402218|474313450|FG002|Overall Study|Lack of Efficacy|1|||
131736799|NCT02402218|474313448|FG000|Overall Study|Death|1|||
131736800|NCT02402218|474313449|FG001|Overall Study|Death|0|||
131736801|NCT02402218|474313450|FG002|Overall Study|Death|0|||
131736802|NCT02402218|474313448|FG000|Overall Study|Reinfection|0|||
131736803|NCT02402218|474313449|FG001|Overall Study|Reinfection|0|||
131736804|NCT02402218|474313450|FG002|Overall Study|Reinfection|1|||
131736805|NCT02402218|474313448|FG000|Overall Study|Adverse Event|0|||
131736806|NCT02402218|474313449|FG001|Overall Study|Adverse Event|2|||
131736807|NCT02402218|474313450|FG002|Overall Study|Adverse Event|1|||
131736808|NCT02402218|474313448|FG000|Overall Study|Withdrawal by Subject|1|||
131736809|NCT02402218|474313449|FG001|Overall Study|Withdrawal by Subject|1|||
131736810|NCT02402218|474313450|FG002|Overall Study|Withdrawal by Subject|1|||
131736811|NCT00807846|474313452|FG000|Overall Study|Adverse Event|5|||
131736812|NCT00807846|474313453|FG001|Overall Study|Adverse Event|0|||
131808039|NCT02039908|474582923|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
131736813|NCT00807846|474313452|FG000|Overall Study|Lack of Efficacy|2|||
131736814|NCT00807846|474313453|FG001|Overall Study|Lack of Efficacy|0|||
131736815|NCT00807846|474313452|FG000|Overall Study|Protocol Violation|2|||
131736816|NCT00807846|474313453|FG001|Overall Study|Protocol Violation|1|||
131736817|NCT00807846|474313452|FG000|Overall Study|Withdrawal by Subject|2|||
131808040|NCT02039908|474582920|FG000|Phase 1-Summer|Protocol Violation|6|||
131736818|NCT00807846|474313453|FG001|Overall Study|Withdrawal by Subject|1|||
131736819|NCT00807846|474313452|FG000|Overall Study|Other|1|||
131736820|NCT00807846|474313453|FG001|Overall Study|Other|2|||
131736821|NCT01081873|474313454|FG000|Overall Study|Death|86|||
131736822|NCT01081873|474313454|FG000|Overall Study|Withdrawal by Subject|10|||
131736823|NCT01081873|474313454|FG000|Overall Study|Lost to Follow-up|142|||
131736824|NCT01081873|474313454|FG000|Overall Study|Progression of prostate cancer|13|||
131448877|NCT01208207|473272743|FG006|Part I|Non-Compliance With Study Drug|0|||
131448878|NCT01208207|473272737|FG000|Part I|Physician Decision|0|||
131448879|NCT01208207|473272738|FG001|Part I|Physician Decision|1|||
131736825|NCT01081873|474313454|FG000|Overall Study|Other|47|||
131736826|NCT02491073|474313456|FG000|Overall Study|screen failure|1|||
131736827|NCT02491073|474313457|FG001|Overall Study|screen failure|0|||
131736828|NCT01165021|474313458|FG000|Overall Study|Death|1|||
131736829|NCT03738566|474313459|FG000|Initial Study Phase|Withdrawal by Subject|1|||
131736830|NCT03738566|474313460|FG001|Initial Study Phase|Withdrawal by Subject|1|||
131736831|NCT03738566|474313461|FG002|Initial Study Phase|Withdrawal by Subject|2|||
131736832|NCT03738566|474313462|FG003|Initial Study Phase|Withdrawal by Subject|0|||
131736833|NCT03738566|474313459|FG000|Initial Study Phase|Death|0|||
131736834|NCT03738566|474313460|FG001|Initial Study Phase|Death|1|||
131736835|NCT03738566|474313461|FG002|Initial Study Phase|Death|0|||
131736836|NCT03738566|474313462|FG003|Initial Study Phase|Death|0|||
131736837|NCT03738566|474313459|FG000|Initial Study Phase|Treatment failure|5|||
131736838|NCT03738566|474313460|FG001|Initial Study Phase|Treatment failure|0|||
131736839|NCT03738566|474313461|FG002|Initial Study Phase|Treatment failure|0|||
131736840|NCT03738566|474313462|FG003|Initial Study Phase|Treatment failure|0|||
131736841|NCT03738566|474313459|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
131736842|NCT03738566|474313460|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
131736843|NCT03738566|474313461|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
131736844|NCT03738566|474313462|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
131736845|NCT01419665|474313463|FG000|Combination Treatment|Adverse Event|7|||
131736846|NCT01419665|474313464|FG001|Combination Treatment|Adverse Event|10|||
131736847|NCT01419665|474313463|FG000|Combination Treatment|Physician Decision|5|||
131736848|NCT01419665|474313464|FG001|Combination Treatment|Physician Decision|8|||
131736849|NCT01419665|474313463|FG000|Combination Treatment|Protocol Violation|6|||
131736850|NCT01419665|474313464|FG001|Combination Treatment|Protocol Violation|2|||
131736851|NCT01419665|474313463|FG000|Combination Treatment|disease progression|10|||
131736852|NCT01419665|474313464|FG001|Combination Treatment|disease progression|9|||
131736853|NCT01419665|474313463|FG000|Combination Treatment|Death|5|||
131736854|NCT01419665|474313464|FG001|Combination Treatment|Death|7|||
131736855|NCT01419665|474313463|FG000|Combination Treatment|administrative problems|0|||
131736856|NCT01419665|474313464|FG001|Combination Treatment|administrative problems|1|||
131736857|NCT01419665|474313463|FG000|Combination Treatment|Withdrawal by Subject|5|||
131736858|NCT01419665|474313464|FG001|Combination Treatment|Withdrawal by Subject|4|||
131736859|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
131736860|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
131736861|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
131736862|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
131736863|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
131736864|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
131736865|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
131736866|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
131736867|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
131736868|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
131736869|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
131736870|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
131736871|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|Death|1|||
131736872|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|Death|2|||
131736873|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
131736874|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
131736875|NCT01419665|474313463|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
131736876|NCT01419665|474313464|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
131736877|NCT01419665|474313463|FG000|Open Label Phase|Death|1|||
131736878|NCT01419665|474313464|FG001|Open Label Phase|Death|0|||
131736879|NCT01419665|474313463|FG000|Open Label Phase|disease progression|0|||
131736880|NCT01419665|474313464|FG001|Open Label Phase|disease progression|1|||
131448880|NCT01208207|473272739|FG002|Part I|Physician Decision|0|||
131448881|NCT01208207|473272740|FG003|Part I|Physician Decision|0|||
131736881|NCT03126539|474313470|FG000|Overall Study|Lost to Follow-up|1|||
131736882|NCT03126539|474313471|FG001|Overall Study|Lost to Follow-up|1|||
131736883|NCT03126539|474313472|FG002|Overall Study|Lost to Follow-up|1|||
131736884|NCT03126539|474313473|FG003|Overall Study|Lost to Follow-up|0|||
131736885|NCT03126539|474313474|FG004|Overall Study|Lost to Follow-up|0|||
131736886|NCT03352414|474313475|FG000|Overall Study|Ineligible by operative criteria|12|||
131736887|NCT03352414|474313476|FG001|Overall Study|Ineligible by operative criteria|10|||
131736888|NCT02632110|474313477|FG000|Overall Study|Withdrawal by Subject|1|||
131736889|NCT02632110|474313478|FG001|Overall Study|Withdrawal by Subject|1|||
131736890|NCT02632110|474313479|FG002|Overall Study|Withdrawal by Subject|0|||
131736891|NCT02632110|474313480|FG003|Overall Study|Withdrawal by Subject|0|||
131736892|NCT02632110|474313481|FG004|Overall Study|Withdrawal by Subject|1|||
131736893|NCT02632110|474313482|FG005|Overall Study|Withdrawal by Subject|1|||
131736894|NCT02632110|474313483|FG006|Overall Study|Withdrawal by Subject|3|||
131736895|NCT02632110|474313484|FG007|Overall Study|Withdrawal by Subject|3|||
131736896|NCT02632110|474313485|FG008|Overall Study|Withdrawal by Subject|1|||
131736897|NCT02632110|474313486|FG009|Overall Study|Withdrawal by Subject|1|||
131736898|NCT00516269|474313487|FG000|Overall Study|Adverse Event|2|||
131736899|NCT00516269|474313488|FG001|Overall Study|Adverse Event|1|||
131736900|NCT00516269|474313487|FG000|Overall Study|Lost to Follow-up|0|||
131736901|NCT00516269|474313488|FG001|Overall Study|Lost to Follow-up|1|||
131736902|NCT00516269|474313487|FG000|Overall Study|Protocol Violation|0|||
131736903|NCT00516269|474313488|FG001|Overall Study|Protocol Violation|1|||
131736904|NCT02998554|474313494|FG000|Overall Study|Adverse Event|8|||
131736905|NCT02998554|474313495|FG001|Overall Study|Adverse Event|3|||
131736906|NCT02998554|474313494|FG000|Overall Study|Protocol deviation|1|||
131736907|NCT02998554|474313495|FG001|Overall Study|Protocol deviation|0|||
131736908|NCT02998554|474313494|FG000|Overall Study|Withdrawal by Subject|2|||
131736909|NCT02998554|474313495|FG001|Overall Study|Withdrawal by Subject|6|||
131736910|NCT02998554|474313494|FG000|Overall Study|Lost to Follow-up|0|||
131736911|NCT02998554|474313495|FG001|Overall Study|Lost to Follow-up|1|||
131808041|NCT02039908|474582921|FG001|Phase 1-Summer|Protocol Violation|0|||
131808042|NCT02039908|474582922|FG002|Phase 1-Summer|Protocol Violation|0|||
131808043|NCT02039908|474582923|FG003|Phase 1-Summer|Protocol Violation|0|||
131808044|NCT02039908|474582920|FG000|Phase 2-School Year|Lost to Follow-up|0|||
131808045|NCT02039908|474582921|FG001|Phase 2-School Year|Lost to Follow-up|0|||
131808046|NCT02039908|474582922|FG002|Phase 2-School Year|Lost to Follow-up|1|||
131808047|NCT02039908|474582923|FG003|Phase 2-School Year|Lost to Follow-up|3|||
131808048|NCT02039908|474582920|FG000|Phase 2-School Year|Protocol Violation|0|||
131808049|NCT02039908|474582921|FG001|Phase 2-School Year|Protocol Violation|0|||
131808050|NCT02039908|474582922|FG002|Phase 2-School Year|Protocol Violation|3|||
131808051|NCT02039908|474582923|FG003|Phase 2-School Year|Protocol Violation|0|||
131808052|NCT02039908|474582920|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
131808053|NCT02039908|474582921|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
131808054|NCT02039908|474582922|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
131808055|NCT02039908|474582923|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
131736912|NCT02998554|474313494|FG000|Overall Study|Lack of Efficacy|0|||
131736913|NCT02998554|474313495|FG001|Overall Study|Lack of Efficacy|1|||
131736914|NCT01079962|474313496|FG000|Overall Study|Adverse Event|2|||
131736915|NCT01079962|474313497|FG001|Overall Study|Adverse Event|2|||
131736916|NCT01079962|474313496|FG000|Overall Study|Withdrawal by Subject|5|||
131736917|NCT01079962|474313497|FG001|Overall Study|Withdrawal by Subject|7|||
131736918|NCT01079962|474313496|FG000|Overall Study|Protocol Violation|2|||
131736919|NCT01079962|474313497|FG001|Overall Study|Protocol Violation|2|||
131808056|NCT00819741|474582926|FG000|Overall Study|Adverse Event|5|||
131808057|NCT00819741|474582927|FG001|Overall Study|Adverse Event|2|||
131736920|NCT01079962|474313496|FG000|Overall Study|No blood pressure (BP) control|3|||
131736921|NCT01079962|474313497|FG001|Overall Study|No blood pressure (BP) control|0|||
131736922|NCT01079962|474313496|FG000|Overall Study|Inclusion/exclusion criteria|1|||
131736923|NCT01079962|474313497|FG001|Overall Study|Inclusion/exclusion criteria|3|||
131736924|NCT01079962|474313496|FG000|Overall Study|Participant not returning for next visit|1|||
131808058|NCT00819741|474582926|FG000|Overall Study|Lack of Efficacy|0|||
131736925|NCT01079962|474313497|FG001|Overall Study|Participant not returning for next visit|0|||
131736926|NCT01079962|474313496|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
131736927|NCT01079962|474313497|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
131736928|NCT01072539|474313498|FG000|Overall Study|Treated prior to the Site Initiation|1|||
131736929|NCT01072539|474313498|FG000|Overall Study|Protocol Violation|2|||
131808059|NCT00819741|474582927|FG001|Overall Study|Lack of Efficacy|2|||
131808060|NCT00819741|474582926|FG000|Overall Study|Lost to Follow-up|3|||
131808061|NCT00819741|474582927|FG001|Overall Study|Lost to Follow-up|1|||
131736930|NCT01331239|474313499|FG000|Part II: Core Study|Adverse Event|0|||
131736931|NCT01331239|474313500|FG001|Part II: Core Study|Adverse Event|3|||
131736932|NCT01331239|474313501|FG002|Part II: Core Study|Adverse Event|0|||
131736933|NCT01331239|474313499|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
131736934|NCT01331239|474313500|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
131736935|NCT01331239|474313501|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
131736936|NCT01331239|474313499|FG000|Part II: Core Study|Withdrawal by Subject|0|||
131736937|NCT01331239|474313500|FG001|Part II: Core Study|Withdrawal by Subject|2|||
131736938|NCT01331239|474313501|FG002|Part II: Core Study|Withdrawal by Subject|0|||
131736939|NCT01331239|474313499|FG000|Part II: Core Study|Administrative problems|0|||
131736940|NCT01331239|474313500|FG001|Part II: Core Study|Administrative problems|1|||
131736941|NCT01331239|474313501|FG002|Part II: Core Study|Administrative problems|0|||
131736942|NCT00946530|474313502|FG000|Overall Study|Withdrawal by Subject|0|||
131736943|NCT00946530|474313503|FG001|Overall Study|Withdrawal by Subject|3|||
131736944|NCT00946530|474313504|FG002|Overall Study|Withdrawal by Subject|0|||
131736945|NCT00946530|474313505|FG003|Overall Study|Withdrawal by Subject|3|||
131736946|NCT00946530|474313502|FG000|Overall Study|Physician Decision|1|||
131736947|NCT00946530|474313503|FG001|Overall Study|Physician Decision|1|||
131736948|NCT00946530|474313504|FG002|Overall Study|Physician Decision|1|||
131736949|NCT00946530|474313505|FG003|Overall Study|Physician Decision|1|||
131736950|NCT01008995|474313506|FG000|Controlled Period|Adverse Event|1|||
131736951|NCT01008995|474313507|FG001|Controlled Period|Adverse Event|2|||
131736952|NCT01008995|474313508|FG002|Controlled Period|Adverse Event|0|||
131736953|NCT01008995|474313509|FG003|Controlled Period|Adverse Event|0|||
131736954|NCT01008995|474313506|FG000|Controlled Period|Other|2|||
131736955|NCT01008995|474313507|FG001|Controlled Period|Other|1|||
131736956|NCT01008995|474313508|FG002|Controlled Period|Other|0|||
131736957|NCT01008995|474313509|FG003|Controlled Period|Other|0|||
131736958|NCT01008995|474313506|FG000|After Controlled Period|Adverse Event|0|||
131736959|NCT01008995|474313507|FG001|After Controlled Period|Adverse Event|0|||
131736960|NCT01008995|474313508|FG002|After Controlled Period|Adverse Event|1|||
131736961|NCT01008995|474313509|FG003|After Controlled Period|Adverse Event|1|||
131736962|NCT01008995|474313506|FG000|After Controlled Period|Other|0|||
131736963|NCT01008995|474313507|FG001|After Controlled Period|Other|0|||
131736964|NCT01008995|474313508|FG002|After Controlled Period|Other|1|||
131736965|NCT01008995|474313509|FG003|After Controlled Period|Other|0|||
131736966|NCT00115804|474313512|FG000|Overall Study|Adverse Event|2|||
131736967|NCT01752842|474313513|FG000|Overall Study|Adverse Event|3|||
131736968|NCT01752842|474313514|FG001|Overall Study|Adverse Event|0|||
131736969|NCT01752842|474313513|FG000|Overall Study|Withdrawal by Subject|0|||
131736970|NCT01752842|474313514|FG001|Overall Study|Withdrawal by Subject|2|||
131736971|NCT01683071|474313515|FG000|Part 1|Lack of Efficacy|1|||
131736972|NCT01683071|474313516|FG001|Part 1|Lack of Efficacy|0|||
131736973|NCT01683071|474313517|FG002|Part 1|Lack of Efficacy|0|||
131736974|NCT01683071|474313518|FG003|Part 1|Lack of Efficacy|3|||
131736975|NCT01683071|474313519|FG004|Part 1|Lack of Efficacy|0|||
131736976|NCT01683071|474313520|FG005|Part 1|Lack of Efficacy|0|||
131736977|NCT01683071|474313515|FG000|Part 1|Withdrawal by Subject|1|||
131905289|NCT01926028|474940870|FG001|Overall Study|Withdrawal by Subject|9|||
131905290|NCT01926028|474940871|FG002|Overall Study|Withdrawal by Subject|2|||
131905291|NCT01926028|474940869|FG000|Overall Study|Non compliance or other reasons|4|||
131736978|NCT01683071|474313516|FG001|Part 1|Withdrawal by Subject|2|||
131736979|NCT01683071|474313517|FG002|Part 1|Withdrawal by Subject|2|||
131736980|NCT01683071|474313518|FG003|Part 1|Withdrawal by Subject|1|||
131736981|NCT01683071|474313519|FG004|Part 1|Withdrawal by Subject|0|||
131736982|NCT01683071|474313520|FG005|Part 1|Withdrawal by Subject|0|||
131736983|NCT01683071|474313515|FG000|Part 1|Surgery Cancelled|1|||
131736984|NCT01683071|474313516|FG001|Part 1|Surgery Cancelled|0|||
131736985|NCT01683071|474313517|FG002|Part 1|Surgery Cancelled|0|||
131736986|NCT01683071|474313518|FG003|Part 1|Surgery Cancelled|0|||
131736987|NCT01683071|474313519|FG004|Part 1|Surgery Cancelled|0|||
131736988|NCT01683071|474313520|FG005|Part 1|Surgery Cancelled|0|||
131736989|NCT01683071|474313515|FG000|Part 1|Did not receive study drug|1|||
131736990|NCT01683071|474313516|FG001|Part 1|Did not receive study drug|0|||
131736991|NCT01683071|474313517|FG002|Part 1|Did not receive study drug|0|||
131736992|NCT01683071|474313518|FG003|Part 1|Did not receive study drug|1|||
131736993|NCT01683071|474313519|FG004|Part 1|Did not receive study drug|0|||
131736994|NCT01683071|474313520|FG005|Part 1|Did not receive study drug|0|||
131736995|NCT01683071|474313515|FG000|Part 1|Early termination; met exclusion criteria|0|||
131736996|NCT01683071|474313516|FG001|Part 1|Early termination; met exclusion criteria|2|||
131736997|NCT01683071|474313517|FG002|Part 1|Early termination; met exclusion criteria|1|||
131736998|NCT01683071|474313518|FG003|Part 1|Early termination; met exclusion criteria|0|||
131736999|NCT01683071|474313519|FG004|Part 1|Early termination; met exclusion criteria|0|||
131905292|NCT01926028|474940870|FG001|Overall Study|Non compliance or other reasons|2|||
131737000|NCT01683071|474313520|FG005|Part 1|Early termination; met exclusion criteria|0|||
131737001|NCT01683071|474313515|FG000|Part 2|Lack of Efficacy|0|||
131737002|NCT01683071|474313516|FG001|Part 2|Lack of Efficacy|0|||
131737003|NCT01683071|474313517|FG002|Part 2|Lack of Efficacy|0|||
131737004|NCT01683071|474313518|FG003|Part 2|Lack of Efficacy|0|||
131737005|NCT01683071|474313519|FG004|Part 2|Lack of Efficacy|3|||
131737006|NCT01683071|474313520|FG005|Part 2|Lack of Efficacy|4|||
131737007|NCT01683071|474313515|FG000|Part 2|Lost to Follow-up|0|||
131737008|NCT01683071|474313516|FG001|Part 2|Lost to Follow-up|0|||
131737009|NCT01683071|474313517|FG002|Part 2|Lost to Follow-up|0|||
131737010|NCT01683071|474313518|FG003|Part 2|Lost to Follow-up|0|||
131737011|NCT01683071|474313519|FG004|Part 2|Lost to Follow-up|2|||
131737012|NCT01683071|474313520|FG005|Part 2|Lost to Follow-up|0|||
131737013|NCT01683071|474313515|FG000|Part 2|Withdrawal by Subject|0|||
131737014|NCT01683071|474313516|FG001|Part 2|Withdrawal by Subject|0|||
131737015|NCT01683071|474313517|FG002|Part 2|Withdrawal by Subject|0|||
131737016|NCT01683071|474313518|FG003|Part 2|Withdrawal by Subject|0|||
131737017|NCT01683071|474313519|FG004|Part 2|Withdrawal by Subject|3|||
131737018|NCT01683071|474313520|FG005|Part 2|Withdrawal by Subject|3|||
131737019|NCT01683071|474313515|FG000|Part 2|Surgery cancelled|0|||
131737020|NCT01683071|474313516|FG001|Part 2|Surgery cancelled|0|||
131737021|NCT01683071|474313517|FG002|Part 2|Surgery cancelled|0|||
131737022|NCT01683071|474313518|FG003|Part 2|Surgery cancelled|0|||
131737023|NCT01683071|474313519|FG004|Part 2|Surgery cancelled|4|||
131737024|NCT01683071|474313520|FG005|Part 2|Surgery cancelled|2|||
131737025|NCT01683071|474313515|FG000|Part 2|Did not receive study drug|0|||
131737026|NCT01683071|474313516|FG001|Part 2|Did not receive study drug|0|||
131737027|NCT01683071|474313517|FG002|Part 2|Did not receive study drug|0|||
131737028|NCT01683071|474313518|FG003|Part 2|Did not receive study drug|0|||
131737029|NCT01683071|474313519|FG004|Part 2|Did not receive study drug|2|||
131737030|NCT01683071|474313520|FG005|Part 2|Did not receive study drug|1|||
131737031|NCT01683071|474313515|FG000|Part 2|Met exclusion criterion|0|||
131737032|NCT01683071|474313516|FG001|Part 2|Met exclusion criterion|0|||
131737033|NCT01683071|474313517|FG002|Part 2|Met exclusion criterion|0|||
131737034|NCT01683071|474313518|FG003|Part 2|Met exclusion criterion|0|||
131737035|NCT01683071|474313519|FG004|Part 2|Met exclusion criterion|1|||
131737036|NCT01683071|474313520|FG005|Part 2|Met exclusion criterion|1|||
131737037|NCT01683071|474313515|FG000|Part 2|Protocol deviation|0|||
131737038|NCT01683071|474313516|FG001|Part 2|Protocol deviation|0|||
131737039|NCT01683071|474313517|FG002|Part 2|Protocol deviation|0|||
131737040|NCT01683071|474313518|FG003|Part 2|Protocol deviation|0|||
131737041|NCT01683071|474313519|FG004|Part 2|Protocol deviation|1|||
131737042|NCT01683071|474313520|FG005|Part 2|Protocol deviation|2|||
131737043|NCT01683071|474313515|FG000|Part 2|Withdrawal by investigator decision|0|||
131737044|NCT01683071|474313516|FG001|Part 2|Withdrawal by investigator decision|0|||
131737045|NCT01683071|474313517|FG002|Part 2|Withdrawal by investigator decision|0|||
131737046|NCT01683071|474313518|FG003|Part 2|Withdrawal by investigator decision|0|||
131737047|NCT01683071|474313519|FG004|Part 2|Withdrawal by investigator decision|1|||
131737048|NCT01683071|474313520|FG005|Part 2|Withdrawal by investigator decision|2|||
131737049|NCT01968187|474313526|FG000|Overall Study|Adverse Event|0|||
131737050|NCT01968187|474313527|FG001|Overall Study|Adverse Event|1|||
131737051|NCT01968187|474313526|FG000|Overall Study|Randomized but not treated|1|||
131737052|NCT01968187|474313527|FG001|Overall Study|Randomized but not treated|0|||
131737053|NCT01877382|474313528|FG000|Dose Escalation|Progressive disease|2|||
131737054|NCT01877382|474313529|FG001|Dose Escalation|Progressive disease|0|||
131737055|NCT01877382|474313530|FG002|Dose Escalation|Progressive disease|1|||
131737056|NCT01877382|474313531|FG003|Dose Escalation|Progressive disease|6|||
131808062|NCT00819741|474582926|FG000|Overall Study|Protocol Violation|3|||
131808063|NCT00819741|474582927|FG001|Overall Study|Protocol Violation|4|||
131808064|NCT00819741|474582926|FG000|Overall Study|Withdrawal by Subject|2|||
131808065|NCT00819741|474582927|FG001|Overall Study|Withdrawal by Subject|2|||
131737057|NCT01877382|474313532|FG004|Dose Escalation|Progressive disease|1|||
131737058|NCT01877382|474313533|FG005|Dose Escalation|Progressive disease|0|||
131737059|NCT01877382|474313534|FG006|Dose Escalation|Progressive disease|3|||
131737060|NCT01877382|474313535|FG007|Dose Escalation|Progressive disease|10|||
131737061|NCT01877382|474313536|FG008|Dose Escalation|Progressive disease|4|||
131737062|NCT01877382|474313537|FG009|Dose Escalation|Progressive disease|2|||
131808066|NCT00819741|474582926|FG000|Overall Study|Unclassified|6|||
131808067|NCT00819741|474582927|FG001|Overall Study|Unclassified|0|||
131808068|NCT00819741|474582926|FG000|Overall Study|Reasons unknown|3|||
131808069|NCT00819741|474582927|FG001|Overall Study|Reasons unknown|3|||
131737063|NCT01877382|474313538|FG010|Dose Escalation|Progressive disease|3|||
131737064|NCT01877382|474313539|FG011|Dose Escalation|Progressive disease|3|||
131808070|NCT00119015|474582928|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
131737065|NCT01877382|474313540|FG012|Dose Escalation|Progressive disease|13|||
131737066|NCT01877382|474313541|FG013|Dose Escalation|Progressive disease|1|||
131737067|NCT01877382|474313542|FG014|Dose Escalation|Progressive disease|0|||
131737068|NCT01877382|474313528|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131737069|NCT01877382|474313529|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737070|NCT01877382|474313530|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131808071|NCT00119015|474582929|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
131737071|NCT01877382|474313531|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131737072|NCT01877382|474313532|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737073|NCT01877382|474313533|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737074|NCT01877382|474313534|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131737075|NCT01877382|474313535|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737076|NCT01877382|474313536|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737077|NCT01877382|474313537|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737078|NCT01877382|474313538|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737079|NCT01877382|474313539|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737080|NCT01877382|474313540|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737081|NCT01877382|474313541|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737082|NCT01877382|474313542|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737083|NCT01877382|474313528|FG000|Dose Escalation|Clinical progression|0|||
131737084|NCT01877382|474313529|FG001|Dose Escalation|Clinical progression|1|||
131737085|NCT01877382|474313530|FG002|Dose Escalation|Clinical progression|0|||
131737086|NCT01877382|474313531|FG003|Dose Escalation|Clinical progression|2|||
131737087|NCT01877382|474313532|FG004|Dose Escalation|Clinical progression|0|||
131737088|NCT01877382|474313533|FG005|Dose Escalation|Clinical progression|0|||
131737089|NCT01877382|474313534|FG006|Dose Escalation|Clinical progression|1|||
131737090|NCT01877382|474313535|FG007|Dose Escalation|Clinical progression|0|||
131737091|NCT01877382|474313536|FG008|Dose Escalation|Clinical progression|0|||
131737092|NCT01877382|474313537|FG009|Dose Escalation|Clinical progression|1|||
131737093|NCT01877382|474313538|FG010|Dose Escalation|Clinical progression|0|||
131737094|NCT01877382|474313539|FG011|Dose Escalation|Clinical progression|0|||
131737095|NCT01877382|474313540|FG012|Dose Escalation|Clinical progression|2|||
131737096|NCT01877382|474313541|FG013|Dose Escalation|Clinical progression|1|||
131737097|NCT01877382|474313542|FG014|Dose Escalation|Clinical progression|0|||
131737098|NCT01877382|474313528|FG000|Dose Escalation|Adverse Event|0|||
131737099|NCT01877382|474313529|FG001|Dose Escalation|Adverse Event|0|||
131737100|NCT01877382|474313530|FG002|Dose Escalation|Adverse Event|0|||
131737101|NCT01877382|474313531|FG003|Dose Escalation|Adverse Event|4|||
131737102|NCT01877382|474313532|FG004|Dose Escalation|Adverse Event|1|||
131737103|NCT01877382|474313533|FG005|Dose Escalation|Adverse Event|2|||
131737104|NCT01877382|474313534|FG006|Dose Escalation|Adverse Event|1|||
131737105|NCT01877382|474313535|FG007|Dose Escalation|Adverse Event|2|||
131737106|NCT01877382|474313536|FG008|Dose Escalation|Adverse Event|0|||
131737107|NCT01877382|474313537|FG009|Dose Escalation|Adverse Event|0|||
131737108|NCT01877382|474313538|FG010|Dose Escalation|Adverse Event|0|||
131737109|NCT01877382|474313539|FG011|Dose Escalation|Adverse Event|0|||
131737110|NCT01877382|474313540|FG012|Dose Escalation|Adverse Event|1|||
131737111|NCT01877382|474313541|FG013|Dose Escalation|Adverse Event|0|||
131737112|NCT01877382|474313542|FG014|Dose Escalation|Adverse Event|0|||
131737113|NCT01877382|474313528|FG000|Dose Escalation|Withdrawal by Subject|0|||
131737114|NCT01877382|474313529|FG001|Dose Escalation|Withdrawal by Subject|0|||
131737115|NCT01877382|474313530|FG002|Dose Escalation|Withdrawal by Subject|0|||
131737116|NCT01877382|474313531|FG003|Dose Escalation|Withdrawal by Subject|0|||
131737117|NCT01877382|474313532|FG004|Dose Escalation|Withdrawal by Subject|0|||
131737118|NCT01877382|474313533|FG005|Dose Escalation|Withdrawal by Subject|3|||
131737119|NCT01877382|474313534|FG006|Dose Escalation|Withdrawal by Subject|2|||
131737120|NCT01877382|474313535|FG007|Dose Escalation|Withdrawal by Subject|1|||
131737121|NCT01877382|474313536|FG008|Dose Escalation|Withdrawal by Subject|1|||
131808072|NCT00119015|474582930|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
131808073|NCT01597245|474582931|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
131808074|NCT01597245|474582932|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
131808075|NCT01597245|474582933|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
131808076|NCT01597245|474582934|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
131808077|NCT01597245|474582935|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131737122|NCT01877382|474313537|FG009|Dose Escalation|Withdrawal by Subject|0|||
131737123|NCT01877382|474313538|FG010|Dose Escalation|Withdrawal by Subject|0|||
131808078|NCT01597245|474582936|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131737124|NCT01877382|474313539|FG011|Dose Escalation|Withdrawal by Subject|0|||
131737125|NCT01877382|474313540|FG012|Dose Escalation|Withdrawal by Subject|0|||
131737126|NCT01877382|474313541|FG013|Dose Escalation|Withdrawal by Subject|0|||
131737127|NCT01877382|474313542|FG014|Dose Escalation|Withdrawal by Subject|0|||
131737128|NCT01877382|474313528|FG000|Dose Escalation|Protocol Violation|0|||
131737129|NCT01877382|474313529|FG001|Dose Escalation|Protocol Violation|0|||
131737130|NCT01877382|474313530|FG002|Dose Escalation|Protocol Violation|0|||
131737131|NCT01877382|474313531|FG003|Dose Escalation|Protocol Violation|0|||
131737132|NCT01877382|474313532|FG004|Dose Escalation|Protocol Violation|0|||
131737133|NCT01877382|474313533|FG005|Dose Escalation|Protocol Violation|0|||
131737134|NCT01877382|474313534|FG006|Dose Escalation|Protocol Violation|1|||
131737135|NCT01877382|474313535|FG007|Dose Escalation|Protocol Violation|0|||
131737136|NCT01877382|474313536|FG008|Dose Escalation|Protocol Violation|0|||
131737137|NCT01877382|474313537|FG009|Dose Escalation|Protocol Violation|0|||
131737138|NCT01877382|474313538|FG010|Dose Escalation|Protocol Violation|0|||
131737139|NCT01877382|474313539|FG011|Dose Escalation|Protocol Violation|0|||
131737140|NCT01877382|474313540|FG012|Dose Escalation|Protocol Violation|0|||
131737141|NCT01877382|474313541|FG013|Dose Escalation|Protocol Violation|0|||
131737142|NCT01877382|474313542|FG014|Dose Escalation|Protocol Violation|0|||
131737143|NCT01877382|474313528|FG000|Dose Escalation|Study terminated by sponsor|0|||
131737144|NCT01877382|474313529|FG001|Dose Escalation|Study terminated by sponsor|0|||
131737145|NCT01877382|474313530|FG002|Dose Escalation|Study terminated by sponsor|0|||
131737146|NCT01877382|474313531|FG003|Dose Escalation|Study terminated by sponsor|0|||
131737147|NCT01877382|474313532|FG004|Dose Escalation|Study terminated by sponsor|0|||
131737148|NCT01877382|474313533|FG005|Dose Escalation|Study terminated by sponsor|0|||
131737149|NCT01877382|474313534|FG006|Dose Escalation|Study terminated by sponsor|0|||
131737150|NCT01877382|474313535|FG007|Dose Escalation|Study terminated by sponsor|1|||
131737151|NCT01877382|474313536|FG008|Dose Escalation|Study terminated by sponsor|1|||
131737152|NCT01877382|474313537|FG009|Dose Escalation|Study terminated by sponsor|0|||
131737153|NCT01877382|474313538|FG010|Dose Escalation|Study terminated by sponsor|0|||
131737154|NCT01877382|474313539|FG011|Dose Escalation|Study terminated by sponsor|0|||
131737155|NCT01877382|474313540|FG012|Dose Escalation|Study terminated by sponsor|3|||
131737156|NCT01877382|474313541|FG013|Dose Escalation|Study terminated by sponsor|0|||
131737157|NCT01877382|474313542|FG014|Dose Escalation|Study terminated by sponsor|0|||
131737158|NCT01877382|474313528|FG000|Dose Escalation|Death|0|||
131737159|NCT01877382|474313529|FG001|Dose Escalation|Death|0|||
131737160|NCT01877382|474313530|FG002|Dose Escalation|Death|0|||
131737161|NCT01877382|474313531|FG003|Dose Escalation|Death|0|||
131737162|NCT01877382|474313532|FG004|Dose Escalation|Death|0|||
131737163|NCT01877382|474313533|FG005|Dose Escalation|Death|0|||
131737164|NCT01877382|474313534|FG006|Dose Escalation|Death|0|||
131737165|NCT01877382|474313535|FG007|Dose Escalation|Death|1|||
131737166|NCT01877382|474313536|FG008|Dose Escalation|Death|0|||
131737167|NCT01877382|474313537|FG009|Dose Escalation|Death|0|||
131737168|NCT01877382|474313538|FG010|Dose Escalation|Death|0|||
131737169|NCT01877382|474313539|FG011|Dose Escalation|Death|0|||
131737170|NCT01877382|474313540|FG012|Dose Escalation|Death|1|||
131737171|NCT01877382|474313541|FG013|Dose Escalation|Death|1|||
131737172|NCT01877382|474313542|FG014|Dose Escalation|Death|0|||
131737173|NCT01877382|474313528|FG000|Dose Expansion|Progressive disease|0|||
131737174|NCT01877382|474313529|FG001|Dose Expansion|Progressive disease|0|||
131737175|NCT01877382|474313530|FG002|Dose Expansion|Progressive disease|0|||
131737176|NCT01877382|474313531|FG003|Dose Expansion|Progressive disease|0|||
131737177|NCT01877382|474313532|FG004|Dose Expansion|Progressive disease|0|||
131737178|NCT01877382|474313533|FG005|Dose Expansion|Progressive disease|0|||
131737179|NCT01877382|474313534|FG006|Dose Expansion|Progressive disease|0|||
131737180|NCT01877382|474313535|FG007|Dose Expansion|Progressive disease|0|||
131737181|NCT01877382|474313536|FG008|Dose Expansion|Progressive disease|0|||
131737182|NCT01877382|474313537|FG009|Dose Expansion|Progressive disease|0|||
131737183|NCT01877382|474313538|FG010|Dose Expansion|Progressive disease|0|||
131737184|NCT01877382|474313539|FG011|Dose Expansion|Progressive disease|0|||
131737185|NCT01877382|474313540|FG012|Dose Expansion|Progressive disease|0|||
131737186|NCT01877382|474313541|FG013|Dose Expansion|Progressive disease|0|||
131737187|NCT01877382|474313542|FG014|Dose Expansion|Progressive disease|11|||
131737188|NCT01877382|474313528|FG000|Dose Expansion|Clinical progression|0|||
131737189|NCT01877382|474313529|FG001|Dose Expansion|Clinical progression|0|||
131737190|NCT01877382|474313530|FG002|Dose Expansion|Clinical progression|0|||
131737191|NCT01877382|474313531|FG003|Dose Expansion|Clinical progression|0|||
131737192|NCT01877382|474313532|FG004|Dose Expansion|Clinical progression|0|||
131737193|NCT01877382|474313533|FG005|Dose Expansion|Clinical progression|0|||
131737194|NCT01877382|474313534|FG006|Dose Expansion|Clinical progression|0|||
131737195|NCT01877382|474313535|FG007|Dose Expansion|Clinical progression|0|||
131737196|NCT01877382|474313536|FG008|Dose Expansion|Clinical progression|0|||
131737197|NCT01877382|474313537|FG009|Dose Expansion|Clinical progression|0|||
131808079|NCT01597245|474582937|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808080|NCT01597245|474582938|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131737198|NCT01877382|474313538|FG010|Dose Expansion|Clinical progression|0|||
131737199|NCT01877382|474313539|FG011|Dose Expansion|Clinical progression|0|||
131737200|NCT01877382|474313540|FG012|Dose Expansion|Clinical progression|0|||
131737201|NCT01877382|474313541|FG013|Dose Expansion|Clinical progression|0|||
131737202|NCT01877382|474313542|FG014|Dose Expansion|Clinical progression|6|||
131808081|NCT01597245|474582939|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131737203|NCT01877382|474313528|FG000|Dose Expansion|Adverse Event|0|||
131737204|NCT01877382|474313529|FG001|Dose Expansion|Adverse Event|0|||
131737205|NCT01877382|474313530|FG002|Dose Expansion|Adverse Event|0|||
131737206|NCT01877382|474313531|FG003|Dose Expansion|Adverse Event|0|||
131737207|NCT01877382|474313532|FG004|Dose Expansion|Adverse Event|0|||
131737208|NCT01877382|474313533|FG005|Dose Expansion|Adverse Event|0|||
131737209|NCT01877382|474313534|FG006|Dose Expansion|Adverse Event|0|||
131737210|NCT01877382|474313535|FG007|Dose Expansion|Adverse Event|0|||
131737211|NCT01877382|474313536|FG008|Dose Expansion|Adverse Event|0|||
131737212|NCT01877382|474313537|FG009|Dose Expansion|Adverse Event|0|||
131737213|NCT01877382|474313538|FG010|Dose Expansion|Adverse Event|0|||
131737214|NCT01877382|474313539|FG011|Dose Expansion|Adverse Event|0|||
131737215|NCT01877382|474313540|FG012|Dose Expansion|Adverse Event|0|||
131737216|NCT01877382|474313541|FG013|Dose Expansion|Adverse Event|0|||
131737217|NCT01877382|474313542|FG014|Dose Expansion|Adverse Event|1|||
131737218|NCT01877382|474313528|FG000|Dose Expansion|Death|0|||
131737219|NCT01877382|474313529|FG001|Dose Expansion|Death|0|||
131737220|NCT01877382|474313530|FG002|Dose Expansion|Death|0|||
131737221|NCT01877382|474313531|FG003|Dose Expansion|Death|0|||
131737222|NCT01877382|474313532|FG004|Dose Expansion|Death|0|||
131737223|NCT01877382|474313533|FG005|Dose Expansion|Death|0|||
131737224|NCT01877382|474313534|FG006|Dose Expansion|Death|0|||
131737225|NCT01877382|474313535|FG007|Dose Expansion|Death|0|||
131737226|NCT01877382|474313536|FG008|Dose Expansion|Death|0|||
131737227|NCT01877382|474313537|FG009|Dose Expansion|Death|0|||
131737228|NCT01877382|474313538|FG010|Dose Expansion|Death|0|||
131737229|NCT01877382|474313539|FG011|Dose Expansion|Death|0|||
131737230|NCT01877382|474313540|FG012|Dose Expansion|Death|0|||
131737231|NCT01877382|474313541|FG013|Dose Expansion|Death|0|||
131737232|NCT01877382|474313542|FG014|Dose Expansion|Death|1|||
131737233|NCT01877382|474313528|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737234|NCT01877382|474313529|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737235|NCT01877382|474313530|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737236|NCT01877382|474313531|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737237|NCT01877382|474313532|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737238|NCT01877382|474313533|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737239|NCT01877382|474313534|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737240|NCT01877382|474313535|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737241|NCT01877382|474313536|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737242|NCT01877382|474313537|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737243|NCT01877382|474313538|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131808082|NCT01597245|474582940|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808083|NCT01597245|474582941|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808084|NCT01597245|474582942|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808085|NCT01597245|474582943|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808086|NCT01597245|474582944|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808087|NCT01597245|474582945|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808088|NCT01597245|474582946|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808089|NCT01597245|474582947|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808090|NCT01597245|474582948|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808091|NCT01597245|474582949|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808092|NCT01597245|474582950|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808093|NCT01597245|474582951|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
131808094|NCT01597245|474582931|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
131808095|NCT01597245|474582932|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
131808096|NCT01597245|474582933|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
131808097|NCT01597245|474582934|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
131808098|NCT01597245|474582935|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808099|NCT01597245|474582936|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808100|NCT01597245|474582937|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808101|NCT01597245|474582938|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808102|NCT01597245|474582939|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808103|NCT01597245|474582940|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131737244|NCT01877382|474313539|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737245|NCT01877382|474313540|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737246|NCT01877382|474313541|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131737247|NCT01877382|474313542|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131808104|NCT01597245|474582941|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131737248|NCT04095286|474313545|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737249|NCT04095286|474313546|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
131737250|NCT04095286|474313547|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737251|NCT04095286|474313548|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737252|NCT04095286|474313549|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737253|NCT04095286|474313550|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737254|NCT04095286|474313545|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
131737255|NCT04095286|474313546|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131737256|NCT04095286|474313547|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131737257|NCT04095286|474313548|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131737258|NCT04095286|474313549|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131737259|NCT04095286|474313550|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131737260|NCT04095286|474313545|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131737261|NCT04095286|474313546|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131737262|NCT04095286|474313547|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
131737263|NCT04095286|474313548|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131737264|NCT04095286|474313549|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131737265|NCT04095286|474313550|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131737266|NCT04095286|474313545|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737267|NCT04095286|474313546|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737268|NCT04095286|474313547|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
131737269|NCT04095286|474313548|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737270|NCT04095286|474313549|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737271|NCT04095286|474313550|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131737272|NCT04095286|474313545|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131737273|NCT04095286|474313546|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131737274|NCT04095286|474313547|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131737275|NCT04095286|474313548|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131737276|NCT04095286|474313549|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
131737277|NCT04095286|474313550|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131737278|NCT02395653|474315236|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
131737279|NCT02395653|474315236|FG000|Overall Study|Consent Withdrawn at Screening|1|||
131737280|NCT02395653|474315236|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
131737281|NCT02395653|474315236|FG000|Overall Study|Investigator Decision at Screening|1|||
131737282|NCT02395653|474315236|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
131737283|NCT02395653|474315236|FG000|Overall Study|Withdrawal by Subject|1|||
131737284|NCT02395653|474315236|FG000|Overall Study|Lost to Follow-up|1|||
131737285|NCT00296725|474315240|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
131737286|NCT00296725|474315240|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
131737287|NCT00296725|474315240|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
131737288|NCT02622724|474315241|FG000|Overall Study|Death|51|||
131737289|NCT02622724|474315242|FG001|Overall Study|Death|53|||
131737290|NCT02622724|474315241|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
131737291|NCT02622724|474315242|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
131737292|NCT02622724|474315241|FG000|Overall Study|Early termination of study|38|||
131737293|NCT02622724|474315242|FG001|Overall Study|Early termination of study|43|||
131737294|NCT00487084|474315243|FG000|Overall Study|Did not receive intervention|4|||
131737295|NCT00487084|474315244|FG001|Overall Study|Did not receive intervention|3|||
131737296|NCT00487084|474315245|FG002|Overall Study|Did not receive intervention|5|||
131737297|NCT00356863|474315246|FG000|Overall Study|Death|16|||
131737298|NCT00356863|474315247|FG001|Overall Study|Death|32|||
131737299|NCT00356863|474315246|FG000|Overall Study|Lost to Follow-up|76|||
131737300|NCT00356863|474315247|FG001|Overall Study|Lost to Follow-up|43|||
131737301|NCT00333619|474315248|FG000|Overall Study|Death|12|||
131737302|NCT00333619|474315249|FG001|Overall Study|Death|6|||
131737303|NCT00333619|474315248|FG000|Overall Study|Withdrawal by Subject|6|||
131737304|NCT00333619|474315249|FG001|Overall Study|Withdrawal by Subject|1|||
131737305|NCT00333619|474315248|FG000|Overall Study|Lost to Follow-up|3|||
131737306|NCT00333619|474315249|FG001|Overall Study|Lost to Follow-up|3|||
131737307|NCT00280150|474315250|FG000|Overall Study|Adverse Event|0|||
131737308|NCT00280150|474315251|FG001|Overall Study|Adverse Event|1|||
131737309|NCT00280150|474315252|FG002|Overall Study|Adverse Event|2|||
131737310|NCT00280150|474315253|FG003|Overall Study|Adverse Event|3|||
131737311|NCT00280150|474315250|FG000|Overall Study|Lack of Efficacy|0|||
131737312|NCT00280150|474315251|FG001|Overall Study|Lack of Efficacy|0|||
131737313|NCT00280150|474315252|FG002|Overall Study|Lack of Efficacy|0|||
131737314|NCT00280150|474315253|FG003|Overall Study|Lack of Efficacy|3|||
131737315|NCT00280150|474315250|FG000|Overall Study|Physician Decision|0|||
131737316|NCT00280150|474315251|FG001|Overall Study|Physician Decision|0|||
131737317|NCT00280150|474315252|FG002|Overall Study|Physician Decision|0|||
131737318|NCT00280150|474315253|FG003|Overall Study|Physician Decision|1|||
131737319|NCT00280150|474315250|FG000|Overall Study|Protocol Violation|0|||
131808105|NCT01597245|474582942|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131737320|NCT00280150|474315251|FG001|Overall Study|Protocol Violation|0|||
131737321|NCT00280150|474315252|FG002|Overall Study|Protocol Violation|0|||
131737322|NCT00280150|474315253|FG003|Overall Study|Protocol Violation|1|||
131737323|NCT00280150|474315250|FG000|Overall Study|Withdrawal by Subject|0|||
131737324|NCT00280150|474315251|FG001|Overall Study|Withdrawal by Subject|0|||
131737325|NCT00280150|474315252|FG002|Overall Study|Withdrawal by Subject|0|||
131737326|NCT00280150|474315253|FG003|Overall Study|Withdrawal by Subject|1|||
131737327|NCT00280150|474315250|FG000|Overall Study|Did not get consolidation therapy|3|||
131737328|NCT00280150|474315251|FG001|Overall Study|Did not get consolidation therapy|0|||
131737329|NCT00280150|474315252|FG002|Overall Study|Did not get consolidation therapy|3|||
131737330|NCT00280150|474315253|FG003|Overall Study|Did not get consolidation therapy|0|||
131737331|NCT00280150|474315250|FG000|Overall Study|Declining Performance Status|0|||
131737332|NCT00280150|474315251|FG001|Overall Study|Declining Performance Status|0|||
131737333|NCT00280150|474315252|FG002|Overall Study|Declining Performance Status|0|||
131737334|NCT00280150|474315253|FG003|Overall Study|Declining Performance Status|1|||
131737335|NCT02690207|474315260|FG000|Overall Study|Lost to Follow-up|48|||
131737336|NCT02690207|474315260|FG000|Overall Study|Withdrawal by Subject|46|||
131737337|NCT02690207|474315260|FG000|Overall Study|Protocol Violation|2|||
131737338|NCT02690207|474315260|FG000|Overall Study|Serious adverse event|110|||
131737339|NCT02690207|474315260|FG000|Overall Study|Non-serious Adverse Event|18|||
131737340|NCT02690207|474315260|FG000|Overall Study|Migrated/moved from study area|5|||
131737341|NCT02690207|474315260|FG000|Overall Study|Suspected HZ Episode|1|||
131905293|NCT01926028|474940871|FG002|Overall Study|Non compliance or other reasons|0|||
131905294|NCT04635839|474940872|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
131737342|NCT02690207|474315260|FG000|Overall Study|Other reasons for withdrawal|23|||
131737343|NCT03712345|474315263|FG000|Overall Study|Failure to meet randomization criteria|0|||
131737344|NCT03712345|474315264|FG001|Overall Study|Failure to meet randomization criteria|0|||
131737345|NCT03712345|474315265|FG002|Overall Study|Failure to meet randomization criteria|1|||
131737346|NCT02338492|474315266|FG000|Overall Study|Death|32|||
131737347|NCT02338492|474315266|FG000|Overall Study|Adverse Event|3|||
131737348|NCT02338492|474315266|FG000|Overall Study|Lost to Follow-up|4|||
131737349|NCT02338492|474315266|FG000|Overall Study|Reason not captured above|6|||
131737350|NCT00485589|474315267|FG000|Overall Study|Death|2|||
131737351|NCT00485589|474315268|FG001|Overall Study|Death|2|||
131737352|NCT00485589|474315269|FG002|Overall Study|Death|0|||
131737353|NCT00485589|474315267|FG000|Overall Study|Failure to return|6|||
131737354|NCT00485589|474315268|FG001|Overall Study|Failure to return|5|||
131737355|NCT00485589|474315269|FG002|Overall Study|Failure to return|1|||
131737356|NCT00485589|474315267|FG000|Overall Study|Protocol Violation|1|||
131737357|NCT00485589|474315268|FG001|Overall Study|Protocol Violation|0|||
131737358|NCT00485589|474315269|FG002|Overall Study|Protocol Violation|0|||
131737359|NCT00485589|474315267|FG000|Overall Study|Violation of selection criteria at entry|0|||
131737360|NCT00485589|474315268|FG001|Overall Study|Violation of selection criteria at entry|3|||
131737361|NCT00485589|474315269|FG002|Overall Study|Violation of selection criteria at entry|1|||
131737362|NCT00485589|474315267|FG000|Overall Study|Administrative/Other|1|||
131737363|NCT00485589|474315268|FG001|Overall Study|Administrative/Other|2|||
131737364|NCT00485589|474315269|FG002|Overall Study|Administrative/Other|1|||
131737365|NCT00485589|474315267|FG000|Overall Study|Insufficient therapeutic response|10|||
131737366|NCT00485589|474315268|FG001|Overall Study|Insufficient therapeutic response|3|||
131737367|NCT00485589|474315269|FG002|Overall Study|Insufficient therapeutic response|1|||
131737368|NCT00485589|474315267|FG000|Overall Study|Refused treatment/did not cooperate|1|||
131737369|NCT00485589|474315268|FG001|Overall Study|Refused treatment/did not cooperate|0|||
131737370|NCT00485589|474315269|FG002|Overall Study|Refused treatment/did not cooperate|2|||
131737371|NCT00485589|474315267|FG000|Overall Study|Withdrawal by Subject|3|||
131737372|NCT00485589|474315268|FG001|Overall Study|Withdrawal by Subject|2|||
131737373|NCT00485589|474315269|FG002|Overall Study|Withdrawal by Subject|2|||
131737374|NCT00485589|474315267|FG000|Overall Study|Adverse Event|3|||
131737375|NCT00485589|474315268|FG001|Overall Study|Adverse Event|3|||
131737376|NCT00485589|474315269|FG002|Overall Study|Adverse Event|10|||
131737377|NCT02585999|474315270|FG000|Overall Study|Lost to Follow-up|1|||
131737378|NCT02585999|474315270|FG000|Overall Study|Protocol Violation|1|||
131737379|NCT01369849|474315271|FG000|Overall Study|Ineligible prior to treatment|0|||
131737380|NCT01369849|474315272|FG001|Overall Study|Ineligible prior to treatment|0|||
131737381|NCT01369849|474315273|FG002|Overall Study|Ineligible prior to treatment|1|||
131737382|NCT01369849|474315271|FG000|Overall Study|Ineligible after receiving treatment|0|||
131737383|NCT01369849|474315272|FG001|Overall Study|Ineligible after receiving treatment|1|||
131737384|NCT01369849|474315273|FG002|Overall Study|Ineligible after receiving treatment|0|||
131737385|NCT00756886|474315274|FG000|Overall Study|Lost to Follow-up|1|||
131737386|NCT00756886|474315275|FG001|Overall Study|Lost to Follow-up|0|||
131737387|NCT00756886|474315274|FG000|Overall Study|Adverse Event|0|||
131737388|NCT00756886|474315275|FG001|Overall Study|Adverse Event|3|||
131737389|NCT00756886|474315274|FG000|Overall Study|Lack of Efficacy|1|||
131737390|NCT00756886|474315275|FG001|Overall Study|Lack of Efficacy|0|||
131737391|NCT00756886|474315274|FG000|Overall Study|Ineligible|9|||
131737392|NCT00756886|474315275|FG001|Overall Study|Ineligible|4|||
131737393|NCT00174785|474315279|FG000|Overall Study|Adverse Event|293|||
131737394|NCT00174785|474315280|FG001|Overall Study|Adverse Event|191|||
131737395|NCT00174785|474315279|FG000|Overall Study|Protocol Violation|14|||
131737396|NCT00174785|474315280|FG001|Overall Study|Protocol Violation|14|||
131737397|NCT00174785|474315279|FG000|Overall Study|Withdrawal by Subject|173|||
131737398|NCT00174785|474315280|FG001|Overall Study|Withdrawal by Subject|175|||
131737399|NCT00174785|474315279|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
131737400|NCT00174785|474315280|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
131737401|NCT00174785|474315279|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
131737402|NCT00174785|474315280|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
131737403|NCT00174785|474315279|FG000|Overall Study|Other prohibited medication|5|||
131737404|NCT00174785|474315280|FG001|Overall Study|Other prohibited medication|3|||
131737405|NCT00174785|474315279|FG000|Overall Study|Family request|6|||
131737406|NCT00174785|474315280|FG001|Overall Study|Family request|8|||
131737407|NCT00174785|474315279|FG000|Overall Study|Not pre-specified/Not coded|56|||
131737408|NCT00174785|474315280|FG001|Overall Study|Not pre-specified/Not coded|70|||
131737409|NCT00120289|474315282|FG000|Overall Study|Death|96|||
131737410|NCT00120289|474315283|FG001|Overall Study|Death|82|||
131737411|NCT00120289|474315282|FG000|Overall Study|Lost to Follow-up|11|||
131737412|NCT00120289|474315283|FG001|Overall Study|Lost to Follow-up|14|||
131737413|NCT00120289|474315282|FG000|Overall Study|Withdrawal by Subject|14|||
131737414|NCT00120289|474315283|FG001|Overall Study|Withdrawal by Subject|13|||
131737415|NCT01944969|474315284|FG000|Overall Study|Adverse Event|1|||
131737416|NCT01944969|474315284|FG000|Overall Study|Lack of Efficacy|1|||
131737417|NCT01944969|474315284|FG000|Overall Study|Non-compliance with IMP|1|||
131737418|NCT01944969|474315284|FG000|Overall Study|Administrative or other reasons|23|||
131737419|NCT00310388|474315285|FG000|Primary Reporting Phase|Adverse Event|101|||
131737420|NCT00310388|474315286|FG001|Primary Reporting Phase|Adverse Event|0|||
131737421|NCT00310388|474315285|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
131737422|NCT00310388|474315286|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
131737423|NCT00310388|474315285|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
131737424|NCT00310388|474315286|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
131737425|NCT00310388|474315285|FG000|Primary Reporting Phase|Protocol Violation|10|||
131737426|NCT00310388|474315286|FG001|Primary Reporting Phase|Protocol Violation|0|||
131737427|NCT00310388|474315285|FG000|Primary Reporting Phase|Pregnancy|3|||
131737428|NCT00310388|474315286|FG001|Primary Reporting Phase|Pregnancy|0|||
131737429|NCT00310388|474315285|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
131737430|NCT00310388|474315286|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
131737431|NCT00310388|474315285|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
131737432|NCT00310388|474315286|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
131737433|NCT00310388|474315285|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
131737434|NCT00310388|474315286|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
131737435|NCT00310388|474315285|FG000|Primary Reporting Phase|Physician Decision|2|||
131737436|NCT00310388|474315286|FG001|Primary Reporting Phase|Physician Decision|0|||
131737437|NCT00310388|474315285|FG000|Primary Reporting Phase|Request of the sponsor|19|||
131737438|NCT00310388|474315286|FG001|Primary Reporting Phase|Request of the sponsor|0|||
131737439|NCT00310388|474315285|FG000|Primary Reporting Phase|Failed to return|8|||
131737440|NCT00310388|474315286|FG001|Primary Reporting Phase|Failed to return|0|||
131737441|NCT00310388|474315285|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
131737442|NCT00310388|474315286|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
131737443|NCT00310388|474315285|FG000|Primary Reporting Phase|Participant request|2|||
131737444|NCT00310388|474315286|FG001|Primary Reporting Phase|Participant request|0|||
131737445|NCT00310388|474315285|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
131737446|NCT00310388|474315286|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
131737447|NCT00310388|474315285|FG000|Primary Reporting Phase|Discontinuation of study|1|||
131737448|NCT00310388|474315286|FG001|Primary Reporting Phase|Discontinuation of study|0|||
131737449|NCT00310388|474315285|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
131737450|NCT00310388|474315286|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
131737451|NCT00310388|474315285|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
131737452|NCT00310388|474315286|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
131737453|NCT00310388|474315285|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
131737454|NCT00310388|474315286|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
131737455|NCT00310388|474315285|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
131737456|NCT00310388|474315286|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
131737457|NCT00310388|474315285|FG000|Primary Reporting Phase|Participant passed away|1|||
131737458|NCT00310388|474315286|FG001|Primary Reporting Phase|Participant passed away|0|||
131737459|NCT00310388|474315285|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
131737460|NCT00310388|474315286|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
131737461|NCT00310388|474315285|FG000|Primary Reporting Phase|Missing|1|||
131737462|NCT00310388|474315286|FG001|Primary Reporting Phase|Missing|0|||
131737463|NCT00310388|474315285|FG000|Primary Reporting Phase|Other|1|||
131737464|NCT00310388|474315286|FG001|Primary Reporting Phase|Other|0|||
131737465|NCT00310388|474315285|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
131737466|NCT00310388|474315286|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
131737467|NCT00310388|474315285|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
131737468|NCT00310388|474315286|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
131737469|NCT00310388|474315285|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
131737470|NCT00310388|474315286|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
131808106|NCT01597245|474582943|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808107|NCT01597245|474582944|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808108|NCT01597245|474582945|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808109|NCT01597245|474582946|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808110|NCT01597245|474582947|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808111|NCT01597245|474582948|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808112|NCT01597245|474582949|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808113|NCT01597245|474582950|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808114|NCT01597245|474582951|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
131808115|NCT01597245|474582931|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
131808116|NCT01597245|474582932|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
131808117|NCT01597245|474582933|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
131808118|NCT01597245|474582934|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
131808119|NCT01597245|474582935|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808120|NCT01597245|474582936|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808121|NCT01597245|474582937|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808122|NCT01597245|474582938|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808123|NCT01597245|474582939|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808124|NCT01597245|474582940|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808125|NCT01597245|474582941|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808126|NCT01597245|474582942|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808127|NCT01597245|474582943|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808128|NCT01597245|474582944|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808129|NCT01597245|474582945|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808130|NCT01597245|474582946|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808131|NCT01597245|474582947|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808132|NCT01597245|474582948|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808133|NCT01597245|474582949|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808134|NCT01597245|474582950|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808135|NCT01597245|474582951|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
131808136|NCT01597245|474582931|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
131808137|NCT01597245|474582932|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
131808138|NCT01597245|474582933|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
131808139|NCT01597245|474582934|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808140|NCT01597245|474582935|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808141|NCT01597245|474582936|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808142|NCT01597245|474582937|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808143|NCT01597245|474582938|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808144|NCT01597245|474582939|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808145|NCT01597245|474582940|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808146|NCT01597245|474582941|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808147|NCT01597245|474582942|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808148|NCT01597245|474582943|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808149|NCT01597245|474582944|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808150|NCT01597245|474582945|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808151|NCT01597245|474582946|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808152|NCT01597245|474582947|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131737471|NCT00310388|474315285|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
131808153|NCT01597245|474582948|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808154|NCT01597245|474582949|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808155|NCT01597245|474582950|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808156|NCT01597245|474582951|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
131808157|NCT01597245|474582931|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
131808158|NCT01597245|474582932|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808159|NCT01597245|474582933|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808160|NCT01597245|474582934|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
131808161|NCT01597245|474582935|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808162|NCT01597245|474582936|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808163|NCT01597245|474582937|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808164|NCT01597245|474582938|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808165|NCT01597245|474582939|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808166|NCT01597245|474582940|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808167|NCT01597245|474582941|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808168|NCT01597245|474582942|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131737472|NCT00310388|474315286|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
131737473|NCT03421964|474315300|FG000|Overall Study|Lost to Follow-up|11|||
131737474|NCT03421964|474315301|FG001|Overall Study|Lost to Follow-up|21|||
131737475|NCT03421964|474315300|FG000|Overall Study|Withdrawal by Subject|9|||
131737476|NCT03421964|474315301|FG001|Overall Study|Withdrawal by Subject|3|||
131737477|NCT03421964|474315300|FG000|Overall Study|Incarcerated|1|||
131737478|NCT03421964|474315301|FG001|Overall Study|Incarcerated|0|||
131737479|NCT03421964|474315300|FG000|Overall Study|Inpt Treatment Facility|1|||
131737480|NCT03421964|474315301|FG001|Overall Study|Inpt Treatment Facility|1|||
131737481|NCT03421964|474315300|FG000|Overall Study|Virtual Platform Issues|1|||
131737482|NCT03421964|474315301|FG001|Overall Study|Virtual Platform Issues|1|||
131737483|NCT02938585|474315302|FG000|Overall Study|Withdrawal by parent or guardian|0|||
131737484|NCT02938585|474315303|FG001|Overall Study|Withdrawal by parent or guardian|1|||
131737485|NCT02938585|474315304|FG002|Overall Study|Withdrawal by parent or guardian|0|||
131737486|NCT02938585|474315305|FG003|Overall Study|Withdrawal by parent or guardian|0|||
131737487|NCT02938585|474315302|FG000|Overall Study|Withdrawal by Subject|0|||
131737488|NCT02938585|474315303|FG001|Overall Study|Withdrawal by Subject|0|||
131737489|NCT02938585|474315304|FG002|Overall Study|Withdrawal by Subject|0|||
131737490|NCT02938585|474315305|FG003|Overall Study|Withdrawal by Subject|5|||
131737491|NCT00229203|474315309|FG000|Overall Study|Progressive disease|18|||
131737492|NCT00229203|474315310|FG001|Overall Study|Progressive disease|9|||
131737493|NCT00229203|474315309|FG000|Overall Study|Toxicity|6|||
131737494|NCT00229203|474315310|FG001|Overall Study|Toxicity|1|||
131737495|NCT00229203|474315309|FG000|Overall Study|Death|4|||
131737496|NCT00229203|474315310|FG001|Overall Study|Death|2|||
131737497|NCT00229203|474315309|FG000|Overall Study|Other|3|||
131737498|NCT00229203|474315310|FG001|Overall Study|Other|3|||
131737499|NCT00229203|474315309|FG000|Overall Study|Withdrawal by Subject|1|||
131737500|NCT00229203|474315310|FG001|Overall Study|Withdrawal by Subject|4|||
131737501|NCT00213980|474315311|FG000|Overall Study|Withdrawal by Subject|3|||
131737502|NCT00213980|474315312|FG001|Overall Study|Withdrawal by Subject|1|||
131737503|NCT00213980|474315311|FG000|Overall Study|Adverse Event|1|||
131737504|NCT00213980|474315312|FG001|Overall Study|Adverse Event|1|||
131737505|NCT00213980|474315311|FG000|Overall Study|Disease progression|0|||
131737506|NCT00213980|474315312|FG001|Overall Study|Disease progression|2|||
131737507|NCT00213980|474315311|FG000|Overall Study|Developed ovarian cancer|1|||
131737508|NCT00213980|474315312|FG001|Overall Study|Developed ovarian cancer|0|||
131737509|NCT00213980|474315311|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
131737510|NCT00213980|474315312|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
131737511|NCT03607838|474315313|FG000|Overall Study|Lack of Efficacy|14|||
131737512|NCT03607838|474315314|FG001|Overall Study|Lack of Efficacy|20|||
131737513|NCT03607838|474315313|FG000|Overall Study|Withdrawal by Subject|13|||
131737514|NCT03607838|474315314|FG001|Overall Study|Withdrawal by Subject|8|||
131737515|NCT03607838|474315313|FG000|Overall Study|Lost to Follow-up|6|||
131737516|NCT03607838|474315314|FG001|Overall Study|Lost to Follow-up|11|||
131737517|NCT03607838|474315313|FG000|Overall Study|Adverse Event|2|||
131737518|NCT03607838|474315314|FG001|Overall Study|Adverse Event|2|||
131737519|NCT03607838|474315313|FG000|Overall Study|Physician Decision|2|||
131737520|NCT03607838|474315314|FG001|Overall Study|Physician Decision|0|||
131737521|NCT03607838|474315313|FG000|Overall Study|Failure to meet randomization criteria|1|||
131808169|NCT01597245|474582943|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808170|NCT01597245|474582944|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131737522|NCT03607838|474315314|FG001|Overall Study|Failure to meet randomization criteria|2|||
131737523|NCT03607838|474315313|FG000|Overall Study|Pregnancy|1|||
131737524|NCT03607838|474315314|FG001|Overall Study|Pregnancy|0|||
131737525|NCT03607838|474315313|FG000|Overall Study|Protocol Violation|1|||
131737526|NCT03607838|474315314|FG001|Overall Study|Protocol Violation|0|||
131737527|NCT03607838|474315313|FG000|Overall Study|Due to work|1|||
131737528|NCT03607838|474315314|FG001|Overall Study|Due to work|0|||
131737529|NCT03607838|474315313|FG000|Overall Study|Litigation|0|||
131737530|NCT03607838|474315314|FG001|Overall Study|Litigation|1|||
131737531|NCT03607838|474315313|FG000|Overall Study|Temperature excursion for study drug|0|||
131737532|NCT03607838|474315314|FG001|Overall Study|Temperature excursion for study drug|1|||
131737533|NCT03607838|474315313|FG000|Overall Study|Change of mind|0|||
131737534|NCT03607838|474315314|FG001|Overall Study|Change of mind|1|||
131737535|NCT02411201|474315315|FG000|Overall Study|Adverse Event|2|||
131737536|NCT02411201|474315315|FG000|Overall Study|Withdrawal by Subject|2|||
131737537|NCT02411201|474315315|FG000|Overall Study|Age group completed|2|||
131737538|NCT01260467|474315316|FG000|Overall Study|Withdrawal by Subject|2|||
131737539|NCT03364608|474315325|FG000|Overall Study|Withdrawal by Subject|4|||
131737540|NCT03364608|474315325|FG000|Overall Study|Protocol Violation|2|||
131737541|NCT03364608|474315325|FG000|Overall Study|Lost to Follow-up|2|||
131737542|NCT03888391|474315328|FG000|Overall Study|Lost to Follow-up|15|||
131737543|NCT00423735|474315329|FG000|Overall Study|Ineligible / No protocol treatment|8|||
131737544|NCT00423735|474315330|FG001|Overall Study|Ineligible / No protocol treatment|6|||
131737545|NCT00423735|474315331|FG002|Overall Study|Ineligible / No protocol treatment|0|||
131737546|NCT00579501|474315338|FG000|Overall Study|Death|1|||
131737547|NCT00579501|474315338|FG000|Overall Study|End of neoadjuvant therapy|25|||
131737548|NCT00579501|474315338|FG000|Overall Study|toxicity|1|||
131737549|NCT00579501|474315338|FG000|Overall Study|Secondary lesion|1|||
131737550|NCT00579501|474315338|FG000|Overall Study|Radiation therapy before surgery|1|||
131737551|NCT02504268|474315340|FG000|Overall Study|Adverse Event|18|||
131737552|NCT02504268|474315341|FG001|Overall Study|Adverse Event|8|||
131737553|NCT02504268|474315342|FG002|Overall Study|Adverse Event|14|||
131737554|NCT02504268|474315343|FG003|Overall Study|Adverse Event|0|||
131737555|NCT02504268|474315344|FG004|Overall Study|Adverse Event|0|||
131737556|NCT02504268|474315345|FG005|Overall Study|Adverse Event|0|||
131737557|NCT02504268|474315346|FG006|Overall Study|Adverse Event|0|||
131737558|NCT02504268|474315347|FG007|Overall Study|Adverse Event|0|||
131737559|NCT02504268|474315348|FG008|Overall Study|Adverse Event|0|||
131737560|NCT02504268|474315340|FG000|Overall Study|Withdrawal of Consent|11|||
131737561|NCT02504268|474315341|FG001|Overall Study|Withdrawal of Consent|10|||
131737562|NCT02504268|474315342|FG002|Overall Study|Withdrawal of Consent|3|||
131737563|NCT02504268|474315343|FG003|Overall Study|Withdrawal of Consent|0|||
131737564|NCT02504268|474315344|FG004|Overall Study|Withdrawal of Consent|0|||
131737565|NCT02504268|474315345|FG005|Overall Study|Withdrawal of Consent|0|||
131737566|NCT02504268|474315346|FG006|Overall Study|Withdrawal of Consent|0|||
131737567|NCT02504268|474315347|FG007|Overall Study|Withdrawal of Consent|0|||
131737568|NCT02504268|474315348|FG008|Overall Study|Withdrawal of Consent|0|||
131737569|NCT02504268|474315340|FG000|Overall Study|Pregnancy|2|||
131737570|NCT02504268|474315341|FG001|Overall Study|Pregnancy|0|||
131737571|NCT02504268|474315342|FG002|Overall Study|Pregnancy|0|||
131737572|NCT02504268|474315343|FG003|Overall Study|Pregnancy|0|||
131737573|NCT02504268|474315344|FG004|Overall Study|Pregnancy|0|||
131737574|NCT02504268|474315345|FG005|Overall Study|Pregnancy|0|||
131737575|NCT02504268|474315346|FG006|Overall Study|Pregnancy|0|||
131737576|NCT02504268|474315347|FG007|Overall Study|Pregnancy|0|||
131737577|NCT02504268|474315348|FG008|Overall Study|Pregnancy|0|||
131737578|NCT02504268|474315340|FG000|Overall Study|Lost to Follow-up|3|||
131737579|NCT02504268|474315341|FG001|Overall Study|Lost to Follow-up|6|||
131737580|NCT02504268|474315342|FG002|Overall Study|Lost to Follow-up|4|||
131737581|NCT02504268|474315343|FG003|Overall Study|Lost to Follow-up|0|||
131737582|NCT02504268|474315344|FG004|Overall Study|Lost to Follow-up|0|||
131737583|NCT02504268|474315345|FG005|Overall Study|Lost to Follow-up|0|||
131737584|NCT02504268|474315346|FG006|Overall Study|Lost to Follow-up|0|||
131737585|NCT02504268|474315347|FG007|Overall Study|Lost to Follow-up|0|||
131737586|NCT02504268|474315348|FG008|Overall Study|Lost to Follow-up|0|||
131737587|NCT02504268|474315340|FG000|Overall Study|Death|1|||
131737588|NCT02504268|474315341|FG001|Overall Study|Death|1|||
131737589|NCT02504268|474315342|FG002|Overall Study|Death|0|||
131737590|NCT02504268|474315343|FG003|Overall Study|Death|0|||
131737591|NCT02504268|474315344|FG004|Overall Study|Death|0|||
131737592|NCT02504268|474315345|FG005|Overall Study|Death|0|||
131737593|NCT02504268|474315346|FG006|Overall Study|Death|0|||
131737594|NCT02504268|474315347|FG007|Overall Study|Death|0|||
131737595|NCT02504268|474315348|FG008|Overall Study|Death|0|||
131737596|NCT02504268|474315340|FG000|Overall Study|Subject Request to Discontinue|11|||
131737597|NCT02504268|474315341|FG001|Overall Study|Subject Request to Discontinue|3|||
131737598|NCT02504268|474315342|FG002|Overall Study|Subject Request to Discontinue|6|||
131737599|NCT02504268|474315343|FG003|Overall Study|Subject Request to Discontinue|0|||
131737600|NCT02504268|474315344|FG004|Overall Study|Subject Request to Discontinue|0|||
131737601|NCT02504268|474315345|FG005|Overall Study|Subject Request to Discontinue|0|||
131737602|NCT02504268|474315346|FG006|Overall Study|Subject Request to Discontinue|0|||
131737603|NCT02504268|474315347|FG007|Overall Study|Subject Request to Discontinue|0|||
131737604|NCT02504268|474315348|FG008|Overall Study|Subject Request to Discontinue|0|||
131737605|NCT02504268|474315340|FG000|Overall Study|No Longer Meets Study Criteria|2|||
131737606|NCT02504268|474315341|FG001|Overall Study|No Longer Meets Study Criteria|3|||
131737607|NCT02504268|474315342|FG002|Overall Study|No Longer Meets Study Criteria|0|||
131737608|NCT02504268|474315343|FG003|Overall Study|No Longer Meets Study Criteria|0|||
131737609|NCT02504268|474315344|FG004|Overall Study|No Longer Meets Study Criteria|0|||
131737610|NCT02504268|474315345|FG005|Overall Study|No Longer Meets Study Criteria|0|||
131737611|NCT02504268|474315346|FG006|Overall Study|No Longer Meets Study Criteria|0|||
131737612|NCT02504268|474315347|FG007|Overall Study|No Longer Meets Study Criteria|0|||
131737613|NCT02504268|474315348|FG008|Overall Study|No Longer Meets Study Criteria|0|||
131737614|NCT02504268|474315340|FG000|Overall Study|Lack of Efficacy|11|||
131737615|NCT02504268|474315341|FG001|Overall Study|Lack of Efficacy|35|||
131737616|NCT02504268|474315342|FG002|Overall Study|Lack of Efficacy|9|||
131737617|NCT02504268|474315343|FG003|Overall Study|Lack of Efficacy|0|||
131737618|NCT02504268|474315344|FG004|Overall Study|Lack of Efficacy|0|||
131737619|NCT02504268|474315345|FG005|Overall Study|Lack of Efficacy|0|||
131737620|NCT02504268|474315346|FG006|Overall Study|Lack of Efficacy|0|||
131737621|NCT02504268|474315347|FG007|Overall Study|Lack of Efficacy|0|||
131737622|NCT02504268|474315348|FG008|Overall Study|Lack of Efficacy|0|||
131737623|NCT02504268|474315340|FG000|Overall Study|Poor/Non-Compliance|3|||
131737624|NCT02504268|474315341|FG001|Overall Study|Poor/Non-Compliance|2|||
131737625|NCT02504268|474315342|FG002|Overall Study|Poor/Non-Compliance|3|||
131737626|NCT02504268|474315343|FG003|Overall Study|Poor/Non-Compliance|0|||
131737627|NCT02504268|474315344|FG004|Overall Study|Poor/Non-Compliance|0|||
131737628|NCT02504268|474315345|FG005|Overall Study|Poor/Non-Compliance|0|||
131737629|NCT02504268|474315346|FG006|Overall Study|Poor/Non-Compliance|0|||
131737630|NCT02504268|474315347|FG007|Overall Study|Poor/Non-Compliance|0|||
131737631|NCT02504268|474315348|FG008|Overall Study|Poor/Non-Compliance|0|||
131737632|NCT02504268|474315340|FG000|Overall Study|Not Disclosed|1|||
131737633|NCT02504268|474315341|FG001|Overall Study|Not Disclosed|0|||
131737634|NCT02504268|474315342|FG002|Overall Study|Not Disclosed|2|||
131737635|NCT02504268|474315343|FG003|Overall Study|Not Disclosed|0|||
131737636|NCT02504268|474315344|FG004|Overall Study|Not Disclosed|0|||
131737637|NCT02504268|474315345|FG005|Overall Study|Not Disclosed|0|||
131737638|NCT02504268|474315346|FG006|Overall Study|Not Disclosed|0|||
131737639|NCT02504268|474315347|FG007|Overall Study|Not Disclosed|0|||
131737640|NCT02504268|474315348|FG008|Overall Study|Not Disclosed|0|||
131737641|NCT03025217|474315349|FG000|Overall Study|Pregnancy|1|||
131737642|NCT03025217|474315349|FG000|Overall Study|Lost to Follow-up|1|||
131737643|NCT03025217|474315349|FG000|Overall Study|Not eligible, poor English|2|||
131737644|NCT04069156|474315350|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
131737645|NCT04069156|474315351|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
131737646|NCT04069156|474315350|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
131737647|NCT04069156|474315351|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
131737648|NCT04069156|474315350|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
131737649|NCT04069156|474315351|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
131737650|NCT04069156|474315350|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
131737651|NCT04069156|474315351|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
131808171|NCT01597245|474582945|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808172|NCT01597245|474582946|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131737652|NCT00209170|474315354|FG000|Overall Study|Adverse Event|0|||
131737653|NCT00209170|474315355|FG001|Overall Study|Adverse Event|1|||
131737654|NCT00209170|474315354|FG000|Overall Study|Withdrawal by Subject|2|||
131737655|NCT00209170|474315355|FG001|Overall Study|Withdrawal by Subject|1|||
131737656|NCT00209170|474315354|FG000|Overall Study|Lack of Efficacy|0|||
131737657|NCT00209170|474315355|FG001|Overall Study|Lack of Efficacy|1|||
131737658|NCT03150095|474315356|FG000|Overall Study|Death|0|||
131737659|NCT03150095|474315357|FG001|Overall Study|Death|1|||
131737660|NCT03150095|474315356|FG000|Overall Study|Lost to Follow-up|1|||
131737661|NCT03150095|474315357|FG001|Overall Study|Lost to Follow-up|1|||
131737662|NCT03150095|474315356|FG000|Overall Study|Withdrawal by Subject|4|||
131737663|NCT03150095|474315357|FG001|Overall Study|Withdrawal by Subject|0|||
131737664|NCT03150095|474315356|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
131737665|NCT03150095|474315357|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
131737666|NCT02124707|474315358|FG000|Overall Study|Adverse Event|5|||
131737667|NCT02124707|474315358|FG000|Overall Study|Physician Decision|1|||
131737668|NCT02124707|474315358|FG000|Overall Study|Death|1|||
131737669|NCT01088438|474315371|FG000|Overall Study|Withdrawal by Subject|11|||
131737670|NCT01088438|474315372|FG001|Overall Study|Withdrawal by Subject|6|||
131737671|NCT01088438|474315371|FG000|Overall Study|Lost to Follow-up|18|||
131737672|NCT01088438|474315372|FG001|Overall Study|Lost to Follow-up|30|||
131737673|NCT00089479|474315373|FG000|Overall Study|Death|108|||
131737674|NCT00089479|474315374|FG001|Overall Study|Death|75|||
131737675|NCT00089479|474315373|FG000|Overall Study|Withdrawal by Subject|86|||
131737676|NCT00089479|474315374|FG001|Overall Study|Withdrawal by Subject|107|||
131737677|NCT00089479|474315373|FG000|Overall Study|Lost to Follow-up|137|||
131737678|NCT00089479|474315374|FG001|Overall Study|Lost to Follow-up|107|||
131737679|NCT00511342|474315377|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
131737680|NCT00511342|474315378|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
131737681|NCT00511342|474315377|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
131737682|NCT00511342|474315378|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
131737683|NCT00511342|474315377|FG000|Overall Study|Pregnancy|0|||
131737684|NCT00511342|474315378|FG001|Overall Study|Pregnancy|1|||
131737685|NCT00511342|474315377|FG000|Overall Study|Pregnancy wish|0|||
131737686|NCT00511342|474315378|FG001|Overall Study|Pregnancy wish|1|||
131737687|NCT00511342|474315377|FG000|Overall Study|Lost to Follow-up|1|||
131737688|NCT00511342|474315378|FG001|Overall Study|Lost to Follow-up|5|||
131737689|NCT00511342|474315377|FG000|Overall Study|Other Reason|2|||
131737690|NCT00511342|474315378|FG001|Overall Study|Other Reason|2|||
131737691|NCT01124448|474315379|FG000|Overall Study|Lost to Follow-up|0|||
131737692|NCT01124448|474315380|FG001|Overall Study|Lost to Follow-up|3|||
131737693|NCT01124448|474315379|FG000|Overall Study|Protocol Violation|2|||
131737694|NCT01124448|474315380|FG001|Overall Study|Protocol Violation|0|||
131737695|NCT03198754|474315382|FG000|Overall Study|Withdrawal by Subject|5|||
131737696|NCT03198754|474315383|FG001|Overall Study|Withdrawal by Subject|4|||
131737697|NCT03198754|474315382|FG000|Overall Study|Lost to Follow-up|4|||
131737698|NCT03198754|474315383|FG001|Overall Study|Lost to Follow-up|3|||
131737699|NCT03198754|474315382|FG000|Overall Study|Ineligible|2|||
131737700|NCT03198754|474315383|FG001|Overall Study|Ineligible|1|||
131737701|NCT00678587|474315388|FG000|Overall Study|Adverse Event|3|||
131737702|NCT00678587|474315389|FG001|Overall Study|Adverse Event|3|||
131737703|NCT00678587|474315388|FG000|Overall Study|Lack of Efficacy|1|||
131737704|NCT00678587|474315389|FG001|Overall Study|Lack of Efficacy|0|||
131737705|NCT00678587|474315388|FG000|Overall Study|Protocol Violation|2|||
131737706|NCT00678587|474315389|FG001|Overall Study|Protocol Violation|1|||
131737707|NCT00678587|474315388|FG000|Overall Study|Study Closed/Terminated|1|||
131737708|NCT00678587|474315389|FG001|Overall Study|Study Closed/Terminated|0|||
131737709|NCT00678587|474315388|FG000|Overall Study|Lost to Follow-up|3|||
131737710|NCT00678587|474315389|FG001|Overall Study|Lost to Follow-up|5|||
131737711|NCT00678587|474315388|FG000|Overall Study|Investigator Discretion|2|||
131737712|NCT00678587|474315389|FG001|Overall Study|Investigator Discretion|6|||
131737713|NCT00678587|474315388|FG000|Overall Study|Withdrew Consent|8|||
131737714|NCT00678587|474315389|FG001|Overall Study|Withdrew Consent|3|||
131737715|NCT01479374|474315394|FG000|Overall Study|Adverse Event|2|||
131737716|NCT01479374|474315395|FG001|Overall Study|Adverse Event|1|||
131737717|NCT01479374|474315396|FG002|Overall Study|Adverse Event|0|||
131737718|NCT01479374|474315394|FG000|Overall Study|Lost to Follow-up|1|||
131737719|NCT01479374|474315395|FG001|Overall Study|Lost to Follow-up|2|||
131737720|NCT01479374|474315396|FG002|Overall Study|Lost to Follow-up|0|||
131737721|NCT01479374|474315394|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
131737722|NCT01479374|474315395|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
131737723|NCT01479374|474315396|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
131737724|NCT01479374|474315394|FG000|Overall Study|Other|0|||
131737725|NCT01479374|474315395|FG001|Overall Study|Other|4|||
131737726|NCT01479374|474315396|FG002|Overall Study|Other|5|||
131737727|NCT05086289|474315397|FG000|Overall Study|Adverse Event|4|||
131737728|NCT05086289|474315398|FG001|Overall Study|Adverse Event|2|||
131737729|NCT05086289|474315397|FG000|Overall Study|Lost to Follow-up|2|||
131737730|NCT05086289|474315398|FG001|Overall Study|Lost to Follow-up|0|||
131737731|NCT05086289|474315397|FG000|Overall Study|Non-compliance with study drug|2|||
131737732|NCT05086289|474315398|FG001|Overall Study|Non-compliance with study drug|1|||
131737733|NCT05086289|474315397|FG000|Overall Study|Physician Decision|2|||
131737734|NCT05086289|474315398|FG001|Overall Study|Physician Decision|0|||
131737735|NCT05086289|474315397|FG000|Overall Study|Withdrawal by Subject|5|||
131737736|NCT05086289|474315398|FG001|Overall Study|Withdrawal by Subject|2|||
131737737|NCT01996748|474315399|FG000|Overall Study|Personal reason|1|||
131737738|NCT01996748|474315400|FG001|Overall Study|Personal reason|0|||
131737739|NCT01996748|474315399|FG000|Overall Study|Physician Decision|2|||
131737740|NCT01996748|474315400|FG001|Overall Study|Physician Decision|0|||
131737741|NCT01996748|474315399|FG000|Overall Study|Adverse Event|1|||
131737742|NCT01996748|474315400|FG001|Overall Study|Adverse Event|4|||
131737743|NCT01996748|474315399|FG000|Overall Study|Withdrawal by Subject|0|||
131737744|NCT01996748|474315400|FG001|Overall Study|Withdrawal by Subject|1|||
131737745|NCT01996748|474315399|FG000|Overall Study|Lost to Follow-up|4|||
131737746|NCT01996748|474315400|FG001|Overall Study|Lost to Follow-up|1|||
131737747|NCT03599141|474315403|FG000|Overall Study|Lost to Follow-up|3|||
131737748|NCT03599141|474315404|FG001|Overall Study|Lost to Follow-up|1|||
131737749|NCT01934192|474315405|FG000|Overall Study|Protocol Violation|0|||
131737750|NCT01934192|474315406|FG001|Overall Study|Protocol Violation|0|||
131737751|NCT01934192|474315407|FG002|Overall Study|Protocol Violation|0|||
131737752|NCT01934192|474315408|FG003|Overall Study|Protocol Violation|1|||
131737753|NCT01934192|474315405|FG000|Overall Study|Other: reached stopping criteria|6|||
131737754|NCT01934192|474315406|FG001|Overall Study|Other: reached stopping criteria|5|||
131737755|NCT01934192|474315407|FG002|Overall Study|Other: reached stopping criteria|1|||
131737756|NCT01934192|474315408|FG003|Overall Study|Other: reached stopping criteria|0|||
131737757|NCT01934192|474315405|FG000|Overall Study|Physician Decision|3|||
131737758|NCT01934192|474315406|FG001|Overall Study|Physician Decision|2|||
131737759|NCT01934192|474315407|FG002|Overall Study|Physician Decision|0|||
131737760|NCT01934192|474315408|FG003|Overall Study|Physician Decision|0|||
131737761|NCT01189435|474315409|FG000|Overall Study|Withdrawal by Subject|1|||
131737762|NCT01189435|474315409|FG000|Overall Study|Physician Decision|1|||
131737763|NCT04092816|474317667|FG000|Overall Study|Lost to Follow-up|1|||
131737764|NCT04092816|474317668|FG001|Overall Study|Lost to Follow-up|2|||
131737765|NCT02115113|474317669|FG000|Participants in Run-in Period|Death|0|||
131737766|NCT02115113|474317670|FG001|Participants in Run-in Period|Death|0|||
131737767|NCT02115113|474317671|FG002|Participants in Run-in Period|Death|1|||
131737768|NCT02115113|474317669|FG000|Participants in Run-in Period|Administrative problems|0|||
131737769|NCT02115113|474317670|FG001|Participants in Run-in Period|Administrative problems|0|||
131737770|NCT02115113|474317671|FG002|Participants in Run-in Period|Administrative problems|1|||
131737771|NCT02115113|474317669|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
131737772|NCT02115113|474317670|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
131737773|NCT02115113|474317671|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
131737774|NCT02115113|474317669|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
131737775|NCT02115113|474317670|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
131448882|NCT01208207|473272741|FG004|Part I|Physician Decision|0|||
131737776|NCT02115113|474317671|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
131737777|NCT02115113|474317669|FG000|Participants Randomized|Lost to Follow-up|1|||
131737778|NCT02115113|474317670|FG001|Participants Randomized|Lost to Follow-up|0|||
131737779|NCT02115113|474317671|FG002|Participants Randomized|Lost to Follow-up|0|||
131737780|NCT02115113|474317669|FG000|Participants Randomized|Death|1|||
131737781|NCT02115113|474317670|FG001|Participants Randomized|Death|0|||
131737782|NCT02115113|474317671|FG002|Participants Randomized|Death|0|||
131737783|NCT03162055|474317675|FG000|Overall Study|Adverse Event|6|||
131737784|NCT03162055|474317676|FG001|Overall Study|Adverse Event|5|||
131737785|NCT03162055|474317675|FG000|Overall Study|Death|3|||
131737786|NCT03162055|474317676|FG001|Overall Study|Death|3|||
131737787|NCT03162055|474317675|FG000|Overall Study|Lost to Follow-up|0|||
131737788|NCT03162055|474317676|FG001|Overall Study|Lost to Follow-up|1|||
131737789|NCT03162055|474317675|FG000|Overall Study|Study-specific withdrawal criteria|22|||
131737790|NCT03162055|474317676|FG001|Overall Study|Study-specific withdrawal criteria|14|||
131737791|NCT03162055|474317675|FG000|Overall Study|Withdrawal by Subject|17|||
131737792|NCT03162055|474317676|FG001|Overall Study|Withdrawal by Subject|2|||
131737793|NCT03162055|474317675|FG000|Overall Study|Did not receive treatment|2|||
131737794|NCT03162055|474317676|FG001|Overall Study|Did not receive treatment|0|||
131737795|NCT03162055|474317675|FG000|Overall Study|Incorrect randomization|4|||
131737796|NCT03162055|474317676|FG001|Overall Study|Incorrect randomization|3|||
131737797|NCT03162055|474317675|FG000|Overall Study|Other|8|||
131737798|NCT03162055|474317676|FG001|Overall Study|Other|15|||
131737799|NCT01993615|474317677|FG000|Overall Study|Death|1|||
131737800|NCT01993615|474317678|FG001|Overall Study|Death|0|||
131737801|NCT00798694|474317680|FG000|Overall Study|Lost to Follow-up|1|||
131737802|NCT00798694|474317681|FG001|Overall Study|Lost to Follow-up|1|||
131737803|NCT00798694|474317680|FG000|Overall Study|Physician Decision|1|||
131737804|NCT00798694|474317681|FG001|Overall Study|Physician Decision|0|||
131737805|NCT01774344|474317683|FG000|Overall Study|Withdrawal by Subject|3|||
131737806|NCT01774344|474317684|FG001|Overall Study|Withdrawal by Subject|10|||
131737807|NCT01774344|474317683|FG000|Overall Study|Protocol Violation|0|||
131737808|NCT01774344|474317684|FG001|Overall Study|Protocol Violation|1|||
131737809|NCT01774344|474317683|FG000|Overall Study|Lost to Follow-up|4|||
131737810|NCT01774344|474317684|FG001|Overall Study|Lost to Follow-up|10|||
131737811|NCT01774344|474317683|FG000|Overall Study|End of survival follow-up not available|2|||
131737812|NCT01774344|474317684|FG001|Overall Study|End of survival follow-up not available|2|||
131737813|NCT01774344|474317683|FG000|Overall Study|Data collection finished|4|||
131737814|NCT01774344|474317684|FG001|Overall Study|Data collection finished|14|||
131737815|NCT01774344|474317683|FG000|Overall Study|Other|0|||
131737816|NCT01774344|474317684|FG001|Overall Study|Other|1|||
131737817|NCT01774344|474317683|FG000|Overall Study|Did not enter Survival Follow up|49|||
131737818|NCT01774344|474317684|FG001|Overall Study|Did not enter Survival Follow up|83|||
131737819|NCT01163253|474317689|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
131737820|NCT01163253|474317690|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
131737821|NCT01163253|474317689|FG000|Overall Study|Study Terminated by Sponsor|978|||
131737822|NCT01163253|474317690|FG001|Overall Study|Study Terminated by Sponsor|349|||
131737823|NCT01163253|474317689|FG000|Overall Study|Protocol Violation|43|||
131737824|NCT01163253|474317690|FG001|Overall Study|Protocol Violation|12|||
131737825|NCT01163253|474317689|FG000|Overall Study|Withdrawal by Subject|199|||
131737826|NCT01163253|474317690|FG001|Overall Study|Withdrawal by Subject|50|||
131737827|NCT01163253|474317689|FG000|Overall Study|Medication Error|1|||
131737828|NCT01163253|474317690|FG001|Overall Study|Medication Error|0|||
131737829|NCT01163253|474317689|FG000|Overall Study|Lost to Follow-up|125|||
131737830|NCT01163253|474317690|FG001|Overall Study|Lost to Follow-up|23|||
131808173|NCT01597245|474582947|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808174|NCT01597245|474582948|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808175|NCT01597245|474582949|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808176|NCT01597245|474582950|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808177|NCT01597245|474582951|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
131808178|NCT01597245|474582931|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
131808179|NCT01597245|474582932|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
131808180|NCT01597245|474582933|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
131808181|NCT01597245|474582934|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808182|NCT01597245|474582935|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808183|NCT01597245|474582936|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808184|NCT01597245|474582937|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808185|NCT01597245|474582938|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808186|NCT01597245|474582939|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808187|NCT01597245|474582940|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808188|NCT01597245|474582941|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808189|NCT01597245|474582942|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808190|NCT01597245|474582943|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131737831|NCT01163253|474317689|FG000|Overall Study|Insufficient Clinical Response|423|||
131737832|NCT01163253|474317690|FG001|Overall Study|Insufficient Clinical Response|29|||
131737833|NCT01163253|474317689|FG000|Overall Study|Adverse Event|300|||
131737834|NCT01163253|474317690|FG001|Overall Study|Adverse Event|78|||
131737835|NCT01163253|474317689|FG000|Overall Study|Death|17|||
131448883|NCT01208207|473272742|FG005|Part I|Physician Decision|0|||
131737836|NCT01163253|474317690|FG001|Overall Study|Death|5|||
131737837|NCT01163253|474317689|FG000|Overall Study|Ongoing|13|||
131737838|NCT01163253|474317690|FG001|Overall Study|Ongoing|4|||
131737839|NCT01163253|474317689|FG000|Overall Study|Other Unspecified|170|||
131737840|NCT01163253|474317690|FG001|Overall Study|Other Unspecified|34|||
131737841|NCT02492997|474317691|FG000|Overall Study|Withdrawal by Subject|1|||
131737842|NCT02492997|474317692|FG001|Overall Study|Withdrawal by Subject|0|||
131737843|NCT02492997|474317691|FG000|Overall Study|Gained Weight|1|||
131737844|NCT02492997|474317692|FG001|Overall Study|Gained Weight|0|||
131737845|NCT02492997|474317691|FG000|Overall Study|Lost to Follow-up|0|||
131737846|NCT02492997|474317692|FG001|Overall Study|Lost to Follow-up|1|||
131737847|NCT01397552|474317693|FG000|Overall Study|Adverse Event|1|||
131737848|NCT01397552|474317694|FG001|Overall Study|Adverse Event|0|||
131737849|NCT01397552|474317693|FG000|Overall Study|Withdrawal by Subject|2|||
131737850|NCT01397552|474317694|FG001|Overall Study|Withdrawal by Subject|1|||
131737851|NCT02130427|474317695|FG000|Overall Study|Imaging results not interpretable|30|||
131737852|NCT00862849|474317700|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131737853|NCT00862849|474317701|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
131737854|NCT00862849|474317702|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131737855|NCT00862849|474317703|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131737856|NCT00862849|474317704|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131737857|NCT00862849|474317705|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131737858|NCT00862849|474317700|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131737859|NCT00862849|474317701|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
131737860|NCT00862849|474317702|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131737861|NCT00862849|474317703|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131737862|NCT00862849|474317704|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131737863|NCT00862849|474317705|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131737864|NCT04032171|474317711|FG000|Overall Study|Study Termination|1|||
131737865|NCT04032171|474317712|FG001|Overall Study|Study Termination|0|||
131737866|NCT00992784|474317713|FG000|Overall Study|Adverse Event|2|||
131737867|NCT00992784|474317714|FG001|Overall Study|Adverse Event|1|||
131737868|NCT00992784|474317715|FG002|Overall Study|Adverse Event|0|||
131737869|NCT00992784|474317713|FG000|Overall Study|Withdrawal by Subject|1|||
131737870|NCT00992784|474317714|FG001|Overall Study|Withdrawal by Subject|1|||
131737871|NCT00992784|474317715|FG002|Overall Study|Withdrawal by Subject|1|||
131737872|NCT01363713|474317720|FG000|Overall Study|Adverse Event|1|||
131737873|NCT01363713|474317720|FG000|Overall Study|Protocol Violation|3|||
131737874|NCT01363713|474317720|FG000|Overall Study|Withdrawal by Subject|2|||
131737875|NCT02108951|474317728|FG000|Overall Study|Lost to Follow-up|1|||
131737876|NCT02108951|474317728|FG000|Overall Study|Patient's/guardian's decision|1|||
131737877|NCT02108951|474317728|FG000|Overall Study|Study Terminated by Sponsor|14|||
131737878|NCT03806179|474317729|FG000|Overall Study|Progressive disease|0|||
131737879|NCT03806179|474317730|FG001|Overall Study|Progressive disease|2|||
131737880|NCT00608530|474317733|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
131737881|NCT00608530|474317734|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
131737882|NCT00608530|474317735|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
131737883|NCT00608530|474317736|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
131737884|NCT00608530|474317733|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
131737885|NCT00608530|474317734|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
131737886|NCT00608530|474317735|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
131737887|NCT00608530|474317736|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
131737888|NCT00608530|474317733|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
131737889|NCT00608530|474317734|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
131808191|NCT01597245|474582944|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131737890|NCT00608530|474317735|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
131737891|NCT00608530|474317736|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
131737892|NCT00608530|474317733|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
131737893|NCT00608530|474317734|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
131737894|NCT00608530|474317735|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
131737895|NCT00608530|474317736|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
131737896|NCT00608530|474317733|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
131737897|NCT00608530|474317734|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
131448884|NCT01208207|473272743|FG006|Part I|Physician Decision|0|||
131737898|NCT00608530|474317735|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
131737899|NCT00608530|474317736|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
131737900|NCT00608530|474317733|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
131737901|NCT00608530|474317734|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
131737902|NCT00608530|474317735|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
131737903|NCT00608530|474317736|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
131737904|NCT00305253|474317739|FG000|Overall Study|Withdrawal by Subject|0|||
131737905|NCT00305253|474317740|FG001|Overall Study|Withdrawal by Subject|1|||
131737906|NCT01357915|474317741|FG000|Overall Study|Lost to Follow-up|3|||
131737907|NCT01357915|474317742|FG001|Overall Study|Lost to Follow-up|0|||
131737908|NCT01019486|474317745|FG000|Overall Study|Withdrawal by Subject|1|||
131737909|NCT01019486|474317746|FG001|Overall Study|Withdrawal by Subject|1|||
131737910|NCT01019486|474317747|FG002|Overall Study|Withdrawal by Subject|1|||
131737911|NCT02841787|474317748|FG000|Overall Study|Lost to Follow-up|1|||
131737912|NCT02841787|474317749|FG001|Overall Study|Lost to Follow-up|0|||
131737913|NCT02841787|474317750|FG002|Overall Study|Lost to Follow-up|0|||
131737914|NCT02841787|474317748|FG000|Overall Study|Symptoms dropped below threshold|1|||
131737915|NCT02841787|474317749|FG001|Overall Study|Symptoms dropped below threshold|0|||
131737916|NCT02841787|474317750|FG002|Overall Study|Symptoms dropped below threshold|0|||
131737917|NCT02841787|474317748|FG000|Overall Study|Withdrawal by Subject|1|||
131737918|NCT02841787|474317749|FG001|Overall Study|Withdrawal by Subject|4|||
131737919|NCT02841787|474317750|FG002|Overall Study|Withdrawal by Subject|0|||
131737920|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
131737921|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
131737922|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Death|2|||
131737923|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Death|1|||
131737924|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
131737925|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
131737926|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
131737927|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
131737928|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
131737929|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
131737930|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
131737931|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
131737932|NCT03633227|474317751|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
131737933|NCT03633227|474317752|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
131737934|NCT03633227|474317751|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
131737935|NCT03633227|474317752|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
131737936|NCT03633227|474317751|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
131737937|NCT03633227|474317752|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
131737938|NCT03633227|474317751|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
131737939|NCT03633227|474317752|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
131737940|NCT03633227|474317751|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
131737941|NCT03633227|474317752|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
131737942|NCT03633227|474317751|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
131737943|NCT03633227|474317752|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
131737944|NCT02951988|474317757|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
131737945|NCT02951988|474317758|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
131737946|NCT02951988|474317759|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
131737947|NCT02951988|474317760|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
131737948|NCT02951988|474317757|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
131737949|NCT02951988|474317758|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
131737950|NCT02951988|474317759|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
131737951|NCT02951988|474317760|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
131737952|NCT02951988|474317757|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
131737953|NCT02951988|474317758|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
131737954|NCT02951988|474317759|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
131808192|NCT01597245|474582945|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131737955|NCT02951988|474317760|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
131737956|NCT02951988|474317757|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
131737957|NCT02951988|474317758|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
131737958|NCT02951988|474317759|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
131737959|NCT02951988|474317760|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
131737960|NCT02951988|474317757|FG000|Open-Label Treatment Period|Protocol Violation|22|||
131737961|NCT02951988|474317758|FG001|Open-Label Treatment Period|Protocol Violation|0|||
131737962|NCT02951988|474317759|FG002|Open-Label Treatment Period|Protocol Violation|0|||
131737963|NCT02951988|474317760|FG003|Open-Label Treatment Period|Protocol Violation|0|||
131737964|NCT02951988|474317757|FG000|Open-Label Treatment Period|Pregnancy|2|||
131737965|NCT02951988|474317758|FG001|Open-Label Treatment Period|Pregnancy|0|||
131737966|NCT02951988|474317759|FG002|Open-Label Treatment Period|Pregnancy|0|||
131737967|NCT02951988|474317760|FG003|Open-Label Treatment Period|Pregnancy|0|||
131737968|NCT02951988|474317757|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
131737969|NCT02951988|474317758|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
131737970|NCT02951988|474317759|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
131737971|NCT02951988|474317760|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
131737972|NCT02951988|474317757|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
131737973|NCT02951988|474317758|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
131737974|NCT02951988|474317759|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
131737975|NCT02951988|474317760|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
131737976|NCT02951988|474317757|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
131737977|NCT02951988|474317758|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
131737978|NCT02951988|474317759|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131737979|NCT02951988|474317760|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
131737980|NCT02951988|474317757|FG000|Open-Label Treatment Period|Adverse Event|45|||
131737981|NCT02951988|474317758|FG001|Open-Label Treatment Period|Adverse Event|0|||
131737982|NCT02951988|474317759|FG002|Open-Label Treatment Period|Adverse Event|0|||
131737983|NCT02951988|474317760|FG003|Open-Label Treatment Period|Adverse Event|0|||
131737984|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
131737985|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
131737986|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
131737987|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
131737988|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
131737989|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
131737990|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
131737991|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
131737992|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
131737993|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
131737994|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
131737995|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
131737996|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131737997|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
131737998|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
131737999|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
131738000|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Pregnancy|0|||
131738001|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Pregnancy|1|||
131738002|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Pregnancy|1|||
131738003|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Pregnancy|0|||
131738004|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131738005|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
131738006|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
131738007|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
131738008|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131738009|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
131738010|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
131738011|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
131738012|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131738013|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Adverse Event|8|||
131738014|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Adverse Event|3|||
131738015|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Adverse Event|6|||
131738016|NCT02951988|474317757|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
131738017|NCT02951988|474317758|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
131738018|NCT02951988|474317759|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
131738019|NCT02951988|474317760|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
131738020|NCT05836818|474317761|FG000|Overall Study|Physician Decision|1|||
131738021|NCT05836818|474317762|FG001|Overall Study|Physician Decision|1|||
131738022|NCT05836818|474317763|FG002|Overall Study|Physician Decision|0|||
131738023|NCT05836818|474317761|FG000|Overall Study|Withdrawal by Subject|0|||
131738024|NCT05836818|474317762|FG001|Overall Study|Withdrawal by Subject|0|||
131738025|NCT05836818|474317763|FG002|Overall Study|Withdrawal by Subject|1|||
131738026|NCT05836818|474317761|FG000|Overall Study|Later found to be previously vaccinated|0|||
131738027|NCT05836818|474317762|FG001|Overall Study|Later found to be previously vaccinated|1|||
131738028|NCT05836818|474317763|FG002|Overall Study|Later found to be previously vaccinated|3|||
131738029|NCT05836818|474317761|FG000|Overall Study|Pregnancy|0|||
131738030|NCT05836818|474317762|FG001|Overall Study|Pregnancy|1|||
131738031|NCT05836818|474317763|FG002|Overall Study|Pregnancy|0|||
131738032|NCT05836818|474317761|FG000|Overall Study|Allergic to vaccines|0|||
131738033|NCT05836818|474317762|FG001|Overall Study|Allergic to vaccines|1|||
131738034|NCT05836818|474317763|FG002|Overall Study|Allergic to vaccines|0|||
131738035|NCT03977727|474317764|FG000|Second Treatment|Lost to Follow-up|0|||
131738036|NCT03977727|474317765|FG001|Second Treatment|Lost to Follow-up|3|||
131738037|NCT01655823|474317767|FG000|Overall Study|Lost to Follow-up|0|||
131738038|NCT01655823|474317768|FG001|Overall Study|Lost to Follow-up|1|||
131738039|NCT01655823|474317769|FG002|Overall Study|Lost to Follow-up|0|||
131738040|NCT01655823|474317770|FG003|Overall Study|Lost to Follow-up|0|||
131738041|NCT01655823|474317771|FG004|Overall Study|Lost to Follow-up|1|||
131738042|NCT01655823|474317767|FG000|Overall Study|Withdrawal by Subject|0|||
131738043|NCT01655823|474317768|FG001|Overall Study|Withdrawal by Subject|1|||
131738044|NCT01655823|474317769|FG002|Overall Study|Withdrawal by Subject|0|||
131738045|NCT01655823|474317770|FG003|Overall Study|Withdrawal by Subject|1|||
131738046|NCT01655823|474317771|FG004|Overall Study|Withdrawal by Subject|0|||
131738047|NCT04799405|474317774|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
131738048|NCT00603980|474317775|FG000|Study Qualification|Protocol Violation|3|||
131738049|NCT00603980|474317775|FG000|Study Qualification|Inconsistent data reporting|13|||
131738050|NCT00603980|474317775|FG000|Main Study|14th subject completed trial|1|||
131738051|NCT02683525|474317776|FG000|Overall Study|Lost to Follow-up|1|||
131738052|NCT02683525|474317776|FG000|Overall Study|Physician Decision|1|||
131738053|NCT02683525|474317776|FG000|Overall Study|Disease Progression|6|||
131738054|NCT01627067|474317777|FG000|Overall Study|Screen Failure|1|||
131738055|NCT00926796|474317781|FG000|Overall Study|Did not receive randomized treatment|4|||
131738056|NCT00926796|474317782|FG001|Overall Study|Did not receive randomized treatment|7|||
131738057|NCT00926796|474317781|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
131738058|NCT00926796|474317782|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
131738059|NCT00926796|474317781|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
131738060|NCT00926796|474317782|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
131738061|NCT00926796|474317781|FG000|Overall Study|Adverse Event|7|||
131738062|NCT00926796|474317782|FG001|Overall Study|Adverse Event|14|||
131738063|NCT00926796|474317781|FG000|Overall Study|Lost to Follow-up|22|||
131738064|NCT00926796|474317782|FG001|Overall Study|Lost to Follow-up|13|||
131738065|NCT00926796|474317781|FG000|Overall Study|Protocol Violation|15|||
131738066|NCT00926796|474317782|FG001|Overall Study|Protocol Violation|11|||
131738067|NCT00926796|474317781|FG000|Overall Study|Withdrawal by Subject|1|||
131738068|NCT00926796|474317782|FG001|Overall Study|Withdrawal by Subject|0|||
131738069|NCT01341652|474317783|FG000|Overall Study|Incorrect Random Assignment|0|||
131738070|NCT01341652|474317784|FG001|Overall Study|Incorrect Random Assignment|1|||
131738071|NCT01341652|474317783|FG000|Overall Study|ineligible; presence metastatic disease|0|||
131738072|NCT01341652|474317784|FG001|Overall Study|ineligible; presence metastatic disease|1|||
131738073|NCT00632463|474317788|FG000|Overall Study|Adverse Event|0|||
131738074|NCT00632463|474317789|FG001|Overall Study|Adverse Event|1|||
131738075|NCT00632463|474317790|FG002|Overall Study|Adverse Event|0|||
131738076|NCT00586924|474317791|FG000|Overall Study|Adverse event/serious adverse event|0|||
131738077|NCT00586924|474317792|FG001|Overall Study|Adverse event/serious adverse event|0|||
131738078|NCT00586924|474317793|FG002|Overall Study|Adverse event/serious adverse event|0|||
131738079|NCT00586924|474317794|FG003|Overall Study|Adverse event/serious adverse event|1|||
131738080|NCT00586924|474317795|FG004|Overall Study|Adverse event/serious adverse event|0|||
131738081|NCT00586924|474317796|FG005|Overall Study|Adverse event/serious adverse event|2|||
131738082|NCT00586924|474317791|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
131738083|NCT00586924|474317792|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
131738084|NCT00586924|474317793|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
131738085|NCT00586924|474317794|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
131738086|NCT00586924|474317795|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
131808193|NCT01597245|474582946|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808194|NCT01597245|474582947|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808195|NCT01597245|474582948|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131738087|NCT00586924|474317796|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
131738088|NCT00586924|474317791|FG000|Overall Study|Disease progression|0|||
131448885|NCT01208207|473272737|FG000|Part I|Progressive Disease|1|||
131738089|NCT00586924|474317792|FG001|Overall Study|Disease progression|0|||
131738090|NCT00586924|474317793|FG002|Overall Study|Disease progression|0|||
131738091|NCT00586924|474317794|FG003|Overall Study|Disease progression|1|||
131808196|NCT01597245|474582949|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131738092|NCT00586924|474317795|FG004|Overall Study|Disease progression|1|||
131738093|NCT00586924|474317796|FG005|Overall Study|Disease progression|0|||
131738094|NCT00586924|474317791|FG000|Overall Study|Development of neutralizing antibodies|2|||
131738095|NCT00586924|474317792|FG001|Overall Study|Development of neutralizing antibodies|2|||
131738096|NCT00586924|474317793|FG002|Overall Study|Development of neutralizing antibodies|2|||
131738097|NCT00586924|474317794|FG003|Overall Study|Development of neutralizing antibodies|0|||
131738098|NCT00586924|474317795|FG004|Overall Study|Development of neutralizing antibodies|0|||
131738099|NCT00586924|474317796|FG005|Overall Study|Development of neutralizing antibodies|22|||
131738100|NCT00586924|474317791|FG000|Overall Study|Complete response|0|||
131738101|NCT00586924|474317792|FG001|Overall Study|Complete response|1|||
131738102|NCT00586924|474317793|FG002|Overall Study|Complete response|0|||
131738103|NCT00586924|474317794|FG003|Overall Study|Complete response|0|||
131738104|NCT00586924|474317795|FG004|Overall Study|Complete response|2|||
131738105|NCT00586924|474317796|FG005|Overall Study|Complete response|2|||
131738106|NCT00586924|474317791|FG000|Overall Study|Other|1|||
131738107|NCT00586924|474317792|FG001|Overall Study|Other|0|||
131738108|NCT00586924|474317793|FG002|Overall Study|Other|1|||
131738109|NCT00586924|474317794|FG003|Overall Study|Other|1|||
131738110|NCT00586924|474317795|FG004|Overall Study|Other|1|||
131738111|NCT00586924|474317796|FG005|Overall Study|Other|6|||
131738112|NCT04167306|474317799|FG000|Overall Study|Lost to Follow-up|2|||
131738113|NCT04167306|474317800|FG001|Overall Study|Lost to Follow-up|2|||
131738114|NCT04167306|474317801|FG002|Overall Study|Lost to Follow-up|5|||
131738115|NCT04167306|474317802|FG003|Overall Study|Lost to Follow-up|5|||
131738116|NCT04167306|474317799|FG000|Overall Study|Adverse Event|13|||
131738117|NCT04167306|474317800|FG001|Overall Study|Adverse Event|14|||
131738118|NCT04167306|474317801|FG002|Overall Study|Adverse Event|5|||
131738119|NCT04167306|474317802|FG003|Overall Study|Adverse Event|4|||
131738120|NCT04167306|474317799|FG000|Overall Study|Withdrawal by Subject|4|||
131738121|NCT04167306|474317800|FG001|Overall Study|Withdrawal by Subject|6|||
131738122|NCT04167306|474317801|FG002|Overall Study|Withdrawal by Subject|8|||
131738123|NCT04167306|474317802|FG003|Overall Study|Withdrawal by Subject|3|||
131738124|NCT04167306|474317799|FG000|Overall Study|covid|1|||
131738125|NCT04167306|474317800|FG001|Overall Study|covid|1|||
131738126|NCT04167306|474317801|FG002|Overall Study|covid|2|||
131738127|NCT04167306|474317802|FG003|Overall Study|covid|1|||
131738128|NCT04167306|474317799|FG000|Overall Study|concomitant medication|0|||
131738129|NCT04167306|474317800|FG001|Overall Study|concomitant medication|0|||
131738130|NCT04167306|474317801|FG002|Overall Study|concomitant medication|0|||
131738131|NCT04167306|474317802|FG003|Overall Study|concomitant medication|1|||
131738132|NCT04167306|474317799|FG000|Overall Study|Alcohol treatment|0|||
131738133|NCT04167306|474317800|FG001|Overall Study|Alcohol treatment|4|||
131738134|NCT04167306|474317801|FG002|Overall Study|Alcohol treatment|3|||
131738135|NCT04167306|474317802|FG003|Overall Study|Alcohol treatment|2|||
131738136|NCT04167306|474317799|FG000|Overall Study|non-compliance|0|||
131738137|NCT04167306|474317800|FG001|Overall Study|non-compliance|0|||
131738138|NCT04167306|474317801|FG002|Overall Study|non-compliance|1|||
131738139|NCT04167306|474317802|FG003|Overall Study|non-compliance|0|||
131738140|NCT04167306|474317799|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
131738141|NCT04167306|474317800|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
131738142|NCT04167306|474317801|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
131738143|NCT04167306|474317802|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
131738144|NCT04146467|474317806|FG000|Overall Study|Adverse Event|0|||
131738145|NCT04146467|474317807|FG001|Overall Study|Adverse Event|1|||
131738146|NCT04146467|474317806|FG000|Overall Study|Lost to Follow-up|0|||
131738147|NCT04146467|474317807|FG001|Overall Study|Lost to Follow-up|2|||
131738148|NCT03731364|474317810|FG000|Overall Study|Adverse Event|0|||
131738149|NCT03731364|474317811|FG001|Overall Study|Adverse Event|0|||
131738150|NCT03731364|474317812|FG002|Overall Study|Adverse Event|1|||
131738151|NCT03731364|474317813|FG003|Overall Study|Adverse Event|2|||
131738152|NCT03731364|474317814|FG004|Overall Study|Adverse Event|1|||
131808197|NCT01597245|474582950|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131808198|NCT01597245|474582951|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
131738153|NCT02357849|474317815|FG000|Overall Study|Withdrawal by Subject|2|||
131738154|NCT02357849|474317816|FG001|Overall Study|Withdrawal by Subject|3|||
131738155|NCT04633473|474317817|FG000|Overall Study|Withdrawal by Subject|6|||
131738156|NCT01982773|474317819|FG000|Overall Study|Withdrawal by Subject|1|||
131738157|NCT01982773|474317820|FG001|Overall Study|Withdrawal by Subject|3|||
131738158|NCT01982773|474317819|FG000|Overall Study|Lost to Follow-up|7|||
131738159|NCT01982773|474317820|FG001|Overall Study|Lost to Follow-up|1|||
131738160|NCT01029886|474317823|FG000|Overall Study|Adverse Event|12|||
131738161|NCT01029886|474317824|FG001|Overall Study|Adverse Event|25|||
131738162|NCT01029886|474317823|FG000|Overall Study|Lost to Follow-up|1|||
131738163|NCT01029886|474317824|FG001|Overall Study|Lost to Follow-up|0|||
131738164|NCT01029886|474317823|FG000|Overall Study|Physician Decision|2|||
131738165|NCT01029886|474317824|FG001|Overall Study|Physician Decision|6|||
131738166|NCT01029886|474317823|FG000|Overall Study|Protocol Violation|17|||
131738167|NCT01029886|474317824|FG001|Overall Study|Protocol Violation|5|||
131738168|NCT01029886|474317823|FG000|Overall Study|Withdrawal by Subject|8|||
131738169|NCT01029886|474317824|FG001|Overall Study|Withdrawal by Subject|18|||
131738170|NCT01029886|474317823|FG000|Overall Study|Entry Criteria Not Met|13|||
131738171|NCT01029886|474317824|FG001|Overall Study|Entry Criteria Not Met|5|||
131738172|NCT01029886|474317823|FG000|Overall Study|Sponsor Decision|1|||
131738173|NCT01029886|474317824|FG001|Overall Study|Sponsor Decision|0|||
131738174|NCT01029886|474317823|FG000|Overall Study|Loss Glucose Control|7|||
131738175|NCT01029886|474317824|FG001|Overall Study|Loss Glucose Control|1|||
131738176|NCT03095521|474317825|FG000|Overall Study|Withdrawal by Subject|0|||
131738177|NCT03095521|474317826|FG001|Overall Study|Withdrawal by Subject|1|||
131738178|NCT03095521|474317825|FG000|Overall Study|Lost to Follow-up|0|||
131738179|NCT03095521|474317826|FG001|Overall Study|Lost to Follow-up|1|||
131738180|NCT01536119|474317827|FG000|Overall Study|Lost to Follow-up|17|||
131738181|NCT01536119|474317828|FG001|Overall Study|Lost to Follow-up|14|||
131738182|NCT01810042|474317829|FG000|Overall Study|Lost to Follow-up|10|||
131738183|NCT02773238|474317831|FG000|Overall Study|Lack of Efficacy|4|||
131738184|NCT02370498|474319605|FG000|Overall Study|Adverse Event|10|||
131738185|NCT02370498|474319606|FG001|Overall Study|Adverse Event|8|||
131738186|NCT02370498|474319605|FG000|Overall Study|Death|263|||
131738187|NCT02370498|474319606|FG001|Overall Study|Death|265|||
131738188|NCT02370498|474319605|FG000|Overall Study|Protocol Violation|1|||
131738189|NCT02370498|474319606|FG001|Overall Study|Protocol Violation|2|||
131738190|NCT02370498|474319605|FG000|Overall Study|Withdrawal by Subject|7|||
131738191|NCT02370498|474319606|FG001|Overall Study|Withdrawal by Subject|12|||
131738192|NCT02370498|474319605|FG000|Overall Study|Sponsor's decision|15|||
131738193|NCT02370498|474319606|FG001|Overall Study|Sponsor's decision|9|||
131738194|NCT01089582|474319608|FG000|Overall Study|Death|2|||
131738195|NCT01089582|474319608|FG000|Overall Study|Adverse Event|15|||
131738196|NCT01089582|474319608|FG000|Overall Study|Lost to Follow-up|8|||
131738197|NCT01089582|474319608|FG000|Overall Study|Other|4|||
131738198|NCT01089582|474319608|FG000|Overall Study|Withdrawal by Subject|1|||
131738199|NCT02108600|474319610|FG000|Overall Study|Withdrawal by Subject|2|||
131738200|NCT02108600|474319611|FG001|Overall Study|Withdrawal by Subject|0|||
131738201|NCT02108600|474319610|FG000|Overall Study|Lost to Follow-up|1|||
131738202|NCT02108600|474319611|FG001|Overall Study|Lost to Follow-up|1|||
131738203|NCT03943953|474319614|FG000|Trial of ITG 1|Lost to Follow-up|19|||
131738204|NCT03943953|474319615|FG001|Trial of ITG 1|Lost to Follow-up|1|||
131738205|NCT03943953|474319614|FG000|Trial of ITG 2|Lost to Follow-up|8|||
131738206|NCT03943953|474319615|FG001|Trial of ITG 2|Lost to Follow-up|0|||
131808199|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131448886|NCT01208207|473272738|FG001|Part I|Progressive Disease|0|||
131738207|NCT03943953|474319614|FG000|Trial of ITG 3|Lost to Follow-up|2|||
131738208|NCT03943953|474319615|FG001|Trial of ITG 3|Lost to Follow-up|0|||
131738209|NCT03943953|474319614|FG000|Trial of ITG 4|Lost to Follow-up|2|||
131738210|NCT03943953|474319615|FG001|Trial of ITG 4|Lost to Follow-up|0|||
131808200|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131738211|NCT00289185|474319616|FG000|Overall Study|Withdrawal by Subject|4|||
131738212|NCT00289185|474319617|FG001|Overall Study|Withdrawal by Subject|8|||
131738213|NCT00289185|474319616|FG000|Overall Study|Lost to Follow-up|23|||
131738214|NCT00289185|474319617|FG001|Overall Study|Lost to Follow-up|17|||
131738215|NCT00289185|474319616|FG000|Overall Study|Death|1|||
131738216|NCT00289185|474319617|FG001|Overall Study|Death|1|||
131738217|NCT01658579|474319618|FG000|Treatment Period A|Other|0|||
131738218|NCT01658579|474319619|FG001|Treatment Period A|Other|0|||
131738219|NCT01658579|474319620|FG002|Treatment Period A|Other|1|||
131738220|NCT01658579|474319621|FG003|Treatment Period A|Other|1|||
131738221|NCT01658579|474319618|FG000|Treatment Period A|Adverse Event|1|||
131738222|NCT01658579|474319619|FG001|Treatment Period A|Adverse Event|0|||
131738223|NCT01658579|474319620|FG002|Treatment Period A|Adverse Event|0|||
131738224|NCT01658579|474319621|FG003|Treatment Period A|Adverse Event|0|||
131738225|NCT01658579|474319618|FG000|Treatment Period B|Other|0|||
131738226|NCT01658579|474319619|FG001|Treatment Period B|Other|0|||
131738227|NCT01658579|474319620|FG002|Treatment Period B|Other|0|||
131738228|NCT01658579|474319621|FG003|Treatment Period B|Other|1|||
131738229|NCT02432040|474319624|FG000|Overall Study|Lack of Efficacy|3|||
131738230|NCT02432040|474319625|FG001|Overall Study|Lack of Efficacy|0|||
131738231|NCT02432040|474319624|FG000|Overall Study|Lost to Follow-up|4|||
131738232|NCT02432040|474319625|FG001|Overall Study|Lost to Follow-up|5|||
131738233|NCT02432040|474319624|FG000|Overall Study|Physician Decision|1|||
131738234|NCT02432040|474319625|FG001|Overall Study|Physician Decision|1|||
131738235|NCT01514188|474319626|FG000|Overall Study|Adverse Event|3|||
131738236|NCT01514188|474319627|FG001|Overall Study|Adverse Event|5|||
131738237|NCT01514188|474319626|FG000|Overall Study|Withdrawal by Subject|2|||
131738238|NCT01514188|474319627|FG001|Overall Study|Withdrawal by Subject|4|||
131738239|NCT01514188|474319626|FG000|Overall Study|Protocol Violation|2|||
131738240|NCT01514188|474319627|FG001|Overall Study|Protocol Violation|4|||
131738241|NCT01514188|474319626|FG000|Overall Study|Physician Decision|0|||
131738242|NCT01514188|474319627|FG001|Overall Study|Physician Decision|2|||
131738243|NCT01514188|474319626|FG000|Overall Study|Disease Progression|13|||
131738244|NCT01514188|474319627|FG001|Overall Study|Disease Progression|14|||
131738245|NCT01514188|474319626|FG000|Overall Study|Death|1|||
131738246|NCT01514188|474319627|FG001|Overall Study|Death|3|||
131738247|NCT01514188|474319626|FG000|Overall Study|Other|2|||
131738248|NCT01514188|474319627|FG001|Overall Study|Other|1|||
131738249|NCT02932332|474319632|FG000|Overall Study|Withdrawal by Subject|1|||
131738250|NCT02932332|474319633|FG001|Overall Study|Withdrawal by Subject|1|||
131738251|NCT02932332|474319634|FG002|Overall Study|Withdrawal by Subject|0|||
131738252|NCT02932332|474319635|FG003|Overall Study|Withdrawal by Subject|1|||
131738253|NCT02932332|474319632|FG000|Overall Study|Chest pain|0|||
131738254|NCT02932332|474319633|FG001|Overall Study|Chest pain|0|||
131738255|NCT02932332|474319634|FG002|Overall Study|Chest pain|0|||
131738256|NCT02932332|474319635|FG003|Overall Study|Chest pain|1|||
131738257|NCT02932332|474319632|FG000|Overall Study|Not Dyspneic cough|1|||
131738258|NCT02932332|474319633|FG001|Overall Study|Not Dyspneic cough|2|||
131738259|NCT02932332|474319634|FG002|Overall Study|Not Dyspneic cough|1|||
131738260|NCT02932332|474319635|FG003|Overall Study|Not Dyspneic cough|0|||
131738261|NCT03029650|474319638|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
131738262|NCT03029650|474319639|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
131738263|NCT03029650|474319638|FG000|Washout (1 Week)|Physician Decision|0|||
131738264|NCT03029650|474319639|FG001|Washout (1 Week)|Physician Decision|1|||
131738265|NCT01875367|474319640|FG000|Overall Study|Not complete at least 2 questionaries|4|||
131738266|NCT01875367|474319641|FG001|Overall Study|Not complete at least 2 questionaries|2|||
131738267|NCT01875367|474319640|FG000|Overall Study|Not receive study treatment|1|||
131738268|NCT01875367|474319641|FG001|Overall Study|Not receive study treatment|0|||
131738269|NCT02237157|474319644|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
131738270|NCT02237157|474319645|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
131738271|NCT02237157|474319646|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
131738272|NCT02237157|474319647|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
131738273|NCT02237157|474319644|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
131738274|NCT02237157|474319645|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
131738275|NCT02237157|474319646|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
131738276|NCT02237157|474319647|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
131738277|NCT04533815|474319648|FG000|Overall Study|Adverse Event|2|||
131738278|NCT04533815|474319648|FG000|Overall Study|Site withdrew|5|||
131738279|NCT00488592|474319651|FG000|Overall Study|Withdrawal by Subject|1|||
131738280|NCT00488592|474319651|FG000|Overall Study|Disease progression|1|||
131738281|NCT00488592|474319651|FG000|Overall Study|Enrolled but not treated|1|||
131738282|NCT00621855|474319652|FG000|Overall Study|Adverse Event|32|||
131738283|NCT00621855|474319653|FG001|Overall Study|Adverse Event|31|||
131738284|NCT00621855|474319654|FG002|Overall Study|Adverse Event|48|||
131738285|NCT00621855|474319655|FG003|Overall Study|Adverse Event|34|||
131738286|NCT00621855|474319656|FG004|Overall Study|Adverse Event|31|||
131738287|NCT00621855|474319652|FG000|Overall Study|Lost to Follow-up|0|||
131738288|NCT00621855|474319653|FG001|Overall Study|Lost to Follow-up|1|||
131738289|NCT00621855|474319654|FG002|Overall Study|Lost to Follow-up|3|||
131738290|NCT00621855|474319655|FG003|Overall Study|Lost to Follow-up|4|||
131738291|NCT00621855|474319656|FG004|Overall Study|Lost to Follow-up|1|||
131738292|NCT00621855|474319652|FG000|Overall Study|Protocol Violation|16|||
131738293|NCT00621855|474319653|FG001|Overall Study|Protocol Violation|8|||
131738294|NCT00621855|474319654|FG002|Overall Study|Protocol Violation|6|||
131738295|NCT00621855|474319655|FG003|Overall Study|Protocol Violation|7|||
131738296|NCT00621855|474319656|FG004|Overall Study|Protocol Violation|8|||
131738297|NCT00621855|474319652|FG000|Overall Study|Withdrawal by Subject|16|||
131738298|NCT00621855|474319653|FG001|Overall Study|Withdrawal by Subject|11|||
131738299|NCT00621855|474319654|FG002|Overall Study|Withdrawal by Subject|13|||
131738300|NCT00621855|474319655|FG003|Overall Study|Withdrawal by Subject|13|||
131738301|NCT00621855|474319656|FG004|Overall Study|Withdrawal by Subject|9|||
131738302|NCT00621855|474319652|FG000|Overall Study|Other|9|||
131738303|NCT00621855|474319653|FG001|Overall Study|Other|7|||
131738304|NCT00621855|474319654|FG002|Overall Study|Other|6|||
131738305|NCT00621855|474319655|FG003|Overall Study|Other|5|||
131738306|NCT00621855|474319656|FG004|Overall Study|Other|4|||
131738307|NCT00621855|474319652|FG000|Overall Study|Patients did not receive study drug|3|||
131738308|NCT00621855|474319653|FG001|Overall Study|Patients did not receive study drug|3|||
131738309|NCT00621855|474319654|FG002|Overall Study|Patients did not receive study drug|5|||
131738310|NCT00621855|474319655|FG003|Overall Study|Patients did not receive study drug|4|||
131738311|NCT00621855|474319656|FG004|Overall Study|Patients did not receive study drug|2|||
131738312|NCT02953782|474319657|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
131738313|NCT02953782|474319658|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
131738314|NCT02953782|474319659|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
131738315|NCT02953782|474319660|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
131738316|NCT02953782|474319661|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
131738317|NCT02953782|474319662|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
131738318|NCT02953782|474319663|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
131738319|NCT02953782|474319664|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
131738320|NCT02953782|474319657|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
131738321|NCT02953782|474319658|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131738322|NCT02953782|474319659|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
131738323|NCT02953782|474319660|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131738324|NCT02953782|474319661|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
131738325|NCT02953782|474319662|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131738326|NCT02953782|474319663|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131738327|NCT02953782|474319664|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131738328|NCT02953782|474319657|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131738329|NCT02953782|474319658|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
131738330|NCT02953782|474319659|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131738331|NCT02953782|474319660|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
131738332|NCT02953782|474319661|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
131738333|NCT02953782|474319662|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131738334|NCT02953782|474319663|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131738335|NCT02953782|474319664|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131738336|NCT02953782|474319657|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131738337|NCT02953782|474319658|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131738338|NCT02953782|474319659|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
131738339|NCT02953782|474319660|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
131738340|NCT02953782|474319661|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131738341|NCT02953782|474319662|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131738342|NCT02953782|474319663|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131738343|NCT02953782|474319664|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131738344|NCT02953782|474319657|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131738345|NCT02953782|474319658|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131738346|NCT02953782|474319659|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131738347|NCT02953782|474319660|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131738348|NCT02953782|474319661|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131738349|NCT02953782|474319662|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
131738350|NCT02953782|474319663|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
131738351|NCT02953782|474319664|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
131738352|NCT02953782|474319657|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131738353|NCT02953782|474319658|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131738354|NCT02953782|474319659|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131738355|NCT02953782|474319660|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131738356|NCT02953782|474319661|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131738357|NCT02953782|474319662|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
131738358|NCT02953782|474319663|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
131738359|NCT02953782|474319664|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
131738360|NCT02953782|474319657|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131738361|NCT02953782|474319658|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131738362|NCT02953782|474319659|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131738363|NCT02953782|474319660|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131738364|NCT02953782|474319661|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131738365|NCT02953782|474319662|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
131738366|NCT02953782|474319663|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
131738367|NCT02953782|474319664|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
131738368|NCT02953782|474319657|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738369|NCT02953782|474319658|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738370|NCT02953782|474319659|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738371|NCT02953782|474319660|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738372|NCT02953782|474319661|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738373|NCT02953782|474319662|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738374|NCT02953782|474319663|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
131738375|NCT02953782|474319664|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131738376|NCT01737840|474319665|FG000|Overall Study|Diagnosed with an other pathology|2|||
131738377|NCT01737840|474319666|FG001|Overall Study|Diagnosed with an other pathology|2|||
131738378|NCT00403559|474319669|FG000|Overall Study|Adverse Event|0|||
131738379|NCT00403559|474319670|FG001|Overall Study|Adverse Event|1|||
131738380|NCT00403559|474319669|FG000|Overall Study|Lost to Follow-up|3|||
131738381|NCT00403559|474319670|FG001|Overall Study|Lost to Follow-up|3|||
131738382|NCT00403559|474319669|FG000|Overall Study|Withdrawal by Subject|1|||
131738383|NCT00403559|474319670|FG001|Overall Study|Withdrawal by Subject|0|||
131738384|NCT03105700|474319671|FG000|Overall Study|screen fail|3|||
131738385|NCT03105700|474319671|FG000|Overall Study|Lost to Follow-up|4|||
131905295|NCT04635839|474940873|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
131905296|NCT02870868|474940874|FG000|Overall Study|Withdrawal by Subject|2|||
131905297|NCT02870868|474940875|FG001|Overall Study|Withdrawal by Subject|1|||
131738386|NCT01253421|474319672|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
131738387|NCT01253421|474319673|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
131738388|NCT01253421|474319674|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
131738389|NCT01253421|474319675|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
131738390|NCT01253421|474319676|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
131738391|NCT01253421|474319672|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
131738392|NCT01253421|474319673|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
131738393|NCT01253421|474319674|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
131738394|NCT01253421|474319675|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
131738395|NCT01253421|474319676|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
131738396|NCT01253421|474319672|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
131738397|NCT01253421|474319673|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
131738398|NCT01253421|474319674|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
131738399|NCT01253421|474319675|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
131738400|NCT01253421|474319676|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
131738401|NCT01253421|474319672|FG000|Assessment and Scheduling|Physician Decision|1|||
131738402|NCT01253421|474319673|FG001|Assessment and Scheduling|Physician Decision|0|||
131738403|NCT01253421|474319674|FG002|Assessment and Scheduling|Physician Decision|0|||
131738404|NCT01253421|474319675|FG003|Assessment and Scheduling|Physician Decision|0|||
131738405|NCT01253421|474319676|FG004|Assessment and Scheduling|Physician Decision|0|||
131738406|NCT01253421|474319672|FG000|Drug+Scanning Visit|Physician Decision|0|||
131738407|NCT01253421|474319673|FG001|Drug+Scanning Visit|Physician Decision|0|||
131738408|NCT01253421|474319674|FG002|Drug+Scanning Visit|Physician Decision|0|||
131738409|NCT01253421|474319675|FG003|Drug+Scanning Visit|Physician Decision|0|||
131738410|NCT01253421|474319676|FG004|Drug+Scanning Visit|Physician Decision|1|||
131738411|NCT00929734|474319677|FG000|Overall Study|Lost to Follow-up|2|||
131738412|NCT00929734|474319678|FG001|Overall Study|Lost to Follow-up|1|||
131738413|NCT00929734|474319677|FG000|Overall Study|Withdrawal by Subject|0|||
131738414|NCT00929734|474319678|FG001|Overall Study|Withdrawal by Subject|2|||
131738415|NCT02921919|474319679|FG000|Overall Study|Other|5|||
131738416|NCT02921919|474319680|FG001|Overall Study|Other|6|||
131738417|NCT02921919|474319679|FG000|Overall Study|Lost to Follow-up|0|||
131905298|NCT00744939|474940876|FG000|Overall Study|Withdrawal by Subject|9|||
131905299|NCT00744939|474940876|FG000|Overall Study|Protocol Violation|13|||
131905300|NCT00744939|474940876|FG000|Overall Study|Death|24|||
131905301|NCT00744939|474940876|FG000|Overall Study|distance|4|||
131905302|NCT00744939|474940876|FG000|Overall Study|Lost to Follow-up|12|||
131905303|NCT00744939|474940876|FG000|Overall Study|Medical history exclusionary|1|||
131738418|NCT02921919|474319680|FG001|Overall Study|Lost to Follow-up|1|||
131738419|NCT02921919|474319679|FG000|Overall Study|Withdrawal by Subject|5|||
131738420|NCT02921919|474319680|FG001|Overall Study|Withdrawal by Subject|1|||
131738421|NCT02921919|474319679|FG000|Overall Study|Disease Progression|47|||
131738422|NCT02921919|474319680|FG001|Overall Study|Disease Progression|38|||
131738423|NCT02921919|474319679|FG000|Overall Study|Physician Decision|3|||
131738424|NCT02921919|474319680|FG001|Overall Study|Physician Decision|2|||
131738425|NCT02921919|474319679|FG000|Overall Study|Adverse Event|6|||
131738426|NCT02921919|474319680|FG001|Overall Study|Adverse Event|4|||
131738427|NCT03666858|474319681|FG000|Cohort 1|Adverse Event|1|||
131738428|NCT03666858|474319682|FG001|Cohort 1|Adverse Event|0|||
131738429|NCT03666858|474319681|FG000|Cohort 2|Adverse Event|0|||
131738430|NCT03666858|474319682|FG001|Cohort 2|Adverse Event|1|||
131738431|NCT00980980|474319683|FG000|Overall Study|Withdrawal by Hospital|0|||
131738432|NCT00980980|474319684|FG001|Overall Study|Withdrawal by Hospital|1|||
131738433|NCT00980980|474319685|FG002|Overall Study|Withdrawal by Hospital|0|||
131738434|NCT00121992|474319687|FG000|Overall Study|Treatment not received|2|||
131738435|NCT00121992|474319688|FG001|Overall Study|Treatment not received|11|||
131738436|NCT03282357|474319689|FG000|Overall Study|Lost to Follow-up|3|||
131738437|NCT03282357|474319689|FG000|Overall Study|Withdrawal by Subject|4|||
131738438|NCT03282357|474319689|FG000|Overall Study|Adverse Event|1|||
131738439|NCT03282357|474319689|FG000|Overall Study|Other|9|||
131738440|NCT01586156|474319690|FG000|Overall Study|Pregnancy|0|||
131738441|NCT01586156|474319691|FG001|Overall Study|Pregnancy|1|||
131738442|NCT01586156|474319692|FG002|Overall Study|Pregnancy|0|||
131738443|NCT00547378|474319693|FG000|Randomized Cohort|Withdrawal by Subject|7|||
131738444|NCT00547378|474319694|FG001|Randomized Cohort|Withdrawal by Subject|5|||
131738445|NCT00547378|474319695|FG002|Randomized Cohort|Withdrawal by Subject|0|||
131738446|NCT00547378|474319693|FG000|Randomized Cohort|Death|0|||
131738447|NCT00547378|474319694|FG001|Randomized Cohort|Death|1|||
131738448|NCT00547378|474319695|FG002|Randomized Cohort|Death|0|||
131905304|NCT00744939|474940876|FG000|Overall Study|Did not receive Magnevist|7|||
131448887|NCT01208207|473272739|FG002|Part I|Progressive Disease|0|||
131738449|NCT00547378|474319693|FG000|Randomized Cohort|Lost to Follow-up|1|||
131738450|NCT00547378|474319694|FG001|Randomized Cohort|Lost to Follow-up|0|||
131905305|NCT00744939|474940876|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
131738451|NCT00547378|474319695|FG002|Randomized Cohort|Lost to Follow-up|0|||
131738452|NCT00547378|474319693|FG000|Randomized Cohort|Adverse Event|1|||
131738453|NCT00547378|474319694|FG001|Randomized Cohort|Adverse Event|0|||
131738454|NCT00547378|474319695|FG002|Randomized Cohort|Adverse Event|0|||
131738455|NCT00547378|474319693|FG000|Randomized Cohort|Other reasons|2|||
131738456|NCT00547378|474319694|FG001|Randomized Cohort|Other reasons|0|||
131738457|NCT00547378|474319695|FG002|Randomized Cohort|Other reasons|0|||
131738458|NCT00547378|474319693|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
131738459|NCT00547378|474319694|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
131738460|NCT00547378|474319695|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
131738461|NCT00547378|474319693|FG000|All Implanted Cohort|Adverse Event|4|||
131738462|NCT00547378|474319694|FG001|All Implanted Cohort|Adverse Event|10|||
131738463|NCT00547378|474319695|FG002|All Implanted Cohort|Adverse Event|17|||
131738464|NCT00547378|474319693|FG000|All Implanted Cohort|Lost to Follow-up|0|||
131738465|NCT00547378|474319694|FG001|All Implanted Cohort|Lost to Follow-up|1|||
131738466|NCT00547378|474319695|FG002|All Implanted Cohort|Lost to Follow-up|14|||
131738467|NCT00547378|474319693|FG000|All Implanted Cohort|Death|3|||
131738468|NCT00547378|474319694|FG001|All Implanted Cohort|Death|1|||
131738469|NCT00547378|474319695|FG002|All Implanted Cohort|Death|4|||
131738470|NCT00547378|474319693|FG000|All Implanted Cohort|Physician Decision|0|||
131738471|NCT00547378|474319694|FG001|All Implanted Cohort|Physician Decision|2|||
131738472|NCT00547378|474319695|FG002|All Implanted Cohort|Physician Decision|6|||
131738473|NCT00547378|474319693|FG000|All Implanted Cohort|Site closure|2|||
131738474|NCT00547378|474319694|FG001|All Implanted Cohort|Site closure|0|||
131738475|NCT00547378|474319695|FG002|All Implanted Cohort|Site closure|1|||
131738476|NCT00547378|474319693|FG000|All Implanted Cohort|Other reasons|1|||
131738477|NCT00547378|474319694|FG001|All Implanted Cohort|Other reasons|0|||
131738478|NCT00547378|474319695|FG002|All Implanted Cohort|Other reasons|1|||
131738479|NCT04105244|474319696|FG000|Overall Study|Withdrawal by Subject|10|||
131738480|NCT04105244|474319697|FG001|Overall Study|Withdrawal by Subject|12|||
131738481|NCT04105244|474319696|FG000|Overall Study|Lost to Follow-up|20|||
131738482|NCT04105244|474319697|FG001|Overall Study|Lost to Follow-up|15|||
131738483|NCT04105244|474319696|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
131738484|NCT04105244|474319697|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
131738485|NCT04105244|474319696|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
131738486|NCT04105244|474319697|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
131738487|NCT01449682|474319698|FG000|Overall Study|Death|0|||
131738488|NCT01449682|474319699|FG001|Overall Study|Death|1|||
131738489|NCT01449682|474319698|FG000|Overall Study|Adverse Event|1|||
131738490|NCT01449682|474319699|FG001|Overall Study|Adverse Event|0|||
131738491|NCT02112994|474319700|FG000|Overall Study|Progressive Disease|0|||
131738492|NCT02112994|474319701|FG001|Overall Study|Progressive Disease|0|||
131738493|NCT02112994|474319702|FG002|Overall Study|Progressive Disease|1|||
131738494|NCT02112994|474319700|FG000|Overall Study|Pregnancy|0|||
131738495|NCT02112994|474319701|FG001|Overall Study|Pregnancy|1|||
131738496|NCT02112994|474319702|FG002|Overall Study|Pregnancy|1|||
131738497|NCT02112994|474319700|FG000|Overall Study|Liver Transplant|0|||
131738498|NCT02112994|474319701|FG001|Overall Study|Liver Transplant|1|||
131738499|NCT02112994|474319702|FG002|Overall Study|Liver Transplant|0|||
131738500|NCT02112994|474319700|FG000|Overall Study|Withdrawal by Subject|0|||
131738501|NCT02112994|474319701|FG001|Overall Study|Withdrawal by Subject|0|||
131738502|NCT02112994|474319702|FG002|Overall Study|Withdrawal by Subject|1|||
131738503|NCT02768194|474319703|FG000|Period 1|Adverse Event|0|||
131808201|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131738504|NCT02768194|474319704|FG001|Period 1|Adverse Event|0|||
131738505|NCT02768194|474319705|FG002|Period 1|Adverse Event|0|||
131738506|NCT02768194|474319706|FG003|Period 1|Adverse Event|1|||
131738507|NCT02768194|474319707|FG004|Period 1|Adverse Event|0|||
131738508|NCT02768194|474319708|FG005|Period 1|Adverse Event|0|||
131738509|NCT02768194|474319703|FG000|Period 2|Other (Reason not specified)|1|||
131738510|NCT02768194|474319704|FG001|Period 2|Other (Reason not specified)|0|||
131738511|NCT02768194|474319705|FG002|Period 2|Other (Reason not specified)|0|||
131738512|NCT02768194|474319706|FG003|Period 2|Other (Reason not specified)|0|||
131738513|NCT02768194|474319707|FG004|Period 2|Other (Reason not specified)|0|||
131738514|NCT02768194|474319708|FG005|Period 2|Other (Reason not specified)|0|||
131738515|NCT02768194|474319703|FG000|Period 3|Other (Reason not specified)|0|||
131738516|NCT02768194|474319704|FG001|Period 3|Other (Reason not specified)|1|||
131738517|NCT02768194|474319705|FG002|Period 3|Other (Reason not specified)|0|||
131738518|NCT02768194|474319706|FG003|Period 3|Other (Reason not specified)|0|||
131738519|NCT02768194|474319707|FG004|Period 3|Other (Reason not specified)|0|||
131738520|NCT02768194|474319708|FG005|Period 3|Other (Reason not specified)|0|||
131738521|NCT03294681|474319709|FG000|Overall Study|Withdrawal by Subject|1|||
131738522|NCT03089216|474319712|FG000|Overall Study|Adverse Event|0|||
131738523|NCT03089216|474319713|FG001|Overall Study|Adverse Event|0|||
131738524|NCT03089216|474319714|FG002|Overall Study|Adverse Event|0|||
131738525|NCT03089216|474319715|FG003|Overall Study|Adverse Event|1|||
131738526|NCT00417976|474319718|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
131738527|NCT00417976|474319718|FG000|Overall Study|Treatment -related toxicity|2|||
131738528|NCT01778127|474319719|FG000|Overall Study|Lost to Follow-up|5|||
131738529|NCT01778127|474319720|FG001|Overall Study|Lost to Follow-up|1|||
131738530|NCT01778127|474319721|FG002|Overall Study|Lost to Follow-up|2|||
131738531|NCT01778127|474319719|FG000|Overall Study|Withdrawal by Subject|3|||
131738532|NCT01778127|474319720|FG001|Overall Study|Withdrawal by Subject|1|||
131738533|NCT01778127|474319721|FG002|Overall Study|Withdrawal by Subject|4|||
131738534|NCT01348425|474319727|FG000|Overall Study|Imaging was not taken.|1|||
131738535|NCT01348425|474319728|FG001|Overall Study|Imaging was not taken.|1|||
131738536|NCT02720016|474319729|FG000|Overall Study|Separation of couple|6|||
131738537|NCT02720016|474319730|FG001|Overall Study|Separation of couple|8|||
131738538|NCT02720016|474319731|FG002|Overall Study|Separation of couple|2|||
131738539|NCT02720016|474319729|FG000|Overall Study|Withdrawal by Subject|6|||
131738540|NCT02720016|474319730|FG001|Overall Study|Withdrawal by Subject|6|||
131738541|NCT02720016|474319731|FG002|Overall Study|Withdrawal by Subject|4|||
131738542|NCT02720016|474319729|FG000|Overall Study|Scheduling issues|2|||
131738543|NCT02720016|474319730|FG001|Overall Study|Scheduling issues|4|||
131738544|NCT02720016|474319731|FG002|Overall Study|Scheduling issues|7|||
131808202|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808203|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808204|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
131808205|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
131808206|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808207|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808208|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808209|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808210|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808211|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808212|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808213|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808214|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808215|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808216|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808217|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808218|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808219|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
131808220|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808221|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808222|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808223|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808224|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
131808225|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
131808226|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
131808227|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
131738545|NCT02720016|474319729|FG000|Overall Study|Childcare|2|||
131738546|NCT02720016|474319730|FG001|Overall Study|Childcare|0|||
131738547|NCT02720016|474319731|FG002|Overall Study|Childcare|2|||
131738548|NCT02720016|474319729|FG000|Overall Study|Withdrawal by PI|2|||
131738549|NCT02720016|474319730|FG001|Overall Study|Withdrawal by PI|2|||
131738550|NCT02720016|474319731|FG002|Overall Study|Withdrawal by PI|0|||
131738551|NCT02720016|474319729|FG000|Overall Study|Moved away|2|||
131808228|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808229|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
131808230|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808231|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808232|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808233|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808234|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808235|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808236|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808237|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808238|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808239|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808240|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131808241|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808242|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808243|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808244|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808245|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808246|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
131808247|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808248|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131905306|NCT00744939|474940876|FG000|Overall Study|coma|1|||
131905307|NCT00744939|474940876|FG000|Overall Study|incorrect race|1|||
131905308|NCT04040439|474940877|FG000|Overall Study|Invalid registration|11|||
131905309|NCT04040439|474940877|FG000|Overall Study|No IC* on publication of study results|2|||
131905310|NCT01309386|474940878|FG000|Overall Study|Other|2|||
131905311|NCT01309386|474940879|FG001|Overall Study|Other|0|||
131905312|NCT01309386|474940878|FG000|Overall Study|Withdrawal by Subject|2|||
131905313|NCT01309386|474940879|FG001|Overall Study|Withdrawal by Subject|0|||
131738552|NCT02720016|474319730|FG001|Overall Study|Moved away|0|||
131738553|NCT02720016|474319731|FG002|Overall Study|Moved away|0|||
131738554|NCT02720016|474319729|FG000|Overall Study|Not Primary Health Concern|0|||
131738555|NCT02720016|474319730|FG001|Overall Study|Not Primary Health Concern|0|||
131738556|NCT02720016|474319731|FG002|Overall Study|Not Primary Health Concern|2|||
131738557|NCT02720016|474319729|FG000|Overall Study|Transportation issues|0|||
131738558|NCT02720016|474319730|FG001|Overall Study|Transportation issues|0|||
131738559|NCT02720016|474319731|FG002|Overall Study|Transportation issues|1|||
131738560|NCT02720016|474319729|FG000|Overall Study|Other|0|||
131738561|NCT02720016|474319730|FG001|Overall Study|Other|0|||
131738562|NCT02720016|474319731|FG002|Overall Study|Other|2|||
131738563|NCT03722784|474319736|FG000|Overall Study|Withdrawal by Subject|1|||
131738564|NCT03722784|474319737|FG001|Overall Study|Withdrawal by Subject|0|||
131738565|NCT03722784|474319736|FG000|Overall Study|Physician Decision|1|||
131738566|NCT03722784|474319737|FG001|Overall Study|Physician Decision|1|||
131738567|NCT03722784|474319736|FG000|Overall Study|Protocol Violation|0|||
131738568|NCT03722784|474319737|FG001|Overall Study|Protocol Violation|1|||
131738569|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
131738570|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
131738571|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
131738572|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
131738573|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
131738574|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
131738575|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
131738576|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
131738577|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
131738578|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
131738579|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
131738580|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
131738581|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131738582|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131738583|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
131738584|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131738585|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131808249|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
131808250|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808251|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
131808252|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
131808253|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
131808254|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808255|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131905314|NCT01309386|474940878|FG000|Overall Study|Progressive disease|9|||
131905315|NCT01309386|474940879|FG001|Overall Study|Progressive disease|11|||
131738586|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131738587|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131738588|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131738589|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
131738590|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
131738591|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131738592|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131738593|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
131738594|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
131738595|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
131738596|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
131738597|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
131738598|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
131738599|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131738600|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131738601|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131738602|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
131738603|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131738604|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131738605|NCT01963208|474319738|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131738606|NCT01963208|474319739|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131738607|NCT01963208|474319740|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131738608|NCT01963208|474319741|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
131738609|NCT01963208|474319742|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131738610|NCT01963208|474319743|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131738611|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131738612|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131738613|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131738614|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131738615|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
131738616|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
131738617|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131738618|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131738619|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131808256|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808257|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808258|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808259|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808260|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808261|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
131808262|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808263|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808264|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808265|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131738620|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131738621|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
131738622|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
131738623|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131738624|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131738625|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131738626|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131738627|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131738628|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
131738629|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131808266|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
131808267|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
131808268|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
131808269|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
131808270|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
131808271|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
131738630|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131738631|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131738632|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131738633|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131738634|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
131738635|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
131738636|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
131738637|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
131738638|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
131738639|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
131738640|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
131738641|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131738642|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131738643|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131738644|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131738645|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
131738646|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
131738647|NCT01963208|474319738|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
131738648|NCT01963208|474319739|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
131738649|NCT01963208|474319740|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
131738650|NCT01963208|474319741|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
131738651|NCT01963208|474319742|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
131738652|NCT01963208|474319743|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
131738653|NCT00448916|474319744|FG000|Overall Study|Adverse Event|2|||
131738654|NCT00448916|474319745|FG001|Overall Study|Adverse Event|2|||
131738655|NCT00448916|474319746|FG002|Overall Study|Adverse Event|3|||
131738656|NCT00448916|474319747|FG003|Overall Study|Adverse Event|2|||
131738657|NCT00448916|474319744|FG000|Overall Study|Lack of Efficacy|1|||
131738658|NCT00448916|474319745|FG001|Overall Study|Lack of Efficacy|0|||
131738659|NCT00448916|474319746|FG002|Overall Study|Lack of Efficacy|2|||
131738660|NCT00448916|474319747|FG003|Overall Study|Lack of Efficacy|1|||
131738661|NCT00448916|474319744|FG000|Overall Study|Withdrawal by Subject|3|||
131738662|NCT00448916|474319745|FG001|Overall Study|Withdrawal by Subject|3|||
131738663|NCT00448916|474319746|FG002|Overall Study|Withdrawal by Subject|1|||
131738664|NCT00448916|474319747|FG003|Overall Study|Withdrawal by Subject|1|||
131738665|NCT00448916|474319744|FG000|Overall Study|Other|1|||
131738666|NCT00448916|474319745|FG001|Overall Study|Other|0|||
131738667|NCT00448916|474319746|FG002|Overall Study|Other|0|||
131738668|NCT00448916|474319747|FG003|Overall Study|Other|0|||
131738669|NCT00448916|474319744|FG000|Overall Study|Lost to Follow-up|0|||
131738670|NCT00448916|474319745|FG001|Overall Study|Lost to Follow-up|1|||
131738671|NCT00448916|474319746|FG002|Overall Study|Lost to Follow-up|0|||
131738672|NCT00448916|474319747|FG003|Overall Study|Lost to Follow-up|1|||
131738673|NCT00448916|474319744|FG000|Overall Study|Protocol Violation|0|||
131738674|NCT00448916|474319745|FG001|Overall Study|Protocol Violation|0|||
131738675|NCT00448916|474319746|FG002|Overall Study|Protocol Violation|0|||
131738676|NCT00448916|474319747|FG003|Overall Study|Protocol Violation|1|||
131738677|NCT03707158|474319750|FG000|Midtreatment|Lost to Follow-up|16|||
131738678|NCT03707158|474319751|FG001|Midtreatment|Lost to Follow-up|7|||
131738679|NCT03707158|474319750|FG000|Midtreatment|Withdrawal by Subject|28|||
131738680|NCT03707158|474319751|FG001|Midtreatment|Withdrawal by Subject|19|||
131738681|NCT03707158|474319750|FG000|Posttreatment|Lost to Follow-up|0|||
131738682|NCT03707158|474319751|FG001|Posttreatment|Lost to Follow-up|5|||
131738683|NCT03707158|474319750|FG000|Follow-up|Lost to Follow-up|19|||
131738684|NCT03707158|474319751|FG001|Follow-up|Lost to Follow-up|18|||
131738685|NCT03707158|474319750|FG000|Follow-up|Withdrawal by Subject|13|||
131738686|NCT03707158|474319751|FG001|Follow-up|Withdrawal by Subject|6|||
131738687|NCT01208038|474319752|FG000|Overall Study|Withdrawal by Subject|1|||
131738688|NCT03260205|474319753|FG000|Overall Study|Adverse Event|2|||
131448888|NCT01208207|473272740|FG003|Part I|Progressive Disease|0|||
131448889|NCT01208207|473272741|FG004|Part I|Progressive Disease|0|||
131738689|NCT03260205|474319754|FG001|Overall Study|Adverse Event|0|||
131738690|NCT03260205|474319755|FG002|Overall Study|Adverse Event|2|||
131738691|NCT03260205|474319756|FG003|Overall Study|Adverse Event|2|||
131738692|NCT03260205|474319757|FG004|Overall Study|Adverse Event|4|||
131738693|NCT03260205|474319753|FG000|Overall Study|Lost to Follow-up|2|||
131448890|NCT01208207|473272742|FG005|Part I|Progressive Disease|0|||
131448891|NCT01208207|473272743|FG006|Part I|Progressive Disease|0|||
131738694|NCT03260205|474319754|FG001|Overall Study|Lost to Follow-up|2|||
131738695|NCT03260205|474319755|FG002|Overall Study|Lost to Follow-up|1|||
131738696|NCT03260205|474319756|FG003|Overall Study|Lost to Follow-up|1|||
131738697|NCT03260205|474319757|FG004|Overall Study|Lost to Follow-up|5|||
131738698|NCT03260205|474319753|FG000|Overall Study|Protocol Violation|0|||
131738699|NCT03260205|474319754|FG001|Overall Study|Protocol Violation|0|||
131738700|NCT03260205|474319755|FG002|Overall Study|Protocol Violation|2|||
131738701|NCT03260205|474319756|FG003|Overall Study|Protocol Violation|0|||
131738702|NCT03260205|474319757|FG004|Overall Study|Protocol Violation|1|||
131738703|NCT03260205|474319753|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
131738704|NCT03260205|474319754|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
131448892|NCT01208207|473272737|FG000|Part I|Protocol Violation|8|||
131448893|NCT01208207|473272738|FG001|Part I|Protocol Violation|0|||
131738705|NCT03260205|474319755|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
131738706|NCT03260205|474319756|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
131738707|NCT03260205|474319757|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
131738708|NCT03260205|474319753|FG000|Overall Study|Other: Unspecified|0|||
131738709|NCT03260205|474319754|FG001|Overall Study|Other: Unspecified|0|||
131738710|NCT03260205|474319755|FG002|Overall Study|Other: Unspecified|3|||
131738711|NCT03260205|474319756|FG003|Overall Study|Other: Unspecified|1|||
131738712|NCT03260205|474319757|FG004|Overall Study|Other: Unspecified|1|||
131738713|NCT03260205|474319753|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
131738714|NCT03260205|474319754|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
131738715|NCT03260205|474319755|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
131738716|NCT03260205|474319756|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
131738717|NCT03260205|474319757|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
131738718|NCT05301322|474319758|FG000|Overall Study|Adverse Event|7|||
131738719|NCT05301322|474319759|FG001|Overall Study|Adverse Event|3|||
131738720|NCT05301322|474319758|FG000|Overall Study|Death|0|||
131738721|NCT05301322|474319759|FG001|Overall Study|Death|1|||
131738722|NCT05301322|474319758|FG000|Overall Study|Lost to Follow-up|2|||
131738723|NCT05301322|474319759|FG001|Overall Study|Lost to Follow-up|1|||
131738724|NCT05301322|474319758|FG000|Overall Study|Protocol Violation|3|||
131738725|NCT05301322|474319759|FG001|Overall Study|Protocol Violation|1|||
131738726|NCT05301322|474319758|FG000|Overall Study|Withdrawal by Subject|3|||
131738727|NCT05301322|474319759|FG001|Overall Study|Withdrawal by Subject|0|||
131738728|NCT05301322|474319758|FG000|Overall Study|Other|4|||
131738729|NCT05301322|474319759|FG001|Overall Study|Other|0|||
131738730|NCT00808249|474319762|FG000|Overall Study|Adverse Event|4|||
131738731|NCT00808249|474319763|FG001|Overall Study|Adverse Event|7|||
131738732|NCT00808249|474319764|FG002|Overall Study|Adverse Event|10|||
131738733|NCT00808249|474319765|FG003|Overall Study|Adverse Event|6|||
131738734|NCT00808249|474319762|FG000|Overall Study|Lost to Follow-up|2|||
131738735|NCT00808249|474319763|FG001|Overall Study|Lost to Follow-up|3|||
131738736|NCT00808249|474319764|FG002|Overall Study|Lost to Follow-up|3|||
131738737|NCT00808249|474319765|FG003|Overall Study|Lost to Follow-up|5|||
131738738|NCT00808249|474319762|FG000|Overall Study|Withdrawal by Subject|4|||
131738739|NCT00808249|474319763|FG001|Overall Study|Withdrawal by Subject|0|||
131738740|NCT00808249|474319764|FG002|Overall Study|Withdrawal by Subject|2|||
131738741|NCT00808249|474319765|FG003|Overall Study|Withdrawal by Subject|4|||
131738742|NCT00808249|474319762|FG000|Overall Study|Protocol Violation|3|||
131738743|NCT00808249|474319763|FG001|Overall Study|Protocol Violation|3|||
131738744|NCT00808249|474319764|FG002|Overall Study|Protocol Violation|3|||
131738745|NCT00808249|474319765|FG003|Overall Study|Protocol Violation|0|||
131738746|NCT00808249|474319762|FG000|Overall Study|Lack of Efficacy|1|||
131738747|NCT00808249|474319763|FG001|Overall Study|Lack of Efficacy|1|||
131738748|NCT00808249|474319764|FG002|Overall Study|Lack of Efficacy|0|||
131738749|NCT00808249|474319765|FG003|Overall Study|Lack of Efficacy|0|||
131738750|NCT00808249|474319762|FG000|Overall Study|study specific discontinuation criteria|1|||
131738751|NCT00808249|474319763|FG001|Overall Study|study specific discontinuation criteria|0|||
131738752|NCT00808249|474319764|FG002|Overall Study|study specific discontinuation criteria|1|||
131738753|NCT00808249|474319765|FG003|Overall Study|study specific discontinuation criteria|0|||
131738754|NCT00808249|474319762|FG000|Overall Study|All other reasons|2|||
131738755|NCT00808249|474319763|FG001|Overall Study|All other reasons|1|||
131738756|NCT00808249|474319764|FG002|Overall Study|All other reasons|3|||
131738757|NCT00808249|474319765|FG003|Overall Study|All other reasons|1|||
131738758|NCT03829332|474319766|FG000|Overall Study|Death|225|||
131738759|NCT03829332|474319767|FG001|Overall Study|Death|230|||
131738760|NCT03829332|474319766|FG000|Overall Study|Lost to Follow-up|1|||
131738761|NCT03829332|474319767|FG001|Overall Study|Lost to Follow-up|3|||
131738762|NCT03829332|474319766|FG000|Overall Study|Physician Decision|1|||
131738763|NCT03829332|474319767|FG001|Overall Study|Physician Decision|0|||
131738764|NCT03829332|474319766|FG000|Overall Study|Sponsor Decision|71|||
131738765|NCT03829332|474319767|FG001|Overall Study|Sponsor Decision|72|||
131738766|NCT03829332|474319766|FG000|Overall Study|Withdrawal by Subject|11|||
131738767|NCT03829332|474319767|FG001|Overall Study|Withdrawal by Subject|9|||
131738768|NCT00430521|474319768|FG000|Overall Study|Adverse Event|0|||
131738769|NCT00430521|474319769|FG001|Overall Study|Adverse Event|0|||
131738770|NCT00430521|474319770|FG002|Overall Study|Adverse Event|0|||
131738771|NCT00430521|474319771|FG003|Overall Study|Adverse Event|0|||
131738772|NCT00430521|474319772|FG004|Overall Study|Adverse Event|0|||
131738773|NCT00430521|474319773|FG005|Overall Study|Adverse Event|2|||
131738774|NCT00430521|474319774|FG006|Overall Study|Adverse Event|1|||
131738775|NCT00430521|474319775|FG007|Overall Study|Adverse Event|0|||
131738776|NCT00430521|474319768|FG000|Overall Study|Lost to Follow-up|7|||
131738777|NCT00430521|474319769|FG001|Overall Study|Lost to Follow-up|8|||
131738778|NCT00430521|474319770|FG002|Overall Study|Lost to Follow-up|3|||
131738779|NCT00430521|474319771|FG003|Overall Study|Lost to Follow-up|5|||
131738780|NCT00430521|474319772|FG004|Overall Study|Lost to Follow-up|5|||
131738781|NCT00430521|474319773|FG005|Overall Study|Lost to Follow-up|2|||
131738782|NCT00430521|474319774|FG006|Overall Study|Lost to Follow-up|8|||
131738783|NCT00430521|474319775|FG007|Overall Study|Lost to Follow-up|10|||
131738784|NCT00430521|474319768|FG000|Overall Study|Pregnancy|0|||
131738785|NCT00430521|474319769|FG001|Overall Study|Pregnancy|0|||
131738786|NCT00430521|474319770|FG002|Overall Study|Pregnancy|0|||
131738787|NCT00430521|474319771|FG003|Overall Study|Pregnancy|0|||
131738788|NCT00430521|474319772|FG004|Overall Study|Pregnancy|0|||
131738789|NCT00430521|474319773|FG005|Overall Study|Pregnancy|0|||
131738790|NCT00430521|474319774|FG006|Overall Study|Pregnancy|1|||
131738791|NCT00430521|474319775|FG007|Overall Study|Pregnancy|0|||
131738792|NCT00430521|474319768|FG000|Overall Study|Vaccine Expired|0|||
131738793|NCT00430521|474319769|FG001|Overall Study|Vaccine Expired|0|||
131738794|NCT00430521|474319770|FG002|Overall Study|Vaccine Expired|0|||
131738795|NCT00430521|474319771|FG003|Overall Study|Vaccine Expired|0|||
131738796|NCT00430521|474319772|FG004|Overall Study|Vaccine Expired|0|||
131738797|NCT00430521|474319773|FG005|Overall Study|Vaccine Expired|1|||
131738798|NCT00430521|474319774|FG006|Overall Study|Vaccine Expired|0|||
131738799|NCT00430521|474319775|FG007|Overall Study|Vaccine Expired|0|||
131738800|NCT00430521|474319768|FG000|Overall Study|Protocol Violation|1|||
131738801|NCT00430521|474319769|FG001|Overall Study|Protocol Violation|0|||
131738802|NCT00430521|474319770|FG002|Overall Study|Protocol Violation|0|||
131738803|NCT00430521|474319771|FG003|Overall Study|Protocol Violation|0|||
131738804|NCT00430521|474319772|FG004|Overall Study|Protocol Violation|0|||
131738805|NCT00430521|474319773|FG005|Overall Study|Protocol Violation|0|||
131738806|NCT00430521|474319774|FG006|Overall Study|Protocol Violation|0|||
131738807|NCT00430521|474319775|FG007|Overall Study|Protocol Violation|0|||
131738808|NCT00430521|474319768|FG000|Overall Study|Withdrawal by Subject|3|||
131738809|NCT00430521|474319769|FG001|Overall Study|Withdrawal by Subject|1|||
131738810|NCT00430521|474319770|FG002|Overall Study|Withdrawal by Subject|0|||
131738811|NCT00430521|474319771|FG003|Overall Study|Withdrawal by Subject|3|||
131738812|NCT00430521|474319772|FG004|Overall Study|Withdrawal by Subject|0|||
131738813|NCT00430521|474319773|FG005|Overall Study|Withdrawal by Subject|0|||
131738814|NCT00430521|474319774|FG006|Overall Study|Withdrawal by Subject|0|||
131738815|NCT00430521|474319775|FG007|Overall Study|Withdrawal by Subject|2|||
131738816|NCT05108805|474319776|FG000|Overall Study|T-cell expansion was not successful.|5|||
131738817|NCT04752189|474319777|FG000|Overall Study|Withdrawal by Subject|0|||
131738818|NCT04752189|474319778|FG001|Overall Study|Withdrawal by Subject|150|||
131738819|NCT04752189|474319777|FG000|Overall Study|Lost to Follow-up|261|||
131738820|NCT04752189|474319778|FG001|Overall Study|Lost to Follow-up|126|||
131738821|NCT03422133|474319779|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
131738822|NCT03422133|474319780|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
131738823|NCT03003403|474319781|FG000|Overall Study|Ineligible|8|||
131738824|NCT03003403|474319782|FG001|Overall Study|Ineligible|7|||
131738825|NCT03003403|474319781|FG000|Overall Study|Withdrawal by Subject|3|||
131738826|NCT03003403|474319782|FG001|Overall Study|Withdrawal by Subject|1|||
131738827|NCT02198651|474321303|FG000|Lead-in Period|Withdrew consent|13|||
131738828|NCT02198651|474321304|FG001|Lead-in Period|Withdrew consent|0|||
131738829|NCT02198651|474321305|FG002|Lead-in Period|Withdrew consent|0|||
131738830|NCT02198651|474321306|FG003|Lead-in Period|Withdrew consent|0|||
131738831|NCT02198651|474321307|FG004|Lead-in Period|Withdrew consent|0|||
131738832|NCT02198651|474321303|FG000|Lead-in Period|Adverse Event|2|||
131738833|NCT02198651|474321304|FG001|Lead-in Period|Adverse Event|0|||
131738834|NCT02198651|474321305|FG002|Lead-in Period|Adverse Event|0|||
131738835|NCT02198651|474321306|FG003|Lead-in Period|Adverse Event|0|||
131738836|NCT02198651|474321307|FG004|Lead-in Period|Adverse Event|0|||
131738837|NCT02198651|474321303|FG000|Lead-in Period|Other, not specified|22|||
131738838|NCT02198651|474321304|FG001|Lead-in Period|Other, not specified|0|||
131738839|NCT02198651|474321305|FG002|Lead-in Period|Other, not specified|0|||
131738840|NCT02198651|474321306|FG003|Lead-in Period|Other, not specified|0|||
131738841|NCT02198651|474321307|FG004|Lead-in Period|Other, not specified|0|||
131738842|NCT02198651|474321303|FG000|Double-blind Period|Withdrew consent|0|||
131738843|NCT02198651|474321304|FG001|Double-blind Period|Withdrew consent|4|||
131905316|NCT01309386|474940878|FG000|Overall Study|Physician Decision|1|||
131738844|NCT02198651|474321305|FG002|Double-blind Period|Withdrew consent|0|||
131738845|NCT02198651|474321306|FG003|Double-blind Period|Withdrew consent|0|||
131738846|NCT02198651|474321307|FG004|Double-blind Period|Withdrew consent|0|||
131738847|NCT02198651|474321303|FG000|Double-blind Period|Adverse Event|0|||
131738848|NCT02198651|474321304|FG001|Double-blind Period|Adverse Event|1|||
131738849|NCT02198651|474321305|FG002|Double-blind Period|Adverse Event|0|||
131738850|NCT02198651|474321306|FG003|Double-blind Period|Adverse Event|0|||
131738851|NCT02198651|474321307|FG004|Double-blind Period|Adverse Event|0|||
131738852|NCT02198651|474321303|FG000|Double-blind Period|Other, not specified|0|||
131738853|NCT02198651|474321304|FG001|Double-blind Period|Other, not specified|4|||
131905317|NCT01309386|474940879|FG001|Overall Study|Physician Decision|1|||
131905318|NCT01309386|474940878|FG000|Overall Study|Lack of Efficacy|3|||
131905319|NCT01309386|474940879|FG001|Overall Study|Lack of Efficacy|1|||
131905320|NCT01309386|474940878|FG000|Overall Study|Adverse Event|5|||
131905321|NCT01309386|474940879|FG001|Overall Study|Adverse Event|8|||
131905322|NCT01674725|474940880|FG000|Overall Study|Adverse Event|1|||
131905323|NCT01674725|474940881|FG001|Overall Study|Adverse Event|0|||
131905324|NCT01674725|474940880|FG000|Overall Study|Did not receive study drug|1|||
131905325|NCT01674725|474940881|FG001|Overall Study|Did not receive study drug|0|||
131905326|NCT01674725|474940880|FG000|Overall Study|Withdrawal by Subject|1|||
131905327|NCT01674725|474940881|FG001|Overall Study|Withdrawal by Subject|0|||
131905328|NCT01674725|474940880|FG000|Overall Study|Lost to Follow-up|0|||
131905329|NCT01674725|474940881|FG001|Overall Study|Lost to Follow-up|1|||
131905330|NCT02900352|474940882|FG000|Overall Study|Lost to Follow-up|28|||
131905331|NCT02900352|474940883|FG001|Overall Study|Lost to Follow-up|17|||
131905332|NCT03074695|474940884|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
131905333|NCT03074695|474940885|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
131905334|NCT03074695|474940884|FG000|Overall Study|Research staff not available|1|||
131905335|NCT03074695|474940885|FG001|Overall Study|Research staff not available|2|||
131905336|NCT03074695|474940884|FG000|Overall Study|Did not receive neuraxial block|2|||
131905337|NCT03074695|474940885|FG001|Overall Study|Did not receive neuraxial block|2|||
131905338|NCT01774981|474940886|FG000|Overall Study|Adverse Event|0|||
131905339|NCT01774981|474940887|FG001|Overall Study|Adverse Event|0|||
131905340|NCT01774981|474940888|FG002|Overall Study|Adverse Event|0|||
131905341|NCT01774981|474940889|FG003|Overall Study|Adverse Event|0|||
131905342|NCT01774981|474940890|FG004|Overall Study|Adverse Event|0|||
131905343|NCT01774981|474940891|FG005|Overall Study|Adverse Event|1|||
131905344|NCT01774981|474940892|FG006|Overall Study|Adverse Event|0|||
131738854|NCT02198651|474321305|FG002|Double-blind Period|Other, not specified|1|||
131738855|NCT02198651|474321306|FG003|Double-blind Period|Other, not specified|0|||
131738856|NCT02198651|474321307|FG004|Double-blind Period|Other, not specified|0|||
131738857|NCT02198651|474321303|FG000|Open-label Rescue Period|Withdrew consent|0|||
131738858|NCT02198651|474321304|FG001|Open-label Rescue Period|Withdrew consent|0|||
131738859|NCT02198651|474321305|FG002|Open-label Rescue Period|Withdrew consent|0|||
131738860|NCT02198651|474321306|FG003|Open-label Rescue Period|Withdrew consent|2|||
131738861|NCT02198651|474321307|FG004|Open-label Rescue Period|Withdrew consent|0|||
131738862|NCT02198651|474321303|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131738863|NCT02198651|474321304|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131738864|NCT02198651|474321305|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131738865|NCT02198651|474321306|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
131738866|NCT02198651|474321307|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131738867|NCT03073213|474321308|FG000|Multiple Dose Period|Protocol Violation|0|||
131738868|NCT03073213|474321309|FG001|Multiple Dose Period|Protocol Violation|0|||
131738869|NCT03073213|474321310|FG002|Multiple Dose Period|Protocol Violation|1|||
131738870|NCT02871401|474321320|FG000|Overall Study|Adverse Event|1|||
131738871|NCT02871401|474321321|FG001|Overall Study|Adverse Event|0|||
131738872|NCT01120379|474321322|FG000|One Year Timepoint|Withdrawal by Subject|41|||
131738873|NCT01120379|474321322|FG000|One Year Timepoint|Lost to Follow-up|115|||
131738874|NCT01120379|474321322|FG000|One Year Timepoint|Death|108|||
131738875|NCT01120379|474321322|FG000|One Year Timepoint|Physician Decision|9|||
131738876|NCT01120379|474321322|FG000|One Year Timepoint|Any other reason for early termination|5|||
131738877|NCT01120379|474321322|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
131738878|NCT01120379|474321322|FG000|Two Year Timepoint|Lost to Follow-up|87|||
131905345|NCT01774981|474940893|FG007|Overall Study|Adverse Event|0|||
131905346|NCT01774981|474940886|FG000|Overall Study|Withdrawal by Subject|0|||
131905347|NCT01774981|474940887|FG001|Overall Study|Withdrawal by Subject|0|||
131905348|NCT01774981|474940888|FG002|Overall Study|Withdrawal by Subject|0|||
131905349|NCT01774981|474940889|FG003|Overall Study|Withdrawal by Subject|0|||
131905350|NCT01774981|474940890|FG004|Overall Study|Withdrawal by Subject|0|||
131905351|NCT01774981|474940891|FG005|Overall Study|Withdrawal by Subject|0|||
131905352|NCT01774981|474940892|FG006|Overall Study|Withdrawal by Subject|0|||
131905353|NCT01774981|474940893|FG007|Overall Study|Withdrawal by Subject|1|||
131905354|NCT01774981|474940886|FG000|Overall Study|Death|0|||
131905355|NCT01774981|474940887|FG001|Overall Study|Death|0|||
131905356|NCT01774981|474940888|FG002|Overall Study|Death|0|||
131738879|NCT01120379|474321322|FG000|Two Year Timepoint|Death|123|||
131738880|NCT01120379|474321322|FG000|Two Year Timepoint|Physician Decision|12|||
131738881|NCT01120379|474321322|FG000|Two Year Timepoint|Any other reason for early termination|4|||
131738882|NCT01120379|474321322|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
131738883|NCT01120379|474321322|FG000|Three Year Timepoint|Lost to Follow-up|43|||
131738884|NCT01120379|474321322|FG000|Three Year Timepoint|Death|120|||
131738885|NCT01120379|474321322|FG000|Three Year Timepoint|Physician Decision|9|||
131738886|NCT01120379|474321322|FG000|Three Year Timepoint|Any other reason for early termination|17|||
131738887|NCT01120379|474321322|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
131738888|NCT01120379|474321322|FG000|Four Year Timepoint|Lost to Follow-up|10|||
131738889|NCT01120379|474321322|FG000|Four Year Timepoint|Death|131|||
131738890|NCT01120379|474321322|FG000|Four Year Timepoint|Physician Decision|5|||
131738891|NCT01120379|474321322|FG000|Four Year Timepoint|Any other reason for early termination|217|||
131738892|NCT01617655|474321323|FG000|Overall Study|Adverse Event|2|||
131738893|NCT01617655|474321324|FG001|Overall Study|Adverse Event|3|||
131738894|NCT01617655|474321323|FG000|Overall Study|Poor compliance to protocol|1|||
131738895|NCT01617655|474321324|FG001|Overall Study|Poor compliance to protocol|4|||
131738896|NCT01617655|474321323|FG000|Overall Study|Participants moved|0|||
131738897|NCT01617655|474321324|FG001|Overall Study|Participants moved|4|||
131738898|NCT01617655|474321323|FG000|Overall Study|Consent withdrawn by participant|1|||
131738899|NCT01617655|474321324|FG001|Overall Study|Consent withdrawn by participant|1|||
131738900|NCT01617655|474321323|FG000|Overall Study|Last visit outside protocol visit window|1|||
131738901|NCT01617655|474321324|FG001|Overall Study|Last visit outside protocol visit window|10|||
131738902|NCT01617655|474321323|FG000|Overall Study|Site closure|3|||
131738903|NCT01617655|474321324|FG001|Overall Study|Site closure|5|||
131738904|NCT01617655|474321323|FG000|Overall Study|Other than specified above|1|||
131738905|NCT01617655|474321324|FG001|Overall Study|Other than specified above|2|||
131738906|NCT01175213|474321325|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
131738907|NCT01175213|474321326|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
131738908|NCT01175213|474321325|FG000|IGSC, 10%/rHuPH20|Death|1|||
131738909|NCT01175213|474321326|FG001|IGSC, 10%/rHuPH20|Death|0|||
131738910|NCT01175213|474321325|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
131738911|NCT01175213|474321326|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
131738912|NCT01175213|474321325|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
131738913|NCT01175213|474321326|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
131738914|NCT01175213|474321325|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
131738915|NCT01175213|474321326|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
131738916|NCT01175213|474321325|FG000|Safety Follow-up|Adverse Event|1|||
131738917|NCT01175213|474321326|FG001|Safety Follow-up|Adverse Event|0|||
131738918|NCT00003476|474321333|FG000|Overall Study|Not evaluable|1|||
131738919|NCT03057951|474321336|FG000|Overall Study|Adverse Event|553|||
131738920|NCT03057951|474321337|FG001|Overall Study|Adverse Event|575|||
131738921|NCT03057951|474321336|FG000|Overall Study|Protocol Violation|30|||
131738922|NCT03057951|474321337|FG001|Overall Study|Protocol Violation|24|||
131738923|NCT03057951|474321336|FG000|Overall Study|Lost to Follow-up|6|||
131738924|NCT03057951|474321337|FG001|Overall Study|Lost to Follow-up|16|||
131738925|NCT03057951|474321336|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
131738926|NCT03057951|474321337|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
131738927|NCT03057951|474321336|FG000|Overall Study|Study drug stopped, reason missing|6|||
131738928|NCT03057951|474321337|FG001|Overall Study|Study drug stopped, reason missing|1|||
131738929|NCT03057951|474321336|FG000|Overall Study|Medical advice|6|||
131738930|NCT03057951|474321337|FG001|Overall Study|Medical advice|2|||
131738931|NCT03057951|474321336|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
131738932|NCT03057951|474321337|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
131738933|NCT03057951|474321336|FG000|Overall Study|Investigator decision|2|||
131738934|NCT03057951|474321337|FG001|Overall Study|Investigator decision|0|||
131738935|NCT03057951|474321336|FG000|Overall Study|Patient decision|5|||
131738936|NCT03057951|474321337|FG001|Overall Study|Patient decision|2|||
131738937|NCT03057951|474321336|FG000|Overall Study|Not attending study visits|3|||
131738938|NCT03057951|474321337|FG001|Overall Study|Not attending study visits|0|||
131738939|NCT03057951|474321336|FG000|Overall Study|Patient moved away|3|||
131738940|NCT03057951|474321337|FG001|Overall Study|Patient moved away|4|||
131905357|NCT01774981|474940889|FG003|Overall Study|Death|0|||
131905358|NCT01774981|474940890|FG004|Overall Study|Death|1|||
131738941|NCT03057951|474321336|FG000|Overall Study|Other reason than stated above|23|||
131738942|NCT03057951|474321337|FG001|Overall Study|Other reason than stated above|29|||
131738943|NCT03057951|474321336|FG000|Overall Study|Not treated|2|||
131738944|NCT03057951|474321337|FG001|Overall Study|Not treated|1|||
131738945|NCT00696436|474321338|FG000|Overall Study|Adverse Event|7|||
131738946|NCT00696436|474321339|FG001|Overall Study|Adverse Event|9|||
131738947|NCT00696436|474321340|FG002|Overall Study|Adverse Event|8|||
131738948|NCT00696436|474321341|FG003|Overall Study|Adverse Event|6|||
131738949|NCT00696436|474321342|FG004|Overall Study|Adverse Event|4|||
131738950|NCT00696436|474321338|FG000|Overall Study|Protocol Violation|3|||
131738951|NCT00696436|474321339|FG001|Overall Study|Protocol Violation|2|||
131905359|NCT01774981|474940891|FG005|Overall Study|Death|0|||
131738952|NCT00696436|474321340|FG002|Overall Study|Protocol Violation|2|||
131738953|NCT00696436|474321341|FG003|Overall Study|Protocol Violation|0|||
131738954|NCT00696436|474321342|FG004|Overall Study|Protocol Violation|1|||
131738955|NCT00696436|474321338|FG000|Overall Study|Lost to Follow-up|1|||
131738956|NCT00696436|474321339|FG001|Overall Study|Lost to Follow-up|6|||
131738957|NCT00696436|474321340|FG002|Overall Study|Lost to Follow-up|2|||
131738958|NCT00696436|474321341|FG003|Overall Study|Lost to Follow-up|4|||
131738959|NCT00696436|474321342|FG004|Overall Study|Lost to Follow-up|3|||
131738960|NCT00696436|474321338|FG000|Overall Study|Withdrawal by Subject|4|||
131738961|NCT00696436|474321339|FG001|Overall Study|Withdrawal by Subject|11|||
131738962|NCT00696436|474321340|FG002|Overall Study|Withdrawal by Subject|5|||
131738963|NCT00696436|474321341|FG003|Overall Study|Withdrawal by Subject|7|||
131738964|NCT00696436|474321342|FG004|Overall Study|Withdrawal by Subject|1|||
131738965|NCT00696436|474321338|FG000|Overall Study|Lack of Efficacy|3|||
131738966|NCT00696436|474321339|FG001|Overall Study|Lack of Efficacy|1|||
131738967|NCT00696436|474321340|FG002|Overall Study|Lack of Efficacy|5|||
131738968|NCT00696436|474321341|FG003|Overall Study|Lack of Efficacy|2|||
131738969|NCT00696436|474321342|FG004|Overall Study|Lack of Efficacy|4|||
131738970|NCT00696436|474321338|FG000|Overall Study|Participant Unavailability|2|||
131738971|NCT00696436|474321339|FG001|Overall Study|Participant Unavailability|0|||
131738972|NCT00696436|474321340|FG002|Overall Study|Participant Unavailability|2|||
131738973|NCT00696436|474321341|FG003|Overall Study|Participant Unavailability|1|||
131738974|NCT00696436|474321342|FG004|Overall Study|Participant Unavailability|0|||
131738975|NCT00696436|474321338|FG000|Overall Study|Administrative Error|2|||
131738976|NCT00696436|474321339|FG001|Overall Study|Administrative Error|0|||
131738977|NCT00696436|474321340|FG002|Overall Study|Administrative Error|2|||
131738978|NCT00696436|474321341|FG003|Overall Study|Administrative Error|0|||
131738979|NCT00696436|474321342|FG004|Overall Study|Administrative Error|0|||
131738980|NCT00696436|474321338|FG000|Overall Study|Participant Non-compliance|0|||
131738981|NCT00696436|474321339|FG001|Overall Study|Participant Non-compliance|0|||
131738982|NCT00696436|474321340|FG002|Overall Study|Participant Non-compliance|1|||
131738983|NCT00696436|474321341|FG003|Overall Study|Participant Non-compliance|2|||
131738984|NCT00696436|474321342|FG004|Overall Study|Participant Non-compliance|0|||
131738985|NCT00696436|474321338|FG000|Overall Study|Administrative Decision|1|||
131738986|NCT00696436|474321339|FG001|Overall Study|Administrative Decision|0|||
131738987|NCT00696436|474321340|FG002|Overall Study|Administrative Decision|0|||
131738988|NCT00696436|474321341|FG003|Overall Study|Administrative Decision|0|||
131738989|NCT00696436|474321342|FG004|Overall Study|Administrative Decision|0|||
131738990|NCT00696436|474321338|FG000|Overall Study|Missing|0|||
131738991|NCT00696436|474321339|FG001|Overall Study|Missing|1|||
131738992|NCT00696436|474321340|FG002|Overall Study|Missing|1|||
131738993|NCT00696436|474321341|FG003|Overall Study|Missing|0|||
131738994|NCT00696436|474321342|FG004|Overall Study|Missing|0|||
131738995|NCT02282982|474321343|FG000|Overall Study|Lost to Follow-up|15|||
131738996|NCT02282982|474321343|FG000|Overall Study|Withdrew consent|2|||
131738997|NCT02282982|474321343|FG000|Overall Study|Death|4|||
131738998|NCT02282982|474321343|FG000|Overall Study|Lack of product|156|||
131738999|NCT02282982|474321343|FG000|Overall Study|Palivizumab is ended|11|||
131739000|NCT02282982|474321343|FG000|Overall Study|Other, not specified|18|||
131739001|NCT02924688|474321344|FG000|Overall Study|Adverse Event|9|||
131739002|NCT02924688|474321345|FG001|Overall Study|Adverse Event|3|||
131739003|NCT02924688|474321346|FG002|Overall Study|Adverse Event|2|||
131739004|NCT02924688|474321347|FG003|Overall Study|Adverse Event|2|||
131739005|NCT02924688|474321348|FG004|Overall Study|Adverse Event|3|||
131739006|NCT02924688|474321349|FG005|Overall Study|Adverse Event|2|||
131739007|NCT02924688|474321344|FG000|Overall Study|Lack of Efficacy|2|||
131739008|NCT02924688|474321345|FG001|Overall Study|Lack of Efficacy|3|||
131739009|NCT02924688|474321346|FG002|Overall Study|Lack of Efficacy|4|||
131739010|NCT02924688|474321347|FG003|Overall Study|Lack of Efficacy|2|||
131739011|NCT02924688|474321348|FG004|Overall Study|Lack of Efficacy|1|||
131739012|NCT02924688|474321349|FG005|Overall Study|Lack of Efficacy|1|||
131739013|NCT02924688|474321344|FG000|Overall Study|Protocol Violation|3|||
131739014|NCT02924688|474321345|FG001|Overall Study|Protocol Violation|7|||
131739015|NCT02924688|474321346|FG002|Overall Study|Protocol Violation|5|||
131739016|NCT02924688|474321347|FG003|Overall Study|Protocol Violation|6|||
131739017|NCT02924688|474321348|FG004|Overall Study|Protocol Violation|2|||
131739018|NCT02924688|474321349|FG005|Overall Study|Protocol Violation|2|||
131739019|NCT02924688|474321344|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
131739020|NCT02924688|474321345|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
131739021|NCT02924688|474321346|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
131739022|NCT02924688|474321347|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
131739023|NCT02924688|474321348|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
131739024|NCT02924688|474321349|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
131739025|NCT02924688|474321344|FG000|Overall Study|Lost to Follow-up|2|||
131739026|NCT02924688|474321345|FG001|Overall Study|Lost to Follow-up|4|||
131739027|NCT02924688|474321346|FG002|Overall Study|Lost to Follow-up|2|||
131739028|NCT02924688|474321347|FG003|Overall Study|Lost to Follow-up|4|||
131739029|NCT02924688|474321348|FG004|Overall Study|Lost to Follow-up|2|||
131739030|NCT02924688|474321349|FG005|Overall Study|Lost to Follow-up|4|||
131739031|NCT02924688|474321344|FG000|Overall Study|Physician Decision|2|||
131739032|NCT02924688|474321345|FG001|Overall Study|Physician Decision|1|||
131739033|NCT02924688|474321346|FG002|Overall Study|Physician Decision|0|||
131739034|NCT02924688|474321347|FG003|Overall Study|Physician Decision|1|||
131739035|NCT02924688|474321348|FG004|Overall Study|Physician Decision|1|||
131739036|NCT02924688|474321349|FG005|Overall Study|Physician Decision|1|||
131739037|NCT02924688|474321344|FG000|Overall Study|Withdrawal by Subject|14|||
131739038|NCT02924688|474321345|FG001|Overall Study|Withdrawal by Subject|13|||
131739039|NCT02924688|474321346|FG002|Overall Study|Withdrawal by Subject|9|||
131739040|NCT02924688|474321347|FG003|Overall Study|Withdrawal by Subject|12|||
131739041|NCT02924688|474321348|FG004|Overall Study|Withdrawal by Subject|13|||
131739042|NCT02924688|474321349|FG005|Overall Study|Withdrawal by Subject|14|||
131739043|NCT00848250|474321352|FG000|Overall Study|surgery was completed without cardiopulm|0|||
131739044|NCT00848250|474321353|FG001|Overall Study|surgery was completed without cardiopulm|1|||
131739045|NCT00571688|474321357|FG000|Overall Study|Lost to Follow-up|3|||
131739046|NCT00571688|474321358|FG001|Overall Study|Lost to Follow-up|6|||
131739047|NCT00571688|474321357|FG000|Overall Study|subject did not tolerate Consta|1|||
131739048|NCT00571688|474321358|FG001|Overall Study|subject did not tolerate Consta|0|||
131739049|NCT00571688|474321357|FG000|Overall Study|subject moved out of the area|1|||
131739050|NCT00571688|474321358|FG001|Overall Study|subject moved out of the area|0|||
131739051|NCT03457103|474321359|FG000|Overall Study|illness/hospitalization|4|||
131739052|NCT03457103|474321360|FG001|Overall Study|illness/hospitalization|2|||
131739053|NCT03457103|474321359|FG000|Overall Study|Lost to Follow-up|2|||
131739054|NCT03457103|474321360|FG001|Overall Study|Lost to Follow-up|1|||
131739055|NCT03457103|474321359|FG000|Overall Study|Withdrawal by Subject|1|||
131739056|NCT03457103|474321360|FG001|Overall Study|Withdrawal by Subject|2|||
131739057|NCT03457103|474321359|FG000|Overall Study|financial/ insurance issues|1|||
131739058|NCT03457103|474321360|FG001|Overall Study|financial/ insurance issues|1|||
131739059|NCT00502320|474321361|FG000|Overall Study|Lost to Follow-up|1|||
131739060|NCT00502320|474321362|FG001|Overall Study|Lost to Follow-up|1|||
131739061|NCT00502320|474321361|FG000|Overall Study|Withdrew Consent|1|||
131739062|NCT00502320|474321362|FG001|Overall Study|Withdrew Consent|0|||
131739063|NCT00502320|474321361|FG000|Overall Study|No longer met criteria|1|||
131739064|NCT00502320|474321362|FG001|Overall Study|No longer met criteria|0|||
131739065|NCT00502320|474321361|FG000|Overall Study|Screen Failure|0|||
131739066|NCT00502320|474321362|FG001|Overall Study|Screen Failure|1|||
131739067|NCT00502320|474321361|FG000|Overall Study|Adverse Event|3|||
131739068|NCT00502320|474321362|FG001|Overall Study|Adverse Event|5|||
131739069|NCT03654755|474321368|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
131739070|NCT03654755|474321369|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
131739071|NCT03654755|474321370|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
131739072|NCT03654755|474321368|FG000|Overall Study|Withdrawal by Subject|2|||
131739073|NCT03654755|474321369|FG001|Overall Study|Withdrawal by Subject|4|||
131739074|NCT03654755|474321370|FG002|Overall Study|Withdrawal by Subject|8|||
131739075|NCT03654755|474321368|FG000|Overall Study|Lost to Follow-up|1|||
131739076|NCT03654755|474321369|FG001|Overall Study|Lost to Follow-up|3|||
131739077|NCT03654755|474321370|FG002|Overall Study|Lost to Follow-up|7|||
131739078|NCT03654755|474321368|FG000|Overall Study|Physician Decision|0|||
131739079|NCT03654755|474321369|FG001|Overall Study|Physician Decision|1|||
131739080|NCT03654755|474321370|FG002|Overall Study|Physician Decision|0|||
131739081|NCT03654755|474321368|FG000|Overall Study|Adverse Event|0|||
131739082|NCT03654755|474321369|FG001|Overall Study|Adverse Event|0|||
131739083|NCT03654755|474321370|FG002|Overall Study|Adverse Event|4|||
131739084|NCT03654755|474321368|FG000|Overall Study|Lack of Efficacy|0|||
131739085|NCT03654755|474321369|FG001|Overall Study|Lack of Efficacy|0|||
131739086|NCT03654755|474321370|FG002|Overall Study|Lack of Efficacy|1|||
131739087|NCT02394808|474321371|FG000|Period 1|Unsatisfactory lens fitting|0|||
131739088|NCT02394808|474321372|FG001|Period 1|Unsatisfactory lens fitting|1|||
131739089|NCT02394808|474321371|FG000|Period 2|Lost to Follow-up|1|||
131739090|NCT02394808|474321372|FG001|Period 2|Lost to Follow-up|0|||
131739091|NCT04580394|474321374|FG000|First Intervention|Incorrectly Randomized|1|||
131739092|NCT04580394|474321374|FG000|First Intervention|Physician Decision|1|||
131739093|NCT04580394|474321374|FG000|First Intervention|Lost to Follow-up|1|||
131739094|NCT04580394|474321374|FG000|Washout (One Week)|Withdrawal by Subject|1|||
131739095|NCT04580394|474321374|FG000|Washout (One Week)|Adverse Event|1|||
131739096|NCT04580394|474321374|FG000|Washout (One Week)|Withdrawal by Subject|2|||
131739097|NCT04580394|474321374|FG000|Third Intervention|Adverse Event|1|||
131739098|NCT04580394|474321374|FG000|Third Intervention|Withdrawal by Subject|1|||
131739099|NCT04580394|474321374|FG000|Washout (One Week)|Withdrawal by Subject|2|||
131739100|NCT00642746|474321376|FG000|Overall Study|Patient unevaluable|1|||
131739101|NCT00642746|474321377|FG001|Overall Study|Patient unevaluable|0|||
131739102|NCT03337152|474321380|FG000|Overall Study|Physician Decision|1|||
131739103|NCT03337152|474321381|FG001|Overall Study|Physician Decision|0|||
131739104|NCT03337152|474321380|FG000|Overall Study|Lost to Follow-up|1|||
131739105|NCT03337152|474321381|FG001|Overall Study|Lost to Follow-up|3|||
131739106|NCT03337152|474321380|FG000|Overall Study|Adverse Event|3|||
131739107|NCT03337152|474321381|FG001|Overall Study|Adverse Event|1|||
131739108|NCT03337152|474321380|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
131739109|NCT03337152|474321381|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
131739110|NCT00077610|474321382|FG000|Overall Study|Adverse Event|9|||
131739111|NCT00077610|474321383|FG001|Overall Study|Adverse Event|7|||
131739112|NCT00077610|474321384|FG002|Overall Study|Adverse Event|1|||
131739113|NCT00077610|474321382|FG000|Overall Study|Lost to Follow-up|0|||
131739114|NCT00077610|474321383|FG001|Overall Study|Lost to Follow-up|1|||
131739115|NCT00077610|474321384|FG002|Overall Study|Lost to Follow-up|2|||
131739116|NCT00077610|474321382|FG000|Overall Study|Withdrawal by Subject|4|||
131739117|NCT00077610|474321383|FG001|Overall Study|Withdrawal by Subject|10|||
131739118|NCT00077610|474321384|FG002|Overall Study|Withdrawal by Subject|6|||
131739119|NCT00077610|474321382|FG000|Overall Study|Death|17|||
131739120|NCT00077610|474321383|FG001|Overall Study|Death|13|||
131739121|NCT00077610|474321384|FG002|Overall Study|Death|13|||
131739122|NCT00077610|474321382|FG000|Overall Study|Renal transplant|12|||
131739123|NCT00077610|474321383|FG001|Overall Study|Renal transplant|15|||
131739124|NCT00077610|474321384|FG002|Overall Study|Renal transplant|11|||
131739125|NCT00077610|474321382|FG000|Overall Study|Withdrew from dialysis care|5|||
131739126|NCT00077610|474321383|FG001|Overall Study|Withdrew from dialysis care|0|||
131739127|NCT00077610|474321384|FG002|Overall Study|Withdrew from dialysis care|3|||
131739128|NCT00077610|474321382|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131739129|NCT00077610|474321383|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131739130|NCT00077610|474321384|FG002|Overall Study|Insufficient Therapeutic Response|0|||
131739131|NCT00077610|474321382|FG000|Overall Study|Multiple blood transfusions|0|||
131739132|NCT00077610|474321383|FG001|Overall Study|Multiple blood transfusions|0|||
131739133|NCT00077610|474321384|FG002|Overall Study|Multiple blood transfusions|1|||
131739134|NCT00077610|474321382|FG000|Overall Study|Principal Investigator's decision|1|||
131739135|NCT00077610|474321383|FG001|Overall Study|Principal Investigator's decision|0|||
131739136|NCT00077610|474321384|FG002|Overall Study|Principal Investigator's decision|1|||
131739137|NCT00077610|474321382|FG000|Overall Study|Worsening of health condition|1|||
131739138|NCT00077610|474321383|FG001|Overall Study|Worsening of health condition|1|||
131739139|NCT00077610|474321384|FG002|Overall Study|Worsening of health condition|0|||
131739140|NCT00077610|474321382|FG000|Overall Study|Given Epogen in hospital|1|||
131739141|NCT00077610|474321383|FG001|Overall Study|Given Epogen in hospital|0|||
131739142|NCT00077610|474321384|FG002|Overall Study|Given Epogen in hospital|0|||
131739143|NCT00077610|474321382|FG000|Overall Study|Transferred to other unit|0|||
131739144|NCT00077610|474321383|FG001|Overall Study|Transferred to other unit|0|||
131739145|NCT00077610|474321384|FG002|Overall Study|Transferred to other unit|1|||
131739146|NCT00077610|474321382|FG000|Overall Study|Transferred to nursing home|0|||
131739147|NCT00077610|474321383|FG001|Overall Study|Transferred to nursing home|0|||
131739148|NCT00077610|474321384|FG002|Overall Study|Transferred to nursing home|1|||
131739149|NCT00077610|474321382|FG000|Overall Study|Transfer to satellite unit|1|||
131739150|NCT00077610|474321383|FG001|Overall Study|Transfer to satellite unit|0|||
131739151|NCT00077610|474321384|FG002|Overall Study|Transfer to satellite unit|0|||
131739152|NCT00077610|474321382|FG000|Overall Study|Transfer to other center for surgery|1|||
131739153|NCT00077610|474321383|FG001|Overall Study|Transfer to other center for surgery|0|||
131739154|NCT00077610|474321384|FG002|Overall Study|Transfer to other center for surgery|0|||
131739155|NCT00077610|474321382|FG000|Overall Study|Change in dialysis modality|1|||
131739156|NCT00077610|474321383|FG001|Overall Study|Change in dialysis modality|0|||
131739157|NCT00077610|474321384|FG002|Overall Study|Change in dialysis modality|0|||
131739158|NCT00077610|474321382|FG000|Overall Study|Relocation|0|||
131739159|NCT00077610|474321383|FG001|Overall Study|Relocation|8|||
131739160|NCT00077610|474321384|FG002|Overall Study|Relocation|5|||
131739161|NCT00077610|474321382|FG000|Overall Study|Financial issues|0|||
131739162|NCT00077610|474321383|FG001|Overall Study|Financial issues|1|||
131739163|NCT00077610|474321384|FG002|Overall Study|Financial issues|0|||
131739164|NCT00077610|474321382|FG000|Overall Study|Sponsors decision to withdraw|0|||
131739165|NCT00077610|474321383|FG001|Overall Study|Sponsors decision to withdraw|0|||
131739166|NCT00077610|474321384|FG002|Overall Study|Sponsors decision to withdraw|1|||
131739167|NCT00976950|474321385|FG000|Overall Study|Adverse Event|3|||
131739168|NCT00976950|474321385|FG000|Overall Study|Events with no relationship to Aptivus|3|||
131739169|NCT00304915|474321386|FG000|Overall Study|Lost to Follow-up|11|||
131739170|NCT00304915|474321387|FG001|Overall Study|Lost to Follow-up|11|||
131739171|NCT00304915|474321386|FG000|Overall Study|Death|4|||
131739172|NCT00304915|474321387|FG001|Overall Study|Death|5|||
131739173|NCT00304915|474321386|FG000|Overall Study|Withdrawal by Subject|3|||
131739174|NCT00304915|474321387|FG001|Overall Study|Withdrawal by Subject|0|||
131739175|NCT04863014|474321388|FG000|Overall Study|Lost to Follow-up|3|||
131739176|NCT04863014|474321389|FG001|Overall Study|Lost to Follow-up|2|||
131739177|NCT04863014|474321388|FG000|Overall Study|Subject Decision|0|||
131739178|NCT04863014|474321389|FG001|Overall Study|Subject Decision|4|||
131739179|NCT01553916|474321390|FG000|Overall Study|Withdrawal by Subject|2|||
131739180|NCT01553916|474321390|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
131739181|NCT04348591|474321396|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
131739182|NCT04348591|474321397|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
131739183|NCT04348591|474321396|FG000|Imaging Session (120 Min)|Physician Decision|0|||
131739184|NCT04348591|474321397|FG001|Imaging Session (120 Min)|Physician Decision|1|||
131739185|NCT04348591|474321396|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
131739186|NCT04348591|474321397|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
131739187|NCT02104804|474321398|FG000|Overall Study|Did not take study medication|0|||
131739188|NCT02104804|474321399|FG001|Overall Study|Did not take study medication|1|||
131739189|NCT02104804|474321398|FG000|Overall Study|Study specific discontinuation criteria|6|||
131739190|NCT02104804|474321399|FG001|Overall Study|Study specific discontinuation criteria|1|||
131739191|NCT02104804|474321398|FG000|Overall Study|Other listed|2|||
131739192|NCT02104804|474321399|FG001|Overall Study|Other listed|1|||
131739193|NCT02104804|474321398|FG000|Overall Study|Protocol Violation|0|||
131739194|NCT02104804|474321399|FG001|Overall Study|Protocol Violation|1|||
131739195|NCT02104804|474321398|FG000|Overall Study|Adverse Event|4|||
131739196|NCT02104804|474321399|FG001|Overall Study|Adverse Event|3|||
131739197|NCT02104804|474321398|FG000|Overall Study|Withdrawal by Subject|4|||
131739198|NCT02104804|474321399|FG001|Overall Study|Withdrawal by Subject|12|||
131739199|NCT04501679|474321400|FG000|Overall Study|Pregnancy|0|||
131739200|NCT04501679|474321401|FG001|Overall Study|Pregnancy|1|||
131739201|NCT04501679|474321400|FG000|Overall Study|Adverse Event|4|||
131739202|NCT04501679|474321401|FG001|Overall Study|Adverse Event|2|||
131739203|NCT04501679|474321400|FG000|Overall Study|Withdrawal by Subject|2|||
131739204|NCT04501679|474321401|FG001|Overall Study|Withdrawal by Subject|0|||
131739205|NCT04501679|474321400|FG000|Overall Study|Physician Decision|1|||
131739206|NCT04501679|474321401|FG001|Overall Study|Physician Decision|0|||
131739207|NCT04501679|474321400|FG000|Overall Study|Lost to Follow-up|2|||
131739208|NCT04501679|474321401|FG001|Overall Study|Lost to Follow-up|0|||
131739209|NCT01968954|474321407|FG000|Overall Study|Adverse Event|6|||
131739210|NCT01968954|474321408|FG001|Overall Study|Adverse Event|3|||
131739211|NCT01968954|474321407|FG000|Overall Study|Death|1|||
131739212|NCT01968954|474321408|FG001|Overall Study|Death|2|||
131739213|NCT01968954|474321407|FG000|Overall Study|Lost to Follow-up|6|||
131739214|NCT01968954|474321408|FG001|Overall Study|Lost to Follow-up|4|||
131739215|NCT01968954|474321407|FG000|Overall Study|Withdrawal by Subject|20|||
131739216|NCT01968954|474321408|FG001|Overall Study|Withdrawal by Subject|23|||
131739217|NCT01968954|474321407|FG000|Overall Study|Other|7|||
131739218|NCT01968954|474321408|FG001|Overall Study|Other|8|||
131739219|NCT01968954|474321407|FG000|Overall Study|Protocol Violation|0|||
131739220|NCT01968954|474321408|FG001|Overall Study|Protocol Violation|1|||
131739221|NCT01968954|474321407|FG000|Overall Study|Did not met inclusion criteria|0|||
131739222|NCT01968954|474321408|FG001|Overall Study|Did not met inclusion criteria|2|||
131739223|NCT00751114|474321410|FG000|Overall Study|Adverse Event|2|||
131739224|NCT00751114|474321411|FG001|Overall Study|Adverse Event|4|||
131739225|NCT00751114|474321410|FG000|Overall Study|Protocol Violation|8|||
131739226|NCT00751114|474321411|FG001|Overall Study|Protocol Violation|9|||
131739227|NCT00751114|474321410|FG000|Overall Study|Withdrawal by Subject|9|||
131739228|NCT00751114|474321411|FG001|Overall Study|Withdrawal by Subject|4|||
131739229|NCT00751114|474321410|FG000|Overall Study|Lost to Follow-up|4|||
131739230|NCT00751114|474321411|FG001|Overall Study|Lost to Follow-up|7|||
131739231|NCT00751114|474321410|FG000|Overall Study|Lack of Efficacy|0|||
131739232|NCT00751114|474321411|FG001|Overall Study|Lack of Efficacy|7|||
131739233|NCT00751114|474321410|FG000|Overall Study|Not Treated|13|||
131739234|NCT00751114|474321411|FG001|Overall Study|Not Treated|1|||
131739235|NCT00751114|474321410|FG000|Overall Study|Out of country for 2 months|1|||
131739236|NCT00751114|474321411|FG001|Overall Study|Out of country for 2 months|0|||
131739237|NCT00751114|474321410|FG000|Overall Study|Move to another city|1|||
131739238|NCT00751114|474321411|FG001|Overall Study|Move to another city|0|||
131739239|NCT05319080|474321412|FG000|Overall Study|Withdrawal by Subject|2|||
131739240|NCT05319080|474321412|FG000|Overall Study|Physician Decision|4|||
131739241|NCT02358369|474321413|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
131739242|NCT02358369|474321414|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131739243|NCT02358369|474321415|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131739244|NCT02358369|474321416|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131739245|NCT02358369|474321417|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131739246|NCT02358369|474321413|FG000|Treatment Period A/B|Adverse Event|0|||
131739247|NCT02358369|474321414|FG001|Treatment Period A/B|Adverse Event|0|||
131739248|NCT02358369|474321415|FG002|Treatment Period A/B|Adverse Event|1|||
131739249|NCT02358369|474321416|FG003|Treatment Period A/B|Adverse Event|2|||
131739250|NCT02358369|474321417|FG004|Treatment Period A/B|Adverse Event|0|||
131739251|NCT02358369|474321413|FG000|Treatment Period A/B|Death|0|||
131739252|NCT02358369|474321414|FG001|Treatment Period A/B|Death|0|||
131739253|NCT02358369|474321415|FG002|Treatment Period A/B|Death|1|||
131739254|NCT02358369|474321416|FG003|Treatment Period A/B|Death|0|||
131739255|NCT02358369|474321417|FG004|Treatment Period A/B|Death|0|||
131739256|NCT02358369|474321413|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
131739257|NCT02358369|474321414|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
131808272|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
131808273|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
131808274|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
131808275|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131739258|NCT02358369|474321415|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
131739259|NCT02358369|474321416|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
131739260|NCT02358369|474321417|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
131739261|NCT02358369|474321413|FG000|Treatment Period C|Adverse Event|0|||
131739262|NCT02358369|474321414|FG001|Treatment Period C|Adverse Event|0|||
131739263|NCT02358369|474321415|FG002|Treatment Period C|Adverse Event|0|||
131739264|NCT02358369|474321416|FG003|Treatment Period C|Adverse Event|0|||
131739265|NCT02358369|474321417|FG004|Treatment Period C|Adverse Event|7|||
131739266|NCT03259490|474321422|FG000|Period 1|Withdrawal by Subject|0|||
131739267|NCT03259490|474321423|FG001|Period 1|Withdrawal by Subject|1|||
131739268|NCT03259490|474321422|FG000|Period 2|Protocol Violation|1|||
131739269|NCT03259490|474321423|FG001|Period 2|Protocol Violation|0|||
131739270|NCT00434122|474321424|FG000|Overall Study|Non-compliance with protocol|0|||
131739271|NCT00434122|474321425|FG001|Overall Study|Non-compliance with protocol|1|||
131739272|NCT00434122|474321424|FG000|Overall Study|loss of subject contact|1|||
131739273|NCT00434122|474321425|FG001|Overall Study|loss of subject contact|1|||
131739274|NCT00434122|474321424|FG000|Overall Study|Personal reasons|1|||
131739275|NCT00434122|474321425|FG001|Overall Study|Personal reasons|1|||
131739276|NCT00434122|474321424|FG000|Overall Study|Large follicle size|2|||
131739277|NCT00434122|474321425|FG001|Overall Study|Large follicle size|2|||
131739278|NCT00434122|474321424|FG000|Overall Study|Low follicular response.|1|||
131739279|NCT00434122|474321425|FG001|Overall Study|Low follicular response.|2|||
131739280|NCT00434122|474321424|FG000|Overall Study|Travelling of subject.|1|||
131739281|NCT00434122|474321425|FG001|Overall Study|Travelling of subject.|0|||
131739282|NCT04191577|474321429|FG000|Overall Study|Withdrawal by Subject|2|||
131739283|NCT04191577|474321430|FG001|Overall Study|Withdrawal by Subject|2|||
131739284|NCT04191577|474321431|FG002|Overall Study|Withdrawal by Subject|1|||
131739285|NCT04191577|474321429|FG000|Overall Study|Physician Decision|1|||
131739286|NCT04191577|474321430|FG001|Overall Study|Physician Decision|1|||
131739287|NCT04191577|474321431|FG002|Overall Study|Physician Decision|0|||
131739288|NCT04191577|474321429|FG000|Overall Study|Adverse Event|0|||
131739289|NCT04191577|474321430|FG001|Overall Study|Adverse Event|0|||
131739290|NCT04191577|474321431|FG002|Overall Study|Adverse Event|1|||
131739291|NCT04191577|474321429|FG000|Overall Study|Death|0|||
131739292|NCT04191577|474321430|FG001|Overall Study|Death|0|||
131739293|NCT04191577|474321431|FG002|Overall Study|Death|1|||
131739294|NCT03655717|474321432|FG000|Overall Study|Withdrawal by Subject|4|||
131739295|NCT03655717|474321433|FG001|Overall Study|Withdrawal by Subject|8|||
131739296|NCT03655717|474321434|FG002|Overall Study|Withdrawal by Subject|1|||
131739297|NCT03655717|474321435|FG003|Overall Study|Withdrawal by Subject|0|||
131739298|NCT03655717|474321436|FG004|Overall Study|Withdrawal by Subject|0|||
131739299|NCT03655717|474321437|FG005|Overall Study|Withdrawal by Subject|1|||
131739300|NCT03655717|474321438|FG006|Overall Study|Withdrawal by Subject|3|||
131739301|NCT03655717|474321439|FG007|Overall Study|Withdrawal by Subject|1|||
131739302|NCT03655717|474321440|FG008|Overall Study|Withdrawal by Subject|2|||
131739303|NCT03655717|474321441|FG009|Overall Study|Withdrawal by Subject|0|||
131739304|NCT03655717|474321442|FG010|Overall Study|Withdrawal by Subject|0|||
131739305|NCT03655717|474321443|FG011|Overall Study|Withdrawal by Subject|1|||
131739306|NCT03655717|474321444|FG012|Overall Study|Withdrawal by Subject|0|||
131739307|NCT03655717|474321445|FG013|Overall Study|Withdrawal by Subject|3|||
131739308|NCT03655717|474321446|FG014|Overall Study|Withdrawal by Subject|0|||
131739309|NCT03655717|474321447|FG015|Overall Study|Withdrawal by Subject|1|||
131739310|NCT03655717|474321448|FG016|Overall Study|Withdrawal by Subject|0|||
131739311|NCT03655717|474321449|FG017|Overall Study|Withdrawal by Subject|0|||
131739312|NCT03655717|474321450|FG018|Overall Study|Withdrawal by Subject|1|||
131739313|NCT03655717|474321451|FG019|Overall Study|Withdrawal by Subject|0|||
131739314|NCT03655717|474321452|FG020|Overall Study|Withdrawal by Subject|0|||
131739315|NCT03655717|474321453|FG021|Overall Study|Withdrawal by Subject|1|||
131739316|NCT03655717|474321454|FG022|Overall Study|Withdrawal by Subject|2|||
131739317|NCT03655717|474321455|FG023|Overall Study|Withdrawal by Subject|1|||
131739318|NCT03655717|474321456|FG024|Overall Study|Withdrawal by Subject|1|||
131739319|NCT03655717|474321457|FG025|Overall Study|Withdrawal by Subject|0|||
131739320|NCT03655717|474321432|FG000|Overall Study|Physician Decision|3|||
131739321|NCT03655717|474321433|FG001|Overall Study|Physician Decision|3|||
131739322|NCT03655717|474321434|FG002|Overall Study|Physician Decision|0|||
131739323|NCT03655717|474321435|FG003|Overall Study|Physician Decision|0|||
131808276|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808277|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131739324|NCT03655717|474321436|FG004|Overall Study|Physician Decision|0|||
131739325|NCT03655717|474321437|FG005|Overall Study|Physician Decision|0|||
131739326|NCT03655717|474321438|FG006|Overall Study|Physician Decision|0|||
131739327|NCT03655717|474321439|FG007|Overall Study|Physician Decision|0|||
131739328|NCT03655717|474321440|FG008|Overall Study|Physician Decision|0|||
131739329|NCT03655717|474321441|FG009|Overall Study|Physician Decision|1|||
131739330|NCT03655717|474321442|FG010|Overall Study|Physician Decision|0|||
131739331|NCT03655717|474321443|FG011|Overall Study|Physician Decision|0|||
131739332|NCT03655717|474321444|FG012|Overall Study|Physician Decision|0|||
131739333|NCT03655717|474321445|FG013|Overall Study|Physician Decision|0|||
131739334|NCT03655717|474321446|FG014|Overall Study|Physician Decision|0|||
131739335|NCT03655717|474321447|FG015|Overall Study|Physician Decision|0|||
131739336|NCT03655717|474321448|FG016|Overall Study|Physician Decision|0|||
131739337|NCT03655717|474321449|FG017|Overall Study|Physician Decision|0|||
131739338|NCT03655717|474321450|FG018|Overall Study|Physician Decision|0|||
131739339|NCT03655717|474321451|FG019|Overall Study|Physician Decision|1|||
131739340|NCT03655717|474321452|FG020|Overall Study|Physician Decision|0|||
131739341|NCT03655717|474321453|FG021|Overall Study|Physician Decision|0|||
131739342|NCT03655717|474321454|FG022|Overall Study|Physician Decision|0|||
131739343|NCT03655717|474321455|FG023|Overall Study|Physician Decision|1|||
131739344|NCT03655717|474321456|FG024|Overall Study|Physician Decision|0|||
131739345|NCT03655717|474321457|FG025|Overall Study|Physician Decision|0|||
131739346|NCT03655717|474321432|FG000|Overall Study|Lost to Follow-up|3|||
131739347|NCT03655717|474321433|FG001|Overall Study|Lost to Follow-up|1|||
131739348|NCT03655717|474321434|FG002|Overall Study|Lost to Follow-up|0|||
131739349|NCT03655717|474321435|FG003|Overall Study|Lost to Follow-up|1|||
131739350|NCT03655717|474321436|FG004|Overall Study|Lost to Follow-up|0|||
131739351|NCT03655717|474321437|FG005|Overall Study|Lost to Follow-up|1|||
131739352|NCT03655717|474321438|FG006|Overall Study|Lost to Follow-up|0|||
131739353|NCT03655717|474321439|FG007|Overall Study|Lost to Follow-up|0|||
131739354|NCT03655717|474321440|FG008|Overall Study|Lost to Follow-up|0|||
131739355|NCT03655717|474321441|FG009|Overall Study|Lost to Follow-up|0|||
131739356|NCT03655717|474321442|FG010|Overall Study|Lost to Follow-up|0|||
131739357|NCT03655717|474321443|FG011|Overall Study|Lost to Follow-up|1|||
131739358|NCT03655717|474321444|FG012|Overall Study|Lost to Follow-up|0|||
131739359|NCT03655717|474321445|FG013|Overall Study|Lost to Follow-up|0|||
131739360|NCT03655717|474321446|FG014|Overall Study|Lost to Follow-up|0|||
131739361|NCT03655717|474321447|FG015|Overall Study|Lost to Follow-up|0|||
131739362|NCT03655717|474321448|FG016|Overall Study|Lost to Follow-up|0|||
131739363|NCT03655717|474321449|FG017|Overall Study|Lost to Follow-up|0|||
131739364|NCT03655717|474321450|FG018|Overall Study|Lost to Follow-up|0|||
131739365|NCT03655717|474321451|FG019|Overall Study|Lost to Follow-up|0|||
131739366|NCT03655717|474321452|FG020|Overall Study|Lost to Follow-up|0|||
131739367|NCT03655717|474321453|FG021|Overall Study|Lost to Follow-up|0|||
131739368|NCT03655717|474321454|FG022|Overall Study|Lost to Follow-up|0|||
131739369|NCT03655717|474321455|FG023|Overall Study|Lost to Follow-up|0|||
131739370|NCT03655717|474321456|FG024|Overall Study|Lost to Follow-up|0|||
131739371|NCT03655717|474321457|FG025|Overall Study|Lost to Follow-up|0|||
131739372|NCT01185249|474321458|FG000|Overall Study|Patients discharged or change in status|42|||
131739373|NCT03521193|474321459|FG000|Overall Study|Withdrawal by Subject|8|||
131739374|NCT03521193|474321460|FG001|Overall Study|Withdrawal by Subject|0|||
131739375|NCT03521193|474321459|FG000|Overall Study|non compliant to ASA treatment|8|||
131739376|NCT03521193|474321460|FG001|Overall Study|non compliant to ASA treatment|0|||
131739377|NCT00406783|474321463|FG000|Overall Study|Adverse Event|4|||
131739378|NCT00406783|474321464|FG001|Overall Study|Adverse Event|4|||
131739379|NCT00406783|474321463|FG000|Overall Study|Treatment Failure|2|||
131739380|NCT00406783|474321464|FG001|Overall Study|Treatment Failure|3|||
131739381|NCT00406783|474321463|FG000|Overall Study|Lost to Follow-up|3|||
131739382|NCT00406783|474321464|FG001|Overall Study|Lost to Follow-up|0|||
131739383|NCT00406783|474321463|FG000|Overall Study|Withdrawal by Subject|1|||
131739384|NCT00406783|474321464|FG001|Overall Study|Withdrawal by Subject|4|||
131739385|NCT00406783|474321463|FG000|Overall Study|Protocol Violation|4|||
131739386|NCT00406783|474321464|FG001|Overall Study|Protocol Violation|4|||
131739387|NCT00012012|474321465|FG000|Overall Study|Protocol Violation|1|||
131739388|NCT00012012|474321466|FG001|Overall Study|Protocol Violation|1|||
131739389|NCT00012012|474321465|FG000|Overall Study|Withdrawal by Subject|0|||
131739390|NCT00012012|474321466|FG001|Overall Study|Withdrawal by Subject|2|||
131739391|NCT01391819|474321467|FG000|Overall Study|Withdrawal by Subject|56|||
131739392|NCT01391819|474321467|FG000|Overall Study|Migrated/moved from study area|82|||
131739393|NCT01391819|474321467|FG000|Overall Study|Lost to Follow-up|252|||
131739394|NCT01391819|474321467|FG000|Overall Study|Death|3|||
131739395|NCT01391819|474321467|FG000|Overall Study|Other|9|||
131739396|NCT00479557|474321473|FG000|Overall Study|Death|0|||
131739397|NCT00479557|474321474|FG001|Overall Study|Death|0|||
131739398|NCT00479557|474321475|FG002|Overall Study|Death|0|||
131739399|NCT00479557|474321476|FG003|Overall Study|Death|0|||
131739400|NCT00479557|474321477|FG004|Overall Study|Death|0|||
131739401|NCT00479557|474321478|FG005|Overall Study|Death|1|||
131739402|NCT00479557|474321479|FG006|Overall Study|Death|0|||
131739403|NCT00479557|474321473|FG000|Overall Study|Lack of Efficacy|1|||
131739404|NCT00479557|474321474|FG001|Overall Study|Lack of Efficacy|0|||
131739405|NCT00479557|474321475|FG002|Overall Study|Lack of Efficacy|0|||
131739406|NCT00479557|474321476|FG003|Overall Study|Lack of Efficacy|0|||
131739407|NCT00479557|474321477|FG004|Overall Study|Lack of Efficacy|0|||
131739408|NCT00479557|474321478|FG005|Overall Study|Lack of Efficacy|0|||
131739409|NCT00479557|474321479|FG006|Overall Study|Lack of Efficacy|0|||
131739410|NCT00479557|474321473|FG000|Overall Study|Lost to Follow-up|0|||
131739411|NCT00479557|474321474|FG001|Overall Study|Lost to Follow-up|2|||
131739412|NCT00479557|474321475|FG002|Overall Study|Lost to Follow-up|0|||
131739413|NCT00479557|474321476|FG003|Overall Study|Lost to Follow-up|2|||
131739414|NCT00479557|474321477|FG004|Overall Study|Lost to Follow-up|0|||
131739415|NCT00479557|474321478|FG005|Overall Study|Lost to Follow-up|0|||
131739416|NCT00479557|474321479|FG006|Overall Study|Lost to Follow-up|0|||
131739417|NCT00479557|474321473|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
131739418|NCT00479557|474321474|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131739419|NCT00479557|474321475|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
131739420|NCT00479557|474321476|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
131739421|NCT00479557|474321477|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131739422|NCT00479557|474321478|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
131739423|NCT00479557|474321479|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131739424|NCT00479557|474321473|FG000|Overall Study|AE not related to Study Drug|1|||
131739425|NCT00479557|474321474|FG001|Overall Study|AE not related to Study Drug|3|||
131739426|NCT00479557|474321475|FG002|Overall Study|AE not related to Study Drug|0|||
131739427|NCT00479557|474321476|FG003|Overall Study|AE not related to Study Drug|0|||
131739428|NCT00479557|474321477|FG004|Overall Study|AE not related to Study Drug|2|||
131739429|NCT00479557|474321478|FG005|Overall Study|AE not related to Study Drug|2|||
131739430|NCT00479557|474321479|FG006|Overall Study|AE not related to Study Drug|1|||
131739431|NCT00479557|474321473|FG000|Overall Study|Caregiver Request|2|||
131739432|NCT00479557|474321474|FG001|Overall Study|Caregiver Request|2|||
131739433|NCT00479557|474321475|FG002|Overall Study|Caregiver Request|2|||
131739434|NCT00479557|474321476|FG003|Overall Study|Caregiver Request|0|||
131739435|NCT00479557|474321477|FG004|Overall Study|Caregiver Request|1|||
131739436|NCT00479557|474321478|FG005|Overall Study|Caregiver Request|2|||
131739437|NCT00479557|474321479|FG006|Overall Study|Caregiver Request|0|||
131739438|NCT00479557|474321473|FG000|Overall Study|Investigator Request|0|||
131739439|NCT00479557|474321474|FG001|Overall Study|Investigator Request|0|||
131739440|NCT00479557|474321475|FG002|Overall Study|Investigator Request|1|||
131739441|NCT00479557|474321476|FG003|Overall Study|Investigator Request|0|||
131739442|NCT00479557|474321477|FG004|Overall Study|Investigator Request|0|||
131739443|NCT00479557|474321478|FG005|Overall Study|Investigator Request|0|||
131739444|NCT00479557|474321479|FG006|Overall Study|Investigator Request|0|||
131739445|NCT00479557|474321473|FG000|Overall Study|Subject Request|3|||
131739446|NCT00479557|474321474|FG001|Overall Study|Subject Request|0|||
131739447|NCT00479557|474321475|FG002|Overall Study|Subject Request|1|||
131739448|NCT00479557|474321476|FG003|Overall Study|Subject Request|1|||
131739449|NCT00479557|474321477|FG004|Overall Study|Subject Request|1|||
131739450|NCT00479557|474321478|FG005|Overall Study|Subject Request|4|||
131739451|NCT00479557|474321479|FG006|Overall Study|Subject Request|1|||
131739452|NCT00479557|474321473|FG000|Overall Study|Other|2|||
131739453|NCT00479557|474321474|FG001|Overall Study|Other|3|||
131739454|NCT00479557|474321475|FG002|Overall Study|Other|1|||
131739455|NCT00479557|474321476|FG003|Overall Study|Other|0|||
131739456|NCT00479557|474321477|FG004|Overall Study|Other|0|||
131739457|NCT00479557|474321478|FG005|Overall Study|Other|3|||
131739458|NCT00479557|474321479|FG006|Overall Study|Other|0|||
131739459|NCT01754922|474323282|FG000|Overall Study|Adverse Event|0|||
131739460|NCT01754922|474323283|FG001|Overall Study|Adverse Event|1|||
131739461|NCT01199055|474323291|FG000|Overall Study|Death|0|||
131739462|NCT01199055|474323292|FG001|Overall Study|Death|1|||
131739463|NCT01199055|474323293|FG002|Overall Study|Death|0|||
131739464|NCT01199055|474323291|FG000|Overall Study|Physician Decision|0|||
131739465|NCT01199055|474323292|FG001|Overall Study|Physician Decision|1|||
131739466|NCT01199055|474323293|FG002|Overall Study|Physician Decision|1|||
131739467|NCT01199055|474323291|FG000|Overall Study|Progressive disease|2|||
131739468|NCT01199055|474323292|FG001|Overall Study|Progressive disease|1|||
131739469|NCT01199055|474323293|FG002|Overall Study|Progressive disease|2|||
131905360|NCT01774981|474940892|FG006|Overall Study|Death|0|||
131739470|NCT01199055|474323291|FG000|Overall Study|Withdrawal by Subject|0|||
131739471|NCT01199055|474323292|FG001|Overall Study|Withdrawal by Subject|0|||
131739472|NCT01199055|474323293|FG002|Overall Study|Withdrawal by Subject|1|||
131739473|NCT02662985|474323302|FG000|Treatment Period 1|Adverse Event|0|||
131739474|NCT02662985|474323303|FG001|Treatment Period 1|Adverse Event|2|||
131739475|NCT02662985|474323302|FG000|Treatment Period 1|Protocol Violation|0|||
131739476|NCT02662985|474323303|FG001|Treatment Period 1|Protocol Violation|1|||
131739477|NCT02662985|474323302|FG000|Treatment Period 1|Physician Decision|1|||
131739478|NCT02662985|474323303|FG001|Treatment Period 1|Physician Decision|0|||
131739479|NCT02662985|474323302|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131739480|NCT02662985|474323303|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131739481|NCT02662985|474323302|FG000|Treatment Period 2|Lack of Efficacy|0|||
131739482|NCT02662985|474323303|FG001|Treatment Period 2|Lack of Efficacy|1|||
131739483|NCT02662985|474323302|FG000|Treatment Period 2|Lost to Follow-up|1|||
131739484|NCT02662985|474323303|FG001|Treatment Period 2|Lost to Follow-up|0|||
131739485|NCT02662985|474323302|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
131739486|NCT02662985|474323303|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
131739487|NCT02662985|474323302|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
131739488|NCT02662985|474323303|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
131739489|NCT02662985|474323302|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
131739490|NCT02662985|474323303|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
131739491|NCT02662985|474323302|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
131739492|NCT02662985|474323303|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
131739493|NCT02662985|474323302|FG000|Treatment Period 3 (Extension Period)|Death|0|||
131739494|NCT02662985|474323303|FG001|Treatment Period 3 (Extension Period)|Death|1|||
131739495|NCT03442829|474323304|FG000|Overall Study|Scheduling clash|3|||
131739496|NCT03442829|474323305|FG001|Overall Study|Scheduling clash|1|||
131739497|NCT03442829|474323304|FG000|Overall Study|Illness unrelated to study|1|||
131739498|NCT03442829|474323305|FG001|Overall Study|Illness unrelated to study|1|||
131739499|NCT01486784|474323306|FG000|Overall Study|Withdrawal by Subject|0|||
131739500|NCT01486784|474323307|FG001|Overall Study|Withdrawal by Subject|0|||
131739501|NCT01486784|474323308|FG002|Overall Study|Withdrawal by Subject|1|||
131739502|NCT01486784|474323309|FG003|Overall Study|Withdrawal by Subject|0|||
131739503|NCT01486784|474323310|FG004|Overall Study|Withdrawal by Subject|1|||
131739504|NCT01486784|474323311|FG005|Overall Study|Withdrawal by Subject|2|||
131739505|NCT01486784|474323306|FG000|Overall Study|Subject did not meet entry criteria|0|||
131739506|NCT01486784|474323307|FG001|Overall Study|Subject did not meet entry criteria|0|||
131739507|NCT01486784|474323308|FG002|Overall Study|Subject did not meet entry criteria|0|||
131739508|NCT01486784|474323309|FG003|Overall Study|Subject did not meet entry criteria|0|||
131739509|NCT01486784|474323310|FG004|Overall Study|Subject did not meet entry criteria|1|||
131739510|NCT01486784|474323311|FG005|Overall Study|Subject did not meet entry criteria|0|||
131739511|NCT01486784|474323306|FG000|Overall Study|Death|0|||
131739512|NCT01486784|474323307|FG001|Overall Study|Death|0|||
131739513|NCT01486784|474323308|FG002|Overall Study|Death|0|||
131739514|NCT01486784|474323309|FG003|Overall Study|Death|0|||
131739515|NCT01486784|474323310|FG004|Overall Study|Death|0|||
131739516|NCT01486784|474323311|FG005|Overall Study|Death|1|||
131808278|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808279|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808280|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808281|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808282|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
131808283|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808284|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808285|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808286|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808287|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
131808288|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
131808289|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
131808290|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808291|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
131808292|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
131905361|NCT01774981|474940893|FG007|Overall Study|Death|0|||
131905362|NCT00960193|474940894|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
131739517|NCT01021852|474323314|FG000|Treatment Period 1|Adverse Event|3|||
131739518|NCT01021852|474323315|FG001|Treatment Period 1|Adverse Event|1|||
131739519|NCT01021852|474323316|FG002|Treatment Period 1|Adverse Event|1|||
131739520|NCT01021852|474323317|FG003|Treatment Period 1|Adverse Event|0|||
131739521|NCT01021852|474323318|FG004|Treatment Period 1|Adverse Event|2|||
131739522|NCT01021852|474323319|FG005|Treatment Period 1|Adverse Event|2|||
131739523|NCT01021852|474323320|FG006|Treatment Period 1|Adverse Event|0|||
131739524|NCT01021852|474323321|FG007|Treatment Period 1|Adverse Event|0|||
131739525|NCT01021852|474323314|FG000|Treatment Period 1|Pregnancy|0|||
131739526|NCT01021852|474323315|FG001|Treatment Period 1|Pregnancy|0|||
131808293|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
131808294|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
131808295|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
131808296|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808297|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808298|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131739527|NCT01021852|474323316|FG002|Treatment Period 1|Pregnancy|1|||
131739528|NCT01021852|474323317|FG003|Treatment Period 1|Pregnancy|0|||
131739529|NCT01021852|474323318|FG004|Treatment Period 1|Pregnancy|0|||
131739530|NCT01021852|474323319|FG005|Treatment Period 1|Pregnancy|0|||
131739531|NCT01021852|474323320|FG006|Treatment Period 1|Pregnancy|0|||
131739532|NCT01021852|474323321|FG007|Treatment Period 1|Pregnancy|0|||
131739533|NCT01021852|474323314|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131739534|NCT01021852|474323315|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131739535|NCT01021852|474323316|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131739536|NCT01021852|474323317|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131739537|NCT01021852|474323318|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131739538|NCT01021852|474323319|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131739539|NCT01021852|474323320|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131739540|NCT01021852|474323321|FG007|Treatment Period 1|Withdrawal by Subject|1|||
131739541|NCT01021852|474323314|FG000|Treatment Period 1|Not Treated|0|||
131739542|NCT01021852|474323315|FG001|Treatment Period 1|Not Treated|0|||
131739543|NCT01021852|474323316|FG002|Treatment Period 1|Not Treated|0|||
131739544|NCT01021852|474323317|FG003|Treatment Period 1|Not Treated|2|||
131739545|NCT01021852|474323318|FG004|Treatment Period 1|Not Treated|0|||
131739546|NCT01021852|474323319|FG005|Treatment Period 1|Not Treated|0|||
131739547|NCT01021852|474323320|FG006|Treatment Period 1|Not Treated|0|||
131739548|NCT01021852|474323321|FG007|Treatment Period 1|Not Treated|0|||
131739549|NCT01021852|474323314|FG000|Washout Period-Placebo|Adverse Event|0|||
131739550|NCT01021852|474323315|FG001|Washout Period-Placebo|Adverse Event|0|||
131739551|NCT01021852|474323316|FG002|Washout Period-Placebo|Adverse Event|0|||
131739552|NCT01021852|474323317|FG003|Washout Period-Placebo|Adverse Event|1|||
131739553|NCT01021852|474323318|FG004|Washout Period-Placebo|Adverse Event|0|||
131739554|NCT01021852|474323319|FG005|Washout Period-Placebo|Adverse Event|1|||
131739555|NCT01021852|474323320|FG006|Washout Period-Placebo|Adverse Event|0|||
131739556|NCT01021852|474323321|FG007|Washout Period-Placebo|Adverse Event|0|||
131739557|NCT01021852|474323314|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
131739558|NCT01021852|474323315|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
131739559|NCT01021852|474323316|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
131739560|NCT01021852|474323317|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
131739561|NCT01021852|474323318|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
131739562|NCT01021852|474323319|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
131739563|NCT01021852|474323320|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
131739564|NCT01021852|474323321|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
131739565|NCT01021852|474323314|FG000|Washout Period-Placebo|Protocol Violation|0|||
131739566|NCT01021852|474323315|FG001|Washout Period-Placebo|Protocol Violation|0|||
131739567|NCT01021852|474323316|FG002|Washout Period-Placebo|Protocol Violation|0|||
131739568|NCT01021852|474323317|FG003|Washout Period-Placebo|Protocol Violation|0|||
131739569|NCT01021852|474323318|FG004|Washout Period-Placebo|Protocol Violation|0|||
131739570|NCT01021852|474323319|FG005|Washout Period-Placebo|Protocol Violation|0|||
131739571|NCT01021852|474323320|FG006|Washout Period-Placebo|Protocol Violation|1|||
131739572|NCT01021852|474323321|FG007|Washout Period-Placebo|Protocol Violation|0|||
131739573|NCT01021852|474323314|FG000|Washout Period-No Drug|Adverse Event|1|||
131739574|NCT01021852|474323315|FG001|Washout Period-No Drug|Adverse Event|0|||
131739575|NCT01021852|474323316|FG002|Washout Period-No Drug|Adverse Event|0|||
131739576|NCT01021852|474323317|FG003|Washout Period-No Drug|Adverse Event|0|||
131739577|NCT01021852|474323318|FG004|Washout Period-No Drug|Adverse Event|0|||
131739578|NCT01021852|474323319|FG005|Washout Period-No Drug|Adverse Event|1|||
131739579|NCT01021852|474323320|FG006|Washout Period-No Drug|Adverse Event|0|||
131739580|NCT01021852|474323321|FG007|Washout Period-No Drug|Adverse Event|0|||
131739581|NCT01021852|474323314|FG000|Treatment Period 2|Adverse Event|0|||
131739582|NCT01021852|474323315|FG001|Treatment Period 2|Adverse Event|1|||
131739583|NCT01021852|474323316|FG002|Treatment Period 2|Adverse Event|0|||
131739584|NCT01021852|474323317|FG003|Treatment Period 2|Adverse Event|0|||
131739585|NCT01021852|474323318|FG004|Treatment Period 2|Adverse Event|1|||
131739586|NCT01021852|474323319|FG005|Treatment Period 2|Adverse Event|0|||
131739587|NCT01021852|474323320|FG006|Treatment Period 2|Adverse Event|1|||
131739588|NCT01021852|474323321|FG007|Treatment Period 2|Adverse Event|0|||
131739589|NCT01021852|474323314|FG000|Treatment Period 2|Lack of Efficacy|0|||
131739590|NCT01021852|474323315|FG001|Treatment Period 2|Lack of Efficacy|0|||
131739591|NCT01021852|474323316|FG002|Treatment Period 2|Lack of Efficacy|0|||
131739592|NCT01021852|474323317|FG003|Treatment Period 2|Lack of Efficacy|0|||
131739593|NCT01021852|474323318|FG004|Treatment Period 2|Lack of Efficacy|0|||
131739594|NCT01021852|474323319|FG005|Treatment Period 2|Lack of Efficacy|1|||
131739595|NCT01021852|474323320|FG006|Treatment Period 2|Lack of Efficacy|0|||
131739596|NCT01021852|474323321|FG007|Treatment Period 2|Lack of Efficacy|0|||
131739597|NCT01021852|474323314|FG000|Treatment Period 2|Physician Decision|0|||
131739598|NCT01021852|474323315|FG001|Treatment Period 2|Physician Decision|0|||
131739599|NCT01021852|474323316|FG002|Treatment Period 2|Physician Decision|1|||
131739600|NCT01021852|474323317|FG003|Treatment Period 2|Physician Decision|0|||
131739601|NCT01021852|474323318|FG004|Treatment Period 2|Physician Decision|0|||
131739602|NCT01021852|474323319|FG005|Treatment Period 2|Physician Decision|0|||
131739603|NCT01021852|474323320|FG006|Treatment Period 2|Physician Decision|0|||
131739604|NCT01021852|474323321|FG007|Treatment Period 2|Physician Decision|0|||
131739605|NCT01021852|474323314|FG000|Treatment Period 2|Protocol Violation|0|||
131739606|NCT01021852|474323315|FG001|Treatment Period 2|Protocol Violation|0|||
131739607|NCT01021852|474323316|FG002|Treatment Period 2|Protocol Violation|0|||
131739608|NCT01021852|474323317|FG003|Treatment Period 2|Protocol Violation|0|||
131739609|NCT01021852|474323318|FG004|Treatment Period 2|Protocol Violation|1|||
131739610|NCT01021852|474323319|FG005|Treatment Period 2|Protocol Violation|0|||
131739611|NCT01021852|474323320|FG006|Treatment Period 2|Protocol Violation|1|||
131739612|NCT01021852|474323321|FG007|Treatment Period 2|Protocol Violation|0|||
131739613|NCT01021852|474323314|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131739614|NCT01021852|474323315|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131739615|NCT01021852|474323316|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131739616|NCT01021852|474323317|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131739617|NCT01021852|474323318|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131739618|NCT01021852|474323319|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131739619|NCT01021852|474323320|FG006|Treatment Period 2|Withdrawal by Subject|1|||
131739620|NCT01021852|474323321|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131739621|NCT02493426|474323322|FG000|Overall Study|Withdrawal by Subject|0|||
131739622|NCT02493426|474323323|FG001|Overall Study|Withdrawal by Subject|1|||
131739623|NCT03491553|474323324|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
131739624|NCT03491553|474323325|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
131739625|NCT03491553|474323326|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
131739626|NCT03491553|474323327|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
131739627|NCT03491553|474323328|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
131739628|NCT03491553|474323329|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
131739629|NCT03491553|474323324|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
131739630|NCT03491553|474323325|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
131739631|NCT03491553|474323326|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
131739632|NCT03491553|474323327|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
131739633|NCT03491553|474323328|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
131739634|NCT03491553|474323329|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
131739635|NCT01069523|474323330|FG000|Overall Study|Withdrawal by Subject|4|||
131739636|NCT01069523|474323331|FG001|Overall Study|Withdrawal by Subject|7|||
131739637|NCT01551758|474323351|FG000|Overall Study|Adverse Event|29|||
131739638|NCT01551758|474323352|FG001|Overall Study|Adverse Event|43|||
131739639|NCT01551758|474323351|FG000|Overall Study|Lack of Efficacy|0|||
131739640|NCT01551758|474323352|FG001|Overall Study|Lack of Efficacy|1|||
131739641|NCT01551758|474323351|FG000|Overall Study|Protocol Violation|5|||
131739642|NCT01551758|474323352|FG001|Overall Study|Protocol Violation|6|||
131739643|NCT01551758|474323351|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
131739644|NCT01551758|474323352|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
131739645|NCT01551758|474323351|FG000|Overall Study|Lost to Follow-up|29|||
131739646|NCT01551758|474323352|FG001|Overall Study|Lost to Follow-up|25|||
131739647|NCT01551758|474323351|FG000|Overall Study|Physician Decision|9|||
131739648|NCT01551758|474323352|FG001|Overall Study|Physician Decision|3|||
131739649|NCT01551758|474323351|FG000|Overall Study|Withdrawal by Subject|14|||
131739650|NCT01551758|474323352|FG001|Overall Study|Withdrawal by Subject|17|||
131739651|NCT03670641|474323359|FG000|Overall Study|Lost to Follow-up|3|||
131739652|NCT01096849|474323360|FG000|Overall Study|Consent Withdrawn|1|||
131739653|NCT01096849|474323361|FG001|Overall Study|Consent Withdrawn|4|||
131739654|NCT01096849|474323362|FG002|Overall Study|Consent Withdrawn|2|||
131739655|NCT01096849|474323360|FG000|Overall Study|Lack of Efficacy|0|||
131739656|NCT01096849|474323361|FG001|Overall Study|Lack of Efficacy|2|||
131808299|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808300|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131739657|NCT01096849|474323362|FG002|Overall Study|Lack of Efficacy|0|||
131739658|NCT01096849|474323360|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
131739659|NCT01096849|474323361|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
131739660|NCT01096849|474323362|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
131739661|NCT01096849|474323360|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
131739662|NCT01096849|474323361|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
131739663|NCT01096849|474323362|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
131739664|NCT01096849|474323360|FG000|Overall Study|Administrative Reasons|0|||
131739665|NCT01096849|474323361|FG001|Overall Study|Administrative Reasons|1|||
131808301|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808302|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131808303|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131739666|NCT01096849|474323362|FG002|Overall Study|Administrative Reasons|2|||
131739667|NCT01096849|474323360|FG000|Overall Study|Lost to Follow-up|1|||
131739668|NCT01096849|474323361|FG001|Overall Study|Lost to Follow-up|3|||
131739669|NCT01096849|474323362|FG002|Overall Study|Lost to Follow-up|1|||
131739670|NCT00118482|474323364|FG000|Overall Study|Lost to Follow-up|7|||
131739671|NCT00118482|474323365|FG001|Overall Study|Lost to Follow-up|7|||
131739672|NCT00118482|474323364|FG000|Overall Study|Withdrawal by Subject|23|||
131739673|NCT00118482|474323365|FG001|Overall Study|Withdrawal by Subject|22|||
131739674|NCT00242580|474323366|FG000|Overall Study|Adverse Event|3|||
131739675|NCT00242580|474323367|FG001|Overall Study|Adverse Event|0|||
131739676|NCT00242580|474323368|FG002|Overall Study|Adverse Event|2|||
131739677|NCT00242580|474323366|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131739678|NCT00242580|474323367|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
131739679|NCT00242580|474323368|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
131739680|NCT00242580|474323366|FG000|Overall Study|Protocol Violation|0|||
131739681|NCT00242580|474323367|FG001|Overall Study|Protocol Violation|0|||
131739682|NCT00242580|474323368|FG002|Overall Study|Protocol Violation|1|||
131739683|NCT00242580|474323366|FG000|Overall Study|Subject withdrew consent|2|||
131739684|NCT00242580|474323367|FG001|Overall Study|Subject withdrew consent|2|||
131739685|NCT00242580|474323368|FG002|Overall Study|Subject withdrew consent|5|||
131739686|NCT00242580|474323366|FG000|Overall Study|Lost to Follow-up|0|||
131739687|NCT00242580|474323367|FG001|Overall Study|Lost to Follow-up|3|||
131739688|NCT00242580|474323368|FG002|Overall Study|Lost to Follow-up|0|||
131739689|NCT00242580|474323366|FG000|Overall Study|Death|1|||
131739690|NCT00242580|474323367|FG001|Overall Study|Death|2|||
131739691|NCT00242580|474323368|FG002|Overall Study|Death|1|||
131739692|NCT01232894|474323369|FG000|Overall Study|Lost to Follow-up|0|||
131739693|NCT01232894|474323370|FG001|Overall Study|Lost to Follow-up|1|||
131739694|NCT01232894|474323369|FG000|Overall Study|Death|1|||
131739695|NCT01232894|474323370|FG001|Overall Study|Death|0|||
131739696|NCT01232894|474323369|FG000|Overall Study|Protocol Violation|1|||
131739697|NCT01232894|474323370|FG001|Overall Study|Protocol Violation|1|||
131739698|NCT01232894|474323369|FG000|Overall Study|Withdrawal by Subject|8|||
131739699|NCT01232894|474323370|FG001|Overall Study|Withdrawal by Subject|5|||
131739700|NCT01232894|474323369|FG000|Overall Study|Physician Decision|2|||
131739701|NCT01232894|474323370|FG001|Overall Study|Physician Decision|1|||
131739702|NCT03970395|474323373|FG000|Overall Study|Withdrawal by Subject|3|||
131739703|NCT03970395|474323374|FG001|Overall Study|Withdrawal by Subject|4|||
131739704|NCT03970395|474323373|FG000|Overall Study|Lost to Follow-up|4|||
131739705|NCT03970395|474323374|FG001|Overall Study|Lost to Follow-up|8|||
131739706|NCT00125190|474323376|FG000|Overall Study|Subject/Parent Decision|7|||
131739707|NCT00125190|474323376|FG000|Overall Study|Non-compliance|2|||
131739708|NCT00125190|474323376|FG000|Overall Study|Adverse Event|1|||
131739709|NCT00125190|474323376|FG000|Overall Study|Other|1|||
131739710|NCT00125190|474323376|FG000|Overall Study|Lost to Follow-up|4|||
131739711|NCT02128763|474323377|FG000|Overall Study|Death|1|||
131739712|NCT02128763|474323378|FG001|Overall Study|Death|0|||
131739713|NCT02128763|474323377|FG000|Overall Study|Lost to Follow-up|19|||
131739714|NCT02128763|474323378|FG001|Overall Study|Lost to Follow-up|16|||
131739715|NCT00414960|474323382|FG000|Overall Study|Adverse Event|4|||
131739716|NCT00414960|474323383|FG001|Overall Study|Adverse Event|0|||
131739717|NCT00414960|474323382|FG000|Overall Study|Withdrawal by Subject|3|||
131808304|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808305|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808306|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808307|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808308|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
131905363|NCT00083915|474940895|FG000|Overall Study|Death|6|||
131739718|NCT00414960|474323383|FG001|Overall Study|Withdrawal by Subject|0|||
131739719|NCT00414960|474323382|FG000|Overall Study|Physician Decision|0|||
131739720|NCT00414960|474323383|FG001|Overall Study|Physician Decision|1|||
131739721|NCT01608724|474323384|FG000|Overall Study|Withdrawal by Subject|131|||
131739722|NCT01608724|474323384|FG000|Overall Study|Lost to Follow-up|41|||
131739723|NCT01608724|474323384|FG000|Overall Study|Study-specific discontinuation criteria|32|||
131739724|NCT01608724|474323384|FG000|Overall Study|Adverse Event|29|||
131739725|NCT01608724|474323384|FG000|Overall Study|Protocol Violation|6|||
131808309|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808310|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131905364|NCT00083915|474940896|FG001|Overall Study|Death|3|||
131739726|NCT01608724|474323384|FG000|Overall Study|bood sugar too high, etc.|3|||
131739727|NCT01608724|474323384|FG000|Overall Study|Safety reasons|1|||
131739728|NCT00363246|474323385|FG000|Overall Study|Death|40|||
131739729|NCT00363246|474323385|FG000|Overall Study|Withdrawal by Subject|19|||
131739730|NCT00363246|474323385|FG000|Overall Study|Lost to Follow-up|14|||
131739731|NCT00363246|474323385|FG000|Overall Study|Bad health|6|||
131739732|NCT00363246|474323385|FG000|Overall Study|Stopped using wheelchair|11|||
131739733|NCT00363246|474323385|FG000|Overall Study|Subject expressed security concerns|2|||
131739734|NCT00363246|474323385|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
131739735|NCT04387136|474323390|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
131739736|NCT04387136|474323391|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
131739737|NCT00264849|474323392|FG000|Overall Study|Adverse Event|7|||
131739738|NCT00264849|474323393|FG001|Overall Study|Adverse Event|2|||
131739739|NCT00264849|474323392|FG000|Overall Study|Withdrawal by Subject|7|||
131739740|NCT00264849|474323393|FG001|Overall Study|Withdrawal by Subject|11|||
131739741|NCT00264849|474323392|FG000|Overall Study|Protocol Violation|5|||
131739742|NCT00264849|474323393|FG001|Overall Study|Protocol Violation|3|||
131739743|NCT00264849|474323392|FG000|Overall Study|Lack of Efficacy|1|||
131739744|NCT00264849|474323393|FG001|Overall Study|Lack of Efficacy|6|||
131739745|NCT00264849|474323392|FG000|Overall Study|Lost to Follow-up|0|||
131739746|NCT00264849|474323393|FG001|Overall Study|Lost to Follow-up|2|||
131739747|NCT00264849|474323392|FG000|Overall Study|Death|0|||
131739748|NCT00264849|474323393|FG001|Overall Study|Death|1|||
131739749|NCT00264849|474323392|FG000|Overall Study|Administrative Problems|2|||
131739750|NCT00264849|474323393|FG001|Overall Study|Administrative Problems|0|||
131739751|NCT00099359|474323396|FG000|Overall Study|Death|11|||
131739752|NCT00099359|474323397|FG001|Overall Study|Death|15|||
131739753|NCT00099359|474323398|FG002|Overall Study|Death|17|||
131739754|NCT00099359|474323396|FG000|Overall Study|Withdrawal by Subject|19|||
131739755|NCT00099359|474323397|FG001|Overall Study|Withdrawal by Subject|19|||
131739756|NCT00099359|474323398|FG002|Overall Study|Withdrawal by Subject|23|||
131739757|NCT00099359|474323396|FG000|Overall Study|Lost to Follow-up|15|||
131739758|NCT00099359|474323397|FG001|Overall Study|Lost to Follow-up|24|||
131739759|NCT00099359|474323398|FG002|Overall Study|Lost to Follow-up|24|||
131739760|NCT00099359|474323396|FG000|Overall Study|moved out of area|9|||
131739761|NCT00099359|474323397|FG001|Overall Study|moved out of area|7|||
131739762|NCT00099359|474323398|FG002|Overall Study|moved out of area|4|||
131739763|NCT02756650|474323399|FG000|Overall Study|Physician Decision|1|||
131739764|NCT02756650|474323399|FG000|Overall Study|Adverse Event|1|||
131739765|NCT01822691|474323400|FG000|Overall Study|Withdrawal by Subject|2|||
131739766|NCT00717366|474323401|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
131739767|NCT00717366|474323402|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
131739768|NCT00717366|474323401|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
131739769|NCT00717366|474323402|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
131739770|NCT00717366|474323401|FG000|Core Study Period (20 Weeks)|Death|0|||
131739771|NCT00717366|474323402|FG001|Core Study Period (20 Weeks)|Death|1|||
131739772|NCT00717366|474323401|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
131739773|NCT00717366|474323402|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
131739774|NCT00717366|474323401|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
131739775|NCT00717366|474323402|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
131739776|NCT00717366|474323401|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
131739777|NCT00717366|474323402|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
131739778|NCT00717366|474323401|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
131739779|NCT00717366|474323402|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
131739780|NCT00910429|474323403|FG000|Overall Study|Death|18|||
131739781|NCT00910429|474323404|FG001|Overall Study|Death|12|||
131739782|NCT00910429|474323403|FG000|Overall Study|Withdrawal by Subject|3|||
131739783|NCT00910429|474323404|FG001|Overall Study|Withdrawal by Subject|2|||
131739784|NCT00910429|474323403|FG000|Overall Study|Protocol Violation|1|||
131739785|NCT00910429|474323404|FG001|Overall Study|Protocol Violation|0|||
131739786|NCT00910429|474323403|FG000|Overall Study|Lost to Follow-up|2|||
131739787|NCT00910429|474323404|FG001|Overall Study|Lost to Follow-up|1|||
131739788|NCT00910429|474323403|FG000|Overall Study|Adverse Event|10|||
131808311|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131739789|NCT00910429|474323404|FG001|Overall Study|Adverse Event|5|||
131739790|NCT00910429|474323403|FG000|Overall Study|Drug non-compliance|1|||
131739791|NCT00910429|474323404|FG001|Overall Study|Drug non-compliance|0|||
131739792|NCT00910429|474323403|FG000|Overall Study|Lack of Efficacy|4|||
131739793|NCT00910429|474323404|FG001|Overall Study|Lack of Efficacy|1|||
131808312|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
131808313|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
131808314|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
131808315|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808316|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
131739794|NCT02121756|474323408|FG000|Overall Study|Adverse Event|3|||
131739795|NCT02121756|474323409|FG001|Overall Study|Adverse Event|0|||
131739796|NCT02121756|474323408|FG000|Overall Study|Protocol Violation|1|||
131739797|NCT02121756|474323409|FG001|Overall Study|Protocol Violation|1|||
131739798|NCT02121756|474323408|FG000|Overall Study|Physician Decision|2|||
131905365|NCT00083915|474940895|FG000|Overall Study|Physician Decision|11|||
131739799|NCT02121756|474323409|FG001|Overall Study|Physician Decision|1|||
131739800|NCT04465396|474323412|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
131739801|NCT04465396|474323413|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
131739802|NCT04465396|474323414|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
131739803|NCT04465396|474323415|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
131739804|NCT02648724|474323416|FG000|Overall Study|Withdrawal by Subject|0|||
131739805|NCT02648724|474323417|FG001|Overall Study|Withdrawal by Subject|1|||
131739806|NCT02648724|474323418|FG002|Overall Study|Withdrawal by Subject|1|||
131739807|NCT02648724|474323419|FG003|Overall Study|Withdrawal by Subject|0|||
131739808|NCT02648724|474323420|FG004|Overall Study|Withdrawal by Subject|1|||
131739809|NCT02648724|474323421|FG005|Overall Study|Withdrawal by Subject|0|||
131739810|NCT02648724|474323422|FG006|Overall Study|Withdrawal by Subject|0|||
131739811|NCT02648724|474323416|FG000|Overall Study|Progressive disease|2|||
131739812|NCT02648724|474323417|FG001|Overall Study|Progressive disease|2|||
131739813|NCT02648724|474323418|FG002|Overall Study|Progressive disease|2|||
131739814|NCT02648724|474323419|FG003|Overall Study|Progressive disease|3|||
131739815|NCT02648724|474323420|FG004|Overall Study|Progressive disease|22|||
131739816|NCT02648724|474323421|FG005|Overall Study|Progressive disease|7|||
131739817|NCT02648724|474323422|FG006|Overall Study|Progressive disease|8|||
131739818|NCT02648724|474323416|FG000|Overall Study|Other reason (unknown)|1|||
131739819|NCT02648724|474323417|FG001|Overall Study|Other reason (unknown)|0|||
131739820|NCT02648724|474323418|FG002|Overall Study|Other reason (unknown)|0|||
131739821|NCT02648724|474323419|FG003|Overall Study|Other reason (unknown)|0|||
131739822|NCT02648724|474323420|FG004|Overall Study|Other reason (unknown)|0|||
131739823|NCT02648724|474323421|FG005|Overall Study|Other reason (unknown)|0|||
131739824|NCT02648724|474323422|FG006|Overall Study|Other reason (unknown)|0|||
131739825|NCT02648724|474323416|FG000|Overall Study|Protocol Violation|0|||
131739826|NCT02648724|474323417|FG001|Overall Study|Protocol Violation|0|||
131739827|NCT02648724|474323418|FG002|Overall Study|Protocol Violation|0|||
131739828|NCT02648724|474323419|FG003|Overall Study|Protocol Violation|0|||
131739829|NCT02648724|474323420|FG004|Overall Study|Protocol Violation|1|||
131739830|NCT02648724|474323421|FG005|Overall Study|Protocol Violation|0|||
131739831|NCT02648724|474323422|FG006|Overall Study|Protocol Violation|0|||
131739832|NCT02648724|474323416|FG000|Overall Study|Death|0|||
131739833|NCT02648724|474323417|FG001|Overall Study|Death|0|||
131739834|NCT02648724|474323418|FG002|Overall Study|Death|0|||
131739835|NCT02648724|474323419|FG003|Overall Study|Death|0|||
131739836|NCT02648724|474323420|FG004|Overall Study|Death|0|||
131739837|NCT02648724|474323421|FG005|Overall Study|Death|0|||
131739838|NCT02648724|474323422|FG006|Overall Study|Death|3|||
131739839|NCT02648724|474323416|FG000|Overall Study|Physician Decision|0|||
131739840|NCT02648724|474323417|FG001|Overall Study|Physician Decision|0|||
131739841|NCT02648724|474323418|FG002|Overall Study|Physician Decision|0|||
131739842|NCT02648724|474323419|FG003|Overall Study|Physician Decision|0|||
131739843|NCT02648724|474323420|FG004|Overall Study|Physician Decision|1|||
131739844|NCT02648724|474323421|FG005|Overall Study|Physician Decision|0|||
131739845|NCT02648724|474323422|FG006|Overall Study|Physician Decision|1|||
131739846|NCT02648724|474323416|FG000|Overall Study|Transferred to named patient program|0|||
131739847|NCT02648724|474323417|FG001|Overall Study|Transferred to named patient program|0|||
131739848|NCT02648724|474323418|FG002|Overall Study|Transferred to named patient program|0|||
131739849|NCT02648724|474323419|FG003|Overall Study|Transferred to named patient program|0|||
131739850|NCT02648724|474323420|FG004|Overall Study|Transferred to named patient program|0|||
131739851|NCT02648724|474323421|FG005|Overall Study|Transferred to named patient program|1|||
131739852|NCT02648724|474323422|FG006|Overall Study|Transferred to named patient program|0|||
131739853|NCT03076190|474323424|FG000|Overall Study|Lost to Follow-up|9|||
131739854|NCT03076190|474323425|FG001|Overall Study|Lost to Follow-up|34|||
131739855|NCT03076190|474323424|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
131739856|NCT03076190|474323425|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
131739857|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
131739858|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
131739859|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
131739860|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
131739861|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
131739862|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
131905366|NCT00083915|474940896|FG001|Overall Study|Physician Decision|6|||
131448894|NCT01208207|473272739|FG002|Part I|Protocol Violation|2|||
131739863|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
131739864|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
131739865|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
131905367|NCT00083915|474940895|FG000|Overall Study|Withdrawal by Subject|8|||
131905368|NCT00083915|474940896|FG001|Overall Study|Withdrawal by Subject|3|||
131739866|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
131739867|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
131739868|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
131739869|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
131739870|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
131739871|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
131739872|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
131739873|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Missing|3|||
131739874|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Missing|1|||
131739875|NCT00838916|474323426|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
131739876|NCT00838916|474323427|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
131739877|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
131739878|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
131739879|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
131739880|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
131739881|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
131739882|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
131739883|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
131739884|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
131739885|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
131739886|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
131739887|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
131739888|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
131739889|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
131739890|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
131739891|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
131739892|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
131739893|NCT00838916|474323426|FG000|Follow-up Period (8 Weeks)|Missing|3|||
131739894|NCT00838916|474323427|FG001|Follow-up Period (8 Weeks)|Missing|0|||
131739895|NCT02034474|474323428|FG000|Overall Study|Adverse Event|3|||
131739896|NCT02034474|474323429|FG001|Overall Study|Adverse Event|2|||
131739897|NCT02034474|474323428|FG000|Overall Study|Withdrawal by Subject|1|||
131739898|NCT02034474|474323429|FG001|Overall Study|Withdrawal by Subject|2|||
131739899|NCT00675103|474323430|FG000|Overall Study|Lack of Efficacy|2|||
131739900|NCT00675103|474323430|FG000|Overall Study|Adverse Event|1|||
131739901|NCT00975195|474323433|FG000|Overall Study|Adverse Event|108|||
131739902|NCT00975195|474323434|FG001|Overall Study|Adverse Event|101|||
131739903|NCT00975195|474323433|FG000|Overall Study|Lack of Efficacy|6|||
131739904|NCT00975195|474323434|FG001|Overall Study|Lack of Efficacy|6|||
131739905|NCT00975195|474323433|FG000|Overall Study|Protocol Violation|27|||
131739906|NCT00975195|474323434|FG001|Overall Study|Protocol Violation|23|||
131739907|NCT00975195|474323433|FG000|Overall Study|Lost to Follow-up|9|||
131739908|NCT00975195|474323434|FG001|Overall Study|Lost to Follow-up|7|||
131739909|NCT00975195|474323433|FG000|Overall Study|Withdrawal by Subject|48|||
131739910|NCT00975195|474323434|FG001|Overall Study|Withdrawal by Subject|61|||
131739911|NCT00975195|474323433|FG000|Overall Study|Other reason not defined above|29|||
131739912|NCT00975195|474323434|FG001|Overall Study|Other reason not defined above|33|||
131739913|NCT00975195|474323433|FG000|Overall Study|Not treated|1|||
131739914|NCT00975195|474323434|FG001|Overall Study|Not treated|2|||
131739915|NCT01179347|474324928|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
131739916|NCT01179347|474324929|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
131739917|NCT01179347|474324928|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
131739918|NCT01179347|474324929|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
131739919|NCT01179347|474324928|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
131739920|NCT01179347|474324929|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
131739921|NCT01179347|474324928|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
131739922|NCT01179347|474324929|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
131739923|NCT01179347|474324928|FG000|Double-blind Period (12 Weeks)|Other|2|||
131739924|NCT01179347|474324929|FG001|Double-blind Period (12 Weeks)|Other|4|||
131739925|NCT01179347|474324928|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
131739926|NCT01179347|474324929|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
131905369|NCT00083915|474940895|FG000|Overall Study|disease progression|18|||
131739927|NCT01179347|474324928|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
131739928|NCT01179347|474324929|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
131739929|NCT01179347|474324928|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
131739930|NCT01179347|474324929|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
131739931|NCT01179347|474324928|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
131739932|NCT01179347|474324929|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
131739933|NCT01179347|474324928|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
131905370|NCT00083915|474940896|FG001|Overall Study|disease progression|23|||
131905371|NCT00083915|474940895|FG000|Overall Study|Failure to collect|3|||
131905372|NCT00083915|474940896|FG001|Overall Study|Failure to collect|0|||
131739934|NCT01179347|474324929|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
131739935|NCT01179347|474324928|FG000|Open-label Period (12 Weeks)|Other|7|||
131739936|NCT01179347|474324929|FG001|Open-label Period (12 Weeks)|Other|4|||
131739937|NCT00369967|474324930|FG000|Overall Study|Lost to Follow-up|23|||
131905373|NCT00083915|474940895|FG000|Overall Study|No response|3|||
131739938|NCT00369967|474324931|FG001|Overall Study|Lost to Follow-up|12|||
131739939|NCT02586077|474324932|FG000|Overall Study|Withdrawal by Subject|1|||
131739940|NCT02586077|474324932|FG000|Overall Study|Physician Decision|4|||
131739941|NCT02586077|474324932|FG000|Overall Study|Lost to Follow-up|3|||
131739942|NCT01245764|474324933|FG000|Study Phase A|Other|3|||
131739943|NCT01245764|474324934|FG001|Study Phase A|Other|2|||
131739944|NCT01245764|474324935|FG002|Study Phase A|Other|3|||
131739945|NCT01245764|474324936|FG003|Study Phase A|Other|1|||
131739946|NCT01245764|474324933|FG000|Study Phase A|Protocol Violation|6|||
131739947|NCT01245764|474324934|FG001|Study Phase A|Protocol Violation|3|||
131739948|NCT01245764|474324935|FG002|Study Phase A|Protocol Violation|2|||
131739949|NCT01245764|474324936|FG003|Study Phase A|Protocol Violation|2|||
131739950|NCT01245764|474324933|FG000|Study Phase A|Lost to Follow-up|0|||
131739951|NCT01245764|474324934|FG001|Study Phase A|Lost to Follow-up|0|||
131739952|NCT01245764|474324935|FG002|Study Phase A|Lost to Follow-up|5|||
131739953|NCT01245764|474324936|FG003|Study Phase A|Lost to Follow-up|0|||
131739954|NCT00781963|474324939|FG000|Overall Study|Death|3|||
131739955|NCT00781963|474324940|FG001|Overall Study|Death|0|||
131739956|NCT00781963|474324939|FG000|Overall Study|Lost to Follow-up|2|||
131739957|NCT00781963|474324940|FG001|Overall Study|Lost to Follow-up|1|||
131739958|NCT00781963|474324939|FG000|Overall Study|Withdrawal by Subject|3|||
131739959|NCT00781963|474324940|FG001|Overall Study|Withdrawal by Subject|1|||
131739960|NCT00781963|474324939|FG000|Overall Study|Refused follow-up|9|||
131739961|NCT00781963|474324940|FG001|Overall Study|Refused follow-up|0|||
131739962|NCT02064205|474324944|FG000|Overall Study|Withdrawal by Subject|1|||
131739963|NCT02062463|474324946|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
131739964|NCT02062463|474324947|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
131739965|NCT02062463|474324948|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
131739966|NCT02062463|474324949|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
131739967|NCT02062463|474324946|FG000|Stage 2|Adverse Event|0|||
131739968|NCT02062463|474324947|FG001|Stage 2|Adverse Event|0|||
131739969|NCT02062463|474324948|FG002|Stage 2|Adverse Event|12|||
131739970|NCT02062463|474324949|FG003|Stage 2|Adverse Event|20|||
131739971|NCT02062463|474324946|FG000|Stage 2|Lack of Efficacy|0|||
131739972|NCT02062463|474324947|FG001|Stage 2|Lack of Efficacy|0|||
131739973|NCT02062463|474324948|FG002|Stage 2|Lack of Efficacy|3|||
131739974|NCT02062463|474324949|FG003|Stage 2|Lack of Efficacy|4|||
131739975|NCT02062463|474324946|FG000|Stage 2|Lost to Follow-up|0|||
131739976|NCT02062463|474324947|FG001|Stage 2|Lost to Follow-up|0|||
131739977|NCT02062463|474324948|FG002|Stage 2|Lost to Follow-up|20|||
131739978|NCT02062463|474324949|FG003|Stage 2|Lost to Follow-up|20|||
131739979|NCT02062463|474324946|FG000|Stage 2|Non-Compliance|0|||
131739980|NCT02062463|474324947|FG001|Stage 2|Non-Compliance|0|||
131739981|NCT02062463|474324948|FG002|Stage 2|Non-Compliance|0|||
131739982|NCT02062463|474324949|FG003|Stage 2|Non-Compliance|1|||
131739983|NCT02062463|474324946|FG000|Stage 2|Other than specified|0|||
131739984|NCT02062463|474324947|FG001|Stage 2|Other than specified|0|||
131739985|NCT02062463|474324948|FG002|Stage 2|Other than specified|3|||
131739986|NCT02062463|474324949|FG003|Stage 2|Other than specified|1|||
131739987|NCT02062463|474324946|FG000|Stage 2|Withdrawal by Subject|0|||
131739988|NCT02062463|474324947|FG001|Stage 2|Withdrawal by Subject|0|||
131739989|NCT02062463|474324948|FG002|Stage 2|Withdrawal by Subject|15|||
131739990|NCT02062463|474324949|FG003|Stage 2|Withdrawal by Subject|10|||
131739991|NCT01830816|474324958|FG000|Overall Study|Progressive Disease|12|||
131739992|NCT01830816|474324959|FG001|Overall Study|Progressive Disease|7|||
131739993|NCT01830816|474324960|FG002|Overall Study|Progressive Disease|7|||
131739994|NCT01830816|474324958|FG000|Overall Study|Adverse Event|3|||
131739995|NCT01830816|474324959|FG001|Overall Study|Adverse Event|4|||
131739996|NCT01830816|474324960|FG002|Overall Study|Adverse Event|0|||
131739997|NCT01830816|474324958|FG000|Overall Study|Study Terminated by Sponsor|1|||
131739998|NCT01830816|474324959|FG001|Overall Study|Study Terminated by Sponsor|1|||
131739999|NCT01830816|474324960|FG002|Overall Study|Study Terminated by Sponsor|0|||
131808317|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808318|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808319|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808320|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808321|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808322|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131905374|NCT00083915|474940896|FG001|Overall Study|No response|1|||
131808323|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131740000|NCT01830816|474324958|FG000|Overall Study|Withdrawal by Subject|1|||
131740001|NCT01830816|474324959|FG001|Overall Study|Withdrawal by Subject|1|||
131740002|NCT01830816|474324960|FG002|Overall Study|Withdrawal by Subject|0|||
131740003|NCT01830816|474324958|FG000|Overall Study|Lost to Follow-up|0|||
131740004|NCT01830816|474324959|FG001|Overall Study|Lost to Follow-up|1|||
131740005|NCT01830816|474324960|FG002|Overall Study|Lost to Follow-up|0|||
131740006|NCT01830816|474324958|FG000|Overall Study|Symptomatic Deterioration|1|||
131740007|NCT01830816|474324959|FG001|Overall Study|Symptomatic Deterioration|0|||
131740008|NCT01830816|474324960|FG002|Overall Study|Symptomatic Deterioration|0|||
131740009|NCT01830816|474324958|FG000|Overall Study|Reason not Specified|2|||
131740010|NCT01830816|474324959|FG001|Overall Study|Reason not Specified|0|||
131740011|NCT01830816|474324960|FG002|Overall Study|Reason not Specified|0|||
131740012|NCT04124692|474324961|FG000|Overall Study|Medical reason|0|||
131740013|NCT04124692|474324962|FG001|Overall Study|Medical reason|1|||
131740014|NCT04124692|474324961|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
131740015|NCT04124692|474324962|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
131740016|NCT04124692|474324961|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
131740017|NCT04124692|474324962|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
131740018|NCT04124692|474324961|FG000|Overall Study|Lost to Follow-up|2|||
131740019|NCT04124692|474324962|FG001|Overall Study|Lost to Follow-up|4|||
131740020|NCT04124692|474324961|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
131740021|NCT04124692|474324962|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
131740022|NCT00205699|474324965|FG000|Overall Study|Lost to Follow-up|1|||
131740023|NCT00205699|474324966|FG001|Overall Study|Lost to Follow-up|3|||
131740024|NCT00205699|474324967|FG002|Overall Study|Lost to Follow-up|5|||
131740025|NCT00205699|474324965|FG000|Overall Study|Adverse Event|1|||
131740026|NCT00205699|474324966|FG001|Overall Study|Adverse Event|0|||
131740027|NCT00205699|474324967|FG002|Overall Study|Adverse Event|0|||
131740028|NCT00205699|474324965|FG000|Overall Study|Withdrawal by Subject|1|||
131740029|NCT00205699|474324966|FG001|Overall Study|Withdrawal by Subject|2|||
131740030|NCT00205699|474324967|FG002|Overall Study|Withdrawal by Subject|1|||
131740031|NCT00205699|474324965|FG000|Overall Study|Lack of Efficacy|0|||
131740032|NCT00205699|474324966|FG001|Overall Study|Lack of Efficacy|1|||
131740033|NCT00205699|474324967|FG002|Overall Study|Lack of Efficacy|0|||
131740034|NCT03225716|474324971|FG000|Overall Study|Withdrawal by Subject|2|||
131740035|NCT03225716|474324972|FG001|Overall Study|Withdrawal by Subject|2|||
131740036|NCT03225716|474324973|FG002|Overall Study|Withdrawal by Subject|0|||
131740037|NCT03225716|474324971|FG000|Overall Study|Lack of Efficacy|1|||
131740038|NCT03225716|474324972|FG001|Overall Study|Lack of Efficacy|0|||
131740039|NCT03225716|474324973|FG002|Overall Study|Lack of Efficacy|0|||
131740040|NCT03225716|474324971|FG000|Overall Study|Adverse Event|2|||
131740041|NCT03225716|474324972|FG001|Overall Study|Adverse Event|0|||
131740042|NCT03225716|474324973|FG002|Overall Study|Adverse Event|1|||
131740043|NCT03225716|474324971|FG000|Overall Study|Study early termination by Sponsor|0|||
131740044|NCT03225716|474324972|FG001|Overall Study|Study early termination by Sponsor|0|||
131740045|NCT03225716|474324973|FG002|Overall Study|Study early termination by Sponsor|2|||
131740046|NCT01107405|474324974|FG000|Overall Study|Adverse Event|1|||
131740047|NCT01107405|474324975|FG001|Overall Study|Adverse Event|1|||
131740048|NCT01107405|474324976|FG002|Overall Study|Adverse Event|0|||
131740049|NCT01107405|474324977|FG003|Overall Study|Adverse Event|0|||
131740050|NCT01107405|474324978|FG004|Overall Study|Adverse Event|2|||
131740051|NCT01107405|474324974|FG000|Overall Study|Withdrawal by Subject|1|||
131740052|NCT01107405|474324975|FG001|Overall Study|Withdrawal by Subject|0|||
131740053|NCT01107405|474324976|FG002|Overall Study|Withdrawal by Subject|1|||
131740054|NCT01107405|474324977|FG003|Overall Study|Withdrawal by Subject|2|||
131448895|NCT01208207|473272740|FG003|Part I|Protocol Violation|0|||
131448896|NCT01208207|473272741|FG004|Part I|Protocol Violation|0|||
131740055|NCT01107405|474324978|FG004|Overall Study|Withdrawal by Subject|1|||
131740056|NCT01107405|474324974|FG000|Overall Study|Protocol Violation|0|||
131740057|NCT01107405|474324975|FG001|Overall Study|Protocol Violation|0|||
131740058|NCT01107405|474324976|FG002|Overall Study|Protocol Violation|1|||
131740059|NCT01107405|474324977|FG003|Overall Study|Protocol Violation|1|||
131740060|NCT01107405|474324978|FG004|Overall Study|Protocol Violation|0|||
131740061|NCT01025817|474324982|FG000|Completed Study Medication|Adverse Event|66|||
131905375|NCT00083915|474940895|FG000|Overall Study|Insurance issues|1|||
131905376|NCT00083915|474940896|FG001|Overall Study|Insurance issues|1|||
131448897|NCT01208207|473272742|FG005|Part I|Protocol Violation|0|||
131448898|NCT01208207|473272743|FG006|Part I|Protocol Violation|0|||
131740062|NCT01025817|474324983|FG001|Completed Study Medication|Adverse Event|39|||
131740063|NCT01025817|474324982|FG000|Completed Study Medication|Protocol Deviation|9|||
131740064|NCT01025817|474324983|FG001|Completed Study Medication|Protocol Deviation|8|||
131740065|NCT01025817|474324982|FG000|Completed Study Medication|Withdrawal by Subject|8|||
131740066|NCT01025817|474324983|FG001|Completed Study Medication|Withdrawal by Subject|9|||
131740067|NCT01025817|474324982|FG000|Completed Study Medication|Administrative problems|7|||
131740068|NCT01025817|474324983|FG001|Completed Study Medication|Administrative problems|5|||
131740069|NCT01025817|474324982|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
131740070|NCT01025817|474324983|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
131740071|NCT01025817|474324982|FG000|Completed Study Medication|Abnormal test procedure|4|||
131740072|NCT01025817|474324983|FG001|Completed Study Medication|Abnormal test procedure|0|||
131740073|NCT01025817|474324982|FG000|Completed Study Medication|Graft loss|2|||
131740074|NCT01025817|474324983|FG001|Completed Study Medication|Graft loss|5|||
131740075|NCT01025817|474324982|FG000|Completed Study Medication|Death|2|||
131740076|NCT01025817|474324983|FG001|Completed Study Medication|Death|2|||
131740077|NCT01025817|474324982|FG000|Completed Study Medication|Abnormal lab values|0|||
131740078|NCT01025817|474324983|FG001|Completed Study Medication|Abnormal lab values|2|||
131740079|NCT01025817|474324982|FG000|Completed Study Medication|Subject no longer required study drug|0|||
131740080|NCT01025817|474324983|FG001|Completed Study Medication|Subject no longer required study drug|1|||
131740081|NCT01025817|474324982|FG000|Completed Study Medication|Lost to Follow-up|0|||
131740082|NCT01025817|474324983|FG001|Completed Study Medication|Lost to Follow-up|1|||
131740083|NCT01025817|474324982|FG000|Completed Study|Withdrawal by Subject|8|||
131740084|NCT01025817|474324983|FG001|Completed Study|Withdrawal by Subject|16|||
131740085|NCT01025817|474324982|FG000|Completed Study|Death|6|||
131740086|NCT01025817|474324983|FG001|Completed Study|Death|5|||
131740087|NCT01025817|474324982|FG000|Completed Study|Missing|2|||
131740088|NCT01025817|474324983|FG001|Completed Study|Missing|0|||
131740089|NCT01025817|474324982|FG000|Completed Study|Lost to Follow-up|0|||
131740090|NCT01025817|474324983|FG001|Completed Study|Lost to Follow-up|1|||
131740091|NCT00973921|474324984|FG000|Overall Study|IVUS results were not available|9|||
131740092|NCT04404010|474324988|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
131740093|NCT04404010|474324989|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
131740094|NCT02120157|474324990|FG000|Overall Study|Death|8|||
131740095|NCT01354431|474324994|FG000|Pre-Treatment Period|Not reported|1|||
131740096|NCT01354431|474324995|FG001|Pre-Treatment Period|Not reported|0|||
131740097|NCT01354431|474324996|FG002|Pre-Treatment Period|Not reported|0|||
131740098|NCT01354431|474324994|FG000|Treatment Period|Disease Progression|50|||
131740099|NCT01354431|474324995|FG001|Treatment Period|Disease Progression|40|||
131740100|NCT01354431|474324996|FG002|Treatment Period|Disease Progression|44|||
131740101|NCT01354431|474324994|FG000|Treatment Period|Study Drug Toxicity|5|||
131740102|NCT01354431|474324995|FG001|Treatment Period|Study Drug Toxicity|8|||
131740103|NCT01354431|474324996|FG002|Treatment Period|Study Drug Toxicity|4|||
131740104|NCT01354431|474324994|FG000|Treatment Period|Death|0|||
131740105|NCT01354431|474324995|FG001|Treatment Period|Death|1|||
131740106|NCT01354431|474324996|FG002|Treatment Period|Death|0|||
131740107|NCT01354431|474324994|FG000|Treatment Period|AE unrelated to study drug|1|||
131740108|NCT01354431|474324995|FG001|Treatment Period|AE unrelated to study drug|2|||
131740109|NCT01354431|474324996|FG002|Treatment Period|AE unrelated to study drug|5|||
131740110|NCT01354431|474324994|FG000|Treatment Period|Participant request to discontinue|2|||
131740111|NCT01354431|474324995|FG001|Treatment Period|Participant request to discontinue|2|||
131740112|NCT01354431|474324996|FG002|Treatment Period|Participant request to discontinue|1|||
131740113|NCT01354431|474324994|FG000|Treatment Period|Participant withdrew consent|0|||
131740114|NCT01354431|474324995|FG001|Treatment Period|Participant withdrew consent|1|||
131740115|NCT01354431|474324996|FG002|Treatment Period|Participant withdrew consent|0|||
131740116|NCT01354431|474324994|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
131740117|NCT01354431|474324995|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
131740118|NCT01354431|474324996|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
131740119|NCT01599754|474324997|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
131740120|NCT01599754|474324998|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
131740121|NCT01599754|474324997|FG000|Overall Study|Participant noncompliance|4|||
131740122|NCT01599754|474324998|FG001|Overall Study|Participant noncompliance|4|||
131740123|NCT01599754|474324997|FG000|Overall Study|Lost to Follow-up|13|||
131740124|NCT01599754|474324998|FG001|Overall Study|Lost to Follow-up|6|||
131740125|NCT01599754|474324997|FG000|Overall Study|Death|31|||
131740126|NCT01599754|474324998|FG001|Overall Study|Death|33|||
131740127|NCT01599754|474324997|FG000|Overall Study|Adverse Event|3|||
131740128|NCT01599754|474324998|FG001|Overall Study|Adverse Event|2|||
131740129|NCT01599754|474324997|FG000|Overall Study|Investigator decision|1|||
131740130|NCT01599754|474324998|FG001|Overall Study|Investigator decision|3|||
131740131|NCT01599754|474324997|FG000|Overall Study|Withdrawal by Subject|24|||
131740132|NCT01599754|474324998|FG001|Overall Study|Withdrawal by Subject|25|||
131905377|NCT01239797|474940897|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
131740133|NCT01599754|474324997|FG000|Overall Study|Study terminated by sponsor|282|||
131740134|NCT01599754|474324998|FG001|Overall Study|Study terminated by sponsor|285|||
131740135|NCT00702052|474324999|FG000|Overall Study|Adverse Event|23|||
131740136|NCT00702052|474324999|FG000|Overall Study|Disease Progression|30|||
131740137|NCT00702052|474324999|FG000|Overall Study|Withdrawal by Subject|5|||
131740138|NCT00101192|474325000|FG000|Overall Study|Ineligible|6|||
131740139|NCT00101192|474325000|FG000|Overall Study|Inevaluable|1|||
131740140|NCT02618928|474325001|FG000|Overall Study|Failure to Return|28|||
131740141|NCT02618928|474325001|FG000|Overall Study|Insufficient Virological Response|1|||
131740142|NCT02618928|474325001|FG000|Overall Study|Withdrawal by Subject|2|||
131740143|NCT02618928|474325001|FG000|Overall Study|Death|3|||
131740144|NCT02618928|474325001|FG000|Overall Study|Other|11|||
131740145|NCT02618928|474325001|FG000|Overall Study|Missing|6|||
131740146|NCT02618928|474325001|FG000|Overall Study|Treatment Never Started|7|||
131740147|NCT00916370|474325002|FG000|Overall Study|Death|3|||
131740148|NCT00916370|474325003|FG001|Overall Study|Death|1|||
131740149|NCT00916370|474325002|FG000|Overall Study|Withdrawal by Subject|2|||
131740150|NCT00916370|474325003|FG001|Overall Study|Withdrawal by Subject|0|||
131740151|NCT00916370|474325002|FG000|Overall Study|Physician Decision|0|||
131740152|NCT00916370|474325003|FG001|Overall Study|Physician Decision|1|||
131740153|NCT00255086|474325004|FG000|Overall Study|Adverse Event|1|||
131740154|NCT00255086|474325005|FG001|Overall Study|Adverse Event|1|||
131740155|NCT00255086|474325004|FG000|Overall Study|Protocol Violation|1|||
131740156|NCT00255086|474325005|FG001|Overall Study|Protocol Violation|1|||
131740157|NCT00438399|474325006|FG000|Overall Study|Lost to Follow-up|2|||
131740158|NCT00438399|474325007|FG001|Overall Study|Lost to Follow-up|2|||
131740159|NCT00438399|474325008|FG002|Overall Study|Lost to Follow-up|1|||
131740160|NCT00438399|474325009|FG003|Overall Study|Lost to Follow-up|1|||
131740161|NCT00438399|474325010|FG004|Overall Study|Lost to Follow-up|1|||
131740162|NCT00438399|474325011|FG005|Overall Study|Lost to Follow-up|1|||
131740163|NCT00438399|474325006|FG000|Overall Study|Adverse Event|0|||
131740164|NCT00438399|474325007|FG001|Overall Study|Adverse Event|0|||
131740165|NCT00438399|474325008|FG002|Overall Study|Adverse Event|1|||
131740166|NCT00438399|474325009|FG003|Overall Study|Adverse Event|1|||
131740167|NCT00438399|474325010|FG004|Overall Study|Adverse Event|0|||
131740168|NCT00438399|474325011|FG005|Overall Study|Adverse Event|1|||
131740169|NCT00438399|474325006|FG000|Overall Study|Withdrawal by Subject|5|||
131740170|NCT00438399|474325007|FG001|Overall Study|Withdrawal by Subject|6|||
131740171|NCT00438399|474325008|FG002|Overall Study|Withdrawal by Subject|3|||
131740172|NCT00438399|474325009|FG003|Overall Study|Withdrawal by Subject|2|||
131740173|NCT00438399|474325010|FG004|Overall Study|Withdrawal by Subject|2|||
131740174|NCT00438399|474325011|FG005|Overall Study|Withdrawal by Subject|2|||
131740175|NCT00438399|474325006|FG000|Overall Study|Protocol Violation|0|||
131740176|NCT00438399|474325007|FG001|Overall Study|Protocol Violation|0|||
131740177|NCT00438399|474325008|FG002|Overall Study|Protocol Violation|1|||
131740178|NCT00438399|474325009|FG003|Overall Study|Protocol Violation|0|||
131740179|NCT00438399|474325010|FG004|Overall Study|Protocol Violation|0|||
131740180|NCT00438399|474325011|FG005|Overall Study|Protocol Violation|1|||
131740181|NCT00438399|474325006|FG000|Overall Study|Subje stopped study|0|||
131740182|NCT00438399|474325007|FG001|Overall Study|Subje stopped study|0|||
131740183|NCT00438399|474325008|FG002|Overall Study|Subje stopped study|1|||
131740184|NCT00438399|474325009|FG003|Overall Study|Subje stopped study|0|||
131740185|NCT00438399|474325010|FG004|Overall Study|Subje stopped study|0|||
131740186|NCT00438399|474325011|FG005|Overall Study|Subje stopped study|0|||
131740187|NCT00438399|474325006|FG000|Overall Study|Pregnancy|0|||
131740188|NCT00438399|474325007|FG001|Overall Study|Pregnancy|0|||
131740189|NCT00438399|474325008|FG002|Overall Study|Pregnancy|0|||
131740190|NCT00438399|474325009|FG003|Overall Study|Pregnancy|0|||
131740191|NCT00438399|474325010|FG004|Overall Study|Pregnancy|0|||
131740192|NCT00438399|474325011|FG005|Overall Study|Pregnancy|1|||
131740193|NCT00438399|474325006|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
131740194|NCT00438399|474325007|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
131740195|NCT00438399|474325008|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
131740196|NCT00438399|474325009|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
131808324|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
131808325|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808326|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808327|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131740197|NCT00438399|474325010|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
131740198|NCT00438399|474325011|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
131808328|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808329|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
131808330|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
131740199|NCT02365584|474325013|FG000|Overall Study|Adverse Event|2|||
131740200|NCT02365584|474325014|FG001|Overall Study|Adverse Event|2|||
131740201|NCT02365584|474325013|FG000|Overall Study|Withdrawal by Subject|1|||
131740202|NCT02365584|474325014|FG001|Overall Study|Withdrawal by Subject|0|||
131740203|NCT02365584|474325013|FG000|Overall Study|Disease Progression|9|||
131740204|NCT02365584|474325014|FG001|Overall Study|Disease Progression|12|||
131740205|NCT01973452|474325015|FG000|Overall Study|Lack of Efficacy|0|||
131740206|NCT01973452|474325016|FG001|Overall Study|Lack of Efficacy|1|||
131740207|NCT01973452|474325015|FG000|Overall Study|Lost to Follow-up|1|||
131740208|NCT01973452|474325016|FG001|Overall Study|Lost to Follow-up|0|||
131740209|NCT01973452|474325015|FG000|Overall Study|Withdrawal by Subject|10|||
131740210|NCT01973452|474325016|FG001|Overall Study|Withdrawal by Subject|9|||
131740211|NCT01973452|474325015|FG000|Overall Study|Ineligible|1|||
131740212|NCT01973452|474325016|FG001|Overall Study|Ineligible|1|||
131740213|NCT01973452|474325015|FG000|Overall Study|Surgery canceled by participant|5|||
131740214|NCT01973452|474325016|FG001|Overall Study|Surgery canceled by participant|3|||
131740215|NCT00349752|474325021|FG000|Overall Study|Adverse Event|8|||
131740216|NCT00349752|474325022|FG001|Overall Study|Adverse Event|12|||
131740217|NCT00349752|474325021|FG000|Overall Study|Lack of Efficacy|37|||
131740218|NCT00349752|474325022|FG001|Overall Study|Lack of Efficacy|42|||
131740219|NCT00349752|474325021|FG000|Overall Study|Lost to Follow-up|4|||
131740220|NCT00349752|474325022|FG001|Overall Study|Lost to Follow-up|2|||
131740221|NCT00349752|474325021|FG000|Overall Study|Personal reasons|6|||
131740222|NCT00349752|474325022|FG001|Overall Study|Personal reasons|5|||
131740223|NCT00349752|474325021|FG000|Overall Study|Other: Required exclusionary medication|0|||
131740224|NCT00349752|474325022|FG001|Overall Study|Other: Required exclusionary medication|1|||
131740225|NCT00349752|474325021|FG000|Overall Study|Other: Non compliance|0|||
131740226|NCT00349752|474325022|FG001|Overall Study|Other: Non compliance|1|||
131740227|NCT00349752|474325021|FG000|Overall Study|Other: Patient stopped steroids|0|||
131740228|NCT00349752|474325022|FG001|Overall Study|Other: Patient stopped steroids|1|||
131740229|NCT00349752|474325021|FG000|Overall Study|Other: Patient's steroid use|1|||
131740230|NCT00349752|474325022|FG001|Overall Study|Other: Patient's steroid use|0|||
131740231|NCT00349752|474325021|FG000|Overall Study|Other: Ineligible|1|||
131740232|NCT00349752|474325022|FG001|Overall Study|Other: Ineligible|0|||
131740233|NCT00349752|474325021|FG000|Overall Study|Other: Inadvertently unblinded|1|||
131740234|NCT00349752|474325022|FG001|Overall Study|Other: Inadvertently unblinded|0|||
131740235|NCT00349752|474325021|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
131740236|NCT00349752|474325022|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
131740237|NCT05294211|474325024|FG000|Overall Study|Withdrawal by Subject|3|||
131740238|NCT05294211|474325024|FG000|Overall Study|Physician Decision|2|||
131740239|NCT05294211|474325024|FG000|Overall Study|Progressed to active labor|1|||
131740240|NCT05294211|474325024|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
131740241|NCT05294211|474325024|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
131740242|NCT00064350|474325025|FG000|Induction Treatment|Disease Progression|5|||
131740243|NCT00064350|474325026|FG001|Induction Treatment|Disease Progression|1|||
131740244|NCT00064350|474325027|FG002|Induction Treatment|Disease Progression|110|||
131740245|NCT00064350|474325025|FG000|Induction Treatment|Adverse Event|0|||
131740246|NCT00064350|474325026|FG001|Induction Treatment|Adverse Event|2|||
131740247|NCT00064350|474325027|FG002|Induction Treatment|Adverse Event|49|||
131740248|NCT00064350|474325025|FG000|Induction Treatment|Death|0|||
131740249|NCT00064350|474325026|FG001|Induction Treatment|Death|0|||
131740250|NCT00064350|474325027|FG002|Induction Treatment|Death|9|||
131740251|NCT00064350|474325025|FG000|Induction Treatment|Withdrawal by Subject|0|||
131740252|NCT00064350|474325026|FG001|Induction Treatment|Withdrawal by Subject|0|||
131740253|NCT00064350|474325027|FG002|Induction Treatment|Withdrawal by Subject|21|||
131740254|NCT00064350|474325025|FG000|Induction Treatment|Ineligible or never started treatment|3|||
131740255|NCT00064350|474325026|FG001|Induction Treatment|Ineligible or never started treatment|6|||
131740256|NCT00064350|474325027|FG002|Induction Treatment|Ineligible or never started treatment|34|||
131740257|NCT00064350|474325025|FG000|Induction Treatment|Other|0|||
131740258|NCT00064350|474325026|FG001|Induction Treatment|Other|0|||
131740259|NCT00064350|474325027|FG002|Induction Treatment|Other|13|||
131740260|NCT00064350|474325025|FG000|Randomization|Adverse Event|8|||
131740261|NCT00064350|474325026|FG001|Randomization|Adverse Event|3|||
131740262|NCT00064350|474325027|FG002|Randomization|Adverse Event|0|||
131740263|NCT00064350|474325025|FG000|Randomization|Death|3|||
131740264|NCT00064350|474325026|FG001|Randomization|Death|0|||
131740265|NCT00064350|474325027|FG002|Randomization|Death|0|||
131740266|NCT00064350|474325025|FG000|Randomization|Withdrawal by Subject|1|||
131740267|NCT00064350|474325026|FG001|Randomization|Withdrawal by Subject|0|||
131740268|NCT00064350|474325027|FG002|Randomization|Withdrawal by Subject|0|||
131740269|NCT00064350|474325025|FG000|Randomization|Ineligible or never started treatment|9|||
131740270|NCT00064350|474325026|FG001|Randomization|Ineligible or never started treatment|15|||
131740271|NCT00064350|474325027|FG002|Randomization|Ineligible or never started treatment|0|||
131740272|NCT00064350|474325025|FG000|Randomization|Other|5|||
131740273|NCT00064350|474325026|FG001|Randomization|Other|0|||
131740274|NCT00064350|474325027|FG002|Randomization|Other|0|||
131740275|NCT00064350|474325025|FG000|Cross-Over|Adverse Event|0|||
131740276|NCT00064350|474325026|FG001|Cross-Over|Adverse Event|1|||
131740277|NCT00064350|474325027|FG002|Cross-Over|Adverse Event|0|||
131740278|NCT00064350|474325025|FG000|Cross-Over|Death|1|||
131740279|NCT00064350|474325026|FG001|Cross-Over|Death|3|||
131740280|NCT00064350|474325027|FG002|Cross-Over|Death|0|||
131740281|NCT00064350|474325025|FG000|Cross-Over|Withdrawal by Subject|2|||
131740282|NCT00064350|474325026|FG001|Cross-Over|Withdrawal by Subject|2|||
131740283|NCT00064350|474325027|FG002|Cross-Over|Withdrawal by Subject|0|||
131740284|NCT00064350|474325025|FG000|Cross-Over|Ineligible or never started treatment|3|||
131740285|NCT00064350|474325026|FG001|Cross-Over|Ineligible or never started treatment|6|||
131740286|NCT00064350|474325027|FG002|Cross-Over|Ineligible or never started treatment|0|||
131740287|NCT00064350|474325025|FG000|Cross-Over|Other|0|||
131740288|NCT00064350|474325026|FG001|Cross-Over|Other|2|||
131740289|NCT00064350|474325027|FG002|Cross-Over|Other|0|||
131740290|NCT01842607|474325028|FG000|Overall Study|Adverse Event|11|||
131740291|NCT01842607|474325028|FG000|Overall Study|Lack of Efficacy|19|||
131740292|NCT01842607|474325028|FG000|Overall Study|Protocol Violation|8|||
131740293|NCT01842607|474325028|FG000|Overall Study|Protocol defined stopping criteria|2|||
131740294|NCT01842607|474325028|FG000|Overall Study|Lost to Follow-up|3|||
131740295|NCT01842607|474325028|FG000|Overall Study|Physician Decision|9|||
131740296|NCT01842607|474325028|FG000|Overall Study|Withdrawal by Subject|14|||
131740297|NCT01927419|474325029|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131740298|NCT01927419|474325030|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
131740299|NCT01927419|474325029|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
131740300|NCT01927419|474325030|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
131740301|NCT01927419|474325029|FG000|Treatment Period|Disease progression|17|||
131740302|NCT01927419|474325030|FG001|Treatment Period|Disease progression|20|||
131740303|NCT01927419|474325029|FG000|Treatment Period|Study drug toxicity|48|||
131740304|NCT01927419|474325030|FG001|Treatment Period|Study drug toxicity|10|||
131740305|NCT01927419|474325029|FG000|Treatment Period|Death|0|||
131740306|NCT01927419|474325030|FG001|Treatment Period|Death|1|||
131740307|NCT01927419|474325029|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
131740308|NCT01927419|474325030|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
131740309|NCT01927419|474325029|FG000|Treatment Period|Participant request to discontinue|12|||
131740310|NCT01927419|474325030|FG001|Treatment Period|Participant request to discontinue|4|||
131740311|NCT01927419|474325029|FG000|Treatment Period|Withdrawal by Subject|1|||
131740312|NCT01927419|474325030|FG001|Treatment Period|Withdrawal by Subject|1|||
131740313|NCT01927419|474325029|FG000|Treatment Period|Maximum Clinical Benefit|6|||
131740314|NCT01927419|474325030|FG001|Treatment Period|Maximum Clinical Benefit|2|||
131740315|NCT01927419|474325029|FG000|Treatment Period|Other reasons|3|||
131740316|NCT01927419|474325030|FG001|Treatment Period|Other reasons|4|||
131740317|NCT01927419|474325029|FG000|Treatment Period|Not Reported|1|||
131740318|NCT01927419|474325030|FG001|Treatment Period|Not Reported|1|||
131740319|NCT03488251|474325031|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
131740320|NCT03488251|474325032|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
131740321|NCT03488251|474325033|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
131740322|NCT03488251|474325034|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
131740323|NCT03488251|474325031|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
131740324|NCT03488251|474325032|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
131740325|NCT03488251|474325033|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
131740326|NCT03488251|474325034|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
131740327|NCT03488251|474325031|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
131740328|NCT03488251|474325032|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
131740329|NCT03488251|474325033|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
131740330|NCT03488251|474325034|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
131740331|NCT03488251|474325031|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
131740332|NCT03488251|474325032|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
131740333|NCT03488251|474325033|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
131740334|NCT03488251|474325034|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
131740335|NCT03488251|474325031|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
131740336|NCT03488251|474325032|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
131740337|NCT03488251|474325033|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
131740338|NCT03488251|474325034|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
131740339|NCT03600714|474325035|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
131740340|NCT01935336|474325037|FG000|Overall Study|Adverse Event|1|||
131740341|NCT01935336|474325038|FG001|Overall Study|Adverse Event|0|||
131740342|NCT01935336|474325039|FG002|Overall Study|Adverse Event|0|||
131740343|NCT01935336|474325040|FG003|Overall Study|Adverse Event|0|||
131740344|NCT01935336|474325037|FG000|Overall Study|Progressive disease|5|||
131740345|NCT01935336|474325038|FG001|Overall Study|Progressive disease|3|||
131740346|NCT01935336|474325039|FG002|Overall Study|Progressive disease|47|||
131740347|NCT01935336|474325040|FG003|Overall Study|Progressive disease|66|||
131740348|NCT00592553|474325041|FG000|Overall Study|Protocol Noncompliance|1|||
131740349|NCT00592553|474325042|FG001|Overall Study|Protocol Noncompliance|0|||
131740350|NCT00592553|474325043|FG002|Overall Study|Protocol Noncompliance|0|||
131740351|NCT02379390|474325044|FG000|Overall Study|Adverse Event|1|||
131740352|NCT02379390|474325045|FG001|Overall Study|Adverse Event|1|||
131740353|NCT02379390|474325044|FG000|Overall Study|Investigator's decision|1|||
131740354|NCT02379390|474325045|FG001|Overall Study|Investigator's decision|0|||
131740355|NCT02379390|474325044|FG000|Overall Study|Study Termination|0|||
131740356|NCT02379390|474325045|FG001|Overall Study|Study Termination|1|||
131740357|NCT01244191|474325046|FG000|Overall Study|Progressive disease|295|||
131740358|NCT01244191|474325047|FG001|Overall Study|Progressive disease|350|||
131740359|NCT01244191|474325046|FG000|Overall Study|Clinical disease progression|54|||
131740360|NCT01244191|474325047|FG001|Overall Study|Clinical disease progression|36|||
131740361|NCT01244191|474325046|FG000|Overall Study|Adverse Event|65|||
131740362|NCT01244191|474325047|FG001|Overall Study|Adverse Event|48|||
131740363|NCT01244191|474325046|FG000|Overall Study|Death|22|||
131740364|NCT01244191|474325047|FG001|Overall Study|Death|29|||
131740365|NCT01244191|474325046|FG000|Overall Study|Lost to Follow-up|0|||
131740366|NCT01244191|474325047|FG001|Overall Study|Lost to Follow-up|2|||
131740367|NCT01244191|474325046|FG000|Overall Study|Protocol Violation|1|||
131740368|NCT01244191|474325047|FG001|Overall Study|Protocol Violation|2|||
131740369|NCT01244191|474325046|FG000|Overall Study|Withdrawal by Subject|31|||
131740370|NCT01244191|474325047|FG001|Overall Study|Withdrawal by Subject|23|||
131740371|NCT01244191|474325046|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
131740372|NCT01244191|474325047|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
131740373|NCT02164513|474325048|FG000|Overall Study|Adverse Event|162|||
131740374|NCT02164513|474325049|FG001|Overall Study|Adverse Event|180|||
131740375|NCT02164513|474325050|FG002|Overall Study|Adverse Event|111|||
131740376|NCT02164513|474325048|FG000|Overall Study|Other: Study Closed or terminated|5|||
131740377|NCT02164513|474325049|FG001|Overall Study|Other: Study Closed or terminated|2|||
131740378|NCT02164513|474325050|FG002|Overall Study|Other: Study Closed or terminated|4|||
131740379|NCT02164513|474325048|FG000|Overall Study|Lost to Follow-up|30|||
131740380|NCT02164513|474325049|FG001|Overall Study|Lost to Follow-up|36|||
131740381|NCT02164513|474325050|FG002|Overall Study|Lost to Follow-up|22|||
131740382|NCT02164513|474325048|FG000|Overall Study|Physician Decision|47|||
131740383|NCT02164513|474325049|FG001|Overall Study|Physician Decision|57|||
131740384|NCT02164513|474325050|FG002|Overall Study|Physician Decision|28|||
131740385|NCT02164513|474325048|FG000|Overall Study|Withdrawal by Subject|192|||
131740386|NCT02164513|474325049|FG001|Overall Study|Withdrawal by Subject|261|||
131740387|NCT02164513|474325050|FG002|Overall Study|Withdrawal by Subject|130|||
131740388|NCT02164513|474325048|FG000|Overall Study|Other: Reason not provided by site|1|||
131740389|NCT02164513|474325049|FG001|Overall Study|Other: Reason not provided by site|0|||
131740390|NCT02164513|474325050|FG002|Overall Study|Other: Reason not provided by site|0|||
131740391|NCT02509494|474325058|FG000|Overall Study|Lost to Follow-up|8|||
131740392|NCT02509494|474325059|FG001|Overall Study|Lost to Follow-up|47|||
131740393|NCT02509494|474325060|FG002|Overall Study|Lost to Follow-up|19|||
131740394|NCT02509494|474325061|FG003|Overall Study|Lost to Follow-up|6|||
131740395|NCT02509494|474325062|FG004|Overall Study|Lost to Follow-up|3|||
131740396|NCT02509494|474325063|FG005|Overall Study|Lost to Follow-up|3|||
131740397|NCT02509494|474325064|FG006|Overall Study|Lost to Follow-up|1|||
131740398|NCT02509494|474325065|FG007|Overall Study|Lost to Follow-up|3|||
131740399|NCT02509494|474325066|FG008|Overall Study|Lost to Follow-up|1|||
131740400|NCT02509494|474325058|FG000|Overall Study|Physician Decision|2|||
131740401|NCT02509494|474325059|FG001|Overall Study|Physician Decision|1|||
131740402|NCT02509494|474325060|FG002|Overall Study|Physician Decision|0|||
131740403|NCT02509494|474325061|FG003|Overall Study|Physician Decision|0|||
131740404|NCT02509494|474325062|FG004|Overall Study|Physician Decision|0|||
131740405|NCT02509494|474325063|FG005|Overall Study|Physician Decision|0|||
131740406|NCT02509494|474325064|FG006|Overall Study|Physician Decision|0|||
131740407|NCT02509494|474325065|FG007|Overall Study|Physician Decision|0|||
131740408|NCT02509494|474325066|FG008|Overall Study|Physician Decision|0|||
131740409|NCT02509494|474325058|FG000|Overall Study|Withdrawal by Subject|4|||
131740410|NCT02509494|474325059|FG001|Overall Study|Withdrawal by Subject|17|||
131740411|NCT02509494|474325060|FG002|Overall Study|Withdrawal by Subject|7|||
131740412|NCT02509494|474325061|FG003|Overall Study|Withdrawal by Subject|5|||
131740413|NCT02509494|474325062|FG004|Overall Study|Withdrawal by Subject|0|||
131740414|NCT02509494|474325063|FG005|Overall Study|Withdrawal by Subject|6|||
131740415|NCT02509494|474325064|FG006|Overall Study|Withdrawal by Subject|1|||
131740416|NCT02509494|474325065|FG007|Overall Study|Withdrawal by Subject|2|||
131740417|NCT02509494|474325066|FG008|Overall Study|Withdrawal by Subject|1|||
131448899|NCT01208207|473272737|FG000|Part I|Withdrawal by Subject|14|||
131740418|NCT02509494|474325058|FG000|Overall Study|Death|0|||
131740419|NCT02509494|474325059|FG001|Overall Study|Death|1|||
131740420|NCT02509494|474325060|FG002|Overall Study|Death|0|||
131740421|NCT02509494|474325061|FG003|Overall Study|Death|0|||
131740422|NCT02509494|474325062|FG004|Overall Study|Death|1|||
131740423|NCT02509494|474325063|FG005|Overall Study|Death|0|||
131740424|NCT02509494|474325064|FG006|Overall Study|Death|0|||
131740425|NCT02509494|474325065|FG007|Overall Study|Death|1|||
131808331|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
131740426|NCT02509494|474325066|FG008|Overall Study|Death|0|||
131740427|NCT02509494|474325058|FG000|Overall Study|Other|0|||
131740428|NCT02509494|474325059|FG001|Overall Study|Other|4|||
131448900|NCT01208207|473272738|FG001|Part I|Withdrawal by Subject|4|||
131740429|NCT02509494|474325060|FG002|Overall Study|Other|5|||
131740430|NCT02509494|474325061|FG003|Overall Study|Other|0|||
131740431|NCT02509494|474325062|FG004|Overall Study|Other|0|||
131740432|NCT02509494|474325063|FG005|Overall Study|Other|0|||
131740433|NCT02509494|474325064|FG006|Overall Study|Other|0|||
131740434|NCT02509494|474325065|FG007|Overall Study|Other|0|||
131740435|NCT02509494|474325066|FG008|Overall Study|Other|0|||
131740436|NCT02509494|474325058|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131740437|NCT02509494|474325059|FG001|Overall Study|Non-Compliance With Study Drug|11|||
131740438|NCT02509494|474325060|FG002|Overall Study|Non-Compliance With Study Drug|7|||
131740439|NCT02509494|474325061|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131740440|NCT02509494|474325062|FG004|Overall Study|Non-Compliance With Study Drug|1|||
131740441|NCT02509494|474325063|FG005|Overall Study|Non-Compliance With Study Drug|2|||
131740442|NCT02509494|474325064|FG006|Overall Study|Non-Compliance With Study Drug|1|||
131740443|NCT02509494|474325065|FG007|Overall Study|Non-Compliance With Study Drug|1|||
131740444|NCT02509494|474325066|FG008|Overall Study|Non-Compliance With Study Drug|0|||
131740445|NCT01511107|474325067|FG000|Overall Study|Ineligible|3|||
131740446|NCT01511107|474325068|FG001|Overall Study|Ineligible|2|||
131740447|NCT01511107|474325067|FG000|Overall Study|Lost to Follow-up|10|||
131740448|NCT01511107|474325068|FG001|Overall Study|Lost to Follow-up|19|||
131740449|NCT01511107|474325067|FG000|Overall Study|Withdrawal by Subject|9|||
131740450|NCT01511107|474325068|FG001|Overall Study|Withdrawal by Subject|20|||
131740451|NCT01146951|474327408|FG000|Overall Study|Adverse Event|4|||
131740452|NCT01146951|474327409|FG001|Overall Study|Adverse Event|1|||
131740453|NCT01747811|474327411|FG000|Overall Study|Lack of Efficacy|2|||
131740454|NCT01747811|474327412|FG001|Overall Study|Lack of Efficacy|4|||
131740455|NCT01337167|474327416|FG000|Infant Series|Adverse Event|1|||
131740456|NCT01337167|474327417|FG001|Infant Series|Adverse Event|1|||
131740457|NCT01337167|474327416|FG000|Infant Series|Death|1|||
131740458|NCT01337167|474327417|FG001|Infant Series|Death|1|||
131740459|NCT01337167|474327416|FG000|Infant Series|Lost to Follow-up|13|||
131740460|NCT01337167|474327417|FG001|Infant Series|Lost to Follow-up|7|||
131740461|NCT01337167|474327416|FG000|Infant Series|Non-compliance with study drug|2|||
131740462|NCT01337167|474327417|FG001|Infant Series|Non-compliance with study drug|1|||
131740463|NCT01337167|474327416|FG000|Infant Series|Physician Decision|3|||
131740464|NCT01337167|474327417|FG001|Infant Series|Physician Decision|1|||
131740465|NCT01337167|474327416|FG000|Infant Series|Protocol Violation|22|||
131740466|NCT01337167|474327417|FG001|Infant Series|Protocol Violation|9|||
131740467|NCT01337167|474327416|FG000|Infant Series|Withdrawal by Subject|15|||
131740468|NCT01337167|474327417|FG001|Infant Series|Withdrawal by Subject|4|||
131740469|NCT01337167|474327416|FG000|Infant Series|Randomized but not vaccinated|5|||
131740470|NCT01337167|474327417|FG001|Infant Series|Randomized but not vaccinated|3|||
131740471|NCT01337167|474327416|FG000|Interim Period|Lost to Follow-up|51|||
131740472|NCT01337167|474327417|FG001|Interim Period|Lost to Follow-up|23|||
131740473|NCT01337167|474327416|FG000|Interim Period|Non-compliance with study drug|1|||
131740474|NCT01337167|474327417|FG001|Interim Period|Non-compliance with study drug|0|||
131740475|NCT01337167|474327416|FG000|Interim Period|Physician Decision|6|||
131740476|NCT01337167|474327417|FG001|Interim Period|Physician Decision|3|||
131740477|NCT01337167|474327416|FG000|Interim Period|Protocol Violation|5|||
131740478|NCT01337167|474327417|FG001|Interim Period|Protocol Violation|3|||
131740479|NCT01337167|474327416|FG000|Interim Period|Withdrawal by Subject|18|||
131740480|NCT01337167|474327417|FG001|Interim Period|Withdrawal by Subject|10|||
131740481|NCT01337167|474327416|FG000|Interim Period|Other protocol criterion not met|0|||
131740482|NCT01337167|474327417|FG001|Interim Period|Other protocol criterion not met|1|||
131740483|NCT01337167|474327416|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
131740484|NCT01337167|474327417|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
131808332|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131448901|NCT01208207|473272739|FG002|Part I|Withdrawal by Subject|4|||
131448902|NCT01208207|473272740|FG003|Part I|Withdrawal by Subject|0|||
131448903|NCT01208207|473272741|FG004|Part I|Withdrawal by Subject|0|||
131448904|NCT01208207|473272742|FG005|Part I|Withdrawal by Subject|0|||
131448905|NCT01208207|473272743|FG006|Part I|Withdrawal by Subject|0|||
131740485|NCT01337167|474327416|FG000|Toddler Vaccinations|Protocol Violation|0|||
131740486|NCT01337167|474327417|FG001|Toddler Vaccinations|Protocol Violation|1|||
131740487|NCT01337167|474327416|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
131740488|NCT01337167|474327417|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
131740489|NCT03833817|474327418|FG000|Overall Study|Withdrawal by Subject|3|||
131740490|NCT03833817|474327419|FG001|Overall Study|Withdrawal by Subject|3|||
131740491|NCT03833817|474327418|FG000|Overall Study|Lost to Follow-up|3|||
131740492|NCT03833817|474327419|FG001|Overall Study|Lost to Follow-up|3|||
131740493|NCT02126670|474327424|FG000|Overall Study|Withdrawal by Subject|1|||
131740494|NCT02126670|474327425|FG001|Overall Study|Withdrawal by Subject|0|||
131740495|NCT02126670|474327426|FG002|Overall Study|Withdrawal by Subject|0|||
131448906|NCT01208207|473272737|FG000|Part II|Withdrawal by Subject|0|||
131448907|NCT01208207|473272738|FG001|Part II|Withdrawal by Subject|0|||
131448908|NCT01208207|473272739|FG002|Part II|Withdrawal by Subject|0|||
131740496|NCT02126670|474327427|FG003|Overall Study|Withdrawal by Subject|1|||
131808333|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
131808334|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
131808335|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
131808336|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
131808337|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
131808338|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808339|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808340|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808341|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808342|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808343|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808344|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808345|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131808346|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808347|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808348|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808349|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808350|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808351|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131808352|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808353|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808354|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131808355|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131808356|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131808357|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131808358|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131448909|NCT01208207|473272740|FG003|Part II|Withdrawal by Subject|10|||
131740497|NCT03363919|474327430|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
131740498|NCT03363919|474327431|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
131740499|NCT03363919|474327430|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
131740500|NCT03363919|474327431|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
131740501|NCT01646398|474327432|FG000|Overall Study|Withdrawal by Subject|1|||
131740502|NCT01646398|474327433|FG001|Overall Study|Withdrawal by Subject|0|||
131740503|NCT00255034|474327434|FG000|Overall Study|Withdrawal by Subject|15|||
131740504|NCT00255034|474327435|FG001|Overall Study|Withdrawal by Subject|38|||
131740505|NCT01827319|474327436|FG000|Overall Study|Lost to Follow-up|3|||
131740506|NCT03947255|474327440|FG000|Overall Study|Study Closure by Sponsor|2|||
131740507|NCT03947255|474327441|FG001|Overall Study|Study Closure by Sponsor|2|||
131740508|NCT03947255|474327440|FG000|Overall Study|Withdrawal by Subject|2|||
131740509|NCT03947255|474327441|FG001|Overall Study|Withdrawal by Subject|2|||
131740510|NCT03947255|474327440|FG000|Overall Study|Lost to Follow-up|2|||
131740511|NCT03947255|474327441|FG001|Overall Study|Lost to Follow-up|0|||
131740512|NCT03947255|474327440|FG000|Overall Study|Death|0|||
131740513|NCT03947255|474327441|FG001|Overall Study|Death|2|||
131740514|NCT00363051|474327442|FG000|Overall Study|Adminstrative problems|1|||
131740515|NCT00363051|474327443|FG001|Overall Study|Adminstrative problems|1|||
131740516|NCT00363051|474327442|FG000|Overall Study|Adverse Event|21|||
131740517|NCT00363051|474327443|FG001|Overall Study|Adverse Event|12|||
131448910|NCT01208207|473272741|FG004|Part II|Withdrawal by Subject|9|||
131448911|NCT01208207|473272742|FG005|Part II|Withdrawal by Subject|3|||
131448912|NCT01208207|473272743|FG006|Part II|Withdrawal by Subject|5|||
131448913|NCT01208207|473272737|FG000|Part II|Adverse Event|0|||
131448914|NCT01208207|473272738|FG001|Part II|Adverse Event|0|||
131448915|NCT01208207|473272739|FG002|Part II|Adverse Event|0|||
131740518|NCT00363051|474327442|FG000|Overall Study|New Cancer Therapy|2|||
131740519|NCT00363051|474327443|FG001|Overall Study|New Cancer Therapy|1|||
131740520|NCT00363051|474327442|FG000|Overall Study|Withdrawal by Subject|11|||
131740521|NCT00363051|474327443|FG001|Overall Study|Withdrawal by Subject|3|||
131740522|NCT00363051|474327442|FG000|Overall Study|Lost to Follow-up|0|||
131740523|NCT00363051|474327443|FG001|Overall Study|Lost to Follow-up|1|||
131740524|NCT00363051|474327442|FG000|Overall Study|Protocol Violation|0|||
131740525|NCT00363051|474327443|FG001|Overall Study|Protocol Violation|2|||
131740526|NCT00363051|474327442|FG000|Overall Study|Death|3|||
131740527|NCT00363051|474327443|FG001|Overall Study|Death|2|||
131740528|NCT00830115|474327446|FG000|Overall Study|Adverse Event|2|||
131740529|NCT00830115|474327446|FG000|Overall Study|Improvement/recovery|1|||
131740530|NCT01207388|474327454|FG000|Overall Study|Death|67|||
131448916|NCT01208207|473272740|FG003|Part II|Adverse Event|5|||
131740531|NCT01207388|474327454|FG000|Overall Study|Withdrawal by Subject|1|||
131448917|NCT01208207|473272741|FG004|Part II|Adverse Event|9|||
131448918|NCT01208207|473272742|FG005|Part II|Adverse Event|4|||
131808359|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131740532|NCT01885078|474327455|FG000|Treatment Period|Adverse Event|52|||
131740533|NCT01885078|474327456|FG001|Treatment Period|Adverse Event|136|||
131740534|NCT01885078|474327457|FG002|Treatment Period|Adverse Event|30|||
131740535|NCT01885078|474327458|FG003|Treatment Period|Adverse Event|73|||
131740536|NCT01885078|474327459|FG004|Treatment Period|Adverse Event|17|||
131740537|NCT01885078|474327460|FG005|Treatment Period|Adverse Event|72|||
131740538|NCT01885078|474327461|FG006|Treatment Period|Adverse Event|24|||
131740539|NCT01885078|474327462|FG007|Treatment Period|Adverse Event|5|||
131740540|NCT01885078|474327463|FG008|Treatment Period|Adverse Event|0|||
131740541|NCT01885078|474327464|FG009|Treatment Period|Adverse Event|0|||
131740542|NCT01885078|474327455|FG000|Treatment Period|Death|13|||
131740543|NCT01885078|474327456|FG001|Treatment Period|Death|33|||
131740544|NCT01885078|474327457|FG002|Treatment Period|Death|5|||
131740545|NCT01885078|474327458|FG003|Treatment Period|Death|9|||
131740546|NCT01885078|474327459|FG004|Treatment Period|Death|2|||
131740547|NCT01885078|474327460|FG005|Treatment Period|Death|10|||
131740548|NCT01885078|474327461|FG006|Treatment Period|Death|3|||
131740549|NCT01885078|474327462|FG007|Treatment Period|Death|2|||
131740550|NCT01885078|474327463|FG008|Treatment Period|Death|0|||
131740551|NCT01885078|474327464|FG009|Treatment Period|Death|0|||
131740552|NCT01885078|474327455|FG000|Treatment Period|Lack of Efficacy|12|||
131740553|NCT01885078|474327456|FG001|Treatment Period|Lack of Efficacy|33|||
131740554|NCT01885078|474327457|FG002|Treatment Period|Lack of Efficacy|10|||
131740555|NCT01885078|474327458|FG003|Treatment Period|Lack of Efficacy|23|||
131740556|NCT01885078|474327459|FG004|Treatment Period|Lack of Efficacy|24|||
131740557|NCT01885078|474327460|FG005|Treatment Period|Lack of Efficacy|58|||
131740558|NCT01885078|474327461|FG006|Treatment Period|Lack of Efficacy|9|||
131740559|NCT01885078|474327462|FG007|Treatment Period|Lack of Efficacy|5|||
131740560|NCT01885078|474327463|FG008|Treatment Period|Lack of Efficacy|0|||
131740561|NCT01885078|474327464|FG009|Treatment Period|Lack of Efficacy|0|||
131740562|NCT01885078|474327455|FG000|Treatment Period|Lost to Follow-up|16|||
131740563|NCT01885078|474327456|FG001|Treatment Period|Lost to Follow-up|19|||
131740564|NCT01885078|474327457|FG002|Treatment Period|Lost to Follow-up|7|||
131740565|NCT01885078|474327458|FG003|Treatment Period|Lost to Follow-up|9|||
131740566|NCT01885078|474327459|FG004|Treatment Period|Lost to Follow-up|2|||
131740567|NCT01885078|474327460|FG005|Treatment Period|Lost to Follow-up|8|||
131740568|NCT01885078|474327461|FG006|Treatment Period|Lost to Follow-up|2|||
131740569|NCT01885078|474327462|FG007|Treatment Period|Lost to Follow-up|0|||
131740570|NCT01885078|474327463|FG008|Treatment Period|Lost to Follow-up|0|||
131740571|NCT01885078|474327464|FG009|Treatment Period|Lost to Follow-up|0|||
131740572|NCT01885078|474327455|FG000|Treatment Period|Physician Decision|19|||
131740573|NCT01885078|474327456|FG001|Treatment Period|Physician Decision|21|||
131740574|NCT01885078|474327457|FG002|Treatment Period|Physician Decision|5|||
131740575|NCT01885078|474327458|FG003|Treatment Period|Physician Decision|12|||
131740576|NCT01885078|474327459|FG004|Treatment Period|Physician Decision|9|||
131740577|NCT01885078|474327460|FG005|Treatment Period|Physician Decision|24|||
131740578|NCT01885078|474327461|FG006|Treatment Period|Physician Decision|4|||
131740579|NCT01885078|474327462|FG007|Treatment Period|Physician Decision|3|||
131740580|NCT01885078|474327463|FG008|Treatment Period|Physician Decision|0|||
131740581|NCT01885078|474327464|FG009|Treatment Period|Physician Decision|0|||
131740582|NCT01885078|474327455|FG000|Treatment Period|Protocol Violation|3|||
131740583|NCT01885078|474327456|FG001|Treatment Period|Protocol Violation|5|||
131740584|NCT01885078|474327457|FG002|Treatment Period|Protocol Violation|0|||
131740585|NCT01885078|474327458|FG003|Treatment Period|Protocol Violation|3|||
131740586|NCT01885078|474327459|FG004|Treatment Period|Protocol Violation|1|||
131740587|NCT01885078|474327460|FG005|Treatment Period|Protocol Violation|6|||
131740588|NCT01885078|474327461|FG006|Treatment Period|Protocol Violation|0|||
131740589|NCT01885078|474327462|FG007|Treatment Period|Protocol Violation|0|||
131740590|NCT01885078|474327463|FG008|Treatment Period|Protocol Violation|0|||
131740591|NCT01885078|474327464|FG009|Treatment Period|Protocol Violation|0|||
131740592|NCT01885078|474327455|FG000|Treatment Period|Sponsor Decision|245|||
131740593|NCT01885078|474327456|FG001|Treatment Period|Sponsor Decision|648|||
131740594|NCT01885078|474327457|FG002|Treatment Period|Sponsor Decision|49|||
131740595|NCT01885078|474327458|FG003|Treatment Period|Sponsor Decision|90|||
131808360|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131448919|NCT01208207|473272743|FG006|Part II|Adverse Event|2|||
131740596|NCT01885078|474327459|FG004|Treatment Period|Sponsor Decision|20|||
131740597|NCT01885078|474327460|FG005|Treatment Period|Sponsor Decision|38|||
131740598|NCT01885078|474327461|FG006|Treatment Period|Sponsor Decision|162|||
131740599|NCT01885078|474327462|FG007|Treatment Period|Sponsor Decision|3|||
131740600|NCT01885078|474327463|FG008|Treatment Period|Sponsor Decision|0|||
131740601|NCT01885078|474327464|FG009|Treatment Period|Sponsor Decision|0|||
131448920|NCT01208207|473272737|FG000|Part II|Lack of Efficacy|0|||
131740602|NCT01885078|474327455|FG000|Treatment Period|Withdrawal by Subject|72|||
131740603|NCT01885078|474327456|FG001|Treatment Period|Withdrawal by Subject|132|||
131740604|NCT01885078|474327457|FG002|Treatment Period|Withdrawal by Subject|25|||
131740605|NCT01885078|474327458|FG003|Treatment Period|Withdrawal by Subject|63|||
131740606|NCT01885078|474327459|FG004|Treatment Period|Withdrawal by Subject|15|||
131905378|NCT01239797|474940898|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
131905379|NCT01239797|474940897|FG000|Randomized Participants|Participant withdrew consent|1|||
131905380|NCT01239797|474940898|FG001|Randomized Participants|Participant withdrew consent|7|||
131905381|NCT01239797|474940897|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
131905382|NCT01239797|474940898|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
131448921|NCT01208207|473272738|FG001|Part II|Lack of Efficacy|0|||
131740607|NCT01885078|474327460|FG005|Treatment Period|Withdrawal by Subject|34|||
131740608|NCT01885078|474327461|FG006|Treatment Period|Withdrawal by Subject|17|||
131740609|NCT01885078|474327462|FG007|Treatment Period|Withdrawal by Subject|10|||
131740610|NCT01885078|474327463|FG008|Treatment Period|Withdrawal by Subject|0|||
131740611|NCT01885078|474327464|FG009|Treatment Period|Withdrawal by Subject|0|||
131740612|NCT01885078|474327455|FG000|Treatment Period|Other|0|||
131740613|NCT01885078|474327456|FG001|Treatment Period|Other|0|||
131740614|NCT01885078|474327457|FG002|Treatment Period|Other|0|||
131740615|NCT01885078|474327458|FG003|Treatment Period|Other|1|||
131740616|NCT01885078|474327459|FG004|Treatment Period|Other|0|||
131740617|NCT01885078|474327460|FG005|Treatment Period|Other|0|||
131740618|NCT01885078|474327461|FG006|Treatment Period|Other|0|||
131740619|NCT01885078|474327462|FG007|Treatment Period|Other|0|||
131740620|NCT01885078|474327463|FG008|Treatment Period|Other|0|||
131740621|NCT01885078|474327464|FG009|Treatment Period|Other|0|||
131740622|NCT01885078|474327455|FG000|Step-down Period|Sponsor Decision|0|||
131740623|NCT01885078|474327456|FG001|Step-down Period|Sponsor Decision|0|||
131740624|NCT01885078|474327457|FG002|Step-down Period|Sponsor Decision|0|||
131740625|NCT01885078|474327458|FG003|Step-down Period|Sponsor Decision|0|||
131740626|NCT01885078|474327459|FG004|Step-down Period|Sponsor Decision|0|||
131740627|NCT01885078|474327460|FG005|Step-down Period|Sponsor Decision|0|||
131905383|NCT01239797|474940897|FG000|Treated Participants|Disease progression|185|||
131905384|NCT01239797|474940898|FG001|Treated Participants|Disease progression|185|||
131740628|NCT01885078|474327461|FG006|Step-down Period|Sponsor Decision|0|||
131740629|NCT01885078|474327462|FG007|Step-down Period|Sponsor Decision|0|||
131740630|NCT01885078|474327463|FG008|Step-down Period|Sponsor Decision|1|||
131740631|NCT01885078|474327464|FG009|Step-down Period|Sponsor Decision|1|||
131740632|NCT01885078|474327455|FG000|Step-down Period|Adverse Event|0|||
131740633|NCT01885078|474327456|FG001|Step-down Period|Adverse Event|0|||
131740634|NCT01885078|474327457|FG002|Step-down Period|Adverse Event|0|||
131740635|NCT01885078|474327458|FG003|Step-down Period|Adverse Event|0|||
131740636|NCT01885078|474327459|FG004|Step-down Period|Adverse Event|0|||
131740637|NCT01885078|474327460|FG005|Step-down Period|Adverse Event|0|||
131740638|NCT01885078|474327461|FG006|Step-down Period|Adverse Event|0|||
131740639|NCT01885078|474327462|FG007|Step-down Period|Adverse Event|0|||
131740640|NCT01885078|474327463|FG008|Step-down Period|Adverse Event|29|||
131740641|NCT01885078|474327464|FG009|Step-down Period|Adverse Event|38|||
131740642|NCT01885078|474327455|FG000|Step-down Period|Withdrawal by Subject|0|||
131740643|NCT01885078|474327456|FG001|Step-down Period|Withdrawal by Subject|0|||
131740644|NCT01885078|474327457|FG002|Step-down Period|Withdrawal by Subject|0|||
131740645|NCT01885078|474327458|FG003|Step-down Period|Withdrawal by Subject|0|||
131740646|NCT01885078|474327459|FG004|Step-down Period|Withdrawal by Subject|0|||
131740647|NCT01885078|474327460|FG005|Step-down Period|Withdrawal by Subject|0|||
131740648|NCT01885078|474327461|FG006|Step-down Period|Withdrawal by Subject|0|||
131740649|NCT01885078|474327462|FG007|Step-down Period|Withdrawal by Subject|0|||
131740650|NCT01885078|474327463|FG008|Step-down Period|Withdrawal by Subject|25|||
131740651|NCT01885078|474327464|FG009|Step-down Period|Withdrawal by Subject|15|||
131740652|NCT01885078|474327455|FG000|Step-down Period|Physician Decision|0|||
131740653|NCT01885078|474327456|FG001|Step-down Period|Physician Decision|0|||
131740654|NCT01885078|474327457|FG002|Step-down Period|Physician Decision|0|||
131740655|NCT01885078|474327458|FG003|Step-down Period|Physician Decision|0|||
131740656|NCT01885078|474327459|FG004|Step-down Period|Physician Decision|0|||
131740657|NCT01885078|474327460|FG005|Step-down Period|Physician Decision|0|||
131740658|NCT01885078|474327461|FG006|Step-down Period|Physician Decision|0|||
131740659|NCT01885078|474327462|FG007|Step-down Period|Physician Decision|0|||
131740660|NCT01885078|474327463|FG008|Step-down Period|Physician Decision|7|||
131740661|NCT01885078|474327464|FG009|Step-down Period|Physician Decision|2|||
131740662|NCT01885078|474327455|FG000|Step-down Period|Death|0|||
131740663|NCT01885078|474327456|FG001|Step-down Period|Death|0|||
131740664|NCT01885078|474327457|FG002|Step-down Period|Death|0|||
131740665|NCT01885078|474327458|FG003|Step-down Period|Death|0|||
131740666|NCT01885078|474327459|FG004|Step-down Period|Death|0|||
131740667|NCT01885078|474327460|FG005|Step-down Period|Death|0|||
131740668|NCT01885078|474327461|FG006|Step-down Period|Death|0|||
131740669|NCT01885078|474327462|FG007|Step-down Period|Death|0|||
131740670|NCT01885078|474327463|FG008|Step-down Period|Death|4|||
131740671|NCT01885078|474327464|FG009|Step-down Period|Death|3|||
131740672|NCT01885078|474327455|FG000|Step-down Period|Lost to Follow-up|0|||
131740673|NCT01885078|474327456|FG001|Step-down Period|Lost to Follow-up|0|||
131740674|NCT01885078|474327457|FG002|Step-down Period|Lost to Follow-up|0|||
131740675|NCT01885078|474327458|FG003|Step-down Period|Lost to Follow-up|0|||
131740676|NCT01885078|474327459|FG004|Step-down Period|Lost to Follow-up|0|||
131740677|NCT01885078|474327460|FG005|Step-down Period|Lost to Follow-up|0|||
131740678|NCT01885078|474327461|FG006|Step-down Period|Lost to Follow-up|0|||
131740679|NCT01885078|474327462|FG007|Step-down Period|Lost to Follow-up|0|||
131740680|NCT01885078|474327463|FG008|Step-down Period|Lost to Follow-up|1|||
131740681|NCT01885078|474327464|FG009|Step-down Period|Lost to Follow-up|1|||
131740682|NCT01885078|474327455|FG000|Step-down Period|Lack of Efficacy|0|||
131740683|NCT01885078|474327456|FG001|Step-down Period|Lack of Efficacy|0|||
131740684|NCT01885078|474327457|FG002|Step-down Period|Lack of Efficacy|0|||
131740685|NCT01885078|474327458|FG003|Step-down Period|Lack of Efficacy|0|||
131740686|NCT01885078|474327459|FG004|Step-down Period|Lack of Efficacy|0|||
131740687|NCT01885078|474327460|FG005|Step-down Period|Lack of Efficacy|0|||
131740688|NCT01885078|474327461|FG006|Step-down Period|Lack of Efficacy|0|||
131740689|NCT01885078|474327462|FG007|Step-down Period|Lack of Efficacy|0|||
131740690|NCT01885078|474327463|FG008|Step-down Period|Lack of Efficacy|1|||
131740691|NCT01885078|474327464|FG009|Step-down Period|Lack of Efficacy|0|||
131740692|NCT01885078|474327455|FG000|Step-down Period|Protocol Violation|0|||
131740693|NCT01885078|474327456|FG001|Step-down Period|Protocol Violation|0|||
131740694|NCT01885078|474327457|FG002|Step-down Period|Protocol Violation|0|||
131740695|NCT01885078|474327458|FG003|Step-down Period|Protocol Violation|0|||
131740696|NCT01885078|474327459|FG004|Step-down Period|Protocol Violation|0|||
131740697|NCT01885078|474327460|FG005|Step-down Period|Protocol Violation|0|||
131740698|NCT01885078|474327461|FG006|Step-down Period|Protocol Violation|0|||
131740699|NCT01885078|474327462|FG007|Step-down Period|Protocol Violation|0|||
131740700|NCT01885078|474327463|FG008|Step-down Period|Protocol Violation|1|||
131740701|NCT01885078|474327464|FG009|Step-down Period|Protocol Violation|1|||
131740702|NCT03115112|474327465|FG000|Overall Study|Adverse Event|5|||
131740703|NCT03115112|474327466|FG001|Overall Study|Adverse Event|1|||
131740704|NCT03115112|474327465|FG000|Overall Study|Withdrawal by Subject|4|||
131740705|NCT03115112|474327466|FG001|Overall Study|Withdrawal by Subject|2|||
131740706|NCT03115112|474327465|FG000|Overall Study|Lost to Follow-up|0|||
131740707|NCT03115112|474327466|FG001|Overall Study|Lost to Follow-up|1|||
131740708|NCT03115112|474327465|FG000|Overall Study|Death|1|||
131740709|NCT03115112|474327466|FG001|Overall Study|Death|0|||
131740710|NCT03115112|474327465|FG000|Overall Study|Pregnancy|1|||
131740711|NCT03115112|474327466|FG001|Overall Study|Pregnancy|0|||
131740712|NCT03115112|474327465|FG000|Overall Study|Site closure|1|||
131740713|NCT03115112|474327466|FG001|Overall Study|Site closure|1|||
131740714|NCT04019795|474327468|FG000|Overall Study|Withdrawal by Subject|1|||
131740715|NCT04019795|474327469|FG001|Overall Study|Withdrawal by Subject|2|||
131740716|NCT04019795|474327470|FG002|Overall Study|Withdrawal by Subject|2|||
131740717|NCT04019795|474327471|FG003|Overall Study|Withdrawal by Subject|1|||
131740718|NCT04019795|474327468|FG000|Overall Study|Lost to Follow-up|0|||
131740719|NCT04019795|474327469|FG001|Overall Study|Lost to Follow-up|1|||
131740720|NCT04019795|474327470|FG002|Overall Study|Lost to Follow-up|1|||
131740721|NCT04019795|474327471|FG003|Overall Study|Lost to Follow-up|2|||
131740722|NCT04019795|474327468|FG000|Overall Study|Treatment non-compliance|3|||
131740723|NCT04019795|474327469|FG001|Overall Study|Treatment non-compliance|1|||
131740724|NCT04019795|474327470|FG002|Overall Study|Treatment non-compliance|2|||
131740725|NCT04019795|474327471|FG003|Overall Study|Treatment non-compliance|0|||
131740726|NCT04019795|474327468|FG000|Overall Study|Physician Decision|0|||
131740727|NCT04019795|474327469|FG001|Overall Study|Physician Decision|0|||
131740728|NCT04019795|474327470|FG002|Overall Study|Physician Decision|1|||
131740729|NCT04019795|474327471|FG003|Overall Study|Physician Decision|0|||
131740730|NCT04019795|474327468|FG000|Overall Study|Adverse Event|1|||
131740731|NCT04019795|474327469|FG001|Overall Study|Adverse Event|0|||
131740732|NCT04019795|474327470|FG002|Overall Study|Adverse Event|0|||
131740733|NCT04019795|474327471|FG003|Overall Study|Adverse Event|0|||
131740734|NCT01895452|474327472|FG000|Overall Study|Adverse Event|1|||
131740735|NCT01895452|474327473|FG001|Overall Study|Adverse Event|4|||
131740736|NCT01895452|474327472|FG000|Overall Study|Lost to Follow-up|1|||
131740737|NCT01895452|474327473|FG001|Overall Study|Lost to Follow-up|5|||
131740738|NCT01895452|474327472|FG000|Overall Study|Pregnancy|0|||
131740739|NCT01895452|474327473|FG001|Overall Study|Pregnancy|1|||
131740740|NCT01895452|474327472|FG000|Overall Study|Withdrawal by Subject|2|||
131740741|NCT01895452|474327473|FG001|Overall Study|Withdrawal by Subject|14|||
131740742|NCT01895452|474327472|FG000|Overall Study|Underlying disease|0|||
131740743|NCT01895452|474327473|FG001|Overall Study|Underlying disease|3|||
131740744|NCT01895452|474327472|FG000|Overall Study|Noncompliance with study drug|0|||
131740745|NCT01895452|474327473|FG001|Overall Study|Noncompliance with study drug|1|||
131740746|NCT01653158|474327474|FG000|Overall Study|Death|0|||
131740747|NCT01653158|474327475|FG001|Overall Study|Death|0|||
131740748|NCT01653158|474327476|FG002|Overall Study|Death|0|||
131740749|NCT01653158|474327477|FG003|Overall Study|Death|1|||
131740750|NCT01653158|474327478|FG004|Overall Study|Death|0|||
131740751|NCT01653158|474327479|FG005|Overall Study|Death|0|||
131740752|NCT01653158|474327480|FG006|Overall Study|Death|0|||
131740753|NCT01653158|474327481|FG007|Overall Study|Death|2|||
131740754|NCT01653158|474327474|FG000|Overall Study|Adverse Event|0|||
131740755|NCT01653158|474327475|FG001|Overall Study|Adverse Event|0|||
131740756|NCT01653158|474327476|FG002|Overall Study|Adverse Event|0|||
131740757|NCT01653158|474327477|FG003|Overall Study|Adverse Event|1|||
131740758|NCT01653158|474327478|FG004|Overall Study|Adverse Event|0|||
131740759|NCT01653158|474327479|FG005|Overall Study|Adverse Event|0|||
131740760|NCT01653158|474327480|FG006|Overall Study|Adverse Event|0|||
131740761|NCT01653158|474327481|FG007|Overall Study|Adverse Event|3|||
131740762|NCT01653158|474327474|FG000|Overall Study|Other|0|||
131740763|NCT01653158|474327475|FG001|Overall Study|Other|0|||
131740764|NCT01653158|474327476|FG002|Overall Study|Other|0|||
131740765|NCT01653158|474327477|FG003|Overall Study|Other|0|||
131740766|NCT01653158|474327478|FG004|Overall Study|Other|0|||
131740767|NCT01653158|474327479|FG005|Overall Study|Other|0|||
131740768|NCT01653158|474327480|FG006|Overall Study|Other|0|||
131740769|NCT01653158|474327481|FG007|Overall Study|Other|1|||
131740770|NCT01653158|474327474|FG000|Overall Study|Progressive disease|0|||
131740771|NCT01653158|474327475|FG001|Overall Study|Progressive disease|0|||
131740772|NCT01653158|474327476|FG002|Overall Study|Progressive disease|0|||
131740773|NCT01653158|474327477|FG003|Overall Study|Progressive disease|0|||
131740774|NCT01653158|474327478|FG004|Overall Study|Progressive disease|1|||
131740775|NCT01653158|474327479|FG005|Overall Study|Progressive disease|1|||
131740776|NCT01653158|474327480|FG006|Overall Study|Progressive disease|2|||
131740777|NCT01653158|474327481|FG007|Overall Study|Progressive disease|9|||
131740778|NCT01653158|474327474|FG000|Overall Study|Withdrawal by Subject|1|||
131740779|NCT01653158|474327475|FG001|Overall Study|Withdrawal by Subject|0|||
131740780|NCT01653158|474327476|FG002|Overall Study|Withdrawal by Subject|0|||
131740781|NCT01653158|474327477|FG003|Overall Study|Withdrawal by Subject|0|||
131740782|NCT01653158|474327478|FG004|Overall Study|Withdrawal by Subject|0|||
131740783|NCT01653158|474327479|FG005|Overall Study|Withdrawal by Subject|0|||
131740784|NCT01653158|474327480|FG006|Overall Study|Withdrawal by Subject|0|||
131740785|NCT01653158|474327481|FG007|Overall Study|Withdrawal by Subject|0|||
131740786|NCT00980343|474327482|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
131740787|NCT00980343|474327483|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
131740788|NCT01204697|474327490|FG000|Overall Study|Death|26|||
131740789|NCT01204697|474327491|FG001|Overall Study|Death|27|||
131740790|NCT01204697|474327490|FG000|Overall Study|Lost to Follow-up|3|||
131740791|NCT01204697|474327491|FG001|Overall Study|Lost to Follow-up|4|||
131740792|NCT01204697|474327490|FG000|Overall Study|Withdrawal by Subject|2|||
131740793|NCT01204697|474327491|FG001|Overall Study|Withdrawal by Subject|4|||
131740794|NCT01204697|474327490|FG000|Overall Study|Randomized, but not treated|0|||
131740795|NCT01204697|474327491|FG001|Overall Study|Randomized, but not treated|1|||
131740796|NCT01170702|474327492|FG000|Overall Study|Exclusion criteria met after consent|1|||
131740797|NCT01170702|474327493|FG001|Overall Study|Exclusion criteria met after consent|2|||
131740798|NCT01170702|474327494|FG002|Overall Study|Exclusion criteria met after consent|0|||
131740799|NCT01170702|474327495|FG003|Overall Study|Exclusion criteria met after consent|2|||
131740800|NCT01205451|474327496|FG000|Overall Study|Lost to Follow-up|1|||
131740801|NCT01205451|474327497|FG001|Overall Study|Lost to Follow-up|1|||
131740802|NCT01205451|474327496|FG000|Overall Study|Withdrawal by Subject|5|||
131740803|NCT01205451|474327497|FG001|Overall Study|Withdrawal by Subject|9|||
131740804|NCT01194869|474327498|FG000|Overall Study|Disease Progression|2|||
131740805|NCT01194869|474327498|FG000|Overall Study|Toxicity|2|||
131740806|NCT04321252|474327499|FG000|Overall Study|Withdrawal by Subject|0|||
131740807|NCT04321252|474327500|FG001|Overall Study|Withdrawal by Subject|0|||
131740808|NCT04321252|474327501|FG002|Overall Study|Withdrawal by Subject|0|||
131740809|NCT04321252|474327502|FG003|Overall Study|Withdrawal by Subject|0|||
131740810|NCT04321252|474327503|FG004|Overall Study|Withdrawal by Subject|0|||
131740811|NCT04321252|474327504|FG005|Overall Study|Withdrawal by Subject|1|||
131740812|NCT04321252|474327505|FG006|Overall Study|Withdrawal by Subject|0|||
131740813|NCT04321252|474327506|FG007|Overall Study|Withdrawal by Subject|0|||
131740814|NCT04321252|474327507|FG008|Overall Study|Withdrawal by Subject|0|||
131740815|NCT03004469|474327508|FG000|Overall Study|Adverse Event|6|||
131740816|NCT03004469|474327509|FG001|Overall Study|Adverse Event|4|||
131740817|NCT03004469|474327510|FG002|Overall Study|Adverse Event|6|||
131740818|NCT03004469|474327508|FG000|Overall Study|Lack of Efficacy|1|||
131740819|NCT03004469|474327509|FG001|Overall Study|Lack of Efficacy|0|||
131740820|NCT03004469|474327510|FG002|Overall Study|Lack of Efficacy|1|||
131740821|NCT03004469|474327508|FG000|Overall Study|Lost to Follow-up|23|||
131740822|NCT03004469|474327509|FG001|Overall Study|Lost to Follow-up|14|||
131740823|NCT03004469|474327510|FG002|Overall Study|Lost to Follow-up|6|||
131740824|NCT03004469|474327508|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131740825|NCT03004469|474327509|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131740826|NCT03004469|474327510|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131740827|NCT03004469|474327508|FG000|Overall Study|Protocol Violation|0|||
131740828|NCT03004469|474327509|FG001|Overall Study|Protocol Violation|0|||
131740829|NCT03004469|474327510|FG002|Overall Study|Protocol Violation|1|||
131740830|NCT03004469|474327508|FG000|Overall Study|Withdrawal by Subject|29|||
131740831|NCT03004469|474327509|FG001|Overall Study|Withdrawal by Subject|27|||
131740832|NCT03004469|474327510|FG002|Overall Study|Withdrawal by Subject|10|||
131740833|NCT03004469|474327508|FG000|Overall Study|Other unspecified reason|0|||
131740834|NCT03004469|474327509|FG001|Overall Study|Other unspecified reason|4|||
131740835|NCT03004469|474327510|FG002|Overall Study|Other unspecified reason|1|||
131740836|NCT00259740|474327511|FG000|Overall Study|Physician Decision|1|||
131740837|NCT00259740|474327512|FG001|Overall Study|Physician Decision|1|||
131740838|NCT00259740|474327511|FG000|Overall Study|Adverse Event|0|||
131740839|NCT00259740|474327512|FG001|Overall Study|Adverse Event|2|||
131740840|NCT00259740|474327511|FG000|Overall Study|Withdrawal by Subject|2|||
131740841|NCT00259740|474327512|FG001|Overall Study|Withdrawal by Subject|6|||
131740842|NCT00259740|474327511|FG000|Overall Study|Death|1|||
131740843|NCT00259740|474327512|FG001|Overall Study|Death|1|||
131740844|NCT00259740|474327511|FG000|Overall Study|Disease progression|19|||
131740845|NCT00259740|474327512|FG001|Overall Study|Disease progression|36|||
131740846|NCT00259740|474327511|FG000|Overall Study|Ongoing|17|||
131740847|NCT00259740|474327512|FG001|Overall Study|Ongoing|3|||
131740848|NCT00259740|474327511|FG000|Overall Study|Other|3|||
131740849|NCT00259740|474327512|FG001|Overall Study|Other|0|||
131740850|NCT00259740|474327511|FG000|Overall Study|Requirement for alternative therapy|0|||
131740851|NCT00259740|474327512|FG001|Overall Study|Requirement for alternative therapy|4|||
131740852|NCT00190983|474327513|FG000|Overall Study|Inevaluable (never treated)|2|||
131740853|NCT02287402|474327514|FG000|Treatment Period|Adverse Event|17|||
131808361|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131740854|NCT02287402|474327514|FG000|Treatment Period|Voluntary Withdrawal|10|||
131740855|NCT02287402|474327514|FG000|Follow-up|Lost to Follow-up|1|||
131740856|NCT02287402|474327514|FG000|Follow-up|Voluntary Withdrawal|2|||
131740857|NCT01844830|474327515|FG000|Overall Study|Withdrawal by Subject|1|||
131740858|NCT01844830|474327516|FG001|Overall Study|Withdrawal by Subject|0|||
131740859|NCT04247815|474327517|FG000|Overall Study|Adverse Event|1|||
131740860|NCT04247815|474327518|FG001|Overall Study|Adverse Event|0|||
131740861|NCT04247815|474327517|FG000|Overall Study|Withdrawal by Subject|1|||
131740862|NCT04247815|474327518|FG001|Overall Study|Withdrawal by Subject|0|||
131740863|NCT04247815|474327517|FG000|Overall Study|Protocol Violation|0|||
131740864|NCT04247815|474327518|FG001|Overall Study|Protocol Violation|1|||
131740865|NCT01453998|474327520|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
131740866|NCT01453998|474327521|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
131740867|NCT01453998|474327522|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
131740868|NCT03495453|474327529|FG000|Overall Study|Withdrawal by Subject|0|||
131740869|NCT03495453|474327530|FG001|Overall Study|Withdrawal by Subject|1|||
131740870|NCT03341923|474327533|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
131740871|NCT03341923|474327534|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
131740872|NCT04929613|474327535|FG000|Overall Study|Withdrawal by Subject|12|||
131740873|NCT01742078|474327536|FG000|Overall Study|Withdrawal by Subject|0|||
131740874|NCT01742078|474327537|FG001|Overall Study|Withdrawal by Subject|0|||
131740875|NCT01742078|474327538|FG002|Overall Study|Withdrawal by Subject|0|||
131740876|NCT01742078|474327539|FG003|Overall Study|Withdrawal by Subject|1|||
131740877|NCT01742078|474327540|FG004|Overall Study|Withdrawal by Subject|0|||
131740878|NCT01742078|474327541|FG005|Overall Study|Withdrawal by Subject|0|||
131740879|NCT01742078|474327542|FG006|Overall Study|Withdrawal by Subject|0|||
131740880|NCT01742078|474327543|FG007|Overall Study|Withdrawal by Subject|0|||
131740881|NCT01742078|474327544|FG008|Overall Study|Withdrawal by Subject|0|||
131740882|NCT03247413|474327548|FG000|Overall Study|Lost to Follow-up|28|||
131740883|NCT02767856|474327549|FG000|Overall Study|Lost to Follow-up|9|||
131740884|NCT02767856|474327550|FG001|Overall Study|Lost to Follow-up|1|||
131740885|NCT02767856|474327549|FG000|Overall Study|Withdrawal by Subject|2|||
131740886|NCT02767856|474327550|FG001|Overall Study|Withdrawal by Subject|1|||
131740887|NCT00091026|474327553|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
131740888|NCT00091026|474327554|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
131740889|NCT00091026|474327553|FG000|Overall Study|Patient withdrew and never received trea|0|||
131740890|NCT00091026|474327554|FG001|Overall Study|Patient withdrew and never received trea|2|||
131740891|NCT00091026|474327553|FG000|Overall Study|Unknown-never received treatment|0|||
131740892|NCT00091026|474327554|FG001|Overall Study|Unknown-never received treatment|1|||
131740893|NCT04397718|474327555|FG000|Overall Study|Death|7|||
131740894|NCT04397718|474327556|FG001|Overall Study|Death|11|||
131740895|NCT04397718|474327555|FG000|Overall Study|Lost to Follow-up|0|||
131740896|NCT04397718|474327556|FG001|Overall Study|Lost to Follow-up|4|||
131740897|NCT01797965|474327557|FG000|Overall Study|Adverse Event|104|||
131740898|NCT01797965|474327558|FG001|Overall Study|Adverse Event|129|||
131740899|NCT01797965|474327559|FG002|Overall Study|Adverse Event|4|||
131740900|NCT01797965|474327560|FG003|Overall Study|Adverse Event|21|||
131740901|NCT01797965|474327557|FG000|Overall Study|Lost to Follow-up|9|||
131740902|NCT01797965|474327558|FG001|Overall Study|Lost to Follow-up|8|||
131740903|NCT01797965|474327559|FG002|Overall Study|Lost to Follow-up|1|||
131740904|NCT01797965|474327560|FG003|Overall Study|Lost to Follow-up|2|||
131740905|NCT01797965|474327557|FG000|Overall Study|Consent withdrawn|130|||
131740906|NCT01797965|474327558|FG001|Overall Study|Consent withdrawn|117|||
131740907|NCT01797965|474327559|FG002|Overall Study|Consent withdrawn|3|||
131740908|NCT01797965|474327560|FG003|Overall Study|Consent withdrawn|35|||
131740909|NCT01797965|474327557|FG000|Overall Study|Investigator decision|21|||
131740910|NCT01797965|474327558|FG001|Overall Study|Investigator decision|15|||
131740911|NCT01797965|474327559|FG002|Overall Study|Investigator decision|0|||
131740912|NCT01797965|474327560|FG003|Overall Study|Investigator decision|0|||
131740913|NCT01797965|474327557|FG000|Overall Study|Death|2|||
131740914|NCT01797965|474327558|FG001|Overall Study|Death|4|||
131740915|NCT01797965|474327559|FG002|Overall Study|Death|0|||
131740916|NCT01797965|474327560|FG003|Overall Study|Death|0|||
131740917|NCT01797965|474327557|FG000|Overall Study|Disease progression, defined by protocol|3|||
131740918|NCT01797965|474327558|FG001|Overall Study|Disease progression, defined by protocol|1|||
131740919|NCT01797965|474327559|FG002|Overall Study|Disease progression, defined by protocol|0|||
131740920|NCT01797965|474327560|FG003|Overall Study|Disease progression, defined by protocol|0|||
131740921|NCT01797965|474327557|FG000|Overall Study|Reason Not Specified|280|||
131740922|NCT01797965|474327558|FG001|Overall Study|Reason Not Specified|295|||
131740923|NCT01797965|474327559|FG002|Overall Study|Reason Not Specified|0|||
131740924|NCT01797965|474327560|FG003|Overall Study|Reason Not Specified|15|||
131740925|NCT00441103|474327562|FG000|Overall Study|Adverse Event|2|||
131740926|NCT00441103|474327563|FG001|Overall Study|Adverse Event|1|||
131740927|NCT00441103|474327562|FG000|Overall Study|Death|1|||
131740928|NCT00441103|474327563|FG001|Overall Study|Death|0|||
131740929|NCT00441103|474327562|FG000|Overall Study|Disease Progression|2|||
131740930|NCT00441103|474327563|FG001|Overall Study|Disease Progression|0|||
131740931|NCT00441103|474327562|FG000|Overall Study|Lost to Follow-up|1|||
131740932|NCT00441103|474327563|FG001|Overall Study|Lost to Follow-up|0|||
131740933|NCT00441103|474327562|FG000|Overall Study|Protocol Violation|1|||
131740934|NCT00441103|474327563|FG001|Overall Study|Protocol Violation|0|||
131740935|NCT00441103|474327562|FG000|Overall Study|Participant unable to use Rebiject II|1|||
131740936|NCT00441103|474327563|FG001|Overall Study|Participant unable to use Rebiject II|0|||
131740937|NCT00441103|474327562|FG000|Overall Study|Participant refused MRI|1|||
131740938|NCT00441103|474327563|FG001|Overall Study|Participant refused MRI|0|||
131740939|NCT00441103|474327562|FG000|Overall Study|Inclusion criteria absent|1|||
131740940|NCT00441103|474327563|FG001|Overall Study|Inclusion criteria absent|0|||
131740941|NCT00441103|474327562|FG000|Overall Study|Non-compliant|0|||
131740942|NCT00441103|474327563|FG001|Overall Study|Non-compliant|1|||
131740943|NCT00441103|474327562|FG000|Overall Study|Participant decided to withdraw|1|||
131740944|NCT00441103|474327563|FG001|Overall Study|Participant decided to withdraw|0|||
131740945|NCT00441103|474327562|FG000|Overall Study|Participant's reason|0|||
131740946|NCT00441103|474327563|FG001|Overall Study|Participant's reason|1|||
131740947|NCT00441103|474327562|FG000|Overall Study|Participant decided to stop|0|||
131740948|NCT00441103|474327563|FG001|Overall Study|Participant decided to stop|1|||
131740949|NCT02802878|474327566|FG000|Overall Study|Withdrawal by Subject|3|||
131740950|NCT02802878|474327567|FG001|Overall Study|Withdrawal by Subject|3|||
131740951|NCT02802878|474327566|FG000|Overall Study|Protocol Violation|1|||
131740952|NCT02802878|474327567|FG001|Overall Study|Protocol Violation|0|||
131740953|NCT01029002|474327568|FG000|Overall Study|Lost to Follow-up|2|||
131740954|NCT01029002|474327569|FG001|Overall Study|Lost to Follow-up|4|||
131740955|NCT01577160|474327570|FG000|Overall Study|Adverse Event|9|||
131740956|NCT01577160|474327570|FG000|Overall Study|Lack of Efficacy|15|||
131740957|NCT01577160|474327570|FG000|Overall Study|Lost to Follow-up|40|||
131740958|NCT01577160|474327570|FG000|Overall Study|Withdrawal by Subject|18|||
131740959|NCT01577160|474327570|FG000|Overall Study|Subject Uncooperative|7|||
131740960|NCT01577160|474327570|FG000|Overall Study|Other|9|||
131740961|NCT01317615|474327573|FG000|Overall Study|Disease progression|25|||
131740962|NCT01317615|474327573|FG000|Overall Study|New cancer therapy|5|||
131740963|NCT01317615|474327573|FG000|Overall Study|Death|6|||
131740964|NCT01317615|474327573|FG000|Overall Study|Withdrawal by Subject|5|||
131740965|NCT01317615|474327573|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131740966|NCT01317615|474327573|FG000|Overall Study|Adverse Event|7|||
131740967|NCT02667457|474329263|FG000|Overall Study|Withdrawal by Subject|1|||
131740968|NCT02667457|474329264|FG001|Overall Study|Withdrawal by Subject|0|||
131740969|NCT02667457|474329263|FG000|Overall Study|Other Reason|0|||
131740970|NCT02667457|474329264|FG001|Overall Study|Other Reason|2|||
131740971|NCT02475850|474329265|FG000|Overall Study|Death|155|||
131740972|NCT02475850|474329266|FG001|Overall Study|Death|141|||
131740973|NCT02475850|474329265|FG000|Overall Study|Lost to Follow-up|217|||
131740974|NCT02475850|474329266|FG001|Overall Study|Lost to Follow-up|188|||
131740975|NCT02475850|474329265|FG000|Overall Study|Withdrawal by Subject|221|||
131740976|NCT02475850|474329266|FG001|Overall Study|Withdrawal by Subject|155|||
131740977|NCT03297216|474329271|FG000|Overall Study|Death|0|||
131740978|NCT03297216|474329272|FG001|Overall Study|Death|1|||
131740979|NCT03297216|474329271|FG000|Overall Study|Miscarriage|0|||
131740980|NCT03297216|474329272|FG001|Overall Study|Miscarriage|2|||
131740981|NCT03297216|474329271|FG000|Overall Study|Lost to Follow-up|3|||
131740982|NCT03297216|474329272|FG001|Overall Study|Lost to Follow-up|2|||
131740983|NCT02700919|474329273|FG000|Overall Study|Physician Decision|1|||
131740984|NCT02700919|474329274|FG001|Overall Study|Physician Decision|0|||
131740985|NCT02700919|474329275|FG002|Overall Study|Physician Decision|0|||
131740986|NCT02700919|474329273|FG000|Overall Study|Protocol Violation|1|||
131740987|NCT02700919|474329274|FG001|Overall Study|Protocol Violation|0|||
131740988|NCT02700919|474329275|FG002|Overall Study|Protocol Violation|0|||
131740989|NCT02700919|474329273|FG000|Overall Study|Adverse Event|1|||
131740990|NCT02700919|474329274|FG001|Overall Study|Adverse Event|3|||
131740991|NCT02700919|474329275|FG002|Overall Study|Adverse Event|1|||
131740992|NCT02700919|474329273|FG000|Overall Study|Withdrawal by Subject|5|||
131740993|NCT02700919|474329274|FG001|Overall Study|Withdrawal by Subject|8|||
131740994|NCT02700919|474329275|FG002|Overall Study|Withdrawal by Subject|2|||
131740995|NCT02700919|474329273|FG000|Overall Study|Lost to Follow-up|2|||
131740996|NCT02700919|474329274|FG001|Overall Study|Lost to Follow-up|0|||
131740997|NCT02700919|474329275|FG002|Overall Study|Lost to Follow-up|0|||
131740998|NCT02700919|474329273|FG000|Overall Study|Other|2|||
131740999|NCT02700919|474329274|FG001|Overall Study|Other|1|||
131741000|NCT02700919|474329275|FG002|Overall Study|Other|1|||
131741001|NCT03434418|474329276|FG000|Overall Study|Disease Progression|11|||
131741002|NCT03434418|474329276|FG000|Overall Study|Adverse Event|2|||
131741003|NCT03434418|474329276|FG000|Overall Study|Physician Decision|1|||
131741004|NCT03434418|474329276|FG000|Overall Study|Decline in Performance Status (PS)|1|||
131741005|NCT01061736|474329286|FG000|Overall Study|Dose regimen not selected|0|||
131741006|NCT01061736|474329287|FG001|Overall Study|Dose regimen not selected|0|||
131741007|NCT01061736|474329288|FG002|Overall Study|Dose regimen not selected|0|||
131741008|NCT01061736|474329289|FG003|Overall Study|Dose regimen not selected|0|||
131741009|NCT01061736|474329290|FG004|Overall Study|Dose regimen not selected|0|||
131741010|NCT01061736|474329291|FG005|Overall Study|Dose regimen not selected|0|||
131741011|NCT01061736|474329292|FG006|Overall Study|Dose regimen not selected|79|||
131741012|NCT01061736|474329293|FG007|Overall Study|Dose regimen not selected|0|||
131741013|NCT01061736|474329294|FG008|Overall Study|Dose regimen not selected|0|||
131741014|NCT01061736|474329295|FG009|Overall Study|Dose regimen not selected|0|||
131741015|NCT01061736|474329286|FG000|Overall Study|Adverse Event|13|||
131741016|NCT01061736|474329287|FG001|Overall Study|Adverse Event|1|||
131741017|NCT01061736|474329288|FG002|Overall Study|Adverse Event|3|||
131741018|NCT01061736|474329289|FG003|Overall Study|Adverse Event|2|||
131741019|NCT01061736|474329290|FG004|Overall Study|Adverse Event|4|||
131741020|NCT01061736|474329291|FG005|Overall Study|Adverse Event|1|||
131741021|NCT01061736|474329292|FG006|Overall Study|Adverse Event|4|||
131741022|NCT01061736|474329293|FG007|Overall Study|Adverse Event|63|||
131741023|NCT01061736|474329294|FG008|Overall Study|Adverse Event|67|||
131741024|NCT01061736|474329295|FG009|Overall Study|Adverse Event|34|||
131741025|NCT01061736|474329286|FG000|Overall Study|Lack of Efficacy|0|||
131741026|NCT01061736|474329287|FG001|Overall Study|Lack of Efficacy|2|||
131741027|NCT01061736|474329288|FG002|Overall Study|Lack of Efficacy|1|||
131741028|NCT01061736|474329289|FG003|Overall Study|Lack of Efficacy|1|||
131741029|NCT01061736|474329290|FG004|Overall Study|Lack of Efficacy|1|||
131741030|NCT01061736|474329291|FG005|Overall Study|Lack of Efficacy|2|||
131741031|NCT01061736|474329292|FG006|Overall Study|Lack of Efficacy|1|||
131741032|NCT01061736|474329293|FG007|Overall Study|Lack of Efficacy|9|||
131741033|NCT01061736|474329294|FG008|Overall Study|Lack of Efficacy|9|||
131741034|NCT01061736|474329295|FG009|Overall Study|Lack of Efficacy|10|||
131741035|NCT01061736|474329286|FG000|Overall Study|Poor compliance to protocol|0|||
131741036|NCT01061736|474329287|FG001|Overall Study|Poor compliance to protocol|0|||
131741037|NCT01061736|474329288|FG002|Overall Study|Poor compliance to protocol|0|||
131741038|NCT01061736|474329289|FG003|Overall Study|Poor compliance to protocol|0|||
131741039|NCT01061736|474329290|FG004|Overall Study|Poor compliance to protocol|0|||
131741040|NCT01061736|474329291|FG005|Overall Study|Poor compliance to protocol|0|||
131741041|NCT01061736|474329292|FG006|Overall Study|Poor compliance to protocol|0|||
131741042|NCT01061736|474329293|FG007|Overall Study|Poor compliance to protocol|2|||
131741043|NCT01061736|474329294|FG008|Overall Study|Poor compliance to protocol|5|||
131741044|NCT01061736|474329295|FG009|Overall Study|Poor compliance to protocol|9|||
131741045|NCT01061736|474329286|FG000|Overall Study|Not treated|0|||
131741046|NCT01061736|474329287|FG001|Overall Study|Not treated|0|||
131741047|NCT01061736|474329288|FG002|Overall Study|Not treated|0|||
131741048|NCT01061736|474329289|FG003|Overall Study|Not treated|0|||
131741049|NCT01061736|474329290|FG004|Overall Study|Not treated|1|||
131741050|NCT01061736|474329291|FG005|Overall Study|Not treated|0|||
131741051|NCT01061736|474329292|FG006|Overall Study|Not treated|0|||
131741052|NCT01061736|474329293|FG007|Overall Study|Not treated|2|||
131741053|NCT01061736|474329294|FG008|Overall Study|Not treated|1|||
131741054|NCT01061736|474329295|FG009|Overall Study|Not treated|0|||
131741055|NCT01061736|474329286|FG000|Overall Study|Other than specified above|0|||
131741056|NCT01061736|474329287|FG001|Overall Study|Other than specified above|1|||
131741057|NCT01061736|474329288|FG002|Overall Study|Other than specified above|2|||
131741058|NCT01061736|474329289|FG003|Overall Study|Other than specified above|0|||
131741059|NCT01061736|474329290|FG004|Overall Study|Other than specified above|1|||
131741060|NCT01061736|474329291|FG005|Overall Study|Other than specified above|0|||
131741061|NCT01061736|474329292|FG006|Overall Study|Other than specified above|0|||
131741062|NCT01061736|474329293|FG007|Overall Study|Other than specified above|18|||
131741063|NCT01061736|474329294|FG008|Overall Study|Other than specified above|15|||
131741064|NCT01061736|474329295|FG009|Overall Study|Other than specified above|21|||
131741065|NCT02168803|474329296|FG000|Overall Study|Lost to Follow-up|1|||
131741066|NCT02168803|474329297|FG001|Overall Study|Lost to Follow-up|0|||
131741067|NCT02168803|474329298|FG002|Overall Study|Lost to Follow-up|1|||
131741068|NCT02168803|474329296|FG000|Overall Study|Withdrawal by Subject|1|||
131741069|NCT02168803|474329297|FG001|Overall Study|Withdrawal by Subject|1|||
131741070|NCT02168803|474329298|FG002|Overall Study|Withdrawal by Subject|2|||
131741071|NCT02168803|474329296|FG000|Overall Study|Physician Decision|0|||
131741072|NCT02168803|474329297|FG001|Overall Study|Physician Decision|1|||
131741073|NCT02168803|474329298|FG002|Overall Study|Physician Decision|0|||
131741074|NCT02168803|474329296|FG000|Overall Study|Adverse Event|0|||
131741075|NCT02168803|474329297|FG001|Overall Study|Adverse Event|1|||
131741076|NCT02168803|474329298|FG002|Overall Study|Adverse Event|1|||
131741077|NCT02168803|474329296|FG000|Overall Study|Death|0|||
131741078|NCT02168803|474329297|FG001|Overall Study|Death|0|||
131741079|NCT02168803|474329298|FG002|Overall Study|Death|1|||
131741080|NCT02168803|474329296|FG000|Overall Study|Sponsor Decision|0|||
131741081|NCT02168803|474329297|FG001|Overall Study|Sponsor Decision|0|||
131741082|NCT02168803|474329298|FG002|Overall Study|Sponsor Decision|1|||
131741083|NCT01114373|474329303|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
131741084|NCT01114373|474329304|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
131741085|NCT01114373|474329303|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
131741086|NCT01114373|474329304|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
131741087|NCT01114373|474329303|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
131741088|NCT01114373|474329304|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
131741089|NCT01114373|474329303|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
131741090|NCT01114373|474329304|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
131741091|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131741092|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131741093|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
131741094|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
131741095|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131448922|NCT01208207|473272739|FG002|Part II|Lack of Efficacy|0|||
131448923|NCT01208207|473272740|FG003|Part II|Lack of Efficacy|6|||
131741096|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131741097|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
131741098|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
131741099|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
131741100|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
131741101|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
131741102|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
131905385|NCT01239797|474940897|FG000|Treated Participants|Study drug toxicity|39|||
131448924|NCT01208207|473272741|FG004|Part II|Lack of Efficacy|4|||
131448925|NCT01208207|473272742|FG005|Part II|Lack of Efficacy|3|||
131741103|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
131741104|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
131741105|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
131741106|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131741107|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131741108|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131741109|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
131741110|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
131741111|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131741112|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131741113|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131741114|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131741115|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
131741116|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
131741117|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131741118|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131741119|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131741120|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131741121|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
131741122|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131741123|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131741124|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131741125|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131741126|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131741127|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
131741128|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
131741129|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
131741130|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
131741131|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
131741132|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
131741133|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
131741134|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
131741135|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131741136|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131741137|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131741138|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131741139|NCT03444870|474329307|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
131741140|NCT03444870|474329308|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131741141|NCT03444870|474329309|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131741142|NCT03444870|474329310|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131741143|NCT03444870|474329311|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131741144|NCT03444870|474329312|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131741145|NCT03444870|474329307|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131741146|NCT03444870|474329308|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131741147|NCT03444870|474329309|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131741148|NCT03444870|474329310|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131741149|NCT03444870|474329311|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
131741150|NCT03444870|474329312|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
131741151|NCT03444870|474329307|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
131741152|NCT03444870|474329308|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
131741153|NCT03444870|474329309|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
131741154|NCT03444870|474329310|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
131741155|NCT03444870|474329311|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
131741156|NCT03444870|474329312|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
131741157|NCT03444870|474329307|FG000|Open-Label Extension (OLE) Period|Death|0|||
131741158|NCT03444870|474329308|FG001|Open-Label Extension (OLE) Period|Death|0|||
131741159|NCT03444870|474329309|FG002|Open-Label Extension (OLE) Period|Death|0|||
131741160|NCT03444870|474329310|FG003|Open-Label Extension (OLE) Period|Death|0|||
131741161|NCT03444870|474329311|FG004|Open-Label Extension (OLE) Period|Death|1|||
131741162|NCT03444870|474329312|FG005|Open-Label Extension (OLE) Period|Death|0|||
131741163|NCT02310906|474329315|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
131741164|NCT02310906|474329316|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
131741165|NCT02310906|474329317|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
131808362|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808363|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808364|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131741166|NCT02310906|474329318|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
131741167|NCT02310906|474329315|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
131741168|NCT02310906|474329316|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
131741169|NCT02310906|474329317|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
131741170|NCT02310906|474329318|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
131741171|NCT02310906|474329315|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
131741172|NCT02310906|474329316|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
131741173|NCT02310906|474329317|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
131741174|NCT02310906|474329318|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
131741175|NCT02310906|474329315|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
131741176|NCT02310906|474329316|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
131741177|NCT02310906|474329317|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
131741178|NCT02310906|474329318|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
131741179|NCT02680587|474329319|FG000|Overall Study|Withdrawal by Subject|1|||
131741180|NCT02680587|474329320|FG001|Overall Study|Withdrawal by Subject|0|||
131741181|NCT01677507|474329322|FG000|Initial Assignment|Adverse Event|0|||
131741182|NCT01677507|474329323|FG001|Initial Assignment|Adverse Event|1|||
131741183|NCT01677507|474329322|FG000|Initial Assignment|Protocol Violation|0|||
131741184|NCT01677507|474329323|FG001|Initial Assignment|Protocol Violation|1|||
131741185|NCT01677507|474329322|FG000|Second Assigment|Withdrawal by Subject|2|||
131741186|NCT01677507|474329323|FG001|Second Assigment|Withdrawal by Subject|2|||
131741187|NCT01677507|474329322|FG000|Second Assigment|Adverse Event|1|||
131741188|NCT01677507|474329323|FG001|Second Assigment|Adverse Event|3|||
131741189|NCT00098020|474329328|FG000|Overall Study|Adverse Event|2|||
131741190|NCT00098020|474329328|FG000|Overall Study|Lost to Follow-up|1|||
131741191|NCT00098020|474329328|FG000|Overall Study|elevated liver enzymes|1|||
131741192|NCT00098020|474329328|FG000|Overall Study|Low urine PCR|1|||
131741193|NCT00098020|474329328|FG000|Overall Study|Low epidermal growth factor receptor|1|||
131741194|NCT01840228|474329332|FG000|Overall Study|Lost to Follow-up|1|||
131741195|NCT01840228|474329333|FG001|Overall Study|Lost to Follow-up|1|||
131741196|NCT00712933|474329336|FG000|Overall Study|Adverse Event|69|||
131741197|NCT00712933|474329336|FG000|Overall Study|Lack of Efficacy|6|||
131741198|NCT00712933|474329336|FG000|Overall Study|Lost to Follow-up|22|||
131741199|NCT00712933|474329336|FG000|Overall Study|Non-compliance with study drug|13|||
131741200|NCT00712933|474329336|FG000|Overall Study|Other Pregnancy|37|||
131741201|NCT00712933|474329336|FG000|Overall Study|Sponsor decision|14|||
131741202|NCT00712933|474329336|FG000|Overall Study|Withdrew consent|4|||
131741203|NCT00712933|474329336|FG000|Overall Study|Hip replacement surgery|1|||
131741204|NCT00712933|474329336|FG000|Overall Study|Involved in Clinical research|3|||
131741205|NCT00712933|474329336|FG000|Overall Study|Participant hospitalized|1|||
131741206|NCT00712933|474329336|FG000|Overall Study|Participant travelled overseas|2|||
131741207|NCT00712933|474329336|FG000|Overall Study|Death of patient|1|||
131741208|NCT00712933|474329336|FG000|Overall Study|Other Physician decision|1|||
131741209|NCT00712933|474329336|FG000|Overall Study|Not committed to contraception|1|||
131741210|NCT00712933|474329336|FG000|Overall Study|Participant received medication|1|||
131741211|NCT00712933|474329336|FG000|Overall Study|Physician Decision|36|||
131741212|NCT00712933|474329336|FG000|Overall Study|Protocol Violation|4|||
131741213|NCT00712933|474329336|FG000|Overall Study|Withdrawal by Subject|151|||
131741214|NCT01295580|474329342|FG000|Overall Study|Protocol Violation|4|||
131741215|NCT01295580|474329343|FG001|Overall Study|Protocol Violation|2|||
131741216|NCT01295580|474329342|FG000|Overall Study|Withdrawal by Subject|1|||
131741217|NCT01295580|474329343|FG001|Overall Study|Withdrawal by Subject|4|||
131741218|NCT01295580|474329342|FG000|Overall Study|Adverse Event|2|||
131741219|NCT01295580|474329343|FG001|Overall Study|Adverse Event|1|||
131741220|NCT01295580|474329342|FG000|Overall Study|Lost to Follow-up|1|||
131741221|NCT01295580|474329343|FG001|Overall Study|Lost to Follow-up|0|||
131741222|NCT01295580|474329342|FG000|Overall Study|Lack of Efficacy|1|||
131741223|NCT01295580|474329343|FG001|Overall Study|Lack of Efficacy|0|||
131741224|NCT01295580|474329342|FG000|Overall Study|Other: inconvenience|1|||
131741225|NCT01295580|474329343|FG001|Overall Study|Other: inconvenience|0|||
131808365|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808366|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131808367|NCT01597245|474582931|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808368|NCT01597245|474582932|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808369|NCT01597245|474582933|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808370|NCT01597245|474582934|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808371|NCT01597245|474582935|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808372|NCT01597245|474582936|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808373|NCT01597245|474582937|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808374|NCT01597245|474582938|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131741226|NCT01295580|474329342|FG000|Overall Study|Other: family objection|0|||
131741227|NCT01295580|474329343|FG001|Overall Study|Other: family objection|1|||
131741228|NCT03084718|474329349|FG000|Overall Study|Withdrawal by Subject|4|||
131741229|NCT03084718|474329350|FG001|Overall Study|Withdrawal by Subject|3|||
131741230|NCT03084718|474329351|FG002|Overall Study|Withdrawal by Subject|4|||
131741231|NCT03084718|474329352|FG003|Overall Study|Withdrawal by Subject|0|||
131741232|NCT03084718|474329353|FG004|Overall Study|Withdrawal by Subject|0|||
131741233|NCT03084718|474329349|FG000|Overall Study|Physician Decision|1|||
131741234|NCT03084718|474329350|FG001|Overall Study|Physician Decision|0|||
131741235|NCT03084718|474329351|FG002|Overall Study|Physician Decision|0|||
131741236|NCT03084718|474329352|FG003|Overall Study|Physician Decision|0|||
131741237|NCT03084718|474329353|FG004|Overall Study|Physician Decision|0|||
131741238|NCT03084718|474329349|FG000|Overall Study|Adverse Event|3|||
131741239|NCT03084718|474329350|FG001|Overall Study|Adverse Event|5|||
131741240|NCT03084718|474329351|FG002|Overall Study|Adverse Event|5|||
131741241|NCT03084718|474329352|FG003|Overall Study|Adverse Event|8|||
131741242|NCT03084718|474329353|FG004|Overall Study|Adverse Event|2|||
131741243|NCT03084718|474329349|FG000|Overall Study|Lack of Efficacy|2|||
131741244|NCT03084718|474329350|FG001|Overall Study|Lack of Efficacy|0|||
131741245|NCT03084718|474329351|FG002|Overall Study|Lack of Efficacy|1|||
131741246|NCT03084718|474329352|FG003|Overall Study|Lack of Efficacy|4|||
131741247|NCT03084718|474329353|FG004|Overall Study|Lack of Efficacy|0|||
131741248|NCT03084718|474329349|FG000|Overall Study|Lost to Follow-up|0|||
131741249|NCT03084718|474329350|FG001|Overall Study|Lost to Follow-up|1|||
131741250|NCT03084718|474329351|FG002|Overall Study|Lost to Follow-up|0|||
131741251|NCT03084718|474329352|FG003|Overall Study|Lost to Follow-up|0|||
131741252|NCT03084718|474329353|FG004|Overall Study|Lost to Follow-up|2|||
131741253|NCT03084718|474329349|FG000|Overall Study|Protocol Violation|0|||
131741254|NCT03084718|474329350|FG001|Overall Study|Protocol Violation|0|||
131741255|NCT03084718|474329351|FG002|Overall Study|Protocol Violation|1|||
131741256|NCT03084718|474329352|FG003|Overall Study|Protocol Violation|0|||
131741257|NCT03084718|474329353|FG004|Overall Study|Protocol Violation|0|||
131741258|NCT03084718|474329349|FG000|Overall Study|Death|0|||
131741259|NCT03084718|474329350|FG001|Overall Study|Death|1|||
131741260|NCT03084718|474329351|FG002|Overall Study|Death|0|||
131741261|NCT03084718|474329352|FG003|Overall Study|Death|0|||
131741262|NCT03084718|474329353|FG004|Overall Study|Death|0|||
131741263|NCT03084718|474329349|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
131741264|NCT03084718|474329350|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
131741265|NCT03084718|474329351|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
131741266|NCT03084718|474329352|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
131741267|NCT03084718|474329353|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
131741268|NCT00424294|474329354|FG000|Overall Study|Adverse Event|4|||
131741269|NCT00424294|474329355|FG001|Overall Study|Adverse Event|10|||
131741270|NCT00424294|474329354|FG000|Overall Study|Lack of Efficacy|2|||
131741271|NCT00424294|474329355|FG001|Overall Study|Lack of Efficacy|1|||
131741272|NCT00424294|474329354|FG000|Overall Study|Withdrawal by Subject|1|||
131741273|NCT00424294|474329355|FG001|Overall Study|Withdrawal by Subject|2|||
131741274|NCT00424294|474329354|FG000|Overall Study|Other|0|||
131741275|NCT00424294|474329355|FG001|Overall Study|Other|2|||
131741276|NCT00424294|474329354|FG000|Overall Study|Randomized but not Treated|1|||
131741277|NCT00424294|474329355|FG001|Overall Study|Randomized but not Treated|0|||
131741278|NCT01464788|474329356|FG000|Overall Study|Lost to Follow-up|0|||
131741279|NCT01464788|474329357|FG001|Overall Study|Lost to Follow-up|1|||
131741280|NCT01464788|474329358|FG002|Overall Study|Lost to Follow-up|0|||
131741281|NCT01464788|474329356|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
131741282|NCT01464788|474329357|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
131741283|NCT01464788|474329358|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
131741284|NCT00239837|474329360|FG000|Overall Study|Lost to Follow-up|3|||
131741285|NCT00239837|474329361|FG001|Overall Study|Lost to Follow-up|7|||
131741286|NCT01153893|474329362|FG000|Overall Study|Adverse Event|1|||
131448926|NCT01208207|473272743|FG006|Part II|Lack of Efficacy|3|||
131741287|NCT01153893|474329363|FG001|Overall Study|Adverse Event|0|||
131741288|NCT01838590|474329364|FG000|Overall Study|Lack of Efficacy|12|||
131741289|NCT01838590|474329365|FG001|Overall Study|Lack of Efficacy|4|||
131741290|NCT01838590|474329364|FG000|Overall Study|Lost to Follow-up|0|||
131741291|NCT01838590|474329365|FG001|Overall Study|Lost to Follow-up|1|||
131741292|NCT00536978|474329366|FG000|Overall Study|Not eligible for Adback Infusion|22|||
131741293|NCT03550131|474329368|FG000|Overall Study|Lost to Follow-up|16|||
131741294|NCT03550131|474329369|FG001|Overall Study|Lost to Follow-up|24|||
131741295|NCT03550131|474329368|FG000|Overall Study|Withdrawal by Subject|36|||
131808375|NCT01597245|474582939|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131448927|NCT01208207|473272737|FG000|Part II|Lost to Follow-up|0|||
131741296|NCT03550131|474329369|FG001|Overall Study|Withdrawal by Subject|28|||
131741297|NCT03550131|474329368|FG000|Overall Study|Illness of dyad member|10|||
131741298|NCT03550131|474329369|FG001|Overall Study|Illness of dyad member|2|||
131741299|NCT03550131|474329368|FG000|Overall Study|Death of person with dementia|4|||
131741300|NCT03550131|474329369|FG001|Overall Study|Death of person with dementia|8|||
131448928|NCT01208207|473272738|FG001|Part II|Lost to Follow-up|0|||
131448929|NCT01208207|473272739|FG002|Part II|Lost to Follow-up|0|||
131448930|NCT01208207|473272740|FG003|Part II|Lost to Follow-up|4|||
131448931|NCT01208207|473272741|FG004|Part II|Lost to Follow-up|0|||
131448932|NCT01208207|473272742|FG005|Part II|Lost to Follow-up|2|||
131741301|NCT01318512|474329370|FG000|Maintenance Period (6 Months)|Death|2|||
131741302|NCT01318512|474329370|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
131741303|NCT01364233|474329374|FG000|Overall Study|Lost to Follow-up|1|||
131741304|NCT00302718|474329378|FG000|Overall Study|Participant left the hospital|1|||
131741305|NCT00302718|474329379|FG001|Overall Study|Participant left the hospital|0|||
131741306|NCT00302718|474329380|FG002|Overall Study|Participant left the hospital|0|||
131741307|NCT00302718|474329381|FG003|Overall Study|Participant left the hospital|1|||
131741308|NCT00302718|474329378|FG000|Overall Study|Withdrawal by Subject|0|||
131741309|NCT00302718|474329379|FG001|Overall Study|Withdrawal by Subject|1|||
131741310|NCT00302718|474329380|FG002|Overall Study|Withdrawal by Subject|0|||
131741311|NCT00302718|474329381|FG003|Overall Study|Withdrawal by Subject|0|||
131741312|NCT00302718|474329378|FG000|Overall Study|Participant left primary care setting|0|||
131741313|NCT00302718|474329379|FG001|Overall Study|Participant left primary care setting|0|||
131741314|NCT00302718|474329380|FG002|Overall Study|Participant left primary care setting|2|||
131741315|NCT00302718|474329381|FG003|Overall Study|Participant left primary care setting|1|||
131741316|NCT00819585|474329382|FG000|Core Study|Adverse Event|2|||
131741317|NCT00819585|474329383|FG001|Core Study|Adverse Event|1|||
131741318|NCT00819585|474329384|FG002|Core Study|Adverse Event|1|||
131741319|NCT00819585|474329385|FG003|Core Study|Adverse Event|4|||
131741320|NCT00819585|474329386|FG004|Core Study|Adverse Event|1|||
131741321|NCT00819585|474329387|FG005|Core Study|Adverse Event|0|||
131741322|NCT00819585|474329388|FG006|Core Study|Adverse Event|2|||
131741323|NCT00819585|474329389|FG007|Core Study|Adverse Event|0|||
131741324|NCT00819585|474329390|FG008|Core Study|Adverse Event|0|||
131741325|NCT00819585|474329391|FG009|Core Study|Adverse Event|0|||
131741326|NCT00819585|474329392|FG010|Core Study|Adverse Event|0|||
131741327|NCT00819585|474329382|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
131741328|NCT00819585|474329383|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
131741329|NCT00819585|474329384|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
131741330|NCT00819585|474329385|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
131741331|NCT00819585|474329386|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
131741332|NCT00819585|474329387|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
131741333|NCT00819585|474329388|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
131741334|NCT00819585|474329389|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
131741335|NCT00819585|474329390|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
131741336|NCT00819585|474329391|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
131741337|NCT00819585|474329392|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
131741338|NCT00819585|474329382|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741339|NCT00819585|474329383|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
131741340|NCT00819585|474329384|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741341|NCT00819585|474329385|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741342|NCT00819585|474329386|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741343|NCT00819585|474329387|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741344|NCT00819585|474329388|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
131741345|NCT00819585|474329389|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741346|NCT00819585|474329390|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741347|NCT00819585|474329391|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
131741348|NCT00819585|474329392|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
131808376|NCT01597245|474582940|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808377|NCT01597245|474582941|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
131808378|NCT01597245|474582942|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808379|NCT01597245|474582943|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808380|NCT01597245|474582944|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808381|NCT01597245|474582945|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808382|NCT01597245|474582946|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131741349|NCT00819585|474329382|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
131741350|NCT00819585|474329383|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
131741351|NCT00819585|474329384|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
131741352|NCT00819585|474329385|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
131741353|NCT00819585|474329386|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
131741354|NCT00819585|474329387|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
131741355|NCT00819585|474329388|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
131741356|NCT00819585|474329389|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
131741357|NCT00819585|474329390|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
131741358|NCT00819585|474329391|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
131448933|NCT01208207|473272743|FG006|Part II|Lost to Follow-up|1|||
131741359|NCT00819585|474329392|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
131448934|NCT01208207|473272737|FG000|Part II|Non-Compliance With Study Drug|0|||
131741360|NCT00819585|474329382|FG000|Core Study|Subject Withdrew Consent|0|||
131741361|NCT00819585|474329383|FG001|Core Study|Subject Withdrew Consent|3|||
131741362|NCT00819585|474329384|FG002|Core Study|Subject Withdrew Consent|2|||
131741363|NCT00819585|474329385|FG003|Core Study|Subject Withdrew Consent|1|||
131741364|NCT00819585|474329386|FG004|Core Study|Subject Withdrew Consent|0|||
131741365|NCT00819585|474329387|FG005|Core Study|Subject Withdrew Consent|0|||
131741366|NCT00819585|474329388|FG006|Core Study|Subject Withdrew Consent|3|||
131741367|NCT00819585|474329389|FG007|Core Study|Subject Withdrew Consent|0|||
131741368|NCT00819585|474329390|FG008|Core Study|Subject Withdrew Consent|0|||
131741369|NCT00819585|474329391|FG009|Core Study|Subject Withdrew Consent|0|||
131741370|NCT00819585|474329392|FG010|Core Study|Subject Withdrew Consent|0|||
131741371|NCT00819585|474329382|FG000|Core Study|Lost to Follow-up|2|||
131741372|NCT00819585|474329383|FG001|Core Study|Lost to Follow-up|1|||
131741373|NCT00819585|474329384|FG002|Core Study|Lost to Follow-up|2|||
131741374|NCT00819585|474329385|FG003|Core Study|Lost to Follow-up|0|||
131741375|NCT00819585|474329386|FG004|Core Study|Lost to Follow-up|1|||
131741376|NCT00819585|474329387|FG005|Core Study|Lost to Follow-up|1|||
131741377|NCT00819585|474329388|FG006|Core Study|Lost to Follow-up|1|||
131741378|NCT00819585|474329389|FG007|Core Study|Lost to Follow-up|0|||
131741379|NCT00819585|474329390|FG008|Core Study|Lost to Follow-up|0|||
131741380|NCT00819585|474329391|FG009|Core Study|Lost to Follow-up|0|||
131741381|NCT00819585|474329392|FG010|Core Study|Lost to Follow-up|0|||
131741382|NCT00819585|474329382|FG000|Core Study|Administrative Problems|0|||
131741383|NCT00819585|474329383|FG001|Core Study|Administrative Problems|0|||
131741384|NCT00819585|474329384|FG002|Core Study|Administrative Problems|0|||
131741385|NCT00819585|474329385|FG003|Core Study|Administrative Problems|0|||
131741386|NCT00819585|474329386|FG004|Core Study|Administrative Problems|0|||
131741387|NCT00819585|474329387|FG005|Core Study|Administrative Problems|0|||
131741388|NCT00819585|474329388|FG006|Core Study|Administrative Problems|2|||
131741389|NCT00819585|474329389|FG007|Core Study|Administrative Problems|0|||
131741390|NCT00819585|474329390|FG008|Core Study|Administrative Problems|0|||
131741391|NCT00819585|474329391|FG009|Core Study|Administrative Problems|0|||
131741392|NCT00819585|474329392|FG010|Core Study|Administrative Problems|0|||
131741393|NCT00819585|474329382|FG000|Core Study|Death|0|||
131741394|NCT00819585|474329383|FG001|Core Study|Death|0|||
131741395|NCT00819585|474329384|FG002|Core Study|Death|0|||
131741396|NCT00819585|474329385|FG003|Core Study|Death|0|||
131741397|NCT00819585|474329386|FG004|Core Study|Death|0|||
131741398|NCT00819585|474329387|FG005|Core Study|Death|0|||
131741399|NCT00819585|474329388|FG006|Core Study|Death|1|||
131741400|NCT00819585|474329389|FG007|Core Study|Death|0|||
131741401|NCT00819585|474329390|FG008|Core Study|Death|0|||
131741402|NCT00819585|474329391|FG009|Core Study|Death|0|||
131741403|NCT00819585|474329392|FG010|Core Study|Death|0|||
131741404|NCT00819585|474329382|FG000|Core Study|Protocol Violation|0|||
131741405|NCT00819585|474329383|FG001|Core Study|Protocol Violation|0|||
131741406|NCT00819585|474329384|FG002|Core Study|Protocol Violation|1|||
131741407|NCT00819585|474329385|FG003|Core Study|Protocol Violation|0|||
131741408|NCT00819585|474329386|FG004|Core Study|Protocol Violation|0|||
131741409|NCT00819585|474329387|FG005|Core Study|Protocol Violation|1|||
131741410|NCT00819585|474329388|FG006|Core Study|Protocol Violation|3|||
131741411|NCT00819585|474329389|FG007|Core Study|Protocol Violation|0|||
131741412|NCT00819585|474329390|FG008|Core Study|Protocol Violation|0|||
131741413|NCT00819585|474329391|FG009|Core Study|Protocol Violation|0|||
131741414|NCT00819585|474329392|FG010|Core Study|Protocol Violation|0|||
131741415|NCT00819585|474329382|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
131741416|NCT00819585|474329383|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
131741417|NCT00819585|474329384|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
131741418|NCT00819585|474329385|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
131741419|NCT00819585|474329386|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
131741420|NCT00819585|474329387|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
131741421|NCT00819585|474329388|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
131905386|NCT01239797|474940898|FG001|Treated Participants|Study drug toxicity|45|||
131741422|NCT00819585|474329389|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
131741423|NCT00819585|474329390|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
131741424|NCT00819585|474329391|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
131741425|NCT00819585|474329392|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
131741426|NCT00819585|474329382|FG000|Extension Study|Subject Withdrew Consent|0|||
131741427|NCT00819585|474329383|FG001|Extension Study|Subject Withdrew Consent|0|||
131741428|NCT00819585|474329384|FG002|Extension Study|Subject Withdrew Consent|0|||
131741429|NCT00819585|474329385|FG003|Extension Study|Subject Withdrew Consent|0|||
131741430|NCT00819585|474329386|FG004|Extension Study|Subject Withdrew Consent|0|||
131741431|NCT00819585|474329387|FG005|Extension Study|Subject Withdrew Consent|0|||
131741432|NCT00819585|474329388|FG006|Extension Study|Subject Withdrew Consent|0|||
131741433|NCT00819585|474329389|FG007|Extension Study|Subject Withdrew Consent|0|||
131741434|NCT00819585|474329390|FG008|Extension Study|Subject Withdrew Consent|3|||
131741435|NCT00819585|474329391|FG009|Extension Study|Subject Withdrew Consent|0|||
131741436|NCT00819585|474329392|FG010|Extension Study|Subject Withdrew Consent|1|||
131741437|NCT00819585|474329382|FG000|Extension Study|Lost to Follow-up|0|||
131741438|NCT00819585|474329383|FG001|Extension Study|Lost to Follow-up|0|||
131741439|NCT00819585|474329384|FG002|Extension Study|Lost to Follow-up|0|||
131741440|NCT00819585|474329385|FG003|Extension Study|Lost to Follow-up|0|||
131741441|NCT00819585|474329386|FG004|Extension Study|Lost to Follow-up|0|||
131741442|NCT00819585|474329387|FG005|Extension Study|Lost to Follow-up|0|||
131741443|NCT00819585|474329388|FG006|Extension Study|Lost to Follow-up|0|||
131741444|NCT00819585|474329389|FG007|Extension Study|Lost to Follow-up|0|||
131741445|NCT00819585|474329390|FG008|Extension Study|Lost to Follow-up|2|||
131741446|NCT00819585|474329391|FG009|Extension Study|Lost to Follow-up|1|||
131741447|NCT00819585|474329392|FG010|Extension Study|Lost to Follow-up|1|||
131741448|NCT00819585|474329382|FG000|Extension Study|Death|0|||
131741449|NCT00819585|474329383|FG001|Extension Study|Death|0|||
131741450|NCT00819585|474329384|FG002|Extension Study|Death|0|||
131741451|NCT00819585|474329385|FG003|Extension Study|Death|0|||
131741452|NCT00819585|474329386|FG004|Extension Study|Death|0|||
131741453|NCT00819585|474329387|FG005|Extension Study|Death|0|||
131741454|NCT00819585|474329388|FG006|Extension Study|Death|0|||
131741455|NCT00819585|474329389|FG007|Extension Study|Death|0|||
131741456|NCT00819585|474329390|FG008|Extension Study|Death|2|||
131741457|NCT00819585|474329391|FG009|Extension Study|Death|0|||
131741458|NCT00819585|474329392|FG010|Extension Study|Death|0|||
131741459|NCT00632541|474329393|FG000|Overall Study|Adverse Event|7|||
131741460|NCT02159469|474329397|FG000|Overall Study|Missing Completion status|1|||
131741461|NCT02159469|474329397|FG000|Overall Study|Adverse Event|5|||
131741462|NCT02159469|474329397|FG000|Overall Study|Non-compliance|2|||
131741463|NCT02159469|474329397|FG000|Overall Study|Withdrawal by Subject|9|||
131741464|NCT02159469|474329397|FG000|Overall Study|Lost to Follow-up|1|||
131741465|NCT02159469|474329397|FG000|Overall Study|Sponsor's request|2|||
131741466|NCT02159469|474329397|FG000|Overall Study|Met Stopping Criteria|3|||
131741467|NCT02159469|474329397|FG000|Overall Study|Other|1|||
131741468|NCT02159469|474329397|FG000|Overall Study|Multiple|29|||
131741469|NCT02927873|474329398|FG000|Overall Study|Lost to Follow-up|0|||
131741470|NCT02927873|474329399|FG001|Overall Study|Lost to Follow-up|1|||
131741471|NCT02927873|474329400|FG002|Overall Study|Lost to Follow-up|0|||
131741472|NCT02927873|474329401|FG003|Overall Study|Lost to Follow-up|0|||
131741473|NCT02927873|474329402|FG004|Overall Study|Lost to Follow-up|0|||
131741474|NCT02927873|474329403|FG005|Overall Study|Lost to Follow-up|0|||
131741475|NCT02927873|474329398|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131741476|NCT02927873|474329399|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
131741477|NCT02927873|474329400|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131741478|NCT02927873|474329401|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131741479|NCT02927873|474329402|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131741480|NCT02927873|474329403|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131741481|NCT02927873|474329398|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131741482|NCT02927873|474329399|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131741483|NCT02927873|474329400|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131741484|NCT02927873|474329401|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131741485|NCT02927873|474329402|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131741486|NCT02927873|474329403|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131741487|NCT02927873|474329398|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131741488|NCT02927873|474329399|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
131741489|NCT02927873|474329400|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131741490|NCT02927873|474329401|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131741491|NCT02927873|474329402|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131741492|NCT02927873|474329403|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131741493|NCT02927873|474329398|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
131741494|NCT02927873|474329399|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131741495|NCT02927873|474329400|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131741496|NCT02927873|474329401|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131741497|NCT02927873|474329402|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131808383|NCT01597245|474582947|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808384|NCT01597245|474582948|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131741498|NCT02927873|474329403|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131741499|NCT02927873|474329398|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
131741500|NCT02927873|474329399|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131741501|NCT02927873|474329400|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131741502|NCT02927873|474329401|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131741503|NCT02927873|474329402|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131741504|NCT02927873|474329403|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131741505|NCT03629041|474329409|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
131741506|NCT03629041|474329410|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
131741507|NCT03629041|474329411|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
131741508|NCT03629041|474329412|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
131741509|NCT00393913|474329414|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
131741510|NCT00393913|474329414|FG000|Initial Assessment|Withdrawal by Subject|16|||
131741511|NCT00393913|474329414|FG000|CPAP|Withdrawal by Subject|3|||
131741512|NCT00393913|474329414|FG000|CPAP|Physician Decision|1|||
131741513|NCT00393913|474329414|FG000|CPAP|TEchnical problem with CPAP|3|||
131741514|NCT00995670|474329417|FG000|Overall Study|Failed arterial cannulation|1|||
131741515|NCT00995670|474329418|FG001|Overall Study|Failed arterial cannulation|0|||
131741516|NCT00995670|474329419|FG002|Overall Study|Failed arterial cannulation|3|||
131741517|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
131741518|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
131741519|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
131741520|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
131741521|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
131741522|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
131741523|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
131741524|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
131741525|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
131741526|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
131741527|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
131741528|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
131741529|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
131741530|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
131741531|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
131741532|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
131741533|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
131741534|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
131741535|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
131741536|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
131741537|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
131741538|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
131741539|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
131741540|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
131741541|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
131741542|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
131741543|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
131741544|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
131741545|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
131741546|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
131741547|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
131741548|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
131741549|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
131741550|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
131741551|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
131741552|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
131741553|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
131741554|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
131741555|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
131741556|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
131741557|NCT00383721|474329423|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
131741558|NCT00383721|474329424|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
131741559|NCT00383721|474329425|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
131741560|NCT00383721|474329426|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
131741561|NCT00383721|474329427|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
131741562|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
131741563|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
131741564|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
131741565|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
131741566|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
131741567|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
131741568|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
131741569|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
131741570|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
131741571|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
131741572|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
131741573|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
131741574|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
131741575|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
131741576|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
131741577|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
131741578|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
131741579|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
131741580|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
131741581|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
131741582|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131741583|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131741584|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131741585|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131741586|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
131741587|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
131741588|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131741589|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131741590|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
131741591|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
131741592|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131741593|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131741594|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131741595|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131741596|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131741597|NCT00383721|474329423|FG000|26-Week Treatment Safety Extension|Administrative|1|||
131741598|NCT00383721|474329424|FG001|26-Week Treatment Safety Extension|Administrative|2|||
131741599|NCT00383721|474329425|FG002|26-Week Treatment Safety Extension|Administrative|3|||
131741600|NCT00383721|474329426|FG003|26-Week Treatment Safety Extension|Administrative|1|||
131741601|NCT00383721|474329427|FG004|26-Week Treatment Safety Extension|Administrative|0|||
131741602|NCT03519516|474329428|FG000|Overall Study|Adverse Event|0|||
131741603|NCT03519516|474329429|FG001|Overall Study|Adverse Event|1|||
131741604|NCT01255306|474331138|FG000|Overall Study|Physician Decision|1|||
131741605|NCT01255306|474331139|FG001|Overall Study|Physician Decision|1|||
131741606|NCT01283997|474331140|FG000|Overall Study|Physician Decision|8|||
131741607|NCT01283997|474331141|FG001|Overall Study|Physician Decision|10|||
131741608|NCT01283997|474331140|FG000|Overall Study|Withdrawal by Subject|3|||
131741609|NCT01283997|474331141|FG001|Overall Study|Withdrawal by Subject|2|||
131741610|NCT01283997|474331140|FG000|Overall Study|Physically unable to continue|0|||
131741611|NCT01283997|474331141|FG001|Overall Study|Physically unable to continue|1|||
131741612|NCT01283997|474331140|FG000|Overall Study|Progressive disease|1|||
131741613|NCT01283997|474331141|FG001|Overall Study|Progressive disease|0|||
131741614|NCT01283997|474331140|FG000|Overall Study|Other|4|||
131741615|NCT01283997|474331141|FG001|Overall Study|Other|4|||
131741616|NCT02017899|474331142|FG000|Overall Study|Withdrawal by Subject|0|||
131741617|NCT02017899|474331143|FG001|Overall Study|Withdrawal by Subject|0|||
131741618|NCT02017899|474331144|FG002|Overall Study|Withdrawal by Subject|0|||
131741619|NCT02017899|474331145|FG003|Overall Study|Withdrawal by Subject|1|||
131741620|NCT02017899|474331146|FG004|Overall Study|Withdrawal by Subject|1|||
131741621|NCT02017899|474331147|FG005|Overall Study|Withdrawal by Subject|0|||
131741622|NCT01677624|474331151|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
131741623|NCT00804843|474331152|FG000|Overall Study|Protocol Violation|1|||
131741624|NCT00804843|474331153|FG001|Overall Study|Protocol Violation|0|||
131741625|NCT00804843|474331152|FG000|Overall Study|Adverse Event|8|||
131741626|NCT00804843|474331153|FG001|Overall Study|Adverse Event|5|||
131741627|NCT00804843|474331152|FG000|Overall Study|Withdrawal by Subject|1|||
131741628|NCT00804843|474331153|FG001|Overall Study|Withdrawal by Subject|2|||
131741629|NCT00884221|474331158|FG000|Overall Study|Withdrawal by Subject|0|||
131741630|NCT00884221|474331159|FG001|Overall Study|Withdrawal by Subject|3|||
131808385|NCT01597245|474582949|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808386|NCT01597245|474582950|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131905387|NCT01239797|474940897|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
131905388|NCT01239797|474940898|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
131905389|NCT01239797|474940897|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
131905390|NCT01239797|474940898|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
131905391|NCT01239797|474940897|FG000|Treated Participants|Administrative reason by sponsor|13|||
131905392|NCT01239797|474940898|FG001|Treated Participants|Administrative reason by sponsor|4|||
131905393|NCT01239797|474940897|FG000|Treated Participants|Other reasons|14|||
131905394|NCT01239797|474940898|FG001|Treated Participants|Other reasons|14|||
131905395|NCT01239797|474940897|FG000|Treated Participants|Participant withdrew consent|6|||
131905396|NCT01239797|474940898|FG001|Treated Participants|Participant withdrew consent|11|||
131905397|NCT01239797|474940897|FG000|Treated Participants|Death|1|||
131905398|NCT01239797|474940898|FG001|Treated Participants|Death|1|||
131905399|NCT01239797|474940897|FG000|Treated Participants|Participant no longer meets study criteria|1|||
131905400|NCT01239797|474940898|FG001|Treated Participants|Participant no longer meets study criteria|1|||
131905401|NCT01239797|474940897|FG000|Treated Participants|Poor/non-compliance|0|||
131905402|NCT01239797|474940898|FG001|Treated Participants|Poor/non-compliance|1|||
131905403|NCT00853762|474940902|FG000|Overall Study|Premature Termination|16|||
131905404|NCT00853762|474940903|FG001|Overall Study|Premature Termination|15|||
131905405|NCT00853762|474940904|FG002|Overall Study|Premature Termination|14|||
131905406|NCT00853762|474940905|FG003|Overall Study|Premature Termination|21|||
131905407|NCT00853762|474940902|FG000|Overall Study|Protocol Violation|0|||
131905408|NCT00853762|474940903|FG001|Overall Study|Protocol Violation|0|||
131905409|NCT00853762|474940904|FG002|Overall Study|Protocol Violation|0|||
131905410|NCT00853762|474940905|FG003|Overall Study|Protocol Violation|1|||
131905411|NCT00853762|474940902|FG000|Overall Study|Withdrawal by Subject|0|||
131905412|NCT00853762|474940903|FG001|Overall Study|Withdrawal by Subject|0|||
131905413|NCT00853762|474940904|FG002|Overall Study|Withdrawal by Subject|1|||
131905414|NCT00853762|474940905|FG003|Overall Study|Withdrawal by Subject|0|||
131905415|NCT00853762|474940902|FG000|Overall Study|Other|0|||
131905416|NCT00853762|474940903|FG001|Overall Study|Other|2|||
131905417|NCT00853762|474940904|FG002|Overall Study|Other|0|||
131905418|NCT00853762|474940905|FG003|Overall Study|Other|0|||
131905419|NCT00853762|474940902|FG000|Overall Study|Randomised but not Treated|0|||
131905420|NCT00853762|474940903|FG001|Overall Study|Randomised but not Treated|2|||
131905421|NCT00853762|474940904|FG002|Overall Study|Randomised but not Treated|2|||
131905422|NCT00853762|474940905|FG003|Overall Study|Randomised but not Treated|0|||
131905423|NCT02000921|474940906|FG000|Overall Study|Withdrawal by Subject|3|||
131905424|NCT02000921|474940907|FG001|Overall Study|Withdrawal by Subject|10|||
131905425|NCT02000921|474940908|FG002|Overall Study|Withdrawal by Subject|5|||
131905426|NCT02000921|474940906|FG000|Overall Study|Lost to Follow-up|2|||
131905427|NCT02000921|474940907|FG001|Overall Study|Lost to Follow-up|4|||
131905428|NCT02000921|474940908|FG002|Overall Study|Lost to Follow-up|5|||
131905429|NCT02000921|474940906|FG000|Overall Study|Physician Decision|0|||
131905430|NCT02000921|474940907|FG001|Overall Study|Physician Decision|2|||
131905431|NCT02000921|474940908|FG002|Overall Study|Physician Decision|0|||
131905432|NCT02051296|474940913|FG000|Overall Study|Lost to Follow-up|1|||
131905433|NCT02051296|474940914|FG001|Overall Study|Lost to Follow-up|2|||
131905434|NCT02051296|474940913|FG000|Overall Study|withdraw prior to treatment|7|||
131905435|NCT02051296|474940914|FG001|Overall Study|withdraw prior to treatment|7|||
131905436|NCT02631941|474940915|FG000|Overall Study|Physician Decision|0|||
131905437|NCT02631941|474940916|FG001|Overall Study|Physician Decision|1|||
131905438|NCT02631941|474940917|FG002|Overall Study|Physician Decision|0|||
131905439|NCT02631941|474940918|FG003|Overall Study|Physician Decision|0|||
131905440|NCT02631941|474940919|FG004|Overall Study|Physician Decision|0|||
131905441|NCT02631941|474940920|FG005|Overall Study|Physician Decision|0|||
131905442|NCT02631941|474940921|FG006|Overall Study|Physician Decision|0|||
131741631|NCT00884221|474331158|FG000|Overall Study|Adverse Event|6|||
131741632|NCT00884221|474331159|FG001|Overall Study|Adverse Event|3|||
131741633|NCT00884221|474331158|FG000|Overall Study|Protocol Violation|16|||
131741634|NCT00884221|474331159|FG001|Overall Study|Protocol Violation|13|||
131741635|NCT00884221|474331158|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
131905443|NCT02631941|474940922|FG007|Overall Study|Physician Decision|0|||
131905444|NCT02631941|474940923|FG008|Overall Study|Physician Decision|0|||
131905445|NCT02631941|474940924|FG009|Overall Study|Physician Decision|0|||
131905446|NCT02631941|474940915|FG000|Overall Study|Adverse Event|0|||
131905447|NCT02631941|474940916|FG001|Overall Study|Adverse Event|1|||
131905448|NCT02631941|474940917|FG002|Overall Study|Adverse Event|0|||
131905449|NCT02631941|474940918|FG003|Overall Study|Adverse Event|0|||
131905450|NCT02631941|474940919|FG004|Overall Study|Adverse Event|0|||
131905451|NCT02631941|474940920|FG005|Overall Study|Adverse Event|0|||
131741636|NCT00884221|474331159|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
131905452|NCT02631941|474940921|FG006|Overall Study|Adverse Event|0|||
131741637|NCT01975246|474331162|FG000|Overall Study|Adverse Event|2|||
131741638|NCT01975246|474331163|FG001|Overall Study|Adverse Event|1|||
131741639|NCT01975246|474331162|FG000|Overall Study|Lack of Efficacy|1|||
131741640|NCT01975246|474331163|FG001|Overall Study|Lack of Efficacy|0|||
131741641|NCT01975246|474331162|FG000|Overall Study|Protocol Violation|1|||
131741642|NCT01975246|474331163|FG001|Overall Study|Protocol Violation|0|||
131741643|NCT01975246|474331162|FG000|Overall Study|Other than stated|0|||
131741644|NCT01975246|474331163|FG001|Overall Study|Other than stated|1|||
131741645|NCT01263093|474331164|FG000|Washout|Physician Decision|1|||
131741646|NCT01263093|474331165|FG001|Washout|Physician Decision|0|||
131741647|NCT01263093|474331164|FG000|Period 2|Adverse Event|1|||
131741648|NCT01263093|474331165|FG001|Period 2|Adverse Event|0|||
131808387|NCT01597245|474582951|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131808388|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808389|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808390|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808391|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808392|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808393|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808394|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808395|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808396|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808397|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808398|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808399|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808400|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808401|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
131808402|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
131808403|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
131808404|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808405|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808406|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808407|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808408|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131808409|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808410|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808411|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808412|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808413|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808414|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808415|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808416|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808417|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808418|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808419|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808420|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808421|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808422|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
131808423|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
131808424|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
131808425|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808426|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808427|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808428|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808429|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131808430|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808431|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808432|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808433|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808434|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131905453|NCT02631941|474940922|FG007|Overall Study|Adverse Event|0|||
131741649|NCT00424346|474331166|FG000|Core Study|Adverse Event|5|||
131741650|NCT00424346|474331167|FG001|Core Study|Adverse Event|3|||
131741651|NCT00424346|474331168|FG002|Core Study|Adverse Event|1|||
131741652|NCT00424346|474331169|FG003|Core Study|Adverse Event|1|||
131741653|NCT00424346|474331166|FG000|Core Study|Abnormal Laboratory Values|0|||
131741654|NCT00424346|474331167|FG001|Core Study|Abnormal Laboratory Values|1|||
131741655|NCT00424346|474331168|FG002|Core Study|Abnormal Laboratory Values|0|||
131741656|NCT00424346|474331169|FG003|Core Study|Abnormal Laboratory Values|0|||
131741657|NCT00424346|474331166|FG000|Core Study|Lack of Efficacy|1|||
131741658|NCT00424346|474331167|FG001|Core Study|Lack of Efficacy|3|||
131741659|NCT00424346|474331168|FG002|Core Study|Lack of Efficacy|0|||
131741660|NCT00424346|474331169|FG003|Core Study|Lack of Efficacy|4|||
131741661|NCT00424346|474331166|FG000|Core Study|Withdrawal by Subject|1|||
131741662|NCT00424346|474331167|FG001|Core Study|Withdrawal by Subject|0|||
131741663|NCT00424346|474331168|FG002|Core Study|Withdrawal by Subject|0|||
131741664|NCT00424346|474331169|FG003|Core Study|Withdrawal by Subject|2|||
131741665|NCT00424346|474331166|FG000|Core Study|Lost to Follow-up|1|||
131808435|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808436|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808437|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808438|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808439|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808440|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808441|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808442|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808443|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808444|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
131808445|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
131808446|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808447|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808448|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808449|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808450|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131808451|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808452|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808453|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808454|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808455|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808456|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808457|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808458|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808459|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808460|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808461|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808462|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808463|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808464|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808465|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
131808466|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
131808467|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808468|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808469|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808470|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808471|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
131808472|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808473|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808474|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808475|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808476|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808477|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131741666|NCT00424346|474331167|FG001|Core Study|Lost to Follow-up|1|||
131741667|NCT00424346|474331168|FG002|Core Study|Lost to Follow-up|0|||
131741668|NCT00424346|474331169|FG003|Core Study|Lost to Follow-up|0|||
131741669|NCT00424346|474331166|FG000|Core Study|Administrative Problems|1|||
131741670|NCT00424346|474331167|FG001|Core Study|Administrative Problems|0|||
131741671|NCT00424346|474331168|FG002|Core Study|Administrative Problems|1|||
131741672|NCT00424346|474331169|FG003|Core Study|Administrative Problems|0|||
131741673|NCT00424346|474331166|FG000|Core Study|Protocol Violation|0|||
131741674|NCT00424346|474331167|FG001|Core Study|Protocol Violation|0|||
131741675|NCT00424346|474331168|FG002|Core Study|Protocol Violation|2|||
131741676|NCT00424346|474331169|FG003|Core Study|Protocol Violation|0|||
131741677|NCT00424346|474331166|FG000|Extension Phase|Adverse Event|0|||
131741678|NCT00424346|474331167|FG001|Extension Phase|Adverse Event|9|||
131741679|NCT00424346|474331168|FG002|Extension Phase|Adverse Event|5|||
131741680|NCT00424346|474331169|FG003|Extension Phase|Adverse Event|4|||
131741681|NCT00424346|474331166|FG000|Extension Phase|Lack of Efficacy|0|||
131741682|NCT00424346|474331167|FG001|Extension Phase|Lack of Efficacy|16|||
131741683|NCT00424346|474331168|FG002|Extension Phase|Lack of Efficacy|14|||
131741684|NCT00424346|474331169|FG003|Extension Phase|Lack of Efficacy|11|||
131741685|NCT00424346|474331166|FG000|Extension Phase|Withdrawal by Subject|0|||
131741686|NCT00424346|474331167|FG001|Extension Phase|Withdrawal by Subject|5|||
131741687|NCT00424346|474331168|FG002|Extension Phase|Withdrawal by Subject|3|||
131741688|NCT00424346|474331169|FG003|Extension Phase|Withdrawal by Subject|4|||
131741689|NCT00424346|474331166|FG000|Extension Phase|Lost to Follow-up|0|||
131741690|NCT00424346|474331167|FG001|Extension Phase|Lost to Follow-up|2|||
131741691|NCT00424346|474331168|FG002|Extension Phase|Lost to Follow-up|0|||
131741692|NCT00424346|474331169|FG003|Extension Phase|Lost to Follow-up|0|||
131741693|NCT00424346|474331166|FG000|Extension Phase|Administrative Problems|0|||
131741694|NCT00424346|474331167|FG001|Extension Phase|Administrative Problems|69|||
131741695|NCT00424346|474331168|FG002|Extension Phase|Administrative Problems|32|||
131741696|NCT00424346|474331169|FG003|Extension Phase|Administrative Problems|35|||
131741697|NCT00424346|474331166|FG000|Extension Phase|Death|0|||
131741698|NCT00424346|474331167|FG001|Extension Phase|Death|0|||
131741699|NCT00424346|474331168|FG002|Extension Phase|Death|0|||
131741700|NCT00424346|474331169|FG003|Extension Phase|Death|1|||
131741701|NCT00424346|474331166|FG000|Extension Phase|Protocol Violation|0|||
131741702|NCT00424346|474331167|FG001|Extension Phase|Protocol Violation|1|||
131741703|NCT00424346|474331168|FG002|Extension Phase|Protocol Violation|1|||
131741704|NCT00424346|474331169|FG003|Extension Phase|Protocol Violation|0|||
131741705|NCT00571519|474331170|FG000|Overall Study|Subject withdrew consent|0|||
131741706|NCT00571519|474331171|FG001|Overall Study|Subject withdrew consent|1|||
131741707|NCT00571519|474331172|FG002|Overall Study|Subject withdrew consent|0|||
131741708|NCT00571519|474331173|FG003|Overall Study|Subject withdrew consent|2|||
131741709|NCT00571519|474331174|FG004|Overall Study|Subject withdrew consent|1|||
131741710|NCT00571519|474331175|FG005|Overall Study|Subject withdrew consent|1|||
131741711|NCT00571519|474331176|FG006|Overall Study|Subject withdrew consent|2|||
131741712|NCT00571519|474331170|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
131741713|NCT00571519|474331171|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131741714|NCT00571519|474331172|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
131741715|NCT00571519|474331173|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
131741716|NCT00571519|474331174|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131741717|NCT00571519|474331175|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131741718|NCT00571519|474331176|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131741719|NCT00571519|474331170|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
131741720|NCT00571519|474331171|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
131741721|NCT00571519|474331172|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
131741722|NCT00571519|474331173|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
131741723|NCT00571519|474331174|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
131741724|NCT00571519|474331175|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
131741725|NCT00571519|474331176|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
131741726|NCT00571519|474331170|FG000|Overall Study|Termination of study by Sponsor|2|||
131741727|NCT00571519|474331171|FG001|Overall Study|Termination of study by Sponsor|7|||
131741728|NCT00571519|474331172|FG002|Overall Study|Termination of study by Sponsor|10|||
131741729|NCT00571519|474331173|FG003|Overall Study|Termination of study by Sponsor|24|||
131741730|NCT00571519|474331174|FG004|Overall Study|Termination of study by Sponsor|8|||
131741731|NCT00571519|474331175|FG005|Overall Study|Termination of study by Sponsor|9|||
131741732|NCT00571519|474331176|FG006|Overall Study|Termination of study by Sponsor|22|||
131741733|NCT00571519|474331170|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131808478|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131741734|NCT00571519|474331171|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131741735|NCT00571519|474331172|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
131741736|NCT00571519|474331173|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131741737|NCT00571519|474331174|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131808479|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808480|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131741738|NCT00571519|474331175|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131741739|NCT00571519|474331176|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131741740|NCT02499575|474331177|FG000|Overall Study|Protocol Violation|0|||
131741741|NCT02499575|474331178|FG001|Overall Study|Protocol Violation|1|||
131741742|NCT02658968|474331179|FG000|Received Rituximab|Adverse Event|0|||
131741743|NCT02658968|474331180|FG001|Received Rituximab|Adverse Event|0|||
131741744|NCT02658968|474331181|FG002|Received Rituximab|Adverse Event|0|||
131741745|NCT02658968|474331182|FG003|Received Rituximab|Adverse Event|0|||
131741746|NCT02658968|474331183|FG004|Received Rituximab|Adverse Event|1|||
131741747|NCT02658968|474331179|FG000|Received Rituximab|Progressive disease|0|||
131741748|NCT02658968|474331180|FG001|Received Rituximab|Progressive disease|0|||
131741749|NCT02658968|474331181|FG002|Received Rituximab|Progressive disease|0|||
131741750|NCT02658968|474331182|FG003|Received Rituximab|Progressive disease|0|||
131741751|NCT02658968|474331183|FG004|Received Rituximab|Progressive disease|1|||
131741752|NCT02658968|474331179|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
131741753|NCT02658968|474331180|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
131905454|NCT02631941|474940923|FG008|Overall Study|Adverse Event|0|||
131905455|NCT02631941|474940924|FG009|Overall Study|Adverse Event|0|||
131905456|NCT02631941|474940915|FG000|Overall Study|Withdrawal by Subject|0|||
131905457|NCT02631941|474940916|FG001|Overall Study|Withdrawal by Subject|0|||
131741754|NCT02658968|474331181|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
131741755|NCT02658968|474331182|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
131741756|NCT02658968|474331183|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
131905458|NCT02631941|474940917|FG002|Overall Study|Withdrawal by Subject|0|||
131905459|NCT02631941|474940918|FG003|Overall Study|Withdrawal by Subject|0|||
131741757|NCT02658968|474331179|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
131741758|NCT02658968|474331180|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
131741759|NCT02658968|474331181|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
131741760|NCT02658968|474331182|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
131741761|NCT02658968|474331183|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
131741762|NCT02658968|474331179|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
131741763|NCT02658968|474331180|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
131741764|NCT02658968|474331181|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
131741765|NCT02658968|474331182|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
131741766|NCT02658968|474331183|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
131741767|NCT02658968|474331179|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131741768|NCT02658968|474331180|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
131741769|NCT02658968|474331181|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131741770|NCT02658968|474331182|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131741771|NCT02658968|474331183|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131741772|NCT02658968|474331179|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
131741773|NCT02658968|474331180|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
131741774|NCT02658968|474331181|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
131741775|NCT02658968|474331182|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
131741776|NCT02658968|474331183|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
131741777|NCT00574119|474331184|FG000|Overall Study|Adverse Event|1|||
131741778|NCT00574119|474331184|FG000|Overall Study|Protocol Violation|1|||
131741779|NCT00574119|474331184|FG000|Overall Study|Withdrawal by Subject|1|||
131741780|NCT00574119|474331184|FG000|Overall Study|Physician Decision|1|||
131741781|NCT03039738|474331189|FG000|Overall Study|Incomplete data sets|54|||
131741782|NCT03039738|474331190|FG001|Overall Study|Incomplete data sets|0|||
131741783|NCT00912340|474331192|FG000|Overall Study|Adverse Event|2|||
131741784|NCT00912340|474331193|FG001|Overall Study|Adverse Event|4|||
131741785|NCT00912340|474331194|FG002|Overall Study|Adverse Event|0|||
131741786|NCT00912340|474331192|FG000|Overall Study|Protocol revised to remove arm|0|||
131741787|NCT00912340|474331193|FG001|Overall Study|Protocol revised to remove arm|0|||
131741788|NCT00912340|474331194|FG002|Overall Study|Protocol revised to remove arm|4|||
131741789|NCT01517412|474331197|FG000|Overall Study|Adverse Event|10|||
131741790|NCT01517412|474331198|FG001|Overall Study|Adverse Event|11|||
131741791|NCT01517412|474331197|FG000|Overall Study|Lack of Efficacy|10|||
131741792|NCT01517412|474331198|FG001|Overall Study|Lack of Efficacy|5|||
131741793|NCT01517412|474331197|FG000|Overall Study|Poor compliance to protocol|8|||
131741794|NCT01517412|474331198|FG001|Overall Study|Poor compliance to protocol|3|||
131741795|NCT01517412|474331197|FG000|Overall Study|Other than specified above|8|||
131741796|NCT01517412|474331198|FG001|Overall Study|Other than specified above|5|||
131905460|NCT02631941|474940919|FG004|Overall Study|Withdrawal by Subject|1|||
131905461|NCT02631941|474940920|FG005|Overall Study|Withdrawal by Subject|0|||
131905462|NCT02631941|474940921|FG006|Overall Study|Withdrawal by Subject|0|||
131905463|NCT02631941|474940922|FG007|Overall Study|Withdrawal by Subject|1|||
131905464|NCT02631941|474940923|FG008|Overall Study|Withdrawal by Subject|0|||
131905465|NCT02631941|474940924|FG009|Overall Study|Withdrawal by Subject|0|||
131905466|NCT02631941|474940915|FG000|Overall Study|Lost to Follow-up|0|||
131905467|NCT02631941|474940916|FG001|Overall Study|Lost to Follow-up|0|||
131905468|NCT02631941|474940917|FG002|Overall Study|Lost to Follow-up|0|||
131905469|NCT02631941|474940918|FG003|Overall Study|Lost to Follow-up|0|||
131905470|NCT02631941|474940919|FG004|Overall Study|Lost to Follow-up|0|||
131905471|NCT02631941|474940920|FG005|Overall Study|Lost to Follow-up|0|||
131905472|NCT02631941|474940921|FG006|Overall Study|Lost to Follow-up|0|||
131905473|NCT02631941|474940922|FG007|Overall Study|Lost to Follow-up|0|||
131905474|NCT02631941|474940923|FG008|Overall Study|Lost to Follow-up|1|||
131905475|NCT02631941|474940924|FG009|Overall Study|Lost to Follow-up|0|||
131905476|NCT02915835|474940925|FG000|Overall Study|Physician Decision|1|||
131905477|NCT02915835|474940926|FG001|Overall Study|Physician Decision|0|||
131905478|NCT02915835|474940925|FG000|Overall Study|Withdrawal by Subject|0|||
131905479|NCT02915835|474940926|FG001|Overall Study|Withdrawal by Subject|1|||
131905480|NCT03722576|474940927|FG000|Overall Study|Withdrawal by Subject|3|||
131905481|NCT03722576|474940927|FG000|Overall Study|Adverse Event|2|||
131905482|NCT03722576|474940927|FG000|Overall Study|Physician Decision|1|||
131905483|NCT03722576|474940927|FG000|Overall Study|Lost to Follow-up|1|||
131905484|NCT01408706|474940931|FG000|Overall Study|Physician Decision|1|||
131905485|NCT01408706|474940932|FG001|Overall Study|Physician Decision|0|||
131905486|NCT00113607|474940933|FG000|Overall Study|Adverse Event|40|||
131905487|NCT00113607|474940934|FG001|Overall Study|Adverse Event|71|||
131905488|NCT00113607|474940933|FG000|Overall Study|Death|8|||
131905489|NCT00113607|474940934|FG001|Overall Study|Death|8|||
131905490|NCT00113607|474940933|FG000|Overall Study|Withdrawal by Subject|50|||
131905491|NCT00113607|474940934|FG001|Overall Study|Withdrawal by Subject|58|||
131741797|NCT01253187|474331199|FG000|Period 2|Withdrawal by Subject|0|||
131741798|NCT01253187|474331200|FG001|Period 2|Withdrawal by Subject|0|||
131905492|NCT00113607|474940933|FG000|Overall Study|Lost to Follow-up|0|||
131905493|NCT00113607|474940934|FG001|Overall Study|Lost to Follow-up|2|||
131905494|NCT00113607|474940933|FG000|Overall Study|Disease Progression|180|||
131905495|NCT00113607|474940934|FG001|Overall Study|Disease Progression|142|||
131905496|NCT00113607|474940933|FG000|Overall Study|Complete Response (Confirmed)|14|||
131905497|NCT00113607|474940934|FG001|Overall Study|Complete Response (Confirmed)|24|||
131905498|NCT00113607|474940933|FG000|Overall Study|Other|43|||
131905499|NCT00113607|474940934|FG001|Overall Study|Other|32|||
131741799|NCT01253187|474331201|FG002|Period 2|Withdrawal by Subject|0|||
131741800|NCT01253187|474331202|FG003|Period 2|Withdrawal by Subject|0|||
131741801|NCT01253187|474331203|FG004|Period 2|Withdrawal by Subject|1|||
131741802|NCT01253187|474331204|FG005|Period 2|Withdrawal by Subject|0|||
131741803|NCT01253187|474331199|FG000|Period 3|Pregnancy|1|||
131741804|NCT01253187|474331200|FG001|Period 3|Pregnancy|0|||
131741805|NCT01253187|474331201|FG002|Period 3|Pregnancy|0|||
131741806|NCT01253187|474331202|FG003|Period 3|Pregnancy|0|||
131741807|NCT01253187|474331203|FG004|Period 3|Pregnancy|0|||
131741808|NCT01253187|474331204|FG005|Period 3|Pregnancy|0|||
131741809|NCT01253187|474331199|FG000|Period 3|difficulty with blood sampling|0|||
131741810|NCT01253187|474331200|FG001|Period 3|difficulty with blood sampling|1|||
131741811|NCT01253187|474331201|FG002|Period 3|difficulty with blood sampling|0|||
131741812|NCT01253187|474331202|FG003|Period 3|difficulty with blood sampling|0|||
131741813|NCT01253187|474331203|FG004|Period 3|difficulty with blood sampling|0|||
131741814|NCT01253187|474331204|FG005|Period 3|difficulty with blood sampling|0|||
131741815|NCT01253187|474331199|FG000|Period 3|non-compliance|0|||
131741816|NCT01253187|474331200|FG001|Period 3|non-compliance|0|||
131741817|NCT01253187|474331201|FG002|Period 3|non-compliance|0|||
131741818|NCT01253187|474331202|FG003|Period 3|non-compliance|0|||
131741819|NCT01253187|474331203|FG004|Period 3|non-compliance|1|||
131741820|NCT01253187|474331204|FG005|Period 3|non-compliance|0|||
131905500|NCT00909844|474940935|FG000|Overall Study|Adverse Event|1|||
131905501|NCT00909844|474940935|FG000|Overall Study|Withdrawal by Subject|1|||
131905502|NCT00909844|474940935|FG000|Overall Study|Lost to Follow-up|2|||
131905503|NCT01064479|474940936|FG000|Overall Study|Death|10|||
131741821|NCT01956240|474331210|FG000|Overall Study|Lost to Follow-up|6|||
131905504|NCT01064479|474940937|FG001|Overall Study|Death|11|||
131741822|NCT01956240|474331211|FG001|Overall Study|Lost to Follow-up|20|||
131741823|NCT01956240|474331210|FG000|Overall Study|Adverse Event|17|||
131741824|NCT01956240|474331211|FG001|Overall Study|Adverse Event|4|||
131905505|NCT01064479|474940936|FG000|Overall Study|Withdrawal by Subject|2|||
131905506|NCT01064479|474940937|FG001|Overall Study|Withdrawal by Subject|2|||
131741825|NCT00600028|474331214|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131741826|NCT00600028|474331215|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
131741827|NCT00600028|474331214|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
131741828|NCT00600028|474331215|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
131741829|NCT00600028|474331214|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
131741830|NCT00600028|474331215|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
131741831|NCT03172481|474331216|FG000|Double-blind|Withdrawal by Subject|1|||
131741832|NCT03172481|474331217|FG001|Double-blind|Withdrawal by Subject|0|||
131741833|NCT02716194|474331218|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
131741834|NCT02716194|474331219|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
131741835|NCT02716194|474331220|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
131741836|NCT01957709|474331224|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
131741837|NCT01610076|474331225|FG000|Overall Study|Technical issue with video|0|||
131741838|NCT01610076|474331226|FG001|Overall Study|Technical issue with video|1|||
131741839|NCT01610076|474331225|FG000|Overall Study|Lost to Follow-up|3|||
131741840|NCT01610076|474331226|FG001|Overall Study|Lost to Follow-up|4|||
131741841|NCT02899377|474331229|FG000|Overall Study|Adverse Event|1|||
131741842|NCT02899377|474331230|FG001|Overall Study|Adverse Event|0|||
131741843|NCT00469209|474331232|FG000|Overall Study|Adverse Event|1|||
131741844|NCT00469209|474331233|FG001|Overall Study|Adverse Event|0|||
131741845|NCT00469209|474331234|FG002|Overall Study|Adverse Event|1|||
131741846|NCT02022033|474331235|FG000|Overall Study|Physician Decision|1|||
131741847|NCT01879319|474331238|FG000|Overall Study|Withdrawal by Subject|1|||
131741848|NCT01879319|474331239|FG001|Overall Study|Withdrawal by Subject|0|||
131741849|NCT01879319|474331238|FG000|Overall Study|Lost to Follow-up|1|||
131741850|NCT01879319|474331239|FG001|Overall Study|Lost to Follow-up|5|||
131741851|NCT01360762|474331240|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
131741852|NCT01360762|474331240|FG000|Main Study Period (12-month Treatment)|Death|5|||
131741853|NCT01360762|474331240|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
131741854|NCT01360762|474331240|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
131741855|NCT01360762|474331240|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
131741856|NCT01360762|474331240|FG000|Whole Study Period|Lost to Follow-up|10|||
131741857|NCT01360762|474331240|FG000|Whole Study Period|Death|7|||
131741858|NCT01360762|474331240|FG000|Whole Study Period|Patient relapsed|18|||
131741859|NCT01360762|474331240|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
131741860|NCT01103778|474331241|FG000|Overall Study|Lost to Follow-up|1|||
131741861|NCT01103778|474331241|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
131741862|NCT01103778|474331241|FG000|Overall Study|Screen failure|1|||
131741863|NCT04724733|474331242|FG000|Overall Study|Lost to Follow-up|1|||
131741864|NCT04724733|474331243|FG001|Overall Study|Lost to Follow-up|1|||
131741865|NCT04724733|474331244|FG002|Overall Study|Lost to Follow-up|1|||
131741866|NCT03986190|474331245|FG000|Overall Study|Withdrawal by Subject|12|||
131741867|NCT03986190|474331246|FG001|Overall Study|Withdrawal by Subject|0|||
131741868|NCT04511819|474331247|FG000|Overall Study|Non-compliance with study drug|5|||
131741869|NCT04511819|474331248|FG001|Overall Study|Non-compliance with study drug|1|||
131741870|NCT04511819|474331247|FG000|Overall Study|Withdrawal by Subject|0|||
131741871|NCT04511819|474331248|FG001|Overall Study|Withdrawal by Subject|3|||
131741872|NCT04511819|474331247|FG000|Overall Study|Adverse Event|0|||
131741873|NCT04511819|474331248|FG001|Overall Study|Adverse Event|1|||
131741874|NCT04511819|474331247|FG000|Overall Study|Protocol deviation|1|||
131741875|NCT04511819|474331248|FG001|Overall Study|Protocol deviation|0|||
131741876|NCT00084929|474331249|FG000|Overall Study|ineligible - medical contraindication|1|||
131741877|NCT00084929|474331249|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
131741878|NCT00084929|474331249|FG000|Overall Study|Ineligible - Medical history|6|||
131741879|NCT00084929|474331249|FG000|Overall Study|Withdrawal by Subject|10|||
131741880|NCT00084929|474331249|FG000|Overall Study|Missing/incomplete CTC exam|9|||
131741881|NCT00084929|474331249|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
131741882|NCT00844649|474331250|FG000|Overall Study|Progressive Disease|196|||
131741883|NCT00844649|474331251|FG001|Overall Study|Progressive Disease|245|||
131741884|NCT00844649|474331250|FG000|Overall Study|Adverse Event|128|||
131741885|NCT00844649|474331251|FG001|Overall Study|Adverse Event|73|||
131741886|NCT00844649|474331250|FG000|Overall Study|Physician Decision|25|||
131741887|NCT00844649|474331251|FG001|Overall Study|Physician Decision|18|||
131741888|NCT00844649|474331250|FG000|Overall Study|Protocol Violation|10|||
131741889|NCT00844649|474331251|FG001|Overall Study|Protocol Violation|6|||
131905507|NCT01064479|474940936|FG000|Overall Study|Disease progression|1|||
131741890|NCT00844649|474331250|FG000|Overall Study|Withdrawal by Subject|28|||
131741891|NCT00844649|474331251|FG001|Overall Study|Withdrawal by Subject|39|||
131741892|NCT00844649|474331250|FG000|Overall Study|Other|7|||
131741893|NCT00844649|474331251|FG001|Overall Study|Other|10|||
131741894|NCT00844649|474331250|FG000|Overall Study|Withdrew prior to starting treatment|11|||
131741895|NCT00844649|474331251|FG001|Overall Study|Withdrew prior to starting treatment|27|||
131741896|NCT00664209|474331252|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
131905508|NCT01064479|474940937|FG001|Overall Study|Disease progression|1|||
131741897|NCT00664209|474331252|FG000|Study Treatment Period|Physician Decision|4|||
131741898|NCT00664209|474331252|FG000|Study Treatment Period|Withdrawal by Subject|2|||
131741899|NCT00065442|474331263|FG000|Overall Study|Lost to Follow-up|1|||
131741900|NCT00065442|474331264|FG001|Overall Study|Lost to Follow-up|1|||
131905509|NCT01064479|474940936|FG000|Overall Study|Toxicity|1|||
131905510|NCT01064479|474940937|FG001|Overall Study|Toxicity|1|||
131905511|NCT01064479|474940936|FG000|Overall Study|Other|1|||
131905512|NCT01064479|474940937|FG001|Overall Study|Other|2|||
131741901|NCT00065442|474331263|FG000|Overall Study|Death|121|||
131741902|NCT00065442|474331264|FG001|Overall Study|Death|210|||
131741903|NCT00065442|474331263|FG000|Overall Study|Withdrawal by Subject|3|||
131741904|NCT00065442|474331264|FG001|Overall Study|Withdrawal by Subject|9|||
131741905|NCT01594333|474331265|FG000|Overall Study|Death|96|||
131741906|NCT01594333|474331266|FG001|Overall Study|Death|83|||
131741907|NCT01594333|474331265|FG000|Overall Study|Lost to Follow-up|5|||
131741908|NCT01594333|474331266|FG001|Overall Study|Lost to Follow-up|5|||
131741909|NCT01594333|474331265|FG000|Overall Study|Withdrawal by Subject|60|||
131741910|NCT01594333|474331266|FG001|Overall Study|Withdrawal by Subject|63|||
131741911|NCT00589979|474331267|FG000|Run-In Period|Adverse Event|5|||
131741912|NCT00589979|474331268|FG001|Run-In Period|Adverse Event|0|||
131741913|NCT00589979|474331269|FG002|Run-In Period|Adverse Event|0|||
131741914|NCT00589979|474331267|FG000|Run-In Period|Protocol Violation|3|||
131741915|NCT00589979|474331268|FG001|Run-In Period|Protocol Violation|0|||
131741916|NCT00589979|474331269|FG002|Run-In Period|Protocol Violation|0|||
131741917|NCT00589979|474331267|FG000|Run-In Period|Did not qualify for randomization|54|||
131741918|NCT00589979|474331268|FG001|Run-In Period|Did not qualify for randomization|0|||
131741919|NCT00589979|474331269|FG002|Run-In Period|Did not qualify for randomization|0|||
131741920|NCT00589979|474331267|FG000|Run-In Period|Withdrawal by Subject|10|||
131741921|NCT00589979|474331268|FG001|Run-In Period|Withdrawal by Subject|0|||
131741922|NCT00589979|474331269|FG002|Run-In Period|Withdrawal by Subject|0|||
131741923|NCT00589979|474331267|FG000|Run-In Period|Informed Consent Withdrawn|4|||
131741924|NCT00589979|474331268|FG001|Run-In Period|Informed Consent Withdrawn|0|||
131741925|NCT00589979|474331269|FG002|Run-In Period|Informed Consent Withdrawn|0|||
131741926|NCT00589979|474331267|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
131741927|NCT00589979|474331268|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
131741928|NCT00589979|474331269|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
131741929|NCT00589979|474331267|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
131741930|NCT00589979|474331268|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
131741931|NCT00589979|474331269|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
131741932|NCT00589979|474331267|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
131741933|NCT00589979|474331268|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
131741934|NCT00589979|474331269|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
131741935|NCT00589979|474331267|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
131741936|NCT00589979|474331268|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
131741937|NCT00589979|474331269|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
131741938|NCT00589979|474331267|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
131741939|NCT00589979|474331268|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
131741940|NCT00589979|474331269|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
131741941|NCT00589979|474331267|FG000|Double-Blind Treatment Period 2|Other|0|||
131741942|NCT00589979|474331268|FG001|Double-Blind Treatment Period 2|Other|0|||
131741943|NCT00589979|474331269|FG002|Double-Blind Treatment Period 2|Other|1|||
131741944|NCT00589979|474331267|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
131741945|NCT00589979|474331268|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
131741946|NCT00589979|474331269|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
131741947|NCT00589979|474331267|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
131741948|NCT00589979|474331268|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
131741949|NCT00589979|474331269|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
131741950|NCT00712322|474331270|FG000|Overall Study|Protocol deviation|0|||
131741951|NCT00712322|474331271|FG001|Overall Study|Protocol deviation|1|||
131741952|NCT00712322|474331272|FG002|Overall Study|Protocol deviation|0|||
131741953|NCT02670330|474331274|FG000|Overall Study|Protocol Deviation|1|||
131741954|NCT02670330|474331275|FG001|Overall Study|Protocol Deviation|0|||
131741955|NCT02670330|474331274|FG000|Overall Study|Study Terminated By Sponsor|36|||
131741956|NCT02670330|474331275|FG001|Overall Study|Study Terminated By Sponsor|43|||
131741957|NCT02670330|474331274|FG000|Overall Study|Adverse Event|1|||
131741958|NCT02670330|474331275|FG001|Overall Study|Adverse Event|3|||
131905513|NCT00780975|474940946|FG000|Overall Study|Progressive disease|3|||
131905514|NCT00780975|474940946|FG000|Overall Study|Toxicity|5|||
131741959|NCT02670330|474331274|FG000|Overall Study|Withdrawal by Subject|34|||
131741960|NCT02670330|474331275|FG001|Overall Study|Withdrawal by Subject|29|||
131741961|NCT02670330|474331274|FG000|Overall Study|Lost to Follow-up|3|||
131741962|NCT02670330|474331275|FG001|Overall Study|Lost to Follow-up|2|||
131741963|NCT02180217|474331278|FG000|Overall Study|Adverse Event|3|||
131741964|NCT02180217|474331279|FG001|Overall Study|Adverse Event|2|||
131741965|NCT02180217|474331280|FG002|Overall Study|Adverse Event|22|||
131741966|NCT02180217|474331278|FG000|Overall Study|Death|1|||
131741967|NCT02180217|474331279|FG001|Overall Study|Death|1|||
131905515|NCT01939314|474940949|FG000|Overall Study|Withdrawal by Subject|3|||
131905516|NCT01939314|474940950|FG001|Overall Study|Withdrawal by Subject|1|||
131905517|NCT01939314|474940949|FG000|Overall Study|Protocol Violation|1|||
131905518|NCT01939314|474940950|FG001|Overall Study|Protocol Violation|0|||
131905519|NCT01939314|474940949|FG000|Overall Study|Pregnancy|0|||
131905520|NCT01939314|474940950|FG001|Overall Study|Pregnancy|1|||
131905521|NCT01939314|474940949|FG000|Overall Study|Lost to Follow-up|5|||
131905522|NCT01939314|474940950|FG001|Overall Study|Lost to Follow-up|6|||
131905523|NCT00969228|474940952|FG000|Overall Study|Adverse Event|1|||
131905524|NCT00969228|474940953|FG001|Overall Study|Adverse Event|0|||
131905525|NCT00969228|474940952|FG000|Overall Study|Withdrawal by Subject|4|||
131905526|NCT00969228|474940953|FG001|Overall Study|Withdrawal by Subject|0|||
131905527|NCT00969228|474940952|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
131905528|NCT00969228|474940953|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
131905529|NCT02563899|474940954|FG000|Overall Study|Protocol Violation|1|||
131741968|NCT02180217|474331280|FG002|Overall Study|Death|0|||
131741969|NCT02180217|474331278|FG000|Overall Study|Withdrawal by Subject|1|||
131741970|NCT02180217|474331279|FG001|Overall Study|Withdrawal by Subject|1|||
131741971|NCT02180217|474331280|FG002|Overall Study|Withdrawal by Subject|4|||
131741972|NCT02180217|474331278|FG000|Overall Study|Subject/Guardian decision|5|||
131741973|NCT02180217|474331279|FG001|Overall Study|Subject/Guardian decision|3|||
131741974|NCT02180217|474331280|FG002|Overall Study|Subject/Guardian decision|6|||
131741975|NCT02180217|474331278|FG000|Overall Study|Physician Decision|1|||
131741976|NCT02180217|474331279|FG001|Overall Study|Physician Decision|1|||
131741977|NCT02180217|474331280|FG002|Overall Study|Physician Decision|6|||
131741978|NCT02180217|474331278|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131741979|NCT02180217|474331279|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131741980|NCT02180217|474331280|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131741981|NCT00878215|474331281|FG000|Overall Study|Determined to be ineligible|0|||
131741982|NCT00878215|474331282|FG001|Overall Study|Determined to be ineligible|10|||
131741983|NCT00878215|474331283|FG002|Overall Study|Determined to be ineligible|0|||
131741984|NCT00878215|474331284|FG003|Overall Study|Determined to be ineligible|0|||
131741985|NCT00738374|474331285|FG000|Induction Treatment Phase|Adverse Event|14|||
131741986|NCT00738374|474331286|FG001|Induction Treatment Phase|Adverse Event|0|||
131741987|NCT00738374|474331287|FG002|Induction Treatment Phase|Adverse Event|0|||
131741988|NCT00738374|474331288|FG003|Induction Treatment Phase|Adverse Event|0|||
131741989|NCT00738374|474331285|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
131741990|NCT00738374|474331286|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
131741991|NCT00738374|474331287|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
131741992|NCT00738374|474331288|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
131741993|NCT00738374|474331285|FG000|Induction Treatment Phase|Physician Decision|2|||
131741994|NCT00738374|474331286|FG001|Induction Treatment Phase|Physician Decision|0|||
131741995|NCT00738374|474331287|FG002|Induction Treatment Phase|Physician Decision|0|||
131741996|NCT00738374|474331288|FG003|Induction Treatment Phase|Physician Decision|0|||
131741997|NCT00738374|474331285|FG000|Induction Treatment Phase|Protocol Violation|2|||
131741998|NCT00738374|474331286|FG001|Induction Treatment Phase|Protocol Violation|0|||
131741999|NCT00738374|474331287|FG002|Induction Treatment Phase|Protocol Violation|0|||
131742000|NCT00738374|474331288|FG003|Induction Treatment Phase|Protocol Violation|0|||
131742001|NCT00738374|474331285|FG000|Induction Treatment Phase|Non-compliance|1|||
131742002|NCT00738374|474331286|FG001|Induction Treatment Phase|Non-compliance|0|||
131742003|NCT00738374|474331287|FG002|Induction Treatment Phase|Non-compliance|0|||
131742004|NCT00738374|474331288|FG003|Induction Treatment Phase|Non-compliance|0|||
131742005|NCT00738374|474331285|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
131742006|NCT00738374|474331286|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
131742007|NCT00738374|474331287|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
131742008|NCT00738374|474331288|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
131742009|NCT00738374|474331285|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
131742010|NCT00738374|474331286|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
131742011|NCT00738374|474331287|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
131742012|NCT00738374|474331288|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
131905530|NCT02563899|474940955|FG001|Overall Study|Protocol Violation|0|||
131905531|NCT02563899|474940956|FG002|Overall Study|Protocol Violation|0|||
131742013|NCT00738374|474331285|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
131742014|NCT00738374|474331286|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
131742015|NCT00738374|474331287|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
131742016|NCT00738374|474331288|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
131742017|NCT00738374|474331285|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
131742018|NCT00738374|474331286|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
131742019|NCT00738374|474331287|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
131742020|NCT00738374|474331288|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
131742021|NCT00738374|474331285|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
131742022|NCT00738374|474331286|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
131742023|NCT00738374|474331287|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
131742024|NCT00738374|474331288|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
131742025|NCT00738374|474331285|FG000|Maintenance Treatment/Observation Phase|Other|0|||
131742026|NCT00738374|474331286|FG001|Maintenance Treatment/Observation Phase|Other|1|||
131742027|NCT00738374|474331287|FG002|Maintenance Treatment/Observation Phase|Other|0|||
131742028|NCT00738374|474331288|FG003|Maintenance Treatment/Observation Phase|Other|0|||
131742029|NCT03334396|474331289|FG000|Overall Study|Adverse Event|1|||
131742030|NCT03334396|474331290|FG001|Overall Study|Adverse Event|0|||
131742031|NCT03334396|474331291|FG002|Overall Study|Adverse Event|1|||
131742032|NCT03334396|474331292|FG003|Overall Study|Adverse Event|0|||
131742033|NCT03334396|474331293|FG004|Overall Study|Adverse Event|0|||
131742034|NCT03334396|474331294|FG005|Overall Study|Adverse Event|0|||
131742035|NCT03334396|474331295|FG006|Overall Study|Adverse Event|0|||
131742036|NCT03334396|474331296|FG007|Overall Study|Adverse Event|0|||
131742037|NCT03334396|474331289|FG000|Overall Study|Lack of Efficacy|10|||
131742038|NCT03334396|474331290|FG001|Overall Study|Lack of Efficacy|4|||
131742039|NCT03334396|474331291|FG002|Overall Study|Lack of Efficacy|1|||
131742040|NCT03334396|474331292|FG003|Overall Study|Lack of Efficacy|3|||
131742041|NCT03334396|474331293|FG004|Overall Study|Lack of Efficacy|1|||
131742042|NCT03334396|474331294|FG005|Overall Study|Lack of Efficacy|0|||
131742043|NCT03334396|474331295|FG006|Overall Study|Lack of Efficacy|0|||
131742044|NCT03334396|474331296|FG007|Overall Study|Lack of Efficacy|1|||
131742045|NCT03334396|474331289|FG000|Overall Study|Lost to Follow-up|0|||
131742046|NCT03334396|474331290|FG001|Overall Study|Lost to Follow-up|0|||
131742047|NCT03334396|474331291|FG002|Overall Study|Lost to Follow-up|1|||
131742048|NCT03334396|474331292|FG003|Overall Study|Lost to Follow-up|0|||
131742049|NCT03334396|474331293|FG004|Overall Study|Lost to Follow-up|0|||
131742050|NCT03334396|474331294|FG005|Overall Study|Lost to Follow-up|0|||
131742051|NCT03334396|474331295|FG006|Overall Study|Lost to Follow-up|1|||
131742052|NCT03334396|474331296|FG007|Overall Study|Lost to Follow-up|0|||
131742053|NCT03334396|474331289|FG000|Overall Study|Physician Decision|1|||
131742054|NCT03334396|474331290|FG001|Overall Study|Physician Decision|0|||
131742055|NCT03334396|474331291|FG002|Overall Study|Physician Decision|0|||
131742056|NCT03334396|474331292|FG003|Overall Study|Physician Decision|0|||
131742057|NCT03334396|474331293|FG004|Overall Study|Physician Decision|0|||
131742058|NCT03334396|474331294|FG005|Overall Study|Physician Decision|0|||
131742059|NCT03334396|474331295|FG006|Overall Study|Physician Decision|0|||
131742060|NCT03334396|474331296|FG007|Overall Study|Physician Decision|0|||
131742061|NCT03334396|474331289|FG000|Overall Study|Withdrawal by Subject|10|||
131742062|NCT03334396|474331290|FG001|Overall Study|Withdrawal by Subject|5|||
131742063|NCT03334396|474331291|FG002|Overall Study|Withdrawal by Subject|7|||
131742064|NCT03334396|474331292|FG003|Overall Study|Withdrawal by Subject|2|||
131742065|NCT03334396|474331293|FG004|Overall Study|Withdrawal by Subject|2|||
131742066|NCT03334396|474331294|FG005|Overall Study|Withdrawal by Subject|1|||
131742067|NCT03334396|474331295|FG006|Overall Study|Withdrawal by Subject|2|||
131742068|NCT03334396|474331296|FG007|Overall Study|Withdrawal by Subject|0|||
131742069|NCT03334396|474331289|FG000|Overall Study|Pregnancy|0|||
131742070|NCT03334396|474331290|FG001|Overall Study|Pregnancy|1|||
131742071|NCT03334396|474331291|FG002|Overall Study|Pregnancy|0|||
131742072|NCT03334396|474331292|FG003|Overall Study|Pregnancy|0|||
131742073|NCT03334396|474331293|FG004|Overall Study|Pregnancy|0|||
131742074|NCT03334396|474331294|FG005|Overall Study|Pregnancy|0|||
131742075|NCT03334396|474331295|FG006|Overall Study|Pregnancy|0|||
131742076|NCT03334396|474331296|FG007|Overall Study|Pregnancy|0|||
131742077|NCT03334396|474331289|FG000|Overall Study|Ineligible|0|||
131742078|NCT03334396|474331290|FG001|Overall Study|Ineligible|1|||
131742079|NCT03334396|474331291|FG002|Overall Study|Ineligible|0|||
131742080|NCT03334396|474331292|FG003|Overall Study|Ineligible|0|||
131742081|NCT03334396|474331293|FG004|Overall Study|Ineligible|0|||
131742082|NCT03334396|474331294|FG005|Overall Study|Ineligible|0|||
131742083|NCT03334396|474331295|FG006|Overall Study|Ineligible|0|||
131742084|NCT03334396|474331296|FG007|Overall Study|Ineligible|0|||
131742085|NCT03334396|474331289|FG000|Overall Study|Started New Job|1|||
131742086|NCT03334396|474331290|FG001|Overall Study|Started New Job|0|||
131742087|NCT03334396|474331291|FG002|Overall Study|Started New Job|0|||
131742088|NCT03334396|474331292|FG003|Overall Study|Started New Job|0|||
131742089|NCT03334396|474331293|FG004|Overall Study|Started New Job|0|||
131742090|NCT03334396|474331294|FG005|Overall Study|Started New Job|0|||
131742091|NCT03334396|474331295|FG006|Overall Study|Started New Job|0|||
131742092|NCT03334396|474331296|FG007|Overall Study|Started New Job|0|||
131742093|NCT01969799|474331297|FG000|Overall Study|Adverse Event|0|||
131742094|NCT01969799|474331298|FG001|Overall Study|Adverse Event|1|||
131742095|NCT01969799|474331297|FG000|Overall Study|Death|16|||
131742096|NCT01969799|474331298|FG001|Overall Study|Death|11|||
131742097|NCT01969799|474331297|FG000|Overall Study|Lost to Follow-up|0|||
131742098|NCT01969799|474331298|FG001|Overall Study|Lost to Follow-up|2|||
131742099|NCT01969799|474331297|FG000|Overall Study|Physician Decision|1|||
131742100|NCT01969799|474331298|FG001|Overall Study|Physician Decision|0|||
131742101|NCT03337139|474331301|FG000|Phase I|Withdrawal by Subject|10|||
131742102|NCT03337139|474331302|FG001|Phase I|Withdrawal by Subject|0|||
131742103|NCT00077376|474331303|FG000|Overall Study|Adverse Event|8|||
131742104|NCT00077376|474331303|FG000|Overall Study|Withdrawal by Subject|2|||
131742105|NCT00077376|474331303|FG000|Overall Study|Death|1|||
131742106|NCT00077376|474331303|FG000|Overall Study|Physician Decision|1|||
131742107|NCT00077376|474331303|FG000|Overall Study|Alternative therapy|5|||
131742108|NCT00077376|474331303|FG000|Overall Study|Complicating disease|1|||
131742109|NCT00077376|474331303|FG000|Overall Study|Still on treatment|1|||
131742110|NCT00077376|474331303|FG000|Overall Study|Symptomatic deterioration|1|||
131742111|NCT00077376|474331303|FG000|Overall Study|Surgery|1|||
131742112|NCT00077376|474331303|FG000|Overall Study|Insurance ran out|1|||
131742113|NCT03288493|474331304|FG000|Overall Study|Withdrawal by Subject|4|||
131742114|NCT03288493|474331305|FG001|Overall Study|Withdrawal by Subject|0|||
131742115|NCT03288493|474331306|FG002|Overall Study|Withdrawal by Subject|0|||
131742116|NCT03288493|474331307|FG003|Overall Study|Withdrawal by Subject|0|||
131742117|NCT03288493|474331308|FG004|Overall Study|Withdrawal by Subject|0|||
131742118|NCT03288493|474331309|FG005|Overall Study|Withdrawal by Subject|2|||
131742119|NCT03288493|474331310|FG006|Overall Study|Withdrawal by Subject|0|||
131742120|NCT03288493|474331304|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
131742121|NCT03288493|474331305|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
131742122|NCT03288493|474331306|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
131742123|NCT03288493|474331307|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
131742124|NCT03288493|474331308|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
131742125|NCT03288493|474331309|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
131742126|NCT03288493|474331310|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
131742127|NCT03288493|474331304|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
131742128|NCT03288493|474331305|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131742129|NCT03288493|474331306|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131742130|NCT03288493|474331307|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
131742131|NCT03288493|474331308|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131742132|NCT03288493|474331309|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
131742133|NCT03288493|474331310|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131742134|NCT03288493|474331304|FG000|Overall Study|Death|2|||
131742135|NCT03288493|474331305|FG001|Overall Study|Death|0|||
131742136|NCT03288493|474331306|FG002|Overall Study|Death|0|||
131742137|NCT03288493|474331307|FG003|Overall Study|Death|0|||
131742138|NCT03288493|474331308|FG004|Overall Study|Death|0|||
131742139|NCT03288493|474331309|FG005|Overall Study|Death|0|||
131742140|NCT03288493|474331310|FG006|Overall Study|Death|0|||
131742141|NCT03288493|474331304|FG000|Overall Study|other reason not listed above|2|||
131742142|NCT03288493|474331305|FG001|Overall Study|other reason not listed above|0|||
131742143|NCT03288493|474331306|FG002|Overall Study|other reason not listed above|0|||
131742144|NCT03288493|474331307|FG003|Overall Study|other reason not listed above|0|||
131742145|NCT03288493|474331308|FG004|Overall Study|other reason not listed above|0|||
131742146|NCT03288493|474331309|FG005|Overall Study|other reason not listed above|0|||
131742147|NCT03288493|474331310|FG006|Overall Study|other reason not listed above|0|||
131742148|NCT03784027|474331311|FG000|Period 1|Withdrawal by Subject|0|||
131742149|NCT03784027|474331312|FG001|Period 1|Withdrawal by Subject|1|||
131742150|NCT04656418|474333139|FG000|Overall Study|Withdrawal by Subject|1|||
131742151|NCT04656418|474333140|FG001|Overall Study|Withdrawal by Subject|3|||
131742152|NCT03097614|474333141|FG000|Overall Study|Adverse Event|3|||
131742153|NCT01149343|474333148|FG000|Overall Study|Withdrawal by Subject|1|||
131742154|NCT01149343|474333149|FG001|Overall Study|Withdrawal by Subject|1|||
131742155|NCT01149343|474333150|FG002|Overall Study|Withdrawal by Subject|1|||
131742156|NCT01149343|474333151|FG003|Overall Study|Withdrawal by Subject|5|||
131742157|NCT01149343|474333148|FG000|Overall Study|Death|10|||
131742158|NCT01149343|474333149|FG001|Overall Study|Death|13|||
131742159|NCT01149343|474333150|FG002|Overall Study|Death|18|||
131742160|NCT01149343|474333151|FG003|Overall Study|Death|18|||
131742161|NCT01149343|474333148|FG000|Overall Study|Lost to Follow-up|1|||
131742162|NCT01149343|474333149|FG001|Overall Study|Lost to Follow-up|0|||
131742163|NCT01149343|474333150|FG002|Overall Study|Lost to Follow-up|0|||
131742164|NCT01149343|474333151|FG003|Overall Study|Lost to Follow-up|1|||
131742165|NCT01149343|474333148|FG000|Overall Study|Other|8|||
131742166|NCT01149343|474333149|FG001|Overall Study|Other|10|||
131742167|NCT01149343|474333150|FG002|Overall Study|Other|2|||
131742168|NCT01149343|474333151|FG003|Overall Study|Other|14|||
131742169|NCT01149343|474333148|FG000|Overall Study|Sponsor study termination|0|||
131742170|NCT01149343|474333149|FG001|Overall Study|Sponsor study termination|0|||
131742171|NCT01149343|474333150|FG002|Overall Study|Sponsor study termination|0|||
131742172|NCT01149343|474333151|FG003|Overall Study|Sponsor study termination|2|||
131742173|NCT01149343|474333148|FG000|Overall Study|Recurrence / Progressive disease|0|||
131742174|NCT01149343|474333149|FG001|Overall Study|Recurrence / Progressive disease|0|||
131742175|NCT01149343|474333150|FG002|Overall Study|Recurrence / Progressive disease|1|||
131742176|NCT01149343|474333151|FG003|Overall Study|Recurrence / Progressive disease|0|||
131742177|NCT01925612|474333152|FG000|Overall Study|Progressive Disease|1|||
131742178|NCT01925612|474333153|FG001|Overall Study|Progressive Disease|1|||
131742179|NCT01925612|474333154|FG002|Overall Study|Progressive Disease|1|||
131742180|NCT01925612|474333155|FG003|Overall Study|Progressive Disease|0|||
131742181|NCT01925612|474333156|FG004|Overall Study|Progressive Disease|0|||
131742182|NCT01925612|474333152|FG000|Overall Study|Adverse Event|3|||
131742183|NCT01925612|474333153|FG001|Overall Study|Adverse Event|3|||
131742184|NCT01925612|474333154|FG002|Overall Study|Adverse Event|0|||
131742185|NCT01925612|474333155|FG003|Overall Study|Adverse Event|1|||
131742186|NCT01925612|474333156|FG004|Overall Study|Adverse Event|2|||
131742187|NCT01093755|474333160|FG000|Overall Study|Withdrawal by Subject|3|||
131742188|NCT01093755|474333161|FG001|Overall Study|Withdrawal by Subject|4|||
131742189|NCT00225147|474333162|FG000|Open-label Phase|Lost to Follow-up|0|||
131742190|NCT00225147|474333163|FG001|Open-label Phase|Lost to Follow-up|0|||
131742191|NCT00225147|474333164|FG002|Open-label Phase|Lost to Follow-up|0|||
131742192|NCT00225147|474333165|FG003|Open-label Phase|Lost to Follow-up|4|||
131742193|NCT00225147|474333162|FG000|Open-label Phase|Withdrawal by Subject|0|||
131742194|NCT00225147|474333163|FG001|Open-label Phase|Withdrawal by Subject|0|||
131742195|NCT00225147|474333164|FG002|Open-label Phase|Withdrawal by Subject|0|||
131742196|NCT00225147|474333165|FG003|Open-label Phase|Withdrawal by Subject|6|||
131742197|NCT00868166|474333169|FG000|Overall Study|Death|58|||
131742198|NCT00868166|474333170|FG001|Overall Study|Death|65|||
131742199|NCT00868166|474333169|FG000|Overall Study|Withdrawal by Subject|33|||
131742200|NCT00868166|474333170|FG001|Overall Study|Withdrawal by Subject|25|||
131742201|NCT00868166|474333169|FG000|Overall Study|Protocol Violation|1|||
131742202|NCT00868166|474333170|FG001|Overall Study|Protocol Violation|0|||
131742203|NCT00868166|474333169|FG000|Overall Study|Lost to Follow-up|1|||
131742204|NCT00868166|474333170|FG001|Overall Study|Lost to Follow-up|3|||
131742205|NCT00868166|474333169|FG000|Overall Study|Adverse Event|9|||
131742206|NCT00868166|474333170|FG001|Overall Study|Adverse Event|10|||
131742207|NCT00868166|474333169|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
131808481|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808482|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808483|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131905532|NCT02563899|474940957|FG003|Overall Study|Protocol Violation|0|||
131742208|NCT00868166|474333170|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
131742209|NCT00868166|474333169|FG000|Overall Study|Non-compliance with IMP|1|||
131742210|NCT00868166|474333170|FG001|Overall Study|Non-compliance with IMP|1|||
131742211|NCT01231607|474333180|FG000|Overall Study|Adverse Event|0|||
131742212|NCT01231607|474333181|FG001|Overall Study|Adverse Event|8|||
131742213|NCT01231607|474333182|FG002|Overall Study|Adverse Event|4|||
131742214|NCT01231607|474333183|FG003|Overall Study|Adverse Event|4|||
131742215|NCT01231607|474333184|FG004|Overall Study|Adverse Event|5|||
131742216|NCT01231607|474333180|FG000|Overall Study|Lost to Follow-up|13|||
131742217|NCT01231607|474333181|FG001|Overall Study|Lost to Follow-up|11|||
131742218|NCT01231607|474333182|FG002|Overall Study|Lost to Follow-up|10|||
131742219|NCT01231607|474333183|FG003|Overall Study|Lost to Follow-up|10|||
131742220|NCT01231607|474333184|FG004|Overall Study|Lost to Follow-up|4|||
131742221|NCT01231607|474333180|FG000|Overall Study|Physician Decision|4|||
131742222|NCT01231607|474333181|FG001|Overall Study|Physician Decision|4|||
131742223|NCT01231607|474333182|FG002|Overall Study|Physician Decision|3|||
131742224|NCT01231607|474333183|FG003|Overall Study|Physician Decision|5|||
131742225|NCT01231607|474333184|FG004|Overall Study|Physician Decision|4|||
131742226|NCT01231607|474333180|FG000|Overall Study|Protocol Violation|3|||
131742227|NCT01231607|474333181|FG001|Overall Study|Protocol Violation|2|||
131742228|NCT01231607|474333182|FG002|Overall Study|Protocol Violation|0|||
131742229|NCT01231607|474333183|FG003|Overall Study|Protocol Violation|2|||
131742230|NCT01231607|474333184|FG004|Overall Study|Protocol Violation|2|||
131742231|NCT01231607|474333180|FG000|Overall Study|Withdrawal by Subject|9|||
131742232|NCT01231607|474333181|FG001|Overall Study|Withdrawal by Subject|9|||
131742233|NCT01231607|474333182|FG002|Overall Study|Withdrawal by Subject|14|||
131742234|NCT01231607|474333183|FG003|Overall Study|Withdrawal by Subject|17|||
131742235|NCT01231607|474333184|FG004|Overall Study|Withdrawal by Subject|9|||
131742236|NCT02267278|474333185|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
131742237|NCT02267278|474333185|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
131742238|NCT02267278|474333185|FG000|Overall Study|Developed new cancer diagnoses|2|||
131742239|NCT02267278|474333185|FG000|Overall Study|prescribed prohibited medication|1|||
131742240|NCT00085917|474333193|FG000|Overall Study|Adverse Event|4|||
131742241|NCT00085917|474333194|FG001|Overall Study|Adverse Event|3|||
131742242|NCT03372603|474333196|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
131742243|NCT03372603|474333197|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
131742244|NCT03372603|474333196|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
131742245|NCT03372603|474333197|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
131742246|NCT00865189|474333201|FG000|Overall Study|Other|1|||
131742247|NCT00865189|474333202|FG001|Overall Study|Other|2|||
131742248|NCT00865189|474333201|FG000|Overall Study|Death|4|||
131742249|NCT00865189|474333202|FG001|Overall Study|Death|11|||
131742250|NCT00865189|474333201|FG000|Overall Study|Lost to Follow-up|6|||
131742251|NCT00865189|474333202|FG001|Overall Study|Lost to Follow-up|6|||
131742252|NCT00865189|474333201|FG000|Overall Study|Withdrawal by Subject|1|||
131742253|NCT00865189|474333202|FG001|Overall Study|Withdrawal by Subject|0|||
131742254|NCT00418379|474333208|FG000|Year 1|Adverse Event|9|||
131742255|NCT00418379|474333209|FG001|Year 1|Adverse Event|15|||
131742256|NCT00418379|474333210|FG002|Year 1|Adverse Event|3|||
131742257|NCT00418379|474333208|FG000|Year 1|Withdrawal by Subject|7|||
131742258|NCT00418379|474333209|FG001|Year 1|Withdrawal by Subject|8|||
131742259|NCT00418379|474333210|FG002|Year 1|Withdrawal by Subject|5|||
131742260|NCT00418379|474333208|FG000|Year 1|Any other reason not above-mentioned|2|||
131742261|NCT00418379|474333209|FG001|Year 1|Any other reason not above-mentioned|5|||
131742262|NCT00418379|474333210|FG002|Year 1|Any other reason not above-mentioned|7|||
131742263|NCT00418379|474333208|FG000|Year 2|Adverse Event|5|||
131742264|NCT00418379|474333209|FG001|Year 2|Adverse Event|2|||
131742265|NCT00418379|474333210|FG002|Year 2|Adverse Event|1|||
131742266|NCT00418379|474333208|FG000|Year 2|Withdrawal by Subject|1|||
131742267|NCT00418379|474333209|FG001|Year 2|Withdrawal by Subject|1|||
131742268|NCT00418379|474333210|FG002|Year 2|Withdrawal by Subject|3|||
131742269|NCT00418379|474333208|FG000|Year 2|Any other reason not above-mentioned|2|||
131742270|NCT00418379|474333209|FG001|Year 2|Any other reason not above-mentioned|1|||
131742271|NCT00418379|474333210|FG002|Year 2|Any other reason not above-mentioned|6|||
131742272|NCT00418379|474333208|FG000|Year 3|Withdrawal by Subject|1|||
131742273|NCT00418379|474333209|FG001|Year 3|Withdrawal by Subject|1|||
131742274|NCT00418379|474333210|FG002|Year 3|Withdrawal by Subject|2|||
131742275|NCT00418379|474333208|FG000|Year 3|Any other reason not above-mentioned|2|||
131742276|NCT00418379|474333209|FG001|Year 3|Any other reason not above-mentioned|1|||
131742277|NCT00418379|474333210|FG002|Year 3|Any other reason not above-mentioned|1|||
131742278|NCT00418379|474333208|FG000|Year 4|Adverse Event|0|||
131742279|NCT00418379|474333209|FG001|Year 4|Adverse Event|1|||
131742280|NCT00418379|474333210|FG002|Year 4|Adverse Event|0|||
131742281|NCT00418379|474333208|FG000|Year 4|Withdrawal by Subject|2|||
131742282|NCT00418379|474333209|FG001|Year 4|Withdrawal by Subject|3|||
131742283|NCT00418379|474333210|FG002|Year 4|Withdrawal by Subject|2|||
131742284|NCT00418379|474333208|FG000|Year 4|Any other reason not above-mentioned|1|||
131742285|NCT00418379|474333209|FG001|Year 4|Any other reason not above-mentioned|1|||
131742286|NCT00418379|474333210|FG002|Year 4|Any other reason not above-mentioned|0|||
131742287|NCT00418379|474333208|FG000|Year 5|Adverse Event|0|||
131742288|NCT00418379|474333209|FG001|Year 5|Adverse Event|1|||
131742289|NCT00418379|474333210|FG002|Year 5|Adverse Event|0|||
131742290|NCT00418379|474333208|FG000|Year 5|Any other reason not above-mentioned|2|||
131742291|NCT00418379|474333209|FG001|Year 5|Any other reason not above-mentioned|4|||
131742292|NCT00418379|474333210|FG002|Year 5|Any other reason not above-mentioned|3|||
131742293|NCT00843843|474333211|FG000|Overall Study|Physician Decision|1|||
131742294|NCT00843843|474333212|FG001|Overall Study|Physician Decision|1|||
131742295|NCT00843843|474333211|FG000|Overall Study|Protocol Violation|1|||
131742296|NCT00843843|474333212|FG001|Overall Study|Protocol Violation|1|||
131742297|NCT00565058|474333213|FG000|Overall Study|Adverse Event|1|||
131742298|NCT00565058|474333214|FG001|Overall Study|Adverse Event|0|||
131742299|NCT01153841|474333215|FG000|Overall Study|Adverse Event|1|||
131742300|NCT01153841|474333216|FG001|Overall Study|Adverse Event|0|||
131742301|NCT01153841|474333215|FG000|Overall Study|Withdrawal by Subject|1|||
131742302|NCT01153841|474333216|FG001|Overall Study|Withdrawal by Subject|0|||
131742303|NCT01153841|474333215|FG000|Overall Study|Protocol Violation|2|||
131742304|NCT01153841|474333216|FG001|Overall Study|Protocol Violation|0|||
131742305|NCT01153841|474333215|FG000|Overall Study|Lost to Follow-up|2|||
131742306|NCT01153841|474333216|FG001|Overall Study|Lost to Follow-up|0|||
131742307|NCT00830804|474333219|FG000|Overall Study|Lost to Follow-up|4|||
131742308|NCT00830804|474333219|FG000|Overall Study|Death|1|||
131742309|NCT00830804|474333219|FG000|Overall Study|Unable to get to clinic|7|||
131742310|NCT00830804|474333219|FG000|Overall Study|Consent withdrawn|2|||
131742311|NCT00830804|474333219|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
131742312|NCT03428997|474333227|FG000|Overall Study|Sponsor decision.|1|||
131742313|NCT03428997|474333227|FG000|Overall Study|Withdrawal by Subject|3|||
131742314|NCT03428997|474333227|FG000|Overall Study|Lost to Follow-up|4|||
131742315|NCT00510068|474333232|FG000|Double-blind Period|Disease progression|98|||
131742316|NCT00510068|474333233|FG001|Double-blind Period|Disease progression|169|||
131742317|NCT00510068|474333232|FG000|Double-blind Period|Final primary analysis|52|||
131742318|NCT00510068|474333233|FG001|Double-blind Period|Final primary analysis|18|||
131742319|NCT00510068|474333232|FG000|Double-blind Period|Adverse Event|37|||
131742320|NCT00510068|474333233|FG001|Double-blind Period|Adverse Event|7|||
131742321|NCT00510068|474333232|FG000|Double-blind Period|Withdrawal by Subject|8|||
131742322|NCT00510068|474333233|FG001|Double-blind Period|Withdrawal by Subject|6|||
131742323|NCT00510068|474333232|FG000|Double-blind Period|Death|4|||
131742324|NCT00510068|474333233|FG001|Double-blind Period|Death|3|||
131742325|NCT00510068|474333232|FG000|Double-blind Period|Abnormal test result (s)|1|||
131742326|NCT00510068|474333233|FG001|Double-blind Period|Abnormal test result (s)|0|||
131742327|NCT00510068|474333232|FG000|Double-blind Period|Lost to Follow-up|1|||
131742328|NCT00510068|474333233|FG001|Double-blind Period|Lost to Follow-up|0|||
131742329|NCT00510068|474333232|FG000|Double-blind Period|Protocol Violation|6|||
131742330|NCT00510068|474333233|FG001|Double-blind Period|Protocol Violation|0|||
131742331|NCT00510068|474333232|FG000|Open-label Period|Disease Progression|124|||
131742332|NCT00510068|474333233|FG001|Open-label Period|Disease Progression|0|||
131742333|NCT00510068|474333232|FG000|Open-label Period|Adverse Event|46|||
131742334|NCT00510068|474333233|FG001|Open-label Period|Adverse Event|0|||
131742335|NCT00510068|474333232|FG000|Open-label Period|Withdrawal by Subject|21|||
131742336|NCT00510068|474333233|FG001|Open-label Period|Withdrawal by Subject|0|||
131742337|NCT00510068|474333232|FG000|Open-label Period|Administrative problems|17|||
131742338|NCT00510068|474333233|FG001|Open-label Period|Administrative problems|0|||
131742339|NCT00510068|474333232|FG000|Open-label Period|Death|7|||
131742340|NCT00510068|474333233|FG001|Open-label Period|Death|0|||
131742341|NCT00510068|474333232|FG000|Open-label Period|New cancer therapy|7|||
131742342|NCT00510068|474333233|FG001|Open-label Period|New cancer therapy|0|||
131742343|NCT00510068|474333232|FG000|Open-label Period|Protocol Violation|2|||
131742344|NCT00510068|474333233|FG001|Open-label Period|Protocol Violation|0|||
131742345|NCT00510068|474333232|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
131742346|NCT00510068|474333233|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
131742347|NCT01397448|474333235|FG000|Overall Study|Adverse Event|4|||
131742348|NCT01397448|474333236|FG001|Overall Study|Adverse Event|4|||
131742349|NCT01397448|474333237|FG002|Overall Study|Adverse Event|6|||
131742350|NCT01397448|474333235|FG000|Overall Study|Withdrawal by Subject|4|||
131742351|NCT01397448|474333236|FG001|Overall Study|Withdrawal by Subject|4|||
131742352|NCT01397448|474333237|FG002|Overall Study|Withdrawal by Subject|3|||
131742353|NCT01397448|474333235|FG000|Overall Study|Lack of Efficacy|2|||
131742354|NCT01397448|474333236|FG001|Overall Study|Lack of Efficacy|0|||
131742355|NCT01397448|474333237|FG002|Overall Study|Lack of Efficacy|5|||
131742356|NCT01397448|474333235|FG000|Overall Study|Other|8|||
131742357|NCT01397448|474333236|FG001|Overall Study|Other|7|||
131742358|NCT01397448|474333237|FG002|Overall Study|Other|4|||
131742359|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
131905533|NCT02563899|474940954|FG000|Overall Study|Withdrawal by Subject|0|||
131905534|NCT02563899|474940955|FG001|Overall Study|Withdrawal by Subject|0|||
131905535|NCT02563899|474940956|FG002|Overall Study|Withdrawal by Subject|1|||
131905536|NCT02563899|474940957|FG003|Overall Study|Withdrawal by Subject|0|||
131742360|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
131742361|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
131742362|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
131742363|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
131742364|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
131742365|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Death|1|||
131742366|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Death|3|||
131742367|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
131742368|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
131742369|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
131742370|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
131742371|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
131742372|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
131742373|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
131742374|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
131742375|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
131742376|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
131742377|NCT02553317|474333240|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
131742378|NCT02553317|474333241|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
131742379|NCT03176277|474333242|FG000|Part A Dose Escalation Study|Adverse Event|1|||
131742380|NCT03176277|474333243|FG001|Part A Dose Escalation Study|Adverse Event|0|||
131742381|NCT03176277|474333244|FG002|Part A Dose Escalation Study|Adverse Event|1|||
131742382|NCT03176277|474333245|FG003|Part A Dose Escalation Study|Adverse Event|0|||
131742383|NCT03176277|474333242|FG000|Part A Dose Escalation Study|Physician Decision|1|||
131742384|NCT03176277|474333243|FG001|Part A Dose Escalation Study|Physician Decision|1|||
131742385|NCT03176277|474333244|FG002|Part A Dose Escalation Study|Physician Decision|2|||
131742386|NCT03176277|474333245|FG003|Part A Dose Escalation Study|Physician Decision|0|||
131742387|NCT03176277|474333242|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
131742388|NCT03176277|474333243|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
131742389|NCT03176277|474333244|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
131742390|NCT03176277|474333245|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
131742391|NCT03176277|474333242|FG000|Part A Dose Escalation Study|Progressive disease|3|||
131742392|NCT03176277|474333243|FG001|Part A Dose Escalation Study|Progressive disease|1|||
131742393|NCT03176277|474333244|FG002|Part A Dose Escalation Study|Progressive disease|3|||
131742394|NCT03176277|474333245|FG003|Part A Dose Escalation Study|Progressive disease|0|||
131742395|NCT00634114|474333246|FG000|Overall Study|Adverse Event|6|||
131742396|NCT00634114|474333247|FG001|Overall Study|Adverse Event|8|||
131742397|NCT00634114|474333248|FG002|Overall Study|Adverse Event|3|||
131742398|NCT00634114|474333246|FG000|Overall Study|Withdrawal by Subject|9|||
131742399|NCT00634114|474333247|FG001|Overall Study|Withdrawal by Subject|6|||
131742400|NCT00634114|474333248|FG002|Overall Study|Withdrawal by Subject|11|||
131742401|NCT00634114|474333246|FG000|Overall Study|Lost to Follow-up|0|||
131742402|NCT00634114|474333247|FG001|Overall Study|Lost to Follow-up|0|||
131742403|NCT00634114|474333248|FG002|Overall Study|Lost to Follow-up|1|||
131742404|NCT00634114|474333246|FG000|Overall Study|Protocol Violation|3|||
131742405|NCT00634114|474333247|FG001|Overall Study|Protocol Violation|3|||
131742406|NCT00634114|474333248|FG002|Overall Study|Protocol Violation|1|||
131742407|NCT00634114|474333246|FG000|Overall Study|Pregnancy|1|||
131742408|NCT00634114|474333247|FG001|Overall Study|Pregnancy|0|||
131742409|NCT00634114|474333248|FG002|Overall Study|Pregnancy|0|||
131742410|NCT00634114|474333246|FG000|Overall Study|Incorrect enrolment|0|||
131742411|NCT00634114|474333247|FG001|Overall Study|Incorrect enrolment|1|||
131742412|NCT00634114|474333248|FG002|Overall Study|Incorrect enrolment|0|||
131742413|NCT00634114|474333246|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
131742414|NCT00634114|474333247|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
131742415|NCT00634114|474333248|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
131742416|NCT00634114|474333246|FG000|Overall Study|Difficult to continue|3|||
131742417|NCT00634114|474333247|FG001|Overall Study|Difficult to continue|1|||
131742418|NCT00634114|474333248|FG002|Overall Study|Difficult to continue|1|||
131742419|NCT00634114|474333246|FG000|Overall Study|Other reason|1|||
131742420|NCT00634114|474333247|FG001|Overall Study|Other reason|1|||
131742421|NCT00634114|474333248|FG002|Overall Study|Other reason|1|||
131742422|NCT03691610|474333249|FG000|Overall Study|Adverse Event|0|||
131742423|NCT03691610|474333250|FG001|Overall Study|Adverse Event|1|||
131742424|NCT03691610|474333251|FG002|Overall Study|Adverse Event|0|||
131742425|NCT03691610|474333252|FG003|Overall Study|Adverse Event|0|||
131742426|NCT03691610|474333249|FG000|Overall Study|Protocol Deviation|15|||
131905537|NCT03669588|474940958|FG000|Overall Study|Adverse Event|1|||
131742427|NCT03691610|474333250|FG001|Overall Study|Protocol Deviation|8|||
131742428|NCT03691610|474333251|FG002|Overall Study|Protocol Deviation|1|||
131742429|NCT03691610|474333252|FG003|Overall Study|Protocol Deviation|2|||
131742430|NCT03691610|474333249|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
131742431|NCT03691610|474333250|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
131742432|NCT03691610|474333251|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
131742433|NCT03691610|474333252|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
131742434|NCT03691610|474333249|FG000|Overall Study|Lost to Follow-up|20|||
131742435|NCT03691610|474333250|FG001|Overall Study|Lost to Follow-up|11|||
131742436|NCT03691610|474333251|FG002|Overall Study|Lost to Follow-up|5|||
131742437|NCT03691610|474333252|FG003|Overall Study|Lost to Follow-up|2|||
131742438|NCT00622869|474333260|FG000|Overall Study|Subject Withdrew Consent|13|||
131742439|NCT00622869|474333261|FG001|Overall Study|Subject Withdrew Consent|17|||
131742440|NCT00622869|474333262|FG002|Overall Study|Subject Withdrew Consent|11|||
131742441|NCT00622869|474333260|FG000|Overall Study|Administrative Problems|11|||
131742442|NCT00622869|474333261|FG001|Overall Study|Administrative Problems|17|||
131742443|NCT00622869|474333262|FG002|Overall Study|Administrative Problems|13|||
131742444|NCT00622869|474333260|FG000|Overall Study|Death|12|||
131742445|NCT00622869|474333261|FG001|Overall Study|Death|15|||
131742446|NCT00622869|474333262|FG002|Overall Study|Death|10|||
131742447|NCT00622869|474333260|FG000|Overall Study|Lost to Follow-up|2|||
131742448|NCT00622869|474333261|FG001|Overall Study|Lost to Follow-up|4|||
131742449|NCT00622869|474333262|FG002|Overall Study|Lost to Follow-up|2|||
131742450|NCT00622869|474333260|FG000|Overall Study|Graft Loss|5|||
131742451|NCT00622869|474333261|FG001|Overall Study|Graft Loss|3|||
131742452|NCT00622869|474333262|FG002|Overall Study|Graft Loss|2|||
131742453|NCT00622869|474333260|FG000|Overall Study|Missing|0|||
131742454|NCT00622869|474333261|FG001|Overall Study|Missing|1|||
131742455|NCT00622869|474333262|FG002|Overall Study|Missing|1|||
131742456|NCT00645567|474333263|FG000|Overall Study|Adverse Event|1|||
131742457|NCT02475395|474333267|FG000|Overall Study|Protocol Violation|30|||
131742458|NCT02475395|474333268|FG001|Overall Study|Protocol Violation|3|||
131742459|NCT03730194|474333269|FG000|First Stage Treatment|Withdrawal by Subject|1|||
131742460|NCT03730194|474333270|FG001|First Stage Treatment|Withdrawal by Subject|1|||
131742461|NCT03730194|474333271|FG002|First Stage Treatment|Withdrawal by Subject|0|||
131742462|NCT03730194|474333272|FG003|First Stage Treatment|Withdrawal by Subject|0|||
131742463|NCT03730194|474333273|FG004|First Stage Treatment|Withdrawal by Subject|0|||
131742464|NCT03730194|474333274|FG005|First Stage Treatment|Withdrawal by Subject|0|||
131742465|NCT03730194|474333269|FG000|First Stage Treatment|Protocol Violation|3|||
131742466|NCT03730194|474333270|FG001|First Stage Treatment|Protocol Violation|3|||
131742467|NCT03730194|474333271|FG002|First Stage Treatment|Protocol Violation|0|||
131742468|NCT03730194|474333272|FG003|First Stage Treatment|Protocol Violation|0|||
131742469|NCT03730194|474333273|FG004|First Stage Treatment|Protocol Violation|0|||
131742470|NCT03730194|474333274|FG005|First Stage Treatment|Protocol Violation|0|||
131742471|NCT00115765|474333275|FG000|Overall Study|Withdrawal by Subject|22|||
131742472|NCT00115765|474333276|FG001|Overall Study|Withdrawal by Subject|53|||
131742473|NCT00115765|474333277|FG002|Overall Study|Withdrawal by Subject|76|||
131742474|NCT00115765|474333278|FG003|Overall Study|Withdrawal by Subject|15|||
131742475|NCT00115765|474333275|FG000|Overall Study|Physician Decision|4|||
131742476|NCT00115765|474333276|FG001|Overall Study|Physician Decision|15|||
131742477|NCT00115765|474333277|FG002|Overall Study|Physician Decision|18|||
131742478|NCT00115765|474333278|FG003|Overall Study|Physician Decision|13|||
131742479|NCT00115765|474333275|FG000|Overall Study|Lost to Follow-up|3|||
131742480|NCT00115765|474333276|FG001|Overall Study|Lost to Follow-up|20|||
131742481|NCT00115765|474333277|FG002|Overall Study|Lost to Follow-up|18|||
131742482|NCT00115765|474333278|FG003|Overall Study|Lost to Follow-up|1|||
131742483|NCT00115765|474333275|FG000|Overall Study|Other|6|||
131742484|NCT00115765|474333276|FG001|Overall Study|Other|12|||
131742485|NCT00115765|474333277|FG002|Overall Study|Other|9|||
131742486|NCT00115765|474333278|FG003|Overall Study|Other|2|||
131742487|NCT03814590|474333281|FG000|Overall Study|Adverse Event|0|||
131742488|NCT03814590|474333282|FG001|Overall Study|Adverse Event|0|||
131742489|NCT03814590|474333283|FG002|Overall Study|Adverse Event|0|||
131742490|NCT03814590|474333284|FG003|Overall Study|Adverse Event|0|||
131742491|NCT03814590|474333285|FG004|Overall Study|Adverse Event|0|||
131742492|NCT03814590|474333286|FG005|Overall Study|Adverse Event|1|||
131742493|NCT03814590|474333287|FG006|Overall Study|Adverse Event|1|||
131742494|NCT03814590|474333288|FG007|Overall Study|Adverse Event|1|||
131742495|NCT03814590|474333289|FG008|Overall Study|Adverse Event|0|||
131742496|NCT03814590|474333290|FG009|Overall Study|Adverse Event|0|||
131742497|NCT03814590|474333291|FG010|Overall Study|Adverse Event|1|||
131742498|NCT03814590|474333292|FG011|Overall Study|Adverse Event|0|||
131742499|NCT03814590|474333293|FG012|Overall Study|Adverse Event|3|||
131742500|NCT03814590|474333294|FG013|Overall Study|Adverse Event|0|||
131742501|NCT03814590|474333281|FG000|Overall Study|Lost to Follow-up|0|||
131742502|NCT03814590|474333282|FG001|Overall Study|Lost to Follow-up|2|||
131742503|NCT03814590|474333283|FG002|Overall Study|Lost to Follow-up|1|||
131742504|NCT03814590|474333284|FG003|Overall Study|Lost to Follow-up|0|||
131742505|NCT03814590|474333285|FG004|Overall Study|Lost to Follow-up|1|||
131905538|NCT03669588|474940959|FG001|Overall Study|Adverse Event|0|||
131905539|NCT03669588|474940958|FG000|Overall Study|Physician Decision|0|||
131905540|NCT03669588|474940959|FG001|Overall Study|Physician Decision|1|||
131905541|NCT03669588|474940958|FG000|Overall Study|Protocol Violation|1|||
131905542|NCT03669588|474940959|FG001|Overall Study|Protocol Violation|0|||
131905543|NCT03669588|474940958|FG000|Overall Study|Sponsor Decision|1|||
131905544|NCT03669588|474940959|FG001|Overall Study|Sponsor Decision|1|||
131905545|NCT03669588|474940958|FG000|Overall Study|Withdrawal by Subject|1|||
131905546|NCT03669588|474940959|FG001|Overall Study|Withdrawal by Subject|4|||
131905547|NCT03669588|474940958|FG000|Overall Study|Rescue Therapy Needed|0|||
131905548|NCT03669588|474940959|FG001|Overall Study|Rescue Therapy Needed|1|||
131905549|NCT00369343|474940962|FG000|Double-blind Phase|Adverse Event|19|||
131905550|NCT00369343|474940963|FG001|Double-blind Phase|Adverse Event|4|||
131905551|NCT00369343|474940962|FG000|Double-blind Phase|Failed to return|2|||
131905552|NCT00369343|474940963|FG001|Double-blind Phase|Failed to return|0|||
131905553|NCT00369343|474940962|FG000|Double-blind Phase|Lost to Follow-up|9|||
131905554|NCT00369343|474940963|FG001|Double-blind Phase|Lost to Follow-up|2|||
131905555|NCT00369343|474940962|FG000|Double-blind Phase|Protocol Violation|2|||
131905556|NCT00369343|474940963|FG001|Double-blind Phase|Protocol Violation|0|||
131742506|NCT03814590|474333286|FG005|Overall Study|Lost to Follow-up|1|||
131742507|NCT03814590|474333287|FG006|Overall Study|Lost to Follow-up|1|||
131742508|NCT03814590|474333288|FG007|Overall Study|Lost to Follow-up|1|||
131742509|NCT03814590|474333289|FG008|Overall Study|Lost to Follow-up|0|||
131742510|NCT03814590|474333290|FG009|Overall Study|Lost to Follow-up|0|||
131742511|NCT03814590|474333291|FG010|Overall Study|Lost to Follow-up|1|||
131742512|NCT03814590|474333292|FG011|Overall Study|Lost to Follow-up|0|||
131742513|NCT03814590|474333293|FG012|Overall Study|Lost to Follow-up|0|||
131742514|NCT03814590|474333294|FG013|Overall Study|Lost to Follow-up|1|||
131742515|NCT03814590|474333281|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742516|NCT03814590|474333282|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742517|NCT03814590|474333283|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742518|NCT03814590|474333284|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742519|NCT03814590|474333285|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742520|NCT03814590|474333286|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131905557|NCT00369343|474940962|FG000|Double-blind Phase|Withdrawal by Subject|8|||
131905558|NCT00369343|474940963|FG001|Double-blind Phase|Withdrawal by Subject|6|||
131742521|NCT03814590|474333287|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742522|NCT03814590|474333288|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742523|NCT03814590|474333289|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742524|NCT03814590|474333290|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
131742525|NCT03814590|474333291|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742526|NCT03814590|474333292|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742527|NCT03814590|474333293|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742528|NCT03814590|474333294|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131742529|NCT03814590|474333281|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742530|NCT03814590|474333282|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742531|NCT03814590|474333283|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742532|NCT03814590|474333284|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742533|NCT03814590|474333285|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742534|NCT03814590|474333286|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
131742535|NCT03814590|474333287|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
131742536|NCT03814590|474333288|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
131742537|NCT03814590|474333289|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742538|NCT03814590|474333290|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
131742539|NCT03814590|474333291|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
131742540|NCT03814590|474333292|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131742541|NCT03814590|474333293|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
131905559|NCT00369343|474940962|FG000|Double-blind Phase|Lack of Efficacy|0|||
131905560|NCT00369343|474940963|FG001|Double-blind Phase|Lack of Efficacy|4|||
131905561|NCT00369343|474940962|FG000|Double-blind Phase|Protocol deviation|4|||
131905562|NCT00369343|474940963|FG001|Double-blind Phase|Protocol deviation|0|||
131905563|NCT00369343|474940962|FG000|Open-label Phase|Adverse Event|19|||
131905564|NCT00369343|474940963|FG001|Open-label Phase|Adverse Event|7|||
131905565|NCT00369343|474940962|FG000|Open-label Phase|Failed to return|4|||
131905566|NCT00369343|474940963|FG001|Open-label Phase|Failed to return|0|||
131905567|NCT00369343|474940962|FG000|Open-label Phase|Physician Decision|2|||
131742542|NCT03814590|474333294|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
131742543|NCT03814590|474333281|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742544|NCT03814590|474333282|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742545|NCT03814590|474333283|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742546|NCT03814590|474333284|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742547|NCT03814590|474333285|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742548|NCT03814590|474333286|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742549|NCT03814590|474333287|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742550|NCT03814590|474333288|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131742551|NCT03814590|474333289|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742552|NCT03814590|474333290|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131742553|NCT03814590|474333291|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742554|NCT03814590|474333292|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742555|NCT03814590|474333293|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742556|NCT03814590|474333294|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131742557|NCT03814590|474333281|FG000|Overall Study|UNKNOWN REASON|0|||
131742558|NCT03814590|474333282|FG001|Overall Study|UNKNOWN REASON|0|||
131742559|NCT03814590|474333283|FG002|Overall Study|UNKNOWN REASON|0|||
131742560|NCT03814590|474333284|FG003|Overall Study|UNKNOWN REASON|0|||
131742561|NCT03814590|474333285|FG004|Overall Study|UNKNOWN REASON|0|||
131742562|NCT03814590|474333286|FG005|Overall Study|UNKNOWN REASON|0|||
131742563|NCT03814590|474333287|FG006|Overall Study|UNKNOWN REASON|0|||
131742564|NCT03814590|474333288|FG007|Overall Study|UNKNOWN REASON|1|||
131742565|NCT03814590|474333289|FG008|Overall Study|UNKNOWN REASON|0|||
131742566|NCT03814590|474333290|FG009|Overall Study|UNKNOWN REASON|0|||
131742567|NCT03814590|474333291|FG010|Overall Study|UNKNOWN REASON|0|||
131742568|NCT03814590|474333292|FG011|Overall Study|UNKNOWN REASON|0|||
131742569|NCT03814590|474333293|FG012|Overall Study|UNKNOWN REASON|0|||
131742570|NCT03814590|474333294|FG013|Overall Study|UNKNOWN REASON|0|||
131742571|NCT03956225|474333297|FG000|Overall Study|Lack of Efficacy|1|||
131742572|NCT03956225|474333298|FG001|Overall Study|Lack of Efficacy|1|||
131742573|NCT03956225|474333297|FG000|Overall Study|Lost to Follow-up|0|||
131742574|NCT03956225|474333298|FG001|Overall Study|Lost to Follow-up|1|||
131742575|NCT03956225|474333297|FG000|Overall Study|Withdrawal by Subject|2|||
131742576|NCT03956225|474333298|FG001|Overall Study|Withdrawal by Subject|1|||
131742577|NCT03956225|474333297|FG000|Overall Study|Other Reasons|2|||
131742578|NCT03956225|474333298|FG001|Overall Study|Other Reasons|1|||
131742579|NCT02260648|474333299|FG000|Overall Study|Adverse Event|3|||
131742580|NCT02260648|474333300|FG001|Overall Study|Adverse Event|0|||
131742581|NCT02260648|474333301|FG002|Overall Study|Adverse Event|1|||
131742582|NCT02260648|474333299|FG000|Overall Study|Withdrawal by Subject|1|||
131742583|NCT02260648|474333300|FG001|Overall Study|Withdrawal by Subject|1|||
131742584|NCT02260648|474333301|FG002|Overall Study|Withdrawal by Subject|0|||
131742585|NCT02260648|474333299|FG000|Overall Study|Protocol Violation|1|||
131742586|NCT02260648|474333300|FG001|Overall Study|Protocol Violation|0|||
131742587|NCT02260648|474333301|FG002|Overall Study|Protocol Violation|0|||
131742588|NCT02260648|474333299|FG000|Overall Study|Discontinue Due to Study Termination|13|||
131742589|NCT02260648|474333300|FG001|Overall Study|Discontinue Due to Study Termination|12|||
131742590|NCT02260648|474333301|FG002|Overall Study|Discontinue Due to Study Termination|7|||
131742591|NCT04093258|474333302|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
131742592|NCT04093258|474333303|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
131742593|NCT00594204|474333304|FG000|Overall Study|Adverse Event|15|||
131742594|NCT00594204|474333305|FG001|Overall Study|Adverse Event|3|||
131742595|NCT00594204|474333304|FG000|Overall Study|Lost to Follow-up|9|||
131742596|NCT00594204|474333305|FG001|Overall Study|Lost to Follow-up|5|||
131742597|NCT00594204|474333304|FG000|Overall Study|Withdrawal by Subject|23|||
131742598|NCT00594204|474333305|FG001|Overall Study|Withdrawal by Subject|29|||
131742599|NCT00594204|474333304|FG000|Overall Study|Other|4|||
131742600|NCT00594204|474333305|FG001|Overall Study|Other|3|||
131742601|NCT00594204|474333304|FG000|Overall Study|Lack of Efficacy|3|||
131742602|NCT00594204|474333305|FG001|Overall Study|Lack of Efficacy|4|||
131742603|NCT00594204|474333304|FG000|Overall Study|Randomized but not treated|4|||
131742604|NCT00594204|474333305|FG001|Overall Study|Randomized but not treated|1|||
131742605|NCT06025396|474335524|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
131742606|NCT06025396|474335525|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
131742607|NCT06025396|474335526|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
131742608|NCT06025396|474335527|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
131742609|NCT06025396|474335528|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
131742610|NCT06025396|474335524|FG000|Overall Study|Withdrawal by Subject|0|||
131742611|NCT06025396|474335525|FG001|Overall Study|Withdrawal by Subject|1|||
131742612|NCT06025396|474335526|FG002|Overall Study|Withdrawal by Subject|1|||
131742613|NCT06025396|474335527|FG003|Overall Study|Withdrawal by Subject|0|||
131742614|NCT06025396|474335528|FG004|Overall Study|Withdrawal by Subject|0|||
131742615|NCT00646113|474335529|FG000|Overall Study|Lost to Follow-up|5|||
131905568|NCT00369343|474940963|FG001|Open-label Phase|Physician Decision|0|||
131905569|NCT00369343|474940962|FG000|Open-label Phase|Lost to Follow-up|5|||
131905570|NCT00369343|474940963|FG001|Open-label Phase|Lost to Follow-up|3|||
131905571|NCT00369343|474940962|FG000|Open-label Phase|inadvertently reported study completers|3|||
131905572|NCT00369343|474940963|FG001|Open-label Phase|inadvertently reported study completers|2|||
131905573|NCT00369343|474940962|FG000|Open-label Phase|Protocol Violation|1|||
131905574|NCT00369343|474940963|FG001|Open-label Phase|Protocol Violation|3|||
131905575|NCT00369343|474940962|FG000|Open-label Phase|Withdrawal by Subject|15|||
131905576|NCT00369343|474940963|FG001|Open-label Phase|Withdrawal by Subject|6|||
131905577|NCT00369343|474940962|FG000|Open-label Phase|Lack of Efficacy|4|||
131905578|NCT00369343|474940963|FG001|Open-label Phase|Lack of Efficacy|3|||
131905579|NCT00369343|474940962|FG000|Open-label Phase|Lack of continuance tolerability|3|||
131905580|NCT00369343|474940963|FG001|Open-label Phase|Lack of continuance tolerability|4|||
131905581|NCT00369343|474940962|FG000|Open-label Phase|did not take study drug|1|||
131905582|NCT00369343|474940963|FG001|Open-label Phase|did not take study drug|2|||
131905583|NCT01100502|474940966|FG000|Overall Study|Withdrawal by Subject|18|||
131905584|NCT01100502|474940967|FG001|Overall Study|Withdrawal by Subject|25|||
131905585|NCT01100502|474940966|FG000|Overall Study|Lost to Follow-up|13|||
131905586|NCT01100502|474940967|FG001|Overall Study|Lost to Follow-up|28|||
131905587|NCT01100502|474940966|FG000|Overall Study|Site request to end participation in study|0|||
131905588|NCT01100502|474940967|FG001|Overall Study|Site request to end participation in study|1|||
131905589|NCT01100502|474940966|FG000|Overall Study|Death|45|||
131905590|NCT01100502|474940967|FG001|Overall Study|Death|40|||
131905591|NCT02322749|474940968|FG000|Period 2|Adverse Event|0|||
131905592|NCT02322749|474940969|FG001|Period 2|Adverse Event|0|||
131905593|NCT02322749|474940970|FG002|Period 2|Adverse Event|0|||
131905594|NCT02322749|474940971|FG003|Period 2|Adverse Event|1|||
131905595|NCT02322749|474940972|FG004|Period 2|Adverse Event|0|||
131905596|NCT02322749|474940973|FG005|Period 2|Adverse Event|0|||
131905597|NCT02322749|474940968|FG000|Period 2|Withdrawal by Subject|0|||
131905598|NCT02322749|474940969|FG001|Period 2|Withdrawal by Subject|0|||
131905599|NCT02322749|474940970|FG002|Period 2|Withdrawal by Subject|0|||
131905600|NCT02322749|474940971|FG003|Period 2|Withdrawal by Subject|1|||
131905601|NCT02322749|474940972|FG004|Period 2|Withdrawal by Subject|0|||
131905602|NCT02322749|474940973|FG005|Period 2|Withdrawal by Subject|0|||
131905603|NCT02322749|474940968|FG000|Period 3|Withdrawal by Subject|0|||
131905604|NCT02322749|474940969|FG001|Period 3|Withdrawal by Subject|0|||
131905605|NCT02322749|474940970|FG002|Period 3|Withdrawal by Subject|1|||
131905606|NCT02322749|474940971|FG003|Period 3|Withdrawal by Subject|0|||
131905607|NCT02322749|474940972|FG004|Period 3|Withdrawal by Subject|0|||
131905608|NCT02322749|474940973|FG005|Period 3|Withdrawal by Subject|0|||
131905609|NCT05158140|474940984|FG000|Overall Study|Death|0|||
131905610|NCT05158140|474940985|FG001|Overall Study|Death|0|||
131905611|NCT05158140|474940986|FG002|Overall Study|Death|0|||
131905612|NCT05158140|474940987|FG003|Overall Study|Death|1|||
131905613|NCT05158140|474940984|FG000|Overall Study|Lost to Follow-up|3|||
131905614|NCT05158140|474940985|FG001|Overall Study|Lost to Follow-up|6|||
131905615|NCT05158140|474940986|FG002|Overall Study|Lost to Follow-up|4|||
131905616|NCT05158140|474940987|FG003|Overall Study|Lost to Follow-up|3|||
131905617|NCT05158140|474940984|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131905618|NCT05158140|474940985|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131905619|NCT05158140|474940986|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
131905620|NCT05158140|474940987|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131905621|NCT05158140|474940984|FG000|Overall Study|Withdrawal by Subject|3|||
131742616|NCT00646113|474335529|FG000|Overall Study|Adverse Event|3|||
131742617|NCT02109744|474335530|FG000|Overall Study|Death|1|||
131742618|NCT02109744|474335531|FG001|Overall Study|Death|1|||
131742619|NCT02109744|474335530|FG000|Overall Study|no marrow exam|1|||
131742620|NCT02109744|474335531|FG001|Overall Study|no marrow exam|0|||
131742621|NCT04095442|474335532|FG000|Overall Study|Lost to Follow-up|0|||
131905622|NCT05158140|474940985|FG001|Overall Study|Withdrawal by Subject|7|||
131905623|NCT05158140|474940986|FG002|Overall Study|Withdrawal by Subject|3|||
131905624|NCT05158140|474940987|FG003|Overall Study|Withdrawal by Subject|7|||
131905625|NCT00807365|474940991|FG000|Overall Study|Study Terminated|5|||
131905626|NCT01526785|474940992|FG000|Overall Study|Study Terminated by Sponsor|8|||
131905627|NCT01526785|474940992|FG000|Overall Study|Death|2|||
131905628|NCT01526785|474940992|FG000|Overall Study|Physician Decision|1|||
131905629|NCT01526785|474940992|FG000|Overall Study|Withdrawal by Subject|2|||
131905630|NCT01814007|474940998|FG000|Overall Study|Withdrawal by Subject|1|||
131742622|NCT04095442|474335533|FG001|Overall Study|Lost to Follow-up|1|||
131742623|NCT04095442|474335532|FG000|Overall Study|Screen failure|1|||
131742624|NCT04095442|474335533|FG001|Overall Study|Screen failure|0|||
131742625|NCT00562640|474335534|FG000|Overall Study|Death|0|||
131742626|NCT00562640|474335535|FG001|Overall Study|Death|1|||
131742627|NCT00562640|474335536|FG002|Overall Study|Death|1|||
131742628|NCT00562640|474335537|FG003|Overall Study|Death|0|||
131742629|NCT05263921|474335538|FG000|Overall Study|Other: family emergency.|0|||
131742630|NCT05263921|474335539|FG001|Overall Study|Other: family emergency.|0|||
131742631|NCT05263921|474335540|FG002|Overall Study|Other: family emergency.|1|||
131742632|NCT05263921|474335541|FG003|Overall Study|Other: family emergency.|0|||
131742633|NCT00603733|474335548|FG000|Active Phase ITT|Adverse Event|8|||
131742634|NCT00603733|474335549|FG001|Active Phase ITT|Adverse Event|7|||
131742635|NCT00603733|474335548|FG000|Active Phase ITT|Withdrawal by Subject|0|||
131742636|NCT00603733|474335549|FG001|Active Phase ITT|Withdrawal by Subject|3|||
131742637|NCT00603733|474335548|FG000|Active Phase ITT|Lost to Follow-up|0|||
131742638|NCT00603733|474335549|FG001|Active Phase ITT|Lost to Follow-up|1|||
131742639|NCT00603733|474335548|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
131742640|NCT00603733|474335549|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
131742641|NCT00603733|474335548|FG000|Active Phase ITT|Lack of Efficacy|1|||
131742642|NCT00603733|474335549|FG001|Active Phase ITT|Lack of Efficacy|2|||
131742643|NCT00603733|474335548|FG000|Active Phase ITT|Subject moved, site closed|1|||
131742644|NCT00603733|474335549|FG001|Active Phase ITT|Subject moved, site closed|1|||
131742645|NCT00603733|474335548|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
131742646|NCT00603733|474335549|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
131742647|NCT00603733|474335548|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
131742648|NCT00603733|474335549|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
131742649|NCT00603733|474335548|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
131742650|NCT00603733|474335549|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
131742651|NCT00603733|474335548|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
131742652|NCT00603733|474335549|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
131742653|NCT00603733|474335548|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
131742654|NCT00603733|474335549|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
131742655|NCT00603733|474335548|FG000|Maintenance Phase ITT|Adverse Event|3|||
131742656|NCT00603733|474335549|FG001|Maintenance Phase ITT|Adverse Event|6|||
131742657|NCT00603733|474335548|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
131742658|NCT00603733|474335549|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
131742659|NCT00603733|474335548|FG000|Maintenance Phase ITT|Protocol Violation|1|||
131742660|NCT00603733|474335549|FG001|Maintenance Phase ITT|Protocol Violation|1|||
131742661|NCT00603733|474335548|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
131742662|NCT00603733|474335549|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
131742663|NCT00603733|474335548|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
131742664|NCT00603733|474335549|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
131742665|NCT00603733|474335548|FG000|Maintenance Phase ITT|Physician Decision|0|||
131742666|NCT00603733|474335549|FG001|Maintenance Phase ITT|Physician Decision|1|||
131742667|NCT00603733|474335548|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
131742668|NCT00603733|474335549|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
131742669|NCT01297309|474335553|FG000|Overall Study|Eligibility failure|2|||
131742670|NCT01297309|474335553|FG000|Overall Study|Screen failure|2|||
131742671|NCT01297309|474335553|FG000|Overall Study|Withdrawal by Subject|5|||
131742672|NCT01297309|474335553|FG000|Overall Study|Adverse Event|1|||
131742673|NCT01297309|474335553|FG000|Overall Study|Investigator Decision|2|||
131742674|NCT01297309|474335553|FG000|Overall Study|Death|1|||
131742675|NCT01297309|474335553|FG000|Overall Study|Participant not entering extensionperiod|1|||
131742676|NCT02254551|474335558|FG000|Dose Escalation|Physician Decision|1|||
131742677|NCT02254551|474335558|FG000|Dose Escalation|Dose-limiting toxicity|2|||
131742678|NCT02759562|474335562|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
131742679|NCT02759562|474335563|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
131742680|NCT02759562|474335562|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
131742681|NCT02759562|474335563|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
131742682|NCT03587584|474335564|FG000|Overall Study|SOC deviations|4|||
131905631|NCT04350827|474940999|FG000|Overall Study|Lost to Follow-up|1|||
131742683|NCT03587584|474335565|FG001|Overall Study|SOC deviations|6|||
131905632|NCT04350827|474941000|FG001|Overall Study|Lost to Follow-up|2|||
131742684|NCT03587584|474335564|FG000|Overall Study|Incomplete data|0|||
131742685|NCT03587584|474335565|FG001|Overall Study|Incomplete data|3|||
131742686|NCT00387348|474335566|FG000|Overall Study|Death|1|||
131742687|NCT00387348|474335567|FG001|Overall Study|Death|1|||
131742688|NCT00387348|474335568|FG002|Overall Study|Death|0|||
131742689|NCT00387348|474335566|FG000|Overall Study|Physician Decision|1|||
131742690|NCT00387348|474335567|FG001|Overall Study|Physician Decision|0|||
131742691|NCT00387348|474335568|FG002|Overall Study|Physician Decision|1|||
131742692|NCT00387348|474335566|FG000|Overall Study|Withdrawal by Subject|0|||
131742693|NCT00387348|474335567|FG001|Overall Study|Withdrawal by Subject|2|||
131742694|NCT00387348|474335568|FG002|Overall Study|Withdrawal by Subject|2|||
131742695|NCT00387348|474335566|FG000|Overall Study|Adverse Event|1|||
131742696|NCT00387348|474335567|FG001|Overall Study|Adverse Event|0|||
131742697|NCT00387348|474335568|FG002|Overall Study|Adverse Event|1|||
131742698|NCT00505752|474335571|FG000|Overall Study|Adverse Event|1|||
131742699|NCT00505752|474335572|FG001|Overall Study|Adverse Event|0|||
131742700|NCT00505752|474335573|FG002|Overall Study|Adverse Event|1|||
131742701|NCT00505752|474335574|FG003|Overall Study|Adverse Event|0|||
131742702|NCT00505752|474335571|FG000|Overall Study|Lost to Follow-up|1|||
131742703|NCT00505752|474335572|FG001|Overall Study|Lost to Follow-up|0|||
131742704|NCT00505752|474335573|FG002|Overall Study|Lost to Follow-up|0|||
131742705|NCT00505752|474335574|FG003|Overall Study|Lost to Follow-up|0|||
131742706|NCT00505752|474335571|FG000|Overall Study|Lack of ovarian response|1|||
131742707|NCT00505752|474335572|FG001|Overall Study|Lack of ovarian response|3|||
131742708|NCT00505752|474335573|FG002|Overall Study|Lack of ovarian response|0|||
131742709|NCT00505752|474335574|FG003|Overall Study|Lack of ovarian response|0|||
131742710|NCT00505752|474335571|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131742711|NCT00505752|474335572|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131742712|NCT00505752|474335573|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
131742713|NCT00505752|474335574|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131742714|NCT00505752|474335571|FG000|Overall Study|No oocytes retrieved|0|||
131742715|NCT00505752|474335572|FG001|Overall Study|No oocytes retrieved|2|||
131742716|NCT00505752|474335573|FG002|Overall Study|No oocytes retrieved|0|||
131742717|NCT00505752|474335574|FG003|Overall Study|No oocytes retrieved|1|||
131742718|NCT00505752|474335571|FG000|Overall Study|No Fertilization|1|||
131742719|NCT00505752|474335572|FG001|Overall Study|No Fertilization|1|||
131742720|NCT00505752|474335573|FG002|Overall Study|No Fertilization|2|||
131742721|NCT00505752|474335574|FG003|Overall Study|No Fertilization|1|||
131742722|NCT00505752|474335571|FG000|Overall Study|All embryos/blastocysts discarded|0|||
131742723|NCT00505752|474335572|FG001|Overall Study|All embryos/blastocysts discarded|0|||
131742724|NCT00505752|474335573|FG002|Overall Study|All embryos/blastocysts discarded|1|||
131742725|NCT00505752|474335574|FG003|Overall Study|All embryos/blastocysts discarded|1|||
131742726|NCT00505752|474335571|FG000|Overall Study|Other|1|||
131742727|NCT00505752|474335572|FG001|Overall Study|Other|2|||
131742728|NCT00505752|474335573|FG002|Overall Study|Other|1|||
131742729|NCT00505752|474335574|FG003|Overall Study|Other|2|||
131742730|NCT04624672|474335575|FG000|Overall Study|Early Study Closure|2|||
131742731|NCT04624672|474335576|FG001|Overall Study|Early Study Closure|1|||
131742732|NCT03472040|474335577|FG000|Overall Study|Physician Decision|0|||
131742733|NCT03472040|474335578|FG001|Overall Study|Physician Decision|3|||
131742734|NCT03472040|474335577|FG000|Overall Study|Withdrawal by Subject|10|||
131742735|NCT03472040|474335578|FG001|Overall Study|Withdrawal by Subject|23|||
131742736|NCT03472040|474335577|FG000|Overall Study|Perceived Lack of Efficacy|29|||
131742737|NCT03472040|474335578|FG001|Overall Study|Perceived Lack of Efficacy|30|||
131742738|NCT03472040|474335577|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
131742739|NCT03472040|474335578|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
131742740|NCT03472040|474335577|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
131742741|NCT03472040|474335578|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
131742742|NCT03472040|474335577|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
131742743|NCT03472040|474335578|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
131742744|NCT03472040|474335577|FG000|Overall Study|Subject Non-compliance|2|||
131742745|NCT03472040|474335578|FG001|Overall Study|Subject Non-compliance|5|||
131742746|NCT03472040|474335577|FG000|Overall Study|Discontinuation due to Rash|0|||
131742747|NCT03472040|474335578|FG001|Overall Study|Discontinuation due to Rash|1|||
131742748|NCT03472040|474335577|FG000|Overall Study|Subsequent Ineligibility|0|||
131742749|NCT03472040|474335578|FG001|Overall Study|Subsequent Ineligibility|2|||
131742750|NCT03472040|474335577|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
131742751|NCT03472040|474335578|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
131742752|NCT02769832|474335579|FG000|Overall Study|Death|30|||
131742753|NCT02685995|474335588|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
131742754|NCT02685995|474335589|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
131448935|NCT01208207|473272738|FG001|Part II|Non-Compliance With Study Drug|0|||
131448936|NCT01208207|473272739|FG002|Part II|Non-Compliance With Study Drug|0|||
131742755|NCT03625141|474335590|FG000|Overall Study|Adverse Event|0|||
131742756|NCT03625141|474335591|FG001|Overall Study|Adverse Event|2|||
131742757|NCT03625141|474335590|FG000|Overall Study|Study Terminated By Sponsor|1|||
131742758|NCT03625141|474335591|FG001|Overall Study|Study Terminated By Sponsor|13|||
131742759|NCT03625141|474335590|FG000|Overall Study|Withdrawal by Subject|3|||
131742760|NCT03625141|474335591|FG001|Overall Study|Withdrawal by Subject|0|||
131742761|NCT03625141|474335590|FG000|Overall Study|Withdrawal Of Consent|0|||
131742762|NCT03625141|474335591|FG001|Overall Study|Withdrawal Of Consent|1|||
131742763|NCT03625141|474335590|FG000|Overall Study|Death|11|||
131742764|NCT03625141|474335591|FG001|Overall Study|Death|47|||
131448937|NCT01208207|473272740|FG003|Part II|Non-Compliance With Study Drug|4|||
131742765|NCT03625141|474335590|FG000|Overall Study|Progressive Disease|0|||
131448938|NCT01208207|473272741|FG004|Part II|Non-Compliance With Study Drug|1|||
131742766|NCT03625141|474335591|FG001|Overall Study|Progressive Disease|2|||
131742767|NCT03819218|474335592|FG000|Overall Study|Protocol Violation|1|||
131742768|NCT00433446|474335593|FG000|Overall Study|Adverse Event|4|||
131742769|NCT00433446|474335593|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131742770|NCT00433446|474335593|FG000|Overall Study|Progression|44|||
131742771|NCT00433446|474335593|FG000|Overall Study|Other - Not Protocol specified|3|||
131742772|NCT00433446|474335593|FG000|Overall Study|Ineligible|9|||
131742773|NCT02501902|474335594|FG000|Overall Study|Subject Refused Further Follow-up|0|||
131742774|NCT02501902|474335595|FG001|Overall Study|Subject Refused Further Follow-up|0|||
131742775|NCT02501902|474335596|FG002|Overall Study|Subject Refused Further Follow-up|0|||
131742776|NCT02501902|474335597|FG003|Overall Study|Subject Refused Further Follow-up|0|||
131742777|NCT02501902|474335598|FG004|Overall Study|Subject Refused Further Follow-up|0|||
131742778|NCT02501902|474335599|FG005|Overall Study|Subject Refused Further Follow-up|0|||
131742779|NCT02501902|474335600|FG006|Overall Study|Subject Refused Further Follow-up|0|||
131742780|NCT02501902|474335601|FG007|Overall Study|Subject Refused Further Follow-up|1|||
131742781|NCT02501902|474335594|FG000|Overall Study|Study Terminated by Sponsor|0|||
131742782|NCT02501902|474335595|FG001|Overall Study|Study Terminated by Sponsor|3|||
131742783|NCT02501902|474335596|FG002|Overall Study|Study Terminated by Sponsor|0|||
131742784|NCT02501902|474335597|FG003|Overall Study|Study Terminated by Sponsor|1|||
131742785|NCT02501902|474335598|FG004|Overall Study|Study Terminated by Sponsor|1|||
131742786|NCT02501902|474335599|FG005|Overall Study|Study Terminated by Sponsor|0|||
131742787|NCT02501902|474335600|FG006|Overall Study|Study Terminated by Sponsor|2|||
131742788|NCT02501902|474335601|FG007|Overall Study|Study Terminated by Sponsor|4|||
131742789|NCT02501902|474335594|FG000|Overall Study|Death|3|||
131742790|NCT02501902|474335595|FG001|Overall Study|Death|4|||
131742791|NCT02501902|474335596|FG002|Overall Study|Death|4|||
131742792|NCT02501902|474335597|FG003|Overall Study|Death|10|||
131742793|NCT02501902|474335598|FG004|Overall Study|Death|10|||
131742794|NCT02501902|474335599|FG005|Overall Study|Death|11|||
131742795|NCT02501902|474335600|FG006|Overall Study|Death|7|||
131742796|NCT02501902|474335601|FG007|Overall Study|Death|15|||
131742797|NCT02513771|474335602|FG000|Overall Study|Lost to Follow-up|1|||
131742798|NCT02513771|474335603|FG001|Overall Study|Lost to Follow-up|1|||
131742799|NCT02513771|474335602|FG000|Overall Study|Not being able to get to clinic|1|||
131742800|NCT02513771|474335603|FG001|Overall Study|Not being able to get to clinic|0|||
131742801|NCT01797445|474335604|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
131742802|NCT01797445|474335605|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
131742803|NCT01797445|474335604|FG000|Double-Blind Phase|Adverse Event|3|||
131742804|NCT01797445|474335605|FG001|Double-Blind Phase|Adverse Event|0|||
131742805|NCT01797445|474335604|FG000|Double-Blind Phase|Death|5|||
131742806|NCT01797445|474335605|FG001|Double-Blind Phase|Death|4|||
131742807|NCT01797445|474335604|FG000|Double-Blind Phase|Pregnancy|0|||
131742808|NCT01797445|474335605|FG001|Double-Blind Phase|Pregnancy|1|||
131742809|NCT01797445|474335604|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131742810|NCT01797445|474335605|FG001|Double-Blind Phase|Lack of Efficacy|2|||
131742811|NCT01797445|474335604|FG000|Double-Blind Phase|Investigator's Discretion|15|||
131742812|NCT01797445|474335605|FG001|Double-Blind Phase|Investigator's Discretion|17|||
131742813|NCT01797445|474335604|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
131742814|NCT01797445|474335605|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
131742815|NCT01797445|474335604|FG000|Double-Blind Phase|Protocol Violation|0|||
131742816|NCT01797445|474335605|FG001|Double-Blind Phase|Protocol Violation|1|||
131742817|NCT01797445|474335604|FG000|Double-Blind Phase|Withdrew Consent|20|||
131742818|NCT01797445|474335605|FG001|Double-Blind Phase|Withdrew Consent|35|||
131742819|NCT01797445|474335604|FG000|Double-Blind Phase|Lost to Follow-up|34|||
131742820|NCT01797445|474335605|FG001|Double-Blind Phase|Lost to Follow-up|26|||
131742821|NCT01797445|474335604|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
131742822|NCT01797445|474335605|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
131742823|NCT01595438|474335606|FG000|Overall Study|Lost to Follow-up|20|||
131742824|NCT01595438|474335607|FG001|Overall Study|Lost to Follow-up|20|||
131742825|NCT01595438|474335606|FG000|Overall Study|Withdrawal by Subject|12|||
131742826|NCT01595438|474335607|FG001|Overall Study|Withdrawal by Subject|12|||
131742827|NCT01595438|474335606|FG000|Overall Study|Other Eligibility criteria|11|||
131742828|NCT01595438|474335607|FG001|Overall Study|Other Eligibility criteria|9|||
131742829|NCT00650091|474335608|FG000|Amended Study Design|Withdrawal by Subject|12|||
131742830|NCT00650091|474335609|FG001|Amended Study Design|Withdrawal by Subject|11|||
131742831|NCT00650091|474335610|FG002|Amended Study Design|Withdrawal by Subject|0|||
131742832|NCT00650091|474335608|FG000|Amended Study Design|Physician Decision|5|||
131742833|NCT00650091|474335609|FG001|Amended Study Design|Physician Decision|0|||
131742834|NCT00650091|474335610|FG002|Amended Study Design|Physician Decision|0|||
131742835|NCT00650091|474335608|FG000|Amended Study Design|Adverse Event|1|||
131742836|NCT00650091|474335609|FG001|Amended Study Design|Adverse Event|4|||
131742837|NCT00650091|474335610|FG002|Amended Study Design|Adverse Event|0|||
131742838|NCT00650091|474335608|FG000|Amended Study Design|Lung transplantation|4|||
131742839|NCT00650091|474335609|FG001|Amended Study Design|Lung transplantation|2|||
131742840|NCT00650091|474335610|FG002|Amended Study Design|Lung transplantation|0|||
131742841|NCT00650091|474335608|FG000|Amended Study Design|Other|1|||
131742842|NCT00650091|474335609|FG001|Amended Study Design|Other|3|||
131742843|NCT00650091|474335610|FG002|Amended Study Design|Other|0|||
131742844|NCT04116073|474335619|FG000|Overall Study|Withdrawal by Subject|2|||
131742845|NCT04116073|474335619|FG000|Overall Study|failed to maintained eligibility|1|||
131742846|NCT01429077|474335624|FG000|Overall Study|Lost to Follow-up|0|||
131742847|NCT01429077|474335625|FG001|Overall Study|Lost to Follow-up|3|||
131742848|NCT03483116|474335626|FG000|Overall Study|Adverse Event|0|||
131742849|NCT03483116|474335627|FG001|Overall Study|Adverse Event|1|||
131742850|NCT03483116|474335628|FG002|Overall Study|Adverse Event|0|||
131742851|NCT03483116|474335629|FG003|Overall Study|Adverse Event|1|||
131742852|NCT03483116|474335626|FG000|Overall Study|Protocol Violation|1|||
131742853|NCT03483116|474335627|FG001|Overall Study|Protocol Violation|0|||
131742854|NCT03483116|474335628|FG002|Overall Study|Protocol Violation|0|||
131742855|NCT03483116|474335629|FG003|Overall Study|Protocol Violation|7|||
131742856|NCT03483116|474335626|FG000|Overall Study|Lost to Follow-up|9|||
131742857|NCT03483116|474335627|FG001|Overall Study|Lost to Follow-up|4|||
131742858|NCT03483116|474335628|FG002|Overall Study|Lost to Follow-up|9|||
131742859|NCT03483116|474335629|FG003|Overall Study|Lost to Follow-up|5|||
131742860|NCT03483116|474335626|FG000|Overall Study|Death|1|||
131742861|NCT03483116|474335627|FG001|Overall Study|Death|0|||
131742862|NCT03483116|474335628|FG002|Overall Study|Death|2|||
131742863|NCT03483116|474335629|FG003|Overall Study|Death|1|||
131742864|NCT03483116|474335626|FG000|Overall Study|Withdrawal by Subject|14|||
131742865|NCT03483116|474335627|FG001|Overall Study|Withdrawal by Subject|16|||
131742866|NCT03483116|474335628|FG002|Overall Study|Withdrawal by Subject|14|||
131742867|NCT03483116|474335629|FG003|Overall Study|Withdrawal by Subject|16|||
131742868|NCT03483116|474335626|FG000|Overall Study|Unknown other reason|3|||
131742869|NCT03483116|474335627|FG001|Overall Study|Unknown other reason|2|||
131742870|NCT03483116|474335628|FG002|Overall Study|Unknown other reason|1|||
131742871|NCT03483116|474335629|FG003|Overall Study|Unknown other reason|1|||
131742872|NCT01181102|474335630|FG000|Overall Study|Adverse Event|28|||
131742873|NCT01181102|474335631|FG001|Overall Study|Adverse Event|26|||
131742874|NCT01181102|474335630|FG000|Overall Study|Lack of Efficacy|3|||
131742875|NCT01181102|474335631|FG001|Overall Study|Lack of Efficacy|1|||
131742876|NCT01181102|474335630|FG000|Overall Study|Lost to Follow-up|2|||
131742877|NCT01181102|474335631|FG001|Overall Study|Lost to Follow-up|0|||
131742878|NCT01181102|474335630|FG000|Overall Study|Physician Decision|3|||
131742879|NCT01181102|474335631|FG001|Overall Study|Physician Decision|1|||
131742880|NCT01181102|474335630|FG000|Overall Study|Protocol Violation|5|||
131742881|NCT01181102|474335631|FG001|Overall Study|Protocol Violation|6|||
131742882|NCT01181102|474335630|FG000|Overall Study|Withdrawal by Subject|10|||
131742883|NCT01181102|474335631|FG001|Overall Study|Withdrawal by Subject|12|||
131742884|NCT00567541|474335639|FG000|Overall Study|Adverse Event|0|||
131742885|NCT00567541|474335640|FG001|Overall Study|Adverse Event|1|||
131742886|NCT01890512|474335641|FG000|Overall Study|Physician Decision|1|||
131742887|NCT01890512|474335641|FG000|Overall Study|Withdrawal by Subject|1|||
131742888|NCT01890512|474335641|FG000|Overall Study|Protocol Violation|1|||
131742889|NCT01529385|474335642|FG000|Overall Study|Lost to Follow-up|2|||
131742890|NCT01529385|474335643|FG001|Overall Study|Lost to Follow-up|1|||
131742891|NCT00964158|474335646|FG000|Overall Study|Lost to Follow-up|0|||
131742892|NCT00964158|474335647|FG001|Overall Study|Lost to Follow-up|1|||
131742893|NCT00964158|474335648|FG002|Overall Study|Lost to Follow-up|2|||
131742894|NCT00964158|474335646|FG000|Overall Study|Withdrawal by Subject|0|||
131742895|NCT00964158|474335647|FG001|Overall Study|Withdrawal by Subject|0|||
131742896|NCT00964158|474335648|FG002|Overall Study|Withdrawal by Subject|6|||
131742897|NCT00986427|474335649|FG000|Overall Study|Lost to Follow-up|2|||
131742898|NCT00986427|474335650|FG001|Overall Study|Lost to Follow-up|0|||
131742899|NCT00986427|474335649|FG000|Overall Study|Lack of Efficacy|1|||
131742900|NCT00986427|474335650|FG001|Overall Study|Lack of Efficacy|0|||
131742901|NCT00986427|474335649|FG000|Overall Study|Withdrawal by Subject|1|||
131742902|NCT00986427|474335650|FG001|Overall Study|Withdrawal by Subject|0|||
131742903|NCT01401465|474335651|FG000|Treatment Period 1|Adverse Event|4|||
131742904|NCT01401465|474335652|FG001|Treatment Period 1|Adverse Event|1|||
131742905|NCT01401465|474335651|FG000|Treatment Period 1|Pregnancy|0|||
131742906|NCT01401465|474335652|FG001|Treatment Period 1|Pregnancy|1|||
131742907|NCT01401465|474335651|FG000|Treatment Period 1|Protocol Violation|5|||
131742908|NCT01401465|474335652|FG001|Treatment Period 1|Protocol Violation|0|||
131742909|NCT01401465|474335651|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131742910|NCT01401465|474335652|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131742911|NCT01401465|474335651|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
131742912|NCT01401465|474335652|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
131742913|NCT01401465|474335651|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
131742914|NCT01401465|474335652|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
131905633|NCT05630196|474943100|FG000|Overall Study|Adverse Event|2|||
131742915|NCT01401465|474335651|FG000|Treatment Period 1|Scheduling Difficulties|1|||
131742916|NCT01401465|474335652|FG001|Treatment Period 1|Scheduling Difficulties|1|||
131742917|NCT01401465|474335651|FG000|Treatment Period 2|Lost to Follow-up|0|||
131742918|NCT01401465|474335652|FG001|Treatment Period 2|Lost to Follow-up|1|||
131742919|NCT01401465|474335651|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131742920|NCT01401465|474335652|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131742921|NCT01115738|474335653|FG000|Overall Study|Death|1|||
131742922|NCT01115738|474335654|FG001|Overall Study|Death|0|||
131742923|NCT01115738|474335655|FG002|Overall Study|Death|0|||
131742924|NCT01115738|474335653|FG000|Overall Study|Lost to Follow-up|0|||
131742925|NCT01115738|474335654|FG001|Overall Study|Lost to Follow-up|0|||
131742926|NCT01115738|474335655|FG002|Overall Study|Lost to Follow-up|1|||
131742927|NCT01115738|474335653|FG000|Overall Study|Physician Decision|18|||
131742928|NCT01115738|474335654|FG001|Overall Study|Physician Decision|15|||
131742929|NCT01115738|474335655|FG002|Overall Study|Physician Decision|17|||
131742930|NCT01115738|474335653|FG000|Overall Study|Withdrawal by Subject|6|||
131742931|NCT01115738|474335654|FG001|Overall Study|Withdrawal by Subject|6|||
131742932|NCT01115738|474335655|FG002|Overall Study|Withdrawal by Subject|9|||
131742933|NCT01054976|474335667|FG000|Overall Study|Adverse Event|16|||
131742934|NCT01054976|474335667|FG000|Overall Study|Uncooperative participations to study|7|||
131742935|NCT01054976|474335667|FG000|Overall Study|Withdrawal by Subject|4|||
131742936|NCT01054976|474335667|FG000|Overall Study|Other|8|||
131742937|NCT01763866|474335668|FG000|Overall Study|Withdrawal by Subject|2|||
131742938|NCT01763866|474335669|FG001|Overall Study|Withdrawal by Subject|1|||
131742939|NCT01763866|474335670|FG002|Overall Study|Withdrawal by Subject|4|||
131742940|NCT01763866|474335671|FG003|Overall Study|Withdrawal by Subject|0|||
131742941|NCT01763866|474335672|FG004|Overall Study|Withdrawal by Subject|0|||
131742942|NCT01763866|474335673|FG005|Overall Study|Withdrawal by Subject|3|||
131742943|NCT01763866|474335674|FG006|Overall Study|Withdrawal by Subject|4|||
131742944|NCT01763866|474335675|FG007|Overall Study|Withdrawal by Subject|0|||
131742945|NCT01763866|474335676|FG008|Overall Study|Withdrawal by Subject|1|||
131742946|NCT01763866|474335677|FG009|Overall Study|Withdrawal by Subject|1|||
131742947|NCT01763866|474335678|FG010|Overall Study|Withdrawal by Subject|2|||
131742948|NCT01763866|474335679|FG011|Overall Study|Withdrawal by Subject|2|||
131742949|NCT01763866|474335680|FG012|Overall Study|Withdrawal by Subject|2|||
131742950|NCT01763866|474335681|FG013|Overall Study|Withdrawal by Subject|0|||
131742951|NCT01763866|474335682|FG014|Overall Study|Withdrawal by Subject|6|||
131742952|NCT01763866|474335683|FG015|Overall Study|Withdrawal by Subject|3|||
131742953|NCT01763866|474335684|FG016|Overall Study|Withdrawal by Subject|0|||
131742954|NCT01763866|474335685|FG017|Overall Study|Withdrawal by Subject|1|||
131742955|NCT01763866|474335686|FG018|Overall Study|Withdrawal by Subject|1|||
131742956|NCT01763866|474335687|FG019|Overall Study|Withdrawal by Subject|1|||
131742957|NCT01763866|474335688|FG020|Overall Study|Withdrawal by Subject|2|||
131742958|NCT01763866|474335689|FG021|Overall Study|Withdrawal by Subject|1|||
131742959|NCT01763866|474335690|FG022|Overall Study|Withdrawal by Subject|2|||
131742960|NCT01763866|474335691|FG023|Overall Study|Withdrawal by Subject|1|||
131742961|NCT01763866|474335668|FG000|Overall Study|Decision by sponsor|0|||
131742962|NCT01763866|474335669|FG001|Overall Study|Decision by sponsor|0|||
131742963|NCT01763866|474335670|FG002|Overall Study|Decision by sponsor|1|||
131742964|NCT01763866|474335671|FG003|Overall Study|Decision by sponsor|0|||
131742965|NCT01763866|474335672|FG004|Overall Study|Decision by sponsor|2|||
131742966|NCT01763866|474335673|FG005|Overall Study|Decision by sponsor|0|||
131742967|NCT01763866|474335674|FG006|Overall Study|Decision by sponsor|2|||
131742968|NCT01763866|474335675|FG007|Overall Study|Decision by sponsor|0|||
131742969|NCT01763866|474335676|FG008|Overall Study|Decision by sponsor|2|||
131742970|NCT01763866|474335677|FG009|Overall Study|Decision by sponsor|0|||
131742971|NCT01763866|474335678|FG010|Overall Study|Decision by sponsor|6|||
131742972|NCT01763866|474335679|FG011|Overall Study|Decision by sponsor|0|||
131742973|NCT01763866|474335680|FG012|Overall Study|Decision by sponsor|1|||
131742974|NCT01763866|474335681|FG013|Overall Study|Decision by sponsor|0|||
131742975|NCT01763866|474335682|FG014|Overall Study|Decision by sponsor|5|||
131742976|NCT01763866|474335683|FG015|Overall Study|Decision by sponsor|0|||
131742977|NCT01763866|474335684|FG016|Overall Study|Decision by sponsor|0|||
131742978|NCT01763866|474335685|FG017|Overall Study|Decision by sponsor|0|||
131742979|NCT01763866|474335686|FG018|Overall Study|Decision by sponsor|4|||
131742980|NCT01763866|474335687|FG019|Overall Study|Decision by sponsor|0|||
131742981|NCT01763866|474335688|FG020|Overall Study|Decision by sponsor|2|||
131742982|NCT01763866|474335689|FG021|Overall Study|Decision by sponsor|0|||
131742983|NCT01763866|474335690|FG022|Overall Study|Decision by sponsor|1|||
131742984|NCT01763866|474335691|FG023|Overall Study|Decision by sponsor|0|||
131742985|NCT01763866|474335668|FG000|Overall Study|Lost to Follow-up|0|||
131742986|NCT01763866|474335669|FG001|Overall Study|Lost to Follow-up|0|||
131742987|NCT01763866|474335670|FG002|Overall Study|Lost to Follow-up|0|||
131742988|NCT01763866|474335671|FG003|Overall Study|Lost to Follow-up|0|||
131742989|NCT01763866|474335672|FG004|Overall Study|Lost to Follow-up|0|||
131742990|NCT01763866|474335673|FG005|Overall Study|Lost to Follow-up|0|||
131742991|NCT01763866|474335674|FG006|Overall Study|Lost to Follow-up|1|||
131742992|NCT01763866|474335675|FG007|Overall Study|Lost to Follow-up|0|||
131742993|NCT01763866|474335676|FG008|Overall Study|Lost to Follow-up|0|||
131742994|NCT01763866|474335677|FG009|Overall Study|Lost to Follow-up|0|||
131742995|NCT01763866|474335678|FG010|Overall Study|Lost to Follow-up|0|||
131742996|NCT01763866|474335679|FG011|Overall Study|Lost to Follow-up|0|||
131742997|NCT01763866|474335680|FG012|Overall Study|Lost to Follow-up|1|||
131742998|NCT01763866|474335681|FG013|Overall Study|Lost to Follow-up|0|||
131742999|NCT01763866|474335682|FG014|Overall Study|Lost to Follow-up|1|||
131743000|NCT01763866|474335683|FG015|Overall Study|Lost to Follow-up|0|||
131743001|NCT01763866|474335684|FG016|Overall Study|Lost to Follow-up|0|||
131743002|NCT01763866|474335685|FG017|Overall Study|Lost to Follow-up|0|||
131743003|NCT01763866|474335686|FG018|Overall Study|Lost to Follow-up|1|||
131743004|NCT01763866|474335687|FG019|Overall Study|Lost to Follow-up|1|||
131743005|NCT01763866|474335688|FG020|Overall Study|Lost to Follow-up|0|||
131743006|NCT01763866|474335689|FG021|Overall Study|Lost to Follow-up|0|||
131743007|NCT01763866|474335690|FG022|Overall Study|Lost to Follow-up|0|||
131743008|NCT01763866|474335691|FG023|Overall Study|Lost to Follow-up|1|||
131743009|NCT01763866|474335668|FG000|Overall Study|Death|0|||
131743010|NCT01763866|474335669|FG001|Overall Study|Death|0|||
131743011|NCT01763866|474335670|FG002|Overall Study|Death|0|||
131743012|NCT01763866|474335671|FG003|Overall Study|Death|0|||
131743013|NCT01763866|474335672|FG004|Overall Study|Death|0|||
131743014|NCT01763866|474335673|FG005|Overall Study|Death|0|||
131448939|NCT01208207|473272742|FG005|Part II|Non-Compliance With Study Drug|1|||
131448940|NCT01208207|473272743|FG006|Part II|Non-Compliance With Study Drug|0|||
131448941|NCT01208207|473272737|FG000|Part II|Physician Decision|0|||
131448942|NCT01208207|473272738|FG001|Part II|Physician Decision|0|||
131448943|NCT01208207|473272739|FG002|Part II|Physician Decision|0|||
131743015|NCT01763866|474335674|FG006|Overall Study|Death|0|||
131743016|NCT01763866|474335675|FG007|Overall Study|Death|0|||
131743017|NCT01763866|474335676|FG008|Overall Study|Death|0|||
131743018|NCT01763866|474335677|FG009|Overall Study|Death|0|||
131743019|NCT01763866|474335678|FG010|Overall Study|Death|0|||
131743020|NCT01763866|474335679|FG011|Overall Study|Death|0|||
131743021|NCT01763866|474335680|FG012|Overall Study|Death|0|||
131743022|NCT01763866|474335681|FG013|Overall Study|Death|0|||
131743023|NCT01763866|474335682|FG014|Overall Study|Death|0|||
131743024|NCT01763866|474335683|FG015|Overall Study|Death|0|||
131743025|NCT01763866|474335684|FG016|Overall Study|Death|1|||
131743026|NCT01763866|474335685|FG017|Overall Study|Death|0|||
131743027|NCT01763866|474335686|FG018|Overall Study|Death|0|||
131743028|NCT01763866|474335687|FG019|Overall Study|Death|0|||
131743029|NCT01763866|474335688|FG020|Overall Study|Death|0|||
131743030|NCT01763866|474335689|FG021|Overall Study|Death|0|||
131743031|NCT01763866|474335690|FG022|Overall Study|Death|0|||
131743032|NCT01763866|474335691|FG023|Overall Study|Death|0|||
131743033|NCT01669811|474335698|FG000|Overall Study|Investigator decision|0|||
131743034|NCT01669811|474335699|FG001|Overall Study|Investigator decision|1|||
131743035|NCT01669811|474335698|FG000|Overall Study|Withdrawal by Subject|1|||
131743036|NCT01669811|474335699|FG001|Overall Study|Withdrawal by Subject|2|||
131743037|NCT01669811|474335698|FG000|Overall Study|Adverse Event|2|||
131743038|NCT01669811|474335699|FG001|Overall Study|Adverse Event|6|||
131905634|NCT05630196|474943101|FG001|Overall Study|Adverse Event|1|||
131448944|NCT01208207|473272740|FG003|Part II|Physician Decision|1|||
131448945|NCT01208207|473272741|FG004|Part II|Physician Decision|0|||
131448946|NCT01208207|473272742|FG005|Part II|Physician Decision|2|||
131743039|NCT01669811|474335698|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131743040|NCT01669811|474335699|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
131743041|NCT03245723|474335705|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
131743042|NCT03245723|474335706|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
131743043|NCT03245723|474335705|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
131743044|NCT03245723|474335706|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
131743045|NCT03245723|474335705|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
131905635|NCT05630196|474943100|FG000|Overall Study|Lost to Follow-up|1|||
131743046|NCT03245723|474335706|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
131743047|NCT03245723|474335705|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
131743048|NCT03245723|474335706|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
131808484|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808485|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
131808486|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
131808487|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
131808488|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808489|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808490|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808491|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808492|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
131808493|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808494|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808495|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808496|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808497|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808498|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808499|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808500|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808501|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808502|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808503|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808504|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808505|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808506|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808507|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
131808508|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
131808509|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808510|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808511|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808512|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808513|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
131808514|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808515|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808516|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808517|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808518|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808519|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808520|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808521|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808522|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808523|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808524|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808525|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808526|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808527|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808528|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
131808529|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
131808530|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808531|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808532|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808533|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808534|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131808535|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808536|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808537|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131743049|NCT01512108|474337352|FG000|Overall Study|Adverse Event|9|||
131743050|NCT01512108|474337353|FG001|Overall Study|Adverse Event|4|||
131743051|NCT01512108|474337352|FG000|Overall Study|Protocol Violation|1|||
131743052|NCT01512108|474337353|FG001|Overall Study|Protocol Violation|2|||
131743053|NCT01512108|474337352|FG000|Overall Study|Withdrawal Criteria|1|||
131743054|NCT01512108|474337353|FG001|Overall Study|Withdrawal Criteria|0|||
131743055|NCT01512108|474337352|FG000|Overall Study|Unclassified|11|||
131743056|NCT01512108|474337353|FG001|Overall Study|Unclassified|3|||
131743057|NCT06422377|474337358|FG000|Overall Study|Study Terminated by Sponsor|1|||
131743058|NCT02843178|474337362|FG000|Overall Study|Lost to Follow-up|8|||
131743059|NCT02843178|474337363|FG001|Overall Study|Lost to Follow-up|8|||
131743060|NCT02843178|474337364|FG002|Overall Study|Lost to Follow-up|6|||
131743061|NCT02843178|474337365|FG003|Overall Study|Lost to Follow-up|3|||
131743062|NCT02843178|474337362|FG000|Overall Study|Withdrawal by Subject|0|||
131743063|NCT02843178|474337363|FG001|Overall Study|Withdrawal by Subject|0|||
131743064|NCT02843178|474337364|FG002|Overall Study|Withdrawal by Subject|1|||
131743065|NCT02843178|474337365|FG003|Overall Study|Withdrawal by Subject|1|||
131743066|NCT03287245|474337368|FG000|Overall Study|Study terminated by sponsor|3|||
131743067|NCT03287245|474337369|FG001|Overall Study|Study terminated by sponsor|0|||
131743068|NCT03287245|474337370|FG002|Overall Study|Study terminated by sponsor|3|||
131743069|NCT03287245|474337371|FG003|Overall Study|Study terminated by sponsor|1|||
131743070|NCT03287245|474337368|FG000|Overall Study|Adverse Event|1|||
131743071|NCT03287245|474337369|FG001|Overall Study|Adverse Event|0|||
131743072|NCT03287245|474337370|FG002|Overall Study|Adverse Event|0|||
131743073|NCT03287245|474337371|FG003|Overall Study|Adverse Event|0|||
131743074|NCT03287245|474337368|FG000|Overall Study|Withdrawal by Subject|8|||
131743075|NCT03287245|474337369|FG001|Overall Study|Withdrawal by Subject|3|||
131743076|NCT03287245|474337370|FG002|Overall Study|Withdrawal by Subject|3|||
131743077|NCT03287245|474337371|FG003|Overall Study|Withdrawal by Subject|0|||
131743078|NCT03287245|474337368|FG000|Overall Study|Physician Decision|3|||
131743079|NCT03287245|474337369|FG001|Overall Study|Physician Decision|2|||
131743080|NCT03287245|474337370|FG002|Overall Study|Physician Decision|0|||
131743081|NCT03287245|474337371|FG003|Overall Study|Physician Decision|0|||
131743082|NCT02701192|474337372|FG000|Overall Study|Protocol Violation|2|||
131743083|NCT02701192|474337372|FG000|Overall Study|Lost to Follow-up|4|||
131743084|NCT00949910|474337373|FG000|Overall Study|Progressive Disease|3750|||
131743085|NCT00949910|474337373|FG000|Overall Study|Symptomatic Deterioration|1088|||
131743086|NCT00949910|474337373|FG000|Overall Study|Lost to Follow-up|100|||
131743087|NCT00949910|474337373|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
131743088|NCT00949910|474337373|FG000|Overall Study|Participant Refusal|390|||
131743089|NCT00949910|474337373|FG000|Overall Study|Death Due to Malignant Disease|456|||
131743090|NCT00949910|474337373|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
131743091|NCT00949910|474337373|FG000|Overall Study|Death Due to Adverse Event|115|||
131743092|NCT00949910|474337373|FG000|Overall Study|Death Due to Toxicity|3|||
131743093|NCT00949910|474337373|FG000|Overall Study|Death from Unknown Cause|5|||
131743094|NCT00949910|474337373|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
131743095|NCT00949910|474337373|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
131743096|NCT00949910|474337373|FG000|Overall Study|Switched to Commercial Treatment|4|||
131743097|NCT00949910|474337373|FG000|Overall Study|Violation of Eligibility|23|||
131743098|NCT00949910|474337373|FG000|Overall Study|Logistical Reasons|13|||
131905636|NCT05630196|474943101|FG001|Overall Study|Lost to Follow-up|1|||
131905637|NCT05630196|474943100|FG000|Overall Study|Protocol Violation|2|||
131905638|NCT05630196|474943101|FG001|Overall Study|Protocol Violation|3|||
131905639|NCT05630196|474943100|FG000|Overall Study|Physician Decision|1|||
131905640|NCT05630196|474943101|FG001|Overall Study|Physician Decision|0|||
131905641|NCT05630196|474943100|FG000|Overall Study|Withdrawal by Subject|3|||
131905642|NCT05630196|474943101|FG001|Overall Study|Withdrawal by Subject|4|||
131905643|NCT01655901|474943102|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
131905644|NCT01655901|474943103|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
131743099|NCT00949910|474337373|FG000|Overall Study|Non-Compliance|10|||
131743100|NCT00949910|474337373|FG000|Overall Study|Prolonged Dosing Interruption|4|||
131743101|NCT00949910|474337373|FG000|Overall Study|Adverse Event|83|||
131743102|NCT00949910|474337373|FG000|Overall Study|Serious Adverse Event|6|||
131743103|NCT00949910|474337373|FG000|Overall Study|Physician/Participant Decision|7|||
131743104|NCT00949910|474337373|FG000|Overall Study|Other|4|||
131743105|NCT00949910|474337373|FG000|Overall Study|No Data|9|||
131743106|NCT02150213|474337374|FG000|Overall Study|Lost to Follow-up|1|||
131905645|NCT01655901|474943104|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
131905646|NCT01655901|474943105|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
131905647|NCT01655901|474943106|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
131905648|NCT01655901|474943107|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
131905649|NCT00922636|474943108|FG000|Overall Study|Adverse Event|3|||
131905650|NCT00922636|474943109|FG001|Overall Study|Adverse Event|3|||
131905651|NCT00922636|474943110|FG002|Overall Study|Adverse Event|2|||
131905652|NCT00922636|474943111|FG003|Overall Study|Adverse Event|3|||
131743107|NCT02150213|474337374|FG000|Overall Study|Withdrawal by Subject|1|||
131743108|NCT02678312|474337375|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
131743109|NCT02678312|474337376|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131743110|NCT02678312|474337377|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131743111|NCT02678312|474337378|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131743112|NCT02678312|474337379|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131743113|NCT02678312|474337375|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
131743114|NCT02678312|474337376|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131743115|NCT02678312|474337377|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131743116|NCT02678312|474337378|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131743117|NCT02678312|474337379|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131743118|NCT02678312|474337375|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
131743119|NCT02678312|474337376|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131743120|NCT02678312|474337377|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131743121|NCT02678312|474337378|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131743122|NCT02678312|474337379|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131743123|NCT02678312|474337375|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
131743124|NCT02678312|474337376|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
131743125|NCT02678312|474337377|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
131743126|NCT02678312|474337378|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
131743127|NCT02678312|474337379|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
131743128|NCT02678312|474337375|FG000|Part 2 Double Blind Epoch|Death|0|||
131743129|NCT02678312|474337376|FG001|Part 2 Double Blind Epoch|Death|0|||
131743130|NCT02678312|474337377|FG002|Part 2 Double Blind Epoch|Death|0|||
131743131|NCT02678312|474337378|FG003|Part 2 Double Blind Epoch|Death|8|||
131743132|NCT02678312|474337379|FG004|Part 2 Double Blind Epoch|Death|12|||
131743133|NCT02678312|474337375|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
131743134|NCT02678312|474337376|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
131743135|NCT02678312|474337377|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
131743136|NCT02678312|474337378|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
131743137|NCT02678312|474337379|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
131743138|NCT02678312|474337375|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131743139|NCT02678312|474337376|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131743140|NCT02678312|474337377|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131743141|NCT02678312|474337378|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131743142|NCT02678312|474337379|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
131743143|NCT02678312|474337375|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
131743144|NCT02678312|474337376|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
131743145|NCT02678312|474337377|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
131743146|NCT02678312|474337378|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
131743147|NCT02678312|474337379|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
131743148|NCT00971425|474337380|FG000|Overall Study|Adverse Event|1|||
131743149|NCT00971425|474337381|FG001|Overall Study|Adverse Event|1|||
131743150|NCT00971425|474337380|FG000|Overall Study|Withdrawal by Subject|0|||
131743151|NCT00971425|474337381|FG001|Overall Study|Withdrawal by Subject|1|||
131743152|NCT02293993|474337384|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
131743153|NCT02293993|474337385|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
131905653|NCT00922636|474943112|FG004|Overall Study|Adverse Event|2|||
131743154|NCT02293993|474337386|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
131743155|NCT02293993|474337387|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
131743156|NCT02293993|474337384|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
131743157|NCT02293993|474337385|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
131743158|NCT02293993|474337386|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
131743159|NCT02293993|474337387|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
131743160|NCT02293993|474337384|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
131743161|NCT02293993|474337385|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
131743162|NCT02293993|474337386|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
131743163|NCT02293993|474337387|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
131743164|NCT02293993|474337384|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
131743165|NCT02293993|474337385|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
131743166|NCT02293993|474337386|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
131743167|NCT02293993|474337387|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
131743168|NCT02293993|474337384|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
131743169|NCT02293993|474337385|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
131743170|NCT02293993|474337386|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
131743171|NCT02293993|474337387|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
131743172|NCT01188538|474337391|FG000|Overall Study|Lost to Follow-up|0|||
131743173|NCT01188538|474337392|FG001|Overall Study|Lost to Follow-up|1|||
131743174|NCT04295356|474337397|FG000|Overall Study|Physician Decision|1|||
131743175|NCT04295356|474337398|FG001|Overall Study|Physician Decision|0|||
131743176|NCT04295356|474337397|FG000|Overall Study|Lost to Follow-up|0|||
131743177|NCT04295356|474337398|FG001|Overall Study|Lost to Follow-up|3|||
131743178|NCT04295356|474337397|FG000|Overall Study|Protocol Violation|0|||
131743179|NCT04295356|474337398|FG001|Overall Study|Protocol Violation|1|||
131743180|NCT01280266|474337399|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
131743181|NCT01280266|474337400|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
131743182|NCT01280266|474337399|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
131743183|NCT01280266|474337400|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
131743184|NCT01106391|474337403|FG000|Overall Study|Death|12|||
131743185|NCT01106391|474337403|FG000|Overall Study|Withdrawal by Subject|7|||
131743186|NCT03067129|474337404|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
131743187|NCT03067129|474337405|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
131743188|NCT03067129|474337406|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
131743189|NCT03067129|474337407|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
131743190|NCT03067129|474337404|FG000|Overall Study|Withdrawal by Subject|0|||
131743191|NCT03067129|474337405|FG001|Overall Study|Withdrawal by Subject|0|||
131743192|NCT03067129|474337406|FG002|Overall Study|Withdrawal by Subject|1|||
131743193|NCT03067129|474337407|FG003|Overall Study|Withdrawal by Subject|2|||
131743194|NCT03067129|474337404|FG000|Overall Study|Lost to Follow-up|5|||
131743195|NCT03067129|474337405|FG001|Overall Study|Lost to Follow-up|5|||
131743196|NCT03067129|474337406|FG002|Overall Study|Lost to Follow-up|4|||
131743197|NCT03067129|474337407|FG003|Overall Study|Lost to Follow-up|3|||
131743198|NCT02806947|474337408|FG000|Overall Study|Withdrawal by Subject|5|||
131743199|NCT02806947|474337409|FG001|Overall Study|Withdrawal by Subject|1|||
131743200|NCT02029638|474337411|FG000|Overall Study|Death|0|||
131743201|NCT02029638|474337412|FG001|Overall Study|Death|0|||
131743202|NCT02029638|474337413|FG002|Overall Study|Death|1|||
131743203|NCT02029638|474337411|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
131743204|NCT02029638|474337412|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
131743205|NCT02029638|474337413|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
131743206|NCT02563925|474337414|FG000|Overall Study|Withdrawal by Subject|2|||
131743207|NCT00400712|474337415|FG000|Overall Study|Death|1|||
131743208|NCT00400712|474337416|FG001|Overall Study|Death|0|||
131743209|NCT00400712|474337415|FG000|Overall Study|Withdrawal by Subject|11|||
131743210|NCT00400712|474337416|FG001|Overall Study|Withdrawal by Subject|12|||
131743211|NCT00400712|474337415|FG000|Overall Study|Physician Decision|5|||
131743212|NCT00400712|474337416|FG001|Overall Study|Physician Decision|4|||
131905654|NCT00922636|474943108|FG000|Overall Study|Lack of Efficacy|1|||
131743213|NCT04685499|474337419|FG000|Overall Study|Study Terminated Early|1|||
131743214|NCT01996904|474337420|FG000|Overall Study|Lost to Follow-up|38|||
131743215|NCT01996904|474337421|FG001|Overall Study|Lost to Follow-up|27|||
131743216|NCT04664855|474337422|FG000|Overall Study|Withdrawal by Subject|0|||
131743217|NCT04664855|474337423|FG001|Overall Study|Withdrawal by Subject|2|||
131743218|NCT02219087|474337424|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
131743219|NCT02219087|474337425|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
131743220|NCT05127421|474337426|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
131743221|NCT05127421|474337427|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
131743222|NCT05127421|474337428|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
131743223|NCT05127421|474337429|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
131743224|NCT05127421|474337426|FG000|4-Week Double-Blind Period|Physician Decision|1|||
131743225|NCT05127421|474337427|FG001|4-Week Double-Blind Period|Physician Decision|0|||
131743226|NCT05127421|474337428|FG002|4-Week Double-Blind Period|Physician Decision|0|||
131743227|NCT05127421|474337429|FG003|4-Week Double-Blind Period|Physician Decision|0|||
131743228|NCT05127421|474337426|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
131743229|NCT05127421|474337427|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
131743230|NCT05127421|474337428|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
131743231|NCT05127421|474337429|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
131743232|NCT05127421|474337426|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
131743233|NCT05127421|474337427|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
131743234|NCT05127421|474337428|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
131743235|NCT05127421|474337429|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
131743236|NCT05127421|474337426|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
131743237|NCT05127421|474337427|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
131743238|NCT05127421|474337428|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
131743239|NCT05127421|474337429|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
131743240|NCT05127421|474337426|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
131743241|NCT05127421|474337427|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
131743242|NCT05127421|474337428|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
131743243|NCT05127421|474337429|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
131743244|NCT05127421|474337426|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
131743245|NCT05127421|474337427|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
131743246|NCT05127421|474337428|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
131743247|NCT05127421|474337429|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
131743248|NCT05127421|474337426|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
131743249|NCT05127421|474337427|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
131743250|NCT05127421|474337428|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
131743251|NCT05127421|474337429|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
131743252|NCT00574496|474337430|FG000|Overall Study|Withdrawal by Subject|1|||
131743253|NCT03543358|474337431|FG000|Overall Study|Death|1|||
131743254|NCT03543358|474337432|FG001|Overall Study|Death|0|||
131743255|NCT03543358|474337431|FG000|Overall Study|Disease Progression|1|||
131743256|NCT03543358|474337432|FG001|Overall Study|Disease Progression|0|||
131743257|NCT03543358|474337431|FG000|Overall Study|Parent Study Closure|1|||
131743258|NCT03543358|474337432|FG001|Overall Study|Parent Study Closure|0|||
131743259|NCT01518244|474337433|FG000|Overall Study|Adverse Event|3|||
131743260|NCT01766817|474337435|FG000|Overall Study|Drug-related adverse event|1|||
131743261|NCT01766817|474337436|FG001|Overall Study|Drug-related adverse event|2|||
131743262|NCT01766817|474337437|FG002|Overall Study|Drug-related adverse event|1|||
131743263|NCT01766817|474337435|FG000|Overall Study|Drug-unrelated adverse event|3|||
131743264|NCT01766817|474337436|FG001|Overall Study|Drug-unrelated adverse event|3|||
131743265|NCT01766817|474337437|FG002|Overall Study|Drug-unrelated adverse event|3|||
131743266|NCT01766817|474337435|FG000|Overall Study|Death|1|||
131743267|NCT01766817|474337436|FG001|Overall Study|Death|1|||
131743268|NCT01766817|474337437|FG002|Overall Study|Death|0|||
131743269|NCT01766817|474337435|FG000|Overall Study|Unable to take study drug|0|||
131743270|NCT01766817|474337436|FG001|Overall Study|Unable to take study drug|1|||
131743271|NCT01766817|474337437|FG002|Overall Study|Unable to take study drug|0|||
131743272|NCT01766817|474337435|FG000|Overall Study|Withdrawal by Subject|2|||
131743273|NCT01766817|474337436|FG001|Overall Study|Withdrawal by Subject|0|||
131743274|NCT01766817|474337437|FG002|Overall Study|Withdrawal by Subject|3|||
131743275|NCT01766817|474337435|FG000|Overall Study|Subject non-compliance|0|||
131743276|NCT01766817|474337436|FG001|Overall Study|Subject non-compliance|1|||
131743277|NCT01766817|474337437|FG002|Overall Study|Subject non-compliance|2|||
131743278|NCT01766817|474337435|FG000|Overall Study|Physician Decision|3|||
131743279|NCT01766817|474337436|FG001|Overall Study|Physician Decision|3|||
131743280|NCT01766817|474337437|FG002|Overall Study|Physician Decision|4|||
131743281|NCT01766817|474337435|FG000|Overall Study|Other|1|||
131743282|NCT01766817|474337436|FG001|Overall Study|Other|0|||
131743283|NCT01766817|474337437|FG002|Overall Study|Other|0|||
131743284|NCT00178464|474337438|FG000|Overall Study|Withdrawal by Subject|1|||
131743285|NCT00178464|474337438|FG000|Overall Study|Physician Decision|1|||
131743286|NCT00870818|474337439|FG000|Overall Study|Lost to Follow-up|3|||
131743287|NCT00870818|474337440|FG001|Overall Study|Lost to Follow-up|2|||
131743288|NCT00870818|474337441|FG002|Overall Study|Lost to Follow-up|1|||
131743289|NCT00870818|474337442|FG003|Overall Study|Lost to Follow-up|0|||
131743290|NCT00870818|474337443|FG004|Overall Study|Lost to Follow-up|0|||
131743291|NCT00870818|474337439|FG000|Overall Study|Withdrawal by Subject|0|||
131743292|NCT00870818|474337440|FG001|Overall Study|Withdrawal by Subject|0|||
131743293|NCT00870818|474337441|FG002|Overall Study|Withdrawal by Subject|1|||
131743294|NCT00870818|474337442|FG003|Overall Study|Withdrawal by Subject|2|||
131743295|NCT00870818|474337443|FG004|Overall Study|Withdrawal by Subject|0|||
131743296|NCT00870818|474337439|FG000|Overall Study|Terminated by sponsor|29|||
131743297|NCT00870818|474337440|FG001|Overall Study|Terminated by sponsor|70|||
131743298|NCT00870818|474337441|FG002|Overall Study|Terminated by sponsor|36|||
131743299|NCT00870818|474337442|FG003|Overall Study|Terminated by sponsor|36|||
131743300|NCT00870818|474337443|FG004|Overall Study|Terminated by sponsor|38|||
131743301|NCT00870818|474337439|FG000|Overall Study|Other|0|||
131743302|NCT00870818|474337440|FG001|Overall Study|Other|1|||
131743303|NCT00870818|474337441|FG002|Overall Study|Other|0|||
131743304|NCT00870818|474337442|FG003|Overall Study|Other|0|||
131743305|NCT00870818|474337443|FG004|Overall Study|Other|0|||
131743306|NCT04900038|474337444|FG000|Overall Study|Adverse Event|1|||
131743307|NCT04900038|474337445|FG001|Overall Study|Adverse Event|0|||
131743308|NCT04900038|474337446|FG002|Overall Study|Adverse Event|1|||
131743309|NCT04900038|474337447|FG003|Overall Study|Adverse Event|1|||
131743310|NCT04900038|474337444|FG000|Overall Study|Withdrawal by Subject|0|||
131743311|NCT04900038|474337445|FG001|Overall Study|Withdrawal by Subject|1|||
131743312|NCT04900038|474337446|FG002|Overall Study|Withdrawal by Subject|0|||
131743313|NCT04900038|474337447|FG003|Overall Study|Withdrawal by Subject|0|||
131743314|NCT04900038|474337444|FG000|Overall Study|Study terminated by sponsor|18|||
131743315|NCT04900038|474337445|FG001|Overall Study|Study terminated by sponsor|15|||
131743316|NCT04900038|474337446|FG002|Overall Study|Study terminated by sponsor|17|||
131743317|NCT04900038|474337447|FG003|Overall Study|Study terminated by sponsor|14|||
131743318|NCT04900038|474337444|FG000|Overall Study|Protocol Deviation|1|||
131743319|NCT04900038|474337445|FG001|Overall Study|Protocol Deviation|1|||
131743320|NCT04900038|474337446|FG002|Overall Study|Protocol Deviation|0|||
131743321|NCT04900038|474337447|FG003|Overall Study|Protocol Deviation|0|||
131743322|NCT04900038|474337444|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
131743323|NCT04900038|474337445|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
131743324|NCT04900038|474337446|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
131743325|NCT04900038|474337447|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
131743326|NCT04900038|474337444|FG000|Overall Study|Lost to Follow-up|0|||
131743327|NCT04900038|474337445|FG001|Overall Study|Lost to Follow-up|0|||
131743328|NCT04900038|474337446|FG002|Overall Study|Lost to Follow-up|0|||
131743329|NCT04900038|474337447|FG003|Overall Study|Lost to Follow-up|1|||
131743330|NCT02227108|474337450|FG000|Overall Study|Did not receive treatment|2|||
131743331|NCT02227108|474337450|FG000|Overall Study|Other|3|||
131743332|NCT02227108|474337450|FG000|Overall Study|Progressive disease|17|||
131743333|NCT02227108|474337450|FG000|Overall Study|Initiation of alternative therapy|2|||
131743334|NCT02227108|474337450|FG000|Overall Study|Investigator discretion|1|||
131743335|NCT02227108|474337450|FG000|Overall Study|Adverse Event|6|||
131743336|NCT02486952|474337452|FG000|Overall Study|Not Started Induction Therapy|3|||
131743337|NCT02486952|474337452|FG000|Overall Study|Adverse Event|1|||
131743338|NCT02486952|474337452|FG000|Overall Study|Death|15|||
131743339|NCT02486952|474337452|FG000|Overall Study|Lack of Efficacy|3|||
131743340|NCT02486952|474337452|FG000|Overall Study|Lost to Follow-up|26|||
131743341|NCT02486952|474337452|FG000|Overall Study|Other|2|||
131743342|NCT01928485|474337453|FG000|Overall Study|Physician Decision|0|||
131743343|NCT01928485|474337454|FG001|Overall Study|Physician Decision|1|||
131743344|NCT04111107|474337455|FG000|Overall Study|Withdrawal by Subject|6|||
131743345|NCT04111107|474337455|FG000|Overall Study|Declining Health|5|||
131743346|NCT02721251|474337458|FG000|Overall Study|Withdrawal by Subject|8|||
131743347|NCT02721251|474337459|FG001|Overall Study|Withdrawal by Subject|7|||
131743348|NCT02721251|474337460|FG002|Overall Study|Withdrawal by Subject|9|||
131743349|NCT02721251|474337458|FG000|Overall Study|poor adherence|2|||
131743350|NCT02721251|474337459|FG001|Overall Study|poor adherence|2|||
131743351|NCT02721251|474337460|FG002|Overall Study|poor adherence|2|||
131743352|NCT01714817|474337461|FG000|Year 1 Period|Lack of Efficacy|11|||
131743353|NCT01714817|474337462|FG001|Year 1 Period|Lack of Efficacy|9|||
131743354|NCT01714817|474337461|FG000|Year 1 Period|Adverse Event|20|||
131743355|NCT01714817|474337462|FG001|Year 1 Period|Adverse Event|17|||
131743356|NCT01714817|474337461|FG000|Year 1 Period|Withdrawal by Subject|6|||
131743357|NCT01714817|474337462|FG001|Year 1 Period|Withdrawal by Subject|7|||
131743358|NCT01714817|474337461|FG000|Year 1 Period|Death|1|||
131743359|NCT01714817|474337462|FG001|Year 1 Period|Death|1|||
131743360|NCT01714817|474337461|FG000|Year 1 Period|Lost to Follow-up|0|||
131743361|NCT01714817|474337462|FG001|Year 1 Period|Lost to Follow-up|2|||
131743362|NCT01714817|474337461|FG000|Year 1 Period|Poor / non-compliance|0|||
131743363|NCT01714817|474337462|FG001|Year 1 Period|Poor / non-compliance|1|||
131743364|NCT01714817|474337461|FG000|Year 1 Period|Pregnancy|2|||
131743365|NCT01714817|474337462|FG001|Year 1 Period|Pregnancy|0|||
131743366|NCT01714817|474337461|FG000|Year 1 Period|Participant no longer meets criteria|6|||
131743367|NCT01714817|474337462|FG001|Year 1 Period|Participant no longer meets criteria|2|||
131743368|NCT01714817|474337461|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
131743369|NCT01714817|474337462|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
131743370|NCT01714817|474337461|FG000|Year 1 Period|Change in Concomitant Medication|0|||
131743371|NCT01714817|474337462|FG001|Year 1 Period|Change in Concomitant Medication|1|||
131743372|NCT01714817|474337461|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
131743373|NCT01714817|474337462|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
131743374|NCT01714817|474337461|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
131743375|NCT01714817|474337462|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
131743376|NCT01714817|474337461|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
131743377|NCT01714817|474337462|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
131743378|NCT01714817|474337461|FG000|Year 2 Period|Lack of Efficacy|4|||
131743379|NCT01714817|474337462|FG001|Year 2 Period|Lack of Efficacy|12|||
131743380|NCT01714817|474337461|FG000|Year 2 Period|Adverse Event|7|||
131743381|NCT01714817|474337462|FG001|Year 2 Period|Adverse Event|6|||
131743382|NCT01714817|474337461|FG000|Year 2 Period|Participant request to stop treatment|4|||
131743383|NCT01714817|474337462|FG001|Year 2 Period|Participant request to stop treatment|4|||
131743384|NCT01714817|474337461|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
131743385|NCT01714817|474337462|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
131743386|NCT01714817|474337461|FG000|Year 2 Period|Participant withdrew consent|1|||
131743387|NCT01714817|474337462|FG001|Year 2 Period|Participant withdrew consent|5|||
131743388|NCT01714817|474337461|FG000|Year 2 Period|Participant no longer meets criteria|1|||
131743389|NCT01714817|474337462|FG001|Year 2 Period|Participant no longer meets criteria|4|||
131743390|NCT01714817|474337461|FG000|Year 2 Period|Lost to Follow-up|2|||
131743391|NCT01714817|474337462|FG001|Year 2 Period|Lost to Follow-up|0|||
131743392|NCT01714817|474337461|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
131743393|NCT01714817|474337462|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
131743394|NCT01714817|474337461|FG000|Year 2 Period|Pregnancy|1|||
131743395|NCT01714817|474337462|FG001|Year 2 Period|Pregnancy|1|||
131743396|NCT01714817|474337461|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
131743397|NCT01714817|474337462|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
131743398|NCT01714817|474337461|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
131743399|NCT01714817|474337462|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
131743400|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
131743401|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
131743402|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
131743403|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
131743404|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
131743405|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
131743406|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
131743407|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
131743408|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
131743409|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
131743410|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
131743411|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
131743412|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131743413|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
131743414|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
131743415|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
131743416|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
131743417|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
131743418|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
131743419|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
131743420|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
131743421|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
131743422|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
131743423|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
131905655|NCT00922636|474943109|FG001|Overall Study|Lack of Efficacy|7|||
131905656|NCT00922636|474943110|FG002|Overall Study|Lack of Efficacy|3|||
131905657|NCT00922636|474943111|FG003|Overall Study|Lack of Efficacy|2|||
131905658|NCT00922636|474943112|FG004|Overall Study|Lack of Efficacy|4|||
131905659|NCT00922636|474943108|FG000|Overall Study|Sponsor Decision|0|||
131905660|NCT00922636|474943109|FG001|Overall Study|Sponsor Decision|0|||
131905661|NCT00922636|474943110|FG002|Overall Study|Sponsor Decision|2|||
131905662|NCT00922636|474943111|FG003|Overall Study|Sponsor Decision|0|||
131905663|NCT00922636|474943112|FG004|Overall Study|Sponsor Decision|0|||
131905664|NCT00922636|474943108|FG000|Overall Study|Withdrawal by Subject|0|||
131905665|NCT00922636|474943109|FG001|Overall Study|Withdrawal by Subject|0|||
131905666|NCT00922636|474943110|FG002|Overall Study|Withdrawal by Subject|5|||
131905667|NCT00922636|474943111|FG003|Overall Study|Withdrawal by Subject|2|||
131905668|NCT00922636|474943112|FG004|Overall Study|Withdrawal by Subject|4|||
131905669|NCT00922636|474943108|FG000|Overall Study|Protocol Violation|0|||
131905670|NCT00922636|474943109|FG001|Overall Study|Protocol Violation|0|||
131905671|NCT00922636|474943110|FG002|Overall Study|Protocol Violation|2|||
131905672|NCT00922636|474943111|FG003|Overall Study|Protocol Violation|2|||
131905673|NCT00922636|474943112|FG004|Overall Study|Protocol Violation|0|||
131905674|NCT00922636|474943108|FG000|Overall Study|Entry Criteria Not Met|0|||
131905675|NCT00922636|474943109|FG001|Overall Study|Entry Criteria Not Met|0|||
131905676|NCT00922636|474943110|FG002|Overall Study|Entry Criteria Not Met|1|||
131905677|NCT00922636|474943111|FG003|Overall Study|Entry Criteria Not Met|1|||
131905678|NCT00922636|474943112|FG004|Overall Study|Entry Criteria Not Met|0|||
131743424|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
131743425|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
131743426|NCT01714817|474337461|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
131743427|NCT01714817|474337462|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
131905679|NCT00922636|474943108|FG000|Overall Study|Parent/Caregiver Decision|2|||
131905680|NCT00922636|474943109|FG001|Overall Study|Parent/Caregiver Decision|4|||
131905681|NCT00922636|474943110|FG002|Overall Study|Parent/Caregiver Decision|3|||
131743428|NCT02921763|474337463|FG000|Overall Study|Adverse Event|4|||
131743429|NCT02921763|474337463|FG000|Overall Study|Lost to Follow-up|4|||
131743430|NCT02921763|474337463|FG000|Overall Study|Lack of Efficacy|3|||
131743431|NCT02921763|474337463|FG000|Overall Study|Protocol Violation|2|||
131743432|NCT02921763|474337463|FG000|Overall Study|Withdrawal by Subject|2|||
131743433|NCT02921763|474337463|FG000|Overall Study|Physician Decision|1|||
131743434|NCT02921763|474337463|FG000|Overall Study|No data obtained|2|||
131743435|NCT04142216|474337464|FG000|Overall Study|Hospitalization|0|||
131743436|NCT04142216|474337465|FG001|Overall Study|Hospitalization|2|||
131743437|NCT04142216|474337464|FG000|Overall Study|Death|3|||
131743438|NCT04142216|474337465|FG001|Overall Study|Death|1|||
131743439|NCT04142216|474337464|FG000|Overall Study|Referral to another hemodialysis unit|3|||
131743440|NCT04142216|474337465|FG001|Overall Study|Referral to another hemodialysis unit|2|||
131743441|NCT04142216|474337464|FG000|Overall Study|Use of clove|0|||
131743442|NCT04142216|474337465|FG001|Overall Study|Use of clove|1|||
131743443|NCT01582971|474337466|FG000|Overall Study|Death|2|||
131743444|NCT01582971|474337467|FG001|Overall Study|Death|1|||
131743445|NCT01582971|474337466|FG000|Overall Study|Lost to Follow-up|18|||
131743446|NCT01582971|474337467|FG001|Overall Study|Lost to Follow-up|21|||
131743447|NCT01582971|474337466|FG000|Overall Study|Withdrawal by Subject|4|||
131743448|NCT01582971|474337467|FG001|Overall Study|Withdrawal by Subject|2|||
131743449|NCT01582971|474337466|FG000|Overall Study|Other|15|||
131743450|NCT01582971|474337467|FG001|Overall Study|Other|13|||
131743451|NCT02554253|474337475|FG000|Overall Study|ineligible after enrollment|1|||
131743452|NCT02554253|474337476|FG001|Overall Study|ineligible after enrollment|0|||
131743453|NCT02554253|474337475|FG000|Overall Study|converted to transcatheter procedure|0|||
131743454|NCT02554253|474337476|FG001|Overall Study|converted to transcatheter procedure|1|||
131743455|NCT02554253|474337475|FG000|Overall Study|received both drugs|0|||
131743456|NCT02554253|474337476|FG001|Overall Study|received both drugs|1|||
131743457|NCT01736254|474337479|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
131743458|NCT01736254|474337479|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
131743459|NCT02559206|474337480|FG000|Overall Study|Adverse Event|0|||
131743460|NCT02559206|474337481|FG001|Overall Study|Adverse Event|4|||
131905682|NCT00922636|474943111|FG003|Overall Study|Parent/Caregiver Decision|5|||
131743461|NCT02559206|474337482|FG002|Overall Study|Adverse Event|1|||
131905683|NCT00922636|474943112|FG004|Overall Study|Parent/Caregiver Decision|2|||
131905684|NCT00922636|474943108|FG000|Overall Study|Lost to Follow-up|1|||
131743462|NCT02559206|474337483|FG003|Overall Study|Adverse Event|5|||
131743463|NCT02559206|474337484|FG004|Overall Study|Adverse Event|3|||
131743464|NCT02559206|474337485|FG005|Overall Study|Adverse Event|0|||
131743465|NCT02559206|474337486|FG006|Overall Study|Adverse Event|1|||
131905685|NCT00922636|474943109|FG001|Overall Study|Lost to Follow-up|2|||
131905686|NCT00922636|474943110|FG002|Overall Study|Lost to Follow-up|2|||
131905687|NCT00922636|474943111|FG003|Overall Study|Lost to Follow-up|2|||
131905688|NCT00922636|474943112|FG004|Overall Study|Lost to Follow-up|4|||
131905689|NCT00557466|474943113|FG000|Overall Study|Adverse Event|3|||
131905690|NCT00557466|474943114|FG001|Overall Study|Adverse Event|1|||
131905691|NCT00557466|474943115|FG002|Overall Study|Adverse Event|4|||
131905692|NCT00557466|474943116|FG003|Overall Study|Adverse Event|1|||
131905693|NCT00557466|474943117|FG004|Overall Study|Adverse Event|2|||
131905694|NCT00557466|474943118|FG005|Overall Study|Adverse Event|4|||
131905695|NCT00557466|474943113|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131905696|NCT00557466|474943114|FG001|Overall Study|Abnormal laboratory value(s)|2|||
131905697|NCT00557466|474943115|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131905698|NCT00557466|474943116|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131905699|NCT00557466|474943117|FG004|Overall Study|Abnormal laboratory value(s)|0|||
131905700|NCT00557466|474943118|FG005|Overall Study|Abnormal laboratory value(s)|0|||
131905701|NCT00557466|474943113|FG000|Overall Study|Protocol deviation|0|||
131905702|NCT00557466|474943114|FG001|Overall Study|Protocol deviation|1|||
131905703|NCT00557466|474943115|FG002|Overall Study|Protocol deviation|0|||
131905704|NCT00557466|474943116|FG003|Overall Study|Protocol deviation|2|||
131905705|NCT00557466|474943117|FG004|Overall Study|Protocol deviation|0|||
131905706|NCT00557466|474943118|FG005|Overall Study|Protocol deviation|0|||
131905707|NCT00557466|474943113|FG000|Overall Study|Subject withdrew consent|0|||
131905708|NCT00557466|474943114|FG001|Overall Study|Subject withdrew consent|0|||
131905709|NCT00557466|474943115|FG002|Overall Study|Subject withdrew consent|0|||
131905710|NCT00557466|474943116|FG003|Overall Study|Subject withdrew consent|0|||
131905711|NCT00557466|474943117|FG004|Overall Study|Subject withdrew consent|1|||
131905712|NCT00557466|474943118|FG005|Overall Study|Subject withdrew consent|2|||
131905713|NCT00557466|474943113|FG000|Overall Study|Administrative problems|0|||
131905714|NCT00557466|474943114|FG001|Overall Study|Administrative problems|1|||
131905715|NCT00557466|474943115|FG002|Overall Study|Administrative problems|1|||
131905716|NCT00557466|474943116|FG003|Overall Study|Administrative problems|0|||
131905717|NCT00557466|474943117|FG004|Overall Study|Administrative problems|0|||
131905718|NCT00557466|474943118|FG005|Overall Study|Administrative problems|0|||
131905719|NCT00557466|474943113|FG000|Overall Study|Abnormal test procedure results|0|||
131905720|NCT00557466|474943114|FG001|Overall Study|Abnormal test procedure results|0|||
131905721|NCT00557466|474943115|FG002|Overall Study|Abnormal test procedure results|1|||
131905722|NCT00557466|474943116|FG003|Overall Study|Abnormal test procedure results|0|||
131905723|NCT00557466|474943117|FG004|Overall Study|Abnormal test procedure results|0|||
131905724|NCT00557466|474943118|FG005|Overall Study|Abnormal test procedure results|0|||
131905725|NCT00557466|474943113|FG000|Overall Study|Lost to Follow-up|0|||
131905726|NCT00557466|474943114|FG001|Overall Study|Lost to Follow-up|0|||
131905727|NCT00557466|474943115|FG002|Overall Study|Lost to Follow-up|0|||
131905728|NCT00557466|474943116|FG003|Overall Study|Lost to Follow-up|1|||
131905729|NCT00557466|474943117|FG004|Overall Study|Lost to Follow-up|0|||
131905730|NCT00557466|474943118|FG005|Overall Study|Lost to Follow-up|0|||
131905731|NCT01251952|474943121|FG000|Overall Study|Adverse Event|1|||
131905732|NCT00496769|474943122|FG000|Double Blind|>=1 reason assigned per patient|558|||
131905733|NCT00496769|474943123|FG001|Double Blind|>=1 reason assigned per patient|649|||
131905734|NCT00496769|474943124|FG002|Double Blind|>=1 reason assigned per patient|0|||
131905735|NCT00496769|474943122|FG000|Open Label|>=1 reason assigned per patient|0|||
131905736|NCT00496769|474943123|FG001|Open Label|>=1 reason assigned per patient|0|||
131905737|NCT00496769|474943124|FG002|Open Label|>=1 reason assigned per patient|1011|||
131905738|NCT02486692|474943125|FG000|Overall Study|did not login for randomization|4|||
131905739|NCT02486692|474943126|FG001|Overall Study|did not login for randomization|7|||
131905740|NCT03342001|474943127|FG000|Overall Study|Adverse Event|1|||
131905741|NCT03342001|474943127|FG000|Overall Study|Lost to Follow-up|1|||
131905742|NCT01130272|474943128|FG000|Overall Study|Adverse Event|2|||
131905743|NCT01130272|474943129|FG001|Overall Study|Adverse Event|5|||
131905744|NCT01130272|474943130|FG002|Overall Study|Adverse Event|6|||
131905745|NCT01130272|474943131|FG003|Overall Study|Adverse Event|22|||
131905746|NCT01130272|474943132|FG004|Overall Study|Adverse Event|7|||
131905747|NCT01130272|474943128|FG000|Overall Study|IVRS-confirmed constipation|0|||
131905748|NCT01130272|474943129|FG001|Overall Study|IVRS-confirmed constipation|1|||
131905749|NCT01130272|474943130|FG002|Overall Study|IVRS-confirmed constipation|1|||
131905750|NCT01130272|474943131|FG003|Overall Study|IVRS-confirmed constipation|2|||
131905751|NCT01130272|474943132|FG004|Overall Study|IVRS-confirmed constipation|0|||
131905752|NCT01130272|474943128|FG000|Overall Study|Rescue medications due to diarrhea|3|||
131905753|NCT01130272|474943129|FG001|Overall Study|Rescue medications due to diarrhea|5|||
131905754|NCT01130272|474943130|FG002|Overall Study|Rescue medications due to diarrhea|8|||
131905755|NCT01130272|474943131|FG003|Overall Study|Rescue medications due to diarrhea|8|||
131448947|NCT01208207|473272743|FG006|Part II|Physician Decision|0|||
131743466|NCT02559206|474337487|FG007|Overall Study|Adverse Event|0|||
131905756|NCT01130272|474943132|FG004|Overall Study|Rescue medications due to diarrhea|6|||
131905757|NCT01130272|474943128|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
131905758|NCT01130272|474943129|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
131905759|NCT01130272|474943130|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
131743467|NCT02559206|474337480|FG000|Overall Study|Protocol Violation|1|||
131743468|NCT02559206|474337481|FG001|Overall Study|Protocol Violation|0|||
131743469|NCT02559206|474337482|FG002|Overall Study|Protocol Violation|1|||
131743470|NCT02559206|474337483|FG003|Overall Study|Protocol Violation|0|||
131743471|NCT02559206|474337484|FG004|Overall Study|Protocol Violation|0|||
131743472|NCT02559206|474337485|FG005|Overall Study|Protocol Violation|2|||
131743473|NCT02559206|474337486|FG006|Overall Study|Protocol Violation|0|||
131743474|NCT02559206|474337487|FG007|Overall Study|Protocol Violation|0|||
131743475|NCT02559206|474337480|FG000|Overall Study|Withdrawal by Subject|3|||
131743476|NCT02559206|474337481|FG001|Overall Study|Withdrawal by Subject|3|||
131743477|NCT02559206|474337482|FG002|Overall Study|Withdrawal by Subject|1|||
131743478|NCT02559206|474337483|FG003|Overall Study|Withdrawal by Subject|3|||
131743479|NCT02559206|474337484|FG004|Overall Study|Withdrawal by Subject|5|||
131743480|NCT02559206|474337485|FG005|Overall Study|Withdrawal by Subject|4|||
131743481|NCT02559206|474337486|FG006|Overall Study|Withdrawal by Subject|1|||
131743482|NCT02559206|474337487|FG007|Overall Study|Withdrawal by Subject|2|||
131743483|NCT02559206|474337480|FG000|Overall Study|Lost to Follow-up|3|||
131743484|NCT02559206|474337481|FG001|Overall Study|Lost to Follow-up|5|||
131743485|NCT02559206|474337482|FG002|Overall Study|Lost to Follow-up|3|||
131743486|NCT02559206|474337483|FG003|Overall Study|Lost to Follow-up|3|||
131743487|NCT02559206|474337484|FG004|Overall Study|Lost to Follow-up|2|||
131743488|NCT02559206|474337485|FG005|Overall Study|Lost to Follow-up|5|||
131743489|NCT02559206|474337486|FG006|Overall Study|Lost to Follow-up|1|||
131743490|NCT02559206|474337487|FG007|Overall Study|Lost to Follow-up|4|||
131743491|NCT02559206|474337480|FG000|Overall Study|Lack of Efficacy|1|||
131743492|NCT02559206|474337481|FG001|Overall Study|Lack of Efficacy|0|||
131743493|NCT02559206|474337482|FG002|Overall Study|Lack of Efficacy|3|||
131743494|NCT02559206|474337483|FG003|Overall Study|Lack of Efficacy|2|||
131743495|NCT02559206|474337484|FG004|Overall Study|Lack of Efficacy|2|||
131743496|NCT02559206|474337485|FG005|Overall Study|Lack of Efficacy|3|||
131743497|NCT02559206|474337486|FG006|Overall Study|Lack of Efficacy|3|||
131743498|NCT02559206|474337487|FG007|Overall Study|Lack of Efficacy|3|||
131743499|NCT02559206|474337480|FG000|Overall Study|Other Not Specified|0|||
131743500|NCT02559206|474337481|FG001|Overall Study|Other Not Specified|0|||
131743501|NCT02559206|474337482|FG002|Overall Study|Other Not Specified|0|||
131743502|NCT02559206|474337483|FG003|Overall Study|Other Not Specified|1|||
131743503|NCT02559206|474337484|FG004|Overall Study|Other Not Specified|0|||
131743504|NCT02559206|474337485|FG005|Overall Study|Other Not Specified|0|||
131743505|NCT02559206|474337486|FG006|Overall Study|Other Not Specified|0|||
131743506|NCT02559206|474337487|FG007|Overall Study|Other Not Specified|0|||
131743507|NCT01561560|474337488|FG000|First Two Weeks of Wear|Time/job conflict|0|||
131743508|NCT01561560|474337489|FG001|First Two Weeks of Wear|Time/job conflict|1|||
131743509|NCT01561560|474337488|FG000|First Two Weeks of Wear|Adverse Event|0|||
131743510|NCT01561560|474337489|FG001|First Two Weeks of Wear|Adverse Event|1|||
131743511|NCT01561560|474337488|FG000|Second Two Weeks of Wear|Adverse Event|0|||
131743512|NCT01561560|474337489|FG001|Second Two Weeks of Wear|Adverse Event|1|||
131743513|NCT01871896|474337492|FG000|Overall Study|Lost to Follow-up|1|||
131743514|NCT00453180|474338661|FG000|Overall Study|Lost to Follow-up|2|||
131743515|NCT00453180|474338662|FG001|Overall Study|Lost to Follow-up|1|||
131743516|NCT00453180|474338661|FG000|Overall Study|Adverse Event|1|||
131743517|NCT00453180|474338662|FG001|Overall Study|Adverse Event|2|||
131743518|NCT02420795|474338669|FG000|Overall Study|Withdrawal by Subject|1|||
131743519|NCT02420795|474338670|FG001|Overall Study|Withdrawal by Subject|0|||
131743520|NCT02420795|474338671|FG002|Overall Study|Withdrawal by Subject|0|||
131743521|NCT02420795|474338669|FG000|Overall Study|Adverse Event|1|||
131743522|NCT02420795|474338670|FG001|Overall Study|Adverse Event|0|||
131743523|NCT02420795|474338671|FG002|Overall Study|Adverse Event|0|||
131743524|NCT02420795|474338669|FG000|Overall Study|Progressive disease|2|||
131743525|NCT02420795|474338670|FG001|Overall Study|Progressive disease|2|||
131743526|NCT02420795|474338671|FG002|Overall Study|Progressive disease|4|||
131743527|NCT02420795|474338669|FG000|Overall Study|Death|0|||
131743528|NCT02420795|474338670|FG001|Overall Study|Death|0|||
131743529|NCT02420795|474338671|FG002|Overall Study|Death|1|||
131743530|NCT01002742|474338674|FG000|Overall Study|Determined to be ineligible|0|||
131743531|NCT01002742|474338675|FG001|Overall Study|Determined to be ineligible|1|||
131743532|NCT02862548|474338687|FG000|Randomized Phase (Up to Week 48)|Death|0|||
131743533|NCT02862548|474338688|FG001|Randomized Phase (Up to Week 48)|Death|1|||
131743534|NCT02862548|474338687|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
131743535|NCT02862548|474338688|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
131743536|NCT02862548|474338687|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
131743537|NCT02862548|474338688|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
131743538|NCT02862548|474338687|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
131743539|NCT02862548|474338688|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
131743540|NCT00880763|474338689|FG000|Extension Period (Part 2)|Adverse Event|0|||
131743541|NCT00880763|474338690|FG001|Extension Period (Part 2)|Adverse Event|0|||
131743542|NCT00880763|474338691|FG002|Extension Period (Part 2)|Adverse Event|1|||
131743543|NCT00880763|474338692|FG003|Extension Period (Part 2)|Adverse Event|1|||
131743544|NCT00880763|474338689|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
131743545|NCT00880763|474338690|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
131743546|NCT00880763|474338691|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
131743547|NCT00880763|474338692|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
131743548|NCT00880763|474338689|FG000|Extension Period (Part 2)|Physician Decision|0|||
131743549|NCT00880763|474338690|FG001|Extension Period (Part 2)|Physician Decision|1|||
131743550|NCT00880763|474338691|FG002|Extension Period (Part 2)|Physician Decision|1|||
131743551|NCT00880763|474338692|FG003|Extension Period (Part 2)|Physician Decision|0|||
131743552|NCT00880763|474338689|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
131743553|NCT00880763|474338690|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
131743554|NCT00880763|474338691|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
131743555|NCT00880763|474338692|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
131743556|NCT00656084|474338693|FG000|Overall Study|Adverse Event|4|||
131743557|NCT00656084|474338693|FG000|Overall Study|Withdrawal by Subject|1|||
131743558|NCT00656084|474338693|FG000|Overall Study|Patient Request|1|||
131743559|NCT00656084|474338693|FG000|Overall Study|Investigator Request|1|||
131743560|NCT01293006|474338694|FG000|Period 2|Lost to Follow-up|1|||
131743561|NCT01293006|474338695|FG001|Period 2|Lost to Follow-up|0|||
131743562|NCT01293006|474338696|FG002|Period 2|Lost to Follow-up|0|||
131743563|NCT01293006|474338697|FG003|Period 2|Lost to Follow-up|0|||
131743564|NCT01494987|474338698|FG000|Overall Study|Adverse Event|6|||
131743565|NCT01494987|474338699|FG001|Overall Study|Adverse Event|5|||
131743566|NCT01494987|474338698|FG000|Overall Study|Hyperglycemia|6|||
131743567|NCT01494987|474338699|FG001|Overall Study|Hyperglycemia|4|||
131743568|NCT01494987|474338698|FG000|Overall Study|Investigator's Discretion|1|||
131743569|NCT01494987|474338699|FG001|Overall Study|Investigator's Discretion|2|||
131743570|NCT01494987|474338698|FG000|Overall Study|Lost to Follow-up|1|||
131743571|NCT01494987|474338699|FG001|Overall Study|Lost to Follow-up|1|||
131743572|NCT01494987|474338698|FG000|Overall Study|Protocol Violation|3|||
131743573|NCT01494987|474338699|FG001|Overall Study|Protocol Violation|3|||
131743574|NCT01494987|474338698|FG000|Overall Study|Subject Non-Compliance|9|||
131743575|NCT01494987|474338699|FG001|Overall Study|Subject Non-Compliance|10|||
131743576|NCT01494987|474338698|FG000|Overall Study|Subject Withdrew Consent|2|||
131743577|NCT01494987|474338699|FG001|Overall Study|Subject Withdrew Consent|3|||
131743578|NCT00436982|474338700|FG000|Overall Study|Withdrawal by Subject|3|||
131743579|NCT00436982|474338701|FG001|Overall Study|Withdrawal by Subject|1|||
131743580|NCT00436982|474338700|FG000|Overall Study|Did not receive allocated intervention|0|||
131743581|NCT00436982|474338701|FG001|Overall Study|Did not receive allocated intervention|1|||
131743582|NCT00436982|474338700|FG000|Overall Study|no RSA data|1|||
131743583|NCT00436982|474338701|FG001|Overall Study|no RSA data|2|||
131743584|NCT00953225|474338702|FG000|Overall Study|Withdrawal by Subject|2|||
131448948|NCT01208207|473272737|FG000|Part II|Protocol Violation|0|||
131448949|NCT01208207|473272738|FG001|Part II|Protocol Violation|0|||
131448950|NCT01208207|473272739|FG002|Part II|Protocol Violation|0|||
131448951|NCT01208207|473272740|FG003|Part II|Protocol Violation|1|||
131448952|NCT01208207|473272741|FG004|Part II|Protocol Violation|0|||
131448953|NCT01208207|473272742|FG005|Part II|Protocol Violation|0|||
131448954|NCT01208207|473272743|FG006|Part II|Protocol Violation|0|||
131448955|NCT01208207|473272737|FG000|Part II|Technical Problems|0|||
131448956|NCT01208207|473272738|FG001|Part II|Technical Problems|0|||
131448957|NCT01208207|473272739|FG002|Part II|Technical Problems|0|||
131448958|NCT01208207|473272740|FG003|Part II|Technical Problems|1|||
131448959|NCT01208207|473272741|FG004|Part II|Technical Problems|0|||
131448960|NCT01208207|473272742|FG005|Part II|Technical Problems|1|||
131448961|NCT01208207|473272743|FG006|Part II|Technical Problems|0|||
131448962|NCT00724698|473272744|FG000|Overall Study|Adverse Event|9|||
131448963|NCT00724698|473272744|FG000|Overall Study|Failure of Therapy|4|||
131448964|NCT00724698|473272744|FG000|Overall Study|Poor Compliance|16|||
131448965|NCT00724698|473272744|FG000|Overall Study|Lost to Follow-up|36|||
131448966|NCT00724698|473272744|FG000|Overall Study|No Info|25|||
131743585|NCT00953225|474338703|FG001|Overall Study|Withdrawal by Subject|0|||
131743586|NCT02384395|474338707|FG000|Overall Study|Physician Decision|4|||
131743587|NCT02384395|474338707|FG000|Overall Study|Withdrawal by Subject|3|||
131743588|NCT02384395|474338707|FG000|Overall Study|Lost to Follow-up|3|||
131743589|NCT00291499|474338708|FG000|Overall Study|Adverse Event|3|||
131448967|NCT02177032|473272747|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
131448968|NCT02177032|473272748|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
131448969|NCT02177032|473272749|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
131448970|NCT02177032|473272750|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
131448971|NCT02177032|473272747|FG000|Overall Study|Lost to Follow-up|0|||
131743590|NCT00291499|474338709|FG001|Overall Study|Adverse Event|8|||
131743591|NCT00291499|474338708|FG000|Overall Study|Change to other therapy|2|||
131743592|NCT00291499|474338709|FG001|Overall Study|Change to other therapy|1|||
131743593|NCT00291499|474338708|FG000|Overall Study|Intercurrent illness|1|||
131743594|NCT00291499|474338709|FG001|Overall Study|Intercurrent illness|0|||
131743595|NCT00291499|474338708|FG000|Overall Study|Protocol Violation|2|||
131743596|NCT00291499|474338709|FG001|Overall Study|Protocol Violation|2|||
131743597|NCT00291499|474338708|FG000|Overall Study|Other reasons|1|||
131743598|NCT00291499|474338709|FG001|Overall Study|Other reasons|4|||
131743599|NCT03939637|474338719|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
131743600|NCT03939637|474338720|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
131743601|NCT03939637|474338719|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
131743602|NCT03939637|474338720|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
131743603|NCT04268004|474338721|FG000|Overall Study|Excluded from analyses|0|||
131743604|NCT04268004|474338722|FG001|Overall Study|Excluded from analyses|1|||
131743605|NCT03783442|474338723|FG000|Overall Study|Death|252|||
131905760|NCT01130272|474943131|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
131905761|NCT01130272|474943132|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
131905762|NCT01130272|474943128|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
131905763|NCT01130272|474943129|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
131905764|NCT01130272|474943130|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
131905765|NCT01130272|474943131|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
131905766|NCT01130272|474943132|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
131905767|NCT01130272|474943128|FG000|Overall Study|Protocol Violation|0|||
131905768|NCT01130272|474943129|FG001|Overall Study|Protocol Violation|0|||
131905769|NCT01130272|474943130|FG002|Overall Study|Protocol Violation|3|||
131905770|NCT01130272|474943131|FG003|Overall Study|Protocol Violation|5|||
131743606|NCT03783442|474338724|FG001|Overall Study|Death|268|||
131743607|NCT03783442|474338723|FG000|Overall Study|Withdrawal by Subject|19|||
131743608|NCT03783442|474338724|FG001|Overall Study|Withdrawal by Subject|21|||
131743609|NCT03783442|474338723|FG000|Overall Study|Lost to Follow-up|7|||
131743610|NCT03783442|474338724|FG001|Overall Study|Lost to Follow-up|6|||
131743611|NCT03783442|474338723|FG000|Overall Study|Sponsor Ended Study|48|||
131743612|NCT03783442|474338724|FG001|Overall Study|Sponsor Ended Study|28|||
131743613|NCT04325906|474338725|FG000|Overall Study|Withdrawal by Subject|2|||
131743614|NCT04325906|474338726|FG001|Overall Study|Withdrawal by Subject|0|||
131743615|NCT01082367|474338727|FG000|Double-blind Period|Administrative problems|0|||
131743616|NCT01082367|474338728|FG001|Double-blind Period|Administrative problems|1|||
131743617|NCT01082367|474338727|FG000|Double-blind Period|Lack of Efficacy|5|||
131743618|NCT01082367|474338728|FG001|Double-blind Period|Lack of Efficacy|11|||
131743619|NCT01082367|474338727|FG000|Double-blind Period|Adverse Event|0|||
131743620|NCT01082367|474338728|FG001|Double-blind Period|Adverse Event|1|||
131743621|NCT01082367|474338727|FG000|Follow-up (F-U) Period|Administrative problems|1|||
131905771|NCT01130272|474943132|FG004|Overall Study|Protocol Violation|5|||
131905772|NCT01130272|474943128|FG000|Overall Study|Lost to Follow-up|4|||
131905773|NCT01130272|474943129|FG001|Overall Study|Lost to Follow-up|3|||
131905774|NCT01130272|474943130|FG002|Overall Study|Lost to Follow-up|4|||
131905775|NCT01130272|474943131|FG003|Overall Study|Lost to Follow-up|7|||
131905776|NCT01130272|474943132|FG004|Overall Study|Lost to Follow-up|6|||
131905777|NCT01130272|474943128|FG000|Overall Study|Withdrawal by Subject|4|||
131905778|NCT01130272|474943129|FG001|Overall Study|Withdrawal by Subject|11|||
131905779|NCT01130272|474943130|FG002|Overall Study|Withdrawal by Subject|10|||
131743622|NCT01082367|474338728|FG001|Follow-up (F-U) Period|Administrative problems|0|||
131743623|NCT01082367|474338727|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
131743624|NCT01082367|474338728|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
131743625|NCT01082367|474338727|FG000|Follow-up (F-U) Period|Adverse Event|0|||
131743626|NCT01082367|474338728|FG001|Follow-up (F-U) Period|Adverse Event|1|||
131743627|NCT00881361|474338729|FG000|Overall Study|Terminated prior to surgery|27|||
131743628|NCT00881361|474338730|FG001|Overall Study|Terminated prior to surgery|7|||
131743629|NCT00881361|474338731|FG002|Overall Study|Terminated prior to surgery|0|||
131743630|NCT00881361|474338729|FG000|Overall Study|Ineligible|17|||
131743631|NCT00881361|474338730|FG001|Overall Study|Ineligible|2|||
131743632|NCT00881361|474338731|FG002|Overall Study|Ineligible|2|||
131743633|NCT01381718|474338732|FG000|Overall Study|Withdrawal by Subject|2|||
131743634|NCT01381718|474338733|FG001|Overall Study|Withdrawal by Subject|5|||
131743635|NCT01381718|474338732|FG000|Overall Study|Lost to Follow-up|3|||
131743636|NCT01381718|474338733|FG001|Overall Study|Lost to Follow-up|5|||
131905780|NCT01130272|474943131|FG003|Overall Study|Withdrawal by Subject|9|||
131743637|NCT01381718|474338732|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
131905781|NCT01130272|474943132|FG004|Overall Study|Withdrawal by Subject|8|||
131905782|NCT01130272|474943128|FG000|Overall Study|Physician Decision|1|||
131905783|NCT01130272|474943129|FG001|Overall Study|Physician Decision|1|||
131743638|NCT01381718|474338733|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
131743639|NCT01522443|474338736|FG000|Overall Study|No longer receiving clinical benefit|36|||
131743640|NCT01522443|474338737|FG001|Overall Study|No longer receiving clinical benefit|28|||
131743641|NCT01522443|474338736|FG000|Overall Study|Adverse Event|10|||
131743642|NCT01522443|474338737|FG001|Overall Study|Adverse Event|15|||
131743643|NCT01522443|474338736|FG000|Overall Study|Withdrawal by Subject|5|||
131743644|NCT01522443|474338737|FG001|Overall Study|Withdrawal by Subject|8|||
131743645|NCT01522443|474338736|FG000|Overall Study|No study treatment given|1|||
131743646|NCT01522443|474338737|FG001|Overall Study|No study treatment given|1|||
131743647|NCT01522443|474338736|FG000|Overall Study|Other|1|||
131743648|NCT01522443|474338737|FG001|Overall Study|Other|3|||
131743649|NCT05590767|474338740|FG000|Overall Study|Protocol Violation|1|||
131743650|NCT05590767|474338740|FG000|Overall Study|surgery canceled|1|||
131743651|NCT05590767|474338740|FG000|Overall Study|interscalene brachial block not performed|1|||
131743652|NCT01764256|474338741|FG000|Received All Vaccinations|Adverse Event|1|||
131743653|NCT01764256|474338742|FG001|Received All Vaccinations|Adverse Event|1|||
131743654|NCT01764256|474338743|FG002|Received All Vaccinations|Adverse Event|0|||
131448972|NCT02177032|473272748|FG001|Overall Study|Lost to Follow-up|2|||
131448973|NCT02177032|473272749|FG002|Overall Study|Lost to Follow-up|0|||
131448974|NCT02177032|473272750|FG003|Overall Study|Lost to Follow-up|0|||
131448975|NCT02177032|473272747|FG000|Overall Study|OTHER|2|||
131448976|NCT02177032|473272748|FG001|Overall Study|OTHER|0|||
131743655|NCT01764256|474338744|FG003|Received All Vaccinations|Adverse Event|0|||
131743656|NCT01764256|474338741|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
131743657|NCT01764256|474338742|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
131743658|NCT01764256|474338743|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
131743659|NCT01764256|474338744|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
131743660|NCT01764256|474338741|FG000|Received All Vaccinations|Lost to Follow-up|1|||
131743661|NCT01764256|474338742|FG001|Received All Vaccinations|Lost to Follow-up|0|||
131743662|NCT01764256|474338743|FG002|Received All Vaccinations|Lost to Follow-up|0|||
131743663|NCT01764256|474338744|FG003|Received All Vaccinations|Lost to Follow-up|0|||
131743664|NCT01764256|474338741|FG000|Completed Study|Lost to Follow-up|0|||
131743665|NCT01764256|474338742|FG001|Completed Study|Lost to Follow-up|0|||
131743666|NCT01764256|474338743|FG002|Completed Study|Lost to Follow-up|0|||
131743667|NCT01764256|474338744|FG003|Completed Study|Lost to Follow-up|1|||
131743668|NCT00776555|474338754|FG000|Overall Study|Study terminated|3|||
131743669|NCT00776555|474338755|FG001|Overall Study|Study terminated|0|||
131743670|NCT02940626|474338758|FG000|Overall Study|Death|40|||
131743671|NCT02940626|474338759|FG001|Overall Study|Death|32|||
131743672|NCT02940626|474338758|FG000|Overall Study|Lost to Follow-up|5|||
131743673|NCT02940626|474338759|FG001|Overall Study|Lost to Follow-up|2|||
131905784|NCT01130272|474943130|FG002|Overall Study|Physician Decision|0|||
131743674|NCT02940626|474338758|FG000|Overall Study|Withdrawal by Subject|1|||
131743675|NCT02940626|474338759|FG001|Overall Study|Withdrawal by Subject|0|||
131743676|NCT02940626|474338758|FG000|Overall Study|Transfer to Hospice Care|1|||
131743677|NCT02940626|474338759|FG001|Overall Study|Transfer to Hospice Care|0|||
131743678|NCT02940626|474338758|FG000|Overall Study|Prohibited Concomitant Medication|0|||
131743679|NCT02940626|474338759|FG001|Overall Study|Prohibited Concomitant Medication|1|||
131743680|NCT00585923|474338761|FG000|Overall Study|Physician decided not to continue|31|||
131743681|NCT00585923|474338762|FG001|Overall Study|Physician decided not to continue|33|||
131743682|NCT00618449|474338763|FG000|Overall Study|Lost to Follow-up|98|||
131743683|NCT00618449|474338764|FG001|Overall Study|Lost to Follow-up|110|||
131743684|NCT01441115|474338765|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
131743685|NCT04311177|474338768|FG000|Overall Study|Adverse Event|3|||
131743686|NCT04311177|474338769|FG001|Overall Study|Adverse Event|1|||
131743687|NCT04311177|474338768|FG000|Overall Study|Physician Decision|4|||
131743688|NCT04311177|474338769|FG001|Overall Study|Physician Decision|3|||
131743689|NCT04311177|474338768|FG000|Overall Study|Withdrawal by Subject|1|||
131905785|NCT01130272|474943131|FG003|Overall Study|Physician Decision|1|||
131905786|NCT01130272|474943132|FG004|Overall Study|Physician Decision|2|||
131905787|NCT01130272|474943128|FG000|Overall Study|Sponsor decision|6|||
131905788|NCT01130272|474943129|FG001|Overall Study|Sponsor decision|15|||
131905789|NCT01130272|474943130|FG002|Overall Study|Sponsor decision|16|||
131905790|NCT01130272|474943131|FG003|Overall Study|Sponsor decision|13|||
131905791|NCT01130272|474943132|FG004|Overall Study|Sponsor decision|16|||
131905792|NCT01130272|474943128|FG000|Overall Study|Study arm discontinued|38|||
131905793|NCT01130272|474943129|FG001|Overall Study|Study arm discontinued|0|||
131905794|NCT01130272|474943130|FG002|Overall Study|Study arm discontinued|0|||
131905795|NCT01130272|474943131|FG003|Overall Study|Study arm discontinued|0|||
131905796|NCT01130272|474943132|FG004|Overall Study|Study arm discontinued|0|||
131905797|NCT01548404|474943133|FG000|Overall Study|Adverse Event|3|||
131905798|NCT01548404|474943134|FG001|Overall Study|Adverse Event|1|||
131905799|NCT01548404|474943133|FG000|Overall Study|Physician Decision|2|||
131448977|NCT02177032|473272749|FG002|Overall Study|OTHER|1|||
131448978|NCT02177032|473272750|FG003|Overall Study|OTHER|0|||
131743690|NCT04311177|474338769|FG001|Overall Study|Withdrawal by Subject|0|||
131743691|NCT03454412|474338776|FG000|Baseline Assesment|Physician Decision|12|||
131905800|NCT01548404|474943134|FG001|Overall Study|Physician Decision|1|||
131905801|NCT01548404|474943133|FG000|Overall Study|Inadequate response to study treatment|23|||
131905802|NCT01548404|474943134|FG001|Overall Study|Inadequate response to study treatment|7|||
131905803|NCT01548404|474943133|FG000|Overall Study|Lost to Follow-up|2|||
131905804|NCT01548404|474943134|FG001|Overall Study|Lost to Follow-up|0|||
131905805|NCT01548404|474943133|FG000|Overall Study|Withdrawal by Subject|0|||
131905806|NCT01548404|474943134|FG001|Overall Study|Withdrawal by Subject|3|||
131905807|NCT01548404|474943133|FG000|Overall Study|Other than specified above|0|||
131905808|NCT01548404|474943134|FG001|Overall Study|Other than specified above|2|||
131905809|NCT02351934|474943135|FG000|Allocation|POD weight<pre-op weight|3|||
131905810|NCT02351934|474943136|FG001|Allocation|POD weight<pre-op weight|0|||
131905811|NCT02351934|474943135|FG000|Allocation|Hypotension preventing administration|2|||
131905812|NCT02351934|474943136|FG001|Allocation|Hypotension preventing administration|0|||
131905813|NCT02351934|474943135|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
131905814|NCT02351934|474943136|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
131905815|NCT02351934|474943135|FG000|Follow-Up|POD weight<pre-op weight|3|||
131905816|NCT02351934|474943136|FG001|Follow-Up|POD weight<pre-op weight|0|||
131905817|NCT02351934|474943135|FG000|Follow-Up|Acute Kidney Injury|1|||
131905818|NCT02351934|474943136|FG001|Follow-Up|Acute Kidney Injury|0|||
131905819|NCT02351934|474943135|FG000|Follow-Up|Early dismissal|3|||
131905820|NCT02351934|474943136|FG001|Follow-Up|Early dismissal|0|||
131905821|NCT02351934|474943135|FG000|Follow-Up|Hypotension|3|||
131905822|NCT02351934|474943136|FG001|Follow-Up|Hypotension|0|||
131743692|NCT01681576|474338777|FG000|Period 1|Adverse Event|1|||
131743693|NCT01681576|474338778|FG001|Period 1|Adverse Event|0|||
131743694|NCT01681576|474338777|FG000|Period 1|Protocol Deviation|1|||
131743695|NCT01681576|474338778|FG001|Period 1|Protocol Deviation|0|||
131743696|NCT01681576|474338777|FG000|Period 2|subject/guardian decision|3|||
131743697|NCT01681576|474338778|FG001|Period 2|subject/guardian decision|1|||
131743698|NCT01681576|474338777|FG000|Period 2|Non-compliance with study treatment|1|||
131743699|NCT01681576|474338778|FG001|Period 2|Non-compliance with study treatment|0|||
131743700|NCT00377429|474338782|FG000|Overall Study|Withdrawal by Subject|5|||
131743701|NCT00377429|474338782|FG000|Overall Study|Adverse Event|8|||
131743702|NCT00377429|474338782|FG000|Overall Study|Physician Decision|1|||
131743703|NCT00377429|474338782|FG000|Overall Study|Patient non-compliance|1|||
131743704|NCT00640146|474340637|FG000|Overall Study|Adverse Event|2|||
131743705|NCT00640146|474340638|FG001|Overall Study|Adverse Event|0|||
131743706|NCT00640146|474340637|FG000|Overall Study|Lost to Follow-up|0|||
131743707|NCT00640146|474340638|FG001|Overall Study|Lost to Follow-up|1|||
131743708|NCT00640146|474340637|FG000|Overall Study|Lack of Efficacy|0|||
131743709|NCT00640146|474340638|FG001|Overall Study|Lack of Efficacy|1|||
131905823|NCT02351934|474943135|FG000|Follow-Up|No documentation|2|||
131905824|NCT02351934|474943136|FG001|Follow-Up|No documentation|0|||
131905825|NCT02351934|474943135|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
131905826|NCT02351934|474943136|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
131905827|NCT02351934|474943135|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
131905828|NCT02351934|474943136|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
131905829|NCT01739335|474943138|FG000|Overall Study|Lost to Follow-up|7|||
131905830|NCT01739335|474943139|FG001|Overall Study|Lost to Follow-up|4|||
131905831|NCT01739335|474943138|FG000|Overall Study|Ineligible patient randomized|0|||
131905832|NCT01739335|474943139|FG001|Overall Study|Ineligible patient randomized|1|||
131905833|NCT00752089|474943144|FG000|Overall Study|Adverse Event|1|||
131905834|NCT00752089|474943144|FG000|Overall Study|Protocol Deviation|2|||
131905835|NCT00752089|474943144|FG000|Overall Study|Could not attend visit 9|1|||
131905836|NCT00752089|474943144|FG000|Overall Study|Not capable of wearing partial denture|1|||
131905837|NCT00752089|474943144|FG000|Overall Study|Cannot continue the study|1|||
131905838|NCT01324102|474943145|FG000|Overall Study|illness|1|||
131905839|NCT01324102|474943146|FG001|Overall Study|illness|6|||
131448979|NCT02177032|473272747|FG000|Overall Study|Withdrawal by Subject|1|||
131448980|NCT02177032|473272748|FG001|Overall Study|Withdrawal by Subject|0|||
131743710|NCT00640146|474340637|FG000|Overall Study|Withdrawal by Subject|1|||
131905840|NCT01232790|474943149|FG000|Randomization|Withdrawal by Subject|2|||
131905841|NCT01232790|474943150|FG001|Randomization|Withdrawal by Subject|0|||
131905842|NCT01232790|474943149|FG000|Randomization|Protocol Violation|0|||
131905843|NCT01232790|474943150|FG001|Randomization|Protocol Violation|1|||
131905844|NCT01232790|474943149|FG000|Randomization|Physician Decision|0|||
131905845|NCT01232790|474943150|FG001|Randomization|Physician Decision|1|||
131743711|NCT00640146|474340638|FG001|Overall Study|Withdrawal by Subject|1|||
131743712|NCT00640146|474340637|FG000|Overall Study|Randomized but not treated|1|||
131743713|NCT00640146|474340638|FG001|Overall Study|Randomized but not treated|3|||
131905846|NCT01232790|474943149|FG000|Initial Assessment|Withdrawal by Subject|0|||
131905847|NCT01232790|474943150|FG001|Initial Assessment|Withdrawal by Subject|1|||
131905848|NCT01232790|474943149|FG000|First Crossover|Withdrawal by Subject|1|||
131905849|NCT01232790|474943150|FG001|First Crossover|Withdrawal by Subject|0|||
131905850|NCT01232790|474943149|FG000|Second Crossover|Withdrawal by Subject|1|||
131905851|NCT01232790|474943150|FG001|Second Crossover|Withdrawal by Subject|2|||
131448981|NCT02177032|473272749|FG002|Overall Study|Withdrawal by Subject|1|||
131905852|NCT02914834|474943151|FG000|Overall Study|Study halted due to COVID|1|||
131905853|NCT02914834|474943152|FG001|Overall Study|Study halted due to COVID|1|||
131905854|NCT02914834|474943151|FG000|Overall Study|1 subject withdrew|0|||
131905855|NCT02914834|474943152|FG001|Overall Study|1 subject withdrew|1|||
131905856|NCT01245101|474943155|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
131905857|NCT01245101|474943156|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
131905858|NCT01245101|474943155|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
131905859|NCT01245101|474943156|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
131905860|NCT01245101|474943155|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
131905861|NCT01245101|474943156|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
131905862|NCT01225549|474943157|FG000|Period 4 - Washout|Disallowed medication|0|||
131905863|NCT01225549|474943158|FG001|Period 4 - Washout|Disallowed medication|1|||
131905864|NCT01225549|474943159|FG002|Period 4 - Washout|Disallowed medication|0|||
131905865|NCT01225549|474943160|FG003|Period 4 - Washout|Disallowed medication|0|||
131905866|NCT01225549|474943161|FG004|Period 4 - Washout|Disallowed medication|0|||
131905867|NCT01225549|474943162|FG005|Period 4 - Washout|Disallowed medication|0|||
131905868|NCT01225549|474943163|FG006|Period 4 - Washout|Disallowed medication|0|||
131905869|NCT01225549|474943164|FG007|Period 4 - Washout|Disallowed medication|0|||
131905870|NCT01225549|474943165|FG008|Period 4 - Washout|Disallowed medication|0|||
131905871|NCT01225549|474943166|FG009|Period 4 - Washout|Disallowed medication|0|||
131905872|NCT01225549|474943157|FG000|Period 6 - Washout|Disallowed medication|0|||
131905873|NCT01225549|474943158|FG001|Period 6 - Washout|Disallowed medication|0|||
131905874|NCT01225549|474943159|FG002|Period 6 - Washout|Disallowed medication|0|||
131905875|NCT01225549|474943160|FG003|Period 6 - Washout|Disallowed medication|1|||
131905876|NCT01225549|474943161|FG004|Period 6 - Washout|Disallowed medication|0|||
131905877|NCT01225549|474943162|FG005|Period 6 - Washout|Disallowed medication|0|||
131905878|NCT01225549|474943163|FG006|Period 6 - Washout|Disallowed medication|0|||
131905879|NCT01225549|474943164|FG007|Period 6 - Washout|Disallowed medication|0|||
131905880|NCT01225549|474943165|FG008|Period 6 - Washout|Disallowed medication|0|||
131905881|NCT01225549|474943166|FG009|Period 6 - Washout|Disallowed medication|0|||
131905882|NCT04456686|474943169|FG000|Overall Study|Adverse Event|2|||
131905883|NCT04456686|474943170|FG001|Overall Study|Adverse Event|1|||
131905884|NCT04456686|474943169|FG000|Overall Study|Lack of Efficacy|3|||
131905885|NCT04456686|474943170|FG001|Overall Study|Lack of Efficacy|1|||
131905886|NCT04456686|474943169|FG000|Overall Study|Withdrew consent|3|||
131905887|NCT04456686|474943170|FG001|Overall Study|Withdrew consent|1|||
131905888|NCT04456686|474943169|FG000|Overall Study|Physician Decision|2|||
131905889|NCT04456686|474943170|FG001|Overall Study|Physician Decision|2|||
131905890|NCT04456686|474943169|FG000|Overall Study|Withdrawal by Subject|5|||
131905891|NCT04456686|474943170|FG001|Overall Study|Withdrawal by Subject|1|||
131905892|NCT04456686|474943169|FG000|Overall Study|Protocol Violation|0|||
131905893|NCT04456686|474943170|FG001|Overall Study|Protocol Violation|1|||
131905894|NCT00891813|474943172|FG000|Overall Study|Adverse Event|3|||
131905895|NCT00891813|474943172|FG000|Overall Study|Withdrawal by Subject|1|||
131905896|NCT00891813|474943172|FG000|Overall Study|Patient Noncompliance|6|||
131905897|NCT00891813|474943172|FG000|Overall Study|Protocol Violation|2|||
131905898|NCT00473083|474943177|FG000|Overall Study|Adverse Event|1|||
131905899|NCT00473083|474943178|FG001|Overall Study|Adverse Event|0|||
131905900|NCT00473083|474943179|FG002|Overall Study|Adverse Event|0|||
131905901|NCT02858401|474943180|FG000|Overall Study|Withdrew Consent|0|||
131905902|NCT02858401|474943181|FG001|Overall Study|Withdrew Consent|0|||
131905903|NCT02858401|474943182|FG002|Overall Study|Withdrew Consent|0|||
131905904|NCT02858401|474943183|FG003|Overall Study|Withdrew Consent|0|||
131905905|NCT02858401|474943184|FG004|Overall Study|Withdrew Consent|0|||
131905906|NCT02858401|474943185|FG005|Overall Study|Withdrew Consent|1|||
131905907|NCT02858401|474943186|FG006|Overall Study|Withdrew Consent|0|||
131905908|NCT02858401|474943180|FG000|Overall Study|Lost to Follow-up|0|||
131905909|NCT02858401|474943181|FG001|Overall Study|Lost to Follow-up|1|||
131905910|NCT02858401|474943182|FG002|Overall Study|Lost to Follow-up|0|||
131905911|NCT02858401|474943183|FG003|Overall Study|Lost to Follow-up|0|||
131905912|NCT02858401|474943184|FG004|Overall Study|Lost to Follow-up|0|||
131905913|NCT02858401|474943185|FG005|Overall Study|Lost to Follow-up|0|||
131905914|NCT02858401|474943186|FG006|Overall Study|Lost to Follow-up|0|||
131905915|NCT02513550|474943187|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
131905916|NCT02513550|474943188|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
131905917|NCT02513550|474943189|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
131905918|NCT02513550|474943190|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
131905919|NCT02513550|474943191|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131905920|NCT02513550|474943192|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
131905921|NCT02513550|474943187|FG000|Double Blind Treatment Period|Adverse Event|5|||
131905922|NCT02513550|474943188|FG001|Double Blind Treatment Period|Adverse Event|13|||
131905923|NCT02513550|474943189|FG002|Double Blind Treatment Period|Adverse Event|17|||
131905924|NCT02513550|474943190|FG003|Double Blind Treatment Period|Adverse Event|0|||
131905925|NCT02513550|474943191|FG004|Double Blind Treatment Period|Adverse Event|1|||
131905926|NCT02513550|474943192|FG005|Double Blind Treatment Period|Adverse Event|0|||
131905927|NCT02513550|474943187|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
131743714|NCT02528253|474340641|FG000|Overall Study|Adverse Event|3|||
131743715|NCT02528253|474340642|FG001|Overall Study|Adverse Event|4|||
131743716|NCT02528253|474340643|FG002|Overall Study|Adverse Event|4|||
131743717|NCT02528253|474340644|FG003|Overall Study|Adverse Event|8|||
131743718|NCT02528253|474340645|FG004|Overall Study|Adverse Event|18|||
131743719|NCT02528253|474340641|FG000|Overall Study|Death|2|||
131743720|NCT02528253|474340642|FG001|Overall Study|Death|2|||
131743721|NCT02528253|474340643|FG002|Overall Study|Death|1|||
131743722|NCT02528253|474340644|FG003|Overall Study|Death|0|||
131743723|NCT02528253|474340645|FG004|Overall Study|Death|1|||
131743724|NCT02528253|474340641|FG000|Overall Study|Insufficient clinical response|7|||
131743725|NCT02528253|474340642|FG001|Overall Study|Insufficient clinical response|10|||
131743726|NCT02528253|474340643|FG002|Overall Study|Insufficient clinical response|13|||
131743727|NCT02528253|474340644|FG003|Overall Study|Insufficient clinical response|12|||
131743728|NCT02528253|474340645|FG004|Overall Study|Insufficient clinical response|16|||
131743729|NCT02528253|474340641|FG000|Overall Study|Lost to Follow-up|16|||
131743730|NCT02528253|474340642|FG001|Overall Study|Lost to Follow-up|9|||
131743731|NCT02528253|474340643|FG002|Overall Study|Lost to Follow-up|31|||
131743732|NCT02528253|474340644|FG003|Overall Study|Lost to Follow-up|16|||
131743733|NCT02528253|474340645|FG004|Overall Study|Lost to Follow-up|34|||
131743734|NCT02528253|474340641|FG000|Overall Study|Other|21|||
131743735|NCT02528253|474340642|FG001|Overall Study|Other|22|||
131743736|NCT02528253|474340643|FG002|Overall Study|Other|58|||
131743737|NCT02528253|474340644|FG003|Overall Study|Other|52|||
131743738|NCT02528253|474340645|FG004|Overall Study|Other|76|||
131743739|NCT02528253|474340641|FG000|Overall Study|Withdrawal by Subject|25|||
131743740|NCT02528253|474340642|FG001|Overall Study|Withdrawal by Subject|20|||
131743741|NCT02528253|474340643|FG002|Overall Study|Withdrawal by Subject|29|||
131743742|NCT02528253|474340644|FG003|Overall Study|Withdrawal by Subject|48|||
131743743|NCT02528253|474340645|FG004|Overall Study|Withdrawal by Subject|73|||
131743744|NCT02528253|474340641|FG000|Overall Study|Protocol Violation|1|||
131743745|NCT02528253|474340642|FG001|Overall Study|Protocol Violation|2|||
131743746|NCT02528253|474340643|FG002|Overall Study|Protocol Violation|4|||
131743747|NCT02528253|474340644|FG003|Overall Study|Protocol Violation|0|||
131743748|NCT02528253|474340645|FG004|Overall Study|Protocol Violation|4|||
131743749|NCT02528253|474340641|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
131743750|NCT02528253|474340642|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
131743751|NCT02528253|474340643|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
131743752|NCT02528253|474340644|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
131743753|NCT02528253|474340645|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
131743754|NCT02966353|474340648|FG000|Overall Study|Withdrawal by Subject|7|||
131743755|NCT02966353|474340648|FG000|Overall Study|Adverse Event|4|||
131743756|NCT02966353|474340648|FG000|Overall Study|Death|4|||
131743757|NCT02966353|474340648|FG000|Overall Study|Physician Decision|3|||
131743758|NCT02966353|474340648|FG000|Overall Study|Progressive disease|2|||
131743759|NCT02966353|474340648|FG000|Overall Study|Protocol deviation|2|||
131743760|NCT03024255|474340651|FG000|Overall Study|Adverse Event|1|||
131743761|NCT03024255|474340652|FG001|Overall Study|Adverse Event|4|||
131743762|NCT03024255|474340653|FG002|Overall Study|Adverse Event|8|||
131743763|NCT03024255|474340654|FG003|Overall Study|Adverse Event|0|||
131743764|NCT03024255|474340651|FG000|Overall Study|Withdrawal by Subject|3|||
131743765|NCT03024255|474340652|FG001|Overall Study|Withdrawal by Subject|1|||
131743766|NCT03024255|474340653|FG002|Overall Study|Withdrawal by Subject|0|||
131743767|NCT03024255|474340654|FG003|Overall Study|Withdrawal by Subject|3|||
131743768|NCT03024255|474340651|FG000|Overall Study|Protocol Violation|0|||
131743769|NCT03024255|474340652|FG001|Overall Study|Protocol Violation|0|||
131743770|NCT03024255|474340653|FG002|Overall Study|Protocol Violation|2|||
131743771|NCT03024255|474340654|FG003|Overall Study|Protocol Violation|0|||
131743772|NCT03024255|474340651|FG000|Overall Study|Lost to Follow-up|1|||
131743773|NCT03024255|474340652|FG001|Overall Study|Lost to Follow-up|2|||
131743774|NCT03024255|474340653|FG002|Overall Study|Lost to Follow-up|1|||
131743775|NCT03024255|474340654|FG003|Overall Study|Lost to Follow-up|1|||
131743776|NCT03024255|474340651|FG000|Overall Study|Lack of Efficacy|1|||
131743777|NCT03024255|474340652|FG001|Overall Study|Lack of Efficacy|0|||
131743778|NCT03024255|474340653|FG002|Overall Study|Lack of Efficacy|0|||
131743779|NCT03024255|474340654|FG003|Overall Study|Lack of Efficacy|0|||
131743780|NCT03024255|474340651|FG000|Overall Study|Protocol Noncompliance|1|||
131743781|NCT03024255|474340652|FG001|Overall Study|Protocol Noncompliance|1|||
131743782|NCT03024255|474340653|FG002|Overall Study|Protocol Noncompliance|0|||
131743783|NCT03024255|474340654|FG003|Overall Study|Protocol Noncompliance|1|||
131743784|NCT03583606|474340655|FG000|Overall Study|Lost to Follow-up|0|||
131743785|NCT03583606|474340656|FG001|Overall Study|Lost to Follow-up|1|||
131743786|NCT03583606|474340657|FG002|Overall Study|Lost to Follow-up|0|||
131743787|NCT03583606|474340655|FG000|Overall Study|Ineligible at baseline|1|||
131743788|NCT03583606|474340656|FG001|Overall Study|Ineligible at baseline|0|||
131743789|NCT03583606|474340657|FG002|Overall Study|Ineligible at baseline|0|||
131743790|NCT03250377|474340662|FG000|Overall Study|Adverse Event|2|||
131743791|NCT03250377|474340663|FG001|Overall Study|Adverse Event|4|||
131743792|NCT03250377|474340664|FG002|Overall Study|Adverse Event|0|||
131743793|NCT03250377|474340665|FG003|Overall Study|Adverse Event|4|||
131743794|NCT03250377|474340662|FG000|Overall Study|Lack of Efficacy|5|||
131743795|NCT03250377|474340663|FG001|Overall Study|Lack of Efficacy|14|||
131743796|NCT03250377|474340664|FG002|Overall Study|Lack of Efficacy|1|||
131743797|NCT03250377|474340665|FG003|Overall Study|Lack of Efficacy|3|||
131743798|NCT03250377|474340662|FG000|Overall Study|Protocol Violation|0|||
131743799|NCT03250377|474340663|FG001|Overall Study|Protocol Violation|2|||
131743800|NCT03250377|474340664|FG002|Overall Study|Protocol Violation|0|||
131743801|NCT03250377|474340665|FG003|Overall Study|Protocol Violation|1|||
131743802|NCT03250377|474340662|FG000|Overall Study|Lost to Follow-up|0|||
131743803|NCT03250377|474340663|FG001|Overall Study|Lost to Follow-up|1|||
131743804|NCT03250377|474340664|FG002|Overall Study|Lost to Follow-up|0|||
131743805|NCT03250377|474340665|FG003|Overall Study|Lost to Follow-up|0|||
131743806|NCT03250377|474340662|FG000|Overall Study|Withdrawal by Subject|7|||
131743807|NCT03250377|474340663|FG001|Overall Study|Withdrawal by Subject|7|||
131743808|NCT03250377|474340664|FG002|Overall Study|Withdrawal by Subject|0|||
131743809|NCT03250377|474340665|FG003|Overall Study|Withdrawal by Subject|4|||
131743810|NCT03250377|474340662|FG000|Overall Study|Investigator's Judgment|1|||
131743811|NCT03250377|474340663|FG001|Overall Study|Investigator's Judgment|0|||
131743812|NCT03250377|474340664|FG002|Overall Study|Investigator's Judgment|0|||
131743813|NCT03250377|474340665|FG003|Overall Study|Investigator's Judgment|0|||
131743814|NCT03250377|474340662|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
131743815|NCT03250377|474340663|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
131743816|NCT03250377|474340664|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
131743817|NCT03250377|474340665|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
131743818|NCT03250377|474340662|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
131743819|NCT03250377|474340663|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
131743820|NCT03250377|474340664|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
131743821|NCT03250377|474340665|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
131743822|NCT03250377|474340662|FG000|Overall Study|Epilepsy Surgery|0|||
131905928|NCT02513550|474943188|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
131905929|NCT02513550|474943189|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
131905930|NCT02513550|474943190|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
131905931|NCT02513550|474943191|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
131905932|NCT02513550|474943192|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
131905933|NCT02513550|474943187|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
131905934|NCT02513550|474943188|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
131905935|NCT02513550|474943189|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
131905936|NCT02513550|474943190|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
131743823|NCT03250377|474340663|FG001|Overall Study|Epilepsy Surgery|1|||
131743824|NCT03250377|474340664|FG002|Overall Study|Epilepsy Surgery|2|||
131743825|NCT03250377|474340665|FG003|Overall Study|Epilepsy Surgery|0|||
131743826|NCT03250377|474340662|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
131743827|NCT03250377|474340663|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
131743828|NCT03250377|474340664|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
131743829|NCT03250377|474340665|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
131743830|NCT03250377|474340662|FG000|Overall Study|Request From The Sponsor|0|||
131743831|NCT03250377|474340663|FG001|Overall Study|Request From The Sponsor|1|||
131743832|NCT03250377|474340664|FG002|Overall Study|Request From The Sponsor|0|||
131743833|NCT03250377|474340665|FG003|Overall Study|Request From The Sponsor|0|||
131743834|NCT03250377|474340662|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
131743835|NCT03250377|474340663|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
131743836|NCT03250377|474340664|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
131743837|NCT03250377|474340665|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
131743838|NCT03250377|474340662|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
131743839|NCT03250377|474340663|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
131743840|NCT03250377|474340664|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
131743841|NCT03250377|474340665|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
131743842|NCT03250377|474340662|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
131905937|NCT02513550|474943191|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
131905938|NCT02513550|474943192|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
131905939|NCT02513550|474943187|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131905940|NCT02513550|474943188|FG001|Double Blind Treatment Period|Protocol Violation|1|||
131905941|NCT02513550|474943189|FG002|Double Blind Treatment Period|Protocol Violation|4|||
131905942|NCT02513550|474943190|FG003|Double Blind Treatment Period|Protocol Violation|0|||
131905943|NCT02513550|474943191|FG004|Double Blind Treatment Period|Protocol Violation|0|||
131905944|NCT02513550|474943192|FG005|Double Blind Treatment Period|Protocol Violation|0|||
131905945|NCT02513550|474943187|FG000|Double Blind Treatment Period|Physician Decision|2|||
131905946|NCT02513550|474943188|FG001|Double Blind Treatment Period|Physician Decision|0|||
131743843|NCT03250377|474340663|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
131905947|NCT02513550|474943189|FG002|Double Blind Treatment Period|Physician Decision|4|||
131743844|NCT03250377|474340664|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
131743845|NCT03250377|474340665|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
131743846|NCT03250377|474340662|FG000|Overall Study|Pregnancy Event|0|||
131743847|NCT03250377|474340663|FG001|Overall Study|Pregnancy Event|1|||
131743848|NCT03250377|474340664|FG002|Overall Study|Pregnancy Event|0|||
131743849|NCT03250377|474340665|FG003|Overall Study|Pregnancy Event|0|||
131743850|NCT03250377|474340662|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
131743851|NCT03250377|474340663|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
131743852|NCT03250377|474340664|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
131743853|NCT03250377|474340665|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
131743854|NCT03250377|474340662|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
131743855|NCT03250377|474340663|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
131743856|NCT03250377|474340664|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
131743857|NCT03250377|474340665|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
131743858|NCT03250377|474340662|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
131743859|NCT03250377|474340663|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
131743860|NCT03250377|474340664|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
131743861|NCT03250377|474340665|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
131743862|NCT03250377|474340662|FG000|Overall Study|Patient requested to change hospital|0|||
131743863|NCT03250377|474340663|FG001|Overall Study|Patient requested to change hospital|0|||
131743864|NCT03250377|474340664|FG002|Overall Study|Patient requested to change hospital|0|||
131743865|NCT03250377|474340665|FG003|Overall Study|Patient requested to change hospital|1|||
131743866|NCT03250377|474340662|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
131743867|NCT03250377|474340663|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
131743868|NCT03250377|474340664|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
131743869|NCT03250377|474340665|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
131743870|NCT00817206|474340666|FG000|Overall Study|Adverse Event|10|||
131743871|NCT00817206|474340667|FG001|Overall Study|Adverse Event|3|||
131743872|NCT00817206|474340666|FG000|Overall Study|Protocol Violation|0|||
131743873|NCT00817206|474340667|FG001|Overall Study|Protocol Violation|2|||
131743874|NCT00817206|474340666|FG000|Overall Study|Lost to Follow-up|0|||
131743875|NCT00817206|474340667|FG001|Overall Study|Lost to Follow-up|1|||
131743876|NCT00817206|474340666|FG000|Overall Study|Death|2|||
131743877|NCT00817206|474340667|FG001|Overall Study|Death|0|||
131743878|NCT00817206|474340666|FG000|Overall Study|Withdrawal by Subject|7|||
131743879|NCT00817206|474340667|FG001|Overall Study|Withdrawal by Subject|3|||
131743880|NCT00817206|474340666|FG000|Overall Study|Physician Decision|2|||
131743881|NCT00817206|474340667|FG001|Overall Study|Physician Decision|0|||
131743882|NCT00126581|474340668|FG000|Overall Study|Adverse Event|3|||
131743883|NCT00126581|474340669|FG001|Overall Study|Adverse Event|7|||
131743884|NCT00126581|474340668|FG000|Overall Study|Death|3|||
131743885|NCT00126581|474340669|FG001|Overall Study|Death|2|||
131743886|NCT00126581|474340668|FG000|Overall Study|Withdrawal by Subject|1|||
131743887|NCT00126581|474340669|FG001|Overall Study|Withdrawal by Subject|4|||
131743888|NCT00126581|474340668|FG000|Overall Study|Alternative therapy|3|||
131743889|NCT00126581|474340669|FG001|Overall Study|Alternative therapy|3|||
131743890|NCT00126581|474340668|FG000|Overall Study|Other illness/MD discretion|3|||
131743891|NCT00126581|474340669|FG001|Overall Study|Other illness/MD discretion|4|||
131743892|NCT03728140|474340671|FG000|Overall Study|Abnormal embryo transfer operation|10|||
131743893|NCT03728140|474340672|FG001|Overall Study|Abnormal embryo transfer operation|7|||
131743894|NCT02034552|474340673|FG000|Overall Study|Never treated|3|||
131743895|NCT02034552|474340674|FG001|Overall Study|Never treated|2|||
131743896|NCT02034552|474340675|FG002|Overall Study|Never treated|0|||
131743897|NCT02034552|474340673|FG000|Overall Study|Radiological progression|3|||
131743898|NCT02034552|474340674|FG001|Overall Study|Radiological progression|5|||
131743899|NCT02034552|474340675|FG002|Overall Study|Radiological progression|4|||
131743900|NCT02034552|474340673|FG000|Overall Study|AE not assoc. with disease progression|1|||
131743901|NCT02034552|474340674|FG001|Overall Study|AE not assoc. with disease progression|4|||
131743902|NCT02034552|474340675|FG002|Overall Study|AE not assoc. with disease progression|2|||
131743903|NCT02034552|474340673|FG000|Overall Study|AE associated with disease progression|0|||
131743904|NCT02034552|474340674|FG001|Overall Study|AE associated with disease progression|1|||
131743905|NCT02034552|474340675|FG002|Overall Study|AE associated with disease progression|0|||
131743906|NCT02034552|474340673|FG000|Overall Study|Withdrawal by Subject|2|||
131743907|NCT02034552|474340674|FG001|Overall Study|Withdrawal by Subject|1|||
131743908|NCT02034552|474340675|FG002|Overall Study|Withdrawal by Subject|1|||
131743909|NCT02034552|474340673|FG000|Overall Study|Non-compliance with study drug|0|||
131743910|NCT02034552|474340674|FG001|Overall Study|Non-compliance with study drug|0|||
131743911|NCT02034552|474340675|FG002|Overall Study|Non-compliance with study drug|1|||
131743912|NCT02034552|474340673|FG000|Overall Study|Clinical progression|5|||
131743913|NCT02034552|474340674|FG001|Overall Study|Clinical progression|7|||
131743914|NCT02034552|474340675|FG002|Overall Study|Clinical progression|9|||
131743915|NCT05224076|474340676|FG000|Overall Study|Lost to Follow-up|24|||
131743916|NCT04190186|474340677|FG000|Overall Study|ILR is no longer functioning|0|||
131743917|NCT04190186|474340678|FG001|Overall Study|ILR is no longer functioning|1|||
131743918|NCT04190186|474340677|FG000|Overall Study|Lost to Follow-up|0|||
131743919|NCT04190186|474340678|FG001|Overall Study|Lost to Follow-up|1|||
131743920|NCT04190186|474340677|FG000|Overall Study|Withdrawal by Subject|2|||
131743921|NCT04190186|474340678|FG001|Overall Study|Withdrawal by Subject|0|||
131743922|NCT04190186|474340677|FG000|Overall Study|Subject choice to explant|1|||
131743923|NCT04190186|474340678|FG001|Overall Study|Subject choice to explant|0|||
131743924|NCT04190186|474340677|FG000|Overall Study|Physician Decision|0|||
131743925|NCT04190186|474340678|FG001|Overall Study|Physician Decision|1|||
131743926|NCT04190186|474340677|FG000|Overall Study|Study was stopped|4|||
131743927|NCT04190186|474340678|FG001|Overall Study|Study was stopped|5|||
131743928|NCT02016898|474340679|FG000|Overall Study|Death|1|||
131743929|NCT02016898|474340680|FG001|Overall Study|Death|1|||
131743930|NCT02016898|474340679|FG000|Overall Study|Lost to Follow-up|4|||
131743931|NCT02016898|474340680|FG001|Overall Study|Lost to Follow-up|4|||
131743932|NCT01665768|474340681|FG000|Overall Study|Adverse Event|3|||
131743933|NCT01665768|474340681|FG000|Overall Study|Lack of Efficacy|19|||
131743934|NCT01665768|474340681|FG000|Overall Study|Withdrawal by Subject|1|||
131743935|NCT01413542|474340686|FG000|Overall Study|Physician Decision|1|||
131743936|NCT01413542|474340687|FG001|Overall Study|Physician Decision|0|||
131743937|NCT01413542|474340688|FG002|Overall Study|Physician Decision|3|||
131743938|NCT01413542|474340689|FG003|Overall Study|Physician Decision|0|||
131743939|NCT01413542|474340686|FG000|Overall Study|Adverse Event|0|||
131743940|NCT01413542|474340687|FG001|Overall Study|Adverse Event|0|||
131743941|NCT01413542|474340688|FG002|Overall Study|Adverse Event|0|||
131743942|NCT01413542|474340689|FG003|Overall Study|Adverse Event|1|||
131743943|NCT02505542|474340690|FG000|Part A: Open-Label Period|Adverse Event|31|||
131743944|NCT02505542|474340691|FG001|Part A: Open-Label Period|Adverse Event|0|||
131743945|NCT02505542|474340692|FG002|Part A: Open-Label Period|Adverse Event|0|||
131743946|NCT02505542|474340693|FG003|Part A: Open-Label Period|Adverse Event|0|||
131743947|NCT02505542|474340690|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
131743948|NCT02505542|474340691|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
131743949|NCT02505542|474340692|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
131743950|NCT02505542|474340693|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
131743951|NCT02505542|474340690|FG000|Part A: Open-Label Period|Protocol Violation|1|||
131743952|NCT02505542|474340691|FG001|Part A: Open-Label Period|Protocol Violation|0|||
131743953|NCT02505542|474340692|FG002|Part A: Open-Label Period|Protocol Violation|0|||
131743954|NCT02505542|474340693|FG003|Part A: Open-Label Period|Protocol Violation|0|||
131743955|NCT02505542|474340690|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
131743956|NCT02505542|474340691|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
131743957|NCT02505542|474340692|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
131743958|NCT02505542|474340693|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
131743959|NCT02505542|474340690|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
131743960|NCT02505542|474340691|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
131743961|NCT02505542|474340692|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
131743962|NCT02505542|474340693|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
131743963|NCT02505542|474340690|FG000|Part A: Open-Label Period|New medical history available|1|||
131743964|NCT02505542|474340691|FG001|Part A: Open-Label Period|New medical history available|0|||
131743965|NCT02505542|474340692|FG002|Part A: Open-Label Period|New medical history available|0|||
131743966|NCT02505542|474340693|FG003|Part A: Open-Label Period|New medical history available|0|||
131743967|NCT02505542|474340690|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
131743968|NCT02505542|474340691|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
131743969|NCT02505542|474340692|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
131743970|NCT02505542|474340693|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
131743971|NCT02505542|474340690|FG000|Part A: Open-Label Period|Pregnancy|2|||
131743972|NCT02505542|474340691|FG001|Part A: Open-Label Period|Pregnancy|0|||
131743973|NCT02505542|474340692|FG002|Part A: Open-Label Period|Pregnancy|0|||
131743974|NCT02505542|474340693|FG003|Part A: Open-Label Period|Pregnancy|0|||
131743975|NCT02505542|474340690|FG000|Part A: Open-Label Period|Sponsor directive|1|||
131743976|NCT02505542|474340691|FG001|Part A: Open-Label Period|Sponsor directive|0|||
131743977|NCT02505542|474340692|FG002|Part A: Open-Label Period|Sponsor directive|0|||
131743978|NCT02505542|474340693|FG003|Part A: Open-Label Period|Sponsor directive|0|||
131743979|NCT02505542|474340690|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
131743980|NCT02505542|474340691|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
131743981|NCT02505542|474340692|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
131743982|NCT02505542|474340693|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
131743983|NCT02505542|474340690|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
131743984|NCT02505542|474340691|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
131743985|NCT02505542|474340692|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
131743986|NCT02505542|474340693|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
131743987|NCT02505542|474340690|FG000|Part A: Open-Label Period|Non-compliance|1|||
131743988|NCT02505542|474340691|FG001|Part A: Open-Label Period|Non-compliance|0|||
131743989|NCT02505542|474340692|FG002|Part A: Open-Label Period|Non-compliance|0|||
131743990|NCT02505542|474340693|FG003|Part A: Open-Label Period|Non-compliance|0|||
131743991|NCT02505542|474340690|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
131743992|NCT02505542|474340691|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
131743993|NCT02505542|474340692|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
131743994|NCT02505542|474340693|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
131743995|NCT02505542|474340690|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
131743996|NCT02505542|474340691|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
131743997|NCT02505542|474340692|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
131743998|NCT02505542|474340693|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
131743999|NCT02505542|474340690|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
131744000|NCT02505542|474340691|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
131744001|NCT02505542|474340692|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
131744002|NCT02505542|474340693|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
131744003|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Adverse Event|0|||
131744004|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Adverse Event|0|||
131744005|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Adverse Event|1|||
131744006|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Adverse Event|3|||
131744007|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
131744008|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
131744009|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
131744010|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
131744011|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
131744012|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
131744013|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
131744014|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
131744015|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
131744016|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
131744017|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
131744018|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
131744019|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
131744020|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
131744021|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
131744022|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
131744023|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
131744024|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
131744025|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
131744026|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
131744027|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
131744028|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
131744029|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
131744030|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
131744031|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Miscalculation|0|||
131744032|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Miscalculation|1|||
131744033|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Miscalculation|0|||
131744034|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Miscalculation|0|||
131744035|NCT02505542|474340690|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
131744036|NCT02505542|474340691|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
131744037|NCT02505542|474340692|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
131744038|NCT02505542|474340693|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
131744039|NCT02759861|474340694|FG000|Overall Study|Death|1|||
131744040|NCT00618995|474340695|FG000|Period 1|Adverse Event|0|||
131744041|NCT00618995|474340696|FG001|Period 1|Adverse Event|0|||
131744042|NCT00618995|474340697|FG002|Period 1|Adverse Event|1|||
131744043|NCT00618995|474340698|FG003|Period 1|Adverse Event|0|||
131744044|NCT00618995|474340695|FG000|Period 1|Protocol Violation|0|||
131448982|NCT02177032|473272750|FG003|Overall Study|Withdrawal by Subject|0|||
131744045|NCT00618995|474340696|FG001|Period 1|Protocol Violation|1|||
131744046|NCT00618995|474340697|FG002|Period 1|Protocol Violation|1|||
131744047|NCT00618995|474340698|FG003|Period 1|Protocol Violation|0|||
131744048|NCT00618995|474340695|FG000|Period 2|Protocol Violation|0|||
131744049|NCT00618995|474340696|FG001|Period 2|Protocol Violation|0|||
131744050|NCT00618995|474340697|FG002|Period 2|Protocol Violation|1|||
131744051|NCT00618995|474340698|FG003|Period 2|Protocol Violation|0|||
131744052|NCT00618995|474340695|FG000|Period 4|Adverse Event|1|||
131744053|NCT00618995|474340696|FG001|Period 4|Adverse Event|0|||
131744054|NCT00618995|474340697|FG002|Period 4|Adverse Event|0|||
131744055|NCT00618995|474340698|FG003|Period 4|Adverse Event|0|||
131744056|NCT02988219|474340701|FG000|Overall Study|Lack of Efficacy|1|||
131744057|NCT02988219|474340702|FG001|Overall Study|Lack of Efficacy|1|||
131744058|NCT02988219|474340701|FG000|Overall Study|Withdrawal by Subject|0|||
131744059|NCT02988219|474340702|FG001|Overall Study|Withdrawal by Subject|2|||
131744060|NCT00992186|474340703|FG000|Overall Study|Withdrawal by Subject|2|||
131744061|NCT00992186|474340703|FG000|Overall Study|Protocol Violation|1|||
131744062|NCT00992186|474340703|FG000|Overall Study|Physician Decision|1|||
131744063|NCT00992186|474340703|FG000|Overall Study|Adverse Event|9|||
131744064|NCT00992186|474340703|FG000|Overall Study|Progressive Disease|30|||
131744065|NCT00992186|474340703|FG000|Overall Study|Refusal To Receive Study Agent|3|||
131744066|NCT01896856|474340704|FG000|Overall Study|Transportation issues / Non-compliance|0|||
131744067|NCT01896856|474340705|FG001|Overall Study|Transportation issues / Non-compliance|0|||
131744068|NCT01896856|474340706|FG002|Overall Study|Transportation issues / Non-compliance|1|||
131744069|NCT01896856|474340707|FG003|Overall Study|Transportation issues / Non-compliance|0|||
131744070|NCT01896856|474340708|FG004|Overall Study|Transportation issues / Non-compliance|0|||
131744071|NCT01896856|474340709|FG005|Overall Study|Transportation issues / Non-compliance|0|||
131744072|NCT00225212|474340716|FG000|Overall Study|Disease progression|2|||
131744073|NCT00225212|474340716|FG000|Overall Study|Death|1|||
131744074|NCT00225212|474340716|FG000|Overall Study|Adverse Event|2|||
131744075|NCT00225212|474340716|FG000|Overall Study|Intercurrent illness|1|||
131744076|NCT05159362|474340719|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
131744077|NCT05159362|474340720|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
131744078|NCT05159362|474340721|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
131744079|NCT01309841|474340722|FG000|Overall Study|Other|0|||
131744080|NCT01309841|474340723|FG001|Overall Study|Other|1|||
131744081|NCT01309841|474340724|FG002|Overall Study|Other|1|||
131744082|NCT01309841|474340722|FG000|Overall Study|Lost to Follow-up|7|||
131744083|NCT01309841|474340723|FG001|Overall Study|Lost to Follow-up|6|||
131744084|NCT01309841|474340724|FG002|Overall Study|Lost to Follow-up|4|||
131744085|NCT01309841|474340722|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
131744086|NCT01309841|474340723|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
131744087|NCT01309841|474340724|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
131744088|NCT01309841|474340722|FG000|Overall Study|Lack of Efficacy|0|||
131744089|NCT01309841|474340723|FG001|Overall Study|Lack of Efficacy|0|||
131744090|NCT01309841|474340724|FG002|Overall Study|Lack of Efficacy|2|||
131744091|NCT01309841|474340722|FG000|Overall Study|Adverse Event|9|||
131744092|NCT01309841|474340723|FG001|Overall Study|Adverse Event|22|||
131744093|NCT01309841|474340724|FG002|Overall Study|Adverse Event|11|||
131744094|NCT01309841|474340722|FG000|Overall Study|Death|1|||
131744095|NCT01309841|474340723|FG001|Overall Study|Death|0|||
131744096|NCT01309841|474340724|FG002|Overall Study|Death|0|||
131744097|NCT01309841|474340722|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131744098|NCT01309841|474340723|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131744099|NCT01309841|474340724|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
131744100|NCT01309841|474340722|FG000|Overall Study|Withdrawal by Subject|17|||
131744101|NCT01309841|474340723|FG001|Overall Study|Withdrawal by Subject|6|||
131744102|NCT01309841|474340724|FG002|Overall Study|Withdrawal by Subject|13|||
131744103|NCT01309841|474340722|FG000|Overall Study|Did Not Receive Treatment|2|||
131744104|NCT01309841|474340723|FG001|Overall Study|Did Not Receive Treatment|0|||
131744105|NCT01309841|474340724|FG002|Overall Study|Did Not Receive Treatment|1|||
131744106|NCT01309841|474340722|FG000|Overall Study|Severe non-compliance with protocol|0|||
131744107|NCT01309841|474340723|FG001|Overall Study|Severe non-compliance with protocol|5|||
131744108|NCT01309841|474340724|FG002|Overall Study|Severe non-compliance with protocol|2|||
131744109|NCT00105560|474340725|FG000|Overall Study|Lost to Follow-up|1|||
131744110|NCT03699631|474340727|FG000|Overall Study|Adverse Event|3|||
131744111|NCT01324622|474340728|FG000|Overall Study|Lost to Follow-up|7|||
131744112|NCT01324622|474340729|FG001|Overall Study|Lost to Follow-up|7|||
131744113|NCT01324622|474340728|FG000|Overall Study|Death|1|||
131905948|NCT02513550|474943190|FG003|Double Blind Treatment Period|Physician Decision|0|||
131744114|NCT01324622|474340729|FG001|Overall Study|Death|0|||
131744115|NCT01324622|474340728|FG000|Overall Study|Lack of Efficacy|1|||
131744116|NCT01324622|474340729|FG001|Overall Study|Lack of Efficacy|0|||
131744117|NCT00138424|474340730|FG000|Overall Study|Physician Decision|0|||
131744118|NCT00138424|474340731|FG001|Overall Study|Physician Decision|1|||
131744119|NCT00138424|474340732|FG002|Overall Study|Physician Decision|0|||
131744120|NCT00138424|474340733|FG003|Overall Study|Physician Decision|0|||
131744121|NCT00413062|474340734|FG000|Overall Study|Adverse event/serious adverse event|289|||
131744122|NCT00413062|474340735|FG001|Overall Study|Adverse event/serious adverse event|56|||
131744123|NCT00413062|474340734|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
131744124|NCT00413062|474340735|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
131744125|NCT00413062|474340734|FG000|Overall Study|Withdrawal of informed consent|111|||
131744126|NCT00413062|474340735|FG001|Overall Study|Withdrawal of informed consent|36|||
131744127|NCT00413062|474340734|FG000|Overall Study|Pregnancy|15|||
131744128|NCT00413062|474340735|FG001|Overall Study|Pregnancy|5|||
131744129|NCT00413062|474340734|FG000|Overall Study|Pregnancy wish|17|||
131744130|NCT00413062|474340735|FG001|Overall Study|Pregnancy wish|6|||
131744131|NCT00413062|474340734|FG000|Overall Study|Lost to Follow-up|175|||
131744132|NCT00413062|474340735|FG001|Overall Study|Lost to Follow-up|73|||
131744133|NCT00413062|474340734|FG000|Overall Study|Other reason|70|||
131744134|NCT00413062|474340735|FG001|Overall Study|Other reason|34|||
131744135|NCT02176291|474340736|FG000|Overall Study|Death|1|||
131744136|NCT02176291|474340737|FG001|Overall Study|Death|0|||
131744137|NCT02176291|474340736|FG000|Overall Study|non compliance with protocol|2|||
131744138|NCT02176291|474340737|FG001|Overall Study|non compliance with protocol|0|||
131744139|NCT02176291|474340736|FG000|Overall Study|Withdrawal by Subject|2|||
131744140|NCT02176291|474340737|FG001|Overall Study|Withdrawal by Subject|0|||
131744141|NCT02815293|474340740|FG000|Overall Study|Study termination by sponsor|10|||
131744142|NCT02815293|474340741|FG001|Overall Study|Study termination by sponsor|7|||
131744143|NCT02815293|474340742|FG002|Overall Study|Study termination by sponsor|0|||
131744144|NCT02815293|474340740|FG000|Overall Study|Participants not randomized|0|||
131744145|NCT02815293|474340741|FG001|Overall Study|Participants not randomized|0|||
131744146|NCT02815293|474340742|FG002|Overall Study|Participants not randomized|18|||
131744147|NCT02815293|474340740|FG000|Overall Study|Adverse Event|0|||
131744148|NCT02815293|474340741|FG001|Overall Study|Adverse Event|1|||
131744149|NCT02815293|474340742|FG002|Overall Study|Adverse Event|0|||
131744150|NCT00006604|474340745|FG000|Overall Study|Met study objective - no further FU|1|||
131744151|NCT00006604|474340746|FG001|Overall Study|Met study objective - no further FU|0|||
131744152|NCT00006604|474340747|FG002|Overall Study|Met study objective - no further FU|0|||
131744153|NCT00006604|474340748|FG003|Overall Study|Met study objective - no further FU|0|||
131744154|NCT00006604|474340749|FG004|Overall Study|Met study objective - no further FU|0|||
131744155|NCT00006604|474340750|FG005|Overall Study|Met study objective - no further FU|0|||
131744156|NCT00006604|474340751|FG006|Overall Study|Met study objective - no further FU|0|||
131744157|NCT00006604|474340752|FG007|Overall Study|Met study objective - no further FU|0|||
131744158|NCT00006604|474340753|FG008|Overall Study|Met study objective - no further FU|0|||
131744159|NCT00006604|474340754|FG009|Overall Study|Met study objective - no further FU|0|||
131744160|NCT00006604|474340755|FG010|Overall Study|Met study objective - no further FU|0|||
131744161|NCT00006604|474340756|FG011|Overall Study|Met study objective - no further FU|0|||
131744162|NCT00006604|474340757|FG012|Overall Study|Met study objective - no further FU|0|||
131744163|NCT00006604|474340758|FG013|Overall Study|Met study objective - no further FU|0|||
131744164|NCT00006604|474340759|FG014|Overall Study|Met study objective - no further FU|1|||
131744165|NCT00006604|474340760|FG015|Overall Study|Met study objective - no further FU|1|||
131744166|NCT00006604|474340761|FG016|Overall Study|Met study objective - no further FU|0|||
131744167|NCT00006604|474340745|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
131744168|NCT00006604|474340746|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
131744169|NCT00006604|474340747|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
131744170|NCT00006604|474340748|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
131744171|NCT00006604|474340749|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
131744172|NCT00006604|474340750|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
131744173|NCT00006604|474340751|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
131744174|NCT00006604|474340752|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
131744175|NCT00006604|474340753|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
131744176|NCT00006604|474340754|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
131744177|NCT00006604|474340755|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
131744178|NCT00006604|474340756|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
131744179|NCT00006604|474340757|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
131744180|NCT00006604|474340758|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
131744181|NCT00006604|474340759|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
131744182|NCT00006604|474340760|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
131744183|NCT00006604|474340761|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
131744184|NCT00006604|474340745|FG000|Overall Study|Death|0|||
131744185|NCT00006604|474340746|FG001|Overall Study|Death|0|||
131744186|NCT00006604|474340747|FG002|Overall Study|Death|0|||
131744187|NCT00006604|474340748|FG003|Overall Study|Death|0|||
131744188|NCT00006604|474340749|FG004|Overall Study|Death|0|||
131744189|NCT00006604|474340750|FG005|Overall Study|Death|0|||
131744190|NCT00006604|474340751|FG006|Overall Study|Death|0|||
131744191|NCT00006604|474340752|FG007|Overall Study|Death|0|||
131744192|NCT00006604|474340753|FG008|Overall Study|Death|0|||
131744193|NCT00006604|474340754|FG009|Overall Study|Death|1|||
131744194|NCT00006604|474340755|FG010|Overall Study|Death|1|||
131744195|NCT00006604|474340756|FG011|Overall Study|Death|1|||
131744196|NCT00006604|474340757|FG012|Overall Study|Death|0|||
131744197|NCT00006604|474340758|FG013|Overall Study|Death|0|||
131744198|NCT00006604|474340759|FG014|Overall Study|Death|0|||
131744199|NCT00006604|474340760|FG015|Overall Study|Death|0|||
131744200|NCT00006604|474340761|FG016|Overall Study|Death|0|||
131744201|NCT00006604|474340745|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131744202|NCT00006604|474340746|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131744203|NCT00006604|474340747|FG002|Overall Study|Severe debilitation, unable to continue|0|||
131744204|NCT00006604|474340748|FG003|Overall Study|Severe debilitation, unable to continue|0|||
131744205|NCT00006604|474340749|FG004|Overall Study|Severe debilitation, unable to continue|0|||
131744206|NCT00006604|474340750|FG005|Overall Study|Severe debilitation, unable to continue|0|||
131744207|NCT00006604|474340751|FG006|Overall Study|Severe debilitation, unable to continue|3|||
131744208|NCT00006604|474340752|FG007|Overall Study|Severe debilitation, unable to continue|0|||
131744209|NCT00006604|474340753|FG008|Overall Study|Severe debilitation, unable to continue|0|||
131744210|NCT00006604|474340754|FG009|Overall Study|Severe debilitation, unable to continue|5|||
131744211|NCT00006604|474340755|FG010|Overall Study|Severe debilitation, unable to continue|0|||
131744212|NCT00006604|474340756|FG011|Overall Study|Severe debilitation, unable to continue|2|||
131744213|NCT00006604|474340757|FG012|Overall Study|Severe debilitation, unable to continue|1|||
131744214|NCT00006604|474340758|FG013|Overall Study|Severe debilitation, unable to continue|0|||
131744215|NCT00006604|474340759|FG014|Overall Study|Severe debilitation, unable to continue|2|||
131744216|NCT00006604|474340760|FG015|Overall Study|Severe debilitation, unable to continue|0|||
131744217|NCT00006604|474340761|FG016|Overall Study|Severe debilitation, unable to continue|0|||
131744218|NCT00006604|474340745|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
131744219|NCT00006604|474340746|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
131744220|NCT00006604|474340747|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
131744221|NCT00006604|474340748|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
131744222|NCT00006604|474340749|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
131744223|NCT00006604|474340750|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
131744224|NCT00006604|474340751|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
131744225|NCT00006604|474340752|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
131744226|NCT00006604|474340753|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
131744227|NCT00006604|474340754|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
131744228|NCT00006604|474340755|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
131744229|NCT00006604|474340756|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
131744230|NCT00006604|474340757|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
131744231|NCT00006604|474340758|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
131744232|NCT00006604|474340759|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
131744233|NCT00006604|474340760|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
131744234|NCT00006604|474340761|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
131744235|NCT00006604|474340745|FG000|Overall Study|Site closing|0|||
131744236|NCT00006604|474340746|FG001|Overall Study|Site closing|0|||
131744237|NCT00006604|474340747|FG002|Overall Study|Site closing|1|||
131744238|NCT00006604|474340748|FG003|Overall Study|Site closing|1|||
131744239|NCT00006604|474340749|FG004|Overall Study|Site closing|0|||
131744240|NCT00006604|474340750|FG005|Overall Study|Site closing|0|||
131744241|NCT00006604|474340751|FG006|Overall Study|Site closing|0|||
131744242|NCT00006604|474340752|FG007|Overall Study|Site closing|1|||
131744243|NCT00006604|474340753|FG008|Overall Study|Site closing|0|||
131744244|NCT00006604|474340754|FG009|Overall Study|Site closing|0|||
131744245|NCT00006604|474340755|FG010|Overall Study|Site closing|0|||
131744246|NCT00006604|474340756|FG011|Overall Study|Site closing|1|||
131744247|NCT00006604|474340757|FG012|Overall Study|Site closing|1|||
131744248|NCT00006604|474340758|FG013|Overall Study|Site closing|1|||
131744249|NCT00006604|474340759|FG014|Overall Study|Site closing|0|||
131744250|NCT00006604|474340760|FG015|Overall Study|Site closing|0|||
131744251|NCT00006604|474340761|FG016|Overall Study|Site closing|1|||
131744252|NCT00006604|474340745|FG000|Overall Study|Withdrawal by Subject|1|||
131744253|NCT00006604|474340746|FG001|Overall Study|Withdrawal by Subject|0|||
131744254|NCT00006604|474340747|FG002|Overall Study|Withdrawal by Subject|2|||
131744255|NCT00006604|474340748|FG003|Overall Study|Withdrawal by Subject|0|||
131744256|NCT00006604|474340749|FG004|Overall Study|Withdrawal by Subject|1|||
131744257|NCT00006604|474340750|FG005|Overall Study|Withdrawal by Subject|2|||
131744258|NCT00006604|474340751|FG006|Overall Study|Withdrawal by Subject|2|||
131744259|NCT00006604|474340752|FG007|Overall Study|Withdrawal by Subject|0|||
131744260|NCT00006604|474340753|FG008|Overall Study|Withdrawal by Subject|1|||
131744261|NCT00006604|474340754|FG009|Overall Study|Withdrawal by Subject|3|||
131744262|NCT00006604|474340755|FG010|Overall Study|Withdrawal by Subject|2|||
131744263|NCT00006604|474340756|FG011|Overall Study|Withdrawal by Subject|0|||
131744264|NCT00006604|474340757|FG012|Overall Study|Withdrawal by Subject|1|||
131744265|NCT00006604|474340758|FG013|Overall Study|Withdrawal by Subject|2|||
131744266|NCT00006604|474340759|FG014|Overall Study|Withdrawal by Subject|1|||
131744267|NCT00006604|474340760|FG015|Overall Study|Withdrawal by Subject|0|||
131744268|NCT00006604|474340761|FG016|Overall Study|Withdrawal by Subject|1|||
131744269|NCT00006604|474340745|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
131744270|NCT00006604|474340746|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
131744271|NCT00006604|474340747|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
131744272|NCT00006604|474340748|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
131744273|NCT00006604|474340749|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
131744274|NCT00006604|474340750|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
131744275|NCT00006604|474340751|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
131744276|NCT00006604|474340752|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
131744277|NCT00006604|474340753|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
131744278|NCT00006604|474340754|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
131744279|NCT00006604|474340755|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
131744280|NCT00006604|474340756|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
131744281|NCT00006604|474340757|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
131744282|NCT00006604|474340758|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
131744283|NCT00006604|474340759|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
131744284|NCT00006604|474340760|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
131744285|NCT00006604|474340761|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
131744286|NCT00006604|474340745|FG000|Overall Study|Lost to Follow-up|0|||
131744287|NCT00006604|474340746|FG001|Overall Study|Lost to Follow-up|0|||
131744288|NCT00006604|474340747|FG002|Overall Study|Lost to Follow-up|0|||
131744289|NCT00006604|474340748|FG003|Overall Study|Lost to Follow-up|0|||
131744290|NCT00006604|474340749|FG004|Overall Study|Lost to Follow-up|0|||
131744291|NCT00006604|474340750|FG005|Overall Study|Lost to Follow-up|0|||
131744292|NCT00006604|474340751|FG006|Overall Study|Lost to Follow-up|0|||
131744293|NCT00006604|474340752|FG007|Overall Study|Lost to Follow-up|1|||
131744294|NCT00006604|474340753|FG008|Overall Study|Lost to Follow-up|0|||
131744295|NCT00006604|474340754|FG009|Overall Study|Lost to Follow-up|2|||
131744296|NCT00006604|474340755|FG010|Overall Study|Lost to Follow-up|0|||
131744297|NCT00006604|474340756|FG011|Overall Study|Lost to Follow-up|0|||
131744298|NCT00006604|474340757|FG012|Overall Study|Lost to Follow-up|0|||
131744299|NCT00006604|474340758|FG013|Overall Study|Lost to Follow-up|0|||
131744300|NCT00006604|474340759|FG014|Overall Study|Lost to Follow-up|0|||
131744301|NCT00006604|474340760|FG015|Overall Study|Lost to Follow-up|1|||
131744302|NCT00006604|474340761|FG016|Overall Study|Lost to Follow-up|3|||
131744303|NCT00006604|474340745|FG000|Overall Study|Other Reason|0|||
131744304|NCT00006604|474340746|FG001|Overall Study|Other Reason|0|||
131744305|NCT00006604|474340747|FG002|Overall Study|Other Reason|0|||
131744306|NCT00006604|474340748|FG003|Overall Study|Other Reason|0|||
131744307|NCT00006604|474340749|FG004|Overall Study|Other Reason|0|||
131744308|NCT00006604|474340750|FG005|Overall Study|Other Reason|1|||
131744309|NCT00006604|474340751|FG006|Overall Study|Other Reason|0|||
131744310|NCT00006604|474340752|FG007|Overall Study|Other Reason|0|||
131744311|NCT00006604|474340753|FG008|Overall Study|Other Reason|0|||
131744312|NCT00006604|474340754|FG009|Overall Study|Other Reason|1|||
131744313|NCT00006604|474340755|FG010|Overall Study|Other Reason|0|||
131744314|NCT00006604|474340756|FG011|Overall Study|Other Reason|0|||
131744315|NCT00006604|474340757|FG012|Overall Study|Other Reason|0|||
131448983|NCT00665652|473272751|FG000|Overall Study|Adverse Event|4|||
131448984|NCT00665652|473272751|FG000|Overall Study|Death|1|||
131744316|NCT00006604|474340758|FG013|Overall Study|Other Reason|0|||
131744317|NCT00006604|474340759|FG014|Overall Study|Other Reason|0|||
131744318|NCT00006604|474340760|FG015|Overall Study|Other Reason|0|||
131744319|NCT00006604|474340761|FG016|Overall Study|Other Reason|0|||
131744320|NCT01056341|474340762|FG000|Overall Study|Treatment Intolerance|0|||
131744321|NCT01056341|474340763|FG001|Overall Study|Treatment Intolerance|2|||
131744322|NCT01056341|474340764|FG002|Overall Study|Treatment Intolerance|0|||
131744323|NCT01056341|474340765|FG003|Overall Study|Treatment Intolerance|2|||
131744324|NCT01056341|474340766|FG004|Overall Study|Treatment Intolerance|0|||
131905949|NCT02513550|474943191|FG004|Double Blind Treatment Period|Physician Decision|0|||
131905950|NCT02513550|474943192|FG005|Double Blind Treatment Period|Physician Decision|0|||
131744325|NCT01056341|474340762|FG000|Overall Study|Lack of Efficacy|32|||
131744326|NCT01056341|474340763|FG001|Overall Study|Lack of Efficacy|30|||
131744327|NCT01056341|474340764|FG002|Overall Study|Lack of Efficacy|7|||
131744328|NCT01056341|474340765|FG003|Overall Study|Lack of Efficacy|25|||
131744329|NCT01056341|474340766|FG004|Overall Study|Lack of Efficacy|9|||
131744330|NCT01056341|474340762|FG000|Overall Study|Other reasons|4|||
131744331|NCT01056341|474340763|FG001|Overall Study|Other reasons|4|||
131744332|NCT01056341|474340764|FG002|Overall Study|Other reasons|8|||
131744333|NCT01056341|474340765|FG003|Overall Study|Other reasons|9|||
131744334|NCT01056341|474340766|FG004|Overall Study|Other reasons|5|||
131744335|NCT01167582|474340767|FG000|Overall Study|Lost to Follow-up|0|||
131744336|NCT01167582|474340768|FG001|Overall Study|Lost to Follow-up|1|||
131744337|NCT00805545|474340769|FG000|Overall Study|Protocol Violation|3|||
131744338|NCT00805545|474340770|FG001|Overall Study|Protocol Violation|2|||
131744339|NCT00805545|474340769|FG000|Overall Study|Protocol Violation|3|||
131744340|NCT00805545|474340770|FG001|Overall Study|Protocol Violation|1|||
131744341|NCT01182337|474340771|FG000|Overall Study|Withdrawal by Subject|3|||
131744342|NCT01182337|474340772|FG001|Overall Study|Withdrawal by Subject|1|||
131744343|NCT01182337|474340771|FG000|Overall Study|Lost to Follow-up|0|||
131744344|NCT01182337|474340772|FG001|Overall Study|Lost to Follow-up|1|||
131744345|NCT03448224|474340773|FG000|Overall Study|Provided same answer to every question|1|||
131744346|NCT03448224|474340774|FG001|Overall Study|Provided same answer to every question|0|||
131744347|NCT01021813|474340775|FG000|DB Treatment Phase|Adverse Event|60|||
131744348|NCT01021813|474340776|FG001|DB Treatment Phase|Adverse Event|22|||
131744349|NCT01021813|474340777|FG002|DB Treatment Phase|Adverse Event|0|||
131744350|NCT01021813|474340778|FG003|DB Treatment Phase|Adverse Event|0|||
131744351|NCT01021813|474340779|FG004|DB Treatment Phase|Adverse Event|0|||
131744352|NCT01021813|474340775|FG000|DB Treatment Phase|Lack of Efficacy|44|||
131744353|NCT01021813|474340776|FG001|DB Treatment Phase|Lack of Efficacy|28|||
131744354|NCT01021813|474340777|FG002|DB Treatment Phase|Lack of Efficacy|0|||
131744355|NCT01021813|474340778|FG003|DB Treatment Phase|Lack of Efficacy|0|||
131744356|NCT01021813|474340779|FG004|DB Treatment Phase|Lack of Efficacy|0|||
131744357|NCT01021813|474340775|FG000|DB Treatment Phase|Lost to Follow-up|14|||
131744358|NCT01021813|474340776|FG001|DB Treatment Phase|Lost to Follow-up|12|||
131744359|NCT01021813|474340777|FG002|DB Treatment Phase|Lost to Follow-up|0|||
131744360|NCT01021813|474340778|FG003|DB Treatment Phase|Lost to Follow-up|0|||
131744361|NCT01021813|474340779|FG004|DB Treatment Phase|Lost to Follow-up|0|||
131744362|NCT01021813|474340775|FG000|DB Treatment Phase|Physician Decision|17|||
131744363|NCT01021813|474340776|FG001|DB Treatment Phase|Physician Decision|8|||
131744364|NCT01021813|474340777|FG002|DB Treatment Phase|Physician Decision|0|||
131744365|NCT01021813|474340778|FG003|DB Treatment Phase|Physician Decision|0|||
131744366|NCT01021813|474340779|FG004|DB Treatment Phase|Physician Decision|0|||
131744367|NCT01021813|474340775|FG000|DB Treatment Phase|Pregnancy|1|||
131744368|NCT01021813|474340776|FG001|DB Treatment Phase|Pregnancy|0|||
131744369|NCT01021813|474340777|FG002|DB Treatment Phase|Pregnancy|0|||
131744370|NCT01021813|474340778|FG003|DB Treatment Phase|Pregnancy|0|||
131744371|NCT01021813|474340779|FG004|DB Treatment Phase|Pregnancy|0|||
131744372|NCT01021813|474340775|FG000|DB Treatment Phase|Protocol Violation|4|||
131744373|NCT01021813|474340776|FG001|DB Treatment Phase|Protocol Violation|3|||
131744374|NCT01021813|474340777|FG002|DB Treatment Phase|Protocol Violation|0|||
131744375|NCT01021813|474340778|FG003|DB Treatment Phase|Protocol Violation|0|||
131744376|NCT01021813|474340779|FG004|DB Treatment Phase|Protocol Violation|0|||
131744377|NCT01021813|474340775|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
131744378|NCT01021813|474340776|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
131744379|NCT01021813|474340777|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
131744380|NCT01021813|474340778|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
131744381|NCT01021813|474340779|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
131905951|NCT02513550|474943187|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
131905952|NCT02513550|474943188|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
131905953|NCT02513550|474943189|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
131744382|NCT01021813|474340775|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
131744383|NCT01021813|474340776|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
131744384|NCT01021813|474340777|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
131744385|NCT01021813|474340778|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
131744386|NCT01021813|474340779|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
131744387|NCT01021813|474340775|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131744388|NCT01021813|474340776|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131744389|NCT01021813|474340777|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131744390|NCT01021813|474340778|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
131744391|NCT01021813|474340779|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131744392|NCT01021813|474340775|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131744393|NCT01021813|474340776|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131744394|NCT01021813|474340777|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131744395|NCT01021813|474340778|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131744396|NCT01021813|474340779|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
131744397|NCT01021813|474340775|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131744398|NCT01021813|474340776|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131744399|NCT01021813|474340777|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
131744400|NCT01021813|474340778|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131744401|NCT01021813|474340779|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131744402|NCT01021813|474340775|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
131744403|NCT01021813|474340776|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
131744404|NCT01021813|474340777|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
131744405|NCT01021813|474340778|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
131744406|NCT01021813|474340779|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
131744407|NCT03103906|474340780|FG000|Overall Study|Adverse Event|2|||
131744408|NCT03103906|474340781|FG001|Overall Study|Adverse Event|3|||
131744409|NCT03103906|474340780|FG000|Overall Study|Other|2|||
131744410|NCT03103906|474340781|FG001|Overall Study|Other|0|||
131744411|NCT03571256|474340782|FG000|Overall Study|Adverse Event|3|||
131744412|NCT03571256|474340783|FG001|Overall Study|Adverse Event|0|||
131744413|NCT03571256|474340784|FG002|Overall Study|Adverse Event|1|||
131744414|NCT03571256|474340782|FG000|Overall Study|Withdrawal by Subject|3|||
131744415|NCT03571256|474340783|FG001|Overall Study|Withdrawal by Subject|1|||
131744416|NCT03571256|474340784|FG002|Overall Study|Withdrawal by Subject|1|||
131744417|NCT03571256|474340782|FG000|Overall Study|Other than specified|0|||
131744418|NCT03571256|474340783|FG001|Overall Study|Other than specified|1|||
131744419|NCT03571256|474340784|FG002|Overall Study|Other than specified|1|||
131744420|NCT03571256|474340782|FG000|Overall Study|Protocol Violation|0|||
131744421|NCT03571256|474340783|FG001|Overall Study|Protocol Violation|1|||
131744422|NCT03571256|474340784|FG002|Overall Study|Protocol Violation|1|||
131744423|NCT00575094|474340785|FG000|Overall Study|Adverse Event|2|||
131744424|NCT00575094|474340785|FG000|Overall Study|Withdrawal by Subject|1|||
131744425|NCT00772382|474340790|FG000|Overall Study|Adverse Event|19|||
131744426|NCT00772382|474340790|FG000|Overall Study|Death|6|||
131744427|NCT00772382|474340790|FG000|Overall Study|Lack of Efficacy|4|||
131744428|NCT00772382|474340790|FG000|Overall Study|Physician Decision|5|||
131744429|NCT00772382|474340790|FG000|Overall Study|Protocol Violation|1|||
131744430|NCT00772382|474340790|FG000|Overall Study|Withdrawal by Subject|10|||
131744431|NCT00772382|474340790|FG000|Overall Study|Other Reasons|10|||
131744432|NCT00643604|474340792|FG000|Overall Study|Death|1|||
131744433|NCT02702011|474340795|FG000|Overall Study|Withdrawal by Subject|0|||
131744434|NCT02702011|474340796|FG001|Overall Study|Withdrawal by Subject|1|||
131744435|NCT02702011|474340797|FG002|Overall Study|Withdrawal by Subject|0|||
131744436|NCT02702011|474340798|FG003|Overall Study|Withdrawal by Subject|0|||
131744437|NCT02007954|474340800|FG000|Overall Study|Received liver transplant|3|||
131744438|NCT02007954|474340800|FG000|Overall Study|Switch in treatment modality|2|||
131744439|NCT02007954|474340800|FG000|Overall Study|Disease progression and unrelated AE|1|||
131744440|NCT02007954|474340800|FG000|Overall Study|Death|1|||
131744441|NCT01195363|474340803|FG000|Overall Study|Lost to Follow-up|7|||
131744442|NCT01195363|474340804|FG001|Overall Study|Lost to Follow-up|4|||
131744443|NCT01195363|474340803|FG000|Overall Study|Adverse Event|3|||
131744444|NCT01195363|474340804|FG001|Overall Study|Adverse Event|1|||
131744445|NCT01195363|474340803|FG000|Overall Study|Lack of Efficacy|0|||
131744446|NCT01195363|474340804|FG001|Overall Study|Lack of Efficacy|4|||
131744447|NCT01195363|474340803|FG000|Overall Study|incarceration|1|||
131744448|NCT01195363|474340804|FG001|Overall Study|incarceration|0|||
131744449|NCT00475540|474340805|FG000|36 Months|Lost to Follow-up|4|||
131744450|NCT00475540|474340806|FG001|36 Months|Lost to Follow-up|4|||
131744451|NCT00475540|474340805|FG000|36 Months|Death|1|||
131744452|NCT00475540|474340806|FG001|36 Months|Death|2|||
131744453|NCT00475540|474340805|FG000|36 Months|Censored due to reoperation|3|||
131744454|NCT00475540|474340806|FG001|36 Months|Censored due to reoperation|0|||
131744455|NCT02148211|474340809|FG000|Overall Study|Lost to Follow-up|352|||
131744456|NCT02726113|474340812|FG000|Total Enrollment|Physician Decision|0|||
131744457|NCT02726113|474340813|FG001|Total Enrollment|Physician Decision|1|||
131744458|NCT02726113|474340812|FG000|Total Enrollment|Protocol Violation|1|||
131744459|NCT02726113|474340813|FG001|Total Enrollment|Protocol Violation|0|||
131744460|NCT02726113|474340812|FG000|Total Enrollment|Withdrawal by Subject|2|||
131744461|NCT02726113|474340813|FG001|Total Enrollment|Withdrawal by Subject|1|||
131744462|NCT02726113|474340812|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
131744463|NCT02726113|474340813|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
131744464|NCT02726113|474340812|FG000|Genomic Analysis|Protocol Violation|1|||
131744465|NCT02726113|474340813|FG001|Genomic Analysis|Protocol Violation|0|||
131744466|NCT02726113|474340812|FG000|Genomic Analysis|Withdrawal by Subject|2|||
131744467|NCT02726113|474340813|FG001|Genomic Analysis|Withdrawal by Subject|1|||
131744468|NCT02726113|474340812|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
131744469|NCT02726113|474340813|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
131744470|NCT05691829|474342671|FG000|Overall Study|Physician Decision|2|||
131744471|NCT05691829|474342671|FG000|Overall Study|Eligibility criteria not met|3|||
131744472|NCT03326869|474342672|FG000|Overall Study|Study data has been lost to natural disa|1|||
131744473|NCT03326869|474342673|FG001|Overall Study|Study data has been lost to natural disa|1|||
131744474|NCT03287869|474342677|FG000|Overall Study|Adverse Event|14|||
131744475|NCT03287869|474342678|FG001|Overall Study|Adverse Event|12|||
131744476|NCT03287869|474342677|FG000|Overall Study|Lack of Efficacy|1|||
131744477|NCT03287869|474342678|FG001|Overall Study|Lack of Efficacy|0|||
131744478|NCT03287869|474342677|FG000|Overall Study|Lost to Follow-up|13|||
131744479|NCT03287869|474342678|FG001|Overall Study|Lost to Follow-up|19|||
131744480|NCT03287869|474342677|FG000|Overall Study|Non-Compliance With Study Drug|5|||
131744481|NCT03287869|474342678|FG001|Overall Study|Non-Compliance With Study Drug|9|||
131744482|NCT03287869|474342677|FG000|Overall Study|Progressive Disease|1|||
131744483|NCT03287869|474342678|FG001|Overall Study|Progressive Disease|0|||
131744484|NCT03287869|474342677|FG000|Overall Study|Protocol Deviation|2|||
131744485|NCT03287869|474342678|FG001|Overall Study|Protocol Deviation|1|||
131744486|NCT03287869|474342677|FG000|Overall Study|Withdrawal by Subject|36|||
131905954|NCT02513550|474943190|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
131905955|NCT02513550|474943191|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
131905956|NCT02513550|474943192|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
131905957|NCT02513550|474943187|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131744487|NCT03287869|474342678|FG001|Overall Study|Withdrawal by Subject|43|||
131905958|NCT02513550|474943188|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131744488|NCT03287869|474342677|FG000|Overall Study|Early Closure of the Site|0|||
131744489|NCT03287869|474342678|FG001|Overall Study|Early Closure of the Site|1|||
131744490|NCT03287869|474342677|FG000|Overall Study|Physician Decision|5|||
131744491|NCT03287869|474342678|FG001|Overall Study|Physician Decision|5|||
131744492|NCT03287869|474342677|FG000|Overall Study|Reason not Specified|6|||
131744493|NCT03287869|474342678|FG001|Overall Study|Reason not Specified|3|||
131744494|NCT03488238|474342679|FG000|Overall Study|Equipment malfunction|1|||
131744495|NCT03488238|474342679|FG000|Overall Study|Adverse Event|1|||
131744496|NCT02670928|474342680|FG000|Overall Study|Adverse Event|3|||
131744497|NCT02670928|474342681|FG001|Overall Study|Adverse Event|1|||
131744498|NCT02670928|474342680|FG000|Overall Study|Withdrawal by Subject|4|||
131744499|NCT02670928|474342681|FG001|Overall Study|Withdrawal by Subject|0|||
131744500|NCT02670928|474342680|FG000|Overall Study|Lost to Follow-up|1|||
131744501|NCT02670928|474342681|FG001|Overall Study|Lost to Follow-up|0|||
131744502|NCT02670928|474342680|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
131744503|NCT02670928|474342681|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
131744504|NCT02591238|474342682|FG000|Overall Study|Pregnancy|1|||
131448985|NCT00665652|473272751|FG000|Overall Study|No longer met inclusion criteria.|1|||
131744505|NCT02591238|474342683|FG001|Overall Study|Pregnancy|0|||
131744506|NCT02591238|474342684|FG002|Overall Study|Pregnancy|0|||
131744507|NCT02591238|474342685|FG003|Overall Study|Pregnancy|0|||
131744508|NCT02591238|474342682|FG000|Overall Study|Withdrawal by Subject|0|||
131744509|NCT02591238|474342683|FG001|Overall Study|Withdrawal by Subject|0|||
131744510|NCT02591238|474342684|FG002|Overall Study|Withdrawal by Subject|0|||
131744511|NCT02591238|474342685|FG003|Overall Study|Withdrawal by Subject|1|||
131744512|NCT02591238|474342682|FG000|Overall Study|influenza|0|||
131744513|NCT02591238|474342683|FG001|Overall Study|influenza|0|||
131744514|NCT02591238|474342684|FG002|Overall Study|influenza|0|||
131744515|NCT02591238|474342685|FG003|Overall Study|influenza|1|||
131744516|NCT02591238|474342682|FG000|Overall Study|personal circumstances|0|||
131744517|NCT02591238|474342683|FG001|Overall Study|personal circumstances|0|||
131744518|NCT02591238|474342684|FG002|Overall Study|personal circumstances|0|||
131744519|NCT02591238|474342685|FG003|Overall Study|personal circumstances|1|||
131744520|NCT02591238|474342682|FG000|Overall Study|personal circumstances|0|||
131744521|NCT02591238|474342683|FG001|Overall Study|personal circumstances|1|||
131744522|NCT02591238|474342684|FG002|Overall Study|personal circumstances|0|||
131744523|NCT02591238|474342685|FG003|Overall Study|personal circumstances|0|||
131744524|NCT00525785|474342689|FG000|Overall Study|Withdrawal by Subject|1|||
131744525|NCT00525785|474342689|FG000|Overall Study|Lack of Efficacy|1|||
131744526|NCT00525785|474342689|FG000|Overall Study|Physician Decision|1|||
131744527|NCT01316939|474342690|FG000|Overall Study|Study closed/terminated|26|||
131744528|NCT01316939|474342691|FG001|Overall Study|Study closed/terminated|25|||
131744529|NCT01316939|474342692|FG002|Overall Study|Study closed/terminated|23|||
131744530|NCT01316939|474342690|FG000|Overall Study|Lack of Efficacy|24|||
131744531|NCT01316939|474342691|FG001|Overall Study|Lack of Efficacy|25|||
131744532|NCT01316939|474342692|FG002|Overall Study|Lack of Efficacy|25|||
131744533|NCT01316939|474342690|FG000|Overall Study|Adverse Event|9|||
131744534|NCT01316939|474342691|FG001|Overall Study|Adverse Event|12|||
131744535|NCT01316939|474342692|FG002|Overall Study|Adverse Event|11|||
131744536|NCT01316939|474342690|FG000|Overall Study|Withdrawal by Subject|1|||
131744537|NCT01316939|474342691|FG001|Overall Study|Withdrawal by Subject|3|||
131744538|NCT01316939|474342692|FG002|Overall Study|Withdrawal by Subject|6|||
131744539|NCT01316939|474342690|FG000|Overall Study|Physician Decision|2|||
131744540|NCT01316939|474342691|FG001|Overall Study|Physician Decision|2|||
131744541|NCT01316939|474342692|FG002|Overall Study|Physician Decision|1|||
131744542|NCT01316939|474342690|FG000|Overall Study|Lost to Follow-up|0|||
131744543|NCT01316939|474342691|FG001|Overall Study|Lost to Follow-up|0|||
131744544|NCT01316939|474342692|FG002|Overall Study|Lost to Follow-up|2|||
131744545|NCT01316939|474342690|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
131744546|NCT01316939|474342691|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
131744547|NCT01316939|474342692|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
131744548|NCT01316939|474342690|FG000|Overall Study|Protocol Violation|0|||
131744549|NCT01316939|474342691|FG001|Overall Study|Protocol Violation|1|||
131744550|NCT01316939|474342692|FG002|Overall Study|Protocol Violation|0|||
131744551|NCT02215616|474342693|FG000|Overall Study|Sponsor requested to stop study drug|0|||
131744552|NCT02215616|474342694|FG001|Overall Study|Sponsor requested to stop study drug|0|||
131744553|NCT02215616|474342695|FG002|Overall Study|Sponsor requested to stop study drug|1|||
131744554|NCT02215616|474342696|FG003|Overall Study|Sponsor requested to stop study drug|4|||
131744555|NCT02215616|474342693|FG000|Overall Study|Death|1|||
131744556|NCT02215616|474342694|FG001|Overall Study|Death|0|||
131744557|NCT02215616|474342695|FG002|Overall Study|Death|0|||
131744558|NCT02215616|474342696|FG003|Overall Study|Death|0|||
131448986|NCT02556177|473272754|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
131448987|NCT02556177|473272755|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
131744559|NCT02215616|474342693|FG000|Overall Study|Adverse Event|7|||
131744560|NCT02215616|474342694|FG001|Overall Study|Adverse Event|4|||
131744561|NCT02215616|474342695|FG002|Overall Study|Adverse Event|9|||
131744562|NCT02215616|474342696|FG003|Overall Study|Adverse Event|2|||
131744563|NCT02215616|474342693|FG000|Overall Study|Withdrawal by Subject|1|||
131744564|NCT02215616|474342694|FG001|Overall Study|Withdrawal by Subject|8|||
131744565|NCT02215616|474342695|FG002|Overall Study|Withdrawal by Subject|2|||
131744566|NCT02215616|474342696|FG003|Overall Study|Withdrawal by Subject|5|||
131744567|NCT02215616|474342693|FG000|Overall Study|Non-compliance|0|||
131744568|NCT02215616|474342694|FG001|Overall Study|Non-compliance|2|||
131744569|NCT02215616|474342695|FG002|Overall Study|Non-compliance|1|||
131744570|NCT02215616|474342696|FG003|Overall Study|Non-compliance|0|||
131744571|NCT02215616|474342693|FG000|Overall Study|Protocol Violation|0|||
131744572|NCT02215616|474342694|FG001|Overall Study|Protocol Violation|2|||
131744573|NCT02215616|474342695|FG002|Overall Study|Protocol Violation|0|||
131744574|NCT02215616|474342696|FG003|Overall Study|Protocol Violation|0|||
131744575|NCT02215616|474342693|FG000|Overall Study|Lost to Follow-up|1|||
131744576|NCT02215616|474342694|FG001|Overall Study|Lost to Follow-up|1|||
131448988|NCT00771758|473272761|FG000|Overall Study|Adverse Event|2|||
131744577|NCT02215616|474342695|FG002|Overall Study|Lost to Follow-up|0|||
131744578|NCT02215616|474342696|FG003|Overall Study|Lost to Follow-up|1|||
131744579|NCT02215616|474342693|FG000|Overall Study|Other than specified|1|||
131744580|NCT02215616|474342694|FG001|Overall Study|Other than specified|0|||
131744581|NCT02215616|474342695|FG002|Overall Study|Other than specified|1|||
131744582|NCT02215616|474342696|FG003|Overall Study|Other than specified|1|||
131744583|NCT04847141|474342697|FG000|Overall Study|Adverse Event|1|||
131744584|NCT04847141|474342698|FG001|Overall Study|Adverse Event|0|||
131744585|NCT04847141|474342699|FG002|Overall Study|Adverse Event|1|||
131744586|NCT04847141|474342697|FG000|Overall Study|Withdrawal by Subject|2|||
131744587|NCT04847141|474342698|FG001|Overall Study|Withdrawal by Subject|4|||
131744588|NCT04847141|474342699|FG002|Overall Study|Withdrawal by Subject|3|||
131744589|NCT04847141|474342697|FG000|Overall Study|Lost to Follow-up|7|||
131744590|NCT04847141|474342698|FG001|Overall Study|Lost to Follow-up|5|||
131744591|NCT04847141|474342699|FG002|Overall Study|Lost to Follow-up|7|||
131905959|NCT02513550|474943189|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
131905960|NCT02513550|474943190|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131905961|NCT02513550|474943191|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131905962|NCT02513550|474943192|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131905963|NCT02513550|474943187|FG000|Double Blind Treatment Period|Due to personal business|2|||
131905964|NCT02513550|474943188|FG001|Double Blind Treatment Period|Due to personal business|0|||
131905965|NCT02513550|474943189|FG002|Double Blind Treatment Period|Due to personal business|1|||
131905966|NCT02513550|474943190|FG003|Double Blind Treatment Period|Due to personal business|0|||
131905967|NCT02513550|474943191|FG004|Double Blind Treatment Period|Due to personal business|0|||
131905968|NCT02513550|474943192|FG005|Double Blind Treatment Period|Due to personal business|0|||
131905969|NCT02513550|474943187|FG000|Double Blind Treatment Period|Death|1|||
131905970|NCT02513550|474943188|FG001|Double Blind Treatment Period|Death|0|||
131905971|NCT02513550|474943189|FG002|Double Blind Treatment Period|Death|2|||
131905972|NCT02513550|474943190|FG003|Double Blind Treatment Period|Death|0|||
131905973|NCT02513550|474943191|FG004|Double Blind Treatment Period|Death|0|||
131905974|NCT02513550|474943192|FG005|Double Blind Treatment Period|Death|0|||
131905975|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
131905976|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
131905977|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
131905978|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131905979|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131905980|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131905981|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
131905982|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
131905983|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
131744592|NCT04847141|474342697|FG000|Overall Study|Reason not Specified|0|||
131744593|NCT04847141|474342698|FG001|Overall Study|Reason not Specified|1|||
131744594|NCT04847141|474342699|FG002|Overall Study|Reason not Specified|0|||
131744595|NCT04058158|474342700|FG000|Period 1|Death|1|||
131744596|NCT04058158|474342701|FG001|Period 1|Death|0|||
131744597|NCT04058158|474342700|FG000|Period 1|Adverse Event|1|||
131744598|NCT04058158|474342701|FG001|Period 1|Adverse Event|1|||
131744599|NCT04058158|474342700|FG000|Period 1|Pregnancy|0|||
131744600|NCT04058158|474342701|FG001|Period 1|Pregnancy|1|||
131744601|NCT01634113|474342702|FG000|Overall Study|Not treated|0|||
131744602|NCT01634113|474342703|FG001|Overall Study|Not treated|0|||
131744603|NCT01634113|474342704|FG002|Overall Study|Not treated|1|||
131744604|NCT00324740|474342705|FG000|Overall Study|Withdrawal by Subject|1|||
131744605|NCT00324740|474342706|FG001|Overall Study|Withdrawal by Subject|0|||
131744606|NCT00324740|474342707|FG002|Overall Study|Withdrawal by Subject|1|||
131744607|NCT00520299|474342710|FG000|Overall Study|Withdrawal by Subject|0|||
131744608|NCT00520299|474342711|FG001|Overall Study|Withdrawal by Subject|0|||
131744609|NCT00520299|474342712|FG002|Overall Study|Withdrawal by Subject|2|||
131744610|NCT00520299|474342710|FG000|Overall Study|Progressive disease|0|||
131744611|NCT00520299|474342711|FG001|Overall Study|Progressive disease|3|||
131744612|NCT00520299|474342712|FG002|Overall Study|Progressive disease|4|||
131905984|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
131905985|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
131744613|NCT01352845|474342713|FG000|Overall Study|Lost to Follow-up|313|||
131744614|NCT01352845|474342714|FG001|Overall Study|Lost to Follow-up|92|||
131744615|NCT01352845|474342713|FG000|Overall Study|No Longer Willing to Participate|205|||
131744616|NCT01352845|474342714|FG001|Overall Study|No Longer Willing to Participate|58|||
131744617|NCT01352845|474342713|FG000|Overall Study|Withdrawal by Subject|48|||
131744618|NCT01352845|474342714|FG001|Overall Study|Withdrawal by Subject|16|||
131744619|NCT01352845|474342713|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
131744620|NCT01352845|474342714|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
131744621|NCT01352845|474342713|FG000|Overall Study|Pregnancy|27|||
131744622|NCT01352845|474342714|FG001|Overall Study|Pregnancy|7|||
131744623|NCT01352845|474342713|FG000|Overall Study|Adverse Event|22|||
131744624|NCT01352845|474342714|FG001|Overall Study|Adverse Event|6|||
131744625|NCT01352845|474342713|FG000|Overall Study|Other|17|||
131744626|NCT01352845|474342714|FG001|Overall Study|Other|7|||
131744627|NCT01352845|474342713|FG000|Overall Study|Protocol Violation|12|||
131744628|NCT01352845|474342714|FG001|Overall Study|Protocol Violation|6|||
131744629|NCT01352845|474342713|FG000|Overall Study|Death|3|||
131744630|NCT01352845|474342714|FG001|Overall Study|Death|0|||
131744631|NCT01357980|474342720|FG000|Overall Study|Lack of Efficacy|0|||
131744632|NCT01357980|474342721|FG001|Overall Study|Lack of Efficacy|1|||
131744633|NCT01357980|474342722|FG002|Overall Study|Lack of Efficacy|0|||
131744634|NCT01357980|474342723|FG003|Overall Study|Lack of Efficacy|0|||
131744635|NCT01357980|474342720|FG000|Overall Study|Consent withdrawn|0|||
131744636|NCT01357980|474342721|FG001|Overall Study|Consent withdrawn|0|||
131744637|NCT01357980|474342722|FG002|Overall Study|Consent withdrawn|1|||
131744638|NCT01357980|474342723|FG003|Overall Study|Consent withdrawn|0|||
131744639|NCT04507776|474342724|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
131744640|NCT00094835|474342725|FG000|Overall Study|Physician Decision|1|||
131744641|NCT00094835|474342726|FG001|Overall Study|Physician Decision|0|||
131744642|NCT00094835|474342727|FG002|Overall Study|Physician Decision|0|||
131744643|NCT00094835|474342728|FG003|Overall Study|Physician Decision|0|||
131744644|NCT00094835|474342729|FG004|Overall Study|Physician Decision|0|||
131744645|NCT00094835|474342730|FG005|Overall Study|Physician Decision|1|||
131744646|NCT00094835|474342731|FG006|Overall Study|Physician Decision|0|||
131744647|NCT00094835|474342725|FG000|Overall Study|Withdrawal by Subject|0|||
131744648|NCT00094835|474342726|FG001|Overall Study|Withdrawal by Subject|0|||
131744649|NCT00094835|474342727|FG002|Overall Study|Withdrawal by Subject|0|||
131744650|NCT00094835|474342728|FG003|Overall Study|Withdrawal by Subject|0|||
131744651|NCT00094835|474342729|FG004|Overall Study|Withdrawal by Subject|0|||
131744652|NCT00094835|474342730|FG005|Overall Study|Withdrawal by Subject|0|||
131744653|NCT00094835|474342731|FG006|Overall Study|Withdrawal by Subject|1|||
131744654|NCT00094835|474342725|FG000|Overall Study|Lost to Follow-up|0|||
131744655|NCT00094835|474342726|FG001|Overall Study|Lost to Follow-up|0|||
131744656|NCT00094835|474342727|FG002|Overall Study|Lost to Follow-up|0|||
131744657|NCT00094835|474342728|FG003|Overall Study|Lost to Follow-up|0|||
131744658|NCT00094835|474342729|FG004|Overall Study|Lost to Follow-up|1|||
131744659|NCT00094835|474342730|FG005|Overall Study|Lost to Follow-up|0|||
131744660|NCT00094835|474342731|FG006|Overall Study|Lost to Follow-up|0|||
131744661|NCT00094835|474342725|FG000|Overall Study|Death|1|||
131744662|NCT00094835|474342726|FG001|Overall Study|Death|0|||
131744663|NCT00094835|474342727|FG002|Overall Study|Death|0|||
131744664|NCT00094835|474342728|FG003|Overall Study|Death|0|||
131744665|NCT00094835|474342729|FG004|Overall Study|Death|1|||
131744666|NCT00094835|474342730|FG005|Overall Study|Death|0|||
131744667|NCT00094835|474342731|FG006|Overall Study|Death|0|||
131744668|NCT00094835|474342725|FG000|Overall Study|Non-compliance|1|||
131744669|NCT00094835|474342726|FG001|Overall Study|Non-compliance|2|||
131744670|NCT00094835|474342727|FG002|Overall Study|Non-compliance|2|||
131744671|NCT00094835|474342728|FG003|Overall Study|Non-compliance|0|||
131744672|NCT00094835|474342729|FG004|Overall Study|Non-compliance|2|||
131744673|NCT00094835|474342730|FG005|Overall Study|Non-compliance|2|||
131744674|NCT00094835|474342731|FG006|Overall Study|Non-compliance|1|||
131744675|NCT00094835|474342725|FG000|Overall Study|Other|1|||
131744676|NCT00094835|474342726|FG001|Overall Study|Other|1|||
131744677|NCT00094835|474342727|FG002|Overall Study|Other|1|||
131744678|NCT00094835|474342728|FG003|Overall Study|Other|1|||
131744679|NCT00094835|474342729|FG004|Overall Study|Other|0|||
131744680|NCT00094835|474342730|FG005|Overall Study|Other|0|||
131744681|NCT00094835|474342731|FG006|Overall Study|Other|0|||
131744682|NCT01624506|474342732|FG000|Overall Study|Lost to Follow-up|29|||
131744683|NCT01624506|474342733|FG001|Overall Study|Lost to Follow-up|15|||
131744684|NCT01624506|474342732|FG000|Overall Study|Withdrawal by Subject|9|||
131744685|NCT01624506|474342733|FG001|Overall Study|Withdrawal by Subject|2|||
131744686|NCT01624506|474342732|FG000|Overall Study|Death|1|||
131744687|NCT01624506|474342733|FG001|Overall Study|Death|0|||
131744688|NCT01624506|474342732|FG000|Overall Study|LINX explants|23|||
131744689|NCT01624506|474342733|FG001|Overall Study|LINX explants|0|||
131744690|NCT01624506|474342732|FG000|Overall Study|Adverse Event|3|||
131744691|NCT01624506|474342733|FG001|Overall Study|Adverse Event|0|||
131744692|NCT00132314|474342737|FG000|Overall Study|Lost to Follow-up|70|||
131744693|NCT00132314|474342738|FG001|Overall Study|Lost to Follow-up|62|||
131744694|NCT00132314|474342737|FG000|Overall Study|Lacked SSN|1|||
131744695|NCT00132314|474342738|FG001|Overall Study|Lacked SSN|3|||
131744696|NCT00132314|474342737|FG000|Overall Study|Refused intervention at baseline|2|||
131744697|NCT00132314|474342738|FG001|Overall Study|Refused intervention at baseline|7|||
131744698|NCT05905601|474342739|FG000|Overall Study|Lost to Follow-up|1|||
131744699|NCT05905601|474342740|FG001|Overall Study|Lost to Follow-up|3|||
131744700|NCT02514772|474342741|FG000|Overall Study|Adverse Event|1|||
131744701|NCT02514772|474342742|FG001|Overall Study|Adverse Event|0|||
131744702|NCT02514772|474342741|FG000|Overall Study|Death|0|||
131744703|NCT02514772|474342742|FG001|Overall Study|Death|1|||
131744704|NCT02514772|474342741|FG000|Overall Study|Withdrawal by Subject|2|||
131744705|NCT02514772|474342742|FG001|Overall Study|Withdrawal by Subject|1|||
131744706|NCT01415908|474342743|FG000|Overall Study|Withdrawal by Subject|1|||
131744707|NCT01415908|474342744|FG001|Overall Study|Withdrawal by Subject|0|||
131744708|NCT00793182|474342745|FG000|Overall Study|Adverse Event|0|||
131744709|NCT00793182|474342746|FG001|Overall Study|Adverse Event|1|||
131744710|NCT00851253|474342753|FG000|Overall Study|Disease Progression|1|||
131744711|NCT00851253|474342754|FG001|Overall Study|Disease Progression|0|||
131744712|NCT02197897|474342755|FG000|Overall Study|not eligible|1|||
131744713|NCT01705587|474342761|FG000|Overall Study|Withdrawal by Subject|0|||
131744714|NCT01705587|474342762|FG001|Overall Study|Withdrawal by Subject|1|||
131744715|NCT01532570|474342764|FG000|Overall Study|Lack of Efficacy|1|||
131744716|NCT01532570|474342765|FG001|Overall Study|Lack of Efficacy|0|||
131744717|NCT01532570|474342766|FG002|Overall Study|Lack of Efficacy|0|||
131744718|NCT01532570|474342767|FG003|Overall Study|Lack of Efficacy|0|||
131744719|NCT01532570|474342764|FG000|Overall Study|Withdrawal by Subject|0|||
131744720|NCT01532570|474342765|FG001|Overall Study|Withdrawal by Subject|1|||
131744721|NCT01532570|474342766|FG002|Overall Study|Withdrawal by Subject|0|||
131744722|NCT01532570|474342767|FG003|Overall Study|Withdrawal by Subject|0|||
131744723|NCT01329341|474342773|FG000|Overall Study|Withdrawal by Subject|44|||
131744724|NCT03017846|474342774|FG000|Overall Study|Lost to Follow-up|3|||
131744725|NCT03017846|474342774|FG000|Overall Study|Adverse Event|2|||
131744726|NCT04603391|474342775|FG000|First Intervention (4 Days)|Adverse Event|1|||
131744727|NCT04603391|474342776|FG001|First Intervention (4 Days)|Adverse Event|0|||
131744728|NCT04603391|474342775|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
131744729|NCT04603391|474342776|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
131744730|NCT02151682|474342777|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131744731|NCT02151682|474342778|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
131744732|NCT02151682|474342779|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131744733|NCT02151682|474342780|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131744734|NCT02151682|474342781|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131744735|NCT02151682|474342782|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131744736|NCT02151682|474342777|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131744737|NCT02151682|474342778|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
131744738|NCT02151682|474342779|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131744739|NCT02151682|474342780|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131744740|NCT02151682|474342781|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131744741|NCT02151682|474342782|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131744742|NCT02151682|474342777|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131744743|NCT02151682|474342778|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
131744744|NCT02151682|474342779|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131744745|NCT02151682|474342780|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131744746|NCT02151682|474342781|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131744747|NCT02151682|474342782|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131744748|NCT02151682|474342777|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
131744749|NCT02151682|474342778|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
131744750|NCT02151682|474342779|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131744751|NCT02151682|474342780|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131744752|NCT02151682|474342781|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131744753|NCT02151682|474342782|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131744754|NCT02151682|474342777|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
131744755|NCT02151682|474342778|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131744756|NCT02151682|474342779|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131744757|NCT02151682|474342780|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131744758|NCT02151682|474342781|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131744759|NCT02151682|474342782|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131744760|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131744761|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131744762|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
131744763|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131744764|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131744765|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131744766|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
131744767|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
131744768|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
131744769|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
131744770|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
131744771|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
131744772|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131744773|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131744774|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
131744775|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
131744776|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131744777|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131744778|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131744779|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131744780|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
131744781|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131744782|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131744783|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131744784|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131744785|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131744786|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
131744787|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131744788|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131744789|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131744790|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131744791|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131744792|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
131744793|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131744794|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131744795|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131744796|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
131744797|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
131744798|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
131744799|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
131744800|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
131744801|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
131744802|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
131744803|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
131744804|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
131744805|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
131744806|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
131744807|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
131744808|NCT02151682|474342777|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131744809|NCT02151682|474342778|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131744810|NCT02151682|474342779|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
131744811|NCT02151682|474342780|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131744812|NCT02151682|474342781|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131744813|NCT02151682|474342782|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131744814|NCT02151682|474342777|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131744815|NCT02151682|474342778|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131744816|NCT02151682|474342779|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131744817|NCT02151682|474342780|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131744818|NCT02151682|474342781|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131744819|NCT02151682|474342782|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
131744820|NCT02151682|474342777|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131744821|NCT02151682|474342778|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131744822|NCT02151682|474342779|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131744823|NCT02151682|474342780|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131744824|NCT02151682|474342781|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131744825|NCT02151682|474342782|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
131744826|NCT02151682|474342777|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131744827|NCT02151682|474342778|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131744828|NCT02151682|474342779|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131744829|NCT02151682|474342780|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131744830|NCT02151682|474342781|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131744831|NCT02151682|474342782|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
131744832|NCT02151682|474342777|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131744833|NCT02151682|474342778|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131744834|NCT02151682|474342779|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131744835|NCT02151682|474342780|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131744836|NCT02151682|474342781|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131744837|NCT02151682|474342782|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
131744838|NCT00168064|474342783|FG000|Overall Study|Adverse Event|26|||
131744839|NCT00168064|474342784|FG001|Overall Study|Adverse Event|22|||
131744840|NCT00168064|474342783|FG000|Overall Study|Withdrawal by Subject|3|||
131744841|NCT00168064|474342784|FG001|Overall Study|Withdrawal by Subject|4|||
131744842|NCT00168064|474342783|FG000|Overall Study|Lack of Efficacy|4|||
131744843|NCT00168064|474342784|FG001|Overall Study|Lack of Efficacy|4|||
131744844|NCT00168064|474342783|FG000|Overall Study|Lost to Follow-up|4|||
131744845|NCT00168064|474342784|FG001|Overall Study|Lost to Follow-up|3|||
131744846|NCT00168064|474342783|FG000|Overall Study|Non-compliance|2|||
131744847|NCT00168064|474342784|FG001|Overall Study|Non-compliance|3|||
131744848|NCT00168064|474342783|FG000|Overall Study|Concurrent Illness|4|||
131744849|NCT00168064|474342784|FG001|Overall Study|Concurrent Illness|3|||
131744850|NCT00168064|474342783|FG000|Overall Study|Subject's Best interest|2|||
131744851|NCT00168064|474342784|FG001|Overall Study|Subject's Best interest|2|||
131744852|NCT00168064|474342783|FG000|Overall Study|Various|4|||
131744853|NCT00168064|474342784|FG001|Overall Study|Various|3|||
131744854|NCT00318565|474342785|FG000|Overall Study|Excluded per protocol|24|||
131744855|NCT00282867|474342786|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
131744856|NCT00282867|474342787|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
131744857|NCT00282867|474342788|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
131744858|NCT02677220|474342789|FG000|Overall Study|Adverse Event|1|||
131744859|NCT00965146|474342790|FG000|Overall Study|Death|7|||
131744860|NCT00965146|474342790|FG000|Overall Study|Lost to Follow-up|22|||
131744861|NCT00965146|474342790|FG000|Overall Study|Withdrawal by Subject|17|||
131744862|NCT00965146|474342790|FG000|Overall Study|Unable to return|1|||
131744863|NCT00965146|474342790|FG000|Overall Study|Unwilling to return|11|||
131744864|NCT00965146|474342790|FG000|Overall Study|Intercurrent illness|1|||
131744865|NCT00965146|474342790|FG000|Overall Study|Revision / Removal of Study Implant|6|||
131744866|NCT00965146|474342790|FG000|Overall Study|Overall Study Termination|145|||
131744867|NCT00830960|474342791|FG000|Overall Study|Death|5|||
131744868|NCT00830960|474342792|FG001|Overall Study|Death|4|||
131744869|NCT00830960|474342793|FG002|Overall Study|Death|3|||
131744870|NCT00830960|474342794|FG003|Overall Study|Death|2|||
131744871|NCT00830960|474342795|FG004|Overall Study|Death|6|||
131744872|NCT00830960|474342796|FG005|Overall Study|Death|1|||
131744873|NCT00830960|474342791|FG000|Overall Study|Lost to Follow-up|1|||
131744874|NCT00830960|474342792|FG001|Overall Study|Lost to Follow-up|1|||
131744875|NCT00830960|474342793|FG002|Overall Study|Lost to Follow-up|1|||
131744876|NCT00830960|474342794|FG003|Overall Study|Lost to Follow-up|0|||
131744877|NCT00830960|474342795|FG004|Overall Study|Lost to Follow-up|0|||
131744878|NCT00830960|474342796|FG005|Overall Study|Lost to Follow-up|1|||
131744879|NCT00830960|474342791|FG000|Overall Study|Withdrawal by Subject|19|||
131744880|NCT00830960|474342792|FG001|Overall Study|Withdrawal by Subject|19|||
131744881|NCT00830960|474342793|FG002|Overall Study|Withdrawal by Subject|18|||
131744882|NCT00830960|474342794|FG003|Overall Study|Withdrawal by Subject|23|||
131744883|NCT00830960|474342795|FG004|Overall Study|Withdrawal by Subject|16|||
131744884|NCT00830960|474342796|FG005|Overall Study|Withdrawal by Subject|21|||
131744885|NCT00830960|474342791|FG000|Overall Study|Sponsor Decision|1|||
131744886|NCT00830960|474342792|FG001|Overall Study|Sponsor Decision|2|||
131744887|NCT00830960|474342793|FG002|Overall Study|Sponsor Decision|3|||
131744888|NCT00830960|474342794|FG003|Overall Study|Sponsor Decision|4|||
131744889|NCT00830960|474342795|FG004|Overall Study|Sponsor Decision|5|||
131744890|NCT00830960|474342796|FG005|Overall Study|Sponsor Decision|7|||
131744891|NCT00830960|474342791|FG000|Overall Study|No study drug received|7|||
131744892|NCT00830960|474342792|FG001|Overall Study|No study drug received|2|||
131744893|NCT00830960|474342793|FG002|Overall Study|No study drug received|4|||
131744894|NCT00830960|474342794|FG003|Overall Study|No study drug received|3|||
131744895|NCT00830960|474342795|FG004|Overall Study|No study drug received|5|||
131744896|NCT00830960|474342796|FG005|Overall Study|No study drug received|7|||
131744897|NCT02855450|474342797|FG000|Overall Study|Adverse Event|1|||
131744898|NCT02855450|474342798|FG001|Overall Study|Adverse Event|0|||
131744899|NCT02855450|474342797|FG000|Overall Study|Lost to Follow-up|4|||
131744900|NCT02855450|474342798|FG001|Overall Study|Lost to Follow-up|0|||
131744901|NCT01504971|474342799|FG000|Overall Study|Physician Decision|13|||
131744902|NCT00936117|474342800|FG000|Overall Study|Adverse Event|7|||
131744903|NCT00936117|474342800|FG000|Overall Study|Unable to continue oral medication|3|||
131744904|NCT01376245|474342801|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
131744905|NCT01376245|474342802|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131744906|NCT01376245|474342803|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131744907|NCT01376245|474342804|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131744908|NCT01376245|474342805|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131744909|NCT01376245|474342801|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
131744910|NCT01376245|474342802|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131744911|NCT01376245|474342803|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131744912|NCT01376245|474342804|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131744913|NCT01376245|474342805|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131744914|NCT01376245|474342801|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
131744915|NCT01376245|474342802|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131744916|NCT01376245|474342803|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131744917|NCT01376245|474342804|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131744918|NCT01376245|474342805|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131744919|NCT01376245|474342801|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
131744920|NCT01376245|474342802|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131744921|NCT01376245|474342803|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131744922|NCT01376245|474342804|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131744923|NCT01376245|474342805|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131744924|NCT01376245|474342801|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
131744925|NCT01376245|474342802|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131744926|NCT01376245|474342803|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131744927|NCT01376245|474342804|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131744928|NCT01376245|474342805|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131744929|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
131744930|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
131744931|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
131744932|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
131744933|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
131744934|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131744935|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
131744936|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
131744937|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
131744938|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
131744939|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131744940|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
131744941|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131744942|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
131744943|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
131744944|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131744945|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
131744946|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
131744947|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
131744948|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131744949|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131744950|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
131744951|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131744952|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131744953|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131744954|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
131744955|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
131744956|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
131744957|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
131744958|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
131744959|NCT01376245|474342801|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131744960|NCT01376245|474342802|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
131744961|NCT01376245|474342803|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
131744962|NCT01376245|474342804|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
131744963|NCT01376245|474342805|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
131744964|NCT01335698|474342806|FG000|Treatment Stage 1|Lack of Efficacy|3|||
131744965|NCT01335698|474342807|FG001|Treatment Stage 1|Lack of Efficacy|1|||
131744966|NCT01335698|474342808|FG002|Treatment Stage 1|Lack of Efficacy|3|||
131744967|NCT01335698|474342809|FG003|Treatment Stage 1|Lack of Efficacy|3|||
131744968|NCT01335698|474342810|FG004|Treatment Stage 1|Lack of Efficacy|1|||
131744969|NCT01335698|474342806|FG000|Treatment Stage 1|Adverse Event|1|||
131744970|NCT01335698|474342807|FG001|Treatment Stage 1|Adverse Event|2|||
131744971|NCT01335698|474342808|FG002|Treatment Stage 1|Adverse Event|2|||
131744972|NCT01335698|474342809|FG003|Treatment Stage 1|Adverse Event|1|||
131744973|NCT01335698|474342810|FG004|Treatment Stage 1|Adverse Event|1|||
131744974|NCT01335698|474342806|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
131744975|NCT01335698|474342807|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
131744976|NCT01335698|474342808|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
131744977|NCT01335698|474342809|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
131744978|NCT01335698|474342810|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
131744979|NCT01335698|474342806|FG000|Treatment Stage 1|Lost to Follow-up|1|||
131744980|NCT01335698|474342807|FG001|Treatment Stage 1|Lost to Follow-up|1|||
131744981|NCT01335698|474342808|FG002|Treatment Stage 1|Lost to Follow-up|0|||
131744982|NCT01335698|474342809|FG003|Treatment Stage 1|Lost to Follow-up|0|||
131744983|NCT01335698|474342810|FG004|Treatment Stage 1|Lost to Follow-up|0|||
131744984|NCT01335698|474342806|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
131744985|NCT01335698|474342807|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
131744986|NCT01335698|474342808|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
131744987|NCT01335698|474342809|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
131744988|NCT01335698|474342810|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
131744989|NCT01335698|474342806|FG000|Treatment Stage 1|No longer meets study criteria|1|||
131744990|NCT01335698|474342807|FG001|Treatment Stage 1|No longer meets study criteria|1|||
131744991|NCT01335698|474342808|FG002|Treatment Stage 1|No longer meets study criteria|0|||
131744992|NCT01335698|474342809|FG003|Treatment Stage 1|No longer meets study criteria|1|||
131744993|NCT01335698|474342810|FG004|Treatment Stage 1|No longer meets study criteria|0|||
131744994|NCT01335698|474342806|FG000|Treatment Stage 1|Other|1|||
131744995|NCT01335698|474342807|FG001|Treatment Stage 1|Other|0|||
131744996|NCT01335698|474342808|FG002|Treatment Stage 1|Other|0|||
131744997|NCT01335698|474342809|FG003|Treatment Stage 1|Other|1|||
131744998|NCT01335698|474342810|FG004|Treatment Stage 1|Other|0|||
131744999|NCT01335698|474342806|FG000|Treatment Stage 2|Lack of Efficacy|2|||
131745000|NCT01335698|474342807|FG001|Treatment Stage 2|Lack of Efficacy|1|||
131745001|NCT01335698|474342808|FG002|Treatment Stage 2|Lack of Efficacy|3|||
131745002|NCT01335698|474342809|FG003|Treatment Stage 2|Lack of Efficacy|1|||
131745003|NCT01335698|474342810|FG004|Treatment Stage 2|Lack of Efficacy|0|||
131745004|NCT01335698|474342806|FG000|Treatment Stage 2|Adverse Event|2|||
131745005|NCT01335698|474342807|FG001|Treatment Stage 2|Adverse Event|0|||
131745006|NCT01335698|474342808|FG002|Treatment Stage 2|Adverse Event|0|||
131745007|NCT01335698|474342809|FG003|Treatment Stage 2|Adverse Event|3|||
131745008|NCT01335698|474342810|FG004|Treatment Stage 2|Adverse Event|0|||
131745009|NCT01335698|474342806|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
131745010|NCT01335698|474342807|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
131745011|NCT01335698|474342808|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
131745012|NCT01335698|474342809|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
131745013|NCT01335698|474342810|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
131745014|NCT01335698|474342806|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
131745015|NCT01335698|474342807|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
131745016|NCT01335698|474342808|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
131745017|NCT01335698|474342809|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
131745018|NCT01335698|474342810|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
131745019|NCT01335698|474342806|FG000|Treatment Stage 2|Lost to Follow-up|1|||
131745020|NCT01335698|474342807|FG001|Treatment Stage 2|Lost to Follow-up|0|||
131745021|NCT01335698|474342808|FG002|Treatment Stage 2|Lost to Follow-up|0|||
131745022|NCT01335698|474342809|FG003|Treatment Stage 2|Lost to Follow-up|0|||
131745023|NCT01335698|474342810|FG004|Treatment Stage 2|Lost to Follow-up|0|||
131745024|NCT01335698|474342806|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
131745025|NCT01335698|474342807|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
131745026|NCT01335698|474342808|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
131745027|NCT01335698|474342809|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
131745028|NCT01335698|474342810|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
131745029|NCT01335698|474342806|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
131745030|NCT01335698|474342807|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
131745031|NCT01335698|474342808|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
131745032|NCT01335698|474342809|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
131745033|NCT01335698|474342810|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
131745034|NCT01335698|474342806|FG000|Treatment Stage 2|Switched to another formulation|1|||
131745035|NCT01335698|474342807|FG001|Treatment Stage 2|Switched to another formulation|1|||
131745036|NCT01335698|474342808|FG002|Treatment Stage 2|Switched to another formulation|0|||
131745037|NCT01335698|474342809|FG003|Treatment Stage 2|Switched to another formulation|0|||
131745038|NCT01335698|474342810|FG004|Treatment Stage 2|Switched to another formulation|0|||
131745039|NCT01357889|474342811|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
131745040|NCT01357889|474342812|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
131745041|NCT01357889|474342811|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
131745042|NCT01357889|474342812|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
131745043|NCT01357889|474342811|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
131745044|NCT01357889|474342812|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
131745045|NCT01357889|474342811|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
131745046|NCT01357889|474342812|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
131745047|NCT01357889|474342811|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
131745048|NCT01357889|474342812|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
131745049|NCT01357889|474342811|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
131745050|NCT01357889|474342812|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
131745051|NCT01357889|474342811|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
131745052|NCT01357889|474342812|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
131745053|NCT01357889|474342811|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
131745054|NCT01357889|474342812|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
131745055|NCT01357889|474342811|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
131745056|NCT01357889|474342812|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
131745057|NCT01357889|474342811|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
131745058|NCT01357889|474342812|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
131745059|NCT01357889|474342811|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
131745060|NCT01357889|474342812|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
131745061|NCT01357889|474342811|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
131745062|NCT01357889|474342812|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
131745063|NCT01357889|474342811|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
131745064|NCT01357889|474342812|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
131745065|NCT02431468|474342819|FG000|Overall Study|Adverse Event|2|||
131745066|NCT02431468|474342820|FG001|Overall Study|Adverse Event|4|||
131745067|NCT02431468|474342821|FG002|Overall Study|Adverse Event|5|||
131745068|NCT02431468|474342819|FG000|Overall Study|Withdrawal by Subject|4|||
131745069|NCT02431468|474342820|FG001|Overall Study|Withdrawal by Subject|12|||
131745070|NCT02431468|474342821|FG002|Overall Study|Withdrawal by Subject|2|||
131745071|NCT02431468|474342819|FG000|Overall Study|noncompliance, investigator termination,|2|||
131745072|NCT02431468|474342820|FG001|Overall Study|noncompliance, investigator termination,|2|||
131745073|NCT02431468|474342821|FG002|Overall Study|noncompliance, investigator termination,|2|||
131745074|NCT01361919|474342822|FG000|Overall Study|technical issues|10|||
131745075|NCT01361919|474342823|FG001|Overall Study|technical issues|12|||
131745076|NCT01361919|474342824|FG002|Overall Study|technical issues|10|||
131745077|NCT01086150|474342825|FG000|Overall Study|Withdrawal by Subject|0|||
131745078|NCT01086150|474342826|FG001|Overall Study|Withdrawal by Subject|4|||
131745079|NCT01086150|474342827|FG002|Overall Study|Withdrawal by Subject|1|||
131745080|NCT01086150|474342825|FG000|Overall Study|Lost to Follow-up|0|||
131745081|NCT01086150|474342826|FG001|Overall Study|Lost to Follow-up|1|||
131745082|NCT01086150|474342827|FG002|Overall Study|Lost to Follow-up|0|||
131745083|NCT01086150|474342825|FG000|Overall Study|Screen Failure|0|||
131745084|NCT01086150|474342826|FG001|Overall Study|Screen Failure|1|||
131745085|NCT01086150|474342827|FG002|Overall Study|Screen Failure|0|||
131745086|NCT03589885|474342831|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
131745087|NCT03589885|474342832|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
131745088|NCT03589885|474342833|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
131745089|NCT03589885|474342834|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
131745090|NCT03589885|474342835|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
131745091|NCT03589885|474342831|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131745092|NCT03589885|474342832|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131745093|NCT03589885|474342833|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
131745094|NCT03589885|474342834|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131745095|NCT03589885|474342835|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131745096|NCT03589885|474342831|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131745097|NCT03589885|474342832|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
131745098|NCT03589885|474342833|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131745099|NCT03589885|474342834|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131745100|NCT03589885|474342835|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131745101|NCT03589885|474342831|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131745102|NCT03589885|474342832|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131745103|NCT03589885|474342833|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
131745104|NCT03589885|474342834|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131745105|NCT03589885|474342835|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131745106|NCT03589885|474342831|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
131745107|NCT03589885|474342832|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
131745108|NCT03589885|474342833|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
131745109|NCT03589885|474342834|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
131745110|NCT03589885|474342835|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
131745111|NCT03589885|474342831|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
131745112|NCT03589885|474342832|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
131745113|NCT03589885|474342833|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
131745114|NCT03589885|474342834|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
131745115|NCT03589885|474342835|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
131745116|NCT03589885|474342831|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
131745117|NCT03589885|474342832|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
131745118|NCT03589885|474342833|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
131745119|NCT03589885|474342834|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
131745120|NCT03589885|474342835|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
131745121|NCT03589885|474342831|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131745122|NCT03589885|474342832|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
131745123|NCT03589885|474342833|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131745124|NCT03589885|474342834|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131745125|NCT03589885|474342835|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131745126|NCT00764478|474342836|FG000|Overall Study|Adverse Event|1|||
131745127|NCT00764478|474342837|FG001|Overall Study|Adverse Event|1|||
131745128|NCT00764478|474342838|FG002|Overall Study|Adverse Event|1|||
131745129|NCT00764478|474342836|FG000|Overall Study|Withdrawal by Subject|7|||
131745130|NCT00764478|474342837|FG001|Overall Study|Withdrawal by Subject|12|||
131745131|NCT00764478|474342838|FG002|Overall Study|Withdrawal by Subject|1|||
131745132|NCT00764478|474342836|FG000|Overall Study|Lost to Follow-up|7|||
131745133|NCT00764478|474342837|FG001|Overall Study|Lost to Follow-up|8|||
131745134|NCT00764478|474342838|FG002|Overall Study|Lost to Follow-up|5|||
131745135|NCT00764478|474342836|FG000|Overall Study|Protocol Violation|0|||
131745136|NCT00764478|474342837|FG001|Overall Study|Protocol Violation|1|||
131745137|NCT00764478|474342838|FG002|Overall Study|Protocol Violation|1|||
131745138|NCT02270684|474342839|FG000|Overall Study|Lost to Follow-up|0|||
131745139|NCT02270684|474342840|FG001|Overall Study|Lost to Follow-up|3|||
131745140|NCT02270684|474342839|FG000|Overall Study|Study terminated|1|||
131745141|NCT02270684|474342840|FG001|Overall Study|Study terminated|0|||
131745142|NCT01740388|474342841|FG000|Overall Study|Withdrawal by Subject|1|||
131745143|NCT01740388|474342842|FG001|Overall Study|Withdrawal by Subject|2|||
131745144|NCT01740388|474342841|FG000|Overall Study|Lost to Follow-up|2|||
131745145|NCT01740388|474342842|FG001|Overall Study|Lost to Follow-up|0|||
131745146|NCT01740388|474342841|FG000|Overall Study|Physician Decision|2|||
131745147|NCT01740388|474342842|FG001|Overall Study|Physician Decision|6|||
131745148|NCT01740388|474342841|FG000|Overall Study|Subjects missing data, completed|41|||
131745149|NCT01740388|474342842|FG001|Overall Study|Subjects missing data, completed|36|||
131745150|NCT00862121|474342845|FG000|Overall Study|Adverse Event|1|||
131745151|NCT00862121|474342846|FG001|Overall Study|Adverse Event|2|||
131745152|NCT00862121|474342845|FG000|Overall Study|Lack of Efficacy|0|||
131745153|NCT00862121|474342846|FG001|Overall Study|Lack of Efficacy|3|||
131745154|NCT00862121|474342845|FG000|Overall Study|Protocol Violation|0|||
131745155|NCT00862121|474342846|FG001|Overall Study|Protocol Violation|1|||
131745156|NCT00862121|474342845|FG000|Overall Study|Exclusion criterion violation|0|||
131745157|NCT00862121|474342846|FG001|Overall Study|Exclusion criterion violation|1|||
131745158|NCT00862121|474342845|FG000|Overall Study|Incorrect randomisation|0|||
131745159|NCT00862121|474342846|FG001|Overall Study|Incorrect randomisation|1|||
131745160|NCT00171314|474342851|FG000|Overall Study|Adverse Event|44|||
131745161|NCT00171314|474342852|FG001|Overall Study|Adverse Event|41|||
131745162|NCT00171314|474342851|FG000|Overall Study|Lack of Efficacy|19|||
131745163|NCT00171314|474342852|FG001|Overall Study|Lack of Efficacy|14|||
131745164|NCT00171314|474342851|FG000|Overall Study|Withdrawal by Subject|9|||
131745165|NCT00171314|474342852|FG001|Overall Study|Withdrawal by Subject|6|||
131745166|NCT00171314|474342851|FG000|Overall Study|Abnormal Test Procedure Results|9|||
131745167|NCT00171314|474342852|FG001|Overall Study|Abnormal Test Procedure Results|3|||
131745168|NCT00171314|474342851|FG000|Overall Study|Protocol Violation|3|||
131745169|NCT00171314|474342852|FG001|Overall Study|Protocol Violation|7|||
131745170|NCT00171314|474342851|FG000|Overall Study|Administrative Problems|4|||
131745171|NCT00171314|474342852|FG001|Overall Study|Administrative Problems|3|||
131745172|NCT00171314|474342851|FG000|Overall Study|Lost to Follow-up|1|||
131745173|NCT00171314|474342852|FG001|Overall Study|Lost to Follow-up|3|||
131745174|NCT00171314|474342851|FG000|Overall Study|Death|2|||
131745175|NCT00171314|474342852|FG001|Overall Study|Death|1|||
131745176|NCT01033487|474342853|FG000|Fourth Intervention Period|Adverse Event|0|||
131745177|NCT01033487|474342854|FG001|Fourth Intervention Period|Adverse Event|0|||
131745178|NCT01033487|474342855|FG002|Fourth Intervention Period|Adverse Event|0|||
131745179|NCT01033487|474342856|FG003|Fourth Intervention Period|Adverse Event|0|||
131745180|NCT01033487|474342857|FG004|Fourth Intervention Period|Adverse Event|0|||
131745181|NCT01033487|474342858|FG005|Fourth Intervention Period|Adverse Event|0|||
131745182|NCT01033487|474342859|FG006|Fourth Intervention Period|Adverse Event|0|||
131745183|NCT01033487|474342860|FG007|Fourth Intervention Period|Adverse Event|0|||
131745184|NCT01033487|474342861|FG008|Fourth Intervention Period|Adverse Event|1|||
131745185|NCT01033487|474342862|FG009|Fourth Intervention Period|Adverse Event|0|||
131745186|NCT02939599|474342866|FG000|Overall Study|Adverse Event|1|||
131745187|NCT02939599|474342867|FG001|Overall Study|Adverse Event|0|||
131745188|NCT02939599|474342866|FG000|Overall Study|Study Terminated By Sponsor|2|||
131745189|NCT02939599|474342867|FG001|Overall Study|Study Terminated By Sponsor|2|||
131745190|NCT03479216|474342871|FG000|Overall Study|Withdrawal by Subject|3|||
131745191|NCT03479216|474342872|FG001|Overall Study|Withdrawal by Subject|2|||
131745192|NCT03479216|474342871|FG000|Overall Study|Physician Decision|2|||
131745193|NCT03479216|474342872|FG001|Overall Study|Physician Decision|3|||
131745194|NCT05489081|474344512|FG000|Overall Study|student left classroom|0|||
131745195|NCT05489081|474344513|FG001|Overall Study|student left classroom|1|||
131745196|NCT05489081|474344512|FG000|Overall Study|teacher left school|0|||
131745197|NCT05489081|474344513|FG001|Overall Study|teacher left school|2|||
131745198|NCT00810810|474344514|FG000|Overall Study|Withdrawal by Subject|0|||
131745199|NCT00810810|474344515|FG001|Overall Study|Withdrawal by Subject|8|||
131745200|NCT00810810|474344516|FG002|Overall Study|Withdrawal by Subject|10|||
131745201|NCT00810810|474344517|FG003|Overall Study|Withdrawal by Subject|8|||
131745202|NCT00810810|474344514|FG000|Overall Study|Physician Decision|0|||
131745203|NCT00810810|474344515|FG001|Overall Study|Physician Decision|3|||
131745204|NCT00810810|474344516|FG002|Overall Study|Physician Decision|1|||
131745205|NCT00810810|474344517|FG003|Overall Study|Physician Decision|5|||
131745206|NCT01409993|474344518|FG000|Overall Study|Adverse Event|4|||
131745207|NCT01409993|474344519|FG001|Overall Study|Adverse Event|4|||
131745208|NCT01409993|474344520|FG002|Overall Study|Adverse Event|3|||
131745209|NCT01409993|474344521|FG003|Overall Study|Adverse Event|1|||
131745210|NCT01409993|474344518|FG000|Overall Study|Withdrawal by Subject|0|||
131745211|NCT01409993|474344519|FG001|Overall Study|Withdrawal by Subject|0|||
131745212|NCT01409993|474344520|FG002|Overall Study|Withdrawal by Subject|0|||
131745213|NCT01409993|474344521|FG003|Overall Study|Withdrawal by Subject|4|||
131745214|NCT01409993|474344518|FG000|Overall Study|Lost to Follow-up|0|||
131745215|NCT01409993|474344519|FG001|Overall Study|Lost to Follow-up|1|||
131745216|NCT01409993|474344520|FG002|Overall Study|Lost to Follow-up|0|||
131745217|NCT01409993|474344521|FG003|Overall Study|Lost to Follow-up|0|||
131745218|NCT00067470|474344522|FG000|Overall Study|Withdrawal by Subject|0|||
131745219|NCT00067470|474344523|FG001|Overall Study|Withdrawal by Subject|1|||
131745220|NCT03074149|474344524|FG000|Overall Study|Reason unknown|22|||
131745221|NCT03074149|474344525|FG001|Overall Study|Reason unknown|35|||
131745222|NCT03074149|474344524|FG000|Overall Study|Death|10|||
131745223|NCT03074149|474344525|FG001|Overall Study|Death|45|||
131745224|NCT00050622|474344526|FG000|Overall Study|Adverse Event|1|||
131745225|NCT00050960|474344530|FG000|Overall Study|Progressive Disease|137|||
131745226|NCT00050960|474344531|FG001|Overall Study|Progressive Disease|93|||
131745227|NCT00050960|474344530|FG000|Overall Study|Stable Disease|19|||
131745228|NCT00050960|474344531|FG001|Overall Study|Stable Disease|48|||
131745229|NCT00050960|474344530|FG000|Overall Study|Partial Response|14|||
131745230|NCT00050960|474344531|FG001|Overall Study|Partial Response|19|||
131745231|NCT00050960|474344530|FG000|Overall Study|Complete Response|0|||
131745232|NCT00050960|474344531|FG001|Overall Study|Complete Response|2|||
131745233|NCT00050960|474344530|FG000|Overall Study|Adverse Event|62|||
131745234|NCT00050960|474344531|FG001|Overall Study|Adverse Event|61|||
131745235|NCT00050960|474344530|FG000|Overall Study|Lost to Follow-up|0|||
131745236|NCT00050960|474344531|FG001|Overall Study|Lost to Follow-up|1|||
131745237|NCT00050960|474344530|FG000|Overall Study|Withdrawal by Subject|23|||
131745238|NCT00050960|474344531|FG001|Overall Study|Withdrawal by Subject|18|||
131745239|NCT00050960|474344530|FG000|Overall Study|Administrative|31|||
131745240|NCT00050960|474344531|FG001|Overall Study|Administrative|46|||
131745241|NCT00050960|474344530|FG000|Overall Study|Non-compliance|3|||
131745242|NCT00050960|474344531|FG001|Overall Study|Non-compliance|1|||
131745243|NCT00050960|474344530|FG000|Overall Study|Death|13|||
131745244|NCT00050960|474344531|FG001|Overall Study|Death|15|||
131745245|NCT02727660|474344532|FG000|Overall Study|Lack of Efficacy|40|||
131745246|NCT02727660|474344533|FG001|Overall Study|Lack of Efficacy|40|||
131745247|NCT02727660|474344534|FG002|Overall Study|Lack of Efficacy|70|||
131745248|NCT02727660|474344532|FG000|Overall Study|Adverse Event|28|||
131745249|NCT02727660|474344533|FG001|Overall Study|Adverse Event|21|||
131745250|NCT02727660|474344534|FG002|Overall Study|Adverse Event|32|||
131745251|NCT02727660|474344532|FG000|Overall Study|Withdrawal by Subject|26|||
131745252|NCT02727660|474344533|FG001|Overall Study|Withdrawal by Subject|25|||
131745253|NCT02727660|474344534|FG002|Overall Study|Withdrawal by Subject|30|||
131745254|NCT02727660|474344532|FG000|Overall Study|Physician Decision|3|||
131745255|NCT02727660|474344533|FG001|Overall Study|Physician Decision|8|||
131745256|NCT02727660|474344534|FG002|Overall Study|Physician Decision|14|||
131745257|NCT02727660|474344532|FG000|Overall Study|Lost to Follow-up|5|||
131745258|NCT02727660|474344533|FG001|Overall Study|Lost to Follow-up|9|||
131745259|NCT02727660|474344534|FG002|Overall Study|Lost to Follow-up|8|||
131745260|NCT02727660|474344532|FG000|Overall Study|Protocol Violation|7|||
131745261|NCT02727660|474344533|FG001|Overall Study|Protocol Violation|5|||
131745262|NCT02727660|474344534|FG002|Overall Study|Protocol Violation|5|||
131745263|NCT02727660|474344532|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
131745264|NCT02727660|474344533|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
131745265|NCT02727660|474344534|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
131745266|NCT02727660|474344532|FG000|Overall Study|Administrative Reasons|2|||
131745267|NCT02727660|474344533|FG001|Overall Study|Administrative Reasons|3|||
131745268|NCT02727660|474344534|FG002|Overall Study|Administrative Reasons|4|||
131745269|NCT00764946|474344535|FG000|Overall Study|Lack of Efficacy|1|||
131745270|NCT00764946|474344536|FG001|Overall Study|Lack of Efficacy|0|||
131745271|NCT00764946|474344537|FG002|Overall Study|Lack of Efficacy|0|||
131745272|NCT00764946|474344535|FG000|Overall Study|Lost to Follow-up|3|||
131745273|NCT00764946|474344536|FG001|Overall Study|Lost to Follow-up|4|||
131745274|NCT00764946|474344537|FG002|Overall Study|Lost to Follow-up|0|||
131745275|NCT00764946|474344535|FG000|Overall Study|Physician Decision|2|||
131745276|NCT00764946|474344536|FG001|Overall Study|Physician Decision|4|||
131745277|NCT00764946|474344537|FG002|Overall Study|Physician Decision|0|||
131745278|NCT00764946|474344535|FG000|Overall Study|Adverse Event|3|||
131745279|NCT00764946|474344536|FG001|Overall Study|Adverse Event|2|||
131905986|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
131905987|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
131905988|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
131905989|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
131905990|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131905991|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131905992|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131905993|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
131905994|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
131905995|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
131905996|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
131905997|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
131905998|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
131905999|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
131906000|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
131906001|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
131906002|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
131906003|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
131906004|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
131906005|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Death|0|||
131906006|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Death|0|||
131906007|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Death|1|||
131906008|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Death|0|||
131906009|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Death|0|||
131906010|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Death|0|||
131906011|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
131906012|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
131906013|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
131906014|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
131906015|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
131906016|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
131906017|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
131906018|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
131906019|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
131906020|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
131906021|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
131906022|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
131906023|NCT02513550|474943187|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
131906024|NCT02513550|474943188|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
131906025|NCT02513550|474943189|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
131906026|NCT02513550|474943190|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
131906027|NCT02513550|474943191|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
131906028|NCT02513550|474943192|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
131745280|NCT00764946|474344537|FG002|Overall Study|Adverse Event|1|||
131745281|NCT00764946|474344535|FG000|Overall Study|Withdrawal by Subject|3|||
131745282|NCT00764946|474344536|FG001|Overall Study|Withdrawal by Subject|6|||
131745283|NCT00764946|474344537|FG002|Overall Study|Withdrawal by Subject|2|||
131745284|NCT00764946|474344535|FG000|Overall Study|Never Treated|1|||
131745285|NCT00764946|474344536|FG001|Overall Study|Never Treated|1|||
131745286|NCT00764946|474344537|FG002|Overall Study|Never Treated|1|||
131745287|NCT01767519|474344538|FG000|Overall Study|Other Reasons|4|||
131745288|NCT01767519|474344539|FG001|Overall Study|Other Reasons|4|||
131906029|NCT00192114|474943196|FG000|Overall Study|Objective Tumor Progression|19|||
131906030|NCT00192114|474943196|FG000|Overall Study|Adverse Event|2|||
131745289|NCT01767519|474344540|FG002|Overall Study|Other Reasons|2|||
131906031|NCT00192114|474943196|FG000|Overall Study|Clinical Progression|2|||
131906032|NCT00192114|474943196|FG000|Overall Study|Death|1|||
131906033|NCT00492297|474943197|FG000|Treatment|Death|2|||
131906034|NCT00492297|474943197|FG000|Treatment|Study terminated by sponsor|3|||
131906035|NCT00492297|474943197|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
131906036|NCT00492297|474943197|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
131745290|NCT01767519|474344538|FG000|Overall Study|Protocol Violation|0|||
131745291|NCT01767519|474344539|FG001|Overall Study|Protocol Violation|3|||
131745292|NCT01767519|474344540|FG002|Overall Study|Protocol Violation|0|||
131745293|NCT01767519|474344538|FG000|Overall Study|Personal Reasons|1|||
131745294|NCT01767519|474344539|FG001|Overall Study|Personal Reasons|0|||
131745295|NCT01767519|474344540|FG002|Overall Study|Personal Reasons|0|||
131745296|NCT01767519|474344538|FG000|Overall Study|Lost to Follow-up|3|||
131745297|NCT01767519|474344539|FG001|Overall Study|Lost to Follow-up|1|||
131745298|NCT01767519|474344540|FG002|Overall Study|Lost to Follow-up|2|||
131745299|NCT01767519|474344538|FG000|Overall Study|Lack of Efficacy|1|||
131745300|NCT01767519|474344539|FG001|Overall Study|Lack of Efficacy|0|||
131745301|NCT01767519|474344540|FG002|Overall Study|Lack of Efficacy|0|||
131745302|NCT01767519|474344538|FG000|Overall Study|Adverse Event|5|||
131745303|NCT01767519|474344539|FG001|Overall Study|Adverse Event|5|||
131745304|NCT01767519|474344540|FG002|Overall Study|Adverse Event|1|||
131745305|NCT00039741|474344541|FG000|Overall Study|Death|0|||
131745306|NCT00039741|474344542|FG001|Overall Study|Death|1|||
131745307|NCT00039741|474344543|FG002|Overall Study|Death|0|||
131745308|NCT00039741|474344544|FG003|Overall Study|Death|0|||
131745309|NCT00039741|474344541|FG000|Overall Study|Lost to Follow-up|3|||
131745310|NCT00039741|474344542|FG001|Overall Study|Lost to Follow-up|1|||
131745311|NCT00039741|474344543|FG002|Overall Study|Lost to Follow-up|5|||
131745312|NCT00039741|474344544|FG003|Overall Study|Lost to Follow-up|2|||
131745313|NCT00039741|474344541|FG000|Overall Study|Confounding medical condition|1|||
131745314|NCT00039741|474344542|FG001|Overall Study|Confounding medical condition|0|||
131745315|NCT00039741|474344543|FG002|Overall Study|Confounding medical condition|0|||
131745316|NCT00039741|474344544|FG003|Overall Study|Confounding medical condition|0|||
131745317|NCT00039741|474344541|FG000|Overall Study|Not able to get to clinic|5|||
131745318|NCT00039741|474344542|FG001|Overall Study|Not able to get to clinic|2|||
131745319|NCT00039741|474344543|FG002|Overall Study|Not able to get to clinic|0|||
131745320|NCT00039741|474344544|FG003|Overall Study|Not able to get to clinic|3|||
131745321|NCT00039741|474344541|FG000|Overall Study|Moved|3|||
131745322|NCT00039741|474344542|FG001|Overall Study|Moved|2|||
131745323|NCT00039741|474344543|FG002|Overall Study|Moved|3|||
131745324|NCT00039741|474344544|FG003|Overall Study|Moved|6|||
131745325|NCT00039741|474344541|FG000|Overall Study|Non-compliance with protocol|1|||
131745326|NCT00039741|474344542|FG001|Overall Study|Non-compliance with protocol|0|||
131745327|NCT00039741|474344543|FG002|Overall Study|Non-compliance with protocol|1|||
131745328|NCT00039741|474344544|FG003|Overall Study|Non-compliance with protocol|0|||
131745329|NCT00039741|474344541|FG000|Overall Study|Withdrew consent|0|||
131745330|NCT00039741|474344542|FG001|Overall Study|Withdrew consent|5|||
131745331|NCT00039741|474344543|FG002|Overall Study|Withdrew consent|0|||
131745332|NCT00039741|474344544|FG003|Overall Study|Withdrew consent|1|||
131745333|NCT00039741|474344541|FG000|Overall Study|Missed final visit|2|||
131745334|NCT00039741|474344542|FG001|Overall Study|Missed final visit|1|||
131745335|NCT00039741|474344543|FG002|Overall Study|Missed final visit|2|||
131745336|NCT00039741|474344544|FG003|Overall Study|Missed final visit|2|||
131745337|NCT00946881|474344545|FG000|First Treatment|Withdrawal by Subject|1|||
131745338|NCT00946881|474344545|FG000|First Treatment|Patient relocated to another state|1|||
131745339|NCT00946881|474344545|FG000|Retreatment|Withdrawal by Subject|1|||
131745340|NCT00293423|474344546|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
131745341|NCT00293423|474344547|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
131745342|NCT00293423|474344546|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
131745343|NCT00293423|474344547|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
131745344|NCT00293423|474344546|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
131745345|NCT00293423|474344547|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
131745346|NCT00293423|474344546|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
131745347|NCT00293423|474344547|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
131745348|NCT00293423|474344546|FG000|Surgical Resection|processing error during surgical resection|1|||
131745349|NCT00293423|474344547|FG001|Surgical Resection|processing error during surgical resection|0|||
131745350|NCT00293423|474344546|FG000|Surgical Resection|Withdrawal by Subject|4|||
131745351|NCT00293423|474344547|FG001|Surgical Resection|Withdrawal by Subject|0|||
131745352|NCT00293423|474344546|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
131745353|NCT00293423|474344547|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
131745354|NCT00507416|474344548|FG000|Overall Study|Adverse Event|58|||
131745355|NCT00507416|474344549|FG001|Overall Study|Adverse Event|67|||
131745356|NCT00507416|474344550|FG002|Overall Study|Adverse Event|65|||
131745357|NCT00507416|474344548|FG000|Overall Study|Protocol Violation|1|||
131745358|NCT00507416|474344549|FG001|Overall Study|Protocol Violation|2|||
131745359|NCT00507416|474344550|FG002|Overall Study|Protocol Violation|0|||
131745360|NCT00507416|474344548|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
131745361|NCT00507416|474344549|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
131906037|NCT00492297|474943197|FG000|Survival Only Follow-up|Death|46|||
131745362|NCT00507416|474344550|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
131745363|NCT00507416|474344548|FG000|Overall Study|Progressive Disease|20|||
131745364|NCT00507416|474344549|FG001|Overall Study|Progressive Disease|10|||
131745365|NCT00507416|474344550|FG002|Overall Study|Progressive Disease|13|||
131745366|NCT00507416|474344548|FG000|Overall Study|Patient declined further treatment|18|||
131745367|NCT00507416|474344549|FG001|Overall Study|Patient declined further treatment|14|||
131745368|NCT00507416|474344550|FG002|Overall Study|Patient declined further treatment|11|||
131745369|NCT00507416|474344548|FG000|Overall Study|Other|11|||
131745370|NCT00507416|474344549|FG001|Overall Study|Other|16|||
131745371|NCT00507416|474344550|FG002|Overall Study|Other|13|||
131745372|NCT00507416|474344548|FG000|Overall Study|Did not Receive Study Treatment|3|||
131906038|NCT00492297|474943197|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
131906039|NCT00492297|474943197|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
131906040|NCT01222104|474943198|FG000|Overall Study|Lost to Follow-up|37|||
131906041|NCT01222104|474943198|FG000|Overall Study|Death|10|||
131906042|NCT01418339|474943200|FG000|Overall Study|Adverse Event|5|||
131906043|NCT01418339|474943201|FG001|Overall Study|Adverse Event|2|||
131906044|NCT01418339|474943200|FG000|Overall Study|Subject Withdrew Consent|1|||
131745373|NCT00507416|474344549|FG001|Overall Study|Did not Receive Study Treatment|9|||
131745374|NCT00507416|474344550|FG002|Overall Study|Did not Receive Study Treatment|4|||
131745375|NCT02157506|474344553|FG000|Overall Study|Adverse Event|0|||
131745376|NCT02157506|474344554|FG001|Overall Study|Adverse Event|1|||
131745377|NCT02157506|474344555|FG002|Overall Study|Adverse Event|0|||
131745378|NCT02157506|474344556|FG003|Overall Study|Adverse Event|0|||
131745379|NCT02157506|474344557|FG004|Overall Study|Adverse Event|0|||
131745380|NCT02157506|474344553|FG000|Overall Study|Lost to Follow-up|0|||
131745381|NCT02157506|474344554|FG001|Overall Study|Lost to Follow-up|0|||
131745382|NCT02157506|474344555|FG002|Overall Study|Lost to Follow-up|1|||
131745383|NCT02157506|474344556|FG003|Overall Study|Lost to Follow-up|0|||
131906045|NCT01418339|474943201|FG001|Overall Study|Subject Withdrew Consent|2|||
131906046|NCT01418339|474943200|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
131745384|NCT02157506|474344557|FG004|Overall Study|Lost to Follow-up|0|||
131745385|NCT03101514|474344558|FG000|Overall Study|Withdrawal by Subject|4|||
131906047|NCT01418339|474943201|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
131906048|NCT03885908|474943202|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
131906049|NCT03885908|474943203|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
131906050|NCT03885908|474943202|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
131906051|NCT03885908|474943203|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
131906052|NCT03885908|474943202|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
131906053|NCT03885908|474943203|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
131906054|NCT03885908|474943202|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
131906055|NCT03885908|474943203|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
131906056|NCT02204917|474943204|FG000|Overall Study|Protocol Violation|1|||
131906057|NCT03669549|474943205|FG000|Overall Study|Adverse Event|4|||
131906058|NCT03669549|474943205|FG000|Overall Study|Withdrawal by Subject|1|||
131906059|NCT03669549|474943205|FG000|Overall Study|Study terminated by the Sponsor|1|||
131906060|NCT00698815|474943206|FG000|Overall Study|Death|1|||
131906061|NCT00698815|474943207|FG001|Overall Study|Death|2|||
131906062|NCT00698815|474943208|FG002|Overall Study|Death|4|||
131906063|NCT00698815|474943206|FG000|Overall Study|Withdrawal by Subject|6|||
131906064|NCT00698815|474943207|FG001|Overall Study|Withdrawal by Subject|3|||
131906065|NCT00698815|474943208|FG002|Overall Study|Withdrawal by Subject|2|||
131906066|NCT00698815|474943206|FG000|Overall Study|MD discretion|2|||
131906067|NCT00698815|474943207|FG001|Overall Study|MD discretion|7|||
131906068|NCT00698815|474943208|FG002|Overall Study|MD discretion|2|||
131906069|NCT00698815|474943206|FG000|Overall Study|Did not receive protocol treatment|1|||
131906070|NCT00698815|474943207|FG001|Overall Study|Did not receive protocol treatment|2|||
131906071|NCT00698815|474943208|FG002|Overall Study|Did not receive protocol treatment|2|||
131906072|NCT00749398|474943209|FG000|Overall Study|Lack of Efficacy|7|||
131906073|NCT00749398|474943209|FG000|Overall Study|Adverse Event|4|||
131745386|NCT03101514|474344558|FG000|Overall Study|Protocol Violation|2|||
131906074|NCT00749398|474943209|FG000|Overall Study|Serious adverse event|11|||
131745387|NCT03101514|474344558|FG000|Overall Study|patient's information was incomplete|1|||
131745388|NCT02247401|474344561|FG000|Overall Study|Adverse Event|1|||
131745389|NCT02247401|474344562|FG001|Overall Study|Adverse Event|0|||
131745390|NCT02247401|474344563|FG002|Overall Study|Adverse Event|0|||
131906075|NCT00749398|474943209|FG000|Overall Study|Withdrawal by Subject|17|||
131906076|NCT00749398|474943209|FG000|Overall Study|Lost to Follow-up|11|||
131906077|NCT00749398|474943209|FG000|Overall Study|Reason not specified|2|||
131906078|NCT00749398|474943209|FG000|Overall Study|Unknown reason|1|||
131745391|NCT02247401|474344561|FG000|Overall Study|Withdrawal by Subject|4|||
131745392|NCT02247401|474344562|FG001|Overall Study|Withdrawal by Subject|1|||
131745393|NCT02247401|474344563|FG002|Overall Study|Withdrawal by Subject|1|||
131745394|NCT02247401|474344561|FG000|Overall Study|Lost to Follow-up|1|||
131745395|NCT02247401|474344562|FG001|Overall Study|Lost to Follow-up|1|||
131745396|NCT02247401|474344563|FG002|Overall Study|Lost to Follow-up|1|||
131745397|NCT03498287|474344570|FG000|Overall Study|Withdrawal by Subject|3|||
131745398|NCT03498287|474344571|FG001|Overall Study|Withdrawal by Subject|0|||
131745399|NCT03498287|474344570|FG000|Overall Study|Protocol Violation|0|||
131745400|NCT03498287|474344571|FG001|Overall Study|Protocol Violation|4|||
131745401|NCT03498287|474344570|FG000|Overall Study|Adverse Event|0|||
131745402|NCT03498287|474344571|FG001|Overall Study|Adverse Event|1|||
131745403|NCT01374217|474344574|FG000|Overall Study|Lack of Efficacy|13|||
131745404|NCT01117012|474344575|FG000|Overall Study|Adverse Event|0|||
131745405|NCT01117012|474344576|FG001|Overall Study|Adverse Event|1|||
131745406|NCT01117012|474344575|FG000|Overall Study|Death|1|||
131745407|NCT01117012|474344576|FG001|Overall Study|Death|1|||
131745408|NCT01117012|474344575|FG000|Overall Study|Withdrawal by Subject|3|||
131745409|NCT01117012|474344576|FG001|Overall Study|Withdrawal by Subject|0|||
131745410|NCT01117012|474344575|FG000|Overall Study|Undefined|4|||
131745411|NCT01117012|474344576|FG001|Overall Study|Undefined|3|||
131745412|NCT03695393|474344577|FG000|Overall Study|Death|3|||
131745413|NCT03695393|474344578|FG001|Overall Study|Death|1|||
131745414|NCT03695393|474344577|FG000|Overall Study|Lost to Follow-up|0|||
131745415|NCT03695393|474344578|FG001|Overall Study|Lost to Follow-up|1|||
131745416|NCT01641991|474344581|FG000|Overall Study|Physician Decision|0|||
131745417|NCT01641991|474344582|FG001|Overall Study|Physician Decision|1|||
131745418|NCT01641991|474344583|FG002|Overall Study|Physician Decision|7|||
131745419|NCT01641991|474344584|FG003|Overall Study|Physician Decision|5|||
131745420|NCT01641991|474344581|FG000|Overall Study|Withdrawal by Subject|4|||
131745421|NCT01641991|474344582|FG001|Overall Study|Withdrawal by Subject|2|||
131745422|NCT01641991|474344583|FG002|Overall Study|Withdrawal by Subject|1|||
131745423|NCT01641991|474344584|FG003|Overall Study|Withdrawal by Subject|5|||
131745424|NCT01641991|474344581|FG000|Overall Study|Adverse Event|2|||
131745425|NCT01641991|474344582|FG001|Overall Study|Adverse Event|1|||
131745426|NCT01641991|474344583|FG002|Overall Study|Adverse Event|2|||
131745427|NCT01641991|474344584|FG003|Overall Study|Adverse Event|1|||
131745428|NCT01641991|474344581|FG000|Overall Study|Lost to Follow-up|0|||
131745429|NCT01641991|474344582|FG001|Overall Study|Lost to Follow-up|2|||
131745430|NCT01641991|474344583|FG002|Overall Study|Lost to Follow-up|3|||
131745431|NCT01641991|474344584|FG003|Overall Study|Lost to Follow-up|1|||
131745432|NCT01641991|474344581|FG000|Overall Study|Protocol Violation|1|||
131745433|NCT01641991|474344582|FG001|Overall Study|Protocol Violation|1|||
131745434|NCT01641991|474344583|FG002|Overall Study|Protocol Violation|3|||
131745435|NCT01641991|474344584|FG003|Overall Study|Protocol Violation|0|||
131745436|NCT01641991|474344581|FG000|Overall Study|Pregnancy|0|||
131745437|NCT01641991|474344582|FG001|Overall Study|Pregnancy|0|||
131745438|NCT01641991|474344583|FG002|Overall Study|Pregnancy|1|||
131745439|NCT01641991|474344584|FG003|Overall Study|Pregnancy|0|||
131745440|NCT01641991|474344581|FG000|Overall Study|no longer eligible|2|||
131745441|NCT01641991|474344582|FG001|Overall Study|no longer eligible|1|||
131745442|NCT01641991|474344583|FG002|Overall Study|no longer eligible|0|||
131745443|NCT01641991|474344584|FG003|Overall Study|no longer eligible|4|||
131745444|NCT00673894|474344585|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
131745445|NCT00673894|474344586|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
131745446|NCT00673894|474344585|FG000|First Intervention 4 Weeks|Adverse Event|1|||
131745447|NCT00673894|474344586|FG001|First Intervention 4 Weeks|Adverse Event|0|||
131745448|NCT00493974|474344587|FG000|Overall Study|Death|1|||
131745449|NCT00493974|474344588|FG001|Overall Study|Death|2|||
131745450|NCT00493974|474344587|FG000|Overall Study|Withdrawal by Subject|8|||
131745451|NCT00493974|474344588|FG001|Overall Study|Withdrawal by Subject|6|||
131745452|NCT00493974|474344587|FG000|Overall Study|Lost to Follow-up|4|||
131745453|NCT00493974|474344588|FG001|Overall Study|Lost to Follow-up|6|||
131745454|NCT02555657|474344589|FG000|Overall Study|Death|274|||
131745455|NCT02555657|474344590|FG001|Overall Study|Death|262|||
131745456|NCT02555657|474344589|FG000|Overall Study|Physician Decision|0|||
131745457|NCT02555657|474344590|FG001|Overall Study|Physician Decision|1|||
131745458|NCT02555657|474344589|FG000|Overall Study|Sponsor Decision|27|||
131745459|NCT02555657|474344590|FG001|Overall Study|Sponsor Decision|15|||
131745460|NCT02555657|474344589|FG000|Overall Study|Withdrawal by Subject|11|||
131745461|NCT02555657|474344590|FG001|Overall Study|Withdrawal by Subject|32|||
131745462|NCT02807363|474344591|FG000|Dosing Period|Adverse Event|0|||
131745463|NCT02807363|474344592|FG001|Dosing Period|Adverse Event|1|||
131745464|NCT02807363|474344593|FG002|Dosing Period|Adverse Event|0|||
131745465|NCT02807363|474344594|FG003|Dosing Period|Adverse Event|0|||
131745466|NCT02188719|474344595|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
131745467|NCT02188719|474344596|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
131745468|NCT02188719|474344597|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
131745469|NCT02188719|474344598|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
131745470|NCT01578785|474344600|FG000|Overall Study|Withdrawal by Subject|0|||
131745471|NCT01578785|474344601|FG001|Overall Study|Withdrawal by Subject|1|||
131745472|NCT01578785|474344600|FG000|Overall Study|Study terminated by sponsor|59|||
131745473|NCT01578785|474344601|FG001|Overall Study|Study terminated by sponsor|118|||
131745474|NCT00966693|474344602|FG000|Overall Study|Adverse Event|0|||
131906079|NCT03093181|474943214|FG000|Overall Study|Withdrawal by Subject|2|||
131906080|NCT03093181|474943215|FG001|Overall Study|Withdrawal by Subject|1|||
131906081|NCT03093181|474943216|FG002|Overall Study|Withdrawal by Subject|2|||
131906082|NCT03093181|474943214|FG000|Overall Study|Other (Not specified)|1|||
131906083|NCT03093181|474943215|FG001|Overall Study|Other (Not specified)|0|||
131906084|NCT03093181|474943216|FG002|Overall Study|Other (Not specified)|0|||
131906085|NCT03093181|474943214|FG000|Overall Study|Adverse Event|0|||
131906086|NCT03093181|474943215|FG001|Overall Study|Adverse Event|1|||
131906087|NCT03093181|474943216|FG002|Overall Study|Adverse Event|0|||
131906088|NCT03093181|474943214|FG000|Overall Study|Other (Protocol violation)|0|||
131906089|NCT03093181|474943215|FG001|Overall Study|Other (Protocol violation)|0|||
131906090|NCT03093181|474943216|FG002|Overall Study|Other (Protocol violation)|1|||
131906091|NCT01663402|474943217|FG000|Overall Study|Randomized but not treated|19|||
131906092|NCT01663402|474943218|FG001|Overall Study|Randomized but not treated|11|||
131906093|NCT01663402|474943217|FG000|Overall Study|Adverse Event|347|||
131906094|NCT01663402|474943218|FG001|Overall Study|Adverse Event|362|||
131906095|NCT01663402|474943217|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
131906096|NCT01663402|474943218|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
131906097|NCT01663402|474943217|FG000|Overall Study|Poor compliance to protocol|529|||
131906098|NCT01663402|474943218|FG001|Overall Study|Poor compliance to protocol|454|||
131906099|NCT01663402|474943217|FG000|Overall Study|Physician Decision|77|||
131906100|NCT01663402|474943218|FG001|Overall Study|Physician Decision|62|||
131906101|NCT01663402|474943217|FG000|Overall Study|Site terminated by sponsor|1|||
131906102|NCT01663402|474943218|FG001|Overall Study|Site terminated by sponsor|3|||
131906103|NCT01663402|474943217|FG000|Overall Study|Participant moved|139|||
131906104|NCT01663402|474943218|FG001|Overall Study|Participant moved|104|||
131906105|NCT01663402|474943217|FG000|Overall Study|Withdrawal by Subject|118|||
131906106|NCT01663402|474943218|FG001|Overall Study|Withdrawal by Subject|91|||
131906107|NCT01663402|474943217|FG000|Overall Study|Related to study drug administration|96|||
131906108|NCT01663402|474943218|FG001|Overall Study|Related to study drug administration|105|||
131906109|NCT01663402|474943217|FG000|Overall Study|Lost to Follow-up|17|||
131906110|NCT01663402|474943218|FG001|Overall Study|Lost to Follow-up|15|||
131906111|NCT01663402|474943217|FG000|Overall Study|Other than specified above|172|||
131906112|NCT01663402|474943218|FG001|Overall Study|Other than specified above|147|||
131906113|NCT04210986|474943223|FG000|Overall Study|Lost to Follow-up|5|||
131745475|NCT00966693|474344603|FG001|Overall Study|Adverse Event|0|||
131745476|NCT00966693|474344604|FG002|Overall Study|Adverse Event|1|||
131745477|NCT00966693|474344605|FG003|Overall Study|Adverse Event|2|||
131745478|NCT00966693|474344602|FG000|Overall Study|Death|0|||
131745479|NCT00966693|474344603|FG001|Overall Study|Death|0|||
131745480|NCT00966693|474344604|FG002|Overall Study|Death|1|||
131745481|NCT00966693|474344605|FG003|Overall Study|Death|0|||
131745482|NCT00966693|474344602|FG000|Overall Study|Withdrawal by Subject|1|||
131745483|NCT00966693|474344603|FG001|Overall Study|Withdrawal by Subject|0|||
131745484|NCT00966693|474344604|FG002|Overall Study|Withdrawal by Subject|0|||
131745485|NCT00966693|474344605|FG003|Overall Study|Withdrawal by Subject|5|||
131745486|NCT00966693|474344602|FG000|Overall Study|Disease Progression|0|||
131745487|NCT00966693|474344603|FG001|Overall Study|Disease Progression|0|||
131745488|NCT00966693|474344604|FG002|Overall Study|Disease Progression|1|||
131745489|NCT00966693|474344605|FG003|Overall Study|Disease Progression|16|||
131745490|NCT01164865|474344606|FG000|Overall Study|Lost to Follow-up|2|||
131745491|NCT01164865|474344607|FG001|Overall Study|Lost to Follow-up|1|||
131745492|NCT00192036|474344608|FG000|Overall Study|Protocol Violation|3|||
131745493|NCT00192036|474344608|FG000|Overall Study|Adverse Event|6|||
131906114|NCT04210986|474943224|FG001|Overall Study|Lost to Follow-up|2|||
131906115|NCT04210986|474943223|FG000|Overall Study|Withdrawal by Subject|3|||
131906116|NCT04210986|474943224|FG001|Overall Study|Withdrawal by Subject|1|||
131906117|NCT04210986|474943223|FG000|Overall Study|Protocol Violation|1|||
131906118|NCT04210986|474943224|FG001|Overall Study|Protocol Violation|1|||
131906119|NCT04210986|474943223|FG000|Overall Study|Physician Decision|0|||
131906120|NCT04210986|474943224|FG001|Overall Study|Physician Decision|1|||
131906121|NCT02666222|474943226|FG000|Overall Study|Death|2|||
131906122|NCT04233879|474943227|FG000|Overall Study|Death|2|||
131745494|NCT00192036|474344608|FG000|Overall Study|Patient/Physician Perception|1|||
131745495|NCT00192036|474344608|FG000|Overall Study|Objective Tumor Progression|4|||
131745496|NCT00192036|474344608|FG000|Overall Study|Clinical Disease Progression|1|||
131745497|NCT00192036|474344608|FG000|Overall Study|Death|1|||
131448989|NCT00771758|473272762|FG001|Overall Study|Adverse Event|8|||
131745498|NCT00192036|474344608|FG000|Overall Study|Unknown or Not Specified|5|||
131745499|NCT03371732|474344609|FG000|Overall Study|Withdrawal by Subject|9|||
131745500|NCT03371732|474344610|FG001|Overall Study|Withdrawal by Subject|3|||
131745501|NCT03371732|474344609|FG000|Overall Study|Refusal to continue|3|||
131745502|NCT03371732|474344610|FG001|Overall Study|Refusal to continue|4|||
131745503|NCT02581982|474344613|FG000|Overall Study|Lack of Efficacy|12|||
131745504|NCT02581982|474344613|FG000|Overall Study|Adverse Event|3|||
131745505|NCT02581982|474344613|FG000|Overall Study|Physician Decision|1|||
131745506|NCT00599027|474344614|FG000|Overall Study|Withdrawal by Subject|1|||
131745507|NCT00599027|474344615|FG001|Overall Study|Withdrawal by Subject|1|||
131745508|NCT00599027|474344614|FG000|Overall Study|Adverse Event|0|||
131745509|NCT00599027|474344615|FG001|Overall Study|Adverse Event|1|||
131745510|NCT00599027|474344614|FG000|Overall Study|Treatment Failure|0|||
131745511|NCT00599027|474344615|FG001|Overall Study|Treatment Failure|1|||
131745512|NCT00405821|474344616|FG000|Overall Study|Death|5|||
131745513|NCT00405821|474344617|FG001|Overall Study|Death|7|||
131745514|NCT00405821|474344616|FG000|Overall Study|Lost to Follow-up|7|||
131745515|NCT00405821|474344617|FG001|Overall Study|Lost to Follow-up|7|||
131745516|NCT00405821|474344616|FG000|Overall Study|Protocol Violation|1|||
131745517|NCT00405821|474344617|FG001|Overall Study|Protocol Violation|0|||
131745518|NCT00405821|474344616|FG000|Overall Study|initiated ART|9|||
131745519|NCT00405821|474344617|FG001|Overall Study|initiated ART|8|||
131745520|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
131745521|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
131745522|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
131745523|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
131745524|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
131745525|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
131745526|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
131745527|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
131745528|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
131745529|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
131745530|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
131745531|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
131745532|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
131745533|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
131745534|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
131745535|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
131745536|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
131745537|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
131745538|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
131745539|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
131745540|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
131745541|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
131745542|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
131745543|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
131745544|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
131745545|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
131745546|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
131745547|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
131745548|NCT00476996|474344619|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
131808538|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131745549|NCT00476996|474344620|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
131745550|NCT00476996|474344621|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
131745551|NCT00476996|474344622|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
131745552|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
131745553|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
131745554|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
131745555|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
131745556|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
131745557|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
131745558|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
131745559|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
131745560|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Death|0|||
131745561|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Death|0|||
131745562|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Death|0|||
131745563|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Death|7|||
131745564|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
131448990|NCT00771758|473272763|FG002|Overall Study|Adverse Event|1|||
131745565|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
131745566|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
131745567|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
131745568|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
131745569|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
131745570|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
131745571|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
131745572|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
131745573|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
131745574|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
131745575|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
131745576|NCT00476996|474344619|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
131745577|NCT00476996|474344620|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
131745578|NCT00476996|474344621|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
131745579|NCT00476996|474344622|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
131745580|NCT01769469|474344626|FG000|Overall Study|Consent Withdrawn|5|||
131745581|NCT01769469|474344626|FG000|Overall Study|Moved Out Of Area|3|||
131745582|NCT01769469|474344626|FG000|Overall Study|Lost to Follow-up|17|||
131745583|NCT01769469|474344626|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
131745584|NCT01769469|474344626|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
131745585|NCT02394795|474344634|FG000|Overall Study|Adverse Event|92|||
131745586|NCT02394795|474344635|FG001|Overall Study|Adverse Event|70|||
131745587|NCT02394795|474344634|FG000|Overall Study|Lost to Follow-up|0|||
131745588|NCT02394795|474344635|FG001|Overall Study|Lost to Follow-up|1|||
131745589|NCT02394795|474344634|FG000|Overall Study|Withdrawal by Subject|17|||
131745590|NCT02394795|474344635|FG001|Overall Study|Withdrawal by Subject|26|||
131745591|NCT02394795|474344634|FG000|Overall Study|Lack of Efficacy|181|||
131745592|NCT02394795|474344635|FG001|Overall Study|Lack of Efficacy|211|||
131745593|NCT02394795|474344634|FG000|Overall Study|Death|4|||
131745594|NCT02394795|474344635|FG001|Overall Study|Death|5|||
131745595|NCT02394795|474344634|FG000|Overall Study|Physician Decision|109|||
131745596|NCT02394795|474344635|FG001|Overall Study|Physician Decision|93|||
131745597|NCT02031432|474344650|FG000|Overall Study|Protocol Violation|1|||
131745598|NCT02031432|474344650|FG000|Overall Study|Lack of Efficacy|5|||
131745599|NCT02031432|474344650|FG000|Overall Study|Cancer Progression|2|||
131745600|NCT02031432|474344650|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
131745601|NCT02031432|474344650|FG000|Overall Study|Adverse Event|8|||
131745602|NCT02031432|474344650|FG000|Overall Study|Withdrawal by Subject|5|||
131745603|NCT02031432|474344650|FG000|Overall Study|Lost to Follow-up|1|||
131745604|NCT02031432|474344650|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
131745605|NCT02031432|474344650|FG000|Overall Study|Death|10|||
131745606|NCT01181778|474344651|FG000|Overall Study|Physician Decision|48|||
131745607|NCT01617187|474344652|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
131745608|NCT01617187|474344653|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
131745609|NCT01617187|474344654|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
131745610|NCT01617187|474344655|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
131745611|NCT01617187|474344652|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
131745612|NCT01617187|474344653|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
131745613|NCT01617187|474344654|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
131745614|NCT01617187|474344655|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
131745615|NCT01617187|474344652|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
131745616|NCT01617187|474344653|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
131745617|NCT01617187|474344654|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
131745618|NCT01617187|474344655|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
131745619|NCT01617187|474344652|FG000|Treatment Through Study Completion|Adverse Event|1|||
131745620|NCT01617187|474344653|FG001|Treatment Through Study Completion|Adverse Event|1|||
131745621|NCT01617187|474344654|FG002|Treatment Through Study Completion|Adverse Event|0|||
131745622|NCT01617187|474344655|FG003|Treatment Through Study Completion|Adverse Event|1|||
131745623|NCT01617187|474344652|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
131745624|NCT01617187|474344653|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
131745625|NCT01617187|474344654|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
131745626|NCT01617187|474344655|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
131745627|NCT01617187|474344652|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
131745628|NCT01617187|474344653|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
131745629|NCT01617187|474344654|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
131745630|NCT01617187|474344655|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
131745631|NCT01617187|474344652|FG000|Treatment Through Study Completion|Protocol Violation|1|||
131745632|NCT01617187|474344653|FG001|Treatment Through Study Completion|Protocol Violation|0|||
131745633|NCT01617187|474344654|FG002|Treatment Through Study Completion|Protocol Violation|0|||
131906123|NCT04233879|474943228|FG001|Overall Study|Death|0|||
131906124|NCT04233879|474943227|FG000|Overall Study|Lost to Follow-up|3|||
131906125|NCT04233879|474943228|FG001|Overall Study|Lost to Follow-up|8|||
131906126|NCT04233879|474943227|FG000|Overall Study|Physician Decision|4|||
131906127|NCT04233879|474943228|FG001|Overall Study|Physician Decision|4|||
131906128|NCT04233879|474943227|FG000|Overall Study|Withdrawal by Subject|7|||
131906129|NCT04233879|474943228|FG001|Overall Study|Withdrawal by Subject|10|||
131906130|NCT04233879|474943227|FG000|Overall Study|Other|281|||
131906131|NCT04233879|474943228|FG001|Overall Study|Other|279|||
131906132|NCT03585270|474943231|FG000|Overall Study|Withdrawal by Subject|2|||
131906133|NCT03585270|474943232|FG001|Overall Study|Withdrawal by Subject|6|||
131906134|NCT03585270|474943231|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
131906135|NCT03585270|474943232|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
131906136|NCT03585270|474943231|FG000|Overall Study|Adverse Event|5|||
131906137|NCT03585270|474943232|FG001|Overall Study|Adverse Event|2|||
131906138|NCT03585270|474943231|FG000|Overall Study|Lost to Follow-up|1|||
131745634|NCT01617187|474344655|FG003|Treatment Through Study Completion|Protocol Violation|1|||
131745635|NCT01265420|474344656|FG000|Overall Study|Lost to Follow-up|1|||
131745636|NCT03862131|474344660|FG000|Overall Study|Lost to Follow-up|1|||
131745637|NCT03862131|474344661|FG001|Overall Study|Lost to Follow-up|0|||
131745638|NCT03862131|474344662|FG002|Overall Study|Lost to Follow-up|1|||
131745639|NCT03862131|474344660|FG000|Overall Study|Determined to be ineligible|0|||
131745640|NCT03862131|474344661|FG001|Overall Study|Determined to be ineligible|0|||
131745641|NCT03862131|474344662|FG002|Overall Study|Determined to be ineligible|5|||
131745642|NCT03862131|474344660|FG000|Overall Study|Death|4|||
131745643|NCT03862131|474344661|FG001|Overall Study|Death|4|||
131745644|NCT03862131|474344662|FG002|Overall Study|Death|0|||
131745645|NCT03862131|474344660|FG000|Overall Study|Withdrawal by Subject|5|||
131745646|NCT03862131|474344661|FG001|Overall Study|Withdrawal by Subject|3|||
131745647|NCT03862131|474344662|FG002|Overall Study|Withdrawal by Subject|0|||
131745648|NCT03862131|474344660|FG000|Overall Study|Physician Decision|0|||
131745649|NCT03862131|474344661|FG001|Overall Study|Physician Decision|1|||
131745650|NCT03862131|474344662|FG002|Overall Study|Physician Decision|0|||
131745651|NCT02293902|474344663|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
131745652|NCT02293902|474344664|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
131745653|NCT02293902|474344665|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
131745654|NCT02293902|474344666|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
131745655|NCT02293902|474344667|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
131745656|NCT02293902|474344663|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
131745657|NCT02293902|474344664|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
131745658|NCT02293902|474344665|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
131745659|NCT02293902|474344666|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
131745660|NCT02293902|474344667|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
131745661|NCT02293902|474344663|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
131745662|NCT02293902|474344664|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131745663|NCT02293902|474344665|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131745664|NCT02293902|474344666|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131745665|NCT02293902|474344667|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131745666|NCT02293902|474344663|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
131745667|NCT02293902|474344664|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
131745668|NCT02293902|474344665|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
131745669|NCT02293902|474344666|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
131745670|NCT02293902|474344667|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
131745671|NCT02293902|474344663|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
131745672|NCT02293902|474344664|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
131745673|NCT02293902|474344665|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
131906139|NCT03585270|474943232|FG001|Overall Study|Lost to Follow-up|4|||
131745674|NCT02293902|474344666|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
131745675|NCT02293902|474344667|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
131745676|NCT01770145|474346760|FG000|Baseline|Adverse Event|20|||
131745677|NCT01770145|474346760|FG000|Baseline|Withdrawal by Subject|1|||
131745678|NCT01770145|474346760|FG000|Baseline|Lost to Follow-up|1|||
131745679|NCT01770145|474346760|FG000|Baseline|Unable to define optimal dose|4|||
131906140|NCT03585270|474943231|FG000|Overall Study|Death|5|||
131906141|NCT03585270|474943232|FG001|Overall Study|Death|3|||
131906142|NCT03585270|474943231|FG000|Overall Study|Other reasons|2|||
131906143|NCT03585270|474943232|FG001|Overall Study|Other reasons|2|||
131745680|NCT01770145|474346760|FG000|Treatment|Adverse Event|3|||
131745681|NCT01770145|474346760|FG000|Treatment|Withdrawal by Subject|1|||
131745682|NCT02332798|474346761|FG000|Overall Study|Unwilling to Participate in Study|0|||
131745683|NCT02332798|474346762|FG001|Overall Study|Unwilling to Participate in Study|1|||
131745684|NCT02332798|474346763|FG002|Overall Study|Unwilling to Participate in Study|1|||
131745685|NCT02332798|474346761|FG000|Overall Study|Positive Urine Drug Test|0|||
131745686|NCT02332798|474346762|FG001|Overall Study|Positive Urine Drug Test|1|||
131745687|NCT02332798|474346763|FG002|Overall Study|Positive Urine Drug Test|0|||
131745688|NCT02332798|474346761|FG000|Overall Study|Abnormal Laboratory Findings|1|||
131745689|NCT02332798|474346762|FG001|Overall Study|Abnormal Laboratory Findings|0|||
131745690|NCT02332798|474346763|FG002|Overall Study|Abnormal Laboratory Findings|0|||
131745691|NCT00595868|474346764|FG000|Overall Study|Lost to Follow-up|45|||
131745692|NCT00595868|474346765|FG001|Overall Study|Lost to Follow-up|50|||
131745693|NCT05406440|474346766|FG000|Overall Study|Lost to Follow-up|0|||
131745694|NCT05406440|474346767|FG001|Overall Study|Lost to Follow-up|0|||
131745695|NCT05406440|474346768|FG002|Overall Study|Lost to Follow-up|0|||
131745696|NCT05406440|474346769|FG003|Overall Study|Lost to Follow-up|0|||
131745697|NCT05406440|474346770|FG004|Overall Study|Lost to Follow-up|2|||
131745698|NCT05406440|474346771|FG005|Overall Study|Lost to Follow-up|0|||
131745699|NCT05406440|474346772|FG006|Overall Study|Lost to Follow-up|0|||
131745700|NCT05406440|474346766|FG000|Overall Study|Physician Decision|0|||
131745701|NCT05406440|474346767|FG001|Overall Study|Physician Decision|0|||
131906144|NCT01664091|474943233|FG000|Overall Study|Death|1|||
131906145|NCT01664091|474943233|FG000|Overall Study|Disease Progression|2|||
131745702|NCT05406440|474346768|FG002|Overall Study|Physician Decision|0|||
131745703|NCT05406440|474346769|FG003|Overall Study|Physician Decision|0|||
131745704|NCT05406440|474346770|FG004|Overall Study|Physician Decision|1|||
131745705|NCT05406440|474346771|FG005|Overall Study|Physician Decision|0|||
131745706|NCT05406440|474346772|FG006|Overall Study|Physician Decision|0|||
131745707|NCT05406440|474346766|FG000|Overall Study|Withdrawal by Subject|0|||
131745708|NCT05406440|474346767|FG001|Overall Study|Withdrawal by Subject|0|||
131745709|NCT05406440|474346768|FG002|Overall Study|Withdrawal by Subject|0|||
131745710|NCT05406440|474346769|FG003|Overall Study|Withdrawal by Subject|0|||
131745711|NCT05406440|474346770|FG004|Overall Study|Withdrawal by Subject|0|||
131745712|NCT05406440|474346771|FG005|Overall Study|Withdrawal by Subject|2|||
131745713|NCT05406440|474346772|FG006|Overall Study|Withdrawal by Subject|0|||
131745714|NCT03788967|474346774|FG000|Overall Study|Lost to Follow-up|14|||
131745715|NCT03788967|474346775|FG001|Overall Study|Lost to Follow-up|10|||
131745716|NCT03788967|474346774|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
131745717|NCT03788967|474346775|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
131745718|NCT03788967|474346774|FG000|Overall Study|Participant Withdrawal of Consent|13|||
131745719|NCT03788967|474346775|FG001|Overall Study|Participant Withdrawal of Consent|5|||
131745720|NCT03788967|474346774|FG000|Overall Study|Adverse Event|1|||
131745721|NCT03788967|474346775|FG001|Overall Study|Adverse Event|1|||
131745722|NCT03788967|474346774|FG000|Overall Study|COVID-19|1|||
131745723|NCT03788967|474346775|FG001|Overall Study|COVID-19|2|||
131745724|NCT04268303|474346776|FG000|Overall Study|Lost to Follow-up|1|||
131745725|NCT04268303|474346777|FG001|Overall Study|Lost to Follow-up|1|||
131745726|NCT04268303|474346778|FG002|Overall Study|Lost to Follow-up|2|||
131745727|NCT04268303|474346776|FG000|Overall Study|Withdrawal by Subject|0|||
131745728|NCT04268303|474346777|FG001|Overall Study|Withdrawal by Subject|1|||
131745729|NCT04268303|474346778|FG002|Overall Study|Withdrawal by Subject|1|||
131745730|NCT04268303|474346776|FG000|Overall Study|Adverse Event|2|||
131745731|NCT04268303|474346777|FG001|Overall Study|Adverse Event|0|||
131745732|NCT04268303|474346778|FG002|Overall Study|Adverse Event|0|||
131745733|NCT03927911|474346779|FG000|Overall Study|problems with eDiary|0|||
131745734|NCT03927911|474346780|FG001|Overall Study|problems with eDiary|1|||
131906146|NCT01664091|474943233|FG000|Overall Study|Lost to Follow-up|2|||
131906147|NCT01664091|474943233|FG000|Overall Study|Withdrawal by Subject|1|||
131906148|NCT01076543|474943238|FG000|Overall Study|Withdrawal by Subject|2|||
131906149|NCT01076543|474943239|FG001|Overall Study|Withdrawal by Subject|0|||
131906150|NCT01076543|474943240|FG002|Overall Study|Withdrawal by Subject|0|||
131906151|NCT01076543|474943241|FG003|Overall Study|Withdrawal by Subject|0|||
131906152|NCT01076543|474943242|FG004|Overall Study|Withdrawal by Subject|0|||
131906153|NCT01076543|474943243|FG005|Overall Study|Withdrawal by Subject|0|||
131745735|NCT03927911|474346781|FG002|Overall Study|problems with eDiary|0|||
131745736|NCT03927911|474346782|FG003|Overall Study|problems with eDiary|1|||
131745737|NCT03927911|474346783|FG004|Overall Study|problems with eDiary|0|||
131745738|NCT03927911|474346784|FG005|Overall Study|problems with eDiary|4|||
131745739|NCT03927911|474346779|FG000|Overall Study|Adverse Event|0|||
131745740|NCT03927911|474346780|FG001|Overall Study|Adverse Event|0|||
131745741|NCT03927911|474346781|FG002|Overall Study|Adverse Event|0|||
131745742|NCT03927911|474346782|FG003|Overall Study|Adverse Event|0|||
131745743|NCT03927911|474346783|FG004|Overall Study|Adverse Event|0|||
131745744|NCT03927911|474346784|FG005|Overall Study|Adverse Event|1|||
131745745|NCT03927911|474346779|FG000|Overall Study|not treated -study terminated by sponsor|0|||
131745746|NCT03927911|474346780|FG001|Overall Study|not treated -study terminated by sponsor|1|||
131448991|NCT00771758|473272761|FG000|Overall Study|Lack of Efficacy|0|||
131448992|NCT00771758|473272762|FG001|Overall Study|Lack of Efficacy|2|||
131745747|NCT03927911|474346781|FG002|Overall Study|not treated -study terminated by sponsor|0|||
131745748|NCT03927911|474346782|FG003|Overall Study|not treated -study terminated by sponsor|0|||
131745749|NCT03927911|474346783|FG004|Overall Study|not treated -study terminated by sponsor|0|||
131745750|NCT03927911|474346784|FG005|Overall Study|not treated -study terminated by sponsor|0|||
131745751|NCT03927911|474346779|FG000|Overall Study|Surgery cancelled|0|||
131745752|NCT03927911|474346780|FG001|Overall Study|Surgery cancelled|0|||
131745753|NCT03927911|474346781|FG002|Overall Study|Surgery cancelled|0|||
131745754|NCT03927911|474346782|FG003|Overall Study|Surgery cancelled|1|||
131745755|NCT03927911|474346783|FG004|Overall Study|Surgery cancelled|0|||
131745756|NCT03927911|474346784|FG005|Overall Study|Surgery cancelled|1|||
131745757|NCT03927911|474346779|FG000|Overall Study|Protocol Violation|0|||
131745758|NCT03927911|474346780|FG001|Overall Study|Protocol Violation|0|||
131745759|NCT03927911|474346781|FG002|Overall Study|Protocol Violation|0|||
131745760|NCT03927911|474346782|FG003|Overall Study|Protocol Violation|0|||
131745761|NCT03927911|474346783|FG004|Overall Study|Protocol Violation|0|||
131745762|NCT03927911|474346784|FG005|Overall Study|Protocol Violation|1|||
131745763|NCT04432376|474346785|FG000|Double-blind Treatment Period|Adverse Event|2|||
131745764|NCT04432376|474346786|FG001|Double-blind Treatment Period|Adverse Event|6|||
131745765|NCT04432376|474346787|FG002|Double-blind Treatment Period|Adverse Event|0|||
131745766|NCT04432376|474346785|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
131745767|NCT04432376|474346786|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
131745768|NCT04432376|474346787|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131745769|NCT04432376|474346785|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131745770|NCT04432376|474346786|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131745771|NCT04432376|474346787|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131745772|NCT04432376|474346785|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131745773|NCT04432376|474346786|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131745774|NCT04432376|474346787|FG002|Double-blind Treatment Period|Protocol Violation|0|||
131745775|NCT04432376|474346785|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
131745776|NCT04432376|474346786|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
131745777|NCT04432376|474346787|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
131745778|NCT01824693|474346788|FG000|Overall Study|Death|0|||
131745779|NCT01824693|474346789|FG001|Overall Study|Death|1|||
131745780|NCT01824693|474346790|FG002|Overall Study|Death|0|||
131745781|NCT01824693|474346788|FG000|Overall Study|Physician Decision|1|||
131745782|NCT01824693|474346789|FG001|Overall Study|Physician Decision|1|||
131745783|NCT01824693|474346790|FG002|Overall Study|Physician Decision|1|||
131745784|NCT01824693|474346788|FG000|Overall Study|Withdrawal by Subject|0|||
131745785|NCT01824693|474346789|FG001|Overall Study|Withdrawal by Subject|0|||
131745786|NCT01824693|474346790|FG002|Overall Study|Withdrawal by Subject|1|||
131745787|NCT01824693|474346788|FG000|Overall Study|Progressive Disease|0|||
131745788|NCT01824693|474346789|FG001|Overall Study|Progressive Disease|5|||
131745789|NCT01824693|474346790|FG002|Overall Study|Progressive Disease|0|||
131745790|NCT01824693|474346788|FG000|Overall Study|Ineligible|0|||
131745791|NCT01824693|474346789|FG001|Overall Study|Ineligible|0|||
131745792|NCT01824693|474346790|FG002|Overall Study|Ineligible|3|||
131745793|NCT01824693|474346788|FG000|Overall Study|No Transplant Planned|0|||
131745794|NCT01824693|474346789|FG001|Overall Study|No Transplant Planned|0|||
131745795|NCT01824693|474346790|FG002|Overall Study|No Transplant Planned|10|||
131745796|NCT02455388|474346791|FG000|Overall Study|Protocol Violation|1|||
131745797|NCT02455388|474346792|FG001|Overall Study|Protocol Violation|0|||
131745798|NCT02455388|474346793|FG002|Overall Study|Protocol Violation|4|||
131745799|NCT02455388|474346791|FG000|Overall Study|Withdrawal by Subject|0|||
131745800|NCT02455388|474346792|FG001|Overall Study|Withdrawal by Subject|0|||
131745801|NCT02455388|474346793|FG002|Overall Study|Withdrawal by Subject|7|||
131745802|NCT03628599|474346795|FG000|Overall Study|Adverse Event|0|||
131745803|NCT03628599|474346796|FG001|Overall Study|Adverse Event|1|||
131745804|NCT00801892|474346797|FG000|Main Study Period|Withdrawal by Subject|0|||
131745805|NCT00801892|474346798|FG001|Main Study Period|Withdrawal by Subject|1|||
131745806|NCT00801892|474346797|FG000|Sham Crossover Period|Lost to Follow-up|0|||
131745807|NCT00801892|474346798|FG001|Sham Crossover Period|Lost to Follow-up|2|||
131745808|NCT01175590|474346801|FG000|Overall Study|Lost to Follow-up|1|||
131745809|NCT01175590|474346802|FG001|Overall Study|Lost to Follow-up|0|||
131745810|NCT01175590|474346801|FG000|Overall Study|Withdrawal by Subject|0|||
131745811|NCT01175590|474346802|FG001|Overall Study|Withdrawal by Subject|2|||
131745812|NCT01175590|474346801|FG000|Overall Study|Adverse Event|4|||
131745813|NCT01175590|474346802|FG001|Overall Study|Adverse Event|0|||
131745814|NCT01175590|474346801|FG000|Overall Study|Physician Decision|1|||
131745815|NCT01175590|474346802|FG001|Overall Study|Physician Decision|4|||
131745816|NCT01175590|474346801|FG000|Overall Study|Lack of Efficacy|1|||
131745817|NCT01175590|474346802|FG001|Overall Study|Lack of Efficacy|1|||
131745818|NCT01175590|474346801|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
131745819|NCT01175590|474346802|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
131745820|NCT01175590|474346801|FG000|Overall Study|Treated not as randomized|3|||
131448993|NCT00771758|473272763|FG002|Overall Study|Lack of Efficacy|1|||
131448994|NCT00771758|473272761|FG000|Overall Study|Lost to Follow-up|1|||
131448995|NCT00771758|473272762|FG001|Overall Study|Lost to Follow-up|0|||
131448996|NCT00771758|473272763|FG002|Overall Study|Lost to Follow-up|0|||
131448997|NCT00771758|473272761|FG000|Overall Study|Protocol Violation|1|||
131448998|NCT00771758|473272762|FG001|Overall Study|Protocol Violation|0|||
131448999|NCT00771758|473272763|FG002|Overall Study|Protocol Violation|0|||
131449000|NCT00771758|473272761|FG000|Overall Study|Withdrawal by Subject|1|||
131745821|NCT01175590|474346802|FG001|Overall Study|Treated not as randomized|2|||
131745822|NCT01175590|474346801|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
131745823|NCT01175590|474346802|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
131745824|NCT01175590|474346801|FG000|Overall Study|Protocol Violation|0|||
131745825|NCT01175590|474346802|FG001|Overall Study|Protocol Violation|1|||
131745826|NCT00092677|474346813|FG000|Overall Study|Lost to Follow-up|0|||
131745827|NCT00092677|474346814|FG001|Overall Study|Lost to Follow-up|2|||
131745828|NCT00092677|474346813|FG000|Overall Study|Adminstrative|5|||
131745829|NCT00092677|474346814|FG001|Overall Study|Adminstrative|9|||
131745830|NCT01601704|474346815|FG000|Overall Study|Randomized but not dispensed study med|1|||
131745831|NCT01601704|474346816|FG001|Overall Study|Randomized but not dispensed study med|4|||
131745832|NCT00093470|474346822|FG000|Overall Study|Disease progression|39|||
131745833|NCT00093470|474346823|FG001|Overall Study|Disease progression|0|||
131745834|NCT00093470|474346822|FG000|Overall Study|Adverse Event|15|||
131745835|NCT00093470|474346823|FG001|Overall Study|Adverse Event|0|||
131745836|NCT00093470|474346822|FG000|Overall Study|Death|2|||
131745837|NCT00093470|474346823|FG001|Overall Study|Death|0|||
131745838|NCT00093470|474346822|FG000|Overall Study|Withdrawal by Subject|8|||
131745839|NCT00093470|474346823|FG001|Overall Study|Withdrawal by Subject|0|||
131745840|NCT00093470|474346822|FG000|Overall Study|Alternative therapy|2|||
131745841|NCT00093470|474346823|FG001|Overall Study|Alternative therapy|0|||
131745842|NCT00093470|474346822|FG000|Overall Study|Other complicating disease|3|||
131745843|NCT00093470|474346823|FG001|Overall Study|Other complicating disease|0|||
131745844|NCT00093470|474346822|FG000|Overall Study|Physician Decision|2|||
131745845|NCT00093470|474346823|FG001|Overall Study|Physician Decision|0|||
131745846|NCT00093470|474346822|FG000|Overall Study|Never started treatment|1|||
131745847|NCT00093470|474346823|FG001|Overall Study|Never started treatment|0|||
131745848|NCT00093470|474346822|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
131745849|NCT00093470|474346823|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
131745850|NCT00877006|474346824|FG000|Treatment Period|Death|2|||
131745851|NCT00877006|474346825|FG001|Treatment Period|Death|1|||
131745852|NCT00877006|474346824|FG000|Treatment Period|Adverse Event|10|||
131745853|NCT00877006|474346825|FG001|Treatment Period|Adverse Event|3|||
131745854|NCT00877006|474346824|FG000|Treatment Period|Withdrawal by Subject|2|||
131745855|NCT00877006|474346825|FG001|Treatment Period|Withdrawal by Subject|3|||
131745856|NCT00877006|474346824|FG000|Treatment Period|Protocol Violation|1|||
131745857|NCT00877006|474346825|FG001|Treatment Period|Protocol Violation|0|||
131745858|NCT00877006|474346824|FG000|Treatment Period|Lost to Follow-up|0|||
131745859|NCT00877006|474346825|FG001|Treatment Period|Lost to Follow-up|1|||
131745860|NCT00877006|474346824|FG000|Treatment Period|Disease Progression|1|||
131745861|NCT00877006|474346825|FG001|Treatment Period|Disease Progression|2|||
131745862|NCT00877006|474346824|FG000|Treatment Period|Started New Treatment Regimen|2|||
131745863|NCT00877006|474346825|FG001|Treatment Period|Started New Treatment Regimen|5|||
131745864|NCT00877006|474346824|FG000|Treatment Period|Other|4|||
131745865|NCT00877006|474346825|FG001|Treatment Period|Other|4|||
131745866|NCT00877006|474346824|FG000|Treatment Period|Randomized but Not Treated|3|||
131745867|NCT00877006|474346825|FG001|Treatment Period|Randomized but Not Treated|8|||
131745868|NCT00877006|474346824|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
131745869|NCT00877006|474346825|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
131745870|NCT00877006|474346824|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
131745871|NCT00877006|474346825|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
131745872|NCT00877006|474346824|FG000|Long-Term Follow-up Period|Death|26|||
131745873|NCT00877006|474346825|FG001|Long-Term Follow-up Period|Death|18|||
131745874|NCT00877006|474346824|FG000|Long-Term Follow-up Period|Other|7|||
131808539|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808540|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808541|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808542|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808543|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808544|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808545|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808546|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808547|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808548|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131449001|NCT00771758|473272762|FG001|Overall Study|Withdrawal by Subject|0|||
131449002|NCT00771758|473272763|FG002|Overall Study|Withdrawal by Subject|0|||
131449003|NCT00771758|473272761|FG000|Overall Study|Other|3|||
131745875|NCT00877006|474346825|FG001|Long-Term Follow-up Period|Other|9|||
131745876|NCT04671342|474346826|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
131745877|NCT04671342|474346826|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
131745878|NCT04671342|474346826|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
131745879|NCT04671342|474346826|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
131745880|NCT04671342|474346826|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
131745881|NCT04671342|474346826|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
131745882|NCT01188096|474346827|FG000|Overall Study|progression of disease|4|||
131745883|NCT01188096|474346827|FG000|Overall Study|Withdrawal by Subject|2|||
131745884|NCT02062398|474346828|FG000|Overall Study|Implant removal|1|||
131745885|NCT01779648|474346829|FG000|Overall Study|Protocol Violation|1|||
131745886|NCT01779648|474346830|FG001|Overall Study|Protocol Violation|0|||
131745887|NCT00415519|474346831|FG000|Overall Study|Adverse Event|1|||
131745888|NCT00415519|474346832|FG001|Overall Study|Adverse Event|0|||
131745889|NCT00415519|474346831|FG000|Overall Study|Withdrawal by Subject|2|||
131745890|NCT00415519|474346832|FG001|Overall Study|Withdrawal by Subject|0|||
131745891|NCT00415519|474346831|FG000|Overall Study|Patient's convenience|1|||
131745892|NCT00415519|474346832|FG001|Overall Study|Patient's convenience|0|||
131745893|NCT03485222|474346835|FG000|Overall Study|Death|0|||
131745894|NCT03485222|474346836|FG001|Overall Study|Death|1|||
131745895|NCT03485222|474346835|FG000|Overall Study|Lost to Follow-up|2|||
131745896|NCT03485222|474346836|FG001|Overall Study|Lost to Follow-up|1|||
131745897|NCT03657810|474346837|FG000|Overall Study|Adverse Event|0|||
131745898|NCT03657810|474346838|FG001|Overall Study|Adverse Event|1|||
131745899|NCT03657810|474346839|FG002|Overall Study|Adverse Event|0|||
131745900|NCT03657810|474346837|FG000|Overall Study|Lack of Efficacy|4|||
131745901|NCT03657810|474346838|FG001|Overall Study|Lack of Efficacy|1|||
131745902|NCT03657810|474346839|FG002|Overall Study|Lack of Efficacy|3|||
131745903|NCT03657810|474346837|FG000|Overall Study|Protocol Violation|1|||
131745904|NCT03657810|474346838|FG001|Overall Study|Protocol Violation|0|||
131745905|NCT03657810|474346839|FG002|Overall Study|Protocol Violation|0|||
131745906|NCT03657810|474346837|FG000|Overall Study|Lost to Follow-up|0|||
131745907|NCT03657810|474346838|FG001|Overall Study|Lost to Follow-up|1|||
131745908|NCT03657810|474346839|FG002|Overall Study|Lost to Follow-up|0|||
131745909|NCT03657810|474346837|FG000|Overall Study|Not provided|0|||
131745910|NCT03657810|474346838|FG001|Overall Study|Not provided|1|||
131745911|NCT03657810|474346839|FG002|Overall Study|Not provided|0|||
131745912|NCT00688545|474346840|FG000|Overall Study|Lost to Follow-up|1|||
131745913|NCT00688545|474346841|FG001|Overall Study|Lost to Follow-up|4|||
131745914|NCT00688545|474346840|FG000|Overall Study|Insurance/cost of drug|0|||
131745915|NCT00688545|474346841|FG001|Overall Study|Insurance/cost of drug|1|||
131745916|NCT00688545|474346840|FG000|Overall Study|Withdrawal by Subject|2|||
131745917|NCT00688545|474346841|FG001|Overall Study|Withdrawal by Subject|3|||
131745918|NCT00688545|474346840|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
131745919|NCT00688545|474346841|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
131745920|NCT03911869|474346842|FG000|Safety Lead-in Phase|Death|7|||
131745921|NCT03911869|474346843|FG001|Safety Lead-in Phase|Death|0|||
131745922|NCT03911869|474346844|FG002|Safety Lead-in Phase|Death|0|||
131745923|NCT03911869|474346842|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
131745924|NCT03911869|474346843|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
131745925|NCT03911869|474346844|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
131745926|NCT03911869|474346842|FG000|Safety Lead-in Phase|Other|1|||
131745927|NCT03911869|474346843|FG001|Safety Lead-in Phase|Other|0|||
131745928|NCT03911869|474346844|FG002|Safety Lead-in Phase|Other|0|||
131745929|NCT03911869|474346842|FG000|Phase 2|Death|0|||
131745930|NCT03911869|474346843|FG001|Phase 2|Death|3|||
131745931|NCT03911869|474346844|FG002|Phase 2|Death|0|||
131745932|NCT01878097|474346845|FG000|Baseline|Surveys not fully completed|2497|||
131745933|NCT01878097|474346846|FG001|Baseline|Surveys not fully completed|1800|||
131745934|NCT01878097|474346845|FG000|Implementation Year 1|Surveys not fully completed|3202|||
131745935|NCT01878097|474346846|FG001|Implementation Year 1|Surveys not fully completed|2549|||
131745936|NCT01878097|474346845|FG000|Implementation Year 2|Surveys not fully completed|3281|||
131745937|NCT01878097|474346846|FG001|Implementation Year 2|Surveys not fully completed|2841|||
131745938|NCT01878097|474346845|FG000|Implementation Year 3|Surveys not fully completed|3494|||
131745939|NCT01878097|474346846|FG001|Implementation Year 3|Surveys not fully completed|2980|||
131745940|NCT01878097|474346845|FG000|Implementation Year 4|Surveys not fully completed|3604|||
131745941|NCT01878097|474346846|FG001|Implementation Year 4|Surveys not fully completed|3007|||
131745942|NCT00367341|474346848|FG000|Overall Study|Physician Decision|1|||
131745943|NCT00367341|474346849|FG001|Overall Study|Physician Decision|0|||
131745944|NCT00367341|474346848|FG000|Overall Study|Protocol Violation|1|||
131745945|NCT00367341|474346849|FG001|Overall Study|Protocol Violation|0|||
131745946|NCT02119026|474346852|FG000|1st-line Treatment|Adverse Event|9|||
131745947|NCT02119026|474346853|FG001|1st-line Treatment|Adverse Event|14|||
131745948|NCT02119026|474346852|FG000|1st-line Treatment|Physician Decision|3|||
131745949|NCT02119026|474346853|FG001|1st-line Treatment|Physician Decision|8|||
131745950|NCT02119026|474346852|FG000|1st-line Treatment|Withdrawal by Subject|4|||
131745951|NCT02119026|474346853|FG001|1st-line Treatment|Withdrawal by Subject|10|||
131745952|NCT02119026|474346852|FG000|1st-line Treatment|Patient condition or compliance|6|||
131745953|NCT02119026|474346853|FG001|1st-line Treatment|Patient condition or compliance|4|||
131745954|NCT02119026|474346852|FG000|1st-line Treatment|Surgery of metastases|2|||
131745955|NCT02119026|474346853|FG001|1st-line Treatment|Surgery of metastases|1|||
131745956|NCT02119026|474346852|FG000|1st-line Treatment|Death|2|||
131745957|NCT02119026|474346853|FG001|1st-line Treatment|Death|1|||
131745958|NCT02119026|474346852|FG000|2nd-line Treatment|Lost to Follow-up|2|||
131745959|NCT02119026|474346853|FG001|2nd-line Treatment|Lost to Follow-up|0|||
131745960|NCT02119026|474346852|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
131745961|NCT02119026|474346853|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
131745962|NCT02119026|474346852|FG000|2nd-line Treatment|Adverse Event|4|||
131745963|NCT02119026|474346853|FG001|2nd-line Treatment|Adverse Event|1|||
131745964|NCT01373918|474346854|FG000|Overall Study|Physician Decision|0|||
131745965|NCT01373918|474346855|FG001|Overall Study|Physician Decision|1|||
131745966|NCT03004976|474346856|FG000|Overall Study|Lost to Follow-up|7|||
131745967|NCT03004976|474346857|FG001|Overall Study|Lost to Follow-up|5|||
131745968|NCT03004976|474346856|FG000|Overall Study|Physician Decision|1|||
131745969|NCT03004976|474346857|FG001|Overall Study|Physician Decision|0|||
131745970|NCT03004976|474346856|FG000|Overall Study|Withdrawal by Subject|1|||
131745971|NCT03004976|474346857|FG001|Overall Study|Withdrawal by Subject|0|||
131745972|NCT03004976|474346856|FG000|Overall Study|Death|4|||
131745973|NCT03004976|474346857|FG001|Overall Study|Death|1|||
131745974|NCT02786836|474346862|FG000|Overall Study|Death|1|||
131745975|NCT02786836|474346862|FG000|Overall Study|Lack of Efficacy|2|||
131745976|NCT02786836|474346862|FG000|Overall Study|Protocol Violation|3|||
131745977|NCT02786836|474346862|FG000|Overall Study|Withdrawal by Subject|3|||
131745978|NCT02786836|474346862|FG000|Overall Study|Liver Transplantation|2|||
131745979|NCT02786836|474346862|FG000|Overall Study|Device or Pharmacy Issues|3|||
131745980|NCT01143714|474346864|FG000|Overall Study|Adverse Event|4|||
131745981|NCT01143714|474346865|FG001|Overall Study|Adverse Event|2|||
131745982|NCT01143714|474346864|FG000|Overall Study|Withdrawal by Subject|1|||
131745983|NCT01143714|474346865|FG001|Overall Study|Withdrawal by Subject|0|||
131745984|NCT01143714|474346864|FG000|Overall Study|Subject non-compliance|0|||
131745985|NCT01143714|474346865|FG001|Overall Study|Subject non-compliance|1|||
131745986|NCT01143714|474346864|FG000|Overall Study|wound closed = deemed healed|1|||
131745987|NCT01143714|474346865|FG001|Overall Study|wound closed = deemed healed|0|||
131745988|NCT01143714|474346864|FG000|Overall Study|wound size increased|1|||
131745989|NCT01143714|474346865|FG001|Overall Study|wound size increased|0|||
131745990|NCT01387074|474346866|FG000|Overall Study|Lost to Follow-up|7|||
131745991|NCT01387074|474346866|FG000|Overall Study|Lack of Efficacy|1|||
131745992|NCT00150345|474346869|FG000|Overall Study|Death|5|||
131745993|NCT00150345|474346870|FG001|Overall Study|Death|2|||
131745994|NCT00150345|474346869|FG000|Overall Study|Adverse Event|8|||
131745995|NCT00150345|474346870|FG001|Overall Study|Adverse Event|6|||
131745996|NCT00150345|474346869|FG000|Overall Study|Lack of Efficacy|5|||
131745997|NCT00150345|474346870|FG001|Overall Study|Lack of Efficacy|4|||
131745998|NCT00150345|474346869|FG000|Overall Study|Withdrawal by Subject|3|||
131745999|NCT00150345|474346870|FG001|Overall Study|Withdrawal by Subject|4|||
131746000|NCT00150345|474346869|FG000|Overall Study|Laboratory abnormality|1|||
131746001|NCT00150345|474346870|FG001|Overall Study|Laboratory abnormality|2|||
131746002|NCT00150345|474346869|FG000|Overall Study|Other|12|||
131746003|NCT00150345|474346870|FG001|Overall Study|Other|14|||
131746004|NCT03892707|474346877|FG000|Overall Study|Screen failure|6|||
131746005|NCT03892707|474346878|FG001|Overall Study|Screen failure|0|||
131746006|NCT03892707|474346877|FG000|Overall Study|Pain resolution|0|||
131746007|NCT03892707|474346878|FG001|Overall Study|Pain resolution|4|||
131746008|NCT03892707|474346877|FG000|Overall Study|Withdrawal by Subject|0|||
131746009|NCT03892707|474346878|FG001|Overall Study|Withdrawal by Subject|1|||
131746010|NCT03892707|474346877|FG000|Overall Study|Other (long business trip)|0|||
131746011|NCT03892707|474346878|FG001|Overall Study|Other (long business trip)|1|||
131746012|NCT01807949|474346880|FG000|Overall Study|Adverse Event|1|||
131746013|NCT01807949|474346881|FG001|Overall Study|Adverse Event|2|||
131746014|NCT01807949|474346882|FG002|Overall Study|Adverse Event|2|||
131746015|NCT01807949|474346880|FG000|Overall Study|Withdrawal by Subject|1|||
131746016|NCT01807949|474346881|FG001|Overall Study|Withdrawal by Subject|2|||
131746017|NCT01807949|474346882|FG002|Overall Study|Withdrawal by Subject|2|||
131746018|NCT01807949|474346880|FG000|Overall Study|Non-Compliance|0|||
131746019|NCT01807949|474346881|FG001|Overall Study|Non-Compliance|0|||
131746020|NCT01807949|474346882|FG002|Overall Study|Non-Compliance|1|||
131746021|NCT01807949|474346880|FG000|Overall Study|Undefined|0|||
131746022|NCT01807949|474346881|FG001|Overall Study|Undefined|1|||
131746023|NCT01807949|474346882|FG002|Overall Study|Undefined|2|||
131746024|NCT01807949|474346880|FG000|Overall Study|Randomized But Not Treated|0|||
131746025|NCT01807949|474346881|FG001|Overall Study|Randomized But Not Treated|2|||
131746026|NCT01807949|474346882|FG002|Overall Study|Randomized But Not Treated|2|||
131746027|NCT02137837|474346885|FG000|Overall Study|Adverse Event|0|||
131746028|NCT02137837|474346886|FG001|Overall Study|Adverse Event|2|||
131746029|NCT02137837|474346887|FG002|Overall Study|Adverse Event|1|||
131746030|NCT02137837|474346885|FG000|Overall Study|Refusal unrelated to adverse event|2|||
131746031|NCT02137837|474346886|FG001|Overall Study|Refusal unrelated to adverse event|2|||
131746032|NCT02137837|474346887|FG002|Overall Study|Refusal unrelated to adverse event|1|||
131746033|NCT02137837|474346885|FG000|Overall Study|Progression/relapse|9|||
131746034|NCT02137837|474346886|FG001|Overall Study|Progression/relapse|7|||
131746035|NCT02137837|474346887|FG002|Overall Study|Progression/relapse|7|||
131746036|NCT02137837|474346885|FG000|Overall Study|Not protocol specified|2|||
131746037|NCT02137837|474346886|FG001|Overall Study|Not protocol specified|1|||
131746038|NCT02137837|474346887|FG002|Overall Study|Not protocol specified|3|||
131746039|NCT02141217|474346888|FG000|Overall Study|Adverse Event|1|||
131746040|NCT02141217|474346889|FG001|Overall Study|Adverse Event|2|||
131746041|NCT02141217|474346888|FG000|Overall Study|Protocol Violation|1|||
131746042|NCT02141217|474346889|FG001|Overall Study|Protocol Violation|4|||
131746043|NCT02141217|474346888|FG000|Overall Study|Withdrawal by Subject|6|||
131746044|NCT02141217|474346889|FG001|Overall Study|Withdrawal by Subject|0|||
131746045|NCT02141217|474346888|FG000|Overall Study|Lost to Follow-up|1|||
131746046|NCT02141217|474346889|FG001|Overall Study|Lost to Follow-up|1|||
131746047|NCT02141217|474346888|FG000|Overall Study|Physician Decision|1|||
131746048|NCT02141217|474346889|FG001|Overall Study|Physician Decision|0|||
131746049|NCT02141217|474346888|FG000|Overall Study|Surgical Intervention|1|||
131746050|NCT02141217|474346889|FG001|Overall Study|Surgical Intervention|1|||
131746051|NCT00448760|474346892|FG000|Overall Study|Death|3|||
131746052|NCT01306032|474346898|FG000|First Intervention|Adverse Event|1|||
131746053|NCT01306032|474346899|FG001|First Intervention|Adverse Event|0|||
131746054|NCT01306032|474346900|FG002|First Intervention|Adverse Event|1|||
131746055|NCT01306032|474346901|FG003|First Intervention|Adverse Event|0|||
131746056|NCT01306032|474346902|FG004|First Intervention|Adverse Event|0|||
131746057|NCT01306032|474346903|FG005|First Intervention|Adverse Event|1|||
131746058|NCT01306032|474346898|FG000|First Intervention|Withdrawal by Subject|0|||
131746059|NCT01306032|474346899|FG001|First Intervention|Withdrawal by Subject|2|||
131746060|NCT01306032|474346900|FG002|First Intervention|Withdrawal by Subject|0|||
131746061|NCT01306032|474346901|FG003|First Intervention|Withdrawal by Subject|1|||
131746062|NCT01306032|474346902|FG004|First Intervention|Withdrawal by Subject|0|||
131746063|NCT01306032|474346903|FG005|First Intervention|Withdrawal by Subject|0|||
131746064|NCT01306032|474346898|FG000|First Intervention|Death|0|||
131746065|NCT01306032|474346899|FG001|First Intervention|Death|0|||
131746066|NCT01306032|474346900|FG002|First Intervention|Death|1|||
131746067|NCT01306032|474346901|FG003|First Intervention|Death|0|||
131746068|NCT01306032|474346902|FG004|First Intervention|Death|0|||
131746069|NCT01306032|474346903|FG005|First Intervention|Death|0|||
131746070|NCT01306032|474346898|FG000|First Intervention|Ineligible|0|||
131746071|NCT01306032|474346899|FG001|First Intervention|Ineligible|0|||
131746072|NCT01306032|474346900|FG002|First Intervention|Ineligible|0|||
131746073|NCT01306032|474346901|FG003|First Intervention|Ineligible|0|||
131746074|NCT01306032|474346902|FG004|First Intervention|Ineligible|0|||
131746075|NCT01306032|474346903|FG005|First Intervention|Ineligible|1|||
131746076|NCT01306032|474346898|FG000|First Intervention|Progressive disease|0|||
131746077|NCT01306032|474346899|FG001|First Intervention|Progressive disease|0|||
131746078|NCT01306032|474346900|FG002|First Intervention|Progressive disease|0|||
131746079|NCT01306032|474346901|FG003|First Intervention|Progressive disease|0|||
131746080|NCT01306032|474346902|FG004|First Intervention|Progressive disease|2|||
131746081|NCT01306032|474346903|FG005|First Intervention|Progressive disease|0|||
131746082|NCT01306032|474346898|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
131746083|NCT01306032|474346899|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
131746084|NCT01306032|474346900|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
131746085|NCT01306032|474346901|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
131746086|NCT01306032|474346902|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
131746087|NCT01306032|474346903|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
131746088|NCT01306032|474346898|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
131746089|NCT01306032|474346899|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
131746090|NCT01306032|474346900|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
131746091|NCT01306032|474346901|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
131746092|NCT01306032|474346902|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
131746093|NCT01306032|474346903|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
131746094|NCT01213264|474346904|FG000|Overall Study|Adverse Event|1|||
131746095|NCT01213264|474346905|FG001|Overall Study|Adverse Event|0|||
131746096|NCT01213264|474346906|FG002|Overall Study|Adverse Event|0|||
131746097|NCT01213264|474346904|FG000|Overall Study|Lost to Follow-up|1|||
131746098|NCT01213264|474346905|FG001|Overall Study|Lost to Follow-up|2|||
131746099|NCT01213264|474346906|FG002|Overall Study|Lost to Follow-up|6|||
131746100|NCT03260894|474346908|FG000|Overall Study|Death|6|||
131746101|NCT03260894|474346909|FG001|Overall Study|Death|8|||
131746102|NCT03260894|474346908|FG000|Overall Study|Withdrawal by Subject|4|||
131746103|NCT03260894|474346909|FG001|Overall Study|Withdrawal by Subject|11|||
131746104|NCT03260894|474346908|FG000|Overall Study|On-going at clinical cut off date|36|||
131746105|NCT03260894|474346909|FG001|Overall Study|On-going at clinical cut off date|31|||
131746106|NCT05014542|474346911|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
131746107|NCT05014542|474346912|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
131746108|NCT05014542|474346911|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
131746109|NCT05014542|474346912|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
131746110|NCT05014542|474346911|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
131746111|NCT05014542|474346912|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
131746112|NCT05014542|474346911|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
131746113|NCT05014542|474346912|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
131746114|NCT05507580|474346913|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131746115|NCT05507580|474346914|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131746116|NCT05507580|474346915|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
131808549|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
131808550|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
131808551|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808552|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808553|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808554|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808555|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
131808556|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808557|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131906154|NCT05222880|474943244|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
131906155|NCT05222880|474943244|FG000|Overall Study|Withdrew Consent during Study|1|||
131906156|NCT05222880|474943244|FG000|Overall Study|COVID-19 Related|1|||
131906157|NCT02984982|474943245|FG000|Overall Study|Adverse Event|2|||
131808558|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808559|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808560|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808561|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808562|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131906158|NCT02984982|474943246|FG001|Overall Study|Adverse Event|5|||
131906159|NCT02984982|474943245|FG000|Overall Study|Poor Compliance to Protocol|4|||
131906160|NCT02984982|474943246|FG001|Overall Study|Poor Compliance to Protocol|4|||
131906161|NCT02984982|474943245|FG000|Overall Study|Withdrawal by Subject|2|||
131906162|NCT02984982|474943246|FG001|Overall Study|Withdrawal by Subject|0|||
131906163|NCT02984982|474943245|FG000|Overall Study|Randomized but not treated|0|||
131906164|NCT02984982|474943246|FG001|Overall Study|Randomized but not treated|1|||
131906165|NCT01791985|474943247|FG000|Overall Study|Adverse Event|7|||
131906166|NCT01791985|474943247|FG000|Overall Study|Withdrawal by Subject|1|||
131906167|NCT01103323|474943248|FG000|Without/Before Drug Switch|Adverse Event|50|||
131906168|NCT01103323|474943249|FG001|Without/Before Drug Switch|Adverse Event|7|||
131906169|NCT01103323|474943248|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
131906170|NCT01103323|474943249|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
131906171|NCT01103323|474943248|FG000|Without/Before Drug Switch|Protocol Violation|2|||
131906172|NCT01103323|474943249|FG001|Without/Before Drug Switch|Protocol Violation|0|||
131906173|NCT01103323|474943248|FG000|Without/Before Drug Switch|Physician Decision|2|||
131906174|NCT01103323|474943249|FG001|Without/Before Drug Switch|Physician Decision|0|||
131906175|NCT01103323|474943248|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
131906176|NCT01103323|474943249|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
131906177|NCT01103323|474943248|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
131906178|NCT01103323|474943249|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
131906179|NCT01103323|474943248|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
131906180|NCT01103323|474943249|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
131906181|NCT01614470|474943255|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
131906182|NCT01614470|474943256|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131906183|NCT01614470|474943257|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131906184|NCT01614470|474943255|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
131906185|NCT01614470|474943256|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
131906186|NCT01614470|474943257|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
131906187|NCT03217591|474943258|FG000|Overall Study|Adverse Event|1|||
131906188|NCT03217591|474943259|FG001|Overall Study|Adverse Event|2|||
131906189|NCT03217591|474943260|FG002|Overall Study|Adverse Event|6|||
131906190|NCT03217591|474943258|FG000|Overall Study|Withdrawal by Subject|0|||
131906191|NCT03217591|474943259|FG001|Overall Study|Withdrawal by Subject|1|||
131906192|NCT03217591|474943260|FG002|Overall Study|Withdrawal by Subject|3|||
131906193|NCT03217591|474943258|FG000|Overall Study|Lost to Follow-up|1|||
131906194|NCT03217591|474943259|FG001|Overall Study|Lost to Follow-up|0|||
131746117|NCT05507580|474346916|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
131746118|NCT05507580|474346917|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
131449004|NCT00771758|473272762|FG001|Overall Study|Other|2|||
131746119|NCT05507580|474346918|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
131746120|NCT05507580|474346913|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
131746121|NCT05507580|474346914|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131746122|NCT05507580|474346915|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131746123|NCT05507580|474346916|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131746124|NCT05507580|474346917|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131746125|NCT05507580|474346918|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131746126|NCT05507580|474346913|FG000|Double-Blind Treatment Period|Other, not specified|5|||
131906195|NCT03217591|474943260|FG002|Overall Study|Lost to Follow-up|0|||
131746127|NCT05507580|474346914|FG001|Double-Blind Treatment Period|Other, not specified|4|||
131906196|NCT03217591|474943258|FG000|Overall Study|Protocol Violation|1|||
131906197|NCT03217591|474943259|FG001|Overall Study|Protocol Violation|0|||
131906198|NCT03217591|474943260|FG002|Overall Study|Protocol Violation|1|||
131906199|NCT02895347|474943261|FG000|Overall Study|Withdrawal by Subject|3|||
131906200|NCT02895347|474943262|FG001|Overall Study|Withdrawal by Subject|1|||
131449005|NCT00771758|473272763|FG002|Overall Study|Other|0|||
131746128|NCT05507580|474346915|FG002|Double-Blind Treatment Period|Other, not specified|0|||
131746129|NCT05507580|474346916|FG003|Double-Blind Treatment Period|Other, not specified|0|||
131746130|NCT05507580|474346917|FG004|Double-Blind Treatment Period|Other, not specified|0|||
131746131|NCT05507580|474346918|FG005|Double-Blind Treatment Period|Other, not specified|0|||
131746132|NCT05507580|474346913|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
131746133|NCT05507580|474346914|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
131746134|NCT05507580|474346915|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
131746135|NCT05507580|474346916|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
131746136|NCT05507580|474346917|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
131746137|NCT05507580|474346918|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
131746138|NCT05507580|474346913|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
131746139|NCT05507580|474346914|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
131746140|NCT05507580|474346915|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
131746141|NCT05507580|474346916|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
131746142|NCT05507580|474346917|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
131746143|NCT05507580|474346918|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
131746144|NCT05507580|474346913|FG000|Single-Blind Treatment Period|Other, not specified|0|||
131746145|NCT05507580|474346914|FG001|Single-Blind Treatment Period|Other, not specified|0|||
131746146|NCT05507580|474346915|FG002|Single-Blind Treatment Period|Other, not specified|2|||
131746147|NCT05507580|474346916|FG003|Single-Blind Treatment Period|Other, not specified|7|||
131746148|NCT05507580|474346917|FG004|Single-Blind Treatment Period|Other, not specified|3|||
131746149|NCT05507580|474346918|FG005|Single-Blind Treatment Period|Other, not specified|5|||
131746150|NCT00555568|474346919|FG000|Overall Study|Lost to Follow-up|26|||
131746151|NCT00555568|474346920|FG001|Overall Study|Lost to Follow-up|16|||
131746152|NCT00555568|474346921|FG002|Overall Study|Lost to Follow-up|16|||
131746153|NCT04702984|474346924|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
131746154|NCT03496662|474346925|FG000|Overall Study|Adverse Event|0|||
131746155|NCT03496662|474346926|FG001|Overall Study|Adverse Event|0|||
131746156|NCT03496662|474346927|FG002|Overall Study|Adverse Event|4|||
131746157|NCT03496662|474346925|FG000|Overall Study|Withdrawal by Subject|1|||
131746158|NCT03496662|474346926|FG001|Overall Study|Withdrawal by Subject|0|||
131746159|NCT03496662|474346927|FG002|Overall Study|Withdrawal by Subject|2|||
131746160|NCT03496662|474346925|FG000|Overall Study|Death|0|||
131746161|NCT03496662|474346926|FG001|Overall Study|Death|0|||
131746162|NCT03496662|474346927|FG002|Overall Study|Death|2|||
131746163|NCT03496662|474346925|FG000|Overall Study|Noncompliance|0|||
131746164|NCT03496662|474346926|FG001|Overall Study|Noncompliance|0|||
131746165|NCT03496662|474346927|FG002|Overall Study|Noncompliance|1|||
131746166|NCT02378883|474346928|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
131746167|NCT02378883|474346928|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
131746168|NCT02378883|474346928|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
131746169|NCT02378883|474346928|FG000|30 Day Follow-Up|Physician Decision|2|||
131746170|NCT02378883|474346928|FG000|30 Day Follow-Up|Missed Visit|2|||
131746171|NCT02378883|474346928|FG000|30 Day Follow-Up|Death|1|||
131746172|NCT02378883|474346928|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
131746173|NCT02378883|474346928|FG000|12 Months Follow-Up|Death|2|||
131746174|NCT03037307|474346929|FG000|Period 1|Did Not Meet Study Criteria|0|||
131746175|NCT03037307|474346930|FG001|Period 1|Did Not Meet Study Criteria|0|||
131746176|NCT03037307|474346931|FG002|Period 1|Did Not Meet Study Criteria|0|||
131746177|NCT03037307|474346932|FG003|Period 1|Did Not Meet Study Criteria|1|||
131746178|NCT03037307|474346933|FG004|Period 1|Did Not Meet Study Criteria|0|||
131746179|NCT03037307|474346934|FG005|Period 1|Did Not Meet Study Criteria|0|||
131746180|NCT00691093|474346935|FG000|Overall Study|Adverse Event|1|||
131746181|NCT00691093|474346935|FG000|Overall Study|Lost to Follow-up|1|||
131746182|NCT00691093|474346935|FG000|Overall Study|Lack of Efficacy|1|||
131746183|NCT00691093|474346935|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
131746184|NCT00493467|474346936|FG000|Overall Study|Death|1|||
131746185|NCT01700985|474346937|FG000|Overall Study|Incarcerated|0|||
131746186|NCT01700985|474346938|FG001|Overall Study|Incarcerated|1|||
131746187|NCT00426556|474346941|FG000|Phase I - Core Phase|Disease Progression|0|||
131746188|NCT00426556|474346942|FG001|Phase I - Core Phase|Disease Progression|6|||
131746189|NCT00426556|474346943|FG002|Phase I - Core Phase|Disease Progression|2|||
131746190|NCT00426556|474346944|FG003|Phase I - Core Phase|Disease Progression|0|||
131746191|NCT00426556|474346941|FG000|Phase I - Core Phase|Adverse Event|1|||
131746192|NCT00426556|474346942|FG001|Phase I - Core Phase|Adverse Event|3|||
131746193|NCT00426556|474346943|FG002|Phase I - Core Phase|Adverse Event|1|||
131746194|NCT00426556|474346944|FG003|Phase I - Core Phase|Adverse Event|0|||
131808563|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131906201|NCT03177148|474943266|FG000|Overall Study|Lost to Follow-up|50|||
131906202|NCT03177148|474943267|FG001|Overall Study|Lost to Follow-up|1|||
131906203|NCT03177148|474943266|FG000|Overall Study|Death|1|||
131906204|NCT03177148|474943267|FG001|Overall Study|Death|0|||
131906205|NCT03160716|474943268|FG000|Overall Study|Lost to Follow-up|1|||
131906206|NCT00875810|474943269|FG000|Overall Study|Withdrawal by Subject|1|||
131906207|NCT00875810|474943269|FG000|Overall Study|Physician Decision|3|||
131906208|NCT00875810|474943269|FG000|Overall Study|Lost to Follow-up|39|||
131746195|NCT00426556|474346941|FG000|Phase I - Core Phase|Death|0|||
131746196|NCT00426556|474346942|FG001|Phase I - Core Phase|Death|1|||
131746197|NCT00426556|474346943|FG002|Phase I - Core Phase|Death|0|||
131746198|NCT00426556|474346944|FG003|Phase I - Core Phase|Death|0|||
131746199|NCT00426556|474346941|FG000|Phase I - Extension Phase|Adverse Event|0|||
131746200|NCT00426556|474346942|FG001|Phase I - Extension Phase|Adverse Event|1|||
131746201|NCT00426556|474346943|FG002|Phase I - Extension Phase|Adverse Event|1|||
131746202|NCT00426556|474346944|FG003|Phase I - Extension Phase|Adverse Event|0|||
131746203|NCT00426556|474346941|FG000|Phase I - Extension Phase|Disease Progression|5|||
131746204|NCT00426556|474346942|FG001|Phase I - Extension Phase|Disease Progression|5|||
131746205|NCT00426556|474346943|FG002|Phase I - Extension Phase|Disease Progression|6|||
131746206|NCT00426556|474346944|FG003|Phase I - Extension Phase|Disease Progression|0|||
131746207|NCT00426556|474346941|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
131746208|NCT00426556|474346942|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
131746209|NCT00426556|474346943|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
131746210|NCT00426556|474346944|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
131746211|NCT00426556|474346941|FG000|Phase II - Core Phase|Disease Progression|0|||
131746212|NCT00426556|474346942|FG001|Phase II - Core Phase|Disease Progression|0|||
131746213|NCT00426556|474346943|FG002|Phase II - Core Phase|Disease Progression|0|||
131746214|NCT00426556|474346944|FG003|Phase II - Core Phase|Disease Progression|16|||
131746215|NCT00426556|474346941|FG000|Phase II - Core Phase|Adverse Event|0|||
131746216|NCT00426556|474346942|FG001|Phase II - Core Phase|Adverse Event|0|||
131746217|NCT00426556|474346943|FG002|Phase II - Core Phase|Adverse Event|0|||
131746218|NCT00426556|474346944|FG003|Phase II - Core Phase|Adverse Event|8|||
131746219|NCT00426556|474346941|FG000|Phase II - Extension Phase|Disease Progression|0|||
131746220|NCT00426556|474346942|FG001|Phase II - Extension Phase|Disease Progression|0|||
131746221|NCT00426556|474346943|FG002|Phase II - Extension Phase|Disease Progression|0|||
131746222|NCT00426556|474346944|FG003|Phase II - Extension Phase|Disease Progression|21|||
131746223|NCT00426556|474346941|FG000|Phase II - Extension Phase|Adverse Event|0|||
131746224|NCT00426556|474346942|FG001|Phase II - Extension Phase|Adverse Event|0|||
131746225|NCT00426556|474346943|FG002|Phase II - Extension Phase|Adverse Event|0|||
131746226|NCT00426556|474346944|FG003|Phase II - Extension Phase|Adverse Event|2|||
131906209|NCT00875810|474943269|FG000|Overall Study|Patient enroled but not implanted|2|||
131906210|NCT00875810|474943269|FG000|Overall Study|Device explanted|1|||
131746227|NCT03970824|474346945|FG000|Overall Study|Withdrawal by Subject|1|||
131746228|NCT03970824|474346946|FG001|Overall Study|Withdrawal by Subject|1|||
131746229|NCT03970824|474346947|FG002|Overall Study|Withdrawal by Subject|3|||
131746230|NCT03970824|474346945|FG000|Overall Study|Lost to Follow-up|0|||
131746231|NCT03970824|474346946|FG001|Overall Study|Lost to Follow-up|2|||
131746232|NCT03970824|474346947|FG002|Overall Study|Lost to Follow-up|1|||
131746233|NCT03970824|474346945|FG000|Overall Study|Adverse Event|1|||
131746234|NCT03970824|474346946|FG001|Overall Study|Adverse Event|0|||
131746235|NCT03970824|474346947|FG002|Overall Study|Adverse Event|0|||
131746236|NCT00416312|474346948|FG000|Overall Study|tumors not visible on imaging|2|||
131746237|NCT00305604|474346951|FG000|Overall Study|Adverse Event|6|||
131746238|NCT00305604|474346952|FG001|Overall Study|Adverse Event|3|||
131746239|NCT00305604|474346951|FG000|Overall Study|Lack of Efficacy|11|||
131746240|NCT00305604|474346952|FG001|Overall Study|Lack of Efficacy|18|||
131746241|NCT00305604|474346951|FG000|Overall Study|Lost to Follow-up|0|||
131746242|NCT00305604|474346952|FG001|Overall Study|Lost to Follow-up|4|||
131746243|NCT00305604|474346951|FG000|Overall Study|Protocol Violation|2|||
131746244|NCT00305604|474346952|FG001|Overall Study|Protocol Violation|1|||
131746245|NCT00305604|474346951|FG000|Overall Study|Withdrawal by Subject|12|||
131746246|NCT00305604|474346952|FG001|Overall Study|Withdrawal by Subject|21|||
131746247|NCT00305604|474346951|FG000|Overall Study|Patient moved|1|||
131746248|NCT00305604|474346952|FG001|Overall Study|Patient moved|0|||
131746249|NCT01248364|474346953|FG000|Overall Study|Adverse Event|0|||
131746250|NCT01248364|474346954|FG001|Overall Study|Adverse Event|1|||
131746251|NCT01248364|474346955|FG002|Overall Study|Adverse Event|0|||
131746252|NCT01248364|474346956|FG003|Overall Study|Adverse Event|0|||
131746253|NCT01192204|474346958|FG000|Overall Study|could not keep recall appointments|1|||
131746254|NCT01192204|474346959|FG001|Overall Study|could not keep recall appointments|0|||
131746255|NCT02146248|474346960|FG000|Overall Study|Withdrawal by Subject|2|||
131746256|NCT00728936|474348907|FG000|Overall Study|Withdrawal by Subject|0|||
131746257|NCT00728936|474348908|FG001|Overall Study|Withdrawal by Subject|0|||
131746258|NCT00728936|474348909|FG002|Overall Study|Withdrawal by Subject|0|||
131746259|NCT00728936|474348910|FG003|Overall Study|Withdrawal by Subject|0|||
131906211|NCT00794664|474943272|FG000|Treatment Period|Withdrawal by Subject|0|||
131746260|NCT00728936|474348911|FG004|Overall Study|Withdrawal by Subject|0|||
131746261|NCT00728936|474348912|FG005|Overall Study|Withdrawal by Subject|1|||
131746262|NCT00728936|474348913|FG006|Overall Study|Withdrawal by Subject|0|||
131746263|NCT05355818|474348919|FG000|Overall Study|Adverse Event|1|||
131746264|NCT05355818|474348920|FG001|Overall Study|Adverse Event|1|||
131746265|NCT05355818|474348919|FG000|Overall Study|Lack of Efficacy|2|||
131746266|NCT05355818|474348920|FG001|Overall Study|Lack of Efficacy|1|||
131746267|NCT05355818|474348919|FG000|Overall Study|Lost to Follow-up|0|||
131746268|NCT05355818|474348920|FG001|Overall Study|Lost to Follow-up|1|||
131746269|NCT03325556|474348929|FG000|Open-label Period|Lack of Response in OL period|70|||
131746270|NCT03325556|474348930|FG001|Open-label Period|Lack of Response in OL period|0|||
131746271|NCT03325556|474348931|FG002|Open-label Period|Lack of Response in OL period|0|||
131746272|NCT03325556|474348929|FG000|Open-label Period|Adverse Event|27|||
131746273|NCT03325556|474348930|FG001|Open-label Period|Adverse Event|0|||
131746274|NCT03325556|474348931|FG002|Open-label Period|Adverse Event|0|||
131746275|NCT03325556|474348929|FG000|Open-label Period|Death|1|||
131746276|NCT03325556|474348930|FG001|Open-label Period|Death|0|||
131746277|NCT03325556|474348931|FG002|Open-label Period|Death|0|||
131746278|NCT03325556|474348929|FG000|Open-label Period|Lost to Follow-up|1|||
131746279|NCT03325556|474348930|FG001|Open-label Period|Lost to Follow-up|0|||
131746280|NCT03325556|474348931|FG002|Open-label Period|Lost to Follow-up|0|||
131746281|NCT03325556|474348929|FG000|Open-label Period|Non-compliance with study drug|5|||
131746282|NCT03325556|474348930|FG001|Open-label Period|Non-compliance with study drug|0|||
131746283|NCT03325556|474348931|FG002|Open-label Period|Non-compliance with study drug|0|||
131746284|NCT03325556|474348929|FG000|Open-label Period|Use of prohibited medication|1|||
131746285|NCT03325556|474348930|FG001|Open-label Period|Use of prohibited medication|0|||
131746286|NCT03325556|474348931|FG002|Open-label Period|Use of prohibited medication|0|||
131746287|NCT03325556|474348929|FG000|Open-label Period|Protocol Violation|4|||
131746288|NCT03325556|474348930|FG001|Open-label Period|Protocol Violation|0|||
131746289|NCT03325556|474348931|FG002|Open-label Period|Protocol Violation|0|||
131746290|NCT03325556|474348929|FG000|Open-label Period|Withdrawal by Subject|17|||
131746291|NCT03325556|474348930|FG001|Open-label Period|Withdrawal by Subject|0|||
131746292|NCT03325556|474348931|FG002|Open-label Period|Withdrawal by Subject|0|||
131746293|NCT03325556|474348929|FG000|Open-label Period|Not otherwise specified|8|||
131746294|NCT03325556|474348930|FG001|Open-label Period|Not otherwise specified|0|||
131746295|NCT03325556|474348931|FG002|Open-label Period|Not otherwise specified|0|||
131746296|NCT03325556|474348929|FG000|Open-label Period|Administrative discont. at study termination|41|||
131746297|NCT03325556|474348930|FG001|Open-label Period|Administrative discont. at study termination|0|||
131746298|NCT03325556|474348931|FG002|Open-label Period|Administrative discont. at study termination|0|||
131746299|NCT03325556|474348929|FG000|Double-blind Period|Relapse|0|||
131746300|NCT03325556|474348930|FG001|Double-blind Period|Relapse|15|||
131746301|NCT03325556|474348931|FG002|Double-blind Period|Relapse|34|||
131746302|NCT03325556|474348929|FG000|Double-blind Period|Adverse Event|0|||
131746303|NCT03325556|474348930|FG001|Double-blind Period|Adverse Event|3|||
131746304|NCT03325556|474348931|FG002|Double-blind Period|Adverse Event|1|||
131746305|NCT03325556|474348929|FG000|Double-blind Period|Noncompliance with study drug|0|||
131746306|NCT03325556|474348930|FG001|Double-blind Period|Noncompliance with study drug|0|||
131746307|NCT03325556|474348931|FG002|Double-blind Period|Noncompliance with study drug|1|||
131746308|NCT03325556|474348929|FG000|Double-blind Period|Use of prohibited medication|0|||
131746309|NCT03325556|474348930|FG001|Double-blind Period|Use of prohibited medication|1|||
131746310|NCT03325556|474348931|FG002|Double-blind Period|Use of prohibited medication|0|||
131746311|NCT03325556|474348929|FG000|Double-blind Period|Physician Decision|0|||
131746312|NCT03325556|474348930|FG001|Double-blind Period|Physician Decision|0|||
131746313|NCT03325556|474348931|FG002|Double-blind Period|Physician Decision|1|||
131746314|NCT03325556|474348929|FG000|Double-blind Period|Withdrawal by Subject|0|||
131746315|NCT03325556|474348930|FG001|Double-blind Period|Withdrawal by Subject|6|||
131746316|NCT03325556|474348931|FG002|Double-blind Period|Withdrawal by Subject|4|||
131746317|NCT03325556|474348929|FG000|Double-blind Period|Not otherwise specified|0|||
131746318|NCT03325556|474348930|FG001|Double-blind Period|Not otherwise specified|1|||
131746319|NCT03325556|474348931|FG002|Double-blind Period|Not otherwise specified|5|||
131746320|NCT03325556|474348929|FG000|Double-blind Period|Administrative discont. at study termination|0|||
131746321|NCT03325556|474348930|FG001|Double-blind Period|Administrative discont. at study termination|35|||
131746322|NCT03325556|474348931|FG002|Double-blind Period|Administrative discont. at study termination|31|||
131746323|NCT00340834|474348934|FG000|Core Phase of Study|Adverse Event|26|||
131746324|NCT00340834|474348935|FG001|Core Phase of Study|Adverse Event|9|||
131746325|NCT00340834|474348936|FG002|Core Phase of Study|Adverse Event|9|||
131746326|NCT00340834|474348937|FG003|Core Phase of Study|Adverse Event|0|||
131746327|NCT00340834|474348938|FG004|Core Phase of Study|Adverse Event|0|||
131746328|NCT00340834|474348934|FG000|Core Phase of Study|Withdrawal by Subject|11|||
131746329|NCT00340834|474348935|FG001|Core Phase of Study|Withdrawal by Subject|9|||
131746330|NCT00340834|474348936|FG002|Core Phase of Study|Withdrawal by Subject|16|||
131746331|NCT00340834|474348937|FG003|Core Phase of Study|Withdrawal by Subject|0|||
131746332|NCT00340834|474348938|FG004|Core Phase of Study|Withdrawal by Subject|0|||
131746333|NCT00340834|474348934|FG000|Core Phase of Study|Administrative Problems|6|||
131746334|NCT00340834|474348935|FG001|Core Phase of Study|Administrative Problems|2|||
131746335|NCT00340834|474348936|FG002|Core Phase of Study|Administrative Problems|7|||
131746336|NCT00340834|474348937|FG003|Core Phase of Study|Administrative Problems|0|||
131746337|NCT00340834|474348938|FG004|Core Phase of Study|Administrative Problems|0|||
131746338|NCT00340834|474348934|FG000|Core Phase of Study|Lack of Efficacy|3|||
131746339|NCT00340834|474348935|FG001|Core Phase of Study|Lack of Efficacy|3|||
131746340|NCT00340834|474348936|FG002|Core Phase of Study|Lack of Efficacy|7|||
131746341|NCT00340834|474348937|FG003|Core Phase of Study|Lack of Efficacy|0|||
131746342|NCT00340834|474348938|FG004|Core Phase of Study|Lack of Efficacy|0|||
131746343|NCT00340834|474348934|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
131449006|NCT00935584|473272766|FG000|Overall Study|Withdrawal by Subject|9|||
131746344|NCT00340834|474348935|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
131746345|NCT00340834|474348936|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
131746346|NCT00340834|474348937|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
131746347|NCT00340834|474348938|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
131746348|NCT00340834|474348934|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
131746349|NCT00340834|474348935|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
131746350|NCT00340834|474348936|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
131449007|NCT00935584|473272767|FG001|Overall Study|Withdrawal by Subject|0|||
131746351|NCT00340834|474348937|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
131746352|NCT00340834|474348938|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
131746353|NCT00340834|474348934|FG000|Core Phase of Study|Lost to Follow-up|1|||
131746354|NCT00340834|474348935|FG001|Core Phase of Study|Lost to Follow-up|1|||
131746355|NCT00340834|474348936|FG002|Core Phase of Study|Lost to Follow-up|4|||
131746356|NCT00340834|474348937|FG003|Core Phase of Study|Lost to Follow-up|0|||
131746357|NCT00340834|474348938|FG004|Core Phase of Study|Lost to Follow-up|0|||
131746358|NCT00340834|474348934|FG000|Core Phase of Study|Death|2|||
131746359|NCT00340834|474348935|FG001|Core Phase of Study|Death|0|||
131906212|NCT00794664|474943273|FG001|Treatment Period|Withdrawal by Subject|2|||
131746360|NCT00340834|474348936|FG002|Core Phase of Study|Death|0|||
131746361|NCT00340834|474348937|FG003|Core Phase of Study|Death|0|||
131746362|NCT00340834|474348938|FG004|Core Phase of Study|Death|0|||
131746363|NCT00340834|474348934|FG000|Core Phase of Study|Protocol Violation|0|||
131746364|NCT00340834|474348935|FG001|Core Phase of Study|Protocol Violation|0|||
131746365|NCT00340834|474348936|FG002|Core Phase of Study|Protocol Violation|2|||
131746366|NCT00340834|474348937|FG003|Core Phase of Study|Protocol Violation|0|||
131746367|NCT00340834|474348938|FG004|Core Phase of Study|Protocol Violation|0|||
131746368|NCT00340834|474348934|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
131746369|NCT00340834|474348935|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
131746370|NCT00340834|474348936|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
131746371|NCT00340834|474348937|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
131746372|NCT00340834|474348938|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
131746373|NCT00340834|474348934|FG000|Extension Phase of Study|Subject withdrew consent|26|||
131746374|NCT00340834|474348935|FG001|Extension Phase of Study|Subject withdrew consent|31|||
131746375|NCT00340834|474348936|FG002|Extension Phase of Study|Subject withdrew consent|0|||
131746376|NCT00340834|474348937|FG003|Extension Phase of Study|Subject withdrew consent|12|||
131746377|NCT00340834|474348938|FG004|Extension Phase of Study|Subject withdrew consent|15|||
131746378|NCT00340834|474348934|FG000|Extension Phase of Study|Adverse Event|21|||
131746379|NCT00340834|474348935|FG001|Extension Phase of Study|Adverse Event|22|||
131746380|NCT00340834|474348936|FG002|Extension Phase of Study|Adverse Event|0|||
131746381|NCT00340834|474348937|FG003|Extension Phase of Study|Adverse Event|19|||
131746382|NCT00340834|474348938|FG004|Extension Phase of Study|Adverse Event|7|||
131746383|NCT00340834|474348934|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
131746384|NCT00340834|474348935|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
131746385|NCT00340834|474348936|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
131746386|NCT00340834|474348937|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
131746387|NCT00340834|474348938|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
131746388|NCT00340834|474348934|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
131746389|NCT00340834|474348935|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
131746390|NCT00340834|474348936|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
131746391|NCT00340834|474348937|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
131746392|NCT00340834|474348938|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
131746393|NCT00340834|474348934|FG000|Extension Phase of Study|Lost to Follow-up|1|||
131746394|NCT00340834|474348935|FG001|Extension Phase of Study|Lost to Follow-up|1|||
131746395|NCT00340834|474348936|FG002|Extension Phase of Study|Lost to Follow-up|0|||
131746396|NCT00340834|474348937|FG003|Extension Phase of Study|Lost to Follow-up|2|||
131746397|NCT00340834|474348938|FG004|Extension Phase of Study|Lost to Follow-up|3|||
131746398|NCT00340834|474348934|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
131746399|NCT00340834|474348935|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
131746400|NCT00340834|474348936|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
131746401|NCT00340834|474348937|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
131746402|NCT00340834|474348938|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
131746403|NCT00340834|474348934|FG000|Extension Phase of Study|Administrative problems|3|||
131746404|NCT00340834|474348935|FG001|Extension Phase of Study|Administrative problems|0|||
131746405|NCT00340834|474348936|FG002|Extension Phase of Study|Administrative problems|0|||
131746406|NCT00340834|474348937|FG003|Extension Phase of Study|Administrative problems|1|||
131746407|NCT00340834|474348938|FG004|Extension Phase of Study|Administrative problems|1|||
131746408|NCT00340834|474348934|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
131746409|NCT00340834|474348935|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
131746410|NCT00340834|474348936|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
131746411|NCT00340834|474348937|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
131746412|NCT00340834|474348938|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
131746413|NCT00340834|474348934|FG000|Extension Phase of Study|Protocol Violation|3|||
131746414|NCT00340834|474348935|FG001|Extension Phase of Study|Protocol Violation|0|||
131746415|NCT00340834|474348936|FG002|Extension Phase of Study|Protocol Violation|0|||
131746416|NCT00340834|474348937|FG003|Extension Phase of Study|Protocol Violation|0|||
131746417|NCT00340834|474348938|FG004|Extension Phase of Study|Protocol Violation|0|||
131746418|NCT00340834|474348934|FG000|Extension Phase of Study|Death|0|||
131746419|NCT00340834|474348935|FG001|Extension Phase of Study|Death|0|||
131746420|NCT00340834|474348936|FG002|Extension Phase of Study|Death|0|||
131746421|NCT00340834|474348937|FG003|Extension Phase of Study|Death|0|||
131746422|NCT00340834|474348938|FG004|Extension Phase of Study|Death|1|||
131746423|NCT00762268|474348939|FG000|Overall Study|Withdrawal by Subject|3|||
131746424|NCT00762268|474348940|FG001|Overall Study|Withdrawal by Subject|3|||
131746425|NCT01457924|474348941|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
131746426|NCT01457924|474348942|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
131746427|NCT01457924|474348943|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
131746428|NCT01457924|474348944|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
131746429|NCT01457924|474348945|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
131746430|NCT01457924|474348941|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131746431|NCT01457924|474348942|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131746432|NCT01457924|474348943|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131746433|NCT01457924|474348944|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131746434|NCT01457924|474348945|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
131746435|NCT01457924|474348941|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
131746436|NCT01457924|474348942|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131746437|NCT01457924|474348943|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131746438|NCT01457924|474348944|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131746439|NCT01457924|474348945|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131746440|NCT01457924|474348941|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
131746441|NCT01457924|474348942|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
131746442|NCT01457924|474348943|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
131746443|NCT01457924|474348944|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
131746444|NCT01457924|474348945|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
131746445|NCT01457924|474348941|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
131746446|NCT01457924|474348942|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
131746447|NCT01457924|474348943|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
131746448|NCT01457924|474348944|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
131746449|NCT01457924|474348945|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
131746450|NCT01457924|474348941|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
131746451|NCT01457924|474348942|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
131746452|NCT01457924|474348943|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
131746453|NCT01457924|474348944|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
131746454|NCT01457924|474348945|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
131746455|NCT01457924|474348941|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
131746456|NCT01457924|474348942|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
131746457|NCT01457924|474348943|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
131746458|NCT01457924|474348944|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
131746459|NCT01457924|474348945|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
131746460|NCT01457924|474348941|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
131746461|NCT01457924|474348942|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
131746462|NCT01457924|474348943|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
131746463|NCT01457924|474348944|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
131746464|NCT01457924|474348945|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
131746465|NCT01457924|474348941|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131746466|NCT01457924|474348942|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131746467|NCT01457924|474348943|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131746468|NCT01457924|474348944|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
131746469|NCT01457924|474348945|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131746470|NCT01457924|474348941|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
131746471|NCT01457924|474348942|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
131746472|NCT01457924|474348943|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
131746473|NCT01457924|474348944|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
131746474|NCT01457924|474348945|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
131746475|NCT01457924|474348941|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
131746476|NCT01457924|474348942|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
131746477|NCT01457924|474348943|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
131746478|NCT01457924|474348944|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
131746479|NCT01457924|474348945|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
131746480|NCT01457924|474348941|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
131746481|NCT01457924|474348942|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
131746482|NCT01457924|474348943|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
131746483|NCT01457924|474348944|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
131746484|NCT01457924|474348945|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
131746485|NCT01457924|474348941|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
131746486|NCT01457924|474348942|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
131746487|NCT01457924|474348943|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
131746488|NCT01457924|474348944|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
131746489|NCT01457924|474348945|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
131746490|NCT01181141|474348946|FG000|Overall Study|Adverse Event|2|||
131746491|NCT01181141|474348947|FG001|Overall Study|Adverse Event|1|||
131746492|NCT01181141|474348946|FG000|Overall Study|Lack of Efficacy|1|||
131746493|NCT01181141|474348947|FG001|Overall Study|Lack of Efficacy|0|||
131746494|NCT01181141|474348946|FG000|Overall Study|Lost to Follow-up|1|||
131746495|NCT01181141|474348947|FG001|Overall Study|Lost to Follow-up|1|||
131746496|NCT01181141|474348946|FG000|Overall Study|Physician Decision|2|||
131746497|NCT01181141|474348947|FG001|Overall Study|Physician Decision|0|||
131746498|NCT01181141|474348946|FG000|Overall Study|Protocol Violation|3|||
131746499|NCT01181141|474348947|FG001|Overall Study|Protocol Violation|1|||
131746500|NCT01181141|474348946|FG000|Overall Study|Withdrawal by Subject|3|||
131746501|NCT01181141|474348947|FG001|Overall Study|Withdrawal by Subject|1|||
131746502|NCT00290589|474348948|FG000|Overall Study|Lost to Follow-up|2|||
131746503|NCT00290589|474348949|FG001|Overall Study|Lost to Follow-up|2|||
131746504|NCT00118911|474348950|FG000|Overall Study|Withdrawal by Subject|2|||
131746505|NCT00118911|474348951|FG001|Overall Study|Withdrawal by Subject|5|||
131746506|NCT01438307|474348952|FG000|Overall Study|Death|1|||
131746507|NCT01438307|474348953|FG001|Overall Study|Death|1|||
131746508|NCT00973622|474348955|FG000|Overall Study|did not attend MRI|14|||
131746509|NCT00973622|474348956|FG001|Overall Study|did not attend MRI|3|||
131746510|NCT00973622|474348955|FG000|Overall Study|did not pass MRI screen|6|||
131746511|NCT00973622|474348956|FG001|Overall Study|did not pass MRI screen|0|||
131746512|NCT00973622|474348955|FG000|Overall Study|did not complete rTMS sessions|11|||
131746513|NCT00973622|474348956|FG001|Overall Study|did not complete rTMS sessions|2|||
131746514|NCT06000501|474348957|FG000|Overall Study|Screen failure|3|||
131746515|NCT06000501|474348957|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
131746516|NCT06000501|474348957|FG000|Overall Study|Physician Decision|4|||
131746517|NCT06000501|474348957|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
131746518|NCT06000501|474348957|FG000|Overall Study|Scheduling issues|2|||
131746519|NCT01588353|474348958|FG000|Step2|Withdrawal by Subject|0|||
131746520|NCT01588353|474348959|FG001|Step2|Withdrawal by Subject|1|||
131746521|NCT01588353|474348960|FG002|Step2|Withdrawal by Subject|0|||
131746522|NCT01588353|474348958|FG000|Step3|Adverse Event|0|||
131746523|NCT01588353|474348959|FG001|Step3|Adverse Event|0|||
131746524|NCT01588353|474348960|FG002|Step3|Adverse Event|2|||
131746525|NCT03814005|474348964|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
131746526|NCT03814005|474348965|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
131746527|NCT03814005|474348966|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
131746528|NCT03814005|474348964|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
131746529|NCT03814005|474348965|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
131746530|NCT03814005|474348966|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
131746531|NCT03814005|474348964|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
131746532|NCT03814005|474348965|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
131746533|NCT03814005|474348966|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
131746534|NCT03814005|474348964|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
131746535|NCT03814005|474348965|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
131746536|NCT03814005|474348966|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
131746537|NCT03814005|474348964|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
131746538|NCT03814005|474348965|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
131746539|NCT03814005|474348966|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
131746540|NCT03814005|474348964|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
131746541|NCT03814005|474348965|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
131746542|NCT03814005|474348966|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
131746543|NCT03395223|474348967|FG000|Overall Study|Lost to Follow-up|3|||
131746544|NCT03395223|474348967|FG000|Overall Study|Other|1|||
131746545|NCT01855945|474348970|FG000|Overall Study|Adverse Event|0|||
131746546|NCT01855945|474348971|FG001|Overall Study|Adverse Event|0|||
131746547|NCT01855945|474348972|FG002|Overall Study|Adverse Event|0|||
131746548|NCT01855945|474348973|FG003|Overall Study|Adverse Event|0|||
131746549|NCT01855945|474348974|FG004|Overall Study|Adverse Event|0|||
131746550|NCT01855945|474348975|FG005|Overall Study|Adverse Event|0|||
131746551|NCT01855945|474348976|FG006|Overall Study|Adverse Event|1|||
131746552|NCT01855945|474348977|FG007|Overall Study|Adverse Event|0|||
131746553|NCT01855945|474348978|FG008|Overall Study|Adverse Event|0|||
131746554|NCT01855945|474348979|FG009|Overall Study|Adverse Event|0|||
131746555|NCT01855945|474348980|FG010|Overall Study|Adverse Event|0|||
131746556|NCT01855945|474348981|FG011|Overall Study|Adverse Event|0|||
131746557|NCT01855945|474348970|FG000|Overall Study|Death|0|||
131746558|NCT01855945|474348971|FG001|Overall Study|Death|0|||
131746559|NCT01855945|474348972|FG002|Overall Study|Death|0|||
131746560|NCT01855945|474348973|FG003|Overall Study|Death|0|||
131746561|NCT01855945|474348974|FG004|Overall Study|Death|0|||
131746562|NCT01855945|474348975|FG005|Overall Study|Death|0|||
131746563|NCT01855945|474348976|FG006|Overall Study|Death|2|||
131746564|NCT01855945|474348977|FG007|Overall Study|Death|0|||
131746565|NCT01855945|474348978|FG008|Overall Study|Death|0|||
131906213|NCT00794664|474943272|FG000|Treatment Period|Protocol non-compliance|0|||
131906214|NCT00794664|474943273|FG001|Treatment Period|Protocol non-compliance|1|||
131746566|NCT01855945|474348979|FG009|Overall Study|Death|0|||
131746567|NCT01855945|474348980|FG010|Overall Study|Death|0|||
131746568|NCT01855945|474348981|FG011|Overall Study|Death|0|||
131746569|NCT01855945|474348970|FG000|Overall Study|Lost to Follow-up|11|||
131746570|NCT01855945|474348971|FG001|Overall Study|Lost to Follow-up|10|||
131746571|NCT01855945|474348972|FG002|Overall Study|Lost to Follow-up|7|||
131746572|NCT01855945|474348973|FG003|Overall Study|Lost to Follow-up|3|||
131746573|NCT01855945|474348974|FG004|Overall Study|Lost to Follow-up|0|||
131746574|NCT01855945|474348975|FG005|Overall Study|Lost to Follow-up|3|||
131746575|NCT01855945|474348976|FG006|Overall Study|Lost to Follow-up|4|||
131746576|NCT01855945|474348977|FG007|Overall Study|Lost to Follow-up|7|||
131746577|NCT01855945|474348978|FG008|Overall Study|Lost to Follow-up|2|||
131746578|NCT01855945|474348979|FG009|Overall Study|Lost to Follow-up|0|||
131746579|NCT01855945|474348980|FG010|Overall Study|Lost to Follow-up|0|||
131746580|NCT01855945|474348981|FG011|Overall Study|Lost to Follow-up|2|||
131746581|NCT01855945|474348970|FG000|Overall Study|Other - Unclassified|1|||
131746582|NCT01855945|474348971|FG001|Overall Study|Other - Unclassified|1|||
131746583|NCT01855945|474348972|FG002|Overall Study|Other - Unclassified|1|||
131746584|NCT01855945|474348973|FG003|Overall Study|Other - Unclassified|0|||
131746585|NCT01855945|474348974|FG004|Overall Study|Other - Unclassified|0|||
131746586|NCT01855945|474348975|FG005|Overall Study|Other - Unclassified|0|||
131746587|NCT01855945|474348976|FG006|Overall Study|Other - Unclassified|2|||
131746588|NCT01855945|474348977|FG007|Overall Study|Other - Unclassified|1|||
131746589|NCT01855945|474348978|FG008|Overall Study|Other - Unclassified|0|||
131746590|NCT01855945|474348979|FG009|Overall Study|Other - Unclassified|0|||
131746591|NCT01855945|474348980|FG010|Overall Study|Other - Unclassified|1|||
131746592|NCT01855945|474348981|FG011|Overall Study|Other - Unclassified|0|||
131746593|NCT01855945|474348970|FG000|Overall Study|Withdrawal by Subject|4|||
131746594|NCT01855945|474348971|FG001|Overall Study|Withdrawal by Subject|0|||
131746595|NCT01855945|474348972|FG002|Overall Study|Withdrawal by Subject|4|||
131746596|NCT01855945|474348973|FG003|Overall Study|Withdrawal by Subject|1|||
131746597|NCT01855945|474348974|FG004|Overall Study|Withdrawal by Subject|1|||
131746598|NCT01855945|474348975|FG005|Overall Study|Withdrawal by Subject|0|||
131746599|NCT01855945|474348976|FG006|Overall Study|Withdrawal by Subject|1|||
131906215|NCT00794664|474943272|FG000|Treatment Period|Other|0|||
131906216|NCT00794664|474943273|FG001|Treatment Period|Other|1|||
131906217|NCT00794664|474943272|FG000|Treatment Period|Adverse Event|1|||
131906218|NCT00794664|474943273|FG001|Treatment Period|Adverse Event|8|||
131906219|NCT00794664|474943272|FG000|Follow-up Period|Other|1|||
131906220|NCT00794664|474943273|FG001|Follow-up Period|Other|2|||
131906221|NCT00794664|474943272|FG000|Follow-up Period|Withdrawal by Subject|0|||
131906222|NCT00794664|474943273|FG001|Follow-up Period|Withdrawal by Subject|2|||
131906223|NCT00794664|474943272|FG000|Follow-up Period|Protocol non-compliance|0|||
131906224|NCT00794664|474943273|FG001|Follow-up Period|Protocol non-compliance|1|||
131906225|NCT01305564|474943274|FG000|Overall Study|Death|21|||
131906226|NCT01305564|474943274|FG000|Overall Study|Lost to Follow-up|12|||
131906227|NCT01305564|474943274|FG000|Overall Study|Withdrawal by Subject|1|||
131906228|NCT01305564|474943274|FG000|Overall Study|Physician Decision|3|||
131906229|NCT02357459|474945095|FG000|Overall Study|Adverse Event|0|||
131906230|NCT02357459|474945096|FG001|Overall Study|Adverse Event|1|||
131906231|NCT02357459|474945097|FG002|Overall Study|Adverse Event|1|||
131906232|NCT02357459|474945095|FG000|Overall Study|Withdrawal by Subject|5|||
131906233|NCT02357459|474945096|FG001|Overall Study|Withdrawal by Subject|3|||
131906234|NCT02357459|474945097|FG002|Overall Study|Withdrawal by Subject|3|||
131906235|NCT02357459|474945095|FG000|Overall Study|Physician Decision|0|||
131906236|NCT02357459|474945096|FG001|Overall Study|Physician Decision|2|||
131906237|NCT02357459|474945097|FG002|Overall Study|Physician Decision|0|||
131906238|NCT02357459|474945095|FG000|Overall Study|Protocol Violation|1|||
131906239|NCT02357459|474945096|FG001|Overall Study|Protocol Violation|1|||
131906240|NCT02357459|474945097|FG002|Overall Study|Protocol Violation|0|||
131746600|NCT01855945|474348977|FG007|Overall Study|Withdrawal by Subject|0|||
131746601|NCT01855945|474348978|FG008|Overall Study|Withdrawal by Subject|0|||
131746602|NCT01855945|474348979|FG009|Overall Study|Withdrawal by Subject|2|||
131746603|NCT01855945|474348980|FG010|Overall Study|Withdrawal by Subject|4|||
131746604|NCT01855945|474348981|FG011|Overall Study|Withdrawal by Subject|1|||
131746605|NCT05067452|474348982|FG000|Overall Study|Lost to Follow-up|0|||
131746606|NCT05067452|474348983|FG001|Overall Study|Lost to Follow-up|4|||
131746607|NCT01148693|474348984|FG000|Overall Study|Attempts for cannulation were failed|13|||
131906241|NCT02357459|474945095|FG000|Overall Study|Lost to Follow-up|1|||
131906242|NCT02357459|474945096|FG001|Overall Study|Lost to Follow-up|3|||
131906243|NCT02357459|474945097|FG002|Overall Study|Lost to Follow-up|0|||
131906244|NCT02357459|474945095|FG000|Overall Study|Lack of Efficacy|7|||
131906245|NCT02357459|474945096|FG001|Overall Study|Lack of Efficacy|4|||
131906246|NCT02357459|474945097|FG002|Overall Study|Lack of Efficacy|4|||
131746608|NCT01148693|474348985|FG001|Overall Study|Attempts for cannulation were failed|10|||
131746609|NCT01135017|474348986|FG000|Overall Study|Adverse Event|3|||
131746610|NCT01135017|474348987|FG001|Overall Study|Adverse Event|8|||
131746611|NCT01135017|474348986|FG000|Overall Study|Other than above|3|||
131746612|NCT01135017|474348987|FG001|Overall Study|Other than above|4|||
131746613|NCT01074658|474348990|FG000|Overall Study|No implant attempted|19|||
131906247|NCT02357459|474945095|FG000|Overall Study|Patient Relocated|2|||
131906248|NCT02357459|474945096|FG001|Overall Study|Patient Relocated|0|||
131906249|NCT02357459|474945097|FG002|Overall Study|Patient Relocated|0|||
131746614|NCT01342952|474348991|FG000|Overall Study|Adverse Event|0|||
131746615|NCT01342952|474348992|FG001|Overall Study|Adverse Event|5|||
131746616|NCT01342952|474348993|FG002|Overall Study|Adverse Event|1|||
131746617|NCT01342952|474348994|FG003|Overall Study|Adverse Event|0|||
131746618|NCT01342952|474348991|FG000|Overall Study|Lost to Follow-up|0|||
131746619|NCT01342952|474348992|FG001|Overall Study|Lost to Follow-up|2|||
131746620|NCT01342952|474348993|FG002|Overall Study|Lost to Follow-up|0|||
131746621|NCT01342952|474348994|FG003|Overall Study|Lost to Follow-up|0|||
131746622|NCT01342952|474348991|FG000|Overall Study|Withdrawal by Subject|1|||
131746623|NCT01342952|474348992|FG001|Overall Study|Withdrawal by Subject|1|||
131746624|NCT01342952|474348993|FG002|Overall Study|Withdrawal by Subject|0|||
131746625|NCT01342952|474348994|FG003|Overall Study|Withdrawal by Subject|0|||
131746626|NCT01342952|474348991|FG000|Overall Study|Physician Decision|3|||
131746627|NCT01342952|474348992|FG001|Overall Study|Physician Decision|3|||
131746628|NCT01342952|474348993|FG002|Overall Study|Physician Decision|1|||
131746629|NCT01342952|474348994|FG003|Overall Study|Physician Decision|0|||
131746630|NCT02156804|474348995|FG000|Overall Study|Withdrawal by Subject|1|||
131746631|NCT03228394|474348996|FG000|Overall Study|Lost to Follow-up|0|||
131746632|NCT03228394|474348997|FG001|Overall Study|Lost to Follow-up|0|||
131746633|NCT03228394|474348998|FG002|Overall Study|Lost to Follow-up|1|||
131746634|NCT03228394|474348999|FG003|Overall Study|Lost to Follow-up|1|||
131746635|NCT03228394|474349000|FG004|Overall Study|Lost to Follow-up|0|||
131746636|NCT03228394|474349001|FG005|Overall Study|Lost to Follow-up|0|||
131746637|NCT03228394|474349002|FG006|Overall Study|Lost to Follow-up|2|||
131746638|NCT03228394|474349003|FG007|Overall Study|Lost to Follow-up|0|||
131746639|NCT03228394|474348996|FG000|Overall Study|Withdrawal by Subject|0|||
131746640|NCT03228394|474348997|FG001|Overall Study|Withdrawal by Subject|0|||
131746641|NCT03228394|474348998|FG002|Overall Study|Withdrawal by Subject|1|||
131746642|NCT03228394|474348999|FG003|Overall Study|Withdrawal by Subject|0|||
131746643|NCT03228394|474349000|FG004|Overall Study|Withdrawal by Subject|0|||
131746644|NCT03228394|474349001|FG005|Overall Study|Withdrawal by Subject|0|||
131746645|NCT03228394|474349002|FG006|Overall Study|Withdrawal by Subject|1|||
131746646|NCT03228394|474349003|FG007|Overall Study|Withdrawal by Subject|3|||
131746647|NCT03228394|474348996|FG000|Overall Study|Protocol Violation|0|||
131746648|NCT03228394|474348997|FG001|Overall Study|Protocol Violation|0|||
131746649|NCT03228394|474348998|FG002|Overall Study|Protocol Violation|0|||
131746650|NCT03228394|474348999|FG003|Overall Study|Protocol Violation|1|||
131746651|NCT03228394|474349000|FG004|Overall Study|Protocol Violation|0|||
131746652|NCT03228394|474349001|FG005|Overall Study|Protocol Violation|0|||
131746653|NCT03228394|474349002|FG006|Overall Study|Protocol Violation|0|||
131746654|NCT03228394|474349003|FG007|Overall Study|Protocol Violation|0|||
131746655|NCT03228394|474348996|FG000|Overall Study|Physician Decision|0|||
131746656|NCT03228394|474348997|FG001|Overall Study|Physician Decision|0|||
131746657|NCT03228394|474348998|FG002|Overall Study|Physician Decision|0|||
131746658|NCT03228394|474348999|FG003|Overall Study|Physician Decision|0|||
131746659|NCT03228394|474349000|FG004|Overall Study|Physician Decision|0|||
131746660|NCT03228394|474349001|FG005|Overall Study|Physician Decision|0|||
131746661|NCT03228394|474349002|FG006|Overall Study|Physician Decision|1|||
131746662|NCT03228394|474349003|FG007|Overall Study|Physician Decision|0|||
131746663|NCT03228394|474348996|FG000|Overall Study|Noncompliance|0|||
131746664|NCT03228394|474348997|FG001|Overall Study|Noncompliance|0|||
131746665|NCT03228394|474348998|FG002|Overall Study|Noncompliance|0|||
131746666|NCT03228394|474348999|FG003|Overall Study|Noncompliance|0|||
131746667|NCT03228394|474349000|FG004|Overall Study|Noncompliance|0|||
131746668|NCT03228394|474349001|FG005|Overall Study|Noncompliance|0|||
131746669|NCT03228394|474349002|FG006|Overall Study|Noncompliance|1|||
131746670|NCT03228394|474349003|FG007|Overall Study|Noncompliance|0|||
131746671|NCT04581863|474349004|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
131746672|NCT04581863|474349005|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
131746673|NCT01803711|474349010|FG000|Overall Study|Adverse Event|1|||
131746674|NCT01803711|474349011|FG001|Overall Study|Adverse Event|1|||
131746675|NCT01170221|474349015|FG000|Overall Study|Lost to Follow-up|22|||
131746676|NCT01170221|474349016|FG001|Overall Study|Lost to Follow-up|21|||
131746677|NCT01170221|474349015|FG000|Overall Study|Withdrawal by Subject|9|||
131746678|NCT01170221|474349016|FG001|Overall Study|Withdrawal by Subject|7|||
131746679|NCT01170221|474349015|FG000|Overall Study|Subject completed only screening and LFU|1|||
131746680|NCT01170221|474349016|FG001|Overall Study|Subject completed only screening and LFU|0|||
131746681|NCT01170221|474349015|FG000|Overall Study|Randomized but not treated|1|||
131746682|NCT01170221|474349016|FG001|Overall Study|Randomized but not treated|0|||
131746683|NCT00432562|474349017|FG000|Overall Study|Death|3|||
131746684|NCT00432562|474349018|FG001|Overall Study|Death|0|||
131746685|NCT02693691|474349019|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
131746686|NCT02693691|474349019|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
131746687|NCT02693691|474349019|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
131746688|NCT02693691|474349019|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
131746689|NCT02693691|474349019|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
131746690|NCT02693691|474349019|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
131746691|NCT02693691|474349019|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
131746692|NCT01162304|474349024|FG000|Overall Study|Beck scale to high|11|||
131746693|NCT00425100|474349025|FG000|Overall Study|Adverse Event|36|||
131746694|NCT00425100|474349025|FG000|Overall Study|Lack of Efficacy|4|||
131746695|NCT00425100|474349025|FG000|Overall Study|Lost to Follow-up|2|||
131746696|NCT00425100|474349025|FG000|Overall Study|Protocol Violation|4|||
131746697|NCT00425100|474349025|FG000|Overall Study|Withdrawal by Subject|7|||
131746698|NCT01315847|474349026|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
131746699|NCT01315847|474349027|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
131746700|NCT01315847|474349026|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
131746701|NCT01315847|474349027|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
131746702|NCT05425719|474349032|FG000|Overall Study|Lost to Follow-up|4|||
131746703|NCT05425719|474349033|FG001|Overall Study|Lost to Follow-up|0|||
131746704|NCT05425719|474349032|FG000|Overall Study|Withdrew consent|1|||
131746705|NCT05425719|474349033|FG001|Overall Study|Withdrew consent|1|||
131746706|NCT04682353|474349034|FG000|Overall Study|Lost to Follow-up|0|||
131746707|NCT04682353|474349035|FG001|Overall Study|Lost to Follow-up|1|||
131746708|NCT04682353|474349036|FG002|Overall Study|Lost to Follow-up|0|||
131746709|NCT04682353|474349037|FG003|Overall Study|Lost to Follow-up|1|||
131746710|NCT04682353|474349034|FG000|Overall Study|Personal reasons|0|||
131746711|NCT04682353|474349035|FG001|Overall Study|Personal reasons|1|||
131746712|NCT04682353|474349036|FG002|Overall Study|Personal reasons|0|||
131746713|NCT04682353|474349037|FG003|Overall Study|Personal reasons|0|||
131746714|NCT01586806|474349038|FG000|Overall Study|Protocol Violation|0|||
131746715|NCT01586806|474349039|FG001|Overall Study|Protocol Violation|1|||
131746716|NCT01586806|474349040|FG002|Overall Study|Protocol Violation|0|||
131746717|NCT01586806|474349038|FG000|Overall Study|Withdrawal by Subject|1|||
131746718|NCT01586806|474349039|FG001|Overall Study|Withdrawal by Subject|0|||
131746719|NCT01586806|474349040|FG002|Overall Study|Withdrawal by Subject|0|||
131746720|NCT01586806|474349038|FG000|Overall Study|Lost to Follow-up|2|||
131746721|NCT01586806|474349039|FG001|Overall Study|Lost to Follow-up|3|||
131746722|NCT01586806|474349040|FG002|Overall Study|Lost to Follow-up|2|||
131906250|NCT02357459|474945095|FG000|Overall Study|Instruction from PCP|1|||
131906251|NCT02357459|474945096|FG001|Overall Study|Instruction from PCP|0|||
131906252|NCT02357459|474945097|FG002|Overall Study|Instruction from PCP|0|||
131746723|NCT00862654|474349041|FG000|Overall Study|Lack of Efficacy|1|||
131746724|NCT00862654|474349042|FG001|Overall Study|Lack of Efficacy|0|||
131746725|NCT00862654|474349043|FG002|Overall Study|Lack of Efficacy|1|||
131746726|NCT00862654|474349044|FG003|Overall Study|Lack of Efficacy|0|||
131746727|NCT00862654|474349041|FG000|Overall Study|Lost to Follow-up|1|||
131746728|NCT00862654|474349042|FG001|Overall Study|Lost to Follow-up|2|||
131746729|NCT00862654|474349043|FG002|Overall Study|Lost to Follow-up|1|||
131746730|NCT00862654|474349044|FG003|Overall Study|Lost to Follow-up|3|||
131746731|NCT00862654|474349041|FG000|Overall Study|Adverse Event|0|||
131746732|NCT00862654|474349042|FG001|Overall Study|Adverse Event|1|||
131746733|NCT00862654|474349043|FG002|Overall Study|Adverse Event|1|||
131746734|NCT00862654|474349044|FG003|Overall Study|Adverse Event|0|||
131746735|NCT00862654|474349041|FG000|Overall Study|Pregnancy|1|||
131746736|NCT00862654|474349042|FG001|Overall Study|Pregnancy|1|||
131906253|NCT02357459|474945095|FG000|Overall Study|Incarceration|0|||
131746737|NCT00862654|474349043|FG002|Overall Study|Pregnancy|0|||
131746738|NCT00862654|474349044|FG003|Overall Study|Pregnancy|0|||
131906254|NCT02357459|474945096|FG001|Overall Study|Incarceration|0|||
131746739|NCT00862654|474349041|FG000|Overall Study|Withdrawal by Subject|2|||
131746740|NCT00862654|474349042|FG001|Overall Study|Withdrawal by Subject|2|||
131746741|NCT00862654|474349043|FG002|Overall Study|Withdrawal by Subject|2|||
131746742|NCT00862654|474349044|FG003|Overall Study|Withdrawal by Subject|3|||
131746743|NCT00862654|474349041|FG000|Overall Study|Subject mistake|0|||
131746744|NCT00862654|474349042|FG001|Overall Study|Subject mistake|1|||
131746745|NCT00862654|474349043|FG002|Overall Study|Subject mistake|0|||
131746746|NCT00862654|474349044|FG003|Overall Study|Subject mistake|0|||
131746747|NCT00862654|474349041|FG000|Overall Study|Familly constraint|0|||
131746748|NCT00862654|474349042|FG001|Overall Study|Familly constraint|1|||
131746749|NCT00862654|474349043|FG002|Overall Study|Familly constraint|0|||
131746750|NCT00862654|474349044|FG003|Overall Study|Familly constraint|0|||
131746751|NCT00862654|474349041|FG000|Overall Study|Never used study drugs|1|||
131746752|NCT00862654|474349042|FG001|Overall Study|Never used study drugs|0|||
131746753|NCT00862654|474349043|FG002|Overall Study|Never used study drugs|0|||
131746754|NCT00862654|474349044|FG003|Overall Study|Never used study drugs|0|||
131746755|NCT00862654|474349041|FG000|Overall Study|Included after end of inclusions|0|||
131746756|NCT00862654|474349042|FG001|Overall Study|Included after end of inclusions|0|||
131746757|NCT00862654|474349043|FG002|Overall Study|Included after end of inclusions|1|||
131746758|NCT00862654|474349044|FG003|Overall Study|Included after end of inclusions|0|||
131746759|NCT04377672|474349045|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
131746760|NCT03954444|474349046|FG000|Overall Study|Withdrawal by Subject|5|||
131746761|NCT03954444|474349047|FG001|Overall Study|Withdrawal by Subject|5|||
131746762|NCT03954444|474349048|FG002|Overall Study|Withdrawal by Subject|5|||
131746763|NCT03954444|474349046|FG000|Overall Study|Adverse Event|1|||
131746764|NCT03954444|474349047|FG001|Overall Study|Adverse Event|3|||
131746765|NCT03954444|474349048|FG002|Overall Study|Adverse Event|2|||
131746766|NCT03954444|474349046|FG000|Overall Study|Protocol Violation|0|||
131746767|NCT03954444|474349047|FG001|Overall Study|Protocol Violation|3|||
131746768|NCT03954444|474349048|FG002|Overall Study|Protocol Violation|5|||
131746769|NCT03954444|474349046|FG000|Overall Study|Use of prohibited therapy|1|||
131746770|NCT03954444|474349047|FG001|Overall Study|Use of prohibited therapy|1|||
131746771|NCT03954444|474349048|FG002|Overall Study|Use of prohibited therapy|2|||
131746772|NCT03954444|474349046|FG000|Overall Study|Lost to Follow-up|1|||
131746773|NCT03954444|474349047|FG001|Overall Study|Lost to Follow-up|0|||
131746774|NCT03954444|474349048|FG002|Overall Study|Lost to Follow-up|1|||
131746775|NCT03954444|474349046|FG000|Overall Study|Non-compliant with study drug application|2|||
131746776|NCT03954444|474349047|FG001|Overall Study|Non-compliant with study drug application|2|||
131746777|NCT03954444|474349048|FG002|Overall Study|Non-compliant with study drug application|0|||
131746778|NCT03954444|474349046|FG000|Overall Study|Administrative reasons|0|||
131746779|NCT03954444|474349047|FG001|Overall Study|Administrative reasons|0|||
131746780|NCT03954444|474349048|FG002|Overall Study|Administrative reasons|1|||
131746781|NCT03954444|474349046|FG000|Overall Study|Miscellaneous|3|||
131746782|NCT03954444|474349047|FG001|Overall Study|Miscellaneous|2|||
131746783|NCT03954444|474349048|FG002|Overall Study|Miscellaneous|1|||
131746784|NCT02447458|474349049|FG000|Overall Study|Other|0|||
131746785|NCT02447458|474349050|FG001|Overall Study|Other|0|||
131746786|NCT02447458|474349051|FG002|Overall Study|Other|1|||
131746787|NCT02447458|474349052|FG003|Overall Study|Other|0|||
131746788|NCT02447458|474349053|FG004|Overall Study|Other|0|||
131746789|NCT02447458|474349054|FG005|Overall Study|Other|0|||
131746790|NCT02133742|474349055|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
131746791|NCT02133742|474349055|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
131746792|NCT02133742|474349055|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
131746793|NCT02133742|474349055|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
131746794|NCT02133742|474349055|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
131746795|NCT01688635|474349057|FG000|Washout 1|Withdrawal by Subject|1|||
131449008|NCT00935584|473272766|FG000|Overall Study|Death|3|||
131449009|NCT00935584|473272767|FG001|Overall Study|Death|0|||
131449010|NCT00935584|473272766|FG000|Overall Study|Lost to Follow-up|8|||
131449011|NCT00935584|473272767|FG001|Overall Study|Lost to Follow-up|0|||
131449012|NCT00935584|473272766|FG000|Overall Study|No show|9|||
131449013|NCT00935584|473272767|FG001|Overall Study|No show|0|||
131449014|NCT00935584|473272766|FG000|Overall Study|Relocated|3|||
131449015|NCT00935584|473272767|FG001|Overall Study|Relocated|0|||
131449016|NCT00935584|473272766|FG000|Overall Study|Patient changed provider|3|||
131449017|NCT00935584|473272767|FG001|Overall Study|Patient changed provider|0|||
131449018|NCT00935584|473272766|FG000|Overall Study|Provider dropped out of study|14|||
131746796|NCT01688635|474349058|FG001|Washout 1|Withdrawal by Subject|0|||
131746797|NCT01688635|474349057|FG000|Washout 1|Adverse Event|0|||
131746798|NCT01688635|474349058|FG001|Washout 1|Adverse Event|1|||
131746799|NCT01688635|474349057|FG000|Washout 1|Physician Decision|0|||
131449019|NCT00935584|473272767|FG001|Overall Study|Provider dropped out of study|4|||
131449020|NCT00687193|473272768|FG000|Overall Study|Adverse Event|0|||
131449021|NCT00687193|473272769|FG001|Overall Study|Adverse Event|1|||
131746800|NCT01688635|474349058|FG001|Washout 1|Physician Decision|1|||
131746801|NCT01688635|474349057|FG000|Washout 2|Physician Decision|1|||
131746802|NCT01688635|474349058|FG001|Washout 2|Physician Decision|0|||
131746803|NCT01688635|474349057|FG000|Washout 2|Withdrawal by Subject|1|||
131746804|NCT01688635|474349058|FG001|Washout 2|Withdrawal by Subject|0|||
131746805|NCT01688635|474349057|FG000|Washout 2|Sponsor Decision|1|||
131746806|NCT01688635|474349058|FG001|Washout 2|Sponsor Decision|2|||
131746807|NCT01688635|474349057|FG000|Washout 3|Withdrawal by Subject|1|||
131746808|NCT01688635|474349058|FG001|Washout 3|Withdrawal by Subject|0|||
131746809|NCT02947022|474349060|FG000|Overall Study|Study Stopped|1|||
131746810|NCT01230749|474349061|FG000|Overall Study|Adverse Event|0|||
131746811|NCT01230749|474349062|FG001|Overall Study|Adverse Event|0|||
131746812|NCT01230749|474349063|FG002|Overall Study|Adverse Event|0|||
131746813|NCT01230749|474349064|FG003|Overall Study|Adverse Event|1|||
131746814|NCT01230749|474349061|FG000|Overall Study|Physician Decision|0|||
131746815|NCT01230749|474349062|FG001|Overall Study|Physician Decision|0|||
131746816|NCT01230749|474349063|FG002|Overall Study|Physician Decision|1|||
131746817|NCT01230749|474349064|FG003|Overall Study|Physician Decision|0|||
131746818|NCT01230749|474349061|FG000|Overall Study|Withdrawal by Subject|0|||
131746819|NCT01230749|474349062|FG001|Overall Study|Withdrawal by Subject|1|||
131746820|NCT01230749|474349063|FG002|Overall Study|Withdrawal by Subject|0|||
131746821|NCT01230749|474349064|FG003|Overall Study|Withdrawal by Subject|0|||
131746822|NCT01230749|474349061|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
131746823|NCT01230749|474349062|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
131746824|NCT01230749|474349063|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
131746825|NCT01230749|474349064|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
131746826|NCT04021706|474350686|FG000|Overall Study|Adverse Event|2|||
131746827|NCT04021706|474350687|FG001|Overall Study|Adverse Event|0|||
131746828|NCT04021706|474350686|FG000|Overall Study|Withdrawal by Subject|1|||
131746829|NCT04021706|474350687|FG001|Overall Study|Withdrawal by Subject|2|||
131746830|NCT04021706|474350686|FG000|Overall Study|Physician Decision|1|||
131746831|NCT04021706|474350687|FG001|Overall Study|Physician Decision|0|||
131746832|NCT01412151|474350688|FG000|Week 0 - 306 - Treatment Period|Death|1|||
131746833|NCT01412151|474350688|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
131746834|NCT01412151|474350688|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
131808564|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808565|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808566|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808567|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808568|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808569|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808570|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
131808571|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
131808572|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808573|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808574|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808575|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808576|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131808577|NCT01597245|474582931|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808578|NCT01597245|474582932|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808579|NCT01597245|474582933|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808580|NCT01597245|474582934|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808581|NCT01597245|474582935|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808582|NCT01597245|474582936|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808583|NCT01597245|474582937|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808584|NCT01597245|474582938|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808585|NCT01597245|474582939|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808586|NCT01597245|474582940|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808587|NCT01597245|474582941|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808588|NCT01597245|474582942|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808589|NCT01597245|474582943|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808590|NCT01597245|474582944|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
131808591|NCT01597245|474582945|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808592|NCT01597245|474582946|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808593|NCT01597245|474582947|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808594|NCT01597245|474582948|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808595|NCT01597245|474582949|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808596|NCT01597245|474582950|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808597|NCT01597245|474582951|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
131808598|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808599|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131906255|NCT02357459|474945097|FG002|Overall Study|Incarceration|1|||
131746835|NCT01412151|474350688|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
131746836|NCT03127852|474350690|FG000|Overall Study|Withdrawal by Subject|4|||
131746837|NCT03127852|474350691|FG001|Overall Study|Withdrawal by Subject|1|||
131746838|NCT03127852|474350690|FG000|Overall Study|Death|1|||
131746839|NCT03127852|474350691|FG001|Overall Study|Death|1|||
131746840|NCT00859573|474350693|FG000|Overall Study|Withdrawal by Subject|4|||
131746841|NCT00859573|474350694|FG001|Overall Study|Withdrawal by Subject|1|||
131746842|NCT00859573|474350693|FG000|Overall Study|Physician Decision|1|||
131746843|NCT00859573|474350694|FG001|Overall Study|Physician Decision|1|||
131746844|NCT05742841|474350695|FG000|Overall Study|Withdrawal by Subject|1|||
131746845|NCT05742841|474350695|FG000|Overall Study|Lost to Follow-up|1|||
131746846|NCT01432457|474350696|FG000|Overall Study|Adverse Event|7|||
131746847|NCT01432457|474350697|FG001|Overall Study|Adverse Event|10|||
131746848|NCT01432457|474350698|FG002|Overall Study|Adverse Event|16|||
131746849|NCT01432457|474350696|FG000|Overall Study|Lack of Efficacy|2|||
131746850|NCT01432457|474350697|FG001|Overall Study|Lack of Efficacy|1|||
131746851|NCT01432457|474350698|FG002|Overall Study|Lack of Efficacy|1|||
131746852|NCT01432457|474350696|FG000|Overall Study|Lost to Follow-up|11|||
131746853|NCT01432457|474350697|FG001|Overall Study|Lost to Follow-up|15|||
131746854|NCT01432457|474350698|FG002|Overall Study|Lost to Follow-up|20|||
131746855|NCT01432457|474350696|FG000|Overall Study|Protocol Violation|3|||
131746856|NCT01432457|474350697|FG001|Overall Study|Protocol Violation|2|||
131746857|NCT01432457|474350698|FG002|Overall Study|Protocol Violation|6|||
131746858|NCT01432457|474350696|FG000|Overall Study|Withdrawal by Subject|6|||
131746859|NCT01432457|474350697|FG001|Overall Study|Withdrawal by Subject|11|||
131746860|NCT01432457|474350698|FG002|Overall Study|Withdrawal by Subject|9|||
131746861|NCT01432457|474350696|FG000|Overall Study|Reasons not defined|2|||
131746862|NCT01432457|474350697|FG001|Overall Study|Reasons not defined|3|||
131746863|NCT01432457|474350698|FG002|Overall Study|Reasons not defined|4|||
131746864|NCT01432457|474350696|FG000|Overall Study|Did not take study drug|6|||
131746865|NCT01432457|474350697|FG001|Overall Study|Did not take study drug|6|||
131746866|NCT01432457|474350698|FG002|Overall Study|Did not take study drug|3|||
131746867|NCT02574481|474350699|FG000|Overall Study|Withdrawal by Subject|29|||
131746868|NCT02574481|474350700|FG001|Overall Study|Withdrawal by Subject|15|||
131746869|NCT02574481|474350701|FG002|Overall Study|Withdrawal by Subject|4|||
131746870|NCT02574481|474350702|FG003|Overall Study|Withdrawal by Subject|1|||
131746871|NCT02574481|474350699|FG000|Overall Study|Adverse Event|5|||
131746872|NCT02574481|474350700|FG001|Overall Study|Adverse Event|1|||
131746873|NCT02574481|474350701|FG002|Overall Study|Adverse Event|1|||
131746874|NCT02574481|474350702|FG003|Overall Study|Adverse Event|0|||
131746875|NCT02574481|474350699|FG000|Overall Study|Visit Missed|15|||
131746876|NCT02574481|474350700|FG001|Overall Study|Visit Missed|7|||
131746877|NCT02574481|474350701|FG002|Overall Study|Visit Missed|5|||
131746878|NCT02574481|474350702|FG003|Overall Study|Visit Missed|0|||
131746879|NCT02574481|474350699|FG000|Overall Study|Other|7|||
131746880|NCT02574481|474350700|FG001|Overall Study|Other|2|||
131746881|NCT02574481|474350701|FG002|Overall Study|Other|0|||
131746882|NCT02574481|474350702|FG003|Overall Study|Other|0|||
131746883|NCT02574481|474350699|FG000|Overall Study|Death|48|||
131746884|NCT02574481|474350700|FG001|Overall Study|Death|26|||
131746885|NCT02574481|474350701|FG002|Overall Study|Death|12|||
131746886|NCT02574481|474350702|FG003|Overall Study|Death|4|||
131746887|NCT02574481|474350699|FG000|Overall Study|Physician Decision|5|||
131746888|NCT02574481|474350700|FG001|Overall Study|Physician Decision|2|||
131746889|NCT02574481|474350701|FG002|Overall Study|Physician Decision|0|||
131746890|NCT02574481|474350702|FG003|Overall Study|Physician Decision|0|||
131746891|NCT02574481|474350699|FG000|Overall Study|Lost to Follow-up|5|||
131746892|NCT02574481|474350700|FG001|Overall Study|Lost to Follow-up|1|||
131746893|NCT02574481|474350701|FG002|Overall Study|Lost to Follow-up|3|||
131746894|NCT02574481|474350702|FG003|Overall Study|Lost to Follow-up|0|||
131746895|NCT04134728|474350703|FG000|Overall Study|Adverse Event|3|||
131746896|NCT04134728|474350704|FG001|Overall Study|Adverse Event|2|||
131746897|NCT04134728|474350705|FG002|Overall Study|Adverse Event|9|||
131746898|NCT04134728|474350706|FG003|Overall Study|Adverse Event|0|||
131746899|NCT04134728|474350707|FG004|Overall Study|Adverse Event|0|||
131746900|NCT04134728|474350708|FG005|Overall Study|Adverse Event|0|||
131746901|NCT04134728|474350703|FG000|Overall Study|Lack of Efficacy|3|||
131746902|NCT04134728|474350704|FG001|Overall Study|Lack of Efficacy|3|||
131746903|NCT04134728|474350705|FG002|Overall Study|Lack of Efficacy|1|||
131746904|NCT04134728|474350706|FG003|Overall Study|Lack of Efficacy|2|||
131746905|NCT04134728|474350707|FG004|Overall Study|Lack of Efficacy|0|||
131746906|NCT04134728|474350708|FG005|Overall Study|Lack of Efficacy|0|||
131746907|NCT04134728|474350703|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131746908|NCT04134728|474350704|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131746909|NCT04134728|474350705|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
131746910|NCT04134728|474350706|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131746911|NCT04134728|474350707|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131746912|NCT04134728|474350708|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131746913|NCT04134728|474350703|FG000|Overall Study|Protocol Deviation|0|||
131449022|NCT00687193|473272770|FG002|Overall Study|Adverse Event|2|||
131746914|NCT04134728|474350704|FG001|Overall Study|Protocol Deviation|0|||
131746915|NCT04134728|474350705|FG002|Overall Study|Protocol Deviation|1|||
131746916|NCT04134728|474350706|FG003|Overall Study|Protocol Deviation|0|||
131746917|NCT04134728|474350707|FG004|Overall Study|Protocol Deviation|0|||
131746918|NCT04134728|474350708|FG005|Overall Study|Protocol Deviation|0|||
131746919|NCT04134728|474350703|FG000|Overall Study|Informed Consent Withdrawn|3|||
131746920|NCT04134728|474350704|FG001|Overall Study|Informed Consent Withdrawn|6|||
131746921|NCT04134728|474350705|FG002|Overall Study|Informed Consent Withdrawn|8|||
131746922|NCT04134728|474350706|FG003|Overall Study|Informed Consent Withdrawn|1|||
131746923|NCT04134728|474350707|FG004|Overall Study|Informed Consent Withdrawn|1|||
131746924|NCT04134728|474350708|FG005|Overall Study|Informed Consent Withdrawn|0|||
131746925|NCT04134728|474350703|FG000|Overall Study|Physician Decision|2|||
131746926|NCT04134728|474350704|FG001|Overall Study|Physician Decision|0|||
131746927|NCT04134728|474350705|FG002|Overall Study|Physician Decision|0|||
131746928|NCT04134728|474350706|FG003|Overall Study|Physician Decision|0|||
131746929|NCT04134728|474350707|FG004|Overall Study|Physician Decision|0|||
131746930|NCT04134728|474350708|FG005|Overall Study|Physician Decision|0|||
131746931|NCT04134728|474350703|FG000|Overall Study|Lost to Follow-up|1|||
131746932|NCT04134728|474350704|FG001|Overall Study|Lost to Follow-up|2|||
131746933|NCT04134728|474350705|FG002|Overall Study|Lost to Follow-up|1|||
131746934|NCT04134728|474350706|FG003|Overall Study|Lost to Follow-up|0|||
131746935|NCT04134728|474350707|FG004|Overall Study|Lost to Follow-up|0|||
131746936|NCT04134728|474350708|FG005|Overall Study|Lost to Follow-up|1|||
131746937|NCT04134728|474350703|FG000|Overall Study|Investigator Site Closed|0|||
131746938|NCT04134728|474350704|FG001|Overall Study|Investigator Site Closed|1|||
131746939|NCT04134728|474350705|FG002|Overall Study|Investigator Site Closed|1|||
131746940|NCT04134728|474350706|FG003|Overall Study|Investigator Site Closed|0|||
131746941|NCT04134728|474350707|FG004|Overall Study|Investigator Site Closed|0|||
131746942|NCT04134728|474350708|FG005|Overall Study|Investigator Site Closed|0|||
131746943|NCT01711541|474350713|FG000|Overall Study|Cancel prior to treatment|0|||
131746944|NCT01711541|474350714|FG001|Overall Study|Cancel prior to treatment|0|||
131746945|NCT01711541|474350715|FG002|Overall Study|Cancel prior to treatment|0|||
131746946|NCT01711541|474350716|FG003|Overall Study|Cancel prior to treatment|1|||
131746947|NCT01711541|474350717|FG004|Overall Study|Cancel prior to treatment|0|||
131746948|NCT01711541|474350713|FG000|Overall Study|Ineligible|0|||
131746949|NCT01711541|474350714|FG001|Overall Study|Ineligible|1|||
131746950|NCT01711541|474350715|FG002|Overall Study|Ineligible|0|||
131746951|NCT01711541|474350716|FG003|Overall Study|Ineligible|0|||
131746952|NCT01711541|474350717|FG004|Overall Study|Ineligible|0|||
131746953|NCT02905825|474350722|FG000|Overall Study|Protocol Violation|11|||
131746954|NCT02905825|474350722|FG000|Overall Study|Device Malfunction|1|||
131746955|NCT01281189|474350723|FG000|Overall Study|Adverse Event|7|||
131746956|NCT01281189|474350724|FG001|Overall Study|Adverse Event|9|||
131746957|NCT01281189|474350723|FG000|Overall Study|Lost to Follow-up|6|||
131746958|NCT01281189|474350724|FG001|Overall Study|Lost to Follow-up|4|||
131746959|NCT01281189|474350723|FG000|Overall Study|Withdrawal by Subject|21|||
131746960|NCT01281189|474350724|FG001|Overall Study|Withdrawal by Subject|24|||
131746961|NCT01281189|474350723|FG000|Overall Study|Physician Decision|2|||
131746962|NCT01281189|474350724|FG001|Overall Study|Physician Decision|3|||
131746963|NCT01281189|474350723|FG000|Overall Study|Death|103|||
131746964|NCT01281189|474350724|FG001|Overall Study|Death|91|||
131746965|NCT01281189|474350723|FG000|Overall Study|Other|8|||
131746966|NCT01281189|474350724|FG001|Overall Study|Other|12|||
131746967|NCT01136746|474350725|FG000|Overall Study|Lost to Follow-up|0|||
131746968|NCT01136746|474350726|FG001|Overall Study|Lost to Follow-up|2|||
131746969|NCT01136746|474350725|FG000|Overall Study|Protocol Violation|2|||
131746970|NCT01136746|474350726|FG001|Overall Study|Protocol Violation|1|||
131746971|NCT01136746|474350725|FG000|Overall Study|Death|1|||
131746972|NCT01136746|474350726|FG001|Overall Study|Death|0|||
131746973|NCT01090102|474350732|FG000|First 12 Weeks|Withdrawal by Subject|1|||
131746974|NCT01090102|474350733|FG001|First 12 Weeks|Withdrawal by Subject|1|||
131746975|NCT01090102|474350732|FG000|First 12 Weeks|Adverse Event|2|||
131746976|NCT01090102|474350733|FG001|First 12 Weeks|Adverse Event|0|||
131746977|NCT01090102|474350732|FG000|First 12 Weeks|Death|1|||
131746978|NCT01090102|474350733|FG001|First 12 Weeks|Death|1|||
131746979|NCT01090102|474350732|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
131746980|NCT01090102|474350733|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
131746981|NCT03518034|474350734|FG000|Overall Study|Not Treated|5|||
131746982|NCT03518034|474350735|FG001|Overall Study|Not Treated|1|||
131746983|NCT03518034|474350734|FG000|Overall Study|Withdrawal by Subject|309|||
131746984|NCT03518034|474350735|FG001|Overall Study|Withdrawal by Subject|351|||
131746985|NCT03518034|474350734|FG000|Overall Study|Lost to Follow-up|446|||
131449023|NCT00687193|473272771|FG003|Overall Study|Adverse Event|3|||
131746986|NCT03518034|474350735|FG001|Overall Study|Lost to Follow-up|458|||
131746987|NCT03518034|474350734|FG000|Overall Study|Adverse Event|138|||
131746988|NCT03518034|474350735|FG001|Overall Study|Adverse Event|130|||
131746989|NCT03518034|474350734|FG000|Overall Study|Lack of Efficacy|11|||
131746990|NCT03518034|474350735|FG001|Overall Study|Lack of Efficacy|23|||
131746991|NCT03518034|474350734|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
131746992|NCT03518034|474350735|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
131746993|NCT03518034|474350734|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
131746994|NCT03518034|474350735|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
131746995|NCT03518034|474350734|FG000|Overall Study|Other, Not Specified|84|||
131746996|NCT03518034|474350735|FG001|Overall Study|Other, Not Specified|53|||
131746997|NCT03518034|474350734|FG000|Overall Study|Reason Missing|2|||
131746998|NCT03518034|474350735|FG001|Overall Study|Reason Missing|3|||
131449024|NCT00687193|473272772|FG004|Overall Study|Adverse Event|0|||
131449025|NCT00687193|473272773|FG005|Overall Study|Adverse Event|2|||
131449026|NCT00687193|473272768|FG000|Overall Study|Lack of Efficacy|1|||
131449027|NCT00687193|473272769|FG001|Overall Study|Lack of Efficacy|1|||
131746999|NCT00010803|474350741|FG000|Overall Study|Withdrawal by Subject|97|||
131747000|NCT00010803|474350742|FG001|Overall Study|Withdrawal by Subject|98|||
131747001|NCT01019252|474350743|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
131747002|NCT01019252|474350744|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
131449028|NCT00687193|473272770|FG002|Overall Study|Lack of Efficacy|0|||
131747003|NCT01019252|474350743|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
131449029|NCT00687193|473272771|FG003|Overall Study|Lack of Efficacy|0|||
131747004|NCT01019252|474350744|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
131747005|NCT01019252|474350743|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
131747006|NCT01019252|474350744|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
131747007|NCT01019252|474350743|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
131747008|NCT01019252|474350744|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
131747009|NCT02273037|474350745|FG000|Overall Study|Lost to Follow-up|1|||
131747010|NCT02273037|474350746|FG001|Overall Study|Lost to Follow-up|0|||
131747011|NCT02273037|474350745|FG000|Overall Study|Delivered before monitoring initiated|1|||
131747012|NCT02273037|474350746|FG001|Overall Study|Delivered before monitoring initiated|3|||
131747013|NCT02273037|474350745|FG000|Overall Study|Breech delivery|2|||
131747014|NCT02273037|474350746|FG001|Overall Study|Breech delivery|3|||
131747015|NCT02273037|474350745|FG000|Overall Study|Multiple delivery|2|||
131747016|NCT02273037|474350746|FG001|Overall Study|Multiple delivery|2|||
131747017|NCT02273037|474350745|FG000|Overall Study|Other complication|2|||
131747018|NCT02273037|474350746|FG001|Overall Study|Other complication|0|||
131747019|NCT03351478|474350749|FG000|Overall Study|At the subject's own request|11|||
131747020|NCT03351478|474350750|FG001|Overall Study|At the subject's own request|12|||
131747021|NCT03351478|474350751|FG002|Overall Study|At the subject's own request|5|||
131747022|NCT03351478|474350749|FG000|Overall Study|Adverse Event|1|||
131747023|NCT03351478|474350750|FG001|Overall Study|Adverse Event|2|||
131747024|NCT03351478|474350751|FG002|Overall Study|Adverse Event|1|||
131747025|NCT03351478|474350749|FG000|Overall Study|Poor compliance to protocol|1|||
131747026|NCT03351478|474350750|FG001|Overall Study|Poor compliance to protocol|0|||
131747027|NCT03351478|474350751|FG002|Overall Study|Poor compliance to protocol|0|||
131747028|NCT03351478|474350749|FG000|Overall Study|Reason not Specified|1|||
131747029|NCT03351478|474350750|FG001|Overall Study|Reason not Specified|3|||
131747030|NCT03351478|474350751|FG002|Overall Study|Reason not Specified|0|||
131747031|NCT03351478|474350749|FG000|Overall Study|Lost to Follow-up|0|||
131747032|NCT03351478|474350750|FG001|Overall Study|Lost to Follow-up|0|||
131747033|NCT03351478|474350751|FG002|Overall Study|Lost to Follow-up|1|||
131747034|NCT00985738|474350755|FG000|Overall Study|Study closed prematurely|8|||
131747035|NCT00985738|474350756|FG001|Overall Study|Study closed prematurely|8|||
131747036|NCT02227849|474350758|FG000|Overall Study|Adverse Event|4|||
131747037|NCT02227849|474350758|FG000|Overall Study|Physician Decision|1|||
131747038|NCT02227849|474350758|FG000|Overall Study|Withdrawal by Subject|3|||
131747039|NCT00510484|474350761|FG000|Wash-out Period|Adverse Event|0|||
131747040|NCT00510484|474350762|FG001|Wash-out Period|Adverse Event|1|||
131747041|NCT01590212|474350763|FG000|Overall Study|Withdrawal by Subject|2|||
131747042|NCT01590212|474350764|FG001|Overall Study|Withdrawal by Subject|2|||
131906256|NCT02357459|474945095|FG000|Overall Study|Pre-planned Knee surgery|0|||
131906257|NCT02357459|474945096|FG001|Overall Study|Pre-planned Knee surgery|0|||
131906258|NCT02357459|474945097|FG002|Overall Study|Pre-planned Knee surgery|2|||
131906259|NCT02357459|474945095|FG000|Overall Study|Job Commitments|0|||
131906260|NCT02357459|474945096|FG001|Overall Study|Job Commitments|0|||
131906261|NCT02357459|474945097|FG002|Overall Study|Job Commitments|1|||
131906262|NCT01548599|474945098|FG000|Overall Study|Lost to Follow-up|0|||
131906263|NCT01548599|474945099|FG001|Overall Study|Lost to Follow-up|1|||
131906264|NCT01548599|474945098|FG000|Overall Study|Withdrawal by Subject|4|||
131906265|NCT01548599|474945099|FG001|Overall Study|Withdrawal by Subject|0|||
131747043|NCT01590212|474350765|FG002|Overall Study|Withdrawal by Subject|2|||
131747044|NCT01590212|474350763|FG000|Overall Study|Lost to Follow-up|1|||
131747045|NCT01590212|474350764|FG001|Overall Study|Lost to Follow-up|2|||
131906266|NCT01548599|474945098|FG000|Overall Study|Death|2|||
131906267|NCT01548599|474945099|FG001|Overall Study|Death|1|||
131906268|NCT00352118|474945101|FG000|Overall Study|Physician Decision|4|||
131906269|NCT02990000|474945102|FG000|Overall Study|Failed to provide data beyond baseline|36|||
131906270|NCT02990000|474945103|FG001|Overall Study|Failed to provide data beyond baseline|34|||
131906271|NCT02308046|474945104|FG000|Overall Study|Negative yeast culture at Baseline|32|||
131906272|NCT02308046|474945105|FG001|Overall Study|Negative yeast culture at Baseline|33|||
131747046|NCT01590212|474350765|FG002|Overall Study|Lost to Follow-up|3|||
131747047|NCT02533401|474350766|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
131747048|NCT02533401|474350766|FG000|Overall Study|Death|5|||
131906273|NCT02308046|474945104|FG000|Overall Study|Positive for STD at Baseline|1|||
131906274|NCT02308046|474945105|FG001|Overall Study|Positive for STD at Baseline|2|||
131747049|NCT02533401|474350766|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
131906275|NCT02308046|474945104|FG000|Overall Study|Lost to Follow-up|1|||
131747050|NCT02533401|474350766|FG000|Overall Study|Lost to Follow-up|1|||
131747051|NCT02533401|474350766|FG000|Overall Study|Violation of Selection Criteria|1|||
131906276|NCT02308046|474945105|FG001|Overall Study|Lost to Follow-up|3|||
131906277|NCT02812186|474945108|FG000|Period 1|Post randomization screen failure|5|||
131906278|NCT02812186|474945109|FG001|Period 1|Post randomization screen failure|9|||
131747052|NCT04897594|474350769|FG000|Overall Study|Lost to Follow-up|0|||
131747053|NCT04897594|474350770|FG001|Overall Study|Lost to Follow-up|1|||
131906279|NCT02812186|474945108|FG000|Period 1|nonevaluable data sets|6|||
131906280|NCT02812186|474945109|FG001|Period 1|nonevaluable data sets|6|||
131747054|NCT04897594|474350771|FG002|Overall Study|Lost to Follow-up|1|||
131747055|NCT04897594|474350769|FG000|Overall Study|Sponsor Decision|0|||
131747056|NCT04897594|474350770|FG001|Overall Study|Sponsor Decision|0|||
131747057|NCT04897594|474350771|FG002|Overall Study|Sponsor Decision|1|||
131747058|NCT04897594|474350769|FG000|Overall Study|Withdrawal by Subject|1|||
131747059|NCT04897594|474350770|FG001|Overall Study|Withdrawal by Subject|0|||
131747060|NCT04897594|474350771|FG002|Overall Study|Withdrawal by Subject|1|||
131747061|NCT01467661|474350781|FG000|Overall Study|Adverse Event|16|||
131747062|NCT01467661|474350781|FG000|Overall Study|Withdrawal by Subject|1|||
131747063|NCT01467661|474350781|FG000|Overall Study|Lack of Efficacy|3|||
131747064|NCT01467661|474350781|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
131747065|NCT00270998|474350784|FG000|3 Month Follow-up|Adverse Event|1|||
131747066|NCT00270998|474350785|FG001|3 Month Follow-up|Adverse Event|0|||
131747067|NCT00270998|474350786|FG002|3 Month Follow-up|Adverse Event|0|||
131747068|NCT00270998|474350784|FG000|3 Month Follow-up|Lack of Efficacy|1|||
131747069|NCT00270998|474350785|FG001|3 Month Follow-up|Lack of Efficacy|2|||
131747070|NCT00270998|474350786|FG002|3 Month Follow-up|Lack of Efficacy|1|||
131747071|NCT00270998|474350784|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
131747072|NCT00270998|474350785|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
131747073|NCT00270998|474350786|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
131747074|NCT00270998|474350784|FG000|3 Month Follow-up|Pessary did not fit|12|||
131747075|NCT00270998|474350785|FG001|3 Month Follow-up|Pessary did not fit|0|||
131747076|NCT00270998|474350786|FG002|3 Month Follow-up|Pessary did not fit|0|||
131747077|NCT00270998|474350784|FG000|3 Month Follow-up|Personal/family health|1|||
131747078|NCT00270998|474350785|FG001|3 Month Follow-up|Personal/family health|1|||
131747079|NCT00270998|474350786|FG002|3 Month Follow-up|Personal/family health|0|||
131747080|NCT00270998|474350784|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
131747081|NCT00270998|474350785|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
131747082|NCT00270998|474350786|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
131747083|NCT00270998|474350784|FG000|12 Month Follow-up|Lack of Efficacy|5|||
131747084|NCT00270998|474350785|FG001|12 Month Follow-up|Lack of Efficacy|4|||
131747085|NCT00270998|474350786|FG002|12 Month Follow-up|Lack of Efficacy|3|||
131747086|NCT00270998|474350784|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
131747087|NCT00270998|474350785|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
131747088|NCT00270998|474350786|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
131747089|NCT00270998|474350784|FG000|12 Month Follow-up|Pessary did not fit|1|||
131747090|NCT00270998|474350785|FG001|12 Month Follow-up|Pessary did not fit|0|||
131747091|NCT00270998|474350786|FG002|12 Month Follow-up|Pessary did not fit|0|||
131747092|NCT00270998|474350784|FG000|12 Month Follow-up|Personal/family health|0|||
131747093|NCT00270998|474350785|FG001|12 Month Follow-up|Personal/family health|5|||
131747094|NCT00270998|474350786|FG002|12 Month Follow-up|Personal/family health|1|||
131747095|NCT00270998|474350784|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
131747096|NCT00270998|474350785|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
131747097|NCT00270998|474350786|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
131747098|NCT03495817|474350791|FG000|26 Week Open Label|Adverse Event|3|||
131747099|NCT03495817|474350791|FG000|26 Week Open Label|Withdrawal by Subject|4|||
131747100|NCT03495817|474350791|FG000|26 Week Open Label|Lost to Follow-up|1|||
131747101|NCT03495817|474350791|FG000|26 Week Extension|Lost to Follow-up|2|||
131747102|NCT04169061|474350792|FG000|Overall Study|Adverse Event|2|||
131747103|NCT04169061|474350792|FG000|Overall Study|Death|1|||
131747104|NCT04169061|474350792|FG000|Overall Study|Withdrawal by Subject|1|||
131747105|NCT04169061|474350792|FG000|Overall Study|Protocol Violation|1|||
131747106|NCT04585451|474350793|FG000|Overall Study|Withdrawal by Subject|26|||
131747107|NCT04585451|474350794|FG001|Overall Study|Withdrawal by Subject|0|||
131747108|NCT00326417|474350795|FG000|Overall Study|Withdrawal by Subject|0|||
131747109|NCT00326417|474350796|FG001|Overall Study|Withdrawal by Subject|0|||
131747110|NCT00326417|474350797|FG002|Overall Study|Withdrawal by Subject|1|||
131747111|NCT00326417|474350798|FG003|Overall Study|Withdrawal by Subject|0|||
131747112|NCT00326417|474350795|FG000|Overall Study|Arm Closed|7|||
131747113|NCT00326417|474350796|FG001|Overall Study|Arm Closed|0|||
131747114|NCT00326417|474350797|FG002|Overall Study|Arm Closed|0|||
131747115|NCT00326417|474350798|FG003|Overall Study|Arm Closed|3|||
131747116|NCT00326417|474350795|FG000|Overall Study|Death|7|||
131747117|NCT00326417|474350796|FG001|Overall Study|Death|0|||
131747118|NCT00326417|474350797|FG002|Overall Study|Death|0|||
131747119|NCT00326417|474350798|FG003|Overall Study|Death|0|||
131747120|NCT00844285|474350799|FG000|Overall Study|Other|0|||
131747121|NCT00844285|474350800|FG001|Overall Study|Other|1|||
131747122|NCT00844285|474350801|FG002|Overall Study|Other|0|||
131747123|NCT00844285|474350799|FG000|Overall Study|Other than specified|95|||
131747124|NCT00844285|474350800|FG001|Overall Study|Other than specified|129|||
131747125|NCT00844285|474350801|FG002|Overall Study|Other than specified|12|||
131747126|NCT00844285|474350799|FG000|Overall Study|Site closure|256|||
131747127|NCT00844285|474350800|FG001|Overall Study|Site closure|450|||
131747128|NCT00844285|474350801|FG002|Overall Study|Site closure|50|||
131747129|NCT00844285|474350799|FG000|Overall Study|Follow-up < 8 years|16|||
131747130|NCT00844285|474350800|FG001|Overall Study|Follow-up < 8 years|23|||
131747131|NCT00844285|474350801|FG002|Overall Study|Follow-up < 8 years|4|||
131747132|NCT00844285|474350799|FG000|Overall Study|Protocol Violation|26|||
131747133|NCT00844285|474350800|FG001|Overall Study|Protocol Violation|28|||
131747134|NCT00844285|474350801|FG002|Overall Study|Protocol Violation|54|||
131747135|NCT00844285|474350799|FG000|Overall Study|Death|22|||
131747136|NCT00844285|474350800|FG001|Overall Study|Death|21|||
131747137|NCT00844285|474350801|FG002|Overall Study|Death|8|||
131747138|NCT00844285|474350799|FG000|Overall Study|Withdrew Consent|344|||
131747139|NCT00844285|474350800|FG001|Overall Study|Withdrew Consent|466|||
131747140|NCT00844285|474350801|FG002|Overall Study|Withdrew Consent|70|||
131747141|NCT00844285|474350799|FG000|Overall Study|Lost to Follow-up|330|||
131747142|NCT00844285|474350800|FG001|Overall Study|Lost to Follow-up|486|||
131747143|NCT00844285|474350801|FG002|Overall Study|Lost to Follow-up|74|||
131747144|NCT00555906|474350806|FG000|Phase 1|Objective Progression or Relapse|3|||
131747145|NCT00555906|474350807|FG001|Phase 1|Objective Progression or Relapse|5|||
131747146|NCT00555906|474350808|FG002|Phase 1|Objective Progression or Relapse|3|||
131747147|NCT00555906|474350809|FG003|Phase 1|Objective Progression or Relapse|1|||
131747148|NCT00555906|474350810|FG004|Phase 1|Objective Progression or Relapse|0|||
131747149|NCT00555906|474350806|FG000|Phase 1|Global Deterioration of Health Status|0|||
131747150|NCT00555906|474350807|FG001|Phase 1|Global Deterioration of Health Status|1|||
131747151|NCT00555906|474350808|FG002|Phase 1|Global Deterioration of Health Status|1|||
131747152|NCT00555906|474350809|FG003|Phase 1|Global Deterioration of Health Status|1|||
131747153|NCT00555906|474350810|FG004|Phase 1|Global Deterioration of Health Status|0|||
131747154|NCT00555906|474350806|FG000|Phase 1|Adverse Event|0|||
131747155|NCT00555906|474350807|FG001|Phase 1|Adverse Event|0|||
131747156|NCT00555906|474350808|FG002|Phase 1|Adverse Event|3|||
131747157|NCT00555906|474350809|FG003|Phase 1|Adverse Event|2|||
131747158|NCT00555906|474350810|FG004|Phase 1|Adverse Event|0|||
131747159|NCT00555906|474350806|FG000|Phase 1|Withdrawal by Subject|0|||
131747160|NCT00555906|474350807|FG001|Phase 1|Withdrawal by Subject|0|||
131906281|NCT01307787|474945110|FG000|Overall Study|Withdrawal by Subject|2|||
131906282|NCT01307787|474945111|FG001|Overall Study|Withdrawal by Subject|0|||
131747161|NCT00555906|474350808|FG002|Phase 1|Withdrawal by Subject|0|||
131747162|NCT00555906|474350809|FG003|Phase 1|Withdrawal by Subject|1|||
131747163|NCT00555906|474350810|FG004|Phase 1|Withdrawal by Subject|0|||
131747164|NCT00555906|474350806|FG000|Phase 2|Adverse Event|0|||
131747165|NCT00555906|474350807|FG001|Phase 2|Adverse Event|0|||
131747166|NCT00555906|474350808|FG002|Phase 2|Adverse Event|0|||
131747167|NCT00555906|474350809|FG003|Phase 2|Adverse Event|0|||
131747168|NCT00555906|474350810|FG004|Phase 2|Adverse Event|4|||
131747169|NCT00555906|474350806|FG000|Phase 2|Global Deterioration of Health Status|0|||
131747170|NCT00555906|474350807|FG001|Phase 2|Global Deterioration of Health Status|0|||
131747171|NCT00555906|474350808|FG002|Phase 2|Global Deterioration of Health Status|0|||
131747172|NCT00555906|474350809|FG003|Phase 2|Global Deterioration of Health Status|0|||
131747173|NCT00555906|474350810|FG004|Phase 2|Global Deterioration of Health Status|2|||
131747174|NCT00555906|474350806|FG000|Phase 2|Objective Progression or Relapse|0|||
131747175|NCT00555906|474350807|FG001|Phase 2|Objective Progression or Relapse|0|||
131747176|NCT00555906|474350808|FG002|Phase 2|Objective Progression or Relapse|0|||
131747177|NCT00555906|474350809|FG003|Phase 2|Objective Progression or Relapse|0|||
131747178|NCT00555906|474350810|FG004|Phase 2|Objective Progression or Relapse|16|||
131747179|NCT00555906|474350806|FG000|Phase 2|Withdrawal by Subject|0|||
131747180|NCT00555906|474350807|FG001|Phase 2|Withdrawal by Subject|0|||
131747181|NCT00555906|474350808|FG002|Phase 2|Withdrawal by Subject|0|||
131747182|NCT00555906|474350809|FG003|Phase 2|Withdrawal by Subject|0|||
131747183|NCT00555906|474350810|FG004|Phase 2|Withdrawal by Subject|2|||
131747184|NCT00555906|474350806|FG000|Phase 2|Other|0|||
131747185|NCT00555906|474350807|FG001|Phase 2|Other|0|||
131747186|NCT00555906|474350808|FG002|Phase 2|Other|0|||
131747187|NCT00555906|474350809|FG003|Phase 2|Other|0|||
131747188|NCT00555906|474350810|FG004|Phase 2|Other|6|||
131747189|NCT00555906|474350806|FG000|Phase 2|Randomized but not Treated|0|||
131747190|NCT00555906|474350807|FG001|Phase 2|Randomized but not Treated|0|||
131747191|NCT00555906|474350808|FG002|Phase 2|Randomized but not Treated|0|||
131747192|NCT00555906|474350809|FG003|Phase 2|Randomized but not Treated|0|||
131747193|NCT00555906|474350810|FG004|Phase 2|Randomized but not Treated|2|||
131747194|NCT04046341|474350812|FG000|Overall Study|Lost to Follow-up|2|||
131747195|NCT04046341|474350812|FG000|Overall Study|Withdrawal by Subject|1|||
131747196|NCT00405652|474350813|FG000|Overall Study|Adverse Event|4|||
131747197|NCT00435994|474350815|FG000|Overall Study|Lost to Follow-up|7|||
131747198|NCT00435994|474350816|FG001|Overall Study|Lost to Follow-up|0|||
131747199|NCT00435994|474350817|FG002|Overall Study|Lost to Follow-up|0|||
131747200|NCT03505749|474350818|FG000|Overall Study|Lost to Follow-up|7|||
131747201|NCT03505749|474350819|FG001|Overall Study|Lost to Follow-up|11|||
131747202|NCT03505749|474350818|FG000|Overall Study|Withdrawal by Subject|6|||
131747203|NCT03505749|474350819|FG001|Overall Study|Withdrawal by Subject|0|||
131747204|NCT03505749|474350818|FG000|Overall Study|Discharged from treatment|3|||
131906283|NCT01573000|474945112|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
131747205|NCT03505749|474350819|FG001|Overall Study|Discharged from treatment|6|||
131747206|NCT03549117|474350823|FG000|Overall Study|Withdrawal by Subject|1|||
131747207|NCT03549117|474350824|FG001|Overall Study|Withdrawal by Subject|0|||
131747208|NCT00888615|474350825|FG000|Overall Study|No treatment|2|||
131747209|NCT02091921|474350828|FG000|Overall Study|Adverse Event|3|||
131747210|NCT03307629|474350829|FG000|Overall Study|Withdrawal by Subject|0|||
131747211|NCT03307629|474350830|FG001|Overall Study|Withdrawal by Subject|0|||
131747212|NCT03307629|474350831|FG002|Overall Study|Withdrawal by Subject|0|||
131747213|NCT03307629|474350832|FG003|Overall Study|Withdrawal by Subject|2|||
131747214|NCT03307629|474350829|FG000|Overall Study|Disease Progression|0|||
131747215|NCT03307629|474350830|FG001|Overall Study|Disease Progression|0|||
131747216|NCT03307629|474350831|FG002|Overall Study|Disease Progression|0|||
131747217|NCT03307629|474350832|FG003|Overall Study|Disease Progression|3|||
131906284|NCT01573000|474945113|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
131906285|NCT01573000|474945112|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
131906286|NCT01573000|474945113|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
131906287|NCT01573000|474945112|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
131906288|NCT01573000|474945113|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
131906289|NCT01573000|474945112|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
131906290|NCT01573000|474945113|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
131906291|NCT01573000|474945112|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
131906292|NCT01573000|474945113|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
131906293|NCT01573000|474945112|FG000|Crossover Phase|Lack of Efficacy|0|||
131906294|NCT01573000|474945113|FG001|Crossover Phase|Lack of Efficacy|13|||
131906295|NCT01573000|474945112|FG000|Crossover Phase|Lost to Follow-up|0|||
131906296|NCT01573000|474945113|FG001|Crossover Phase|Lost to Follow-up|2|||
131906297|NCT01573000|474945112|FG000|Crossover Phase|Death|0|||
131906298|NCT01573000|474945113|FG001|Crossover Phase|Death|3|||
131906299|NCT01573000|474945112|FG000|Long-Term Follow-Up|Death|3|||
131906300|NCT01573000|474945113|FG001|Long-Term Follow-Up|Death|0|||
131906301|NCT01573000|474945112|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
131906302|NCT01573000|474945113|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
131906303|NCT03353792|474945114|FG000|Overall Study|Lost to Follow-up|1|||
131906304|NCT03353792|474945115|FG001|Overall Study|Lost to Follow-up|0|||
131906305|NCT03353792|474945114|FG000|Overall Study|Participant Unable to Manage Device|1|||
131906306|NCT03353792|474945115|FG001|Overall Study|Participant Unable to Manage Device|0|||
131906307|NCT01433159|474945119|FG000|Overall Study|Adverse Event|1|||
131906308|NCT01433159|474945120|FG001|Overall Study|Adverse Event|0|||
131906309|NCT01433159|474945119|FG000|Overall Study|Physician Decision|1|||
131906310|NCT01433159|474945120|FG001|Overall Study|Physician Decision|0|||
131906311|NCT01433159|474945119|FG000|Overall Study|Protocol Violation|0|||
131747218|NCT03307629|474350829|FG000|Overall Study|Death|0|||
131747219|NCT03307629|474350830|FG001|Overall Study|Death|3|||
131747220|NCT03307629|474350831|FG002|Overall Study|Death|0|||
131747221|NCT03307629|474350832|FG003|Overall Study|Death|1|||
131747222|NCT00719953|474350837|FG000|Overall Study|Adverse Event|4|||
131747223|NCT01626989|474350838|FG000|Screening Period|Screen Failure|15|||
131747224|NCT01626989|474350839|FG001|Screening Period|Screen Failure|0|||
131747225|NCT01626989|474350840|FG002|Screening Period|Screen Failure|0|||
131747226|NCT01626989|474350838|FG000|Screening Period|Withdrawal by Subject|2|||
131747227|NCT01626989|474350839|FG001|Screening Period|Withdrawal by Subject|0|||
131747228|NCT01626989|474350840|FG002|Screening Period|Withdrawal by Subject|0|||
131747229|NCT00438464|474352454|FG000|Overall Study|Terminated Early|14|||
131747230|NCT00438464|474352455|FG001|Overall Study|Terminated Early|5|||
131747231|NCT00438464|474352454|FG000|Overall Study|Incomplete data submission|0|||
131747232|NCT00438464|474352455|FG001|Overall Study|Incomplete data submission|2|||
131747233|NCT03943446|474352457|FG000|Overall Study|Lost to Follow-up|0|||
131747234|NCT03943446|474352458|FG001|Overall Study|Lost to Follow-up|0|||
131747235|NCT03943446|474352459|FG002|Overall Study|Lost to Follow-up|1|||
131747236|NCT03943446|474352457|FG000|Overall Study|Withdrawal by Subject|1|||
131747237|NCT03943446|474352458|FG001|Overall Study|Withdrawal by Subject|1|||
131747238|NCT03943446|474352459|FG002|Overall Study|Withdrawal by Subject|2|||
131747239|NCT03943446|474352457|FG000|Overall Study|Study Terminated by Sponsor|1|||
131747240|NCT03943446|474352458|FG001|Overall Study|Study Terminated by Sponsor|2|||
131747241|NCT03943446|474352459|FG002|Overall Study|Study Terminated by Sponsor|1|||
131747242|NCT03943446|474352457|FG000|Overall Study|Reason not Specified|5|||
131747243|NCT03943446|474352458|FG001|Overall Study|Reason not Specified|1|||
131747244|NCT03943446|474352459|FG002|Overall Study|Reason not Specified|3|||
131747245|NCT04209530|474352462|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
131747246|NCT04209530|474352463|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
131747247|NCT04209530|474352462|FG000|Overall Study|Withdrawal by Subject|0|||
131747248|NCT04209530|474352463|FG001|Overall Study|Withdrawal by Subject|1|||
131747249|NCT03673956|474352466|FG000|Overall Study|Lost to Follow-up|1|||
131747250|NCT03673956|474352467|FG001|Overall Study|Lost to Follow-up|0|||
131906312|NCT01433159|474945120|FG001|Overall Study|Protocol Violation|1|||
131747251|NCT03673956|474352468|FG002|Overall Study|Lost to Follow-up|0|||
131747252|NCT03673956|474352469|FG003|Overall Study|Lost to Follow-up|0|||
131747253|NCT03673956|474352466|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
131747254|NCT03673956|474352467|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
131747255|NCT03673956|474352468|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
131747256|NCT03673956|474352469|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
131747257|NCT00636441|474352470|FG000|Overall Study|Adverse Event|0|||
131747258|NCT00636441|474352471|FG001|Overall Study|Adverse Event|1|||
131747259|NCT00636441|474352472|FG002|Overall Study|Adverse Event|1|||
131747260|NCT00636441|474352473|FG003|Overall Study|Adverse Event|0|||
131747261|NCT00636441|474352474|FG004|Overall Study|Adverse Event|0|||
131747262|NCT00636441|474352475|FG005|Overall Study|Adverse Event|1|||
131747263|NCT00636441|474352476|FG006|Overall Study|Adverse Event|0|||
131747264|NCT00636441|474352470|FG000|Overall Study|Late, ineligible|0|||
131747265|NCT00636441|474352471|FG001|Overall Study|Late, ineligible|0|||
131747266|NCT00636441|474352472|FG002|Overall Study|Late, ineligible|0|||
131747267|NCT00636441|474352473|FG003|Overall Study|Late, ineligible|0|||
131747268|NCT00636441|474352474|FG004|Overall Study|Late, ineligible|0|||
131747269|NCT00636441|474352475|FG005|Overall Study|Late, ineligible|0|||
131747270|NCT00636441|474352476|FG006|Overall Study|Late, ineligible|1|||
131747271|NCT00636441|474352470|FG000|Overall Study|Screen Failure|0|||
131747272|NCT00636441|474352471|FG001|Overall Study|Screen Failure|0|||
131747273|NCT00636441|474352472|FG002|Overall Study|Screen Failure|0|||
131747274|NCT00636441|474352473|FG003|Overall Study|Screen Failure|0|||
131747275|NCT00636441|474352474|FG004|Overall Study|Screen Failure|0|||
131747276|NCT00636441|474352475|FG005|Overall Study|Screen Failure|0|||
131747277|NCT00636441|474352476|FG006|Overall Study|Screen Failure|17|||
131747278|NCT03219567|474352481|FG000|Overall Study|Withdrawal by Subject|0|||
131747279|NCT03219567|474352482|FG001|Overall Study|Withdrawal by Subject|1|||
131747280|NCT02849626|474352483|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
131747281|NCT02849626|474352484|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
131747282|NCT02849626|474352485|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
131747283|NCT02849626|474352486|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
131747284|NCT02849626|474352483|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
131747285|NCT02849626|474352484|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
131747286|NCT02849626|474352485|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
131747287|NCT02849626|474352486|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
131747288|NCT02849626|474352483|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
131747289|NCT02849626|474352484|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
131747290|NCT02849626|474352485|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
131747291|NCT02849626|474352486|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
131747292|NCT02849626|474352483|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
131747293|NCT02849626|474352484|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
131747294|NCT02849626|474352485|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
131747295|NCT02849626|474352486|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
131747296|NCT02849626|474352483|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
131747297|NCT02849626|474352484|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
131747298|NCT02849626|474352485|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
131747299|NCT02849626|474352486|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
131747300|NCT02849626|474352483|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
131747301|NCT02849626|474352484|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
131747302|NCT02849626|474352485|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
131747303|NCT02849626|474352486|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
131747304|NCT02849626|474352483|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
131747305|NCT02849626|474352484|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
131747306|NCT02849626|474352485|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
131747307|NCT02849626|474352486|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
131747308|NCT02849626|474352483|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
131747309|NCT02849626|474352484|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
131747310|NCT02849626|474352485|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
131747311|NCT02849626|474352486|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
131747312|NCT02849626|474352483|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
131747313|NCT02849626|474352484|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
131747314|NCT02849626|474352485|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
131747315|NCT02849626|474352486|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
131747316|NCT02849626|474352483|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
131747317|NCT02849626|474352484|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
131747318|NCT02849626|474352485|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
131747319|NCT02849626|474352486|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
131747320|NCT02849626|474352483|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
131747321|NCT02849626|474352484|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
131906313|NCT04161391|474945125|FG000|Overall Study|Adverse Event|0|||
131906314|NCT04161391|474945126|FG001|Overall Study|Adverse Event|1|||
131906315|NCT04161391|474945127|FG002|Overall Study|Adverse Event|0|||
131906316|NCT04161391|474945128|FG003|Overall Study|Adverse Event|1|||
131906317|NCT04161391|474945129|FG004|Overall Study|Adverse Event|0|||
131906318|NCT04161391|474945130|FG005|Overall Study|Adverse Event|0|||
131906319|NCT04161391|474945131|FG006|Overall Study|Adverse Event|0|||
131906320|NCT04161391|474945132|FG007|Overall Study|Adverse Event|3|||
131906321|NCT04161391|474945133|FG008|Overall Study|Adverse Event|0|||
131906322|NCT04161391|474945125|FG000|Overall Study|Death|0|||
131906323|NCT04161391|474945126|FG001|Overall Study|Death|0|||
131906324|NCT04161391|474945127|FG002|Overall Study|Death|0|||
131906325|NCT04161391|474945128|FG003|Overall Study|Death|0|||
131906326|NCT04161391|474945129|FG004|Overall Study|Death|0|||
131906327|NCT04161391|474945130|FG005|Overall Study|Death|0|||
131906328|NCT04161391|474945131|FG006|Overall Study|Death|0|||
131906329|NCT04161391|474945132|FG007|Overall Study|Death|1|||
131906330|NCT04161391|474945133|FG008|Overall Study|Death|0|||
131906331|NCT04161391|474945125|FG000|Overall Study|Physician Decision|0|||
131906332|NCT04161391|474945126|FG001|Overall Study|Physician Decision|0|||
131906333|NCT04161391|474945127|FG002|Overall Study|Physician Decision|1|||
131906334|NCT04161391|474945128|FG003|Overall Study|Physician Decision|2|||
131906335|NCT04161391|474945129|FG004|Overall Study|Physician Decision|0|||
131906336|NCT04161391|474945130|FG005|Overall Study|Physician Decision|0|||
131906337|NCT04161391|474945131|FG006|Overall Study|Physician Decision|2|||
131906338|NCT04161391|474945132|FG007|Overall Study|Physician Decision|0|||
131906339|NCT04161391|474945133|FG008|Overall Study|Physician Decision|0|||
131906340|NCT04161391|474945125|FG000|Overall Study|Progressive Disease|4|||
131906341|NCT04161391|474945126|FG001|Overall Study|Progressive Disease|3|||
131906342|NCT04161391|474945127|FG002|Overall Study|Progressive Disease|3|||
131906343|NCT04161391|474945128|FG003|Overall Study|Progressive Disease|5|||
131906344|NCT04161391|474945129|FG004|Overall Study|Progressive Disease|3|||
131906345|NCT04161391|474945130|FG005|Overall Study|Progressive Disease|3|||
131906346|NCT04161391|474945131|FG006|Overall Study|Progressive Disease|5|||
131906347|NCT04161391|474945132|FG007|Overall Study|Progressive Disease|2|||
131906348|NCT04161391|474945133|FG008|Overall Study|Progressive Disease|2|||
131906349|NCT01190891|474945134|FG000|Overall Study|Protocol Violation|1|||
131906350|NCT01190891|474945135|FG001|Overall Study|Protocol Violation|0|||
131808600|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808601|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808602|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808603|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808604|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808605|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808606|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808607|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808608|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808609|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808610|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808611|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808612|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808613|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
131808614|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
131808615|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
131808616|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
131808617|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
131808618|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
131808619|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808620|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131906351|NCT01190891|474945134|FG000|Overall Study|Withdrawal by Subject|5|||
131906352|NCT01190891|474945135|FG001|Overall Study|Withdrawal by Subject|0|||
131906353|NCT00737048|474945136|FG000|Overall Study|Physician Decision|0|||
131906354|NCT00737048|474945137|FG001|Overall Study|Physician Decision|0|||
131808621|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808622|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131906355|NCT00737048|474945138|FG002|Overall Study|Physician Decision|1|||
131906356|NCT00737048|474945136|FG000|Overall Study|Adverse Event|0|||
131906357|NCT00737048|474945137|FG001|Overall Study|Adverse Event|1|||
131906358|NCT00737048|474945138|FG002|Overall Study|Adverse Event|0|||
131906359|NCT00737048|474945136|FG000|Overall Study|Worsening of the symptoms|3|||
131906360|NCT00737048|474945137|FG001|Overall Study|Worsening of the symptoms|5|||
131906361|NCT00737048|474945138|FG002|Overall Study|Worsening of the symptoms|3|||
131906362|NCT00641056|474945139|FG000|Overall Study|Adverse Event|12|||
131906363|NCT00641056|474945140|FG001|Overall Study|Adverse Event|2|||
131906364|NCT00641056|474945139|FG000|Overall Study|Lost to Follow-up|2|||
131906365|NCT00641056|474945140|FG001|Overall Study|Lost to Follow-up|1|||
131747322|NCT02849626|474352485|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
131747323|NCT02849626|474352486|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
131747324|NCT01313208|474352487|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
131747325|NCT01313208|474352488|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
131747326|NCT01313208|474352487|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
131747327|NCT01313208|474352488|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
131747328|NCT01313208|474352487|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
131747329|NCT01313208|474352488|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
131747330|NCT01313208|474352487|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
131747331|NCT01313208|474352488|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
131747332|NCT01313208|474352487|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
131747333|NCT01313208|474352488|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
131747334|NCT01313208|474352487|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
131747335|NCT01313208|474352488|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
131747336|NCT01313208|474352487|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
131747337|NCT01313208|474352488|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
131747338|NCT01313208|474352487|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
131747339|NCT01313208|474352488|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
131747340|NCT01313208|474352487|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
131747341|NCT01313208|474352488|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
131747342|NCT01654523|474352489|FG000|Overall Study|Withdrawal by Subject|1|||
131747343|NCT01957787|474352490|FG000|Overall Study|Death|18|||
131747344|NCT01957787|474352490|FG000|Overall Study|Lost to Follow-up|3|||
131747345|NCT01957787|474352490|FG000|Overall Study|Withdrawal by Subject|3|||
131747346|NCT01957787|474352490|FG000|Overall Study|Entered Hospice or Similar Program|2|||
131747347|NCT01957787|474352490|FG000|Overall Study|Index Tumor(s) Resected|2|||
131747348|NCT01957787|474352490|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
131747349|NCT01957787|474352490|FG000|Overall Study|Local therapy, not cryoablation|6|||
131747350|NCT04176445|474352493|FG000|Overall Study|Adverse Event|0|||
131747351|NCT04176445|474352494|FG001|Overall Study|Adverse Event|1|||
131747352|NCT04176445|474352493|FG000|Overall Study|change plans weaning after first intervention|0|||
131747353|NCT04176445|474352494|FG001|Overall Study|change plans weaning after first intervention|1|||
131747354|NCT03846219|474352498|FG000|Overall Study|Withdrawal by Subject|3|||
131747355|NCT03846219|474352499|FG001|Overall Study|Withdrawal by Subject|2|||
131747356|NCT03846219|474352500|FG002|Overall Study|Withdrawal by Subject|2|||
131747357|NCT03846219|474352498|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
131747358|NCT03846219|474352499|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
131747359|NCT03846219|474352500|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
131747360|NCT03846219|474352498|FG000|Overall Study|Physician Decision|0|||
131747361|NCT03846219|474352499|FG001|Overall Study|Physician Decision|0|||
131747362|NCT03846219|474352500|FG002|Overall Study|Physician Decision|2|||
131747363|NCT05109702|474352501|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
131747364|NCT05109702|474352502|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
131747365|NCT05109702|474352503|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
131747366|NCT05109702|474352501|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
131747367|NCT05109702|474352502|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
131747368|NCT05109702|474352503|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
131747369|NCT05109702|474352501|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
131747370|NCT05109702|474352502|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
131747371|NCT05109702|474352503|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
131747372|NCT05109702|474352501|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
131747373|NCT05109702|474352502|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
131747374|NCT05109702|474352503|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
131808623|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808624|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808625|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808626|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808627|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131747375|NCT05109702|474352501|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
131747376|NCT05109702|474352502|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
131747377|NCT05109702|474352503|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
131747378|NCT03094832|474352508|FG000|Overall Study|Lost to Follow-up|0|||
131747379|NCT03094832|474352509|FG001|Overall Study|Lost to Follow-up|0|||
131747380|NCT03094832|474352510|FG002|Overall Study|Lost to Follow-up|0|||
131906366|NCT00641056|474945139|FG000|Overall Study|Physician Decision|3|||
131747381|NCT03094832|474352511|FG003|Overall Study|Lost to Follow-up|1|||
131747382|NCT03094832|474352512|FG004|Overall Study|Lost to Follow-up|1|||
131747383|NCT03094832|474352508|FG000|Overall Study|Death|1|||
131747384|NCT03094832|474352509|FG001|Overall Study|Death|0|||
131747385|NCT03094832|474352510|FG002|Overall Study|Death|0|||
131747386|NCT03094832|474352511|FG003|Overall Study|Death|0|||
131747387|NCT03094832|474352512|FG004|Overall Study|Death|0|||
131449030|NCT00687193|473272772|FG004|Overall Study|Lack of Efficacy|0|||
131747388|NCT03094832|474352508|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131747389|NCT03094832|474352509|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131747390|NCT03094832|474352510|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131449031|NCT00687193|473272773|FG005|Overall Study|Lack of Efficacy|2|||
131449032|NCT00687193|473272768|FG000|Overall Study|Protocol Violation|1|||
131449033|NCT00687193|473272769|FG001|Overall Study|Protocol Violation|2|||
131449034|NCT00687193|473272770|FG002|Overall Study|Protocol Violation|0|||
131449035|NCT00687193|473272771|FG003|Overall Study|Protocol Violation|1|||
131449036|NCT00687193|473272772|FG004|Overall Study|Protocol Violation|2|||
131449037|NCT00687193|473272773|FG005|Overall Study|Protocol Violation|0|||
131449038|NCT01285557|473272774|FG000|Overall Study|Death|173|||
131449039|NCT01285557|473272775|FG001|Overall Study|Death|90|||
131449040|NCT01285557|473272774|FG000|Overall Study|Lost to Follow-up|6|||
131449041|NCT01285557|473272775|FG001|Overall Study|Lost to Follow-up|2|||
131449042|NCT01285557|473272774|FG000|Overall Study|Withdrew Consent|6|||
131449043|NCT01285557|473272775|FG001|Overall Study|Withdrew Consent|1|||
131747391|NCT03094832|474352511|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131747392|NCT03094832|474352512|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131747393|NCT03094832|474352508|FG000|Overall Study|Other|13|||
131747394|NCT03094832|474352509|FG001|Overall Study|Other|20|||
131747395|NCT03094832|474352510|FG002|Overall Study|Other|1|||
131747396|NCT03094832|474352511|FG003|Overall Study|Other|7|||
131747397|NCT03094832|474352512|FG004|Overall Study|Other|1|||
131747398|NCT01392378|474352513|FG000|Infant Series|Adverse Event|0|||
131747399|NCT01392378|474352514|FG001|Infant Series|Adverse Event|0|||
131747400|NCT01392378|474352515|FG002|Infant Series|Adverse Event|0|||
131747401|NCT01392378|474352516|FG003|Infant Series|Adverse Event|1|||
131747402|NCT01392378|474352517|FG004|Infant Series|Adverse Event|0|||
131747403|NCT01392378|474352513|FG000|Infant Series|Lost to Follow-up|0|||
131747404|NCT01392378|474352514|FG001|Infant Series|Lost to Follow-up|0|||
131747405|NCT01392378|474352515|FG002|Infant Series|Lost to Follow-up|0|||
131747406|NCT01392378|474352516|FG003|Infant Series|Lost to Follow-up|1|||
131747407|NCT01392378|474352517|FG004|Infant Series|Lost to Follow-up|0|||
131747408|NCT01392378|474352513|FG000|Infant Series|Protocol Violation|0|||
131747409|NCT01392378|474352514|FG001|Infant Series|Protocol Violation|1|||
131747410|NCT01392378|474352515|FG002|Infant Series|Protocol Violation|0|||
131808628|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808629|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808630|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808631|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808632|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808633|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808634|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808635|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131808636|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
131808637|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
131808638|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
131808639|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
131906367|NCT00641056|474945140|FG001|Overall Study|Physician Decision|1|||
131906368|NCT00641056|474945139|FG000|Overall Study|Protocol Violation|2|||
131906369|NCT00641056|474945140|FG001|Overall Study|Protocol Violation|0|||
131906370|NCT00641056|474945139|FG000|Overall Study|Entry Criteria Not Met|3|||
131906371|NCT00641056|474945140|FG001|Overall Study|Entry Criteria Not Met|0|||
131906372|NCT00641056|474945139|FG000|Overall Study|Subject Decision|6|||
131449044|NCT01285557|473272774|FG000|Overall Study|Sponsor Study Termination|23|||
131449045|NCT01285557|473272775|FG001|Overall Study|Sponsor Study Termination|13|||
131449046|NCT01285557|473272774|FG000|Overall Study|Randomized but not treated|1|||
131747411|NCT01392378|474352516|FG003|Infant Series|Protocol Violation|0|||
131747412|NCT01392378|474352517|FG004|Infant Series|Protocol Violation|0|||
131449047|NCT01285557|473272775|FG001|Overall Study|Randomized but not treated|1|||
131449048|NCT01285557|473272774|FG000|Overall Study|Study follow-up ongoing|28|||
131449049|NCT01285557|473272775|FG001|Overall Study|Study follow-up ongoing|14|||
131747413|NCT01392378|474352513|FG000|Infant Series|Withdrawal by Parent|4|||
131747414|NCT01392378|474352514|FG001|Infant Series|Withdrawal by Parent|1|||
131747415|NCT01392378|474352515|FG002|Infant Series|Withdrawal by Parent|0|||
131747416|NCT01392378|474352516|FG003|Infant Series|Withdrawal by Parent|0|||
131747417|NCT01392378|474352517|FG004|Infant Series|Withdrawal by Parent|0|||
131747418|NCT01392378|474352513|FG000|After Infant Series|Lost to Follow-up|0|||
131747419|NCT01392378|474352514|FG001|After Infant Series|Lost to Follow-up|0|||
131747420|NCT01392378|474352515|FG002|After Infant Series|Lost to Follow-up|1|||
131747421|NCT01392378|474352516|FG003|After Infant Series|Lost to Follow-up|0|||
131747422|NCT01392378|474352517|FG004|After Infant Series|Lost to Follow-up|0|||
131747423|NCT01392378|474352513|FG000|After Infant Series|Withdrawal by Parent|0|||
131747424|NCT01392378|474352514|FG001|After Infant Series|Withdrawal by Parent|1|||
131808640|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808641|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808642|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808643|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808644|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808645|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808646|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808647|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808648|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808649|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808650|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808651|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808652|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808653|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808654|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808655|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808656|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
131808657|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131747425|NCT01392378|474352515|FG002|After Infant Series|Withdrawal by Parent|1|||
131747426|NCT01392378|474352516|FG003|After Infant Series|Withdrawal by Parent|0|||
131747427|NCT01392378|474352517|FG004|After Infant Series|Withdrawal by Parent|1|||
131747428|NCT01392378|474352513|FG000|Toddler Dose|Lost to Follow-up|0|||
131747429|NCT01392378|474352514|FG001|Toddler Dose|Lost to Follow-up|0|||
131747430|NCT01392378|474352515|FG002|Toddler Dose|Lost to Follow-up|0|||
131747431|NCT01392378|474352516|FG003|Toddler Dose|Lost to Follow-up|1|||
131747432|NCT01392378|474352517|FG004|Toddler Dose|Lost to Follow-up|0|||
131747433|NCT01392378|474352513|FG000|Toddler Dose|Withdrawal by Parent|0|||
131747434|NCT01392378|474352514|FG001|Toddler Dose|Withdrawal by Parent|1|||
131747435|NCT01392378|474352515|FG002|Toddler Dose|Withdrawal by Parent|0|||
131747436|NCT01392378|474352516|FG003|Toddler Dose|Withdrawal by Parent|1|||
131747437|NCT01392378|474352517|FG004|Toddler Dose|Withdrawal by Parent|1|||
131747438|NCT02322411|474352522|FG000|Overall Study|Lost to Follow-up|4|||
131747439|NCT02322411|474352523|FG001|Overall Study|Lost to Follow-up|7|||
131747440|NCT02322411|474352522|FG000|Overall Study|Withdrawal by Subject|1|||
131747441|NCT02322411|474352523|FG001|Overall Study|Withdrawal by Subject|0|||
131747442|NCT00788697|474352524|FG000|Overall Study|No study drug administered|12|||
131747443|NCT00788697|474352524|FG000|Overall Study|Training Patients|74|||
131747444|NCT00788697|474352524|FG000|Overall Study|no truth standard procedure available|5|||
131747445|NCT00788697|474352524|FG000|Overall Study|Technically inadequate truth standard|1|||
131747446|NCT00788697|474352524|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
131747447|NCT01998880|474352529|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
131747448|NCT01998880|474352530|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
131747449|NCT01998880|474352529|FG000|Overall Study|Disease Progression|1|||
131747450|NCT01998880|474352530|FG001|Overall Study|Disease Progression|8|||
131747451|NCT01998880|474352529|FG000|Overall Study|Withdrew Consent|2|||
131747452|NCT01998880|474352530|FG001|Overall Study|Withdrew Consent|1|||
131747453|NCT01998880|474352529|FG000|Overall Study|Death|3|||
131747454|NCT01998880|474352530|FG001|Overall Study|Death|6|||
131747455|NCT01998880|474352529|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131747456|NCT01998880|474352530|FG001|Overall Study|Insufficient Therapeutic Response|5|||
131747457|NCT01998880|474352529|FG000|Overall Study|Administrative/Other|1|||
131747458|NCT01998880|474352530|FG001|Overall Study|Administrative/Other|1|||
131747459|NCT01998880|474352529|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
131747460|NCT01998880|474352530|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131747461|NCT01998880|474352529|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
131747462|NCT01998880|474352530|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131747463|NCT01998880|474352529|FG000|Overall Study|Did Not Receive Treatment|3|||
131747464|NCT01998880|474352530|FG001|Overall Study|Did Not Receive Treatment|2|||
131747465|NCT02671461|474352531|FG000|Treatment|Adverse Event|0|||
131747466|NCT02671461|474352532|FG001|Treatment|Adverse Event|0|||
131449050|NCT01285557|473272774|FG000|Overall Study|Sponsor Decision|2|||
131906373|NCT00641056|474945140|FG001|Overall Study|Subject Decision|19|||
131906374|NCT00641056|474945139|FG000|Overall Study|Sponsor Decision|1|||
131906375|NCT00641056|474945140|FG001|Overall Study|Sponsor Decision|2|||
131906376|NCT00896493|474945141|FG000|Overall Study|Early disease relapse|3|||
131906377|NCT00883181|474945143|FG000|Overall Study|Hematological Adverse Event|26|||
131906378|NCT00883181|474945143|FG000|Overall Study|Non-hematological Adverse Event|55|||
131906379|NCT00883181|474945143|FG000|Overall Study|Disease Progression|94|||
131906380|NCT00883181|474945143|FG000|Overall Study|Administrative Reason|24|||
131906381|NCT00883181|474945143|FG000|Overall Study|Withdrawal by Subject|4|||
131906382|NCT00883181|474945143|FG000|Overall Study|Death|31|||
131906383|NCT00883181|474945143|FG000|Overall Study|Other|38|||
131906384|NCT00883181|474945143|FG000|Overall Study|Protocol Deviation|3|||
131906385|NCT00883181|474945143|FG000|Overall Study|Noncompliance|3|||
131906386|NCT01587885|474945146|FG000|Treatment Period 1|Failure to Return|0|||
131906387|NCT01587885|474945147|FG001|Treatment Period 1|Failure to Return|1|||
131906388|NCT01587885|474945146|FG000|Treatment Period 1|Protocol Violation|0|||
131906389|NCT01587885|474945147|FG001|Treatment Period 1|Protocol Violation|2|||
131906390|NCT02062437|474945148|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
131906391|NCT02062437|474945148|FG000|Overall Study|Patient not available for the 2y visit|18|||
131906392|NCT02062437|474945148|FG000|Overall Study|Death|2|||
131906393|NCT02062437|474945148|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
131906394|NCT00386334|474945157|FG000|Double Blind Period|Adverse Event|9|||
131906395|NCT00386334|474945158|FG001|Double Blind Period|Adverse Event|14|||
131906396|NCT00386334|474945157|FG000|Double Blind Period|Protocol Violation|1|||
131906397|NCT00386334|474945158|FG001|Double Blind Period|Protocol Violation|1|||
131906398|NCT00386334|474945157|FG000|Double Blind Period|Withdrawal by Subject|9|||
131906399|NCT00386334|474945158|FG001|Double Blind Period|Withdrawal by Subject|13|||
131906400|NCT00386334|474945157|FG000|Double Blind Period|Lack of Efficacy|20|||
131747467|NCT02671461|474352533|FG002|Treatment|Adverse Event|1|||
131747468|NCT02671461|474352531|FG000|Treatment|Administrative Reason by Sponsor|1|||
131747469|NCT02671461|474352532|FG001|Treatment|Administrative Reason by Sponsor|3|||
131747470|NCT02671461|474352533|FG002|Treatment|Administrative Reason by Sponsor|4|||
131747471|NCT02671461|474352531|FG000|Treatment|Randomized, not treated|1|||
131747472|NCT02671461|474352532|FG001|Treatment|Randomized, not treated|0|||
131747473|NCT02671461|474352533|FG002|Treatment|Randomized, not treated|0|||
131747474|NCT02671461|474352531|FG000|Follow-up|Withdrawal by Subject|1|||
131747475|NCT02671461|474352532|FG001|Follow-up|Withdrawal by Subject|0|||
131747476|NCT02671461|474352533|FG002|Follow-up|Withdrawal by Subject|0|||
131747477|NCT02671461|474352531|FG000|Follow-up|Lost to Follow-up|0|||
131747478|NCT02671461|474352532|FG001|Follow-up|Lost to Follow-up|0|||
131747479|NCT02671461|474352533|FG002|Follow-up|Lost to Follow-up|1|||
131747480|NCT02671461|474352531|FG000|Follow-up|Administrative Reason by Sponsor|0|||
131747481|NCT02671461|474352532|FG001|Follow-up|Administrative Reason by Sponsor|1|||
131747482|NCT02671461|474352533|FG002|Follow-up|Administrative Reason by Sponsor|0|||
131747483|NCT01412060|474352534|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
131747484|NCT01412060|474352535|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
131747485|NCT01412060|474352536|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
131747486|NCT01412060|474352534|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
131747487|NCT01412060|474352535|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
131747488|NCT01412060|474352536|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
131747489|NCT01412060|474352534|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
131808658|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
131808659|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
131808660|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
131808661|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808662|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808663|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808664|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808665|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808666|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808667|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131747490|NCT01412060|474352535|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
131747491|NCT01412060|474352536|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
131747492|NCT01412060|474352534|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
131808668|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808669|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808670|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808671|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808672|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131449051|NCT01285557|473272775|FG001|Overall Study|Sponsor Decision|1|||
131449052|NCT03467750|473272776|FG000|Overall Study|Surgery canceled|1|||
131449053|NCT03467750|473272777|FG001|Overall Study|Surgery canceled|0|||
131449054|NCT03467750|473272776|FG000|Overall Study|Protocol Violation|1|||
131747493|NCT01412060|474352535|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
131747494|NCT01412060|474352536|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
131747495|NCT01412060|474352534|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
131747496|NCT01412060|474352535|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
131808673|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808674|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808675|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808676|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808677|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808678|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131808679|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
131747497|NCT01412060|474352536|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
131747498|NCT01412060|474352534|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
131747499|NCT01412060|474352535|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
131747500|NCT01412060|474352536|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
131747501|NCT01412060|474352534|FG000|Period Between RIP and SP|Adverse Event|4|||
131747502|NCT01412060|474352535|FG001|Period Between RIP and SP|Adverse Event|0|||
131747503|NCT01412060|474352536|FG002|Period Between RIP and SP|Adverse Event|0|||
131747504|NCT01412060|474352534|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
131747505|NCT01412060|474352535|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
131747506|NCT01412060|474352536|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
131747507|NCT01412060|474352534|FG000|Period Between RIP and SP|Protocol Violation|2|||
131747508|NCT01412060|474352535|FG001|Period Between RIP and SP|Protocol Violation|0|||
131747509|NCT01412060|474352536|FG002|Period Between RIP and SP|Protocol Violation|0|||
131747510|NCT01412060|474352534|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
131747511|NCT01412060|474352535|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
131747512|NCT01412060|474352536|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
131747513|NCT01412060|474352534|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
131747514|NCT01412060|474352535|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
131449055|NCT03467750|473272777|FG001|Overall Study|Protocol Violation|1|||
131747515|NCT01412060|474352536|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
131747516|NCT01412060|474352534|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
131747517|NCT01412060|474352535|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
131747518|NCT01412060|474352536|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
131747519|NCT01412060|474352534|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
131747520|NCT01412060|474352535|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
131747521|NCT01412060|474352536|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
131747522|NCT01412060|474352534|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
131747523|NCT01412060|474352535|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
131747524|NCT01412060|474352536|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
131747525|NCT01412060|474352534|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
131747526|NCT01412060|474352535|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
131747527|NCT01412060|474352536|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
131747528|NCT01412060|474352534|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
131747529|NCT01412060|474352535|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
131747530|NCT01412060|474352536|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
131747531|NCT01412060|474352534|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
131747532|NCT01412060|474352535|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
131747533|NCT01412060|474352536|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
131747534|NCT01412060|474352534|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
131747535|NCT01412060|474352535|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
131747536|NCT01412060|474352536|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
131747537|NCT01412060|474352534|FG000|Period Between SP and DBP|Protocol Violation|2|||
131747538|NCT01412060|474352535|FG001|Period Between SP and DBP|Protocol Violation|0|||
131747539|NCT01412060|474352536|FG002|Period Between SP and DBP|Protocol Violation|0|||
131747540|NCT01412060|474352534|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
131747541|NCT01412060|474352535|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
131747542|NCT01412060|474352536|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
131747543|NCT01412060|474352534|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
131747544|NCT01412060|474352535|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
131747545|NCT01412060|474352536|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
131747546|NCT01412060|474352534|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
131747547|NCT01412060|474352535|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
131747548|NCT01412060|474352536|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
131747549|NCT01412060|474352534|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
131747550|NCT01412060|474352535|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
131747551|NCT01412060|474352536|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
131747552|NCT01412060|474352534|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
131747553|NCT01412060|474352535|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
131747554|NCT01412060|474352536|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
131747555|NCT01412060|474352534|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
131747556|NCT01412060|474352535|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
131747557|NCT01412060|474352536|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
131808680|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
131808681|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
131808682|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808683|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808684|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808685|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808686|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808687|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808688|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808689|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808690|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808691|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808692|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808693|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808694|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808695|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808696|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808697|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808698|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
131808699|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808700|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
131808701|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
131808702|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
131808703|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808704|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808705|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808706|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808707|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808708|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808709|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808710|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808711|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808712|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131906401|NCT00386334|474945158|FG001|Double Blind Period|Lack of Efficacy|11|||
131906402|NCT00386334|474945157|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
131808713|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131747558|NCT01412060|474352534|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
131747559|NCT01412060|474352535|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
131747560|NCT01412060|474352536|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
131747561|NCT01412060|474352534|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
131747562|NCT01412060|474352535|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
131747563|NCT01412060|474352536|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
131747564|NCT01412060|474352534|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
131747565|NCT01412060|474352535|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
131747566|NCT01412060|474352536|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
131747567|NCT01412060|474352534|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
131747568|NCT01412060|474352535|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
131449056|NCT03467750|473272776|FG000|Overall Study|Withdrawal by Subject|0|||
131747569|NCT01412060|474352536|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
131747570|NCT00004732|474352538|FG000|Overall Study|Withdrawal by Subject|36|||
131449057|NCT03467750|473272777|FG001|Overall Study|Withdrawal by Subject|1|||
131449058|NCT04721977|473272780|FG000|Overall Study|Death|15|||
131449059|NCT04721977|473272780|FG000|Overall Study|Ongoing|51|||
131449060|NCT00753506|473274778|FG000|Overall Study|Withdrawal by Subject|4|||
131449061|NCT00753506|473274779|FG001|Overall Study|Withdrawal by Subject|1|||
131449062|NCT00753506|473274778|FG000|Overall Study|Lost to Follow-up|2|||
131449063|NCT00753506|473274779|FG001|Overall Study|Lost to Follow-up|0|||
131449064|NCT00753506|473274778|FG000|Overall Study|Other reason|1|||
131449065|NCT00753506|473274779|FG001|Overall Study|Other reason|1|||
131449066|NCT01600716|473274780|FG000|Overall Study|Other Reasons|3|||
131449067|NCT01600716|473274781|FG001|Overall Study|Other Reasons|1|||
131449068|NCT01600716|473274780|FG000|Overall Study|Personal Reasons|0|||
131449069|NCT01600716|473274781|FG001|Overall Study|Personal Reasons|2|||
131449070|NCT01600716|473274780|FG000|Overall Study|Lost to Follow-up|0|||
131449071|NCT01600716|473274781|FG001|Overall Study|Lost to Follow-up|2|||
131449072|NCT01600716|473274780|FG000|Overall Study|Pregnancy|1|||
131449073|NCT01600716|473274781|FG001|Overall Study|Pregnancy|0|||
131449074|NCT01600716|473274780|FG000|Overall Study|Lack of Efficacy|2|||
131449075|NCT01600716|473274781|FG001|Overall Study|Lack of Efficacy|1|||
131449076|NCT01600716|473274780|FG000|Overall Study|Adverse Event|1|||
131449077|NCT01600716|473274781|FG001|Overall Study|Adverse Event|1|||
131449078|NCT03038880|473274784|FG000|Overall Study|Death|1|||
131449079|NCT03038880|473274785|FG001|Overall Study|Death|2|||
131449080|NCT03038880|473274786|FG002|Overall Study|Death|0|||
131449081|NCT03038880|473274784|FG000|Overall Study|Physician Decision|2|||
131449082|NCT03038880|473274785|FG001|Overall Study|Physician Decision|1|||
131449083|NCT03038880|473274786|FG002|Overall Study|Physician Decision|0|||
131449084|NCT00602472|473274787|FG000|Overall Study|Adverse Event|5|||
131449085|NCT00602472|473274788|FG001|Overall Study|Adverse Event|23|||
131449086|NCT00602472|473274787|FG000|Overall Study|Protocol Violation|4|||
131449087|NCT00602472|473274788|FG001|Overall Study|Protocol Violation|19|||
131449088|NCT00602472|473274787|FG000|Overall Study|Withdrawal by Subject|8|||
131449089|NCT00602472|473274788|FG001|Overall Study|Withdrawal by Subject|14|||
131449090|NCT00602472|473274787|FG000|Overall Study|Other incl. lack of efficacy|4|||
131449091|NCT00602472|473274788|FG001|Overall Study|Other incl. lack of efficacy|2|||
131449092|NCT02803580|473274789|FG000|Overall Study|Death|13|||
131449093|NCT02803580|473274789|FG000|Overall Study|Lost to Follow-up|19|||
131449094|NCT02803580|473274789|FG000|Overall Study|Withdrawal by Subject|3|||
131449095|NCT02803580|473274789|FG000|Overall Study|Inclusion in clinical trial|1|||
131449096|NCT02054104|473274794|FG000|Overall Study|Did not want to continue due to college classes|1|||
131449097|NCT02054104|473274795|FG001|Overall Study|Did not want to continue due to college classes|0|||
131449098|NCT02054104|473274794|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
131747571|NCT00004732|474352539|FG001|Overall Study|Withdrawal by Subject|64|||
131747572|NCT00004732|474352538|FG000|Overall Study|Lost to Follow-up|33|||
131747573|NCT00004732|474352539|FG001|Overall Study|Lost to Follow-up|47|||
131747574|NCT02674685|474352543|FG000|Overall Study|Withdrawal by Subject|4|||
131747575|NCT02713789|474352545|FG000|Overall Study|Lost to Follow-up|0|||
131747576|NCT02713789|474352546|FG001|Overall Study|Lost to Follow-up|1|||
131747577|NCT02713789|474352547|FG002|Overall Study|Lost to Follow-up|1|||
131747578|NCT02661464|474352548|FG000|Overall Study|Lost to Follow-up|28|||
131747579|NCT02661464|474352549|FG001|Overall Study|Lost to Follow-up|0|||
131747580|NCT02661464|474352550|FG002|Overall Study|Lost to Follow-up|0|||
131747581|NCT02661464|474352551|FG003|Overall Study|Lost to Follow-up|0|||
131747582|NCT02661464|474352548|FG000|Overall Study|Withdrawal by Subject|3|||
131747583|NCT02661464|474352549|FG001|Overall Study|Withdrawal by Subject|1|||
131747584|NCT02661464|474352550|FG002|Overall Study|Withdrawal by Subject|0|||
131747585|NCT02661464|474352551|FG003|Overall Study|Withdrawal by Subject|0|||
131747586|NCT02661464|474352548|FG000|Overall Study|Participants terminated prematurely|288|||
131747587|NCT02661464|474352549|FG001|Overall Study|Participants terminated prematurely|52|||
131747588|NCT02661464|474352550|FG002|Overall Study|Participants terminated prematurely|1|||
131747589|NCT02661464|474352551|FG003|Overall Study|Participants terminated prematurely|1|||
131808714|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808715|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131449099|NCT02054104|473274795|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
131449100|NCT02054104|473274794|FG000|Overall Study|No evidence of immunologic response|2|||
131449101|NCT02054104|473274795|FG001|Overall Study|No evidence of immunologic response|2|||
131449102|NCT02054104|473274794|FG000|Overall Study|Disease Progression On Study|4|||
131449103|NCT02054104|473274795|FG001|Overall Study|Disease Progression On Study|5|||
131449104|NCT02054104|473274794|FG000|Overall Study|Diagnosis of lymphoma|0|||
131449105|NCT02054104|473274795|FG001|Overall Study|Diagnosis of lymphoma|1|||
131449106|NCT02054104|473274794|FG000|Overall Study|Inconclusive response|0|||
131449107|NCT02054104|473274795|FG001|Overall Study|Inconclusive response|1|||
131449108|NCT03926611|473274797|FG000|Overall Study|Adverse Event|0|||
131449109|NCT03926611|473274798|FG001|Overall Study|Adverse Event|0|||
131449110|NCT03926611|473274799|FG002|Overall Study|Adverse Event|0|||
131449111|NCT03926611|473274800|FG003|Overall Study|Adverse Event|3|||
131449112|NCT03926611|473274801|FG004|Overall Study|Adverse Event|1|||
131449113|NCT03926611|473274802|FG005|Overall Study|Adverse Event|3|||
131449114|NCT03926611|473274803|FG006|Overall Study|Adverse Event|0|||
131449115|NCT03926611|473274797|FG000|Overall Study|Lack of Efficacy|1|||
131449116|NCT03926611|473274798|FG001|Overall Study|Lack of Efficacy|2|||
131449117|NCT03926611|473274799|FG002|Overall Study|Lack of Efficacy|0|||
131449118|NCT03926611|473274800|FG003|Overall Study|Lack of Efficacy|0|||
131449119|NCT03926611|473274801|FG004|Overall Study|Lack of Efficacy|1|||
131449120|NCT03926611|473274802|FG005|Overall Study|Lack of Efficacy|0|||
131449121|NCT03926611|473274803|FG006|Overall Study|Lack of Efficacy|1|||
131449122|NCT03926611|473274797|FG000|Overall Study|Physician Decision|0|||
131449123|NCT03926611|473274798|FG001|Overall Study|Physician Decision|0|||
131808716|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808717|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808718|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808719|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
131808720|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808721|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
131808722|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
131808723|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
131808724|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808725|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131449124|NCT03926611|473274799|FG002|Overall Study|Physician Decision|0|||
131449125|NCT03926611|473274800|FG003|Overall Study|Physician Decision|0|||
131449126|NCT03926611|473274801|FG004|Overall Study|Physician Decision|0|||
131747590|NCT02661464|474352548|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
131747591|NCT02661464|474352549|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
131747592|NCT02661464|474352550|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
131747593|NCT02661464|474352551|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
131747594|NCT00903370|474352552|FG000|Overall Study|Death|13|||
131747595|NCT00903370|474352553|FG001|Overall Study|Death|10|||
131747596|NCT00903370|474352552|FG000|Overall Study|Withdrawal by Subject|9|||
131747597|NCT00903370|474352553|FG001|Overall Study|Withdrawal by Subject|6|||
131747598|NCT00903370|474352552|FG000|Overall Study|Lost to Follow-up|6|||
131747599|NCT00903370|474352553|FG001|Overall Study|Lost to Follow-up|8|||
131747600|NCT00367432|474352554|FG000|First Period (16 Weeks)|Adverse Event|6|||
131747601|NCT00367432|474352555|FG001|First Period (16 Weeks)|Adverse Event|0|||
131747602|NCT00367432|474352554|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
131747603|NCT00367432|474352555|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
131747604|NCT00367432|474352554|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
131747605|NCT00367432|474352555|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
131747606|NCT00367432|474352554|FG000|First Period (16 Weeks)|Other Reason|2|||
131747607|NCT00367432|474352555|FG001|First Period (16 Weeks)|Other Reason|0|||
131747608|NCT00367432|474352554|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
131747609|NCT00367432|474352555|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
131747610|NCT00367432|474352554|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
131747611|NCT00367432|474352555|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
131747612|NCT00367432|474352554|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
131747613|NCT00367432|474352555|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
131747614|NCT00367432|474352554|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
131747615|NCT00367432|474352555|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
131747616|NCT00367432|474352554|FG000|Second Period (up to 54 Months)|Other Reason|6|||
131747617|NCT00367432|474352555|FG001|Second Period (up to 54 Months)|Other Reason|2|||
131747618|NCT00014911|474352556|FG000|Overall Study|Adverse Event|1|||
131747619|NCT00014911|474352556|FG000|Overall Study|Lost to Follow-up|1|||
131747620|NCT00014911|474352556|FG000|Overall Study|Withdrawal by Subject|6|||
131747621|NCT00014911|474352556|FG000|Overall Study|Unknown Reasons|2|||
131747622|NCT00014911|474352556|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
131747623|NCT03148756|474352560|FG000|Overall Study|Study Terminated|0|||
131747624|NCT03148756|474352561|FG001|Overall Study|Study Terminated|1|||
131747625|NCT05567393|474352562|FG000|Overall Study|Voluntary Withdrawal|0|||
131747626|NCT05567393|474352563|FG001|Overall Study|Voluntary Withdrawal|0|||
131747627|NCT05567393|474352564|FG002|Overall Study|Voluntary Withdrawal|0|||
131747628|NCT05567393|474352565|FG003|Overall Study|Voluntary Withdrawal|0|||
131747629|NCT05567393|474352566|FG004|Overall Study|Voluntary Withdrawal|0|||
131747630|NCT05567393|474352567|FG005|Overall Study|Voluntary Withdrawal|0|||
131747631|NCT05567393|474352568|FG006|Overall Study|Voluntary Withdrawal|0|||
131747632|NCT05567393|474352569|FG007|Overall Study|Voluntary Withdrawal|0|||
131747633|NCT05567393|474352570|FG008|Overall Study|Voluntary Withdrawal|0|||
131747634|NCT05567393|474352571|FG009|Overall Study|Voluntary Withdrawal|0|||
131747635|NCT05567393|474352572|FG010|Overall Study|Voluntary Withdrawal|0|||
131747636|NCT05567393|474352573|FG011|Overall Study|Voluntary Withdrawal|0|||
131747637|NCT05567393|474352574|FG012|Overall Study|Voluntary Withdrawal|0|||
131747638|NCT05567393|474352575|FG013|Overall Study|Voluntary Withdrawal|1|||
131747639|NCT05567393|474352576|FG014|Overall Study|Voluntary Withdrawal|0|||
131747640|NCT05567393|474352577|FG015|Overall Study|Voluntary Withdrawal|0|||
131747641|NCT05567393|474352578|FG016|Overall Study|Voluntary Withdrawal|0|||
131747642|NCT05567393|474352579|FG017|Overall Study|Voluntary Withdrawal|0|||
131747643|NCT01924299|474352582|FG000|Period 2|Withdrawal by Subject|1|||
131747644|NCT01924299|474352583|FG001|Period 2|Withdrawal by Subject|0|||
131747645|NCT01924299|474352582|FG000|Period 2|Adverse Event|0|||
131747646|NCT01924299|474352583|FG001|Period 2|Adverse Event|1|||
131747647|NCT04199793|474352584|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
131747648|NCT04199793|474352585|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
131747649|NCT04199793|474352584|FG000|Overall Study|Withdrawal by Subject|1|||
131747650|NCT04199793|474352585|FG001|Overall Study|Withdrawal by Subject|1|||
131747651|NCT03820726|474352590|FG000|Overall Study|Other than listed|23|||
131747652|NCT03820726|474352590|FG000|Overall Study|Withdrawal by Subject|37|||
131747653|NCT03820726|474352590|FG000|Overall Study|Lost to Follow-up|3|||
131747654|NCT03820726|474352590|FG000|Overall Study|Protocol deviation|1|||
131747655|NCT03820726|474352590|FG000|Overall Study|Adverse Event|146|||
131747656|NCT03820726|474352590|FG000|Overall Study|Not treated|1|||
131747657|NCT00345540|474352594|FG000|Overall Study|Withdrawal by Subject|1|||
131747658|NCT01406652|474352595|FG000|Overall Study|Lost-to-follow-up|3|||
131747659|NCT01406652|474352596|FG001|Overall Study|Lost-to-follow-up|4|||
131747660|NCT01406652|474352595|FG000|Overall Study|Withdrawal by Subject|2|||
131906403|NCT00386334|474945158|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
131747661|NCT01406652|474352596|FG001|Overall Study|Withdrawal by Subject|2|||
131747662|NCT01406652|474352595|FG000|Overall Study|Insufficient follow-up|5|||
131747663|NCT01406652|474352596|FG001|Overall Study|Insufficient follow-up|4|||
131747664|NCT01406652|474352595|FG000|Overall Study|Infection not sure|10|||
131747665|NCT01406652|474352596|FG001|Overall Study|Infection not sure|10|||
131747666|NCT00141037|474352597|FG000|Overall Study|Physician Decision|1|||
131747667|NCT00141037|474352598|FG001|Overall Study|Physician Decision|2|||
131747668|NCT00141037|474352597|FG000|Overall Study|Lost to Follow-up|3|||
131747669|NCT00141037|474352598|FG001|Overall Study|Lost to Follow-up|1|||
131747670|NCT00141037|474352597|FG000|Overall Study|Protocol Violation|0|||
131747671|NCT00141037|474352598|FG001|Overall Study|Protocol Violation|2|||
131747672|NCT00141037|474352597|FG000|Overall Study|Withdrawal by Subject|2|||
131747673|NCT00141037|474352598|FG001|Overall Study|Withdrawal by Subject|1|||
131747674|NCT00141037|474352597|FG000|Overall Study|Other|0|||
131747675|NCT00141037|474352598|FG001|Overall Study|Other|1|||
131747676|NCT00141037|474352597|FG000|Overall Study|Moved from area|1|||
131747677|NCT00141037|474352598|FG001|Overall Study|Moved from area|7|||
131747678|NCT00141037|474352597|FG000|Overall Study|Graft Failure|3|||
131747679|NCT00141037|474352598|FG001|Overall Study|Graft Failure|4|||
131747680|NCT04179786|474352599|FG000|Overall Study|Withdrawal by Subject|8|||
131747681|NCT01938001|474352600|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
131747682|NCT01938001|474352601|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
131747683|NCT01938001|474352600|FG000|Pre-Treatment|Death|1|||
131747684|NCT01938001|474352601|FG001|Pre-Treatment|Death|0|||
131747685|NCT01938001|474352600|FG000|Treatment|Death|2|||
131747686|NCT01938001|474352601|FG001|Treatment|Death|0|||
131808726|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808727|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808728|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808729|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808730|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808731|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808732|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808733|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131747687|NCT01938001|474352600|FG000|Treatment|Adverse Event|14|||
131747688|NCT01938001|474352601|FG001|Treatment|Adverse Event|8|||
131747689|NCT01938001|474352600|FG000|Treatment|Progressive Disease|21|||
131747690|NCT01938001|474352601|FG001|Treatment|Progressive Disease|54|||
131747691|NCT01938001|474352600|FG000|Treatment|Withdrawal by Subject|13|||
131747692|NCT01938001|474352601|FG001|Treatment|Withdrawal by Subject|7|||
131747693|NCT01938001|474352600|FG000|Treatment|Other reasons|2|||
131747694|NCT01938001|474352601|FG001|Treatment|Other reasons|1|||
131747695|NCT03310580|474352602|FG000|Overall Study|Adverse Event|0|||
131747696|NCT03310580|474352603|FG001|Overall Study|Adverse Event|1|||
131747697|NCT03310580|474352604|FG002|Overall Study|Adverse Event|0|||
131747698|NCT04186663|474352607|FG000|Overall Study|Lost to Follow-up|1|||
131747699|NCT04186663|474352607|FG000|Overall Study|Unable to complete blood draw|3|||
131747700|NCT01184846|474352608|FG000|Overall Study|Adverse Event|2|||
131747701|NCT01184846|474352608|FG000|Overall Study|Insufficient response|1|||
131747702|NCT00355134|474354127|FG000|Core Phase|Withdrawal by Subject|35|||
131747703|NCT00355134|474354128|FG001|Core Phase|Withdrawal by Subject|24|||
131747704|NCT00355134|474354129|FG002|Core Phase|Withdrawal by Subject|35|||
131747705|NCT00355134|474354130|FG003|Core Phase|Withdrawal by Subject|0|||
131747706|NCT00355134|474354131|FG004|Core Phase|Withdrawal by Subject|0|||
131747707|NCT00355134|474354127|FG000|Core Phase|Adverse Event|28|||
131747708|NCT00355134|474354128|FG001|Core Phase|Adverse Event|22|||
131747709|NCT00355134|474354129|FG002|Core Phase|Adverse Event|16|||
131747710|NCT00355134|474354130|FG003|Core Phase|Adverse Event|0|||
131747711|NCT00355134|474354131|FG004|Core Phase|Adverse Event|0|||
131747712|NCT00355134|474354127|FG000|Core Phase|Lost to Follow-up|17|||
131747713|NCT00355134|474354128|FG001|Core Phase|Lost to Follow-up|13|||
131747714|NCT00355134|474354129|FG002|Core Phase|Lost to Follow-up|21|||
131747715|NCT00355134|474354130|FG003|Core Phase|Lost to Follow-up|0|||
131747716|NCT00355134|474354131|FG004|Core Phase|Lost to Follow-up|0|||
131747717|NCT00355134|474354127|FG000|Core Phase|Abnormal laboratory value(s)|19|||
131747718|NCT00355134|474354128|FG001|Core Phase|Abnormal laboratory value(s)|14|||
131747719|NCT00355134|474354129|FG002|Core Phase|Abnormal laboratory value(s)|2|||
131747720|NCT00355134|474354130|FG003|Core Phase|Abnormal laboratory value(s)|0|||
131747721|NCT00355134|474354131|FG004|Core Phase|Abnormal laboratory value(s)|0|||
131808734|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131747722|NCT00355134|474354127|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
131747723|NCT00355134|474354128|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
131747724|NCT00355134|474354129|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
131747725|NCT00355134|474354130|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
131747726|NCT00355134|474354131|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
131747727|NCT00355134|474354127|FG000|Core Phase|Administrative problems|5|||
131747728|NCT00355134|474354128|FG001|Core Phase|Administrative problems|3|||
131747729|NCT00355134|474354129|FG002|Core Phase|Administrative problems|5|||
131747730|NCT00355134|474354130|FG003|Core Phase|Administrative problems|0|||
131747731|NCT00355134|474354131|FG004|Core Phase|Administrative problems|0|||
131747732|NCT00355134|474354127|FG000|Core Phase|Protocol Violation|3|||
131747733|NCT00355134|474354128|FG001|Core Phase|Protocol Violation|2|||
131747734|NCT00355134|474354129|FG002|Core Phase|Protocol Violation|2|||
131747735|NCT00355134|474354130|FG003|Core Phase|Protocol Violation|0|||
131747736|NCT00355134|474354131|FG004|Core Phase|Protocol Violation|0|||
131808735|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808736|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808737|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808738|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131747737|NCT00355134|474354127|FG000|Core Phase|Abnormal test procedure result(s)|1|||
131747738|NCT00355134|474354128|FG001|Core Phase|Abnormal test procedure result(s)|2|||
131747739|NCT00355134|474354129|FG002|Core Phase|Abnormal test procedure result(s)|1|||
131747740|NCT00355134|474354130|FG003|Core Phase|Abnormal test procedure result(s)|0|||
131747741|NCT00355134|474354131|FG004|Core Phase|Abnormal test procedure result(s)|0|||
131747742|NCT00355134|474354127|FG000|Core Phase|Condition no longer requires study drug|1|||
131747743|NCT00355134|474354128|FG001|Core Phase|Condition no longer requires study drug|0|||
131747744|NCT00355134|474354129|FG002|Core Phase|Condition no longer requires study drug|1|||
131747745|NCT00355134|474354130|FG003|Core Phase|Condition no longer requires study drug|0|||
131747746|NCT00355134|474354131|FG004|Core Phase|Condition no longer requires study drug|0|||
131808739|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808740|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
131808741|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808742|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131747747|NCT00355134|474354127|FG000|Extension Phase|Withdrawal by Subject|7|||
131906404|NCT00386334|474945157|FG000|Double Blind Period|Other|3|||
131747748|NCT00355134|474354128|FG001|Extension Phase|Withdrawal by Subject|11|||
131747749|NCT00355134|474354129|FG002|Extension Phase|Withdrawal by Subject|0|||
131747750|NCT00355134|474354130|FG003|Extension Phase|Withdrawal by Subject|7|||
131747751|NCT00355134|474354131|FG004|Extension Phase|Withdrawal by Subject|5|||
131747752|NCT00355134|474354127|FG000|Extension Phase|Adverse Event|13|||
131747753|NCT00355134|474354128|FG001|Extension Phase|Adverse Event|9|||
131747754|NCT00355134|474354129|FG002|Extension Phase|Adverse Event|0|||
131747755|NCT00355134|474354130|FG003|Extension Phase|Adverse Event|3|||
131747756|NCT00355134|474354131|FG004|Extension Phase|Adverse Event|5|||
131747757|NCT00355134|474354127|FG000|Extension Phase|Lost to Follow-up|2|||
131747758|NCT00355134|474354128|FG001|Extension Phase|Lost to Follow-up|6|||
131747759|NCT00355134|474354129|FG002|Extension Phase|Lost to Follow-up|0|||
131747760|NCT00355134|474354130|FG003|Extension Phase|Lost to Follow-up|2|||
131747761|NCT00355134|474354131|FG004|Extension Phase|Lost to Follow-up|4|||
131747762|NCT00355134|474354127|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
131747763|NCT00355134|474354128|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
131747764|NCT00355134|474354129|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
131747765|NCT00355134|474354130|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
131747766|NCT00355134|474354131|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
131747767|NCT00355134|474354127|FG000|Extension Phase|Administrative problems|2|||
131747768|NCT00355134|474354128|FG001|Extension Phase|Administrative problems|4|||
131747769|NCT00355134|474354129|FG002|Extension Phase|Administrative problems|0|||
131747770|NCT00355134|474354130|FG003|Extension Phase|Administrative problems|1|||
131747771|NCT00355134|474354131|FG004|Extension Phase|Administrative problems|1|||
131747772|NCT00355134|474354127|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
131747773|NCT00355134|474354128|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
131747774|NCT00355134|474354129|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
131747775|NCT00355134|474354130|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
131747776|NCT00355134|474354131|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
131747777|NCT00355134|474354127|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
131747778|NCT00355134|474354128|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
131747779|NCT00355134|474354129|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
131747780|NCT00355134|474354130|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
131747781|NCT00355134|474354131|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
131747782|NCT00355134|474354127|FG000|Extension Phase|Protocol Violation|0|||
131747783|NCT00355134|474354128|FG001|Extension Phase|Protocol Violation|0|||
131747784|NCT00355134|474354129|FG002|Extension Phase|Protocol Violation|0|||
131747785|NCT00355134|474354130|FG003|Extension Phase|Protocol Violation|1|||
131747786|NCT00355134|474354131|FG004|Extension Phase|Protocol Violation|0|||
131747787|NCT02848313|474354132|FG000|Overall Study|Adverse Event|1|||
131747788|NCT02848313|474354133|FG001|Overall Study|Adverse Event|2|||
131747789|NCT02848313|474354132|FG000|Overall Study|Lack of Efficacy|0|||
131747790|NCT02848313|474354133|FG001|Overall Study|Lack of Efficacy|1|||
131747791|NCT02848313|474354132|FG000|Overall Study|Withdrawal by Subject|1|||
131747792|NCT02848313|474354133|FG001|Overall Study|Withdrawal by Subject|1|||
131747793|NCT02848313|474354132|FG000|Overall Study|Lost to follow up|1|||
131747794|NCT02848313|474354133|FG001|Overall Study|Lost to follow up|0|||
131747795|NCT01544478|474354134|FG000|Overall Study|Adverse Event|1|||
131747796|NCT01544478|474354134|FG000|Overall Study|Death|1|||
131747797|NCT01544478|474354134|FG000|Overall Study|Lost to Follow-up|48|||
131747798|NCT01544478|474354134|FG000|Overall Study|Physician Decision|15|||
131747799|NCT01544478|474354134|FG000|Overall Study|Pregnancy|1|||
131747800|NCT01544478|474354134|FG000|Overall Study|Withdrawal by Subject|52|||
131747801|NCT03382262|474354138|FG000|Overall Study|Physician Decision|0|||
131747802|NCT03382262|474354139|FG001|Overall Study|Physician Decision|0|||
131747803|NCT03382262|474354140|FG002|Overall Study|Physician Decision|1|||
131747804|NCT03382262|474354141|FG003|Overall Study|Physician Decision|0|||
131747805|NCT03382262|474354138|FG000|Overall Study|Withdrawal by Subject|0|||
131747806|NCT03382262|474354139|FG001|Overall Study|Withdrawal by Subject|0|||
131747807|NCT03382262|474354140|FG002|Overall Study|Withdrawal by Subject|0|||
131747808|NCT03382262|474354141|FG003|Overall Study|Withdrawal by Subject|1|||
131747809|NCT02038790|474354143|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
131808743|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
131808744|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131808745|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131747810|NCT02038790|474354144|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
131747811|NCT00294684|474354153|FG000|Overall Study|Lost to Follow-up|5|||
131747812|NCT00294684|474354154|FG001|Overall Study|Lost to Follow-up|8|||
131747813|NCT03379376|474354156|FG000|Overall Study|Lost to Follow-up|2|||
131747814|NCT03379376|474354156|FG000|Overall Study|Did not wish to complete follow up|1|||
131747815|NCT03379376|474354156|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
131747816|NCT03379376|474354156|FG000|Overall Study|Death|1|||
131747817|NCT00753623|474354157|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
131747818|NCT00753623|474354158|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
131747819|NCT00753623|474354157|FG000|Phase I (14 Days)|Physician Decision|1|||
131906405|NCT00386334|474945158|FG001|Double Blind Period|Other|3|||
131449127|NCT03926611|473274802|FG005|Overall Study|Physician Decision|1|||
131449128|NCT03926611|473274803|FG006|Overall Study|Physician Decision|0|||
131449129|NCT03926611|473274797|FG000|Overall Study|Protocol Violation|1|||
131449130|NCT03926611|473274798|FG001|Overall Study|Protocol Violation|0|||
131449131|NCT03926611|473274799|FG002|Overall Study|Protocol Violation|0|||
131449132|NCT03926611|473274800|FG003|Overall Study|Protocol Violation|1|||
131449133|NCT03926611|473274801|FG004|Overall Study|Protocol Violation|1|||
131449134|NCT03926611|473274802|FG005|Overall Study|Protocol Violation|1|||
131449135|NCT03926611|473274803|FG006|Overall Study|Protocol Violation|1|||
131449136|NCT03926611|473274797|FG000|Overall Study|Technical problems|0|||
131449137|NCT03926611|473274798|FG001|Overall Study|Technical problems|0|||
131449138|NCT03926611|473274799|FG002|Overall Study|Technical problems|0|||
131449139|NCT03926611|473274800|FG003|Overall Study|Technical problems|0|||
131449140|NCT03926611|473274801|FG004|Overall Study|Technical problems|0|||
131449141|NCT03926611|473274802|FG005|Overall Study|Technical problems|1|||
131449142|NCT03926611|473274803|FG006|Overall Study|Technical problems|0|||
131449143|NCT03926611|473274797|FG000|Overall Study|Withdrawal by Subject|1|||
131449144|NCT03926611|473274798|FG001|Overall Study|Withdrawal by Subject|1|||
131449145|NCT03926611|473274799|FG002|Overall Study|Withdrawal by Subject|1|||
131449146|NCT03926611|473274800|FG003|Overall Study|Withdrawal by Subject|0|||
131449147|NCT03926611|473274801|FG004|Overall Study|Withdrawal by Subject|0|||
131449148|NCT03926611|473274802|FG005|Overall Study|Withdrawal by Subject|1|||
131449149|NCT03926611|473274803|FG006|Overall Study|Withdrawal by Subject|3|||
131449150|NCT03926611|473274797|FG000|Overall Study|Covid-19 pandemic|0|||
131449151|NCT03926611|473274798|FG001|Overall Study|Covid-19 pandemic|0|||
131449152|NCT03926611|473274799|FG002|Overall Study|Covid-19 pandemic|1|||
131449153|NCT03926611|473274800|FG003|Overall Study|Covid-19 pandemic|0|||
131449154|NCT03926611|473274801|FG004|Overall Study|Covid-19 pandemic|1|||
131449155|NCT03926611|473274802|FG005|Overall Study|Covid-19 pandemic|2|||
131449156|NCT03926611|473274803|FG006|Overall Study|Covid-19 pandemic|0|||
131449157|NCT00084136|473274804|FG000|PI Comparison|Death|10|||
131449158|NCT00084136|473274805|FG001|PI Comparison|Death|9|||
131449159|NCT00084136|473274806|FG002|PI Comparison|Death|0|||
131449160|NCT00084136|473274804|FG000|PI Comparison|Lost to Follow-up|11|||
131449161|NCT00084136|473274805|FG001|PI Comparison|Lost to Follow-up|8|||
131449162|NCT00084136|473274806|FG002|PI Comparison|Lost to Follow-up|0|||
131449163|NCT00084136|473274804|FG000|PI Comparison|Withdrawal by Subject|33|||
131449164|NCT00084136|473274805|FG001|PI Comparison|Withdrawal by Subject|30|||
131449165|NCT00084136|473274806|FG002|PI Comparison|Withdrawal by Subject|0|||
131449166|NCT00084136|473274804|FG000|PI Comparison|Clinic site closed|1|||
131449167|NCT00084136|473274805|FG001|PI Comparison|Clinic site closed|0|||
131449168|NCT00084136|473274806|FG002|PI Comparison|Clinic site closed|0|||
131449169|NCT00084136|473274804|FG000|NRTI Comparison|Death|20|||
131449170|NCT00084136|473274805|FG001|NRTI Comparison|Death|0|||
131449171|NCT00084136|473274806|FG002|NRTI Comparison|Death|18|||
131449172|NCT00084136|473274804|FG000|NRTI Comparison|Lost to Follow-up|14|||
131449173|NCT00084136|473274805|FG001|NRTI Comparison|Lost to Follow-up|0|||
131449174|NCT00084136|473274806|FG002|NRTI Comparison|Lost to Follow-up|12|||
131449175|NCT00084136|473274804|FG000|NRTI Comparison|Withdrawal by Subject|54|||
131449176|NCT00084136|473274805|FG001|NRTI Comparison|Withdrawal by Subject|0|||
131449177|NCT00084136|473274806|FG002|NRTI Comparison|Withdrawal by Subject|38|||
131449178|NCT00084136|473274804|FG000|NRTI Comparison|Clinic site closed|12|||
131449179|NCT00084136|473274805|FG001|NRTI Comparison|Clinic site closed|0|||
131449180|NCT00084136|473274806|FG002|NRTI Comparison|Clinic site closed|14|||
131747820|NCT00753623|474354158|FG001|Phase I (14 Days)|Physician Decision|2|||
131747821|NCT00753623|474354157|FG000|Phase I (14 Days)|Adverse Event|0|||
131747822|NCT00753623|474354158|FG001|Phase I (14 Days)|Adverse Event|1|||
131747823|NCT00753623|474354157|FG000|Washout (7 Days)|Physician Decision|1|||
131747824|NCT00753623|474354158|FG001|Washout (7 Days)|Physician Decision|0|||
131747825|NCT00753623|474354157|FG000|Phase II (14 Days)|Physician Decision|0|||
131747826|NCT00753623|474354158|FG001|Phase II (14 Days)|Physician Decision|1|||
131747827|NCT02559713|474354162|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
131747828|NCT00889681|474354167|FG000|Overall Study|Not meeting qualification Criteria|2|||
131747829|NCT00889681|474354167|FG000|Overall Study|Insurance disapproval|1|||
131747830|NCT01686958|474354168|FG000|Overall Study|Withdrawal by Subject|1|||
131747831|NCT01151540|474354173|FG000|Overall Study|Other|2|||
131747832|NCT01151540|474354173|FG000|Overall Study|Adverse event, non-fatal|4|||
131449181|NCT00084136|473274804|FG000|NRTI Comparison|Not reason above|1|||
131449182|NCT00084136|473274805|FG001|NRTI Comparison|Not reason above|0|||
131449183|NCT00084136|473274806|FG002|NRTI Comparison|Not reason above|0|||
131449184|NCT00836693|473274809|FG000|Overall Study|Adverse Event|4|||
131449185|NCT00836693|473274810|FG001|Overall Study|Adverse Event|1|||
131449186|NCT00836693|473274809|FG000|Overall Study|Sponsor Decision|0|||
131449187|NCT00836693|473274810|FG001|Overall Study|Sponsor Decision|1|||
131449188|NCT00836693|473274809|FG000|Overall Study|Physician Decision|2|||
131449189|NCT00836693|473274810|FG001|Overall Study|Physician Decision|0|||
131449190|NCT00836693|473274809|FG000|Overall Study|Withdrawal by Subject|9|||
131449191|NCT00836693|473274810|FG001|Overall Study|Withdrawal by Subject|4|||
131449192|NCT00836693|473274809|FG000|Overall Study|Protocol Violation|1|||
131747833|NCT01151540|474354173|FG000|Overall Study|Withdrawal by Subject|7|||
131747834|NCT02261883|474354174|FG000|Overall Study|Death|3|||
131747835|NCT02261883|474354175|FG001|Overall Study|Death|2|||
131747836|NCT02261883|474354174|FG000|Overall Study|Physician Decision|1|||
131747837|NCT02261883|474354175|FG001|Overall Study|Physician Decision|0|||
131747838|NCT02261883|474354174|FG000|Overall Study|Protocol Violation|1|||
131747839|NCT02261883|474354175|FG001|Overall Study|Protocol Violation|0|||
131747840|NCT02261883|474354174|FG000|Overall Study|Withdrawal by Subject|0|||
131747841|NCT02261883|474354175|FG001|Overall Study|Withdrawal by Subject|1|||
131747842|NCT02261883|474354174|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
131747843|NCT02261883|474354175|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
131747844|NCT02177175|474354178|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
131747845|NCT02177175|474354179|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
131747846|NCT00628758|474354180|FG000|Overall Study|Adverse Event|2|||
131747847|NCT00628758|474354181|FG001|Overall Study|Adverse Event|3|||
131747848|NCT00628758|474354180|FG000|Overall Study|Withdrawal by Subject|6|||
131747849|NCT00628758|474354181|FG001|Overall Study|Withdrawal by Subject|3|||
131747850|NCT00628758|474354180|FG000|Overall Study|Death|1|||
131747851|NCT00628758|474354181|FG001|Overall Study|Death|0|||
131747852|NCT00628758|474354180|FG000|Overall Study|Protocol Violation|5|||
131747853|NCT00628758|474354181|FG001|Overall Study|Protocol Violation|1|||
131747854|NCT00628758|474354180|FG000|Overall Study|Lost to Follow-up|25|||
131747855|NCT00628758|474354181|FG001|Overall Study|Lost to Follow-up|31|||
131747856|NCT00628758|474354180|FG000|Overall Study|Pregnancy|2|||
131747857|NCT00628758|474354181|FG001|Overall Study|Pregnancy|2|||
131747858|NCT00628758|474354180|FG000|Overall Study|Investigator Moved|3|||
131747859|NCT00628758|474354181|FG001|Overall Study|Investigator Moved|0|||
131747860|NCT00628758|474354180|FG000|Overall Study|Treatment Failure|0|||
131747861|NCT00628758|474354181|FG001|Overall Study|Treatment Failure|2|||
131747862|NCT00637377|474354182|FG000|Overall Study|Adverse Event|2|||
131747863|NCT00637377|474354183|FG001|Overall Study|Adverse Event|6|||
131747864|NCT00637377|474354184|FG002|Overall Study|Adverse Event|8|||
131747865|NCT00637377|474354185|FG003|Overall Study|Adverse Event|9|||
131747866|NCT00637377|474354182|FG000|Overall Study|Death|1|||
131747867|NCT00637377|474354183|FG001|Overall Study|Death|3|||
131747868|NCT00637377|474354184|FG002|Overall Study|Death|2|||
131747869|NCT00637377|474354185|FG003|Overall Study|Death|1|||
131747870|NCT00637377|474354182|FG000|Overall Study|Lack of Efficacy|0|||
131747871|NCT00637377|474354183|FG001|Overall Study|Lack of Efficacy|0|||
131747872|NCT00637377|474354184|FG002|Overall Study|Lack of Efficacy|1|||
131747873|NCT00637377|474354185|FG003|Overall Study|Lack of Efficacy|1|||
131747874|NCT00637377|474354182|FG000|Overall Study|Lost to Follow-up|4|||
131747875|NCT00637377|474354183|FG001|Overall Study|Lost to Follow-up|1|||
131747876|NCT00637377|474354184|FG002|Overall Study|Lost to Follow-up|2|||
131747877|NCT00637377|474354185|FG003|Overall Study|Lost to Follow-up|2|||
131747878|NCT00637377|474354182|FG000|Overall Study|Protocol Violation|2|||
131747879|NCT00637377|474354183|FG001|Overall Study|Protocol Violation|1|||
131747880|NCT00637377|474354184|FG002|Overall Study|Protocol Violation|1|||
131747881|NCT00637377|474354185|FG003|Overall Study|Protocol Violation|0|||
131747882|NCT00637377|474354182|FG000|Overall Study|Withdrawal by Subject|11|||
131747883|NCT00637377|474354183|FG001|Overall Study|Withdrawal by Subject|15|||
131747884|NCT00637377|474354184|FG002|Overall Study|Withdrawal by Subject|13|||
131747885|NCT00637377|474354185|FG003|Overall Study|Withdrawal by Subject|11|||
131747886|NCT00637377|474354182|FG000|Overall Study|Other (no further information available)|7|||
131747887|NCT00637377|474354183|FG001|Overall Study|Other (no further information available)|6|||
131747888|NCT00637377|474354184|FG002|Overall Study|Other (no further information available)|10|||
131747889|NCT00637377|474354185|FG003|Overall Study|Other (no further information available)|5|||
131747890|NCT00994162|474354187|FG000|Overall Study|Withdrawal by Subject|1|||
131747891|NCT00994162|474354187|FG000|Overall Study|Lost to Follow-up|2|||
131747892|NCT00994162|474354187|FG000|Overall Study|Product Complaint|1|||
131747893|NCT00994162|474354187|FG000|Overall Study|Poor Compliance|5|||
131747894|NCT00994162|474354187|FG000|Overall Study|Lack of Response|3|||
131747895|NCT00994162|474354187|FG000|Overall Study|Discharged from Hospital|4|||
131747896|NCT00994162|474354187|FG000|Overall Study|Death|2|||
131747897|NCT00994162|474354187|FG000|Overall Study|Care Transferred to Another Physician|2|||
131747898|NCT00994162|474354187|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
131747899|NCT00994162|474354187|FG000|Overall Study|Physician Decision|2|||
131747900|NCT00994162|474354187|FG000|Overall Study|Surrounding Wound Erythematous|1|||
131747901|NCT00994162|474354187|FG000|Overall Study|Machine Losing Vaccum|1|||
131747902|NCT00994162|474354187|FG000|Overall Study|Patient Lived Too Far Away|1|||
131747903|NCT00994162|474354187|FG000|Overall Study|Above Knee Amputation|1|||
131747904|NCT00994162|474354187|FG000|Overall Study|Reason Not Reported By Site|1|||
131747905|NCT01425749|474354188|FG000|Overall Study|progression of melanoma|0|||
131747906|NCT01425749|474354189|FG001|Overall Study|progression of melanoma|1|||
131747907|NCT01293084|474354190|FG000|Overall Study|Physician Decision|3|||
131747908|NCT01293084|474354190|FG000|Overall Study|Withdrawal by Subject|2|||
131747909|NCT02983799|474354191|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
131747910|NCT02983799|474354192|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
131747911|NCT02983799|474354193|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
131747912|NCT02983799|474354194|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
131747913|NCT02983799|474354195|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
131808746|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808747|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808748|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808749|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808750|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131747914|NCT02983799|474354191|FG000|Overall Study|Death|20|||
131747915|NCT02983799|474354192|FG001|Overall Study|Death|5|||
131747916|NCT02983799|474354193|FG002|Overall Study|Death|23|||
131747917|NCT02983799|474354194|FG003|Overall Study|Death|47|||
131747918|NCT02983799|474354195|FG004|Overall Study|Death|7|||
131747919|NCT02983799|474354191|FG000|Overall Study|Withdrawal by Subject|1|||
131747920|NCT02983799|474354192|FG001|Overall Study|Withdrawal by Subject|0|||
131747921|NCT02983799|474354193|FG002|Overall Study|Withdrawal by Subject|3|||
131747922|NCT02983799|474354194|FG003|Overall Study|Withdrawal by Subject|4|||
131747923|NCT02983799|474354195|FG004|Overall Study|Withdrawal by Subject|1|||
131747924|NCT02983799|474354191|FG000|Overall Study|Protocol Violation|0|||
131747925|NCT02983799|474354192|FG001|Overall Study|Protocol Violation|1|||
131747926|NCT02983799|474354193|FG002|Overall Study|Protocol Violation|0|||
131747927|NCT02983799|474354194|FG003|Overall Study|Protocol Violation|0|||
131747928|NCT02983799|474354195|FG004|Overall Study|Protocol Violation|1|||
131747929|NCT02983799|474354191|FG000|Overall Study|Lost to Follow-up|1|||
131747930|NCT02983799|474354192|FG001|Overall Study|Lost to Follow-up|0|||
131808751|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808752|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808753|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808754|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808755|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808756|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808757|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808758|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808759|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131747931|NCT02983799|474354193|FG002|Overall Study|Lost to Follow-up|1|||
131747932|NCT02983799|474354194|FG003|Overall Study|Lost to Follow-up|0|||
131747933|NCT02983799|474354195|FG004|Overall Study|Lost to Follow-up|0|||
131747934|NCT02762708|474354203|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
131747935|NCT02762708|474354204|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
131747936|NCT02762708|474354205|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
131747937|NCT02762708|474354206|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
131747938|NCT01468701|474354211|FG000|Overall Study|Not eligible|91|||
131747939|NCT01468701|474354212|FG001|Overall Study|Not eligible|140|||
131747940|NCT01468701|474354213|FG002|Overall Study|Not eligible|29|||
131747941|NCT01468701|474354214|FG003|Overall Study|Not eligible|12|||
131747942|NCT01468701|474354215|FG004|Overall Study|Not eligible|22|||
131747943|NCT01468701|474354216|FG005|Overall Study|Not eligible|2|||
131747944|NCT01468701|474354217|FG006|Overall Study|Not eligible|39|||
131747945|NCT01468701|474354218|FG007|Overall Study|Not eligible|1|||
131747946|NCT01468701|474354219|FG008|Overall Study|Not eligible|40|||
131747947|NCT01468701|474354220|FG009|Overall Study|Not eligible|126|||
131808760|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808761|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
131808762|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131747948|NCT01468701|474354221|FG010|Overall Study|Not eligible|39|||
131747949|NCT01468701|474354222|FG011|Overall Study|Not eligible|33|||
131747950|NCT01468701|474354223|FG012|Overall Study|Not eligible|1|||
131747951|NCT01468701|474354224|FG013|Overall Study|Not eligible|19|||
131808763|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808764|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
131808765|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
131808766|NCT01597245|474582931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808767|NCT01597245|474582932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808768|NCT01597245|474582933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808769|NCT01597245|474582934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808770|NCT01597245|474582935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131747952|NCT01468701|474354225|FG014|Overall Study|Not eligible|1|||
131747953|NCT01468701|474354226|FG015|Overall Study|Not eligible|32|||
131747954|NCT01468701|474354227|FG016|Overall Study|Not eligible|0|||
131747955|NCT01468701|474354211|FG000|Overall Study|Lost to Follow-up|306|||
131747956|NCT01468701|474354212|FG001|Overall Study|Lost to Follow-up|0|||
131747957|NCT01468701|474354213|FG002|Overall Study|Lost to Follow-up|0|||
131747958|NCT01468701|474354214|FG003|Overall Study|Lost to Follow-up|0|||
131747959|NCT01468701|474354215|FG004|Overall Study|Lost to Follow-up|0|||
131747960|NCT01468701|474354216|FG005|Overall Study|Lost to Follow-up|0|||
131747961|NCT01468701|474354217|FG006|Overall Study|Lost to Follow-up|0|||
131747962|NCT01468701|474354218|FG007|Overall Study|Lost to Follow-up|0|||
131747963|NCT01468701|474354219|FG008|Overall Study|Lost to Follow-up|215|||
131747964|NCT01468701|474354220|FG009|Overall Study|Lost to Follow-up|309|||
131747965|NCT01468701|474354221|FG010|Overall Study|Lost to Follow-up|224|||
131747966|NCT01468701|474354222|FG011|Overall Study|Lost to Follow-up|212|||
131747967|NCT01468701|474354223|FG012|Overall Study|Lost to Follow-up|11|||
131747968|NCT01468701|474354224|FG013|Overall Study|Lost to Follow-up|164|||
131747969|NCT01468701|474354225|FG014|Overall Study|Lost to Follow-up|17|||
131747970|NCT01468701|474354226|FG015|Overall Study|Lost to Follow-up|127|||
131747971|NCT01468701|474354227|FG016|Overall Study|Lost to Follow-up|1|||
131747972|NCT01468701|474354211|FG000|Overall Study|Withdrawal by Subject|165|||
131747973|NCT01468701|474354212|FG001|Overall Study|Withdrawal by Subject|0|||
131747974|NCT01468701|474354213|FG002|Overall Study|Withdrawal by Subject|0|||
131747975|NCT01468701|474354214|FG003|Overall Study|Withdrawal by Subject|0|||
131747976|NCT01468701|474354215|FG004|Overall Study|Withdrawal by Subject|0|||
131747977|NCT01468701|474354216|FG005|Overall Study|Withdrawal by Subject|0|||
131747978|NCT01468701|474354217|FG006|Overall Study|Withdrawal by Subject|0|||
131747979|NCT01468701|474354218|FG007|Overall Study|Withdrawal by Subject|0|||
131747980|NCT01468701|474354219|FG008|Overall Study|Withdrawal by Subject|83|||
131747981|NCT01468701|474354220|FG009|Overall Study|Withdrawal by Subject|88|||
131747982|NCT01468701|474354221|FG010|Overall Study|Withdrawal by Subject|100|||
131747983|NCT01468701|474354222|FG011|Overall Study|Withdrawal by Subject|114|||
131747984|NCT01468701|474354223|FG012|Overall Study|Withdrawal by Subject|9|||
131747985|NCT01468701|474354224|FG013|Overall Study|Withdrawal by Subject|47|||
131747986|NCT01468701|474354225|FG014|Overall Study|Withdrawal by Subject|6|||
131747987|NCT01468701|474354226|FG015|Overall Study|Withdrawal by Subject|31|||
131747988|NCT01468701|474354227|FG016|Overall Study|Withdrawal by Subject|0|||
131747989|NCT01468701|474354211|FG000|Overall Study|Other reasons than listed|437|||
131747990|NCT01468701|474354212|FG001|Overall Study|Other reasons than listed|0|||
131747991|NCT01468701|474354213|FG002|Overall Study|Other reasons than listed|0|||
131747992|NCT01468701|474354214|FG003|Overall Study|Other reasons than listed|0|||
131747993|NCT01468701|474354215|FG004|Overall Study|Other reasons than listed|0|||
131747994|NCT01468701|474354216|FG005|Overall Study|Other reasons than listed|0|||
131747995|NCT01468701|474354217|FG006|Overall Study|Other reasons than listed|0|||
131747996|NCT01468701|474354218|FG007|Overall Study|Other reasons than listed|0|||
131747997|NCT01468701|474354219|FG008|Overall Study|Other reasons than listed|318|||
131747998|NCT01468701|474354220|FG009|Overall Study|Other reasons than listed|658|||
131747999|NCT01468701|474354221|FG010|Overall Study|Other reasons than listed|433|||
131748000|NCT01468701|474354222|FG011|Overall Study|Other reasons than listed|504|||
131748001|NCT01468701|474354223|FG012|Overall Study|Other reasons than listed|28|||
131748002|NCT01468701|474354224|FG013|Overall Study|Other reasons than listed|239|||
131748003|NCT01468701|474354225|FG014|Overall Study|Other reasons than listed|39|||
131748004|NCT01468701|474354226|FG015|Overall Study|Other reasons than listed|172|||
131748005|NCT01468701|474354227|FG016|Overall Study|Other reasons than listed|0|||
131748006|NCT01468701|474354211|FG000|Overall Study|No end of study case report form|0|||
131748007|NCT01468701|474354212|FG001|Overall Study|No end of study case report form|0|||
131748008|NCT01468701|474354213|FG002|Overall Study|No end of study case report form|0|||
131748009|NCT01468701|474354214|FG003|Overall Study|No end of study case report form|0|||
131748010|NCT01468701|474354215|FG004|Overall Study|No end of study case report form|0|||
131748011|NCT01468701|474354216|FG005|Overall Study|No end of study case report form|0|||
131748012|NCT01468701|474354217|FG006|Overall Study|No end of study case report form|0|||
131748013|NCT01468701|474354218|FG007|Overall Study|No end of study case report form|0|||
131748014|NCT01468701|474354219|FG008|Overall Study|No end of study case report form|4|||
131748015|NCT01468701|474354220|FG009|Overall Study|No end of study case report form|1|||
131748016|NCT01468701|474354221|FG010|Overall Study|No end of study case report form|2|||
131748017|NCT01468701|474354222|FG011|Overall Study|No end of study case report form|3|||
131748018|NCT01468701|474354223|FG012|Overall Study|No end of study case report form|0|||
131748019|NCT01468701|474354224|FG013|Overall Study|No end of study case report form|1|||
131748020|NCT01468701|474354225|FG014|Overall Study|No end of study case report form|0|||
131748021|NCT01468701|474354226|FG015|Overall Study|No end of study case report form|0|||
131748022|NCT01468701|474354227|FG016|Overall Study|No end of study case report form|0|||
131748023|NCT01468701|474354211|FG000|Overall Study|Not being followed up|0|||
131748024|NCT01468701|474354212|FG001|Overall Study|Not being followed up|4963|||
131748025|NCT01468701|474354213|FG002|Overall Study|Not being followed up|1755|||
131748026|NCT01468701|474354214|FG003|Overall Study|Not being followed up|703|||
131748027|NCT01468701|474354215|FG004|Overall Study|Not being followed up|1714|||
131748028|NCT01468701|474354216|FG005|Overall Study|Not being followed up|126|||
131748029|NCT01468701|474354217|FG006|Overall Study|Not being followed up|1170|||
131748030|NCT01468701|474354218|FG007|Overall Study|Not being followed up|4|||
131748031|NCT01468701|474354219|FG008|Overall Study|Not being followed up|0|||
131748032|NCT01468701|474354220|FG009|Overall Study|Not being followed up|0|||
131748033|NCT01468701|474354221|FG010|Overall Study|Not being followed up|0|||
131748034|NCT01468701|474354222|FG011|Overall Study|Not being followed up|0|||
131748035|NCT01468701|474354223|FG012|Overall Study|Not being followed up|0|||
131748036|NCT01468701|474354224|FG013|Overall Study|Not being followed up|0|||
131748037|NCT01468701|474354225|FG014|Overall Study|Not being followed up|0|||
131748038|NCT01468701|474354226|FG015|Overall Study|Not being followed up|0|||
131748039|NCT01468701|474354227|FG016|Overall Study|Not being followed up|0|||
131748040|NCT01068717|474354228|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
131748041|NCT01068717|474354229|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
131748042|NCT01068717|474354230|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
131748043|NCT01068717|474354231|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
131748044|NCT01822223|474354232|FG000|Overall Study|Death|0|||
131748045|NCT01822223|474354233|FG001|Overall Study|Death|1|||
131748046|NCT00719862|474354244|FG000|Overall Study|Adverse Event|1|||
131906406|NCT00386334|474945157|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
131906407|NCT00386334|474945158|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
131906408|NCT00902577|474945159|FG000|Overall Study|Withdrawal by Subject|6|||
131906409|NCT00902577|474945159|FG000|Overall Study|FMISO production failure|2|||
131748047|NCT00719862|474354245|FG001|Overall Study|Adverse Event|2|||
131748048|NCT00719862|474354244|FG000|Overall Study|Lack of Efficacy|3|||
131748049|NCT00719862|474354245|FG001|Overall Study|Lack of Efficacy|0|||
131748050|NCT00719862|474354244|FG000|Overall Study|Non-Compliance|1|||
131748051|NCT00719862|474354245|FG001|Overall Study|Non-Compliance|0|||
131748052|NCT00719862|474354244|FG000|Overall Study|Withdrawal by Subject|1|||
131748053|NCT00719862|474354245|FG001|Overall Study|Withdrawal by Subject|0|||
131748054|NCT00719862|474354244|FG000|Overall Study|Lost to Follow-up|0|||
131748055|NCT00719862|474354245|FG001|Overall Study|Lost to Follow-up|1|||
131748056|NCT00719862|474354244|FG000|Overall Study|Other|2|||
131748057|NCT00719862|474354245|FG001|Overall Study|Other|3|||
131748058|NCT00892957|474354246|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
131748059|NCT00892957|474354247|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
131748060|NCT00892957|474354246|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
131748061|NCT00892957|474354247|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
131748062|NCT01999946|474354248|FG000|Overall Study|Participant not released from jail|2|||
131748063|NCT01999946|474354249|FG001|Overall Study|Participant not released from jail|2|||
131748064|NCT01999946|474354250|FG002|Overall Study|Participant not released from jail|0|||
131748065|NCT01999946|474354248|FG000|Overall Study|Not included in primary outcome analysis|0|||
131748066|NCT01999946|474354249|FG001|Overall Study|Not included in primary outcome analysis|0|||
131748067|NCT01999946|474354250|FG002|Overall Study|Not included in primary outcome analysis|79|||
131748068|NCT04876599|474354253|FG000|Overall Study|Missed|2|||
131748069|NCT04876599|474354254|FG001|Overall Study|Missed|0|||
131748070|NCT04876599|474354253|FG000|Overall Study|Declined|2|||
131748071|NCT04876599|474354254|FG001|Overall Study|Declined|3|||
131748072|NCT03175562|474354255|FG000|Overall Study|Adverse Event|1|||
131748073|NCT03175562|474354255|FG000|Overall Study|Lost to Follow-up|3|||
131748074|NCT03175562|474354255|FG000|Overall Study|Withdrawal by Subject|7|||
131748075|NCT03175562|474354255|FG000|Overall Study|Other (Not Specified)|5|||
131748076|NCT02146833|474354256|FG000|Overall Study|Death|10|||
131748077|NCT02146833|474354256|FG000|Overall Study|No longer consented to study treatment|1|||
131748078|NCT03700736|474354261|FG000|Overall Study|Pregnancy|1|||
131748079|NCT03700736|474354262|FG001|Overall Study|Pregnancy|1|||
131748080|NCT03700736|474354261|FG000|Overall Study|Withdrawal by Subject|2|||
131748081|NCT03700736|474354262|FG001|Overall Study|Withdrawal by Subject|6|||
131748082|NCT00642018|474354263|FG000|Overall Study|Adverse Event|11|||
131748083|NCT00642018|474354264|FG001|Overall Study|Adverse Event|36|||
131748084|NCT00642018|474354263|FG000|Overall Study|Withdrawal by Subject|4|||
131748085|NCT00642018|474354264|FG001|Overall Study|Withdrawal by Subject|10|||
131748086|NCT00642018|474354263|FG000|Overall Study|Progressive Disease|13|||
131748087|NCT00642018|474354264|FG001|Overall Study|Progressive Disease|18|||
131748088|NCT00642018|474354263|FG000|Overall Study|Physician Decision|0|||
131748089|NCT00642018|474354264|FG001|Overall Study|Physician Decision|10|||
131748090|NCT00642018|474354263|FG000|Overall Study|Protocol Violation|0|||
131748091|NCT00642018|474354264|FG001|Overall Study|Protocol Violation|1|||
131748092|NCT00642018|474354263|FG000|Overall Study|Death|0|||
131748093|NCT00642018|474354264|FG001|Overall Study|Death|3|||
131748094|NCT00642018|474354263|FG000|Overall Study|Entry Criteria Not Met|0|||
131748095|NCT00642018|474354264|FG001|Overall Study|Entry Criteria Not Met|1|||
131748096|NCT04126031|474354267|FG000|Part A|Withdrawal by Subject|0|||
131748097|NCT04126031|474354268|FG001|Part A|Withdrawal by Subject|0|||
131748098|NCT04126031|474354269|FG002|Part A|Withdrawal by Subject|1|||
131748099|NCT04126031|474354270|FG003|Part A|Withdrawal by Subject|0|||
131748100|NCT04126031|474354271|FG004|Part A|Withdrawal by Subject|0|||
131748101|NCT04126031|474354272|FG005|Part A|Withdrawal by Subject|0|||
131748102|NCT04126031|474354267|FG000|Part A|Other|1|||
131748103|NCT04126031|474354268|FG001|Part A|Other|0|||
131748104|NCT04126031|474354269|FG002|Part A|Other|0|||
131748105|NCT04126031|474354270|FG003|Part A|Other|0|||
131748106|NCT04126031|474354271|FG004|Part A|Other|0|||
131748107|NCT04126031|474354272|FG005|Part A|Other|0|||
131748108|NCT04126031|474354267|FG000|Part B|Adverse Event|0|||
131748109|NCT04126031|474354268|FG001|Part B|Adverse Event|0|||
131748110|NCT04126031|474354269|FG002|Part B|Adverse Event|0|||
131748111|NCT04126031|474354270|FG003|Part B|Adverse Event|0|||
131748112|NCT04126031|474354271|FG004|Part B|Adverse Event|0|||
131748113|NCT04126031|474354272|FG005|Part B|Adverse Event|2|||
131748114|NCT04126031|474354267|FG000|Part B|Pre-existing hypertransaminasemia|0|||
131748115|NCT04126031|474354268|FG001|Part B|Pre-existing hypertransaminasemia|0|||
131748116|NCT04126031|474354269|FG002|Part B|Pre-existing hypertransaminasemia|0|||
131748117|NCT04126031|474354270|FG003|Part B|Pre-existing hypertransaminasemia|0|||
131748118|NCT04126031|474354271|FG004|Part B|Pre-existing hypertransaminasemia|1|||
131748119|NCT04126031|474354272|FG005|Part B|Pre-existing hypertransaminasemia|0|||
131748120|NCT00131664|474354273|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
131748121|NCT00131664|474354274|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
131748122|NCT00131664|474354275|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
131748123|NCT00131664|474354276|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
131748124|NCT00131664|474354277|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
131748125|NCT00131664|474354278|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
131748126|NCT00131664|474354273|FG000|First Period (First 6 Months)|Death|0|||
131748127|NCT00131664|474354274|FG001|First Period (First 6 Months)|Death|1|||
131748128|NCT00131664|474354275|FG002|First Period (First 6 Months)|Death|0|||
131748129|NCT00131664|474354276|FG003|First Period (First 6 Months)|Death|0|||
131748130|NCT00131664|474354277|FG004|First Period (First 6 Months)|Death|0|||
131748131|NCT00131664|474354278|FG005|First Period (First 6 Months)|Death|0|||
131748132|NCT00131664|474354273|FG000|First Period (First 6 Months)|Protocol Violation|2|||
131748133|NCT00131664|474354274|FG001|First Period (First 6 Months)|Protocol Violation|2|||
131748134|NCT00131664|474354275|FG002|First Period (First 6 Months)|Protocol Violation|1|||
131748135|NCT00131664|474354276|FG003|First Period (First 6 Months)|Protocol Violation|0|||
131748136|NCT00131664|474354277|FG004|First Period (First 6 Months)|Protocol Violation|0|||
131748137|NCT00131664|474354278|FG005|First Period (First 6 Months)|Protocol Violation|0|||
131748138|NCT00131664|474354273|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
131748139|NCT00131664|474354274|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
131748140|NCT00131664|474354275|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
131748141|NCT00131664|474354276|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
131748142|NCT00131664|474354277|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
131748143|NCT00131664|474354278|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
131748144|NCT00131664|474354273|FG000|First Period (First 6 Months)|Adverse Event|9|||
131748145|NCT00131664|474354274|FG001|First Period (First 6 Months)|Adverse Event|4|||
131748146|NCT00131664|474354275|FG002|First Period (First 6 Months)|Adverse Event|5|||
131748147|NCT00131664|474354276|FG003|First Period (First 6 Months)|Adverse Event|0|||
131748148|NCT00131664|474354277|FG004|First Period (First 6 Months)|Adverse Event|0|||
131748149|NCT00131664|474354278|FG005|First Period (First 6 Months)|Adverse Event|0|||
131748150|NCT00131664|474354273|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
131748151|NCT00131664|474354274|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
131748152|NCT00131664|474354275|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131449193|NCT00836693|473274810|FG001|Overall Study|Protocol Violation|0|||
131748153|NCT00131664|474354276|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131748154|NCT00131664|474354277|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131748155|NCT00131664|474354278|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131748156|NCT00131664|474354273|FG000|First Period (First 6 Months)|Administrative reasons|2|||
131748157|NCT00131664|474354274|FG001|First Period (First 6 Months)|Administrative reasons|0|||
131748158|NCT00131664|474354275|FG002|First Period (First 6 Months)|Administrative reasons|5|||
131748159|NCT00131664|474354276|FG003|First Period (First 6 Months)|Administrative reasons|0|||
131748160|NCT00131664|474354277|FG004|First Period (First 6 Months)|Administrative reasons|0|||
131748161|NCT00131664|474354278|FG005|First Period (First 6 Months)|Administrative reasons|0|||
131748162|NCT00131664|474354273|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
131748163|NCT00131664|474354274|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
131748164|NCT00131664|474354275|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
131748165|NCT00131664|474354276|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
131748166|NCT00131664|474354277|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
131748167|NCT00131664|474354278|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
131748168|NCT00131664|474354273|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
131748169|NCT00131664|474354274|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
131748170|NCT00131664|474354275|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
131748171|NCT00131664|474354276|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
131748172|NCT00131664|474354277|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
131748173|NCT00131664|474354278|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
131748174|NCT00131664|474354273|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
131748175|NCT00131664|474354274|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131748176|NCT00131664|474354275|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131748177|NCT00131664|474354276|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131748178|NCT00131664|474354277|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131748179|NCT00131664|474354278|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131748180|NCT00131664|474354273|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
131748181|NCT00131664|474354274|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
131748182|NCT00131664|474354275|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
131748183|NCT00131664|474354276|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
131748184|NCT00131664|474354277|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
131748185|NCT00131664|474354278|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
131748186|NCT00131664|474354273|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131748187|NCT00131664|474354274|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131748188|NCT00131664|474354275|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131748189|NCT00131664|474354276|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
131748190|NCT00131664|474354277|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131748191|NCT00131664|474354278|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131748192|NCT00131664|474354273|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
131748193|NCT00131664|474354274|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
131748194|NCT00131664|474354275|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
131748195|NCT00131664|474354276|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
131748196|NCT00131664|474354277|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
131748197|NCT00131664|474354278|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
131748198|NCT00617656|474354279|FG000|Overall Study|Inclusion error|4|||
131748199|NCT00617656|474354280|FG001|Overall Study|Inclusion error|4|||
131748200|NCT00617656|474354281|FG002|Overall Study|Inclusion error|0|||
131808771|NCT01597245|474582936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808772|NCT01597245|474582937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808773|NCT01597245|474582938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808774|NCT01597245|474582939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808775|NCT01597245|474582940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808776|NCT01597245|474582941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808777|NCT01597245|474582942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808778|NCT01597245|474582943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808779|NCT01597245|474582944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808780|NCT01597245|474582945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808781|NCT01597245|474582946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808782|NCT01597245|474582947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808783|NCT01597245|474582948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808784|NCT01597245|474582949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808785|NCT01597245|474582950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
131748201|NCT00617656|474354282|FG003|Overall Study|Inclusion error|0|||
131748202|NCT00617656|474354279|FG000|Overall Study|Missing data|44|||
131748203|NCT00617656|474354280|FG001|Overall Study|Missing data|30|||
131748204|NCT00617656|474354281|FG002|Overall Study|Missing data|13|||
131748205|NCT00617656|474354282|FG003|Overall Study|Missing data|6|||
131748206|NCT00617656|474354279|FG000|Overall Study|Withdrawal by Subject|0|||
131748207|NCT00617656|474354280|FG001|Overall Study|Withdrawal by Subject|2|||
131748208|NCT00617656|474354281|FG002|Overall Study|Withdrawal by Subject|0|||
131748209|NCT00617656|474354282|FG003|Overall Study|Withdrawal by Subject|0|||
131748210|NCT00107172|474356269|FG000|Overall Study|Withdrawal by Subject|1|||
131748211|NCT00107172|474356270|FG001|Overall Study|Withdrawal by Subject|0|||
131748212|NCT00107172|474356269|FG000|Overall Study|Death|0|||
131748213|NCT00107172|474356270|FG001|Overall Study|Death|2|||
131748214|NCT00107172|474356269|FG000|Overall Study|Other Reason|4|||
131748215|NCT00107172|474356270|FG001|Overall Study|Other Reason|3|||
131748216|NCT02688153|474356271|FG000|Overall Study|Death|7|||
131748217|NCT02688153|474356272|FG001|Overall Study|Death|5|||
131748218|NCT02688153|474356271|FG000|Overall Study|Withdrawal by Subject|4|||
131748219|NCT02688153|474356272|FG001|Overall Study|Withdrawal by Subject|2|||
131748220|NCT02688153|474356271|FG000|Overall Study|Valve Explant|1|||
131748221|NCT02688153|474356272|FG001|Overall Study|Valve Explant|0|||
131748222|NCT02688153|474356271|FG000|Overall Study|Conversion to Commercial Valve|3|||
131748223|NCT02688153|474356272|FG001|Overall Study|Conversion to Commercial Valve|0|||
131748224|NCT01102140|474356273|FG000|Overall Study|Lost to Follow-up|1|||
131748225|NCT01102140|474356274|FG001|Overall Study|Lost to Follow-up|0|||
131748226|NCT01102140|474356273|FG000|Overall Study|Investigator terminated study|2|||
131748227|NCT01102140|474356274|FG001|Overall Study|Investigator terminated study|2|||
131748228|NCT03682055|474356275|FG000|Overall Study|Lack of Efficacy|1|||
131748229|NCT03682055|474356276|FG001|Overall Study|Lack of Efficacy|2|||
131748230|NCT03682055|474356277|FG002|Overall Study|Lack of Efficacy|1|||
131748231|NCT03682055|474356278|FG003|Overall Study|Lack of Efficacy|2|||
131748232|NCT03682055|474356279|FG004|Overall Study|Lack of Efficacy|1|||
131748233|NCT03682055|474356280|FG005|Overall Study|Lack of Efficacy|3|||
131748234|NCT03682055|474356275|FG000|Overall Study|Withdrawal by Subject|0|||
131748235|NCT03682055|474356276|FG001|Overall Study|Withdrawal by Subject|0|||
131748236|NCT03682055|474356277|FG002|Overall Study|Withdrawal by Subject|0|||
131748237|NCT03682055|474356278|FG003|Overall Study|Withdrawal by Subject|0|||
131748238|NCT03682055|474356279|FG004|Overall Study|Withdrawal by Subject|0|||
131748239|NCT03682055|474356280|FG005|Overall Study|Withdrawal by Subject|1|||
131748240|NCT03682055|474356275|FG000|Overall Study|Termination of Study by Sponsor|0|||
131748241|NCT03682055|474356276|FG001|Overall Study|Termination of Study by Sponsor|0|||
131748242|NCT03682055|474356277|FG002|Overall Study|Termination of Study by Sponsor|0|||
131748243|NCT03682055|474356278|FG003|Overall Study|Termination of Study by Sponsor|0|||
131748244|NCT03682055|474356279|FG004|Overall Study|Termination of Study by Sponsor|0|||
131748245|NCT03682055|474356280|FG005|Overall Study|Termination of Study by Sponsor|3|||
131748246|NCT02687711|474356281|FG000|Overall Study|Adverse Event|89|||
131748247|NCT02687711|474356281|FG000|Overall Study|Lack of Efficacy|70|||
131748248|NCT02687711|474356281|FG000|Overall Study|Lost to Follow-up|20|||
131748249|NCT02687711|474356281|FG000|Overall Study|Consent withdrawn|15|||
131748250|NCT02687711|474356281|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
131748251|NCT02687711|474356281|FG000|Overall Study|Too expensive|4|||
131748252|NCT02687711|474356281|FG000|Overall Study|Participant moved abroad|1|||
131748253|NCT02687711|474356281|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
131748254|NCT02687711|474356281|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
131748255|NCT02687711|474356281|FG000|Overall Study|Disliked taste|1|||
131748256|NCT02687711|474356281|FG000|Overall Study|Low mood|1|||
131748257|NCT02687711|474356281|FG000|Overall Study|Side effects|1|||
131748258|NCT02687711|474356281|FG000|Overall Study|Change of Hospital|1|||
131748259|NCT02687711|474356281|FG000|Overall Study|Liver Encephalopathy|1|||
131748260|NCT02687711|474356281|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
131748261|NCT02687711|474356281|FG000|Overall Study|Withdrawn due to intake interruption|1|||
131748262|NCT02687711|474356281|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
131748263|NCT02687711|474356281|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
131748264|NCT02687711|474356281|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
131748265|NCT03621189|474356282|FG000|Overall Study|Withdrawal by Subject|0|||
131748266|NCT03621189|474356283|FG001|Overall Study|Withdrawal by Subject|3|||
131748267|NCT03621189|474356282|FG000|Overall Study|Physician Decision|0|||
131748268|NCT03621189|474356283|FG001|Overall Study|Physician Decision|2|||
131748269|NCT01135394|474356284|FG000|Screening|Lost to Follow-up|2|||
131748270|NCT01135394|474356284|FG000|Screening|Withdrawal by Subject|10|||
131748271|NCT01135394|474356284|FG000|Screening|Screening failure|16|||
131748272|NCT01135394|474356284|FG000|Screening|Physician Decision|5|||
131748273|NCT01135394|474356284|FG000|Baseline Assessment|Withdrawal by Subject|9|||
131748274|NCT01135394|474356284|FG000|Baseline Assessment|Physician Decision|3|||
131748275|NCT01135394|474356284|FG000|Baseline Assessment|Lost to Follow-up|2|||
131748276|NCT01135394|474356284|FG000|Baseline Assessment|Adverse Event|1|||
131748277|NCT01135394|474356284|FG000|Study Treatment|Withdrawal by Subject|1|||
131748278|NCT01135394|474356284|FG000|Study Treatment|Physician Decision|1|||
131808786|NCT01597245|474582951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131808787|NCT01313780|474582952|FG000|Overall Study|Lack of Efficacy|4|||
131808788|NCT01313780|474582953|FG001|Overall Study|Lack of Efficacy|2|||
131808789|NCT01313780|474582952|FG000|Overall Study|Adverse Event|6|||
131808790|NCT01313780|474582953|FG001|Overall Study|Adverse Event|11|||
131808791|NCT01313780|474582952|FG000|Overall Study|Withdrawal by Subject|2|||
131808792|NCT01313780|474582953|FG001|Overall Study|Withdrawal by Subject|8|||
131808793|NCT01313780|474582952|FG000|Overall Study|Protocol Violation|10|||
131808794|NCT01313780|474582953|FG001|Overall Study|Protocol Violation|4|||
131808795|NCT01313780|474582952|FG000|Overall Study|missing data|3|||
131748279|NCT01135394|474356284|FG000|Study Treatment|Adverse Event|2|||
131748280|NCT00191386|474356285|FG000|Overall Study|Adverse Event|16|||
131748281|NCT00191386|474356285|FG000|Overall Study|Lost to Follow-up|1|||
131748282|NCT00191386|474356285|FG000|Overall Study|Entry Criteria Exclusion|3|||
131748283|NCT00191386|474356285|FG000|Overall Study|Protocol Violation|18|||
131748284|NCT00191386|474356285|FG000|Overall Study|Withdrawal by Subject|96|||
131748285|NCT00191386|474356285|FG000|Overall Study|Physician Decision|11|||
131748286|NCT00191386|474356285|FG000|Overall Study|Lack of Efficacy|15|||
131748287|NCT00462488|474356286|FG000|Overall Study|Protocol Violation|1|||
131748288|NCT00462488|474356287|FG001|Overall Study|Protocol Violation|0|||
131748289|NCT00462488|474356286|FG000|Overall Study|Lack of Efficacy|19|||
131748290|NCT00462488|474356287|FG001|Overall Study|Lack of Efficacy|17|||
131748291|NCT01742091|474356292|FG000|Overall Study|Adverse Event|0|||
131748292|NCT01742091|474356293|FG001|Overall Study|Adverse Event|0|||
131748293|NCT01742091|474356294|FG002|Overall Study|Adverse Event|0|||
131748294|NCT01742091|474356295|FG003|Overall Study|Adverse Event|0|||
131748295|NCT01742091|474356296|FG004|Overall Study|Adverse Event|1|||
131748296|NCT01742091|474356297|FG005|Overall Study|Adverse Event|0|||
131748297|NCT01742091|474356292|FG000|Overall Study|Physician Decision|0|||
131748298|NCT01742091|474356293|FG001|Overall Study|Physician Decision|0|||
131748299|NCT01742091|474356294|FG002|Overall Study|Physician Decision|0|||
131748300|NCT01742091|474356295|FG003|Overall Study|Physician Decision|0|||
131748301|NCT01742091|474356296|FG004|Overall Study|Physician Decision|0|||
131748302|NCT01742091|474356297|FG005|Overall Study|Physician Decision|1|||
131748303|NCT01742091|474356292|FG000|Overall Study|Withdrawal by Subject|0|||
131748304|NCT01742091|474356293|FG001|Overall Study|Withdrawal by Subject|0|||
131748305|NCT01742091|474356294|FG002|Overall Study|Withdrawal by Subject|0|||
131748306|NCT01742091|474356295|FG003|Overall Study|Withdrawal by Subject|1|||
131748307|NCT01742091|474356296|FG004|Overall Study|Withdrawal by Subject|0|||
131748308|NCT01742091|474356297|FG005|Overall Study|Withdrawal by Subject|0|||
131748309|NCT01742091|474356292|FG000|Overall Study|Lost to Follow-up|0|||
131748310|NCT01742091|474356293|FG001|Overall Study|Lost to Follow-up|0|||
131748311|NCT01742091|474356294|FG002|Overall Study|Lost to Follow-up|0|||
131748312|NCT01742091|474356295|FG003|Overall Study|Lost to Follow-up|0|||
131748313|NCT01742091|474356296|FG004|Overall Study|Lost to Follow-up|0|||
131748314|NCT01742091|474356297|FG005|Overall Study|Lost to Follow-up|1|||
131748315|NCT03706040|474356298|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
131808796|NCT01313780|474582953|FG001|Overall Study|missing data|3|||
131808797|NCT01802320|474582954|FG000|Overall Study|Death|1|||
131808798|NCT01802320|474582954|FG000|Overall Study|Withdrawal by Subject|1|||
131748316|NCT03706040|474356299|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
131748317|NCT03706040|474356300|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
131748318|NCT03706040|474356301|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
131748319|NCT03706040|474356302|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
131808799|NCT05369208|474584287|FG000|Core Phase|Prohibited Medication Required|2|||
131808800|NCT05369208|474584287|FG000|Core Phase|Adverse Event|1|||
131808801|NCT05369208|474584287|FG000|Core Phase|Lack of Efficacy|1|||
131748320|NCT03706040|474356303|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
131748321|NCT03706040|474356304|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
131748322|NCT03706040|474356298|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
131748323|NCT03706040|474356299|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
131748324|NCT03706040|474356300|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
131748325|NCT03706040|474356301|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131748326|NCT03706040|474356302|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131748327|NCT03706040|474356303|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131748328|NCT03706040|474356304|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131748329|NCT03706040|474356298|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
131748330|NCT03706040|474356299|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
131748331|NCT03706040|474356300|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
131748332|NCT03706040|474356301|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131748333|NCT03706040|474356302|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131748334|NCT03706040|474356303|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131748335|NCT03706040|474356304|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131748336|NCT03706040|474356298|FG000|Period A (Week 0 to Week 16)|Other|2|||
131748337|NCT03706040|474356299|FG001|Period A (Week 0 to Week 16)|Other|0|||
131748338|NCT03706040|474356300|FG002|Period A (Week 0 to Week 16)|Other|2|||
131748339|NCT03706040|474356301|FG003|Period A (Week 0 to Week 16)|Other|0|||
131748340|NCT03706040|474356302|FG004|Period A (Week 0 to Week 16)|Other|0|||
131748341|NCT03706040|474356303|FG005|Period A (Week 0 to Week 16)|Other|0|||
131748342|NCT03706040|474356304|FG006|Period A (Week 0 to Week 16)|Other|0|||
131748343|NCT03706040|474356298|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
131748344|NCT03706040|474356299|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
131748345|NCT03706040|474356300|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
131748346|NCT03706040|474356301|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
131748347|NCT03706040|474356302|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
131748348|NCT03706040|474356303|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
131748349|NCT03706040|474356304|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
131748350|NCT03706040|474356298|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
131748351|NCT03706040|474356299|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
131748352|NCT03706040|474356300|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
131748353|NCT03706040|474356301|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
131748354|NCT03706040|474356302|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
131748355|NCT03706040|474356303|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
131748356|NCT03706040|474356304|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
131748357|NCT03706040|474356298|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131748358|NCT03706040|474356299|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131748359|NCT03706040|474356300|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131748360|NCT03706040|474356301|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131748361|NCT03706040|474356302|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131748362|NCT03706040|474356303|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
131748363|NCT03706040|474356304|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
131748364|NCT03706040|474356298|FG000|Period B (Week 16 to Week 52)|Other|0|||
131748365|NCT03706040|474356299|FG001|Period B (Week 16 to Week 52)|Other|0|||
131748366|NCT03706040|474356300|FG002|Period B (Week 16 to Week 52)|Other|0|||
131748367|NCT03706040|474356301|FG003|Period B (Week 16 to Week 52)|Other|4|||
131748368|NCT03706040|474356302|FG004|Period B (Week 16 to Week 52)|Other|5|||
131748369|NCT03706040|474356303|FG005|Period B (Week 16 to Week 52)|Other|23|||
131748370|NCT03706040|474356304|FG006|Period B (Week 16 to Week 52)|Other|17|||
131748371|NCT03077243|474356305|FG000|Overall Study|Death|1|||
131748372|NCT03077243|474356306|FG001|Overall Study|Death|2|||
131748373|NCT03077243|474356307|FG002|Overall Study|Death|0|||
131748374|NCT03077243|474356308|FG003|Overall Study|Death|0|||
131748375|NCT03077243|474356305|FG000|Overall Study|Withdrawal by Subject|1|||
131748376|NCT03077243|474356306|FG001|Overall Study|Withdrawal by Subject|3|||
131748377|NCT03077243|474356307|FG002|Overall Study|Withdrawal by Subject|0|||
131748378|NCT03077243|474356308|FG003|Overall Study|Withdrawal by Subject|0|||
131748379|NCT03077243|474356305|FG000|Overall Study|Physician Decision|1|||
131748380|NCT03077243|474356306|FG001|Overall Study|Physician Decision|0|||
131748381|NCT03077243|474356307|FG002|Overall Study|Physician Decision|0|||
131748382|NCT03077243|474356308|FG003|Overall Study|Physician Decision|0|||
131748383|NCT03077243|474356305|FG000|Overall Study|Research at two study sites terminated early|0|||
131748384|NCT03077243|474356306|FG001|Overall Study|Research at two study sites terminated early|0|||
131748385|NCT03077243|474356307|FG002|Overall Study|Research at two study sites terminated early|0|||
131748386|NCT03077243|474356308|FG003|Overall Study|Research at two study sites terminated early|69|||
131748387|NCT00212758|474356312|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
131748388|NCT00212758|474356313|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
131748389|NCT00212758|474356312|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
131748390|NCT00212758|474356313|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
131748391|NCT03510910|474356314|FG000|Overall Study|Incomplete Survey|2|||
131748392|NCT03510910|474356315|FG001|Overall Study|Incomplete Survey|3|||
131748393|NCT01105936|474356316|FG000|Period 1|Adverse Event|0|||
131748394|NCT01105936|474356317|FG001|Period 1|Adverse Event|0|||
131748395|NCT01105936|474356318|FG002|Period 1|Adverse Event|0|||
131748396|NCT01105936|474356319|FG003|Period 1|Adverse Event|1|||
131748397|NCT01105936|474356316|FG000|Period 2|Adverse Event|1|||
131748398|NCT01105936|474356317|FG001|Period 2|Adverse Event|0|||
131748399|NCT01105936|474356318|FG002|Period 2|Adverse Event|0|||
131748400|NCT01105936|474356319|FG003|Period 2|Adverse Event|0|||
131748401|NCT01105936|474356316|FG000|Period 3|Protocol Violation|0|||
131748402|NCT01105936|474356317|FG001|Period 3|Protocol Violation|2|||
131748403|NCT01105936|474356318|FG002|Period 3|Protocol Violation|0|||
131748404|NCT01105936|474356319|FG003|Period 3|Protocol Violation|0|||
131748405|NCT01673490|474356320|FG000|Overall Study|Lost to Follow-up|1|||
131748406|NCT01673490|474356320|FG000|Overall Study|Adverse Event|3|||
131748407|NCT01673490|474356320|FG000|Overall Study|Withdrawal by Subject|3|||
131748408|NCT02940860|474356328|FG000|Overall Study|Non-serious AE|1|||
131748409|NCT02940860|474356329|FG001|Overall Study|Non-serious AE|2|||
131748410|NCT02940860|474356328|FG000|Overall Study|Serious AE|7|||
131748411|NCT02940860|474356329|FG001|Overall Study|Serious AE|3|||
131748412|NCT02940860|474356328|FG000|Overall Study|Withdrawal by Subject|19|||
131748413|NCT02940860|474356329|FG001|Overall Study|Withdrawal by Subject|9|||
131748414|NCT02940860|474356328|FG000|Overall Study|Lost to Follow-up|13|||
131748415|NCT02940860|474356329|FG001|Overall Study|Lost to Follow-up|7|||
131748416|NCT02940860|474356328|FG000|Overall Study|Physician Decision|5|||
131748417|NCT02940860|474356329|FG001|Overall Study|Physician Decision|3|||
131748418|NCT02940860|474356328|FG000|Overall Study|Sponsor Decision|0|||
131748419|NCT02940860|474356329|FG001|Overall Study|Sponsor Decision|1|||
131748420|NCT02940860|474356328|FG000|Overall Study|Protocol Violation|0|||
131748421|NCT02940860|474356329|FG001|Overall Study|Protocol Violation|2|||
131748422|NCT02940860|474356328|FG000|Overall Study|Death|3|||
131748423|NCT02940860|474356329|FG001|Overall Study|Death|2|||
131748424|NCT02940860|474356328|FG000|Overall Study|Moved, poor venous access, transport|6|||
131748425|NCT02940860|474356329|FG001|Overall Study|Moved, poor venous access, transport|4|||
131748426|NCT02940860|474356328|FG000|Overall Study|Not treated|2|||
131748427|NCT02940860|474356329|FG001|Overall Study|Not treated|2|||
131748428|NCT02715804|474356330|FG000|Overall Study|Death|222|||
131748429|NCT02715804|474356331|FG001|Overall Study|Death|106|||
131748430|NCT02715804|474356330|FG000|Overall Study|Withdrawal by Subject|5|||
131748431|NCT02715804|474356331|FG001|Overall Study|Withdrawal by Subject|4|||
131748432|NCT02715804|474356330|FG000|Overall Study|Other than specified|2|||
131748433|NCT02715804|474356331|FG001|Overall Study|Other than specified|3|||
131748434|NCT00948194|474356332|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
131748435|NCT00948194|474356333|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
131748436|NCT02431793|474356334|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
131748437|NCT02431793|474356335|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
131748438|NCT02431793|474356336|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
131748439|NCT02431793|474356334|FG000|Overall Study|Withdrawal by Subject|7|||
131748440|NCT02431793|474356335|FG001|Overall Study|Withdrawal by Subject|5|||
131748441|NCT02431793|474356336|FG002|Overall Study|Withdrawal by Subject|5|||
131748442|NCT02431793|474356334|FG000|Overall Study|Lost to Follow-up|101|||
131748443|NCT02431793|474356335|FG001|Overall Study|Lost to Follow-up|122|||
131748444|NCT02431793|474356336|FG002|Overall Study|Lost to Follow-up|104|||
131748445|NCT00233324|474356337|FG000|Main Study|Death|68|||
131748446|NCT00233324|474356338|FG001|Main Study|Death|60|||
131748447|NCT00233324|474356339|FG002|Main Study|Death|62|||
131748448|NCT00233324|474356340|FG003|Main Study|Death|47|||
131748449|NCT00233324|474356337|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
131748450|NCT00233324|474356338|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
131748451|NCT00233324|474356339|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
131748452|NCT00233324|474356340|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
131748453|NCT00233324|474356337|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
131748454|NCT00233324|474356338|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
131808802|NCT03235739|474584288|FG000|Overall Study|Withdrawal by Subject|2|||
131808803|NCT03235739|474584289|FG001|Overall Study|Withdrawal by Subject|2|||
131808804|NCT03235739|474584288|FG000|Overall Study|Physician Decision|0|||
131748455|NCT00233324|474356339|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
131748456|NCT00233324|474356340|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
131748457|NCT03170258|474356346|FG000|Overall Study|Physician Decision|4|||
131808805|NCT03235739|474584289|FG001|Overall Study|Physician Decision|1|||
131808806|NCT00467896|474584290|FG000|Overall Study|Consent Withdrawal|18|||
131808807|NCT00467896|474584290|FG000|Overall Study|Adverse Event|7|||
131748458|NCT03170258|474356347|FG001|Overall Study|Physician Decision|0|||
131748459|NCT03170258|474356346|FG000|Overall Study|Equipment issues|1|||
131748460|NCT03170258|474356347|FG001|Overall Study|Equipment issues|0|||
131748461|NCT03170258|474356346|FG000|Overall Study|Medication|1|||
131748462|NCT03170258|474356347|FG001|Overall Study|Medication|0|||
131748463|NCT03170258|474356346|FG000|Overall Study|Sleep issues|1|||
131748464|NCT03170258|474356347|FG001|Overall Study|Sleep issues|0|||
131748465|NCT01563107|474356348|FG000|Overall Study|Physician Decision|0|||
131808808|NCT00467896|474584290|FG000|Overall Study|Serious Adverse Event|13|||
131748466|NCT01563107|474356349|FG001|Overall Study|Physician Decision|1|||
131748467|NCT01563107|474356350|FG002|Overall Study|Physician Decision|1|||
131748468|NCT01563107|474356351|FG003|Overall Study|Physician Decision|3|||
131748469|NCT01563107|474356348|FG000|Overall Study|Withdrawal by Subject|1|||
131748470|NCT01563107|474356349|FG001|Overall Study|Withdrawal by Subject|2|||
131748471|NCT01563107|474356350|FG002|Overall Study|Withdrawal by Subject|1|||
131748472|NCT01563107|474356351|FG003|Overall Study|Withdrawal by Subject|2|||
131748473|NCT00247273|474356355|FG000|Overall Study|Adverse Event|85|||
131748474|NCT00247273|474356356|FG001|Overall Study|Adverse Event|80|||
131748475|NCT00247273|474356355|FG000|Overall Study|Physician Decision|6|||
131748476|NCT00247273|474356356|FG001|Overall Study|Physician Decision|3|||
131748477|NCT00247273|474356355|FG000|Overall Study|Lost to Follow-up|7|||
131748478|NCT00247273|474356356|FG001|Overall Study|Lost to Follow-up|7|||
131748479|NCT00247273|474356355|FG000|Overall Study|Withdrawal by Subject|46|||
131748480|NCT00247273|474356356|FG001|Overall Study|Withdrawal by Subject|47|||
131748481|NCT00247273|474356355|FG000|Overall Study|Did not take any study drug|2|||
131748482|NCT00247273|474356356|FG001|Overall Study|Did not take any study drug|0|||
131748483|NCT01419015|474356358|FG000|Overall Study|Death|2|||
131748484|NCT03276572|474356360|FG000|Overall Study|In follow-up|0|||
131748485|NCT03276572|474356361|FG001|Overall Study|In follow-up|0|||
131748486|NCT03276572|474356362|FG002|Overall Study|In follow-up|0|||
131748487|NCT03276572|474356363|FG003|Overall Study|In follow-up|0|||
131748488|NCT03276572|474356364|FG004|Overall Study|In follow-up|0|||
131748489|NCT03276572|474356365|FG005|Overall Study|In follow-up|1|||
131748490|NCT03276572|474356366|FG006|Overall Study|In follow-up|1|||
131748491|NCT03276572|474356360|FG000|Overall Study|Lost to Follow-up|0|||
131748492|NCT03276572|474356361|FG001|Overall Study|Lost to Follow-up|0|||
131748493|NCT03276572|474356362|FG002|Overall Study|Lost to Follow-up|0|||
131748494|NCT03276572|474356363|FG003|Overall Study|Lost to Follow-up|0|||
131748495|NCT03276572|474356364|FG004|Overall Study|Lost to Follow-up|0|||
131748496|NCT03276572|474356365|FG005|Overall Study|Lost to Follow-up|0|||
131748497|NCT03276572|474356366|FG006|Overall Study|Lost to Follow-up|1|||
131748498|NCT02580240|474356367|FG000|Overall Study|Physician Decision|2|||
131748499|NCT02580240|474356368|FG001|Overall Study|Physician Decision|0|||
131748500|NCT00607919|474356381|FG000|Acute Phase|Adverse Event|9|||
131748501|NCT00607919|474356382|FG001|Acute Phase|Adverse Event|2|||
131748502|NCT00607919|474356381|FG000|Acute Phase|Entry Criteria Not Met|1|||
131748503|NCT00607919|474356382|FG001|Acute Phase|Entry Criteria Not Met|1|||
131748504|NCT00607919|474356381|FG000|Acute Phase|Lack of Efficacy|1|||
131748505|NCT00607919|474356382|FG001|Acute Phase|Lack of Efficacy|2|||
131748506|NCT00607919|474356381|FG000|Acute Phase|Lost to Follow-up|9|||
131748507|NCT00607919|474356382|FG001|Acute Phase|Lost to Follow-up|3|||
131748508|NCT00607919|474356381|FG000|Acute Phase|Parent/Caregiver Decision|6|||
131748509|NCT00607919|474356382|FG001|Acute Phase|Parent/Caregiver Decision|4|||
131808809|NCT00467896|474584290|FG000|Overall Study|Non-compliance|3|||
131808810|NCT00467896|474584290|FG000|Overall Study|Changed therapy|2|||
131808811|NCT00467896|474584290|FG000|Overall Study|Patient received transplant|2|||
131808812|NCT00467896|474584290|FG000|Overall Study|Patient had atrial septostomy|1|||
131808813|NCT00467896|474584290|FG000|Overall Study|Patient weaned off iloprost|1|||
131808814|NCT00467896|474584290|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
131808815|NCT00467896|474584290|FG000|Overall Study|Started intravenous prostacyclin|1|||
131808816|NCT00467896|474584290|FG000|Overall Study|Started inhaled Remodulin|1|||
131808817|NCT00467896|474584290|FG000|Overall Study|Patient had no improvement|1|||
131808818|NCT03772522|474584291|FG000|Pre-intervention|Withdrawal by Subject|3|||
131808819|NCT03772522|474584292|FG001|Pre-intervention|Withdrawal by Subject|4|||
131808820|NCT03772522|474584291|FG000|Intervention|Withdrawal by Subject|1|||
131808821|NCT03772522|474584292|FG001|Intervention|Withdrawal by Subject|0|||
131808822|NCT03772522|474584291|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
131808823|NCT03772522|474584292|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
131808824|NCT03818581|474584293|FG000|Overall Study|Adverse Event|1|||
131808825|NCT03818581|474584294|FG001|Overall Study|Adverse Event|0|||
131808826|NCT03818581|474584295|FG002|Overall Study|Adverse Event|0|||
131808827|NCT03818581|474584296|FG003|Overall Study|Adverse Event|0|||
131808828|NCT03818581|474584297|FG004|Overall Study|Adverse Event|0|||
131808829|NCT03818581|474584293|FG000|Overall Study|Covid-19|2|||
131748510|NCT00607919|474356381|FG000|Acute Phase|Protocol Violation|5|||
131808830|NCT03818581|474584294|FG001|Overall Study|Covid-19|0|||
131808831|NCT03818581|474584295|FG002|Overall Study|Covid-19|0|||
131808832|NCT03818581|474584296|FG003|Overall Study|Covid-19|0|||
131808833|NCT03818581|474584297|FG004|Overall Study|Covid-19|1|||
131808834|NCT03818581|474584293|FG000|Overall Study|Withdrawal by Subject|0|||
131808835|NCT03818581|474584294|FG001|Overall Study|Withdrawal by Subject|0|||
131748511|NCT00607919|474356382|FG001|Acute Phase|Protocol Violation|1|||
131748512|NCT00607919|474356381|FG000|Acute Phase|Withdrawal by Subject|3|||
131748513|NCT00607919|474356382|FG001|Acute Phase|Withdrawal by Subject|3|||
131748514|NCT00607919|474356381|FG000|Open-Label Phase|Adverse Event|1|||
131748515|NCT00607919|474356382|FG001|Open-Label Phase|Adverse Event|5|||
131748516|NCT00607919|474356381|FG000|Open-Label Phase|Lost to Follow-up|4|||
131808836|NCT03818581|474584295|FG002|Overall Study|Withdrawal by Subject|0|||
131748517|NCT00607919|474356382|FG001|Open-Label Phase|Lost to Follow-up|1|||
131748518|NCT00607919|474356381|FG000|Open-Label Phase|Protocol Violation|2|||
131748519|NCT00607919|474356382|FG001|Open-Label Phase|Protocol Violation|2|||
131748520|NCT00607919|474356381|FG000|Open-Label Phase|Withdrawal by Subject|2|||
131748521|NCT00607919|474356382|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131748522|NCT00607919|474356381|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
131748523|NCT00607919|474356382|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
131748524|NCT02007252|474356383|FG000|Overall Study|Administrative problems|3|||
131748525|NCT02007252|474356384|FG001|Overall Study|Administrative problems|7|||
131748526|NCT02007252|474356383|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131906410|NCT00785356|474945162|FG000|Overall Study|Study prematurely terminated|8|||
131906411|NCT03238417|474945164|FG000|Overall|non-response|955|||
131906412|NCT03238417|474945165|FG001|Overall|non-response|1920|||
131748527|NCT02007252|474356384|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131748528|NCT02007252|474356383|FG000|Overall Study|Adverse Event|7|||
131748529|NCT02007252|474356384|FG001|Overall Study|Adverse Event|4|||
131748530|NCT00527072|474356385|FG000|Overall Study|Adverse Event|13|||
131748531|NCT00527072|474356385|FG000|Overall Study|Lack of Efficacy|11|||
131748532|NCT00527072|474356385|FG000|Overall Study|Lost to Follow-up|3|||
131748533|NCT00527072|474356385|FG000|Overall Study|Protocol Violation|2|||
131748534|NCT00527072|474356385|FG000|Overall Study|Withdrawal by Subject|7|||
131748535|NCT02657434|474356386|FG000|Overall Study|Study Terminated By Sponsor|64|||
131748536|NCT02657434|474356387|FG001|Overall Study|Study Terminated By Sponsor|82|||
131748537|NCT02657434|474356386|FG000|Overall Study|Death|189|||
131748538|NCT02657434|474356387|FG001|Overall Study|Death|190|||
131748539|NCT02657434|474356386|FG000|Overall Study|Lost to Follow-up|2|||
131748540|NCT02657434|474356387|FG001|Overall Study|Lost to Follow-up|2|||
131748541|NCT02657434|474356386|FG000|Overall Study|Randomization by Error|2|||
131748542|NCT02657434|474356387|FG001|Overall Study|Randomization by Error|0|||
131748543|NCT02657434|474356386|FG000|Overall Study|Withdrawal by Subject|28|||
131748544|NCT02657434|474356387|FG001|Overall Study|Withdrawal by Subject|17|||
131748545|NCT02657434|474356386|FG000|Overall Study|Protocol Violation|1|||
131748546|NCT02657434|474356387|FG001|Overall Study|Protocol Violation|0|||
131748547|NCT02657434|474356386|FG000|Overall Study|Physician Decision|0|||
131748548|NCT02657434|474356387|FG001|Overall Study|Physician Decision|1|||
131748549|NCT02001688|474356388|FG000|Overall Study|Withdrawal by Subject|0|||
131748550|NCT02001688|474356389|FG001|Overall Study|Withdrawal by Subject|0|||
131748551|NCT02001688|474356390|FG002|Overall Study|Withdrawal by Subject|1|||
131748552|NCT02001688|474356388|FG000|Overall Study|Adverse Event|0|||
131748553|NCT02001688|474356389|FG001|Overall Study|Adverse Event|1|||
131748554|NCT02001688|474356390|FG002|Overall Study|Adverse Event|0|||
131748555|NCT01989754|474356391|FG000|Overall Study|Withdrawal by Subject|10|||
131748556|NCT01989754|474356392|FG001|Overall Study|Withdrawal by Subject|14|||
131748557|NCT01989754|474356391|FG000|Overall Study|Lost to Follow-up|28|||
131748558|NCT01989754|474356392|FG001|Overall Study|Lost to Follow-up|20|||
131748559|NCT01989754|474356391|FG000|Overall Study|Closed Site|1|||
131748560|NCT01989754|474356392|FG001|Overall Study|Closed Site|1|||
131748561|NCT00813917|474356396|FG000|Overall Study|Adverse Event|0|||
131748562|NCT00813917|474356397|FG001|Overall Study|Adverse Event|1|||
131748563|NCT00813917|474356396|FG000|Overall Study|Withdrawal by Subject|3|||
131748564|NCT00813917|474356397|FG001|Overall Study|Withdrawal by Subject|4|||
131748565|NCT00813917|474356396|FG000|Overall Study|Lost to Follow-up|3|||
131748566|NCT00813917|474356397|FG001|Overall Study|Lost to Follow-up|1|||
131748567|NCT05441540|474356398|FG000|Overall Study|Withdrawal by Subject|2|||
131748568|NCT03862495|474356402|FG000|Overall Study|Lost to Follow-up|37|||
131748569|NCT03862495|474356403|FG001|Overall Study|Lost to Follow-up|35|||
131748570|NCT00615914|474356404|FG000|Overall Study|Adverse Event|274|||
131748571|NCT00615914|474356404|FG000|Overall Study|Death|20|||
131748572|NCT00615914|474356404|FG000|Overall Study|Lack of Efficacy|59|||
131748573|NCT00615914|474356404|FG000|Overall Study|Lost to Follow-up|187|||
131748574|NCT00615914|474356404|FG000|Overall Study|Withdrawal by Subject|16|||
131748575|NCT00615914|474356404|FG000|Overall Study|Physician Decision|4|||
131748576|NCT00615914|474356404|FG000|Overall Study|No data was collected.|65|||
131748577|NCT00615914|474356404|FG000|Overall Study|No treatment|2|||
131748578|NCT00615914|474356404|FG000|Overall Study|Irregularly enrolled patients|10|||
131748579|NCT00425113|474356405|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
131748580|NCT00425113|474356406|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
131748581|NCT00425113|474356405|FG000|Overall Study|diagnosis of abdominal TB|0|||
131748582|NCT00425113|474356406|FG001|Overall Study|diagnosis of abdominal TB|1|||
131748583|NCT00425113|474356405|FG000|Overall Study|missing study drug more than 14 days|0|||
131748584|NCT00425113|474356406|FG001|Overall Study|missing study drug more than 14 days|1|||
131748585|NCT00425113|474356405|FG000|Overall Study|Withdrawal by Subject|1|||
131748586|NCT00425113|474356406|FG001|Overall Study|Withdrawal by Subject|0|||
131748587|NCT00879437|474356407|FG000|Overall Study|Protocol Violation|0|||
131748588|NCT00879437|474356408|FG001|Overall Study|Protocol Violation|1|||
131748589|NCT00879437|474356407|FG000|Overall Study|Death|1|||
131906413|NCT03238417|474945164|FG000|Overall|partial completion|48|||
131808837|NCT03818581|474584296|FG003|Overall Study|Withdrawal by Subject|0|||
131808838|NCT03818581|474584297|FG004|Overall Study|Withdrawal by Subject|1|||
131808839|NCT03818581|474584293|FG000|Overall Study|No longer met study criteria|0|||
131808840|NCT03818581|474584294|FG001|Overall Study|No longer met study criteria|0|||
131808841|NCT03818581|474584295|FG002|Overall Study|No longer met study criteria|0|||
131808842|NCT03818581|474584296|FG003|Overall Study|No longer met study criteria|0|||
131808843|NCT03818581|474584297|FG004|Overall Study|No longer met study criteria|1|||
131808844|NCT00462345|474584298|FG000|Overall Study|Withdrawal by Subject|2|||
131808845|NCT00462345|474584298|FG000|Overall Study|Did not complete second course|1|||
131808846|NCT01149473|474584299|FG000|First Intervention|Adverse Event|1|||
131808847|NCT01149473|474584300|FG001|First Intervention|Adverse Event|1|||
131808848|NCT01149473|474584299|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131808849|NCT01149473|474584300|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
131808850|NCT04089735|474584301|FG000|Overall Study|Adverse Event|1|||
131808851|NCT04089735|474584302|FG001|Overall Study|Adverse Event|0|||
131808852|NCT04089735|474584303|FG002|Overall Study|Adverse Event|1|||
131449194|NCT00836693|473274809|FG000|Overall Study|Lost to Follow-up|1|||
131449195|NCT00836693|473274810|FG001|Overall Study|Lost to Follow-up|0|||
131808853|NCT04089735|474584304|FG003|Overall Study|Adverse Event|1|||
131808854|NCT04089735|474584305|FG004|Overall Study|Adverse Event|0|||
131808855|NCT04089735|474584306|FG005|Overall Study|Adverse Event|0|||
131808856|NCT04089735|474584301|FG000|Overall Study|Physician Decision|0|||
131808857|NCT04089735|474584302|FG001|Overall Study|Physician Decision|3|||
131808858|NCT04089735|474584303|FG002|Overall Study|Physician Decision|0|||
131808859|NCT04089735|474584304|FG003|Overall Study|Physician Decision|0|||
131808860|NCT04089735|474584305|FG004|Overall Study|Physician Decision|0|||
131808861|NCT04089735|474584306|FG005|Overall Study|Physician Decision|0|||
131808862|NCT04089735|474584301|FG000|Overall Study|Withdrawal by Subject|0|||
131808863|NCT04089735|474584302|FG001|Overall Study|Withdrawal by Subject|0|||
131808864|NCT04089735|474584303|FG002|Overall Study|Withdrawal by Subject|1|||
131808865|NCT04089735|474584304|FG003|Overall Study|Withdrawal by Subject|0|||
131449196|NCT02612779|473274811|FG000|Overall Study|Administrative reason by sponsor|4|||
131449197|NCT02612779|473274812|FG001|Overall Study|Administrative reason by sponsor|1|||
131449198|NCT02612779|473274811|FG000|Overall Study|No longer meet study criteria|0|||
131449199|NCT02612779|473274812|FG001|Overall Study|No longer meet study criteria|1|||
131449200|NCT02612779|473274811|FG000|Overall Study|Disease progression|29|||
131449201|NCT02612779|473274812|FG001|Overall Study|Disease progression|2|||
131449202|NCT02612779|473274811|FG000|Overall Study|Study drug toxicity|10|||
131449203|NCT02612779|473274812|FG001|Overall Study|Study drug toxicity|1|||
131449204|NCT02612779|473274811|FG000|Overall Study|Death|1|||
131449205|NCT02612779|473274812|FG001|Overall Study|Death|0|||
131449206|NCT02612779|473274811|FG000|Overall Study|Adverse event unrelated to study drug|5|||
131449207|NCT02612779|473274812|FG001|Overall Study|Adverse event unrelated to study drug|0|||
131449208|NCT02612779|473274811|FG000|Overall Study|Participant withdrew consent|4|||
131449209|NCT02612779|473274812|FG001|Overall Study|Participant withdrew consent|0|||
131449210|NCT02612779|473274811|FG000|Overall Study|Lost to Follow-up|1|||
131449211|NCT02612779|473274812|FG001|Overall Study|Lost to Follow-up|0|||
131449212|NCT02612779|473274811|FG000|Overall Study|Maximum clinical benefit|10|||
131449213|NCT02612779|473274812|FG001|Overall Study|Maximum clinical benefit|1|||
131449214|NCT02612779|473274811|FG000|Overall Study|Other reasons|4|||
131808866|NCT04089735|474584305|FG004|Overall Study|Withdrawal by Subject|0|||
131808867|NCT04089735|474584306|FG005|Overall Study|Withdrawal by Subject|0|||
131808868|NCT04089735|474584301|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
131808869|NCT04089735|474584302|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
131808870|NCT04089735|474584303|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
131808871|NCT04089735|474584304|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
131808872|NCT04089735|474584305|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
131449215|NCT02612779|473274812|FG001|Overall Study|Other reasons|0|||
131449216|NCT01002339|473274813|FG000|Overall Study|Withdrawal by Subject|0|||
131449217|NCT01002339|473274814|FG001|Overall Study|Withdrawal by Subject|1|||
131449218|NCT01002339|473274815|FG002|Overall Study|Withdrawal by Subject|0|||
131449219|NCT01002339|473274813|FG000|Overall Study|Incorrect treatment assignment|0|||
131748590|NCT00879437|474356408|FG001|Overall Study|Death|0|||
131748591|NCT03000686|474356409|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
131748592|NCT03000686|474356410|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
131748593|NCT03000686|474356411|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
131748594|NCT03000686|474356412|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
131748595|NCT01112982|474356415|FG000|Overall Study|Withdrawal by Subject|1|||
131748596|NCT01112982|474356415|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
131748597|NCT00389441|474356416|FG000|Overall Study|Adverse Event|7|||
131748598|NCT00389441|474356416|FG000|Overall Study|Death|4|||
131748599|NCT00389441|474356416|FG000|Overall Study|Lost to Follow-up|2|||
131748600|NCT00389441|474356416|FG000|Overall Study|Withdrawal by Subject|4|||
131748601|NCT00389441|474356416|FG000|Overall Study|Physician Decision|1|||
131748602|NCT00389441|474356416|FG000|Overall Study|Protocol Violation|1|||
131748603|NCT00389441|474356416|FG000|Overall Study|Global deterioration of health status|4|||
131748604|NCT00389441|474356416|FG000|Overall Study|Objective progression or relapse|26|||
131748605|NCT00389441|474356416|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
131748606|NCT00389441|474356416|FG000|Overall Study|Clinical progression|1|||
131748607|NCT01981109|474356417|FG000|Overall Study|Death|36|||
131748608|NCT01981109|474356417|FG000|Overall Study|Withdrawal by Subject|40|||
131748609|NCT01981109|474356417|FG000|Overall Study|Lost to Follow-up|9|||
131748610|NCT01981109|474356417|FG000|Overall Study|No Discontinuation Documentation|37|||
131748611|NCT01981109|474356417|FG000|Overall Study|Study Termination|100|||
131748612|NCT01981109|474356417|FG000|Overall Study|No data available|2|||
131748613|NCT00126672|474356420|FG000|Overall Study|Adverse Event|4|||
131748614|NCT00126672|474356420|FG000|Overall Study|Lost to Follow-up|4|||
131748615|NCT01001234|474356426|FG000|Overall Study|Withdrawal by Subject|2|||
131748616|NCT01001234|474356427|FG001|Overall Study|Withdrawal by Subject|0|||
131748617|NCT01001234|474356428|FG002|Overall Study|Withdrawal by Subject|3|||
131748618|NCT01001234|474356429|FG003|Overall Study|Withdrawal by Subject|0|||
131748619|NCT01001234|474356430|FG004|Overall Study|Withdrawal by Subject|0|||
131748620|NCT01001234|474356426|FG000|Overall Study|Protocol Violation|34|||
131748621|NCT01001234|474356427|FG001|Overall Study|Protocol Violation|3|||
131748622|NCT01001234|474356428|FG002|Overall Study|Protocol Violation|19|||
131748623|NCT01001234|474356429|FG003|Overall Study|Protocol Violation|18|||
131748624|NCT01001234|474356430|FG004|Overall Study|Protocol Violation|0|||
131748625|NCT01001234|474356426|FG000|Overall Study|Lost to Follow-up|0|||
131748626|NCT01001234|474356427|FG001|Overall Study|Lost to Follow-up|0|||
131748627|NCT01001234|474356428|FG002|Overall Study|Lost to Follow-up|1|||
131748628|NCT01001234|474356429|FG003|Overall Study|Lost to Follow-up|2|||
131748629|NCT01001234|474356430|FG004|Overall Study|Lost to Follow-up|0|||
131748630|NCT01001234|474356426|FG000|Overall Study|Physician Decision|1|||
131748631|NCT01001234|474356427|FG001|Overall Study|Physician Decision|0|||
131748632|NCT01001234|474356428|FG002|Overall Study|Physician Decision|0|||
131748633|NCT01001234|474356429|FG003|Overall Study|Physician Decision|0|||
131748634|NCT01001234|474356430|FG004|Overall Study|Physician Decision|0|||
131748635|NCT01001234|474356426|FG000|Overall Study|Not Treated: Adverse Event|1|||
131748636|NCT01001234|474356427|FG001|Overall Study|Not Treated: Adverse Event|0|||
131748637|NCT01001234|474356428|FG002|Overall Study|Not Treated: Adverse Event|0|||
131748638|NCT01001234|474356429|FG003|Overall Study|Not Treated: Adverse Event|0|||
131748639|NCT01001234|474356430|FG004|Overall Study|Not Treated: Adverse Event|0|||
131748640|NCT01001234|474356426|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
131748641|NCT01001234|474356427|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
131748642|NCT01001234|474356428|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
131748643|NCT01001234|474356429|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
131808873|NCT04089735|474584306|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
131808874|NCT01439880|474584307|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
131808875|NCT01439880|474584308|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
131808876|NCT01439880|474584307|FG000|SOC-controlled Period (Year 1)|Death|2|||
131808877|NCT01439880|474584308|FG001|SOC-controlled Period (Year 1)|Death|1|||
131808878|NCT01439880|474584307|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
131808879|NCT01439880|474584308|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
131808880|NCT01439880|474584307|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
131808881|NCT01439880|474584308|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
131748644|NCT01001234|474356430|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
131748645|NCT01001234|474356426|FG000|Overall Study|Not Treated: Protocol Violation|3|||
131748646|NCT01001234|474356427|FG001|Overall Study|Not Treated: Protocol Violation|0|||
131748647|NCT01001234|474356428|FG002|Overall Study|Not Treated: Protocol Violation|0|||
131748648|NCT01001234|474356429|FG003|Overall Study|Not Treated: Protocol Violation|0|||
131748649|NCT01001234|474356430|FG004|Overall Study|Not Treated: Protocol Violation|0|||
131748650|NCT01001234|474356426|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
131748651|NCT01001234|474356427|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
131748652|NCT01001234|474356428|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
131748653|NCT01001234|474356429|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
131748654|NCT01001234|474356430|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
131748655|NCT01001234|474356426|FG000|Overall Study|Not Treated: Pregnancy|3|||
131748656|NCT01001234|474356427|FG001|Overall Study|Not Treated: Pregnancy|0|||
131748657|NCT01001234|474356428|FG002|Overall Study|Not Treated: Pregnancy|0|||
131748658|NCT01001234|474356429|FG003|Overall Study|Not Treated: Pregnancy|0|||
131748659|NCT01001234|474356430|FG004|Overall Study|Not Treated: Pregnancy|0|||
131748660|NCT01001234|474356426|FG000|Overall Study|Not Treated: Physician Decision|37|||
131748661|NCT01001234|474356427|FG001|Overall Study|Not Treated: Physician Decision|4|||
131748662|NCT01001234|474356428|FG002|Overall Study|Not Treated: Physician Decision|0|||
131748663|NCT01001234|474356429|FG003|Overall Study|Not Treated: Physician Decision|0|||
131748664|NCT01001234|474356430|FG004|Overall Study|Not Treated: Physician Decision|0|||
131748665|NCT01001234|474356426|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
131748666|NCT01001234|474356427|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
131748667|NCT01001234|474356428|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
131748668|NCT01001234|474356429|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
131748669|NCT01001234|474356430|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
131748670|NCT02076334|474356431|FG000|Overall Study|Protocol Violation|1|||
131748671|NCT02076334|474356432|FG001|Overall Study|Protocol Violation|0|||
131748672|NCT02076334|474356433|FG002|Overall Study|Protocol Violation|0|||
131748673|NCT02076334|474356434|FG003|Overall Study|Protocol Violation|0|||
131748674|NCT02076334|474356431|FG000|Overall Study|Lost to Follow-up|0|||
131748675|NCT02076334|474356432|FG001|Overall Study|Lost to Follow-up|1|||
131748676|NCT02076334|474356433|FG002|Overall Study|Lost to Follow-up|1|||
131748677|NCT02076334|474356434|FG003|Overall Study|Lost to Follow-up|0|||
131748678|NCT02076334|474356431|FG000|Overall Study|muscle soreness|0|||
131748679|NCT02076334|474356432|FG001|Overall Study|muscle soreness|0|||
131748680|NCT02076334|474356433|FG002|Overall Study|muscle soreness|0|||
131748681|NCT02076334|474356434|FG003|Overall Study|muscle soreness|1|||
131748682|NCT01611298|474356435|FG000|Overall Study|Relapsed|2|||
131748683|NCT03332303|474356436|FG000|Overall Study|Participant did not dose|1|||
131748684|NCT03332303|474356437|FG001|Overall Study|Participant did not dose|2|||
131748685|NCT03332303|474356438|FG002|Overall Study|Participant did not dose|0|||
131748686|NCT03332303|474356436|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
131748687|NCT03332303|474356437|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
131748688|NCT03332303|474356438|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
131748689|NCT03332303|474356436|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
131748690|NCT03332303|474356437|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
131748691|NCT03332303|474356438|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
131748692|NCT03332303|474356436|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
131748693|NCT03332303|474356437|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
131748694|NCT03332303|474356438|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
131748695|NCT03332303|474356436|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
131748696|NCT03332303|474356437|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
131748697|NCT03332303|474356438|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
131748698|NCT03332303|474356436|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
131748699|NCT03332303|474356437|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
131748700|NCT03332303|474356438|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
131748701|NCT03332303|474356436|FG000|Overall Study|Participant had a significant protocol deviation|0|||
131808882|NCT01439880|474584307|FG000|SOC-controlled Period (Year 1)|Other|8|||
131808883|NCT01439880|474584308|FG001|SOC-controlled Period (Year 1)|Other|13|||
131808884|NCT01439880|474584307|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
131808885|NCT01439880|474584308|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
131808886|NCT01439880|474584307|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
131808887|NCT01439880|474584308|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
131808888|NCT01439880|474584307|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
131808889|NCT01439880|474584308|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
131808890|NCT01439880|474584307|FG000|All-IP Period (Years 2 to 5)|Death|3|||
131748702|NCT03332303|474356437|FG001|Overall Study|Participant had a significant protocol deviation|1|||
131748703|NCT03332303|474356438|FG002|Overall Study|Participant had a significant protocol deviation|0|||
131748704|NCT01296698|474356439|FG000|Overall Study|Adverse Event|1|||
131748705|NCT01296698|474356440|FG001|Overall Study|Adverse Event|0|||
131748706|NCT01296698|474356439|FG000|Overall Study|Death|1|||
131748707|NCT01296698|474356440|FG001|Overall Study|Death|0|||
131748708|NCT01296698|474356439|FG000|Overall Study|Lost to Follow-up|19|||
131748709|NCT01296698|474356440|FG001|Overall Study|Lost to Follow-up|1|||
131748710|NCT01296698|474356439|FG000|Overall Study|Withdrawal by Subject|12|||
131748711|NCT01296698|474356440|FG001|Overall Study|Withdrawal by Subject|0|||
131808891|NCT01439880|474584308|FG001|All-IP Period (Years 2 to 5)|Death|13|||
131808892|NCT01439880|474584307|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
131808893|NCT01439880|474584308|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
131748712|NCT01296698|474356439|FG000|Overall Study|Difficulty Contacting Subject|2|||
131748713|NCT01296698|474356440|FG001|Overall Study|Difficulty Contacting Subject|0|||
131748714|NCT01296698|474356439|FG000|Overall Study|Study Terminated by Sponsor|209|||
131748715|NCT01296698|474356440|FG001|Overall Study|Study Terminated by Sponsor|12|||
131748716|NCT03639987|474356441|FG000|Overall Study|Study terminated by sponsor|26|||
131748717|NCT03639987|474356442|FG001|Overall Study|Study terminated by sponsor|25|||
131748718|NCT03639987|474356441|FG000|Overall Study|Lost to Follow-up|0|||
131748719|NCT03639987|474356442|FG001|Overall Study|Lost to Follow-up|1|||
131748720|NCT02193828|474356446|FG000|Overall Study|Withdrawal by Subject|0|||
131748721|NCT02193828|474356447|FG001|Overall Study|Withdrawal by Subject|0|||
131748722|NCT02193828|474356448|FG002|Overall Study|Withdrawal by Subject|1|||
131748723|NCT02193828|474356449|FG003|Overall Study|Withdrawal by Subject|1|||
131748724|NCT01185704|474356450|FG000|Overall Study|Randomized but not treated|3|||
131748725|NCT01185704|474356451|FG001|Overall Study|Randomized but not treated|3|||
131748726|NCT01185704|474356450|FG000|Overall Study|Lack of ovarian response|5|||
131748727|NCT01185704|474356451|FG001|Overall Study|Lack of ovarian response|1|||
131748728|NCT01185704|474356450|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
131748729|NCT01185704|474356451|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
131748730|NCT01185704|474356450|FG000|Overall Study|Ectopic pregnancy|0|||
131748731|NCT01185704|474356451|FG001|Overall Study|Ectopic pregnancy|1|||
131748732|NCT02248857|474356452|FG000|3 Month|Withdrawal by Subject|9|||
131748733|NCT02248857|474356453|FG001|3 Month|Withdrawal by Subject|3|||
131748734|NCT02248857|474356454|FG002|3 Month|Withdrawal by Subject|4|||
131748735|NCT02248857|474356452|FG000|3 Month|Unable to reach for 3 month|35|||
131748736|NCT02248857|474356453|FG001|3 Month|Unable to reach for 3 month|29|||
131748737|NCT02248857|474356454|FG002|3 Month|Unable to reach for 3 month|26|||
131748738|NCT02248857|474356452|FG000|3 Month|Partially completed, unable to finish|2|||
131748739|NCT02248857|474356453|FG001|3 Month|Partially completed, unable to finish|2|||
131748740|NCT02248857|474356454|FG002|3 Month|Partially completed, unable to finish|1|||
131748741|NCT02248857|474356452|FG000|6 Month|Lost to Follow-up|27|||
131748742|NCT02248857|474356453|FG001|6 Month|Lost to Follow-up|26|||
131748743|NCT02248857|474356454|FG002|6 Month|Lost to Follow-up|15|||
131748744|NCT02248857|474356452|FG000|6 Month|Partially completed, unable to finish|0|||
131748745|NCT02248857|474356453|FG001|6 Month|Partially completed, unable to finish|1|||
131748746|NCT02248857|474356454|FG002|6 Month|Partially completed, unable to finish|0|||
131748747|NCT02248857|474356452|FG000|6 Month|Withdrawal by Subject|0|||
131748748|NCT02248857|474356453|FG001|6 Month|Withdrawal by Subject|2|||
131748749|NCT02248857|474356454|FG002|6 Month|Withdrawal by Subject|2|||
131748750|NCT02248857|474356452|FG000|6 Month|Death|1|||
131748751|NCT02248857|474356453|FG001|6 Month|Death|0|||
131748752|NCT02248857|474356454|FG002|6 Month|Death|0|||
131748753|NCT00861380|474356458|FG000|Overall Study|Withdrawal Information not recorded|8427|||
131748754|NCT00861380|474356459|FG001|Overall Study|Withdrawal Information not recorded|9112|||
131748755|NCT00861380|474356460|FG002|Overall Study|Withdrawal Information not recorded|8872|||
131748756|NCT00861380|474356461|FG003|Overall Study|Withdrawal Information not recorded|3689|||
131748757|NCT00861380|474356462|FG004|Overall Study|Withdrawal Information not recorded|1812|||
131748758|NCT00861380|474356463|FG005|Overall Study|Withdrawal Information not recorded|6249|||
131748759|NCT00861380|474356464|FG006|Overall Study|Withdrawal Information not recorded|3020|||
131748760|NCT00260429|474356465|FG000|Overall Study|failure to follow appointments|1|||
131748761|NCT00260429|474356466|FG001|Overall Study|failure to follow appointments|0|||
131748762|NCT00260429|474356465|FG000|Overall Study|scheduled hand surgery|1|||
131748763|NCT00260429|474356466|FG001|Overall Study|scheduled hand surgery|0|||
131748764|NCT03750240|474358616|FG000|Overall Study|Technical Difficulties|2|||
131748765|NCT00927758|474358617|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131748766|NCT00927758|474358618|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131748767|NCT00927758|474358619|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131748768|NCT00927758|474358620|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
131748769|NCT00927758|474358621|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131748770|NCT00927758|474358622|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
131748771|NCT00927758|474358617|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
131748772|NCT00927758|474358618|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
131748773|NCT00927758|474358619|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
131748774|NCT00927758|474358620|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
131748775|NCT00927758|474358621|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
131748776|NCT00927758|474358622|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
131748777|NCT00439725|474358624|FG000|Treatment Period|Withdrawal by Subject|22|||
131748778|NCT00439725|474358625|FG001|Treatment Period|Withdrawal by Subject|19|||
131748779|NCT00439725|474358624|FG000|Treatment Period|Study terminated by sponsor|156|||
131748780|NCT00439725|474358625|FG001|Treatment Period|Study terminated by sponsor|148|||
131748781|NCT00439725|474358624|FG000|Treatment Period|Site closed by investigator|1|||
131748782|NCT00439725|474358625|FG001|Treatment Period|Site closed by investigator|2|||
131748783|NCT00439725|474358624|FG000|Treatment Period|Adverse Event|39|||
131748784|NCT00439725|474358625|FG001|Treatment Period|Adverse Event|18|||
131808894|NCT01439880|474584307|FG000|All-IP Period (Years 2 to 5)|Other|14|||
131808895|NCT01439880|474584308|FG001|All-IP Period (Years 2 to 5)|Other|31|||
131808896|NCT01439880|474584307|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
131748785|NCT00439725|474358624|FG000|Treatment Period|Physician Decision|1|||
131748786|NCT00439725|474358625|FG001|Treatment Period|Physician Decision|1|||
131748787|NCT00439725|474358624|FG000|Treatment Period|Protocol Violation|2|||
131748788|NCT00439725|474358625|FG001|Treatment Period|Protocol Violation|1|||
131748789|NCT00439725|474358624|FG000|Treatment Period|Clinical endpoint reached|6|||
131748790|NCT00439725|474358625|FG001|Treatment Period|Clinical endpoint reached|50|||
131748791|NCT00439725|474358624|FG000|Treatment Period|Technical problems|1|||
131748792|NCT00439725|474358625|FG001|Treatment Period|Technical problems|0|||
131748793|NCT00439725|474358624|FG000|Treatment Period|Lost to Follow-up|1|||
131748794|NCT00439725|474358625|FG001|Treatment Period|Lost to Follow-up|1|||
131748795|NCT00439725|474358624|FG000|Treatment Period|Participant convenience|1|||
131748796|NCT00439725|474358625|FG001|Treatment Period|Participant convenience|0|||
131748797|NCT00439725|474358624|FG000|Treatment Period|Protocol driven decision point|1|||
131748798|NCT00439725|474358625|FG001|Treatment Period|Protocol driven decision point|1|||
131748799|NCT00439725|474358624|FG000|Treatment Period|Death|1|||
131748800|NCT00439725|474358625|FG001|Treatment Period|Death|1|||
131748801|NCT00439725|474358624|FG000|Treatment Period|Participant did not receive treatment|4|||
131748802|NCT00439725|474358625|FG001|Treatment Period|Participant did not receive treatment|4|||
131748803|NCT00439725|474358624|FG000|Observational Period|Withdrawal by Subject|2|||
131748804|NCT00439725|474358625|FG001|Observational Period|Withdrawal by Subject|2|||
131748805|NCT00439725|474358624|FG000|Observational Period|Lost to Follow-up|0|||
131748806|NCT00439725|474358625|FG001|Observational Period|Lost to Follow-up|1|||
131748807|NCT00439725|474358624|FG000|Observational Period|Death|0|||
131748808|NCT00439725|474358625|FG001|Observational Period|Death|2|||
131748809|NCT00439725|474358624|FG000|Observational Period|Study termination by sponsor|1|||
131748810|NCT00439725|474358625|FG001|Observational Period|Study termination by sponsor|1|||
131748811|NCT00439725|474358624|FG000|Observational Period|Clinical endpoint reached|3|||
131748812|NCT00439725|474358625|FG001|Observational Period|Clinical endpoint reached|1|||
131748813|NCT00439725|474358624|FG000|Observational Period|Technical problems|1|||
131748814|NCT00439725|474358625|FG001|Observational Period|Technical problems|0|||
131748815|NCT00439725|474358624|FG000|Observational Period|Participant convenience|1|||
131748816|NCT00439725|474358625|FG001|Observational Period|Participant convenience|0|||
131748817|NCT00379236|474358626|FG000|Double-blind|Adverse Event|11|||
131748818|NCT00379236|474358627|FG001|Double-blind|Adverse Event|6|||
131748819|NCT00379236|474358628|FG002|Double-blind|Adverse Event|0|||
131748820|NCT00379236|474358626|FG000|Double-blind|Protocol Violation|3|||
131748821|NCT00379236|474358627|FG001|Double-blind|Protocol Violation|3|||
131748822|NCT00379236|474358628|FG002|Double-blind|Protocol Violation|0|||
131748823|NCT00379236|474358626|FG000|Double-blind|Withdrawal by Subject|12|||
131748824|NCT00379236|474358627|FG001|Double-blind|Withdrawal by Subject|13|||
131748825|NCT00379236|474358628|FG002|Double-blind|Withdrawal by Subject|0|||
131748826|NCT00379236|474358626|FG000|Double-blind|Lost to Follow-up|4|||
131748827|NCT00379236|474358627|FG001|Double-blind|Lost to Follow-up|3|||
131748828|NCT00379236|474358628|FG002|Double-blind|Lost to Follow-up|0|||
131748829|NCT00379236|474358626|FG000|Double-blind|Use of exclusionary medication|1|||
131748830|NCT00379236|474358627|FG001|Double-blind|Use of exclusionary medication|2|||
131748831|NCT00379236|474358628|FG002|Double-blind|Use of exclusionary medication|0|||
131748832|NCT00379236|474358626|FG000|Double-blind|Other|3|||
131748833|NCT00379236|474358627|FG001|Double-blind|Other|7|||
131748834|NCT00379236|474358628|FG002|Double-blind|Other|0|||
131748835|NCT00379236|474358626|FG000|Double-blind|Data could not be retrieved|2|||
131748836|NCT00379236|474358627|FG001|Double-blind|Data could not be retrieved|2|||
131748837|NCT00379236|474358628|FG002|Double-blind|Data could not be retrieved|0|||
131748838|NCT00379236|474358626|FG000|Open-label Extension|Adverse Event|0|||
131748839|NCT00379236|474358627|FG001|Open-label Extension|Adverse Event|0|||
131748840|NCT00379236|474358628|FG002|Open-label Extension|Adverse Event|13|||
131748841|NCT00379236|474358626|FG000|Open-label Extension|Protocol Violation|0|||
131748842|NCT00379236|474358627|FG001|Open-label Extension|Protocol Violation|0|||
131748843|NCT00379236|474358628|FG002|Open-label Extension|Protocol Violation|7|||
131748844|NCT00379236|474358626|FG000|Open-label Extension|Withdrawal by Subject|0|||
131748845|NCT00379236|474358627|FG001|Open-label Extension|Withdrawal by Subject|0|||
131808897|NCT01439880|474584308|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
131808898|NCT03874715|474584311|FG000|Overall Study|Adverse Event|2|||
131748846|NCT00379236|474358628|FG002|Open-label Extension|Withdrawal by Subject|13|||
131748847|NCT00379236|474358626|FG000|Open-label Extension|Lost to Follow-up|0|||
131748848|NCT00379236|474358627|FG001|Open-label Extension|Lost to Follow-up|0|||
131748849|NCT00379236|474358628|FG002|Open-label Extension|Lost to Follow-up|12|||
131748850|NCT00379236|474358626|FG000|Open-label Extension|Use of exclusionary medication|0|||
131748851|NCT00379236|474358627|FG001|Open-label Extension|Use of exclusionary medication|0|||
131748852|NCT00379236|474358628|FG002|Open-label Extension|Use of exclusionary medication|3|||
131748853|NCT00379236|474358626|FG000|Open-label Extension|Other|0|||
131748854|NCT00379236|474358627|FG001|Open-label Extension|Other|0|||
131748855|NCT00379236|474358628|FG002|Open-label Extension|Other|7|||
131748856|NCT04914819|474358629|FG000|Overall Study|Pregnancy|3|||
131748857|NCT04914819|474358630|FG001|Overall Study|Pregnancy|1|||
131748858|NCT04914819|474358629|FG000|Overall Study|Discontinued study|4|||
131748859|NCT04914819|474358630|FG001|Overall Study|Discontinued study|1|||
131748860|NCT04914819|474358629|FG000|Overall Study|Lost to Follow-up|7|||
131748861|NCT04914819|474358630|FG001|Overall Study|Lost to Follow-up|0|||
131748862|NCT04038385|474358631|FG000|Overall Study|Completed baseline assessment only|7|||
131748863|NCT04038385|474358632|FG001|Overall Study|Completed baseline assessment only|4|||
131748864|NCT04038385|474358631|FG000|Overall Study|Moved out of area|4|||
131748865|NCT04038385|474358632|FG001|Overall Study|Moved out of area|2|||
131748866|NCT04038385|474358631|FG000|Overall Study|Discontinued study involvement|6|||
131748867|NCT04038385|474358632|FG001|Overall Study|Discontinued study involvement|1|||
131808899|NCT03874715|474584312|FG001|Overall Study|Adverse Event|0|||
131808900|NCT03874715|474584311|FG000|Overall Study|Poor compliance to protocol|5|||
131808901|NCT03874715|474584312|FG001|Overall Study|Poor compliance to protocol|1|||
131808902|NCT03874715|474584311|FG000|Overall Study|Withdrawal by Subject|1|||
131808903|NCT03874715|474584312|FG001|Overall Study|Withdrawal by Subject|0|||
131808904|NCT03874715|474584311|FG000|Overall Study|Other-unspecified|1|||
131808905|NCT03874715|474584312|FG001|Overall Study|Other-unspecified|0|||
131808906|NCT00834249|474584313|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131808907|NCT00834249|474584314|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
131808908|NCT00834249|474584313|FG000|Second Intervention|Adverse Event|1|||
131808909|NCT00834249|474584314|FG001|Second Intervention|Adverse Event|0|||
131808910|NCT01015703|474584317|FG000|Overall Study|Withdrawal by Subject|0|||
131808911|NCT01015703|474584318|FG001|Overall Study|Withdrawal by Subject|1|||
131808912|NCT01015703|474584319|FG002|Overall Study|Withdrawal by Subject|0|||
131808913|NCT01015703|474584320|FG003|Overall Study|Withdrawal by Subject|0|||
131808914|NCT01015703|474584321|FG004|Overall Study|Withdrawal by Subject|0|||
131808915|NCT01015703|474584317|FG000|Overall Study|Adverse Event|1|||
131808916|NCT01015703|474584318|FG001|Overall Study|Adverse Event|0|||
131808917|NCT01015703|474584319|FG002|Overall Study|Adverse Event|0|||
131808918|NCT01015703|474584320|FG003|Overall Study|Adverse Event|0|||
131808919|NCT01015703|474584321|FG004|Overall Study|Adverse Event|0|||
131808920|NCT01015703|474584317|FG000|Overall Study|Protocol Violation|1|||
131808921|NCT01015703|474584318|FG001|Overall Study|Protocol Violation|0|||
131808922|NCT01015703|474584319|FG002|Overall Study|Protocol Violation|0|||
131748868|NCT01625611|474358633|FG000|Overall Study|No adlib drinks Lab 1|3|||
131748869|NCT01625611|474358634|FG001|Overall Study|No adlib drinks Lab 1|0|||
131808923|NCT01015703|474584320|FG003|Overall Study|Protocol Violation|0|||
131808924|NCT01015703|474584321|FG004|Overall Study|Protocol Violation|0|||
131808925|NCT01083693|474584325|FG000|Overall Study|Adverse Event|1|||
131748870|NCT01625611|474358633|FG000|Overall Study|Technical issues with PET|1|||
131808926|NCT01083693|474584326|FG001|Overall Study|Adverse Event|1|||
131808927|NCT01083693|474584327|FG002|Overall Study|Adverse Event|0|||
131748871|NCT01625611|474358634|FG001|Overall Study|Technical issues with PET|0|||
131748872|NCT01625611|474358633|FG000|Overall Study|Unable to complete study procedures|1|||
131748873|NCT01625611|474358634|FG001|Overall Study|Unable to complete study procedures|0|||
131748874|NCT01625611|474358633|FG000|Overall Study|Withdrawal by Subject|3|||
131748875|NCT01625611|474358634|FG001|Overall Study|Withdrawal by Subject|0|||
131748876|NCT01527110|474358635|FG000|Overall Study|Adverse Event|1|||
131808928|NCT01083693|474584325|FG000|Overall Study|Lost to Follow-up|2|||
131808929|NCT01083693|474584326|FG001|Overall Study|Lost to Follow-up|0|||
131748877|NCT01709708|474358636|FG000|Overall Study|Protocol Violation|1|||
131748878|NCT01709708|474358637|FG001|Overall Study|Protocol Violation|2|||
131748879|NCT00511108|474358640|FG000|Overall Study|Adverse Event|2|||
131748880|NCT00511108|474358641|FG001|Overall Study|Adverse Event|0|||
131748881|NCT00511108|474358642|FG002|Overall Study|Adverse Event|1|||
131748882|NCT00511108|474358643|FG003|Overall Study|Adverse Event|2|||
131748883|NCT00511108|474358640|FG000|Overall Study|Lost to Follow-up|0|||
131748884|NCT00511108|474358641|FG001|Overall Study|Lost to Follow-up|2|||
131748885|NCT00511108|474358642|FG002|Overall Study|Lost to Follow-up|1|||
131748886|NCT00511108|474358643|FG003|Overall Study|Lost to Follow-up|0|||
131748887|NCT00511108|474358640|FG000|Overall Study|Physician Decision|0|||
131748888|NCT00511108|474358641|FG001|Overall Study|Physician Decision|0|||
131748889|NCT00511108|474358642|FG002|Overall Study|Physician Decision|0|||
131748890|NCT00511108|474358643|FG003|Overall Study|Physician Decision|1|||
131748891|NCT00511108|474358640|FG000|Overall Study|Withdrawal by Subject|4|||
131748892|NCT00511108|474358641|FG001|Overall Study|Withdrawal by Subject|0|||
131748893|NCT00511108|474358642|FG002|Overall Study|Withdrawal by Subject|3|||
131748894|NCT00511108|474358643|FG003|Overall Study|Withdrawal by Subject|2|||
131748895|NCT02147691|474358646|FG000|Overall Study|Withdrawal by Subject|2|||
131748896|NCT02147691|474358647|FG001|Overall Study|Withdrawal by Subject|0|||
131748897|NCT02147691|474358646|FG000|Overall Study|Adverse Event|2|||
131748898|NCT02147691|474358647|FG001|Overall Study|Adverse Event|0|||
131748899|NCT02147691|474358646|FG000|Overall Study|Lost to Follow-up|0|||
131748900|NCT02147691|474358647|FG001|Overall Study|Lost to Follow-up|1|||
131748901|NCT02954952|474358648|FG000|Overall Study|Withdrawal by Subject|1|||
131748902|NCT02954952|474358649|FG001|Overall Study|Withdrawal by Subject|0|||
131748903|NCT02954952|474358650|FG002|Overall Study|Withdrawal by Subject|0|||
131748904|NCT02954952|474358648|FG000|Overall Study|No data collected|0|||
131748905|NCT02954952|474358649|FG001|Overall Study|No data collected|1|||
131748906|NCT02954952|474358650|FG002|Overall Study|No data collected|0|||
131748907|NCT01392742|474358651|FG000|Overall Study|Premature study termination|42|||
131748908|NCT01392742|474358651|FG000|Overall Study|Failure to return|35|||
131748909|NCT01392742|474358651|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
131748910|NCT01392742|474358651|FG000|Overall Study|Lost to Follow-up|34|||
131748911|NCT01392742|474358651|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
131748912|NCT01392742|474358651|FG000|Overall Study|ITR and Protocol deviation|1|||
131748913|NCT01392742|474358651|FG000|Overall Study|Adverse event/intercurrent illness|17|||
131748914|NCT01392742|474358651|FG000|Overall Study|Protocol Violation|14|||
131748915|NCT01392742|474358651|FG000|Overall Study|Other|3|||
131748916|NCT01392742|474358651|FG000|Overall Study|Missing information|13|||
131748917|NCT04179032|474358652|FG000|Part B (Up to Week 52)|Adverse Event|1|||
131748918|NCT04179032|474358652|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
131748919|NCT04179032|474358652|FG000|Access Extension Phase|Ongoing|11|||
131748920|NCT01998958|474358653|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748921|NCT01998958|474358654|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
131748922|NCT01998958|474358655|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748923|NCT01998958|474358656|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748924|NCT01998958|474358657|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748925|NCT01998958|474358658|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748926|NCT01998958|474358659|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748927|NCT01998958|474358660|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748928|NCT01998958|474358661|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748929|NCT01998958|474358662|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748930|NCT01998958|474358663|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748931|NCT01998958|474358664|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748932|NCT01998958|474358665|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748933|NCT01998958|474358666|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748934|NCT01998958|474358667|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748935|NCT01998958|474358668|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748936|NCT01998958|474358669|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748937|NCT01998958|474358670|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748938|NCT01998958|474358671|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748939|NCT01998958|474358672|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748940|NCT01998958|474358673|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131808930|NCT01083693|474584327|FG002|Overall Study|Lost to Follow-up|2|||
131808931|NCT01083693|474584325|FG000|Overall Study|Lack of effectiveness|13|||
131748941|NCT01998958|474358674|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748942|NCT01998958|474358675|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748943|NCT01998958|474358676|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748944|NCT01998958|474358677|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748945|NCT01998958|474358678|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748946|NCT01998958|474358679|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748947|NCT01998958|474358680|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748948|NCT01998958|474358681|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748949|NCT01998958|474358682|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748950|NCT01998958|474358683|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748951|NCT01998958|474358684|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131748952|NCT01998958|474358653|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748953|NCT01998958|474358654|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
131748954|NCT01998958|474358655|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748955|NCT01998958|474358656|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748956|NCT01998958|474358657|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748957|NCT01998958|474358658|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748958|NCT01998958|474358659|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748959|NCT01998958|474358660|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748960|NCT01998958|474358661|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748961|NCT01998958|474358662|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748962|NCT01998958|474358663|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748963|NCT01998958|474358664|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748964|NCT01998958|474358665|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748965|NCT01998958|474358666|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748966|NCT01998958|474358667|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748967|NCT01998958|474358668|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748968|NCT01998958|474358669|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748969|NCT01998958|474358670|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748970|NCT01998958|474358671|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748971|NCT01998958|474358672|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748972|NCT01998958|474358673|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748973|NCT01998958|474358674|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748974|NCT01998958|474358675|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748975|NCT01998958|474358676|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748976|NCT01998958|474358677|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748977|NCT01998958|474358678|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748978|NCT01998958|474358679|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748979|NCT01998958|474358680|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748980|NCT01998958|474358681|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748981|NCT01998958|474358682|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748982|NCT01998958|474358683|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748983|NCT01998958|474358684|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131748984|NCT01998958|474358653|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
131748985|NCT01998958|474358654|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
131748986|NCT01998958|474358655|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
131748987|NCT01998958|474358656|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
131748988|NCT01998958|474358657|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
131748989|NCT01998958|474358658|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
131748990|NCT01998958|474358659|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
131748991|NCT01998958|474358660|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
131748992|NCT01998958|474358661|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
131748993|NCT01998958|474358662|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
131748994|NCT01998958|474358663|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
131748995|NCT01998958|474358664|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
131748996|NCT01998958|474358665|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
131748997|NCT01998958|474358666|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
131748998|NCT01998958|474358667|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
131748999|NCT01998958|474358668|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
131749000|NCT01998958|474358669|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
131749001|NCT01998958|474358670|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
131749002|NCT01998958|474358671|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
131749003|NCT01998958|474358672|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
131749004|NCT01998958|474358673|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
131749005|NCT01998958|474358674|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
131749006|NCT01998958|474358675|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
131749007|NCT01998958|474358676|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
131749008|NCT01998958|474358677|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
131749009|NCT01998958|474358678|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
131749010|NCT01998958|474358679|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
131749011|NCT01998958|474358680|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
131749012|NCT01998958|474358681|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
131749013|NCT01998958|474358682|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
131749014|NCT01998958|474358683|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
131749015|NCT01998958|474358684|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
131749016|NCT01998958|474358653|FG000|Period 1 (Panel A and B)|Other|1|||
131749017|NCT01998958|474358654|FG001|Period 1 (Panel A and B)|Other|0|||
131449220|NCT01002339|473274814|FG001|Overall Study|Incorrect treatment assignment|0|||
131749018|NCT01998958|474358655|FG002|Period 1 (Panel A and B)|Other|0|||
131749019|NCT01998958|474358656|FG003|Period 1 (Panel A and B)|Other|0|||
131749020|NCT01998958|474358657|FG004|Period 1 (Panel A and B)|Other|0|||
131808932|NCT01083693|474584326|FG001|Overall Study|Lack of effectiveness|2|||
131808933|NCT01083693|474584327|FG002|Overall Study|Lack of effectiveness|2|||
131808934|NCT01083693|474584325|FG000|Overall Study|Patient Moved|0|||
131749021|NCT01998958|474358658|FG005|Period 1 (Panel A and B)|Other|0|||
131749022|NCT01998958|474358659|FG006|Period 1 (Panel A and B)|Other|0|||
131749023|NCT01998958|474358660|FG007|Period 1 (Panel A and B)|Other|0|||
131749024|NCT01998958|474358661|FG008|Period 1 (Panel A and B)|Other|0|||
131749025|NCT01998958|474358662|FG009|Period 1 (Panel A and B)|Other|0|||
131749026|NCT01998958|474358663|FG010|Period 1 (Panel A and B)|Other|0|||
131749027|NCT01998958|474358664|FG011|Period 1 (Panel A and B)|Other|0|||
131749028|NCT01998958|474358665|FG012|Period 1 (Panel A and B)|Other|0|||
131749029|NCT01998958|474358666|FG013|Period 1 (Panel A and B)|Other|0|||
131749030|NCT01998958|474358667|FG014|Period 1 (Panel A and B)|Other|0|||
131749031|NCT01998958|474358668|FG015|Period 1 (Panel A and B)|Other|0|||
131749032|NCT01998958|474358669|FG016|Period 1 (Panel A and B)|Other|0|||
131749033|NCT01998958|474358670|FG017|Period 1 (Panel A and B)|Other|0|||
131749034|NCT01998958|474358671|FG018|Period 1 (Panel A and B)|Other|0|||
131749035|NCT01998958|474358672|FG019|Period 1 (Panel A and B)|Other|0|||
131749036|NCT01998958|474358673|FG020|Period 1 (Panel A and B)|Other|0|||
131749037|NCT01998958|474358674|FG021|Period 1 (Panel A and B)|Other|0|||
131749038|NCT01998958|474358675|FG022|Period 1 (Panel A and B)|Other|0|||
131749039|NCT01998958|474358676|FG023|Period 1 (Panel A and B)|Other|0|||
131749040|NCT01998958|474358677|FG024|Period 1 (Panel A and B)|Other|0|||
131749041|NCT01998958|474358678|FG025|Period 1 (Panel A and B)|Other|0|||
131749042|NCT01998958|474358679|FG026|Period 1 (Panel A and B)|Other|0|||
131749043|NCT01998958|474358680|FG027|Period 1 (Panel A and B)|Other|0|||
131749044|NCT01998958|474358681|FG028|Period 1 (Panel A and B)|Other|0|||
131749045|NCT01998958|474358682|FG029|Period 1 (Panel A and B)|Other|0|||
131749046|NCT01998958|474358683|FG030|Period 1 (Panel A and B)|Other|0|||
131749047|NCT01998958|474358684|FG031|Period 1 (Panel A and B)|Other|0|||
131749048|NCT01998958|474358653|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
131749049|NCT01998958|474358654|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
131749050|NCT01998958|474358655|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
131749051|NCT01998958|474358656|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
131749052|NCT01998958|474358657|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
131749053|NCT01998958|474358658|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
131749054|NCT01998958|474358659|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
131749055|NCT01998958|474358660|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
131749056|NCT01998958|474358661|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
131808935|NCT01083693|474584326|FG001|Overall Study|Patient Moved|1|||
131808936|NCT01083693|474584327|FG002|Overall Study|Patient Moved|0|||
131808937|NCT01083693|474584325|FG000|Overall Study|Complete remission|0|||
131808938|NCT01083693|474584326|FG001|Overall Study|Complete remission|1|||
131808939|NCT01083693|474584327|FG002|Overall Study|Complete remission|0|||
131449221|NCT01002339|473274815|FG002|Overall Study|Incorrect treatment assignment|1|||
131749057|NCT01998958|474358662|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
131749058|NCT01998958|474358663|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
131808940|NCT01083693|474584325|FG000|Overall Study|Other medical condition/surgery|1|||
131808941|NCT01083693|474584326|FG001|Overall Study|Other medical condition/surgery|1|||
131808942|NCT01083693|474584327|FG002|Overall Study|Other medical condition/surgery|0|||
131808943|NCT01083693|474584325|FG000|Overall Study|Withdrawal by Subject|3|||
131808944|NCT01083693|474584326|FG001|Overall Study|Withdrawal by Subject|0|||
131808945|NCT01083693|474584327|FG002|Overall Study|Withdrawal by Subject|2|||
131808946|NCT01083693|474584325|FG000|Overall Study|Reason unknown|0|||
131808947|NCT01083693|474584326|FG001|Overall Study|Reason unknown|0|||
131808948|NCT01083693|474584327|FG002|Overall Study|Reason unknown|1|||
131808949|NCT00834418|474584328|FG000|Overall Study|Adverse Event|0|||
131808950|NCT00834418|474584329|FG001|Overall Study|Adverse Event|2|||
131749059|NCT01998958|474358664|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
131749060|NCT01998958|474358665|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
131749061|NCT01998958|474358666|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
131749062|NCT01998958|474358667|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
131749063|NCT01998958|474358668|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
131749064|NCT01998958|474358669|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
131808951|NCT02543203|474584330|FG000|Overall Study|Unpalatable Fragrance|2|||
131906414|NCT03238417|474945165|FG001|Overall|partial completion|68|||
131808952|NCT02543203|474584331|FG001|Overall Study|Unpalatable Fragrance|2|||
131906415|NCT03238417|474945164|FG000|Baseline|Partial completion|17|||
131808953|NCT02543203|474584330|FG000|Overall Study|Lost to Follow-up|1|||
131749065|NCT01998958|474358670|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
131906416|NCT03238417|474945165|FG001|Baseline|Partial completion|48|||
131749066|NCT01998958|474358671|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
131749067|NCT01998958|474358672|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
131749068|NCT01998958|474358673|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
131749069|NCT01998958|474358674|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
131749070|NCT01998958|474358675|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
131749071|NCT01998958|474358676|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
131749072|NCT01998958|474358677|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
131749073|NCT01998958|474358678|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
131749074|NCT01998958|474358679|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
131749075|NCT01998958|474358680|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
131749076|NCT01998958|474358681|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
131749077|NCT01998958|474358682|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
131749078|NCT01998958|474358683|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
131749079|NCT01998958|474358684|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
131749080|NCT01998958|474358653|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749081|NCT01998958|474358654|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749082|NCT01998958|474358655|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749083|NCT01998958|474358656|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749084|NCT01998958|474358657|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749085|NCT01998958|474358658|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749086|NCT01998958|474358659|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749087|NCT01998958|474358660|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749088|NCT01998958|474358661|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749089|NCT01998958|474358662|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749090|NCT01998958|474358663|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749091|NCT01998958|474358664|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749092|NCT01998958|474358665|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749093|NCT01998958|474358666|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749094|NCT01998958|474358667|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
131749095|NCT01998958|474358668|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749096|NCT01998958|474358669|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749097|NCT01998958|474358670|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749098|NCT01998958|474358671|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
131749099|NCT01998958|474358672|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749100|NCT01998958|474358673|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749101|NCT01998958|474358674|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749102|NCT01998958|474358675|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749103|NCT01998958|474358676|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749104|NCT01998958|474358677|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749105|NCT01998958|474358678|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749106|NCT01998958|474358679|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749107|NCT01998958|474358680|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749108|NCT01998958|474358681|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749109|NCT01998958|474358682|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749110|NCT01998958|474358683|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749111|NCT01998958|474358684|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131749112|NCT01998958|474358653|FG000|Open Label Phase (Optional)|Adverse Event|0|||
131749113|NCT01998958|474358654|FG001|Open Label Phase (Optional)|Adverse Event|0|||
131749114|NCT01998958|474358655|FG002|Open Label Phase (Optional)|Adverse Event|0|||
131749115|NCT01998958|474358656|FG003|Open Label Phase (Optional)|Adverse Event|0|||
131749116|NCT01998958|474358657|FG004|Open Label Phase (Optional)|Adverse Event|0|||
131749117|NCT01998958|474358658|FG005|Open Label Phase (Optional)|Adverse Event|0|||
131749118|NCT01998958|474358659|FG006|Open Label Phase (Optional)|Adverse Event|0|||
131749119|NCT01998958|474358660|FG007|Open Label Phase (Optional)|Adverse Event|0|||
131749120|NCT01998958|474358661|FG008|Open Label Phase (Optional)|Adverse Event|0|||
131749121|NCT01998958|474358662|FG009|Open Label Phase (Optional)|Adverse Event|0|||
131749122|NCT01998958|474358663|FG010|Open Label Phase (Optional)|Adverse Event|0|||
131749123|NCT01998958|474358664|FG011|Open Label Phase (Optional)|Adverse Event|0|||
131749124|NCT01998958|474358665|FG012|Open Label Phase (Optional)|Adverse Event|0|||
131749125|NCT01998958|474358666|FG013|Open Label Phase (Optional)|Adverse Event|0|||
131749126|NCT01998958|474358667|FG014|Open Label Phase (Optional)|Adverse Event|0|||
131749127|NCT01998958|474358668|FG015|Open Label Phase (Optional)|Adverse Event|0|||
131749128|NCT01998958|474358669|FG016|Open Label Phase (Optional)|Adverse Event|0|||
131749129|NCT01998958|474358670|FG017|Open Label Phase (Optional)|Adverse Event|0|||
131749130|NCT01998958|474358671|FG018|Open Label Phase (Optional)|Adverse Event|0|||
131749131|NCT01998958|474358672|FG019|Open Label Phase (Optional)|Adverse Event|0|||
131749132|NCT01998958|474358673|FG020|Open Label Phase (Optional)|Adverse Event|0|||
131749133|NCT01998958|474358674|FG021|Open Label Phase (Optional)|Adverse Event|0|||
131449222|NCT01002339|473274813|FG000|Overall Study|Protocol Violation|0|||
131749134|NCT01998958|474358675|FG022|Open Label Phase (Optional)|Adverse Event|0|||
131808954|NCT02543203|474584331|FG001|Overall Study|Lost to Follow-up|0|||
131808955|NCT02543203|474584330|FG000|Overall Study|Increased Irritability|1|||
131808956|NCT02543203|474584331|FG001|Overall Study|Increased Irritability|0|||
131808957|NCT02543203|474584330|FG000|Overall Study|Family|1|||
131808958|NCT02543203|474584331|FG001|Overall Study|Family|2|||
131808959|NCT02543203|474584330|FG000|Overall Study|Negative Behavior|1|||
131808960|NCT02543203|474584331|FG001|Overall Study|Negative Behavior|0|||
131808961|NCT02543203|474584330|FG000|Overall Study|Withdrawal by Subject|0|||
131808962|NCT02543203|474584331|FG001|Overall Study|Withdrawal by Subject|1|||
131808963|NCT01273805|474584332|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
131808964|NCT01273805|474584333|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
131808965|NCT01602419|474584334|FG000|Overall Study|Not treated with Wilate|9|||
131808966|NCT01602419|474584334|FG000|Overall Study|Adverse Drug Reaction|4|||
131808967|NCT01602419|474584334|FG000|Overall Study|Insurance issues|3|||
131808968|NCT01602419|474584334|FG000|Overall Study|Changed treatment centre|1|||
131808969|NCT01602419|474584334|FG000|Overall Study|Treatment centre closed|1|||
131808970|NCT01602419|474584334|FG000|Overall Study|Withdrawal by Subject|5|||
131808971|NCT01602419|474584334|FG000|Overall Study|Lost to Follow-up|6|||
131808972|NCT01792635|474584335|FG000|Part B|Adverse Event|0|||
131808973|NCT01792635|474584336|FG001|Part B|Adverse Event|0|||
131808974|NCT01792635|474584337|FG002|Part B|Adverse Event|1|||
131808975|NCT01792635|474584335|FG000|Part B|Study terminated|0|||
131808976|NCT01792635|474584336|FG001|Part B|Study terminated|4|||
131808977|NCT01792635|474584337|FG002|Part B|Study terminated|3|||
131808978|NCT01401647|474584342|FG000|Overall Study|Withdrawal by Subject|1|||
131808979|NCT01401647|474584343|FG001|Overall Study|Withdrawal by Subject|5|||
131808980|NCT01401647|474584344|FG002|Overall Study|Withdrawal by Subject|2|||
131808981|NCT01401647|474584342|FG000|Overall Study|Lost to Follow-up|3|||
131449223|NCT01002339|473274814|FG001|Overall Study|Protocol Violation|0|||
131749135|NCT01998958|474358676|FG023|Open Label Phase (Optional)|Adverse Event|1|||
131749136|NCT01998958|474358677|FG024|Open Label Phase (Optional)|Adverse Event|0|||
131749137|NCT01998958|474358678|FG025|Open Label Phase (Optional)|Adverse Event|0|||
131749138|NCT01998958|474358679|FG026|Open Label Phase (Optional)|Adverse Event|0|||
131749139|NCT01998958|474358680|FG027|Open Label Phase (Optional)|Adverse Event|0|||
131749140|NCT01998958|474358681|FG028|Open Label Phase (Optional)|Adverse Event|0|||
131749141|NCT01998958|474358682|FG029|Open Label Phase (Optional)|Adverse Event|0|||
131749142|NCT01998958|474358683|FG030|Open Label Phase (Optional)|Adverse Event|0|||
131749143|NCT01998958|474358684|FG031|Open Label Phase (Optional)|Adverse Event|0|||
131749144|NCT01998958|474358653|FG000|Open Label Phase (Optional)|Other|0|||
131749145|NCT01998958|474358654|FG001|Open Label Phase (Optional)|Other|0|||
131749146|NCT01998958|474358655|FG002|Open Label Phase (Optional)|Other|0|||
131749147|NCT01998958|474358656|FG003|Open Label Phase (Optional)|Other|0|||
131749148|NCT01998958|474358657|FG004|Open Label Phase (Optional)|Other|0|||
131749149|NCT01998958|474358658|FG005|Open Label Phase (Optional)|Other|0|||
131749150|NCT01998958|474358659|FG006|Open Label Phase (Optional)|Other|0|||
131749151|NCT01998958|474358660|FG007|Open Label Phase (Optional)|Other|0|||
131749152|NCT01998958|474358661|FG008|Open Label Phase (Optional)|Other|0|||
131749153|NCT01998958|474358662|FG009|Open Label Phase (Optional)|Other|0|||
131749154|NCT01998958|474358663|FG010|Open Label Phase (Optional)|Other|0|||
131749155|NCT01998958|474358664|FG011|Open Label Phase (Optional)|Other|0|||
131749156|NCT01998958|474358665|FG012|Open Label Phase (Optional)|Other|0|||
131749157|NCT01998958|474358666|FG013|Open Label Phase (Optional)|Other|0|||
131749158|NCT01998958|474358667|FG014|Open Label Phase (Optional)|Other|0|||
131749159|NCT01998958|474358668|FG015|Open Label Phase (Optional)|Other|0|||
131749160|NCT01998958|474358669|FG016|Open Label Phase (Optional)|Other|0|||
131749161|NCT01998958|474358670|FG017|Open Label Phase (Optional)|Other|0|||
131749162|NCT01998958|474358671|FG018|Open Label Phase (Optional)|Other|0|||
131749163|NCT01998958|474358672|FG019|Open Label Phase (Optional)|Other|0|||
131749164|NCT01998958|474358673|FG020|Open Label Phase (Optional)|Other|0|||
131749165|NCT01998958|474358674|FG021|Open Label Phase (Optional)|Other|0|||
131749166|NCT01998958|474358675|FG022|Open Label Phase (Optional)|Other|5|||
131749167|NCT01998958|474358676|FG023|Open Label Phase (Optional)|Other|1|||
131749168|NCT01998958|474358677|FG024|Open Label Phase (Optional)|Other|0|||
131808982|NCT01401647|474584343|FG001|Overall Study|Lost to Follow-up|3|||
131808983|NCT01401647|474584344|FG002|Overall Study|Lost to Follow-up|1|||
131449224|NCT01002339|473274815|FG002|Overall Study|Protocol Violation|2|||
131749169|NCT01998958|474358678|FG025|Open Label Phase (Optional)|Other|0|||
131808984|NCT00473330|474584347|FG000|Core Study|Adverse Event|4|||
131808985|NCT00473330|474584348|FG001|Core Study|Adverse Event|4|||
131808986|NCT00473330|474584349|FG002|Core Study|Adverse Event|1|||
131808987|NCT00473330|474584347|FG000|Core Study|Death|6|||
131808988|NCT00473330|474584348|FG001|Core Study|Death|4|||
131808989|NCT00473330|474584349|FG002|Core Study|Death|4|||
131449225|NCT01002339|473274813|FG000|Overall Study|Lung cancer detected before transplant|0|||
131749170|NCT01998958|474358679|FG026|Open Label Phase (Optional)|Other|0|||
131749171|NCT01998958|474358680|FG027|Open Label Phase (Optional)|Other|0|||
131749172|NCT01998958|474358681|FG028|Open Label Phase (Optional)|Other|0|||
131808990|NCT00473330|474584347|FG000|Core Study|Lost to Follow-up|5|||
131749173|NCT01998958|474358682|FG029|Open Label Phase (Optional)|Other|0|||
131749174|NCT01998958|474358683|FG030|Open Label Phase (Optional)|Other|0|||
131749175|NCT01998958|474358684|FG031|Open Label Phase (Optional)|Other|0|||
131749176|NCT01998958|474358653|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749177|NCT01998958|474358654|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749178|NCT01998958|474358655|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749179|NCT01998958|474358656|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749180|NCT01998958|474358657|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749181|NCT01998958|474358658|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749182|NCT01998958|474358659|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749183|NCT01998958|474358660|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749184|NCT01998958|474358661|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749185|NCT01998958|474358662|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749186|NCT01998958|474358663|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749187|NCT01998958|474358664|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749188|NCT01998958|474358665|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749189|NCT01998958|474358666|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749190|NCT01998958|474358667|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749191|NCT01998958|474358668|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749192|NCT01998958|474358669|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749193|NCT01998958|474358670|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749194|NCT01998958|474358671|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749195|NCT01998958|474358672|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749196|NCT01998958|474358673|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749197|NCT01998958|474358674|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749198|NCT01998958|474358675|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
131749199|NCT01998958|474358676|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749200|NCT01998958|474358677|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749201|NCT01998958|474358678|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749202|NCT01998958|474358679|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749203|NCT01998958|474358680|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749204|NCT01998958|474358681|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749205|NCT01998958|474358682|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749206|NCT01998958|474358683|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749207|NCT01998958|474358684|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
131749208|NCT01998958|474358653|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749209|NCT01998958|474358654|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749210|NCT01998958|474358655|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749211|NCT01998958|474358656|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749212|NCT01998958|474358657|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749213|NCT01998958|474358658|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749214|NCT01998958|474358659|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749215|NCT01998958|474358660|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749216|NCT01998958|474358661|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749217|NCT01998958|474358662|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749218|NCT01998958|474358663|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749219|NCT01998958|474358664|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749220|NCT01998958|474358665|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749221|NCT01998958|474358666|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749222|NCT01998958|474358667|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749223|NCT01998958|474358668|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749224|NCT01998958|474358669|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749225|NCT01998958|474358670|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749226|NCT01998958|474358671|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749227|NCT01998958|474358672|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749228|NCT01998958|474358673|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749229|NCT01998958|474358674|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
131749230|NCT01998958|474358675|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
131749231|NCT01998958|474358676|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749232|NCT01998958|474358677|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749233|NCT01998958|474358678|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749234|NCT01998958|474358679|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749235|NCT01998958|474358680|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749236|NCT01998958|474358681|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749237|NCT01998958|474358682|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
131749238|NCT01998958|474358683|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
131808991|NCT00473330|474584348|FG001|Core Study|Lost to Follow-up|5|||
131808992|NCT00473330|474584349|FG002|Core Study|Lost to Follow-up|10|||
131749239|NCT01998958|474358684|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
131808993|NCT00473330|474584347|FG000|Core Study|Physician Decision|2|||
131808994|NCT00473330|474584348|FG001|Core Study|Physician Decision|1|||
131749240|NCT01998958|474358653|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749241|NCT01998958|474358654|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749242|NCT01998958|474358655|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749243|NCT01998958|474358656|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749244|NCT01998958|474358657|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749245|NCT01998958|474358658|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749246|NCT01998958|474358659|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749247|NCT01998958|474358660|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749248|NCT01998958|474358661|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749249|NCT01998958|474358662|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749250|NCT01998958|474358663|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749251|NCT01998958|474358664|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749252|NCT01998958|474358665|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749253|NCT01998958|474358666|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749254|NCT01998958|474358667|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749255|NCT01998958|474358668|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749256|NCT01998958|474358669|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749257|NCT01998958|474358670|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749258|NCT01998958|474358671|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749259|NCT01998958|474358672|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749260|NCT01998958|474358673|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749261|NCT01998958|474358674|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
131749262|NCT01998958|474358675|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
131749263|NCT01998958|474358676|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
131749264|NCT01998958|474358677|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749265|NCT01998958|474358678|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749266|NCT01998958|474358679|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749267|NCT01998958|474358680|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749268|NCT01998958|474358681|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749269|NCT01998958|474358682|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749270|NCT01998958|474358683|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749271|NCT01998958|474358684|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131749272|NCT02432703|474358685|FG000|Overall Study|Adverse Event|1|||
131749273|NCT02432703|474358686|FG001|Overall Study|Adverse Event|4|||
131749274|NCT02432703|474358685|FG000|Overall Study|Lack of Efficacy|1|||
131749275|NCT02432703|474358686|FG001|Overall Study|Lack of Efficacy|0|||
131749276|NCT02432703|474358685|FG000|Overall Study|Lost to Follow-up|5|||
131749277|NCT02432703|474358686|FG001|Overall Study|Lost to Follow-up|3|||
131749278|NCT02432703|474358685|FG000|Overall Study|Withdrawal by Subject|9|||
131749279|NCT02432703|474358686|FG001|Overall Study|Withdrawal by Subject|6|||
131749280|NCT02432703|474358685|FG000|Overall Study|Other|6|||
131749281|NCT02432703|474358686|FG001|Overall Study|Other|5|||
131749282|NCT01628393|474358687|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
131749283|NCT01628393|474358688|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131749284|NCT01628393|474358689|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131749285|NCT01628393|474358690|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131749286|NCT01628393|474358691|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131749287|NCT01628393|474358687|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
131749288|NCT01628393|474358688|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
131749289|NCT01628393|474358689|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
131749290|NCT01628393|474358690|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
131749291|NCT01628393|474358691|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
131749292|NCT01628393|474358687|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
131749293|NCT01628393|474358688|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
131749294|NCT01628393|474358689|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
131749295|NCT01628393|474358690|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131749296|NCT01628393|474358691|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131749297|NCT01628393|474358687|FG000|Blinded Active Extension Period|Adverse Event|0|||
131749298|NCT01628393|474358688|FG001|Blinded Active Extension Period|Adverse Event|1|||
131749299|NCT01628393|474358689|FG002|Blinded Active Extension Period|Adverse Event|0|||
131749300|NCT01628393|474358690|FG003|Blinded Active Extension Period|Adverse Event|2|||
131749301|NCT01628393|474358691|FG004|Blinded Active Extension Period|Adverse Event|2|||
131749302|NCT01628393|474358687|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
131749303|NCT01628393|474358688|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
131749304|NCT01628393|474358689|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
131749305|NCT01628393|474358690|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
131749306|NCT01628393|474358691|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
131749307|NCT01628393|474358687|FG000|Blinded Active Extension Period|Physician Decision|0|||
131749308|NCT01628393|474358688|FG001|Blinded Active Extension Period|Physician Decision|3|||
131749309|NCT01628393|474358689|FG002|Blinded Active Extension Period|Physician Decision|0|||
131749310|NCT01628393|474358690|FG003|Blinded Active Extension Period|Physician Decision|1|||
131749311|NCT01628393|474358691|FG004|Blinded Active Extension Period|Physician Decision|0|||
131749312|NCT01628393|474358687|FG000|Blinded Active Extension Period|Protocol Violation|0|||
131749313|NCT01628393|474358688|FG001|Blinded Active Extension Period|Protocol Violation|0|||
131749314|NCT01628393|474358689|FG002|Blinded Active Extension Period|Protocol Violation|2|||
131749315|NCT01628393|474358690|FG003|Blinded Active Extension Period|Protocol Violation|1|||
131749316|NCT01628393|474358691|FG004|Blinded Active Extension Period|Protocol Violation|0|||
131749317|NCT01628393|474358687|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
131749318|NCT01628393|474358688|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
131749319|NCT01628393|474358689|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
131749320|NCT01628393|474358690|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
131749321|NCT01628393|474358691|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
131749322|NCT00445341|474358692|FG000|Overall Study|refused further treatment|1|||
131749323|NCT00445341|474358692|FG000|Overall Study|taken off treatment too early|1|||
131749324|NCT01369225|474358695|FG000|Overall Study|Withdrawal by Subject|1|||
131749325|NCT01369225|474358696|FG001|Overall Study|Withdrawal by Subject|0|||
131749326|NCT01369225|474358697|FG002|Overall Study|Withdrawal by Subject|2|||
131749327|NCT01369225|474358698|FG003|Overall Study|Withdrawal by Subject|1|||
131749328|NCT01369225|474358699|FG004|Overall Study|Withdrawal by Subject|0|||
131749329|NCT01369225|474358700|FG005|Overall Study|Withdrawal by Subject|0|||
131749330|NCT01369225|474358695|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
131749331|NCT01369225|474358696|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
131749332|NCT01369225|474358697|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
131749333|NCT01369225|474358698|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
131749334|NCT01369225|474358699|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
131749335|NCT01369225|474358700|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
131749336|NCT01369225|474358695|FG000|Overall Study|Other|1|||
131749337|NCT01369225|474358696|FG001|Overall Study|Other|0|||
131749338|NCT01369225|474358697|FG002|Overall Study|Other|0|||
131749339|NCT01369225|474358698|FG003|Overall Study|Other|0|||
131749340|NCT01369225|474358699|FG004|Overall Study|Other|1|||
131749341|NCT01369225|474358700|FG005|Overall Study|Other|0|||
131749342|NCT01369225|474358695|FG000|Overall Study|Adverse Event|0|||
131749343|NCT01369225|474358696|FG001|Overall Study|Adverse Event|0|||
131749344|NCT01369225|474358697|FG002|Overall Study|Adverse Event|0|||
131749345|NCT01369225|474358698|FG003|Overall Study|Adverse Event|1|||
131749346|NCT01369225|474358699|FG004|Overall Study|Adverse Event|1|||
131749347|NCT01369225|474358700|FG005|Overall Study|Adverse Event|0|||
131749348|NCT00105183|474358702|FG000|Overall Study|Death|19|||
131749349|NCT00105183|474358703|FG001|Overall Study|Death|13|||
131749350|NCT00105183|474358704|FG002|Overall Study|Death|15|||
131749351|NCT00105183|474358702|FG000|Overall Study|Withdrawal by Subject|1|||
131749352|NCT00105183|474358703|FG001|Overall Study|Withdrawal by Subject|1|||
131749353|NCT00105183|474358704|FG002|Overall Study|Withdrawal by Subject|4|||
131749354|NCT00105183|474358702|FG000|Overall Study|Physician Decision|1|||
131749355|NCT00105183|474358703|FG001|Overall Study|Physician Decision|2|||
131749356|NCT00105183|474358704|FG002|Overall Study|Physician Decision|3|||
131749357|NCT00105183|474358702|FG000|Overall Study|Lost to Follow-up|0|||
131749358|NCT00105183|474358703|FG001|Overall Study|Lost to Follow-up|1|||
131749359|NCT00105183|474358704|FG002|Overall Study|Lost to Follow-up|1|||
131749360|NCT00105183|474358702|FG000|Overall Study|Other reason|1|||
131749361|NCT00105183|474358703|FG001|Overall Study|Other reason|2|||
131749362|NCT00105183|474358704|FG002|Overall Study|Other reason|0|||
131808995|NCT00473330|474584349|FG002|Core Study|Physician Decision|3|||
131808996|NCT00473330|474584347|FG000|Core Study|Subject Non-compliance|1|||
131749363|NCT00792701|474358705|FG000|Overall Study|Adverse Event|0|||
131749364|NCT00792701|474358706|FG001|Overall Study|Adverse Event|22|||
131749365|NCT00792701|474358705|FG000|Overall Study|Ineligible|1|||
131749366|NCT00792701|474358706|FG001|Overall Study|Ineligible|3|||
131808997|NCT00473330|474584348|FG001|Core Study|Subject Non-compliance|2|||
131749367|NCT00792701|474358705|FG000|Overall Study|Withdrawal by Subject|1|||
131749368|NCT00792701|474358706|FG001|Overall Study|Withdrawal by Subject|19|||
131749369|NCT00792701|474358705|FG000|Overall Study|Not protocol specified|17|||
131749370|NCT00792701|474358706|FG001|Overall Study|Not protocol specified|0|||
131749371|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
131749372|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
131749373|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
131749374|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
131749375|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
131749376|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
131749377|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
131749378|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
131749379|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
131749380|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
131749381|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131749382|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131749383|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131749384|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
131749385|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131749386|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
131749387|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
131749388|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
131749389|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
131749390|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
131749391|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
131749392|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
131749393|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
131749394|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
131749395|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
131749396|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Other|1|||
131749397|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Other|0|||
131749398|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Other|0|||
131749399|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Other|0|||
131749400|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Other|1|||
131749401|NCT02980692|474358707|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
131749402|NCT02980692|474358708|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
131749403|NCT02980692|474358709|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
131749404|NCT02980692|474358710|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
131749405|NCT02980692|474358711|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
131749406|NCT02980692|474358707|FG000|Double-blind Follow-up Period|Adverse Event|0|||
131749407|NCT02980692|474358708|FG001|Double-blind Follow-up Period|Adverse Event|0|||
131749408|NCT02980692|474358709|FG002|Double-blind Follow-up Period|Adverse Event|0|||
131749409|NCT02980692|474358710|FG003|Double-blind Follow-up Period|Adverse Event|1|||
131749410|NCT02980692|474358711|FG004|Double-blind Follow-up Period|Adverse Event|1|||
131749411|NCT02980692|474358707|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
131749412|NCT02980692|474358708|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
131749413|NCT02980692|474358709|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
131749414|NCT02980692|474358710|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
131749415|NCT02980692|474358711|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
131749416|NCT02980692|474358707|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
131749417|NCT02980692|474358708|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
131749418|NCT02980692|474358709|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
131749419|NCT02980692|474358710|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
131749420|NCT02980692|474358711|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
131749421|NCT02980692|474358707|FG000|Double-blind Follow-up Period|Pregnancy|0|||
131749422|NCT02980692|474358708|FG001|Double-blind Follow-up Period|Pregnancy|0|||
131749423|NCT02980692|474358709|FG002|Double-blind Follow-up Period|Pregnancy|1|||
131749424|NCT02980692|474358710|FG003|Double-blind Follow-up Period|Pregnancy|1|||
131749425|NCT02980692|474358711|FG004|Double-blind Follow-up Period|Pregnancy|0|||
131749426|NCT02980692|474358707|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
131749427|NCT02980692|474358708|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
131749428|NCT02980692|474358709|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
131749429|NCT02980692|474358710|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
131808998|NCT00473330|474584349|FG002|Core Study|Subject Non-compliance|1|||
131808999|NCT00473330|474584347|FG000|Core Study|Subject Required Other Therapy|0|||
131809000|NCT00473330|474584348|FG001|Core Study|Subject Required Other Therapy|1|||
131809001|NCT00473330|474584349|FG002|Core Study|Subject Required Other Therapy|3|||
131749430|NCT02980692|474358711|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
131749431|NCT02980692|474358707|FG000|Double-blind Follow-up Period|Other|0|||
131749432|NCT02980692|474358708|FG001|Double-blind Follow-up Period|Other|0|||
131749433|NCT02980692|474358709|FG002|Double-blind Follow-up Period|Other|1|||
131749434|NCT02980692|474358710|FG003|Double-blind Follow-up Period|Other|1|||
131749435|NCT02980692|474358711|FG004|Double-blind Follow-up Period|Other|3|||
131749436|NCT02143141|474358721|FG000|Overall Study|pain scores at 24 hours not collected|1|||
131749437|NCT02143141|474358722|FG001|Overall Study|pain scores at 24 hours not collected|0|||
131749438|NCT00064077|474358723|FG000|Overall Study|Improper prior treatment|1|||
131749439|NCT00064077|474358724|FG001|Overall Study|Improper prior treatment|0|||
131749440|NCT00064077|474358725|FG002|Overall Study|Improper prior treatment|0|||
131749441|NCT00064077|474358726|FG003|Overall Study|Improper prior treatment|0|||
131749442|NCT00064077|474358723|FG000|Overall Study|Poor risk|2|||
131749443|NCT00064077|474358724|FG001|Overall Study|Poor risk|0|||
131749444|NCT00064077|474358725|FG002|Overall Study|Poor risk|1|||
131749445|NCT00064077|474358726|FG003|Overall Study|Poor risk|1|||
131749446|NCT00064077|474358723|FG000|Overall Study|Pathology|10|||
131749447|NCT00064077|474358724|FG001|Overall Study|Pathology|7|||
131749448|NCT00064077|474358725|FG002|Overall Study|Pathology|3|||
131749449|NCT00064077|474358726|FG003|Overall Study|Pathology|4|||
131749450|NCT00064077|474358723|FG000|Overall Study|No surgery|0|||
131749451|NCT00064077|474358724|FG001|Overall Study|No surgery|0|||
131749452|NCT00064077|474358725|FG002|Overall Study|No surgery|1|||
131749453|NCT00064077|474358726|FG003|Overall Study|No surgery|0|||
131749454|NCT00064077|474358723|FG000|Overall Study|No tumor|0|||
131749455|NCT00064077|474358724|FG001|Overall Study|No tumor|0|||
131749456|NCT00064077|474358725|FG002|Overall Study|No tumor|1|||
131749457|NCT00064077|474358726|FG003|Overall Study|No tumor|0|||
131749458|NCT00064077|474358723|FG000|Overall Study|Other reasons|2|||
131749459|NCT00064077|474358724|FG001|Overall Study|Other reasons|2|||
131749460|NCT00064077|474358725|FG002|Overall Study|Other reasons|1|||
131749461|NCT00064077|474358726|FG003|Overall Study|Other reasons|2|||
131749462|NCT01831804|474358731|FG000|Overall Study|Adverse Event|0|||
131749463|NCT01831804|474358732|FG001|Overall Study|Adverse Event|0|||
131749464|NCT01831804|474358733|FG002|Overall Study|Adverse Event|0|||
131749465|NCT01831804|474358734|FG003|Overall Study|Adverse Event|0|||
131749466|NCT01831804|474358735|FG004|Overall Study|Adverse Event|0|||
131749467|NCT01831804|474358736|FG005|Overall Study|Adverse Event|0|||
131749468|NCT01831804|474358737|FG006|Overall Study|Adverse Event|1|||
131749469|NCT01831804|474358738|FG007|Overall Study|Adverse Event|0|||
131749470|NCT01831804|474358739|FG008|Overall Study|Adverse Event|1|||
131749471|NCT01831804|474358731|FG000|Overall Study|Protocol Violation|0|||
131749472|NCT01831804|474358732|FG001|Overall Study|Protocol Violation|0|||
131749473|NCT01831804|474358733|FG002|Overall Study|Protocol Violation|2|||
131749474|NCT01831804|474358734|FG003|Overall Study|Protocol Violation|0|||
131749475|NCT01831804|474358735|FG004|Overall Study|Protocol Violation|0|||
131749476|NCT01831804|474358736|FG005|Overall Study|Protocol Violation|0|||
131749477|NCT01831804|474358737|FG006|Overall Study|Protocol Violation|0|||
131749478|NCT01831804|474358738|FG007|Overall Study|Protocol Violation|0|||
131749479|NCT01831804|474358739|FG008|Overall Study|Protocol Violation|0|||
131749480|NCT01831804|474358731|FG000|Overall Study|Protocol defined stopping criteria|1|||
131749481|NCT01831804|474358732|FG001|Overall Study|Protocol defined stopping criteria|1|||
131749482|NCT01831804|474358733|FG002|Overall Study|Protocol defined stopping criteria|3|||
131749483|NCT01831804|474358734|FG003|Overall Study|Protocol defined stopping criteria|0|||
131749484|NCT01831804|474358735|FG004|Overall Study|Protocol defined stopping criteria|1|||
131749485|NCT01831804|474358736|FG005|Overall Study|Protocol defined stopping criteria|0|||
131749486|NCT01831804|474358737|FG006|Overall Study|Protocol defined stopping criteria|0|||
131749487|NCT01831804|474358738|FG007|Overall Study|Protocol defined stopping criteria|0|||
131749488|NCT01831804|474358739|FG008|Overall Study|Protocol defined stopping criteria|0|||
131749489|NCT01831804|474358731|FG000|Overall Study|Lost to Follow-up|0|||
131749490|NCT01831804|474358732|FG001|Overall Study|Lost to Follow-up|0|||
131749491|NCT01831804|474358733|FG002|Overall Study|Lost to Follow-up|1|||
131749492|NCT01831804|474358734|FG003|Overall Study|Lost to Follow-up|0|||
131749493|NCT01831804|474358735|FG004|Overall Study|Lost to Follow-up|0|||
131749494|NCT01831804|474358736|FG005|Overall Study|Lost to Follow-up|0|||
131906417|NCT03238417|474945164|FG000|Baseline|non-response|372|||
131749495|NCT01831804|474358737|FG006|Overall Study|Lost to Follow-up|0|||
131749496|NCT01831804|474358738|FG007|Overall Study|Lost to Follow-up|0|||
131749497|NCT01831804|474358739|FG008|Overall Study|Lost to Follow-up|1|||
131749498|NCT01831804|474358731|FG000|Overall Study|Investigator discretion|0|||
131749499|NCT01831804|474358732|FG001|Overall Study|Investigator discretion|0|||
131749500|NCT01831804|474358733|FG002|Overall Study|Investigator discretion|0|||
131749501|NCT01831804|474358734|FG003|Overall Study|Investigator discretion|0|||
131749502|NCT01831804|474358735|FG004|Overall Study|Investigator discretion|1|||
131749503|NCT01831804|474358736|FG005|Overall Study|Investigator discretion|0|||
131749504|NCT01831804|474358737|FG006|Overall Study|Investigator discretion|0|||
131749505|NCT01831804|474358738|FG007|Overall Study|Investigator discretion|1|||
131749506|NCT01831804|474358739|FG008|Overall Study|Investigator discretion|0|||
131749507|NCT01831804|474358731|FG000|Overall Study|Withdrew Consent|0|||
131906418|NCT03238417|474945165|FG001|Baseline|non-response|669|||
131906419|NCT03238417|474945164|FG000|12-month|non-response|296|||
131906420|NCT03238417|474945165|FG001|12-month|non-response|669|||
131906421|NCT03238417|474945164|FG000|12-month|partial completion|23|||
131906422|NCT03238417|474945165|FG001|12-month|partial completion|37|||
131906423|NCT03238417|474945164|FG000|24-month|non-response|287|||
131906424|NCT03238417|474945165|FG001|24-month|non-response|594|||
131906425|NCT03238417|474945164|FG000|24-month|partial completion|8|||
131906426|NCT03238417|474945165|FG001|24-month|partial completion|31|||
131906427|NCT00001566|474945166|FG000|Overall Study|patients' choice to discontinue protocol|3|||
131906428|NCT00001566|474945166|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
131906429|NCT00001566|474945166|FG000|Overall Study|Death|13|||
131906430|NCT00001566|474945166|FG000|Overall Study|Lost to Follow-up|1|||
131906431|NCT00001566|474945166|FG000|Overall Study|unable to complete initial apheresis|1|||
131906432|NCT00975416|474945171|FG000|Overall Study|early discharge from tx|3|||
131906433|NCT00975416|474945172|FG001|Overall Study|early discharge from tx|5|||
131906434|NCT00106002|474945173|FG000|Overall Study|Did not take any study drug|1|||
131906435|NCT00106002|474945173|FG000|Overall Study|Ineligible after Registration|1|||
131906436|NCT01249131|474945178|FG000|Washout Period of 10 Days|Adverse Event|0|||
131906437|NCT01249131|474945179|FG001|Washout Period of 10 Days|Adverse Event|0|||
131906438|NCT01249131|474945180|FG002|Washout Period of 10 Days|Adverse Event|0|||
131906439|NCT01249131|474945181|FG003|Washout Period of 10 Days|Adverse Event|0|||
131906440|NCT01249131|474945182|FG004|Washout Period of 10 Days|Adverse Event|1|||
131906441|NCT01249131|474945183|FG005|Washout Period of 10 Days|Adverse Event|0|||
131906442|NCT02674516|474945184|FG000|Overall Study|Lost to Follow-up|3|||
131749508|NCT01831804|474358732|FG001|Overall Study|Withdrew Consent|1|||
131749509|NCT01831804|474358733|FG002|Overall Study|Withdrew Consent|0|||
131749510|NCT01831804|474358734|FG003|Overall Study|Withdrew Consent|0|||
131749511|NCT01831804|474358735|FG004|Overall Study|Withdrew Consent|0|||
131749512|NCT01831804|474358736|FG005|Overall Study|Withdrew Consent|0|||
131749513|NCT01831804|474358737|FG006|Overall Study|Withdrew Consent|0|||
131749514|NCT01831804|474358738|FG007|Overall Study|Withdrew Consent|2|||
131749515|NCT01831804|474358739|FG008|Overall Study|Withdrew Consent|0|||
131749516|NCT00563368|474358740|FG000|Overall Study|Lost to Follow-up|14|||
131749517|NCT00563368|474358741|FG001|Overall Study|Lost to Follow-up|14|||
131749518|NCT00563368|474358742|FG002|Overall Study|Lost to Follow-up|12|||
131749519|NCT00563368|474358743|FG003|Overall Study|Lost to Follow-up|6|||
131749520|NCT00563368|474358744|FG004|Overall Study|Lost to Follow-up|9|||
131749521|NCT00563368|474358745|FG005|Overall Study|Lost to Follow-up|8|||
131749522|NCT00563368|474358746|FG006|Overall Study|Lost to Follow-up|9|||
131749523|NCT00563368|474358740|FG000|Overall Study|Adverse Event|3|||
131749524|NCT00563368|474358741|FG001|Overall Study|Adverse Event|4|||
131749525|NCT00563368|474358742|FG002|Overall Study|Adverse Event|5|||
131749526|NCT00563368|474358743|FG003|Overall Study|Adverse Event|9|||
131749527|NCT00563368|474358744|FG004|Overall Study|Adverse Event|6|||
131749528|NCT00563368|474358745|FG005|Overall Study|Adverse Event|10|||
131749529|NCT00563368|474358746|FG006|Overall Study|Adverse Event|17|||
131749530|NCT00563368|474358740|FG000|Overall Study|Withdrawal by Subject|11|||
131749531|NCT00563368|474358741|FG001|Overall Study|Withdrawal by Subject|6|||
131749532|NCT00563368|474358742|FG002|Overall Study|Withdrawal by Subject|5|||
131749533|NCT00563368|474358743|FG003|Overall Study|Withdrawal by Subject|7|||
131749534|NCT00563368|474358744|FG004|Overall Study|Withdrawal by Subject|8|||
131749535|NCT00563368|474358745|FG005|Overall Study|Withdrawal by Subject|5|||
131749536|NCT00563368|474358746|FG006|Overall Study|Withdrawal by Subject|4|||
131749537|NCT00563368|474358740|FG000|Overall Study|protocol non-compliance|1|||
131749538|NCT00563368|474358741|FG001|Overall Study|protocol non-compliance|1|||
131749539|NCT00563368|474358742|FG002|Overall Study|protocol non-compliance|2|||
131749540|NCT00563368|474358743|FG003|Overall Study|protocol non-compliance|1|||
131749541|NCT00563368|474358744|FG004|Overall Study|protocol non-compliance|0|||
131749542|NCT00563368|474358745|FG005|Overall Study|protocol non-compliance|1|||
131749543|NCT00563368|474358746|FG006|Overall Study|protocol non-compliance|3|||
131749544|NCT00563368|474358740|FG000|Overall Study|Pregnancy|1|||
131749545|NCT00563368|474358741|FG001|Overall Study|Pregnancy|0|||
131749546|NCT00563368|474358742|FG002|Overall Study|Pregnancy|1|||
131749547|NCT00563368|474358743|FG003|Overall Study|Pregnancy|2|||
131749548|NCT00563368|474358744|FG004|Overall Study|Pregnancy|1|||
131906443|NCT02674516|474945185|FG001|Overall Study|Lost to Follow-up|0|||
131906444|NCT02674516|474945184|FG000|Overall Study|Protocol Violation|0|||
131906445|NCT02674516|474945185|FG001|Overall Study|Protocol Violation|4|||
131906446|NCT02674516|474945184|FG000|Overall Study|Knowledge of study hypothesis|1|||
131906447|NCT02674516|474945185|FG001|Overall Study|Knowledge of study hypothesis|0|||
131906448|NCT02662569|474945187|FG000|Overall Study|Withdrawal by Subject|6|||
131906449|NCT02662569|474945188|FG001|Overall Study|Withdrawal by Subject|1|||
131809002|NCT00473330|474584347|FG000|Core Study|Subject's Decision|9|||
131809003|NCT00473330|474584348|FG001|Core Study|Subject's Decision|8|||
131809004|NCT00473330|474584349|FG002|Core Study|Subject's Decision|19|||
131809005|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
131809006|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
131809007|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
131809008|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Death|2|||
131809009|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Death|0|||
131809010|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Death|0|||
131809011|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
131809012|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
131809013|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
131809014|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
131749549|NCT00563368|474358745|FG005|Overall Study|Pregnancy|2|||
131749550|NCT00563368|474358746|FG006|Overall Study|Pregnancy|0|||
131749551|NCT00563368|474358740|FG000|Overall Study|requirement for restricted medication|0|||
131749552|NCT00563368|474358741|FG001|Overall Study|requirement for restricted medication|0|||
131749553|NCT00563368|474358742|FG002|Overall Study|requirement for restricted medication|2|||
131749554|NCT00563368|474358743|FG003|Overall Study|requirement for restricted medication|0|||
131749555|NCT00563368|474358744|FG004|Overall Study|requirement for restricted medication|0|||
131749556|NCT00563368|474358745|FG005|Overall Study|requirement for restricted medication|0|||
131749557|NCT00563368|474358746|FG006|Overall Study|requirement for restricted medication|0|||
131749558|NCT00563368|474358740|FG000|Overall Study|Other|5|||
131749559|NCT00563368|474358741|FG001|Overall Study|Other|5|||
131749560|NCT00563368|474358742|FG002|Overall Study|Other|3|||
131749561|NCT00563368|474358743|FG003|Overall Study|Other|4|||
131749562|NCT00563368|474358744|FG004|Overall Study|Other|4|||
131749563|NCT00563368|474358745|FG005|Overall Study|Other|4|||
131749564|NCT00563368|474358746|FG006|Overall Study|Other|0|||
131749565|NCT01156532|474358747|FG000|Overall Study|Family Reasons|1|||
131749566|NCT01156532|474358747|FG000|Overall Study|Lost to Follow-up|1|||
131749567|NCT01819506|474358748|FG000|Overall Study|Physician Decision|5|||
131749568|NCT01819506|474358749|FG001|Overall Study|Physician Decision|2|||
131749569|NCT01819506|474358748|FG000|Overall Study|Withdrawal by Subject|3|||
131749570|NCT01819506|474358749|FG001|Overall Study|Withdrawal by Subject|3|||
131749571|NCT00968708|474358751|FG000|Overall Study|Adverse Event|169|||
131749572|NCT00968708|474358752|FG001|Overall Study|Adverse Event|150|||
131749573|NCT00968708|474358751|FG000|Overall Study|Major Protocol Deviation|0|||
131749574|NCT00968708|474358752|FG001|Overall Study|Major Protocol Deviation|1|||
131749575|NCT00968708|474358751|FG000|Overall Study|Lost to Follow-up|19|||
131749576|NCT00968708|474358752|FG001|Overall Study|Lost to Follow-up|11|||
131749577|NCT00968708|474358751|FG000|Overall Study|Voluntary Withdrawal|104|||
131749578|NCT00968708|474358752|FG001|Overall Study|Voluntary Withdrawal|101|||
131749579|NCT00968708|474358751|FG000|Overall Study|Investigator Discretion|0|||
131749580|NCT00968708|474358752|FG001|Overall Study|Investigator Discretion|1|||
131749581|NCT00968708|474358751|FG000|Overall Study|Other|26|||
131749582|NCT00968708|474358752|FG001|Overall Study|Other|34|||
131749583|NCT02023268|474358753|FG000|Overall Study|Lack of Efficacy|0|||
131749584|NCT02023268|474358754|FG001|Overall Study|Lack of Efficacy|1|||
131749585|NCT02023268|474358753|FG000|Overall Study|Adverse Event|0|||
131749586|NCT02023268|474358754|FG001|Overall Study|Adverse Event|2|||
131749587|NCT02023268|474358753|FG000|Overall Study|Withdrawal by Subject|0|||
131749588|NCT02023268|474358754|FG001|Overall Study|Withdrawal by Subject|1|||
131809015|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
131809016|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
131809017|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
131809018|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
131809019|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
131809020|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
131749589|NCT03407170|474358755|FG000|Overall Study|Adverse Event|1|||
131749590|NCT00615459|474358757|FG000|Period I|Adverse Event|2|||
131749591|NCT00615459|474358758|FG001|Period I|Adverse Event|0|||
131749592|NCT00615459|474358759|FG002|Period I|Adverse Event|1|||
131749593|NCT00615459|474358760|FG003|Period I|Adverse Event|0|||
131449226|NCT01002339|473274814|FG001|Overall Study|Lung cancer detected before transplant|0|||
131749594|NCT00615459|474358757|FG000|Period I|Subject withdrew consent|1|||
131749595|NCT00615459|474358758|FG001|Period I|Subject withdrew consent|0|||
131749596|NCT00615459|474358759|FG002|Period I|Subject withdrew consent|0|||
131749597|NCT00615459|474358760|FG003|Period I|Subject withdrew consent|1|||
131749598|NCT00615459|474358757|FG000|Period I|Abnormal test procedure results|1|||
131749599|NCT00615459|474358758|FG001|Period I|Abnormal test procedure results|1|||
131749600|NCT00615459|474358759|FG002|Period I|Abnormal test procedure results|1|||
131749601|NCT00615459|474358760|FG003|Period I|Abnormal test procedure results|0|||
131749602|NCT00615459|474358757|FG000|Period II|Adverse Event|1|||
131749603|NCT00615459|474358758|FG001|Period II|Adverse Event|0|||
131749604|NCT00615459|474358759|FG002|Period II|Adverse Event|0|||
131749605|NCT00615459|474358760|FG003|Period II|Adverse Event|0|||
131749606|NCT00615459|474358757|FG000|Period II|Lost to Follow-up|0|||
131749607|NCT00615459|474358758|FG001|Period II|Lost to Follow-up|0|||
131749608|NCT00615459|474358759|FG002|Period II|Lost to Follow-up|0|||
131749609|NCT00615459|474358760|FG003|Period II|Lost to Follow-up|1|||
131749610|NCT00615459|474358757|FG000|Period III|Adverse Event|0|||
131749611|NCT00615459|474358758|FG001|Period III|Adverse Event|1|||
131749612|NCT00615459|474358759|FG002|Period III|Adverse Event|0|||
131749613|NCT00615459|474358760|FG003|Period III|Adverse Event|0|||
131749614|NCT00615459|474358757|FG000|Period III|Administrative problems|0|||
131749615|NCT00615459|474358758|FG001|Period III|Administrative problems|1|||
131749616|NCT00615459|474358759|FG002|Period III|Administrative problems|1|||
131749617|NCT00615459|474358760|FG003|Period III|Administrative problems|0|||
131749618|NCT00615459|474358757|FG000|Period III|Unsatisfactory therapeutic effect|0|||
131749619|NCT00615459|474358758|FG001|Period III|Unsatisfactory therapeutic effect|1|||
131749620|NCT00615459|474358759|FG002|Period III|Unsatisfactory therapeutic effect|0|||
131749621|NCT00615459|474358760|FG003|Period III|Unsatisfactory therapeutic effect|0|||
131749622|NCT01963780|474358762|FG000|Overall Study|Death|7|||
131749623|NCT04153929|474358763|FG000|Overall Study|Other than listed|2|||
131749624|NCT04153929|474358764|FG001|Overall Study|Other than listed|2|||
131749625|NCT04153929|474358765|FG002|Overall Study|Other than listed|0|||
131749626|NCT04153929|474358766|FG003|Overall Study|Other than listed|1|||
131749627|NCT04153929|474358767|FG004|Overall Study|Other than listed|0|||
131749628|NCT04153929|474358768|FG005|Overall Study|Other than listed|2|||
131749629|NCT04153929|474358769|FG006|Overall Study|Other than listed|2|||
131749630|NCT04153929|474358770|FG007|Overall Study|Other than listed|1|||
131749631|NCT04153929|474358763|FG000|Overall Study|Lost to Follow-up|2|||
131749632|NCT04153929|474358764|FG001|Overall Study|Lost to Follow-up|1|||
131749633|NCT04153929|474358765|FG002|Overall Study|Lost to Follow-up|0|||
131749634|NCT04153929|474358766|FG003|Overall Study|Lost to Follow-up|1|||
131749635|NCT04153929|474358767|FG004|Overall Study|Lost to Follow-up|1|||
131749636|NCT04153929|474358768|FG005|Overall Study|Lost to Follow-up|0|||
131749637|NCT04153929|474358769|FG006|Overall Study|Lost to Follow-up|0|||
131749638|NCT04153929|474358770|FG007|Overall Study|Lost to Follow-up|0|||
131809021|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
131809022|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
131809023|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
131809024|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
131809025|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
131809026|NCT00473330|474584347|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
131809027|NCT00473330|474584348|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
131809028|NCT00473330|474584349|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
131809029|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
131809030|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
131809031|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
131809032|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Death|2|||
131809033|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Death|2|||
131809034|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Death|1|||
131809035|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
131809036|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
131809037|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
131809038|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
131809039|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
131809040|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
131809041|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
131809042|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
131809043|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
131809044|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
131809045|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
131809046|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
131809047|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
131809048|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
131749639|NCT04153929|474358763|FG000|Overall Study|Withdrawal by Subject|3|||
131749640|NCT04153929|474358764|FG001|Overall Study|Withdrawal by Subject|1|||
131749641|NCT04153929|474358765|FG002|Overall Study|Withdrawal by Subject|0|||
131749642|NCT04153929|474358766|FG003|Overall Study|Withdrawal by Subject|3|||
131749643|NCT04153929|474358767|FG004|Overall Study|Withdrawal by Subject|1|||
131749644|NCT04153929|474358768|FG005|Overall Study|Withdrawal by Subject|0|||
131749645|NCT04153929|474358769|FG006|Overall Study|Withdrawal by Subject|1|||
131749646|NCT04153929|474358770|FG007|Overall Study|Withdrawal by Subject|0|||
131749647|NCT04153929|474358763|FG000|Overall Study|Protocol Violation|0|||
131749648|NCT04153929|474358764|FG001|Overall Study|Protocol Violation|0|||
131749649|NCT04153929|474358765|FG002|Overall Study|Protocol Violation|0|||
131749650|NCT04153929|474358766|FG003|Overall Study|Protocol Violation|0|||
131749651|NCT04153929|474358767|FG004|Overall Study|Protocol Violation|0|||
131749652|NCT04153929|474358768|FG005|Overall Study|Protocol Violation|0|||
131749653|NCT04153929|474358769|FG006|Overall Study|Protocol Violation|1|||
131749654|NCT04153929|474358770|FG007|Overall Study|Protocol Violation|2|||
131749655|NCT04153929|474358763|FG000|Overall Study|Adverse Event|3|||
131749656|NCT04153929|474358764|FG001|Overall Study|Adverse Event|5|||
131749657|NCT04153929|474358765|FG002|Overall Study|Adverse Event|5|||
131749658|NCT04153929|474358766|FG003|Overall Study|Adverse Event|11|||
131749659|NCT04153929|474358767|FG004|Overall Study|Adverse Event|15|||
131749660|NCT04153929|474358768|FG005|Overall Study|Adverse Event|4|||
131749661|NCT04153929|474358769|FG006|Overall Study|Adverse Event|8|||
131906450|NCT02662569|474945189|FG002|Overall Study|Withdrawal by Subject|6|||
131906451|NCT02662569|474945190|FG003|Overall Study|Withdrawal by Subject|4|||
131749662|NCT04153929|474358770|FG007|Overall Study|Adverse Event|2|||
131749663|NCT04153929|474358763|FG000|Overall Study|Not treated|1|||
131749664|NCT04153929|474358764|FG001|Overall Study|Not treated|0|||
131749665|NCT04153929|474358765|FG002|Overall Study|Not treated|0|||
131749666|NCT04153929|474358766|FG003|Overall Study|Not treated|0|||
131749667|NCT04153929|474358767|FG004|Overall Study|Not treated|0|||
131749668|NCT04153929|474358768|FG005|Overall Study|Not treated|0|||
131749669|NCT04153929|474358769|FG006|Overall Study|Not treated|1|||
131749670|NCT04153929|474358770|FG007|Overall Study|Not treated|0|||
131749671|NCT04083794|474358771|FG000|Overall Study|Lost to Follow-up|9|||
131749672|NCT01235728|474358775|FG000|Overall Study|Protocol Violation|0|||
131749673|NCT01235728|474358776|FG001|Overall Study|Protocol Violation|0|||
131749674|NCT01235728|474358777|FG002|Overall Study|Protocol Violation|0|||
131749675|NCT01235728|474358778|FG003|Overall Study|Protocol Violation|1|||
131749676|NCT01235728|474358779|FG004|Overall Study|Protocol Violation|0|||
131749677|NCT01235728|474358780|FG005|Overall Study|Protocol Violation|0|||
131749678|NCT01235728|474358781|FG006|Overall Study|Protocol Violation|0|||
131749679|NCT01235728|474358782|FG007|Overall Study|Protocol Violation|0|||
131749680|NCT01202760|474358783|FG000|Overall Study|Entry Criteria Not Met|0|||
131749681|NCT01202760|474358784|FG001|Overall Study|Entry Criteria Not Met|3|||
131749682|NCT01202760|474358785|FG002|Overall Study|Entry Criteria Not Met|1|||
131749683|NCT01202760|474358783|FG000|Overall Study|Adverse Event|11|||
131749684|NCT01202760|474358784|FG001|Overall Study|Adverse Event|9|||
131749685|NCT01202760|474358785|FG002|Overall Study|Adverse Event|10|||
131749686|NCT01202760|474358783|FG000|Overall Study|Death|2|||
131749687|NCT01202760|474358784|FG001|Overall Study|Death|1|||
131749688|NCT01202760|474358785|FG002|Overall Study|Death|0|||
131749689|NCT01202760|474358783|FG000|Overall Study|Lack of Efficacy|6|||
131749690|NCT01202760|474358784|FG001|Overall Study|Lack of Efficacy|8|||
131749691|NCT01202760|474358785|FG002|Overall Study|Lack of Efficacy|7|||
131749692|NCT01202760|474358783|FG000|Overall Study|Lost to Follow-up|0|||
131749693|NCT01202760|474358784|FG001|Overall Study|Lost to Follow-up|2|||
131749694|NCT01202760|474358785|FG002|Overall Study|Lost to Follow-up|1|||
131749695|NCT01202760|474358783|FG000|Overall Study|Parent / Caregiver Decision|0|||
131749696|NCT01202760|474358784|FG001|Overall Study|Parent / Caregiver Decision|1|||
131749697|NCT01202760|474358785|FG002|Overall Study|Parent / Caregiver Decision|0|||
131749698|NCT01202760|474358783|FG000|Overall Study|Withdrawal by Subject|17|||
131749699|NCT01202760|474358784|FG001|Overall Study|Withdrawal by Subject|18|||
131749700|NCT01202760|474358785|FG002|Overall Study|Withdrawal by Subject|14|||
131749701|NCT01202760|474358783|FG000|Overall Study|Physician Decision|0|||
131749702|NCT01202760|474358784|FG001|Overall Study|Physician Decision|1|||
131749703|NCT01202760|474358785|FG002|Overall Study|Physician Decision|0|||
131749704|NCT01202760|474358783|FG000|Overall Study|Protocol Violation|7|||
131749705|NCT01202760|474358784|FG001|Overall Study|Protocol Violation|5|||
131749706|NCT01202760|474358785|FG002|Overall Study|Protocol Violation|2|||
131749707|NCT01202760|474358783|FG000|Overall Study|Sponsor Decision|4|||
131749708|NCT01202760|474358784|FG001|Overall Study|Sponsor Decision|4|||
131749709|NCT01202760|474358785|FG002|Overall Study|Sponsor Decision|0|||
131749710|NCT00871572|474358786|FG000|Overall Study|Adverse Event|0|||
131749711|NCT00871572|474358787|FG001|Overall Study|Adverse Event|2|||
131749712|NCT00871572|474358788|FG002|Overall Study|Adverse Event|0|||
131749713|NCT00871572|474358789|FG003|Overall Study|Adverse Event|3|||
131749714|NCT00871572|474358786|FG000|Overall Study|Investigator Decision|0|||
131749715|NCT00871572|474358787|FG001|Overall Study|Investigator Decision|1|||
131749716|NCT00871572|474358788|FG002|Overall Study|Investigator Decision|0|||
131749717|NCT00871572|474358789|FG003|Overall Study|Investigator Decision|1|||
131749718|NCT00871572|474358786|FG000|Overall Study|Lost to Follow-up|0|||
131749719|NCT00871572|474358787|FG001|Overall Study|Lost to Follow-up|1|||
131749720|NCT00871572|474358788|FG002|Overall Study|Lost to Follow-up|0|||
131749721|NCT00871572|474358789|FG003|Overall Study|Lost to Follow-up|1|||
131906452|NCT02662569|474945187|FG000|Overall Study|Lost to Follow-up|1|||
131749722|NCT00871572|474358786|FG000|Overall Study|Protocol Violation|0|||
131749723|NCT00871572|474358787|FG001|Overall Study|Protocol Violation|0|||
131749724|NCT00871572|474358788|FG002|Overall Study|Protocol Violation|1|||
131749725|NCT00871572|474358789|FG003|Overall Study|Protocol Violation|1|||
131749726|NCT00871572|474358786|FG000|Overall Study|Sponsor Decision|1|||
131749727|NCT00871572|474358787|FG001|Overall Study|Sponsor Decision|0|||
131749728|NCT00871572|474358788|FG002|Overall Study|Sponsor Decision|0|||
131749729|NCT00871572|474358789|FG003|Overall Study|Sponsor Decision|0|||
131749730|NCT00871572|474358786|FG000|Overall Study|Withdrawal by Subject|1|||
131749731|NCT00871572|474358787|FG001|Overall Study|Withdrawal by Subject|2|||
131749732|NCT00871572|474358788|FG002|Overall Study|Withdrawal by Subject|3|||
131749733|NCT00871572|474358789|FG003|Overall Study|Withdrawal by Subject|1|||
131749734|NCT04354155|474358792|FG000|Overall Study|Withdrawal by Subject|1|||
131749735|NCT04354155|474358792|FG000|Overall Study|Did not meet criteria for study intervention|1|||
131749736|NCT00187889|474358793|FG000|Overall Study|Withdrawal by Subject|6|||
131749737|NCT00187889|474358794|FG001|Overall Study|Withdrawal by Subject|4|||
131749738|NCT01419080|474358795|FG000|Overall Study|Withdrawal by Subject|75|||
131749739|NCT01419080|474358795|FG000|Overall Study|Death|30|||
131749740|NCT01419080|474358795|FG000|Overall Study|Lost to Follow-up|23|||
131749741|NCT01419080|474358795|FG000|Overall Study|Too Ill|3|||
131749742|NCT01575899|474358796|FG000|Overall Study|Lost to Follow-up|3|||
131749743|NCT01575899|474358797|FG001|Overall Study|Lost to Follow-up|4|||
131749744|NCT01575899|474358798|FG002|Overall Study|Lost to Follow-up|2|||
131749745|NCT01575899|474358796|FG000|Overall Study|Protocol Violation|2|||
131749746|NCT01575899|474358797|FG001|Overall Study|Protocol Violation|1|||
131749747|NCT01575899|474358798|FG002|Overall Study|Protocol Violation|0|||
131749748|NCT04294095|474358799|FG000|Overall Study|Adverse Event|1|||
131749749|NCT04294095|474358800|FG001|Overall Study|Adverse Event|0|||
131749750|NCT03205982|474358805|FG000|Overall Study|Lost to Follow-up|20|||
131749751|NCT03205982|474358806|FG001|Overall Study|Lost to Follow-up|19|||
131749752|NCT03205982|474358805|FG000|Overall Study|Withdrawal by Subject|4|||
131749753|NCT03205982|474358806|FG001|Overall Study|Withdrawal by Subject|3|||
131749754|NCT03205982|474358805|FG000|Overall Study|Withdrawal by PI|0|||
131749755|NCT03205982|474358806|FG001|Overall Study|Withdrawal by PI|1|||
131749756|NCT03136367|474358809|FG000|T1 Consultation|discontinued mistakenly included|2|||
131749757|NCT03136367|474358810|FG001|T1 Consultation|discontinued mistakenly included|6|||
131749758|NCT03136367|474358811|FG002|T1 Consultation|discontinued mistakenly included|1|||
131749759|NCT03136367|474358809|FG000|T1 Consultation|Discontinued other|0|||
131749760|NCT03136367|474358810|FG001|T1 Consultation|Discontinued other|1|||
131749761|NCT03136367|474358811|FG002|T1 Consultation|Discontinued other|0|||
131749762|NCT03136367|474358809|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
131749763|NCT03136367|474358810|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
131749764|NCT03136367|474358811|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
131749765|NCT03136367|474358809|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
131749766|NCT03136367|474358810|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
131749767|NCT03136367|474358811|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
131749768|NCT03136367|474358809|FG000|T2 Post-consultation|Discontinued other|0|||
131749769|NCT03136367|474358810|FG001|T2 Post-consultation|Discontinued other|2|||
131809049|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
131809050|NCT00473330|474584347|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
131809051|NCT00473330|474584348|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
131809052|NCT00473330|474584349|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
131809053|NCT01975948|474584350|FG000|Overall Study|Withdrawal by Subject|17|||
131809054|NCT01975948|474584351|FG001|Overall Study|Withdrawal by Subject|21|||
131809055|NCT01975948|474584352|FG002|Overall Study|Withdrawal by Subject|7|||
131809056|NCT01975948|474584353|FG003|Overall Study|Withdrawal by Subject|6|||
131809057|NCT01675765|474584354|FG000|Overall Study|Progressive disease|4|||
131809058|NCT01675765|474584355|FG001|Overall Study|Progressive disease|4|||
131809059|NCT01675765|474584354|FG000|Overall Study|Adverse Event|1|||
131749770|NCT03136367|474358811|FG002|T2 Post-consultation|Discontinued other|6|||
131809060|NCT01675765|474584355|FG001|Overall Study|Adverse Event|2|||
131809061|NCT01675765|474584354|FG000|Overall Study|Withdrawal by Subject|2|||
131809062|NCT01675765|474584355|FG001|Overall Study|Withdrawal by Subject|0|||
131809063|NCT01675765|474584354|FG000|Overall Study|Death|1|||
131809064|NCT01675765|474584355|FG001|Overall Study|Death|0|||
131809065|NCT01675765|474584354|FG000|Overall Study|Clinical progression|3|||
131809066|NCT01675765|474584355|FG001|Overall Study|Clinical progression|2|||
131809067|NCT00365846|474584357|FG000|Overall Study|Lost to Follow-up|1|||
131809068|NCT03965091|474584358|FG000|Overall Study|Adverse Event|0|||
131809069|NCT03965091|474584359|FG001|Overall Study|Adverse Event|2|||
131809070|NCT03965091|474584360|FG002|Overall Study|Adverse Event|3|||
131809071|NCT03965091|474584358|FG000|Overall Study|Withdrawal by Subject|11|||
131749771|NCT03136367|474358809|FG000|T2 Post-consultation|Discontinued transferred care|0|||
131749772|NCT03136367|474358810|FG001|T2 Post-consultation|Discontinued transferred care|0|||
131809072|NCT03965091|474584359|FG001|Overall Study|Withdrawal by Subject|3|||
131749773|NCT03136367|474358811|FG002|T2 Post-consultation|Discontinued transferred care|3|||
131749774|NCT03136367|474358809|FG000|T2 Post-consultation|Discontinued lost contact|0|||
131749775|NCT03136367|474358810|FG001|T2 Post-consultation|Discontinued lost contact|1|||
131749776|NCT03136367|474358811|FG002|T2 Post-consultation|Discontinued lost contact|0|||
131749777|NCT03136367|474358809|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
131749778|NCT03136367|474358810|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
131749779|NCT03136367|474358811|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
131749780|NCT03136367|474358809|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
131749781|NCT03136367|474358810|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
131749782|NCT03136367|474358811|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
131749783|NCT03136367|474358809|FG000|T3 1 Week After Surgery|other discontinued|2|||
131749784|NCT03136367|474358810|FG001|T3 1 Week After Surgery|other discontinued|4|||
131749785|NCT03136367|474358811|FG002|T3 1 Week After Surgery|other discontinued|3|||
131749786|NCT03136367|474358809|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
131749787|NCT03136367|474358810|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
131749788|NCT03136367|474358811|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
131749789|NCT03136367|474358809|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
131749790|NCT03136367|474358810|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
131749791|NCT03136367|474358811|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
131749792|NCT03136367|474358809|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
131749793|NCT03136367|474358810|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
131749794|NCT03136367|474358811|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
131749795|NCT03136367|474358809|FG000|T4 12 Weeks After Surgery|Death|0|||
131749796|NCT03136367|474358810|FG001|T4 12 Weeks After Surgery|Death|1|||
131749797|NCT03136367|474358811|FG002|T4 12 Weeks After Surgery|Death|3|||
131749798|NCT03136367|474358809|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
131749799|NCT03136367|474358810|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
131749800|NCT03136367|474358811|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
131749801|NCT03136367|474358809|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
131749802|NCT03136367|474358810|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
131749803|NCT03136367|474358811|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
131749804|NCT03136367|474358809|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
131749805|NCT03136367|474358810|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
131749806|NCT03136367|474358811|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
131749807|NCT03136367|474358809|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
131749808|NCT03136367|474358810|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
131749809|NCT03136367|474358811|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
131749810|NCT03136367|474358809|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
131749811|NCT03136367|474358810|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
131749812|NCT03136367|474358811|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
131749813|NCT03136367|474358809|FG000|T5 1 Year After Surgery|Death|0|||
131749814|NCT03136367|474358810|FG001|T5 1 Year After Surgery|Death|0|||
131749815|NCT03136367|474358811|FG002|T5 1 Year After Surgery|Death|1|||
131749816|NCT03136367|474358809|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
131749817|NCT03136367|474358810|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
131749818|NCT03136367|474358811|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
131749819|NCT03136367|474358809|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
131749820|NCT03136367|474358810|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
131749821|NCT03136367|474358811|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
131749822|NCT03136367|474358809|FG000|T5 1 Year After Surgery|study ended before due|31|||
131749823|NCT03136367|474358810|FG001|T5 1 Year After Surgery|study ended before due|103|||
131749824|NCT03136367|474358811|FG002|T5 1 Year After Surgery|study ended before due|110|||
131749825|NCT03136367|474358809|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
131749826|NCT03136367|474358810|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
131749827|NCT03136367|474358811|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
131749828|NCT05200455|474358812|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
131749829|NCT02483078|474358822|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
131749830|NCT02483078|474358823|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
131749831|NCT02483078|474358822|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
131749832|NCT02483078|474358823|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
131749833|NCT02483078|474358822|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
131749834|NCT02483078|474358823|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
131749835|NCT02483078|474358822|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
131749836|NCT02483078|474358823|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
131749837|NCT02483078|474358822|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
131749838|NCT02483078|474358823|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
131809073|NCT03965091|474584360|FG002|Overall Study|Withdrawal by Subject|5|||
131749839|NCT02483078|474358822|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
131749840|NCT02483078|474358823|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
131749841|NCT02853032|474358824|FG000|Overall Study|Adverse Event|4|||
131749842|NCT02853032|474358825|FG001|Overall Study|Adverse Event|0|||
131749843|NCT02853032|474358824|FG000|Overall Study|Withdrawal by Subject|3|||
131749844|NCT02853032|474358825|FG001|Overall Study|Withdrawal by Subject|1|||
131749845|NCT02853032|474358824|FG000|Overall Study|Requested to withdraw from all treatment|2|||
131749846|NCT02853032|474358825|FG001|Overall Study|Requested to withdraw from all treatment|2|||
131749847|NCT00676208|474358828|FG000|Overall Study|Lost to Follow-up|0|||
131749848|NCT00676208|474358829|FG001|Overall Study|Lost to Follow-up|2|||
131749849|NCT00676208|474358828|FG000|Overall Study|Incomplete data|2|||
131749850|NCT00676208|474358829|FG001|Overall Study|Incomplete data|4|||
131749851|NCT03726333|474358830|FG000|Overall Study|Progressive Disease|0|||
131749852|NCT03726333|474358831|FG001|Overall Study|Progressive Disease|0|||
131749853|NCT03726333|474358832|FG002|Overall Study|Progressive Disease|1|||
131749854|NCT03726333|474358833|FG003|Overall Study|Progressive Disease|0|||
131749855|NCT03726333|474358834|FG004|Overall Study|Progressive Disease|0|||
131749856|NCT01410799|474358835|FG000|Overall Study|PI decision|13|||
131749857|NCT01946412|474358836|FG000|Overall Study|Adverse Event|1|||
131749858|NCT01946412|474358836|FG000|Overall Study|Non-Compliance|1|||
131749859|NCT01946412|474358836|FG000|Overall Study|Continued with commercial Kalydeco|2|||
131749860|NCT01946412|474358836|FG000|Overall Study|Difficulty in swallowing|1|||
131749861|NCT03907969|474361555|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
131749862|NCT03907969|474361556|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
131749863|NCT03907969|474361557|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
131749864|NCT03907969|474361558|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
131749865|NCT03907969|474361559|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
131749866|NCT03907969|474361560|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
131749867|NCT03907969|474361561|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
131749868|NCT03907969|474361562|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
131749869|NCT03907969|474361563|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
131749870|NCT03907969|474361564|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
131749871|NCT03907969|474361565|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
131809074|NCT03965091|474584358|FG000|Overall Study|Non-compliance with study drug|0|||
131809075|NCT03965091|474584359|FG001|Overall Study|Non-compliance with study drug|0|||
131809076|NCT03965091|474584360|FG002|Overall Study|Non-compliance with study drug|1|||
131809077|NCT03965091|474584358|FG000|Overall Study|Lost to Follow-up|1|||
131809078|NCT03965091|474584359|FG001|Overall Study|Lost to Follow-up|1|||
131809079|NCT03965091|474584360|FG002|Overall Study|Lost to Follow-up|1|||
131809080|NCT03965091|474584358|FG000|Overall Study|Lack of Efficacy|2|||
131809081|NCT03965091|474584359|FG001|Overall Study|Lack of Efficacy|0|||
131809082|NCT03965091|474584360|FG002|Overall Study|Lack of Efficacy|0|||
131809083|NCT03965091|474584358|FG000|Overall Study|Other than specified|9|||
131809084|NCT03965091|474584359|FG001|Overall Study|Other than specified|11|||
131809085|NCT03965091|474584360|FG002|Overall Study|Other than specified|8|||
131809086|NCT02576938|474584361|FG000|Overall Study|Adverse Event|5|||
131809087|NCT02576938|474584362|FG001|Overall Study|Adverse Event|3|||
131809088|NCT02576938|474584363|FG002|Overall Study|Adverse Event|6|||
131809089|NCT02576938|474584361|FG000|Overall Study|Protocol Violation|1|||
131809090|NCT02576938|474584362|FG001|Overall Study|Protocol Violation|1|||
131809091|NCT02576938|474584363|FG002|Overall Study|Protocol Violation|1|||
131809092|NCT02576938|474584361|FG000|Overall Study|Withdrawal by Subject|3|||
131809093|NCT02576938|474584362|FG001|Overall Study|Withdrawal by Subject|2|||
131809094|NCT02576938|474584363|FG002|Overall Study|Withdrawal by Subject|4|||
131809095|NCT02576938|474584361|FG000|Overall Study|Lack of Efficacy|9|||
131749872|NCT03907969|474361555|FG000|Monotherapy Part A|Progressive Disease|0|||
131749873|NCT03907969|474361556|FG001|Monotherapy Part A|Progressive Disease|1|||
131809096|NCT02576938|474584362|FG001|Overall Study|Lack of Efficacy|4|||
131809097|NCT02576938|474584363|FG002|Overall Study|Lack of Efficacy|0|||
131809098|NCT02576938|474584361|FG000|Overall Study|Lost to Follow-up|2|||
131809099|NCT02576938|474584362|FG001|Overall Study|Lost to Follow-up|0|||
131809100|NCT02576938|474584363|FG002|Overall Study|Lost to Follow-up|1|||
131809101|NCT02576938|474584361|FG000|Overall Study|Physician Decision|0|||
131809102|NCT02576938|474584362|FG001|Overall Study|Physician Decision|1|||
131809103|NCT02576938|474584363|FG002|Overall Study|Physician Decision|0|||
131809104|NCT02576938|474584361|FG000|Overall Study|Met Exclusion Criteria|0|||
131749874|NCT03907969|474361557|FG002|Monotherapy Part A|Progressive Disease|0|||
131749875|NCT03907969|474361558|FG003|Monotherapy Part A|Progressive Disease|0|||
131749876|NCT03907969|474361559|FG004|Monotherapy Part A|Progressive Disease|0|||
131809105|NCT02576938|474584362|FG001|Overall Study|Met Exclusion Criteria|1|||
131809106|NCT02576938|474584363|FG002|Overall Study|Met Exclusion Criteria|0|||
131809107|NCT03500341|474584364|FG000|Overall Study|Withdrawn prior to Completion|2|||
131749877|NCT03907969|474361560|FG005|Monotherapy Part A|Progressive Disease|1|||
131749878|NCT03907969|474361561|FG006|Monotherapy Part A|Progressive Disease|2|||
131809108|NCT04400890|474584374|FG000|Overall Study|Withdrawal by Subject|3|||
131809109|NCT04400890|474584375|FG001|Overall Study|Withdrawal by Subject|2|||
131749879|NCT03907969|474361562|FG007|Monotherapy Part A|Progressive Disease|0|||
131749880|NCT03907969|474361563|FG008|Monotherapy Part A|Progressive Disease|0|||
131749881|NCT03907969|474361564|FG009|Monotherapy Part A|Progressive Disease|0|||
131749882|NCT03907969|474361565|FG010|Monotherapy Part A|Progressive Disease|0|||
131749883|NCT03907969|474361555|FG000|Monotherapy Part A|Death|0|||
131749884|NCT03907969|474361556|FG001|Monotherapy Part A|Death|0|||
131749885|NCT03907969|474361557|FG002|Monotherapy Part A|Death|1|||
131749886|NCT03907969|474361558|FG003|Monotherapy Part A|Death|1|||
131749887|NCT03907969|474361559|FG004|Monotherapy Part A|Death|0|||
131749888|NCT03907969|474361560|FG005|Monotherapy Part A|Death|1|||
131749889|NCT03907969|474361561|FG006|Monotherapy Part A|Death|0|||
131749890|NCT03907969|474361562|FG007|Monotherapy Part A|Death|0|||
131749891|NCT03907969|474361563|FG008|Monotherapy Part A|Death|0|||
131749892|NCT03907969|474361564|FG009|Monotherapy Part A|Death|0|||
131749893|NCT03907969|474361565|FG010|Monotherapy Part A|Death|0|||
131749894|NCT03907969|474361555|FG000|Combination Therapy Part A|Adverse Event|0|||
131749895|NCT03907969|474361556|FG001|Combination Therapy Part A|Adverse Event|0|||
131749896|NCT03907969|474361557|FG002|Combination Therapy Part A|Adverse Event|0|||
131749897|NCT03907969|474361558|FG003|Combination Therapy Part A|Adverse Event|0|||
131749898|NCT03907969|474361559|FG004|Combination Therapy Part A|Adverse Event|0|||
131749899|NCT03907969|474361560|FG005|Combination Therapy Part A|Adverse Event|0|||
131749900|NCT03907969|474361561|FG006|Combination Therapy Part A|Adverse Event|0|||
131749901|NCT03907969|474361562|FG007|Combination Therapy Part A|Adverse Event|0|||
131749902|NCT03907969|474361563|FG008|Combination Therapy Part A|Adverse Event|0|||
131749903|NCT03907969|474361564|FG009|Combination Therapy Part A|Adverse Event|1|||
131749904|NCT03907969|474361565|FG010|Combination Therapy Part A|Adverse Event|1|||
131749905|NCT03907969|474361555|FG000|Combination Therapy Part A|Progressive disease|0|||
131749906|NCT03907969|474361556|FG001|Combination Therapy Part A|Progressive disease|0|||
131749907|NCT03907969|474361557|FG002|Combination Therapy Part A|Progressive disease|0|||
131749908|NCT03907969|474361558|FG003|Combination Therapy Part A|Progressive disease|0|||
131749909|NCT03907969|474361559|FG004|Combination Therapy Part A|Progressive disease|0|||
131749910|NCT03907969|474361560|FG005|Combination Therapy Part A|Progressive disease|0|||
131749911|NCT03907969|474361561|FG006|Combination Therapy Part A|Progressive disease|0|||
131809110|NCT04405570|474584376|FG000|Overall Study|Adverse Event|0|||
131809111|NCT04405570|474584377|FG001|Overall Study|Adverse Event|1|||
131809112|NCT04405570|474584378|FG002|Overall Study|Adverse Event|1|||
131809113|NCT04405570|474584379|FG003|Overall Study|Adverse Event|1|||
131809114|NCT04405570|474584376|FG000|Overall Study|Lost to Follow-up|0|||
131809115|NCT04405570|474584377|FG001|Overall Study|Lost to Follow-up|1|||
131809116|NCT04405570|474584378|FG002|Overall Study|Lost to Follow-up|0|||
131809117|NCT04405570|474584379|FG003|Overall Study|Lost to Follow-up|0|||
131809118|NCT04405570|474584376|FG000|Overall Study|Physician Decision|0|||
131809119|NCT04405570|474584377|FG001|Overall Study|Physician Decision|0|||
131809120|NCT04405570|474584378|FG002|Overall Study|Physician Decision|1|||
131809121|NCT04405570|474584379|FG003|Overall Study|Physician Decision|0|||
131809122|NCT04405570|474584376|FG000|Overall Study|Withdrawal by Subject|0|||
131809123|NCT04405570|474584377|FG001|Overall Study|Withdrawal by Subject|1|||
131809124|NCT04405570|474584378|FG002|Overall Study|Withdrawal by Subject|1|||
131809125|NCT04405570|474584379|FG003|Overall Study|Withdrawal by Subject|0|||
131809126|NCT04405570|474584376|FG000|Overall Study|Randomized not dosed|0|||
131809127|NCT04405570|474584377|FG001|Overall Study|Randomized not dosed|2|||
131809128|NCT04405570|474584378|FG002|Overall Study|Randomized not dosed|0|||
131809129|NCT04405570|474584379|FG003|Overall Study|Randomized not dosed|0|||
131809130|NCT00723710|474584380|FG000|Overall Study|Disease progression|48|||
131809131|NCT00723710|474584380|FG000|Overall Study|Adverse Event|88|||
131809132|NCT00723710|474584380|FG000|Overall Study|Withdrawal by Subject|36|||
131809133|NCT00723710|474584380|FG000|Overall Study|Physician Decision|2|||
131809134|NCT04499963|474584381|FG000|Overall Study|Adverse Event|3|||
131809135|NCT04499963|474584382|FG001|Overall Study|Adverse Event|0|||
131809136|NCT04499963|474584381|FG000|Overall Study|Death|3|||
131809137|NCT04499963|474584382|FG001|Overall Study|Death|0|||
131809138|NCT04499963|474584381|FG000|Overall Study|Lack of Efficacy|7|||
131809139|NCT04499963|474584382|FG001|Overall Study|Lack of Efficacy|0|||
131809140|NCT04499963|474584381|FG000|Overall Study|Lost to Follow-up|2|||
131809141|NCT04499963|474584382|FG001|Overall Study|Lost to Follow-up|0|||
131809142|NCT00465270|474584393|FG000|Overall Study|Death|7|||
131809143|NCT00465270|474584394|FG001|Overall Study|Death|11|||
131809144|NCT00465270|474584393|FG000|Overall Study|Withdrawal by Subject|34|||
131809145|NCT00465270|474584394|FG001|Overall Study|Withdrawal by Subject|78|||
131749912|NCT03907969|474361562|FG007|Combination Therapy Part A|Progressive disease|1|||
131749913|NCT03907969|474361563|FG008|Combination Therapy Part A|Progressive disease|0|||
131749914|NCT03907969|474361564|FG009|Combination Therapy Part A|Progressive disease|2|||
131749915|NCT03907969|474361565|FG010|Combination Therapy Part A|Progressive disease|3|||
131749916|NCT03907969|474361555|FG000|Combination Therapy Part A|Death|0|||
131749917|NCT03907969|474361556|FG001|Combination Therapy Part A|Death|0|||
131749918|NCT03907969|474361557|FG002|Combination Therapy Part A|Death|0|||
131749919|NCT03907969|474361558|FG003|Combination Therapy Part A|Death|0|||
131809146|NCT00465270|474584393|FG000|Overall Study|Lost to Follow-up|60|||
131809147|NCT00465270|474584394|FG001|Overall Study|Lost to Follow-up|67|||
131749920|NCT03907969|474361559|FG004|Combination Therapy Part A|Death|0|||
131749921|NCT03907969|474361560|FG005|Combination Therapy Part A|Death|0|||
131749922|NCT03907969|474361561|FG006|Combination Therapy Part A|Death|0|||
131749923|NCT03907969|474361562|FG007|Combination Therapy Part A|Death|0|||
131749924|NCT03907969|474361563|FG008|Combination Therapy Part A|Death|1|||
131749925|NCT03907969|474361564|FG009|Combination Therapy Part A|Death|0|||
131749926|NCT03907969|474361565|FG010|Combination Therapy Part A|Death|1|||
131749927|NCT03907969|474361555|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
131749928|NCT03907969|474361556|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
131749929|NCT03907969|474361557|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
131749930|NCT03907969|474361558|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
131749931|NCT03907969|474361559|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
131749932|NCT03907969|474361560|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
131749933|NCT03907969|474361561|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
131749934|NCT03907969|474361562|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
131749935|NCT03907969|474361563|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
131749936|NCT03907969|474361564|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
131749937|NCT03907969|474361565|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
131749938|NCT03907969|474361555|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
131749939|NCT03907969|474361556|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
131749940|NCT03907969|474361557|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
131749941|NCT03907969|474361558|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
131749942|NCT03907969|474361559|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
131749943|NCT03907969|474361560|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
131749944|NCT03907969|474361561|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
131749945|NCT03907969|474361562|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
131749946|NCT03907969|474361563|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
131749947|NCT03907969|474361564|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
131749948|NCT03907969|474361565|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
131749949|NCT03907969|474361555|FG000|Combination Therapy Part A|Physician Decision|0|||
131749950|NCT03907969|474361556|FG001|Combination Therapy Part A|Physician Decision|0|||
131749951|NCT03907969|474361557|FG002|Combination Therapy Part A|Physician Decision|0|||
131749952|NCT03907969|474361558|FG003|Combination Therapy Part A|Physician Decision|0|||
131749953|NCT03907969|474361559|FG004|Combination Therapy Part A|Physician Decision|0|||
131749954|NCT03907969|474361560|FG005|Combination Therapy Part A|Physician Decision|0|||
131749955|NCT03907969|474361561|FG006|Combination Therapy Part A|Physician Decision|0|||
131749956|NCT03907969|474361562|FG007|Combination Therapy Part A|Physician Decision|1|||
131749957|NCT03907969|474361563|FG008|Combination Therapy Part A|Physician Decision|0|||
131749958|NCT03907969|474361564|FG009|Combination Therapy Part A|Physician Decision|0|||
131809148|NCT00465270|474584393|FG000|Overall Study|Investigator request|3|||
131809149|NCT00465270|474584394|FG001|Overall Study|Investigator request|4|||
131809150|NCT03233724|474584395|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
131809151|NCT03233724|474584396|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
131809152|NCT03233724|474584397|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
131809153|NCT03233724|474584398|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
131809154|NCT03233724|474584399|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
131809155|NCT03233724|474584395|FG000|Phase I Dose Escalation|Best interest of participant|1|||
131809156|NCT03233724|474584396|FG001|Phase I Dose Escalation|Best interest of participant|1|||
131809157|NCT03233724|474584397|FG002|Phase I Dose Escalation|Best interest of participant|1|||
131809158|NCT03233724|474584398|FG003|Phase I Dose Escalation|Best interest of participant|0|||
131809159|NCT03233724|474584399|FG004|Phase I Dose Escalation|Best interest of participant|0|||
131809160|NCT03233724|474584395|FG000|Phase I Dose Escalation|Physician Decision|0|||
131809161|NCT03233724|474584396|FG001|Phase I Dose Escalation|Physician Decision|0|||
131809162|NCT03233724|474584397|FG002|Phase I Dose Escalation|Physician Decision|1|||
131809163|NCT03233724|474584398|FG003|Phase I Dose Escalation|Physician Decision|0|||
131809164|NCT03233724|474584399|FG004|Phase I Dose Escalation|Physician Decision|0|||
131809165|NCT03233724|474584395|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
131809166|NCT03233724|474584396|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
131809167|NCT03233724|474584397|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
131809168|NCT03233724|474584398|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
131809169|NCT03233724|474584399|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
131749959|NCT03907969|474361565|FG010|Combination Therapy Part A|Physician Decision|1|||
131749960|NCT00063986|474361569|FG000|Overall Study|Withdrawal by Subject|1|||
131749961|NCT00063986|474361569|FG000|Overall Study|Ineligible|1|||
131749962|NCT00063986|474361569|FG000|Overall Study|Intra-operatively ineligible|4|||
131749963|NCT00724815|474361572|FG000|Overall Study|Randomized, not treated|31|||
131749964|NCT00724815|474361573|FG001|Overall Study|Randomized, not treated|30|||
131749965|NCT00724815|474361572|FG000|Overall Study|Adverse Event|5|||
131749966|NCT00724815|474361573|FG001|Overall Study|Adverse Event|3|||
131749967|NCT00724815|474361572|FG000|Overall Study|Lost to Follow-up|4|||
131749968|NCT00724815|474361573|FG001|Overall Study|Lost to Follow-up|1|||
131749969|NCT00724815|474361572|FG000|Overall Study|Other Various|3|||
131749970|NCT00724815|474361573|FG001|Overall Study|Other Various|5|||
131749971|NCT00810043|474361574|FG000|Overall Study|Withdrawal by Subject|1|||
131749972|NCT00810043|474361575|FG001|Overall Study|Withdrawal by Subject|0|||
131749973|NCT00810043|474361576|FG002|Overall Study|Withdrawal by Subject|2|||
131749974|NCT00810043|474361574|FG000|Overall Study|Lost to Follow-up|1|||
131749975|NCT00810043|474361575|FG001|Overall Study|Lost to Follow-up|0|||
131749976|NCT00810043|474361576|FG002|Overall Study|Lost to Follow-up|0|||
131749977|NCT00810043|474361574|FG000|Overall Study|Physician Decision|0|||
131749978|NCT00810043|474361575|FG001|Overall Study|Physician Decision|0|||
131749979|NCT00810043|474361576|FG002|Overall Study|Physician Decision|2|||
131749980|NCT00810043|474361574|FG000|Overall Study|Death|2|||
131749981|NCT00810043|474361575|FG001|Overall Study|Death|0|||
131749982|NCT00810043|474361576|FG002|Overall Study|Death|0|||
131749983|NCT00810043|474361574|FG000|Overall Study|Unrelated medical problem|0|||
131749984|NCT00810043|474361575|FG001|Overall Study|Unrelated medical problem|1|||
131749985|NCT00810043|474361576|FG002|Overall Study|Unrelated medical problem|0|||
131749986|NCT00810043|474361574|FG000|Overall Study|Non-medical problem|0|||
131749987|NCT00810043|474361575|FG001|Overall Study|Non-medical problem|0|||
131749988|NCT00810043|474361576|FG002|Overall Study|Non-medical problem|1|||
131749989|NCT00810043|474361574|FG000|Overall Study|No longer met enrollment criteria|0|||
131749990|NCT00810043|474361575|FG001|Overall Study|No longer met enrollment criteria|0|||
131749991|NCT00810043|474361576|FG002|Overall Study|No longer met enrollment criteria|3|||
131749992|NCT01359046|474361577|FG000|Overall Study|Did not receive allocated intervention|6|||
131749993|NCT01359046|474361578|FG001|Overall Study|Did not receive allocated intervention|6|||
131749994|NCT01359046|474361577|FG000|Overall Study|Physician Decision|1|||
131749995|NCT01359046|474361578|FG001|Overall Study|Physician Decision|11|||
131749996|NCT04539262|474361582|FG000|Overall Study|Adverse Event|0|||
131749997|NCT04539262|474361583|FG001|Overall Study|Adverse Event|0|||
131749998|NCT04539262|474361584|FG002|Overall Study|Adverse Event|1|||
131749999|NCT04539262|474361585|FG003|Overall Study|Adverse Event|0|||
131750000|NCT04539262|474361586|FG004|Overall Study|Adverse Event|0|||
131750001|NCT04539262|474361587|FG005|Overall Study|Adverse Event|0|||
131750002|NCT04539262|474361588|FG006|Overall Study|Adverse Event|0|||
131750003|NCT04539262|474361589|FG007|Overall Study|Adverse Event|0|||
131750004|NCT04539262|474361582|FG000|Overall Study|Withdrew Consent|0|||
131750005|NCT04539262|474361583|FG001|Overall Study|Withdrew Consent|0|||
131750006|NCT04539262|474361584|FG002|Overall Study|Withdrew Consent|0|||
131750007|NCT04539262|474361585|FG003|Overall Study|Withdrew Consent|1|||
131750008|NCT04539262|474361586|FG004|Overall Study|Withdrew Consent|0|||
131750009|NCT04539262|474361587|FG005|Overall Study|Withdrew Consent|0|||
131750010|NCT04539262|474361588|FG006|Overall Study|Withdrew Consent|0|||
131750011|NCT04539262|474361589|FG007|Overall Study|Withdrew Consent|0|||
131750012|NCT04539262|474361582|FG000|Overall Study|Randomized, Not treated|0|||
131750013|NCT04539262|474361583|FG001|Overall Study|Randomized, Not treated|1|||
131750014|NCT04539262|474361584|FG002|Overall Study|Randomized, Not treated|0|||
131750015|NCT04539262|474361585|FG003|Overall Study|Randomized, Not treated|0|||
131750016|NCT04539262|474361586|FG004|Overall Study|Randomized, Not treated|0|||
131750017|NCT04539262|474361587|FG005|Overall Study|Randomized, Not treated|0|||
131750018|NCT04539262|474361588|FG006|Overall Study|Randomized, Not treated|1|||
131750019|NCT04539262|474361589|FG007|Overall Study|Randomized, Not treated|0|||
131750020|NCT01061567|474361596|FG000|Overall Study|Adverse Event|32|||
131750021|NCT01061567|474361596|FG000|Overall Study|Death|2|||
131750022|NCT01061567|474361596|FG000|Overall Study|Lack of Efficacy|3|||
131750023|NCT01061567|474361596|FG000|Overall Study|Lost to Follow-up|24|||
131750024|NCT01061567|474361596|FG000|Overall Study|Protocol Violation|1|||
131750025|NCT01061567|474361596|FG000|Overall Study|Withdrawal by Subject|11|||
131750026|NCT01061567|474361596|FG000|Overall Study|Other reason than stated above|3|||
131750027|NCT02255760|474361597|FG000|Overall Study|Lost to Follow-up|0|||
131750028|NCT02255760|474361598|FG001|Overall Study|Lost to Follow-up|1|||
131750029|NCT02255760|474361599|FG002|Overall Study|Lost to Follow-up|0|||
131449227|NCT01002339|473274815|FG002|Overall Study|Lung cancer detected before transplant|1|||
131750030|NCT02255760|474361600|FG003|Overall Study|Lost to Follow-up|0|||
131750031|NCT02255760|474361601|FG004|Overall Study|Lost to Follow-up|0|||
131750032|NCT00618813|474361602|FG000|Overall Study|Lack of Efficacy|1|||
131750033|NCT00618813|474361602|FG000|Overall Study|Physician Decision|2|||
131750034|NCT00618813|474361602|FG000|Overall Study|Withdrawal by Subject|1|||
131750035|NCT00003838|474361603|FG000|Overall Study|Death|0|||
131750036|NCT00003838|474361604|FG001|Overall Study|Death|12|||
131750037|NCT00003838|474361605|FG002|Overall Study|Death|7|||
131750038|NCT00003838|474361603|FG000|Overall Study|Lost to Follow-up|0|||
131750039|NCT00003838|474361604|FG001|Overall Study|Lost to Follow-up|1|||
131750040|NCT00003838|474361605|FG002|Overall Study|Lost to Follow-up|1|||
131750041|NCT00003838|474361603|FG000|Overall Study|Disease Progression|0|||
131750042|NCT00003838|474361604|FG001|Overall Study|Disease Progression|12|||
131750043|NCT00003838|474361605|FG002|Overall Study|Disease Progression|0|||
131750044|NCT01809197|474361606|FG000|Overall Study|Lost to Follow-up|4|||
131750045|NCT01809197|474361607|FG001|Overall Study|Lost to Follow-up|2|||
131750046|NCT01809197|474361606|FG000|Overall Study|Adverse Event|2|||
131750047|NCT01809197|474361607|FG001|Overall Study|Adverse Event|3|||
131750048|NCT01809197|474361606|FG000|Overall Study|Failed slit lamp exam|1|||
131750049|NCT01809197|474361607|FG001|Overall Study|Failed slit lamp exam|0|||
131750050|NCT01809197|474361606|FG000|Overall Study|Non-Compliance|1|||
131750051|NCT01809197|474361607|FG001|Overall Study|Non-Compliance|1|||
131750052|NCT01809197|474361606|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
131750053|NCT01809197|474361607|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
131750054|NCT01809197|474361606|FG000|Overall Study|Withdrawal by Subject|1|||
131750055|NCT01809197|474361607|FG001|Overall Study|Withdrawal by Subject|1|||
131750056|NCT01809197|474361606|FG000|Overall Study|Product not available|0|||
131750057|NCT01809197|474361607|FG001|Overall Study|Product not available|1|||
131750058|NCT00268463|474361610|FG000|Overall Study|study terminated due to low accrual|10|||
131750059|NCT00268463|474361611|FG001|Overall Study|study terminated due to low accrual|12|||
131750060|NCT02920450|474361612|FG000|Overall Study|Death|1|||
131750061|NCT02920450|474361613|FG001|Overall Study|Death|0|||
131750062|NCT02920450|474361614|FG002|Overall Study|Death|0|||
131750063|NCT02920450|474361615|FG003|Overall Study|Death|0|||
131750064|NCT02920450|474361612|FG000|Overall Study|Withdrawal by Subject|1|||
131750065|NCT02920450|474361613|FG001|Overall Study|Withdrawal by Subject|0|||
131750066|NCT02920450|474361614|FG002|Overall Study|Withdrawal by Subject|0|||
131750067|NCT02920450|474361615|FG003|Overall Study|Withdrawal by Subject|0|||
131750068|NCT01851863|474361618|FG000|Overall Study|Did not receive study medication|2|||
131750069|NCT01851863|474361619|FG001|Overall Study|Did not receive study medication|5|||
131750070|NCT01851863|474361620|FG002|Overall Study|Did not receive study medication|3|||
131750071|NCT01851863|474361621|FG003|Overall Study|Did not receive study medication|0|||
131750072|NCT01851863|474361618|FG000|Overall Study|Lost to Follow-up|3|||
131750073|NCT01851863|474361619|FG001|Overall Study|Lost to Follow-up|4|||
131750074|NCT01851863|474361620|FG002|Overall Study|Lost to Follow-up|2|||
131750075|NCT01851863|474361621|FG003|Overall Study|Lost to Follow-up|3|||
131750076|NCT03238352|474361622|FG000|Overall Study|Lost to Follow-up|0|||
131750077|NCT03238352|474361623|FG001|Overall Study|Lost to Follow-up|2|||
131750078|NCT03238352|474361624|FG002|Overall Study|Lost to Follow-up|1|||
131750079|NCT03238352|474361622|FG000|Overall Study|Withdrawal by Subject|0|||
131750080|NCT03238352|474361623|FG001|Overall Study|Withdrawal by Subject|1|||
131750081|NCT03238352|474361624|FG002|Overall Study|Withdrawal by Subject|0|||
131750082|NCT00928512|474361625|FG000|Overall Study|Adverse Event|4|||
131750083|NCT00928512|474361626|FG001|Overall Study|Adverse Event|3|||
131750084|NCT00928512|474361627|FG002|Overall Study|Adverse Event|2|||
131750085|NCT00928512|474361628|FG003|Overall Study|Adverse Event|8|||
131750086|NCT00928512|474361629|FG004|Overall Study|Adverse Event|6|||
131750087|NCT00928512|474361625|FG000|Overall Study|Lack of Efficacy|2|||
131750088|NCT00928512|474361626|FG001|Overall Study|Lack of Efficacy|0|||
131750089|NCT00928512|474361627|FG002|Overall Study|Lack of Efficacy|4|||
131750090|NCT00928512|474361628|FG003|Overall Study|Lack of Efficacy|7|||
131750091|NCT00928512|474361629|FG004|Overall Study|Lack of Efficacy|3|||
131750092|NCT00928512|474361625|FG000|Overall Study|Protocol Violation|0|||
131750093|NCT00928512|474361626|FG001|Overall Study|Protocol Violation|1|||
131750094|NCT00928512|474361627|FG002|Overall Study|Protocol Violation|0|||
131750095|NCT00928512|474361628|FG003|Overall Study|Protocol Violation|1|||
131750096|NCT00928512|474361629|FG004|Overall Study|Protocol Violation|3|||
131750097|NCT00928512|474361625|FG000|Overall Study|Withdrawal by Subject|3|||
131750098|NCT00928512|474361626|FG001|Overall Study|Withdrawal by Subject|0|||
131750099|NCT00928512|474361627|FG002|Overall Study|Withdrawal by Subject|3|||
131750100|NCT00928512|474361628|FG003|Overall Study|Withdrawal by Subject|4|||
131750101|NCT00928512|474361629|FG004|Overall Study|Withdrawal by Subject|0|||
131750102|NCT00928512|474361625|FG000|Overall Study|Lost to Follow-up|1|||
131750103|NCT00928512|474361626|FG001|Overall Study|Lost to Follow-up|1|||
131750104|NCT00928512|474361627|FG002|Overall Study|Lost to Follow-up|2|||
131750105|NCT00928512|474361628|FG003|Overall Study|Lost to Follow-up|1|||
131750106|NCT00928512|474361629|FG004|Overall Study|Lost to Follow-up|3|||
131750107|NCT00928512|474361625|FG000|Overall Study|Administrative Problems|0|||
131750108|NCT00928512|474361626|FG001|Overall Study|Administrative Problems|1|||
131750109|NCT00928512|474361627|FG002|Overall Study|Administrative Problems|0|||
131750110|NCT00928512|474361628|FG003|Overall Study|Administrative Problems|0|||
131750111|NCT00928512|474361629|FG004|Overall Study|Administrative Problems|0|||
131750112|NCT03383614|474361630|FG000|Overall Study|Withdrawal by Subject|0|||
131750113|NCT03383614|474361631|FG001|Overall Study|Withdrawal by Subject|1|||
131750114|NCT03383614|474361632|FG002|Overall Study|Withdrawal by Subject|0|||
131750115|NCT03383614|474361633|FG003|Overall Study|Withdrawal by Subject|0|||
131750116|NCT01975675|474361636|FG000|Overall Study|Death|0|||
131750117|NCT01975675|474361637|FG001|Overall Study|Death|1|||
131750118|NCT01975675|474361638|FG002|Overall Study|Death|0|||
131750119|NCT01975675|474361639|FG003|Overall Study|Death|0|||
131750120|NCT00224003|474361640|FG000|Overall Study|Adverse Event|1|||
131750121|NCT00224003|474361640|FG000|Overall Study|Protocol Violation|2|||
131750122|NCT00224003|474361640|FG000|Overall Study|Withdrawal by Subject|1|||
131750123|NCT00224003|474361640|FG000|Overall Study|unk|3|||
131750124|NCT00729326|474361643|FG000|Overall Study|Lost to Follow-up|2|||
131750125|NCT00729326|474361644|FG001|Overall Study|Lost to Follow-up|0|||
131750126|NCT00729326|474361643|FG000|Overall Study|Physician Decision|0|||
131750127|NCT00729326|474361644|FG001|Overall Study|Physician Decision|1|||
131750128|NCT00729326|474361643|FG000|Overall Study|Protocol Violation|3|||
131750129|NCT00729326|474361644|FG001|Overall Study|Protocol Violation|2|||
131750130|NCT00729326|474361643|FG000|Overall Study|Subject Decision|4|||
131750131|NCT00729326|474361644|FG001|Overall Study|Subject Decision|4|||
131750132|NCT00729326|474361643|FG000|Overall Study|Sponsor Decision|1|||
131750133|NCT00729326|474361644|FG001|Overall Study|Sponsor Decision|2|||
131750134|NCT03199638|474361654|FG000|Overall Study|inability to drink glutamine during regularly|0|||
131750135|NCT03199638|474361655|FG001|Overall Study|inability to drink glutamine during regularly|2|||
131750136|NCT02807844|474361656|FG000|Overall Study|Physician Decision|0|||
131750137|NCT02807844|474361657|FG001|Overall Study|Physician Decision|0|||
131750138|NCT02807844|474361658|FG002|Overall Study|Physician Decision|0|||
131750139|NCT02807844|474361659|FG003|Overall Study|Physician Decision|0|||
131750140|NCT02807844|474361660|FG004|Overall Study|Physician Decision|0|||
131750141|NCT02807844|474361661|FG005|Overall Study|Physician Decision|0|||
131750142|NCT02807844|474361662|FG006|Overall Study|Physician Decision|3|||
131750143|NCT02807844|474361663|FG007|Overall Study|Physician Decision|0|||
131750144|NCT02807844|474361664|FG008|Overall Study|Physician Decision|1|||
131750145|NCT02807844|474361665|FG009|Overall Study|Physician Decision|2|||
131750146|NCT02807844|474361656|FG000|Overall Study|Death|0|||
131750147|NCT02807844|474361657|FG001|Overall Study|Death|0|||
131750148|NCT02807844|474361658|FG002|Overall Study|Death|2|||
131750149|NCT02807844|474361659|FG003|Overall Study|Death|4|||
131750150|NCT02807844|474361660|FG004|Overall Study|Death|1|||
131750151|NCT02807844|474361661|FG005|Overall Study|Death|2|||
131750152|NCT02807844|474361662|FG006|Overall Study|Death|1|||
131750153|NCT02807844|474361663|FG007|Overall Study|Death|2|||
131750154|NCT02807844|474361664|FG008|Overall Study|Death|0|||
131750155|NCT02807844|474361665|FG009|Overall Study|Death|1|||
131750156|NCT02807844|474361656|FG000|Overall Study|Withdrawal by Subject|0|||
131750157|NCT02807844|474361657|FG001|Overall Study|Withdrawal by Subject|0|||
131809170|NCT02242201|474584400|FG000|Overall Study|preoperative identified neuropathy|2|||
131809171|NCT02242201|474584401|FG001|Overall Study|preoperative identified neuropathy|0|||
131750158|NCT02807844|474361658|FG002|Overall Study|Withdrawal by Subject|2|||
131750159|NCT02807844|474361659|FG003|Overall Study|Withdrawal by Subject|1|||
131750160|NCT02807844|474361660|FG004|Overall Study|Withdrawal by Subject|1|||
131750161|NCT02807844|474361661|FG005|Overall Study|Withdrawal by Subject|0|||
131750162|NCT02807844|474361662|FG006|Overall Study|Withdrawal by Subject|1|||
131750163|NCT02807844|474361663|FG007|Overall Study|Withdrawal by Subject|0|||
131750164|NCT02807844|474361664|FG008|Overall Study|Withdrawal by Subject|0|||
131750165|NCT02807844|474361665|FG009|Overall Study|Withdrawal by Subject|0|||
131750166|NCT02807844|474361656|FG000|Overall Study|Progressive disease|5|||
131750167|NCT02807844|474361657|FG001|Overall Study|Progressive disease|12|||
131750168|NCT02807844|474361658|FG002|Overall Study|Progressive disease|8|||
131750169|NCT02807844|474361659|FG003|Overall Study|Progressive disease|8|||
131750170|NCT02807844|474361660|FG004|Overall Study|Progressive disease|3|||
131750171|NCT02807844|474361661|FG005|Overall Study|Progressive disease|8|||
131750172|NCT02807844|474361662|FG006|Overall Study|Progressive disease|14|||
131750173|NCT02807844|474361663|FG007|Overall Study|Progressive disease|17|||
131750174|NCT02807844|474361664|FG008|Overall Study|Progressive disease|19|||
131750175|NCT02807844|474361665|FG009|Overall Study|Progressive disease|15|||
131750176|NCT02807844|474361656|FG000|Overall Study|Adverse Event|1|||
131750177|NCT02807844|474361657|FG001|Overall Study|Adverse Event|0|||
131750178|NCT02807844|474361658|FG002|Overall Study|Adverse Event|0|||
131750179|NCT02807844|474361659|FG003|Overall Study|Adverse Event|0|||
131750180|NCT02807844|474361660|FG004|Overall Study|Adverse Event|1|||
131750181|NCT02807844|474361661|FG005|Overall Study|Adverse Event|1|||
131750182|NCT02807844|474361662|FG006|Overall Study|Adverse Event|1|||
131750183|NCT02807844|474361663|FG007|Overall Study|Adverse Event|1|||
131750184|NCT02807844|474361664|FG008|Overall Study|Adverse Event|1|||
131750185|NCT02807844|474361665|FG009|Overall Study|Adverse Event|2|||
131750186|NCT03097029|474361666|FG000|Overall Study|Withdrawal by Subject|1|||
131750187|NCT00709124|474361668|FG000|Overall Study|Death|3|||
131750188|NCT00709124|474361669|FG001|Overall Study|Death|1|||
131750189|NCT00709124|474361668|FG000|Overall Study|encephalopathy; can't do assessment|1|||
131750190|NCT00709124|474361669|FG001|Overall Study|encephalopathy; can't do assessment|0|||
131750191|NCT00373490|474361670|FG000|Overall Study|Adverse Event|0|||
131750192|NCT00373490|474361671|FG001|Overall Study|Adverse Event|1|||
131750193|NCT00373490|474361670|FG000|Overall Study|Lack of Efficacy|9|||
131750194|NCT00373490|474361671|FG001|Overall Study|Lack of Efficacy|4|||
131750195|NCT00373490|474361670|FG000|Overall Study|Withdrawal by Subject|0|||
131750196|NCT00373490|474361671|FG001|Overall Study|Withdrawal by Subject|1|||
131750197|NCT00108953|474361678|FG000|Follow-up|Death|18|||
131750198|NCT00108953|474361679|FG001|Follow-up|Death|26|||
131750199|NCT00108953|474361678|FG000|Follow-up|Lost to Follow-up|1|||
131750200|NCT00108953|474361679|FG001|Follow-up|Lost to Follow-up|1|||
131750201|NCT00108953|474361678|FG000|Follow-up|Study terminated by sponsor|10|||
131750202|NCT00108953|474361679|FG001|Follow-up|Study terminated by sponsor|6|||
131750203|NCT02999100|474361685|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
131750204|NCT02999100|474361686|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
131750205|NCT02999100|474361687|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
131750206|NCT02999100|474361688|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
131750207|NCT02999100|474361689|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
131750208|NCT02999100|474361690|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
131750209|NCT02999100|474361685|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131750210|NCT02999100|474361686|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131750211|NCT02999100|474361687|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131750212|NCT02999100|474361688|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131750213|NCT02999100|474361689|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131750214|NCT02999100|474361690|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
131750215|NCT02999100|474361685|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131750216|NCT02999100|474361686|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131750217|NCT02999100|474361687|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
131750218|NCT02999100|474361688|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131750219|NCT02999100|474361689|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131750220|NCT02999100|474361690|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131750221|NCT03595384|474361691|FG000|Overall Study|Other time commitments|8|||
131750222|NCT03595384|474361691|FG000|Overall Study|Changes to session time|7|||
131750223|NCT03595384|474361691|FG000|Overall Study|Relocation out of country|1|||
131750224|NCT03803202|474361692|FG000|Overall Study|Other|0|||
131750225|NCT03803202|474361693|FG001|Overall Study|Other|1|||
131750226|NCT03803202|474361694|FG002|Overall Study|Other|0|||
131750227|NCT03803202|474361695|FG003|Overall Study|Other|0|||
131750228|NCT03803202|474361696|FG004|Overall Study|Other|0|||
131750229|NCT03803202|474361697|FG005|Overall Study|Other|0|||
131750230|NCT03803202|474361698|FG006|Overall Study|Other|0|||
131750231|NCT03803202|474361699|FG007|Overall Study|Other|0|||
131750232|NCT03803202|474361700|FG008|Overall Study|Other|0|||
131750233|NCT03803202|474361692|FG000|Overall Study|Death|0|||
131750234|NCT03803202|474361693|FG001|Overall Study|Death|0|||
131750235|NCT03803202|474361694|FG002|Overall Study|Death|0|||
131750236|NCT03803202|474361695|FG003|Overall Study|Death|0|||
131750237|NCT03803202|474361696|FG004|Overall Study|Death|0|||
131750238|NCT03803202|474361697|FG005|Overall Study|Death|1|||
131750239|NCT03803202|474361698|FG006|Overall Study|Death|0|||
131750240|NCT03803202|474361699|FG007|Overall Study|Death|0|||
131750241|NCT03803202|474361700|FG008|Overall Study|Death|0|||
131750242|NCT03803202|474361692|FG000|Overall Study|Withdrawal by Subject|0|||
131750243|NCT03803202|474361693|FG001|Overall Study|Withdrawal by Subject|0|||
131750244|NCT03803202|474361694|FG002|Overall Study|Withdrawal by Subject|1|||
131750245|NCT03803202|474361695|FG003|Overall Study|Withdrawal by Subject|0|||
131750246|NCT03803202|474361696|FG004|Overall Study|Withdrawal by Subject|0|||
131750247|NCT03803202|474361697|FG005|Overall Study|Withdrawal by Subject|0|||
131750248|NCT03803202|474361698|FG006|Overall Study|Withdrawal by Subject|0|||
131750249|NCT03803202|474361699|FG007|Overall Study|Withdrawal by Subject|1|||
131750250|NCT03803202|474361700|FG008|Overall Study|Withdrawal by Subject|0|||
131750251|NCT03803202|474361692|FG000|Overall Study|Lost to Follow-up|0|||
131750252|NCT03803202|474361693|FG001|Overall Study|Lost to Follow-up|0|||
131750253|NCT03803202|474361694|FG002|Overall Study|Lost to Follow-up|0|||
131750254|NCT03803202|474361695|FG003|Overall Study|Lost to Follow-up|1|||
131750255|NCT03803202|474361696|FG004|Overall Study|Lost to Follow-up|1|||
131750256|NCT03803202|474361697|FG005|Overall Study|Lost to Follow-up|0|||
131750257|NCT03803202|474361698|FG006|Overall Study|Lost to Follow-up|1|||
131750258|NCT03803202|474361699|FG007|Overall Study|Lost to Follow-up|0|||
131750259|NCT03803202|474361700|FG008|Overall Study|Lost to Follow-up|0|||
131750260|NCT00293241|474361701|FG000|Overall Study|Lost to Follow-up|9|||
131750261|NCT00293241|474361702|FG001|Overall Study|Lost to Follow-up|16|||
131750262|NCT00293241|474361701|FG000|Overall Study|Physician Decision|23|||
131750263|NCT00293241|474361702|FG001|Overall Study|Physician Decision|17|||
131750264|NCT00293241|474361701|FG000|Overall Study|Withdrawal by Subject|4|||
131750265|NCT00293241|474361702|FG001|Overall Study|Withdrawal by Subject|8|||
131750266|NCT01125293|474361703|FG000|Overall Study|Disease Progression|1|||
131750267|NCT01125293|474361704|FG001|Overall Study|Disease Progression|3|||
131750268|NCT01125293|474361705|FG002|Overall Study|Disease Progression|4|||
131750269|NCT01125293|474361706|FG003|Overall Study|Disease Progression|3|||
131750270|NCT01125293|474361707|FG004|Overall Study|Disease Progression|5|||
131750271|NCT01125293|474361708|FG005|Overall Study|Disease Progression|12|||
131750272|NCT01125293|474361703|FG000|Overall Study|Adverse Event|1|||
131750273|NCT01125293|474361704|FG001|Overall Study|Adverse Event|0|||
131750274|NCT01125293|474361705|FG002|Overall Study|Adverse Event|0|||
131750275|NCT01125293|474361706|FG003|Overall Study|Adverse Event|0|||
131750276|NCT01125293|474361707|FG004|Overall Study|Adverse Event|2|||
131750277|NCT01125293|474361708|FG005|Overall Study|Adverse Event|8|||
131750278|NCT01125293|474361703|FG000|Overall Study|Symptomatic Deterioration|1|||
131750279|NCT01125293|474361704|FG001|Overall Study|Symptomatic Deterioration|0|||
131750280|NCT01125293|474361705|FG002|Overall Study|Symptomatic Deterioration|0|||
131750281|NCT01125293|474361706|FG003|Overall Study|Symptomatic Deterioration|0|||
131750282|NCT01125293|474361707|FG004|Overall Study|Symptomatic Deterioration|0|||
131750283|NCT01125293|474361708|FG005|Overall Study|Symptomatic Deterioration|0|||
131750284|NCT01125293|474361703|FG000|Overall Study|Death|0|||
131750285|NCT01125293|474361704|FG001|Overall Study|Death|0|||
131750286|NCT01125293|474361705|FG002|Overall Study|Death|0|||
131750287|NCT01125293|474361706|FG003|Overall Study|Death|0|||
131750288|NCT01125293|474361707|FG004|Overall Study|Death|1|||
131750289|NCT01125293|474361708|FG005|Overall Study|Death|0|||
131750290|NCT01125293|474361703|FG000|Overall Study|Withdrawal by Subject|0|||
131750291|NCT01125293|474361704|FG001|Overall Study|Withdrawal by Subject|0|||
131750292|NCT01125293|474361705|FG002|Overall Study|Withdrawal by Subject|0|||
131750293|NCT01125293|474361706|FG003|Overall Study|Withdrawal by Subject|0|||
131750294|NCT01125293|474361707|FG004|Overall Study|Withdrawal by Subject|2|||
131750295|NCT01125293|474361708|FG005|Overall Study|Withdrawal by Subject|1|||
131750296|NCT01125293|474361703|FG000|Overall Study|Physician Decision|0|||
131750297|NCT01125293|474361704|FG001|Overall Study|Physician Decision|0|||
131750298|NCT01125293|474361705|FG002|Overall Study|Physician Decision|0|||
131750299|NCT01125293|474361706|FG003|Overall Study|Physician Decision|0|||
131750300|NCT01125293|474361707|FG004|Overall Study|Physician Decision|0|||
131750301|NCT01125293|474361708|FG005|Overall Study|Physician Decision|2|||
131750302|NCT02224638|474361709|FG000|Overall Study|Adverse Event|1|||
131750303|NCT02224638|474361710|FG001|Overall Study|Adverse Event|1|||
131750304|NCT01270958|474361713|FG000|Overall Study|Lost to Follow-up|2|||
131750305|NCT01270958|474361713|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
131750306|NCT00587301|474361724|FG000|Overall Study|Screen Failure|9|||
131750307|NCT00587301|474361724|FG000|Overall Study|Lost to Follow-up|22|||
131750308|NCT00587301|474361724|FG000|Overall Study|Withdrawal by Subject|7|||
131809172|NCT02242201|474584402|FG002|Overall Study|preoperative identified neuropathy|0|||
131750309|NCT00587301|474361724|FG000|Overall Study|Protocol Violation|7|||
131750310|NCT01496274|474361725|FG000|Overall Study|Protocol Violation|0|||
131750311|NCT01496274|474361726|FG001|Overall Study|Protocol Violation|1|||
131750312|NCT01496274|474361725|FG000|Overall Study|Adverse Event|1|||
131750313|NCT01496274|474361726|FG001|Overall Study|Adverse Event|1|||
131750314|NCT01496274|474361725|FG000|Overall Study|Withdrawal by Subject|2|||
131750315|NCT01496274|474361726|FG001|Overall Study|Withdrawal by Subject|0|||
131750316|NCT01496274|474361725|FG000|Overall Study|Lost to Follow-up|0|||
131750317|NCT01496274|474361726|FG001|Overall Study|Lost to Follow-up|3|||
131750318|NCT02758613|474361728|FG000|Treatment|Physician and Sponsor Decision|1|||
131750319|NCT02758613|474361729|FG001|Treatment|Physician and Sponsor Decision|0|||
131750320|NCT02758613|474361730|FG002|Treatment|Physician and Sponsor Decision|0|||
131750321|NCT02758613|474361731|FG003|Treatment|Physician and Sponsor Decision|0|||
131750322|NCT02758613|474361728|FG000|Treatment|Withdrawal by Subject|1|||
131750323|NCT02758613|474361729|FG001|Treatment|Withdrawal by Subject|0|||
131750324|NCT02758613|474361730|FG002|Treatment|Withdrawal by Subject|1|||
131750325|NCT02758613|474361731|FG003|Treatment|Withdrawal by Subject|0|||
131750326|NCT02910219|474361732|FG000|Overall Study|Withdrawal by Subject|1|||
131750327|NCT02910219|474361733|FG001|Overall Study|Withdrawal by Subject|1|||
131750328|NCT02096042|474361734|FG000|Overall Study|Disease Progression|1|||
131750329|NCT02096042|474361735|FG001|Overall Study|Disease Progression|0|||
131750330|NCT02096042|474361736|FG002|Overall Study|Disease Progression|0|||
131750331|NCT00701441|474361737|FG000|Overall Study|failure in cpap compliance|0|||
131750332|NCT00701441|474361738|FG001|Overall Study|failure in cpap compliance|4|||
131750333|NCT01313078|474361740|FG000|Overall Study|Death|1|||
131750334|NCT01313078|474361740|FG000|Overall Study|Discontinued study drug|1|||
131750335|NCT01313078|474361740|FG000|Overall Study|Withdrawal by Subject|1|||
131750336|NCT02679781|474361745|FG000|Overall Study|Lost to Follow-up|1|||
131750337|NCT02679781|474361746|FG001|Overall Study|Lost to Follow-up|2|||
131750338|NCT02679781|474361745|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
131750339|NCT02679781|474361746|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
131750340|NCT04209400|474361747|FG000|Overall Study|Withdrawal by Subject|0|||
131750341|NCT04209400|474361748|FG001|Overall Study|Withdrawal by Subject|1|||
131750342|NCT00631540|474361761|FG000|Overall Study|Withdrawal by Subject|5|||
131750343|NCT00631540|474361761|FG000|Overall Study|Death|4|||
131750344|NCT00631540|474361761|FG000|Overall Study|Lost to Follow-up|2|||
131750345|NCT00631540|474361761|FG000|Overall Study|Core Lab Data Unavailable|3|||
131750346|NCT00970268|474361762|FG000|Overall Study|Withdrawal by Subject|12|||
131750347|NCT00970268|474361763|FG001|Overall Study|Withdrawal by Subject|19|||
131750348|NCT00970268|474361762|FG000|Overall Study|Adverse Event|15|||
131750349|NCT00970268|474361763|FG001|Overall Study|Adverse Event|12|||
131750350|NCT00970268|474361762|FG000|Overall Study|Lack of Efficacy|3|||
131750351|NCT00970268|474361763|FG001|Overall Study|Lack of Efficacy|6|||
131750352|NCT00970268|474361762|FG000|Overall Study|Protocol Violation|4|||
131750353|NCT00970268|474361763|FG001|Overall Study|Protocol Violation|7|||
131750354|NCT00970268|474361762|FG000|Overall Study|Other Reason|3|||
131750355|NCT00970268|474361763|FG001|Overall Study|Other Reason|1|||
131750356|NCT00970268|474361762|FG000|Overall Study|COPD Exacerbation|4|||
131750357|NCT00970268|474361763|FG001|Overall Study|COPD Exacerbation|2|||
131750358|NCT00970268|474361762|FG000|Overall Study|Lost to Follow-up|1|||
131750359|NCT00970268|474361763|FG001|Overall Study|Lost to Follow-up|2|||
131750360|NCT00970268|474361762|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
131750361|NCT00970268|474361763|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
131750362|NCT01602549|474361768|FG000|Overall Study|Protocol Violation|0|||
131750363|NCT01602549|474361769|FG001|Overall Study|Protocol Violation|1|||
131750364|NCT01602549|474361768|FG000|Overall Study|Withdrawal by Subject|1|||
131750365|NCT01602549|474361769|FG001|Overall Study|Withdrawal by Subject|0|||
131750366|NCT01375647|474363865|FG000|Overall Study|Lost to Follow-up|3|||
131750367|NCT01375647|474363866|FG001|Overall Study|Lost to Follow-up|3|||
131750368|NCT01375647|474363867|FG002|Overall Study|Lost to Follow-up|7|||
131750369|NCT01375647|474363868|FG003|Overall Study|Lost to Follow-up|10|||
131750370|NCT01375647|474363865|FG000|Overall Study|Death|1|||
131750371|NCT01375647|474363866|FG001|Overall Study|Death|2|||
131750372|NCT01375647|474363867|FG002|Overall Study|Death|1|||
131750373|NCT01375647|474363868|FG003|Overall Study|Death|0|||
131750374|NCT01375647|474363865|FG000|Overall Study|Withdrawal by Subject|17|||
131750375|NCT01375647|474363866|FG001|Overall Study|Withdrawal by Subject|20|||
131750376|NCT01375647|474363867|FG002|Overall Study|Withdrawal by Subject|26|||
131750377|NCT01375647|474363868|FG003|Overall Study|Withdrawal by Subject|14|||
131750378|NCT01375647|474363865|FG000|Overall Study|Physician Decision|1|||
131750379|NCT01375647|474363866|FG001|Overall Study|Physician Decision|0|||
131750380|NCT01375647|474363867|FG002|Overall Study|Physician Decision|0|||
131750381|NCT01375647|474363868|FG003|Overall Study|Physician Decision|0|||
131750382|NCT03366844|474363869|FG000|Overall Study|Physician Decision|1|||
131750383|NCT03366844|474363869|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
131750384|NCT02088541|474363874|FG000|Overall Study|Adverse Event|3|||
131750385|NCT02088541|474363875|FG001|Overall Study|Adverse Event|0|||
131750386|NCT02088541|474363876|FG002|Overall Study|Adverse Event|3|||
131750387|NCT02088541|474363877|FG003|Overall Study|Adverse Event|3|||
131750388|NCT02088541|474363878|FG004|Overall Study|Adverse Event|0|||
131750389|NCT02088541|474363874|FG000|Overall Study|Death|51|||
131750390|NCT02088541|474363875|FG001|Overall Study|Death|21|||
131750391|NCT02088541|474363876|FG002|Overall Study|Death|85|||
131750392|NCT02088541|474363877|FG003|Overall Study|Death|28|||
131750393|NCT02088541|474363878|FG004|Overall Study|Death|38|||
131750394|NCT02088541|474363874|FG000|Overall Study|Lost to Follow-up|2|||
131750395|NCT02088541|474363875|FG001|Overall Study|Lost to Follow-up|0|||
131750396|NCT02088541|474363876|FG002|Overall Study|Lost to Follow-up|1|||
131750397|NCT02088541|474363877|FG003|Overall Study|Lost to Follow-up|0|||
131750398|NCT02088541|474363878|FG004|Overall Study|Lost to Follow-up|0|||
131750399|NCT02088541|474363874|FG000|Overall Study|Physician Decision|2|||
131750400|NCT02088541|474363875|FG001|Overall Study|Physician Decision|1|||
131750401|NCT02088541|474363876|FG002|Overall Study|Physician Decision|2|||
131750402|NCT02088541|474363877|FG003|Overall Study|Physician Decision|0|||
131750403|NCT02088541|474363878|FG004|Overall Study|Physician Decision|2|||
131750404|NCT02088541|474363874|FG000|Overall Study|Disease progression|7|||
131750405|NCT02088541|474363875|FG001|Overall Study|Disease progression|1|||
131750406|NCT02088541|474363876|FG002|Overall Study|Disease progression|2|||
131750407|NCT02088541|474363877|FG003|Overall Study|Disease progression|3|||
131750408|NCT02088541|474363878|FG004|Overall Study|Disease progression|1|||
131750409|NCT02088541|474363874|FG000|Overall Study|Study terminated by sponsor|1|||
131750410|NCT02088541|474363875|FG001|Overall Study|Study terminated by sponsor|1|||
131750411|NCT02088541|474363876|FG002|Overall Study|Study terminated by sponsor|12|||
131750412|NCT02088541|474363877|FG003|Overall Study|Study terminated by sponsor|2|||
131750413|NCT02088541|474363878|FG004|Overall Study|Study terminated by sponsor|6|||
131750414|NCT02088541|474363874|FG000|Overall Study|Withdrawal by Subject|3|||
131750415|NCT02088541|474363875|FG001|Overall Study|Withdrawal by Subject|2|||
131750416|NCT02088541|474363876|FG002|Overall Study|Withdrawal by Subject|9|||
131750417|NCT02088541|474363877|FG003|Overall Study|Withdrawal by Subject|7|||
131750418|NCT02088541|474363878|FG004|Overall Study|Withdrawal by Subject|10|||
131750419|NCT02088541|474363874|FG000|Overall Study|Other|2|||
131750420|NCT02088541|474363875|FG001|Overall Study|Other|1|||
131750421|NCT02088541|474363876|FG002|Overall Study|Other|3|||
131750422|NCT02088541|474363877|FG003|Overall Study|Other|1|||
131750423|NCT02088541|474363878|FG004|Overall Study|Other|1|||
131750424|NCT00323310|474363880|FG000|Overall Study|Withdrawal by Subject|1|||
131750425|NCT00323310|474363880|FG000|Overall Study|a parent refused blood draw|1|||
131750426|NCT00323310|474363880|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
131750427|NCT03984812|474363881|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750428|NCT03984812|474363882|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750429|NCT03984812|474363883|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
131750430|NCT03984812|474363884|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750431|NCT03984812|474363885|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750432|NCT03984812|474363886|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750433|NCT03984812|474363887|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750434|NCT03984812|474363888|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750435|NCT03984812|474363889|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750436|NCT03984812|474363890|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750437|NCT03984812|474363891|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131750438|NCT00446641|474363892|FG000|Overall Study|Withdrawal by Subject|8|||
131750439|NCT00446641|474363893|FG001|Overall Study|Withdrawal by Subject|3|||
131750440|NCT00446641|474363892|FG000|Overall Study|poor compliance|8|||
131750441|NCT00446641|474363893|FG001|Overall Study|poor compliance|6|||
131750442|NCT00446641|474363892|FG000|Overall Study|Lost to Follow-up|1|||
131750443|NCT00446641|474363893|FG001|Overall Study|Lost to Follow-up|1|||
131750444|NCT02707601|474363896|FG000|Overall Study|Death|0|||
131750445|NCT02707601|474363897|FG001|Overall Study|Death|1|||
131750446|NCT02707601|474363896|FG000|Overall Study|Lack of Efficacy|0|||
131750447|NCT02707601|474363897|FG001|Overall Study|Lack of Efficacy|1|||
131750448|NCT02707601|474363896|FG000|Overall Study|Investigator's Discretion|1|||
131750449|NCT02707601|474363897|FG001|Overall Study|Investigator's Discretion|0|||
131750450|NCT02707601|474363896|FG000|Overall Study|Withdrew Consent|0|||
131750451|NCT02707601|474363897|FG001|Overall Study|Withdrew Consent|1|||
131750452|NCT02707601|474363896|FG000|Overall Study|Lost to Follow-up|1|||
131750453|NCT02707601|474363897|FG001|Overall Study|Lost to Follow-up|1|||
131750454|NCT02707601|474363896|FG000|Overall Study|Participants Randomized but Not Treated|2|||
131750455|NCT02707601|474363897|FG001|Overall Study|Participants Randomized but Not Treated|0|||
131809173|NCT02242201|474584400|FG000|Overall Study|planned post-op anticoagulation|1|||
131809174|NCT02242201|474584401|FG001|Overall Study|planned post-op anticoagulation|0|||
131809175|NCT02242201|474584402|FG002|Overall Study|planned post-op anticoagulation|0|||
131750456|NCT00666536|474363899|FG000|Overall Study|Adverse Event|9|||
131750457|NCT00666536|474363900|FG001|Overall Study|Adverse Event|19|||
131750458|NCT00666536|474363899|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131750459|NCT00666536|474363900|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131750460|NCT00666536|474363899|FG000|Overall Study|Protocol deviation(s)|8|||
131750461|NCT00666536|474363900|FG001|Overall Study|Protocol deviation(s)|6|||
131750462|NCT00666536|474363899|FG000|Overall Study|Withdrawal by Subject|10|||
131750463|NCT00666536|474363900|FG001|Overall Study|Withdrawal by Subject|9|||
131750464|NCT00666536|474363899|FG000|Overall Study|Lost to Follow-up|4|||
131750465|NCT00666536|474363900|FG001|Overall Study|Lost to Follow-up|3|||
131809176|NCT02242201|474584400|FG000|Overall Study|changed surgical procedure|1|||
131809177|NCT02242201|474584401|FG001|Overall Study|changed surgical procedure|0|||
131750466|NCT04839393|474363901|FG000|Overall Study|Adverse Event|0|||
131750467|NCT04839393|474363902|FG001|Overall Study|Adverse Event|0|||
131750468|NCT04839393|474363903|FG002|Overall Study|Adverse Event|2|||
131750469|NCT04839393|474363901|FG000|Overall Study|Withdrawal by participant|0|||
131750470|NCT04839393|474363902|FG001|Overall Study|Withdrawal by participant|0|||
131750471|NCT04839393|474363903|FG002|Overall Study|Withdrawal by participant|1|||
131750472|NCT00608881|474363908|FG000|Overall Study|Death|22|||
131750473|NCT00608881|474363909|FG001|Overall Study|Death|13|||
131750474|NCT00608881|474363908|FG000|Overall Study|Adverse Event|5|||
131750475|NCT00608881|474363909|FG001|Overall Study|Adverse Event|3|||
131750476|NCT00608881|474363908|FG000|Overall Study|Lost to Follow-up|28|||
131750477|NCT00608881|474363909|FG001|Overall Study|Lost to Follow-up|14|||
131750478|NCT00608881|474363908|FG000|Overall Study|Withdrawal by Subject|18|||
131750479|NCT00608881|474363909|FG001|Overall Study|Withdrawal by Subject|29|||
131750480|NCT00608881|474363908|FG000|Overall Study|Physician Decision|5|||
131750481|NCT00608881|474363909|FG001|Overall Study|Physician Decision|5|||
131750482|NCT00608881|474363908|FG000|Overall Study|Institutionalized|1|||
131750483|NCT00608881|474363909|FG001|Overall Study|Institutionalized|2|||
131750484|NCT00633893|474363910|FG000|Overall Study|Death|1|||
131750485|NCT00633893|474363911|FG001|Overall Study|Death|3|||
131750486|NCT00633893|474363912|FG002|Overall Study|Death|9|||
131750487|NCT00633893|474363910|FG000|Overall Study|Adverse Event|65|||
131750488|NCT00633893|474363911|FG001|Overall Study|Adverse Event|58|||
131750489|NCT00633893|474363912|FG002|Overall Study|Adverse Event|126|||
131750490|NCT00633893|474363910|FG000|Overall Study|Withdrawal by Subject|7|||
131750491|NCT00633893|474363911|FG001|Overall Study|Withdrawal by Subject|12|||
131750492|NCT00633893|474363912|FG002|Overall Study|Withdrawal by Subject|6|||
131750493|NCT00633893|474363910|FG000|Overall Study|Lost to Follow-up|2|||
131750494|NCT00633893|474363911|FG001|Overall Study|Lost to Follow-up|4|||
131750495|NCT00633893|474363912|FG002|Overall Study|Lost to Follow-up|8|||
131750496|NCT00633893|474363910|FG000|Overall Study|Poor/non-compliance|5|||
131750497|NCT00633893|474363911|FG001|Overall Study|Poor/non-compliance|12|||
131750498|NCT00633893|474363912|FG002|Overall Study|Poor/non-compliance|3|||
131750499|NCT00633893|474363910|FG000|Overall Study|Pregnancy|2|||
131750500|NCT00633893|474363911|FG001|Overall Study|Pregnancy|1|||
131750501|NCT00633893|474363912|FG002|Overall Study|Pregnancy|1|||
131750502|NCT00633893|474363910|FG000|Overall Study|Not meet/no longer meets criteria|4|||
131750503|NCT00633893|474363911|FG001|Overall Study|Not meet/no longer meets criteria|6|||
131750504|NCT00633893|474363912|FG002|Overall Study|Not meet/no longer meets criteria|4|||
131750505|NCT00633893|474363910|FG000|Overall Study|Other|28|||
131750506|NCT00633893|474363911|FG001|Overall Study|Other|33|||
131750507|NCT00633893|474363912|FG002|Overall Study|Other|31|||
131750508|NCT05091918|474363913|FG000|Overall Study|Adverse Event|1|||
131750509|NCT05091918|474363913|FG000|Overall Study|Withdrawal by Subject|81|||
131750510|NCT00239356|474363915|FG000|Overall Study|Lack of Efficacy|1|||
131750511|NCT00239356|474363916|FG001|Overall Study|Lack of Efficacy|0|||
131750512|NCT00239356|474363915|FG000|Overall Study|Adverse Event|6|||
131750513|NCT00239356|474363916|FG001|Overall Study|Adverse Event|0|||
131750514|NCT00239356|474363915|FG000|Overall Study|Withdrawal by Subject|15|||
131750515|NCT00239356|474363916|FG001|Overall Study|Withdrawal by Subject|6|||
131750516|NCT00239356|474363915|FG000|Overall Study|Lost to Follow-up|3|||
131750517|NCT00239356|474363916|FG001|Overall Study|Lost to Follow-up|0|||
131750518|NCT00239356|474363915|FG000|Overall Study|poor/non-compliance|2|||
131750519|NCT00239356|474363916|FG001|Overall Study|poor/non-compliance|0|||
131750520|NCT00239356|474363915|FG000|Overall Study|Pregnancy|1|||
131750521|NCT00239356|474363916|FG001|Overall Study|Pregnancy|0|||
131750522|NCT00239356|474363915|FG000|Overall Study|Administrative reason|0|||
131750523|NCT00239356|474363916|FG001|Overall Study|Administrative reason|1|||
131750524|NCT00239356|474363915|FG000|Overall Study|Drug available on market|11|||
131750525|NCT00239356|474363916|FG001|Overall Study|Drug available on market|2|||
131750526|NCT02044822|474363917|FG000|Overall Study|Study Terminated by Sponsor|77|||
131750527|NCT02044822|474363917|FG000|Overall Study|Investigator's Discretion|10|||
131750528|NCT02044822|474363917|FG000|Overall Study|Withdrew Consent|3|||
131750529|NCT02044822|474363917|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
131750530|NCT02044822|474363917|FG000|Overall Study|Lost to Follow-up|1|||
131750531|NCT03417505|474363918|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
131750532|NCT03417505|474363919|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
131750533|NCT03210220|474363920|FG000|Overall Study|Physician Decision|1|||
131750534|NCT03210220|474363921|FG001|Overall Study|Physician Decision|0|||
131750535|NCT00653328|474363922|FG000|Overall Study|Withdrawal by Subject|1|||
131906453|NCT02662569|474945188|FG001|Overall Study|Lost to Follow-up|0|||
131906454|NCT02662569|474945189|FG002|Overall Study|Lost to Follow-up|0|||
131750536|NCT00653328|474363922|FG000|Overall Study|Adverse Event|2|||
131750537|NCT00653328|474363922|FG000|Overall Study|Disease progression|10|||
131750538|NCT00653328|474363922|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
131750539|NCT02911519|474363923|FG000|Overall Study|Lost to Follow-up|2|||
131906455|NCT02662569|474945190|FG003|Overall Study|Lost to Follow-up|0|||
131750540|NCT02911519|474363924|FG001|Overall Study|Lost to Follow-up|2|||
131750541|NCT02911519|474363923|FG000|Overall Study|Death|0|||
131750542|NCT02911519|474363924|FG001|Overall Study|Death|2|||
131750543|NCT01237223|474363933|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
131750544|NCT01237223|474363934|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131750545|NCT01237223|474363935|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131750546|NCT01237223|474363936|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131750547|NCT01237223|474363937|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131750548|NCT01237223|474363938|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131750549|NCT01237223|474363933|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
131750550|NCT01237223|474363934|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131750551|NCT01237223|474363935|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131750552|NCT01237223|474363936|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131750553|NCT01237223|474363937|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131750554|NCT01237223|474363938|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131750555|NCT01237223|474363933|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
131750556|NCT01237223|474363934|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131750557|NCT01237223|474363935|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131750558|NCT01237223|474363936|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131750559|NCT01237223|474363937|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131750560|NCT01237223|474363938|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131750561|NCT01237223|474363933|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
131750562|NCT01237223|474363934|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131750563|NCT01237223|474363935|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131750564|NCT01237223|474363936|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131750565|NCT01237223|474363937|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131750566|NCT01237223|474363938|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131750567|NCT01237223|474363933|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
131750568|NCT01237223|474363934|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131750569|NCT01237223|474363935|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131750570|NCT01237223|474363936|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131750571|NCT01237223|474363937|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131750572|NCT01237223|474363938|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131750573|NCT01237223|474363933|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
131750574|NCT01237223|474363934|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
131750575|NCT01237223|474363935|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
131750576|NCT01237223|474363936|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
131750577|NCT01237223|474363937|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
131750578|NCT01237223|474363938|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
131750579|NCT01237223|474363933|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
131750580|NCT01237223|474363934|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
131750581|NCT01237223|474363935|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
131750582|NCT01237223|474363936|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
131809178|NCT02242201|474584402|FG002|Overall Study|changed surgical procedure|0|||
131809179|NCT02242201|474584400|FG000|Overall Study|postponed surgery|0|||
131809180|NCT02242201|474584401|FG001|Overall Study|postponed surgery|0|||
131750583|NCT01237223|474363937|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
131750584|NCT01237223|474363938|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
131750585|NCT01237223|474363933|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
131750586|NCT01237223|474363934|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
131750587|NCT01237223|474363935|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
131750588|NCT01237223|474363936|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
131750589|NCT01237223|474363937|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
131750590|NCT01237223|474363938|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
131750591|NCT01237223|474363933|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131750592|NCT01237223|474363934|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131750593|NCT01237223|474363935|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131750594|NCT01237223|474363936|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131750595|NCT01237223|474363937|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131809181|NCT02242201|474584402|FG002|Overall Study|postponed surgery|1|||
131809182|NCT02242201|474584400|FG000|Overall Study|preoperative opioid consumption|0|||
131809183|NCT02242201|474584401|FG001|Overall Study|preoperative opioid consumption|1|||
131809184|NCT02242201|474584402|FG002|Overall Study|preoperative opioid consumption|0|||
131750596|NCT01237223|474363938|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
131750597|NCT01237223|474363933|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
131750598|NCT01237223|474363934|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131750599|NCT01237223|474363935|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131750600|NCT01237223|474363936|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
131750601|NCT01237223|474363937|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131750602|NCT01237223|474363938|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131750603|NCT00839436|474363939|FG000|Overall Study|Developed exclusionary condition|1|||
131750604|NCT00839436|474363940|FG001|Overall Study|Developed exclusionary condition|0|||
131750605|NCT00839436|474363941|FG002|Overall Study|Developed exclusionary condition|0|||
131750606|NCT00839436|474363939|FG000|Overall Study|Withdrawal by Subject|0|||
131750607|NCT00839436|474363940|FG001|Overall Study|Withdrawal by Subject|1|||
131750608|NCT00839436|474363941|FG002|Overall Study|Withdrawal by Subject|0|||
131750609|NCT00839436|474363939|FG000|Overall Study|Study drug no longer available|0|||
131750610|NCT00839436|474363940|FG001|Overall Study|Study drug no longer available|0|||
131750611|NCT00839436|474363941|FG002|Overall Study|Study drug no longer available|1|||
131750612|NCT00407550|474363946|FG000|Overall Study|Adverse Event|0|||
131750613|NCT00407550|474363947|FG001|Overall Study|Adverse Event|1|||
131750614|NCT00407550|474363946|FG000|Overall Study|Withdrawal by Subject|0|||
131750615|NCT00407550|474363947|FG001|Overall Study|Withdrawal by Subject|2|||
131750616|NCT00407550|474363946|FG000|Overall Study|Death|1|||
131750617|NCT00407550|474363947|FG001|Overall Study|Death|0|||
131750618|NCT00407550|474363946|FG000|Overall Study|Insurance or Other medical condition|2|||
131750619|NCT00407550|474363947|FG001|Overall Study|Insurance or Other medical condition|1|||
131750620|NCT01444898|474363949|FG000|Overall Study|Withdrawal by Subject|1|||
131750621|NCT00443846|474363951|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
131750622|NCT00443846|474363952|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
131750623|NCT00443846|474363951|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
131750624|NCT00443846|474363952|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
131750625|NCT00443846|474363951|FG000|Overall Study|Adverse Event|0|||
131750626|NCT00443846|474363952|FG001|Overall Study|Adverse Event|1|||
131750627|NCT00443846|474363951|FG000|Overall Study|Personal reason|8|||
131750628|NCT00443846|474363952|FG001|Overall Study|Personal reason|3|||
131750629|NCT00443846|474363951|FG000|Overall Study|Lost to Follow-up|1|||
131750630|NCT00443846|474363952|FG001|Overall Study|Lost to Follow-up|2|||
131750631|NCT02580591|474363953|FG000|Overall Study|Adverse Event|0|||
131750632|NCT02580591|474363954|FG001|Overall Study|Adverse Event|1|||
131750633|NCT02580591|474363955|FG002|Overall Study|Adverse Event|2|||
131750634|NCT02580591|474363956|FG003|Overall Study|Adverse Event|5|||
131750635|NCT02580591|474363953|FG000|Overall Study|Protocol Violation|3|||
131750636|NCT02580591|474363954|FG001|Overall Study|Protocol Violation|2|||
131750637|NCT02580591|474363955|FG002|Overall Study|Protocol Violation|1|||
131750638|NCT02580591|474363956|FG003|Overall Study|Protocol Violation|1|||
131750639|NCT02580591|474363953|FG000|Overall Study|Lost to Follow-up|5|||
131750640|NCT02580591|474363954|FG001|Overall Study|Lost to Follow-up|3|||
131750641|NCT02580591|474363955|FG002|Overall Study|Lost to Follow-up|3|||
131750642|NCT02580591|474363956|FG003|Overall Study|Lost to Follow-up|1|||
131750643|NCT02580591|474363953|FG000|Overall Study|Withdrawal by Subject|6|||
131750644|NCT02580591|474363954|FG001|Overall Study|Withdrawal by Subject|1|||
131750645|NCT02580591|474363955|FG002|Overall Study|Withdrawal by Subject|2|||
131750646|NCT02580591|474363956|FG003|Overall Study|Withdrawal by Subject|3|||
131750647|NCT02580591|474363953|FG000|Overall Study|Not treated|1|||
131750648|NCT02580591|474363954|FG001|Overall Study|Not treated|1|||
131750649|NCT02580591|474363955|FG002|Overall Study|Not treated|0|||
131750650|NCT02580591|474363956|FG003|Overall Study|Not treated|0|||
131750651|NCT02580591|474363953|FG000|Overall Study|Other than specified|3|||
131750652|NCT02580591|474363954|FG001|Overall Study|Other than specified|2|||
131750653|NCT02580591|474363955|FG002|Overall Study|Other than specified|5|||
131750654|NCT02580591|474363956|FG003|Overall Study|Other than specified|2|||
131750655|NCT00291187|474363962|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
131750656|NCT00291187|474363963|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
131750657|NCT00291187|474363964|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
131750658|NCT00291187|474363965|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
131750659|NCT02443805|474363969|FG000|Overall Study|Adverse Event|100|||
131750660|NCT02443805|474363970|FG001|Overall Study|Adverse Event|18|||
131750661|NCT02443805|474363969|FG000|Overall Study|Withdrawal by Subject|73|||
131750662|NCT02443805|474363970|FG001|Overall Study|Withdrawal by Subject|74|||
131750663|NCT02443805|474363969|FG000|Overall Study|Lost to Follow-up|19|||
131750664|NCT02443805|474363970|FG001|Overall Study|Lost to Follow-up|14|||
131750665|NCT02443805|474363969|FG000|Overall Study|Pregnancy|6|||
131809185|NCT01424644|474584403|FG000|Overall Study|Adverse Event|2|||
131750666|NCT02443805|474363970|FG001|Overall Study|Pregnancy|5|||
131750667|NCT02443805|474363969|FG000|Overall Study|Protocol Violation|2|||
131750668|NCT02443805|474363970|FG001|Overall Study|Protocol Violation|4|||
131750669|NCT02443805|474363969|FG000|Overall Study|Lack of Efficacy|1|||
131750670|NCT02443805|474363970|FG001|Overall Study|Lack of Efficacy|1|||
131750671|NCT02443805|474363969|FG000|Overall Study|Non-compliance with study drug|6|||
131750672|NCT02443805|474363970|FG001|Overall Study|Non-compliance with study drug|4|||
131750673|NCT02443805|474363969|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131750674|NCT02443805|474363970|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131750675|NCT02443805|474363969|FG000|Overall Study|Any other reason not above-mentioned|3|||
131750676|NCT02443805|474363970|FG001|Overall Study|Any other reason not above-mentioned|2|||
131750677|NCT04362813|474363971|FG000|Overall Study|Death|12|||
131750678|NCT04362813|474363972|FG001|Overall Study|Death|16|||
131750679|NCT04362813|474363971|FG000|Overall Study|Withdrawal by Subject|3|||
131750680|NCT04362813|474363972|FG001|Overall Study|Withdrawal by Subject|1|||
131750681|NCT04362813|474363971|FG000|Overall Study|Protocol Violation|0|||
131750682|NCT04362813|474363972|FG001|Overall Study|Protocol Violation|3|||
131750683|NCT04362813|474363971|FG000|Overall Study|Lost to Follow-up|1|||
131750684|NCT04362813|474363972|FG001|Overall Study|Lost to Follow-up|1|||
131750685|NCT04362813|474363971|FG000|Overall Study|Enrolled but did not receive treatment|2|||
131750686|NCT04362813|474363972|FG001|Overall Study|Enrolled but did not receive treatment|4|||
131750687|NCT00961116|474363973|FG000|Washout Period of 7 Days|Adverse Event|1|||
131750688|NCT00961116|474363974|FG001|Washout Period of 7 Days|Adverse Event|1|||
131750689|NCT00961116|474363973|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131750690|NCT00961116|474363974|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131750691|NCT00961116|474363973|FG000|Washout Period of 7 Days|Protocol Violation|0|||
131750692|NCT00961116|474363974|FG001|Washout Period of 7 Days|Protocol Violation|1|||
131750693|NCT02708966|474363975|FG000|Overall Study|Lost to Follow-up|2|||
131750694|NCT02708966|474363976|FG001|Overall Study|Lost to Follow-up|2|||
131750695|NCT02260388|474363979|FG000|Overall Study|Lost to Follow-up|2|||
131750696|NCT02260388|474363980|FG001|Overall Study|Lost to Follow-up|8|||
131750697|NCT02260388|474363981|FG002|Overall Study|Lost to Follow-up|3|||
131750698|NCT02260388|474363982|FG003|Overall Study|Lost to Follow-up|4|||
131750699|NCT01732107|474363983|FG000|Overall Study|Adverse Event|2|||
131750700|NCT01732107|474363983|FG000|Overall Study|Disease Progression|8|||
131750701|NCT01732107|474363983|FG000|Overall Study|Physician Decision|1|||
131750702|NCT01732107|474363983|FG000|Overall Study|Withdrawal by Subject|2|||
131750703|NCT02959190|474363984|FG000|Open Label|Adverse Event|5|||
131750704|NCT02959190|474363985|FG001|Open Label|Adverse Event|7|||
131750705|NCT02959190|474363986|FG002|Open Label|Adverse Event|3|||
131750706|NCT02959190|474363987|FG003|Open Label|Adverse Event|4|||
131750707|NCT02959190|474363984|FG000|Open Label|Pregnancy|0|||
131750708|NCT02959190|474363985|FG001|Open Label|Pregnancy|1|||
131750709|NCT02959190|474363986|FG002|Open Label|Pregnancy|0|||
131750710|NCT02959190|474363987|FG003|Open Label|Pregnancy|0|||
131750711|NCT02959190|474363984|FG000|Open Label|Withdrawal by Subject|2|||
131750712|NCT02959190|474363985|FG001|Open Label|Withdrawal by Subject|8|||
131750713|NCT02959190|474363986|FG002|Open Label|Withdrawal by Subject|0|||
131750714|NCT02959190|474363987|FG003|Open Label|Withdrawal by Subject|0|||
131750715|NCT02959190|474363984|FG000|Open Label|Physician Decision|0|||
131750716|NCT02959190|474363985|FG001|Open Label|Physician Decision|0|||
131750717|NCT02959190|474363986|FG002|Open Label|Physician Decision|1|||
131809186|NCT01424644|474584404|FG001|Overall Study|Adverse Event|0|||
131809187|NCT01424644|474584403|FG000|Overall Study|Withdrawal by Subject|9|||
131809188|NCT01424644|474584404|FG001|Overall Study|Withdrawal by Subject|12|||
131750718|NCT02959190|474363987|FG003|Open Label|Physician Decision|0|||
131750719|NCT02959190|474363984|FG000|Open Label|Protocol Violation|0|||
131750720|NCT02959190|474363985|FG001|Open Label|Protocol Violation|0|||
131750721|NCT02959190|474363986|FG002|Open Label|Protocol Violation|0|||
131750722|NCT02959190|474363987|FG003|Open Label|Protocol Violation|2|||
131750723|NCT02959190|474363984|FG000|Post Treatment Follow Up|Adverse Event|1|||
131750724|NCT02959190|474363985|FG001|Post Treatment Follow Up|Adverse Event|1|||
131750725|NCT02959190|474363986|FG002|Post Treatment Follow Up|Adverse Event|0|||
131809189|NCT01424644|474584403|FG000|Overall Study|Lost to Follow-up|16|||
131906456|NCT04076917|474945191|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
131906457|NCT04076917|474945191|FG000|Overall Study|Study closure|13|||
131906458|NCT04076917|474945191|FG000|Overall Study|Physician Decision|3|||
131906459|NCT04076917|474945191|FG000|Overall Study|Death|1|||
131906460|NCT04076917|474945191|FG000|Overall Study|Lost to Follow-up|1|||
131906461|NCT04076917|474945191|FG000|Overall Study|Withdrawal by Subject|1|||
131906462|NCT04076917|474945191|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
131906463|NCT01474486|474945192|FG000|Overall Study|Death|2|||
131906464|NCT01474486|474945192|FG000|Overall Study|Withdrawal by Subject|4|||
131906465|NCT01474486|474945192|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
131906466|NCT03504917|474945193|FG000|Blinded Treatment Period|Protocol Violation|1|||
131906467|NCT03504917|474945194|FG001|Blinded Treatment Period|Protocol Violation|0|||
131906468|NCT03504917|474945193|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
131906469|NCT03504917|474945194|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
131906470|NCT03504917|474945193|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
131906471|NCT03504917|474945194|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
131906472|NCT03504917|474945193|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
131906473|NCT03504917|474945194|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
131906474|NCT03504917|474945193|FG000|Blinded Treatment Period|Adverse Event|4|||
131906475|NCT03504917|474945194|FG001|Blinded Treatment Period|Adverse Event|4|||
131906476|NCT03504917|474945193|FG000|Blinded Treatment Period|Physician Decision|1|||
131906477|NCT03504917|474945194|FG001|Blinded Treatment Period|Physician Decision|0|||
131906478|NCT03504917|474945193|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
131906479|NCT03504917|474945194|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
131750726|NCT02959190|474363987|FG003|Post Treatment Follow Up|Adverse Event|0|||
131750727|NCT02959190|474363984|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
131750728|NCT02959190|474363985|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
131750729|NCT02959190|474363986|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
131750730|NCT02959190|474363987|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
131750731|NCT00753688|474363988|FG000|Overall Study|Death|102|||
131750732|NCT00753688|474363989|FG001|Overall Study|Death|203|||
131750733|NCT00753688|474363988|FG000|Overall Study|Missing|4|||
131750734|NCT00753688|474363989|FG001|Overall Study|Missing|9|||
131750735|NCT00753688|474363988|FG000|Overall Study|Participant Withdrew Consent|2|||
131750736|NCT00753688|474363989|FG001|Overall Study|Participant Withdrew Consent|2|||
131750737|NCT00753688|474363988|FG000|Overall Study|Ongoing - in Follow-up|15|||
131750738|NCT00753688|474363989|FG001|Overall Study|Ongoing - in Follow-up|31|||
131750739|NCT00753688|474363988|FG000|Overall Study|Adverse Event|0|||
131750740|NCT00753688|474363989|FG001|Overall Study|Adverse Event|1|||
131750741|NCT00659126|474363990|FG000|Overall Study|Adverse Event|2|||
131750742|NCT00659126|474363991|FG001|Overall Study|Adverse Event|2|||
131750743|NCT00659126|474363990|FG000|Overall Study|Screen failure|1|||
131750744|NCT00659126|474363991|FG001|Overall Study|Screen failure|1|||
131750745|NCT00659126|474363990|FG000|Overall Study|Technical problems with MRI|0|||
131750746|NCT00659126|474363991|FG001|Overall Study|Technical problems with MRI|1|||
131750747|NCT02633046|474363994|FG000|Overall Study|Adverse Event|8|||
131750748|NCT02633046|474363994|FG000|Overall Study|Physician Decision|7|||
131750749|NCT02633046|474363994|FG000|Overall Study|Withdrawal by Subject|8|||
131750750|NCT02633046|474363994|FG000|Overall Study|Increased proteinuria|2|||
131750751|NCT02633046|474363994|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
131750752|NCT02633046|474363994|FG000|Overall Study|Mutual decision patient and physician|1|||
131750753|NCT02925312|474363995|FG000|Overall Study|Lost to Follow-up|25|||
131750754|NCT02925312|474363996|FG001|Overall Study|Lost to Follow-up|0|||
131750755|NCT02925312|474363995|FG000|Overall Study|Adverse Event|2|||
131750756|NCT02925312|474363996|FG001|Overall Study|Adverse Event|0|||
131750757|NCT01998399|474364005|FG000|Overall Study|Lost to Follow-up|1|||
131750758|NCT01998399|474364006|FG001|Overall Study|Lost to Follow-up|3|||
131750759|NCT01998399|474364005|FG000|Overall Study|Death|4|||
131750760|NCT01998399|474364006|FG001|Overall Study|Death|2|||
131809190|NCT01424644|474584404|FG001|Overall Study|Lost to Follow-up|12|||
131809191|NCT01424644|474584403|FG000|Overall Study|Protocol Violation|4|||
131809192|NCT01424644|474584404|FG001|Overall Study|Protocol Violation|3|||
131809193|NCT01424644|474584403|FG000|Overall Study|Administrative Reason|1|||
131809194|NCT01424644|474584404|FG001|Overall Study|Administrative Reason|0|||
131809195|NCT01424644|474584403|FG000|Overall Study|Unable to Classify|1|||
131809196|NCT01424644|474584404|FG001|Overall Study|Unable to Classify|0|||
131809197|NCT04611789|474584407|FG000|Overall Study|Lost to Follow-up|1|||
131809198|NCT04611789|474584408|FG001|Overall Study|Lost to Follow-up|0|||
131750761|NCT01998399|474364005|FG000|Overall Study|Study stopped before dosing completed|3|||
131750762|NCT01998399|474364006|FG001|Overall Study|Study stopped before dosing completed|3|||
131750763|NCT01998399|474364005|FG000|Overall Study|Withdrawal by Subject|0|||
131809199|NCT04611789|474584409|FG002|Overall Study|Lost to Follow-up|0|||
131809200|NCT02131129|474584410|FG000|Overall Study|Withdrawal by Subject|1|||
131750764|NCT01998399|474364006|FG001|Overall Study|Withdrawal by Subject|1|||
131750765|NCT00376246|474364008|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
131750766|NCT00376246|474364009|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
131750767|NCT00376246|474364008|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131750768|NCT00376246|474364009|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
131750769|NCT00376246|474364008|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
131750770|NCT00376246|474364009|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131809201|NCT02131129|474584411|FG001|Overall Study|Withdrawal by Subject|0|||
131809202|NCT00727961|474584412|FG000|Overall Study|Lost to Follow-up|1|||
131809203|NCT00727961|474584412|FG000|Overall Study|Adverse Event|4|||
131809204|NCT00727961|474584412|FG000|Overall Study|Patient's refusal|2|||
131809205|NCT00727961|474584412|FG000|Overall Study|Progression|30|||
131809206|NCT03880266|474584413|FG000|Overall Study|Withdrawal by Subject|0|||
131809207|NCT03880266|474584414|FG001|Overall Study|Withdrawal by Subject|1|||
131809208|NCT03880266|474584415|FG002|Overall Study|Withdrawal by Subject|1|||
131809209|NCT03880266|474584416|FG003|Overall Study|Withdrawal by Subject|0|||
131809210|NCT03880266|474584417|FG004|Overall Study|Withdrawal by Subject|0|||
131809211|NCT03880266|474584418|FG005|Overall Study|Withdrawal by Subject|0|||
131809212|NCT03880266|474584419|FG006|Overall Study|Withdrawal by Subject|0|||
131809213|NCT03880266|474584420|FG007|Overall Study|Withdrawal by Subject|0|||
131809214|NCT03161405|474584421|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
131809215|NCT00837486|474584422|FG000|Blinded-treatment Phase|Physician Decision|1|||
131809216|NCT00837486|474584423|FG001|Blinded-treatment Phase|Physician Decision|0|||
131809217|NCT00837486|474584422|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
131809218|NCT00837486|474584423|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
131809219|NCT00837486|474584422|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
131809220|NCT00837486|474584423|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
131809221|NCT00837486|474584422|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
131809222|NCT00837486|474584423|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
131809223|NCT02655679|474584424|FG000|Overall Study|Adverse Event|0|||
131809224|NCT02655679|474584425|FG001|Overall Study|Adverse Event|1|||
131809225|NCT02655679|474584426|FG002|Overall Study|Adverse Event|0|||
131809226|NCT02655679|474584427|FG003|Overall Study|Adverse Event|0|||
131809227|NCT02655679|474584428|FG004|Overall Study|Adverse Event|0|||
131809228|NCT02655679|474584424|FG000|Overall Study|Withdrawal by Subject|1|||
131809229|NCT02655679|474584425|FG001|Overall Study|Withdrawal by Subject|1|||
131906480|NCT03504917|474945193|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
131906481|NCT03504917|474945194|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
131906482|NCT03504917|474945193|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
131906483|NCT03504917|474945194|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
131750771|NCT01455415|474364013|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
131750772|NCT01455415|474364014|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
131750773|NCT01455415|474364013|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
131750774|NCT01455415|474364014|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
131809230|NCT02655679|474584426|FG002|Overall Study|Withdrawal by Subject|0|||
131809231|NCT02655679|474584427|FG003|Overall Study|Withdrawal by Subject|3|||
131906484|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
131906485|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
131906486|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
131906487|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
131906488|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
131906489|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
131906490|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
131906491|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
131906492|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
131906493|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
131906494|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
131906495|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
131906496|NCT03504917|474945193|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
131750775|NCT01455415|474364013|FG000|Period 1|Drug Error not Associated to AE|0|||
131750776|NCT01455415|474364014|FG001|Period 1|Drug Error not Associated to AE|1|||
131750777|NCT01455415|474364013|FG000|Period 1|AE Not Related to Study Drug|2|||
131750778|NCT01455415|474364014|FG001|Period 1|AE Not Related to Study Drug|6|||
131750779|NCT01455415|474364013|FG000|Period 1|Withdrawal by Subject|4|||
131809232|NCT02655679|474584428|FG004|Overall Study|Withdrawal by Subject|1|||
131809233|NCT02655679|474584424|FG000|Overall Study|Inability to Comply with the Protocol|1|||
131809234|NCT02655679|474584425|FG001|Overall Study|Inability to Comply with the Protocol|0|||
131809235|NCT02655679|474584426|FG002|Overall Study|Inability to Comply with the Protocol|0|||
131809236|NCT02655679|474584427|FG003|Overall Study|Inability to Comply with the Protocol|0|||
131809237|NCT02655679|474584428|FG004|Overall Study|Inability to Comply with the Protocol|0|||
131750780|NCT01455415|474364014|FG001|Period 1|Withdrawal by Subject|5|||
131750781|NCT01455415|474364013|FG000|Period 1|Unspecified Reason|1|||
131750782|NCT01455415|474364014|FG001|Period 1|Unspecified Reason|1|||
131750783|NCT01455415|474364013|FG000|Period 1|Protocol Violation|0|||
131750784|NCT01455415|474364014|FG001|Period 1|Protocol Violation|2|||
131750785|NCT01455415|474364013|FG000|Washout|AE Related to Study Drug|2|||
131750786|NCT01455415|474364014|FG001|Washout|AE Related to Study Drug|0|||
131750787|NCT01455415|474364013|FG000|Washout|Lost to Follow-up|1|||
131750788|NCT01455415|474364014|FG001|Washout|Lost to Follow-up|0|||
131750789|NCT01455415|474364013|FG000|Washout|Drug Error not Associated to AE|2|||
131750790|NCT01455415|474364014|FG001|Washout|Drug Error not Associated to AE|1|||
131750791|NCT01455415|474364013|FG000|Washout|AE Not Related to Study Drug|2|||
131750792|NCT01455415|474364014|FG001|Washout|AE Not Related to Study Drug|3|||
131750793|NCT01455415|474364013|FG000|Washout|Unspecified Reason|1|||
131750794|NCT01455415|474364014|FG001|Washout|Unspecified Reason|2|||
131750795|NCT01455415|474364013|FG000|Washout|Protocol Violation|0|||
131750796|NCT01455415|474364014|FG001|Washout|Protocol Violation|1|||
131750797|NCT01455415|474364013|FG000|Period 2|AE Related to Study Drug|1|||
131750798|NCT01455415|474364014|FG001|Period 2|AE Related to Study Drug|2|||
131750799|NCT01455415|474364013|FG000|Period 2|Lost to Follow-up|2|||
131750800|NCT01455415|474364014|FG001|Period 2|Lost to Follow-up|1|||
131750801|NCT01455415|474364013|FG000|Period 2|AE Not Related to Study Drug|2|||
131750802|NCT01455415|474364014|FG001|Period 2|AE Not Related to Study Drug|1|||
131750803|NCT01455415|474364013|FG000|Period 2|Lack of Efficacy|2|||
131750804|NCT01455415|474364014|FG001|Period 2|Lack of Efficacy|0|||
131750805|NCT01455415|474364013|FG000|Period 2|Withdrawal by Subject|2|||
131750806|NCT01455415|474364014|FG001|Period 2|Withdrawal by Subject|3|||
131750807|NCT01455415|474364013|FG000|Period 2|Unspecified Reason|2|||
131750808|NCT01455415|474364014|FG001|Period 2|Unspecified Reason|3|||
131750809|NCT01455415|474364013|FG000|Period 2|Protocol Violation|2|||
131750810|NCT01455415|474364014|FG001|Period 2|Protocol Violation|0|||
131750811|NCT01455415|474364013|FG000|Follow-up|AE Related to Study Drug|0|||
131750812|NCT01455415|474364014|FG001|Follow-up|AE Related to Study Drug|1|||
131750813|NCT01455415|474364013|FG000|Follow-up|Lack of Efficacy|0|||
131750814|NCT01455415|474364014|FG001|Follow-up|Lack of Efficacy|1|||
131750815|NCT01455415|474364013|FG000|Follow-up|Withdrawal by Subject|2|||
131750816|NCT01455415|474364014|FG001|Follow-up|Withdrawal by Subject|0|||
131750817|NCT01455415|474364013|FG000|Follow-up|Unspecified Reason|1|||
131750818|NCT01455415|474364014|FG001|Follow-up|Unspecified Reason|0|||
131750819|NCT00351819|474364016|FG000|Overall Study|Lost to Follow-up|4|||
131750820|NCT00351819|474364017|FG001|Overall Study|Lost to Follow-up|4|||
131750821|NCT00351819|474364016|FG000|Overall Study|Withdrawal by Subject|0|||
131750822|NCT00351819|474364017|FG001|Overall Study|Withdrawal by Subject|4|||
131750823|NCT00351819|474364016|FG000|Overall Study|Elevated PSA|1|||
131750824|NCT00351819|474364017|FG001|Overall Study|Elevated PSA|1|||
131750825|NCT00351819|474364016|FG000|Overall Study|Traumatic ankle fracture|1|||
131750826|NCT00351819|474364017|FG001|Overall Study|Traumatic ankle fracture|0|||
131750827|NCT00351819|474364016|FG000|Overall Study|Unprofessional behavior|1|||
131750828|NCT00351819|474364017|FG001|Overall Study|Unprofessional behavior|0|||
131750829|NCT00351819|474364016|FG000|Overall Study|Non-compliance|0|||
131750830|NCT00351819|474364017|FG001|Overall Study|Non-compliance|1|||
131750831|NCT00351819|474364016|FG000|Overall Study|Incarcerated|0|||
131750832|NCT00351819|474364017|FG001|Overall Study|Incarcerated|1|||
131750833|NCT00351819|474364016|FG000|Overall Study|Enrolled in another trial|0|||
131750834|NCT00351819|474364017|FG001|Overall Study|Enrolled in another trial|1|||
131750835|NCT00418717|474364019|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
131750836|NCT00418717|474364019|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
131750837|NCT00719537|474364022|FG000|Overall Study|Withdrawal by Subject|1|||
131750838|NCT00719537|474364023|FG001|Overall Study|Withdrawal by Subject|0|||
131750839|NCT00719537|474364022|FG000|Overall Study|Lost to Follow-up|0|||
131750840|NCT00719537|474364023|FG001|Overall Study|Lost to Follow-up|1|||
131750841|NCT01142193|474364024|FG000|Overall Study|Adverse Event|12|||
131750842|NCT01142193|474364025|FG001|Overall Study|Adverse Event|4|||
131750843|NCT01142193|474364024|FG000|Overall Study|Lack of Efficacy|2|||
131750844|NCT01142193|474364025|FG001|Overall Study|Lack of Efficacy|1|||
131750845|NCT01142193|474364024|FG000|Overall Study|Physician Decision|1|||
131750846|NCT01142193|474364025|FG001|Overall Study|Physician Decision|1|||
131750847|NCT01142193|474364024|FG000|Overall Study|Withdrawal by Subject|4|||
131750848|NCT01142193|474364025|FG001|Overall Study|Withdrawal by Subject|3|||
131750849|NCT01142193|474364024|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
131750850|NCT01142193|474364025|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
131750851|NCT01142193|474364024|FG000|Overall Study|Other|1|||
131750852|NCT01142193|474364025|FG001|Overall Study|Other|2|||
131750853|NCT01015820|474364026|FG000|Overall Study|Suboptimal measurements|1|||
131750854|NCT01015820|474364027|FG001|Overall Study|Suboptimal measurements|0|||
131750855|NCT01225172|474364028|FG000|Overall Study|Subject decision to stop|1|||
131750856|NCT01225172|474364029|FG001|Overall Study|Subject decision to stop|0|||
131750857|NCT01225172|474364028|FG000|Overall Study|Subject request to discontinue treatment|3|||
131750858|NCT01225172|474364029|FG001|Overall Study|Subject request to discontinue treatment|1|||
131750859|NCT01225172|474364028|FG000|Overall Study|Subject no longer meets study criteria|1|||
131750860|NCT01225172|474364029|FG001|Overall Study|Subject no longer meets study criteria|0|||
131750861|NCT01225172|474364028|FG000|Overall Study|Withdrawal by Subject|1|||
131750862|NCT01225172|474364029|FG001|Overall Study|Withdrawal by Subject|0|||
131750863|NCT00795509|474364030|FG000|Overall Study|Protocol Violation|31|||
131750864|NCT00383708|474364031|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
131750865|NCT00383708|474364031|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
131750866|NCT00383708|474364031|FG000|Run-in Period|Protocol Violation|4|||
131750867|NCT00383708|474364031|FG000|Run-in Period|Adverse Event|2|||
131750868|NCT00383708|474364031|FG000|Run-in Period|Claustrophobia|1|||
131750869|NCT00383708|474364031|FG000|Co-administration Period|Adverse Event|5|||
131750870|NCT01576406|474364033|FG000|Overall Study|Lost to Follow-up|1|||
131750871|NCT01576406|474364034|FG001|Overall Study|Lost to Follow-up|2|||
131750872|NCT01576406|474364035|FG002|Overall Study|Lost to Follow-up|0|||
131750873|NCT01576406|474364036|FG003|Overall Study|Lost to Follow-up|0|||
131750874|NCT01576406|474364037|FG004|Overall Study|Lost to Follow-up|0|||
131750875|NCT01576406|474364038|FG005|Overall Study|Lost to Follow-up|0|||
131750876|NCT01576406|474364033|FG000|Overall Study|Death|3|||
131750877|NCT01576406|474364034|FG001|Overall Study|Death|4|||
131750878|NCT01576406|474364035|FG002|Overall Study|Death|8|||
131809238|NCT02655679|474584424|FG000|Overall Study|Lost to Follow-up|0|||
131809239|NCT02655679|474584425|FG001|Overall Study|Lost to Follow-up|1|||
131809240|NCT02655679|474584426|FG002|Overall Study|Lost to Follow-up|1|||
131809241|NCT02655679|474584427|FG003|Overall Study|Lost to Follow-up|1|||
131809242|NCT02655679|474584428|FG004|Overall Study|Lost to Follow-up|0|||
131809243|NCT02655679|474584424|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131809244|NCT02655679|474584425|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131750879|NCT01576406|474364036|FG003|Overall Study|Death|5|||
131750880|NCT01576406|474364037|FG004|Overall Study|Death|7|||
131750881|NCT01576406|474364038|FG005|Overall Study|Death|9|||
131750882|NCT01576406|474364033|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131750883|NCT01576406|474364034|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131750884|NCT01576406|474364035|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
131750885|NCT01576406|474364036|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
131750886|NCT01576406|474364037|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131809245|NCT02655679|474584426|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131906497|NCT03504917|474945194|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
131906498|NCT03101020|474945195|FG000|Overall Study|Lack of time to participate|1|||
131906499|NCT03101020|474945196|FG001|Overall Study|Lack of time to participate|0|||
131906500|NCT03101020|474945195|FG000|Overall Study|Ran over by a car|0|||
131906501|NCT03101020|474945196|FG001|Overall Study|Ran over by a car|1|||
131906502|NCT03101020|474945195|FG000|Overall Study|Withdrawal by Subject|0|||
131906503|NCT03101020|474945196|FG001|Overall Study|Withdrawal by Subject|2|||
131750887|NCT01576406|474364038|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131906504|NCT05817669|474945197|FG000|Overall Study|Prohibited medication used|1|||
131906505|NCT05817669|474945198|FG001|Overall Study|Prohibited medication used|2|||
131906506|NCT05817669|474945197|FG000|Overall Study|Adverse Event|1|||
131906507|NCT05817669|474945198|FG001|Overall Study|Adverse Event|0|||
131906508|NCT05817669|474945197|FG000|Overall Study|Withdrawal by Subject|1|||
131750888|NCT01576406|474364033|FG000|Overall Study|Withdrawal the consent|2|||
131750889|NCT01576406|474364034|FG001|Overall Study|Withdrawal the consent|2|||
131750890|NCT01576406|474364035|FG002|Overall Study|Withdrawal the consent|5|||
131750891|NCT01576406|474364036|FG003|Overall Study|Withdrawal the consent|1|||
131750892|NCT01576406|474364037|FG004|Overall Study|Withdrawal the consent|1|||
131750893|NCT01576406|474364038|FG005|Overall Study|Withdrawal the consent|3|||
131750894|NCT01576406|474364033|FG000|Overall Study|Other|0|||
131750895|NCT01576406|474364034|FG001|Overall Study|Other|0|||
131750896|NCT01576406|474364035|FG002|Overall Study|Other|2|||
131750897|NCT01576406|474364036|FG003|Overall Study|Other|2|||
131750898|NCT01576406|474364037|FG004|Overall Study|Other|0|||
131750899|NCT01576406|474364038|FG005|Overall Study|Other|0|||
131750900|NCT00669032|474364043|FG000|Overall Study|Lost to Follow-up|6|||
131750901|NCT00669032|474364044|FG001|Overall Study|Lost to Follow-up|5|||
131750902|NCT00669032|474364043|FG000|Overall Study|Lack of Efficacy|8|||
131906509|NCT05817669|474945198|FG001|Overall Study|Withdrawal by Subject|2|||
131906510|NCT03786380|474945199|FG000|Overall Study|Adverse Event|1|||
131906511|NCT03786380|474945200|FG001|Overall Study|Adverse Event|0|||
131906512|NCT03786380|474945201|FG002|Overall Study|Adverse Event|0|||
131906513|NCT03786380|474945202|FG003|Overall Study|Adverse Event|3|||
131906514|NCT03786380|474945203|FG004|Overall Study|Adverse Event|1|||
131906515|NCT03786380|474945199|FG000|Overall Study|Lack of Efficacy|0|||
131906516|NCT03786380|474945200|FG001|Overall Study|Lack of Efficacy|0|||
131906517|NCT03786380|474945201|FG002|Overall Study|Lack of Efficacy|0|||
131906518|NCT03786380|474945202|FG003|Overall Study|Lack of Efficacy|0|||
131906519|NCT03786380|474945203|FG004|Overall Study|Lack of Efficacy|1|||
131906520|NCT03786380|474945199|FG000|Overall Study|Withdrawal by Subject|1|||
131906521|NCT03786380|474945200|FG001|Overall Study|Withdrawal by Subject|2|||
131906522|NCT03786380|474945201|FG002|Overall Study|Withdrawal by Subject|2|||
131906523|NCT03786380|474945202|FG003|Overall Study|Withdrawal by Subject|1|||
131906524|NCT03786380|474945203|FG004|Overall Study|Withdrawal by Subject|2|||
131906525|NCT03786380|474945199|FG000|Overall Study|Lost to Follow-up|3|||
131906526|NCT03786380|474945200|FG001|Overall Study|Lost to Follow-up|0|||
131906527|NCT03786380|474945201|FG002|Overall Study|Lost to Follow-up|1|||
131906528|NCT03786380|474945202|FG003|Overall Study|Lost to Follow-up|2|||
131906529|NCT03786380|474945203|FG004|Overall Study|Lost to Follow-up|0|||
131750903|NCT00669032|474364044|FG001|Overall Study|Lack of Efficacy|19|||
131750904|NCT00669032|474364043|FG000|Overall Study|Withdrawal by Subject|12|||
131750905|NCT00669032|474364044|FG001|Overall Study|Withdrawal by Subject|13|||
131750906|NCT00669032|474364043|FG000|Overall Study|Adverse Event|12|||
131750907|NCT00669032|474364044|FG001|Overall Study|Adverse Event|16|||
131750908|NCT00669032|474364043|FG000|Overall Study|Physician Decision|1|||
131750909|NCT00669032|474364044|FG001|Overall Study|Physician Decision|1|||
131750910|NCT00669032|474364043|FG000|Overall Study|No fulfilment of the selection criteria|5|||
131750911|NCT00669032|474364044|FG001|Overall Study|No fulfilment of the selection criteria|5|||
131750912|NCT01607073|474364045|FG000|Overall Study|Adverse Event|1|||
131750913|NCT03565991|474366203|FG000|Overall Study|Other|11|||
131750914|NCT03565991|474366204|FG001|Overall Study|Other|0|||
131750915|NCT03565991|474366203|FG000|Overall Study|Global deterioration of health status|14|||
131750916|NCT03565991|474366204|FG001|Overall Study|Global deterioration of health status|4|||
131750917|NCT03565991|474366203|FG000|Overall Study|Withdrawal by Subject|2|||
131906530|NCT03786380|474945199|FG000|Overall Study|Physician Decision|0|||
131906531|NCT03786380|474945200|FG001|Overall Study|Physician Decision|0|||
131906532|NCT03786380|474945201|FG002|Overall Study|Physician Decision|1|||
131906533|NCT03786380|474945202|FG003|Overall Study|Physician Decision|0|||
131750918|NCT03565991|474366204|FG001|Overall Study|Withdrawal by Subject|6|||
131906534|NCT03786380|474945203|FG004|Overall Study|Physician Decision|0|||
131906535|NCT03786380|474945199|FG000|Overall Study|Study Terminated by the Sponsor|30|||
131750919|NCT03565991|474366203|FG000|Overall Study|Progressive disease|121|||
131750920|NCT03565991|474366204|FG001|Overall Study|Progressive disease|29|||
131750921|NCT03565991|474366203|FG000|Overall Study|Death|3|||
131750922|NCT03565991|474366204|FG001|Overall Study|Death|0|||
131750923|NCT03565991|474366203|FG000|Overall Study|Adverse Event|7|||
131750924|NCT03565991|474366204|FG001|Overall Study|Adverse Event|2|||
131750925|NCT00784459|474366205|FG000|Overall Study|Adverse Event|0|||
131750926|NCT00784459|474366206|FG001|Overall Study|Adverse Event|2|||
131750927|NCT02741310|474366219|FG000|Overall Study|Sponsor Decision|2|||
131750928|NCT02741310|474366220|FG001|Overall Study|Sponsor Decision|2|||
131750929|NCT03235726|474366223|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750930|NCT03235726|474366224|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750931|NCT03235726|474366225|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750932|NCT03235726|474366226|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750933|NCT03235726|474366227|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
131750934|NCT03235726|474366228|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750935|NCT03235726|474366229|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750936|NCT03235726|474366230|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750937|NCT03235726|474366231|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750938|NCT03235726|474366232|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131750939|NCT03235726|474366223|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750940|NCT03235726|474366224|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750941|NCT03235726|474366225|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750942|NCT03235726|474366226|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750943|NCT03235726|474366227|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
131750944|NCT03235726|474366228|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750945|NCT03235726|474366229|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750946|NCT03235726|474366230|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750947|NCT03235726|474366231|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750948|NCT03235726|474366232|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131750949|NCT00561340|474366234|FG000|Overall Study|refused to drink pediasure|6|||
131750950|NCT00561340|474366235|FG001|Overall Study|refused to drink pediasure|0|||
131750951|NCT03051217|474366236|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
131750952|NCT03051217|474366237|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131750953|NCT03051217|474366238|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
131750954|NCT03051217|474366239|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131750955|NCT03051217|474366240|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131750956|NCT03051217|474366241|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131750957|NCT03051217|474366242|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131750958|NCT03051217|474366236|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131750959|NCT03051217|474366237|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
131750960|NCT03051217|474366238|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131750961|NCT03051217|474366239|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131750962|NCT03051217|474366240|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131750963|NCT03051217|474366241|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131750964|NCT03051217|474366242|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131750965|NCT03051217|474366236|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131750966|NCT03051217|474366237|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131750967|NCT03051217|474366238|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131750968|NCT03051217|474366239|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131750969|NCT03051217|474366240|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131750970|NCT03051217|474366241|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131750971|NCT03051217|474366242|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131750972|NCT03051217|474366236|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
131750973|NCT03051217|474366237|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
131750974|NCT03051217|474366238|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
131750975|NCT03051217|474366239|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
131750976|NCT03051217|474366240|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
131750977|NCT03051217|474366241|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
131809246|NCT02655679|474584427|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131809247|NCT02655679|474584428|FG004|Overall Study|Other Miscellaneous Reasons|0|||
131809248|NCT01421277|474584429|FG000|Overall Study|Lack of qualifying event|0|||
131809249|NCT01421277|474584430|FG001|Overall Study|Lack of qualifying event|61|||
131750978|NCT03051217|474366242|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
131750979|NCT03051217|474366236|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131750980|NCT03051217|474366237|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131809250|NCT01421277|474584429|FG000|Overall Study|Incomplete baseline data|0|||
131809251|NCT01421277|474584430|FG001|Overall Study|Incomplete baseline data|31|||
131809252|NCT00731783|474584435|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
131809253|NCT00731783|474584436|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
131906536|NCT03786380|474945200|FG001|Overall Study|Study Terminated by the Sponsor|20|||
131906537|NCT03786380|474945201|FG002|Overall Study|Study Terminated by the Sponsor|50|||
131906538|NCT03786380|474945202|FG003|Overall Study|Study Terminated by the Sponsor|57|||
131906539|NCT03786380|474945203|FG004|Overall Study|Study Terminated by the Sponsor|23|||
131750981|NCT03051217|474366238|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131750982|NCT03051217|474366239|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
131750983|NCT03051217|474366240|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131750984|NCT03051217|474366241|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131750985|NCT03051217|474366242|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131750986|NCT03051217|474366236|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131750987|NCT03051217|474366237|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131750988|NCT03051217|474366238|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131750989|NCT03051217|474366239|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
131750990|NCT03051217|474366240|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131750991|NCT03051217|474366241|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131750992|NCT03051217|474366242|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131750993|NCT03051217|474366236|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131750994|NCT03051217|474366237|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131750995|NCT03051217|474366238|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131750996|NCT03051217|474366239|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131750997|NCT03051217|474366240|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
131750998|NCT03051217|474366241|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131750999|NCT03051217|474366242|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131751000|NCT03051217|474366236|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131751001|NCT03051217|474366237|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131751002|NCT03051217|474366238|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131751003|NCT03051217|474366239|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131751004|NCT03051217|474366240|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131751005|NCT03051217|474366241|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
131751006|NCT03051217|474366242|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131751007|NCT00641706|474366245|FG000|Overall Study|Adverse Event|2|||
131751008|NCT00641706|474366246|FG001|Overall Study|Adverse Event|1|||
131751009|NCT00641706|474366245|FG000|Overall Study|Withdrawal by Subject|6|||
131751010|NCT00641706|474366246|FG001|Overall Study|Withdrawal by Subject|1|||
131751011|NCT00641706|474366245|FG000|Overall Study|Clinical Decline|1|||
131751012|NCT00641706|474366246|FG001|Overall Study|Clinical Decline|0|||
131751013|NCT00641706|474366245|FG000|Overall Study|Lead Investigator Decision|0|||
131751014|NCT00641706|474366246|FG001|Overall Study|Lead Investigator Decision|1|||
131751015|NCT01675141|474366247|FG000|Overall Study|Lenalidomide outside NIH|3|||
131751016|NCT01675141|474366247|FG000|Overall Study|Withdrawal by Subject|3|||
131751017|NCT01675141|474366247|FG000|Overall Study|Physician Decision|4|||
131751018|NCT01675141|474366247|FG000|Overall Study|No treatment, per protocol|1|||
131751019|NCT00109772|474366250|FG000|Double-blind Treatment|Adverse Event|14|||
131751020|NCT00109772|474366251|FG001|Double-blind Treatment|Adverse Event|5|||
131751021|NCT00109772|474366250|FG000|Double-blind Treatment|Lack of Efficacy|1|||
131751022|NCT00109772|474366251|FG001|Double-blind Treatment|Lack of Efficacy|0|||
131751023|NCT00109772|474366250|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
131751024|NCT00109772|474366251|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
131751025|NCT00109772|474366250|FG000|Double-blind Treatment|Lost to Follow-up|2|||
131751026|NCT00109772|474366251|FG001|Double-blind Treatment|Lost to Follow-up|3|||
131751027|NCT00109772|474366250|FG000|Double-blind Treatment|Protocol Violation|0|||
131751028|NCT00109772|474366251|FG001|Double-blind Treatment|Protocol Violation|1|||
131751029|NCT00109772|474366250|FG000|Double-blind Treatment|Other|0|||
131751030|NCT00109772|474366251|FG001|Double-blind Treatment|Other|4|||
131751031|NCT00109772|474366250|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
131751032|NCT00109772|474366251|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
131751033|NCT00109772|474366250|FG000|Open-label Extension|Adverse Event|10|||
131751034|NCT00109772|474366251|FG001|Open-label Extension|Adverse Event|19|||
131751035|NCT00109772|474366250|FG000|Open-label Extension|Lack of Efficacy|19|||
131751036|NCT00109772|474366251|FG001|Open-label Extension|Lack of Efficacy|11|||
131751037|NCT00109772|474366250|FG000|Open-label Extension|Withdrawal by Subject|9|||
131751038|NCT00109772|474366251|FG001|Open-label Extension|Withdrawal by Subject|6|||
131751039|NCT00109772|474366250|FG000|Open-label Extension|Lost to Follow-up|1|||
131751040|NCT00109772|474366251|FG001|Open-label Extension|Lost to Follow-up|0|||
131751041|NCT00109772|474366250|FG000|Open-label Extension|Death|0|||
131751042|NCT00109772|474366251|FG001|Open-label Extension|Death|1|||
131751043|NCT00109772|474366250|FG000|Open-label Extension|Protocol Violation|2|||
131751044|NCT00109772|474366251|FG001|Open-label Extension|Protocol Violation|2|||
131906540|NCT03786380|474945199|FG000|Overall Study|Reason Not Specified|0|||
131751045|NCT00109772|474366250|FG000|Open-label Extension|Other|4|||
131751046|NCT00109772|474366251|FG001|Open-label Extension|Other|10|||
131751047|NCT00391807|474366254|FG000|Overall Study|Did not receive study medication|23|||
131751048|NCT00391807|474366254|FG000|Overall Study|Adverse Event|177|||
131751049|NCT00391807|474366254|FG000|Overall Study|Pregnancy|25|||
131751050|NCT00391807|474366254|FG000|Overall Study|Lost to Follow-up|227|||
131751051|NCT00391807|474366254|FG000|Overall Study|Withdrawal by Subject|147|||
131751052|NCT00391807|474366254|FG000|Overall Study|Protocol Violation|20|||
131751053|NCT00391807|474366254|FG000|Overall Study|Various|96|||
131751054|NCT00282568|474366257|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
131751055|NCT00282568|474366257|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
131751056|NCT00282568|474366257|FG000|Extended Treatment Period|Adverse Event|17|||
131751057|NCT00282568|474366257|FG000|Extended Treatment Period|Non-compliance|4|||
131751058|NCT00282568|474366257|FG000|Extended Treatment Period|Physician Decision|1|||
131751059|NCT00282568|474366257|FG000|Extended Treatment Period|Lost to Follow-up|2|||
131751060|NCT03006926|474366258|FG000|Overall Study|Adverse Event|0|||
131751061|NCT03006926|474366259|FG001|Overall Study|Adverse Event|27|||
131751062|NCT03006926|474366258|FG000|Overall Study|Withdrawal by Subject|0|||
131751063|NCT03006926|474366259|FG001|Overall Study|Withdrawal by Subject|1|||
131751064|NCT03006926|474366258|FG000|Overall Study|Radiological Disease Progression|0|||
131751065|NCT03006926|474366259|FG001|Overall Study|Radiological Disease Progression|52|||
131751066|NCT03006926|474366258|FG000|Overall Study|Clinical Disease Progression|0|||
131751067|NCT03006926|474366259|FG001|Overall Study|Clinical Disease Progression|10|||
131751068|NCT03006926|474366258|FG000|Overall Study|Other|0|||
131751069|NCT03006926|474366259|FG001|Overall Study|Other|8|||
131751070|NCT00990249|474366264|FG000|Overall Study|Disease Progression|8|||
131751071|NCT00990249|474366264|FG000|Overall Study|Non-Compliance|1|||
131751072|NCT00990249|474366264|FG000|Overall Study|Death|2|||
131751073|NCT00990249|474366264|FG000|Overall Study|Not treated|2|||
131751074|NCT03725293|474366265|FG000|Overall Study|Physician Decision|9|||
131751075|NCT03725293|474366266|FG001|Overall Study|Physician Decision|6|||
131751076|NCT03725293|474366265|FG000|Overall Study|alternative vascular access needs|1|||
131751077|NCT03725293|474366266|FG001|Overall Study|alternative vascular access needs|2|||
131751078|NCT03725293|474366265|FG000|Overall Study|venous anatomy screen failures|2|||
131751079|NCT03725293|474366266|FG001|Overall Study|venous anatomy screen failures|1|||
131751080|NCT04583969|474366269|FG000|Overall Study|Death|31|||
131751081|NCT04583969|474366270|FG001|Overall Study|Death|38|||
131751082|NCT04583969|474366269|FG000|Overall Study|Lost to Follow-up|16|||
131751083|NCT04583969|474366270|FG001|Overall Study|Lost to Follow-up|13|||
131751084|NCT04583969|474366269|FG000|Overall Study|Protocol Violation|1|||
131751085|NCT04583969|474366270|FG001|Overall Study|Protocol Violation|0|||
131751086|NCT04583969|474366269|FG000|Overall Study|Withdrawal by Subject|3|||
131751087|NCT04583969|474366270|FG001|Overall Study|Withdrawal by Subject|3|||
131751088|NCT04583969|474366269|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
131751089|NCT04583969|474366270|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
131751090|NCT04583969|474366269|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
131751091|NCT04583969|474366270|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
131751092|NCT04583969|474366269|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
131751093|NCT04583969|474366270|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
131751094|NCT04583969|474366269|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
131751095|NCT04583969|474366270|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
131751096|NCT04583969|474366269|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
131751097|NCT04583969|474366270|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
131751098|NCT04397796|474366271|FG000|Overall Study|Death|3|||
131751099|NCT04397796|474366272|FG001|Overall Study|Death|1|||
131751100|NCT01057862|474366273|FG000|Overall Study|Withdrawal by Subject|1|||
131751101|NCT01057862|474366274|FG001|Overall Study|Withdrawal by Subject|2|||
131751102|NCT00415584|474366275|FG000|Overall Study|Withdrawal by Subject|1|||
131751103|NCT00802867|474366276|FG000|Overall Study|Lost to Follow-up|6|||
131751104|NCT00802867|474366276|FG000|Overall Study|Protocol Violation|6|||
131751105|NCT00802867|474366276|FG000|Overall Study|Withdrawal by Subject|1|||
131751106|NCT02640755|474366277|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
131751107|NCT02640755|474366278|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
131809254|NCT00731783|474584435|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
131809255|NCT00731783|474584436|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
131809256|NCT00731783|474584435|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
131751108|NCT02640755|474366277|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
131751109|NCT02640755|474366278|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
131751110|NCT02640755|474366277|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
131751111|NCT02640755|474366278|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
131751112|NCT04075396|474366279|FG000|Overall Study|Death|11|||
131751113|NCT04075396|474366280|FG001|Overall Study|Death|9|||
131751114|NCT04075396|474366279|FG000|Overall Study|Withdrawal by Subject|1|||
131751115|NCT04075396|474366280|FG001|Overall Study|Withdrawal by Subject|2|||
131751116|NCT04075396|474366279|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
131751117|NCT04075396|474366280|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
131751118|NCT04075396|474366279|FG000|Overall Study|Enrolled but not-treated|0|||
131809257|NCT00731783|474584436|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
131751119|NCT04075396|474366280|FG001|Overall Study|Enrolled but not-treated|1|||
131751120|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
131751121|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
131751122|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
131751123|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
131751124|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
131751125|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
131751126|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
131751127|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
131751128|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
131809258|NCT00731783|474584435|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
131809259|NCT00731783|474584436|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
131809260|NCT00461786|474585999|FG000|Overall Study|Entry Criteria Not Met|2|||
131809261|NCT00461786|474585999|FG000|Overall Study|Inevaluable (Never Treated)|1|||
131809262|NCT00934050|474586000|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
131809263|NCT00934050|474586001|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
131809264|NCT00934050|474586002|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
131809265|NCT00934050|474586003|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
131809266|NCT00934050|474586004|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
131809267|NCT00934050|474586005|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
131809268|NCT00934050|474586000|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
131809269|NCT00934050|474586001|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
131809270|NCT00934050|474586002|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
131809271|NCT00934050|474586003|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
131809272|NCT00934050|474586004|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
131809273|NCT00934050|474586005|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
131809274|NCT00934050|474586000|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
131809275|NCT00934050|474586001|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
131809276|NCT00934050|474586002|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
131809277|NCT00934050|474586003|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
131809278|NCT00934050|474586004|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
131809279|NCT00934050|474586005|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
131809280|NCT00934050|474586000|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
131809281|NCT00934050|474586001|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
131809282|NCT00934050|474586002|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
131809283|NCT00934050|474586003|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
131809284|NCT00934050|474586004|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
131809285|NCT00934050|474586005|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
131809286|NCT00934050|474586000|FG000|Enrolled After 15 Dec 2009|Death|0|||
131809287|NCT00934050|474586001|FG001|Enrolled After 15 Dec 2009|Death|0|||
131809288|NCT00934050|474586002|FG002|Enrolled After 15 Dec 2009|Death|0|||
131809289|NCT00934050|474586003|FG003|Enrolled After 15 Dec 2009|Death|0|||
131809290|NCT00934050|474586004|FG004|Enrolled After 15 Dec 2009|Death|0|||
131809291|NCT00934050|474586005|FG005|Enrolled After 15 Dec 2009|Death|1|||
131809292|NCT00934050|474586000|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
131809293|NCT00934050|474586001|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
131809294|NCT00934050|474586002|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
131809295|NCT00934050|474586003|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
131809296|NCT00934050|474586004|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
131809297|NCT00934050|474586005|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
131809298|NCT00934050|474586000|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
131809299|NCT00934050|474586001|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
131809300|NCT00934050|474586002|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
131809301|NCT00934050|474586003|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
131809302|NCT00934050|474586004|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
131809303|NCT00934050|474586005|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
131809304|NCT00835991|474586006|FG000|First Intervention|Adverse Event|0|||
131809305|NCT00835991|474586007|FG001|First Intervention|Adverse Event|1|||
131809306|NCT00835991|474586006|FG000|Washout|Protocol Violation|0|||
131809307|NCT00835991|474586007|FG001|Washout|Protocol Violation|2|||
131809308|NCT00835991|474586006|FG000|Washout|Withdrawal by Subject|3|||
131809309|NCT00835991|474586007|FG001|Washout|Withdrawal by Subject|1|||
131809310|NCT02149420|474586008|FG000|Core Study|Administrative problems|0|||
131906541|NCT03786380|474945200|FG001|Overall Study|Reason Not Specified|0|||
131751129|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
131751130|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
131751131|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
131751132|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
131751133|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
131751134|NCT03434041|474366281|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
131751135|NCT03434041|474366282|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
131751136|NCT03434041|474366281|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
131751137|NCT03434041|474366282|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
131751138|NCT03434041|474366281|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
131751139|NCT03434041|474366282|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
131751140|NCT03434041|474366281|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
131751141|NCT03434041|474366282|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
131751142|NCT03363165|474366289|FG000|3-month Follow-up|Death|0|||
131751143|NCT03363165|474366290|FG001|3-month Follow-up|Death|1|||
131751144|NCT03363165|474366289|FG000|6-month Follow-up|Death|0|||
131751145|NCT03363165|474366290|FG001|6-month Follow-up|Death|1|||
131751146|NCT03363165|474366289|FG000|6-month Follow-up|Withdrawal by Subject|1|||
131751147|NCT03363165|474366290|FG001|6-month Follow-up|Withdrawal by Subject|1|||
131809311|NCT02149420|474586009|FG001|Core Study|Administrative problems|1|||
131809312|NCT02149420|474586010|FG002|Core Study|Administrative problems|2|||
131809313|NCT02149420|474586008|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
131809314|NCT02149420|474586009|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
131809315|NCT02149420|474586010|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
131809316|NCT01111461|474586011|FG000|Overall Study|Adverse Event|32|||
131809317|NCT01111461|474586011|FG000|Overall Study|Participant choice|11|||
131809318|NCT01111461|474586011|FG000|Overall Study|Lost to Follow-up|1|||
131809319|NCT01111461|474586011|FG000|Overall Study|Withdrawal by Subject|1|||
131809320|NCT01111461|474586011|FG000|Overall Study|Other|6|||
131809321|NCT00834067|474586014|FG000|Washout of 21 Days|Protocol Violation|0|||
131809322|NCT00834067|474586015|FG001|Washout of 21 Days|Protocol Violation|1|||
131809323|NCT02378935|474586016|FG000|Overall Study|Lack of Efficacy|10|||
131809324|NCT02378935|474586017|FG001|Overall Study|Lack of Efficacy|0|||
131809325|NCT02378935|474586018|FG002|Overall Study|Lack of Efficacy|2|||
131809326|NCT02378935|474586019|FG003|Overall Study|Lack of Efficacy|6|||
131809327|NCT02378935|474586020|FG004|Overall Study|Lack of Efficacy|0|||
131809328|NCT02378935|474586021|FG005|Overall Study|Lack of Efficacy|0|||
131809329|NCT02378935|474586022|FG006|Overall Study|Lack of Efficacy|0|||
131809330|NCT02378935|474586016|FG000|Overall Study|Death|0|||
131809331|NCT02378935|474586017|FG001|Overall Study|Death|0|||
131809332|NCT02378935|474586018|FG002|Overall Study|Death|1|||
131809333|NCT02378935|474586019|FG003|Overall Study|Death|0|||
131809334|NCT02378935|474586020|FG004|Overall Study|Death|0|||
131809335|NCT02378935|474586021|FG005|Overall Study|Death|0|||
131809336|NCT02378935|474586022|FG006|Overall Study|Death|0|||
131809337|NCT02146105|474586025|FG000|Overall Study|Adverse Event|1|||
131809338|NCT02146105|474586025|FG000|Overall Study|Withdrawal by Subject|5|||
131809339|NCT05755282|474586026|FG000|Overall Study|Protocol Violation|0|||
131809340|NCT05755282|474586027|FG001|Overall Study|Protocol Violation|1|||
131809341|NCT03935880|474586029|FG000|Overall Study|Lost to Follow-up|0|||
131809342|NCT03935880|474586030|FG001|Overall Study|Lost to Follow-up|1|||
131809343|NCT02476994|474586031|FG000|Overall Study|Based on feedback from FDA|1|||
131809344|NCT02476994|474586032|FG001|Overall Study|Based on feedback from FDA|0|||
131809345|NCT02563561|474586033|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
131809346|NCT02563561|474586034|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
131809347|NCT02563561|474586035|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
131809348|NCT02563561|474586033|FG000|Overall Study|Withdrew of Consent|1|||
131809349|NCT02563561|474586034|FG001|Overall Study|Withdrew of Consent|1|||
131809350|NCT02563561|474586035|FG002|Overall Study|Withdrew of Consent|2|||
131809351|NCT02563561|474586033|FG000|Overall Study|Lost to Follow-up|1|||
131809352|NCT02563561|474586034|FG001|Overall Study|Lost to Follow-up|1|||
131809353|NCT02563561|474586035|FG002|Overall Study|Lost to Follow-up|0|||
131809354|NCT02563561|474586033|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
131809355|NCT02563561|474586034|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
131809356|NCT02563561|474586035|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
131809357|NCT02563561|474586033|FG000|Overall Study|Investigator Decision|3|||
131809358|NCT02563561|474586034|FG001|Overall Study|Investigator Decision|4|||
131809359|NCT02563561|474586035|FG002|Overall Study|Investigator Decision|2|||
131809360|NCT02563561|474586033|FG000|Overall Study|Sponsor Decision|5|||
131809361|NCT02563561|474586034|FG001|Overall Study|Sponsor Decision|2|||
131809362|NCT02563561|474586035|FG002|Overall Study|Sponsor Decision|4|||
131751148|NCT03363165|474366289|FG000|12-month Follow-up|Death|1|||
131751149|NCT03363165|474366290|FG001|12-month Follow-up|Death|1|||
131751150|NCT03363165|474366289|FG000|12-month Follow-up|Withdrawal by Subject|1|||
131751151|NCT03363165|474366290|FG001|12-month Follow-up|Withdrawal by Subject|1|||
131751152|NCT00770224|474366296|FG000|Step 1: Induction|Adverse Event|3|||
131751153|NCT00770224|474366297|FG001|Step 1: Induction|Adverse Event|0|||
131751154|NCT00770224|474366296|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
131751155|NCT00770224|474366297|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
131751156|NCT00770224|474366296|FG000|Step 1: Induction|Other reason not protocol specified|2|||
131751157|NCT00770224|474366297|FG001|Step 1: Induction|Other reason not protocol specified|0|||
131751158|NCT00770224|474366296|FG000|Step 1: Induction|Ineligible|2|||
131751159|NCT00770224|474366297|FG001|Step 1: Induction|Ineligible|0|||
131751160|NCT00770224|474366296|FG000|Step 1: Induction|No protocol treatment given|1|||
131751161|NCT00770224|474366297|FG001|Step 1: Induction|No protocol treatment given|0|||
131751162|NCT00770224|474366296|FG000|Step 2: Maintenance|Adverse Event|0|||
131751163|NCT00770224|474366297|FG001|Step 2: Maintenance|Adverse Event|10|||
131751164|NCT00770224|474366296|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
131751165|NCT00770224|474366297|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
131751166|NCT00770224|474366296|FG000|Step 2: Maintenance|Progression/relapse|0|||
131751167|NCT00770224|474366297|FG001|Step 2: Maintenance|Progression/relapse|1|||
131751168|NCT00770224|474366296|FG000|Step 2: Maintenance|Death|0|||
131751169|NCT00770224|474366297|FG001|Step 2: Maintenance|Death|2|||
131751170|NCT00770224|474366296|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
131751171|NCT00770224|474366297|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
131751172|NCT00770224|474366296|FG000|Step 2: Maintenance|Ineligible|0|||
131751173|NCT00770224|474366297|FG001|Step 2: Maintenance|Ineligible|2|||
131751174|NCT01484561|474366298|FG000|Overall Study|Lack of Efficacy|3|||
131751175|NCT01484561|474366299|FG001|Overall Study|Lack of Efficacy|1|||
131751176|NCT01484561|474366298|FG000|Overall Study|Lost to Follow-up|1|||
131751177|NCT01484561|474366299|FG001|Overall Study|Lost to Follow-up|0|||
131751178|NCT01484561|474366298|FG000|Overall Study|Withdrawal by Subject|3|||
131751179|NCT01484561|474366299|FG001|Overall Study|Withdrawal by Subject|0|||
131751180|NCT01484561|474366298|FG000|Overall Study|Other|1|||
131751181|NCT01484561|474366299|FG001|Overall Study|Other|1|||
131751182|NCT01484561|474366298|FG000|Overall Study|Adverse Event|1|||
131751183|NCT01484561|474366299|FG001|Overall Study|Adverse Event|4|||
131751184|NCT03371251|474366300|FG000|Overall Study|Withdrawal by Subject|1|||
131751185|NCT03371251|474366301|FG001|Overall Study|Withdrawal by Subject|0|||
131751186|NCT03371251|474366302|FG002|Overall Study|Withdrawal by Subject|1|||
131751187|NCT03371251|474366303|FG003|Overall Study|Withdrawal by Subject|0|||
131751188|NCT03371251|474366304|FG004|Overall Study|Withdrawal by Subject|2|||
131751189|NCT03371251|474366305|FG005|Overall Study|Withdrawal by Subject|2|||
131751190|NCT03371251|474366300|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
131751191|NCT03371251|474366301|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
131751192|NCT03371251|474366302|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
131751193|NCT03371251|474366303|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
131751194|NCT03371251|474366304|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
131751195|NCT03371251|474366305|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
131751196|NCT03371251|474366300|FG000|Overall Study|Adverse Event|0|||
131751197|NCT03371251|474366301|FG001|Overall Study|Adverse Event|0|||
131751198|NCT03371251|474366302|FG002|Overall Study|Adverse Event|0|||
131751199|NCT03371251|474366303|FG003|Overall Study|Adverse Event|0|||
131751200|NCT03371251|474366304|FG004|Overall Study|Adverse Event|1|||
131751201|NCT03371251|474366305|FG005|Overall Study|Adverse Event|0|||
131751202|NCT03371251|474366300|FG000|Overall Study|Decision by Sponsor|0|||
131751203|NCT03371251|474366301|FG001|Overall Study|Decision by Sponsor|0|||
131751204|NCT03371251|474366302|FG002|Overall Study|Decision by Sponsor|0|||
131751205|NCT03371251|474366303|FG003|Overall Study|Decision by Sponsor|0|||
131751206|NCT03371251|474366304|FG004|Overall Study|Decision by Sponsor|2|||
131751207|NCT03371251|474366305|FG005|Overall Study|Decision by Sponsor|0|||
131751208|NCT00114218|474366306|FG000|Overall Study|Wrong Cell Type|2|||
131751209|NCT00114218|474366306|FG000|Overall Study|Wrong Primary|1|||
131751210|NCT00114218|474366306|FG000|Overall Study|Never Treated|1|||
131751211|NCT02228564|474366313|FG000|Overall Study|Withdrawal by Subject|10|||
131751212|NCT02228564|474366313|FG000|Overall Study|Death|11|||
131751213|NCT02228564|474366313|FG000|Overall Study|Physician Decision|5|||
131751214|NCT02228564|474366313|FG000|Overall Study|Lost to Follow-up|17|||
131751215|NCT02228564|474366313|FG000|Overall Study|Other|6|||
131751216|NCT02142504|474366314|FG000|Overall Study|Protocol Violation|2|||
131751217|NCT02142504|474366315|FG001|Overall Study|Protocol Violation|1|||
131751218|NCT02142504|474366316|FG002|Overall Study|Protocol Violation|2|||
131751219|NCT02142504|474366314|FG000|Overall Study|Adverse Event|2|||
131751220|NCT02142504|474366315|FG001|Overall Study|Adverse Event|3|||
131751221|NCT02142504|474366316|FG002|Overall Study|Adverse Event|4|||
131751222|NCT02142504|474366314|FG000|Overall Study|Lost to Follow-up|12|||
131751223|NCT02142504|474366315|FG001|Overall Study|Lost to Follow-up|19|||
131751224|NCT02142504|474366316|FG002|Overall Study|Lost to Follow-up|17|||
131751225|NCT02142504|474366314|FG000|Overall Study|Withdrawal by Subject|7|||
131751226|NCT02142504|474366315|FG001|Overall Study|Withdrawal by Subject|9|||
131751227|NCT02142504|474366316|FG002|Overall Study|Withdrawal by Subject|11|||
131751228|NCT02142504|474366314|FG000|Overall Study|Pregnancy|4|||
131751229|NCT02142504|474366315|FG001|Overall Study|Pregnancy|4|||
131751230|NCT02142504|474366316|FG002|Overall Study|Pregnancy|2|||
131751231|NCT02142504|474366314|FG000|Overall Study|Physician Decision|0|||
131751232|NCT02142504|474366315|FG001|Overall Study|Physician Decision|1|||
131751233|NCT02142504|474366316|FG002|Overall Study|Physician Decision|3|||
131751234|NCT02142504|474366314|FG000|Overall Study|Reason Not Specified|4|||
131751235|NCT02142504|474366315|FG001|Overall Study|Reason Not Specified|5|||
131751236|NCT02142504|474366316|FG002|Overall Study|Reason Not Specified|4|||
131751237|NCT00617591|474366320|FG000|Overall Study|Withdrew consent during Induction|4|||
131751238|NCT00617591|474366320|FG000|Overall Study|Withdrew consent during Maintenance|6|||
131751239|NCT01400139|474366325|FG000|HYD Core Study|Adverse Event|210|||
131751240|NCT01400139|474366325|FG000|HYD Core Study|Lack of Efficacy|59|||
131751241|NCT01400139|474366325|FG000|HYD Core Study|Withdrawal by Subject|114|||
131751242|NCT01400139|474366325|FG000|HYD Core Study|Lost to Follow-up|39|||
131751243|NCT01400139|474366325|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
131751244|NCT01400139|474366325|FG000|HYD Core Study|Administrative|56|||
131751245|NCT01400139|474366325|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
131751246|NCT01400139|474366325|FG000|HYD Extension Period|Adverse Event|8|||
131751247|NCT01400139|474366325|FG000|HYD Extension Period|Withdrawal by Subject|5|||
131751248|NCT01400139|474366325|FG000|HYD Extension Period|Administrative|10|||
131751249|NCT00249795|474366326|FG000|Overall Study|Not treated|16|||
131751250|NCT00249795|474366327|FG001|Overall Study|Not treated|14|||
131751251|NCT00249795|474366326|FG000|Overall Study|Symptomatic hypotension|127|||
131751252|NCT00249795|474366327|FG001|Overall Study|Symptomatic hypotension|64|||
131751253|NCT00249795|474366326|FG000|Overall Study|Other Serious Adverse Event|84|||
131751254|NCT00249795|474366327|FG001|Overall Study|Other Serious Adverse Event|93|||
131751255|NCT00249795|474366326|FG000|Overall Study|Qualifying condition not present|26|||
131751256|NCT00249795|474366327|FG001|Overall Study|Qualifying condition not present|29|||
131751257|NCT00249795|474366326|FG000|Overall Study|Withdrawal by Subject|678|||
131751258|NCT00249795|474366327|FG001|Overall Study|Withdrawal by Subject|742|||
131809363|NCT02563561|474586033|FG000|Overall Study|Other|1|||
131809364|NCT02563561|474586034|FG001|Overall Study|Other|5|||
131809365|NCT02563561|474586035|FG002|Overall Study|Other|2|||
131809366|NCT03122535|474586038|FG000|Overall Study|Lost to Follow-up|68|||
131809367|NCT03122535|474586039|FG001|Overall Study|Lost to Follow-up|68|||
131809368|NCT03122535|474586038|FG000|Overall Study|Physician Decision|3|||
131809369|NCT03122535|474586039|FG001|Overall Study|Physician Decision|3|||
131809370|NCT03122535|474586038|FG000|Overall Study|Withdrawal by Subject|2|||
131809371|NCT03122535|474586039|FG001|Overall Study|Withdrawal by Subject|2|||
131809372|NCT02718326|474586040|FG000|Overall Study|Adverse Event|4|||
131809373|NCT02718326|474586041|FG001|Overall Study|Adverse Event|9|||
131809374|NCT02718326|474586042|FG002|Overall Study|Adverse Event|0|||
131809375|NCT02718326|474586040|FG000|Overall Study|Death|8|||
131809376|NCT02718326|474586041|FG001|Overall Study|Death|1|||
131809377|NCT02718326|474586042|FG002|Overall Study|Death|2|||
131809378|NCT02718326|474586040|FG000|Overall Study|Withdrawal by Subject|4|||
131809379|NCT02718326|474586041|FG001|Overall Study|Withdrawal by Subject|9|||
131809380|NCT02718326|474586042|FG002|Overall Study|Withdrawal by Subject|6|||
131809381|NCT02718326|474586040|FG000|Overall Study|Lost to Follow-up|18|||
131809382|NCT02718326|474586041|FG001|Overall Study|Lost to Follow-up|5|||
131809383|NCT02718326|474586042|FG002|Overall Study|Lost to Follow-up|14|||
131809384|NCT02718326|474586040|FG000|Overall Study|Protocol Deviation|1|||
131809385|NCT02718326|474586041|FG001|Overall Study|Protocol Deviation|0|||
131809386|NCT02718326|474586042|FG002|Overall Study|Protocol Deviation|0|||
131809387|NCT02718326|474586040|FG000|Overall Study|Pregnancy|1|||
131809388|NCT02718326|474586041|FG001|Overall Study|Pregnancy|0|||
131809389|NCT02718326|474586042|FG002|Overall Study|Pregnancy|0|||
131809390|NCT02646124|474586043|FG000|Overall Study|Lost to Follow-up|0|||
131809391|NCT02646124|474586044|FG001|Overall Study|Lost to Follow-up|2|||
131809392|NCT00857454|474586047|FG000|Overall Study|Withdrawal by Subject|2|||
131809393|NCT00857454|474586047|FG000|Overall Study|Lost to Follow-up|1|||
131809394|NCT00857454|474586047|FG000|Overall Study|Adverse Event|2|||
131809395|NCT00857454|474586047|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
131751259|NCT00249795|474366326|FG000|Overall Study|Thromboembolic / outcome event|39|||
131751260|NCT00249795|474366327|FG001|Overall Study|Thromboembolic / outcome event|45|||
131751261|NCT00249795|474366326|FG000|Overall Study|Oral anticoagulant required|2|||
131751262|NCT00249795|474366327|FG001|Overall Study|Oral anticoagulant required|0|||
131751263|NCT00249795|474366326|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
131751264|NCT00249795|474366327|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
131751265|NCT00249795|474366326|FG000|Overall Study|Non-compliance|71|||
131751266|NCT00249795|474366327|FG001|Overall Study|Non-compliance|69|||
131751267|NCT00249795|474366326|FG000|Overall Study|Study drug intolerance|3|||
131751268|NCT00249795|474366327|FG001|Overall Study|Study drug intolerance|3|||
131751269|NCT00249795|474366326|FG000|Overall Study|Other adverse events (non-serious)|188|||
131751270|NCT00249795|474366327|FG001|Overall Study|Other adverse events (non-serious)|159|||
131751271|NCT00249795|474366326|FG000|Overall Study|Physician withdrew consent|71|||
131751272|NCT00249795|474366327|FG001|Overall Study|Physician withdrew consent|63|||
131751273|NCT00249795|474366326|FG000|Overall Study|Surgery / procedure|4|||
131751274|NCT00249795|474366327|FG001|Overall Study|Surgery / procedure|5|||
131751275|NCT00249795|474366326|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
131751276|NCT00249795|474366327|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
131751277|NCT00249795|474366326|FG000|Overall Study|Lightheadedness / dizziness|15|||
131751278|NCT00249795|474366327|FG001|Overall Study|Lightheadedness / dizziness|11|||
131751279|NCT00249795|474366326|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
131751280|NCT00249795|474366327|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
131751281|NCT00249795|474366326|FG000|Overall Study|Other contraindicated medication|1|||
131751282|NCT00249795|474366327|FG001|Overall Study|Other contraindicated medication|1|||
131751283|NCT00249795|474366326|FG000|Overall Study|Event related to cardiac condition|17|||
131751284|NCT00249795|474366327|FG001|Overall Study|Event related to cardiac condition|16|||
131751285|NCT00249795|474366326|FG000|Overall Study|Patient not wish to continue after May08|4|||
131751286|NCT00249795|474366327|FG001|Overall Study|Patient not wish to continue after May08|6|||
131751287|NCT00249795|474366326|FG000|Overall Study|Site not agree to continue after May08|1|||
131751288|NCT00249795|474366327|FG001|Overall Study|Site not agree to continue after May08|1|||
131751289|NCT00249795|474366326|FG000|Overall Study|Lost to Follow-up|0|||
131751290|NCT00249795|474366327|FG001|Overall Study|Lost to Follow-up|2|||
131751291|NCT00249795|474366326|FG000|Overall Study|Missing|0|||
131751292|NCT00249795|474366327|FG001|Overall Study|Missing|1|||
131751293|NCT02460978|474366328|FG000|Overall Study|Adverse Event|17|||
131751294|NCT02460978|474366329|FG001|Overall Study|Adverse Event|11|||
131751295|NCT02460978|474366330|FG002|Overall Study|Adverse Event|11|||
131751296|NCT02460978|474366328|FG000|Overall Study|Withdrawal by Subject|5|||
131751297|NCT02460978|474366329|FG001|Overall Study|Withdrawal by Subject|5|||
131751298|NCT02460978|474366330|FG002|Overall Study|Withdrawal by Subject|14|||
131751299|NCT02460978|474366328|FG000|Overall Study|Lost to Follow-up|2|||
131751300|NCT02460978|474366329|FG001|Overall Study|Lost to Follow-up|3|||
131751301|NCT02460978|474366330|FG002|Overall Study|Lost to Follow-up|1|||
131751302|NCT02460978|474366328|FG000|Overall Study|Protocol Violation|1|||
131751303|NCT02460978|474366329|FG001|Overall Study|Protocol Violation|1|||
131751304|NCT02460978|474366330|FG002|Overall Study|Protocol Violation|1|||
131751305|NCT02460978|474366328|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
131751306|NCT02460978|474366329|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
131751307|NCT02460978|474366330|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
131751308|NCT02460978|474366328|FG000|Overall Study|Pregnancy|0|||
131751309|NCT02460978|474366329|FG001|Overall Study|Pregnancy|0|||
131751310|NCT02460978|474366330|FG002|Overall Study|Pregnancy|2|||
131751311|NCT03549429|474366333|FG000|Overall Study|Protocol Violation|5|||
131751312|NCT03549429|474366334|FG001|Overall Study|Protocol Violation|3|||
131751313|NCT00588523|474366338|FG000|Overall Study|Not treated|3|||
131751314|NCT01459068|474366341|FG000|Overall Study|Withdrawal by Subject|8|||
131751315|NCT01459068|474366342|FG001|Overall Study|Withdrawal by Subject|18|||
131751316|NCT01459068|474366341|FG000|Overall Study|Lost to Follow-up|31|||
131751317|NCT01459068|474366342|FG001|Overall Study|Lost to Follow-up|15|||
131751318|NCT01459068|474366341|FG000|Overall Study|Death|0|||
131751319|NCT01459068|474366342|FG001|Overall Study|Death|1|||
131751320|NCT01203787|474366343|FG000|Overall Study|Death|12|||
131751321|NCT01203787|474366344|FG001|Overall Study|Death|10|||
131751322|NCT01203787|474366343|FG000|Overall Study|Withdrawal by Subject|6|||
131751323|NCT01203787|474366344|FG001|Overall Study|Withdrawal by Subject|2|||
131751324|NCT01203787|474366343|FG000|Overall Study|Lost to Follow-up|2|||
131751325|NCT01203787|474366344|FG001|Overall Study|Lost to Follow-up|0|||
131751326|NCT01203787|474366343|FG000|Overall Study|Adverse Event|11|||
131906542|NCT03786380|474945201|FG002|Overall Study|Reason Not Specified|0|||
131906543|NCT03786380|474945202|FG003|Overall Study|Reason Not Specified|0|||
131906544|NCT03786380|474945203|FG004|Overall Study|Reason Not Specified|1|||
131906545|NCT01909804|474945208|FG000|Overall Study|Randomized but Never Treated|0|||
131906546|NCT01909804|474945209|FG001|Overall Study|Randomized but Never Treated|0|||
131906547|NCT01909804|474945210|FG002|Overall Study|Randomized but Never Treated|0|||
131906548|NCT01909804|474945211|FG003|Overall Study|Randomized but Never Treated|0|||
131906549|NCT01909804|474945212|FG004|Overall Study|Randomized but Never Treated|0|||
131906550|NCT01909804|474945213|FG005|Overall Study|Randomized but Never Treated|0|||
131906551|NCT01909804|474945214|FG006|Overall Study|Randomized but Never Treated|1|||
131906552|NCT01909804|474945215|FG007|Overall Study|Randomized but Never Treated|0|||
131751327|NCT01203787|474366344|FG001|Overall Study|Adverse Event|15|||
131751328|NCT03404518|474366345|FG000|Overall Study|Lost to Follow-up|28|||
131751329|NCT03404518|474366346|FG001|Overall Study|Lost to Follow-up|30|||
131751330|NCT03404518|474366345|FG000|Overall Study|Protocol Violation|13|||
131751331|NCT03404518|474366346|FG001|Overall Study|Protocol Violation|6|||
131751332|NCT03693404|474366350|FG000|Overall Study|Withdrawal by Subject|1|||
131751333|NCT03693404|474366351|FG001|Overall Study|Withdrawal by Subject|0|||
131751334|NCT03693404|474366350|FG000|Overall Study|Lost to Follow-up|0|||
131751335|NCT03693404|474366351|FG001|Overall Study|Lost to Follow-up|5|||
131751336|NCT03693404|474366350|FG000|Overall Study|Excluded from Analysis|0|||
131751337|NCT03693404|474366351|FG001|Overall Study|Excluded from Analysis|1|||
131751338|NCT02079519|474366352|FG000|Overall Study|Disease Progression|9|||
131751339|NCT02079519|474366352|FG000|Overall Study|Adverse Event|1|||
131751340|NCT01041404|474366358|FG000|Overall Study|Adverse Event|45|||
131751341|NCT01041404|474366359|FG001|Overall Study|Adverse Event|35|||
131751342|NCT01041404|474366358|FG000|Overall Study|Lack of Efficacy|200|||
131751343|NCT01041404|474366359|FG001|Overall Study|Lack of Efficacy|210|||
131751344|NCT01041404|474366358|FG000|Overall Study|Violation of Selection Criteria|0|||
131751345|NCT01041404|474366359|FG001|Overall Study|Violation of Selection Criteria|1|||
131751346|NCT01041404|474366358|FG000|Overall Study|Protocol Violation|4|||
131751347|NCT01041404|474366359|FG001|Overall Study|Protocol Violation|0|||
131751348|NCT01041404|474366358|FG000|Overall Study|Withdrawal by Subject|29|||
131751349|NCT01041404|474366359|FG001|Overall Study|Withdrawal by Subject|23|||
131751350|NCT01041404|474366358|FG000|Overall Study|Failure to Return|1|||
131751351|NCT01041404|474366359|FG001|Overall Study|Failure to Return|2|||
131751352|NCT01041404|474366358|FG000|Overall Study|Other|11|||
131751353|NCT01041404|474366359|FG001|Overall Study|Other|23|||
131751354|NCT01176240|474366360|FG000|Study 306A|Lack of Efficacy|2|||
131751355|NCT01176240|474366361|FG001|Study 306A|Lack of Efficacy|1|||
131751356|NCT01176240|474366360|FG000|Study 306A|Protocol Violation|0|||
131751357|NCT01176240|474366361|FG001|Study 306A|Protocol Violation|1|||
131751358|NCT01176240|474366360|FG000|Study 306A|Withdrawal by Subject|0|||
131751359|NCT01176240|474366361|FG001|Study 306A|Withdrawal by Subject|1|||
131751360|NCT01176240|474366360|FG000|Study 306A|Stop due to diverse problems|1|||
131751361|NCT01176240|474366361|FG001|Study 306A|Stop due to diverse problems|0|||
131751362|NCT01176240|474366360|FG000|Study 306B|Lack of Efficacy|5|||
131751363|NCT01176240|474366361|FG001|Study 306B|Lack of Efficacy|3|||
131751364|NCT01176240|474366360|FG000|Study 306B|Adverse Event|10|||
131751365|NCT01176240|474366361|FG001|Study 306B|Adverse Event|5|||
131751366|NCT01176240|474366360|FG000|Study 306B|Protocol Violation|2|||
131809396|NCT00857454|474586047|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
131809397|NCT00857454|474586047|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
131809398|NCT03154047|474586048|FG000|Overall Study|Death|1|||
131809399|NCT03154047|474586048|FG000|Overall Study|Study terminated by sponsor|76|||
131809400|NCT03154047|474586048|FG000|Overall Study|Withdrawal by Subject|3|||
131809401|NCT01705574|474586052|FG000|Double-Blind Phase|Lost to Follow-up|12|||
131809402|NCT01705574|474586053|FG001|Double-Blind Phase|Lost to Follow-up|16|||
131809403|NCT01705574|474586054|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131809404|NCT01705574|474586055|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131809405|NCT01705574|474586052|FG000|Double-Blind Phase|Adverse Event|3|||
131809406|NCT01705574|474586053|FG001|Double-Blind Phase|Adverse Event|10|||
131809407|NCT01705574|474586054|FG002|Double-Blind Phase|Adverse Event|0|||
131809408|NCT01705574|474586055|FG003|Double-Blind Phase|Adverse Event|0|||
131809409|NCT01705574|474586052|FG000|Double-Blind Phase|Withdrew Consent|8|||
131809410|NCT01705574|474586053|FG001|Double-Blind Phase|Withdrew Consent|5|||
131809411|NCT01705574|474586054|FG002|Double-Blind Phase|Withdrew Consent|0|||
131809412|NCT01705574|474586055|FG003|Double-Blind Phase|Withdrew Consent|0|||
131809413|NCT01705574|474586052|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
131809414|NCT01705574|474586053|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
131809415|NCT01705574|474586054|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
131751367|NCT01176240|474366361|FG001|Study 306B|Protocol Violation|3|||
131751368|NCT01176240|474366360|FG000|Study 306B|Withdrawal by Subject|4|||
131809416|NCT01705574|474586055|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
131809417|NCT01705574|474586052|FG000|Double-Blind Phase|Pregnancy|1|||
131751369|NCT01176240|474366361|FG001|Study 306B|Withdrawal by Subject|1|||
131751370|NCT01176240|474366360|FG000|Study 306B|Physician Decision|2|||
131906553|NCT01909804|474945216|FG008|Overall Study|Randomized but Never Treated|0|||
131906554|NCT01909804|474945217|FG009|Overall Study|Randomized but Never Treated|0|||
131906555|NCT01909804|474945218|FG010|Overall Study|Randomized but Never Treated|0|||
131906556|NCT01909804|474945219|FG011|Overall Study|Randomized but Never Treated|1|||
131906557|NCT01909804|474945208|FG000|Overall Study|Death|0|||
131906558|NCT01909804|474945209|FG001|Overall Study|Death|0|||
131906559|NCT01909804|474945210|FG002|Overall Study|Death|0|||
131906560|NCT01909804|474945211|FG003|Overall Study|Death|0|||
131906561|NCT01909804|474945212|FG004|Overall Study|Death|0|||
131906562|NCT01909804|474945213|FG005|Overall Study|Death|0|||
131906563|NCT01909804|474945214|FG006|Overall Study|Death|0|||
131906564|NCT01909804|474945215|FG007|Overall Study|Death|0|||
131906565|NCT01909804|474945216|FG008|Overall Study|Death|0|||
131906566|NCT01909804|474945217|FG009|Overall Study|Death|0|||
131906567|NCT01909804|474945218|FG010|Overall Study|Death|1|||
131906568|NCT01909804|474945219|FG011|Overall Study|Death|0|||
131906569|NCT01909804|474945208|FG000|Overall Study|Lack of Efficacy|4|||
131906570|NCT01909804|474945209|FG001|Overall Study|Lack of Efficacy|1|||
131906571|NCT01909804|474945210|FG002|Overall Study|Lack of Efficacy|0|||
131906572|NCT01909804|474945211|FG003|Overall Study|Lack of Efficacy|0|||
131906573|NCT01909804|474945212|FG004|Overall Study|Lack of Efficacy|7|||
131906574|NCT01909804|474945213|FG005|Overall Study|Lack of Efficacy|3|||
131906575|NCT01909804|474945214|FG006|Overall Study|Lack of Efficacy|1|||
131906576|NCT01909804|474945215|FG007|Overall Study|Lack of Efficacy|1|||
131906577|NCT01909804|474945216|FG008|Overall Study|Lack of Efficacy|0|||
131906578|NCT01909804|474945217|FG009|Overall Study|Lack of Efficacy|1|||
131906579|NCT01909804|474945218|FG010|Overall Study|Lack of Efficacy|0|||
131906580|NCT01909804|474945219|FG011|Overall Study|Lack of Efficacy|1|||
131906581|NCT01909804|474945208|FG000|Overall Study|Withdrew Consent|0|||
131906582|NCT01909804|474945209|FG001|Overall Study|Withdrew Consent|0|||
131906583|NCT01909804|474945210|FG002|Overall Study|Withdrew Consent|0|||
131906584|NCT01909804|474945211|FG003|Overall Study|Withdrew Consent|0|||
131906585|NCT01909804|474945212|FG004|Overall Study|Withdrew Consent|1|||
131906586|NCT01909804|474945213|FG005|Overall Study|Withdrew Consent|1|||
131906587|NCT01909804|474945214|FG006|Overall Study|Withdrew Consent|0|||
131906588|NCT01909804|474945215|FG007|Overall Study|Withdrew Consent|0|||
131906589|NCT01909804|474945216|FG008|Overall Study|Withdrew Consent|0|||
131906590|NCT01909804|474945217|FG009|Overall Study|Withdrew Consent|0|||
131906591|NCT01909804|474945218|FG010|Overall Study|Withdrew Consent|0|||
131906592|NCT01909804|474945219|FG011|Overall Study|Withdrew Consent|0|||
131906593|NCT01909804|474945208|FG000|Overall Study|Protocol Violation|0|||
131906594|NCT01909804|474945209|FG001|Overall Study|Protocol Violation|0|||
131906595|NCT01909804|474945210|FG002|Overall Study|Protocol Violation|0|||
131906596|NCT01909804|474945211|FG003|Overall Study|Protocol Violation|0|||
131906597|NCT01909804|474945212|FG004|Overall Study|Protocol Violation|0|||
131906598|NCT01909804|474945213|FG005|Overall Study|Protocol Violation|0|||
131906599|NCT01909804|474945214|FG006|Overall Study|Protocol Violation|0|||
131906600|NCT01909804|474945215|FG007|Overall Study|Protocol Violation|0|||
131906601|NCT01909804|474945216|FG008|Overall Study|Protocol Violation|0|||
131906602|NCT01909804|474945217|FG009|Overall Study|Protocol Violation|0|||
131906603|NCT01909804|474945218|FG010|Overall Study|Protocol Violation|0|||
131906604|NCT01909804|474945219|FG011|Overall Study|Protocol Violation|1|||
131906605|NCT01038687|474945220|FG000|Overall Study|Adverse Event|0|||
131906606|NCT01038687|474945221|FG001|Overall Study|Adverse Event|2|||
131906607|NCT01038687|474945222|FG002|Overall Study|Adverse Event|1|||
131906608|NCT00338741|474945223|FG000|Overall Study|Lost to Follow-up|2|||
131906609|NCT00338741|474945224|FG001|Overall Study|Lost to Follow-up|0|||
131906610|NCT02314728|474945225|FG000|Overall Study|Protocol Violation|1|||
131906611|NCT02314728|474945226|FG001|Overall Study|Protocol Violation|0|||
131906612|NCT02314728|474945225|FG000|Overall Study|Lost to Follow-up|0|||
131906613|NCT02314728|474945226|FG001|Overall Study|Lost to Follow-up|1|||
131906614|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
131906615|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
131449228|NCT01002339|473274813|FG000|Overall Study|Randomized. Not transplanted|0|||
131449229|NCT01002339|473274814|FG001|Overall Study|Randomized. Not transplanted|0|||
131449230|NCT01002339|473274815|FG002|Overall Study|Randomized. Not transplanted|1|||
131751371|NCT01176240|474366361|FG001|Study 306B|Physician Decision|1|||
131751372|NCT01176240|474366360|FG000|Study 306B|Supine Hypertension|1|||
131906616|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
131906617|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
131906618|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
131906619|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
131906620|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
131906621|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
131906622|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
131906623|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
131906624|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
131906625|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
131906626|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
131809418|NCT01705574|474586053|FG001|Double-Blind Phase|Pregnancy|1|||
131809419|NCT01705574|474586054|FG002|Double-Blind Phase|Pregnancy|0|||
131809420|NCT01705574|474586055|FG003|Double-Blind Phase|Pregnancy|0|||
131809421|NCT01705574|474586052|FG000|Double-Blind Phase|Protocol Violation|1|||
131809422|NCT01705574|474586053|FG001|Double-Blind Phase|Protocol Violation|0|||
131809423|NCT01705574|474586054|FG002|Double-Blind Phase|Protocol Violation|0|||
131809424|NCT01705574|474586055|FG003|Double-Blind Phase|Protocol Violation|0|||
131809425|NCT01705574|474586052|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
131751373|NCT01176240|474366361|FG001|Study 306B|Supine Hypertension|2|||
131751374|NCT01176240|474366360|FG000|Study 306B|Lost to Follow-up|0|||
131751375|NCT01176240|474366361|FG001|Study 306B|Lost to Follow-up|1|||
131751376|NCT01176240|474366360|FG000|Study 306B|withdrew prior to dosing|2|||
131751377|NCT01176240|474366361|FG001|Study 306B|withdrew prior to dosing|1|||
131751378|NCT01685203|474366364|FG000|Overall Study|Lost to Follow-up|3|||
131751379|NCT01685203|474366365|FG001|Overall Study|Lost to Follow-up|3|||
131751380|NCT01685203|474366366|FG002|Overall Study|Lost to Follow-up|0|||
131751381|NCT01685203|474366367|FG003|Overall Study|Lost to Follow-up|1|||
131751382|NCT01685203|474366368|FG004|Overall Study|Lost to Follow-up|0|||
131751383|NCT01685203|474366369|FG005|Overall Study|Lost to Follow-up|0|||
131751384|NCT01685203|474366370|FG006|Overall Study|Lost to Follow-up|0|||
131751385|NCT01685203|474366364|FG000|Overall Study|Adverse Event|0|||
131751386|NCT01685203|474366365|FG001|Overall Study|Adverse Event|0|||
131751387|NCT01685203|474366366|FG002|Overall Study|Adverse Event|0|||
131751388|NCT01685203|474366367|FG003|Overall Study|Adverse Event|0|||
131751389|NCT01685203|474366368|FG004|Overall Study|Adverse Event|0|||
131751390|NCT01685203|474366369|FG005|Overall Study|Adverse Event|2|||
131751391|NCT01685203|474366370|FG006|Overall Study|Adverse Event|0|||
131751392|NCT01685203|474366364|FG000|Overall Study|Adverse event and withdrew consent|1|||
131751393|NCT01685203|474366365|FG001|Overall Study|Adverse event and withdrew consent|0|||
131751394|NCT01685203|474366366|FG002|Overall Study|Adverse event and withdrew consent|0|||
131751395|NCT01685203|474366367|FG003|Overall Study|Adverse event and withdrew consent|0|||
131751396|NCT01685203|474366368|FG004|Overall Study|Adverse event and withdrew consent|0|||
131751397|NCT01685203|474366369|FG005|Overall Study|Adverse event and withdrew consent|0|||
131751398|NCT01685203|474366370|FG006|Overall Study|Adverse event and withdrew consent|0|||
131751399|NCT01685203|474366364|FG000|Overall Study|Patient's decision|0|||
131751400|NCT01685203|474366365|FG001|Overall Study|Patient's decision|0|||
131751401|NCT01685203|474366366|FG002|Overall Study|Patient's decision|0|||
131751402|NCT01685203|474366367|FG003|Overall Study|Patient's decision|0|||
131751403|NCT01685203|474366368|FG004|Overall Study|Patient's decision|0|||
131751404|NCT01685203|474366369|FG005|Overall Study|Patient's decision|1|||
131751405|NCT01685203|474366370|FG006|Overall Study|Patient's decision|0|||
131751406|NCT00318370|474366374|FG000|Period 1|Lack of Efficacy|5|||
131751407|NCT00318370|474366375|FG001|Period 1|Lack of Efficacy|0|||
131751408|NCT00318370|474366376|FG002|Period 1|Lack of Efficacy|0|||
131751409|NCT00318370|474366374|FG000|Period 1|Physician Decision|1|||
131751410|NCT00318370|474366375|FG001|Period 1|Physician Decision|0|||
131751411|NCT00318370|474366376|FG002|Period 1|Physician Decision|0|||
131751412|NCT00318370|474366374|FG000|Period 1|Withdrawal by Subject|1|||
131751413|NCT00318370|474366375|FG001|Period 1|Withdrawal by Subject|0|||
131751414|NCT00318370|474366376|FG002|Period 1|Withdrawal by Subject|0|||
131751415|NCT00318370|474366374|FG000|Period 2|Adverse Event|0|||
131809426|NCT01705574|474586053|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
131809427|NCT01705574|474586054|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
131751416|NCT00318370|474366375|FG001|Period 2|Adverse Event|3|||
131751417|NCT00318370|474366376|FG002|Period 2|Adverse Event|0|||
131751418|NCT00318370|474366374|FG000|Period 2|Lack of Efficacy|0|||
131751419|NCT00318370|474366375|FG001|Period 2|Lack of Efficacy|5|||
131751420|NCT00318370|474366376|FG002|Period 2|Lack of Efficacy|0|||
131751421|NCT00318370|474366374|FG000|Period 2|Physician Decision|0|||
131751422|NCT00318370|474366375|FG001|Period 2|Physician Decision|1|||
131751423|NCT00318370|474366376|FG002|Period 2|Physician Decision|0|||
131809428|NCT01705574|474586055|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
131751424|NCT00318370|474366374|FG000|Period 2|Withdrawal by Subject|0|||
131751425|NCT00318370|474366375|FG001|Period 2|Withdrawal by Subject|1|||
131751426|NCT00318370|474366376|FG002|Period 2|Withdrawal by Subject|0|||
131751427|NCT00318370|474366374|FG000|Period 2|Other|0|||
131751428|NCT00318370|474366375|FG001|Period 2|Other|1|||
131751429|NCT00318370|474366376|FG002|Period 2|Other|0|||
131751430|NCT00318370|474366374|FG000|Period 3|Adverse Event|0|||
131751431|NCT00318370|474366375|FG001|Period 3|Adverse Event|0|||
131751432|NCT00318370|474366376|FG002|Period 3|Adverse Event|1|||
131751433|NCT00318370|474366374|FG000|Period 3|Lack of Efficacy|0|||
131751434|NCT00318370|474366375|FG001|Period 3|Lack of Efficacy|0|||
131751435|NCT00318370|474366376|FG002|Period 3|Lack of Efficacy|24|||
131751436|NCT00318370|474366374|FG000|Period 3|Death|0|||
131751437|NCT00318370|474366375|FG001|Period 3|Death|0|||
131751438|NCT00318370|474366376|FG002|Period 3|Death|1|||
131751439|NCT00318370|474366374|FG000|Period 3|Physician Decision|0|||
131751440|NCT00318370|474366375|FG001|Period 3|Physician Decision|0|||
131751441|NCT00318370|474366376|FG002|Period 3|Physician Decision|1|||
131751442|NCT00318370|474366374|FG000|Period 3|Withdrawal by Subject|0|||
131751443|NCT00318370|474366375|FG001|Period 3|Withdrawal by Subject|0|||
131751444|NCT00318370|474366376|FG002|Period 3|Withdrawal by Subject|3|||
131751445|NCT00318370|474366374|FG000|Period 3|Other|0|||
131751446|NCT00318370|474366375|FG001|Period 3|Other|0|||
131751447|NCT00318370|474366376|FG002|Period 3|Other|3|||
131751448|NCT01750840|474366379|FG000|Overall Study|Lost to Follow-up|4|||
131751449|NCT00807014|474366380|FG000|Overall Study|Participant Considered Disease Cured|13|||
131751450|NCT00807014|474366381|FG001|Overall Study|Participant Considered Disease Cured|2|||
131751451|NCT00807014|474366380|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
131751452|NCT00807014|474366381|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
131751453|NCT00807014|474366380|FG000|Overall Study|Protocol Violation|2|||
131751454|NCT00807014|474366381|FG001|Overall Study|Protocol Violation|8|||
131751455|NCT00807014|474366380|FG000|Overall Study|Adverse Event|0|||
131751456|NCT00807014|474366381|FG001|Overall Study|Adverse Event|2|||
131751457|NCT00807014|474366380|FG000|Overall Study|Lost to Follow-up|9|||
131751458|NCT00807014|474366381|FG001|Overall Study|Lost to Follow-up|7|||
131751459|NCT00807014|474366380|FG000|Overall Study|Recovery|1|||
131751460|NCT00807014|474366381|FG001|Overall Study|Recovery|0|||
131751461|NCT00807014|474366380|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
131751462|NCT00807014|474366381|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
131751463|NCT00651313|474366382|FG000|Overall Study|Adverse Event|0|||
131751464|NCT00651313|474366383|FG001|Overall Study|Adverse Event|1|||
131751465|NCT00651313|474366382|FG000|Overall Study|Withdrawal by Subject|3|||
131751466|NCT00651313|474366383|FG001|Overall Study|Withdrawal by Subject|1|||
131751467|NCT00651313|474366382|FG000|Overall Study|Lost to Follow-up|1|||
131751468|NCT00651313|474366383|FG001|Overall Study|Lost to Follow-up|1|||
131751469|NCT00651313|474366382|FG000|Overall Study|Adminstrative Discontinuation|2|||
131751470|NCT00651313|474366383|FG001|Overall Study|Adminstrative Discontinuation|3|||
131751471|NCT02650895|474366384|FG000|Overall Study|Withdrawal by Subject|0|||
131751472|NCT02650895|474366385|FG001|Overall Study|Withdrawal by Subject|1|||
131751473|NCT02650895|474366386|FG002|Overall Study|Withdrawal by Subject|0|||
131751474|NCT02650895|474366387|FG003|Overall Study|Withdrawal by Subject|0|||
131751475|NCT02650895|474366388|FG004|Overall Study|Withdrawal by Subject|0|||
131751476|NCT02650895|474366389|FG005|Overall Study|Withdrawal by Subject|0|||
131751477|NCT03627494|474366390|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
131751478|NCT03627494|474366391|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751479|NCT03627494|474366392|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
131751480|NCT03627494|474366393|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751481|NCT03627494|474366394|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751482|NCT03627494|474366395|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751483|NCT03627494|474366396|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751484|NCT03627494|474366397|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751485|NCT03627494|474366398|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751486|NCT03627494|474366399|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751487|NCT03627494|474366400|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751488|NCT03627494|474366401|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
131751489|NCT03627494|474366390|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751490|NCT03627494|474366391|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751491|NCT03627494|474366392|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751492|NCT03627494|474366393|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751493|NCT03627494|474366394|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751494|NCT03627494|474366395|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751495|NCT03627494|474366396|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751496|NCT03627494|474366397|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751497|NCT03627494|474366398|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
131751498|NCT03627494|474366399|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751499|NCT03627494|474366400|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751500|NCT03627494|474366401|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
131751501|NCT03627494|474366390|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751502|NCT03627494|474366391|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751503|NCT03627494|474366392|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751504|NCT03627494|474366393|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751505|NCT03627494|474366394|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751506|NCT03627494|474366395|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751507|NCT03627494|474366396|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751508|NCT03627494|474366397|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751509|NCT03627494|474366398|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751510|NCT03627494|474366399|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
131751511|NCT03627494|474366400|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
131751512|NCT03627494|474366401|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
131751513|NCT00402285|474368040|FG000|Overall Study|insufficient RNA quality|7|||
131751514|NCT00402285|474368041|FG001|Overall Study|insufficient RNA quality|6|||
131751515|NCT00402285|474368042|FG002|Overall Study|insufficient RNA quality|2|||
131751516|NCT02431702|474368045|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
131751517|NCT02431702|474368046|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131751518|NCT02431702|474368047|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131751519|NCT02431702|474368048|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131751520|NCT02431702|474368049|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131751521|NCT02431702|474368050|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131751522|NCT02431702|474368051|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131751523|NCT02431702|474368045|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
131751524|NCT02431702|474368046|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131751525|NCT02431702|474368047|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131751526|NCT02431702|474368048|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131751527|NCT02431702|474368049|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131751528|NCT02431702|474368050|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131751529|NCT02431702|474368051|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
131751530|NCT02431702|474368045|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
131751531|NCT02431702|474368046|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131751532|NCT02431702|474368047|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131751533|NCT02431702|474368048|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131751534|NCT02431702|474368049|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131751535|NCT02431702|474368050|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131751536|NCT02431702|474368051|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
131751537|NCT02431702|474368045|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
131751538|NCT02431702|474368046|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131751539|NCT02431702|474368047|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131751540|NCT02431702|474368048|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131751541|NCT02431702|474368049|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131751542|NCT02431702|474368050|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131751543|NCT02431702|474368051|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
131751544|NCT02431702|474368045|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
131751545|NCT02431702|474368046|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131751546|NCT02431702|474368047|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131751547|NCT02431702|474368048|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131751548|NCT02431702|474368049|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131751549|NCT02431702|474368050|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131751550|NCT02431702|474368051|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131751551|NCT02431702|474368045|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131751552|NCT02431702|474368046|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
131751553|NCT02431702|474368047|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
131751554|NCT02431702|474368048|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131751555|NCT02431702|474368049|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131809429|NCT01705574|474586052|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
131809430|NCT01705574|474586053|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
131809431|NCT01705574|474586054|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
131809432|NCT01705574|474586055|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
131809433|NCT01705574|474586052|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
131809434|NCT01705574|474586053|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
131809435|NCT01705574|474586054|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
131809436|NCT01705574|474586055|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
131809437|NCT01705574|474586052|FG000|Open-Label Extension Phase|Adverse Event|3|||
131809438|NCT01705574|474586053|FG001|Open-Label Extension Phase|Adverse Event|0|||
131809439|NCT01705574|474586054|FG002|Open-Label Extension Phase|Adverse Event|0|||
131809440|NCT01705574|474586055|FG003|Open-Label Extension Phase|Adverse Event|1|||
131751556|NCT02431702|474368050|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131751557|NCT02431702|474368051|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131751558|NCT02431702|474368045|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131751559|NCT02431702|474368046|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
131751560|NCT02431702|474368047|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
131751561|NCT02431702|474368048|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131751562|NCT02431702|474368049|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131751563|NCT02431702|474368050|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131751564|NCT02431702|474368051|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131751565|NCT02431702|474368045|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131751566|NCT02431702|474368046|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
131751567|NCT02431702|474368047|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
131751568|NCT02431702|474368048|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131751569|NCT02431702|474368049|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131751570|NCT02431702|474368050|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131751571|NCT02431702|474368051|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131751572|NCT02431702|474368045|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131751573|NCT02431702|474368046|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
131751574|NCT02431702|474368047|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131751575|NCT02431702|474368048|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131751576|NCT02431702|474368049|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131751577|NCT02431702|474368050|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131751578|NCT02431702|474368051|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131751579|NCT02431702|474368045|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
131751580|NCT02431702|474368046|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
131751581|NCT02431702|474368047|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
131751582|NCT02431702|474368048|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
131751583|NCT02431702|474368049|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
131751584|NCT02431702|474368050|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
131751585|NCT02431702|474368051|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
131751586|NCT02431702|474368045|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131751587|NCT02431702|474368046|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131751588|NCT02431702|474368047|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
131751589|NCT02431702|474368048|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131751590|NCT02431702|474368049|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131751591|NCT02431702|474368050|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131751592|NCT02431702|474368051|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131751593|NCT02431702|474368045|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131751594|NCT02431702|474368046|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131751595|NCT02431702|474368047|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131751596|NCT02431702|474368048|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
131751597|NCT02431702|474368049|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
131751598|NCT02431702|474368050|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131751599|NCT02431702|474368051|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131751600|NCT02431702|474368045|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131751601|NCT02431702|474368046|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131751602|NCT02431702|474368047|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131751603|NCT02431702|474368048|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
131751604|NCT02431702|474368049|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131751605|NCT02431702|474368050|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
131751606|NCT02431702|474368051|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131751607|NCT02431702|474368045|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131751608|NCT02431702|474368046|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131751609|NCT02431702|474368047|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131751610|NCT02431702|474368048|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
131809441|NCT01705574|474586052|FG000|Open-Label Extension Phase|Death|2|||
131809442|NCT01705574|474586053|FG001|Open-Label Extension Phase|Death|0|||
131809443|NCT01705574|474586054|FG002|Open-Label Extension Phase|Death|1|||
131809444|NCT01705574|474586055|FG003|Open-Label Extension Phase|Death|0|||
131809445|NCT01705574|474586052|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
131809446|NCT01705574|474586053|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
131809447|NCT01705574|474586054|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
131809448|NCT01705574|474586055|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
131751611|NCT02431702|474368049|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
131751612|NCT02431702|474368050|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
131751613|NCT02431702|474368051|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131751614|NCT02431702|474368045|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
131751615|NCT02431702|474368046|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
131751616|NCT02431702|474368047|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
131751617|NCT02431702|474368048|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
131751618|NCT02431702|474368049|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
131751619|NCT02431702|474368050|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
131751620|NCT02431702|474368051|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
131751621|NCT02009930|474368052|FG000|Overall Study|withdrawn|5|||
131751622|NCT02959970|474368056|FG000|Overall Study|Adverse Event|1|||
131751623|NCT02959970|474368057|FG001|Overall Study|Adverse Event|0|||
131751624|NCT02959970|474368056|FG000|Overall Study|Withdrawal by Subject|0|||
131751625|NCT02959970|474368057|FG001|Overall Study|Withdrawal by Subject|2|||
131751626|NCT02959970|474368056|FG000|Overall Study|Lost to Follow-up|1|||
131751627|NCT02959970|474368057|FG001|Overall Study|Lost to Follow-up|5|||
131751628|NCT00693420|474368058|FG000|Overall Study|Adverse Event|4|||
131751629|NCT00693420|474368059|FG001|Overall Study|Adverse Event|4|||
131751630|NCT00693420|474368058|FG000|Overall Study|Lost to Follow-up|0|||
131751631|NCT00693420|474368059|FG001|Overall Study|Lost to Follow-up|3|||
131751632|NCT00693420|474368058|FG000|Overall Study|Withdrawal by Subject|1|||
131751633|NCT00693420|474368059|FG001|Overall Study|Withdrawal by Subject|0|||
131751634|NCT00693420|474368058|FG000|Overall Study|Protocol Violation|0|||
131751635|NCT00693420|474368059|FG001|Overall Study|Protocol Violation|2|||
131751636|NCT00693420|474368058|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
131751637|NCT00693420|474368059|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
131751638|NCT00693420|474368058|FG000|Overall Study|Personal Reasons|1|||
131751639|NCT00693420|474368059|FG001|Overall Study|Personal Reasons|4|||
131751640|NCT03250624|474368062|FG000|Overall Study|Lack of Efficacy|1|||
131751641|NCT03250624|474368063|FG001|Overall Study|Lack of Efficacy|4|||
131751642|NCT03250624|474368062|FG000|Overall Study|Adverse Event|0|||
131751643|NCT03250624|474368063|FG001|Overall Study|Adverse Event|1|||
131751644|NCT03250624|474368062|FG000|Overall Study|Other|1|||
131751645|NCT03250624|474368063|FG001|Overall Study|Other|2|||
131751646|NCT00948428|474368067|FG000|Overall Study|Withdrawal by Subject|6|||
131751647|NCT00948428|474368068|FG001|Overall Study|Withdrawal by Subject|12|||
131751648|NCT00948428|474368069|FG002|Overall Study|Withdrawal by Subject|7|||
131751649|NCT00948428|474368067|FG000|Overall Study|Adverse Event|6|||
131751650|NCT00948428|474368068|FG001|Overall Study|Adverse Event|3|||
131751651|NCT00948428|474368069|FG002|Overall Study|Adverse Event|0|||
131751652|NCT00948428|474368067|FG000|Overall Study|Lost to Follow-up|2|||
131751653|NCT00948428|474368068|FG001|Overall Study|Lost to Follow-up|1|||
131751654|NCT00948428|474368069|FG002|Overall Study|Lost to Follow-up|1|||
131449231|NCT02118961|473274816|FG000|Overall Study|Withdrawal by Subject|1|||
131449232|NCT02118961|473274817|FG001|Overall Study|Withdrawal by Subject|0|||
131449233|NCT01657019|473274818|FG000|Overall Study|Withdrawal by Subject|65|||
131449234|NCT01657019|473274818|FG000|Overall Study|Adverse Event|55|||
131449235|NCT01657019|473274818|FG000|Overall Study|Lost to Follow-up|48|||
131449236|NCT01657019|473274818|FG000|Overall Study|Protocol Violation|6|||
131449237|NCT01657019|473274818|FG000|Overall Study|Lack of Efficacy|3|||
131449238|NCT01657019|473274818|FG000|Overall Study|Other|58|||
131449239|NCT03126591|473274819|FG000|Overall Study|Death|6|||
131449240|NCT03126591|473274820|FG001|Overall Study|Death|3|||
131449241|NCT03126591|473274821|FG002|Overall Study|Death|17|||
131449242|NCT03126591|473274819|FG000|Overall Study|Progressive Disease|0|||
131449243|NCT03126591|473274820|FG001|Overall Study|Progressive Disease|1|||
131449244|NCT03126591|473274821|FG002|Overall Study|Progressive Disease|2|||
131449245|NCT03126591|473274819|FG000|Overall Study|Terminated by Sponsor|0|||
131751655|NCT00948428|474368067|FG000|Overall Study|Death|2|||
131751656|NCT00948428|474368068|FG001|Overall Study|Death|0|||
131751657|NCT00948428|474368069|FG002|Overall Study|Death|0|||
131751658|NCT00948428|474368067|FG000|Overall Study|Intercurrent Illness|1|||
131809449|NCT01705574|474586052|FG000|Open-Label Extension Phase|Physician Decision|0|||
131809450|NCT01705574|474586053|FG001|Open-Label Extension Phase|Physician Decision|0|||
131449246|NCT03126591|473274820|FG001|Overall Study|Terminated by Sponsor|1|||
131449247|NCT03126591|473274821|FG002|Overall Study|Terminated by Sponsor|4|||
131751659|NCT00948428|474368068|FG001|Overall Study|Intercurrent Illness|0|||
131751660|NCT00948428|474368069|FG002|Overall Study|Intercurrent Illness|0|||
131751661|NCT00948428|474368067|FG000|Overall Study|Non-compliance|1|||
131751662|NCT00948428|474368068|FG001|Overall Study|Non-compliance|2|||
131751663|NCT00948428|474368069|FG002|Overall Study|Non-compliance|0|||
131449248|NCT03126591|473274819|FG000|Overall Study|Withdrawal by Subject|1|||
131751664|NCT00509028|474368070|FG000|Overall Study|Adverse Event|2|||
131449249|NCT03126591|473274820|FG001|Overall Study|Withdrawal by Subject|1|||
131449250|NCT03126591|473274821|FG002|Overall Study|Withdrawal by Subject|4|||
131449251|NCT02158546|473274822|FG000|Overall Study|Physician Decision|0|||
131809451|NCT01705574|474586054|FG002|Open-Label Extension Phase|Physician Decision|2|||
131809452|NCT01705574|474586055|FG003|Open-Label Extension Phase|Physician Decision|0|||
131809453|NCT01705574|474586052|FG000|Open-Label Extension Phase|Pregnancy|0|||
131809454|NCT01705574|474586053|FG001|Open-Label Extension Phase|Pregnancy|0|||
131809455|NCT01705574|474586054|FG002|Open-Label Extension Phase|Pregnancy|1|||
131809456|NCT01705574|474586055|FG003|Open-Label Extension Phase|Pregnancy|1|||
131809457|NCT00777023|474586056|FG000|Overall Study|Adverse Event|15|||
131809458|NCT00777023|474586057|FG001|Overall Study|Adverse Event|21|||
131809459|NCT00777023|474586058|FG002|Overall Study|Adverse Event|8|||
131809460|NCT00777023|474586056|FG000|Overall Study|Lack of Efficacy|1|||
131809461|NCT00777023|474586057|FG001|Overall Study|Lack of Efficacy|0|||
131809462|NCT00777023|474586058|FG002|Overall Study|Lack of Efficacy|14|||
131809463|NCT00777023|474586056|FG000|Overall Study|Protocol Violation|2|||
131809464|NCT00777023|474586057|FG001|Overall Study|Protocol Violation|1|||
131809465|NCT00777023|474586058|FG002|Overall Study|Protocol Violation|1|||
131809466|NCT00777023|474586056|FG000|Overall Study|Lost to Follow-up|2|||
131809467|NCT00777023|474586057|FG001|Overall Study|Lost to Follow-up|3|||
131809468|NCT00777023|474586058|FG002|Overall Study|Lost to Follow-up|3|||
131809469|NCT00777023|474586056|FG000|Overall Study|Death|0|||
131809470|NCT00777023|474586057|FG001|Overall Study|Death|1|||
131809471|NCT00777023|474586058|FG002|Overall Study|Death|0|||
131809472|NCT00777023|474586056|FG000|Overall Study|Withdrawal by Subject|7|||
131809473|NCT00777023|474586057|FG001|Overall Study|Withdrawal by Subject|7|||
131809474|NCT00777023|474586058|FG002|Overall Study|Withdrawal by Subject|8|||
131809475|NCT00777023|474586056|FG000|Overall Study|Missing data|1|||
131809476|NCT00777023|474586057|FG001|Overall Study|Missing data|1|||
131809477|NCT00777023|474586058|FG002|Overall Study|Missing data|0|||
131809478|NCT00777023|474586056|FG000|Overall Study|Reasons not specified|4|||
131809479|NCT00777023|474586057|FG001|Overall Study|Reasons not specified|4|||
131809480|NCT00777023|474586058|FG002|Overall Study|Reasons not specified|2|||
131809481|NCT00777023|474586056|FG000|Overall Study|Last dose date unknown|3|||
131809482|NCT00777023|474586057|FG001|Overall Study|Last dose date unknown|3|||
131809483|NCT00777023|474586058|FG002|Overall Study|Last dose date unknown|1|||
131809484|NCT02659150|474586061|FG000|Subject Enrollment|Physician Decision|3|||
131809485|NCT02659150|474586061|FG000|Subject Enrollment|Withdrawal by Subject|2|||
131809486|NCT02659150|474586061|FG000|Baseline Imaging|Withdrawal by Subject|1|||
131809487|NCT02659150|474586061|FG000|Baseline Imaging|Physician Decision|1|||
131809488|NCT02659150|474586061|FG000|Study Drug Dosing|Adverse Event|1|||
131809489|NCT00448019|474586062|FG000|Overall Study|Withdrawal by Subject|3|||
131809490|NCT00448019|474586062|FG000|Overall Study|Disease progression|1|||
131809491|NCT00448019|474586062|FG000|Overall Study|Death|2|||
131809492|NCT00448019|474586062|FG000|Overall Study|Insurance Issues|1|||
131809493|NCT00089661|474586063|FG000|Overall Study|Adverse Event|0|||
131809494|NCT00089661|474586064|FG001|Overall Study|Adverse Event|2|||
131809495|NCT00089661|474586063|FG000|Overall Study|Death|1|||
131809496|NCT00089661|474586064|FG001|Overall Study|Death|0|||
131809497|NCT00089661|474586063|FG000|Overall Study|Lost to Follow-up|0|||
131809498|NCT00089661|474586064|FG001|Overall Study|Lost to Follow-up|3|||
131809499|NCT00089661|474586063|FG000|Overall Study|Withdrawal by Subject|11|||
131809500|NCT00089661|474586064|FG001|Overall Study|Withdrawal by Subject|9|||
131809501|NCT00089661|474586063|FG000|Overall Study|Disease progression|1|||
131809502|NCT00089661|474586064|FG001|Overall Study|Disease progression|3|||
131809503|NCT00089661|474586063|FG000|Overall Study|Ineligibility determined|4|||
131809504|NCT00089661|474586064|FG001|Overall Study|Ineligibility determined|4|||
131809505|NCT00089661|474586063|FG000|Overall Study|Noncompliance|2|||
131809506|NCT00089661|474586064|FG001|Overall Study|Noncompliance|4|||
131809507|NCT00089661|474586063|FG000|Overall Study|Other|2|||
131809508|NCT00089661|474586064|FG001|Overall Study|Other|1|||
131809509|NCT02647944|474586065|FG000|Overall Study|Withdrawal by Subject|0|||
131809510|NCT02647944|474586066|FG001|Overall Study|Withdrawal by Subject|3|||
131809511|NCT02647944|474586065|FG000|Overall Study|Adverse Event|2|||
131809512|NCT02647944|474586066|FG001|Overall Study|Adverse Event|0|||
131809513|NCT02760368|474586068|FG000|Overall Study|Withdrawal by Subject|8|||
131809514|NCT02760368|474586069|FG001|Overall Study|Withdrawal by Subject|12|||
131809515|NCT02760368|474586070|FG002|Overall Study|Withdrawal by Subject|9|||
131809516|NCT02760368|474586068|FG000|Overall Study|Screen Failure|0|||
131809517|NCT02760368|474586069|FG001|Overall Study|Screen Failure|0|||
131809518|NCT02760368|474586070|FG002|Overall Study|Screen Failure|1|||
131809519|NCT02760368|474586068|FG000|Overall Study|Death|0|||
131809520|NCT02760368|474586069|FG001|Overall Study|Death|1|||
131809521|NCT02760368|474586070|FG002|Overall Study|Death|0|||
131809522|NCT02760368|474586068|FG000|Overall Study|Withdrawal by Sponsor|0|||
131906627|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
131906628|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
131906629|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
131906630|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
131906631|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
131906632|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
131906633|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
131906634|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
131906635|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
131906636|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
131906637|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
131751665|NCT00509028|474368071|FG001|Overall Study|Adverse Event|0|||
131751666|NCT00509028|474368070|FG000|Overall Study|Withdrawal by Subject|4|||
131751667|NCT00509028|474368071|FG001|Overall Study|Withdrawal by Subject|3|||
131751668|NCT00509028|474368070|FG000|Overall Study|Lost to Follow-up|0|||
131751669|NCT00509028|474368071|FG001|Overall Study|Lost to Follow-up|1|||
131751670|NCT00509028|474368070|FG000|Overall Study|Protocol Violation|4|||
131751671|NCT00509028|474368071|FG001|Overall Study|Protocol Violation|2|||
131751672|NCT00509028|474368070|FG000|Overall Study|Non-compliance|2|||
131751673|NCT00509028|474368071|FG001|Overall Study|Non-compliance|1|||
131751674|NCT02471586|474368072|FG000|Overall Study|Lost to Follow-up|3|||
131751675|NCT02471586|474368073|FG001|Overall Study|Lost to Follow-up|8|||
131751676|NCT02471586|474368074|FG002|Overall Study|Lost to Follow-up|4|||
131751677|NCT02471586|474368072|FG000|Overall Study|Death|2|||
131906638|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
131906639|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
131906640|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
131906641|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
131906642|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
131906643|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
131906644|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
131906645|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
131906646|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
131906647|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
131906648|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
131906649|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
131906650|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
131906651|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
131906652|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
131906653|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
131906654|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
131906655|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
131906656|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
131906657|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
131906658|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
131906659|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
131906660|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
131906661|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
131906662|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
131906663|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
131906664|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
131906665|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
131906666|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
131906667|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
131906668|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
131906669|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
131906670|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
131906671|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
131906672|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
131906673|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
131906674|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
131906675|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
131906676|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
131906677|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
131906678|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
131906679|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
131906680|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
131906681|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
131906682|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
131906683|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
131906684|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
131906685|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
131906686|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
131751678|NCT02471586|474368073|FG001|Overall Study|Death|2|||
131751679|NCT02471586|474368074|FG002|Overall Study|Death|0|||
131751680|NCT00369278|474368077|FG000|Overall Study|Adverse Event|14|||
131751681|NCT00369278|474368078|FG001|Overall Study|Adverse Event|11|||
131751682|NCT00369278|474368077|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131906687|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
131906688|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
131751683|NCT00369278|474368078|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
131751684|NCT00369278|474368077|FG000|Overall Study|Protocol Violation|2|||
131751685|NCT00369278|474368078|FG001|Overall Study|Protocol Violation|1|||
131751686|NCT00369278|474368077|FG000|Overall Study|Withdrawal by Subject|2|||
131751687|NCT00369278|474368078|FG001|Overall Study|Withdrawal by Subject|2|||
131751688|NCT00369278|474368077|FG000|Overall Study|Lost to Follow-up|1|||
131751689|NCT00369278|474368078|FG001|Overall Study|Lost to Follow-up|0|||
131751690|NCT00369278|474368077|FG000|Overall Study|Graft loss|1|||
131751691|NCT00369278|474368078|FG001|Overall Study|Graft loss|2|||
131751692|NCT02873208|474368079|FG000|Overall Study|Withdrawal by Subject|36|||
131751693|NCT02873208|474368079|FG000|Overall Study|Lost to Follow-up|22|||
131906689|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
131906690|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
131906691|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
131906692|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
131906693|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
131906694|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
131906695|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
131906696|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
131751694|NCT02873208|474368079|FG000|Overall Study|Adverse Event|15|||
131751695|NCT02873208|474368079|FG000|Overall Study|Non-compliance with study drug|12|||
131751696|NCT02873208|474368079|FG000|Overall Study|Protocol Violation|8|||
131906697|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
131751697|NCT02873208|474368079|FG000|Overall Study|Pregnancy|2|||
131751698|NCT02873208|474368079|FG000|Overall Study|Incarceration|1|||
131751699|NCT02873208|474368079|FG000|Overall Study|Lack of Efficacy|1|||
131751700|NCT02873208|474368079|FG000|Overall Study|Physician Decision|1|||
131751701|NCT01585168|474368080|FG000|Overall Study|Lost to Follow-up|3|||
131751702|NCT01585168|474368081|FG001|Overall Study|Lost to Follow-up|1|||
131751703|NCT01585168|474368082|FG002|Overall Study|Lost to Follow-up|1|||
131751704|NCT01585168|474368083|FG003|Overall Study|Lost to Follow-up|1|||
131751705|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
131751706|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
131751707|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
131751708|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
131751709|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
131751710|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
131751711|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
131751712|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
131751713|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
131751714|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
131751715|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
131809523|NCT02760368|474586069|FG001|Overall Study|Withdrawal by Sponsor|0|||
131809524|NCT02760368|474586070|FG002|Overall Study|Withdrawal by Sponsor|1|||
131809525|NCT02714062|474586071|FG000|Overall Study|Adverse Event|0|||
131809526|NCT02714062|474586072|FG001|Overall Study|Adverse Event|0|||
131809527|NCT02714062|474586073|FG002|Overall Study|Adverse Event|2|||
131809528|NCT02714062|474586071|FG000|Overall Study|Withdrawal by Subject|1|||
131809529|NCT02714062|474586072|FG001|Overall Study|Withdrawal by Subject|0|||
131809530|NCT02714062|474586073|FG002|Overall Study|Withdrawal by Subject|1|||
131809531|NCT02714062|474586071|FG000|Overall Study|Protocol Violation|0|||
131809532|NCT02714062|474586072|FG001|Overall Study|Protocol Violation|1|||
131809533|NCT02714062|474586073|FG002|Overall Study|Protocol Violation|0|||
131809534|NCT02294604|474586074|FG000|Overall Study|Did not provide samples for culture|0|||
131809535|NCT02294604|474586075|FG001|Overall Study|Did not provide samples for culture|1|||
131809536|NCT02294604|474586076|FG002|Overall Study|Did not provide samples for culture|0|||
131809537|NCT02294604|474586074|FG000|Overall Study|Culture contamination|1|||
131809538|NCT02294604|474586075|FG001|Overall Study|Culture contamination|2|||
131809539|NCT02294604|474586076|FG002|Overall Study|Culture contamination|0|||
131809540|NCT02902211|474586081|FG000|First Three Months|Withdrawal by Subject|7|||
131809541|NCT02902211|474586082|FG001|First Three Months|Withdrawal by Subject|3|||
131809542|NCT01200810|474586092|FG000|Overall Study|Physician Decision|1|||
131809543|NCT01200810|474586093|FG001|Overall Study|Physician Decision|0|||
131809544|NCT01200810|474586092|FG000|Overall Study|Withdrawal by Subject|1|||
131809545|NCT01200810|474586093|FG001|Overall Study|Withdrawal by Subject|2|||
131809546|NCT01200810|474586092|FG000|Overall Study|Sponsor stopped making study drug|3|||
131809547|NCT01200810|474586093|FG001|Overall Study|Sponsor stopped making study drug|3|||
131809548|NCT00003659|474586095|FG000|Overall Study|Withdrawal by Subject|3|||
131809549|NCT04022954|474586096|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
131809550|NCT04022954|474586096|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
131809551|NCT04022954|474586096|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
131809552|NCT03017885|474586097|FG000|Overall Study|Adverse Event|2|||
131809553|NCT03017885|474586098|FG001|Overall Study|Adverse Event|0|||
131809554|NCT03017885|474586099|FG002|Overall Study|Adverse Event|0|||
131809555|NCT03017885|474586100|FG003|Overall Study|Adverse Event|0|||
131809556|NCT03017885|474586101|FG004|Overall Study|Adverse Event|0|||
131809557|NCT03017885|474586102|FG005|Overall Study|Adverse Event|0|||
131809558|NCT03017885|474586097|FG000|Overall Study|Progression of disease|4|||
131906698|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
131751716|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
131809559|NCT03017885|474586098|FG001|Overall Study|Progression of disease|3|||
131809560|NCT03017885|474586099|FG002|Overall Study|Progression of disease|4|||
131809561|NCT03017885|474586100|FG003|Overall Study|Progression of disease|0|||
131809562|NCT03017885|474586101|FG004|Overall Study|Progression of disease|0|||
131809563|NCT03017885|474586102|FG005|Overall Study|Progression of disease|0|||
131809564|NCT03017885|474586097|FG000|Overall Study|Other than listed|1|||
131809565|NCT03017885|474586098|FG001|Overall Study|Other than listed|2|||
131809566|NCT03017885|474586099|FG002|Overall Study|Other than listed|1|||
131809567|NCT03017885|474586100|FG003|Overall Study|Other than listed|0|||
131809568|NCT03017885|474586101|FG004|Overall Study|Other than listed|0|||
131751717|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
131751718|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
131751719|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
131751720|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
131751721|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
131751722|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
131751723|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
131751724|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
131751725|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
131751726|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
131751727|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
131751728|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
131751729|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Other|0|||
131751730|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Other|1|||
131751731|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Other|0|||
131751732|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Other|0|||
131751733|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
131751734|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
131751735|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
131751736|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
131751737|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
131751738|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
131751739|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
131751740|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
131751741|NCT01194414|474368084|FG000|24 Weeks Double Blind Period|Death|0|||
131751742|NCT01194414|474368085|FG001|24 Weeks Double Blind Period|Death|1|||
131751743|NCT01194414|474368086|FG002|24 Weeks Double Blind Period|Death|0|||
131751744|NCT01194414|474368087|FG003|24 Weeks Double Blind Period|Death|0|||
131751745|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
131751746|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
131751747|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
131751748|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
131751749|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
131751750|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
131751751|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
131751752|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
131751753|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
131751754|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
131751755|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
131751756|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
131751757|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
131751758|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
131751759|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
131751760|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
131751761|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
131751762|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
131751763|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
131751764|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
131751765|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
131751766|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
131751767|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
131751768|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
131751769|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Other|2|||
131751770|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Other|1|||
131751771|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Other|0|||
131751772|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Other|0|||
131751773|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
131751774|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
131751775|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
131751776|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
131751777|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
131751778|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
131751779|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
131751780|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
131751781|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
131751782|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
131751783|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
131751784|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
131751785|NCT01194414|474368084|FG000|72 Weeks Open Label Extension|Death|1|||
131751786|NCT01194414|474368085|FG001|72 Weeks Open Label Extension|Death|2|||
131751787|NCT01194414|474368086|FG002|72 Weeks Open Label Extension|Death|0|||
131751788|NCT01194414|474368087|FG003|72 Weeks Open Label Extension|Death|2|||
131751789|NCT04737759|474368094|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
131751790|NCT04737759|474368095|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
131751791|NCT04737759|474368094|FG000|Overall Study|Death|2|||
131751792|NCT04737759|474368095|FG001|Overall Study|Death|0|||
131751793|NCT04737759|474368094|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
131751794|NCT04737759|474368095|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
131751795|NCT04737759|474368094|FG000|Overall Study|Lost to Follow-up|4|||
131751796|NCT04737759|474368095|FG001|Overall Study|Lost to Follow-up|12|||
131751797|NCT01505114|474368104|FG000|Overall Study|Withdrawal by Subject|5|||
131751798|NCT01505114|474368105|FG001|Overall Study|Withdrawal by Subject|4|||
131751799|NCT01505114|474368106|FG002|Overall Study|Withdrawal by Subject|4|||
131751800|NCT01505114|474368107|FG003|Overall Study|Withdrawal by Subject|7|||
131751801|NCT01505114|474368104|FG000|Overall Study|Death|1|||
131751802|NCT01505114|474368105|FG001|Overall Study|Death|0|||
131751803|NCT01505114|474368106|FG002|Overall Study|Death|0|||
131751804|NCT01505114|474368107|FG003|Overall Study|Death|1|||
131751805|NCT01505114|474368104|FG000|Overall Study|unable to adhere to visit schedule|3|||
131751806|NCT01505114|474368105|FG001|Overall Study|unable to adhere to visit schedule|2|||
131751807|NCT01505114|474368106|FG002|Overall Study|unable to adhere to visit schedule|3|||
131751808|NCT01505114|474368107|FG003|Overall Study|unable to adhere to visit schedule|3|||
131751809|NCT01505114|474368104|FG000|Overall Study|Lost to Follow-up|11|||
131751810|NCT01505114|474368105|FG001|Overall Study|Lost to Follow-up|5|||
131751811|NCT01505114|474368106|FG002|Overall Study|Lost to Follow-up|8|||
131751812|NCT01505114|474368107|FG003|Overall Study|Lost to Follow-up|7|||
131751813|NCT01505114|474368104|FG000|Overall Study|relocated|4|||
131751814|NCT01505114|474368105|FG001|Overall Study|relocated|2|||
131751815|NCT01505114|474368106|FG002|Overall Study|relocated|2|||
131751816|NCT01505114|474368107|FG003|Overall Study|relocated|3|||
131751817|NCT01505114|474368104|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
131751818|NCT01505114|474368105|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
131751819|NCT01505114|474368106|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
131751820|NCT01505114|474368107|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
131751821|NCT01505114|474368104|FG000|Overall Study|staff safety concerns|0|||
131751822|NCT01505114|474368105|FG001|Overall Study|staff safety concerns|0|||
131751823|NCT01505114|474368106|FG002|Overall Study|staff safety concerns|0|||
131751824|NCT01505114|474368107|FG003|Overall Study|staff safety concerns|1|||
131751825|NCT01505114|474368104|FG000|Overall Study|investigator decision|1|||
131751826|NCT01505114|474368105|FG001|Overall Study|investigator decision|0|||
131751827|NCT01505114|474368106|FG002|Overall Study|investigator decision|1|||
131751828|NCT01505114|474368107|FG003|Overall Study|investigator decision|0|||
131751829|NCT03168555|474368108|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
131751830|NCT03168555|474368108|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
131751831|NCT03168555|474368108|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
131751832|NCT03168555|474368108|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
131751833|NCT01040845|474368109|FG000|Overall Study|Withdrawal by Subject|1|||
131751834|NCT01040845|474368110|FG001|Overall Study|Withdrawal by Subject|1|||
131751835|NCT01040845|474368109|FG000|Overall Study|Physician Decision|1|||
131751836|NCT01040845|474368110|FG001|Overall Study|Physician Decision|0|||
131751837|NCT04445688|474368116|FG000|Washout (One Week)|Adverse Event|2|||
131751838|NCT04445688|474368116|FG000|Washout (One Week)|Withdrawal by Subject|1|||
131751839|NCT01235507|474368118|FG000|Overall Study|Adverse Event|1|||
131809569|NCT03017885|474586102|FG005|Overall Study|Other than listed|0|||
131809570|NCT03017885|474586097|FG000|Overall Study|Lost to Follow-up|2|||
131809571|NCT03017885|474586098|FG001|Overall Study|Lost to Follow-up|0|||
131809572|NCT03017885|474586099|FG002|Overall Study|Lost to Follow-up|3|||
131809573|NCT03017885|474586100|FG003|Overall Study|Lost to Follow-up|0|||
131809574|NCT03017885|474586101|FG004|Overall Study|Lost to Follow-up|0|||
131809575|NCT03017885|474586102|FG005|Overall Study|Lost to Follow-up|0|||
131809576|NCT03017885|474586097|FG000|Overall Study|Change to other anti-cancer therapy|0|||
131809577|NCT03017885|474586098|FG001|Overall Study|Change to other anti-cancer therapy|0|||
131809578|NCT03017885|474586099|FG002|Overall Study|Change to other anti-cancer therapy|1|||
131751840|NCT01235507|474368118|FG000|Overall Study|Withdrawal by Subject|1|||
131906699|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
131906700|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
131906701|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
131906702|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
131906703|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
131906704|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
131906705|NCT01791595|474945227|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
131751841|NCT02017704|474368124|FG000|Overall Study|Withdrawal by Subject|2|||
131751842|NCT02017704|474368125|FG001|Overall Study|Withdrawal by Subject|0|||
131751843|NCT01587274|474368126|FG000|Overall Study|Lost to Follow-up|4|||
131751844|NCT01587274|474368127|FG001|Overall Study|Lost to Follow-up|5|||
131751845|NCT01587274|474368128|FG002|Overall Study|Lost to Follow-up|3|||
131751846|NCT00918346|474368129|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
131751847|NCT00918346|474368130|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
131751848|NCT02475629|474368131|FG000|Overall Study|Adverse Event|1|||
131751849|NCT02475629|474368131|FG000|Overall Study|Death|4|||
131751850|NCT02475629|474368131|FG000|Overall Study|Physician Decision|1|||
131751851|NCT02475629|474368131|FG000|Overall Study|Withdrawal by Subject|1|||
131751852|NCT02475629|474368131|FG000|Overall Study|Lost to Follow-up|1|||
131751853|NCT02475629|474368131|FG000|Overall Study|Subject non-compliance|1|||
131751854|NCT01421069|474368132|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
131751855|NCT01421069|474368132|FG000|Parent Study|Failed to return|3|||
131751856|NCT01421069|474368132|FG000|Parent Study|Withdrawal by Subject|1|||
131751857|NCT01421069|474368132|FG000|Parent Study|Lost to Follow-up|2|||
131751858|NCT01421069|474368132|FG000|Parent Study|Lack of Efficacy|1|||
131751859|NCT01421069|474368132|FG000|Overall Period for Extension Study|Other|2|||
131751860|NCT01421069|474368132|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
131751861|NCT01421069|474368132|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
131751862|NCT01421069|474368132|FG000|Overall Period for Extension Study|Pregnancy|1|||
131751863|NCT01421069|474368132|FG000|Overall Period for Extension Study|Adverse Event|1|||
131751864|NCT01421069|474368132|FG000|Overall Period for Extension Study|Protocol Violation|1|||
131751865|NCT01421069|474368132|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
131751866|NCT01421069|474368132|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
131751867|NCT01421069|474368132|FG000|Active Treatment Period|Other|1|||
131751868|NCT01421069|474368132|FG000|Active Treatment Period|No longer willing to participate in study|8|||
131751869|NCT01421069|474368132|FG000|Active Treatment Period|Insufficient clinical response|1|||
131809579|NCT03017885|474586100|FG003|Overall Study|Change to other anti-cancer therapy|0|||
131809580|NCT03017885|474586101|FG004|Overall Study|Change to other anti-cancer therapy|0|||
131809581|NCT03017885|474586102|FG005|Overall Study|Change to other anti-cancer therapy|0|||
131809582|NCT00984126|474586106|FG000|Overall Study|Protocol Violation|0|||
131809583|NCT00984126|474586107|FG001|Overall Study|Protocol Violation|0|||
131809584|NCT00984126|474586108|FG002|Overall Study|Protocol Violation|1|||
131809585|NCT00984126|474586109|FG003|Overall Study|Protocol Violation|2|||
131809586|NCT00984126|474586106|FG000|Overall Study|Adverse Event|0|||
131809587|NCT00984126|474586107|FG001|Overall Study|Adverse Event|0|||
131809588|NCT00984126|474586108|FG002|Overall Study|Adverse Event|0|||
131809589|NCT00984126|474586109|FG003|Overall Study|Adverse Event|2|||
131751870|NCT01421069|474368132|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
131809590|NCT00984126|474586106|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
131809591|NCT00984126|474586107|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
131906706|NCT01791595|474945228|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
131906707|NCT01791595|474945229|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
131906708|NCT01791595|474945230|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
131906709|NCT01791595|474945231|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
131906710|NCT01791595|474945232|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
131906711|NCT01791595|474945233|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
131906712|NCT01791595|474945227|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
131906713|NCT01791595|474945228|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
131906714|NCT01791595|474945229|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
131906715|NCT01791595|474945230|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
131906716|NCT01791595|474945231|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
131906717|NCT01791595|474945232|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
131906718|NCT01791595|474945233|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
131906719|NCT01791595|474945227|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
131906720|NCT01791595|474945228|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
131906721|NCT01791595|474945229|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
131906722|NCT01791595|474945230|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
131906723|NCT01791595|474945231|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
131906724|NCT01791595|474945232|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
131906725|NCT01791595|474945233|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
131751871|NCT01421069|474368132|FG000|Active Treatment Period|Pregnancy|1|||
131751872|NCT01421069|474368132|FG000|Active Treatment Period|Adverse Event|1|||
131751873|NCT01421069|474368132|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
131751874|NCT01421069|474368132|FG000|Active Treatment Period|Enrolled in observational period|29|||
131751875|NCT01421069|474368132|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
131751876|NCT01421069|474368132|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
131751877|NCT01421069|474368132|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
131751878|NCT01421069|474368132|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
131751879|NCT01421069|474368132|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
131751880|NCT01421069|474368132|FG000|2b. Retreatment Period|Protocol Violation|1|||
131751881|NCT01421069|474368132|FG000|Observational Period|Other|1|||
131751882|NCT01421069|474368132|FG000|Observational Period|No longer willing to participate in study|4|||
131751883|NCT01421069|474368132|FG000|Observational Period|Lost to Follow-up|3|||
131751884|NCT01641081|474368138|FG000|Period 1|Sponsor request (potential unblinding)|0|||
131751885|NCT01641081|474368139|FG001|Period 1|Sponsor request (potential unblinding)|0|||
131751886|NCT01641081|474368140|FG002|Period 1|Sponsor request (potential unblinding)|0|||
131751887|NCT01641081|474368141|FG003|Period 1|Sponsor request (potential unblinding)|0|||
131751888|NCT01641081|474368142|FG004|Period 1|Sponsor request (potential unblinding)|0|||
131751889|NCT01641081|474368143|FG005|Period 1|Sponsor request (potential unblinding)|0|||
131751890|NCT01641081|474368144|FG006|Period 1|Sponsor request (potential unblinding)|1|||
131751891|NCT01641081|474368145|FG007|Period 1|Sponsor request (potential unblinding)|0|||
131751892|NCT01641081|474368146|FG008|Period 1|Sponsor request (potential unblinding)|0|||
131906726|NCT01791595|474945227|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
131906727|NCT01791595|474945228|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
131449252|NCT02158546|473274823|FG001|Overall Study|Physician Decision|1|||
131751893|NCT01641081|474368147|FG009|Period 1|Sponsor request (potential unblinding)|0|||
131751894|NCT01641081|474368138|FG000|Period 1|Protocol Violation|0|||
131751895|NCT01641081|474368139|FG001|Period 1|Protocol Violation|0|||
131751896|NCT01641081|474368140|FG002|Period 1|Protocol Violation|0|||
131751897|NCT01641081|474368141|FG003|Period 1|Protocol Violation|0|||
131751898|NCT01641081|474368142|FG004|Period 1|Protocol Violation|1|||
131751899|NCT01641081|474368143|FG005|Period 1|Protocol Violation|0|||
131751900|NCT01641081|474368144|FG006|Period 1|Protocol Violation|0|||
131751901|NCT01641081|474368145|FG007|Period 1|Protocol Violation|1|||
131751902|NCT01641081|474368146|FG008|Period 1|Protocol Violation|0|||
131751903|NCT01641081|474368147|FG009|Period 1|Protocol Violation|0|||
131751904|NCT01641081|474368138|FG000|Period 1|Adverse Event|1|||
131809592|NCT00984126|474586108|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
131809593|NCT00984126|474586109|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
131809594|NCT00984126|474586106|FG000|Overall Study|Withdrawal criteria|0|||
131809595|NCT00984126|474586107|FG001|Overall Study|Withdrawal criteria|1|||
131809596|NCT00984126|474586108|FG002|Overall Study|Withdrawal criteria|3|||
131809597|NCT00984126|474586109|FG003|Overall Study|Withdrawal criteria|9|||
131809598|NCT01001208|474586110|FG000|Overall Study|Adverse Event|10|||
131809599|NCT01001208|474586111|FG001|Overall Study|Adverse Event|5|||
131809600|NCT01001208|474586110|FG000|Overall Study|Lost to Follow-up|5|||
131809601|NCT01001208|474586111|FG001|Overall Study|Lost to Follow-up|9|||
131809602|NCT01001208|474586110|FG000|Overall Study|Physician Decision|1|||
131809603|NCT01001208|474586111|FG001|Overall Study|Physician Decision|0|||
131809604|NCT01001208|474586110|FG000|Overall Study|Withdrawal by Subject|4|||
131809605|NCT01001208|474586111|FG001|Overall Study|Withdrawal by Subject|5|||
131809606|NCT01001208|474586110|FG000|Overall Study|Ineligibility Determined|4|||
131809607|NCT01001208|474586111|FG001|Overall Study|Ineligibility Determined|2|||
131809608|NCT01001208|474586110|FG000|Overall Study|Noncompliance|4|||
131809609|NCT01001208|474586111|FG001|Overall Study|Noncompliance|7|||
131809610|NCT01001208|474586110|FG000|Overall Study|Disease Progression|0|||
131809611|NCT01001208|474586111|FG001|Overall Study|Disease Progression|3|||
131809612|NCT01001208|474586110|FG000|Overall Study|Other|0|||
131809613|NCT01001208|474586111|FG001|Overall Study|Other|2|||
131809614|NCT01864174|474586112|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
131809615|NCT01864174|474586113|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
131809616|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
131809617|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
131809618|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
131809619|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
131809620|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
131809621|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
131751905|NCT01641081|474368139|FG001|Period 1|Adverse Event|0|||
131751906|NCT01641081|474368140|FG002|Period 1|Adverse Event|0|||
131751907|NCT01641081|474368141|FG003|Period 1|Adverse Event|0|||
131751908|NCT01641081|474368142|FG004|Period 1|Adverse Event|0|||
131751909|NCT01641081|474368143|FG005|Period 1|Adverse Event|0|||
131751910|NCT01641081|474368144|FG006|Period 1|Adverse Event|0|||
131751911|NCT01641081|474368145|FG007|Period 1|Adverse Event|2|||
131751912|NCT01641081|474368146|FG008|Period 1|Adverse Event|0|||
131751913|NCT01641081|474368147|FG009|Period 1|Adverse Event|0|||
131751914|NCT01641081|474368138|FG000|Period 2|Adverse Event|0|||
131751915|NCT01641081|474368139|FG001|Period 2|Adverse Event|0|||
131809622|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Death|1|||
131809623|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Death|0|||
131809624|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
131809625|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
131809626|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
131809627|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
131809628|NCT01864174|474586112|FG000|Double Blind - Compliant Randomized|Other|6|||
131809629|NCT01864174|474586113|FG001|Double Blind - Compliant Randomized|Other|10|||
131906728|NCT01791595|474945229|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
131449253|NCT02158546|473274824|FG002|Overall Study|Physician Decision|0|||
131751916|NCT01641081|474368140|FG002|Period 2|Adverse Event|0|||
131751917|NCT01641081|474368141|FG003|Period 2|Adverse Event|0|||
131751918|NCT01641081|474368142|FG004|Period 2|Adverse Event|0|||
131751919|NCT01641081|474368143|FG005|Period 2|Adverse Event|1|||
131751920|NCT01641081|474368144|FG006|Period 2|Adverse Event|0|||
131751921|NCT01641081|474368145|FG007|Period 2|Adverse Event|0|||
131751922|NCT01641081|474368146|FG008|Period 2|Adverse Event|0|||
131751923|NCT01641081|474368147|FG009|Period 2|Adverse Event|0|||
131751924|NCT01641081|474368138|FG000|Period 2|Withdrawal by Subject|0|||
131751925|NCT01641081|474368139|FG001|Period 2|Withdrawal by Subject|0|||
131751926|NCT01641081|474368140|FG002|Period 2|Withdrawal by Subject|0|||
131809630|NCT01864174|474586112|FG000|Off Treatment Follow-Up|Other|2|||
131809631|NCT01864174|474586113|FG001|Off Treatment Follow-Up|Other|0|||
131809632|NCT01864174|474586112|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
131809633|NCT01864174|474586113|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
131809634|NCT03546842|474586117|FG000|Overall Study|Protocol Violation|1|||
131809635|NCT03546842|474586117|FG000|Overall Study|Withdrawal by Subject|2|||
131809636|NCT01723397|474586119|FG000|Study Period 1|Protocol Violation|0|||
131809637|NCT01723397|474586120|FG001|Study Period 1|Protocol Violation|1|||
131809638|NCT01723397|474586119|FG000|Study Period 2|Protocol Violation|0|||
131809639|NCT01723397|474586120|FG001|Study Period 2|Protocol Violation|1|||
131809640|NCT00468286|474586124|FG000|Overall Study|Adverse Event|1|||
131809641|NCT00468286|474586125|FG001|Overall Study|Adverse Event|6|||
131809642|NCT00468286|474586124|FG000|Overall Study|Protocol Violation|2|||
131809643|NCT00468286|474586125|FG001|Overall Study|Protocol Violation|2|||
131809644|NCT00468286|474586124|FG000|Overall Study|Withdrawal by Subject|4|||
131809645|NCT00468286|474586125|FG001|Overall Study|Withdrawal by Subject|3|||
131809646|NCT00468286|474586124|FG000|Overall Study|Physician Decision|0|||
131809647|NCT00468286|474586125|FG001|Overall Study|Physician Decision|1|||
131809648|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
131809649|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
131809650|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
131809651|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
131809652|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
131809653|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
131809654|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
131809655|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
131809656|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
131809657|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
131809658|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
131809659|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
131809660|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
131809661|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
131809662|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
131751927|NCT01641081|474368141|FG003|Period 2|Withdrawal by Subject|1|||
131809663|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
131809664|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
131809665|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
131809666|NCT02009163|474586126|FG000|Open-label Period (Non-randomized)|Other|13|||
131751928|NCT01641081|474368142|FG004|Period 2|Withdrawal by Subject|0|||
131751929|NCT01641081|474368143|FG005|Period 2|Withdrawal by Subject|0|||
131751930|NCT01641081|474368144|FG006|Period 2|Withdrawal by Subject|2|||
131751931|NCT01641081|474368145|FG007|Period 2|Withdrawal by Subject|0|||
131751932|NCT01641081|474368146|FG008|Period 2|Withdrawal by Subject|0|||
131751933|NCT01641081|474368147|FG009|Period 2|Withdrawal by Subject|0|||
131751934|NCT01641081|474368138|FG000|Period 2|Protocol Violation|1|||
131751935|NCT01641081|474368139|FG001|Period 2|Protocol Violation|0|||
131751936|NCT01641081|474368140|FG002|Period 2|Protocol Violation|0|||
131751937|NCT01641081|474368141|FG003|Period 2|Protocol Violation|0|||
131751938|NCT01641081|474368142|FG004|Period 2|Protocol Violation|0|||
131751939|NCT01641081|474368143|FG005|Period 2|Protocol Violation|0|||
131751940|NCT01641081|474368144|FG006|Period 2|Protocol Violation|0|||
131751941|NCT01641081|474368145|FG007|Period 2|Protocol Violation|0|||
131809667|NCT02009163|474586127|FG001|Open-label Period (Non-randomized)|Other|0|||
131809668|NCT02009163|474586128|FG002|Open-label Period (Non-randomized)|Other|0|||
131809669|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
131809670|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
131751942|NCT01641081|474368146|FG008|Period 2|Protocol Violation|0|||
131751943|NCT01641081|474368147|FG009|Period 2|Protocol Violation|0|||
131751944|NCT01641081|474368138|FG000|Period 3|Adverse Event|0|||
131809671|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
131809672|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
131809673|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
131809674|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
131809675|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Adverse Event|0|||
131809676|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Adverse Event|0|||
131809677|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Adverse Event|6|||
131809678|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
131809679|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
131809680|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
131809681|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
131809682|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
131809683|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
131809684|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Pregnancy|0|||
131449254|NCT02158546|473274825|FG003|Overall Study|Physician Decision|0|||
131449255|NCT02158546|473274822|FG000|Overall Study|Non-compliance|0|||
131449256|NCT02158546|473274823|FG001|Overall Study|Non-compliance|1|||
131449257|NCT02158546|473274824|FG002|Overall Study|Non-compliance|0|||
131751945|NCT01641081|474368139|FG001|Period 3|Adverse Event|0|||
131751946|NCT01641081|474368140|FG002|Period 3|Adverse Event|1|||
131751947|NCT01641081|474368141|FG003|Period 3|Adverse Event|0|||
131751948|NCT01641081|474368142|FG004|Period 3|Adverse Event|0|||
131751949|NCT01641081|474368143|FG005|Period 3|Adverse Event|0|||
131751950|NCT01641081|474368144|FG006|Period 3|Adverse Event|0|||
131751951|NCT01641081|474368145|FG007|Period 3|Adverse Event|0|||
131751952|NCT01641081|474368146|FG008|Period 3|Adverse Event|0|||
131751953|NCT01641081|474368147|FG009|Period 3|Adverse Event|0|||
131751954|NCT01641081|474368138|FG000|Period 3|Withdrawal by Subject|0|||
131751955|NCT01641081|474368139|FG001|Period 3|Withdrawal by Subject|0|||
131751956|NCT01641081|474368140|FG002|Period 3|Withdrawal by Subject|0|||
131751957|NCT01641081|474368141|FG003|Period 3|Withdrawal by Subject|0|||
131751958|NCT01641081|474368142|FG004|Period 3|Withdrawal by Subject|0|||
131751959|NCT01641081|474368143|FG005|Period 3|Withdrawal by Subject|0|||
131809685|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Pregnancy|0|||
131751960|NCT01641081|474368144|FG006|Period 3|Withdrawal by Subject|0|||
131751961|NCT01641081|474368145|FG007|Period 3|Withdrawal by Subject|0|||
131449258|NCT02158546|473274825|FG003|Overall Study|Non-compliance|1|||
131751962|NCT01641081|474368146|FG008|Period 3|Withdrawal by Subject|1|||
131751963|NCT01641081|474368147|FG009|Period 3|Withdrawal by Subject|0|||
131751964|NCT01641081|474368138|FG000|Period 4|Adverse Event|0|||
131751965|NCT01641081|474368139|FG001|Period 4|Adverse Event|1|||
131751966|NCT01641081|474368140|FG002|Period 4|Adverse Event|0|||
131751967|NCT01641081|474368141|FG003|Period 4|Adverse Event|1|||
131751968|NCT01641081|474368142|FG004|Period 4|Adverse Event|0|||
131449259|NCT02158546|473274822|FG000|Overall Study|Failure to meet eligibility criteria|0|||
131449260|NCT02158546|473274823|FG001|Overall Study|Failure to meet eligibility criteria|1|||
131751969|NCT01641081|474368143|FG005|Period 4|Adverse Event|0|||
131751970|NCT01641081|474368144|FG006|Period 4|Adverse Event|0|||
131751971|NCT01641081|474368145|FG007|Period 4|Adverse Event|0|||
131751972|NCT01641081|474368146|FG008|Period 4|Adverse Event|0|||
131751973|NCT01641081|474368147|FG009|Period 4|Adverse Event|0|||
131751974|NCT01641081|474368138|FG000|Period 5|Adverse Event|0|||
131751975|NCT01641081|474368139|FG001|Period 5|Adverse Event|0|||
131751976|NCT01641081|474368140|FG002|Period 5|Adverse Event|2|||
131751977|NCT01641081|474368141|FG003|Period 5|Adverse Event|0|||
131751978|NCT01641081|474368142|FG004|Period 5|Adverse Event|0|||
131751979|NCT01641081|474368143|FG005|Period 5|Adverse Event|0|||
131751980|NCT01641081|474368144|FG006|Period 5|Adverse Event|0|||
131751981|NCT01641081|474368145|FG007|Period 5|Adverse Event|0|||
131751982|NCT01641081|474368146|FG008|Period 5|Adverse Event|0|||
131751983|NCT01641081|474368147|FG009|Period 5|Adverse Event|0|||
131751984|NCT01749800|474368151|FG000|Overall Study|not meeting inclusion criteria|3|||
131751985|NCT01749800|474368152|FG001|Overall Study|not meeting inclusion criteria|0|||
131751986|NCT01749800|474368153|FG002|Overall Study|not meeting inclusion criteria|0|||
131751987|NCT01749800|474368151|FG000|Overall Study|Withdrawal by Subject|0|||
131751988|NCT01749800|474368152|FG001|Overall Study|Withdrawal by Subject|1|||
131751989|NCT01749800|474368153|FG002|Overall Study|Withdrawal by Subject|0|||
131751990|NCT01451398|474368159|FG000|Overall Study|Adverse Event|7|||
131751991|NCT01451398|474368160|FG001|Overall Study|Adverse Event|9|||
131751992|NCT01451398|474368159|FG000|Overall Study|Protocol Violation|1|||
131751993|NCT01451398|474368160|FG001|Overall Study|Protocol Violation|2|||
131751994|NCT01451398|474368159|FG000|Overall Study|Physician Decision|1|||
131751995|NCT01451398|474368160|FG001|Overall Study|Physician Decision|1|||
131751996|NCT01451398|474368159|FG000|Overall Study|Withdrawal by Subject|10|||
131751997|NCT01451398|474368160|FG001|Overall Study|Withdrawal by Subject|14|||
131751998|NCT01451398|474368159|FG000|Overall Study|Lost to Follow-up|6|||
131751999|NCT01451398|474368160|FG001|Overall Study|Lost to Follow-up|4|||
131752000|NCT01451398|474368159|FG000|Overall Study|Non-compliance with study drug|1|||
131752001|NCT01451398|474368160|FG001|Overall Study|Non-compliance with study drug|3|||
131752002|NCT01451398|474368159|FG000|Overall Study|Non-compliance with protocol|1|||
131752003|NCT01451398|474368160|FG001|Overall Study|Non-compliance with protocol|1|||
131752004|NCT01451398|474368159|FG000|Overall Study|Moved out of country|0|||
131752005|NCT01451398|474368160|FG001|Overall Study|Moved out of country|1|||
131752006|NCT01451398|474368159|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
131752007|NCT01451398|474368160|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
131752008|NCT01451398|474368159|FG000|Overall Study|Lack of Efficacy|0|||
131752009|NCT01451398|474368160|FG001|Overall Study|Lack of Efficacy|1|||
131809686|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Pregnancy|2|||
131809687|NCT02009163|474586126|FG000|Randomized-withdrawal Period|Other|0|||
131809688|NCT02009163|474586127|FG001|Randomized-withdrawal Period|Other|9|||
131809689|NCT02009163|474586128|FG002|Randomized-withdrawal Period|Other|5|||
131809690|NCT02453386|474586131|FG000|Overall Study|Adverse Event|22|||
131809691|NCT02453386|474586132|FG001|Overall Study|Adverse Event|30|||
131809692|NCT02453386|474586133|FG002|Overall Study|Adverse Event|15|||
131752010|NCT01000025|474368164|FG000|Overall Study|Adverse Event|43|||
131752011|NCT01000025|474368165|FG001|Overall Study|Adverse Event|2|||
131752012|NCT01000025|474368164|FG000|Overall Study|Withdrawal by Subject|13|||
131752013|NCT01000025|474368165|FG001|Overall Study|Withdrawal by Subject|8|||
131752014|NCT01000025|474368164|FG000|Overall Study|Death|23|||
131752015|NCT01000025|474368165|FG001|Overall Study|Death|13|||
131752016|NCT01000025|474368164|FG000|Overall Study|Lack of Efficacy|363|||
131752017|NCT01000025|474368165|FG001|Overall Study|Lack of Efficacy|208|||
131752018|NCT01000025|474368164|FG000|Overall Study|Intercurrent Illness|26|||
131752019|NCT01000025|474368165|FG001|Overall Study|Intercurrent Illness|7|||
131752020|NCT04423757|474368166|FG000|Overall Study|Adverse Event|2|||
131809693|NCT02453386|474586131|FG000|Overall Study|Protocol Violation|1|||
131809694|NCT02453386|474586132|FG001|Overall Study|Protocol Violation|0|||
131809695|NCT02453386|474586133|FG002|Overall Study|Protocol Violation|1|||
131809696|NCT02453386|474586131|FG000|Overall Study|Withdrawal by Subject|10|||
131809697|NCT02453386|474586132|FG001|Overall Study|Withdrawal by Subject|9|||
131809698|NCT02453386|474586133|FG002|Overall Study|Withdrawal by Subject|9|||
131809699|NCT02453386|474586131|FG000|Overall Study|Sponsor Terminated Study|14|||
131809700|NCT02453386|474586132|FG001|Overall Study|Sponsor Terminated Study|8|||
131809701|NCT02453386|474586133|FG002|Overall Study|Sponsor Terminated Study|11|||
131809702|NCT02453386|474586131|FG000|Overall Study|Subject Terminated by Sponsor|1|||
131809703|NCT02453386|474586132|FG001|Overall Study|Subject Terminated by Sponsor|1|||
131809704|NCT02453386|474586133|FG002|Overall Study|Subject Terminated by Sponsor|1|||
131809705|NCT02453386|474586131|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
131809706|NCT02453386|474586132|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
131809707|NCT02453386|474586133|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
131809708|NCT02453386|474586131|FG000|Overall Study|Lost to Follow-up|0|||
131809709|NCT02453386|474586132|FG001|Overall Study|Lost to Follow-up|0|||
131809710|NCT02453386|474586133|FG002|Overall Study|Lost to Follow-up|1|||
131809711|NCT02453386|474586131|FG000|Overall Study|Other|1|||
131809712|NCT02453386|474586132|FG001|Overall Study|Other|0|||
131809713|NCT02453386|474586133|FG002|Overall Study|Other|1|||
131809714|NCT01218867|474586138|FG000|Overall Study|Death during treatment|0|||
131809715|NCT01218867|474586139|FG001|Overall Study|Death during treatment|0|||
131809716|NCT01218867|474586140|FG002|Overall Study|Death during treatment|0|||
131809717|NCT01218867|474586141|FG003|Overall Study|Death during treatment|0|||
131809718|NCT01218867|474586142|FG004|Overall Study|Death during treatment|0|||
131809719|NCT01218867|474586143|FG005|Overall Study|Death during treatment|0|||
131449261|NCT02158546|473274824|FG002|Overall Study|Failure to meet eligibility criteria|0|||
131449262|NCT02158546|473274825|FG003|Overall Study|Failure to meet eligibility criteria|0|||
131449263|NCT02158546|473274822|FG000|Overall Study|Lack of Efficacy|1|||
131449264|NCT02158546|473274823|FG001|Overall Study|Lack of Efficacy|1|||
131449265|NCT02158546|473274824|FG002|Overall Study|Lack of Efficacy|0|||
131449266|NCT02158546|473274825|FG003|Overall Study|Lack of Efficacy|0|||
131449267|NCT02158546|473274822|FG000|Overall Study|Adverse Event|2|||
131449268|NCT02158546|473274823|FG001|Overall Study|Adverse Event|2|||
131449269|NCT02158546|473274824|FG002|Overall Study|Adverse Event|0|||
131449270|NCT02158546|473274825|FG003|Overall Study|Adverse Event|0|||
131449271|NCT02158546|473274822|FG000|Overall Study|Withdrawal by Subject|6|||
131449272|NCT02158546|473274823|FG001|Overall Study|Withdrawal by Subject|2|||
131449273|NCT02158546|473274824|FG002|Overall Study|Withdrawal by Subject|1|||
131449274|NCT02158546|473274825|FG003|Overall Study|Withdrawal by Subject|0|||
131449275|NCT02158546|473274822|FG000|Overall Study|Lost to Follow-up|5|||
131449276|NCT02158546|473274823|FG001|Overall Study|Lost to Follow-up|4|||
131449277|NCT02158546|473274824|FG002|Overall Study|Lost to Follow-up|0|||
131449278|NCT02158546|473274825|FG003|Overall Study|Lost to Follow-up|1|||
131449279|NCT02158546|473274822|FG000|Overall Study|Site Excluded|5|||
131809720|NCT01218867|474586144|FG006|Overall Study|Death during treatment|1|||
131809721|NCT01218867|474586145|FG007|Overall Study|Death during treatment|0|||
131809722|NCT01218867|474586146|FG008|Overall Study|Death during treatment|0|||
131809723|NCT01218867|474586147|FG009|Overall Study|Death during treatment|0|||
131809724|NCT01218867|474586148|FG010|Overall Study|Death during treatment|0|||
131809725|NCT03792477|474586149|FG000|Overall Study|Adverse Event|0|||
131809726|NCT03792477|474586150|FG001|Overall Study|Adverse Event|0|||
131752021|NCT04423757|474368167|FG001|Overall Study|Adverse Event|0|||
131752022|NCT04423757|474368166|FG000|Overall Study|Not treated|1|||
131752023|NCT04423757|474368167|FG001|Overall Study|Not treated|1|||
131752024|NCT00422669|474368168|FG000|Overall Study|The study was terminated early.|98|||
131752025|NCT00422669|474368169|FG001|Overall Study|The study was terminated early.|100|||
131752026|NCT00422669|474368170|FG002|Overall Study|The study was terminated early.|7|||
131752027|NCT02709109|474368171|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
131752028|NCT02709109|474368172|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
131752029|NCT02709109|474368173|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
131752030|NCT02709109|474368174|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
131752031|NCT02709109|474368171|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
131809727|NCT03792477|474586151|FG002|Overall Study|Adverse Event|0|||
131752032|NCT02709109|474368172|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
131752033|NCT02709109|474368173|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
131809728|NCT03792477|474586152|FG003|Overall Study|Adverse Event|1|||
131906729|NCT01791595|474945230|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
131449280|NCT02158546|473274823|FG001|Overall Study|Site Excluded|5|||
131449281|NCT02158546|473274824|FG002|Overall Study|Site Excluded|3|||
131809729|NCT03792477|474586153|FG004|Overall Study|Adverse Event|0|||
131809730|NCT03792477|474586149|FG000|Overall Study|Lost to Follow-up|0|||
131809731|NCT03792477|474586150|FG001|Overall Study|Lost to Follow-up|0|||
131809732|NCT03792477|474586151|FG002|Overall Study|Lost to Follow-up|2|||
131449282|NCT02158546|473274825|FG003|Overall Study|Site Excluded|4|||
131809733|NCT03792477|474586152|FG003|Overall Study|Lost to Follow-up|0|||
131809734|NCT03792477|474586153|FG004|Overall Study|Lost to Follow-up|0|||
131809735|NCT03792477|474586149|FG000|Overall Study|Other|0|||
131809736|NCT03792477|474586150|FG001|Overall Study|Other|0|||
131809737|NCT03792477|474586151|FG002|Overall Study|Other|0|||
131809738|NCT03792477|474586152|FG003|Overall Study|Other|0|||
131809739|NCT03792477|474586153|FG004|Overall Study|Other|1|||
131809740|NCT01474551|474586155|FG000|Overall Study|Death|1|||
131809741|NCT00840411|474586156|FG000|First Intervention|Adverse Event|1|||
131809742|NCT00840411|474586157|FG001|First Intervention|Adverse Event|0|||
131809743|NCT00840411|474586156|FG000|Washout|Withdrawal by Subject|1|||
131809744|NCT00840411|474586157|FG001|Washout|Withdrawal by Subject|0|||
131809745|NCT04419311|474586158|FG000|Overall Study|Lost to Follow-up|1|||
131809746|NCT04419311|474586159|FG001|Overall Study|Lost to Follow-up|0|||
131809747|NCT01921062|474586175|FG000|Overall Study|Withdrawal by Subject|0|||
131809748|NCT01921062|474586176|FG001|Overall Study|Withdrawal by Subject|7|||
131809749|NCT01921062|474586175|FG000|Overall Study|Adverse Event|5|||
131809750|NCT01921062|474586176|FG001|Overall Study|Adverse Event|6|||
131809751|NCT01921062|474586175|FG000|Overall Study|Protocol Violation|0|||
131809752|NCT01921062|474586176|FG001|Overall Study|Protocol Violation|1|||
131809753|NCT01921062|474586175|FG000|Overall Study|VMIQ score > 72|4|||
131809754|NCT01921062|474586176|FG001|Overall Study|VMIQ score > 72|1|||
131809755|NCT01921062|474586175|FG000|Overall Study|Logistic error|0|||
131809756|NCT01921062|474586176|FG001|Overall Study|Logistic error|1|||
131809757|NCT00576056|474586177|FG000|Overall Study|Adverse Event|1|||
131809758|NCT00576056|474586177|FG000|Overall Study|Death|1|||
131809759|NCT00576056|474586177|FG000|Overall Study|Lack of Efficacy|1|||
131809760|NCT00576056|474586177|FG000|Overall Study|Withdrawal by Subject|2|||
131809761|NCT00576056|474586177|FG000|Overall Study|did not meet eligibility criteria|8|||
131809762|NCT00576056|474586177|FG000|Overall Study|Physician Decision|1|||
131809763|NCT01854047|474586178|FG000|Overall Study|Lack of Efficacy|1|||
131809764|NCT01854047|474586179|FG001|Overall Study|Lack of Efficacy|0|||
131809765|NCT01854047|474586180|FG002|Overall Study|Lack of Efficacy|0|||
131809766|NCT01854047|474586181|FG003|Overall Study|Lack of Efficacy|0|||
131809767|NCT01854047|474586182|FG004|Overall Study|Lack of Efficacy|0|||
131809768|NCT01854047|474586178|FG000|Overall Study|Poor compliance to protocol|3|||
131809769|NCT01854047|474586179|FG001|Overall Study|Poor compliance to protocol|0|||
131809770|NCT01854047|474586180|FG002|Overall Study|Poor compliance to protocol|2|||
131809771|NCT01854047|474586181|FG003|Overall Study|Poor compliance to protocol|0|||
131809772|NCT01854047|474586182|FG004|Overall Study|Poor compliance to protocol|0|||
131809773|NCT01854047|474586178|FG000|Overall Study|Adverse Event|5|||
131809774|NCT01854047|474586179|FG001|Overall Study|Adverse Event|4|||
131809775|NCT01854047|474586180|FG002|Overall Study|Adverse Event|6|||
131809776|NCT01854047|474586181|FG003|Overall Study|Adverse Event|10|||
131809777|NCT01854047|474586182|FG004|Overall Study|Adverse Event|7|||
131809778|NCT01854047|474586178|FG000|Overall Study|Randomized but not treated|0|||
131809779|NCT01854047|474586179|FG001|Overall Study|Randomized but not treated|1|||
131809780|NCT01854047|474586180|FG002|Overall Study|Randomized but not treated|2|||
131809781|NCT01854047|474586181|FG003|Overall Study|Randomized but not treated|0|||
131809782|NCT01854047|474586182|FG004|Overall Study|Randomized but not treated|4|||
131809783|NCT01854047|474586178|FG000|Overall Study|Other than specified above|3|||
131809784|NCT01854047|474586179|FG001|Overall Study|Other than specified above|3|||
131809785|NCT01854047|474586180|FG002|Overall Study|Other than specified above|3|||
131809786|NCT01854047|474586181|FG003|Overall Study|Other than specified above|5|||
131809787|NCT01854047|474586182|FG004|Overall Study|Other than specified above|8|||
131809788|NCT02605928|474586183|FG000|Overall Study|Model tuning phase|28|||
131809789|NCT02605928|474586183|FG000|Overall Study|Lack of Efficacy|5|||
131809790|NCT02089997|474586193|FG000|Overall Study|Case report forms uncollected|99|||
131809791|NCT02089997|474586193|FG000|Overall Study|Protocol Violation|147|||
131809792|NCT02441309|474586194|FG000|Overall Study|Disease progression|2|||
131809793|NCT02441309|474586195|FG001|Overall Study|Disease progression|1|||
131809794|NCT02441309|474586196|FG002|Overall Study|Disease progression|2|||
131809795|NCT02441309|474586194|FG000|Overall Study|Adverse Event|0|||
131809796|NCT02441309|474586195|FG001|Overall Study|Adverse Event|1|||
131809797|NCT02441309|474586196|FG002|Overall Study|Adverse Event|0|||
131809798|NCT02441309|474586194|FG000|Overall Study|Withdrawal by Subject|1|||
131809799|NCT02441309|474586195|FG001|Overall Study|Withdrawal by Subject|0|||
131809800|NCT02441309|474586196|FG002|Overall Study|Withdrawal by Subject|1|||
131809801|NCT02374853|474586203|FG000|Overall Study|Surgery Cancelled|5|||
131809802|NCT02374853|474586204|FG001|Overall Study|Surgery Cancelled|11|||
131809803|NCT02281084|474586205|FG000|Overall Study|Death|21|||
131809804|NCT02281084|474586206|FG001|Overall Study|Death|18|||
131809805|NCT02281084|474586207|FG002|Overall Study|Death|3|||
131809806|NCT02281084|474586208|FG003|Overall Study|Death|5|||
131809807|NCT02281084|474586205|FG000|Overall Study|Adverse Event|1|||
131809808|NCT02281084|474586206|FG001|Overall Study|Adverse Event|0|||
131809809|NCT02281084|474586207|FG002|Overall Study|Adverse Event|0|||
131809810|NCT02281084|474586208|FG003|Overall Study|Adverse Event|0|||
131809811|NCT02281084|474586205|FG000|Overall Study|Withdrawal by Subject|2|||
131809812|NCT02281084|474586206|FG001|Overall Study|Withdrawal by Subject|2|||
131906730|NCT01791595|474945231|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
131906731|NCT01791595|474945232|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
131906732|NCT01791595|474945233|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
131906733|NCT01791595|474945227|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
131906734|NCT01791595|474945228|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
131906735|NCT01791595|474945229|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
131906736|NCT01791595|474945230|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
131906737|NCT01791595|474945231|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
131906738|NCT01791595|474945232|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
131906739|NCT01791595|474945233|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
131906740|NCT03118934|474945234|FG000|Overall Study|Adverse Event|0|||
131752034|NCT02709109|474368174|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
131752035|NCT02709109|474368171|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
131752036|NCT02709109|474368172|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
131752037|NCT02709109|474368173|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
131752038|NCT02709109|474368174|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
131752039|NCT02709109|474368171|FG000|Washout Period (28 Days)|Other|2|||
131752040|NCT02709109|474368172|FG001|Washout Period (28 Days)|Other|2|||
131752041|NCT02709109|474368173|FG002|Washout Period (28 Days)|Other|3|||
131752042|NCT02709109|474368174|FG003|Washout Period (28 Days)|Other|0|||
131752043|NCT02709109|474368171|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
131752044|NCT02709109|474368172|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
131752045|NCT02709109|474368173|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
131752046|NCT02709109|474368174|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
131752047|NCT02709109|474368171|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
131752048|NCT02709109|474368172|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
131752049|NCT02709109|474368173|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
131752050|NCT02709109|474368174|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
131752051|NCT02709109|474368171|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
131752052|NCT02709109|474368172|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
131752053|NCT02709109|474368173|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
131752054|NCT02709109|474368174|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
131752055|NCT02709109|474368171|FG000|Treatment Period 2 (28 Days)|Other|0|||
131752056|NCT02709109|474368172|FG001|Treatment Period 2 (28 Days)|Other|0|||
131752057|NCT02709109|474368173|FG002|Treatment Period 2 (28 Days)|Other|1|||
131752058|NCT02709109|474368174|FG003|Treatment Period 2 (28 Days)|Other|0|||
131752059|NCT02738580|474368175|FG000|Overall Study|Adverse Event|1|||
131449283|NCT02488915|473274828|FG000|Overall Study|Death|21|||
131752060|NCT02738580|474368176|FG001|Overall Study|Adverse Event|0|||
131752061|NCT02738580|474368175|FG000|Overall Study|Lack of Efficacy|3|||
131752062|NCT02738580|474368176|FG001|Overall Study|Lack of Efficacy|2|||
131752063|NCT02738580|474368175|FG000|Overall Study|Withdrawal by Subject|0|||
131752064|NCT02738580|474368176|FG001|Overall Study|Withdrawal by Subject|1|||
131752065|NCT02738580|474368175|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
131752066|NCT02738580|474368176|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
131752067|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
131752068|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
131752069|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
131752070|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
131752071|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
131752072|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
131752073|NCT00996593|474368177|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
131752074|NCT00996593|474368177|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
131752075|NCT00996593|474368177|FG000|Long-Term Follow-Up|Site Closed|1|||
131752076|NCT02565615|474368178|FG000|Overall Study|Death|0|||
131752077|NCT02565615|474368179|FG001|Overall Study|Death|1|||
131752078|NCT02565615|474368180|FG002|Overall Study|Death|0|||
131752079|NCT02565615|474368181|FG003|Overall Study|Death|0|||
131752080|NCT02565615|474368182|FG004|Overall Study|Death|4|||
131752081|NCT02565615|474368178|FG000|Overall Study|Not willing to participate in study|2|||
131752082|NCT02565615|474368179|FG001|Overall Study|Not willing to participate in study|21|||
131752083|NCT02565615|474368180|FG002|Overall Study|Not willing to participate in study|0|||
131752084|NCT02565615|474368181|FG003|Overall Study|Not willing to participate in study|1|||
131752085|NCT02565615|474368182|FG004|Overall Study|Not willing to participate in study|169|||
131752086|NCT02565615|474368178|FG000|Overall Study|Lost to Follow-up|0|||
131752087|NCT02565615|474368179|FG001|Overall Study|Lost to Follow-up|4|||
131752088|NCT02565615|474368180|FG002|Overall Study|Lost to Follow-up|0|||
131752089|NCT02565615|474368181|FG003|Overall Study|Lost to Follow-up|1|||
131752090|NCT02565615|474368182|FG004|Overall Study|Lost to Follow-up|765|||
131752091|NCT02565615|474368178|FG000|Overall Study|Not meeting eligibility criteria|0|||
131752092|NCT02565615|474368179|FG001|Overall Study|Not meeting eligibility criteria|7|||
131752093|NCT02565615|474368180|FG002|Overall Study|Not meeting eligibility criteria|0|||
131752094|NCT02565615|474368181|FG003|Overall Study|Not meeting eligibility criteria|0|||
131752095|NCT02565615|474368182|FG004|Overall Study|Not meeting eligibility criteria|25|||
131752096|NCT02565615|474368178|FG000|Overall Study|Reason not defined|0|||
131752097|NCT02565615|474368179|FG001|Overall Study|Reason not defined|2|||
131752098|NCT02565615|474368180|FG002|Overall Study|Reason not defined|0|||
131752099|NCT02565615|474368181|FG003|Overall Study|Reason not defined|1|||
131752100|NCT02565615|474368182|FG004|Overall Study|Reason not defined|62|||
131752101|NCT02565615|474368178|FG000|Overall Study|Adverse Event|1|||
131752102|NCT02565615|474368179|FG001|Overall Study|Adverse Event|1|||
131752103|NCT02565615|474368180|FG002|Overall Study|Adverse Event|0|||
131752104|NCT02565615|474368181|FG003|Overall Study|Adverse Event|0|||
131752105|NCT02565615|474368182|FG004|Overall Study|Adverse Event|9|||
131752106|NCT02565615|474368178|FG000|Overall Study|Untreated|0|||
131752107|NCT02565615|474368179|FG001|Overall Study|Untreated|0|||
131752108|NCT02565615|474368180|FG002|Overall Study|Untreated|0|||
131752109|NCT02565615|474368181|FG003|Overall Study|Untreated|0|||
131752110|NCT02565615|474368182|FG004|Overall Study|Untreated|567|||
131752111|NCT01250756|474368183|FG000|Infant Series|Withdrawal by Subject|4|||
131752112|NCT01250756|474368184|FG001|Infant Series|Withdrawal by Subject|5|||
131752113|NCT01250756|474368183|FG000|Infant Series|Randomized, Not Vaccinated|2|||
131752114|NCT01250756|474368184|FG001|Infant Series|Randomized, Not Vaccinated|2|||
131752115|NCT01250756|474368183|FG000|Infant Series|Other|22|||
131752116|NCT01250756|474368184|FG001|Infant Series|Other|0|||
131752117|NCT01250756|474368183|FG000|After Infant Series|Adverse Event|5|||
131752118|NCT01250756|474368184|FG001|After Infant Series|Adverse Event|2|||
131752119|NCT01250756|474368183|FG000|After Infant Series|Withdrawal by Subject|4|||
131752120|NCT01250756|474368184|FG001|After Infant Series|Withdrawal by Subject|1|||
131752121|NCT01250756|474368183|FG000|After Infant Series|Other|2|||
131752122|NCT01250756|474368184|FG001|After Infant Series|Other|1|||
131752123|NCT01250756|474368183|FG000|Toddler Dose|Adverse Event|0|||
131752124|NCT01250756|474368184|FG001|Toddler Dose|Adverse Event|1|||
131752125|NCT01250756|474368183|FG000|After Toddler Dose|Adverse Event|0|||
131752126|NCT01250756|474368184|FG001|After Toddler Dose|Adverse Event|1|||
131752127|NCT01815580|474368186|FG000|Overall Study|Lost to Follow-up|4|||
131752128|NCT01815580|474368187|FG001|Overall Study|Lost to Follow-up|7|||
131752129|NCT01815580|474368186|FG000|Overall Study|Withdrawal by Subject|3|||
131752130|NCT01815580|474368187|FG001|Overall Study|Withdrawal by Subject|4|||
131752131|NCT01815580|474368186|FG000|Overall Study|Excluded from analysis|5|||
131752132|NCT01815580|474368187|FG001|Overall Study|Excluded from analysis|4|||
131752133|NCT04114539|474368190|FG000|Overall Study|Adverse Event|14|||
131752134|NCT04114539|474368190|FG000|Overall Study|Lost to Follow-up|2|||
131752135|NCT04114539|474368190|FG000|Overall Study|Non-compliance with Protocol|2|||
131752136|NCT04114539|474368190|FG000|Overall Study|Non-compliance with Study Drug|1|||
131752137|NCT04114539|474368190|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
131752138|NCT04114539|474368190|FG000|Overall Study|Withdrew consent|10|||
131752139|NCT04114539|474368190|FG000|Overall Study|Others not specified|5|||
131752140|NCT04114539|474368190|FG000|Overall Study|Investigator Decision|2|||
131752141|NCT01072448|474368193|FG000|Overall Study|Adverse Event|9|||
131752142|NCT01072448|474368194|FG001|Overall Study|Adverse Event|10|||
131752143|NCT01072448|474368193|FG000|Overall Study|Subject withdrew consent|4|||
131809813|NCT02281084|474586207|FG002|Overall Study|Withdrawal by Subject|0|||
131809814|NCT02281084|474586208|FG003|Overall Study|Withdrawal by Subject|0|||
131809815|NCT02281084|474586205|FG000|Overall Study|Site Closure by Sponsor|5|||
131809816|NCT02281084|474586206|FG001|Overall Study|Site Closure by Sponsor|1|||
131809817|NCT02281084|474586207|FG002|Overall Study|Site Closure by Sponsor|2|||
131809818|NCT02281084|474586208|FG003|Overall Study|Site Closure by Sponsor|0|||
131809819|NCT02335658|474586209|FG000|Overall Study|Adverse Event|18|||
131809820|NCT02335658|474586210|FG001|Overall Study|Adverse Event|12|||
131809821|NCT02335658|474586209|FG000|Overall Study|Lack of Efficacy|4|||
131809822|NCT02335658|474586210|FG001|Overall Study|Lack of Efficacy|5|||
131809823|NCT02335658|474586209|FG000|Overall Study|Pregnancy|1|||
131809824|NCT02335658|474586210|FG001|Overall Study|Pregnancy|0|||
131809825|NCT02335658|474586209|FG000|Overall Study|Withdrawal by Subject|13|||
131809826|NCT02335658|474586210|FG001|Overall Study|Withdrawal by Subject|21|||
131809827|NCT02335658|474586209|FG000|Overall Study|non-compliance|2|||
131449284|NCT02488915|473274828|FG000|Overall Study|Lost to Follow-up|4|||
131752144|NCT01072448|474368194|FG001|Overall Study|Subject withdrew consent|9|||
131752145|NCT01072448|474368193|FG000|Overall Study|Protocol deviation|3|||
131752146|NCT01072448|474368194|FG001|Overall Study|Protocol deviation|4|||
131752147|NCT01072448|474368193|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131752148|NCT01072448|474368194|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131809828|NCT02335658|474586210|FG001|Overall Study|non-compliance|3|||
131809829|NCT02335658|474586209|FG000|Overall Study|other reason|2|||
131809830|NCT02335658|474586210|FG001|Overall Study|other reason|3|||
131809831|NCT02305758|474586211|FG000|Overall Study|Death|27|||
131752149|NCT01072448|474368193|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131752150|NCT01072448|474368194|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131752151|NCT01072448|474368193|FG000|Overall Study|Lost to Follow-up|1|||
131449285|NCT02488915|473274828|FG000|Overall Study|Withdrawal by Subject|1|||
131449286|NCT00734539|473274829|FG000|Main Study|Death|33|||
131449287|NCT00734539|473274830|FG001|Main Study|Death|32|||
131449288|NCT00734539|473274829|FG000|Main Study|Physician Decision|2|||
131449289|NCT00734539|473274830|FG001|Main Study|Physician Decision|0|||
131449290|NCT00734539|473274829|FG000|Main Study|Withdrawal by Subject|1|||
131449291|NCT00734539|473274830|FG001|Main Study|Withdrawal by Subject|3|||
131449292|NCT00734539|473274829|FG000|Main Study|Enrolled in error; ineligible|1|||
131449293|NCT00734539|473274830|FG001|Main Study|Enrolled in error; ineligible|0|||
131449294|NCT02504151|473274835|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
131449295|NCT02504151|473274836|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
131449296|NCT02504151|473274835|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
131449297|NCT02504151|473274836|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
131449298|NCT02504151|473274835|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
131449299|NCT02504151|473274836|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131449300|NCT02504151|473274835|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
131449301|NCT02504151|473274836|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
131449302|NCT05038982|473274837|FG000|Overall Study|Withdrawal by Subject|0|||
131449303|NCT05038982|473274838|FG001|Overall Study|Withdrawal by Subject|2|||
131449304|NCT02557139|473274844|FG000|Overall Study|Significant liver elevation|1|||
131449305|NCT02557139|473274845|FG001|Overall Study|Significant liver elevation|0|||
131449306|NCT02557139|473274846|FG002|Overall Study|Significant liver elevation|1|||
131449307|NCT02557139|473274844|FG000|Overall Study|Withdrawal by Subject|1|||
131449308|NCT02557139|473274845|FG001|Overall Study|Withdrawal by Subject|0|||
131449309|NCT02557139|473274846|FG002|Overall Study|Withdrawal by Subject|0|||
131449310|NCT02557139|473274844|FG000|Overall Study|Illness of prohibited medication|0|||
131449311|NCT02557139|473274845|FG001|Overall Study|Illness of prohibited medication|0|||
131449312|NCT02557139|473274846|FG002|Overall Study|Illness of prohibited medication|1|||
131449313|NCT01454102|473274848|FG000|Overall Study|Continuing in the treatment period|0|||
131449314|NCT01454102|473274849|FG001|Overall Study|Continuing in the treatment period|0|||
131449315|NCT01454102|473274850|FG002|Overall Study|Continuing in the treatment period|0|||
131449316|NCT01454102|473274851|FG003|Overall Study|Continuing in the treatment period|0|||
131449317|NCT01454102|473274852|FG004|Overall Study|Continuing in the treatment period|3|||
131449318|NCT01454102|473274853|FG005|Overall Study|Continuing in the treatment period|3|||
131449319|NCT01454102|473274854|FG006|Overall Study|Continuing in the treatment period|2|||
131449320|NCT01454102|473274855|FG007|Overall Study|Continuing in the treatment period|0|||
131449321|NCT01454102|473274856|FG008|Overall Study|Continuing in the treatment period|1|||
131449322|NCT01454102|473274857|FG009|Overall Study|Continuing in the treatment period|0|||
131449323|NCT01454102|473274858|FG010|Overall Study|Continuing in the treatment period|0|||
131449324|NCT01454102|473274859|FG011|Overall Study|Continuing in the treatment period|4|||
131752152|NCT01072448|474368194|FG001|Overall Study|Lost to Follow-up|1|||
131752153|NCT01072448|474368193|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131752154|NCT01072448|474368194|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131752155|NCT01072448|474368193|FG000|Overall Study|Death|0|||
131752156|NCT01072448|474368194|FG001|Overall Study|Death|2|||
131752157|NCT00196196|474368196|FG000|Overall Study|Withdrawal by Subject|2|||
131752158|NCT00196196|474368196|FG000|Overall Study|Did not have required condition (hydroce|5|||
131752159|NCT01601470|474368197|FG000|Period 2 - LCZ696|Physician Decision|1|||
131752160|NCT03032510|474368198|FG000|Overall Study|Adverse Event|5|||
131752161|NCT03032510|474368199|FG001|Overall Study|Adverse Event|2|||
131752162|NCT03032510|474368198|FG000|Overall Study|Lost to Follow-up|8|||
131752163|NCT03032510|474368199|FG001|Overall Study|Lost to Follow-up|7|||
131449325|NCT01454102|473274860|FG012|Overall Study|Continuing in the treatment period|7|||
131449326|NCT01454102|473274861|FG013|Overall Study|Continuing in the treatment period|4|||
131449327|NCT01454102|473274862|FG014|Overall Study|Continuing in the treatment period|3|||
131449328|NCT01454102|473274863|FG015|Overall Study|Continuing in the treatment period|1|||
131449329|NCT01782378|473274868|FG000|First Series|Lost to Follow-up|7|||
131752164|NCT03032510|474368198|FG000|Overall Study|Withdrawal by Subject|8|||
131752165|NCT03032510|474368199|FG001|Overall Study|Withdrawal by Subject|7|||
131752166|NCT03032510|474368198|FG000|Overall Study|Subject noncompliance|4|||
131752167|NCT03032510|474368199|FG001|Overall Study|Subject noncompliance|2|||
131906741|NCT03118934|474945235|FG001|Overall Study|Adverse Event|0|||
131906742|NCT03118934|474945236|FG002|Overall Study|Adverse Event|0|||
131449330|NCT01782378|473274869|FG001|First Series|Lost to Follow-up|8|||
131449331|NCT01782378|473274868|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
131449332|NCT01782378|473274869|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
131449333|NCT01782378|473274868|FG000|Second Series|Lost to Follow-up|8|||
131752168|NCT03032510|474368198|FG000|Overall Study|Physician Decision|2|||
131752169|NCT03032510|474368199|FG001|Overall Study|Physician Decision|0|||
131752170|NCT01079195|474368200|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
131906743|NCT03118934|474945237|FG003|Overall Study|Adverse Event|0|||
131449334|NCT01782378|473274869|FG001|Second Series|Lost to Follow-up|7|||
131449335|NCT01782378|473274868|FG000|Second Series|Did not choose to complete S2 Optional|18|||
131449336|NCT01782378|473274869|FG001|Second Series|Did not choose to complete S2 Optional|0|||
131809832|NCT02305758|474586212|FG001|Overall Study|Death|27|||
131809833|NCT02305758|474586211|FG000|Overall Study|Withdrew consent|9|||
131809834|NCT02305758|474586212|FG001|Overall Study|Withdrew consent|2|||
131809835|NCT02305758|474586211|FG000|Overall Study|Lost to Follow-up|6|||
131809836|NCT02305758|474586212|FG001|Overall Study|Lost to Follow-up|1|||
131809837|NCT02305758|474586211|FG000|Overall Study|Study Terminated by Sponsor|21|||
131809838|NCT02305758|474586212|FG001|Overall Study|Study Terminated by Sponsor|34|||
131809839|NCT02305758|474586211|FG000|Overall Study|Other, not specified|2|||
131809840|NCT02305758|474586212|FG001|Overall Study|Other, not specified|1|||
131809841|NCT05472038|474587938|FG000|Overall Study|Adverse Event|0|||
131752171|NCT01079195|474368200|FG000|Overall Study|No Documentation Available|437|||
131752172|NCT01079195|474368200|FG000|Overall Study|Adverse Event|157|||
131752173|NCT01079195|474368200|FG000|Overall Study|Reason Unknown|39|||
131752174|NCT01079195|474368200|FG000|Overall Study|Withdrawal by Subject|18|||
131752175|NCT01079195|474368200|FG000|Overall Study|Financial Reasons|15|||
131752176|NCT01079195|474368200|FG000|Overall Study|Lack of Effectiveness|12|||
131752177|NCT01079195|474368200|FG000|Overall Study|Physician Decision|4|||
131752178|NCT01079195|474368200|FG000|Overall Study|Improved Status of Participant|4|||
131752179|NCT01079195|474368200|FG000|Overall Study|No Follow-up Documentation Available|4|||
131752180|NCT01079195|474368200|FG000|Overall Study|Non-compliance|2|||
131752181|NCT01826448|474370022|FG000|Overall Study|Adverse Event|1|||
131752182|NCT01826448|474370023|FG001|Overall Study|Adverse Event|3|||
131752183|NCT01826448|474370022|FG000|Overall Study|Disease progression|2|||
131809842|NCT05472038|474587939|FG001|Overall Study|Adverse Event|0|||
131752184|NCT01826448|474370023|FG001|Overall Study|Disease progression|4|||
131752185|NCT01826448|474370022|FG000|Overall Study|Withdrawal by Subject|1|||
131752186|NCT01826448|474370023|FG001|Overall Study|Withdrawal by Subject|0|||
131752187|NCT01826448|474370022|FG000|Overall Study|Physician Decision|0|||
131752188|NCT01826448|474370023|FG001|Overall Study|Physician Decision|1|||
131752189|NCT01826448|474370022|FG000|Overall Study|2 active cancers|0|||
131752190|NCT01826448|474370023|FG001|Overall Study|2 active cancers|1|||
131752191|NCT00790218|474370027|FG000|Overall Study|Death|1|||
131752192|NCT00790218|474370028|FG001|Overall Study|Death|0|||
131752193|NCT00790218|474370029|FG002|Overall Study|Death|0|||
131752194|NCT00086385|474370030|FG000|Overall Study|Death|2|||
131752195|NCT00086385|474370031|FG001|Overall Study|Death|2|||
131752196|NCT00086385|474370032|FG002|Overall Study|Death|1|||
131752197|NCT00086385|474370033|FG003|Overall Study|Death|1|||
131752198|NCT00880100|474370038|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
131752199|NCT00880100|474370038|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
131752200|NCT00880100|474370038|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
131752201|NCT03424044|474370040|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752202|NCT03424044|474370041|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752203|NCT03424044|474370042|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
131752204|NCT03424044|474370043|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752205|NCT03424044|474370044|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752206|NCT03424044|474370045|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752207|NCT03424044|474370046|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752208|NCT03424044|474370047|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752209|NCT03424044|474370048|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131752210|NCT03424044|474370040|FG000|First Intervention (76 Hours)|Adverse Event|0|||
131752211|NCT03424044|474370041|FG001|First Intervention (76 Hours)|Adverse Event|0|||
131752212|NCT03424044|474370042|FG002|First Intervention (76 Hours)|Adverse Event|0|||
131752213|NCT03424044|474370043|FG003|First Intervention (76 Hours)|Adverse Event|0|||
131752214|NCT03424044|474370044|FG004|First Intervention (76 Hours)|Adverse Event|1|||
131752215|NCT03424044|474370045|FG005|First Intervention (76 Hours)|Adverse Event|0|||
131752216|NCT03424044|474370046|FG006|First Intervention (76 Hours)|Adverse Event|0|||
131752217|NCT03424044|474370047|FG007|First Intervention (76 Hours)|Adverse Event|0|||
131752218|NCT03424044|474370048|FG008|First Intervention (76 Hours)|Adverse Event|0|||
131752219|NCT03424044|474370040|FG000|First Intervention (76 Hours)|device issues|0|||
131752220|NCT03424044|474370041|FG001|First Intervention (76 Hours)|device issues|0|||
131752221|NCT03424044|474370042|FG002|First Intervention (76 Hours)|device issues|0|||
131752222|NCT03424044|474370043|FG003|First Intervention (76 Hours)|device issues|0|||
131752223|NCT03424044|474370044|FG004|First Intervention (76 Hours)|device issues|0|||
131752224|NCT03424044|474370045|FG005|First Intervention (76 Hours)|device issues|0|||
131752225|NCT03424044|474370046|FG006|First Intervention (76 Hours)|device issues|1|||
131752226|NCT03424044|474370047|FG007|First Intervention (76 Hours)|device issues|1|||
131752227|NCT03424044|474370048|FG008|First Intervention (76 Hours)|device issues|1|||
131752228|NCT03424044|474370040|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
131752229|NCT03424044|474370041|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
131752230|NCT03424044|474370042|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
131752231|NCT03424044|474370043|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
131752232|NCT03424044|474370044|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
131752233|NCT03424044|474370045|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
131752234|NCT03424044|474370046|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
131752235|NCT03424044|474370047|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
131752236|NCT03424044|474370048|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
131752237|NCT03424044|474370040|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752238|NCT03424044|474370041|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131809843|NCT05472038|474587940|FG002|Overall Study|Adverse Event|1|||
131809844|NCT05472038|474587941|FG003|Overall Study|Adverse Event|0|||
131809845|NCT05472038|474587942|FG004|Overall Study|Adverse Event|0|||
131809846|NCT05472038|474587943|FG005|Overall Study|Adverse Event|0|||
131809847|NCT05472038|474587944|FG006|Overall Study|Adverse Event|0|||
131809848|NCT05472038|474587945|FG007|Overall Study|Adverse Event|0|||
131809849|NCT05472038|474587946|FG008|Overall Study|Adverse Event|0|||
131809850|NCT05472038|474587947|FG009|Overall Study|Adverse Event|0|||
131809851|NCT05472038|474587948|FG010|Overall Study|Adverse Event|0|||
131752239|NCT03424044|474370042|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752240|NCT03424044|474370043|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
131752241|NCT03424044|474370044|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752242|NCT03424044|474370045|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752243|NCT03424044|474370046|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752244|NCT03424044|474370047|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752245|NCT03424044|474370048|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131752246|NCT02971007|474370051|FG000|Overall Study|Adverse Event|1|||
131752247|NCT02971007|474370052|FG001|Overall Study|Adverse Event|0|||
131752248|NCT02971007|474370053|FG002|Overall Study|Adverse Event|0|||
131906744|NCT03118934|474945238|FG004|Overall Study|Adverse Event|0|||
131906745|NCT03118934|474945239|FG005|Overall Study|Adverse Event|1|||
131906746|NCT03118934|474945234|FG000|Overall Study|Physician Decision|0|||
131906747|NCT03118934|474945235|FG001|Overall Study|Physician Decision|0|||
131906748|NCT03118934|474945236|FG002|Overall Study|Physician Decision|0|||
131906749|NCT03118934|474945237|FG003|Overall Study|Physician Decision|0|||
131906750|NCT03118934|474945238|FG004|Overall Study|Physician Decision|0|||
131906751|NCT03118934|474945239|FG005|Overall Study|Physician Decision|1|||
131906752|NCT03118934|474945234|FG000|Overall Study|Discontinued prior to exposure|0|||
131906753|NCT03118934|474945235|FG001|Overall Study|Discontinued prior to exposure|1|||
131906754|NCT03118934|474945236|FG002|Overall Study|Discontinued prior to exposure|1|||
131752249|NCT02971007|474370051|FG000|Overall Study|Lost to Follow-up|0|||
131752250|NCT02971007|474370052|FG001|Overall Study|Lost to Follow-up|1|||
131809852|NCT05472038|474587949|FG011|Overall Study|Adverse Event|0|||
131906755|NCT03118934|474945237|FG003|Overall Study|Discontinued prior to exposure|1|||
131809853|NCT05472038|474587938|FG000|Overall Study|Death|0|||
131752251|NCT02971007|474370053|FG002|Overall Study|Lost to Follow-up|1|||
131752252|NCT02971007|474370051|FG000|Overall Study|Withdrawal by Subject|0|||
131752253|NCT02971007|474370052|FG001|Overall Study|Withdrawal by Subject|1|||
131752254|NCT02971007|474370053|FG002|Overall Study|Withdrawal by Subject|0|||
131752255|NCT02971007|474370051|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
131752256|NCT02971007|474370052|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
131752257|NCT02971007|474370053|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
131752258|NCT02971007|474370051|FG000|Overall Study|Patient discontinued study drug|0|||
131752259|NCT02971007|474370052|FG001|Overall Study|Patient discontinued study drug|1|||
131752260|NCT02971007|474370053|FG002|Overall Study|Patient discontinued study drug|0|||
131752261|NCT02408484|474370063|FG000|Overall Study|Withdrawal by Subject|3|||
131752262|NCT02408484|474370063|FG000|Overall Study|Not treated during study period|1|||
131752263|NCT05516134|474370071|FG000|Overall Study|Lost to Follow-up|1|||
131752264|NCT05516134|474370072|FG001|Overall Study|Lost to Follow-up|0|||
131752265|NCT05516134|474370073|FG002|Overall Study|Lost to Follow-up|0|||
131752266|NCT03805971|474370074|FG000|Overall Study|Withdrawal by Subject|1|||
131752267|NCT03805971|474370074|FG000|Overall Study|Protocol Violation|2|||
131752268|NCT00254163|474370075|FG000|Overall Study|Adverse Event|29|||
131752269|NCT00254163|474370076|FG001|Overall Study|Adverse Event|26|||
131752270|NCT00254163|474370075|FG000|Overall Study|Patient request/withdrew consent|6|||
131752271|NCT00254163|474370076|FG001|Overall Study|Patient request/withdrew consent|4|||
131752272|NCT00254163|474370075|FG000|Overall Study|Investigator request|1|||
131752273|NCT00254163|474370076|FG001|Overall Study|Investigator request|3|||
131752274|NCT00254163|474370075|FG000|Overall Study|Failed entry|1|||
131752275|NCT00254163|474370076|FG001|Overall Study|Failed entry|3|||
131752276|NCT00254163|474370075|FG000|Overall Study|Progressive disease|0|||
131752277|NCT00254163|474370076|FG001|Overall Study|Progressive disease|1|||
131752278|NCT00254163|474370075|FG000|Overall Study|Death|0|||
131752279|NCT00254163|474370076|FG001|Overall Study|Death|1|||
131752280|NCT00254163|474370075|FG000|Overall Study|Other|8|||
131752281|NCT00254163|474370076|FG001|Overall Study|Other|8|||
131752282|NCT00517413|474370082|FG000|Overall Study|Adverse Event|7|||
131752283|NCT00517413|474370082|FG000|Overall Study|Death|13|||
131752284|NCT00517413|474370082|FG000|Overall Study|Protocol Violation|15|||
131752285|NCT00517413|474370082|FG000|Overall Study|Withdrawal by Subject|2|||
131752286|NCT00517413|474370082|FG000|Overall Study|Failure to return|1|||
131752287|NCT00517413|474370082|FG000|Overall Study|Other-Reasons|23|||
131752288|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Death|3|||
131752289|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Death|0|||
131752290|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Death|0|||
131752291|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Death|0|||
131752292|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Death|0|||
131752293|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
131752294|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
131752295|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
131809854|NCT05472038|474587939|FG001|Overall Study|Death|0|||
131809855|NCT05472038|474587940|FG002|Overall Study|Death|0|||
131809856|NCT05472038|474587941|FG003|Overall Study|Death|0|||
131809857|NCT05472038|474587942|FG004|Overall Study|Death|0|||
131809858|NCT05472038|474587943|FG005|Overall Study|Death|1|||
131809859|NCT05472038|474587944|FG006|Overall Study|Death|0|||
131809860|NCT05472038|474587945|FG007|Overall Study|Death|0|||
131809861|NCT05472038|474587946|FG008|Overall Study|Death|0|||
131809862|NCT05472038|474587947|FG009|Overall Study|Death|0|||
131809863|NCT05472038|474587948|FG010|Overall Study|Death|0|||
131809864|NCT05472038|474587949|FG011|Overall Study|Death|0|||
131752296|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
131752297|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
131752298|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131752299|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
131752300|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
131809865|NCT05472038|474587938|FG000|Overall Study|Lost to Follow-up|1|||
131809866|NCT05472038|474587939|FG001|Overall Study|Lost to Follow-up|3|||
131752301|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131752302|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
131809867|NCT05472038|474587940|FG002|Overall Study|Lost to Follow-up|3|||
131809868|NCT05472038|474587941|FG003|Overall Study|Lost to Follow-up|9|||
131752303|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Other|0|||
131752304|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Other|0|||
131752305|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Other|1|||
131752306|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Other|0|||
131752307|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Other|0|||
131809869|NCT05472038|474587942|FG004|Overall Study|Lost to Follow-up|2|||
131809870|NCT05472038|474587943|FG005|Overall Study|Lost to Follow-up|2|||
131752308|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
131752309|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
131752310|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
131752311|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
131752312|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
131752313|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
131752314|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
131752315|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
131752316|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
131752317|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
131752318|NCT01224106|474370083|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131752319|NCT01224106|474370084|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131752320|NCT01224106|474370085|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131752321|NCT01224106|474370086|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131752322|NCT01224106|474370087|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131752323|NCT01224106|474370083|FG000|Open-Label Extension (OLE) Phase|Death|0|||
131752324|NCT01224106|474370084|FG001|Open-Label Extension (OLE) Phase|Death|0|||
131752325|NCT01224106|474370085|FG002|Open-Label Extension (OLE) Phase|Death|0|||
131752326|NCT01224106|474370086|FG003|Open-Label Extension (OLE) Phase|Death|1|||
131752327|NCT01224106|474370087|FG004|Open-Label Extension (OLE) Phase|Death|3|||
131752328|NCT01224106|474370083|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131752329|NCT01224106|474370084|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131752330|NCT01224106|474370085|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131752331|NCT01224106|474370086|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
131752332|NCT01224106|474370087|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
131752333|NCT01224106|474370083|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
131752334|NCT01224106|474370084|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
131752335|NCT01224106|474370085|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
131752336|NCT01224106|474370086|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
131752337|NCT01224106|474370087|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
131752338|NCT01224106|474370083|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
131752339|NCT01224106|474370084|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
131752340|NCT01224106|474370085|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
131752341|NCT01224106|474370086|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
131752342|NCT01224106|474370087|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
131752343|NCT01224106|474370083|FG000|Open-Label Extension (OLE) Phase|Other|0|||
131752344|NCT01224106|474370084|FG001|Open-Label Extension (OLE) Phase|Other|0|||
131752345|NCT01224106|474370085|FG002|Open-Label Extension (OLE) Phase|Other|0|||
131752346|NCT01224106|474370086|FG003|Open-Label Extension (OLE) Phase|Other|5|||
131752347|NCT01224106|474370087|FG004|Open-Label Extension (OLE) Phase|Other|3|||
131752348|NCT00446797|474370090|FG000|Overall Study|Lack of Efficacy|0|||
131752349|NCT00446797|474370091|FG001|Overall Study|Lack of Efficacy|2|||
131752350|NCT00446797|474370090|FG000|Overall Study|Lost to Follow-up|5|||
131752351|NCT00446797|474370091|FG001|Overall Study|Lost to Follow-up|3|||
131752352|NCT00446797|474370090|FG000|Overall Study|Withdrawal by Subject|2|||
131752353|NCT00446797|474370091|FG001|Overall Study|Withdrawal by Subject|2|||
131752354|NCT00446797|474370090|FG000|Overall Study|Protocol Violation|1|||
131752355|NCT00446797|474370091|FG001|Overall Study|Protocol Violation|3|||
131752356|NCT00446797|474370090|FG000|Overall Study|subject entered at another site|0|||
131752357|NCT00446797|474370091|FG001|Overall Study|subject entered at another site|1|||
131752358|NCT00446797|474370090|FG000|Overall Study|did not meet entrance criteria|0|||
131752359|NCT00446797|474370091|FG001|Overall Study|did not meet entrance criteria|1|||
131752360|NCT00441727|474370092|FG000|Overall Study|Protocol Violation|19|||
131752361|NCT00441727|474370093|FG001|Overall Study|Protocol Violation|28|||
131752362|NCT00441727|474370094|FG002|Overall Study|Protocol Violation|32|||
131752363|NCT00441727|474370092|FG000|Overall Study|Adverse Event|26|||
131752364|NCT00441727|474370093|FG001|Overall Study|Adverse Event|33|||
131752365|NCT00441727|474370094|FG002|Overall Study|Adverse Event|28|||
131752366|NCT00441727|474370092|FG000|Overall Study|Lack of Efficacy|7|||
131752367|NCT00441727|474370093|FG001|Overall Study|Lack of Efficacy|8|||
131752368|NCT00441727|474370094|FG002|Overall Study|Lack of Efficacy|48|||
131752369|NCT00441727|474370092|FG000|Overall Study|Withdrawal by Subject|40|||
131752370|NCT00441727|474370093|FG001|Overall Study|Withdrawal by Subject|34|||
131752371|NCT00441727|474370094|FG002|Overall Study|Withdrawal by Subject|47|||
131752372|NCT00441727|474370092|FG000|Overall Study|Lost to Follow-up|5|||
131752373|NCT00441727|474370093|FG001|Overall Study|Lost to Follow-up|6|||
131752374|NCT00441727|474370094|FG002|Overall Study|Lost to Follow-up|5|||
131752375|NCT00441727|474370092|FG000|Overall Study|Safety Reasons|3|||
131752376|NCT00441727|474370093|FG001|Overall Study|Safety Reasons|1|||
131752377|NCT00441727|474370094|FG002|Overall Study|Safety Reasons|3|||
131752378|NCT00441727|474370092|FG000|Overall Study|Various reason specified|6|||
131752379|NCT00441727|474370093|FG001|Overall Study|Various reason specified|8|||
131752380|NCT00441727|474370094|FG002|Overall Study|Various reason specified|5|||
131752381|NCT03551626|474370099|FG000|Overall Study|Adverse Event|88|||
131752382|NCT03551626|474370099|FG000|Overall Study|Disease relapse|18|||
131752383|NCT03551626|474370099|FG000|Overall Study|Withdrawal of informed consent|6|||
131752384|NCT03551626|474370099|FG000|Overall Study|Patient decision|5|||
131752385|NCT03551626|474370099|FG000|Overall Study|Physician Decision|4|||
131752386|NCT03551626|474370099|FG000|Overall Study|Lost to Follow-up|3|||
131752387|NCT03551626|474370099|FG000|Overall Study|Pregnancy|1|||
131752388|NCT03551626|474370099|FG000|Overall Study|Protocol deviation|1|||
131752389|NCT03551626|474370099|FG000|Overall Study|Technical problems|1|||
131752390|NCT02133001|474370100|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
131752391|NCT02133001|474370101|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
131752392|NCT02133001|474370100|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
131752393|NCT02133001|474370101|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
131752394|NCT02133001|474370100|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
131752395|NCT02133001|474370101|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
131752396|NCT02133001|474370100|FG000|Double Blind (Day 1-25)|Other|2|||
131752397|NCT02133001|474370101|FG001|Double Blind (Day 1-25)|Other|2|||
131752398|NCT02133001|474370100|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
131752399|NCT02133001|474370101|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
131752400|NCT02133001|474370100|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
131752401|NCT02133001|474370101|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
131752402|NCT02133001|474370100|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
131752403|NCT02133001|474370101|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
131752404|NCT02133001|474370100|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
131752405|NCT02133001|474370101|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
131752406|NCT04211961|474370102|FG000|Overall Study|Death|0|||
131752407|NCT04211961|474370103|FG001|Overall Study|Death|1|||
131752408|NCT04211961|474370102|FG000|Overall Study|Lost to Follow-up|0|||
131752409|NCT04211961|474370103|FG001|Overall Study|Lost to Follow-up|1|||
131752410|NCT04211961|474370102|FG000|Overall Study|Withdrawal by Subject|0|||
131752411|NCT04211961|474370103|FG001|Overall Study|Withdrawal by Subject|1|||
131752412|NCT03135262|474370110|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
131752413|NCT03135262|474370111|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131809871|NCT05472038|474587944|FG006|Overall Study|Lost to Follow-up|1|||
131809872|NCT05472038|474587945|FG007|Overall Study|Lost to Follow-up|0|||
131809873|NCT05472038|474587946|FG008|Overall Study|Lost to Follow-up|1|||
131809874|NCT05472038|474587947|FG009|Overall Study|Lost to Follow-up|0|||
131809875|NCT05472038|474587948|FG010|Overall Study|Lost to Follow-up|2|||
131809876|NCT05472038|474587949|FG011|Overall Study|Lost to Follow-up|1|||
131809877|NCT05472038|474587938|FG000|Overall Study|Physician Decision|0|||
131809878|NCT05472038|474587939|FG001|Overall Study|Physician Decision|0|||
131809879|NCT05472038|474587940|FG002|Overall Study|Physician Decision|0|||
131809880|NCT05472038|474587941|FG003|Overall Study|Physician Decision|0|||
131809881|NCT05472038|474587942|FG004|Overall Study|Physician Decision|1|||
131809882|NCT05472038|474587943|FG005|Overall Study|Physician Decision|0|||
131752414|NCT03135262|474370112|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131752415|NCT03135262|474370113|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131809883|NCT05472038|474587944|FG006|Overall Study|Physician Decision|0|||
131906756|NCT03118934|474945238|FG004|Overall Study|Discontinued prior to exposure|2|||
131752416|NCT03135262|474370114|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131752417|NCT03135262|474370110|FG000|Overall Study|Progression of disease|0|||
131752418|NCT03135262|474370111|FG001|Overall Study|Progression of disease|0|||
131752419|NCT03135262|474370112|FG002|Overall Study|Progression of disease|0|||
131752420|NCT03135262|474370113|FG003|Overall Study|Progression of disease|1|||
131809884|NCT05472038|474587945|FG007|Overall Study|Physician Decision|0|||
131752421|NCT03135262|474370114|FG004|Overall Study|Progression of disease|0|||
131752422|NCT03135262|474370110|FG000|Overall Study|Death|6|||
131752423|NCT03135262|474370111|FG001|Overall Study|Death|2|||
131752424|NCT03135262|474370112|FG002|Overall Study|Death|2|||
131752425|NCT03135262|474370113|FG003|Overall Study|Death|2|||
131906757|NCT03118934|474945239|FG005|Overall Study|Discontinued prior to exposure|0|||
131906758|NCT02848664|474945253|FG000|Overall Study|Withdrawal by Subject|2|||
131906759|NCT02848664|474945253|FG000|Overall Study|Adverse Event|1|||
131906760|NCT02848664|474945253|FG000|Overall Study|no assistance for device training|1|||
131906761|NCT01204671|474945254|FG000|Overall Study|Adverse Event|4|||
131906762|NCT01204671|474945255|FG001|Overall Study|Adverse Event|3|||
131906763|NCT01204671|474945256|FG002|Overall Study|Adverse Event|3|||
131906764|NCT01204671|474945257|FG003|Overall Study|Adverse Event|3|||
131906765|NCT01204671|474945258|FG004|Overall Study|Adverse Event|1|||
131906766|NCT01204671|474945254|FG000|Overall Study|Withdrawal by Subject|2|||
131906767|NCT01204671|474945255|FG001|Overall Study|Withdrawal by Subject|3|||
131906768|NCT01204671|474945256|FG002|Overall Study|Withdrawal by Subject|4|||
131906769|NCT01204671|474945257|FG003|Overall Study|Withdrawal by Subject|5|||
131906770|NCT01204671|474945258|FG004|Overall Study|Withdrawal by Subject|3|||
131906771|NCT01204671|474945254|FG000|Overall Study|Lost to Follow-up|7|||
131906772|NCT01204671|474945255|FG001|Overall Study|Lost to Follow-up|8|||
131906773|NCT01204671|474945256|FG002|Overall Study|Lost to Follow-up|6|||
131906774|NCT01204671|474945257|FG003|Overall Study|Lost to Follow-up|4|||
131906775|NCT01204671|474945258|FG004|Overall Study|Lost to Follow-up|0|||
131906776|NCT01204671|474945254|FG000|Overall Study|Unknown Completion Status|1|||
131906777|NCT01204671|474945255|FG001|Overall Study|Unknown Completion Status|1|||
131906778|NCT01204671|474945256|FG002|Overall Study|Unknown Completion Status|0|||
131906779|NCT01204671|474945257|FG003|Overall Study|Unknown Completion Status|0|||
131906780|NCT01204671|474945258|FG004|Overall Study|Unknown Completion Status|0|||
131906781|NCT01204671|474945254|FG000|Overall Study|Physician Decision|0|||
131906782|NCT01204671|474945255|FG001|Overall Study|Physician Decision|0|||
131906783|NCT01204671|474945256|FG002|Overall Study|Physician Decision|0|||
131906784|NCT01204671|474945257|FG003|Overall Study|Physician Decision|1|||
131906785|NCT01204671|474945258|FG004|Overall Study|Physician Decision|0|||
131906786|NCT00449163|474945259|FG000|Overall Study|Physician Decision|3|||
131906787|NCT03106077|474945260|FG000|Overall Study|Screen Failure|94|||
131906788|NCT03106077|474945261|FG001|Overall Study|Screen Failure|0|||
131906789|NCT01274533|474945264|FG000|Overall Study|Withdrawal by Subject|1|||
131906790|NCT01274533|474945264|FG000|Overall Study|Non-compliance|1|||
131906791|NCT01274533|474945264|FG000|Overall Study|Disease progression|2|||
131906792|NCT00492726|474945273|FG000|Overall Study|Adverse Event|10|||
131906793|NCT00492726|474945274|FG001|Overall Study|Adverse Event|6|||
131906794|NCT00492726|474945273|FG000|Overall Study|Death|7|||
131906795|NCT00492726|474945274|FG001|Overall Study|Death|2|||
131906796|NCT00492726|474945273|FG000|Overall Study|Lack of Efficacy|0|||
131906797|NCT00492726|474945274|FG001|Overall Study|Lack of Efficacy|2|||
131906798|NCT00492726|474945273|FG000|Overall Study|Lost to Follow-up|27|||
131906799|NCT00492726|474945274|FG001|Overall Study|Lost to Follow-up|19|||
131906800|NCT00492726|474945273|FG000|Overall Study|Physician Decision|0|||
131906801|NCT00492726|474945274|FG001|Overall Study|Physician Decision|1|||
131752426|NCT03135262|474370114|FG004|Overall Study|Death|0|||
131752427|NCT03135262|474370110|FG000|Overall Study|Withdrawal by Subject|0|||
131906802|NCT00492726|474945273|FG000|Overall Study|Withdrawal by Subject|6|||
131906803|NCT00492726|474945274|FG001|Overall Study|Withdrawal by Subject|3|||
131906804|NCT00492726|474945273|FG000|Overall Study|Non compliant with study medication|0|||
131906805|NCT00492726|474945274|FG001|Overall Study|Non compliant with study medication|3|||
131906806|NCT04386902|474945275|FG000|Overall Study|Withdrawal by Subject|5|||
131906807|NCT04386902|474945275|FG000|Overall Study|Technical problems in the recording|5|||
131906808|NCT01712516|474946602|FG000|Overall Study|Technical problems|0|||
131906809|NCT01712516|474946603|FG001|Overall Study|Technical problems|0|||
131906810|NCT01712516|474946604|FG002|Overall Study|Technical problems|0|||
131906811|NCT01712516|474946605|FG003|Overall Study|Technical problems|2|||
131906812|NCT01712516|474946602|FG000|Overall Study|Lost to Follow-up|0|||
131906813|NCT01712516|474946603|FG001|Overall Study|Lost to Follow-up|0|||
131906814|NCT01712516|474946604|FG002|Overall Study|Lost to Follow-up|2|||
131906815|NCT01712516|474946605|FG003|Overall Study|Lost to Follow-up|1|||
131906816|NCT01712516|474946602|FG000|Overall Study|Death|0|||
131906817|NCT01712516|474946603|FG001|Overall Study|Death|1|||
131906818|NCT01712516|474946604|FG002|Overall Study|Death|0|||
131906819|NCT01712516|474946605|FG003|Overall Study|Death|0|||
131906820|NCT01712516|474946602|FG000|Overall Study|Protocol deviation|1|||
131906821|NCT01712516|474946603|FG001|Overall Study|Protocol deviation|0|||
131906822|NCT01712516|474946604|FG002|Overall Study|Protocol deviation|1|||
131906823|NCT01712516|474946605|FG003|Overall Study|Protocol deviation|0|||
131906824|NCT01712516|474946602|FG000|Overall Study|Physician Decision|2|||
131906825|NCT01712516|474946603|FG001|Overall Study|Physician Decision|0|||
131906826|NCT01712516|474946604|FG002|Overall Study|Physician Decision|0|||
131906827|NCT01712516|474946605|FG003|Overall Study|Physician Decision|1|||
131906828|NCT01712516|474946602|FG000|Overall Study|Withdrawal by Subject|3|||
131906829|NCT01712516|474946603|FG001|Overall Study|Withdrawal by Subject|9|||
131906830|NCT01712516|474946604|FG002|Overall Study|Withdrawal by Subject|3|||
131906831|NCT01712516|474946605|FG003|Overall Study|Withdrawal by Subject|9|||
131906832|NCT01181167|474946606|FG000|Overall Study|Adverse Event|11|||
131906833|NCT01181167|474946607|FG001|Overall Study|Adverse Event|21|||
131906834|NCT01181167|474946606|FG000|Overall Study|Lost to Follow-up|1|||
131809885|NCT05472038|474587946|FG008|Overall Study|Physician Decision|0|||
131809886|NCT05472038|474587947|FG009|Overall Study|Physician Decision|0|||
131809887|NCT05472038|474587948|FG010|Overall Study|Physician Decision|0|||
131809888|NCT05472038|474587949|FG011|Overall Study|Physician Decision|0|||
131809889|NCT05472038|474587938|FG000|Overall Study|Withdrawal by Subject|1|||
131809890|NCT05472038|474587939|FG001|Overall Study|Withdrawal by Subject|3|||
131809891|NCT05472038|474587940|FG002|Overall Study|Withdrawal by Subject|1|||
131809892|NCT05472038|474587941|FG003|Overall Study|Withdrawal by Subject|6|||
131809893|NCT05472038|474587942|FG004|Overall Study|Withdrawal by Subject|1|||
131809894|NCT05472038|474587943|FG005|Overall Study|Withdrawal by Subject|3|||
131809895|NCT05472038|474587944|FG006|Overall Study|Withdrawal by Subject|0|||
131809896|NCT05472038|474587945|FG007|Overall Study|Withdrawal by Subject|2|||
131809897|NCT05472038|474587946|FG008|Overall Study|Withdrawal by Subject|3|||
131809898|NCT05472038|474587947|FG009|Overall Study|Withdrawal by Subject|1|||
131809899|NCT05472038|474587948|FG010|Overall Study|Withdrawal by Subject|2|||
131809900|NCT05472038|474587949|FG011|Overall Study|Withdrawal by Subject|2|||
131809901|NCT05472038|474587938|FG000|Overall Study|Protocol Violation|0|||
131809902|NCT05472038|474587939|FG001|Overall Study|Protocol Violation|0|||
131809903|NCT05472038|474587940|FG002|Overall Study|Protocol Violation|0|||
131809904|NCT05472038|474587941|FG003|Overall Study|Protocol Violation|0|||
131809905|NCT05472038|474587942|FG004|Overall Study|Protocol Violation|0|||
131809906|NCT05472038|474587943|FG005|Overall Study|Protocol Violation|0|||
131809907|NCT05472038|474587944|FG006|Overall Study|Protocol Violation|0|||
131809908|NCT05472038|474587945|FG007|Overall Study|Protocol Violation|1|||
131809909|NCT05472038|474587946|FG008|Overall Study|Protocol Violation|1|||
131809910|NCT05472038|474587947|FG009|Overall Study|Protocol Violation|1|||
131809911|NCT05472038|474587948|FG010|Overall Study|Protocol Violation|1|||
131809912|NCT05472038|474587949|FG011|Overall Study|Protocol Violation|1|||
131809913|NCT05472038|474587938|FG000|Overall Study|Not vaccinated|0|||
131809914|NCT05472038|474587939|FG001|Overall Study|Not vaccinated|0|||
131809915|NCT05472038|474587940|FG002|Overall Study|Not vaccinated|0|||
131809916|NCT05472038|474587941|FG003|Overall Study|Not vaccinated|1|||
131809917|NCT05472038|474587942|FG004|Overall Study|Not vaccinated|0|||
131809918|NCT05472038|474587943|FG005|Overall Study|Not vaccinated|0|||
131809919|NCT05472038|474587944|FG006|Overall Study|Not vaccinated|0|||
131809920|NCT05472038|474587945|FG007|Overall Study|Not vaccinated|0|||
131809921|NCT05472038|474587946|FG008|Overall Study|Not vaccinated|0|||
131809922|NCT05472038|474587947|FG009|Overall Study|Not vaccinated|0|||
131809923|NCT05472038|474587948|FG010|Overall Study|Not vaccinated|0|||
131809924|NCT05472038|474587949|FG011|Overall Study|Not vaccinated|0|||
131809925|NCT02847650|474587954|FG000|Overall Study|Adverse Event|2|||
131809926|NCT02847650|474587955|FG001|Overall Study|Adverse Event|4|||
131809927|NCT02847650|474587954|FG000|Overall Study|Lost to Follow-up|1|||
131809928|NCT02847650|474587955|FG001|Overall Study|Lost to Follow-up|0|||
131809929|NCT02847650|474587954|FG000|Overall Study|Protocol Violation|0|||
131809930|NCT02847650|474587955|FG001|Overall Study|Protocol Violation|1|||
131809931|NCT02847650|474587954|FG000|Overall Study|Withdrawal by Subject|1|||
131809932|NCT02847650|474587955|FG001|Overall Study|Withdrawal by Subject|1|||
131809933|NCT02175095|474587958|FG000|Overall Study|Withdrawal by Subject|3|||
131809934|NCT03255733|474587959|FG000|Overall Study|Lost to Follow-up|4|||
131449337|NCT02592798|473274870|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
131449338|NCT02592798|473274871|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
131449339|NCT02592798|473274870|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
131449340|NCT02592798|473274871|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
131449341|NCT02592798|473274870|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
131449342|NCT02592798|473274871|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
131449343|NCT02592798|473274870|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
131449344|NCT02592798|473274871|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
131449345|NCT02592798|473274870|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
131449346|NCT02592798|473274871|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
131449347|NCT02592798|473274870|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
131449348|NCT02592798|473274871|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
131449349|NCT02592798|473274870|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
131449350|NCT02592798|473274871|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
131449351|NCT02592798|473274870|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
131449352|NCT02592798|473274871|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
131449353|NCT02592798|473274870|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
131449354|NCT02592798|473274871|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
131449355|NCT02592798|473274870|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
131449356|NCT02592798|473274871|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
131449357|NCT02592798|473274870|FG000|Transition From DB2 to OLE|Other reasons|1|||
131449358|NCT02592798|473274871|FG001|Transition From DB2 to OLE|Other reasons|0|||
131449359|NCT02592798|473274870|FG000|Open Label Period (OLE)|Other reasons|0|||
131449360|NCT02592798|473274871|FG001|Open Label Period (OLE)|Other reasons|2|||
131809935|NCT03653507|474587961|FG000|Overall Study|Miscellaneous|28|||
131809936|NCT03653507|474587962|FG001|Overall Study|Miscellaneous|19|||
131809937|NCT03653507|474587961|FG000|Overall Study|Withdrawal by Subject|37|||
131809938|NCT03653507|474587962|FG001|Overall Study|Withdrawal by Subject|22|||
131809939|NCT03653507|474587961|FG000|Overall Study|Protocol Deviation|2|||
131449361|NCT02592798|473274870|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
131449362|NCT02592798|473274871|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
131449363|NCT02592798|473274870|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
131449364|NCT02592798|473274871|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
131449365|NCT02592798|473274870|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
131449366|NCT02592798|473274871|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
131449367|NCT02592798|473274870|FG000|Open Label Period (OLE)|Adverse Event|0|||
131449368|NCT02592798|473274871|FG001|Open Label Period (OLE)|Adverse Event|1|||
131449369|NCT00705016|473274872|FG000|Overall Study|Adverse Event|6|||
131449370|NCT00705016|473274873|FG001|Overall Study|Adverse Event|11|||
131449371|NCT00705016|473274874|FG002|Overall Study|Adverse Event|10|||
131449372|NCT00705016|473274872|FG000|Overall Study|Death|5|||
131449373|NCT00705016|473274873|FG001|Overall Study|Death|7|||
131449374|NCT00705016|473274874|FG002|Overall Study|Death|5|||
131449375|NCT00705016|473274872|FG000|Overall Study|Protocol Violation|0|||
131449376|NCT00705016|473274873|FG001|Overall Study|Protocol Violation|1|||
131449377|NCT00705016|473274874|FG002|Overall Study|Protocol Violation|1|||
131449378|NCT00705016|473274872|FG000|Overall Study|Withdrawal by Subject|4|||
131449379|NCT00705016|473274873|FG001|Overall Study|Withdrawal by Subject|3|||
131449380|NCT00705016|473274874|FG002|Overall Study|Withdrawal by Subject|2|||
131449381|NCT00705016|473274872|FG000|Overall Study|Progressive Disease|33|||
131449382|NCT00705016|473274873|FG001|Overall Study|Progressive Disease|29|||
131449383|NCT00705016|473274874|FG002|Overall Study|Progressive Disease|33|||
131449384|NCT00705016|473274872|FG000|Overall Study|Symptomatic Deterioration|3|||
131449385|NCT00705016|473274873|FG001|Overall Study|Symptomatic Deterioration|1|||
131449386|NCT00705016|473274874|FG002|Overall Study|Symptomatic Deterioration|1|||
131449387|NCT00705016|473274872|FG000|Overall Study|Other|9|||
131752428|NCT03135262|474370111|FG001|Overall Study|Withdrawal by Subject|0|||
131752429|NCT03135262|474370112|FG002|Overall Study|Withdrawal by Subject|1|||
131752430|NCT03135262|474370113|FG003|Overall Study|Withdrawal by Subject|0|||
131752431|NCT03135262|474370114|FG004|Overall Study|Withdrawal by Subject|1|||
131752432|NCT03135262|474370110|FG000|Overall Study|Study terminated by sponsor|2|||
131752433|NCT03135262|474370111|FG001|Overall Study|Study terminated by sponsor|4|||
131752434|NCT03135262|474370112|FG002|Overall Study|Study terminated by sponsor|4|||
131752435|NCT03135262|474370113|FG003|Overall Study|Study terminated by sponsor|3|||
131809940|NCT03653507|474587962|FG001|Overall Study|Protocol Deviation|1|||
131809941|NCT03653507|474587961|FG000|Overall Study|Progressive disease|117|||
131809942|NCT03653507|474587962|FG001|Overall Study|Progressive disease|168|||
131449388|NCT00705016|473274873|FG001|Overall Study|Other|6|||
131449389|NCT00705016|473274874|FG002|Overall Study|Other|6|||
131752436|NCT03135262|474370114|FG004|Overall Study|Study terminated by sponsor|0|||
131752437|NCT01599806|474370116|FG000|Overall Study|Lost to Follow-up|20|||
131752438|NCT01599806|474370117|FG001|Overall Study|Lost to Follow-up|20|||
131809943|NCT03653507|474587961|FG000|Overall Study|Lost to Follow-up|1|||
131809944|NCT03653507|474587962|FG001|Overall Study|Lost to Follow-up|1|||
131809945|NCT03653507|474587961|FG000|Overall Study|Death|25|||
131752439|NCT01599806|474370116|FG000|Overall Study|Withdrawal by Subject|12|||
131752440|NCT01599806|474370117|FG001|Overall Study|Withdrawal by Subject|12|||
131752441|NCT01599806|474370116|FG000|Overall Study|Other Eligibility criteria|11|||
131752442|NCT01599806|474370117|FG001|Overall Study|Other Eligibility criteria|9|||
131752443|NCT01266070|474370127|FG000|Overall Study|Adverse Event|3|||
131752444|NCT01266070|474370127|FG000|Overall Study|Protocol Violation|1|||
131752445|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
131752446|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
131752447|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
131752448|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
131752449|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
131752450|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131752451|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
131752452|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131752453|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131752454|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131752455|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131752456|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
131449390|NCT03853109|473274877|FG000|Overall Study|Withdrawal by Subject|0|||
131449391|NCT03853109|473274878|FG001|Overall Study|Withdrawal by Subject|0|||
131752457|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131752458|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131752459|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131752460|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
131752461|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
131752462|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
131752463|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
131752464|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
131752465|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
131752466|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
131752467|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
131752468|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
131752469|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
131752470|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
131752471|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
131752472|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
131752473|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
131752474|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
131752475|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
131752476|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
131752477|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
131752478|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
131752479|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
131752480|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
131752481|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
131752482|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
131752483|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
131752484|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
131752485|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
131752486|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
131752487|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
131752488|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
131752489|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
131752490|NCT03689972|474370128|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
131752491|NCT03689972|474370129|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
131752492|NCT03689972|474370130|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
131809946|NCT03653507|474587962|FG001|Overall Study|Death|22|||
131809947|NCT03653507|474587961|FG000|Overall Study|Adverse Event|35|||
131809948|NCT03653507|474587962|FG001|Overall Study|Adverse Event|14|||
131809949|NCT03697109|474587963|FG000|Open-label (OL) Phase|Adverse Event|24|||
131809950|NCT03697109|474587964|FG001|Open-label (OL) Phase|Adverse Event|0|||
131809951|NCT03697109|474587965|FG002|Open-label (OL) Phase|Adverse Event|0|||
131809952|NCT03697109|474587963|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
131809953|NCT03697109|474587964|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
131809954|NCT03697109|474587965|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
131809955|NCT03697109|474587963|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
131809956|NCT03697109|474587964|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
131906835|NCT01181167|474946607|FG001|Overall Study|Lost to Follow-up|0|||
131449392|NCT03853109|473274879|FG002|Overall Study|Withdrawal by Subject|1|||
131449393|NCT03853109|473274880|FG003|Overall Study|Withdrawal by Subject|2|||
131449394|NCT03853109|473274881|FG004|Overall Study|Withdrawal by Subject|1|||
131449395|NCT03853109|473274882|FG005|Overall Study|Withdrawal by Subject|4|||
131449396|NCT03853109|473274883|FG006|Overall Study|Withdrawal by Subject|5|||
131449397|NCT03853109|473274884|FG007|Overall Study|Withdrawal by Subject|3|||
131449398|NCT03853109|473274877|FG000|Overall Study|Decision by Sponsor|0|||
131449399|NCT03853109|473274878|FG001|Overall Study|Decision by Sponsor|0|||
131449400|NCT03853109|473274879|FG002|Overall Study|Decision by Sponsor|1|||
131449401|NCT03853109|473274880|FG003|Overall Study|Decision by Sponsor|0|||
131449402|NCT03853109|473274881|FG004|Overall Study|Decision by Sponsor|1|||
131449403|NCT03853109|473274882|FG005|Overall Study|Decision by Sponsor|1|||
131449404|NCT03853109|473274883|FG006|Overall Study|Decision by Sponsor|10|||
131449405|NCT03853109|473274884|FG007|Overall Study|Decision by Sponsor|2|||
131449406|NCT03853109|473274877|FG000|Overall Study|Lost to Follow-up|0|||
131449407|NCT03853109|473274878|FG001|Overall Study|Lost to Follow-up|0|||
131449408|NCT03853109|473274879|FG002|Overall Study|Lost to Follow-up|0|||
131449409|NCT03853109|473274880|FG003|Overall Study|Lost to Follow-up|0|||
131449410|NCT03853109|473274881|FG004|Overall Study|Lost to Follow-up|1|||
131449411|NCT03853109|473274882|FG005|Overall Study|Lost to Follow-up|3|||
131449412|NCT03853109|473274883|FG006|Overall Study|Lost to Follow-up|0|||
131449413|NCT03853109|473274884|FG007|Overall Study|Lost to Follow-up|0|||
131449414|NCT03853109|473274877|FG000|Overall Study|Death|2|||
131449415|NCT03853109|473274878|FG001|Overall Study|Death|5|||
131449416|NCT03853109|473274879|FG002|Overall Study|Death|8|||
131449417|NCT03853109|473274880|FG003|Overall Study|Death|10|||
131449418|NCT03853109|473274881|FG004|Overall Study|Death|3|||
131449419|NCT03853109|473274882|FG005|Overall Study|Death|20|||
131449420|NCT03853109|473274883|FG006|Overall Study|Death|10|||
131449421|NCT03853109|473274884|FG007|Overall Study|Death|5|||
131449422|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
131449423|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
131449424|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
131449425|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
131449426|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
131449427|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
131809957|NCT03697109|474587965|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
131809958|NCT03697109|474587963|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
131809959|NCT03697109|474587964|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
131809960|NCT03697109|474587965|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
131809961|NCT03697109|474587963|FG000|Open-label (OL) Phase|Physician Decision|2|||
131809962|NCT03697109|474587964|FG001|Open-label (OL) Phase|Physician Decision|0|||
131809963|NCT03697109|474587965|FG002|Open-label (OL) Phase|Physician Decision|0|||
131809964|NCT03697109|474587963|FG000|Open-label (OL) Phase|Death|2|||
131449428|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
131449429|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
131449430|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
131449431|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
131449432|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
131449433|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
131449434|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
131449435|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
131449436|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
131449437|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
131449438|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
131449439|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
131449440|NCT02952820|473274889|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
131449441|NCT02952820|473274890|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
131449442|NCT02952820|473274891|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
131449443|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
131449444|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
131449445|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
131809965|NCT03697109|474587964|FG001|Open-label (OL) Phase|Death|0|||
131809966|NCT03697109|474587965|FG002|Open-label (OL) Phase|Death|0|||
131809967|NCT03697109|474587963|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
131809968|NCT03697109|474587964|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
131449446|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
131449447|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
131449448|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
131449449|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
131449450|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
131449451|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
131449452|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
131752493|NCT03689972|474370131|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
131752494|NCT03689972|474370132|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
131752495|NCT03689972|474370128|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131752496|NCT03689972|474370129|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131752497|NCT03689972|474370130|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
131752498|NCT03689972|474370131|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131752499|NCT03689972|474370132|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131752500|NCT03689972|474370128|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131752501|NCT03689972|474370129|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131752502|NCT03689972|474370130|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
131752503|NCT03689972|474370131|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131752504|NCT03689972|474370132|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131752505|NCT03689972|474370128|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131752506|NCT03689972|474370129|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131752507|NCT03689972|474370130|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
131752508|NCT03689972|474370131|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131752509|NCT03689972|474370132|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131752510|NCT03689972|474370128|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
131752511|NCT03689972|474370129|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
131752512|NCT03689972|474370130|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
131752513|NCT03689972|474370131|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
131752514|NCT03689972|474370132|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
131752515|NCT03689972|474370128|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
131752516|NCT03689972|474370129|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
131752517|NCT03689972|474370130|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
131752518|NCT03689972|474370131|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
131752519|NCT03689972|474370132|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
131752520|NCT03689972|474370128|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
131752521|NCT03689972|474370129|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
131752522|NCT03689972|474370130|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
131752523|NCT03689972|474370131|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
131752524|NCT03689972|474370132|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
131752525|NCT03689972|474370128|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131752526|NCT03689972|474370129|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131752527|NCT03689972|474370130|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131752528|NCT03689972|474370131|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131752529|NCT03689972|474370132|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
131449453|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
131752530|NCT03689972|474370128|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
131752531|NCT03689972|474370129|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
131752532|NCT03689972|474370130|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
131752533|NCT03689972|474370131|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
131752534|NCT03689972|474370132|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
131752535|NCT03689972|474370128|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131752536|NCT03689972|474370129|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131752537|NCT03689972|474370130|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131752538|NCT03689972|474370131|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131752539|NCT03689972|474370132|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
131752540|NCT01838213|474370133|FG000|Overall Study|Ineligible|166|||
131752541|NCT01838213|474370134|FG001|Overall Study|Ineligible|191|||
131752542|NCT02417064|474370135|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
131752543|NCT02417064|474370136|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
131752544|NCT02417064|474370137|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
131752545|NCT02417064|474370135|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
131752546|NCT02417064|474370136|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
131752547|NCT02417064|474370137|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
131752548|NCT02417064|474370135|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
131752549|NCT02417064|474370136|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
131752550|NCT02417064|474370137|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
131752551|NCT02417064|474370135|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
131752552|NCT02417064|474370136|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
131752553|NCT02417064|474370137|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
131752554|NCT02417064|474370135|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
131752555|NCT02417064|474370136|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
131752556|NCT02417064|474370137|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
131809969|NCT03697109|474587965|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
131809970|NCT03697109|474587963|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
131809971|NCT03697109|474587964|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
131809972|NCT03697109|474587965|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
131809973|NCT03697109|474587963|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
131809974|NCT03697109|474587964|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
131752557|NCT02417064|474370135|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
131752558|NCT02417064|474370136|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
131906836|NCT01181167|474946606|FG000|Overall Study|Physician Decision|2|||
131906837|NCT01181167|474946607|FG001|Overall Study|Physician Decision|3|||
131809975|NCT03697109|474587965|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
131809976|NCT02096211|474587966|FG000|Overall Study|Death|2|||
131809977|NCT02096211|474587966|FG000|Overall Study|Withdrawal by Subject|8|||
131809978|NCT02096211|474587966|FG000|Overall Study|Revision of implant|7|||
131809979|NCT02096211|474587966|FG000|Overall Study|Lost to Follow-up|43|||
131809980|NCT00834522|474587969|FG000|Washout|Adverse Event|1|||
131809981|NCT00834522|474587970|FG001|Washout|Adverse Event|0|||
131809982|NCT00834522|474587969|FG000|Washout|Withdrawal by Subject|2|||
131809983|NCT00834522|474587970|FG001|Washout|Withdrawal by Subject|1|||
131809984|NCT04516967|474587971|FG000|Core Phase|Adverse Event|2|||
131809985|NCT04516967|474587972|FG001|Core Phase|Adverse Event|1|||
131809986|NCT04516967|474587973|FG002|Core Phase|Adverse Event|0|||
131809987|NCT04516967|474587971|FG000|Core Phase|Physician Decision|1|||
131809988|NCT04516967|474587972|FG001|Core Phase|Physician Decision|1|||
131809989|NCT04516967|474587973|FG002|Core Phase|Physician Decision|0|||
131809990|NCT04516967|474587971|FG000|Core Phase|Lack of Efficacy|7|||
131809991|NCT04516967|474587972|FG001|Core Phase|Lack of Efficacy|18|||
131809992|NCT04516967|474587973|FG002|Core Phase|Lack of Efficacy|0|||
131809993|NCT00519194|474587974|FG000|Overall Study|Withdrawal by Subject|9|||
131809994|NCT00519194|474587974|FG000|Overall Study|Death|9|||
131809995|NCT00519194|474587974|FG000|Overall Study|Lost to Follow-up|3|||
131809996|NCT03165994|474587975|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
131809997|NCT03165994|474587975|FG000|Overall Study|Death|2|||
131809998|NCT03165994|474587975|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
131809999|NCT03165994|474587975|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
131810000|NCT03165994|474587975|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
131810001|NCT03165994|474587975|FG000|Overall Study|Miscellaneous|1|||
131810002|NCT03616535|474587980|FG000|Overall Study|Death|2|||
131810003|NCT03616535|474587981|FG001|Overall Study|Death|0|||
131810004|NCT03616535|474587982|FG002|Overall Study|Death|0|||
131810005|NCT03616535|474587983|FG003|Overall Study|Death|1|||
131810006|NCT03616535|474587980|FG000|Overall Study|Lost to Follow-up|2|||
131810007|NCT03616535|474587981|FG001|Overall Study|Lost to Follow-up|1|||
131810008|NCT03616535|474587982|FG002|Overall Study|Lost to Follow-up|0|||
131810009|NCT03616535|474587983|FG003|Overall Study|Lost to Follow-up|2|||
131810010|NCT03616535|474587980|FG000|Overall Study|Withdrawal by Subject|1|||
131810011|NCT03616535|474587981|FG001|Overall Study|Withdrawal by Subject|2|||
131810012|NCT03616535|474587982|FG002|Overall Study|Withdrawal by Subject|5|||
131810013|NCT03616535|474587983|FG003|Overall Study|Withdrawal by Subject|1|||
131810014|NCT03616535|474587980|FG000|Overall Study|Not specified or change in eligibility|2|||
131810015|NCT03616535|474587981|FG001|Overall Study|Not specified or change in eligibility|3|||
131810016|NCT03616535|474587982|FG002|Overall Study|Not specified or change in eligibility|3|||
131810017|NCT03616535|474587983|FG003|Overall Study|Not specified or change in eligibility|1|||
131810018|NCT00365365|474587984|FG000|Overall Study|Randomized but not treated|0|||
131810019|NCT00365365|474587985|FG001|Overall Study|Randomized but not treated|2|||
131810020|NCT00365365|474587986|FG002|Overall Study|Randomized but not treated|0|||
131810021|NCT00365365|474587984|FG000|Overall Study|Poor compliance to protocol|0|||
131810022|NCT00365365|474587985|FG001|Overall Study|Poor compliance to protocol|1|||
131810023|NCT00365365|474587986|FG002|Overall Study|Poor compliance to protocol|0|||
131810024|NCT00365365|474587984|FG000|Overall Study|Lost to Follow-up|3|||
131810025|NCT00365365|474587985|FG001|Overall Study|Lost to Follow-up|3|||
131810026|NCT00365365|474587986|FG002|Overall Study|Lost to Follow-up|3|||
131810027|NCT00365365|474587984|FG000|Overall Study|Death|1|||
131810028|NCT00365365|474587985|FG001|Overall Study|Death|3|||
131810029|NCT00365365|474587986|FG002|Overall Study|Death|0|||
131810030|NCT00365365|474587984|FG000|Overall Study|Subject's request|11|||
131810031|NCT00365365|474587985|FG001|Overall Study|Subject's request|13|||
131810032|NCT00365365|474587986|FG002|Overall Study|Subject's request|1|||
131810033|NCT00365365|474587984|FG000|Overall Study|Disease progression/relapse|9|||
131810034|NCT00365365|474587985|FG001|Overall Study|Disease progression/relapse|6|||
131810035|NCT00365365|474587986|FG002|Overall Study|Disease progression/relapse|7|||
131810036|NCT00365365|474587984|FG000|Overall Study|Adverse Event|6|||
131810037|NCT00365365|474587985|FG001|Overall Study|Adverse Event|6|||
131810038|NCT00365365|474587986|FG002|Overall Study|Adverse Event|3|||
131810039|NCT00365365|474587984|FG000|Overall Study|Moved|2|||
131810040|NCT00365365|474587985|FG001|Overall Study|Moved|0|||
131810041|NCT00365365|474587986|FG002|Overall Study|Moved|0|||
131810042|NCT00365365|474587984|FG000|Overall Study|New cancer|1|||
131810043|NCT00365365|474587985|FG001|Overall Study|New cancer|0|||
131810044|NCT00365365|474587986|FG002|Overall Study|New cancer|0|||
131810045|NCT00365365|474587984|FG000|Overall Study|Withdrew consent|1|||
131810046|NCT00365365|474587985|FG001|Overall Study|Withdrew consent|1|||
131810047|NCT00365365|474587986|FG002|Overall Study|Withdrew consent|0|||
131810048|NCT00365365|474587984|FG000|Overall Study|Second malignancy|0|||
131810049|NCT00365365|474587985|FG001|Overall Study|Second malignancy|1|||
131810050|NCT00365365|474587986|FG002|Overall Study|Second malignancy|0|||
131810051|NCT00365365|474587984|FG000|Overall Study|Patient/physician decision|0|||
131810052|NCT00365365|474587985|FG001|Overall Study|Patient/physician decision|0|||
131810053|NCT00365365|474587986|FG002|Overall Study|Patient/physician decision|1|||
131449454|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
131449455|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
131449456|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
131449457|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
131449458|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
131449459|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
131449460|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
131449461|NCT02952820|473274889|FG000|Active Treatment Period (6 Months)|Not treated|0|||
131449462|NCT02952820|473274890|FG001|Active Treatment Period (6 Months)|Not treated|0|||
131449463|NCT02952820|473274891|FG002|Active Treatment Period (6 Months)|Not treated|1|||
131449464|NCT03486834|473274892|FG000|Overall Study|Withdrawal by Subject|46|||
131449465|NCT03486834|473274893|FG001|Overall Study|Withdrawal by Subject|46|||
131449466|NCT03486834|473274894|FG002|Overall Study|Withdrawal by Subject|52|||
131449467|NCT03486834|473274892|FG000|Overall Study|Adverse Event|8|||
131449468|NCT03486834|473274893|FG001|Overall Study|Adverse Event|7|||
131449469|NCT03486834|473274894|FG002|Overall Study|Adverse Event|0|||
131449470|NCT03486834|473274892|FG000|Overall Study|Lost to Follow-up|41|||
131449471|NCT03486834|473274893|FG001|Overall Study|Lost to Follow-up|24|||
131449472|NCT03486834|473274894|FG002|Overall Study|Lost to Follow-up|39|||
131449473|NCT03486834|473274892|FG000|Overall Study|Non-compliance with Study Drug|2|||
131449474|NCT03486834|473274893|FG001|Overall Study|Non-compliance with Study Drug|2|||
131449475|NCT03486834|473274894|FG002|Overall Study|Non-compliance with Study Drug|0|||
131449476|NCT03486834|473274892|FG000|Overall Study|Physician Decision|5|||
131449477|NCT03486834|473274893|FG001|Overall Study|Physician Decision|2|||
131449478|NCT03486834|473274894|FG002|Overall Study|Physician Decision|3|||
131449479|NCT03486834|473274892|FG000|Overall Study|Pregnancy|10|||
131449480|NCT03486834|473274893|FG001|Overall Study|Pregnancy|12|||
131449481|NCT03486834|473274894|FG002|Overall Study|Pregnancy|12|||
131449482|NCT03486834|473274892|FG000|Overall Study|Protocol Deviation|2|||
131449483|NCT03486834|473274893|FG001|Overall Study|Protocol Deviation|3|||
131449484|NCT03486834|473274894|FG002|Overall Study|Protocol Deviation|3|||
131449485|NCT03486834|473274892|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131449486|NCT03486834|473274893|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131449487|NCT03486834|473274894|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
131449488|NCT03486834|473274892|FG000|Overall Study|Randomized but not treated|4|||
131449489|NCT03486834|473274893|FG001|Overall Study|Randomized but not treated|4|||
131449490|NCT03486834|473274894|FG002|Overall Study|Randomized but not treated|1|||
131449491|NCT01094119|473274895|FG000|Overall Study|Lack of Efficacy|2|||
131449492|NCT01094119|473274896|FG001|Overall Study|Lack of Efficacy|4|||
131449493|NCT03326713|473274905|FG000|Overall Study|Death|2|||
131449494|NCT03326713|473274906|FG001|Overall Study|Death|1|||
131449495|NCT03326713|473274907|FG002|Overall Study|Death|0|||
131449496|NCT03326713|473274905|FG000|Overall Study|Lost to Follow-up|20|||
131449497|NCT03326713|473274906|FG001|Overall Study|Lost to Follow-up|21|||
131449498|NCT03326713|473274907|FG002|Overall Study|Lost to Follow-up|33|||
131752559|NCT02417064|474370137|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
131449499|NCT03326713|473274905|FG000|Overall Study|Withdrawal by Subject|1|||
131752560|NCT02417064|474370135|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
131752561|NCT02417064|474370136|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
131752562|NCT02417064|474370137|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
131752563|NCT02417064|474370135|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
131752564|NCT02417064|474370136|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
131752565|NCT02417064|474370137|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
131752566|NCT02417064|474370135|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
131752567|NCT02417064|474370136|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
131752568|NCT02417064|474370137|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
131752569|NCT02417064|474370135|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
131752570|NCT02417064|474370136|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
131752571|NCT02417064|474370137|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
131752572|NCT02417064|474370135|FG000|Follow-up Phase (24 Weeks)|Other|2|||
131752573|NCT02417064|474370136|FG001|Follow-up Phase (24 Weeks)|Other|2|||
131752574|NCT02417064|474370137|FG002|Follow-up Phase (24 Weeks)|Other|3|||
131752575|NCT01548417|474370140|FG000|Overall Study|Withdrawal by Subject|0|||
131752576|NCT01548417|474370141|FG001|Overall Study|Withdrawal by Subject|2|||
131752577|NCT02810951|474370143|FG000|Overall Study|Adverse Event|1|||
131752578|NCT01928082|474370147|FG000|Overall Study|Study terminated.|1|||
131449500|NCT03326713|473274906|FG001|Overall Study|Withdrawal by Subject|2|||
131449501|NCT03326713|473274907|FG002|Overall Study|Withdrawal by Subject|11|||
131449502|NCT03326713|473274905|FG000|Overall Study|Found Ineligible|11|||
131449503|NCT03326713|473274906|FG001|Overall Study|Found Ineligible|11|||
131449504|NCT03326713|473274907|FG002|Overall Study|Found Ineligible|8|||
131449505|NCT01394016|473274910|FG000|Overall Study|Progressive Disease|2|||
131449506|NCT01394016|473274911|FG001|Overall Study|Progressive Disease|0|||
131449507|NCT01394016|473274912|FG002|Overall Study|Progressive Disease|0|||
131810054|NCT00984022|474587987|FG000|Overall Study|Lost to Follow-up|10|||
131810055|NCT00984022|474587988|FG001|Overall Study|Lost to Follow-up|14|||
131810056|NCT00573443|474587989|FG000|Double-Blind Phase|Lost to Follow-up|1|||
131810057|NCT00573443|474587990|FG001|Double-Blind Phase|Lost to Follow-up|3|||
131810058|NCT00573443|474587991|FG002|Double-Blind Phase|Lost to Follow-up|2|||
131810059|NCT00573443|474587989|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
131810060|NCT00573443|474587990|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
131810061|NCT00573443|474587991|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
131810062|NCT00573443|474587989|FG000|Double-Blind Phase|Adverse Event|1|||
131810063|NCT00573443|474587990|FG001|Double-Blind Phase|Adverse Event|5|||
131810064|NCT00573443|474587991|FG002|Double-Blind Phase|Adverse Event|0|||
131810065|NCT00573443|474587989|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
131810066|NCT00573443|474587990|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
131810067|NCT00573443|474587991|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
131810068|NCT00573443|474587989|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
131810069|NCT00573443|474587990|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
131810070|NCT00573443|474587991|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
131810071|NCT00573443|474587989|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
131810072|NCT00573443|474587990|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
131810073|NCT00573443|474587991|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
131810074|NCT00573443|474587989|FG000|Double-Blind Phase|Protocol Violation|0|||
131810075|NCT00573443|474587990|FG001|Double-Blind Phase|Protocol Violation|2|||
131810076|NCT00573443|474587991|FG002|Double-Blind Phase|Protocol Violation|1|||
131810077|NCT00573443|474587989|FG000|Double-Blind Phase|Other|0|||
131810078|NCT00573443|474587990|FG001|Double-Blind Phase|Other|2|||
131810079|NCT00573443|474587991|FG002|Double-Blind Phase|Other|3|||
131810080|NCT00573443|474587989|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
131810081|NCT00573443|474587990|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
131449508|NCT01394016|473274913|FG003|Overall Study|Progressive Disease|0|||
131449509|NCT01394016|473274914|FG004|Overall Study|Progressive Disease|0|||
131449510|NCT01394016|473274915|FG005|Overall Study|Progressive Disease|0|||
131449511|NCT01394016|473274916|FG006|Overall Study|Progressive Disease|0|||
131449512|NCT01394016|473274917|FG007|Overall Study|Progressive Disease|0|||
131449513|NCT01394016|473274918|FG008|Overall Study|Progressive Disease|0|||
131449514|NCT01394016|473274919|FG009|Overall Study|Progressive Disease|0|||
131449515|NCT01394016|473274920|FG010|Overall Study|Progressive Disease|0|||
131449516|NCT01394016|473274921|FG011|Overall Study|Progressive Disease|0|||
131449517|NCT01394016|473274922|FG012|Overall Study|Progressive Disease|0|||
131810082|NCT00573443|474587991|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
131810083|NCT00573443|474587989|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
131810084|NCT00573443|474587990|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
131810085|NCT00573443|474587991|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
131810086|NCT00573443|474587989|FG000|Open-Label Extension Phase|Adverse Event|3|||
131810087|NCT00573443|474587990|FG001|Open-Label Extension Phase|Adverse Event|0|||
131810088|NCT00573443|474587991|FG002|Open-Label Extension Phase|Adverse Event|0|||
131810089|NCT00573443|474587989|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
131810090|NCT00573443|474587990|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
131810091|NCT00573443|474587991|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
131810092|NCT00573443|474587989|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
131810093|NCT00573443|474587990|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
131810094|NCT00573443|474587991|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
131810095|NCT00573443|474587989|FG000|Open-Label Extension Phase|Protocol Violation|2|||
131810096|NCT00573443|474587990|FG001|Open-Label Extension Phase|Protocol Violation|0|||
131810097|NCT00573443|474587991|FG002|Open-Label Extension Phase|Protocol Violation|0|||
131810098|NCT00573443|474587989|FG000|Open-Label Extension Phase|Other|2|||
131810099|NCT00573443|474587990|FG001|Open-Label Extension Phase|Other|0|||
131810100|NCT00573443|474587991|FG002|Open-Label Extension Phase|Other|0|||
131810101|NCT00905606|474587992|FG000|Period 1|Adverse Event|0|||
131810102|NCT00905606|474587993|FG001|Period 1|Adverse Event|1|||
131810103|NCT00905606|474587992|FG000|Washout|Withdrawal by Subject|1|||
131810104|NCT00905606|474587993|FG001|Washout|Withdrawal by Subject|0|||
131810105|NCT00804856|474587996|FG000|Overall Study|Progressive Disease|3|||
131810106|NCT00804856|474587997|FG001|Overall Study|Progressive Disease|2|||
131810107|NCT00804856|474587998|FG002|Overall Study|Progressive Disease|4|||
131810108|NCT00804856|474587999|FG003|Overall Study|Progressive Disease|6|||
131810109|NCT00804856|474588000|FG004|Overall Study|Progressive Disease|4|||
131810110|NCT00804856|474588001|FG005|Overall Study|Progressive Disease|1|||
131810111|NCT00804856|474588002|FG006|Overall Study|Progressive Disease|8|||
131810112|NCT00804856|474588003|FG007|Overall Study|Progressive Disease|2|||
131810113|NCT00804856|474588004|FG008|Overall Study|Progressive Disease|4|||
131810114|NCT00804856|474588005|FG009|Overall Study|Progressive Disease|5|||
131810115|NCT00804856|474588006|FG010|Overall Study|Progressive Disease|12|||
131810116|NCT00804856|474588007|FG011|Overall Study|Progressive Disease|2|||
131810117|NCT00804856|474588008|FG012|Overall Study|Progressive Disease|2|||
131810118|NCT00804856|474588009|FG013|Overall Study|Progressive Disease|26|||
131810119|NCT00804856|474588010|FG014|Overall Study|Progressive Disease|20|||
131810120|NCT00804856|474587996|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810121|NCT00804856|474587997|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810122|NCT00804856|474587998|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810123|NCT00804856|474587999|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810124|NCT00804856|474588000|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131810125|NCT00804856|474588001|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810126|NCT00804856|474588002|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810127|NCT00804856|474588003|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810128|NCT00804856|474588004|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810129|NCT00804856|474588005|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131449518|NCT01394016|473274923|FG013|Overall Study|Progressive Disease|0|||
131449519|NCT01394016|473274924|FG014|Overall Study|Progressive Disease|0|||
131810130|NCT00804856|474588006|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810131|NCT00804856|474588007|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810132|NCT00804856|474588008|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810133|NCT00804856|474588009|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131810134|NCT00804856|474588010|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131810135|NCT00804856|474587996|FG000|Overall Study|Other Adverse Event|1|||
131810136|NCT00804856|474587997|FG001|Overall Study|Other Adverse Event|1|||
131810137|NCT00804856|474587998|FG002|Overall Study|Other Adverse Event|1|||
131906838|NCT01181167|474946606|FG000|Overall Study|Protocol Violation|3|||
131449520|NCT01394016|473274925|FG015|Overall Study|Progressive Disease|0|||
131449521|NCT01394016|473274926|FG016|Overall Study|Progressive Disease|0|||
131449522|NCT01394016|473274927|FG017|Overall Study|Progressive Disease|0|||
131810138|NCT00804856|474587999|FG003|Overall Study|Other Adverse Event|2|||
131810139|NCT00804856|474588000|FG004|Overall Study|Other Adverse Event|2|||
131810140|NCT00804856|474588001|FG005|Overall Study|Other Adverse Event|1|||
131810141|NCT00804856|474588002|FG006|Overall Study|Other Adverse Event|3|||
131810142|NCT00804856|474588003|FG007|Overall Study|Other Adverse Event|0|||
131810143|NCT00804856|474588004|FG008|Overall Study|Other Adverse Event|0|||
131810144|NCT00804856|474588005|FG009|Overall Study|Other Adverse Event|1|||
131810145|NCT00804856|474588006|FG010|Overall Study|Other Adverse Event|5|||
131810146|NCT00804856|474588007|FG011|Overall Study|Other Adverse Event|2|||
131810147|NCT00804856|474588008|FG012|Overall Study|Other Adverse Event|0|||
131810148|NCT00804856|474588009|FG013|Overall Study|Other Adverse Event|6|||
131810149|NCT00804856|474588010|FG014|Overall Study|Other Adverse Event|13|||
131810150|NCT00804856|474587996|FG000|Overall Study|Non compliance with protocol|0|||
131397452|NCT01436656|473077382|FG000|Dose Escalation|Death|1|||
131397453|NCT01436656|473077383|FG001|Dose Escalation|Death|3|||
131397454|NCT01436656|473077384|FG002|Dose Escalation|Death|1|||
131397455|NCT01436656|473077385|FG003|Dose Escalation|Death|0|||
131397456|NCT01436656|473077386|FG004|Dose Escalation|Death|2|||
131397457|NCT01436656|473077387|FG005|Dose Escalation|Death|1|||
131397458|NCT01436656|473077388|FG006|Dose Escalation|Death|1|||
131397459|NCT01436656|473077389|FG007|Dose Escalation|Death|1|||
131397460|NCT01436656|473077390|FG008|Dose Escalation|Death|1|||
131397461|NCT01436656|473077391|FG009|Dose Escalation|Death|0|||
131397462|NCT01436656|473077392|FG010|Dose Escalation|Death|0|||
131397463|NCT01436656|473077393|FG011|Dose Escalation|Death|0|||
131397464|NCT01436656|473077394|FG012|Dose Escalation|Death|0|||
131397465|NCT01436656|473077395|FG013|Dose Escalation|Death|0|||
131397466|NCT01436656|473077396|FG014|Dose Escalation|Death|0|||
131397467|NCT01436656|473077397|FG015|Dose Escalation|Death|0|||
131397468|NCT01436656|473077398|FG016|Dose Escalation|Death|0|||
131397469|NCT01436656|473077399|FG017|Dose Escalation|Death|0|||
131397470|NCT01436656|473077382|FG000|Dose Escalation|Protocol Violation|0|||
131397471|NCT01436656|473077383|FG001|Dose Escalation|Protocol Violation|0|||
131397472|NCT01436656|473077384|FG002|Dose Escalation|Protocol Violation|0|||
131397473|NCT01436656|473077385|FG003|Dose Escalation|Protocol Violation|0|||
131397474|NCT01436656|473077386|FG004|Dose Escalation|Protocol Violation|0|||
131397475|NCT01436656|473077387|FG005|Dose Escalation|Protocol Violation|1|||
131397476|NCT01436656|473077388|FG006|Dose Escalation|Protocol Violation|0|||
131397477|NCT01436656|473077389|FG007|Dose Escalation|Protocol Violation|0|||
131397478|NCT01436656|473077390|FG008|Dose Escalation|Protocol Violation|0|||
131397479|NCT01436656|473077391|FG009|Dose Escalation|Protocol Violation|0|||
131397480|NCT01436656|473077392|FG010|Dose Escalation|Protocol Violation|0|||
131397481|NCT01436656|473077393|FG011|Dose Escalation|Protocol Violation|0|||
131397482|NCT01436656|473077394|FG012|Dose Escalation|Protocol Violation|0|||
131397483|NCT01436656|473077395|FG013|Dose Escalation|Protocol Violation|0|||
131810151|NCT00804856|474587997|FG001|Overall Study|Non compliance with protocol|0|||
131397484|NCT01436656|473077396|FG014|Dose Escalation|Protocol Violation|0|||
131397485|NCT01436656|473077397|FG015|Dose Escalation|Protocol Violation|0|||
131397486|NCT01436656|473077398|FG016|Dose Escalation|Protocol Violation|0|||
131449523|NCT01394016|473274928|FG018|Overall Study|Progressive Disease|0|||
131906839|NCT01181167|474946607|FG001|Overall Study|Protocol Violation|0|||
131397487|NCT01436656|473077399|FG017|Dose Escalation|Protocol Violation|0|||
131397488|NCT01436656|473077382|FG000|Dose Escalation|Withdrawal by Subject|0|||
131397489|NCT01436656|473077383|FG001|Dose Escalation|Withdrawal by Subject|0|||
131397490|NCT01436656|473077384|FG002|Dose Escalation|Withdrawal by Subject|0|||
131397491|NCT01436656|473077385|FG003|Dose Escalation|Withdrawal by Subject|0|||
131397492|NCT01436656|473077386|FG004|Dose Escalation|Withdrawal by Subject|1|||
131397493|NCT01436656|473077387|FG005|Dose Escalation|Withdrawal by Subject|0|||
131397494|NCT01436656|473077388|FG006|Dose Escalation|Withdrawal by Subject|0|||
131397495|NCT01436656|473077389|FG007|Dose Escalation|Withdrawal by Subject|2|||
131810152|NCT00804856|474587998|FG002|Overall Study|Non compliance with protocol|0|||
131810153|NCT00804856|474587999|FG003|Overall Study|Non compliance with protocol|0|||
131449524|NCT01394016|473274910|FG000|Overall Study|Withdrawal by Subject|0|||
131449525|NCT01394016|473274911|FG001|Overall Study|Withdrawal by Subject|0|||
131449526|NCT01394016|473274912|FG002|Overall Study|Withdrawal by Subject|0|||
131449527|NCT01394016|473274913|FG003|Overall Study|Withdrawal by Subject|0|||
131906840|NCT01181167|474946606|FG000|Overall Study|Withdrawal by Subject|6|||
131906841|NCT01181167|474946607|FG001|Overall Study|Withdrawal by Subject|8|||
131906842|NCT00161213|474946608|FG000|Overall Study|Withdrawal by Subject|1|||
131906843|NCT00161213|474946608|FG000|Overall Study|Evaluable for toxicity but not response|1|||
131449528|NCT01394016|473274914|FG004|Overall Study|Withdrawal by Subject|0|||
131449529|NCT01394016|473274915|FG005|Overall Study|Withdrawal by Subject|0|||
131449530|NCT01394016|473274916|FG006|Overall Study|Withdrawal by Subject|0|||
131449531|NCT01394016|473274917|FG007|Overall Study|Withdrawal by Subject|1|||
131449532|NCT01394016|473274918|FG008|Overall Study|Withdrawal by Subject|1|||
131449533|NCT01394016|473274919|FG009|Overall Study|Withdrawal by Subject|1|||
131449534|NCT01394016|473274920|FG010|Overall Study|Withdrawal by Subject|4|||
131449535|NCT01394016|473274921|FG011|Overall Study|Withdrawal by Subject|0|||
131449536|NCT01394016|473274922|FG012|Overall Study|Withdrawal by Subject|0|||
131449537|NCT01394016|473274923|FG013|Overall Study|Withdrawal by Subject|3|||
131449538|NCT01394016|473274924|FG014|Overall Study|Withdrawal by Subject|1|||
131449539|NCT01394016|473274925|FG015|Overall Study|Withdrawal by Subject|3|||
131752579|NCT05563714|474370148|FG000|Overall Study|Death|2|||
131752580|NCT05563714|474370149|FG001|Overall Study|Death|2|||
131752581|NCT05563714|474370150|FG002|Overall Study|Death|0|||
131752582|NCT05563714|474370151|FG003|Overall Study|Death|0|||
131752583|NCT05563714|474370148|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
131752584|NCT05563714|474370149|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
131752585|NCT05563714|474370150|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
131752586|NCT05563714|474370151|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
131752587|NCT05563714|474370148|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
131752588|NCT05563714|474370149|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
131752589|NCT05563714|474370150|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
131752590|NCT05563714|474370151|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
131752591|NCT05563714|474370148|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
131752592|NCT05563714|474370149|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
131752593|NCT05563714|474370150|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
131752594|NCT05563714|474370151|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
131752595|NCT05563714|474370148|FG000|Overall Study|Lost to Follow-up|22|||
131752596|NCT05563714|474370149|FG001|Overall Study|Lost to Follow-up|19|||
131752597|NCT05563714|474370150|FG002|Overall Study|Lost to Follow-up|0|||
131752598|NCT05563714|474370151|FG003|Overall Study|Lost to Follow-up|0|||
131752599|NCT01610206|474370157|FG000|Overall Study|Adverse Event|10|||
131752600|NCT01610206|474370158|FG001|Overall Study|Adverse Event|30|||
131752601|NCT00166517|474370159|FG000|Overall Study|Lost to Follow-up|1|||
131752602|NCT00166517|474370160|FG001|Overall Study|Lost to Follow-up|0|||
131752603|NCT00166517|474370159|FG000|Overall Study|Protocol Violation|4|||
131752604|NCT00166517|474370160|FG001|Overall Study|Protocol Violation|1|||
131752605|NCT00166517|474370159|FG000|Overall Study|Withdrawal by Subject|0|||
131752606|NCT00166517|474370160|FG001|Overall Study|Withdrawal by Subject|1|||
131752607|NCT02186561|474370161|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
131752608|NCT02186561|474370161|FG000|Enrollment|Enrollment Cap Reached|5|||
131752609|NCT02186561|474370161|FG000|Enrollment|Insurance Denial|2|||
131752610|NCT02186561|474370161|FG000|Enrollment|Withdrawal by Subject|2|||
131752611|NCT02186561|474370161|FG000|Enrollment|Investigator Withdrew Consent|1|||
131752612|NCT02186561|474370161|FG000|30-Day Post Index Procedure Visit|Death|1|||
131752613|NCT02186561|474370161|FG000|1- Year Post Index Procedure Visit|Death|1|||
131752614|NCT02186561|474370161|FG000|1- Year Post Index Procedure Visit|Missed|1|||
131752615|NCT00842361|474370162|FG000|Overall Study|Protocol Violation|1|||
131752616|NCT00842361|474370163|FG001|Overall Study|Protocol Violation|0|||
131906844|NCT03103503|474946609|FG000|Overall Study|Death|64|||
131449540|NCT01394016|473274926|FG016|Overall Study|Withdrawal by Subject|1|||
131752617|NCT00842361|474370162|FG000|Overall Study|Unclassified|0|||
131752618|NCT00842361|474370163|FG001|Overall Study|Unclassified|2|||
131752619|NCT04285853|474370164|FG000|Overall Study|Withdrawal by Subject|1|||
131752620|NCT04285853|474370165|FG001|Overall Study|Withdrawal by Subject|0|||
131752621|NCT04285853|474370164|FG000|Overall Study|Lost to Follow-up|9|||
131752622|NCT04285853|474370165|FG001|Overall Study|Lost to Follow-up|5|||
131752623|NCT02917629|474370168|FG000|Overall Study|Withdrawal by Subject|0|||
131752624|NCT02917629|474370169|FG001|Overall Study|Withdrawal by Subject|1|||
131449541|NCT01394016|473274927|FG017|Overall Study|Withdrawal by Subject|1|||
131449542|NCT01394016|473274928|FG018|Overall Study|Withdrawal by Subject|2|||
131906845|NCT03103503|474946609|FG000|Overall Study|Physician Decision|57|||
131906846|NCT03103503|474946609|FG000|Overall Study|Withdrawal by Subject|10|||
131906847|NCT03103503|474946609|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
131906848|NCT03103503|474946609|FG000|Overall Study|Lost to Follow-up|3|||
131906849|NCT03103503|474946609|FG000|Overall Study|Study Closure|757|||
131906850|NCT01384877|474946610|FG000|Treatment 2|Lost to Follow-up|2|||
131906851|NCT01384877|474946611|FG001|Treatment 2|Lost to Follow-up|2|||
131906852|NCT03630393|474946612|FG000|Overall Study|Death|1|||
131906853|NCT03630393|474946613|FG001|Overall Study|Death|0|||
131752625|NCT00718523|474370170|FG000|Overall Study|Withdrawal by Subject|5|||
131752626|NCT00718523|474370171|FG001|Overall Study|Withdrawal by Subject|7|||
131752627|NCT00718523|474370170|FG000|Overall Study|Death|13|||
131752628|NCT00718523|474370171|FG001|Overall Study|Death|17|||
131752629|NCT03136484|474370172|FG000|Overall Study|Withdrawal by Subject|19|||
131752630|NCT03136484|474370173|FG001|Overall Study|Withdrawal by Subject|14|||
131752631|NCT03136484|474370172|FG000|Overall Study|Lost to Follow-up|7|||
131752632|NCT03136484|474370173|FG001|Overall Study|Lost to Follow-up|8|||
131752633|NCT03136484|474370172|FG000|Overall Study|Death|1|||
131752634|NCT03136484|474370173|FG001|Overall Study|Death|0|||
131752635|NCT05041062|474370178|FG000|Overall Study|Adverse Event|2|||
131752636|NCT01802515|474370183|FG000|Overall Study|Withdrawal by Subject|3|||
131752637|NCT01802515|474370184|FG001|Overall Study|Withdrawal by Subject|0|||
131810154|NCT00804856|474588000|FG004|Overall Study|Non compliance with protocol|0|||
131810155|NCT00804856|474588001|FG005|Overall Study|Non compliance with protocol|0|||
131810156|NCT00804856|474588002|FG006|Overall Study|Non compliance with protocol|0|||
131906854|NCT00408499|474946614|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
131906855|NCT00408499|474946615|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
131906856|NCT00408499|474946616|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
131906857|NCT00408499|474946617|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
131906858|NCT00408499|474946618|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
131906859|NCT00408499|474946614|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
131906860|NCT00408499|474946615|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
131906861|NCT00408499|474946616|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
131906862|NCT00408499|474946617|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
131906863|NCT00408499|474946618|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
131906864|NCT00408499|474946614|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
131906865|NCT00408499|474946615|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
131810157|NCT00804856|474588003|FG007|Overall Study|Non compliance with protocol|0|||
131810158|NCT00804856|474588004|FG008|Overall Study|Non compliance with protocol|0|||
131810159|NCT00804856|474588005|FG009|Overall Study|Non compliance with protocol|0|||
131810160|NCT00804856|474588006|FG010|Overall Study|Non compliance with protocol|0|||
131810161|NCT00804856|474588007|FG011|Overall Study|Non compliance with protocol|0|||
131810162|NCT00804856|474588008|FG012|Overall Study|Non compliance with protocol|0|||
131810163|NCT00804856|474588009|FG013|Overall Study|Non compliance with protocol|2|||
131810164|NCT00804856|474588010|FG014|Overall Study|Non compliance with protocol|0|||
131810165|NCT00804856|474587996|FG000|Overall Study|Refused to continue medication|0|||
131810166|NCT00804856|474587997|FG001|Overall Study|Refused to continue medication|0|||
131810167|NCT00804856|474587998|FG002|Overall Study|Refused to continue medication|0|||
131810168|NCT00804856|474587999|FG003|Overall Study|Refused to continue medication|1|||
131810169|NCT00804856|474588000|FG004|Overall Study|Refused to continue medication|1|||
131810170|NCT00804856|474588001|FG005|Overall Study|Refused to continue medication|0|||
131810171|NCT00804856|474588002|FG006|Overall Study|Refused to continue medication|0|||
131810172|NCT00804856|474588003|FG007|Overall Study|Refused to continue medication|0|||
131810173|NCT00804856|474588004|FG008|Overall Study|Refused to continue medication|0|||
131810174|NCT00804856|474588005|FG009|Overall Study|Refused to continue medication|0|||
131810175|NCT00804856|474588006|FG010|Overall Study|Refused to continue medication|3|||
131810176|NCT00804856|474588007|FG011|Overall Study|Refused to continue medication|0|||
131810177|NCT00804856|474588008|FG012|Overall Study|Refused to continue medication|1|||
131810178|NCT00804856|474588009|FG013|Overall Study|Refused to continue medication|1|||
131810179|NCT00804856|474588010|FG014|Overall Study|Refused to continue medication|5|||
131810180|NCT00804856|474587996|FG000|Overall Study|Other reason than listed above|0|||
131810181|NCT00804856|474587997|FG001|Overall Study|Other reason than listed above|0|||
131906866|NCT00408499|474946616|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
131906867|NCT00408499|474946617|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
131449543|NCT01394016|473274910|FG000|Overall Study|Adverse Event|0|||
131752638|NCT01802515|474370185|FG002|Overall Study|Withdrawal by Subject|0|||
131752639|NCT00981682|474370190|FG000|Overall Study|Adverse Event|48|||
131752640|NCT00981682|474370190|FG000|Overall Study|Withdrawal by Subject|52|||
131810182|NCT00804856|474587998|FG002|Overall Study|Other reason than listed above|0|||
131810183|NCT00804856|474587999|FG003|Overall Study|Other reason than listed above|0|||
131752641|NCT00981682|474370190|FG000|Overall Study|Lost to Follow-up|14|||
131810184|NCT00804856|474588000|FG004|Overall Study|Other reason than listed above|0|||
131906868|NCT00408499|474946618|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
131906869|NCT00408499|474946614|FG000|Phase II- MTD Expansion|Adverse Event|0|||
131397496|NCT01436656|473077390|FG008|Dose Escalation|Withdrawal by Subject|0|||
131397497|NCT01436656|473077391|FG009|Dose Escalation|Withdrawal by Subject|1|||
131397498|NCT01436656|473077392|FG010|Dose Escalation|Withdrawal by Subject|1|||
131397499|NCT01436656|473077393|FG011|Dose Escalation|Withdrawal by Subject|0|||
131397500|NCT01436656|473077394|FG012|Dose Escalation|Withdrawal by Subject|0|||
131397501|NCT01436656|473077395|FG013|Dose Escalation|Withdrawal by Subject|0|||
131397502|NCT01436656|473077396|FG014|Dose Escalation|Withdrawal by Subject|0|||
131397503|NCT01436656|473077397|FG015|Dose Escalation|Withdrawal by Subject|0|||
131397504|NCT01436656|473077398|FG016|Dose Escalation|Withdrawal by Subject|0|||
131397505|NCT01436656|473077399|FG017|Dose Escalation|Withdrawal by Subject|0|||
131397506|NCT01436656|473077382|FG000|Dose Escalation|Administrative problems|0|||
131397507|NCT01436656|473077383|FG001|Dose Escalation|Administrative problems|1|||
131397508|NCT01436656|473077384|FG002|Dose Escalation|Administrative problems|0|||
131397509|NCT01436656|473077385|FG003|Dose Escalation|Administrative problems|0|||
131397510|NCT01436656|473077386|FG004|Dose Escalation|Administrative problems|0|||
131397511|NCT01436656|473077387|FG005|Dose Escalation|Administrative problems|0|||
131397512|NCT01436656|473077388|FG006|Dose Escalation|Administrative problems|0|||
131397513|NCT01436656|473077389|FG007|Dose Escalation|Administrative problems|0|||
131397514|NCT01436656|473077390|FG008|Dose Escalation|Administrative problems|0|||
131397515|NCT01436656|473077391|FG009|Dose Escalation|Administrative problems|0|||
131397516|NCT01436656|473077392|FG010|Dose Escalation|Administrative problems|0|||
131397517|NCT01436656|473077393|FG011|Dose Escalation|Administrative problems|0|||
131397518|NCT01436656|473077394|FG012|Dose Escalation|Administrative problems|0|||
131397519|NCT01436656|473077395|FG013|Dose Escalation|Administrative problems|0|||
131397520|NCT01436656|473077396|FG014|Dose Escalation|Administrative problems|0|||
131397521|NCT01436656|473077397|FG015|Dose Escalation|Administrative problems|0|||
131397522|NCT01436656|473077398|FG016|Dose Escalation|Administrative problems|0|||
131397523|NCT01436656|473077399|FG017|Dose Escalation|Administrative problems|0|||
131397524|NCT01436656|473077382|FG000|Dose Escalation|Lost to Follow-up|1|||
131397525|NCT01436656|473077383|FG001|Dose Escalation|Lost to Follow-up|0|||
131397526|NCT01436656|473077384|FG002|Dose Escalation|Lost to Follow-up|0|||
131397527|NCT01436656|473077385|FG003|Dose Escalation|Lost to Follow-up|0|||
131752642|NCT00981682|474370190|FG000|Overall Study|Lack of Efficacy|13|||
131752643|NCT00981682|474370190|FG000|Overall Study|Protocol Violation|6|||
131752644|NCT00981682|474370190|FG000|Overall Study|administrative|9|||
131752645|NCT03906136|474372099|FG000|Overall Study|Adverse Event|1|||
131752646|NCT03906136|474372100|FG001|Overall Study|Adverse Event|0|||
131752647|NCT03906136|474372099|FG000|Overall Study|Lost to Follow-up|7|||
131752648|NCT03906136|474372100|FG001|Overall Study|Lost to Follow-up|4|||
131752649|NCT03906136|474372099|FG000|Overall Study|Physician Decision|1|||
131752650|NCT03906136|474372100|FG001|Overall Study|Physician Decision|0|||
131752651|NCT03906136|474372099|FG000|Overall Study|Withdrawal by Subject|3|||
131752652|NCT03906136|474372100|FG001|Overall Study|Withdrawal by Subject|7|||
131752653|NCT03038672|474372103|FG000|Initial Treatment|Unacceptable chemistry|0|||
131752654|NCT03038672|474372104|FG001|Initial Treatment|Unacceptable chemistry|1|||
131752655|NCT03038672|474372103|FG000|Initial Treatment|Progression prior to treatment|1|||
131752656|NCT03038672|474372104|FG001|Initial Treatment|Progression prior to treatment|0|||
131752657|NCT03038672|474372103|FG000|Initial Treatment|No treatment per protocol|1|||
131752658|NCT03038672|474372104|FG001|Initial Treatment|No treatment per protocol|0|||
131752659|NCT01696396|474372107|FG000|Overall Study|Withdrawal by Subject|19|||
131752660|NCT01696396|474372108|FG001|Overall Study|Withdrawal by Subject|5|||
131752661|NCT01696396|474372109|FG002|Overall Study|Withdrawal by Subject|19|||
131752662|NCT01696396|474372110|FG003|Overall Study|Withdrawal by Subject|11|||
131752663|NCT01696396|474372107|FG000|Overall Study|Decision by Sponsor|3|||
131752664|NCT01696396|474372108|FG001|Overall Study|Decision by Sponsor|1|||
131752665|NCT01696396|474372109|FG002|Overall Study|Decision by Sponsor|2|||
131752666|NCT01696396|474372110|FG003|Overall Study|Decision by Sponsor|2|||
131752667|NCT01696396|474372107|FG000|Overall Study|Lost to Follow-up|9|||
131752668|NCT01696396|474372108|FG001|Overall Study|Lost to Follow-up|1|||
131752669|NCT01696396|474372109|FG002|Overall Study|Lost to Follow-up|4|||
131397528|NCT01436656|473077386|FG004|Dose Escalation|Lost to Follow-up|1|||
131752670|NCT01696396|474372110|FG003|Overall Study|Lost to Follow-up|1|||
131752671|NCT01696396|474372107|FG000|Overall Study|Death|0|||
131752672|NCT01696396|474372108|FG001|Overall Study|Death|0|||
131752673|NCT01696396|474372109|FG002|Overall Study|Death|1|||
131752674|NCT01696396|474372110|FG003|Overall Study|Death|0|||
131752675|NCT02371980|474372117|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
131752676|NCT02371980|474372118|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
131752677|NCT02371980|474372119|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
131752678|NCT02371980|474372120|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
131810185|NCT00804856|474588001|FG005|Overall Study|Other reason than listed above|1|||
131810186|NCT00804856|474588002|FG006|Overall Study|Other reason than listed above|0|||
131397529|NCT01436656|473077387|FG005|Dose Escalation|Lost to Follow-up|0|||
131397530|NCT01436656|473077388|FG006|Dose Escalation|Lost to Follow-up|0|||
131397531|NCT01436656|473077389|FG007|Dose Escalation|Lost to Follow-up|0|||
131752679|NCT02371980|474372121|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
131810187|NCT00804856|474588003|FG007|Overall Study|Other reason than listed above|0|||
131810188|NCT00804856|474588004|FG008|Overall Study|Other reason than listed above|1|||
131810189|NCT00804856|474588005|FG009|Overall Study|Other reason than listed above|0|||
131810190|NCT00804856|474588006|FG010|Overall Study|Other reason than listed above|3|||
131810191|NCT00804856|474588007|FG011|Overall Study|Other reason than listed above|1|||
131810192|NCT00804856|474588008|FG012|Overall Study|Other reason than listed above|1|||
131810193|NCT00804856|474588009|FG013|Overall Study|Other reason than listed above|10|||
131810194|NCT00804856|474588010|FG014|Overall Study|Other reason than listed above|3|||
131810195|NCT01796171|474588011|FG000|Enrolled|Death|0|||
131810196|NCT01796171|474588012|FG001|Enrolled|Death|0|||
131810197|NCT01796171|474588013|FG002|Enrolled|Death|0|||
131810198|NCT01796171|474588014|FG003|Enrolled|Death|0|||
131810199|NCT01796171|474588015|FG004|Enrolled|Death|0|||
131810200|NCT01796171|474588016|FG005|Enrolled|Death|0|||
131810201|NCT01796171|474588017|FG006|Enrolled|Death|0|||
131810202|NCT01796171|474588018|FG007|Enrolled|Death|0|||
131810203|NCT01796171|474588019|FG008|Enrolled|Death|0|||
131810204|NCT01796171|474588020|FG009|Enrolled|Death|0|||
131810205|NCT01796171|474588021|FG010|Enrolled|Death|0|||
131810206|NCT01796171|474588022|FG011|Enrolled|Death|0|||
131810207|NCT01796171|474588023|FG012|Enrolled|Death|0|||
131810208|NCT01796171|474588024|FG013|Enrolled|Death|0|||
131810209|NCT01796171|474588025|FG014|Enrolled|Death|1|||
131810210|NCT01796171|474588011|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
131810211|NCT01796171|474588012|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
131810212|NCT01796171|474588013|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
131810213|NCT01796171|474588014|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
131810214|NCT01796171|474588015|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
131810215|NCT01796171|474588016|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
131810216|NCT01796171|474588017|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
131810217|NCT01796171|474588018|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
131810218|NCT01796171|474588019|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
131810219|NCT01796171|474588020|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
131810220|NCT01796171|474588021|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
131810221|NCT01796171|474588022|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
131810222|NCT01796171|474588023|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
131810223|NCT01796171|474588024|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
131810224|NCT01796171|474588025|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
131810225|NCT01796171|474588011|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810226|NCT01796171|474588012|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810227|NCT01796171|474588013|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810228|NCT01796171|474588014|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810229|NCT01796171|474588015|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810230|NCT01796171|474588016|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810231|NCT01796171|474588017|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810232|NCT01796171|474588018|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810233|NCT01796171|474588019|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810234|NCT01796171|474588020|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810235|NCT01796171|474588021|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810236|NCT01796171|474588022|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810237|NCT01796171|474588023|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810238|NCT01796171|474588024|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
131810239|NCT01796171|474588025|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
131810240|NCT01796171|474588011|FG000|Treatment Period With Betalutin|Progressive disease|0|||
131810241|NCT01796171|474588012|FG001|Treatment Period With Betalutin|Progressive disease|1|||
131810242|NCT01796171|474588013|FG002|Treatment Period With Betalutin|Progressive disease|0|||
131810243|NCT01796171|474588014|FG003|Treatment Period With Betalutin|Progressive disease|0|||
131810244|NCT01796171|474588015|FG004|Treatment Period With Betalutin|Progressive disease|0|||
131810245|NCT01796171|474588016|FG005|Treatment Period With Betalutin|Progressive disease|0|||
131810246|NCT01796171|474588017|FG006|Treatment Period With Betalutin|Progressive disease|0|||
131810247|NCT01796171|474588018|FG007|Treatment Period With Betalutin|Progressive disease|0|||
131810248|NCT01796171|474588019|FG008|Treatment Period With Betalutin|Progressive disease|0|||
131810249|NCT01796171|474588020|FG009|Treatment Period With Betalutin|Progressive disease|0|||
131810250|NCT01796171|474588021|FG010|Treatment Period With Betalutin|Progressive disease|0|||
131810251|NCT01796171|474588022|FG011|Treatment Period With Betalutin|Progressive disease|0|||
131810252|NCT01796171|474588023|FG012|Treatment Period With Betalutin|Progressive disease|0|||
131810253|NCT01796171|474588024|FG013|Treatment Period With Betalutin|Progressive disease|0|||
131810254|NCT01796171|474588025|FG014|Treatment Period With Betalutin|Progressive disease|0|||
131810255|NCT01796171|474588011|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810256|NCT01796171|474588012|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810257|NCT01796171|474588013|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810258|NCT01796171|474588014|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810259|NCT01796171|474588015|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131752680|NCT02371980|474372117|FG000|Open-label Period|Significant Protocol Deviation|19|||
131752681|NCT02371980|474372118|FG001|Open-label Period|Significant Protocol Deviation|0|||
131752682|NCT02371980|474372119|FG002|Open-label Period|Significant Protocol Deviation|0|||
131752683|NCT02371980|474372120|FG003|Open-label Period|Significant Protocol Deviation|0|||
131752684|NCT02371980|474372121|FG004|Open-label Period|Significant Protocol Deviation|0|||
131752685|NCT02371980|474372117|FG000|Open-label Period|Noncompliance with Study Drug|10|||
131752686|NCT02371980|474372118|FG001|Open-label Period|Noncompliance with Study Drug|0|||
131752687|NCT02371980|474372119|FG002|Open-label Period|Noncompliance with Study Drug|0|||
131752688|NCT02371980|474372120|FG003|Open-label Period|Noncompliance with Study Drug|0|||
131752689|NCT02371980|474372121|FG004|Open-label Period|Noncompliance with Study Drug|0|||
131752690|NCT02371980|474372117|FG000|Open-label Period|Lost to Follow-up|55|||
131752691|NCT02371980|474372118|FG001|Open-label Period|Lost to Follow-up|0|||
131752692|NCT02371980|474372119|FG002|Open-label Period|Lost to Follow-up|0|||
131752693|NCT02371980|474372120|FG003|Open-label Period|Lost to Follow-up|0|||
131752694|NCT02371980|474372121|FG004|Open-label Period|Lost to Follow-up|0|||
131397532|NCT01436656|473077390|FG008|Dose Escalation|Lost to Follow-up|0|||
131397533|NCT01436656|473077391|FG009|Dose Escalation|Lost to Follow-up|0|||
131397534|NCT01436656|473077392|FG010|Dose Escalation|Lost to Follow-up|0|||
131397535|NCT01436656|473077393|FG011|Dose Escalation|Lost to Follow-up|0|||
131397536|NCT01436656|473077394|FG012|Dose Escalation|Lost to Follow-up|0|||
131397537|NCT01436656|473077395|FG013|Dose Escalation|Lost to Follow-up|0|||
131397538|NCT01436656|473077396|FG014|Dose Escalation|Lost to Follow-up|0|||
131397539|NCT01436656|473077397|FG015|Dose Escalation|Lost to Follow-up|0|||
131397540|NCT01436656|473077398|FG016|Dose Escalation|Lost to Follow-up|0|||
131397541|NCT01436656|473077399|FG017|Dose Escalation|Lost to Follow-up|0|||
131397542|NCT01436656|473077382|FG000|Dose Escalation|New anti-cancer therapy|1|||
131397543|NCT01436656|473077383|FG001|Dose Escalation|New anti-cancer therapy|0|||
131397544|NCT01436656|473077384|FG002|Dose Escalation|New anti-cancer therapy|0|||
131397545|NCT01436656|473077385|FG003|Dose Escalation|New anti-cancer therapy|0|||
131397546|NCT01436656|473077386|FG004|Dose Escalation|New anti-cancer therapy|0|||
131397547|NCT01436656|473077387|FG005|Dose Escalation|New anti-cancer therapy|0|||
131397548|NCT01436656|473077388|FG006|Dose Escalation|New anti-cancer therapy|0|||
131397549|NCT01436656|473077389|FG007|Dose Escalation|New anti-cancer therapy|0|||
131397550|NCT01436656|473077390|FG008|Dose Escalation|New anti-cancer therapy|1|||
131397551|NCT01436656|473077391|FG009|Dose Escalation|New anti-cancer therapy|1|||
131397552|NCT01436656|473077392|FG010|Dose Escalation|New anti-cancer therapy|0|||
131397553|NCT01436656|473077393|FG011|Dose Escalation|New anti-cancer therapy|0|||
131397554|NCT01436656|473077394|FG012|Dose Escalation|New anti-cancer therapy|0|||
131397555|NCT01436656|473077395|FG013|Dose Escalation|New anti-cancer therapy|0|||
131397556|NCT01436656|473077396|FG014|Dose Escalation|New anti-cancer therapy|0|||
131397557|NCT01436656|473077397|FG015|Dose Escalation|New anti-cancer therapy|0|||
131397558|NCT01436656|473077398|FG016|Dose Escalation|New anti-cancer therapy|0|||
131397559|NCT01436656|473077399|FG017|Dose Escalation|New anti-cancer therapy|0|||
131397560|NCT01436656|473077382|FG000|Dose Expansion|Adverse Event|0|||
131397561|NCT01436656|473077383|FG001|Dose Expansion|Adverse Event|0|||
131397562|NCT01436656|473077384|FG002|Dose Expansion|Adverse Event|0|||
131397563|NCT01436656|473077385|FG003|Dose Expansion|Adverse Event|0|||
131397564|NCT01436656|473077386|FG004|Dose Expansion|Adverse Event|0|||
131397565|NCT01436656|473077387|FG005|Dose Expansion|Adverse Event|0|||
131397566|NCT01436656|473077388|FG006|Dose Expansion|Adverse Event|0|||
131397567|NCT01436656|473077389|FG007|Dose Expansion|Adverse Event|0|||
131397568|NCT01436656|473077390|FG008|Dose Expansion|Adverse Event|0|||
131397569|NCT01436656|473077391|FG009|Dose Expansion|Adverse Event|0|||
131397570|NCT01436656|473077392|FG010|Dose Expansion|Adverse Event|0|||
131397571|NCT01436656|473077393|FG011|Dose Expansion|Adverse Event|1|||
131397572|NCT01436656|473077394|FG012|Dose Expansion|Adverse Event|0|||
131397573|NCT01436656|473077395|FG013|Dose Expansion|Adverse Event|0|||
131397574|NCT01436656|473077396|FG014|Dose Expansion|Adverse Event|0|||
131397575|NCT01436656|473077397|FG015|Dose Expansion|Adverse Event|0|||
131397576|NCT01436656|473077398|FG016|Dose Expansion|Adverse Event|0|||
131397577|NCT01436656|473077399|FG017|Dose Expansion|Adverse Event|0|||
131397578|NCT01436656|473077382|FG000|Dose Expansion|Withdrawal by Subject|0|||
131397579|NCT01436656|473077383|FG001|Dose Expansion|Withdrawal by Subject|0|||
131397580|NCT01436656|473077384|FG002|Dose Expansion|Withdrawal by Subject|0|||
131397581|NCT01436656|473077385|FG003|Dose Expansion|Withdrawal by Subject|0|||
131397582|NCT01436656|473077386|FG004|Dose Expansion|Withdrawal by Subject|0|||
131397583|NCT01436656|473077387|FG005|Dose Expansion|Withdrawal by Subject|0|||
131397584|NCT01436656|473077388|FG006|Dose Expansion|Withdrawal by Subject|0|||
131397585|NCT01436656|473077389|FG007|Dose Expansion|Withdrawal by Subject|0|||
131752695|NCT02371980|474372117|FG000|Open-label Period|Voluntary Withdrawal|91|||
131752696|NCT02371980|474372118|FG001|Open-label Period|Voluntary Withdrawal|0|||
131752697|NCT02371980|474372119|FG002|Open-label Period|Voluntary Withdrawal|0|||
131752698|NCT02371980|474372120|FG003|Open-label Period|Voluntary Withdrawal|0|||
131397586|NCT01436656|473077390|FG008|Dose Expansion|Withdrawal by Subject|0|||
131397587|NCT01436656|473077391|FG009|Dose Expansion|Withdrawal by Subject|0|||
131397588|NCT01436656|473077392|FG010|Dose Expansion|Withdrawal by Subject|0|||
131810260|NCT01796171|474588016|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810261|NCT01796171|474588017|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810262|NCT01796171|474588018|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810263|NCT01796171|474588019|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
131810264|NCT01796171|474588020|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810265|NCT01796171|474588021|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
131810266|NCT01796171|474588022|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
131810267|NCT01796171|474588023|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810268|NCT01796171|474588024|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810269|NCT01796171|474588025|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
131810270|NCT01796171|474588011|FG000|Treatment Period With Betalutin|Physician Decision|0|||
131810271|NCT01796171|474588012|FG001|Treatment Period With Betalutin|Physician Decision|0|||
131810272|NCT01796171|474588013|FG002|Treatment Period With Betalutin|Physician Decision|0|||
131810273|NCT01796171|474588014|FG003|Treatment Period With Betalutin|Physician Decision|0|||
131810274|NCT01796171|474588015|FG004|Treatment Period With Betalutin|Physician Decision|0|||
131810275|NCT01796171|474588016|FG005|Treatment Period With Betalutin|Physician Decision|0|||
131810276|NCT01796171|474588017|FG006|Treatment Period With Betalutin|Physician Decision|0|||
131810277|NCT01796171|474588018|FG007|Treatment Period With Betalutin|Physician Decision|0|||
131810278|NCT01796171|474588019|FG008|Treatment Period With Betalutin|Physician Decision|0|||
131810279|NCT01796171|474588020|FG009|Treatment Period With Betalutin|Physician Decision|0|||
131810280|NCT01796171|474588021|FG010|Treatment Period With Betalutin|Physician Decision|5|||
131810281|NCT01796171|474588022|FG011|Treatment Period With Betalutin|Physician Decision|1|||
131810282|NCT01796171|474588023|FG012|Treatment Period With Betalutin|Physician Decision|1|||
131810283|NCT01796171|474588024|FG013|Treatment Period With Betalutin|Physician Decision|0|||
131810284|NCT01796171|474588025|FG014|Treatment Period With Betalutin|Physician Decision|0|||
131810285|NCT01796171|474588011|FG000|Treatment Period With Betalutin|Death|0|||
131810286|NCT01796171|474588012|FG001|Treatment Period With Betalutin|Death|0|||
131810287|NCT01796171|474588013|FG002|Treatment Period With Betalutin|Death|0|||
131810288|NCT01796171|474588014|FG003|Treatment Period With Betalutin|Death|0|||
131810289|NCT01796171|474588015|FG004|Treatment Period With Betalutin|Death|0|||
131810290|NCT01796171|474588016|FG005|Treatment Period With Betalutin|Death|0|||
131810291|NCT01796171|474588017|FG006|Treatment Period With Betalutin|Death|0|||
131810292|NCT01796171|474588018|FG007|Treatment Period With Betalutin|Death|0|||
131810293|NCT01796171|474588019|FG008|Treatment Period With Betalutin|Death|0|||
131810294|NCT01796171|474588020|FG009|Treatment Period With Betalutin|Death|0|||
131810295|NCT01796171|474588021|FG010|Treatment Period With Betalutin|Death|2|||
131810296|NCT01796171|474588022|FG011|Treatment Period With Betalutin|Death|0|||
131810297|NCT01796171|474588023|FG012|Treatment Period With Betalutin|Death|0|||
131810298|NCT01796171|474588024|FG013|Treatment Period With Betalutin|Death|0|||
131810299|NCT01796171|474588025|FG014|Treatment Period With Betalutin|Death|0|||
131810300|NCT01796171|474588011|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
131810301|NCT01796171|474588012|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
131810302|NCT01796171|474588013|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
131810303|NCT01796171|474588014|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
131397589|NCT01436656|473077393|FG011|Dose Expansion|Withdrawal by Subject|1|||
131397590|NCT01436656|473077394|FG012|Dose Expansion|Withdrawal by Subject|3|||
131397591|NCT01436656|473077395|FG013|Dose Expansion|Withdrawal by Subject|1|||
131752699|NCT02371980|474372121|FG004|Open-label Period|Voluntary Withdrawal|0|||
131752700|NCT02371980|474372117|FG000|Open-label Period|Pregnancy|1|||
131752701|NCT02371980|474372118|FG001|Open-label Period|Pregnancy|0|||
131752702|NCT02371980|474372119|FG002|Open-label Period|Pregnancy|0|||
131752703|NCT02371980|474372120|FG003|Open-label Period|Pregnancy|0|||
131752704|NCT02371980|474372121|FG004|Open-label Period|Pregnancy|0|||
131752705|NCT02371980|474372117|FG000|Open-label Period|Lack of Efficacy|116|||
131752706|NCT02371980|474372118|FG001|Open-label Period|Lack of Efficacy|0|||
131752707|NCT02371980|474372119|FG002|Open-label Period|Lack of Efficacy|0|||
131752708|NCT02371980|474372120|FG003|Open-label Period|Lack of Efficacy|0|||
131752709|NCT02371980|474372121|FG004|Open-label Period|Lack of Efficacy|0|||
131752710|NCT02371980|474372117|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
131752711|NCT02371980|474372118|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
131810304|NCT01796171|474588015|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
131810305|NCT01796171|474588016|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
131810306|NCT01796171|474588017|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
131810307|NCT01796171|474588018|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
131810308|NCT01796171|474588019|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
131810309|NCT01796171|474588020|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
131752712|NCT02371980|474372119|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
131397592|NCT01436656|473077396|FG014|Dose Expansion|Withdrawal by Subject|2|||
131752713|NCT02371980|474372120|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
131752714|NCT02371980|474372121|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
131752715|NCT02371980|474372117|FG000|Open-label Period|Reason not Specified|9|||
131752716|NCT02371980|474372118|FG001|Open-label Period|Reason not Specified|0|||
131752717|NCT02371980|474372119|FG002|Open-label Period|Reason not Specified|0|||
131752718|NCT02371980|474372120|FG003|Open-label Period|Reason not Specified|0|||
131752719|NCT02371980|474372121|FG004|Open-label Period|Reason not Specified|0|||
131752720|NCT02371980|474372117|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
131752721|NCT02371980|474372118|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
131752722|NCT02371980|474372119|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
131752723|NCT02371980|474372120|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
131752724|NCT02371980|474372121|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
131752725|NCT02371980|474372117|FG000|Double-blind Period|Significant Protocol Deviation|0|||
131752726|NCT02371980|474372118|FG001|Double-blind Period|Significant Protocol Deviation|2|||
131752727|NCT02371980|474372119|FG002|Double-blind Period|Significant Protocol Deviation|7|||
131752728|NCT02371980|474372120|FG003|Double-blind Period|Significant Protocol Deviation|3|||
131752729|NCT02371980|474372121|FG004|Double-blind Period|Significant Protocol Deviation|3|||
131752730|NCT02371980|474372117|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
131752731|NCT02371980|474372118|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
131752732|NCT02371980|474372119|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
131752733|NCT02371980|474372120|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
131752734|NCT02371980|474372121|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
131752735|NCT02371980|474372117|FG000|Double-blind Period|Lost to Follow-up|0|||
131752736|NCT02371980|474372118|FG001|Double-blind Period|Lost to Follow-up|8|||
131752737|NCT02371980|474372119|FG002|Double-blind Period|Lost to Follow-up|8|||
131752738|NCT02371980|474372120|FG003|Double-blind Period|Lost to Follow-up|6|||
131752739|NCT02371980|474372121|FG004|Double-blind Period|Lost to Follow-up|5|||
131752740|NCT02371980|474372117|FG000|Double-blind Period|Voluntary Withdrawal|0|||
131752741|NCT02371980|474372118|FG001|Double-blind Period|Voluntary Withdrawal|12|||
131752742|NCT02371980|474372119|FG002|Double-blind Period|Voluntary Withdrawal|8|||
131752743|NCT02371980|474372120|FG003|Double-blind Period|Voluntary Withdrawal|9|||
131752744|NCT02371980|474372121|FG004|Double-blind Period|Voluntary Withdrawal|11|||
131752745|NCT02371980|474372117|FG000|Double-blind Period|Relapse|0|||
131752746|NCT02371980|474372118|FG001|Double-blind Period|Relapse|50|||
131752747|NCT02371980|474372119|FG002|Double-blind Period|Relapse|25|||
131752748|NCT02371980|474372120|FG003|Double-blind Period|Relapse|25|||
131752749|NCT02371980|474372121|FG004|Double-blind Period|Relapse|26|||
131752750|NCT02371980|474372117|FG000|Double-blind Period|Reason not Specified|0|||
131752751|NCT02371980|474372118|FG001|Double-blind Period|Reason not Specified|3|||
131752752|NCT02371980|474372119|FG002|Double-blind Period|Reason not Specified|3|||
131752753|NCT02371980|474372120|FG003|Double-blind Period|Reason not Specified|2|||
131752754|NCT02371980|474372121|FG004|Double-blind Period|Reason not Specified|1|||
131752755|NCT02371980|474372117|FG000|Double-blind Period|Missing|0|||
131752756|NCT02371980|474372118|FG001|Double-blind Period|Missing|1|||
131752757|NCT02371980|474372119|FG002|Double-blind Period|Missing|0|||
131752758|NCT02371980|474372120|FG003|Double-blind Period|Missing|0|||
131752759|NCT02371980|474372121|FG004|Double-blind Period|Missing|0|||
131752760|NCT02712008|474372123|FG000|Baseline (Day 1) up to Week 12|Death|3|||
131752761|NCT02712008|474372124|FG001|Baseline (Day 1) up to Week 12|Death|0|||
131752762|NCT02712008|474372125|FG002|Baseline (Day 1) up to Week 12|Death|0|||
131752763|NCT02712008|474372126|FG003|Baseline (Day 1) up to Week 12|Death|0|||
131752764|NCT02712008|474372127|FG004|Baseline (Day 1) up to Week 12|Death|0|||
131752765|NCT02712008|474372128|FG005|Baseline (Day 1) up to Week 12|Death|0|||
131752766|NCT02712008|474372129|FG006|Baseline (Day 1) up to Week 12|Death|0|||
131752767|NCT02712008|474372130|FG007|Baseline (Day 1) up to Week 12|Death|0|||
131752768|NCT02712008|474372123|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131752769|NCT02712008|474372124|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
131752770|NCT02712008|474372125|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
131752771|NCT02712008|474372126|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131752772|NCT02712008|474372127|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131752773|NCT02712008|474372128|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131752774|NCT02712008|474372129|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131752775|NCT02712008|474372130|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131752776|NCT02712008|474372123|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
131752777|NCT02712008|474372124|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131752778|NCT02712008|474372125|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
131752779|NCT02712008|474372126|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131752780|NCT02712008|474372127|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131810310|NCT01796171|474588021|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
131810311|NCT01796171|474588022|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
131810312|NCT01796171|474588023|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
131810313|NCT01796171|474588024|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
131810314|NCT01796171|474588025|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
131752781|NCT02712008|474372128|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131752782|NCT02712008|474372129|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131752783|NCT02712008|474372130|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131752784|NCT02712008|474372123|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752785|NCT02712008|474372124|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752786|NCT02712008|474372125|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
131752787|NCT02712008|474372126|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752788|NCT02712008|474372127|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752789|NCT02712008|474372128|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752790|NCT02712008|474372129|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752791|NCT02712008|474372130|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131752792|NCT02712008|474372123|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752793|NCT02712008|474372124|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
131752794|NCT02712008|474372125|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752795|NCT02712008|474372126|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752796|NCT02712008|474372127|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752797|NCT02712008|474372128|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752798|NCT02712008|474372129|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752799|NCT02712008|474372130|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131752800|NCT02712008|474372123|FG000|From Week 12 up to Week 36|Adverse Event|0|||
131752801|NCT02712008|474372124|FG001|From Week 12 up to Week 36|Adverse Event|0|||
131752802|NCT02712008|474372125|FG002|From Week 12 up to Week 36|Adverse Event|0|||
131752803|NCT02712008|474372126|FG003|From Week 12 up to Week 36|Adverse Event|0|||
131752804|NCT02712008|474372127|FG004|From Week 12 up to Week 36|Adverse Event|1|||
131752805|NCT02712008|474372128|FG005|From Week 12 up to Week 36|Adverse Event|0|||
131752806|NCT02712008|474372129|FG006|From Week 12 up to Week 36|Adverse Event|0|||
131752807|NCT02712008|474372130|FG007|From Week 12 up to Week 36|Adverse Event|2|||
131752808|NCT02712008|474372123|FG000|From Week 12 up to Week 36|Death|1|||
131752809|NCT02712008|474372124|FG001|From Week 12 up to Week 36|Death|0|||
131752810|NCT02712008|474372125|FG002|From Week 12 up to Week 36|Death|0|||
131752811|NCT02712008|474372126|FG003|From Week 12 up to Week 36|Death|0|||
131752812|NCT02712008|474372127|FG004|From Week 12 up to Week 36|Death|0|||
131752813|NCT02712008|474372128|FG005|From Week 12 up to Week 36|Death|0|||
131752814|NCT02712008|474372129|FG006|From Week 12 up to Week 36|Death|1|||
131752815|NCT02712008|474372130|FG007|From Week 12 up to Week 36|Death|0|||
131752816|NCT02712008|474372123|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
131752817|NCT02712008|474372124|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
131752818|NCT02712008|474372125|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
131752819|NCT02712008|474372126|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
131752820|NCT02712008|474372127|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
131752821|NCT02712008|474372128|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
131810315|NCT01796171|474588011|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810316|NCT01796171|474588012|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810317|NCT01796171|474588013|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810318|NCT01796171|474588014|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810319|NCT01796171|474588015|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810320|NCT01796171|474588016|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810321|NCT01796171|474588017|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810322|NCT01796171|474588018|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810323|NCT01796171|474588019|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810324|NCT01796171|474588020|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810325|NCT01796171|474588021|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
131810326|NCT01796171|474588022|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
131397593|NCT01436656|473077397|FG015|Dose Expansion|Withdrawal by Subject|0|||
131397594|NCT01436656|473077398|FG016|Dose Expansion|Withdrawal by Subject|1|||
131397595|NCT01436656|473077399|FG017|Dose Expansion|Withdrawal by Subject|1|||
131397596|NCT01436656|473077382|FG000|Dose Expansion|Death|0|||
131397597|NCT01436656|473077383|FG001|Dose Expansion|Death|0|||
131397598|NCT01436656|473077384|FG002|Dose Expansion|Death|0|||
131397599|NCT01436656|473077385|FG003|Dose Expansion|Death|0|||
131397600|NCT01436656|473077386|FG004|Dose Expansion|Death|0|||
131397601|NCT01436656|473077387|FG005|Dose Expansion|Death|0|||
131397602|NCT01436656|473077388|FG006|Dose Expansion|Death|0|||
131397603|NCT01436656|473077389|FG007|Dose Expansion|Death|0|||
131397604|NCT01436656|473077390|FG008|Dose Expansion|Death|0|||
131397605|NCT01436656|473077391|FG009|Dose Expansion|Death|0|||
131397606|NCT01436656|473077392|FG010|Dose Expansion|Death|0|||
131397607|NCT01436656|473077393|FG011|Dose Expansion|Death|0|||
131397608|NCT01436656|473077394|FG012|Dose Expansion|Death|1|||
131397609|NCT01436656|473077395|FG013|Dose Expansion|Death|0|||
131752822|NCT02712008|474372129|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
131397610|NCT01436656|473077396|FG014|Dose Expansion|Death|3|||
131397611|NCT01436656|473077397|FG015|Dose Expansion|Death|0|||
131397612|NCT01436656|473077398|FG016|Dose Expansion|Death|3|||
131397613|NCT01436656|473077399|FG017|Dose Expansion|Death|3|||
131752823|NCT02712008|474372130|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
131752824|NCT02712008|474372123|FG000|From Week 12 up to Week 36|Physician Decision|0|||
131752825|NCT02712008|474372124|FG001|From Week 12 up to Week 36|Physician Decision|0|||
131752826|NCT02712008|474372125|FG002|From Week 12 up to Week 36|Physician Decision|0|||
131752827|NCT02712008|474372126|FG003|From Week 12 up to Week 36|Physician Decision|1|||
131752828|NCT02712008|474372127|FG004|From Week 12 up to Week 36|Physician Decision|1|||
131752829|NCT02712008|474372128|FG005|From Week 12 up to Week 36|Physician Decision|0|||
131752830|NCT02712008|474372129|FG006|From Week 12 up to Week 36|Physician Decision|0|||
131752831|NCT02712008|474372130|FG007|From Week 12 up to Week 36|Physician Decision|0|||
131752832|NCT02712008|474372123|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131752833|NCT02712008|474372124|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131752834|NCT02712008|474372125|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131752835|NCT02712008|474372126|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131752836|NCT02712008|474372127|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131752837|NCT02712008|474372128|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131752838|NCT02712008|474372129|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
131752839|NCT02712008|474372130|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
131752840|NCT01731990|474372131|FG000|Overall Study|Adverse Event|1|||
131752841|NCT01731990|474372132|FG001|Overall Study|Adverse Event|5|||
131752842|NCT01731990|474372131|FG000|Overall Study|Withdrawal by Subject|1|||
131752843|NCT01731990|474372132|FG001|Overall Study|Withdrawal by Subject|1|||
131752844|NCT01731990|474372131|FG000|Overall Study|Protocol deviation|1|||
131752845|NCT01731990|474372132|FG001|Overall Study|Protocol deviation|2|||
131752846|NCT01731990|474372131|FG000|Overall Study|Death|1|||
131752847|NCT01731990|474372132|FG001|Overall Study|Death|0|||
131752848|NCT01280812|474372133|FG000|Overall Study|Withdrawal by Subject|2|||
131752849|NCT01280812|474372134|FG001|Overall Study|Withdrawal by Subject|1|||
131752850|NCT01280812|474372135|FG002|Overall Study|Withdrawal by Subject|0|||
131752851|NCT01280812|474372133|FG000|Overall Study|Lost to Follow-up|1|||
131752852|NCT01280812|474372134|FG001|Overall Study|Lost to Follow-up|1|||
131752853|NCT01280812|474372135|FG002|Overall Study|Lost to Follow-up|1|||
131752854|NCT04483544|474372136|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
131752855|NCT04483544|474372136|FG000|Post-Treatment|Admitted to hospice|2|||
131752856|NCT04483544|474372136|FG000|Post-Treatment|Study terminated|3|||
131752857|NCT01131078|474372143|FG000|Overall Study|Adverse Event|22|||
131397614|NCT01436656|473077382|FG000|Dose Expansion|Lost to Follow-up|0|||
131397615|NCT01436656|473077383|FG001|Dose Expansion|Lost to Follow-up|0|||
131397616|NCT01436656|473077384|FG002|Dose Expansion|Lost to Follow-up|0|||
131397617|NCT01436656|473077385|FG003|Dose Expansion|Lost to Follow-up|0|||
131397618|NCT01436656|473077386|FG004|Dose Expansion|Lost to Follow-up|0|||
131397619|NCT01436656|473077387|FG005|Dose Expansion|Lost to Follow-up|0|||
131397620|NCT01436656|473077388|FG006|Dose Expansion|Lost to Follow-up|0|||
131397621|NCT01436656|473077389|FG007|Dose Expansion|Lost to Follow-up|0|||
131397622|NCT01436656|473077390|FG008|Dose Expansion|Lost to Follow-up|0|||
131397623|NCT01436656|473077391|FG009|Dose Expansion|Lost to Follow-up|0|||
131397624|NCT01436656|473077392|FG010|Dose Expansion|Lost to Follow-up|0|||
131397625|NCT01436656|473077393|FG011|Dose Expansion|Lost to Follow-up|0|||
131397626|NCT01436656|473077394|FG012|Dose Expansion|Lost to Follow-up|0|||
131397627|NCT01436656|473077395|FG013|Dose Expansion|Lost to Follow-up|0|||
131397628|NCT01436656|473077396|FG014|Dose Expansion|Lost to Follow-up|0|||
131397629|NCT01436656|473077397|FG015|Dose Expansion|Lost to Follow-up|0|||
131397630|NCT01436656|473077398|FG016|Dose Expansion|Lost to Follow-up|0|||
131397631|NCT01436656|473077399|FG017|Dose Expansion|Lost to Follow-up|3|||
131397632|NCT01436656|473077382|FG000|Dose Expansion|Disease progression|0|||
131397633|NCT01436656|473077383|FG001|Dose Expansion|Disease progression|0|||
131397634|NCT01436656|473077384|FG002|Dose Expansion|Disease progression|0|||
131397635|NCT01436656|473077385|FG003|Dose Expansion|Disease progression|0|||
131397636|NCT01436656|473077386|FG004|Dose Expansion|Disease progression|0|||
131397637|NCT01436656|473077387|FG005|Dose Expansion|Disease progression|0|||
131397638|NCT01436656|473077388|FG006|Dose Expansion|Disease progression|0|||
131397639|NCT01436656|473077389|FG007|Dose Expansion|Disease progression|0|||
131397640|NCT01436656|473077390|FG008|Dose Expansion|Disease progression|0|||
131397641|NCT01436656|473077391|FG009|Dose Expansion|Disease progression|0|||
131397642|NCT01436656|473077392|FG010|Dose Expansion|Disease progression|0|||
131397643|NCT01436656|473077393|FG011|Dose Expansion|Disease progression|3|||
131397644|NCT01436656|473077394|FG012|Dose Expansion|Disease progression|1|||
131752858|NCT01131078|474372144|FG001|Overall Study|Adverse Event|12|||
131397645|NCT01436656|473077395|FG013|Dose Expansion|Disease progression|0|||
131397646|NCT01436656|473077396|FG014|Dose Expansion|Disease progression|1|||
131397647|NCT01436656|473077397|FG015|Dose Expansion|Disease progression|0|||
131752859|NCT01131078|474372145|FG002|Overall Study|Adverse Event|17|||
131752860|NCT01131078|474372143|FG000|Overall Study|Progressive Disease|58|||
131752861|NCT01131078|474372144|FG001|Overall Study|Progressive Disease|77|||
131752862|NCT01131078|474372145|FG002|Overall Study|Progressive Disease|71|||
131752863|NCT01131078|474372143|FG000|Overall Study|Protocol Violation|1|||
131752864|NCT01131078|474372144|FG001|Overall Study|Protocol Violation|0|||
131752865|NCT01131078|474372145|FG002|Overall Study|Protocol Violation|0|||
131752866|NCT01131078|474372143|FG000|Overall Study|Lost to Follow-up|1|||
131752867|NCT01131078|474372144|FG001|Overall Study|Lost to Follow-up|1|||
131752868|NCT01131078|474372145|FG002|Overall Study|Lost to Follow-up|1|||
131752869|NCT01131078|474372143|FG000|Overall Study|Withdrawal by Subject|2|||
131752870|NCT01131078|474372144|FG001|Overall Study|Withdrawal by Subject|4|||
131752871|NCT01131078|474372145|FG002|Overall Study|Withdrawal by Subject|3|||
131752872|NCT01131078|474372143|FG000|Overall Study|Non-compliance|3|||
131752873|NCT01131078|474372144|FG001|Overall Study|Non-compliance|0|||
131752874|NCT01131078|474372145|FG002|Overall Study|Non-compliance|0|||
131752875|NCT01131078|474372143|FG000|Overall Study|Physician Decision|10|||
131752876|NCT01131078|474372144|FG001|Overall Study|Physician Decision|6|||
131752877|NCT01131078|474372145|FG002|Overall Study|Physician Decision|8|||
131752878|NCT01131078|474372143|FG000|Overall Study|Death|4|||
131752879|NCT01131078|474372144|FG001|Overall Study|Death|0|||
131752880|NCT01131078|474372145|FG002|Overall Study|Death|2|||
131752881|NCT01131078|474372143|FG000|Overall Study|Other|0|||
131752882|NCT01131078|474372144|FG001|Overall Study|Other|1|||
131752883|NCT01131078|474372145|FG002|Overall Study|Other|0|||
131752884|NCT01199198|474372146|FG000|Overall Study|Adverse Event|3|||
131752885|NCT01199198|474372147|FG001|Overall Study|Adverse Event|0|||
131752886|NCT01199198|474372146|FG000|Overall Study|Lost to Follow-up|1|||
131752887|NCT01199198|474372147|FG001|Overall Study|Lost to Follow-up|5|||
131752888|NCT01199198|474372146|FG000|Overall Study|Withdrawal by Subject|1|||
131752889|NCT01199198|474372147|FG001|Overall Study|Withdrawal by Subject|2|||
131752890|NCT01199198|474372146|FG000|Overall Study|ICU Transfer|1|||
131752891|NCT01199198|474372147|FG001|Overall Study|ICU Transfer|2|||
131906870|NCT00408499|474946615|FG001|Phase II- MTD Expansion|Adverse Event|0|||
131906871|NCT00408499|474946616|FG002|Phase II- MTD Expansion|Adverse Event|0|||
131906872|NCT00408499|474946617|FG003|Phase II- MTD Expansion|Adverse Event|0|||
131906873|NCT00408499|474946618|FG004|Phase II- MTD Expansion|Adverse Event|9|||
131906874|NCT00408499|474946614|FG000|Phase II- MTD Expansion|Death|0|||
131906875|NCT00408499|474946615|FG001|Phase II- MTD Expansion|Death|0|||
131906876|NCT00408499|474946616|FG002|Phase II- MTD Expansion|Death|0|||
131906877|NCT00408499|474946617|FG003|Phase II- MTD Expansion|Death|0|||
131906878|NCT00408499|474946618|FG004|Phase II- MTD Expansion|Death|2|||
131906879|NCT00408499|474946614|FG000|Phase II- MTD Expansion|Physician Decision|0|||
131906880|NCT00408499|474946615|FG001|Phase II- MTD Expansion|Physician Decision|0|||
131906881|NCT00408499|474946616|FG002|Phase II- MTD Expansion|Physician Decision|0|||
131752892|NCT01199198|474372146|FG000|Overall Study|Hospice-care transfer|1|||
131906882|NCT00408499|474946617|FG003|Phase II- MTD Expansion|Physician Decision|0|||
131906883|NCT00408499|474946618|FG004|Phase II- MTD Expansion|Physician Decision|1|||
131906884|NCT00408499|474946614|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
131906885|NCT00408499|474946615|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
131906886|NCT00408499|474946616|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
131906887|NCT00408499|474946617|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
131906888|NCT00408499|474946618|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
131906889|NCT00408499|474946614|FG000|Phase II- MTD Expansion|treatment delay|0|||
131906890|NCT00408499|474946615|FG001|Phase II- MTD Expansion|treatment delay|0|||
131906891|NCT00408499|474946616|FG002|Phase II- MTD Expansion|treatment delay|0|||
131906892|NCT00408499|474946617|FG003|Phase II- MTD Expansion|treatment delay|0|||
131906893|NCT00408499|474946618|FG004|Phase II- MTD Expansion|treatment delay|3|||
131906894|NCT02683109|474946620|FG000|Overall Study|Adverse Event|1|||
131906895|NCT02683109|474946621|FG001|Overall Study|Adverse Event|0|||
131906896|NCT00183430|474946622|FG000|Overall Study|Adverse Event|1|||
131906897|NCT00183430|474946623|FG001|Overall Study|Adverse Event|0|||
131906898|NCT00183430|474946622|FG000|Overall Study|Lost to Follow-up|3|||
131906899|NCT00183430|474946623|FG001|Overall Study|Lost to Follow-up|0|||
131906900|NCT00183430|474946622|FG000|Overall Study|did not meet inclusion criteria|1|||
131906901|NCT00183430|474946623|FG001|Overall Study|did not meet inclusion criteria|0|||
131906902|NCT00183430|474946622|FG000|Overall Study|Withdrawal by Subject|1|||
131906903|NCT00183430|474946623|FG001|Overall Study|Withdrawal by Subject|0|||
131906904|NCT01248455|474946630|FG000|Overall Study|switched to alternate treatment|1|||
131906905|NCT00426270|474946631|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
131906906|NCT00426270|474946631|FG000|Overall Study|Adverse Event|5|||
131906907|NCT01117870|474946633|FG000|Overall Study|Inability to place needle|1|||
131397648|NCT01436656|473077398|FG016|Dose Expansion|Disease progression|0|||
131752893|NCT01199198|474372147|FG001|Overall Study|Hospice-care transfer|2|||
131752894|NCT00959894|474372149|FG000|Overall Study|Lost to Follow-up|10|||
131752895|NCT00959894|474372149|FG000|Overall Study|Adverse Event|3|||
131752896|NCT00959894|474372149|FG000|Overall Study|Withdrawal by Subject|1|||
131752897|NCT00959894|474372149|FG000|Overall Study|Need for contraindicated medication|1|||
131752898|NCT00959894|474372149|FG000|Overall Study|Subject moved out of town|1|||
131752899|NCT00653068|474372150|FG000|Overall Study|Death|9|||
131752900|NCT00653068|474372150|FG000|Overall Study|Lack of Efficacy|34|||
131752901|NCT00653068|474372150|FG000|Overall Study|Physician Decision|4|||
131752902|NCT00653068|474372150|FG000|Overall Study|Withdrawal by Subject|1|||
131906908|NCT01117870|474946634|FG001|Overall Study|Inability to place needle|0|||
131397649|NCT01436656|473077399|FG017|Dose Expansion|Disease progression|1|||
131397650|NCT01436656|473077382|FG000|Dose Expansion|New cancer therapy|0|||
131397651|NCT01436656|473077383|FG001|Dose Expansion|New cancer therapy|0|||
131397652|NCT01436656|473077384|FG002|Dose Expansion|New cancer therapy|0|||
131397653|NCT01436656|473077385|FG003|Dose Expansion|New cancer therapy|0|||
131397654|NCT01436656|473077386|FG004|Dose Expansion|New cancer therapy|0|||
131397655|NCT01436656|473077387|FG005|Dose Expansion|New cancer therapy|0|||
131397656|NCT01436656|473077388|FG006|Dose Expansion|New cancer therapy|0|||
131397657|NCT01436656|473077389|FG007|Dose Expansion|New cancer therapy|0|||
131397658|NCT01436656|473077390|FG008|Dose Expansion|New cancer therapy|0|||
131397659|NCT01436656|473077391|FG009|Dose Expansion|New cancer therapy|0|||
131397660|NCT01436656|473077392|FG010|Dose Expansion|New cancer therapy|0|||
131397661|NCT01436656|473077393|FG011|Dose Expansion|New cancer therapy|1|||
131397662|NCT01436656|473077394|FG012|Dose Expansion|New cancer therapy|1|||
131397663|NCT01436656|473077395|FG013|Dose Expansion|New cancer therapy|0|||
131397664|NCT01436656|473077396|FG014|Dose Expansion|New cancer therapy|2|||
131397665|NCT01436656|473077397|FG015|Dose Expansion|New cancer therapy|0|||
131397666|NCT01436656|473077398|FG016|Dose Expansion|New cancer therapy|0|||
131397667|NCT01436656|473077399|FG017|Dose Expansion|New cancer therapy|0|||
131397668|NCT04729972|473077400|FG000|Overall Study|Adverse Event|1|||
131397673|NCT02516982|473077403|FG000|Overall Study|Called in to antenatal appointment|32|||
131397674|NCT02516982|473077404|FG001|Overall Study|Called in to antenatal appointment|35|||
131397675|NCT02516982|473077405|FG002|Overall Study|Called in to antenatal appointment|0|||
131397676|NCT02516982|473077406|FG003|Overall Study|Called in to antenatal appointment|0|||
131397677|NCT02516982|473077403|FG000|Overall Study|Withdrawal by Subject|0|||
131397678|NCT02516982|473077404|FG001|Overall Study|Withdrawal by Subject|0|||
131397679|NCT02516982|473077405|FG002|Overall Study|Withdrawal by Subject|1|||
131397680|NCT02516982|473077406|FG003|Overall Study|Withdrawal by Subject|2|||
131397681|NCT02516982|473077403|FG000|Overall Study|Protocol Violation|0|||
131397682|NCT02516982|473077404|FG001|Overall Study|Protocol Violation|0|||
131397683|NCT02516982|473077405|FG002|Overall Study|Protocol Violation|1|||
131397684|NCT02516982|473077406|FG003|Overall Study|Protocol Violation|1|||
131397685|NCT02516982|473077403|FG000|Overall Study|Did not install the app|0|||
131397686|NCT02516982|473077404|FG001|Overall Study|Did not install the app|0|||
131397687|NCT02516982|473077405|FG002|Overall Study|Did not install the app|46|||
131397688|NCT02516982|473077406|FG003|Overall Study|Did not install the app|47|||
131397689|NCT01814878|473077409|FG000|Overall Study|Adverse Event|16|||
131397690|NCT01814878|473077410|FG001|Overall Study|Adverse Event|5|||
131397691|NCT01814878|473077409|FG000|Overall Study|Withdrawal by Subject|20|||
131397692|NCT01814878|473077410|FG001|Overall Study|Withdrawal by Subject|16|||
131752903|NCT00653068|474372150|FG000|Overall Study|Ineligible|2|||
131752904|NCT01305941|474372151|FG000|Overall Study|Adverse Event|6|||
131752905|NCT01305941|474372151|FG000|Overall Study|Clinical decline|2|||
131752906|NCT01305941|474372151|FG000|Overall Study|Withdrawal by Subject|1|||
131752907|NCT01305941|474372151|FG000|Overall Study|Death|1|||
131752908|NCT02892734|474372152|FG000|Treatment on Study|Progressive Disease|2|||
131752909|NCT02892734|474372152|FG000|Follow up for 2 Years|Death|2|||
131752910|NCT02892734|474372152|FG000|Follow up for 2 Years|Study closed early|1|||
131752911|NCT02043509|474372153|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
131752912|NCT02043509|474372154|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
131752913|NCT02043509|474372153|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
131752914|NCT02043509|474372154|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
131752915|NCT02043509|474372153|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
131752916|NCT02043509|474372154|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
131752917|NCT02043509|474372153|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
131752918|NCT02043509|474372154|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
131752919|NCT03597503|474372155|FG000|Overall Study|Withdrawal by Subject|0|||
131752920|NCT03597503|474372156|FG001|Overall Study|Withdrawal by Subject|2|||
131752921|NCT03597503|474372155|FG000|Overall Study|Lost to Follow-up|1|||
131752922|NCT03597503|474372156|FG001|Overall Study|Lost to Follow-up|2|||
131752923|NCT03597503|474372155|FG000|Overall Study|Protocol Violation|1|||
131752924|NCT03597503|474372156|FG001|Overall Study|Protocol Violation|0|||
131752925|NCT01376388|474372157|FG000|Overall Study|Adverse Event|13|||
131752926|NCT01376388|474372157|FG000|Overall Study|Lack of Efficacy|2|||
131752927|NCT01376388|474372157|FG000|Overall Study|Withdrawal by Subject|3|||
131752928|NCT02853123|474372165|FG000|Treatment Period 1|Adverse Event|0|||
131752929|NCT02853123|474372166|FG001|Treatment Period 1|Adverse Event|3|||
131752930|NCT02853123|474372165|FG000|Washout Period|Worsening of COPD|0|||
131752931|NCT02853123|474372166|FG001|Washout Period|Worsening of COPD|3|||
131752932|NCT02853123|474372165|FG000|Washout Period|Adverse Event|1|||
131752933|NCT02853123|474372166|FG001|Washout Period|Adverse Event|0|||
131397693|NCT01814878|473077409|FG000|Overall Study|Protocol Violation|5|||
131397694|NCT01814878|473077410|FG001|Overall Study|Protocol Violation|5|||
131397695|NCT01814878|473077409|FG000|Overall Study|Physician Decision|3|||
131397696|NCT01814878|473077410|FG001|Overall Study|Physician Decision|1|||
131397697|NCT01814878|473077409|FG000|Overall Study|Screening failure (drop-out)|0|||
131397698|NCT01814878|473077410|FG001|Overall Study|Screening failure (drop-out)|3|||
131397699|NCT01814878|473077409|FG000|Overall Study|Other|2|||
131397700|NCT01814878|473077410|FG001|Overall Study|Other|0|||
131397701|NCT01977729|473077415|FG000|Overall Study|Study terminated|1|||
131397702|NCT01268046|473077416|FG000|Overall Study|Withdrawal by Subject|1|||
131397703|NCT01268046|473077417|FG001|Overall Study|Withdrawal by Subject|0|||
131397704|NCT01268046|473077418|FG002|Overall Study|Withdrawal by Subject|0|||
131397705|NCT01268046|473077419|FG003|Overall Study|Withdrawal by Subject|1|||
131397706|NCT01268046|473077416|FG000|Overall Study|Lost to Follow-up|0|||
131397707|NCT01268046|473077417|FG001|Overall Study|Lost to Follow-up|0|||
131397708|NCT01268046|473077418|FG002|Overall Study|Lost to Follow-up|1|||
131397709|NCT01268046|473077419|FG003|Overall Study|Lost to Follow-up|0|||
131397710|NCT02836717|473077420|FG000|Test Phase|Lack of Efficacy|14|||
131397711|NCT02836717|473077421|FG001|Test Phase|Lack of Efficacy|8|||
131397712|NCT02836717|473077422|FG002|Test Phase|Lack of Efficacy|0|||
131397713|NCT02836717|473077420|FG000|Study Phase|Adverse Event|2|||
131397714|NCT02836717|473077421|FG001|Study Phase|Adverse Event|0|||
131397715|NCT02836717|473077422|FG002|Study Phase|Adverse Event|0|||
131397716|NCT02836717|473077420|FG000|Study Phase|Lack of Efficacy|8|||
131397717|NCT02836717|473077421|FG001|Study Phase|Lack of Efficacy|6|||
131397718|NCT02836717|473077422|FG002|Study Phase|Lack of Efficacy|1|||
131397719|NCT02836717|473077420|FG000|Study Phase|Withdrawal by Subject|1|||
131397720|NCT02836717|473077421|FG001|Study Phase|Withdrawal by Subject|0|||
131397721|NCT02836717|473077422|FG002|Study Phase|Withdrawal by Subject|0|||
131397722|NCT02836717|473077420|FG000|Study Phase|Death|1|||
131397723|NCT02836717|473077421|FG001|Study Phase|Death|0|||
131397724|NCT02836717|473077422|FG002|Study Phase|Death|0|||
131397725|NCT02836717|473077420|FG000|Study Phase|abdominal surgeries|2|||
131397726|NCT02836717|473077421|FG001|Study Phase|abdominal surgeries|1|||
131397727|NCT02836717|473077422|FG002|Study Phase|abdominal surgeries|0|||
131397728|NCT00438360|473077423|FG000|Overall Study|Adverse Event|6|||
131397729|NCT00438360|473077424|FG001|Overall Study|Adverse Event|1|||
131397730|NCT00438360|473077423|FG000|Overall Study|Lack of Efficacy|42|||
131397731|NCT00438360|473077424|FG001|Overall Study|Lack of Efficacy|27|||
131397732|NCT00438360|473077423|FG000|Overall Study|Other|24|||
131397733|NCT00438360|473077424|FG001|Overall Study|Other|15|||
131397735|NCT01804049|473077428|FG000|Overall Study|Adverse Event|2|||
131397736|NCT01804049|473077429|FG001|Overall Study|Adverse Event|10|||
131397737|NCT01804049|473077428|FG000|Overall Study|Lost to Follow-up|2|||
131397738|NCT01804049|473077429|FG001|Overall Study|Lost to Follow-up|1|||
131397739|NCT01804049|473077428|FG000|Overall Study|Decreased interest/personal|4|||
131449544|NCT01394016|473274911|FG001|Overall Study|Adverse Event|0|||
131752934|NCT05283499|474372169|FG000|Overall Study|Did not receive intervention|1|||
131752935|NCT05283499|474372170|FG001|Overall Study|Did not receive intervention|2|||
131752936|NCT00136357|474372173|FG000|Overall Study|Withdrawal by Subject|3|||
131752937|NCT00136357|474372174|FG001|Overall Study|Withdrawal by Subject|2|||
131752938|NCT01510028|474372175|FG000|Overall Study|Lack of Efficacy|1|||
131752939|NCT01510028|474372176|FG001|Overall Study|Lack of Efficacy|0|||
131752940|NCT01510028|474372177|FG002|Overall Study|Lack of Efficacy|0|||
131752941|NCT01510028|474372178|FG003|Overall Study|Lack of Efficacy|0|||
131752942|NCT01355497|474372179|FG000|Overall Study|Death|19|||
131752943|NCT01355497|474372180|FG001|Overall Study|Death|18|||
131752944|NCT01355497|474372179|FG000|Overall Study|Lost to Follow-up|3|||
131752945|NCT01355497|474372180|FG001|Overall Study|Lost to Follow-up|0|||
131752946|NCT01355497|474372179|FG000|Overall Study|Protocol Violation|0|||
131752947|NCT01355497|474372180|FG001|Overall Study|Protocol Violation|1|||
131752948|NCT01355497|474372179|FG000|Overall Study|other-not provided|9|||
131752949|NCT01355497|474372180|FG001|Overall Study|other-not provided|4|||
131752950|NCT01355497|474372179|FG000|Overall Study|Withdrawal by Subject|12|||
131752951|NCT01355497|474372180|FG001|Overall Study|Withdrawal by Subject|20|||
131752952|NCT01355497|474372179|FG000|Overall Study|noncompliance|1|||
131752953|NCT01355497|474372180|FG001|Overall Study|noncompliance|2|||
131752954|NCT01355497|474372179|FG000|Overall Study|progressive disease|11|||
131752955|NCT01355497|474372180|FG001|Overall Study|progressive disease|8|||
131752956|NCT01355497|474372179|FG000|Overall Study|Adverse Event|11|||
131752957|NCT01355497|474372180|FG001|Overall Study|Adverse Event|10|||
131752958|NCT01784211|474372193|FG000|Part A (Days 1-15)|Adverse Event|1|||
131752959|NCT01784211|474372194|FG001|Part A (Days 1-15)|Adverse Event|1|||
131752960|NCT01784211|474372195|FG002|Part A (Days 1-15)|Adverse Event|0|||
131752961|NCT01784211|474372196|FG003|Part A (Days 1-15)|Adverse Event|0|||
131752962|NCT01784211|474372197|FG004|Part A (Days 1-15)|Adverse Event|0|||
131752963|NCT01784211|474372198|FG005|Part A (Days 1-15)|Adverse Event|0|||
131752964|NCT01784211|474372193|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
131752965|NCT01784211|474372194|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
131752966|NCT01784211|474372195|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
131752967|NCT01784211|474372196|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
131752968|NCT01784211|474372197|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
131397740|NCT01804049|473077429|FG001|Overall Study|Decreased interest/personal|5|||
131397741|NCT01804049|473077428|FG000|Overall Study|Other health concerns|2|||
131397742|NCT01804049|473077429|FG001|Overall Study|Other health concerns|7|||
131449545|NCT01394016|473274912|FG002|Overall Study|Adverse Event|0|||
131449546|NCT01394016|473274913|FG003|Overall Study|Adverse Event|0|||
131449547|NCT01394016|473274914|FG004|Overall Study|Adverse Event|0|||
131449548|NCT01394016|473274915|FG005|Overall Study|Adverse Event|0|||
131449549|NCT01394016|473274916|FG006|Overall Study|Adverse Event|0|||
131449550|NCT01394016|473274917|FG007|Overall Study|Adverse Event|0|||
131449551|NCT01394016|473274918|FG008|Overall Study|Adverse Event|0|||
131449552|NCT01394016|473274919|FG009|Overall Study|Adverse Event|1|||
131449553|NCT01394016|473274920|FG010|Overall Study|Adverse Event|0|||
131449554|NCT01394016|473274921|FG011|Overall Study|Adverse Event|0|||
131449555|NCT01394016|473274922|FG012|Overall Study|Adverse Event|0|||
131449556|NCT01394016|473274923|FG013|Overall Study|Adverse Event|0|||
131449557|NCT01394016|473274924|FG014|Overall Study|Adverse Event|0|||
131449558|NCT01394016|473274925|FG015|Overall Study|Adverse Event|0|||
131449559|NCT01394016|473274926|FG016|Overall Study|Adverse Event|1|||
131449560|NCT01394016|473274927|FG017|Overall Study|Adverse Event|1|||
131449561|NCT01394016|473274928|FG018|Overall Study|Adverse Event|0|||
131449562|NCT01394016|473274910|FG000|Overall Study|Sponsor Decision|0|||
131449563|NCT01394016|473274911|FG001|Overall Study|Sponsor Decision|0|||
131449564|NCT01394016|473274912|FG002|Overall Study|Sponsor Decision|0|||
131449565|NCT01394016|473274913|FG003|Overall Study|Sponsor Decision|0|||
131397743|NCT01804049|473077428|FG000|Overall Study|Moved out of area|0|||
131397744|NCT01804049|473077429|FG001|Overall Study|Moved out of area|7|||
131397745|NCT01804049|473077428|FG000|Overall Study|other MD recommended|1|||
131397746|NCT01804049|473077429|FG001|Overall Study|other MD recommended|1|||
131397747|NCT01804049|473077428|FG000|Overall Study|Enrollment in dual studies|0|||
131397748|NCT01804049|473077429|FG001|Overall Study|Enrollment in dual studies|1|||
131397749|NCT01147250|473077434|FG000|Overall Study|Lost to Follow-up|14|||
131397750|NCT01147250|473077435|FG001|Overall Study|Lost to Follow-up|11|||
131397751|NCT01147250|473077434|FG000|Overall Study|Withdrawal by Subject|83|||
131397752|NCT01147250|473077435|FG001|Overall Study|Withdrawal by Subject|88|||
131397753|NCT01147250|473077434|FG000|Overall Study|Site termination by sponsor|13|||
131397754|NCT01147250|473077435|FG001|Overall Study|Site termination by sponsor|5|||
131397755|NCT01147250|473077434|FG000|Overall Study|Other than specified|0|||
131397756|NCT01147250|473077435|FG001|Overall Study|Other than specified|1|||
131449566|NCT01394016|473274914|FG004|Overall Study|Sponsor Decision|0|||
131449567|NCT01394016|473274915|FG005|Overall Study|Sponsor Decision|0|||
131449568|NCT01394016|473274916|FG006|Overall Study|Sponsor Decision|0|||
131449569|NCT01394016|473274917|FG007|Overall Study|Sponsor Decision|0|||
131449570|NCT01394016|473274918|FG008|Overall Study|Sponsor Decision|0|||
131449571|NCT01394016|473274919|FG009|Overall Study|Sponsor Decision|0|||
131449572|NCT01394016|473274920|FG010|Overall Study|Sponsor Decision|0|||
131449573|NCT01394016|473274921|FG011|Overall Study|Sponsor Decision|0|||
131752969|NCT01784211|474372198|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
131752970|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
131752971|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
131752972|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
131752973|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
131752974|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
131752975|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
131752976|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
131752977|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
131752978|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
131752979|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
131752980|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
131752981|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
131752982|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
131752983|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
131752984|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
131752985|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
131752986|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
131449574|NCT01394016|473274922|FG012|Overall Study|Sponsor Decision|1|||
131752987|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
131906909|NCT00958074|474946635|FG000|Overall Study|Withdrawal by Subject|0|||
131906910|NCT00958074|474946636|FG001|Overall Study|Withdrawal by Subject|1|||
131449575|NCT01394016|473274923|FG013|Overall Study|Sponsor Decision|0|||
131449576|NCT01394016|473274924|FG014|Overall Study|Sponsor Decision|0|||
131449577|NCT01394016|473274925|FG015|Overall Study|Sponsor Decision|0|||
131449578|NCT01394016|473274926|FG016|Overall Study|Sponsor Decision|0|||
131449579|NCT01394016|473274927|FG017|Overall Study|Sponsor Decision|0|||
131449580|NCT01394016|473274928|FG018|Overall Study|Sponsor Decision|0|||
131752988|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
131752989|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
131752990|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
131449581|NCT01394016|473274910|FG000|Overall Study|Lost to Follow-up|0|||
131449582|NCT01394016|473274911|FG001|Overall Study|Lost to Follow-up|0|||
131449583|NCT01394016|473274912|FG002|Overall Study|Lost to Follow-up|0|||
131449584|NCT01394016|473274913|FG003|Overall Study|Lost to Follow-up|0|||
131449585|NCT01394016|473274914|FG004|Overall Study|Lost to Follow-up|0|||
131449586|NCT01394016|473274915|FG005|Overall Study|Lost to Follow-up|0|||
131449587|NCT01394016|473274916|FG006|Overall Study|Lost to Follow-up|0|||
131449588|NCT01394016|473274917|FG007|Overall Study|Lost to Follow-up|0|||
131449589|NCT01394016|473274918|FG008|Overall Study|Lost to Follow-up|0|||
131449590|NCT01394016|473274919|FG009|Overall Study|Lost to Follow-up|0|||
131449591|NCT01394016|473274920|FG010|Overall Study|Lost to Follow-up|0|||
131449592|NCT01394016|473274921|FG011|Overall Study|Lost to Follow-up|0|||
131449593|NCT01394016|473274922|FG012|Overall Study|Lost to Follow-up|0|||
131449594|NCT01394016|473274923|FG013|Overall Study|Lost to Follow-up|0|||
131449595|NCT01394016|473274924|FG014|Overall Study|Lost to Follow-up|0|||
131449596|NCT01394016|473274925|FG015|Overall Study|Lost to Follow-up|0|||
131449597|NCT01394016|473274926|FG016|Overall Study|Lost to Follow-up|0|||
131449598|NCT01394016|473274927|FG017|Overall Study|Lost to Follow-up|0|||
131449599|NCT01394016|473274928|FG018|Overall Study|Lost to Follow-up|1|||
131449600|NCT03534804|473274929|FG000|Overall Study|Withdrawal by Subject|1|||
131449601|NCT00174187|473274930|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
131449602|NCT00174187|473274931|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
131449603|NCT00174187|473274932|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
131449604|NCT00174187|473274930|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
131449605|NCT00174187|473274931|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
131449606|NCT00174187|473274932|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
131449607|NCT00174187|473274930|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
131449608|NCT00174187|473274931|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
131449609|NCT00174187|473274932|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
131449610|NCT00174187|473274930|FG000|Period 1 (up to 3 Years)|Other|0|||
131449611|NCT00174187|473274931|FG001|Period 1 (up to 3 Years)|Other|1|||
131449612|NCT00174187|473274932|FG002|Period 1 (up to 3 Years)|Other|0|||
131449613|NCT00174187|473274930|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
131449614|NCT00174187|473274931|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
131449615|NCT00174187|473274932|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
131449616|NCT00174187|473274930|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
131449617|NCT00174187|473274931|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
131752991|NCT01001572|474372199|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
131752992|NCT01001572|474372200|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
131752993|NCT01001572|474372201|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
131752994|NCT01001572|474372199|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131906911|NCT03102762|474946637|FG000|Overall Study|Lost to Follow-up|1|||
131906912|NCT03102762|474946638|FG001|Overall Study|Lost to Follow-up|0|||
131449618|NCT00174187|473274932|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
131449619|NCT00174187|473274930|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
131449620|NCT00174187|473274931|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
131449621|NCT00174187|473274932|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
131449622|NCT00174187|473274930|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
131449623|NCT00174187|473274931|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
131449624|NCT00174187|473274932|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
131752995|NCT01001572|474372200|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
131752996|NCT01001572|474372201|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
131752997|NCT01001572|474372199|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131752998|NCT01001572|474372200|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
131752999|NCT01001572|474372201|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
131753000|NCT01001572|474372199|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
131753001|NCT01001572|474372200|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
131753002|NCT01001572|474372201|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
131753003|NCT01001572|474372199|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
131753004|NCT01001572|474372200|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
131753005|NCT01001572|474372201|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
131753006|NCT01001572|474372199|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
131753007|NCT01001572|474372200|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
131753008|NCT01001572|474372201|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
131753009|NCT01001572|474372199|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131753010|NCT01001572|474372200|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131753011|NCT01001572|474372201|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131753012|NCT01094808|474372202|FG000|Overall Study|Withdrawal by Subject|1|||
131753013|NCT01094808|474372203|FG001|Overall Study|Withdrawal by Subject|1|||
131810327|NCT01796171|474588023|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810328|NCT01796171|474588024|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810329|NCT01796171|474588025|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
131810330|NCT01796171|474588011|FG000|Follow-up Period|Start of further anticancer therapy|4|||
131810331|NCT01796171|474588012|FG001|Follow-up Period|Start of further anticancer therapy|25|||
131810332|NCT01796171|474588013|FG002|Follow-up Period|Start of further anticancer therapy|2|||
131397901|NCT01355679|473077462|FG000|Overall Study|benign tumor types found at biopsy|2|||
131397902|NCT00904670|473077463|FG000|Open Label Phase|Withdrawal by Subject|2|||
131397903|NCT00904670|473077464|FG001|Open Label Phase|Withdrawal by Subject|0|||
131397904|NCT00904670|473077463|FG000|Open Label Phase|Adverse Event|2|||
131397905|NCT00904670|473077464|FG001|Open Label Phase|Adverse Event|0|||
131397906|NCT00904670|473077463|FG000|Open Label Phase|Lack of Efficacy|1|||
131397907|NCT00904670|473077464|FG001|Open Label Phase|Lack of Efficacy|0|||
131397908|NCT00904670|473077463|FG000|Open Label Phase|Lost to Follow-up|1|||
131397909|NCT00904670|473077464|FG001|Open Label Phase|Lost to Follow-up|0|||
131397910|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
131397911|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
131397912|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
131397913|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
131397914|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Death|58|||
131397915|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Death|65|||
131397916|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Adverse Event|28|||
131397917|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Adverse Event|40|||
131397918|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Disease Progression|22|||
131397919|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Disease Progression|35|||
131397920|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Other|25|||
131397921|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Other|33|||
131397922|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
131397923|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
131397924|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Noncompliance|8|||
131397925|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Noncompliance|8|||
131397926|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
131397927|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
131397928|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
131397929|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
131397930|NCT00286091|473077465|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
131397931|NCT00286091|473077466|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
131397932|NCT00286091|473077465|FG000|Open-label Treatment Phase|Physician Decision|24|||
131397933|NCT00286091|473077466|FG001|Open-label Treatment Phase|Physician Decision|21|||
131397934|NCT00286091|473077465|FG000|Open-label Treatment Phase|Adverse Event|5|||
131397935|NCT00286091|473077466|FG001|Open-label Treatment Phase|Adverse Event|16|||
131397936|NCT00286091|473077465|FG000|Open-label Treatment Phase|Other|11|||
131397937|NCT00286091|473077466|FG001|Open-label Treatment Phase|Other|11|||
131397938|NCT00286091|473077465|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
131397939|NCT00286091|473077466|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
131397940|NCT00286091|473077465|FG000|Open-label Treatment Phase|Death|10|||
131397941|NCT00286091|473077466|FG001|Open-label Treatment Phase|Death|7|||
131397942|NCT00286091|473077465|FG000|Open-label Treatment Phase|Disease Progression|9|||
131397943|NCT00286091|473077466|FG001|Open-label Treatment Phase|Disease Progression|3|||
131397944|NCT00286091|473077465|FG000|Open-label Treatment Phase|Noncompliance|3|||
131397945|NCT00286091|473077466|FG001|Open-label Treatment Phase|Noncompliance|1|||
131397946|NCT00286091|473077465|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
131397947|NCT00286091|473077466|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
131397948|NCT00286091|473077465|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
131397949|NCT00286091|473077466|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
131397950|NCT00286091|473077465|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
131397951|NCT00286091|473077466|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
131753014|NCT01094808|474372204|FG002|Overall Study|Withdrawal by Subject|0|||
131753015|NCT02025530|474372205|FG000|Overall Study|No longer met elligibility criteria|5|||
131810333|NCT01796171|474588014|FG003|Follow-up Period|Start of further anticancer therapy|1|||
131449625|NCT00174187|473274930|FG000|Period 2 (After 3 Years)|Other|0|||
131449626|NCT00174187|473274931|FG001|Period 2 (After 3 Years)|Other|0|||
131449627|NCT00174187|473274932|FG002|Period 2 (After 3 Years)|Other|5|||
131449628|NCT00759941|473274933|FG000|Overall Study|Use of medication|1|||
131449629|NCT00759941|473274934|FG001|Overall Study|Use of medication|0|||
131449630|NCT00759941|473274933|FG000|Overall Study|Adverse Event|1|||
131449631|NCT00759941|473274934|FG001|Overall Study|Adverse Event|0|||
131449632|NCT00759941|473274933|FG000|Overall Study|Exited in error by site|1|||
131449633|NCT00759941|473274934|FG001|Overall Study|Exited in error by site|1|||
131449634|NCT06078124|473274935|FG000|Overall Study|Lost to Follow-up|14|||
131449635|NCT06078124|473274936|FG001|Overall Study|Lost to Follow-up|14|||
131449636|NCT01198977|473274937|FG000|Overall Study|Lost to Follow-up|1|||
131449637|NCT01198977|473274938|FG001|Overall Study|Lost to Follow-up|0|||
131449638|NCT05615922|473274939|FG000|Overall Study|Lost to Follow-up|1|||
131449639|NCT03173248|473274943|FG000|Overall Study|Death|28|||
131449640|NCT03173248|473274944|FG001|Overall Study|Death|46|||
131449641|NCT03173248|473274943|FG000|Overall Study|Lost to Follow-up|0|||
131449642|NCT03173248|473274944|FG001|Overall Study|Lost to Follow-up|1|||
131449643|NCT03173248|473274943|FG000|Overall Study|Withdrawal by Subject|6|||
131449644|NCT03173248|473274944|FG001|Overall Study|Withdrawal by Subject|4|||
131753016|NCT02025530|474372206|FG001|Overall Study|No longer met elligibility criteria|1|||
131753017|NCT02498392|474372207|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
131753018|NCT02498392|474372208|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
131753019|NCT02498392|474372207|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
131753020|NCT02498392|474372208|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
131753021|NCT02498392|474372207|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
131753022|NCT02498392|474372208|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
131753023|NCT02498392|474372207|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
131753024|NCT02498392|474372208|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
131753025|NCT02498392|474372207|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
131753026|NCT02498392|474372208|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
131753027|NCT02498392|474372207|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
131753028|NCT02498392|474372208|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
131753029|NCT05784129|474372209|FG000|Overall Study|Study terminated by sponsor|2|||
131753030|NCT05784129|474372210|FG001|Overall Study|Study terminated by sponsor|2|||
131753031|NCT01156363|474372211|FG000|Overall Study|Adverse Event|6|||
131753032|NCT01156363|474372211|FG000|Overall Study|Insufficient Therapeutic Response|5|||
131753033|NCT01156363|474372211|FG000|Overall Study|Failure to Return|1|||
131753034|NCT01156363|474372211|FG000|Overall Study|Refused Treatment|4|||
131753035|NCT01156363|474372211|FG000|Overall Study|Other|6|||
131753036|NCT04882072|474372216|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
131753037|NCT04882072|474372217|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
131753038|NCT04882072|474372216|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
131753039|NCT04882072|474372217|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
131753040|NCT04882072|474372216|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
131753041|NCT04882072|474372217|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
131753042|NCT04080752|474372218|FG000|Overall Study|Adverse Event|2|||
131753043|NCT04080752|474372219|FG001|Overall Study|Adverse Event|3|||
131753044|NCT04080752|474372218|FG000|Overall Study|Lack of Efficacy|1|||
131753045|NCT04080752|474372219|FG001|Overall Study|Lack of Efficacy|0|||
131753046|NCT04080752|474372218|FG000|Overall Study|Lost to Follow-up|1|||
131753047|NCT04080752|474372219|FG001|Overall Study|Lost to Follow-up|0|||
131753048|NCT04080752|474372218|FG000|Overall Study|Pregnancy|0|||
131753049|NCT04080752|474372219|FG001|Overall Study|Pregnancy|1|||
131753050|NCT04080752|474372218|FG000|Overall Study|Withdrawal by Subject|7|||
131753051|NCT04080752|474372219|FG001|Overall Study|Withdrawal by Subject|0|||
131753052|NCT04080752|474372218|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131753053|NCT04080752|474372219|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131753054|NCT04080752|474372218|FG000|Overall Study|Other|2|||
131449645|NCT03173248|473274943|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
131449646|NCT03173248|473274944|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
131449647|NCT02991768|473274946|FG000|Overall Study|Physician Decision|4|||
131449648|NCT04500158|473274949|FG000|Overall Study|Physician Decision|17|||
131449649|NCT04500158|473274950|FG001|Overall Study|Physician Decision|11|||
131449650|NCT02807402|473274955|FG000|Overall Study|Failure to Return|1|||
131753055|NCT04080752|474372219|FG001|Overall Study|Other|1|||
131753056|NCT01192100|474372220|FG000|Overall Study|Withdrawal by Subject|0|||
131753057|NCT01192100|474372221|FG001|Overall Study|Withdrawal by Subject|0|||
131449651|NCT02807402|473274955|FG000|Overall Study|Death|3|||
131449652|NCT02807402|473274955|FG000|Overall Study|Other|2|||
131449653|NCT04922216|473274957|FG000|Overall Study|Withdrawal by Subject|0|||
131753058|NCT01192100|474372222|FG002|Overall Study|Withdrawal by Subject|0|||
131753059|NCT01192100|474372223|FG003|Overall Study|Withdrawal by Subject|0|||
131753060|NCT01192100|474372224|FG004|Overall Study|Withdrawal by Subject|1|||
131397957|NCT01479764|473077468|FG000|Randomized|Adverse Event|1|||
131397958|NCT01479764|473077469|FG001|Randomized|Adverse Event|1|||
131397959|NCT01479764|473077468|FG000|Randomized|Withdrawal by Subject|1|||
131397960|NCT01479764|473077469|FG001|Randomized|Withdrawal by Subject|0|||
131397961|NCT01479764|473077468|FG000|Treated|Lost to Follow-up|0|||
131397962|NCT01479764|473077469|FG001|Treated|Lost to Follow-up|2|||
131449654|NCT04922216|473274958|FG001|Overall Study|Withdrawal by Subject|1|||
131753061|NCT01192100|474372225|FG005|Overall Study|Withdrawal by Subject|0|||
131753062|NCT01192100|474372220|FG000|Overall Study|Protocol Violation|0|||
131753063|NCT01192100|474372221|FG001|Overall Study|Protocol Violation|0|||
131753064|NCT01192100|474372222|FG002|Overall Study|Protocol Violation|0|||
131753065|NCT01192100|474372223|FG003|Overall Study|Protocol Violation|1|||
131753066|NCT01192100|474372224|FG004|Overall Study|Protocol Violation|0|||
131753067|NCT01192100|474372225|FG005|Overall Study|Protocol Violation|0|||
131753068|NCT04685538|474372227|FG000|Overall Study|Adverse Event|0|||
131753069|NCT04685538|474372228|FG001|Overall Study|Adverse Event|1|||
131753070|NCT04685538|474372227|FG000|Overall Study|Lost to Follow-up|0|||
131753071|NCT04685538|474372228|FG001|Overall Study|Lost to Follow-up|2|||
131753072|NCT01095666|474372229|FG000|Overall Study|Lack of Efficacy|0|||
131753073|NCT01095666|474372230|FG001|Overall Study|Lack of Efficacy|0|||
131753074|NCT01095666|474372231|FG002|Overall Study|Lack of Efficacy|1|||
131753075|NCT01095666|474372229|FG000|Overall Study|Adverse Event|2|||
131753076|NCT01095666|474372230|FG001|Overall Study|Adverse Event|1|||
131753077|NCT01095666|474372231|FG002|Overall Study|Adverse Event|3|||
131753078|NCT01095666|474372229|FG000|Overall Study|Lost to Follow-up|2|||
131753079|NCT01095666|474372230|FG001|Overall Study|Lost to Follow-up|2|||
131753080|NCT01095666|474372231|FG002|Overall Study|Lost to Follow-up|0|||
131753081|NCT01095666|474372229|FG000|Overall Study|Withdrawal by Subject|6|||
131753082|NCT01095666|474372230|FG001|Overall Study|Withdrawal by Subject|6|||
131753083|NCT01095666|474372231|FG002|Overall Study|Withdrawal by Subject|1|||
131753084|NCT01095666|474372229|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
131753085|NCT01095666|474372230|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
131753086|NCT01095666|474372231|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
131753087|NCT00841672|474372239|FG000|Overall Study|Adverse Event|7|||
131753088|NCT00841672|474372240|FG001|Overall Study|Adverse Event|16|||
131753089|NCT00841672|474372239|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131753090|NCT00841672|474372240|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131753091|NCT00841672|474372239|FG000|Overall Study|Subject withdrew consent|2|||
131753092|NCT00841672|474372240|FG001|Overall Study|Subject withdrew consent|4|||
131753093|NCT00841672|474372239|FG000|Overall Study|Lost to Follow-up|1|||
131753094|NCT00841672|474372240|FG001|Overall Study|Lost to Follow-up|1|||
131753095|NCT00841672|474372239|FG000|Overall Study|Administrative problems|9|||
131753096|NCT00841672|474372240|FG001|Overall Study|Administrative problems|9|||
131753097|NCT00841672|474372239|FG000|Overall Study|Misrandomized|1|||
131753098|NCT00841672|474372240|FG001|Overall Study|Misrandomized|0|||
131753099|NCT00841672|474372239|FG000|Overall Study|Protocol Deviation|0|||
131753100|NCT00841672|474372240|FG001|Overall Study|Protocol Deviation|1|||
131753101|NCT00741260|474372245|FG000|Overall Study|Disease Progression|3|||
131753102|NCT00741260|474372246|FG001|Overall Study|Disease Progression|5|||
131753103|NCT00741260|474372247|FG002|Overall Study|Disease Progression|3|||
131753104|NCT00741260|474372248|FG003|Overall Study|Disease Progression|3|||
131753105|NCT00741260|474372249|FG004|Overall Study|Disease Progression|5|||
131753106|NCT00741260|474372250|FG005|Overall Study|Disease Progression|37|||
131753107|NCT00741260|474372251|FG006|Overall Study|Disease Progression|4|||
131753108|NCT00741260|474372245|FG000|Overall Study|Death|0|||
131753109|NCT00741260|474372246|FG001|Overall Study|Death|1|||
131753110|NCT00741260|474372247|FG002|Overall Study|Death|0|||
131753111|NCT00741260|474372248|FG003|Overall Study|Death|1|||
131753112|NCT00741260|474372249|FG004|Overall Study|Death|2|||
131753113|NCT00741260|474372250|FG005|Overall Study|Death|2|||
131753114|NCT00741260|474372251|FG006|Overall Study|Death|1|||
131753115|NCT00741260|474372245|FG000|Overall Study|Withdrawal by Subject|0|||
131753116|NCT00741260|474372246|FG001|Overall Study|Withdrawal by Subject|0|||
131753117|NCT00741260|474372247|FG002|Overall Study|Withdrawal by Subject|0|||
131397977|NCT03098433|473077475|FG000|Overall Study|Withdrawal by Subject|10|||
131397978|NCT01104545|473077476|FG000|Overall Study|Adverse Event|0|||
131397979|NCT01104545|473077477|FG001|Overall Study|Adverse Event|1|||
131397980|NCT01104545|473077478|FG002|Overall Study|Adverse Event|2|||
131397981|NCT03585764|473077481|FG000|Overall Study|Death|3|||
131397982|NCT03585764|473077482|FG001|Overall Study|Death|2|||
131397983|NCT03585764|473077483|FG002|Overall Study|Death|3|||
131397984|NCT03585764|473077484|FG003|Overall Study|Death|0|||
131397985|NCT03585764|473077481|FG000|Overall Study|Lost to Follow-up|0|||
131397986|NCT03585764|473077482|FG001|Overall Study|Lost to Follow-up|1|||
131397987|NCT03585764|473077483|FG002|Overall Study|Lost to Follow-up|0|||
131753118|NCT00741260|474372248|FG003|Overall Study|Withdrawal by Subject|0|||
131753119|NCT00741260|474372249|FG004|Overall Study|Withdrawal by Subject|1|||
131753120|NCT00741260|474372250|FG005|Overall Study|Withdrawal by Subject|3|||
131753121|NCT00741260|474372251|FG006|Overall Study|Withdrawal by Subject|1|||
131753122|NCT00741260|474372245|FG000|Overall Study|Physician Decision|1|||
131753123|NCT00741260|474372246|FG001|Overall Study|Physician Decision|1|||
131753124|NCT00741260|474372247|FG002|Overall Study|Physician Decision|0|||
131753125|NCT00741260|474372248|FG003|Overall Study|Physician Decision|0|||
131753126|NCT00741260|474372249|FG004|Overall Study|Physician Decision|0|||
131753127|NCT00741260|474372250|FG005|Overall Study|Physician Decision|0|||
131753128|NCT00741260|474372251|FG006|Overall Study|Physician Decision|0|||
131753129|NCT00741260|474372245|FG000|Overall Study|Other|2|||
131753130|NCT00741260|474372246|FG001|Overall Study|Other|1|||
131753131|NCT00741260|474372247|FG002|Overall Study|Other|1|||
131753132|NCT00741260|474372248|FG003|Overall Study|Other|2|||
131753133|NCT00741260|474372249|FG004|Overall Study|Other|1|||
131753134|NCT00741260|474372250|FG005|Overall Study|Other|3|||
131753135|NCT00741260|474372251|FG006|Overall Study|Other|1|||
131753136|NCT02427100|474372255|FG000|Overall Study|Lost to Follow-up|0|||
131753137|NCT02427100|474372256|FG001|Overall Study|Lost to Follow-up|2|||
131753138|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
131753139|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
131753140|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
131753141|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
131753142|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
131753143|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
131753144|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
131753145|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
131753146|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131753147|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131753148|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131753149|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131753150|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131753151|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131753152|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
131753153|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
131753154|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
131753155|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
131753156|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
131753157|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
131753158|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
131753159|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
131753160|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131753161|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131753162|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131753163|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131753164|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131753165|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131753166|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
131753167|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131397988|NCT03585764|473077484|FG003|Overall Study|Lost to Follow-up|0|||
131397989|NCT03585764|473077481|FG000|Overall Study|Physician Decision|0|||
131397990|NCT03585764|473077482|FG001|Overall Study|Physician Decision|0|||
131397991|NCT03585764|473077483|FG002|Overall Study|Physician Decision|2|||
131397992|NCT03585764|473077484|FG003|Overall Study|Physician Decision|0|||
131753168|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131753169|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131753170|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131753171|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131753172|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131753173|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
131753174|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131753175|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131397993|NCT03640507|473077485|FG000|Overall Study|Withdrawal by Subject|0|||
131397994|NCT03640507|473077486|FG001|Overall Study|Withdrawal by Subject|0|||
131397995|NCT03640507|473077487|FG002|Overall Study|Withdrawal by Subject|1|||
131753176|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131753177|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131753178|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131753179|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131753180|NCT02120352|474372257|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
131753181|NCT02120352|474372258|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
131753182|NCT02120352|474372259|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
131753183|NCT02120352|474372260|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
131753184|NCT02120352|474372261|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
131753185|NCT02120352|474372262|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
131753186|NCT02120352|474372263|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
131753187|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131753188|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
131753189|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
131753190|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
131753191|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131753192|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131753193|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131753194|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131753195|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
131753196|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131753197|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
131810334|NCT01796171|474588015|FG004|Follow-up Period|Start of further anticancer therapy|2|||
131810335|NCT01796171|474588016|FG005|Follow-up Period|Start of further anticancer therapy|2|||
131810336|NCT01796171|474588017|FG006|Follow-up Period|Start of further anticancer therapy|1|||
131810337|NCT01796171|474588018|FG007|Follow-up Period|Start of further anticancer therapy|15|||
131753198|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131753199|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131753200|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131753201|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131810338|NCT01796171|474588019|FG008|Follow-up Period|Start of further anticancer therapy|2|||
131398055|NCT02954406|473079104|FG000|Overall Study|Adverse Event|0|||
131398056|NCT02954406|473079105|FG001|Overall Study|Adverse Event|1|||
131398057|NCT02954406|473079106|FG002|Overall Study|Adverse Event|0|||
131398058|NCT02954406|473079107|FG003|Overall Study|Adverse Event|0|||
131398059|NCT02954406|473079108|FG004|Overall Study|Adverse Event|1|||
131398060|NCT02954406|473079109|FG005|Overall Study|Adverse Event|0|||
131398061|NCT02954406|473079110|FG006|Overall Study|Adverse Event|0|||
131398062|NCT02954406|473079111|FG007|Overall Study|Adverse Event|0|||
131398063|NCT02954406|473079112|FG008|Overall Study|Adverse Event|1|||
131398064|NCT02954406|473079113|FG009|Overall Study|Adverse Event|1|||
131398065|NCT02954406|473079114|FG010|Overall Study|Adverse Event|0|||
131398066|NCT02954406|473079104|FG000|Overall Study|Progressive Disease|3|||
131398067|NCT02954406|473079105|FG001|Overall Study|Progressive Disease|4|||
131398068|NCT02954406|473079106|FG002|Overall Study|Progressive Disease|3|||
131398069|NCT02954406|473079107|FG003|Overall Study|Progressive Disease|4|||
131398070|NCT02954406|473079108|FG004|Overall Study|Progressive Disease|3|||
131398071|NCT02954406|473079109|FG005|Overall Study|Progressive Disease|3|||
131398072|NCT02954406|473079110|FG006|Overall Study|Progressive Disease|2|||
131398073|NCT02954406|473079111|FG007|Overall Study|Progressive Disease|2|||
131398074|NCT02954406|473079112|FG008|Overall Study|Progressive Disease|1|||
131398075|NCT02954406|473079113|FG009|Overall Study|Progressive Disease|1|||
131398076|NCT02954406|473079114|FG010|Overall Study|Progressive Disease|0|||
131398077|NCT02954406|473079104|FG000|Overall Study|Symptomatic Deterioration|0|||
131398078|NCT02954406|473079105|FG001|Overall Study|Symptomatic Deterioration|1|||
131398079|NCT02954406|473079106|FG002|Overall Study|Symptomatic Deterioration|0|||
131398080|NCT02954406|473079107|FG003|Overall Study|Symptomatic Deterioration|0|||
131398081|NCT02954406|473079108|FG004|Overall Study|Symptomatic Deterioration|0|||
131398082|NCT02954406|473079109|FG005|Overall Study|Symptomatic Deterioration|0|||
131398083|NCT02954406|473079110|FG006|Overall Study|Symptomatic Deterioration|0|||
131398084|NCT02954406|473079111|FG007|Overall Study|Symptomatic Deterioration|0|||
131398085|NCT02954406|473079112|FG008|Overall Study|Symptomatic Deterioration|0|||
131398086|NCT02954406|473079113|FG009|Overall Study|Symptomatic Deterioration|0|||
131398087|NCT02954406|473079114|FG010|Overall Study|Symptomatic Deterioration|0|||
131398088|NCT02954406|473079104|FG000|Overall Study|Death|0|||
131398089|NCT02954406|473079105|FG001|Overall Study|Death|0|||
131398090|NCT02954406|473079106|FG002|Overall Study|Death|0|||
131398091|NCT02954406|473079107|FG003|Overall Study|Death|0|||
131398092|NCT02954406|473079108|FG004|Overall Study|Death|1|||
131449655|NCT04922216|473274959|FG002|Overall Study|Withdrawal by Subject|0|||
131398093|NCT02954406|473079109|FG005|Overall Study|Death|0|||
131398094|NCT02954406|473079110|FG006|Overall Study|Death|0|||
131449656|NCT04922216|473274960|FG003|Overall Study|Withdrawal by Subject|0|||
131753202|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
131398095|NCT02954406|473079111|FG007|Overall Study|Death|0|||
131753203|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
131398096|NCT02954406|473079112|FG008|Overall Study|Death|1|||
131398097|NCT02954406|473079113|FG009|Overall Study|Death|1|||
131398098|NCT02954406|473079114|FG010|Overall Study|Death|0|||
131398099|NCT02954406|473079104|FG000|Overall Study|Reason Not Specified|0|||
131398100|NCT02954406|473079105|FG001|Overall Study|Reason Not Specified|0|||
131398101|NCT02954406|473079106|FG002|Overall Study|Reason Not Specified|3|||
131398102|NCT02954406|473079107|FG003|Overall Study|Reason Not Specified|2|||
131398103|NCT02954406|473079108|FG004|Overall Study|Reason Not Specified|2|||
131398104|NCT02954406|473079109|FG005|Overall Study|Reason Not Specified|0|||
131398105|NCT02954406|473079110|FG006|Overall Study|Reason Not Specified|1|||
131398106|NCT02954406|473079111|FG007|Overall Study|Reason Not Specified|0|||
131449657|NCT04922216|473274961|FG004|Overall Study|Withdrawal by Subject|0|||
131449658|NCT04922216|473274962|FG005|Overall Study|Withdrawal by Subject|0|||
131449659|NCT04922216|473274963|FG006|Overall Study|Withdrawal by Subject|0|||
131449660|NCT04922216|473274964|FG007|Overall Study|Withdrawal by Subject|2|||
131449661|NCT04922216|473274965|FG008|Overall Study|Withdrawal by Subject|0|||
131449662|NCT04922216|473274966|FG009|Overall Study|Withdrawal by Subject|0|||
131449663|NCT04922216|473274967|FG010|Overall Study|Withdrawal by Subject|0|||
131449664|NCT04922216|473274968|FG011|Overall Study|Withdrawal by Subject|0|||
131449665|NCT04922216|473274969|FG012|Overall Study|Withdrawal by Subject|1|||
131449666|NCT04922216|473274970|FG013|Overall Study|Withdrawal by Subject|1|||
131449667|NCT04922216|473274971|FG014|Overall Study|Withdrawal by Subject|1|||
131449668|NCT04922216|473274972|FG015|Overall Study|Withdrawal by Subject|0|||
131449669|NCT04922216|473274973|FG016|Overall Study|Withdrawal by Subject|0|||
131449670|NCT04922216|473274974|FG017|Overall Study|Withdrawal by Subject|1|||
131449671|NCT04922216|473274975|FG018|Overall Study|Withdrawal by Subject|1|||
131753204|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131753205|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131753206|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131753207|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131753208|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131753209|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131753210|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
131753211|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
131753212|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131753213|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131753214|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131753215|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131753216|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131753217|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131753218|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
131753219|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131753220|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131753221|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131753222|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131753223|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
131753224|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
131753225|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
131753226|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131753227|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131753228|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131753229|NCT02120352|474372257|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131753230|NCT02120352|474372258|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
131449672|NCT04922216|473274976|FG019|Overall Study|Withdrawal by Subject|1|||
131753231|NCT02120352|474372259|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131753232|NCT02120352|474372260|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131753233|NCT02120352|474372261|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131753234|NCT02120352|474372262|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131753235|NCT02120352|474372263|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131753236|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
131753237|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
131753238|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
131753239|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
131753240|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
131753241|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
131753242|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
131753243|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131753244|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131753245|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131753246|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131753247|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
131753248|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131753249|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131449673|NCT04922216|473274977|FG020|Overall Study|Withdrawal by Subject|1|||
131449674|NCT04922216|473274978|FG021|Overall Study|Withdrawal by Subject|0|||
131449675|NCT04922216|473274979|FG022|Overall Study|Withdrawal by Subject|0|||
131449676|NCT04922216|473274980|FG023|Overall Study|Withdrawal by Subject|2|||
131449677|NCT04922216|473274981|FG024|Overall Study|Withdrawal by Subject|0|||
131753250|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131753251|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
131753252|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
131753253|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131753254|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
131753255|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131753256|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131753257|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131753258|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
131753259|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
131753260|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131753261|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
131753262|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131753263|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131753264|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131753265|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
131753266|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
131753267|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131753268|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
131753269|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131753270|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131753271|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131753272|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
131753273|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
131753274|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131753275|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131753276|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131753277|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131753278|NCT02120352|474372257|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
131753279|NCT02120352|474372258|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
131753280|NCT02120352|474372259|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
131753281|NCT02120352|474372260|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
131753282|NCT02120352|474372261|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
131753283|NCT02120352|474372262|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
131753284|NCT02120352|474372263|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
131753285|NCT02120352|474372257|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131753286|NCT02120352|474372258|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131753287|NCT02120352|474372259|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131753288|NCT02120352|474372260|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131753289|NCT02120352|474372261|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131753290|NCT02120352|474372262|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131753291|NCT02120352|474372263|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
131753292|NCT01814826|474372272|FG000|Overall Study|Other|3|||
131753293|NCT01814826|474372273|FG001|Overall Study|Other|5|||
131753294|NCT01814826|474372274|FG002|Overall Study|Other|0|||
131753295|NCT01814826|474372272|FG000|Overall Study|Death|29|||
131753296|NCT01814826|474372273|FG001|Overall Study|Death|24|||
131753297|NCT01814826|474372274|FG002|Overall Study|Death|3|||
131753298|NCT03034057|474372275|FG000|Overall Study|Withdrawal by Subject|10|||
131753299|NCT03034057|474372275|FG000|Overall Study|Protocol Violation|1|||
131753300|NCT03034057|474372275|FG000|Overall Study|Not defined|2|||
131906913|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
131398107|NCT02954406|473079112|FG008|Overall Study|Reason Not Specified|1|||
131398108|NCT02954406|473079113|FG009|Overall Study|Reason Not Specified|0|||
131398109|NCT02954406|473079114|FG010|Overall Study|Reason Not Specified|0|||
131753301|NCT03034057|474372275|FG000|Overall Study|Lost to Follow-up|19|||
131753302|NCT03034057|474372275|FG000|Overall Study|Adverse Event|22|||
131753303|NCT03034057|474372275|FG000|Overall Study|Medication error without associated AE|1|||
131753304|NCT03271307|474372276|FG000|Overall Study|Lost to Follow-up|0|||
131753305|NCT03271307|474372277|FG001|Overall Study|Lost to Follow-up|0|||
131753306|NCT03271307|474372278|FG002|Overall Study|Lost to Follow-up|0|||
131753307|NCT03271307|474372279|FG003|Overall Study|Lost to Follow-up|28|||
131753308|NCT03271307|474372280|FG004|Overall Study|Lost to Follow-up|91|||
131753309|NCT00856986|474372283|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
131753310|NCT00856986|474372284|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
131753311|NCT00856986|474372285|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
131753312|NCT00856986|474372286|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
131753313|NCT00856986|474372287|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
131753314|NCT00856986|474372283|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131398110|NCT03522246|473079115|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
131398111|NCT03522246|473079116|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
131398112|NCT03522246|473079117|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
131398113|NCT03522246|473079118|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
131398114|NCT03522246|473079119|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
131398115|NCT04683029|473079120|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
131398116|NCT04683029|473079121|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
131398117|NCT04683029|473079122|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
131398118|NCT04683029|473079123|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
131398119|NCT04683029|473079120|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
131398120|NCT04683029|473079121|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
131398121|NCT04683029|473079122|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
131753315|NCT00856986|474372284|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131753316|NCT00856986|474372285|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131753317|NCT00856986|474372286|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
131753318|NCT00856986|474372287|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131753319|NCT00856986|474372283|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131753320|NCT00856986|474372284|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131753321|NCT00856986|474372285|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131753322|NCT00856986|474372286|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
131753323|NCT00856986|474372287|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131753324|NCT00856986|474372283|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131753325|NCT00856986|474372284|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131753326|NCT00856986|474372285|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131753327|NCT00856986|474372286|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
131753328|NCT00856986|474372287|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131753329|NCT00856986|474372283|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131753330|NCT00856986|474372284|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131753331|NCT00856986|474372285|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131753332|NCT00856986|474372286|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
131753333|NCT00856986|474372287|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131753334|NCT00856986|474372283|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
131753335|NCT00856986|474372284|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
131753336|NCT00856986|474372285|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
131753337|NCT00856986|474372286|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
131753338|NCT00856986|474372287|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
131753339|NCT00856986|474372283|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
131753340|NCT00856986|474372284|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
131753341|NCT00856986|474372285|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
131753342|NCT00856986|474372286|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
131753343|NCT00856986|474372287|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
131398122|NCT04683029|473079123|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
131398123|NCT04683029|473079120|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
131398124|NCT04683029|473079121|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
131398125|NCT04683029|473079122|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
131398126|NCT04683029|473079123|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
131398127|NCT00814580|473079124|FG000|Overall Study|Adverse Event|6|||
131398128|NCT00814580|473079125|FG001|Overall Study|Adverse Event|15|||
131398129|NCT00814580|473079124|FG000|Overall Study|Lack of Efficacy|18|||
131398130|NCT00814580|473079125|FG001|Overall Study|Lack of Efficacy|25|||
131398131|NCT00814580|473079124|FG000|Overall Study|Protocol Violation|2|||
131398132|NCT00814580|473079125|FG001|Overall Study|Protocol Violation|0|||
131398133|NCT00814580|473079124|FG000|Overall Study|Withdrawal by Subject|2|||
131398134|NCT00814580|473079125|FG001|Overall Study|Withdrawal by Subject|2|||
131753344|NCT00856986|474372283|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
131753345|NCT00856986|474372284|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
131753346|NCT00856986|474372285|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
131753347|NCT00856986|474372286|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
131753348|NCT00856986|474372287|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
131753349|NCT00856986|474372283|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
131753350|NCT00856986|474372284|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
131753351|NCT00856986|474372285|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
131753352|NCT00856986|474372286|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
131753353|NCT00856986|474372287|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
131753354|NCT00856986|474372283|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
131398135|NCT00814580|473079124|FG000|Overall Study|Other|1|||
131449678|NCT04922216|473274982|FG025|Overall Study|Withdrawal by Subject|0|||
131753355|NCT00856986|474372284|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
131398136|NCT00814580|473079125|FG001|Overall Study|Other|3|||
131449679|NCT04922216|473274983|FG026|Overall Study|Withdrawal by Subject|1|||
131753356|NCT00856986|474372285|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
131753357|NCT00856986|474372286|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
131398137|NCT00814580|473079124|FG000|Overall Study|Did Not Take Drug|2|||
131398138|NCT00814580|473079125|FG001|Overall Study|Did Not Take Drug|2|||
131398139|NCT00459875|473079126|FG000|Overall Study|Ineligible participant|1|||
131398140|NCT00459875|473079126|FG000|Overall Study|Adverse Event|2|||
131398141|NCT03286543|473079135|FG000|Consented|Screen failure before randomization|2|||
131753358|NCT00856986|474372287|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
131753359|NCT00856986|474372283|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
131753360|NCT00856986|474372284|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
131753361|NCT00856986|474372285|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
131753362|NCT00856986|474372286|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
131753363|NCT00856986|474372287|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
131753364|NCT00856986|474372283|FG000|Main Period, Weeks 0-26|Unclassified|7|||
131753365|NCT00856986|474372284|FG001|Main Period, Weeks 0-26|Unclassified|6|||
131753366|NCT00856986|474372285|FG002|Main Period, Weeks 0-26|Unclassified|7|||
131753367|NCT00856986|474372286|FG003|Main Period, Weeks 0-26|Unclassified|0|||
131753368|NCT00856986|474372287|FG004|Main Period, Weeks 0-26|Unclassified|0|||
131753369|NCT00856986|474372283|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
131753370|NCT00856986|474372284|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
131753371|NCT00856986|474372285|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
131753372|NCT00856986|474372286|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
131753373|NCT00856986|474372287|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
131753374|NCT00856986|474372283|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
131753375|NCT00856986|474372284|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
131753376|NCT00856986|474372285|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
131753377|NCT00856986|474372286|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
131753378|NCT00856986|474372287|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
131753379|NCT00856986|474372283|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
131753380|NCT00856986|474372284|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
131753381|NCT00856986|474372285|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
131753382|NCT00856986|474372286|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
131753383|NCT00856986|474372287|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
131753384|NCT00856986|474372283|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
131753385|NCT00856986|474372284|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
131753386|NCT00856986|474372285|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
131753387|NCT00856986|474372286|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
131753388|NCT00856986|474372287|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
131753389|NCT00856986|474372283|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
131753390|NCT00856986|474372284|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
131753391|NCT00856986|474372285|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
131753392|NCT00856986|474372286|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
131753393|NCT00856986|474372287|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
131753394|NCT00856986|474372283|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
131753395|NCT00856986|474372284|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
131753396|NCT00856986|474372285|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
131753397|NCT00856986|474372286|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
131753398|NCT00856986|474372287|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
131753399|NCT00608244|474374276|FG000|Overall Study|Adverse Event|1|||
131753400|NCT00608244|474374276|FG000|Overall Study|Low trough levels|1|||
131753401|NCT01685060|474374288|FG000|Overall Study|Rollover patients|16|||
131753402|NCT01685060|474374288|FG000|Overall Study|Adverse Event|12|||
131753403|NCT01685060|474374288|FG000|Overall Study|Progressive disease|69|||
131753404|NCT01685060|474374288|FG000|Overall Study|Physician Decision|14|||
131753405|NCT01685060|474374288|FG000|Overall Study|Subject/guardian decision|20|||
131753406|NCT01685060|474374288|FG000|Overall Study|Lost to Follow-up|1|||
131753407|NCT01685060|474374288|FG000|Overall Study|Death|8|||
131753408|NCT02944513|474374289|FG000|Overall Study|Withdrawal by Subject|4|||
131753409|NCT02944513|474374290|FG001|Overall Study|Withdrawal by Subject|1|||
131753410|NCT00937326|474374293|FG000|Overall Study|Adverse Event|0|||
131753411|NCT00937326|474374294|FG001|Overall Study|Adverse Event|3|||
131753412|NCT00937326|474374295|FG002|Overall Study|Adverse Event|1|||
131753413|NCT00937326|474374296|FG003|Overall Study|Adverse Event|1|||
131753414|NCT00937326|474374297|FG004|Overall Study|Adverse Event|2|||
131398142|NCT03286543|473079136|FG001|Consented|Screen failure before randomization|0|||
131753415|NCT00937326|474374293|FG000|Overall Study|Death|0|||
131753416|NCT00937326|474374294|FG001|Overall Study|Death|0|||
131753417|NCT00937326|474374295|FG002|Overall Study|Death|1|||
131753418|NCT00937326|474374296|FG003|Overall Study|Death|0|||
131753419|NCT00937326|474374297|FG004|Overall Study|Death|0|||
131753420|NCT00937326|474374293|FG000|Overall Study|Withdrawal by Subject|3|||
131906914|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
131398143|NCT03286543|473079137|FG002|Consented|Screen failure before randomization|0|||
131753421|NCT00937326|474374294|FG001|Overall Study|Withdrawal by Subject|4|||
131753422|NCT00937326|474374295|FG002|Overall Study|Withdrawal by Subject|1|||
131753423|NCT00937326|474374296|FG003|Overall Study|Withdrawal by Subject|4|||
131810339|NCT01796171|474588020|FG009|Follow-up Period|Start of further anticancer therapy|0|||
131810340|NCT01796171|474588021|FG010|Follow-up Period|Start of further anticancer therapy|0|||
131810341|NCT01796171|474588022|FG011|Follow-up Period|Start of further anticancer therapy|0|||
131810342|NCT01796171|474588023|FG012|Follow-up Period|Start of further anticancer therapy|0|||
131810343|NCT01796171|474588024|FG013|Follow-up Period|Start of further anticancer therapy|0|||
131810344|NCT01796171|474588025|FG014|Follow-up Period|Start of further anticancer therapy|0|||
131753424|NCT00937326|474374297|FG004|Overall Study|Withdrawal by Subject|3|||
131753425|NCT00937326|474374293|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131753426|NCT00937326|474374294|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131753427|NCT00937326|474374295|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
131753428|NCT00937326|474374296|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131753429|NCT00937326|474374297|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131753430|NCT02578992|474374298|FG000|Overall Study|equipment not available or malfunction|3|||
131753431|NCT02578992|474374299|FG001|Overall Study|equipment not available or malfunction|3|||
131753432|NCT02443155|474374300|FG000|Overall Study|Adverse Event|3|||
131753433|NCT02443155|474374301|FG001|Overall Study|Adverse Event|4|||
131753434|NCT02443155|474374302|FG002|Overall Study|Adverse Event|1|||
131753435|NCT02443155|474374303|FG003|Overall Study|Adverse Event|2|||
131753436|NCT02443155|474374300|FG000|Overall Study|Unclassified|0|||
131753437|NCT02443155|474374301|FG001|Overall Study|Unclassified|0|||
131753438|NCT02443155|474374302|FG002|Overall Study|Unclassified|2|||
131753439|NCT02443155|474374303|FG003|Overall Study|Unclassified|1|||
131753440|NCT02443155|474374300|FG000|Overall Study|Withdrawal by Subject|4|||
131753441|NCT02443155|474374301|FG001|Overall Study|Withdrawal by Subject|7|||
131753442|NCT02443155|474374302|FG002|Overall Study|Withdrawal by Subject|3|||
131753443|NCT02443155|474374303|FG003|Overall Study|Withdrawal by Subject|9|||
131753444|NCT02443155|474374300|FG000|Overall Study|Pregnancy|3|||
131753445|NCT02443155|474374301|FG001|Overall Study|Pregnancy|1|||
131753446|NCT02443155|474374302|FG002|Overall Study|Pregnancy|1|||
131753447|NCT02443155|474374303|FG003|Overall Study|Pregnancy|2|||
131753448|NCT02443155|474374300|FG000|Overall Study|Lost to Follow-up|1|||
131753449|NCT02443155|474374301|FG001|Overall Study|Lost to Follow-up|2|||
131753450|NCT02443155|474374302|FG002|Overall Study|Lost to Follow-up|0|||
131753451|NCT02443155|474374303|FG003|Overall Study|Lost to Follow-up|1|||
131753452|NCT02443155|474374300|FG000|Overall Study|Protocol Violation|1|||
131753453|NCT02443155|474374301|FG001|Overall Study|Protocol Violation|0|||
131753454|NCT02443155|474374302|FG002|Overall Study|Protocol Violation|1|||
131753455|NCT02443155|474374303|FG003|Overall Study|Protocol Violation|1|||
131753456|NCT02443155|474374300|FG000|Overall Study|Death|0|||
131753457|NCT02443155|474374301|FG001|Overall Study|Death|0|||
131753458|NCT02443155|474374302|FG002|Overall Study|Death|1|||
131753459|NCT02443155|474374303|FG003|Overall Study|Death|0|||
131753460|NCT02000219|474374305|FG000|14-Week Study Period|Physician Decision|1|||
131753461|NCT02000219|474374305|FG000|14-Week Study Period|Adverse Event|1|||
131753462|NCT02000219|474374305|FG000|14-Week Study Period|Underwent transplantation|1|||
131753463|NCT02000219|474374305|FG000|Continuation Period|Withdrawal by Subject|1|||
131753464|NCT02000219|474374305|FG000|Continuation Period|Had liver transplant|2|||
131753465|NCT02000219|474374305|FG000|Continuation Period|Non-compliance with study drug|2|||
131753466|NCT00405275|474374311|FG000|Overall Study|Death|1|||
131753467|NCT00405275|474374312|FG001|Overall Study|Death|0|||
131753468|NCT00405275|474374311|FG000|Overall Study|Lost to Follow-up|5|||
131753469|NCT00405275|474374312|FG001|Overall Study|Lost to Follow-up|1|||
131753470|NCT00405275|474374311|FG000|Overall Study|Withdrawal by Subject|7|||
131753471|NCT00405275|474374312|FG001|Overall Study|Withdrawal by Subject|9|||
131753472|NCT00405275|474374311|FG000|Overall Study|Unwilling to continue|10|||
131753473|NCT00405275|474374312|FG001|Overall Study|Unwilling to continue|9|||
131753474|NCT00731666|474374313|FG000|Overall Study|Adverse Event|2|||
131753475|NCT00731666|474374313|FG000|Overall Study|Lost to Follow-up|8|||
131753476|NCT00731666|474374313|FG000|Overall Study|Withdrawal by Subject|2|||
131753477|NCT00608894|474374317|FG000|Overall Study|Withdrawal by Subject|0|||
131753478|NCT00608894|474374318|FG001|Overall Study|Withdrawal by Subject|2|||
131753479|NCT00106249|474374323|FG000|Overall Study|Lost to Follow-up|3|||
131753480|NCT00106249|474374324|FG001|Overall Study|Lost to Follow-up|2|||
131753481|NCT01235338|474374325|FG000|Overall Study|Adverse Event|3|||
131810345|NCT01796171|474588011|FG000|Follow-up Period|Progressive disease|0|||
131810346|NCT01796171|474588012|FG001|Follow-up Period|Progressive disease|1|||
131810347|NCT01796171|474588013|FG002|Follow-up Period|Progressive disease|0|||
131753482|NCT01235338|474374326|FG001|Overall Study|Adverse Event|2|||
131753483|NCT01235338|474374325|FG000|Overall Study|Protocol Violation|1|||
131810348|NCT01796171|474588014|FG003|Follow-up Period|Progressive disease|0|||
131810349|NCT01796171|474588015|FG004|Follow-up Period|Progressive disease|0|||
131810350|NCT01796171|474588016|FG005|Follow-up Period|Progressive disease|0|||
131753484|NCT01235338|474374326|FG001|Overall Study|Protocol Violation|1|||
131753485|NCT01235338|474374325|FG000|Overall Study|Withdrawal by Subject|5|||
131753486|NCT01235338|474374326|FG001|Overall Study|Withdrawal by Subject|0|||
131753487|NCT01235338|474374325|FG000|Overall Study|Exclusion criteria violations|1|||
131753488|NCT01235338|474374326|FG001|Overall Study|Exclusion criteria violations|1|||
131753489|NCT01235338|474374325|FG000|Overall Study|Positive drug screen|0|||
131753490|NCT01235338|474374326|FG001|Overall Study|Positive drug screen|1|||
131753491|NCT01235338|474374325|FG000|Overall Study|Prohibited meds|1|||
131753492|NCT01235338|474374326|FG001|Overall Study|Prohibited meds|0|||
131753493|NCT02809118|474374327|FG000|Overall Study|Withdrawal by Subject|0|||
131753494|NCT02809118|474374328|FG001|Overall Study|Withdrawal by Subject|1|||
131810351|NCT01796171|474588017|FG006|Follow-up Period|Progressive disease|0|||
131810352|NCT01796171|474588018|FG007|Follow-up Period|Progressive disease|3|||
131810353|NCT01796171|474588019|FG008|Follow-up Period|Progressive disease|0|||
131810354|NCT01796171|474588020|FG009|Follow-up Period|Progressive disease|0|||
131810355|NCT01796171|474588021|FG010|Follow-up Period|Progressive disease|0|||
131810356|NCT01796171|474588022|FG011|Follow-up Period|Progressive disease|0|||
131810357|NCT01796171|474588023|FG012|Follow-up Period|Progressive disease|0|||
131810358|NCT01796171|474588024|FG013|Follow-up Period|Progressive disease|0|||
131810359|NCT01796171|474588025|FG014|Follow-up Period|Progressive disease|0|||
131810360|NCT01796171|474588011|FG000|Follow-up Period|Physician Decision|0|||
131810361|NCT01796171|474588012|FG001|Follow-up Period|Physician Decision|2|||
131810362|NCT01796171|474588013|FG002|Follow-up Period|Physician Decision|0|||
131810363|NCT01796171|474588014|FG003|Follow-up Period|Physician Decision|0|||
131810364|NCT01796171|474588015|FG004|Follow-up Period|Physician Decision|0|||
131810365|NCT01796171|474588016|FG005|Follow-up Period|Physician Decision|0|||
131810366|NCT01796171|474588017|FG006|Follow-up Period|Physician Decision|0|||
131810367|NCT01796171|474588018|FG007|Follow-up Period|Physician Decision|0|||
131810368|NCT01796171|474588019|FG008|Follow-up Period|Physician Decision|0|||
131810369|NCT01796171|474588020|FG009|Follow-up Period|Physician Decision|0|||
131810370|NCT01796171|474588021|FG010|Follow-up Period|Physician Decision|5|||
131810371|NCT01796171|474588022|FG011|Follow-up Period|Physician Decision|0|||
131810372|NCT01796171|474588023|FG012|Follow-up Period|Physician Decision|0|||
131810373|NCT01796171|474588024|FG013|Follow-up Period|Physician Decision|0|||
131810374|NCT01796171|474588025|FG014|Follow-up Period|Physician Decision|0|||
131810375|NCT01796171|474588011|FG000|Follow-up Period|Withdrawal by Subject|0|||
131810376|NCT01796171|474588012|FG001|Follow-up Period|Withdrawal by Subject|1|||
131810377|NCT01796171|474588013|FG002|Follow-up Period|Withdrawal by Subject|0|||
131810378|NCT01796171|474588014|FG003|Follow-up Period|Withdrawal by Subject|0|||
131810379|NCT01796171|474588015|FG004|Follow-up Period|Withdrawal by Subject|0|||
131810380|NCT01796171|474588016|FG005|Follow-up Period|Withdrawal by Subject|1|||
131810381|NCT01796171|474588017|FG006|Follow-up Period|Withdrawal by Subject|0|||
131810382|NCT01796171|474588018|FG007|Follow-up Period|Withdrawal by Subject|0|||
131810383|NCT01796171|474588019|FG008|Follow-up Period|Withdrawal by Subject|0|||
131810384|NCT01796171|474588020|FG009|Follow-up Period|Withdrawal by Subject|0|||
131810385|NCT01796171|474588021|FG010|Follow-up Period|Withdrawal by Subject|3|||
131810386|NCT01796171|474588022|FG011|Follow-up Period|Withdrawal by Subject|1|||
131810387|NCT01796171|474588023|FG012|Follow-up Period|Withdrawal by Subject|0|||
131810388|NCT01796171|474588024|FG013|Follow-up Period|Withdrawal by Subject|0|||
131810389|NCT01796171|474588025|FG014|Follow-up Period|Withdrawal by Subject|0|||
131810390|NCT01796171|474588011|FG000|Follow-up Period|Death|0|||
131810391|NCT01796171|474588012|FG001|Follow-up Period|Death|0|||
131753495|NCT02809118|474374329|FG002|Overall Study|Withdrawal by Subject|1|||
131753496|NCT01495689|474374336|FG000|Overall Study|Death|0|||
131753497|NCT01495689|474374337|FG001|Overall Study|Death|1|||
131753498|NCT01495689|474374336|FG000|Overall Study|Withdrawal by Subject|3|||
131810392|NCT01796171|474588013|FG002|Follow-up Period|Death|0|||
131810393|NCT01796171|474588014|FG003|Follow-up Period|Death|0|||
131810394|NCT01796171|474588015|FG004|Follow-up Period|Death|0|||
131810395|NCT01796171|474588016|FG005|Follow-up Period|Death|0|||
131810396|NCT01796171|474588017|FG006|Follow-up Period|Death|1|||
131810397|NCT01796171|474588018|FG007|Follow-up Period|Death|0|||
131810398|NCT01796171|474588019|FG008|Follow-up Period|Death|0|||
131810399|NCT01796171|474588020|FG009|Follow-up Period|Death|0|||
131810400|NCT01796171|474588021|FG010|Follow-up Period|Death|17|||
131810401|NCT01796171|474588022|FG011|Follow-up Period|Death|9|||
131810402|NCT01796171|474588023|FG012|Follow-up Period|Death|1|||
131810403|NCT01796171|474588024|FG013|Follow-up Period|Death|0|||
131810404|NCT01796171|474588025|FG014|Follow-up Period|Death|0|||
131810405|NCT01796171|474588011|FG000|Follow-up Period|Patient transferred to other hospital|0|||
131810406|NCT01796171|474588012|FG001|Follow-up Period|Patient transferred to other hospital|1|||
131810407|NCT01796171|474588013|FG002|Follow-up Period|Patient transferred to other hospital|0|||
131810408|NCT01796171|474588014|FG003|Follow-up Period|Patient transferred to other hospital|0|||
131810409|NCT01796171|474588015|FG004|Follow-up Period|Patient transferred to other hospital|0|||
131810410|NCT01796171|474588016|FG005|Follow-up Period|Patient transferred to other hospital|0|||
131810411|NCT01796171|474588017|FG006|Follow-up Period|Patient transferred to other hospital|0|||
131810412|NCT01796171|474588018|FG007|Follow-up Period|Patient transferred to other hospital|0|||
131810413|NCT01796171|474588019|FG008|Follow-up Period|Patient transferred to other hospital|0|||
131810414|NCT01796171|474588020|FG009|Follow-up Period|Patient transferred to other hospital|0|||
131810415|NCT01796171|474588021|FG010|Follow-up Period|Patient transferred to other hospital|0|||
131810416|NCT01796171|474588022|FG011|Follow-up Period|Patient transferred to other hospital|0|||
131810417|NCT01796171|474588023|FG012|Follow-up Period|Patient transferred to other hospital|0|||
131810418|NCT01796171|474588024|FG013|Follow-up Period|Patient transferred to other hospital|0|||
131810419|NCT01796171|474588025|FG014|Follow-up Period|Patient transferred to other hospital|0|||
131810420|NCT01796171|474588011|FG000|Follow-up Period|Sponsor Decision|0|||
131810421|NCT01796171|474588012|FG001|Follow-up Period|Sponsor Decision|0|||
131810422|NCT01796171|474588013|FG002|Follow-up Period|Sponsor Decision|0|||
131810423|NCT01796171|474588014|FG003|Follow-up Period|Sponsor Decision|0|||
131810424|NCT01796171|474588015|FG004|Follow-up Period|Sponsor Decision|0|||
131810425|NCT01796171|474588016|FG005|Follow-up Period|Sponsor Decision|0|||
131810426|NCT01796171|474588017|FG006|Follow-up Period|Sponsor Decision|0|||
131810427|NCT01796171|474588018|FG007|Follow-up Period|Sponsor Decision|0|||
131810428|NCT01796171|474588019|FG008|Follow-up Period|Sponsor Decision|0|||
131810429|NCT01796171|474588020|FG009|Follow-up Period|Sponsor Decision|0|||
131810430|NCT01796171|474588021|FG010|Follow-up Period|Sponsor Decision|40|||
131810431|NCT01796171|474588022|FG011|Follow-up Period|Sponsor Decision|15|||
131810432|NCT01796171|474588023|FG012|Follow-up Period|Sponsor Decision|7|||
131810433|NCT01796171|474588024|FG013|Follow-up Period|Sponsor Decision|0|||
131810434|NCT01796171|474588025|FG014|Follow-up Period|Sponsor Decision|0|||
131810435|NCT00418561|474588026|FG000|Overall Study|Participant's (guardian's) decision|0|||
131810436|NCT00418561|474588027|FG001|Overall Study|Participant's (guardian's) decision|1|||
131810437|NCT00418561|474588028|FG002|Overall Study|Participant's (guardian's) decision|0|||
131810438|NCT00829309|474588031|FG000|Washout: 7 Days|Protocol Violation|1|||
131810439|NCT00829309|474588032|FG001|Washout: 7 Days|Protocol Violation|0|||
131810440|NCT01558635|474588033|FG000|Overall Study|Death|1|||
131810441|NCT01558635|474588033|FG000|Overall Study|Withdrawal by Subject|2|||
131810442|NCT01558635|474588033|FG000|Overall Study|Physician Decision|1|||
131810443|NCT01558635|474588033|FG000|Overall Study|Subject received other treatment|1|||
131810444|NCT01558635|474588033|FG000|Overall Study|Reveal XT was explanted|1|||
131810445|NCT00455312|474588034|FG000|Overall Study|Death|0|||
131810446|NCT00455312|474588035|FG001|Overall Study|Death|1|||
131810447|NCT01693523|474588036|FG000|Overall Study|Adverse Event|2|||
131810448|NCT01693523|474588037|FG001|Overall Study|Adverse Event|1|||
131810449|NCT01693523|474588038|FG002|Overall Study|Adverse Event|0|||
131810450|NCT01693523|474588036|FG000|Overall Study|Death|0|||
131810451|NCT01693523|474588037|FG001|Overall Study|Death|1|||
131810452|NCT01693523|474588038|FG002|Overall Study|Death|1|||
131810453|NCT01693523|474588036|FG000|Overall Study|Lost to Follow-up|0|||
131810454|NCT01693523|474588037|FG001|Overall Study|Lost to Follow-up|0|||
131810455|NCT01693523|474588038|FG002|Overall Study|Lost to Follow-up|4|||
131810456|NCT01693523|474588036|FG000|Overall Study|Physician Decision|0|||
131810457|NCT01693523|474588037|FG001|Overall Study|Physician Decision|0|||
131810458|NCT01693523|474588038|FG002|Overall Study|Physician Decision|1|||
131810459|NCT01693523|474588036|FG000|Overall Study|Withdrawal by Subject|1|||
131906915|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
131906916|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
131753499|NCT01495689|474374337|FG001|Overall Study|Withdrawal by Subject|0|||
131753500|NCT01495689|474374336|FG000|Overall Study|Lost to Follow-up|7|||
131753501|NCT01495689|474374337|FG001|Overall Study|Lost to Follow-up|6|||
131753502|NCT00524043|474374342|FG000|Overall Study|Lack of Efficacy|15|||
131753503|NCT00524043|474374343|FG001|Overall Study|Lack of Efficacy|13|||
131753504|NCT00524043|474374344|FG002|Overall Study|Lack of Efficacy|14|||
131753505|NCT00524043|474374342|FG000|Overall Study|Withdrawal by Subject|5|||
131753506|NCT00524043|474374343|FG001|Overall Study|Withdrawal by Subject|7|||
131753507|NCT00524043|474374344|FG002|Overall Study|Withdrawal by Subject|7|||
131753508|NCT00524043|474374342|FG000|Overall Study|Adverse Event|5|||
131753509|NCT00524043|474374343|FG001|Overall Study|Adverse Event|2|||
131753510|NCT00524043|474374344|FG002|Overall Study|Adverse Event|7|||
131753511|NCT00524043|474374342|FG000|Overall Study|Lost to Follow-up|3|||
131753512|NCT00524043|474374343|FG001|Overall Study|Lost to Follow-up|5|||
131753513|NCT00524043|474374344|FG002|Overall Study|Lost to Follow-up|3|||
131753514|NCT00524043|474374342|FG000|Overall Study|Various (eg, incarceration)|2|||
131810460|NCT01693523|474588037|FG001|Overall Study|Withdrawal by Subject|2|||
131906917|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
131753515|NCT00524043|474374343|FG001|Overall Study|Various (eg, incarceration)|1|||
131753516|NCT00524043|474374344|FG002|Overall Study|Various (eg, incarceration)|0|||
131753517|NCT01843205|474374345|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
131810461|NCT01693523|474588038|FG002|Overall Study|Withdrawal by Subject|2|||
131810462|NCT01693523|474588036|FG000|Overall Study|Lack of compliance study medication|1|||
131810463|NCT01693523|474588037|FG001|Overall Study|Lack of compliance study medication|2|||
131810464|NCT01693523|474588038|FG002|Overall Study|Lack of compliance study medication|0|||
131810465|NCT01693523|474588036|FG000|Overall Study|Chemotherapy was held|1|||
131810466|NCT01693523|474588037|FG001|Overall Study|Chemotherapy was held|2|||
131810467|NCT01693523|474588038|FG002|Overall Study|Chemotherapy was held|0|||
131810468|NCT03343535|474588039|FG000|Overall Study|Lost to Follow-up|1|||
131810469|NCT03343535|474588039|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
131810470|NCT03343535|474588039|FG000|Overall Study|Death|12|||
131398144|NCT03286543|473079135|FG000|Consented|Screen failure before enrollment|4|||
131398145|NCT03286543|473079136|FG001|Consented|Screen failure before enrollment|0|||
131398146|NCT03286543|473079137|FG002|Consented|Screen failure before enrollment|0|||
131398147|NCT03286543|473079135|FG000|Consented|TKA cancelled after enrollment|1|||
131398148|NCT03286543|473079136|FG001|Consented|TKA cancelled after enrollment|0|||
131398149|NCT03286543|473079137|FG002|Consented|TKA cancelled after enrollment|0|||
131398150|NCT03286543|473079135|FG000|Consented|Withdrawn from study|12|||
131398151|NCT03286543|473079136|FG001|Consented|Withdrawn from study|0|||
131398152|NCT03286543|473079137|FG002|Consented|Withdrawn from study|0|||
131398153|NCT03286543|473079135|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
131398154|NCT03286543|473079136|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
131398155|NCT03286543|473079137|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
131398156|NCT03286543|473079135|FG000|Study Enrollment|Withdrawn from study|0|||
131398157|NCT03286543|473079136|FG001|Study Enrollment|Withdrawn from study|6|||
131398158|NCT03286543|473079137|FG002|Study Enrollment|Withdrawn from study|6|||
131398159|NCT01822899|473079138|FG000|Overall Study|Adverse Event|6|||
131398160|NCT01822899|473079139|FG001|Overall Study|Adverse Event|5|||
131398161|NCT01822899|473079138|FG000|Overall Study|Lack of Efficacy|6|||
131398162|NCT01822899|473079139|FG001|Overall Study|Lack of Efficacy|3|||
131398163|NCT01822899|473079138|FG000|Overall Study|Protocol Violation|6|||
131398164|NCT01822899|473079139|FG001|Overall Study|Protocol Violation|3|||
131398165|NCT01822899|473079138|FG000|Overall Study|Lost to Follow-up|1|||
131398166|NCT01822899|473079139|FG001|Overall Study|Lost to Follow-up|0|||
131398167|NCT01822899|473079138|FG000|Overall Study|Withdrawal by Subject|5|||
131398168|NCT01822899|473079139|FG001|Overall Study|Withdrawal by Subject|7|||
131398169|NCT05332392|473079140|FG000|Overall Study|Did not meet inclusion criteria|25|||
131398170|NCT05332392|473079140|FG000|Overall Study|Principal Investigator's decision|17|||
131398171|NCT05332392|473079140|FG000|Overall Study|Adverse Event|1|||
131398172|NCT05332392|473079140|FG000|Overall Study|Subject's decision|1|||
131398173|NCT04560816|473079142|FG000|Overall Study|Withdrawal by Subject|1|||
131398174|NCT04560816|473079143|FG001|Overall Study|Withdrawal by Subject|1|||
131398175|NCT04560816|473079144|FG002|Overall Study|Withdrawal by Subject|1|||
131398176|NCT04560816|473079145|FG003|Overall Study|Withdrawal by Subject|0|||
131398177|NCT04560816|473079146|FG004|Overall Study|Withdrawal by Subject|3|||
131398178|NCT04560816|473079147|FG005|Overall Study|Withdrawal by Subject|0|||
131398179|NCT04560816|473079142|FG000|Overall Study|Lost to Follow-up|1|||
131398180|NCT04560816|473079143|FG001|Overall Study|Lost to Follow-up|0|||
131398181|NCT04560816|473079144|FG002|Overall Study|Lost to Follow-up|0|||
131398182|NCT04560816|473079145|FG003|Overall Study|Lost to Follow-up|0|||
131398183|NCT04560816|473079146|FG004|Overall Study|Lost to Follow-up|0|||
131398184|NCT04560816|473079147|FG005|Overall Study|Lost to Follow-up|0|||
131398185|NCT04560816|473079142|FG000|Overall Study|Protocol Violation|1|||
131398186|NCT04560816|473079143|FG001|Overall Study|Protocol Violation|0|||
131398187|NCT04560816|473079144|FG002|Overall Study|Protocol Violation|0|||
131398188|NCT04560816|473079145|FG003|Overall Study|Protocol Violation|0|||
131398189|NCT04560816|473079146|FG004|Overall Study|Protocol Violation|0|||
131753518|NCT01843205|474374346|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
131753519|NCT00606177|474374347|FG000|Overall Study|Adverse Event|9|||
131753520|NCT00606177|474374348|FG001|Overall Study|Adverse Event|5|||
131753521|NCT00606177|474374347|FG000|Overall Study|Lack of Efficacy|3|||
131753522|NCT00606177|474374348|FG001|Overall Study|Lack of Efficacy|7|||
131753523|NCT00606177|474374347|FG000|Overall Study|Physician Decision|1|||
131753524|NCT00606177|474374348|FG001|Overall Study|Physician Decision|0|||
131753525|NCT00606177|474374347|FG000|Overall Study|Protocol Violation|1|||
131753526|NCT00606177|474374348|FG001|Overall Study|Protocol Violation|4|||
131753527|NCT00606177|474374347|FG000|Overall Study|Withdrawal by Subject|5|||
131753528|NCT00606177|474374348|FG001|Overall Study|Withdrawal by Subject|6|||
131753529|NCT00606177|474374347|FG000|Overall Study|Progression to depressive phase|6|||
131753530|NCT00606177|474374348|FG001|Overall Study|Progression to depressive phase|1|||
131753531|NCT00606177|474374347|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
131398190|NCT04560816|473079147|FG005|Overall Study|Protocol Violation|0|||
131398191|NCT03818607|473079148|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
131398192|NCT03818607|473079149|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
131398193|NCT03818607|473079148|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
131398194|NCT03818607|473079149|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
131398195|NCT03818607|473079148|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
131398196|NCT03818607|473079149|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
131398197|NCT00588237|473079151|FG000|Overall Study|Evaluable for toxicity only|3|||
131398198|NCT00588237|473079151|FG000|Overall Study|Patien not treated|1|||
131398199|NCT00441142|473079153|FG000|Overall Study|Adverse Event|2|||
131398200|NCT00441142|473079154|FG001|Overall Study|Adverse Event|3|||
131398201|NCT00441142|473079155|FG002|Overall Study|Adverse Event|3|||
131398202|NCT00441142|473079156|FG003|Overall Study|Adverse Event|22|||
131753532|NCT00606177|474374348|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
131753533|NCT00606177|474374347|FG000|Overall Study|Change of residence or other commitments|1|||
131753534|NCT00606177|474374348|FG001|Overall Study|Change of residence or other commitments|1|||
131753535|NCT00216086|474374349|FG000|Overall Study|Protocol Violation|1|||
131753536|NCT00216086|474374349|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
131753537|NCT00216086|474374349|FG000|Overall Study|Social Reasons|2|||
131753538|NCT01017549|474374352|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
131753539|NCT01017549|474374352|FG000|One-year Follow-up|Lost to Follow-up|2|||
131753540|NCT01017549|474374352|FG000|One-year Follow-up|Withdrawal by Subject|5|||
131753541|NCT01017549|474374352|FG000|5 Year Follow-up|Lost to Follow-up|9|||
131753542|NCT01017549|474374352|FG000|5 Year Follow-up|Mastectomy|3|||
131753543|NCT02728206|474374354|FG000|Overall Study|Death|1|||
131753544|NCT02773368|474374357|FG000|Overall Study|Lost to Follow-up|4|||
131753545|NCT02773368|474374358|FG001|Overall Study|Lost to Follow-up|1|||
131753546|NCT02773368|474374357|FG000|Overall Study|Withdrawal by Subject|5|||
131753547|NCT02773368|474374358|FG001|Overall Study|Withdrawal by Subject|1|||
131753548|NCT02773368|474374357|FG000|Overall Study|Unclassified|1|||
131753549|NCT02773368|474374358|FG001|Overall Study|Unclassified|1|||
131753550|NCT02773368|474374357|FG000|Overall Study|Missing|0|||
131753551|NCT02773368|474374358|FG001|Overall Study|Missing|1|||
131753552|NCT01929018|474374359|FG000|Overall Study|Lost to Follow-up|1|||
131753553|NCT01929018|474374360|FG001|Overall Study|Lost to Follow-up|0|||
131753554|NCT01929018|474374359|FG000|Overall Study|Hospitalization|0|||
131753555|NCT01929018|474374360|FG001|Overall Study|Hospitalization|1|||
131753556|NCT03097133|474374361|FG000|Overall Study|Lost to Follow-up|3|||
131753557|NCT03097133|474374362|FG001|Overall Study|Lost to Follow-up|2|||
131753558|NCT03097133|474374361|FG000|Overall Study|Withdrawal by Subject|2|||
131753559|NCT03097133|474374362|FG001|Overall Study|Withdrawal by Subject|5|||
131753560|NCT03097133|474374361|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
131753561|NCT03097133|474374362|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
131753562|NCT03097133|474374361|FG000|Overall Study|Other|3|||
131753563|NCT03097133|474374362|FG001|Overall Study|Other|2|||
131753564|NCT03097133|474374361|FG000|Overall Study|Adverse Event|1|||
131753565|NCT03097133|474374362|FG001|Overall Study|Adverse Event|0|||
131753566|NCT03094611|474374363|FG000|Overall Study|Lack of Efficacy|1|||
131753567|NCT03094611|474374363|FG000|Overall Study|Stem Cell Transplant|1|||
131753568|NCT02023112|474374366|FG000|Overall Study|Withdrawal by Subject|2|||
131753569|NCT02023112|474374367|FG001|Overall Study|Withdrawal by Subject|1|||
131753570|NCT00981747|474374370|FG000|Losartan|Withdrawal by Subject|1|||
131753571|NCT00981747|474374370|FG000|Losartan|Death|1|||
131753572|NCT00981747|474374370|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
131753573|NCT03339401|474374372|FG000|Overall Study|Death|2|||
131753574|NCT03339401|474374373|FG001|Overall Study|Death|1|||
131753575|NCT03339401|474374372|FG000|Overall Study|Withdrawal by Subject|2|||
131753576|NCT03339401|474374373|FG001|Overall Study|Withdrawal by Subject|0|||
131753577|NCT03339401|474374372|FG000|Overall Study|Study terminated|4|||
131753578|NCT03339401|474374373|FG001|Overall Study|Study terminated|3|||
131753579|NCT03339401|474374372|FG000|Overall Study|Investigator Decision|1|||
131753580|NCT03339401|474374373|FG001|Overall Study|Investigator Decision|0|||
131398203|NCT00441142|473079153|FG000|Overall Study|Lack of Efficacy|3|||
131398204|NCT00441142|473079154|FG001|Overall Study|Lack of Efficacy|3|||
131398205|NCT00441142|473079155|FG002|Overall Study|Lack of Efficacy|17|||
131398206|NCT00441142|473079156|FG003|Overall Study|Lack of Efficacy|32|||
131398207|NCT00441142|473079153|FG000|Overall Study|Withdrawal by Subject|0|||
131398208|NCT00441142|473079154|FG001|Overall Study|Withdrawal by Subject|0|||
131398209|NCT00441142|473079155|FG002|Overall Study|Withdrawal by Subject|2|||
131398210|NCT00441142|473079156|FG003|Overall Study|Withdrawal by Subject|10|||
131398211|NCT00441142|473079153|FG000|Overall Study|Patient still receiving active study tx|1|||
131398212|NCT00441142|473079154|FG001|Overall Study|Patient still receiving active study tx|0|||
131398213|NCT00441142|473079155|FG002|Overall Study|Patient still receiving active study tx|0|||
131398214|NCT00441142|473079156|FG003|Overall Study|Patient still receiving active study tx|2|||
131398215|NCT00441142|473079153|FG000|Overall Study|Physician Decision|0|||
131398216|NCT00441142|473079154|FG001|Overall Study|Physician Decision|1|||
131398217|NCT00441142|473079155|FG002|Overall Study|Physician Decision|0|||
131398218|NCT00441142|473079156|FG003|Overall Study|Physician Decision|1|||
131398219|NCT00441142|473079153|FG000|Overall Study|Death|0|||
131398220|NCT00441142|473079154|FG001|Overall Study|Death|0|||
131398221|NCT00441142|473079155|FG002|Overall Study|Death|0|||
131398222|NCT00441142|473079156|FG003|Overall Study|Death|1|||
131398223|NCT04952597|473079157|FG000|Overall Study|Death|12|||
131398224|NCT04952597|473079158|FG001|Overall Study|Death|13|||
131398225|NCT04952597|473079159|FG002|Overall Study|Death|14|||
131398226|NCT04952597|473079157|FG000|Overall Study|Withdrawal by Subject|1|||
131398227|NCT04952597|473079158|FG001|Overall Study|Withdrawal by Subject|0|||
131398228|NCT04952597|473079159|FG002|Overall Study|Withdrawal by Subject|3|||
131398229|NCT04952597|473079157|FG000|Overall Study|Lost to Follow-up|0|||
131398230|NCT04952597|473079158|FG001|Overall Study|Lost to Follow-up|1|||
131398231|NCT04952597|473079159|FG002|Overall Study|Lost to Follow-up|1|||
131398232|NCT01265563|473079160|FG000|Overall Study|Withdrawal by Subject|0|||
131398233|NCT01265563|473079161|FG001|Overall Study|Withdrawal by Subject|1|||
131398234|NCT01265563|473079162|FG002|Overall Study|Withdrawal by Subject|1|||
131398235|NCT01265563|473079163|FG003|Overall Study|Withdrawal by Subject|0|||
131398236|NCT01265563|473079164|FG004|Overall Study|Withdrawal by Subject|2|||
131398237|NCT02141399|473079169|FG000|Overall Study|Adverse Event|158|||
131398238|NCT02141399|473079169|FG000|Overall Study|Lack of Efficacy|62|||
131398239|NCT02141399|473079169|FG000|Overall Study|Lost to Follow-up|151|||
131398240|NCT02141399|473079169|FG000|Overall Study|Non-compliance with study drug|18|||
131398241|NCT02141399|473079169|FG000|Overall Study|Other|45|||
131398242|NCT02141399|473079169|FG000|Overall Study|Physician Decision|17|||
131398243|NCT02141399|473079169|FG000|Overall Study|Pregnancy|3|||
131398244|NCT02141399|473079169|FG000|Overall Study|Protocol Violation|38|||
131398245|NCT02141399|473079169|FG000|Overall Study|Withdrawal by Subject|238|||
131753600|NCT01042938|474374393|FG000|Overall Study|Withdrawal by Subject|1|||
131753601|NCT01042938|474374394|FG001|Overall Study|Withdrawal by Subject|1|||
131753602|NCT01042938|474374393|FG000|Overall Study|Protocol Violation|1|||
131753603|NCT01042938|474374394|FG001|Overall Study|Protocol Violation|1|||
131753604|NCT01042938|474374393|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
131753605|NCT01042938|474374394|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
131753606|NCT03997760|474374395|FG000|Overall Study|Protocol Deviation|0|||
131753607|NCT03997760|474374396|FG001|Overall Study|Protocol Deviation|1|||
131753608|NCT03997760|474374397|FG002|Overall Study|Protocol Deviation|0|||
131753609|NCT03997760|474374398|FG003|Overall Study|Protocol Deviation|0|||
131753610|NCT02671760|474374399|FG000|Overall Study|Lost to Follow-up|0|||
131753611|NCT02671760|474374400|FG001|Overall Study|Lost to Follow-up|1|||
131753612|NCT02671760|474374401|FG002|Overall Study|Lost to Follow-up|0|||
131753613|NCT02999191|474374402|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
131753614|NCT02999191|474374403|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
131753615|NCT02999191|474374404|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
131753616|NCT02566109|474374406|FG000|Overall Study|Withdrawal by Subject|1|||
131753617|NCT01906476|474374407|FG000|Overall Study|Lost to Follow-up|17|||
131753618|NCT01906476|474374408|FG001|Overall Study|Lost to Follow-up|16|||
131753619|NCT01993667|474374409|FG000|Overall Study|Insufficient data to analyze|16|||
131753620|NCT01993667|474374410|FG001|Overall Study|Insufficient data to analyze|16|||
131810471|NCT03699020|474588041|FG000|Overall Study|Withdrawal by Subject|3|||
131398246|NCT02141399|473079169|FG000|Overall Study|Failure to meet eligibility criteria|14|||
131398247|NCT03249909|473079176|FG000|Overall Study|Withdrawal by Subject|3|||
131398248|NCT03249909|473079177|FG001|Overall Study|Withdrawal by Subject|0|||
131398249|NCT03249909|473079178|FG002|Overall Study|Withdrawal by Subject|0|||
131398250|NCT03249909|473079176|FG000|Overall Study|Adverse Event|3|||
131398251|NCT03249909|473079177|FG001|Overall Study|Adverse Event|0|||
131398252|NCT03249909|473079178|FG002|Overall Study|Adverse Event|0|||
131398253|NCT03249909|473079176|FG000|Overall Study|Lost to Follow-up|0|||
131398254|NCT03249909|473079177|FG001|Overall Study|Lost to Follow-up|1|||
131398255|NCT03249909|473079178|FG002|Overall Study|Lost to Follow-up|0|||
131398256|NCT00606034|473079179|FG000|Overall Study|incarceration|1|||
131753621|NCT01993667|474374409|FG000|Overall Study|Insufficient altitude reached|3|||
131810472|NCT03699020|474588042|FG001|Overall Study|Withdrawal by Subject|2|||
131810473|NCT00904215|474588045|FG000|Overall Study|Adverse Event|25|||
131810474|NCT00904215|474588045|FG000|Overall Study|Protocol Violation|10|||
131398257|NCT05286658|473079183|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
131398258|NCT05286658|473079183|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
131398259|NCT01035463|473079184|FG000|Overall Study|Adverse Event|0|||
131398260|NCT01035463|473079185|FG001|Overall Study|Adverse Event|0|||
131398261|NCT01035463|473079186|FG002|Overall Study|Adverse Event|4|||
131753622|NCT01993667|474374410|FG001|Overall Study|Insufficient altitude reached|1|||
131753623|NCT01993667|474374409|FG000|Overall Study|Lost to Follow-up|2|||
131753624|NCT01993667|474374410|FG001|Overall Study|Lost to Follow-up|2|||
131810475|NCT00904215|474588045|FG000|Overall Study|Lost to Follow-up|63|||
131753625|NCT01931150|474374411|FG000|Overall Study|Withdrawal by Subject|1|||
131753626|NCT01931150|474374412|FG001|Overall Study|Withdrawal by Subject|2|||
131753627|NCT02896192|474374413|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
131753628|NCT02896192|474374413|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
131753629|NCT02896192|474374413|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
131753630|NCT00479167|474374418|FG000|Overall Study|Withdrawal by Subject|1|||
131753631|NCT01997281|474374421|FG000|Overall Study|Withdrawal by Subject|1|||
131753632|NCT01997281|474374422|FG001|Overall Study|Withdrawal by Subject|0|||
131753633|NCT00634751|474376127|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
131753634|NCT00634751|474376128|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
131753635|NCT00634751|474376129|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
131753636|NCT00634751|474376130|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
131753637|NCT00634751|474376127|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
131753638|NCT00634751|474376128|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
131753639|NCT00634751|474376129|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
131753640|NCT00634751|474376130|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
131753641|NCT00634751|474376127|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
131753642|NCT00634751|474376128|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
131753643|NCT00634751|474376129|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
131753644|NCT00634751|474376130|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
131753645|NCT04402385|474376133|FG000|Overall Study|Withdrawal by Subject|4|||
131753646|NCT04402385|474376134|FG001|Overall Study|Withdrawal by Subject|4|||
131753647|NCT04402385|474376133|FG000|Overall Study|Lost to Follow-up|1|||
131753648|NCT04402385|474376134|FG001|Overall Study|Lost to Follow-up|1|||
131753649|NCT04402385|474376133|FG000|Overall Study|Physician Decision|0|||
131753650|NCT04402385|474376134|FG001|Overall Study|Physician Decision|1|||
131753651|NCT00088595|474376135|FG000|Overall Study|Adverse Event|11|||
131753652|NCT00088595|474376135|FG000|Overall Study|Withdrawal by Subject|8|||
131753653|NCT00088595|474376135|FG000|Overall Study|Ongoing (After Core)|7|||
131753654|NCT00088595|474376135|FG000|Overall Study|New Cancer Therapy|2|||
131753655|NCT01308853|474376141|FG000|Overall Study|Adverse Event|1|||
131753656|NCT01308853|474376141|FG000|Overall Study|Lost to Follow-up|2|||
131753657|NCT01308853|474376141|FG000|Overall Study|Insertion of permanent implants|1|||
131753658|NCT03938636|474376142|FG000|Overall Study|Protocol Violation|0|||
131753659|NCT03938636|474376143|FG001|Overall Study|Protocol Violation|1|||
131753660|NCT03938636|474376144|FG002|Overall Study|Protocol Violation|1|||
131753661|NCT03938636|474376142|FG000|Overall Study|Subject withdrew due to death in family|0|||
131753662|NCT03938636|474376143|FG001|Overall Study|Subject withdrew due to death in family|1|||
131753663|NCT03938636|474376144|FG002|Overall Study|Subject withdrew due to death in family|0|||
131753664|NCT03938636|474376142|FG000|Overall Study|Missed visit|0|||
131753665|NCT03938636|474376143|FG001|Overall Study|Missed visit|1|||
131753666|NCT03938636|474376144|FG002|Overall Study|Missed visit|0|||
131753667|NCT03938636|474376142|FG000|Overall Study|Adverse Event|0|||
131753668|NCT03938636|474376143|FG001|Overall Study|Adverse Event|0|||
131753669|NCT03938636|474376144|FG002|Overall Study|Adverse Event|1|||
131753670|NCT03938636|474376142|FG000|Overall Study|Lost to Follow-up|0|||
131753671|NCT03938636|474376143|FG001|Overall Study|Lost to Follow-up|0|||
131753672|NCT03938636|474376144|FG002|Overall Study|Lost to Follow-up|1|||
131753673|NCT01100658|474376145|FG000|Overall Study|Withdrawal by Subject|1|||
131753674|NCT00711412|474376146|FG000|Induction Treatment|Death|2|||
131753675|NCT00711412|474376146|FG000|Induction Treatment|Adverse Event|1|||
131753676|NCT00711412|474376146|FG000|Induction Treatment|Other|1|||
131398262|NCT01035463|473079187|FG003|Overall Study|Adverse Event|1|||
131398263|NCT01035463|473079188|FG004|Overall Study|Adverse Event|5|||
131398264|NCT01035463|473079189|FG005|Overall Study|Adverse Event|7|||
131398265|NCT01035463|473079184|FG000|Overall Study|Withdrawal by Subject|0|||
131753677|NCT00711412|474376146|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
131753678|NCT00711412|474376146|FG000|Evaluated for Combination Treatment|Death|1|||
131753679|NCT00711412|474376146|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
131753680|NCT00711412|474376146|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
131810476|NCT00904215|474588045|FG000|Overall Study|Withdrawal by Subject|9|||
131810477|NCT00904215|474588045|FG000|Overall Study|Other|28|||
131810478|NCT00960297|474588046|FG000|Overall Study|Physician Decision|1|||
131810479|NCT00960297|474588046|FG000|Overall Study|Venous port infection|1|||
131398266|NCT01035463|473079185|FG001|Overall Study|Withdrawal by Subject|2|||
131753681|NCT00711412|474376146|FG000|Combination Treatment|Progressive Disease|1|||
131753682|NCT00711412|474376146|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
131753683|NCT00711412|474376146|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
131753684|NCT00711412|474376146|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
131753685|NCT00711412|474376146|FG000|Evaluation for Response and Surgery|Death|1|||
131753686|NCT00711412|474376146|FG000|Survival Follow up Until Death|Other|12|||
131753687|NCT00420342|474376150|FG000|Overall Study|Lost to Follow-up|1|||
131753688|NCT00420342|474376151|FG001|Overall Study|Lost to Follow-up|0|||
131753689|NCT00420342|474376152|FG002|Overall Study|Lost to Follow-up|1|||
131753690|NCT00420342|474376150|FG000|Overall Study|Withdrawal by Subject|0|||
131753691|NCT00420342|474376151|FG001|Overall Study|Withdrawal by Subject|2|||
131753692|NCT00420342|474376152|FG002|Overall Study|Withdrawal by Subject|0|||
131753693|NCT04072575|474376153|FG000|Overall Study|Physician Decision|1|||
131753694|NCT04072575|474376153|FG000|Overall Study|Adverse Event|7|||
131753695|NCT04072575|474376153|FG000|Overall Study|Withdrawal by Subject|14|||
131753696|NCT04072575|474376153|FG000|Overall Study|Other|2|||
131753697|NCT02473289|474376154|FG000|Overall Study|Adverse Event|2|||
131753698|NCT02473289|474376155|FG001|Overall Study|Adverse Event|3|||
131753699|NCT02473289|474376154|FG000|Overall Study|Lost to Follow-up|1|||
131753700|NCT02473289|474376155|FG001|Overall Study|Lost to Follow-up|1|||
131753701|NCT02473289|474376154|FG000|Overall Study|Protocol Violation|0|||
131753702|NCT02473289|474376155|FG001|Overall Study|Protocol Violation|1|||
131753703|NCT02473289|474376154|FG000|Overall Study|Withdrawal of consent|6|||
131753704|NCT02473289|474376155|FG001|Overall Study|Withdrawal of consent|7|||
131753705|NCT02473289|474376154|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
131753706|NCT02473289|474376155|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
131753707|NCT02473289|474376154|FG000|Overall Study|Other|2|||
131753708|NCT02473289|474376155|FG001|Overall Study|Other|0|||
131753709|NCT02244619|474376156|FG000|Overall Study|Did not receive study intervention|8|||
131753710|NCT02244619|474376157|FG001|Overall Study|Did not receive study intervention|21|||
131753711|NCT03285490|474376159|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
131753712|NCT03285490|474376160|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
131753713|NCT03285490|474376159|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
131753714|NCT03285490|474376160|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
131753715|NCT03745989|474376161|FG000|Overall Study|Death|3|||
131753716|NCT03745989|474376162|FG001|Overall Study|Death|7|||
131753717|NCT03745989|474376163|FG002|Overall Study|Death|4|||
131753718|NCT03745989|474376161|FG000|Overall Study|Lost to Follow-up|0|||
131753719|NCT03745989|474376162|FG001|Overall Study|Lost to Follow-up|2|||
131753720|NCT03745989|474376163|FG002|Overall Study|Lost to Follow-up|0|||
131753721|NCT03745989|474376161|FG000|Overall Study|Sponsor Decision|0|||
131753722|NCT03745989|474376162|FG001|Overall Study|Sponsor Decision|2|||
131753723|NCT03745989|474376163|FG002|Overall Study|Sponsor Decision|8|||
131753724|NCT03745989|474376161|FG000|Overall Study|Withdrawal by Subject|0|||
131753725|NCT03745989|474376162|FG001|Overall Study|Withdrawal by Subject|1|||
131753726|NCT03745989|474376163|FG002|Overall Study|Withdrawal by Subject|3|||
131753727|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
131753728|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
131753729|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
131753730|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
131753731|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
131753732|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
131753733|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
131753734|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
131753735|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
131753736|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
131753737|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
131753738|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
131753739|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
131753740|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
131753741|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
131753742|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
131753743|NCT01291511|474376167|FG000|Cross-Titration and Stabilization Phase|Death|1|||
131753744|NCT01291511|474376168|FG001|Cross-Titration and Stabilization Phase|Death|0|||
131753745|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
131753746|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
131753747|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
131753748|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
131753749|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
131753750|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
131753751|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
131753752|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
131753753|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
131753754|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
131906918|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
131906919|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
131449680|NCT04922216|473274984|FG027|Overall Study|Withdrawal by Subject|0|||
131753755|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
131753756|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
131753757|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
131753758|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
131753759|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
131753760|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
131753761|NCT01291511|474376167|FG000|Double-blind Relapse Prevention Phase|Death|1|||
131753762|NCT01291511|474376168|FG001|Double-blind Relapse Prevention Phase|Death|0|||
131753763|NCT00429572|474376170|FG000|Overall Study|Disease progression|1|||
131753764|NCT01047436|474376173|FG000|Overall Study|Protocol Violation|1|||
131753765|NCT01047436|474376174|FG001|Overall Study|Protocol Violation|0|||
131753766|NCT02635867|474376177|FG000|Overall Study|Lost to Follow-up|4|||
131753767|NCT02635867|474376178|FG001|Overall Study|Lost to Follow-up|3|||
131753768|NCT02635867|474376179|FG002|Overall Study|Lost to Follow-up|3|||
131753769|NCT02635867|474376180|FG003|Overall Study|Lost to Follow-up|4|||
131753770|NCT02635867|474376181|FG004|Overall Study|Lost to Follow-up|1|||
131753771|NCT02565576|474376182|FG000|Overall Study|abnormal lab value|2|||
131753772|NCT02565576|474376183|FG001|Overall Study|abnormal lab value|0|||
131753773|NCT02565576|474376182|FG000|Overall Study|subject / guardian decision|1|||
131753774|NCT02565576|474376183|FG001|Overall Study|subject / guardian decision|3|||
131753775|NCT02565576|474376182|FG000|Overall Study|Lost to Follow-up|1|||
131753776|NCT02565576|474376183|FG001|Overall Study|Lost to Follow-up|0|||
131753777|NCT02565576|474376182|FG000|Overall Study|Death|0|||
131753778|NCT02565576|474376183|FG001|Overall Study|Death|2|||
131753779|NCT02565576|474376182|FG000|Overall Study|Adverse Event|1|||
131753780|NCT02565576|474376183|FG001|Overall Study|Adverse Event|0|||
131753781|NCT00939341|474376184|FG000|Overall Study|Adverse Event|15|||
131753782|NCT00939341|474376184|FG000|Overall Study|Pregnancy|1|||
131753783|NCT00939341|474376184|FG000|Overall Study|Lost to Follow-up|23|||
131753784|NCT00939341|474376184|FG000|Overall Study|Withdrawal by Subject|13|||
131753785|NCT00939341|474376184|FG000|Overall Study|Protocol Violation|6|||
131753786|NCT00939341|474376184|FG000|Overall Study|Incorrect enrolment|8|||
131753787|NCT02918318|474376185|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
131753788|NCT02918318|474376186|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
131753789|NCT02918318|474376187|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
131753790|NCT02918318|474376188|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
131753791|NCT02918318|474376189|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
131753792|NCT02918318|474376185|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131753793|NCT02918318|474376186|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131753794|NCT02918318|474376187|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131753795|NCT02918318|474376188|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
131753796|NCT02918318|474376189|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131753797|NCT02918318|474376185|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131753798|NCT02918318|474376186|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131753799|NCT02918318|474376187|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131753800|NCT02918318|474376188|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
131753801|NCT02918318|474376189|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131753802|NCT02918318|474376185|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
131753803|NCT02918318|474376186|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
131753804|NCT02918318|474376187|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
131753805|NCT02918318|474376188|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
131753806|NCT02918318|474376189|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
131753807|NCT02918318|474376185|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131753808|NCT02918318|474376186|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131753809|NCT02918318|474376187|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131753810|NCT02918318|474376188|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
131753811|NCT02918318|474376189|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131753812|NCT02918318|474376185|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
131753813|NCT02918318|474376186|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
131753814|NCT02918318|474376187|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
131753815|NCT02918318|474376188|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
131398267|NCT01035463|473079186|FG002|Overall Study|Withdrawal by Subject|1|||
131398268|NCT01035463|473079187|FG003|Overall Study|Withdrawal by Subject|0|||
131398269|NCT01035463|473079188|FG004|Overall Study|Withdrawal by Subject|1|||
131398270|NCT01035463|473079189|FG005|Overall Study|Withdrawal by Subject|4|||
131753816|NCT02918318|474376189|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
131753817|NCT02918318|474376185|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131753818|NCT02918318|474376186|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131753819|NCT02918318|474376187|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131753820|NCT02918318|474376188|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
131753821|NCT02918318|474376189|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131753822|NCT02918318|474376185|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
131753823|NCT02918318|474376186|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
131753824|NCT02918318|474376187|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
131398271|NCT01035463|473079184|FG000|Overall Study|Disease progression|0|||
131398272|NCT01035463|473079185|FG001|Overall Study|Disease progression|0|||
131753825|NCT02918318|474376188|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
131753826|NCT02918318|474376189|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
131753827|NCT02918318|474376185|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
131753828|NCT02918318|474376186|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
131753829|NCT02918318|474376187|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
131753830|NCT02918318|474376188|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
131753831|NCT02918318|474376189|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
131753832|NCT02918318|474376185|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
131753833|NCT02918318|474376186|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
131753834|NCT02918318|474376187|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
131753835|NCT02918318|474376188|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
131753836|NCT02918318|474376189|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
131753837|NCT02918318|474376185|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131753838|NCT02918318|474376186|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131753839|NCT02918318|474376187|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131753840|NCT02918318|474376188|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131753841|NCT02918318|474376189|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
131753842|NCT02918318|474376185|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131753843|NCT02918318|474376186|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131753844|NCT02918318|474376187|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131753845|NCT02918318|474376188|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131753846|NCT02918318|474376189|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
131753847|NCT03981744|474376190|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
131753848|NCT03981744|474376191|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
131753849|NCT03981744|474376192|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
131753850|NCT03981744|474376193|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
131753851|NCT03981744|474376190|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
131753852|NCT03981744|474376191|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
131753853|NCT03981744|474376192|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
131753854|NCT03981744|474376193|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
131753855|NCT03981744|474376190|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
131753856|NCT03981744|474376191|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
131753857|NCT03981744|474376192|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
131753858|NCT03981744|474376193|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
131753859|NCT02782104|474376194|FG000|Overall Study|Other|215|||
131753860|NCT02782104|474376194|FG000|Overall Study|Induction Day 28 Non Responder|9|||
131753861|NCT02782104|474376194|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131753862|NCT02782104|474376194|FG000|Overall Study|Death|8|||
131753863|NCT02782104|474376194|FG000|Overall Study|Pregnancy|6|||
131753864|NCT02782104|474376194|FG000|Overall Study|Withdrawal by Subject|63|||
131753865|NCT02782104|474376194|FG000|Overall Study|Protocol Violation|7|||
131753866|NCT02782104|474376194|FG000|Overall Study|Lack of Efficacy|61|||
131753867|NCT02782104|474376194|FG000|Overall Study|Lost to Follow-up|23|||
131753868|NCT02782104|474376194|FG000|Overall Study|Adverse Event|74|||
131753869|NCT03185819|474376195|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
131753870|NCT03185819|474376196|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
131398273|NCT01035463|473079186|FG002|Overall Study|Disease progression|0|||
131398274|NCT01035463|473079187|FG003|Overall Study|Disease progression|0|||
131753871|NCT03185819|474376197|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
131753872|NCT03185819|474376198|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
131753873|NCT03185819|474376195|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
131753874|NCT03185819|474376196|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
131753875|NCT03185819|474376197|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
131753876|NCT03185819|474376198|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
131753877|NCT03185819|474376195|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
131753878|NCT03185819|474376196|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
131753879|NCT03185819|474376197|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
131753880|NCT03185819|474376198|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
131753881|NCT03185819|474376195|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
131753882|NCT03185819|474376196|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
131753883|NCT03185819|474376197|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
131753884|NCT03185819|474376198|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
131753885|NCT03185819|474376195|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
131753886|NCT03185819|474376196|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
131753887|NCT03185819|474376197|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
131753888|NCT03185819|474376198|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
131810480|NCT00960297|474588046|FG000|Overall Study|Disease progression|1|||
131398275|NCT01035463|473079188|FG004|Overall Study|Disease progression|0|||
131398276|NCT01035463|473079189|FG005|Overall Study|Disease progression|3|||
131753889|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
131753890|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
131753891|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
131753892|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
131753893|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
131753894|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
131753895|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
131753896|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
131753897|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
131753898|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
131753899|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
131753900|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
131753901|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
131753902|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
131753903|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
131753904|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
131753905|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
131753906|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
131753907|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
131753908|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
131753909|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
131753910|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
131753911|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
131753912|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
131753913|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
131753914|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
131753915|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
131753916|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
131753917|NCT03185819|474376195|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
131753918|NCT03185819|474376196|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
131753919|NCT03185819|474376197|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
131753920|NCT03185819|474376198|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
131753921|NCT02438787|474376199|FG000|Overall Study|Adverse Event|1|||
131753922|NCT02438787|474376200|FG001|Overall Study|Adverse Event|0|||
131753923|NCT02438787|474376201|FG002|Overall Study|Adverse Event|2|||
131753924|NCT02438787|474376199|FG000|Overall Study|Lack of Efficacy|1|||
131753925|NCT02438787|474376200|FG001|Overall Study|Lack of Efficacy|2|||
131753926|NCT02438787|474376201|FG002|Overall Study|Lack of Efficacy|0|||
131753927|NCT02438787|474376199|FG000|Overall Study|Lost to Follow-up|0|||
131753928|NCT02438787|474376200|FG001|Overall Study|Lost to Follow-up|1|||
131753929|NCT02438787|474376201|FG002|Overall Study|Lost to Follow-up|0|||
131753930|NCT02438787|474376199|FG000|Overall Study|Protocol Violation|0|||
131753931|NCT02438787|474376200|FG001|Overall Study|Protocol Violation|0|||
131753932|NCT02438787|474376201|FG002|Overall Study|Protocol Violation|1|||
131753933|NCT02438787|474376199|FG000|Overall Study|Withdrawal by Subject|15|||
131753934|NCT02438787|474376200|FG001|Overall Study|Withdrawal by Subject|7|||
131753935|NCT02438787|474376201|FG002|Overall Study|Withdrawal by Subject|10|||
131753936|NCT02438787|474376199|FG000|Overall Study|Study discontinued by sponsor|64|||
131753937|NCT02438787|474376200|FG001|Overall Study|Study discontinued by sponsor|72|||
131753938|NCT02438787|474376201|FG002|Overall Study|Study discontinued by sponsor|69|||
131753939|NCT02438787|474376199|FG000|Overall Study|Other|0|||
131753940|NCT02438787|474376200|FG001|Overall Study|Other|1|||
131810481|NCT00838630|474588055|FG000|First Intervention|Adverse Event|1|||
131810482|NCT00838630|474588056|FG001|First Intervention|Adverse Event|0|||
131810483|NCT00838630|474588055|FG000|Washout: 7 Days|Protocol Violation|1|||
131753941|NCT02438787|474376201|FG002|Overall Study|Other|0|||
131753942|NCT02438787|474376199|FG000|Overall Study|Site terminated by sponsor|0|||
131753943|NCT02438787|474376200|FG001|Overall Study|Site terminated by sponsor|0|||
131753944|NCT02438787|474376201|FG002|Overall Study|Site terminated by sponsor|1|||
131753945|NCT00732641|474376202|FG000|Overall Study|Relapse or Progressive Disease|65|||
131810484|NCT00838630|474588056|FG001|Washout: 7 Days|Protocol Violation|0|||
131810485|NCT00571064|474588057|FG000|Overall Study|Adverse Event|13|||
131398277|NCT01035463|473079184|FG000|Overall Study|Other Malignancy|0|||
131398278|NCT01035463|473079185|FG001|Overall Study|Other Malignancy|0|||
131810486|NCT00571064|474588057|FG000|Overall Study|Protocol Violation|4|||
131810487|NCT00571064|474588057|FG000|Overall Study|Withdrawal by Subject|2|||
131398279|NCT01035463|473079186|FG002|Overall Study|Other Malignancy|0|||
131398280|NCT01035463|473079187|FG003|Overall Study|Other Malignancy|0|||
131906920|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
131906921|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
131906922|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
131398281|NCT01035463|473079188|FG004|Overall Study|Other Malignancy|0|||
131753946|NCT00732641|474376203|FG001|Overall Study|Relapse or Progressive Disease|101|||
131753947|NCT00732641|474376202|FG000|Overall Study|Serious Adverse Events|12|||
131753948|NCT00732641|474376203|FG001|Overall Study|Serious Adverse Events|3|||
131753949|NCT00732641|474376202|FG000|Overall Study|Physician Decision|6|||
131753950|NCT00732641|474376203|FG001|Overall Study|Physician Decision|0|||
131753951|NCT00732641|474376202|FG000|Overall Study|Withdrawal by Subject|4|||
131753952|NCT00732641|474376203|FG001|Overall Study|Withdrawal by Subject|2|||
131753953|NCT00732641|474376202|FG000|Overall Study|Unable to Complete|1|||
131753954|NCT00732641|474376203|FG001|Overall Study|Unable to Complete|1|||
131753955|NCT00732641|474376202|FG000|Overall Study|Other|18|||
131753956|NCT00732641|474376203|FG001|Overall Study|Other|5|||
131753957|NCT02910089|474376204|FG000|Overall Study|Lost insurance eligibility|22|||
131753958|NCT02910089|474376205|FG001|Overall Study|Lost insurance eligibility|16|||
131753959|NCT00732238|474376206|FG000|Overall Study|Bacteremia|4|||
131753960|NCT00732238|474376207|FG001|Overall Study|Bacteremia|1|||
131753961|NCT00732238|474376206|FG000|Overall Study|Asymptomatic bacteriuria|1|||
131753962|NCT00732238|474376207|FG001|Overall Study|Asymptomatic bacteriuria|0|||
131753963|NCT01782885|474376208|FG000|Overall Study|Lost to Follow-up|4|||
131753964|NCT01782885|474376209|FG001|Overall Study|Lost to Follow-up|6|||
131753965|NCT02977507|474376213|FG000|Overall Study|Protocol Deviation|1|||
131753966|NCT02977507|474376214|FG001|Overall Study|Protocol Deviation|0|||
131753967|NCT02977507|474376213|FG000|Overall Study|Lost to Follow-up|1|||
131753968|NCT02977507|474376214|FG001|Overall Study|Lost to Follow-up|0|||
131753969|NCT00633360|474376215|FG000|Overall Study|Lost to Follow-up|1|||
131753970|NCT00633360|474376216|FG001|Overall Study|Lost to Follow-up|1|||
131753971|NCT00633360|474376215|FG000|Overall Study|Adverse Event|3|||
131753972|NCT00633360|474376216|FG001|Overall Study|Adverse Event|1|||
131753973|NCT00633360|474376215|FG000|Overall Study|Protocol Violation|0|||
131753974|NCT00633360|474376216|FG001|Overall Study|Protocol Violation|1|||
131753975|NCT00329784|474376217|FG000|Overall Study|Lost to Follow-up|0|||
131753976|NCT00329784|474376218|FG001|Overall Study|Lost to Follow-up|1|||
131753977|NCT00329784|474376219|FG002|Overall Study|Lost to Follow-up|0|||
131753978|NCT00329784|474376220|FG003|Overall Study|Lost to Follow-up|0|||
131753979|NCT00329784|474376217|FG000|Overall Study|Withdrawal by Subject|4|||
131753980|NCT00329784|474376218|FG001|Overall Study|Withdrawal by Subject|2|||
131753981|NCT00329784|474376219|FG002|Overall Study|Withdrawal by Subject|0|||
131753982|NCT00329784|474376220|FG003|Overall Study|Withdrawal by Subject|0|||
131753983|NCT00329784|474376217|FG000|Overall Study|Other|1|||
131753984|NCT00329784|474376218|FG001|Overall Study|Other|2|||
131753985|NCT00329784|474376219|FG002|Overall Study|Other|0|||
131753986|NCT00329784|474376220|FG003|Overall Study|Other|0|||
131753987|NCT00924729|474376225|FG000|Overall Study|insufficient volume for analysis|1|||
131753988|NCT00924729|474376226|FG001|Overall Study|insufficient volume for analysis|0|||
131753989|NCT00924729|474376225|FG000|Overall Study|Protocol Violation|1|||
131753990|NCT00924729|474376226|FG001|Overall Study|Protocol Violation|0|||
131753991|NCT01449955|474376227|FG000|Overall Study|Withdrawal by Subject|1|||
131753992|NCT01449955|474376228|FG001|Overall Study|Withdrawal by Subject|2|||
131753993|NCT04018612|474376229|FG000|Overall Study|Withdrawal by Subject|1|||
131753994|NCT04018612|474376230|FG001|Overall Study|Withdrawal by Subject|0|||
131753995|NCT04018612|474376231|FG002|Overall Study|Withdrawal by Subject|1|||
131753996|NCT01915095|474376232|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
131753997|NCT01915095|474376233|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
131753998|NCT01915095|474376234|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
131753999|NCT01915095|474376235|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
131754000|NCT01915095|474376236|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
131754001|NCT00361218|474376239|FG000|Overall Study|Lost to Follow-up|11|||
131754002|NCT00361218|474376239|FG000|Overall Study|Personal Reasons|7|||
131754003|NCT00361218|474376239|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
131754004|NCT02067533|474376240|FG000|Overall Study|Lost to Follow-up|4|||
131754005|NCT02067533|474376241|FG001|Overall Study|Lost to Follow-up|2|||
131754006|NCT01570309|474376243|FG000|Overall Study|Withdrawal by Subject|3|||
131754007|NCT01570309|474376244|FG001|Overall Study|Withdrawal by Subject|3|||
131754008|NCT00560794|474376245|FG000|Overall Study|Adverse Event|2|||
131754009|NCT00560794|474376245|FG000|Overall Study|Patient was not Compliant|1|||
131754010|NCT00560794|474376245|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
131754011|NCT00560794|474376245|FG000|Overall Study|Hematological Relapse|1|||
131754012|NCT00560794|474376245|FG000|Overall Study|Received Bone Marrow Transplant|6|||
131754013|NCT04857892|474376246|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
131398282|NCT01035463|473079189|FG005|Overall Study|Other Malignancy|2|||
131754014|NCT04857892|474376247|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131754015|NCT04857892|474376248|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131754016|NCT04857892|474376249|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131398283|NCT01035463|473079184|FG000|Overall Study|Other|0|||
131398284|NCT01035463|473079185|FG001|Overall Study|Other|0|||
131754017|NCT04857892|474376250|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131754018|NCT04857892|474376246|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
131754019|NCT04857892|474376247|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
131754020|NCT04857892|474376248|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
131754021|NCT04857892|474376249|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
131754022|NCT04857892|474376250|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
131754023|NCT04857892|474376246|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131754024|NCT04857892|474376247|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131754025|NCT04857892|474376248|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131754026|NCT04857892|474376249|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131754027|NCT04857892|474376250|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
131754028|NCT01390038|474376251|FG000|Overall Study|Death|1|||
131754029|NCT01390038|474376251|FG000|Overall Study|Lost to Follow-up|1|||
131754030|NCT01390038|474376251|FG000|Overall Study|Withdrawal by Subject|4|||
131754031|NCT01390038|474376251|FG000|Overall Study|Simpliciti System Removal|2|||
131754032|NCT00368472|474376257|FG000|Overall Study|Adverse Event|22|||
131754033|NCT00368472|474376257|FG000|Overall Study|Medication non-compliance|4|||
131754034|NCT00368472|474376257|FG000|Overall Study|Protocol Violation|2|||
131754035|NCT00368472|474376257|FG000|Overall Study|Request of Investigator or Sponsor|3|||
131754036|NCT00368472|474376257|FG000|Overall Study|Withdrawal by Subject|40|||
131754037|NCT00368472|474376257|FG000|Overall Study|Diary non-compliance|1|||
131754038|NCT00368472|474376257|FG000|Overall Study|Other|32|||
131754039|NCT00368472|474376257|FG000|Overall Study|Missing Final Disposition Date|1|||
131754040|NCT02384993|474376261|FG000|Overall Study|Adverse Event|0|||
131754041|NCT02384993|474376262|FG001|Overall Study|Adverse Event|1|||
131754042|NCT04095793|474376263|FG000|Overall Study|Adverse Event|3|||
131754043|NCT04095793|474376263|FG000|Overall Study|Study Terminated by Sponsor|103|||
131754044|NCT04095793|474376263|FG000|Overall Study|Withdrawal by Subject|4|||
131754045|NCT03619837|474376264|FG000|Screening|received organs from HCV-negative donors|47|||
131754046|NCT03619837|474376264|FG000|Screening|died on the wait-list|2|||
131754047|NCT03619837|474376264|FG000|Screening|remained on the wait list|40|||
131754048|NCT03619837|474376264|FG000|Screening|didn't meet eligibility criteria|3|||
131754049|NCT03619837|474376264|FG000|Screening|withdrew consent|2|||
131754050|NCT03619837|474376264|FG000|Screening|never listed for HCV-viremic donor|1|||
131810488|NCT00571064|474588057|FG000|Overall Study|Other|2|||
131810489|NCT02159950|474588065|FG000|Overall Study|Adverse Event|0|||
131810490|NCT02159950|474588066|FG001|Overall Study|Adverse Event|1|||
131810491|NCT02159950|474588065|FG000|Overall Study|Progression|0|||
131810492|NCT02159950|474588066|FG001|Overall Study|Progression|1|||
131810493|NCT03925532|474588067|FG000|Overall Study|Lost to Follow-up|1|||
131810494|NCT02446600|474588068|FG000|Overall Study|Never treated|20|||
131810495|NCT02446600|474588069|FG001|Overall Study|Never treated|2|||
131810496|NCT02446600|474588070|FG002|Overall Study|Never treated|6|||
131810497|NCT02446600|474588071|FG003|Overall Study|Never treated|0|||
131810498|NCT02446600|474588068|FG000|Overall Study|Withdrawal by Subject|19|||
131810499|NCT02446600|474588069|FG001|Overall Study|Withdrawal by Subject|5|||
131810500|NCT02446600|474588070|FG002|Overall Study|Withdrawal by Subject|17|||
131810501|NCT02446600|474588071|FG003|Overall Study|Withdrawal by Subject|0|||
131810502|NCT02446600|474588068|FG000|Overall Study|Ineligible|1|||
131810503|NCT02446600|474588069|FG001|Overall Study|Ineligible|4|||
131810504|NCT02446600|474588070|FG002|Overall Study|Ineligible|4|||
131810505|NCT02446600|474588071|FG003|Overall Study|Ineligible|1|||
131810506|NCT02446600|474588068|FG000|Overall Study|Duplicate Enrollment|0|||
131810507|NCT02446600|474588069|FG001|Overall Study|Duplicate Enrollment|1|||
131810508|NCT02446600|474588070|FG002|Overall Study|Duplicate Enrollment|0|||
131810509|NCT02446600|474588071|FG003|Overall Study|Duplicate Enrollment|0|||
131810510|NCT04108858|474588072|FG000|Overall Study|Adverse Event|1|||
131810511|NCT01208337|474588076|FG000|Overall Study|Death|3|||
131810512|NCT03663179|474588077|FG000|Overall Study|Withdrawal by Subject|2|||
131810513|NCT03663179|474588078|FG001|Overall Study|Withdrawal by Subject|0|||
131398285|NCT01035463|473079186|FG002|Overall Study|Other|0|||
131398286|NCT01035463|473079187|FG003|Overall Study|Other|1|||
131398287|NCT01035463|473079188|FG004|Overall Study|Other|0|||
131754051|NCT03619837|474376264|FG000|Screening|developed exclusion criteria|2|||
131810514|NCT03663179|474588077|FG000|Overall Study|Lost to Follow-up|1|||
131810515|NCT03663179|474588078|FG001|Overall Study|Lost to Follow-up|1|||
131810516|NCT03663179|474588077|FG000|Overall Study|Revealed exclusionary condition|1|||
131810517|NCT03663179|474588078|FG001|Overall Study|Revealed exclusionary condition|0|||
131398288|NCT01035463|473079189|FG005|Overall Study|Other|2|||
131398289|NCT01092780|473079190|FG000|Washout Period 1|Adverse Event|0|||
131754052|NCT03619837|474376264|FG000|Screening|excluded by the investigator due to non-compliance|1|||
131810518|NCT01615198|474588079|FG000|Overall Study|Withdrawal by Subject|5|||
131810519|NCT01615198|474588080|FG001|Overall Study|Withdrawal by Subject|5|||
131810520|NCT01615198|474588079|FG000|Overall Study|Protocol deviation|1|||
131810521|NCT01615198|474588080|FG001|Overall Study|Protocol deviation|1|||
131810522|NCT01615198|474588079|FG000|Overall Study|Physician Decision|5|||
131810523|NCT01615198|474588080|FG001|Overall Study|Physician Decision|1|||
131810524|NCT01615198|474588079|FG000|Overall Study|Lost to Follow-up|1|||
131810525|NCT01615198|474588080|FG001|Overall Study|Lost to Follow-up|1|||
131810526|NCT01615198|474588079|FG000|Overall Study|Lack of Efficacy|1|||
131810527|NCT01615198|474588080|FG001|Overall Study|Lack of Efficacy|6|||
131810528|NCT01615198|474588079|FG000|Overall Study|Adverse Event|11|||
131810529|NCT01615198|474588080|FG001|Overall Study|Adverse Event|5|||
131810530|NCT02739997|474588081|FG000|Overall Study|Death|1|||
131810531|NCT02739997|474588081|FG000|Overall Study|Withdrawal by Subject|1|||
131810532|NCT02196675|474588082|FG000|Overall Study|Withdrawal by Subject|1|||
131810533|NCT02196675|474588083|FG001|Overall Study|Withdrawal by Subject|0|||
131810534|NCT02196675|474588084|FG002|Overall Study|Withdrawal by Subject|0|||
131810535|NCT02196675|474588082|FG000|Overall Study|Intra-operative surgical exclusion|1|||
131810536|NCT02196675|474588083|FG001|Overall Study|Intra-operative surgical exclusion|1|||
131810537|NCT02196675|474588084|FG002|Overall Study|Intra-operative surgical exclusion|0|||
131810538|NCT02196675|474588082|FG000|Overall Study|Protocol Violation|0|||
131810539|NCT02196675|474588083|FG001|Overall Study|Protocol Violation|1|||
131810540|NCT02196675|474588084|FG002|Overall Study|Protocol Violation|0|||
131810541|NCT02196675|474588082|FG000|Overall Study|Death|0|||
131810542|NCT02196675|474588083|FG001|Overall Study|Death|0|||
131810543|NCT02196675|474588084|FG002|Overall Study|Death|1|||
131810544|NCT03552393|474588087|FG000|Core Period|Kidney Transplant|1|||
131810545|NCT03552393|474588087|FG000|Core Period|Prohibited Medication|1|||
131810546|NCT03552393|474588087|FG000|Safety Extension Period|Kidney Transplant|4|||
131810547|NCT02414152|474588089|FG000|Overall Study|Withdrawal by Subject|1|||
131810548|NCT02414152|474588089|FG000|Overall Study|Lack of Efficacy|1|||
131810549|NCT02601625|474588090|FG000|Overall Study|Lost to Follow-up|0|||
131810550|NCT02601625|474588091|FG001|Overall Study|Lost to Follow-up|0|||
131810551|NCT02601625|474588092|FG002|Overall Study|Lost to Follow-up|1|||
131810552|NCT02601625|474588093|FG003|Overall Study|Lost to Follow-up|1|||
131810553|NCT00359281|474588094|FG000|Overall Study|Adverse Event|1|||
131810554|NCT00359281|474588095|FG001|Overall Study|Adverse Event|0|||
131810555|NCT00359281|474588096|FG002|Overall Study|Adverse Event|0|||
131810556|NCT00359281|474588097|FG003|Overall Study|Adverse Event|0|||
131810557|NCT00359281|474588098|FG004|Overall Study|Adverse Event|0|||
131810558|NCT00359281|474588099|FG005|Overall Study|Adverse Event|0|||
131810559|NCT00359281|474588100|FG006|Overall Study|Adverse Event|1|||
131810560|NCT00359281|474588101|FG007|Overall Study|Adverse Event|0|||
131810561|NCT00359281|474588102|FG008|Overall Study|Adverse Event|0|||
131810562|NCT00359281|474588094|FG000|Overall Study|Withdrawal by Subject|0|||
131810563|NCT00359281|474588095|FG001|Overall Study|Withdrawal by Subject|0|||
131810564|NCT00359281|474588096|FG002|Overall Study|Withdrawal by Subject|0|||
131810565|NCT00359281|474588097|FG003|Overall Study|Withdrawal by Subject|0|||
131810566|NCT00359281|474588098|FG004|Overall Study|Withdrawal by Subject|0|||
131810567|NCT00359281|474588099|FG005|Overall Study|Withdrawal by Subject|0|||
131810568|NCT00359281|474588100|FG006|Overall Study|Withdrawal by Subject|1|||
131810569|NCT00359281|474588101|FG007|Overall Study|Withdrawal by Subject|0|||
131810570|NCT00359281|474588102|FG008|Overall Study|Withdrawal by Subject|0|||
131810571|NCT01289262|474588106|FG000|Overall Study|Lost to Follow-up|29|||
131810572|NCT01289262|474588107|FG001|Overall Study|Lost to Follow-up|16|||
131810573|NCT01289262|474588106|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
131810574|NCT01289262|474588107|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
131810575|NCT04887415|474588108|FG000|Overall Study|Lost to Follow-up|2|||
131810576|NCT00838279|474588109|FG000|Washout|Protocol Violation|1|||
131810577|NCT00838279|474588110|FG001|Washout|Protocol Violation|0|||
131810578|NCT00838279|474588109|FG000|Washout|Withdrawal by Subject|0|||
131810579|NCT00838279|474588110|FG001|Washout|Withdrawal by Subject|1|||
131810580|NCT04608188|474588111|FG000|Overall Study|Withdrawal by Subject|4|||
131810581|NCT04608188|474588112|FG001|Overall Study|Withdrawal by Subject|8|||
131810582|NCT05604170|474589433|FG000|Overall Study|Lack of Efficacy|5|||
131810583|NCT05604170|474589433|FG000|Overall Study|Adverse Event|6|||
131398290|NCT01092780|473079191|FG001|Washout Period 1|Adverse Event|1|||
131810584|NCT05604170|474589433|FG000|Overall Study|Physician Decision|6|||
131810585|NCT05604170|474589433|FG000|Overall Study|Lost to Follow-up|6|||
131810586|NCT05604170|474589433|FG000|Overall Study|Withdrawal by Subject|11|||
131810587|NCT05604170|474589433|FG000|Overall Study|Early study termination by sponsor|77|||
131810588|NCT05604170|474589433|FG000|Overall Study|Other|6|||
131810589|NCT02869867|474589434|FG000|Overall Study|Protocol Violation|1|||
131810590|NCT02869867|474589435|FG001|Overall Study|Protocol Violation|0|||
131810591|NCT02869867|474589434|FG000|Overall Study|Lost to Follow-up|5|||
131398291|NCT01092780|473079192|FG002|Washout Period 1|Adverse Event|0|||
131810592|NCT02869867|474589435|FG001|Overall Study|Lost to Follow-up|5|||
131810593|NCT00272779|474589439|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
131810594|NCT00272779|474589440|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
131810595|NCT00272779|474589439|FG000|Baseline Through Week 48|Death before Week 48|4|||
131754053|NCT00044213|474376266|FG000|Overall Study|Withdrawal by Subject|50|||
131754054|NCT00044213|474376267|FG001|Overall Study|Withdrawal by Subject|65|||
131754055|NCT00044213|474376268|FG002|Overall Study|Withdrawal by Subject|91|||
131754056|NCT00044213|474376269|FG003|Overall Study|Withdrawal by Subject|83|||
131754057|NCT00044213|474376266|FG000|Overall Study|Death|42|||
131754058|NCT00044213|474376267|FG001|Overall Study|Death|42|||
131754059|NCT00044213|474376268|FG002|Overall Study|Death|42|||
131754060|NCT00044213|474376269|FG003|Overall Study|Death|49|||
131754061|NCT00044213|474376266|FG000|Overall Study|Lost to Follow-up|8|||
131754062|NCT00044213|474376267|FG001|Overall Study|Lost to Follow-up|5|||
131754063|NCT00044213|474376268|FG002|Overall Study|Lost to Follow-up|5|||
131754064|NCT00044213|474376269|FG003|Overall Study|Lost to Follow-up|4|||
131754065|NCT01927068|474376270|FG000|Overall Study|Death|37|||
131754066|NCT01927068|474376271|FG001|Overall Study|Death|3|||
131754067|NCT01927068|474376270|FG000|Overall Study|Withdrawal by Subject|50|||
131754068|NCT01927068|474376271|FG001|Overall Study|Withdrawal by Subject|3|||
131398292|NCT01092780|473079193|FG003|Washout Period 1|Adverse Event|0|||
131398293|NCT01092780|473079190|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
131398294|NCT01092780|473079191|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
131398295|NCT01092780|473079192|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
131754069|NCT01927068|474376270|FG000|Overall Study|Lost to Follow-up|10|||
131754070|NCT01927068|474376271|FG001|Overall Study|Lost to Follow-up|2|||
131754071|NCT01927068|474376270|FG000|Overall Study|Physician Decision|9|||
131754072|NCT01927068|474376271|FG001|Overall Study|Physician Decision|0|||
131398296|NCT01092780|473079193|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
131398297|NCT01092780|473079190|FG000|Washout Period 2|Adverse Event|0|||
131398298|NCT01092780|473079191|FG001|Washout Period 2|Adverse Event|1|||
131398299|NCT01092780|473079192|FG002|Washout Period 2|Adverse Event|1|||
131398300|NCT01092780|473079193|FG003|Washout Period 2|Adverse Event|0|||
131398301|NCT05411822|473079206|FG000|Overall Study|Withdrawal by Subject|2|||
131398302|NCT05411822|473079207|FG001|Overall Study|Withdrawal by Subject|1|||
131398303|NCT02027311|473079209|FG000|Overall Study|Protocol Violation|3|||
131398304|NCT02027311|473079210|FG001|Overall Study|Protocol Violation|2|||
131398305|NCT00851552|473079211|FG000|Overall Study|Death|2|||
131398306|NCT00851552|473079211|FG000|Overall Study|Adverse Event|1|||
131398307|NCT00851552|473079211|FG000|Overall Study|Disease Progression|4|||
131754073|NCT01927068|474376270|FG000|Overall Study|Missed last follow-up visit|2|||
131754074|NCT01927068|474376271|FG001|Overall Study|Missed last follow-up visit|0|||
131754075|NCT00880607|474376272|FG000|Overall Study|Physician Decision|2|||
131754076|NCT00880607|474376273|FG001|Overall Study|Physician Decision|2|||
131754077|NCT00880607|474376272|FG000|Overall Study|Protocol Violation|2|||
131754078|NCT00880607|474376273|FG001|Overall Study|Protocol Violation|1|||
131754079|NCT00880607|474376272|FG000|Overall Study|surgery did not extend past L1 level|3|||
131754080|NCT00880607|474376273|FG001|Overall Study|surgery did not extend past L1 level|0|||
131754081|NCT02963766|474376275|FG000|Double-Blind Period|Adverse Event|1|||
131754082|NCT02963766|474376276|FG001|Double-Blind Period|Adverse Event|0|||
131754083|NCT02963766|474376277|FG002|Double-Blind Period|Adverse Event|1|||
131754084|NCT02963766|474376275|FG000|Double-Blind Period|Physician Decision|1|||
131754085|NCT02963766|474376276|FG001|Double-Blind Period|Physician Decision|0|||
131754086|NCT02963766|474376277|FG002|Double-Blind Period|Physician Decision|0|||
131754087|NCT02963766|474376275|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131754088|NCT02963766|474376276|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131754089|NCT02963766|474376277|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131754090|NCT02963766|474376275|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
131810596|NCT00272779|474589440|FG001|Baseline Through Week 48|Death before Week 48|4|||
131810597|NCT00272779|474589439|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
131810598|NCT00272779|474589440|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
131810599|NCT00272779|474589439|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
131810600|NCT00272779|474589440|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
131810601|NCT00272779|474589439|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
131810602|NCT00272779|474589440|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
131810603|NCT00272779|474589439|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
131810604|NCT00272779|474589440|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
131810605|NCT00272779|474589439|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
131810606|NCT00272779|474589440|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
131810607|NCT00272779|474589439|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
131810608|NCT00272779|474589440|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
131810609|NCT00272779|474589439|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
131810610|NCT00272779|474589440|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
131810611|NCT00272779|474589439|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
131810612|NCT00272779|474589440|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
131810613|NCT00272779|474589439|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
131754091|NCT02963766|474376276|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
131754092|NCT02963766|474376277|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
131906923|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
131906924|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
131906925|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
131906926|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
131906927|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
131906928|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
131906929|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
131906930|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
131906931|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
131906932|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
131906933|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
131906934|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
131906935|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
131906936|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
131906937|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
131906938|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
131906939|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
131906940|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
131906941|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
131906942|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
131906943|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
131906944|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
131906945|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
131906946|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
131906947|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
131906948|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
131906949|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
131810614|NCT00272779|474589440|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
131810615|NCT00272779|474589439|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
131810616|NCT00272779|474589440|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
131810617|NCT00272779|474589439|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
131810618|NCT00272779|474589440|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
131810619|NCT00272779|474589439|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
131810620|NCT00272779|474589440|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
131810621|NCT00272779|474589439|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
131810622|NCT00272779|474589440|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
131810623|NCT00272779|474589439|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
131810624|NCT00272779|474589440|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
131810625|NCT00272779|474589439|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
131810626|NCT00272779|474589440|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
131810627|NCT00272779|474589439|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
131810628|NCT00272779|474589440|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
131810629|NCT00272779|474589439|FG000|Baseline Through Week 48|Continuing treatment|385|||
131906950|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
131906951|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
131906952|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
131906953|NCT02709746|474946639|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
131906954|NCT02709746|474946640|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
131906955|NCT02709746|474946641|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
131906956|NCT02709746|474946642|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
131906957|NCT02709746|474946643|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
131906958|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
131906959|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
131906960|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
131906961|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
131906962|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
131906963|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
131906964|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
131906965|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
131810630|NCT00272779|474589440|FG001|Baseline Through Week 48|Continuing treatment|368|||
131810631|NCT00272779|474589439|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
131810632|NCT00272779|474589440|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
131398308|NCT01270880|473079213|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
131398309|NCT00182078|473079214|FG000|Overall Study|Withdrawal by Subject|1|||
131398310|NCT00182078|473079215|FG001|Overall Study|Withdrawal by Subject|0|||
131398311|NCT01076205|473079217|FG000|Overall Study|Adverse Drug Reaction|299|||
131398312|NCT01076205|473079217|FG000|Overall Study|Lack of Effectiveness|1423|||
131398313|NCT01076205|473079217|FG000|Overall Study|Other Reason|1075|||
131398314|NCT01076205|473079217|FG000|Overall Study|Unknown Reason|71|||
131398315|NCT01076205|473079217|FG000|Overall Study|Lost to Follow-up|3151|||
131398316|NCT01606176|473079218|FG000|Overall Study|Adverse Event|2|||
131398317|NCT01606176|473079219|FG001|Overall Study|Adverse Event|3|||
131398318|NCT01606176|473079218|FG000|Overall Study|Disease progression|1|||
131398319|NCT01606176|473079219|FG001|Overall Study|Disease progression|0|||
131398320|NCT01606176|473079218|FG000|Overall Study|Withdrawal by Subject|1|||
131398321|NCT01606176|473079219|FG001|Overall Study|Withdrawal by Subject|0|||
131398322|NCT01832493|473079220|FG000|Overall Study|Physician Decision|2|||
131398323|NCT01832493|473079220|FG000|Overall Study|Protocol Violation|4|||
131398324|NCT01832493|473079220|FG000|Overall Study|Unable to place LV lead|2|||
131398325|NCT01732510|473079225|FG000|Overall Study|Adverse Event|0|||
131398326|NCT01732510|473079226|FG001|Overall Study|Adverse Event|1|||
131398327|NCT01732510|473079227|FG002|Overall Study|Adverse Event|1|||
131398328|NCT01732510|473079228|FG003|Overall Study|Adverse Event|0|||
131398329|NCT01732510|473079229|FG004|Overall Study|Adverse Event|0|||
131398330|NCT01732510|473079230|FG005|Overall Study|Adverse Event|0|||
131398331|NCT01732510|473079231|FG006|Overall Study|Adverse Event|1|||
131398332|NCT01732510|473079225|FG000|Overall Study|Protocol Violation|0|||
131398333|NCT01732510|473079226|FG001|Overall Study|Protocol Violation|0|||
131398334|NCT01732510|473079227|FG002|Overall Study|Protocol Violation|0|||
131398335|NCT01732510|473079228|FG003|Overall Study|Protocol Violation|1|||
131398336|NCT01732510|473079229|FG004|Overall Study|Protocol Violation|0|||
131398337|NCT01732510|473079230|FG005|Overall Study|Protocol Violation|0|||
131398338|NCT01732510|473079231|FG006|Overall Study|Protocol Violation|0|||
131398339|NCT01732510|473079225|FG000|Overall Study|Withdrawal by Subject|1|||
131398340|NCT01732510|473079226|FG001|Overall Study|Withdrawal by Subject|3|||
131398341|NCT01732510|473079227|FG002|Overall Study|Withdrawal by Subject|2|||
131398342|NCT01732510|473079228|FG003|Overall Study|Withdrawal by Subject|1|||
131398343|NCT01732510|473079229|FG004|Overall Study|Withdrawal by Subject|5|||
131398344|NCT01732510|473079230|FG005|Overall Study|Withdrawal by Subject|0|||
131398345|NCT01732510|473079231|FG006|Overall Study|Withdrawal by Subject|1|||
131398346|NCT01732510|473079225|FG000|Overall Study|Lost to Follow-up|0|||
131398347|NCT01732510|473079226|FG001|Overall Study|Lost to Follow-up|0|||
131398348|NCT01732510|473079227|FG002|Overall Study|Lost to Follow-up|1|||
131398349|NCT01732510|473079228|FG003|Overall Study|Lost to Follow-up|1|||
131398350|NCT01732510|473079229|FG004|Overall Study|Lost to Follow-up|0|||
131398351|NCT01732510|473079230|FG005|Overall Study|Lost to Follow-up|1|||
131398352|NCT01732510|473079231|FG006|Overall Study|Lost to Follow-up|0|||
131398353|NCT01732510|473079225|FG000|Overall Study|Physician Decision|0|||
131398354|NCT01732510|473079226|FG001|Overall Study|Physician Decision|1|||
131398355|NCT01732510|473079227|FG002|Overall Study|Physician Decision|0|||
131398356|NCT01732510|473079228|FG003|Overall Study|Physician Decision|0|||
131398357|NCT01732510|473079229|FG004|Overall Study|Physician Decision|0|||
131398358|NCT01732510|473079230|FG005|Overall Study|Physician Decision|0|||
131398359|NCT01732510|473079231|FG006|Overall Study|Physician Decision|0|||
131398360|NCT01732510|473079225|FG000|Overall Study|Pregnancy|0|||
131398361|NCT01732510|473079226|FG001|Overall Study|Pregnancy|0|||
131398362|NCT01732510|473079227|FG002|Overall Study|Pregnancy|0|||
131398363|NCT01732510|473079228|FG003|Overall Study|Pregnancy|1|||
131398364|NCT01732510|473079229|FG004|Overall Study|Pregnancy|0|||
131398365|NCT01732510|473079230|FG005|Overall Study|Pregnancy|0|||
131398366|NCT01732510|473079231|FG006|Overall Study|Pregnancy|0|||
131398367|NCT01732510|473079225|FG000|Overall Study|Study Terminated By Sponsor|0|||
131398368|NCT01732510|473079226|FG001|Overall Study|Study Terminated By Sponsor|0|||
131398369|NCT01732510|473079227|FG002|Overall Study|Study Terminated By Sponsor|0|||
131398370|NCT01732510|473079228|FG003|Overall Study|Study Terminated By Sponsor|1|||
131398371|NCT01732510|473079229|FG004|Overall Study|Study Terminated By Sponsor|0|||
131398372|NCT01732510|473079230|FG005|Overall Study|Study Terminated By Sponsor|12|||
131398373|NCT01732510|473079231|FG006|Overall Study|Study Terminated By Sponsor|6|||
131398374|NCT01262560|473079243|FG000|Overall Study|Protocol Violation|0|||
131398375|NCT01262560|473079244|FG001|Overall Study|Protocol Violation|1|||
131398376|NCT01262560|473079245|FG002|Overall Study|Protocol Violation|2|||
131398377|NCT03213938|473079246|FG000|Overall Study|Lost to Follow-up|4|||
131398378|NCT03213938|473079247|FG001|Overall Study|Lost to Follow-up|3|||
131398379|NCT03213938|473079246|FG000|Overall Study|Lack of Efficacy|1|||
131398380|NCT03213938|473079247|FG001|Overall Study|Lack of Efficacy|0|||
131398381|NCT03213938|473079246|FG000|Overall Study|Decline to participate|5|||
131398382|NCT03213938|473079247|FG001|Overall Study|Decline to participate|4|||
131398383|NCT03213938|473079246|FG000|Overall Study|Without reason|4|||
131398384|NCT03213938|473079247|FG001|Overall Study|Without reason|5|||
131398385|NCT04238481|473079250|FG000|Overall Study|Miscellaneous|0|||
131398386|NCT04238481|473079251|FG001|Overall Study|Miscellaneous|1|||
131398387|NCT04238481|473079252|FG002|Overall Study|Miscellaneous|0|||
131398388|NCT04238481|473079253|FG003|Overall Study|Miscellaneous|0|||
131398389|NCT01932372|473079254|FG000|Overall Study|Not meeting eligibility criteria|33|||
131398390|NCT01932372|473079255|FG001|Overall Study|Not meeting eligibility criteria|179|||
131398391|NCT00673231|473079256|FG000|Overall Study|Withdrawal by Subject|14|||
131398392|NCT00673231|473079257|FG001|Overall Study|Withdrawal by Subject|10|||
131398393|NCT00673231|473079258|FG002|Overall Study|Withdrawal by Subject|8|||
131398394|NCT00673231|473079259|FG003|Overall Study|Withdrawal by Subject|6|||
131398395|NCT00673231|473079256|FG000|Overall Study|Adverse Event|6|||
131754093|NCT02963766|474376275|FG000|Double-Blind Period|Protocol Violation|1|||
131754094|NCT02963766|474376276|FG001|Double-Blind Period|Protocol Violation|0|||
131754095|NCT02963766|474376277|FG002|Double-Blind Period|Protocol Violation|0|||
131754096|NCT02963766|474376275|FG000|Double-Blind Period|Lost to Follow-up|0|||
131754097|NCT02963766|474376276|FG001|Double-Blind Period|Lost to Follow-up|1|||
131754098|NCT02963766|474376277|FG002|Double-Blind Period|Lost to Follow-up|0|||
131754099|NCT02963766|474376275|FG000|Open Label Extension (OLE)|Physician Decision|1|||
131754100|NCT02963766|474376276|FG001|Open Label Extension (OLE)|Physician Decision|2|||
131754101|NCT02963766|474376277|FG002|Open Label Extension (OLE)|Physician Decision|2|||
131398396|NCT00673231|473079257|FG001|Overall Study|Adverse Event|5|||
131398397|NCT00673231|473079258|FG002|Overall Study|Adverse Event|9|||
131398398|NCT00673231|473079259|FG003|Overall Study|Adverse Event|6|||
131398399|NCT00673231|473079256|FG000|Overall Study|Lost to Follow-up|1|||
131398400|NCT00673231|473079257|FG001|Overall Study|Lost to Follow-up|2|||
131398401|NCT00673231|473079258|FG002|Overall Study|Lost to Follow-up|1|||
131398402|NCT00673231|473079259|FG003|Overall Study|Lost to Follow-up|2|||
131398403|NCT00673231|473079256|FG000|Overall Study|Death|0|||
131398404|NCT00673231|473079257|FG001|Overall Study|Death|0|||
131398405|NCT00673231|473079258|FG002|Overall Study|Death|1|||
131398406|NCT00673231|473079259|FG003|Overall Study|Death|0|||
131398407|NCT00673231|473079256|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
131754102|NCT02963766|474376275|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
131754103|NCT02963766|474376276|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
131754104|NCT02963766|474376277|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
131754105|NCT04315298|474378096|FG000|Overall Study|Withdrawal by Subject|0|||
131754106|NCT04315298|474378097|FG001|Overall Study|Withdrawal by Subject|0|||
131754107|NCT04315298|474378098|FG002|Overall Study|Withdrawal by Subject|0|||
131754108|NCT04315298|474378099|FG003|Overall Study|Withdrawal by Subject|2|||
131754109|NCT04315298|474378100|FG004|Overall Study|Withdrawal by Subject|2|||
131754110|NCT04315298|474378101|FG005|Overall Study|Withdrawal by Subject|2|||
131754111|NCT04315298|474378102|FG006|Overall Study|Withdrawal by Subject|0|||
131754112|NCT04315298|474378103|FG007|Overall Study|Withdrawal by Subject|1|||
131754113|NCT04315298|474378104|FG008|Overall Study|Withdrawal by Subject|1|||
131398408|NCT00673231|473079257|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
131398409|NCT00673231|473079258|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
131398410|NCT00673231|473079259|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
131398411|NCT03594747|473079260|FG000|Overall Study|Death|78|||
131398412|NCT03594747|473079261|FG001|Overall Study|Death|86|||
131398413|NCT03594747|473079262|FG002|Overall Study|Death|87|||
131398414|NCT03594747|473079260|FG000|Overall Study|Withdrawal by Subject|5|||
131398415|NCT03594747|473079261|FG001|Overall Study|Withdrawal by Subject|2|||
131398416|NCT03594747|473079262|FG002|Overall Study|Withdrawal by Subject|11|||
131398417|NCT03594747|473079260|FG000|Overall Study|Lost to Follow-up|4|||
131398418|NCT03594747|473079261|FG001|Overall Study|Lost to Follow-up|1|||
131398419|NCT03594747|473079262|FG002|Overall Study|Lost to Follow-up|1|||
131398420|NCT03594747|473079260|FG000|Overall Study|Physician Decision|0|||
131398421|NCT03594747|473079261|FG001|Overall Study|Physician Decision|1|||
131398422|NCT03594747|473079262|FG002|Overall Study|Physician Decision|0|||
131398423|NCT03594747|473079260|FG000|Overall Study|Sponsor decision|23|||
131398424|NCT03594747|473079261|FG001|Overall Study|Sponsor decision|17|||
131398425|NCT03594747|473079262|FG002|Overall Study|Sponsor decision|16|||
131398426|NCT03594747|473079260|FG000|Overall Study|Did not meet inclusion criteria|0|||
131398427|NCT03594747|473079261|FG001|Overall Study|Did not meet inclusion criteria|0|||
131398428|NCT03594747|473079262|FG002|Overall Study|Did not meet inclusion criteria|1|||
131754114|NCT04315298|474378105|FG009|Overall Study|Withdrawal by Subject|1|||
131754115|NCT04315298|474378106|FG010|Overall Study|Withdrawal by Subject|0|||
131754116|NCT04315298|474378107|FG011|Overall Study|Withdrawal by Subject|0|||
131754117|NCT04315298|474378108|FG012|Overall Study|Withdrawal by Subject|0|||
131754118|NCT04315298|474378109|FG013|Overall Study|Withdrawal by Subject|0|||
131398429|NCT03594747|473079260|FG000|Overall Study|Transfer to long term extension study|10|||
131398430|NCT03594747|473079261|FG001|Overall Study|Transfer to long term extension study|12|||
131754119|NCT04315298|474378110|FG014|Overall Study|Withdrawal by Subject|0|||
131398431|NCT03594747|473079262|FG002|Overall Study|Transfer to long term extension study|5|||
131398432|NCT02907216|473079263|FG000|Overall Study|No benefit to be obtained by continuing|0|||
131754120|NCT04315298|474378111|FG015|Overall Study|Withdrawal by Subject|0|||
131754121|NCT04315298|474378112|FG016|Overall Study|Withdrawal by Subject|0|||
131398433|NCT02907216|473079264|FG001|Overall Study|No benefit to be obtained by continuing|1|||
131449681|NCT04922216|473274985|FG028|Overall Study|Withdrawal by Subject|0|||
131449682|NCT04922216|473274986|FG029|Overall Study|Withdrawal by Subject|0|||
131449683|NCT04922216|473274987|FG030|Overall Study|Withdrawal by Subject|1|||
131449684|NCT04922216|473274988|FG031|Overall Study|Withdrawal by Subject|0|||
131449685|NCT04922216|473274957|FG000|Overall Study|Lost to Follow-up|1|||
131449686|NCT04922216|473274958|FG001|Overall Study|Lost to Follow-up|0|||
131449687|NCT04922216|473274959|FG002|Overall Study|Lost to Follow-up|2|||
131449688|NCT04922216|473274960|FG003|Overall Study|Lost to Follow-up|0|||
131449689|NCT04922216|473274961|FG004|Overall Study|Lost to Follow-up|0|||
131449690|NCT04922216|473274962|FG005|Overall Study|Lost to Follow-up|2|||
131754122|NCT04315298|474378113|FG017|Overall Study|Withdrawal by Subject|0|||
131754123|NCT04315298|474378114|FG018|Overall Study|Withdrawal by Subject|0|||
131754124|NCT04315298|474378096|FG000|Overall Study|Physician Decision|0|||
131754125|NCT04315298|474378097|FG001|Overall Study|Physician Decision|0|||
131754126|NCT04315298|474378098|FG002|Overall Study|Physician Decision|0|||
131754127|NCT04315298|474378099|FG003|Overall Study|Physician Decision|0|||
131754128|NCT04315298|474378100|FG004|Overall Study|Physician Decision|1|||
131754129|NCT04315298|474378101|FG005|Overall Study|Physician Decision|0|||
131754130|NCT04315298|474378102|FG006|Overall Study|Physician Decision|0|||
131754131|NCT04315298|474378103|FG007|Overall Study|Physician Decision|0|||
131754132|NCT04315298|474378104|FG008|Overall Study|Physician Decision|0|||
131754133|NCT04315298|474378105|FG009|Overall Study|Physician Decision|0|||
131754134|NCT04315298|474378106|FG010|Overall Study|Physician Decision|0|||
131754135|NCT04315298|474378107|FG011|Overall Study|Physician Decision|0|||
131754136|NCT04315298|474378108|FG012|Overall Study|Physician Decision|0|||
131754137|NCT04315298|474378109|FG013|Overall Study|Physician Decision|0|||
131754138|NCT04315298|474378110|FG014|Overall Study|Physician Decision|0|||
131754139|NCT04315298|474378111|FG015|Overall Study|Physician Decision|0|||
131754140|NCT04315298|474378112|FG016|Overall Study|Physician Decision|0|||
131754141|NCT04315298|474378113|FG017|Overall Study|Physician Decision|0|||
131754142|NCT04315298|474378114|FG018|Overall Study|Physician Decision|0|||
131754143|NCT04315298|474378096|FG000|Overall Study|Lost to Follow-up|5|||
131754144|NCT04315298|474378097|FG001|Overall Study|Lost to Follow-up|10|||
131754145|NCT04315298|474378098|FG002|Overall Study|Lost to Follow-up|6|||
131754146|NCT04315298|474378099|FG003|Overall Study|Lost to Follow-up|8|||
131754147|NCT04315298|474378100|FG004|Overall Study|Lost to Follow-up|12|||
131754148|NCT04315298|474378101|FG005|Overall Study|Lost to Follow-up|13|||
131754149|NCT04315298|474378102|FG006|Overall Study|Lost to Follow-up|9|||
131754150|NCT04315298|474378103|FG007|Overall Study|Lost to Follow-up|16|||
131754151|NCT04315298|474378104|FG008|Overall Study|Lost to Follow-up|14|||
131754152|NCT04315298|474378105|FG009|Overall Study|Lost to Follow-up|0|||
131754153|NCT04315298|474378106|FG010|Overall Study|Lost to Follow-up|2|||
131754154|NCT04315298|474378107|FG011|Overall Study|Lost to Follow-up|1|||
131754155|NCT04315298|474378108|FG012|Overall Study|Lost to Follow-up|0|||
131754156|NCT04315298|474378109|FG013|Overall Study|Lost to Follow-up|0|||
131754157|NCT04315298|474378110|FG014|Overall Study|Lost to Follow-up|0|||
131754158|NCT04315298|474378111|FG015|Overall Study|Lost to Follow-up|2|||
131754159|NCT04315298|474378112|FG016|Overall Study|Lost to Follow-up|0|||
131754160|NCT04315298|474378113|FG017|Overall Study|Lost to Follow-up|0|||
131754161|NCT04315298|474378114|FG018|Overall Study|Lost to Follow-up|0|||
131754162|NCT04315298|474378096|FG000|Overall Study|Death|24|||
131754163|NCT04315298|474378097|FG001|Overall Study|Death|60|||
131754164|NCT04315298|474378098|FG002|Overall Study|Death|49|||
131754165|NCT04315298|474378099|FG003|Overall Study|Death|59|||
131754166|NCT04315298|474378100|FG004|Overall Study|Death|70|||
131754167|NCT04315298|474378101|FG005|Overall Study|Death|114|||
131754168|NCT04315298|474378102|FG006|Overall Study|Death|9|||
131754169|NCT04315298|474378103|FG007|Overall Study|Death|12|||
131754170|NCT04315298|474378104|FG008|Overall Study|Death|21|||
131754171|NCT04315298|474378105|FG009|Overall Study|Death|16|||
131754172|NCT04315298|474378106|FG010|Overall Study|Death|40|||
131754173|NCT04315298|474378107|FG011|Overall Study|Death|40|||
131754174|NCT04315298|474378108|FG012|Overall Study|Death|3|||
131754175|NCT04315298|474378109|FG013|Overall Study|Death|4|||
131754176|NCT04315298|474378110|FG014|Overall Study|Death|6|||
131754177|NCT04315298|474378111|FG015|Overall Study|Death|4|||
131449691|NCT04922216|473274963|FG006|Overall Study|Lost to Follow-up|0|||
131449692|NCT04922216|473274964|FG007|Overall Study|Lost to Follow-up|1|||
131449693|NCT04922216|473274965|FG008|Overall Study|Lost to Follow-up|1|||
131754178|NCT04315298|474378112|FG016|Overall Study|Death|3|||
131754179|NCT04315298|474378113|FG017|Overall Study|Death|1|||
131754180|NCT04315298|474378114|FG018|Overall Study|Death|0|||
131754181|NCT00736385|474378115|FG000|Overall Study|Withdrawal by Subject|2|||
131754182|NCT00736385|474378116|FG001|Overall Study|Withdrawal by Subject|2|||
131754183|NCT00736385|474378115|FG000|Overall Study|Adverse Event|0|||
131754184|NCT00736385|474378116|FG001|Overall Study|Adverse Event|1|||
131754185|NCT01183104|474378117|FG000|Overall Study|Adverse Event|8|||
131754186|NCT01183104|474378118|FG001|Overall Study|Adverse Event|6|||
131754187|NCT01183104|474378117|FG000|Overall Study|Death|0|||
131754188|NCT01183104|474378118|FG001|Overall Study|Death|1|||
131754189|NCT01183104|474378117|FG000|Overall Study|Lost to Follow-up|14|||
131754190|NCT01183104|474378118|FG001|Overall Study|Lost to Follow-up|7|||
131810633|NCT00272779|474589439|FG000|Baseline Through Week 48|Never treated|2|||
131810634|NCT00272779|474589440|FG001|Baseline Through Week 48|Never treated|3|||
131810635|NCT00272779|474589439|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
131810636|NCT00272779|474589440|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
131810637|NCT00272779|474589439|FG000|Baseline Through Week 96|Death before Week 96|6|||
131810638|NCT00272779|474589440|FG001|Baseline Through Week 96|Death before Week 96|5|||
131810639|NCT00272779|474589439|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
131810640|NCT00272779|474589440|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
131810641|NCT00272779|474589439|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
131810642|NCT00272779|474589440|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
131810643|NCT00272779|474589439|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
131810644|NCT00272779|474589440|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
131810645|NCT00272779|474589439|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
131810646|NCT00272779|474589440|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
131810647|NCT00272779|474589439|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
131810648|NCT00272779|474589440|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
131810649|NCT00272779|474589439|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
131810650|NCT00272779|474589440|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
131810651|NCT00272779|474589439|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
131398434|NCT02907216|473079263|FG000|Overall Study|Withdrawal by Subject|1|||
131398435|NCT02907216|473079264|FG001|Overall Study|Withdrawal by Subject|0|||
131398436|NCT02241733|473079265|FG000|Overall Study|Lost to Follow-up|9|||
131398437|NCT02241733|473079266|FG001|Overall Study|Lost to Follow-up|4|||
131398438|NCT02241733|473079265|FG000|Overall Study|Physician Decision|6|||
131398439|NCT02241733|473079266|FG001|Overall Study|Physician Decision|2|||
131398440|NCT02241733|473079265|FG000|Overall Study|Withdrawal by Subject|0|||
131398441|NCT02241733|473079266|FG001|Overall Study|Withdrawal by Subject|2|||
131398442|NCT02241733|473079265|FG000|Overall Study|Death|0|||
131398443|NCT02241733|473079266|FG001|Overall Study|Death|2|||
131398444|NCT02095873|473079273|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
131398445|NCT02095873|473079274|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131398446|NCT02095873|473079273|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
131398447|NCT02095873|473079274|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
131398448|NCT02095873|473079273|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
131398449|NCT02095873|473079274|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
131398450|NCT00792740|473079276|FG000|Overall Study|Disease Worsening|3|||
131398451|NCT00792740|473079277|FG001|Overall Study|Disease Worsening|2|||
131398452|NCT00792740|473079276|FG000|Overall Study|Personal Reason|1|||
131398453|NCT00792740|473079277|FG001|Overall Study|Personal Reason|0|||
131398454|NCT00792740|473079276|FG000|Overall Study|Adverse Event|1|||
131398455|NCT00792740|473079277|FG001|Overall Study|Adverse Event|3|||
131398456|NCT00792740|473079276|FG000|Overall Study|Patient's withdrawal of consent|0|||
131398457|NCT00792740|473079277|FG001|Overall Study|Patient's withdrawal of consent|1|||
131398458|NCT00792740|473079276|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
131398459|NCT00792740|473079277|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
131398460|NCT00792740|473079276|FG000|Overall Study|Other reasons|0|||
131398461|NCT00792740|473079277|FG001|Overall Study|Other reasons|1|||
131398462|NCT00703846|473079278|FG000|Overall Study|Adverse Event|8|||
131398463|NCT00703846|473079278|FG000|Overall Study|Lost to Follow-up|55|||
131398464|NCT00703846|473079278|FG000|Overall Study|Lack of Efficacy|15|||
131398465|NCT00703846|473079278|FG000|Overall Study|Noncompliance with Study Treatment|2|||
131398466|NCT00703846|473079278|FG000|Overall Study|Withdrawal by Subject|40|||
131398467|NCT00703846|473079278|FG000|Overall Study|Death|1|||
131398468|NCT00703846|473079278|FG000|Overall Study|Other|14|||
131754191|NCT01183104|474378117|FG000|Overall Study|Physician Decision|5|||
131754192|NCT01183104|474378118|FG001|Overall Study|Physician Decision|8|||
131754193|NCT01183104|474378117|FG000|Overall Study|Withdrawal by Subject|6|||
131754194|NCT01183104|474378118|FG001|Overall Study|Withdrawal by Subject|11|||
131754195|NCT01183104|474378117|FG000|Overall Study|Nonparticipation in Extension Study|39|||
131754196|NCT01183104|474378118|FG001|Overall Study|Nonparticipation in Extension Study|50|||
131754197|NCT01183104|474378117|FG000|Overall Study|Did not receive study drug|5|||
131754198|NCT01183104|474378118|FG001|Overall Study|Did not receive study drug|9|||
131754199|NCT03267511|474378119|FG000|Overall Study|Lost to Follow-up|0|||
131754200|NCT03267511|474378120|FG001|Overall Study|Lost to Follow-up|0|||
131754201|NCT03267511|474378121|FG002|Overall Study|Lost to Follow-up|0|||
131754202|NCT03267511|474378122|FG003|Overall Study|Lost to Follow-up|1|||
131754203|NCT01594749|474378123|FG000|Overall Study|Adverse Event|2|||
131754204|NCT01594749|474378124|FG001|Overall Study|Adverse Event|1|||
131754205|NCT01594749|474378123|FG000|Overall Study|Withdrawal by Subject|2|||
131754206|NCT01594749|474378124|FG001|Overall Study|Withdrawal by Subject|2|||
131754207|NCT01594749|474378123|FG000|Overall Study|Protocol Violation|2|||
131754208|NCT01594749|474378124|FG001|Overall Study|Protocol Violation|0|||
131754209|NCT01594749|474378123|FG000|Overall Study|Physician Decision|1|||
131449694|NCT04922216|473274966|FG009|Overall Study|Lost to Follow-up|2|||
131449695|NCT04922216|473274967|FG010|Overall Study|Lost to Follow-up|2|||
131449696|NCT04922216|473274968|FG011|Overall Study|Lost to Follow-up|1|||
131449697|NCT04922216|473274969|FG012|Overall Study|Lost to Follow-up|1|||
131449698|NCT04922216|473274970|FG013|Overall Study|Lost to Follow-up|0|||
131449699|NCT04922216|473274971|FG014|Overall Study|Lost to Follow-up|1|||
131449700|NCT04922216|473274972|FG015|Overall Study|Lost to Follow-up|0|||
131449701|NCT04922216|473274973|FG016|Overall Study|Lost to Follow-up|0|||
131449702|NCT04922216|473274974|FG017|Overall Study|Lost to Follow-up|2|||
131449703|NCT04922216|473274975|FG018|Overall Study|Lost to Follow-up|1|||
131449704|NCT04922216|473274976|FG019|Overall Study|Lost to Follow-up|0|||
131449705|NCT04922216|473274977|FG020|Overall Study|Lost to Follow-up|1|||
131449706|NCT04922216|473274978|FG021|Overall Study|Lost to Follow-up|0|||
131449707|NCT04922216|473274979|FG022|Overall Study|Lost to Follow-up|2|||
131449708|NCT04922216|473274980|FG023|Overall Study|Lost to Follow-up|1|||
131449709|NCT04922216|473274981|FG024|Overall Study|Lost to Follow-up|0|||
131449710|NCT04922216|473274982|FG025|Overall Study|Lost to Follow-up|2|||
131449711|NCT04922216|473274983|FG026|Overall Study|Lost to Follow-up|0|||
131449712|NCT04922216|473274984|FG027|Overall Study|Lost to Follow-up|0|||
131449713|NCT04922216|473274985|FG028|Overall Study|Lost to Follow-up|1|||
131449714|NCT04922216|473274986|FG029|Overall Study|Lost to Follow-up|0|||
131449715|NCT04922216|473274987|FG030|Overall Study|Lost to Follow-up|2|||
131449716|NCT04922216|473274988|FG031|Overall Study|Lost to Follow-up|1|||
131449717|NCT04801420|473274989|FG000|Overall Study|Other|1|||
131449718|NCT04801420|473274990|FG001|Overall Study|Other|2|||
131449719|NCT04801420|473274991|FG002|Overall Study|Other|1|||
131449720|NCT04801420|473274989|FG000|Overall Study|Lost to Follow-up|7|||
131449721|NCT04801420|473274990|FG001|Overall Study|Lost to Follow-up|9|||
131449722|NCT04801420|473274991|FG002|Overall Study|Lost to Follow-up|10|||
131449723|NCT04801420|473274989|FG000|Overall Study|Moved from study area|0|||
131449724|NCT04801420|473274990|FG001|Overall Study|Moved from study area|1|||
131449725|NCT04801420|473274991|FG002|Overall Study|Moved from study area|1|||
131449726|NCT04801420|473274989|FG000|Overall Study|Withdrawal by Subject|5|||
131449727|NCT04801420|473274990|FG001|Overall Study|Withdrawal by Subject|1|||
131449728|NCT04801420|473274991|FG002|Overall Study|Withdrawal by Subject|4|||
131449729|NCT04801420|473274989|FG000|Overall Study|Individual stopping criteria reached|0|||
131449730|NCT04801420|473274990|FG001|Overall Study|Individual stopping criteria reached|1|||
131449731|NCT04801420|473274991|FG002|Overall Study|Individual stopping criteria reached|0|||
131449732|NCT04801420|473274989|FG000|Overall Study|Ongoing in the study|195|||
131449733|NCT04801420|473274990|FG001|Overall Study|Ongoing in the study|195|||
131449734|NCT04801420|473274991|FG002|Overall Study|Ongoing in the study|192|||
131449735|NCT04774094|473274992|FG000|Overall Study|Other|2|||
131449736|NCT04774094|473274992|FG000|Overall Study|Withdrawal by Subject|9|||
131449737|NCT04774094|473274992|FG000|Overall Study|Lost to Follow-up|7|||
131449738|NCT04774094|473274992|FG000|Overall Study|Lack of Efficacy|5|||
131449739|NCT04774094|473274992|FG000|Overall Study|Death|17|||
131449740|NCT04774094|473274992|FG000|Overall Study|Adverse Event|4|||
131449741|NCT03584789|473276689|FG000|Overall Study|refused EHR permission|19|||
131449742|NCT03584789|473276690|FG001|Overall Study|refused EHR permission|28|||
131449743|NCT03584789|473276691|FG002|Overall Study|refused EHR permission|23|||
131449744|NCT03584789|473276689|FG000|Overall Study|patients tied to a provider who retired|0|||
131449745|NCT03584789|473276690|FG001|Overall Study|patients tied to a provider who retired|0|||
131449746|NCT03584789|473276691|FG002|Overall Study|patients tied to a provider who retired|3|||
131449747|NCT02035267|473276692|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
131449748|NCT02035267|473276693|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
131449749|NCT02035267|473276694|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
131449750|NCT02035267|473276695|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
131449751|NCT02035267|473276692|FG000|Overall Study|Adverse Event|0|||
131449752|NCT02035267|473276693|FG001|Overall Study|Adverse Event|0|||
131449753|NCT02035267|473276694|FG002|Overall Study|Adverse Event|1|||
131449754|NCT02035267|473276695|FG003|Overall Study|Adverse Event|0|||
131449755|NCT02035267|473276692|FG000|Overall Study|Lost to Follow-up|0|||
131449756|NCT02035267|473276693|FG001|Overall Study|Lost to Follow-up|0|||
131810652|NCT00272779|474589440|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
131449757|NCT02035267|473276694|FG002|Overall Study|Lost to Follow-up|0|||
131449758|NCT02035267|473276695|FG003|Overall Study|Lost to Follow-up|1|||
131449759|NCT02035267|473276692|FG000|Overall Study|Other unspecified|0|||
131449760|NCT02035267|473276693|FG001|Overall Study|Other unspecified|1|||
131449761|NCT02035267|473276694|FG002|Overall Study|Other unspecified|0|||
131449762|NCT02035267|473276695|FG003|Overall Study|Other unspecified|0|||
131449763|NCT00823615|473276704|FG000|Period 2|Lost to Follow-up|2|||
131449764|NCT00823615|473276705|FG001|Period 2|Lost to Follow-up|0|||
131449765|NCT00823615|473276704|FG000|Period 2|Time/Job Conflict|1|||
131810653|NCT00272779|474589439|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
131449766|NCT00823615|473276705|FG001|Period 2|Time/Job Conflict|2|||
131449767|NCT00098813|473276706|FG000|Overall Study|Death|8|||
131449768|NCT00098813|473276706|FG000|Overall Study|Protocol Violation|1|||
131810654|NCT00272779|474589440|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
131754210|NCT01594749|474378124|FG001|Overall Study|Physician Decision|1|||
131754211|NCT01594749|474378123|FG000|Overall Study|Non-compliance with Protocol|0|||
131754212|NCT01594749|474378124|FG001|Overall Study|Non-compliance with Protocol|1|||
131754213|NCT01594749|474378123|FG000|Overall Study|Lost to Follow-up|1|||
131754214|NCT01594749|474378124|FG001|Overall Study|Lost to Follow-up|0|||
131754215|NCT01594749|474378123|FG000|Overall Study|Death|9|||
131754216|NCT01594749|474378124|FG001|Overall Study|Death|3|||
131754217|NCT01594749|474378123|FG000|Overall Study|Not Treated|4|||
131754218|NCT01594749|474378124|FG001|Overall Study|Not Treated|10|||
131754219|NCT01594749|474378123|FG000|Overall Study|Lost Source Documentation|1|||
131754220|NCT01594749|474378124|FG001|Overall Study|Lost Source Documentation|0|||
131754221|NCT00364351|474378125|FG000|Overall Study|Adverse Event|90|||
131754222|NCT00364351|474378126|FG001|Overall Study|Adverse Event|44|||
131754223|NCT00364351|474378125|FG000|Overall Study|Condition under investigation worsened|469|||
131754224|NCT00364351|474378126|FG001|Overall Study|Condition under investigation worsened|497|||
131754225|NCT00364351|474378125|FG000|Overall Study|Prohibited concomitant medication|0|||
131810655|NCT00272779|474589439|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
131810656|NCT00272779|474589440|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
131810657|NCT00272779|474589439|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
131810658|NCT00272779|474589440|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
131810659|NCT00272779|474589439|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
131810660|NCT00272779|474589440|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
131810661|NCT00272779|474589439|FG000|Baseline Through Week 96|Never treated|2|||
131810662|NCT00272779|474589440|FG001|Baseline Through Week 96|Never treated|3|||
131810663|NCT00272779|474589439|FG000|Baseline Through Week 96|Continuing on treatment|61|||
131810664|NCT00272779|474589440|FG001|Baseline Through Week 96|Continuing on treatment|38|||
131810665|NCT00440518|474589441|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
131810666|NCT00440518|474589442|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
131810667|NCT00440518|474589443|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
131810668|NCT00440518|474589441|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
131810669|NCT00440518|474589442|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
131810670|NCT00440518|474589443|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
131810671|NCT00440518|474589441|FG000|Randomized /Titration Period|Protocol Deviation|1|||
131810672|NCT00440518|474589442|FG001|Randomized /Titration Period|Protocol Deviation|0|||
131810673|NCT00440518|474589443|FG002|Randomized /Titration Period|Protocol Deviation|0|||
131810674|NCT00440518|474589441|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
131810675|NCT00440518|474589442|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
131810676|NCT00440518|474589443|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
131810677|NCT00440518|474589441|FG000|Randomized /Titration Period|Other|1|||
131810678|NCT00440518|474589442|FG001|Randomized /Titration Period|Other|0|||
131810679|NCT00440518|474589443|FG002|Randomized /Titration Period|Other|0|||
131810680|NCT00440518|474589441|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
131810681|NCT00440518|474589442|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
131810682|NCT00440518|474589443|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
131810683|NCT00440518|474589441|FG000|Randomized /Titration Period|Adverse Event|2|||
131810684|NCT00440518|474589442|FG001|Randomized /Titration Period|Adverse Event|3|||
131810685|NCT00440518|474589443|FG002|Randomized /Titration Period|Adverse Event|0|||
131810686|NCT00440518|474589441|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
131810687|NCT00440518|474589442|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
131810688|NCT00440518|474589443|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
131810689|NCT00440518|474589441|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
131754226|NCT00364351|474378126|FG001|Overall Study|Prohibited concomitant medication|2|||
131754227|NCT00364351|474378125|FG000|Overall Study|Lost to Follow-up|1|||
131754228|NCT00364351|474378126|FG001|Overall Study|Lost to Follow-up|1|||
131754229|NCT00364351|474378125|FG000|Overall Study|Withdrawal by Subject|30|||
131754230|NCT00364351|474378126|FG001|Overall Study|Withdrawal by Subject|29|||
131754231|NCT00364351|474378125|FG000|Overall Study|Incorrect enrollment|1|||
131810690|NCT00440518|474589442|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
131810691|NCT00440518|474589443|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
131810692|NCT00440518|474589441|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
131810693|NCT00440518|474589442|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
131810694|NCT00440518|474589443|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
131810695|NCT00440518|474589441|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
131810696|NCT00440518|474589442|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
131810697|NCT00440518|474589443|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
131810698|NCT00440518|474589441|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
131810699|NCT00440518|474589442|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
131810700|NCT00440518|474589443|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
131754232|NCT00364351|474378126|FG001|Overall Study|Incorrect enrollment|1|||
131754233|NCT00364351|474378125|FG000|Overall Study|Sponsor decision|1|||
131449769|NCT00098813|473276706|FG000|Overall Study|Withdrawal by Subject|7|||
131449770|NCT00098813|473276706|FG000|Overall Study|Progression of Disease|1|||
131449771|NCT00098813|473276706|FG000|Overall Study|Other complicating disease|1|||
131449772|NCT00098813|473276706|FG000|Overall Study|Reversal of RAI resistance|1|||
131449773|NCT02230670|473276709|FG000|Overall Study|Adverse Event|1|||
131449774|NCT02230670|473276710|FG001|Overall Study|Adverse Event|2|||
131449775|NCT02230670|473276709|FG000|Overall Study|Withdrawal by Subject|2|||
131449776|NCT02230670|473276710|FG001|Overall Study|Withdrawal by Subject|2|||
131449777|NCT02230670|473276709|FG000|Overall Study|Physician Decision|0|||
131449778|NCT02230670|473276710|FG001|Overall Study|Physician Decision|1|||
131449779|NCT02230670|473276709|FG000|Overall Study|Protocol Violation|0|||
131810701|NCT00440518|474589441|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
131810702|NCT00440518|474589442|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
131810703|NCT00440518|474589443|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
131810704|NCT00561015|474589444|FG000|Overall Study|Adverse Event|0|||
131810705|NCT00561015|474589445|FG001|Overall Study|Adverse Event|0|||
131810706|NCT00561015|474589446|FG002|Overall Study|Adverse Event|0|||
131810707|NCT00561015|474589447|FG003|Overall Study|Adverse Event|0|||
131810708|NCT00561015|474589448|FG004|Overall Study|Adverse Event|1|||
131810709|NCT00561015|474589449|FG005|Overall Study|Adverse Event|0|||
131810710|NCT00561015|474589444|FG000|Overall Study|Lost to Follow-up|2|||
131810711|NCT00561015|474589445|FG001|Overall Study|Lost to Follow-up|0|||
131810712|NCT00561015|474589446|FG002|Overall Study|Lost to Follow-up|0|||
131810713|NCT00561015|474589447|FG003|Overall Study|Lost to Follow-up|1|||
131810714|NCT00561015|474589448|FG004|Overall Study|Lost to Follow-up|0|||
131810715|NCT00561015|474589449|FG005|Overall Study|Lost to Follow-up|3|||
131810716|NCT00561015|474589444|FG000|Overall Study|Participant non-compliance|2|||
131810717|NCT00561015|474589445|FG001|Overall Study|Participant non-compliance|0|||
131810718|NCT00561015|474589446|FG002|Overall Study|Participant non-compliance|0|||
131810719|NCT00561015|474589447|FG003|Overall Study|Participant non-compliance|0|||
131810720|NCT00561015|474589448|FG004|Overall Study|Participant non-compliance|0|||
131810721|NCT00561015|474589449|FG005|Overall Study|Participant non-compliance|0|||
131810722|NCT02440711|474589450|FG000|Second Intervention|Lost to Follow-up|1|||
131810723|NCT02440711|474589451|FG001|Second Intervention|Lost to Follow-up|0|||
131810724|NCT02246920|474589458|FG000|Overall Study|Adverse Event|3|||
131810725|NCT02246920|474589459|FG001|Overall Study|Adverse Event|1|||
131810726|NCT02246920|474589460|FG002|Overall Study|Adverse Event|1|||
131810727|NCT02246920|474589458|FG000|Overall Study|Lost to Follow-up|2|||
131810728|NCT02246920|474589459|FG001|Overall Study|Lost to Follow-up|1|||
131810729|NCT02246920|474589460|FG002|Overall Study|Lost to Follow-up|0|||
131810730|NCT02246920|474589458|FG000|Overall Study|Protocol Violation|2|||
131810731|NCT02246920|474589459|FG001|Overall Study|Protocol Violation|5|||
131810732|NCT02246920|474589460|FG002|Overall Study|Protocol Violation|1|||
131810733|NCT02246920|474589458|FG000|Overall Study|Withdrawal by Subject|0|||
131810734|NCT02246920|474589459|FG001|Overall Study|Withdrawal by Subject|0|||
131810735|NCT02246920|474589460|FG002|Overall Study|Withdrawal by Subject|1|||
131810736|NCT01037114|474589461|FG000|Year 20|Others|1|||
131810737|NCT03620747|474589463|FG000|Overall Study|Participant decision|7|||
131810738|NCT03620747|474589463|FG000|Overall Study|Adverse Event|6|||
131810739|NCT03620747|474589463|FG000|Overall Study|Lack of Efficacy|1|||
131810740|NCT03620747|474589463|FG000|Overall Study|Poor compliance to protocol|2|||
131810741|NCT03620747|474589463|FG000|Overall Study|Other-unspecified|3|||
131810742|NCT03181594|474589466|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
131810743|NCT03181594|474589466|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
131810744|NCT03181594|474589466|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
131810745|NCT03181594|474589466|FG000|Initial Study Protocol (12-month FU)|Death|1|||
131810746|NCT03181594|474589466|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
131810747|NCT03181594|474589466|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
131449780|NCT02230670|473276710|FG001|Overall Study|Protocol Violation|1|||
131449781|NCT02230670|473276709|FG000|Overall Study|Progression to Child-Pugh C|1|||
131449782|NCT02230670|473276710|FG001|Overall Study|Progression to Child-Pugh C|2|||
131449783|NCT01750229|473276714|FG000|Randomized Crossover Phase|Adverse Event|1|||
131449784|NCT01750229|473276714|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
131754234|NCT00364351|474378126|FG001|Overall Study|Sponsor decision|0|||
131754235|NCT00364351|474378125|FG000|Overall Study|Poor treatment compliance|0|||
131754236|NCT00364351|474378126|FG001|Overall Study|Poor treatment compliance|3|||
131754237|NCT00364351|474378125|FG000|Overall Study|Investigator error|0|||
131754238|NCT00364351|474378126|FG001|Overall Study|Investigator error|2|||
131754239|NCT00364351|474378125|FG000|Overall Study|Patient could not travel to site|0|||
131754240|NCT00364351|474378126|FG001|Overall Study|Patient could not travel to site|1|||
131754241|NCT00364351|474378125|FG000|Overall Study|Randomised treatment not started|0|||
131754242|NCT00364351|474378126|FG001|Overall Study|Randomised treatment not started|3|||
131754243|NCT00922974|474378127|FG000|Phase II Component|Protocol Violation|2|||
131754244|NCT00922974|474378128|FG001|Phase II Component|Protocol Violation|0|||
131754245|NCT00922974|474378127|FG000|Phase II Component|Not evaluable for treatment review|5|||
131906966|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
131906967|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
131906968|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
131906969|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
131906970|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
131906971|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
131906972|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
131906973|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
131906974|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
131906975|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
131906976|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
131906977|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
131906978|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
131906979|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
131906980|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
131906981|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
131906982|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
131906983|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
131906984|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
131906985|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
131906986|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
131906987|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
131906988|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
131906989|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
131906990|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
131906991|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
131906992|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
131906993|NCT02709746|474946639|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
131906994|NCT02709746|474946640|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
131906995|NCT02709746|474946641|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
131906996|NCT02709746|474946642|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
131906997|NCT02709746|474946643|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
131906998|NCT03322293|474946649|FG000|Overall Study|Lost to Follow-up|0|||
131906999|NCT03322293|474946650|FG001|Overall Study|Lost to Follow-up|0|||
131907000|NCT03322293|474946651|FG002|Overall Study|Lost to Follow-up|1|||
131907001|NCT01178294|474946652|FG000|Overall Study|Adverse Event|4|||
131907002|NCT01178294|474946652|FG000|Overall Study|Lost to Follow-up|2|||
131907003|NCT01178294|474946652|FG000|Overall Study|Lack of Efficacy|1|||
131907004|NCT01178294|474946652|FG000|Overall Study|Death|1|||
131907005|NCT01178294|474946652|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
131907006|NCT01178294|474946652|FG000|Overall Study|Subject status is terminal|1|||
131907007|NCT01178294|474946652|FG000|Overall Study|Completion status could not be verified|1|||
131907008|NCT02089347|474946653|FG000|Overall Study|Protocol Violation|1|||
131907009|NCT02089347|474946654|FG001|Overall Study|Protocol Violation|0|||
131907010|NCT00551369|474946655|FG000|Overall Study|Protocol Violation|5|||
131907011|NCT00551369|474946655|FG000|Overall Study|Withdrawal by Subject|1|||
131907012|NCT00551369|474946655|FG000|Overall Study|Not treated per protocol and re|1|||
131907013|NCT00719901|474946660|FG000|Overall Study|Adverse Event|5|||
131907014|NCT00719901|474946660|FG000|Overall Study|Withdrawal by Subject|1|||
131907015|NCT00719901|474946660|FG000|Overall Study|Alternate Treatment|1|||
131907016|NCT00719901|474946660|FG000|Overall Study|Disease Progression|3|||
131907017|NCT00719901|474946660|FG000|Overall Study|Availability of Study Drug|1|||
131907018|NCT01122173|474946661|FG000|Overall Study|Lost to Follow-up|3|||
131907019|NCT01122173|474946661|FG000|Overall Study|Withdrawal by Subject|3|||
131907020|NCT01122173|474946661|FG000|Overall Study|Left study for other reasons|3|||
131907021|NCT01184872|474946662|FG000|Overall Study|Adverse Event|3|||
131907022|NCT01184872|474946663|FG001|Overall Study|Adverse Event|4|||
131907023|NCT01184872|474946662|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
131907024|NCT01184872|474946663|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131907025|NCT01184872|474946662|FG000|Overall Study|Withdrawal by Subject|2|||
131907026|NCT01184872|474946663|FG001|Overall Study|Withdrawal by Subject|0|||
131907027|NCT01184872|474946662|FG000|Overall Study|Lost to Follow-up|0|||
131907028|NCT01184872|474946663|FG001|Overall Study|Lost to Follow-up|1|||
131907029|NCT01184872|474946662|FG000|Overall Study|Administrative problems|1|||
131907030|NCT01184872|474946663|FG001|Overall Study|Administrative problems|1|||
131907031|NCT01184872|474946662|FG000|Overall Study|Protocol deviation|1|||
131907032|NCT01184872|474946663|FG001|Overall Study|Protocol deviation|0|||
131398469|NCT00703846|473079278|FG000|Overall Study|Did Not Receive Study Drug|2|||
131907033|NCT02378662|474946664|FG000|Overall Study|Early Discontinuation|2|||
131907034|NCT02378662|474946665|FG001|Overall Study|Early Discontinuation|0|||
131810748|NCT03247972|474589468|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
131810749|NCT03247972|474589468|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
131810750|NCT00968812|474589469|FG000|Overall Study|Adverse Event|30|||
131810751|NCT00968812|474589470|FG001|Overall Study|Adverse Event|46|||
131810752|NCT00968812|474589471|FG002|Overall Study|Adverse Event|33|||
131810753|NCT00968812|474589469|FG000|Overall Study|Death|2|||
131810754|NCT00968812|474589470|FG001|Overall Study|Death|2|||
131810755|NCT00968812|474589471|FG002|Overall Study|Death|1|||
131810756|NCT00968812|474589469|FG000|Overall Study|Lack of Efficacy|9|||
131810757|NCT00968812|474589470|FG001|Overall Study|Lack of Efficacy|7|||
131810758|NCT00968812|474589471|FG002|Overall Study|Lack of Efficacy|16|||
131810759|NCT00968812|474589469|FG000|Overall Study|Lost to Follow-up|17|||
131810760|NCT00968812|474589470|FG001|Overall Study|Lost to Follow-up|12|||
131810761|NCT00968812|474589471|FG002|Overall Study|Lost to Follow-up|11|||
131810762|NCT00968812|474589469|FG000|Overall Study|Physician Decision|8|||
131810763|NCT00968812|474589470|FG001|Overall Study|Physician Decision|5|||
131810764|NCT00968812|474589471|FG002|Overall Study|Physician Decision|9|||
131810765|NCT00968812|474589469|FG000|Overall Study|Protocol Violation|7|||
131810766|NCT00968812|474589470|FG001|Overall Study|Protocol Violation|4|||
131810767|NCT00968812|474589471|FG002|Overall Study|Protocol Violation|3|||
131810768|NCT00968812|474589469|FG000|Overall Study|Withdrawal by Subject|17|||
131810769|NCT00968812|474589470|FG001|Overall Study|Withdrawal by Subject|23|||
131810770|NCT00968812|474589471|FG002|Overall Study|Withdrawal by Subject|25|||
131810771|NCT00968812|474589469|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
131810772|NCT00968812|474589470|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
131810773|NCT00968812|474589471|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
131810774|NCT00968812|474589469|FG000|Overall Study|Noncompliance with study drug|4|||
131810775|NCT00968812|474589470|FG001|Overall Study|Noncompliance with study drug|1|||
131810776|NCT00968812|474589471|FG002|Overall Study|Noncompliance with study drug|6|||
131810777|NCT00968812|474589469|FG000|Overall Study|Unable to take rescue therapy|12|||
131810778|NCT00968812|474589470|FG001|Overall Study|Unable to take rescue therapy|12|||
131810779|NCT00968812|474589471|FG002|Overall Study|Unable to take rescue therapy|17|||
131810780|NCT00968812|474589469|FG000|Overall Study|Other|25|||
131810781|NCT00968812|474589470|FG001|Overall Study|Other|37|||
131810782|NCT00968812|474589471|FG002|Overall Study|Other|40|||
131810783|NCT00640562|474589476|FG000|Overall Study|Adverse Event|8|||
131810784|NCT00640562|474589477|FG001|Overall Study|Adverse Event|5|||
131810785|NCT00640562|474589476|FG000|Overall Study|Lack of Efficacy|1|||
131810786|NCT00640562|474589477|FG001|Overall Study|Lack of Efficacy|4|||
131810787|NCT00640562|474589476|FG000|Overall Study|Protocol Violation|2|||
131810788|NCT00640562|474589477|FG001|Overall Study|Protocol Violation|4|||
131810789|NCT00640562|474589476|FG000|Overall Study|Withdrawal by Subject|6|||
131810790|NCT00640562|474589477|FG001|Overall Study|Withdrawal by Subject|10|||
131810791|NCT00640562|474589476|FG000|Overall Study|Known risperidone intolerance|0|||
131810792|NCT00640562|474589477|FG001|Overall Study|Known risperidone intolerance|1|||
131810793|NCT00640562|474589476|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
131810794|NCT00640562|474589477|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
131810795|NCT00640562|474589476|FG000|Overall Study|Low study drug dose|0|||
131810796|NCT00640562|474589477|FG001|Overall Study|Low study drug dose|1|||
131810797|NCT00640562|474589476|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
131810798|NCT00640562|474589477|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
131810799|NCT00448591|474589478|FG000|Overall Study|Withdrawal by Subject|178|||
131810800|NCT00448591|474589478|FG000|Overall Study|Progressive Disease|1382|||
131810801|NCT00448591|474589478|FG000|Overall Study|Adverse Event|382|||
131810802|NCT00448591|474589478|FG000|Overall Study|Protocol Violation|41|||
131810803|NCT00448591|474589478|FG000|Overall Study|Lost to Follow-up|19|||
131810804|NCT00448591|474589478|FG000|Overall Study|Treatment Regimen Completed|70|||
131810805|NCT00448591|474589478|FG000|Overall Study|Other|154|||
131810806|NCT00448591|474589478|FG000|Overall Study|Termination of Study|70|||
131810807|NCT02937870|474589479|FG000|Overall Study|Adverse Event|1|||
131810808|NCT02937870|474589479|FG000|Overall Study|Protocol Deviation|2|||
131810809|NCT00609674|474589483|FG000|Overall Study|Adverse Event|1|||
131810810|NCT00609674|474589484|FG001|Overall Study|Adverse Event|1|||
131810811|NCT00609674|474589483|FG000|Overall Study|Protocol Violation|3|||
131810812|NCT00609674|474589484|FG001|Overall Study|Protocol Violation|5|||
131810813|NCT00609674|474589483|FG000|Overall Study|Lost to Follow-up|1|||
131810814|NCT00609674|474589484|FG001|Overall Study|Lost to Follow-up|0|||
131810815|NCT00609674|474589483|FG000|Overall Study|Withdrew consent|2|||
131810816|NCT00609674|474589484|FG001|Overall Study|Withdrew consent|1|||
131810817|NCT03098394|474589485|FG000|Overall Study|Pregnancy|0|||
131810818|NCT03098394|474589486|FG001|Overall Study|Pregnancy|1|||
131810819|NCT00244764|474589488|FG000|Overall Study|Adverse Event|37|||
131810820|NCT00244764|474589488|FG000|Overall Study|Lost to Follow-up|23|||
131810821|NCT00244764|474589488|FG000|Overall Study|Withdrawal by Subject|12|||
131810822|NCT00244764|474589488|FG000|Overall Study|Disease Progression|13|||
131810823|NCT00244764|474589488|FG000|Overall Study|Protocol Violation|2|||
131810824|NCT00244764|474589488|FG000|Overall Study|Death|1|||
131810825|NCT00244764|474589488|FG000|Overall Study|Off Study Medication for >21 Days|1|||
131810826|NCT00244764|474589488|FG000|Overall Study|Declining Performance Status|1|||
131810827|NCT00244764|474589488|FG000|Overall Study|Participant was Hospitalized until Death|1|||
131810828|NCT00244764|474589488|FG000|Overall Study|Primary Investigator Discretion|2|||
131810829|NCT00244764|474589488|FG000|Overall Study|Sponsor Terminated Study|2|||
131810830|NCT00244764|474589488|FG000|Overall Study|Developed Secondary Malignancy|1|||
131810831|NCT03872128|474589491|FG000|Overall Study|Dropped out before treatment|1|||
131810832|NCT03872128|474589492|FG001|Overall Study|Dropped out before treatment|0|||
131810833|NCT03872128|474589493|FG002|Overall Study|Dropped out before treatment|4|||
131810834|NCT03872128|474589491|FG000|Overall Study|Lost to Follow-up|2|||
131810835|NCT03872128|474589492|FG001|Overall Study|Lost to Follow-up|5|||
131810836|NCT03872128|474589493|FG002|Overall Study|Lost to Follow-up|8|||
131810837|NCT03285594|474589496|FG000|Overall Study|At the Participant's Own Request|10|||
131810838|NCT03285594|474589497|FG001|Overall Study|At the Participant's Own Request|5|||
131810839|NCT03285594|474589498|FG002|Overall Study|At the Participant's Own Request|21|||
131810840|NCT03285594|474589496|FG000|Overall Study|Adverse Event|2|||
131810841|NCT03285594|474589497|FG001|Overall Study|Adverse Event|2|||
131810842|NCT03285594|474589498|FG002|Overall Study|Adverse Event|6|||
131810843|NCT03285594|474589496|FG000|Overall Study|Poor Compliance to Protocol|0|||
131810844|NCT03285594|474589497|FG001|Overall Study|Poor Compliance to Protocol|0|||
131810845|NCT03285594|474589498|FG002|Overall Study|Poor Compliance to Protocol|1|||
131810846|NCT03285594|474589496|FG000|Overall Study|Lost to Follow-up|0|||
131810847|NCT03285594|474589497|FG001|Overall Study|Lost to Follow-up|0|||
131810848|NCT03285594|474589498|FG002|Overall Study|Lost to Follow-up|1|||
131810849|NCT03285594|474589496|FG000|Overall Study|Reason Not Specified|3|||
131810850|NCT03285594|474589497|FG001|Overall Study|Reason Not Specified|4|||
131810851|NCT03285594|474589498|FG002|Overall Study|Reason Not Specified|8|||
131810852|NCT02648438|474589501|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131810853|NCT02648438|474589502|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
131810854|NCT02648438|474589503|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
131810855|NCT02648438|474589501|FG000|Overall Study|Protocol Violation|2|||
131810856|NCT02648438|474589502|FG001|Overall Study|Protocol Violation|0|||
131810857|NCT02648438|474589503|FG002|Overall Study|Protocol Violation|0|||
131810858|NCT02648438|474589501|FG000|Overall Study|Withdrawal by Subject|1|||
131810859|NCT02648438|474589502|FG001|Overall Study|Withdrawal by Subject|1|||
131810860|NCT02648438|474589503|FG002|Overall Study|Withdrawal by Subject|0|||
131810861|NCT04604275|474589504|FG000|Washout-1 Week|Withdrawal by Subject|1|||
131810862|NCT04604275|474589505|FG001|Washout-1 Week|Withdrawal by Subject|0|||
131810863|NCT05615935|474589506|FG000|Overall Study|Lost to Follow-up|1|||
131810864|NCT05615935|474589507|FG001|Overall Study|Lost to Follow-up|1|||
131810865|NCT02258074|474589508|FG000|Overall Study|Withdrawal by Subject|1|||
131810866|NCT02258074|474589509|FG001|Overall Study|Withdrawal by Subject|0|||
131810867|NCT02258074|474589510|FG002|Overall Study|Withdrawal by Subject|0|||
131810868|NCT02258074|474589511|FG003|Overall Study|Withdrawal by Subject|0|||
131810869|NCT05446870|474589512|FG000|Overall Study|Death|6|||
131810870|NCT05446870|474589513|FG001|Overall Study|Death|5|||
131810871|NCT05446870|474589512|FG000|Overall Study|Lost to Follow-up|0|||
131810872|NCT05446870|474589513|FG001|Overall Study|Lost to Follow-up|1|||
131810873|NCT05446870|474589512|FG000|Overall Study|Physician Decision|52|||
131810874|NCT05446870|474589513|FG001|Overall Study|Physician Decision|53|||
131810875|NCT05446870|474589512|FG000|Overall Study|Withdrawal by Subject|3|||
131907035|NCT01774591|474946666|FG000|Overall Study|Physician Decision|1|||
131907036|NCT01774591|474946667|FG001|Overall Study|Physician Decision|1|||
131907037|NCT01774591|474946666|FG000|Overall Study|Withdrawal by Subject|0|||
131398470|NCT02566785|473079281|FG000|Overall Study|Lost to Follow-up|0|||
131907038|NCT01774591|474946667|FG001|Overall Study|Withdrawal by Subject|1|||
131907039|NCT01774591|474946666|FG000|Overall Study|Adverse Event|0|||
131907040|NCT01774591|474946667|FG001|Overall Study|Adverse Event|2|||
131810876|NCT05446870|474589513|FG001|Overall Study|Withdrawal by Subject|3|||
131810877|NCT02689505|474589515|FG000|Overall Study|Progressive disease|2|||
131810878|NCT02689505|474589516|FG001|Overall Study|Progressive disease|2|||
131810879|NCT02689505|474589517|FG002|Overall Study|Progressive disease|3|||
131810880|NCT02689505|474589518|FG003|Overall Study|Progressive disease|9|||
131810881|NCT02689505|474589519|FG004|Overall Study|Progressive disease|1|||
131810882|NCT02689505|474589515|FG000|Overall Study|Dose Limiting Toxicity|0|||
131398471|NCT02566785|473079282|FG001|Overall Study|Lost to Follow-up|2|||
131398472|NCT02566785|473079281|FG000|Overall Study|Worsening condition|1|||
131398473|NCT02566785|473079282|FG001|Overall Study|Worsening condition|1|||
131810883|NCT02689505|474589516|FG001|Overall Study|Dose Limiting Toxicity|1|||
131810884|NCT02689505|474589517|FG002|Overall Study|Dose Limiting Toxicity|0|||
131810885|NCT02689505|474589518|FG003|Overall Study|Dose Limiting Toxicity|0|||
131810886|NCT02689505|474589519|FG004|Overall Study|Dose Limiting Toxicity|2|||
131810887|NCT02689505|474589515|FG000|Overall Study|Other AE or clinical progression|0|||
131810888|NCT02689505|474589516|FG001|Overall Study|Other AE or clinical progression|2|||
131810889|NCT02689505|474589517|FG002|Overall Study|Other AE or clinical progression|0|||
131810890|NCT02689505|474589518|FG003|Overall Study|Other AE or clinical progression|2|||
131810891|NCT02689505|474589519|FG004|Overall Study|Other AE or clinical progression|0|||
131907041|NCT01701245|474946668|FG000|Overall Study|Protocol Violation|1|||
131907042|NCT01701245|474946669|FG001|Overall Study|Protocol Violation|3|||
131907043|NCT01701245|474946668|FG000|Overall Study|Did not complete the open label period|11|||
131907044|NCT01701245|474946669|FG001|Overall Study|Did not complete the open label period|12|||
131907045|NCT01159574|474946670|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
131907046|NCT01159574|474946670|FG000|Treatment Phase|Adverse Event|3|||
131907047|NCT01159574|474946670|FG000|Treatment Phase|Death|6|||
131907048|NCT01159574|474946670|FG000|Treatment Phase|Physician Decision|2|||
131907049|NCT01159574|474946670|FG000|Treatment Phase|Withdrawal by Subject|7|||
131907050|NCT01159574|474946670|FG000|Treatment Phase|still on treatment|2|||
131907051|NCT01159574|474946670|FG000|Follow Up Phase|Lost to Follow-up|2|||
131907052|NCT01159574|474946670|FG000|Follow Up Phase|still being followed for overall surviva|18|||
131907053|NCT03555149|474946675|FG000|Overall Study|Death|18|||
131907054|NCT03555149|474946676|FG001|Overall Study|Death|15|||
131907055|NCT03555149|474946677|FG002|Overall Study|Death|15|||
131907056|NCT03555149|474946678|FG003|Overall Study|Death|4|||
131907057|NCT03555149|474946679|FG004|Overall Study|Death|4|||
131907058|NCT03555149|474946680|FG005|Overall Study|Death|11|||
131907059|NCT03555149|474946681|FG006|Overall Study|Death|12|||
131907060|NCT03555149|474946682|FG007|Overall Study|Death|1|||
131754246|NCT00922974|474378128|FG001|Phase II Component|Not evaluable for treatment review|0|||
131754247|NCT00922974|474378127|FG000|Phase III Component|Protocol Violation|8|||
131754248|NCT00922974|474378128|FG001|Phase III Component|Protocol Violation|6|||
131754249|NCT02177786|474378129|FG000|Overall Study|Withdrew Consent|2|||
131754250|NCT02177786|474378130|FG001|Overall Study|Withdrew Consent|6|||
131907061|NCT03555149|474946675|FG000|Overall Study|Lost to Follow-up|1|||
131907062|NCT03555149|474946676|FG001|Overall Study|Lost to Follow-up|0|||
131907063|NCT03555149|474946677|FG002|Overall Study|Lost to Follow-up|0|||
131907064|NCT03555149|474946678|FG003|Overall Study|Lost to Follow-up|0|||
131907065|NCT03555149|474946679|FG004|Overall Study|Lost to Follow-up|0|||
131907066|NCT03555149|474946680|FG005|Overall Study|Lost to Follow-up|1|||
131907067|NCT03555149|474946681|FG006|Overall Study|Lost to Follow-up|0|||
131907068|NCT03555149|474946682|FG007|Overall Study|Lost to Follow-up|0|||
131907069|NCT03555149|474946675|FG000|Overall Study|Physician Decision|1|||
131907070|NCT03555149|474946676|FG001|Overall Study|Physician Decision|0|||
131907071|NCT03555149|474946677|FG002|Overall Study|Physician Decision|0|||
131907072|NCT03555149|474946678|FG003|Overall Study|Physician Decision|0|||
131907073|NCT03555149|474946679|FG004|Overall Study|Physician Decision|0|||
131907074|NCT03555149|474946680|FG005|Overall Study|Physician Decision|0|||
131907075|NCT03555149|474946681|FG006|Overall Study|Physician Decision|0|||
131907076|NCT03555149|474946682|FG007|Overall Study|Physician Decision|0|||
131907077|NCT03555149|474946675|FG000|Overall Study|Study Terminated By Sponsor|1|||
131907078|NCT03555149|474946676|FG001|Overall Study|Study Terminated By Sponsor|0|||
131907079|NCT03555149|474946677|FG002|Overall Study|Study Terminated By Sponsor|0|||
131907080|NCT03555149|474946678|FG003|Overall Study|Study Terminated By Sponsor|0|||
131907081|NCT03555149|474946679|FG004|Overall Study|Study Terminated By Sponsor|0|||
131907082|NCT03555149|474946680|FG005|Overall Study|Study Terminated By Sponsor|2|||
131907083|NCT03555149|474946681|FG006|Overall Study|Study Terminated By Sponsor|3|||
131907084|NCT03555149|474946682|FG007|Overall Study|Study Terminated By Sponsor|1|||
131907085|NCT03555149|474946675|FG000|Overall Study|Withdrawal by Subject|3|||
131907086|NCT03555149|474946676|FG001|Overall Study|Withdrawal by Subject|0|||
131907087|NCT03555149|474946677|FG002|Overall Study|Withdrawal by Subject|0|||
131907088|NCT03555149|474946678|FG003|Overall Study|Withdrawal by Subject|2|||
131907089|NCT03555149|474946679|FG004|Overall Study|Withdrawal by Subject|0|||
131907090|NCT03555149|474946680|FG005|Overall Study|Withdrawal by Subject|1|||
131907091|NCT03555149|474946681|FG006|Overall Study|Withdrawal by Subject|0|||
131907092|NCT03555149|474946682|FG007|Overall Study|Withdrawal by Subject|0|||
131907093|NCT04219189|474946688|FG000|Overall Study|Withdrawal by Subject|1|||
131907094|NCT04219189|474946689|FG001|Overall Study|Withdrawal by Subject|2|||
131907095|NCT04219189|474946688|FG000|Overall Study|Protocol Violation|0|||
131907096|NCT04219189|474946689|FG001|Overall Study|Protocol Violation|1|||
131907097|NCT04219189|474946688|FG000|Overall Study|Lost to Follow-up|0|||
131907098|NCT04219189|474946689|FG001|Overall Study|Lost to Follow-up|1|||
131907099|NCT04219189|474946688|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
131907100|NCT04219189|474946689|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
131907101|NCT03863353|474946690|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
131907102|NCT03863353|474946691|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
131907103|NCT02747927|474946692|FG000|Overall Study|Adverse Event|5|||
131907104|NCT02747927|474946693|FG001|Overall Study|Adverse Event|14|||
131754251|NCT02177786|474378131|FG002|Overall Study|Withdrew Consent|9|||
131754252|NCT02177786|474378132|FG003|Overall Study|Withdrew Consent|5|||
131754253|NCT02177786|474378129|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
131754254|NCT02177786|474378130|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
131907105|NCT02747927|474946692|FG000|Overall Study|Lost to Follow-up|22|||
131907106|NCT02747927|474946693|FG001|Overall Study|Lost to Follow-up|43|||
131907107|NCT02747927|474946692|FG000|Overall Study|Pregnancy|34|||
131907108|NCT02747927|474946693|FG001|Overall Study|Pregnancy|66|||
131907109|NCT02747927|474946692|FG000|Overall Study|Protocol Violation|2|||
131907110|NCT02747927|474946693|FG001|Overall Study|Protocol Violation|4|||
131907111|NCT02747927|474946692|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
131907112|NCT02747927|474946693|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
131907113|NCT02747927|474946692|FG000|Overall Study|Reason not Specified|11|||
131907114|NCT02747927|474946693|FG001|Overall Study|Reason not Specified|27|||
131907115|NCT03292016|474946694|FG000|Second Washout|Adverse Event|0|||
131907116|NCT03292016|474946695|FG001|Second Washout|Adverse Event|1|||
131907117|NCT03292016|474946696|FG002|Second Washout|Adverse Event|0|||
131907118|NCT03292016|474946697|FG003|Second Washout|Adverse Event|0|||
131907119|NCT03292016|474946698|FG004|Second Washout|Adverse Event|0|||
131907120|NCT03292016|474946699|FG005|Second Washout|Adverse Event|0|||
131907121|NCT02144701|474946701|FG000|Overall Study|development of relapse, GVHD or death|9|||
131907122|NCT02144701|474946702|FG001|Overall Study|development of relapse, GVHD or death|3|||
131907123|NCT01218802|474946704|FG000|Overall Study|Lost to Follow-up|5|||
131907124|NCT01218802|474946705|FG001|Overall Study|Lost to Follow-up|6|||
131907125|NCT01218802|474946704|FG000|Overall Study|Withdrawal by Subject|3|||
131907126|NCT01218802|474946705|FG001|Overall Study|Withdrawal by Subject|10|||
131907127|NCT01218802|474946704|FG000|Overall Study|Adverse Event|0|||
131907128|NCT01218802|474946705|FG001|Overall Study|Adverse Event|2|||
131907129|NCT01218802|474946704|FG000|Overall Study|Incarcerated|2|||
131907130|NCT01218802|474946705|FG001|Overall Study|Incarcerated|0|||
131907131|NCT03327324|474946706|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907132|NCT03327324|474946707|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
131907133|NCT03327324|474946708|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907134|NCT03327324|474946709|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
131907135|NCT03327324|474946710|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907136|NCT03327324|474946711|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
131907137|NCT03327324|474946706|FG000|Baseline (Month 0-Month 3)|Refused|0|||
131907138|NCT03327324|474946707|FG001|Baseline (Month 0-Month 3)|Refused|0|||
131907139|NCT03327324|474946708|FG002|Baseline (Month 0-Month 3)|Refused|0|||
131907140|NCT03327324|474946709|FG003|Baseline (Month 0-Month 3)|Refused|0|||
131907141|NCT03327324|474946710|FG004|Baseline (Month 0-Month 3)|Refused|1|||
131907142|NCT03327324|474946711|FG005|Baseline (Month 0-Month 3)|Refused|0|||
131907143|NCT03327324|474946706|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
131907144|NCT03327324|474946707|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
131907145|NCT03327324|474946708|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
131907146|NCT03327324|474946709|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
131907147|NCT03327324|474946710|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
131907148|NCT03327324|474946711|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
131907149|NCT03327324|474946706|FG000|Baseline (Month 0-Month 3)|Death|0|||
131907150|NCT03327324|474946707|FG001|Baseline (Month 0-Month 3)|Death|0|||
131907151|NCT03327324|474946708|FG002|Baseline (Month 0-Month 3)|Death|0|||
131907152|NCT03327324|474946709|FG003|Baseline (Month 0-Month 3)|Death|0|||
131907153|NCT03327324|474946710|FG004|Baseline (Month 0-Month 3)|Death|1|||
131907154|NCT03327324|474946711|FG005|Baseline (Month 0-Month 3)|Death|0|||
131907155|NCT03327324|474946706|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907156|NCT03327324|474946707|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907157|NCT03327324|474946708|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907158|NCT03327324|474946709|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907159|NCT03327324|474946710|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907160|NCT03327324|474946711|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
131907161|NCT03327324|474946706|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131754255|NCT02177786|474378131|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
131754256|NCT02177786|474378132|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
131754257|NCT02177786|474378129|FG000|Overall Study|Adverse Event|1|||
131754258|NCT02177786|474378130|FG001|Overall Study|Adverse Event|1|||
131754259|NCT02177786|474378131|FG002|Overall Study|Adverse Event|2|||
131754260|NCT02177786|474378132|FG003|Overall Study|Adverse Event|3|||
131754261|NCT02177786|474378129|FG000|Overall Study|Death|1|||
131754262|NCT02177786|474378130|FG001|Overall Study|Death|1|||
131754263|NCT02177786|474378131|FG002|Overall Study|Death|1|||
131754264|NCT02177786|474378132|FG003|Overall Study|Death|1|||
131754265|NCT02177786|474378129|FG000|Overall Study|Lost to Follow-up|0|||
131754266|NCT02177786|474378130|FG001|Overall Study|Lost to Follow-up|0|||
131810892|NCT01005745|474589520|FG000|Overall Study|No TIL growth|1|||
131810893|NCT01005745|474589520|FG000|Overall Study|Disease progressed during TIL growth|3|||
131810894|NCT01005745|474589520|FG000|Overall Study|Death prior to treatment|1|||
131810895|NCT01005745|474589520|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
131810896|NCT01415986|474589521|FG000|Overall Study|Lost to Follow-up|1|||
131810897|NCT01250912|474589523|FG000|Overall Study|Lost to Follow-up|1|||
131810898|NCT03273153|474589524|FG000|Overall Study|Adverse Event|1|||
131810899|NCT03273153|474589525|FG001|Overall Study|Adverse Event|2|||
131810900|NCT03273153|474589524|FG000|Overall Study|Missing|0|||
131810901|NCT03273153|474589525|FG001|Overall Study|Missing|2|||
131810902|NCT03273153|474589524|FG000|Overall Study|Other|3|||
131810903|NCT03273153|474589525|FG001|Overall Study|Other|2|||
131810904|NCT03273153|474589524|FG000|Overall Study|Symptomatic Deterioration|0|||
131810905|NCT03273153|474589525|FG001|Overall Study|Symptomatic Deterioration|1|||
131810906|NCT03273153|474589524|FG000|Overall Study|Progressive Disease|6|||
131810907|NCT03273153|474589525|FG001|Overall Study|Progressive Disease|5|||
131810908|NCT03273153|474589524|FG000|Overall Study|Physician Decision|1|||
131810909|NCT03273153|474589525|FG001|Overall Study|Physician Decision|3|||
131810910|NCT03273153|474589524|FG000|Overall Study|Study Terminated by Sponsor|112|||
131810911|NCT03273153|474589525|FG001|Overall Study|Study Terminated by Sponsor|102|||
131810912|NCT03273153|474589524|FG000|Overall Study|Withdrawal by Subject|26|||
131810913|NCT03273153|474589525|FG001|Overall Study|Withdrawal by Subject|25|||
131810914|NCT03273153|474589524|FG000|Overall Study|Protocol Deviation|3|||
131810915|NCT03273153|474589525|FG001|Overall Study|Protocol Deviation|0|||
131810916|NCT03273153|474589524|FG000|Overall Study|Lost to Follow-up|6|||
131810917|NCT03273153|474589525|FG001|Overall Study|Lost to Follow-up|11|||
131810918|NCT03273153|474589524|FG000|Overall Study|Death|66|||
131810919|NCT03273153|474589525|FG001|Overall Study|Death|69|||
131810920|NCT05323396|474589526|FG000|Overall Study|Lost to Follow-up|1|||
131810921|NCT05323396|474589527|FG001|Overall Study|Lost to Follow-up|35|||
131810922|NCT05323396|474589526|FG000|Overall Study|Pregnancy|1|||
131810923|NCT05323396|474589527|FG001|Overall Study|Pregnancy|0|||
131810924|NCT04646213|474589530|FG000|Overall Study|Physician Decision|3|||
131810925|NCT04646213|474589530|FG000|Overall Study|Withdrawal by Subject|2|||
131810926|NCT00415363|474589535|FG000|Overall Study|Withdrawal by Subject|4|||
131810927|NCT00415363|474589536|FG001|Overall Study|Withdrawal by Subject|4|||
131810928|NCT00415363|474589535|FG000|Overall Study|Adverse Event|4|||
131810929|NCT00415363|474589536|FG001|Overall Study|Adverse Event|4|||
131810930|NCT00415363|474589535|FG000|Overall Study|Lost to Follow-up|2|||
131810931|NCT00415363|474589536|FG001|Overall Study|Lost to Follow-up|1|||
131810932|NCT00415363|474589535|FG000|Overall Study|Physician Decision|3|||
131810933|NCT00415363|474589536|FG001|Overall Study|Physician Decision|1|||
131810934|NCT00415363|474589535|FG000|Overall Study|Death|16|||
131810935|NCT00415363|474589536|FG001|Overall Study|Death|12|||
131810936|NCT00415363|474589535|FG000|Overall Study|Progressive disease|26|||
131810937|NCT00415363|474589536|FG001|Overall Study|Progressive disease|32|||
131810938|NCT00095212|474589537|FG000|Overall Study|Withdrawal by Subject|1|||
131810939|NCT00095212|474589538|FG001|Overall Study|Withdrawal by Subject|3|||
131810940|NCT05341622|474589539|FG000|Overall Study|Death|0|||
131754267|NCT02177786|474378131|FG002|Overall Study|Lost to Follow-up|2|||
131754268|NCT02177786|474378132|FG003|Overall Study|Lost to Follow-up|2|||
131754269|NCT02177786|474378129|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131754270|NCT02177786|474378130|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131754271|NCT02177786|474378131|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131754272|NCT02177786|474378132|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131754273|NCT02177786|474378129|FG000|Overall Study|Protocol Violation|0|||
131754274|NCT02177786|474378130|FG001|Overall Study|Protocol Violation|0|||
131754275|NCT02177786|474378131|FG002|Overall Study|Protocol Violation|2|||
131754276|NCT02177786|474378132|FG003|Overall Study|Protocol Violation|0|||
131754277|NCT02177786|474378129|FG000|Overall Study|Progressive Disease|0|||
131754278|NCT02177786|474378130|FG001|Overall Study|Progressive Disease|1|||
131754279|NCT02177786|474378131|FG002|Overall Study|Progressive Disease|0|||
131754280|NCT02177786|474378132|FG003|Overall Study|Progressive Disease|0|||
131754281|NCT02177786|474378129|FG000|Overall Study|Missing study completion status|0|||
131754282|NCT02177786|474378130|FG001|Overall Study|Missing study completion status|1|||
131810941|NCT05341622|474589540|FG001|Overall Study|Death|0|||
131810942|NCT05341622|474589541|FG002|Overall Study|Death|0|||
131810943|NCT05341622|474589542|FG003|Overall Study|Death|0|||
131810944|NCT05341622|474589543|FG004|Overall Study|Death|1|||
131810945|NCT05341622|474589544|FG005|Overall Study|Death|0|||
131810946|NCT05341622|474589545|FG006|Overall Study|Death|0|||
131810947|NCT05341622|474589546|FG007|Overall Study|Death|1|||
131810948|NCT05341622|474589539|FG000|Overall Study|Invalid Address|0|||
131810949|NCT05341622|474589540|FG001|Overall Study|Invalid Address|1|||
131810950|NCT05341622|474589541|FG002|Overall Study|Invalid Address|0|||
131810951|NCT05341622|474589542|FG003|Overall Study|Invalid Address|0|||
131810952|NCT05341622|474589543|FG004|Overall Study|Invalid Address|0|||
131810953|NCT05341622|474589544|FG005|Overall Study|Invalid Address|0|||
131810954|NCT05341622|474589545|FG006|Overall Study|Invalid Address|0|||
131810955|NCT05341622|474589546|FG007|Overall Study|Invalid Address|0|||
131754283|NCT02177786|474378131|FG002|Overall Study|Missing study completion status|0|||
131754284|NCT02177786|474378132|FG003|Overall Study|Missing study completion status|0|||
131754285|NCT03950440|474378133|FG000|Overall Study|Death|8|||
131754286|NCT03950440|474378134|FG001|Overall Study|Death|2|||
131754287|NCT03950440|474378135|FG002|Overall Study|Death|1|||
131754288|NCT00439309|474378136|FG000|Follow-Up|Death|1|||
131754289|NCT00439309|474378137|FG001|Follow-Up|Death|0|||
131754290|NCT00439309|474378136|FG000|Follow-Up|Lost to Follow-up|2|||
131810956|NCT05341622|474589539|FG000|Overall Study|Ineligible|26|||
131810957|NCT05341622|474589540|FG001|Overall Study|Ineligible|21|||
131810958|NCT05341622|474589541|FG002|Overall Study|Ineligible|28|||
131810959|NCT05341622|474589542|FG003|Overall Study|Ineligible|24|||
131810960|NCT05341622|474589543|FG004|Overall Study|Ineligible|29|||
131810961|NCT05341622|474589544|FG005|Overall Study|Ineligible|31|||
131810962|NCT05341622|474589545|FG006|Overall Study|Ineligible|28|||
131810963|NCT05341622|474589546|FG007|Overall Study|Ineligible|26|||
131810964|NCT02658084|474589547|FG000|Overall Study|Withdrawal by Subject|1|||
131810965|NCT02658084|474589548|FG001|Overall Study|Withdrawal by Subject|0|||
131810966|NCT02658084|474589547|FG000|Overall Study|Study Termination|1|||
131810967|NCT02658084|474589548|FG001|Overall Study|Study Termination|0|||
131810968|NCT02674152|474590752|FG000|Overall Study|Personal Reasons|1|||
131810969|NCT02674152|474590753|FG001|Overall Study|Personal Reasons|0|||
131810970|NCT02674152|474590754|FG002|Overall Study|Personal Reasons|0|||
131810971|NCT02674152|474590755|FG003|Overall Study|Personal Reasons|1|||
131810972|NCT02674152|474590756|FG004|Overall Study|Personal Reasons|1|||
131810973|NCT02674152|474590752|FG000|Overall Study|Other adverse event or clinical progression|0|||
131810974|NCT02674152|474590753|FG001|Overall Study|Other adverse event or clinical progression|1|||
131810975|NCT02674152|474590754|FG002|Overall Study|Other adverse event or clinical progression|0|||
131810976|NCT02674152|474590755|FG003|Overall Study|Other adverse event or clinical progression|3|||
131810977|NCT02674152|474590756|FG004|Overall Study|Other adverse event or clinical progression|0|||
131810978|NCT02674152|474590752|FG000|Overall Study|Dose-limiting toxicity|0|||
131810979|NCT02674152|474590753|FG001|Overall Study|Dose-limiting toxicity|0|||
131810980|NCT02674152|474590754|FG002|Overall Study|Dose-limiting toxicity|0|||
131810981|NCT02674152|474590755|FG003|Overall Study|Dose-limiting toxicity|0|||
131810982|NCT02674152|474590756|FG004|Overall Study|Dose-limiting toxicity|1|||
131810983|NCT02674152|474590752|FG000|Overall Study|Progressive Disease|2|||
131810984|NCT02674152|474590753|FG001|Overall Study|Progressive Disease|1|||
131810985|NCT02674152|474590754|FG002|Overall Study|Progressive Disease|1|||
131810986|NCT02674152|474590755|FG003|Overall Study|Progressive Disease|13|||
131810987|NCT02674152|474590756|FG004|Overall Study|Progressive Disease|2|||
131810988|NCT02674152|474590752|FG000|Overall Study|Adverse Event|0|||
131810989|NCT02674152|474590753|FG001|Overall Study|Adverse Event|0|||
131810990|NCT02674152|474590754|FG002|Overall Study|Adverse Event|1|||
131810991|NCT02674152|474590755|FG003|Overall Study|Adverse Event|0|||
131810992|NCT02674152|474590756|FG004|Overall Study|Adverse Event|1|||
131810993|NCT04934722|474590757|FG000|Overall Study|Death|4|||
131810994|NCT04934722|474590758|FG001|Overall Study|Death|3|||
131810995|NCT04934722|474590757|FG000|Overall Study|Participants Ongoing|88|||
131810996|NCT04934722|474590758|FG001|Overall Study|Participants Ongoing|91|||
131810997|NCT05265624|474590759|FG000|Overall Study|Lost to Follow-up|3|||
131810998|NCT05265624|474590760|FG001|Overall Study|Lost to Follow-up|0|||
131810999|NCT05265624|474590759|FG000|Overall Study|Withdrawal by Subject|1|||
131811000|NCT05265624|474590760|FG001|Overall Study|Withdrawal by Subject|0|||
131811001|NCT03071575|474590761|FG000|Overall Study|Death|0|||
131811002|NCT03071575|474590762|FG001|Overall Study|Death|1|||
131811003|NCT03071575|474590761|FG000|Overall Study|Lost to Follow-up|5|||
131811004|NCT03071575|474590762|FG001|Overall Study|Lost to Follow-up|11|||
131811005|NCT03071575|474590761|FG000|Overall Study|Withdrawal by Subject|4|||
131811006|NCT03071575|474590762|FG001|Overall Study|Withdrawal by Subject|2|||
131811007|NCT00834795|474590763|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
131811008|NCT00834795|474590764|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
131811009|NCT00834795|474590763|FG000|Second Intervention|Adverse Event|1|||
131811010|NCT00834795|474590764|FG001|Second Intervention|Adverse Event|0|||
131811011|NCT00579345|474590765|FG000|Overall Study|Withdrawal by Subject|2|||
131811012|NCT00579345|474590766|FG001|Overall Study|Withdrawal by Subject|0|||
131811013|NCT00579345|474590767|FG002|Overall Study|Withdrawal by Subject|0|||
131811014|NCT00579345|474590768|FG003|Overall Study|Withdrawal by Subject|0|||
131811015|NCT00579345|474590769|FG004|Overall Study|Withdrawal by Subject|0|||
131811016|NCT00579345|474590770|FG005|Overall Study|Withdrawal by Subject|0|||
131811017|NCT00579345|474590771|FG006|Overall Study|Withdrawal by Subject|0|||
131811018|NCT00579345|474590772|FG007|Overall Study|Withdrawal by Subject|1|||
131811019|NCT00579345|474590765|FG000|Overall Study|Lost to Follow-up|1|||
131811020|NCT00579345|474590766|FG001|Overall Study|Lost to Follow-up|0|||
131811021|NCT00579345|474590767|FG002|Overall Study|Lost to Follow-up|0|||
131754291|NCT00439309|474378137|FG001|Follow-Up|Lost to Follow-up|0|||
131811022|NCT00579345|474590768|FG003|Overall Study|Lost to Follow-up|0|||
131754292|NCT00439309|474378136|FG000|Follow-Up|Withdrawal by Subject|0|||
131811023|NCT00579345|474590769|FG004|Overall Study|Lost to Follow-up|0|||
131907162|NCT03327324|474946707|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907163|NCT03327324|474946708|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
131907164|NCT03327324|474946709|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907165|NCT03327324|474946710|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907166|NCT03327324|474946711|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907167|NCT03327324|474946706|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
131907168|NCT03327324|474946707|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
131907169|NCT03327324|474946708|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
131907170|NCT03327324|474946709|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
131907171|NCT03327324|474946710|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
131907172|NCT03327324|474946711|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
131907173|NCT03327324|474946706|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
131907174|NCT03327324|474946707|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
131907175|NCT03327324|474946708|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
131907176|NCT03327324|474946709|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
131907177|NCT03327324|474946710|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
131907178|NCT03327324|474946711|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
131907179|NCT03327324|474946706|FG000|Intervention (Month 3-Month 6)|Death|1|||
131907180|NCT03327324|474946707|FG001|Intervention (Month 3-Month 6)|Death|0|||
131907181|NCT03327324|474946708|FG002|Intervention (Month 3-Month 6)|Death|1|||
131907182|NCT03327324|474946709|FG003|Intervention (Month 3-Month 6)|Death|1|||
131907183|NCT03327324|474946710|FG004|Intervention (Month 3-Month 6)|Death|1|||
131907184|NCT03327324|474946711|FG005|Intervention (Month 3-Month 6)|Death|0|||
131907185|NCT03327324|474946706|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907186|NCT03327324|474946707|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907187|NCT03327324|474946708|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907188|NCT03327324|474946709|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907189|NCT03327324|474946710|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907190|NCT03327324|474946711|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
131907191|NCT03327324|474946706|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
131907192|NCT03327324|474946707|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907193|NCT03327324|474946708|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907194|NCT03327324|474946709|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907195|NCT03327324|474946710|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907196|NCT03327324|474946711|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
131907197|NCT03327324|474946706|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
131907198|NCT03327324|474946707|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
131907199|NCT03327324|474946708|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
131907200|NCT03327324|474946709|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
131907201|NCT03327324|474946710|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
131907202|NCT03327324|474946711|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
131907203|NCT03327324|474946706|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
131907204|NCT03327324|474946707|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
131907205|NCT03327324|474946708|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
131907206|NCT03327324|474946709|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
131907207|NCT03327324|474946710|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
131907208|NCT03327324|474946711|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
131907209|NCT03327324|474946706|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907210|NCT03327324|474946707|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907211|NCT03327324|474946708|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907212|NCT03327324|474946709|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
131907213|NCT03327324|474946710|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
131907214|NCT03327324|474946711|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
131907215|NCT03327324|474946706|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
131907216|NCT03327324|474946707|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
131907217|NCT03327324|474946708|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
131907218|NCT03327324|474946709|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
131907219|NCT03327324|474946710|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
131907220|NCT03327324|474946711|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
131907221|NCT03327324|474946706|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
131907222|NCT03327324|474946707|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
131907223|NCT03327324|474946708|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
131907224|NCT03327324|474946709|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
131907225|NCT03327324|474946710|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
131907226|NCT03327324|474946711|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
131907227|NCT00249834|474946715|FG000|Overall Study|Ovarian stimulation failed|1|||
131907228|NCT00249834|474946716|FG001|Overall Study|Ovarian stimulation failed|0|||
131907229|NCT00249834|474946717|FG002|Overall Study|Ovarian stimulation failed|0|||
131754293|NCT00439309|474378137|FG001|Follow-Up|Withdrawal by Subject|1|||
131754294|NCT00439309|474378136|FG000|Follow-Up|Late response by subject|0|||
131754295|NCT00439309|474378137|FG001|Follow-Up|Late response by subject|1|||
131754296|NCT00430027|474378138|FG000|Overall Study|Study terminated|8|||
131754297|NCT01957215|474378139|FG000|Overall Study|Adverse Event|2|||
131754298|NCT01957215|474378140|FG001|Overall Study|Adverse Event|2|||
131754299|NCT01957215|474378139|FG000|Overall Study|Lost to Follow-up|3|||
131754300|NCT01957215|474378140|FG001|Overall Study|Lost to Follow-up|3|||
131754301|NCT01957215|474378139|FG000|Overall Study|Protocol Violation|1|||
131754302|NCT01957215|474378140|FG001|Overall Study|Protocol Violation|2|||
131754303|NCT01957215|474378139|FG000|Overall Study|Withdrawal by Subject|7|||
131754304|NCT01957215|474378140|FG001|Overall Study|Withdrawal by Subject|5|||
131754305|NCT01977040|474378141|FG000|Overall Study|Vasa previa not confirmed|2|||
131754306|NCT00688623|474378142|FG000|Overall Study|Adverse Event|22|||
131754307|NCT00688623|474378142|FG000|Overall Study|abnormal lab value|1|||
131907230|NCT00249834|474946718|FG003|Overall Study|Ovarian stimulation failed|0|||
131907231|NCT00249834|474946719|FG004|Overall Study|Ovarian stimulation failed|0|||
131907232|NCT00249834|474946720|FG005|Overall Study|Ovarian stimulation failed|0|||
131907233|NCT00249834|474946721|FG006|Overall Study|Ovarian stimulation failed|0|||
131907234|NCT00249834|474946722|FG007|Overall Study|Ovarian stimulation failed|0|||
131907235|NCT00249834|474946715|FG000|Overall Study|Failure of down-regulation|0|||
131907236|NCT00249834|474946716|FG001|Overall Study|Failure of down-regulation|0|||
131907237|NCT00249834|474946717|FG002|Overall Study|Failure of down-regulation|0|||
131907238|NCT00249834|474946718|FG003|Overall Study|Failure of down-regulation|0|||
131907239|NCT00249834|474946719|FG004|Overall Study|Failure of down-regulation|0|||
131907240|NCT00249834|474946720|FG005|Overall Study|Failure of down-regulation|0|||
131907241|NCT00249834|474946721|FG006|Overall Study|Failure of down-regulation|1|||
131907242|NCT00249834|474946722|FG007|Overall Study|Failure of down-regulation|0|||
131907243|NCT00249834|474946715|FG000|Overall Study|Protocol Violation|0|||
131907244|NCT00249834|474946716|FG001|Overall Study|Protocol Violation|19|||
131907245|NCT00249834|474946717|FG002|Overall Study|Protocol Violation|14|||
131907246|NCT00249834|474946718|FG003|Overall Study|Protocol Violation|8|||
131907247|NCT00249834|474946719|FG004|Overall Study|Protocol Violation|5|||
131907248|NCT00249834|474946720|FG005|Overall Study|Protocol Violation|2|||
131907249|NCT00249834|474946721|FG006|Overall Study|Protocol Violation|0|||
131907250|NCT00249834|474946722|FG007|Overall Study|Protocol Violation|0|||
131907251|NCT00887484|474946725|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
131907252|NCT00887484|474946725|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
131907253|NCT00887484|474946725|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
131907254|NCT03044314|474946726|FG000|Overall Study|Physician Decision|2|||
131907255|NCT03044314|474946726|FG000|Overall Study|Withdrawal by Subject|1|||
131907256|NCT03044314|474946726|FG000|Overall Study|Connector tubing not available|1|||
131907257|NCT01316224|474946727|FG000|Overall Study|Protocol Violation|3|||
131907258|NCT01316224|474946727|FG000|Overall Study|Adverse Event|3|||
131907259|NCT01316224|474946727|FG000|Overall Study|Lack of Efficacy|1|||
131907260|NCT01316224|474946727|FG000|Overall Study|Withdrawal by Subject|1|||
131907261|NCT01316224|474946727|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
131907262|NCT01316224|474946727|FG000|Overall Study|Other|1|||
131907263|NCT00606307|474946728|FG000|Overall Study|Adverse Event|2|||
131907264|NCT00606307|474946728|FG000|Overall Study|Withdrawal by Subject|2|||
131907265|NCT00606307|474946728|FG000|Overall Study|Disease progression|6|||
131907266|NCT00606307|474946728|FG000|Overall Study|QTc prolongation|1|||
131449785|NCT01750229|473276714|FG000|Long-term Follow-up Phase|Adverse Event|2|||
131907267|NCT02008526|474946734|FG000|Overall Study|Death|0|||
131907268|NCT02008526|474946735|FG001|Overall Study|Death|2|||
131907269|NCT02008526|474946736|FG002|Overall Study|Death|1|||
131754308|NCT00688623|474378142|FG000|Overall Study|Withdrawal by Subject|4|||
131754309|NCT00688623|474378142|FG000|Overall Study|Death|3|||
131754310|NCT00688623|474378142|FG000|Overall Study|disease progression|23|||
131754311|NCT00688623|474378142|FG000|Overall Study|Protocol Violation|2|||
131754312|NCT02667236|474378143|FG000|Overall Study|Adverse Event|1|||
131754313|NCT02667236|474378144|FG001|Overall Study|Adverse Event|1|||
131811024|NCT00579345|474590770|FG005|Overall Study|Lost to Follow-up|0|||
131907270|NCT02008526|474946734|FG000|Overall Study|Withdrawal by Subject|3|||
131811025|NCT00579345|474590771|FG006|Overall Study|Lost to Follow-up|0|||
131811026|NCT00579345|474590772|FG007|Overall Study|Lost to Follow-up|0|||
131811027|NCT00579345|474590765|FG000|Overall Study|Adverse Event|0|||
131907271|NCT02008526|474946735|FG001|Overall Study|Withdrawal by Subject|3|||
131907272|NCT02008526|474946736|FG002|Overall Study|Withdrawal by Subject|2|||
131907273|NCT02008526|474946734|FG000|Overall Study|Lost to Follow-up|5|||
131907274|NCT02008526|474946735|FG001|Overall Study|Lost to Follow-up|9|||
131907275|NCT02008526|474946736|FG002|Overall Study|Lost to Follow-up|6|||
131907276|NCT02230891|474946738|FG000|Baseline|Did not meet inclusion|0|||
131907277|NCT02230891|474946739|FG001|Baseline|Did not meet inclusion|1|||
131907278|NCT02230891|474946740|FG002|Baseline|Did not meet inclusion|1|||
131907279|NCT02230891|474946738|FG000|2 Week|Withdrawal by Subject|2|||
131907280|NCT02230891|474946739|FG001|2 Week|Withdrawal by Subject|2|||
131907281|NCT02230891|474946740|FG002|2 Week|Withdrawal by Subject|0|||
131907282|NCT02230891|474946738|FG000|2 Week|Consent withdrawn|1|||
131907283|NCT02230891|474946739|FG001|2 Week|Consent withdrawn|0|||
131907284|NCT02230891|474946740|FG002|2 Week|Consent withdrawn|0|||
131907285|NCT02230891|474946738|FG000|6 Month|Withdrawal by Subject|1|||
131907286|NCT02230891|474946739|FG001|6 Month|Withdrawal by Subject|1|||
131907287|NCT02230891|474946740|FG002|6 Month|Withdrawal by Subject|1|||
131907288|NCT02230891|474946738|FG000|6 Month|Physician Decision|0|||
131907289|NCT02230891|474946739|FG001|6 Month|Physician Decision|2|||
131907290|NCT02230891|474946740|FG002|6 Month|Physician Decision|0|||
131907291|NCT02230891|474946738|FG000|12 Month|Death|1|||
131907292|NCT02230891|474946739|FG001|12 Month|Death|0|||
131907293|NCT02230891|474946740|FG002|12 Month|Death|0|||
131907294|NCT02230891|474946738|FG000|12 Month|Lost to Follow-up|0|||
131907295|NCT02230891|474946739|FG001|12 Month|Lost to Follow-up|1|||
131754314|NCT02667236|474378143|FG000|Overall Study|Withdrawal by Subject|2|||
131754315|NCT02667236|474378144|FG001|Overall Study|Withdrawal by Subject|0|||
131754316|NCT01473355|474378148|FG000|Overall Study|Protocol Violation|2|||
131754317|NCT01473355|474378148|FG000|Overall Study|Adverse Event|2|||
131754318|NCT01473355|474378148|FG000|Overall Study|Lost to Follow-up|2|||
131754319|NCT01119963|474378149|FG000|Overall Study|Lost to Follow-up|1|||
131754320|NCT01119963|474378150|FG001|Overall Study|Lost to Follow-up|1|||
131754321|NCT02603172|474378151|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754322|NCT02603172|474378152|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754323|NCT02603172|474378153|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
131754324|NCT02603172|474378154|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754325|NCT02603172|474378155|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754326|NCT02603172|474378156|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754327|NCT02603172|474378157|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754328|NCT02603172|474378158|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131754329|NCT00809614|474378159|FG000|Overall Study|Lack of Efficacy|2|||
131754330|NCT00809614|474378160|FG001|Overall Study|Lack of Efficacy|3|||
131754331|NCT00809614|474378159|FG000|Overall Study|Withdrawal by Subject|1|||
131754332|NCT00809614|474378160|FG001|Overall Study|Withdrawal by Subject|1|||
131754333|NCT01080625|474378161|FG000|Overall Study|Physician Decision|0|||
131754334|NCT01080625|474378162|FG001|Overall Study|Physician Decision|2|||
131811028|NCT00579345|474590766|FG001|Overall Study|Adverse Event|0|||
131811029|NCT00579345|474590767|FG002|Overall Study|Adverse Event|1|||
131811030|NCT00579345|474590768|FG003|Overall Study|Adverse Event|0|||
131811031|NCT00579345|474590769|FG004|Overall Study|Adverse Event|0|||
131811032|NCT00579345|474590770|FG005|Overall Study|Adverse Event|0|||
131811033|NCT00579345|474590771|FG006|Overall Study|Adverse Event|0|||
131811034|NCT00579345|474590772|FG007|Overall Study|Adverse Event|0|||
131811035|NCT00579345|474590765|FG000|Overall Study|Protocol Violation|1|||
131811036|NCT00579345|474590766|FG001|Overall Study|Protocol Violation|0|||
131811037|NCT00579345|474590767|FG002|Overall Study|Protocol Violation|0|||
131811038|NCT00579345|474590768|FG003|Overall Study|Protocol Violation|0|||
131754335|NCT01080625|474378163|FG002|Overall Study|Physician Decision|1|||
131907296|NCT02230891|474946740|FG002|12 Month|Lost to Follow-up|0|||
131907297|NCT02230891|474946738|FG000|12 Month|Withdrawal by Subject|0|||
131907298|NCT02230891|474946739|FG001|12 Month|Withdrawal by Subject|2|||
131907299|NCT02230891|474946740|FG002|12 Month|Withdrawal by Subject|0|||
131907300|NCT02230891|474946738|FG000|18 Month End of Study|Death|0|||
131907301|NCT02230891|474946739|FG001|18 Month End of Study|Death|0|||
131754336|NCT00364832|474378164|FG000|Core Period|Early Withdrawals|2|||
131754337|NCT00364832|474378165|FG001|Core Period|Early Withdrawals|2|||
131754338|NCT00364832|474378166|FG002|Core Period|Early Withdrawals|1|||
131754339|NCT00364832|474378167|FG003|Core Period|Early Withdrawals|1|||
131811039|NCT00579345|474590769|FG004|Overall Study|Protocol Violation|0|||
131811040|NCT00579345|474590770|FG005|Overall Study|Protocol Violation|0|||
131907302|NCT02230891|474946740|FG002|18 Month End of Study|Death|1|||
131907303|NCT02230891|474946738|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
131907304|NCT02230891|474946739|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
131907305|NCT02230891|474946740|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
131907306|NCT02404545|474946741|FG000|Overall Study|Sponsor Termination|6|||
131907307|NCT02404545|474946742|FG001|Overall Study|Sponsor Termination|6|||
131907308|NCT02370511|474946745|FG000|Overall Study|Death|10|||
131754340|NCT00364832|474378168|FG004|Core Period|Early Withdrawals|0|||
131754341|NCT00364832|474378169|FG005|Core Period|Early Withdrawals|0|||
131754342|NCT00364832|474378170|FG006|Core Period|Early Withdrawals|4|||
131754343|NCT00364832|474378171|FG007|Core Period|Early Withdrawals|1|||
131754344|NCT00364832|474378172|FG008|Core Period|Early Withdrawals|0|||
131907309|NCT02370511|474946746|FG001|Overall Study|Death|7|||
131907310|NCT02370511|474946747|FG002|Overall Study|Death|1|||
131907311|NCT02370511|474946745|FG000|Overall Study|Withdrawal by Subject|2|||
131907312|NCT02370511|474946746|FG001|Overall Study|Withdrawal by Subject|0|||
131907313|NCT02370511|474946747|FG002|Overall Study|Withdrawal by Subject|0|||
131907314|NCT02370511|474946745|FG000|Overall Study|Lost to Follow-up|0|||
131907315|NCT02370511|474946746|FG001|Overall Study|Lost to Follow-up|4|||
131907316|NCT02370511|474946747|FG002|Overall Study|Lost to Follow-up|0|||
131907317|NCT03882918|474946756|FG000|Overall Study|Study terminated by sponsor|98|||
131907318|NCT03882918|474946756|FG000|Overall Study|Protocol Violation|1|||
131907319|NCT03882918|474946756|FG000|Overall Study|Other|9|||
131907320|NCT03882918|474946756|FG000|Overall Study|Lack of Efficacy|14|||
131907321|NCT03882918|474946756|FG000|Overall Study|Adverse Event|13|||
131907322|NCT03882918|474946756|FG000|Overall Study|Withdrawal by Subject|5|||
131907323|NCT02100124|474946762|FG000|Overall Study|Lost to Follow-up|5|||
131907324|NCT02100124|474946763|FG001|Overall Study|Lost to Follow-up|11|||
131907325|NCT02100124|474946764|FG002|Overall Study|Lost to Follow-up|3|||
131907326|NCT02100124|474946762|FG000|Overall Study|Withdrawal by Subject|1|||
131907327|NCT02100124|474946763|FG001|Overall Study|Withdrawal by Subject|0|||
131907328|NCT02100124|474946764|FG002|Overall Study|Withdrawal by Subject|0|||
131907329|NCT00870727|474948722|FG000|Overall Study|Lost to Follow-up|0|||
131907330|NCT00870727|474948723|FG001|Overall Study|Lost to Follow-up|1|||
131907331|NCT00870727|474948722|FG000|Overall Study|Lack of Efficacy|1|||
131907332|NCT00870727|474948723|FG001|Overall Study|Lack of Efficacy|3|||
131907333|NCT00870727|474948722|FG000|Overall Study|Adverse Event|0|||
131907334|NCT00870727|474948723|FG001|Overall Study|Adverse Event|1|||
131907335|NCT00997334|474948729|FG000|Overall Study|still on therapy|12|||
131907336|NCT00997334|474948729|FG000|Overall Study|Adverse Event|3|||
131907337|NCT00997334|474948729|FG000|Overall Study|Patient non-compliance|1|||
131907338|NCT00997334|474948729|FG000|Overall Study|Withdrawal by Subject|3|||
131907339|NCT00997334|474948729|FG000|Overall Study|Death|2|||
131907340|NCT00997334|474948729|FG000|Overall Study|Urgent Palliative Care|2|||
131907341|NCT00997334|474948729|FG000|Overall Study|No lesion amenable|1|||
131907342|NCT00997334|474948729|FG000|Overall Study|Ineligible|1|||
131907343|NCT01586195|474948730|FG000|Overall Study|Death|11|||
131907344|NCT01586195|474948730|FG000|Overall Study|Withdrawal of Consent|5|||
131907345|NCT01586195|474948730|FG000|Overall Study|Started new anti-melanoma therapy|1|||
131907346|NCT01586195|474948730|FG000|Overall Study|Reason not specified|9|||
131907347|NCT04745351|474948733|FG000|Overall Study|Death|51|||
131907348|NCT04745351|474948734|FG001|Overall Study|Death|25|||
131907349|NCT04745351|474948733|FG000|Overall Study|Lost to Follow-up|9|||
131907350|NCT04745351|474948734|FG001|Overall Study|Lost to Follow-up|3|||
131907351|NCT04745351|474948733|FG000|Overall Study|Randomized but Never Treated|3|||
131907352|NCT04745351|474948734|FG001|Overall Study|Randomized but Never Treated|3|||
131907353|NCT04745351|474948733|FG000|Overall Study|Adverse Event|4|||
131907354|NCT04745351|474948734|FG001|Overall Study|Adverse Event|0|||
131907355|NCT04745351|474948733|FG000|Overall Study|Withdrew Consent|1|||
131907356|NCT04745351|474948734|FG001|Overall Study|Withdrew Consent|2|||
131907357|NCT04745351|474948733|FG000|Overall Study|Investigator's Discretion|2|||
131907358|NCT04745351|474948734|FG001|Overall Study|Investigator's Discretion|0|||
131907359|NCT04745351|474948733|FG000|Overall Study|Protocol Violation|1|||
131907360|NCT04745351|474948734|FG001|Overall Study|Protocol Violation|0|||
131907361|NCT03426345|474948737|FG000|Overall Study|Adverse Event|4|||
131907362|NCT03426345|474948738|FG001|Overall Study|Adverse Event|4|||
131907363|NCT03426345|474948737|FG000|Overall Study|Lack of Efficacy|1|||
131907364|NCT03426345|474948738|FG001|Overall Study|Lack of Efficacy|0|||
131907365|NCT03426345|474948737|FG000|Overall Study|Withdrawal by Subject|5|||
131907366|NCT03426345|474948738|FG001|Overall Study|Withdrawal by Subject|6|||
131907367|NCT03426345|474948737|FG000|Overall Study|Lost to Follow-up|3|||
131754345|NCT00364832|474378173|FG009|Core Period|Early Withdrawals|0|||
131907368|NCT03426345|474948738|FG001|Overall Study|Lost to Follow-up|1|||
131907369|NCT03426345|474948737|FG000|Overall Study|Protocol Deviation|3|||
131907370|NCT03426345|474948738|FG001|Overall Study|Protocol Deviation|4|||
131907371|NCT03426345|474948737|FG000|Overall Study|Reason Not Specified|1|||
131907372|NCT03426345|474948738|FG001|Overall Study|Reason Not Specified|2|||
131907373|NCT03426345|474948737|FG000|Overall Study|Missing Completion Status|1|||
131754346|NCT00364832|474378174|FG010|Core Period|Early Withdrawals|0|||
131907374|NCT03426345|474948738|FG001|Overall Study|Missing Completion Status|0|||
131754347|NCT00364832|474378175|FG011|Core Period|Early Withdrawals|0|||
131907375|NCT01026493|474948739|FG000|Overall Study|Protocol Violation|0|||
131907376|NCT01026493|474948740|FG001|Overall Study|Protocol Violation|1|||
131907377|NCT01026493|474948741|FG002|Overall Study|Protocol Violation|0|||
131754348|NCT00364832|474378164|FG000|Extension Year 1|Early Withdrawals|0|||
131754349|NCT00364832|474378165|FG001|Extension Year 1|Early Withdrawals|0|||
131907378|NCT01026493|474948742|FG003|Overall Study|Protocol Violation|0|||
131907379|NCT01026493|474948743|FG004|Overall Study|Protocol Violation|2|||
131907380|NCT01026493|474948744|FG005|Overall Study|Protocol Violation|3|||
131754350|NCT00364832|474378166|FG002|Extension Year 1|Early Withdrawals|0|||
131754351|NCT00364832|474378167|FG003|Extension Year 1|Early Withdrawals|0|||
131754352|NCT00364832|474378168|FG004|Extension Year 1|Early Withdrawals|0|||
131754353|NCT00364832|474378169|FG005|Extension Year 1|Early Withdrawals|0|||
131754354|NCT00364832|474378170|FG006|Extension Year 1|Early Withdrawals|0|||
131754355|NCT00364832|474378171|FG007|Extension Year 1|Early Withdrawals|0|||
131754356|NCT00364832|474378172|FG008|Extension Year 1|Early Withdrawals|0|||
131754357|NCT00364832|474378173|FG009|Extension Year 1|Early Withdrawals|4|||
131754358|NCT00364832|474378174|FG010|Extension Year 1|Early Withdrawals|2|||
131754359|NCT00364832|474378175|FG011|Extension Year 1|Early Withdrawals|10|||
131754360|NCT00364832|474378164|FG000|Extension Year 2|Early Withdrawals|0|||
131449786|NCT01750229|473276714|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
131754361|NCT00364832|474378165|FG001|Extension Year 2|Early Withdrawals|0|||
131754362|NCT00364832|474378166|FG002|Extension Year 2|Early Withdrawals|0|||
131907381|NCT01026493|474948745|FG006|Overall Study|Protocol Violation|4|||
131907382|NCT01026493|474948746|FG007|Overall Study|Protocol Violation|1|||
131907383|NCT00630916|474948750|FG000|Overall Study|Death|110|||
131907384|NCT00630916|474948750|FG000|Overall Study|Explant|8|||
131907385|NCT00630916|474948750|FG000|Overall Study|Lost to Follow-up|5|||
131907386|NCT00630916|474948750|FG000|Overall Study|Withdrawal by Subject|30|||
131907387|NCT00630916|474948750|FG000|Overall Study|Protocol Violation|7|||
131907388|NCT00630916|474948750|FG000|Overall Study|Physician Decision|47|||
131907389|NCT00630916|474948750|FG000|Overall Study|Lack of Efficacy|3|||
131907390|NCT01299584|474948758|FG000|Overall Study|Protocol Violation|9|||
131907391|NCT00324155|474948759|FG000|Enrolled and Randomized|No longer met study criteria|3|||
131907392|NCT00324155|474948760|FG001|Enrolled and Randomized|No longer met study criteria|0|||
131907393|NCT00324155|474948759|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
131907394|NCT00324155|474948760|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
131907395|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
131907396|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
131907397|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
131907398|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
131907399|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Death|8|||
131907400|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Death|15|||
131907401|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
131907402|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
131907403|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
131907404|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
131398474|NCT00334737|473079284|FG000|Hospital Phase|Death|1|||
131398475|NCT00334737|473079285|FG001|Hospital Phase|Death|2|||
131398476|NCT00334737|473079286|FG002|Hospital Phase|Death|3|||
131398477|NCT00334737|473079284|FG000|Hospital Phase|Withdrawal by Subject|0|||
131398478|NCT00334737|473079285|FG001|Hospital Phase|Withdrawal by Subject|0|||
131398479|NCT00334737|473079286|FG002|Hospital Phase|Withdrawal by Subject|1|||
131398480|NCT00334737|473079284|FG000|Hospital Phase|Did not receive study drug|1|||
131398481|NCT00334737|473079285|FG001|Hospital Phase|Did not receive study drug|0|||
131398482|NCT00334737|473079286|FG002|Hospital Phase|Did not receive study drug|0|||
131398483|NCT00334737|473079284|FG000|Follow up Phase|Lost to Follow-up|5|||
131398484|NCT00334737|473079285|FG001|Follow up Phase|Lost to Follow-up|3|||
131398485|NCT00334737|473079286|FG002|Follow up Phase|Lost to Follow-up|6|||
131398486|NCT00583752|473079287|FG000|Overall Study|Lost to Follow-up|5|||
131398487|NCT00583752|473079288|FG001|Overall Study|Lost to Follow-up|5|||
131398488|NCT02147197|473079289|FG000|Overall Study|Adverse Event|1|||
131907405|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
131907406|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
131398489|NCT02147197|473079290|FG001|Overall Study|Adverse Event|0|||
131398490|NCT02147197|473079291|FG002|Overall Study|Adverse Event|0|||
131398491|NCT02147197|473079289|FG000|Overall Study|Withdrawal of Consent|4|||
131398492|NCT02147197|473079290|FG001|Overall Study|Withdrawal of Consent|3|||
131907407|NCT00324155|474948759|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
131907408|NCT00324155|474948760|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
131449787|NCT02346721|473276715|FG000|Overall Study|Withdrew Consent|3|||
131449788|NCT02346721|473276715|FG000|Overall Study|Lack of Efficacy|1|||
131754363|NCT00364832|474378167|FG003|Extension Year 2|Early Withdrawals|0|||
131754364|NCT00364832|474378168|FG004|Extension Year 2|Early Withdrawals|0|||
131907409|NCT00324155|474948759|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
131398493|NCT02147197|473079291|FG002|Overall Study|Withdrawal of Consent|2|||
131398494|NCT02147197|473079289|FG000|Overall Study|Lost to Follow-up|2|||
131398495|NCT02147197|473079290|FG001|Overall Study|Lost to Follow-up|3|||
131754365|NCT00364832|474378169|FG005|Extension Year 2|Early Withdrawals|0|||
131754366|NCT00364832|474378170|FG006|Extension Year 2|Early Withdrawals|0|||
131754367|NCT00364832|474378171|FG007|Extension Year 2|Early Withdrawals|0|||
131754368|NCT00364832|474378172|FG008|Extension Year 2|Early Withdrawals|0|||
131754369|NCT00364832|474378173|FG009|Extension Year 2|Early Withdrawals|5|||
131754370|NCT00364832|474378174|FG010|Extension Year 2|Early Withdrawals|5|||
131754371|NCT00364832|474378175|FG011|Extension Year 2|Early Withdrawals|3|||
131754372|NCT02939976|474378178|FG000|Overall Study|Lost to Follow-up|7|||
131754373|NCT02939976|474378179|FG001|Overall Study|Lost to Follow-up|1|||
131754374|NCT02939976|474378180|FG002|Overall Study|Lost to Follow-up|1|||
131754375|NCT02939976|474378181|FG003|Overall Study|Lost to Follow-up|2|||
131754376|NCT02939976|474378178|FG000|Overall Study|Withdrawal by Subject|4|||
131754377|NCT02939976|474378179|FG001|Overall Study|Withdrawal by Subject|0|||
131754378|NCT02939976|474378180|FG002|Overall Study|Withdrawal by Subject|2|||
131754379|NCT02939976|474378181|FG003|Overall Study|Withdrawal by Subject|4|||
131754380|NCT02939976|474378178|FG000|Overall Study|Due to early study closure|4|||
131754381|NCT02939976|474378179|FG001|Overall Study|Due to early study closure|3|||
131754382|NCT02939976|474378180|FG002|Overall Study|Due to early study closure|2|||
131754383|NCT02939976|474378181|FG003|Overall Study|Due to early study closure|3|||
131754384|NCT01872897|474378182|FG000|Overall Study|Withdrawal by Subject|1|||
131754385|NCT01872897|474378183|FG001|Overall Study|Withdrawal by Subject|0|||
131754386|NCT04159701|474378186|FG000|Period 1: Treatment Period|Pregnancy|1|||
131754387|NCT04159701|474378187|FG001|Period 1: Treatment Period|Pregnancy|0|||
131754388|NCT04159701|474378186|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
131754389|NCT04159701|474378187|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
131754390|NCT04159701|474378186|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
131754391|NCT04159701|474378187|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
131754392|NCT04159701|474378186|FG000|Washout Period|site terminated by sponsor|0|||
131754393|NCT04159701|474378187|FG001|Washout Period|site terminated by sponsor|1|||
131754394|NCT04159701|474378186|FG000|Washout Period|study terminated by sponsor|10|||
131754395|NCT04159701|474378187|FG001|Washout Period|study terminated by sponsor|3|||
131754396|NCT04159701|474378186|FG000|Washout Period|Withdrawal by Subject|1|||
131754397|NCT04159701|474378187|FG001|Washout Period|Withdrawal by Subject|0|||
131754398|NCT04159701|474378186|FG000|Washout Period|Inadvertent Enrollment|1|||
131754399|NCT04159701|474378187|FG001|Washout Period|Inadvertent Enrollment|0|||
131754400|NCT04159701|474378186|FG000|Washout Period|Miscellaneous|1|||
131754401|NCT04159701|474378187|FG001|Washout Period|Miscellaneous|0|||
131754402|NCT04159701|474378186|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
131754403|NCT04159701|474378187|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
131754404|NCT04159701|474378186|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
131754405|NCT04159701|474378187|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
131754406|NCT04159701|474378186|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
131754407|NCT04159701|474378187|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
131754408|NCT04159701|474378186|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
131754409|NCT04159701|474378187|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
131754410|NCT04159701|474378186|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
131754411|NCT04159701|474378187|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
131754412|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
131754413|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
131754414|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
131754415|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
131754416|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
131754417|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
131754418|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
131754419|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
131754420|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
131754421|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
131754422|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
131754423|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
131754424|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
131754425|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
131754426|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
131754427|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
131754428|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
131754429|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
131754430|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
131754431|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
131754432|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
131754433|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
131754434|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
131398496|NCT02147197|473079291|FG002|Overall Study|Lost to Follow-up|1|||
131398497|NCT02147197|473079289|FG000|Overall Study|Protocol Violation|1|||
131398498|NCT02147197|473079290|FG001|Overall Study|Protocol Violation|0|||
131398499|NCT02147197|473079291|FG002|Overall Study|Protocol Violation|3|||
131398500|NCT02147197|473079289|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131907410|NCT00324155|474948760|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
131907411|NCT00324155|474948759|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
131398501|NCT02147197|473079290|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131398502|NCT02147197|473079291|FG002|Overall Study|Other Miscellaneous Reasons|3|||
131398503|NCT00782171|473081174|FG000|Overall Study|Lost to Follow-up|2|||
131398504|NCT00782171|473081175|FG001|Overall Study|Lost to Follow-up|2|||
131398505|NCT00782171|473081174|FG000|Overall Study|Withdrawal by Subject|2|||
131398506|NCT00782171|473081175|FG001|Overall Study|Withdrawal by Subject|1|||
131398507|NCT00782171|473081174|FG000|Overall Study|complications|3|||
131398508|NCT00782171|473081175|FG001|Overall Study|complications|1|||
131398509|NCT00782171|473081174|FG000|Overall Study|others|7|||
131398510|NCT00782171|473081175|FG001|Overall Study|others|9|||
131398511|NCT00782171|473081174|FG000|Overall Study|not eligible|8|||
131398512|NCT00782171|473081175|FG001|Overall Study|not eligible|6|||
131398513|NCT02482428|473081188|FG000|Overall Study|Lost to Follow-up|4|||
131398514|NCT02482428|473081189|FG001|Overall Study|Lost to Follow-up|9|||
131398515|NCT02482428|473081190|FG002|Overall Study|Lost to Follow-up|1|||
131398516|NCT02482428|473081191|FG003|Overall Study|Lost to Follow-up|2|||
131398517|NCT02482428|473081192|FG004|Overall Study|Lost to Follow-up|4|||
131398518|NCT02482428|473081188|FG000|Overall Study|Physician Decision|0|||
131398519|NCT02482428|473081189|FG001|Overall Study|Physician Decision|0|||
131398520|NCT02482428|473081190|FG002|Overall Study|Physician Decision|0|||
131398521|NCT02482428|473081191|FG003|Overall Study|Physician Decision|0|||
131398522|NCT02482428|473081192|FG004|Overall Study|Physician Decision|1|||
131398523|NCT02482428|473081188|FG000|Overall Study|protocol deviation|1|||
131398524|NCT02482428|473081189|FG001|Overall Study|protocol deviation|1|||
131398525|NCT02482428|473081190|FG002|Overall Study|protocol deviation|0|||
131398526|NCT02482428|473081191|FG003|Overall Study|protocol deviation|0|||
131398527|NCT02482428|473081192|FG004|Overall Study|protocol deviation|0|||
131398528|NCT02482428|473081188|FG000|Overall Study|subject/guardian decision|4|||
131398529|NCT02482428|473081189|FG001|Overall Study|subject/guardian decision|2|||
131398530|NCT02482428|473081190|FG002|Overall Study|subject/guardian decision|0|||
131398531|NCT02482428|473081191|FG003|Overall Study|subject/guardian decision|0|||
131398532|NCT02482428|473081192|FG004|Overall Study|subject/guardian decision|2|||
131398533|NCT04308239|473081199|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
131398534|NCT04308239|473081200|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
131398535|NCT04308239|473081199|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
131398536|NCT04308239|473081200|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
131398537|NCT04308239|473081199|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
131398538|NCT04308239|473081200|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
131398539|NCT04308239|473081199|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
131398540|NCT04308239|473081200|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
131398541|NCT01443364|473081201|FG000|Overall Study|Lack of Efficacy|14|||
131398542|NCT01443364|473081201|FG000|Overall Study|Lost to Follow-up|3|||
131398543|NCT01443364|473081201|FG000|Overall Study|Withdrawal by Subject|5|||
131398544|NCT01443364|473081201|FG000|Overall Study|Other Reason|4|||
131398545|NCT01443364|473081201|FG000|Overall Study|SAE, non-fatal|6|||
131398546|NCT01443364|473081201|FG000|Overall Study|AE, non-serious non-fatal|8|||
131398547|NCT01443364|473081201|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131398548|NCT00559845|473081204|FG000|Overall Study|Withdrew Consent|1|||
131398549|NCT00559845|473081204|FG000|Overall Study|Disease Progression|1|||
131398550|NCT00559845|473081204|FG000|Overall Study|Adverse Event|3|||
131398551|NCT00559845|473081204|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
131398552|NCT00559845|473081204|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
131398553|NCT01406938|473081207|FG000|Induction Period|Subject/guardian decision|6|||
131398554|NCT01406938|473081208|FG001|Induction Period|Subject/guardian decision|8|||
131398555|NCT01406938|473081209|FG002|Induction Period|Subject/guardian decision|0|||
131907412|NCT00324155|474948760|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
131907413|NCT00324155|474948759|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
131907414|NCT00324155|474948760|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
131907415|NCT00324155|474948759|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
131907416|NCT00324155|474948760|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
131907417|NCT00324155|474948759|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
131907418|NCT00324155|474948760|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
131907419|NCT00324155|474948759|FG000|Follow-up Phase|On-going participants still on drug|11|||
131907420|NCT00324155|474948760|FG001|Follow-up Phase|On-going participants still on drug|6|||
131398556|NCT01406938|473081210|FG003|Induction Period|Subject/guardian decision|0|||
131398557|NCT01406938|473081211|FG004|Induction Period|Subject/guardian decision|0|||
131398558|NCT01406938|473081212|FG005|Induction Period|Subject/guardian decision|0|||
131398559|NCT01406938|473081207|FG000|Induction Period|Protocol deviation|1|||
131398560|NCT01406938|473081208|FG001|Induction Period|Protocol deviation|0|||
131398561|NCT01406938|473081209|FG002|Induction Period|Protocol deviation|0|||
131754435|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
131754436|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
131754437|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
131754438|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
131754439|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
131754440|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
131754441|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
131754442|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
131754443|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
131754444|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
131754445|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
131754446|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
131754447|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
131754448|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
131754449|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
131754450|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
131754451|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
131754452|NCT03605836|474378188|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
131754453|NCT03605836|474378189|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
131754454|NCT03605836|474378190|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
131754455|NCT03605836|474378191|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
131754456|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
131754457|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
131754458|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
131754459|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
131754460|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
131754461|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
131754462|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
131754463|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
131811041|NCT00579345|474590771|FG006|Overall Study|Protocol Violation|0|||
131811042|NCT00579345|474590772|FG007|Overall Study|Protocol Violation|1|||
131811043|NCT00579345|474590765|FG000|Overall Study|Death|1|||
131811044|NCT00579345|474590766|FG001|Overall Study|Death|1|||
131811045|NCT00579345|474590767|FG002|Overall Study|Death|1|||
131811046|NCT00579345|474590768|FG003|Overall Study|Death|1|||
131811047|NCT00579345|474590769|FG004|Overall Study|Death|0|||
131811048|NCT00579345|474590770|FG005|Overall Study|Death|0|||
131811049|NCT00579345|474590771|FG006|Overall Study|Death|0|||
131811050|NCT00579345|474590772|FG007|Overall Study|Death|0|||
131811051|NCT01701674|474590776|FG000|Overall Study|Unable to safely complete treatment|1|||
131811052|NCT03032172|474590777|FG000|Treatment Period|Adverse Event|0|||
131811053|NCT03032172|474590778|FG001|Treatment Period|Adverse Event|1|||
131811054|NCT03032172|474590779|FG002|Treatment Period|Adverse Event|0|||
131811055|NCT03032172|474590780|FG003|Treatment Period|Adverse Event|0|||
131811056|NCT03032172|474590781|FG004|Treatment Period|Adverse Event|0|||
131811057|NCT03032172|474590782|FG005|Treatment Period|Adverse Event|0|||
131811058|NCT03032172|474590783|FG006|Treatment Period|Adverse Event|0|||
131811059|NCT03032172|474590784|FG007|Treatment Period|Adverse Event|0|||
131811060|NCT03032172|474590777|FG000|Treatment Period|Lack of Efficacy|0|||
131811061|NCT03032172|474590778|FG001|Treatment Period|Lack of Efficacy|1|||
131811062|NCT03032172|474590779|FG002|Treatment Period|Lack of Efficacy|0|||
131811063|NCT03032172|474590780|FG003|Treatment Period|Lack of Efficacy|0|||
131811064|NCT03032172|474590781|FG004|Treatment Period|Lack of Efficacy|0|||
131811065|NCT03032172|474590782|FG005|Treatment Period|Lack of Efficacy|0|||
131811066|NCT03032172|474590783|FG006|Treatment Period|Lack of Efficacy|0|||
131811067|NCT03032172|474590784|FG007|Treatment Period|Lack of Efficacy|0|||
131811068|NCT03032172|474590777|FG000|Treatment Period|Non-compliance With Study Drug|0|||
131811069|NCT03032172|474590778|FG001|Treatment Period|Non-compliance With Study Drug|1|||
131811070|NCT03032172|474590779|FG002|Treatment Period|Non-compliance With Study Drug|0|||
131811071|NCT03032172|474590780|FG003|Treatment Period|Non-compliance With Study Drug|0|||
131811072|NCT03032172|474590781|FG004|Treatment Period|Non-compliance With Study Drug|0|||
131811073|NCT03032172|474590782|FG005|Treatment Period|Non-compliance With Study Drug|0|||
131811074|NCT03032172|474590783|FG006|Treatment Period|Non-compliance With Study Drug|0|||
131811075|NCT03032172|474590784|FG007|Treatment Period|Non-compliance With Study Drug|0|||
131811076|NCT03032172|474590777|FG000|Treatment Period|Reason Not Specified|0|||
131907421|NCT00390689|474948761|FG000|Overall Study|Adverse Event|2|||
131907422|NCT00390689|474948762|FG001|Overall Study|Adverse Event|5|||
131907423|NCT00390689|474948763|FG002|Overall Study|Adverse Event|2|||
131907424|NCT00390689|474948761|FG000|Overall Study|Lack of Efficacy|0|||
131907425|NCT00390689|474948762|FG001|Overall Study|Lack of Efficacy|0|||
131907426|NCT00390689|474948763|FG002|Overall Study|Lack of Efficacy|1|||
131907427|NCT00390689|474948761|FG000|Overall Study|Protocol Violation|1|||
131907428|NCT00390689|474948762|FG001|Overall Study|Protocol Violation|0|||
131907429|NCT00390689|474948763|FG002|Overall Study|Protocol Violation|0|||
131907430|NCT00390689|474948761|FG000|Overall Study|Investigator's judgement|2|||
131907431|NCT00390689|474948762|FG001|Overall Study|Investigator's judgement|0|||
131907432|NCT00390689|474948763|FG002|Overall Study|Investigator's judgement|0|||
131907433|NCT03810183|474948767|FG000|Overall Study|Study terminated by Sponsor|2|||
131907434|NCT03810183|474948768|FG001|Overall Study|Study terminated by Sponsor|1|||
131907435|NCT00323063|474948769|FG000|Overall Study|Adverse Event|1|||
131907436|NCT00323063|474948770|FG001|Overall Study|Adverse Event|0|||
131907437|NCT00323063|474948769|FG000|Overall Study|brain mets discovered prior to treatment|1|||
131907438|NCT00323063|474948770|FG001|Overall Study|brain mets discovered prior to treatment|0|||
131907439|NCT00423046|474948772|FG000|Overall Study|Other|340|||
131907440|NCT00423046|474948773|FG001|Overall Study|Other|345|||
131907441|NCT00830128|474948774|FG000|Overall Study|Adverse Event|5|||
131907442|NCT00830128|474948774|FG000|Overall Study|Lack of Efficacy|7|||
131907443|NCT00830128|474948774|FG000|Overall Study|Protocol Violation|1|||
131907444|NCT00830128|474948774|FG000|Overall Study|Withdrawal by Subject|2|||
131907445|NCT00830128|474948774|FG000|Overall Study|Family obligation|1|||
131907446|NCT00830128|474948774|FG000|Overall Study|Relocation|1|||
131907447|NCT00830128|474948774|FG000|Overall Study|Work obligation|1|||
131907448|NCT00830128|474948774|FG000|Overall Study|Operating a vehicle|1|||
131907449|NCT03080935|474948784|FG000|Overall Study|Death|34|||
131907450|NCT03080935|474948785|FG001|Overall Study|Death|50|||
131907451|NCT03080935|474948784|FG000|Overall Study|Lost to Follow-up|5|||
131907452|NCT03080935|474948785|FG001|Overall Study|Lost to Follow-up|4|||
131907453|NCT03080935|474948784|FG000|Overall Study|Withdrawal by Subject|11|||
131907454|NCT03080935|474948785|FG001|Overall Study|Withdrawal by Subject|15|||
131907455|NCT02175121|474948786|FG000|Overall Study|Lack of Efficacy|1|||
131907456|NCT02175121|474948787|FG001|Overall Study|Lack of Efficacy|0|||
131907457|NCT02175121|474948788|FG002|Overall Study|Lack of Efficacy|0|||
131907458|NCT02175121|474948789|FG003|Overall Study|Lack of Efficacy|0|||
131907459|NCT02175121|474948790|FG004|Overall Study|Lack of Efficacy|0|||
131907460|NCT02175121|474948786|FG000|Overall Study|Lost to Follow-up|0|||
131907461|NCT02175121|474948787|FG001|Overall Study|Lost to Follow-up|1|||
131907462|NCT02175121|474948788|FG002|Overall Study|Lost to Follow-up|0|||
131907463|NCT02175121|474948789|FG003|Overall Study|Lost to Follow-up|1|||
131907464|NCT02175121|474948790|FG004|Overall Study|Lost to Follow-up|0|||
131907465|NCT02175121|474948786|FG000|Overall Study|Personal emergency|0|||
131907466|NCT02175121|474948787|FG001|Overall Study|Personal emergency|0|||
131907467|NCT02175121|474948788|FG002|Overall Study|Personal emergency|0|||
131907468|NCT02175121|474948789|FG003|Overall Study|Personal emergency|0|||
131907469|NCT02175121|474948790|FG004|Overall Study|Personal emergency|1|||
131907470|NCT02175121|474948786|FG000|Overall Study|Schedule conflict|0|||
131907471|NCT02175121|474948787|FG001|Overall Study|Schedule conflict|0|||
131907472|NCT02175121|474948788|FG002|Overall Study|Schedule conflict|1|||
131907473|NCT02175121|474948789|FG003|Overall Study|Schedule conflict|0|||
131907474|NCT02175121|474948790|FG004|Overall Study|Schedule conflict|0|||
131907475|NCT02175121|474948786|FG000|Overall Study|Time issues|0|||
131907476|NCT02175121|474948787|FG001|Overall Study|Time issues|0|||
131907477|NCT02175121|474948788|FG002|Overall Study|Time issues|1|||
131907478|NCT02175121|474948789|FG003|Overall Study|Time issues|0|||
131907479|NCT02175121|474948790|FG004|Overall Study|Time issues|0|||
131907480|NCT00269152|474948797|FG000|Overall Study|Adverse Event|9|||
131907481|NCT00269152|474948798|FG001|Overall Study|Adverse Event|3|||
131907482|NCT00269152|474948797|FG000|Overall Study|Withdrawal by Subject|7|||
131907483|NCT00269152|474948798|FG001|Overall Study|Withdrawal by Subject|3|||
131907484|NCT00269152|474948797|FG000|Overall Study|Physician Decision|2|||
131907485|NCT00269152|474948798|FG001|Overall Study|Physician Decision|3|||
131907486|NCT00269152|474948797|FG000|Overall Study|Protocol Violation|0|||
131907487|NCT00269152|474948798|FG001|Overall Study|Protocol Violation|1|||
131907488|NCT04249427|474948799|FG000|Overall Study|Adverse Event|3|||
131907489|NCT04249427|474948800|FG001|Overall Study|Adverse Event|1|||
131907490|NCT04249427|474948799|FG000|Overall Study|Lack of Efficacy|0|||
131907491|NCT04249427|474948800|FG001|Overall Study|Lack of Efficacy|1|||
131907492|NCT04249427|474948799|FG000|Overall Study|Withdrawal by Subject|1|||
131907493|NCT04249427|474948800|FG001|Overall Study|Withdrawal by Subject|2|||
131907494|NCT01673178|474948801|FG000|Overall Study|Lost to Follow-up|0|||
131907495|NCT01673178|474948802|FG001|Overall Study|Lost to Follow-up|1|||
131907496|NCT01673178|474948803|FG002|Overall Study|Lost to Follow-up|0|||
131907497|NCT01673178|474948804|FG003|Overall Study|Lost to Follow-up|0|||
131907498|NCT01673178|474948805|FG004|Overall Study|Lost to Follow-up|0|||
131907499|NCT01673178|474948801|FG000|Overall Study|Withdrawal by Subject|0|||
131907500|NCT01673178|474948802|FG001|Overall Study|Withdrawal by Subject|0|||
131907501|NCT01673178|474948803|FG002|Overall Study|Withdrawal by Subject|1|||
131907502|NCT01673178|474948804|FG003|Overall Study|Withdrawal by Subject|4|||
131907503|NCT01673178|474948805|FG004|Overall Study|Withdrawal by Subject|2|||
131907504|NCT01673178|474948801|FG000|Overall Study|Protocol Violation|1|||
131907505|NCT01673178|474948802|FG001|Overall Study|Protocol Violation|1|||
131907506|NCT01673178|474948803|FG002|Overall Study|Protocol Violation|0|||
131907507|NCT01673178|474948804|FG003|Overall Study|Protocol Violation|1|||
131907508|NCT01673178|474948805|FG004|Overall Study|Protocol Violation|0|||
131907509|NCT01673178|474948801|FG000|Overall Study|Adverse Event|1|||
131907510|NCT01673178|474948802|FG001|Overall Study|Adverse Event|0|||
131907511|NCT01673178|474948803|FG002|Overall Study|Adverse Event|0|||
131907512|NCT01673178|474948804|FG003|Overall Study|Adverse Event|2|||
131907513|NCT01673178|474948805|FG004|Overall Study|Adverse Event|0|||
131907514|NCT01673178|474948801|FG000|Overall Study|Other|1|||
131907515|NCT01673178|474948802|FG001|Overall Study|Other|0|||
131907516|NCT01673178|474948803|FG002|Overall Study|Other|2|||
131907517|NCT01673178|474948804|FG003|Overall Study|Other|1|||
131907518|NCT01673178|474948805|FG004|Overall Study|Other|0|||
131907519|NCT01419314|474948806|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
131907520|NCT01419314|474948807|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
131907521|NCT01419314|474948806|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
131907522|NCT01419314|474948807|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
131907523|NCT01419314|474948806|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
131907524|NCT01419314|474948807|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
131907525|NCT00402727|474948809|FG000|Overall Study|Adverse Event|10|||
131907526|NCT00402727|474948810|FG001|Overall Study|Adverse Event|6|||
131907527|NCT00402727|474948809|FG000|Overall Study|Death|1|||
131907528|NCT00402727|474948810|FG001|Overall Study|Death|0|||
131907529|NCT00402727|474948809|FG000|Overall Study|Lack of Efficacy|1|||
131907530|NCT00402727|474948810|FG001|Overall Study|Lack of Efficacy|3|||
131907531|NCT00402727|474948809|FG000|Overall Study|Lost to Follow-up|24|||
131907532|NCT00402727|474948810|FG001|Overall Study|Lost to Follow-up|11|||
131907533|NCT00402727|474948809|FG000|Overall Study|Physician Decision|1|||
131907534|NCT00402727|474948810|FG001|Overall Study|Physician Decision|1|||
131907535|NCT00402727|474948809|FG000|Overall Study|Protocol Violation|0|||
131907536|NCT00402727|474948810|FG001|Overall Study|Protocol Violation|4|||
131907537|NCT00402727|474948809|FG000|Overall Study|Withdrawal by Subject|3|||
131907538|NCT00402727|474948810|FG001|Overall Study|Withdrawal by Subject|7|||
131907539|NCT00402727|474948809|FG000|Overall Study|supply problems|2|||
131907540|NCT00402727|474948810|FG001|Overall Study|supply problems|1|||
131907541|NCT00402727|474948809|FG000|Overall Study|non-compliance|0|||
131907542|NCT00402727|474948810|FG001|Overall Study|non-compliance|1|||
131907543|NCT03188055|474948811|FG000|Overall Study|Unavailable for training|0|||
131907544|NCT03188055|474948812|FG001|Overall Study|Unavailable for training|0|||
131907545|NCT03188055|474948813|FG002|Overall Study|Unavailable for training|19|||
131907546|NCT03188055|474948814|FG003|Overall Study|Unavailable for training|0|||
131907547|NCT03188055|474948815|FG004|Overall Study|Unavailable for training|0|||
131907548|NCT03188055|474948816|FG005|Overall Study|Unavailable for training|0|||
131907549|NCT03188055|474948811|FG000|Overall Study|Lost to Follow-up|0|||
131907550|NCT03188055|474948812|FG001|Overall Study|Lost to Follow-up|18|||
131907551|NCT03188055|474948813|FG002|Overall Study|Lost to Follow-up|0|||
131907552|NCT03188055|474948814|FG003|Overall Study|Lost to Follow-up|11|||
131907553|NCT03188055|474948815|FG004|Overall Study|Lost to Follow-up|0|||
131907554|NCT03188055|474948816|FG005|Overall Study|Lost to Follow-up|0|||
131907555|NCT03188055|474948811|FG000|Overall Study|Withdrawal by Subject|0|||
131907556|NCT03188055|474948812|FG001|Overall Study|Withdrawal by Subject|1|||
131907557|NCT03188055|474948813|FG002|Overall Study|Withdrawal by Subject|0|||
131907558|NCT03188055|474948814|FG003|Overall Study|Withdrawal by Subject|1|||
131907559|NCT03188055|474948815|FG004|Overall Study|Withdrawal by Subject|0|||
131907560|NCT03188055|474948816|FG005|Overall Study|Withdrawal by Subject|0|||
131907561|NCT01405898|474948817|FG000|Overall Study|Withdrawal by Subject|2|||
131907562|NCT01405898|474948818|FG001|Overall Study|Withdrawal by Subject|2|||
131907563|NCT01687218|474948820|FG000|Overall Study|Withdrawal by Subject|2|||
131907564|NCT01687218|474948821|FG001|Overall Study|Withdrawal by Subject|3|||
131907565|NCT01687218|474948822|FG002|Overall Study|Withdrawal by Subject|0|||
131907566|NCT01687218|474948823|FG003|Overall Study|Withdrawal by Subject|1|||
131907567|NCT01687218|474948824|FG004|Overall Study|Withdrawal by Subject|1|||
131907568|NCT01687218|474948825|FG005|Overall Study|Withdrawal by Subject|0|||
131907569|NCT01687218|474948820|FG000|Overall Study|Relocated, no follow-up planned|1|||
131907570|NCT01687218|474948821|FG001|Overall Study|Relocated, no follow-up planned|0|||
131907571|NCT01687218|474948822|FG002|Overall Study|Relocated, no follow-up planned|1|||
131907572|NCT01687218|474948823|FG003|Overall Study|Relocated, no follow-up planned|1|||
131907573|NCT01687218|474948824|FG004|Overall Study|Relocated, no follow-up planned|0|||
131907574|NCT01687218|474948825|FG005|Overall Study|Relocated, no follow-up planned|0|||
131907575|NCT03139552|474948839|FG000|Overall Study|unable to attend tasting due to schedule|3|||
131907576|NCT00264147|474948855|FG000|Treatment I Period|Adverse Event|3|||
131907577|NCT00264147|474948856|FG001|Treatment I Period|Adverse Event|6|||
131754464|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
131754465|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
131754466|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
131754467|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
131754468|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
131754469|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
131754470|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
131754471|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
131754472|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
131754473|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
131754474|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
131754475|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
131754476|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
131754477|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
131754478|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
131754479|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
131811077|NCT03032172|474590778|FG001|Treatment Period|Reason Not Specified|4|||
131811078|NCT03032172|474590779|FG002|Treatment Period|Reason Not Specified|1|||
131811079|NCT03032172|474590780|FG003|Treatment Period|Reason Not Specified|0|||
131811080|NCT03032172|474590781|FG004|Treatment Period|Reason Not Specified|0|||
131811081|NCT03032172|474590782|FG005|Treatment Period|Reason Not Specified|0|||
131811082|NCT03032172|474590783|FG006|Treatment Period|Reason Not Specified|0|||
131811083|NCT03032172|474590784|FG007|Treatment Period|Reason Not Specified|0|||
131811084|NCT03032172|474590777|FG000|Treatment Period|Physician Decision|0|||
131811085|NCT03032172|474590778|FG001|Treatment Period|Physician Decision|2|||
131811086|NCT03032172|474590779|FG002|Treatment Period|Physician Decision|1|||
131811087|NCT03032172|474590780|FG003|Treatment Period|Physician Decision|0|||
131811088|NCT03032172|474590781|FG004|Treatment Period|Physician Decision|0|||
131811089|NCT03032172|474590782|FG005|Treatment Period|Physician Decision|0|||
131811090|NCT03032172|474590783|FG006|Treatment Period|Physician Decision|0|||
131811091|NCT03032172|474590784|FG007|Treatment Period|Physician Decision|0|||
131811092|NCT03032172|474590777|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
131811093|NCT03032172|474590778|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
131811094|NCT03032172|474590779|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
131811095|NCT03032172|474590780|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
131811096|NCT03032172|474590781|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
131811097|NCT03032172|474590782|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
131811098|NCT03032172|474590783|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
131811099|NCT03032172|474590784|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
131811100|NCT03032172|474590777|FG000|Treatment Period|Withdrawal by Subject|2|||
131811101|NCT03032172|474590778|FG001|Treatment Period|Withdrawal by Subject|0|||
131811102|NCT03032172|474590779|FG002|Treatment Period|Withdrawal by Subject|3|||
131811103|NCT03032172|474590780|FG003|Treatment Period|Withdrawal by Subject|0|||
131811104|NCT03032172|474590781|FG004|Treatment Period|Withdrawal by Subject|0|||
131811105|NCT03032172|474590782|FG005|Treatment Period|Withdrawal by Subject|0|||
131811106|NCT03032172|474590783|FG006|Treatment Period|Withdrawal by Subject|0|||
131811107|NCT03032172|474590784|FG007|Treatment Period|Withdrawal by Subject|0|||
131811108|NCT03032172|474590777|FG000|Open-label Extension Period|Death|0|||
131811109|NCT03032172|474590778|FG001|Open-label Extension Period|Death|0|||
131811110|NCT03032172|474590779|FG002|Open-label Extension Period|Death|0|||
131811111|NCT03032172|474590780|FG003|Open-label Extension Period|Death|0|||
131811112|NCT03032172|474590781|FG004|Open-label Extension Period|Death|0|||
131811113|NCT03032172|474590782|FG005|Open-label Extension Period|Death|0|||
131811114|NCT03032172|474590783|FG006|Open-label Extension Period|Death|0|||
131811115|NCT03032172|474590784|FG007|Open-label Extension Period|Death|2|||
131811116|NCT03032172|474590777|FG000|Open-label Extension Period|Reason Not Specified|0|||
131811117|NCT03032172|474590778|FG001|Open-label Extension Period|Reason Not Specified|0|||
131811118|NCT03032172|474590779|FG002|Open-label Extension Period|Reason Not Specified|0|||
131811119|NCT03032172|474590780|FG003|Open-label Extension Period|Reason Not Specified|0|||
131811120|NCT03032172|474590781|FG004|Open-label Extension Period|Reason Not Specified|0|||
131811121|NCT03032172|474590782|FG005|Open-label Extension Period|Reason Not Specified|5|||
131811122|NCT03032172|474590783|FG006|Open-label Extension Period|Reason Not Specified|3|||
131811123|NCT03032172|474590784|FG007|Open-label Extension Period|Reason Not Specified|0|||
131811124|NCT03032172|474590777|FG000|Open-label Extension Period|Pregnancy|0|||
131811125|NCT03032172|474590778|FG001|Open-label Extension Period|Pregnancy|0|||
131811126|NCT03032172|474590779|FG002|Open-label Extension Period|Pregnancy|0|||
131907578|NCT00264147|474948857|FG002|Treatment I Period|Adverse Event|3|||
131907579|NCT00264147|474948858|FG003|Treatment I Period|Adverse Event|5|||
131907580|NCT00264147|474948859|FG004|Treatment I Period|Adverse Event|7|||
131907581|NCT00264147|474948860|FG005|Treatment I Period|Adverse Event|0|||
131907582|NCT00264147|474948855|FG000|Treatment I Period|Laboratory Adverse Event|0|||
131907583|NCT00264147|474948856|FG001|Treatment I Period|Laboratory Adverse Event|0|||
131907584|NCT00264147|474948857|FG002|Treatment I Period|Laboratory Adverse Event|0|||
131907585|NCT00264147|474948858|FG003|Treatment I Period|Laboratory Adverse Event|1|||
131907586|NCT00264147|474948859|FG004|Treatment I Period|Laboratory Adverse Event|0|||
131907587|NCT00264147|474948860|FG005|Treatment I Period|Laboratory Adverse Event|0|||
131907588|NCT00264147|474948855|FG000|Treatment I Period|Lack of Efficacy|6|||
131907589|NCT00264147|474948856|FG001|Treatment I Period|Lack of Efficacy|2|||
131907590|NCT00264147|474948857|FG002|Treatment I Period|Lack of Efficacy|8|||
131907591|NCT00264147|474948858|FG003|Treatment I Period|Lack of Efficacy|0|||
131907592|NCT00264147|474948859|FG004|Treatment I Period|Lack of Efficacy|1|||
131907593|NCT00264147|474948860|FG005|Treatment I Period|Lack of Efficacy|0|||
131907594|NCT00264147|474948855|FG000|Treatment I Period|Lost to Follow-up|1|||
131907595|NCT00264147|474948856|FG001|Treatment I Period|Lost to Follow-up|0|||
131907596|NCT00264147|474948857|FG002|Treatment I Period|Lost to Follow-up|0|||
131907597|NCT00264147|474948858|FG003|Treatment I Period|Lost to Follow-up|1|||
131907598|NCT00264147|474948859|FG004|Treatment I Period|Lost to Follow-up|1|||
131907599|NCT00264147|474948860|FG005|Treatment I Period|Lost to Follow-up|0|||
131907600|NCT00264147|474948855|FG000|Treatment I Period|Protocol Violation|2|||
131907601|NCT00264147|474948856|FG001|Treatment I Period|Protocol Violation|2|||
131907602|NCT00264147|474948857|FG002|Treatment I Period|Protocol Violation|0|||
131907603|NCT00264147|474948858|FG003|Treatment I Period|Protocol Violation|0|||
131907604|NCT00264147|474948859|FG004|Treatment I Period|Protocol Violation|0|||
131907605|NCT00264147|474948860|FG005|Treatment I Period|Protocol Violation|0|||
131907606|NCT00264147|474948855|FG000|Treatment I Period|Withdrawal by Subject|2|||
131907607|NCT00264147|474948856|FG001|Treatment I Period|Withdrawal by Subject|0|||
131907608|NCT00264147|474948857|FG002|Treatment I Period|Withdrawal by Subject|0|||
131907609|NCT00264147|474948858|FG003|Treatment I Period|Withdrawal by Subject|2|||
131907610|NCT00264147|474948859|FG004|Treatment I Period|Withdrawal by Subject|2|||
131907611|NCT00264147|474948860|FG005|Treatment I Period|Withdrawal by Subject|0|||
131907612|NCT00264147|474948855|FG000|Treatment I Period|Patient out of town for an extended time|0|||
131907613|NCT00264147|474948856|FG001|Treatment I Period|Patient out of town for an extended time|1|||
131907614|NCT00264147|474948857|FG002|Treatment I Period|Patient out of town for an extended time|0|||
131907615|NCT00264147|474948858|FG003|Treatment I Period|Patient out of town for an extended time|0|||
131907616|NCT00264147|474948859|FG004|Treatment I Period|Patient out of town for an extended time|0|||
131907617|NCT00264147|474948860|FG005|Treatment I Period|Patient out of town for an extended time|0|||
131907618|NCT00264147|474948855|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
131907619|NCT00264147|474948856|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
131907620|NCT00264147|474948857|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
131907621|NCT00264147|474948858|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
131907622|NCT00264147|474948859|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
131907623|NCT00264147|474948860|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
131907624|NCT00264147|474948855|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
131449789|NCT04396639|473276716|FG000|Overall Study|Withdrawal by Subject|1|||
131449790|NCT04396639|473276716|FG000|Overall Study|Other|1|||
131754480|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
131754481|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
131754482|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
131754483|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
131754484|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
131754485|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
131754486|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
131754487|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
131754488|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
131754489|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
131754490|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
131754491|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
131907625|NCT00264147|474948856|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
131907626|NCT00264147|474948857|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
131907627|NCT00264147|474948858|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
131907628|NCT00264147|474948859|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
131907629|NCT00264147|474948860|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
131907630|NCT00264147|474948855|FG000|Treatment II Period|Adverse Event|0|||
131907631|NCT00264147|474948856|FG001|Treatment II Period|Adverse Event|0|||
131907632|NCT00264147|474948857|FG002|Treatment II Period|Adverse Event|0|||
131907633|NCT00264147|474948858|FG003|Treatment II Period|Adverse Event|0|||
131907634|NCT00264147|474948859|FG004|Treatment II Period|Adverse Event|9|||
131449791|NCT03809104|473276717|FG000|Overall Study|Withdrawal by Subject|3|||
131907635|NCT00264147|474948860|FG005|Treatment II Period|Adverse Event|9|||
131907636|NCT00264147|474948855|FG000|Treatment II Period|Laboratory Adverse Event|0|||
131907637|NCT00264147|474948856|FG001|Treatment II Period|Laboratory Adverse Event|0|||
131907638|NCT00264147|474948857|FG002|Treatment II Period|Laboratory Adverse Event|0|||
131907639|NCT00264147|474948858|FG003|Treatment II Period|Laboratory Adverse Event|0|||
131907640|NCT00264147|474948859|FG004|Treatment II Period|Laboratory Adverse Event|0|||
131907641|NCT00264147|474948860|FG005|Treatment II Period|Laboratory Adverse Event|1|||
131907642|NCT00264147|474948855|FG000|Treatment II Period|Lack of Efficacy|0|||
131907643|NCT00264147|474948856|FG001|Treatment II Period|Lack of Efficacy|0|||
131907644|NCT00264147|474948857|FG002|Treatment II Period|Lack of Efficacy|0|||
131907645|NCT00264147|474948858|FG003|Treatment II Period|Lack of Efficacy|0|||
131907646|NCT00264147|474948859|FG004|Treatment II Period|Lack of Efficacy|20|||
131907647|NCT00264147|474948860|FG005|Treatment II Period|Lack of Efficacy|19|||
131907648|NCT00264147|474948855|FG000|Treatment II Period|Lost to Follow-up|0|||
131907649|NCT00264147|474948856|FG001|Treatment II Period|Lost to Follow-up|0|||
131907650|NCT00264147|474948857|FG002|Treatment II Period|Lost to Follow-up|0|||
131907651|NCT00264147|474948858|FG003|Treatment II Period|Lost to Follow-up|0|||
131907652|NCT00264147|474948859|FG004|Treatment II Period|Lost to Follow-up|1|||
131907653|NCT00264147|474948860|FG005|Treatment II Period|Lost to Follow-up|1|||
131907654|NCT00264147|474948855|FG000|Treatment II Period|Withdrawal by Subject|0|||
131907655|NCT00264147|474948856|FG001|Treatment II Period|Withdrawal by Subject|0|||
131907656|NCT00264147|474948857|FG002|Treatment II Period|Withdrawal by Subject|0|||
131907657|NCT00264147|474948858|FG003|Treatment II Period|Withdrawal by Subject|0|||
131907658|NCT00264147|474948859|FG004|Treatment II Period|Withdrawal by Subject|3|||
131907659|NCT00264147|474948860|FG005|Treatment II Period|Withdrawal by Subject|2|||
131907660|NCT00264147|474948855|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
131907661|NCT00264147|474948856|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
131907662|NCT00264147|474948857|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
131907663|NCT00264147|474948858|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
131754492|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
131754493|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
131754494|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
131754495|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
131754496|NCT03605836|474378188|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
131754497|NCT03605836|474378189|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
131754498|NCT03605836|474378190|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
131754499|NCT03605836|474378191|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
131754500|NCT02057068|474378197|FG000|Overall Study|Withdrawal by Subject|2|||
131754501|NCT02057068|474378198|FG001|Overall Study|Withdrawal by Subject|2|||
131754502|NCT02057068|474378197|FG000|Overall Study|Caregiver (CG) Health|0|||
131754503|NCT02057068|474378198|FG001|Overall Study|Caregiver (CG) Health|2|||
131754504|NCT02057068|474378197|FG000|Overall Study|Carepartner (CP) Health|4|||
131754505|NCT02057068|474378198|FG001|Overall Study|Carepartner (CP) Health|2|||
131754506|NCT02057068|474378197|FG000|Overall Study|Lost to Follow-up|2|||
131754507|NCT02057068|474378198|FG001|Overall Study|Lost to Follow-up|2|||
131754508|NCT00865046|474378199|FG000|Overall Study|Lost to Follow-up|1|||
131754509|NCT00865046|474378200|FG001|Overall Study|Lost to Follow-up|4|||
131754510|NCT00865046|474378201|FG002|Overall Study|Lost to Follow-up|0|||
131754511|NCT00865046|474378199|FG000|Overall Study|Death|0|||
131754512|NCT00865046|474378200|FG001|Overall Study|Death|1|||
131754513|NCT00865046|474378201|FG002|Overall Study|Death|1|||
131754514|NCT00865046|474378199|FG000|Overall Study|Withdrawal by Subject|5|||
131754515|NCT00865046|474378200|FG001|Overall Study|Withdrawal by Subject|0|||
131754516|NCT00865046|474378201|FG002|Overall Study|Withdrawal by Subject|0|||
131754517|NCT03447821|474378202|FG000|Overall Study|Withdrawal by Subject|1|||
131754518|NCT03447821|474378203|FG001|Overall Study|Withdrawal by Subject|1|||
131754519|NCT03447821|474378204|FG002|Overall Study|Withdrawal by Subject|0|||
131754520|NCT03447821|474378202|FG000|Overall Study|Lost to Follow-up|0|||
131754521|NCT03447821|474378203|FG001|Overall Study|Lost to Follow-up|0|||
131754522|NCT03447821|474378204|FG002|Overall Study|Lost to Follow-up|1|||
131754523|NCT00481988|474378208|FG000|Overall Study|Withdrawal by Subject|1|||
131754524|NCT00481988|474378209|FG001|Overall Study|Withdrawal by Subject|1|||
131754525|NCT00654420|474378210|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
131754526|NCT00654420|474378211|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
131754527|NCT00654420|474378212|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
131754528|NCT00654420|474378213|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
131754529|NCT00654420|474378210|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
131754530|NCT00654420|474378211|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
131754531|NCT00654420|474378212|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
131754532|NCT00654420|474378213|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
131754533|NCT00654420|474378210|FG000|Phase II|Adverse Event|0|||
131754534|NCT00654420|474378211|FG001|Phase II|Adverse Event|0|||
131449792|NCT02968004|473276718|FG000|Main Study Phase|Adverse Event|1|||
131754535|NCT00654420|474378212|FG002|Phase II|Adverse Event|3|||
131907664|NCT00264147|474948859|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
131907665|NCT00264147|474948860|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
131907666|NCT03234465|474948861|FG000|Overall Study|Adverse Event|4|||
131907667|NCT03234465|474948862|FG001|Overall Study|Adverse Event|2|||
131907668|NCT03234465|474948861|FG000|Overall Study|Death|0|||
131907669|NCT03234465|474948862|FG001|Overall Study|Death|1|||
131907670|NCT03234465|474948861|FG000|Overall Study|Lost to Follow-up|1|||
131907671|NCT03234465|474948862|FG001|Overall Study|Lost to Follow-up|1|||
131907672|NCT03234465|474948861|FG000|Overall Study|Withdrawal by Subject|12|||
131907673|NCT03234465|474948862|FG001|Overall Study|Withdrawal by Subject|27|||
131398562|NCT01406938|473081210|FG003|Induction Period|Protocol deviation|0|||
131398563|NCT01406938|473081211|FG004|Induction Period|Protocol deviation|0|||
131398564|NCT01406938|473081212|FG005|Induction Period|Protocol deviation|0|||
131754536|NCT00654420|474378213|FG003|Phase II|Adverse Event|3|||
131754537|NCT00654420|474378210|FG000|Phase II|Lost to Follow-up|0|||
131754538|NCT00654420|474378211|FG001|Phase II|Lost to Follow-up|0|||
131754539|NCT00654420|474378212|FG002|Phase II|Lost to Follow-up|0|||
131754540|NCT00654420|474378213|FG003|Phase II|Lost to Follow-up|1|||
131754541|NCT00654420|474378210|FG000|Phase II|Physician Decision|0|||
131754542|NCT00654420|474378211|FG001|Phase II|Physician Decision|0|||
131754543|NCT00654420|474378212|FG002|Phase II|Physician Decision|0|||
131754544|NCT00654420|474378213|FG003|Phase II|Physician Decision|4|||
131754545|NCT00654420|474378210|FG000|Phase II|Progressive Disease|0|||
131754546|NCT00654420|474378211|FG001|Phase II|Progressive Disease|0|||
131754547|NCT00654420|474378212|FG002|Phase II|Progressive Disease|29|||
131754548|NCT00654420|474378213|FG003|Phase II|Progressive Disease|29|||
131754549|NCT00654420|474378210|FG000|Phase II|Withdrawal by Subject|0|||
131754550|NCT00654420|474378211|FG001|Phase II|Withdrawal by Subject|0|||
131754551|NCT00654420|474378212|FG002|Phase II|Withdrawal by Subject|4|||
131754552|NCT00654420|474378213|FG003|Phase II|Withdrawal by Subject|1|||
131754553|NCT00654420|474378210|FG000|Phase II|Missing Disposition Record|0|||
131754554|NCT00654420|474378211|FG001|Phase II|Missing Disposition Record|0|||
131754555|NCT00654420|474378212|FG002|Phase II|Missing Disposition Record|1|||
131754556|NCT00654420|474378213|FG003|Phase II|Missing Disposition Record|0|||
131754557|NCT00610207|474378216|FG000|Overall Study|Lost to Follow-up|3|||
131754558|NCT02465489|474378219|FG000|Overall Study|Adverse Event|5|||
131754559|NCT00045630|474378222|FG000|Overall Study|Adverse Event|1|||
131754560|NCT00045630|474378222|FG000|Overall Study|Refusal unrelated to adverse event|1|||
131754561|NCT00045630|474378222|FG000|Overall Study|Progression/relapse|1|||
131754562|NCT00045630|474378222|FG000|Overall Study|Death|1|||
131754563|NCT00045630|474378222|FG000|Overall Study|Ineligible|2|||
131754564|NCT00701103|474378223|FG000|Overall Study|Adverse Event|0|||
131754565|NCT00701103|474378224|FG001|Overall Study|Adverse Event|0|||
131754566|NCT00701103|474378225|FG002|Overall Study|Adverse Event|1|||
131754567|NCT00701103|474378226|FG003|Overall Study|Adverse Event|1|||
131754568|NCT00701103|474378227|FG004|Overall Study|Adverse Event|0|||
131754569|NCT00701103|474378228|FG005|Overall Study|Adverse Event|1|||
131754570|NCT00701103|474378229|FG006|Overall Study|Adverse Event|1|||
131754571|NCT00701103|474378230|FG007|Overall Study|Adverse Event|0|||
131754572|NCT00701103|474378231|FG008|Overall Study|Adverse Event|0|||
131754573|NCT00701103|474378232|FG009|Overall Study|Adverse Event|2|||
131811127|NCT03032172|474590780|FG003|Open-label Extension Period|Pregnancy|0|||
131811128|NCT03032172|474590781|FG004|Open-label Extension Period|Pregnancy|0|||
131811129|NCT03032172|474590782|FG005|Open-label Extension Period|Pregnancy|0|||
131811130|NCT03032172|474590783|FG006|Open-label Extension Period|Pregnancy|1|||
131811131|NCT03032172|474590784|FG007|Open-label Extension Period|Pregnancy|0|||
131811132|NCT03032172|474590777|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131811133|NCT03032172|474590778|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
131811134|NCT03032172|474590779|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
131811135|NCT03032172|474590780|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
131811136|NCT03032172|474590781|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
131811137|NCT03032172|474590782|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
131811138|NCT03032172|474590783|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
131811139|NCT03032172|474590784|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
131811140|NCT03570749|474590787|FG000|Overall Study|Ongoing|26|||
131811141|NCT03570749|474590788|FG001|Overall Study|Ongoing|25|||
131754574|NCT00701103|474378233|FG010|Overall Study|Adverse Event|0|||
131754575|NCT00701103|474378223|FG000|Overall Study|Progressive Disease|5|||
131754576|NCT00701103|474378224|FG001|Overall Study|Progressive Disease|2|||
131754577|NCT00701103|474378225|FG002|Overall Study|Progressive Disease|6|||
131754578|NCT00701103|474378226|FG003|Overall Study|Progressive Disease|5|||
131754579|NCT00701103|474378227|FG004|Overall Study|Progressive Disease|6|||
131754580|NCT00701103|474378228|FG005|Overall Study|Progressive Disease|5|||
131754581|NCT00701103|474378229|FG006|Overall Study|Progressive Disease|7|||
131754582|NCT00701103|474378230|FG007|Overall Study|Progressive Disease|7|||
131811142|NCT03570749|474590789|FG002|Overall Study|Ongoing|25|||
131907674|NCT03234465|474948861|FG000|Overall Study|Symptomatic deterioration|0|||
131907675|NCT03234465|474948862|FG001|Overall Study|Symptomatic deterioration|1|||
131754583|NCT00701103|474378231|FG008|Overall Study|Progressive Disease|8|||
131398565|NCT01406938|473081207|FG000|Induction Period|Adverse Event|8|||
131398566|NCT01406938|473081208|FG001|Induction Period|Adverse Event|9|||
131398567|NCT01406938|473081209|FG002|Induction Period|Adverse Event|0|||
131398568|NCT01406938|473081210|FG003|Induction Period|Adverse Event|0|||
131398569|NCT01406938|473081211|FG004|Induction Period|Adverse Event|0|||
131398570|NCT01406938|473081212|FG005|Induction Period|Adverse Event|0|||
131398571|NCT01406938|473081207|FG000|Induction Period|Lack of Efficacy|1|||
131398572|NCT01406938|473081208|FG001|Induction Period|Lack of Efficacy|0|||
131398573|NCT01406938|473081209|FG002|Induction Period|Lack of Efficacy|0|||
131398574|NCT01406938|473081210|FG003|Induction Period|Lack of Efficacy|0|||
131398575|NCT01406938|473081211|FG004|Induction Period|Lack of Efficacy|0|||
131398576|NCT01406938|473081212|FG005|Induction Period|Lack of Efficacy|0|||
131754584|NCT00701103|474378232|FG009|Overall Study|Progressive Disease|8|||
131754585|NCT00701103|474378233|FG010|Overall Study|Progressive Disease|11|||
131754586|NCT00701103|474378223|FG000|Overall Study|Withdrawal by Subject|0|||
131754587|NCT00701103|474378224|FG001|Overall Study|Withdrawal by Subject|1|||
131754588|NCT00701103|474378225|FG002|Overall Study|Withdrawal by Subject|1|||
131754589|NCT00701103|474378226|FG003|Overall Study|Withdrawal by Subject|0|||
131754590|NCT00701103|474378227|FG004|Overall Study|Withdrawal by Subject|0|||
131754591|NCT00701103|474378228|FG005|Overall Study|Withdrawal by Subject|0|||
131754592|NCT00701103|474378229|FG006|Overall Study|Withdrawal by Subject|0|||
131754593|NCT00701103|474378230|FG007|Overall Study|Withdrawal by Subject|0|||
131754594|NCT00701103|474378231|FG008|Overall Study|Withdrawal by Subject|0|||
131754595|NCT00701103|474378232|FG009|Overall Study|Withdrawal by Subject|0|||
131754596|NCT00701103|474378233|FG010|Overall Study|Withdrawal by Subject|0|||
131754597|NCT00701103|474378223|FG000|Overall Study|Other|0|||
131754598|NCT00701103|474378224|FG001|Overall Study|Other|0|||
131754599|NCT00701103|474378225|FG002|Overall Study|Other|0|||
131754600|NCT00701103|474378226|FG003|Overall Study|Other|0|||
131754601|NCT00701103|474378227|FG004|Overall Study|Other|0|||
131754602|NCT00701103|474378228|FG005|Overall Study|Other|0|||
131754603|NCT00701103|474378229|FG006|Overall Study|Other|0|||
131754604|NCT00701103|474378230|FG007|Overall Study|Other|0|||
131754605|NCT00701103|474378231|FG008|Overall Study|Other|1|||
131754606|NCT00701103|474378232|FG009|Overall Study|Other|1|||
131754607|NCT00701103|474378233|FG010|Overall Study|Other|0|||
131754608|NCT01929707|474378234|FG000|Intervention Period 1|Lost to Follow-up|0|||
131754609|NCT01929707|474378235|FG001|Intervention Period 1|Lost to Follow-up|0|||
131754610|NCT01929707|474378236|FG002|Intervention Period 1|Lost to Follow-up|0|||
131754611|NCT01929707|474378237|FG003|Intervention Period 1|Lost to Follow-up|1|||
131754612|NCT01929707|474378238|FG004|Intervention Period 1|Lost to Follow-up|0|||
131754613|NCT01929707|474378239|FG005|Intervention Period 1|Lost to Follow-up|0|||
131754614|NCT01929707|474378240|FG006|Intervention Period 1|Lost to Follow-up|0|||
131754615|NCT01929707|474378241|FG007|Intervention Period 1|Lost to Follow-up|0|||
131754616|NCT01929707|474378234|FG000|Intervention Period 1|Withdrawal by Subject|0|||
131811143|NCT03570749|474590790|FG003|Overall Study|Ongoing|26|||
131811144|NCT03570749|474590791|FG004|Overall Study|Ongoing|140|||
131811145|NCT03570749|474590792|FG005|Overall Study|Ongoing|142|||
131811146|NCT03570749|474590793|FG006|Overall Study|Ongoing|220|||
131811147|NCT03570749|474590787|FG000|Overall Study|Adverse Event|0|||
131811148|NCT03570749|474590788|FG001|Overall Study|Adverse Event|0|||
131811149|NCT03570749|474590789|FG002|Overall Study|Adverse Event|0|||
131811150|NCT03570749|474590790|FG003|Overall Study|Adverse Event|0|||
131811151|NCT03570749|474590791|FG004|Overall Study|Adverse Event|2|||
131811152|NCT03570749|474590792|FG005|Overall Study|Adverse Event|3|||
131811153|NCT03570749|474590793|FG006|Overall Study|Adverse Event|6|||
131811154|NCT03570749|474590787|FG000|Overall Study|Lack of Efficacy|0|||
131811155|NCT03570749|474590788|FG001|Overall Study|Lack of Efficacy|0|||
131811156|NCT03570749|474590789|FG002|Overall Study|Lack of Efficacy|0|||
131811157|NCT03570749|474590790|FG003|Overall Study|Lack of Efficacy|0|||
131811158|NCT03570749|474590791|FG004|Overall Study|Lack of Efficacy|8|||
131811159|NCT03570749|474590792|FG005|Overall Study|Lack of Efficacy|2|||
131811160|NCT03570749|474590793|FG006|Overall Study|Lack of Efficacy|7|||
131811161|NCT03570749|474590787|FG000|Overall Study|Lost to Follow-up|0|||
131811162|NCT03570749|474590788|FG001|Overall Study|Lost to Follow-up|0|||
131811163|NCT03570749|474590789|FG002|Overall Study|Lost to Follow-up|0|||
131811164|NCT03570749|474590790|FG003|Overall Study|Lost to Follow-up|0|||
131811165|NCT03570749|474590791|FG004|Overall Study|Lost to Follow-up|5|||
131811166|NCT03570749|474590792|FG005|Overall Study|Lost to Follow-up|10|||
131811167|NCT03570749|474590793|FG006|Overall Study|Lost to Follow-up|10|||
131811168|NCT03570749|474590787|FG000|Overall Study|Pregnancy|0|||
131754617|NCT01929707|474378235|FG001|Intervention Period 1|Withdrawal by Subject|0|||
131811169|NCT03570749|474590788|FG001|Overall Study|Pregnancy|0|||
131811170|NCT03570749|474590789|FG002|Overall Study|Pregnancy|0|||
131398577|NCT01406938|473081207|FG000|Induction Period|Lost to Follow-up|2|||
131754618|NCT01929707|474378236|FG002|Intervention Period 1|Withdrawal by Subject|0|||
131754619|NCT01929707|474378237|FG003|Intervention Period 1|Withdrawal by Subject|2|||
131754620|NCT01929707|474378238|FG004|Intervention Period 1|Withdrawal by Subject|0|||
131811171|NCT03570749|474590790|FG003|Overall Study|Pregnancy|0|||
131811172|NCT03570749|474590791|FG004|Overall Study|Pregnancy|0|||
131907676|NCT03234465|474948861|FG000|Overall Study|Non-compliance|2|||
131907677|NCT03234465|474948862|FG001|Overall Study|Non-compliance|0|||
131907678|NCT03234465|474948861|FG000|Overall Study|Other|14|||
131907679|NCT03234465|474948862|FG001|Overall Study|Other|8|||
131907680|NCT03368807|474948865|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
131907681|NCT03368807|474948865|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
131907682|NCT03368807|474948865|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
131907683|NCT03368807|474948865|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
131907684|NCT01118052|474948870|FG000|Overall Study|Never treated|2|||
131907685|NCT02949947|474948871|FG000|Overall Study|Non Compliance|0|||
131907686|NCT02949947|474948872|FG001|Overall Study|Non Compliance|1|||
131907687|NCT02949947|474948871|FG000|Overall Study|Insurance change|1|||
131907688|NCT02949947|474948872|FG001|Overall Study|Insurance change|0|||
131907689|NCT01973218|474948873|FG000|Overall Study|Adverse Event|1|||
131398578|NCT01406938|473081208|FG001|Induction Period|Lost to Follow-up|3|||
131754621|NCT01929707|474378239|FG005|Intervention Period 1|Withdrawal by Subject|0|||
131754622|NCT01929707|474378240|FG006|Intervention Period 1|Withdrawal by Subject|0|||
131754623|NCT01929707|474378241|FG007|Intervention Period 1|Withdrawal by Subject|0|||
131754624|NCT01929707|474378234|FG000|Intervention Period 2|Withdrawal by Subject|0|||
131754625|NCT01929707|474378235|FG001|Intervention Period 2|Withdrawal by Subject|0|||
131754626|NCT01929707|474378236|FG002|Intervention Period 2|Withdrawal by Subject|0|||
131754627|NCT01929707|474378237|FG003|Intervention Period 2|Withdrawal by Subject|0|||
131754628|NCT01929707|474378238|FG004|Intervention Period 2|Withdrawal by Subject|0|||
131754629|NCT01929707|474378239|FG005|Intervention Period 2|Withdrawal by Subject|2|||
131754630|NCT01929707|474378240|FG006|Intervention Period 2|Withdrawal by Subject|0|||
131754631|NCT01929707|474378241|FG007|Intervention Period 2|Withdrawal by Subject|0|||
131754632|NCT00179517|474378242|FG000|Overall Study|Withdrawal by Subject|2|||
131754633|NCT00179517|474378243|FG001|Overall Study|Withdrawal by Subject|1|||
131754634|NCT00437203|474378244|FG000|Overall Study|Death|0|||
131754635|NCT00437203|474378245|FG001|Overall Study|Death|0|||
131754636|NCT00437203|474378246|FG002|Overall Study|Death|1|||
131754637|NCT00437203|474378247|FG003|Overall Study|Death|0|||
131754638|NCT00437203|474378248|FG004|Overall Study|Death|0|||
131754639|NCT00437203|474378249|FG005|Overall Study|Death|0|||
131754640|NCT00437203|474378250|FG006|Overall Study|Death|0|||
131754641|NCT00437203|474378251|FG007|Overall Study|Death|1|||
131754642|NCT00437203|474378252|FG008|Overall Study|Death|0|||
131754643|NCT00437203|474378253|FG009|Overall Study|Death|1|||
131754644|NCT00437203|474378244|FG000|Overall Study|Adverse Event|1|||
131754645|NCT00437203|474378245|FG001|Overall Study|Adverse Event|1|||
131754646|NCT00437203|474378246|FG002|Overall Study|Adverse Event|0|||
131754647|NCT00437203|474378247|FG003|Overall Study|Adverse Event|0|||
131754648|NCT00437203|474378248|FG004|Overall Study|Adverse Event|0|||
131754649|NCT00437203|474378249|FG005|Overall Study|Adverse Event|0|||
131754650|NCT00437203|474378250|FG006|Overall Study|Adverse Event|0|||
131754651|NCT00437203|474378251|FG007|Overall Study|Adverse Event|1|||
131754652|NCT00437203|474378252|FG008|Overall Study|Adverse Event|0|||
131754653|NCT00437203|474378253|FG009|Overall Study|Adverse Event|1|||
131754654|NCT00437203|474378244|FG000|Overall Study|Study terminated by sponsor|0|||
131754655|NCT00437203|474378245|FG001|Overall Study|Study terminated by sponsor|0|||
131754656|NCT00437203|474378246|FG002|Overall Study|Study terminated by sponsor|0|||
131754657|NCT00437203|474378247|FG003|Overall Study|Study terminated by sponsor|0|||
131754658|NCT00437203|474378248|FG004|Overall Study|Study terminated by sponsor|0|||
131754659|NCT00437203|474378249|FG005|Overall Study|Study terminated by sponsor|0|||
131754660|NCT00437203|474378250|FG006|Overall Study|Study terminated by sponsor|0|||
131754661|NCT00437203|474378251|FG007|Overall Study|Study terminated by sponsor|0|||
131754662|NCT00437203|474378252|FG008|Overall Study|Study terminated by sponsor|1|||
131754663|NCT00437203|474378253|FG009|Overall Study|Study terminated by sponsor|0|||
131754664|NCT00437203|474378244|FG000|Overall Study|Objective progression or relapse|5|||
131754665|NCT00437203|474378245|FG001|Overall Study|Objective progression or relapse|6|||
131754666|NCT00437203|474378246|FG002|Overall Study|Objective progression or relapse|2|||
131398579|NCT01406938|473081209|FG002|Induction Period|Lost to Follow-up|0|||
131398580|NCT01406938|473081210|FG003|Induction Period|Lost to Follow-up|0|||
131754667|NCT00437203|474378247|FG003|Overall Study|Objective progression or relapse|3|||
131754668|NCT00437203|474378248|FG004|Overall Study|Objective progression or relapse|3|||
131754669|NCT00437203|474378249|FG005|Overall Study|Objective progression or relapse|3|||
131754670|NCT00437203|474378250|FG006|Overall Study|Objective progression or relapse|6|||
131754671|NCT00437203|474378251|FG007|Overall Study|Objective progression or relapse|1|||
131754672|NCT00437203|474378252|FG008|Overall Study|Objective progression or relapse|2|||
131754673|NCT00437203|474378253|FG009|Overall Study|Objective progression or relapse|2|||
131754674|NCT00437203|474378244|FG000|Overall Study|Other|0|||
131754675|NCT00437203|474378245|FG001|Overall Study|Other|1|||
131754676|NCT00437203|474378246|FG002|Overall Study|Other|0|||
131907690|NCT01973218|474948874|FG001|Overall Study|Adverse Event|0|||
131754677|NCT00437203|474378247|FG003|Overall Study|Other|0|||
131754678|NCT00437203|474378248|FG004|Overall Study|Other|0|||
131754679|NCT00437203|474378249|FG005|Overall Study|Other|0|||
131907691|NCT01973218|474948873|FG000|Overall Study|Withdrawal by Subject|1|||
131811173|NCT03570749|474590792|FG005|Overall Study|Pregnancy|1|||
131811174|NCT03570749|474590793|FG006|Overall Study|Pregnancy|1|||
131811175|NCT03570749|474590787|FG000|Overall Study|Screen Fail|0|||
131811176|NCT03570749|474590788|FG001|Overall Study|Screen Fail|0|||
131811177|NCT03570749|474590789|FG002|Overall Study|Screen Fail|0|||
131811178|NCT03570749|474590790|FG003|Overall Study|Screen Fail|0|||
131811179|NCT03570749|474590791|FG004|Overall Study|Screen Fail|0|||
131811180|NCT03570749|474590792|FG005|Overall Study|Screen Fail|0|||
131811181|NCT03570749|474590793|FG006|Overall Study|Screen Fail|1|||
131811182|NCT03570749|474590787|FG000|Overall Study|Withdrawal by Subject|2|||
131811183|NCT03570749|474590788|FG001|Overall Study|Withdrawal by Subject|3|||
131811184|NCT03570749|474590789|FG002|Overall Study|Withdrawal by Subject|2|||
131811185|NCT03570749|474590790|FG003|Overall Study|Withdrawal by Subject|1|||
131811186|NCT03570749|474590791|FG004|Overall Study|Withdrawal by Subject|17|||
131811187|NCT03570749|474590792|FG005|Overall Study|Withdrawal by Subject|12|||
131811188|NCT03570749|474590793|FG006|Overall Study|Withdrawal by Subject|15|||
131811189|NCT03570749|474590787|FG000|Overall Study|Other|0|||
131811190|NCT03570749|474590788|FG001|Overall Study|Other|0|||
131811191|NCT03570749|474590789|FG002|Overall Study|Other|0|||
131811192|NCT03570749|474590790|FG003|Overall Study|Other|0|||
131811193|NCT03570749|474590791|FG004|Overall Study|Other|17|||
131811194|NCT03570749|474590792|FG005|Overall Study|Other|14|||
131811195|NCT03570749|474590793|FG006|Overall Study|Other|21|||
131811196|NCT00163657|474590794|FG000|Overall Study|Death|12|||
131811197|NCT00163657|474590795|FG001|Overall Study|Death|14|||
131811198|NCT00163657|474590796|FG002|Overall Study|Death|19|||
131811199|NCT00163657|474590794|FG000|Overall Study|graft loss|4|||
131811200|NCT00163657|474590795|FG001|Overall Study|graft loss|1|||
131811201|NCT00163657|474590796|FG002|Overall Study|graft loss|2|||
131811202|NCT00163657|474590794|FG000|Overall Study|Withdrawal by Subject|2|||
131811203|NCT00163657|474590795|FG001|Overall Study|Withdrawal by Subject|3|||
131811204|NCT00163657|474590796|FG002|Overall Study|Withdrawal by Subject|2|||
131811205|NCT00163657|474590794|FG000|Overall Study|Physician Decision|0|||
131811206|NCT00163657|474590795|FG001|Overall Study|Physician Decision|1|||
131811207|NCT00163657|474590796|FG002|Overall Study|Physician Decision|1|||
131811208|NCT00163657|474590794|FG000|Overall Study|Non Compliance|1|||
131811209|NCT00163657|474590795|FG001|Overall Study|Non Compliance|0|||
131811210|NCT00163657|474590796|FG002|Overall Study|Non Compliance|0|||
131811211|NCT00163657|474590794|FG000|Overall Study|Lost to Follow-up|1|||
131811212|NCT00163657|474590795|FG001|Overall Study|Lost to Follow-up|3|||
131811213|NCT00163657|474590796|FG002|Overall Study|Lost to Follow-up|10|||
131811214|NCT00163657|474590794|FG000|Overall Study|Other reason|0|||
131811215|NCT00163657|474590795|FG001|Overall Study|Other reason|1|||
131811216|NCT00163657|474590796|FG002|Overall Study|Other reason|3|||
131811217|NCT02436005|474590797|FG000|Second Intervention|Adverse Event|0|||
131811218|NCT02436005|474590798|FG001|Second Intervention|Adverse Event|1|||
131811219|NCT00583453|474590799|FG000|Overall Study|discontinued intervention|0|||
131811220|NCT00583453|474590800|FG001|Overall Study|discontinued intervention|2|||
131811221|NCT03868891|474590803|FG000|Overall Study|Adverse Event|1|||
131811222|NCT03868891|474590804|FG001|Overall Study|Adverse Event|0|||
131811223|NCT03868891|474590803|FG000|Overall Study|Lost to Follow-up|2|||
131811224|NCT03868891|474590804|FG001|Overall Study|Lost to Follow-up|1|||
131811225|NCT03868891|474590803|FG000|Overall Study|COVID-19 Restrictions|1|||
131811226|NCT03868891|474590804|FG001|Overall Study|COVID-19 Restrictions|2|||
131811227|NCT03123094|474590806|FG000|Overall Study|Withdrawal by Subject|0|||
131811228|NCT03123094|474590807|FG001|Overall Study|Withdrawal by Subject|2|||
131811229|NCT03123094|474590808|FG002|Overall Study|Withdrawal by Subject|1|||
131811230|NCT03123094|474590809|FG003|Overall Study|Withdrawal by Subject|0|||
131811231|NCT03123094|474590810|FG004|Overall Study|Withdrawal by Subject|1|||
131907692|NCT01973218|474948874|FG001|Overall Study|Withdrawal by Subject|0|||
131907693|NCT02247466|474948875|FG000|Overall Study|Procedure changed to open surgery|0|||
131811232|NCT04247282|474590811|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
131811233|NCT04247282|474590812|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
131811234|NCT04247282|474590813|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
131811235|NCT04247282|474590814|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
131811236|NCT04247282|474590811|FG000|Overall Study|Refused further treatment|0|||
131811237|NCT04247282|474590812|FG001|Overall Study|Refused further treatment|1|||
131811238|NCT04247282|474590813|FG002|Overall Study|Refused further treatment|0|||
131811239|NCT04247282|474590814|FG003|Overall Study|Refused further treatment|0|||
131811240|NCT00794963|474590821|FG000|Overall Study|Withdrawal by Subject|1|||
131811241|NCT00794963|474590822|FG001|Overall Study|Withdrawal by Subject|4|||
131811242|NCT05646251|474590830|FG000|Overall Study|Physician Decision|1|||
131811243|NCT05646251|474590831|FG001|Overall Study|Physician Decision|0|||
131811244|NCT05646251|474590832|FG002|Overall Study|Physician Decision|2|||
131811245|NCT03122457|474590834|FG000|Overall Study|Withdrawal by Subject|6|||
131811246|NCT00835536|474590835|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
131811247|NCT00835536|474590836|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
131811248|NCT00657553|474590840|FG000|Overall Study|low accrual, no analysis run|5|||
131811249|NCT00657553|474590841|FG001|Overall Study|low accrual, no analysis run|5|||
131811250|NCT03173547|474590842|FG000|Overall Study|Adverse Event|2|||
131811251|NCT03173547|474590843|FG001|Overall Study|Adverse Event|0|||
131811252|NCT03173547|474590842|FG000|Overall Study|Withdrawal by Subject|2|||
131811253|NCT03173547|474590843|FG001|Overall Study|Withdrawal by Subject|2|||
131811254|NCT00446563|474590844|FG000|Overall Study|Adverse Event|4|||
131811255|NCT00446563|474590845|FG001|Overall Study|Adverse Event|3|||
131811256|NCT00446563|474590844|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131811257|NCT00446563|474590845|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131811258|NCT00446563|474590844|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131811259|NCT00446563|474590845|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131811260|NCT00446563|474590844|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131811261|NCT00446563|474590845|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131811262|NCT00446563|474590844|FG000|Overall Study|Withdrawal by Subject|2|||
131811263|NCT00446563|474590845|FG001|Overall Study|Withdrawal by Subject|1|||
131811264|NCT00446563|474590844|FG000|Overall Study|Administrative problems|0|||
131811265|NCT00446563|474590845|FG001|Overall Study|Administrative problems|1|||
131811266|NCT01169558|474590846|FG000|Overall Study|Disease progression|98|||
131811267|NCT01169558|474590846|FG000|Overall Study|Adverse Event|25|||
131811268|NCT01169558|474590846|FG000|Overall Study|Withdrawal of Consent|8|||
131811269|NCT01169558|474590846|FG000|Overall Study|Medical Decision|7|||
131811270|NCT01169558|474590846|FG000|Overall Study|Stable Disease|4|||
131811271|NCT01169558|474590846|FG000|Overall Study|Lost to Follow-up|4|||
131811272|NCT01169558|474590846|FG000|Overall Study|Need for Surgery|4|||
131811273|NCT01169558|474590846|FG000|Overall Study|Non-compliance|2|||
131811274|NCT01169558|474590846|FG000|Overall Study|Protocol Violation|2|||
131811275|NCT01169558|474590846|FG000|Overall Study|Partial response|2|||
131811276|NCT00838539|474590848|FG000|Overall Study|Disease Progression|2|||
131811277|NCT00838539|474590849|FG001|Overall Study|Disease Progression|4|||
131811278|NCT00838539|474590850|FG002|Overall Study|Disease Progression|3|||
131811279|NCT00838539|474590851|FG003|Overall Study|Disease Progression|2|||
131811280|NCT00838539|474590852|FG004|Overall Study|Disease Progression|4|||
131811281|NCT00838539|474590853|FG005|Overall Study|Disease Progression|2|||
131811282|NCT00838539|474590854|FG006|Overall Study|Disease Progression|3|||
131811283|NCT00838539|474590855|FG007|Overall Study|Disease Progression|4|||
131811284|NCT00838539|474590856|FG008|Overall Study|Disease Progression|4|||
131811285|NCT00838539|474590857|FG009|Overall Study|Disease Progression|5|||
131811286|NCT00838539|474590858|FG010|Overall Study|Disease Progression|1|||
131811287|NCT00838539|474590859|FG011|Overall Study|Disease Progression|4|||
131811288|NCT00838539|474590848|FG000|Overall Study|Adverse Event|1|||
131811289|NCT00838539|474590849|FG001|Overall Study|Adverse Event|1|||
131811290|NCT00838539|474590850|FG002|Overall Study|Adverse Event|1|||
131811291|NCT00838539|474590851|FG003|Overall Study|Adverse Event|1|||
131811292|NCT00838539|474590852|FG004|Overall Study|Adverse Event|2|||
131811293|NCT00838539|474590853|FG005|Overall Study|Adverse Event|1|||
131811294|NCT00838539|474590854|FG006|Overall Study|Adverse Event|0|||
131811295|NCT00838539|474590855|FG007|Overall Study|Adverse Event|2|||
131811296|NCT00838539|474590856|FG008|Overall Study|Adverse Event|0|||
131811297|NCT00838539|474590857|FG009|Overall Study|Adverse Event|1|||
131811298|NCT00838539|474590858|FG010|Overall Study|Adverse Event|2|||
131811299|NCT00838539|474590859|FG011|Overall Study|Adverse Event|0|||
131811300|NCT00838539|474590848|FG000|Overall Study|Withdrawal by Subject|0|||
131811301|NCT00838539|474590849|FG001|Overall Study|Withdrawal by Subject|1|||
131811302|NCT00838539|474590850|FG002|Overall Study|Withdrawal by Subject|0|||
131811303|NCT00838539|474590851|FG003|Overall Study|Withdrawal by Subject|0|||
131811304|NCT00838539|474590852|FG004|Overall Study|Withdrawal by Subject|0|||
131907694|NCT02247466|474948876|FG001|Overall Study|Procedure changed to open surgery|3|||
131907695|NCT00828711|474948877|FG000|Overall Study|Lost to Follow-up|1|||
131811305|NCT00838539|474590853|FG005|Overall Study|Withdrawal by Subject|0|||
131811306|NCT00838539|474590854|FG006|Overall Study|Withdrawal by Subject|0|||
131811307|NCT00838539|474590855|FG007|Overall Study|Withdrawal by Subject|0|||
131811308|NCT00838539|474590856|FG008|Overall Study|Withdrawal by Subject|0|||
131811309|NCT00838539|474590857|FG009|Overall Study|Withdrawal by Subject|1|||
131811310|NCT00838539|474590858|FG010|Overall Study|Withdrawal by Subject|2|||
131811311|NCT00838539|474590859|FG011|Overall Study|Withdrawal by Subject|0|||
131811312|NCT00838539|474590848|FG000|Overall Study|Death|0|||
131811313|NCT00838539|474590849|FG001|Overall Study|Death|0|||
131811314|NCT00838539|474590850|FG002|Overall Study|Death|0|||
131811315|NCT00838539|474590851|FG003|Overall Study|Death|0|||
131811316|NCT00838539|474590852|FG004|Overall Study|Death|0|||
131811317|NCT00838539|474590853|FG005|Overall Study|Death|0|||
131811318|NCT00838539|474590854|FG006|Overall Study|Death|1|||
131811319|NCT00838539|474590855|FG007|Overall Study|Death|0|||
131811320|NCT00838539|474590856|FG008|Overall Study|Death|0|||
131811321|NCT00838539|474590857|FG009|Overall Study|Death|0|||
131811322|NCT00838539|474590858|FG010|Overall Study|Death|0|||
131811323|NCT00838539|474590859|FG011|Overall Study|Death|0|||
131811324|NCT00838539|474590848|FG000|Overall Study|Physician Decision|0|||
131811325|NCT00838539|474590849|FG001|Overall Study|Physician Decision|0|||
131754680|NCT00437203|474378250|FG006|Overall Study|Other|1|||
131754681|NCT00437203|474378251|FG007|Overall Study|Other|0|||
131754682|NCT00437203|474378252|FG008|Overall Study|Other|0|||
131754683|NCT00437203|474378253|FG009|Overall Study|Other|0|||
131754684|NCT00431496|474378260|FG000|Overall Study|Adverse Event|3|||
131754685|NCT00431496|474378260|FG000|Overall Study|Lost to Follow-up|1|||
131754686|NCT00431496|474378260|FG000|Overall Study|Withdrawal by Subject|2|||
131754687|NCT00431496|474378260|FG000|Overall Study|Protocol-specified criteria|5|||
131754688|NCT00499460|474378266|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
131754689|NCT00499460|474378267|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
131754690|NCT00499460|474378266|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
131754691|NCT00499460|474378267|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
131754692|NCT00499460|474378266|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
131754693|NCT00499460|474378267|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
131754694|NCT02290340|474378269|FG000|Overall Study|Lost to Follow-up|0|||
131754695|NCT02290340|474378270|FG001|Overall Study|Lost to Follow-up|0|||
131754696|NCT02290340|474378271|FG002|Overall Study|Lost to Follow-up|0|||
131754697|NCT02290340|474378272|FG003|Overall Study|Lost to Follow-up|1|||
131754698|NCT02290340|474378269|FG000|Overall Study|Withdrawal by Subject|1|||
131754699|NCT02290340|474378270|FG001|Overall Study|Withdrawal by Subject|0|||
131754700|NCT02290340|474378271|FG002|Overall Study|Withdrawal by Subject|0|||
131754701|NCT02290340|474378272|FG003|Overall Study|Withdrawal by Subject|0|||
131754702|NCT02290340|474378269|FG000|Overall Study|Other|1|||
131754703|NCT02290340|474378270|FG001|Overall Study|Other|0|||
131754704|NCT02290340|474378271|FG002|Overall Study|Other|0|||
131754705|NCT02290340|474378272|FG003|Overall Study|Other|1|||
131754706|NCT00098865|474381062|FG000|Overall Study|Progressive Disease|6|||
131754707|NCT00098865|474381062|FG000|Overall Study|Adverse Event|2|||
131754708|NCT00098865|474381062|FG000|Overall Study|Alternative Therapy|1|||
131754709|NCT00464620|474381063|FG000|Overall Study|Physician Decision|1|||
131754710|NCT00464620|474381064|FG001|Overall Study|Physician Decision|0|||
131754711|NCT00464620|474381065|FG002|Overall Study|Physician Decision|0|||
131754712|NCT00464620|474381063|FG000|Overall Study|Withdrawal by Subject|1|||
131754713|NCT00464620|474381064|FG001|Overall Study|Withdrawal by Subject|0|||
131754714|NCT00464620|474381065|FG002|Overall Study|Withdrawal by Subject|3|||
131754715|NCT00464620|474381063|FG000|Overall Study|Ineligible sarcoma subtype|0|||
131754716|NCT00464620|474381064|FG001|Overall Study|Ineligible sarcoma subtype|2|||
131754717|NCT00464620|474381065|FG002|Overall Study|Ineligible sarcoma subtype|2|||
131754718|NCT00464620|474381063|FG000|Overall Study|Use of prohibited concomitant medication|0|||
131754719|NCT00464620|474381064|FG001|Overall Study|Use of prohibited concomitant medication|0|||
131754720|NCT00464620|474381065|FG002|Overall Study|Use of prohibited concomitant medication|2|||
131754721|NCT03654560|474381066|FG000|Overall Study|Death|3|||
131754722|NCT03654560|474381067|FG001|Overall Study|Death|1|||
131754723|NCT03654560|474381066|FG000|Overall Study|Lost to Follow-up|1|||
131754724|NCT03654560|474381067|FG001|Overall Study|Lost to Follow-up|0|||
131754725|NCT04222673|474381070|FG000|Overall Study|Lost to Follow-up|5|||
131811326|NCT00838539|474590850|FG002|Overall Study|Physician Decision|0|||
131811327|NCT00838539|474590851|FG003|Overall Study|Physician Decision|0|||
131811328|NCT00838539|474590852|FG004|Overall Study|Physician Decision|0|||
131811329|NCT00838539|474590853|FG005|Overall Study|Physician Decision|0|||
131811330|NCT00838539|474590854|FG006|Overall Study|Physician Decision|0|||
131811331|NCT00838539|474590855|FG007|Overall Study|Physician Decision|0|||
131811332|NCT00838539|474590856|FG008|Overall Study|Physician Decision|1|||
131811333|NCT00838539|474590857|FG009|Overall Study|Physician Decision|0|||
131811334|NCT00838539|474590858|FG010|Overall Study|Physician Decision|0|||
131811335|NCT00838539|474590859|FG011|Overall Study|Physician Decision|0|||
131811336|NCT00838539|474590848|FG000|Overall Study|Clinical Progression|0|||
131811337|NCT00838539|474590849|FG001|Overall Study|Clinical Progression|0|||
131811338|NCT00838539|474590850|FG002|Overall Study|Clinical Progression|0|||
131811339|NCT00838539|474590851|FG003|Overall Study|Clinical Progression|0|||
131811340|NCT00838539|474590852|FG004|Overall Study|Clinical Progression|0|||
131811341|NCT00838539|474590853|FG005|Overall Study|Clinical Progression|0|||
131811342|NCT00838539|474590854|FG006|Overall Study|Clinical Progression|1|||
131811343|NCT00838539|474590855|FG007|Overall Study|Clinical Progression|0|||
131811344|NCT00838539|474590856|FG008|Overall Study|Clinical Progression|0|||
131754726|NCT00047008|474381071|FG000|Overall Study|Withdrawn consent|2|||
131754727|NCT00047008|474381072|FG001|Overall Study|Withdrawn consent|3|||
131754728|NCT00047008|474381071|FG000|Overall Study|Ineligible|9|||
131398581|NCT01406938|473081211|FG004|Induction Period|Lost to Follow-up|0|||
131398582|NCT01406938|473081212|FG005|Induction Period|Lost to Follow-up|0|||
131398583|NCT01406938|473081207|FG000|Maintenance Period|Adverse Event|0|||
131811345|NCT00838539|474590857|FG009|Overall Study|Clinical Progression|0|||
131811346|NCT00838539|474590858|FG010|Overall Study|Clinical Progression|0|||
131811347|NCT00838539|474590859|FG011|Overall Study|Clinical Progression|0|||
131811348|NCT00838539|474590848|FG000|Overall Study|Symptomatic Deterioration|0|||
131811349|NCT00838539|474590849|FG001|Overall Study|Symptomatic Deterioration|0|||
131811350|NCT00838539|474590850|FG002|Overall Study|Symptomatic Deterioration|1|||
131811351|NCT00838539|474590851|FG003|Overall Study|Symptomatic Deterioration|1|||
131907696|NCT00828711|474948878|FG001|Overall Study|Lost to Follow-up|0|||
131907697|NCT00828711|474948879|FG002|Overall Study|Lost to Follow-up|0|||
131907698|NCT01618968|474948880|FG000|Overall Study|Adverse Event|1|||
131907699|NCT01618968|474948881|FG001|Overall Study|Adverse Event|0|||
131907700|NCT01618968|474948882|FG002|Overall Study|Adverse Event|0|||
131907701|NCT01618968|474948883|FG003|Overall Study|Adverse Event|0|||
131907702|NCT01618968|474948880|FG000|Overall Study|Death|0|||
131907703|NCT01618968|474948881|FG001|Overall Study|Death|0|||
131907704|NCT01618968|474948882|FG002|Overall Study|Death|0|||
131907705|NCT01618968|474948883|FG003|Overall Study|Death|1|||
131907706|NCT00721799|474948886|FG000|Overall Study|Withdrawal by Subject|7|||
131907707|NCT00721799|474948886|FG000|Overall Study|withdraw by subject after scan 1|1|||
131907708|NCT02033759|474948887|FG000|Overall Study|Withdrawal by Subject|2|||
131907709|NCT02033759|474948888|FG001|Overall Study|Withdrawal by Subject|1|||
131907710|NCT02033759|474948887|FG000|Overall Study|Protocol Violation|1|||
131811352|NCT00838539|474590852|FG004|Overall Study|Symptomatic Deterioration|0|||
131811353|NCT00838539|474590853|FG005|Overall Study|Symptomatic Deterioration|1|||
131811354|NCT00838539|474590854|FG006|Overall Study|Symptomatic Deterioration|0|||
131811355|NCT00838539|474590855|FG007|Overall Study|Symptomatic Deterioration|0|||
131811356|NCT00838539|474590856|FG008|Overall Study|Symptomatic Deterioration|0|||
131811357|NCT00838539|474590857|FG009|Overall Study|Symptomatic Deterioration|1|||
131398584|NCT01406938|473081208|FG001|Maintenance Period|Adverse Event|0|||
131811358|NCT00838539|474590858|FG010|Overall Study|Symptomatic Deterioration|0|||
131811359|NCT00838539|474590859|FG011|Overall Study|Symptomatic Deterioration|0|||
131811360|NCT03134222|474590864|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
131811361|NCT03134222|474590865|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
131811362|NCT03134222|474590866|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
131811363|NCT03134222|474590867|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
131811364|NCT03134222|474590868|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
131811365|NCT03134222|474590864|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
131811366|NCT03134222|474590865|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
131811367|NCT03134222|474590866|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
131811368|NCT03134222|474590867|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
131811369|NCT03134222|474590868|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
131811370|NCT03134222|474590864|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
131811371|NCT03134222|474590865|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
131811372|NCT03134222|474590866|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
131811373|NCT03134222|474590867|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
131811374|NCT03134222|474590868|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
131811375|NCT03134222|474590864|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
131811376|NCT03134222|474590865|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
131811377|NCT03134222|474590866|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
131907711|NCT02033759|474948888|FG001|Overall Study|Protocol Violation|1|||
131907712|NCT04356937|474948891|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
131907713|NCT04356937|474948892|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
131907714|NCT03533751|474948893|FG000|Overall Study|Withdrawal by Subject|12|||
131907715|NCT03533751|474948894|FG001|Overall Study|Withdrawal by Subject|6|||
131907716|NCT03533751|474948895|FG002|Overall Study|Withdrawal by Subject|11|||
131907717|NCT03533751|474948896|FG003|Overall Study|Withdrawal by Subject|9|||
131907718|NCT03533751|474948897|FG004|Overall Study|Withdrawal by Subject|10|||
131398585|NCT01406938|473081209|FG002|Maintenance Period|Adverse Event|2|||
131398586|NCT01406938|473081210|FG003|Maintenance Period|Adverse Event|8|||
131398587|NCT01406938|473081211|FG004|Maintenance Period|Adverse Event|4|||
131398588|NCT01406938|473081212|FG005|Maintenance Period|Adverse Event|2|||
131398589|NCT01406938|473081207|FG000|Maintenance Period|Death|0|||
131398590|NCT01406938|473081208|FG001|Maintenance Period|Death|0|||
131754729|NCT00047008|474381072|FG001|Overall Study|Ineligible|8|||
131754730|NCT01366534|474381073|FG000|Overall Study|Lost to Follow-up|1|||
131754731|NCT01366534|474381074|FG001|Overall Study|Lost to Follow-up|0|||
131754732|NCT01366534|474381075|FG002|Overall Study|Lost to Follow-up|0|||
131754733|NCT01366534|474381073|FG000|Overall Study|Migrated|1|||
131907719|NCT03533751|474948893|FG000|Overall Study|Adverse Event|4|||
131907720|NCT03533751|474948894|FG001|Overall Study|Adverse Event|7|||
131907721|NCT03533751|474948895|FG002|Overall Study|Adverse Event|2|||
131754734|NCT01366534|474381074|FG001|Overall Study|Migrated|1|||
131754735|NCT01366534|474381075|FG002|Overall Study|Migrated|0|||
131754736|NCT01366534|474381073|FG000|Overall Study|Declined challenged|0|||
131754737|NCT01366534|474381074|FG001|Overall Study|Declined challenged|1|||
131754738|NCT01366534|474381075|FG002|Overall Study|Declined challenged|0|||
131754739|NCT03377452|474381076|FG000|Overall Study|Refused assessment|0|||
131754740|NCT03377452|474381077|FG001|Overall Study|Refused assessment|2|||
131754741|NCT03377452|474381076|FG000|Overall Study|Lost to Follow-up|5|||
131754742|NCT03377452|474381077|FG001|Overall Study|Lost to Follow-up|4|||
131754743|NCT00424099|474381078|FG000|Overall Study|Adverse Event|0|||
131754744|NCT00424099|474381079|FG001|Overall Study|Adverse Event|1|||
131754745|NCT00424099|474381080|FG002|Overall Study|Adverse Event|1|||
131907722|NCT03533751|474948896|FG003|Overall Study|Adverse Event|4|||
131907723|NCT03533751|474948897|FG004|Overall Study|Adverse Event|5|||
131907724|NCT03533751|474948893|FG000|Overall Study|Physician Decision|0|||
131907725|NCT03533751|474948894|FG001|Overall Study|Physician Decision|2|||
131907726|NCT03533751|474948895|FG002|Overall Study|Physician Decision|1|||
131907727|NCT03533751|474948896|FG003|Overall Study|Physician Decision|2|||
131907728|NCT03533751|474948897|FG004|Overall Study|Physician Decision|1|||
131907729|NCT03533751|474948893|FG000|Overall Study|Sponsor Decision|0|||
131907730|NCT03533751|474948894|FG001|Overall Study|Sponsor Decision|0|||
131907731|NCT03533751|474948895|FG002|Overall Study|Sponsor Decision|1|||
131907732|NCT03533751|474948896|FG003|Overall Study|Sponsor Decision|1|||
131907733|NCT03533751|474948897|FG004|Overall Study|Sponsor Decision|0|||
131907734|NCT03533751|474948893|FG000|Overall Study|Lost to Follow-up|3|||
131907735|NCT03533751|474948894|FG001|Overall Study|Lost to Follow-up|7|||
131907736|NCT03533751|474948895|FG002|Overall Study|Lost to Follow-up|6|||
131907737|NCT03533751|474948896|FG003|Overall Study|Lost to Follow-up|4|||
131907738|NCT03533751|474948897|FG004|Overall Study|Lost to Follow-up|3|||
131907739|NCT03533751|474948893|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
131907740|NCT03533751|474948894|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
131907741|NCT03533751|474948895|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
131907742|NCT03533751|474948896|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
131907743|NCT03533751|474948897|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
131907744|NCT03533751|474948893|FG000|Overall Study|Other|0|||
131907745|NCT03533751|474948894|FG001|Overall Study|Other|2|||
131907746|NCT03533751|474948895|FG002|Overall Study|Other|1|||
131907747|NCT03533751|474948896|FG003|Overall Study|Other|0|||
131907748|NCT03533751|474948897|FG004|Overall Study|Other|3|||
131907749|NCT05117060|474948898|FG000|Overall Study|Adverse Event|3|||
131754746|NCT00424099|474381081|FG003|Overall Study|Adverse Event|0|||
131754747|NCT00424099|474381078|FG000|Overall Study|Death|0|||
131754748|NCT00424099|474381079|FG001|Overall Study|Death|1|||
131754749|NCT00424099|474381080|FG002|Overall Study|Death|0|||
131754750|NCT00424099|474381081|FG003|Overall Study|Death|0|||
131754751|NCT00424099|474381078|FG000|Overall Study|Illness|2|||
131754752|NCT00424099|474381079|FG001|Overall Study|Illness|0|||
131754753|NCT00424099|474381080|FG002|Overall Study|Illness|1|||
131754754|NCT00424099|474381081|FG003|Overall Study|Illness|4|||
131754755|NCT00424099|474381078|FG000|Overall Study|Lost to Follow-up|0|||
131754756|NCT00424099|474381079|FG001|Overall Study|Lost to Follow-up|0|||
131754757|NCT00424099|474381080|FG002|Overall Study|Lost to Follow-up|3|||
131754758|NCT00424099|474381081|FG003|Overall Study|Lost to Follow-up|0|||
131754759|NCT00424099|474381078|FG000|Overall Study|Hospitalized|1|||
131754760|NCT00424099|474381079|FG001|Overall Study|Hospitalized|2|||
131754761|NCT00424099|474381080|FG002|Overall Study|Hospitalized|1|||
131754762|NCT00424099|474381081|FG003|Overall Study|Hospitalized|3|||
131907750|NCT05117060|474948899|FG001|Overall Study|Adverse Event|5|||
131907751|NCT05117060|474948900|FG002|Overall Study|Adverse Event|6|||
131907752|NCT05117060|474948901|FG003|Overall Study|Adverse Event|1|||
131907753|NCT05117060|474948898|FG000|Overall Study|Lost to Follow-up|0|||
131907754|NCT05117060|474948899|FG001|Overall Study|Lost to Follow-up|0|||
131907755|NCT05117060|474948900|FG002|Overall Study|Lost to Follow-up|0|||
131907756|NCT05117060|474948901|FG003|Overall Study|Lost to Follow-up|1|||
131907757|NCT05117060|474948898|FG000|Overall Study|Lack of Efficacy|4|||
131907758|NCT05117060|474948899|FG001|Overall Study|Lack of Efficacy|5|||
131907759|NCT05117060|474948900|FG002|Overall Study|Lack of Efficacy|2|||
131907760|NCT05117060|474948901|FG003|Overall Study|Lack of Efficacy|6|||
131907761|NCT05117060|474948898|FG000|Overall Study|Withdrawal by Subject|8|||
131907762|NCT05117060|474948899|FG001|Overall Study|Withdrawal by Subject|5|||
131907763|NCT05117060|474948900|FG002|Overall Study|Withdrawal by Subject|5|||
131907764|NCT05117060|474948901|FG003|Overall Study|Withdrawal by Subject|6|||
131907765|NCT05117060|474948898|FG000|Overall Study|Other|2|||
131907766|NCT05117060|474948899|FG001|Overall Study|Other|1|||
131907767|NCT05117060|474948900|FG002|Overall Study|Other|3|||
131907768|NCT05117060|474948901|FG003|Overall Study|Other|1|||
131907769|NCT03141359|474948902|FG000|Overall Study|Death|32|||
131907770|NCT03141359|474948902|FG000|Overall Study|Still On Study (in follow up)|29|||
131907771|NCT01081626|474948903|FG000|Overall Study|Dosing error|1|||
131907772|NCT01081626|474948904|FG001|Overall Study|Dosing error|1|||
131907773|NCT01081626|474948903|FG000|Overall Study|Missing Estradiol|25|||
131907774|NCT01081626|474948904|FG001|Overall Study|Missing Estradiol|28|||
131907775|NCT01081626|474948903|FG000|Overall Study|Low antral follicle count|1|||
131754763|NCT00424099|474381078|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
131754764|NCT00424099|474381079|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
131754765|NCT00424099|474381080|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
131754766|NCT00424099|474381081|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
131907776|NCT01081626|474948904|FG001|Overall Study|Low antral follicle count|0|||
131907777|NCT01081626|474948903|FG000|Overall Study|Overstimulation|0|||
131907778|NCT01081626|474948904|FG001|Overall Study|Overstimulation|1|||
131907779|NCT01081626|474948903|FG000|Overall Study|Lost to Follow-up|0|||
131907780|NCT01081626|474948904|FG001|Overall Study|Lost to Follow-up|1|||
131754767|NCT00424099|474381078|FG000|Overall Study|Withdrawal by Subject|1|||
131754768|NCT00424099|474381079|FG001|Overall Study|Withdrawal by Subject|9|||
131754769|NCT00424099|474381080|FG002|Overall Study|Withdrawal by Subject|4|||
131754770|NCT00424099|474381081|FG003|Overall Study|Withdrawal by Subject|6|||
131754771|NCT00424099|474381078|FG000|Overall Study|Physician Decision|0|||
131754772|NCT00424099|474381079|FG001|Overall Study|Physician Decision|0|||
131754773|NCT00424099|474381080|FG002|Overall Study|Physician Decision|1|||
131754774|NCT00424099|474381081|FG003|Overall Study|Physician Decision|0|||
131754775|NCT00424099|474381078|FG000|Overall Study|Missing|0|||
131754776|NCT00424099|474381079|FG001|Overall Study|Missing|0|||
131754777|NCT00424099|474381080|FG002|Overall Study|Missing|1|||
131754778|NCT00424099|474381081|FG003|Overall Study|Missing|0|||
131754779|NCT01408732|474381082|FG000|Overall Study|Withdrawal by Subject|2|||
131754780|NCT01408732|474381083|FG001|Overall Study|Withdrawal by Subject|2|||
131754781|NCT00796003|474381085|FG000|Overall Study|Disease Progression|2|||
131754782|NCT00796003|474381086|FG001|Overall Study|Disease Progression|13|||
131754783|NCT00796003|474381085|FG000|Overall Study|Adverse Event|1|||
131754784|NCT00796003|474381086|FG001|Overall Study|Adverse Event|7|||
131754785|NCT00796003|474381085|FG000|Overall Study|Specified organ function not met|0|||
131754786|NCT00796003|474381086|FG001|Overall Study|Specified organ function not met|1|||
131754787|NCT00796003|474381085|FG000|Overall Study|Physician Decision|0|||
131754788|NCT00796003|474381086|FG001|Overall Study|Physician Decision|4|||
131754789|NCT00796003|474381085|FG000|Overall Study|Withdrawal by Subject|0|||
131754790|NCT00796003|474381086|FG001|Overall Study|Withdrawal by Subject|1|||
131754791|NCT00796003|474381085|FG000|Overall Study|Other|0|||
131754792|NCT00796003|474381086|FG001|Overall Study|Other|1|||
131754793|NCT00796003|474381085|FG000|Overall Study|Participants Not treated|0|||
131754794|NCT00796003|474381086|FG001|Overall Study|Participants Not treated|2|||
131754795|NCT05179057|474381087|FG000|Overall Study|Adverse Event|3|||
131754796|NCT05179057|474381088|FG001|Overall Study|Adverse Event|2|||
131754797|NCT05179057|474381087|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
131754798|NCT05179057|474381088|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
131754799|NCT05179057|474381087|FG000|Overall Study|Study terminated|13|||
131754800|NCT05179057|474381088|FG001|Overall Study|Study terminated|7|||
131754801|NCT05179057|474381087|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
131754802|NCT05179057|474381088|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
131754803|NCT05179057|474381087|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
131754804|NCT05179057|474381088|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
131754805|NCT03345342|474381089|FG000|Open-Label Phase|Adverse Event|30|||
131754806|NCT03345342|474381090|FG001|Open-Label Phase|Adverse Event|0|||
131754807|NCT03345342|474381091|FG002|Open-Label Phase|Adverse Event|0|||
131754808|NCT03345342|474381092|FG003|Open-Label Phase|Adverse Event|0|||
131754809|NCT03345342|474381093|FG004|Open-Label Phase|Adverse Event|0|||
131754810|NCT03345342|474381089|FG000|Open-Label Phase|Death|1|||
131754811|NCT03345342|474381090|FG001|Open-Label Phase|Death|0|||
131754812|NCT03345342|474381091|FG002|Open-Label Phase|Death|0|||
131754813|NCT03345342|474381092|FG003|Open-Label Phase|Death|0|||
131754814|NCT03345342|474381093|FG004|Open-Label Phase|Death|0|||
131754815|NCT03345342|474381089|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
131754816|NCT03345342|474381090|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
131754817|NCT03345342|474381091|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
131754818|NCT03345342|474381092|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
131754819|NCT03345342|474381093|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
131754820|NCT03345342|474381089|FG000|Open-Label Phase|Lack of Efficacy|6|||
131754821|NCT03345342|474381090|FG001|Open-Label Phase|Lack of Efficacy|0|||
131754822|NCT03345342|474381091|FG002|Open-Label Phase|Lack of Efficacy|0|||
131754823|NCT03345342|474381092|FG003|Open-Label Phase|Lack of Efficacy|0|||
131754824|NCT03345342|474381093|FG004|Open-Label Phase|Lack of Efficacy|0|||
131754825|NCT03345342|474381089|FG000|Open-Label Phase|Lost to Follow-up|9|||
131754826|NCT03345342|474381090|FG001|Open-Label Phase|Lost to Follow-up|0|||
131754827|NCT03345342|474381091|FG002|Open-Label Phase|Lost to Follow-up|0|||
131754828|NCT03345342|474381092|FG003|Open-Label Phase|Lost to Follow-up|0|||
131754829|NCT03345342|474381093|FG004|Open-Label Phase|Lost to Follow-up|0|||
131754830|NCT03345342|474381089|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
131754831|NCT03345342|474381090|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
131754832|NCT03345342|474381091|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
131754833|NCT03345342|474381092|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
131754834|NCT03345342|474381093|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
131754835|NCT03345342|474381089|FG000|Open-Label Phase|Physician Decision|4|||
131754836|NCT03345342|474381090|FG001|Open-Label Phase|Physician Decision|0|||
131754837|NCT03345342|474381091|FG002|Open-Label Phase|Physician Decision|0|||
131754838|NCT03345342|474381092|FG003|Open-Label Phase|Physician Decision|0|||
131754839|NCT03345342|474381093|FG004|Open-Label Phase|Physician Decision|0|||
131754840|NCT03345342|474381089|FG000|Open-Label Phase|Protocol Violation|8|||
131811378|NCT03134222|474590867|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
131811379|NCT03134222|474590868|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
131811380|NCT03134222|474590864|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
131811381|NCT03134222|474590865|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
131811382|NCT03134222|474590866|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
131811383|NCT03134222|474590867|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
131754841|NCT03345342|474381090|FG001|Open-Label Phase|Protocol Violation|0|||
131754842|NCT03345342|474381091|FG002|Open-Label Phase|Protocol Violation|0|||
131811384|NCT03134222|474590868|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
131811385|NCT03134222|474590864|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
131811386|NCT03134222|474590865|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
131811387|NCT03134222|474590866|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
131811388|NCT03134222|474590867|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
131811389|NCT03134222|474590868|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
131754843|NCT03345342|474381092|FG003|Open-Label Phase|Protocol Violation|0|||
131754844|NCT03345342|474381093|FG004|Open-Label Phase|Protocol Violation|0|||
131754845|NCT03345342|474381089|FG000|Open-Label Phase|Withdrawal by Subject|57|||
131754846|NCT03345342|474381090|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131754847|NCT03345342|474381091|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131754848|NCT03345342|474381092|FG003|Open-Label Phase|Withdrawal by Subject|0|||
131754849|NCT03345342|474381093|FG004|Open-Label Phase|Withdrawal by Subject|0|||
131754850|NCT03345342|474381089|FG000|Open-Label Phase|Other|15|||
131754851|NCT03345342|474381090|FG001|Open-Label Phase|Other|0|||
131754852|NCT03345342|474381091|FG002|Open-Label Phase|Other|0|||
131754853|NCT03345342|474381092|FG003|Open-Label Phase|Other|0|||
131754854|NCT03345342|474381093|FG004|Open-Label Phase|Other|0|||
131754855|NCT03345342|474381089|FG000|Double-Blind Phase|Adverse Event|0|||
131754856|NCT03345342|474381090|FG001|Double-Blind Phase|Adverse Event|1|||
131754857|NCT03345342|474381091|FG002|Double-Blind Phase|Adverse Event|6|||
131754858|NCT03345342|474381092|FG003|Double-Blind Phase|Adverse Event|0|||
131754859|NCT03345342|474381093|FG004|Double-Blind Phase|Adverse Event|0|||
131754860|NCT03345342|474381089|FG000|Double-Blind Phase|Death|0|||
131754861|NCT03345342|474381090|FG001|Double-Blind Phase|Death|2|||
131754862|NCT03345342|474381091|FG002|Double-Blind Phase|Death|1|||
131754863|NCT03345342|474381092|FG003|Double-Blind Phase|Death|0|||
131754864|NCT03345342|474381093|FG004|Double-Blind Phase|Death|0|||
131754865|NCT03345342|474381089|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
131754866|NCT03345342|474381090|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
131754867|NCT03345342|474381091|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
131754868|NCT03345342|474381092|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
131754869|NCT03345342|474381093|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
131754870|NCT03345342|474381089|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131754871|NCT03345342|474381090|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131754872|NCT03345342|474381091|FG002|Double-Blind Phase|Lost to Follow-up|7|||
131754873|NCT03345342|474381092|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131754874|NCT03345342|474381093|FG004|Double-Blind Phase|Lost to Follow-up|0|||
131754875|NCT03345342|474381089|FG000|Double-Blind Phase|Physician Decision|0|||
131754876|NCT03345342|474381090|FG001|Double-Blind Phase|Physician Decision|1|||
131754877|NCT03345342|474381091|FG002|Double-Blind Phase|Physician Decision|4|||
131754878|NCT03345342|474381092|FG003|Double-Blind Phase|Physician Decision|0|||
131754879|NCT03345342|474381093|FG004|Double-Blind Phase|Physician Decision|0|||
131754880|NCT03345342|474381089|FG000|Double-Blind Phase|Protocol Violation|0|||
131754881|NCT03345342|474381090|FG001|Double-Blind Phase|Protocol Violation|0|||
131754882|NCT03345342|474381091|FG002|Double-Blind Phase|Protocol Violation|1|||
131754883|NCT03345342|474381092|FG003|Double-Blind Phase|Protocol Violation|0|||
131754884|NCT03345342|474381093|FG004|Double-Blind Phase|Protocol Violation|0|||
131754885|NCT03345342|474381089|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131754886|NCT03345342|474381090|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
131754887|NCT03345342|474381091|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
131754888|NCT03345342|474381092|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131811390|NCT03134222|474590864|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
131811391|NCT03134222|474590865|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
131811392|NCT03134222|474590866|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
131811393|NCT03134222|474590867|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
131811394|NCT03134222|474590868|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
131811395|NCT03134222|474590864|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
131811396|NCT03134222|474590865|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
131907781|NCT01081626|474948903|FG000|Overall Study|Other|33|||
131754889|NCT03345342|474381093|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
131754890|NCT03345342|474381089|FG000|Double-Blind Phase|Other|0|||
131754891|NCT03345342|474381090|FG001|Double-Blind Phase|Other|1|||
131754892|NCT03345342|474381091|FG002|Double-Blind Phase|Other|3|||
131754893|NCT03345342|474381092|FG003|Double-Blind Phase|Other|0|||
131754894|NCT03345342|474381093|FG004|Double-Blind Phase|Other|0|||
131754895|NCT03345342|474381089|FG000|Follow-Up Phase|Adverse Event|0|||
131754896|NCT03345342|474381090|FG001|Follow-Up Phase|Adverse Event|0|||
131754897|NCT03345342|474381091|FG002|Follow-Up Phase|Adverse Event|0|||
131754898|NCT03345342|474381092|FG003|Follow-Up Phase|Adverse Event|0|||
131754899|NCT03345342|474381093|FG004|Follow-Up Phase|Adverse Event|4|||
131754900|NCT03345342|474381089|FG000|Follow-Up Phase|Lost to Follow-up|0|||
131754901|NCT03345342|474381090|FG001|Follow-Up Phase|Lost to Follow-up|0|||
131754902|NCT03345342|474381091|FG002|Follow-Up Phase|Lost to Follow-up|0|||
131754903|NCT03345342|474381092|FG003|Follow-Up Phase|Lost to Follow-up|0|||
131754904|NCT03345342|474381093|FG004|Follow-Up Phase|Lost to Follow-up|6|||
131754905|NCT03345342|474381089|FG000|Follow-Up Phase|Physician Decision|0|||
131754906|NCT03345342|474381090|FG001|Follow-Up Phase|Physician Decision|0|||
131754907|NCT03345342|474381091|FG002|Follow-Up Phase|Physician Decision|0|||
131754908|NCT03345342|474381092|FG003|Follow-Up Phase|Physician Decision|0|||
131754909|NCT03345342|474381093|FG004|Follow-Up Phase|Physician Decision|5|||
131754910|NCT03345342|474381089|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
131754911|NCT03345342|474381090|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
131754912|NCT03345342|474381091|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
131754913|NCT03345342|474381092|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
131754914|NCT03345342|474381093|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
131754915|NCT03345342|474381089|FG000|Follow-Up Phase|Other|0|||
131754916|NCT03345342|474381090|FG001|Follow-Up Phase|Other|0|||
131754917|NCT03345342|474381091|FG002|Follow-Up Phase|Other|0|||
131754918|NCT03345342|474381092|FG003|Follow-Up Phase|Other|3|||
131754919|NCT03345342|474381093|FG004|Follow-Up Phase|Other|1|||
131754920|NCT02437162|474381094|FG000|Overall Study|Protocol Violation|0|||
131754921|NCT02437162|474381095|FG001|Overall Study|Protocol Violation|1|||
131754922|NCT02437162|474381096|FG002|Overall Study|Protocol Violation|0|||
131754923|NCT02437162|474381094|FG000|Overall Study|Randomized but not treated|0|||
131754924|NCT02437162|474381095|FG001|Overall Study|Randomized but not treated|0|||
131754925|NCT02437162|474381096|FG002|Overall Study|Randomized but not treated|1|||
131754926|NCT02437162|474381094|FG000|Overall Study|Study discontinued by Sponsor|93|||
131754927|NCT02437162|474381095|FG001|Overall Study|Study discontinued by Sponsor|98|||
131754928|NCT02437162|474381096|FG002|Overall Study|Study discontinued by Sponsor|97|||
131754929|NCT02437162|474381094|FG000|Overall Study|Withdrawal by Subject|13|||
131754930|NCT02437162|474381095|FG001|Overall Study|Withdrawal by Subject|7|||
131754931|NCT02437162|474381096|FG002|Overall Study|Withdrawal by Subject|9|||
131754932|NCT02437162|474381094|FG000|Overall Study|Adverse Event|0|||
131754933|NCT02437162|474381095|FG001|Overall Study|Adverse Event|1|||
131754934|NCT02437162|474381096|FG002|Overall Study|Adverse Event|0|||
131754935|NCT02437162|474381094|FG000|Overall Study|Lost to Follow-up|1|||
131754936|NCT02437162|474381095|FG001|Overall Study|Lost to Follow-up|0|||
131754937|NCT02437162|474381096|FG002|Overall Study|Lost to Follow-up|1|||
131754938|NCT02437162|474381094|FG000|Overall Study|Death|0|||
131754939|NCT02437162|474381095|FG001|Overall Study|Death|1|||
131754940|NCT02437162|474381096|FG002|Overall Study|Death|0|||
131754941|NCT02437162|474381094|FG000|Overall Study|Other|0|||
131754942|NCT02437162|474381095|FG001|Overall Study|Other|0|||
131754943|NCT02437162|474381096|FG002|Overall Study|Other|1|||
131754944|NCT04338321|474381101|FG000|Overall Study|Adverse Event|4|||
131754945|NCT04338321|474381102|FG001|Overall Study|Adverse Event|10|||
131754946|NCT04338321|474381101|FG000|Overall Study|Death|1|||
131754947|NCT04338321|474381102|FG001|Overall Study|Death|1|||
131754948|NCT04338321|474381101|FG000|Overall Study|Lost to Follow-up|4|||
131754949|NCT04338321|474381102|FG001|Overall Study|Lost to Follow-up|9|||
131811397|NCT03134222|474590866|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
131811398|NCT03134222|474590867|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
131811399|NCT03134222|474590868|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
131811400|NCT04659603|474590869|FG000|Overall Study|Study terminated by sponsor|0|||
131811401|NCT04659603|474590870|FG001|Overall Study|Study terminated by sponsor|0|||
131811402|NCT04659603|474590871|FG002|Overall Study|Study terminated by sponsor|2|||
131811403|NCT04659603|474590869|FG000|Overall Study|Withdrawal by Subject|0|||
131811404|NCT04659603|474590870|FG001|Overall Study|Withdrawal by Subject|5|||
131811405|NCT04659603|474590871|FG002|Overall Study|Withdrawal by Subject|0|||
131811406|NCT04659603|474590869|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
131811407|NCT04659603|474590870|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
131907782|NCT01081626|474948904|FG001|Overall Study|Other|30|||
131754950|NCT04338321|474381101|FG000|Overall Study|Withdrawal by Subject|45|||
131754951|NCT04338321|474381102|FG001|Overall Study|Withdrawal by Subject|69|||
131754952|NCT04338321|474381101|FG000|Overall Study|Physician Decision|5|||
131754953|NCT04338321|474381102|FG001|Overall Study|Physician Decision|9|||
131754954|NCT04338321|474381101|FG000|Overall Study|Other|3|||
131754955|NCT04338321|474381102|FG001|Overall Study|Other|10|||
131754956|NCT03375203|474381103|FG000|Overall Study|Protocol Violation|0|||
131754957|NCT03375203|474381104|FG001|Overall Study|Protocol Violation|0|||
131754958|NCT03375203|474381105|FG002|Overall Study|Protocol Violation|1|||
131754959|NCT03375203|474381106|FG003|Overall Study|Protocol Violation|0|||
131754960|NCT03375203|474381107|FG004|Overall Study|Protocol Violation|0|||
131754961|NCT03375203|474381103|FG000|Overall Study|Adverse Event|2|||
131754962|NCT03375203|474381104|FG001|Overall Study|Adverse Event|3|||
131754963|NCT03375203|474381105|FG002|Overall Study|Adverse Event|0|||
131907783|NCT04158219|474948905|FG000|Overall Study|Lost to Follow-up|1|||
131907784|NCT01419535|474948906|FG000|Overall Study|could not maintain iv line|1|||
131907785|NCT01419535|474948907|FG001|Overall Study|could not maintain iv line|1|||
131907786|NCT01419535|474948906|FG000|Overall Study|Withdrawal by Subject|0|||
131907787|NCT01419535|474948907|FG001|Overall Study|Withdrawal by Subject|1|||
131907788|NCT02074514|474948910|FG000|Overall Study|Lack of Efficacy|3|||
131907789|NCT02074514|474948911|FG001|Overall Study|Lack of Efficacy|2|||
131907790|NCT02074514|474948910|FG000|Overall Study|Lost to Follow-up|0|||
131907791|NCT02074514|474948911|FG001|Overall Study|Lost to Follow-up|1|||
131907792|NCT02074514|474948910|FG000|Overall Study|Withdrew Consent|0|||
131907793|NCT02074514|474948911|FG001|Overall Study|Withdrew Consent|1|||
131907794|NCT02873689|474950728|FG000|Overall Study|Lack of Efficacy|1|||
131907795|NCT02873689|474950729|FG001|Overall Study|Lack of Efficacy|0|||
131907796|NCT02873689|474950728|FG000|Overall Study|Withdrawal by Subject|2|||
131907797|NCT02873689|474950729|FG001|Overall Study|Withdrawal by Subject|2|||
131907798|NCT02873689|474950728|FG000|Overall Study|Protocol Violation|1|||
131907799|NCT02873689|474950729|FG001|Overall Study|Protocol Violation|0|||
131907800|NCT02873689|474950728|FG000|Overall Study|Adverse Event|2|||
131907801|NCT02873689|474950729|FG001|Overall Study|Adverse Event|2|||
131907802|NCT02873689|474950728|FG000|Overall Study|Randomized but not Treated|1|||
131907803|NCT02873689|474950729|FG001|Overall Study|Randomized but not Treated|1|||
131907804|NCT00720278|474950737|FG000|Overall Study|Adverse Event|5|||
131754964|NCT03375203|474381106|FG003|Overall Study|Adverse Event|2|||
131754965|NCT03375203|474381107|FG004|Overall Study|Adverse Event|2|||
131754966|NCT03375203|474381103|FG000|Overall Study|Withdrawal by Subject|3|||
131754967|NCT03375203|474381104|FG001|Overall Study|Withdrawal by Subject|0|||
131754968|NCT03375203|474381105|FG002|Overall Study|Withdrawal by Subject|1|||
131754969|NCT03375203|474381106|FG003|Overall Study|Withdrawal by Subject|0|||
131754970|NCT03375203|474381107|FG004|Overall Study|Withdrawal by Subject|2|||
131754971|NCT03375203|474381103|FG000|Overall Study|Non-compliance with study drug|1|||
131754972|NCT03375203|474381104|FG001|Overall Study|Non-compliance with study drug|0|||
131754973|NCT03375203|474381105|FG002|Overall Study|Non-compliance with study drug|0|||
131754974|NCT03375203|474381106|FG003|Overall Study|Non-compliance with study drug|0|||
131754975|NCT03375203|474381107|FG004|Overall Study|Non-compliance with study drug|0|||
131754976|NCT03375203|474381103|FG000|Overall Study|Randomized, not treated.|0|||
131754977|NCT03375203|474381104|FG001|Overall Study|Randomized, not treated.|1|||
131754978|NCT03375203|474381105|FG002|Overall Study|Randomized, not treated.|0|||
131754979|NCT03375203|474381106|FG003|Overall Study|Randomized, not treated.|0|||
131754980|NCT03375203|474381107|FG004|Overall Study|Randomized, not treated.|0|||
131754981|NCT03107793|474381108|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
131754982|NCT03107793|474381109|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
131754983|NCT03107793|474381110|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
131754984|NCT03107793|474381111|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
131754985|NCT03107793|474381112|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
131754986|NCT03107793|474381108|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
131754987|NCT03107793|474381109|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
131754988|NCT03107793|474381110|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
131754989|NCT03107793|474381111|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
131754990|NCT03107793|474381112|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
131754991|NCT03107793|474381108|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
131754992|NCT03107793|474381109|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
131754993|NCT03107793|474381110|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
131754994|NCT03107793|474381111|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
131754995|NCT03107793|474381112|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
131754996|NCT03107793|474381108|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
131754997|NCT03107793|474381109|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131754998|NCT03107793|474381110|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131754999|NCT03107793|474381111|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131755000|NCT03107793|474381112|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131755001|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131755002|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
131755003|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
131755004|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131755005|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131755006|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131755007|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
131755008|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
131755009|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131755010|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131907805|NCT00720278|474950738|FG001|Overall Study|Adverse Event|3|||
131907806|NCT00720278|474950739|FG002|Overall Study|Adverse Event|4|||
131907807|NCT00720278|474950737|FG000|Overall Study|Withdrawal by Subject|0|||
131907808|NCT00720278|474950738|FG001|Overall Study|Withdrawal by Subject|1|||
131907809|NCT00720278|474950739|FG002|Overall Study|Withdrawal by Subject|0|||
131755011|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131755012|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131755013|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
131755014|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131755015|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131755016|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131755017|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
131755018|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
131755019|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131755020|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131755021|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
131755022|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
131755023|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
131755024|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
131755025|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
131755026|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
131755027|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
131755028|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
131755029|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
131755030|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
131755031|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131755032|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
131755033|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131755034|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131755035|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131755036|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
131755037|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
131755038|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
131755039|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
131755040|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
131755041|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131755042|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131755043|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
131755044|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131755045|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131755046|NCT03107793|474381108|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131755047|NCT03107793|474381109|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
131755048|NCT03107793|474381110|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
131755049|NCT03107793|474381111|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131755050|NCT03107793|474381112|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131755051|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
131755052|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
131755053|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
131755054|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
131755055|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
131755056|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131755057|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131755058|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131755059|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131755060|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
131755061|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
131755062|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
131755063|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
131755064|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
131755065|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
131755066|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Death|0|||
131755067|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Death|0|||
131755068|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Death|0|||
131755069|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Death|0|||
131755070|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Death|1|||
131755071|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131755072|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131811408|NCT04659603|474590871|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
131811409|NCT01231906|474590872|FG000|Overall Study|Lack of Efficacy|75|||
131811410|NCT01231906|474590873|FG001|Overall Study|Lack of Efficacy|68|||
131811411|NCT01231906|474590872|FG000|Overall Study|Lost to Follow-up|1|||
131907810|NCT00720278|474950737|FG000|Overall Study|Lost to Follow-up|0|||
131907811|NCT00720278|474950738|FG001|Overall Study|Lost to Follow-up|0|||
131907812|NCT00720278|474950739|FG002|Overall Study|Lost to Follow-up|1|||
131907813|NCT00720278|474950737|FG000|Overall Study|Non-compliance|1|||
131907814|NCT00720278|474950738|FG001|Overall Study|Non-compliance|0|||
131907815|NCT00720278|474950739|FG002|Overall Study|Non-compliance|0|||
131907816|NCT00720278|474950737|FG000|Overall Study|eligibility criteria violation|1|||
131907817|NCT00720278|474950738|FG001|Overall Study|eligibility criteria violation|0|||
131907818|NCT00720278|474950739|FG002|Overall Study|eligibility criteria violation|1|||
131907819|NCT00607893|474950749|FG000|Overall Study|Lost to Follow-up|4|||
131907820|NCT00607893|474950750|FG001|Overall Study|Lost to Follow-up|0|||
131907821|NCT00607893|474950749|FG000|Overall Study|withdrew due to loss of interest|0|||
131907822|NCT00607893|474950750|FG001|Overall Study|withdrew due to loss of interest|1|||
131907823|NCT00607893|474950749|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
131907824|NCT00607893|474950750|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
131907825|NCT00607893|474950749|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
131907826|NCT00607893|474950750|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
131907827|NCT00607893|474950749|FG000|Overall Study|Declined to be treated|1|||
131907828|NCT00607893|474950750|FG001|Overall Study|Declined to be treated|0|||
131907829|NCT00607893|474950749|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
131907830|NCT00607893|474950750|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
131907831|NCT01863771|474950754|FG000|Induction Phase|Adverse Event|9|||
131907832|NCT01863771|474950755|FG001|Induction Phase|Adverse Event|0|||
131907833|NCT01863771|474950756|FG002|Induction Phase|Adverse Event|0|||
131907834|NCT01863771|474950757|FG003|Induction Phase|Adverse Event|0|||
131907835|NCT01863771|474950754|FG000|Induction Phase|Lack of Efficacy|10|||
131907836|NCT01863771|474950755|FG001|Induction Phase|Lack of Efficacy|0|||
131907837|NCT01863771|474950756|FG002|Induction Phase|Lack of Efficacy|0|||
131907838|NCT01863771|474950757|FG003|Induction Phase|Lack of Efficacy|0|||
131907839|NCT01863771|474950754|FG000|Induction Phase|Withdrawal by Subject|2|||
131907840|NCT01863771|474950755|FG001|Induction Phase|Withdrawal by Subject|0|||
131907841|NCT01863771|474950756|FG002|Induction Phase|Withdrawal by Subject|0|||
131907842|NCT01863771|474950757|FG003|Induction Phase|Withdrawal by Subject|0|||
131907843|NCT01863771|474950754|FG000|Maintenance Phase|Adverse Event|0|||
131907844|NCT01863771|474950755|FG001|Maintenance Phase|Adverse Event|0|||
131907845|NCT01863771|474950756|FG002|Maintenance Phase|Adverse Event|1|||
131907846|NCT01863771|474950757|FG003|Maintenance Phase|Adverse Event|1|||
131907847|NCT01863771|474950754|FG000|Maintenance Phase|Lack of Efficacy|0|||
131907848|NCT01863771|474950755|FG001|Maintenance Phase|Lack of Efficacy|3|||
131907849|NCT01863771|474950756|FG002|Maintenance Phase|Lack of Efficacy|7|||
131907850|NCT01863771|474950757|FG003|Maintenance Phase|Lack of Efficacy|38|||
131907851|NCT01863771|474950754|FG000|Maintenance Phase|Physician Decision|0|||
131907852|NCT01863771|474950755|FG001|Maintenance Phase|Physician Decision|0|||
131907853|NCT01863771|474950756|FG002|Maintenance Phase|Physician Decision|2|||
131907854|NCT01863771|474950757|FG003|Maintenance Phase|Physician Decision|1|||
131907855|NCT01863771|474950754|FG000|Maintenance Phase|Pregnancy|0|||
131907856|NCT01863771|474950755|FG001|Maintenance Phase|Pregnancy|1|||
131907857|NCT01863771|474950756|FG002|Maintenance Phase|Pregnancy|0|||
131907858|NCT01863771|474950757|FG003|Maintenance Phase|Pregnancy|0|||
131907859|NCT01863771|474950754|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131907860|NCT01863771|474950755|FG001|Maintenance Phase|Withdrawal by Subject|1|||
131907861|NCT01863771|474950756|FG002|Maintenance Phase|Withdrawal by Subject|2|||
131907862|NCT01863771|474950757|FG003|Maintenance Phase|Withdrawal by Subject|3|||
131907863|NCT03499795|474950758|FG000|Overall Study|Adverse Event|1|||
131907864|NCT03499795|474950758|FG000|Overall Study|Lost to Follow-up|1|||
131907865|NCT03636256|474950761|FG000|Overall Study|Lost to Follow-up|3|||
131907866|NCT03636256|474950762|FG001|Overall Study|Lost to Follow-up|0|||
131907867|NCT03636256|474950763|FG002|Overall Study|Lost to Follow-up|2|||
131907868|NCT03636256|474950764|FG003|Overall Study|Lost to Follow-up|1|||
131907869|NCT03636256|474950765|FG004|Overall Study|Lost to Follow-up|0|||
131907870|NCT03636256|474950766|FG005|Overall Study|Lost to Follow-up|4|||
131907871|NCT03636256|474950767|FG006|Overall Study|Lost to Follow-up|2|||
131907872|NCT03636256|474950768|FG007|Overall Study|Lost to Follow-up|0|||
131907873|NCT03636256|474950769|FG008|Overall Study|Lost to Follow-up|4|||
131907874|NCT03636256|474950761|FG000|Overall Study|Withdrawal by Subject|0|||
131907875|NCT03636256|474950762|FG001|Overall Study|Withdrawal by Subject|0|||
131907876|NCT03636256|474950763|FG002|Overall Study|Withdrawal by Subject|0|||
131907877|NCT03636256|474950764|FG003|Overall Study|Withdrawal by Subject|0|||
131907878|NCT03636256|474950765|FG004|Overall Study|Withdrawal by Subject|0|||
131907879|NCT03636256|474950766|FG005|Overall Study|Withdrawal by Subject|0|||
131907880|NCT03636256|474950767|FG006|Overall Study|Withdrawal by Subject|0|||
131907881|NCT03636256|474950768|FG007|Overall Study|Withdrawal by Subject|0|||
131907882|NCT03636256|474950769|FG008|Overall Study|Withdrawal by Subject|1|||
131907883|NCT01218308|474950770|FG000|Overall Study|Adverse Event|1|||
131907884|NCT01218308|474950771|FG001|Overall Study|Adverse Event|2|||
131907885|NCT01218308|474950770|FG000|Overall Study|Protocol Violation|0|||
131907886|NCT01218308|474950771|FG001|Overall Study|Protocol Violation|2|||
131398591|NCT01406938|473081209|FG002|Maintenance Period|Death|0|||
131755073|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131755074|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131755075|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
131755076|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
131755077|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
131755078|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
131755079|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
131755080|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
131755081|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
131755082|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
131755083|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
131755084|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
131755085|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
131755086|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131755087|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131755088|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131755089|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131755090|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
131755091|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131755092|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131755093|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131755094|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
131755095|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131811412|NCT01231906|474590873|FG001|Overall Study|Lost to Follow-up|0|||
131811413|NCT01231906|474590872|FG000|Overall Study|Physician Decision|34|||
131811414|NCT01231906|474590873|FG001|Overall Study|Physician Decision|24|||
131811415|NCT01231906|474590872|FG000|Overall Study|Withdrawal by Subject|0|||
131811416|NCT01231906|474590873|FG001|Overall Study|Withdrawal by Subject|4|||
131811417|NCT01231906|474590872|FG000|Overall Study|Ineligible|10|||
131811418|NCT01231906|474590873|FG001|Overall Study|Ineligible|3|||
131811419|NCT01231906|474590872|FG000|Overall Study|No treatment|1|||
131811420|NCT01231906|474590873|FG001|Overall Study|No treatment|2|||
131811421|NCT01136174|474590874|FG000|Overall Study|Adverse Event|0|||
131811422|NCT01136174|474590875|FG001|Overall Study|Adverse Event|0|||
131811423|NCT01136174|474590876|FG002|Overall Study|Adverse Event|0|||
131811424|NCT01136174|474590877|FG003|Overall Study|Adverse Event|4|||
131811425|NCT03238781|474590878|FG000|Overall Study|Adverse Event|1|||
131811426|NCT03238781|474590879|FG001|Overall Study|Adverse Event|1|||
131811427|NCT03238781|474590880|FG002|Overall Study|Adverse Event|2|||
131811428|NCT03238781|474590878|FG000|Overall Study|Lost to Follow-up|2|||
131811429|NCT03238781|474590879|FG001|Overall Study|Lost to Follow-up|1|||
131811430|NCT03238781|474590880|FG002|Overall Study|Lost to Follow-up|2|||
131811431|NCT03238781|474590878|FG000|Overall Study|Withdrawal by Subject|23|||
131811432|NCT03238781|474590879|FG001|Overall Study|Withdrawal by Subject|14|||
131811433|NCT03238781|474590880|FG002|Overall Study|Withdrawal by Subject|16|||
131811434|NCT03238781|474590878|FG000|Overall Study|Decision by sponsor|0|||
131811435|NCT03238781|474590879|FG001|Overall Study|Decision by sponsor|1|||
131811436|NCT03238781|474590880|FG002|Overall Study|Decision by sponsor|0|||
131811437|NCT00813592|474590893|FG000|Overall Study|Disease assessment was not completed per|2|||
131811438|NCT00811655|474590894|FG000|Overall Study|Physician Decision|1|||
131811439|NCT02820350|474590897|FG000|Overall Study|Withdrawal by Subject|3|||
131811440|NCT02820350|474590897|FG000|Overall Study|Death|4|||
131811441|NCT01754597|474590898|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
131811442|NCT01754597|474590899|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
131811443|NCT01588236|474590900|FG000|Overall Study|Adverse Event|5|||
131811444|NCT01588236|474590901|FG001|Overall Study|Adverse Event|4|||
131811445|NCT01588236|474590902|FG002|Overall Study|Adverse Event|1|||
131811446|NCT01588236|474590900|FG000|Overall Study|Lost to Follow-up|8|||
131811447|NCT01588236|474590901|FG001|Overall Study|Lost to Follow-up|13|||
131811448|NCT01588236|474590902|FG002|Overall Study|Lost to Follow-up|6|||
131811449|NCT01588236|474590900|FG000|Overall Study|Physician Decision|1|||
131811450|NCT01588236|474590901|FG001|Overall Study|Physician Decision|2|||
131811451|NCT01588236|474590902|FG002|Overall Study|Physician Decision|0|||
131811452|NCT01588236|474590900|FG000|Overall Study|Protocol Violation|0|||
131811453|NCT01588236|474590901|FG001|Overall Study|Protocol Violation|1|||
131811454|NCT01588236|474590902|FG002|Overall Study|Protocol Violation|1|||
131811455|NCT01588236|474590900|FG000|Overall Study|Withdrawal by Subject|14|||
131811456|NCT01588236|474590901|FG001|Overall Study|Withdrawal by Subject|16|||
131811457|NCT01588236|474590902|FG002|Overall Study|Withdrawal by Subject|18|||
131811458|NCT01588236|474590900|FG000|Overall Study|Exclusion Criteria met during study|2|||
131811459|NCT01588236|474590901|FG001|Overall Study|Exclusion Criteria met during study|1|||
131398592|NCT01406938|473081210|FG003|Maintenance Period|Death|0|||
131907887|NCT01218308|474950770|FG000|Overall Study|Withdrawal by Subject|61|||
131907888|NCT01218308|474950771|FG001|Overall Study|Withdrawal by Subject|64|||
131907889|NCT01218308|474950770|FG000|Overall Study|Lost to Follow-up|27|||
131907890|NCT01218308|474950771|FG001|Overall Study|Lost to Follow-up|31|||
131907891|NCT01218308|474950770|FG000|Overall Study|Other|14|||
131907892|NCT01218308|474950771|FG001|Overall Study|Other|21|||
131907893|NCT00547339|474950772|FG000|Overall Study|Physician Decision|0|||
131907894|NCT00547339|474950773|FG001|Overall Study|Physician Decision|0|||
131907895|NCT00547339|474950774|FG002|Overall Study|Physician Decision|1|||
131907896|NCT00547339|474950775|FG003|Overall Study|Physician Decision|0|||
131907897|NCT04748718|474950776|FG000|Overall Study|Lost to Follow-up|50|||
131907898|NCT01450813|474950777|FG000|Overall Study|Physician Decision|1|||
131907899|NCT01450813|474950778|FG001|Overall Study|Physician Decision|1|||
131907900|NCT01450813|474950779|FG002|Overall Study|Physician Decision|0|||
131907901|NCT01450813|474950780|FG003|Overall Study|Physician Decision|3|||
131907902|NCT00723229|474950784|FG000|First Intervention|Lost to Follow-up|7|||
131907903|NCT00723229|474950785|FG001|First Intervention|Lost to Follow-up|3|||
131907904|NCT01079780|474950786|FG000|Overall Study|Disease progression|43|||
131907905|NCT01079780|474950787|FG001|Overall Study|Disease progression|7|||
131907906|NCT01079780|474950788|FG002|Overall Study|Disease progression|31|||
131907907|NCT01079780|474950786|FG000|Overall Study|Adverse Event|13|||
131907908|NCT01079780|474950787|FG001|Overall Study|Adverse Event|5|||
131907909|NCT01079780|474950788|FG002|Overall Study|Adverse Event|7|||
131907910|NCT01079780|474950786|FG000|Overall Study|Death|2|||
131907911|NCT01079780|474950787|FG001|Overall Study|Death|0|||
131907912|NCT01079780|474950788|FG002|Overall Study|Death|2|||
131907913|NCT01079780|474950786|FG000|Overall Study|Withdrawal by Subject|6|||
131907914|NCT01079780|474950787|FG001|Overall Study|Withdrawal by Subject|4|||
131907915|NCT01079780|474950788|FG002|Overall Study|Withdrawal by Subject|4|||
131907916|NCT01079780|474950786|FG000|Overall Study|Alternative therapy|2|||
131907917|NCT01079780|474950787|FG001|Overall Study|Alternative therapy|0|||
131907918|NCT01079780|474950788|FG002|Overall Study|Alternative therapy|2|||
131907919|NCT01079780|474950786|FG000|Overall Study|Physician Decision|1|||
131907920|NCT01079780|474950787|FG001|Overall Study|Physician Decision|0|||
131907921|NCT01079780|474950788|FG002|Overall Study|Physician Decision|1|||
131907922|NCT01079780|474950786|FG000|Overall Study|Error made in lesion measurement|1|||
131907923|NCT01079780|474950787|FG001|Overall Study|Error made in lesion measurement|0|||
131907924|NCT01079780|474950788|FG002|Overall Study|Error made in lesion measurement|0|||
131907925|NCT01079780|474950786|FG000|Overall Study|Patient had surgery|1|||
131907926|NCT01079780|474950787|FG001|Overall Study|Patient had surgery|0|||
131907927|NCT01079780|474950788|FG002|Overall Study|Patient had surgery|0|||
131907928|NCT01079780|474950786|FG000|Overall Study|Treatment cycle delay|0|||
131907929|NCT01079780|474950787|FG001|Overall Study|Treatment cycle delay|0|||
131907930|NCT01079780|474950788|FG002|Overall Study|Treatment cycle delay|1|||
131907931|NCT01079780|474950786|FG000|Overall Study|Never started treatment|1|||
131907932|NCT01079780|474950787|FG001|Overall Study|Never started treatment|0|||
131907933|NCT01079780|474950788|FG002|Overall Study|Never started treatment|2|||
131907934|NCT02530385|474950795|FG000|Overall Study|Withdrawal by Subject|0|||
131907935|NCT02530385|474950796|FG001|Overall Study|Withdrawal by Subject|1|||
131907936|NCT01569022|474950798|FG000|First Intervention|Lost to Follow-up|2|||
131907937|NCT01569022|474950799|FG001|First Intervention|Lost to Follow-up|1|||
131907938|NCT01569022|474950798|FG000|Second Intervention|Lost to Follow-up|2|||
131907939|NCT01569022|474950799|FG001|Second Intervention|Lost to Follow-up|2|||
131907940|NCT02111083|474950804|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
131907941|NCT02111083|474950805|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
131907942|NCT00116142|474950806|FG000|Overall Study|Adverse Event|8|||
131907943|NCT00116142|474950807|FG001|Overall Study|Adverse Event|7|||
131907944|NCT00116142|474950806|FG000|Overall Study|Protocol Violation|2|||
131907945|NCT00116142|474950807|FG001|Overall Study|Protocol Violation|1|||
131907946|NCT00116142|474950806|FG000|Overall Study|Withdrawal by Subject|5|||
131907947|NCT00116142|474950807|FG001|Overall Study|Withdrawal by Subject|5|||
131907948|NCT00116142|474950806|FG000|Overall Study|Physician Decision|3|||
131907949|NCT00116142|474950807|FG001|Overall Study|Physician Decision|1|||
131907950|NCT00116142|474950806|FG000|Overall Study|Delayed Radiation Therapy|1|||
131907951|NCT00116142|474950807|FG001|Overall Study|Delayed Radiation Therapy|0|||
131907952|NCT00116142|474950806|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
131907953|NCT00116142|474950807|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
131907954|NCT00116142|474950806|FG000|Overall Study|Patient stopped due to depression|0|||
131907955|NCT00116142|474950807|FG001|Overall Study|Patient stopped due to depression|1|||
131907956|NCT00116142|474950806|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
131907957|NCT00116142|474950807|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
131907958|NCT00116142|474950806|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
131907959|NCT00116142|474950807|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
131907960|NCT00116142|474950806|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
131907961|NCT00116142|474950807|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
131907962|NCT00433836|474950808|FG000|Overall Study|Adverse Event|7|||
131907963|NCT00433836|474950809|FG001|Overall Study|Adverse Event|0|||
131907964|NCT00433836|474950808|FG000|Overall Study|Lost to Follow-up|3|||
131907965|NCT00433836|474950809|FG001|Overall Study|Lost to Follow-up|0|||
131907966|NCT00433836|474950808|FG000|Overall Study|Withdrawal by Subject|2|||
131907967|NCT00433836|474950809|FG001|Overall Study|Withdrawal by Subject|1|||
131907968|NCT00433836|474950808|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131907969|NCT00433836|474950809|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131907970|NCT00433836|474950808|FG000|Overall Study|Protocol Violation|0|||
131907971|NCT00433836|474950809|FG001|Overall Study|Protocol Violation|2|||
131907972|NCT00433836|474950808|FG000|Overall Study|Condition no longer requires study drug|0|||
131907973|NCT00433836|474950809|FG001|Overall Study|Condition no longer requires study drug|1|||
131907974|NCT00433836|474950808|FG000|Overall Study|Abnormal laboratory values|0|||
131907975|NCT00433836|474950809|FG001|Overall Study|Abnormal laboratory values|1|||
131907976|NCT00644059|474950810|FG000|Overall Study|Lost to Follow-up|37|||
131907977|NCT00644059|474950811|FG001|Overall Study|Lost to Follow-up|34|||
131907978|NCT00644059|474950812|FG002|Overall Study|Lost to Follow-up|16|||
131907979|NCT00644059|474950810|FG000|Overall Study|Withdrawal by Subject|52|||
131907980|NCT00644059|474950811|FG001|Overall Study|Withdrawal by Subject|60|||
131907981|NCT00644059|474950812|FG002|Overall Study|Withdrawal by Subject|30|||
131907982|NCT00644059|474950810|FG000|Overall Study|Adverse Event|8|||
131907983|NCT00644059|474950811|FG001|Overall Study|Adverse Event|5|||
131907984|NCT00644059|474950812|FG002|Overall Study|Adverse Event|1|||
131907985|NCT00644059|474950810|FG000|Overall Study|Inappropriate Enrollment|1|||
131907986|NCT00644059|474950811|FG001|Overall Study|Inappropriate Enrollment|3|||
131907987|NCT00644059|474950812|FG002|Overall Study|Inappropriate Enrollment|0|||
131907988|NCT00644059|474950810|FG000|Overall Study|Protocol Deviation/violation|20|||
131907989|NCT00644059|474950811|FG001|Overall Study|Protocol Deviation/violation|19|||
131907990|NCT00644059|474950812|FG002|Overall Study|Protocol Deviation/violation|15|||
131907991|NCT00644059|474950810|FG000|Overall Study|Unable to classify|6|||
131907992|NCT00644059|474950811|FG001|Overall Study|Unable to classify|2|||
131907993|NCT00644059|474950812|FG002|Overall Study|Unable to classify|3|||
131907994|NCT02133508|474950813|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
131907995|NCT02133508|474950813|FG000|Overall Study|Death|12|||
131907996|NCT02133508|474950813|FG000|Overall Study|Lost to Follow-up|2|||
131907997|NCT02446691|474950820|FG000|Overall Study|Withdrawal by Subject|2|||
131907998|NCT02446691|474950820|FG000|Overall Study|Lost to Follow-up|8|||
131907999|NCT02446691|474950820|FG000|Overall Study|Protocol Violation|1|||
131908000|NCT02497469|474950821|FG000|Overall Study|Randomized but not Treated|0|||
131908001|NCT02497469|474950822|FG001|Overall Study|Randomized but not Treated|2|||
131908002|NCT02497469|474950821|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
131908003|NCT02497469|474950822|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
131908004|NCT02497469|474950821|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
131908005|NCT02497469|474950822|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
131908006|NCT02497469|474950821|FG000|Overall Study|Significant Protocol Deviation|4|||
131908007|NCT02497469|474950822|FG001|Overall Study|Significant Protocol Deviation|5|||
131908008|NCT02497469|474950821|FG000|Overall Study|Lost to Follow-up|14|||
131908009|NCT02497469|474950822|FG001|Overall Study|Lost to Follow-up|4|||
131908010|NCT02497469|474950821|FG000|Overall Study|Voluntary Withdrawal|39|||
131908011|NCT02497469|474950822|FG001|Overall Study|Voluntary Withdrawal|41|||
131908012|NCT02497469|474950821|FG000|Overall Study|Pregnancy|1|||
131908013|NCT02497469|474950822|FG001|Overall Study|Pregnancy|1|||
131908014|NCT02497469|474950821|FG000|Overall Study|Lack of Efficacy|86|||
131908015|NCT02497469|474950822|FG001|Overall Study|Lack of Efficacy|40|||
131908016|NCT02497469|474950821|FG000|Overall Study|Reason not Specified|6|||
131908017|NCT02497469|474950822|FG001|Overall Study|Reason not Specified|6|||
131908018|NCT00472420|474950823|FG000|Induction Treatment Period|Physician Decision|9|||
131908019|NCT00472420|474950823|FG000|Induction Treatment Period|Adverse Event|3|||
131908020|NCT00472420|474950823|FG000|Induction Treatment Period|Non-compliance|1|||
131908021|NCT00472420|474950823|FG000|Induction Treatment Period|Death|3|||
131908022|NCT00472420|474950823|FG000|Follow-up Period|Death|5|||
131908023|NCT00472420|474950823|FG000|Follow-up Period|Physician Decision|9|||
131908024|NCT00472420|474950823|FG000|Follow-up Period|Lost to Follow-up|2|||
131908025|NCT00472420|474950823|FG000|Follow-up Period|Protocol Violation|1|||
131908026|NCT01787552|474950830|FG000|Overall Study|Withdrawal by Subject|2|||
131908027|NCT01787552|474950831|FG001|Overall Study|Withdrawal by Subject|0|||
131908028|NCT01787552|474950832|FG002|Overall Study|Withdrawal by Subject|0|||
131908029|NCT01787552|474950833|FG003|Overall Study|Withdrawal by Subject|4|||
131908030|NCT01787552|474950830|FG000|Overall Study|Physician Decision|2|||
131908031|NCT01787552|474950831|FG001|Overall Study|Physician Decision|2|||
131908032|NCT01787552|474950832|FG002|Overall Study|Physician Decision|1|||
131908033|NCT01787552|474950833|FG003|Overall Study|Physician Decision|2|||
131908034|NCT01787552|474950830|FG000|Overall Study|Death|0|||
131908035|NCT01787552|474950831|FG001|Overall Study|Death|0|||
131908036|NCT01787552|474950832|FG002|Overall Study|Death|0|||
131908037|NCT01787552|474950833|FG003|Overall Study|Death|1|||
131908038|NCT01787552|474950830|FG000|Overall Study|Adverse Event|2|||
131908039|NCT01787552|474950831|FG001|Overall Study|Adverse Event|5|||
131908040|NCT01787552|474950832|FG002|Overall Study|Adverse Event|2|||
131908041|NCT01787552|474950833|FG003|Overall Study|Adverse Event|16|||
131908042|NCT01787552|474950830|FG000|Overall Study|Study terminated by Sponsor|0|||
131908043|NCT01787552|474950831|FG001|Overall Study|Study terminated by Sponsor|0|||
131908044|NCT01787552|474950832|FG002|Overall Study|Study terminated by Sponsor|1|||
131908045|NCT01787552|474950833|FG003|Overall Study|Study terminated by Sponsor|3|||
131908046|NCT01787552|474950830|FG000|Overall Study|Progressive Disease|2|||
131908047|NCT01787552|474950831|FG001|Overall Study|Progressive Disease|2|||
131908048|NCT01787552|474950832|FG002|Overall Study|Progressive Disease|1|||
131908049|NCT01787552|474950833|FG003|Overall Study|Progressive Disease|1|||
131908050|NCT02295644|474950837|FG000|Overall Study|Did not meet inclusion criterion|0|||
131908051|NCT02295644|474950838|FG001|Overall Study|Did not meet inclusion criterion|0|||
131908052|NCT02295644|474950839|FG002|Overall Study|Did not meet inclusion criterion|1|||
131908053|NCT02295644|474950840|FG003|Overall Study|Did not meet inclusion criterion|2|||
131908054|NCT04079790|474950841|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
131908055|NCT04079790|474950842|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
131908056|NCT04079790|474950843|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
131908057|NCT04079790|474950844|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
131908058|NCT04079790|474950841|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
131908059|NCT04079790|474950842|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
131908060|NCT04079790|474950843|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
131908061|NCT04079790|474950844|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
131908062|NCT04079790|474950841|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
131908063|NCT04079790|474950842|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
131908064|NCT04079790|474950843|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
131908065|NCT04079790|474950844|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
131908066|NCT01253161|474950845|FG000|Overall Study|Adverse Event|1|||
131908067|NCT01924533|474950847|FG000|Overall Study|Death|181|||
131908068|NCT01924533|474950848|FG001|Overall Study|Death|200|||
131908069|NCT01924533|474950847|FG000|Overall Study|Lost to Follow-up|0|||
131908070|NCT01924533|474950848|FG001|Overall Study|Lost to Follow-up|1|||
131908071|NCT01924533|474950847|FG000|Overall Study|Withdrawal by Subject|7|||
131908072|NCT01924533|474950848|FG001|Overall Study|Withdrawal by Subject|3|||
131908073|NCT01924533|474950847|FG000|Overall Study|Other Eligibility criteria|1|||
131908074|NCT01924533|474950848|FG001|Overall Study|Other Eligibility criteria|1|||
131908075|NCT05412134|474950849|FG000|Overall Study|Lost to Follow-up|2|||
131908076|NCT05412134|474950850|FG001|Overall Study|Lost to Follow-up|0|||
131908077|NCT03307174|474950852|FG000|Overall Study|Unplanned ICU Administrion|5|||
131908078|NCT03307174|474950853|FG001|Overall Study|Unplanned ICU Administrion|3|||
131908079|NCT03307174|474950852|FG000|Overall Study|Aborted Surgery|1|||
131908080|NCT03307174|474950853|FG001|Overall Study|Aborted Surgery|2|||
131908081|NCT03307174|474950852|FG000|Overall Study|Hypotension|6|||
131908082|NCT03307174|474950853|FG001|Overall Study|Hypotension|0|||
131908083|NCT03307174|474950852|FG000|Overall Study|Nonfunctional epidural|1|||
131908084|NCT03307174|474950853|FG001|Overall Study|Nonfunctional epidural|1|||
131908085|NCT03307174|474950852|FG000|Overall Study|Planned epidural removal|1|||
131908086|NCT03307174|474950853|FG001|Overall Study|Planned epidural removal|0|||
131908087|NCT03307174|474950852|FG000|Overall Study|Intrathecal catheter placement|0|||
131908088|NCT03307174|474950853|FG001|Overall Study|Intrathecal catheter placement|1|||
131908089|NCT04275336|474950854|FG000|Overall Study|First venipuncture failed|4|||
131908090|NCT04275336|474950855|FG001|Overall Study|First venipuncture failed|6|||
131908091|NCT04275336|474950856|FG002|Overall Study|First venipuncture failed|5|||
131908092|NCT04275336|474950854|FG000|Overall Study|Unscheduled venipuncture|9|||
131908093|NCT04275336|474950855|FG001|Overall Study|Unscheduled venipuncture|13|||
131908094|NCT04275336|474950856|FG002|Overall Study|Unscheduled venipuncture|7|||
131908095|NCT04275336|474950854|FG000|Overall Study|Failed specimen of saliva|4|||
131908096|NCT04275336|474950855|FG001|Overall Study|Failed specimen of saliva|3|||
131908097|NCT04275336|474950856|FG002|Overall Study|Failed specimen of saliva|4|||
131908098|NCT03167242|474950857|FG000|Overall Study|Patient/Guardian Decision|0|||
131908099|NCT03167242|474950858|FG001|Overall Study|Patient/Guardian Decision|1|||
131908100|NCT03167242|474950859|FG002|Overall Study|Patient/Guardian Decision|2|||
131908101|NCT03167242|474950860|FG003|Overall Study|Patient/Guardian Decision|1|||
131908102|NCT03167242|474950861|FG004|Overall Study|Patient/Guardian Decision|1|||
131398593|NCT01406938|473081211|FG004|Maintenance Period|Death|1|||
131398594|NCT01406938|473081212|FG005|Maintenance Period|Death|0|||
131398595|NCT01406938|473081207|FG000|Maintenance Period|Subject/guardian decision|0|||
131398596|NCT01406938|473081208|FG001|Maintenance Period|Subject/guardian decision|0|||
131398597|NCT01406938|473081209|FG002|Maintenance Period|Subject/guardian decision|11|||
131398598|NCT01406938|473081210|FG003|Maintenance Period|Subject/guardian decision|7|||
131398599|NCT01406938|473081211|FG004|Maintenance Period|Subject/guardian decision|10|||
131398600|NCT01406938|473081212|FG005|Maintenance Period|Subject/guardian decision|7|||
131908103|NCT03167242|474950862|FG005|Overall Study|Patient/Guardian Decision|1|||
131908104|NCT03167242|474950863|FG006|Overall Study|Patient/Guardian Decision|0|||
131908105|NCT03167242|474950864|FG007|Overall Study|Patient/Guardian Decision|0|||
131908106|NCT03167242|474950865|FG008|Overall Study|Patient/Guardian Decision|0|||
131908107|NCT03167242|474950866|FG009|Overall Study|Patient/Guardian Decision|0|||
131908108|NCT03167242|474950867|FG010|Overall Study|Patient/Guardian Decision|1|||
131908109|NCT03167242|474950868|FG011|Overall Study|Patient/Guardian Decision|0|||
131908110|NCT03167242|474950857|FG000|Overall Study|Lost to Follow-up|0|||
131908111|NCT03167242|474950858|FG001|Overall Study|Lost to Follow-up|0|||
131908112|NCT03167242|474950859|FG002|Overall Study|Lost to Follow-up|1|||
131908113|NCT03167242|474950860|FG003|Overall Study|Lost to Follow-up|0|||
131908114|NCT03167242|474950861|FG004|Overall Study|Lost to Follow-up|0|||
131908115|NCT03167242|474950862|FG005|Overall Study|Lost to Follow-up|1|||
131908116|NCT03167242|474950863|FG006|Overall Study|Lost to Follow-up|2|||
131908117|NCT03167242|474950864|FG007|Overall Study|Lost to Follow-up|1|||
131908118|NCT03167242|474950865|FG008|Overall Study|Lost to Follow-up|0|||
131908119|NCT03167242|474950866|FG009|Overall Study|Lost to Follow-up|0|||
131908120|NCT03167242|474950867|FG010|Overall Study|Lost to Follow-up|1|||
131908121|NCT03167242|474950868|FG011|Overall Study|Lost to Follow-up|1|||
131908122|NCT03167242|474950857|FG000|Overall Study|Reason not provided|0|||
131908123|NCT03167242|474950858|FG001|Overall Study|Reason not provided|0|||
131908124|NCT03167242|474950859|FG002|Overall Study|Reason not provided|0|||
131908125|NCT03167242|474950860|FG003|Overall Study|Reason not provided|0|||
131908126|NCT03167242|474950861|FG004|Overall Study|Reason not provided|0|||
131908127|NCT03167242|474950862|FG005|Overall Study|Reason not provided|0|||
131908128|NCT03167242|474950863|FG006|Overall Study|Reason not provided|0|||
131908129|NCT03167242|474950864|FG007|Overall Study|Reason not provided|0|||
131398601|NCT01406938|473081207|FG000|Maintenance Period|Protocol Violation|0|||
131398602|NCT01406938|473081208|FG001|Maintenance Period|Protocol Violation|0|||
131398603|NCT01406938|473081209|FG002|Maintenance Period|Protocol Violation|2|||
131398604|NCT01406938|473081210|FG003|Maintenance Period|Protocol Violation|2|||
131398605|NCT01406938|473081211|FG004|Maintenance Period|Protocol Violation|2|||
131398606|NCT01406938|473081212|FG005|Maintenance Period|Protocol Violation|2|||
131398607|NCT01406938|473081207|FG000|Maintenance Period|Pregnancy|0|||
131398608|NCT01406938|473081208|FG001|Maintenance Period|Pregnancy|0|||
131908130|NCT03167242|474950865|FG008|Overall Study|Reason not provided|1|||
131908131|NCT03167242|474950866|FG009|Overall Study|Reason not provided|0|||
131908132|NCT03167242|474950867|FG010|Overall Study|Reason not provided|0|||
131908133|NCT03167242|474950868|FG011|Overall Study|Reason not provided|0|||
131908134|NCT05401565|474950875|FG000|Overall Study|Lost to Follow-up|1|||
131908135|NCT05401565|474950876|FG001|Overall Study|Lost to Follow-up|0|||
131908136|NCT05401565|474950875|FG000|Overall Study|Adverse Event|2|||
131908137|NCT05401565|474950876|FG001|Overall Study|Adverse Event|0|||
131908138|NCT00726609|474950877|FG000|Overall Study|Adverse Event|10|||
131908139|NCT00726609|474950877|FG000|Overall Study|Withdrawal by Subject|2|||
131908140|NCT00726609|474950877|FG000|Overall Study|Lack of Efficacy|25|||
131908141|NCT00726609|474950877|FG000|Overall Study|Other|16|||
131908142|NCT00726609|474950877|FG000|Overall Study|Missing|42|||
131908143|NCT00726609|474950877|FG000|Overall Study|Other|3|||
131908144|NCT03329885|474950885|FG000|Overall Study|Sponsor discontinued the study early|0|||
131908145|NCT03329885|474950886|FG001|Overall Study|Sponsor discontinued the study early|0|||
131908146|NCT03329885|474950887|FG002|Overall Study|Sponsor discontinued the study early|0|||
131908147|NCT03329885|474950888|FG003|Overall Study|Sponsor discontinued the study early|0|||
131908148|NCT03329885|474950889|FG004|Overall Study|Sponsor discontinued the study early|0|||
131908149|NCT03329885|474950890|FG005|Overall Study|Sponsor discontinued the study early|0|||
131908150|NCT03329885|474950891|FG006|Overall Study|Sponsor discontinued the study early|1|||
131908151|NCT03329885|474950892|FG007|Overall Study|Sponsor discontinued the study early|1|||
131908152|NCT03329885|474950893|FG008|Overall Study|Sponsor discontinued the study early|0|||
131908153|NCT03886272|474950896|FG000|Period 1|Withdrawal by Subject|0|||
131908154|NCT03886272|474950897|FG001|Period 1|Withdrawal by Subject|0|||
131908155|NCT03886272|474950898|FG002|Period 1|Withdrawal by Subject|0|||
131908156|NCT03886272|474950899|FG003|Period 1|Withdrawal by Subject|0|||
131908157|NCT03886272|474950900|FG004|Period 1|Withdrawal by Subject|0|||
131908158|NCT03886272|474950901|FG005|Period 1|Withdrawal by Subject|1|||
131908159|NCT03886272|474950902|FG006|Period 1|Withdrawal by Subject|0|||
131398609|NCT01406938|473081209|FG002|Maintenance Period|Pregnancy|0|||
131398610|NCT01406938|473081210|FG003|Maintenance Period|Pregnancy|0|||
131398611|NCT01406938|473081211|FG004|Maintenance Period|Pregnancy|1|||
131398612|NCT01406938|473081212|FG005|Maintenance Period|Pregnancy|0|||
131398613|NCT01406938|473081207|FG000|Maintenance Period|Lost to Follow-up|0|||
131398614|NCT01406938|473081208|FG001|Maintenance Period|Lost to Follow-up|0|||
131398615|NCT01406938|473081209|FG002|Maintenance Period|Lost to Follow-up|0|||
131449793|NCT02968004|473276719|FG001|Main Study Phase|Adverse Event|0|||
131908160|NCT02557399|474950905|FG000|Overall Study|Adverse Event|6|||
131908161|NCT02557399|474950906|FG001|Overall Study|Adverse Event|5|||
131908162|NCT02557399|474950905|FG000|Overall Study|Protocol Violation|0|||
131908163|NCT02557399|474950906|FG001|Overall Study|Protocol Violation|1|||
131908164|NCT02557399|474950905|FG000|Overall Study|Protocol-defined stopping criteria|0|||
131908165|NCT02557399|474950906|FG001|Overall Study|Protocol-defined stopping criteria|1|||
131398616|NCT01406938|473081210|FG003|Maintenance Period|Lost to Follow-up|0|||
131908166|NCT02557399|474950905|FG000|Overall Study|Withdrawal by Subject|1|||
131908167|NCT02557399|474950906|FG001|Overall Study|Withdrawal by Subject|1|||
131908168|NCT00931632|474950907|FG000|Overall Study|Withdrawal by Subject|2|||
131908169|NCT00931632|474950908|FG001|Overall Study|Withdrawal by Subject|3|||
131908170|NCT00931632|474950907|FG000|Overall Study|Adverse Event|19|||
131908171|NCT00931632|474950908|FG001|Overall Study|Adverse Event|15|||
131908172|NCT03372798|474950911|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
131908173|NCT03372798|474950912|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
131908174|NCT03372798|474950911|FG000|Overall Study|Failure of imaging probe|0|||
131908175|NCT03372798|474950912|FG001|Overall Study|Failure of imaging probe|1|||
131908176|NCT00350545|474952856|FG000|Overall Study|Withdrawal by Subject|2|||
131908177|NCT02337764|474952860|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
131908178|NCT02337764|474952860|FG000|Overall Study|Voluntary Withdrawal|12|||
131908179|NCT02337764|474952860|FG000|Overall Study|Lack of Efficacy|2|||
131908180|NCT00368251|474952861|FG000|Overall Study|SAE, non-fatal|1|||
131908181|NCT00368251|474952862|FG001|Overall Study|SAE, non-fatal|0|||
131908182|NCT00368251|474952863|FG002|Overall Study|SAE, non-fatal|0|||
131908183|NCT00368251|474952861|FG000|Overall Study|AE, non-serious non-fatal|0|||
131908184|NCT00368251|474952862|FG001|Overall Study|AE, non-serious non-fatal|0|||
131908185|NCT00368251|474952863|FG002|Overall Study|AE, non-serious non-fatal|1|||
131908186|NCT03312738|474952864|FG000|Overall Study|Progressive disease|58|||
131908187|NCT03312738|474952865|FG001|Overall Study|Progressive disease|67|||
131908188|NCT03312738|474952864|FG000|Overall Study|Patient/guardian decision|13|||
131908189|NCT03312738|474952865|FG001|Overall Study|Patient/guardian decision|5|||
131908190|NCT03312738|474952864|FG000|Overall Study|Adverse Event|5|||
131908191|NCT03312738|474952865|FG001|Overall Study|Adverse Event|3|||
131908192|NCT03312738|474952864|FG000|Overall Study|Protocol deviation|2|||
131908193|NCT03312738|474952865|FG001|Overall Study|Protocol deviation|0|||
131908194|NCT03312738|474952864|FG000|Overall Study|Technical problems|0|||
131908195|NCT03312738|474952865|FG001|Overall Study|Technical problems|1|||
131908196|NCT03312738|474952864|FG000|Overall Study|Physician Decision|2|||
131908197|NCT03312738|474952865|FG001|Overall Study|Physician Decision|3|||
131908198|NCT02466399|474952869|FG000|Overall Study|Adverse Event|1|||
131908199|NCT02466399|474952870|FG001|Overall Study|Adverse Event|0|||
131908200|NCT02466399|474952869|FG000|Overall Study|Early exit due to family emergency|1|||
131908201|NCT02466399|474952870|FG001|Overall Study|Early exit due to family emergency|0|||
131908202|NCT01373164|474952871|FG000|Overall Study|Lost to Follow-up|0|||
131908203|NCT01373164|474952872|FG001|Overall Study|Lost to Follow-up|0|||
131755096|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Other|0|||
131755097|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Other|0|||
131908204|NCT01373164|474952873|FG002|Overall Study|Lost to Follow-up|1|||
131908205|NCT01373164|474952874|FG003|Overall Study|Lost to Follow-up|2|||
131908206|NCT01373164|474952875|FG004|Overall Study|Lost to Follow-up|0|||
131908207|NCT01373164|474952871|FG000|Overall Study|Withdrawal by Subject|0|||
131908208|NCT01373164|474952872|FG001|Overall Study|Withdrawal by Subject|1|||
131908209|NCT01373164|474952873|FG002|Overall Study|Withdrawal by Subject|0|||
131908210|NCT01373164|474952874|FG003|Overall Study|Withdrawal by Subject|10|||
131908211|NCT01373164|474952875|FG004|Overall Study|Withdrawal by Subject|2|||
131908212|NCT02669849|474952876|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
131908213|NCT02669849|474952877|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
131908214|NCT02669849|474952878|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
131908215|NCT02669849|474952876|FG000|Overall Study|Lost to Follow-up|1|||
131908216|NCT02669849|474952877|FG001|Overall Study|Lost to Follow-up|0|||
131908217|NCT02669849|474952878|FG002|Overall Study|Lost to Follow-up|3|||
131908218|NCT02669849|474952876|FG000|Overall Study|Death|1|||
131398617|NCT01406938|473081211|FG004|Maintenance Period|Lost to Follow-up|4|||
131398618|NCT01406938|473081212|FG005|Maintenance Period|Lost to Follow-up|0|||
131398619|NCT01406938|473081207|FG000|Maintenance Period|Lack of Efficacy|0|||
131398620|NCT01406938|473081208|FG001|Maintenance Period|Lack of Efficacy|0|||
131398621|NCT01406938|473081209|FG002|Maintenance Period|Lack of Efficacy|2|||
131398622|NCT01406938|473081210|FG003|Maintenance Period|Lack of Efficacy|1|||
131398623|NCT01406938|473081211|FG004|Maintenance Period|Lack of Efficacy|3|||
131398624|NCT01406938|473081212|FG005|Maintenance Period|Lack of Efficacy|5|||
131908219|NCT02669849|474952877|FG001|Overall Study|Death|1|||
131398625|NCT01406938|473081207|FG000|Follow up|Lack of Efficacy|3|||
131398626|NCT01406938|473081208|FG001|Follow up|Lack of Efficacy|2|||
131908220|NCT02669849|474952878|FG002|Overall Study|Death|2|||
131908221|NCT02669849|474952876|FG000|Overall Study|Study terminated by sponsor|16|||
131398627|NCT01406938|473081209|FG002|Follow up|Lack of Efficacy|1|||
131755098|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Other|0|||
131908222|NCT02669849|474952877|FG001|Overall Study|Study terminated by sponsor|1|||
131908223|NCT02669849|474952878|FG002|Overall Study|Study terminated by sponsor|14|||
131908224|NCT02669849|474952876|FG000|Overall Study|Other|0|||
131908225|NCT02669849|474952877|FG001|Overall Study|Other|0|||
131908226|NCT02669849|474952878|FG002|Overall Study|Other|2|||
131398628|NCT01406938|473081210|FG003|Follow up|Lack of Efficacy|0|||
131908227|NCT03408899|474952881|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
131398629|NCT01406938|473081211|FG004|Follow up|Lack of Efficacy|0|||
131755099|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Other|1|||
131755100|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Other|3|||
131755101|NCT03107793|474381108|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
131755102|NCT03107793|474381109|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
131755103|NCT03107793|474381110|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
131755104|NCT03107793|474381111|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
131755105|NCT03107793|474381112|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
131755106|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
131755107|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
131755108|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
131908228|NCT00606008|474952882|FG000|Overall Study|Adverse Event|1|||
131908229|NCT00606008|474952882|FG000|Overall Study|Withdrawal by Subject|4|||
131908230|NCT02014272|474952883|FG000|Intervention Period 1|Withdrawal by Subject|1|||
131908231|NCT02014272|474952884|FG001|Intervention Period 1|Withdrawal by Subject|0|||
131908232|NCT02014272|474952883|FG000|Intervention Period 1|Adverse Event|0|||
131908233|NCT02014272|474952884|FG001|Intervention Period 1|Adverse Event|1|||
131908234|NCT01516216|474952889|FG000|Overall Study|Adverse Event|2|||
131908235|NCT01516216|474952890|FG001|Overall Study|Adverse Event|4|||
131908236|NCT01516216|474952889|FG000|Overall Study|Disease Progression|38|||
131908237|NCT01516216|474952890|FG001|Overall Study|Disease Progression|34|||
131908238|NCT01516216|474952889|FG000|Overall Study|Withdrawal by Subject|9|||
131908239|NCT01516216|474952890|FG001|Overall Study|Withdrawal by Subject|11|||
131908240|NCT01516216|474952889|FG000|Overall Study|Potentially Curative Resection|6|||
131908241|NCT01516216|474952890|FG001|Overall Study|Potentially Curative Resection|12|||
131908242|NCT01516216|474952889|FG000|Overall Study|Nonadherence|2|||
131908243|NCT01516216|474952890|FG001|Overall Study|Nonadherence|3|||
131908244|NCT01516216|474952889|FG000|Overall Study|Physician Decision|6|||
131908245|NCT01516216|474952890|FG001|Overall Study|Physician Decision|3|||
131908246|NCT01516216|474952889|FG000|Overall Study|Prolonged Treatment Delay|5|||
131908247|NCT01516216|474952890|FG001|Overall Study|Prolonged Treatment Delay|1|||
131908248|NCT01516216|474952889|FG000|Overall Study|Intercurrent Illness|1|||
131908249|NCT01516216|474952890|FG001|Overall Study|Intercurrent Illness|0|||
131908250|NCT01516216|474952889|FG000|Overall Study|Death|1|||
131908251|NCT01516216|474952890|FG001|Overall Study|Death|1|||
131908252|NCT02419807|474952891|FG000|Overall Study|Withdrawal by Subject|4|||
131908253|NCT02419807|474952891|FG000|Overall Study|Physician Decision|1|||
131908254|NCT02419807|474952891|FG000|Overall Study|Protocol Violation|5|||
131908255|NCT01458587|474952892|FG000|Overall Study|Withdrawal by Subject|1|||
131755109|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
131908256|NCT01458587|474952893|FG001|Overall Study|Withdrawal by Subject|0|||
131908257|NCT01603602|474952894|FG000|Overall Study|Adverse Event|1|||
131755110|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
131755111|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
131755112|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
131755113|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
131755114|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
131755115|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
131755116|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
131755117|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
131755118|NCT03321526|474381113|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
131755119|NCT03321526|474381114|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
131755120|NCT03321526|474381113|FG000|Follow-up Phase (2 Weeks)|Other|24|||
131755121|NCT03321526|474381114|FG001|Follow-up Phase (2 Weeks)|Other|24|||
131755122|NCT01989572|474381118|FG000|Overall Study|Lack of Efficacy|35|||
131755123|NCT01989572|474381119|FG001|Overall Study|Lack of Efficacy|48|||
131755124|NCT01989572|474381120|FG002|Overall Study|Lack of Efficacy|48|||
131755125|NCT01989572|474381121|FG003|Overall Study|Lack of Efficacy|43|||
131755126|NCT01989572|474381122|FG004|Overall Study|Lack of Efficacy|71|||
131755127|NCT01989572|474381123|FG005|Overall Study|Lack of Efficacy|79|||
131908258|NCT01603602|474952895|FG001|Overall Study|Adverse Event|0|||
131755128|NCT01989572|474381118|FG000|Overall Study|Adverse Event|2|||
131755129|NCT01989572|474381119|FG001|Overall Study|Adverse Event|1|||
131755130|NCT01989572|474381120|FG002|Overall Study|Adverse Event|3|||
131755131|NCT01989572|474381121|FG003|Overall Study|Adverse Event|0|||
131755132|NCT01989572|474381122|FG004|Overall Study|Adverse Event|3|||
131755133|NCT01989572|474381123|FG005|Overall Study|Adverse Event|0|||
131755134|NCT01989572|474381118|FG000|Overall Study|Death|0|||
131908259|NCT01603602|474952896|FG002|Overall Study|Adverse Event|0|||
131908260|NCT01603602|474952894|FG000|Overall Study|Personal Reasons|1|||
131908261|NCT01603602|474952895|FG001|Overall Study|Personal Reasons|0|||
131755135|NCT01989572|474381119|FG001|Overall Study|Death|0|||
131755136|NCT01989572|474381120|FG002|Overall Study|Death|0|||
131908262|NCT01603602|474952896|FG002|Overall Study|Personal Reasons|1|||
131755137|NCT01989572|474381121|FG003|Overall Study|Death|0|||
131908263|NCT01065818|474952899|FG000|Overall Study|Withdrawal by Subject|1|||
131811460|NCT01588236|474590902|FG002|Overall Study|Exclusion Criteria met during study|0|||
131811461|NCT01588236|474590900|FG000|Overall Study|sponsor decision|1|||
131811462|NCT01588236|474590901|FG001|Overall Study|sponsor decision|6|||
131811463|NCT01588236|474590902|FG002|Overall Study|sponsor decision|2|||
131811464|NCT06284525|474592033|FG000|Overall Study|Withdrawal by Subject|1|||
131811465|NCT03635320|474592034|FG000|Overall Study|not implanted the device|1|||
131811466|NCT03635320|474592035|FG001|Overall Study|not implanted the device|2|||
131811467|NCT03635320|474592034|FG000|Overall Study|Withdrawal by Subject|11|||
131811468|NCT03635320|474592035|FG001|Overall Study|Withdrawal by Subject|6|||
131811469|NCT01735994|474592038|FG000|Overall Study|Withdrawal by Subject|6|||
131811470|NCT01735994|474592039|FG001|Overall Study|Withdrawal by Subject|4|||
131811471|NCT01735994|474592038|FG000|Overall Study|Injury|2|||
131811472|NCT01735994|474592039|FG001|Overall Study|Injury|0|||
131755138|NCT01989572|474381122|FG004|Overall Study|Death|1|||
131755139|NCT01989572|474381123|FG005|Overall Study|Death|0|||
131755140|NCT01989572|474381118|FG000|Overall Study|Withdrawal by Subject|4|||
131755141|NCT01989572|474381119|FG001|Overall Study|Withdrawal by Subject|1|||
131755142|NCT01989572|474381120|FG002|Overall Study|Withdrawal by Subject|5|||
131755143|NCT01989572|474381121|FG003|Overall Study|Withdrawal by Subject|1|||
131755144|NCT01989572|474381122|FG004|Overall Study|Withdrawal by Subject|12|||
131755145|NCT01989572|474381123|FG005|Overall Study|Withdrawal by Subject|4|||
131755146|NCT01989572|474381118|FG000|Overall Study|complicating disease|1|||
131755147|NCT01989572|474381119|FG001|Overall Study|complicating disease|1|||
131755148|NCT01989572|474381120|FG002|Overall Study|complicating disease|2|||
131755149|NCT01989572|474381121|FG003|Overall Study|complicating disease|0|||
131755150|NCT01989572|474381122|FG004|Overall Study|complicating disease|1|||
131755151|NCT01989572|474381123|FG005|Overall Study|complicating disease|0|||
131811473|NCT01735994|474592038|FG000|Overall Study|Kicked off team|5|||
131811474|NCT01735994|474592039|FG001|Overall Study|Kicked off team|0|||
131811475|NCT01735994|474592038|FG000|Overall Study|Lost to Follow-up|50|||
131811476|NCT01735994|474592039|FG001|Overall Study|Lost to Follow-up|62|||
131811477|NCT03496623|474592040|FG000|Run-In Period (2 Weeks)|Death|1|||
131811478|NCT03496623|474592041|FG001|Run-In Period (2 Weeks)|Death|0|||
131811479|NCT03496623|474592042|FG002|Run-In Period (2 Weeks)|Death|0|||
131811480|NCT03496623|474592043|FG003|Run-In Period (2 Weeks)|Death|0|||
131811481|NCT03496623|474592044|FG004|Run-In Period (2 Weeks)|Death|0|||
131811482|NCT03496623|474592040|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
131811483|NCT03496623|474592041|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
131811484|NCT03496623|474592042|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
131811485|NCT03496623|474592043|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
131811486|NCT03496623|474592044|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
131811487|NCT03496623|474592040|FG000|Period 1 (12 Weeks)|Death|0|||
131811488|NCT03496623|474592041|FG001|Period 1 (12 Weeks)|Death|3|||
131811489|NCT03496623|474592042|FG002|Period 1 (12 Weeks)|Death|0|||
131811490|NCT03496623|474592043|FG003|Period 1 (12 Weeks)|Death|0|||
131811491|NCT03496623|474592044|FG004|Period 1 (12 Weeks)|Death|0|||
131811492|NCT03496623|474592040|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
131811493|NCT03496623|474592041|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
131811494|NCT03496623|474592042|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
131811495|NCT03496623|474592043|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
131811496|NCT03496623|474592044|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
131811497|NCT03496623|474592040|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131811498|NCT03496623|474592041|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
131811499|NCT03496623|474592042|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
131811500|NCT03496623|474592043|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131811501|NCT03496623|474592044|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131811502|NCT03496623|474592040|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
131811503|NCT03496623|474592041|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
131811504|NCT03496623|474592042|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
131811505|NCT03496623|474592043|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
131811506|NCT03496623|474592044|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
131811507|NCT03496623|474592040|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131811508|NCT03496623|474592041|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131908264|NCT01065818|474952899|FG000|Overall Study|Not a candidate for surgery|1|||
131755152|NCT01989572|474381118|FG000|Overall Study|error|2|||
131755153|NCT01989572|474381119|FG001|Overall Study|error|1|||
131755154|NCT01989572|474381120|FG002|Overall Study|error|1|||
131755155|NCT01989572|474381121|FG003|Overall Study|error|1|||
131755156|NCT01989572|474381122|FG004|Overall Study|error|1|||
131755157|NCT01989572|474381123|FG005|Overall Study|error|1|||
131755158|NCT01989572|474381118|FG000|Overall Study|maximum dose reached|0|||
131811509|NCT03496623|474592042|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
131755159|NCT01989572|474381119|FG001|Overall Study|maximum dose reached|1|||
131811510|NCT03496623|474592043|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131811511|NCT03496623|474592044|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131755160|NCT01989572|474381120|FG002|Overall Study|maximum dose reached|0|||
131811512|NCT03496623|474592040|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
131811513|NCT03496623|474592041|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
131811514|NCT03496623|474592042|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
131811515|NCT03496623|474592043|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
131811516|NCT03496623|474592044|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
131811517|NCT03496623|474592040|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131811518|NCT03496623|474592041|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
131811519|NCT03496623|474592042|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131811520|NCT03496623|474592043|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131811521|NCT03496623|474592044|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131811522|NCT00123734|474592052|FG000|Overall Study|Death|3|||
131811523|NCT00123734|474592052|FG000|Overall Study|Lost to Follow-up|3|||
131811524|NCT00123734|474592052|FG000|Overall Study|Dropout|1|||
131811525|NCT00123734|474592052|FG000|Overall Study|Withdrawal by Subject|1|||
131811526|NCT00834340|474592053|FG000|Washout|Adverse Event|1|||
131811527|NCT00834340|474592054|FG001|Washout|Adverse Event|0|||
131811528|NCT00834340|474592053|FG000|Washout|Withdrawal by Subject|1|||
131811529|NCT00834340|474592054|FG001|Washout|Withdrawal by Subject|0|||
131811530|NCT04238754|474592060|FG000|Washout - 1 Week|Lost to Follow-up|1|||
131811531|NCT04238754|474592061|FG001|Washout - 1 Week|Lost to Follow-up|0|||
131811532|NCT01175018|474592062|FG000|Overall Study|Adverse Event|3|||
131811533|NCT01175018|474592063|FG001|Overall Study|Adverse Event|1|||
131811534|NCT00840073|474592064|FG000|Second Intervention|Missed 72 hour blood draw|1|||
131811535|NCT00840073|474592065|FG001|Second Intervention|Missed 72 hour blood draw|1|||
131811536|NCT02838420|474592069|FG000|Overall Study|Ongoing in Study|113|||
131811537|NCT02838420|474592070|FG001|Overall Study|Ongoing in Study|45|||
131811538|NCT02838420|474592069|FG000|Overall Study|Lost to Follow-up|1|||
131811539|NCT02838420|474592070|FG001|Overall Study|Lost to Follow-up|0|||
131811540|NCT02838420|474592069|FG000|Overall Study|Withdrawal by Subject|3|||
131811541|NCT02838420|474592070|FG001|Overall Study|Withdrawal by Subject|4|||
131811542|NCT02838420|474592069|FG000|Overall Study|Death|8|||
131811543|NCT02838420|474592070|FG001|Overall Study|Death|13|||
131811544|NCT02964039|474592071|FG000|Overall Study|Medical reason unrelated to study participation|1|||
131811545|NCT02964039|474592072|FG001|Overall Study|Medical reason unrelated to study participation|0|||
131811546|NCT02964039|474592073|FG002|Overall Study|Medical reason unrelated to study participation|3|||
131811547|NCT02964039|474592071|FG000|Overall Study|Research shutdown due to pandemic|2|||
131811548|NCT02964039|474592072|FG001|Overall Study|Research shutdown due to pandemic|0|||
131811549|NCT02964039|474592073|FG002|Overall Study|Research shutdown due to pandemic|1|||
131811550|NCT02964039|474592071|FG000|Overall Study|Withdrawal by Subject|0|||
131811551|NCT02964039|474592072|FG001|Overall Study|Withdrawal by Subject|1|||
131811552|NCT02964039|474592073|FG002|Overall Study|Withdrawal by Subject|0|||
131811553|NCT02964039|474592071|FG000|Overall Study|Lost to Follow-up|1|||
131811554|NCT02964039|474592072|FG001|Overall Study|Lost to Follow-up|0|||
131811555|NCT02964039|474592073|FG002|Overall Study|Lost to Follow-up|1|||
131811556|NCT01103713|474592077|FG000|Overall Study|Lost to Follow-up|2|||
131811557|NCT01103713|474592077|FG000|Overall Study|Withdrawal by Subject|8|||
131811558|NCT01103713|474592077|FG000|Overall Study|Study terminated by sponsor|2|||
131811559|NCT01103713|474592077|FG000|Overall Study|Other|1|||
131811560|NCT01576042|474592082|FG000|Overall Study|Physician Decision|2|||
131811561|NCT01576042|474592083|FG001|Overall Study|Physician Decision|0|||
131811562|NCT03769025|474592087|FG000|Overall Study|Withdrawal by Subject|1|||
131811563|NCT03769025|474592088|FG001|Overall Study|Withdrawal by Subject|1|||
131811564|NCT03769025|474592087|FG000|Overall Study|Lost to Follow-up|4|||
131811565|NCT03769025|474592088|FG001|Overall Study|Lost to Follow-up|3|||
131811566|NCT02409355|474592093|FG000|Overall Study|Withdrawal by Subject|1|||
131811567|NCT02409355|474592094|FG001|Overall Study|Withdrawal by Subject|0|||
131811568|NCT02409355|474592093|FG000|Overall Study|Death|1|||
131811569|NCT02409355|474592094|FG001|Overall Study|Death|1|||
131811570|NCT02409355|474592093|FG000|Overall Study|Study terminated by Sponsor|2|||
131811571|NCT02409355|474592094|FG001|Overall Study|Study terminated by Sponsor|3|||
131811572|NCT01908205|474592095|FG000|Overall Study|Lost to Follow-up|2|||
131811573|NCT01908205|474592096|FG001|Overall Study|Lost to Follow-up|0|||
131811574|NCT01908205|474592095|FG000|Overall Study|Withdrawal by Subject|3|||
131811575|NCT01908205|474592096|FG001|Overall Study|Withdrawal by Subject|1|||
131811576|NCT03482882|474592099|FG000|Overall Study|Adverse Event|3|||
131811577|NCT03482882|474592099|FG000|Overall Study|Lost to Follow-up|1|||
131811578|NCT03482882|474592099|FG000|Overall Study|Protocol Violation|2|||
131811579|NCT03482882|474592099|FG000|Overall Study|Not further specified|1|||
131811580|NCT01110005|474592104|FG000|Overall Study|ineligible|1|||
131811581|NCT01110005|474592105|FG001|Overall Study|ineligible|2|||
131811582|NCT01110005|474592104|FG000|Overall Study|missing consent|3|||
131811583|NCT01110005|474592105|FG001|Overall Study|missing consent|2|||
131811584|NCT01110005|474592104|FG000|Overall Study|Withdrawal by Subject|0|||
131811585|NCT01110005|474592105|FG001|Overall Study|Withdrawal by Subject|1|||
131811586|NCT03123471|474592106|FG000|Placebo-controlled Phase|Adverse Event|3|||
131811587|NCT03123471|474592107|FG001|Placebo-controlled Phase|Adverse Event|8|||
131811588|NCT03123471|474592106|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
131908265|NCT01935089|474952901|FG000|Overall Study|Adverse Event|2|||
131908266|NCT01935089|474952901|FG000|Overall Study|Withdrawal by Subject|1|||
131908267|NCT03157089|474952902|FG000|Overall Study|Treated only with pembrolizumab|1|||
131908268|NCT03157089|474952903|FG001|Overall Study|Treated only with pembrolizumab|0|||
131908269|NCT03157089|474952902|FG000|Overall Study|Adverse Event|5|||
131908270|NCT03157089|474952903|FG001|Overall Study|Adverse Event|4|||
131908271|NCT03157089|474952902|FG000|Overall Study|Progressive disease|6|||
131908272|NCT03157089|474952903|FG001|Overall Study|Progressive disease|8|||
131908273|NCT02337491|474952904|FG000|Overall Study|Death|1|||
131908274|NCT02337491|474952905|FG001|Overall Study|Death|1|||
131908275|NCT02337491|474952904|FG000|Overall Study|Adverse Event|0|||
131908276|NCT02337491|474952905|FG001|Overall Study|Adverse Event|1|||
131908277|NCT02337491|474952904|FG000|Overall Study|Withdrawal by Subject|3|||
131908278|NCT02337491|474952905|FG001|Overall Study|Withdrawal by Subject|0|||
131908279|NCT02337491|474952904|FG000|Overall Study|Progressive Disease|44|||
131908280|NCT02337491|474952905|FG001|Overall Study|Progressive Disease|28|||
131908281|NCT02337491|474952904|FG000|Overall Study|On Treatment|2|||
131908282|NCT02337491|474952905|FG001|Overall Study|On Treatment|0|||
131908283|NCT00095979|474952906|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
131908284|NCT01483118|474952907|FG000|Overall Study|Lost to Follow-up|12|||
131908285|NCT01483118|474952908|FG001|Overall Study|Lost to Follow-up|16|||
131908286|NCT02783066|474952910|FG000|Overall Study|Withdrawal by Subject|13|||
131908287|NCT03712280|474952911|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
131908288|NCT03712280|474952912|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
131908289|NCT03712280|474952913|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
131908290|NCT03712280|474952914|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
131908291|NCT03712280|474952911|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
131908292|NCT03712280|474952912|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
131908293|NCT03712280|474952913|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
131908294|NCT03712280|474952914|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
131908295|NCT03712280|474952911|FG000|Overall Study|Adverse Event|0|||
131908296|NCT03712280|474952912|FG001|Overall Study|Adverse Event|0|||
131908297|NCT03712280|474952913|FG002|Overall Study|Adverse Event|1|||
131908298|NCT03712280|474952914|FG003|Overall Study|Adverse Event|0|||
131755161|NCT01989572|474381121|FG003|Overall Study|maximum dose reached|0|||
131755162|NCT01989572|474381122|FG004|Overall Study|maximum dose reached|1|||
131755163|NCT01989572|474381123|FG005|Overall Study|maximum dose reached|0|||
131908299|NCT05379920|474952915|FG000|Overall Study|Lost to Follow-up|0|||
131908300|NCT05379920|474952916|FG001|Overall Study|Lost to Follow-up|5|||
131908301|NCT05379920|474952917|FG002|Overall Study|Lost to Follow-up|0|||
131908302|NCT05379920|474952918|FG003|Overall Study|Lost to Follow-up|0|||
131908303|NCT03176771|474952921|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
131908304|NCT03176771|474952922|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
131908305|NCT03176771|474952923|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
131908306|NCT03176771|474952924|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
131908307|NCT03176771|474952925|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
131908308|NCT03176771|474952921|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
131908309|NCT03176771|474952922|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
131908310|NCT03176771|474952923|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
131908311|NCT03176771|474952924|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
131908312|NCT03176771|474952925|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
131908313|NCT03176771|474952921|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
131908314|NCT03176771|474952922|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
131908315|NCT03176771|474952923|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
131908316|NCT03176771|474952924|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
131908317|NCT03176771|474952925|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
131908318|NCT03176771|474952921|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
131908319|NCT03176771|474952922|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
131908320|NCT03176771|474952923|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
131908321|NCT03176771|474952924|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
131908322|NCT03176771|474952925|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
131908323|NCT03176771|474952921|FG000|Double-Blind Extension Period|Adverse Event|0|||
131908324|NCT03176771|474952922|FG001|Double-Blind Extension Period|Adverse Event|0|||
131908325|NCT03176771|474952923|FG002|Double-Blind Extension Period|Adverse Event|0|||
131908326|NCT03176771|474952924|FG003|Double-Blind Extension Period|Adverse Event|15|||
131398630|NCT01406938|473081212|FG005|Follow up|Lack of Efficacy|0|||
131398631|NCT01406938|473081207|FG000|Follow up|Patient/guardian decision|4|||
131398632|NCT01406938|473081208|FG001|Follow up|Patient/guardian decision|2|||
131755164|NCT01989572|474381118|FG000|Overall Study|unknown/not specify|3|||
131755165|NCT01989572|474381119|FG001|Overall Study|unknown/not specify|4|||
131755166|NCT01989572|474381120|FG002|Overall Study|unknown/not specify|1|||
131398633|NCT01406938|473081209|FG002|Follow up|Patient/guardian decision|4|||
131398634|NCT01406938|473081210|FG003|Follow up|Patient/guardian decision|2|||
131755167|NCT01989572|474381121|FG003|Overall Study|unknown/not specify|3|||
131755168|NCT01989572|474381122|FG004|Overall Study|unknown/not specify|3|||
131755169|NCT01989572|474381123|FG005|Overall Study|unknown/not specify|5|||
131755170|NCT01989572|474381118|FG000|Overall Study|not start protocol therapy|5|||
131755171|NCT01989572|474381119|FG001|Overall Study|not start protocol therapy|1|||
131755172|NCT01989572|474381120|FG002|Overall Study|not start protocol therapy|2|||
131755173|NCT01989572|474381121|FG003|Overall Study|not start protocol therapy|3|||
131755174|NCT01989572|474381122|FG004|Overall Study|not start protocol therapy|4|||
131755175|NCT01989572|474381123|FG005|Overall Study|not start protocol therapy|18|||
131755176|NCT01989572|474381118|FG000|Overall Study|alternative therapy|3|||
131755177|NCT01989572|474381119|FG001|Overall Study|alternative therapy|0|||
131755178|NCT01989572|474381120|FG002|Overall Study|alternative therapy|0|||
131755179|NCT01989572|474381121|FG003|Overall Study|alternative therapy|0|||
131755180|NCT01989572|474381122|FG004|Overall Study|alternative therapy|1|||
131755181|NCT01989572|474381123|FG005|Overall Study|alternative therapy|3|||
131755182|NCT02280096|474381124|FG000|Overall Study|Pregnancy|1|||
131755183|NCT02280096|474381125|FG001|Overall Study|Pregnancy|0|||
131755184|NCT02280096|474381124|FG000|Overall Study|Functional neurological disorder|1|||
131755185|NCT02280096|474381125|FG001|Overall Study|Functional neurological disorder|0|||
131755186|NCT02280096|474381124|FG000|Overall Study|Lack of attachment|0|||
131755187|NCT02280096|474381125|FG001|Overall Study|Lack of attachment|1|||
131755188|NCT00246376|474381126|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
131755189|NCT00246376|474381127|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
131755190|NCT00246376|474381128|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
131755191|NCT00246376|474381129|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
131755192|NCT00246376|474381130|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
131755193|NCT00246376|474381126|FG000|Overall Study|Adverse Event|2|||
131755194|NCT00246376|474381127|FG001|Overall Study|Adverse Event|3|||
131755195|NCT00246376|474381128|FG002|Overall Study|Adverse Event|1|||
131755196|NCT00246376|474381129|FG003|Overall Study|Adverse Event|3|||
131755197|NCT00246376|474381130|FG004|Overall Study|Adverse Event|1|||
131755198|NCT00246376|474381126|FG000|Overall Study|Lost to Follow-up|2|||
131755199|NCT00246376|474381127|FG001|Overall Study|Lost to Follow-up|11|||
131755200|NCT00246376|474381128|FG002|Overall Study|Lost to Follow-up|11|||
131755201|NCT00246376|474381129|FG003|Overall Study|Lost to Follow-up|16|||
131755202|NCT00246376|474381130|FG004|Overall Study|Lost to Follow-up|13|||
131755203|NCT02418585|474381131|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
131811589|NCT03123471|474592107|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
131811590|NCT03123471|474592106|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
131811591|NCT03123471|474592107|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
131811592|NCT03123471|474592106|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
131811593|NCT03123471|474592107|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
131811594|NCT03123471|474592106|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
131811595|NCT03123471|474592107|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
131811596|NCT03123471|474592106|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
131811597|NCT03123471|474592107|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
131811598|NCT03123471|474592106|FG000|Placebo-controlled Phase|Miscellaneous|0|||
131811599|NCT03123471|474592107|FG001|Placebo-controlled Phase|Miscellaneous|1|||
131811600|NCT03123471|474592106|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
131398635|NCT01406938|473081211|FG004|Follow up|Patient/guardian decision|4|||
131398636|NCT01406938|473081212|FG005|Follow up|Patient/guardian decision|1|||
131398637|NCT01406938|473081207|FG000|Follow up|Protocol Violation|0|||
131398638|NCT01406938|473081208|FG001|Follow up|Protocol Violation|0|||
131755204|NCT02418585|474381132|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
131755205|NCT02418585|474381131|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
131755206|NCT02418585|474381132|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
131755207|NCT02418585|474381131|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
131755208|NCT02418585|474381132|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
131755209|NCT02418585|474381131|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
131755210|NCT02418585|474381132|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
131755211|NCT02418585|474381131|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
131811601|NCT03123471|474592107|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
131811602|NCT03123471|474592106|FG000|Apremilast Extension Phase|Adverse Event|1|||
131755212|NCT02418585|474381132|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
131755213|NCT02418585|474381131|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
131755214|NCT02418585|474381132|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
131755215|NCT02418585|474381131|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
131755216|NCT02418585|474381132|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
131755217|NCT02418585|474381131|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
131811603|NCT03123471|474592107|FG001|Apremilast Extension Phase|Adverse Event|5|||
131755218|NCT02418585|474381132|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
131811604|NCT03123471|474592106|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
131908327|NCT03176771|474952925|FG004|Double-Blind Extension Period|Adverse Event|18|||
131908328|NCT03176771|474952921|FG000|Double-Blind Extension Period|Death|0|||
131908329|NCT03176771|474952922|FG001|Double-Blind Extension Period|Death|0|||
131908330|NCT03176771|474952923|FG002|Double-Blind Extension Period|Death|0|||
131908331|NCT03176771|474952924|FG003|Double-Blind Extension Period|Death|3|||
131908332|NCT03176771|474952925|FG004|Double-Blind Extension Period|Death|4|||
131908333|NCT03176771|474952921|FG000|Double-Blind Extension Period|Physician Decision|0|||
131398639|NCT01406938|473081209|FG002|Follow up|Protocol Violation|1|||
131398640|NCT01406938|473081210|FG003|Follow up|Protocol Violation|0|||
131398641|NCT01406938|473081211|FG004|Follow up|Protocol Violation|0|||
131398642|NCT01406938|473081212|FG005|Follow up|Protocol Violation|0|||
131908334|NCT03176771|474952922|FG001|Double-Blind Extension Period|Physician Decision|0|||
131908335|NCT03176771|474952923|FG002|Double-Blind Extension Period|Physician Decision|0|||
131908336|NCT03176771|474952924|FG003|Double-Blind Extension Period|Physician Decision|3|||
131908337|NCT03176771|474952925|FG004|Double-Blind Extension Period|Physician Decision|1|||
131908338|NCT03176771|474952921|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
131908339|NCT03176771|474952922|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
131908340|NCT03176771|474952923|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
131908341|NCT03176771|474952924|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
131908342|NCT03176771|474952925|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
131908343|NCT03530293|474952926|FG000|Pre-randomization|Adverse Event|12|||
131908344|NCT03530293|474952927|FG001|Pre-randomization|Adverse Event|0|||
131908345|NCT03530293|474952928|FG002|Pre-randomization|Adverse Event|0|||
131908346|NCT03530293|474952926|FG000|Pre-randomization|Protocol Violation|2|||
131908347|NCT03530293|474952927|FG001|Pre-randomization|Protocol Violation|0|||
131908348|NCT03530293|474952928|FG002|Pre-randomization|Protocol Violation|0|||
131908349|NCT03530293|474952926|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
131908350|NCT03530293|474952927|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
131908351|NCT03530293|474952928|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
131908352|NCT03530293|474952926|FG000|Pre-randomization|Withdrawal by Subject|5|||
131908353|NCT03530293|474952927|FG001|Pre-randomization|Withdrawal by Subject|0|||
131908354|NCT03530293|474952928|FG002|Pre-randomization|Withdrawal by Subject|0|||
131908355|NCT03530293|474952926|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
131908356|NCT03530293|474952927|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
131908357|NCT03530293|474952928|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
131908358|NCT03530293|474952926|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
131908359|NCT03530293|474952927|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
131908360|NCT03530293|474952928|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
131908361|NCT03530293|474952926|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
131908362|NCT03530293|474952927|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
131908363|NCT03530293|474952928|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
131908364|NCT03530293|474952926|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
131908365|NCT03530293|474952927|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
131908366|NCT03530293|474952928|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
131908367|NCT03530293|474952926|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
131908368|NCT03530293|474952927|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
131908369|NCT03530293|474952928|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
131908370|NCT02732639|474952930|FG000|Overall Study|Lost to Follow-up|1|||
131908371|NCT02265510|474952931|FG000|Overall Study|Withdrawal by Subject|1|||
131908372|NCT02265510|474952932|FG001|Overall Study|Withdrawal by Subject|1|||
131908373|NCT02265510|474952933|FG002|Overall Study|Withdrawal by Subject|2|||
131908374|NCT02265510|474952934|FG003|Overall Study|Withdrawal by Subject|1|||
131908375|NCT02265510|474952935|FG004|Overall Study|Withdrawal by Subject|0|||
131908376|NCT02265510|474952936|FG005|Overall Study|Withdrawal by Subject|2|||
131908377|NCT02265510|474952937|FG006|Overall Study|Withdrawal by Subject|0|||
131908378|NCT02265510|474952938|FG007|Overall Study|Withdrawal by Subject|2|||
131908379|NCT02265510|474952939|FG008|Overall Study|Withdrawal by Subject|0|||
131908380|NCT02265510|474952940|FG009|Overall Study|Withdrawal by Subject|0|||
131398643|NCT01406938|473081207|FG000|Follow up|Physician Decision|0|||
131755219|NCT02418585|474381131|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
131755220|NCT02418585|474381132|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
131755221|NCT02418585|474381131|FG000|Follow-up Phase (24 Weeks)|Other|3|||
131755222|NCT02418585|474381132|FG001|Follow-up Phase (24 Weeks)|Other|2|||
131755223|NCT02040857|474381133|FG000|Overall Study|Adverse Event|14|||
131755224|NCT02040857|474381133|FG000|Overall Study|Physician Decision|5|||
131755225|NCT02040857|474381133|FG000|Overall Study|Withdrawal by Subject|31|||
131755226|NCT02040857|474381133|FG000|Overall Study|patient non-compliance|3|||
131755227|NCT02040857|474381133|FG000|Overall Study|Lost to Follow-up|2|||
131755228|NCT02040857|474381133|FG000|Overall Study|recurrence|4|||
131908381|NCT02265510|474952941|FG010|Overall Study|Withdrawal by Subject|0|||
131908382|NCT02265510|474952942|FG011|Overall Study|Withdrawal by Subject|0|||
131908383|NCT02265510|474952943|FG012|Overall Study|Withdrawal by Subject|1|||
131755229|NCT02040857|474381133|FG000|Overall Study|ineligible|1|||
131755230|NCT02972593|474381138|FG000|Overall Study|Lost to Follow-up|19|||
131755231|NCT02972593|474381139|FG001|Overall Study|Lost to Follow-up|15|||
131755232|NCT02972593|474381138|FG000|Overall Study|Protocol Violation|1|||
131755233|NCT02972593|474381139|FG001|Overall Study|Protocol Violation|0|||
131755234|NCT00693693|474381140|FG000|Overall Study|Lost to Follow-up|1|||
131755235|NCT00693693|474381141|FG001|Overall Study|Lost to Follow-up|1|||
131755236|NCT00693693|474381142|FG002|Overall Study|Lost to Follow-up|2|||
131755237|NCT04599972|474381147|FG000|Overall Study|Withdrawal by Subject|6|||
131755238|NCT04599972|474381148|FG001|Overall Study|Withdrawal by Subject|1|||
131755239|NCT04599972|474381147|FG000|Overall Study|Adverse Event|1|||
131755240|NCT04599972|474381148|FG001|Overall Study|Adverse Event|1|||
131755241|NCT04599972|474381147|FG000|Overall Study|Lost to Follow-up|1|||
131755242|NCT04599972|474381148|FG001|Overall Study|Lost to Follow-up|6|||
131755243|NCT04599972|474381147|FG000|Overall Study|Protocol Violation|1|||
131755244|NCT04599972|474381148|FG001|Overall Study|Protocol Violation|0|||
131755245|NCT04599972|474381147|FG000|Overall Study|Other reason|1|||
131755246|NCT04599972|474381148|FG001|Overall Study|Other reason|0|||
131755247|NCT00638690|474381155|FG000|Overall Study|Death|655|||
131755248|NCT00638690|474381156|FG001|Overall Study|Death|335|||
131755249|NCT00638690|474381155|FG000|Overall Study|Withdrawal by Subject|22|||
131755250|NCT00638690|474381156|FG001|Overall Study|Withdrawal by Subject|5|||
131755251|NCT00638690|474381155|FG000|Overall Study|Lost to Follow-up|4|||
131755252|NCT00638690|474381156|FG001|Overall Study|Lost to Follow-up|2|||
131755253|NCT00471276|474381161|FG000|Overall Study|Death|2|||
131755254|NCT00471276|474381161|FG000|Overall Study|Adverse Event|16|||
131755255|NCT00471276|474381161|FG000|Overall Study|Protocol Violation|1|||
131755256|NCT00471276|474381161|FG000|Overall Study|Objective progression or relapse|54|||
131755257|NCT00471276|474381161|FG000|Overall Study|Global deterioration of health status|1|||
131755258|NCT00471276|474381161|FG000|Overall Study|Other|3|||
131755259|NCT00471276|474381161|FG000|Overall Study|Refused treatment|6|||
131755260|NCT01594411|474381164|FG000|Overall Study|Lost to Follow-up|2|||
131755261|NCT04449276|474381170|FG000|Overall Study|Adverse Event|1|||
131755262|NCT04449276|474381171|FG001|Overall Study|Adverse Event|2|||
131755263|NCT04449276|474381172|FG002|Overall Study|Adverse Event|0|||
131755264|NCT04449276|474381173|FG003|Overall Study|Adverse Event|0|||
131755265|NCT04449276|474381174|FG004|Overall Study|Adverse Event|2|||
131755266|NCT04449276|474381175|FG005|Overall Study|Adverse Event|0|||
131755267|NCT04449276|474381176|FG006|Overall Study|Adverse Event|0|||
131755268|NCT04449276|474381177|FG007|Overall Study|Adverse Event|1|||
131755269|NCT04449276|474381170|FG000|Overall Study|Withdrawal by Subject|2|||
131755270|NCT04449276|474381171|FG001|Overall Study|Withdrawal by Subject|0|||
131755271|NCT04449276|474381172|FG002|Overall Study|Withdrawal by Subject|0|||
131755272|NCT04449276|474381173|FG003|Overall Study|Withdrawal by Subject|1|||
131755273|NCT04449276|474381174|FG004|Overall Study|Withdrawal by Subject|0|||
131755274|NCT04449276|474381175|FG005|Overall Study|Withdrawal by Subject|0|||
131755275|NCT04449276|474381176|FG006|Overall Study|Withdrawal by Subject|0|||
131755276|NCT04449276|474381177|FG007|Overall Study|Withdrawal by Subject|0|||
131755277|NCT04449276|474381170|FG000|Overall Study|Other|0|||
131755278|NCT04449276|474381171|FG001|Overall Study|Other|2|||
131755279|NCT04449276|474381172|FG002|Overall Study|Other|3|||
131755280|NCT04449276|474381173|FG003|Overall Study|Other|2|||
131755281|NCT04449276|474381174|FG004|Overall Study|Other|0|||
131755282|NCT04449276|474381175|FG005|Overall Study|Other|0|||
131755283|NCT04449276|474381176|FG006|Overall Study|Other|0|||
131755284|NCT04449276|474381177|FG007|Overall Study|Other|1|||
131755285|NCT01614795|474381178|FG000|Overall Study|Adverse Event|0|||
131755286|NCT01614795|474381179|FG001|Overall Study|Adverse Event|0|||
131755287|NCT01614795|474381180|FG002|Overall Study|Adverse Event|1|||
131755288|NCT01614795|474381181|FG003|Overall Study|Adverse Event|1|||
131755289|NCT01614795|474381178|FG000|Overall Study|Lack of Efficacy|10|||
131755290|NCT01614795|474381179|FG001|Overall Study|Lack of Efficacy|10|||
131755291|NCT01614795|474381180|FG002|Overall Study|Lack of Efficacy|9|||
131755292|NCT01614795|474381181|FG003|Overall Study|Lack of Efficacy|8|||
131811605|NCT03123471|474592107|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
131811606|NCT03123471|474592106|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
131811607|NCT03123471|474592107|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
131755293|NCT01614795|474381178|FG000|Overall Study|Physician Decision|1|||
131755294|NCT01614795|474381179|FG001|Overall Study|Physician Decision|0|||
131755295|NCT01614795|474381180|FG002|Overall Study|Physician Decision|1|||
131755296|NCT01614795|474381181|FG003|Overall Study|Physician Decision|1|||
131755297|NCT01614795|474381178|FG000|Overall Study|Withdrawal by Subject|0|||
131755298|NCT01614795|474381179|FG001|Overall Study|Withdrawal by Subject|1|||
131755299|NCT01614795|474381180|FG002|Overall Study|Withdrawal by Subject|0|||
131755300|NCT01614795|474381181|FG003|Overall Study|Withdrawal by Subject|2|||
131755301|NCT01614795|474381178|FG000|Overall Study|Ineligible|0|||
131755302|NCT01614795|474381179|FG001|Overall Study|Ineligible|1|||
131755303|NCT01614795|474381180|FG002|Overall Study|Ineligible|0|||
131755304|NCT01614795|474381181|FG003|Overall Study|Ineligible|0|||
131755305|NCT00910728|474381185|FG000|Overall Study|Lack of Efficacy|2|||
131755306|NCT00910728|474381186|FG001|Overall Study|Lack of Efficacy|3|||
131755307|NCT00910728|474381187|FG002|Overall Study|Lack of Efficacy|1|||
131755308|NCT00910728|474381188|FG003|Overall Study|Lack of Efficacy|2|||
131755309|NCT00910728|474381189|FG004|Overall Study|Lack of Efficacy|1|||
131755310|NCT00910728|474381190|FG005|Overall Study|Lack of Efficacy|0|||
131755311|NCT00910728|474381191|FG006|Overall Study|Lack of Efficacy|2|||
131755312|NCT00910728|474381192|FG007|Overall Study|Lack of Efficacy|2|||
131755313|NCT00910728|474381193|FG008|Overall Study|Lack of Efficacy|2|||
131908384|NCT02265510|474952944|FG013|Overall Study|Withdrawal by Subject|0|||
131908385|NCT02265510|474952931|FG000|Overall Study|Disease Progression|0|||
131908386|NCT02265510|474952932|FG001|Overall Study|Disease Progression|1|||
131908387|NCT02265510|474952933|FG002|Overall Study|Disease Progression|2|||
131908388|NCT02265510|474952934|FG003|Overall Study|Disease Progression|1|||
131908389|NCT02265510|474952935|FG004|Overall Study|Disease Progression|1|||
131908390|NCT02265510|474952936|FG005|Overall Study|Disease Progression|0|||
131908391|NCT02265510|474952937|FG006|Overall Study|Disease Progression|0|||
131908392|NCT02265510|474952938|FG007|Overall Study|Disease Progression|0|||
131908393|NCT02265510|474952939|FG008|Overall Study|Disease Progression|0|||
131908394|NCT02265510|474952940|FG009|Overall Study|Disease Progression|0|||
131908395|NCT02265510|474952941|FG010|Overall Study|Disease Progression|0|||
131908396|NCT02265510|474952942|FG011|Overall Study|Disease Progression|0|||
131908397|NCT02265510|474952943|FG012|Overall Study|Disease Progression|0|||
131908398|NCT02265510|474952944|FG013|Overall Study|Disease Progression|0|||
131908399|NCT02265510|474952931|FG000|Overall Study|Death|2|||
131908400|NCT02265510|474952932|FG001|Overall Study|Death|0|||
131908401|NCT02265510|474952933|FG002|Overall Study|Death|2|||
131908402|NCT02265510|474952934|FG003|Overall Study|Death|2|||
131908403|NCT02265510|474952935|FG004|Overall Study|Death|1|||
131908404|NCT02265510|474952936|FG005|Overall Study|Death|3|||
131908405|NCT02265510|474952937|FG006|Overall Study|Death|2|||
131908406|NCT02265510|474952938|FG007|Overall Study|Death|1|||
131908407|NCT02265510|474952939|FG008|Overall Study|Death|3|||
131908408|NCT02265510|474952940|FG009|Overall Study|Death|3|||
131908409|NCT02265510|474952941|FG010|Overall Study|Death|4|||
131908410|NCT02265510|474952942|FG011|Overall Study|Death|12|||
131908411|NCT02265510|474952943|FG012|Overall Study|Death|7|||
131908412|NCT02265510|474952944|FG013|Overall Study|Death|6|||
131908413|NCT02265510|474952931|FG000|Overall Study|Lost to Follow-up|0|||
131908414|NCT02265510|474952932|FG001|Overall Study|Lost to Follow-up|0|||
131908415|NCT02265510|474952933|FG002|Overall Study|Lost to Follow-up|0|||
131908416|NCT02265510|474952934|FG003|Overall Study|Lost to Follow-up|0|||
131908417|NCT02265510|474952935|FG004|Overall Study|Lost to Follow-up|1|||
131908418|NCT02265510|474952936|FG005|Overall Study|Lost to Follow-up|0|||
131908419|NCT02265510|474952937|FG006|Overall Study|Lost to Follow-up|0|||
131908420|NCT02265510|474952938|FG007|Overall Study|Lost to Follow-up|0|||
131908421|NCT02265510|474952939|FG008|Overall Study|Lost to Follow-up|0|||
131908422|NCT02265510|474952940|FG009|Overall Study|Lost to Follow-up|2|||
131908423|NCT02265510|474952941|FG010|Overall Study|Lost to Follow-up|0|||
131908424|NCT02265510|474952942|FG011|Overall Study|Lost to Follow-up|0|||
131908425|NCT02265510|474952943|FG012|Overall Study|Lost to Follow-up|0|||
131908426|NCT02265510|474952944|FG013|Overall Study|Lost to Follow-up|2|||
131908427|NCT02265510|474952931|FG000|Overall Study|Other|0|||
131908428|NCT02265510|474952932|FG001|Overall Study|Other|1|||
131908429|NCT02265510|474952933|FG002|Overall Study|Other|0|||
131908430|NCT02265510|474952934|FG003|Overall Study|Other|0|||
131908431|NCT02265510|474952935|FG004|Overall Study|Other|0|||
131908432|NCT02265510|474952936|FG005|Overall Study|Other|0|||
131908433|NCT02265510|474952937|FG006|Overall Study|Other|0|||
131908434|NCT02265510|474952938|FG007|Overall Study|Other|0|||
131908435|NCT02265510|474952939|FG008|Overall Study|Other|0|||
131908436|NCT02265510|474952940|FG009|Overall Study|Other|0|||
131908437|NCT02265510|474952941|FG010|Overall Study|Other|0|||
131908438|NCT02265510|474952942|FG011|Overall Study|Other|0|||
131908439|NCT02265510|474952943|FG012|Overall Study|Other|0|||
131908440|NCT02265510|474952944|FG013|Overall Study|Other|0|||
131908441|NCT02265510|474952931|FG000|Overall Study|Study Terminated by Sponsor|0|||
131908442|NCT02265510|474952932|FG001|Overall Study|Study Terminated by Sponsor|0|||
131908443|NCT02265510|474952933|FG002|Overall Study|Study Terminated by Sponsor|0|||
131908444|NCT02265510|474952934|FG003|Overall Study|Study Terminated by Sponsor|0|||
131908445|NCT02265510|474952935|FG004|Overall Study|Study Terminated by Sponsor|0|||
131908446|NCT02265510|474952936|FG005|Overall Study|Study Terminated by Sponsor|1|||
131908447|NCT02265510|474952937|FG006|Overall Study|Study Terminated by Sponsor|1|||
131755314|NCT00910728|474381185|FG000|Overall Study|Withdrawal by Subject|0|||
131755315|NCT00910728|474381186|FG001|Overall Study|Withdrawal by Subject|0|||
131908448|NCT02265510|474952938|FG007|Overall Study|Study Terminated by Sponsor|1|||
131908449|NCT02265510|474952939|FG008|Overall Study|Study Terminated by Sponsor|1|||
131908450|NCT02265510|474952940|FG009|Overall Study|Study Terminated by Sponsor|2|||
131908451|NCT02265510|474952941|FG010|Overall Study|Study Terminated by Sponsor|1|||
131908452|NCT02265510|474952942|FG011|Overall Study|Study Terminated by Sponsor|4|||
131908453|NCT02265510|474952943|FG012|Overall Study|Study Terminated by Sponsor|1|||
131908454|NCT02265510|474952944|FG013|Overall Study|Study Terminated by Sponsor|2|||
131908455|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
131811608|NCT03681470|474592112|FG000|Overall Study|Lack of Efficacy|3|||
131811609|NCT03681470|474592112|FG000|Overall Study|Lost to Follow-up|1|||
131811610|NCT03681470|474592112|FG000|Overall Study|Protocol Violation|3|||
131811611|NCT03681470|474592112|FG000|Overall Study|Withdrawal by Subject|1|||
131811612|NCT01686477|474592113|FG000|Feeding Intervention|Death|1|||
131811613|NCT01686477|474592114|FG001|Feeding Intervention|Death|0|||
131811614|NCT01686477|474592115|FG002|Feeding Intervention|Death|1|||
131811615|NCT01686477|474592113|FG000|Feeding Intervention|Withdrawal by Subject|0|||
131811616|NCT01686477|474592114|FG001|Feeding Intervention|Withdrawal by Subject|6|||
131811617|NCT01686477|474592115|FG002|Feeding Intervention|Withdrawal by Subject|0|||
131811618|NCT01686477|474592113|FG000|Feeding Intervention|Physician Decision|1|||
131811619|NCT01686477|474592114|FG001|Feeding Intervention|Physician Decision|2|||
131811620|NCT01686477|474592115|FG002|Feeding Intervention|Physician Decision|0|||
131811621|NCT01686477|474592113|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
131811622|NCT01686477|474592114|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
131811623|NCT01686477|474592115|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
131811624|NCT01686477|474592113|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
131811625|NCT01686477|474592114|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
131811626|NCT01686477|474592115|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
131811627|NCT01686477|474592113|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
131811628|NCT01686477|474592114|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
131811629|NCT01686477|474592115|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
131811630|NCT01686477|474592113|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
131811631|NCT01686477|474592114|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
131811632|NCT01686477|474592115|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
131811633|NCT01686477|474592113|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
131811634|NCT01686477|474592114|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
131908456|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
131908457|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
131908458|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
131811635|NCT01686477|474592115|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
131811636|NCT01686477|474592113|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
131811637|NCT01686477|474592114|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
131811638|NCT01686477|474592115|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
131811639|NCT01686477|474592113|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
131811640|NCT01686477|474592114|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
131811641|NCT01686477|474592115|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
131811642|NCT03290781|474592121|FG000|Overall Study|Adverse Event|5|||
131811643|NCT03290781|474592122|FG001|Overall Study|Adverse Event|7|||
131811644|NCT03290781|474592123|FG002|Overall Study|Adverse Event|4|||
131811645|NCT03290781|474592124|FG003|Overall Study|Adverse Event|1|||
131811646|NCT03290781|474592125|FG004|Overall Study|Adverse Event|0|||
131811647|NCT03290781|474592126|FG005|Overall Study|Adverse Event|0|||
131811648|NCT03290781|474592127|FG006|Overall Study|Adverse Event|0|||
131811649|NCT03290781|474592121|FG000|Overall Study|Death|0|||
131811650|NCT03290781|474592122|FG001|Overall Study|Death|0|||
131811651|NCT03290781|474592123|FG002|Overall Study|Death|1|||
131908459|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
131908460|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
131908461|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
131908462|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
131908463|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
131908464|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
131908465|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
131908466|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
131908467|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
131908468|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
131908469|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
131908470|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
131908471|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
131811652|NCT03290781|474592124|FG003|Overall Study|Death|0|||
131811653|NCT03290781|474592125|FG004|Overall Study|Death|1|||
131811654|NCT03290781|474592126|FG005|Overall Study|Death|0|||
131908472|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
131908473|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
131811655|NCT03290781|474592127|FG006|Overall Study|Death|0|||
131811656|NCT03290781|474592121|FG000|Overall Study|Withdrawal by Subject|6|||
131811657|NCT03290781|474592122|FG001|Overall Study|Withdrawal by Subject|5|||
131811658|NCT03290781|474592123|FG002|Overall Study|Withdrawal by Subject|9|||
131811659|NCT03290781|474592124|FG003|Overall Study|Withdrawal by Subject|10|||
131811660|NCT03290781|474592125|FG004|Overall Study|Withdrawal by Subject|1|||
131908474|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
131398644|NCT01406938|473081208|FG001|Follow up|Physician Decision|0|||
131398645|NCT01406938|473081209|FG002|Follow up|Physician Decision|2|||
131398646|NCT01406938|473081210|FG003|Follow up|Physician Decision|0|||
131398647|NCT01406938|473081211|FG004|Follow up|Physician Decision|3|||
131398648|NCT01406938|473081212|FG005|Follow up|Physician Decision|1|||
131755316|NCT00910728|474381187|FG002|Overall Study|Withdrawal by Subject|0|||
131755317|NCT00910728|474381188|FG003|Overall Study|Withdrawal by Subject|0|||
131755318|NCT00910728|474381189|FG004|Overall Study|Withdrawal by Subject|3|||
131755319|NCT00910728|474381190|FG005|Overall Study|Withdrawal by Subject|1|||
131755320|NCT00910728|474381191|FG006|Overall Study|Withdrawal by Subject|2|||
131755321|NCT00910728|474381192|FG007|Overall Study|Withdrawal by Subject|0|||
131755322|NCT00910728|474381193|FG008|Overall Study|Withdrawal by Subject|0|||
131755323|NCT00910728|474381185|FG000|Overall Study|(not specified)|2|||
131755324|NCT00910728|474381186|FG001|Overall Study|(not specified)|0|||
131755325|NCT00910728|474381187|FG002|Overall Study|(not specified)|1|||
131755326|NCT00910728|474381188|FG003|Overall Study|(not specified)|0|||
131755327|NCT00910728|474381189|FG004|Overall Study|(not specified)|1|||
131755328|NCT00910728|474381190|FG005|Overall Study|(not specified)|0|||
131755329|NCT00910728|474381191|FG006|Overall Study|(not specified)|0|||
131755330|NCT00910728|474381192|FG007|Overall Study|(not specified)|0|||
131755331|NCT00910728|474381193|FG008|Overall Study|(not specified)|0|||
131755332|NCT00910728|474381185|FG000|Overall Study|Adverse Event|2|||
131755333|NCT00910728|474381186|FG001|Overall Study|Adverse Event|0|||
131811661|NCT03290781|474592126|FG005|Overall Study|Withdrawal by Subject|2|||
131811662|NCT03290781|474592127|FG006|Overall Study|Withdrawal by Subject|0|||
131811663|NCT03290781|474592121|FG000|Overall Study|Physician Decision|0|||
131811664|NCT03290781|474592122|FG001|Overall Study|Physician Decision|1|||
131811665|NCT03290781|474592123|FG002|Overall Study|Physician Decision|0|||
131811666|NCT03290781|474592124|FG003|Overall Study|Physician Decision|0|||
131811667|NCT03290781|474592125|FG004|Overall Study|Physician Decision|0|||
131811668|NCT03290781|474592126|FG005|Overall Study|Physician Decision|0|||
131811669|NCT03290781|474592127|FG006|Overall Study|Physician Decision|0|||
131811670|NCT03290781|474592121|FG000|Overall Study|Site Terminated by Sponsor|1|||
131811671|NCT03290781|474592122|FG001|Overall Study|Site Terminated by Sponsor|0|||
131811672|NCT03290781|474592123|FG002|Overall Study|Site Terminated by Sponsor|2|||
131811673|NCT03290781|474592124|FG003|Overall Study|Site Terminated by Sponsor|1|||
131811674|NCT03290781|474592125|FG004|Overall Study|Site Terminated by Sponsor|0|||
131811675|NCT03290781|474592126|FG005|Overall Study|Site Terminated by Sponsor|0|||
131811676|NCT03290781|474592127|FG006|Overall Study|Site Terminated by Sponsor|0|||
131811677|NCT03290781|474592121|FG000|Overall Study|Lost to Follow-up|0|||
131811678|NCT03290781|474592122|FG001|Overall Study|Lost to Follow-up|0|||
131811679|NCT03290781|474592123|FG002|Overall Study|Lost to Follow-up|0|||
131811680|NCT03290781|474592124|FG003|Overall Study|Lost to Follow-up|1|||
131811681|NCT03290781|474592125|FG004|Overall Study|Lost to Follow-up|0|||
131811682|NCT03290781|474592126|FG005|Overall Study|Lost to Follow-up|0|||
131811683|NCT03290781|474592127|FG006|Overall Study|Lost to Follow-up|0|||
131811684|NCT03290781|474592121|FG000|Overall Study|Protocol Deviation|2|||
131811685|NCT03290781|474592122|FG001|Overall Study|Protocol Deviation|0|||
131811686|NCT03290781|474592123|FG002|Overall Study|Protocol Deviation|0|||
131811687|NCT03290781|474592124|FG003|Overall Study|Protocol Deviation|1|||
131811688|NCT03290781|474592125|FG004|Overall Study|Protocol Deviation|0|||
131811689|NCT03290781|474592126|FG005|Overall Study|Protocol Deviation|0|||
131811690|NCT03290781|474592127|FG006|Overall Study|Protocol Deviation|0|||
131811691|NCT03290781|474592121|FG000|Overall Study|Disease Relapse|32|||
131811692|NCT03290781|474592122|FG001|Overall Study|Disease Relapse|5|||
131811693|NCT03290781|474592123|FG002|Overall Study|Disease Relapse|38|||
131811694|NCT03290781|474592124|FG003|Overall Study|Disease Relapse|7|||
131811695|NCT03290781|474592125|FG004|Overall Study|Disease Relapse|3|||
131811696|NCT03290781|474592126|FG005|Overall Study|Disease Relapse|1|||
131811697|NCT03290781|474592127|FG006|Overall Study|Disease Relapse|4|||
131811698|NCT03290781|474592121|FG000|Overall Study|Other|3|||
131811699|NCT03290781|474592122|FG001|Overall Study|Other|0|||
131811700|NCT03290781|474592123|FG002|Overall Study|Other|2|||
131398649|NCT01406938|473081207|FG000|Follow up|Lost to Follow-up|1|||
131398650|NCT01406938|473081208|FG001|Follow up|Lost to Follow-up|1|||
131755334|NCT00910728|474381187|FG002|Overall Study|Adverse Event|1|||
131755335|NCT00910728|474381188|FG003|Overall Study|Adverse Event|1|||
131755336|NCT00910728|474381189|FG004|Overall Study|Adverse Event|0|||
131811701|NCT03290781|474592124|FG003|Overall Study|Other|2|||
131811702|NCT03290781|474592125|FG004|Overall Study|Other|0|||
131811703|NCT03290781|474592126|FG005|Overall Study|Other|0|||
131811704|NCT03290781|474592127|FG006|Overall Study|Other|0|||
131811705|NCT02957942|474592128|FG000|Overall Study|Withdrawal by Subject|0|||
131811706|NCT02957942|474592129|FG001|Overall Study|Withdrawal by Subject|1|||
131811707|NCT02957942|474592128|FG000|Overall Study|Practicing experiment protocol|0|||
131811708|NCT02957942|474592129|FG001|Overall Study|Practicing experiment protocol|6|||
131811709|NCT04544410|474592130|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131811710|NCT04544410|474592131|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131811711|NCT04544410|474592130|FG000|Double-blind Treatment Period|Adverse Event|1|||
131755337|NCT00910728|474381190|FG005|Overall Study|Adverse Event|0|||
131755338|NCT00910728|474381191|FG006|Overall Study|Adverse Event|2|||
131755339|NCT00910728|474381192|FG007|Overall Study|Adverse Event|1|||
131755340|NCT00910728|474381193|FG008|Overall Study|Adverse Event|1|||
131755341|NCT00023712|474381194|FG000|Overall Study|Not platinum sensitive|1|||
131755342|NCT00023712|474381195|FG001|Overall Study|Not platinum sensitive|0|||
131755343|NCT00023712|474381194|FG000|Overall Study|Never treated|1|||
131755344|NCT00023712|474381195|FG001|Overall Study|Never treated|1|||
131755345|NCT00565812|474381198|FG000|Overall Study|Death|2|||
131755346|NCT00565812|474381199|FG001|Overall Study|Death|1|||
131755347|NCT00565812|474381200|FG002|Overall Study|Death|3|||
131755348|NCT00565812|474381198|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
131755349|NCT00565812|474381199|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
131755350|NCT00565812|474381200|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
131755351|NCT00565812|474381198|FG000|Overall Study|Lost to Follow-up|10|||
131755352|NCT00565812|474381199|FG001|Overall Study|Lost to Follow-up|8|||
131755353|NCT00565812|474381200|FG002|Overall Study|Lost to Follow-up|8|||
131755354|NCT00565812|474381198|FG000|Overall Study|Withdrawal by Subject|58|||
131811712|NCT04544410|474592131|FG001|Double-blind Treatment Period|Adverse Event|0|||
131811713|NCT04544410|474592130|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
131811714|NCT04544410|474592131|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131811715|NCT04544410|474592130|FG000|Double-blind Treatment Period|Protocol Violation|1|||
131755355|NCT00565812|474381199|FG001|Overall Study|Withdrawal by Subject|47|||
131755356|NCT00565812|474381200|FG002|Overall Study|Withdrawal by Subject|48|||
131755357|NCT00565812|474381198|FG000|Overall Study|Work Schedule|5|||
131755358|NCT00565812|474381199|FG001|Overall Study|Work Schedule|3|||
131755359|NCT00565812|474381200|FG002|Overall Study|Work Schedule|1|||
131755360|NCT00565812|474381198|FG000|Overall Study|Protocol Violation|2|||
131755361|NCT00565812|474381199|FG001|Overall Study|Protocol Violation|6|||
131755362|NCT00565812|474381200|FG002|Overall Study|Protocol Violation|4|||
131755363|NCT00565812|474381198|FG000|Overall Study|Adverse Event|41|||
131755364|NCT00565812|474381199|FG001|Overall Study|Adverse Event|54|||
131755365|NCT00565812|474381200|FG002|Overall Study|Adverse Event|40|||
131755366|NCT00565812|474381198|FG000|Overall Study|Jury Duty|1|||
131755367|NCT00565812|474381199|FG001|Overall Study|Jury Duty|0|||
131755368|NCT00565812|474381200|FG002|Overall Study|Jury Duty|0|||
131755369|NCT00565812|474381198|FG000|Overall Study|Relocated Out of Area|5|||
131755370|NCT00565812|474381199|FG001|Overall Study|Relocated Out of Area|8|||
131755371|NCT00565812|474381200|FG002|Overall Study|Relocated Out of Area|9|||
131755372|NCT00565812|474381198|FG000|Overall Study|Sponsor Decision|1|||
131755373|NCT00565812|474381199|FG001|Overall Study|Sponsor Decision|5|||
131755374|NCT00565812|474381200|FG002|Overall Study|Sponsor Decision|1|||
131755375|NCT00565812|474381198|FG000|Overall Study|Domestic Reasons|7|||
131755376|NCT00565812|474381199|FG001|Overall Study|Domestic Reasons|1|||
131755377|NCT00565812|474381200|FG002|Overall Study|Domestic Reasons|3|||
131755378|NCT00565812|474381198|FG000|Overall Study|Research Site Closure|6|||
131755379|NCT00565812|474381199|FG001|Overall Study|Research Site Closure|1|||
131755380|NCT00565812|474381200|FG002|Overall Study|Research Site Closure|8|||
131755381|NCT00565812|474381198|FG000|Overall Study|Surgical Intervention|0|||
131755382|NCT00565812|474381199|FG001|Overall Study|Surgical Intervention|1|||
131755383|NCT00565812|474381200|FG002|Overall Study|Surgical Intervention|2|||
131755384|NCT00565812|474381198|FG000|Overall Study|Low Compliance|1|||
131755385|NCT00565812|474381199|FG001|Overall Study|Low Compliance|0|||
131755386|NCT00565812|474381200|FG002|Overall Study|Low Compliance|1|||
131755387|NCT00565812|474381198|FG000|Overall Study|Follow-up Visit Not Completed|2|||
131755388|NCT00565812|474381199|FG001|Overall Study|Follow-up Visit Not Completed|0|||
131755389|NCT00565812|474381200|FG002|Overall Study|Follow-up Visit Not Completed|1|||
131811716|NCT04544410|474592131|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131811717|NCT04544410|474592130|FG000|Open-Label Treatment Period|Study Terminated|15|||
131811718|NCT04544410|474592131|FG001|Open-Label Treatment Period|Study Terminated|19|||
131811719|NCT04544410|474592130|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
131811720|NCT04544410|474592131|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
131811721|NCT04544410|474592130|FG000|Open-Label Treatment Period|Adverse Event|0|||
131811722|NCT04544410|474592131|FG001|Open-Label Treatment Period|Adverse Event|1|||
131811723|NCT04544410|474592130|FG000|Open-Label Treatment Period|Physician Decision|1|||
131811724|NCT04544410|474592131|FG001|Open-Label Treatment Period|Physician Decision|0|||
131811725|NCT04544410|474592130|FG000|Open-Label Treatment Period|Other|0|||
131811726|NCT04544410|474592131|FG001|Open-Label Treatment Period|Other|1|||
131811727|NCT03761173|474592132|FG000|Overall Study|Lost to Follow-up|93|||
131811728|NCT03761173|474592132|FG000|Overall Study|Withdrawal by Subject|74|||
131811729|NCT03761173|474592132|FG000|Overall Study|Death|45|||
131811730|NCT03761173|474592132|FG000|Overall Study|Withdrawal for Other Reasons|29|||
131811731|NCT03761173|474592132|FG000|Overall Study|Protocol Violation|1|||
131811732|NCT00594035|474593660|FG000|Overall Study|Lost to Follow-up|1|||
131811733|NCT00594035|474593661|FG001|Overall Study|Lost to Follow-up|1|||
131811734|NCT00594035|474593660|FG000|Overall Study|Withdrawal by Subject|1|||
131811735|NCT00594035|474593661|FG001|Overall Study|Withdrawal by Subject|0|||
131908475|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
131908476|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
131908477|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
131908478|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
131908479|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
131908480|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
131908481|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
131908482|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
131908483|NCT01668797|474952945|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
131908484|NCT01668797|474952946|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
131908485|NCT01668797|474952947|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
131908486|NCT01668797|474952948|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
131908487|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
131908488|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
131908489|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
131908490|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
131908491|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
131908492|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
131908493|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
131908494|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
131908495|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
131908496|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
131908497|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
131908498|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
131908499|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
131908500|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
131908501|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
131908502|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
131908503|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
131908504|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
131908505|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
131908506|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
131908507|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
131908508|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
131908509|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
131908510|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
131908511|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
131908512|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
131908513|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
131908514|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
131908515|NCT01668797|474952945|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
131908516|NCT01668797|474952946|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
131908517|NCT01668797|474952947|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
131908518|NCT01668797|474952948|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
131908519|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
131908520|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
131908521|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
131908522|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
131908523|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
131908524|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
131908525|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
131908526|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
131908527|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
131755390|NCT00565812|474381198|FG000|Overall Study|Physician Decision|2|||
131755391|NCT00565812|474381199|FG001|Overall Study|Physician Decision|0|||
131755392|NCT00565812|474381200|FG002|Overall Study|Physician Decision|0|||
131755393|NCT04968353|474381201|FG000|Overall Study|Non-compliance|1|||
131755394|NCT04968353|474381202|FG001|Overall Study|Non-compliance|0|||
131755395|NCT04968353|474381203|FG002|Overall Study|Non-compliance|2|||
131755396|NCT04968353|474381204|FG003|Overall Study|Non-compliance|0|||
131755397|NCT00814307|474381211|FG000|Overall Study|Randomized but not treated|1|||
131755398|NCT00814307|474381212|FG001|Overall Study|Randomized but not treated|0|||
131755399|NCT00814307|474381213|FG002|Overall Study|Randomized but not treated|0|||
131398651|NCT01406938|473081209|FG002|Follow up|Lost to Follow-up|0|||
131755400|NCT00814307|474381214|FG003|Overall Study|Randomized but not treated|0|||
131755401|NCT00814307|474381211|FG000|Overall Study|Adverse Event|3|||
131755402|NCT00814307|474381212|FG001|Overall Study|Adverse Event|9|||
131755403|NCT00814307|474381213|FG002|Overall Study|Adverse Event|3|||
131755404|NCT00814307|474381214|FG003|Overall Study|Adverse Event|2|||
131755405|NCT00814307|474381211|FG000|Overall Study|Lack of Efficacy|1|||
131755406|NCT00814307|474381212|FG001|Overall Study|Lack of Efficacy|1|||
131755407|NCT00814307|474381213|FG002|Overall Study|Lack of Efficacy|3|||
131755408|NCT00814307|474381214|FG003|Overall Study|Lack of Efficacy|4|||
131755409|NCT00814307|474381211|FG000|Overall Study|Other|1|||
131755410|NCT00814307|474381212|FG001|Overall Study|Other|2|||
131755411|NCT00814307|474381213|FG002|Overall Study|Other|0|||
131755412|NCT00814307|474381214|FG003|Overall Study|Other|1|||
131755413|NCT00814307|474381211|FG000|Overall Study|Protocol Violation|2|||
131755414|NCT00814307|474381212|FG001|Overall Study|Protocol Violation|8|||
131755415|NCT00814307|474381213|FG002|Overall Study|Protocol Violation|1|||
131755416|NCT00814307|474381214|FG003|Overall Study|Protocol Violation|1|||
131755417|NCT00814307|474381211|FG000|Overall Study|Withdrawal by Subject|4|||
131755418|NCT00814307|474381212|FG001|Overall Study|Withdrawal by Subject|6|||
131755419|NCT00814307|474381213|FG002|Overall Study|Withdrawal by Subject|0|||
131755420|NCT00814307|474381214|FG003|Overall Study|Withdrawal by Subject|2|||
131755421|NCT00814307|474381211|FG000|Overall Study|Death|0|||
131755422|NCT00814307|474381212|FG001|Overall Study|Death|1|||
131755423|NCT00814307|474381213|FG002|Overall Study|Death|0|||
131755424|NCT00814307|474381214|FG003|Overall Study|Death|0|||
131755425|NCT03209362|474381219|FG000|Overall Study|Adverse Event|0|||
131755426|NCT03209362|474381220|FG001|Overall Study|Adverse Event|1|||
131755427|NCT03209362|474381219|FG000|Overall Study|Lost to Follow-up|0|||
131755428|NCT03209362|474381220|FG001|Overall Study|Lost to Follow-up|1|||
131755429|NCT03209362|474381219|FG000|Overall Study|Withdrawal by Subject|2|||
131755430|NCT03209362|474381220|FG001|Overall Study|Withdrawal by Subject|0|||
131755431|NCT03209362|474381219|FG000|Overall Study|Other|0|||
131755432|NCT03209362|474381220|FG001|Overall Study|Other|1|||
131755433|NCT00251589|474381225|FG000|Overall Study|Adverse Event|5|||
131755434|NCT00251589|474381226|FG001|Overall Study|Adverse Event|1|||
131755435|NCT00251589|474381227|FG002|Overall Study|Adverse Event|2|||
131755436|NCT00251589|474381228|FG003|Overall Study|Adverse Event|1|||
131755437|NCT00251589|474381225|FG000|Overall Study|Withdrawal by Subject|1|||
131755438|NCT00251589|474381226|FG001|Overall Study|Withdrawal by Subject|1|||
131755439|NCT00251589|474381227|FG002|Overall Study|Withdrawal by Subject|0|||
131755440|NCT00251589|474381228|FG003|Overall Study|Withdrawal by Subject|0|||
131755441|NCT00251589|474381225|FG000|Overall Study|Discontinued due to progressive disease|9|||
131755442|NCT00251589|474381226|FG001|Overall Study|Discontinued due to progressive disease|1|||
131755443|NCT00251589|474381227|FG002|Overall Study|Discontinued due to progressive disease|0|||
131755444|NCT00251589|474381228|FG003|Overall Study|Discontinued due to progressive disease|1|||
131755445|NCT02571972|474381231|FG000|Overall Study|Protocol Violation|2|||
131755446|NCT02571972|474381231|FG000|Overall Study|Withdrawal by Subject|2|||
131755447|NCT03039192|474381234|FG000|Overall Study|Lost to Follow-up|4|||
131755448|NCT03039192|474381235|FG001|Overall Study|Lost to Follow-up|4|||
131755449|NCT03039192|474381234|FG000|Overall Study|Adverse event, serious fatal|0|||
131755450|NCT03039192|474381235|FG001|Overall Study|Adverse event, serious fatal|1|||
131755451|NCT03039192|474381234|FG000|Overall Study|Adverse event, non-fatal|0|||
131755452|NCT03039192|474381235|FG001|Overall Study|Adverse event, non-fatal|2|||
131755453|NCT03039192|474381234|FG000|Overall Study|Withdrawal by Subject|6|||
131755454|NCT03039192|474381235|FG001|Overall Study|Withdrawal by Subject|9|||
131755455|NCT03039192|474381234|FG000|Overall Study|Discontinued from treatment phase|19|||
131755456|NCT03039192|474381235|FG001|Overall Study|Discontinued from treatment phase|12|||
131755457|NCT03039192|474381234|FG000|Overall Study|Other|3|||
131755458|NCT03039192|474381235|FG001|Overall Study|Other|2|||
131755459|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Adverse Event|22|||
131755460|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Adverse Event|0|||
131755461|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
131755462|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
131755463|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
131755464|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
131755465|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
131755466|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
131755467|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
131755468|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
131755469|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
131755470|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
131755471|NCT02493868|474381236|FG000|Induction Phase: DE Participants|Other|8|||
131755472|NCT02493868|474381237|FG001|Induction Phase: DE Participants|Other|0|||
131755473|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
131755474|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
131755475|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
131755476|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
131755477|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
131755478|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
131755479|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
131755480|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
131755481|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
131755482|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
131755483|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
131755484|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
131755485|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
131755486|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
131755487|NCT02493868|474381236|FG000|Optimization Phase: DE+TE Participants|Other|10|||
131755488|NCT02493868|474381237|FG001|Optimization Phase: DE+TE Participants|Other|2|||
131755489|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
131755490|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
131755491|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
131755492|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
131755493|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
131755494|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
131755495|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
131755496|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
131755497|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
131755498|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
131755499|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
131755500|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
131755501|NCT02493868|474381236|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
131755502|NCT02493868|474381237|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
131755503|NCT02493868|474381236|FG000|Follow-up Phase|Lost to Follow-up|1|||
131755504|NCT02493868|474381237|FG001|Follow-up Phase|Lost to Follow-up|0|||
131755505|NCT02493868|474381236|FG000|Follow-up Phase|Withdrawal by Subject|3|||
131755506|NCT02493868|474381237|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131755507|NCT02493868|474381236|FG000|Follow-up Phase|Investigator Decision|5|||
131755508|NCT02493868|474381237|FG001|Follow-up Phase|Investigator Decision|1|||
131755509|NCT02493868|474381236|FG000|Follow-up Phase|Other|2|||
131755510|NCT02493868|474381237|FG001|Follow-up Phase|Other|1|||
131755511|NCT02407236|474381238|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
131755512|NCT02407236|474381239|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
131755513|NCT02407236|474381240|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
131755514|NCT02407236|474381241|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
131755515|NCT02407236|474381242|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
131755516|NCT02407236|474381243|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
131755517|NCT02407236|474381244|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
131755518|NCT02407236|474381245|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
131755519|NCT02407236|474381246|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
131755520|NCT02407236|474381247|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
131755521|NCT02407236|474381248|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
131755522|NCT02407236|474381249|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
131755523|NCT02407236|474381250|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
131755524|NCT02407236|474381238|FG000|Induction Study (8 Weeks)|Death|0|||
131755525|NCT02407236|474381239|FG001|Induction Study (8 Weeks)|Death|0|||
131755526|NCT02407236|474381240|FG002|Induction Study (8 Weeks)|Death|1|||
131811736|NCT00594035|474593660|FG000|Overall Study|Subject transferred to nursing home|0|||
131811737|NCT00594035|474593661|FG001|Overall Study|Subject transferred to nursing home|1|||
131811738|NCT00594035|474593660|FG000|Overall Study|Subject couldn't return due to job|0|||
131811739|NCT00594035|474593661|FG001|Overall Study|Subject couldn't return due to job|1|||
131811740|NCT00795821|474593662|FG000|Acute Treatment Phase|Adverse Event|23|||
131755527|NCT02407236|474381241|FG003|Induction Study (8 Weeks)|Death|0|||
131755528|NCT02407236|474381242|FG004|Induction Study (8 Weeks)|Death|0|||
131755529|NCT02407236|474381243|FG005|Induction Study (8 Weeks)|Death|0|||
131755530|NCT02407236|474381244|FG006|Induction Study (8 Weeks)|Death|0|||
131755531|NCT02407236|474381245|FG007|Induction Study (8 Weeks)|Death|0|||
131755532|NCT02407236|474381246|FG008|Induction Study (8 Weeks)|Death|0|||
131755533|NCT02407236|474381247|FG009|Induction Study (8 Weeks)|Death|0|||
131755534|NCT02407236|474381248|FG010|Induction Study (8 Weeks)|Death|0|||
131811741|NCT00795821|474593663|FG001|Acute Treatment Phase|Adverse Event|4|||
131755535|NCT02407236|474381249|FG011|Induction Study (8 Weeks)|Death|0|||
131755536|NCT02407236|474381250|FG012|Induction Study (8 Weeks)|Death|0|||
131755537|NCT02407236|474381238|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
131755538|NCT02407236|474381239|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
131755539|NCT02407236|474381240|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
131755540|NCT02407236|474381241|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755541|NCT02407236|474381242|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755542|NCT02407236|474381243|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755543|NCT02407236|474381244|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755544|NCT02407236|474381245|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755545|NCT02407236|474381246|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755546|NCT02407236|474381247|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755547|NCT02407236|474381248|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755548|NCT02407236|474381249|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755549|NCT02407236|474381250|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131755550|NCT02407236|474381238|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755551|NCT02407236|474381239|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755552|NCT02407236|474381240|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
131755553|NCT02407236|474381241|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755554|NCT02407236|474381242|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755555|NCT02407236|474381243|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755556|NCT02407236|474381244|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755557|NCT02407236|474381245|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755558|NCT02407236|474381246|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755559|NCT02407236|474381247|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755560|NCT02407236|474381248|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755561|NCT02407236|474381249|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755562|NCT02407236|474381250|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131755563|NCT02407236|474381238|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
131755564|NCT02407236|474381239|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
131755565|NCT02407236|474381240|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
131755566|NCT02407236|474381241|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
131755567|NCT02407236|474381242|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
131755568|NCT02407236|474381243|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
131755569|NCT02407236|474381244|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
131755570|NCT02407236|474381245|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
131755571|NCT02407236|474381246|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
131755572|NCT02407236|474381247|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
131755573|NCT02407236|474381248|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
131755574|NCT02407236|474381249|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
131755575|NCT02407236|474381250|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
131755576|NCT02407236|474381238|FG000|Induction Study (8 Weeks)|Other|2|||
131755577|NCT02407236|474381239|FG001|Induction Study (8 Weeks)|Other|1|||
131755578|NCT02407236|474381240|FG002|Induction Study (8 Weeks)|Other|5|||
131755579|NCT02407236|474381241|FG003|Induction Study (8 Weeks)|Other|0|||
131755580|NCT02407236|474381242|FG004|Induction Study (8 Weeks)|Other|0|||
131755581|NCT02407236|474381243|FG005|Induction Study (8 Weeks)|Other|0|||
131755582|NCT02407236|474381244|FG006|Induction Study (8 Weeks)|Other|0|||
131755583|NCT02407236|474381245|FG007|Induction Study (8 Weeks)|Other|0|||
131755584|NCT02407236|474381246|FG008|Induction Study (8 Weeks)|Other|0|||
131755585|NCT02407236|474381247|FG009|Induction Study (8 Weeks)|Other|0|||
131755586|NCT02407236|474381248|FG010|Induction Study (8 Weeks)|Other|0|||
131755587|NCT02407236|474381249|FG011|Induction Study (8 Weeks)|Other|0|||
131755588|NCT02407236|474381250|FG012|Induction Study (8 Weeks)|Other|0|||
131755589|NCT02407236|474381238|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755590|NCT02407236|474381239|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755591|NCT02407236|474381240|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755592|NCT02407236|474381241|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
131755593|NCT02407236|474381242|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
131755594|NCT02407236|474381243|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
131755595|NCT02407236|474381244|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
131755596|NCT02407236|474381245|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
131755597|NCT02407236|474381246|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755598|NCT02407236|474381247|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755599|NCT02407236|474381248|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755600|NCT02407236|474381249|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755601|NCT02407236|474381250|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
131755602|NCT02407236|474381238|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755603|NCT02407236|474381239|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755604|NCT02407236|474381240|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755605|NCT02407236|474381241|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
131755606|NCT02407236|474381242|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
131755607|NCT02407236|474381243|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
131908528|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
131908529|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
131755608|NCT02407236|474381244|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
131755609|NCT02407236|474381245|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
131755610|NCT02407236|474381246|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755611|NCT02407236|474381247|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755612|NCT02407236|474381248|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755613|NCT02407236|474381249|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755614|NCT02407236|474381250|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131755615|NCT02407236|474381238|FG000|Maintenance Study (44 Weeks)|Other|0|||
131755616|NCT02407236|474381239|FG001|Maintenance Study (44 Weeks)|Other|0|||
131755617|NCT02407236|474381240|FG002|Maintenance Study (44 Weeks)|Other|0|||
131755618|NCT02407236|474381241|FG003|Maintenance Study (44 Weeks)|Other|5|||
131755619|NCT02407236|474381242|FG004|Maintenance Study (44 Weeks)|Other|7|||
131755620|NCT02407236|474381243|FG005|Maintenance Study (44 Weeks)|Other|8|||
131755621|NCT02407236|474381244|FG006|Maintenance Study (44 Weeks)|Other|4|||
131755622|NCT02407236|474381245|FG007|Maintenance Study (44 Weeks)|Other|6|||
131755623|NCT02407236|474381246|FG008|Maintenance Study (44 Weeks)|Other|0|||
131755624|NCT02407236|474381247|FG009|Maintenance Study (44 Weeks)|Other|0|||
131755625|NCT02407236|474381248|FG010|Maintenance Study (44 Weeks)|Other|0|||
131755626|NCT02407236|474381249|FG011|Maintenance Study (44 Weeks)|Other|0|||
131755627|NCT02407236|474381250|FG012|Maintenance Study (44 Weeks)|Other|0|||
131755628|NCT02407236|474381238|FG000|Maintenance Study (44 Weeks)|Death|0|||
131755629|NCT02407236|474381239|FG001|Maintenance Study (44 Weeks)|Death|0|||
131755630|NCT02407236|474381240|FG002|Maintenance Study (44 Weeks)|Death|0|||
131755631|NCT02407236|474381241|FG003|Maintenance Study (44 Weeks)|Death|0|||
131755632|NCT02407236|474381242|FG004|Maintenance Study (44 Weeks)|Death|0|||
131755633|NCT02407236|474381243|FG005|Maintenance Study (44 Weeks)|Death|0|||
131755634|NCT02407236|474381244|FG006|Maintenance Study (44 Weeks)|Death|0|||
131755635|NCT02407236|474381245|FG007|Maintenance Study (44 Weeks)|Death|1|||
131755636|NCT02407236|474381246|FG008|Maintenance Study (44 Weeks)|Death|0|||
131755637|NCT02407236|474381247|FG009|Maintenance Study (44 Weeks)|Death|0|||
131755638|NCT02407236|474381248|FG010|Maintenance Study (44 Weeks)|Death|0|||
131755639|NCT02407236|474381249|FG011|Maintenance Study (44 Weeks)|Death|0|||
131755640|NCT02407236|474381250|FG012|Maintenance Study (44 Weeks)|Death|0|||
131755641|NCT02407236|474381238|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755642|NCT02407236|474381239|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755643|NCT02407236|474381240|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755644|NCT02407236|474381241|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755645|NCT02407236|474381242|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755646|NCT02407236|474381243|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755647|NCT02407236|474381244|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755648|NCT02407236|474381245|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131755649|NCT02407236|474381246|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
131755650|NCT02407236|474381247|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
131755651|NCT02407236|474381248|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
131755652|NCT02407236|474381249|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
131755653|NCT02407236|474381250|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
131755654|NCT02407236|474381238|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755655|NCT02407236|474381239|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755656|NCT02407236|474381240|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755657|NCT02407236|474381241|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755658|NCT02407236|474381242|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755659|NCT02407236|474381243|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755660|NCT02407236|474381244|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755661|NCT02407236|474381245|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755662|NCT02407236|474381246|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755663|NCT02407236|474381247|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755664|NCT02407236|474381248|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
131755665|NCT02407236|474381249|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755666|NCT02407236|474381250|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131755667|NCT02407236|474381238|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755668|NCT02407236|474381239|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755669|NCT02407236|474381240|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755670|NCT02407236|474381241|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755671|NCT02407236|474381242|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755672|NCT02407236|474381243|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755673|NCT02407236|474381244|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755674|NCT02407236|474381245|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131755675|NCT02407236|474381246|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
131755676|NCT02407236|474381247|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
131755677|NCT02407236|474381248|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
131755678|NCT02407236|474381249|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
131755679|NCT02407236|474381250|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
131811742|NCT00795821|474593662|FG000|Acute Treatment Phase|Death|1|||
131811743|NCT00795821|474593663|FG001|Acute Treatment Phase|Death|0|||
131811744|NCT00795821|474593662|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
131811745|NCT00795821|474593663|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
131811746|NCT00795821|474593662|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
131811747|NCT00795821|474593663|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
131811748|NCT00795821|474593662|FG000|Acute Treatment Phase|Physician Decision|1|||
131811749|NCT00795821|474593663|FG001|Acute Treatment Phase|Physician Decision|1|||
131811750|NCT00795821|474593662|FG000|Acute Treatment Phase|Protocol Violation|1|||
131811751|NCT00795821|474593663|FG001|Acute Treatment Phase|Protocol Violation|2|||
131811752|NCT00795821|474593662|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
131908530|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
131755680|NCT02407236|474381238|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
131755681|NCT02407236|474381239|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
131755682|NCT02407236|474381240|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
131755683|NCT02407236|474381241|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
131755684|NCT02407236|474381242|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
131755685|NCT02407236|474381243|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
131755686|NCT02407236|474381244|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
131755687|NCT02407236|474381245|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
131755688|NCT02407236|474381246|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
131755689|NCT02407236|474381247|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
131755690|NCT02407236|474381248|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
131755691|NCT02407236|474381249|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
131755692|NCT02407236|474381250|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
131755693|NCT02177812|474381251|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131755694|NCT02177812|474381252|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131755695|NCT02177812|474381253|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131755696|NCT02177812|474381254|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131755697|NCT02177812|474381255|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131755698|NCT02177812|474381256|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
131755699|NCT02177812|474381257|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
131755700|NCT02177812|474381258|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
131755701|NCT02177812|474381259|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131755702|NCT02177812|474381251|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755703|NCT02177812|474381252|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755704|NCT02177812|474381253|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755705|NCT02177812|474381254|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755706|NCT02177812|474381255|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755707|NCT02177812|474381256|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
131755708|NCT02177812|474381257|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
131755709|NCT02177812|474381258|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755710|NCT02177812|474381259|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131755711|NCT02177812|474381251|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131755712|NCT02177812|474381252|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131755713|NCT02177812|474381253|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131755714|NCT02177812|474381254|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131908531|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
131908532|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
131908533|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
131908534|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
131908535|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
131908536|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
131908537|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
131908538|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
131908539|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
131908540|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
131908541|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
131908542|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
131908543|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
131908544|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
131908545|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
131398652|NCT01406938|473081210|FG003|Follow up|Lost to Follow-up|1|||
131398653|NCT01406938|473081211|FG004|Follow up|Lost to Follow-up|2|||
131398654|NCT01406938|473081212|FG005|Follow up|Lost to Follow-up|1|||
131811753|NCT00795821|474593663|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
131398655|NCT01951586|473081214|FG000|Overall Study|Death|61|||
131398656|NCT01951586|473081215|FG001|Overall Study|Death|120|||
131811754|NCT00795821|474593662|FG000|Long-term Extension Phase|Adverse Event|25|||
131811755|NCT00795821|474593663|FG001|Long-term Extension Phase|Adverse Event|32|||
131755715|NCT02177812|474381255|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131755716|NCT02177812|474381256|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131755717|NCT02177812|474381257|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
131755718|NCT02177812|474381258|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131755719|NCT02177812|474381259|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131755720|NCT00089999|474381260|FG000|Overall Study|Adverse Event|4|||
131755721|NCT00089999|474381261|FG001|Overall Study|Adverse Event|7|||
131755722|NCT00089999|474381260|FG000|Overall Study|Withdrawal by Subject|0|||
131755723|NCT00089999|474381261|FG001|Overall Study|Withdrawal by Subject|4|||
131755724|NCT00089999|474381260|FG000|Overall Study|Lost to Follow-up|2|||
131755725|NCT00089999|474381261|FG001|Overall Study|Lost to Follow-up|1|||
131755726|NCT00089999|474381260|FG000|Overall Study|Radiological Progression of Cancer|52|||
131755727|NCT00089999|474381261|FG001|Overall Study|Radiological Progression of Cancer|44|||
131755728|NCT00089999|474381260|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
131755729|NCT00089999|474381261|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
131755730|NCT00089999|474381260|FG000|Overall Study|Death|3|||
131755731|NCT00089999|474381261|FG001|Overall Study|Death|3|||
131755732|NCT00089999|474381260|FG000|Overall Study|Poor General Condition|1|||
131755733|NCT00089999|474381261|FG001|Overall Study|Poor General Condition|0|||
131755734|NCT00089999|474381260|FG000|Overall Study|Clinical Progression|1|||
131755735|NCT00089999|474381261|FG001|Overall Study|Clinical Progression|2|||
131755736|NCT00089999|474381260|FG000|Overall Study|Physician Decision|2|||
131755737|NCT00089999|474381261|FG001|Overall Study|Physician Decision|2|||
131755738|NCT00089999|474381260|FG000|Overall Study|Patient Underwent Surgery|2|||
131755739|NCT00089999|474381261|FG001|Overall Study|Patient Underwent Surgery|0|||
131755740|NCT00089999|474381260|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
131755741|NCT00089999|474381261|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
131755742|NCT00777257|474382958|FG000|Overall Study|Adverse Event|3|||
131755743|NCT00777257|474382959|FG001|Overall Study|Adverse Event|1|||
131755744|NCT00777257|474382960|FG002|Overall Study|Adverse Event|0|||
131755745|NCT00777257|474382958|FG000|Overall Study|Lost to Follow-up|3|||
131755746|NCT00777257|474382959|FG001|Overall Study|Lost to Follow-up|3|||
131755747|NCT00777257|474382960|FG002|Overall Study|Lost to Follow-up|2|||
131755748|NCT00777257|474382958|FG000|Overall Study|Protocol Violation|2|||
131755749|NCT00777257|474382959|FG001|Overall Study|Protocol Violation|2|||
131811756|NCT00795821|474593662|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
131811757|NCT00795821|474593663|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
131811758|NCT00795821|474593662|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
131811759|NCT00795821|474593663|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
131811760|NCT00795821|474593662|FG000|Long-term Extension Phase|Physician Decision|1|||
131811761|NCT00795821|474593663|FG001|Long-term Extension Phase|Physician Decision|2|||
131811762|NCT00795821|474593662|FG000|Long-term Extension Phase|Protocol Violation|3|||
131811763|NCT00795821|474593663|FG001|Long-term Extension Phase|Protocol Violation|5|||
131811764|NCT00795821|474593662|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
131811765|NCT00795821|474593663|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
131811766|NCT00795821|474593662|FG000|Taper Phase|Adverse Event|2|||
131811767|NCT00795821|474593663|FG001|Taper Phase|Adverse Event|0|||
131811768|NCT00795821|474593662|FG000|Taper Phase|Lost to Follow-up|1|||
131811769|NCT00795821|474593663|FG001|Taper Phase|Lost to Follow-up|0|||
131811770|NCT00795821|474593662|FG000|Taper Phase|Physician Decision|2|||
131811771|NCT00795821|474593663|FG001|Taper Phase|Physician Decision|0|||
131908546|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
131908547|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
131908548|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
131908549|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
131811772|NCT00795821|474593662|FG000|Taper Phase|Withdrawal by Subject|4|||
131811773|NCT00795821|474593663|FG001|Taper Phase|Withdrawal by Subject|0|||
131811774|NCT03049748|474593676|FG000|Overall Study|Lost to Follow-up|1|||
131811775|NCT03049748|474593677|FG001|Overall Study|Lost to Follow-up|0|||
131811776|NCT03049748|474593676|FG000|Overall Study|Death|3|||
131908550|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
131908551|NCT01668797|474952945|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
131908552|NCT01668797|474952946|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
131755750|NCT00777257|474382960|FG002|Overall Study|Protocol Violation|2|||
131755751|NCT00777257|474382958|FG000|Overall Study|Withdrawal by Subject|3|||
131755752|NCT00777257|474382959|FG001|Overall Study|Withdrawal by Subject|6|||
131755753|NCT00777257|474382960|FG002|Overall Study|Withdrawal by Subject|5|||
131755754|NCT04984876|474382962|FG000|Overall Study|Subject decision|2|||
131755755|NCT04984876|474382963|FG001|Overall Study|Subject decision|10|||
131755756|NCT04984876|474382964|FG002|Overall Study|Subject decision|3|||
131811777|NCT03049748|474593677|FG001|Overall Study|Death|0|||
131811778|NCT03049748|474593676|FG000|Overall Study|Withdrawal by Subject|0|||
131811779|NCT03049748|474593677|FG001|Overall Study|Withdrawal by Subject|3|||
131811780|NCT03049748|474593676|FG000|Overall Study|Protocol Violation|0|||
131908553|NCT01668797|474952947|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
131755757|NCT04984876|474382965|FG003|Overall Study|Subject decision|3|||
131755758|NCT04984876|474382966|FG004|Overall Study|Subject decision|3|||
131755759|NCT04984876|474382967|FG005|Overall Study|Subject decision|0|||
131755760|NCT04984876|474382962|FG000|Overall Study|Guardian decision|0|||
131755761|NCT04984876|474382963|FG001|Overall Study|Guardian decision|1|||
131755762|NCT04984876|474382964|FG002|Overall Study|Guardian decision|0|||
131755763|NCT04984876|474382965|FG003|Overall Study|Guardian decision|2|||
131755764|NCT04984876|474382966|FG004|Overall Study|Guardian decision|0|||
131755765|NCT04984876|474382967|FG005|Overall Study|Guardian decision|1|||
131755766|NCT04984876|474382962|FG000|Overall Study|Lost to Follow-up|0|||
131755767|NCT04984876|474382963|FG001|Overall Study|Lost to Follow-up|0|||
131755768|NCT04984876|474382964|FG002|Overall Study|Lost to Follow-up|1|||
131755769|NCT04984876|474382965|FG003|Overall Study|Lost to Follow-up|1|||
131755770|NCT04984876|474382966|FG004|Overall Study|Lost to Follow-up|0|||
131755771|NCT04984876|474382967|FG005|Overall Study|Lost to Follow-up|0|||
131755772|NCT04984876|474382962|FG000|Overall Study|Physician Decision|1|||
131755773|NCT04984876|474382963|FG001|Overall Study|Physician Decision|0|||
131755774|NCT04984876|474382964|FG002|Overall Study|Physician Decision|0|||
131755775|NCT04984876|474382965|FG003|Overall Study|Physician Decision|1|||
131755776|NCT04984876|474382966|FG004|Overall Study|Physician Decision|0|||
131755777|NCT04984876|474382967|FG005|Overall Study|Physician Decision|0|||
131755778|NCT04984876|474382962|FG000|Overall Study|Adverse Event|0|||
131755779|NCT04984876|474382963|FG001|Overall Study|Adverse Event|0|||
131755780|NCT04984876|474382964|FG002|Overall Study|Adverse Event|1|||
131755781|NCT04984876|474382965|FG003|Overall Study|Adverse Event|0|||
131755782|NCT04984876|474382966|FG004|Overall Study|Adverse Event|0|||
131755783|NCT04984876|474382967|FG005|Overall Study|Adverse Event|0|||
131755784|NCT02204410|474382968|FG000|Overall Study|Lost to Follow-up|5|||
131755785|NCT02204410|474382968|FG000|Overall Study|Physician Decision|2|||
131755786|NCT02204410|474382968|FG000|Overall Study|Protocol Violation|1|||
131755787|NCT02204410|474382968|FG000|Overall Study|Withdrawal by Subject|3|||
131755788|NCT00209092|474382971|FG000|Overall Study|Progression of disease|7|||
131755789|NCT00209092|474382972|FG001|Overall Study|Progression of disease|1|||
131755790|NCT00209092|474382971|FG000|Overall Study|Adverse Event|0|||
131398657|NCT01951586|473081214|FG000|Overall Study|Withdrawal by Subject|8|||
131398658|NCT01951586|473081215|FG001|Overall Study|Withdrawal by Subject|17|||
131755791|NCT00209092|474382972|FG001|Overall Study|Adverse Event|1|||
131755792|NCT00209092|474382971|FG000|Overall Study|Withdrawal by Subject|1|||
131755793|NCT00209092|474382972|FG001|Overall Study|Withdrawal by Subject|0|||
131755794|NCT01462045|474382973|FG000|Overall Study|Family matter|0|||
131755795|NCT01462045|474382974|FG001|Overall Study|Family matter|1|||
131755796|NCT01462045|474382975|FG002|Overall Study|Family matter|0|||
131755797|NCT02436915|474382978|FG000|Overall Study|Withdrawal by Subject|0|||
131811781|NCT03049748|474593677|FG001|Overall Study|Protocol Violation|2|||
131811782|NCT03049748|474593676|FG000|Overall Study|Moved out of state (relocation)|0|||
131811783|NCT03049748|474593677|FG001|Overall Study|Moved out of state (relocation)|1|||
131811784|NCT03502811|474593680|FG000|Overall Study|Death|157|||
131811785|NCT03502811|474593680|FG000|Overall Study|Withdrawal by Subject|105|||
131811786|NCT03502811|474593680|FG000|Overall Study|Lost to Follow-up|26|||
131811787|NCT03502811|474593680|FG000|Overall Study|No Visits (Missed)|31|||
131811788|NCT00905840|474593683|FG000|Overall Study|Lost to Follow-up|11|||
131811789|NCT00905840|474593683|FG000|Overall Study|Death|3|||
131811790|NCT00905840|474593683|FG000|Overall Study|Withdrawal by Subject|1|||
131811791|NCT00905840|474593683|FG000|Overall Study|Adverse Event|1|||
131811792|NCT01527006|474593684|FG000|Core Study|Adverse Event|0|||
131811793|NCT01527006|474593685|FG001|Core Study|Adverse Event|2|||
131811794|NCT01527006|474593684|FG000|Core Study|Lost to Follow-up|0|||
131811795|NCT01527006|474593685|FG001|Core Study|Lost to Follow-up|1|||
131811796|NCT01527006|474593684|FG000|Core Study|Subject Choice|1|||
131811797|NCT01527006|474593685|FG001|Core Study|Subject Choice|0|||
131811798|NCT01527006|474593684|FG000|Core Study|Inadequate Therapeutic Effect|1|||
131811799|NCT01527006|474593685|FG001|Core Study|Inadequate Therapeutic Effect|0|||
131811800|NCT01527006|474593684|FG000|Core Study|Withdrawal by Subject|0|||
131811801|NCT01527006|474593685|FG001|Core Study|Withdrawal by Subject|1|||
131811802|NCT01527006|474593684|FG000|Core Study|Other|0|||
131811803|NCT01527006|474593685|FG001|Core Study|Other|2|||
131811804|NCT01527006|474593684|FG000|Extension Phase|Adverse Event|4|||
131811805|NCT01527006|474593685|FG001|Extension Phase|Adverse Event|2|||
131811806|NCT01527006|474593684|FG000|Extension Phase|Lost to Follow-up|0|||
131811807|NCT01527006|474593685|FG001|Extension Phase|Lost to Follow-up|1|||
131811808|NCT01527006|474593684|FG000|Extension Phase|Subject Choice|1|||
131811809|NCT01527006|474593685|FG001|Extension Phase|Subject Choice|1|||
131811810|NCT01527006|474593684|FG000|Extension Phase|Inadequate therapeutic effect|1|||
131811811|NCT01527006|474593685|FG001|Extension Phase|Inadequate therapeutic effect|1|||
131811812|NCT01527006|474593684|FG000|Extension Phase|Other|0|||
131811813|NCT01527006|474593685|FG001|Extension Phase|Other|3|||
131811814|NCT02294786|474593688|FG000|Overall Study|Withdrawal by Subject|0|||
131755798|NCT02436915|474382979|FG001|Overall Study|Withdrawal by Subject|1|||
131755799|NCT01117181|474382986|FG000|Overall Study|Lost to Follow-up|1|||
131755800|NCT01117181|474382987|FG001|Overall Study|Lost to Follow-up|0|||
131755801|NCT01117181|474382986|FG000|Overall Study|Withdrawal by Subject|0|||
131755802|NCT01117181|474382987|FG001|Overall Study|Withdrawal by Subject|2|||
131755803|NCT01518309|474382988|FG000|Overall Study|Adverse Event|6|||
131755804|NCT01518309|474382988|FG000|Overall Study|Death|6|||
131755805|NCT01518309|474382988|FG000|Overall Study|Lack of Efficacy|7|||
131755806|NCT01518309|474382988|FG000|Overall Study|Withdrawal by Subject|6|||
131755807|NCT01518309|474382988|FG000|Overall Study|Physician Decision|3|||
131755808|NCT01518309|474382988|FG000|Overall Study|Sponsor Decision|2|||
131755809|NCT01518309|474382988|FG000|Overall Study|Not in Predefined Categories|9|||
131755810|NCT00863317|474382989|FG000|Overall Study|Lost to Follow-up|8|||
131755811|NCT00863317|474382990|FG001|Overall Study|Lost to Follow-up|9|||
131755812|NCT02579863|474382991|FG000|Overall Study|Final Disposition Unknown|2|||
131755813|NCT02579863|474382992|FG001|Overall Study|Final Disposition Unknown|1|||
131755814|NCT02579863|474382991|FG000|Overall Study|Adverse Event|18|||
131755815|NCT02579863|474382992|FG001|Overall Study|Adverse Event|11|||
131755816|NCT02579863|474382991|FG000|Overall Study|Death|31|||
131755817|NCT02579863|474382992|FG001|Overall Study|Death|29|||
131755818|NCT02579863|474382991|FG000|Overall Study|Lost to Follow-up|2|||
131755819|NCT02579863|474382992|FG001|Overall Study|Lost to Follow-up|1|||
131755820|NCT02579863|474382991|FG000|Overall Study|Physician Decision|1|||
131755821|NCT02579863|474382992|FG001|Overall Study|Physician Decision|2|||
131908554|NCT01668797|474952948|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
131908555|NCT01004614|474952949|FG000|Washout|Withdrawal by Subject|0|||
131755822|NCT02579863|474382991|FG000|Overall Study|Screen Failure|0|||
131755823|NCT02579863|474382992|FG001|Overall Study|Screen Failure|2|||
131755824|NCT02579863|474382991|FG000|Overall Study|Study Terminated at Selected Sites|82|||
131755825|NCT02579863|474382992|FG001|Overall Study|Study Terminated at Selected Sites|88|||
131755826|NCT02579863|474382991|FG000|Overall Study|Withdrawal by Subject|20|||
131755827|NCT02579863|474382992|FG001|Overall Study|Withdrawal by Subject|20|||
131755828|NCT00038142|474382995|FG000|Overall Study|Ineligible|1|||
131755829|NCT00038142|474382996|FG001|Overall Study|Ineligible|0|||
131755830|NCT00038142|474382995|FG000|Overall Study|Progressive Disease|11|||
131755831|NCT00038142|474382996|FG001|Overall Study|Progressive Disease|7|||
131755832|NCT00038142|474382995|FG000|Overall Study|Death|1|||
131755833|NCT00038142|474382996|FG001|Overall Study|Death|0|||
131755834|NCT00038142|474382995|FG000|Overall Study|Adverse Event|1|||
131755835|NCT00038142|474382996|FG001|Overall Study|Adverse Event|0|||
131755836|NCT00038142|474382995|FG000|Overall Study|Unknown Reason|8|||
131755837|NCT00038142|474382996|FG001|Overall Study|Unknown Reason|0|||
131755838|NCT02658149|474383007|FG000|Overall Study|Physician Decision|1|||
131755839|NCT02658149|474383008|FG001|Overall Study|Physician Decision|0|||
131755840|NCT01440972|474383015|FG000|Overall Study|Withdrawal by Subject|3|||
131755841|NCT01440972|474383016|FG001|Overall Study|Withdrawal by Subject|2|||
131755842|NCT03933215|474383017|FG000|Overall Study|Other|6|||
131755843|NCT03933215|474383017|FG000|Overall Study|Sponsor decision|5|||
131755844|NCT03933215|474383017|FG000|Overall Study|Protocol Violation|5|||
131908556|NCT01004614|474952950|FG001|Washout|Withdrawal by Subject|1|||
131908557|NCT01004614|474952951|FG002|Washout|Withdrawal by Subject|0|||
131908558|NCT01004614|474952952|FG003|Washout|Withdrawal by Subject|0|||
131908559|NCT01302899|474952953|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
131908560|NCT01302899|474952954|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
131908561|NCT01302899|474952953|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
131908562|NCT01302899|474952954|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
131908563|NCT03558516|474952955|FG000|Overall Study|Protocol Violation|2|||
131908564|NCT03558516|474952956|FG001|Overall Study|Protocol Violation|2|||
131908565|NCT04494646|474952960|FG000|Overall Study|Adverse Event|0|||
131908566|NCT04494646|474952961|FG001|Overall Study|Adverse Event|1|||
131908567|NCT04494646|474952960|FG000|Overall Study|Withdrawal by Subject|0|||
131908568|NCT04494646|474952961|FG001|Overall Study|Withdrawal by Subject|1|||
131908569|NCT02785939|474952964|FG000|Overall Study|Progression|25|||
131908570|NCT02785939|474952965|FG001|Overall Study|Progression|8|||
131908571|NCT02785939|474952964|FG000|Overall Study|Adverse Event|3|||
131908572|NCT02785939|474952965|FG001|Overall Study|Adverse Event|1|||
131908573|NCT02785939|474952964|FG000|Overall Study|Death|1|||
131908574|NCT02785939|474952965|FG001|Overall Study|Death|0|||
131908575|NCT02785939|474952964|FG000|Overall Study|Refusal|1|||
131755845|NCT03933215|474383017|FG000|Overall Study|Withdrawal by Subject|6|||
131755846|NCT03933215|474383017|FG000|Overall Study|Lost to Follow-up|6|||
131755847|NCT03933215|474383017|FG000|Overall Study|Enrolled but not treated|38|||
131755848|NCT00068822|474383018|FG000|First Randomized Intervention|Lost to Follow-up|1|||
131755849|NCT00068822|474383019|FG001|First Randomized Intervention|Lost to Follow-up|2|||
131755850|NCT00735072|474383023|FG000|Overall Study|interrupted study med during ARV change|1|||
131755851|NCT00735072|474383024|FG001|Overall Study|interrupted study med during ARV change|0|||
131755852|NCT00735072|474383023|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
131755853|NCT00735072|474383024|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
131755854|NCT01678313|474383029|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
131755855|NCT01678313|474383030|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
131755856|NCT01678313|474383029|FG000|Completed the 3-month Therapy|Physician Decision|3|||
131755857|NCT01678313|474383030|FG001|Completed the 3-month Therapy|Physician Decision|4|||
131755858|NCT01678313|474383029|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
131755859|NCT01678313|474383030|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
131755860|NCT01678313|474383029|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
131755861|NCT01678313|474383030|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
131755862|NCT01131130|474383031|FG000|Period 1 - Baseline|Pregnancy|1|||
131755863|NCT01131130|474383031|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
131755864|NCT03464136|474383032|FG000|Overall Study|Lost to Follow-up|5|||
131755865|NCT03464136|474383033|FG001|Overall Study|Lost to Follow-up|8|||
131755866|NCT03464136|474383032|FG000|Overall Study|Withdrawal by Subject|16|||
131755867|NCT03464136|474383033|FG001|Overall Study|Withdrawal by Subject|13|||
131755868|NCT03464136|474383032|FG000|Overall Study|Death|1|||
131755869|NCT03464136|474383033|FG001|Overall Study|Death|0|||
131755870|NCT03464136|474383032|FG000|Overall Study|Other|8|||
131755871|NCT03464136|474383033|FG001|Overall Study|Other|4|||
131755872|NCT03412565|474383034|FG000|Overall Study|Lost to Follow-up|0|||
131755873|NCT03412565|474383035|FG001|Overall Study|Lost to Follow-up|0|||
131755874|NCT03412565|474383036|FG002|Overall Study|Lost to Follow-up|1|||
131755875|NCT03412565|474383037|FG003|Overall Study|Lost to Follow-up|0|||
131755876|NCT03412565|474383034|FG000|Overall Study|Physician Decision|0|||
131755877|NCT03412565|474383035|FG001|Overall Study|Physician Decision|0|||
131755878|NCT03412565|474383036|FG002|Overall Study|Physician Decision|0|||
131755879|NCT03412565|474383037|FG003|Overall Study|Physician Decision|1|||
131755880|NCT03412565|474383034|FG000|Overall Study|Withdrawal by Subject|0|||
131755881|NCT03412565|474383035|FG001|Overall Study|Withdrawal by Subject|4|||
131755882|NCT03412565|474383036|FG002|Overall Study|Withdrawal by Subject|5|||
131755883|NCT03412565|474383037|FG003|Overall Study|Withdrawal by Subject|5|||
131755884|NCT03412565|474383034|FG000|Overall Study|Death|1|||
131755885|NCT03412565|474383035|FG001|Overall Study|Death|3|||
131755886|NCT03412565|474383036|FG002|Overall Study|Death|4|||
131755887|NCT03412565|474383037|FG003|Overall Study|Death|5|||
131755888|NCT03412565|474383034|FG000|Overall Study|Data collection ended|0|||
131755889|NCT03412565|474383035|FG001|Overall Study|Data collection ended|41|||
131755890|NCT03412565|474383036|FG002|Overall Study|Data collection ended|41|||
131755891|NCT03412565|474383037|FG003|Overall Study|Data collection ended|40|||
131755892|NCT03146403|474383040|FG000|Overall Study|Withdrawal by Subject|0|||
131755893|NCT03146403|474383041|FG001|Overall Study|Withdrawal by Subject|3|||
131755894|NCT03146403|474383040|FG000|Overall Study|Lost to Follow-up|2|||
131755895|NCT03146403|474383041|FG001|Overall Study|Lost to Follow-up|0|||
131755896|NCT01024920|474383042|FG000|Overall Study|Progressive disease|47|||
131755897|NCT01024920|474383043|FG001|Overall Study|Progressive disease|25|||
131755898|NCT01024920|474383042|FG000|Overall Study|Adverse Event|8|||
131755899|NCT01024920|474383043|FG001|Overall Study|Adverse Event|4|||
131755900|NCT01024920|474383042|FG000|Overall Study|Lost to Follow-up|0|||
131755901|NCT01024920|474383043|FG001|Overall Study|Lost to Follow-up|1|||
131755902|NCT01024920|474383042|FG000|Overall Study|Patient refusal to continue|4|||
131755903|NCT01024920|474383043|FG001|Overall Study|Patient refusal to continue|0|||
131755904|NCT01024920|474383042|FG000|Overall Study|Other than listed|5|||
131755905|NCT01024920|474383043|FG001|Overall Study|Other than listed|1|||
131755906|NCT01024920|474383042|FG000|Overall Study|Not treated|3|||
131755907|NCT01024920|474383043|FG001|Overall Study|Not treated|0|||
131755908|NCT01024920|474383042|FG000|Overall Study|Protocol Violation|0|||
131755909|NCT01024920|474383043|FG001|Overall Study|Protocol Violation|1|||
131755910|NCT01098032|474383045|FG000|Overall Study|Withdrawal by Subject|1|||
131755911|NCT01098032|474383046|FG001|Overall Study|Withdrawal by Subject|1|||
131755912|NCT02182999|474383050|FG000|Overall Study|Adverse Event|4|||
131755913|NCT02182999|474383051|FG001|Overall Study|Adverse Event|3|||
131755914|NCT02182999|474383050|FG000|Overall Study|Physician Decision|1|||
131755915|NCT02182999|474383051|FG001|Overall Study|Physician Decision|0|||
131755916|NCT02252588|474383052|FG000|Overall Study|Withdrawal by Subject|4|||
131755917|NCT02252588|474383053|FG001|Overall Study|Withdrawal by Subject|0|||
131755918|NCT03039790|474383055|FG000|Overall Study|Lost to Follow-up|2|||
131755919|NCT03039790|474383056|FG001|Overall Study|Lost to Follow-up|0|||
131755920|NCT03039790|474383057|FG002|Overall Study|Lost to Follow-up|1|||
131755921|NCT03039790|474383058|FG003|Overall Study|Lost to Follow-up|1|||
131755922|NCT03039790|474383059|FG004|Overall Study|Lost to Follow-up|0|||
131755923|NCT03039790|474383060|FG005|Overall Study|Lost to Follow-up|1|||
131908576|NCT02785939|474952965|FG001|Overall Study|Refusal|0|||
131755924|NCT03039790|474383061|FG006|Overall Study|Lost to Follow-up|1|||
131755925|NCT03039790|474383062|FG007|Overall Study|Lost to Follow-up|1|||
131755926|NCT03039790|474383063|FG008|Overall Study|Lost to Follow-up|0|||
131755927|NCT03039790|474383064|FG009|Overall Study|Lost to Follow-up|1|||
131755928|NCT03039790|474383065|FG010|Overall Study|Lost to Follow-up|1|||
131755929|NCT03039790|474383066|FG011|Overall Study|Lost to Follow-up|0|||
131908577|NCT02785939|474952964|FG000|Overall Study|Deteriorating health|1|||
131755930|NCT03039790|474383067|FG012|Overall Study|Lost to Follow-up|1|||
131755931|NCT03039790|474383068|FG013|Overall Study|Lost to Follow-up|0|||
131755932|NCT03039790|474383069|FG014|Overall Study|Lost to Follow-up|3|||
131755933|NCT03039790|474383070|FG015|Overall Study|Lost to Follow-up|1|||
131755934|NCT03039790|474383071|FG016|Overall Study|Lost to Follow-up|2|||
131755935|NCT03039790|474383072|FG017|Overall Study|Lost to Follow-up|2|||
131755936|NCT03039790|474383073|FG018|Overall Study|Lost to Follow-up|1|||
131755937|NCT03039790|474383074|FG019|Overall Study|Lost to Follow-up|3|||
131755938|NCT03039790|474383055|FG000|Overall Study|Withdrawal of Consent|1|||
131755939|NCT03039790|474383056|FG001|Overall Study|Withdrawal of Consent|0|||
131755940|NCT03039790|474383057|FG002|Overall Study|Withdrawal of Consent|0|||
131755941|NCT03039790|474383058|FG003|Overall Study|Withdrawal of Consent|1|||
131755942|NCT03039790|474383059|FG004|Overall Study|Withdrawal of Consent|0|||
131755943|NCT03039790|474383060|FG005|Overall Study|Withdrawal of Consent|0|||
131755944|NCT03039790|474383061|FG006|Overall Study|Withdrawal of Consent|0|||
131755945|NCT03039790|474383062|FG007|Overall Study|Withdrawal of Consent|0|||
131755946|NCT03039790|474383063|FG008|Overall Study|Withdrawal of Consent|0|||
131755947|NCT03039790|474383064|FG009|Overall Study|Withdrawal of Consent|1|||
131755948|NCT03039790|474383065|FG010|Overall Study|Withdrawal of Consent|0|||
131755949|NCT03039790|474383066|FG011|Overall Study|Withdrawal of Consent|0|||
131755950|NCT03039790|474383067|FG012|Overall Study|Withdrawal of Consent|2|||
131755951|NCT03039790|474383068|FG013|Overall Study|Withdrawal of Consent|0|||
131755952|NCT03039790|474383069|FG014|Overall Study|Withdrawal of Consent|1|||
131755953|NCT03039790|474383070|FG015|Overall Study|Withdrawal of Consent|5|||
131755954|NCT03039790|474383071|FG016|Overall Study|Withdrawal of Consent|3|||
131755955|NCT03039790|474383072|FG017|Overall Study|Withdrawal of Consent|0|||
131755956|NCT03039790|474383073|FG018|Overall Study|Withdrawal of Consent|2|||
131755957|NCT03039790|474383074|FG019|Overall Study|Withdrawal of Consent|5|||
131755958|NCT03039790|474383055|FG000|Overall Study|Death|0|||
131755959|NCT03039790|474383056|FG001|Overall Study|Death|0|||
131755960|NCT03039790|474383057|FG002|Overall Study|Death|0|||
131755961|NCT03039790|474383058|FG003|Overall Study|Death|0|||
131755962|NCT03039790|474383059|FG004|Overall Study|Death|0|||
131755963|NCT03039790|474383060|FG005|Overall Study|Death|0|||
131755964|NCT03039790|474383061|FG006|Overall Study|Death|0|||
131755965|NCT03039790|474383062|FG007|Overall Study|Death|0|||
131755966|NCT03039790|474383063|FG008|Overall Study|Death|0|||
131755967|NCT03039790|474383064|FG009|Overall Study|Death|0|||
131755968|NCT03039790|474383065|FG010|Overall Study|Death|0|||
131755969|NCT03039790|474383066|FG011|Overall Study|Death|0|||
131755970|NCT03039790|474383067|FG012|Overall Study|Death|0|||
131755971|NCT03039790|474383068|FG013|Overall Study|Death|0|||
131755972|NCT03039790|474383069|FG014|Overall Study|Death|0|||
131755973|NCT03039790|474383070|FG015|Overall Study|Death|1|||
131755974|NCT03039790|474383071|FG016|Overall Study|Death|3|||
131755975|NCT03039790|474383072|FG017|Overall Study|Death|0|||
131755976|NCT03039790|474383073|FG018|Overall Study|Death|2|||
131755977|NCT03039790|474383074|FG019|Overall Study|Death|0|||
131755978|NCT03039790|474383055|FG000|Overall Study|Reason, not Specified|1|||
131755979|NCT03039790|474383056|FG001|Overall Study|Reason, not Specified|0|||
131755980|NCT03039790|474383057|FG002|Overall Study|Reason, not Specified|0|||
131755981|NCT03039790|474383058|FG003|Overall Study|Reason, not Specified|0|||
131755982|NCT03039790|474383059|FG004|Overall Study|Reason, not Specified|0|||
131755983|NCT03039790|474383060|FG005|Overall Study|Reason, not Specified|0|||
131755984|NCT03039790|474383061|FG006|Overall Study|Reason, not Specified|0|||
131755985|NCT03039790|474383062|FG007|Overall Study|Reason, not Specified|0|||
131755986|NCT03039790|474383063|FG008|Overall Study|Reason, not Specified|0|||
131755987|NCT03039790|474383064|FG009|Overall Study|Reason, not Specified|0|||
131755988|NCT03039790|474383065|FG010|Overall Study|Reason, not Specified|0|||
131755989|NCT03039790|474383066|FG011|Overall Study|Reason, not Specified|0|||
131755990|NCT03039790|474383067|FG012|Overall Study|Reason, not Specified|0|||
131755991|NCT03039790|474383068|FG013|Overall Study|Reason, not Specified|0|||
131755992|NCT03039790|474383069|FG014|Overall Study|Reason, not Specified|0|||
131755993|NCT03039790|474383070|FG015|Overall Study|Reason, not Specified|0|||
131755994|NCT03039790|474383071|FG016|Overall Study|Reason, not Specified|2|||
131755995|NCT03039790|474383072|FG017|Overall Study|Reason, not Specified|0|||
131755996|NCT03039790|474383073|FG018|Overall Study|Reason, not Specified|1|||
131755997|NCT03039790|474383074|FG019|Overall Study|Reason, not Specified|0|||
131755998|NCT00498368|474383082|FG000|Overall Study|Withdrawal by Subject|3|||
131755999|NCT00498368|474383083|FG001|Overall Study|Withdrawal by Subject|2|||
131756000|NCT02266004|474383084|FG000|Overall Study|unrelated adverse event|1|||
131756001|NCT02266004|474383084|FG000|Overall Study|Physician Decision|1|||
131756002|NCT00537771|474383089|FG000|Overall Study|Withdrawal by Subject|6|||
131756003|NCT00537771|474383090|FG001|Overall Study|Withdrawal by Subject|23|||
131756004|NCT00537771|474383089|FG000|Overall Study|Adverse Event|8|||
131756005|NCT00537771|474383090|FG001|Overall Study|Adverse Event|15|||
131398659|NCT01951586|473081214|FG000|Overall Study|Lost to Follow-up|0|||
131756006|NCT00537771|474383089|FG000|Overall Study|Lost to Follow-up|9|||
131756007|NCT00537771|474383090|FG001|Overall Study|Lost to Follow-up|15|||
131756008|NCT00537771|474383089|FG000|Overall Study|Protocol Violation|2|||
131756009|NCT00537771|474383090|FG001|Overall Study|Protocol Violation|6|||
131756010|NCT00537771|474383089|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
131756011|NCT00537771|474383090|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
131756012|NCT00621244|474383101|FG000|Overall Study|Withdrawal by Subject|7|||
131756013|NCT00621244|474383102|FG001|Overall Study|Withdrawal by Subject|3|||
131756014|NCT00621244|474383103|FG002|Overall Study|Withdrawal by Subject|3|||
131756015|NCT00621244|474383104|FG003|Overall Study|Withdrawal by Subject|3|||
131756016|NCT00621244|474383101|FG000|Overall Study|Disease progression|44|||
131756017|NCT00621244|474383102|FG001|Overall Study|Disease progression|20|||
131756018|NCT00621244|474383103|FG002|Overall Study|Disease progression|20|||
131756019|NCT00621244|474383104|FG003|Overall Study|Disease progression|15|||
131756020|NCT00621244|474383101|FG000|Overall Study|Death|3|||
131756021|NCT00621244|474383102|FG001|Overall Study|Death|3|||
131756022|NCT00621244|474383103|FG002|Overall Study|Death|1|||
131756023|NCT00621244|474383104|FG003|Overall Study|Death|1|||
131756024|NCT00621244|474383101|FG000|Overall Study|Adverse Event|27|||
131756025|NCT00621244|474383102|FG001|Overall Study|Adverse Event|7|||
131756026|NCT00621244|474383103|FG002|Overall Study|Adverse Event|9|||
131756027|NCT00621244|474383104|FG003|Overall Study|Adverse Event|2|||
131756028|NCT00621244|474383101|FG000|Overall Study|Administrative problems|5|||
131756029|NCT00621244|474383102|FG001|Overall Study|Administrative problems|1|||
131756030|NCT00621244|474383103|FG002|Overall Study|Administrative problems|0|||
131756031|NCT00621244|474383104|FG003|Overall Study|Administrative problems|2|||
131756032|NCT03215667|474383108|FG000|Overall Study|Physician Decision|4|||
131756033|NCT01810380|474383109|FG000|Overall Study|Randomised not treated|2|||
131756034|NCT01810380|474383110|FG001|Overall Study|Randomised not treated|1|||
131756035|NCT01810380|474383111|FG002|Overall Study|Randomised not treated|1|||
131756036|NCT01810380|474383109|FG000|Overall Study|Adverse Event|11|||
131756037|NCT01810380|474383110|FG001|Overall Study|Adverse Event|14|||
131756038|NCT01810380|474383111|FG002|Overall Study|Adverse Event|4|||
131756039|NCT01810380|474383109|FG000|Overall Study|Lack of Efficacy|24|||
131756040|NCT01810380|474383110|FG001|Overall Study|Lack of Efficacy|10|||
131756041|NCT01810380|474383111|FG002|Overall Study|Lack of Efficacy|11|||
131756042|NCT01810380|474383109|FG000|Overall Study|Protocol Violation|1|||
131756043|NCT01810380|474383110|FG001|Overall Study|Protocol Violation|0|||
131756044|NCT01810380|474383111|FG002|Overall Study|Protocol Violation|1|||
131756045|NCT01810380|474383109|FG000|Overall Study|Withdrawal by Subject|6|||
131756046|NCT01810380|474383110|FG001|Overall Study|Withdrawal by Subject|0|||
131756047|NCT01810380|474383111|FG002|Overall Study|Withdrawal by Subject|6|||
131756048|NCT01810380|474383109|FG000|Overall Study|Administrative or other reasons|11|||
131756049|NCT01810380|474383110|FG001|Overall Study|Administrative or other reasons|13|||
131756050|NCT01810380|474383111|FG002|Overall Study|Administrative or other reasons|9|||
131756051|NCT00614991|474383112|FG000|Overall Study|Adverse Event|3|||
131756052|NCT00614991|474383113|FG001|Overall Study|Adverse Event|3|||
131756053|NCT00614991|474383114|FG002|Overall Study|Adverse Event|0|||
131756054|NCT00614991|474383115|FG003|Overall Study|Adverse Event|0|||
131756055|NCT00614991|474383116|FG004|Overall Study|Adverse Event|1|||
131756056|NCT00614991|474383117|FG005|Overall Study|Adverse Event|0|||
131756057|NCT03148795|474383120|FG000|Overall Study|Progressive Disease|1|||
131756058|NCT04489940|474383121|FG000|Overall Study|Other|2|||
131756059|NCT04489940|474383121|FG000|Overall Study|Withdrawal by Subject|2|||
131756060|NCT04489940|474383121|FG000|Overall Study|Death|5|||
131756061|NCT04489940|474383121|FG000|Overall Study|Lost to Follow-up|1|||
131756062|NCT02725268|474383122|FG000|Overall Study|Death|58|||
131811815|NCT02294786|474593689|FG001|Overall Study|Withdrawal by Subject|1|||
131811816|NCT02294786|474593688|FG000|Overall Study|Physician Decision|6|||
131811817|NCT02294786|474593689|FG001|Overall Study|Physician Decision|7|||
131811818|NCT02294786|474593688|FG000|Overall Study|Lost to Follow-up|1|||
131811819|NCT02294786|474593689|FG001|Overall Study|Lost to Follow-up|2|||
131811820|NCT02294786|474593688|FG000|Overall Study|Protocol Violation|1|||
131811821|NCT02294786|474593689|FG001|Overall Study|Protocol Violation|0|||
131908578|NCT02785939|474952965|FG001|Overall Study|Deteriorating health|0|||
131908579|NCT02785939|474952964|FG000|Overall Study|Not protocol specified|0|||
131811822|NCT02294786|474593688|FG000|Overall Study|Adverse Event|1|||
131811823|NCT02294786|474593689|FG001|Overall Study|Adverse Event|1|||
131811824|NCT02294786|474593688|FG000|Overall Study|Death|2|||
131811825|NCT02294786|474593689|FG001|Overall Study|Death|3|||
131756063|NCT02725268|474383123|FG001|Overall Study|Death|59|||
131756064|NCT02725268|474383124|FG002|Overall Study|Death|30|||
131756065|NCT02725268|474383125|FG003|Overall Study|Death|16|||
131756066|NCT02725268|474383122|FG000|Overall Study|Lost to Follow-up|4|||
131756067|NCT02725268|474383123|FG001|Overall Study|Lost to Follow-up|3|||
131811826|NCT01778010|474593690|FG000|Overall Study|Withdrawal by Subject|2|||
131811827|NCT01778010|474593690|FG000|Overall Study|abnormal ECG before meds|1|||
131756068|NCT02725268|474383124|FG002|Overall Study|Lost to Follow-up|0|||
131756069|NCT02725268|474383125|FG003|Overall Study|Lost to Follow-up|1|||
131756070|NCT02725268|474383122|FG000|Overall Study|Site Terminated by Sponsor|0|||
131756071|NCT02725268|474383123|FG001|Overall Study|Site Terminated by Sponsor|1|||
131756072|NCT02725268|474383124|FG002|Overall Study|Site Terminated by Sponsor|0|||
131756073|NCT02725268|474383125|FG003|Overall Study|Site Terminated by Sponsor|0|||
131756074|NCT02725268|474383122|FG000|Overall Study|Withdrawal by Subject|8|||
131756075|NCT02725268|474383123|FG001|Overall Study|Withdrawal by Subject|6|||
131756076|NCT02725268|474383124|FG002|Overall Study|Withdrawal by Subject|8|||
131756077|NCT02725268|474383125|FG003|Overall Study|Withdrawal by Subject|1|||
131756078|NCT02725268|474383122|FG000|Overall Study|Reason not Specified|2|||
131756079|NCT02725268|474383123|FG001|Overall Study|Reason not Specified|1|||
131756080|NCT02725268|474383124|FG002|Overall Study|Reason not Specified|0|||
131756081|NCT02725268|474383125|FG003|Overall Study|Reason not Specified|0|||
131756082|NCT04498468|474383126|FG000|Overall Study|Lost to Follow-up|3|||
131756083|NCT00398138|474383127|FG000|Overall Study|Adverse Event|2|||
131756084|NCT04973085|474383135|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
131756085|NCT04973085|474383136|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
131756086|NCT02224274|474383137|FG000|Overall Study|Death|1|||
131756087|NCT02224274|474383138|FG001|Overall Study|Death|0|||
131756088|NCT00887068|474383139|FG000|Overall Study|Withdrawal by Subject|2|||
131756089|NCT00887068|474383140|FG001|Overall Study|Withdrawal by Subject|0|||
131756090|NCT00887068|474383139|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
131756091|NCT00887068|474383140|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
131756092|NCT01976624|474383141|FG000|Overall Study|Participants contraindicated|2|||
131756093|NCT01976624|474383141|FG000|Overall Study|Participants age less than 19 years|12|||
131756094|NCT01387594|474383142|FG000|Overall Study|Withdrawal by Subject|0|||
131756095|NCT01387594|474383143|FG001|Overall Study|Withdrawal by Subject|2|||
131756096|NCT01387594|474383142|FG000|Overall Study|Lost to Follow-up|0|||
131756097|NCT01387594|474383143|FG001|Overall Study|Lost to Follow-up|1|||
131756098|NCT03074318|474383151|FG000|Overall Study|Adverse Event|0|||
131756099|NCT03074318|474383152|FG001|Overall Study|Adverse Event|1|||
131756100|NCT03074318|474383153|FG002|Overall Study|Adverse Event|1|||
131756101|NCT03074318|474383154|FG003|Overall Study|Adverse Event|1|||
131756102|NCT03074318|474383151|FG000|Overall Study|Death|1|||
131756103|NCT03074318|474383152|FG001|Overall Study|Death|0|||
131756104|NCT03074318|474383153|FG002|Overall Study|Death|0|||
131756105|NCT03074318|474383154|FG003|Overall Study|Death|0|||
131756106|NCT03074318|474383151|FG000|Overall Study|Withdrawal by Subject|1|||
131756107|NCT03074318|474383152|FG001|Overall Study|Withdrawal by Subject|2|||
131756108|NCT03074318|474383153|FG002|Overall Study|Withdrawal by Subject|2|||
131756109|NCT03074318|474383154|FG003|Overall Study|Withdrawal by Subject|4|||
131756110|NCT03074318|474383151|FG000|Overall Study|Trial Closure|2|||
131756111|NCT03074318|474383152|FG001|Overall Study|Trial Closure|2|||
131756112|NCT03074318|474383153|FG002|Overall Study|Trial Closure|3|||
131756113|NCT03074318|474383154|FG003|Overall Study|Trial Closure|11|||
131756114|NCT01627782|474383157|FG000|Overall Study|Adverse Event|1|||
131756115|NCT01627782|474383158|FG001|Overall Study|Adverse Event|2|||
131756116|NCT01627782|474383159|FG002|Overall Study|Adverse Event|0|||
131756117|NCT01627782|474383160|FG003|Overall Study|Adverse Event|1|||
131756118|NCT01627782|474383157|FG000|Overall Study|Lack of Efficacy|11|||
131756119|NCT01627782|474383158|FG001|Overall Study|Lack of Efficacy|1|||
131756120|NCT01627782|474383159|FG002|Overall Study|Lack of Efficacy|15|||
131756121|NCT01627782|474383160|FG003|Overall Study|Lack of Efficacy|2|||
131756122|NCT01627782|474383157|FG000|Overall Study|Protocol Violation|1|||
131756123|NCT01627782|474383158|FG001|Overall Study|Protocol Violation|0|||
131756124|NCT01627782|474383159|FG002|Overall Study|Protocol Violation|0|||
131756125|NCT01627782|474383160|FG003|Overall Study|Protocol Violation|0|||
131756126|NCT01627782|474383157|FG000|Overall Study|Withdrawal by Subject|2|||
131756127|NCT01627782|474383158|FG001|Overall Study|Withdrawal by Subject|1|||
131756128|NCT01627782|474383159|FG002|Overall Study|Withdrawal by Subject|0|||
131756129|NCT01627782|474383160|FG003|Overall Study|Withdrawal by Subject|0|||
131811828|NCT01778010|474593690|FG000|Overall Study|Arrested|1|||
131811829|NCT01778010|474593690|FG000|Overall Study|rash while on placebo|1|||
131811830|NCT01518972|474593694|FG000|Overall Study|Lost to Follow-up|2|||
131811831|NCT01518972|474593695|FG001|Overall Study|Lost to Follow-up|1|||
131811832|NCT01518972|474593694|FG000|Overall Study|Withdrawal by Subject|1|||
131756130|NCT01627782|474383157|FG000|Overall Study|Other|0|||
131756131|NCT01627782|474383158|FG001|Overall Study|Other|2|||
131756132|NCT01627782|474383159|FG002|Overall Study|Other|0|||
131756133|NCT01627782|474383160|FG003|Overall Study|Other|3|||
131756134|NCT01627782|474383157|FG000|Overall Study|Randomized But Not Treated|1|||
131811833|NCT01518972|474593695|FG001|Overall Study|Withdrawal by Subject|0|||
131811834|NCT01518972|474593694|FG000|Overall Study|Moved from area|1|||
131811835|NCT01518972|474593695|FG001|Overall Study|Moved from area|0|||
131908580|NCT02785939|474952965|FG001|Overall Study|Not protocol specified|1|||
131908581|NCT02147626|474952968|FG000|Overall Study|Lost to Follow-up|4|||
131756135|NCT01627782|474383158|FG001|Overall Study|Randomized But Not Treated|0|||
131756136|NCT01627782|474383159|FG002|Overall Study|Randomized But Not Treated|0|||
131756137|NCT01627782|474383160|FG003|Overall Study|Randomized But Not Treated|0|||
131756138|NCT00643448|474383161|FG000|Overall Study|Lack of Efficacy|2|||
131811836|NCT01518972|474593694|FG000|Overall Study|Transportation problems|1|||
131811837|NCT01518972|474593695|FG001|Overall Study|Transportation problems|0|||
131756139|NCT00643448|474383162|FG001|Overall Study|Lack of Efficacy|0|||
131756140|NCT00643448|474383163|FG002|Overall Study|Lack of Efficacy|4|||
131756141|NCT00643448|474383161|FG000|Overall Study|Adverse Event|2|||
131756142|NCT00643448|474383162|FG001|Overall Study|Adverse Event|2|||
131756143|NCT00643448|474383163|FG002|Overall Study|Adverse Event|2|||
131908582|NCT02147626|474952969|FG001|Overall Study|Lost to Follow-up|4|||
131756144|NCT00643448|474383161|FG000|Overall Study|QTcF>550 ms|0|||
131756145|NCT00643448|474383162|FG001|Overall Study|QTcF>550 ms|3|||
131756146|NCT00643448|474383163|FG002|Overall Study|QTcF>550 ms|0|||
131756147|NCT05166603|474383165|FG000|Overall Study|Withdrawal by Subject|68|||
131756148|NCT05166603|474383166|FG001|Overall Study|Withdrawal by Subject|0|||
131756149|NCT04507360|474384688|FG000|Week 1|Lost to Follow-up|0|||
131756150|NCT04507360|474384689|FG001|Week 1|Lost to Follow-up|0|||
131756151|NCT04507360|474384690|FG002|Week 1|Lost to Follow-up|0|||
131756152|NCT04507360|474384691|FG003|Week 1|Lost to Follow-up|0|||
131756153|NCT04507360|474384692|FG004|Week 1|Lost to Follow-up|0|||
131756154|NCT04507360|474384693|FG005|Week 1|Lost to Follow-up|0|||
131756155|NCT04507360|474384694|FG006|Week 1|Lost to Follow-up|0|||
131756156|NCT04507360|474384695|FG007|Week 1|Lost to Follow-up|0|||
131756157|NCT04507360|474384696|FG008|Week 1|Lost to Follow-up|72|||
131756158|NCT04507360|474384697|FG009|Week 1|Lost to Follow-up|22|||
131756159|NCT04507360|474384698|FG010|Week 1|Lost to Follow-up|10|||
131756160|NCT04507360|474384688|FG000|Week 2|Lost to Follow-up|0|||
131756161|NCT04507360|474384689|FG001|Week 2|Lost to Follow-up|0|||
131756162|NCT04507360|474384690|FG002|Week 2|Lost to Follow-up|0|||
131756163|NCT04507360|474384691|FG003|Week 2|Lost to Follow-up|0|||
131756164|NCT04507360|474384692|FG004|Week 2|Lost to Follow-up|0|||
131756165|NCT04507360|474384693|FG005|Week 2|Lost to Follow-up|0|||
131756166|NCT04507360|474384694|FG006|Week 2|Lost to Follow-up|0|||
131756167|NCT04507360|474384695|FG007|Week 2|Lost to Follow-up|0|||
131756168|NCT04507360|474384696|FG008|Week 2|Lost to Follow-up|121|||
131756169|NCT04507360|474384697|FG009|Week 2|Lost to Follow-up|85|||
131756170|NCT04507360|474384698|FG010|Week 2|Lost to Follow-up|82|||
131756171|NCT04507360|474384688|FG000|Week 3|Lost to Follow-up|0|||
131756172|NCT04507360|474384689|FG001|Week 3|Lost to Follow-up|0|||
131756173|NCT04507360|474384690|FG002|Week 3|Lost to Follow-up|0|||
131811838|NCT01518972|474593694|FG000|Overall Study|Exclusionary medical condition|1|||
131811839|NCT01518972|474593695|FG001|Overall Study|Exclusionary medical condition|0|||
131811840|NCT01518972|474593694|FG000|Overall Study|Missed safety visits|0|||
131811841|NCT01518972|474593695|FG001|Overall Study|Missed safety visits|1|||
131811842|NCT01518972|474593694|FG000|Overall Study|Exclusionary medication|0|||
131811843|NCT01518972|474593695|FG001|Overall Study|Exclusionary medication|1|||
131811844|NCT01518972|474593694|FG000|Overall Study|Declined medication starting on day 12|0|||
131811845|NCT01518972|474593695|FG001|Overall Study|Declined medication starting on day 12|1|||
131811846|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
131811847|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
131811848|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
131811849|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
131811850|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
131811851|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
131811852|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
131811853|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
131811854|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
131811855|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
131811856|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
131811857|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
131811858|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
131908583|NCT02147626|474952968|FG000|Overall Study|Pregnancy|1|||
131908584|NCT02147626|474952969|FG001|Overall Study|Pregnancy|2|||
131908585|NCT02147626|474952968|FG000|Overall Study|Withdrawal by Subject|0|||
131908586|NCT02147626|474952969|FG001|Overall Study|Withdrawal by Subject|1|||
131908587|NCT00572832|474952970|FG000|Overall Study|Lost to Follow-up|0|||
131908588|NCT00572832|474952971|FG001|Overall Study|Lost to Follow-up|11|||
131908589|NCT00572832|474952970|FG000|Overall Study|Pregnancy|0|||
131908590|NCT00572832|474952971|FG001|Overall Study|Pregnancy|1|||
131398660|NCT01951586|473081215|FG001|Overall Study|Lost to Follow-up|1|||
131756174|NCT04507360|474384691|FG003|Week 3|Lost to Follow-up|0|||
131908591|NCT03055936|474952975|FG000|Overall Study|Adverse Event|0|||
131756175|NCT04507360|474384692|FG004|Week 3|Lost to Follow-up|0|||
131756176|NCT04507360|474384693|FG005|Week 3|Lost to Follow-up|0|||
131756177|NCT04507360|474384694|FG006|Week 3|Lost to Follow-up|0|||
131756178|NCT04507360|474384695|FG007|Week 3|Lost to Follow-up|0|||
131811859|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
131811860|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
131908592|NCT03055936|474952976|FG001|Overall Study|Adverse Event|1|||
131756179|NCT04507360|474384696|FG008|Week 3|Lost to Follow-up|123|||
131756180|NCT04507360|474384697|FG009|Week 3|Lost to Follow-up|92|||
131756181|NCT04507360|474384698|FG010|Week 3|Lost to Follow-up|84|||
131756182|NCT04507360|474384688|FG000|Week 4|Lost to Follow-up|0|||
131756183|NCT04507360|474384689|FG001|Week 4|Lost to Follow-up|0|||
131811861|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
131811862|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
131811863|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
131811864|NCT01667679|474593696|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
131811865|NCT01667679|474593697|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
131811866|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
131811867|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
131811868|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
131811869|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
131756184|NCT04507360|474384690|FG002|Week 4|Lost to Follow-up|0|||
131756185|NCT04507360|474384691|FG003|Week 4|Lost to Follow-up|0|||
131756186|NCT04507360|474384692|FG004|Week 4|Lost to Follow-up|0|||
131756187|NCT04507360|474384693|FG005|Week 4|Lost to Follow-up|0|||
131756188|NCT04507360|474384694|FG006|Week 4|Lost to Follow-up|0|||
131756189|NCT04507360|474384695|FG007|Week 4|Lost to Follow-up|0|||
131756190|NCT04507360|474384696|FG008|Week 4|Lost to Follow-up|131|||
131756191|NCT04507360|474384697|FG009|Week 4|Lost to Follow-up|115|||
131756192|NCT04507360|474384698|FG010|Week 4|Lost to Follow-up|102|||
131756193|NCT04507360|474384688|FG000|Week 5|Lost to Follow-up|0|||
131756194|NCT04507360|474384689|FG001|Week 5|Lost to Follow-up|0|||
131756195|NCT04507360|474384690|FG002|Week 5|Lost to Follow-up|0|||
131756196|NCT04507360|474384691|FG003|Week 5|Lost to Follow-up|0|||
131756197|NCT04507360|474384692|FG004|Week 5|Lost to Follow-up|0|||
131756198|NCT04507360|474384693|FG005|Week 5|Lost to Follow-up|0|||
131756199|NCT04507360|474384694|FG006|Week 5|Lost to Follow-up|0|||
131756200|NCT04507360|474384695|FG007|Week 5|Lost to Follow-up|0|||
131756201|NCT04507360|474384696|FG008|Week 5|Lost to Follow-up|103|||
131756202|NCT04507360|474384697|FG009|Week 5|Lost to Follow-up|135|||
131756203|NCT04507360|474384698|FG010|Week 5|Lost to Follow-up|143|||
131756204|NCT04507360|474384688|FG000|Week 8|Lost to Follow-up|0|||
131756205|NCT04507360|474384689|FG001|Week 8|Lost to Follow-up|0|||
131756206|NCT04507360|474384690|FG002|Week 8|Lost to Follow-up|0|||
131756207|NCT04507360|474384691|FG003|Week 8|Lost to Follow-up|0|||
131756208|NCT04507360|474384692|FG004|Week 8|Lost to Follow-up|0|||
131756209|NCT04507360|474384693|FG005|Week 8|Lost to Follow-up|0|||
131756210|NCT04507360|474384694|FG006|Week 8|Lost to Follow-up|0|||
131756211|NCT04507360|474384695|FG007|Week 8|Lost to Follow-up|0|||
131756212|NCT04507360|474384696|FG008|Week 8|Lost to Follow-up|139|||
131756213|NCT04507360|474384697|FG009|Week 8|Lost to Follow-up|145|||
131756214|NCT04507360|474384698|FG010|Week 8|Lost to Follow-up|152|||
131756215|NCT01004159|474384699|FG000|Overall Study|Adverse Event|2|||
131756216|NCT01004159|474384699|FG000|Overall Study|Disease Progression|18|||
131756217|NCT03050307|474384703|FG000|Overall Study|Adverse Event|4|||
131756218|NCT03050307|474384704|FG001|Overall Study|Adverse Event|2|||
131756219|NCT03050307|474384703|FG000|Overall Study|Significant Protocol Deviation|0|||
131756220|NCT03050307|474384704|FG001|Overall Study|Significant Protocol Deviation|1|||
131756221|NCT03050307|474384703|FG000|Overall Study|Lost to Follow-up|0|||
131756222|NCT03050307|474384704|FG001|Overall Study|Lost to Follow-up|1|||
131756223|NCT03050307|474384703|FG000|Overall Study|Voluntary Withdrawal|3|||
131756224|NCT03050307|474384704|FG001|Overall Study|Voluntary Withdrawal|4|||
131756225|NCT03050307|474384703|FG000|Overall Study|Reason not Specified|1|||
131756226|NCT03050307|474384704|FG001|Overall Study|Reason not Specified|1|||
131756227|NCT02828644|474384707|FG000|Overall Study|Lost to Follow-up|23|||
131756228|NCT02828644|474384708|FG001|Overall Study|Lost to Follow-up|22|||
131756229|NCT01938391|474384709|FG000|6 Month Follow up|Withdrawal by Subject|1|||
131756230|NCT01938391|474384709|FG000|12 Month Follow up|Physician Decision|1|||
131756231|NCT01938391|474384709|FG000|12 Month Follow up|Withdrawal by Subject|1|||
131756232|NCT01077193|474384710|FG000|Overall Study|Lost to Follow-up|1|||
131756233|NCT01077193|474384710|FG000|Overall Study|Withdrawal by Subject|2|||
131756234|NCT01077193|474384710|FG000|Overall Study|Lack of Efficacy|1|||
131756235|NCT01077193|474384710|FG000|Overall Study|Study Terminated by Sponsor|40|||
131908593|NCT03055936|474952977|FG002|Overall Study|Adverse Event|1|||
131811870|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
131811871|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
131811872|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
131811873|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
131811874|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
131811875|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
131811876|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
131811877|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
131811878|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
131811879|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
131811880|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
131811881|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
131811882|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
131756264|NCT02352090|474384717|FG000|Overall Study|general malaise|1|||
131756265|NCT02352090|474384718|FG001|Overall Study|general malaise|0|||
131756266|NCT02352090|474384719|FG002|Overall Study|general malaise|0|||
131756267|NCT02352090|474384717|FG000|Overall Study|non-specified mild side-effects|0|||
131756268|NCT02352090|474384718|FG001|Overall Study|non-specified mild side-effects|0|||
131756269|NCT02352090|474384719|FG002|Overall Study|non-specified mild side-effects|2|||
131756270|NCT00911144|474384720|FG000|Overall Study|Withdrawal by Subject|16|||
131756271|NCT00911144|474384721|FG001|Overall Study|Withdrawal by Subject|5|||
131756272|NCT00981292|474384722|FG000|Day 1|Protocol Violation|1|||
131756273|NCT00981292|474384723|FG001|Day 1|Protocol Violation|0|||
131756274|NCT00981292|474384724|FG002|Day 1|Protocol Violation|0|||
131756275|NCT00981292|474384725|FG003|Day 1|Protocol Violation|0|||
131756276|NCT00981292|474384726|FG004|Day 1|Protocol Violation|0|||
131756277|NCT00981292|474384727|FG005|Day 1|Protocol Violation|2|||
131756278|NCT00981292|474384722|FG000|Day 2|Protocol Violation|2|||
131756279|NCT00981292|474384723|FG001|Day 2|Protocol Violation|0|||
131756280|NCT00981292|474384724|FG002|Day 2|Protocol Violation|0|||
131756281|NCT00981292|474384725|FG003|Day 2|Protocol Violation|0|||
131756282|NCT00981292|474384726|FG004|Day 2|Protocol Violation|0|||
131756283|NCT00981292|474384727|FG005|Day 2|Protocol Violation|0|||
131756284|NCT00981292|474384722|FG000|Day 3|Protocol Violation|0|||
131756285|NCT00981292|474384723|FG001|Day 3|Protocol Violation|0|||
131756286|NCT00981292|474384724|FG002|Day 3|Protocol Violation|0|||
131756287|NCT00981292|474384725|FG003|Day 3|Protocol Violation|0|||
131756288|NCT00981292|474384726|FG004|Day 3|Protocol Violation|0|||
131756289|NCT00981292|474384727|FG005|Day 3|Protocol Violation|1|||
131756290|NCT01849562|474384728|FG000|Overall Study|Lost to Follow-up|1|||
131756291|NCT01849562|474384729|FG001|Overall Study|Lost to Follow-up|0|||
131756292|NCT01849562|474384730|FG002|Overall Study|Lost to Follow-up|0|||
131756293|NCT01849562|474384728|FG000|Overall Study|Non-compliance with Study Drug|1|||
131756294|NCT01849562|474384729|FG001|Overall Study|Non-compliance with Study Drug|0|||
131756295|NCT01849562|474384730|FG002|Overall Study|Non-compliance with Study Drug|0|||
131756296|NCT01347073|474384731|FG000|Overall Study|Adverse Event|1|||
131756297|NCT01347073|474384731|FG000|Overall Study|Liver Transplant|1|||
131756298|NCT03236506|474384732|FG000|Overall Study|Death|1|||
131756299|NCT03236506|474384733|FG001|Overall Study|Death|1|||
131811883|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
131811884|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
131811885|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
131811886|NCT01667679|474593696|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
131811887|NCT01667679|474593697|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
131908594|NCT03055936|474952978|FG003|Overall Study|Adverse Event|1|||
131756300|NCT03236506|474384734|FG002|Overall Study|Death|1|||
131756301|NCT03236506|474384732|FG000|Overall Study|Withdrawal by Subject|3|||
131756302|NCT03236506|474384733|FG001|Overall Study|Withdrawal by Subject|3|||
131756303|NCT03236506|474384734|FG002|Overall Study|Withdrawal by Subject|4|||
131756304|NCT03236506|474384732|FG000|Overall Study|Did not initiate treatment|2|||
131756305|NCT03236506|474384733|FG001|Overall Study|Did not initiate treatment|1|||
131756306|NCT03236506|474384734|FG002|Overall Study|Did not initiate treatment|2|||
131756307|NCT01690988|474384737|FG000|Overall Study|Withdrawal by Subject|2|||
131756308|NCT01690988|474384738|FG001|Overall Study|Withdrawal by Subject|2|||
131756309|NCT01690988|474384739|FG002|Overall Study|Withdrawal by Subject|3|||
131756310|NCT01690988|474384737|FG000|Overall Study|Physician Decision|0|||
131756311|NCT01690988|474384738|FG001|Overall Study|Physician Decision|0|||
131756312|NCT01690988|474384739|FG002|Overall Study|Physician Decision|1|||
131756313|NCT01690988|474384737|FG000|Overall Study|Operation Cancelled|1|||
131756314|NCT01690988|474384738|FG001|Overall Study|Operation Cancelled|1|||
131756315|NCT01690988|474384739|FG002|Overall Study|Operation Cancelled|0|||
131756316|NCT01690988|474384737|FG000|Overall Study|Determined ineligible|1|||
131756317|NCT01690988|474384738|FG001|Overall Study|Determined ineligible|0|||
131756318|NCT01690988|474384739|FG002|Overall Study|Determined ineligible|0|||
131756319|NCT01690988|474384737|FG000|Overall Study|Death|1|||
131756320|NCT01690988|474384738|FG001|Overall Study|Death|1|||
131756321|NCT01690988|474384739|FG002|Overall Study|Death|1|||
131756322|NCT01690988|474384737|FG000|Overall Study|Sedated|1|||
131756323|NCT01690988|474384738|FG001|Overall Study|Sedated|1|||
131756324|NCT01690988|474384739|FG002|Overall Study|Sedated|2|||
131756325|NCT00372489|474384740|FG000|Overall Study|Adverse Event|18|||
131756326|NCT00372489|474384740|FG000|Overall Study|Lack of Efficacy|1|||
131756327|NCT00372489|474384740|FG000|Overall Study|Lost to Follow-up|3|||
131756328|NCT00372489|474384740|FG000|Overall Study|Physician Decision|3|||
131756329|NCT00372489|474384740|FG000|Overall Study|Withdrawal by Subject|5|||
131756330|NCT00372489|474384740|FG000|Overall Study|Patient Relocation|2|||
131756331|NCT00372489|474384740|FG000|Overall Study|Renal transplant|6|||
131756332|NCT00372489|474384740|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
131756333|NCT03696576|474384754|FG000|Overall Study|Soreness of throat after therapy|1|||
131756334|NCT03696576|474384755|FG001|Overall Study|Soreness of throat after therapy|1|||
131756335|NCT03696576|474384754|FG000|Overall Study|Lost to Follow-up|2|||
131756336|NCT03696576|474384755|FG001|Overall Study|Lost to Follow-up|4|||
131756337|NCT01634100|474384758|FG000|Overall Study|Withdrawal by Subject|1|||
131756338|NCT01634100|474384759|FG001|Overall Study|Withdrawal by Subject|0|||
131756339|NCT01634100|474384760|FG002|Overall Study|Withdrawal by Subject|1|||
131756340|NCT01634100|474384761|FG003|Overall Study|Withdrawal by Subject|0|||
131756341|NCT01634100|474384762|FG004|Overall Study|Withdrawal by Subject|0|||
131756342|NCT01634100|474384763|FG005|Overall Study|Withdrawal by Subject|0|||
131756343|NCT00552344|474384764|FG000|Overall Study|Lack of Efficacy|55|||
131756344|NCT00552344|474384764|FG000|Overall Study|Loss of efficacy|75|||
131756345|NCT00552344|474384764|FG000|Overall Study|Lost to Follow-up|8|||
131756346|NCT00552344|474384764|FG000|Overall Study|Withdrawal by Subject|48|||
131756347|NCT00552344|474384764|FG000|Overall Study|SAE, non-fatal|6|||
131756348|NCT00552344|474384764|FG000|Overall Study|AE, non-serious non-fatal|38|||
131756349|NCT00552344|474384764|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
131756350|NCT00552344|474384764|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
131756351|NCT00552344|474384764|FG000|Overall Study|Other Reason|22|||
131756352|NCT01662986|474384767|FG000|Overall Study|Adverse Event|5|||
131756353|NCT01662986|474384768|FG001|Overall Study|Adverse Event|4|||
131756354|NCT01662986|474384767|FG000|Overall Study|Protocol Violation|2|||
131756355|NCT01662986|474384768|FG001|Overall Study|Protocol Violation|3|||
131756356|NCT01662986|474384767|FG000|Overall Study|Lost to Follow-up|5|||
131756357|NCT01662986|474384768|FG001|Overall Study|Lost to Follow-up|4|||
131756358|NCT01662986|474384767|FG000|Overall Study|Withdrawal by Subject|2|||
131756359|NCT01662986|474384768|FG001|Overall Study|Withdrawal by Subject|2|||
131756360|NCT01662986|474384767|FG000|Overall Study|Not Treated|1|||
131756361|NCT01662986|474384768|FG001|Overall Study|Not Treated|0|||
131756362|NCT01662986|474384767|FG000|Overall Study|Other than stated above|3|||
131756363|NCT01662986|474384768|FG001|Overall Study|Other than stated above|0|||
131756364|NCT02343952|474384778|FG000|Study Treatment|Disease Progression|23|||
131756365|NCT02343952|474384778|FG000|Study Treatment|Death|3|||
131756366|NCT02343952|474384778|FG000|Study Treatment|Adverse Event|19|||
131756367|NCT02343952|474384778|FG000|Study Treatment|Withdrawal by Subject|7|||
131756368|NCT02343952|474384778|FG000|Study Treatment|other complicating Diseases|1|||
131756369|NCT02343952|474384778|FG000|Follow up|Withdrawal by Subject|3|||
131756370|NCT02343952|474384778|FG000|Follow up|Death|33|||
131756371|NCT02343952|474384778|FG000|Follow up|Patient does not meet eligibility for study.|1|||
131756372|NCT02343952|474384778|FG000|Follow up|Research department closed by the practice.|5|||
131756373|NCT02343952|474384778|FG000|Follow up|Patient went home to Russia|1|||
131756374|NCT02343952|474384778|FG000|Follow up|Disease Progression|1|||
131756375|NCT02343952|474384778|FG000|Follow up|study terminated|1|||
131756376|NCT00845845|474384782|FG000|Overall Study|Lost to Follow-up|0|||
131756377|NCT00845845|474384783|FG001|Overall Study|Lost to Follow-up|4|||
131756378|NCT02033850|474384785|FG000|Overall Study|Death|1|||
131756379|NCT02033850|474384786|FG001|Overall Study|Death|0|||
131756380|NCT02033850|474384785|FG000|Overall Study|unrelated medical reason|1|||
131756381|NCT02033850|474384786|FG001|Overall Study|unrelated medical reason|1|||
131756382|NCT02820038|474384787|FG000|Overall Study|Lost to Follow-up|7|||
131756383|NCT02820038|474384788|FG001|Overall Study|Lost to Follow-up|11|||
131756384|NCT02820038|474384789|FG002|Overall Study|Lost to Follow-up|2|||
131756385|NCT02820038|474384790|FG003|Overall Study|Lost to Follow-up|9|||
131756386|NCT02820038|474384787|FG000|Overall Study|Withdrawal by Subject|3|||
131756387|NCT02820038|474384788|FG001|Overall Study|Withdrawal by Subject|14|||
131756388|NCT02820038|474384789|FG002|Overall Study|Withdrawal by Subject|3|||
131756389|NCT02820038|474384790|FG003|Overall Study|Withdrawal by Subject|13|||
131756390|NCT00033371|474384791|FG000|Overall Study|Adverse Event|1|||
131756391|NCT00033371|474384792|FG001|Overall Study|Adverse Event|5|||
131756392|NCT00033371|474384791|FG000|Overall Study|Lost to Follow-up|2|||
131756393|NCT00033371|474384792|FG001|Overall Study|Lost to Follow-up|1|||
131756394|NCT00033371|474384791|FG000|Overall Study|Withdrawal by Subject|3|||
131756395|NCT00033371|474384792|FG001|Overall Study|Withdrawal by Subject|3|||
131756396|NCT00033371|474384791|FG000|Overall Study|Disease Progression|0|||
131756397|NCT00033371|474384792|FG001|Overall Study|Disease Progression|1|||
131756398|NCT03799627|474384793|FG000|Overall Study|Adverse Event|1|||
131756399|NCT03799627|474384794|FG001|Overall Study|Adverse Event|2|||
131756400|NCT03799627|474384795|FG002|Overall Study|Adverse Event|0|||
131756401|NCT03799627|474384796|FG003|Overall Study|Adverse Event|0|||
131756402|NCT03799627|474384797|FG004|Overall Study|Adverse Event|2|||
131756403|NCT03799627|474384798|FG005|Overall Study|Adverse Event|5|||
131756404|NCT03799627|474384799|FG006|Overall Study|Adverse Event|0|||
131756405|NCT03799627|474384800|FG007|Overall Study|Adverse Event|2|||
131756406|NCT03799627|474384801|FG008|Overall Study|Adverse Event|0|||
131756407|NCT03799627|474384793|FG000|Overall Study|Physician Decision|2|||
131756408|NCT03799627|474384794|FG001|Overall Study|Physician Decision|2|||
131756409|NCT03799627|474384795|FG002|Overall Study|Physician Decision|0|||
131756410|NCT03799627|474384796|FG003|Overall Study|Physician Decision|0|||
131756411|NCT03799627|474384797|FG004|Overall Study|Physician Decision|2|||
131756412|NCT03799627|474384798|FG005|Overall Study|Physician Decision|2|||
131756413|NCT03799627|474384799|FG006|Overall Study|Physician Decision|0|||
131756414|NCT03799627|474384800|FG007|Overall Study|Physician Decision|0|||
131756415|NCT03799627|474384801|FG008|Overall Study|Physician Decision|0|||
131756416|NCT03799627|474384793|FG000|Overall Study|Withdrawal by Subject|1|||
131756417|NCT03799627|474384794|FG001|Overall Study|Withdrawal by Subject|1|||
131756418|NCT03799627|474384795|FG002|Overall Study|Withdrawal by Subject|0|||
131756419|NCT03799627|474384796|FG003|Overall Study|Withdrawal by Subject|2|||
131756420|NCT03799627|474384797|FG004|Overall Study|Withdrawal by Subject|0|||
131756421|NCT03799627|474384798|FG005|Overall Study|Withdrawal by Subject|3|||
131756422|NCT03799627|474384799|FG006|Overall Study|Withdrawal by Subject|0|||
131756423|NCT03799627|474384800|FG007|Overall Study|Withdrawal by Subject|0|||
131756424|NCT03799627|474384801|FG008|Overall Study|Withdrawal by Subject|0|||
131756425|NCT03799627|474384793|FG000|Overall Study|Lack of Efficacy|0|||
131756426|NCT03799627|474384794|FG001|Overall Study|Lack of Efficacy|0|||
131756427|NCT03799627|474384795|FG002|Overall Study|Lack of Efficacy|0|||
131756428|NCT03799627|474384796|FG003|Overall Study|Lack of Efficacy|1|||
131756429|NCT03799627|474384797|FG004|Overall Study|Lack of Efficacy|0|||
131756430|NCT03799627|474384798|FG005|Overall Study|Lack of Efficacy|0|||
131756431|NCT03799627|474384799|FG006|Overall Study|Lack of Efficacy|0|||
131756432|NCT03799627|474384800|FG007|Overall Study|Lack of Efficacy|0|||
131756433|NCT03799627|474384801|FG008|Overall Study|Lack of Efficacy|0|||
131756434|NCT03799627|474384793|FG000|Overall Study|Lost to Follow-up|0|||
131756435|NCT03799627|474384794|FG001|Overall Study|Lost to Follow-up|0|||
131756436|NCT03799627|474384795|FG002|Overall Study|Lost to Follow-up|0|||
131756437|NCT03799627|474384796|FG003|Overall Study|Lost to Follow-up|0|||
131756438|NCT03799627|474384797|FG004|Overall Study|Lost to Follow-up|0|||
131756439|NCT03799627|474384798|FG005|Overall Study|Lost to Follow-up|0|||
131756440|NCT03799627|474384799|FG006|Overall Study|Lost to Follow-up|1|||
131756441|NCT03799627|474384800|FG007|Overall Study|Lost to Follow-up|0|||
131756442|NCT03799627|474384801|FG008|Overall Study|Lost to Follow-up|1|||
131756443|NCT03799627|474384793|FG000|Overall Study|Death|0|||
131756444|NCT03799627|474384794|FG001|Overall Study|Death|0|||
131756445|NCT03799627|474384795|FG002|Overall Study|Death|0|||
131756446|NCT03799627|474384796|FG003|Overall Study|Death|1|||
131756447|NCT03799627|474384797|FG004|Overall Study|Death|0|||
131756448|NCT03799627|474384798|FG005|Overall Study|Death|0|||
131756449|NCT03799627|474384799|FG006|Overall Study|Death|0|||
131756450|NCT03799627|474384800|FG007|Overall Study|Death|0|||
131756451|NCT03799627|474384801|FG008|Overall Study|Death|0|||
131756452|NCT03799627|474384793|FG000|Overall Study|Study Drug Put on Hold|1|||
131756453|NCT03799627|474384794|FG001|Overall Study|Study Drug Put on Hold|0|||
131756454|NCT03799627|474384795|FG002|Overall Study|Study Drug Put on Hold|0|||
131756455|NCT03799627|474384796|FG003|Overall Study|Study Drug Put on Hold|0|||
131756456|NCT03799627|474384797|FG004|Overall Study|Study Drug Put on Hold|0|||
131756457|NCT03799627|474384798|FG005|Overall Study|Study Drug Put on Hold|0|||
131756458|NCT03799627|474384799|FG006|Overall Study|Study Drug Put on Hold|0|||
131811888|NCT02159183|474593698|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
131756459|NCT03799627|474384800|FG007|Overall Study|Study Drug Put on Hold|0|||
131756460|NCT03799627|474384801|FG008|Overall Study|Study Drug Put on Hold|0|||
131756461|NCT03799627|474384793|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
131756462|NCT03799627|474384794|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
131756463|NCT03799627|474384795|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
131756464|NCT03799627|474384796|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
131756465|NCT03799627|474384797|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
131756466|NCT03799627|474384798|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
131811889|NCT02159183|474593699|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
131756467|NCT03799627|474384799|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
131756468|NCT03799627|474384800|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
131756469|NCT03799627|474384801|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
131756470|NCT03799627|474384793|FG000|Overall Study|Kidney Transplantation|1|||
131756471|NCT03799627|474384794|FG001|Overall Study|Kidney Transplantation|0|||
131756472|NCT03799627|474384795|FG002|Overall Study|Kidney Transplantation|0|||
131756473|NCT03799627|474384796|FG003|Overall Study|Kidney Transplantation|1|||
131756474|NCT03799627|474384797|FG004|Overall Study|Kidney Transplantation|1|||
131756475|NCT03799627|474384798|FG005|Overall Study|Kidney Transplantation|0|||
131756476|NCT03799627|474384799|FG006|Overall Study|Kidney Transplantation|0|||
131756477|NCT03799627|474384800|FG007|Overall Study|Kidney Transplantation|0|||
131756478|NCT03799627|474384801|FG008|Overall Study|Kidney Transplantation|0|||
131756479|NCT03799627|474384793|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
131756480|NCT03799627|474384794|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
131756481|NCT03799627|474384795|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
131756482|NCT03799627|474384796|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
131756483|NCT03799627|474384797|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
131756484|NCT03799627|474384798|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
131756485|NCT03799627|474384799|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
131756486|NCT03799627|474384800|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
131756487|NCT03799627|474384801|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
131756488|NCT03799627|474384793|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756489|NCT03799627|474384794|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
131756490|NCT03799627|474384795|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756491|NCT03799627|474384796|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756492|NCT03799627|474384797|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756493|NCT03799627|474384798|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756494|NCT03799627|474384799|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756495|NCT03799627|474384800|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756496|NCT03799627|474384801|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131756497|NCT03799627|474384793|FG000|Overall Study|Met Exclusion Criteria|0|||
131756498|NCT03799627|474384794|FG001|Overall Study|Met Exclusion Criteria|0|||
131756499|NCT03799627|474384795|FG002|Overall Study|Met Exclusion Criteria|0|||
131756500|NCT03799627|474384796|FG003|Overall Study|Met Exclusion Criteria|1|||
131756501|NCT03799627|474384797|FG004|Overall Study|Met Exclusion Criteria|0|||
131756502|NCT03799627|474384798|FG005|Overall Study|Met Exclusion Criteria|0|||
131756503|NCT03799627|474384799|FG006|Overall Study|Met Exclusion Criteria|0|||
131756504|NCT03799627|474384800|FG007|Overall Study|Met Exclusion Criteria|0|||
131756505|NCT03799627|474384801|FG008|Overall Study|Met Exclusion Criteria|0|||
131756506|NCT03799627|474384793|FG000|Overall Study|Investigational Product Noncompliance|0|||
131756507|NCT03799627|474384794|FG001|Overall Study|Investigational Product Noncompliance|0|||
131756508|NCT03799627|474384795|FG002|Overall Study|Investigational Product Noncompliance|0|||
131756509|NCT03799627|474384796|FG003|Overall Study|Investigational Product Noncompliance|1|||
131756510|NCT03799627|474384797|FG004|Overall Study|Investigational Product Noncompliance|0|||
131756511|NCT03799627|474384798|FG005|Overall Study|Investigational Product Noncompliance|0|||
131756512|NCT03799627|474384799|FG006|Overall Study|Investigational Product Noncompliance|0|||
131756513|NCT03799627|474384800|FG007|Overall Study|Investigational Product Noncompliance|0|||
131756514|NCT03799627|474384801|FG008|Overall Study|Investigational Product Noncompliance|0|||
131756515|NCT03799627|474384793|FG000|Overall Study|Participant Relocation|0|||
131756516|NCT03799627|474384794|FG001|Overall Study|Participant Relocation|0|||
131756517|NCT03799627|474384795|FG002|Overall Study|Participant Relocation|0|||
131756518|NCT03799627|474384796|FG003|Overall Study|Participant Relocation|1|||
131756519|NCT03799627|474384797|FG004|Overall Study|Participant Relocation|0|||
131756520|NCT03799627|474384798|FG005|Overall Study|Participant Relocation|1|||
131811890|NCT02159183|474593698|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
131811891|NCT02159183|474593699|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
131811892|NCT02159183|474593698|FG000|Analysis After the 36 Months Follow-up|Death|0|||
131756521|NCT03799627|474384799|FG006|Overall Study|Participant Relocation|0|||
131756522|NCT03799627|474384800|FG007|Overall Study|Participant Relocation|0|||
131756523|NCT03799627|474384801|FG008|Overall Study|Participant Relocation|0|||
131756524|NCT03799627|474384793|FG000|Overall Study|Eurofin Issue|0|||
131756525|NCT03799627|474384794|FG001|Overall Study|Eurofin Issue|0|||
131756526|NCT03799627|474384795|FG002|Overall Study|Eurofin Issue|0|||
131756527|NCT03799627|474384796|FG003|Overall Study|Eurofin Issue|0|||
131756528|NCT03799627|474384797|FG004|Overall Study|Eurofin Issue|1|||
131756529|NCT03799627|474384798|FG005|Overall Study|Eurofin Issue|0|||
131756530|NCT03799627|474384799|FG006|Overall Study|Eurofin Issue|0|||
131756531|NCT03799627|474384800|FG007|Overall Study|Eurofin Issue|0|||
131756532|NCT03799627|474384801|FG008|Overall Study|Eurofin Issue|0|||
131756533|NCT03799627|474384793|FG000|Overall Study|Noncompliance with Site Instructions|0|||
131811893|NCT02159183|474593699|FG001|Analysis After the 36 Months Follow-up|Death|1|||
131908595|NCT03055936|474952975|FG000|Overall Study|Personal reason|2|||
131756534|NCT03799627|474384794|FG001|Overall Study|Noncompliance with Site Instructions|0|||
131756535|NCT03799627|474384795|FG002|Overall Study|Noncompliance with Site Instructions|0|||
131756536|NCT03799627|474384796|FG003|Overall Study|Noncompliance with Site Instructions|0|||
131756537|NCT03799627|474384797|FG004|Overall Study|Noncompliance with Site Instructions|1|||
131756538|NCT03799627|474384798|FG005|Overall Study|Noncompliance with Site Instructions|0|||
131756539|NCT03799627|474384799|FG006|Overall Study|Noncompliance with Site Instructions|0|||
131756540|NCT03799627|474384800|FG007|Overall Study|Noncompliance with Site Instructions|0|||
131756541|NCT03799627|474384801|FG008|Overall Study|Noncompliance with Site Instructions|0|||
131756542|NCT03799627|474384793|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756543|NCT03799627|474384794|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756544|NCT03799627|474384795|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756545|NCT03799627|474384796|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756546|NCT03799627|474384797|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
131756547|NCT03799627|474384798|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756548|NCT03799627|474384799|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756549|NCT03799627|474384800|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756550|NCT03799627|474384801|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131756551|NCT03799627|474384793|FG000|Overall Study|Changes In Hemoglobin Values|1|||
131756552|NCT03799627|474384794|FG001|Overall Study|Changes In Hemoglobin Values|2|||
131756553|NCT03799627|474384795|FG002|Overall Study|Changes In Hemoglobin Values|1|||
131756554|NCT03799627|474384796|FG003|Overall Study|Changes In Hemoglobin Values|0|||
131756555|NCT03799627|474384797|FG004|Overall Study|Changes In Hemoglobin Values|0|||
131756556|NCT03799627|474384798|FG005|Overall Study|Changes In Hemoglobin Values|2|||
131756557|NCT03799627|474384799|FG006|Overall Study|Changes In Hemoglobin Values|1|||
131756558|NCT03799627|474384800|FG007|Overall Study|Changes In Hemoglobin Values|0|||
131756559|NCT03799627|474384801|FG008|Overall Study|Changes In Hemoglobin Values|1|||
131756560|NCT02092324|474384806|FG000|Overall Study|Adverse Event|1|||
131756561|NCT02092324|474384806|FG000|Overall Study|Lack of Efficacy|6|||
131756562|NCT02092324|474384806|FG000|Overall Study|Proceed to Transplant|3|||
131756563|NCT02092324|474384806|FG000|Overall Study|Physician Decision|7|||
131756564|NCT02092324|474384806|FG000|Overall Study|Misdiagnosis|2|||
131756565|NCT01922739|474384807|FG000|Titration/Adjustment Period|Adverse Event|3|||
131756566|NCT01922739|474384807|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
131756567|NCT01922739|474384807|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
131756568|NCT01922739|474384807|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
131756569|NCT01922739|474384807|FG000|Open-label Treatment Period|Adverse Event|6|||
131756570|NCT01922739|474384807|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
131756571|NCT01922739|474384807|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
131756572|NCT01922739|474384807|FG000|Open-label Treatment Period|Protocol Violation|5|||
131756573|NCT01922739|474384807|FG000|Open-label Treatment Period|Pregnancy|1|||
131811894|NCT02159183|474593698|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
131811895|NCT02159183|474593699|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
131811896|NCT02159183|474593698|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
131811897|NCT02159183|474593699|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
131811898|NCT03084471|474593706|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
131811899|NCT03084471|474593706|FG000|Overall Study|Condition under investigation worsened|84|||
131811900|NCT03084471|474593706|FG000|Overall Study|Lack of therapeutic response|2|||
131811901|NCT03084471|474593706|FG000|Overall Study|Protocol Violation|1|||
131811902|NCT03084471|474593706|FG000|Overall Study|Adverse Event|73|||
131811903|NCT03084471|474593706|FG000|Overall Study|Withdrawal by Subject|12|||
131811904|NCT03084471|474593706|FG000|Overall Study|Disease relapse|181|||
131811905|NCT03084471|474593706|FG000|Overall Study|Subjective disease progression|359|||
131811906|NCT03084471|474593706|FG000|Overall Study|Other (as recorded)|33|||
131811907|NCT03084471|474593706|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
131811908|NCT00505622|474593707|FG000|Overall Study|Adverse Event|5|||
131811909|NCT00505622|474593708|FG001|Overall Study|Adverse Event|6|||
131811910|NCT00505622|474593709|FG002|Overall Study|Adverse Event|4|||
131811911|NCT00505622|474593707|FG000|Overall Study|Protocol Violation|1|||
131811912|NCT00505622|474593708|FG001|Overall Study|Protocol Violation|1|||
131811913|NCT00505622|474593709|FG002|Overall Study|Protocol Violation|0|||
131811914|NCT00505622|474593707|FG000|Overall Study|Withdrawal by Subject|0|||
131756574|NCT01922739|474384807|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
131756575|NCT01922739|474384807|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
131756576|NCT01922739|474384807|FG000|Open-label Treatment Period|Physician Decision|1|||
131811915|NCT00505622|474593708|FG001|Overall Study|Withdrawal by Subject|3|||
131811916|NCT00505622|474593709|FG002|Overall Study|Withdrawal by Subject|2|||
131811917|NCT00505622|474593707|FG000|Overall Study|Study termination by sponsor|115|||
131811918|NCT00505622|474593708|FG001|Overall Study|Study termination by sponsor|98|||
131811919|NCT00505622|474593709|FG002|Overall Study|Study termination by sponsor|90|||
131908596|NCT03055936|474952976|FG001|Overall Study|Personal reason|0|||
131756577|NCT01922739|474384807|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
131811920|NCT00796653|474593710|FG000|Overall Study|Adverse Event|19|||
131811921|NCT00796653|474593711|FG001|Overall Study|Adverse Event|16|||
131811922|NCT00796653|474593712|FG002|Overall Study|Adverse Event|16|||
131811923|NCT00796653|474593713|FG003|Overall Study|Adverse Event|16|||
131811924|NCT00796653|474593710|FG000|Overall Study|Lost to Follow-up|2|||
131811925|NCT00796653|474593711|FG001|Overall Study|Lost to Follow-up|1|||
131811926|NCT00796653|474593712|FG002|Overall Study|Lost to Follow-up|2|||
131811927|NCT00796653|474593713|FG003|Overall Study|Lost to Follow-up|3|||
131811928|NCT00796653|474593710|FG000|Overall Study|Withdrawal by Subject|16|||
131811929|NCT00796653|474593711|FG001|Overall Study|Withdrawal by Subject|8|||
131811930|NCT00796653|474593712|FG002|Overall Study|Withdrawal by Subject|8|||
131811931|NCT00796653|474593713|FG003|Overall Study|Withdrawal by Subject|13|||
131811932|NCT00796653|474593710|FG000|Overall Study|Lack of Efficacy|8|||
131811933|NCT00796653|474593711|FG001|Overall Study|Lack of Efficacy|1|||
131811934|NCT00796653|474593712|FG002|Overall Study|Lack of Efficacy|3|||
131811935|NCT00796653|474593713|FG003|Overall Study|Lack of Efficacy|2|||
131811936|NCT00796653|474593710|FG000|Overall Study|Non compliance with protocol|2|||
131811937|NCT00796653|474593711|FG001|Overall Study|Non compliance with protocol|2|||
131811938|NCT00796653|474593712|FG002|Overall Study|Non compliance with protocol|0|||
131811939|NCT00796653|474593713|FG003|Overall Study|Non compliance with protocol|2|||
131811940|NCT00796653|474593710|FG000|Overall Study|Other reason not described above|4|||
131811941|NCT00796653|474593711|FG001|Overall Study|Other reason not described above|9|||
131811942|NCT00796653|474593712|FG002|Overall Study|Other reason not described above|7|||
131811943|NCT00796653|474593713|FG003|Overall Study|Other reason not described above|4|||
131811944|NCT01757392|474593722|FG000|Overall Study|Withdrawal by Subject|1|||
131811945|NCT01757392|474593722|FG000|Overall Study|Screen Fail|3|||
131811946|NCT00207090|474593727|FG000|Overall Study|Study drug toxicity|3|||
131811947|NCT00207090|474593727|FG000|Overall Study|Chest wall mass larger|1|||
131811948|NCT00207090|474593727|FG000|Overall Study|Disease progression/relapse|2|||
131811949|NCT00207090|474593727|FG000|Overall Study|Physician Decision|1|||
131811950|NCT00841698|474593730|FG000|First Intervention|Withdrawal by Subject|1|||
131811951|NCT00841698|474593731|FG001|First Intervention|Withdrawal by Subject|0|||
131811952|NCT00185458|474593734|FG000|Contraception Phase|Adverse Event|37|||
131811953|NCT00185458|474593734|FG000|Contraception Phase|Lost to Follow-up|10|||
131811954|NCT00185458|474593734|FG000|Contraception Phase|Protocol Violation|2|||
131756578|NCT00441012|474384808|FG000|Overall Study|Adverse Event|0|||
131756579|NCT00441012|474384809|FG001|Overall Study|Adverse Event|1|||
131756580|NCT00441012|474384808|FG000|Overall Study|Lost to Follow-up|3|||
131756581|NCT00441012|474384809|FG001|Overall Study|Lost to Follow-up|3|||
131756582|NCT00441012|474384808|FG000|Overall Study|Protocol Violation|10|||
131756583|NCT00441012|474384809|FG001|Overall Study|Protocol Violation|9|||
131756584|NCT00441012|474384808|FG000|Overall Study|Withdrawal by Subject|4|||
131756585|NCT00441012|474384809|FG001|Overall Study|Withdrawal by Subject|0|||
131756586|NCT00441012|474384808|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
131756587|NCT00441012|474384809|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
131756588|NCT00262314|474384814|FG000|Overall Study|Changing physicians|38|||
131756589|NCT00262314|474384814|FG000|Overall Study|Death|12|||
131756590|NCT00262314|474384814|FG000|Overall Study|Patient's decision|92|||
131756591|NCT00262314|474384814|FG000|Overall Study|Other|95|||
131756592|NCT00262314|474384814|FG000|Overall Study|Lost to Follow-up|70|||
131756593|NCT00262314|474384814|FG000|Overall Study|Administrative withdrawal|30|||
131756594|NCT05104749|474384815|FG000|Overall Study|Lost to Follow-up|2|||
131811955|NCT00185458|474593734|FG000|Contraception Phase|Physician Decision|2|||
131811956|NCT00185458|474593734|FG000|Contraception Phase|Withdrawal by Subject|7|||
131811957|NCT00185458|474593734|FG000|HRT Phase|Adverse Event|18|||
131811958|NCT00185458|474593734|FG000|HRT Phase|Lost to Follow-up|4|||
131811959|NCT00185458|474593734|FG000|HRT Phase|Protocol Violation|2|||
131811960|NCT00185458|474593734|FG000|HRT Phase|Withdrawal by Subject|3|||
131811961|NCT00251979|474593735|FG000|Overall Study|Protocol Violation|3|||
131756595|NCT05104749|474384816|FG001|Overall Study|Lost to Follow-up|3|||
131756596|NCT03964493|474384817|FG000|Overall Study|Withdrawal by Subject|4|||
131756597|NCT03964493|474384818|FG001|Overall Study|Withdrawal by Subject|1|||
131756598|NCT03964493|474384817|FG000|Overall Study|Lost to Follow-up|13|||
131756599|NCT03964493|474384818|FG001|Overall Study|Lost to Follow-up|4|||
131756600|NCT02470429|474384819|FG000|Overall Study|Adverse Event|1|||
131811962|NCT00251979|474593736|FG001|Overall Study|Protocol Violation|5|||
131811963|NCT00251979|474593735|FG000|Overall Study|Adverse Event|11|||
131811964|NCT00251979|474593736|FG001|Overall Study|Adverse Event|17|||
131811965|NCT00251979|474593735|FG000|Overall Study|Withdrawal by Subject|13|||
131811966|NCT00251979|474593736|FG001|Overall Study|Withdrawal by Subject|7|||
131811967|NCT00251979|474593735|FG000|Overall Study|Lost to Follow-up|8|||
131811968|NCT00251979|474593736|FG001|Overall Study|Lost to Follow-up|6|||
131811969|NCT00251979|474593735|FG000|Overall Study|Death|3|||
131811970|NCT00251979|474593736|FG001|Overall Study|Death|5|||
131811971|NCT01302548|474593741|FG000|Overall Study|Lost to Follow-up|2|||
131811972|NCT01302548|474593742|FG001|Overall Study|Lost to Follow-up|1|||
131811973|NCT01249651|474593744|FG000|Overall Study|Withdrawal by Subject|4|||
131756601|NCT02470429|474384820|FG001|Overall Study|Adverse Event|0|||
131756602|NCT02470429|474384819|FG000|Overall Study|Withdrawal by Subject|1|||
131756603|NCT02470429|474384820|FG001|Overall Study|Withdrawal by Subject|0|||
131756604|NCT00901394|474384821|FG000|Overall Study|Physician Decision|1|||
131756605|NCT00901394|474384822|FG001|Overall Study|Physician Decision|1|||
131756606|NCT00901394|474384823|FG002|Overall Study|Physician Decision|2|||
131756607|NCT03277794|474384831|FG000|Overall Study|Lost to Follow-up|2|||
131756608|NCT03277794|474384832|FG001|Overall Study|Lost to Follow-up|4|||
131756609|NCT03277794|474384831|FG000|Overall Study|Withdrew due to high acuity|1|||
131756610|NCT03277794|474384832|FG001|Overall Study|Withdrew due to high acuity|0|||
131756611|NCT03039569|474384837|FG000|Overall Study|Lost to Follow-up|5|||
131756612|NCT03039569|474384838|FG001|Overall Study|Lost to Follow-up|4|||
131756613|NCT01167153|474384839|FG000|Overall Study|Non-effective therapy|1|||
131756614|NCT01167153|474384840|FG001|Overall Study|Non-effective therapy|4|||
131756615|NCT01167153|474384839|FG000|Overall Study|AE including clinical laboratory AE|2|||
131756616|NCT01167153|474384840|FG001|Overall Study|AE including clinical laboratory AE|8|||
131756617|NCT01167153|474384839|FG000|Overall Study|Hypotension|1|||
131756618|NCT01167153|474384840|FG001|Overall Study|Hypotension|0|||
131756619|NCT01167153|474384839|FG000|Overall Study|Lost to Follow-up|7|||
131756620|NCT01167153|474384840|FG001|Overall Study|Lost to Follow-up|9|||
131756621|NCT01167153|474384839|FG000|Overall Study|Non-compliance to concomitant medication|0|||
131756622|NCT01167153|474384840|FG001|Overall Study|Non-compliance to concomitant medication|2|||
131756623|NCT01167153|474384839|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
131756624|NCT01167153|474384840|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
131756625|NCT01167153|474384839|FG000|Overall Study|Withdrawal consent|1|||
131756626|NCT01167153|474384840|FG001|Overall Study|Withdrawal consent|1|||
131756627|NCT01167153|474384839|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
131756628|NCT01167153|474384840|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
131756629|NCT00444951|474386458|FG000|Overall Study|Lost to Follow-up|1|||
131756630|NCT00444951|474386459|FG001|Overall Study|Lost to Follow-up|1|||
131756631|NCT00444951|474386460|FG002|Overall Study|Lost to Follow-up|0|||
131756632|NCT00444951|474386458|FG000|Overall Study|Withdrawal by Subject|4|||
131756633|NCT00444951|474386459|FG001|Overall Study|Withdrawal by Subject|5|||
131756634|NCT00444951|474386460|FG002|Overall Study|Withdrawal by Subject|3|||
131756635|NCT02996110|474386469|FG000|Pre-Treatment|Other Reasons|0|||
131756636|NCT02996110|474386470|FG001|Pre-Treatment|Other Reasons|1|||
131756637|NCT02996110|474386471|FG002|Pre-Treatment|Other Reasons|0|||
131756638|NCT02996110|474386472|FG003|Pre-Treatment|Other Reasons|0|||
131756639|NCT02996110|474386473|FG004|Pre-Treatment|Other Reasons|1|||
131756640|NCT02996110|474386469|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
131756641|NCT02996110|474386470|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
131756642|NCT02996110|474386471|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
131756643|NCT02996110|474386472|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
131756644|NCT02996110|474386473|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
131756645|NCT02996110|474386469|FG000|Track 1|Disease Progression|15|||
131756646|NCT02996110|474386470|FG001|Track 1|Disease Progression|17|||
131756647|NCT02996110|474386471|FG002|Track 1|Disease Progression|0|||
131756648|NCT02996110|474386472|FG003|Track 1|Disease Progression|0|||
131756649|NCT02996110|474386473|FG004|Track 1|Disease Progression|0|||
131756650|NCT02996110|474386469|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
131756651|NCT02996110|474386470|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
131756652|NCT02996110|474386471|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
131756653|NCT02996110|474386472|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
131756654|NCT02996110|474386473|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
131398661|NCT01951586|473081214|FG000|Overall Study|Sponsor Decision|9|||
131398662|NCT01951586|473081215|FG001|Overall Study|Sponsor Decision|10|||
131756655|NCT02996110|474386469|FG000|Track 1|Study Drug Toxicity|5|||
131756656|NCT02996110|474386470|FG001|Track 1|Study Drug Toxicity|3|||
131756657|NCT02996110|474386471|FG002|Track 1|Study Drug Toxicity|0|||
131756658|NCT02996110|474386472|FG003|Track 1|Study Drug Toxicity|0|||
131756659|NCT02996110|474386473|FG004|Track 1|Study Drug Toxicity|0|||
131756660|NCT02996110|474386469|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
131756661|NCT02996110|474386470|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131756662|NCT02996110|474386471|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131756663|NCT02996110|474386472|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131756664|NCT02996110|474386473|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131756665|NCT02996110|474386469|FG000|Track 1|Administrative Reason by Sponsor|0|||
131756666|NCT02996110|474386470|FG001|Track 1|Administrative Reason by Sponsor|1|||
131756667|NCT02996110|474386471|FG002|Track 1|Administrative Reason by Sponsor|0|||
131756668|NCT02996110|474386472|FG003|Track 1|Administrative Reason by Sponsor|0|||
131756669|NCT02996110|474386473|FG004|Track 1|Administrative Reason by Sponsor|0|||
131756670|NCT02996110|474386469|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
131756671|NCT02996110|474386470|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
131756672|NCT02996110|474386471|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
131756673|NCT02996110|474386472|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
131756674|NCT02996110|474386473|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
131908597|NCT03055936|474952977|FG002|Overall Study|Personal reason|1|||
131756675|NCT02996110|474386469|FG000|Track 2|Disease Progression|33|||
131756676|NCT02996110|474386470|FG001|Track 2|Disease Progression|26|||
131756677|NCT02996110|474386471|FG002|Track 2|Disease Progression|19|||
131756678|NCT02996110|474386472|FG003|Track 2|Disease Progression|16|||
131756679|NCT02996110|474386473|FG004|Track 2|Disease Progression|15|||
131756680|NCT02996110|474386469|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
131756681|NCT02996110|474386470|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
131756682|NCT02996110|474386471|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
131756683|NCT02996110|474386472|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
131756684|NCT02996110|474386473|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
131756685|NCT02996110|474386469|FG000|Track 2|Death|0|||
131756686|NCT02996110|474386470|FG001|Track 2|Death|0|||
131756687|NCT02996110|474386471|FG002|Track 2|Death|1|||
131756688|NCT02996110|474386472|FG003|Track 2|Death|0|||
131756689|NCT02996110|474386473|FG004|Track 2|Death|1|||
131756690|NCT02996110|474386469|FG000|Track 2|Study Drug Toxicity|4|||
131756691|NCT02996110|474386470|FG001|Track 2|Study Drug Toxicity|1|||
131756692|NCT02996110|474386471|FG002|Track 2|Study Drug Toxicity|4|||
131756693|NCT02996110|474386472|FG003|Track 2|Study Drug Toxicity|1|||
131756694|NCT02996110|474386473|FG004|Track 2|Study Drug Toxicity|0|||
131756695|NCT02996110|474386469|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
131756696|NCT02996110|474386470|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
131756697|NCT02996110|474386471|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
131756698|NCT02996110|474386472|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
131756699|NCT02996110|474386473|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
131756700|NCT02996110|474386469|FG000|Track 2|Participant Withdrew Consent|1|||
131756701|NCT02996110|474386470|FG001|Track 2|Participant Withdrew Consent|2|||
131756702|NCT02996110|474386471|FG002|Track 2|Participant Withdrew Consent|3|||
131756703|NCT02996110|474386472|FG003|Track 2|Participant Withdrew Consent|1|||
131756704|NCT02996110|474386473|FG004|Track 2|Participant Withdrew Consent|1|||
131756705|NCT02996110|474386469|FG000|Track 2|Other Reasons|0|||
131756706|NCT02996110|474386470|FG001|Track 2|Other Reasons|0|||
131756707|NCT02996110|474386471|FG002|Track 2|Other Reasons|1|||
131756708|NCT02996110|474386472|FG003|Track 2|Other Reasons|0|||
131756709|NCT02996110|474386473|FG004|Track 2|Other Reasons|1|||
131756710|NCT06048809|474386477|FG000|Overall Study|Adverse Event|2|||
131756711|NCT06048809|474386478|FG001|Overall Study|Adverse Event|0|||
131756712|NCT06048809|474386477|FG000|Overall Study|Withdrawal by Subject|1|||
131756713|NCT06048809|474386478|FG001|Overall Study|Withdrawal by Subject|1|||
131908598|NCT03055936|474952978|FG003|Overall Study|Personal reason|0|||
131908599|NCT01704261|474952979|FG000|Overall Study|Withdrawal by Subject|12|||
131908600|NCT01704261|474952980|FG001|Overall Study|Withdrawal by Subject|15|||
131908601|NCT01704261|474952979|FG000|Overall Study|Lost to Follow-up|1|||
131908602|NCT01704261|474952980|FG001|Overall Study|Lost to Follow-up|0|||
131398663|NCT00878254|473081217|FG000|Overall Study|Physician Decision|1|||
131398664|NCT00878254|473081217|FG000|Overall Study|Death|1|||
131908603|NCT02722967|474952981|FG000|Overall Study|Adverse Event|1|||
131756714|NCT02158728|474386479|FG000|Overall Study|no procedure according to CIP done|3|||
131756715|NCT02158728|474386479|FG000|Overall Study|no qualified dataset|24|||
131756716|NCT03878160|474386485|FG000|Overall Study|Lost to Follow-up|1|||
131756717|NCT03878160|474386486|FG001|Overall Study|Lost to Follow-up|1|||
131756718|NCT03878160|474386487|FG002|Overall Study|Lost to Follow-up|1|||
131756719|NCT03878160|474386485|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
131756720|NCT03878160|474386486|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
131756721|NCT03878160|474386487|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
131756722|NCT00589602|474386503|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
131756723|NCT01536418|474386504|FG000|Overall Study|Protocol Violation|2|||
131908604|NCT02722967|474952982|FG001|Overall Study|Adverse Event|0|||
131908605|NCT02722967|474952983|FG002|Overall Study|Adverse Event|0|||
131908606|NCT02722967|474952981|FG000|Overall Study|Lost to Follow-up|0|||
131908607|NCT02722967|474952982|FG001|Overall Study|Lost to Follow-up|1|||
131756724|NCT01536418|474386505|FG001|Overall Study|Protocol Violation|3|||
131756725|NCT01536418|474386504|FG000|Overall Study|Physician Decision|1|||
131756726|NCT01536418|474386505|FG001|Overall Study|Physician Decision|3|||
131756727|NCT01536418|474386504|FG000|Overall Study|Study closed/terminated|41|||
131908608|NCT02722967|474952983|FG002|Overall Study|Lost to Follow-up|0|||
131756728|NCT01536418|474386505|FG001|Overall Study|Study closed/terminated|37|||
131756729|NCT01536418|474386504|FG000|Overall Study|Lack of Efficacy|10|||
131756730|NCT01536418|474386505|FG001|Overall Study|Lack of Efficacy|16|||
131756731|NCT01536418|474386504|FG000|Overall Study|Adverse Event|9|||
131756732|NCT01536418|474386505|FG001|Overall Study|Adverse Event|4|||
131756733|NCT01536418|474386504|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
131756734|NCT01536418|474386505|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
131756735|NCT01536418|474386504|FG000|Overall Study|Withdrawal by Subject|5|||
131908609|NCT02722967|474952981|FG000|Overall Study|Non-compliance with patch wearing|2|||
131756736|NCT01536418|474386505|FG001|Overall Study|Withdrawal by Subject|3|||
131756737|NCT03887052|474386511|FG000|Overall Study|Adverse Event|2|||
131756738|NCT03887052|474386511|FG000|Overall Study|Physician Decision|2|||
131756739|NCT03887052|474386511|FG000|Overall Study|Withdrawal by Subject|3|||
131756740|NCT03887052|474386511|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
131756741|NCT03887052|474386511|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
131756742|NCT01804842|474386512|FG000|Overall Study|Adverse Event|1|||
131756743|NCT01804842|474386513|FG001|Overall Study|Adverse Event|1|||
131756744|NCT01804842|474386514|FG002|Overall Study|Adverse Event|0|||
131756745|NCT01804842|474386512|FG000|Overall Study|Lost to Follow-up|1|||
131756746|NCT01804842|474386513|FG001|Overall Study|Lost to Follow-up|0|||
131756747|NCT01804842|474386514|FG002|Overall Study|Lost to Follow-up|0|||
131756748|NCT01804842|474386512|FG000|Overall Study|Non-Compliance|1|||
131756749|NCT01804842|474386513|FG001|Overall Study|Non-Compliance|1|||
131756750|NCT01804842|474386514|FG002|Overall Study|Non-Compliance|0|||
131756751|NCT01804842|474386512|FG000|Overall Study|Personal Reason|0|||
131756752|NCT01804842|474386513|FG001|Overall Study|Personal Reason|0|||
131756753|NCT01804842|474386514|FG002|Overall Study|Personal Reason|1|||
131756754|NCT04097028|474386517|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
131756755|NCT04097028|474386517|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
131756756|NCT04097028|474386517|FG000|Overall Study|Disease Progression prior to Surgery|2|||
131756757|NCT04097028|474386517|FG000|Overall Study|Adverse Event prior to Surgery|1|||
131756758|NCT03687827|474386518|FG000|Treatment Period 1|Death|0|||
131756759|NCT03687827|474386519|FG001|Treatment Period 1|Death|1|||
131756760|NCT03687827|474386518|FG000|Treatment Period 1|Lost to Follow-up|2|||
131756761|NCT03687827|474386519|FG001|Treatment Period 1|Lost to Follow-up|2|||
131756762|NCT03687827|474386518|FG000|Treatment Period 1|Physician Decision|5|||
131756763|NCT03687827|474386519|FG001|Treatment Period 1|Physician Decision|2|||
131756764|NCT03687827|474386518|FG000|Treatment Period 1|Withdrawal by Subject|7|||
131756765|NCT03687827|474386519|FG001|Treatment Period 1|Withdrawal by Subject|3|||
131756766|NCT03687827|474386518|FG000|Treatment Period 2|Physician Decision|4|||
131756767|NCT03687827|474386519|FG001|Treatment Period 2|Physician Decision|1|||
131756768|NCT03687827|474386518|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131756769|NCT03687827|474386519|FG001|Treatment Period 2|Withdrawal by Subject|2|||
131756770|NCT03277105|474386522|FG000|Overall Study|Death|129|||
131756771|NCT03277105|474386523|FG001|Overall Study|Death|124|||
131756772|NCT03277105|474386522|FG000|Overall Study|Lost to Follow-up|2|||
131756773|NCT03277105|474386523|FG001|Overall Study|Lost to Follow-up|4|||
131756774|NCT03277105|474386522|FG000|Overall Study|Withdrawal by Subject|10|||
131756775|NCT03277105|474386523|FG001|Overall Study|Withdrawal by Subject|10|||
131756776|NCT03277105|474386522|FG000|Overall Study|Other|118|||
131756777|NCT03277105|474386523|FG001|Overall Study|Other|125|||
131756778|NCT02736929|474386531|FG000|Main Study|Lost to Follow-up|7|||
131756779|NCT02736929|474386532|FG001|Main Study|Lost to Follow-up|1|||
131756780|NCT02736929|474386533|FG002|Main Study|Lost to Follow-up|0|||
131756781|NCT02736929|474386531|FG000|Main Study|Withdrawal by Subject|1|||
131756782|NCT02736929|474386532|FG001|Main Study|Withdrawal by Subject|1|||
131756783|NCT02736929|474386533|FG002|Main Study|Withdrawal by Subject|0|||
131756784|NCT02736929|474386531|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
131756785|NCT02736929|474386532|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
131756786|NCT02736929|474386533|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
131756787|NCT00285649|474386534|FG000|Overall Study|Lost to Follow-up|6|||
131756788|NCT00285649|474386535|FG001|Overall Study|Lost to Follow-up|4|||
131756789|NCT00285649|474386536|FG002|Overall Study|Lost to Follow-up|4|||
131756790|NCT00285649|474386534|FG000|Overall Study|Withdrawal by Subject|3|||
131756791|NCT00285649|474386535|FG001|Overall Study|Withdrawal by Subject|2|||
131756792|NCT00285649|474386536|FG002|Overall Study|Withdrawal by Subject|2|||
131756793|NCT01855425|474386537|FG000|Overall Study|Physician Decision|20|||
131756794|NCT00373880|474386538|FG000|Overall Study|Physician Decision|3|||
131756795|NCT00373880|474386538|FG000|Overall Study|Arrested|1|||
131756796|NCT00373880|474386538|FG000|Overall Study|Protocol Violation|14|||
131756797|NCT04043416|474386539|FG000|Washout|Change in health condition|0|||
131756798|NCT04043416|474386540|FG001|Washout|Change in health condition|1|||
131756799|NCT02865928|474386541|FG000|Overall Study|Withdrawal by Subject|1|||
131756800|NCT02865928|474386542|FG001|Overall Study|Withdrawal by Subject|0|||
131756801|NCT02865928|474386541|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
131756802|NCT02865928|474386542|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
131756803|NCT02865928|474386541|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
131756804|NCT02865928|474386542|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
131756805|NCT01925014|474386545|FG000|Overall Study|Inappropriate enrollment|4|||
131756806|NCT01925014|474386546|FG001|Overall Study|Inappropriate enrollment|6|||
131756807|NCT01925014|474386545|FG000|Overall Study|Withdrawal by Subject|5|||
131756808|NCT01925014|474386546|FG001|Overall Study|Withdrawal by Subject|13|||
131756809|NCT00312728|474386547|FG000|Overall Study|Progressive disease|53|||
131756810|NCT00312728|474386547|FG000|Overall Study|Adverse Event|32|||
131756811|NCT00312728|474386547|FG000|Overall Study|Withdrawal by Subject|10|||
131756812|NCT00312728|474386547|FG000|Overall Study|Required non-protocol cancer treatment|2|||
131756813|NCT00312728|474386547|FG000|Overall Study|Protocol Violation|2|||
131756814|NCT00312728|474386547|FG000|Overall Study|Other|10|||
131756815|NCT00312728|474386547|FG000|Overall Study|Other|1|||
131756816|NCT01487863|474386548|FG000|Overall Study|Death|19|||
131756817|NCT01487863|474386549|FG001|Overall Study|Death|19|||
131756818|NCT00486889|474386550|FG000|Overall Study|Death|3|||
131756819|NCT00486889|474386550|FG000|Overall Study|Non-compliant|2|||
131756820|NCT00486889|474386550|FG000|Overall Study|Withdrawal by Subject|6|||
131756821|NCT00893763|474386551|FG000|Overall Study|extubated|110|||
131756822|NCT00893763|474386552|FG001|Overall Study|extubated|110|||
131756823|NCT01512693|474386553|FG000|Overall Study|Withdrawal by Subject|0|||
131756824|NCT01512693|474386554|FG001|Overall Study|Withdrawal by Subject|1|||
131756825|NCT01975376|474386555|FG000|Overall Study|Adverse Event|5|||
131756826|NCT01975376|474386556|FG001|Overall Study|Adverse Event|5|||
131756827|NCT01975376|474386555|FG000|Overall Study|Death|65|||
131756828|NCT01975376|474386556|FG001|Overall Study|Death|72|||
131756829|NCT01975376|474386555|FG000|Overall Study|Lost to Follow-up|70|||
131756830|NCT01975376|474386556|FG001|Overall Study|Lost to Follow-up|66|||
131756831|NCT01975376|474386555|FG000|Overall Study|Withdrew consent|68|||
131756832|NCT01975376|474386556|FG001|Overall Study|Withdrew consent|62|||
131756833|NCT01975376|474386555|FG000|Overall Study|Other|2|||
131756834|NCT01975376|474386556|FG001|Overall Study|Other|4|||
131756835|NCT01975376|474386555|FG000|Overall Study|Randomized, Not Treated|16|||
131756836|NCT01975376|474386556|FG001|Overall Study|Randomized, Not Treated|8|||
131756837|NCT04731922|474386566|FG000|Overall Study|Adverse Event|0|||
131756838|NCT04731922|474386567|FG001|Overall Study|Adverse Event|0|||
131756839|NCT04731922|474386568|FG002|Overall Study|Adverse Event|0|||
131756840|NCT04731922|474386569|FG003|Overall Study|Adverse Event|0|||
131756841|NCT04731922|474386570|FG004|Overall Study|Adverse Event|0|||
131756842|NCT04731922|474386571|FG005|Overall Study|Adverse Event|0|||
131756843|NCT04731922|474386572|FG006|Overall Study|Adverse Event|0|||
131756844|NCT04731922|474386573|FG007|Overall Study|Adverse Event|0|||
131756845|NCT04731922|474386574|FG008|Overall Study|Adverse Event|0|||
131756846|NCT04731922|474386575|FG009|Overall Study|Adverse Event|0|||
131756847|NCT04731922|474386576|FG010|Overall Study|Adverse Event|1|||
131756848|NCT04731922|474386577|FG011|Overall Study|Adverse Event|0|||
131756849|NCT04731922|474386578|FG012|Overall Study|Adverse Event|0|||
131756850|NCT04731922|474386579|FG013|Overall Study|Adverse Event|0|||
131756851|NCT04731922|474386580|FG014|Overall Study|Adverse Event|0|||
131756852|NCT04731922|474386581|FG015|Overall Study|Adverse Event|0|||
131756853|NCT04731922|474386582|FG016|Overall Study|Adverse Event|0|||
131756854|NCT04731922|474386566|FG000|Overall Study|Lost to Follow-up|0|||
131756855|NCT04731922|474386567|FG001|Overall Study|Lost to Follow-up|0|||
131756856|NCT04731922|474386568|FG002|Overall Study|Lost to Follow-up|0|||
131756857|NCT04731922|474386569|FG003|Overall Study|Lost to Follow-up|1|||
131756858|NCT04731922|474386570|FG004|Overall Study|Lost to Follow-up|0|||
131756859|NCT04731922|474386571|FG005|Overall Study|Lost to Follow-up|1|||
131756860|NCT04731922|474386572|FG006|Overall Study|Lost to Follow-up|0|||
131756861|NCT04731922|474386573|FG007|Overall Study|Lost to Follow-up|0|||
131756862|NCT04731922|474386574|FG008|Overall Study|Lost to Follow-up|0|||
131756863|NCT04731922|474386575|FG009|Overall Study|Lost to Follow-up|0|||
131756864|NCT04731922|474386576|FG010|Overall Study|Lost to Follow-up|0|||
131756865|NCT04731922|474386577|FG011|Overall Study|Lost to Follow-up|0|||
131756866|NCT04731922|474386578|FG012|Overall Study|Lost to Follow-up|0|||
131756867|NCT04731922|474386579|FG013|Overall Study|Lost to Follow-up|0|||
131756868|NCT04731922|474386580|FG014|Overall Study|Lost to Follow-up|0|||
131756869|NCT04731922|474386581|FG015|Overall Study|Lost to Follow-up|0|||
131756870|NCT04731922|474386582|FG016|Overall Study|Lost to Follow-up|0|||
131756871|NCT04731922|474386566|FG000|Overall Study|Withdrawal by Subject|1|||
131756872|NCT04731922|474386567|FG001|Overall Study|Withdrawal by Subject|0|||
131756873|NCT04731922|474386568|FG002|Overall Study|Withdrawal by Subject|0|||
131756874|NCT04731922|474386569|FG003|Overall Study|Withdrawal by Subject|0|||
131756875|NCT04731922|474386570|FG004|Overall Study|Withdrawal by Subject|1|||
131756876|NCT04731922|474386571|FG005|Overall Study|Withdrawal by Subject|0|||
131756877|NCT04731922|474386572|FG006|Overall Study|Withdrawal by Subject|1|||
131756878|NCT04731922|474386573|FG007|Overall Study|Withdrawal by Subject|0|||
131756879|NCT04731922|474386574|FG008|Overall Study|Withdrawal by Subject|0|||
131756880|NCT04731922|474386575|FG009|Overall Study|Withdrawal by Subject|0|||
131756881|NCT04731922|474386576|FG010|Overall Study|Withdrawal by Subject|0|||
131756882|NCT04731922|474386577|FG011|Overall Study|Withdrawal by Subject|0|||
131756883|NCT04731922|474386578|FG012|Overall Study|Withdrawal by Subject|0|||
131756884|NCT04731922|474386579|FG013|Overall Study|Withdrawal by Subject|1|||
131756885|NCT04731922|474386580|FG014|Overall Study|Withdrawal by Subject|0|||
131756886|NCT04731922|474386581|FG015|Overall Study|Withdrawal by Subject|0|||
131756887|NCT04731922|474386582|FG016|Overall Study|Withdrawal by Subject|0|||
131756888|NCT04731922|474386566|FG000|Overall Study|Other|0|||
131756889|NCT04731922|474386567|FG001|Overall Study|Other|0|||
131756890|NCT04731922|474386568|FG002|Overall Study|Other|0|||
131756891|NCT04731922|474386569|FG003|Overall Study|Other|0|||
131756892|NCT04731922|474386570|FG004|Overall Study|Other|0|||
131756893|NCT04731922|474386571|FG005|Overall Study|Other|0|||
131756894|NCT04731922|474386572|FG006|Overall Study|Other|1|||
131756895|NCT04731922|474386573|FG007|Overall Study|Other|0|||
131756896|NCT04731922|474386574|FG008|Overall Study|Other|0|||
131756897|NCT04731922|474386575|FG009|Overall Study|Other|0|||
131756898|NCT04731922|474386576|FG010|Overall Study|Other|0|||
131756899|NCT04731922|474386577|FG011|Overall Study|Other|0|||
131756900|NCT04731922|474386578|FG012|Overall Study|Other|0|||
131756901|NCT04731922|474386579|FG013|Overall Study|Other|0|||
131756902|NCT04731922|474386580|FG014|Overall Study|Other|0|||
131756903|NCT04731922|474386581|FG015|Overall Study|Other|0|||
131756904|NCT04731922|474386582|FG016|Overall Study|Other|0|||
131756905|NCT01819194|474386584|FG000|Overall Study|Loss of study articles|2|||
131756906|NCT01448707|474386587|FG000|Overall Study|Adverse Event|3|||
131756907|NCT01448707|474386588|FG001|Overall Study|Adverse Event|1|||
131756908|NCT01448707|474386587|FG000|Overall Study|Lost to Follow-up|2|||
131756909|NCT01448707|474386588|FG001|Overall Study|Lost to Follow-up|6|||
131756910|NCT01448707|474386587|FG000|Overall Study|Withdrawal by Subject|6|||
131756911|NCT01448707|474386588|FG001|Overall Study|Withdrawal by Subject|7|||
131756912|NCT01448707|474386587|FG000|Overall Study|Other|7|||
131756913|NCT01448707|474386588|FG001|Overall Study|Other|4|||
131756914|NCT00441480|474386592|FG000|Overall Study|Protocol Violation|1|||
131756915|NCT00441480|474386593|FG001|Overall Study|Protocol Violation|1|||
131756916|NCT00441480|474386592|FG000|Overall Study|Withdrawal by Subject|2|||
131756917|NCT00441480|474386593|FG001|Overall Study|Withdrawal by Subject|3|||
131756918|NCT02623699|474386594|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756919|NCT02623699|474386595|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
131756920|NCT02623699|474386596|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756921|NCT02623699|474386597|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756922|NCT02623699|474386598|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756923|NCT02623699|474386599|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756924|NCT02623699|474386600|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756925|NCT02623699|474386601|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756926|NCT02623699|474386602|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756927|NCT02623699|474386603|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756928|NCT02623699|474386604|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756929|NCT02623699|474386605|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131756930|NCT02623699|474386594|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756931|NCT02623699|474386595|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756932|NCT02623699|474386596|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756933|NCT02623699|474386597|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756934|NCT02623699|474386598|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756935|NCT02623699|474386599|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756936|NCT02623699|474386600|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
131756937|NCT02623699|474386601|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756938|NCT02623699|474386602|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756939|NCT02623699|474386603|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756940|NCT02623699|474386604|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131756941|NCT02623699|474386605|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131811974|NCT01249651|474593744|FG000|Overall Study|Adverse Event|1|||
131811975|NCT01249651|474593744|FG000|Overall Study|Protocol Violation|1|||
131811976|NCT01249651|474593744|FG000|Overall Study|Sponsor Decision|1|||
131811977|NCT03801707|474593749|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
131811978|NCT03873272|474593750|FG000|Overall Study|Withdrawal by Subject|2|||
131811979|NCT03873272|474593751|FG001|Overall Study|Withdrawal by Subject|0|||
131811980|NCT03873272|474593752|FG002|Overall Study|Withdrawal by Subject|1|||
131811981|NCT03873272|474593750|FG000|Overall Study|Death|0|||
131811982|NCT03873272|474593751|FG001|Overall Study|Death|2|||
131811983|NCT03873272|474593752|FG002|Overall Study|Death|1|||
131811984|NCT00787254|474593753|FG000|Overall Study|Adverse Event|24|||
131811985|NCT00787254|474593754|FG001|Overall Study|Adverse Event|23|||
131811986|NCT00787254|474593753|FG000|Overall Study|Protocol Violation|26|||
131811987|NCT00787254|474593754|FG001|Overall Study|Protocol Violation|23|||
131811988|NCT00787254|474593753|FG000|Overall Study|Withdrawal by Subject|16|||
131756942|NCT02623699|474386594|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756943|NCT02623699|474386595|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756944|NCT02623699|474386596|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756945|NCT02623699|474386597|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756946|NCT02623699|474386598|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756947|NCT02623699|474386599|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
131756948|NCT02623699|474386600|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756949|NCT02623699|474386601|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131811989|NCT00787254|474593754|FG001|Overall Study|Withdrawal by Subject|11|||
131811990|NCT00787254|474593753|FG000|Overall Study|Lack of Efficacy|4|||
131811991|NCT00787254|474593754|FG001|Overall Study|Lack of Efficacy|15|||
131811992|NCT00787254|474593753|FG000|Overall Study|NSAIDs discontinuation|1|||
131756950|NCT02623699|474386602|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756951|NCT02623699|474386603|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756952|NCT02623699|474386604|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756953|NCT02623699|474386605|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131756954|NCT02623699|474386594|FG000|Part B (Up to 289 Days)|Death|0|||
131756955|NCT02623699|474386595|FG001|Part B (Up to 289 Days)|Death|0|||
131756956|NCT02623699|474386596|FG002|Part B (Up to 289 Days)|Death|0|||
131756957|NCT02623699|474386597|FG003|Part B (Up to 289 Days)|Death|0|||
131756958|NCT02623699|474386598|FG004|Part B (Up to 289 Days)|Death|0|||
131756959|NCT02623699|474386599|FG005|Part B (Up to 289 Days)|Death|1|||
131756960|NCT02623699|474386600|FG006|Part B (Up to 289 Days)|Death|1|||
131756961|NCT02623699|474386601|FG007|Part B (Up to 289 Days)|Death|0|||
131756962|NCT02623699|474386602|FG008|Part B (Up to 289 Days)|Death|1|||
131756963|NCT02623699|474386603|FG009|Part B (Up to 289 Days)|Death|0|||
131756964|NCT02623699|474386604|FG010|Part B (Up to 289 Days)|Death|0|||
131756965|NCT02623699|474386605|FG011|Part B (Up to 289 Days)|Death|0|||
131756966|NCT02623699|474386594|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
131756967|NCT02623699|474386595|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
131756968|NCT02623699|474386596|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
131756969|NCT02623699|474386597|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
131756970|NCT02623699|474386598|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
131756971|NCT02623699|474386599|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
131756972|NCT02623699|474386600|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
131756973|NCT02623699|474386601|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
131756974|NCT02623699|474386602|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
131756975|NCT02623699|474386603|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
131756976|NCT02623699|474386604|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
131756977|NCT02623699|474386605|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
131756978|NCT02623699|474386594|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756979|NCT02623699|474386595|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756980|NCT02623699|474386596|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756981|NCT02623699|474386597|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756982|NCT02623699|474386598|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756983|NCT02623699|474386599|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756984|NCT02623699|474386600|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756985|NCT02623699|474386601|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756986|NCT02623699|474386602|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756987|NCT02623699|474386603|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131756988|NCT02623699|474386604|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
131756989|NCT02623699|474386605|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
131756990|NCT02623699|474386594|FG000|Part C (Up to 236 Days)|Death|0|||
131756991|NCT02623699|474386595|FG001|Part C (Up to 236 Days)|Death|0|||
131756992|NCT02623699|474386596|FG002|Part C (Up to 236 Days)|Death|0|||
131756993|NCT02623699|474386597|FG003|Part C (Up to 236 Days)|Death|0|||
131756994|NCT02623699|474386598|FG004|Part C (Up to 236 Days)|Death|0|||
131756995|NCT02623699|474386599|FG005|Part C (Up to 236 Days)|Death|0|||
131756996|NCT02623699|474386600|FG006|Part C (Up to 236 Days)|Death|0|||
131756997|NCT02623699|474386601|FG007|Part C (Up to 236 Days)|Death|0|||
131756998|NCT02623699|474386602|FG008|Part C (Up to 236 Days)|Death|0|||
131756999|NCT02623699|474386603|FG009|Part C (Up to 236 Days)|Death|0|||
131757000|NCT02623699|474386604|FG010|Part C (Up to 236 Days)|Death|0|||
131757001|NCT02623699|474386605|FG011|Part C (Up to 236 Days)|Death|1|||
131757002|NCT02623699|474386594|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
131757003|NCT02623699|474386595|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
131757004|NCT02623699|474386596|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
131757005|NCT02623699|474386597|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
131757006|NCT02623699|474386598|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
131757007|NCT02623699|474386599|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
131757008|NCT02623699|474386600|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
131757009|NCT02623699|474386601|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
131757010|NCT02623699|474386602|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
131757011|NCT02623699|474386603|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
131757012|NCT02623699|474386604|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
131757013|NCT02623699|474386605|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
131757014|NCT00899678|474386606|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
131757015|NCT00899678|474386607|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
131757016|NCT00899678|474386608|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
131757017|NCT00899678|474386606|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
131757018|NCT00899678|474386607|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
131757019|NCT00899678|474386608|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
131757020|NCT00899678|474386606|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
131757021|NCT00899678|474386607|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
131757022|NCT00899678|474386608|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
131757023|NCT00899678|474386606|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
131757024|NCT00899678|474386607|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
131757025|NCT00899678|474386608|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
131757026|NCT00899678|474386606|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
131757027|NCT00899678|474386607|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
131757028|NCT00899678|474386608|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
131757029|NCT00899678|474386606|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
131757030|NCT00899678|474386607|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
131757031|NCT00899678|474386608|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
131757032|NCT00899678|474386606|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
131757033|NCT00899678|474386607|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
131757034|NCT00899678|474386608|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
131757035|NCT00899678|474386606|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
131757036|NCT00899678|474386607|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
131757037|NCT00899678|474386608|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
131757038|NCT00899678|474386606|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
131757039|NCT00899678|474386607|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
131757040|NCT00899678|474386608|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
131757041|NCT02699125|474386611|FG000|Placebo|Lost to Follow-up|2|||
131757042|NCT02699125|474386612|FG001|Placebo|Lost to Follow-up|0|||
131757043|NCT02699125|474386611|FG000|Placebo|Protocol Violation|1|||
131757044|NCT02699125|474386612|FG001|Placebo|Protocol Violation|0|||
131757045|NCT02699125|474386611|FG000|Placebo|Withdrawal by Subject|0|||
131757046|NCT02699125|474386612|FG001|Placebo|Withdrawal by Subject|4|||
131757047|NCT02699125|474386611|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
131757048|NCT02699125|474386612|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
131757049|NCT03796195|474386615|FG000|Overall Study|Study closed early|1|||
131757050|NCT01039428|474386618|FG000|Overall Study|Protocol Violation|1|||
131757051|NCT01039428|474386619|FG001|Overall Study|Protocol Violation|0|||
131757052|NCT01039428|474386618|FG000|Overall Study|Withdrawal by Subject|1|||
131757053|NCT01039428|474386619|FG001|Overall Study|Withdrawal by Subject|0|||
131757054|NCT00422240|474386626|FG000|Overall Study|Lack of Efficacy|1|||
131757055|NCT00422240|474386627|FG001|Overall Study|Lack of Efficacy|2|||
131757056|NCT00422240|474386628|FG002|Overall Study|Lack of Efficacy|0|||
131757057|NCT00422240|474386629|FG003|Overall Study|Lack of Efficacy|1|||
131757058|NCT00422240|474386626|FG000|Overall Study|Adverse Event|11|||
131757059|NCT00422240|474386627|FG001|Overall Study|Adverse Event|4|||
131757060|NCT00422240|474386628|FG002|Overall Study|Adverse Event|5|||
131757061|NCT00422240|474386629|FG003|Overall Study|Adverse Event|2|||
131757062|NCT00422240|474386626|FG000|Overall Study|Subject request|21|||
131757063|NCT00422240|474386627|FG001|Overall Study|Subject request|17|||
131757064|NCT00422240|474386628|FG002|Overall Study|Subject request|18|||
131757065|NCT00422240|474386629|FG003|Overall Study|Subject request|30|||
131757066|NCT00422240|474386626|FG000|Overall Study|Protocol Violation|0|||
131757067|NCT00422240|474386627|FG001|Overall Study|Protocol Violation|1|||
131757068|NCT00422240|474386628|FG002|Overall Study|Protocol Violation|0|||
131757069|NCT00422240|474386629|FG003|Overall Study|Protocol Violation|1|||
131757070|NCT00422240|474386626|FG000|Overall Study|Lost to Follow-up|31|||
131757071|NCT00422240|474386627|FG001|Overall Study|Lost to Follow-up|32|||
131757072|NCT00422240|474386628|FG002|Overall Study|Lost to Follow-up|19|||
131757073|NCT00422240|474386629|FG003|Overall Study|Lost to Follow-up|34|||
131757074|NCT00422240|474386626|FG000|Overall Study|Other|1|||
131757075|NCT00422240|474386627|FG001|Overall Study|Other|0|||
131757076|NCT00422240|474386628|FG002|Overall Study|Other|0|||
131757077|NCT00422240|474386629|FG003|Overall Study|Other|1|||
131757078|NCT00422240|474386626|FG000|Overall Study|Pregnancy|3|||
131757079|NCT00422240|474386627|FG001|Overall Study|Pregnancy|1|||
131757080|NCT00422240|474386628|FG002|Overall Study|Pregnancy|1|||
131757081|NCT00422240|474386629|FG003|Overall Study|Pregnancy|2|||
131757082|NCT01624467|474386630|FG000|Overall Study|Withdrawal by Subject|2|||
131811993|NCT00787254|474593754|FG001|Overall Study|NSAIDs discontinuation|2|||
131811994|NCT00787254|474593753|FG000|Overall Study|Institution closed|1|||
131811995|NCT00787254|474593754|FG001|Overall Study|Institution closed|0|||
131811996|NCT00787254|474593753|FG000|Overall Study|Physician Decision|4|||
131811997|NCT00787254|474593754|FG001|Overall Study|Physician Decision|8|||
131811998|NCT02430480|474593757|FG000|Overall Study|Death|1|||
131811999|NCT02430480|474593757|FG000|Overall Study|Anesthesia concerns|1|||
131812000|NCT02430480|474593757|FG000|Overall Study|Progressed on treatment|1|||
131812001|NCT04299087|474595696|FG000|Overall Study|Lost to Follow-up|2|||
131757083|NCT01624467|474386630|FG000|Overall Study|Lost to Follow-up|1|||
131757084|NCT01624467|474386630|FG000|Overall Study|Adverse Event|7|||
131757085|NCT01624467|474386630|FG000|Overall Study|Progressive Disease|19|||
131757086|NCT01624467|474386630|FG000|Overall Study|Per Sponsor Requirement|1|||
131757087|NCT01624467|474386630|FG000|Overall Study|Subject Withdrew from Treatment|1|||
131757088|NCT02201472|474386631|FG000|Overall Study|Lack of Efficacy|2|||
131757089|NCT01300767|474386632|FG000|Overall Study|Discomfort|2|||
131757090|NCT01300767|474386632|FG000|Overall Study|Biomicroscopy|1|||
131812002|NCT04299087|474595697|FG001|Overall Study|Lost to Follow-up|1|||
131812003|NCT02301975|474595702|FG000|Overall Study|Adverse Event|8|||
131812004|NCT02301975|474595703|FG001|Overall Study|Adverse Event|3|||
131757091|NCT01300767|474386632|FG000|Overall Study|Unacceptable fit|1|||
131757092|NCT00117572|474386637|FG000|Overall Study|Site withdrew before starting treatment|2|||
131757093|NCT00117572|474386638|FG001|Overall Study|Site withdrew before starting treatment|3|||
131757094|NCT00117572|474386637|FG000|Overall Study|Withdrawal by Subject|3|||
131757095|NCT00117572|474386638|FG001|Overall Study|Withdrawal by Subject|3|||
131757096|NCT00117572|474386637|FG000|Overall Study|Protocol Violation|1|||
131757097|NCT00117572|474386638|FG001|Overall Study|Protocol Violation|0|||
131757098|NCT02254304|474386644|FG000|Overall Study|Adverse Event|2|||
131757099|NCT02254304|474386645|FG001|Overall Study|Adverse Event|1|||
131757100|NCT02254304|474386644|FG000|Overall Study|Lost to Follow-up|2|||
131757101|NCT02254304|474386645|FG001|Overall Study|Lost to Follow-up|2|||
131757102|NCT02254304|474386644|FG000|Overall Study|Protocol Violation|1|||
131757103|NCT02254304|474386645|FG001|Overall Study|Protocol Violation|0|||
131757104|NCT02254304|474386644|FG000|Overall Study|Withdrawal by Subject|3|||
131757105|NCT02254304|474386645|FG001|Overall Study|Withdrawal by Subject|0|||
131757106|NCT02254304|474386644|FG000|Overall Study|Injection site pain and Injection fear|1|||
131757107|NCT02254304|474386645|FG001|Overall Study|Injection site pain and Injection fear|0|||
131757108|NCT02254304|474386644|FG000|Overall Study|Personal causes|4|||
131757109|NCT02254304|474386645|FG001|Overall Study|Personal causes|1|||
131757110|NCT02254304|474386644|FG000|Overall Study|Personal decision|1|||
131757111|NCT02254304|474386645|FG001|Overall Study|Personal decision|0|||
131757112|NCT02973997|474388616|FG000|Overall Study|Withdrawal by Subject|4|||
131757113|NCT02973997|474388617|FG001|Overall Study|Withdrawal by Subject|0|||
131757114|NCT02973997|474388616|FG000|Overall Study|Adverse Event|4|||
131757115|NCT02973997|474388617|FG001|Overall Study|Adverse Event|1|||
131757116|NCT02973997|474388616|FG000|Overall Study|Disease Progression|11|||
131757117|NCT02973997|474388617|FG001|Overall Study|Disease Progression|20|||
131757118|NCT02973997|474388616|FG000|Overall Study|Alternative Therapy|3|||
131757119|NCT02973997|474388617|FG001|Overall Study|Alternative Therapy|0|||
131757120|NCT02973997|474388616|FG000|Overall Study|Other complicating disease|0|||
131757121|NCT02973997|474388617|FG001|Overall Study|Other complicating disease|1|||
131757122|NCT02973997|474388616|FG000|Overall Study|Death|0|||
131757123|NCT02973997|474388617|FG001|Overall Study|Death|1|||
131757124|NCT01998906|474388618|FG000|Overall Study|Participants ongoing in follow-up|77|||
131757125|NCT01998906|474388619|FG001|Overall Study|Participants ongoing in follow-up|60|||
131757126|NCT01998906|474388620|FG002|Overall Study|Participants ongoing in follow-up|58|||
131757127|NCT01998906|474388618|FG000|Overall Study|Death|21|||
131757128|NCT01998906|474388619|FG001|Overall Study|Death|30|||
131757129|NCT01998906|474388620|FG002|Overall Study|Death|17|||
131757130|NCT01998906|474388618|FG000|Overall Study|Lack of Efficacy|10|||
131757131|NCT01998906|474388619|FG001|Overall Study|Lack of Efficacy|9|||
131757132|NCT01998906|474388620|FG002|Overall Study|Lack of Efficacy|8|||
131757133|NCT01998906|474388618|FG000|Overall Study|Failure to return|0|||
131757134|NCT01998906|474388619|FG001|Overall Study|Failure to return|2|||
131757135|NCT01998906|474388620|FG002|Overall Study|Failure to return|4|||
131757136|NCT01998906|474388618|FG000|Overall Study|Violation of Selection Criteria|0|||
131757137|NCT01998906|474388619|FG001|Overall Study|Violation of Selection Criteria|0|||
131757138|NCT01998906|474388620|FG002|Overall Study|Violation of Selection Criteria|1|||
131757139|NCT01998906|474388618|FG000|Overall Study|Withdrawal by Subject|1|||
131757140|NCT01998906|474388619|FG001|Overall Study|Withdrawal by Subject|4|||
131757141|NCT01998906|474388620|FG002|Overall Study|Withdrawal by Subject|3|||
131757142|NCT01998906|474388618|FG000|Overall Study|Administrative/Other|2|||
131757143|NCT01998906|474388619|FG001|Overall Study|Administrative/Other|1|||
131757144|NCT01998906|474388620|FG002|Overall Study|Administrative/Other|3|||
131757145|NCT01998906|474388618|FG000|Overall Study|Other|3|||
131908610|NCT02722967|474952982|FG001|Overall Study|Non-compliance with patch wearing|1|||
131757146|NCT01998906|474388619|FG001|Overall Study|Other|8|||
131757147|NCT01998906|474388620|FG002|Overall Study|Other|4|||
131757148|NCT03671148|474388623|FG000|Overall Study|Adverse Event|3|||
131757149|NCT03671148|474388624|FG001|Overall Study|Adverse Event|2|||
131757150|NCT03671148|474388623|FG000|Overall Study|Withdrawal by Subject|8|||
131757151|NCT03671148|474388624|FG001|Overall Study|Withdrawal by Subject|2|||
131757152|NCT03671148|474388623|FG000|Overall Study|Lost to Follow-up|1|||
131757153|NCT03671148|474388624|FG001|Overall Study|Lost to Follow-up|2|||
131757154|NCT03671148|474388623|FG000|Overall Study|Lack of Efficacy|7|||
131757155|NCT03671148|474388624|FG001|Overall Study|Lack of Efficacy|2|||
131757156|NCT03671148|474388623|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
131757157|NCT03671148|474388624|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
131757158|NCT03671148|474388623|FG000|Overall Study|Other|1|||
131757159|NCT03671148|474388624|FG001|Overall Study|Other|0|||
131757160|NCT03671148|474388623|FG000|Overall Study|Incomplete Randomization Visit|1|||
131757161|NCT03671148|474388624|FG001|Overall Study|Incomplete Randomization Visit|0|||
131757162|NCT00673816|474388625|FG000|Overall Study|Adverse Event|1|||
131757163|NCT00673816|474388625|FG000|Overall Study|Withdrawal by Subject|1|||
131757164|NCT02234050|474388626|FG000|Overall Study|Lack of Efficacy|38|||
131757165|NCT02234050|474388627|FG001|Overall Study|Lack of Efficacy|22|||
131757166|NCT02234050|474388626|FG000|Overall Study|Adverse Event|13|||
131757167|NCT02234050|474388627|FG001|Overall Study|Adverse Event|1|||
131757168|NCT02234050|474388626|FG000|Overall Study|Withdrawal by Subject|4|||
131757169|NCT02234050|474388627|FG001|Overall Study|Withdrawal by Subject|2|||
131757170|NCT02234050|474388626|FG000|Overall Study|Sponsor's decision|6|||
131757171|NCT02234050|474388627|FG001|Overall Study|Sponsor's decision|0|||
131757172|NCT01680991|474388629|FG000|Overall Study|Adverse Event|1|||
131757173|NCT01680991|474388630|FG001|Overall Study|Adverse Event|0|||
131757174|NCT01680991|474388631|FG002|Overall Study|Adverse Event|0|||
131757175|NCT01680991|474388629|FG000|Overall Study|Death|1|||
131757176|NCT01680991|474388630|FG001|Overall Study|Death|0|||
131757177|NCT01680991|474388631|FG002|Overall Study|Death|1|||
131757178|NCT01680991|474388629|FG000|Overall Study|Protocol Violation|0|||
131757179|NCT01680991|474388630|FG001|Overall Study|Protocol Violation|1|||
131757180|NCT01680991|474388631|FG002|Overall Study|Protocol Violation|0|||
131757181|NCT01680991|474388629|FG000|Overall Study|Withdrawal by Subject|5|||
131757182|NCT01680991|474388630|FG001|Overall Study|Withdrawal by Subject|1|||
131757183|NCT01680991|474388631|FG002|Overall Study|Withdrawal by Subject|0|||
131757184|NCT01680991|474388629|FG000|Overall Study|Progressive disease (PD)|0|||
131757185|NCT01680991|474388630|FG001|Overall Study|Progressive disease (PD)|10|||
131757186|NCT01680991|474388631|FG002|Overall Study|Progressive disease (PD)|0|||
131757187|NCT01680991|474388629|FG000|Overall Study|Physician Decision|0|||
131757188|NCT01680991|474388630|FG001|Overall Study|Physician Decision|7|||
131757189|NCT01680991|474388631|FG002|Overall Study|Physician Decision|2|||
131757190|NCT01680991|474388629|FG000|Overall Study|Bad physical condition|0|||
131757191|NCT01680991|474388630|FG001|Overall Study|Bad physical condition|0|||
131757192|NCT01680991|474388631|FG002|Overall Study|Bad physical condition|1|||
131757193|NCT01680991|474388629|FG000|Overall Study|PD confirmed in other hospital|1|||
131757194|NCT01680991|474388630|FG001|Overall Study|PD confirmed in other hospital|0|||
131757195|NCT01680991|474388631|FG002|Overall Study|PD confirmed in other hospital|0|||
131757196|NCT06073054|474388632|FG000|Overall Study|Withdrawal by Subject|2|||
131757197|NCT03149029|474388633|FG000|Overall Study|Adverse Event|2|||
131757198|NCT03149029|474388634|FG001|Overall Study|Adverse Event|0|||
131757199|NCT00413777|474388639|FG000|Fixed-dose Period|Lost to Follow-up|1|||
131757200|NCT00413777|474388640|FG001|Fixed-dose Period|Lost to Follow-up|1|||
131757201|NCT00413777|474388639|FG000|Fixed-dose Period|Adverse Event|2|||
131757202|NCT00413777|474388640|FG001|Fixed-dose Period|Adverse Event|1|||
131757203|NCT00413777|474388639|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
131757204|NCT00413777|474388640|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
131757205|NCT00413777|474388639|FG000|Fixed-dose Period|Withdrew Consent|0|||
131757206|NCT00413777|474388640|FG001|Fixed-dose Period|Withdrew Consent|1|||
131757207|NCT05505734|474388641|FG000|Overall Study|Withdrawal by Subject|51|||
131757208|NCT05505734|474388642|FG001|Overall Study|Withdrawal by Subject|64|||
131757209|NCT05505734|474388641|FG000|Overall Study|Adverse Event|6|||
131757210|NCT05505734|474388642|FG001|Overall Study|Adverse Event|20|||
131757211|NCT05505734|474388641|FG000|Overall Study|Protocol Violation|8|||
131757212|NCT05505734|474388642|FG001|Overall Study|Protocol Violation|15|||
131757213|NCT05505734|474388641|FG000|Overall Study|Lack of therapeutic response|0|||
131757214|NCT05505734|474388642|FG001|Overall Study|Lack of therapeutic response|1|||
131757215|NCT05505734|474388641|FG000|Overall Study|Lost to Follow-up|247|||
131757216|NCT05505734|474388642|FG001|Overall Study|Lost to Follow-up|237|||
131757217|NCT05505734|474388641|FG000|Overall Study|Physician Decision|22|||
131757218|NCT05505734|474388642|FG001|Overall Study|Physician Decision|13|||
131757219|NCT05505734|474388641|FG000|Overall Study|Death|2|||
131757220|NCT05505734|474388642|FG001|Overall Study|Death|1|||
131757221|NCT05505734|474388641|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131757222|NCT05505734|474388642|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131757223|NCT05505734|474388641|FG000|Overall Study|Pregnancy|1|||
131757224|NCT05505734|474388642|FG001|Overall Study|Pregnancy|0|||
131757225|NCT05505734|474388641|FG000|Overall Study|Other|17|||
131757226|NCT05505734|474388642|FG001|Overall Study|Other|13|||
131757227|NCT00764322|474388643|FG000|Overall Study|Withdrawal by Subject|11|||
131757228|NCT00764322|474388643|FG000|Overall Study|No CYP2D6 genotyping|9|||
131757229|NCT03342404|474388663|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
131908611|NCT02722967|474952983|FG002|Overall Study|Non-compliance with patch wearing|1|||
131757230|NCT03342404|474388664|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
131757231|NCT03342404|474388663|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
131757232|NCT03342404|474388664|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
131757233|NCT03342404|474388663|FG000|Blinded Treatment Phase|Adverse Event|5|||
131757234|NCT03342404|474388664|FG001|Blinded Treatment Phase|Adverse Event|4|||
131908612|NCT02722967|474952981|FG000|Overall Study|Withdrawal by Subject|1|||
131757235|NCT03342404|474388663|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
131757236|NCT03342404|474388664|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
131757237|NCT03342404|474388663|FG000|Blinded Treatment Phase|Other reasons|1|||
131757238|NCT03342404|474388664|FG001|Blinded Treatment Phase|Other reasons|0|||
131757239|NCT03342404|474388663|FG000|Blinded Treatment Phase|Physician Decision|1|||
131757240|NCT03342404|474388664|FG001|Blinded Treatment Phase|Physician Decision|0|||
131757241|NCT03342404|474388663|FG000|Blinded Treatment Phase|Death|1|||
131757242|NCT03342404|474388664|FG001|Blinded Treatment Phase|Death|0|||
131757243|NCT03342404|474388663|FG000|Open-Label Phase|Lost to Follow-up|0|||
131757244|NCT03342404|474388664|FG001|Open-Label Phase|Lost to Follow-up|1|||
131757245|NCT03342404|474388663|FG000|Open-Label Phase|Other reasons|0|||
131757246|NCT03342404|474388664|FG001|Open-Label Phase|Other reasons|1|||
131757247|NCT03342404|474388663|FG000|Open-Label Phase|Adverse Event|0|||
131757248|NCT03342404|474388664|FG001|Open-Label Phase|Adverse Event|3|||
131757249|NCT03342404|474388663|FG000|Open-Label Phase|Withdrawal by Subject|0|||
131757250|NCT03342404|474388664|FG001|Open-Label Phase|Withdrawal by Subject|6|||
131757251|NCT02348840|474388670|FG000|Overall Study|Withdrawal by Subject|2|||
131757252|NCT02348840|474388671|FG001|Overall Study|Withdrawal by Subject|1|||
131757253|NCT02348840|474388672|FG002|Overall Study|Withdrawal by Subject|0|||
131757254|NCT02348840|474388673|FG003|Overall Study|Withdrawal by Subject|0|||
131757255|NCT03748420|474388674|FG000|Overall Study|No 12 month medication adherence data available|0|||
131757256|NCT03748420|474388675|FG001|Overall Study|No 12 month medication adherence data available|1|||
131757257|NCT03748420|474388674|FG000|Overall Study|Death|24|||
131757258|NCT03748420|474388675|FG001|Overall Study|Death|28|||
131757259|NCT03748420|474388674|FG000|Overall Study|Lost to Follow-up|231|||
131757260|NCT03748420|474388675|FG001|Overall Study|Lost to Follow-up|230|||
131757261|NCT01899768|474388677|FG000|Part A|Adverse Event|2|||
131757262|NCT01899768|474388677|FG000|Part A|Withdrawal by Subject|1|||
131757263|NCT01899768|474388677|FG000|Part B|Adverse Event|1|||
131757264|NCT01899768|474388677|FG000|Part B|Withdrawal by Subject|1|||
131757265|NCT02203916|474388679|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131757266|NCT02203916|474388680|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
131757267|NCT02203916|474388681|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
131757268|NCT02203916|474388679|FG000|Overall Study|Major Protocol Deviation|1|||
131757269|NCT02203916|474388680|FG001|Overall Study|Major Protocol Deviation|1|||
131757270|NCT02203916|474388681|FG002|Overall Study|Major Protocol Deviation|0|||
131757271|NCT02203916|474388679|FG000|Overall Study|Lost to Follow-up|0|||
131757272|NCT02203916|474388680|FG001|Overall Study|Lost to Follow-up|1|||
131757273|NCT02203916|474388681|FG002|Overall Study|Lost to Follow-up|0|||
131757274|NCT02203916|474388679|FG000|Overall Study|Voluntary Withdrawal|3|||
131757275|NCT02203916|474388680|FG001|Overall Study|Voluntary Withdrawal|3|||
131757276|NCT02203916|474388681|FG002|Overall Study|Voluntary Withdrawal|8|||
131757277|NCT02203916|474388679|FG000|Overall Study|Lack of Efficacy|3|||
131757278|NCT02203916|474388680|FG001|Overall Study|Lack of Efficacy|0|||
131757279|NCT02203916|474388681|FG002|Overall Study|Lack of Efficacy|0|||
131757280|NCT02203916|474388679|FG000|Overall Study|Reason Not Specified|0|||
131757281|NCT02203916|474388680|FG001|Overall Study|Reason Not Specified|2|||
131757282|NCT02203916|474388681|FG002|Overall Study|Reason Not Specified|1|||
131757283|NCT00414973|474388682|FG000|Overall Study|Withdrawal by Subject|14|||
131757284|NCT00414973|474388683|FG001|Overall Study|Withdrawal by Subject|4|||
131757285|NCT00414973|474388684|FG002|Overall Study|Withdrawal by Subject|1|||
131757286|NCT00414973|474388685|FG003|Overall Study|Withdrawal by Subject|0|||
131757287|NCT00414973|474388682|FG000|Overall Study|Adverse Event|10|||
131757288|NCT00414973|474388683|FG001|Overall Study|Adverse Event|0|||
131757289|NCT00414973|474388684|FG002|Overall Study|Adverse Event|1|||
131757290|NCT00414973|474388685|FG003|Overall Study|Adverse Event|0|||
131757291|NCT00414973|474388682|FG000|Overall Study|Protocol Violation|3|||
131757292|NCT00414973|474388683|FG001|Overall Study|Protocol Violation|4|||
131757293|NCT00414973|474388684|FG002|Overall Study|Protocol Violation|0|||
131757294|NCT00414973|474388685|FG003|Overall Study|Protocol Violation|0|||
131757295|NCT00414973|474388682|FG000|Overall Study|Lost to Follow-up|0|||
131757296|NCT00414973|474388683|FG001|Overall Study|Lost to Follow-up|2|||
131757297|NCT00414973|474388684|FG002|Overall Study|Lost to Follow-up|0|||
131757298|NCT00414973|474388685|FG003|Overall Study|Lost to Follow-up|0|||
131757299|NCT00414973|474388682|FG000|Overall Study|Sponsor Decision|1|||
131757300|NCT00414973|474388683|FG001|Overall Study|Sponsor Decision|0|||
131757301|NCT00414973|474388684|FG002|Overall Study|Sponsor Decision|0|||
131757302|NCT00414973|474388685|FG003|Overall Study|Sponsor Decision|0|||
131757303|NCT00414973|474388682|FG000|Overall Study|Death|0|||
131757304|NCT00414973|474388683|FG001|Overall Study|Death|0|||
131757305|NCT00414973|474388684|FG002|Overall Study|Death|1|||
131757306|NCT00414973|474388685|FG003|Overall Study|Death|0|||
131757307|NCT01466062|474388686|FG000|Overall Study|Adverse Event|1|||
131757308|NCT01466062|474388686|FG000|Overall Study|Withdrawal by Subject|1|||
131757309|NCT03152110|474388693|FG000|Overall Study|Withdrawal by Subject|3|||
131757310|NCT00850135|474388697|FG000|Overall Study|Physician Decision|1|||
131757311|NCT00338806|474388698|FG000|Acute Phase|Withdrawal by Subject|0|||
131757312|NCT00338806|474388699|FG001|Acute Phase|Withdrawal by Subject|1|||
131757313|NCT00338806|474388698|FG000|Follow-up|Lost to Follow-up|1|||
131757314|NCT00338806|474388699|FG001|Follow-up|Lost to Follow-up|3|||
131757315|NCT00744991|474388700|FG000|Overall Study|Progressive Disease|11|||
131757316|NCT00744991|474388700|FG000|Overall Study|Withdrawal by Subject|8|||
131757317|NCT00744991|474388700|FG000|Overall Study|Physician Decision|3|||
131757318|NCT00744991|474388700|FG000|Overall Study|Adverse Event|2|||
131757319|NCT00744991|474388700|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
131757320|NCT01437267|474388702|FG000|Overall Study|Withdrawal by Subject|0|||
131812005|NCT02301975|474595704|FG002|Overall Study|Adverse Event|2|||
131757321|NCT01437267|474388703|FG001|Overall Study|Withdrawal by Subject|0|||
131757322|NCT01437267|474388704|FG002|Overall Study|Withdrawal by Subject|0|||
131757323|NCT01437267|474388705|FG003|Overall Study|Withdrawal by Subject|1|||
131757324|NCT01437267|474388706|FG004|Overall Study|Withdrawal by Subject|0|||
131757325|NCT01437267|474388707|FG005|Overall Study|Withdrawal by Subject|0|||
131757326|NCT01437267|474388702|FG000|Overall Study|Protocol Violation|0|||
131757327|NCT01437267|474388703|FG001|Overall Study|Protocol Violation|1|||
131757328|NCT01437267|474388704|FG002|Overall Study|Protocol Violation|0|||
131757329|NCT01437267|474388705|FG003|Overall Study|Protocol Violation|0|||
131757330|NCT01437267|474388706|FG004|Overall Study|Protocol Violation|0|||
131757331|NCT01437267|474388707|FG005|Overall Study|Protocol Violation|0|||
131757332|NCT00333970|474388710|FG000|Overall Study|Withdrawal by Subject|13|||
131757333|NCT00333970|474388711|FG001|Overall Study|Withdrawal by Subject|7|||
131757334|NCT00608842|474388712|FG000|Overall Study|Participant's Request|0|||
131757335|NCT00608842|474388713|FG001|Overall Study|Participant's Request|1|||
131757336|NCT00608842|474388714|FG002|Overall Study|Participant's Request|2|||
131757337|NCT00608842|474388715|FG003|Overall Study|Participant's Request|1|||
131757338|NCT00608842|474388712|FG000|Overall Study|Lost to Follow-up|1|||
131757339|NCT00608842|474388713|FG001|Overall Study|Lost to Follow-up|0|||
131757340|NCT00608842|474388714|FG002|Overall Study|Lost to Follow-up|0|||
131757341|NCT00608842|474388715|FG003|Overall Study|Lost to Follow-up|0|||
131757342|NCT04445051|474388717|FG000|Overall Study|Adverse Event|0|||
131757343|NCT04445051|474388718|FG001|Overall Study|Adverse Event|0|||
131757344|NCT04445051|474388719|FG002|Overall Study|Adverse Event|1|||
131757345|NCT04445051|474388720|FG003|Overall Study|Adverse Event|0|||
131757346|NCT04445051|474388721|FG004|Overall Study|Adverse Event|0|||
131757347|NCT04445051|474388722|FG005|Overall Study|Adverse Event|0|||
131757348|NCT01188811|474388725|FG000|Overall Study|Withdrawal by Subject|0|||
131757349|NCT01188811|474388726|FG001|Overall Study|Withdrawal by Subject|2|||
131757350|NCT01188811|474388725|FG000|Overall Study|Adverse Event|6|||
131757351|NCT01188811|474388726|FG001|Overall Study|Adverse Event|0|||
131757352|NCT01602744|474388727|FG000|Overall Study|Death|17|||
131757353|NCT01602744|474388728|FG001|Overall Study|Death|15|||
131757354|NCT01602744|474388727|FG000|Overall Study|Lost to Follow-up|13|||
131757355|NCT01602744|474388728|FG001|Overall Study|Lost to Follow-up|8|||
131757356|NCT03924427|474388729|FG000|Overall Study|Adverse Event|4|||
131757357|NCT03924427|474388729|FG000|Overall Study|Lack of Efficacy|1|||
131757358|NCT03924427|474388729|FG000|Overall Study|Withdrawal by Subject|1|||
131757359|NCT03418376|474388730|FG000|Overall Study|Musculoskeletal injury|1|||
131757360|NCT03418376|474388731|FG001|Overall Study|Musculoskeletal injury|2|||
131757361|NCT03418376|474388732|FG002|Overall Study|Musculoskeletal injury|1|||
131757362|NCT03418376|474388733|FG003|Overall Study|Musculoskeletal injury|0|||
131757363|NCT03418376|474388730|FG000|Overall Study|Personal reasons|0|||
131757364|NCT03418376|474388731|FG001|Overall Study|Personal reasons|2|||
131757365|NCT03418376|474388732|FG002|Overall Study|Personal reasons|2|||
131757366|NCT03418376|474388733|FG003|Overall Study|Personal reasons|1|||
131757367|NCT03418376|474388730|FG000|Overall Study|Exacerbation|0|||
131757368|NCT03418376|474388731|FG001|Overall Study|Exacerbation|1|||
131757369|NCT03418376|474388732|FG002|Overall Study|Exacerbation|0|||
131757370|NCT03418376|474388733|FG003|Overall Study|Exacerbation|0|||
131757371|NCT03864627|474388741|FG000|Overall Study|Adverse Event|0|||
131757372|NCT03864627|474388742|FG001|Overall Study|Adverse Event|1|||
131757373|NCT03864627|474388741|FG000|Overall Study|Lack of Efficacy|0|||
131757374|NCT03864627|474388742|FG001|Overall Study|Lack of Efficacy|1|||
131757375|NCT03864627|474388741|FG000|Overall Study|Lost to Follow-up|0|||
131757376|NCT03864627|474388742|FG001|Overall Study|Lost to Follow-up|1|||
131757377|NCT03864627|474388741|FG000|Overall Study|Withdrawal by Subject|4|||
131757378|NCT03864627|474388742|FG001|Overall Study|Withdrawal by Subject|8|||
131757379|NCT03864627|474388741|FG000|Overall Study|Study terminated by sponsor|0|||
131757380|NCT03864627|474388742|FG001|Overall Study|Study terminated by sponsor|1|||
131757381|NCT01388491|474388743|FG000|Overall Study|Adverse Event|10|||
131757382|NCT01388491|474388744|FG001|Overall Study|Adverse Event|9|||
131757383|NCT01388491|474388743|FG000|Overall Study|Sponsor Request|9|||
131757384|NCT01388491|474388744|FG001|Overall Study|Sponsor Request|7|||
131757385|NCT01388491|474388743|FG000|Overall Study|Withdrawal by Subject|6|||
131757386|NCT01388491|474388744|FG001|Overall Study|Withdrawal by Subject|10|||
131757387|NCT01388491|474388743|FG000|Overall Study|Lost to Follow-up|4|||
131757388|NCT01388491|474388744|FG001|Overall Study|Lost to Follow-up|3|||
131757389|NCT01388491|474388743|FG000|Overall Study|Protocol Violation|2|||
131757390|NCT01388491|474388744|FG001|Overall Study|Protocol Violation|0|||
131757391|NCT01388491|474388743|FG000|Overall Study|Noncompliance|2|||
131757392|NCT01388491|474388744|FG001|Overall Study|Noncompliance|0|||
131757393|NCT01388491|474388743|FG000|Overall Study|Pregnancy|1|||
131757394|NCT01388491|474388744|FG001|Overall Study|Pregnancy|0|||
131757395|NCT00412113|474388746|FG000|Overall Study|Adverse Event|11|||
131757396|NCT00412113|474388747|FG001|Overall Study|Adverse Event|15|||
131757397|NCT00412113|474388746|FG000|Overall Study|did not receive treatment|1|||
131757398|NCT00412113|474388747|FG001|Overall Study|did not receive treatment|0|||
131757399|NCT01190020|474388750|FG000|Overall Study|Adverse Event|2|||
131757400|NCT01190020|474388751|FG001|Overall Study|Adverse Event|0|||
131757401|NCT01190020|474388750|FG000|Overall Study|Lost to Follow-up|2|||
131757402|NCT01190020|474388751|FG001|Overall Study|Lost to Follow-up|0|||
131757403|NCT01190020|474388750|FG000|Overall Study|Withdrawal by Subject|3|||
131757404|NCT01190020|474388751|FG001|Overall Study|Withdrawal by Subject|0|||
131757405|NCT00796224|474388752|FG000|Overall Study|Adverse Event|1|||
131757406|NCT00796224|474388753|FG001|Overall Study|Adverse Event|0|||
131757407|NCT00796224|474388752|FG000|Overall Study|Protocol Violation|0|||
131757408|NCT00796224|474388753|FG001|Overall Study|Protocol Violation|1|||
131757409|NCT02569398|474388754|FG000|Overall Study|Adverse Event|0|||
131757410|NCT02569398|474388755|FG001|Overall Study|Adverse Event|1|||
131757411|NCT02569398|474388756|FG002|Overall Study|Adverse Event|6|||
131757412|NCT02569398|474388754|FG000|Overall Study|Withdrawal by Subject|43|||
131757413|NCT02569398|474388755|FG001|Overall Study|Withdrawal by Subject|43|||
131757414|NCT02569398|474388756|FG002|Overall Study|Withdrawal by Subject|30|||
131757415|NCT02569398|474388754|FG000|Overall Study|Study terminated by sponsor|130|||
131757416|NCT02569398|474388755|FG001|Overall Study|Study terminated by sponsor|131|||
131757417|NCT02569398|474388756|FG002|Overall Study|Study terminated by sponsor|134|||
131757418|NCT02569398|474388754|FG000|Overall Study|Other|12|||
131757419|NCT02569398|474388755|FG001|Overall Study|Other|14|||
131757420|NCT02569398|474388756|FG002|Overall Study|Other|13|||
131757421|NCT02116361|474388757|FG000|Overall Study|Pregnancy|0|||
131757422|NCT02116361|474388758|FG001|Overall Study|Pregnancy|0|||
131757423|NCT02116361|474388759|FG002|Overall Study|Pregnancy|0|||
131757424|NCT02116361|474388760|FG003|Overall Study|Pregnancy|1|||
131757425|NCT02116361|474388757|FG000|Overall Study|Protocol Violation|1|||
131757426|NCT02116361|474388758|FG001|Overall Study|Protocol Violation|0|||
131757427|NCT02116361|474388759|FG002|Overall Study|Protocol Violation|0|||
131757428|NCT02116361|474388760|FG003|Overall Study|Protocol Violation|2|||
131757429|NCT02116361|474388757|FG000|Overall Study|Physician Decision|2|||
131757430|NCT02116361|474388758|FG001|Overall Study|Physician Decision|3|||
131757431|NCT02116361|474388759|FG002|Overall Study|Physician Decision|0|||
131757432|NCT02116361|474388760|FG003|Overall Study|Physician Decision|0|||
131757433|NCT02116361|474388757|FG000|Overall Study|Adverse Event|1|||
131757434|NCT02116361|474388758|FG001|Overall Study|Adverse Event|0|||
131757435|NCT02116361|474388759|FG002|Overall Study|Adverse Event|0|||
131757436|NCT02116361|474388760|FG003|Overall Study|Adverse Event|3|||
131757437|NCT02116361|474388757|FG000|Overall Study|Other Reasons|3|||
131757438|NCT02116361|474388758|FG001|Overall Study|Other Reasons|3|||
131757439|NCT02116361|474388759|FG002|Overall Study|Other Reasons|3|||
131757440|NCT02116361|474388760|FG003|Overall Study|Other Reasons|3|||
131757441|NCT02116361|474388757|FG000|Overall Study|Lack of Efficacy|5|||
131757442|NCT02116361|474388758|FG001|Overall Study|Lack of Efficacy|7|||
131757443|NCT02116361|474388759|FG002|Overall Study|Lack of Efficacy|4|||
131757444|NCT02116361|474388760|FG003|Overall Study|Lack of Efficacy|3|||
131757445|NCT02116361|474388757|FG000|Overall Study|Lost to Follow-up|4|||
131757446|NCT02116361|474388758|FG001|Overall Study|Lost to Follow-up|5|||
131757447|NCT02116361|474388759|FG002|Overall Study|Lost to Follow-up|7|||
131757448|NCT02116361|474388760|FG003|Overall Study|Lost to Follow-up|5|||
131757449|NCT02116361|474388757|FG000|Overall Study|Personal Reasons|6|||
131757450|NCT02116361|474388758|FG001|Overall Study|Personal Reasons|6|||
131757451|NCT02116361|474388759|FG002|Overall Study|Personal Reasons|4|||
131757452|NCT02116361|474388760|FG003|Overall Study|Personal Reasons|9|||
131757453|NCT02116361|474388757|FG000|Overall Study|Investigator Decision - Relapse|9|||
131757454|NCT02116361|474388758|FG001|Overall Study|Investigator Decision - Relapse|7|||
131757455|NCT02116361|474388759|FG002|Overall Study|Investigator Decision - Relapse|8|||
131757456|NCT02116361|474388760|FG003|Overall Study|Investigator Decision - Relapse|5|||
131757457|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
131757458|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
131757459|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
131757460|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
131757461|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
131757462|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
131757463|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
131757464|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
131757465|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
131757466|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
131757467|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
131757468|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
131812006|NCT02301975|474595702|FG000|Overall Study|Lack of Efficacy|1|||
131812007|NCT02301975|474595703|FG001|Overall Study|Lack of Efficacy|1|||
131812008|NCT02301975|474595704|FG002|Overall Study|Lack of Efficacy|1|||
131812009|NCT02301975|474595702|FG000|Overall Study|Protocol Violation|3|||
131812010|NCT02301975|474595703|FG001|Overall Study|Protocol Violation|5|||
131812011|NCT02301975|474595704|FG002|Overall Study|Protocol Violation|3|||
131812012|NCT02301975|474595702|FG000|Overall Study|Lost to Follow-up|0|||
131812013|NCT02301975|474595703|FG001|Overall Study|Lost to Follow-up|2|||
131812014|NCT02301975|474595704|FG002|Overall Study|Lost to Follow-up|2|||
131757469|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
131757470|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131757471|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131757472|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131757473|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
131757474|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
131757475|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
131757476|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
131757477|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
131757478|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
131757479|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
131757480|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
131757481|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
131757482|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
131757483|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
131757484|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
131757485|NCT03227224|474388763|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
131757486|NCT03227224|474388764|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
131757487|NCT03227224|474388765|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
131757488|NCT03227224|474388766|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
131757489|NCT03227224|474388763|FG000|Follow-up Phase (2 Weeks)|Other|4|||
131757490|NCT03227224|474388764|FG001|Follow-up Phase (2 Weeks)|Other|4|||
131757491|NCT03227224|474388765|FG002|Follow-up Phase (2 Weeks)|Other|6|||
131757492|NCT03227224|474388766|FG003|Follow-up Phase (2 Weeks)|Other|3|||
131757493|NCT04195750|474388767|FG000|Overall Study|Death|245|||
131812015|NCT02301975|474595702|FG000|Overall Study|Physician Decision|4|||
131812016|NCT02301975|474595703|FG001|Overall Study|Physician Decision|2|||
131812017|NCT02301975|474595704|FG002|Overall Study|Physician Decision|3|||
131812018|NCT02301975|474595702|FG000|Overall Study|Withdrawal by Subject|15|||
131812019|NCT02301975|474595703|FG001|Overall Study|Withdrawal by Subject|12|||
131812020|NCT02301975|474595704|FG002|Overall Study|Withdrawal by Subject|11|||
131812021|NCT01531894|474595709|FG000|Overall Study|Physician Decision|8|||
131812022|NCT01531894|474595709|FG000|Overall Study|Death|1|||
131812023|NCT03086460|474595710|FG000|Study Participants|Lost to Follow-up|2|||
131812024|NCT03086460|474595710|FG000|Study Participants|Protocol Violation|1|||
131812025|NCT03086460|474595710|FG000|Study Participants|Withdrawal by Subject|6|||
131908613|NCT02722967|474952982|FG001|Overall Study|Withdrawal by Subject|0|||
131908614|NCT02722967|474952983|FG002|Overall Study|Withdrawal by Subject|1|||
131757494|NCT04195750|474388768|FG001|Overall Study|Death|253|||
131757495|NCT04195750|474388769|FG002|Overall Study|Death|5|||
131757496|NCT04195750|474388767|FG000|Overall Study|Physician Decision|0|||
131757497|NCT04195750|474388768|FG001|Overall Study|Physician Decision|1|||
131757498|NCT04195750|474388769|FG002|Overall Study|Physician Decision|0|||
131757499|NCT04195750|474388767|FG000|Overall Study|Withdrawal by Subject|9|||
131757500|NCT04195750|474388768|FG001|Overall Study|Withdrawal by Subject|8|||
131757501|NCT04195750|474388769|FG002|Overall Study|Withdrawal by Subject|0|||
131757502|NCT04195750|474388767|FG000|Overall Study|Ongoing|120|||
131757503|NCT04195750|474388768|FG001|Overall Study|Ongoing|110|||
131757504|NCT04195750|474388769|FG002|Overall Study|Ongoing|4|||
131757505|NCT02406027|474388770|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131757506|NCT02406027|474388771|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
131757507|NCT02406027|474388772|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
131757508|NCT02406027|474388773|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131757509|NCT02406027|474388774|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131757510|NCT02406027|474388775|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131757511|NCT02406027|474388776|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131757512|NCT02406027|474388770|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
131757513|NCT02406027|474388771|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131757514|NCT02406027|474388772|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
131757515|NCT02406027|474388773|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131757516|NCT02406027|474388774|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131757517|NCT02406027|474388775|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131757518|NCT02406027|474388776|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131812026|NCT03086460|474595710|FG000|Treatment A|Lost to Follow-up|1|||
131812027|NCT03086460|474595710|FG000|Treatment A|Protocol Violation|1|||
131812028|NCT03086460|474595710|FG000|Treatment A|Withdrawal by Subject|2|||
131812029|NCT03086460|474595710|FG000|Treatment C|Withdrawal by Subject|2|||
131812030|NCT03086460|474595710|FG000|Treatment E|Lost to Follow-up|1|||
131908615|NCT02722967|474952981|FG000|Overall Study|Physician Decision|1|||
131908616|NCT02722967|474952982|FG001|Overall Study|Physician Decision|0|||
131757519|NCT02406027|474388770|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
131757520|NCT02406027|474388771|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
131757521|NCT02406027|474388772|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
131757522|NCT02406027|474388773|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131757523|NCT02406027|474388774|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131757524|NCT02406027|474388775|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131757525|NCT02406027|474388776|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131757526|NCT02406027|474388770|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
131757527|NCT02406027|474388771|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131757528|NCT02406027|474388772|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
131757529|NCT02406027|474388773|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131757530|NCT02406027|474388774|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131757531|NCT02406027|474388775|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131757532|NCT02406027|474388776|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131757533|NCT02406027|474388770|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
131757534|NCT02406027|474388771|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
131757535|NCT02406027|474388772|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
131757536|NCT02406027|474388773|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
131757537|NCT02406027|474388774|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
131757538|NCT02406027|474388775|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
131757539|NCT02406027|474388776|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
131757540|NCT02406027|474388770|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
131757541|NCT02406027|474388771|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
131757542|NCT02406027|474388772|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
131757543|NCT02406027|474388773|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
131757544|NCT02406027|474388774|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
131757545|NCT02406027|474388775|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
131757546|NCT02406027|474388776|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
131757547|NCT02406027|474388770|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131757548|NCT02406027|474388771|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131757549|NCT02406027|474388772|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131757550|NCT02406027|474388773|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
131757551|NCT02406027|474388774|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
131757552|NCT02406027|474388775|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131757553|NCT02406027|474388776|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
131757554|NCT02406027|474388770|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
131757555|NCT02406027|474388771|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
131757556|NCT02406027|474388772|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
131757557|NCT02406027|474388773|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
131757558|NCT02406027|474388774|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
131757559|NCT02406027|474388775|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
131757560|NCT02406027|474388776|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
131757561|NCT02406027|474388770|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131757562|NCT02406027|474388771|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131757563|NCT02406027|474388772|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131757564|NCT02406027|474388773|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131757565|NCT02406027|474388774|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131812031|NCT03086460|474595710|FG000|Treatment E|Withdrawal by Subject|3|||
131812032|NCT03606174|474595711|FG000|Overall Study|Death|37|||
131812033|NCT03606174|474595712|FG001|Overall Study|Death|15|||
131812034|NCT03606174|474595713|FG002|Overall Study|Death|15|||
131812035|NCT03606174|474595714|FG003|Overall Study|Death|7|||
131757566|NCT02406027|474388775|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
131812036|NCT03606174|474595715|FG004|Overall Study|Death|35|||
131812037|NCT03606174|474595716|FG005|Overall Study|Death|12|||
131812038|NCT03606174|474595717|FG006|Overall Study|Death|35|||
131812039|NCT03606174|474595718|FG007|Overall Study|Death|8|||
131812040|NCT03606174|474595719|FG008|Overall Study|Death|5|||
131812041|NCT03606174|474595720|FG009|Overall Study|Death|3|||
131757567|NCT02406027|474388776|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131757568|NCT02406027|474388770|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131757569|NCT02406027|474388771|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131812042|NCT03606174|474595721|FG010|Overall Study|Death|0|||
131812043|NCT03606174|474595711|FG000|Overall Study|Lost to Follow-up|0|||
131812044|NCT03606174|474595712|FG001|Overall Study|Lost to Follow-up|0|||
131812045|NCT03606174|474595713|FG002|Overall Study|Lost to Follow-up|0|||
131812046|NCT03606174|474595714|FG003|Overall Study|Lost to Follow-up|0|||
131812047|NCT03606174|474595715|FG004|Overall Study|Lost to Follow-up|1|||
131398665|NCT00878254|473081217|FG000|Overall Study|Withdrawal by Subject|1|||
131757570|NCT02406027|474388772|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131757571|NCT02406027|474388773|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131757572|NCT02406027|474388774|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
131757573|NCT02406027|474388775|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131757574|NCT02406027|474388776|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131757575|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
131757576|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
131757577|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
131757578|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
131757579|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Other|13|||
131757580|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
131757581|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
131757582|NCT02497287|474388777|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
131757583|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
131757584|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
131757585|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
131757586|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
131757587|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
131757588|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
131757589|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
131757590|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
131757591|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
131757592|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
131757593|NCT02497287|474388777|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
131757594|NCT02497287|474388777|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
131757595|NCT02497287|474388777|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
131757596|NCT02497287|474388777|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
131757597|NCT02497287|474388777|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
131757598|NCT02497287|474388777|FG000|Follow-up Phase (4 Week)|Other|1|||
131757599|NCT03782376|474388778|FG000|Overall Study|Lost to Follow-up|2|||
131757600|NCT03782376|474388779|FG001|Overall Study|Lost to Follow-up|2|||
131757601|NCT03782376|474388778|FG000|Overall Study|Withdrawal by Subject|7|||
131757602|NCT03782376|474388779|FG001|Overall Study|Withdrawal by Subject|11|||
131757603|NCT03782376|474388778|FG000|Overall Study|Death|1|||
131757604|NCT03782376|474388779|FG001|Overall Study|Death|0|||
131757605|NCT03782376|474388778|FG000|Overall Study|Other|16|||
131757606|NCT03782376|474388779|FG001|Overall Study|Other|17|||
131757607|NCT03559192|474388780|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
131757608|NCT03559192|474388781|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
131757609|NCT03559192|474388782|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
131757610|NCT03559192|474388780|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
131757611|NCT03559192|474388781|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
131757612|NCT03559192|474388782|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
131757613|NCT03559192|474388780|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
131757614|NCT03559192|474388781|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
131757615|NCT03559192|474388782|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
131757616|NCT03559192|474388780|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
131757617|NCT03559192|474388781|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
131757618|NCT03559192|474388782|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
131757619|NCT03559192|474388780|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
131757620|NCT03559192|474388781|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
131757621|NCT03559192|474388782|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
131757622|NCT03559192|474388780|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
131757623|NCT03559192|474388781|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
131757624|NCT03559192|474388782|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
131757625|NCT03559192|474388780|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
131757626|NCT03559192|474388781|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
131757627|NCT03559192|474388782|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
131757628|NCT03559192|474388780|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
131757629|NCT03559192|474388781|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
131757630|NCT03559192|474388782|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
131757631|NCT03559192|474388780|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
131757632|NCT03559192|474388781|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
131757633|NCT03559192|474388782|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
131757634|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
131757635|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
131812048|NCT03606174|474595716|FG005|Overall Study|Lost to Follow-up|1|||
131398666|NCT00194077|473081218|FG000|Overall Study|Lack of Efficacy|22|||
131757636|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Death|0|||
131757637|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Death|4|||
131757638|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
131757639|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
131757640|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
131757641|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
131757642|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
131757643|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
131757644|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
131757645|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
131812049|NCT03606174|474595717|FG006|Overall Study|Lost to Follow-up|0|||
131812050|NCT03606174|474595718|FG007|Overall Study|Lost to Follow-up|0|||
131812051|NCT03606174|474595719|FG008|Overall Study|Lost to Follow-up|0|||
131812052|NCT03606174|474595720|FG009|Overall Study|Lost to Follow-up|0|||
131812053|NCT03606174|474595721|FG010|Overall Study|Lost to Follow-up|0|||
131812054|NCT03606174|474595711|FG000|Overall Study|Withdrawal by Subject|6|||
131812055|NCT03606174|474595712|FG001|Overall Study|Withdrawal by Subject|0|||
131812056|NCT03606174|474595713|FG002|Overall Study|Withdrawal by Subject|0|||
131812057|NCT03606174|474595714|FG003|Overall Study|Withdrawal by Subject|1|||
131812058|NCT03606174|474595715|FG004|Overall Study|Withdrawal by Subject|2|||
131757646|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
131757647|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
131757648|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Other|4|||
131757649|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Other|3|||
131757650|NCT03517722|474388783|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
131757651|NCT03517722|474388784|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
131757652|NCT03517722|474388783|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
131757653|NCT03517722|474388784|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
131757654|NCT03517722|474388783|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
131757655|NCT03517722|474388784|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
131757656|NCT03517722|474388783|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
131757657|NCT03517722|474388784|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
131757658|NCT03517722|474388783|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
131757659|NCT03517722|474388784|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
131757660|NCT02422186|474388785|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
131757661|NCT02422186|474388786|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
131757662|NCT02422186|474388785|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
131757663|NCT02422186|474388786|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
131757664|NCT02422186|474388785|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
131757665|NCT02422186|474388786|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
131757666|NCT02422186|474388785|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
131757667|NCT02422186|474388786|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
131757668|NCT02422186|474388785|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
131757669|NCT02422186|474388786|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
131757670|NCT02422186|474388785|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
131757671|NCT02422186|474388786|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
131757672|NCT02422186|474388785|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
131757673|NCT02422186|474388786|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
131757674|NCT02422186|474388785|FG000|Follow-up Phase (2 Weeks)|Other|3|||
131757675|NCT02422186|474388786|FG001|Follow-up Phase (2 Weeks)|Other|0|||
131757676|NCT01226472|474388787|FG000|Overall Study|Progressive Disease|1|||
131757677|NCT00952419|474388790|FG000|Overall Study|Adverse Event|2|||
131757678|NCT00952419|474388791|FG001|Overall Study|Adverse Event|0|||
131757679|NCT00952419|474388792|FG002|Overall Study|Adverse Event|0|||
131757680|NCT00952419|474388790|FG000|Overall Study|Protocol Violation|3|||
131757681|NCT00952419|474388791|FG001|Overall Study|Protocol Violation|7|||
131757682|NCT00952419|474388792|FG002|Overall Study|Protocol Violation|0|||
131757683|NCT00952419|474388790|FG000|Overall Study|Withdrawal by Subject|1|||
131757684|NCT00952419|474388791|FG001|Overall Study|Withdrawal by Subject|3|||
131757685|NCT00952419|474388792|FG002|Overall Study|Withdrawal by Subject|0|||
131757686|NCT03573804|474388793|FG000|Overall Study|claustrophobia or MRI table problems|10|||
131812059|NCT03606174|474595716|FG005|Overall Study|Withdrawal by Subject|1|||
131812060|NCT03606174|474595717|FG006|Overall Study|Withdrawal by Subject|4|||
131812061|NCT03606174|474595718|FG007|Overall Study|Withdrawal by Subject|0|||
131812062|NCT03606174|474595719|FG008|Overall Study|Withdrawal by Subject|0|||
131757687|NCT03399786|474388794|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131812063|NCT03606174|474595720|FG009|Overall Study|Withdrawal by Subject|0|||
131812064|NCT03606174|474595721|FG010|Overall Study|Withdrawal by Subject|1|||
131812065|NCT03606174|474595711|FG000|Overall Study|Study Terminated by Sponsor|5|||
131812066|NCT03606174|474595712|FG001|Overall Study|Study Terminated by Sponsor|7|||
131812067|NCT03606174|474595713|FG002|Overall Study|Study Terminated by Sponsor|3|||
131757688|NCT03399786|474388795|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131757689|NCT03399786|474388796|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131757690|NCT03399786|474388797|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131757691|NCT03399786|474388794|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
131757692|NCT03399786|474388795|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
131757693|NCT03399786|474388796|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
131757694|NCT03399786|474388797|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
131757695|NCT03399786|474388794|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
131757696|NCT03399786|474388795|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
131757697|NCT03399786|474388796|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
131757698|NCT03399786|474388797|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
131757699|NCT00400946|474390439|FG000|Overall Study|Ineligible|0|||
131757700|NCT00400946|474390440|FG001|Overall Study|Ineligible|0|||
131757701|NCT00400946|474390441|FG002|Overall Study|Ineligible|0|||
131757702|NCT00400946|474390442|FG003|Overall Study|Ineligible|5|||
131757703|NCT00400946|474390443|FG004|Overall Study|Ineligible|1|||
131757704|NCT00400946|474390439|FG000|Overall Study|Induction Failure|0|||
131757705|NCT00400946|474390440|FG001|Overall Study|Induction Failure|0|||
131757706|NCT00400946|474390441|FG002|Overall Study|Induction Failure|0|||
131757707|NCT00400946|474390442|FG003|Overall Study|Induction Failure|11|||
131757708|NCT00400946|474390443|FG004|Overall Study|Induction Failure|8|||
131757709|NCT00400946|474390439|FG000|Overall Study|Induction Death|0|||
131757710|NCT00400946|474390440|FG001|Overall Study|Induction Death|0|||
131757711|NCT00400946|474390441|FG002|Overall Study|Induction Death|0|||
131757712|NCT00400946|474390442|FG003|Overall Study|Induction Death|13|||
131757713|NCT00400946|474390443|FG004|Overall Study|Induction Death|3|||
131757714|NCT00400946|474390439|FG000|Overall Study|Lost to Follow-up|1|||
131757715|NCT00400946|474390440|FG001|Overall Study|Lost to Follow-up|1|||
131757716|NCT00400946|474390441|FG002|Overall Study|Lost to Follow-up|0|||
131757717|NCT00400946|474390442|FG003|Overall Study|Lost to Follow-up|0|||
131757718|NCT00400946|474390443|FG004|Overall Study|Lost to Follow-up|1|||
131908617|NCT02722967|474952983|FG002|Overall Study|Physician Decision|0|||
131908618|NCT02722967|474952981|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
131908619|NCT02722967|474952982|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
131757719|NCT00400946|474390439|FG000|Overall Study|Remission Death|1|||
131757720|NCT00400946|474390440|FG001|Overall Study|Remission Death|1|||
131757721|NCT00400946|474390441|FG002|Overall Study|Remission Death|0|||
131757722|NCT00400946|474390442|FG003|Overall Study|Remission Death|0|||
131757723|NCT00400946|474390443|FG004|Overall Study|Remission Death|1|||
131757724|NCT00400946|474390439|FG000|Overall Study|Relapse|9|||
131757725|NCT00400946|474390440|FG001|Overall Study|Relapse|2|||
131757726|NCT00400946|474390441|FG002|Overall Study|Relapse|1|||
131757727|NCT00400946|474390442|FG003|Overall Study|Relapse|1|||
131757728|NCT00400946|474390443|FG004|Overall Study|Relapse|5|||
131757729|NCT00400946|474390439|FG000|Overall Study|Transplant in CR1|0|||
131757730|NCT00400946|474390440|FG001|Overall Study|Transplant in CR1|0|||
131757731|NCT00400946|474390441|FG002|Overall Study|Transplant in CR1|0|||
131757732|NCT00400946|474390442|FG003|Overall Study|Transplant in CR1|10|||
131757733|NCT00400946|474390443|FG004|Overall Study|Transplant in CR1|1|||
131757734|NCT00400946|474390439|FG000|Overall Study|Withdrawal by Subject|2|||
131757735|NCT00400946|474390440|FG001|Overall Study|Withdrawal by Subject|5|||
131757736|NCT00400946|474390441|FG002|Overall Study|Withdrawal by Subject|1|||
131908620|NCT02722967|474952983|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
131398667|NCT00194077|473081219|FG001|Overall Study|Lack of Efficacy|29|||
131757737|NCT00400946|474390442|FG003|Overall Study|Withdrawal by Subject|5|||
131757738|NCT00400946|474390443|FG004|Overall Study|Withdrawal by Subject|8|||
131757739|NCT00400946|474390439|FG000|Overall Study|Clinical|1|||
131757740|NCT00400946|474390440|FG001|Overall Study|Clinical|2|||
131757741|NCT00400946|474390441|FG002|Overall Study|Clinical|0|||
131757742|NCT00400946|474390442|FG003|Overall Study|Clinical|2|||
131757743|NCT00400946|474390443|FG004|Overall Study|Clinical|9|||
131757744|NCT00400946|474390439|FG000|Overall Study|Other|0|||
131757745|NCT00400946|474390440|FG001|Overall Study|Other|0|||
131757746|NCT00400946|474390441|FG002|Overall Study|Other|0|||
131757747|NCT00400946|474390442|FG003|Overall Study|Other|0|||
131757748|NCT00400946|474390443|FG004|Overall Study|Other|1|||
131757749|NCT05643170|474390444|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
131757750|NCT05643170|474390444|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
131757751|NCT01432756|474390445|FG000|Overall Study|Lost to Follow-up|1|||
131757752|NCT01432756|474390446|FG001|Overall Study|Lost to Follow-up|0|||
131757753|NCT01432756|474390447|FG002|Overall Study|Lost to Follow-up|2|||
131757754|NCT01432756|474390448|FG003|Overall Study|Lost to Follow-up|1|||
131757755|NCT01673373|474390457|FG000|Overall Study|Death|2|||
131757756|NCT01431521|474390461|FG000|Overall Study|Withdrawal by Subject|0|||
131908621|NCT00846053|474952986|FG000|Overall Study|Physician Decision|3|||
131908622|NCT00846053|474952987|FG001|Overall Study|Physician Decision|0|||
131908623|NCT00111761|474952988|FG000|Part 1|Physician Decision|0|||
131908624|NCT00111761|474952989|FG001|Part 1|Physician Decision|1|||
131757757|NCT01431521|474390462|FG001|Overall Study|Withdrawal by Subject|0|||
131757758|NCT01431521|474390463|FG002|Overall Study|Withdrawal by Subject|1|||
131757759|NCT01431521|474390464|FG003|Overall Study|Withdrawal by Subject|0|||
131757760|NCT01572844|474390465|FG000|Overall Study|Physician Decision|1|||
131757761|NCT01572844|474390466|FG001|Overall Study|Physician Decision|1|||
131757762|NCT00366444|474390468|FG000|Overall Study|Withdrawal by Subject|1|||
131757763|NCT00366444|474390469|FG001|Overall Study|Withdrawal by Subject|1|||
131757764|NCT00366444|474390468|FG000|Overall Study|Lack of Efficacy|0|||
131757765|NCT00366444|474390469|FG001|Overall Study|Lack of Efficacy|1|||
131757766|NCT05171816|474390470|FG000|Overall Study|Death|18|||
131757767|NCT05171816|474390471|FG001|Overall Study|Death|16|||
131757768|NCT04667949|474390472|FG000|Overall Study|Adverse Event|0|||
131757769|NCT04667949|474390473|FG001|Overall Study|Adverse Event|2|||
131757770|NCT04667949|474390472|FG000|Overall Study|Lost to Follow-up|0|||
131757771|NCT04667949|474390473|FG001|Overall Study|Lost to Follow-up|1|||
131757772|NCT04667949|474390472|FG000|Overall Study|Physician Decision|0|||
131757773|NCT04667949|474390473|FG001|Overall Study|Physician Decision|2|||
131757774|NCT04667949|474390472|FG000|Overall Study|Subject decision|1|||
131757775|NCT04667949|474390473|FG001|Overall Study|Subject decision|7|||
131757776|NCT02365506|474390477|FG000|Overall Study|Investigator's Discretion|0|||
131757777|NCT02365506|474390478|FG001|Overall Study|Investigator's Discretion|0|||
131757778|NCT02365506|474390479|FG002|Overall Study|Investigator's Discretion|1|||
131757779|NCT03774875|474390480|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
131757780|NCT03774875|474390481|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
131757781|NCT03774875|474390480|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
131757782|NCT03774875|474390481|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
131757783|NCT03774875|474390480|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
131757784|NCT03774875|474390481|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
131757785|NCT03774875|474390480|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
131757786|NCT03774875|474390481|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
131757787|NCT03774875|474390480|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
131757788|NCT03774875|474390481|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
131757789|NCT03774875|474390480|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
131757790|NCT03774875|474390481|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
131757791|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
131757792|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
131757793|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
131757794|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
131757795|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
131757796|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
131757797|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
131757798|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
131757799|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
131757800|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
131757801|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
131757802|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
131757803|NCT03774875|474390480|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
131757804|NCT03774875|474390481|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
131757805|NCT04088331|474390484|FG000|Overall Study|Lost to Follow-up|3|||
131757806|NCT04088331|474390484|FG000|Overall Study|Withdrawal by Subject|7|||
131757807|NCT04088331|474390484|FG000|Overall Study|Adverse Event|4|||
131812068|NCT03606174|474595714|FG003|Overall Study|Study Terminated by Sponsor|0|||
131812069|NCT03606174|474595715|FG004|Overall Study|Study Terminated by Sponsor|11|||
131812070|NCT03606174|474595716|FG005|Overall Study|Study Terminated by Sponsor|6|||
131812071|NCT03606174|474595717|FG006|Overall Study|Study Terminated by Sponsor|12|||
131812072|NCT03606174|474595718|FG007|Overall Study|Study Terminated by Sponsor|1|||
131812073|NCT03606174|474595719|FG008|Overall Study|Study Terminated by Sponsor|3|||
131812074|NCT03606174|474595720|FG009|Overall Study|Study Terminated by Sponsor|1|||
131812075|NCT03606174|474595721|FG010|Overall Study|Study Terminated by Sponsor|2|||
131812076|NCT03606174|474595711|FG000|Overall Study|Miscellaneous|1|||
131398668|NCT00194077|473081218|FG000|Overall Study|Study nonadherence|1|||
131812077|NCT03606174|474595712|FG001|Overall Study|Miscellaneous|1|||
131812078|NCT03606174|474595713|FG002|Overall Study|Miscellaneous|0|||
131757838|NCT03233308|474390494|FG000|Overall Study|Adverse Event|1|||
131757839|NCT03233308|474390494|FG000|Overall Study|Protocol Violation|1|||
131757840|NCT02155712|474390500|FG000|Overall Study|Death|12|||
131757841|NCT02155712|474390501|FG001|Overall Study|Death|0|||
131757842|NCT02155712|474390500|FG000|Overall Study|Lost to Follow-up|37|||
131757843|NCT02155712|474390501|FG001|Overall Study|Lost to Follow-up|22|||
131757844|NCT02155712|474390500|FG000|Overall Study|Revision of device|4|||
131757845|NCT02155712|474390501|FG001|Overall Study|Revision of device|3|||
131757846|NCT02155712|474390500|FG000|Overall Study|Withdrawal by Subject|39|||
131757847|NCT02155712|474390501|FG001|Overall Study|Withdrawal by Subject|21|||
131757848|NCT02155712|474390500|FG000|Overall Study|Site termination|77|||
131757849|NCT02155712|474390501|FG001|Overall Study|Site termination|19|||
131757850|NCT02155712|474390500|FG000|Overall Study|Sponsor terminated study early|150|||
131757851|NCT02155712|474390501|FG001|Overall Study|Sponsor terminated study early|0|||
131757852|NCT02155712|474390500|FG000|Overall Study|Missed final 5-year protocol visit|0|||
131757853|NCT02155712|474390501|FG001|Overall Study|Missed final 5-year protocol visit|32|||
131757854|NCT02155712|474390500|FG000|Overall Study|Censored because surgery cancelled|6|||
131757855|NCT02155712|474390501|FG001|Overall Study|Censored because surgery cancelled|10|||
131757856|NCT02155712|474390500|FG000|Overall Study|Censored because study device was not implanted|61|||
131757857|NCT02155712|474390501|FG001|Overall Study|Censored because study device was not implanted|66|||
131757858|NCT02155712|474390500|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
131757859|NCT02155712|474390501|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
131757860|NCT00976963|474390502|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
131757861|NCT00976963|474390503|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
131757862|NCT00976963|474390502|FG000|Overall Study|administrative error|1|||
131757863|NCT00976963|474390503|FG001|Overall Study|administrative error|0|||
131757864|NCT00976963|474390502|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
131757865|NCT00976963|474390503|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
131757866|NCT00085644|474390514|FG000|Double-Blind Period|Adverse Event|5|||
131757867|NCT00085644|474390515|FG001|Double-Blind Period|Adverse Event|2|||
131757868|NCT00085644|474390516|FG002|Double-Blind Period|Adverse Event|0|||
131757869|NCT00085644|474390514|FG000|Double-Blind Period|Withdrawal by Subject|3|||
131757870|NCT00085644|474390515|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131757871|NCT00085644|474390516|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131812079|NCT03606174|474595714|FG003|Overall Study|Miscellaneous|1|||
131812080|NCT03606174|474595715|FG004|Overall Study|Miscellaneous|4|||
131812081|NCT03606174|474595716|FG005|Overall Study|Miscellaneous|7|||
131812082|NCT03606174|474595717|FG006|Overall Study|Miscellaneous|5|||
131812083|NCT03606174|474595718|FG007|Overall Study|Miscellaneous|0|||
131812084|NCT03606174|474595719|FG008|Overall Study|Miscellaneous|0|||
131812085|NCT03606174|474595720|FG009|Overall Study|Miscellaneous|0|||
131757872|NCT00085644|474390514|FG000|Double-Blind Period|Lost to Follow-up|2|||
131757873|NCT00085644|474390515|FG001|Double-Blind Period|Lost to Follow-up|1|||
131757874|NCT00085644|474390516|FG002|Double-Blind Period|Lost to Follow-up|0|||
131757875|NCT00085644|474390514|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
131757876|NCT00085644|474390515|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
131757877|NCT00085644|474390516|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
131757878|NCT00085644|474390514|FG000|Double-Blind Period|Contemplating pregnancy|1|||
131757879|NCT00085644|474390515|FG001|Double-Blind Period|Contemplating pregnancy|0|||
131757880|NCT00085644|474390516|FG002|Double-Blind Period|Contemplating pregnancy|0|||
131812086|NCT03606174|474595721|FG010|Overall Study|Miscellaneous|1|||
131757881|NCT00085644|474390514|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
131757882|NCT00085644|474390515|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
131757883|NCT00085644|474390516|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
131757884|NCT00085644|474390514|FG000|Open-Label Period|Adverse Event|0|||
131757885|NCT00085644|474390515|FG001|Open-Label Period|Adverse Event|0|||
131757886|NCT00085644|474390516|FG002|Open-Label Period|Adverse Event|38|||
131757887|NCT00085644|474390514|FG000|Open-Label Period|Withdrawal by Subject|0|||
131757888|NCT00085644|474390515|FG001|Open-Label Period|Withdrawal by Subject|0|||
131757889|NCT00085644|474390516|FG002|Open-Label Period|Withdrawal by Subject|29|||
131757890|NCT00085644|474390514|FG000|Open-Label Period|Lost to Follow-up|0|||
131757891|NCT00085644|474390515|FG001|Open-Label Period|Lost to Follow-up|0|||
131757892|NCT00085644|474390516|FG002|Open-Label Period|Lost to Follow-up|13|||
131757893|NCT00085644|474390514|FG000|Open-Label Period|Lack of Efficacy|0|||
131757894|NCT00085644|474390515|FG001|Open-Label Period|Lack of Efficacy|0|||
131757895|NCT00085644|474390516|FG002|Open-Label Period|Lack of Efficacy|15|||
131757896|NCT00085644|474390514|FG000|Open-Label Period|Pregnancy|0|||
131757897|NCT00085644|474390515|FG001|Open-Label Period|Pregnancy|0|||
131757898|NCT00085644|474390516|FG002|Open-Label Period|Pregnancy|3|||
131757899|NCT00085644|474390514|FG000|Open-Label Period|Contemplating pregnancy|0|||
131757900|NCT00085644|474390515|FG001|Open-Label Period|Contemplating pregnancy|0|||
131757901|NCT00085644|474390516|FG002|Open-Label Period|Contemplating pregnancy|3|||
131757902|NCT00085644|474390514|FG000|Open-Label Period|Protocol Violation|0|||
131757903|NCT00085644|474390515|FG001|Open-Label Period|Protocol Violation|0|||
131757904|NCT00085644|474390516|FG002|Open-Label Period|Protocol Violation|4|||
131757905|NCT00085644|474390514|FG000|Open-Label Period|Personal reason|0|||
131757906|NCT00085644|474390515|FG001|Open-Label Period|Personal reason|0|||
131757907|NCT00085644|474390516|FG002|Open-Label Period|Personal reason|4|||
131757908|NCT04259346|474390517|FG000|Overall Study|Lost to Follow-up|1|||
131757909|NCT04259346|474390518|FG001|Overall Study|Lost to Follow-up|3|||
131757910|NCT04259346|474390517|FG000|Overall Study|Protocol Violation|1|||
131757911|NCT04259346|474390518|FG001|Overall Study|Protocol Violation|0|||
131757912|NCT04259346|474390517|FG000|Overall Study|Withdrawal by Subject|1|||
131757913|NCT04259346|474390518|FG001|Overall Study|Withdrawal by Subject|0|||
131757914|NCT04259346|474390517|FG000|Overall Study|Adverse Event|1|||
131757915|NCT04259346|474390518|FG001|Overall Study|Adverse Event|1|||
131757916|NCT03330106|474390519|FG000|Part A|Withdrawal by Subject|1|||
131757917|NCT03330106|474390520|FG001|Part A|Withdrawal by Subject|1|||
131757918|NCT03330106|474390521|FG002|Part A|Withdrawal by Subject|0|||
131757919|NCT03330106|474390522|FG003|Part A|Withdrawal by Subject|0|||
131757920|NCT03330106|474390519|FG000|Part A|Death|2|||
131757921|NCT03330106|474390520|FG001|Part A|Death|1|||
131757922|NCT03330106|474390521|FG002|Part A|Death|0|||
131757923|NCT03330106|474390522|FG003|Part A|Death|0|||
131757924|NCT03330106|474390519|FG000|Part A|Adverse Event|0|||
131757925|NCT03330106|474390520|FG001|Part A|Adverse Event|1|||
131757926|NCT03330106|474390521|FG002|Part A|Adverse Event|0|||
131757927|NCT03330106|474390522|FG003|Part A|Adverse Event|0|||
131757928|NCT03330106|474390519|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
131812087|NCT04994535|474595723|FG000|Overall Study|Lost to Follow-up|7|||
131812088|NCT04994535|474595724|FG001|Overall Study|Lost to Follow-up|7|||
131812089|NCT04994535|474595723|FG000|Overall Study|Withdrawal by Subject|10|||
131812090|NCT04994535|474595724|FG001|Overall Study|Withdrawal by Subject|7|||
131812091|NCT04994535|474595723|FG000|Overall Study|Other|1|||
131812092|NCT04994535|474595724|FG001|Overall Study|Other|1|||
131812093|NCT01158118|474595725|FG000|Overall Study|Screen failure|1|||
131812094|NCT01158118|474595726|FG001|Overall Study|Screen failure|0|||
131812095|NCT01158118|474595725|FG000|Overall Study|Donor match was a screen failure|0|||
131812096|NCT01158118|474595726|FG001|Overall Study|Donor match was a screen failure|1|||
131812097|NCT01158118|474595725|FG000|Overall Study|Suffered stroke prior to transplant|0|||
131812098|NCT01158118|474595726|FG001|Overall Study|Suffered stroke prior to transplant|1|||
131812099|NCT01158118|474595725|FG000|Overall Study|Death|0|||
131812100|NCT01158118|474595726|FG001|Overall Study|Death|1|||
131812101|NCT00113386|474595729|FG000|Overall Study|Withdrawal by Subject|1|||
131398669|NCT00194077|473081219|FG001|Overall Study|Study nonadherence|0|||
131757929|NCT03330106|474390520|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
131757930|NCT03330106|474390521|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
131757931|NCT03330106|474390522|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
131757932|NCT03330106|474390519|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
131757933|NCT03330106|474390520|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
131757934|NCT03330106|474390521|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
131757935|NCT03330106|474390522|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
131757936|NCT03330106|474390519|FG000|Part A|Progressive Disease|0|||
131757937|NCT03330106|474390520|FG001|Part A|Progressive Disease|1|||
131757938|NCT03330106|474390521|FG002|Part A|Progressive Disease|0|||
131812102|NCT00113386|474595730|FG001|Overall Study|Withdrawal by Subject|0|||
131812103|NCT00113386|474595729|FG000|Overall Study|Physician Decision|0|||
131812104|NCT00113386|474595730|FG001|Overall Study|Physician Decision|1|||
131757939|NCT03330106|474390522|FG003|Part A|Progressive Disease|0|||
131757940|NCT03330106|474390519|FG000|Part B|Lost to Follow-up|0|||
131757941|NCT03330106|474390520|FG001|Part B|Lost to Follow-up|0|||
131757942|NCT03330106|474390521|FG002|Part B|Lost to Follow-up|0|||
131757943|NCT03330106|474390522|FG003|Part B|Lost to Follow-up|1|||
131757944|NCT03330106|474390519|FG000|Part B|Withdrawal by Subject|0|||
131757945|NCT03330106|474390520|FG001|Part B|Withdrawal by Subject|0|||
131757946|NCT03330106|474390521|FG002|Part B|Withdrawal by Subject|4|||
131757947|NCT03330106|474390522|FG003|Part B|Withdrawal by Subject|0|||
131757948|NCT03330106|474390519|FG000|Part B|Death|0|||
131757949|NCT03330106|474390520|FG001|Part B|Death|0|||
131757950|NCT03330106|474390521|FG002|Part B|Death|2|||
131757951|NCT03330106|474390522|FG003|Part B|Death|0|||
131757952|NCT03330106|474390519|FG000|Part B|Clinical Progression|0|||
131757953|NCT03330106|474390520|FG001|Part B|Clinical Progression|0|||
131757954|NCT03330106|474390521|FG002|Part B|Clinical Progression|1|||
131757955|NCT03330106|474390522|FG003|Part B|Clinical Progression|1|||
131757956|NCT03330106|474390519|FG000|Part B|Symptomatic Deterioration|0|||
131757957|NCT03330106|474390520|FG001|Part B|Symptomatic Deterioration|0|||
131757958|NCT03330106|474390521|FG002|Part B|Symptomatic Deterioration|0|||
131757959|NCT03330106|474390522|FG003|Part B|Symptomatic Deterioration|1|||
131757960|NCT03330106|474390519|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
131757961|NCT03330106|474390520|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
131757962|NCT03330106|474390521|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
131757963|NCT03330106|474390522|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
131757964|NCT03330106|474390519|FG000|Part B|Progressive Disease|0|||
131757965|NCT03330106|474390520|FG001|Part B|Progressive Disease|0|||
131757966|NCT03330106|474390521|FG002|Part B|Progressive Disease|11|||
131757967|NCT03330106|474390522|FG003|Part B|Progressive Disease|4|||
131757968|NCT00623766|474390523|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
131757969|NCT00623766|474390524|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
131757970|NCT00623766|474390523|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
131757971|NCT00623766|474390524|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
131757972|NCT00623766|474390523|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
131757973|NCT00623766|474390524|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
131757974|NCT00623766|474390523|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
131757975|NCT00623766|474390524|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
131757976|NCT00623766|474390523|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
131757977|NCT00623766|474390524|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
131757978|NCT03198728|474390528|FG000|Overall Study|Adverse Event|10|||
131757979|NCT03198728|474390529|FG001|Overall Study|Adverse Event|5|||
131757980|NCT03198728|474390528|FG000|Overall Study|Lost to Follow-up|21|||
131757981|NCT03198728|474390529|FG001|Overall Study|Lost to Follow-up|7|||
131757982|NCT03198728|474390528|FG000|Overall Study|Physician Decision|7|||
131757983|NCT03198728|474390529|FG001|Overall Study|Physician Decision|2|||
131757984|NCT03198728|474390528|FG000|Overall Study|Withdrawal by Subject|14|||
131757985|NCT03198728|474390529|FG001|Overall Study|Withdrawal by Subject|10|||
131757986|NCT04051944|474390533|FG000|Overall Study|Study ending|1|||
131757987|NCT04051944|474390534|FG001|Overall Study|Study ending|1|||
131757988|NCT04051944|474390533|FG000|Overall Study|Early study termination by participant|1|||
131757989|NCT04051944|474390534|FG001|Overall Study|Early study termination by participant|0|||
131757990|NCT04051944|474390533|FG000|Overall Study|Withdrawal by Subject|2|||
131757991|NCT04051944|474390534|FG001|Overall Study|Withdrawal by Subject|2|||
131757992|NCT04051944|474390533|FG000|Overall Study|Lack of Efficacy|3|||
131757993|NCT04051944|474390534|FG001|Overall Study|Lack of Efficacy|0|||
131757994|NCT04051944|474390533|FG000|Overall Study|Adverse event, non- fatal|1|||
131757995|NCT04051944|474390534|FG001|Overall Study|Adverse event, non- fatal|1|||
131757996|NCT02139280|474390535|FG000|Overall Study|No longer eligible|2|||
131757997|NCT02139280|474390536|FG001|Overall Study|No longer eligible|0|||
131757998|NCT00736450|474390537|FG000|Overall Study|Not ABC gene eligible|19|||
131757999|NCT00736450|474390537|FG000|Overall Study|Withdrawal by Subject|5|||
131758000|NCT00736450|474390537|FG000|Overall Study|Physician Decision|1|||
131758001|NCT04157751|474390538|FG000|Overall Study|Withdrawal by Subject|12|||
131812105|NCT00113386|474595729|FG000|Overall Study|Toxicity|3|||
131812106|NCT00113386|474595730|FG001|Overall Study|Toxicity|0|||
131812107|NCT00113386|474595729|FG000|Overall Study|Ineligible|1|||
131812108|NCT00113386|474595730|FG001|Overall Study|Ineligible|2|||
131812109|NCT00113386|474595729|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
131758002|NCT04157751|474390539|FG001|Overall Study|Withdrawal by Subject|17|||
131758003|NCT04157751|474390538|FG000|Overall Study|Lost to Follow-up|6|||
131758004|NCT04157751|474390539|FG001|Overall Study|Lost to Follow-up|2|||
131758005|NCT04157751|474390538|FG000|Overall Study|Adverse Event|34|||
131758006|NCT04157751|474390539|FG001|Overall Study|Adverse Event|23|||
131758007|NCT04157751|474390538|FG000|Overall Study|Not treated|1|||
131758008|NCT04157751|474390539|FG001|Overall Study|Not treated|5|||
131812110|NCT00113386|474595730|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
131812111|NCT00392665|474595731|FG000|Overall Study|Death|16|||
131908625|NCT00111761|474952988|FG000|Part 1|Death|0|||
131908626|NCT00111761|474952989|FG001|Part 1|Death|2|||
131908627|NCT00111761|474952988|FG000|Part 1|Other|0|||
131908628|NCT00111761|474952989|FG001|Part 1|Other|1|||
131908629|NCT00111761|474952988|FG000|Part 1|Withdrawal by Subject|0|||
131908630|NCT00111761|474952989|FG001|Part 1|Withdrawal by Subject|1|||
131908631|NCT00111761|474952988|FG000|Part 2|Adverse Event|1|||
131908632|NCT00111761|474952989|FG001|Part 2|Adverse Event|0|||
131908633|NCT00111761|474952988|FG000|Part 2|Physician Decision|1|||
131908634|NCT00111761|474952989|FG001|Part 2|Physician Decision|0|||
131908635|NCT00111761|474952988|FG000|Part 2|Death|1|||
131908636|NCT00111761|474952989|FG001|Part 2|Death|0|||
131908637|NCT00111761|474952988|FG000|Part 2|Disease progression|3|||
131908638|NCT00111761|474952989|FG001|Part 2|Disease progression|0|||
131908639|NCT00111761|474952988|FG000|Part 2|Protocol-specified criteria|1|||
131908640|NCT00111761|474952989|FG001|Part 2|Protocol-specified criteria|0|||
131908641|NCT00111761|474952988|FG000|Part 2|Other|1|||
131908642|NCT00111761|474952989|FG001|Part 2|Other|0|||
131758009|NCT04157751|474390538|FG000|Overall Study|Other reason not stated above|10|||
131758010|NCT04157751|474390539|FG001|Overall Study|Other reason not stated above|10|||
131758011|NCT00422903|474390548|FG000|Overall Study|Disease Progression|3|||
131758012|NCT00422903|474390549|FG001|Overall Study|Disease Progression|1|||
131758013|NCT00422903|474390548|FG000|Overall Study|Adverse Event|0|||
131758014|NCT00422903|474390549|FG001|Overall Study|Adverse Event|2|||
131758015|NCT00422903|474390548|FG000|Overall Study|Informed Consent Withdrawn|1|||
131758016|NCT00422903|474390549|FG001|Overall Study|Informed Consent Withdrawn|2|||
131758017|NCT01947894|474390554|FG000|Overall Study|Other|3|||
131758018|NCT01947894|474390555|FG001|Overall Study|Other|4|||
131758019|NCT01947894|474390556|FG002|Overall Study|Other|3|||
131758020|NCT01947894|474390554|FG000|Overall Study|Withdrawal by Subject|12|||
131758021|NCT01947894|474390555|FG001|Overall Study|Withdrawal by Subject|4|||
131758022|NCT01947894|474390556|FG002|Overall Study|Withdrawal by Subject|1|||
131758023|NCT01947894|474390554|FG000|Overall Study|Death|12|||
131758024|NCT01947894|474390555|FG001|Overall Study|Death|1|||
131758025|NCT01947894|474390556|FG002|Overall Study|Death|0|||
131758026|NCT01947894|474390554|FG000|Overall Study|Physician Decision|2|||
131758027|NCT01947894|474390555|FG001|Overall Study|Physician Decision|0|||
131758028|NCT01947894|474390556|FG002|Overall Study|Physician Decision|0|||
131758029|NCT01947894|474390554|FG000|Overall Study|Adverse Event|5|||
131758030|NCT01947894|474390555|FG001|Overall Study|Adverse Event|1|||
131758031|NCT01947894|474390556|FG002|Overall Study|Adverse Event|0|||
131758032|NCT01947894|474390554|FG000|Overall Study|Switched to other growth hormone brand|53|||
131758033|NCT01947894|474390555|FG001|Overall Study|Switched to other growth hormone brand|8|||
131758034|NCT01947894|474390556|FG002|Overall Study|Switched to other growth hormone brand|23|||
131758035|NCT01302691|474390557|FG000|Overall Study|Adverse Event|2|||
131758036|NCT01302691|474390558|FG001|Overall Study|Adverse Event|0|||
131758037|NCT01302691|474390557|FG000|Overall Study|Death|0|||
131758038|NCT01302691|474390558|FG001|Overall Study|Death|1|||
131758039|NCT01302691|474390557|FG000|Overall Study|Lost to Follow-up|1|||
131758040|NCT01302691|474390558|FG001|Overall Study|Lost to Follow-up|0|||
131758041|NCT01302691|474390557|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
131758042|NCT01302691|474390558|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
131758043|NCT01302691|474390557|FG000|Overall Study|Physician Decision|0|||
131758044|NCT01302691|474390558|FG001|Overall Study|Physician Decision|1|||
131758045|NCT01302691|474390557|FG000|Overall Study|Protocol Violation|1|||
131758046|NCT01302691|474390558|FG001|Overall Study|Protocol Violation|0|||
131758047|NCT03446612|474390559|FG000|Overall Study|Protocol defined stopping criteria|0|||
131758048|NCT03446612|474390560|FG001|Overall Study|Protocol defined stopping criteria|1|||
131758049|NCT03934203|474390561|FG000|Overall Study|Adverse Event|0|||
131758050|NCT03934203|474390562|FG001|Overall Study|Adverse Event|0|||
131758051|NCT03934203|474390563|FG002|Overall Study|Adverse Event|1|||
131758052|NCT03934203|474390564|FG003|Overall Study|Adverse Event|0|||
131758053|NCT03934203|474390565|FG004|Overall Study|Adverse Event|1|||
131758054|NCT03934203|474390566|FG005|Overall Study|Adverse Event|0|||
131758055|NCT03934203|474390567|FG006|Overall Study|Adverse Event|2|||
131758056|NCT03934203|474390568|FG007|Overall Study|Adverse Event|0|||
131758057|NCT03934203|474390569|FG008|Overall Study|Adverse Event|0|||
131758058|NCT03934203|474390570|FG009|Overall Study|Adverse Event|0|||
131758059|NCT03934203|474390571|FG010|Overall Study|Adverse Event|0|||
131758060|NCT03934203|474390572|FG011|Overall Study|Adverse Event|0|||
131908643|NCT00467519|474952993|FG000|Overall Study|Protocol Violation|8|||
131908644|NCT00467519|474952994|FG001|Overall Study|Protocol Violation|4|||
131908645|NCT00467519|474952993|FG000|Overall Study|Lost to Follow-up|2|||
131908646|NCT00467519|474952994|FG001|Overall Study|Lost to Follow-up|9|||
131908647|NCT00467519|474952993|FG000|Overall Study|Withdrawal by Subject|4|||
131908648|NCT00467519|474952994|FG001|Overall Study|Withdrawal by Subject|10|||
131908649|NCT00843492|474953001|FG000|Overall Study|Adverse Event|0|||
131908650|NCT00843492|474953002|FG001|Overall Study|Adverse Event|3|||
131908651|NCT00843492|474953001|FG000|Overall Study|Lost to Follow-up|4|||
131908652|NCT00843492|474953002|FG001|Overall Study|Lost to Follow-up|4|||
131908653|NCT00843492|474953001|FG000|Overall Study|Withdrawal by Subject|0|||
131758061|NCT03934203|474390573|FG012|Overall Study|Adverse Event|0|||
131758062|NCT03934203|474390574|FG013|Overall Study|Adverse Event|1|||
131758063|NCT03934203|474390575|FG014|Overall Study|Adverse Event|0|||
131758064|NCT00149890|474390579|FG000|Overall Study|Adverse Event|1|||
131758065|NCT00149890|474390580|FG001|Overall Study|Adverse Event|8|||
131758066|NCT00149890|474390579|FG000|Overall Study|Lack of Efficacy|8|||
131758067|NCT00149890|474390580|FG001|Overall Study|Lack of Efficacy|9|||
131758068|NCT00149890|474390579|FG000|Overall Study|Protocol Violation|1|||
131758069|NCT00149890|474390580|FG001|Overall Study|Protocol Violation|0|||
131758070|NCT00149890|474390579|FG000|Overall Study|Lost to Follow-up|1|||
131758071|NCT00149890|474390580|FG001|Overall Study|Lost to Follow-up|0|||
131758072|NCT00149890|474390579|FG000|Overall Study|Graft Loss|2|||
131758073|NCT00149890|474390580|FG001|Overall Study|Graft Loss|1|||
131758074|NCT03325010|474390581|FG000|Overall Study|Adverse Event|3|||
131758075|NCT03325010|474390582|FG001|Overall Study|Adverse Event|8|||
131758076|NCT03325010|474390581|FG000|Overall Study|Protocol Violation|1|||
131758077|NCT03325010|474390582|FG001|Overall Study|Protocol Violation|8|||
131758078|NCT03325010|474390581|FG000|Overall Study|Withdrawal by Subject|1|||
131758079|NCT03325010|474390582|FG001|Overall Study|Withdrawal by Subject|3|||
131758080|NCT03325010|474390581|FG000|Overall Study|Lost to Follow-up|1|||
131758081|NCT03325010|474390582|FG001|Overall Study|Lost to Follow-up|0|||
131758082|NCT03325010|474390581|FG000|Overall Study|Physician Decision|1|||
131758083|NCT03325010|474390582|FG001|Overall Study|Physician Decision|1|||
131758084|NCT03325010|474390581|FG000|Overall Study|Lack of Efficacy|2|||
131758085|NCT03325010|474390582|FG001|Overall Study|Lack of Efficacy|0|||
131758086|NCT04350372|474390587|FG000|Overall Study|Death|1|||
131758087|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
131758088|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
131758089|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
131758090|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
131758091|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
131758092|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
131758093|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
131758094|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
131758095|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
131758096|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
131758097|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
131758098|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
131758099|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
131758100|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
131758101|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
131758102|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131758103|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
131758104|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131758105|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131758106|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131758107|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
131758108|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131758109|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131758110|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131758111|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131758112|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131758113|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
131758114|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131758115|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131758116|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131758117|NCT04757376|474390588|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
131758118|NCT04757376|474390589|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
131812112|NCT00392665|474595732|FG001|Overall Study|Death|14|||
131812113|NCT00392665|474595731|FG000|Overall Study|Lost to Follow-up|1|||
131812114|NCT00392665|474595732|FG001|Overall Study|Lost to Follow-up|1|||
131812115|NCT04408794|474595735|FG000|Overall Study|Adverse Event|43|||
131812116|NCT04408794|474595735|FG000|Overall Study|Infrequent study drug usage|43|||
131812117|NCT04408794|474595735|FG000|Overall Study|Lack of Efficacy|61|||
131812118|NCT04408794|474595735|FG000|Overall Study|Lost to Follow-up|33|||
131812119|NCT04408794|474595735|FG000|Overall Study|Non-compliance|6|||
131812120|NCT04408794|474595735|FG000|Overall Study|Physician Decision|1|||
131812121|NCT04408794|474595735|FG000|Overall Study|Pregnancy|6|||
131812122|NCT04408794|474595735|FG000|Overall Study|Protocol Deviation|9|||
131812123|NCT04408794|474595735|FG000|Overall Study|Sheehan-STS Result|1|||
131812124|NCT04408794|474595735|FG000|Overall Study|Withdrawal by Subject|57|||
131812125|NCT04408794|474595735|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
131812126|NCT04408794|474595735|FG000|Overall Study|Never Treated Migraine|5|||
131812127|NCT00556322|474595738|FG000|Overall Study|Insufficient therapeutic response|158|||
131812128|NCT00556322|474595739|FG001|Overall Study|Insufficient therapeutic response|168|||
131812129|NCT00556322|474595738|FG000|Overall Study|Adverse Event|7|||
131812130|NCT00556322|474595739|FG001|Overall Study|Adverse Event|4|||
131812131|NCT00556322|474595738|FG000|Overall Study|Other|4|||
131812132|NCT00556322|474595739|FG001|Overall Study|Other|1|||
131908654|NCT00843492|474953002|FG001|Overall Study|Withdrawal by Subject|4|||
131908655|NCT00843492|474953001|FG000|Overall Study|Immobilization Stopped|1|||
131908656|NCT00843492|474953002|FG001|Overall Study|Immobilization Stopped|0|||
131908657|NCT00843492|474953001|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
131908658|NCT00843492|474953002|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
131908659|NCT00843492|474953001|FG000|Overall Study|Orthopedic Surgery|0|||
131908660|NCT00843492|474953002|FG001|Overall Study|Orthopedic Surgery|2|||
131908661|NCT00843492|474953001|FG000|Overall Study|Visit Not Performed|1|||
131908662|NCT00843492|474953002|FG001|Overall Study|Visit Not Performed|0|||
131908663|NCT00843492|474953001|FG000|Overall Study|Deep-vein Thrombosis|1|||
131908664|NCT00843492|474953002|FG001|Overall Study|Deep-vein Thrombosis|0|||
131908665|NCT01677741|474953003|FG000|Overall Study|Death|0|||
131908666|NCT01677741|474953004|FG001|Overall Study|Death|0|||
131758119|NCT04757376|474390590|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
131908667|NCT01677741|474953005|FG002|Overall Study|Death|0|||
131908668|NCT01677741|474953006|FG003|Overall Study|Death|1|||
131908669|NCT01677741|474953007|FG004|Overall Study|Death|0|||
131908670|NCT01677741|474953008|FG005|Overall Study|Death|1|||
131908671|NCT01677741|474953009|FG006|Overall Study|Death|0|||
131908672|NCT01677741|474953010|FG007|Overall Study|Death|0|||
131908673|NCT01677741|474953003|FG000|Overall Study|Withdrawal by Subject|2|||
131908674|NCT01677741|474953004|FG001|Overall Study|Withdrawal by Subject|7|||
131908675|NCT01677741|474953005|FG002|Overall Study|Withdrawal by Subject|5|||
131908676|NCT01677741|474953006|FG003|Overall Study|Withdrawal by Subject|4|||
131908677|NCT01677741|474953007|FG004|Overall Study|Withdrawal by Subject|11|||
131908678|NCT01677741|474953008|FG005|Overall Study|Withdrawal by Subject|20|||
131908679|NCT01677741|474953009|FG006|Overall Study|Withdrawal by Subject|4|||
131908680|NCT01677741|474953010|FG007|Overall Study|Withdrawal by Subject|2|||
131908681|NCT01677741|474953003|FG000|Overall Study|Enrolled in a rollover study|0|||
131908682|NCT01677741|474953004|FG001|Overall Study|Enrolled in a rollover study|3|||
131908683|NCT01677741|474953005|FG002|Overall Study|Enrolled in a rollover study|2|||
131908684|NCT01677741|474953006|FG003|Overall Study|Enrolled in a rollover study|1|||
131908685|NCT01677741|474953007|FG004|Overall Study|Enrolled in a rollover study|6|||
131908686|NCT01677741|474953008|FG005|Overall Study|Enrolled in a rollover study|6|||
131908687|NCT01677741|474953009|FG006|Overall Study|Enrolled in a rollover study|7|||
131908688|NCT01677741|474953010|FG007|Overall Study|Enrolled in a rollover study|0|||
131908689|NCT01677741|474953003|FG000|Overall Study|Progressive disease|1|||
131908690|NCT01677741|474953004|FG001|Overall Study|Progressive disease|0|||
131398670|NCT00194077|473081218|FG000|Overall Study|Withdrawal by Subject|1|||
131758120|NCT04757376|474390591|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
131758121|NCT04757376|474390592|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
131758122|NCT04757376|474390588|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131758123|NCT04757376|474390589|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131758124|NCT04757376|474390590|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
131758125|NCT04757376|474390591|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131758126|NCT04757376|474390592|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131758127|NCT01307046|474390593|FG000|Overall Study|Adverse Event|3|||
131758128|NCT01307046|474390594|FG001|Overall Study|Adverse Event|3|||
131758129|NCT01307046|474390593|FG000|Overall Study|Lack of Efficacy|0|||
131758130|NCT01307046|474390594|FG001|Overall Study|Lack of Efficacy|2|||
131758131|NCT01307046|474390593|FG000|Overall Study|Physician Decision|2|||
131812133|NCT00556322|474595738|FG000|Overall Study|Lost to Follow-up|5|||
131812134|NCT00556322|474595739|FG001|Overall Study|Lost to Follow-up|3|||
131812135|NCT00556322|474595738|FG000|Overall Study|Withdrawal by Subject|19|||
131908691|NCT01677741|474953005|FG002|Overall Study|Progressive disease|1|||
131908692|NCT01677741|474953006|FG003|Overall Study|Progressive disease|0|||
131398671|NCT00194077|473081219|FG001|Overall Study|Withdrawal by Subject|1|||
131908693|NCT01677741|474953007|FG004|Overall Study|Progressive disease|0|||
131398672|NCT03470194|473081222|FG000|Overall Study|Lost to Follow-up|11|||
131908694|NCT01677741|474953008|FG005|Overall Study|Progressive disease|1|||
131908695|NCT01677741|474953009|FG006|Overall Study|Progressive disease|0|||
131908696|NCT01677741|474953010|FG007|Overall Study|Progressive disease|0|||
131908697|NCT00720499|474953011|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
131908698|NCT00720499|474953012|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
131908699|NCT00720499|474953011|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
131908700|NCT00720499|474953012|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
131908701|NCT00720499|474953011|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
131908702|NCT00720499|474953012|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
131758132|NCT01307046|474390594|FG001|Overall Study|Physician Decision|0|||
131758133|NCT01307046|474390593|FG000|Overall Study|Withdrawal by Subject|1|||
131758134|NCT01307046|474390594|FG001|Overall Study|Withdrawal by Subject|1|||
131758135|NCT01307046|474390593|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
131758136|NCT01307046|474390594|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
131758137|NCT01307046|474390593|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
131758138|NCT01307046|474390594|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
131758139|NCT01365091|474390599|FG000|Period 1|Adverse Event|1|||
131758140|NCT01365091|474390600|FG001|Period 1|Adverse Event|0|||
131758141|NCT01365091|474390601|FG002|Period 1|Adverse Event|2|||
131758142|NCT01365091|474390602|FG003|Period 1|Adverse Event|3|||
131758143|NCT01365091|474390599|FG000|Period 1|Positive test result for drugs of abuse|1|||
131758144|NCT01365091|474390600|FG001|Period 1|Positive test result for drugs of abuse|0|||
131758145|NCT01365091|474390601|FG002|Period 1|Positive test result for drugs of abuse|0|||
131758146|NCT01365091|474390602|FG003|Period 1|Positive test result for drugs of abuse|0|||
131758147|NCT01365091|474390599|FG000|Period 1|No longer met study criteria|0|||
131758148|NCT01365091|474390600|FG001|Period 1|No longer met study criteria|1|||
131758149|NCT01365091|474390601|FG002|Period 1|No longer met study criteria|0|||
131449794|NCT02968004|473276718|FG000|Main Study Phase|Withdrawal by Subject|0|||
131449795|NCT02968004|473276719|FG001|Main Study Phase|Withdrawal by Subject|1|||
131449796|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
131449797|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
131449798|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
131449799|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
131449800|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
131449801|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
131908703|NCT03642990|474953024|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
131908704|NCT03642990|474953024|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
131449802|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
131449803|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
131449804|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
131449805|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
131449806|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
131449807|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
131449808|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
131449809|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
131449810|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
131449811|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
131449812|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
131449813|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
131449814|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
131449815|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
131449816|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
131449817|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
131449818|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
131449819|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
131449820|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
131449821|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
131449822|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
131449823|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
131449824|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
131449825|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
131449826|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
131449827|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
131758150|NCT01365091|474390602|FG003|Period 1|No longer met study criteria|0|||
131758151|NCT01365091|474390599|FG000|Period 1|Withdrawal by Subject|0|||
131758152|NCT01365091|474390600|FG001|Period 1|Withdrawal by Subject|1|||
131758153|NCT01365091|474390601|FG002|Period 1|Withdrawal by Subject|0|||
131758154|NCT01365091|474390602|FG003|Period 1|Withdrawal by Subject|0|||
131758155|NCT01365091|474390599|FG000|Period 1|Personal reasons|0|||
131758156|NCT01365091|474390600|FG001|Period 1|Personal reasons|0|||
131758157|NCT01365091|474390601|FG002|Period 1|Personal reasons|1|||
131758158|NCT01365091|474390602|FG003|Period 1|Personal reasons|0|||
131758159|NCT01365091|474390599|FG000|Period 2|Withdrawal by Subject|1|||
131758160|NCT01365091|474390600|FG001|Period 2|Withdrawal by Subject|0|||
131908705|NCT03641508|474953025|FG000|First Injection|Lost to Follow-up|2|||
131908706|NCT03641508|474953026|FG001|First Injection|Lost to Follow-up|0|||
131758161|NCT01365091|474390601|FG002|Period 2|Withdrawal by Subject|0|||
131758162|NCT01365091|474390602|FG003|Period 2|Withdrawal by Subject|0|||
131758163|NCT01365091|474390599|FG000|Period 2|Adverse Event|0|||
131758164|NCT01365091|474390600|FG001|Period 2|Adverse Event|0|||
131758165|NCT01365091|474390601|FG002|Period 2|Adverse Event|1|||
131758166|NCT01365091|474390602|FG003|Period 2|Adverse Event|0|||
131758167|NCT05116683|474390604|FG000|Overall Study|Physician Decision|4|||
131758168|NCT01474889|474390605|FG000|Overall Study|Physician Decision|1|||
131758169|NCT01474889|474390606|FG001|Overall Study|Physician Decision|0|||
131758170|NCT01474889|474390607|FG002|Overall Study|Physician Decision|0|||
131758171|NCT01474889|474390605|FG000|Overall Study|Did not meet inclusion|1|||
131758172|NCT01474889|474390606|FG001|Overall Study|Did not meet inclusion|0|||
131758173|NCT01474889|474390607|FG002|Overall Study|Did not meet inclusion|0|||
131758174|NCT01474889|474390605|FG000|Overall Study|Withdrawal by Subject|0|||
131758175|NCT01474889|474390606|FG001|Overall Study|Withdrawal by Subject|1|||
131758176|NCT01474889|474390607|FG002|Overall Study|Withdrawal by Subject|0|||
131758177|NCT03935594|474390611|FG000|Overall Study|Physician Decision|3|||
131758178|NCT01435122|474390612|FG000|Overall Study|Early withdrawal due to toxicity|8|||
131758179|NCT04412668|474390613|FG000|Overall Study|Death - multiple comorbidities|2|||
131758180|NCT04412668|474390614|FG001|Overall Study|Death - multiple comorbidities|0|||
131758181|NCT04412668|474390615|FG002|Overall Study|Death - multiple comorbidities|0|||
131758182|NCT04412668|474390613|FG000|Overall Study|Withdrawal by Subject|3|||
131758183|NCT04412668|474390614|FG001|Overall Study|Withdrawal by Subject|0|||
131758184|NCT04412668|474390615|FG002|Overall Study|Withdrawal by Subject|0|||
131758185|NCT04412668|474390613|FG000|Overall Study|Other than Specified|2|||
131758186|NCT04412668|474390614|FG001|Overall Study|Other than Specified|0|||
131758187|NCT04412668|474390615|FG002|Overall Study|Other than Specified|0|||
131758188|NCT03954704|474390618|FG000|Overall Study|Death|1|||
131758189|NCT03954704|474390619|FG001|Overall Study|Death|1|||
131758190|NCT03954704|474390620|FG002|Overall Study|Death|1|||
131812136|NCT00556322|474595739|FG001|Overall Study|Withdrawal by Subject|7|||
131812137|NCT00556322|474595738|FG000|Overall Study|Protocol Violation|5|||
131812138|NCT00556322|474595739|FG001|Overall Study|Protocol Violation|1|||
131812139|NCT00556322|474595738|FG000|Overall Study|Ongoing at data cutoff|3|||
131812140|NCT00556322|474595739|FG001|Overall Study|Ongoing at data cutoff|5|||
131812141|NCT00556322|474595738|FG000|Overall Study|Death|20|||
131812142|NCT00556322|474595739|FG001|Overall Study|Death|14|||
131812143|NCT03733444|474595740|FG000|Overall Study|Adverse Event|8|||
131812144|NCT03733444|474595741|FG001|Overall Study|Adverse Event|10|||
131812145|NCT03733444|474595742|FG002|Overall Study|Adverse Event|5|||
131812146|NCT03733444|474595740|FG000|Overall Study|Death|20|||
131812147|NCT03733444|474595741|FG001|Overall Study|Death|19|||
131812148|NCT03733444|474595742|FG002|Overall Study|Death|11|||
131812149|NCT03733444|474595740|FG000|Overall Study|Lost to Follow-up|3|||
131812150|NCT03733444|474595741|FG001|Overall Study|Lost to Follow-up|0|||
131812151|NCT03733444|474595742|FG002|Overall Study|Lost to Follow-up|1|||
131812152|NCT03733444|474595740|FG000|Overall Study|Lack of Efficacy|0|||
131812153|NCT03733444|474595741|FG001|Overall Study|Lack of Efficacy|1|||
131812154|NCT03733444|474595742|FG002|Overall Study|Lack of Efficacy|1|||
131812155|NCT03733444|474595740|FG000|Overall Study|Physician Decision|2|||
131812156|NCT03733444|474595741|FG001|Overall Study|Physician Decision|1|||
131812157|NCT03733444|474595742|FG002|Overall Study|Physician Decision|0|||
131812158|NCT03733444|474595740|FG000|Overall Study|Protocol Violation|2|||
131812159|NCT03733444|474595741|FG001|Overall Study|Protocol Violation|1|||
131812160|NCT03733444|474595742|FG002|Overall Study|Protocol Violation|0|||
131812161|NCT03733444|474595740|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
131812162|NCT03733444|474595741|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
131812163|NCT03733444|474595742|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
131812164|NCT03733444|474595740|FG000|Overall Study|Study Terminated by Sponsor|203|||
131812165|NCT03733444|474595741|FG001|Overall Study|Study Terminated by Sponsor|209|||
131812166|NCT03733444|474595742|FG002|Overall Study|Study Terminated by Sponsor|221|||
131812167|NCT03733444|474595740|FG000|Overall Study|Withdrawal by Subject|19|||
131812168|NCT03733444|474595741|FG001|Overall Study|Withdrawal by Subject|18|||
131812169|NCT03733444|474595742|FG002|Overall Study|Withdrawal by Subject|16|||
131812170|NCT03733444|474595740|FG000|Overall Study|Miscellaneous|1|||
131758191|NCT03954704|474390621|FG003|Overall Study|Death|3|||
131758192|NCT03954704|474390622|FG004|Overall Study|Death|2|||
131758193|NCT03954704|474390623|FG005|Overall Study|Death|2|||
131758194|NCT03954704|474390624|FG006|Overall Study|Death|0|||
131758195|NCT03954704|474390618|FG000|Overall Study|Withdrew Consent|0|||
131812171|NCT03733444|474595741|FG001|Overall Study|Miscellaneous|0|||
131812172|NCT03733444|474595742|FG002|Overall Study|Miscellaneous|1|||
131812173|NCT03733444|474595740|FG000|Overall Study|Not Treated|1|||
131758196|NCT03954704|474390619|FG001|Overall Study|Withdrew Consent|0|||
131758197|NCT03954704|474390620|FG002|Overall Study|Withdrew Consent|1|||
131758198|NCT03954704|474390621|FG003|Overall Study|Withdrew Consent|0|||
131812174|NCT03733444|474595741|FG001|Overall Study|Not Treated|2|||
131812175|NCT03733444|474595742|FG002|Overall Study|Not Treated|1|||
131812176|NCT01788423|474595743|FG000|Overall Study|See Comments in Completed (above)|0|||
131908707|NCT00855218|474953027|FG000|Overall Study|Adverse Event|43|||
131758199|NCT03954704|474390622|FG004|Overall Study|Withdrew Consent|0|||
131758200|NCT03954704|474390623|FG005|Overall Study|Withdrew Consent|1|||
131758201|NCT03954704|474390624|FG006|Overall Study|Withdrew Consent|0|||
131758202|NCT03954704|474390618|FG000|Overall Study|Lost to Follow-up|0|||
131758203|NCT03954704|474390619|FG001|Overall Study|Lost to Follow-up|0|||
131758204|NCT03954704|474390620|FG002|Overall Study|Lost to Follow-up|0|||
131758205|NCT03954704|474390621|FG003|Overall Study|Lost to Follow-up|0|||
131758206|NCT03954704|474390622|FG004|Overall Study|Lost to Follow-up|0|||
131758207|NCT03954704|474390623|FG005|Overall Study|Lost to Follow-up|0|||
131758208|NCT03954704|474390624|FG006|Overall Study|Lost to Follow-up|1|||
131758209|NCT03954704|474390618|FG000|Overall Study|Study Terminated by Sponsor|0|||
131758210|NCT03954704|474390619|FG001|Overall Study|Study Terminated by Sponsor|0|||
131758211|NCT03954704|474390620|FG002|Overall Study|Study Terminated by Sponsor|1|||
131758212|NCT03954704|474390621|FG003|Overall Study|Study Terminated by Sponsor|0|||
131758213|NCT03954704|474390622|FG004|Overall Study|Study Terminated by Sponsor|1|||
131758214|NCT03954704|474390623|FG005|Overall Study|Study Terminated by Sponsor|4|||
131758215|NCT03954704|474390624|FG006|Overall Study|Study Terminated by Sponsor|2|||
131758216|NCT03954704|474390618|FG000|Overall Study|Enrolled but not Treated|0|||
131758217|NCT03954704|474390619|FG001|Overall Study|Enrolled but not Treated|0|||
131758218|NCT03954704|474390620|FG002|Overall Study|Enrolled but not Treated|0|||
131758219|NCT03954704|474390621|FG003|Overall Study|Enrolled but not Treated|0|||
131758220|NCT03954704|474390622|FG004|Overall Study|Enrolled but not Treated|0|||
131758221|NCT03954704|474390623|FG005|Overall Study|Enrolled but not Treated|1|||
131758222|NCT03954704|474390624|FG006|Overall Study|Enrolled but not Treated|0|||
131758223|NCT03695471|474392453|FG000|Overall Study|Cancellation|1|||
131758224|NCT02859558|474392454|FG000|Step 1|Not Eligible|0|||
131758225|NCT02859558|474392455|FG001|Step 1|Not Eligible|0|||
131758226|NCT02859558|474392456|FG002|Step 1|Not Eligible|0|||
131758227|NCT02859558|474392457|FG003|Step 1|Not Eligible|0|||
131758228|NCT02859558|474392458|FG004|Step 1|Not Eligible|3|||
131758229|NCT02859558|474392454|FG000|Step 1|Lost to Follow-up|1|||
131758230|NCT02859558|474392455|FG001|Step 1|Lost to Follow-up|3|||
131758231|NCT02859558|474392456|FG002|Step 1|Lost to Follow-up|3|||
131758232|NCT02859558|474392457|FG003|Step 1|Lost to Follow-up|0|||
131758233|NCT02859558|474392458|FG004|Step 1|Lost to Follow-up|0|||
131758234|NCT02859558|474392454|FG000|Step 1|Did Not Return to Clinic|2|||
131758235|NCT02859558|474392455|FG001|Step 1|Did Not Return to Clinic|3|||
131758236|NCT02859558|474392456|FG002|Step 1|Did Not Return to Clinic|4|||
131758237|NCT02859558|474392457|FG003|Step 1|Did Not Return to Clinic|0|||
131758238|NCT02859558|474392458|FG004|Step 1|Did Not Return to Clinic|0|||
131758239|NCT02859558|474392454|FG000|Step 1|Moved|0|||
131758240|NCT02859558|474392455|FG001|Step 1|Moved|1|||
131758241|NCT02859558|474392456|FG002|Step 1|Moved|1|||
131758242|NCT02859558|474392457|FG003|Step 1|Moved|0|||
131758243|NCT02859558|474392458|FG004|Step 1|Moved|0|||
131758244|NCT02859558|474392454|FG000|Step 1|Withdrawal By Participant|1|||
131758245|NCT02859558|474392455|FG001|Step 1|Withdrawal By Participant|2|||
131758246|NCT02859558|474392456|FG002|Step 1|Withdrawal By Participant|1|||
131758247|NCT02859558|474392457|FG003|Step 1|Withdrawal By Participant|0|||
131758248|NCT02859558|474392458|FG004|Step 1|Withdrawal By Participant|0|||
131758249|NCT02859558|474392454|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
131758250|NCT02859558|474392455|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131758251|NCT02859558|474392456|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131758252|NCT02859558|474392457|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131758253|NCT02859558|474392458|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131758254|NCT02859558|474392454|FG000|Step 1|Incarceration|0|||
131758255|NCT02859558|474392455|FG001|Step 1|Incarceration|1|||
131758256|NCT02859558|474392456|FG002|Step 1|Incarceration|0|||
131758257|NCT02859558|474392457|FG003|Step 1|Incarceration|0|||
131758258|NCT02859558|474392458|FG004|Step 1|Incarceration|0|||
131758259|NCT02859558|474392454|FG000|Step 1|Non-Adherence to Study Drug|2|||
131758260|NCT02859558|474392455|FG001|Step 1|Non-Adherence to Study Drug|0|||
131758261|NCT02859558|474392456|FG002|Step 1|Non-Adherence to Study Drug|1|||
131758262|NCT02859558|474392457|FG003|Step 1|Non-Adherence to Study Drug|0|||
131758263|NCT02859558|474392458|FG004|Step 1|Non-Adherence to Study Drug|0|||
131758264|NCT02859558|474392454|FG000|Step 1|Non-Adherence to Study Requirements|3|||
131758265|NCT02859558|474392455|FG001|Step 1|Non-Adherence to Study Requirements|1|||
131758266|NCT02859558|474392456|FG002|Step 1|Non-Adherence to Study Requirements|0|||
131758267|NCT02859558|474392457|FG003|Step 1|Non-Adherence to Study Requirements|0|||
131758268|NCT02859558|474392458|FG004|Step 1|Non-Adherence to Study Requirements|0|||
131758269|NCT02859558|474392454|FG000|Step 1|Virologic Failure|2|||
131758270|NCT02859558|474392455|FG001|Step 1|Virologic Failure|1|||
131758271|NCT02859558|474392456|FG002|Step 1|Virologic Failure|1|||
131758272|NCT02859558|474392457|FG003|Step 1|Virologic Failure|0|||
131758273|NCT02859558|474392458|FG004|Step 1|Virologic Failure|0|||
131758274|NCT02859558|474392454|FG000|Step 2|Lost to Follow-up|3|||
131758275|NCT02859558|474392455|FG001|Step 2|Lost to Follow-up|3|||
131758276|NCT02859558|474392456|FG002|Step 2|Lost to Follow-up|1|||
131758277|NCT02859558|474392457|FG003|Step 2|Lost to Follow-up|0|||
131758278|NCT02859558|474392458|FG004|Step 2|Lost to Follow-up|0|||
131758279|NCT02859558|474392454|FG000|Step 2|Withdrawal by Subject|0|||
131908708|NCT00855218|474953028|FG001|Overall Study|Adverse Event|27|||
131908709|NCT00855218|474953027|FG000|Overall Study|Withdrawal by Subject|10|||
131908710|NCT00855218|474953028|FG001|Overall Study|Withdrawal by Subject|6|||
131908711|NCT00855218|474953027|FG000|Overall Study|Physician Decision|18|||
131908712|NCT00855218|474953028|FG001|Overall Study|Physician Decision|11|||
131908713|NCT00855218|474953027|FG000|Overall Study|Lost to Follow-up|0|||
131908714|NCT00855218|474953028|FG001|Overall Study|Lost to Follow-up|1|||
131908715|NCT00855218|474953027|FG000|Overall Study|Protocol Violation|5|||
131908716|NCT00855218|474953028|FG001|Overall Study|Protocol Violation|9|||
131908717|NCT00855218|474953027|FG000|Overall Study|non-compliant with study drug|3|||
131908718|NCT00855218|474953028|FG001|Overall Study|non-compliant with study drug|1|||
131908719|NCT00855218|474953027|FG000|Overall Study|patient convenience|2|||
131758280|NCT02859558|474392455|FG001|Step 2|Withdrawal by Subject|1|||
131758281|NCT02859558|474392456|FG002|Step 2|Withdrawal by Subject|1|||
131758282|NCT02859558|474392457|FG003|Step 2|Withdrawal by Subject|0|||
131758283|NCT02859558|474392458|FG004|Step 2|Withdrawal by Subject|0|||
131758284|NCT02859558|474392454|FG000|Step 2|Unexpected Closure of Site|0|||
131758285|NCT02859558|474392455|FG001|Step 2|Unexpected Closure of Site|1|||
131758286|NCT02859558|474392456|FG002|Step 2|Unexpected Closure of Site|1|||
131758287|NCT02859558|474392457|FG003|Step 2|Unexpected Closure of Site|0|||
131758288|NCT02859558|474392458|FG004|Step 2|Unexpected Closure of Site|0|||
131758289|NCT02859558|474392454|FG000|Step 2|Death|1|||
131758290|NCT02859558|474392455|FG001|Step 2|Death|0|||
131758291|NCT02859558|474392456|FG002|Step 2|Death|0|||
131758292|NCT02859558|474392457|FG003|Step 2|Death|0|||
131758293|NCT02859558|474392458|FG004|Step 2|Death|0|||
131758294|NCT02859558|474392454|FG000|Step 2|Incarceration|0|||
131758295|NCT02859558|474392455|FG001|Step 2|Incarceration|0|||
131758296|NCT02859558|474392456|FG002|Step 2|Incarceration|1|||
131758297|NCT02859558|474392457|FG003|Step 2|Incarceration|0|||
131758298|NCT02859558|474392458|FG004|Step 2|Incarceration|0|||
131758299|NCT04888507|474392459|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
131758300|NCT00636155|474392460|FG000|Overall Study|Adverse Event|8|||
131758301|NCT00636155|474392460|FG000|Overall Study|Lack of Efficacy|1|||
131758302|NCT00636155|474392460|FG000|Overall Study|Withdrawal by Subject|3|||
131758303|NCT00636155|474392460|FG000|Overall Study|Stem cell transplant|1|||
131758304|NCT00636155|474392460|FG000|Overall Study|Physician Decision|5|||
131758305|NCT00766142|474392461|FG000|Overall Study|Protocol Violation|4|||
131758306|NCT02358863|474392471|FG000|Overall Study|Physician Decision|3|||
131758307|NCT05426460|474392479|FG000|Overall Study|Protocol Violation|1|||
131758308|NCT05426460|474392480|FG001|Overall Study|Protocol Violation|1|||
131758309|NCT05426460|474392481|FG002|Overall Study|Protocol Violation|1|||
131758310|NCT05426460|474392482|FG003|Overall Study|Protocol Violation|0|||
131758311|NCT02000622|474392483|FG000|Overall Study|Withdrawal by Subject|5|||
131758312|NCT02000622|474392484|FG001|Overall Study|Withdrawal by Subject|7|||
131758313|NCT02000622|474392483|FG000|Overall Study|Lost to Follow-up|4|||
131758314|NCT02000622|474392484|FG001|Overall Study|Lost to Follow-up|0|||
131758315|NCT02000622|474392483|FG000|Overall Study|Death|159|||
131758316|NCT02000622|474392484|FG001|Overall Study|Death|73|||
131758317|NCT02000622|474392483|FG000|Overall Study|Withdrawn due to site closure|1|||
131758318|NCT02000622|474392484|FG001|Overall Study|Withdrawn due to site closure|0|||
131758319|NCT01405027|474392488|FG000|Overall Study|Withdrawn consent|3|||
131758320|NCT01405027|474392489|FG001|Overall Study|Withdrawn consent|0|||
131758321|NCT01405027|474392488|FG000|Overall Study|Lost to Follow-up|16|||
131758322|NCT01405027|474392489|FG001|Overall Study|Lost to Follow-up|24|||
131758323|NCT01405027|474392488|FG000|Overall Study|Investigator judgement|0|||
131758324|NCT01405027|474392489|FG001|Overall Study|Investigator judgement|2|||
131758325|NCT01405027|474392488|FG000|Overall Study|Death|1|||
131758326|NCT01405027|474392489|FG001|Overall Study|Death|0|||
131758327|NCT01405027|474392488|FG000|Overall Study|Other or Unknown|12|||
131758328|NCT01405027|474392489|FG001|Overall Study|Other or Unknown|25|||
131758329|NCT01320033|474392491|FG000|Overall Study|Lack of Efficacy|0|||
131758330|NCT01320033|474392492|FG001|Overall Study|Lack of Efficacy|0|||
131758331|NCT01320033|474392493|FG002|Overall Study|Lack of Efficacy|1|||
131758332|NCT01320033|474392491|FG000|Overall Study|Adverse Event|9|||
131758333|NCT01320033|474392492|FG001|Overall Study|Adverse Event|7|||
131758334|NCT01320033|474392493|FG002|Overall Study|Adverse Event|8|||
131908720|NCT00855218|474953028|FG001|Overall Study|patient convenience|0|||
131908721|NCT00855218|474953027|FG000|Overall Study|technical problems|2|||
131758335|NCT01320033|474392491|FG000|Overall Study|Withdrawal by Subject|22|||
131758336|NCT01320033|474392492|FG001|Overall Study|Withdrawal by Subject|23|||
131758337|NCT01320033|474392493|FG002|Overall Study|Withdrawal by Subject|23|||
131758338|NCT01320033|474392491|FG000|Overall Study|Protocol Violation|3|||
131758339|NCT01320033|474392492|FG001|Overall Study|Protocol Violation|5|||
131758340|NCT01320033|474392493|FG002|Overall Study|Protocol Violation|3|||
131758341|NCT01320033|474392491|FG000|Overall Study|Lost to Follow-up|22|||
131758342|NCT01320033|474392492|FG001|Overall Study|Lost to Follow-up|26|||
131758343|NCT01320033|474392493|FG002|Overall Study|Lost to Follow-up|17|||
131758344|NCT01320033|474392491|FG000|Overall Study|Other|2|||
131758345|NCT01320033|474392492|FG001|Overall Study|Other|3|||
131758346|NCT01320033|474392493|FG002|Overall Study|Other|1|||
131758347|NCT00963469|474392494|FG000|Overall Study|Adverse Event|15|||
131758348|NCT00963469|474392495|FG001|Overall Study|Adverse Event|11|||
131758349|NCT00963469|474392496|FG002|Overall Study|Adverse Event|1|||
131758350|NCT00963469|474392494|FG000|Overall Study|Lack of Efficacy|10|||
131758351|NCT00963469|474392495|FG001|Overall Study|Lack of Efficacy|7|||
131758352|NCT00963469|474392496|FG002|Overall Study|Lack of Efficacy|2|||
131758353|NCT00963469|474392494|FG000|Overall Study|Lost to Follow-up|1|||
131758354|NCT00963469|474392495|FG001|Overall Study|Lost to Follow-up|1|||
131758355|NCT00963469|474392496|FG002|Overall Study|Lost to Follow-up|0|||
131758356|NCT00963469|474392494|FG000|Overall Study|Protocol Violation|5|||
131758357|NCT00963469|474392495|FG001|Overall Study|Protocol Violation|5|||
131758358|NCT00963469|474392496|FG002|Overall Study|Protocol Violation|3|||
131758359|NCT00963469|474392494|FG000|Overall Study|Withdrawal by Subject|4|||
131758360|NCT00963469|474392495|FG001|Overall Study|Withdrawal by Subject|1|||
131758361|NCT00963469|474392496|FG002|Overall Study|Withdrawal by Subject|1|||
131758362|NCT00963469|474392494|FG000|Overall Study|Pre-randomization Adverse Event|1|||
131758363|NCT00963469|474392495|FG001|Overall Study|Pre-randomization Adverse Event|2|||
131758364|NCT00963469|474392496|FG002|Overall Study|Pre-randomization Adverse Event|0|||
131758365|NCT00963469|474392494|FG000|Overall Study|Moved|1|||
131758366|NCT00963469|474392495|FG001|Overall Study|Moved|0|||
131758367|NCT00963469|474392496|FG002|Overall Study|Moved|0|||
131758368|NCT00963469|474392494|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
131758369|NCT00963469|474392495|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
131758370|NCT00963469|474392496|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
131758371|NCT00378534|474392510|FG000|Overall Study|Participants did not receive transplant|3|||
131758372|NCT00378534|474392511|FG001|Overall Study|Participants did not receive transplant|0|||
131758373|NCT04969900|474392512|FG000|Overall Study|Physician Decision|1|||
131758374|NCT04969900|474392513|FG001|Overall Study|Physician Decision|1|||
131758375|NCT04969900|474392512|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
131758376|NCT04969900|474392513|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
131758377|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
131758378|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
131758379|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Death|1|||
131758380|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Death|1|||
131758381|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
131758382|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
131758383|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
131758384|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
131758385|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
131758386|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
131758387|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
131758388|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
131758389|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
131758390|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
131758391|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
131758392|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
131758393|NCT03728881|474392519|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
131758394|NCT03728881|474392520|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
131758395|NCT03728881|474392519|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
131758396|NCT03728881|474392520|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
131758397|NCT03728881|474392519|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
131758398|NCT03728881|474392520|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
131758399|NCT05016037|474392521|FG000|Overall Study|Lost to Follow-up|2|||
131758400|NCT01688999|474392524|FG000|Overall Study|Withdrawal by Subject|5|||
131758401|NCT01688999|474392525|FG001|Overall Study|Withdrawal by Subject|1|||
131758402|NCT01688999|474392526|FG002|Overall Study|Withdrawal by Subject|1|||
131758403|NCT01688999|474392524|FG000|Overall Study|Adverse Event|2|||
131758404|NCT01688999|474392525|FG001|Overall Study|Adverse Event|0|||
131758405|NCT01688999|474392526|FG002|Overall Study|Adverse Event|2|||
131758406|NCT01688999|474392524|FG000|Overall Study|Ineligible/Not treated|1|||
131758407|NCT01688999|474392525|FG001|Overall Study|Ineligible/Not treated|0|||
131758408|NCT01688999|474392526|FG002|Overall Study|Ineligible/Not treated|0|||
131758409|NCT02768103|474392527|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
131758410|NCT02148952|474392529|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
131758411|NCT02148952|474392530|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
131758412|NCT02148952|474392529|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
131758413|NCT02148952|474392530|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
131758414|NCT02148952|474392529|FG000|Follow-Up|Lost to Follow-up|219|||
131758415|NCT02148952|474392530|FG001|Follow-Up|Lost to Follow-up|231|||
131758416|NCT02148952|474392529|FG000|Follow-Up|Withdrawal by Subject|46|||
131758417|NCT02148952|474392530|FG001|Follow-Up|Withdrawal by Subject|48|||
131758418|NCT01025232|474392531|FG000|Overall Study|Study drug no longer available|3|||
131758419|NCT01025232|474392532|FG001|Overall Study|Study drug no longer available|6|||
131758420|NCT01600105|474392533|FG000|Total Participants|Withdrawal by Subject|1|||
131758421|NCT01600105|474392534|FG001|Total Participants|Withdrawal by Subject|0|||
131758422|NCT01600105|474392533|FG000|Total Participants|No images in PACS|10|||
131758423|NCT01600105|474392534|FG001|Total Participants|No images in PACS|0|||
131758424|NCT01600105|474392533|FG000|Total Participants|Insufficient image quality|30|||
131758425|NCT01600105|474392534|FG001|Total Participants|Insufficient image quality|10|||
131758426|NCT01600105|474392533|FG000|Sub Study I|Insufficient image quality|0|||
131758427|NCT01600105|474392534|FG001|Sub Study I|Insufficient image quality|10|||
131758428|NCT01600105|474392533|FG000|Sub Study II|Withdrawal by Subject|1|||
131758429|NCT01600105|474392534|FG001|Sub Study II|Withdrawal by Subject|0|||
131758430|NCT01600105|474392533|FG000|Sub Study II|No images in PACS|1|||
131758431|NCT01600105|474392534|FG001|Sub Study II|No images in PACS|0|||
131758432|NCT01600105|474392533|FG000|Sub Study II|Insufficient image quality|3|||
131758433|NCT01600105|474392534|FG001|Sub Study II|Insufficient image quality|0|||
131758434|NCT01600105|474392533|FG000|Sub Study III|Insufficient image quality|5|||
131758435|NCT01600105|474392534|FG001|Sub Study III|Insufficient image quality|0|||
131758436|NCT01600105|474392533|FG000|Sub Study V|Poor Image Quality|2|||
131758437|NCT01600105|474392534|FG001|Sub Study V|Poor Image Quality|0|||
131758438|NCT01263444|474392535|FG000|Overall Study|Adverse Event|8|||
131758439|NCT01263444|474392535|FG000|Overall Study|Withdrawal by Subject|1|||
131758440|NCT01263444|474392535|FG000|Overall Study|Protocol Violation|1|||
131758441|NCT04007367|474392537|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
131758442|NCT04007367|474392538|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
131758443|NCT04007367|474392539|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
131758444|NCT04007367|474392537|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
131758445|NCT04007367|474392538|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
131758446|NCT04007367|474392539|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
131758447|NCT04007367|474392537|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
131758448|NCT04007367|474392538|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
131758449|NCT04007367|474392539|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
131758450|NCT04007367|474392537|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
131758451|NCT04007367|474392538|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
131758452|NCT04007367|474392539|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
131758453|NCT04007367|474392537|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
131758454|NCT04007367|474392538|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
131758455|NCT04007367|474392539|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
131758456|NCT01764022|474392540|FG000|Overall Study|Death|3|||
131758457|NCT01764022|474392541|FG001|Overall Study|Death|5|||
131758458|NCT01764022|474392540|FG000|Overall Study|Withdrawal by Subject|2|||
131758459|NCT01764022|474392541|FG001|Overall Study|Withdrawal by Subject|6|||
131758460|NCT01764022|474392540|FG000|Overall Study|Lack of Efficacy|0|||
131758461|NCT01764022|474392541|FG001|Overall Study|Lack of Efficacy|1|||
131758462|NCT01764022|474392540|FG000|Overall Study|Physician Decision|0|||
131758463|NCT01764022|474392541|FG001|Overall Study|Physician Decision|2|||
131758464|NCT01764022|474392540|FG000|Overall Study|Lost to Follow-up|2|||
131758465|NCT01764022|474392541|FG001|Overall Study|Lost to Follow-up|0|||
131758466|NCT01764022|474392540|FG000|Overall Study|Protocol Violation|1|||
131758467|NCT01764022|474392541|FG001|Overall Study|Protocol Violation|0|||
131758468|NCT02324049|474392544|FG000|Part C|Study terminated|11|||
131758469|NCT03083470|474392546|FG000|Overall Study|Lost to Follow-up|0|||
131758470|NCT03083470|474392547|FG001|Overall Study|Lost to Follow-up|0|||
131758471|NCT03083470|474392548|FG002|Overall Study|Lost to Follow-up|0|||
131758472|NCT03083470|474392549|FG003|Overall Study|Lost to Follow-up|0|||
131758473|NCT03083470|474392550|FG004|Overall Study|Lost to Follow-up|1|||
131758474|NCT03083470|474392546|FG000|Overall Study|Withdrawal by Subject|0|||
131758475|NCT03083470|474392547|FG001|Overall Study|Withdrawal by Subject|0|||
131758476|NCT03083470|474392548|FG002|Overall Study|Withdrawal by Subject|0|||
131758477|NCT03083470|474392549|FG003|Overall Study|Withdrawal by Subject|0|||
131758478|NCT03083470|474392550|FG004|Overall Study|Withdrawal by Subject|1|||
131758479|NCT03077711|474392551|FG000|Overall Study|Lost to Follow-up|2|||
131758480|NCT03077711|474392552|FG001|Overall Study|Lost to Follow-up|2|||
131758481|NCT03077711|474392551|FG000|Overall Study|noncompliant taking medication|2|||
131758482|NCT03077711|474392552|FG001|Overall Study|noncompliant taking medication|0|||
131398673|NCT03470194|473081223|FG001|Overall Study|Lost to Follow-up|17|||
131758483|NCT01526928|474392553|FG000|Overall Study|Progressive Disease|35|||
131758484|NCT01526928|474392554|FG001|Overall Study|Progressive Disease|17|||
131758485|NCT01526928|474392555|FG002|Overall Study|Progressive Disease|150|||
131758486|NCT01526928|474392556|FG003|Overall Study|Progressive Disease|182|||
131758487|NCT01526928|474392557|FG004|Overall Study|Progressive Disease|76|||
131758488|NCT01526928|474392558|FG005|Overall Study|Progressive Disease|4|||
131758489|NCT01526928|474392553|FG000|Overall Study|Adverse Event|2|||
131758490|NCT01526928|474392554|FG001|Overall Study|Adverse Event|1|||
131758491|NCT01526928|474392555|FG002|Overall Study|Adverse Event|29|||
131758492|NCT01526928|474392556|FG003|Overall Study|Adverse Event|40|||
131758493|NCT01526928|474392557|FG004|Overall Study|Adverse Event|13|||
131758494|NCT01526928|474392558|FG005|Overall Study|Adverse Event|2|||
131758495|NCT01526928|474392553|FG000|Overall Study|Death|0|||
131758496|NCT01526928|474392554|FG001|Overall Study|Death|0|||
131758497|NCT01526928|474392555|FG002|Overall Study|Death|3|||
131758498|NCT01526928|474392556|FG003|Overall Study|Death|0|||
131758499|NCT01526928|474392557|FG004|Overall Study|Death|0|||
131758500|NCT01526928|474392558|FG005|Overall Study|Death|0|||
131758501|NCT01526928|474392553|FG000|Overall Study|Withdrawal by Subject|1|||
131758502|NCT01526928|474392554|FG001|Overall Study|Withdrawal by Subject|0|||
131758503|NCT01526928|474392555|FG002|Overall Study|Withdrawal by Subject|13|||
131758504|NCT01526928|474392556|FG003|Overall Study|Withdrawal by Subject|11|||
131758505|NCT01526928|474392557|FG004|Overall Study|Withdrawal by Subject|3|||
131758506|NCT01526928|474392558|FG005|Overall Study|Withdrawal by Subject|0|||
131758507|NCT01526928|474392553|FG000|Overall Study|Physician Decision|0|||
131758508|NCT01526928|474392554|FG001|Overall Study|Physician Decision|0|||
131758509|NCT01526928|474392555|FG002|Overall Study|Physician Decision|2|||
131758510|NCT01526928|474392556|FG003|Overall Study|Physician Decision|5|||
131758511|NCT01526928|474392557|FG004|Overall Study|Physician Decision|0|||
131758512|NCT01526928|474392558|FG005|Overall Study|Physician Decision|0|||
131758513|NCT01526928|474392553|FG000|Overall Study|Other Reason|0|||
131758514|NCT01526928|474392554|FG001|Overall Study|Other Reason|1|||
131758515|NCT01526928|474392555|FG002|Overall Study|Other Reason|11|||
131758516|NCT01526928|474392556|FG003|Overall Study|Other Reason|4|||
131758517|NCT01526928|474392557|FG004|Overall Study|Other Reason|1|||
131758518|NCT01526928|474392558|FG005|Overall Study|Other Reason|0|||
131758519|NCT01526928|474392553|FG000|Overall Study|Lost to Follow-up|0|||
131758520|NCT01526928|474392554|FG001|Overall Study|Lost to Follow-up|0|||
131758521|NCT01526928|474392555|FG002|Overall Study|Lost to Follow-up|0|||
131758522|NCT01526928|474392556|FG003|Overall Study|Lost to Follow-up|1|||
131758523|NCT01526928|474392557|FG004|Overall Study|Lost to Follow-up|0|||
131758524|NCT01526928|474392558|FG005|Overall Study|Lost to Follow-up|0|||
131758525|NCT01526928|474392553|FG000|Overall Study|Protocol Deviation|0|||
131758526|NCT01526928|474392554|FG001|Overall Study|Protocol Deviation|0|||
131758527|NCT01526928|474392555|FG002|Overall Study|Protocol Deviation|0|||
131758528|NCT01526928|474392556|FG003|Overall Study|Protocol Deviation|2|||
131758529|NCT01526928|474392557|FG004|Overall Study|Protocol Deviation|0|||
131758530|NCT01526928|474392558|FG005|Overall Study|Protocol Deviation|0|||
131758531|NCT01526928|474392553|FG000|Overall Study|Missing|0|||
131758532|NCT01526928|474392554|FG001|Overall Study|Missing|0|||
131758533|NCT01526928|474392555|FG002|Overall Study|Missing|1|||
131758534|NCT01526928|474392556|FG003|Overall Study|Missing|0|||
131758535|NCT01526928|474392557|FG004|Overall Study|Missing|2|||
131758536|NCT01526928|474392558|FG005|Overall Study|Missing|0|||
131758537|NCT01108068|474392559|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
131758538|NCT01108068|474392560|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
131758539|NCT02943668|474392564|FG000|Overall Study|Disease Progression|1|||
131758540|NCT00423592|474392565|FG000|Overall Study|Adverse Event (through Week 12)|2|||
131758541|NCT00423592|474392565|FG000|Overall Study|Adverse Event (post Week 12)|5|||
131812177|NCT01788423|474595744|FG001|Overall Study|See Comments in Completed (above)|4|||
131812178|NCT01788423|474595745|FG002|Overall Study|See Comments in Completed (above)|5|||
131812179|NCT03637764|474595746|FG000|Overall Study|Adverse Event|2|||
131812180|NCT03637764|474595747|FG001|Overall Study|Adverse Event|0|||
131812181|NCT03637764|474595748|FG002|Overall Study|Adverse Event|0|||
131812182|NCT03637764|474595749|FG003|Overall Study|Adverse Event|1|||
131812183|NCT03637764|474595746|FG000|Overall Study|Progressive Disease|23|||
131812184|NCT03637764|474595747|FG001|Overall Study|Progressive Disease|23|||
131812185|NCT03637764|474595748|FG002|Overall Study|Progressive Disease|18|||
131812186|NCT03637764|474595749|FG003|Overall Study|Progressive Disease|31|||
131812187|NCT03637764|474595746|FG000|Overall Study|Withdrawal by Subject|1|||
131812188|NCT03637764|474595747|FG001|Overall Study|Withdrawal by Subject|3|||
131812189|NCT03637764|474595748|FG002|Overall Study|Withdrawal by Subject|0|||
131758542|NCT00062647|474392566|FG000|Overall Study|Death|2|||
131758543|NCT00062647|474392567|FG001|Overall Study|Death|2|||
131758544|NCT00062647|474392566|FG000|Overall Study|Adverse Event|1|||
131758545|NCT00062647|474392567|FG001|Overall Study|Adverse Event|1|||
131758546|NCT00062647|474392566|FG000|Overall Study|Withdrawal by Subject|2|||
131758547|NCT00062647|474392567|FG001|Overall Study|Withdrawal by Subject|1|||
131758548|NCT00062647|474392566|FG000|Overall Study|Protocol Violation|1|||
131758549|NCT00062647|474392567|FG001|Overall Study|Protocol Violation|0|||
131758550|NCT00062647|474392566|FG000|Overall Study|Lost to Follow-up|1|||
131758551|NCT00062647|474392567|FG001|Overall Study|Lost to Follow-up|2|||
131758552|NCT00062647|474392566|FG000|Overall Study|Failed continuation criteria|4|||
131758553|NCT00062647|474392567|FG001|Overall Study|Failed continuation criteria|2|||
131758554|NCT00062647|474392566|FG000|Overall Study|Other|4|||
131758555|NCT00062647|474392567|FG001|Overall Study|Other|4|||
131758556|NCT00062647|474392566|FG000|Overall Study|Never received study treatment|1|||
131812190|NCT03637764|474595749|FG003|Overall Study|Withdrawal by Subject|1|||
131758557|NCT00062647|474392567|FG001|Overall Study|Never received study treatment|1|||
131758558|NCT02392468|474392569|FG000|Overall Study|Adverse Event|0|||
131758559|NCT02392468|474392570|FG001|Overall Study|Adverse Event|1|||
131758560|NCT02392468|474392571|FG002|Overall Study|Adverse Event|0|||
131758561|NCT02392468|474392572|FG003|Overall Study|Adverse Event|0|||
131758562|NCT02392468|474392573|FG004|Overall Study|Adverse Event|0|||
131758563|NCT02392468|474392574|FG005|Overall Study|Adverse Event|1|||
131758564|NCT01313039|474392575|FG000|Overall Study|Physician Decision|1|||
131758565|NCT01313039|474392575|FG000|Overall Study|Adverse Event|1|||
131758566|NCT00090766|474392579|FG000|Overall Study|Nephrectomy Planned|0|||
131758567|NCT00090766|474392580|FG001|Overall Study|Nephrectomy Planned|0|||
131758568|NCT00090766|474392581|FG002|Overall Study|Nephrectomy Planned|1|||
131758569|NCT00090766|474392579|FG000|Overall Study|Death|1|||
131758570|NCT00090766|474392580|FG001|Overall Study|Death|0|||
131758571|NCT00090766|474392581|FG002|Overall Study|Death|0|||
131758572|NCT00090766|474392579|FG000|Overall Study|Admin|0|||
131758573|NCT00090766|474392580|FG001|Overall Study|Admin|2|||
131758574|NCT00090766|474392581|FG002|Overall Study|Admin|0|||
131758575|NCT00090766|474392579|FG000|Overall Study|Lost to Follow-up|2|||
131758576|NCT00090766|474392580|FG001|Overall Study|Lost to Follow-up|0|||
131758577|NCT00090766|474392581|FG002|Overall Study|Lost to Follow-up|2|||
131758578|NCT00654368|474392588|FG000|Overall Study|Ineligibility determined|6|||
131758579|NCT00654368|474392589|FG001|Overall Study|Ineligibility determined|0|||
131758580|NCT00654368|474392590|FG002|Overall Study|Ineligibility determined|0|||
131758581|NCT00654368|474392588|FG000|Overall Study|Protocol deviation|3|||
131758582|NCT00654368|474392589|FG001|Overall Study|Protocol deviation|2|||
131758583|NCT00654368|474392590|FG002|Overall Study|Protocol deviation|1|||
131758584|NCT00654368|474392588|FG000|Overall Study|Non-compliance|2|||
131758585|NCT00654368|474392589|FG001|Overall Study|Non-compliance|1|||
131758586|NCT00654368|474392590|FG002|Overall Study|Non-compliance|2|||
131758587|NCT00654368|474392588|FG000|Overall Study|Withdrawal by Subject|5|||
131758588|NCT00654368|474392589|FG001|Overall Study|Withdrawal by Subject|2|||
131758589|NCT00654368|474392590|FG002|Overall Study|Withdrawal by Subject|2|||
131758590|NCT00654368|474392588|FG000|Overall Study|Disease progression|21|||
131758591|NCT00654368|474392589|FG001|Overall Study|Disease progression|31|||
131758592|NCT00654368|474392590|FG002|Overall Study|Disease progression|13|||
131758593|NCT00654368|474392588|FG000|Overall Study|Requirement for alternative therapy|1|||
131758594|NCT00654368|474392589|FG001|Overall Study|Requirement for alternative therapy|1|||
131758595|NCT00654368|474392590|FG002|Overall Study|Requirement for alternative therapy|1|||
131758596|NCT00654368|474392588|FG000|Overall Study|Physician Decision|0|||
131758597|NCT00654368|474392589|FG001|Overall Study|Physician Decision|0|||
131758598|NCT00654368|474392590|FG002|Overall Study|Physician Decision|2|||
131758599|NCT00654368|474392588|FG000|Overall Study|Death|1|||
131758600|NCT00654368|474392589|FG001|Overall Study|Death|0|||
131758601|NCT00654368|474392590|FG002|Overall Study|Death|0|||
131758602|NCT00654368|474392588|FG000|Overall Study|Pregnancy|0|||
131758603|NCT00654368|474392589|FG001|Overall Study|Pregnancy|0|||
131758604|NCT00654368|474392590|FG002|Overall Study|Pregnancy|2|||
131758605|NCT00654368|474392588|FG000|Overall Study|Other|0|||
131758606|NCT00654368|474392589|FG001|Overall Study|Other|2|||
131758607|NCT00654368|474392590|FG002|Overall Study|Other|3|||
131758608|NCT00654368|474392588|FG000|Overall Study|Adverse Event|14|||
131758609|NCT00654368|474392589|FG001|Overall Study|Adverse Event|9|||
131758610|NCT00654368|474392590|FG002|Overall Study|Adverse Event|6|||
131758611|NCT00804986|474392591|FG000|Overall Study|Adverse Event|0|||
131758612|NCT00804986|474392592|FG001|Overall Study|Adverse Event|1|||
131758613|NCT00804986|474392593|FG002|Overall Study|Adverse Event|2|||
131758614|NCT00804986|474392594|FG003|Overall Study|Adverse Event|1|||
131758615|NCT00804986|474392595|FG004|Overall Study|Adverse Event|3|||
131758616|NCT00804986|474392596|FG005|Overall Study|Adverse Event|0|||
131758617|NCT00804986|474392591|FG000|Overall Study|Lack of Efficacy|0|||
131758618|NCT00804986|474392592|FG001|Overall Study|Lack of Efficacy|0|||
131758619|NCT00804986|474392593|FG002|Overall Study|Lack of Efficacy|0|||
131758620|NCT00804986|474392594|FG003|Overall Study|Lack of Efficacy|1|||
131758621|NCT00804986|474392595|FG004|Overall Study|Lack of Efficacy|0|||
131758622|NCT00804986|474392596|FG005|Overall Study|Lack of Efficacy|3|||
131758623|NCT00804986|474392591|FG000|Overall Study|Lost to Follow-up|0|||
131758624|NCT00804986|474392592|FG001|Overall Study|Lost to Follow-up|0|||
131758625|NCT00804986|474392593|FG002|Overall Study|Lost to Follow-up|0|||
131758626|NCT00804986|474392594|FG003|Overall Study|Lost to Follow-up|1|||
131758627|NCT00804986|474392595|FG004|Overall Study|Lost to Follow-up|1|||
131758628|NCT00804986|474392596|FG005|Overall Study|Lost to Follow-up|3|||
131758629|NCT00804986|474392591|FG000|Overall Study|Protocol Violation|0|||
131758630|NCT00804986|474392592|FG001|Overall Study|Protocol Violation|1|||
131758631|NCT00804986|474392593|FG002|Overall Study|Protocol Violation|0|||
131758632|NCT00804986|474392594|FG003|Overall Study|Protocol Violation|1|||
131758633|NCT00804986|474392595|FG004|Overall Study|Protocol Violation|0|||
131758634|NCT00804986|474392596|FG005|Overall Study|Protocol Violation|0|||
131758635|NCT00804986|474392591|FG000|Overall Study|Withdrawal by Subject|0|||
131758636|NCT00804986|474392592|FG001|Overall Study|Withdrawal by Subject|3|||
131758637|NCT00804986|474392593|FG002|Overall Study|Withdrawal by Subject|0|||
131758638|NCT00804986|474392594|FG003|Overall Study|Withdrawal by Subject|3|||
131758639|NCT00804986|474392595|FG004|Overall Study|Withdrawal by Subject|5|||
131758640|NCT00804986|474392596|FG005|Overall Study|Withdrawal by Subject|3|||
131758641|NCT00804986|474392591|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
131758642|NCT00804986|474392592|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
131758643|NCT00804986|474392593|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
131758644|NCT00804986|474392594|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
131758645|NCT00804986|474392595|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
131758646|NCT00804986|474392596|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
131758647|NCT00804986|474392591|FG000|Overall Study|Sponsor Decision|0|||
131758648|NCT00804986|474392592|FG001|Overall Study|Sponsor Decision|1|||
131758649|NCT00804986|474392593|FG002|Overall Study|Sponsor Decision|0|||
131758650|NCT00804986|474392594|FG003|Overall Study|Sponsor Decision|0|||
131758651|NCT00804986|474392595|FG004|Overall Study|Sponsor Decision|0|||
131758652|NCT00804986|474392596|FG005|Overall Study|Sponsor Decision|0|||
131758653|NCT00804986|474392591|FG000|Overall Study|Physician Decision|1|||
131758654|NCT00804986|474392592|FG001|Overall Study|Physician Decision|0|||
131758655|NCT00804986|474392593|FG002|Overall Study|Physician Decision|0|||
131758656|NCT00804986|474392594|FG003|Overall Study|Physician Decision|0|||
131758657|NCT00804986|474392595|FG004|Overall Study|Physician Decision|0|||
131758658|NCT00804986|474392596|FG005|Overall Study|Physician Decision|0|||
131758659|NCT00959699|474392601|FG000|Treatment Period|Adverse Event|3|||
131758660|NCT00959699|474392602|FG001|Treatment Period|Adverse Event|13|||
131758661|NCT00959699|474392601|FG000|Treatment Period|Lack of Efficacy|15|||
131758662|NCT00959699|474392602|FG001|Treatment Period|Lack of Efficacy|6|||
131758663|NCT00959699|474392601|FG000|Treatment Period|Lost to Follow-up|0|||
131758664|NCT00959699|474392602|FG001|Treatment Period|Lost to Follow-up|1|||
131758665|NCT00959699|474392601|FG000|Treatment Period|Withdrawal by Subject|1|||
131758666|NCT00959699|474392602|FG001|Treatment Period|Withdrawal by Subject|3|||
131758667|NCT00959699|474392601|FG000|Treatment Period|Non-Compliance with Protocol|0|||
131758668|NCT00959699|474392602|FG001|Treatment Period|Non-Compliance with Protocol|1|||
131758669|NCT00959699|474392601|FG000|Treatment Period|Did not receive treatment|0|||
131758670|NCT00959699|474392602|FG001|Treatment Period|Did not receive treatment|1|||
131758671|NCT00959699|474392601|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
131758672|NCT00959699|474392602|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
131758673|NCT00959699|474392601|FG000|Follow-up Period|Lost to Follow-up|3|||
131758674|NCT00959699|474392602|FG001|Follow-up Period|Lost to Follow-up|2|||
131758675|NCT00959699|474392601|FG000|Follow-up Period|Withdrawal by Subject|3|||
131758676|NCT00959699|474392602|FG001|Follow-up Period|Withdrawal by Subject|4|||
131758677|NCT04228445|474392605|FG000|Overall Study|Lost to Follow-up|1|||
131758678|NCT04228445|474392606|FG001|Overall Study|Lost to Follow-up|1|||
131758679|NCT04228445|474392605|FG000|Overall Study|Physician Decision|1|||
131758680|NCT04228445|474392606|FG001|Overall Study|Physician Decision|2|||
131758681|NCT04228445|474392605|FG000|Overall Study|Withdrawal by Subject|0|||
131758682|NCT04228445|474392606|FG001|Overall Study|Withdrawal by Subject|1|||
131758683|NCT04228445|474392605|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
131758684|NCT04228445|474392606|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
131758685|NCT00606294|474392607|FG000|Overall Study|Withdrawal by Subject|36|||
131758686|NCT00606294|474392608|FG001|Overall Study|Withdrawal by Subject|0|||
131758687|NCT01316380|474392609|FG000|Overall Study|Adverse Event|0|||
131758688|NCT01316380|474392610|FG001|Overall Study|Adverse Event|2|||
131758689|NCT01316380|474392611|FG002|Overall Study|Adverse Event|1|||
131758690|NCT01316380|474392609|FG000|Overall Study|Protocol Violation|0|||
131758691|NCT01316380|474392610|FG001|Overall Study|Protocol Violation|0|||
131758692|NCT01316380|474392611|FG002|Overall Study|Protocol Violation|1|||
131758693|NCT01316380|474392609|FG000|Overall Study|Withdrawal by Subject|1|||
131758694|NCT01316380|474392610|FG001|Overall Study|Withdrawal by Subject|2|||
131758695|NCT01316380|474392611|FG002|Overall Study|Withdrawal by Subject|0|||
131758696|NCT01316380|474392609|FG000|Overall Study|Other|0|||
131758697|NCT01316380|474392610|FG001|Overall Study|Other|1|||
131758698|NCT01316380|474392611|FG002|Overall Study|Other|1|||
131758699|NCT01316380|474392609|FG000|Overall Study|Not treated|1|||
131758700|NCT01316380|474392610|FG001|Overall Study|Not treated|0|||
131758701|NCT01316380|474392611|FG002|Overall Study|Not treated|0|||
131758702|NCT01894776|474392612|FG000|Overall Study|Withdrawal by Subject|1|||
131758703|NCT02485860|474392613|FG000|Overall Study|Lost to Follow-up|4|||
131758704|NCT02485860|474392614|FG001|Overall Study|Lost to Follow-up|1|||
131758705|NCT02485860|474392613|FG000|Overall Study|Physician Decision|1|||
131758706|NCT02485860|474392614|FG001|Overall Study|Physician Decision|2|||
131758707|NCT02485860|474392613|FG000|Overall Study|Health context (COVID-19)|1|||
131758708|NCT02485860|474392614|FG001|Overall Study|Health context (COVID-19)|0|||
131758709|NCT03073200|474392618|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131758710|NCT03073200|474392619|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131758711|NCT03073200|474392620|FG002|Double Blind Treatment Period|Protocol Violation|0|||
131908722|NCT00855218|474953028|FG001|Overall Study|technical problems|1|||
131398674|NCT00759876|473081227|FG000|Overall Study|Sponsor terminated study early|36|||
131812191|NCT02760927|474595756|FG000|Overall Study|Tube Slippage from Device|1|||
131812192|NCT02105272|474595757|FG000|Overall Study|Adverse Event|1|||
131812193|NCT02105272|474595758|FG001|Overall Study|Adverse Event|2|||
131812194|NCT02105272|474595757|FG000|Overall Study|Physician Decision|0|||
131758712|NCT03073200|474392621|FG003|Double Blind Treatment Period|Protocol Violation|0|||
131758713|NCT03073200|474392622|FG004|Double Blind Treatment Period|Protocol Violation|0|||
131758714|NCT03073200|474392623|FG005|Double Blind Treatment Period|Protocol Violation|0|||
131758715|NCT03073200|474392624|FG006|Double Blind Treatment Period|Protocol Violation|0|||
131758716|NCT03073200|474392625|FG007|Double Blind Treatment Period|Protocol Violation|0|||
131758717|NCT03073200|474392626|FG008|Double Blind Treatment Period|Protocol Violation|0|||
131758718|NCT03073200|474392627|FG009|Double Blind Treatment Period|Protocol Violation|0|||
131758719|NCT03073200|474392628|FG010|Double Blind Treatment Period|Protocol Violation|0|||
131758720|NCT03073200|474392629|FG011|Double Blind Treatment Period|Protocol Violation|0|||
131758721|NCT03073200|474392630|FG012|Double Blind Treatment Period|Protocol Violation|0|||
131758722|NCT03073200|474392631|FG013|Double Blind Treatment Period|Protocol Violation|0|||
131758723|NCT03073200|474392632|FG014|Double Blind Treatment Period|Protocol Violation|0|||
131758724|NCT03073200|474392618|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758725|NCT03073200|474392619|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
131758726|NCT03073200|474392620|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758727|NCT03073200|474392621|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758728|NCT03073200|474392622|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758729|NCT03073200|474392623|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758730|NCT03073200|474392624|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758731|NCT03073200|474392625|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758732|NCT03073200|474392626|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758733|NCT03073200|474392627|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758734|NCT03073200|474392628|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758735|NCT03073200|474392629|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758736|NCT03073200|474392630|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758737|NCT03073200|474392631|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758738|NCT03073200|474392632|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131758739|NCT03073200|474392618|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
131758740|NCT03073200|474392619|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758741|NCT03073200|474392620|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758742|NCT03073200|474392621|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758743|NCT03073200|474392622|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758744|NCT03073200|474392623|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758745|NCT03073200|474392624|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758746|NCT03073200|474392625|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758747|NCT03073200|474392626|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758748|NCT03073200|474392627|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758749|NCT03073200|474392628|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758750|NCT03073200|474392629|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758751|NCT03073200|474392630|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758752|NCT03073200|474392631|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758753|NCT03073200|474392632|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
131758754|NCT03073200|474392618|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758755|NCT03073200|474392619|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758756|NCT03073200|474392620|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
131812195|NCT02105272|474595758|FG001|Overall Study|Physician Decision|1|||
131812196|NCT02105272|474595757|FG000|Overall Study|Protocol Violation|2|||
131758757|NCT03073200|474392621|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
131758758|NCT03073200|474392622|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
131758759|NCT03073200|474392623|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758760|NCT03073200|474392624|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758761|NCT03073200|474392625|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758762|NCT03073200|474392626|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758763|NCT03073200|474392627|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758764|NCT03073200|474392628|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
131812197|NCT02105272|474595758|FG001|Overall Study|Protocol Violation|0|||
131812198|NCT02105272|474595757|FG000|Overall Study|Withdrawal by Subject|2|||
131758765|NCT03073200|474392629|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758766|NCT03073200|474392630|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758767|NCT03073200|474392631|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
131758768|NCT03073200|474392632|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
131812199|NCT02105272|474595758|FG001|Overall Study|Withdrawal by Subject|0|||
131812200|NCT03190915|474595761|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
131908723|NCT00855218|474953027|FG000|Overall Study|Still treated with study medication|0|||
131758769|NCT03073200|474392618|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
131758770|NCT03073200|474392619|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
131758771|NCT03073200|474392620|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
131758772|NCT03073200|474392621|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
131758773|NCT03073200|474392622|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
131758774|NCT03073200|474392623|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
131758775|NCT03073200|474392624|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
131758776|NCT03073200|474392625|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
131758777|NCT03073200|474392626|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
131758778|NCT03073200|474392627|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
131758779|NCT03073200|474392628|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
131758780|NCT03073200|474392629|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
131758781|NCT03073200|474392630|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
131758782|NCT03073200|474392631|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
131758783|NCT03073200|474392632|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
131758784|NCT03073200|474392618|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758785|NCT03073200|474392619|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758786|NCT03073200|474392620|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758787|NCT03073200|474392621|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758788|NCT03073200|474392622|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
131758789|NCT03073200|474392623|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758790|NCT03073200|474392624|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758791|NCT03073200|474392625|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758792|NCT03073200|474392626|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758793|NCT03073200|474392627|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758794|NCT03073200|474392628|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758795|NCT03073200|474392629|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758796|NCT03073200|474392630|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758797|NCT03073200|474392631|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758798|NCT03073200|474392632|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
131758799|NCT03073200|474392618|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758800|NCT03073200|474392619|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758801|NCT03073200|474392620|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758802|NCT03073200|474392621|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
131758803|NCT03073200|474392622|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
131758804|NCT03073200|474392623|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758805|NCT03073200|474392624|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758806|NCT03073200|474392625|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758807|NCT03073200|474392626|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758808|NCT03073200|474392627|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758809|NCT03073200|474392628|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758810|NCT03073200|474392629|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758811|NCT03073200|474392630|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758812|NCT03073200|474392631|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758813|NCT03073200|474392632|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131758814|NCT03073200|474392618|FG000|Extension Period|Lost to Follow-up|0|||
131758815|NCT03073200|474392619|FG001|Extension Period|Lost to Follow-up|0|||
131758816|NCT03073200|474392620|FG002|Extension Period|Lost to Follow-up|0|||
131758817|NCT03073200|474392621|FG003|Extension Period|Lost to Follow-up|0|||
131758818|NCT03073200|474392622|FG004|Extension Period|Lost to Follow-up|0|||
131758819|NCT03073200|474392623|FG005|Extension Period|Lost to Follow-up|0|||
131758820|NCT03073200|474392624|FG006|Extension Period|Lost to Follow-up|1|||
131758821|NCT03073200|474392625|FG007|Extension Period|Lost to Follow-up|1|||
131758822|NCT03073200|474392626|FG008|Extension Period|Lost to Follow-up|0|||
131758823|NCT03073200|474392627|FG009|Extension Period|Lost to Follow-up|0|||
131758824|NCT03073200|474392628|FG010|Extension Period|Lost to Follow-up|0|||
131758825|NCT03073200|474392629|FG011|Extension Period|Lost to Follow-up|0|||
131758826|NCT03073200|474392630|FG012|Extension Period|Lost to Follow-up|0|||
131758827|NCT03073200|474392631|FG013|Extension Period|Lost to Follow-up|0|||
131758828|NCT03073200|474392632|FG014|Extension Period|Lost to Follow-up|0|||
131758829|NCT03073200|474392618|FG000|Extension Period|Sponsor Decision|0|||
131758830|NCT03073200|474392619|FG001|Extension Period|Sponsor Decision|0|||
131758831|NCT03073200|474392620|FG002|Extension Period|Sponsor Decision|0|||
131758832|NCT03073200|474392621|FG003|Extension Period|Sponsor Decision|0|||
131758833|NCT03073200|474392622|FG004|Extension Period|Sponsor Decision|0|||
131758834|NCT03073200|474392623|FG005|Extension Period|Sponsor Decision|0|||
131758835|NCT03073200|474392624|FG006|Extension Period|Sponsor Decision|0|||
131758836|NCT03073200|474392625|FG007|Extension Period|Sponsor Decision|0|||
131758837|NCT03073200|474392626|FG008|Extension Period|Sponsor Decision|1|||
131758838|NCT03073200|474392627|FG009|Extension Period|Sponsor Decision|0|||
131758839|NCT03073200|474392628|FG010|Extension Period|Sponsor Decision|0|||
131758840|NCT03073200|474392629|FG011|Extension Period|Sponsor Decision|0|||
131758841|NCT03073200|474392630|FG012|Extension Period|Sponsor Decision|0|||
131758842|NCT03073200|474392631|FG013|Extension Period|Sponsor Decision|0|||
131758843|NCT03073200|474392632|FG014|Extension Period|Sponsor Decision|0|||
131758844|NCT03073200|474392618|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
131758845|NCT03073200|474392619|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
131758846|NCT03073200|474392620|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
131758847|NCT03073200|474392621|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
131758848|NCT03073200|474392622|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
131758849|NCT03073200|474392623|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
131758850|NCT03073200|474392624|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
131758851|NCT03073200|474392625|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
131758852|NCT03073200|474392626|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
131758853|NCT03073200|474392627|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
131758854|NCT03073200|474392628|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
131758855|NCT03073200|474392629|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
131758856|NCT03073200|474392630|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
131758857|NCT03073200|474392631|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
131758858|NCT03073200|474392632|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
131758859|NCT03073200|474392618|FG000|Extension Period|Withdrawal by Subject|0|||
131758860|NCT03073200|474392619|FG001|Extension Period|Withdrawal by Subject|0|||
131758861|NCT03073200|474392620|FG002|Extension Period|Withdrawal by Subject|0|||
131758862|NCT03073200|474392621|FG003|Extension Period|Withdrawal by Subject|0|||
131758863|NCT03073200|474392622|FG004|Extension Period|Withdrawal by Subject|0|||
131758864|NCT03073200|474392623|FG005|Extension Period|Withdrawal by Subject|0|||
131758865|NCT03073200|474392624|FG006|Extension Period|Withdrawal by Subject|1|||
131758866|NCT03073200|474392625|FG007|Extension Period|Withdrawal by Subject|2|||
131758867|NCT03073200|474392626|FG008|Extension Period|Withdrawal by Subject|0|||
131758868|NCT03073200|474392627|FG009|Extension Period|Withdrawal by Subject|0|||
131758869|NCT03073200|474392628|FG010|Extension Period|Withdrawal by Subject|0|||
131758870|NCT03073200|474392629|FG011|Extension Period|Withdrawal by Subject|0|||
131758871|NCT03073200|474392630|FG012|Extension Period|Withdrawal by Subject|0|||
131758872|NCT03073200|474392631|FG013|Extension Period|Withdrawal by Subject|0|||
131758873|NCT03073200|474392632|FG014|Extension Period|Withdrawal by Subject|0|||
131758874|NCT03073200|474392618|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758875|NCT03073200|474392619|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758876|NCT03073200|474392620|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758877|NCT03073200|474392621|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758878|NCT03073200|474392622|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758879|NCT03073200|474392623|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758880|NCT03073200|474392624|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758881|NCT03073200|474392625|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758882|NCT03073200|474392626|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758883|NCT03073200|474392627|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758884|NCT03073200|474392628|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
131812201|NCT03190915|474595761|FG000|Overall Study|Progressive Disease|3|||
131812202|NCT05630885|474595762|FG000|Study Completion|Took prohibited medications|2|||
131758885|NCT03073200|474392629|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
131758886|NCT03073200|474392630|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758887|NCT03073200|474392631|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758888|NCT03073200|474392632|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
131758889|NCT03073200|474392618|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758890|NCT03073200|474392619|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758891|NCT03073200|474392620|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758892|NCT03073200|474392621|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758893|NCT03073200|474392622|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131812203|NCT05630885|474595763|FG001|Study Completion|Took prohibited medications|0|||
131812204|NCT05630885|474595762|FG000|Study Completion|Non-compliance with study drug|1|||
131812205|NCT05630885|474595763|FG001|Study Completion|Non-compliance with study drug|0|||
131812206|NCT05630885|474595762|FG000|Study Completion|Adverse Event|1|||
131758894|NCT03073200|474392623|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131812207|NCT05630885|474595763|FG001|Study Completion|Adverse Event|0|||
131812208|NCT05630885|474595762|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
131758895|NCT03073200|474392624|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758896|NCT03073200|474392625|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758897|NCT03073200|474392626|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758898|NCT03073200|474392627|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131812209|NCT05630885|474595763|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
131758899|NCT03073200|474392628|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758900|NCT03073200|474392629|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
131758901|NCT03073200|474392630|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758902|NCT03073200|474392631|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758903|NCT03073200|474392632|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131758904|NCT03073200|474392618|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758905|NCT03073200|474392619|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758906|NCT03073200|474392620|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758907|NCT03073200|474392621|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758908|NCT03073200|474392622|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758909|NCT03073200|474392623|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758910|NCT03073200|474392624|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758911|NCT03073200|474392625|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758912|NCT03073200|474392626|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758913|NCT03073200|474392627|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758914|NCT03073200|474392628|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
131758915|NCT03073200|474392629|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
131758916|NCT03073200|474392630|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758917|NCT03073200|474392631|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758918|NCT03073200|474392632|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131758919|NCT03073200|474392618|FG000|Randomized Withdrawal Period|Adverse Event|0|||
131758920|NCT03073200|474392619|FG001|Randomized Withdrawal Period|Adverse Event|0|||
131758921|NCT03073200|474392620|FG002|Randomized Withdrawal Period|Adverse Event|0|||
131758922|NCT03073200|474392621|FG003|Randomized Withdrawal Period|Adverse Event|0|||
131758923|NCT03073200|474392622|FG004|Randomized Withdrawal Period|Adverse Event|0|||
131758924|NCT03073200|474392623|FG005|Randomized Withdrawal Period|Adverse Event|0|||
131758925|NCT03073200|474392624|FG006|Randomized Withdrawal Period|Adverse Event|0|||
131758926|NCT03073200|474392625|FG007|Randomized Withdrawal Period|Adverse Event|0|||
131758927|NCT03073200|474392626|FG008|Randomized Withdrawal Period|Adverse Event|0|||
131758928|NCT03073200|474392627|FG009|Randomized Withdrawal Period|Adverse Event|0|||
131758929|NCT03073200|474392628|FG010|Randomized Withdrawal Period|Adverse Event|1|||
131758930|NCT03073200|474392629|FG011|Randomized Withdrawal Period|Adverse Event|0|||
131758931|NCT03073200|474392630|FG012|Randomized Withdrawal Period|Adverse Event|0|||
131758932|NCT03073200|474392631|FG013|Randomized Withdrawal Period|Adverse Event|0|||
131758933|NCT03073200|474392632|FG014|Randomized Withdrawal Period|Adverse Event|0|||
131758934|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758935|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758936|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758937|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758938|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758939|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758940|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758941|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758942|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758943|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758944|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758945|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758946|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758947|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
131758948|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
131758949|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758950|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758951|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131812210|NCT05630885|474595762|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
131812211|NCT05630885|474595763|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
131812212|NCT06539676|474595764|FG000|Overall Study|Early study termination|1|||
131812213|NCT06539676|474595765|FG001|Overall Study|Early study termination|0|||
131812214|NCT06539676|474595766|FG002|Overall Study|Early study termination|6|||
131812215|NCT03419403|474595767|FG000|Overall Study|Withdrawal by Subject|5|||
131812216|NCT03419403|474595768|FG001|Overall Study|Withdrawal by Subject|2|||
131812217|NCT03419403|474595769|FG002|Overall Study|Withdrawal by Subject|5|||
131758952|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131812218|NCT03419403|474595770|FG003|Overall Study|Withdrawal by Subject|1|||
131812219|NCT03419403|474595767|FG000|Overall Study|Progressive disease (per protocol)|0|||
131812220|NCT03419403|474595768|FG001|Overall Study|Progressive disease (per protocol)|2|||
131812221|NCT03419403|474595769|FG002|Overall Study|Progressive disease (per protocol)|2|||
131812222|NCT03419403|474595770|FG003|Overall Study|Progressive disease (per protocol)|0|||
131812223|NCT03419403|474595767|FG000|Overall Study|Other, not specified|6|||
131758953|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758954|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758955|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758956|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758957|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758958|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758959|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758960|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758961|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758962|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
131758963|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131758964|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758965|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758966|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758967|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758968|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758969|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758970|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758971|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758972|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758973|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758974|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758975|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758976|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758977|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
131758978|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131758979|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758980|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758981|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758982|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758983|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758984|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758985|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758986|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758987|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758988|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758989|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758990|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758991|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758992|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
131758993|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131758994|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131758995|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131758996|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131758997|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131758998|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131758999|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759000|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759001|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759002|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759003|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759004|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759005|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759006|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759007|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131759008|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
131759009|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131812224|NCT03419403|474595768|FG001|Overall Study|Other, not specified|4|||
131812225|NCT03419403|474595769|FG002|Overall Study|Other, not specified|5|||
131812226|NCT03419403|474595770|FG003|Overall Study|Other, not specified|1|||
131812227|NCT03419403|474595767|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
131812228|NCT03419403|474595768|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
131759010|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759011|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759012|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759013|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759014|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759015|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759016|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759017|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759018|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759019|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759020|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759021|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759022|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
131759023|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131759024|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759025|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759026|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759027|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759028|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759029|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759030|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759031|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759032|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759033|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759034|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759035|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759036|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759037|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
131759038|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131759039|NCT03073200|474392618|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759040|NCT03073200|474392619|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759041|NCT03073200|474392620|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759042|NCT03073200|474392621|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759043|NCT03073200|474392622|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759044|NCT03073200|474392623|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759045|NCT03073200|474392624|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131812229|NCT03419403|474595769|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
131812230|NCT03419403|474595770|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
131812231|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Adverse Event|11|||
131812232|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Adverse Event|23|||
131812233|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Adverse Event|29|||
131812234|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Adverse Event|2|||
131812235|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Adverse Event|8|||
131812236|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
131812237|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
131812238|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
131812239|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
131812240|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
131812241|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
131812242|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
131812243|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
131812244|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
131812245|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
131812246|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
131812247|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
131812248|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
131812249|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
131812250|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
131812251|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
131812252|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
131812253|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
131812254|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
131812255|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
131812256|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
131812257|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
131812258|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
131812259|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
131812260|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
131812261|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
131908724|NCT00855218|474953028|FG001|Overall Study|Still treated with study medication|1|||
131759046|NCT03073200|474392625|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759047|NCT03073200|474392626|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759048|NCT03073200|474392627|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759049|NCT03073200|474392628|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759050|NCT03073200|474392629|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759051|NCT03073200|474392630|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759052|NCT03073200|474392631|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
131759053|NCT03073200|474392632|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131759054|NCT00112840|474392633|FG000|Overall Study|Physician Decision|1|||
131759055|NCT00112840|474392634|FG001|Overall Study|Physician Decision|0|||
131759056|NCT00112840|474392635|FG002|Overall Study|Physician Decision|0|||
131759057|NCT00112840|474392633|FG000|Overall Study|Withdrawal by Subject|1|||
131759058|NCT00112840|474392634|FG001|Overall Study|Withdrawal by Subject|0|||
131759059|NCT00112840|474392635|FG002|Overall Study|Withdrawal by Subject|1|||
131759060|NCT00112840|474392633|FG000|Overall Study|Protocol Violation|0|||
131759061|NCT00112840|474392634|FG001|Overall Study|Protocol Violation|0|||
131759062|NCT00112840|474392635|FG002|Overall Study|Protocol Violation|5|||
131759063|NCT00397891|474392636|FG000|Overall Study|Withdrawal by Subject|1|||
131759064|NCT00397891|474392637|FG001|Overall Study|Withdrawal by Subject|0|||
131759065|NCT00397891|474392638|FG002|Overall Study|Withdrawal by Subject|0|||
131759066|NCT00397891|474392639|FG003|Overall Study|Withdrawal by Subject|0|||
131759067|NCT00397891|474392640|FG004|Overall Study|Withdrawal by Subject|1|||
131759068|NCT02531633|474394799|FG000|Part A (52 Weeks)|Sponsor request|24|||
131759069|NCT02531633|474394800|FG001|Part A (52 Weeks)|Sponsor request|24|||
131759070|NCT02531633|474394801|FG002|Part A (52 Weeks)|Sponsor request|18|||
131759071|NCT02531633|474394802|FG003|Part A (52 Weeks)|Sponsor request|18|||
131759072|NCT02531633|474394803|FG004|Part A (52 Weeks)|Sponsor request|19|||
131759073|NCT02531633|474394804|FG005|Part A (52 Weeks)|Sponsor request|0|||
131759074|NCT02531633|474394805|FG006|Part A (52 Weeks)|Sponsor request|0|||
131759075|NCT02531633|474394806|FG007|Part A (52 Weeks)|Sponsor request|0|||
131759076|NCT02531633|474394807|FG008|Part A (52 Weeks)|Sponsor request|0|||
131759077|NCT02531633|474394808|FG009|Part A (52 Weeks)|Sponsor request|0|||
131759078|NCT02531633|474394799|FG000|Part A (52 Weeks)|Protocol Violation|1|||
131759079|NCT02531633|474394800|FG001|Part A (52 Weeks)|Protocol Violation|0|||
131759080|NCT02531633|474394801|FG002|Part A (52 Weeks)|Protocol Violation|0|||
131759081|NCT02531633|474394802|FG003|Part A (52 Weeks)|Protocol Violation|0|||
131759082|NCT02531633|474394803|FG004|Part A (52 Weeks)|Protocol Violation|0|||
131759083|NCT02531633|474394804|FG005|Part A (52 Weeks)|Protocol Violation|0|||
131759084|NCT02531633|474394805|FG006|Part A (52 Weeks)|Protocol Violation|0|||
131759085|NCT02531633|474394806|FG007|Part A (52 Weeks)|Protocol Violation|0|||
131759086|NCT02531633|474394807|FG008|Part A (52 Weeks)|Protocol Violation|0|||
131759087|NCT02531633|474394808|FG009|Part A (52 Weeks)|Protocol Violation|0|||
131759088|NCT02531633|474394799|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
131759089|NCT02531633|474394800|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
131759090|NCT02531633|474394801|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
131759091|NCT02531633|474394802|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
131759092|NCT02531633|474394803|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
131759093|NCT02531633|474394804|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
131759094|NCT02531633|474394805|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
131759095|NCT02531633|474394806|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
131759096|NCT02531633|474394807|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
131759097|NCT02531633|474394808|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
131908725|NCT00855218|474953027|FG000|Overall Study|Untreatable disease progression|54|||
131759098|NCT02531633|474394799|FG000|Part A (52 Weeks)|Physician Decision|1|||
131759099|NCT02531633|474394800|FG001|Part A (52 Weeks)|Physician Decision|4|||
131759100|NCT02531633|474394801|FG002|Part A (52 Weeks)|Physician Decision|3|||
131759101|NCT02531633|474394802|FG003|Part A (52 Weeks)|Physician Decision|1|||
131759102|NCT02531633|474394803|FG004|Part A (52 Weeks)|Physician Decision|0|||
131759103|NCT02531633|474394804|FG005|Part A (52 Weeks)|Physician Decision|0|||
131759104|NCT02531633|474394805|FG006|Part A (52 Weeks)|Physician Decision|0|||
131759105|NCT02531633|474394806|FG007|Part A (52 Weeks)|Physician Decision|0|||
131759106|NCT02531633|474394807|FG008|Part A (52 Weeks)|Physician Decision|0|||
131759107|NCT02531633|474394808|FG009|Part A (52 Weeks)|Physician Decision|0|||
131759108|NCT02531633|474394799|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
131759109|NCT02531633|474394800|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
131398675|NCT03636893|473081228|FG000|Overall Study|Death|0|||
131759110|NCT02531633|474394801|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
131759111|NCT02531633|474394802|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
131759112|NCT02531633|474394803|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
131759113|NCT02531633|474394804|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
131759114|NCT02531633|474394805|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
131759115|NCT02531633|474394806|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
131759116|NCT02531633|474394807|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
131759117|NCT02531633|474394808|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
131759118|NCT02531633|474394799|FG000|Part A (52 Weeks)|Other|2|||
131759119|NCT02531633|474394800|FG001|Part A (52 Weeks)|Other|0|||
131759120|NCT02531633|474394801|FG002|Part A (52 Weeks)|Other|0|||
131759121|NCT02531633|474394802|FG003|Part A (52 Weeks)|Other|0|||
131759122|NCT02531633|474394803|FG004|Part A (52 Weeks)|Other|0|||
131759123|NCT02531633|474394804|FG005|Part A (52 Weeks)|Other|0|||
131759124|NCT02531633|474394805|FG006|Part A (52 Weeks)|Other|0|||
131759125|NCT02531633|474394806|FG007|Part A (52 Weeks)|Other|0|||
131759126|NCT02531633|474394807|FG008|Part A (52 Weeks)|Other|0|||
131759127|NCT02531633|474394808|FG009|Part A (52 Weeks)|Other|0|||
131759128|NCT02531633|474394799|FG000|Part B (104 Weeks)|Sponsor request|0|||
131759129|NCT02531633|474394800|FG001|Part B (104 Weeks)|Sponsor request|0|||
131759130|NCT02531633|474394801|FG002|Part B (104 Weeks)|Sponsor request|0|||
131759131|NCT02531633|474394802|FG003|Part B (104 Weeks)|Sponsor request|0|||
131759132|NCT02531633|474394803|FG004|Part B (104 Weeks)|Sponsor request|0|||
131759133|NCT02531633|474394804|FG005|Part B (104 Weeks)|Sponsor request|8|||
131759134|NCT02531633|474394805|FG006|Part B (104 Weeks)|Sponsor request|5|||
131759135|NCT02531633|474394806|FG007|Part B (104 Weeks)|Sponsor request|3|||
131759136|NCT02531633|474394807|FG008|Part B (104 Weeks)|Sponsor request|5|||
131759137|NCT02531633|474394808|FG009|Part B (104 Weeks)|Sponsor request|4|||
131759138|NCT02531633|474394799|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
131759139|NCT02531633|474394800|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
131759140|NCT02531633|474394801|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
131759141|NCT02531633|474394802|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
131759142|NCT02531633|474394803|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
131759143|NCT02531633|474394804|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
131759144|NCT02531633|474394805|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
131759145|NCT02531633|474394806|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
131759146|NCT02531633|474394807|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
131759147|NCT02531633|474394808|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
131759148|NCT02903966|474394809|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
131759149|NCT02903966|474394810|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
131759150|NCT02903966|474394809|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
131759151|NCT02903966|474394810|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
131759152|NCT02903966|474394809|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
131759153|NCT02903966|474394810|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
131759154|NCT04924114|474394818|FG000|Overall Study|Withdrawal by Subject|0|||
131759155|NCT04924114|474394819|FG001|Overall Study|Withdrawal by Subject|2|||
131759156|NCT04924114|474394820|FG002|Overall Study|Withdrawal by Subject|2|||
131759157|NCT04924114|474394821|FG003|Overall Study|Withdrawal by Subject|0|||
131759158|NCT04924114|474394822|FG004|Overall Study|Withdrawal by Subject|2|||
131759159|NCT04960202|474394823|FG000|Overall Study|Other|5|||
131759160|NCT04960202|474394824|FG001|Overall Study|Other|0|||
131759161|NCT04960202|474394823|FG000|Overall Study|Withdrawal by Subject|37|||
131759162|NCT04960202|474394824|FG001|Overall Study|Withdrawal by Subject|43|||
131759163|NCT04960202|474394823|FG000|Overall Study|Lost to Follow-up|20|||
131759164|NCT04960202|474394824|FG001|Overall Study|Lost to Follow-up|16|||
131759165|NCT04960202|474394823|FG000|Overall Study|Death|0|||
131759166|NCT04960202|474394824|FG001|Overall Study|Death|15|||
131759167|NCT03558828|474394826|FG000|Overall Study|Lost to Follow-up|4|||
131759168|NCT03558828|474394827|FG001|Overall Study|Lost to Follow-up|3|||
131759169|NCT03558828|474394828|FG002|Overall Study|Lost to Follow-up|3|||
131759170|NCT03558828|474394829|FG003|Overall Study|Lost to Follow-up|5|||
131759171|NCT03558828|474394830|FG004|Overall Study|Lost to Follow-up|2|||
131759172|NCT03558828|474394831|FG005|Overall Study|Lost to Follow-up|3|||
131759173|NCT03558828|474394826|FG000|Overall Study|dropped before the intervention|1|||
131759174|NCT03558828|474394827|FG001|Overall Study|dropped before the intervention|1|||
131759175|NCT03558828|474394828|FG002|Overall Study|dropped before the intervention|0|||
131759176|NCT03558828|474394829|FG003|Overall Study|dropped before the intervention|0|||
131759177|NCT03558828|474394830|FG004|Overall Study|dropped before the intervention|0|||
131759178|NCT03558828|474394831|FG005|Overall Study|dropped before the intervention|0|||
131812262|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
131812263|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
131759179|NCT04423718|474394832|FG000|Main Study|Adverse Event|9|||
131759180|NCT04423718|474394833|FG001|Main Study|Adverse Event|5|||
131759181|NCT04423718|474394834|FG002|Main Study|Adverse Event|8|||
131759182|NCT04423718|474394832|FG000|Main Study|Physician Decision|3|||
131759183|NCT04423718|474394833|FG001|Main Study|Physician Decision|3|||
131812264|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
131759184|NCT04423718|474394834|FG002|Main Study|Physician Decision|2|||
131759185|NCT04423718|474394832|FG000|Main Study|Protocol Violation|0|||
131759186|NCT04423718|474394833|FG001|Main Study|Protocol Violation|0|||
131759187|NCT04423718|474394834|FG002|Main Study|Protocol Violation|1|||
131759188|NCT04423718|474394832|FG000|Main Study|Lost to Follow-up|3|||
131759189|NCT04423718|474394833|FG001|Main Study|Lost to Follow-up|3|||
131759190|NCT04423718|474394834|FG002|Main Study|Lost to Follow-up|4|||
131759191|NCT04423718|474394832|FG000|Main Study|Lack of Efficacy|2|||
131759192|NCT04423718|474394833|FG001|Main Study|Lack of Efficacy|1|||
131759193|NCT04423718|474394834|FG002|Main Study|Lack of Efficacy|0|||
131759194|NCT04423718|474394832|FG000|Main Study|Withdrawal by Subject|14|||
131759195|NCT04423718|474394833|FG001|Main Study|Withdrawal by Subject|20|||
131759196|NCT04423718|474394834|FG002|Main Study|Withdrawal by Subject|20|||
131759197|NCT04423718|474394832|FG000|Main Study|Death|10|||
131759198|NCT04423718|474394833|FG001|Main Study|Death|7|||
131759199|NCT04423718|474394834|FG002|Main Study|Death|7|||
131759200|NCT04423718|474394832|FG000|Main Study|COVID-19 pandemic|2|||
131759201|NCT04423718|474394833|FG001|Main Study|COVID-19 pandemic|2|||
131759202|NCT04423718|474394834|FG002|Main Study|COVID-19 pandemic|2|||
131759203|NCT04423718|474394832|FG000|Main Study|Other|7|||
131759204|NCT04423718|474394833|FG001|Main Study|Other|3|||
131759205|NCT04423718|474394834|FG002|Main Study|Other|2|||
131759206|NCT04423718|474394832|FG000|Extension Phase|Other|1|||
131759207|NCT04423718|474394833|FG001|Extension Phase|Other|0|||
131908726|NCT00855218|474953028|FG001|Overall Study|Untreatable disease progression|67|||
131908727|NCT00855218|474953027|FG000|Overall Study|Second malignancy|0|||
131759208|NCT04423718|474394834|FG002|Extension Phase|Other|0|||
131759209|NCT04423718|474394832|FG000|Extension Phase|Logistical problems|0|||
131759210|NCT04423718|474394833|FG001|Extension Phase|Logistical problems|1|||
131759211|NCT04423718|474394834|FG002|Extension Phase|Logistical problems|1|||
131759212|NCT04423718|474394832|FG000|Extension Phase|Physician Decision|1|||
131759213|NCT04423718|474394833|FG001|Extension Phase|Physician Decision|0|||
131759214|NCT04423718|474394834|FG002|Extension Phase|Physician Decision|1|||
131759215|NCT04423718|474394832|FG000|Extension Phase|Lack of Efficacy|2|||
131759216|NCT04423718|474394833|FG001|Extension Phase|Lack of Efficacy|0|||
131759217|NCT04423718|474394834|FG002|Extension Phase|Lack of Efficacy|1|||
131759218|NCT04423718|474394832|FG000|Extension Phase|Lost to Follow-up|0|||
131759219|NCT04423718|474394833|FG001|Extension Phase|Lost to Follow-up|2|||
131759220|NCT04423718|474394834|FG002|Extension Phase|Lost to Follow-up|3|||
131759221|NCT04423718|474394832|FG000|Extension Phase|Adverse Event|2|||
131759222|NCT04423718|474394833|FG001|Extension Phase|Adverse Event|3|||
131759223|NCT04423718|474394834|FG002|Extension Phase|Adverse Event|1|||
131759224|NCT04423718|474394832|FG000|Extension Phase|Death|4|||
131759225|NCT04423718|474394833|FG001|Extension Phase|Death|7|||
131759226|NCT04423718|474394834|FG002|Extension Phase|Death|2|||
131759227|NCT04423718|474394832|FG000|Extension Phase|Withdrawal by Subject|11|||
131759228|NCT04423718|474394833|FG001|Extension Phase|Withdrawal by Subject|11|||
131759229|NCT04423718|474394834|FG002|Extension Phase|Withdrawal by Subject|7|||
131759230|NCT00425945|474394835|FG000|Overall Study|Concern about Supplement|2|||
131759231|NCT00425945|474394836|FG001|Overall Study|Concern about Supplement|0|||
131759232|NCT00425945|474394835|FG000|Overall Study|Inconvenience|0|||
131759233|NCT00425945|474394836|FG001|Overall Study|Inconvenience|2|||
131759234|NCT00425945|474394835|FG000|Overall Study|Lost to Follow-up|0|||
131759235|NCT00425945|474394836|FG001|Overall Study|Lost to Follow-up|2|||
131759236|NCT00425945|474394835|FG000|Overall Study|Began hypertension medication|1|||
131759237|NCT00425945|474394836|FG001|Overall Study|Began hypertension medication|0|||
131759238|NCT00425945|474394835|FG000|Overall Study|Began cancer treatments|1|||
131759239|NCT00425945|474394836|FG001|Overall Study|Began cancer treatments|0|||
131759240|NCT00425945|474394835|FG000|Overall Study|Moved from area|0|||
131759241|NCT00425945|474394836|FG001|Overall Study|Moved from area|1|||
131759242|NCT02881151|474394837|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
131759243|NCT04284787|474394838|FG000|Overall Study|Disease Progression|9|||
131759244|NCT04284787|474394839|FG001|Overall Study|Disease Progression|12|||
131759245|NCT04284787|474394838|FG000|Overall Study|Physician Decision|12|||
131759246|NCT04284787|474394839|FG001|Overall Study|Physician Decision|7|||
131759247|NCT04284787|474394838|FG000|Overall Study|Transplant|5|||
131759248|NCT04284787|474394839|FG001|Overall Study|Transplant|4|||
131759249|NCT04284787|474394838|FG000|Overall Study|Death|1|||
131759250|NCT04284787|474394839|FG001|Overall Study|Death|2|||
131759251|NCT04284787|474394838|FG000|Overall Study|Adverse Event|0|||
131759252|NCT04284787|474394839|FG001|Overall Study|Adverse Event|4|||
131759253|NCT04284787|474394838|FG000|Overall Study|Non-adherence|2|||
131759254|NCT04284787|474394839|FG001|Overall Study|Non-adherence|0|||
131759255|NCT04284787|474394838|FG000|Overall Study|Lack of Efficacy|2|||
131759256|NCT04284787|474394839|FG001|Overall Study|Lack of Efficacy|0|||
131759257|NCT04992507|474394842|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
131759258|NCT04992507|474394843|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
131908728|NCT00855218|474953028|FG001|Overall Study|Second malignancy|1|||
131759259|NCT04992507|474394842|FG000|Overall Study|Death|0|||
131908729|NCT00855218|474953027|FG000|Overall Study|Progression measurement proven|7|||
131759260|NCT04992507|474394843|FG001|Overall Study|Death|1|||
131759261|NCT01852591|474394844|FG000|Overall Study|Withdrawal by Subject|2|||
131759262|NCT01852591|474394844|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
131759263|NCT03287830|474394845|FG000|Overall Study|Withdrawal by Subject|1|||
131759264|NCT03287830|474394846|FG001|Overall Study|Withdrawal by Subject|1|||
131759265|NCT03287830|474394845|FG000|Overall Study|not meeting inclusion criteria|5|||
131908730|NCT00855218|474953028|FG001|Overall Study|Progression measurement proven|15|||
131759266|NCT03287830|474394846|FG001|Overall Study|not meeting inclusion criteria|12|||
131759267|NCT02136134|474394848|FG000|Overall Study|Death|170|||
131759268|NCT02136134|474394849|FG001|Overall Study|Death|148|||
131759269|NCT02136134|474394848|FG000|Overall Study|Withdrawal by Subject|19|||
131759270|NCT02136134|474394849|FG001|Overall Study|Withdrawal by Subject|10|||
131759271|NCT02136134|474394848|FG000|Overall Study|Lost to Follow-up|3|||
131759272|NCT02136134|474394849|FG001|Overall Study|Lost to Follow-up|3|||
131759273|NCT02136134|474394848|FG000|Overall Study|Uspecified|55|||
131759274|NCT02136134|474394849|FG001|Overall Study|Uspecified|90|||
131759275|NCT03070119|474394852|FG000|Overall Study|Adverse Event|0|||
131759276|NCT03070119|474394853|FG001|Overall Study|Adverse Event|0|||
131759277|NCT03070119|474394854|FG002|Overall Study|Adverse Event|1|||
131759278|NCT03070119|474394852|FG000|Overall Study|Lost to Follow-up|0|||
131759279|NCT03070119|474394853|FG001|Overall Study|Lost to Follow-up|1|||
131759280|NCT03070119|474394854|FG002|Overall Study|Lost to Follow-up|0|||
131759281|NCT03070119|474394852|FG000|Overall Study|Consent Withdrawn|6|||
131759282|NCT03070119|474394853|FG001|Overall Study|Consent Withdrawn|5|||
131759283|NCT03070119|474394854|FG002|Overall Study|Consent Withdrawn|3|||
131759284|NCT03070119|474394852|FG000|Overall Study|Investigator Decision|0|||
131759285|NCT03070119|474394853|FG001|Overall Study|Investigator Decision|0|||
131759286|NCT03070119|474394854|FG002|Overall Study|Investigator Decision|1|||
131759287|NCT03070119|474394852|FG000|Overall Study|Death|7|||
131759288|NCT03070119|474394853|FG001|Overall Study|Death|14|||
131759289|NCT03070119|474394854|FG002|Overall Study|Death|5|||
131759290|NCT03070119|474394852|FG000|Overall Study|Disease Progression|5|||
131759291|NCT03070119|474394853|FG001|Overall Study|Disease Progression|7|||
131759292|NCT03070119|474394854|FG002|Overall Study|Disease Progression|7|||
131759293|NCT03070119|474394852|FG000|Overall Study|Reason not Specified|2|||
131759294|NCT03070119|474394853|FG001|Overall Study|Reason not Specified|2|||
131759295|NCT03070119|474394854|FG002|Overall Study|Reason not Specified|1|||
131759296|NCT02974621|474394855|FG000|Overall Study|Didn't receive study treatment|1|||
131759297|NCT02974621|474394856|FG001|Overall Study|Didn't receive study treatment|10|||
131759298|NCT02756845|474394862|FG000|Overall Study|Death|12|||
131759299|NCT02756845|474394863|FG001|Overall Study|Death|2|||
131759300|NCT02756845|474394862|FG000|Overall Study|Withdrawal by Subject|1|||
131759301|NCT02756845|474394863|FG001|Overall Study|Withdrawal by Subject|0|||
131759302|NCT00557323|474394864|FG000|Overall Study|Death|3|||
131759303|NCT00557323|474394864|FG000|Overall Study|Withdrawal by Subject|2|||
131759304|NCT00557323|474394864|FG000|Overall Study|Administrative change|2|||
131759305|NCT03369704|474394870|FG000|Treatment Epoch|technical problems|1|||
131759306|NCT03369704|474394871|FG001|Treatment Epoch|technical problems|0|||
131759307|NCT03369704|474394870|FG000|Treatment Epoch|Protocol Violation|1|||
131759308|NCT03369704|474394871|FG001|Treatment Epoch|Protocol Violation|0|||
131759309|NCT03369704|474394870|FG000|Treatment Epoch|Lost to Follow-up|0|||
131759310|NCT03369704|474394871|FG001|Treatment Epoch|Lost to Follow-up|1|||
131759311|NCT03369704|474394870|FG000|Treatment Epoch|Lack of Efficacy|0|||
131759312|NCT03369704|474394871|FG001|Treatment Epoch|Lack of Efficacy|2|||
131759313|NCT03369704|474394870|FG000|Treatment Epoch|Adverse Event|2|||
131759314|NCT03369704|474394871|FG001|Treatment Epoch|Adverse Event|0|||
131759315|NCT03369704|474394870|FG000|Follow-up Epoch|Lost to Follow-up|1|||
131759316|NCT03369704|474394871|FG001|Follow-up Epoch|Lost to Follow-up|0|||
131759317|NCT01196091|474394872|FG000|Overall Study|Adverse Event|22|||
131812265|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
131812266|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Move|0|||
131812267|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Move|1|||
131812268|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Move|0|||
131812269|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Move|0|||
131812270|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Move|0|||
131812271|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
131812272|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
131812273|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
131812274|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
131812275|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
131812276|NCT00318461|474595773|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
131812277|NCT00318461|474595774|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
131812278|NCT00318461|474595775|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
131812279|NCT00318461|474595776|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
131812280|NCT00318461|474595777|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
131759318|NCT01196091|474394873|FG001|Overall Study|Adverse Event|27|||
131759319|NCT01196091|474394874|FG002|Overall Study|Adverse Event|26|||
131759320|NCT01196091|474394872|FG000|Overall Study|Death|3|||
131759321|NCT01196091|474394873|FG001|Overall Study|Death|2|||
131759322|NCT01196091|474394874|FG002|Overall Study|Death|2|||
131759323|NCT01196091|474394872|FG000|Overall Study|Entry Criteria Not Met|11|||
131759324|NCT01196091|474394873|FG001|Overall Study|Entry Criteria Not Met|11|||
131759325|NCT01196091|474394874|FG002|Overall Study|Entry Criteria Not Met|10|||
131759326|NCT01196091|474394872|FG000|Overall Study|Lack of Efficacy|15|||
131759327|NCT01196091|474394873|FG001|Overall Study|Lack of Efficacy|12|||
131759328|NCT01196091|474394874|FG002|Overall Study|Lack of Efficacy|17|||
131759329|NCT01196091|474394872|FG000|Overall Study|Lost to Follow-up|5|||
131759330|NCT01196091|474394873|FG001|Overall Study|Lost to Follow-up|5|||
131759331|NCT01196091|474394874|FG002|Overall Study|Lost to Follow-up|6|||
131759332|NCT01196091|474394872|FG000|Overall Study|Parent/Caregiver Decision|0|||
131759333|NCT01196091|474394873|FG001|Overall Study|Parent/Caregiver Decision|0|||
131759334|NCT01196091|474394874|FG002|Overall Study|Parent/Caregiver Decision|1|||
131759335|NCT01196091|474394872|FG000|Overall Study|Withdrawal by Subject|16|||
131759336|NCT01196091|474394873|FG001|Overall Study|Withdrawal by Subject|19|||
131759337|NCT01196091|474394874|FG002|Overall Study|Withdrawal by Subject|22|||
131759338|NCT01196091|474394872|FG000|Overall Study|Physician Decision|3|||
131759339|NCT01196091|474394873|FG001|Overall Study|Physician Decision|3|||
131759340|NCT01196091|474394874|FG002|Overall Study|Physician Decision|4|||
131812281|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Work commitment|0|||
131812282|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Work commitment|0|||
131812283|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Work commitment|0|||
131812284|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Work commitment|0|||
131908731|NCT00855218|474953027|FG000|Overall Study|Clinical endpoint reached|10|||
131908732|NCT00855218|474953028|FG001|Overall Study|Clinical endpoint reached|13|||
131908733|NCT00764790|474953029|FG000|Overall Study|Protocol Violation|0|||
131908734|NCT00764790|474953030|FG001|Overall Study|Protocol Violation|0|||
131908735|NCT00764790|474953031|FG002|Overall Study|Protocol Violation|1|||
131908736|NCT00764790|474953029|FG000|Overall Study|Withdrawal by Subject|10|||
131908737|NCT00764790|474953030|FG001|Overall Study|Withdrawal by Subject|12|||
131908738|NCT00764790|474953031|FG002|Overall Study|Withdrawal by Subject|6|||
131908739|NCT00764790|474953029|FG000|Overall Study|Lost to Follow-up|28|||
131908740|NCT00764790|474953030|FG001|Overall Study|Lost to Follow-up|29|||
131908741|NCT00764790|474953031|FG002|Overall Study|Lost to Follow-up|23|||
131908742|NCT03191552|474953032|FG000|Overall Study|Lost to Follow-up|1|||
131908743|NCT03191552|474953033|FG001|Overall Study|Lost to Follow-up|0|||
131908744|NCT03191552|474953034|FG002|Overall Study|Lost to Follow-up|0|||
131908745|NCT03191552|474953032|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
131908746|NCT03191552|474953033|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
131908747|NCT03191552|474953034|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
131908748|NCT01441973|474953035|FG000|Overall Study|Disease progression|8|||
131908749|NCT01441973|474953036|FG001|Overall Study|Disease progression|6|||
131908750|NCT01441973|474953035|FG000|Overall Study|Adverse event unrelated to study drug|3|||
131908751|NCT01441973|474953036|FG001|Overall Study|Adverse event unrelated to study drug|2|||
131908752|NCT01441973|474953035|FG000|Overall Study|Participant request to discontinue|1|||
131908753|NCT01441973|474953036|FG001|Overall Study|Participant request to discontinue|1|||
131908754|NCT01441973|474953035|FG000|Overall Study|Poor compliance/noncompliance|0|||
131908755|NCT01441973|474953036|FG001|Overall Study|Poor compliance/noncompliance|1|||
131908756|NCT01441973|474953035|FG000|Overall Study|Administrative reason by sponsor|3|||
131908757|NCT01441973|474953036|FG001|Overall Study|Administrative reason by sponsor|5|||
131908758|NCT01441973|474953035|FG000|Overall Study|Participant withdrew consent|0|||
131908759|NCT01441973|474953036|FG001|Overall Study|Participant withdrew consent|1|||
131908760|NCT01149655|474953037|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
131908761|NCT01149655|474953038|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
131908762|NCT01149655|474953039|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
131908763|NCT01149655|474953040|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
131908764|NCT01149655|474953037|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
131908765|NCT01149655|474953038|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
131908766|NCT01149655|474953039|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
131908767|NCT01149655|474953040|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
131908768|NCT01149655|474953037|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
131812285|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Work commitment|1|||
131812286|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Investigator decision|0|||
131812287|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Investigator decision|0|||
131812288|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Investigator decision|0|||
131812289|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Investigator decision|0|||
131812290|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Investigator decision|1|||
131812291|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Lack of time|1|||
131908769|NCT01149655|474953038|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
131908770|NCT01149655|474953039|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
131812292|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Lack of time|0|||
131812293|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Lack of time|0|||
131908771|NCT01149655|474953040|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
131908772|NCT01149655|474953037|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
131908773|NCT01149655|474953038|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
131908774|NCT01149655|474953039|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
131759341|NCT01196091|474394872|FG000|Overall Study|Protocol Violation|1|||
131759342|NCT01196091|474394873|FG001|Overall Study|Protocol Violation|3|||
131759343|NCT01196091|474394874|FG002|Overall Study|Protocol Violation|3|||
131759344|NCT01196091|474394872|FG000|Overall Study|Sponsor Decision|6|||
131759345|NCT01196091|474394873|FG001|Overall Study|Sponsor Decision|5|||
131759346|NCT01196091|474394874|FG002|Overall Study|Sponsor Decision|4|||
131759347|NCT01196091|474394872|FG000|Overall Study|Excluded Site|5|||
131759348|NCT01196091|474394873|FG001|Overall Study|Excluded Site|11|||
131759349|NCT01196091|474394874|FG002|Overall Study|Excluded Site|8|||
131759350|NCT01196091|474394872|FG000|Overall Study|Randomized, No Study Drug Received|1|||
131759351|NCT01196091|474394873|FG001|Overall Study|Randomized, No Study Drug Received|0|||
131759352|NCT01196091|474394874|FG002|Overall Study|Randomized, No Study Drug Received|1|||
131759353|NCT03733249|474394875|FG000|Overall Study|Death|7|||
131759354|NCT03733249|474394875|FG000|Overall Study|Disease relapse|16|||
131759355|NCT03733249|474394875|FG000|Overall Study|Lost to Follow-up|4|||
131759356|NCT03733249|474394875|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
131759357|NCT03733249|474394875|FG000|Overall Study|Withdrawal by Subject|1|||
131759358|NCT00772889|474394876|FG000|Overall Study|Adverse Event|7|||
131759359|NCT00772889|474394877|FG001|Overall Study|Adverse Event|4|||
131759360|NCT00772889|474394878|FG002|Overall Study|Adverse Event|0|||
131759361|NCT00772889|474394876|FG000|Overall Study|Withdrawal by Subject|9|||
131759362|NCT00772889|474394877|FG001|Overall Study|Withdrawal by Subject|8|||
131759363|NCT00772889|474394878|FG002|Overall Study|Withdrawal by Subject|9|||
131759364|NCT00772889|474394876|FG000|Overall Study|Lost to Follow-up|6|||
131759365|NCT00772889|474394877|FG001|Overall Study|Lost to Follow-up|6|||
131759366|NCT00772889|474394878|FG002|Overall Study|Lost to Follow-up|7|||
131759367|NCT04247828|474394887|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
131759368|NCT03797144|474394888|FG000|Enrollment|Protocol Violation|4|||
131759369|NCT03797144|474394889|FG001|Enrollment|Protocol Violation|1|||
131759370|NCT03797144|474394888|FG000|Surgery|Protocol Violation|1|||
131759371|NCT03797144|474394889|FG001|Surgery|Protocol Violation|0|||
131759372|NCT03797144|474394888|FG000|3 Month|Early termination cut-off date|2|||
131759373|NCT03797144|474394889|FG001|3 Month|Early termination cut-off date|0|||
131759374|NCT03797144|474394888|FG000|12 Month|Early termination cut-off date|8|||
131759375|NCT03797144|474394889|FG001|12 Month|Early termination cut-off date|9|||
131759376|NCT03797144|474394888|FG000|24 Month|Early termination cut-off date|1|||
131908775|NCT01149655|474953040|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
131908776|NCT01149655|474953037|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
131908777|NCT01149655|474953038|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
131908778|NCT01149655|474953039|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
131908779|NCT01149655|474953040|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
131908780|NCT01149655|474953037|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
131908781|NCT01149655|474953038|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
131908782|NCT01149655|474953039|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
131908783|NCT01149655|474953040|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
131908784|NCT01149655|474953037|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
131759377|NCT03797144|474394889|FG001|24 Month|Early termination cut-off date|1|||
131812294|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Lack of time|0|||
131812295|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Lack of time|0|||
131812296|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
131812297|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
131812298|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
131812299|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
131812300|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
131812301|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
131812302|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
131812303|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
131812304|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
131812305|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
131812306|NCT00318461|474595773|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
131812307|NCT00318461|474595774|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
131812308|NCT00318461|474595775|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
131812309|NCT00318461|474595776|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
131759378|NCT00606229|474394890|FG000|Overall Study|Adverse Event|11|||
131759379|NCT00606229|474394890|FG000|Overall Study|Lack of Efficacy|1|||
131759380|NCT00606229|474394890|FG000|Overall Study|Withdrawal by Subject|4|||
131759381|NCT00606229|474394890|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
131759382|NCT00606229|474394890|FG000|Overall Study|change of residence or other commitments|2|||
131759383|NCT00836953|474394891|FG000|Overall Study|Withdrawal by Subject|1|||
131812310|NCT00318461|474595777|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
131908785|NCT01149655|474953038|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
131908786|NCT01149655|474953039|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
131759384|NCT00836953|474394891|FG000|Overall Study|Lost to Follow-up|1|||
131759385|NCT00376675|474394892|FG000|Overall Study|Withdrawal by Subject|9|||
131759386|NCT00376675|474394893|FG001|Overall Study|Withdrawal by Subject|2|||
131908787|NCT01149655|474953040|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
131908788|NCT01149655|474953037|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
131908789|NCT01149655|474953038|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
131908790|NCT01149655|474953039|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
131908791|NCT01149655|474953040|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
131908792|NCT01149655|474953037|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
131908793|NCT01149655|474953038|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
131759387|NCT00376675|474394892|FG000|Overall Study|Adverse Event|10|||
131759388|NCT00376675|474394893|FG001|Overall Study|Adverse Event|5|||
131759389|NCT00376675|474394892|FG000|Overall Study|Other Reason|1|||
131759390|NCT00376675|474394893|FG001|Overall Study|Other Reason|7|||
131759391|NCT02829775|474394894|FG000|Overall Study|Death|1|||
131759392|NCT02829775|474394894|FG000|Overall Study|Withdrawal by Subject|3|||
131759393|NCT02829775|474394894|FG000|Overall Study|Disease remission|1|||
131759394|NCT01249157|474394895|FG000|Overall Study|Withdrawal by Subject|1|||
131759395|NCT05083949|474394904|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
131759396|NCT05083949|474394905|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
131759397|NCT05083949|474394904|FG000|Period 1|Adverse Event|1|||
131759398|NCT05083949|474394905|FG001|Period 1|Adverse Event|1|||
131759399|NCT05083949|474394904|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
131759400|NCT05083949|474394905|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
131759401|NCT05083949|474394904|FG000|Period 2|Adverse Event|0|||
131759402|NCT05083949|474394905|FG001|Period 2|Adverse Event|2|||
131759403|NCT02996500|474394906|FG000|Overall Study|Adverse Event|1|||
131759404|NCT02996500|474394907|FG001|Overall Study|Adverse Event|1|||
131759405|NCT02996500|474394908|FG002|Overall Study|Adverse Event|4|||
131759406|NCT02996500|474394909|FG003|Overall Study|Adverse Event|3|||
131759407|NCT02996500|474394910|FG004|Overall Study|Adverse Event|1|||
131759408|NCT02996500|474394911|FG005|Overall Study|Adverse Event|2|||
131759409|NCT02996500|474394906|FG000|Overall Study|Lack of Efficacy|0|||
131759410|NCT02996500|474394907|FG001|Overall Study|Lack of Efficacy|0|||
131759411|NCT02996500|474394908|FG002|Overall Study|Lack of Efficacy|0|||
131759412|NCT02996500|474394909|FG003|Overall Study|Lack of Efficacy|0|||
131759413|NCT02996500|474394910|FG004|Overall Study|Lack of Efficacy|2|||
131759414|NCT02996500|474394911|FG005|Overall Study|Lack of Efficacy|0|||
131759415|NCT02996500|474394906|FG000|Overall Study|Lost to Follow-up|1|||
131759416|NCT02996500|474394907|FG001|Overall Study|Lost to Follow-up|0|||
131759417|NCT02996500|474394908|FG002|Overall Study|Lost to Follow-up|0|||
131759418|NCT02996500|474394909|FG003|Overall Study|Lost to Follow-up|0|||
131759419|NCT02996500|474394910|FG004|Overall Study|Lost to Follow-up|0|||
131759420|NCT02996500|474394911|FG005|Overall Study|Lost to Follow-up|1|||
131759421|NCT02996500|474394906|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131759422|NCT02996500|474394907|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131759423|NCT02996500|474394908|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
131759424|NCT02996500|474394909|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
131759425|NCT02996500|474394910|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
131759426|NCT02996500|474394911|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
131759427|NCT02996500|474394906|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131759428|NCT02996500|474394907|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131759429|NCT02996500|474394908|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131759430|NCT02996500|474394909|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131759431|NCT02996500|474394910|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131759432|NCT02996500|474394911|FG005|Overall Study|Non-Compliance With Study Drug|1|||
131759433|NCT02996500|474394906|FG000|Overall Study|Progressive Disease|1|||
131759434|NCT02996500|474394907|FG001|Overall Study|Progressive Disease|0|||
131759435|NCT02996500|474394908|FG002|Overall Study|Progressive Disease|0|||
131759436|NCT02996500|474394909|FG003|Overall Study|Progressive Disease|0|||
131759437|NCT02996500|474394910|FG004|Overall Study|Progressive Disease|0|||
131759438|NCT02996500|474394911|FG005|Overall Study|Progressive Disease|0|||
131759439|NCT02996500|474394906|FG000|Overall Study|Other|2|||
131759440|NCT02996500|474394907|FG001|Overall Study|Other|0|||
131759441|NCT02996500|474394908|FG002|Overall Study|Other|2|||
131759442|NCT02996500|474394909|FG003|Overall Study|Other|0|||
131759443|NCT02996500|474394910|FG004|Overall Study|Other|0|||
131759444|NCT02996500|474394911|FG005|Overall Study|Other|0|||
131759445|NCT02996500|474394906|FG000|Overall Study|Protocol Violation|0|||
131759446|NCT02996500|474394907|FG001|Overall Study|Protocol Violation|0|||
131759447|NCT02996500|474394908|FG002|Overall Study|Protocol Violation|0|||
131759448|NCT02996500|474394909|FG003|Overall Study|Protocol Violation|1|||
131759449|NCT02996500|474394910|FG004|Overall Study|Protocol Violation|0|||
131759450|NCT02996500|474394911|FG005|Overall Study|Protocol Violation|0|||
131759451|NCT02996500|474394906|FG000|Overall Study|Withdrawal by Subject|3|||
131759452|NCT02996500|474394907|FG001|Overall Study|Withdrawal by Subject|0|||
131759453|NCT02996500|474394908|FG002|Overall Study|Withdrawal by Subject|3|||
131759454|NCT02996500|474394909|FG003|Overall Study|Withdrawal by Subject|0|||
131759455|NCT02996500|474394910|FG004|Overall Study|Withdrawal by Subject|2|||
131759456|NCT02996500|474394911|FG005|Overall Study|Withdrawal by Subject|0|||
131759457|NCT01678560|474394912|FG000|Overall Study|Physician Decision|4|||
131759458|NCT01678560|474394913|FG001|Overall Study|Physician Decision|4|||
131759459|NCT01678560|474394912|FG000|Overall Study|Death|0|||
131759460|NCT01678560|474394913|FG001|Overall Study|Death|1|||
131759461|NCT01678560|474394912|FG000|Overall Study|Withdrawal by Subject|0|||
131759462|NCT01678560|474394913|FG001|Overall Study|Withdrawal by Subject|1|||
131759463|NCT00322387|474394914|FG000|Treatment Period|Adverse Event|0|||
131759464|NCT00322387|474394915|FG001|Treatment Period|Adverse Event|1|||
131759465|NCT00322387|474394914|FG000|Follow-up Period|Final assessment not done|1|||
131759466|NCT00322387|474394915|FG001|Follow-up Period|Final assessment not done|3|||
131759467|NCT00322387|474394914|FG000|Follow-up Period|Death|1|||
131759468|NCT00322387|474394915|FG001|Follow-up Period|Death|0|||
131759469|NCT03898323|474394916|FG000|Overall Study|Physician Decision|1|||
131759470|NCT02574520|474394918|FG000|Overall Study|Not dosed|2|||
131759471|NCT02574520|474394919|FG001|Overall Study|Not dosed|0|||
131812311|NCT00318461|474595773|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
131812312|NCT00318461|474595774|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
131812313|NCT00318461|474595775|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
131812314|NCT00318461|474595776|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
131908794|NCT01149655|474953039|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
131908795|NCT01149655|474953040|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
131908796|NCT01149655|474953037|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
131908797|NCT01149655|474953038|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
131908798|NCT01149655|474953039|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
131908799|NCT01149655|474953040|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
131398676|NCT03636893|473081229|FG001|Overall Study|Death|1|||
131398677|NCT03636893|473081228|FG000|Overall Study|Protocol Violation|0|||
131398678|NCT03636893|473081229|FG001|Overall Study|Protocol Violation|3|||
131398679|NCT03636893|473081228|FG000|Overall Study|Withdrawal by Subject|1|||
131398680|NCT03636893|473081229|FG001|Overall Study|Withdrawal by Subject|2|||
131398681|NCT03636893|473081228|FG000|Overall Study|Refusal to surgery|4|||
131759472|NCT02574520|474394920|FG002|Overall Study|Not dosed|5|||
131908800|NCT01149655|474953037|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
131908801|NCT01149655|474953038|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
131908802|NCT01149655|474953039|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
131908803|NCT01149655|474953040|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
131908804|NCT01149655|474953037|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
131759473|NCT02574520|474394921|FG003|Overall Study|Not dosed|4|||
131759474|NCT02574520|474394918|FG000|Overall Study|Adverse Event|0|||
131812315|NCT00318461|474595777|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
131812316|NCT00318461|474595773|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
131812317|NCT00318461|474595774|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
131812318|NCT00318461|474595775|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
131812319|NCT00318461|474595776|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
131812320|NCT00318461|474595777|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
131812321|NCT00318461|474595773|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
131812322|NCT00318461|474595774|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
131812323|NCT00318461|474595775|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
131812324|NCT00318461|474595776|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
131812325|NCT00318461|474595777|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
131812326|NCT00318461|474595773|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
131812327|NCT00318461|474595774|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
131812328|NCT00318461|474595775|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
131812329|NCT00318461|474595776|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
131812330|NCT00318461|474595777|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
131812331|NCT00318461|474595773|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
131812332|NCT00318461|474595774|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
131812333|NCT00318461|474595775|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
131908805|NCT01149655|474953038|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
131759475|NCT02574520|474394919|FG001|Overall Study|Adverse Event|0|||
131759476|NCT02574520|474394920|FG002|Overall Study|Adverse Event|0|||
131759477|NCT02574520|474394921|FG003|Overall Study|Adverse Event|1|||
131398682|NCT03636893|473081229|FG001|Overall Study|Refusal to surgery|3|||
131759478|NCT02574520|474394918|FG000|Overall Study|Withdrawal by Subject|0|||
131759479|NCT02574520|474394919|FG001|Overall Study|Withdrawal by Subject|0|||
131398683|NCT03636893|473081228|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
131759480|NCT02574520|474394920|FG002|Overall Study|Withdrawal by Subject|0|||
131759481|NCT02574520|474394921|FG003|Overall Study|Withdrawal by Subject|1|||
131398684|NCT03636893|473081229|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
131759482|NCT02574520|474394918|FG000|Overall Study|Other|0|||
131759483|NCT02574520|474394919|FG001|Overall Study|Other|0|||
131759484|NCT02574520|474394920|FG002|Overall Study|Other|0|||
131759485|NCT02574520|474394921|FG003|Overall Study|Other|2|||
131759486|NCT01868594|474394929|FG000|Overall Study|Do not meet inclusion criteria|4|||
131759487|NCT01868594|474394930|FG001|Overall Study|Do not meet inclusion criteria|3|||
131759488|NCT04964557|474394933|FG000|Overall Study|Withdrawal by Subject|3|||
131759489|NCT04964557|474394934|FG001|Overall Study|Withdrawal by Subject|2|||
131759490|NCT04964557|474394933|FG000|Overall Study|Lost to Follow-up|1|||
131759491|NCT04964557|474394934|FG001|Overall Study|Lost to Follow-up|2|||
131759492|NCT04964557|474394933|FG000|Overall Study|Physician Decision|2|||
131759493|NCT04964557|474394934|FG001|Overall Study|Physician Decision|0|||
131759494|NCT04964557|474394933|FG000|Overall Study|Death|3|||
131759495|NCT04964557|474394934|FG001|Overall Study|Death|0|||
131759496|NCT04964557|474394933|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
131759497|NCT04964557|474394934|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
131759498|NCT02659098|474394935|FG000|Overall Study|Withdrawal by Subject|7|||
131759499|NCT04363944|474394936|FG000|Overall Study|Withdrawal by Subject|2|||
131759500|NCT04363944|474394937|FG001|Overall Study|Withdrawal by Subject|0|||
131759501|NCT02632344|474396400|FG000|Overall Study|Adverse Event|3|||
131759502|NCT02632344|474396400|FG000|Overall Study|Lack of Efficacy|3|||
131759503|NCT02632344|474396400|FG000|Overall Study|Withdrawal by Subject|2|||
131759504|NCT04076579|474396401|FG000|Overall Study|Adverse Event|2|||
131759505|NCT04076579|474396402|FG001|Overall Study|Adverse Event|0|||
131759506|NCT04076579|474396401|FG000|Overall Study|discontinued due to toxicity|1|||
131759507|NCT04076579|474396402|FG001|Overall Study|discontinued due to toxicity|0|||
131759508|NCT04076579|474396401|FG000|Overall Study|Physician Decision|1|||
131759509|NCT04076579|474396402|FG001|Overall Study|Physician Decision|0|||
131759510|NCT04076579|474396401|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
131759511|NCT04076579|474396402|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
131759512|NCT04076579|474396401|FG000|Overall Study|Noncompliance|0|||
131759513|NCT04076579|474396402|FG001|Overall Study|Noncompliance|1|||
131759514|NCT04076579|474396401|FG000|Overall Study|Withdrawal by Subject|0|||
131759515|NCT04076579|474396402|FG001|Overall Study|Withdrawal by Subject|2|||
131759516|NCT03793010|474396403|FG000|Overall Study|Withdrawal by Subject|5|||
131759517|NCT03793010|474396404|FG001|Overall Study|Withdrawal by Subject|7|||
131759518|NCT03793010|474396403|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
131759519|NCT03793010|474396404|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
131759520|NCT03793010|474396403|FG000|Overall Study|Lost to Follow-up|1|||
131759521|NCT03793010|474396404|FG001|Overall Study|Lost to Follow-up|2|||
131759522|NCT03793010|474396403|FG000|Overall Study|Patient couldn't sit still for injection|1|||
131759523|NCT03793010|474396404|FG001|Overall Study|Patient couldn't sit still for injection|0|||
131759524|NCT03793010|474396403|FG000|Overall Study|Withdrew to pursue other treatment|1|||
131759525|NCT03793010|474396404|FG001|Overall Study|Withdrew to pursue other treatment|0|||
131759526|NCT03793010|474396403|FG000|Overall Study|Did not meet eligibility criteria|1|||
131759527|NCT03793010|474396404|FG001|Overall Study|Did not meet eligibility criteria|0|||
131759528|NCT01874353|474396405|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
131759529|NCT01874353|474396406|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
131759530|NCT01874353|474396407|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
131759531|NCT01874353|474396408|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
131759532|NCT01874353|474396405|FG000|Overall Study|Lost to Follow-up|2|||
131759533|NCT01874353|474396406|FG001|Overall Study|Lost to Follow-up|2|||
131759534|NCT01874353|474396407|FG002|Overall Study|Lost to Follow-up|2|||
131759535|NCT01874353|474396408|FG003|Overall Study|Lost to Follow-up|0|||
131759536|NCT01874353|474396405|FG000|Overall Study|Death|110|||
131759537|NCT01874353|474396406|FG001|Overall Study|Death|60|||
131759538|NCT01874353|474396407|FG002|Overall Study|Death|13|||
131759539|NCT01874353|474396408|FG003|Overall Study|Death|7|||
131759540|NCT01874353|474396405|FG000|Overall Study|Withdrawal by Subject|13|||
131759541|NCT01874353|474396406|FG001|Overall Study|Withdrawal by Subject|11|||
131759542|NCT01874353|474396407|FG002|Overall Study|Withdrawal by Subject|0|||
131759543|NCT01874353|474396408|FG003|Overall Study|Withdrawal by Subject|0|||
131759544|NCT04392154|474396409|FG000|Overall Study|Adverse Event|3|||
131759545|NCT04392154|474396410|FG001|Overall Study|Adverse Event|46|||
131812334|NCT00318461|474595776|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
131812335|NCT00318461|474595777|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
131759546|NCT04392154|474396409|FG000|Overall Study|Due to epidemic/pandemic|0|||
131759547|NCT04392154|474396410|FG001|Overall Study|Due to epidemic/pandemic|1|||
131759548|NCT04392154|474396409|FG000|Overall Study|Lack of Efficacy|1|||
131759549|NCT04392154|474396410|FG001|Overall Study|Lack of Efficacy|47|||
131759550|NCT04392154|474396409|FG000|Overall Study|Lost to Follow-up|11|||
131759551|NCT04392154|474396410|FG001|Overall Study|Lost to Follow-up|61|||
131759552|NCT04392154|474396409|FG000|Overall Study|Geopolitical conflict|1|||
131759553|NCT04392154|474396410|FG001|Overall Study|Geopolitical conflict|1|||
131812336|NCT01848938|474595780|FG000|Overall Study|Lost to Follow-up|1|||
131759554|NCT04392154|474396409|FG000|Overall Study|Physician Decision|1|||
131759555|NCT04392154|474396410|FG001|Overall Study|Physician Decision|5|||
131759556|NCT04392154|474396409|FG000|Overall Study|Pregnancy|1|||
131759557|NCT04392154|474396410|FG001|Overall Study|Pregnancy|8|||
131759558|NCT04392154|474396409|FG000|Overall Study|Protocol deviation|1|||
131759559|NCT04392154|474396410|FG001|Overall Study|Protocol deviation|12|||
131759560|NCT04392154|474396409|FG000|Overall Study|Withdrawal by Subject|18|||
131759561|NCT04392154|474396410|FG001|Overall Study|Withdrawal by Subject|138|||
131759562|NCT04392154|474396409|FG000|Overall Study|Sponsor Decision|1|||
131759563|NCT04392154|474396410|FG001|Overall Study|Sponsor Decision|14|||
131759564|NCT04392154|474396409|FG000|Overall Study|Site Closure|0|||
131759565|NCT04392154|474396410|FG001|Overall Study|Site Closure|4|||
131759566|NCT04517253|474396413|FG000|Primary Treatment Period|Adverse Event|1|||
131759567|NCT04517253|474396414|FG001|Primary Treatment Period|Adverse Event|0|||
131759568|NCT04517253|474396415|FG002|Primary Treatment Period|Adverse Event|0|||
131759569|NCT04517253|474396413|FG000|Primary Treatment Period|Death|0|||
131759570|NCT04517253|474396414|FG001|Primary Treatment Period|Death|1|||
131759571|NCT04517253|474396415|FG002|Primary Treatment Period|Death|0|||
131759572|NCT04517253|474396413|FG000|Maintenance Period|Withdrawal by Subject|1|||
131759573|NCT04517253|474396414|FG001|Maintenance Period|Withdrawal by Subject|0|||
131759574|NCT04517253|474396415|FG002|Maintenance Period|Withdrawal by Subject|0|||
131759575|NCT04517253|474396413|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
131759576|NCT04517253|474396414|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
131759577|NCT04517253|474396415|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
131759578|NCT06048367|474396418|FG000|Overall Study|Withdrawal by Subject|0|||
131759579|NCT06048367|474396419|FG001|Overall Study|Withdrawal by Subject|1|||
131759580|NCT06048367|474396420|FG002|Overall Study|Withdrawal by Subject|0|||
131759581|NCT06048367|474396421|FG003|Overall Study|Withdrawal by Subject|0|||
131759582|NCT06048367|474396422|FG004|Overall Study|Withdrawal by Subject|0|||
131759583|NCT06048367|474396418|FG000|Overall Study|Withdrawal by Subject|0|||
131759584|NCT06048367|474396419|FG001|Overall Study|Withdrawal by Subject|0|||
131759585|NCT06048367|474396420|FG002|Overall Study|Withdrawal by Subject|1|||
131759586|NCT06048367|474396421|FG003|Overall Study|Withdrawal by Subject|0|||
131759587|NCT06048367|474396422|FG004|Overall Study|Withdrawal by Subject|0|||
131759588|NCT06048367|474396418|FG000|Overall Study|Withdrawal by Subject|0|||
131759589|NCT06048367|474396419|FG001|Overall Study|Withdrawal by Subject|0|||
131759590|NCT06048367|474396420|FG002|Overall Study|Withdrawal by Subject|0|||
131759591|NCT06048367|474396421|FG003|Overall Study|Withdrawal by Subject|1|||
131759592|NCT06048367|474396422|FG004|Overall Study|Withdrawal by Subject|0|||
131759593|NCT06048367|474396418|FG000|Overall Study|Withdrawal by Subject|0|||
131759594|NCT06048367|474396419|FG001|Overall Study|Withdrawal by Subject|0|||
131759595|NCT06048367|474396420|FG002|Overall Study|Withdrawal by Subject|0|||
131759596|NCT06048367|474396421|FG003|Overall Study|Withdrawal by Subject|1|||
131759597|NCT06048367|474396422|FG004|Overall Study|Withdrawal by Subject|0|||
131759598|NCT01327573|474396423|FG000|Overall Study|Physician Decision|3|||
131759599|NCT01327573|474396424|FG001|Overall Study|Physician Decision|1|||
131812337|NCT01848938|474595781|FG001|Overall Study|Lost to Follow-up|1|||
131812338|NCT01929863|474595788|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
131812339|NCT01929863|474595789|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
131812340|NCT01929863|474595788|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
131812341|NCT01929863|474595789|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
131812342|NCT01929863|474595788|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
131812343|NCT01929863|474595789|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
131812344|NCT00651820|474595794|FG000|Overall Study|Lost to Follow-up|2|||
131812345|NCT01911676|474595795|FG000|Period 1 of Study|Withdrawal by Subject|4|||
131812346|NCT01911676|474595796|FG001|Period 1 of Study|Withdrawal by Subject|2|||
131812347|NCT01911676|474595797|FG002|Period 1 of Study|Withdrawal by Subject|1|||
131812348|NCT01911676|474595798|FG003|Period 1 of Study|Withdrawal by Subject|2|||
131812349|NCT01911676|474595795|FG000|Period 1 of Study|Physician Decision|2|||
131812350|NCT01911676|474595796|FG001|Period 1 of Study|Physician Decision|0|||
131759600|NCT00732472|474396425|FG000|Overall Study|Adverse Event|0|||
131812351|NCT01911676|474595797|FG002|Period 1 of Study|Physician Decision|0|||
131759601|NCT00732472|474396426|FG001|Overall Study|Adverse Event|1|||
131759602|NCT00732472|474396427|FG002|Overall Study|Adverse Event|1|||
131759603|NCT00732472|474396428|FG003|Overall Study|Adverse Event|1|||
131759604|NCT00732472|474396425|FG000|Overall Study|Protocol Violation|0|||
131759605|NCT00732472|474396426|FG001|Overall Study|Protocol Violation|0|||
131759606|NCT00732472|474396427|FG002|Overall Study|Protocol Violation|0|||
131759607|NCT00732472|474396428|FG003|Overall Study|Protocol Violation|1|||
131759608|NCT00732472|474396425|FG000|Overall Study|Withdrawal by Subject|0|||
131759609|NCT00732472|474396426|FG001|Overall Study|Withdrawal by Subject|2|||
131812352|NCT01911676|474595798|FG003|Period 1 of Study|Physician Decision|1|||
131812353|NCT01911676|474595795|FG000|Period 2 of Study|Physician Decision|2|||
131812354|NCT01911676|474595796|FG001|Period 2 of Study|Physician Decision|0|||
131812355|NCT01911676|474595797|FG002|Period 2 of Study|Physician Decision|0|||
131812356|NCT01911676|474595798|FG003|Period 2 of Study|Physician Decision|1|||
131759610|NCT00732472|474396427|FG002|Overall Study|Withdrawal by Subject|0|||
131759611|NCT00732472|474396428|FG003|Overall Study|Withdrawal by Subject|1|||
131759612|NCT01266876|474396429|FG000|Overall Study|Adverse Event|0|||
131759613|NCT01266876|474396430|FG001|Overall Study|Adverse Event|0|||
131759614|NCT01266876|474396431|FG002|Overall Study|Adverse Event|0|||
131759615|NCT01266876|474396432|FG003|Overall Study|Adverse Event|1|||
131759616|NCT01266876|474396433|FG004|Overall Study|Adverse Event|0|||
131759617|NCT01058395|474396434|FG000|Overall Study|Death|2|||
131759618|NCT01058395|474396435|FG001|Overall Study|Death|1|||
131759619|NCT01058395|474396434|FG000|Overall Study|Lost to Follow-up|1|||
131759620|NCT01058395|474396435|FG001|Overall Study|Lost to Follow-up|0|||
131759621|NCT05180721|474396436|FG000|Overall Study|Lost to Follow-up|4|||
131759622|NCT01996865|474396438|FG000|Induction Period|Protocol Violation|1|||
131759623|NCT01996865|474396439|FG001|Induction Period|Protocol Violation|0|||
131759624|NCT01996865|474396440|FG002|Induction Period|Protocol Violation|0|||
131759625|NCT01996865|474396438|FG000|Induction Period|Progressive Disease|4|||
131759626|NCT01996865|474396439|FG001|Induction Period|Progressive Disease|0|||
131759627|NCT01996865|474396440|FG002|Induction Period|Progressive Disease|0|||
131759628|NCT01996865|474396438|FG000|Induction Period|Lost to Follow-up|10|||
131759629|NCT01996865|474396439|FG001|Induction Period|Lost to Follow-up|0|||
131759630|NCT01996865|474396440|FG002|Induction Period|Lost to Follow-up|0|||
131759631|NCT01996865|474396438|FG000|Induction Period|Other Reasons|13|||
131759632|NCT01996865|474396439|FG001|Induction Period|Other Reasons|0|||
131759633|NCT01996865|474396440|FG002|Induction Period|Other Reasons|0|||
131759634|NCT01996865|474396438|FG000|Induction Period|Adverse Event|20|||
131759635|NCT01996865|474396439|FG001|Induction Period|Adverse Event|0|||
131812357|NCT01911676|474595795|FG000|Period 2 of Study|Lost to Follow-up|0|||
131812358|NCT01911676|474595796|FG001|Period 2 of Study|Lost to Follow-up|0|||
131812359|NCT01911676|474595797|FG002|Period 2 of Study|Lost to Follow-up|0|||
131759636|NCT01996865|474396440|FG002|Induction Period|Adverse Event|0|||
131759637|NCT01996865|474396438|FG000|Induction Period|Withdrawal by Subject|60|||
131759638|NCT01996865|474396439|FG001|Induction Period|Withdrawal by Subject|0|||
131759639|NCT01996865|474396440|FG002|Induction Period|Withdrawal by Subject|0|||
131759640|NCT01996865|474396438|FG000|Induction Period|Death|111|||
131759641|NCT01996865|474396439|FG001|Induction Period|Death|0|||
131759642|NCT01996865|474396440|FG002|Induction Period|Death|0|||
131759643|NCT01996865|474396438|FG000|Maintenance Period|Protocol Violation|0|||
131759644|NCT01996865|474396439|FG001|Maintenance Period|Protocol Violation|1|||
131759645|NCT01996865|474396440|FG002|Maintenance Period|Protocol Violation|1|||
131759646|NCT01996865|474396438|FG000|Maintenance Period|Other reasons|0|||
131759647|NCT01996865|474396439|FG001|Maintenance Period|Other reasons|8|||
131759648|NCT01996865|474396440|FG002|Maintenance Period|Other reasons|5|||
131759649|NCT01996865|474396438|FG000|Maintenance Period|Progressive Disease|0|||
131759650|NCT01996865|474396439|FG001|Maintenance Period|Progressive Disease|6|||
131759651|NCT01996865|474396440|FG002|Maintenance Period|Progressive Disease|23|||
131759652|NCT01996865|474396438|FG000|Maintenance Period|Withdrawal by Subject|0|||
131759653|NCT01996865|474396439|FG001|Maintenance Period|Withdrawal by Subject|18|||
131759654|NCT01996865|474396440|FG002|Maintenance Period|Withdrawal by Subject|4|||
131759655|NCT01996865|474396438|FG000|Maintenance Period|Adverse Event|0|||
131759656|NCT01996865|474396439|FG001|Maintenance Period|Adverse Event|7|||
131759657|NCT01996865|474396440|FG002|Maintenance Period|Adverse Event|7|||
131759658|NCT01996865|474396438|FG000|Maintenance Period|Death|0|||
131759659|NCT01996865|474396439|FG001|Maintenance Period|Death|15|||
131759660|NCT01996865|474396440|FG002|Maintenance Period|Death|3|||
131759661|NCT01996865|474396438|FG000|Maintenance Period|Lost to Follow-up|0|||
131908806|NCT01149655|474953039|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
131908807|NCT01149655|474953040|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
131759662|NCT01996865|474396439|FG001|Maintenance Period|Lost to Follow-up|2|||
131812360|NCT01911676|474595798|FG003|Period 2 of Study|Lost to Follow-up|1|||
131812361|NCT01878292|474595800|FG000|Randomized|Protocol Violation|1|||
131812362|NCT01878292|474595801|FG001|Randomized|Protocol Violation|0|||
131812363|NCT01878292|474595802|FG002|Randomized|Protocol Violation|0|||
131812364|NCT01878292|474595800|FG000|Randomized|Lost to Follow-up|1|||
131759663|NCT01996865|474396440|FG002|Maintenance Period|Lost to Follow-up|0|||
131759664|NCT03575351|474396443|FG000|Overall Study|Adverse Event|1|||
131759665|NCT03575351|474396444|FG001|Overall Study|Adverse Event|0|||
131812365|NCT01878292|474595801|FG001|Randomized|Lost to Follow-up|0|||
131812366|NCT01878292|474595802|FG002|Randomized|Lost to Follow-up|0|||
131812367|NCT01878292|474595800|FG000|Randomized|Adverse Event|1|||
131812368|NCT01878292|474595801|FG001|Randomized|Adverse Event|0|||
131908808|NCT01149655|474953037|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
131759666|NCT03575351|474396443|FG000|Overall Study|Death|2|||
131759667|NCT03575351|474396444|FG001|Overall Study|Death|2|||
131759668|NCT03575351|474396443|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
131759669|NCT03575351|474396444|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
131759670|NCT03575351|474396443|FG000|Overall Study|Lack of Efficacy|28|||
131759671|NCT03575351|474396444|FG001|Overall Study|Lack of Efficacy|0|||
131759672|NCT03575351|474396443|FG000|Overall Study|Withdrawal by Subject|1|||
131759673|NCT03575351|474396444|FG001|Overall Study|Withdrawal by Subject|1|||
131908809|NCT01149655|474953038|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
131908810|NCT01149655|474953039|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
131908811|NCT01149655|474953040|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
131908812|NCT01149655|474953037|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
131908813|NCT01149655|474953038|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
131908814|NCT01149655|474953039|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
131908815|NCT01149655|474953040|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
131908816|NCT01149655|474953037|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
131759674|NCT03575351|474396443|FG000|Overall Study|Physician Decision|3|||
131759675|NCT03575351|474396444|FG001|Overall Study|Physician Decision|0|||
131759676|NCT03575351|474396443|FG000|Overall Study|Disease relapse|15|||
131759677|NCT03575351|474396444|FG001|Overall Study|Disease relapse|6|||
131759678|NCT03575351|474396443|FG000|Overall Study|Study drug manufacturing failure|0|||
131759679|NCT03575351|474396444|FG001|Overall Study|Study drug manufacturing failure|1|||
131759680|NCT03575351|474396443|FG000|Overall Study|other reasons|5|||
131759681|NCT03575351|474396444|FG001|Overall Study|other reasons|0|||
131759682|NCT04288089|474396450|FG000|Overall Study|Ongoing Treatment|2|||
131759683|NCT04288089|474396451|FG001|Overall Study|Ongoing Treatment|1|||
131759684|NCT04288089|474396452|FG002|Overall Study|Ongoing Treatment|1|||
131759685|NCT04288089|474396453|FG003|Overall Study|Ongoing Treatment|4|||
131759686|NCT03323086|474396454|FG000|Overall Study|Lost to Follow-up|3|||
131759687|NCT03323086|474396455|FG001|Overall Study|Lost to Follow-up|2|||
131759688|NCT00355615|474396456|FG000|Randomized Double Blind Period|Adverse Event|1|||
131759689|NCT00355615|474396457|FG001|Randomized Double Blind Period|Adverse Event|0|||
131759690|NCT00355615|474396458|FG002|Randomized Double Blind Period|Adverse Event|0|||
131759691|NCT00355615|474396459|FG003|Randomized Double Blind Period|Adverse Event|0|||
131759692|NCT00355615|474396460|FG004|Randomized Double Blind Period|Adverse Event|0|||
131759693|NCT00355615|474396456|FG000|Randomized Double Blind Period|Protocol Violation|0|||
131759694|NCT00355615|474396457|FG001|Randomized Double Blind Period|Protocol Violation|0|||
131759695|NCT00355615|474396458|FG002|Randomized Double Blind Period|Protocol Violation|1|||
131759696|NCT00355615|474396459|FG003|Randomized Double Blind Period|Protocol Violation|1|||
131759697|NCT00355615|474396460|FG004|Randomized Double Blind Period|Protocol Violation|0|||
131759698|NCT00355615|474396456|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131759699|NCT00355615|474396457|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131759700|NCT00355615|474396458|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131759701|NCT00355615|474396459|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131759702|NCT00355615|474396460|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
131759703|NCT00355615|474396456|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131759704|NCT00355615|474396457|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131759705|NCT00355615|474396458|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131759706|NCT00355615|474396459|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131759707|NCT00355615|474396460|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
131759708|NCT00355615|474396456|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131759709|NCT00355615|474396457|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131759710|NCT00355615|474396458|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131759711|NCT00355615|474396459|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131759712|NCT00355615|474396460|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
131759713|NCT00355615|474396456|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131759714|NCT00355615|474396457|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131759715|NCT00355615|474396458|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131759716|NCT00355615|474396459|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131759717|NCT00355615|474396460|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
131812369|NCT01878292|474595802|FG002|Randomized|Adverse Event|0|||
131812370|NCT01878292|474595800|FG000|Double-blind Treatment Period|Other Reasons|2|||
131812371|NCT01878292|474595801|FG001|Double-blind Treatment Period|Other Reasons|0|||
131812372|NCT01878292|474595802|FG002|Double-blind Treatment Period|Other Reasons|0|||
131812373|NCT01878292|474595800|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
131812374|NCT01878292|474595801|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
131812375|NCT01878292|474595802|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
131812376|NCT01878292|474595800|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
131812377|NCT01878292|474595801|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
131812378|NCT01878292|474595802|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
131812379|NCT01878292|474595800|FG000|Double-blind Treatment Period|Protocol Violation|3|||
131812380|NCT01878292|474595801|FG001|Double-blind Treatment Period|Protocol Violation|4|||
131759718|NCT02159365|474396461|FG000|Overall Study|Disease Progression|23|||
131759719|NCT02159365|474396461|FG000|Overall Study|Other reasons|11|||
131812381|NCT01878292|474595802|FG002|Double-blind Treatment Period|Protocol Violation|2|||
131812382|NCT01878292|474595800|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
131812383|NCT01878292|474595801|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
131759720|NCT02159365|474396461|FG000|Overall Study|Administrative reason by Sponsor|9|||
131759721|NCT02159365|474396461|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
131759722|NCT02159365|474396461|FG000|Overall Study|Study drug toxicity|7|||
131759723|NCT02159365|474396461|FG000|Overall Study|Maximum clinical benefit|3|||
131759724|NCT02159365|474396461|FG000|Overall Study|Subject request to discontinue treatment|3|||
131759725|NCT02159365|474396461|FG000|Overall Study|Subject withdrew consent|3|||
131759726|NCT02159365|474396461|FG000|Overall Study|Death|1|||
131908817|NCT01149655|474953038|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
131908818|NCT01149655|474953039|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
131908819|NCT01149655|474953040|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
131908820|NCT01149655|474953037|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
131908821|NCT01149655|474953038|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
131908822|NCT01149655|474953039|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
131908823|NCT01149655|474953040|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
131908824|NCT05079321|474953041|FG000|Overall Study|Withdrawal by Subject|2|||
131908825|NCT05079321|474953042|FG001|Overall Study|Withdrawal by Subject|2|||
131908826|NCT05079321|474953041|FG000|Overall Study|Lost to Follow-up|0|||
131908827|NCT05079321|474953042|FG001|Overall Study|Lost to Follow-up|1|||
131908828|NCT02003144|474953043|FG000|Open Label Maintenance Phase|Other than specified|2|||
131908829|NCT02003144|474953044|FG001|Open Label Maintenance Phase|Other than specified|4|||
131908830|NCT02003144|474953043|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
131908831|NCT02003144|474953044|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
131908832|NCT02003144|474953043|FG000|Open Label Maintenance Phase|Pregnancy|0|||
131908833|NCT02003144|474953044|FG001|Open Label Maintenance Phase|Pregnancy|2|||
131908834|NCT02003144|474953043|FG000|Open Label Maintenance Phase|Physician Decision|1|||
131398685|NCT03636893|473081228|FG000|Overall Study|Adverse Event|1|||
131759727|NCT02159365|474396461|FG000|Overall Study|Lost to Follow-up|1|||
131908835|NCT02003144|474953044|FG001|Open Label Maintenance Phase|Physician Decision|1|||
131759728|NCT00796549|474396462|FG000|Overall Study|Adverse Event|11|||
131759729|NCT00796549|474396462|FG000|Overall Study|not entered|149|||
131759730|NCT00796549|474396462|FG000|Overall Study|Other|2|||
131759731|NCT00796549|474396462|FG000|Overall Study|Progressive disease|56|||
131759732|NCT01878175|474396464|FG000|Overall Study|Developed contraindicated health problem|2|||
131759733|NCT03523715|474396465|FG000|Overall Study|Lost to Follow-up|11|||
131759734|NCT03523715|474396466|FG001|Overall Study|Lost to Follow-up|14|||
131759735|NCT03523715|474396465|FG000|Overall Study|Did not meet inclusion criteria|1|||
131759736|NCT03523715|474396466|FG001|Overall Study|Did not meet inclusion criteria|0|||
131759737|NCT03523715|474396465|FG000|Overall Study|Internally inconsistent reporting|0|||
131759738|NCT03523715|474396466|FG001|Overall Study|Internally inconsistent reporting|2|||
131759739|NCT04430036|474396467|FG000|Safety Run in Phase|Progression of disease|2|||
131759740|NCT01842334|474396468|FG000|Overall Study|Withdrawal by Subject|3|||
131759741|NCT01842334|474396469|FG001|Overall Study|Withdrawal by Subject|3|||
131759742|NCT01842334|474396468|FG000|Overall Study|Moved away mid-study|0|||
131759743|NCT01842334|474396469|FG001|Overall Study|Moved away mid-study|1|||
131759744|NCT03630016|474396471|FG000|Overall Study|Poor Sensor Placement|1|||
131759745|NCT00002981|474396472|FG000|Overall Study|Inevaluable|6|||
131759746|NCT01833806|474396475|FG000|Overall Study|Alternative treatment|2|||
131759747|NCT01833806|474396475|FG000|Overall Study|Death|5|||
131759748|NCT01833806|474396475|FG000|Overall Study|Physician Decision|1|||
131759749|NCT01833806|474396475|FG000|Overall Study|Lost to Follow-up|1|||
131759750|NCT03457636|474396476|FG000|Overall Study|Lost to Follow-up|2|||
131759751|NCT02724111|474396477|FG000|Overall Study|Protocol Violation|2|||
131759752|NCT02724111|474396478|FG001|Overall Study|Protocol Violation|5|||
131759753|NCT01828567|474396484|FG000|Overall Study|Lost to Follow-up|27|||
131759754|NCT01828567|474396485|FG001|Overall Study|Lost to Follow-up|9|||
131759755|NCT01828567|474396484|FG000|Overall Study|Excluded - did not meet criteria|4|||
131759756|NCT01828567|474396485|FG001|Overall Study|Excluded - did not meet criteria|1|||
131759757|NCT00707486|474396488|FG000|Overall Study|Withdrawal by Subject|1|||
131759758|NCT01885104|474396496|FG000|Overall Study|Withdrawal of Consent|1|||
131759759|NCT01885104|474396497|FG001|Overall Study|Withdrawal of Consent|0|||
131908836|NCT02003144|474953043|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
131908837|NCT02003144|474953044|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
131908838|NCT02003144|474953043|FG000|Open Label Maintenance Phase|Adverse Event|2|||
131759760|NCT01885104|474396496|FG000|Overall Study|Lost to Follow-up|0|||
131759761|NCT01885104|474396497|FG001|Overall Study|Lost to Follow-up|1|||
131759762|NCT01885104|474396496|FG000|Overall Study|Physician Decision|1|||
131759763|NCT01885104|474396497|FG001|Overall Study|Physician Decision|0|||
131759764|NCT00126425|474396501|FG000|Overall Study|Withdrawal by Subject|17|||
131759765|NCT00126425|474396502|FG001|Overall Study|Withdrawal by Subject|1|||
131759766|NCT00126425|474396501|FG000|Overall Study|Lost to Follow-up|8|||
131759767|NCT00126425|474396502|FG001|Overall Study|Lost to Follow-up|4|||
131759768|NCT00126425|474396501|FG000|Overall Study|Protocol Violation|9|||
131759769|NCT00126425|474396502|FG001|Overall Study|Protocol Violation|6|||
131908839|NCT02003144|474953044|FG001|Open Label Maintenance Phase|Adverse Event|1|||
131908840|NCT05965752|474953045|FG000|Overall Study|Adverse Event|0|||
131759770|NCT00126425|474396501|FG000|Overall Study|Adverse Event|1|||
131759771|NCT00126425|474396502|FG001|Overall Study|Adverse Event|0|||
131759772|NCT00126425|474396501|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
131759773|NCT00126425|474396502|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
131759774|NCT00126425|474396501|FG000|Overall Study|Other|5|||
131759775|NCT00126425|474396502|FG001|Overall Study|Other|0|||
131759776|NCT02774291|474396503|FG000|Overall Study|Lost to Follow-up|1|||
131759777|NCT02332876|474396504|FG000|Overall Study|Lost to Follow-up|1|||
131759778|NCT02332876|474396505|FG001|Overall Study|Lost to Follow-up|1|||
131759779|NCT02415595|474396506|FG000|Overall Study|Administrative reason by sponsor|39|||
131759780|NCT02415595|474396507|FG001|Overall Study|Administrative reason by sponsor|40|||
131759781|NCT02415595|474396508|FG002|Overall Study|Administrative reason by sponsor|41|||
131759782|NCT02415595|474396509|FG003|Overall Study|Administrative reason by sponsor|39|||
131759783|NCT02415595|474396506|FG000|Overall Study|Adverse Event|1|||
131759784|NCT02415595|474396507|FG001|Overall Study|Adverse Event|3|||
131759785|NCT02415595|474396508|FG002|Overall Study|Adverse Event|5|||
131759786|NCT02415595|474396509|FG003|Overall Study|Adverse Event|10|||
131759787|NCT02415595|474396506|FG000|Overall Study|Lack of Efficacy|4|||
131759788|NCT02415595|474396507|FG001|Overall Study|Lack of Efficacy|4|||
131759789|NCT02415595|474396508|FG002|Overall Study|Lack of Efficacy|0|||
131759790|NCT02415595|474396509|FG003|Overall Study|Lack of Efficacy|0|||
131759791|NCT02415595|474396506|FG000|Overall Study|Lost to Follow-up|1|||
131759792|NCT02415595|474396507|FG001|Overall Study|Lost to Follow-up|3|||
131759793|NCT02415595|474396508|FG002|Overall Study|Lost to Follow-up|1|||
131759794|NCT02415595|474396509|FG003|Overall Study|Lost to Follow-up|1|||
131759795|NCT02415595|474396506|FG000|Overall Study|Poor/Non-compliance|1|||
131759796|NCT02415595|474396507|FG001|Overall Study|Poor/Non-compliance|0|||
131759797|NCT02415595|474396508|FG002|Overall Study|Poor/Non-compliance|1|||
131759798|NCT02415595|474396509|FG003|Overall Study|Poor/Non-compliance|0|||
131759799|NCT02415595|474396506|FG000|Overall Study|Reached stopping criteria|0|||
131759800|NCT02415595|474396507|FG001|Overall Study|Reached stopping criteria|1|||
131759801|NCT02415595|474396508|FG002|Overall Study|Reached stopping criteria|1|||
131759802|NCT02415595|474396509|FG003|Overall Study|Reached stopping criteria|0|||
131759803|NCT02415595|474396506|FG000|Overall Study|Withdrawal by Subject|4|||
131759804|NCT02415595|474396507|FG001|Overall Study|Withdrawal by Subject|0|||
131759805|NCT02415595|474396508|FG002|Overall Study|Withdrawal by Subject|1|||
131759806|NCT02415595|474396509|FG003|Overall Study|Withdrawal by Subject|3|||
131759807|NCT02415595|474396506|FG000|Overall Study|Other|0|||
131759808|NCT02415595|474396507|FG001|Overall Study|Other|1|||
131759809|NCT02415595|474396508|FG002|Overall Study|Other|1|||
131759810|NCT02415595|474396509|FG003|Overall Study|Other|0|||
131759811|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
131759812|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
131759813|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
131759814|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131759815|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
131759816|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131759817|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131759818|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131759819|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
131759820|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
131759821|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131759822|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131759823|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
131759824|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
131759825|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
131759826|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
131759827|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
131759828|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
131759829|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
131759830|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
131759831|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
131759832|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
131759833|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
131759834|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
131759835|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Screen failure|0|||
131759836|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Screen failure|1|||
131759837|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Screen failure|2|||
131759838|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Screen failure|0|||
131759839|NCT02614261|474396510|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
131759840|NCT02614261|474396511|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131759841|NCT02614261|474396512|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
131759842|NCT02614261|474396513|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131759843|NCT02614261|474396510|FG000|Open-Label Extension Phase|Adverse Event|23|||
131759844|NCT02614261|474396511|FG001|Open-Label Extension Phase|Adverse Event|12|||
131759845|NCT02614261|474396512|FG002|Open-Label Extension Phase|Adverse Event|11|||
131759846|NCT02614261|474396513|FG003|Open-Label Extension Phase|Adverse Event|0|||
131759847|NCT02614261|474396510|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
131759848|NCT02614261|474396511|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
131759849|NCT02614261|474396512|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
131759850|NCT02614261|474396513|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
131759851|NCT02614261|474396510|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
131759852|NCT02614261|474396511|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
131759853|NCT02614261|474396512|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
131759854|NCT02614261|474396513|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
131759855|NCT02614261|474396510|FG000|Open-Label Extension Phase|Physician Decision|2|||
131759856|NCT02614261|474396511|FG001|Open-Label Extension Phase|Physician Decision|0|||
131759857|NCT02614261|474396512|FG002|Open-Label Extension Phase|Physician Decision|0|||
131759858|NCT02614261|474396513|FG003|Open-Label Extension Phase|Physician Decision|0|||
131759859|NCT02614261|474396510|FG000|Open-Label Extension Phase|Pregnancy|1|||
131759860|NCT02614261|474396511|FG001|Open-Label Extension Phase|Pregnancy|2|||
131759861|NCT02614261|474396512|FG002|Open-Label Extension Phase|Pregnancy|1|||
131759862|NCT02614261|474396513|FG003|Open-Label Extension Phase|Pregnancy|0|||
131759863|NCT02614261|474396510|FG000|Open-Label Extension Phase|Protocol Violation|3|||
131759864|NCT02614261|474396511|FG001|Open-Label Extension Phase|Protocol Violation|4|||
131759865|NCT02614261|474396512|FG002|Open-Label Extension Phase|Protocol Violation|1|||
131759866|NCT02614261|474396513|FG003|Open-Label Extension Phase|Protocol Violation|0|||
131759867|NCT02614261|474396510|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
131759868|NCT02614261|474396511|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
131759869|NCT02614261|474396512|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
131759870|NCT02614261|474396513|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
131759871|NCT02614261|474396510|FG000|Follow-up Phase|Adverse Event|2|||
131759872|NCT02614261|474396511|FG001|Follow-up Phase|Adverse Event|0|||
131759873|NCT02614261|474396512|FG002|Follow-up Phase|Adverse Event|1|||
131759874|NCT02614261|474396513|FG003|Follow-up Phase|Adverse Event|0|||
131759875|NCT02614261|474396510|FG000|Follow-up Phase|Lost to Follow-up|12|||
131759876|NCT02614261|474396511|FG001|Follow-up Phase|Lost to Follow-up|5|||
131759877|NCT02614261|474396512|FG002|Follow-up Phase|Lost to Follow-up|2|||
131759878|NCT02614261|474396513|FG003|Follow-up Phase|Lost to Follow-up|0|||
131759879|NCT02614261|474396510|FG000|Follow-up Phase|Physician Decision|5|||
131759880|NCT02614261|474396511|FG001|Follow-up Phase|Physician Decision|1|||
131759881|NCT02614261|474396512|FG002|Follow-up Phase|Physician Decision|0|||
131759882|NCT02614261|474396513|FG003|Follow-up Phase|Physician Decision|0|||
131759883|NCT02614261|474396510|FG000|Follow-up Phase|Pregnancy|0|||
131759884|NCT02614261|474396511|FG001|Follow-up Phase|Pregnancy|1|||
131759885|NCT02614261|474396512|FG002|Follow-up Phase|Pregnancy|0|||
131759886|NCT02614261|474396513|FG003|Follow-up Phase|Pregnancy|0|||
131759887|NCT02614261|474396510|FG000|Follow-up Phase|Protocol Violation|1|||
131759888|NCT02614261|474396511|FG001|Follow-up Phase|Protocol Violation|0|||
131759889|NCT02614261|474396512|FG002|Follow-up Phase|Protocol Violation|0|||
131759890|NCT02614261|474396513|FG003|Follow-up Phase|Protocol Violation|0|||
131759891|NCT02614261|474396510|FG000|Follow-up Phase|Withdrawal by Subject|12|||
131759892|NCT02614261|474396511|FG001|Follow-up Phase|Withdrawal by Subject|4|||
131759893|NCT02614261|474396512|FG002|Follow-up Phase|Withdrawal by Subject|11|||
131759894|NCT02614261|474396513|FG003|Follow-up Phase|Withdrawal by Subject|0|||
131759895|NCT02614261|474396510|FG000|Israel Addendum|Withdrawal by Subject|0|||
131759896|NCT02614261|474396511|FG001|Israel Addendum|Withdrawal by Subject|0|||
131759897|NCT02614261|474396512|FG002|Israel Addendum|Withdrawal by Subject|0|||
131759898|NCT02614261|474396513|FG003|Israel Addendum|Withdrawal by Subject|4|||
131759899|NCT00471315|474396514|FG000|Overall Study|Adverse Event|7|||
131759900|NCT00471315|474396514|FG000|Overall Study|Withdrawal by Subject|1|||
131759901|NCT03512275|474396519|FG000|Overall Study|Withdrawal by Subject|1|||
131759902|NCT03512275|474396520|FG001|Overall Study|Withdrawal by Subject|3|||
131759903|NCT03512275|474396519|FG000|Overall Study|Physician Decision|0|||
131759904|NCT03512275|474396520|FG001|Overall Study|Physician Decision|1|||
131759905|NCT03512275|474396519|FG000|Overall Study|Lost to Follow-up|0|||
131759906|NCT03512275|474396520|FG001|Overall Study|Lost to Follow-up|3|||
131759907|NCT03512275|474396519|FG000|Overall Study|Other|1|||
131759908|NCT03512275|474396520|FG001|Overall Study|Other|0|||
131759909|NCT00113555|474396521|FG000|Overall Study|Baseline Failure|59|||
131759910|NCT00113555|474396521|FG000|Overall Study|Permanently Explanted|7|||
131759911|NCT00113555|474396521|FG000|Overall Study|Death|1|||
131759912|NCT00113555|474396521|FG000|Overall Study|Missed Followup|4|||
131759913|NCT00113555|474396521|FG000|Overall Study|Lost to Follow-up|8|||
131759914|NCT04474366|474396522|FG000|Overall Study|Lost to Follow-up|2|||
131759915|NCT04474366|474396523|FG001|Overall Study|Lost to Follow-up|5|||
131759916|NCT04063865|474396524|FG000|Overall Study|Physician Decision|1|||
131759917|NCT04063865|474396525|FG001|Overall Study|Physician Decision|3|||
131759918|NCT04063865|474396524|FG000|Overall Study|Study Closed Prior to Completion|4|||
131759919|NCT04063865|474396525|FG001|Overall Study|Study Closed Prior to Completion|4|||
131759920|NCT04063865|474396524|FG000|Overall Study|Withdrawal by Subject|1|||
131759921|NCT04063865|474396525|FG001|Overall Study|Withdrawal by Subject|1|||
131759922|NCT00609167|474396526|FG000|Overall Study|Withdrawal by Subject|1|||
131759923|NCT00609167|474396527|FG001|Overall Study|Withdrawal by Subject|0|||
131759924|NCT00609167|474396526|FG000|Overall Study|Lack of Efficacy|1|||
131759925|NCT00609167|474396527|FG001|Overall Study|Lack of Efficacy|0|||
131759926|NCT00609167|474396526|FG000|Overall Study|Adverse Event|5|||
131759927|NCT00609167|474396527|FG001|Overall Study|Adverse Event|1|||
131759928|NCT00609167|474396526|FG000|Overall Study|Disease Progression|1|||
131759929|NCT00609167|474396527|FG001|Overall Study|Disease Progression|0|||
131759930|NCT00609167|474396526|FG000|Overall Study|Stem Cell Transplant|0|||
131759931|NCT00609167|474396527|FG001|Overall Study|Stem Cell Transplant|6|||
131759932|NCT00320190|474396528|FG000|First 12 Months|Completed but did not enter extension|5|||
131759933|NCT00320190|474396529|FG001|First 12 Months|Completed but did not enter extension|3|||
131759934|NCT00320190|474396528|FG000|First 12 Months|Sponsor terminated study|2|||
131759935|NCT00320190|474396529|FG001|First 12 Months|Sponsor terminated study|2|||
131759936|NCT00320190|474396528|FG000|First 12 Months|Lost to Follow-up|0|||
131759937|NCT00320190|474396529|FG001|First 12 Months|Lost to Follow-up|1|||
131759938|NCT00320190|474396528|FG000|First 12 Months|Enrollment failure|0|||
131759939|NCT00320190|474396529|FG001|First 12 Months|Enrollment failure|1|||
131759940|NCT00320190|474396528|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
131759941|NCT00320190|474396529|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
131759942|NCT00320190|474396528|FG000|First 12 Months|Investigator request|0|||
131759943|NCT00320190|474396529|FG001|First 12 Months|Investigator request|1|||
131759944|NCT00320190|474396528|FG000|First 12 Months|Study drug toxicity|0|||
131759945|NCT00320190|474396529|FG001|First 12 Months|Study drug toxicity|1|||
131759946|NCT00320190|474396528|FG000|First 12 Months|Withdrawal by Subject|0|||
131759947|NCT00320190|474396529|FG001|First 12 Months|Withdrawal by Subject|1|||
131759948|NCT00320190|474396528|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
131759949|NCT00320190|474396529|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
131759950|NCT00320190|474396528|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
131759951|NCT00320190|474396529|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
131759952|NCT00320190|474396528|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
131759953|NCT00320190|474396529|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
131759954|NCT00712270|474396530|FG000|Overall Study|Withdrawal by Subject|11|||
131759955|NCT00712270|474396530|FG000|Overall Study|Screen Failure|3|||
131759956|NCT00691054|474396537|FG000|Overall Study|Withdrawal by Subject|1|||
131759957|NCT03595176|474396538|FG000|Overall Study|Death|0|||
131759958|NCT03595176|474396539|FG001|Overall Study|Death|2|||
131759959|NCT03595176|474396538|FG000|Overall Study|Lost to Follow-up|0|||
131759960|NCT03595176|474396539|FG001|Overall Study|Lost to Follow-up|1|||
131759961|NCT03258593|474398278|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
131759962|NCT03258593|474398279|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
131759963|NCT03258593|474398280|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
131759964|NCT03258593|474398281|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
131759965|NCT03258593|474398278|FG000|Run-In Maintenance Phase|Disease progression|3|||
131759966|NCT03258593|474398279|FG001|Run-In Maintenance Phase|Disease progression|0|||
131759967|NCT03258593|474398280|FG002|Run-In Maintenance Phase|Disease progression|0|||
131759968|NCT03258593|474398281|FG003|Run-In Maintenance Phase|Disease progression|0|||
131759969|NCT03258593|474398278|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
131759970|NCT03258593|474398279|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
131759971|NCT03258593|474398280|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
131759972|NCT03258593|474398281|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
131759973|NCT03258593|474398278|FG000|Expansion Maintenance Phase|Physician Decision|0|||
131759974|NCT03258593|474398279|FG001|Expansion Maintenance Phase|Physician Decision|1|||
131759975|NCT03258593|474398280|FG002|Expansion Maintenance Phase|Physician Decision|0|||
131759976|NCT03258593|474398281|FG003|Expansion Maintenance Phase|Physician Decision|0|||
131759977|NCT05318183|474398285|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
131759978|NCT05318183|474398286|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
131759979|NCT05318183|474398285|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
131759980|NCT05318183|474398286|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131759981|NCT03657576|474398287|FG000|Overall Study|Death|0|||
131759982|NCT03657576|474398288|FG001|Overall Study|Death|1|||
131759983|NCT03657576|474398289|FG002|Overall Study|Death|1|||
131759984|NCT03657576|474398290|FG003|Overall Study|Death|0|||
131759985|NCT03657576|474398291|FG004|Overall Study|Death|0|||
131759986|NCT03657576|474398292|FG005|Overall Study|Death|0|||
131759987|NCT03657576|474398287|FG000|Overall Study|Withdrawal by Subject|0|||
131759988|NCT03657576|474398288|FG001|Overall Study|Withdrawal by Subject|0|||
131759989|NCT03657576|474398289|FG002|Overall Study|Withdrawal by Subject|0|||
131759990|NCT03657576|474398290|FG003|Overall Study|Withdrawal by Subject|1|||
131759991|NCT03657576|474398291|FG004|Overall Study|Withdrawal by Subject|0|||
131759992|NCT03657576|474398292|FG005|Overall Study|Withdrawal by Subject|0|||
131759993|NCT03657576|474398287|FG000|Overall Study|Screen Fail|0|||
131759994|NCT03657576|474398288|FG001|Overall Study|Screen Fail|0|||
131812384|NCT01878292|474595802|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
131812385|NCT01878292|474595800|FG000|Double-blind Treatment Period|Adverse Event|4|||
131812386|NCT01878292|474595801|FG001|Double-blind Treatment Period|Adverse Event|9|||
131812387|NCT01878292|474595802|FG002|Double-blind Treatment Period|Adverse Event|8|||
131812388|NCT01878292|474595800|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
131812389|NCT01878292|474595801|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
131812390|NCT01878292|474595802|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
131812391|NCT00773253|474595803|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
131812392|NCT00773253|474595804|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
131812393|NCT01566721|474595805|FG000|Treatment Period|Withdrawal by Subject|35|||
131812394|NCT01566721|474595806|FG001|Treatment Period|Withdrawal by Subject|9|||
131812395|NCT01566721|474595805|FG000|Treatment Period|Disease Progression/Recurrence|37|||
131812396|NCT01566721|474595806|FG001|Treatment Period|Disease Progression/Recurrence|13|||
131812397|NCT01566721|474595805|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
131812398|NCT01566721|474595806|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
131812399|NCT01566721|474595805|FG000|Treatment Period|Other|13|||
131812400|NCT01566721|474595806|FG001|Treatment Period|Other|2|||
131812401|NCT01566721|474595805|FG000|Treatment Period|Lack of Compliance|5|||
131812402|NCT01566721|474595806|FG001|Treatment Period|Lack of Compliance|1|||
131812403|NCT01566721|474595805|FG000|Treatment Period|Adverse Event|100|||
131812404|NCT01566721|474595806|FG001|Treatment Period|Adverse Event|30|||
131812405|NCT01566721|474595805|FG000|Treatment Period|Pregnancy|1|||
131812406|NCT01566721|474595806|FG001|Treatment Period|Pregnancy|0|||
131812407|NCT01566721|474595805|FG000|Safety Follow-up|Physician Decision|6|||
131812408|NCT01566721|474595806|FG001|Safety Follow-up|Physician Decision|4|||
131812409|NCT01566721|474595805|FG000|Safety Follow-up|Lost to Follow-up|101|||
131812410|NCT01566721|474595806|FG001|Safety Follow-up|Lost to Follow-up|48|||
131812411|NCT01566721|474595805|FG000|Safety Follow-up|Withdrawal by Subject|155|||
131812412|NCT01566721|474595806|FG001|Safety Follow-up|Withdrawal by Subject|49|||
131759995|NCT03657576|474398289|FG002|Overall Study|Screen Fail|0|||
131759996|NCT03657576|474398290|FG003|Overall Study|Screen Fail|0|||
131908841|NCT05965752|474953046|FG001|Overall Study|Adverse Event|1|||
131908842|NCT05965752|474953047|FG002|Overall Study|Adverse Event|0|||
131908843|NCT05965752|474953048|FG003|Overall Study|Adverse Event|1|||
131908844|NCT05965752|474953049|FG004|Overall Study|Adverse Event|3|||
131759997|NCT03657576|474398291|FG004|Overall Study|Screen Fail|0|||
131759998|NCT03657576|474398292|FG005|Overall Study|Screen Fail|5|||
131759999|NCT03657576|474398287|FG000|Overall Study|Disease Progression|1|||
131760000|NCT03657576|474398288|FG001|Overall Study|Disease Progression|1|||
131760001|NCT03657576|474398289|FG002|Overall Study|Disease Progression|0|||
131760002|NCT03657576|474398290|FG003|Overall Study|Disease Progression|5|||
131760003|NCT03657576|474398291|FG004|Overall Study|Disease Progression|0|||
131760004|NCT03657576|474398292|FG005|Overall Study|Disease Progression|0|||
131760005|NCT03657576|474398287|FG000|Overall Study|Insurance Coverage|0|||
131760006|NCT03657576|474398288|FG001|Overall Study|Insurance Coverage|0|||
131760007|NCT03657576|474398289|FG002|Overall Study|Insurance Coverage|0|||
131760008|NCT03657576|474398290|FG003|Overall Study|Insurance Coverage|1|||
131760009|NCT03657576|474398291|FG004|Overall Study|Insurance Coverage|0|||
131760010|NCT03657576|474398292|FG005|Overall Study|Insurance Coverage|0|||
131760011|NCT03381274|474398295|FG000|Overall Study|Death|2|||
131760012|NCT03381274|474398296|FG001|Overall Study|Death|9|||
131760013|NCT03381274|474398297|FG002|Overall Study|Death|3|||
131760014|NCT03381274|474398298|FG003|Overall Study|Death|2|||
131760015|NCT03381274|474398299|FG004|Overall Study|Death|3|||
131760016|NCT03381274|474398295|FG000|Overall Study|Lost to Follow-up|0|||
131760017|NCT03381274|474398296|FG001|Overall Study|Lost to Follow-up|0|||
131760018|NCT03381274|474398297|FG002|Overall Study|Lost to Follow-up|0|||
131812413|NCT01566721|474595805|FG000|Safety Follow-up|Death|28|||
131812414|NCT01566721|474595806|FG001|Safety Follow-up|Death|4|||
131812415|NCT01566721|474595805|FG000|Safety Follow-up|Non-compliance|7|||
131812416|NCT01566721|474595806|FG001|Safety Follow-up|Non-compliance|3|||
131812417|NCT01566721|474595805|FG000|Safety Follow-up|Protocol Violation|7|||
131812418|NCT01566721|474595806|FG001|Safety Follow-up|Protocol Violation|0|||
131812419|NCT01566721|474595805|FG000|Safety Follow-up|Site closure|2|||
131812420|NCT01566721|474595806|FG001|Safety Follow-up|Site closure|3|||
131812421|NCT01566721|474595805|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
131812422|NCT01566721|474595806|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
131812423|NCT01566721|474595805|FG000|Safety Follow-up|Missing|7|||
131812424|NCT01566721|474595806|FG001|Safety Follow-up|Missing|2|||
131812425|NCT01566721|474595805|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
131908845|NCT05965752|474953045|FG000|Overall Study|Lost to Follow-up|2|||
131908846|NCT05965752|474953046|FG001|Overall Study|Lost to Follow-up|0|||
131908847|NCT05965752|474953047|FG002|Overall Study|Lost to Follow-up|1|||
131760019|NCT03381274|474398298|FG003|Overall Study|Lost to Follow-up|1|||
131760020|NCT03381274|474398299|FG004|Overall Study|Lost to Follow-up|0|||
131760021|NCT03381274|474398295|FG000|Overall Study|Withdrawal by Subject|2|||
131760022|NCT03381274|474398296|FG001|Overall Study|Withdrawal by Subject|1|||
131760023|NCT03381274|474398297|FG002|Overall Study|Withdrawal by Subject|3|||
131760024|NCT03381274|474398298|FG003|Overall Study|Withdrawal by Subject|1|||
131760025|NCT03381274|474398299|FG004|Overall Study|Withdrawal by Subject|0|||
131760026|NCT03381274|474398295|FG000|Overall Study|Other|1|||
131760027|NCT03381274|474398296|FG001|Overall Study|Other|11|||
131760028|NCT03381274|474398297|FG002|Overall Study|Other|0|||
131760029|NCT03381274|474398298|FG003|Overall Study|Other|2|||
131760030|NCT03381274|474398299|FG004|Overall Study|Other|2|||
131760031|NCT03715205|474398300|FG000|Overall Study|Death|13|||
131760032|NCT03715205|474398300|FG000|Overall Study|Lost to Follow-up|2|||
131760033|NCT03715205|474398300|FG000|Overall Study|Physician Decision|93|||
131760034|NCT03715205|474398300|FG000|Overall Study|Withdrawal by Subject|26|||
131760035|NCT05245071|474398301|FG000|Overall Study|Progressive disease|18|||
131760036|NCT05245071|474398301|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
131760037|NCT05245071|474398301|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
131760038|NCT05304611|474398302|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760039|NCT05304611|474398303|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760040|NCT05304611|474398304|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760041|NCT05304611|474398305|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760042|NCT05304611|474398306|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760043|NCT05304611|474398307|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760044|NCT05304611|474398308|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
131760045|NCT05304611|474398309|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
131760046|NCT05304611|474398310|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
131760047|NCT05304611|474398311|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
131812426|NCT01566721|474595806|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
131812427|NCT01566721|474595805|FG000|Safety Follow-up|Sponsor decision|1|||
131812428|NCT01566721|474595806|FG001|Safety Follow-up|Sponsor decision|0|||
131812429|NCT01566721|474595805|FG000|Safety Follow-up|Adverse Event|8|||
131812430|NCT01566721|474595806|FG001|Safety Follow-up|Adverse Event|4|||
131812431|NCT02911701|474595807|FG000|Overall Study|Withdrawal by Subject|2|||
131812432|NCT02911701|474595808|FG001|Overall Study|Withdrawal by Subject|4|||
131812433|NCT02911701|474595807|FG000|Overall Study|Adverse Event|1|||
131812434|NCT02911701|474595808|FG001|Overall Study|Adverse Event|0|||
131812435|NCT00429416|474595809|FG000|Overall Study|Death|1|||
131812436|NCT01237054|474595810|FG000|Overall Study|imaging 10C0096|1|||
131812437|NCT01983969|474595811|FG000|Overall Study|Disease Progression|0|||
131812438|NCT01983969|474595812|FG001|Overall Study|Disease Progression|1|||
131812439|NCT01983969|474595813|FG002|Overall Study|Disease Progression|0|||
131812440|NCT02619682|474595814|FG000|Overall Study|Withdrawal by Subject|3|||
131812441|NCT02619682|474595814|FG000|Overall Study|Lack of Efficacy|8|||
131812442|NCT02619682|474595814|FG000|Overall Study|new secondary cancer|1|||
131812443|NCT02619682|474595814|FG000|Overall Study|post surgery complications|2|||
131812444|NCT00268203|474595817|FG000|Overall Study|Lost to Follow-up|92|||
131812445|NCT00268203|474595817|FG000|Overall Study|Withdrawal by Subject|9|||
131812446|NCT00268203|474595817|FG000|Overall Study|Received Other NHL Therapy|7|||
131812447|NCT00268203|474595817|FG000|Overall Study|Progressive Disease|359|||
131812448|NCT00268203|474595817|FG000|Overall Study|Death|84|||
131812449|NCT00268203|474595817|FG000|Overall Study|Reason Not Specified|34|||
131812450|NCT00268203|474595817|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
131812451|NCT01097577|474595818|FG000|Overall Study|Adverse Event|0|||
131812452|NCT01097577|474595819|FG001|Overall Study|Adverse Event|1|||
131812453|NCT00316186|474595827|FG000|Overall Study|Adverse Event|6|||
131812454|NCT00316186|474595827|FG000|Overall Study|Disease Progression|4|||
131812455|NCT00316186|474595827|FG000|Overall Study|Lost to Follow-up|1|||
131812456|NCT00316186|474595827|FG000|Overall Study|Other|1|||
131812457|NCT04493684|474595828|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
131812458|NCT04493684|474595829|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812459|NCT04493684|474595830|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
131812460|NCT04493684|474595831|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812461|NCT04493684|474595832|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812462|NCT04493684|474595833|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
131812463|NCT04493684|474595834|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812464|NCT04493684|474595835|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812465|NCT04493684|474595836|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131760048|NCT05304611|474398312|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
131812466|NCT04493684|474595837|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131760049|NCT05304611|474398313|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
131812467|NCT04493684|474595838|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812468|NCT04493684|474595839|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131908848|NCT05965752|474953048|FG003|Overall Study|Lost to Follow-up|1|||
131760050|NCT05304611|474398302|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
131760051|NCT05304611|474398303|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
131760052|NCT05304611|474398304|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
131398686|NCT03636893|473081229|FG001|Overall Study|Adverse Event|1|||
131812469|NCT04493684|474595840|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131760053|NCT05304611|474398305|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
131760054|NCT05304611|474398306|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
131760055|NCT05304611|474398307|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
131760056|NCT05304611|474398308|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
131760057|NCT05304611|474398309|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
131760058|NCT05304611|474398310|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
131760059|NCT05304611|474398311|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
131760060|NCT05304611|474398312|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
131760061|NCT05304611|474398313|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
131760062|NCT05304611|474398302|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
131760063|NCT05304611|474398303|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
131760064|NCT05304611|474398304|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
131760065|NCT05304611|474398305|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
131760066|NCT05304611|474398306|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
131760067|NCT05304611|474398307|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
131760068|NCT05304611|474398308|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
131760069|NCT05304611|474398309|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
131760070|NCT05304611|474398310|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
131760071|NCT05304611|474398311|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
131760072|NCT05304611|474398312|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
131760073|NCT05304611|474398313|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
131760074|NCT02354690|474398314|FG000|Overall Study|Physician Decision|1|||
131760075|NCT00963820|474398315|FG000|Dose Escalation Phase|Progressive Disease|3|||
131760076|NCT00963820|474398316|FG001|Dose Escalation Phase|Progressive Disease|3|||
131760077|NCT00963820|474398317|FG002|Dose Escalation Phase|Progressive Disease|3|||
131760078|NCT00963820|474398318|FG003|Dose Escalation Phase|Progressive Disease|3|||
131760079|NCT00963820|474398319|FG004|Dose Escalation Phase|Progressive Disease|4|||
131760080|NCT00963820|474398320|FG005|Dose Escalation Phase|Progressive Disease|3|||
131760081|NCT00963820|474398321|FG006|Dose Escalation Phase|Progressive Disease|3|||
131760082|NCT00963820|474398322|FG007|Dose Escalation Phase|Progressive Disease|2|||
131760083|NCT00963820|474398323|FG008|Dose Escalation Phase|Progressive Disease|0|||
131760084|NCT00963820|474398324|FG009|Dose Escalation Phase|Progressive Disease|0|||
131760085|NCT00963820|474398325|FG010|Dose Escalation Phase|Progressive Disease|0|||
131760086|NCT00963820|474398326|FG011|Dose Escalation Phase|Progressive Disease|0|||
131760087|NCT00963820|474398315|FG000|Dose Escalation Phase|Adverse Event|0|||
131812470|NCT04493684|474595841|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812471|NCT04493684|474595842|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812472|NCT04493684|474595843|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812473|NCT04493684|474595844|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
131812474|NCT04493684|474595828|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
131812475|NCT04493684|474595829|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812476|NCT04493684|474595830|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812477|NCT04493684|474595831|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812478|NCT04493684|474595832|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812479|NCT04493684|474595833|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812480|NCT04493684|474595834|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812481|NCT04493684|474595835|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812482|NCT04493684|474595836|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812483|NCT04493684|474595837|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812484|NCT04493684|474595838|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812485|NCT04493684|474595839|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812486|NCT04493684|474595840|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812487|NCT04493684|474595841|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812488|NCT04493684|474595842|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812489|NCT04493684|474595843|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131812490|NCT04493684|474595844|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
131760088|NCT00963820|474398316|FG001|Dose Escalation Phase|Adverse Event|0|||
131760089|NCT00963820|474398317|FG002|Dose Escalation Phase|Adverse Event|0|||
131812491|NCT04493684|474595828|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131908849|NCT05965752|474953049|FG004|Overall Study|Lost to Follow-up|1|||
131908850|NCT05965752|474953045|FG000|Overall Study|Withdrawal by Subject|2|||
131908851|NCT05965752|474953046|FG001|Overall Study|Withdrawal by Subject|2|||
131908852|NCT05965752|474953047|FG002|Overall Study|Withdrawal by Subject|1|||
131760090|NCT00963820|474398318|FG003|Dose Escalation Phase|Adverse Event|0|||
131908853|NCT05965752|474953048|FG003|Overall Study|Withdrawal by Subject|5|||
131760091|NCT00963820|474398319|FG004|Dose Escalation Phase|Adverse Event|0|||
131760092|NCT00963820|474398320|FG005|Dose Escalation Phase|Adverse Event|0|||
131760093|NCT00963820|474398321|FG006|Dose Escalation Phase|Adverse Event|3|||
131760094|NCT00963820|474398322|FG007|Dose Escalation Phase|Adverse Event|1|||
131760095|NCT00963820|474398323|FG008|Dose Escalation Phase|Adverse Event|0|||
131760096|NCT00963820|474398324|FG009|Dose Escalation Phase|Adverse Event|0|||
131760097|NCT00963820|474398325|FG010|Dose Escalation Phase|Adverse Event|0|||
131760098|NCT00963820|474398326|FG011|Dose Escalation Phase|Adverse Event|0|||
131760099|NCT00963820|474398315|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131760100|NCT00963820|474398316|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131760101|NCT00963820|474398317|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131760102|NCT00963820|474398318|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131760103|NCT00963820|474398319|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
131760104|NCT00963820|474398320|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
131760105|NCT00963820|474398321|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
131760106|NCT00963820|474398322|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
131760107|NCT00963820|474398323|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
131760108|NCT00963820|474398324|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
131760109|NCT00963820|474398325|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
131760110|NCT00963820|474398326|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
131760111|NCT00963820|474398315|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760112|NCT00963820|474398316|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760113|NCT00963820|474398317|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760114|NCT00963820|474398318|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760115|NCT00963820|474398319|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760116|NCT00963820|474398320|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760117|NCT00963820|474398321|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131760118|NCT00963820|474398322|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760119|NCT00963820|474398323|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760120|NCT00963820|474398324|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760121|NCT00963820|474398325|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760122|NCT00963820|474398326|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131760123|NCT00963820|474398315|FG000|Expansion Phase|Progressive Disease|0|||
131760124|NCT00963820|474398316|FG001|Expansion Phase|Progressive Disease|0|||
131760125|NCT00963820|474398317|FG002|Expansion Phase|Progressive Disease|0|||
131760126|NCT00963820|474398318|FG003|Expansion Phase|Progressive Disease|0|||
131760127|NCT00963820|474398319|FG004|Expansion Phase|Progressive Disease|0|||
131760128|NCT00963820|474398320|FG005|Expansion Phase|Progressive Disease|0|||
131760129|NCT00963820|474398321|FG006|Expansion Phase|Progressive Disease|0|||
131760130|NCT00963820|474398322|FG007|Expansion Phase|Progressive Disease|0|||
131760131|NCT00963820|474398323|FG008|Expansion Phase|Progressive Disease|8|||
131760132|NCT00963820|474398324|FG009|Expansion Phase|Progressive Disease|6|||
131760133|NCT00963820|474398325|FG010|Expansion Phase|Progressive Disease|4|||
131760134|NCT00963820|474398326|FG011|Expansion Phase|Progressive Disease|2|||
131760135|NCT00963820|474398315|FG000|Expansion Phase|Adverse Event|0|||
131760136|NCT00963820|474398316|FG001|Expansion Phase|Adverse Event|0|||
131760137|NCT00963820|474398317|FG002|Expansion Phase|Adverse Event|0|||
131760138|NCT00963820|474398318|FG003|Expansion Phase|Adverse Event|0|||
131760139|NCT00963820|474398319|FG004|Expansion Phase|Adverse Event|0|||
131760140|NCT00963820|474398320|FG005|Expansion Phase|Adverse Event|0|||
131760141|NCT00963820|474398321|FG006|Expansion Phase|Adverse Event|0|||
131760142|NCT00963820|474398322|FG007|Expansion Phase|Adverse Event|0|||
131760143|NCT00963820|474398323|FG008|Expansion Phase|Adverse Event|1|||
131760144|NCT00963820|474398324|FG009|Expansion Phase|Adverse Event|3|||
131760145|NCT00963820|474398325|FG010|Expansion Phase|Adverse Event|0|||
131760146|NCT00963820|474398326|FG011|Expansion Phase|Adverse Event|0|||
131760147|NCT00963820|474398315|FG000|Expansion Phase|Withdrawal by Subject|0|||
131760148|NCT00963820|474398316|FG001|Expansion Phase|Withdrawal by Subject|0|||
131760149|NCT00963820|474398317|FG002|Expansion Phase|Withdrawal by Subject|0|||
131760150|NCT00963820|474398318|FG003|Expansion Phase|Withdrawal by Subject|0|||
131760151|NCT00963820|474398319|FG004|Expansion Phase|Withdrawal by Subject|0|||
131760152|NCT00963820|474398320|FG005|Expansion Phase|Withdrawal by Subject|0|||
131760153|NCT00963820|474398321|FG006|Expansion Phase|Withdrawal by Subject|0|||
131760154|NCT00963820|474398322|FG007|Expansion Phase|Withdrawal by Subject|0|||
131760155|NCT00963820|474398323|FG008|Expansion Phase|Withdrawal by Subject|1|||
131760156|NCT00963820|474398324|FG009|Expansion Phase|Withdrawal by Subject|0|||
131760157|NCT00963820|474398325|FG010|Expansion Phase|Withdrawal by Subject|1|||
131398687|NCT00758069|473081230|FG000|Overall Study|Lack of Efficacy|0|||
131398688|NCT00758069|473081231|FG001|Overall Study|Lack of Efficacy|0|||
131760158|NCT00963820|474398326|FG011|Expansion Phase|Withdrawal by Subject|1|||
131760159|NCT00963820|474398315|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760160|NCT00963820|474398316|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760161|NCT00963820|474398317|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760162|NCT00963820|474398318|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760163|NCT00963820|474398319|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760164|NCT00963820|474398320|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760165|NCT00963820|474398321|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760166|NCT00963820|474398322|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760167|NCT00963820|474398323|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760168|NCT00963820|474398324|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760169|NCT00963820|474398325|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131760170|NCT00963820|474398326|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
131760171|NCT05492877|474398335|FG000|Overall Study|Adverse Event|11|||
131760172|NCT05492877|474398336|FG001|Overall Study|Adverse Event|7|||
131760173|NCT05492877|474398335|FG000|Overall Study|Death|1|||
131760174|NCT05492877|474398336|FG001|Overall Study|Death|0|||
131760175|NCT05492877|474398335|FG000|Overall Study|Lost to Follow-up|1|||
131760176|NCT05492877|474398336|FG001|Overall Study|Lost to Follow-up|1|||
131760177|NCT05492877|474398335|FG000|Overall Study|Physician Decision|1|||
131760178|NCT05492877|474398336|FG001|Overall Study|Physician Decision|2|||
131760179|NCT05492877|474398335|FG000|Overall Study|Protocol Violation|1|||
131760180|NCT05492877|474398336|FG001|Overall Study|Protocol Violation|1|||
131760181|NCT05492877|474398335|FG000|Overall Study|Withdrawal by Subject|3|||
131760182|NCT05492877|474398336|FG001|Overall Study|Withdrawal by Subject|7|||
131760183|NCT05492877|474398335|FG000|Overall Study|Reason not specified|6|||
131760184|NCT05492877|474398336|FG001|Overall Study|Reason not specified|4|||
131760185|NCT01426009|474398338|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
131760186|NCT01426009|474398338|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
131760187|NCT01426009|474398338|FG000|Washout 1|Withdrawal by Subject|1|||
131760188|NCT01426009|474398338|FG000|Washout 1|Personal Reasons|1|||
131760189|NCT01426009|474398338|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
131760190|NCT01426009|474398338|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
131760191|NCT01426009|474398338|FG000|Washout 2|electrive surgery|1|||
131760192|NCT01426009|474398338|FG000|Washout 3|personal reasons|1|||
131760193|NCT01426009|474398338|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
131760194|NCT01426009|474398338|FG000|Washout 4|Lost to Follow-up|1|||
131760195|NCT00515099|474398340|FG000|Overall Study|Lost to Follow-up|0|||
131760196|NCT00515099|474398341|FG001|Overall Study|Lost to Follow-up|4|||
131760197|NCT00515099|474398340|FG000|Overall Study|Withdrawal by Subject|2|||
131760198|NCT00515099|474398341|FG001|Overall Study|Withdrawal by Subject|0|||
131760199|NCT00515099|474398340|FG000|Overall Study|IRB Recommendation|1|||
131760200|NCT00515099|474398341|FG001|Overall Study|IRB Recommendation|0|||
131760201|NCT00592072|474398342|FG000|Wash Out Period|Lost to Follow-up|1|||
131760202|NCT00592072|474398343|FG001|Wash Out Period|Lost to Follow-up|1|||
131760203|NCT05333289|474398346|FG000|Overall Study|Other|1|||
131760204|NCT05333289|474398347|FG001|Overall Study|Other|0|||
131760205|NCT05333289|474398348|FG002|Overall Study|Other|0|||
131760206|NCT05333289|474398349|FG003|Overall Study|Other|1|||
131760207|NCT05333289|474398350|FG004|Overall Study|Other|1|||
131760208|NCT05333289|474398351|FG005|Overall Study|Other|2|||
131760209|NCT05333289|474398352|FG006|Overall Study|Other|2|||
131760210|NCT05333289|474398353|FG007|Overall Study|Other|0|||
131760211|NCT05333289|474398346|FG000|Overall Study|Withdrawal by Subject|1|||
131760212|NCT05333289|474398347|FG001|Overall Study|Withdrawal by Subject|2|||
131760213|NCT05333289|474398348|FG002|Overall Study|Withdrawal by Subject|2|||
131760214|NCT05333289|474398349|FG003|Overall Study|Withdrawal by Subject|1|||
131760215|NCT05333289|474398350|FG004|Overall Study|Withdrawal by Subject|1|||
131760216|NCT05333289|474398351|FG005|Overall Study|Withdrawal by Subject|2|||
131760217|NCT05333289|474398352|FG006|Overall Study|Withdrawal by Subject|1|||
131760218|NCT05333289|474398353|FG007|Overall Study|Withdrawal by Subject|3|||
131760219|NCT05333289|474398346|FG000|Overall Study|Protocol Violation|1|||
131760220|NCT05333289|474398347|FG001|Overall Study|Protocol Violation|0|||
131760221|NCT05333289|474398348|FG002|Overall Study|Protocol Violation|0|||
131760222|NCT05333289|474398349|FG003|Overall Study|Protocol Violation|0|||
131760223|NCT05333289|474398350|FG004|Overall Study|Protocol Violation|0|||
131760224|NCT05333289|474398351|FG005|Overall Study|Protocol Violation|0|||
131760225|NCT05333289|474398352|FG006|Overall Study|Protocol Violation|0|||
131760226|NCT05333289|474398353|FG007|Overall Study|Protocol Violation|0|||
131760227|NCT05333289|474398346|FG000|Overall Study|Physician Decision|0|||
131760228|NCT05333289|474398347|FG001|Overall Study|Physician Decision|0|||
131760229|NCT05333289|474398348|FG002|Overall Study|Physician Decision|1|||
131760230|NCT05333289|474398349|FG003|Overall Study|Physician Decision|0|||
131760231|NCT05333289|474398350|FG004|Overall Study|Physician Decision|0|||
131760232|NCT05333289|474398351|FG005|Overall Study|Physician Decision|2|||
131760233|NCT05333289|474398352|FG006|Overall Study|Physician Decision|0|||
131760234|NCT05333289|474398353|FG007|Overall Study|Physician Decision|0|||
131760235|NCT05333289|474398346|FG000|Overall Study|Lost to Follow-up|6|||
131760236|NCT05333289|474398347|FG001|Overall Study|Lost to Follow-up|0|||
131760237|NCT05333289|474398348|FG002|Overall Study|Lost to Follow-up|1|||
131760238|NCT05333289|474398349|FG003|Overall Study|Lost to Follow-up|6|||
131760239|NCT05333289|474398350|FG004|Overall Study|Lost to Follow-up|3|||
131760240|NCT05333289|474398351|FG005|Overall Study|Lost to Follow-up|3|||
131760241|NCT05333289|474398352|FG006|Overall Study|Lost to Follow-up|2|||
131760242|NCT05333289|474398353|FG007|Overall Study|Lost to Follow-up|1|||
131760243|NCT05333289|474398346|FG000|Overall Study|Death|1|||
131760244|NCT05333289|474398347|FG001|Overall Study|Death|0|||
131760245|NCT05333289|474398348|FG002|Overall Study|Death|0|||
131760246|NCT05333289|474398349|FG003|Overall Study|Death|0|||
131760247|NCT05333289|474398350|FG004|Overall Study|Death|0|||
131760248|NCT05333289|474398351|FG005|Overall Study|Death|0|||
131760249|NCT05333289|474398352|FG006|Overall Study|Death|0|||
131760250|NCT05333289|474398353|FG007|Overall Study|Death|0|||
131760251|NCT04476108|474398355|FG000|Overall Study|Adverse Event|4|||
131760252|NCT04476108|474398356|FG001|Overall Study|Adverse Event|1|||
131760253|NCT04476108|474398355|FG000|Overall Study|Lost to Follow-up|1|||
131760254|NCT04476108|474398356|FG001|Overall Study|Lost to Follow-up|0|||
131760255|NCT04476108|474398355|FG000|Overall Study|Inadvertent Enrollment|1|||
131760256|NCT04476108|474398356|FG001|Overall Study|Inadvertent Enrollment|0|||
131760257|NCT04476108|474398355|FG000|Overall Study|Protocol Violation|1|||
131760258|NCT04476108|474398356|FG001|Overall Study|Protocol Violation|1|||
131760259|NCT04476108|474398355|FG000|Overall Study|Withdrawal by Subject|1|||
131760260|NCT04476108|474398356|FG001|Overall Study|Withdrawal by Subject|1|||
131760261|NCT02253992|474398357|FG000|Overall Study|Study drug toxicity|1|||
131760262|NCT02253992|474398358|FG001|Overall Study|Study drug toxicity|0|||
131760263|NCT02253992|474398359|FG002|Overall Study|Study drug toxicity|10|||
131760264|NCT02253992|474398357|FG000|Overall Study|Disease progression|4|||
131760265|NCT02253992|474398358|FG001|Overall Study|Disease progression|3|||
131760266|NCT02253992|474398359|FG002|Overall Study|Disease progression|98|||
131760267|NCT02253992|474398357|FG000|Overall Study|Withdrawal by Subject|0|||
131760268|NCT02253992|474398358|FG001|Overall Study|Withdrawal by Subject|0|||
131760269|NCT02253992|474398359|FG002|Overall Study|Withdrawal by Subject|3|||
131760270|NCT02253992|474398357|FG000|Overall Study|Adverse Event|0|||
131760271|NCT02253992|474398358|FG001|Overall Study|Adverse Event|0|||
131760272|NCT02253992|474398359|FG002|Overall Study|Adverse Event|8|||
131760273|NCT02253992|474398357|FG000|Overall Study|Death|0|||
131760274|NCT02253992|474398358|FG001|Overall Study|Death|0|||
131760275|NCT02253992|474398359|FG002|Overall Study|Death|1|||
131760276|NCT02253992|474398357|FG000|Overall Study|Subject discontinued study drug|1|||
131760277|NCT02253992|474398358|FG001|Overall Study|Subject discontinued study drug|0|||
131760278|NCT02253992|474398359|FG002|Overall Study|Subject discontinued study drug|1|||
131760279|NCT02253992|474398357|FG000|Overall Study|Completed treatment as per protocol|0|||
131760280|NCT02253992|474398358|FG001|Overall Study|Completed treatment as per protocol|1|||
131760281|NCT02253992|474398359|FG002|Overall Study|Completed treatment as per protocol|22|||
131760282|NCT02253992|474398357|FG000|Overall Study|Other|0|||
131760283|NCT02253992|474398358|FG001|Overall Study|Other|0|||
131760284|NCT02253992|474398359|FG002|Overall Study|Other|1|||
131760285|NCT03685643|474398362|FG000|Overall Study|Lost to Follow-up|14|||
131760286|NCT03685643|474398363|FG001|Overall Study|Lost to Follow-up|22|||
131760287|NCT02201251|474398364|FG000|Overall Study|Adverse Event|1|||
131760288|NCT02201251|474398365|FG001|Overall Study|Adverse Event|1|||
131760289|NCT02201251|474398364|FG000|Overall Study|Protocol Violation|1|||
131760290|NCT02201251|474398365|FG001|Overall Study|Protocol Violation|0|||
131760291|NCT02201251|474398364|FG000|Overall Study|Noncompliance with Study Drug|0|||
131760292|NCT02201251|474398365|FG001|Overall Study|Noncompliance with Study Drug|1|||
131760293|NCT02201251|474398364|FG000|Overall Study|Withdrawal by Subject|2|||
131760294|NCT02201251|474398365|FG001|Overall Study|Withdrawal by Subject|1|||
131760295|NCT02877134|474398369|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760296|NCT02877134|474398370|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
131760297|NCT02877134|474398371|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760298|NCT02877134|474398372|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760299|NCT02877134|474398373|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760300|NCT02877134|474398374|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
131760301|NCT02877134|474398375|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760302|NCT02877134|474398376|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760303|NCT02877134|474398377|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760304|NCT02877134|474398378|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760305|NCT02877134|474398379|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760306|NCT02877134|474398380|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
131760307|NCT02877134|474398369|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760308|NCT02877134|474398370|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
131760309|NCT02877134|474398371|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760310|NCT02877134|474398372|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
131760311|NCT02877134|474398373|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760312|NCT02877134|474398374|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760313|NCT02877134|474398375|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
131760314|NCT02877134|474398376|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760315|NCT02877134|474398377|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760316|NCT02877134|474398378|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760317|NCT02877134|474398379|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760318|NCT02877134|474398380|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131760319|NCT02877134|474398369|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
131760320|NCT02877134|474398370|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
131760321|NCT02877134|474398371|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
131760322|NCT02877134|474398372|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
131760323|NCT02877134|474398373|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
131760324|NCT02877134|474398374|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
131760325|NCT02877134|474398375|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
131760326|NCT02877134|474398376|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131760327|NCT02877134|474398377|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131760328|NCT02877134|474398378|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131760329|NCT02877134|474398379|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131760330|NCT02877134|474398380|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131760331|NCT02877134|474398369|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
131760332|NCT02877134|474398370|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
131760333|NCT02877134|474398371|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
131760334|NCT02877134|474398372|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
131760335|NCT02877134|474398373|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
131760336|NCT02877134|474398374|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
131760337|NCT02877134|474398375|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
131760338|NCT02877134|474398376|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
131760339|NCT02877134|474398377|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
131760340|NCT02877134|474398378|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
131760341|NCT02877134|474398379|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
131760342|NCT02877134|474398380|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
131760343|NCT02877134|474398369|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760344|NCT02877134|474398370|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760345|NCT02877134|474398371|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760346|NCT02877134|474398372|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760347|NCT02877134|474398373|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760348|NCT02877134|474398374|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760349|NCT02877134|474398375|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760350|NCT02877134|474398376|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760351|NCT02877134|474398377|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
131760352|NCT02877134|474398378|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760353|NCT02877134|474398379|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760354|NCT02877134|474398380|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131760355|NCT02877134|474398369|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760356|NCT02877134|474398370|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760357|NCT02877134|474398371|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760358|NCT02877134|474398372|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760359|NCT02877134|474398373|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760360|NCT02877134|474398374|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760361|NCT02877134|474398375|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131760362|NCT02877134|474398376|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
131760363|NCT02877134|474398377|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
131760364|NCT02877134|474398378|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
131760365|NCT02877134|474398379|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
131760366|NCT02877134|474398380|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
131760367|NCT02877134|474398369|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760368|NCT02877134|474398370|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760369|NCT02877134|474398371|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760370|NCT02877134|474398372|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760371|NCT02877134|474398373|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760372|NCT02877134|474398374|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760373|NCT02877134|474398375|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760374|NCT02877134|474398376|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
131760375|NCT02877134|474398377|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
131760376|NCT02877134|474398378|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
131760377|NCT02877134|474398379|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760378|NCT02877134|474398380|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131760379|NCT02877134|474398369|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
131760380|NCT02877134|474398370|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
131760381|NCT02877134|474398371|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
131760382|NCT02877134|474398372|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
131908854|NCT05965752|474953049|FG004|Overall Study|Withdrawal by Subject|0|||
131760383|NCT02877134|474398373|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
131760384|NCT02877134|474398374|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
131760385|NCT02877134|474398375|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
131760386|NCT02877134|474398376|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
131760387|NCT02877134|474398377|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
131760388|NCT02877134|474398378|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
131760389|NCT02877134|474398379|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
131760390|NCT02877134|474398380|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
131760391|NCT01332851|474398381|FG000|Overall Study|Withdrawal by Subject|4|||
131760392|NCT01332851|474398382|FG001|Overall Study|Withdrawal by Subject|2|||
131760393|NCT01332851|474398381|FG000|Overall Study|Lost to Follow-up|7|||
131760394|NCT01332851|474398382|FG001|Overall Study|Lost to Follow-up|11|||
131760395|NCT03299166|474398389|FG000|Overall Study|Adverse Event|9|||
131760396|NCT03299166|474398390|FG001|Overall Study|Adverse Event|4|||
131760397|NCT03299166|474398389|FG000|Overall Study|Withdrawal by Subject|6|||
131760398|NCT03299166|474398390|FG001|Overall Study|Withdrawal by Subject|5|||
131760399|NCT03299166|474398389|FG000|Overall Study|Physician Decision|1|||
131760400|NCT03299166|474398390|FG001|Overall Study|Physician Decision|1|||
131760401|NCT03299166|474398389|FG000|Overall Study|Sponsor Decision|3|||
131760402|NCT03299166|474398390|FG001|Overall Study|Sponsor Decision|0|||
131760403|NCT03299166|474398389|FG000|Overall Study|Lost to Follow-up|2|||
131760404|NCT03299166|474398390|FG001|Overall Study|Lost to Follow-up|4|||
131760405|NCT03299166|474398389|FG000|Overall Study|Randomization Error|0|||
131760406|NCT03299166|474398390|FG001|Overall Study|Randomization Error|1|||
131760407|NCT03299166|474398389|FG000|Overall Study|Subject unable to return due to COVID|1|||
131760408|NCT03299166|474398390|FG001|Overall Study|Subject unable to return due to COVID|0|||
131760409|NCT03299166|474398389|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
131760410|NCT03299166|474398390|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
131760411|NCT01197794|474398393|FG000|Overall Study|Adverse Event|3|||
131760412|NCT01197794|474398394|FG001|Overall Study|Adverse Event|2|||
131760413|NCT01197794|474398395|FG002|Overall Study|Adverse Event|4|||
131760414|NCT01197794|474398396|FG003|Overall Study|Adverse Event|4|||
131760415|NCT01197794|474398397|FG004|Overall Study|Adverse Event|4|||
131760416|NCT01197794|474398398|FG005|Overall Study|Adverse Event|2|||
131760417|NCT01197794|474398399|FG006|Overall Study|Adverse Event|3|||
131760418|NCT01197794|474398393|FG000|Overall Study|Protocol Violation|0|||
131760419|NCT01197794|474398394|FG001|Overall Study|Protocol Violation|0|||
131760420|NCT01197794|474398395|FG002|Overall Study|Protocol Violation|0|||
131760421|NCT01197794|474398396|FG003|Overall Study|Protocol Violation|0|||
131760422|NCT01197794|474398397|FG004|Overall Study|Protocol Violation|2|||
131760423|NCT01197794|474398398|FG005|Overall Study|Protocol Violation|0|||
131760424|NCT01197794|474398399|FG006|Overall Study|Protocol Violation|1|||
131760425|NCT01197794|474398393|FG000|Overall Study|Development of study withdrawal criteria|3|||
131760426|NCT01197794|474398394|FG001|Overall Study|Development of study withdrawal criteria|0|||
131760427|NCT01197794|474398395|FG002|Overall Study|Development of study withdrawal criteria|0|||
131760428|NCT01197794|474398396|FG003|Overall Study|Development of study withdrawal criteria|1|||
131760429|NCT01197794|474398397|FG004|Overall Study|Development of study withdrawal criteria|0|||
131760430|NCT01197794|474398398|FG005|Overall Study|Development of study withdrawal criteria|0|||
131760431|NCT01197794|474398399|FG006|Overall Study|Development of study withdrawal criteria|1|||
131812492|NCT04493684|474595829|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812493|NCT04493684|474595830|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812494|NCT04493684|474595831|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131760432|NCT01197794|474398393|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
131760433|NCT01197794|474398394|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
131760434|NCT01197794|474398395|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
131760435|NCT01197794|474398396|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
131760436|NCT01197794|474398397|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
131812495|NCT04493684|474595832|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131760437|NCT01197794|474398398|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
131760438|NCT01197794|474398399|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
131760439|NCT01197794|474398393|FG000|Overall Study|Withdrawal by Subject|3|||
131760440|NCT01197794|474398394|FG001|Overall Study|Withdrawal by Subject|3|||
131760441|NCT01197794|474398395|FG002|Overall Study|Withdrawal by Subject|4|||
131760442|NCT01197794|474398396|FG003|Overall Study|Withdrawal by Subject|1|||
131760443|NCT01197794|474398397|FG004|Overall Study|Withdrawal by Subject|1|||
131760444|NCT01197794|474398398|FG005|Overall Study|Withdrawal by Subject|5|||
131760445|NCT01197794|474398399|FG006|Overall Study|Withdrawal by Subject|6|||
131760446|NCT01197794|474398393|FG000|Overall Study|Lost to Follow-up|1|||
131760447|NCT01197794|474398394|FG001|Overall Study|Lost to Follow-up|1|||
131760448|NCT01197794|474398395|FG002|Overall Study|Lost to Follow-up|0|||
131908855|NCT05965752|474953045|FG000|Overall Study|Disease Relapse|1|||
131760449|NCT01197794|474398396|FG003|Overall Study|Lost to Follow-up|1|||
131760450|NCT01197794|474398397|FG004|Overall Study|Lost to Follow-up|0|||
131760451|NCT01197794|474398398|FG005|Overall Study|Lost to Follow-up|1|||
131760452|NCT01197794|474398399|FG006|Overall Study|Lost to Follow-up|0|||
131760453|NCT01197794|474398393|FG000|Overall Study|Other|1|||
131760454|NCT01197794|474398394|FG001|Overall Study|Other|1|||
131760455|NCT01197794|474398395|FG002|Overall Study|Other|3|||
131760456|NCT01197794|474398396|FG003|Overall Study|Other|0|||
131760457|NCT01197794|474398397|FG004|Overall Study|Other|2|||
131760458|NCT01197794|474398398|FG005|Overall Study|Other|2|||
131760459|NCT01197794|474398399|FG006|Overall Study|Other|4|||
131760460|NCT01055457|474398400|FG000|Overall Study|Lost to Follow-up|0|||
131760461|NCT01055457|474398401|FG001|Overall Study|Lost to Follow-up|1|||
131760462|NCT01055457|474398402|FG002|Overall Study|Lost to Follow-up|0|||
131760463|NCT01055457|474398403|FG003|Overall Study|Lost to Follow-up|0|||
131760464|NCT01055457|474398404|FG004|Overall Study|Lost to Follow-up|0|||
131760465|NCT01055457|474398405|FG005|Overall Study|Lost to Follow-up|1|||
131760466|NCT01055457|474398406|FG006|Overall Study|Lost to Follow-up|0|||
131760467|NCT01055457|474398407|FG007|Overall Study|Lost to Follow-up|0|||
131760468|NCT01055457|474398408|FG008|Overall Study|Lost to Follow-up|0|||
131760469|NCT01055457|474398409|FG009|Overall Study|Lost to Follow-up|0|||
131760470|NCT01055457|474398400|FG000|Overall Study|Protocol Violation|0|||
131760471|NCT01055457|474398401|FG001|Overall Study|Protocol Violation|0|||
131760472|NCT01055457|474398402|FG002|Overall Study|Protocol Violation|1|||
131760473|NCT01055457|474398403|FG003|Overall Study|Protocol Violation|1|||
131760474|NCT01055457|474398404|FG004|Overall Study|Protocol Violation|1|||
131760475|NCT01055457|474398405|FG005|Overall Study|Protocol Violation|2|||
131760476|NCT01055457|474398406|FG006|Overall Study|Protocol Violation|1|||
131760477|NCT01055457|474398407|FG007|Overall Study|Protocol Violation|0|||
131760478|NCT01055457|474398408|FG008|Overall Study|Protocol Violation|0|||
131760479|NCT01055457|474398409|FG009|Overall Study|Protocol Violation|1|||
131760480|NCT01055457|474398400|FG000|Overall Study|Subject Disinterest|0|||
131760481|NCT01055457|474398401|FG001|Overall Study|Subject Disinterest|0|||
131760482|NCT01055457|474398402|FG002|Overall Study|Subject Disinterest|0|||
131760483|NCT01055457|474398403|FG003|Overall Study|Subject Disinterest|0|||
131760484|NCT01055457|474398404|FG004|Overall Study|Subject Disinterest|0|||
131760485|NCT01055457|474398405|FG005|Overall Study|Subject Disinterest|0|||
131760486|NCT01055457|474398406|FG006|Overall Study|Subject Disinterest|0|||
131760487|NCT01055457|474398407|FG007|Overall Study|Subject Disinterest|1|||
131760488|NCT01055457|474398408|FG008|Overall Study|Subject Disinterest|0|||
131760489|NCT01055457|474398409|FG009|Overall Study|Subject Disinterest|0|||
131760490|NCT01055457|474398400|FG000|Overall Study|Subject Ineligible|1|||
131760491|NCT01055457|474398401|FG001|Overall Study|Subject Ineligible|0|||
131760492|NCT01055457|474398402|FG002|Overall Study|Subject Ineligible|1|||
131760493|NCT01055457|474398403|FG003|Overall Study|Subject Ineligible|0|||
131760494|NCT01055457|474398404|FG004|Overall Study|Subject Ineligible|1|||
131760495|NCT01055457|474398405|FG005|Overall Study|Subject Ineligible|0|||
131760496|NCT01055457|474398406|FG006|Overall Study|Subject Ineligible|0|||
131760497|NCT01055457|474398407|FG007|Overall Study|Subject Ineligible|0|||
131760498|NCT01055457|474398408|FG008|Overall Study|Subject Ineligible|0|||
131760499|NCT01055457|474398409|FG009|Overall Study|Subject Ineligible|0|||
131760500|NCT01055457|474398400|FG000|Overall Study|Discomfort|0|||
131760501|NCT01055457|474398401|FG001|Overall Study|Discomfort|0|||
131760502|NCT01055457|474398402|FG002|Overall Study|Discomfort|0|||
131760503|NCT01055457|474398403|FG003|Overall Study|Discomfort|0|||
131760504|NCT01055457|474398404|FG004|Overall Study|Discomfort|1|||
131760505|NCT01055457|474398405|FG005|Overall Study|Discomfort|0|||
131760506|NCT01055457|474398406|FG006|Overall Study|Discomfort|0|||
131760507|NCT01055457|474398407|FG007|Overall Study|Discomfort|0|||
131812496|NCT04493684|474595833|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812497|NCT04493684|474595834|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
131812498|NCT04493684|474595835|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812499|NCT04493684|474595836|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812500|NCT04493684|474595837|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812501|NCT04493684|474595838|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812502|NCT04493684|474595839|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812503|NCT04493684|474595840|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131908856|NCT05965752|474953046|FG001|Overall Study|Disease Relapse|0|||
131760508|NCT01055457|474398408|FG008|Overall Study|Discomfort|0|||
131760509|NCT01055457|474398409|FG009|Overall Study|Discomfort|0|||
131760510|NCT01055457|474398400|FG000|Overall Study|Pregnancy|0|||
131760511|NCT01055457|474398401|FG001|Overall Study|Pregnancy|0|||
131760512|NCT01055457|474398402|FG002|Overall Study|Pregnancy|0|||
131760513|NCT01055457|474398403|FG003|Overall Study|Pregnancy|1|||
131760514|NCT01055457|474398404|FG004|Overall Study|Pregnancy|0|||
131760515|NCT01055457|474398405|FG005|Overall Study|Pregnancy|0|||
131760516|NCT01055457|474398406|FG006|Overall Study|Pregnancy|0|||
131760517|NCT01055457|474398407|FG007|Overall Study|Pregnancy|0|||
131760518|NCT01055457|474398408|FG008|Overall Study|Pregnancy|0|||
131760519|NCT01055457|474398409|FG009|Overall Study|Pregnancy|0|||
131760520|NCT01055457|474398400|FG000|Overall Study|Adverse Event|0|||
131760521|NCT01055457|474398401|FG001|Overall Study|Adverse Event|0|||
131760522|NCT01055457|474398402|FG002|Overall Study|Adverse Event|0|||
131760523|NCT01055457|474398403|FG003|Overall Study|Adverse Event|1|||
131760524|NCT01055457|474398404|FG004|Overall Study|Adverse Event|0|||
131760525|NCT01055457|474398405|FG005|Overall Study|Adverse Event|0|||
131760526|NCT01055457|474398406|FG006|Overall Study|Adverse Event|0|||
131760527|NCT01055457|474398407|FG007|Overall Study|Adverse Event|0|||
131760528|NCT01055457|474398408|FG008|Overall Study|Adverse Event|0|||
131760529|NCT01055457|474398409|FG009|Overall Study|Adverse Event|0|||
131760530|NCT04055844|474398410|FG000|Overall Study|Adverse Event|12|||
131760531|NCT04055844|474398410|FG000|Overall Study|Poor Performance|1|||
131760532|NCT04055844|474398410|FG000|Overall Study|Death|1|||
131760533|NCT00255008|474398419|FG000|Overall Study|Adverse Event|1|||
131760534|NCT00255008|474398420|FG001|Overall Study|Adverse Event|1|||
131760535|NCT00255008|474398421|FG002|Overall Study|Adverse Event|2|||
131760536|NCT00255008|474398422|FG003|Overall Study|Adverse Event|0|||
131760537|NCT00255008|474398419|FG000|Overall Study|Lost to Follow-up|1|||
131760538|NCT00255008|474398420|FG001|Overall Study|Lost to Follow-up|0|||
131760539|NCT00255008|474398421|FG002|Overall Study|Lost to Follow-up|1|||
131760540|NCT00255008|474398422|FG003|Overall Study|Lost to Follow-up|2|||
131760541|NCT00255008|474398419|FG000|Overall Study|Did not meet viral reduction criteria|4|||
131760542|NCT00255008|474398420|FG001|Overall Study|Did not meet viral reduction criteria|5|||
131760543|NCT00255008|474398421|FG002|Overall Study|Did not meet viral reduction criteria|0|||
131760544|NCT00255008|474398422|FG003|Overall Study|Did not meet viral reduction criteria|1|||
131760545|NCT00255008|474398419|FG000|Overall Study|Withdrew consent|0|||
131760546|NCT00255008|474398420|FG001|Overall Study|Withdrew consent|0|||
131760547|NCT00255008|474398421|FG002|Overall Study|Withdrew consent|2|||
131760548|NCT00255008|474398422|FG003|Overall Study|Withdrew consent|0|||
131760549|NCT00255008|474398419|FG000|Overall Study|Sponsor request|18|||
131760550|NCT00255008|474398420|FG001|Overall Study|Sponsor request|3|||
131760551|NCT00255008|474398421|FG002|Overall Study|Sponsor request|8|||
131760552|NCT00255008|474398422|FG003|Overall Study|Sponsor request|17|||
131760553|NCT00255008|474398419|FG000|Overall Study|Adverse lab experience|1|||
131760554|NCT00255008|474398420|FG001|Overall Study|Adverse lab experience|0|||
131812504|NCT04493684|474595841|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812505|NCT04493684|474595842|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812506|NCT04493684|474595843|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812507|NCT04493684|474595844|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
131812508|NCT04493684|474595828|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
131812509|NCT04493684|474595829|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812510|NCT04493684|474595830|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812511|NCT04493684|474595831|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812512|NCT04493684|474595832|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812513|NCT04493684|474595833|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812514|NCT04493684|474595834|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812515|NCT04493684|474595835|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812516|NCT04493684|474595836|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812517|NCT04493684|474595837|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812518|NCT04493684|474595838|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812519|NCT04493684|474595839|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812520|NCT04493684|474595840|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812521|NCT04493684|474595841|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812522|NCT04493684|474595842|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812523|NCT04493684|474595843|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812524|NCT04493684|474595844|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
131812525|NCT04493684|474595828|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812526|NCT04493684|474595829|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812527|NCT04493684|474595830|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812528|NCT04493684|474595831|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812529|NCT04493684|474595832|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812530|NCT04493684|474595833|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
131812531|NCT04493684|474595834|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812532|NCT04493684|474595835|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812533|NCT04493684|474595836|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812534|NCT04493684|474595837|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131908857|NCT05965752|474953047|FG002|Overall Study|Disease Relapse|1|||
131760555|NCT00255008|474398421|FG002|Overall Study|Adverse lab experience|0|||
131760556|NCT00255008|474398422|FG003|Overall Study|Adverse lab experience|0|||
131760557|NCT00255008|474398419|FG000|Overall Study|Other|7|||
131760558|NCT00255008|474398420|FG001|Overall Study|Other|0|||
131760559|NCT00255008|474398421|FG002|Overall Study|Other|3|||
131760560|NCT00255008|474398422|FG003|Overall Study|Other|2|||
131760561|NCT05307523|474398423|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
131760562|NCT05307523|474398424|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
131760563|NCT05307523|474398423|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
131760564|NCT05307523|474398424|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
131760565|NCT00102804|474398431|FG000|Overall Study|Progressive Disease (PD)|307|||
131760566|NCT00102804|474398432|FG001|Overall Study|Progressive Disease (PD)|196|||
131760567|NCT00102804|474398431|FG000|Overall Study|Withdrawal by Subject|46|||
131760568|NCT00102804|474398432|FG001|Overall Study|Withdrawal by Subject|7|||
131760569|NCT00102804|474398431|FG000|Overall Study|Adverse Event|37|||
131760570|NCT00102804|474398432|FG001|Overall Study|Adverse Event|3|||
131760571|NCT00102804|474398431|FG000|Overall Study|Physician Decision|24|||
131760572|NCT00102804|474398432|FG001|Overall Study|Physician Decision|6|||
131760573|NCT00102804|474398431|FG000|Overall Study|Death|5|||
131760574|NCT00102804|474398432|FG001|Overall Study|Death|6|||
131760575|NCT00102804|474398431|FG000|Overall Study|Enrollment Criteria Not Met|6|||
131760576|NCT00102804|474398432|FG001|Overall Study|Enrollment Criteria Not Met|0|||
131760577|NCT00102804|474398431|FG000|Overall Study|Lost to Follow-up|4|||
131812535|NCT04493684|474595838|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131760578|NCT00102804|474398432|FG001|Overall Study|Lost to Follow-up|1|||
131760579|NCT00102804|474398431|FG000|Overall Study|Protocol Violation|2|||
131760580|NCT00102804|474398432|FG001|Overall Study|Protocol Violation|1|||
131760581|NCT00102804|474398431|FG000|Overall Study|Satisfactory Response|2|||
131760582|NCT00102804|474398432|FG001|Overall Study|Satisfactory Response|0|||
131760583|NCT00102804|474398431|FG000|Overall Study|Sponsor Decision|1|||
131760584|NCT00102804|474398432|FG001|Overall Study|Sponsor Decision|0|||
131760585|NCT00102804|474398431|FG000|Overall Study|Alive, Receiving Treatment|7|||
131760586|NCT00102804|474398432|FG001|Overall Study|Alive, Receiving Treatment|2|||
131760587|NCT04035473|474398433|FG000|Screening/Baseline|Death|0|||
131760588|NCT04035473|474398434|FG001|Screening/Baseline|Death|1|||
131760589|NCT04035473|474398433|FG000|Screening/Baseline|Adverse Event|0|||
131760590|NCT04035473|474398434|FG001|Screening/Baseline|Adverse Event|1|||
131760591|NCT04035473|474398433|FG000|Follow-up Period|Adverse Event|2|||
131760592|NCT04035473|474398434|FG001|Follow-up Period|Adverse Event|0|||
131760593|NCT00683774|474398435|FG000|Overall Study|Withdrawal by Subject|0|||
131760594|NCT00683774|474398436|FG001|Overall Study|Withdrawal by Subject|1|||
131760595|NCT00683774|474398435|FG000|Overall Study|Physician Decision|3|||
131760596|NCT00683774|474398436|FG001|Overall Study|Physician Decision|0|||
131760597|NCT02735044|474398438|FG000|Overall Study|Adverse Event|3|||
131760598|NCT02735044|474398439|FG001|Overall Study|Adverse Event|3|||
131760599|NCT02735044|474398438|FG000|Overall Study|Lack of Efficacy|1|||
131760600|NCT02735044|474398439|FG001|Overall Study|Lack of Efficacy|0|||
131760601|NCT02735044|474398438|FG000|Overall Study|Poor compliance to protocol|7|||
131760602|NCT02735044|474398439|FG001|Overall Study|Poor compliance to protocol|7|||
131760603|NCT02735044|474398438|FG000|Overall Study|Randomized and not treated|0|||
131760604|NCT02735044|474398439|FG001|Overall Study|Randomized and not treated|2|||
131760605|NCT02735044|474398438|FG000|Overall Study|Other, not specified above|5|||
131760606|NCT02735044|474398439|FG001|Overall Study|Other, not specified above|11|||
131760607|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
131760608|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131760609|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131760610|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131760611|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131760612|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131812536|NCT04493684|474595839|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812537|NCT04493684|474595840|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812538|NCT04493684|474595841|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812539|NCT04493684|474595842|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812540|NCT04493684|474595843|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812541|NCT04493684|474595844|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
131812542|NCT04493684|474595828|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812543|NCT04493684|474595829|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131760613|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
131760614|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131760615|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131760616|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131760617|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131760618|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131760619|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
131760620|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131760621|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131760622|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131760623|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131760624|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131760625|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Other|14|||
131760626|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Other|0|||
131812544|NCT04493684|474595830|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812545|NCT04493684|474595831|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812546|NCT04493684|474595832|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812547|NCT04493684|474595833|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812548|NCT04493684|474595834|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812549|NCT04493684|474595835|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812550|NCT04493684|474595836|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131760627|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Other|0|||
131760628|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Other|0|||
131760629|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Other|0|||
131760630|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Other|0|||
131760631|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
131760632|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
131760633|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
131760634|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
131760635|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
131760636|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
131760637|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
131812551|NCT04493684|474595837|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812552|NCT04493684|474595838|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812553|NCT04493684|474595839|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
131812554|NCT04493684|474595840|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812555|NCT04493684|474595841|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812556|NCT04493684|474595842|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131760638|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131760639|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131812557|NCT04493684|474595843|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812558|NCT04493684|474595844|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131812559|NCT04493684|474595828|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812560|NCT04493684|474595829|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812561|NCT04493684|474595830|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812562|NCT04493684|474595831|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812563|NCT04493684|474595832|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812564|NCT04493684|474595833|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812565|NCT04493684|474595834|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812566|NCT04493684|474595835|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812567|NCT04493684|474595836|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812568|NCT04493684|474595837|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812569|NCT04493684|474595838|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812570|NCT04493684|474595839|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812571|NCT04493684|474595840|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812572|NCT04493684|474595841|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812573|NCT04493684|474595842|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812574|NCT04493684|474595843|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
131812575|NCT04493684|474595844|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
131812576|NCT04493684|474595828|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812577|NCT04493684|474595829|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812578|NCT04493684|474595830|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812579|NCT04493684|474595831|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812580|NCT04493684|474595832|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812581|NCT04493684|474595833|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812582|NCT04493684|474595834|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812583|NCT04493684|474595835|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812584|NCT04493684|474595836|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812585|NCT04493684|474595837|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812586|NCT04493684|474595838|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812587|NCT04493684|474595839|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812588|NCT04493684|474595840|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812589|NCT04493684|474595841|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812590|NCT04493684|474595842|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131908858|NCT05965752|474953048|FG003|Overall Study|Disease Relapse|0|||
131760640|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131760641|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131760642|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131760643|NCT02141854|474398441|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
131760644|NCT02141854|474398442|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131760645|NCT02141854|474398443|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131760646|NCT02141854|474398444|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131760647|NCT02141854|474398445|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131760648|NCT02141854|474398446|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131760649|NCT02141854|474398441|FG000|Treatment Period|Protocol Violation|0|||
131760650|NCT02141854|474398442|FG001|Treatment Period|Protocol Violation|1|||
131760651|NCT02141854|474398443|FG002|Treatment Period|Protocol Violation|0|||
131760652|NCT02141854|474398444|FG003|Treatment Period|Protocol Violation|2|||
131760653|NCT02141854|474398445|FG004|Treatment Period|Protocol Violation|2|||
131760654|NCT02141854|474398446|FG005|Treatment Period|Protocol Violation|1|||
131760655|NCT02141854|474398441|FG000|Treatment Period|Noncompliance|0|||
131760656|NCT02141854|474398442|FG001|Treatment Period|Noncompliance|0|||
131760657|NCT02141854|474398443|FG002|Treatment Period|Noncompliance|0|||
131760658|NCT02141854|474398444|FG003|Treatment Period|Noncompliance|1|||
131760659|NCT02141854|474398445|FG004|Treatment Period|Noncompliance|0|||
131760660|NCT02141854|474398446|FG005|Treatment Period|Noncompliance|0|||
131760661|NCT02141854|474398441|FG000|Treatment Period|Lack of Efficacy|0|||
131760662|NCT02141854|474398442|FG001|Treatment Period|Lack of Efficacy|0|||
131760663|NCT02141854|474398443|FG002|Treatment Period|Lack of Efficacy|0|||
131760664|NCT02141854|474398444|FG003|Treatment Period|Lack of Efficacy|1|||
131760665|NCT02141854|474398445|FG004|Treatment Period|Lack of Efficacy|1|||
131760666|NCT02141854|474398446|FG005|Treatment Period|Lack of Efficacy|7|||
131760667|NCT02141854|474398441|FG000|Treatment Period|Pregnancy|0|||
131760668|NCT02141854|474398442|FG001|Treatment Period|Pregnancy|1|||
131760669|NCT02141854|474398443|FG002|Treatment Period|Pregnancy|0|||
131760670|NCT02141854|474398444|FG003|Treatment Period|Pregnancy|0|||
131760671|NCT02141854|474398445|FG004|Treatment Period|Pregnancy|0|||
131760672|NCT02141854|474398446|FG005|Treatment Period|Pregnancy|0|||
131760673|NCT02141854|474398441|FG000|Treatment Period|Other|0|||
131760674|NCT02141854|474398442|FG001|Treatment Period|Other|1|||
131760675|NCT02141854|474398443|FG002|Treatment Period|Other|2|||
131760676|NCT02141854|474398444|FG003|Treatment Period|Other|0|||
131760677|NCT02141854|474398445|FG004|Treatment Period|Other|1|||
131760678|NCT02141854|474398446|FG005|Treatment Period|Other|2|||
131760679|NCT02141854|474398441|FG000|Treatment Period|Adverse Event|0|||
131812591|NCT04493684|474595843|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
131812592|NCT04493684|474595844|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
131812593|NCT01963728|474595845|FG000|Overall Study|Study terminated early|0|||
131812594|NCT01963728|474595846|FG001|Overall Study|Study terminated early|1|||
131812595|NCT05152576|474595849|FG000|Overall Study|Lost to Follow-up|3|||
131812596|NCT05152576|474595850|FG001|Overall Study|Lost to Follow-up|0|||
131812597|NCT05152576|474595851|FG002|Overall Study|Lost to Follow-up|0|||
131812598|NCT05152576|474595852|FG003|Overall Study|Lost to Follow-up|1|||
131812599|NCT05152576|474595849|FG000|Overall Study|Withdrawal by Subject|0|||
131812600|NCT05152576|474595850|FG001|Overall Study|Withdrawal by Subject|1|||
131812601|NCT05152576|474595851|FG002|Overall Study|Withdrawal by Subject|0|||
131908859|NCT05965752|474953049|FG004|Overall Study|Disease Relapse|0|||
131908860|NCT05965752|474953045|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
131908861|NCT05965752|474953046|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
131908862|NCT05965752|474953047|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
131908863|NCT05965752|474953048|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
131908864|NCT05965752|474953049|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
131908865|NCT05965752|474953045|FG000|Overall Study|Unable to Return for Study Visits|0|||
131908866|NCT05965752|474953046|FG001|Overall Study|Unable to Return for Study Visits|1|||
131908867|NCT05965752|474953047|FG002|Overall Study|Unable to Return for Study Visits|0|||
131908868|NCT05965752|474953048|FG003|Overall Study|Unable to Return for Study Visits|3|||
131908869|NCT05965752|474953049|FG004|Overall Study|Unable to Return for Study Visits|1|||
131908870|NCT05965752|474953045|FG000|Overall Study|Early Termination|0|||
131908871|NCT05965752|474953046|FG001|Overall Study|Early Termination|0|||
131908872|NCT05965752|474953047|FG002|Overall Study|Early Termination|1|||
131908873|NCT05965752|474953048|FG003|Overall Study|Early Termination|0|||
131760680|NCT02141854|474398442|FG001|Treatment Period|Adverse Event|2|||
131760681|NCT02141854|474398443|FG002|Treatment Period|Adverse Event|2|||
131760682|NCT02141854|474398444|FG003|Treatment Period|Adverse Event|0|||
131760683|NCT02141854|474398445|FG004|Treatment Period|Adverse Event|2|||
131760684|NCT02141854|474398446|FG005|Treatment Period|Adverse Event|2|||
131760685|NCT02141854|474398441|FG000|Treatment Period|Withdrawal by Subject|0|||
131760686|NCT02141854|474398442|FG001|Treatment Period|Withdrawal by Subject|2|||
131812602|NCT05152576|474595852|FG003|Overall Study|Withdrawal by Subject|1|||
131812603|NCT05152576|474595849|FG000|Overall Study|Other|2|||
131812604|NCT05152576|474595850|FG001|Overall Study|Other|0|||
131908874|NCT05965752|474953049|FG004|Overall Study|Early Termination|0|||
131760687|NCT02141854|474398443|FG002|Treatment Period|Withdrawal by Subject|3|||
131908875|NCT05965752|474953045|FG000|Overall Study|Reported Unwanted Symptoms|0|||
131760688|NCT02141854|474398444|FG003|Treatment Period|Withdrawal by Subject|3|||
131760689|NCT02141854|474398445|FG004|Treatment Period|Withdrawal by Subject|4|||
131760690|NCT02141854|474398446|FG005|Treatment Period|Withdrawal by Subject|7|||
131760691|NCT02141854|474398441|FG000|Treatment Period|Disease progression|0|||
131760692|NCT02141854|474398442|FG001|Treatment Period|Disease progression|2|||
131760693|NCT02141854|474398443|FG002|Treatment Period|Disease progression|1|||
131760694|NCT02141854|474398444|FG003|Treatment Period|Disease progression|3|||
131760695|NCT02141854|474398445|FG004|Treatment Period|Disease progression|0|||
131760696|NCT02141854|474398446|FG005|Treatment Period|Disease progression|18|||
131760697|NCT02141854|474398441|FG000|Treatment Period|Lost to Follow-up|0|||
131760698|NCT02141854|474398442|FG001|Treatment Period|Lost to Follow-up|1|||
131760699|NCT02141854|474398443|FG002|Treatment Period|Lost to Follow-up|1|||
131760700|NCT02141854|474398444|FG003|Treatment Period|Lost to Follow-up|1|||
131760701|NCT02141854|474398445|FG004|Treatment Period|Lost to Follow-up|0|||
131760702|NCT02141854|474398446|FG005|Treatment Period|Lost to Follow-up|1|||
131760703|NCT04191096|474398452|FG000|Overall Study|Death|102|||
131760704|NCT04191096|474398453|FG001|Overall Study|Death|89|||
131760705|NCT04191096|474398452|FG000|Overall Study|Lost to Follow-up|1|||
131760706|NCT04191096|474398453|FG001|Overall Study|Lost to Follow-up|1|||
131760707|NCT04191096|474398452|FG000|Overall Study|Withdrawal by Subject|5|||
131760708|NCT04191096|474398453|FG001|Overall Study|Withdrawal by Subject|5|||
131760709|NCT04191096|474398452|FG000|Overall Study|Participants Ongoing|518|||
131760710|NCT04191096|474398453|FG001|Overall Study|Participants Ongoing|530|||
131760711|NCT03128307|474398454|FG000|Overall Study|Lost to Follow-up|29|||
131760712|NCT03128307|474398454|FG000|Overall Study|Withdrawal by Subject|5|||
131760713|NCT01888965|474400338|FG000|Overall Study|Adverse Event|5|||
131760714|NCT01888965|474400338|FG000|Overall Study|Lack of Efficacy|4|||
131760715|NCT02987205|474400340|FG000|Overall Study|Adverse Event|1|||
131760716|NCT02987205|474400340|FG000|Overall Study|Withdrawal by Subject|3|||
131760717|NCT03345849|474400343|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
131760718|NCT03345849|474400344|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
131760719|NCT03345849|474400345|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
131760720|NCT03345849|474400346|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
131760721|NCT03345849|474400343|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
131760722|NCT03345849|474400344|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
131760723|NCT03345849|474400345|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
131760724|NCT03345849|474400346|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
131760725|NCT03345849|474400343|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
131760726|NCT03345849|474400344|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
131760727|NCT03345849|474400345|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
131760728|NCT03345849|474400346|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
131760729|NCT03345849|474400343|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
131760730|NCT03345849|474400344|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
131760731|NCT03345849|474400345|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
131760732|NCT03345849|474400346|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
131760733|NCT03345849|474400343|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
131760734|NCT03345849|474400344|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
131760735|NCT03345849|474400345|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
131760736|NCT03345849|474400346|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
131760737|NCT03345849|474400343|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
131760738|NCT03345849|474400344|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
131760739|NCT03345849|474400345|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
131760740|NCT03345849|474400346|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
131812605|NCT05152576|474595851|FG002|Overall Study|Other|0|||
131812606|NCT05152576|474595852|FG003|Overall Study|Other|0|||
131812607|NCT00859430|474595853|FG000|First Intervention|Withdrawal by Subject|0|||
131812608|NCT00859430|474595854|FG001|First Intervention|Withdrawal by Subject|1|||
131812609|NCT04115293|474597573|FG000|Overall Study|Adverse Event|0|||
131812610|NCT04115293|474597574|FG001|Overall Study|Adverse Event|2|||
131812611|NCT04115293|474597573|FG000|Overall Study|Withdrawal by Subject|2|||
131812612|NCT04115293|474597574|FG001|Overall Study|Withdrawal by Subject|1|||
131812613|NCT04115293|474597573|FG000|Overall Study|Physician Decision|1|||
131812614|NCT04115293|474597574|FG001|Overall Study|Physician Decision|0|||
131812615|NCT04115293|474597573|FG000|Overall Study|Death|1|||
131812616|NCT04115293|474597574|FG001|Overall Study|Death|1|||
131812617|NCT00001703|474597575|FG000|Overall Study|progressed disease|2|||
131812618|NCT00001703|474597575|FG000|Overall Study|No evidence of disease|1|||
131812619|NCT00001703|474597575|FG000|Overall Study|recurrent disease|2|||
131812620|NCT02286739|474597580|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
131812621|NCT02286739|474597581|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
131812622|NCT02286739|474597580|FG000|Overall Study|No Verasense type documented|0|||
131812623|NCT02286739|474597581|FG001|Overall Study|No Verasense type documented|23|||
131812624|NCT02286739|474597580|FG000|Overall Study|Adverse Event|1|||
131760741|NCT03345849|474400343|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
131812625|NCT02286739|474597581|FG001|Overall Study|Adverse Event|2|||
131812626|NCT02286739|474597580|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
131812627|NCT02286739|474597581|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
131812628|NCT03447353|474597586|FG000|Overall Study|Failure at Screening Visit|2|||
131812629|NCT03447353|474597586|FG000|Overall Study|Lost to Follow-up|4|||
131812630|NCT03447353|474597586|FG000|Overall Study|Scheduling Conflicts|3|||
131908876|NCT05965752|474953046|FG001|Overall Study|Reported Unwanted Symptoms|0|||
131908877|NCT05965752|474953047|FG002|Overall Study|Reported Unwanted Symptoms|0|||
131908878|NCT05965752|474953048|FG003|Overall Study|Reported Unwanted Symptoms|0|||
131908879|NCT05965752|474953049|FG004|Overall Study|Reported Unwanted Symptoms|1|||
131908880|NCT05965752|474953045|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
131908881|NCT05965752|474953046|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
131908882|NCT05965752|474953047|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
131908883|NCT05965752|474953048|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
131908884|NCT05965752|474953049|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
131908885|NCT01324947|474953050|FG000|Overall Study|Adverse Event|7|||
131908886|NCT01324947|474953050|FG000|Overall Study|Death|10|||
131908887|NCT01324947|474953050|FG000|Overall Study|Other|3|||
131908888|NCT01324947|474953050|FG000|Overall Study|Progressive Disease|50|||
131760742|NCT03345849|474400344|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
131760743|NCT03345849|474400345|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
131760744|NCT03345849|474400346|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
131760745|NCT03345849|474400343|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
131760746|NCT03345849|474400344|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
131760747|NCT03345849|474400345|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
131760748|NCT03345849|474400346|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
131760749|NCT03345849|474400343|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131760750|NCT03345849|474400344|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131908889|NCT01324947|474953050|FG000|Overall Study|Withdrawal by Subject|3|||
131908890|NCT01324947|474953050|FG000|Overall Study|1 discontinued before starting drug|1|||
131908891|NCT01274351|474953051|FG000|Overall Study|Lost to Follow-up|1|||
131908892|NCT01274351|474953051|FG000|Overall Study|patient not compliant with the protocol|1|||
131908893|NCT01274351|474953051|FG000|Overall Study|Pregnancy|1|||
131908894|NCT01274351|474953051|FG000|Overall Study|Death|2|||
131908895|NCT01274351|474953051|FG000|Overall Study|Withdrawal by Subject|3|||
131908896|NCT01274351|474953051|FG000|Overall Study|Adverse Event|8|||
131908897|NCT01274351|474953051|FG000|Overall Study|progression of disease|3|||
131908898|NCT01274351|474953051|FG000|Overall Study|hospitalization|1|||
131908899|NCT02160626|474953053|FG000|Overall Study|Adverse Event|1|||
131908900|NCT02160626|474953054|FG001|Overall Study|Adverse Event|0|||
131908901|NCT02160626|474953055|FG002|Overall Study|Adverse Event|0|||
131908902|NCT02160626|474953053|FG000|Overall Study|Schedule not conducive to study visits|0|||
131908903|NCT02160626|474953054|FG001|Overall Study|Schedule not conducive to study visits|0|||
131908904|NCT02160626|474953055|FG002|Overall Study|Schedule not conducive to study visits|1|||
131760751|NCT03345849|474400345|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131760752|NCT03345849|474400346|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
131760753|NCT03345849|474400343|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
131760754|NCT03345849|474400344|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
131760755|NCT03345849|474400345|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
131760756|NCT03345849|474400346|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
131760757|NCT03345849|474400343|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
131760758|NCT03345849|474400344|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
131760759|NCT03345849|474400345|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
131760760|NCT03345849|474400346|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
131812631|NCT03447353|474597586|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
131812632|NCT02642653|474597587|FG000|Overall Study|Adverse Event|2|||
131812633|NCT02642653|474597588|FG001|Overall Study|Adverse Event|0|||
131812634|NCT02057835|474597589|FG000|Overall Study|Withdrawal by Subject|0|||
131812635|NCT02057835|474597590|FG001|Overall Study|Withdrawal by Subject|2|||
131908905|NCT02160626|474953053|FG000|Overall Study|Withdrawal by Subject|0|||
131908906|NCT02160626|474953054|FG001|Overall Study|Withdrawal by Subject|1|||
131908907|NCT02160626|474953055|FG002|Overall Study|Withdrawal by Subject|0|||
131908908|NCT04239924|474953056|FG000|Overall Study|Lost to Follow-up|2|||
131908909|NCT00434252|474954659|FG000|Overall Study|Lack of Efficacy|50|||
131908910|NCT00434252|474954660|FG001|Overall Study|Lack of Efficacy|100|||
131908911|NCT00434252|474954659|FG000|Overall Study|Adverse Event|6|||
131908912|NCT00434252|474954660|FG001|Overall Study|Adverse Event|13|||
131908913|NCT00434252|474954659|FG000|Overall Study|Death|1|||
131760761|NCT03991936|474400347|FG000|Overall Study|Lost to Follow-up|1|||
131760762|NCT03991936|474400348|FG001|Overall Study|Lost to Follow-up|1|||
131760763|NCT03991936|474400349|FG002|Overall Study|Lost to Follow-up|1|||
131760764|NCT03991936|474400350|FG003|Overall Study|Lost to Follow-up|1|||
131760765|NCT03991936|474400351|FG004|Overall Study|Lost to Follow-up|1|||
131760766|NCT00939055|474400352|FG000|Overall Study|Discontinuation prior to procedure|4|||
131760767|NCT00939055|474400353|FG001|Overall Study|Discontinuation prior to procedure|0|||
131760768|NCT00584987|474400356|FG000|Overall Study|Protocol Violation|1|||
131760769|NCT00584987|474400357|FG001|Overall Study|Protocol Violation|1|||
131760770|NCT00584987|474400358|FG002|Overall Study|Protocol Violation|1|||
131760771|NCT00584987|474400359|FG003|Overall Study|Protocol Violation|0|||
131760772|NCT00584987|474400356|FG000|Overall Study|Adverse Event|0|||
131760773|NCT00584987|474400357|FG001|Overall Study|Adverse Event|0|||
131760774|NCT00584987|474400358|FG002|Overall Study|Adverse Event|0|||
131760775|NCT00584987|474400359|FG003|Overall Study|Adverse Event|1|||
131760776|NCT03225833|474400360|FG000|Overall Study|Adverse Event|0|||
131760777|NCT03225833|474400361|FG001|Overall Study|Adverse Event|1|||
131760778|NCT03225833|474400362|FG002|Overall Study|Adverse Event|2|||
131760779|NCT03225833|474400363|FG003|Overall Study|Adverse Event|0|||
131760780|NCT03225833|474400364|FG004|Overall Study|Adverse Event|0|||
131760781|NCT03225833|474400365|FG005|Overall Study|Adverse Event|2|||
131760782|NCT03225833|474400360|FG000|Overall Study|Withdrawal by Subject|1|||
131760783|NCT03225833|474400361|FG001|Overall Study|Withdrawal by Subject|0|||
131760784|NCT03225833|474400362|FG002|Overall Study|Withdrawal by Subject|0|||
131812636|NCT02057835|474597591|FG002|Overall Study|Withdrawal by Subject|0|||
131812637|NCT02057835|474597592|FG003|Overall Study|Withdrawal by Subject|0|||
131812638|NCT02057835|474597593|FG004|Overall Study|Withdrawal by Subject|0|||
131812639|NCT02057835|474597594|FG005|Overall Study|Withdrawal by Subject|0|||
131812640|NCT02057835|474597595|FG006|Overall Study|Withdrawal by Subject|0|||
131812641|NCT02057835|474597596|FG007|Overall Study|Withdrawal by Subject|0|||
131812642|NCT02057835|474597597|FG008|Overall Study|Withdrawal by Subject|0|||
131812643|NCT02057835|474597598|FG009|Overall Study|Withdrawal by Subject|0|||
131812644|NCT01660243|474597599|FG000|Overall Study|Adverse Event|1|||
131812645|NCT01660243|474597600|FG001|Overall Study|Adverse Event|0|||
131812646|NCT01660243|474597601|FG002|Overall Study|Adverse Event|1|||
131812647|NCT01660243|474597602|FG003|Overall Study|Adverse Event|0|||
131812648|NCT01660243|474597599|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
131812649|NCT01660243|474597600|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
131812650|NCT01660243|474597601|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
131812651|NCT01660243|474597602|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
131812652|NCT01660243|474597599|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
131812653|NCT01660243|474597600|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
131908914|NCT00434252|474954660|FG001|Overall Study|Death|2|||
131908915|NCT00434252|474954659|FG000|Overall Study|Lost to Follow-up|0|||
131908916|NCT00434252|474954660|FG001|Overall Study|Lost to Follow-up|1|||
131908917|NCT00434252|474954659|FG000|Overall Study|Physician Decision|4|||
131908918|NCT00434252|474954660|FG001|Overall Study|Physician Decision|8|||
131908919|NCT00434252|474954659|FG000|Overall Study|Withdrawal by Subject|3|||
131908920|NCT00434252|474954660|FG001|Overall Study|Withdrawal by Subject|7|||
131908921|NCT00499122|474954665|FG000|Overall Study|Withdrawal by Subject|2|||
131908922|NCT01799941|474954674|FG000|Overall Study|Adverse Event|34|||
131908923|NCT01799941|474954674|FG000|Overall Study|Withdrawal by Subject|21|||
131908924|NCT01799941|474954674|FG000|Overall Study|Death|2|||
131908925|NCT01799941|474954674|FG000|Overall Study|Investigator Decision|4|||
131908926|NCT01799941|474954674|FG000|Overall Study|Lack of Efficacy|3|||
131908927|NCT01799941|474954674|FG000|Overall Study|Lost to Follow-up|17|||
131908928|NCT01799941|474954674|FG000|Overall Study|Other|15|||
131908929|NCT03736967|474954682|FG000|Overall Study|Withdrawal by Subject|26|||
131908930|NCT03736967|474954683|FG001|Overall Study|Withdrawal by Subject|25|||
131908931|NCT03736967|474954684|FG002|Overall Study|Withdrawal by Subject|23|||
131908932|NCT03736967|474954685|FG003|Overall Study|Withdrawal by Subject|26|||
131760785|NCT03225833|474400363|FG003|Overall Study|Withdrawal by Subject|0|||
131760786|NCT03225833|474400364|FG004|Overall Study|Withdrawal by Subject|1|||
131908933|NCT03736967|474954682|FG000|Overall Study|Lost to Follow-up|3|||
131908934|NCT03736967|474954683|FG001|Overall Study|Lost to Follow-up|2|||
131908935|NCT03736967|474954684|FG002|Overall Study|Lost to Follow-up|1|||
131908936|NCT03736967|474954685|FG003|Overall Study|Lost to Follow-up|1|||
131908937|NCT03736967|474954682|FG000|Overall Study|Physician Decision|1|||
131908938|NCT03736967|474954683|FG001|Overall Study|Physician Decision|0|||
131908939|NCT03736967|474954684|FG002|Overall Study|Physician Decision|0|||
131760787|NCT03225833|474400365|FG005|Overall Study|Withdrawal by Subject|0|||
131760788|NCT03225833|474400360|FG000|Overall Study|Termination of Study by Sponsor|4|||
131760789|NCT03225833|474400361|FG001|Overall Study|Termination of Study by Sponsor|0|||
131760790|NCT03225833|474400362|FG002|Overall Study|Termination of Study by Sponsor|0|||
131760791|NCT03225833|474400363|FG003|Overall Study|Termination of Study by Sponsor|0|||
131812654|NCT01660243|474597601|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
131812655|NCT01660243|474597602|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
131812656|NCT01660243|474597599|FG000|Overall Study|Randomization error|0|||
131812657|NCT01660243|474597600|FG001|Overall Study|Randomization error|0|||
131812658|NCT01660243|474597601|FG002|Overall Study|Randomization error|0|||
131812659|NCT01660243|474597602|FG003|Overall Study|Randomization error|1|||
131812660|NCT00712959|474597603|FG000|Overall Study|Protocol Violation|3|||
131812661|NCT00712959|474597604|FG001|Overall Study|Protocol Violation|1|||
131812662|NCT00712959|474597603|FG000|Overall Study|Lost to Follow-up|13|||
131812663|NCT00712959|474597604|FG001|Overall Study|Lost to Follow-up|2|||
131812664|NCT00712959|474597603|FG000|Overall Study|Withdrawal by Subject|3|||
131812665|NCT00712959|474597604|FG001|Overall Study|Withdrawal by Subject|0|||
131812666|NCT00508651|474597605|FG000|Overall Study|Lost to Follow-up|3|||
131812667|NCT00508651|474597606|FG001|Overall Study|Lost to Follow-up|1|||
131812668|NCT00508651|474597605|FG000|Overall Study|Withdrawal by Subject|1|||
131812669|NCT00508651|474597606|FG001|Overall Study|Withdrawal by Subject|1|||
131812670|NCT02255149|474597614|FG000|Overall Study|Lost to Follow-up|2|||
131812671|NCT02255149|474597614|FG000|Overall Study|Withdrawal by Subject|1|||
131812672|NCT02255149|474597614|FG000|Overall Study|Withdrawal by PI|1|||
131812673|NCT02255149|474597614|FG000|Overall Study|Implant Failure|1|||
131812674|NCT01376037|474597619|FG000|Overall Study|Lost to Follow-up|0|||
131812675|NCT01376037|474597620|FG001|Overall Study|Lost to Follow-up|2|||
131812676|NCT02328040|474597622|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
131812677|NCT02328040|474597623|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
131812678|NCT05710718|474597625|FG000|Overall Study|Withdrawal by Subject|5|||
131812679|NCT05710718|474597626|FG001|Overall Study|Withdrawal by Subject|1|||
131812680|NCT05710718|474597625|FG000|Overall Study|Lost to Follow-up|0|||
131812681|NCT05710718|474597626|FG001|Overall Study|Lost to Follow-up|1|||
131812682|NCT05710718|474597625|FG000|Overall Study|Death|0|||
131812683|NCT05710718|474597626|FG001|Overall Study|Death|1|||
131908940|NCT03736967|474954685|FG003|Overall Study|Physician Decision|1|||
131908941|NCT03736967|474954682|FG000|Overall Study|Adverse Event|0|||
131908942|NCT03736967|474954683|FG001|Overall Study|Adverse Event|1|||
131812684|NCT03121586|474597631|FG000|Overall Study|Study terminated by sponsor|0|||
131812685|NCT03121586|474597632|FG001|Overall Study|Study terminated by sponsor|0|||
131812686|NCT03121586|474597633|FG002|Overall Study|Study terminated by sponsor|99|||
131812687|NCT03121586|474597631|FG000|Overall Study|Withdrawal by Subject|37|||
131812688|NCT03121586|474597632|FG001|Overall Study|Withdrawal by Subject|14|||
131812689|NCT03121586|474597633|FG002|Overall Study|Withdrawal by Subject|9|||
131812690|NCT03121586|474597631|FG000|Overall Study|Not further specified|6|||
131812691|NCT03121586|474597632|FG001|Overall Study|Not further specified|11|||
131812692|NCT03121586|474597633|FG002|Overall Study|Not further specified|10|||
131812693|NCT03121586|474597631|FG000|Overall Study|Adverse Event|16|||
131812694|NCT03121586|474597632|FG001|Overall Study|Adverse Event|5|||
131908943|NCT03736967|474954684|FG002|Overall Study|Adverse Event|0|||
131908944|NCT03736967|474954685|FG003|Overall Study|Adverse Event|1|||
131760792|NCT03225833|474400364|FG004|Overall Study|Termination of Study by Sponsor|0|||
131760793|NCT03225833|474400365|FG005|Overall Study|Termination of Study by Sponsor|7|||
131760794|NCT03225833|474400360|FG000|Overall Study|Sponsor Decision|0|||
131760795|NCT03225833|474400361|FG001|Overall Study|Sponsor Decision|0|||
131760796|NCT03225833|474400362|FG002|Overall Study|Sponsor Decision|0|||
131760797|NCT03225833|474400363|FG003|Overall Study|Sponsor Decision|0|||
131760798|NCT03225833|474400364|FG004|Overall Study|Sponsor Decision|0|||
131760799|NCT03225833|474400365|FG005|Overall Study|Sponsor Decision|1|||
131760800|NCT00081263|474400368|FG000|Overall Study|clerical error|1|||
131760801|NCT00081263|474400369|FG001|Overall Study|clerical error|0|||
131760802|NCT00081263|474400368|FG000|Overall Study|wrong cell type|7|||
131760803|NCT00081263|474400369|FG001|Overall Study|wrong cell type|5|||
131760804|NCT00081263|474400368|FG000|Overall Study|improper pre-protocol therapy|0|||
131760805|NCT00081263|474400369|FG001|Overall Study|improper pre-protocol therapy|1|||
131760806|NCT00081263|474400368|FG000|Overall Study|Inadequate pathology|0|||
131760807|NCT00081263|474400369|FG001|Overall Study|Inadequate pathology|1|||
131812695|NCT03121586|474597633|FG002|Overall Study|Adverse Event|6|||
131812696|NCT03121586|474597631|FG000|Overall Study|Protocol Violation|0|||
131812697|NCT03121586|474597632|FG001|Overall Study|Protocol Violation|5|||
131812698|NCT03121586|474597633|FG002|Overall Study|Protocol Violation|0|||
131812699|NCT03121586|474597631|FG000|Overall Study|Lack of Efficacy|3|||
131812700|NCT03121586|474597632|FG001|Overall Study|Lack of Efficacy|3|||
131812701|NCT03121586|474597633|FG002|Overall Study|Lack of Efficacy|1|||
131760808|NCT00081263|474400368|FG000|Overall Study|Never treated|4|||
131760809|NCT00081263|474400369|FG001|Overall Study|Never treated|5|||
131812702|NCT03121586|474597631|FG000|Overall Study|Physician Decision|2|||
131908945|NCT03736967|474954682|FG000|Overall Study|Death|0|||
131908946|NCT03736967|474954683|FG001|Overall Study|Death|0|||
131760810|NCT00081263|474400368|FG000|Overall Study|Inadequate data|5|||
131760811|NCT00081263|474400369|FG001|Overall Study|Inadequate data|10|||
131760812|NCT04564027|474400384|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
131760813|NCT04564027|474400385|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
131760814|NCT04564027|474400386|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
131760815|NCT04564027|474400387|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
131760816|NCT01267955|474400390|FG000|Stage 1 (6 Months)|Death|3|||
131760817|NCT01267955|474400390|FG000|Stage 2 (6 Months)|Death|5|||
131760818|NCT01267955|474400390|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
131760819|NCT05827978|474400391|FG000|Overall Study|Adverse Event|1|||
131760820|NCT05827978|474400392|FG001|Overall Study|Adverse Event|0|||
131760821|NCT05827978|474400393|FG002|Overall Study|Adverse Event|0|||
131760822|NCT05827978|474400394|FG003|Overall Study|Adverse Event|1|||
131760823|NCT05827978|474400395|FG004|Overall Study|Adverse Event|0|||
131760824|NCT05827978|474400396|FG005|Overall Study|Adverse Event|0|||
131760825|NCT05827978|474400391|FG000|Overall Study|Death|1|||
131760826|NCT05827978|474400392|FG001|Overall Study|Death|5|||
131760827|NCT05827978|474400393|FG002|Overall Study|Death|2|||
131760828|NCT05827978|474400394|FG003|Overall Study|Death|3|||
131760829|NCT05827978|474400395|FG004|Overall Study|Death|1|||
131760830|NCT05827978|474400396|FG005|Overall Study|Death|3|||
131760831|NCT05827978|474400391|FG000|Overall Study|Lost to Follow-up|57|||
131760832|NCT05827978|474400392|FG001|Overall Study|Lost to Follow-up|88|||
131760833|NCT05827978|474400393|FG002|Overall Study|Lost to Follow-up|54|||
131760834|NCT05827978|474400394|FG003|Overall Study|Lost to Follow-up|47|||
131760835|NCT05827978|474400395|FG004|Overall Study|Lost to Follow-up|25|||
131760836|NCT05827978|474400396|FG005|Overall Study|Lost to Follow-up|10|||
131760837|NCT05827978|474400391|FG000|Overall Study|Noncompliance with Study Procedures|0|||
131760838|NCT05827978|474400392|FG001|Overall Study|Noncompliance with Study Procedures|1|||
131760839|NCT05827978|474400393|FG002|Overall Study|Noncompliance with Study Procedures|1|||
131760840|NCT05827978|474400394|FG003|Overall Study|Noncompliance with Study Procedures|1|||
131760841|NCT05827978|474400395|FG004|Overall Study|Noncompliance with Study Procedures|1|||
131760842|NCT05827978|474400396|FG005|Overall Study|Noncompliance with Study Procedures|0|||
131760843|NCT05827978|474400391|FG000|Overall Study|Physician Decision|2|||
131760844|NCT05827978|474400392|FG001|Overall Study|Physician Decision|0|||
131760845|NCT05827978|474400393|FG002|Overall Study|Physician Decision|1|||
131760846|NCT05827978|474400394|FG003|Overall Study|Physician Decision|2|||
131760847|NCT05827978|474400395|FG004|Overall Study|Physician Decision|1|||
131760848|NCT05827978|474400396|FG005|Overall Study|Physician Decision|1|||
131760849|NCT05827978|474400391|FG000|Overall Study|Protocol Violation|5|||
131760850|NCT05827978|474400392|FG001|Overall Study|Protocol Violation|2|||
131760851|NCT05827978|474400393|FG002|Overall Study|Protocol Violation|0|||
131760852|NCT05827978|474400394|FG003|Overall Study|Protocol Violation|0|||
131760853|NCT05827978|474400395|FG004|Overall Study|Protocol Violation|0|||
131760854|NCT05827978|474400396|FG005|Overall Study|Protocol Violation|0|||
131760855|NCT05827978|474400391|FG000|Overall Study|Withdrawal by Subject|17|||
131760856|NCT05827978|474400392|FG001|Overall Study|Withdrawal by Subject|16|||
131760857|NCT05827978|474400393|FG002|Overall Study|Withdrawal by Subject|10|||
131760858|NCT05827978|474400394|FG003|Overall Study|Withdrawal by Subject|12|||
131760859|NCT05827978|474400395|FG004|Overall Study|Withdrawal by Subject|10|||
131760860|NCT05827978|474400396|FG005|Overall Study|Withdrawal by Subject|9|||
131760861|NCT05827978|474400391|FG000|Overall Study|Other Than Specified|0|||
131760862|NCT05827978|474400392|FG001|Overall Study|Other Than Specified|0|||
131760863|NCT05827978|474400393|FG002|Overall Study|Other Than Specified|1|||
131760864|NCT05827978|474400394|FG003|Overall Study|Other Than Specified|0|||
131760865|NCT05827978|474400395|FG004|Overall Study|Other Than Specified|2|||
131760866|NCT05827978|474400396|FG005|Overall Study|Other Than Specified|0|||
131760867|NCT04651777|474400397|FG000|Overall Study|Adverse Event|1|||
131760868|NCT04651777|474400397|FG000|Overall Study|Withdrawal by Subject|2|||
131760869|NCT04566445|474400398|FG000|Overall Study|Death|4|||
131760870|NCT04566445|474400399|FG001|Overall Study|Death|1|||
131760871|NCT04566445|474400400|FG002|Overall Study|Death|1|||
131760872|NCT04566445|474400398|FG000|Overall Study|Lost to Follow-up|3|||
131760873|NCT04566445|474400399|FG001|Overall Study|Lost to Follow-up|1|||
131812703|NCT03121586|474597632|FG001|Overall Study|Physician Decision|2|||
131812704|NCT03121586|474597633|FG002|Overall Study|Physician Decision|0|||
131812705|NCT03121586|474597631|FG000|Overall Study|Noncompliance with study drug|5|||
131812706|NCT03121586|474597632|FG001|Overall Study|Noncompliance with study drug|3|||
131812707|NCT03121586|474597633|FG002|Overall Study|Noncompliance with study drug|5|||
131760874|NCT04566445|474400400|FG002|Overall Study|Lost to Follow-up|1|||
131760875|NCT04566445|474400398|FG000|Overall Study|Study terminated by sponsor|11|||
131760876|NCT04566445|474400399|FG001|Overall Study|Study terminated by sponsor|17|||
131760877|NCT04566445|474400400|FG002|Overall Study|Study terminated by sponsor|32|||
131760878|NCT04566445|474400398|FG000|Overall Study|Withdrawal by Subject|12|||
131760879|NCT04566445|474400399|FG001|Overall Study|Withdrawal by Subject|14|||
131760880|NCT04566445|474400400|FG002|Overall Study|Withdrawal by Subject|13|||
131760881|NCT04566445|474400398|FG000|Overall Study|Randomized but not treated due to AE|2|||
131760882|NCT04566445|474400399|FG001|Overall Study|Randomized but not treated due to AE|1|||
131760883|NCT04566445|474400400|FG002|Overall Study|Randomized but not treated due to AE|0|||
131760884|NCT04566445|474400398|FG000|Overall Study|Adverse Event|1|||
131760885|NCT04566445|474400399|FG001|Overall Study|Adverse Event|1|||
131812708|NCT03121586|474597631|FG000|Overall Study|Lost to Follow-up|4|||
131812709|NCT03121586|474597632|FG001|Overall Study|Lost to Follow-up|2|||
131812710|NCT03121586|474597633|FG002|Overall Study|Lost to Follow-up|0|||
131812711|NCT03121586|474597631|FG000|Overall Study|Death|2|||
131812712|NCT03121586|474597632|FG001|Overall Study|Death|0|||
131812713|NCT03121586|474597633|FG002|Overall Study|Death|0|||
131812714|NCT06381102|474597634|FG000|Washout 5 Days|Withdrawal by Subject|0|||
131812715|NCT06381102|474597635|FG001|Washout 5 Days|Withdrawal by Subject|2|||
131812716|NCT04278560|474597638|FG000|Overall Study|Adverse Event|1|||
131760886|NCT04566445|474400400|FG002|Overall Study|Adverse Event|0|||
131760887|NCT04785144|474400401|FG000|Overall Study|Withdrawal by Subject|4|||
131760888|NCT04785144|474400402|FG001|Overall Study|Withdrawal by Subject|1|||
131760889|NCT04785144|474400403|FG002|Overall Study|Withdrawal by Subject|0|||
131760890|NCT04785144|474400404|FG003|Overall Study|Withdrawal by Subject|0|||
131760891|NCT04785144|474400405|FG004|Overall Study|Withdrawal by Subject|0|||
131760892|NCT04785144|474400406|FG005|Overall Study|Withdrawal by Subject|2|||
131760893|NCT04785144|474400407|FG006|Overall Study|Withdrawal by Subject|2|||
131760894|NCT04785144|474400408|FG007|Overall Study|Withdrawal by Subject|0|||
131760895|NCT04785144|474400409|FG008|Overall Study|Withdrawal by Subject|1|||
131760896|NCT04785144|474400410|FG009|Overall Study|Withdrawal by Subject|0|||
131760897|NCT04785144|474400401|FG000|Overall Study|Lost to Follow-up|1|||
131760898|NCT04785144|474400402|FG001|Overall Study|Lost to Follow-up|0|||
131760899|NCT04785144|474400403|FG002|Overall Study|Lost to Follow-up|0|||
131760900|NCT04785144|474400404|FG003|Overall Study|Lost to Follow-up|0|||
131760901|NCT04785144|474400405|FG004|Overall Study|Lost to Follow-up|1|||
131760902|NCT04785144|474400406|FG005|Overall Study|Lost to Follow-up|2|||
131760903|NCT04785144|474400407|FG006|Overall Study|Lost to Follow-up|1|||
131760904|NCT04785144|474400408|FG007|Overall Study|Lost to Follow-up|2|||
131760905|NCT04785144|474400409|FG008|Overall Study|Lost to Follow-up|4|||
131760906|NCT04785144|474400410|FG009|Overall Study|Lost to Follow-up|1|||
131760907|NCT04785144|474400401|FG000|Overall Study|Protocol Violation|0|||
131760908|NCT04785144|474400402|FG001|Overall Study|Protocol Violation|0|||
131760909|NCT04785144|474400403|FG002|Overall Study|Protocol Violation|0|||
131760910|NCT04785144|474400404|FG003|Overall Study|Protocol Violation|0|||
131760911|NCT04785144|474400405|FG004|Overall Study|Protocol Violation|0|||
131760912|NCT04785144|474400406|FG005|Overall Study|Protocol Violation|0|||
131760913|NCT04785144|474400407|FG006|Overall Study|Protocol Violation|1|||
131760914|NCT04785144|474400408|FG007|Overall Study|Protocol Violation|0|||
131760915|NCT04785144|474400409|FG008|Overall Study|Protocol Violation|0|||
131760916|NCT04785144|474400410|FG009|Overall Study|Protocol Violation|0|||
131760917|NCT04785144|474400401|FG000|Overall Study|Physician Decision|0|||
131760918|NCT04785144|474400402|FG001|Overall Study|Physician Decision|0|||
131760919|NCT04785144|474400403|FG002|Overall Study|Physician Decision|0|||
131760920|NCT04785144|474400404|FG003|Overall Study|Physician Decision|0|||
131760921|NCT04785144|474400405|FG004|Overall Study|Physician Decision|0|||
131760922|NCT04785144|474400406|FG005|Overall Study|Physician Decision|0|||
131760923|NCT04785144|474400407|FG006|Overall Study|Physician Decision|0|||
131760924|NCT04785144|474400408|FG007|Overall Study|Physician Decision|0|||
131760925|NCT04785144|474400409|FG008|Overall Study|Physician Decision|0|||
131760926|NCT04785144|474400410|FG009|Overall Study|Physician Decision|1|||
131760927|NCT04785144|474400401|FG000|Overall Study|Unable to continue due to work schedule|0|||
131760928|NCT04785144|474400402|FG001|Overall Study|Unable to continue due to work schedule|0|||
131760929|NCT04785144|474400403|FG002|Overall Study|Unable to continue due to work schedule|0|||
131760930|NCT04785144|474400404|FG003|Overall Study|Unable to continue due to work schedule|0|||
131812717|NCT04278560|474597639|FG001|Overall Study|Adverse Event|2|||
131812718|NCT04278560|474597638|FG000|Overall Study|Withdrawal by Subject|0|||
131812719|NCT04278560|474597639|FG001|Overall Study|Withdrawal by Subject|1|||
131812720|NCT02832063|474597640|FG000|Overall Study|Adverse Event|2|||
131812721|NCT02832063|474597641|FG001|Overall Study|Adverse Event|1|||
131812722|NCT02832063|474597640|FG000|Overall Study|Physician Decision|5|||
131812723|NCT02832063|474597641|FG001|Overall Study|Physician Decision|7|||
131812724|NCT02832063|474597640|FG000|Overall Study|Lost to Follow-up|15|||
131760931|NCT04785144|474400405|FG004|Overall Study|Unable to continue due to work schedule|0|||
131760932|NCT04785144|474400406|FG005|Overall Study|Unable to continue due to work schedule|0|||
131760933|NCT04785144|474400407|FG006|Overall Study|Unable to continue due to work schedule|0|||
131760934|NCT04785144|474400408|FG007|Overall Study|Unable to continue due to work schedule|0|||
131760935|NCT04785144|474400409|FG008|Overall Study|Unable to continue due to work schedule|0|||
131760936|NCT04785144|474400410|FG009|Overall Study|Unable to continue due to work schedule|1|||
131760937|NCT00610714|474400411|FG000|Overall Study|Adverse Event|3|||
131760938|NCT00610714|474400412|FG001|Overall Study|Adverse Event|1|||
131760939|NCT00610714|474400411|FG000|Overall Study|Death|12|||
131812725|NCT02832063|474597641|FG001|Overall Study|Lost to Follow-up|8|||
131812726|NCT02832063|474597640|FG000|Overall Study|Withdrawal by Subject|10|||
131812727|NCT02832063|474597641|FG001|Overall Study|Withdrawal by Subject|21|||
131812728|NCT02832063|474597640|FG000|Overall Study|Other|2|||
131760940|NCT00610714|474400412|FG001|Overall Study|Death|18|||
131760941|NCT00610714|474400411|FG000|Overall Study|Withdrawal by Subject|9|||
131760942|NCT00610714|474400412|FG001|Overall Study|Withdrawal by Subject|3|||
131760943|NCT00610714|474400411|FG000|Overall Study|Study completion at 120 PFS events|2|||
131760944|NCT00610714|474400412|FG001|Overall Study|Study completion at 120 PFS events|2|||
131760945|NCT00712712|474400413|FG000|Overall Study|Protocol Violation|11|||
131760946|NCT00712712|474400413|FG000|Overall Study|Radiofrequency not done|3|||
131760947|NCT00712712|474400413|FG000|Overall Study|Death|8|||
131760948|NCT00712712|474400413|FG000|Overall Study|Withdrawal by Subject|1|||
131760949|NCT05549505|474400415|FG000|Overall Study|Lost to Follow-up|2|||
131760950|NCT05549505|474400416|FG001|Overall Study|Lost to Follow-up|0|||
131760951|NCT05549505|474400415|FG000|Overall Study|Withdrawal by Subject|3|||
131760952|NCT05549505|474400416|FG001|Overall Study|Withdrawal by Subject|3|||
131760953|NCT05549505|474400415|FG000|Overall Study|Other: Miscellaneous|3|||
131760954|NCT05549505|474400416|FG001|Overall Study|Other: Miscellaneous|6|||
131760955|NCT01602822|474400419|FG000|Overall Study|Adverse Event|11|||
131760956|NCT02286089|474400422|FG000|Overall Study|Ongoing in Study|1|||
131760957|NCT02286089|474400423|FG001|Overall Study|Ongoing in Study|1|||
131760958|NCT02286089|474400424|FG002|Overall Study|Ongoing in Study|4|||
131760959|NCT02286089|474400425|FG003|Overall Study|Ongoing in Study|10|||
131760960|NCT02286089|474400422|FG000|Overall Study|Withdrawal by Subject|0|||
131760961|NCT02286089|474400423|FG001|Overall Study|Withdrawal by Subject|0|||
131760962|NCT02286089|474400424|FG002|Overall Study|Withdrawal by Subject|2|||
131760963|NCT02286089|474400425|FG003|Overall Study|Withdrawal by Subject|2|||
131760964|NCT02871791|474400426|FG000|Phase 1b|Death|0|||
131760965|NCT02871791|474400427|FG001|Phase 1b|Death|1|||
131760966|NCT02871791|474400426|FG000|Phase 1b|progressive disease|6|||
131760967|NCT02871791|474400427|FG001|Phase 1b|progressive disease|2|||
131760968|NCT02871791|474400426|FG000|Phase 2|Death|1|||
131760969|NCT02871791|474400427|FG001|Phase 2|Death|0|||
131760970|NCT02871791|474400426|FG000|Phase 2|Lost to Follow-up|2|||
131760971|NCT02871791|474400427|FG001|Phase 2|Lost to Follow-up|0|||
131760972|NCT00129376|474400428|FG000|Overall Study|Adverse Event|1|||
131760973|NCT00129376|474400428|FG000|Overall Study|Lack of Efficacy|1|||
131760974|NCT03218826|474400435|FG000|Overall Study|Non-compliance with protocol|1|||
131760975|NCT03218826|474400436|FG001|Overall Study|Non-compliance with protocol|0|||
131760976|NCT03218826|474400437|FG002|Overall Study|Non-compliance with protocol|2|||
131760977|NCT03218826|474400438|FG003|Overall Study|Non-compliance with protocol|1|||
131760978|NCT03218826|474400439|FG004|Overall Study|Non-compliance with protocol|1|||
131760979|NCT02723019|474400442|FG000|Overall Study|Death|17|||
131760980|NCT02723019|474400443|FG001|Overall Study|Death|13|||
131760981|NCT02723019|474400442|FG000|Overall Study|Withdrawal by Subject|11|||
131760982|NCT02723019|474400443|FG001|Overall Study|Withdrawal by Subject|7|||
131760983|NCT02723019|474400442|FG000|Overall Study|Lost to Follow-up|57|||
131760984|NCT02723019|474400443|FG001|Overall Study|Lost to Follow-up|70|||
131760985|NCT02750501|474400449|FG000|Overall Study|Adverse Event|4|||
131760986|NCT02750501|474400449|FG000|Overall Study|Physician Decision|1|||
131760987|NCT02750501|474400449|FG000|Overall Study|Protocol Violation|1|||
131812729|NCT02832063|474597641|FG001|Overall Study|Other|1|||
131812730|NCT03733730|474597642|FG000|Overall Study|Lost to Follow-up|1|||
131812731|NCT03733730|474597643|FG001|Overall Study|Lost to Follow-up|32|||
131812732|NCT03733730|474597642|FG000|Overall Study|Other|1|||
131812733|NCT03733730|474597643|FG001|Overall Study|Other|0|||
131812734|NCT03733730|474597642|FG000|Overall Study|Adverse Event|0|||
131812735|NCT03733730|474597643|FG001|Overall Study|Adverse Event|4|||
131812736|NCT03733730|474597642|FG000|Overall Study|Death|0|||
131812737|NCT03733730|474597643|FG001|Overall Study|Death|5|||
131812738|NCT03733730|474597642|FG000|Overall Study|Withdrawal by Subject|0|||
131812739|NCT03733730|474597643|FG001|Overall Study|Withdrawal by Subject|8|||
131812740|NCT01319383|474597644|FG000|Overall Study|No ex vivo or in vivo response|4|||
131812741|NCT01319383|474597645|FG001|Overall Study|No ex vivo or in vivo response|0|||
131812742|NCT01319383|474597644|FG000|Overall Study|Physician Decision|3|||
131812743|NCT01319383|474597645|FG001|Overall Study|Physician Decision|0|||
131908947|NCT03736967|474954684|FG002|Overall Study|Death|0|||
131760988|NCT02750501|474400449|FG000|Overall Study|G-tube came out|1|||
131908948|NCT03736967|474954685|FG003|Overall Study|Death|1|||
131760989|NCT02750501|474400449|FG000|Overall Study|Non-compliant use of PERT|1|||
131812744|NCT01319383|474597644|FG000|Overall Study|Lack of Efficacy|5|||
131812745|NCT01319383|474597645|FG001|Overall Study|Lack of Efficacy|9|||
131812746|NCT01319383|474597644|FG000|Overall Study|No in vivo response to interval doses|0|||
131812747|NCT01319383|474597645|FG001|Overall Study|No in vivo response to interval doses|1|||
131812748|NCT01987765|474597646|FG000|Overall Study|Protocol Violation|65|||
131908949|NCT03736967|474954682|FG000|Overall Study|Randomized but never treated|1|||
131760990|NCT00403390|474400450|FG000|Overall Study|Withdrawal by Subject|1|||
131760991|NCT00403390|474400451|FG001|Overall Study|Withdrawal by Subject|0|||
131760992|NCT00403390|474400450|FG000|Overall Study|samples lost|1|||
131760993|NCT00403390|474400451|FG001|Overall Study|samples lost|0|||
131908950|NCT03736967|474954683|FG001|Overall Study|Randomized but never treated|0|||
131760994|NCT00403390|474400450|FG000|Overall Study|non-compliant|1|||
131760995|NCT00403390|474400451|FG001|Overall Study|non-compliant|0|||
131760996|NCT00942422|474400452|FG000|Overall Study|Withdrawal by Subject|1|||
131760997|NCT00942422|474400452|FG000|Overall Study|Death|1|||
131760998|NCT00942422|474400452|FG000|Overall Study|Progressive diease|1|||
131760999|NCT02711553|474400455|FG000|Overall Study|Withdrawal by Subject|2|||
131761000|NCT02711553|474400456|FG001|Overall Study|Withdrawal by Subject|1|||
131761001|NCT02711553|474400457|FG002|Overall Study|Withdrawal by Subject|1|||
131761002|NCT02711553|474400458|FG003|Overall Study|Withdrawal by Subject|0|||
131761003|NCT02711553|474400455|FG000|Overall Study|Lost to Follow-up|3|||
131761004|NCT02711553|474400456|FG001|Overall Study|Lost to Follow-up|3|||
131761005|NCT02711553|474400457|FG002|Overall Study|Lost to Follow-up|6|||
131761006|NCT02711553|474400458|FG003|Overall Study|Lost to Follow-up|3|||
131761007|NCT02711553|474400455|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
131761008|NCT02711553|474400456|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
131761009|NCT02711553|474400457|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
131761010|NCT02711553|474400458|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
131761014|NCT05559203|474400460|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
131761015|NCT04048876|474400461|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
131761016|NCT04048876|474400462|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
131761017|NCT04048876|474400463|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
131761018|NCT04048876|474400464|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
131761019|NCT04048876|474400461|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
131761020|NCT04048876|474400462|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
131761021|NCT04048876|474400463|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
131761022|NCT04048876|474400464|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
131761023|NCT04048876|474400461|FG000|Placebo Controlled Phase|Adverse Event|0|||
131761024|NCT04048876|474400462|FG001|Placebo Controlled Phase|Adverse Event|1|||
131761025|NCT04048876|474400463|FG002|Placebo Controlled Phase|Adverse Event|0|||
131761026|NCT04048876|474400464|FG003|Placebo Controlled Phase|Adverse Event|0|||
131761027|NCT04048876|474400461|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
131761028|NCT04048876|474400462|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
131761029|NCT04048876|474400463|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
131761030|NCT04048876|474400464|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
131761031|NCT00572728|474400465|FG000|Overall Study|Withdrawal by Subject|10|||
131761032|NCT00572728|474400465|FG000|Overall Study|Ineligible|3|||
131761033|NCT00572728|474400465|FG000|Overall Study|Enrolled under Amendment 4|5|||
131761034|NCT00572728|474400465|FG000|Overall Study|Offstudy due to complicating disease|1|||
131761035|NCT00572728|474400465|FG000|Overall Study|FLT1 not completed|4|||
131761036|NCT00572728|474400465|FG000|Overall Study|First Chemotherapy not initiated|2|||
131761037|NCT00572728|474400465|FG000|Overall Study|FLT2 not completed|5|||
131761038|NCT00572728|474400465|FG000|Overall Study|Second chemotherapy not initiated|1|||
131761039|NCT00572728|474400465|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
131761040|NCT00572728|474400465|FG000|Overall Study|Pathology missing|1|||
131761041|NCT02187224|474400466|FG000|Overall Study|Did not show up for test day|1|||
131761042|NCT02187224|474400467|FG001|Overall Study|Did not show up for test day|0|||
131761043|NCT01347840|474400472|FG000|Overall Study|Withdrawal by Subject|1|||
131761044|NCT03858686|474400479|FG000|Period 1|Adverse Event|1|||
131761045|NCT03858686|474400480|FG001|Period 1|Adverse Event|1|||
131761046|NCT03858686|474400479|FG000|Period 1|Lack of compliance|0|||
131761047|NCT03858686|474400480|FG001|Period 1|Lack of compliance|1|||
131761048|NCT03858686|474400479|FG000|Period 1|Adverse Event|0|||
131761049|NCT03858686|474400480|FG001|Period 1|Adverse Event|1|||
131761050|NCT03858686|474400479|FG000|Period 2|Adverse Event|0|||
131761051|NCT03858686|474400480|FG001|Period 2|Adverse Event|1|||
131761052|NCT03231228|474400482|FG000|Overall Study|Lost to Follow-up|2|||
131761053|NCT03231228|474400483|FG001|Overall Study|Lost to Follow-up|0|||
131761054|NCT03231228|474400482|FG000|Overall Study|Physician Decision|1|||
131761055|NCT03231228|474400483|FG001|Overall Study|Physician Decision|0|||
131761056|NCT00374127|474400484|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
131761057|NCT00374127|474400484|FG000|Overall Study|Blood could not be drawn.|2|||
131761058|NCT00374127|474400484|FG000|Overall Study|Protocol Violation|5|||
131761059|NCT00374127|474400484|FG000|Overall Study|Pregnancy|1|||
131761060|NCT02299206|474400485|FG000|Overall Study|Lost to Follow-up|1|||
131908951|NCT03736967|474954684|FG002|Overall Study|Randomized but never treated|0|||
131908952|NCT03736967|474954685|FG003|Overall Study|Randomized but never treated|0|||
131908953|NCT01006629|474954686|FG000|Overall Study|Adverse Event|1|||
131761061|NCT02299206|474400485|FG000|Overall Study|Withdrawal by Subject|1|||
131761062|NCT02875366|474400486|FG000|Overall Study|Adverse Event|0|||
131761063|NCT02875366|474400487|FG001|Overall Study|Adverse Event|2|||
131761064|NCT02875366|474400486|FG000|Overall Study|Noncompliance|0|||
131761065|NCT02875366|474400487|FG001|Overall Study|Noncompliance|1|||
131761066|NCT01682759|474400491|FG000|Overall Study|Death|2|||
131908954|NCT01006629|474954686|FG000|Overall Study|Parent refused to continue participation|1|||
131761067|NCT01682759|474400492|FG001|Overall Study|Death|1|||
131761068|NCT01682759|474400491|FG000|Overall Study|Lost to Follow-up|10|||
131812749|NCT01987765|474597646|FG000|Overall Study|Lost to Follow-up|37|||
131761069|NCT01682759|474400492|FG001|Overall Study|Lost to Follow-up|13|||
131761070|NCT01682759|474400491|FG000|Overall Study|Physician Decision|1|||
131761071|NCT01682759|474400492|FG001|Overall Study|Physician Decision|1|||
131761072|NCT01682759|474400491|FG000|Overall Study|Withdrawal by Subject|56|||
131761073|NCT01682759|474400492|FG001|Overall Study|Withdrawal by Subject|55|||
131761074|NCT01201967|474400495|FG000|Overall Study|Lost to Follow-up|6|||
131761075|NCT01201967|474400496|FG001|Overall Study|Lost to Follow-up|5|||
131761076|NCT01693562|474402365|FG000|Escalation Phase|Withdrawal by Subject|0|||
131761077|NCT01693562|474402366|FG001|Escalation Phase|Withdrawal by Subject|1|||
131761078|NCT01693562|474402367|FG002|Escalation Phase|Withdrawal by Subject|0|||
131761079|NCT01693562|474402368|FG003|Escalation Phase|Withdrawal by Subject|0|||
131761080|NCT01693562|474402369|FG004|Escalation Phase|Withdrawal by Subject|0|||
131761081|NCT01693562|474402370|FG005|Escalation Phase|Withdrawal by Subject|2|||
131761082|NCT01693562|474402371|FG006|Escalation Phase|Withdrawal by Subject|0|||
131761083|NCT01693562|474402372|FG007|Escalation Phase|Withdrawal by Subject|0|||
131761084|NCT01693562|474402373|FG008|Escalation Phase|Withdrawal by Subject|0|||
131761085|NCT01693562|474402374|FG009|Escalation Phase|Withdrawal by Subject|0|||
131761086|NCT01693562|474402375|FG010|Escalation Phase|Withdrawal by Subject|0|||
131761087|NCT01693562|474402376|FG011|Escalation Phase|Withdrawal by Subject|0|||
131761088|NCT01693562|474402377|FG012|Escalation Phase|Withdrawal by Subject|0|||
131761089|NCT01693562|474402378|FG013|Escalation Phase|Withdrawal by Subject|0|||
131761090|NCT01693562|474402379|FG014|Escalation Phase|Withdrawal by Subject|0|||
131761091|NCT01693562|474402380|FG015|Escalation Phase|Withdrawal by Subject|0|||
131761092|NCT01693562|474402381|FG016|Escalation Phase|Withdrawal by Subject|0|||
131761093|NCT01693562|474402382|FG017|Escalation Phase|Withdrawal by Subject|0|||
131761094|NCT01693562|474402383|FG018|Escalation Phase|Withdrawal by Subject|0|||
131761095|NCT01693562|474402384|FG019|Escalation Phase|Withdrawal by Subject|0|||
131761096|NCT01693562|474402385|FG020|Escalation Phase|Withdrawal by Subject|0|||
131761097|NCT01693562|474402386|FG021|Escalation Phase|Withdrawal by Subject|0|||
131761098|NCT01693562|474402387|FG022|Escalation Phase|Withdrawal by Subject|0|||
131761099|NCT01693562|474402365|FG000|Escalation Phase|Death|4|||
131761100|NCT01693562|474402366|FG001|Escalation Phase|Death|2|||
131761101|NCT01693562|474402367|FG002|Escalation Phase|Death|0|||
131761102|NCT01693562|474402368|FG003|Escalation Phase|Death|3|||
131761103|NCT01693562|474402369|FG004|Escalation Phase|Death|6|||
131812750|NCT01528696|474597655|FG000|Overall Study|See detailed description|18|||
131812751|NCT01528696|474597656|FG001|Overall Study|See detailed description|19|||
131812752|NCT03600805|474597657|FG000|Overall Study|Adverse Event|2|||
131812753|NCT03600805|474597658|FG001|Overall Study|Adverse Event|1|||
131812754|NCT03600805|474597659|FG002|Overall Study|Adverse Event|1|||
131812755|NCT03600805|474597660|FG003|Overall Study|Adverse Event|7|||
131812756|NCT03600805|474597657|FG000|Overall Study|Lack of Efficacy|2|||
131812757|NCT03600805|474597658|FG001|Overall Study|Lack of Efficacy|1|||
131812758|NCT03600805|474597659|FG002|Overall Study|Lack of Efficacy|0|||
131812759|NCT03600805|474597660|FG003|Overall Study|Lack of Efficacy|0|||
131812760|NCT03600805|474597657|FG000|Overall Study|Withdrawal by Subject|1|||
131812761|NCT03600805|474597658|FG001|Overall Study|Withdrawal by Subject|0|||
131812762|NCT03600805|474597659|FG002|Overall Study|Withdrawal by Subject|0|||
131812763|NCT03600805|474597660|FG003|Overall Study|Withdrawal by Subject|1|||
131812764|NCT03600805|474597657|FG000|Overall Study|Other unspecified|14|||
131812765|NCT03600805|474597658|FG001|Overall Study|Other unspecified|6|||
131812766|NCT03600805|474597659|FG002|Overall Study|Other unspecified|7|||
131812767|NCT03600805|474597660|FG003|Overall Study|Other unspecified|11|||
131812768|NCT00835575|474597661|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
131812769|NCT00835575|474597662|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
131812770|NCT01440803|474597663|FG000|Overall Study|Met study stopping rule|2|||
131812771|NCT01440803|474597664|FG001|Overall Study|Met study stopping rule|1|||
131812772|NCT01440803|474597663|FG000|Overall Study|Lost to Follow-up|0|||
131812773|NCT01440803|474597664|FG001|Overall Study|Lost to Follow-up|2|||
131761104|NCT01693562|474402370|FG005|Escalation Phase|Death|4|||
131908955|NCT01006629|474954686|FG000|Overall Study|Parent unable to perform site visit|4|||
131761105|NCT01693562|474402371|FG006|Escalation Phase|Death|0|||
131761106|NCT01693562|474402372|FG007|Escalation Phase|Death|0|||
131812774|NCT01440803|474597663|FG000|Overall Study|Withdrawal by Subject|0|||
131812775|NCT01440803|474597664|FG001|Overall Study|Withdrawal by Subject|1|||
131812776|NCT01609257|474597665|FG000|Overall Study|Lost to Follow-up|2|||
131812777|NCT01609257|474597666|FG001|Overall Study|Lost to Follow-up|1|||
131908956|NCT02932943|474954687|FG000|Overall Study|Lost to Follow-up|0|||
131761107|NCT01693562|474402373|FG008|Escalation Phase|Death|0|||
131761108|NCT01693562|474402374|FG009|Escalation Phase|Death|0|||
131761109|NCT01693562|474402375|FG010|Escalation Phase|Death|0|||
131761110|NCT01693562|474402376|FG011|Escalation Phase|Death|0|||
131812778|NCT01609257|474597665|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
131812779|NCT01609257|474597666|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
131761111|NCT01693562|474402377|FG012|Escalation Phase|Death|0|||
131761112|NCT01693562|474402378|FG013|Escalation Phase|Death|0|||
131761113|NCT01693562|474402379|FG014|Escalation Phase|Death|0|||
131812780|NCT01609257|474597665|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
131761114|NCT01693562|474402380|FG015|Escalation Phase|Death|0|||
131761115|NCT01693562|474402381|FG016|Escalation Phase|Death|0|||
131761116|NCT01693562|474402382|FG017|Escalation Phase|Death|0|||
131761117|NCT01693562|474402383|FG018|Escalation Phase|Death|0|||
131761118|NCT01693562|474402384|FG019|Escalation Phase|Death|0|||
131761119|NCT01693562|474402385|FG020|Escalation Phase|Death|0|||
131761120|NCT01693562|474402386|FG021|Escalation Phase|Death|0|||
131761121|NCT01693562|474402387|FG022|Escalation Phase|Death|0|||
131761122|NCT01693562|474402365|FG000|Escalation Phase|Lost to Follow-up|0|||
131761123|NCT01693562|474402366|FG001|Escalation Phase|Lost to Follow-up|1|||
131761124|NCT01693562|474402367|FG002|Escalation Phase|Lost to Follow-up|1|||
131761125|NCT01693562|474402368|FG003|Escalation Phase|Lost to Follow-up|0|||
131761126|NCT01693562|474402369|FG004|Escalation Phase|Lost to Follow-up|0|||
131761127|NCT01693562|474402370|FG005|Escalation Phase|Lost to Follow-up|0|||
131761128|NCT01693562|474402371|FG006|Escalation Phase|Lost to Follow-up|0|||
131761129|NCT01693562|474402372|FG007|Escalation Phase|Lost to Follow-up|0|||
131761130|NCT01693562|474402373|FG008|Escalation Phase|Lost to Follow-up|0|||
131761131|NCT01693562|474402374|FG009|Escalation Phase|Lost to Follow-up|0|||
131761132|NCT01693562|474402375|FG010|Escalation Phase|Lost to Follow-up|0|||
131761133|NCT01693562|474402376|FG011|Escalation Phase|Lost to Follow-up|0|||
131761134|NCT01693562|474402377|FG012|Escalation Phase|Lost to Follow-up|0|||
131761135|NCT01693562|474402378|FG013|Escalation Phase|Lost to Follow-up|0|||
131761136|NCT01693562|474402379|FG014|Escalation Phase|Lost to Follow-up|0|||
131761137|NCT01693562|474402380|FG015|Escalation Phase|Lost to Follow-up|0|||
131761138|NCT01693562|474402381|FG016|Escalation Phase|Lost to Follow-up|0|||
131761139|NCT01693562|474402382|FG017|Escalation Phase|Lost to Follow-up|0|||
131761140|NCT01693562|474402383|FG018|Escalation Phase|Lost to Follow-up|0|||
131761141|NCT01693562|474402384|FG019|Escalation Phase|Lost to Follow-up|0|||
131761142|NCT01693562|474402385|FG020|Escalation Phase|Lost to Follow-up|0|||
131761143|NCT01693562|474402386|FG021|Escalation Phase|Lost to Follow-up|0|||
131761144|NCT01693562|474402387|FG022|Escalation Phase|Lost to Follow-up|0|||
131761145|NCT01693562|474402365|FG000|Escalation Phase|Other|0|||
131761146|NCT01693562|474402366|FG001|Escalation Phase|Other|0|||
131761147|NCT01693562|474402367|FG002|Escalation Phase|Other|2|||
131761148|NCT01693562|474402368|FG003|Escalation Phase|Other|0|||
131761149|NCT01693562|474402369|FG004|Escalation Phase|Other|0|||
131761150|NCT01693562|474402370|FG005|Escalation Phase|Other|1|||
131761151|NCT01693562|474402371|FG006|Escalation Phase|Other|0|||
131761152|NCT01693562|474402372|FG007|Escalation Phase|Other|0|||
131761153|NCT01693562|474402373|FG008|Escalation Phase|Other|0|||
131761154|NCT01693562|474402374|FG009|Escalation Phase|Other|0|||
131761155|NCT01693562|474402375|FG010|Escalation Phase|Other|0|||
131761156|NCT01693562|474402376|FG011|Escalation Phase|Other|0|||
131761157|NCT01693562|474402377|FG012|Escalation Phase|Other|0|||
131761158|NCT01693562|474402378|FG013|Escalation Phase|Other|0|||
131761159|NCT01693562|474402379|FG014|Escalation Phase|Other|0|||
131761160|NCT01693562|474402380|FG015|Escalation Phase|Other|0|||
131761161|NCT01693562|474402381|FG016|Escalation Phase|Other|0|||
131761162|NCT01693562|474402382|FG017|Escalation Phase|Other|0|||
131761163|NCT01693562|474402383|FG018|Escalation Phase|Other|0|||
131761164|NCT01693562|474402384|FG019|Escalation Phase|Other|0|||
131761165|NCT01693562|474402385|FG020|Escalation Phase|Other|0|||
131761166|NCT01693562|474402386|FG021|Escalation Phase|Other|0|||
131761167|NCT01693562|474402387|FG022|Escalation Phase|Other|0|||
131761168|NCT01693562|474402365|FG000|Exploration Phase|Withdrawal by Subject|0|||
131761169|NCT01693562|474402366|FG001|Exploration Phase|Withdrawal by Subject|0|||
131761170|NCT01693562|474402367|FG002|Exploration Phase|Withdrawal by Subject|0|||
131761171|NCT01693562|474402368|FG003|Exploration Phase|Withdrawal by Subject|0|||
131761172|NCT01693562|474402369|FG004|Exploration Phase|Withdrawal by Subject|0|||
131761173|NCT01693562|474402370|FG005|Exploration Phase|Withdrawal by Subject|0|||
131761174|NCT01693562|474402371|FG006|Exploration Phase|Withdrawal by Subject|2|||
131761175|NCT01693562|474402372|FG007|Exploration Phase|Withdrawal by Subject|0|||
131761176|NCT01693562|474402373|FG008|Exploration Phase|Withdrawal by Subject|0|||
131761177|NCT01693562|474402374|FG009|Exploration Phase|Withdrawal by Subject|0|||
131761178|NCT01693562|474402375|FG010|Exploration Phase|Withdrawal by Subject|0|||
131761179|NCT01693562|474402376|FG011|Exploration Phase|Withdrawal by Subject|0|||
131761180|NCT01693562|474402377|FG012|Exploration Phase|Withdrawal by Subject|0|||
131761181|NCT01693562|474402378|FG013|Exploration Phase|Withdrawal by Subject|0|||
131761182|NCT01693562|474402379|FG014|Exploration Phase|Withdrawal by Subject|0|||
131761183|NCT01693562|474402380|FG015|Exploration Phase|Withdrawal by Subject|0|||
131761184|NCT01693562|474402381|FG016|Exploration Phase|Withdrawal by Subject|0|||
131761185|NCT01693562|474402382|FG017|Exploration Phase|Withdrawal by Subject|0|||
131761186|NCT01693562|474402383|FG018|Exploration Phase|Withdrawal by Subject|0|||
131908957|NCT02932943|474954688|FG001|Overall Study|Lost to Follow-up|2|||
131761187|NCT01693562|474402384|FG019|Exploration Phase|Withdrawal by Subject|0|||
131761188|NCT01693562|474402385|FG020|Exploration Phase|Withdrawal by Subject|0|||
131761189|NCT01693562|474402386|FG021|Exploration Phase|Withdrawal by Subject|0|||
131761190|NCT01693562|474402387|FG022|Exploration Phase|Withdrawal by Subject|0|||
131761191|NCT01693562|474402365|FG000|Exploration Phase|Death|0|||
131761192|NCT01693562|474402366|FG001|Exploration Phase|Death|0|||
131761193|NCT01693562|474402367|FG002|Exploration Phase|Death|0|||
131761194|NCT01693562|474402368|FG003|Exploration Phase|Death|0|||
131761195|NCT01693562|474402369|FG004|Exploration Phase|Death|0|||
131761196|NCT01693562|474402370|FG005|Exploration Phase|Death|0|||
131761197|NCT01693562|474402371|FG006|Exploration Phase|Death|17|||
131761198|NCT01693562|474402372|FG007|Exploration Phase|Death|0|||
131761199|NCT01693562|474402373|FG008|Exploration Phase|Death|0|||
131761200|NCT01693562|474402374|FG009|Exploration Phase|Death|0|||
131761201|NCT01693562|474402375|FG010|Exploration Phase|Death|0|||
131761202|NCT01693562|474402376|FG011|Exploration Phase|Death|0|||
131761203|NCT01693562|474402377|FG012|Exploration Phase|Death|0|||
131761204|NCT01693562|474402378|FG013|Exploration Phase|Death|0|||
131761205|NCT01693562|474402379|FG014|Exploration Phase|Death|0|||
131761206|NCT01693562|474402380|FG015|Exploration Phase|Death|0|||
131761207|NCT01693562|474402381|FG016|Exploration Phase|Death|0|||
131761208|NCT01693562|474402382|FG017|Exploration Phase|Death|0|||
131761209|NCT01693562|474402383|FG018|Exploration Phase|Death|0|||
131761210|NCT01693562|474402384|FG019|Exploration Phase|Death|0|||
131761211|NCT01693562|474402385|FG020|Exploration Phase|Death|0|||
131761212|NCT01693562|474402386|FG021|Exploration Phase|Death|0|||
131761213|NCT01693562|474402387|FG022|Exploration Phase|Death|0|||
131761214|NCT01693562|474402365|FG000|Exploration Phase|Other|0|||
131761215|NCT01693562|474402366|FG001|Exploration Phase|Other|0|||
131761216|NCT01693562|474402367|FG002|Exploration Phase|Other|0|||
131761217|NCT01693562|474402368|FG003|Exploration Phase|Other|0|||
131761218|NCT01693562|474402369|FG004|Exploration Phase|Other|0|||
131761219|NCT01693562|474402370|FG005|Exploration Phase|Other|0|||
131761220|NCT01693562|474402371|FG006|Exploration Phase|Other|2|||
131761221|NCT01693562|474402372|FG007|Exploration Phase|Other|0|||
131761222|NCT01693562|474402373|FG008|Exploration Phase|Other|0|||
131761223|NCT01693562|474402374|FG009|Exploration Phase|Other|0|||
131761224|NCT01693562|474402375|FG010|Exploration Phase|Other|0|||
131761225|NCT01693562|474402376|FG011|Exploration Phase|Other|0|||
131761226|NCT01693562|474402377|FG012|Exploration Phase|Other|0|||
131761227|NCT01693562|474402378|FG013|Exploration Phase|Other|0|||
131761228|NCT01693562|474402379|FG014|Exploration Phase|Other|0|||
131761229|NCT01693562|474402380|FG015|Exploration Phase|Other|0|||
131761230|NCT01693562|474402381|FG016|Exploration Phase|Other|0|||
131761231|NCT01693562|474402382|FG017|Exploration Phase|Other|0|||
131761232|NCT01693562|474402383|FG018|Exploration Phase|Other|0|||
131761233|NCT01693562|474402384|FG019|Exploration Phase|Other|0|||
131761234|NCT01693562|474402385|FG020|Exploration Phase|Other|0|||
131761235|NCT01693562|474402386|FG021|Exploration Phase|Other|0|||
131761236|NCT01693562|474402387|FG022|Exploration Phase|Other|0|||
131761237|NCT01693562|474402365|FG000|Expansion Phase|Withdrawal by Subject|0|||
131761238|NCT01693562|474402366|FG001|Expansion Phase|Withdrawal by Subject|0|||
131761239|NCT01693562|474402367|FG002|Expansion Phase|Withdrawal by Subject|0|||
131761240|NCT01693562|474402368|FG003|Expansion Phase|Withdrawal by Subject|0|||
131761241|NCT01693562|474402369|FG004|Expansion Phase|Withdrawal by Subject|0|||
131761242|NCT01693562|474402370|FG005|Expansion Phase|Withdrawal by Subject|0|||
131761243|NCT01693562|474402371|FG006|Expansion Phase|Withdrawal by Subject|0|||
131761244|NCT01693562|474402372|FG007|Expansion Phase|Withdrawal by Subject|16|||
131812781|NCT01609257|474597666|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
131812782|NCT02125461|474597667|FG000|Overall Study|Withdrawal by Subject|30|||
131812783|NCT02125461|474597668|FG001|Overall Study|Withdrawal by Subject|16|||
131812784|NCT02125461|474597667|FG000|Overall Study|Lost to Follow-up|8|||
131812785|NCT02125461|474597668|FG001|Overall Study|Lost to Follow-up|3|||
131812786|NCT02125461|474597667|FG000|Overall Study|Death|260|||
131812787|NCT02125461|474597668|FG001|Overall Study|Death|149|||
131812788|NCT02125461|474597667|FG000|Overall Study|Missing Termination Reason|0|||
131812789|NCT02125461|474597668|FG001|Overall Study|Missing Termination Reason|1|||
131761245|NCT01693562|474402373|FG008|Expansion Phase|Withdrawal by Subject|2|||
131761246|NCT01693562|474402374|FG009|Expansion Phase|Withdrawal by Subject|54|||
131761247|NCT01693562|474402375|FG010|Expansion Phase|Withdrawal by Subject|2|||
131908958|NCT02932943|474954687|FG000|Overall Study|Adverse Event|2|||
131908959|NCT02932943|474954688|FG001|Overall Study|Adverse Event|2|||
131761248|NCT01693562|474402376|FG011|Expansion Phase|Withdrawal by Subject|2|||
131761249|NCT01693562|474402377|FG012|Expansion Phase|Withdrawal by Subject|3|||
131761250|NCT01693562|474402378|FG013|Expansion Phase|Withdrawal by Subject|5|||
131761251|NCT01693562|474402379|FG014|Expansion Phase|Withdrawal by Subject|16|||
131761252|NCT01693562|474402380|FG015|Expansion Phase|Withdrawal by Subject|7|||
131812790|NCT01244620|474597671|FG000|Overall Study|Study terminated|4|||
131761253|NCT01693562|474402381|FG016|Expansion Phase|Withdrawal by Subject|40|||
131761254|NCT01693562|474402382|FG017|Expansion Phase|Withdrawal by Subject|4|||
131761255|NCT01693562|474402383|FG018|Expansion Phase|Withdrawal by Subject|8|||
131761256|NCT01693562|474402384|FG019|Expansion Phase|Withdrawal by Subject|3|||
131761257|NCT01693562|474402385|FG020|Expansion Phase|Withdrawal by Subject|1|||
131761258|NCT01693562|474402386|FG021|Expansion Phase|Withdrawal by Subject|8|||
131761259|NCT01693562|474402387|FG022|Expansion Phase|Withdrawal by Subject|1|||
131761260|NCT01693562|474402365|FG000|Expansion Phase|Death|0|||
131761261|NCT01693562|474402366|FG001|Expansion Phase|Death|0|||
131761262|NCT01693562|474402367|FG002|Expansion Phase|Death|0|||
131812791|NCT01244620|474597672|FG001|Overall Study|Study terminated|4|||
131761263|NCT01693562|474402368|FG003|Expansion Phase|Death|0|||
131761264|NCT01693562|474402369|FG004|Expansion Phase|Death|0|||
131761265|NCT01693562|474402370|FG005|Expansion Phase|Death|0|||
131761266|NCT01693562|474402371|FG006|Expansion Phase|Death|0|||
131761267|NCT01693562|474402372|FG007|Expansion Phase|Death|42|||
131761268|NCT01693562|474402373|FG008|Expansion Phase|Death|17|||
131761269|NCT01693562|474402374|FG009|Expansion Phase|Death|208|||
131761270|NCT01693562|474402375|FG010|Expansion Phase|Death|30|||
131761271|NCT01693562|474402376|FG011|Expansion Phase|Death|8|||
131761272|NCT01693562|474402377|FG012|Expansion Phase|Death|19|||
131761273|NCT01693562|474402378|FG013|Expansion Phase|Death|42|||
131761274|NCT01693562|474402379|FG014|Expansion Phase|Death|23|||
131761275|NCT01693562|474402380|FG015|Expansion Phase|Death|23|||
131761276|NCT01693562|474402381|FG016|Expansion Phase|Death|128|||
131761277|NCT01693562|474402382|FG017|Expansion Phase|Death|16|||
131761278|NCT01693562|474402383|FG018|Expansion Phase|Death|36|||
131761279|NCT01693562|474402384|FG019|Expansion Phase|Death|16|||
131761280|NCT01693562|474402385|FG020|Expansion Phase|Death|17|||
131761281|NCT01693562|474402386|FG021|Expansion Phase|Death|35|||
131761282|NCT01693562|474402387|FG022|Expansion Phase|Death|7|||
131761283|NCT01693562|474402365|FG000|Expansion Phase|Lost to Follow-up|0|||
131761284|NCT01693562|474402366|FG001|Expansion Phase|Lost to Follow-up|0|||
131761285|NCT01693562|474402367|FG002|Expansion Phase|Lost to Follow-up|0|||
131761286|NCT01693562|474402368|FG003|Expansion Phase|Lost to Follow-up|0|||
131761287|NCT01693562|474402369|FG004|Expansion Phase|Lost to Follow-up|0|||
131761288|NCT01693562|474402370|FG005|Expansion Phase|Lost to Follow-up|0|||
131761289|NCT01693562|474402371|FG006|Expansion Phase|Lost to Follow-up|0|||
131761290|NCT01693562|474402372|FG007|Expansion Phase|Lost to Follow-up|1|||
131761291|NCT01693562|474402373|FG008|Expansion Phase|Lost to Follow-up|2|||
131761292|NCT01693562|474402374|FG009|Expansion Phase|Lost to Follow-up|10|||
131761293|NCT01693562|474402375|FG010|Expansion Phase|Lost to Follow-up|4|||
131761294|NCT01693562|474402376|FG011|Expansion Phase|Lost to Follow-up|4|||
131761295|NCT01693562|474402377|FG012|Expansion Phase|Lost to Follow-up|1|||
131761296|NCT01693562|474402378|FG013|Expansion Phase|Lost to Follow-up|3|||
131761297|NCT01693562|474402379|FG014|Expansion Phase|Lost to Follow-up|0|||
131761298|NCT01693562|474402380|FG015|Expansion Phase|Lost to Follow-up|1|||
131761299|NCT01693562|474402381|FG016|Expansion Phase|Lost to Follow-up|1|||
131761300|NCT01693562|474402382|FG017|Expansion Phase|Lost to Follow-up|0|||
131761301|NCT01693562|474402383|FG018|Expansion Phase|Lost to Follow-up|2|||
131761302|NCT01693562|474402384|FG019|Expansion Phase|Lost to Follow-up|1|||
131761303|NCT01693562|474402385|FG020|Expansion Phase|Lost to Follow-up|2|||
131761304|NCT01693562|474402386|FG021|Expansion Phase|Lost to Follow-up|2|||
131761305|NCT01693562|474402387|FG022|Expansion Phase|Lost to Follow-up|1|||
131761306|NCT01693562|474402365|FG000|Expansion Phase|Other|0|||
131761307|NCT01693562|474402366|FG001|Expansion Phase|Other|0|||
131761308|NCT01693562|474402367|FG002|Expansion Phase|Other|0|||
131761309|NCT01693562|474402368|FG003|Expansion Phase|Other|0|||
131761310|NCT01693562|474402369|FG004|Expansion Phase|Other|0|||
131761311|NCT01693562|474402370|FG005|Expansion Phase|Other|0|||
131761312|NCT01693562|474402371|FG006|Expansion Phase|Other|0|||
131761313|NCT01693562|474402372|FG007|Expansion Phase|Other|3|||
131761314|NCT01693562|474402373|FG008|Expansion Phase|Other|1|||
131761315|NCT01693562|474402374|FG009|Expansion Phase|Other|28|||
131761316|NCT01693562|474402375|FG010|Expansion Phase|Other|4|||
131761317|NCT01693562|474402376|FG011|Expansion Phase|Other|7|||
131761318|NCT01693562|474402377|FG012|Expansion Phase|Other|0|||
131761319|NCT01693562|474402378|FG013|Expansion Phase|Other|1|||
131761320|NCT01693562|474402379|FG014|Expansion Phase|Other|1|||
131761321|NCT01693562|474402380|FG015|Expansion Phase|Other|0|||
131761322|NCT01693562|474402381|FG016|Expansion Phase|Other|28|||
131812792|NCT01244620|474597673|FG002|Overall Study|Study terminated|4|||
131812793|NCT01244620|474597674|FG003|Overall Study|Study terminated|4|||
131812794|NCT01663233|474597676|FG000|Overall Study|Withdrawal by Subject|3|||
131812795|NCT01663233|474597677|FG001|Overall Study|Withdrawal by Subject|2|||
131761323|NCT01693562|474402382|FG017|Expansion Phase|Other|0|||
131761324|NCT01693562|474402383|FG018|Expansion Phase|Other|1|||
131761325|NCT01693562|474402384|FG019|Expansion Phase|Other|0|||
131761326|NCT01693562|474402385|FG020|Expansion Phase|Other|1|||
131761327|NCT01693562|474402386|FG021|Expansion Phase|Other|17|||
131761328|NCT01693562|474402387|FG022|Expansion Phase|Other|1|||
131761329|NCT00186121|474402392|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
131761330|NCT00186121|474402392|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
131761331|NCT00186121|474402392|FG000|Overall Study|Not eligible (no treatment)|1|||
131812796|NCT01663233|474597676|FG000|Overall Study|Protocol Deviation|1|||
131761332|NCT00887822|474402393|FG000|Overall Study|Insufficient therapeutic response|53|||
131812797|NCT01663233|474597677|FG001|Overall Study|Protocol Deviation|4|||
131761333|NCT00887822|474402394|FG001|Overall Study|Insufficient therapeutic response|55|||
131761334|NCT00887822|474402393|FG000|Overall Study|Adverse Event|14|||
131761335|NCT00887822|474402394|FG001|Overall Study|Adverse Event|17|||
131761336|NCT00887822|474402393|FG000|Overall Study|Failure to return|11|||
131761337|NCT00887822|474402394|FG001|Overall Study|Failure to return|11|||
131761338|NCT00887822|474402393|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
131761339|NCT00887822|474402394|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
131761340|NCT00887822|474402393|FG000|Overall Study|Administrative/Other than specified|5|||
131761341|NCT00887822|474402394|FG001|Overall Study|Administrative/Other than specified|4|||
131761342|NCT00887822|474402393|FG000|Overall Study|Death|2|||
131761343|NCT00887822|474402394|FG001|Overall Study|Death|3|||
131761344|NCT00887822|474402393|FG000|Overall Study|Protocol Violation|0|||
131761345|NCT00887822|474402394|FG001|Overall Study|Protocol Violation|1|||
131761346|NCT00887822|474402393|FG000|Overall Study|Randomized but not treated|0|||
131761347|NCT00887822|474402394|FG001|Overall Study|Randomized but not treated|1|||
131761348|NCT05815758|474402395|FG000|Overall Study|Adverse Event|6|||
131761349|NCT05815758|474402396|FG001|Overall Study|Adverse Event|2|||
131761350|NCT05815758|474402395|FG000|Overall Study|Lost to Follow-up|14|||
131761351|NCT05815758|474402396|FG001|Overall Study|Lost to Follow-up|1|||
131761352|NCT05815758|474402395|FG000|Overall Study|Withdrawal by Subject|6|||
131761353|NCT05815758|474402396|FG001|Overall Study|Withdrawal by Subject|6|||
131761354|NCT05815758|474402395|FG000|Overall Study|Protocol Violation|1|||
131761355|NCT05815758|474402396|FG001|Overall Study|Protocol Violation|1|||
131761356|NCT05815758|474402395|FG000|Overall Study|Discontinued|4|||
131761357|NCT05815758|474402396|FG001|Overall Study|Discontinued|4|||
131761358|NCT03661983|474402397|FG000|Open Label Stabilization Phase|Adverse Event|5|||
131761359|NCT03661983|474402398|FG001|Open Label Stabilization Phase|Adverse Event|0|||
131761360|NCT03661983|474402399|FG002|Open Label Stabilization Phase|Adverse Event|0|||
131761361|NCT03661983|474402400|FG003|Open Label Stabilization Phase|Adverse Event|0|||
131761362|NCT03661983|474402397|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
131761363|NCT03661983|474402398|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
131761364|NCT03661983|474402399|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
131761365|NCT03661983|474402400|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
131761366|NCT03661983|474402397|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
131761367|NCT03661983|474402398|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
131761368|NCT03661983|474402399|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
131761369|NCT03661983|474402400|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
131761370|NCT03661983|474402397|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
131761371|NCT03661983|474402398|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
131761372|NCT03661983|474402399|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
131761373|NCT03661983|474402400|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
131761374|NCT03661983|474402397|FG000|Double-blind Randomized Phase|Adverse Event|0|||
131761375|NCT03661983|474402398|FG001|Double-blind Randomized Phase|Adverse Event|1|||
131761376|NCT03661983|474402399|FG002|Double-blind Randomized Phase|Adverse Event|0|||
131761377|NCT03661983|474402400|FG003|Double-blind Randomized Phase|Adverse Event|0|||
131761378|NCT03661983|474402397|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
131761379|NCT03661983|474402398|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
131761380|NCT03661983|474402399|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
131761381|NCT03661983|474402400|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
131761382|NCT03661983|474402397|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
131761383|NCT03661983|474402398|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
131761384|NCT03661983|474402399|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
131761385|NCT03661983|474402400|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
131761386|NCT03661983|474402397|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
131761387|NCT03661983|474402398|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
131761388|NCT03661983|474402399|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
131761389|NCT03661983|474402400|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
131761390|NCT02045979|474402401|FG000|Overall Study|Informed Consent Withdrawn|2|||
131761391|NCT02045979|474402402|FG001|Overall Study|Informed Consent Withdrawn|0|||
131761392|NCT02045979|474402403|FG002|Overall Study|Informed Consent Withdrawn|1|||
131761393|NCT02045979|474402401|FG000|Overall Study|not specified above|0|||
131761394|NCT02045979|474402402|FG001|Overall Study|not specified above|1|||
131812798|NCT01663233|474597676|FG000|Overall Study|Lost to Follow-up|0|||
131812799|NCT01663233|474597677|FG001|Overall Study|Lost to Follow-up|1|||
131812800|NCT02321098|474597678|FG000|12 Weeks Treament|Lost to Follow-up|1|||
131812801|NCT02321098|474597679|FG001|12 Weeks Treament|Lost to Follow-up|1|||
131812802|NCT02321098|474597680|FG002|12 Weeks Treament|Lost to Follow-up|0|||
131812803|NCT02321098|474597678|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
131812804|NCT02321098|474597679|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
131812805|NCT02321098|474597680|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
131812806|NCT02321098|474597678|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
131812807|NCT02321098|474597679|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
131761395|NCT02045979|474402403|FG002|Overall Study|not specified above|0|||
131761396|NCT02145429|474402405|FG000|Overall Study|Death|4|||
131761397|NCT02145429|474402406|FG001|Overall Study|Death|5|||
131761398|NCT02145429|474402405|FG000|Overall Study|Lost to Follow-up|4|||
131761399|NCT02145429|474402406|FG001|Overall Study|Lost to Follow-up|3|||
131812808|NCT02321098|474597680|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
131812809|NCT02321098|474597678|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
131761400|NCT02145429|474402405|FG000|Overall Study|Withdrawal by Subject|8|||
131761401|NCT02145429|474402406|FG001|Overall Study|Withdrawal by Subject|3|||
131761402|NCT02094612|474402407|FG000|Overall Study|Lost to Follow-up|47|||
131761403|NCT02094612|474402408|FG001|Overall Study|Lost to Follow-up|47|||
131761404|NCT02094612|474402407|FG000|Overall Study|Never started ADHD medication|32|||
131761405|NCT02094612|474402408|FG001|Overall Study|Never started ADHD medication|23|||
131761406|NCT04167514|474402409|FG000|Overall Study|Adverse event, not serious|0|||
131761407|NCT04167514|474402410|FG001|Overall Study|Adverse event, not serious|1|||
131761408|NCT04167514|474402409|FG000|Overall Study|Lost to Follow-up|1|||
131761409|NCT04167514|474402410|FG001|Overall Study|Lost to Follow-up|0|||
131761410|NCT04167514|474402409|FG000|Overall Study|Participant Decision|2|||
131761411|NCT04167514|474402410|FG001|Overall Study|Participant Decision|4|||
131761412|NCT04167514|474402409|FG000|Overall Study|Physician Decision|3|||
131761413|NCT04167514|474402410|FG001|Overall Study|Physician Decision|2|||
131761414|NCT04167514|474402409|FG000|Overall Study|Death|14|||
131761415|NCT04167514|474402410|FG001|Overall Study|Death|18|||
131761416|NCT04167514|474402409|FG000|Overall Study|Enrolled but treatment not administered|2|||
131761417|NCT04167514|474402410|FG001|Overall Study|Enrolled but treatment not administered|0|||
131761418|NCT04167514|474402409|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
131761419|NCT04167514|474402410|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
131761420|NCT04167514|474402409|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
131761421|NCT04167514|474402410|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
131761422|NCT03261037|474402411|FG000|Overall Study|Withdrawal by Subject|2|||
131761423|NCT03261037|474402412|FG001|Overall Study|Withdrawal by Subject|13|||
131761424|NCT03261037|474402413|FG002|Overall Study|Withdrawal by Subject|0|||
131761425|NCT03261037|474402414|FG003|Overall Study|Withdrawal by Subject|18|||
131761426|NCT03261037|474402411|FG000|Overall Study|Non-compliance with study procedures|0|||
131761427|NCT03261037|474402412|FG001|Overall Study|Non-compliance with study procedures|2|||
131761428|NCT03261037|474402413|FG002|Overall Study|Non-compliance with study procedures|0|||
131761429|NCT03261037|474402414|FG003|Overall Study|Non-compliance with study procedures|6|||
131761430|NCT03261037|474402411|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
131761431|NCT03261037|474402412|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
131761432|NCT03261037|474402413|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
131761433|NCT03261037|474402414|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
131761434|NCT03261037|474402411|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
131761435|NCT03261037|474402412|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
131761436|NCT03261037|474402413|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
131761437|NCT03261037|474402414|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
131761438|NCT03261037|474402411|FG000|Overall Study|Diagnosed but protocol deviation|1|||
131761439|NCT03261037|474402412|FG001|Overall Study|Diagnosed but protocol deviation|0|||
131761440|NCT03261037|474402413|FG002|Overall Study|Diagnosed but protocol deviation|0|||
131761441|NCT03261037|474402414|FG003|Overall Study|Diagnosed but protocol deviation|0|||
131761442|NCT03261037|474402411|FG000|Overall Study|Participant did not want to continue the study|0|||
131761443|NCT03261037|474402412|FG001|Overall Study|Participant did not want to continue the study|1|||
131761444|NCT03261037|474402413|FG002|Overall Study|Participant did not want to continue the study|0|||
131761445|NCT03261037|474402414|FG003|Overall Study|Participant did not want to continue the study|0|||
131761446|NCT03261037|474402411|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
131761447|NCT03261037|474402412|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
131761448|NCT03261037|474402413|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
131761449|NCT03261037|474402414|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
131761450|NCT03261037|474402411|FG000|Overall Study|Participant presented clinical improvement|0|||
131761451|NCT03261037|474402412|FG001|Overall Study|Participant presented clinical improvement|2|||
131761452|NCT03261037|474402413|FG002|Overall Study|Participant presented clinical improvement|0|||
131761453|NCT03261037|474402414|FG003|Overall Study|Participant presented clinical improvement|0|||
131761454|NCT03261037|474402411|FG000|Overall Study|Technical difficulties|0|||
131761455|NCT03261037|474402412|FG001|Overall Study|Technical difficulties|0|||
131761456|NCT03261037|474402413|FG002|Overall Study|Technical difficulties|0|||
131761457|NCT03261037|474402414|FG003|Overall Study|Technical difficulties|1|||
131812810|NCT02321098|474597679|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
131812811|NCT02321098|474597680|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
131812812|NCT02558491|474597681|FG000|First Invention|Withdrawal by Subject|3|||
131812813|NCT02558491|474597682|FG001|First Invention|Withdrawal by Subject|1|||
131812814|NCT02558491|474597681|FG000|First Invention|Data collection issues|1|||
131812815|NCT02558491|474597682|FG001|First Invention|Data collection issues|0|||
131812816|NCT02558491|474597681|FG000|First Invention|Stopping criteria|0|||
131812817|NCT02558491|474597682|FG001|First Invention|Stopping criteria|1|||
131761458|NCT03261037|474402411|FG000|Overall Study|Equipment failed to work|0|||
131761459|NCT03261037|474402412|FG001|Overall Study|Equipment failed to work|0|||
131761460|NCT03261037|474402413|FG002|Overall Study|Equipment failed to work|0|||
131761461|NCT03261037|474402414|FG003|Overall Study|Equipment failed to work|1|||
131761462|NCT03261037|474402411|FG000|Overall Study|End of study for participant and no follow up|0|||
131761463|NCT03261037|474402412|FG001|Overall Study|End of study for participant and no follow up|0|||
131761464|NCT03261037|474402413|FG002|Overall Study|End of study for participant and no follow up|0|||
131761465|NCT03261037|474402414|FG003|Overall Study|End of study for participant and no follow up|1|||
131761466|NCT03261037|474402411|FG000|Overall Study|Participant was too weak to continue in study|1|||
131761467|NCT03261037|474402412|FG001|Overall Study|Participant was too weak to continue in study|0|||
131761468|NCT03261037|474402413|FG002|Overall Study|Participant was too weak to continue in study|0|||
131761469|NCT03261037|474402414|FG003|Overall Study|Participant was too weak to continue in study|0|||
131761470|NCT02943577|474402415|FG000|Overall Study|Protocol Violation|0|||
131761471|NCT02943577|474402416|FG001|Overall Study|Protocol Violation|1|||
131761472|NCT02943577|474402415|FG000|Overall Study|Adverse Event|3|||
131761473|NCT02943577|474402416|FG001|Overall Study|Adverse Event|2|||
131761474|NCT02943577|474402415|FG000|Overall Study|Lost to Follow-up|0|||
131761475|NCT02943577|474402416|FG001|Overall Study|Lost to Follow-up|1|||
131761476|NCT02943577|474402415|FG000|Overall Study|Withdrawal by Subject|1|||
131761477|NCT02943577|474402416|FG001|Overall Study|Withdrawal by Subject|1|||
131761478|NCT02943577|474402415|FG000|Overall Study|Pregnancy|1|||
131761479|NCT02943577|474402416|FG001|Overall Study|Pregnancy|0|||
131761480|NCT01944462|474402423|FG000|PPPP Educational Program|Lost to Follow-up|60|||
131761481|NCT01222767|474402424|FG000|Overall Study|Progressive disease|13|||
131761482|NCT01222767|474402424|FG000|Overall Study|Adverse Event|2|||
131761483|NCT01222767|474402424|FG000|Overall Study|Surgical resection|1|||
131761484|NCT01222767|474402424|FG000|Overall Study|Never treated|1|||
131761485|NCT00723489|474402425|FG000|Overall Study|Physician Decision|0|||
131761486|NCT00723489|474402426|FG001|Overall Study|Physician Decision|1|||
131761487|NCT00723489|474402427|FG002|Overall Study|Physician Decision|0|||
131761488|NCT00723489|474402428|FG003|Overall Study|Physician Decision|0|||
131761489|NCT00723489|474402425|FG000|Overall Study|Pregnancy|0|||
131761490|NCT00723489|474402426|FG001|Overall Study|Pregnancy|0|||
131761491|NCT00723489|474402427|FG002|Overall Study|Pregnancy|0|||
131761492|NCT00723489|474402428|FG003|Overall Study|Pregnancy|1|||
131761493|NCT00723489|474402425|FG000|Overall Study|Withdrawal by Subject|0|||
131761494|NCT00723489|474402426|FG001|Overall Study|Withdrawal by Subject|0|||
131761495|NCT00723489|474402427|FG002|Overall Study|Withdrawal by Subject|0|||
131761496|NCT00723489|474402428|FG003|Overall Study|Withdrawal by Subject|1|||
131761497|NCT00723489|474402425|FG000|Overall Study|Seropositive at baseline|1|||
131761498|NCT00723489|474402426|FG001|Overall Study|Seropositive at baseline|0|||
131761499|NCT00723489|474402427|FG002|Overall Study|Seropositive at baseline|0|||
131761500|NCT00723489|474402428|FG003|Overall Study|Seropositive at baseline|0|||
131761501|NCT00723489|474402425|FG000|Overall Study|Prohibited Medication|0|||
131761502|NCT00723489|474402426|FG001|Overall Study|Prohibited Medication|0|||
131761503|NCT00723489|474402427|FG002|Overall Study|Prohibited Medication|0|||
131761504|NCT00723489|474402428|FG003|Overall Study|Prohibited Medication|1|||
131761505|NCT00723489|474402425|FG000|Overall Study|Samples Collected Out of Window|0|||
131761506|NCT00723489|474402426|FG001|Overall Study|Samples Collected Out of Window|3|||
131761507|NCT00723489|474402427|FG002|Overall Study|Samples Collected Out of Window|0|||
131761508|NCT00723489|474402428|FG003|Overall Study|Samples Collected Out of Window|0|||
131761509|NCT04437511|474402429|FG000|Overall Study|Adverse Event|50|||
131761510|NCT04437511|474402430|FG001|Overall Study|Adverse Event|21|||
131761511|NCT04437511|474402429|FG000|Overall Study|Death|15|||
131761512|NCT04437511|474402430|FG001|Overall Study|Death|10|||
131761513|NCT04437511|474402429|FG000|Overall Study|Lost to Follow-up|11|||
131761514|NCT04437511|474402430|FG001|Overall Study|Lost to Follow-up|11|||
131812818|NCT02558491|474597681|FG000|First Invention|Changed parameters during trial|1|||
131812819|NCT02558491|474597682|FG001|First Invention|Changed parameters during trial|0|||
131812820|NCT02558491|474597681|FG000|Second Intervention|Withdrawal by Subject|1|||
131812821|NCT02558491|474597682|FG001|Second Intervention|Withdrawal by Subject|0|||
131812822|NCT02558491|474597681|FG000|Second Intervention|Stopping Criteria|1|||
131812823|NCT02558491|474597682|FG001|Second Intervention|Stopping Criteria|0|||
131812824|NCT00834431|474597683|FG000|First Intervention|Adverse Event|0|||
131812825|NCT00834431|474597684|FG001|First Intervention|Adverse Event|1|||
131812826|NCT00834431|474597683|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
131812827|NCT00834431|474597684|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
131812828|NCT05479058|474597687|FG000|Overall Study|Withdrawal by Subject|1|||
131812829|NCT05479058|474597688|FG001|Overall Study|Withdrawal by Subject|1|||
131812830|NCT05479058|474597687|FG000|Overall Study|Study terminated by sponsor|10|||
131812831|NCT05479058|474597688|FG001|Overall Study|Study terminated by sponsor|10|||
131812832|NCT02645409|474597689|FG000|Overall Study|Withdrawal by Subject|3|||
131761515|NCT04437511|474402429|FG000|Overall Study|Physician Decision|19|||
131761516|NCT04437511|474402430|FG001|Overall Study|Physician Decision|10|||
131761517|NCT04437511|474402429|FG000|Overall Study|Progressive Disease|4|||
131761518|NCT04437511|474402430|FG001|Overall Study|Progressive Disease|7|||
131908960|NCT02932943|474954687|FG000|Overall Study|Withdrawal by Subject|3|||
131761519|NCT04437511|474402429|FG000|Overall Study|Withdrawal by Subject|111|||
131761520|NCT04437511|474402430|FG001|Overall Study|Withdrawal by Subject|94|||
131761521|NCT04437511|474402429|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
131761522|NCT04437511|474402430|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
131761523|NCT04437511|474402429|FG000|Overall Study|Continuing Study|7|||
131761524|NCT04437511|474402430|FG001|Overall Study|Continuing Study|5|||
131761525|NCT05618808|474402431|FG000|Overall Study|Withdrawal by Subject|3|||
131761526|NCT05618808|474402432|FG001|Overall Study|Withdrawal by Subject|1|||
131761527|NCT05618808|474402433|FG002|Overall Study|Withdrawal by Subject|3|||
131761528|NCT04654468|474402438|FG000|Overall Study|Death|1|||
131761529|NCT04654468|474402438|FG000|Overall Study|Ongoing in the Study|50|||
131761530|NCT05298774|474402443|FG000|Overall Study|Physician Decision|3|||
131761531|NCT05298774|474402443|FG000|Overall Study|Withdrawal by Subject|2|||
131761532|NCT05298774|474402443|FG000|Overall Study|Lost to Follow-up|3|||
131761533|NCT05298774|474402443|FG000|Overall Study|Screen failure|1|||
131761534|NCT03093350|474402444|FG000|Overall Study|Death|1|||
131761535|NCT03093350|474402444|FG000|Overall Study|Signed consent, never began treartment|1|||
131761536|NCT00777036|474402451|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
131761537|NCT00777036|474402452|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
131761538|NCT00777036|474402453|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
131761539|NCT00777036|474402454|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
131761540|NCT00777036|474402451|FG000|On Treatment|Administrative Reason By Sponsor|1|||
131761541|NCT00777036|474402452|FG001|On Treatment|Administrative Reason By Sponsor|0|||
131761542|NCT00777036|474402453|FG002|On Treatment|Administrative Reason By Sponsor|9|||
131761543|NCT00777036|474402454|FG003|On Treatment|Administrative Reason By Sponsor|0|||
131761544|NCT00777036|474402451|FG000|On Treatment|Failure to Meet Study Criteria|0|||
131761545|NCT00777036|474402452|FG001|On Treatment|Failure to Meet Study Criteria|1|||
131761546|NCT00777036|474402453|FG002|On Treatment|Failure to Meet Study Criteria|4|||
131761547|NCT00777036|474402454|FG003|On Treatment|Failure to Meet Study Criteria|0|||
131761548|NCT00777036|474402451|FG000|On Treatment|Pregnancy|1|||
131761549|NCT00777036|474402452|FG001|On Treatment|Pregnancy|0|||
131761550|NCT00777036|474402453|FG002|On Treatment|Pregnancy|1|||
131761551|NCT00777036|474402454|FG003|On Treatment|Pregnancy|0|||
131761552|NCT00777036|474402451|FG000|On Treatment|Non-compliance with Study Drug|1|||
131761553|NCT00777036|474402452|FG001|On Treatment|Non-compliance with Study Drug|0|||
131761554|NCT00777036|474402453|FG002|On Treatment|Non-compliance with Study Drug|1|||
131761555|NCT00777036|474402454|FG003|On Treatment|Non-compliance with Study Drug|0|||
131761556|NCT00777036|474402451|FG000|On Treatment|Maximum Clinical Benefit|2|||
131761557|NCT00777036|474402452|FG001|On Treatment|Maximum Clinical Benefit|0|||
131761558|NCT00777036|474402453|FG002|On Treatment|Maximum Clinical Benefit|5|||
131761559|NCT00777036|474402454|FG003|On Treatment|Maximum Clinical Benefit|0|||
131761560|NCT00777036|474402451|FG000|On Treatment|Withdrawal by Subject|0|||
131761561|NCT00777036|474402452|FG001|On Treatment|Withdrawal by Subject|2|||
131761562|NCT00777036|474402453|FG002|On Treatment|Withdrawal by Subject|2|||
131761563|NCT00777036|474402454|FG003|On Treatment|Withdrawal by Subject|0|||
131761564|NCT00777036|474402451|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
131761565|NCT00777036|474402452|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
131761566|NCT00777036|474402453|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
131761567|NCT00777036|474402454|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
131761568|NCT00777036|474402451|FG000|On Treatment|Death|0|||
131761569|NCT00777036|474402452|FG001|On Treatment|Death|2|||
131761570|NCT00777036|474402453|FG002|On Treatment|Death|0|||
131761571|NCT00777036|474402454|FG003|On Treatment|Death|0|||
131761572|NCT00777036|474402451|FG000|On Treatment|Study Drug Toxicity|1|||
131761573|NCT00777036|474402452|FG001|On Treatment|Study Drug Toxicity|0|||
131761574|NCT00777036|474402453|FG002|On Treatment|Study Drug Toxicity|4|||
131761575|NCT00777036|474402454|FG003|On Treatment|Study Drug Toxicity|0|||
131761576|NCT00777036|474402451|FG000|On Treatment|Progressive Disease|6|||
131761577|NCT00777036|474402452|FG001|On Treatment|Progressive Disease|4|||
131761578|NCT00777036|474402453|FG002|On Treatment|Progressive Disease|7|||
131761579|NCT00777036|474402454|FG003|On Treatment|Progressive Disease|0|||
131761580|NCT00777036|474402451|FG000|On Treatment|Not Reported|0|||
131761581|NCT00777036|474402452|FG001|On Treatment|Not Reported|0|||
131761582|NCT00777036|474402453|FG002|On Treatment|Not Reported|2|||
131761583|NCT00777036|474402454|FG003|On Treatment|Not Reported|0|||
131761584|NCT00777036|474402451|FG000|On Treatment|Site Closed|0|||
131761585|NCT00777036|474402452|FG001|On Treatment|Site Closed|1|||
131908961|NCT02932943|474954688|FG001|Overall Study|Withdrawal by Subject|3|||
131908962|NCT02300610|474954695|FG000|Overall Study|Withdrawal by Subject|1|||
131761586|NCT00777036|474402453|FG002|On Treatment|Site Closed|1|||
131761587|NCT00777036|474402454|FG003|On Treatment|Site Closed|0|||
131761588|NCT00777036|474402451|FG000|Follow-Up|Withdrawal by Subject|0|||
131761589|NCT00777036|474402452|FG001|Follow-Up|Withdrawal by Subject|0|||
131761590|NCT00777036|474402453|FG002|Follow-Up|Withdrawal by Subject|5|||
131761591|NCT00777036|474402454|FG003|Follow-Up|Withdrawal by Subject|0|||
131761592|NCT00777036|474402451|FG000|Follow-Up|Death|1|||
131761593|NCT00777036|474402452|FG001|Follow-Up|Death|9|||
131761594|NCT00777036|474402453|FG002|Follow-Up|Death|0|||
131761595|NCT00777036|474402454|FG003|Follow-Up|Death|0|||
131761596|NCT00777036|474402451|FG000|Follow-Up|Lost to Follow-up|3|||
131761597|NCT00777036|474402452|FG001|Follow-Up|Lost to Follow-up|0|||
131761598|NCT00777036|474402453|FG002|Follow-Up|Lost to Follow-up|0|||
131761599|NCT00777036|474402454|FG003|Follow-Up|Lost to Follow-up|0|||
131761600|NCT00777036|474402451|FG000|Follow-Up|Reason Not Specified|4|||
131761601|NCT00777036|474402452|FG001|Follow-Up|Reason Not Specified|0|||
131761602|NCT00777036|474402453|FG002|Follow-Up|Reason Not Specified|13|||
131761603|NCT00777036|474402454|FG003|Follow-Up|Reason Not Specified|0|||
131761604|NCT00777036|474402451|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
131761605|NCT00777036|474402452|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
131761606|NCT00777036|474402453|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
131761607|NCT00777036|474402454|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
131761608|NCT05564039|474402455|FG000|Overall Study|Adverse Event|1|||
131761609|NCT05564039|474402456|FG001|Overall Study|Adverse Event|0|||
131761610|NCT05564039|474402455|FG000|Overall Study|Death|1|||
131761611|NCT05564039|474402456|FG001|Overall Study|Death|1|||
131761612|NCT05564039|474402455|FG000|Overall Study|Lost to Follow-up|3|||
131761613|NCT05564039|474402456|FG001|Overall Study|Lost to Follow-up|2|||
131761614|NCT05564039|474402455|FG000|Overall Study|Withdrawal by Subject|2|||
131761615|NCT05564039|474402456|FG001|Overall Study|Withdrawal by Subject|0|||
131761616|NCT05564039|474402455|FG000|Overall Study|Inadvertent enrollment|3|||
131761617|NCT05564039|474402456|FG001|Overall Study|Inadvertent enrollment|6|||
131761618|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
131812833|NCT02645409|474597690|FG001|Overall Study|Withdrawal by Subject|0|||
131812834|NCT02645409|474597689|FG000|Overall Study|Physician Decision|1|||
131812835|NCT02645409|474597690|FG001|Overall Study|Physician Decision|0|||
131812836|NCT02089685|474597693|FG000|Overall Study|Adverse Event|1|||
131812837|NCT02089685|474597694|FG001|Overall Study|Adverse Event|0|||
131812838|NCT02089685|474597695|FG002|Overall Study|Adverse Event|0|||
131812839|NCT02089685|474597696|FG003|Overall Study|Adverse Event|0|||
131812840|NCT02089685|474597697|FG004|Overall Study|Adverse Event|1|||
131812841|NCT02089685|474597698|FG005|Overall Study|Adverse Event|0|||
131908963|NCT02300610|474954696|FG001|Overall Study|Withdrawal by Subject|0|||
131908964|NCT02300610|474954697|FG002|Overall Study|Withdrawal by Subject|1|||
131908965|NCT03435055|474954698|FG000|Screening|Physician Decision|2|||
131908966|NCT03435055|474954698|FG000|Received Intervention|Did not complete nitrous administration|3|||
131908967|NCT01663623|474954701|FG000|Overall Study|Adverse Event|3|||
131908968|NCT01663623|474954702|FG001|Overall Study|Adverse Event|7|||
131908969|NCT01663623|474954701|FG000|Overall Study|Lack of Efficacy|5|||
131908970|NCT01663623|474954702|FG001|Overall Study|Lack of Efficacy|6|||
131908971|NCT01663623|474954701|FG000|Overall Study|Protocol Violation|0|||
131908972|NCT01663623|474954702|FG001|Overall Study|Protocol Violation|1|||
131908973|NCT01663623|474954701|FG000|Overall Study|Other-Study closed/terminated|1|||
131908974|NCT01663623|474954702|FG001|Overall Study|Other-Study closed/terminated|1|||
131908975|NCT01663623|474954701|FG000|Overall Study|Physician Decision|1|||
131908976|NCT01663623|474954702|FG001|Overall Study|Physician Decision|4|||
131908977|NCT01663623|474954701|FG000|Overall Study|Withdrawal by Subject|2|||
131908978|NCT01663623|474954702|FG001|Overall Study|Withdrawal by Subject|1|||
131908979|NCT02251275|474954703|FG000|Overall Study|Adverse Event|23|||
131908980|NCT02251275|474954704|FG001|Overall Study|Adverse Event|60|||
131908981|NCT02251275|474954705|FG002|Overall Study|Adverse Event|28|||
131908982|NCT02251275|474954706|FG003|Overall Study|Adverse Event|0|||
131908983|NCT02251275|474954707|FG004|Overall Study|Adverse Event|0|||
131908984|NCT02251275|474954703|FG000|Overall Study|Lost to Follow-up|5|||
131908985|NCT02251275|474954704|FG001|Overall Study|Lost to Follow-up|6|||
131908986|NCT02251275|474954705|FG002|Overall Study|Lost to Follow-up|4|||
131908987|NCT02251275|474954706|FG003|Overall Study|Lost to Follow-up|0|||
131908988|NCT02251275|474954707|FG004|Overall Study|Lost to Follow-up|0|||
131908989|NCT02251275|474954703|FG000|Overall Study|Physician Decision|19|||
131908990|NCT02251275|474954704|FG001|Overall Study|Physician Decision|30|||
131908991|NCT02251275|474954705|FG002|Overall Study|Physician Decision|26|||
131908992|NCT02251275|474954706|FG003|Overall Study|Physician Decision|0|||
131398689|NCT00758069|473081232|FG002|Overall Study|Lack of Efficacy|1|||
131398690|NCT00758069|473081230|FG000|Overall Study|Incorrect Study Drug|1|||
131761619|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
131761620|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
131812842|NCT02089685|474597693|FG000|Overall Study|Clinical Progression|4|||
131812843|NCT02089685|474597694|FG001|Overall Study|Clinical Progression|0|||
131812844|NCT02089685|474597695|FG002|Overall Study|Clinical Progression|0|||
131908993|NCT02251275|474954707|FG004|Overall Study|Physician Decision|1|||
131908994|NCT02251275|474954703|FG000|Overall Study|Protocol Deviation|0|||
131908995|NCT02251275|474954704|FG001|Overall Study|Protocol Deviation|0|||
131908996|NCT02251275|474954705|FG002|Overall Study|Protocol Deviation|1|||
131908997|NCT02251275|474954706|FG003|Overall Study|Protocol Deviation|0|||
131908998|NCT02251275|474954707|FG004|Overall Study|Protocol Deviation|0|||
131761621|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
131761622|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Death|38|||
131761623|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Death|10|||
131761624|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
131761625|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
131761626|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
131761627|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
131761628|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
131761629|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
131761630|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
131761631|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
131761632|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
131761633|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
131761634|NCT02421939|474402457|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
131761635|NCT02421939|474402458|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
131761636|NCT02421939|474402457|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
131761637|NCT02421939|474402458|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
131761638|NCT02421939|474402457|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
131761639|NCT02421939|474402458|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
131761640|NCT02421939|474402457|FG000|Long Term Follow up: up to 3 Years|Death|118|||
131761641|NCT02421939|474402458|FG001|Long Term Follow up: up to 3 Years|Death|65|||
131761642|NCT02421939|474402457|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
131761643|NCT02421939|474402458|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
131761644|NCT01263470|474402461|FG000|Overall Study|Adverse Event|2|||
131761645|NCT01263470|474402462|FG001|Overall Study|Adverse Event|2|||
131761646|NCT01263470|474402463|FG002|Overall Study|Adverse Event|1|||
131761647|NCT01263470|474402464|FG003|Overall Study|Adverse Event|1|||
131761648|NCT01263470|474402465|FG004|Overall Study|Adverse Event|2|||
131761649|NCT01263470|474402466|FG005|Overall Study|Adverse Event|2|||
131761650|NCT01263470|474402461|FG000|Overall Study|Protocol Violation|0|||
131761651|NCT01263470|474402462|FG001|Overall Study|Protocol Violation|1|||
131761652|NCT01263470|474402463|FG002|Overall Study|Protocol Violation|0|||
131761653|NCT01263470|474402464|FG003|Overall Study|Protocol Violation|0|||
131761654|NCT01263470|474402465|FG004|Overall Study|Protocol Violation|0|||
131761655|NCT01263470|474402466|FG005|Overall Study|Protocol Violation|1|||
131761656|NCT01263470|474402461|FG000|Overall Study|Withdrawal by Subject|0|||
131761657|NCT01263470|474402462|FG001|Overall Study|Withdrawal by Subject|1|||
131761658|NCT01263470|474402463|FG002|Overall Study|Withdrawal by Subject|1|||
131761659|NCT01263470|474402464|FG003|Overall Study|Withdrawal by Subject|2|||
131761660|NCT01263470|474402465|FG004|Overall Study|Withdrawal by Subject|0|||
131761661|NCT01263470|474402466|FG005|Overall Study|Withdrawal by Subject|2|||
131761662|NCT01263470|474402461|FG000|Overall Study|Lack of Efficacy|0|||
131761663|NCT01263470|474402462|FG001|Overall Study|Lack of Efficacy|0|||
131761664|NCT01263470|474402463|FG002|Overall Study|Lack of Efficacy|2|||
131761665|NCT01263470|474402464|FG003|Overall Study|Lack of Efficacy|0|||
131761666|NCT01263470|474402465|FG004|Overall Study|Lack of Efficacy|0|||
131761667|NCT01263470|474402466|FG005|Overall Study|Lack of Efficacy|0|||
131761668|NCT01263470|474402461|FG000|Overall Study|Participant Unavailability|0|||
131761669|NCT01263470|474402462|FG001|Overall Study|Participant Unavailability|1|||
131761670|NCT01263470|474402463|FG002|Overall Study|Participant Unavailability|0|||
131761671|NCT01263470|474402464|FG003|Overall Study|Participant Unavailability|0|||
131761672|NCT01263470|474402465|FG004|Overall Study|Participant Unavailability|0|||
131761673|NCT01263470|474402466|FG005|Overall Study|Participant Unavailability|0|||
131761674|NCT01263470|474402461|FG000|Overall Study|Study Drug Non-compliance|0|||
131812845|NCT02089685|474597696|FG003|Overall Study|Clinical Progression|5|||
131812846|NCT02089685|474597697|FG004|Overall Study|Clinical Progression|1|||
131812847|NCT02089685|474597698|FG005|Overall Study|Clinical Progression|2|||
131812848|NCT02089685|474597693|FG000|Overall Study|Excluded Medication|1|||
131812849|NCT02089685|474597694|FG001|Overall Study|Excluded Medication|0|||
131812850|NCT02089685|474597695|FG002|Overall Study|Excluded Medication|0|||
131812851|NCT02089685|474597696|FG003|Overall Study|Excluded Medication|11|||
131812852|NCT02089685|474597697|FG004|Overall Study|Excluded Medication|2|||
131812853|NCT02089685|474597698|FG005|Overall Study|Excluded Medication|1|||
131812854|NCT02089685|474597693|FG000|Overall Study|Progressive disease|13|||
131812855|NCT02089685|474597694|FG001|Overall Study|Progressive disease|10|||
131812856|NCT02089685|474597695|FG002|Overall Study|Progressive disease|3|||
131812857|NCT02089685|474597696|FG003|Overall Study|Progressive disease|51|||
131812858|NCT02089685|474597697|FG004|Overall Study|Progressive disease|17|||
131812859|NCT02089685|474597698|FG005|Overall Study|Progressive disease|12|||
131812860|NCT02089685|474597693|FG000|Overall Study|Follow up ended by sponsor|2|||
131812861|NCT02089685|474597694|FG001|Overall Study|Follow up ended by sponsor|2|||
131812862|NCT02089685|474597695|FG002|Overall Study|Follow up ended by sponsor|0|||
131812863|NCT02089685|474597696|FG003|Overall Study|Follow up ended by sponsor|70|||
131812864|NCT02089685|474597697|FG004|Overall Study|Follow up ended by sponsor|26|||
131812865|NCT02089685|474597698|FG005|Overall Study|Follow up ended by sponsor|26|||
131908999|NCT02251275|474954703|FG000|Overall Study|Withdrawal by Subject|25|||
131909000|NCT02251275|474954704|FG001|Overall Study|Withdrawal by Subject|51|||
131909001|NCT02251275|474954705|FG002|Overall Study|Withdrawal by Subject|35|||
131909002|NCT02251275|474954706|FG003|Overall Study|Withdrawal by Subject|1|||
131909003|NCT02251275|474954707|FG004|Overall Study|Withdrawal by Subject|0|||
131909004|NCT00856180|474954708|FG000|Overall Study|Adverse Event|4|||
131909005|NCT00856180|474954708|FG000|Overall Study|Progressive Disease|16|||
131909006|NCT02515227|474954709|FG000|Overall Study|Adverse Event|0|||
131909007|NCT02515227|474954710|FG001|Overall Study|Adverse Event|2|||
131909008|NCT02515227|474954709|FG000|Overall Study|Progressive disease|2|||
131909009|NCT02515227|474954710|FG001|Overall Study|Progressive disease|9|||
131909010|NCT02834975|474954711|FG000|Overall Study|Physician Decision|2|||
131761675|NCT01263470|474402462|FG001|Overall Study|Study Drug Non-compliance|0|||
131761676|NCT01263470|474402463|FG002|Overall Study|Study Drug Non-compliance|0|||
131761677|NCT01263470|474402464|FG003|Overall Study|Study Drug Non-compliance|0|||
131761678|NCT01263470|474402465|FG004|Overall Study|Study Drug Non-compliance|1|||
131761679|NCT01263470|474402466|FG005|Overall Study|Study Drug Non-compliance|0|||
131761680|NCT00729560|474402467|FG000|Overall Study|Withdrawal by Subject|3|||
131761681|NCT03662789|474402468|FG000|Overall Study|Lost to Follow-up|1|||
131761682|NCT03662789|474402469|FG001|Overall Study|Lost to Follow-up|2|||
131761683|NCT03662789|474402468|FG000|Overall Study|Could not perform treadmill test|4|||
131761684|NCT03662789|474402469|FG001|Overall Study|Could not perform treadmill test|4|||
131761685|NCT03662789|474402468|FG000|Overall Study|Death|0|||
131761686|NCT03662789|474402469|FG001|Overall Study|Death|1|||
131761687|NCT03598140|474402470|FG000|Overall Study|enrolled but didn't start|1|||
131761688|NCT03598140|474402471|FG001|Overall Study|enrolled but didn't start|0|||
131761689|NCT01029691|474402472|FG000|Continued APAP to Delivery|Death|0|||
131761690|NCT01029691|474402473|FG001|Continued APAP to Delivery|Death|0|||
131398691|NCT00758069|473081231|FG001|Overall Study|Incorrect Study Drug|0|||
131398692|NCT00758069|473081232|FG002|Overall Study|Incorrect Study Drug|0|||
131761691|NCT01029691|474402474|FG002|Continued APAP to Delivery|Death|1|||
131761692|NCT01023516|474402475|FG000|Overall Study|Voluntary discontinuation|7|||
131761693|NCT01023516|474402476|FG001|Overall Study|Voluntary discontinuation|5|||
131761694|NCT01023516|474402475|FG000|Overall Study|Adverse Event|9|||
131761695|NCT01023516|474402476|FG001|Overall Study|Adverse Event|6|||
131761696|NCT01023516|474402475|FG000|Overall Study|Safety reason|0|||
131761697|NCT01023516|474402476|FG001|Overall Study|Safety reason|3|||
131761698|NCT01023516|474402475|FG000|Overall Study|Study-specific criteria|4|||
131761699|NCT01023516|474402476|FG001|Overall Study|Study-specific criteria|2|||
131761700|NCT01023516|474402475|FG000|Overall Study|Incorrect enrolment|4|||
131761701|NCT01023516|474402476|FG001|Overall Study|Incorrect enrolment|2|||
131761702|NCT02559115|474402478|FG000|Overall Study|Withdrawal by Subject|3|||
131761703|NCT02060903|474402483|FG000|Overall Study|Lost to Follow-up|4|||
131761704|NCT02060903|474402484|FG001|Overall Study|Lost to Follow-up|0|||
131761705|NCT02060903|474402483|FG000|Overall Study|Withdrawal by Subject|0|||
131761706|NCT02060903|474402484|FG001|Overall Study|Withdrawal by Subject|7|||
131761707|NCT00137267|474402485|FG000|Overall Study|Lost to Follow-up|15|||
131761708|NCT00137267|474402486|FG001|Overall Study|Lost to Follow-up|21|||
131761709|NCT00638989|474402487|FG000|Overall Study|Lost to Follow-up|0|||
131761710|NCT00638989|474402488|FG001|Overall Study|Lost to Follow-up|0|||
131761711|NCT00638989|474402489|FG002|Overall Study|Lost to Follow-up|1|||
131761712|NCT04556175|474402495|FG000|Overall Study|Study terminated due to COVID-19|8|||
131761713|NCT04556175|474402496|FG001|Overall Study|Study terminated due to COVID-19|8|||
131761714|NCT01553591|474402497|FG000|Overall Study|Voluntarily withdrew|94|||
131761715|NCT01553591|474402498|FG001|Overall Study|Voluntarily withdrew|79|||
131398693|NCT02277691|473081233|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
131398694|NCT02277691|473081233|FG000|Overall Study|Voluntary Withdrawal|7|||
131398695|NCT02277691|473081233|FG000|Overall Study|Lack of Efficacy|5|||
131398696|NCT02277691|473081233|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
131761716|NCT01553591|474402499|FG002|Overall Study|Voluntarily withdrew|96|||
131761717|NCT01553591|474402497|FG000|Overall Study|Adverse Event|36|||
131761718|NCT01553591|474402498|FG001|Overall Study|Adverse Event|45|||
131761719|NCT01553591|474402499|FG002|Overall Study|Adverse Event|16|||
131761720|NCT01553591|474402497|FG000|Overall Study|Lost to Follow-up|25|||
131761721|NCT01553591|474402498|FG001|Overall Study|Lost to Follow-up|23|||
131761722|NCT01553591|474402499|FG002|Overall Study|Lost to Follow-up|16|||
131761723|NCT01553591|474402497|FG000|Overall Study|Physician decision: other|11|||
131761724|NCT01553591|474402498|FG001|Overall Study|Physician decision: other|14|||
131761725|NCT01553591|474402499|FG002|Overall Study|Physician decision: other|16|||
131761726|NCT01553591|474402497|FG000|Overall Study|Physician decision: lack of efficacy|2|||
131909011|NCT02834975|474954711|FG000|Overall Study|Adverse Event|1|||
131761727|NCT01553591|474402498|FG001|Overall Study|Physician decision: lack of efficacy|3|||
131761728|NCT01553591|474402499|FG002|Overall Study|Physician decision: lack of efficacy|7|||
131761729|NCT01553591|474402497|FG000|Overall Study|Protocol Violation|3|||
131909012|NCT02834975|474954711|FG000|Overall Study|Withdrawal by Subject|1|||
131761730|NCT01553591|474402498|FG001|Overall Study|Protocol Violation|4|||
131761731|NCT01553591|474402499|FG002|Overall Study|Protocol Violation|4|||
131812866|NCT02089685|474597693|FG000|Overall Study|Withdrawal by Subject|0|||
131812867|NCT02089685|474597694|FG001|Overall Study|Withdrawal by Subject|2|||
131812868|NCT02089685|474597695|FG002|Overall Study|Withdrawal by Subject|0|||
131812869|NCT02089685|474597696|FG003|Overall Study|Withdrawal by Subject|8|||
131812870|NCT02089685|474597697|FG004|Overall Study|Withdrawal by Subject|1|||
131812871|NCT02089685|474597698|FG005|Overall Study|Withdrawal by Subject|1|||
131812872|NCT02089685|474597693|FG000|Overall Study|Status not recorded|1|||
131812873|NCT02089685|474597694|FG001|Overall Study|Status not recorded|0|||
131812874|NCT02089685|474597695|FG002|Overall Study|Status not recorded|0|||
131812875|NCT02089685|474597696|FG003|Overall Study|Status not recorded|0|||
131812876|NCT02089685|474597697|FG004|Overall Study|Status not recorded|1|||
131812877|NCT02089685|474597698|FG005|Overall Study|Status not recorded|0|||
131812878|NCT02089685|474597693|FG000|Overall Study|Death|0|||
131812879|NCT02089685|474597694|FG001|Overall Study|Death|0|||
131812880|NCT02089685|474597695|FG002|Overall Study|Death|0|||
131812881|NCT02089685|474597696|FG003|Overall Study|Death|7|||
131812882|NCT02089685|474597697|FG004|Overall Study|Death|2|||
131812883|NCT02089685|474597698|FG005|Overall Study|Death|5|||
131812884|NCT02089685|474597693|FG000|Overall Study|Lost to Follow-up|0|||
131812885|NCT02089685|474597694|FG001|Overall Study|Lost to Follow-up|0|||
131812886|NCT02089685|474597695|FG002|Overall Study|Lost to Follow-up|0|||
131812887|NCT02089685|474597696|FG003|Overall Study|Lost to Follow-up|1|||
131812888|NCT02089685|474597697|FG004|Overall Study|Lost to Follow-up|0|||
131812889|NCT02089685|474597698|FG005|Overall Study|Lost to Follow-up|0|||
131812890|NCT02089685|474597693|FG000|Overall Study|Physician Decision|0|||
131812891|NCT02089685|474597694|FG001|Overall Study|Physician Decision|0|||
131812892|NCT02089685|474597695|FG002|Overall Study|Physician Decision|0|||
131812893|NCT02089685|474597696|FG003|Overall Study|Physician Decision|0|||
131812894|NCT02089685|474597697|FG004|Overall Study|Physician Decision|0|||
131812895|NCT02089685|474597698|FG005|Overall Study|Physician Decision|4|||
131812896|NCT02089685|474597693|FG000|Overall Study|Screen failure|1|||
131398697|NCT01164891|473081237|FG000|Overall Study|Disease Progression|5|||
131398698|NCT01164891|473081237|FG000|Overall Study|Adverse Event|1|||
131398699|NCT04908865|473081238|FG000|Overall Study|Adverse Event|2|||
131398700|NCT04908865|473081238|FG000|Overall Study|Lack of Efficacy|5|||
131398701|NCT04908865|473081238|FG000|Overall Study|Lost to Follow-up|1|||
131398702|NCT05730335|473081239|FG000|Overall Study|Lost to Follow-up|8|||
131398703|NCT05730335|473081239|FG000|Overall Study|Withdrawal by Subject|6|||
131761732|NCT01553591|474402497|FG000|Overall Study|Sponsor decision|1|||
131761733|NCT01553591|474402498|FG001|Overall Study|Sponsor decision|0|||
131761734|NCT01553591|474402499|FG002|Overall Study|Sponsor decision|3|||
131761735|NCT01553591|474402497|FG000|Overall Study|Randomized and never dispensed drug|0|||
131761736|NCT01553591|474402498|FG001|Overall Study|Randomized and never dispensed drug|1|||
131761737|NCT01553591|474402499|FG002|Overall Study|Randomized and never dispensed drug|0|||
131761738|NCT04005755|474402500|FG000|Overall Study|Adverse Event|6|||
131761739|NCT04005755|474402500|FG000|Overall Study|Physician Decision|3|||
131761740|NCT04005755|474402500|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
131761741|NCT04005755|474402500|FG000|Overall Study|Withdrawal by Subject|3|||
131761742|NCT04005755|474402500|FG000|Overall Study|Lost to Follow-up|1|||
131761743|NCT00611767|474402501|FG000|Overall Study|Withdrawal by Subject|4|||
131761744|NCT00611767|474402502|FG001|Overall Study|Withdrawal by Subject|1|||
131761745|NCT00611767|474402501|FG000|Overall Study|Thiopental not available|3|||
131761746|NCT00611767|474402502|FG001|Overall Study|Thiopental not available|0|||
131761747|NCT00611767|474402501|FG000|Overall Study|didn't like the medication|1|||
131761748|NCT00611767|474402502|FG001|Overall Study|didn't like the medication|1|||
131761749|NCT00611767|474402501|FG000|Overall Study|Physician Decision|1|||
131761750|NCT00611767|474402502|FG001|Overall Study|Physician Decision|0|||
131761751|NCT02683668|474402506|FG000|Period 2|Withdrawal by Subject|0|||
131761752|NCT02683668|474402507|FG001|Period 2|Withdrawal by Subject|1|||
131761753|NCT02683668|474402508|FG002|Period 2|Withdrawal by Subject|0|||
131761754|NCT03893630|474402509|FG000|Overall Study|Lost to Follow-up|5|||
131761755|NCT03893630|474402510|FG001|Overall Study|Lost to Follow-up|4|||
131761756|NCT03893630|474402511|FG002|Overall Study|Lost to Follow-up|2|||
131909013|NCT02834975|474954711|FG000|Overall Study|Lack of Efficacy|1|||
131909014|NCT00929669|474954717|FG000|Overall Study|elevated glucose levels|1|||
131398704|NCT01296711|473081240|FG000|Overall Study|Adverse Event|3|||
131761757|NCT03893630|474402509|FG000|Overall Study|Withdrawal by Subject|3|||
131761758|NCT03893630|474402510|FG001|Overall Study|Withdrawal by Subject|6|||
131761759|NCT03893630|474402511|FG002|Overall Study|Withdrawal by Subject|3|||
131761760|NCT03893630|474402509|FG000|Overall Study|Discontinued Intervention|0|||
131761761|NCT03893630|474402510|FG001|Overall Study|Discontinued Intervention|4|||
131812897|NCT02089685|474597694|FG001|Overall Study|Screen failure|0|||
131812898|NCT02089685|474597695|FG002|Overall Study|Screen failure|0|||
131812899|NCT02089685|474597696|FG003|Overall Study|Screen failure|0|||
131812900|NCT02089685|474597697|FG004|Overall Study|Screen failure|0|||
131812901|NCT02089685|474597698|FG005|Overall Study|Screen failure|0|||
131812902|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
131812903|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
131812904|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
131761762|NCT03893630|474402511|FG002|Overall Study|Discontinued Intervention|2|||
131761763|NCT01855919|474404082|FG000|Overall Study|Adverse Event|16|||
131761764|NCT01855919|474404083|FG001|Overall Study|Adverse Event|8|||
131761765|NCT01855919|474404082|FG000|Overall Study|Lack of Efficacy|1|||
131761766|NCT01855919|474404083|FG001|Overall Study|Lack of Efficacy|3|||
131761767|NCT01855919|474404082|FG000|Overall Study|Withdrawal by Subject|4|||
131761768|NCT01855919|474404083|FG001|Overall Study|Withdrawal by Subject|10|||
131761769|NCT01855919|474404082|FG000|Overall Study|Entry Criteria Not Met|1|||
131761770|NCT01855919|474404083|FG001|Overall Study|Entry Criteria Not Met|1|||
131761771|NCT01855919|474404082|FG000|Overall Study|Protocol Violation|1|||
131761772|NCT01855919|474404083|FG001|Overall Study|Protocol Violation|4|||
131812905|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
131812906|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
131812907|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
131812908|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131812909|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131812910|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
131812911|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
131812912|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
131812913|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
131812914|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
131812915|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
131812916|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
131812917|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
131812918|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
131812919|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
131812920|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
131812921|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
131812922|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Death|0|||
131812923|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Death|1|||
131812924|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Death|0|||
131812925|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Death|0|||
131812926|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
131812927|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
131812928|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
131812929|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
131812930|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
131812931|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
131812932|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
131812933|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
131812934|NCT01940341|474597702|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131812935|NCT01940341|474597703|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
131812936|NCT01940341|474597704|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131812937|NCT01940341|474597705|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131812938|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
131812939|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
131812940|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
131812941|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
131812942|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
131812943|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
131812944|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
131812945|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
131812946|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131812947|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131812948|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
131812949|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131812950|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
131812951|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
131909015|NCT00686972|474954718|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
131909016|NCT01462942|474954723|FG000|Overall Study|Adverse Event|7|||
131909017|NCT01462942|474954724|FG001|Overall Study|Adverse Event|12|||
131909018|NCT01462942|474954725|FG002|Overall Study|Adverse Event|10|||
131909019|NCT01462942|474954726|FG003|Overall Study|Adverse Event|11|||
131909020|NCT01462942|474954727|FG004|Overall Study|Adverse Event|11|||
131909021|NCT01462942|474954723|FG000|Overall Study|Other, including COPD exacerbation|3|||
131909022|NCT01462942|474954724|FG001|Overall Study|Other, including COPD exacerbation|5|||
131761773|NCT03455530|474404084|FG000|Overall Study|Withdrawal by Subject|9|||
131761774|NCT03455530|474404085|FG001|Overall Study|Withdrawal by Subject|1|||
131761775|NCT03455530|474404086|FG002|Overall Study|Withdrawal by Subject|3|||
131761776|NCT03455530|474404087|FG003|Overall Study|Withdrawal by Subject|3|||
131761777|NCT01592773|474404092|FG000|Overall Study|Study Terminated by Sponsor|582|||
131761778|NCT01592773|474404092|FG000|Overall Study|Withdrawal by Subject|35|||
131761779|NCT01592773|474404092|FG000|Overall Study|Lost to Follow-up|19|||
131761780|NCT01592773|474404092|FG000|Overall Study|Adverse Event|17|||
131761781|NCT01592773|474404092|FG000|Overall Study|Lack of Efficacy|9|||
131761782|NCT01592773|474404092|FG000|Overall Study|Protocol Violation|2|||
131761783|NCT01592773|474404092|FG000|Overall Study|Inclusion/exclusion not meet|1|||
131761784|NCT01592773|474404092|FG000|Overall Study|Other Reason|1|||
131761785|NCT04418427|474404094|FG000|Overall Study|Death|0|||
131761786|NCT04418427|474404095|FG001|Overall Study|Death|1|||
131761787|NCT04418427|474404096|FG002|Overall Study|Death|0|||
131761788|NCT04418427|474404094|FG000|Overall Study|Lost to Follow-up|0|||
131761789|NCT04418427|474404095|FG001|Overall Study|Lost to Follow-up|2|||
131761790|NCT04418427|474404096|FG002|Overall Study|Lost to Follow-up|2|||
131761791|NCT04418427|474404094|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
131761792|NCT04418427|474404095|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
131761793|NCT04418427|474404096|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
131761794|NCT04418427|474404094|FG000|Overall Study|Pre-existing medical condition|0|||
131761795|NCT04418427|474404095|FG001|Overall Study|Pre-existing medical condition|1|||
131761796|NCT04418427|474404096|FG002|Overall Study|Pre-existing medical condition|0|||
131761797|NCT01004861|474404097|FG000|Overall Study|Disease progression|3|||
131761798|NCT01004861|474404098|FG001|Overall Study|Disease progression|4|||
131761799|NCT01004861|474404099|FG002|Overall Study|Disease progression|5|||
131761800|NCT01004861|474404100|FG003|Overall Study|Disease progression|4|||
131761801|NCT01004861|474404101|FG004|Overall Study|Disease progression|4|||
131761802|NCT01004861|474404102|FG005|Overall Study|Disease progression|4|||
131761803|NCT01004861|474404103|FG006|Overall Study|Disease progression|5|||
131761804|NCT01004861|474404104|FG007|Overall Study|Disease progression|1|||
131761805|NCT01004861|474404105|FG008|Overall Study|Disease progression|4|||
131761806|NCT01004861|474404106|FG009|Overall Study|Disease progression|7|||
131761807|NCT01004861|474404107|FG010|Overall Study|Disease progression|6|||
131761808|NCT01004861|474404108|FG011|Overall Study|Disease progression|3|||
131761809|NCT01004861|474404109|FG012|Overall Study|Disease progression|8|||
131761810|NCT01004861|474404097|FG000|Overall Study|Physician Decision|0|||
131761811|NCT01004861|474404098|FG001|Overall Study|Physician Decision|2|||
131761812|NCT01004861|474404099|FG002|Overall Study|Physician Decision|1|||
131761813|NCT01004861|474404100|FG003|Overall Study|Physician Decision|1|||
131761814|NCT01004861|474404101|FG004|Overall Study|Physician Decision|1|||
131761815|NCT01004861|474404102|FG005|Overall Study|Physician Decision|0|||
131761816|NCT01004861|474404103|FG006|Overall Study|Physician Decision|0|||
131761817|NCT01004861|474404104|FG007|Overall Study|Physician Decision|1|||
131761818|NCT01004861|474404105|FG008|Overall Study|Physician Decision|0|||
131761819|NCT01004861|474404106|FG009|Overall Study|Physician Decision|0|||
131761820|NCT01004861|474404107|FG010|Overall Study|Physician Decision|0|||
131761821|NCT01004861|474404108|FG011|Overall Study|Physician Decision|0|||
131761822|NCT01004861|474404109|FG012|Overall Study|Physician Decision|3|||
131761823|NCT01004861|474404097|FG000|Overall Study|Adverse Event|0|||
131761824|NCT01004861|474404098|FG001|Overall Study|Adverse Event|0|||
131761825|NCT01004861|474404099|FG002|Overall Study|Adverse Event|0|||
131761826|NCT01004861|474404100|FG003|Overall Study|Adverse Event|1|||
131761827|NCT01004861|474404101|FG004|Overall Study|Adverse Event|0|||
131761828|NCT01004861|474404102|FG005|Overall Study|Adverse Event|2|||
131761829|NCT01004861|474404103|FG006|Overall Study|Adverse Event|1|||
131761830|NCT01004861|474404104|FG007|Overall Study|Adverse Event|1|||
131761831|NCT01004861|474404105|FG008|Overall Study|Adverse Event|13|||
131761832|NCT01004861|474404106|FG009|Overall Study|Adverse Event|1|||
131761833|NCT01004861|474404107|FG010|Overall Study|Adverse Event|1|||
131761834|NCT01004861|474404108|FG011|Overall Study|Adverse Event|0|||
131761835|NCT01004861|474404109|FG012|Overall Study|Adverse Event|2|||
131761836|NCT01004861|474404097|FG000|Overall Study|Protocol Violation|0|||
131761837|NCT01004861|474404098|FG001|Overall Study|Protocol Violation|0|||
131761838|NCT01004861|474404099|FG002|Overall Study|Protocol Violation|0|||
131761839|NCT01004861|474404100|FG003|Overall Study|Protocol Violation|0|||
131761840|NCT01004861|474404101|FG004|Overall Study|Protocol Violation|1|||
131761841|NCT01004861|474404102|FG005|Overall Study|Protocol Violation|0|||
131761842|NCT01004861|474404103|FG006|Overall Study|Protocol Violation|0|||
131761843|NCT01004861|474404104|FG007|Overall Study|Protocol Violation|0|||
131761844|NCT01004861|474404105|FG008|Overall Study|Protocol Violation|0|||
131761845|NCT01004861|474404106|FG009|Overall Study|Protocol Violation|0|||
131761846|NCT01004861|474404107|FG010|Overall Study|Protocol Violation|0|||
131761847|NCT01004861|474404108|FG011|Overall Study|Protocol Violation|0|||
131761848|NCT01004861|474404109|FG012|Overall Study|Protocol Violation|0|||
131761849|NCT01004861|474404097|FG000|Overall Study|Lost to Follow-up|0|||
131761850|NCT01004861|474404098|FG001|Overall Study|Lost to Follow-up|0|||
131761851|NCT01004861|474404099|FG002|Overall Study|Lost to Follow-up|0|||
131761852|NCT01004861|474404100|FG003|Overall Study|Lost to Follow-up|0|||
131761853|NCT01004861|474404101|FG004|Overall Study|Lost to Follow-up|0|||
131761854|NCT01004861|474404102|FG005|Overall Study|Lost to Follow-up|0|||
131761855|NCT01004861|474404103|FG006|Overall Study|Lost to Follow-up|0|||
131761856|NCT01004861|474404104|FG007|Overall Study|Lost to Follow-up|1|||
131761857|NCT01004861|474404105|FG008|Overall Study|Lost to Follow-up|3|||
131761858|NCT01004861|474404106|FG009|Overall Study|Lost to Follow-up|0|||
131761859|NCT01004861|474404107|FG010|Overall Study|Lost to Follow-up|0|||
131761860|NCT01004861|474404108|FG011|Overall Study|Lost to Follow-up|1|||
131761861|NCT01004861|474404109|FG012|Overall Study|Lost to Follow-up|0|||
131761862|NCT01004861|474404097|FG000|Overall Study|Non-compliance|0|||
131761863|NCT01004861|474404098|FG001|Overall Study|Non-compliance|0|||
131761864|NCT01004861|474404099|FG002|Overall Study|Non-compliance|0|||
131761865|NCT01004861|474404100|FG003|Overall Study|Non-compliance|0|||
131761866|NCT01004861|474404101|FG004|Overall Study|Non-compliance|0|||
131761867|NCT01004861|474404102|FG005|Overall Study|Non-compliance|0|||
131761868|NCT01004861|474404103|FG006|Overall Study|Non-compliance|0|||
131761869|NCT01004861|474404104|FG007|Overall Study|Non-compliance|0|||
131761870|NCT01004861|474404105|FG008|Overall Study|Non-compliance|5|||
131761871|NCT01004861|474404106|FG009|Overall Study|Non-compliance|0|||
131761872|NCT01004861|474404107|FG010|Overall Study|Non-compliance|0|||
131761873|NCT01004861|474404108|FG011|Overall Study|Non-compliance|0|||
131761874|NCT01004861|474404109|FG012|Overall Study|Non-compliance|1|||
131761875|NCT01004861|474404097|FG000|Overall Study|Other|0|||
131761876|NCT01004861|474404098|FG001|Overall Study|Other|0|||
131761877|NCT01004861|474404099|FG002|Overall Study|Other|0|||
131761878|NCT01004861|474404100|FG003|Overall Study|Other|0|||
131761879|NCT01004861|474404101|FG004|Overall Study|Other|0|||
131761880|NCT01004861|474404102|FG005|Overall Study|Other|0|||
131761881|NCT01004861|474404103|FG006|Overall Study|Other|0|||
131761882|NCT01004861|474404104|FG007|Overall Study|Other|0|||
131761883|NCT01004861|474404105|FG008|Overall Study|Other|0|||
131761884|NCT01004861|474404106|FG009|Overall Study|Other|2|||
131761885|NCT01004861|474404107|FG010|Overall Study|Other|1|||
131761886|NCT01004861|474404108|FG011|Overall Study|Other|2|||
131761887|NCT01004861|474404109|FG012|Overall Study|Other|3|||
131761888|NCT01004861|474404097|FG000|Overall Study|Patient decision|0|||
131761889|NCT01004861|474404098|FG001|Overall Study|Patient decision|0|||
131761890|NCT01004861|474404099|FG002|Overall Study|Patient decision|0|||
131761891|NCT01004861|474404100|FG003|Overall Study|Patient decision|0|||
131761892|NCT01004861|474404101|FG004|Overall Study|Patient decision|1|||
131761893|NCT01004861|474404102|FG005|Overall Study|Patient decision|0|||
131761894|NCT01004861|474404103|FG006|Overall Study|Patient decision|1|||
131761895|NCT01004861|474404104|FG007|Overall Study|Patient decision|0|||
131761896|NCT01004861|474404105|FG008|Overall Study|Patient decision|7|||
131761897|NCT01004861|474404106|FG009|Overall Study|Patient decision|1|||
131761898|NCT01004861|474404107|FG010|Overall Study|Patient decision|1|||
131761899|NCT01004861|474404108|FG011|Overall Study|Patient decision|2|||
131761900|NCT01004861|474404109|FG012|Overall Study|Patient decision|3|||
131761901|NCT01004861|474404097|FG000|Overall Study|Transitioned to Phase 4 study|0|||
131761902|NCT01004861|474404098|FG001|Overall Study|Transitioned to Phase 4 study|0|||
131761903|NCT01004861|474404099|FG002|Overall Study|Transitioned to Phase 4 study|0|||
131761904|NCT01004861|474404100|FG003|Overall Study|Transitioned to Phase 4 study|0|||
131761905|NCT01004861|474404101|FG004|Overall Study|Transitioned to Phase 4 study|0|||
131761906|NCT01004861|474404102|FG005|Overall Study|Transitioned to Phase 4 study|0|||
131761907|NCT01004861|474404103|FG006|Overall Study|Transitioned to Phase 4 study|0|||
131761908|NCT01004861|474404104|FG007|Overall Study|Transitioned to Phase 4 study|0|||
131761909|NCT01004861|474404105|FG008|Overall Study|Transitioned to Phase 4 study|2|||
131761910|NCT01004861|474404106|FG009|Overall Study|Transitioned to Phase 4 study|0|||
131761911|NCT01004861|474404107|FG010|Overall Study|Transitioned to Phase 4 study|0|||
131761912|NCT01004861|474404108|FG011|Overall Study|Transitioned to Phase 4 study|0|||
131909023|NCT01462942|474954725|FG002|Overall Study|Other, including COPD exacerbation|2|||
131909024|NCT01462942|474954726|FG003|Overall Study|Other, including COPD exacerbation|8|||
131761913|NCT01004861|474404109|FG012|Overall Study|Transitioned to Phase 4 study|0|||
131761914|NCT01004861|474404097|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761915|NCT01004861|474404098|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761916|NCT01004861|474404099|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761917|NCT01004861|474404100|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761918|NCT01004861|474404101|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761919|NCT01004861|474404102|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761920|NCT01004861|474404103|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761921|NCT01004861|474404104|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131909025|NCT01462942|474954727|FG004|Overall Study|Other, including COPD exacerbation|5|||
131761922|NCT01004861|474404105|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
131761923|NCT01004861|474404106|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761924|NCT01004861|474404107|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131812952|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
131812953|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
131812954|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131812955|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131812956|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
131812957|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131812958|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
131812959|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
131812960|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
131812961|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
131812962|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131812963|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131812964|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
131812965|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131812966|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131812967|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131812968|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131812969|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
131812970|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131812971|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131812972|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131812973|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
131812974|NCT01940341|474597702|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
131812975|NCT01940341|474597703|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
131812976|NCT01940341|474597704|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
131812977|NCT01940341|474597705|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
131812978|NCT00830024|474597709|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131812979|NCT00830024|474597710|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
131812980|NCT00436163|474597711|FG000|Overall Study|Lost to Follow-up|2|||
131812981|NCT00436163|474597711|FG000|Overall Study|Adverse Event|1|||
131812982|NCT02530905|474597712|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
131812983|NCT02530905|474597713|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
131812984|NCT02530905|474597714|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
131812985|NCT00950989|474597716|FG000|Overall Study|Death|0|||
131812986|NCT00950989|474597717|FG001|Overall Study|Death|0|||
131812987|NCT00950989|474597718|FG002|Overall Study|Death|1|||
131909026|NCT01462942|474954723|FG000|Overall Study|Withdrawal by Subject|14|||
131909027|NCT01462942|474954724|FG001|Overall Study|Withdrawal by Subject|10|||
131909028|NCT01462942|474954725|FG002|Overall Study|Withdrawal by Subject|14|||
131909029|NCT01462942|474954726|FG003|Overall Study|Withdrawal by Subject|16|||
131909030|NCT01462942|474954727|FG004|Overall Study|Withdrawal by Subject|19|||
131909031|NCT01462942|474954723|FG000|Overall Study|Lack of Efficacy|6|||
131909032|NCT01462942|474954724|FG001|Overall Study|Lack of Efficacy|0|||
131909033|NCT01462942|474954725|FG002|Overall Study|Lack of Efficacy|4|||
131909034|NCT01462942|474954726|FG003|Overall Study|Lack of Efficacy|5|||
131909035|NCT01462942|474954727|FG004|Overall Study|Lack of Efficacy|3|||
131761925|NCT01004861|474404108|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761926|NCT01004861|474404109|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131761927|NCT01004861|474404097|FG000|Overall Study|Patient withdrew|0|||
131761928|NCT01004861|474404098|FG001|Overall Study|Patient withdrew|0|||
131761929|NCT01004861|474404099|FG002|Overall Study|Patient withdrew|0|||
131761930|NCT01004861|474404100|FG003|Overall Study|Patient withdrew|0|||
131761931|NCT01004861|474404101|FG004|Overall Study|Patient withdrew|0|||
131761932|NCT01004861|474404102|FG005|Overall Study|Patient withdrew|0|||
131761933|NCT01004861|474404103|FG006|Overall Study|Patient withdrew|0|||
131761934|NCT01004861|474404104|FG007|Overall Study|Patient withdrew|0|||
131909036|NCT01462942|474954723|FG000|Overall Study|Lost to Follow-up|0|||
131761935|NCT01004861|474404105|FG008|Overall Study|Patient withdrew|1|||
131761936|NCT01004861|474404106|FG009|Overall Study|Patient withdrew|0|||
131761937|NCT01004861|474404107|FG010|Overall Study|Patient withdrew|0|||
131812988|NCT00950989|474597719|FG003|Overall Study|Death|0|||
131812989|NCT00950989|474597716|FG000|Overall Study|Administrative Decision|0|||
131812990|NCT00950989|474597717|FG001|Overall Study|Administrative Decision|1|||
131909037|NCT01462942|474954724|FG001|Overall Study|Lost to Follow-up|1|||
131812991|NCT00950989|474597718|FG002|Overall Study|Administrative Decision|0|||
131909038|NCT01462942|474954725|FG002|Overall Study|Lost to Follow-up|1|||
131812992|NCT00950989|474597719|FG003|Overall Study|Administrative Decision|0|||
131909039|NCT01462942|474954726|FG003|Overall Study|Lost to Follow-up|1|||
131761938|NCT01004861|474404108|FG011|Overall Study|Patient withdrew|0|||
131909040|NCT01462942|474954727|FG004|Overall Study|Lost to Follow-up|1|||
131909041|NCT01462942|474954723|FG000|Overall Study|Protocol Violation|4|||
131761939|NCT01004861|474404109|FG012|Overall Study|Patient withdrew|0|||
131761940|NCT01004861|474404097|FG000|Overall Study|Surgical resection|0|||
131761941|NCT01004861|474404098|FG001|Overall Study|Surgical resection|0|||
131761942|NCT01004861|474404099|FG002|Overall Study|Surgical resection|0|||
131761943|NCT01004861|474404100|FG003|Overall Study|Surgical resection|0|||
131761944|NCT01004861|474404101|FG004|Overall Study|Surgical resection|0|||
131761945|NCT01004861|474404102|FG005|Overall Study|Surgical resection|0|||
131761946|NCT01004861|474404103|FG006|Overall Study|Surgical resection|0|||
131761947|NCT01004861|474404104|FG007|Overall Study|Surgical resection|0|||
131761948|NCT01004861|474404105|FG008|Overall Study|Surgical resection|1|||
131761949|NCT01004861|474404106|FG009|Overall Study|Surgical resection|0|||
131761950|NCT01004861|474404107|FG010|Overall Study|Surgical resection|0|||
131761951|NCT01004861|474404108|FG011|Overall Study|Surgical resection|0|||
131761952|NCT01004861|474404109|FG012|Overall Study|Surgical resection|0|||
131761953|NCT01004861|474404097|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761954|NCT01004861|474404098|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761955|NCT01004861|474404099|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761956|NCT01004861|474404100|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761957|NCT01004861|474404101|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761958|NCT01004861|474404102|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761959|NCT01004861|474404103|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761960|NCT01004861|474404104|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761961|NCT01004861|474404105|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
131761962|NCT01004861|474404106|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761963|NCT01004861|474404107|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761964|NCT01004861|474404108|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761965|NCT01004861|474404109|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131761966|NCT01004861|474404097|FG000|Overall Study|Study termination by Sponsor|0|||
131761967|NCT01004861|474404098|FG001|Overall Study|Study termination by Sponsor|0|||
131761968|NCT01004861|474404099|FG002|Overall Study|Study termination by Sponsor|0|||
131761969|NCT01004861|474404100|FG003|Overall Study|Study termination by Sponsor|0|||
131761970|NCT01004861|474404101|FG004|Overall Study|Study termination by Sponsor|0|||
131761971|NCT01004861|474404102|FG005|Overall Study|Study termination by Sponsor|0|||
131761972|NCT01004861|474404103|FG006|Overall Study|Study termination by Sponsor|0|||
131761973|NCT01004861|474404104|FG007|Overall Study|Study termination by Sponsor|0|||
131761974|NCT01004861|474404105|FG008|Overall Study|Study termination by Sponsor|1|||
131761975|NCT01004861|474404106|FG009|Overall Study|Study termination by Sponsor|0|||
131761976|NCT01004861|474404107|FG010|Overall Study|Study termination by Sponsor|0|||
131761977|NCT01004861|474404108|FG011|Overall Study|Study termination by Sponsor|0|||
131761978|NCT01004861|474404109|FG012|Overall Study|Study termination by Sponsor|0|||
131761979|NCT02554721|474404111|FG000|Overall Study|Adverse Event|1|||
131761980|NCT02554721|474404112|FG001|Overall Study|Adverse Event|0|||
131761981|NCT02554721|474404113|FG002|Overall Study|Adverse Event|0|||
131761982|NCT02554721|474404114|FG003|Overall Study|Adverse Event|0|||
131761983|NCT02554721|474404115|FG004|Overall Study|Adverse Event|1|||
131761984|NCT02554721|474404111|FG000|Overall Study|Noncompliance|0|||
131761985|NCT02554721|474404112|FG001|Overall Study|Noncompliance|0|||
131761986|NCT02554721|474404113|FG002|Overall Study|Noncompliance|0|||
131761987|NCT02554721|474404114|FG003|Overall Study|Noncompliance|0|||
131761988|NCT02554721|474404115|FG004|Overall Study|Noncompliance|1|||
131761989|NCT00686699|474404116|FG000|Treatment Period 1|Adverse Event|0|||
131761990|NCT00686699|474404117|FG001|Treatment Period 1|Adverse Event|2|||
131761991|NCT04610827|474404118|FG000|Overall Study|Withdrawal by Subject|1|||
131761992|NCT04610827|474404119|FG001|Overall Study|Withdrawal by Subject|1|||
131761993|NCT04610827|474404120|FG002|Overall Study|Withdrawal by Subject|0|||
131761994|NCT00908895|474404121|FG000|Overall Study|Lost to Follow-up|1|||
131761995|NCT00908895|474404122|FG001|Overall Study|Lost to Follow-up|3|||
131761996|NCT00908895|474404121|FG000|Overall Study|algodystrophy|2|||
131761997|NCT00908895|474404122|FG001|Overall Study|algodystrophy|2|||
131761998|NCT00908895|474404121|FG000|Overall Study|Adverse Event|1|||
131761999|NCT00908895|474404122|FG001|Overall Study|Adverse Event|1|||
131762000|NCT00087594|474404131|FG000|Overall Study|Adverse Event|2|||
131909042|NCT01462942|474954724|FG001|Overall Study|Protocol Violation|6|||
131909043|NCT01462942|474954725|FG002|Overall Study|Protocol Violation|9|||
131398705|NCT01296711|473081241|FG001|Overall Study|Adverse Event|1|||
131762001|NCT00087594|474404132|FG001|Overall Study|Adverse Event|3|||
131762002|NCT00087594|474404131|FG000|Overall Study|Lost to Follow-up|0|||
131762003|NCT00087594|474404132|FG001|Overall Study|Lost to Follow-up|2|||
131762004|NCT00087594|474404131|FG000|Overall Study|Withdrawal by Subject|4|||
131762005|NCT00087594|474404132|FG001|Overall Study|Withdrawal by Subject|2|||
131762006|NCT00087594|474404131|FG000|Overall Study|Lack of Efficacy|2|||
131762007|NCT00087594|474404132|FG001|Overall Study|Lack of Efficacy|5|||
131762008|NCT04657003|474404139|FG000|Overall Study|Adverse Event|5|||
131762009|NCT04657003|474404140|FG001|Overall Study|Adverse Event|1|||
131762010|NCT04657003|474404141|FG002|Overall Study|Adverse Event|5|||
131762011|NCT04657003|474404139|FG000|Overall Study|Death|0|||
131762012|NCT04657003|474404140|FG001|Overall Study|Death|2|||
131762013|NCT04657003|474404141|FG002|Overall Study|Death|0|||
131762014|NCT04657003|474404139|FG000|Overall Study|Lost to Follow-up|8|||
131762015|NCT04657003|474404140|FG001|Overall Study|Lost to Follow-up|4|||
131762016|NCT04657003|474404141|FG002|Overall Study|Lost to Follow-up|10|||
131762017|NCT04657003|474404139|FG000|Overall Study|Other - As Reported by Investigator|3|||
131762018|NCT04657003|474404140|FG001|Overall Study|Other - As Reported by Investigator|2|||
131762019|NCT04657003|474404141|FG002|Overall Study|Other - As Reported by Investigator|2|||
131762020|NCT04657003|474404139|FG000|Overall Study|Pregnancy|2|||
131762021|NCT04657003|474404140|FG001|Overall Study|Pregnancy|0|||
131762022|NCT04657003|474404141|FG002|Overall Study|Pregnancy|2|||
131762023|NCT04657003|474404139|FG000|Overall Study|Withdrawal by Subject|16|||
131762024|NCT04657003|474404140|FG001|Overall Study|Withdrawal by Subject|7|||
131762025|NCT04657003|474404141|FG002|Overall Study|Withdrawal by Subject|10|||
131762026|NCT03650387|474404142|FG000|Overall Study|Withdrawal by Subject|13|||
131762027|NCT03650387|474404142|FG000|Overall Study|Lost to Follow-up|12|||
131762028|NCT03650387|474404142|FG000|Overall Study|Adverse Event (Not related)|1|||
131762029|NCT03650387|474404142|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
131762030|NCT01569568|474404143|FG000|Overall Study|Physician Decision|0|||
131762031|NCT01569568|474404144|FG001|Overall Study|Physician Decision|2|||
131762032|NCT02425891|474404146|FG000|Overall Study|Death|333|||
131762033|NCT02425891|474404147|FG001|Overall Study|Death|314|||
131762034|NCT02425891|474404146|FG000|Overall Study|Lost to Follow-up|4|||
131762035|NCT02425891|474404147|FG001|Overall Study|Lost to Follow-up|6|||
131762036|NCT02425891|474404146|FG000|Overall Study|Non-Compliance|1|||
131762037|NCT02425891|474404147|FG001|Overall Study|Non-Compliance|1|||
131762038|NCT02425891|474404146|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
131762039|NCT02425891|474404147|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
131762040|NCT02425891|474404146|FG000|Overall Study|Physician Decision|0|||
131762041|NCT02425891|474404147|FG001|Overall Study|Physician Decision|1|||
131762042|NCT02425891|474404146|FG000|Overall Study|Protocol Violation|1|||
131762043|NCT02425891|474404147|FG001|Overall Study|Protocol Violation|1|||
131762044|NCT02425891|474404146|FG000|Overall Study|Study Terminated By Sponsor|85|||
131762045|NCT02425891|474404147|FG001|Overall Study|Study Terminated By Sponsor|95|||
131762046|NCT02425891|474404146|FG000|Overall Study|Withdrawal by Subject|27|||
131762047|NCT02425891|474404147|FG001|Overall Study|Withdrawal by Subject|32|||
131762048|NCT04124952|474404148|FG000|Overall Study|Lost to Follow-up|1|||
131762049|NCT01654224|474404152|FG000|Overall Study|Lost to Follow-up|2|||
131762050|NCT01654224|474404153|FG001|Overall Study|Lost to Follow-up|2|||
131762051|NCT01654224|474404152|FG000|Overall Study|Did not receive allocation|1|||
131762052|NCT01654224|474404153|FG001|Overall Study|Did not receive allocation|8|||
131762053|NCT01654224|474404152|FG000|Overall Study|Insufficient blood sample|3|||
131762054|NCT01654224|474404153|FG001|Overall Study|Insufficient blood sample|2|||
131762055|NCT00166504|474404154|FG000|Overall Study|Adverse Event|3|||
131762056|NCT00166504|474404155|FG001|Overall Study|Adverse Event|3|||
131762057|NCT00166504|474404154|FG000|Overall Study|Lost to Follow-up|1|||
131762058|NCT00166504|474404155|FG001|Overall Study|Lost to Follow-up|1|||
131762059|NCT00166504|474404154|FG000|Overall Study|Withdrawal by Subject|1|||
131762060|NCT00166504|474404155|FG001|Overall Study|Withdrawal by Subject|0|||
131762061|NCT03558503|474404156|FG000|Overall Study|Adverse Event|1|||
131762062|NCT03558503|474404156|FG000|Overall Study|Death|1|||
131762063|NCT03558503|474404156|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
131762064|NCT02274311|474404157|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
131762065|NCT00103207|474404158|FG000|Overall Study|Adverse Event|3|||
131762066|NCT00103207|474404158|FG000|Overall Study|Death|1|||
131762067|NCT00103207|474404158|FG000|Overall Study|Withdrawal by Subject|2|||
131762068|NCT00103207|474404158|FG000|Overall Study|Other complicating disease|1|||
131762069|NCT00103207|474404158|FG000|Overall Study|Ineligible|4|||
131762070|NCT00103207|474404158|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
131762071|NCT00853112|474404160|FG000|Overall Study|Randomized but not treated|0|||
131762072|NCT00853112|474404161|FG001|Overall Study|Randomized but not treated|1|||
131762073|NCT00853112|474404162|FG002|Overall Study|Randomized but not treated|0|||
131762074|NCT00853112|474404163|FG003|Overall Study|Randomized but not treated|2|||
131762075|NCT00853112|474404164|FG004|Overall Study|Randomized but not treated|0|||
131762076|NCT00853112|474404165|FG005|Overall Study|Randomized but not treated|0|||
131762077|NCT00853112|474404166|FG006|Overall Study|Randomized but not treated|1|||
131762078|NCT02477800|474404169|FG000|Placebo-Controlled Period|Adverse Event|16|||
131762079|NCT02477800|474404170|FG001|Placebo-Controlled Period|Adverse Event|25|||
131762080|NCT02477800|474404171|FG002|Placebo-Controlled Period|Adverse Event|28|||
131812993|NCT00950989|474597716|FG000|Overall Study|Disease Progression|0|||
131762081|NCT02477800|474404172|FG003|Placebo-Controlled Period|Adverse Event|0|||
131762082|NCT02477800|474404173|FG004|Placebo-Controlled Period|Adverse Event|0|||
131762083|NCT02477800|474404174|FG005|Placebo-Controlled Period|Adverse Event|0|||
131812994|NCT00950989|474597717|FG001|Overall Study|Disease Progression|0|||
131812995|NCT00950989|474597718|FG002|Overall Study|Disease Progression|1|||
131812996|NCT00950989|474597719|FG003|Overall Study|Disease Progression|0|||
131812997|NCT00950989|474597716|FG000|Overall Study|Withdrawal by Subject|2|||
131812998|NCT00950989|474597717|FG001|Overall Study|Withdrawal by Subject|1|||
131812999|NCT00950989|474597718|FG002|Overall Study|Withdrawal by Subject|0|||
131813000|NCT00950989|474597719|FG003|Overall Study|Withdrawal by Subject|0|||
131813001|NCT00950989|474597716|FG000|Overall Study|Adverse Event|2|||
131813002|NCT00950989|474597717|FG001|Overall Study|Adverse Event|1|||
131813003|NCT00950989|474597718|FG002|Overall Study|Adverse Event|1|||
131813004|NCT00950989|474597719|FG003|Overall Study|Adverse Event|0|||
131813005|NCT01841554|474597720|FG000|Overall Study|Death|7|||
131813006|NCT01841554|474597720|FG000|Overall Study|No Implantation|1|||
131813007|NCT01841554|474597720|FG000|Overall Study|Discontinued Follow Up|5|||
131813008|NCT01841554|474597720|FG000|Overall Study|Study exit due to secondary intervention|6|||
131813009|NCT03804983|474597724|FG000|Overall Study|Adverse Event|0|||
131813010|NCT03804983|474597725|FG001|Overall Study|Adverse Event|1|||
131813011|NCT03804983|474597724|FG000|Overall Study|Family Obligation|1|||
131813012|NCT03804983|474597725|FG001|Overall Study|Family Obligation|0|||
131813013|NCT03600376|474597726|FG000|Overall Study|Adverse Event|1|||
131813014|NCT03600376|474597727|FG001|Overall Study|Adverse Event|1|||
131813015|NCT03600376|474597726|FG000|Overall Study|Transferred to other facility|1|||
131813016|NCT03600376|474597727|FG001|Overall Study|Transferred to other facility|0|||
131813017|NCT03600376|474597726|FG000|Overall Study|Investigator Decision|0|||
131813018|NCT03600376|474597727|FG001|Overall Study|Investigator Decision|4|||
131762084|NCT02477800|474404175|FG006|Placebo-Controlled Period|Adverse Event|0|||
131762085|NCT02477800|474404169|FG000|Placebo-Controlled Period|Change of Treatment|1|||
131762086|NCT02477800|474404170|FG001|Placebo-Controlled Period|Change of Treatment|2|||
131762087|NCT02477800|474404171|FG002|Placebo-Controlled Period|Change of Treatment|1|||
131762088|NCT02477800|474404172|FG003|Placebo-Controlled Period|Change of Treatment|0|||
131762089|NCT02477800|474404173|FG004|Placebo-Controlled Period|Change of Treatment|0|||
131762090|NCT02477800|474404174|FG005|Placebo-Controlled Period|Change of Treatment|0|||
131762091|NCT02477800|474404175|FG006|Placebo-Controlled Period|Change of Treatment|0|||
131762092|NCT02477800|474404169|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
131762093|NCT02477800|474404170|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
131762094|NCT02477800|474404171|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
131762095|NCT02477800|474404172|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
131762096|NCT02477800|474404173|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
131762097|NCT02477800|474404174|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
131762098|NCT02477800|474404175|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
131762099|NCT02477800|474404169|FG000|Placebo-Controlled Period|Death|0|||
131762100|NCT02477800|474404170|FG001|Placebo-Controlled Period|Death|3|||
131762101|NCT02477800|474404171|FG002|Placebo-Controlled Period|Death|2|||
131762102|NCT02477800|474404172|FG003|Placebo-Controlled Period|Death|0|||
131762103|NCT02477800|474404173|FG004|Placebo-Controlled Period|Death|0|||
131762104|NCT02477800|474404174|FG005|Placebo-Controlled Period|Death|0|||
131762105|NCT02477800|474404175|FG006|Placebo-Controlled Period|Death|0|||
131762106|NCT02477800|474404169|FG000|Placebo-Controlled Period|Disease Progression|1|||
131762107|NCT02477800|474404170|FG001|Placebo-Controlled Period|Disease Progression|0|||
131762108|NCT02477800|474404171|FG002|Placebo-Controlled Period|Disease Progression|1|||
131762109|NCT02477800|474404172|FG003|Placebo-Controlled Period|Disease Progression|0|||
131762110|NCT02477800|474404173|FG004|Placebo-Controlled Period|Disease Progression|0|||
131762111|NCT02477800|474404174|FG005|Placebo-Controlled Period|Disease Progression|0|||
131762112|NCT02477800|474404175|FG006|Placebo-Controlled Period|Disease Progression|0|||
131762113|NCT02477800|474404169|FG000|Placebo-Controlled Period|Investigator Decision|3|||
131762114|NCT02477800|474404170|FG001|Placebo-Controlled Period|Investigator Decision|2|||
131762115|NCT02477800|474404171|FG002|Placebo-Controlled Period|Investigator Decision|1|||
131762116|NCT02477800|474404172|FG003|Placebo-Controlled Period|Investigator Decision|0|||
131813019|NCT03600376|474597726|FG000|Overall Study|Determined to be ineligible for study|0|||
131813020|NCT03600376|474597727|FG001|Overall Study|Determined to be ineligible for study|1|||
131813021|NCT02152163|474597728|FG000|Overall Study|Physician Decision|12|||
131813022|NCT02152163|474597729|FG001|Overall Study|Physician Decision|13|||
131813023|NCT00730691|474597736|FG000|Overall Study|Adverse Event|4|||
131813024|NCT00730691|474597737|FG001|Overall Study|Adverse Event|8|||
131813025|NCT00730691|474597738|FG002|Overall Study|Adverse Event|11|||
131813026|NCT00730691|474597739|FG003|Overall Study|Adverse Event|11|||
131813027|NCT00730691|474597740|FG004|Overall Study|Adverse Event|23|||
131762117|NCT02477800|474404173|FG004|Placebo-Controlled Period|Investigator Decision|0|||
131813028|NCT00730691|474597736|FG000|Overall Study|Lack of Efficacy|4|||
131762118|NCT02477800|474404174|FG005|Placebo-Controlled Period|Investigator Decision|0|||
131762119|NCT02477800|474404175|FG006|Placebo-Controlled Period|Investigator Decision|0|||
131762120|NCT02477800|474404169|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
131813029|NCT00730691|474597737|FG001|Overall Study|Lack of Efficacy|4|||
131813030|NCT00730691|474597738|FG002|Overall Study|Lack of Efficacy|2|||
131813031|NCT00730691|474597739|FG003|Overall Study|Lack of Efficacy|1|||
131813032|NCT00730691|474597740|FG004|Overall Study|Lack of Efficacy|1|||
131813033|NCT00730691|474597736|FG000|Overall Study|Non-compliance with Study Drug|6|||
131813034|NCT00730691|474597737|FG001|Overall Study|Non-compliance with Study Drug|1|||
131813035|NCT00730691|474597738|FG002|Overall Study|Non-compliance with Study Drug|6|||
131813036|NCT00730691|474597739|FG003|Overall Study|Non-compliance with Study Drug|3|||
131813037|NCT00730691|474597740|FG004|Overall Study|Non-compliance with Study Drug|3|||
131813038|NCT00730691|474597736|FG000|Overall Study|Protocol Deviations|3|||
131813039|NCT00730691|474597737|FG001|Overall Study|Protocol Deviations|5|||
131813040|NCT00730691|474597738|FG002|Overall Study|Protocol Deviations|3|||
131813041|NCT00730691|474597739|FG003|Overall Study|Protocol Deviations|7|||
131813042|NCT00730691|474597740|FG004|Overall Study|Protocol Deviations|5|||
131813043|NCT00730691|474597736|FG000|Overall Study|Withdrawal of Consent|7|||
131813044|NCT00730691|474597737|FG001|Overall Study|Withdrawal of Consent|9|||
131813045|NCT00730691|474597738|FG002|Overall Study|Withdrawal of Consent|3|||
131813046|NCT00730691|474597739|FG003|Overall Study|Withdrawal of Consent|6|||
131813047|NCT00730691|474597740|FG004|Overall Study|Withdrawal of Consent|3|||
131813048|NCT00730691|474597736|FG000|Overall Study|Lost to Follow-up|11|||
131813049|NCT00730691|474597737|FG001|Overall Study|Lost to Follow-up|8|||
131813050|NCT00730691|474597738|FG002|Overall Study|Lost to Follow-up|13|||
131813051|NCT00730691|474597739|FG003|Overall Study|Lost to Follow-up|15|||
131813052|NCT00730691|474597740|FG004|Overall Study|Lost to Follow-up|13|||
131813053|NCT00730691|474597736|FG000|Overall Study|Other|1|||
131813054|NCT00730691|474597737|FG001|Overall Study|Other|1|||
131813055|NCT00730691|474597738|FG002|Overall Study|Other|1|||
131813056|NCT00730691|474597739|FG003|Overall Study|Other|2|||
131813057|NCT00730691|474597740|FG004|Overall Study|Other|2|||
131813058|NCT02178787|474597741|FG000|Overall Study|Lost to Follow-up|1|||
131813059|NCT02178787|474597742|FG001|Overall Study|Lost to Follow-up|0|||
131813060|NCT02178787|474597741|FG000|Overall Study|Withdrawal by Subject|0|||
131813061|NCT02178787|474597742|FG001|Overall Study|Withdrawal by Subject|2|||
131813062|NCT02178787|474597741|FG000|Overall Study|No TCD window|3|||
131813063|NCT02178787|474597742|FG001|Overall Study|No TCD window|7|||
131813064|NCT02178787|474597741|FG000|Overall Study|Physician Decision|1|||
131813065|NCT02178787|474597742|FG001|Overall Study|Physician Decision|0|||
131813066|NCT02554890|474597743|FG000|Double-blind|Adverse Event|45|||
131813067|NCT02554890|474597744|FG001|Double-blind|Adverse Event|51|||
131813068|NCT02554890|474597743|FG000|Double-blind|Death|6|||
131813069|NCT02554890|474597744|FG001|Double-blind|Death|4|||
131813070|NCT02554890|474597743|FG000|Double-blind|Protocol Violation|1|||
131813071|NCT02554890|474597744|FG001|Double-blind|Protocol Violation|1|||
131813072|NCT02554890|474597743|FG000|Double-blind|Physician Decision|4|||
131813073|NCT02554890|474597744|FG001|Double-blind|Physician Decision|3|||
131813074|NCT02554890|474597743|FG000|Double-blind|Subject/Guardian decision|21|||
131813075|NCT02554890|474597744|FG001|Double-blind|Subject/Guardian decision|16|||
131813076|NCT02554890|474597743|FG000|Double-blind|Lost to Follow-up|7|||
131813077|NCT02554890|474597744|FG001|Double-blind|Lost to Follow-up|5|||
131813078|NCT02554890|474597743|FG000|Double-blind|Technical problems|1|||
131813079|NCT02554890|474597744|FG001|Double-blind|Technical problems|0|||
131813080|NCT02554890|474597743|FG000|Double-blind|Withdrawal by Subject|5|||
131813081|NCT02554890|474597744|FG001|Double-blind|Withdrawal by Subject|6|||
131813082|NCT02554890|474597743|FG000|Double-blind|Noncompliance with study treatment|6|||
131813083|NCT02554890|474597744|FG001|Double-blind|Noncompliance with study treatment|5|||
131813084|NCT02554890|474597743|FG000|Open-label|Adverse Event|0|||
131813085|NCT02554890|474597744|FG001|Open-label|Adverse Event|30|||
131813086|NCT02554890|474597743|FG000|Open-label|Death|0|||
131813087|NCT02554890|474597744|FG001|Open-label|Death|1|||
131813088|NCT02554890|474597743|FG000|Open-label|Physician Decision|0|||
131813089|NCT02554890|474597744|FG001|Open-label|Physician Decision|1|||
131813090|NCT02554890|474597743|FG000|Open-label|Subject/Guardian decision|0|||
131813091|NCT02554890|474597744|FG001|Open-label|Subject/Guardian decision|11|||
131813092|NCT02554890|474597743|FG000|Open-label|Lost to Follow-up|0|||
131813093|NCT02554890|474597744|FG001|Open-label|Lost to Follow-up|7|||
131813094|NCT02554890|474597743|FG000|Open-label|Technical problems|0|||
131909044|NCT01462942|474954726|FG003|Overall Study|Protocol Violation|9|||
131813095|NCT02554890|474597744|FG001|Open-label|Technical problems|1|||
131813096|NCT02554890|474597743|FG000|Open-label|Withdrawal by Subject|0|||
131813097|NCT02554890|474597744|FG001|Open-label|Withdrawal by Subject|1|||
131813098|NCT03649477|474597745|FG000|Overall Study|Adverse Event|2|||
131813099|NCT03649477|474597746|FG001|Overall Study|Adverse Event|0|||
131813100|NCT03649477|474597747|FG002|Overall Study|Adverse Event|0|||
131813101|NCT03114891|474597750|FG000|First Treatment Round|Lost to Follow-up|0|||
131813102|NCT03114891|474597751|FG001|First Treatment Round|Lost to Follow-up|1|||
131813103|NCT03114891|474597752|FG002|First Treatment Round|Lost to Follow-up|1|||
131813104|NCT03114891|474597753|FG003|First Treatment Round|Lost to Follow-up|0|||
131813105|NCT03114891|474597750|FG000|First Treatment Round|Withdrawal by Subject|0|||
131813106|NCT03114891|474597751|FG001|First Treatment Round|Withdrawal by Subject|2|||
131813107|NCT03114891|474597752|FG002|First Treatment Round|Withdrawal by Subject|0|||
131813108|NCT03114891|474597753|FG003|First Treatment Round|Withdrawal by Subject|1|||
131813109|NCT03114891|474597750|FG000|3 Week Break|Lost to Follow-up|1|||
131813110|NCT03114891|474597751|FG001|3 Week Break|Lost to Follow-up|0|||
131762121|NCT02477800|474404170|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
131762122|NCT02477800|474404171|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
131762123|NCT02477800|474404172|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
131762124|NCT02477800|474404173|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
131762125|NCT02477800|474404174|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
131762126|NCT02477800|474404175|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
131762127|NCT02477800|474404169|FG000|Placebo-Controlled Period|Relocation|2|||
131762128|NCT02477800|474404170|FG001|Placebo-Controlled Period|Relocation|0|||
131762129|NCT02477800|474404171|FG002|Placebo-Controlled Period|Relocation|0|||
131762130|NCT02477800|474404172|FG003|Placebo-Controlled Period|Relocation|0|||
131762131|NCT02477800|474404173|FG004|Placebo-Controlled Period|Relocation|0|||
131762132|NCT02477800|474404174|FG005|Placebo-Controlled Period|Relocation|0|||
131762133|NCT02477800|474404175|FG006|Placebo-Controlled Period|Relocation|0|||
131762134|NCT02477800|474404169|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
131762135|NCT02477800|474404170|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
131762136|NCT02477800|474404171|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
131762137|NCT02477800|474404172|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131762138|NCT02477800|474404173|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131762139|NCT02477800|474404174|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131762140|NCT02477800|474404175|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131762141|NCT02477800|474404169|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
131762142|NCT02477800|474404170|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
131762143|NCT02477800|474404171|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131762144|NCT02477800|474404172|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131762145|NCT02477800|474404173|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131762146|NCT02477800|474404174|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131762147|NCT02477800|474404175|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131762148|NCT02477800|474404169|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
131762149|NCT02477800|474404170|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
131762150|NCT02477800|474404171|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
131762151|NCT02477800|474404172|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
131762152|NCT02477800|474404173|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
131762153|NCT02477800|474404174|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
131762154|NCT02477800|474404175|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
131762155|NCT02477800|474404169|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131762156|NCT02477800|474404170|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
131762157|NCT02477800|474404171|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
131762158|NCT02477800|474404172|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131762159|NCT02477800|474404173|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131762160|NCT02477800|474404174|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131762161|NCT02477800|474404175|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131762162|NCT02477800|474404169|FG000|Placebo-Controlled Period|Reason not Specified|161|||
131762163|NCT02477800|474404170|FG001|Placebo-Controlled Period|Reason not Specified|161|||
131762164|NCT02477800|474404171|FG002|Placebo-Controlled Period|Reason not Specified|189|||
131762165|NCT02477800|474404172|FG003|Placebo-Controlled Period|Reason not Specified|0|||
131813111|NCT03114891|474597752|FG002|3 Week Break|Lost to Follow-up|0|||
131813112|NCT03114891|474597753|FG003|3 Week Break|Lost to Follow-up|1|||
131813113|NCT03114891|474597750|FG000|3 Week Break|Withdrawal by Subject|0|||
131813114|NCT03114891|474597751|FG001|3 Week Break|Withdrawal by Subject|1|||
131813115|NCT03114891|474597752|FG002|3 Week Break|Withdrawal by Subject|0|||
131813116|NCT03114891|474597753|FG003|3 Week Break|Withdrawal by Subject|0|||
131813117|NCT03114891|474597750|FG000|Second Treatment Round|Lost to Follow-up|1|||
131813118|NCT03114891|474597751|FG001|Second Treatment Round|Lost to Follow-up|0|||
131813119|NCT03114891|474597752|FG002|Second Treatment Round|Lost to Follow-up|0|||
131813120|NCT03114891|474597753|FG003|Second Treatment Round|Lost to Follow-up|0|||
131813121|NCT03114891|474597750|FG000|Second Treatment Round|Physician Decision|1|||
131813122|NCT03114891|474597751|FG001|Second Treatment Round|Physician Decision|0|||
131813123|NCT03114891|474597752|FG002|Second Treatment Round|Physician Decision|0|||
131813124|NCT03114891|474597753|FG003|Second Treatment Round|Physician Decision|0|||
131813125|NCT02571907|474598935|FG000|Overall Study|Death|4|||
131813126|NCT02571907|474598935|FG000|Overall Study|Lost to Follow-up|3|||
131813127|NCT02571907|474598935|FG000|Overall Study|Withdrawal by Subject|3|||
131762166|NCT02477800|474404173|FG004|Placebo-Controlled Period|Reason not Specified|0|||
131762167|NCT02477800|474404174|FG005|Placebo-Controlled Period|Reason not Specified|0|||
131762168|NCT02477800|474404175|FG006|Placebo-Controlled Period|Reason not Specified|0|||
131762169|NCT02477800|474404169|FG000|Long Term Extension Period|Adverse Event|0|||
131762170|NCT02477800|474404170|FG001|Long Term Extension Period|Adverse Event|0|||
131762171|NCT02477800|474404171|FG002|Long Term Extension Period|Adverse Event|0|||
131813128|NCT02267187|474598937|FG000|Overall Study|Physician Decision|2|||
131813129|NCT02267187|474598937|FG000|Overall Study|Screen fail|3|||
131813130|NCT02222818|474598943|FG000|Period 1|Eligibility criteria not met|0|||
131762172|NCT02477800|474404172|FG003|Long Term Extension Period|Adverse Event|6|||
131762173|NCT02477800|474404173|FG004|Long Term Extension Period|Adverse Event|2|||
131762174|NCT02477800|474404174|FG005|Long Term Extension Period|Adverse Event|4|||
131762175|NCT02477800|474404175|FG006|Long Term Extension Period|Adverse Event|3|||
131762176|NCT02477800|474404169|FG000|Long Term Extension Period|Death|0|||
131762177|NCT02477800|474404170|FG001|Long Term Extension Period|Death|0|||
131762178|NCT02477800|474404171|FG002|Long Term Extension Period|Death|0|||
131762179|NCT02477800|474404172|FG003|Long Term Extension Period|Death|1|||
131762180|NCT02477800|474404173|FG004|Long Term Extension Period|Death|1|||
131762181|NCT02477800|474404174|FG005|Long Term Extension Period|Death|1|||
131762182|NCT02477800|474404175|FG006|Long Term Extension Period|Death|2|||
131762183|NCT02477800|474404169|FG000|Long Term Extension Period|Consent Withdrawn|0|||
131762184|NCT02477800|474404170|FG001|Long Term Extension Period|Consent Withdrawn|0|||
131762185|NCT02477800|474404171|FG002|Long Term Extension Period|Consent Withdrawn|0|||
131762186|NCT02477800|474404172|FG003|Long Term Extension Period|Consent Withdrawn|10|||
131762187|NCT02477800|474404173|FG004|Long Term Extension Period|Consent Withdrawn|4|||
131762188|NCT02477800|474404174|FG005|Long Term Extension Period|Consent Withdrawn|13|||
131762189|NCT02477800|474404175|FG006|Long Term Extension Period|Consent Withdrawn|16|||
131762190|NCT02477800|474404169|FG000|Long Term Extension Period|Disease Progression|0|||
131762191|NCT02477800|474404170|FG001|Long Term Extension Period|Disease Progression|0|||
131762192|NCT02477800|474404171|FG002|Long Term Extension Period|Disease Progression|0|||
131762193|NCT02477800|474404172|FG003|Long Term Extension Period|Disease Progression|3|||
131762194|NCT02477800|474404173|FG004|Long Term Extension Period|Disease Progression|1|||
131762195|NCT02477800|474404174|FG005|Long Term Extension Period|Disease Progression|1|||
131762196|NCT02477800|474404175|FG006|Long Term Extension Period|Disease Progression|0|||
131762197|NCT02477800|474404169|FG000|Long Term Extension Period|Investigator Decision|0|||
131762198|NCT02477800|474404170|FG001|Long Term Extension Period|Investigator Decision|0|||
131762199|NCT02477800|474404171|FG002|Long Term Extension Period|Investigator Decision|0|||
131762200|NCT02477800|474404172|FG003|Long Term Extension Period|Investigator Decision|0|||
131762201|NCT02477800|474404173|FG004|Long Term Extension Period|Investigator Decision|0|||
131762202|NCT02477800|474404174|FG005|Long Term Extension Period|Investigator Decision|0|||
131762203|NCT02477800|474404175|FG006|Long Term Extension Period|Investigator Decision|2|||
131762204|NCT02477800|474404169|FG000|Long Term Extension Period|Lost to Follow-up|0|||
131762205|NCT02477800|474404170|FG001|Long Term Extension Period|Lost to Follow-up|0|||
131762206|NCT02477800|474404171|FG002|Long Term Extension Period|Lost to Follow-up|0|||
131762207|NCT02477800|474404172|FG003|Long Term Extension Period|Lost to Follow-up|0|||
131762208|NCT02477800|474404173|FG004|Long Term Extension Period|Lost to Follow-up|1|||
131762209|NCT02477800|474404174|FG005|Long Term Extension Period|Lost to Follow-up|3|||
131762210|NCT02477800|474404175|FG006|Long Term Extension Period|Lost to Follow-up|0|||
131762211|NCT02477800|474404169|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
131762212|NCT02477800|474404170|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
131762213|NCT02477800|474404171|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
131762214|NCT02477800|474404172|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
131762215|NCT02477800|474404173|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
131762216|NCT02477800|474404174|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
131762217|NCT02477800|474404175|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
131762218|NCT02477800|474404169|FG000|Long Term Extension Period|Study Visit Burden|0|||
131762219|NCT02477800|474404170|FG001|Long Term Extension Period|Study Visit Burden|0|||
131762220|NCT02477800|474404171|FG002|Long Term Extension Period|Study Visit Burden|0|||
131762221|NCT02477800|474404172|FG003|Long Term Extension Period|Study Visit Burden|3|||
131762222|NCT02477800|474404173|FG004|Long Term Extension Period|Study Visit Burden|0|||
131762223|NCT02477800|474404174|FG005|Long Term Extension Period|Study Visit Burden|2|||
131762224|NCT02477800|474404175|FG006|Long Term Extension Period|Study Visit Burden|2|||
131762225|NCT02477800|474404169|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
131762226|NCT02477800|474404170|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
131762227|NCT02477800|474404171|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
131762228|NCT02477800|474404172|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
131762229|NCT02477800|474404173|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
131762230|NCT02477800|474404174|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
131762231|NCT02477800|474404175|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
131762232|NCT02477800|474404169|FG000|Long Term Extension Period|Reason not Specified|0|||
131762233|NCT02477800|474404170|FG001|Long Term Extension Period|Reason not Specified|0|||
131762234|NCT02477800|474404171|FG002|Long Term Extension Period|Reason not Specified|0|||
131762235|NCT02477800|474404172|FG003|Long Term Extension Period|Reason not Specified|126|||
131762236|NCT02477800|474404173|FG004|Long Term Extension Period|Reason not Specified|140|||
131909045|NCT01462942|474954727|FG004|Overall Study|Protocol Violation|6|||
131762237|NCT02477800|474404174|FG005|Long Term Extension Period|Reason not Specified|270|||
131762238|NCT02477800|474404175|FG006|Long Term Extension Period|Reason not Specified|224|||
131762239|NCT00958191|474404177|FG000|Overall Study|Death|4|||
131762240|NCT00958191|474404177|FG000|Overall Study|Lost to Follow-up|5|||
131762241|NCT00958191|474404177|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
131762242|NCT00958191|474404177|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
131762243|NCT00958191|474404177|FG000|Overall Study|Revision of study device|4|||
131762244|NCT00958191|474404177|FG000|Overall Study|Site termination|11|||
131762245|NCT00958191|474404177|FG000|Overall Study|No 5 yr x-rays|56|||
131762246|NCT01818765|474404178|FG000|Overall Study|Death|2|||
131762247|NCT02010567|474404181|FG000|Overall Study|Adverse Event|0|||
131762248|NCT02010567|474404182|FG001|Overall Study|Adverse Event|0|||
131762249|NCT02010567|474404183|FG002|Overall Study|Adverse Event|1|||
131762250|NCT02010567|474404184|FG003|Overall Study|Adverse Event|0|||
131762251|NCT02010567|474404185|FG004|Overall Study|Adverse Event|1|||
131762252|NCT02005211|474404186|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131762253|NCT02005211|474404187|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131762254|NCT02005211|474404188|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131762255|NCT02005211|474404189|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131762256|NCT02005211|474404190|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
131762257|NCT02005211|474404191|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131762258|NCT02005211|474404192|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131762259|NCT00397631|474404195|FG000|Overall Study|Adverse Event|5|||
131762260|NCT00397631|474404196|FG001|Overall Study|Adverse Event|6|||
131762261|NCT00397631|474404195|FG000|Overall Study|Lack of Efficacy|7|||
131762262|NCT00397631|474404196|FG001|Overall Study|Lack of Efficacy|10|||
131762263|NCT00397631|474404195|FG000|Overall Study|Lost to Follow-up|8|||
131762264|NCT00397631|474404196|FG001|Overall Study|Lost to Follow-up|9|||
131762265|NCT00397631|474404195|FG000|Overall Study|Physician Decision|2|||
131762266|NCT00397631|474404196|FG001|Overall Study|Physician Decision|0|||
131762267|NCT00397631|474404195|FG000|Overall Study|Protocol Violation|0|||
131909046|NCT00368550|474954728|FG000|Overall Study|Adverse Event|7|||
131909047|NCT00368550|474954729|FG001|Overall Study|Adverse Event|4|||
131909048|NCT00368550|474954728|FG000|Overall Study|Lack of Efficacy|4|||
131909049|NCT00368550|474954729|FG001|Overall Study|Lack of Efficacy|9|||
131909050|NCT00368550|474954728|FG000|Overall Study|Withdrawal by Subject|17|||
131909051|NCT00368550|474954729|FG001|Overall Study|Withdrawal by Subject|10|||
131909052|NCT00486044|474954730|FG000|Overall Study|Withdrawal by Subject|2|||
131909053|NCT00486044|474954731|FG001|Overall Study|Withdrawal by Subject|1|||
131762268|NCT00397631|474404196|FG001|Overall Study|Protocol Violation|1|||
131762269|NCT00397631|474404195|FG000|Overall Study|Withdrawal by Subject|7|||
131762270|NCT00397631|474404196|FG001|Overall Study|Withdrawal by Subject|14|||
131762271|NCT00397631|474404195|FG000|Overall Study|protocol discontinuation criteria|1|||
131762272|NCT00397631|474404196|FG001|Overall Study|protocol discontinuation criteria|4|||
131762273|NCT02202161|474404197|FG000|Overall Study|Adverse Event|1|||
131762274|NCT02202161|474404198|FG001|Overall Study|Adverse Event|1|||
131762275|NCT02202161|474404199|FG002|Overall Study|Adverse Event|0|||
131762276|NCT02202161|474404200|FG003|Overall Study|Adverse Event|0|||
131762277|NCT02202161|474404201|FG004|Overall Study|Adverse Event|0|||
131762278|NCT02202161|474404202|FG005|Overall Study|Adverse Event|1|||
131762279|NCT02202161|474404203|FG006|Overall Study|Adverse Event|0|||
131762280|NCT02202161|474404204|FG007|Overall Study|Adverse Event|0|||
131762281|NCT02202161|474404197|FG000|Overall Study|Did not meet continuation criteria|0|||
131762282|NCT02202161|474404198|FG001|Overall Study|Did not meet continuation criteria|0|||
131762283|NCT02202161|474404199|FG002|Overall Study|Did not meet continuation criteria|0|||
131762284|NCT02202161|474404200|FG003|Overall Study|Did not meet continuation criteria|0|||
131762285|NCT02202161|474404201|FG004|Overall Study|Did not meet continuation criteria|0|||
131762286|NCT02202161|474404202|FG005|Overall Study|Did not meet continuation criteria|0|||
131762287|NCT02202161|474404203|FG006|Overall Study|Did not meet continuation criteria|0|||
131762288|NCT02202161|474404204|FG007|Overall Study|Did not meet continuation criteria|3|||
131762289|NCT02202161|474404197|FG000|Overall Study|Physician Decision|0|||
131762290|NCT02202161|474404198|FG001|Overall Study|Physician Decision|0|||
131762291|NCT02202161|474404199|FG002|Overall Study|Physician Decision|0|||
131762292|NCT02202161|474404200|FG003|Overall Study|Physician Decision|0|||
131762293|NCT02202161|474404201|FG004|Overall Study|Physician Decision|0|||
131762294|NCT02202161|474404202|FG005|Overall Study|Physician Decision|0|||
131762295|NCT02202161|474404203|FG006|Overall Study|Physician Decision|0|||
131762296|NCT02202161|474404204|FG007|Overall Study|Physician Decision|3|||
131762297|NCT02202161|474404197|FG000|Overall Study|Withdrawal by Subject|0|||
131762298|NCT02202161|474404198|FG001|Overall Study|Withdrawal by Subject|0|||
131762299|NCT02202161|474404199|FG002|Overall Study|Withdrawal by Subject|0|||
131762300|NCT02202161|474404200|FG003|Overall Study|Withdrawal by Subject|0|||
131762301|NCT02202161|474404201|FG004|Overall Study|Withdrawal by Subject|1|||
131762302|NCT02202161|474404202|FG005|Overall Study|Withdrawal by Subject|0|||
131762303|NCT02202161|474404203|FG006|Overall Study|Withdrawal by Subject|0|||
131762304|NCT02202161|474404204|FG007|Overall Study|Withdrawal by Subject|0|||
131762305|NCT00832091|474404205|FG000|Overall Study|Adverse Event|1|||
131762306|NCT00832091|474404206|FG001|Overall Study|Adverse Event|1|||
131762307|NCT00832091|474404205|FG000|Overall Study|Protocol Violation|1|||
131762308|NCT00832091|474404206|FG001|Overall Study|Protocol Violation|0|||
131909054|NCT00486044|474954730|FG000|Overall Study|Adverse Event|0|||
131762309|NCT00832091|474404205|FG000|Overall Study|Withdrawal by Subject|2|||
131762310|NCT00832091|474404206|FG001|Overall Study|Withdrawal by Subject|1|||
131762311|NCT00832091|474404205|FG000|Overall Study|Prohibited Medication|1|||
131762312|NCT00832091|474404206|FG001|Overall Study|Prohibited Medication|0|||
131762313|NCT01738594|474404207|FG000|Registration and Treatment Start|Adverse Event|0|||
131762314|NCT01738594|474404208|FG001|Registration and Treatment Start|Adverse Event|1|||
131762315|NCT01738594|474404209|FG002|Registration and Treatment Start|Adverse Event|0|||
131762316|NCT01738594|474404210|FG003|Registration and Treatment Start|Adverse Event|0|||
131762317|NCT01738594|474404211|FG004|Registration and Treatment Start|Adverse Event|0|||
131762318|NCT01738594|474404212|FG005|Registration and Treatment Start|Adverse Event|0|||
131762319|NCT01738594|474404213|FG006|Registration and Treatment Start|Adverse Event|0|||
131762320|NCT01738594|474404214|FG007|Registration and Treatment Start|Adverse Event|0|||
131762321|NCT01738594|474404207|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762322|NCT01738594|474404208|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762323|NCT01738594|474404209|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762324|NCT01738594|474404210|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762325|NCT01738594|474404211|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762326|NCT01738594|474404212|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
131762327|NCT01738594|474404213|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762328|NCT01738594|474404214|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131762329|NCT01738594|474404207|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762330|NCT01738594|474404208|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
131762331|NCT01738594|474404209|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762332|NCT01738594|474404210|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762333|NCT01738594|474404211|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762334|NCT01738594|474404212|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762335|NCT01738594|474404213|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762336|NCT01738594|474404214|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
131762337|NCT01738594|474404207|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762338|NCT01738594|474404208|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762339|NCT01738594|474404209|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762340|NCT01738594|474404210|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762341|NCT01738594|474404211|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762342|NCT01738594|474404212|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
131762343|NCT01738594|474404213|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762344|NCT01738594|474404214|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131762345|NCT01738594|474404207|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762346|NCT01738594|474404208|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762347|NCT01738594|474404209|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762348|NCT01738594|474404210|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762349|NCT01738594|474404211|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762350|NCT01738594|474404212|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
131762351|NCT01738594|474404213|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762352|NCT01738594|474404214|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131762353|NCT01738594|474404207|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762354|NCT01738594|474404208|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762355|NCT01738594|474404209|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762356|NCT01738594|474404210|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762357|NCT01738594|474404211|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
131762358|NCT01738594|474404212|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762359|NCT01738594|474404213|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762360|NCT01738594|474404214|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131762361|NCT01738594|474404207|FG000|Follow up for 1 Year|Death|0|||
131762362|NCT01738594|474404208|FG001|Follow up for 1 Year|Death|0|||
131762363|NCT01738594|474404209|FG002|Follow up for 1 Year|Death|0|||
131762364|NCT01738594|474404210|FG003|Follow up for 1 Year|Death|0|||
131762365|NCT01738594|474404211|FG004|Follow up for 1 Year|Death|0|||
131762366|NCT01738594|474404212|FG005|Follow up for 1 Year|Death|1|||
131762367|NCT01738594|474404213|FG006|Follow up for 1 Year|Death|0|||
131762368|NCT01738594|474404214|FG007|Follow up for 1 Year|Death|0|||
131762369|NCT01738594|474404207|FG000|Follow up for 1 Year|Other|0|||
131813131|NCT02222818|474598944|FG001|Period 1|Eligibility criteria not met|3|||
131813132|NCT00834717|474598945|FG000|First Intervention|Adverse Event|1|||
131813133|NCT00834717|474598946|FG001|First Intervention|Adverse Event|0|||
131813134|NCT00834717|474598945|FG000|First Intervention|Withdrawal by Subject|0|||
131813135|NCT00834717|474598946|FG001|First Intervention|Withdrawal by Subject|1|||
131813136|NCT03025087|474598947|FG000|Overall Study|Physician Decision|3|||
131813137|NCT03025087|474598948|FG001|Overall Study|Physician Decision|3|||
131909055|NCT00486044|474954731|FG001|Overall Study|Adverse Event|1|||
131909056|NCT00486044|474954730|FG000|Overall Study|Lost to Follow-up|0|||
131909057|NCT00486044|474954731|FG001|Overall Study|Lost to Follow-up|1|||
131909058|NCT01670292|474954733|FG000|Overall Study|Lost to Follow-up|14|||
131909059|NCT03154086|474954739|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909060|NCT03154086|474954740|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909061|NCT03154086|474954741|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909062|NCT03154086|474954742|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
131909063|NCT03154086|474954743|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909064|NCT03154086|474954744|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909065|NCT03154086|474954745|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909066|NCT03154086|474954746|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909067|NCT03154086|474954747|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909068|NCT03154086|474954748|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909069|NCT03154086|474954749|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909070|NCT03154086|474954750|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909071|NCT03154086|474954751|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909072|NCT03154086|474954752|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909073|NCT03154086|474954753|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
131909074|NCT03154086|474954739|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909075|NCT03154086|474954740|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
131909076|NCT03154086|474954741|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909077|NCT03154086|474954742|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909078|NCT03154086|474954743|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909079|NCT03154086|474954744|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909080|NCT03154086|474954745|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909081|NCT03154086|474954746|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909082|NCT03154086|474954747|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909083|NCT03154086|474954748|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909084|NCT03154086|474954749|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909085|NCT03154086|474954750|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909086|NCT03154086|474954751|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909087|NCT03154086|474954752|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909088|NCT03154086|474954753|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
131909089|NCT03154086|474954739|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909090|NCT03154086|474954740|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909091|NCT03154086|474954741|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
131909092|NCT03154086|474954742|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909093|NCT03154086|474954743|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909094|NCT03154086|474954744|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909095|NCT03154086|474954745|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909096|NCT03154086|474954746|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909097|NCT03154086|474954747|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909098|NCT03154086|474954748|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909099|NCT03154086|474954749|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131762370|NCT01738594|474404208|FG001|Follow up for 1 Year|Other|0|||
131762371|NCT01738594|474404209|FG002|Follow up for 1 Year|Other|0|||
131762372|NCT01738594|474404210|FG003|Follow up for 1 Year|Other|0|||
131762373|NCT01738594|474404211|FG004|Follow up for 1 Year|Other|0|||
131762374|NCT01738594|474404212|FG005|Follow up for 1 Year|Other|2|||
131762375|NCT01738594|474404213|FG006|Follow up for 1 Year|Other|0|||
131762376|NCT01738594|474404214|FG007|Follow up for 1 Year|Other|0|||
131762377|NCT00935701|474404215|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
131762378|NCT03117309|474404216|FG000|Overall Study|Not meeting inclusion criteria|0|||
131762379|NCT03117309|474404217|FG001|Overall Study|Not meeting inclusion criteria|1|||
131762380|NCT01010776|474404221|FG000|Main Phase|Withdrawal by Subject|14|||
131762381|NCT01010776|474404221|FG000|Main Phase|Lack of Efficacy|8|||
131909100|NCT03154086|474954750|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909101|NCT03154086|474954751|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909102|NCT03154086|474954752|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131909103|NCT03154086|474954753|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
131762382|NCT01010776|474404221|FG000|Main Phase|Adverse Event|7|||
131762383|NCT01010776|474404221|FG000|Main Phase|Lost to Follow-up|6|||
131762384|NCT01010776|474404221|FG000|Main Phase|Non-compliance to study medication|5|||
131762385|NCT01010776|474404221|FG000|Main Phase|Selection failure|2|||
131398706|NCT01296711|473081242|FG002|Overall Study|Adverse Event|4|||
131762386|NCT01010776|474404221|FG000|Main Phase|Inform consent withdrawal|1|||
131762387|NCT01010776|474404221|FG000|Main Phase|Other|1|||
131762388|NCT01010776|474404221|FG000|Main Phase|Did not received study medication|5|||
131813138|NCT03025087|474598949|FG002|Overall Study|Physician Decision|0|||
131813139|NCT03025087|474598950|FG003|Overall Study|Physician Decision|0|||
131813140|NCT03025087|474598951|FG004|Overall Study|Physician Decision|0|||
131813141|NCT03025087|474598947|FG000|Overall Study|Withdrawal by Subject|1|||
131813142|NCT03025087|474598948|FG001|Overall Study|Withdrawal by Subject|1|||
131813143|NCT03025087|474598949|FG002|Overall Study|Withdrawal by Subject|0|||
131813144|NCT03025087|474598950|FG003|Overall Study|Withdrawal by Subject|0|||
131813145|NCT03025087|474598951|FG004|Overall Study|Withdrawal by Subject|0|||
131813146|NCT03025087|474598947|FG000|Overall Study|Unable to complete MRI|2|||
131813147|NCT03025087|474598948|FG001|Overall Study|Unable to complete MRI|2|||
131813148|NCT03025087|474598949|FG002|Overall Study|Unable to complete MRI|0|||
131813149|NCT03025087|474598950|FG003|Overall Study|Unable to complete MRI|0|||
131813150|NCT03025087|474598951|FG004|Overall Study|Unable to complete MRI|0|||
131813151|NCT06195579|474598960|FG000|Overall Study|Withdrawal by Subject|1|||
131762389|NCT01010776|474404221|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
131813152|NCT02545283|474598961|FG000|Overall Study|Lost to Follow-up|2|||
131813153|NCT02545283|474598962|FG001|Overall Study|Lost to Follow-up|4|||
131813154|NCT02545283|474598961|FG000|Overall Study|Withdrawal by Subject|5|||
131813155|NCT02545283|474598962|FG001|Overall Study|Withdrawal by Subject|9|||
131813156|NCT02545283|474598961|FG000|Overall Study|Death|109|||
131813157|NCT02545283|474598962|FG001|Overall Study|Death|211|||
131813158|NCT02545283|474598961|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
131813159|NCT02545283|474598962|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
131813160|NCT02545283|474598961|FG000|Overall Study|Study Terminated By Sponsor|33|||
131813161|NCT02545283|474598962|FG001|Overall Study|Study Terminated By Sponsor|71|||
131813162|NCT00604162|474598967|FG000|Overall Study|Physician Decision|3|||
131813163|NCT00604162|474598967|FG000|Overall Study|Withdrawal by Subject|1|||
131813164|NCT02241551|474598968|FG000|Overall Study|Adverse Event|1|||
131813165|NCT02241551|474598969|FG001|Overall Study|Adverse Event|0|||
131813166|NCT01015287|474598970|FG000|Overall Study|Death|21|||
131813167|NCT01015287|474598971|FG001|Overall Study|Death|16|||
131813168|NCT01015287|474598970|FG000|Overall Study|Adverse Event|1|||
131813169|NCT01015287|474598971|FG001|Overall Study|Adverse Event|0|||
131813170|NCT01015287|474598970|FG000|Overall Study|Sponsor Decision|3|||
131813171|NCT01015287|474598971|FG001|Overall Study|Sponsor Decision|7|||
131813172|NCT01015287|474598970|FG000|Overall Study|Physician Decision|19|||
131813173|NCT01015287|474598971|FG001|Overall Study|Physician Decision|21|||
131813174|NCT01015287|474598970|FG000|Overall Study|Withdrawal by Subject|14|||
131813175|NCT01015287|474598971|FG001|Overall Study|Withdrawal by Subject|19|||
131813176|NCT01015287|474598970|FG000|Overall Study|Entry Criteria not Met|11|||
131813177|NCT01015287|474598971|FG001|Overall Study|Entry Criteria not Met|14|||
131813178|NCT01015287|474598970|FG000|Overall Study|Lost to Follow-up|2|||
131762390|NCT01010776|474404221|FG000|Extension Phase|Other|3|||
131762391|NCT01012037|474404226|FG000|Overall Study|Adverse Event|0|||
131762392|NCT01012037|474404227|FG001|Overall Study|Adverse Event|8|||
131762393|NCT01012037|474404228|FG002|Overall Study|Adverse Event|3|||
131762394|NCT01012037|474404226|FG000|Overall Study|Protocol Violation|0|||
131762395|NCT01012037|474404227|FG001|Overall Study|Protocol Violation|3|||
131762396|NCT01012037|474404228|FG002|Overall Study|Protocol Violation|5|||
131762397|NCT01012037|474404226|FG000|Overall Study|Withdrawal by Subject|0|||
131762398|NCT01012037|474404227|FG001|Overall Study|Withdrawal by Subject|4|||
131762399|NCT01012037|474404228|FG002|Overall Study|Withdrawal by Subject|1|||
131762400|NCT01012037|474404226|FG000|Overall Study|Other reason (not specified)|1|||
131762401|NCT01012037|474404227|FG001|Overall Study|Other reason (not specified)|1|||
131762402|NCT01012037|474404228|FG002|Overall Study|Other reason (not specified)|1|||
131762403|NCT02583711|474404229|FG000|Overall Study|Withdrawal by Subject|0|||
131762404|NCT02583711|474404230|FG001|Overall Study|Withdrawal by Subject|10|||
131762405|NCT02583711|474404231|FG002|Overall Study|Withdrawal by Subject|0|||
131762406|NCT01700140|474404235|FG000|Overall Study|Use of rescue drugs|3|||
131762407|NCT01700140|474404236|FG001|Overall Study|Use of rescue drugs|3|||
131762408|NCT01700140|474404237|FG002|Overall Study|Use of rescue drugs|1|||
131762409|NCT01700140|474404235|FG000|Overall Study|Discontinuation of radiotherapy|1|||
131762410|NCT01700140|474404236|FG001|Overall Study|Discontinuation of radiotherapy|0|||
131762411|NCT01700140|474404237|FG002|Overall Study|Discontinuation of radiotherapy|0|||
131762412|NCT01700140|474404235|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
131813179|NCT01015287|474598971|FG001|Overall Study|Lost to Follow-up|1|||
131813180|NCT01015287|474598970|FG000|Overall Study|Protocol Violation|1|||
131813181|NCT01015287|474598971|FG001|Overall Study|Protocol Violation|1|||
131813182|NCT00469898|474598972|FG000|Overall Study|Adverse Event|7|||
131813183|NCT00469898|474598972|FG000|Overall Study|Withdrawal by Subject|4|||
131813184|NCT00469898|474598972|FG000|Overall Study|Death|4|||
131813185|NCT00469898|474598972|FG000|Overall Study|Disease progression|9|||
131813186|NCT00469898|474598972|FG000|Overall Study|Decreased performance status|1|||
131813187|NCT02682238|474598973|FG000|Overall Study|Lost to Follow-up|0|||
131813188|NCT02682238|474598974|FG001|Overall Study|Lost to Follow-up|2|||
131813189|NCT02682238|474598973|FG000|Overall Study|Withdrawal by Subject|1|||
131762413|NCT01700140|474404236|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
131762414|NCT01700140|474404237|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
131762415|NCT01700140|474404235|FG000|Overall Study|Aggravation of symptoms|1|||
131762416|NCT01700140|474404236|FG001|Overall Study|Aggravation of symptoms|0|||
131762417|NCT01700140|474404237|FG002|Overall Study|Aggravation of symptoms|0|||
131762418|NCT01700140|474404235|FG000|Overall Study|Adverse Event|0|||
131762419|NCT01700140|474404236|FG001|Overall Study|Adverse Event|1|||
131762420|NCT01700140|474404237|FG002|Overall Study|Adverse Event|0|||
131762421|NCT01700140|474404235|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
131762422|NCT01700140|474404236|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
131762423|NCT01700140|474404237|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
131762424|NCT01060124|474404238|FG000|Overall Study|Other|16|||
131762425|NCT01060124|474404238|FG000|Overall Study|Adverse Event|14|||
131762426|NCT01060124|474404238|FG000|Overall Study|Withdrawal by Subject|7|||
131762427|NCT00415623|474404239|FG000|Overall Study|Adverse Event|3|||
131762428|NCT00415623|474404240|FG001|Overall Study|Adverse Event|4|||
131762429|NCT00415623|474404239|FG000|Overall Study|Death|1|||
131762430|NCT00415623|474404240|FG001|Overall Study|Death|0|||
131762431|NCT00415623|474404239|FG000|Overall Study|Withdrawal by Subject|1|||
131762432|NCT00415623|474404240|FG001|Overall Study|Withdrawal by Subject|1|||
131762433|NCT01708915|474404244|FG000|Overall Study|Adverse Event|1|||
131762434|NCT01708915|474404245|FG001|Overall Study|Adverse Event|0|||
131762435|NCT01708915|474404246|FG002|Overall Study|Adverse Event|9|||
131762436|NCT01708915|474404247|FG003|Overall Study|Adverse Event|13|||
131762437|NCT01708915|474404244|FG000|Overall Study|Lack of Efficacy|84|||
131762438|NCT01708915|474404245|FG001|Overall Study|Lack of Efficacy|60|||
131762439|NCT01708915|474404246|FG002|Overall Study|Lack of Efficacy|35|||
131762440|NCT01708915|474404247|FG003|Overall Study|Lack of Efficacy|15|||
131762441|NCT01708915|474404244|FG000|Overall Study|Protocol Violation|0|||
131762442|NCT01708915|474404245|FG001|Overall Study|Protocol Violation|0|||
131762443|NCT01708915|474404246|FG002|Overall Study|Protocol Violation|0|||
131762444|NCT01708915|474404247|FG003|Overall Study|Protocol Violation|1|||
131762445|NCT01708915|474404244|FG000|Overall Study|Withdrawal by Subject|0|||
131762446|NCT01708915|474404245|FG001|Overall Study|Withdrawal by Subject|1|||
131762447|NCT01708915|474404246|FG002|Overall Study|Withdrawal by Subject|2|||
131762448|NCT01708915|474404247|FG003|Overall Study|Withdrawal by Subject|2|||
131762449|NCT01708915|474404244|FG000|Overall Study|Other reasons than stated above|1|||
131762450|NCT01708915|474404245|FG001|Overall Study|Other reasons than stated above|1|||
131762451|NCT01708915|474404246|FG002|Overall Study|Other reasons than stated above|0|||
131762452|NCT01708915|474404247|FG003|Overall Study|Other reasons than stated above|2|||
131762453|NCT04223778|474404256|FG000|Overall Study|Death|1|||
131762454|NCT04223778|474404257|FG001|Overall Study|Death|1|||
131762455|NCT04223778|474404256|FG000|Overall Study|Lost to Follow-up|4|||
131762456|NCT04223778|474404257|FG001|Overall Study|Lost to Follow-up|5|||
131762457|NCT04223778|474404256|FG000|Overall Study|Physician Decision|10|||
131762458|NCT04223778|474404257|FG001|Overall Study|Physician Decision|6|||
131762459|NCT04223778|474404256|FG000|Overall Study|Withdrawal by Subject|35|||
131762460|NCT04223778|474404257|FG001|Overall Study|Withdrawal by Subject|17|||
131762461|NCT04223778|474404256|FG000|Overall Study|Not Reported|7|||
131762462|NCT04223778|474404257|FG001|Overall Study|Not Reported|8|||
131762463|NCT00740116|474405470|FG000|Overall Study|Withdrawal by Subject|1|||
131909104|NCT03154086|474954739|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
131909105|NCT03154086|474954740|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909106|NCT03154086|474954741|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909107|NCT03154086|474954742|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909108|NCT03154086|474954743|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131762464|NCT00740116|474405471|FG001|Overall Study|Withdrawal by Subject|1|||
131909109|NCT03154086|474954744|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909110|NCT03154086|474954745|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131762465|NCT00740116|474405470|FG000|Overall Study|Protocol Violation|1|||
131762466|NCT00740116|474405471|FG001|Overall Study|Protocol Violation|4|||
131762467|NCT01293123|474405472|FG000|Overall Study|Lost to Follow-up|0|||
131762468|NCT01293123|474405473|FG001|Overall Study|Lost to Follow-up|1|||
131762469|NCT03031327|474405478|FG000|Overall Study|Withdrawal by Subject|0|||
131762470|NCT03031327|474405479|FG001|Overall Study|Withdrawal by Subject|1|||
131762471|NCT03031327|474405480|FG002|Overall Study|Withdrawal by Subject|1|||
131762472|NCT00211536|474405481|FG000|Overall Study|Withdrawal by Subject|2|||
131762473|NCT00211536|474405482|FG001|Overall Study|Withdrawal by Subject|2|||
131762474|NCT00211536|474405481|FG000|Overall Study|Physician Decision|0|||
131762475|NCT00211536|474405482|FG001|Overall Study|Physician Decision|5|||
131762476|NCT00211536|474405481|FG000|Overall Study|Adverse Event|2|||
131762477|NCT00211536|474405482|FG001|Overall Study|Adverse Event|0|||
131762478|NCT00003389|474405483|FG000|Overall Study|Disease progression|6|||
131762479|NCT00003389|474405484|FG001|Overall Study|Disease progression|1|||
131762480|NCT00003389|474405483|FG000|Overall Study|Adverse Event|13|||
131762481|NCT00003389|474405484|FG001|Overall Study|Adverse Event|2|||
131909111|NCT03154086|474954746|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909112|NCT03154086|474954747|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909113|NCT03154086|474954748|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909114|NCT03154086|474954749|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909115|NCT03154086|474954750|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909116|NCT03154086|474954751|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909117|NCT03154086|474954752|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909118|NCT03154086|474954753|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
131909119|NCT03154086|474954739|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909120|NCT03154086|474954740|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909121|NCT03154086|474954741|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909122|NCT03154086|474954742|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909123|NCT03154086|474954743|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909124|NCT03154086|474954744|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909125|NCT03154086|474954745|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909126|NCT03154086|474954746|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909127|NCT03154086|474954747|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
131909128|NCT03154086|474954748|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909129|NCT03154086|474954749|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909130|NCT03154086|474954750|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909131|NCT03154086|474954751|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909132|NCT03154086|474954752|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909133|NCT03154086|474954753|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
131909134|NCT03154086|474954739|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909135|NCT03154086|474954740|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909136|NCT03154086|474954741|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909137|NCT03154086|474954742|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909138|NCT03154086|474954743|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909139|NCT03154086|474954744|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909140|NCT03154086|474954745|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909141|NCT03154086|474954746|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
131909142|NCT03154086|474954747|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909143|NCT03154086|474954748|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909144|NCT03154086|474954749|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909145|NCT03154086|474954750|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909146|NCT03154086|474954751|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909147|NCT03154086|474954752|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909148|NCT03154086|474954753|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
131909149|NCT03154086|474954739|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
131909150|NCT03154086|474954740|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
131909151|NCT03154086|474954741|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
131909152|NCT03154086|474954742|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
131909153|NCT03154086|474954743|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
131909154|NCT03154086|474954744|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
131909155|NCT03154086|474954745|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
131909156|NCT03154086|474954746|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
131909157|NCT03154086|474954747|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
131909158|NCT03154086|474954748|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
131909159|NCT03154086|474954749|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
131909160|NCT03154086|474954750|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
131909161|NCT03154086|474954751|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
131909162|NCT03154086|474954752|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
131909163|NCT03154086|474954753|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
131909164|NCT01603277|474954754|FG000|Overall Study|Adverse Event|1|||
131909165|NCT01603277|474954755|FG001|Overall Study|Adverse Event|2|||
131909166|NCT01603277|474954754|FG000|Overall Study|Physician Decision|0|||
131909167|NCT01603277|474954755|FG001|Overall Study|Physician Decision|1|||
131909168|NCT01603277|474954754|FG000|Overall Study|Protocol Violation|6|||
131909169|NCT01603277|474954755|FG001|Overall Study|Protocol Violation|10|||
131909170|NCT01603277|474954754|FG000|Overall Study|Withdrawal by Subject|5|||
131762482|NCT00003389|474405483|FG000|Overall Study|Death|0|||
131762483|NCT00003389|474405484|FG001|Overall Study|Death|3|||
131762484|NCT00003389|474405483|FG000|Overall Study|Withdrawal by Subject|12|||
131909171|NCT01603277|474954755|FG001|Overall Study|Withdrawal by Subject|4|||
131909172|NCT01603277|474954754|FG000|Overall Study|Non-Compliance|2|||
131909173|NCT01603277|474954755|FG001|Overall Study|Non-Compliance|1|||
131762485|NCT00003389|474405484|FG001|Overall Study|Withdrawal by Subject|5|||
131762486|NCT00003389|474405483|FG000|Overall Study|Alternative therapy|2|||
131762487|NCT00003389|474405484|FG001|Overall Study|Alternative therapy|1|||
131762488|NCT00003389|474405483|FG000|Overall Study|Complicating disease|1|||
131762489|NCT00003389|474405484|FG001|Overall Study|Complicating disease|0|||
131762490|NCT00003389|474405483|FG000|Overall Study|Off-treatment reason missing|31|||
131762491|NCT00003389|474405484|FG001|Overall Study|Off-treatment reason missing|21|||
131762492|NCT00003389|474405483|FG000|Overall Study|Ineligible|33|||
131762493|NCT00003389|474405484|FG001|Overall Study|Ineligible|27|||
131762494|NCT01997892|474405485|FG000|Overall Study|Physician Decision|2|||
131762495|NCT01997892|474405485|FG000|Overall Study|Lost to Follow-up|6|||
131762496|NCT01997892|474405485|FG000|Overall Study|Death|14|||
131762497|NCT01997892|474405485|FG000|Overall Study|Renal transplant|8|||
131762498|NCT01997892|474405485|FG000|Overall Study|Other|3|||
131762499|NCT01997892|474405485|FG000|Overall Study|Study completion data not recorded|35|||
131762500|NCT02710422|474405486|FG000|Overall Study|Termination of study|9|||
131762501|NCT02710422|474405487|FG001|Overall Study|Termination of study|9|||
131762502|NCT02059174|474405507|FG000|Period 1|Withdrawal by Subject|0|||
131762503|NCT02059174|474405508|FG001|Period 1|Withdrawal by Subject|2|||
131762504|NCT02059174|474405507|FG000|Period 2|Withdrawal by Subject|0|||
131762505|NCT02059174|474405508|FG001|Period 2|Withdrawal by Subject|2|||
131762506|NCT02059174|474405507|FG000|Period 2|Protocol Violation|1|||
131762507|NCT02059174|474405508|FG001|Period 2|Protocol Violation|0|||
131762508|NCT02059174|474405507|FG000|Period 3|Physician Decision|1|||
131762509|NCT02059174|474405508|FG001|Period 3|Physician Decision|0|||
131762510|NCT02306148|474405509|FG000|Overall Study|Adverse Event|12|||
131762511|NCT02306148|474405510|FG001|Overall Study|Adverse Event|6|||
131762512|NCT02306148|474405509|FG000|Overall Study|Lost to Follow-up|1|||
131762513|NCT02306148|474405510|FG001|Overall Study|Lost to Follow-up|4|||
131762514|NCT02608099|474405511|FG000|Overall Study|Ablation procedure not initiated|3|||
131762515|NCT02608099|474405512|FG001|Overall Study|Ablation procedure not initiated|2|||
131762516|NCT01952041|474405516|FG000|Overall Study|Lost to Follow-up|9|||
131762517|NCT01952041|474405517|FG001|Overall Study|Lost to Follow-up|16|||
131762518|NCT01952041|474405516|FG000|Overall Study|Withdrawal by Subject|7|||
131762519|NCT01952041|474405517|FG001|Overall Study|Withdrawal by Subject|5|||
131762520|NCT01952041|474405516|FG000|Overall Study|Death|1|||
131762521|NCT01952041|474405517|FG001|Overall Study|Death|0|||
131762522|NCT01736176|474405518|FG000|Overall Study|Adverse Event|3|||
131762523|NCT01736176|474405518|FG000|Overall Study|Withdrawal by Subject|4|||
131762524|NCT01736176|474405518|FG000|Overall Study|Lack of Efficacy|3|||
131762525|NCT01736176|474405518|FG000|Overall Study|Unable to Complete PEG Placement|1|||
131762526|NCT00417248|474405519|FG000|Overall Study|Study Terminated|6|||
131762527|NCT00417248|474405519|FG000|Overall Study|Death|1|||
131762528|NCT00417248|474405519|FG000|Overall Study|Lack of Efficacy|1|||
131762529|NCT01370499|474405520|FG000|Overall Study|Adverse Event|38|||
131762530|NCT01370499|474405521|FG001|Overall Study|Adverse Event|12|||
131762531|NCT01370499|474405520|FG000|Overall Study|Lack of Efficacy|4|||
131762532|NCT01370499|474405521|FG001|Overall Study|Lack of Efficacy|2|||
131762533|NCT01370499|474405520|FG000|Overall Study|Lost to Follow-up|2|||
131762534|NCT01370499|474405521|FG001|Overall Study|Lost to Follow-up|1|||
131762535|NCT01370499|474405520|FG000|Overall Study|Physician Decision|3|||
131762536|NCT01370499|474405521|FG001|Overall Study|Physician Decision|3|||
131762537|NCT01370499|474405520|FG000|Overall Study|Protocol Violation|5|||
131762538|NCT01370499|474405521|FG001|Overall Study|Protocol Violation|4|||
131762539|NCT01370499|474405520|FG000|Overall Study|Withdrawal by Subject|18|||
131762540|NCT01370499|474405521|FG001|Overall Study|Withdrawal by Subject|7|||
131762541|NCT01370499|474405520|FG000|Overall Study|Sponsor Decision|41|||
131762542|NCT01370499|474405521|FG001|Overall Study|Sponsor Decision|15|||
131762543|NCT00934791|474405522|FG000|Overall Study|Withdrawal by Subject|1|||
131762544|NCT00934791|474405523|FG001|Overall Study|Withdrawal by Subject|0|||
131762545|NCT03763942|474405524|FG000|Overall Study|Lost to Follow-up|114|||
131762546|NCT03763942|474405525|FG001|Overall Study|Lost to Follow-up|54|||
131762547|NCT03763942|474405524|FG000|Overall Study|Protocol Violation|1|||
131762548|NCT03763942|474405525|FG001|Overall Study|Protocol Violation|0|||
131762549|NCT03763942|474405524|FG000|Overall Study|Withdrawal by Subject|2|||
131762550|NCT03763942|474405525|FG001|Overall Study|Withdrawal by Subject|0|||
131762551|NCT03763942|474405524|FG000|Overall Study|Other|2|||
131762552|NCT03763942|474405525|FG001|Overall Study|Other|3|||
131762553|NCT02646891|474405526|FG000|Overall Study|Adverse Event|0|||
131762554|NCT02646891|474405527|FG001|Overall Study|Adverse Event|1|||
131762555|NCT02646891|474405528|FG002|Overall Study|Adverse Event|0|||
131762556|NCT02646891|474405529|FG003|Overall Study|Adverse Event|0|||
131762557|NCT02646891|474405530|FG004|Overall Study|Adverse Event|0|||
131762558|NCT02646891|474405531|FG005|Overall Study|Adverse Event|0|||
131762559|NCT02646891|474405532|FG006|Overall Study|Adverse Event|0|||
131762560|NCT02646891|474405533|FG007|Overall Study|Adverse Event|0|||
131762561|NCT02646891|474405534|FG008|Overall Study|Adverse Event|0|||
131762562|NCT02646891|474405535|FG009|Overall Study|Adverse Event|0|||
131762563|NCT02646891|474405526|FG000|Overall Study|Lost to Follow-up|0|||
131762564|NCT02646891|474405527|FG001|Overall Study|Lost to Follow-up|0|||
131762565|NCT02646891|474405528|FG002|Overall Study|Lost to Follow-up|0|||
131762566|NCT02646891|474405529|FG003|Overall Study|Lost to Follow-up|0|||
131762567|NCT02646891|474405530|FG004|Overall Study|Lost to Follow-up|0|||
131909174|NCT04465422|474954758|FG000|Overall Study|Lost to Follow-up|0|||
131909175|NCT04465422|474954759|FG001|Overall Study|Lost to Follow-up|2|||
131909176|NCT01142336|474954760|FG000|Overall Study|Adverse Event|1|||
131909177|NCT01142336|474954761|FG001|Overall Study|Adverse Event|1|||
131909178|NCT01142336|474954760|FG000|Overall Study|Lost to Follow-up|0|||
131762568|NCT02646891|474405531|FG005|Overall Study|Lost to Follow-up|0|||
131762569|NCT02646891|474405532|FG006|Overall Study|Lost to Follow-up|2|||
131762570|NCT02646891|474405533|FG007|Overall Study|Lost to Follow-up|2|||
131762571|NCT02646891|474405534|FG008|Overall Study|Lost to Follow-up|2|||
131762572|NCT02646891|474405535|FG009|Overall Study|Lost to Follow-up|2|||
131762573|NCT02646891|474405526|FG000|Overall Study|Protocol Violation|0|||
131762574|NCT02646891|474405527|FG001|Overall Study|Protocol Violation|0|||
131762575|NCT02646891|474405528|FG002|Overall Study|Protocol Violation|0|||
131762576|NCT02646891|474405529|FG003|Overall Study|Protocol Violation|0|||
131762577|NCT02646891|474405530|FG004|Overall Study|Protocol Violation|0|||
131762578|NCT02646891|474405531|FG005|Overall Study|Protocol Violation|0|||
131762579|NCT02646891|474405532|FG006|Overall Study|Protocol Violation|1|||
131762580|NCT02646891|474405533|FG007|Overall Study|Protocol Violation|1|||
131762581|NCT02646891|474405534|FG008|Overall Study|Protocol Violation|0|||
131762582|NCT02646891|474405535|FG009|Overall Study|Protocol Violation|0|||
131762583|NCT02646891|474405526|FG000|Overall Study|Withdrawal by Subject|2|||
131762584|NCT02646891|474405527|FG001|Overall Study|Withdrawal by Subject|0|||
131762585|NCT02646891|474405528|FG002|Overall Study|Withdrawal by Subject|1|||
131762586|NCT02646891|474405529|FG003|Overall Study|Withdrawal by Subject|0|||
131762587|NCT02646891|474405530|FG004|Overall Study|Withdrawal by Subject|0|||
131762588|NCT02646891|474405531|FG005|Overall Study|Withdrawal by Subject|0|||
131762589|NCT02646891|474405532|FG006|Overall Study|Withdrawal by Subject|5|||
131762590|NCT02646891|474405533|FG007|Overall Study|Withdrawal by Subject|9|||
131762591|NCT02646891|474405534|FG008|Overall Study|Withdrawal by Subject|7|||
131762592|NCT02646891|474405535|FG009|Overall Study|Withdrawal by Subject|3|||
131762593|NCT02646891|474405526|FG000|Overall Study|Death|0|||
131762594|NCT02646891|474405527|FG001|Overall Study|Death|0|||
131762595|NCT02646891|474405528|FG002|Overall Study|Death|0|||
131762596|NCT02646891|474405529|FG003|Overall Study|Death|0|||
131762597|NCT02646891|474405530|FG004|Overall Study|Death|0|||
131762598|NCT02646891|474405531|FG005|Overall Study|Death|0|||
131762599|NCT02646891|474405532|FG006|Overall Study|Death|1|||
131762600|NCT02646891|474405533|FG007|Overall Study|Death|1|||
131762601|NCT02646891|474405534|FG008|Overall Study|Death|1|||
131762602|NCT02646891|474405535|FG009|Overall Study|Death|0|||
131762603|NCT01599585|474405536|FG000|Overall Study|Withdrawal by Subject|16|||
131762604|NCT01599585|474405537|FG001|Overall Study|Withdrawal by Subject|9|||
131762605|NCT01599585|474405536|FG000|Overall Study|Lost to Follow-up|3|||
131762606|NCT01599585|474405537|FG001|Overall Study|Lost to Follow-up|5|||
131762607|NCT01599585|474405536|FG000|Overall Study|randomized did not start treatment|3|||
131762608|NCT01599585|474405537|FG001|Overall Study|randomized did not start treatment|3|||
131762609|NCT01108263|474405538|FG000|Overall Study|Adverse Event|0|||
131762610|NCT01108263|474405539|FG001|Overall Study|Adverse Event|1|||
131762611|NCT01685372|474405540|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
131762612|NCT01685372|474405541|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
131762613|NCT00811395|474405545|FG000|Extension Treatment|Adverse Event|1|||
131762614|NCT00811395|474405546|FG001|Extension Treatment|Adverse Event|2|||
131762615|NCT00811395|474405547|FG002|Extension Treatment|Adverse Event|2|||
131762616|NCT00811395|474405548|FG003|Extension Treatment|Adverse Event|2|||
131762617|NCT00811395|474405549|FG004|Extension Treatment|Adverse Event|0|||
131762618|NCT00811395|474405550|FG005|Extension Treatment|Adverse Event|1|||
131762619|NCT00811395|474405545|FG000|Extension Treatment|Progressive disease|1|||
131762620|NCT00811395|474405546|FG001|Extension Treatment|Progressive disease|1|||
131762621|NCT00811395|474405547|FG002|Extension Treatment|Progressive disease|0|||
131762622|NCT00811395|474405548|FG003|Extension Treatment|Progressive disease|0|||
131762623|NCT00811395|474405549|FG004|Extension Treatment|Progressive disease|0|||
131762624|NCT00811395|474405550|FG005|Extension Treatment|Progressive disease|0|||
131762625|NCT00811395|474405545|FG000|Extension Treatment|Participant did not wish to continue|0|||
131762626|NCT00811395|474405546|FG001|Extension Treatment|Participant did not wish to continue|3|||
131762627|NCT00811395|474405547|FG002|Extension Treatment|Participant did not wish to continue|0|||
131762628|NCT00811395|474405548|FG003|Extension Treatment|Participant did not wish to continue|1|||
131909179|NCT01142336|474954761|FG001|Overall Study|Lost to Follow-up|1|||
131909180|NCT02391337|474954762|FG000|6 Months Follow-up|Death|5|||
131909181|NCT02391337|474954763|FG001|6 Months Follow-up|Death|4|||
131762629|NCT00811395|474405549|FG004|Extension Treatment|Participant did not wish to continue|0|||
131762630|NCT00811395|474405550|FG005|Extension Treatment|Participant did not wish to continue|1|||
131762631|NCT00811395|474405545|FG000|Extension Treatment|Other than above|0|||
131762632|NCT00811395|474405546|FG001|Extension Treatment|Other than above|0|||
131762633|NCT00811395|474405547|FG002|Extension Treatment|Other than above|1|||
131762634|NCT00811395|474405548|FG003|Extension Treatment|Other than above|0|||
131762635|NCT00811395|474405549|FG004|Extension Treatment|Other than above|0|||
131762636|NCT00811395|474405550|FG005|Extension Treatment|Other than above|0|||
131909182|NCT02391337|474954762|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
131762637|NCT00170846|474405551|FG000|Overall Study|Subject withdrew Informed Consent|5|||
131762638|NCT00170846|474405552|FG001|Overall Study|Subject withdrew Informed Consent|12|||
131762639|NCT00170846|474405553|FG002|Overall Study|Subject withdrew Informed Consent|8|||
131762640|NCT00170846|474405551|FG000|Overall Study|Lost to Follow-up|6|||
131762641|NCT00170846|474405552|FG001|Overall Study|Lost to Follow-up|3|||
131762642|NCT00170846|474405553|FG002|Overall Study|Lost to Follow-up|2|||
131762643|NCT00170846|474405551|FG000|Overall Study|Death|0|||
131762644|NCT00170846|474405552|FG001|Overall Study|Death|3|||
131762645|NCT00170846|474405553|FG002|Overall Study|Death|3|||
131762646|NCT00170846|474405551|FG000|Overall Study|Reason Missing|0|||
131762647|NCT00170846|474405552|FG001|Overall Study|Reason Missing|1|||
131762648|NCT00170846|474405553|FG002|Overall Study|Reason Missing|0|||
131762649|NCT01970540|474405556|FG000|Overall Study|Non-treatment-related AE|0|||
131762650|NCT01970540|474405557|FG001|Overall Study|Non-treatment-related AE|0|||
131762651|NCT01970540|474405558|FG002|Overall Study|Non-treatment-related AE|1|||
131762652|NCT01970540|474405556|FG000|Overall Study|Progressive disease|55|||
131762653|NCT01970540|474405557|FG001|Overall Study|Progressive disease|23|||
131762654|NCT01970540|474405558|FG002|Overall Study|Progressive disease|10|||
131762655|NCT01970540|474405556|FG000|Overall Study|Treatment delay over protocol|0|||
131762656|NCT01970540|474405557|FG001|Overall Study|Treatment delay over protocol|0|||
131762657|NCT01970540|474405558|FG002|Overall Study|Treatment delay over protocol|1|||
131762658|NCT01970540|474405556|FG000|Overall Study|Physician Decision|7|||
131762659|NCT01970540|474405557|FG001|Overall Study|Physician Decision|2|||
131762660|NCT01970540|474405558|FG002|Overall Study|Physician Decision|0|||
131762661|NCT01970540|474405556|FG000|Overall Study|Clinical progression|0|||
131762662|NCT01970540|474405557|FG001|Overall Study|Clinical progression|1|||
131762663|NCT01970540|474405558|FG002|Overall Study|Clinical progression|1|||
131762664|NCT01970540|474405556|FG000|Overall Study|End of study|2|||
131762665|NCT01970540|474405557|FG001|Overall Study|End of study|0|||
131762666|NCT01970540|474405558|FG002|Overall Study|End of study|2|||
131762667|NCT01970540|474405556|FG000|Overall Study|Adverse Event|0|||
131762668|NCT01970540|474405557|FG001|Overall Study|Adverse Event|2|||
131762669|NCT01970540|474405558|FG002|Overall Study|Adverse Event|1|||
131762670|NCT01970540|474405556|FG000|Overall Study|Treatment-related AE|4|||
131762671|NCT01970540|474405557|FG001|Overall Study|Treatment-related AE|0|||
131762672|NCT01970540|474405558|FG002|Overall Study|Treatment-related AE|2|||
131762673|NCT01970540|474405556|FG000|Overall Study|Withdrawal by Subject|4|||
131762674|NCT01970540|474405557|FG001|Overall Study|Withdrawal by Subject|0|||
131762675|NCT01970540|474405558|FG002|Overall Study|Withdrawal by Subject|1|||
131762676|NCT01970540|474405556|FG000|Overall Study|Clinical deterioration|1|||
131762677|NCT01970540|474405557|FG001|Overall Study|Clinical deterioration|0|||
131762678|NCT01970540|474405558|FG002|Overall Study|Clinical deterioration|0|||
131762679|NCT01766401|474405563|FG000|Overall Study|Adverse Event|7|||
131762680|NCT01766401|474405564|FG001|Overall Study|Adverse Event|22|||
131762681|NCT01766401|474405563|FG000|Overall Study|Lack of Efficacy|1|||
131762682|NCT01766401|474405564|FG001|Overall Study|Lack of Efficacy|2|||
131762683|NCT01766401|474405563|FG000|Overall Study|Protocol Violation|3|||
131762684|NCT01766401|474405564|FG001|Overall Study|Protocol Violation|8|||
131762685|NCT01766401|474405563|FG000|Overall Study|Withdrawal by Subject|15|||
131762686|NCT01766401|474405564|FG001|Overall Study|Withdrawal by Subject|12|||
131762687|NCT01766401|474405563|FG000|Overall Study|Lost to Follow-up|10|||
131909183|NCT02391337|474954763|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
131909184|NCT02391337|474954762|FG000|12 Months Follow-up|Death|2|||
131909185|NCT02391337|474954763|FG001|12 Months Follow-up|Death|0|||
131909186|NCT02391337|474954762|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
131909187|NCT02391337|474954763|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
131909188|NCT02391337|474954762|FG000|12 Months Follow-up|Lost to Follow-up|0|||
131909189|NCT02391337|474954763|FG001|12 Months Follow-up|Lost to Follow-up|2|||
131909190|NCT00746551|474954764|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
131909191|NCT00746551|474954765|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
131909192|NCT00746551|474954764|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
131909193|NCT00746551|474954765|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
131909194|NCT00746551|474954764|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
131909195|NCT00746551|474954765|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
131762688|NCT01766401|474405564|FG001|Overall Study|Lost to Follow-up|11|||
131762689|NCT01766401|474405563|FG000|Overall Study|Pregnancy|1|||
131762690|NCT01766401|474405564|FG001|Overall Study|Pregnancy|1|||
131762691|NCT01432938|474405566|FG000|First Intervention|Protocol Violation|1|||
131762692|NCT01432938|474405567|FG001|First Intervention|Protocol Violation|0|||
131762693|NCT01432938|474405566|FG000|First Intervention|Physician Decision|1|||
131762694|NCT01432938|474405567|FG001|First Intervention|Physician Decision|0|||
131762695|NCT01432938|474405566|FG000|Second Intervention|Adverse Event|1|||
131762696|NCT01432938|474405567|FG001|Second Intervention|Adverse Event|0|||
131762697|NCT01601873|474405568|FG000|Overall Study|Lost to Follow-up|2|||
131762698|NCT01601873|474405569|FG001|Overall Study|Lost to Follow-up|3|||
131762699|NCT02096471|474405570|FG000|Overall Study|Adverse Event|1|||
131909196|NCT02029417|474954766|FG000|Overall Study|Death|1|||
131909197|NCT02029417|474954766|FG000|Overall Study|Adverse Event|1|||
131909198|NCT00062166|474954767|FG000|Overall Study|Withdrawal by Subject|6|||
131909199|NCT01776554|474954770|FG000|Overall Study|Adverse Event|1|||
131909200|NCT01776554|474954771|FG001|Overall Study|Adverse Event|0|||
131909201|NCT01776554|474954770|FG000|Overall Study|Withdrawal by Subject|3|||
131909202|NCT01776554|474954771|FG001|Overall Study|Withdrawal by Subject|8|||
131909203|NCT01776554|474954770|FG000|Overall Study|Lost to Follow-up|6|||
131909204|NCT01776554|474954771|FG001|Overall Study|Lost to Follow-up|9|||
131909205|NCT01776554|474954770|FG000|Overall Study|Administrative Reason|2|||
131909206|NCT01776554|474954771|FG001|Overall Study|Administrative Reason|5|||
131909207|NCT01776554|474954770|FG000|Overall Study|Protocol Violation|1|||
131909208|NCT01776554|474954771|FG001|Overall Study|Protocol Violation|0|||
131909209|NCT01776554|474954770|FG000|Overall Study|Unclassified|4|||
131909210|NCT01776554|474954771|FG001|Overall Study|Unclassified|1|||
131909211|NCT02475369|474954772|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
131909212|NCT02475369|474954773|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
131909213|NCT03608826|474954775|FG000|Overall Study|Death|3|||
131909214|NCT03608826|474954775|FG000|Overall Study|Heart Transplant|3|||
131909215|NCT03608826|474954775|FG000|Overall Study|Physician Decision|4|||
131909216|NCT03122171|474954776|FG000|Overall Study|Withdrawal by Subject|1|||
131909217|NCT00617279|474954786|FG000|Overall Study|Study terminated by Sponsor|10|||
131909218|NCT00617279|474954787|FG001|Overall Study|Study terminated by Sponsor|15|||
131909219|NCT00617279|474954786|FG000|Overall Study|Graft abandonment|2|||
131909220|NCT00617279|474954787|FG001|Overall Study|Graft abandonment|0|||
131909221|NCT00617279|474954786|FG000|Overall Study|Lost to Follow-up|1|||
131398707|NCT01296711|473081243|FG003|Overall Study|Adverse Event|3|||
131398708|NCT01296711|473081244|FG004|Overall Study|Adverse Event|1|||
131398709|NCT01296711|473081245|FG005|Overall Study|Adverse Event|6|||
131909222|NCT00617279|474954787|FG001|Overall Study|Lost to Follow-up|0|||
131909223|NCT00617279|474954786|FG000|Overall Study|Death|1|||
131909224|NCT00617279|474954787|FG001|Overall Study|Death|2|||
131909225|NCT00921024|474954792|FG000|Overall Study|Lost to Follow-up|2|||
131909226|NCT00921024|474954793|FG001|Overall Study|Lost to Follow-up|0|||
131909227|NCT00921024|474954792|FG000|Overall Study|Received concomittant therapy|2|||
131909228|NCT00921024|474954793|FG001|Overall Study|Received concomittant therapy|0|||
131909229|NCT00921024|474954792|FG000|Overall Study|Withdrawal by Subject|0|||
131762700|NCT02096471|474405570|FG000|Overall Study|Lack of Efficacy|7|||
131762701|NCT02096471|474405570|FG000|Overall Study|Withdrawal by Subject|3|||
131762702|NCT02096471|474405570|FG000|Overall Study|Non-Compliant|2|||
131762703|NCT02382276|474405571|FG000|Overall Study|Withdrawal by Subject|4|||
131762704|NCT02382276|474405572|FG001|Overall Study|Withdrawal by Subject|8|||
131762705|NCT02382276|474405573|FG002|Overall Study|Withdrawal by Subject|5|||
131762706|NCT02382276|474405571|FG000|Overall Study|Adverse Event|7|||
131762707|NCT02382276|474405572|FG001|Overall Study|Adverse Event|2|||
131762708|NCT02382276|474405573|FG002|Overall Study|Adverse Event|32|||
131762709|NCT02382276|474405571|FG000|Overall Study|Physician Decision|0|||
131762710|NCT02382276|474405572|FG001|Overall Study|Physician Decision|0|||
131762711|NCT02382276|474405573|FG002|Overall Study|Physician Decision|2|||
131762712|NCT00518336|474405574|FG000|Year 7|Lost to Follow-up|2|||
131762713|NCT00518336|474405575|FG001|Year 7|Lost to Follow-up|0|||
131762714|NCT00518336|474405574|FG000|Year 7|Could not attend in time|0|||
131762715|NCT00518336|474405575|FG001|Year 7|Could not attend in time|3|||
131762716|NCT00518336|474405574|FG000|Year 8|Lost to Follow-up|1|||
131762717|NCT00518336|474405575|FG001|Year 8|Lost to Follow-up|1|||
131762718|NCT00518336|474405574|FG000|Year 8|Could not attend in time|0|||
131762719|NCT00518336|474405575|FG001|Year 8|Could not attend in time|1|||
131762720|NCT00518336|474405574|FG000|Year 9|Migrated/moved from study area|1|||
131762721|NCT00518336|474405575|FG001|Year 9|Migrated/moved from study area|1|||
131762722|NCT00518336|474405574|FG000|Year 9|Lost to Follow-up|3|||
131762723|NCT00518336|474405575|FG001|Year 9|Lost to Follow-up|0|||
131909230|NCT00921024|474954793|FG001|Overall Study|Withdrawal by Subject|3|||
131909231|NCT03415178|474954795|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
131909232|NCT03415178|474954796|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
131909233|NCT03415178|474954795|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
131909234|NCT03415178|474954796|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
131909235|NCT01296412|474954802|FG000|Overall Study|Adverse Event|8|||
131909236|NCT01296412|474954803|FG001|Overall Study|Adverse Event|29|||
131909237|NCT01296412|474954802|FG000|Overall Study|Lack of Efficacy|1|||
131909238|NCT01296412|474954803|FG001|Overall Study|Lack of Efficacy|0|||
131909239|NCT01296412|474954802|FG000|Overall Study|Lost to Follow-up|10|||
131762724|NCT00518336|474405574|FG000|Year 9|Personal reasons|1|||
131762725|NCT00518336|474405575|FG001|Year 9|Personal reasons|0|||
131762726|NCT00125268|474405576|FG000|Overall Study|Withdrawal by Subject|1|||
131762727|NCT00125268|474405577|FG001|Overall Study|Withdrawal by Subject|1|||
131762728|NCT00286156|474405579|FG000|Overall Study|Missed 12 month visit|0|||
131762729|NCT00286156|474405580|FG001|Overall Study|Missed 12 month visit|0|||
131762730|NCT00286156|474405581|FG002|Overall Study|Missed 12 month visit|1|||
131909240|NCT01296412|474954803|FG001|Overall Study|Lost to Follow-up|7|||
131762731|NCT00286156|474405579|FG000|Overall Study|AE: pulmonary embolus|0|||
131762732|NCT00286156|474405580|FG001|Overall Study|AE: pulmonary embolus|1|||
131762733|NCT00286156|474405581|FG002|Overall Study|AE: pulmonary embolus|0|||
131762734|NCT00286156|474405579|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
131762735|NCT00286156|474405580|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
131762736|NCT00286156|474405581|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
131762737|NCT00286156|474405579|FG000|Overall Study|AE: pneumonia|1|||
131762738|NCT00286156|474405580|FG001|Overall Study|AE: pneumonia|0|||
131762739|NCT00286156|474405581|FG002|Overall Study|AE: pneumonia|0|||
131762740|NCT06334055|474405582|FG000|Overall Study|Adverse Event|4|||
131762741|NCT06334055|474405582|FG000|Overall Study|Disqualified|72|||
131762742|NCT02449915|474405583|FG000|Overall Study|Exclusion criteria - drug use|1|||
131762743|NCT02449915|474405584|FG001|Overall Study|Exclusion criteria - drug use|0|||
131762744|NCT02449915|474405583|FG000|Overall Study|Withdrawal by Subject|0|||
131762745|NCT02449915|474405584|FG001|Overall Study|Withdrawal by Subject|2|||
131762746|NCT02449915|474405583|FG000|Overall Study|Intraoperative surgical findings|1|||
131762747|NCT02449915|474405584|FG001|Overall Study|Intraoperative surgical findings|1|||
131762748|NCT02449915|474405583|FG000|Overall Study|Abnormal preop lab|0|||
131762749|NCT02449915|474405584|FG001|Overall Study|Abnormal preop lab|1|||
131762750|NCT03037489|474407118|FG000|Overall Study|Adverse Event|4|||
131762751|NCT03037489|474407119|FG001|Overall Study|Adverse Event|0|||
131762752|NCT03037489|474407118|FG000|Overall Study|Withdrawal by Subject|3|||
131762753|NCT03037489|474407119|FG001|Overall Study|Withdrawal by Subject|0|||
131762754|NCT00621764|474407120|FG000|Overall Study|Protocol Violation|0|||
131762755|NCT00621764|474407121|FG001|Overall Study|Protocol Violation|0|||
131762756|NCT00621764|474407122|FG002|Overall Study|Protocol Violation|0|||
131762757|NCT00621764|474407123|FG003|Overall Study|Protocol Violation|1|||
131762758|NCT02499172|474407124|FG000|Overall Study|Financial reason|0|||
131762759|NCT02499172|474407125|FG001|Overall Study|Financial reason|0|||
131762760|NCT02499172|474407126|FG002|Overall Study|Financial reason|523|||
131762761|NCT02499172|474407127|FG003|Overall Study|Financial reason|436|||
131762762|NCT02499172|474407124|FG000|Overall Study|Lost to Follow-up|65|||
131762763|NCT02499172|474407125|FG001|Overall Study|Lost to Follow-up|64|||
131762764|NCT02499172|474407126|FG002|Overall Study|Lost to Follow-up|0|||
131762765|NCT02499172|474407127|FG003|Overall Study|Lost to Follow-up|0|||
131762766|NCT00121485|474407128|FG000|Overall Study|Not implanted|1|||
131762767|NCT00121485|474407129|FG001|Overall Study|Not implanted|5|||
131762768|NCT00121485|474407128|FG000|Overall Study|Crossover|0|||
131762769|NCT00121485|474407129|FG001|Overall Study|Crossover|2|||
131762770|NCT00724243|474407132|FG000|Overall Study|Lack of Efficacy|10|||
131762771|NCT00724243|474407132|FG000|Overall Study|Adverse Event|5|||
131762772|NCT00033514|474407133|FG000|Overall Study|Lost to Follow-up|1|||
131762773|NCT00033514|474407134|FG001|Overall Study|Lost to Follow-up|1|||
131762774|NCT00033514|474407133|FG000|Overall Study|Withdrawal by Subject|0|||
131762775|NCT00033514|474407134|FG001|Overall Study|Withdrawal by Subject|3|||
131762776|NCT00829010|474407138|FG000|Overall Study|Adverse Event|1|||
131762777|NCT00829010|474407139|FG001|Overall Study|Adverse Event|0|||
131762778|NCT00829010|474407140|FG002|Overall Study|Adverse Event|0|||
131762779|NCT00829010|474407141|FG003|Overall Study|Adverse Event|0|||
131762780|NCT00829010|474407142|FG004|Overall Study|Adverse Event|0|||
131762781|NCT00829010|474407138|FG000|Overall Study|Withdrawal by Subject|0|||
131762782|NCT00829010|474407139|FG001|Overall Study|Withdrawal by Subject|1|||
131762783|NCT00829010|474407140|FG002|Overall Study|Withdrawal by Subject|1|||
131762784|NCT00829010|474407141|FG003|Overall Study|Withdrawal by Subject|0|||
131762785|NCT00829010|474407142|FG004|Overall Study|Withdrawal by Subject|2|||
131762786|NCT00829010|474407138|FG000|Overall Study|Lost to Follow-up|1|||
131762787|NCT00829010|474407139|FG001|Overall Study|Lost to Follow-up|0|||
131762788|NCT00829010|474407140|FG002|Overall Study|Lost to Follow-up|2|||
131762789|NCT00829010|474407141|FG003|Overall Study|Lost to Follow-up|0|||
131762790|NCT00829010|474407142|FG004|Overall Study|Lost to Follow-up|0|||
131762791|NCT00829010|474407138|FG000|Overall Study|Fatality|5|||
131762792|NCT00829010|474407139|FG001|Overall Study|Fatality|4|||
131762793|NCT00829010|474407140|FG002|Overall Study|Fatality|0|||
131762794|NCT00829010|474407141|FG003|Overall Study|Fatality|3|||
131762795|NCT00829010|474407142|FG004|Overall Study|Fatality|0|||
131762796|NCT00829010|474407138|FG000|Overall Study|Migrated/Moved from study area|3|||
131762797|NCT00829010|474407139|FG001|Overall Study|Migrated/Moved from study area|4|||
131762798|NCT00829010|474407140|FG002|Overall Study|Migrated/Moved from study area|0|||
131762799|NCT00829010|474407141|FG003|Overall Study|Migrated/Moved from study area|5|||
131762800|NCT00829010|474407142|FG004|Overall Study|Migrated/Moved from study area|0|||
131762801|NCT02289833|474407146|FG000|Overall Study|Study discontinuation|0|||
131762802|NCT02289833|474407147|FG001|Overall Study|Study discontinuation|1|||
131762803|NCT02289833|474407146|FG000|Overall Study|Lost to Follow-up|4|||
131762804|NCT02289833|474407147|FG001|Overall Study|Lost to Follow-up|0|||
131762805|NCT02289833|474407146|FG000|Overall Study|Death|23|||
131762806|NCT02289833|474407147|FG001|Overall Study|Death|16|||
131762807|NCT03442595|474407148|FG000|Overall Study|Lost to Follow-up|94|||
131762808|NCT03442595|474407149|FG001|Overall Study|Lost to Follow-up|0|||
131762809|NCT00118040|474407158|FG000|Overall Study|Adverse Event|0|||
131762810|NCT00118040|474407159|FG001|Overall Study|Adverse Event|1|||
131762811|NCT00118040|474407160|FG002|Overall Study|Adverse Event|0|||
131762812|NCT00118040|474407158|FG000|Overall Study|Withdrawal by Subject|0|||
131762813|NCT00118040|474407159|FG001|Overall Study|Withdrawal by Subject|0|||
131762814|NCT00118040|474407160|FG002|Overall Study|Withdrawal by Subject|2|||
131762815|NCT00118040|474407158|FG000|Overall Study|Medical Contraindication|0|||
131762816|NCT00118040|474407159|FG001|Overall Study|Medical Contraindication|0|||
131762817|NCT00118040|474407160|FG002|Overall Study|Medical Contraindication|1|||
131909241|NCT01296412|474954802|FG000|Overall Study|Non-compliance with study drug|1|||
131909242|NCT01296412|474954803|FG001|Overall Study|Non-compliance with study drug|2|||
131909243|NCT01296412|474954802|FG000|Overall Study|Other reason not specified|20|||
131762818|NCT00118040|474407158|FG000|Overall Study|Non-Compliant Participant|1|||
131762819|NCT00118040|474407159|FG001|Overall Study|Non-Compliant Participant|1|||
131762820|NCT00118040|474407160|FG002|Overall Study|Non-Compliant Participant|2|||
131762821|NCT00118040|474407158|FG000|Overall Study|Other|0|||
131762822|NCT00118040|474407159|FG001|Overall Study|Other|0|||
131762823|NCT00118040|474407160|FG002|Overall Study|Other|1|||
131762824|NCT00952588|474407161|FG000|Overall Study|Death|28|||
131762825|NCT00952588|474407162|FG001|Overall Study|Death|13|||
131762826|NCT00952588|474407161|FG000|Overall Study|Withdrawal by Subject|2|||
131762827|NCT00952588|474407162|FG001|Overall Study|Withdrawal by Subject|5|||
131762828|NCT00952588|474407161|FG000|Overall Study|Adverse Event|2|||
131762829|NCT00952588|474407162|FG001|Overall Study|Adverse Event|3|||
131762830|NCT00952588|474407161|FG000|Overall Study|Lost to Follow-up|2|||
131762831|NCT00952588|474407162|FG001|Overall Study|Lost to Follow-up|0|||
131762832|NCT00952588|474407161|FG000|Overall Study|Physician Decision|0|||
131762833|NCT00952588|474407162|FG001|Overall Study|Physician Decision|1|||
131762834|NCT00952588|474407161|FG000|Overall Study|Lack of Efficacy|2|||
131762835|NCT00952588|474407162|FG001|Overall Study|Lack of Efficacy|2|||
131762836|NCT01796106|474407163|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
131762837|NCT01796106|474407164|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
131762838|NCT02795182|474407168|FG000|Overall Study|Death|5|||
131762839|NCT02795182|474407169|FG001|Overall Study|Death|4|||
131762840|NCT02795182|474407170|FG002|Overall Study|Death|4|||
131762841|NCT02795182|474407171|FG003|Overall Study|Death|18|||
131762842|NCT02795182|474407168|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
131762843|NCT02795182|474407169|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
131762844|NCT02795182|474407170|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
131762845|NCT02795182|474407171|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
131762846|NCT02795182|474407168|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
131762847|NCT02795182|474407169|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
131762848|NCT02795182|474407170|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
131762849|NCT02795182|474407171|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
131762850|NCT02795182|474407168|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
131762851|NCT02795182|474407169|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
131762852|NCT02795182|474407170|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
131762853|NCT02795182|474407171|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
131762854|NCT02795182|474407168|FG000|Overall Study|Withdrawal by Subject|4|||
131762855|NCT02795182|474407169|FG001|Overall Study|Withdrawal by Subject|0|||
131762856|NCT02795182|474407170|FG002|Overall Study|Withdrawal by Subject|0|||
131762857|NCT02795182|474407171|FG003|Overall Study|Withdrawal by Subject|3|||
131762858|NCT02795182|474407168|FG000|Overall Study|Lost to Follow-up|0|||
131762859|NCT02795182|474407169|FG001|Overall Study|Lost to Follow-up|0|||
131762860|NCT02795182|474407170|FG002|Overall Study|Lost to Follow-up|1|||
131762861|NCT02795182|474407171|FG003|Overall Study|Lost to Follow-up|1|||
131762862|NCT02795182|474407168|FG000|Overall Study|Roll Over to Long Term Extension|3|||
131762863|NCT02795182|474407169|FG001|Overall Study|Roll Over to Long Term Extension|3|||
131762864|NCT02795182|474407170|FG002|Overall Study|Roll Over to Long Term Extension|2|||
131762865|NCT02795182|474407171|FG003|Overall Study|Roll Over to Long Term Extension|5|||
131762866|NCT02795182|474407168|FG000|Overall Study|Progressive Disease|0|||
131762867|NCT02795182|474407169|FG001|Overall Study|Progressive Disease|1|||
131762868|NCT02795182|474407170|FG002|Overall Study|Progressive Disease|0|||
131762869|NCT02795182|474407171|FG003|Overall Study|Progressive Disease|4|||
131909244|NCT01296412|474954803|FG001|Overall Study|Other reason not specified|15|||
131762870|NCT02795182|474407168|FG000|Overall Study|Physician Decision|0|||
131762871|NCT02795182|474407169|FG001|Overall Study|Physician Decision|0|||
131762872|NCT02795182|474407170|FG002|Overall Study|Physician Decision|0|||
131762873|NCT02795182|474407171|FG003|Overall Study|Physician Decision|1|||
131762874|NCT04107935|474407172|FG000|Overall Study|Death|1|||
131762875|NCT04107935|474407173|FG001|Overall Study|Death|0|||
131762876|NCT01021553|474407175|FG000|Overall Study|Adverse Event|1|||
131762877|NCT01021553|474407176|FG001|Overall Study|Adverse Event|0|||
131762878|NCT01021553|474407177|FG002|Overall Study|Adverse Event|0|||
131762879|NCT01021553|474407175|FG000|Overall Study|Lack of Efficacy|2|||
131762880|NCT01021553|474407176|FG001|Overall Study|Lack of Efficacy|2|||
131762881|NCT01021553|474407177|FG002|Overall Study|Lack of Efficacy|0|||
131762882|NCT01021553|474407175|FG000|Overall Study|Protocol Violation|0|||
131762883|NCT01021553|474407176|FG001|Overall Study|Protocol Violation|2|||
131762884|NCT01021553|474407177|FG002|Overall Study|Protocol Violation|2|||
131762885|NCT01021553|474407175|FG000|Overall Study|Lost to Follow-up|0|||
131762886|NCT01021553|474407176|FG001|Overall Study|Lost to Follow-up|0|||
131762887|NCT01021553|474407177|FG002|Overall Study|Lost to Follow-up|1|||
131762888|NCT01021553|474407175|FG000|Overall Study|Withdrawal by Subject|1|||
131762889|NCT01021553|474407176|FG001|Overall Study|Withdrawal by Subject|1|||
131762890|NCT01021553|474407177|FG002|Overall Study|Withdrawal by Subject|0|||
131762891|NCT01950364|474407178|FG000|Overall Study|Adverse Event|3|||
131762892|NCT01950364|474407179|FG001|Overall Study|Adverse Event|0|||
131762893|NCT01950364|474407178|FG000|Overall Study|Stem Cell Transplant|2|||
131762894|NCT01950364|474407179|FG001|Overall Study|Stem Cell Transplant|6|||
131762895|NCT01950364|474407178|FG000|Overall Study|Disease Progression|5|||
131762896|NCT01950364|474407179|FG001|Overall Study|Disease Progression|2|||
131762897|NCT01950364|474407178|FG000|Overall Study|Withdrawal by Subject|0|||
131762898|NCT01950364|474407179|FG001|Overall Study|Withdrawal by Subject|1|||
131762899|NCT01950364|474407178|FG000|Overall Study|Protocol Violation|0|||
131762900|NCT01950364|474407179|FG001|Overall Study|Protocol Violation|1|||
131762901|NCT00033293|474407180|FG000|Overall Study|Death|0|||
131762902|NCT00033293|474407181|FG001|Overall Study|Death|1|||
131762903|NCT00033293|474407180|FG000|Overall Study|Lack of Efficacy|5|||
131762904|NCT00033293|474407181|FG001|Overall Study|Lack of Efficacy|8|||
131762905|NCT00033293|474407180|FG000|Overall Study|Lost to Follow-up|0|||
131762906|NCT00033293|474407181|FG001|Overall Study|Lost to Follow-up|1|||
131762907|NCT00033293|474407180|FG000|Overall Study|Physician Decision|3|||
131762908|NCT00033293|474407181|FG001|Overall Study|Physician Decision|1|||
131762909|NCT00033293|474407180|FG000|Overall Study|Withdrawal by Subject|1|||
131762910|NCT00033293|474407181|FG001|Overall Study|Withdrawal by Subject|0|||
131762911|NCT00033293|474407180|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
131762912|NCT00033293|474407181|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
131762913|NCT00033293|474407180|FG000|Overall Study|Treatment refused|0|||
131762914|NCT00033293|474407181|FG001|Overall Study|Treatment refused|6|||
131762915|NCT01289028|474407184|FG000|Overall Study|Progressive Disease|49|||
131762916|NCT01289028|474407184|FG000|Overall Study|Adverse Event|14|||
131762917|NCT01289028|474407184|FG000|Overall Study|Withdrawal by Subject|6|||
131762918|NCT01289028|474407184|FG000|Overall Study|Death|4|||
131762919|NCT01289028|474407184|FG000|Overall Study|Lack of Efficacy|2|||
131762920|NCT01289028|474407184|FG000|Overall Study|No longer required|2|||
131762921|NCT01289028|474407184|FG000|Overall Study|Lost to Follow-up|2|||
131762922|NCT01289028|474407184|FG000|Overall Study|New Cancer Therapy|2|||
131762923|NCT01289028|474407184|FG000|Overall Study|Abnormal Lab Value|1|||
131762924|NCT01289028|474407184|FG000|Overall Study|Missing reason for discon|1|||
131762925|NCT02120469|474407187|FG000|Overall Study|HER-2/neu-amplified|1|||
131762926|NCT02120469|474407188|FG001|Overall Study|HER-2/neu-amplified|0|||
131762927|NCT02120469|474407189|FG002|Overall Study|HER-2/neu-amplified|1|||
131762928|NCT00998985|474407191|FG000|Overall Study|Withdrawal by Subject|0|||
131762929|NCT00998985|474407192|FG001|Overall Study|Withdrawal by Subject|0|||
131762930|NCT00998985|474407193|FG002|Overall Study|Withdrawal by Subject|0|||
131762931|NCT00998985|474407194|FG003|Overall Study|Withdrawal by Subject|0|||
131762932|NCT00998985|474407195|FG004|Overall Study|Withdrawal by Subject|0|||
131762933|NCT00998985|474407196|FG005|Overall Study|Withdrawal by Subject|0|||
131762934|NCT00998985|474407197|FG006|Overall Study|Withdrawal by Subject|0|||
131762935|NCT00998985|474407198|FG007|Overall Study|Withdrawal by Subject|0|||
131762936|NCT00998985|474407199|FG008|Overall Study|Withdrawal by Subject|1|||
131762937|NCT00998985|474407200|FG009|Overall Study|Withdrawal by Subject|0|||
131762938|NCT00998985|474407201|FG010|Overall Study|Withdrawal by Subject|0|||
131762939|NCT00998985|474407202|FG011|Overall Study|Withdrawal by Subject|0|||
131449828|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
131762940|NCT00998985|474407203|FG012|Overall Study|Withdrawal by Subject|0|||
131762941|NCT00998985|474407204|FG013|Overall Study|Withdrawal by Subject|0|||
131762942|NCT00998985|474407191|FG000|Overall Study|Protocol Violation|0|||
131762943|NCT00998985|474407192|FG001|Overall Study|Protocol Violation|0|||
131762944|NCT00998985|474407193|FG002|Overall Study|Protocol Violation|0|||
131762945|NCT00998985|474407194|FG003|Overall Study|Protocol Violation|0|||
131762946|NCT00998985|474407195|FG004|Overall Study|Protocol Violation|0|||
131762947|NCT00998985|474407196|FG005|Overall Study|Protocol Violation|1|||
131762948|NCT00998985|474407197|FG006|Overall Study|Protocol Violation|0|||
131762949|NCT00998985|474407198|FG007|Overall Study|Protocol Violation|0|||
131762950|NCT00998985|474407199|FG008|Overall Study|Protocol Violation|0|||
131762951|NCT00998985|474407200|FG009|Overall Study|Protocol Violation|0|||
131762952|NCT00998985|474407201|FG010|Overall Study|Protocol Violation|0|||
131762953|NCT00998985|474407202|FG011|Overall Study|Protocol Violation|0|||
131762954|NCT00998985|474407203|FG012|Overall Study|Protocol Violation|0|||
131762955|NCT00998985|474407204|FG013|Overall Study|Protocol Violation|0|||
131762956|NCT01040728|474407206|FG000|Overall Study|Adverse Event|4|||
131762957|NCT01040728|474407207|FG001|Overall Study|Adverse Event|8|||
131762958|NCT01040728|474407208|FG002|Overall Study|Adverse Event|0|||
131762959|NCT01040728|474407209|FG003|Overall Study|Adverse Event|4|||
131762960|NCT01040728|474407206|FG000|Overall Study|Withdrawal by Subject|0|||
131762961|NCT01040728|474407207|FG001|Overall Study|Withdrawal by Subject|1|||
131762962|NCT01040728|474407208|FG002|Overall Study|Withdrawal by Subject|1|||
131762963|NCT01040728|474407209|FG003|Overall Study|Withdrawal by Subject|0|||
131762964|NCT01040728|474407206|FG000|Overall Study|Protocol Violation|0|||
131762965|NCT01040728|474407207|FG001|Overall Study|Protocol Violation|0|||
131762966|NCT01040728|474407208|FG002|Overall Study|Protocol Violation|0|||
131762967|NCT01040728|474407209|FG003|Overall Study|Protocol Violation|1|||
131762968|NCT01040728|474407206|FG000|Overall Study|Lack of Efficacy|0|||
131762969|NCT01040728|474407207|FG001|Overall Study|Lack of Efficacy|1|||
131762970|NCT01040728|474407208|FG002|Overall Study|Lack of Efficacy|0|||
131762971|NCT01040728|474407209|FG003|Overall Study|Lack of Efficacy|1|||
131762972|NCT01040728|474407206|FG000|Overall Study|Other reasons not listed above|0|||
131762973|NCT01040728|474407207|FG001|Overall Study|Other reasons not listed above|1|||
131762974|NCT01040728|474407208|FG002|Overall Study|Other reasons not listed above|0|||
131762975|NCT01040728|474407209|FG003|Overall Study|Other reasons not listed above|0|||
131762976|NCT00542425|474407211|FG000|Initial 24 Weeks|Administrative reasons|0|||
131762977|NCT00542425|474407212|FG001|Initial 24 Weeks|Administrative reasons|0|||
131762978|NCT00542425|474407213|FG002|Initial 24 Weeks|Administrative reasons|1|||
131762979|NCT00542425|474407214|FG003|Initial 24 Weeks|Administrative reasons|1|||
131762980|NCT00542425|474407215|FG004|Initial 24 Weeks|Administrative reasons|0|||
131762981|NCT00542425|474407211|FG000|Initial 24 Weeks|Adverse Event|0|||
131762982|NCT00542425|474407212|FG001|Initial 24 Weeks|Adverse Event|1|||
131762983|NCT00542425|474407213|FG002|Initial 24 Weeks|Adverse Event|1|||
131762984|NCT00542425|474407214|FG003|Initial 24 Weeks|Adverse Event|3|||
131762985|NCT00542425|474407215|FG004|Initial 24 Weeks|Adverse Event|2|||
131762986|NCT00542425|474407211|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
131762987|NCT00542425|474407212|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
131762988|NCT00542425|474407213|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
131762989|NCT00542425|474407214|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
131762990|NCT00542425|474407215|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
131762991|NCT00542425|474407211|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
131762992|NCT00542425|474407212|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
131762993|NCT00542425|474407213|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
131762994|NCT00542425|474407214|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
131762995|NCT00542425|474407215|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
131762996|NCT00542425|474407211|FG000|Initial 24 Weeks|Non-compliance|0|||
131762997|NCT00542425|474407212|FG001|Initial 24 Weeks|Non-compliance|0|||
131762998|NCT00542425|474407213|FG002|Initial 24 Weeks|Non-compliance|0|||
131762999|NCT00542425|474407214|FG003|Initial 24 Weeks|Non-compliance|1|||
131763000|NCT00542425|474407215|FG004|Initial 24 Weeks|Non-compliance|1|||
131763001|NCT00542425|474407211|FG000|Initial 24 Weeks|Protocol Violation|0|||
131763002|NCT00542425|474407212|FG001|Initial 24 Weeks|Protocol Violation|0|||
131763003|NCT00542425|474407213|FG002|Initial 24 Weeks|Protocol Violation|0|||
131763004|NCT00542425|474407214|FG003|Initial 24 Weeks|Protocol Violation|1|||
131763005|NCT00542425|474407215|FG004|Initial 24 Weeks|Protocol Violation|0|||
131763006|NCT00542425|474407211|FG000|Initial 24 Weeks|Refusal of treatment|2|||
131763007|NCT00542425|474407212|FG001|Initial 24 Weeks|Refusal of treatment|2|||
131763008|NCT00542425|474407213|FG002|Initial 24 Weeks|Refusal of treatment|1|||
131763009|NCT00542425|474407214|FG003|Initial 24 Weeks|Refusal of treatment|4|||
131763010|NCT00542425|474407215|FG004|Initial 24 Weeks|Refusal of treatment|1|||
131763011|NCT00542425|474407211|FG000|Initial 24 Weeks|Other|0|||
131763012|NCT00542425|474407212|FG001|Initial 24 Weeks|Other|2|||
131763013|NCT00542425|474407213|FG002|Initial 24 Weeks|Other|1|||
131763014|NCT00542425|474407214|FG003|Initial 24 Weeks|Other|0|||
131763015|NCT00542425|474407215|FG004|Initial 24 Weeks|Other|0|||
131763016|NCT00542425|474407211|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
131763017|NCT00542425|474407212|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
131763018|NCT00542425|474407213|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
131763019|NCT00542425|474407214|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
131763020|NCT00542425|474407215|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
131763021|NCT00542425|474407211|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131763022|NCT00542425|474407212|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131763023|NCT00542425|474407213|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
131763024|NCT00542425|474407214|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131763025|NCT00542425|474407215|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131763026|NCT00542425|474407211|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131763027|NCT00542425|474407212|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
131763028|NCT00542425|474407213|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131763029|NCT00542425|474407214|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131763030|NCT00542425|474407215|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131909245|NCT01296412|474954802|FG000|Overall Study|Physician Decision|1|||
131909246|NCT01296412|474954803|FG001|Overall Study|Physician Decision|3|||
131909247|NCT01296412|474954802|FG000|Overall Study|Pregnancy|0|||
131909248|NCT01296412|474954803|FG001|Overall Study|Pregnancy|1|||
131909249|NCT01296412|474954802|FG000|Overall Study|Withdrawal by Subject|10|||
131909250|NCT01296412|474954803|FG001|Overall Study|Withdrawal by Subject|13|||
131909251|NCT02997163|474956670|FG000|Overall Study|Adverse Event|1|||
131909252|NCT02997163|474956671|FG001|Overall Study|Adverse Event|0|||
131909253|NCT02997163|474956672|FG002|Overall Study|Adverse Event|0|||
131763031|NCT00542425|474407211|FG000|Extended 24 Weeks of Treatment|Other|1|||
131763032|NCT00542425|474407212|FG001|Extended 24 Weeks of Treatment|Other|1|||
131763033|NCT00542425|474407213|FG002|Extended 24 Weeks of Treatment|Other|0|||
131763034|NCT00542425|474407214|FG003|Extended 24 Weeks of Treatment|Other|0|||
131763035|NCT00542425|474407215|FG004|Extended 24 Weeks of Treatment|Other|1|||
131763036|NCT03196973|474407216|FG000|Overall Study|Adverse Event|1|||
131763037|NCT03196973|474407217|FG001|Overall Study|Adverse Event|1|||
131763038|NCT03196973|474407218|FG002|Overall Study|Adverse Event|2|||
131763039|NCT03196973|474407216|FG000|Overall Study|Lack of Efficacy|2|||
131763040|NCT03196973|474407217|FG001|Overall Study|Lack of Efficacy|6|||
131763041|NCT03196973|474407218|FG002|Overall Study|Lack of Efficacy|1|||
131763042|NCT03196973|474407216|FG000|Overall Study|Lost to Follow-up|4|||
131763043|NCT03196973|474407217|FG001|Overall Study|Lost to Follow-up|3|||
131763044|NCT03196973|474407218|FG002|Overall Study|Lost to Follow-up|2|||
131763045|NCT03196973|474407216|FG000|Overall Study|Consent withdrawn|2|||
131763046|NCT03196973|474407217|FG001|Overall Study|Consent withdrawn|1|||
131763047|NCT03196973|474407218|FG002|Overall Study|Consent withdrawn|0|||
131763048|NCT03196973|474407216|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
131763049|NCT03196973|474407217|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
131763050|NCT03196973|474407218|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
131763051|NCT01809327|474407219|FG000|Overall Study|Lost to Follow-up|5|||
131763052|NCT01809327|474407220|FG001|Overall Study|Lost to Follow-up|2|||
131763053|NCT01809327|474407221|FG002|Overall Study|Lost to Follow-up|4|||
131763054|NCT01809327|474407222|FG003|Overall Study|Lost to Follow-up|2|||
131763055|NCT01809327|474407223|FG004|Overall Study|Lost to Follow-up|3|||
131763056|NCT01809327|474407219|FG000|Overall Study|Withdrawal by Subject|6|||
131763057|NCT01809327|474407220|FG001|Overall Study|Withdrawal by Subject|4|||
131763058|NCT01809327|474407221|FG002|Overall Study|Withdrawal by Subject|4|||
131763059|NCT01809327|474407222|FG003|Overall Study|Withdrawal by Subject|2|||
131763060|NCT01809327|474407223|FG004|Overall Study|Withdrawal by Subject|5|||
131763061|NCT01809327|474407219|FG000|Overall Study|Adverse Event|4|||
131763062|NCT01809327|474407220|FG001|Overall Study|Adverse Event|3|||
131763063|NCT01809327|474407221|FG002|Overall Study|Adverse Event|7|||
131763064|NCT01809327|474407222|FG003|Overall Study|Adverse Event|4|||
131763065|NCT01809327|474407223|FG004|Overall Study|Adverse Event|8|||
131813190|NCT02682238|474598974|FG001|Overall Study|Withdrawal by Subject|0|||
131813191|NCT02682238|474598973|FG000|Overall Study|Adverse Event|1|||
131813192|NCT02682238|474598974|FG001|Overall Study|Adverse Event|0|||
131813193|NCT02682238|474598973|FG000|Overall Study|Non-compliance with Study Drug|1|||
131813194|NCT02682238|474598974|FG001|Overall Study|Non-compliance with Study Drug|0|||
131813195|NCT02682238|474598973|FG000|Overall Study|Non-compliance with Protocol|0|||
131813196|NCT02682238|474598974|FG001|Overall Study|Non-compliance with Protocol|2|||
131813197|NCT01370317|474598975|FG000|Overall Study|Participant withdrew consent|1|||
131813198|NCT01370317|474598976|FG001|Overall Study|Participant withdrew consent|0|||
131813199|NCT01370317|474598975|FG000|Overall Study|Protocol deviation|0|||
131813200|NCT01370317|474598976|FG001|Overall Study|Protocol deviation|1|||
131813201|NCT02909907|474598978|FG000|Overall Study|Withdrawal by Subject|0|||
131813202|NCT02909907|474598979|FG001|Overall Study|Withdrawal by Subject|1|||
131813203|NCT00075478|474598980|FG000|Overall Study|not eligible|1|||
131813204|NCT00075478|474598981|FG001|Overall Study|not eligible|0|||
131813205|NCT00075478|474598980|FG000|Overall Study|Physician Decision|0|||
131813206|NCT00075478|474598981|FG001|Overall Study|Physician Decision|1|||
131813207|NCT02849457|474598984|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
131813208|NCT02849457|474598985|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
131813209|NCT02849457|474598986|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
131813210|NCT02849457|474598987|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
131813211|NCT02699866|474598988|FG000|Overall Study|Withdrawal by Subject|3|||
131909254|NCT02997163|474956673|FG003|Overall Study|Adverse Event|1|||
131763066|NCT01809327|474407219|FG000|Overall Study|Death|1|||
131763067|NCT01809327|474407220|FG001|Overall Study|Death|0|||
131763068|NCT01809327|474407221|FG002|Overall Study|Death|0|||
131763069|NCT01809327|474407222|FG003|Overall Study|Death|0|||
131763070|NCT01809327|474407223|FG004|Overall Study|Death|0|||
131763071|NCT01809327|474407219|FG000|Overall Study|Protocol Violation|0|||
131763072|NCT01809327|474407220|FG001|Overall Study|Protocol Violation|1|||
131763073|NCT01809327|474407221|FG002|Overall Study|Protocol Violation|0|||
131763074|NCT01809327|474407222|FG003|Overall Study|Protocol Violation|0|||
131763075|NCT01809327|474407223|FG004|Overall Study|Protocol Violation|0|||
131763076|NCT01809327|474407219|FG000|Overall Study|Physician Decision|1|||
131763077|NCT01809327|474407220|FG001|Overall Study|Physician Decision|1|||
131763078|NCT01809327|474407221|FG002|Overall Study|Physician Decision|0|||
131763079|NCT01809327|474407222|FG003|Overall Study|Physician Decision|0|||
131763080|NCT01809327|474407223|FG004|Overall Study|Physician Decision|0|||
131763081|NCT01809327|474407219|FG000|Overall Study|Pregnancy|1|||
131763082|NCT01809327|474407220|FG001|Overall Study|Pregnancy|0|||
131763083|NCT01809327|474407221|FG002|Overall Study|Pregnancy|0|||
131763084|NCT01809327|474407222|FG003|Overall Study|Pregnancy|0|||
131763085|NCT01809327|474407223|FG004|Overall Study|Pregnancy|0|||
131763086|NCT01809327|474407219|FG000|Overall Study|Other|14|||
131763087|NCT01809327|474407220|FG001|Overall Study|Other|15|||
131763088|NCT01809327|474407221|FG002|Overall Study|Other|7|||
131763089|NCT01809327|474407222|FG003|Overall Study|Other|4|||
131763090|NCT01809327|474407223|FG004|Overall Study|Other|9|||
131763091|NCT01610414|474407224|FG000|Study Start - Month 13|Serious Adverse Event|65|||
131763092|NCT01610414|474407225|FG001|Study Start - Month 13|Serious Adverse Event|67|||
131763093|NCT01610414|474407224|FG000|Study Start - Month 13|Adverse Event|14|||
131763094|NCT01610414|474407225|FG001|Study Start - Month 13|Adverse Event|14|||
131763095|NCT01610414|474407224|FG000|Study Start - Month 13|Protocol Violation|3|||
131763096|NCT01610414|474407225|FG001|Study Start - Month 13|Protocol Violation|1|||
131763097|NCT01610414|474407224|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
131763098|NCT01610414|474407225|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
131763099|NCT01610414|474407224|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
131763100|NCT01610414|474407225|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
131763101|NCT01610414|474407224|FG000|Study Start - Month 13|Lost to Follow-up|4|||
131763102|NCT01610414|474407225|FG001|Study Start - Month 13|Lost to Follow-up|6|||
131763103|NCT01610414|474407224|FG000|Study Start - Month 13|Suspected HZ episode|1|||
131763104|NCT01610414|474407225|FG001|Study Start - Month 13|Suspected HZ episode|3|||
131763105|NCT01610414|474407224|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
131763106|NCT01610414|474407225|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
131763107|NCT01610414|474407224|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
131763108|NCT01610414|474407225|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
131763109|NCT01610414|474407224|FG000|Month 13 - Month 25|Adverse Event|8|||
131763110|NCT01610414|474407225|FG001|Month 13 - Month 25|Adverse Event|4|||
131763111|NCT01610414|474407224|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
131763112|NCT01610414|474407225|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
131763113|NCT01610414|474407224|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
131763114|NCT01610414|474407225|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
131763115|NCT01610414|474407224|FG000|Month 13 - Month 25|Protocol Violation|0|||
131763116|NCT01610414|474407225|FG001|Month 13 - Month 25|Protocol Violation|2|||
131763117|NCT01610414|474407224|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
131763118|NCT01610414|474407225|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
131763119|NCT01610414|474407224|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
131763120|NCT01610414|474407225|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
131763121|NCT01610414|474407224|FG000|After Month 25|Study end not reached|48|||
131763122|NCT01610414|474407225|FG001|After Month 25|Study end not reached|53|||
131763123|NCT02736474|474407226|FG000|Overall Study|Lost to Follow-up|0|||
131763124|NCT02736474|474407227|FG001|Overall Study|Lost to Follow-up|1|||
131763125|NCT02463331|474407228|FG000|Overall Study|Adverse Event|4|||
131763126|NCT02463331|474407229|FG001|Overall Study|Adverse Event|2|||
131763127|NCT02463331|474407228|FG000|Overall Study|Lost to Follow-up|1|||
131763128|NCT02463331|474407229|FG001|Overall Study|Lost to Follow-up|1|||
131763129|NCT02463331|474407228|FG000|Overall Study|Pregnancy|2|||
131763130|NCT02463331|474407229|FG001|Overall Study|Pregnancy|3|||
131813212|NCT02699866|474598988|FG000|Overall Study|Physician Decision|2|||
131813213|NCT02699866|474598988|FG000|Overall Study|Adverse Event|3|||
131813214|NCT03673670|474598989|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
131813215|NCT03673670|474598990|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
131813216|NCT03673670|474598991|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
131813217|NCT03673670|474598992|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
131813218|NCT03673670|474598993|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
131763131|NCT02463331|474407228|FG000|Overall Study|Lack of Efficacy|6|||
131763132|NCT02463331|474407229|FG001|Overall Study|Lack of Efficacy|0|||
131813219|NCT03673670|474598994|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
131813220|NCT03673670|474598989|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
131813221|NCT03673670|474598990|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
131813222|NCT03673670|474598991|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
131813223|NCT03673670|474598992|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
131813224|NCT03673670|474598993|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
131763133|NCT02463331|474407228|FG000|Overall Study|Physician Decision|3|||
131763134|NCT02463331|474407229|FG001|Overall Study|Physician Decision|0|||
131763135|NCT00826540|474407230|FG000|Overall Study|ineligible|3|||
131909255|NCT01855958|474956694|FG000|Overall Study|Withdrawal by Subject|1|||
131909256|NCT01855958|474956695|FG001|Overall Study|Withdrawal by Subject|0|||
131909257|NCT00296244|474956696|FG000|Overall Study|Underwent retransplant|0|||
131909258|NCT00296244|474956697|FG001|Overall Study|Underwent retransplant|1|||
131909259|NCT00427934|474956698|FG000|Overall Study|Adverse Event|1|||
131909260|NCT00427934|474956699|FG001|Overall Study|Adverse Event|0|||
131909261|NCT00427934|474956700|FG002|Overall Study|Adverse Event|5|||
131909262|NCT00427934|474956701|FG003|Overall Study|Adverse Event|4|||
131909263|NCT00427934|474956698|FG000|Overall Study|Lack of Efficacy|0|||
131909264|NCT00427934|474956699|FG001|Overall Study|Lack of Efficacy|0|||
131763136|NCT00826540|474407230|FG000|Overall Study|Withdrawal by Subject|1|||
131763137|NCT02483611|474407231|FG000|Overall Study|Protocol Violation|0|||
131763138|NCT02483611|474407232|FG001|Overall Study|Protocol Violation|0|||
131763139|NCT02483611|474407233|FG002|Overall Study|Protocol Violation|1|||
131763140|NCT01222416|474407234|FG000|Overall Study|ineligible;metastasis|3|||
131763141|NCT01222416|474407235|FG001|Overall Study|ineligible;metastasis|0|||
131763142|NCT01222416|474407234|FG000|Overall Study|Adverse Event|4|||
131763143|NCT01222416|474407235|FG001|Overall Study|Adverse Event|0|||
131763144|NCT01222416|474407234|FG000|Overall Study|Withdrawal by Subject|5|||
131763145|NCT01222416|474407235|FG001|Overall Study|Withdrawal by Subject|0|||
131763146|NCT01222416|474407234|FG000|Overall Study|scheduling|6|||
131763147|NCT01222416|474407235|FG001|Overall Study|scheduling|0|||
131763148|NCT01222416|474407234|FG000|Overall Study|missed view/scan|1|||
131763149|NCT01222416|474407235|FG001|Overall Study|missed view/scan|0|||
131763150|NCT01222416|474407234|FG000|Overall Study|Death|1|||
131763151|NCT01222416|474407235|FG001|Overall Study|Death|0|||
131763152|NCT02520141|474407240|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
131763153|NCT02036476|474407241|FG000|Overall Study|Withdrawal by Subject|2|||
131763154|NCT02036476|474407241|FG000|Overall Study|Progressive Disease|4|||
131763155|NCT02036476|474407241|FG000|Overall Study|Unacceptable Toxicity|2|||
131763156|NCT00703781|474407242|FG000|Overall Study|Withdrawal by Subject|1|||
131763157|NCT00703781|474407243|FG001|Overall Study|Withdrawal by Subject|2|||
131763158|NCT00703781|474407242|FG000|Overall Study|Cancelled surgery|1|||
131763159|NCT00703781|474407243|FG001|Overall Study|Cancelled surgery|0|||
131763160|NCT02168816|474407244|FG000|Overall Study|Lost to Follow-up|2|||
131763161|NCT02168816|474407245|FG001|Overall Study|Lost to Follow-up|2|||
131763162|NCT03452397|474407248|FG000|Overall Study|Adverse Event|1|||
131763163|NCT03452397|474407249|FG001|Overall Study|Adverse Event|0|||
131763164|NCT03452397|474407250|FG002|Overall Study|Adverse Event|0|||
131763165|NCT03452397|474407251|FG003|Overall Study|Adverse Event|0|||
131763166|NCT03452397|474407248|FG000|Overall Study|Administrative reason|0|||
131763167|NCT03452397|474407249|FG001|Overall Study|Administrative reason|0|||
131763168|NCT03452397|474407250|FG002|Overall Study|Administrative reason|1|||
131763169|NCT03452397|474407251|FG003|Overall Study|Administrative reason|1|||
131763170|NCT03452397|474407248|FG000|Overall Study|Withdrawal by Subject|0|||
131763171|NCT03452397|474407249|FG001|Overall Study|Withdrawal by Subject|0|||
131763172|NCT03452397|474407250|FG002|Overall Study|Withdrawal by Subject|1|||
131763173|NCT03452397|474407251|FG003|Overall Study|Withdrawal by Subject|0|||
131763174|NCT02691468|474407252|FG000|Overall Study|Bronchial blocker use|2|||
131763175|NCT02691468|474407253|FG001|Overall Study|Bronchial blocker use|1|||
131763176|NCT02691468|474407252|FG000|Overall Study|Lost to Follow-up|2|||
131763177|NCT02691468|474407253|FG001|Overall Study|Lost to Follow-up|1|||
131763178|NCT02691468|474407252|FG000|Overall Study|Failure to advance FOB|2|||
131763179|NCT02691468|474407253|FG001|Overall Study|Failure to advance FOB|0|||
131763180|NCT02545049|474407257|FG000|Overall Study|Withdrawal by Subject|1|||
131763181|NCT02545049|474407258|FG001|Overall Study|Withdrawal by Subject|7|||
131763182|NCT02545049|474407257|FG000|Overall Study|Lost to Follow-up|4|||
131909265|NCT00427934|474956700|FG002|Overall Study|Lack of Efficacy|5|||
131909266|NCT00427934|474956701|FG003|Overall Study|Lack of Efficacy|2|||
131909267|NCT00427934|474956698|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
131909268|NCT00427934|474956699|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
131909269|NCT00427934|474956700|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
131909270|NCT00427934|474956701|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
131763183|NCT02545049|474407258|FG001|Overall Study|Lost to Follow-up|6|||
131763184|NCT02545049|474407257|FG000|Overall Study|GCP violations|37|||
131398710|NCT01296711|473081246|FG006|Overall Study|Adverse Event|11|||
131398711|NCT01296711|473081247|FG007|Overall Study|Adverse Event|3|||
131763185|NCT02545049|474407258|FG001|Overall Study|GCP violations|48|||
131763186|NCT00424463|474407259|FG000|Overall Study|Adverse Event|2|||
131763187|NCT00424463|474407260|FG001|Overall Study|Adverse Event|3|||
131763188|NCT00424463|474407261|FG002|Overall Study|Adverse Event|2|||
131763189|NCT00424463|474407259|FG000|Overall Study|Physician Decision|0|||
131909271|NCT00427934|474956698|FG000|Overall Study|Other|0|||
131763190|NCT00424463|474407260|FG001|Overall Study|Physician Decision|2|||
131909272|NCT00427934|474956699|FG001|Overall Study|Other|0|||
131909273|NCT00427934|474956700|FG002|Overall Study|Other|11|||
131398712|NCT01296711|473081240|FG000|Overall Study|Lack of Efficacy|1|||
131763191|NCT00424463|474407261|FG002|Overall Study|Physician Decision|2|||
131763192|NCT00424463|474407259|FG000|Overall Study|Withdrawal by Subject|4|||
131763193|NCT00424463|474407260|FG001|Overall Study|Withdrawal by Subject|2|||
131763194|NCT00424463|474407261|FG002|Overall Study|Withdrawal by Subject|5|||
131763195|NCT00424463|474407259|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
131763196|NCT00424463|474407260|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
131763197|NCT00424463|474407261|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
131763198|NCT00424463|474407259|FG000|Overall Study|Patient's convenience|0|||
131763199|NCT00424463|474407260|FG001|Overall Study|Patient's convenience|0|||
131763200|NCT00424463|474407261|FG002|Overall Study|Patient's convenience|1|||
131763201|NCT01436357|474407262|FG000|Overall Study|Death|5|||
131763202|NCT01436357|474407263|FG001|Overall Study|Death|1|||
131763203|NCT01436357|474407262|FG000|Overall Study|Enrolled but not vaccinated|1|||
131398713|NCT01296711|473081241|FG001|Overall Study|Lack of Efficacy|4|||
131398714|NCT01296711|473081242|FG002|Overall Study|Lack of Efficacy|1|||
131398715|NCT01296711|473081243|FG003|Overall Study|Lack of Efficacy|1|||
131398716|NCT01296711|473081244|FG004|Overall Study|Lack of Efficacy|1|||
131398717|NCT01296711|473081245|FG005|Overall Study|Lack of Efficacy|0|||
131398718|NCT01296711|473081246|FG006|Overall Study|Lack of Efficacy|2|||
131398719|NCT01296711|473081247|FG007|Overall Study|Lack of Efficacy|3|||
131398720|NCT01296711|473081240|FG000|Overall Study|Lost to Follow-up|0|||
131398721|NCT01296711|473081241|FG001|Overall Study|Lost to Follow-up|0|||
131398722|NCT01296711|473081242|FG002|Overall Study|Lost to Follow-up|1|||
131398723|NCT01296711|473081243|FG003|Overall Study|Lost to Follow-up|1|||
131398724|NCT01296711|473081244|FG004|Overall Study|Lost to Follow-up|2|||
131398725|NCT01296711|473081245|FG005|Overall Study|Lost to Follow-up|0|||
131398726|NCT01296711|473081246|FG006|Overall Study|Lost to Follow-up|4|||
131398727|NCT01296711|473081247|FG007|Overall Study|Lost to Follow-up|2|||
131398728|NCT01296711|473081240|FG000|Overall Study|Protocol Violation|0|||
131398729|NCT01296711|473081241|FG001|Overall Study|Protocol Violation|0|||
131398730|NCT01296711|473081242|FG002|Overall Study|Protocol Violation|0|||
131398731|NCT01296711|473081243|FG003|Overall Study|Protocol Violation|1|||
131398732|NCT01296711|473081244|FG004|Overall Study|Protocol Violation|1|||
131398733|NCT01296711|473081245|FG005|Overall Study|Protocol Violation|0|||
131398734|NCT01296711|473081246|FG006|Overall Study|Protocol Violation|0|||
131398735|NCT01296711|473081247|FG007|Overall Study|Protocol Violation|0|||
131398736|NCT01296711|473081240|FG000|Overall Study|Withdrawal by Subject|4|||
131398737|NCT01296711|473081241|FG001|Overall Study|Withdrawal by Subject|2|||
131398738|NCT01296711|473081242|FG002|Overall Study|Withdrawal by Subject|2|||
131398739|NCT01296711|473081243|FG003|Overall Study|Withdrawal by Subject|1|||
131398740|NCT01296711|473081244|FG004|Overall Study|Withdrawal by Subject|1|||
131398741|NCT01296711|473081245|FG005|Overall Study|Withdrawal by Subject|1|||
131398742|NCT01296711|473081246|FG006|Overall Study|Withdrawal by Subject|2|||
131398743|NCT01296711|473081247|FG007|Overall Study|Withdrawal by Subject|1|||
131398744|NCT01296711|473081240|FG000|Overall Study|Study termination|8|||
131398745|NCT01296711|473081241|FG001|Overall Study|Study termination|1|||
131398746|NCT01296711|473081242|FG002|Overall Study|Study termination|5|||
131398747|NCT01296711|473081243|FG003|Overall Study|Study termination|4|||
131398748|NCT01296711|473081244|FG004|Overall Study|Study termination|4|||
131398749|NCT01296711|473081245|FG005|Overall Study|Study termination|4|||
131398750|NCT01296711|473081246|FG006|Overall Study|Study termination|8|||
131398751|NCT01296711|473081247|FG007|Overall Study|Study termination|10|||
131398752|NCT01296711|473081240|FG000|Overall Study|Continued elevated liver enzymes|0|||
131398753|NCT01296711|473081241|FG001|Overall Study|Continued elevated liver enzymes|0|||
131398754|NCT01296711|473081242|FG002|Overall Study|Continued elevated liver enzymes|0|||
131398755|NCT01296711|473081243|FG003|Overall Study|Continued elevated liver enzymes|1|||
131398756|NCT01296711|473081244|FG004|Overall Study|Continued elevated liver enzymes|0|||
131398757|NCT01296711|473081245|FG005|Overall Study|Continued elevated liver enzymes|0|||
131398758|NCT01296711|473081246|FG006|Overall Study|Continued elevated liver enzymes|0|||
131398759|NCT01296711|473081247|FG007|Overall Study|Continued elevated liver enzymes|0|||
131398760|NCT01296711|473081240|FG000|Overall Study|Methotrexate discontinued|0|||
131398761|NCT01296711|473081241|FG001|Overall Study|Methotrexate discontinued|0|||
131763204|NCT01436357|474407263|FG001|Overall Study|Enrolled but not vaccinated|1|||
131763205|NCT01436357|474407262|FG000|Overall Study|Incarceration|18|||
131763206|NCT01436357|474407263|FG001|Overall Study|Incarceration|20|||
131763207|NCT01436357|474407262|FG000|Overall Study|Lost to Follow-up|67|||
131763208|NCT01436357|474407263|FG001|Overall Study|Lost to Follow-up|61|||
131763209|NCT01436357|474407262|FG000|Overall Study|Protocol Violation|1|||
131763210|NCT01436357|474407263|FG001|Overall Study|Protocol Violation|0|||
131763211|NCT01436357|474407262|FG000|Overall Study|Withdrawal by Subject|26|||
131763212|NCT01436357|474407263|FG001|Overall Study|Withdrawal by Subject|38|||
131763213|NCT01436357|474407262|FG000|Overall Study|Physician Decision|3|||
131763214|NCT01436357|474407263|FG001|Overall Study|Physician Decision|4|||
131763215|NCT01436357|474407262|FG000|Overall Study|Moved out of area|1|||
131763216|NCT01436357|474407263|FG001|Overall Study|Moved out of area|2|||
131763217|NCT01436357|474407262|FG000|Overall Study|Subject in rehab|0|||
131763218|NCT01436357|474407263|FG001|Overall Study|Subject in rehab|1|||
131763219|NCT02200510|474408631|FG000|Overall Study|Death|1|||
131763220|NCT02200510|474408632|FG001|Overall Study|Death|1|||
131763221|NCT02200510|474408631|FG000|Overall Study|Protocol Violation|0|||
131763222|NCT02200510|474408632|FG001|Overall Study|Protocol Violation|1|||
131763223|NCT02200510|474408631|FG000|Overall Study|Lost to Follow-up|7|||
131763224|NCT02200510|474408632|FG001|Overall Study|Lost to Follow-up|1|||
131763225|NCT02200510|474408631|FG000|Overall Study|potential COI - joined study team|1|||
131763226|NCT02200510|474408632|FG001|Overall Study|potential COI - joined study team|0|||
131763227|NCT00290355|474408633|FG000|Overall Study|Serious adverse event|7|||
131763228|NCT00290355|474408634|FG001|Overall Study|Serious adverse event|4|||
131763229|NCT00290355|474408633|FG000|Overall Study|Study product reactogenicity|1|||
131763230|NCT00290355|474408634|FG001|Overall Study|Study product reactogenicity|0|||
131763231|NCT00290355|474408633|FG000|Overall Study|Protocol Violation|1|||
131398762|NCT01296711|473081242|FG002|Overall Study|Methotrexate discontinued|0|||
131398763|NCT01296711|473081243|FG003|Overall Study|Methotrexate discontinued|1|||
131398764|NCT01296711|473081244|FG004|Overall Study|Methotrexate discontinued|0|||
131398765|NCT01296711|473081245|FG005|Overall Study|Methotrexate discontinued|0|||
131398766|NCT01296711|473081246|FG006|Overall Study|Methotrexate discontinued|0|||
131398767|NCT01296711|473081247|FG007|Overall Study|Methotrexate discontinued|0|||
131398768|NCT01296711|473081240|FG000|Overall Study|Investigator discretion|0|||
131398769|NCT01296711|473081241|FG001|Overall Study|Investigator discretion|0|||
131398770|NCT01296711|473081242|FG002|Overall Study|Investigator discretion|0|||
131398771|NCT01296711|473081243|FG003|Overall Study|Investigator discretion|0|||
131398772|NCT01296711|473081244|FG004|Overall Study|Investigator discretion|0|||
131398773|NCT01296711|473081245|FG005|Overall Study|Investigator discretion|0|||
131398774|NCT01296711|473081246|FG006|Overall Study|Investigator discretion|1|||
131398775|NCT01296711|473081247|FG007|Overall Study|Investigator discretion|0|||
131398776|NCT01296711|473081240|FG000|Overall Study|Other|0|||
131398777|NCT01296711|473081241|FG001|Overall Study|Other|0|||
131398778|NCT01296711|473081242|FG002|Overall Study|Other|0|||
131398779|NCT01296711|473081243|FG003|Overall Study|Other|0|||
131398780|NCT01296711|473081244|FG004|Overall Study|Other|0|||
131398781|NCT01296711|473081245|FG005|Overall Study|Other|0|||
131398782|NCT01296711|473081246|FG006|Overall Study|Other|1|||
131398783|NCT01296711|473081247|FG007|Overall Study|Other|0|||
131398784|NCT01296711|473081240|FG000|Overall Study|Required restricted steroid injections|0|||
131398785|NCT01296711|473081241|FG001|Overall Study|Required restricted steroid injections|0|||
131398786|NCT01296711|473081242|FG002|Overall Study|Required restricted steroid injections|0|||
131398787|NCT01296711|473081243|FG003|Overall Study|Required restricted steroid injections|0|||
131398788|NCT01296711|473081244|FG004|Overall Study|Required restricted steroid injections|0|||
131398789|NCT01296711|473081245|FG005|Overall Study|Required restricted steroid injections|0|||
131398790|NCT01296711|473081246|FG006|Overall Study|Required restricted steroid injections|1|||
131398791|NCT01296711|473081247|FG007|Overall Study|Required restricted steroid injections|0|||
131398792|NCT01296711|473081240|FG000|Overall Study|Ongoing missed appointments|0|||
131398793|NCT01296711|473081241|FG001|Overall Study|Ongoing missed appointments|0|||
131398794|NCT01296711|473081242|FG002|Overall Study|Ongoing missed appointments|0|||
131398795|NCT01296711|473081243|FG003|Overall Study|Ongoing missed appointments|0|||
131398796|NCT01296711|473081244|FG004|Overall Study|Ongoing missed appointments|0|||
131398797|NCT01296711|473081245|FG005|Overall Study|Ongoing missed appointments|0|||
131398798|NCT01296711|473081246|FG006|Overall Study|Ongoing missed appointments|1|||
131398799|NCT01296711|473081247|FG007|Overall Study|Ongoing missed appointments|0|||
131398800|NCT01296711|473081240|FG000|Overall Study|Failure to comply with visits|0|||
131398801|NCT01296711|473081241|FG001|Overall Study|Failure to comply with visits|0|||
131398802|NCT01296711|473081242|FG002|Overall Study|Failure to comply with visits|0|||
131398803|NCT01296711|473081243|FG003|Overall Study|Failure to comply with visits|0|||
131398804|NCT01296711|473081244|FG004|Overall Study|Failure to comply with visits|0|||
131398805|NCT01296711|473081245|FG005|Overall Study|Failure to comply with visits|0|||
131398806|NCT01296711|473081246|FG006|Overall Study|Failure to comply with visits|0|||
131398807|NCT01296711|473081247|FG007|Overall Study|Failure to comply with visits|1|||
131398808|NCT01296711|473081240|FG000|Overall Study|Patient decision due to transport|0|||
131398809|NCT01296711|473081241|FG001|Overall Study|Patient decision due to transport|0|||
131398810|NCT01296711|473081242|FG002|Overall Study|Patient decision due to transport|0|||
131398811|NCT01296711|473081243|FG003|Overall Study|Patient decision due to transport|0|||
131398812|NCT01296711|473081244|FG004|Overall Study|Patient decision due to transport|0|||
131398813|NCT01296711|473081245|FG005|Overall Study|Patient decision due to transport|0|||
131398814|NCT01296711|473081246|FG006|Overall Study|Patient decision due to transport|0|||
131398815|NCT01296711|473081247|FG007|Overall Study|Patient decision due to transport|1|||
131398816|NCT01126268|473081250|FG000|Overall Study|Adverse Event|1|||
131398817|NCT00842153|473081251|FG000|Overall Study|Adverse Event|0|||
131398818|NCT00842153|473081252|FG001|Overall Study|Adverse Event|1|||
131398819|NCT00842153|473081251|FG000|Overall Study|Lost to Follow-up|1|||
131398820|NCT00842153|473081252|FG001|Overall Study|Lost to Follow-up|2|||
131398821|NCT00002540|473081253|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
131398822|NCT00002540|473081254|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
131398823|NCT00002540|473081253|FG000|Overall Study|Died Before Randomization|2|||
131398824|NCT00002540|473081254|FG001|Overall Study|Died Before Randomization|6|||
131398825|NCT00002540|473081253|FG000|Overall Study|Died Before ASU (Control)|202|||
131398826|NCT00002540|473081254|FG001|Overall Study|Died Before ASU (Control)|0|||
131398827|NCT00002540|473081253|FG000|Overall Study|Refused ASU (Control)|597|||
131398828|NCT00002540|473081254|FG001|Overall Study|Refused ASU (Control)|0|||
131398829|NCT00002540|473081253|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
131398830|NCT00002540|473081254|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
131398831|NCT05312697|473081255|FG000|Overall Study|Sponsor Terminated Trial|2|||
131398832|NCT04445519|473081256|FG000|Overall Study|Due to adaptive design|3|||
131398833|NCT04445519|473081257|FG001|Overall Study|Due to adaptive design|0|||
131398834|NCT04445519|473081258|FG002|Overall Study|Due to adaptive design|0|||
131398835|NCT04445519|473081256|FG000|Overall Study|Lost to Follow-up|0|||
131398836|NCT04445519|473081257|FG001|Overall Study|Lost to Follow-up|1|||
131398837|NCT04445519|473081258|FG002|Overall Study|Lost to Follow-up|4|||
131398838|NCT04445519|473081256|FG000|Overall Study|Sponsor or IRB Decision|0|||
131398839|NCT04445519|473081257|FG001|Overall Study|Sponsor or IRB Decision|1|||
131398840|NCT04445519|473081258|FG002|Overall Study|Sponsor or IRB Decision|2|||
131398841|NCT04445519|473081256|FG000|Overall Study|Withdrawal by Subject|0|||
131398842|NCT04445519|473081257|FG001|Overall Study|Withdrawal by Subject|3|||
131398843|NCT04445519|473081258|FG002|Overall Study|Withdrawal by Subject|3|||
131398844|NCT04445519|473081256|FG000|Overall Study|Adverse Event|0|||
131398845|NCT04445519|473081257|FG001|Overall Study|Adverse Event|8|||
131763232|NCT00290355|474408634|FG001|Overall Study|Protocol Violation|0|||
131763233|NCT00290355|474408633|FG000|Overall Study|Withdrawal by Subject|2|||
131763234|NCT00290355|474408634|FG001|Overall Study|Withdrawal by Subject|0|||
131763235|NCT00290355|474408633|FG000|Overall Study|Migrated / moved from the study area|1|||
131398846|NCT04445519|473081258|FG002|Overall Study|Adverse Event|6|||
131398847|NCT04445519|473081256|FG000|Overall Study|Other Reason|0|||
131398848|NCT04445519|473081257|FG001|Overall Study|Other Reason|1|||
131763236|NCT00290355|474408634|FG001|Overall Study|Migrated / moved from the study area|0|||
131398849|NCT04445519|473081258|FG002|Overall Study|Other Reason|1|||
131398850|NCT04445519|473081256|FG000|Overall Study|Protocol Violation|0|||
131398851|NCT04445519|473081257|FG001|Overall Study|Protocol Violation|0|||
131398852|NCT04445519|473081258|FG002|Overall Study|Protocol Violation|1|||
131398853|NCT01345929|473081259|FG000|Overall Study|Withdrawal by Subject|9|||
131398854|NCT01345929|473081260|FG001|Overall Study|Withdrawal by Subject|8|||
131398855|NCT01345929|473081259|FG000|Overall Study|Lost to Follow-up|9|||
131398856|NCT01345929|473081260|FG001|Overall Study|Lost to Follow-up|9|||
131398857|NCT01345929|473081259|FG000|Overall Study|Adverse Event|0|||
131398858|NCT01345929|473081260|FG001|Overall Study|Adverse Event|1|||
131398859|NCT01345929|473081259|FG000|Overall Study|Didn't meet eligibility criteria|2|||
131398860|NCT01345929|473081260|FG001|Overall Study|Didn't meet eligibility criteria|0|||
131398861|NCT01345929|473081259|FG000|Overall Study|40,000 CFU/ML|1|||
131398862|NCT01345929|473081260|FG001|Overall Study|40,000 CFU/ML|0|||
131398863|NCT01345929|473081259|FG000|Overall Study|Patient withdrawal|0|||
131398864|NCT01345929|473081260|FG001|Overall Study|Patient withdrawal|1|||
131398865|NCT02151903|473081261|FG000|Overall Study|Withdrawal by Subject|1|||
131398866|NCT02151903|473081262|FG001|Overall Study|Withdrawal by Subject|0|||
131398867|NCT02151903|473081261|FG000|Overall Study|Progressive disease|2|||
131398868|NCT02151903|473081262|FG001|Overall Study|Progressive disease|1|||
131398869|NCT01864148|473081263|FG000|Overall Study|Other|2|||
131398870|NCT01864148|473081264|FG001|Overall Study|Other|1|||
131398871|NCT01864148|473081265|FG002|Overall Study|Other|1|||
131398872|NCT01864148|473081266|FG003|Overall Study|Other|3|||
131398873|NCT01864148|473081267|FG004|Overall Study|Other|1|||
131398874|NCT01864148|473081263|FG000|Overall Study|Death|0|||
131398875|NCT01864148|473081264|FG001|Overall Study|Death|0|||
131398876|NCT01864148|473081265|FG002|Overall Study|Death|0|||
131398877|NCT01864148|473081266|FG003|Overall Study|Death|1|||
131398878|NCT01864148|473081267|FG004|Overall Study|Death|0|||
131398879|NCT01864148|473081263|FG000|Overall Study|Investigator Decision|5|||
131398880|NCT01864148|473081264|FG001|Overall Study|Investigator Decision|0|||
131398881|NCT01864148|473081265|FG002|Overall Study|Investigator Decision|0|||
131398882|NCT01864148|473081266|FG003|Overall Study|Investigator Decision|4|||
131398883|NCT01864148|473081267|FG004|Overall Study|Investigator Decision|6|||
131398884|NCT01864148|473081263|FG000|Overall Study|Withdrawal by Subject|9|||
131398885|NCT01864148|473081264|FG001|Overall Study|Withdrawal by Subject|2|||
131398886|NCT01864148|473081265|FG002|Overall Study|Withdrawal by Subject|6|||
131398887|NCT01864148|473081266|FG003|Overall Study|Withdrawal by Subject|8|||
131398888|NCT01864148|473081267|FG004|Overall Study|Withdrawal by Subject|8|||
131398889|NCT01864148|473081263|FG000|Overall Study|Lost to Follow-up|0|||
131398890|NCT01864148|473081264|FG001|Overall Study|Lost to Follow-up|0|||
131398891|NCT01864148|473081265|FG002|Overall Study|Lost to Follow-up|0|||
131398892|NCT01864148|473081266|FG003|Overall Study|Lost to Follow-up|2|||
131398893|NCT01864148|473081267|FG004|Overall Study|Lost to Follow-up|1|||
131398894|NCT01864148|473081263|FG000|Overall Study|Adverse Event|4|||
131398895|NCT01864148|473081264|FG001|Overall Study|Adverse Event|2|||
131398896|NCT01864148|473081265|FG002|Overall Study|Adverse Event|4|||
131398897|NCT01864148|473081266|FG003|Overall Study|Adverse Event|7|||
131398898|NCT01864148|473081267|FG004|Overall Study|Adverse Event|7|||
131398899|NCT01864148|473081263|FG000|Overall Study|Not Dosed|0|||
131398900|NCT01864148|473081264|FG001|Overall Study|Not Dosed|0|||
131398901|NCT01864148|473081265|FG002|Overall Study|Not Dosed|0|||
131398902|NCT01864148|473081266|FG003|Overall Study|Not Dosed|1|||
131398903|NCT01864148|473081267|FG004|Overall Study|Not Dosed|0|||
131398904|NCT05319600|473081268|FG000|Overall Study|Withdrawal by Subject|1|||
131398905|NCT05319600|473081269|FG001|Overall Study|Withdrawal by Subject|0|||
131398906|NCT05319600|473081268|FG000|Overall Study|Lost to Follow-up|0|||
131398907|NCT05319600|473081269|FG001|Overall Study|Lost to Follow-up|4|||
131398908|NCT03768089|473081270|FG000|Part A|Lost to Follow-up|0|||
131398909|NCT03768089|473081271|FG001|Part A|Lost to Follow-up|0|||
131398910|NCT03768089|473081272|FG002|Part A|Lost to Follow-up|0|||
131398911|NCT03768089|473081273|FG003|Part A|Lost to Follow-up|0|||
131398912|NCT03768089|473081274|FG004|Part A|Lost to Follow-up|1|||
131398913|NCT03768089|473081275|FG005|Part A|Lost to Follow-up|0|||
131813225|NCT03673670|474598994|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
131813226|NCT03673670|474598989|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
131813227|NCT03673670|474598990|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
131813228|NCT03673670|474598991|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
131398914|NCT03768089|473081276|FG006|Part A|Lost to Follow-up|0|||
131398915|NCT03768089|473081277|FG007|Part A|Lost to Follow-up|0|||
131398916|NCT03768089|473081278|FG008|Part A|Lost to Follow-up|0|||
131398917|NCT03768089|473081279|FG009|Part A|Lost to Follow-up|0|||
131398918|NCT03768089|473081280|FG010|Part A|Lost to Follow-up|0|||
131398919|NCT03768089|473081281|FG011|Part A|Lost to Follow-up|0|||
131398920|NCT03768089|473081282|FG012|Part A|Lost to Follow-up|0|||
131398921|NCT03768089|473081283|FG013|Part A|Lost to Follow-up|0|||
131398922|NCT03768089|473081284|FG014|Part A|Lost to Follow-up|0|||
131398923|NCT03768089|473081285|FG015|Part A|Lost to Follow-up|0|||
131398924|NCT03768089|473081286|FG016|Part A|Lost to Follow-up|0|||
131398925|NCT03768089|473081287|FG017|Part A|Lost to Follow-up|0|||
131398926|NCT03768089|473081270|FG000|Part C|Randomized, Never Dosed|0|||
131398927|NCT03768089|473081271|FG001|Part C|Randomized, Never Dosed|0|||
131398928|NCT03768089|473081272|FG002|Part C|Randomized, Never Dosed|0|||
131398929|NCT03768089|473081273|FG003|Part C|Randomized, Never Dosed|0|||
131398930|NCT03768089|473081274|FG004|Part C|Randomized, Never Dosed|0|||
131398931|NCT03768089|473081275|FG005|Part C|Randomized, Never Dosed|0|||
131398932|NCT03768089|473081276|FG006|Part C|Randomized, Never Dosed|0|||
131398933|NCT03768089|473081277|FG007|Part C|Randomized, Never Dosed|0|||
131813229|NCT03673670|474598992|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
131813230|NCT03673670|474598993|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
131813231|NCT03673670|474598994|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
131813232|NCT03673670|474598989|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
131813233|NCT03673670|474598990|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
131813234|NCT03673670|474598991|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
131813235|NCT03673670|474598992|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
131813236|NCT03673670|474598993|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
131813237|NCT03673670|474598994|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
131813238|NCT03673670|474598989|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
131813239|NCT03673670|474598990|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
131813240|NCT03673670|474598991|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
131813241|NCT03673670|474598992|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
131813242|NCT03673670|474598993|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
131813243|NCT03673670|474598994|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
131813244|NCT03673670|474598989|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
131398934|NCT03768089|473081278|FG008|Part C|Randomized, Never Dosed|0|||
131398935|NCT03768089|473081279|FG009|Part C|Randomized, Never Dosed|0|||
131398936|NCT03768089|473081280|FG010|Part C|Randomized, Never Dosed|0|||
131398937|NCT03768089|473081281|FG011|Part C|Randomized, Never Dosed|0|||
131398938|NCT03768089|473081282|FG012|Part C|Randomized, Never Dosed|0|||
131398939|NCT03768089|473081283|FG013|Part C|Randomized, Never Dosed|0|||
131398940|NCT03768089|473081284|FG014|Part C|Randomized, Never Dosed|1|||
131398941|NCT03768089|473081285|FG015|Part C|Randomized, Never Dosed|0|||
131813245|NCT03673670|474598990|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
131813246|NCT03673670|474598991|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
131813247|NCT03673670|474598992|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
131813248|NCT03673670|474598993|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
131813249|NCT03673670|474598994|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
131813250|NCT03673670|474598989|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
131813251|NCT03673670|474598990|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
131813252|NCT03673670|474598991|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
131398942|NCT03768089|473081286|FG016|Part C|Randomized, Never Dosed|0|||
131398943|NCT03768089|473081287|FG017|Part C|Randomized, Never Dosed|0|||
131398944|NCT02466425|473081292|FG000|Overall Study|Adverse Event|3|||
131398945|NCT02466425|473081293|FG001|Overall Study|Adverse Event|11|||
131398946|NCT02466425|473081292|FG000|Overall Study|Lack of Efficacy|4|||
131398947|NCT02466425|473081293|FG001|Overall Study|Lack of Efficacy|1|||
131398948|NCT02466425|473081292|FG000|Overall Study|Lost to Follow-up|3|||
131398949|NCT02466425|473081293|FG001|Overall Study|Lost to Follow-up|0|||
131398950|NCT02466425|473081292|FG000|Overall Study|Protocol Violation|1|||
131398951|NCT02466425|473081293|FG001|Overall Study|Protocol Violation|0|||
131398952|NCT02466425|473081292|FG000|Overall Study|Withdrawal by Subject|0|||
131763237|NCT00290355|474408633|FG000|Overall Study|Lost to Follow-up|3|||
131763238|NCT00290355|474408634|FG001|Overall Study|Lost to Follow-up|1|||
131763239|NCT00290355|474408633|FG000|Overall Study|Other|2|||
131763240|NCT00290355|474408634|FG001|Overall Study|Other|0|||
131763241|NCT01542632|474408635|FG000|Overall Study|Withdrawal of Consent|0|||
131763242|NCT01542632|474408636|FG001|Overall Study|Withdrawal of Consent|0|||
131763243|NCT01542632|474408637|FG002|Overall Study|Withdrawal of Consent|0|||
131763244|NCT01542632|474408638|FG003|Overall Study|Withdrawal of Consent|2|||
131763245|NCT01542632|474408639|FG004|Overall Study|Withdrawal of Consent|3|||
131763246|NCT01542632|474408640|FG005|Overall Study|Withdrawal of Consent|0|||
131763247|NCT01542632|474408635|FG000|Overall Study|Adverse Event|0|||
131763248|NCT01542632|474408636|FG001|Overall Study|Adverse Event|0|||
131763249|NCT01542632|474408637|FG002|Overall Study|Adverse Event|1|||
131763250|NCT01542632|474408638|FG003|Overall Study|Adverse Event|0|||
131763251|NCT01542632|474408639|FG004|Overall Study|Adverse Event|0|||
131763252|NCT01542632|474408640|FG005|Overall Study|Adverse Event|0|||
131763253|NCT01542632|474408635|FG000|Overall Study|Lost to Follow-up|0|||
131763254|NCT01542632|474408636|FG001|Overall Study|Lost to Follow-up|1|||
131763255|NCT01542632|474408637|FG002|Overall Study|Lost to Follow-up|0|||
131763256|NCT01542632|474408638|FG003|Overall Study|Lost to Follow-up|0|||
131763257|NCT01542632|474408639|FG004|Overall Study|Lost to Follow-up|0|||
131763258|NCT01542632|474408640|FG005|Overall Study|Lost to Follow-up|0|||
131763259|NCT01542632|474408635|FG000|Overall Study|Sponsor/Investigator Decision|0|||
131763260|NCT01542632|474408636|FG001|Overall Study|Sponsor/Investigator Decision|0|||
131763261|NCT01542632|474408637|FG002|Overall Study|Sponsor/Investigator Decision|0|||
131763262|NCT01542632|474408638|FG003|Overall Study|Sponsor/Investigator Decision|0|||
131763263|NCT01542632|474408639|FG004|Overall Study|Sponsor/Investigator Decision|1|||
131763264|NCT01542632|474408640|FG005|Overall Study|Sponsor/Investigator Decision|0|||
131763265|NCT01227252|474408650|FG000|Overall Study|Sponsor Decision|0|||
131763266|NCT01227252|474408651|FG001|Overall Study|Sponsor Decision|1|||
131763267|NCT01227252|474408652|FG002|Overall Study|Sponsor Decision|0|||
131763268|NCT01227252|474408653|FG003|Overall Study|Sponsor Decision|0|||
131763269|NCT01227252|474408650|FG000|Overall Study|Lost to Follow-up|0|||
131763270|NCT01227252|474408651|FG001|Overall Study|Lost to Follow-up|1|||
131763271|NCT01227252|474408652|FG002|Overall Study|Lost to Follow-up|0|||
131763272|NCT01227252|474408653|FG003|Overall Study|Lost to Follow-up|0|||
131763273|NCT01227252|474408650|FG000|Overall Study|Withdrawal by Subject|0|||
131763274|NCT01227252|474408651|FG001|Overall Study|Withdrawal by Subject|1|||
131763275|NCT01227252|474408652|FG002|Overall Study|Withdrawal by Subject|0|||
131763276|NCT01227252|474408653|FG003|Overall Study|Withdrawal by Subject|0|||
131398953|NCT02466425|473081293|FG001|Overall Study|Withdrawal by Subject|1|||
131398954|NCT02466425|473081292|FG000|Overall Study|Other|1|||
131398955|NCT02466425|473081293|FG001|Overall Study|Other|3|||
131398956|NCT02466425|473081292|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131398957|NCT02466425|473081293|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131398958|NCT01721486|473081298|FG000|Overall Study|Protocol Violation|1|||
131398959|NCT01721486|473081299|FG001|Overall Study|Protocol Violation|0|||
131398960|NCT01721486|473081298|FG000|Overall Study|Physician Decision|0|||
131398961|NCT01721486|473081299|FG001|Overall Study|Physician Decision|1|||
131398962|NCT00582712|473081300|FG000|Overall Study|Adverse Event|1|||
131398963|NCT00582712|473081300|FG000|Overall Study|Lack of Efficacy|1|||
131398964|NCT00582712|473081300|FG000|Overall Study|Withdrawal by Subject|1|||
131398965|NCT00582712|473081300|FG000|Overall Study|Complicating disease requiring treatment|1|||
131398966|NCT01901289|473081302|FG000|Overall Study|Death|32|||
131398967|NCT01901289|473081302|FG000|Overall Study|Lost to Follow-up|16|||
131398968|NCT01901289|473081302|FG000|Overall Study|Withdrawal by Subject|35|||
131398969|NCT01901289|473081302|FG000|Overall Study|Other type of endpoint met|2|||
131398970|NCT01813058|473081303|FG000|Overall Study|Withdrawal by Subject|5|||
131398971|NCT01813058|473081304|FG001|Overall Study|Withdrawal by Subject|4|||
131398972|NCT00395486|473081305|FG000|Overall Study|Adverse Event|1|||
131398973|NCT00395486|473081306|FG001|Overall Study|Adverse Event|2|||
131398974|NCT00395486|473081305|FG000|Overall Study|Withdrawal by Subject|5|||
131398975|NCT00395486|473081306|FG001|Overall Study|Withdrawal by Subject|2|||
131398976|NCT00395486|473081305|FG000|Overall Study|Lost to Follow-up|0|||
131398977|NCT00395486|473081306|FG001|Overall Study|Lost to Follow-up|1|||
131398978|NCT00361231|473081307|FG000|Overall Study|Physician Decision|3|||
131398979|NCT00361231|473081307|FG000|Overall Study|Symptomatic deterioration|5|||
131398980|NCT00361231|473081307|FG000|Overall Study|Radiographic disease progression|16|||
131398981|NCT00361231|473081307|FG000|Overall Study|Withdrawal by Subject|4|||
131398982|NCT00361231|473081307|FG000|Overall Study|Adverse Event|6|||
131763277|NCT02561273|474408660|FG000|Overall Study|Protocol Violation|1|||
131763278|NCT02561273|474408661|FG001|Overall Study|Protocol Violation|0|||
131398983|NCT01814397|473081310|FG000|Overall Study|Adverse Event|7|||
131398984|NCT01814397|473081310|FG000|Overall Study|Withdrawal by Subject|7|||
131398985|NCT00313144|473081311|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
131398986|NCT00313144|473081311|FG000|Overall Study|Death|7|||
131398987|NCT00313144|473081311|FG000|Overall Study|Lost to Follow-up|5|||
131398988|NCT00313144|473081311|FG000|Overall Study|Withdrawal by Subject|4|||
131398989|NCT00313144|473081311|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
131398990|NCT00313144|473081311|FG000|Overall Study|Physician Decision|4|||
131398991|NCT00313144|473081311|FG000|Overall Study|Adverse event - transient|5|||
131398992|NCT00313144|473081311|FG000|Overall Study|Liver transplant|1|||
131398993|NCT00313144|473081311|FG000|Overall Study|Insurance (homecare provider) change|1|||
131398994|NCT00313144|473081311|FG000|Overall Study|Change to different product|1|||
131398995|NCT00313144|473081311|FG000|Overall Study|Due to termination of the study|66|||
131398996|NCT01917929|473081315|FG000|Overall Study|Death|8|||
131398997|NCT01917929|473081315|FG000|Overall Study|Lost to Follow-up|19|||
131398998|NCT01917929|473081315|FG000|Overall Study|Withdrawal by Subject|33|||
131398999|NCT01917929|473081315|FG000|Overall Study|Adverse Event|6|||
131399000|NCT01917929|473081315|FG000|Overall Study|Investigative Site Terminated|35|||
131399001|NCT01917929|473081315|FG000|Overall Study|Censored because study device not implanted|6|||
131399002|NCT01917929|473081315|FG000|Overall Study|Censored because surgery not performed|3|||
131399003|NCT01917929|473081315|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
131399004|NCT01917929|473081315|FG000|Overall Study|Sponsor terminated study|175|||
131399005|NCT01063062|473081321|FG000|Overall Study|Patient withdrew consent|0|||
131399006|NCT01063062|473081322|FG001|Overall Study|Patient withdrew consent|1|||
131399007|NCT01063062|473081321|FG000|Overall Study|Adverse Event|2|||
131399008|NCT01063062|473081322|FG001|Overall Study|Adverse Event|4|||
131399009|NCT01063062|473081321|FG000|Overall Study|Protocol Violation|5|||
131399010|NCT01063062|473081322|FG001|Overall Study|Protocol Violation|4|||
131399011|NCT01063062|473081321|FG000|Overall Study|Investigator's request|1|||
131399012|NCT01063062|473081322|FG001|Overall Study|Investigator's request|0|||
131399013|NCT01063062|473081321|FG000|Overall Study|Lost to Follow-up|0|||
131399014|NCT01063062|473081322|FG001|Overall Study|Lost to Follow-up|2|||
131399015|NCT01063062|473081321|FG000|Overall Study|Miscellaneous reason|0|||
131399016|NCT01063062|473081322|FG001|Overall Study|Miscellaneous reason|1|||
131399017|NCT02597452|473081325|FG000|Overall Study|testing incomplete|30|||
131399018|NCT04621240|473081326|FG000|Overall Study|Withdrawal by Subject|36|||
131399019|NCT03206918|473081327|FG000|Overall Study|Death|11|||
131399020|NCT03206918|473081327|FG000|Overall Study|Withdrawal by Subject|5|||
131399021|NCT03206918|473081327|FG000|Overall Study|Study terminated by sponsor|12|||
131399022|NCT03206918|473081327|FG000|Overall Study|Lost to Follow-up|3|||
131399023|NCT03206918|473081327|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
131399024|NCT03479541|473081328|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
131399025|NCT03479541|473081329|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
131399026|NCT03479541|473081330|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
131399027|NCT03479541|473081331|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
131399028|NCT03479541|473081328|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
131399029|NCT03479541|473081329|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
131399030|NCT03479541|473081330|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
131399031|NCT03479541|473081331|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
131399032|NCT03479541|473081328|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
131399033|NCT03479541|473081329|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
131399034|NCT03479541|473081330|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
131399035|NCT03479541|473081331|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
131399036|NCT03479541|473081328|FG000|Home Monitoring|Lost to Follow-up|0|||
131399037|NCT03479541|473081329|FG001|Home Monitoring|Lost to Follow-up|0|||
131399038|NCT03479541|473081330|FG002|Home Monitoring|Lost to Follow-up|8|||
131399039|NCT03479541|473081331|FG003|Home Monitoring|Lost to Follow-up|12|||
131399040|NCT03479541|473081328|FG000|Home Monitoring|Withdrawal by Subject|0|||
131399041|NCT03479541|473081329|FG001|Home Monitoring|Withdrawal by Subject|0|||
131399042|NCT03479541|473081330|FG002|Home Monitoring|Withdrawal by Subject|17|||
131399043|NCT03479541|473081331|FG003|Home Monitoring|Withdrawal by Subject|30|||
131399044|NCT03479541|473081328|FG000|Home Monitoring|Early Termination - PI Decision|0|||
131399045|NCT03479541|473081329|FG001|Home Monitoring|Early Termination - PI Decision|0|||
131813253|NCT03673670|474598992|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
131813254|NCT03673670|474598993|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
131813255|NCT03673670|474598994|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
131813256|NCT03437265|474598995|FG000|Overall Study|Protocol Violation|6|||
131813257|NCT00316277|474598996|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
131813258|NCT00316277|474598997|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
131813259|NCT00316277|474598996|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
131813260|NCT00316277|474598997|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
131813261|NCT00316277|474598996|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
131399046|NCT03479541|473081330|FG002|Home Monitoring|Early Termination - PI Decision|4|||
131909274|NCT00427934|474956701|FG003|Overall Study|Other|5|||
131909275|NCT00427934|474956698|FG000|Overall Study|Withdrawal by Subject|0|||
131909276|NCT00427934|474956699|FG001|Overall Study|Withdrawal by Subject|0|||
131909277|NCT00427934|474956700|FG002|Overall Study|Withdrawal by Subject|1|||
131399047|NCT03479541|473081331|FG003|Home Monitoring|Early Termination - PI Decision|6|||
131399048|NCT00107900|473081332|FG000|Overall Study|Adverse Event|3|||
131399049|NCT00107900|473081333|FG001|Overall Study|Adverse Event|2|||
131399050|NCT00107900|473081334|FG002|Overall Study|Adverse Event|10|||
131399051|NCT00107900|473081335|FG003|Overall Study|Adverse Event|3|||
131399052|NCT00107900|473081336|FG004|Overall Study|Adverse Event|5|||
131399053|NCT00107900|473081337|FG005|Overall Study|Adverse Event|3|||
131399054|NCT00107900|473081332|FG000|Overall Study|Death|0|||
131399055|NCT00107900|473081333|FG001|Overall Study|Death|0|||
131399056|NCT00107900|473081334|FG002|Overall Study|Death|0|||
131399057|NCT00107900|473081335|FG003|Overall Study|Death|0|||
131399058|NCT00107900|473081336|FG004|Overall Study|Death|1|||
131399059|NCT00107900|473081337|FG005|Overall Study|Death|0|||
131399060|NCT00107900|473081332|FG000|Overall Study|Lost to Follow-up|4|||
131399061|NCT00107900|473081333|FG001|Overall Study|Lost to Follow-up|1|||
131399062|NCT00107900|473081334|FG002|Overall Study|Lost to Follow-up|3|||
131399063|NCT00107900|473081335|FG003|Overall Study|Lost to Follow-up|2|||
131399064|NCT00107900|473081336|FG004|Overall Study|Lost to Follow-up|5|||
131399065|NCT00107900|473081337|FG005|Overall Study|Lost to Follow-up|5|||
131399066|NCT00107900|473081332|FG000|Overall Study|Protocol Violation|1|||
131399067|NCT00107900|473081333|FG001|Overall Study|Protocol Violation|0|||
131399068|NCT00107900|473081334|FG002|Overall Study|Protocol Violation|5|||
131399069|NCT00107900|473081335|FG003|Overall Study|Protocol Violation|5|||
131399070|NCT00107900|473081336|FG004|Overall Study|Protocol Violation|7|||
131909278|NCT00427934|474956701|FG003|Overall Study|Withdrawal by Subject|3|||
131909279|NCT02791269|474956702|FG000|Overall Study|Lost to Follow-up|0|||
131909280|NCT02791269|474956703|FG001|Overall Study|Lost to Follow-up|1|||
131909281|NCT00903968|474956706|FG000|Overall Study|Adverse Event|0|||
131909282|NCT00903968|474956707|FG001|Overall Study|Adverse Event|0|||
131909283|NCT00903968|474956708|FG002|Overall Study|Adverse Event|0|||
131909284|NCT00903968|474956709|FG003|Overall Study|Adverse Event|0|||
131909285|NCT00903968|474956710|FG004|Overall Study|Adverse Event|0|||
131909286|NCT00903968|474956711|FG005|Overall Study|Adverse Event|0|||
131909287|NCT00903968|474956712|FG006|Overall Study|Adverse Event|1|||
131909288|NCT00903968|474956713|FG007|Overall Study|Adverse Event|8|||
131909289|NCT00903968|474956706|FG000|Overall Study|DLT|0|||
131909290|NCT00903968|474956707|FG001|Overall Study|DLT|0|||
131909291|NCT00903968|474956708|FG002|Overall Study|DLT|0|||
131399071|NCT00107900|473081337|FG005|Overall Study|Protocol Violation|0|||
131399072|NCT00107900|473081332|FG000|Overall Study|Withdrawal by Subject|1|||
131399073|NCT00107900|473081333|FG001|Overall Study|Withdrawal by Subject|0|||
131909292|NCT00903968|474956709|FG003|Overall Study|DLT|0|||
131909293|NCT00903968|474956710|FG004|Overall Study|DLT|0|||
131909294|NCT00903968|474956711|FG005|Overall Study|DLT|0|||
131909295|NCT00903968|474956712|FG006|Overall Study|DLT|2|||
131909296|NCT00903968|474956713|FG007|Overall Study|DLT|0|||
131909297|NCT00903968|474956706|FG000|Overall Study|Withdrawal by Subject|1|||
131909298|NCT00903968|474956707|FG001|Overall Study|Withdrawal by Subject|0|||
131909299|NCT00903968|474956708|FG002|Overall Study|Withdrawal by Subject|1|||
131909300|NCT00903968|474956709|FG003|Overall Study|Withdrawal by Subject|0|||
131909301|NCT00903968|474956710|FG004|Overall Study|Withdrawal by Subject|1|||
131909302|NCT00903968|474956711|FG005|Overall Study|Withdrawal by Subject|1|||
131909303|NCT00903968|474956712|FG006|Overall Study|Withdrawal by Subject|0|||
131909304|NCT00903968|474956713|FG007|Overall Study|Withdrawal by Subject|4|||
131909305|NCT00903968|474956706|FG000|Overall Study|Non-Compliance|0|||
131909306|NCT00903968|474956707|FG001|Overall Study|Non-Compliance|0|||
131909307|NCT00903968|474956708|FG002|Overall Study|Non-Compliance|0|||
131909308|NCT00903968|474956709|FG003|Overall Study|Non-Compliance|0|||
131909309|NCT00903968|474956710|FG004|Overall Study|Non-Compliance|0|||
131909310|NCT00903968|474956711|FG005|Overall Study|Non-Compliance|1|||
131909311|NCT00903968|474956712|FG006|Overall Study|Non-Compliance|0|||
131909312|NCT00903968|474956713|FG007|Overall Study|Non-Compliance|0|||
131399074|NCT00107900|473081334|FG002|Overall Study|Withdrawal by Subject|5|||
131399075|NCT00107900|473081335|FG003|Overall Study|Withdrawal by Subject|0|||
131399076|NCT00107900|473081336|FG004|Overall Study|Withdrawal by Subject|1|||
131399077|NCT00107900|473081337|FG005|Overall Study|Withdrawal by Subject|1|||
131909313|NCT00903968|474956706|FG000|Overall Study|Physician Decision|0|||
131909314|NCT00903968|474956707|FG001|Overall Study|Physician Decision|0|||
131909315|NCT00903968|474956708|FG002|Overall Study|Physician Decision|0|||
131909316|NCT00903968|474956709|FG003|Overall Study|Physician Decision|0|||
131399078|NCT00107900|473081332|FG000|Overall Study|Administrative Reasons|1|||
131399079|NCT00107900|473081333|FG001|Overall Study|Administrative Reasons|0|||
131399080|NCT00107900|473081334|FG002|Overall Study|Administrative Reasons|2|||
131399081|NCT00107900|473081335|FG003|Overall Study|Administrative Reasons|2|||
131399082|NCT00107900|473081336|FG004|Overall Study|Administrative Reasons|2|||
131909317|NCT00903968|474956710|FG004|Overall Study|Physician Decision|0|||
131909318|NCT00903968|474956711|FG005|Overall Study|Physician Decision|1|||
131813262|NCT00316277|474598997|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
131813263|NCT00316277|474598996|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
131813264|NCT00316277|474598997|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
131813265|NCT00316277|474598996|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
131813266|NCT00316277|474598997|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
131813267|NCT01294917|474599003|FG000|Overall Study|Relocation|5|||
131813268|NCT01294917|474599003|FG000|Overall Study|Inconvenience|1|||
131813269|NCT01444378|474599008|FG000|Overall Study|Lost to Follow-up|1|||
131813270|NCT01444378|474599008|FG000|Overall Study|Withdrawal by Subject|1|||
131813271|NCT01444378|474599008|FG000|Overall Study|Death|3|||
131813272|NCT01444378|474599008|FG000|Overall Study|Administrative Closure Of The Study|2|||
131813273|NCT01444378|474599008|FG000|Overall Study|Missed Visits|10|||
131813274|NCT00927069|474599009|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
131813275|NCT00927069|474599010|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
131813276|NCT00927069|474599011|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
131813277|NCT00927069|474599012|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
131813278|NCT00927069|474599009|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
131813279|NCT00927069|474599010|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
131813280|NCT00927069|474599011|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
131813281|NCT00927069|474599012|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
131813282|NCT00927069|474599009|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
131813283|NCT00927069|474599010|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
131813284|NCT00927069|474599011|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
131813285|NCT00927069|474599012|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
131813286|NCT00927069|474599009|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
131813287|NCT00927069|474599010|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
131813288|NCT00927069|474599011|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
131813289|NCT00927069|474599012|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
131813290|NCT00927069|474599009|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
131813291|NCT00927069|474599010|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
131813292|NCT00927069|474599011|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
131813293|NCT00927069|474599012|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
131813294|NCT02911792|474599013|FG000|Overall Study|Lost to Follow-up|3|||
131813295|NCT02911792|474599014|FG001|Overall Study|Lost to Follow-up|3|||
131813296|NCT02911792|474599015|FG002|Overall Study|Lost to Follow-up|3|||
131813297|NCT02911792|474599016|FG003|Overall Study|Lost to Follow-up|3|||
131813298|NCT00835263|474599019|FG000|Second Intervention|Adverse Event|1|||
131813299|NCT00835263|474599020|FG001|Second Intervention|Adverse Event|0|||
131813300|NCT00848536|474599021|FG000|Overall Study|Adverse Event|2|||
131813301|NCT00848536|474599022|FG001|Overall Study|Adverse Event|2|||
131813302|NCT00848536|474599021|FG000|Overall Study|Withdrawal by Subject|0|||
131813303|NCT00848536|474599022|FG001|Overall Study|Withdrawal by Subject|1|||
131813304|NCT00848536|474599021|FG000|Overall Study|Protocol Violation|0|||
131813305|NCT00848536|474599022|FG001|Overall Study|Protocol Violation|1|||
131813306|NCT00848536|474599021|FG000|Overall Study|Noncompliance|1|||
131813307|NCT00848536|474599022|FG001|Overall Study|Noncompliance|0|||
131813308|NCT00848536|474599021|FG000|Overall Study|Inadequate Control of IOP|1|||
131813309|NCT00848536|474599022|FG001|Overall Study|Inadequate Control of IOP|1|||
131813310|NCT00848536|474599021|FG000|Overall Study|Patient Moved|0|||
131813311|NCT00848536|474599022|FG001|Overall Study|Patient Moved|2|||
131813312|NCT03249454|474599023|FG000|Overall Study|Withdrawal by Subject|0|||
131813313|NCT03249454|474599024|FG001|Overall Study|Withdrawal by Subject|0|||
131813314|NCT03249454|474599025|FG002|Overall Study|Withdrawal by Subject|0|||
131813315|NCT03249454|474599026|FG003|Overall Study|Withdrawal by Subject|0|||
131813316|NCT03249454|474599027|FG004|Overall Study|Withdrawal by Subject|0|||
131813317|NCT03249454|474599028|FG005|Overall Study|Withdrawal by Subject|0|||
131813318|NCT03249454|474599029|FG006|Overall Study|Withdrawal by Subject|0|||
131813319|NCT03249454|474599030|FG007|Overall Study|Withdrawal by Subject|0|||
131813320|NCT03249454|474599031|FG008|Overall Study|Withdrawal by Subject|0|||
131813321|NCT03249454|474599032|FG009|Overall Study|Withdrawal by Subject|1|||
131813322|NCT03249454|474599033|FG010|Overall Study|Withdrawal by Subject|1|||
131813323|NCT01913405|474599034|FG000|Overall Study|Withdrawal by Subject|1|||
131813324|NCT01913405|474599034|FG000|Overall Study|Adverse Event|1|||
131813325|NCT03987191|474599037|FG000|Overall Study|COVID-19 related research disruption|0|||
131813326|NCT03987191|474599038|FG001|Overall Study|COVID-19 related research disruption|2|||
131813327|NCT01020474|474599039|FG000|Overall Study|Adverse Event|4|||
131813328|NCT01020474|474599040|FG001|Overall Study|Adverse Event|4|||
131813329|NCT01020474|474599039|FG000|Overall Study|Protocol Violation|0|||
131813330|NCT01020474|474599040|FG001|Overall Study|Protocol Violation|2|||
131813331|NCT01020474|474599039|FG000|Overall Study|Withdrawal by Subject|5|||
131813332|NCT01020474|474599040|FG001|Overall Study|Withdrawal by Subject|7|||
131813333|NCT01020474|474599039|FG000|Overall Study|Other Reasons|1|||
131813334|NCT01020474|474599040|FG001|Overall Study|Other Reasons|1|||
131813335|NCT01020474|474599039|FG000|Overall Study|Insufficient Clinical Response|0|||
131813336|NCT01020474|474599040|FG001|Overall Study|Insufficient Clinical Response|3|||
131909319|NCT00903968|474956712|FG006|Overall Study|Physician Decision|0|||
131813337|NCT03261167|474599041|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
131813338|NCT03261167|474599042|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
131813339|NCT03261167|474599041|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
131813340|NCT03261167|474599042|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
131813341|NCT03261167|474599041|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
131813342|NCT03261167|474599042|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
131813343|NCT03261167|474599041|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
131813344|NCT03261167|474599042|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
131813345|NCT03261167|474599041|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
131813346|NCT03261167|474599042|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
131813347|NCT00466167|474599045|FG000|Overall Study|Adverse Event|8|||
131813348|NCT00466167|474599046|FG001|Overall Study|Adverse Event|8|||
131813349|NCT00466167|474599047|FG002|Overall Study|Adverse Event|7|||
131813350|NCT00466167|474599045|FG000|Overall Study|Lack of Efficacy|2|||
131813351|NCT00466167|474599046|FG001|Overall Study|Lack of Efficacy|0|||
131813352|NCT00466167|474599047|FG002|Overall Study|Lack of Efficacy|3|||
131813353|NCT00466167|474599045|FG000|Overall Study|Protocol Violation|1|||
131813354|NCT00466167|474599046|FG001|Overall Study|Protocol Violation|1|||
131813355|NCT00466167|474599047|FG002|Overall Study|Protocol Violation|2|||
131813356|NCT00466167|474599045|FG000|Overall Study|Lost to Follow-up|3|||
131813357|NCT00466167|474599046|FG001|Overall Study|Lost to Follow-up|2|||
131813358|NCT00466167|474599047|FG002|Overall Study|Lost to Follow-up|2|||
131813359|NCT00466167|474599045|FG000|Overall Study|Withdrawal by Subject|4|||
131813360|NCT00466167|474599046|FG001|Overall Study|Withdrawal by Subject|1|||
131813361|NCT00466167|474599047|FG002|Overall Study|Withdrawal by Subject|6|||
131813362|NCT00466167|474599045|FG000|Overall Study|patient did not meet inclusion criteria|1|||
131813363|NCT00466167|474599046|FG001|Overall Study|patient did not meet inclusion criteria|0|||
131813364|NCT00466167|474599047|FG002|Overall Study|patient did not meet inclusion criteria|1|||
131813365|NCT00466167|474599045|FG000|Overall Study|Not treated|1|||
131813366|NCT00466167|474599046|FG001|Overall Study|Not treated|0|||
131813367|NCT00466167|474599047|FG002|Overall Study|Not treated|0|||
131813368|NCT03199963|474599048|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
131813369|NCT03199963|474599049|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
131813370|NCT03199963|474599048|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
131813371|NCT03199963|474599049|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
131813372|NCT03199963|474599048|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
131813373|NCT03199963|474599049|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
131813374|NCT03199963|474599048|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
131813375|NCT03199963|474599049|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
131813376|NCT03199963|474599048|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
131813377|NCT03199963|474599049|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
131813378|NCT03199963|474599048|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
131813379|NCT03199963|474599049|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
131813380|NCT01572662|474599050|FG000|Overall Study|Withdrawal by Subject|1|||
131813381|NCT01572662|474599051|FG001|Overall Study|Withdrawal by Subject|0|||
131813382|NCT01572662|474599050|FG000|Overall Study|Physician Decision|0|||
131813383|NCT01572662|474599051|FG001|Overall Study|Physician Decision|1|||
131813384|NCT00796562|474599054|FG000|Overall Study|Death|49|||
131813385|NCT00424047|474599055|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
131813386|NCT00424047|474599056|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
131813387|NCT00424047|474599055|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
131813388|NCT00424047|474599056|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
131813389|NCT00424047|474599055|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
131813390|NCT00424047|474599056|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
131813391|NCT00424047|474599055|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
131813392|NCT00424047|474599056|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
131813393|NCT00424047|474599055|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
131813394|NCT00424047|474599056|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
131813395|NCT00424047|474599055|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
131813396|NCT00424047|474599056|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
131909320|NCT00903968|474956713|FG007|Overall Study|Physician Decision|0|||
131909321|NCT00903968|474956706|FG000|Overall Study|Progressive Disease|2|||
131813397|NCT00424047|474599055|FG000|On Study at Time of Unblinding|Adverse Event|22|||
131813398|NCT00424047|474599056|FG001|On Study at Time of Unblinding|Adverse Event|12|||
131813399|NCT00424047|474599055|FG000|On Study at Time of Unblinding|Progression of disease|92|||
131813400|NCT00424047|474599056|FG001|On Study at Time of Unblinding|Progression of disease|128|||
131813401|NCT00424047|474599055|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
131909322|NCT00903968|474956707|FG001|Overall Study|Progressive Disease|3|||
131399083|NCT00107900|473081337|FG005|Overall Study|Administrative Reasons|0|||
131399084|NCT01456195|473083930|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131399085|NCT01456195|473083931|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
131399086|NCT01456195|473083932|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
131399087|NCT01456195|473083930|FG000|Overall Study|Lost to Follow-up|3|||
131399088|NCT01456195|473083931|FG001|Overall Study|Lost to Follow-up|1|||
131399089|NCT01456195|473083932|FG002|Overall Study|Lost to Follow-up|3|||
131399090|NCT01456195|473083930|FG000|Overall Study|Voluntary Withdrawal|5|||
131399091|NCT01456195|473083931|FG001|Overall Study|Voluntary Withdrawal|3|||
131399092|NCT01456195|473083932|FG002|Overall Study|Voluntary Withdrawal|7|||
131399093|NCT01456195|473083930|FG000|Overall Study|Lack of Efficacy|0|||
131399094|NCT01456195|473083931|FG001|Overall Study|Lack of Efficacy|1|||
131399095|NCT01456195|473083932|FG002|Overall Study|Lack of Efficacy|0|||
131399096|NCT01456195|473083930|FG000|Overall Study|Other Reasons|2|||
131399097|NCT01456195|473083931|FG001|Overall Study|Other Reasons|1|||
131399098|NCT01456195|473083932|FG002|Overall Study|Other Reasons|3|||
131399099|NCT04075292|473083935|FG000|Overall Study|Withdrawal by Subject|1|||
131399100|NCT04075292|473083936|FG001|Overall Study|Withdrawal by Subject|9|||
131399101|NCT04075292|473083935|FG000|Overall Study|Death|2|||
131763279|NCT01642004|474408662|FG000|Randomization|Adverse Event unrelated to study drug|1|||
131763280|NCT01642004|474408663|FG001|Randomization|Adverse Event unrelated to study drug|0|||
131763281|NCT01642004|474408662|FG000|Randomization|Participant withdrew consent|1|||
131763282|NCT01642004|474408663|FG001|Randomization|Participant withdrew consent|6|||
131763283|NCT01642004|474408662|FG000|Randomization|No longer meets study criteria|2|||
131763284|NCT01642004|474408663|FG001|Randomization|No longer meets study criteria|2|||
131763285|NCT01642004|474408662|FG000|Treatment|Disease progression|95|||
131813402|NCT00424047|474599056|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
131399102|NCT04075292|473083936|FG001|Overall Study|Death|5|||
131399103|NCT04075292|473083935|FG000|Overall Study|Remained on study at time of DCO|74|||
131399104|NCT04075292|473083936|FG001|Overall Study|Remained on study at time of DCO|64|||
131399105|NCT01681186|473083937|FG000|Washout Period From Second Intervention|Adverse Event|0|||
131399106|NCT01681186|473083938|FG001|Washout Period From Second Intervention|Adverse Event|0|||
131399107|NCT01681186|473083939|FG002|Washout Period From Second Intervention|Adverse Event|0|||
131399108|NCT01681186|473083940|FG003|Washout Period From Second Intervention|Adverse Event|0|||
131399109|NCT01681186|473083941|FG004|Washout Period From Second Intervention|Adverse Event|0|||
131399110|NCT01681186|473083942|FG005|Washout Period From Second Intervention|Adverse Event|0|||
131399111|NCT01681186|473083943|FG006|Washout Period From Second Intervention|Adverse Event|1|||
131399112|NCT01681186|473083944|FG007|Washout Period From Second Intervention|Adverse Event|0|||
131399113|NCT01681186|473083937|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
131399114|NCT01681186|473083938|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
131399115|NCT01681186|473083939|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
131399116|NCT01681186|473083940|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
131399117|NCT01681186|473083941|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
131399118|NCT01681186|473083942|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
131399119|NCT01681186|473083943|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
131399120|NCT01681186|473083944|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
131399121|NCT01681186|473083937|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399122|NCT01681186|473083938|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399123|NCT01681186|473083939|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399124|NCT01681186|473083940|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399125|NCT01681186|473083941|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399126|NCT01681186|473083942|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399127|NCT01681186|473083943|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
131399128|NCT01681186|473083944|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
131399129|NCT01681186|473083937|FG000|Fourth Intervention|Protocol Violation|0|||
131399130|NCT01681186|473083938|FG001|Fourth Intervention|Protocol Violation|0|||
131399131|NCT01681186|473083939|FG002|Fourth Intervention|Protocol Violation|0|||
131399132|NCT01681186|473083940|FG003|Fourth Intervention|Protocol Violation|0|||
131399133|NCT01681186|473083941|FG004|Fourth Intervention|Protocol Violation|0|||
131399134|NCT01681186|473083942|FG005|Fourth Intervention|Protocol Violation|0|||
131399135|NCT01681186|473083943|FG006|Fourth Intervention|Protocol Violation|0|||
131399136|NCT01681186|473083944|FG007|Fourth Intervention|Protocol Violation|1|||
131399137|NCT05160415|473083945|FG000|Overall Study|Withdrawal by Subject|3|||
131399138|NCT03530995|473083946|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
131813403|NCT00424047|474599055|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
131813404|NCT00424047|474599056|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
131399139|NCT03530995|473083947|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
131399140|NCT03530995|473083946|FG000|Part 1 Period 3|Protocol Violation|1|||
131399141|NCT03530995|473083947|FG001|Part 1 Period 3|Protocol Violation|0|||
131399142|NCT03530995|473083946|FG000|Part 1 Period 4|Physician Decision|1|||
131399143|NCT03530995|473083947|FG001|Part 1 Period 4|Physician Decision|0|||
131909323|NCT00903968|474956708|FG002|Overall Study|Progressive Disease|2|||
131909324|NCT00903968|474956709|FG003|Overall Study|Progressive Disease|3|||
131909325|NCT00903968|474956710|FG004|Overall Study|Progressive Disease|3|||
131909326|NCT00903968|474956711|FG005|Overall Study|Progressive Disease|3|||
131909327|NCT00903968|474956712|FG006|Overall Study|Progressive Disease|0|||
131909328|NCT00903968|474956713|FG007|Overall Study|Progressive Disease|18|||
131909329|NCT00903968|474956706|FG000|Overall Study|Lack of Efficacy|0|||
131909330|NCT00903968|474956707|FG001|Overall Study|Lack of Efficacy|0|||
131909331|NCT00903968|474956708|FG002|Overall Study|Lack of Efficacy|0|||
131909332|NCT00903968|474956709|FG003|Overall Study|Lack of Efficacy|0|||
131909333|NCT00903968|474956710|FG004|Overall Study|Lack of Efficacy|0|||
131909334|NCT00903968|474956711|FG005|Overall Study|Lack of Efficacy|0|||
131909335|NCT00903968|474956712|FG006|Overall Study|Lack of Efficacy|0|||
131909336|NCT00903968|474956713|FG007|Overall Study|Lack of Efficacy|3|||
131909337|NCT04539275|474956714|FG000|Overall Study|Death|2|||
131909338|NCT04539275|474956715|FG001|Overall Study|Death|4|||
131813405|NCT00424047|474599055|FG000|On Study at Time of Unblinding|Death|11|||
131909339|NCT04539275|474956714|FG000|Overall Study|Lost to Follow-up|1|||
131909340|NCT04539275|474956715|FG001|Overall Study|Lost to Follow-up|1|||
131909341|NCT04539275|474956714|FG000|Overall Study|Withdrawal by Subject|3|||
131909342|NCT04539275|474956715|FG001|Overall Study|Withdrawal by Subject|0|||
131909343|NCT00420745|474956716|FG000|Overall Study|Adverse Event|2|||
131909344|NCT00420745|474956717|FG001|Overall Study|Adverse Event|2|||
131909345|NCT00420745|474956716|FG000|Overall Study|Lost to Follow-up|10|||
131909346|NCT00420745|474956717|FG001|Overall Study|Lost to Follow-up|2|||
131909347|NCT00420745|474956716|FG000|Overall Study|Protocol Violation|1|||
131909348|NCT00420745|474956717|FG001|Overall Study|Protocol Violation|0|||
131909349|NCT00420745|474956716|FG000|Overall Study|Physician Decision|1|||
131909350|NCT00420745|474956717|FG001|Overall Study|Physician Decision|1|||
131909351|NCT00420745|474956716|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
131909352|NCT00420745|474956717|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
131909353|NCT00420745|474956716|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
131909354|NCT00420745|474956717|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
131909355|NCT01125930|474956718|FG000|Overall Study|Adverse Event|0|||
131909356|NCT01125930|474956719|FG001|Overall Study|Adverse Event|1|||
131909357|NCT01125930|474956718|FG000|Overall Study|Withdrawal by Subject|1|||
131909358|NCT01125930|474956719|FG001|Overall Study|Withdrawal by Subject|6|||
131909359|NCT01125930|474956718|FG000|Overall Study|Protocol Violation|0|||
131909360|NCT01125930|474956719|FG001|Overall Study|Protocol Violation|1|||
131909361|NCT01125930|474956718|FG000|Overall Study|Lost to Follow-up|0|||
131909362|NCT01125930|474956719|FG001|Overall Study|Lost to Follow-up|2|||
131909363|NCT03098979|474956720|FG000|Overall Study|Adverse Event|1|||
131909364|NCT03098979|474956721|FG001|Overall Study|Adverse Event|0|||
131909365|NCT03098979|474956722|FG002|Overall Study|Adverse Event|1|||
131909366|NCT03098979|474956723|FG003|Overall Study|Adverse Event|4|||
131909367|NCT03098979|474956724|FG004|Overall Study|Adverse Event|6|||
131909368|NCT03098979|474956725|FG005|Overall Study|Adverse Event|1|||
131909369|NCT03098979|474956720|FG000|Overall Study|Withdrawal by Subject|2|||
131909370|NCT03098979|474956721|FG001|Overall Study|Withdrawal by Subject|1|||
131909371|NCT03098979|474956722|FG002|Overall Study|Withdrawal by Subject|1|||
131909372|NCT03098979|474956723|FG003|Overall Study|Withdrawal by Subject|1|||
131909373|NCT03098979|474956724|FG004|Overall Study|Withdrawal by Subject|2|||
131909374|NCT03098979|474956725|FG005|Overall Study|Withdrawal by Subject|1|||
131909375|NCT03098979|474956720|FG000|Overall Study|Death|1|||
131909376|NCT03098979|474956721|FG001|Overall Study|Death|0|||
131909377|NCT03098979|474956722|FG002|Overall Study|Death|2|||
131909378|NCT03098979|474956723|FG003|Overall Study|Death|0|||
131909379|NCT03098979|474956724|FG004|Overall Study|Death|1|||
131813406|NCT00424047|474599056|FG001|On Study at Time of Unblinding|Death|11|||
131813407|NCT00424047|474599055|FG000|On Study at Time of Unblinding|Other|5|||
131813408|NCT00424047|474599056|FG001|On Study at Time of Unblinding|Other|4|||
131813409|NCT00424047|474599055|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
131813410|NCT00424047|474599056|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
131813411|NCT00424047|474599055|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
131813412|NCT00424047|474599056|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
131813413|NCT00424047|474599055|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
131813414|NCT00424047|474599056|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
131813415|NCT00424047|474599055|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
131909380|NCT03098979|474956725|FG005|Overall Study|Death|0|||
131909381|NCT03098979|474956720|FG000|Overall Study|Physician Decision|2|||
131909382|NCT03098979|474956721|FG001|Overall Study|Physician Decision|1|||
131909383|NCT03098979|474956722|FG002|Overall Study|Physician Decision|0|||
131813416|NCT00424047|474599056|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
131813417|NCT00424047|474599055|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
131909384|NCT03098979|474956723|FG003|Overall Study|Physician Decision|0|||
131909385|NCT03098979|474956724|FG004|Overall Study|Physician Decision|0|||
131909386|NCT03098979|474956725|FG005|Overall Study|Physician Decision|0|||
131909387|NCT03098979|474956720|FG000|Overall Study|Non-compliance|0|||
131909388|NCT03098979|474956721|FG001|Overall Study|Non-compliance|0|||
131909389|NCT03098979|474956722|FG002|Overall Study|Non-compliance|0|||
131909390|NCT03098979|474956723|FG003|Overall Study|Non-compliance|0|||
131909391|NCT03098979|474956724|FG004|Overall Study|Non-compliance|0|||
131909392|NCT03098979|474956725|FG005|Overall Study|Non-compliance|1|||
131909393|NCT03098979|474956720|FG000|Overall Study|Protocol Violation|0|||
131909394|NCT03098979|474956721|FG001|Overall Study|Protocol Violation|0|||
131909395|NCT03098979|474956722|FG002|Overall Study|Protocol Violation|0|||
131909396|NCT03098979|474956723|FG003|Overall Study|Protocol Violation|0|||
131909397|NCT03098979|474956724|FG004|Overall Study|Protocol Violation|0|||
131909398|NCT03098979|474956725|FG005|Overall Study|Protocol Violation|1|||
131909399|NCT02426684|474956726|FG000|Overall Study|Physician Decision|1|||
131909400|NCT02369653|474956727|FG000|Overall Study|Lost to Follow-up|0|||
131909401|NCT02369653|474956728|FG001|Overall Study|Lost to Follow-up|1|||
131909402|NCT02369653|474956727|FG000|Overall Study|Administrative reason by sponsor|0|||
131909403|NCT02369653|474956728|FG001|Overall Study|Administrative reason by sponsor|1|||
131399144|NCT03530995|473083946|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
131399145|NCT03530995|473083947|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
131399146|NCT01986231|473083949|FG000|Overall Study|Adverse Event|1|||
131909404|NCT02369653|474956727|FG000|Overall Study|Death|1|||
131909405|NCT02369653|474956728|FG001|Overall Study|Death|2|||
131909406|NCT02369653|474956727|FG000|Overall Study|Participant withdrew consent|13|||
131909407|NCT02369653|474956728|FG001|Overall Study|Participant withdrew consent|3|||
131909408|NCT03587636|474956729|FG000|Overall Study|Lost to Follow-up|2|||
131909409|NCT03587636|474956730|FG001|Overall Study|Lost to Follow-up|5|||
131909410|NCT03248037|474956731|FG000|Overall Study|Withdrawal by Subject|6|||
131909411|NCT03248037|474956732|FG001|Overall Study|Withdrawal by Subject|9|||
131909412|NCT03248037|474956731|FG000|Overall Study|Adverse Event|15|||
131909413|NCT03248037|474956732|FG001|Overall Study|Adverse Event|0|||
131909414|NCT02897349|474956733|FG000|Overall Study|Lost to Follow-up|2|||
131909415|NCT02897349|474956734|FG001|Overall Study|Lost to Follow-up|2|||
131909416|NCT02897349|474956733|FG000|Overall Study|Adverse Event|3|||
131909417|NCT02897349|474956734|FG001|Overall Study|Adverse Event|3|||
131909418|NCT02897349|474956733|FG000|Overall Study|Other than listed above|0|||
131909419|NCT02897349|474956734|FG001|Overall Study|Other than listed above|1|||
131909420|NCT00671749|474956742|FG000|Overall Study|Adverse Event|2|||
131909421|NCT00671749|474956742|FG000|Overall Study|Withdrawal by Subject|4|||
131909422|NCT00671749|474956742|FG000|Overall Study|Protocol Violation|1|||
131909423|NCT00671749|474956742|FG000|Overall Study|Lost to Follow-up|1|||
131909424|NCT03363906|474956747|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
131909425|NCT03363906|474956748|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
131909426|NCT03363906|474956747|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
131909427|NCT03363906|474956748|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
131909428|NCT03363906|474956747|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
131909429|NCT03363906|474956748|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
131909430|NCT03363906|474956747|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
131909431|NCT03363906|474956748|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
131909432|NCT02714153|474956750|FG000|Overall Study|Death|1|||
131909433|NCT01027845|474956751|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
131909434|NCT01027845|474956752|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
131909435|NCT01027845|474956753|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
131909436|NCT01027845|474956754|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
131909437|NCT01027845|474956751|FG000|Primary Vaccination Phase|Adverse Event|1|||
131909438|NCT01027845|474956752|FG001|Primary Vaccination Phase|Adverse Event|0|||
131399147|NCT01751906|473083950|FG000|Overall Study|Lost to Follow-up|151|||
131399148|NCT01751906|473083951|FG001|Overall Study|Lost to Follow-up|68|||
131399149|NCT01751906|473083950|FG000|Overall Study|Withdrawal by Subject|22|||
131399150|NCT01751906|473083951|FG001|Overall Study|Withdrawal by Subject|18|||
131399151|NCT01751906|473083950|FG000|Overall Study|Physician Decision|5|||
131399152|NCT01751906|473083951|FG001|Overall Study|Physician Decision|2|||
131399153|NCT01751906|473083950|FG000|Overall Study|Death|84|||
131399154|NCT01751906|473083951|FG001|Overall Study|Death|43|||
131909439|NCT01027845|474956753|FG002|Primary Vaccination Phase|Adverse Event|0|||
131909440|NCT01027845|474956754|FG003|Primary Vaccination Phase|Adverse Event|0|||
131909441|NCT01027845|474956751|FG000|Primary Vaccination Phase|Protocol Violation|1|||
131909442|NCT01027845|474956752|FG001|Primary Vaccination Phase|Protocol Violation|0|||
131909443|NCT01027845|474956753|FG002|Primary Vaccination Phase|Protocol Violation|0|||
131909444|NCT01027845|474956754|FG003|Primary Vaccination Phase|Protocol Violation|0|||
131909445|NCT01027845|474956751|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
131399155|NCT01751906|473083950|FG000|Overall Study|Denied on premises for follow-up by law|1|||
131399156|NCT01751906|473083951|FG001|Overall Study|Denied on premises for follow-up by law|0|||
131399157|NCT01110330|473083952|FG000|Overall Study|Adverse Event|0|||
131909446|NCT01027845|474956752|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
131909447|NCT01027845|474956753|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
131909448|NCT01027845|474956754|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
131399158|NCT01110330|473083953|FG001|Overall Study|Adverse Event|4|||
131763286|NCT01642004|474408663|FG001|Treatment|Disease progression|79|||
131763287|NCT01642004|474408662|FG000|Treatment|Study drug toxicity|10|||
131763288|NCT01642004|474408663|FG001|Treatment|Study drug toxicity|13|||
131763289|NCT01642004|474408662|FG000|Treatment|Death|1|||
131763290|NCT01642004|474408663|FG001|Treatment|Death|1|||
131763291|NCT01642004|474408662|FG000|Treatment|Adverse event unrelated to study drug|9|||
131763292|NCT01642004|474408663|FG001|Treatment|Adverse event unrelated to study drug|13|||
131763293|NCT01642004|474408662|FG000|Treatment|Maximum clinical benefit|1|||
131763294|NCT01642004|474408663|FG001|Treatment|Maximum clinical benefit|9|||
131763295|NCT01642004|474408662|FG000|Treatment|Poor/non-compliance|1|||
131763296|NCT01642004|474408663|FG001|Treatment|Poor/non-compliance|0|||
131763297|NCT01642004|474408662|FG000|Treatment|No longer meets study criteria|1|||
131763298|NCT01642004|474408663|FG001|Treatment|No longer meets study criteria|2|||
131763299|NCT01642004|474408662|FG000|Treatment|Other reasons|2|||
131763300|NCT01642004|474408663|FG001|Treatment|Other reasons|0|||
131399159|NCT01110330|473083954|FG002|Overall Study|Adverse Event|3|||
131399160|NCT01110330|473083952|FG000|Overall Study|Lack of Efficacy|3|||
131399161|NCT01110330|473083953|FG001|Overall Study|Lack of Efficacy|1|||
131399162|NCT01110330|473083954|FG002|Overall Study|Lack of Efficacy|1|||
131399163|NCT01110330|473083952|FG000|Overall Study|Lost to Follow-up|9|||
131399164|NCT01110330|473083953|FG001|Overall Study|Lost to Follow-up|10|||
131399165|NCT01110330|473083954|FG002|Overall Study|Lost to Follow-up|15|||
131399166|NCT01110330|473083952|FG000|Overall Study|Physician Decision|0|||
131399167|NCT01110330|473083953|FG001|Overall Study|Physician Decision|1|||
131399168|NCT01110330|473083954|FG002|Overall Study|Physician Decision|0|||
131399169|NCT01110330|473083952|FG000|Overall Study|Protocol Violation|2|||
131399170|NCT01110330|473083953|FG001|Overall Study|Protocol Violation|0|||
131399171|NCT01110330|473083954|FG002|Overall Study|Protocol Violation|4|||
131399172|NCT01110330|473083952|FG000|Overall Study|Withdrawal by Subject|0|||
131399173|NCT01110330|473083953|FG001|Overall Study|Withdrawal by Subject|6|||
131399174|NCT01110330|473083954|FG002|Overall Study|Withdrawal by Subject|2|||
131399175|NCT01110330|473083952|FG000|Overall Study|Other|1|||
131399176|NCT01110330|473083953|FG001|Overall Study|Other|1|||
131399177|NCT01110330|473083954|FG002|Overall Study|Other|1|||
131399178|NCT00880269|473083955|FG000|Overall Study|Protocol Violation|1|||
131399179|NCT00880269|473083956|FG001|Overall Study|Protocol Violation|0|||
131399180|NCT00880269|473083955|FG000|Overall Study|Disease Progression|13|||
131399181|NCT00880269|473083956|FG001|Overall Study|Disease Progression|11|||
131399182|NCT00880269|473083955|FG000|Overall Study|New Cancer Therapy|1|||
131399183|NCT00880269|473083956|FG001|Overall Study|New Cancer Therapy|0|||
131399184|NCT00880269|473083955|FG000|Overall Study|Death|4|||
131399185|NCT00880269|473083956|FG001|Overall Study|Death|2|||
131399186|NCT00880269|473083955|FG000|Overall Study|Lost to Follow-up|0|||
131399187|NCT00880269|473083956|FG001|Overall Study|Lost to Follow-up|1|||
131399188|NCT00880269|473083955|FG000|Overall Study|Withdrawal by Subject|3|||
131399189|NCT00880269|473083956|FG001|Overall Study|Withdrawal by Subject|4|||
131399190|NCT00880269|473083955|FG000|Overall Study|Adverse Event|10|||
131399191|NCT00880269|473083956|FG001|Overall Study|Adverse Event|9|||
131399192|NCT01811485|473083958|FG000|Overall Study|Adverse Event|1|||
131399193|NCT01811485|473083959|FG001|Overall Study|Adverse Event|3|||
131399194|NCT01811485|473083960|FG002|Overall Study|Adverse Event|2|||
131399195|NCT01811485|473083958|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131399196|NCT01811485|473083959|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131399197|NCT01811485|473083960|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
131399198|NCT01811485|473083958|FG000|Overall Study|Administrative problems|1|||
131399199|NCT01811485|473083959|FG001|Overall Study|Administrative problems|0|||
131399200|NCT01811485|473083960|FG002|Overall Study|Administrative problems|0|||
131399201|NCT01811485|473083958|FG000|Overall Study|Protocol Deviation|0|||
131399202|NCT01811485|473083959|FG001|Overall Study|Protocol Deviation|1|||
131399203|NCT01811485|473083960|FG002|Overall Study|Protocol Deviation|0|||
131399204|NCT01545934|473083961|FG000|Overall Study|Withdrawal by Subject|4|||
131399205|NCT01545934|473083962|FG001|Overall Study|Withdrawal by Subject|3|||
131399206|NCT01545934|473083961|FG000|Overall Study|Lost to Follow-up|1|||
131399207|NCT01545934|473083962|FG001|Overall Study|Lost to Follow-up|0|||
131813418|NCT00424047|474599056|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
131813419|NCT06999265|474599059|FG000|Overall Study|Lost to Follow-up|1|||
131399208|NCT03654404|473083963|FG000|Overall Study|Death|1|||
131399209|NCT03654404|473083963|FG000|Overall Study|Lost to Follow-up|2|||
131399210|NCT03654404|473083963|FG000|Overall Study|Withdrawal by Subject|5|||
131399211|NCT02003638|473083968|FG000|Overall Study|Withdrawal by Subject|1|||
131399212|NCT02003638|473083969|FG001|Overall Study|Withdrawal by Subject|0|||
131813420|NCT06999265|474599060|FG001|Overall Study|Lost to Follow-up|1|||
131399213|NCT03215758|473083970|FG000|Overall Study|Technical Problems|1|||
131399214|NCT03215758|473083971|FG001|Overall Study|Technical Problems|0|||
131399215|NCT03215758|473083970|FG000|Overall Study|Protocol deviation|0|||
131399216|NCT03215758|473083971|FG001|Overall Study|Protocol deviation|1|||
131399217|NCT03215758|473083970|FG000|Overall Study|Physician Decision|0|||
131399218|NCT03215758|473083971|FG001|Overall Study|Physician Decision|1|||
131399219|NCT03215758|473083970|FG000|Overall Study|Death|0|||
131399220|NCT03215758|473083971|FG001|Overall Study|Death|1|||
131399221|NCT03215758|473083970|FG000|Overall Study|Adverse Event|1|||
131399222|NCT03215758|473083971|FG001|Overall Study|Adverse Event|2|||
131399223|NCT03215758|473083970|FG000|Overall Study|Subject/Guardian Decision|3|||
131399224|NCT03215758|473083971|FG001|Overall Study|Subject/Guardian Decision|3|||
131399225|NCT04115748|473083977|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
131399226|NCT04115748|473083978|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
131399227|NCT04115748|473083979|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
131813421|NCT01154231|474599064|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
131813422|NCT01154231|474599064|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
131813423|NCT03552484|474600478|FG000|Overall Study|Death|6|||
131813424|NCT03552484|474600479|FG001|Overall Study|Death|4|||
131813425|NCT03552484|474600478|FG000|Overall Study|Lost to Follow-up|0|||
131813426|NCT03552484|474600479|FG001|Overall Study|Lost to Follow-up|16|||
131813427|NCT01117623|474600483|FG000|Overall Study|Adverse Event|0|||
131813428|NCT01117623|474600484|FG001|Overall Study|Adverse Event|2|||
131813429|NCT01117623|474600485|FG002|Overall Study|Adverse Event|4|||
131813430|NCT01117623|474600486|FG003|Overall Study|Adverse Event|0|||
131813431|NCT01117623|474600487|FG004|Overall Study|Adverse Event|2|||
131813432|NCT01117623|474600488|FG005|Overall Study|Adverse Event|0|||
131813433|NCT01117623|474600489|FG006|Overall Study|Adverse Event|0|||
131813434|NCT01117623|474600490|FG007|Overall Study|Adverse Event|2|||
131813435|NCT01117623|474600483|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
131813436|NCT01117623|474600484|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
131813437|NCT01117623|474600485|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
131813438|NCT01117623|474600486|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
131813439|NCT01117623|474600487|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
131813440|NCT01117623|474600488|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
131813441|NCT01117623|474600489|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
131813442|NCT01117623|474600490|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
131813443|NCT01117623|474600483|FG000|Overall Study|Withdrawal by Subject|0|||
131813444|NCT01117623|474600484|FG001|Overall Study|Withdrawal by Subject|0|||
131813445|NCT01117623|474600485|FG002|Overall Study|Withdrawal by Subject|2|||
131813446|NCT01117623|474600486|FG003|Overall Study|Withdrawal by Subject|0|||
131813447|NCT01117623|474600487|FG004|Overall Study|Withdrawal by Subject|0|||
131813448|NCT01117623|474600488|FG005|Overall Study|Withdrawal by Subject|1|||
131813449|NCT01117623|474600489|FG006|Overall Study|Withdrawal by Subject|1|||
131813450|NCT01117623|474600490|FG007|Overall Study|Withdrawal by Subject|1|||
131813451|NCT01117623|474600483|FG000|Overall Study|Non-compliance with study medication|0|||
131813452|NCT01117623|474600484|FG001|Overall Study|Non-compliance with study medication|0|||
131813453|NCT01117623|474600485|FG002|Overall Study|Non-compliance with study medication|0|||
131813454|NCT01117623|474600486|FG003|Overall Study|Non-compliance with study medication|0|||
131813455|NCT01117623|474600487|FG004|Overall Study|Non-compliance with study medication|0|||
131813456|NCT01117623|474600488|FG005|Overall Study|Non-compliance with study medication|0|||
131813457|NCT01117623|474600489|FG006|Overall Study|Non-compliance with study medication|0|||
131813458|NCT01117623|474600490|FG007|Overall Study|Non-compliance with study medication|1|||
131813459|NCT01117623|474600483|FG000|Overall Study|Invest. text: completed all planned txs|0|||
131813460|NCT01117623|474600484|FG001|Overall Study|Invest. text: completed all planned txs|0|||
131813461|NCT01117623|474600485|FG002|Overall Study|Invest. text: completed all planned txs|0|||
131813462|NCT01117623|474600486|FG003|Overall Study|Invest. text: completed all planned txs|0|||
131813463|NCT01117623|474600487|FG004|Overall Study|Invest. text: completed all planned txs|0|||
131813464|NCT01117623|474600488|FG005|Overall Study|Invest. text: completed all planned txs|1|||
131813465|NCT01117623|474600489|FG006|Overall Study|Invest. text: completed all planned txs|0|||
131813466|NCT01117623|474600490|FG007|Overall Study|Invest. text: completed all planned txs|0|||
131813467|NCT01205035|474600501|FG000|Overall Study|Withdrawal by Subject|1|||
131813468|NCT01205035|474600502|FG001|Overall Study|Withdrawal by Subject|0|||
131813469|NCT01205035|474600501|FG000|Overall Study|Physician Decision|1|||
131813470|NCT01205035|474600502|FG001|Overall Study|Physician Decision|0|||
131813471|NCT02663349|474600504|FG000|Overall Study|Withdrawal by Subject|6|||
131813472|NCT03246503|474600505|FG000|Overall Study|Lost to Follow-up|23|||
131813473|NCT03246503|474600505|FG000|Overall Study|Withdrawal by Subject|20|||
131813474|NCT03246503|474600505|FG000|Overall Study|Physician Decision|5|||
131813475|NCT03246503|474600505|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
131813476|NCT00736190|474600506|FG000|Overall Study|Pregnancy|1|||
131813477|NCT00736190|474600506|FG000|Overall Study|Withdrawal by Subject|1|||
131813478|NCT00736190|474600506|FG000|Overall Study|Adverse Event|1|||
131813479|NCT01492439|474600508|FG000|Overall Study|Withdrew from RTE|4|||
131813480|NCT01492439|474600509|FG001|Overall Study|Withdrew from RTE|9|||
131813481|NCT00716625|474600510|FG000|Overall Study|Safety was not Assessable|1|||
131813482|NCT00488774|474600511|FG000|Overall Study|Withdrawal of consent|2|||
131813483|NCT00488774|474600512|FG001|Overall Study|Withdrawal of consent|2|||
131813484|NCT00488774|474600513|FG002|Overall Study|Withdrawal of consent|2|||
131813485|NCT00488774|474600514|FG003|Overall Study|Withdrawal of consent|0|||
131399228|NCT04115748|473083980|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
131399229|NCT04115748|473083981|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
131399230|NCT04115748|473083982|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
131399231|NCT04115748|473083983|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
131399232|NCT04115748|473083984|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
131399233|NCT04115748|473083985|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
131399234|NCT04115748|473083986|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
131399235|NCT04115748|473083977|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399236|NCT04115748|473083978|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399237|NCT04115748|473083979|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399238|NCT04115748|473083980|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
131399239|NCT04115748|473083981|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399240|NCT04115748|473083982|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399241|NCT04115748|473083983|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399242|NCT04115748|473083984|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399243|NCT04115748|473083985|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399244|NCT04115748|473083986|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
131399245|NCT04115748|473083977|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
131763301|NCT01642004|474408662|FG000|Treatment|Not reported|0|||
131763302|NCT01642004|474408663|FG001|Treatment|Not reported|3|||
131763303|NCT01642004|474408662|FG000|Treatment|Participant request to discontinue study treatment|6|||
131813486|NCT00488774|474600511|FG000|Overall Study|Other|6|||
131399246|NCT04115748|473083978|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
131399247|NCT04115748|473083979|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
131399248|NCT04115748|473083980|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
131399249|NCT04115748|473083981|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
131399250|NCT04115748|473083982|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
131399251|NCT04115748|473083983|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
131399252|NCT04115748|473083984|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
131399253|NCT04115748|473083985|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
131399254|NCT04115748|473083986|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
131399255|NCT04115748|473083977|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399256|NCT04115748|473083978|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399257|NCT04115748|473083979|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399258|NCT04115748|473083980|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399259|NCT04115748|473083981|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399260|NCT04115748|473083982|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399261|NCT04115748|473083983|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399262|NCT04115748|473083984|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399263|NCT04115748|473083985|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
131399264|NCT04115748|473083986|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
131399265|NCT00713349|473083987|FG000|Overall Study|Protocol Violation|1|||
131399266|NCT03367403|473083988|FG000|Overall Study|Adverse Event|20|||
131399267|NCT03367403|473083989|FG001|Overall Study|Adverse Event|6|||
131399268|NCT03367403|473083990|FG002|Overall Study|Adverse Event|2|||
131399269|NCT03367403|473083988|FG000|Overall Study|Withdrawal by Subject|12|||
131399270|NCT03367403|473083989|FG001|Overall Study|Withdrawal by Subject|13|||
131399271|NCT03367403|473083990|FG002|Overall Study|Withdrawal by Subject|1|||
131399272|NCT03367403|473083988|FG000|Overall Study|Death|1|||
131399273|NCT03367403|473083989|FG001|Overall Study|Death|2|||
131399274|NCT03367403|473083990|FG002|Overall Study|Death|0|||
131399275|NCT03367403|473083988|FG000|Overall Study|Physician Decision|0|||
131399276|NCT03367403|473083989|FG001|Overall Study|Physician Decision|1|||
131399277|NCT03367403|473083990|FG002|Overall Study|Physician Decision|0|||
131399278|NCT03367403|473083988|FG000|Overall Study|Protocol Violation|1|||
131399279|NCT03367403|473083989|FG001|Overall Study|Protocol Violation|1|||
131399280|NCT03367403|473083990|FG002|Overall Study|Protocol Violation|0|||
131399281|NCT03367403|473083988|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
131399282|NCT03367403|473083989|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
131399283|NCT03367403|473083990|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
131399284|NCT03367403|473083988|FG000|Overall Study|COVID-19|3|||
131399285|NCT03367403|473083989|FG001|Overall Study|COVID-19|6|||
131399286|NCT03367403|473083990|FG002|Overall Study|COVID-19|0|||
131399287|NCT03367403|473083988|FG000|Overall Study|Abuse of Alcohol Intake|0|||
131399288|NCT03367403|473083989|FG001|Overall Study|Abuse of Alcohol Intake|1|||
131399289|NCT03367403|473083990|FG002|Overall Study|Abuse of Alcohol Intake|0|||
131399290|NCT03367403|473083988|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
131399291|NCT03367403|473083989|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
131399292|NCT03367403|473083990|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
131399293|NCT02314156|473083991|FG000|Overall Study|Adverse Event|1|||
131909449|NCT01027845|474956751|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
131399294|NCT02314156|473083992|FG001|Overall Study|Adverse Event|0|||
131763304|NCT01642004|474408663|FG001|Treatment|Participant request to discontinue study treatment|4|||
131763305|NCT01642004|474408662|FG000|Treatment|Participant withdrew consent|5|||
131763306|NCT01642004|474408663|FG001|Treatment|Participant withdrew consent|5|||
131763307|NCT02192190|474408668|FG000|Overall Study|Adverse Event|1|||
131763308|NCT02192190|474408669|FG001|Overall Study|Adverse Event|1|||
131763309|NCT02192190|474408670|FG002|Overall Study|Adverse Event|0|||
131763310|NCT02192190|474408671|FG003|Overall Study|Adverse Event|0|||
131763311|NCT02192190|474408672|FG004|Overall Study|Adverse Event|0|||
131763312|NCT02192190|474408673|FG005|Overall Study|Adverse Event|0|||
131763313|NCT02192190|474408668|FG000|Overall Study|Lost to Follow-up|3|||
131399295|NCT02314156|473083991|FG000|Overall Study|Withdrawal by Subject|1|||
131399296|NCT02314156|473083992|FG001|Overall Study|Withdrawal by Subject|0|||
131399297|NCT02752633|473083993|FG000|Overall Study|Withdrawal by Subject|1|||
131399298|NCT02846389|473083994|FG000|Overall Study|Withdrawal by Subject|1|||
131399299|NCT02846389|473083995|FG001|Overall Study|Withdrawal by Subject|1|||
131399300|NCT01450696|473083996|FG000|Overall Study|Never Treated|1|||
131399301|NCT01450696|473083997|FG001|Overall Study|Never Treated|1|||
131399302|NCT01450696|473083996|FG000|Overall Study|Death|77|||
131399303|NCT01450696|473083997|FG001|Overall Study|Death|84|||
131399304|NCT01450696|473083996|FG000|Overall Study|Lost to Follow-up|3|||
131399305|NCT01450696|473083997|FG001|Overall Study|Lost to Follow-up|3|||
131399306|NCT01450696|473083996|FG000|Overall Study|Non-Compliance|1|||
131399307|NCT01450696|473083997|FG001|Overall Study|Non-Compliance|0|||
131399308|NCT01450696|473083996|FG000|Overall Study|Withdrawal by Subject|13|||
131399309|NCT01450696|473083997|FG001|Overall Study|Withdrawal by Subject|2|||
131399310|NCT01450696|473083996|FG000|Overall Study|Study Terminated by Sponsor|53|||
131399311|NCT01450696|473083997|FG001|Overall Study|Study Terminated by Sponsor|58|||
131399312|NCT01843673|473083999|FG000|Overall Study|Lack of Efficacy|2|||
131399313|NCT01843673|473083999|FG000|Overall Study|Withdrawal by Subject|4|||
131399314|NCT02249091|473084002|FG000|Overall Study|Lack of Efficacy|8|||
131399315|NCT02249091|473084003|FG001|Overall Study|Lack of Efficacy|3|||
131399316|NCT02249091|473084002|FG000|Overall Study|Physician Decision|4|||
131399317|NCT02249091|473084003|FG001|Overall Study|Physician Decision|1|||
131399318|NCT02249091|473084002|FG000|Overall Study|Withdrawal by Subject|2|||
131399319|NCT02249091|473084003|FG001|Overall Study|Withdrawal by Subject|2|||
131399320|NCT02249091|473084002|FG000|Overall Study|Death|3|||
131399321|NCT02249091|473084003|FG001|Overall Study|Death|4|||
131399322|NCT02249091|473084002|FG000|Overall Study|Adverse Event|1|||
131399323|NCT02249091|473084003|FG001|Overall Study|Adverse Event|0|||
131399324|NCT02249091|473084002|FG000|Overall Study|Stable disease with following SCT|0|||
131399325|NCT02249091|473084003|FG001|Overall Study|Stable disease with following SCT|1|||
131399326|NCT02249091|473084002|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
131763314|NCT02192190|474408669|FG001|Overall Study|Lost to Follow-up|3|||
131763315|NCT02192190|474408670|FG002|Overall Study|Lost to Follow-up|2|||
131763316|NCT02192190|474408671|FG003|Overall Study|Lost to Follow-up|1|||
131763317|NCT02192190|474408672|FG004|Overall Study|Lost to Follow-up|4|||
131763318|NCT02192190|474408673|FG005|Overall Study|Lost to Follow-up|3|||
131763319|NCT02192190|474408668|FG000|Overall Study|Physician Decision|2|||
131763320|NCT02192190|474408669|FG001|Overall Study|Physician Decision|0|||
131763321|NCT02192190|474408670|FG002|Overall Study|Physician Decision|0|||
131763322|NCT02192190|474408671|FG003|Overall Study|Physician Decision|0|||
131763323|NCT02192190|474408672|FG004|Overall Study|Physician Decision|0|||
131763324|NCT02192190|474408673|FG005|Overall Study|Physician Decision|0|||
131763325|NCT02192190|474408668|FG000|Overall Study|Terminated by Sponsor|43|||
131763326|NCT02192190|474408669|FG001|Overall Study|Terminated by Sponsor|23|||
131763327|NCT02192190|474408670|FG002|Overall Study|Terminated by Sponsor|20|||
131763328|NCT02192190|474408671|FG003|Overall Study|Terminated by Sponsor|23|||
131763329|NCT02192190|474408672|FG004|Overall Study|Terminated by Sponsor|21|||
131909450|NCT01027845|474956752|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
131763330|NCT02192190|474408673|FG005|Overall Study|Terminated by Sponsor|23|||
131763331|NCT02192190|474408668|FG000|Overall Study|Withdrawal by Subject|4|||
131763332|NCT02192190|474408669|FG001|Overall Study|Withdrawal by Subject|1|||
131763333|NCT02192190|474408670|FG002|Overall Study|Withdrawal by Subject|2|||
131763334|NCT02192190|474408671|FG003|Overall Study|Withdrawal by Subject|1|||
131763335|NCT02192190|474408672|FG004|Overall Study|Withdrawal by Subject|5|||
131763336|NCT02192190|474408673|FG005|Overall Study|Withdrawal by Subject|3|||
131763337|NCT02192190|474408668|FG000|Overall Study|Could not Keep Visit Schedule|1|||
131763338|NCT02192190|474408669|FG001|Overall Study|Could not Keep Visit Schedule|0|||
131763339|NCT02192190|474408670|FG002|Overall Study|Could not Keep Visit Schedule|0|||
131763340|NCT02192190|474408671|FG003|Overall Study|Could not Keep Visit Schedule|0|||
131763341|NCT02192190|474408672|FG004|Overall Study|Could not Keep Visit Schedule|0|||
131763342|NCT02192190|474408673|FG005|Overall Study|Could not Keep Visit Schedule|0|||
131763343|NCT02192190|474408668|FG000|Overall Study|Positive Drug Screen|0|||
131763344|NCT02192190|474408669|FG001|Overall Study|Positive Drug Screen|0|||
131399327|NCT02249091|473084003|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
131763345|NCT02192190|474408670|FG002|Overall Study|Positive Drug Screen|0|||
131763346|NCT02192190|474408671|FG003|Overall Study|Positive Drug Screen|1|||
131763347|NCT02192190|474408672|FG004|Overall Study|Positive Drug Screen|0|||
131763348|NCT02192190|474408673|FG005|Overall Study|Positive Drug Screen|0|||
131399328|NCT02249091|473084002|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
131399329|NCT02249091|473084003|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
131399330|NCT02249091|473084002|FG000|Overall Study|Refractory AML|1|||
131399331|NCT02249091|473084003|FG001|Overall Study|Refractory AML|1|||
131399332|NCT00433966|473084004|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
131399333|NCT00433966|473084005|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
131399334|NCT00433966|473084006|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
131399335|NCT00433966|473084007|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
131399336|NCT00433966|473084004|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
131399337|NCT00433966|473084005|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
131399338|NCT00433966|473084006|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
131399339|NCT00433966|473084007|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
131399340|NCT00433966|473084004|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
131399341|NCT00433966|473084005|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
131399342|NCT00433966|473084006|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
131399343|NCT00433966|473084007|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
131399344|NCT00433966|473084004|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
131399345|NCT00433966|473084005|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
131399346|NCT00433966|473084006|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
131399347|NCT00433966|473084007|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
131399348|NCT00433966|473084004|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
131399349|NCT00433966|473084005|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
131399350|NCT00433966|473084006|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
131399351|NCT00433966|473084007|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
131399352|NCT05059301|473084008|FG000|Overall Study|Adverse Event|0|||
131909451|NCT01027845|474956753|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
131909452|NCT01027845|474956754|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
131909453|NCT01027845|474956751|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
131909454|NCT01027845|474956752|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
131399353|NCT05059301|473084009|FG001|Overall Study|Adverse Event|2|||
131399354|NCT05059301|473084010|FG002|Overall Study|Adverse Event|2|||
131399355|NCT05059301|473084008|FG000|Overall Study|Lost to Follow-up|2|||
131399356|NCT05059301|473084009|FG001|Overall Study|Lost to Follow-up|3|||
131399357|NCT05059301|473084010|FG002|Overall Study|Lost to Follow-up|3|||
131399358|NCT03497975|473084011|FG000|Overall Study|Withdrew Consent|34|||
131399359|NCT03497975|473084012|FG001|Overall Study|Withdrew Consent|35|||
131399360|NCT03497975|473084011|FG000|Overall Study|Lost to Follow-up|7|||
131399361|NCT03497975|473084012|FG001|Overall Study|Lost to Follow-up|7|||
131399362|NCT03497975|473084011|FG000|Overall Study|Physician Decision|4|||
131399363|NCT03497975|473084012|FG001|Overall Study|Physician Decision|5|||
131399364|NCT03497975|473084011|FG000|Overall Study|Discontinued|42|||
131399365|NCT03497975|473084012|FG001|Overall Study|Discontinued|39|||
131399366|NCT03497975|473084011|FG000|Overall Study|Reason Not Specified|15|||
131399367|NCT03497975|473084012|FG001|Overall Study|Reason Not Specified|14|||
131399368|NCT01257230|473084015|FG000|Overall Study|Not Treated|0|||
131399369|NCT01257230|473084016|FG001|Overall Study|Not Treated|0|||
131399370|NCT01257230|473084017|FG002|Overall Study|Not Treated|1|||
131399371|NCT01257230|473084015|FG000|Overall Study|Adverse Event|2|||
131399372|NCT01257230|473084016|FG001|Overall Study|Adverse Event|0|||
131399373|NCT01257230|473084017|FG002|Overall Study|Adverse Event|0|||
131399374|NCT01257230|473084015|FG000|Overall Study|Lack of Efficacy|0|||
131399375|NCT01257230|473084016|FG001|Overall Study|Lack of Efficacy|1|||
131399376|NCT01257230|473084017|FG002|Overall Study|Lack of Efficacy|0|||
131399377|NCT01257230|473084015|FG000|Overall Study|Protocol Violation|3|||
131399378|NCT01257230|473084016|FG001|Overall Study|Protocol Violation|0|||
131399379|NCT01257230|473084017|FG002|Overall Study|Protocol Violation|1|||
131763349|NCT02192190|474408668|FG000|Overall Study|Inadequate Pain Relief|0|||
131763350|NCT02192190|474408669|FG001|Overall Study|Inadequate Pain Relief|1|||
131763351|NCT02192190|474408670|FG002|Overall Study|Inadequate Pain Relief|1|||
131763352|NCT02192190|474408671|FG003|Overall Study|Inadequate Pain Relief|0|||
131763353|NCT02192190|474408672|FG004|Overall Study|Inadequate Pain Relief|0|||
131763354|NCT02192190|474408673|FG005|Overall Study|Inadequate Pain Relief|0|||
131763355|NCT02607865|474408674|FG000|Overall Study|Lost to Follow-up|9|||
131763356|NCT02607865|474408675|FG001|Overall Study|Lost to Follow-up|7|||
131763357|NCT02607865|474408676|FG002|Overall Study|Lost to Follow-up|7|||
131763358|NCT02607865|474408677|FG003|Overall Study|Lost to Follow-up|5|||
131763359|NCT02607865|474408674|FG000|Overall Study|Withdrawal by Subject|18|||
131763360|NCT02607865|474408675|FG001|Overall Study|Withdrawal by Subject|18|||
131399380|NCT01257230|473084015|FG000|Overall Study|Withdrawal by Subject|0|||
131399381|NCT01257230|473084016|FG001|Overall Study|Withdrawal by Subject|4|||
131399382|NCT01257230|473084017|FG002|Overall Study|Withdrawal by Subject|1|||
131763361|NCT02607865|474408676|FG002|Overall Study|Withdrawal by Subject|17|||
131763362|NCT02607865|474408677|FG003|Overall Study|Withdrawal by Subject|8|||
131399383|NCT01257230|473084015|FG000|Overall Study|Other reason not defined above|1|||
131399384|NCT01257230|473084016|FG001|Overall Study|Other reason not defined above|5|||
131399385|NCT01257230|473084017|FG002|Overall Study|Other reason not defined above|3|||
131399386|NCT01205061|473084020|FG000|Overall Study|Adverse Event|4|||
131399387|NCT01205061|473084020|FG000|Overall Study|Withdrawal by Subject|11|||
131399388|NCT01205061|473084020|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
131399389|NCT01205061|473084020|FG000|Overall Study|Lost to Follow-up|9|||
131399390|NCT01205061|473084020|FG000|Overall Study|Other|1|||
131399391|NCT00765037|473084021|FG000|Overall Study|Lost to Follow-up|5|||
131399392|NCT00765037|473084021|FG000|Overall Study|Adverse Event|1|||
131399393|NCT04026009|473084026|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131399394|NCT04026009|473084027|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131399395|NCT04026009|473084028|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
131399396|NCT04026009|473084029|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
131399397|NCT04026009|473084030|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
131763363|NCT02607865|474408674|FG000|Overall Study|Death|5|||
131763364|NCT02607865|474408675|FG001|Overall Study|Death|4|||
131763365|NCT02607865|474408676|FG002|Overall Study|Death|1|||
131763366|NCT02607865|474408677|FG003|Overall Study|Death|3|||
131763367|NCT02607865|474408674|FG000|Overall Study|Unclassified|1|||
131763368|NCT02607865|474408675|FG001|Overall Study|Unclassified|1|||
131763369|NCT02607865|474408676|FG002|Overall Study|Unclassified|2|||
131763370|NCT02607865|474408677|FG003|Overall Study|Unclassified|0|||
131399398|NCT04026009|473084026|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
131399399|NCT04026009|473084027|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
131399400|NCT04026009|473084028|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
131399401|NCT04026009|473084029|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
131399402|NCT04026009|473084030|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
131399403|NCT01988662|473084031|FG000|Overall Study|Subject/guardian decision|1|||
131399404|NCT01988662|473084032|FG001|Overall Study|Subject/guardian decision|1|||
131399405|NCT01988662|473084031|FG000|Overall Study|Adverse Event|3|||
131399406|NCT01988662|473084032|FG001|Overall Study|Adverse Event|1|||
131399407|NCT02120300|473084040|FG000|Overall Study|Enrolled but Never Treated|2|||
131399408|NCT02120300|473084041|FG001|Overall Study|Enrolled but Never Treated|0|||
131399409|NCT02120300|473084042|FG002|Overall Study|Enrolled but Never Treated|0|||
131399410|NCT02120300|473084043|FG003|Overall Study|Enrolled but Never Treated|0|||
131399411|NCT02120300|473084040|FG000|Overall Study|Lack of Efficacy|0|||
131399412|NCT02120300|473084041|FG001|Overall Study|Lack of Efficacy|0|||
131399413|NCT02120300|473084042|FG002|Overall Study|Lack of Efficacy|0|||
131399414|NCT02120300|473084043|FG003|Overall Study|Lack of Efficacy|1|||
131399415|NCT02120300|473084040|FG000|Overall Study|Lost to Follow-up|1|||
131399416|NCT02120300|473084041|FG001|Overall Study|Lost to Follow-up|0|||
131399417|NCT02120300|473084042|FG002|Overall Study|Lost to Follow-up|0|||
131399418|NCT02120300|473084043|FG003|Overall Study|Lost to Follow-up|0|||
131399419|NCT05141175|473084044|FG000|Overall Study|Withdrawal by Subject|1|||
131399420|NCT00177294|473084045|FG000|Overall Study|Withdrawal by Subject|7|||
131399421|NCT00177294|473084046|FG001|Overall Study|Withdrawal by Subject|5|||
131399422|NCT02443116|473084050|FG000|Part 1|Adverse Event|2|||
131399423|NCT02443116|473084051|FG001|Part 1|Adverse Event|3|||
131399424|NCT02443116|473084052|FG002|Part 1|Adverse Event|0|||
131399425|NCT02443116|473084053|FG003|Part 1|Adverse Event|0|||
131399426|NCT02443116|473084054|FG004|Part 1|Adverse Event|0|||
131399427|NCT02443116|473084055|FG005|Part 1|Adverse Event|0|||
131399428|NCT02443116|473084056|FG006|Part 1|Adverse Event|0|||
131399429|NCT02443116|473084057|FG007|Part 1|Adverse Event|0|||
131399430|NCT02443116|473084058|FG008|Part 1|Adverse Event|0|||
131763371|NCT03227692|474408678|FG000|Overall Study|Protocol Violation|1|||
131763372|NCT03227692|474408679|FG001|Overall Study|Protocol Violation|1|||
131763373|NCT03227692|474408678|FG000|Overall Study|Lost to Follow-up|4|||
131763374|NCT03227692|474408679|FG001|Overall Study|Lost to Follow-up|2|||
131763375|NCT03227692|474408678|FG000|Overall Study|Adverse Event|0|||
131763376|NCT03227692|474408679|FG001|Overall Study|Adverse Event|2|||
131763377|NCT00528840|474408680|FG000|Overall Study|Lost to Follow-up|10|||
131763378|NCT00528840|474408680|FG000|Overall Study|Adverse Event|1|||
131399431|NCT02443116|473084050|FG000|Part 1|Withdrew informed consent|0|||
131399432|NCT02443116|473084051|FG001|Part 1|Withdrew informed consent|1|||
131399433|NCT02443116|473084052|FG002|Part 1|Withdrew informed consent|0|||
131399434|NCT02443116|473084053|FG003|Part 1|Withdrew informed consent|0|||
131399435|NCT02443116|473084054|FG004|Part 1|Withdrew informed consent|0|||
131399436|NCT02443116|473084055|FG005|Part 1|Withdrew informed consent|0|||
131763379|NCT00528840|474408680|FG000|Overall Study|Withdrawal by Subject|17|||
131763380|NCT00528840|474408680|FG000|Overall Study|Death|2|||
131763381|NCT00528840|474408680|FG000|Overall Study|Administrative Reasons|1|||
131763382|NCT00528840|474408680|FG000|Overall Study|Other|2|||
131763383|NCT01657253|474408681|FG000|Overall Study|Lost to Follow-up|6|||
131763384|NCT01657253|474408682|FG001|Overall Study|Lost to Follow-up|5|||
131763385|NCT01657253|474408681|FG000|Overall Study|Withdrawal by Subject|11|||
131763386|NCT01657253|474408682|FG001|Overall Study|Withdrawal by Subject|12|||
131763387|NCT01657253|474408681|FG000|Overall Study|Adverse Event|0|||
131763388|NCT01657253|474408682|FG001|Overall Study|Adverse Event|1|||
131763389|NCT02447952|474408683|FG000|Overall Study|Adverse Event|2|||
131763390|NCT02447952|474408683|FG000|Overall Study|Physician Decision|1|||
131813487|NCT00488774|474600512|FG001|Overall Study|Other|3|||
131813488|NCT00488774|474600513|FG002|Overall Study|Other|2|||
131813489|NCT00488774|474600514|FG003|Overall Study|Other|2|||
131813490|NCT00488774|474600511|FG000|Overall Study|Lost to Follow-up|0|||
131813491|NCT00488774|474600512|FG001|Overall Study|Lost to Follow-up|0|||
131813492|NCT00488774|474600513|FG002|Overall Study|Lost to Follow-up|1|||
131813493|NCT00488774|474600514|FG003|Overall Study|Lost to Follow-up|1|||
131813494|NCT01204294|474600515|FG000|Overall Study|Adverse Event|2|||
131813495|NCT01204294|474600516|FG001|Overall Study|Adverse Event|6|||
131813496|NCT01204294|474600517|FG002|Overall Study|Adverse Event|0|||
131763391|NCT02447952|474408683|FG000|Overall Study|Withdrawal by Subject|4|||
131763392|NCT01603628|474408686|FG000|Overall Study|Personal Reasons|1|||
131763393|NCT01603628|474408687|FG001|Overall Study|Personal Reasons|1|||
131763394|NCT01603628|474408688|FG002|Overall Study|Personal Reasons|2|||
131763395|NCT01603628|474408686|FG000|Overall Study|Protocol Violation|1|||
131763396|NCT01603628|474408687|FG001|Overall Study|Protocol Violation|1|||
131763397|NCT01603628|474408688|FG002|Overall Study|Protocol Violation|0|||
131763398|NCT01603628|474408686|FG000|Overall Study|Lost to Follow-up|0|||
131763399|NCT01603628|474408687|FG001|Overall Study|Lost to Follow-up|1|||
131763400|NCT01603628|474408688|FG002|Overall Study|Lost to Follow-up|0|||
131763401|NCT01603628|474408686|FG000|Overall Study|Other Miscellaneous Reason|1|||
131763402|NCT01603628|474408687|FG001|Overall Study|Other Miscellaneous Reason|0|||
131763403|NCT01603628|474408688|FG002|Overall Study|Other Miscellaneous Reason|0|||
131763404|NCT01756833|474408694|FG000|Overall Study|Withdrawal by Subject|4|||
131763405|NCT01756833|474408695|FG001|Overall Study|Withdrawal by Subject|3|||
131763406|NCT04554394|474408696|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
131763407|NCT04554394|474408697|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
131763408|NCT04554394|474408696|FG000|Overall Study|Withdrawal by Subject|2|||
131763409|NCT04554394|474408697|FG001|Overall Study|Withdrawal by Subject|2|||
131763410|NCT04554394|474408696|FG000|Overall Study|Lost to Follow-up|2|||
131763411|NCT04554394|474408697|FG001|Overall Study|Lost to Follow-up|2|||
131763412|NCT04554394|474408696|FG000|Overall Study|Physician Decision|1|||
131763413|NCT04554394|474408697|FG001|Overall Study|Physician Decision|1|||
131763414|NCT00886587|474408698|FG000|Overall Study|Adverse Event|2|||
131763415|NCT00886587|474408699|FG001|Overall Study|Adverse Event|1|||
131763416|NCT00886587|474408698|FG000|Overall Study|Protocol Violation|2|||
131763417|NCT00886587|474408699|FG001|Overall Study|Protocol Violation|0|||
131763418|NCT00886587|474408698|FG000|Overall Study|Withdrawal by Subject|0|||
131763419|NCT00886587|474408699|FG001|Overall Study|Withdrawal by Subject|1|||
131763420|NCT00398086|474408700|FG000|Overall Study|Unacceptable Toxicity|2|||
131763421|NCT00398086|474408701|FG001|Overall Study|Unacceptable Toxicity|8|||
131763422|NCT00398086|474408702|FG002|Overall Study|Unacceptable Toxicity|2|||
131813497|NCT01204294|474600518|FG003|Overall Study|Adverse Event|7|||
131813498|NCT01204294|474600519|FG004|Overall Study|Adverse Event|1|||
131813499|NCT01204294|474600520|FG005|Overall Study|Adverse Event|4|||
131813500|NCT01204294|474600521|FG006|Overall Study|Adverse Event|0|||
131909455|NCT01027845|474956753|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
131909456|NCT01027845|474956754|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
131909457|NCT01692119|474956760|FG000|Overall Study|Protocol Violation|3|||
131763423|NCT00398086|474408700|FG000|Overall Study|Adverse Event|1|||
131763424|NCT00398086|474408701|FG001|Overall Study|Adverse Event|4|||
131763425|NCT00398086|474408702|FG002|Overall Study|Adverse Event|0|||
131763426|NCT00398086|474408700|FG000|Overall Study|Physician Decision|1|||
131763427|NCT00398086|474408701|FG001|Overall Study|Physician Decision|4|||
131909458|NCT01692119|474956761|FG001|Overall Study|Protocol Violation|1|||
131909459|NCT01692119|474956760|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
131763428|NCT00398086|474408702|FG002|Overall Study|Physician Decision|0|||
131763429|NCT00398086|474408700|FG000|Overall Study|Withdrawal by Subject|5|||
131763430|NCT00398086|474408701|FG001|Overall Study|Withdrawal by Subject|7|||
131763431|NCT00398086|474408702|FG002|Overall Study|Withdrawal by Subject|0|||
131813501|NCT01204294|474600515|FG000|Overall Study|Protocol Violation|1|||
131813502|NCT01204294|474600516|FG001|Overall Study|Protocol Violation|0|||
131813503|NCT01204294|474600517|FG002|Overall Study|Protocol Violation|2|||
131813504|NCT01204294|474600518|FG003|Overall Study|Protocol Violation|1|||
131813505|NCT01204294|474600519|FG004|Overall Study|Protocol Violation|0|||
131763432|NCT00890201|474408703|FG000|Overall Study|Protocol Violation|5|||
131763433|NCT00890201|474408704|FG001|Overall Study|Protocol Violation|56|||
131813506|NCT01204294|474600520|FG005|Overall Study|Protocol Violation|0|||
131813507|NCT01204294|474600521|FG006|Overall Study|Protocol Violation|0|||
131763434|NCT02087241|474408705|FG000|Overall Study|Death|2|||
131763435|NCT02087241|474408706|FG001|Overall Study|Death|1|||
131763436|NCT02087241|474408707|FG002|Overall Study|Death|1|||
131763437|NCT02087241|474408708|FG003|Overall Study|Death|1|||
131763438|NCT02087241|474408705|FG000|Overall Study|Withdrawal by Subject|1|||
131763439|NCT02087241|474408706|FG001|Overall Study|Withdrawal by Subject|0|||
131763440|NCT02087241|474408707|FG002|Overall Study|Withdrawal by Subject|0|||
131763441|NCT02087241|474408708|FG003|Overall Study|Withdrawal by Subject|1|||
131763442|NCT02087241|474408705|FG000|Overall Study|Progressive Disease|0|||
131763443|NCT02087241|474408706|FG001|Overall Study|Progressive Disease|0|||
131763444|NCT02087241|474408707|FG002|Overall Study|Progressive Disease|0|||
131763445|NCT02087241|474408708|FG003|Overall Study|Progressive Disease|1|||
131763446|NCT02087241|474408705|FG000|Overall Study|Study Terminated by Sponsor|0|||
131763447|NCT02087241|474408706|FG001|Overall Study|Study Terminated by Sponsor|2|||
131763448|NCT02087241|474408707|FG002|Overall Study|Study Terminated by Sponsor|0|||
131763449|NCT02087241|474408708|FG003|Overall Study|Study Terminated by Sponsor|4|||
131763450|NCT02181504|474408709|FG000|Overall Study|Adverse Event|1|||
131763451|NCT02181504|474408710|FG001|Overall Study|Adverse Event|1|||
131763452|NCT02181504|474408711|FG002|Overall Study|Adverse Event|1|||
131763453|NCT00374452|474408715|FG000|Overall Study|Left clinic before intervention started|4|||
131763454|NCT00374452|474408716|FG001|Overall Study|Left clinic before intervention started|1|||
131763455|NCT00374452|474408715|FG000|Overall Study|Change in job role before intervention|0|||
131763456|NCT00374452|474408716|FG001|Overall Study|Change in job role before intervention|1|||
131763457|NCT00374452|474408715|FG000|Overall Study|Left clinic after intervention started|1|||
131763458|NCT00374452|474408716|FG001|Overall Study|Left clinic after intervention started|1|||
131763459|NCT00374452|474408715|FG000|Overall Study|Withdrawal by Subject|0|||
131763460|NCT00374452|474408716|FG001|Overall Study|Withdrawal by Subject|2|||
131763461|NCT03267576|474408724|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
131763462|NCT03267576|474408725|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
131763463|NCT03267576|474408724|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
131763464|NCT03267576|474408725|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
131763465|NCT01369069|474408726|FG000|Overall Study|Lost to Follow-up|8|||
131763466|NCT01369069|474408727|FG001|Overall Study|Lost to Follow-up|9|||
131763467|NCT01369069|474408726|FG000|Overall Study|Withdrawal by Subject|9|||
131763468|NCT01369069|474408727|FG001|Overall Study|Withdrawal by Subject|7|||
131763469|NCT02573012|474408728|FG000|Overall Study|Adverse Event|5|||
131763470|NCT02573012|474408729|FG001|Overall Study|Adverse Event|5|||
131763471|NCT02573012|474408728|FG000|Overall Study|Lack of Efficacy|5|||
131763472|NCT02573012|474408729|FG001|Overall Study|Lack of Efficacy|4|||
131763473|NCT02573012|474408728|FG000|Overall Study|Non-compliance|1|||
131763474|NCT02573012|474408729|FG001|Overall Study|Non-compliance|2|||
131813508|NCT01204294|474600515|FG000|Overall Study|Withdrawal by Subject|0|||
131813509|NCT01204294|474600516|FG001|Overall Study|Withdrawal by Subject|2|||
131813510|NCT01204294|474600517|FG002|Overall Study|Withdrawal by Subject|2|||
131813511|NCT01204294|474600518|FG003|Overall Study|Withdrawal by Subject|1|||
131813512|NCT01204294|474600519|FG004|Overall Study|Withdrawal by Subject|1|||
131813513|NCT01204294|474600520|FG005|Overall Study|Withdrawal by Subject|1|||
131813514|NCT01204294|474600521|FG006|Overall Study|Withdrawal by Subject|2|||
131813515|NCT01204294|474600515|FG000|Overall Study|Lack of Efficacy|0|||
131813516|NCT01204294|474600516|FG001|Overall Study|Lack of Efficacy|0|||
131813517|NCT01204294|474600517|FG002|Overall Study|Lack of Efficacy|0|||
131813518|NCT01204294|474600518|FG003|Overall Study|Lack of Efficacy|2|||
131813519|NCT01204294|474600519|FG004|Overall Study|Lack of Efficacy|0|||
131813520|NCT01204294|474600520|FG005|Overall Study|Lack of Efficacy|0|||
131813521|NCT01204294|474600521|FG006|Overall Study|Lack of Efficacy|0|||
131813522|NCT01204294|474600515|FG000|Overall Study|Other (house moving)|0|||
131813523|NCT01204294|474600516|FG001|Overall Study|Other (house moving)|0|||
131813524|NCT01204294|474600517|FG002|Overall Study|Other (house moving)|1|||
131813525|NCT01204294|474600518|FG003|Overall Study|Other (house moving)|0|||
131813526|NCT01204294|474600519|FG004|Overall Study|Other (house moving)|0|||
131813527|NCT01204294|474600520|FG005|Overall Study|Other (house moving)|0|||
131813528|NCT01204294|474600521|FG006|Overall Study|Other (house moving)|0|||
131813529|NCT04590027|474600522|FG000|Overall Study|Lost to Follow-up|17|||
131763475|NCT02573012|474408728|FG000|Overall Study|Withdrawal by Subject|2|||
131763476|NCT02573012|474408729|FG001|Overall Study|Withdrawal by Subject|2|||
131763477|NCT02573012|474408728|FG000|Overall Study|Study Ended per Protocol|1|||
131763478|NCT02573012|474408729|FG001|Overall Study|Study Ended per Protocol|0|||
131763479|NCT02573012|474408728|FG000|Overall Study|Physician Decision|1|||
131763480|NCT02573012|474408729|FG001|Overall Study|Physician Decision|2|||
131763481|NCT00882362|474408730|FG000|Overall Study|Adverse Event|13|||
131763482|NCT00882362|474408731|FG001|Overall Study|Adverse Event|10|||
131763483|NCT00882362|474408730|FG000|Overall Study|Withdrawal by Subject|13|||
131813530|NCT04590027|474600523|FG001|Overall Study|Lost to Follow-up|14|||
131813531|NCT04590027|474600522|FG000|Overall Study|Protocol Violation|0|||
131813532|NCT04590027|474600523|FG001|Overall Study|Protocol Violation|3|||
131813533|NCT03128723|474600526|FG000|Overall Study|Withdrawal by Subject|2|||
131763484|NCT00882362|474408731|FG001|Overall Study|Withdrawal by Subject|10|||
131763485|NCT00882362|474408730|FG000|Overall Study|Lack of Efficacy|3|||
131763486|NCT00882362|474408731|FG001|Overall Study|Lack of Efficacy|0|||
131763487|NCT00882362|474408730|FG000|Overall Study|Protocol Violation|7|||
131763488|NCT00882362|474408731|FG001|Overall Study|Protocol Violation|2|||
131763489|NCT00882362|474408730|FG000|Overall Study|Pregnancy|1|||
131763490|NCT00882362|474408731|FG001|Overall Study|Pregnancy|0|||
131763491|NCT00882362|474408730|FG000|Overall Study|Physician Decision|5|||
131763492|NCT00882362|474408731|FG001|Overall Study|Physician Decision|1|||
131763493|NCT00882362|474408730|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
131763494|NCT00882362|474408731|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
131399437|NCT02443116|473084056|FG006|Part 1|Withdrew informed consent|0|||
131399438|NCT02443116|473084057|FG007|Part 1|Withdrew informed consent|0|||
131399439|NCT02443116|473084058|FG008|Part 1|Withdrew informed consent|0|||
131763495|NCT00882362|474408730|FG000|Overall Study|change of residence or other commitments|5|||
131763496|NCT00882362|474408731|FG001|Overall Study|change of residence or other commitments|0|||
131763497|NCT01268514|474408732|FG000|Overall Study|Adverse Event|20|||
131763498|NCT01268514|474408732|FG000|Overall Study|Death|8|||
131763499|NCT01268514|474408732|FG000|Overall Study|Lost to Follow-up|5|||
131763500|NCT01268514|474408732|FG000|Overall Study|Withdrawal by Subject|3|||
131763501|NCT01268514|474408732|FG000|Overall Study|Withdrawal by Surgeon|5|||
131763502|NCT01846208|474408733|FG000|Overall Study|Withdrew prior to treatment|1|||
131763503|NCT01846208|474408734|FG001|Overall Study|Withdrew prior to treatment|1|||
131763504|NCT01846208|474408735|FG002|Overall Study|Withdrew prior to treatment|1|||
131763505|NCT01846208|474408733|FG000|Overall Study|Dosing Symptoms|1|||
131763506|NCT01846208|474408734|FG001|Overall Study|Dosing Symptoms|2|||
131763507|NCT01846208|474408735|FG002|Overall Study|Dosing Symptoms|6|||
131763508|NCT01846208|474408733|FG000|Overall Study|Withdrawal by Subject|5|||
131763509|NCT01846208|474408734|FG001|Overall Study|Withdrawal by Subject|0|||
131763510|NCT01846208|474408735|FG002|Overall Study|Withdrawal by Subject|0|||
131763511|NCT01846208|474408733|FG000|Overall Study|Non-compliance|1|||
131763512|NCT01846208|474408734|FG001|Overall Study|Non-compliance|1|||
131763513|NCT01846208|474408735|FG002|Overall Study|Non-compliance|0|||
131763514|NCT01846208|474408733|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
131763515|NCT01846208|474408734|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
131763516|NCT01846208|474408735|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
131763517|NCT01846208|474408733|FG000|Overall Study|Refused SU OFC|0|||
131763518|NCT01846208|474408734|FG001|Overall Study|Refused SU OFC|0|||
131763519|NCT01846208|474408735|FG002|Overall Study|Refused SU OFC|1|||
131763520|NCT01424306|474408736|FG000|Overall Study|Protocol Violation|0|||
131763521|NCT01424306|474408737|FG001|Overall Study|Protocol Violation|0|||
131763522|NCT01424306|474408738|FG002|Overall Study|Protocol Violation|0|||
131763523|NCT01424306|474408739|FG003|Overall Study|Protocol Violation|0|||
131763524|NCT01424306|474408740|FG004|Overall Study|Protocol Violation|1|||
131763525|NCT01424306|474408741|FG005|Overall Study|Protocol Violation|0|||
131763526|NCT00590031|474408747|FG000|Overall Study|Adverse Event|3|||
131763527|NCT00590031|474408747|FG000|Overall Study|Withdrawal by Subject|1|||
131763528|NCT00590031|474408747|FG000|Overall Study|Metastatic Disease|1|||
131763529|NCT00590031|474408747|FG000|Overall Study|Admin Hold|1|||
131763530|NCT01875874|474408748|FG000|Overall Study|Death|3|||
131763531|NCT03344562|474408751|FG000|Overall Study|Withdrawal by Subject|2|||
131763532|NCT03344562|474408752|FG001|Overall Study|Withdrawal by Subject|0|||
131763533|NCT01166386|474408770|FG000|Overall Study|Withdrawal by Subject|3|||
131763534|NCT01166386|474408771|FG001|Overall Study|Withdrawal by Subject|5|||
131763535|NCT02178592|474408772|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
131763536|NCT02178592|474408773|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
131763537|NCT02178592|474408772|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
131763538|NCT02178592|474408773|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
131449829|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
131763539|NCT02178592|474408772|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
131399440|NCT02443116|473084050|FG000|Part 1|Lost to Follow-up|0|||
131399441|NCT02443116|473084051|FG001|Part 1|Lost to Follow-up|0|||
131399442|NCT02443116|473084052|FG002|Part 1|Lost to Follow-up|2|||
131399443|NCT02443116|473084053|FG003|Part 1|Lost to Follow-up|0|||
131399444|NCT02443116|473084054|FG004|Part 1|Lost to Follow-up|0|||
131399445|NCT02443116|473084055|FG005|Part 1|Lost to Follow-up|0|||
131399446|NCT02443116|473084056|FG006|Part 1|Lost to Follow-up|0|||
131399447|NCT02443116|473084057|FG007|Part 1|Lost to Follow-up|0|||
131399448|NCT02443116|473084058|FG008|Part 1|Lost to Follow-up|0|||
131399449|NCT02443116|473084050|FG000|Part 1|Participant moved out of state|0|||
131399450|NCT02443116|473084051|FG001|Part 1|Participant moved out of state|0|||
131399451|NCT02443116|473084052|FG002|Part 1|Participant moved out of state|1|||
131399452|NCT02443116|473084053|FG003|Part 1|Participant moved out of state|0|||
131399453|NCT02443116|473084054|FG004|Part 1|Participant moved out of state|0|||
131763540|NCT02178592|474408773|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
131763541|NCT02178592|474408772|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
131813534|NCT02075463|474600529|FG000|Overall Study|Adverse Event|3|||
131399454|NCT02443116|473084055|FG005|Part 1|Participant moved out of state|0|||
131399455|NCT02443116|473084056|FG006|Part 1|Participant moved out of state|0|||
131399456|NCT02443116|473084057|FG007|Part 1|Participant moved out of state|0|||
131399457|NCT02443116|473084058|FG008|Part 1|Participant moved out of state|0|||
131399458|NCT02443116|473084050|FG000|Part 1|Participant enrolled in another clinical trial|0|||
131399459|NCT02443116|473084051|FG001|Part 1|Participant enrolled in another clinical trial|0|||
131399460|NCT02443116|473084052|FG002|Part 1|Participant enrolled in another clinical trial|1|||
131399461|NCT02443116|473084053|FG003|Part 1|Participant enrolled in another clinical trial|0|||
131399462|NCT02443116|473084054|FG004|Part 1|Participant enrolled in another clinical trial|0|||
131399463|NCT02443116|473084055|FG005|Part 1|Participant enrolled in another clinical trial|0|||
131399464|NCT02443116|473084056|FG006|Part 1|Participant enrolled in another clinical trial|0|||
131399465|NCT02443116|473084057|FG007|Part 1|Participant enrolled in another clinical trial|0|||
131399466|NCT02443116|473084058|FG008|Part 1|Participant enrolled in another clinical trial|0|||
131399467|NCT02443116|473084050|FG000|Part 2|Adverse Event|0|||
131399468|NCT02443116|473084051|FG001|Part 2|Adverse Event|0|||
131399469|NCT02443116|473084052|FG002|Part 2|Adverse Event|0|||
131399470|NCT02443116|473084053|FG003|Part 2|Adverse Event|0|||
131399471|NCT02443116|473084054|FG004|Part 2|Adverse Event|1|||
131399472|NCT02443116|473084055|FG005|Part 2|Adverse Event|1|||
131399473|NCT02443116|473084056|FG006|Part 2|Adverse Event|2|||
131399474|NCT02443116|473084057|FG007|Part 2|Adverse Event|0|||
131399475|NCT02443116|473084058|FG008|Part 2|Adverse Event|0|||
131399476|NCT02443116|473084050|FG000|Part 2|Withdrew informed consent|0|||
131399477|NCT02443116|473084051|FG001|Part 2|Withdrew informed consent|0|||
131399478|NCT02443116|473084052|FG002|Part 2|Withdrew informed consent|0|||
131399479|NCT02443116|473084053|FG003|Part 2|Withdrew informed consent|0|||
131399480|NCT02443116|473084054|FG004|Part 2|Withdrew informed consent|0|||
131399481|NCT02443116|473084055|FG005|Part 2|Withdrew informed consent|1|||
131399482|NCT02443116|473084056|FG006|Part 2|Withdrew informed consent|1|||
131399483|NCT02443116|473084057|FG007|Part 2|Withdrew informed consent|0|||
131399484|NCT02443116|473084058|FG008|Part 2|Withdrew informed consent|0|||
131763542|NCT02178592|474408773|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
131763543|NCT02178592|474408772|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
131763544|NCT02178592|474408773|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
131763545|NCT02178592|474408772|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
131763546|NCT02178592|474408773|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
131763547|NCT02178592|474408772|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
131763548|NCT02178592|474408773|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
131763549|NCT02178592|474408772|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
131399485|NCT02443116|473084050|FG000|Part 2|Inability to comply with protocol|0|||
131399486|NCT02443116|473084051|FG001|Part 2|Inability to comply with protocol|0|||
131399487|NCT02443116|473084052|FG002|Part 2|Inability to comply with protocol|0|||
131399488|NCT02443116|473084053|FG003|Part 2|Inability to comply with protocol|1|||
131399489|NCT02443116|473084054|FG004|Part 2|Inability to comply with protocol|0|||
131399490|NCT02443116|473084055|FG005|Part 2|Inability to comply with protocol|0|||
131399491|NCT02443116|473084056|FG006|Part 2|Inability to comply with protocol|0|||
131399492|NCT02443116|473084057|FG007|Part 2|Inability to comply with protocol|0|||
131399493|NCT02443116|473084058|FG008|Part 2|Inability to comply with protocol|0|||
131399494|NCT02443116|473084050|FG000|Part 2|Lost to Follow-up|0|||
131399495|NCT02443116|473084051|FG001|Part 2|Lost to Follow-up|0|||
131399496|NCT02443116|473084052|FG002|Part 2|Lost to Follow-up|0|||
131399497|NCT02443116|473084053|FG003|Part 2|Lost to Follow-up|1|||
131399498|NCT02443116|473084054|FG004|Part 2|Lost to Follow-up|0|||
131399499|NCT02443116|473084055|FG005|Part 2|Lost to Follow-up|0|||
131399500|NCT02443116|473084056|FG006|Part 2|Lost to Follow-up|0|||
131399501|NCT02443116|473084057|FG007|Part 2|Lost to Follow-up|0|||
131399502|NCT02443116|473084058|FG008|Part 2|Lost to Follow-up|0|||
131399503|NCT02443116|473084050|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131399504|NCT02443116|473084051|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131399505|NCT02443116|473084052|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131399506|NCT02443116|473084053|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131909460|NCT01692119|474956761|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
131909461|NCT00997893|474956762|FG000|Overall Study|Adverse Event|1|||
131909462|NCT00997893|474956763|FG001|Overall Study|Adverse Event|0|||
131909463|NCT00997893|474956764|FG002|Overall Study|Adverse Event|0|||
131399507|NCT02443116|473084054|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131909464|NCT00997893|474956762|FG000|Overall Study|Unable to meet study timelines|1|||
131909465|NCT00997893|474956763|FG001|Overall Study|Unable to meet study timelines|0|||
131909466|NCT00997893|474956764|FG002|Overall Study|Unable to meet study timelines|0|||
131399508|NCT02443116|473084055|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
131399509|NCT02443116|473084056|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131399510|NCT02443116|473084057|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131909467|NCT00997893|474956762|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
131909468|NCT00997893|474956763|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
131909469|NCT00997893|474956764|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
131909470|NCT03451045|474956775|FG000|Overall Study|Lack of Efficacy|3|||
131909471|NCT03451045|474956776|FG001|Overall Study|Lack of Efficacy|2|||
131909472|NCT03451045|474956777|FG002|Overall Study|Lack of Efficacy|2|||
131909473|NCT03451045|474956775|FG000|Overall Study|Physician Decision|1|||
131399511|NCT02443116|473084058|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
131399512|NCT02443116|473084050|FG000|Part 3|Adverse Event|0|||
131399513|NCT02443116|473084051|FG001|Part 3|Adverse Event|0|||
131399514|NCT02443116|473084052|FG002|Part 3|Adverse Event|0|||
131399515|NCT02443116|473084053|FG003|Part 3|Adverse Event|0|||
131399516|NCT02443116|473084054|FG004|Part 3|Adverse Event|0|||
131399517|NCT02443116|473084055|FG005|Part 3|Adverse Event|0|||
131399518|NCT02443116|473084056|FG006|Part 3|Adverse Event|0|||
131399519|NCT02443116|473084057|FG007|Part 3|Adverse Event|0|||
131399520|NCT02443116|473084058|FG008|Part 3|Adverse Event|1|||
131399521|NCT02443116|473084050|FG000|Part 3|Withdrew informed consent|0|||
131399522|NCT02443116|473084051|FG001|Part 3|Withdrew informed consent|0|||
131399523|NCT02443116|473084052|FG002|Part 3|Withdrew informed consent|0|||
131399524|NCT02443116|473084053|FG003|Part 3|Withdrew informed consent|0|||
131399525|NCT02443116|473084054|FG004|Part 3|Withdrew informed consent|0|||
131399526|NCT02443116|473084055|FG005|Part 3|Withdrew informed consent|0|||
131399527|NCT02443116|473084056|FG006|Part 3|Withdrew informed consent|0|||
131763550|NCT02178592|474408773|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
131763551|NCT02178592|474408772|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
131763552|NCT02178592|474408773|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
131763553|NCT02178592|474408772|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
131763554|NCT02178592|474408773|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
131763555|NCT02178592|474408772|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
131763556|NCT02178592|474408773|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
131763557|NCT02178592|474408772|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
131763558|NCT02178592|474408773|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
131763559|NCT03053180|474410869|FG000|Overall Study|Failure to Return|1|||
131763560|NCT04144140|474410872|FG000|Overall Study|Other|0|||
131763561|NCT04144140|474410873|FG001|Overall Study|Other|0|||
131399528|NCT02443116|473084057|FG007|Part 3|Withdrew informed consent|3|||
131399529|NCT02443116|473084058|FG008|Part 3|Withdrew informed consent|2|||
131909474|NCT03451045|474956776|FG001|Overall Study|Physician Decision|1|||
131909475|NCT03451045|474956777|FG002|Overall Study|Physician Decision|1|||
131909476|NCT03451045|474956775|FG000|Overall Study|Withdrawal by Subject|4|||
131909477|NCT03451045|474956776|FG001|Overall Study|Withdrawal by Subject|0|||
131909478|NCT03451045|474956777|FG002|Overall Study|Withdrawal by Subject|5|||
131909479|NCT03451045|474956775|FG000|Overall Study|Pregnancy|0|||
131909480|NCT03451045|474956776|FG001|Overall Study|Pregnancy|0|||
131909481|NCT03451045|474956777|FG002|Overall Study|Pregnancy|2|||
131909482|NCT03451045|474956775|FG000|Overall Study|Adverse Event|7|||
131909483|NCT03451045|474956776|FG001|Overall Study|Adverse Event|1|||
131909484|NCT03451045|474956777|FG002|Overall Study|Adverse Event|3|||
131909485|NCT03451045|474956775|FG000|Overall Study|Non-compliance with study|2|||
131399530|NCT02443116|473084050|FG000|Part 3|Lost to Follow-up|0|||
131399531|NCT02443116|473084051|FG001|Part 3|Lost to Follow-up|0|||
131399532|NCT02443116|473084052|FG002|Part 3|Lost to Follow-up|0|||
131399533|NCT02443116|473084053|FG003|Part 3|Lost to Follow-up|0|||
131399534|NCT02443116|473084054|FG004|Part 3|Lost to Follow-up|0|||
131399535|NCT02443116|473084055|FG005|Part 3|Lost to Follow-up|0|||
131399536|NCT02443116|473084056|FG006|Part 3|Lost to Follow-up|0|||
131399537|NCT02443116|473084057|FG007|Part 3|Lost to Follow-up|1|||
131399538|NCT02443116|473084058|FG008|Part 3|Lost to Follow-up|2|||
131399539|NCT02016716|473084063|FG000|Overall Study|Withdrawal by Subject|5|||
131399540|NCT02016716|473084064|FG001|Overall Study|Withdrawal by Subject|5|||
131399541|NCT02016716|473084065|FG002|Overall Study|Withdrawal by Subject|5|||
131399542|NCT02016716|473084063|FG000|Overall Study|Protocol-specified Criteria|0|||
131399543|NCT02016716|473084064|FG001|Overall Study|Protocol-specified Criteria|1|||
131399544|NCT02016716|473084065|FG002|Overall Study|Protocol-specified Criteria|0|||
131399545|NCT02016716|473084063|FG000|Overall Study|Lost to Follow-up|1|||
131909486|NCT03451045|474956776|FG001|Overall Study|Non-compliance with study|0|||
131763562|NCT04144140|474410874|FG002|Overall Study|Other|0|||
131763563|NCT04144140|474410875|FG003|Overall Study|Other|0|||
131763564|NCT04144140|474410876|FG004|Overall Study|Other|0|||
131763565|NCT04144140|474410877|FG005|Overall Study|Other|1|||
131909487|NCT03451045|474956777|FG002|Overall Study|Non-compliance with study|1|||
131909488|NCT03451045|474956775|FG000|Overall Study|any other reason|10|||
131909489|NCT03451045|474956776|FG001|Overall Study|any other reason|2|||
131909490|NCT03451045|474956777|FG002|Overall Study|any other reason|13|||
131399546|NCT02016716|473084064|FG001|Overall Study|Lost to Follow-up|2|||
131399547|NCT02016716|473084065|FG002|Overall Study|Lost to Follow-up|1|||
131399548|NCT02248649|473084066|FG000|Overall Study|Death|7|||
131399549|NCT02248649|473084067|FG001|Overall Study|Death|11|||
131763566|NCT04144140|474410878|FG006|Overall Study|Other|0|||
131763567|NCT01465958|474410879|FG000|Run-in Phase|Protocol Violation|1|||
131763568|NCT01465958|474410880|FG001|Run-in Phase|Protocol Violation|0|||
131399550|NCT02248649|473084066|FG000|Overall Study|Lost to Follow-up|14|||
131399551|NCT02248649|473084067|FG001|Overall Study|Lost to Follow-up|10|||
131399552|NCT01439971|473084068|FG000|Overall Study|Required number in cohort dosed|0|||
131399553|NCT01439971|473084069|FG001|Overall Study|Required number in cohort dosed|1|||
131399554|NCT01439971|473084070|FG002|Overall Study|Required number in cohort dosed|2|||
131399555|NCT01439971|473084071|FG003|Overall Study|Required number in cohort dosed|0|||
131399556|NCT01439971|473084072|FG004|Overall Study|Required number in cohort dosed|1|||
131399557|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
131399558|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
131399559|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
131399560|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
131399561|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
131399562|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
131399563|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
131399564|NCT01673854|473084077|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
131399565|NCT01673854|473084077|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
131399566|NCT01673854|473084077|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
131399567|NCT01673854|473084077|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
131399568|NCT01673854|473084077|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
131399569|NCT00830375|473084081|FG000|Overall Study|Lost to Follow-up|1|||
131399570|NCT01700959|473084082|FG000|Overall Study|Adverse Event|0|||
131399571|NCT01700959|473084083|FG001|Overall Study|Adverse Event|1|||
131399572|NCT01700959|473084084|FG002|Overall Study|Adverse Event|1|||
131399573|NCT01700959|473084085|FG003|Overall Study|Adverse Event|2|||
131399574|NCT01700959|473084086|FG004|Overall Study|Adverse Event|0|||
131399575|NCT01700959|473084087|FG005|Overall Study|Adverse Event|2|||
131399576|NCT01700959|473084082|FG000|Overall Study|Withdrawal by Subject|15|||
131399577|NCT01700959|473084083|FG001|Overall Study|Withdrawal by Subject|9|||
131399578|NCT01700959|473084084|FG002|Overall Study|Withdrawal by Subject|12|||
131399579|NCT01700959|473084085|FG003|Overall Study|Withdrawal by Subject|11|||
131399580|NCT01700959|473084086|FG004|Overall Study|Withdrawal by Subject|8|||
131399581|NCT01700959|473084087|FG005|Overall Study|Withdrawal by Subject|12|||
131399582|NCT01700959|473084082|FG000|Overall Study|Ineligible|2|||
131399583|NCT01700959|473084083|FG001|Overall Study|Ineligible|1|||
131399584|NCT01700959|473084084|FG002|Overall Study|Ineligible|2|||
131399585|NCT01700959|473084085|FG003|Overall Study|Ineligible|0|||
131399586|NCT01700959|473084086|FG004|Overall Study|Ineligible|0|||
131399587|NCT01700959|473084087|FG005|Overall Study|Ineligible|1|||
131399588|NCT01700959|473084082|FG000|Overall Study|Noncompliant|9|||
131399589|NCT01700959|473084083|FG001|Overall Study|Noncompliant|9|||
131399590|NCT01700959|473084084|FG002|Overall Study|Noncompliant|17|||
131399591|NCT01700959|473084085|FG003|Overall Study|Noncompliant|18|||
131399592|NCT01700959|473084086|FG004|Overall Study|Noncompliant|15|||
131399593|NCT01700959|473084087|FG005|Overall Study|Noncompliant|9|||
131399594|NCT01700959|473084082|FG000|Overall Study|Side effects|1|||
131399595|NCT01700959|473084083|FG001|Overall Study|Side effects|4|||
131399596|NCT01700959|473084084|FG002|Overall Study|Side effects|8|||
131399597|NCT01700959|473084085|FG003|Overall Study|Side effects|4|||
131399598|NCT01700959|473084086|FG004|Overall Study|Side effects|4|||
131399599|NCT01700959|473084087|FG005|Overall Study|Side effects|1|||
131399600|NCT00875485|473085906|FG000|Challenge Dose Epoch|Pregnancy|1|||
131399601|NCT00875485|473085907|FG001|Challenge Dose Epoch|Pregnancy|0|||
131399602|NCT01271010|473085908|FG000|Overall Study|Reason not specified|11|||
131763569|NCT01465958|474410879|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
131763570|NCT01465958|474410880|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
131909491|NCT00863707|474956778|FG000|Overall Study|Randomized, but drug not received|4|||
131399603|NCT01271010|473085908|FG000|Overall Study|Start of new CLL therapy|1|||
131399604|NCT01271010|473085908|FG000|Overall Study|Protocol Violation|1|||
131763571|NCT02972658|474410881|FG000|Overall Study|Adverse Event|0|||
131763572|NCT02972658|474410882|FG001|Overall Study|Adverse Event|3|||
131763573|NCT02972658|474410883|FG002|Overall Study|Adverse Event|0|||
131763574|NCT02972658|474410884|FG003|Overall Study|Adverse Event|2|||
131399605|NCT01271010|473085908|FG000|Overall Study|Death|2|||
131909492|NCT00863707|474956779|FG001|Overall Study|Randomized, but drug not received|3|||
131399606|NCT01271010|473085908|FG000|Overall Study|Progression and relapse of disease|1|||
131399607|NCT01271010|473085908|FG000|Overall Study|Withdrawal by Subject|18|||
131399608|NCT01271010|473085908|FG000|Overall Study|Disease progression|27|||
131399609|NCT01631747|473085909|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
131399610|NCT01631747|473085910|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
131399611|NCT01631747|473085909|FG000|Live Birth|Pregnancy Termination|1|||
131399612|NCT01631747|473085910|FG001|Live Birth|Pregnancy Termination|0|||
131399613|NCT01631747|473085909|FG000|Live Birth|MIscarriage|2|||
131399614|NCT01631747|473085910|FG001|Live Birth|MIscarriage|0|||
131399615|NCT01631747|473085909|FG000|Live Birth|Stillbirth|1|||
131763575|NCT02972658|474410881|FG000|Overall Study|Other-determined by Investigator|1|||
131763576|NCT02972658|474410882|FG001|Overall Study|Other-determined by Investigator|1|||
131399616|NCT01631747|473085910|FG001|Live Birth|Stillbirth|1|||
131399617|NCT01631747|473085909|FG000|One Year Infant Outcomes|Patient Refused|13|||
131399618|NCT01631747|473085910|FG001|One Year Infant Outcomes|Patient Refused|9|||
131399619|NCT03100539|473085918|FG000|Overall Study|Lost to Follow-up|60|||
131763577|NCT02972658|474410883|FG002|Overall Study|Other-determined by Investigator|0|||
131763578|NCT02972658|474410884|FG003|Overall Study|Other-determined by Investigator|0|||
131763579|NCT02972658|474410881|FG000|Overall Study|Death|0|||
131763580|NCT02972658|474410882|FG001|Overall Study|Death|0|||
131763581|NCT02972658|474410883|FG002|Overall Study|Death|0|||
131763582|NCT02972658|474410884|FG003|Overall Study|Death|1|||
131763583|NCT02972658|474410881|FG000|Overall Study|Lost to Follow-up|0|||
131763584|NCT02972658|474410882|FG001|Overall Study|Lost to Follow-up|1|||
131763585|NCT02972658|474410883|FG002|Overall Study|Lost to Follow-up|1|||
131763586|NCT02972658|474410884|FG003|Overall Study|Lost to Follow-up|2|||
131763587|NCT02972658|474410881|FG000|Overall Study|Progressive Disease|0|||
131763588|NCT02972658|474410882|FG001|Overall Study|Progressive Disease|1|||
131449830|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
131449831|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
131449832|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
131763589|NCT02972658|474410883|FG002|Overall Study|Progressive Disease|0|||
131763590|NCT02972658|474410884|FG003|Overall Study|Progressive Disease|1|||
131763591|NCT02972658|474410881|FG000|Overall Study|Withdrawal by Subject|4|||
131763592|NCT02972658|474410882|FG001|Overall Study|Withdrawal by Subject|4|||
131763593|NCT02972658|474410883|FG002|Overall Study|Withdrawal by Subject|1|||
131763594|NCT02972658|474410884|FG003|Overall Study|Withdrawal by Subject|6|||
131763595|NCT02972658|474410881|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
131763596|NCT02972658|474410882|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
131763597|NCT02972658|474410883|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
131763598|NCT02972658|474410884|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
131763599|NCT02972658|474410881|FG000|Overall Study|Sponsor Decision|70|||
131763600|NCT02972658|474410882|FG001|Overall Study|Sponsor Decision|127|||
131763601|NCT02972658|474410883|FG002|Overall Study|Sponsor Decision|72|||
131763602|NCT02972658|474410884|FG003|Overall Study|Sponsor Decision|119|||
131763603|NCT03958149|474410885|FG000|Overall Study|Withdrawal by Subject|0|||
131763604|NCT03958149|474410886|FG001|Overall Study|Withdrawal by Subject|1|||
131763605|NCT02785588|474410887|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
131763606|NCT02785588|474410887|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
131763607|NCT02583399|474410889|FG000|Overall Study|Able to be discharged|3|||
131763608|NCT02583399|474410889|FG000|Overall Study|Wanted to use a restricted medication|3|||
131763609|NCT00364611|474410890|FG000|Overall Study|Did not receive study medication|0|||
131763610|NCT00364611|474410891|FG001|Overall Study|Did not receive study medication|1|||
131763611|NCT00364611|474410890|FG000|Overall Study|Adverse Event|7|||
131763612|NCT00364611|474410891|FG001|Overall Study|Adverse Event|4|||
131763613|NCT00364611|474410890|FG000|Overall Study|Participant's Request|3|||
131763614|NCT00364611|474410891|FG001|Overall Study|Participant's Request|4|||
131763615|NCT00364611|474410890|FG000|Overall Study|Disease Progression|38|||
131763616|NCT00364611|474410891|FG001|Overall Study|Disease Progression|8|||
131763617|NCT00364611|474410890|FG000|Overall Study|Investigator decision|2|||
131763618|NCT00364611|474410891|FG001|Overall Study|Investigator decision|2|||
131763619|NCT00364611|474410890|FG000|Overall Study|Found Ineligible|1|||
131399620|NCT03100539|473085919|FG001|Overall Study|Lost to Follow-up|54|||
131399621|NCT03100539|473085920|FG002|Overall Study|Lost to Follow-up|17|||
131399622|NCT03100539|473085918|FG000|Overall Study|Uncollected|8|||
131399623|NCT03100539|473085919|FG001|Overall Study|Uncollected|8|||
131399624|NCT03100539|473085920|FG002|Overall Study|Uncollected|0|||
131399625|NCT03100539|473085918|FG000|Overall Study|Ally Health|0|||
131763620|NCT00364611|474410891|FG001|Overall Study|Found Ineligible|0|||
131763621|NCT00364611|474410890|FG000|Overall Study|Presumed CR on Study|0|||
131763622|NCT00364611|474410891|FG001|Overall Study|Presumed CR on Study|1|||
131763623|NCT00364611|474410890|FG000|Overall Study|Receiving Liver Ablation|0|||
131763624|NCT00364611|474410891|FG001|Overall Study|Receiving Liver Ablation|1|||
131763625|NCT02759939|474410896|FG000|Overall Study|Missing data on first outcome assessed|11|||
131763626|NCT02759939|474410897|FG001|Overall Study|Missing data on first outcome assessed|2|||
131763627|NCT02759939|474410898|FG002|Overall Study|Missing data on first outcome assessed|5|||
131763628|NCT02759939|474410899|FG003|Overall Study|Missing data on first outcome assessed|2|||
131763629|NCT02759939|474410896|FG000|Overall Study|Ineligible for T2 and T3|310|||
131763630|NCT02759939|474410897|FG001|Overall Study|Ineligible for T2 and T3|179|||
131763631|NCT02759939|474410898|FG002|Overall Study|Ineligible for T2 and T3|366|||
131763632|NCT02759939|474410899|FG003|Overall Study|Ineligible for T2 and T3|391|||
131399626|NCT03100539|473085919|FG001|Overall Study|Ally Health|0|||
131763633|NCT02759939|474410896|FG000|Overall Study|Lost to Follow-up|735|||
131763634|NCT02759939|474410897|FG001|Overall Study|Lost to Follow-up|791|||
131763635|NCT02759939|474410898|FG002|Overall Study|Lost to Follow-up|783|||
131763636|NCT02759939|474410899|FG003|Overall Study|Lost to Follow-up|650|||
131763637|NCT04397757|474410901|FG000|Overall Study|Death|3|||
131763638|NCT04397757|474410902|FG001|Overall Study|Death|11|||
131763639|NCT04397757|474410901|FG000|Overall Study|Withdrawal by Subject|2|||
131763640|NCT04397757|474410902|FG001|Overall Study|Withdrawal by Subject|0|||
131763641|NCT04397757|474410901|FG000|Overall Study|Lost to Follow-up|4|||
131763642|NCT04397757|474410902|FG001|Overall Study|Lost to Follow-up|3|||
131763643|NCT00768040|474410903|FG000|Overall Study|Adverse Event|3|||
131763644|NCT00768040|474410904|FG001|Overall Study|Adverse Event|2|||
131763645|NCT00768040|474410903|FG000|Overall Study|Abnormal laboratory value|1|||
131763646|NCT00768040|474410904|FG001|Overall Study|Abnormal laboratory value|1|||
131763647|NCT03557801|474410905|FG000|Overall Study|Protocol Violation|1|||
131763648|NCT03557801|474410906|FG001|Overall Study|Protocol Violation|0|||
131763649|NCT03557801|474410907|FG002|Overall Study|Protocol Violation|0|||
131763650|NCT03557801|474410905|FG000|Overall Study|Withdrawal by Subject|1|||
131763651|NCT03557801|474410906|FG001|Overall Study|Withdrawal by Subject|0|||
131763652|NCT03557801|474410907|FG002|Overall Study|Withdrawal by Subject|3|||
131763653|NCT03557801|474410905|FG000|Overall Study|Lost to Follow-up|0|||
131763654|NCT03557801|474410906|FG001|Overall Study|Lost to Follow-up|1|||
131763655|NCT03557801|474410907|FG002|Overall Study|Lost to Follow-up|0|||
131763656|NCT00141297|474410908|FG000|Overall Study|Adverse Event|0|||
131813535|NCT02075463|474600529|FG000|Overall Study|Par. reached stopping criteria|4|||
131813536|NCT02075463|474600529|FG000|Overall Study|Withdrawal by Subject|1|||
131813537|NCT00673660|474600530|FG000|Overall Study|Lost to Follow-up|107|||
131813538|NCT00824291|474600531|FG000|Overall Study|Adverse Event|15|||
131813539|NCT00824291|474600532|FG001|Overall Study|Adverse Event|6|||
131813540|NCT00824291|474600531|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
131813541|NCT00824291|474600532|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
131813542|NCT00824291|474600531|FG000|Overall Study|Lost to Follow-up|11|||
131813543|NCT00824291|474600532|FG001|Overall Study|Lost to Follow-up|9|||
131813544|NCT00824291|474600531|FG000|Overall Study|Non-compliance|1|||
131813545|NCT00824291|474600532|FG001|Overall Study|Non-compliance|1|||
131813546|NCT00824291|474600531|FG000|Overall Study|Protocol Violation|4|||
131813547|NCT00824291|474600532|FG001|Overall Study|Protocol Violation|1|||
131813548|NCT00824291|474600531|FG000|Overall Study|Withdrawal by Subject|14|||
131813549|NCT00824291|474600532|FG001|Overall Study|Withdrawal by Subject|8|||
131813550|NCT00824291|474600531|FG000|Overall Study|Lack of Efficacy|7|||
131813551|NCT00824291|474600532|FG001|Overall Study|Lack of Efficacy|8|||
131813552|NCT00824291|474600531|FG000|Overall Study|Participant on prohibited medication|1|||
131813553|NCT00824291|474600532|FG001|Overall Study|Participant on prohibited medication|0|||
131813554|NCT00933686|474600533|FG000|Overall Study|Protocol Violation|0|||
131813555|NCT00933686|474600534|FG001|Overall Study|Protocol Violation|1|||
131813556|NCT00933686|474600533|FG000|Overall Study|Lost to Follow-up|2|||
131813557|NCT00933686|474600534|FG001|Overall Study|Lost to Follow-up|2|||
131813558|NCT00933686|474600533|FG000|Overall Study|Withdrawal by Subject|6|||
131813559|NCT00933686|474600534|FG001|Overall Study|Withdrawal by Subject|5|||
131813560|NCT00933686|474600533|FG000|Overall Study|Adverse Event|1|||
131813561|NCT00933686|474600534|FG001|Overall Study|Adverse Event|1|||
131813562|NCT00933686|474600533|FG000|Overall Study|Physician Decision|1|||
131813563|NCT00933686|474600534|FG001|Overall Study|Physician Decision|0|||
131813564|NCT00933686|474600533|FG000|Overall Study|Failure to show up at endpoint visits|0|||
131813565|NCT00933686|474600534|FG001|Overall Study|Failure to show up at endpoint visits|2|||
131813566|NCT01383486|474600535|FG000|Overall Study|Lost to Follow-up|10|||
131813567|NCT01383486|474600535|FG000|Overall Study|Incomplete information for analysis|2|||
131813568|NCT01383486|474600535|FG000|Overall Study|Did not take any product|6|||
131813569|NCT00245063|474600536|FG000|Overall Study|Adverse Event|6|||
131813570|NCT00245063|474600537|FG001|Overall Study|Adverse Event|5|||
131813571|NCT00245063|474600536|FG000|Overall Study|Death|1|||
131813572|NCT00245063|474600537|FG001|Overall Study|Death|0|||
131813573|NCT05099380|474600539|FG000|Overall Study|Subject enrolled in error|1|||
131813574|NCT05099380|474600540|FG001|Overall Study|Subject enrolled in error|0|||
131813575|NCT05099380|474600539|FG000|Overall Study|Study Procedure|1|||
131813576|NCT05099380|474600540|FG001|Overall Study|Study Procedure|0|||
131763657|NCT00141297|474410909|FG001|Overall Study|Adverse Event|0|||
131763658|NCT00141297|474410910|FG002|Overall Study|Adverse Event|1|||
131763659|NCT00141297|474410911|FG003|Overall Study|Adverse Event|0|||
131813577|NCT05099380|474600539|FG000|Overall Study|Protocol Violation|1|||
131813578|NCT05099380|474600540|FG001|Overall Study|Protocol Violation|0|||
131813579|NCT05099380|474600539|FG000|Overall Study|Adverse Event|1|||
131813580|NCT05099380|474600540|FG001|Overall Study|Adverse Event|1|||
131763660|NCT00141297|474410912|FG004|Overall Study|Adverse Event|1|||
131763661|NCT00141297|474410913|FG005|Overall Study|Adverse Event|1|||
131763662|NCT00141297|474410914|FG006|Overall Study|Adverse Event|0|||
131763663|NCT00141297|474410915|FG007|Overall Study|Adverse Event|1|||
131763664|NCT00141297|474410916|FG008|Overall Study|Adverse Event|1|||
131813581|NCT05099380|474600539|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
131813582|NCT05099380|474600540|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
131763665|NCT00141297|474410917|FG009|Overall Study|Adverse Event|0|||
131763666|NCT00141297|474410908|FG000|Overall Study|Death|1|||
131763667|NCT00141297|474410909|FG001|Overall Study|Death|0|||
131763668|NCT00141297|474410910|FG002|Overall Study|Death|0|||
131763669|NCT00141297|474410911|FG003|Overall Study|Death|0|||
131763670|NCT00141297|474410912|FG004|Overall Study|Death|0|||
131763671|NCT00141297|474410913|FG005|Overall Study|Death|0|||
131763672|NCT00141297|474410914|FG006|Overall Study|Death|0|||
131763673|NCT00141297|474410915|FG007|Overall Study|Death|0|||
131763674|NCT00141297|474410916|FG008|Overall Study|Death|1|||
131763675|NCT00141297|474410917|FG009|Overall Study|Death|0|||
131763676|NCT00141297|474410908|FG000|Overall Study|Withdrawal by Subject|0|||
131763677|NCT00141297|474410909|FG001|Overall Study|Withdrawal by Subject|0|||
131763678|NCT00141297|474410910|FG002|Overall Study|Withdrawal by Subject|0|||
131763679|NCT00141297|474410911|FG003|Overall Study|Withdrawal by Subject|0|||
131763680|NCT00141297|474410912|FG004|Overall Study|Withdrawal by Subject|0|||
131763681|NCT00141297|474410913|FG005|Overall Study|Withdrawal by Subject|0|||
131763682|NCT00141297|474410914|FG006|Overall Study|Withdrawal by Subject|0|||
131763683|NCT00141297|474410915|FG007|Overall Study|Withdrawal by Subject|0|||
131763684|NCT00141297|474410916|FG008|Overall Study|Withdrawal by Subject|1|||
131763685|NCT00141297|474410917|FG009|Overall Study|Withdrawal by Subject|0|||
131763686|NCT00141297|474410908|FG000|Overall Study|Other|0|||
131763687|NCT00141297|474410909|FG001|Overall Study|Other|0|||
131763688|NCT00141297|474410910|FG002|Overall Study|Other|0|||
131763689|NCT00141297|474410911|FG003|Overall Study|Other|1|||
131763690|NCT00141297|474410912|FG004|Overall Study|Other|5|||
131763691|NCT00141297|474410913|FG005|Overall Study|Other|0|||
131399627|NCT03100539|473085920|FG002|Overall Study|Ally Health|3|||
131399628|NCT03100539|473085918|FG000|Overall Study|Disinterest|0|||
131763692|NCT00141297|474410914|FG006|Overall Study|Other|0|||
131763693|NCT00141297|474410915|FG007|Overall Study|Other|0|||
131763694|NCT00141297|474410916|FG008|Overall Study|Other|2|||
131813583|NCT01839279|474600541|FG000|Overall Study|Adverse Event|4|||
131813584|NCT01839279|474600542|FG001|Overall Study|Adverse Event|1|||
131813585|NCT01839279|474600543|FG002|Overall Study|Adverse Event|1|||
131813586|NCT01839279|474600541|FG000|Overall Study|Withdrawal by Subject|4|||
131813587|NCT01839279|474600542|FG001|Overall Study|Withdrawal by Subject|1|||
131813588|NCT01839279|474600543|FG002|Overall Study|Withdrawal by Subject|1|||
131813589|NCT01839279|474600541|FG000|Overall Study|Classified as 'Other'|5|||
131813590|NCT01839279|474600542|FG001|Overall Study|Classified as 'Other'|0|||
131813591|NCT01839279|474600543|FG002|Overall Study|Classified as 'Other'|0|||
131813592|NCT00395694|474600546|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
131813593|NCT00395694|474600547|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
131813594|NCT00395694|474600546|FG000|Continuation Phase|Adverse Event|1|||
131813595|NCT00395694|474600547|FG001|Continuation Phase|Adverse Event|0|||
131813596|NCT00395694|474600546|FG000|Continuation Phase|Lack of Efficacy|12|||
131813597|NCT00395694|474600547|FG001|Continuation Phase|Lack of Efficacy|11|||
131813598|NCT00395694|474600546|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
131813599|NCT00395694|474600547|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
131813600|NCT00395694|474600546|FG000|Continuation Phase|Poor Compliance|1|||
131813601|NCT00395694|474600547|FG001|Continuation Phase|Poor Compliance|0|||
131813602|NCT00395694|474600546|FG000|Continuation Phase|Withdrawal by Subject|0|||
131813603|NCT00395694|474600547|FG001|Continuation Phase|Withdrawal by Subject|2|||
131813604|NCT01648582|474600548|FG000|Overall Study|Adverse Event|6|||
131813605|NCT01648582|474600549|FG001|Overall Study|Adverse Event|11|||
131813606|NCT01648582|474600550|FG002|Overall Study|Adverse Event|2|||
131813607|NCT01648582|474600548|FG000|Overall Study|Lost to Follow-up|9|||
131813608|NCT01648582|474600549|FG001|Overall Study|Lost to Follow-up|6|||
131813609|NCT01648582|474600550|FG002|Overall Study|Lost to Follow-up|8|||
131813610|NCT01648582|474600548|FG000|Overall Study|Protocol Violation|1|||
131813611|NCT01648582|474600549|FG001|Overall Study|Protocol Violation|2|||
131813612|NCT01648582|474600550|FG002|Overall Study|Protocol Violation|1|||
131813613|NCT01648582|474600548|FG000|Overall Study|Withdrawal by Subject|15|||
131813614|NCT01648582|474600549|FG001|Overall Study|Withdrawal by Subject|17|||
131813615|NCT01648582|474600550|FG002|Overall Study|Withdrawal by Subject|17|||
131813616|NCT01648582|474600548|FG000|Overall Study|Physician Decision|0|||
131813617|NCT01648582|474600549|FG001|Overall Study|Physician Decision|1|||
131813618|NCT01648582|474600550|FG002|Overall Study|Physician Decision|3|||
131813619|NCT01648582|474600548|FG000|Overall Study|Death|1|||
131813620|NCT01648582|474600549|FG001|Overall Study|Death|0|||
131813621|NCT01648582|474600550|FG002|Overall Study|Death|0|||
131399629|NCT03100539|473085919|FG001|Overall Study|Disinterest|0|||
131763695|NCT00141297|474410917|FG009|Overall Study|Other|0|||
131763696|NCT00141297|474410908|FG000|Overall Study|Progressive Disease|2|||
131763697|NCT00141297|474410909|FG001|Overall Study|Progressive Disease|3|||
131763698|NCT00141297|474410910|FG002|Overall Study|Progressive Disease|6|||
131763699|NCT00141297|474410911|FG003|Overall Study|Progressive Disease|2|||
131763700|NCT00141297|474410912|FG004|Overall Study|Progressive Disease|15|||
131763701|NCT00141297|474410913|FG005|Overall Study|Progressive Disease|2|||
131763702|NCT00141297|474410914|FG006|Overall Study|Progressive Disease|3|||
131763703|NCT00141297|474410915|FG007|Overall Study|Progressive Disease|3|||
131763704|NCT00141297|474410916|FG008|Overall Study|Progressive Disease|15|||
131763705|NCT00141297|474410917|FG009|Overall Study|Progressive Disease|6|||
131763706|NCT00141297|474410908|FG000|Overall Study|Transitioned|0|||
131763707|NCT00141297|474410909|FG001|Overall Study|Transitioned|0|||
131763708|NCT00141297|474410910|FG002|Overall Study|Transitioned|0|||
131763709|NCT00141297|474410911|FG003|Overall Study|Transitioned|0|||
131763710|NCT00141297|474410912|FG004|Overall Study|Transitioned|1|||
131763711|NCT00141297|474410913|FG005|Overall Study|Transitioned|0|||
131763712|NCT00141297|474410914|FG006|Overall Study|Transitioned|0|||
131763713|NCT00141297|474410915|FG007|Overall Study|Transitioned|0|||
131763714|NCT00141297|474410916|FG008|Overall Study|Transitioned|0|||
131763715|NCT00141297|474410917|FG009|Overall Study|Transitioned|0|||
131763716|NCT01488994|474410918|FG000|Overall Study|Withdrawal by Subject|0|||
131763717|NCT01488994|474410919|FG001|Overall Study|Withdrawal by Subject|1|||
131763718|NCT01072500|474410920|FG000|Overall Study|Death|2|||
131763719|NCT01072500|474410921|FG001|Overall Study|Death|2|||
131763720|NCT01072500|474410920|FG000|Overall Study|Lost to Follow-up|5|||
131763721|NCT01072500|474410921|FG001|Overall Study|Lost to Follow-up|2|||
131763722|NCT01072500|474410920|FG000|Overall Study|Withdrawal by Subject|17|||
131763723|NCT01072500|474410921|FG001|Overall Study|Withdrawal by Subject|10|||
131763724|NCT03798366|474410931|FG000|Overall Study|Lost to Follow-up|0|||
131763725|NCT03798366|474410932|FG001|Overall Study|Lost to Follow-up|1|||
131763726|NCT00474539|474410935|FG000|Infant Series|Withdrawal by Subject|3|||
131763727|NCT00474539|474410936|FG001|Infant Series|Withdrawal by Subject|4|||
131763728|NCT00474539|474410935|FG000|Infant Series|Randomization error|5|||
131763729|NCT00474539|474410936|FG001|Infant Series|Randomization error|0|||
131763730|NCT00474539|474410935|FG000|Infant Series|Lost to Follow-up|2|||
131763731|NCT00474539|474410936|FG001|Infant Series|Lost to Follow-up|1|||
131763732|NCT00474539|474410935|FG000|Infant Series|Protocol Violation|0|||
131763733|NCT00474539|474410936|FG001|Infant Series|Protocol Violation|1|||
131763734|NCT00474539|474410935|FG000|After Infant Series|Lost to Follow-up|3|||
131763735|NCT00474539|474410936|FG001|After Infant Series|Lost to Follow-up|0|||
131763736|NCT00474539|474410935|FG000|After Infant Series|Withdrawal by Subject|1|||
131763737|NCT00474539|474410936|FG001|After Infant Series|Withdrawal by Subject|0|||
131763738|NCT00474539|474410935|FG000|Toddler Dose|Protocol Violation|1|||
131763739|NCT00474539|474410936|FG001|Toddler Dose|Protocol Violation|0|||
131763740|NCT02061540|474410937|FG000|Overall Study|Adverse Event|2|||
131763741|NCT02061540|474410937|FG000|Overall Study|Withdrawal by Subject|2|||
131763742|NCT00461552|474410938|FG000|Overall Study|Drug Dispensing error|0|||
131763743|NCT00461552|474410939|FG001|Overall Study|Drug Dispensing error|2|||
131763744|NCT00523744|474410940|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
131763745|NCT00523744|474410940|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
131763746|NCT00523744|474410940|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
131763747|NCT00523744|474410940|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
131763748|NCT00523744|474410940|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
131763749|NCT00523744|474410940|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
131763750|NCT03099304|474410943|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
131763751|NCT03099304|474410944|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
131763752|NCT03099304|474410945|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
131763753|NCT03099304|474410946|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
131763754|NCT03099304|474410947|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
131763755|NCT03099304|474410948|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
131763756|NCT03099304|474410943|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
131763757|NCT03099304|474410944|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
131763758|NCT03099304|474410945|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131763759|NCT03099304|474410946|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131763760|NCT03099304|474410947|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131763761|NCT03099304|474410948|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131763762|NCT03099304|474410943|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
131763763|NCT03099304|474410944|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
131763764|NCT03099304|474410945|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
131763765|NCT03099304|474410946|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
131763766|NCT03099304|474410947|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
131763767|NCT03099304|474410948|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
131763768|NCT03099304|474410943|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
131399630|NCT03100539|473085920|FG002|Overall Study|Disinterest|22|||
131763769|NCT03099304|474410944|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
131763770|NCT03099304|474410945|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
131763771|NCT03099304|474410946|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
131763772|NCT03099304|474410947|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
131763773|NCT03099304|474410948|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
131763774|NCT03099304|474410943|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131763775|NCT03099304|474410944|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131763776|NCT03099304|474410945|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
131763777|NCT03099304|474410946|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
131763778|NCT03099304|474410947|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131763779|NCT03099304|474410948|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131763780|NCT03099304|474410943|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131763781|NCT03099304|474410944|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131763782|NCT03099304|474410945|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
131763783|NCT03099304|474410946|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131763784|NCT03099304|474410947|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131763785|NCT03099304|474410948|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131763786|NCT03099304|474410943|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
131763787|NCT03099304|474410944|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
131763788|NCT03099304|474410945|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
131763789|NCT03099304|474410946|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
131763790|NCT03099304|474410947|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
131763791|NCT03099304|474410948|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
131763792|NCT03099304|474410943|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
131763793|NCT03099304|474410944|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
131763794|NCT03099304|474410945|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
131763795|NCT03099304|474410946|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
131763796|NCT03099304|474410947|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
131763797|NCT03099304|474410948|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
131763798|NCT03099304|474410943|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131763799|NCT03099304|474410944|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131763800|NCT03099304|474410945|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131763801|NCT03099304|474410946|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
131763802|NCT03099304|474410947|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
131763803|NCT03099304|474410948|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131763804|NCT03099304|474410943|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
131763805|NCT03099304|474410944|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
131763806|NCT03099304|474410945|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
131763807|NCT03099304|474410946|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
131763808|NCT03099304|474410947|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
131763809|NCT03099304|474410948|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
131763810|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
131763811|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
131763812|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
131763813|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
131763814|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
131763815|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
131763816|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
131763817|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
131763818|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
131763819|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
131763820|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
131763821|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
131763822|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
131763823|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
131763824|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
131763825|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
131763826|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
131763827|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
131763828|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
131813622|NCT01648582|474600548|FG000|Overall Study|Sponsor Decision|0|||
131813623|NCT01648582|474600549|FG001|Overall Study|Sponsor Decision|1|||
131813624|NCT01648582|474600550|FG002|Overall Study|Sponsor Decision|1|||
131813625|NCT00840216|474600551|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131813626|NCT00840216|474600552|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
131813627|NCT03276754|474600553|FG000|Overall Study|Withdrawal of informed consent|4|||
131813628|NCT03276754|474600553|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
131813629|NCT03276754|474600553|FG000|Overall Study|Lost to Follow-up|27|||
131813630|NCT03276754|474600553|FG000|Overall Study|No data reported at Month 24|31|||
131813631|NCT03276754|474600553|FG000|Overall Study|Death|39|||
131813632|NCT01058668|474600554|FG000|Double-blind Treatment Phase|Adverse Event|8|||
131813633|NCT01058668|474600555|FG001|Double-blind Treatment Phase|Adverse Event|15|||
131763829|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
131399631|NCT03100539|473085918|FG000|Overall Study|Veteran Health|0|||
131813634|NCT01058668|474600556|FG002|Double-blind Treatment Phase|Adverse Event|25|||
131813635|NCT01058668|474600554|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
131763830|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
131763831|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
131399632|NCT03100539|473085919|FG001|Overall Study|Veteran Health|0|||
131399633|NCT03100539|473085920|FG002|Overall Study|Veteran Health|8|||
131399634|NCT03100539|473085918|FG000|Overall Study|Moved|0|||
131399635|NCT03100539|473085919|FG001|Overall Study|Moved|0|||
131399636|NCT03100539|473085920|FG002|Overall Study|Moved|1|||
131399637|NCT03100539|473085918|FG000|Overall Study|Scheduling Conflicts|0|||
131399638|NCT03100539|473085919|FG001|Overall Study|Scheduling Conflicts|0|||
131399639|NCT03100539|473085920|FG002|Overall Study|Scheduling Conflicts|12|||
131399640|NCT05897242|473085921|FG000|Overall Study|Lost to Follow-up|6|||
131399641|NCT05897242|473085922|FG001|Overall Study|Lost to Follow-up|1|||
131399642|NCT05897242|473085921|FG000|Overall Study|Incomplete|1|||
131399643|NCT05897242|473085922|FG001|Overall Study|Incomplete|0|||
131399644|NCT05897242|473085921|FG000|Overall Study|Withdrawal by Subject|1|||
131399645|NCT05897242|473085922|FG001|Overall Study|Withdrawal by Subject|0|||
131399646|NCT04439539|473085926|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
131399647|NCT04439539|473085927|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
131399648|NCT04439539|473085928|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
131399649|NCT04439539|473085926|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
131399650|NCT04439539|473085927|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
131763832|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
131763833|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
131763834|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
131763835|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
131763836|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
131763837|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
131763838|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
131763839|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
131763840|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
131763841|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
131763842|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
131763843|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
131763844|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
131763845|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
131763846|NCT03099304|474410943|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
131763847|NCT03099304|474410944|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
131763848|NCT03099304|474410945|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
131763849|NCT03099304|474410946|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
131763850|NCT03099304|474410947|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
131763851|NCT03099304|474410948|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
131763852|NCT00715949|474410952|FG000|Overall Study|could not finish first test|4|||
131763853|NCT02390362|474410955|FG000|Overall Study|Withdrawal by Subject|0|||
131763854|NCT02390362|474410956|FG001|Overall Study|Withdrawal by Subject|1|||
131763855|NCT04009824|474410957|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
131763856|NCT04009824|474410958|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
131763857|NCT04009824|474410959|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
131763858|NCT04009824|474410960|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
131763859|NCT04009824|474410961|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
131763860|NCT01024946|474410962|FG000|Overall Study|Screen Failure|3|||
131763861|NCT01024946|474410962|FG000|Overall Study|Withdrawal by Subject|1|||
131763862|NCT01024946|474410962|FG000|Overall Study|Adverse Event|1|||
131763863|NCT02274766|474410965|FG000|Overall Study|Withdrawal by Subject|3|||
131763864|NCT02274766|474410966|FG001|Overall Study|Withdrawal by Subject|6|||
131763865|NCT02274766|474410965|FG000|Overall Study|Did Not Receive Study Drug|1|||
131763866|NCT02274766|474410966|FG001|Overall Study|Did Not Receive Study Drug|1|||
131813636|NCT01058668|474600555|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
131813637|NCT01058668|474600556|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
131813638|NCT01058668|474600554|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
131763867|NCT02274766|474410965|FG000|Overall Study|Subject Unwilling to Proceed|0|||
131763868|NCT02274766|474410966|FG001|Overall Study|Subject Unwilling to Proceed|1|||
131763869|NCT02274766|474410965|FG000|Overall Study|Adverse Event|0|||
131763870|NCT02274766|474410966|FG001|Overall Study|Adverse Event|1|||
131763871|NCT01142791|474410976|FG000|Overall Study|Alternative Treatment|1|||
131763872|NCT01142791|474410977|FG001|Overall Study|Alternative Treatment|0|||
131763873|NCT01142791|474410976|FG000|Overall Study|Lost to Follow-up|1|||
131763874|NCT01142791|474410977|FG001|Overall Study|Lost to Follow-up|0|||
131399651|NCT04439539|473085928|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
131763875|NCT01142791|474410976|FG000|Overall Study|Withdrawal by Subject|5|||
131763876|NCT01142791|474410977|FG001|Overall Study|Withdrawal by Subject|0|||
131763877|NCT01142791|474410976|FG000|Overall Study|Received only 1 sonication|0|||
131763878|NCT01142791|474410977|FG001|Overall Study|Received only 1 sonication|6|||
131813639|NCT01058668|474600555|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
131399652|NCT04439539|473085926|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
131763879|NCT02608892|474410978|FG000|Overall Study|Lost to Follow-up|1|||
131763880|NCT02608892|474410979|FG001|Overall Study|Lost to Follow-up|0|||
131763881|NCT02590406|474410980|FG000|Overall Study|Adverse Event|1|||
131763882|NCT02590406|474410981|FG001|Overall Study|Adverse Event|0|||
131763883|NCT02590406|474410980|FG000|Overall Study|Saturometer malfunction|0|||
131763884|NCT02590406|474410981|FG001|Overall Study|Saturometer malfunction|1|||
131763885|NCT03032523|474410984|FG000|Overall Study|Withdrawal by Subject|2|||
131763886|NCT03032523|474410985|FG001|Overall Study|Withdrawal by Subject|2|||
131763887|NCT03032523|474410984|FG000|Overall Study|Physician Decision|1|||
131763888|NCT03032523|474410985|FG001|Overall Study|Physician Decision|0|||
131763889|NCT05375838|474410986|FG000|Overall Study|Other|0|||
131763890|NCT05375838|474410987|FG001|Overall Study|Other|0|||
131763891|NCT05375838|474410988|FG002|Overall Study|Other|0|||
131763892|NCT05375838|474410989|FG003|Overall Study|Other|1|||
131763893|NCT05375838|474410990|FG004|Overall Study|Other|1|||
131763894|NCT05375838|474410991|FG005|Overall Study|Other|0|||
131763895|NCT05375838|474410986|FG000|Overall Study|Withdrawal by Subject|2|||
131763896|NCT05375838|474410987|FG001|Overall Study|Withdrawal by Subject|1|||
131763897|NCT05375838|474410988|FG002|Overall Study|Withdrawal by Subject|3|||
131763898|NCT05375838|474410989|FG003|Overall Study|Withdrawal by Subject|2|||
131763899|NCT05375838|474410990|FG004|Overall Study|Withdrawal by Subject|2|||
131763900|NCT05375838|474410991|FG005|Overall Study|Withdrawal by Subject|0|||
131763901|NCT05375838|474410986|FG000|Overall Study|Protocol Violation|0|||
131763902|NCT05375838|474410987|FG001|Overall Study|Protocol Violation|0|||
131763903|NCT05375838|474410988|FG002|Overall Study|Protocol Violation|0|||
131763904|NCT05375838|474410989|FG003|Overall Study|Protocol Violation|0|||
131763905|NCT05375838|474410990|FG004|Overall Study|Protocol Violation|1|||
131763906|NCT05375838|474410991|FG005|Overall Study|Protocol Violation|0|||
131763907|NCT05375838|474410986|FG000|Overall Study|Physician Decision|0|||
131763908|NCT05375838|474410987|FG001|Overall Study|Physician Decision|1|||
131763909|NCT05375838|474410988|FG002|Overall Study|Physician Decision|0|||
131763910|NCT05375838|474410989|FG003|Overall Study|Physician Decision|0|||
131763911|NCT05375838|474410990|FG004|Overall Study|Physician Decision|0|||
131763912|NCT05375838|474410991|FG005|Overall Study|Physician Decision|1|||
131763913|NCT05375838|474410986|FG000|Overall Study|Lost to Follow-up|2|||
131763914|NCT05375838|474410987|FG001|Overall Study|Lost to Follow-up|7|||
131763915|NCT05375838|474410988|FG002|Overall Study|Lost to Follow-up|0|||
131763916|NCT05375838|474410989|FG003|Overall Study|Lost to Follow-up|4|||
131763917|NCT05375838|474410990|FG004|Overall Study|Lost to Follow-up|2|||
131763918|NCT05375838|474410991|FG005|Overall Study|Lost to Follow-up|3|||
131763919|NCT00957723|474410992|FG000|Overall Study|Death|3|||
131763920|NCT00957723|474410992|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
131763921|NCT00957723|474410992|FG000|Overall Study|Lost to Follow-up|8|||
131763922|NCT00957723|474410992|FG000|Overall Study|Withdrawal by Subject|24|||
131763923|NCT00957723|474410992|FG000|Overall Study|Investigative Site Terminated|61|||
131763924|NCT00957723|474410992|FG000|Overall Study|Intercurrent Illness|2|||
131763925|NCT00957723|474410992|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
131763926|NCT00984009|474410993|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
131763927|NCT00281528|474410994|FG000|Overall Study|Progressive Disease|28|||
131763928|NCT00281528|474410995|FG001|Overall Study|Progressive Disease|18|||
131763929|NCT00281528|474410996|FG002|Overall Study|Progressive Disease|27|||
131763930|NCT00281528|474410994|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
131763931|NCT00281528|474410995|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
131763932|NCT00281528|474410996|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
131763933|NCT00281528|474410994|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
131763934|NCT00281528|474410995|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
131763935|NCT00281528|474410996|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
131399653|NCT04439539|473085927|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
131399654|NCT04439539|473085928|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
131763936|NCT00281528|474410994|FG000|Overall Study|Physician Decision|11|||
131763937|NCT00281528|474410995|FG001|Overall Study|Physician Decision|4|||
131763938|NCT00281528|474410996|FG002|Overall Study|Physician Decision|5|||
131763939|NCT00281528|474410994|FG000|Overall Study|Protocol Violation|1|||
131763940|NCT00281528|474410995|FG001|Overall Study|Protocol Violation|0|||
131399655|NCT02920528|473085931|FG000|Overall Study|Incomplete Data|1|||
131399656|NCT02920528|473085932|FG001|Overall Study|Incomplete Data|1|||
131399657|NCT02920528|473085933|FG002|Overall Study|Incomplete Data|1|||
131399658|NCT02920528|473085931|FG000|Overall Study|Adverse Event|0|||
131399659|NCT02920528|473085932|FG001|Overall Study|Adverse Event|0|||
131399660|NCT02920528|473085933|FG002|Overall Study|Adverse Event|3|||
131399661|NCT02920528|473085931|FG000|Overall Study|Did not meet inclusion criteria|2|||
131399662|NCT02920528|473085932|FG001|Overall Study|Did not meet inclusion criteria|0|||
131399663|NCT02920528|473085933|FG002|Overall Study|Did not meet inclusion criteria|1|||
131399664|NCT00809835|473085934|FG000|Overall Study|Lost to Follow-up|7|||
131399665|NCT00809835|473085935|FG001|Overall Study|Lost to Follow-up|6|||
131763941|NCT00281528|474410996|FG002|Overall Study|Protocol Violation|1|||
131399666|NCT00809835|473085936|FG002|Overall Study|Lost to Follow-up|10|||
131399667|NCT00809835|473085937|FG003|Overall Study|Lost to Follow-up|2|||
131399668|NCT00809835|473085934|FG000|Overall Study|Withdrawal by Subject|1|||
131399669|NCT00809835|473085935|FG001|Overall Study|Withdrawal by Subject|1|||
131399670|NCT00809835|473085936|FG002|Overall Study|Withdrawal by Subject|1|||
131399671|NCT00809835|473085937|FG003|Overall Study|Withdrawal by Subject|0|||
131399672|NCT02547038|473085938|FG000|Overall Study|Lost to Follow-up|3|||
131399673|NCT02547038|473085939|FG001|Overall Study|Lost to Follow-up|2|||
131399674|NCT01340625|473085940|FG000|First Intervention|Adverse Event|1|||
131399675|NCT01340625|473085941|FG001|First Intervention|Adverse Event|0|||
131399676|NCT01340625|473085940|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
131399677|NCT01340625|473085941|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
131399678|NCT00066703|473085942|FG000|Overall Study|Adverse Event|80|||
131399679|NCT00066703|473085943|FG001|Overall Study|Adverse Event|111|||
131399680|NCT00066703|473085942|FG000|Overall Study|Death|3|||
131399681|NCT00066703|473085943|FG001|Overall Study|Death|0|||
131399682|NCT00066703|473085942|FG000|Overall Study|Lack of Efficacy|114|||
131399683|NCT00066703|473085943|FG001|Overall Study|Lack of Efficacy|69|||
131399684|NCT00066703|473085942|FG000|Overall Study|Lost to Follow-up|31|||
131399685|NCT00066703|473085943|FG001|Overall Study|Lost to Follow-up|28|||
131399686|NCT00066703|473085942|FG000|Overall Study|Withdrawal by Subject|38|||
131399687|NCT00066703|473085943|FG001|Overall Study|Withdrawal by Subject|63|||
131399688|NCT00066703|473085942|FG000|Overall Study|Treatment ongoing|346|||
131399689|NCT00066703|473085943|FG001|Overall Study|Treatment ongoing|311|||
131399690|NCT01696968|473085944|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
131399691|NCT01696968|473085945|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
131399692|NCT01696968|473085944|FG000|Overall Study|Died Before Randomization|3|||
131399693|NCT01696968|473085945|FG001|Overall Study|Died Before Randomization|8|||
131399694|NCT01696968|473085944|FG000|Overall Study|Died Before ASU (Control)|278|||
131399695|NCT01696968|473085945|FG001|Overall Study|Died Before ASU (Control)|0|||
131399696|NCT01696968|473085944|FG000|Overall Study|Refused ASU (Control)|920|||
131399697|NCT01696968|473085945|FG001|Overall Study|Refused ASU (Control)|0|||
131399698|NCT01696968|473085944|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
131399699|NCT01696968|473085945|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
131399700|NCT05659719|473085946|FG000|Overall Study|At sponsor's request|0|||
131399701|NCT05659719|473085947|FG001|Overall Study|At sponsor's request|0|||
131399702|NCT05659719|473085948|FG002|Overall Study|At sponsor's request|0|||
131399703|NCT05659719|473085949|FG003|Overall Study|At sponsor's request|95|||
131399704|NCT05659719|473085946|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
131399705|NCT05659719|473085947|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
131399706|NCT05659719|473085948|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
131399707|NCT05659719|473085949|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
131399708|NCT05659719|473085946|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
131399709|NCT05659719|473085947|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
131813640|NCT01058668|474600556|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
131813641|NCT01058668|474600554|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
131813642|NCT01058668|474600555|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
131813643|NCT01058668|474600556|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
131813644|NCT01058668|474600554|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131399710|NCT05659719|473085948|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
131399711|NCT05659719|473085949|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
131399712|NCT05659719|473085946|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
131399713|NCT05659719|473085947|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
131399714|NCT05659719|473085948|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
131399715|NCT05659719|473085949|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
131399716|NCT05659719|473085946|FG000|Overall Study|Lost to Follow-up|0|||
131399717|NCT05659719|473085947|FG001|Overall Study|Lost to Follow-up|0|||
131399718|NCT05659719|473085948|FG002|Overall Study|Lost to Follow-up|0|||
131399719|NCT05659719|473085949|FG003|Overall Study|Lost to Follow-up|2|||
131399720|NCT05659719|473085946|FG000|Overall Study|Moved to another observational study|0|||
131399721|NCT05659719|473085947|FG001|Overall Study|Moved to another observational study|0|||
131399722|NCT05659719|473085948|FG002|Overall Study|Moved to another observational study|0|||
131399723|NCT05659719|473085949|FG003|Overall Study|Moved to another observational study|1|||
131399724|NCT05659719|473085946|FG000|Overall Study|The child was enrolled in an interventional study|0|||
131399725|NCT05659719|473085947|FG001|Overall Study|The child was enrolled in an interventional study|0|||
131399726|NCT05659719|473085948|FG002|Overall Study|The child was enrolled in an interventional study|0|||
131399727|NCT05659719|473085949|FG003|Overall Study|The child was enrolled in an interventional study|55|||
131399728|NCT05659719|473085946|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
131399729|NCT05659719|473085947|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
131399730|NCT05659719|473085948|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
131399731|NCT05659719|473085949|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
131399732|NCT05659719|473085946|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
131399733|NCT05659719|473085947|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
131399734|NCT05659719|473085948|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
131399735|NCT05659719|473085949|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
131399736|NCT02582814|473085956|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131399737|NCT02582814|473085957|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131399738|NCT02582814|473085956|FG000|Overall Study|Withdrawal by Subject|4|||
131399739|NCT02582814|473085957|FG001|Overall Study|Withdrawal by Subject|3|||
131399740|NCT02582814|473085956|FG000|Overall Study|Adverse Event|4|||
131399741|NCT02582814|473085957|FG001|Overall Study|Adverse Event|4|||
131399742|NCT04848220|473085966|FG000|Overall Study|Unable to proceed to study procedure|0|||
131399743|NCT04848220|473085967|FG001|Overall Study|Unable to proceed to study procedure|1|||
131399744|NCT04848220|473085968|FG002|Overall Study|Unable to proceed to study procedure|0|||
131399745|NCT04848220|473085966|FG000|Overall Study|Fractional flow not significant|0|||
131399746|NCT04848220|473085967|FG001|Overall Study|Fractional flow not significant|1|||
131399747|NCT04848220|473085968|FG002|Overall Study|Fractional flow not significant|0|||
131399748|NCT02923830|473085969|FG000|Overall Study|Physician Decision|13|||
131399749|NCT02923830|473085970|FG001|Overall Study|Physician Decision|15|||
131399750|NCT00623233|473085971|FG000|Overall Study|Adverse Event|10|||
131399751|NCT00623233|473085971|FG000|Overall Study|Physician Decision|10|||
131399752|NCT00623233|473085971|FG000|Overall Study|Lost to Follow-up|1|||
131399753|NCT00623233|473085971|FG000|Overall Study|Withdrawal by Subject|3|||
131399754|NCT02557100|473085972|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
131399755|NCT02557100|473085973|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
131399756|NCT02557100|473085974|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
131399757|NCT02557100|473085972|FG000|Single Blind Treatment Period|Death|0|||
131399758|NCT02557100|473085973|FG001|Single Blind Treatment Period|Death|1|||
131399759|NCT02557100|473085974|FG002|Single Blind Treatment Period|Death|0|||
131399760|NCT02557100|473085972|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
131399761|NCT02557100|473085973|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
131399762|NCT02557100|473085974|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
131399763|NCT02557100|473085972|FG000|Single Blind Treatment Period|Adverse Event|0|||
131399764|NCT02557100|473085973|FG001|Single Blind Treatment Period|Adverse Event|1|||
131399765|NCT02557100|473085974|FG002|Single Blind Treatment Period|Adverse Event|0|||
131399766|NCT02557100|473085972|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
131399767|NCT02557100|473085973|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
131399768|NCT02557100|473085974|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
131399769|NCT02557100|473085972|FG000|Cumulative Abatacept Period|Other Reasons|0|||
131399770|NCT02557100|473085973|FG001|Cumulative Abatacept Period|Other Reasons|0|||
131399771|NCT02557100|473085974|FG002|Cumulative Abatacept Period|Other Reasons|1|||
131399772|NCT02557100|473085972|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
131399773|NCT02557100|473085973|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
131399774|NCT02557100|473085974|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
131399775|NCT02557100|473085972|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
131399776|NCT02557100|473085973|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
131399777|NCT02557100|473085974|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
131399778|NCT00510718|473085975|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
131399779|NCT00510718|473085976|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
131399780|NCT00510718|473085975|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
131399781|NCT00510718|473085976|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
131399782|NCT00510718|473085975|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
131399783|NCT00510718|473085976|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
131399784|NCT00510718|473085975|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
131399785|NCT00510718|473085976|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
131399786|NCT00510718|473085975|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
131399787|NCT00510718|473085976|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
131909493|NCT00289276|474956780|FG000|Second Part of FAST Study (Expansion)|Death|0|||
131399788|NCT00510718|473085975|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
131399789|NCT00510718|473085976|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
131909494|NCT00289276|474956781|FG001|Second Part of FAST Study (Expansion)|Death|2|||
131909495|NCT00289276|474956780|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
131909496|NCT00289276|474956781|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
131399790|NCT02150057|473085986|FG000|Overall Study|Lost to Follow-up|6|||
131399791|NCT02150057|473085987|FG001|Overall Study|Lost to Follow-up|4|||
131399792|NCT00489424|473085988|FG000|Overall Study|Adverse Event|3|||
131399793|NCT00489424|473085989|FG001|Overall Study|Adverse Event|3|||
131399794|NCT00489424|473085990|FG002|Overall Study|Adverse Event|4|||
131399795|NCT00489424|473085988|FG000|Overall Study|Lack of Efficacy|1|||
131399796|NCT00489424|473085989|FG001|Overall Study|Lack of Efficacy|0|||
131399797|NCT00489424|473085990|FG002|Overall Study|Lack of Efficacy|0|||
131399798|NCT00489424|473085988|FG000|Overall Study|Administrative problems|0|||
131399799|NCT00489424|473085989|FG001|Overall Study|Administrative problems|2|||
131399800|NCT00489424|473085990|FG002|Overall Study|Administrative problems|1|||
131399801|NCT00394251|473085991|FG000|Overall Study|Adverse Event|7|||
131399802|NCT00394251|473085992|FG001|Overall Study|Adverse Event|5|||
131399803|NCT00394251|473085991|FG000|Overall Study|Unacceptable Toxicity|20|||
131399804|NCT00394251|473085992|FG001|Overall Study|Unacceptable Toxicity|18|||
131399805|NCT00394251|473085991|FG000|Overall Study|Physician Decision|1|||
131399806|NCT00394251|473085992|FG001|Overall Study|Physician Decision|1|||
131399807|NCT00394251|473085991|FG000|Overall Study|Protocol Violation|0|||
131399808|NCT00394251|473085992|FG001|Overall Study|Protocol Violation|1|||
131399809|NCT00394251|473085991|FG000|Overall Study|Withdrawal by Subject|7|||
131399810|NCT00394251|473085992|FG001|Overall Study|Withdrawal by Subject|11|||
131399811|NCT00394251|473085991|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
131399812|NCT00394251|473085992|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
131399813|NCT05791565|473085993|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
131399814|NCT05791565|473085994|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
131399815|NCT01558115|473085995|FG000|Overall Study|Withdrawal by Subject|3|||
131399816|NCT01558115|473085995|FG000|Overall Study|Study closed due to poor enrollment|4|||
131399817|NCT01696994|473085996|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
131399818|NCT01696994|473085997|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
131399819|NCT01696994|473085996|FG000|Overall Study|Died Before Randomization|1|||
131399820|NCT01696994|473085997|FG001|Overall Study|Died Before Randomization|2|||
131399821|NCT01696994|473085996|FG000|Overall Study|Died Before ASU (Control)|73|||
131399822|NCT01696994|473085997|FG001|Overall Study|Died Before ASU (Control)|0|||
131399823|NCT01696994|473085996|FG000|Overall Study|No Ovaries at Baseline|4807|||
131399824|NCT01696994|473085997|FG001|Overall Study|No Ovaries at Baseline|4851|||
131399825|NCT01696994|473085996|FG000|Overall Study|Refused ASU (Control)|311|||
131399826|NCT01696994|473085997|FG001|Overall Study|Refused ASU (Control)|0|||
131399827|NCT01696994|473085996|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
131399828|NCT01696994|473085997|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
131399829|NCT04644276|473085998|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
131399830|NCT04644276|473085999|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
131399831|NCT04644276|473086000|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
131399832|NCT02388165|473086001|FG000|Overall Study|Study terminated by sponsor|5|||
131399833|NCT02388165|473086002|FG001|Overall Study|Study terminated by sponsor|5|||
131399834|NCT02388165|473086001|FG000|Overall Study|Other|11|||
131399835|NCT02388165|473086002|FG001|Overall Study|Other|13|||
131399836|NCT02388165|473086001|FG000|Overall Study|No longer meet eligibility criteria|40|||
131399837|NCT02388165|473086002|FG001|Overall Study|No longer meet eligibility criteria|43|||
131399838|NCT02388165|473086001|FG000|Overall Study|Withdrawal of consent|31|||
131399839|NCT02388165|473086002|FG001|Overall Study|Withdrawal of consent|32|||
131399840|NCT02388165|473086001|FG000|Overall Study|Lost to Follow-up|19|||
131399841|NCT02388165|473086002|FG001|Overall Study|Lost to Follow-up|20|||
131399842|NCT02388165|473086001|FG000|Overall Study|Death|13|||
131399843|NCT02388165|473086002|FG001|Overall Study|Death|10|||
131399844|NCT02388165|473086001|FG000|Overall Study|Adverse Event|3|||
131399845|NCT02388165|473086002|FG001|Overall Study|Adverse Event|5|||
131399846|NCT02388165|473086001|FG000|Overall Study|Did not meet entrance criteria|5|||
131399847|NCT02388165|473086002|FG001|Overall Study|Did not meet entrance criteria|2|||
131399848|NCT00705250|473086003|FG000|Overall Study|Withdrawal by Subject|1|||
131399849|NCT00705250|473086003|FG000|Overall Study|Patient died in car accident|1|||
131399850|NCT01576146|473086004|FG000|Extension Period 1|Adverse Event|2|||
131399851|NCT01576146|473086004|FG000|Extension Period 1|Death|2|||
131813645|NCT01058668|474600555|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
131813646|NCT01058668|474600556|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
131813647|NCT01058668|474600554|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
131813648|NCT01058668|474600555|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
131813649|NCT01058668|474600556|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
131813650|NCT03364192|474600562|FG000|Overall Study|Ineligible|10|||
131399852|NCT01576146|473086004|FG000|Extension Period 1|Physician Decision|2|||
131399853|NCT01576146|473086004|FG000|Extension Period 1|Withdrawal by Subject|1|||
131399854|NCT01576146|473086004|FG000|Extension Period 1|Lost to Follow-up|1|||
131399855|NCT01576146|473086004|FG000|Extension Period 1|Parathyroidectomy|1|||
131399856|NCT01576146|473086004|FG000|Extension Period 1|Renal Transplant|1|||
131399857|NCT01576146|473086004|FG000|Extension Period 2|Sponsor Decision|13|||
131813651|NCT03364192|474600562|FG000|Overall Study|Withdrawal by Subject|5|||
131399858|NCT01576146|473086004|FG000|Extension Period 2|Death|1|||
131399859|NCT01576146|473086004|FG000|Extension Period 2|Adverse Event|1|||
131399860|NCT01576146|473086004|FG000|Extension Period 2|Renal Transplant|1|||
131399861|NCT01576146|473086004|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
131399862|NCT01667224|473086007|FG000|Overall Study|Withdrawal by Subject|3|||
131399863|NCT01667224|473086008|FG001|Overall Study|Withdrawal by Subject|1|||
131399864|NCT01667224|473086007|FG000|Overall Study|Protocol Violation|1|||
131399865|NCT01667224|473086008|FG001|Overall Study|Protocol Violation|1|||
131399866|NCT00316225|473086009|FG000|Overall Study|Adverse Event|2|||
131399867|NCT00316225|473086009|FG000|Overall Study|Physician Decision|3|||
131399868|NCT00316225|473086009|FG000|Overall Study|Progressive Disease|15|||
131399869|NCT00316225|473086009|FG000|Overall Study|Withdrawal by Subject|3|||
131399870|NCT00316225|473086009|FG000|Overall Study|Death|2|||
131399871|NCT03764631|473086010|FG000|Overall Study|Personal Reasons|3|||
131399872|NCT03764631|473086011|FG001|Overall Study|Personal Reasons|2|||
131399873|NCT03764631|473086010|FG000|Overall Study|Switching Therapy|3|||
131399874|NCT03764631|473086011|FG001|Overall Study|Switching Therapy|3|||
131399875|NCT03764631|473086010|FG000|Overall Study|Adverse Event|0|||
131399876|NCT03764631|473086011|FG001|Overall Study|Adverse Event|1|||
131399877|NCT03764631|473086010|FG000|Overall Study|Lost to Follow-up|33|||
131399878|NCT03764631|473086011|FG001|Overall Study|Lost to Follow-up|41|||
131399879|NCT03764631|473086010|FG000|Overall Study|No data as study site was closed|2|||
131399880|NCT03764631|473086011|FG001|Overall Study|No data as study site was closed|6|||
131399881|NCT01200407|473086012|FG000|Overall Study|Lost to Follow-up|56|||
131399882|NCT01200407|473086012|FG000|Overall Study|Adverse Event|3|||
131399883|NCT01200407|473086012|FG000|Overall Study|Withdrawal by Subject|4|||
131399884|NCT01200407|473086012|FG000|Overall Study|Other|19|||
131399885|NCT03299881|473086013|FG000|Overall Study|Study Termination|17|||
131399886|NCT03299881|473086014|FG001|Overall Study|Study Termination|13|||
131399887|NCT02321319|473086018|FG000|Overall Study|Product discontinued|5|||
131763942|NCT00281528|474410994|FG000|Overall Study|Withdrawal by Subject|5|||
131763943|NCT00281528|474410995|FG001|Overall Study|Withdrawal by Subject|5|||
131763944|NCT00281528|474410996|FG002|Overall Study|Withdrawal by Subject|7|||
131763945|NCT00281528|474410994|FG000|Overall Study|Other|6|||
131763946|NCT00281528|474410995|FG001|Overall Study|Other|3|||
131763947|NCT00281528|474410996|FG002|Overall Study|Other|5|||
131763948|NCT01984294|474411008|FG000|Overall Study|Randomized but Never Treated|0|||
131763949|NCT01984294|474411009|FG001|Overall Study|Randomized but Never Treated|0|||
131763950|NCT01984294|474411010|FG002|Overall Study|Randomized but Never Treated|1|||
131763951|NCT01984294|474411008|FG000|Overall Study|Lack of Efficacy|4|||
131763952|NCT01984294|474411009|FG001|Overall Study|Lack of Efficacy|2|||
131763953|NCT01984294|474411010|FG002|Overall Study|Lack of Efficacy|6|||
131763954|NCT01984294|474411008|FG000|Overall Study|Adverse Event|0|||
131763955|NCT01984294|474411009|FG001|Overall Study|Adverse Event|1|||
131763956|NCT01984294|474411010|FG002|Overall Study|Adverse Event|0|||
131763957|NCT01066546|474411011|FG000|Overall Study|Study terminated by sponsor|5|||
131763958|NCT00656799|474411018|FG000|Overall Study|Death|2|||
131763959|NCT05281094|474411019|FG000|Overall Study|Adverse Event|1|||
131763960|NCT05281094|474411020|FG001|Overall Study|Adverse Event|0|||
131763961|NCT05281094|474411019|FG000|Overall Study|Lost to Follow-up|29|||
131763962|NCT05281094|474411020|FG001|Overall Study|Lost to Follow-up|22|||
131763963|NCT05281094|474411019|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
131763964|NCT05281094|474411020|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
131763965|NCT05281094|474411019|FG000|Overall Study|Death|1|||
131399888|NCT00853242|473086020|FG000|Overall Study|Adverse Event|0|||
131399889|NCT00853242|473086021|FG001|Overall Study|Adverse Event|1|||
131399890|NCT00853242|473086022|FG002|Overall Study|Adverse Event|1|||
131399891|NCT00853242|473086023|FG003|Overall Study|Adverse Event|0|||
131399892|NCT00853242|473086024|FG004|Overall Study|Adverse Event|3|||
131399893|NCT00853242|473086025|FG005|Overall Study|Adverse Event|1|||
131399894|NCT00853242|473086026|FG006|Overall Study|Adverse Event|1|||
131399895|NCT00853242|473086020|FG000|Overall Study|Noncompliant|0|||
131399896|NCT00853242|473086021|FG001|Overall Study|Noncompliant|0|||
131399897|NCT00853242|473086022|FG002|Overall Study|Noncompliant|0|||
131813652|NCT03364192|474600562|FG000|Overall Study|Lost to Follow-up|1|||
131813653|NCT03669861|474600563|FG000|Overall Study|Disease Flare|5|||
131813654|NCT03669861|474600563|FG000|Overall Study|Lack of Efficacy|2|||
131813655|NCT00705666|474600565|FG000|Overall Study|No post-treatment questionnaire|279|||
131813656|NCT00705666|474600565|FG000|Overall Study|Withdrawal by Subject|21|||
131813657|NCT00705666|474600565|FG000|Overall Study|Physician Decision|7|||
131813658|NCT00705666|474600565|FG000|Overall Study|Lost to Follow-up|5|||
131813659|NCT00705666|474600565|FG000|Overall Study|Death|1|||
131399898|NCT00853242|473086023|FG003|Overall Study|Noncompliant|0|||
131399899|NCT00853242|473086024|FG004|Overall Study|Noncompliant|1|||
131399900|NCT00853242|473086025|FG005|Overall Study|Noncompliant|0|||
131399901|NCT00853242|473086026|FG006|Overall Study|Noncompliant|0|||
131399902|NCT00853242|473086020|FG000|Overall Study|Withdrawal by Subject|1|||
131763966|NCT05281094|474411020|FG001|Overall Study|Death|2|||
131813660|NCT00705666|474600565|FG000|Overall Study|Adverse Event|4|||
131813661|NCT00705666|474600565|FG000|Overall Study|Other|12|||
131813662|NCT00705666|474600565|FG000|Overall Study|Other|2|||
131399903|NCT00853242|473086021|FG001|Overall Study|Withdrawal by Subject|2|||
131399904|NCT00853242|473086022|FG002|Overall Study|Withdrawal by Subject|0|||
131399905|NCT00853242|473086023|FG003|Overall Study|Withdrawal by Subject|4|||
131399906|NCT00853242|473086024|FG004|Overall Study|Withdrawal by Subject|0|||
131399907|NCT00853242|473086025|FG005|Overall Study|Withdrawal by Subject|0|||
131399908|NCT00853242|473086026|FG006|Overall Study|Withdrawal by Subject|2|||
131399909|NCT00853242|473086020|FG000|Overall Study|Other|2|||
131399910|NCT00853242|473086021|FG001|Overall Study|Other|0|||
131399911|NCT00853242|473086022|FG002|Overall Study|Other|2|||
131399912|NCT00853242|473086023|FG003|Overall Study|Other|0|||
131399913|NCT00853242|473086024|FG004|Overall Study|Other|0|||
131399914|NCT00853242|473086025|FG005|Overall Study|Other|1|||
131399915|NCT00853242|473086026|FG006|Overall Study|Other|2|||
131399916|NCT01471028|473086030|FG000|VTI-208|Adverse Event|39|||
131399917|NCT01471028|473086031|FG001|VTI-208|Adverse Event|41|||
131399918|NCT01471028|473086030|FG000|VTI-208|Withdrawal by Subject|0|||
131399919|NCT01471028|473086031|FG001|VTI-208|Withdrawal by Subject|2|||
131399920|NCT01471028|473086030|FG000|VTI-208|Lost to Follow-up|1|||
131399921|NCT01471028|473086031|FG001|VTI-208|Lost to Follow-up|1|||
131399922|NCT01471028|473086030|FG000|VTI-208E|Death|7|||
131399923|NCT01471028|473086031|FG001|VTI-208E|Death|10|||
131399924|NCT01471028|473086030|FG000|VTI-208E|Withdrawal by Subject|1|||
131399925|NCT01471028|473086031|FG001|VTI-208E|Withdrawal by Subject|0|||
131399926|NCT01471028|473086030|FG000|VTI-208E|Lost to Follow-up|0|||
131399927|NCT01471028|473086031|FG001|VTI-208E|Lost to Follow-up|2|||
131399928|NCT01626118|473086033|FG000|Overall Study|Lack of Efficacy|1|||
131399929|NCT01626118|473086034|FG001|Overall Study|Lack of Efficacy|0|||
131399930|NCT01626118|473086035|FG002|Overall Study|Lack of Efficacy|1|||
131399931|NCT01626118|473086036|FG003|Overall Study|Lack of Efficacy|3|||
131399932|NCT01626118|473086033|FG000|Overall Study|Lost to Follow-up|1|||
131399933|NCT01626118|473086034|FG001|Overall Study|Lost to Follow-up|0|||
131399934|NCT01626118|473086035|FG002|Overall Study|Lost to Follow-up|0|||
131399935|NCT01626118|473086036|FG003|Overall Study|Lost to Follow-up|0|||
131399936|NCT01626118|473086033|FG000|Overall Study|Adverse Event|0|||
131399937|NCT01626118|473086034|FG001|Overall Study|Adverse Event|1|||
131399938|NCT01626118|473086035|FG002|Overall Study|Adverse Event|1|||
131399939|NCT01626118|473086036|FG003|Overall Study|Adverse Event|0|||
131399940|NCT01626118|473086033|FG000|Overall Study|Investigator Decision|0|||
131399941|NCT01626118|473086034|FG001|Overall Study|Investigator Decision|1|||
131399942|NCT01626118|473086035|FG002|Overall Study|Investigator Decision|0|||
131399943|NCT01626118|473086036|FG003|Overall Study|Investigator Decision|0|||
131399944|NCT01500252|473086040|FG000|Overall Study|Death|4|||
131399945|NCT01500252|473086041|FG001|Overall Study|Death|2|||
131399946|NCT01500252|473086040|FG000|Overall Study|Lost to Follow-up|5|||
131399947|NCT01500252|473086041|FG001|Overall Study|Lost to Follow-up|4|||
131399948|NCT04382586|473086047|FG000|Overall Study|Death|3|||
131399949|NCT04382586|473086048|FG001|Overall Study|Death|4|||
131399950|NCT04382586|473086047|FG000|Overall Study|Lost to Follow-up|11|||
131399951|NCT04382586|473086048|FG001|Overall Study|Lost to Follow-up|8|||
131399952|NCT04382586|473086047|FG000|Overall Study|Withdrawal by Subject|3|||
131399953|NCT04382586|473086048|FG001|Overall Study|Withdrawal by Subject|1|||
131399954|NCT04382586|473086047|FG000|Overall Study|Physician Decision|0|||
131399955|NCT04382586|473086048|FG001|Overall Study|Physician Decision|3|||
131399956|NCT02059499|473086052|FG000|Upto Week 20|Lost to Follow-up|2|||
131399957|NCT02059499|473086053|FG001|Upto Week 20|Lost to Follow-up|6|||
131399958|NCT02059499|473086054|FG002|Upto Week 20|Lost to Follow-up|0|||
131399959|NCT02059499|473086052|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
131399960|NCT02059499|473086053|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
131399961|NCT02059499|473086054|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
131399962|NCT02059499|473086052|FG000|Upto Week 20|Withdrawal by Subject|1|||
131399963|NCT02059499|473086053|FG001|Upto Week 20|Withdrawal by Subject|1|||
131399964|NCT02059499|473086054|FG002|Upto Week 20|Withdrawal by Subject|0|||
131399965|NCT02059499|473086052|FG000|Upto Week 20|No treatment per protocol criteria|0|||
131399966|NCT02059499|473086053|FG001|Upto Week 20|No treatment per protocol criteria|0|||
131399967|NCT02059499|473086054|FG002|Upto Week 20|No treatment per protocol criteria|5|||
131399968|NCT02059499|473086052|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
131399969|NCT02059499|473086053|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
131399970|NCT02059499|473086054|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
131399971|NCT02059499|473086052|FG000|Post-week 20|Lost to Follow-up|0|||
131399972|NCT02059499|473086053|FG001|Post-week 20|Lost to Follow-up|2|||
131399973|NCT02059499|473086054|FG002|Post-week 20|Lost to Follow-up|0|||
131399974|NCT02059499|473086052|FG000|Post-week 20|Withdrawal by Subject|0|||
131763967|NCT05281094|474411019|FG000|Overall Study|Not pre-specified reason|8|||
131763968|NCT05281094|474411020|FG001|Overall Study|Not pre-specified reason|5|||
131763969|NCT00631969|474411025|FG000|Overall Study|Adverse Event|3|||
131763970|NCT00631969|474411026|FG001|Overall Study|Adverse Event|1|||
131763971|NCT00631969|474411025|FG000|Overall Study|Lack of Efficacy|2|||
131399975|NCT02059499|473086053|FG001|Post-week 20|Withdrawal by Subject|1|||
131399976|NCT02059499|473086054|FG002|Post-week 20|Withdrawal by Subject|0|||
131763972|NCT00631969|474411026|FG001|Overall Study|Lack of Efficacy|8|||
131763973|NCT00631969|474411025|FG000|Overall Study|Lost to Follow-up|2|||
131763974|NCT00631969|474411026|FG001|Overall Study|Lost to Follow-up|1|||
131763975|NCT00631969|474411025|FG000|Overall Study|Protocol Violation|1|||
131763976|NCT00631969|474411026|FG001|Overall Study|Protocol Violation|1|||
131763977|NCT00631969|474411025|FG000|Overall Study|Consent Withdrawn|5|||
131763978|NCT00631969|474411026|FG001|Overall Study|Consent Withdrawn|7|||
131763979|NCT00631969|474411025|FG000|Overall Study|Noncompliant With Study Medication|0|||
131763980|NCT00631969|474411026|FG001|Overall Study|Noncompliant With Study Medication|1|||
131763981|NCT00631969|474411025|FG000|Overall Study|No Drug Exposure|2|||
131763982|NCT00631969|474411026|FG001|Overall Study|No Drug Exposure|2|||
131763983|NCT05315297|474411027|FG000|Overall Study|Lost to Follow-up|6|||
131763984|NCT05315297|474411028|FG001|Overall Study|Lost to Follow-up|4|||
131763985|NCT05315297|474411027|FG000|Overall Study|Withdrawal by Subject|0|||
131763986|NCT05315297|474411028|FG001|Overall Study|Withdrawal by Subject|1|||
131763987|NCT00669240|474413098|FG000|Overall Study|Lack of Efficacy|33|||
131763988|NCT00669240|474413098|FG000|Overall Study|Withdrawal by Subject|42|||
131763989|NCT00669240|474413098|FG000|Overall Study|Lost to Follow-up|34|||
131763990|NCT00669240|474413098|FG000|Overall Study|Adverse Event|21|||
131763991|NCT00669240|474413098|FG000|Overall Study|Other|19|||
131763992|NCT00669240|474413098|FG000|Overall Study|Enrolled but not treated|15|||
131763993|NCT00669240|474413098|FG000|Overall Study|Enrolled but no dosing record|1|||
131763994|NCT02185040|474413102|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
131763995|NCT02185040|474413103|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
131763996|NCT02185040|474413104|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
131763997|NCT02185040|474413105|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
131763998|NCT02185040|474413106|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
131763999|NCT02185040|474413107|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
131764000|NCT02185040|474413108|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
131764001|NCT02185040|474413102|FG000|Part 1 Treatment Phase|Adverse Event|1|||
131764002|NCT02185040|474413103|FG001|Part 1 Treatment Phase|Adverse Event|0|||
131764003|NCT02185040|474413104|FG002|Part 1 Treatment Phase|Adverse Event|0|||
131764004|NCT02185040|474413105|FG003|Part 1 Treatment Phase|Adverse Event|2|||
131764005|NCT02185040|474413106|FG004|Part 1 Treatment Phase|Adverse Event|3|||
131764006|NCT02185040|474413107|FG005|Part 1 Treatment Phase|Adverse Event|0|||
131764007|NCT02185040|474413108|FG006|Part 1 Treatment Phase|Adverse Event|0|||
131764008|NCT02185040|474413102|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131764009|NCT02185040|474413103|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
131764010|NCT02185040|474413104|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131399977|NCT02059499|473086052|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
131399978|NCT02059499|473086053|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
131399979|NCT02059499|473086054|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
131399980|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
131399981|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131399982|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131399983|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131399984|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131399985|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131399986|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
131399987|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
131399988|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131399989|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131399990|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131399991|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131764011|NCT02185040|474413105|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131764012|NCT02185040|474413106|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131764013|NCT02185040|474413107|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131764014|NCT02185040|474413108|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131764015|NCT02185040|474413102|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
131764016|NCT02185040|474413103|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
131764017|NCT02185040|474413104|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
131813663|NCT00705666|474600565|FG000|Overall Study|Lack of data|3|||
131764018|NCT02185040|474413105|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
131764019|NCT02185040|474413106|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
131764020|NCT02185040|474413107|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
131764021|NCT02185040|474413108|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
131764022|NCT02185040|474413102|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
131764023|NCT02185040|474413103|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
131764024|NCT02185040|474413104|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
131813664|NCT00705666|474600565|FG000|Overall Study|Untreated|5|||
131813665|NCT01604941|474600577|FG000|Overall Study|Adverse Event|1|||
131764025|NCT02185040|474413105|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
131764026|NCT02185040|474413106|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
131909497|NCT02783911|474956782|FG000|Overall Study|Lost to Follow-up|3|||
131909498|NCT02783911|474956783|FG001|Overall Study|Lost to Follow-up|32|||
131909499|NCT00833755|474956786|FG000|Overall Study|Physician Decision|4|||
131399992|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
131399993|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
131399994|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
131399995|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
131399996|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
131399997|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
131399998|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
131399999|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
131400000|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131400001|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131400002|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131400003|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131400004|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
131400005|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
131400006|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
131400007|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
131400008|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
131400009|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
131400010|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
131400011|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
131400012|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
131400013|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
131400014|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
131764027|NCT02185040|474413107|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
131764028|NCT02185040|474413108|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
131764029|NCT02185040|474413102|FG000|Active Treatment Extension Phase|Adverse Event|0|||
131764030|NCT02185040|474413103|FG001|Active Treatment Extension Phase|Adverse Event|0|||
131764031|NCT02185040|474413104|FG002|Active Treatment Extension Phase|Adverse Event|0|||
131764032|NCT02185040|474413105|FG003|Active Treatment Extension Phase|Adverse Event|0|||
131764033|NCT02185040|474413106|FG004|Active Treatment Extension Phase|Adverse Event|0|||
131764034|NCT02185040|474413107|FG005|Active Treatment Extension Phase|Adverse Event|1|||
131764035|NCT02185040|474413108|FG006|Active Treatment Extension Phase|Adverse Event|4|||
131813666|NCT01604941|474600578|FG001|Overall Study|Adverse Event|2|||
131813667|NCT01604941|474600579|FG002|Overall Study|Adverse Event|0|||
131813668|NCT01604941|474600580|FG003|Overall Study|Adverse Event|0|||
131813669|NCT01604941|474600581|FG004|Overall Study|Adverse Event|1|||
131813670|NCT01604941|474600582|FG005|Overall Study|Adverse Event|5|||
131813671|NCT01604941|474600577|FG000|Overall Study|Non-compliance|1|||
131813672|NCT01604941|474600578|FG001|Overall Study|Non-compliance|0|||
131813673|NCT01604941|474600579|FG002|Overall Study|Non-compliance|0|||
131813674|NCT01604941|474600580|FG003|Overall Study|Non-compliance|0|||
131813675|NCT01604941|474600581|FG004|Overall Study|Non-compliance|0|||
131813676|NCT01604941|474600582|FG005|Overall Study|Non-compliance|0|||
131813677|NCT01604941|474600577|FG000|Overall Study|Participant Decision|0|||
131813678|NCT01604941|474600578|FG001|Overall Study|Participant Decision|0|||
131813679|NCT01604941|474600579|FG002|Overall Study|Participant Decision|0|||
131813680|NCT01604941|474600580|FG003|Overall Study|Participant Decision|0|||
131813681|NCT01604941|474600581|FG004|Overall Study|Participant Decision|0|||
131813682|NCT01604941|474600582|FG005|Overall Study|Participant Decision|2|||
131813683|NCT01604941|474600577|FG000|Overall Study|Early Study Termination|9|||
131813684|NCT01604941|474600578|FG001|Overall Study|Early Study Termination|2|||
131813685|NCT01604941|474600579|FG002|Overall Study|Early Study Termination|3|||
131813686|NCT01604941|474600580|FG003|Overall Study|Early Study Termination|3|||
131813687|NCT01604941|474600581|FG004|Overall Study|Early Study Termination|0|||
131813688|NCT01604941|474600582|FG005|Overall Study|Early Study Termination|0|||
131813689|NCT03256695|474600583|FG000|Overall Study|Adverse Event|8|||
131813690|NCT03256695|474600583|FG000|Overall Study|Death|2|||
131813691|NCT03256695|474600583|FG000|Overall Study|Withdrawal by Subject|14|||
131909500|NCT00833755|474956787|FG001|Overall Study|Physician Decision|4|||
131909501|NCT00833755|474956788|FG002|Overall Study|Physician Decision|2|||
131813692|NCT03256695|474600583|FG000|Overall Study|Non-compliance with study drug|1|||
131813693|NCT03256695|474600583|FG000|Overall Study|Lost to Follow-up|3|||
131813694|NCT03256695|474600583|FG000|Overall Study|Lack of Efficacy|3|||
131813695|NCT03256695|474600583|FG000|Overall Study|Protocol Violation|5|||
131813696|NCT03256695|474600583|FG000|Overall Study|Other than specified|3|||
131813697|NCT03930732|474600587|FG000|Overall Study|Adverse Event|9|||
131813698|NCT03930732|474600588|FG001|Overall Study|Adverse Event|7|||
131764036|NCT02185040|474413102|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131400015|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
131400016|NCT03989349|473086055|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
131400017|NCT03989349|473086056|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
131400018|NCT03989349|473086057|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
131400019|NCT03989349|473086058|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
131400020|NCT03989349|473086059|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
131400021|NCT03989349|473086060|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
131400022|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131400023|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131400024|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
131400025|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
131400026|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
131400027|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
131400028|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131400029|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131400030|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
131400031|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
131400032|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
131400033|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
131400034|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131400035|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131400036|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
131400037|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
131400038|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
131400039|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
131400040|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131400041|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131400042|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
131400043|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131400044|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
131400045|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131400046|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131400047|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131400048|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
131400049|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
131764037|NCT02185040|474413103|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131764038|NCT02185040|474413104|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131764039|NCT02185040|474413105|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131764040|NCT02185040|474413106|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131764041|NCT02185040|474413107|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
131764042|NCT02185040|474413108|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
131764043|NCT02185040|474413102|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
131764044|NCT02185040|474413103|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
131764045|NCT02185040|474413104|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
131764046|NCT02185040|474413105|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
131764047|NCT02185040|474413106|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
131764048|NCT02185040|474413107|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
131764049|NCT02185040|474413108|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
131764050|NCT03347279|474413109|FG000|Overall Study|Withdrawal by Subject|8|||
131764051|NCT03347279|474413110|FG001|Overall Study|Withdrawal by Subject|15|||
131764052|NCT03347279|474413109|FG000|Overall Study|Death|0|||
131764053|NCT03347279|474413110|FG001|Overall Study|Death|2|||
131764054|NCT03347279|474413109|FG000|Overall Study|Lost to Follow-up|5|||
131764055|NCT03347279|474413110|FG001|Overall Study|Lost to Follow-up|2|||
131764056|NCT03347279|474413109|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
131764057|NCT03347279|474413110|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
131764058|NCT03818399|474413115|FG000|Overall Study|Lost to Follow-up|11|||
131764059|NCT03818399|474413115|FG000|Overall Study|Withdrawal by Subject|1|||
131764060|NCT03818399|474413115|FG000|Overall Study|Protocol Violation|2|||
131764061|NCT00535236|474413118|FG000|Overall Study|Adverse Event|1|||
131764062|NCT00535236|474413119|FG001|Overall Study|Adverse Event|0|||
131764063|NCT00535236|474413120|FG002|Overall Study|Adverse Event|9|||
131764064|NCT00535236|474413121|FG003|Overall Study|Adverse Event|3|||
131764065|NCT00535236|474413122|FG004|Overall Study|Adverse Event|3|||
131400050|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131400051|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
131400052|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
131400053|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
131400054|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
131400055|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
131400056|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
131400057|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
131400058|NCT03989349|473086055|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
131400059|NCT03989349|473086056|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
131400060|NCT03989349|473086057|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
131400061|NCT03989349|473086058|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
131400062|NCT03989349|473086059|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
131400063|NCT03989349|473086060|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
131400064|NCT01352221|473086061|FG000|Double-blind Phase|Adverse Event|6|||
131400065|NCT01352221|473086062|FG001|Double-blind Phase|Adverse Event|4|||
131400066|NCT01352221|473086063|FG002|Double-blind Phase|Adverse Event|0|||
131400067|NCT01352221|473086064|FG003|Double-blind Phase|Adverse Event|0|||
131400068|NCT01352221|473086061|FG000|Double-blind Phase|Withdrawal by Subject|3|||
131400069|NCT01352221|473086062|FG001|Double-blind Phase|Withdrawal by Subject|5|||
131400070|NCT01352221|473086063|FG002|Double-blind Phase|Withdrawal by Subject|0|||
131400071|NCT01352221|473086064|FG003|Double-blind Phase|Withdrawal by Subject|0|||
131400072|NCT01352221|473086061|FG000|Double-blind Phase|Lost to Follow-up|0|||
131400073|NCT01352221|473086062|FG001|Double-blind Phase|Lost to Follow-up|1|||
131400074|NCT01352221|473086063|FG002|Double-blind Phase|Lost to Follow-up|0|||
131400075|NCT01352221|473086064|FG003|Double-blind Phase|Lost to Follow-up|0|||
131400076|NCT01352221|473086061|FG000|Double-blind Phase|Protocol Violation|0|||
131400077|NCT01352221|473086062|FG001|Double-blind Phase|Protocol Violation|1|||
131813699|NCT03930732|474600587|FG000|Overall Study|Poor compliance to protocol|0|||
131813700|NCT03930732|474600588|FG001|Overall Study|Poor compliance to protocol|1|||
131813701|NCT03930732|474600587|FG000|Overall Study|Withdrawal by Subject|23|||
131813702|NCT03930732|474600588|FG001|Overall Study|Withdrawal by Subject|11|||
131813703|NCT03930732|474600587|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
131813704|NCT03930732|474600588|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
131813705|NCT03930732|474600587|FG000|Overall Study|Other reason not related to COVID-19|5|||
131813706|NCT03930732|474600588|FG001|Overall Study|Other reason not related to COVID-19|8|||
131813707|NCT03406156|474600589|FG000|Overall Study|Death|9|||
131813708|NCT03406156|474600590|FG001|Overall Study|Death|3|||
131813709|NCT03406156|474600589|FG000|Overall Study|Withdrawal by Subject|1|||
131813710|NCT03406156|474600590|FG001|Overall Study|Withdrawal by Subject|2|||
131813711|NCT03406156|474600589|FG000|Overall Study|COVID-19 infection|1|||
131813712|NCT03406156|474600590|FG001|Overall Study|COVID-19 infection|0|||
131909502|NCT00833755|474956789|FG003|Overall Study|Physician Decision|6|||
131400078|NCT01352221|473086063|FG002|Double-blind Phase|Protocol Violation|0|||
131400079|NCT01352221|473086064|FG003|Double-blind Phase|Protocol Violation|0|||
131400080|NCT01352221|473086061|FG000|Open-label Phase|Physician Decision|0|||
131400081|NCT01352221|473086062|FG001|Open-label Phase|Physician Decision|0|||
131400082|NCT01352221|473086063|FG002|Open-label Phase|Physician Decision|2|||
131400083|NCT01352221|473086064|FG003|Open-label Phase|Physician Decision|1|||
131400084|NCT01352221|473086061|FG000|Open-label Phase|Pregnancy|0|||
131400085|NCT01352221|473086062|FG001|Open-label Phase|Pregnancy|0|||
131400086|NCT01352221|473086063|FG002|Open-label Phase|Pregnancy|1|||
131400087|NCT01352221|473086064|FG003|Open-label Phase|Pregnancy|0|||
131400088|NCT01352221|473086061|FG000|Open-label Phase|Adverse Event|0|||
131400089|NCT01352221|473086062|FG001|Open-label Phase|Adverse Event|0|||
131400090|NCT01352221|473086063|FG002|Open-label Phase|Adverse Event|8|||
131400091|NCT01352221|473086064|FG003|Open-label Phase|Adverse Event|4|||
131400092|NCT01352221|473086061|FG000|Open-label Phase|Withdrawal by Subject|0|||
131400093|NCT01352221|473086062|FG001|Open-label Phase|Withdrawal by Subject|0|||
131400094|NCT01352221|473086063|FG002|Open-label Phase|Withdrawal by Subject|1|||
131400095|NCT01352221|473086064|FG003|Open-label Phase|Withdrawal by Subject|6|||
131400096|NCT01352221|473086061|FG000|Open-label Phase|Worsening of IBD|0|||
131400097|NCT01352221|473086062|FG001|Open-label Phase|Worsening of IBD|0|||
131400098|NCT01352221|473086063|FG002|Open-label Phase|Worsening of IBD|1|||
131400099|NCT01352221|473086064|FG003|Open-label Phase|Worsening of IBD|0|||
131813713|NCT03406156|474600589|FG000|Overall Study|Non-compliance with study procedures|1|||
131909503|NCT00833755|474956786|FG000|Overall Study|Subject had scheduling issues|0|||
131909504|NCT00833755|474956787|FG001|Overall Study|Subject had scheduling issues|1|||
131909505|NCT00833755|474956788|FG002|Overall Study|Subject had scheduling issues|0|||
131400100|NCT00079391|473086065|FG000|Overall Study|Withdrawal by Subject|1|||
131813714|NCT03406156|474600590|FG001|Overall Study|Non-compliance with study procedures|1|||
131400101|NCT02628600|473086069|FG000|Overall Study|Death|2|||
131400102|NCT02628600|473086070|FG001|Overall Study|Death|1|||
131400103|NCT02628600|473086069|FG000|Overall Study|Adverse Event|3|||
131400104|NCT02628600|473086070|FG001|Overall Study|Adverse Event|20|||
131400105|NCT02628600|473086069|FG000|Overall Study|Protocol Violation|0|||
131400106|NCT02628600|473086070|FG001|Overall Study|Protocol Violation|1|||
131400107|NCT02628600|473086069|FG000|Overall Study|Lack of Efficacy|2|||
131400108|NCT02628600|473086070|FG001|Overall Study|Lack of Efficacy|0|||
131400109|NCT02628600|473086069|FG000|Overall Study|Withdrawal by Subject|13|||
131400110|NCT02628600|473086070|FG001|Overall Study|Withdrawal by Subject|8|||
131400111|NCT02628600|473086069|FG000|Overall Study|Lost to Follow-up|1|||
131400112|NCT02628600|473086070|FG001|Overall Study|Lost to Follow-up|0|||
131400113|NCT02628600|473086069|FG000|Overall Study|Physician Decision|2|||
131400114|NCT02628600|473086070|FG001|Overall Study|Physician Decision|2|||
131400115|NCT02628600|473086069|FG000|Overall Study|Other not specified|1|||
131813715|NCT03406156|474600589|FG000|Overall Study|Lost to Follow-up|0|||
131813716|NCT03406156|474600590|FG001|Overall Study|Lost to Follow-up|2|||
131813717|NCT03406156|474600589|FG000|Overall Study|Other, not specified|72|||
131813718|NCT03406156|474600590|FG001|Overall Study|Other, not specified|28|||
131813719|NCT01370733|474600595|FG000|Overall Study|Withdrawal by Subject|8|||
131813720|NCT01370733|474600596|FG001|Overall Study|Withdrawal by Subject|8|||
131813721|NCT01370733|474600595|FG000|Overall Study|Lost to Follow-up|3|||
131813722|NCT01370733|474600596|FG001|Overall Study|Lost to Follow-up|0|||
131813723|NCT01370733|474600595|FG000|Overall Study|Adverse Event|2|||
131813724|NCT01370733|474600596|FG001|Overall Study|Adverse Event|4|||
131813725|NCT01370733|474600595|FG000|Overall Study|Lack of Efficacy|3|||
131813726|NCT01370733|474600596|FG001|Overall Study|Lack of Efficacy|5|||
131813727|NCT01370733|474600595|FG000|Overall Study|Physician Decision|0|||
131813728|NCT01370733|474600596|FG001|Overall Study|Physician Decision|2|||
131813729|NCT01370733|474600595|FG000|Overall Study|Protocol Violation|1|||
131813730|NCT01370733|474600596|FG001|Overall Study|Protocol Violation|3|||
131813731|NCT00463684|474600599|FG000|Overall Study|Withdrawal by Subject|1|||
131813732|NCT00463684|474600599|FG000|Overall Study|Lost to Follow-up|3|||
131813733|NCT00191815|474600600|FG000|Overall Study|Adverse Event|2|||
131813734|NCT00191815|474600600|FG000|Overall Study|Disease progression or relapse|24|||
131813735|NCT00191815|474600600|FG000|Overall Study|Death|2|||
131813736|NCT00191815|474600600|FG000|Overall Study|Protocol Violation|3|||
131813737|NCT00191815|474600600|FG000|Overall Study|Physician Decision|2|||
131813738|NCT00191815|474600600|FG000|Overall Study|Withdrawal by Subject|7|||
131813739|NCT03808376|474600601|FG000|Overall Study|Withdrawal by Subject|10|||
131813740|NCT03644550|474600602|FG000|Overall Study|Withdrawal by Subject|3|||
131813741|NCT03644550|474600602|FG000|Overall Study|Progressive disease|15|||
131813742|NCT00323882|474600603|FG000|Overall Study|Adverse Event|2|||
131813743|NCT00323882|474600604|FG001|Overall Study|Adverse Event|1|||
131813744|NCT00323882|474600605|FG002|Overall Study|Adverse Event|1|||
131813745|NCT00323882|474600606|FG003|Overall Study|Adverse Event|1|||
131813746|NCT00323882|474600607|FG004|Overall Study|Adverse Event|3|||
131813747|NCT00323882|474600603|FG000|Overall Study|Disease Progression|6|||
131813748|NCT00323882|474600604|FG001|Overall Study|Disease Progression|4|||
131813749|NCT00323882|474600605|FG002|Overall Study|Disease Progression|10|||
131813750|NCT00323882|474600606|FG003|Overall Study|Disease Progression|5|||
131813751|NCT00323882|474600607|FG004|Overall Study|Disease Progression|22|||
131813752|NCT00323882|474600603|FG000|Overall Study|Death|0|||
131813753|NCT00323882|474600604|FG001|Overall Study|Death|1|||
131813754|NCT00323882|474600605|FG002|Overall Study|Death|1|||
131813755|NCT00323882|474600606|FG003|Overall Study|Death|0|||
131813756|NCT00323882|474600607|FG004|Overall Study|Death|5|||
131813757|NCT00323882|474600603|FG000|Overall Study|Lost to Follow-up|0|||
131813758|NCT00323882|474600604|FG001|Overall Study|Lost to Follow-up|0|||
131813759|NCT00323882|474600605|FG002|Overall Study|Lost to Follow-up|1|||
131813760|NCT00323882|474600606|FG003|Overall Study|Lost to Follow-up|0|||
131813761|NCT00323882|474600607|FG004|Overall Study|Lost to Follow-up|1|||
131400116|NCT02628600|473086070|FG001|Overall Study|Other not specified|0|||
131400117|NCT01221623|473086071|FG000|Overall Study|Withdrawal by Subject|19|||
131400118|NCT01221623|473086072|FG001|Overall Study|Withdrawal by Subject|8|||
131400119|NCT01221623|473086071|FG000|Overall Study|Lost to Follow-up|7|||
131813762|NCT00323882|474600603|FG000|Overall Study|Other|0|||
131813763|NCT00323882|474600604|FG001|Overall Study|Other|0|||
131813764|NCT00323882|474600605|FG002|Overall Study|Other|0|||
131813765|NCT00323882|474600606|FG003|Overall Study|Other|1|||
131813766|NCT00323882|474600607|FG004|Overall Study|Other|1|||
131813767|NCT01794845|474600608|FG000|Overall Study|Withdrawal by Subject|1|||
131813768|NCT01456221|474600609|FG000|Overall Study|Withdrawal by Subject|56|||
131813769|NCT01456221|474600610|FG001|Overall Study|Withdrawal by Subject|49|||
131813770|NCT01456221|474600609|FG000|Overall Study|Lost to Follow-up|1|||
131813771|NCT01456221|474600610|FG001|Overall Study|Lost to Follow-up|4|||
131813772|NCT01456221|474600609|FG000|Overall Study|Received medication|3|||
131400120|NCT01221623|473086072|FG001|Overall Study|Lost to Follow-up|1|||
131400121|NCT01221623|473086071|FG000|Overall Study|Adverse Event|6|||
131400122|NCT01221623|473086072|FG001|Overall Study|Adverse Event|3|||
131813773|NCT01456221|474600610|FG001|Overall Study|Received medication|2|||
131813774|NCT01456221|474600609|FG000|Overall Study|Incomplete data|4|||
131400123|NCT01221623|473086071|FG000|Overall Study|Death|1|||
131400124|NCT01221623|473086072|FG001|Overall Study|Death|0|||
131400125|NCT01221623|473086071|FG000|Overall Study|Other|5|||
131400126|NCT01221623|473086072|FG001|Overall Study|Other|2|||
131400127|NCT00661726|473086073|FG000|Overall Study|Adverse Event|1|||
131400128|NCT02109432|473087638|FG000|Overall Study|Withdrawal by Subject|1|||
131400129|NCT02908685|473087639|FG000|Part 1 OLE|Withdrawal by Subject|0|||
131400130|NCT02908685|473087640|FG001|Part 1 OLE|Withdrawal by Subject|0|||
131400131|NCT02908685|473087641|FG002|Part 1 OLE|Withdrawal by Subject|0|||
131400132|NCT02908685|473087642|FG003|Part 1 OLE|Withdrawal by Subject|0|||
131400133|NCT02908685|473087643|FG004|Part 1 OLE|Withdrawal by Subject|0|||
131400134|NCT02908685|473087644|FG005|Part 1 OLE|Withdrawal by Subject|0|||
131400135|NCT02908685|473087645|FG006|Part 1 OLE|Withdrawal by Subject|0|||
131400136|NCT02908685|473087646|FG007|Part 1 OLE|Withdrawal by Subject|0|||
131400137|NCT02908685|473087647|FG008|Part 1 OLE|Withdrawal by Subject|0|||
131400138|NCT02908685|473087648|FG009|Part 1 OLE|Withdrawal by Subject|0|||
131400139|NCT02908685|473087649|FG010|Part 1 OLE|Withdrawal by Subject|2|||
131400140|NCT02908685|473087650|FG011|Part 1 OLE|Withdrawal by Subject|1|||
131400141|NCT02908685|473087651|FG012|Part 1 OLE|Withdrawal by Subject|0|||
131400142|NCT02908685|473087652|FG013|Part 1 OLE|Withdrawal by Subject|0|||
131400143|NCT02908685|473087639|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400144|NCT02908685|473087640|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400145|NCT02908685|473087641|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400146|NCT02908685|473087642|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400147|NCT02908685|473087643|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400148|NCT02908685|473087644|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400149|NCT02908685|473087645|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400150|NCT02908685|473087646|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400151|NCT02908685|473087647|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400152|NCT02908685|473087648|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400153|NCT02908685|473087649|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400154|NCT02908685|473087650|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
131400155|NCT02908685|473087651|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
131400156|NCT02908685|473087652|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
131400157|NCT02908685|473087639|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400158|NCT02908685|473087640|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400159|NCT02908685|473087641|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400160|NCT02908685|473087642|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400161|NCT02908685|473087643|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400162|NCT02908685|473087644|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400163|NCT02908685|473087645|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400164|NCT02908685|473087646|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400165|NCT02908685|473087647|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400166|NCT02908685|473087648|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400167|NCT02908685|473087649|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400168|NCT02908685|473087650|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400169|NCT02908685|473087651|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
131813775|NCT01456221|474600610|FG001|Overall Study|Incomplete data|2|||
131813776|NCT06647173|474600611|FG000|Overall Study|Lost to Follow-up|24|||
131813777|NCT00312897|474600612|FG000|Overall Study|Adverse Event|1|||
131813778|NCT00312897|474600613|FG001|Overall Study|Adverse Event|0|||
131813779|NCT00312897|474600612|FG000|Overall Study|Lost to Follow-up|2|||
131813780|NCT00312897|474600613|FG001|Overall Study|Lost to Follow-up|0|||
131813781|NCT00312897|474600612|FG000|Overall Study|Physician Decision|1|||
131813782|NCT00312897|474600613|FG001|Overall Study|Physician Decision|0|||
131813783|NCT00312897|474600612|FG000|Overall Study|Withdrawal by Subject|1|||
131813784|NCT00312897|474600613|FG001|Overall Study|Withdrawal by Subject|3|||
131813785|NCT00312897|474600612|FG000|Overall Study|Pregnancy|1|||
131813786|NCT00312897|474600613|FG001|Overall Study|Pregnancy|0|||
131813787|NCT00312897|474600612|FG000|Overall Study|discontinued prior to getting treatment|0|||
131813788|NCT00312897|474600613|FG001|Overall Study|discontinued prior to getting treatment|3|||
131400170|NCT02908685|473087652|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
131400171|NCT02908685|473087639|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400172|NCT02908685|473087640|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400173|NCT02908685|473087641|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400174|NCT02908685|473087642|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400175|NCT02908685|473087643|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131813789|NCT03100344|474600614|FG000|Overall Study|Adverse Event|0|||
131813790|NCT03100344|474600615|FG001|Overall Study|Adverse Event|3|||
131909506|NCT00833755|474956789|FG003|Overall Study|Subject had scheduling issues|0|||
131400176|NCT02908685|473087644|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131813791|NCT03100344|474600616|FG002|Overall Study|Adverse Event|2|||
131400177|NCT02908685|473087645|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400178|NCT02908685|473087646|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400179|NCT02908685|473087647|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400180|NCT02908685|473087648|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400181|NCT02908685|473087649|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400182|NCT02908685|473087650|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400183|NCT02908685|473087651|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
131400184|NCT02908685|473087652|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
131400185|NCT02908685|473087639|FG000|Part 2 OLE: > Month 24|Death|0|||
131400186|NCT02908685|473087640|FG001|Part 2 OLE: > Month 24|Death|0|||
131400187|NCT02908685|473087641|FG002|Part 2 OLE: > Month 24|Death|0|||
131400188|NCT02908685|473087642|FG003|Part 2 OLE: > Month 24|Death|0|||
131400189|NCT02908685|473087643|FG004|Part 2 OLE: > Month 24|Death|0|||
131400190|NCT02908685|473087644|FG005|Part 2 OLE: > Month 24|Death|0|||
131400191|NCT02908685|473087645|FG006|Part 2 OLE: > Month 24|Death|0|||
131400192|NCT02908685|473087646|FG007|Part 2 OLE: > Month 24|Death|0|||
131400193|NCT02908685|473087647|FG008|Part 2 OLE: > Month 24|Death|0|||
131400194|NCT02908685|473087648|FG009|Part 2 OLE: > Month 24|Death|0|||
131400195|NCT02908685|473087649|FG010|Part 2 OLE: > Month 24|Death|0|||
131400196|NCT02908685|473087650|FG011|Part 2 OLE: > Month 24|Death|0|||
131400197|NCT02908685|473087651|FG012|Part 2 OLE: > Month 24|Death|1|||
131400198|NCT02908685|473087652|FG013|Part 2 OLE: > Month 24|Death|0|||
131400199|NCT02908685|473087639|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
131400200|NCT02908685|473087640|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
131400201|NCT02908685|473087641|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
131400202|NCT02908685|473087642|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
131400203|NCT02908685|473087643|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
131400204|NCT02908685|473087644|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
131400205|NCT02908685|473087645|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
131400206|NCT02908685|473087646|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
131400207|NCT02908685|473087647|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
131400208|NCT02908685|473087648|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
131400209|NCT02908685|473087649|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
131400210|NCT02908685|473087650|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
131400211|NCT02908685|473087651|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
131400212|NCT02908685|473087652|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
131400213|NCT02908685|473087639|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400214|NCT02908685|473087640|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400215|NCT02908685|473087641|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400216|NCT02908685|473087642|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400217|NCT02908685|473087643|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400218|NCT02908685|473087644|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400219|NCT02908685|473087645|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400220|NCT02908685|473087646|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400221|NCT02908685|473087647|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400222|NCT02908685|473087648|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400223|NCT02908685|473087649|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400224|NCT02908685|473087650|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
131400225|NCT02908685|473087651|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
131400226|NCT02908685|473087652|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
131400227|NCT01691014|473087653|FG000|Overall Study|Premature Termination|1|||
131400228|NCT01691014|473087654|FG001|Overall Study|Premature Termination|6|||
131400229|NCT01691014|473087655|FG002|Overall Study|Premature Termination|0|||
131400230|NCT01691014|473087656|FG003|Overall Study|Premature Termination|3|||
131400231|NCT01691014|473087653|FG000|Overall Study|Other|0|||
131400232|NCT01691014|473087654|FG001|Overall Study|Other|0|||
131400233|NCT01691014|473087655|FG002|Overall Study|Other|2|||
131400234|NCT01691014|473087656|FG003|Overall Study|Other|0|||
131400235|NCT01691014|473087653|FG000|Overall Study|Withdrawal by Subject|0|||
131400236|NCT01691014|473087654|FG001|Overall Study|Withdrawal by Subject|1|||
131400237|NCT01691014|473087655|FG002|Overall Study|Withdrawal by Subject|1|||
131400238|NCT01691014|473087656|FG003|Overall Study|Withdrawal by Subject|1|||
131400239|NCT01691014|473087653|FG000|Overall Study|Adverse Event|0|||
131400240|NCT01691014|473087654|FG001|Overall Study|Adverse Event|5|||
131400241|NCT01691014|473087655|FG002|Overall Study|Adverse Event|1|||
131400242|NCT01691014|473087656|FG003|Overall Study|Adverse Event|1|||
131400243|NCT01691014|473087653|FG000|Overall Study|Lack of Efficacy|2|||
131400244|NCT01691014|473087654|FG001|Overall Study|Lack of Efficacy|3|||
131400245|NCT01691014|473087655|FG002|Overall Study|Lack of Efficacy|7|||
131400246|NCT01691014|473087656|FG003|Overall Study|Lack of Efficacy|0|||
131400247|NCT02370537|473087657|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
131400248|NCT02370537|473087658|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
131400249|NCT02370537|473087659|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
131400250|NCT02370537|473087657|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
131400251|NCT02370537|473087658|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
131400252|NCT02370537|473087659|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
131400253|NCT02370537|473087657|FG000|Part B|Not randomised to receive treatment|1|||
131400254|NCT02370537|473087658|FG001|Part B|Not randomised to receive treatment|2|||
131400255|NCT02370537|473087659|FG002|Part B|Not randomised to receive treatment|259|||
131400256|NCT02370537|473087657|FG000|Part B|Withdrawal by Subject|0|||
131400257|NCT02370537|473087658|FG001|Part B|Withdrawal by Subject|1|||
131400258|NCT02370537|473087659|FG002|Part B|Withdrawal by Subject|0|||
131400259|NCT01519791|473087662|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
131400260|NCT01519791|473087663|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
131400261|NCT01519791|473087662|FG000|Overall Study|Protocol Violation|6|||
131400262|NCT01519791|473087663|FG001|Overall Study|Protocol Violation|19|||
131400263|NCT01519791|473087662|FG000|Overall Study|Other Reason|87|||
131400264|NCT01519791|473087663|FG001|Overall Study|Other Reason|222|||
131400265|NCT01519791|473087662|FG000|Overall Study|subjects randomized in error|2|||
131400266|NCT01519791|473087663|FG001|Overall Study|subjects randomized in error|0|||
131400267|NCT01519791|473087662|FG000|Overall Study|Lack of Efficacy|16|||
131400268|NCT01519791|473087663|FG001|Overall Study|Lack of Efficacy|20|||
131400269|NCT01519791|473087662|FG000|Overall Study|SAE, non-fatal|6|||
131400270|NCT01519791|473087663|FG001|Overall Study|SAE, non-fatal|22|||
131400271|NCT01519791|473087662|FG000|Overall Study|AE, serious fatal|0|||
131400272|NCT01519791|473087663|FG001|Overall Study|AE, serious fatal|1|||
131400273|NCT01519791|473087662|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
131400274|NCT01519791|473087663|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
131764066|NCT00535236|474413123|FG005|Overall Study|Adverse Event|0|||
131764067|NCT00535236|474413124|FG006|Overall Study|Adverse Event|5|||
131764068|NCT00535236|474413125|FG007|Overall Study|Adverse Event|1|||
131764069|NCT00535236|474413126|FG008|Overall Study|Adverse Event|2|||
131764070|NCT00535236|474413127|FG009|Overall Study|Adverse Event|1|||
131764071|NCT00535236|474413118|FG000|Overall Study|Lost to Follow-up|1|||
131764072|NCT00535236|474413119|FG001|Overall Study|Lost to Follow-up|2|||
131764073|NCT00535236|474413120|FG002|Overall Study|Lost to Follow-up|0|||
131764074|NCT00535236|474413121|FG003|Overall Study|Lost to Follow-up|0|||
131764075|NCT00535236|474413122|FG004|Overall Study|Lost to Follow-up|2|||
131764076|NCT00535236|474413123|FG005|Overall Study|Lost to Follow-up|0|||
131764077|NCT00535236|474413124|FG006|Overall Study|Lost to Follow-up|0|||
131764078|NCT00535236|474413125|FG007|Overall Study|Lost to Follow-up|0|||
131764079|NCT00535236|474413126|FG008|Overall Study|Lost to Follow-up|6|||
131400275|NCT01519791|473087662|FG000|Overall Study|AE, non-serious non-fatal|12|||
131400276|NCT01519791|473087663|FG001|Overall Study|AE, non-serious non-fatal|31|||
131400277|NCT01519791|473087662|FG000|Overall Study|Withdrawal by Subject|15|||
131400278|NCT01519791|473087663|FG001|Overall Study|Withdrawal by Subject|37|||
131400279|NCT01519791|473087662|FG000|Overall Study|Lost to Follow-up|6|||
131400280|NCT01519791|473087663|FG001|Overall Study|Lost to Follow-up|14|||
131400281|NCT02957747|473087676|FG000|Overall Study|Withdrawal by Subject|0|||
131400282|NCT02957747|473087677|FG001|Overall Study|Withdrawal by Subject|3|||
131400283|NCT02957747|473087676|FG000|Overall Study|Lost to Follow-up|10|||
131400284|NCT02957747|473087677|FG001|Overall Study|Lost to Follow-up|5|||
131400285|NCT00632827|473087678|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
131400286|NCT00632827|473087678|FG000|Overall Study|Death|2|||
131400287|NCT00632827|473087678|FG000|Overall Study|Adverse Event|5|||
131400288|NCT00632827|473087678|FG000|Overall Study|Lost to Follow-up|1|||
131400289|NCT03425006|473087681|FG000|Overall Study|Withdrawal by Subject|1|||
131400290|NCT03425006|473087681|FG000|Overall Study|Physician Decision|1|||
131400291|NCT03425006|473087681|FG000|Overall Study|Death|1|||
131400292|NCT03070171|473087687|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
131400293|NCT03070171|473087688|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
131400294|NCT03070171|473087687|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
131400295|NCT03070171|473087688|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
131400296|NCT00610857|473087689|FG000|Overall Study|Not evaluable for response|2|||
131400297|NCT00888329|473087690|FG000|Overall Study|Physician Decision|6|||
131400298|NCT00888329|473087691|FG001|Overall Study|Physician Decision|9|||
131400299|NCT04826094|473087692|FG000|Overall Study|Lost to Follow-up|2|||
131400300|NCT04826094|473087693|FG001|Overall Study|Lost to Follow-up|1|||
131400301|NCT04826094|473087694|FG002|Overall Study|Lost to Follow-up|0|||
131400302|NCT04826094|473087695|FG003|Overall Study|Lost to Follow-up|0|||
131400303|NCT04826094|473087696|FG004|Overall Study|Lost to Follow-up|1|||
131400304|NCT04826094|473087697|FG005|Overall Study|Lost to Follow-up|3|||
131400305|NCT04826094|473087698|FG006|Overall Study|Lost to Follow-up|1|||
131400306|NCT04826094|473087699|FG007|Overall Study|Lost to Follow-up|1|||
131400307|NCT04826094|473087692|FG000|Overall Study|Participant withdrew consent|1|||
131400308|NCT04826094|473087693|FG001|Overall Study|Participant withdrew consent|0|||
131400309|NCT04826094|473087694|FG002|Overall Study|Participant withdrew consent|0|||
131400310|NCT04826094|473087695|FG003|Overall Study|Participant withdrew consent|1|||
131400311|NCT04826094|473087696|FG004|Overall Study|Participant withdrew consent|1|||
131400312|NCT04826094|473087697|FG005|Overall Study|Participant withdrew consent|1|||
131400313|NCT04826094|473087698|FG006|Overall Study|Participant withdrew consent|0|||
131400314|NCT04826094|473087699|FG007|Overall Study|Participant withdrew consent|1|||
131400315|NCT04826094|473087692|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
131400316|NCT04826094|473087693|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
131400317|NCT04826094|473087694|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
131400318|NCT04826094|473087695|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
131400319|NCT04826094|473087696|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
131400320|NCT04826094|473087697|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
131400321|NCT04826094|473087698|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
131400322|NCT04826094|473087699|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
131400323|NCT04826094|473087692|FG000|Overall Study|Withdrawn by Investigator|0|||
131400324|NCT04826094|473087693|FG001|Overall Study|Withdrawn by Investigator|0|||
131400325|NCT04826094|473087694|FG002|Overall Study|Withdrawn by Investigator|0|||
131400326|NCT04826094|473087695|FG003|Overall Study|Withdrawn by Investigator|0|||
131400327|NCT04826094|473087696|FG004|Overall Study|Withdrawn by Investigator|0|||
131400328|NCT04826094|473087697|FG005|Overall Study|Withdrawn by Investigator|1|||
131400329|NCT04826094|473087698|FG006|Overall Study|Withdrawn by Investigator|0|||
131813792|NCT03100344|474600617|FG003|Overall Study|Adverse Event|3|||
131813793|NCT03100344|474600614|FG000|Overall Study|Lack of Efficacy|2|||
131813794|NCT03100344|474600615|FG001|Overall Study|Lack of Efficacy|0|||
131813795|NCT03100344|474600616|FG002|Overall Study|Lack of Efficacy|0|||
131813796|NCT03100344|474600617|FG003|Overall Study|Lack of Efficacy|0|||
131813797|NCT03100344|474600614|FG000|Overall Study|Protocol Violation|1|||
131813798|NCT03100344|474600615|FG001|Overall Study|Protocol Violation|0|||
131813799|NCT03100344|474600616|FG002|Overall Study|Protocol Violation|0|||
131813800|NCT03100344|474600617|FG003|Overall Study|Protocol Violation|0|||
131813801|NCT03100344|474600614|FG000|Overall Study|Withdrawal by Subject|10|||
131813802|NCT03100344|474600615|FG001|Overall Study|Withdrawal by Subject|7|||
131909507|NCT05219162|474956790|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
131909508|NCT05219162|474956790|FG000|Overall Study|Withdrawal by Subject|23|||
131400330|NCT04826094|473087699|FG007|Overall Study|Withdrawn by Investigator|1|||
131400331|NCT04826094|473087692|FG000|Overall Study|Other: Moved from area|1|||
131400332|NCT04826094|473087693|FG001|Overall Study|Other: Moved from area|1|||
131400333|NCT04826094|473087694|FG002|Overall Study|Other: Moved from area|1|||
131400334|NCT04826094|473087695|FG003|Overall Study|Other: Moved from area|0|||
131400335|NCT04826094|473087696|FG004|Overall Study|Other: Moved from area|0|||
131400336|NCT04826094|473087697|FG005|Overall Study|Other: Moved from area|0|||
131400337|NCT04826094|473087698|FG006|Overall Study|Other: Moved from area|0|||
131400338|NCT04826094|473087699|FG007|Overall Study|Other: Moved from area|0|||
131400339|NCT04826094|473087692|FG000|Overall Study|Other: Declined|0|||
131400340|NCT04826094|473087693|FG001|Overall Study|Other: Declined|0|||
131400341|NCT04826094|473087694|FG002|Overall Study|Other: Declined|0|||
131400342|NCT04826094|473087695|FG003|Overall Study|Other: Declined|0|||
131400343|NCT04826094|473087696|FG004|Overall Study|Other: Declined|1|||
131400344|NCT04826094|473087697|FG005|Overall Study|Other: Declined|0|||
131400345|NCT04826094|473087698|FG006|Overall Study|Other: Declined|0|||
131400346|NCT04826094|473087699|FG007|Overall Study|Other: Declined|0|||
131400347|NCT04826094|473087692|FG000|Overall Study|Other: Vaccine not administered|0|||
131400348|NCT04826094|473087693|FG001|Overall Study|Other: Vaccine not administered|0|||
131813803|NCT03100344|474600616|FG002|Overall Study|Withdrawal by Subject|4|||
131813804|NCT03100344|474600617|FG003|Overall Study|Withdrawal by Subject|8|||
131813805|NCT03100344|474600614|FG000|Overall Study|Lost to Follow-up|1|||
131909509|NCT01200329|474956794|FG000|Overall Study|Lack of financial coverage|2|||
131909510|NCT01200329|474956794|FG000|Overall Study|Progressive disease|1|||
131909511|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
131400349|NCT04826094|473087694|FG002|Overall Study|Other: Vaccine not administered|1|||
131400350|NCT04826094|473087695|FG003|Overall Study|Other: Vaccine not administered|0|||
131400351|NCT04826094|473087696|FG004|Overall Study|Other: Vaccine not administered|0|||
131400352|NCT04826094|473087697|FG005|Overall Study|Other: Vaccine not administered|1|||
131400353|NCT04826094|473087698|FG006|Overall Study|Other: Vaccine not administered|1|||
131400354|NCT04826094|473087699|FG007|Overall Study|Other: Vaccine not administered|3|||
131400355|NCT03931382|473087700|FG000|Overall Study|Equipment malfunction|2|||
131813806|NCT03100344|474600615|FG001|Overall Study|Lost to Follow-up|1|||
131813807|NCT03100344|474600616|FG002|Overall Study|Lost to Follow-up|1|||
131813808|NCT03100344|474600617|FG003|Overall Study|Lost to Follow-up|1|||
131400356|NCT03931382|473087701|FG001|Overall Study|Equipment malfunction|0|||
131400357|NCT03931382|473087702|FG002|Overall Study|Equipment malfunction|2|||
131400358|NCT03931382|473087700|FG000|Overall Study|Withdrawal by Subject|0|||
131400359|NCT03931382|473087701|FG001|Overall Study|Withdrawal by Subject|1|||
131400360|NCT03931382|473087702|FG002|Overall Study|Withdrawal by Subject|0|||
131400361|NCT00778375|473087706|FG000|Overall Study|Ineligible|3|||
131400362|NCT00939029|473087707|FG000|Overall Study|Withdrawal by Subject|3|||
131400363|NCT00939029|473087708|FG001|Overall Study|Withdrawal by Subject|7|||
131813809|NCT01010503|474600618|FG000|Overall Study|Adverse Event|1|||
131813810|NCT01010503|474600618|FG000|Overall Study|Death|1|||
131813811|NCT04633564|474600619|FG000|Period 1|Adverse Event|28|||
131813812|NCT04633564|474600620|FG001|Period 1|Adverse Event|19|||
131400364|NCT00939029|473087707|FG000|Overall Study|Lost to Follow-up|3|||
131400365|NCT00939029|473087708|FG001|Overall Study|Lost to Follow-up|4|||
131400366|NCT00939029|473087707|FG000|Overall Study|Adverse Event|0|||
131400367|NCT00939029|473087708|FG001|Overall Study|Adverse Event|1|||
131400368|NCT01421303|473087710|FG000|Overall Study|Lost to Follow-up|13|||
131400369|NCT01421303|473087710|FG000|Overall Study|Non compliance with study procedure|1|||
131400370|NCT01421303|473087710|FG000|Overall Study|Other|7|||
131400371|NCT01421303|473087710|FG000|Overall Study|Withdrawal by Subject|1|||
131400372|NCT06003777|473087711|FG000|Period 1|Adverse Event|0|||
131764080|NCT00535236|474413127|FG009|Overall Study|Lost to Follow-up|1|||
131764081|NCT00535236|474413118|FG000|Overall Study|Physician Decision|0|||
131764082|NCT00535236|474413119|FG001|Overall Study|Physician Decision|0|||
131764083|NCT00535236|474413120|FG002|Overall Study|Physician Decision|0|||
131764084|NCT00535236|474413121|FG003|Overall Study|Physician Decision|0|||
131764085|NCT00535236|474413122|FG004|Overall Study|Physician Decision|1|||
131764086|NCT00535236|474413123|FG005|Overall Study|Physician Decision|0|||
131764087|NCT00535236|474413124|FG006|Overall Study|Physician Decision|1|||
131764088|NCT00535236|474413125|FG007|Overall Study|Physician Decision|0|||
131764089|NCT00535236|474413126|FG008|Overall Study|Physician Decision|0|||
131764090|NCT00535236|474413127|FG009|Overall Study|Physician Decision|0|||
131764091|NCT00535236|474413118|FG000|Overall Study|Protocol Violation|2|||
131764092|NCT00535236|474413119|FG001|Overall Study|Protocol Violation|0|||
131764093|NCT00535236|474413120|FG002|Overall Study|Protocol Violation|1|||
131764094|NCT00535236|474413121|FG003|Overall Study|Protocol Violation|0|||
131764095|NCT00535236|474413122|FG004|Overall Study|Protocol Violation|0|||
131764096|NCT00535236|474413123|FG005|Overall Study|Protocol Violation|0|||
131764097|NCT00535236|474413124|FG006|Overall Study|Protocol Violation|0|||
131764098|NCT00535236|474413125|FG007|Overall Study|Protocol Violation|0|||
131764099|NCT00535236|474413126|FG008|Overall Study|Protocol Violation|1|||
131764100|NCT00535236|474413127|FG009|Overall Study|Protocol Violation|0|||
131764101|NCT00535236|474413118|FG000|Overall Study|Withdrawal by Subject|3|||
131764102|NCT00535236|474413119|FG001|Overall Study|Withdrawal by Subject|0|||
131764103|NCT00535236|474413120|FG002|Overall Study|Withdrawal by Subject|2|||
131764104|NCT00535236|474413121|FG003|Overall Study|Withdrawal by Subject|1|||
131764105|NCT00535236|474413122|FG004|Overall Study|Withdrawal by Subject|6|||
131764106|NCT00535236|474413123|FG005|Overall Study|Withdrawal by Subject|1|||
131764107|NCT00535236|474413124|FG006|Overall Study|Withdrawal by Subject|5|||
131764108|NCT00535236|474413125|FG007|Overall Study|Withdrawal by Subject|0|||
131764109|NCT00535236|474413126|FG008|Overall Study|Withdrawal by Subject|4|||
131764110|NCT00535236|474413127|FG009|Overall Study|Withdrawal by Subject|2|||
131764111|NCT03288987|474413129|FG000|Overall Study|Protocol Violation|10|||
131764112|NCT03288987|474413130|FG001|Overall Study|Protocol Violation|4|||
131764113|NCT02807376|474413131|FG000|Overall Study|Intra-operative exclusion criteria|3|||
131764114|NCT02807376|474413132|FG001|Overall Study|Intra-operative exclusion criteria|0|||
131764115|NCT02807376|474413131|FG000|Overall Study|Lost to Follow-up|0|||
131764116|NCT02807376|474413132|FG001|Overall Study|Lost to Follow-up|1|||
131813813|NCT04633564|474600619|FG000|Period 1|Death|8|||
131813814|NCT04633564|474600620|FG001|Period 1|Death|7|||
131813815|NCT04633564|474600619|FG000|Period 1|Lost to Follow-up|3|||
131813816|NCT04633564|474600620|FG001|Period 1|Lost to Follow-up|5|||
131813817|NCT04633564|474600619|FG000|Period 1|Physician Decision|4|||
131813818|NCT04633564|474600620|FG001|Period 1|Physician Decision|12|||
131813819|NCT04633564|474600619|FG000|Period 1|Protocol Violation|0|||
131813820|NCT04633564|474600620|FG001|Period 1|Protocol Violation|1|||
131813821|NCT04633564|474600619|FG000|Period 1|Withdrawal by Subject|10|||
131813822|NCT04633564|474600620|FG001|Period 1|Withdrawal by Subject|8|||
131813823|NCT04633564|474600619|FG000|Period 1|Progressive disease|47|||
131813824|NCT04633564|474600620|FG001|Period 1|Progressive disease|51|||
131764117|NCT04905563|474413135|FG000|Overall Study|Withdrawal by Subject|1|||
131813825|NCT04633564|474600619|FG000|Period 1|Terminated by Sponsor|8|||
131813826|NCT04633564|474600620|FG001|Period 1|Terminated by Sponsor|6|||
131813827|NCT04633564|474600619|FG000|Period 2|Adverse Event|3|||
131813828|NCT04633564|474600620|FG001|Period 2|Adverse Event|4|||
131813829|NCT04633564|474600619|FG000|Period 2|Death|0|||
131813830|NCT04633564|474600620|FG001|Period 2|Death|2|||
131813831|NCT04633564|474600619|FG000|Period 2|Lost to Follow-up|0|||
131813832|NCT04633564|474600620|FG001|Period 2|Lost to Follow-up|1|||
131813833|NCT04633564|474600619|FG000|Period 2|Physician Decision|2|||
131813834|NCT04633564|474600620|FG001|Period 2|Physician Decision|4|||
131764118|NCT04905563|474413136|FG001|Overall Study|Withdrawal by Subject|0|||
131764119|NCT04905563|474413135|FG000|Overall Study|Standard of care orders entered by resident|1|||
131764120|NCT04905563|474413136|FG001|Overall Study|Standard of care orders entered by resident|0|||
131764121|NCT04905563|474413135|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
131764122|NCT04905563|474413136|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
131764123|NCT04905563|474413135|FG000|Overall Study|Withdrawal by Subject|0|||
131813835|NCT04633564|474600619|FG000|Period 2|Withdrawal by Subject|5|||
131813836|NCT04633564|474600620|FG001|Period 2|Withdrawal by Subject|1|||
131813837|NCT04633564|474600619|FG000|Period 2|Progressive Disease|74|||
131813838|NCT04633564|474600620|FG001|Period 2|Progressive Disease|82|||
131764124|NCT04905563|474413136|FG001|Overall Study|Withdrawal by Subject|1|||
131764125|NCT00808028|474413139|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
131764126|NCT00808028|474413140|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
131764127|NCT00808028|474413141|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
131764128|NCT00808028|474413142|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
131764129|NCT00808028|474413139|FG000|Stage 1 (6 Months)|Other|1|||
131764130|NCT00808028|474413140|FG001|Stage 1 (6 Months)|Other|0|||
131764131|NCT00808028|474413141|FG002|Stage 1 (6 Months)|Other|2|||
131764132|NCT00808028|474413142|FG003|Stage 1 (6 Months)|Other|4|||
131764133|NCT00808028|474413139|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
131764134|NCT00808028|474413140|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
131764135|NCT00808028|474413141|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
131764136|NCT00808028|474413142|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
131764137|NCT00808028|474413139|FG000|Stage 1 (6 Months)|Adverse Event|0|||
131764138|NCT00808028|474413140|FG001|Stage 1 (6 Months)|Adverse Event|0|||
131764139|NCT00808028|474413141|FG002|Stage 1 (6 Months)|Adverse Event|1|||
131764140|NCT00808028|474413142|FG003|Stage 1 (6 Months)|Adverse Event|2|||
131764141|NCT00808028|474413139|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
131764142|NCT00808028|474413140|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
131764143|NCT00808028|474413141|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
131764144|NCT00808028|474413142|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
131764145|NCT00808028|474413139|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
131764146|NCT00808028|474413140|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
131764147|NCT00808028|474413141|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
131764148|NCT00808028|474413142|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
131764149|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
131764150|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
131764151|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
131764152|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
131764153|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
131764154|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
131764155|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
131449833|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
131764156|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
131764157|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
131764158|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
131764159|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
131764160|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
131764161|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
131764162|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
131764163|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
131764164|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
131764165|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
131764166|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
131764167|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
131764168|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
131764169|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
131764170|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
131764171|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
131764172|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
131764173|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
131764174|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
131764175|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
131764176|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
131764177|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
131764178|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
131764179|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
131764180|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
131764181|NCT00808028|474413139|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
131764182|NCT00808028|474413140|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
131764183|NCT00808028|474413141|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
131764184|NCT00808028|474413142|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
131764185|NCT00948389|474413143|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
131764186|NCT00948389|474413144|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
131764187|NCT00948389|474413145|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
131764188|NCT00948389|474413146|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
131764189|NCT00948389|474413147|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
131764190|NCT00948389|474413143|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
131764191|NCT00948389|474413144|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
131764192|NCT00948389|474413145|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
131764193|NCT00948389|474413146|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
131400373|NCT06003777|473087712|FG001|Period 1|Adverse Event|0|||
131400374|NCT06003777|473087713|FG002|Period 1|Adverse Event|1|||
131400375|NCT06003777|473087714|FG003|Period 1|Adverse Event|0|||
131400376|NCT06003777|473087715|FG004|Period 1|Adverse Event|0|||
131764194|NCT00948389|474413147|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
131764195|NCT00948389|474413143|FG000|Overall Study|Both Progression and Toxicity|1|||
131813839|NCT04633564|474600619|FG000|Period 2|Terminated by Sponsor|9|||
131813840|NCT04633564|474600620|FG001|Period 2|Terminated by Sponsor|3|||
131813841|NCT02068794|474601753|FG000|Overall Study|Withdrawal by Subject|0|||
131813842|NCT02068794|474601754|FG001|Overall Study|Withdrawal by Subject|1|||
131813843|NCT02068794|474601755|FG002|Overall Study|Withdrawal by Subject|2|||
131813844|NCT02068794|474601753|FG000|Overall Study|Early Progression|1|||
131813845|NCT02068794|474601754|FG001|Overall Study|Early Progression|0|||
131813846|NCT02068794|474601755|FG002|Overall Study|Early Progression|1|||
131764196|NCT00948389|474413144|FG001|Overall Study|Both Progression and Toxicity|0|||
131764197|NCT00948389|474413145|FG002|Overall Study|Both Progression and Toxicity|0|||
131764198|NCT00948389|474413146|FG003|Overall Study|Both Progression and Toxicity|0|||
131764199|NCT00948389|474413147|FG004|Overall Study|Both Progression and Toxicity|0|||
131764200|NCT00508001|474413148|FG000|Overall Study|Adverse Event|2|||
131764201|NCT00508001|474413149|FG001|Overall Study|Adverse Event|0|||
131764202|NCT00508001|474413150|FG002|Overall Study|Adverse Event|4|||
131764203|NCT00508001|474413148|FG000|Overall Study|condition under investigation worsened|13|||
131764204|NCT00508001|474413149|FG001|Overall Study|condition under investigation worsened|7|||
131764205|NCT00508001|474413150|FG002|Overall Study|condition under investigation worsened|1|||
131764206|NCT00508001|474413148|FG000|Overall Study|Death|0|||
131764207|NCT00508001|474413149|FG001|Overall Study|Death|1|||
131764208|NCT00508001|474413150|FG002|Overall Study|Death|1|||
131764209|NCT00508001|474413148|FG000|Overall Study|Withdrawal by Subject|4|||
131764210|NCT00508001|474413149|FG001|Overall Study|Withdrawal by Subject|4|||
131764211|NCT00508001|474413150|FG002|Overall Study|Withdrawal by Subject|1|||
131764212|NCT00732199|474413153|FG000|Overall Study|Withdrawal by Subject|25|||
131764213|NCT00732199|474413154|FG001|Overall Study|Withdrawal by Subject|18|||
131764214|NCT00732199|474413153|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
131764215|NCT00732199|474413154|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
131764216|NCT02718625|474413163|FG000|Overall Study|Adverse Event|0|||
131764217|NCT02718625|474413164|FG001|Overall Study|Adverse Event|1|||
131764218|NCT02718625|474413163|FG000|Overall Study|Termination of Study by Sponsor|0|||
131764219|NCT02718625|474413164|FG001|Overall Study|Termination of Study by Sponsor|1|||
131764220|NCT01947127|474413169|FG000|Overall Study|Protocol Violation|18|||
131764221|NCT01947127|474413170|FG001|Overall Study|Protocol Violation|38|||
131764222|NCT01947127|474413169|FG000|Overall Study|Withdrawal by Subject|1|||
131764223|NCT01947127|474413170|FG001|Overall Study|Withdrawal by Subject|1|||
131764224|NCT01947127|474413169|FG000|Overall Study|Data loss|4|||
131764225|NCT01947127|474413170|FG001|Overall Study|Data loss|4|||
131764226|NCT01836549|474413171|FG000|Overall Study|Did not receive study drug|0|||
131764227|NCT01836549|474413172|FG001|Overall Study|Did not receive study drug|0|||
131764228|NCT01836549|474413173|FG002|Overall Study|Did not receive study drug|1|||
131764229|NCT01836549|474413174|FG003|Overall Study|Did not receive study drug|0|||
131764230|NCT01836549|474413175|FG004|Overall Study|Did not receive study drug|0|||
131764231|NCT01836549|474413176|FG005|Overall Study|Did not receive study drug|0|||
131764232|NCT01836549|474413177|FG006|Overall Study|Did not receive study drug|0|||
131764233|NCT01836549|474413171|FG000|Overall Study|Patient declared ineligible|0|||
131813847|NCT02068794|474601753|FG000|Overall Study|Ineligible|0|||
131813848|NCT02068794|474601754|FG001|Overall Study|Ineligible|0|||
131813849|NCT02068794|474601755|FG002|Overall Study|Ineligible|1|||
131813850|NCT01958294|474601756|FG000|Overall Study|Clinical Circumstances|2|||
131813851|NCT00682461|474601760|FG000|Overall Study|Adverse Event|5|||
131813852|NCT00682461|474601761|FG001|Overall Study|Adverse Event|7|||
131813853|NCT00682461|474601760|FG000|Overall Study|Lost to Follow-up|8|||
131813854|NCT00682461|474601761|FG001|Overall Study|Lost to Follow-up|5|||
131400377|NCT06003777|473087716|FG005|Period 1|Adverse Event|0|||
131400378|NCT06003777|473087717|FG006|Period 1|Adverse Event|0|||
131813855|NCT00682461|474601760|FG000|Overall Study|Withdrawal by Subject|12|||
131400379|NCT06003777|473087718|FG007|Period 1|Adverse Event|0|||
131764234|NCT01836549|474413172|FG001|Overall Study|Patient declared ineligible|0|||
131813856|NCT00682461|474601761|FG001|Overall Study|Withdrawal by Subject|19|||
131400380|NCT06003777|473087719|FG008|Period 1|Adverse Event|0|||
131400381|NCT06003777|473087720|FG009|Period 1|Adverse Event|0|||
131400382|NCT06003777|473087721|FG010|Period 1|Adverse Event|0|||
131764235|NCT01836549|474413173|FG002|Overall Study|Patient declared ineligible|0|||
131764236|NCT01836549|474413174|FG003|Overall Study|Patient declared ineligible|1|||
131764237|NCT01836549|474413175|FG004|Overall Study|Patient declared ineligible|0|||
131764238|NCT01836549|474413176|FG005|Overall Study|Patient declared ineligible|0|||
131764239|NCT01836549|474413177|FG006|Overall Study|Patient declared ineligible|0|||
131764240|NCT01836549|474413171|FG000|Overall Study|Patient inevaluable to start therapy|0|||
131764241|NCT01836549|474413172|FG001|Overall Study|Patient inevaluable to start therapy|0|||
131764242|NCT01836549|474413173|FG002|Overall Study|Patient inevaluable to start therapy|0|||
131764243|NCT01836549|474413174|FG003|Overall Study|Patient inevaluable to start therapy|0|||
131764244|NCT01836549|474413175|FG004|Overall Study|Patient inevaluable to start therapy|0|||
131764245|NCT01836549|474413176|FG005|Overall Study|Patient inevaluable to start therapy|0|||
131764246|NCT01836549|474413177|FG006|Overall Study|Patient inevaluable to start therapy|1|||
131400383|NCT06003777|473087722|FG011|Period 1|Adverse Event|0|||
131400384|NCT06003777|473087711|FG000|Period 1|Withdrawal by Subject|0|||
131400385|NCT06003777|473087712|FG001|Period 1|Withdrawal by Subject|0|||
131400386|NCT06003777|473087713|FG002|Period 1|Withdrawal by Subject|0|||
131400387|NCT06003777|473087714|FG003|Period 1|Withdrawal by Subject|0|||
131400388|NCT06003777|473087715|FG004|Period 1|Withdrawal by Subject|1|||
131400389|NCT06003777|473087716|FG005|Period 1|Withdrawal by Subject|0|||
131400390|NCT06003777|473087717|FG006|Period 1|Withdrawal by Subject|0|||
131400391|NCT06003777|473087718|FG007|Period 1|Withdrawal by Subject|0|||
131400392|NCT06003777|473087719|FG008|Period 1|Withdrawal by Subject|0|||
131400393|NCT06003777|473087720|FG009|Period 1|Withdrawal by Subject|0|||
131400394|NCT06003777|473087721|FG010|Period 1|Withdrawal by Subject|0|||
131400395|NCT06003777|473087722|FG011|Period 1|Withdrawal by Subject|0|||
131400396|NCT06003777|473087711|FG000|Period 2|Withdrawal by Subject|0|||
131400397|NCT06003777|473087712|FG001|Period 2|Withdrawal by Subject|0|||
131400398|NCT06003777|473087713|FG002|Period 2|Withdrawal by Subject|0|||
131400399|NCT06003777|473087714|FG003|Period 2|Withdrawal by Subject|0|||
131400400|NCT06003777|473087715|FG004|Period 2|Withdrawal by Subject|0|||
131400401|NCT06003777|473087716|FG005|Period 2|Withdrawal by Subject|0|||
131400402|NCT06003777|473087717|FG006|Period 2|Withdrawal by Subject|0|||
131400403|NCT06003777|473087718|FG007|Period 2|Withdrawal by Subject|0|||
131400404|NCT06003777|473087719|FG008|Period 2|Withdrawal by Subject|1|||
131400405|NCT06003777|473087720|FG009|Period 2|Withdrawal by Subject|0|||
131400406|NCT06003777|473087721|FG010|Period 2|Withdrawal by Subject|0|||
131400407|NCT06003777|473087722|FG011|Period 2|Withdrawal by Subject|0|||
131400408|NCT06003777|473087711|FG000|Period 3|Adverse Event|0|||
131400409|NCT06003777|473087712|FG001|Period 3|Adverse Event|0|||
131400410|NCT06003777|473087713|FG002|Period 3|Adverse Event|0|||
131400411|NCT06003777|473087714|FG003|Period 3|Adverse Event|0|||
131400412|NCT06003777|473087715|FG004|Period 3|Adverse Event|0|||
131400413|NCT06003777|473087716|FG005|Period 3|Adverse Event|0|||
131400414|NCT06003777|473087717|FG006|Period 3|Adverse Event|1|||
131400415|NCT06003777|473087718|FG007|Period 3|Adverse Event|0|||
131400416|NCT06003777|473087719|FG008|Period 3|Adverse Event|0|||
131400417|NCT06003777|473087720|FG009|Period 3|Adverse Event|0|||
131400418|NCT06003777|473087721|FG010|Period 3|Adverse Event|0|||
131400419|NCT06003777|473087722|FG011|Period 3|Adverse Event|0|||
131400420|NCT06003777|473087711|FG000|Period 4|No longer met eligibility criteria|0|||
131400421|NCT06003777|473087712|FG001|Period 4|No longer met eligibility criteria|0|||
131400422|NCT06003777|473087713|FG002|Period 4|No longer met eligibility criteria|1|||
131400423|NCT06003777|473087714|FG003|Period 4|No longer met eligibility criteria|0|||
131400424|NCT06003777|473087715|FG004|Period 4|No longer met eligibility criteria|0|||
131400425|NCT06003777|473087716|FG005|Period 4|No longer met eligibility criteria|0|||
131400426|NCT06003777|473087717|FG006|Period 4|No longer met eligibility criteria|0|||
131400427|NCT06003777|473087718|FG007|Period 4|No longer met eligibility criteria|0|||
131400428|NCT06003777|473087719|FG008|Period 4|No longer met eligibility criteria|0|||
131400429|NCT06003777|473087720|FG009|Period 4|No longer met eligibility criteria|0|||
131400430|NCT06003777|473087721|FG010|Period 4|No longer met eligibility criteria|0|||
131400431|NCT06003777|473087722|FG011|Period 4|No longer met eligibility criteria|0|||
131400432|NCT06003777|473087711|FG000|Period 4|Withdrawal by Subject|0|||
131400433|NCT06003777|473087712|FG001|Period 4|Withdrawal by Subject|1|||
131400434|NCT06003777|473087713|FG002|Period 4|Withdrawal by Subject|0|||
131400435|NCT06003777|473087714|FG003|Period 4|Withdrawal by Subject|0|||
131400436|NCT06003777|473087715|FG004|Period 4|Withdrawal by Subject|0|||
131400437|NCT06003777|473087716|FG005|Period 4|Withdrawal by Subject|0|||
131400438|NCT06003777|473087717|FG006|Period 4|Withdrawal by Subject|0|||
131400439|NCT06003777|473087718|FG007|Period 4|Withdrawal by Subject|0|||
131400440|NCT06003777|473087719|FG008|Period 4|Withdrawal by Subject|0|||
131400441|NCT06003777|473087720|FG009|Period 4|Withdrawal by Subject|0|||
131400442|NCT06003777|473087721|FG010|Period 4|Withdrawal by Subject|0|||
131400443|NCT06003777|473087722|FG011|Period 4|Withdrawal by Subject|0|||
131400444|NCT00675441|473087724|FG000|Overall Study|Withdrawal by Subject|2|||
131400445|NCT00675441|473087724|FG000|Overall Study|Death|1|||
131400446|NCT00700882|473087728|FG000|Overall Study|Never received treatment|6|||
131400447|NCT00700882|473087728|FG000|Overall Study|Ineligible|2|||
131400448|NCT00700882|473087728|FG000|Overall Study|No KIT mutation|51|||
131400449|NCT04154293|473087732|FG000|Overall Study|Withdrawal by Subject|2|||
131400450|NCT04154293|473087733|FG001|Overall Study|Withdrawal by Subject|3|||
131400451|NCT04154293|473087734|FG002|Overall Study|Withdrawal by Subject|1|||
131400452|NCT04154293|473087732|FG000|Overall Study|Physician Decision|0|||
131400453|NCT04154293|473087733|FG001|Overall Study|Physician Decision|0|||
131400454|NCT04154293|473087734|FG002|Overall Study|Physician Decision|1|||
131400455|NCT04731298|473087735|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
131400456|NCT04731298|473087736|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
131400457|NCT01208961|473087737|FG000|High-Fat Period III|Protocol Violation|1|||
131400458|NCT01208961|473087738|FG001|High-Fat Period III|Protocol Violation|0|||
131400459|NCT03403361|473087739|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
131400460|NCT02152371|473087741|FG000|Overall Study|Adverse Event|6|||
131400461|NCT02152371|473087742|FG001|Overall Study|Adverse Event|2|||
131400462|NCT02152371|473087741|FG000|Overall Study|Withdrawal by Subject|3|||
131400463|NCT02152371|473087742|FG001|Overall Study|Withdrawal by Subject|7|||
131400464|NCT02152371|473087741|FG000|Overall Study|Protocol Violation|2|||
131400465|NCT02152371|473087742|FG001|Overall Study|Protocol Violation|3|||
131400466|NCT02152371|473087741|FG000|Overall Study|Lost to Follow-up|1|||
131400467|NCT02152371|473087742|FG001|Overall Study|Lost to Follow-up|0|||
131400468|NCT02152371|473087741|FG000|Overall Study|Lack of Efficacy|0|||
131400469|NCT02152371|473087742|FG001|Overall Study|Lack of Efficacy|1|||
131400470|NCT02152371|473087741|FG000|Overall Study|Physician Decision|0|||
131400471|NCT02152371|473087742|FG001|Overall Study|Physician Decision|2|||
131400472|NCT02152371|473087741|FG000|Overall Study|Reason Not Given|0|||
131400473|NCT02152371|473087742|FG001|Overall Study|Reason Not Given|1|||
131400474|NCT04113018|473087749|FG000|Overall Study|Death|2|||
131400475|NCT04113018|473087749|FG000|Overall Study|Lost to Follow-up|1|||
131400476|NCT04113018|473087749|FG000|Overall Study|Still On Study (on study treatment)|24|||
131400477|NCT04113018|473087749|FG000|Overall Study|Still On Study (in follow up)|12|||
131400478|NCT03802630|473087750|FG000|Overall Study|Study terminated by sponsor|130|||
131400479|NCT03802630|473087751|FG001|Overall Study|Study terminated by sponsor|134|||
131400480|NCT03802630|473087750|FG000|Overall Study|Subject decision|16|||
131400481|NCT03802630|473087751|FG001|Overall Study|Subject decision|9|||
131400482|NCT03802630|473087750|FG000|Overall Study|Adverse Event|3|||
131400483|NCT03802630|473087751|FG001|Overall Study|Adverse Event|1|||
131400484|NCT03802630|473087750|FG000|Overall Study|Lost to Follow-up|2|||
131400485|NCT03802630|473087751|FG001|Overall Study|Lost to Follow-up|2|||
131400486|NCT03802630|473087750|FG000|Overall Study|Physician Decision|2|||
131400487|NCT03802630|473087751|FG001|Overall Study|Physician Decision|0|||
131400488|NCT03802630|473087750|FG000|Overall Study|Death|0|||
131400489|NCT03802630|473087751|FG001|Overall Study|Death|2|||
131400490|NCT01108731|473087752|FG000|Overall Study|Withdrawal by Subject|1|||
131400491|NCT01108731|473087753|FG001|Overall Study|Withdrawal by Subject|1|||
131400492|NCT01108731|473087752|FG000|Overall Study|Adverse Event|3|||
131400493|NCT01108731|473087753|FG001|Overall Study|Adverse Event|3|||
131400494|NCT00157196|473087754|FG000|Overall Study|Ongoing at data cut-off|9|||
131400495|NCT04210245|473087755|FG000|Overall Study|Adverse Event|0|||
131400496|NCT04210245|473087756|FG001|Overall Study|Adverse Event|3|||
131400497|NCT04210245|473087757|FG002|Overall Study|Adverse Event|6|||
131400498|NCT04210245|473087758|FG003|Overall Study|Adverse Event|0|||
131400499|NCT04210245|473087755|FG000|Overall Study|Withdrawal by Subject|0|||
131400500|NCT04210245|473087756|FG001|Overall Study|Withdrawal by Subject|1|||
131400501|NCT04210245|473087757|FG002|Overall Study|Withdrawal by Subject|4|||
131400502|NCT04210245|473087758|FG003|Overall Study|Withdrawal by Subject|4|||
131400503|NCT04210245|473087755|FG000|Overall Study|Lost to Follow-up|0|||
131400504|NCT04210245|473087756|FG001|Overall Study|Lost to Follow-up|1|||
131400505|NCT04210245|473087757|FG002|Overall Study|Lost to Follow-up|1|||
131400506|NCT04210245|473087758|FG003|Overall Study|Lost to Follow-up|1|||
131400507|NCT04210245|473087755|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
131400508|NCT04210245|473087756|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
131400509|NCT04210245|473087757|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
131400510|NCT04210245|473087758|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
131400511|NCT06099223|473087759|FG000|Overall Study|Preoperative surveys missed|0|||
131400512|NCT06099223|473087760|FG001|Overall Study|Preoperative surveys missed|1|||
131400513|NCT01802580|473087763|FG000|Overall Study|Physician Decision|1|||
131400514|NCT01802580|473087764|FG001|Overall Study|Physician Decision|0|||
131400515|NCT01802580|473087763|FG000|Overall Study|Protocol Violation|2|||
131400516|NCT01802580|473087764|FG001|Overall Study|Protocol Violation|0|||
131400517|NCT01802580|473087763|FG000|Overall Study|Withdrawal by Subject|5|||
131764247|NCT04652102|474413178|FG000|Overall Study|Adverse Event|14|||
131764248|NCT04652102|474413179|FG001|Overall Study|Adverse Event|13|||
131764249|NCT04652102|474413178|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
131909512|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
131764250|NCT04652102|474413179|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
131400518|NCT01802580|473087764|FG001|Overall Study|Withdrawal by Subject|6|||
131400519|NCT01802580|473087763|FG000|Overall Study|Other|1|||
131400520|NCT01802580|473087764|FG001|Overall Study|Other|3|||
131400521|NCT01802580|473087763|FG000|Overall Study|Lack of Efficacy|0|||
131400522|NCT01802580|473087764|FG001|Overall Study|Lack of Efficacy|2|||
131400523|NCT01252186|473087765|FG000|Overall Study|Adverse Event|9|||
131400524|NCT01252186|473087766|FG001|Overall Study|Adverse Event|6|||
131400525|NCT01252186|473087767|FG002|Overall Study|Adverse Event|8|||
131400526|NCT01252186|473087765|FG000|Overall Study|Withdrawal by Subject|2|||
131400527|NCT01252186|473087766|FG001|Overall Study|Withdrawal by Subject|5|||
131400528|NCT01252186|473087767|FG002|Overall Study|Withdrawal by Subject|2|||
131400529|NCT01252186|473087765|FG000|Overall Study|Physician Decision|0|||
131400530|NCT01252186|473087766|FG001|Overall Study|Physician Decision|0|||
131400531|NCT01252186|473087767|FG002|Overall Study|Physician Decision|1|||
131400532|NCT01252186|473087765|FG000|Overall Study|Non-compliance|0|||
131400533|NCT01252186|473087766|FG001|Overall Study|Non-compliance|3|||
131400534|NCT01252186|473087767|FG002|Overall Study|Non-compliance|4|||
131400535|NCT01252186|473087765|FG000|Overall Study|Protocol Violation|0|||
131400536|NCT01252186|473087766|FG001|Overall Study|Protocol Violation|0|||
131400537|NCT01252186|473087767|FG002|Overall Study|Protocol Violation|1|||
131400538|NCT01252186|473087765|FG000|Overall Study|Pregnancy|2|||
131400539|NCT01252186|473087766|FG001|Overall Study|Pregnancy|2|||
131400540|NCT01252186|473087767|FG002|Overall Study|Pregnancy|0|||
131400541|NCT01252186|473087765|FG000|Overall Study|Sponsor Request|2|||
131400542|NCT01252186|473087766|FG001|Overall Study|Sponsor Request|1|||
131400543|NCT01252186|473087767|FG002|Overall Study|Sponsor Request|0|||
131400544|NCT01252186|473087765|FG000|Overall Study|Lost to Follow-up|10|||
131400545|NCT01252186|473087766|FG001|Overall Study|Lost to Follow-up|10|||
131400546|NCT01252186|473087767|FG002|Overall Study|Lost to Follow-up|11|||
131400547|NCT01252186|473087765|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
131400548|NCT01252186|473087766|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
131400549|NCT01252186|473087767|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
131400550|NCT02644096|473087772|FG000|Overall Study|Withdrawal by Subject|28|||
131400551|NCT02644096|473087773|FG001|Overall Study|Withdrawal by Subject|25|||
131400552|NCT02461290|473087774|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
131400553|NCT02461290|473087774|FG000|Overall Study|Lost to Follow-up|3|||
131813857|NCT00772603|474601762|FG000|Overall Study|Withdrawal by Subject|11|||
131813858|NCT00772603|474601763|FG001|Overall Study|Withdrawal by Subject|10|||
131813859|NCT00772603|474601764|FG002|Overall Study|Withdrawal by Subject|6|||
131813860|NCT00772603|474601762|FG000|Overall Study|Adverse Event|37|||
131813861|NCT00772603|474601763|FG001|Overall Study|Adverse Event|18|||
131813862|NCT00772603|474601764|FG002|Overall Study|Adverse Event|10|||
131813863|NCT00772603|474601762|FG000|Overall Study|Subject Non-compliance|1|||
131813864|NCT00772603|474601763|FG001|Overall Study|Subject Non-compliance|6|||
131813865|NCT00772603|474601764|FG002|Overall Study|Subject Non-compliance|4|||
131813866|NCT00772603|474601762|FG000|Overall Study|Protocol Violation|0|||
131813867|NCT00772603|474601763|FG001|Overall Study|Protocol Violation|1|||
131813868|NCT00772603|474601764|FG002|Overall Study|Protocol Violation|1|||
131813869|NCT00772603|474601762|FG000|Overall Study|Lost to Follow-up|1|||
131813870|NCT00772603|474601763|FG001|Overall Study|Lost to Follow-up|5|||
131813871|NCT00772603|474601764|FG002|Overall Study|Lost to Follow-up|2|||
131813872|NCT00772603|474601762|FG000|Overall Study|Physician Decision|0|||
131813873|NCT00772603|474601763|FG001|Overall Study|Physician Decision|0|||
131813874|NCT00772603|474601764|FG002|Overall Study|Physician Decision|1|||
131813875|NCT00772603|474601762|FG000|Overall Study|Other|2|||
131813876|NCT00772603|474601763|FG001|Overall Study|Other|0|||
131813877|NCT00772603|474601764|FG002|Overall Study|Other|2|||
131813878|NCT01056484|474601767|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
131813879|NCT01056484|474601768|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
131813880|NCT01056484|474601767|FG000|Randomized Controlled Trial|Physician Decision|1|||
131813881|NCT01056484|474601768|FG001|Randomized Controlled Trial|Physician Decision|0|||
131813882|NCT01056484|474601767|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
131813883|NCT01056484|474601768|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
131813884|NCT00446966|474601771|FG000|Overall Study|Lost to Follow-up|10|||
131813885|NCT00446966|474601772|FG001|Overall Study|Lost to Follow-up|7|||
131813886|NCT00443651|474601773|FG000|Overall Study|Death|1|||
131813887|NCT00443651|474601774|FG001|Overall Study|Death|5|||
131813888|NCT00443651|474601773|FG000|Overall Study|Adverse Event|5|||
131813889|NCT00443651|474601774|FG001|Overall Study|Adverse Event|6|||
131813890|NCT00443651|474601773|FG000|Overall Study|Lost to Follow-up|18|||
131813891|NCT00443651|474601774|FG001|Overall Study|Lost to Follow-up|12|||
131813892|NCT00443651|474601773|FG000|Overall Study|Patient's/Guardian's Decision|58|||
131813893|NCT00443651|474601774|FG001|Overall Study|Patient's/Guardian's Decision|30|||
131813894|NCT00443651|474601773|FG000|Overall Study|Physician Decision|13|||
131813895|NCT00443651|474601774|FG001|Overall Study|Physician Decision|4|||
131813896|NCT00443651|474601773|FG000|Overall Study|Pregnancy|0|||
131813897|NCT00443651|474601774|FG001|Overall Study|Pregnancy|1|||
131813898|NCT01564394|474601777|FG000|Overall Study|Withdrawal by Subject|6|||
131813899|NCT01564394|474601778|FG001|Overall Study|Withdrawal by Subject|10|||
131813900|NCT00859521|474601779|FG000|Washout|Withdrawal by Subject|0|||
131813901|NCT00859521|474601780|FG001|Washout|Withdrawal by Subject|1|||
131813902|NCT02888756|474601781|FG000|Analytical Treatment Interruption|Physician Decision|10|||
131813903|NCT02888756|474601782|FG001|Analytical Treatment Interruption|Physician Decision|6|||
131813904|NCT02888756|474601783|FG002|Analytical Treatment Interruption|Physician Decision|5|||
131813905|NCT01547286|474601793|FG000|Overall Study|Did not meet all eligibility criteria|1|||
131813906|NCT01547286|474601793|FG000|Overall Study|Physician Decision|1|||
131813907|NCT03415308|474601796|FG000|Overall Study|Lost to Follow-up|0|||
131813908|NCT03415308|474601797|FG001|Overall Study|Lost to Follow-up|0|||
131764251|NCT04652102|474413178|FG000|Overall Study|Physician Decision|78|||
131764252|NCT04652102|474413179|FG001|Overall Study|Physician Decision|40|||
131764253|NCT04652102|474413178|FG000|Overall Study|Study Ended by Sponsor|64|||
131764254|NCT04652102|474413179|FG001|Overall Study|Study Ended by Sponsor|17|||
131764255|NCT04652102|474413178|FG000|Overall Study|Withdrawal by Subject|4625|||
131764256|NCT04652102|474413179|FG001|Overall Study|Withdrawal by Subject|5594|||
131764257|NCT04652102|474413178|FG000|Overall Study|Lost to Follow-up|2019|||
131764258|NCT04652102|474413179|FG001|Overall Study|Lost to Follow-up|1082|||
131764259|NCT04652102|474413178|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
131764260|NCT04652102|474413179|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
131764261|NCT04652102|474413178|FG000|Overall Study|Miscellaneous|80|||
131764262|NCT04652102|474413179|FG001|Overall Study|Miscellaneous|64|||
131764263|NCT01969565|474413182|FG000|Overall Study|Withdrawal by Subject|1|||
131764264|NCT00696774|474413183|FG000|Period II|Adverse Event|0|||
131764265|NCT00696774|474413184|FG001|Period II|Adverse Event|0|||
131764266|NCT00696774|474413185|FG002|Period II|Adverse Event|15|||
131764267|NCT00696774|474413183|FG000|Period II|Lost to Follow-up|0|||
131764268|NCT00696774|474413184|FG001|Period II|Lost to Follow-up|0|||
131764269|NCT00696774|474413185|FG002|Period II|Lost to Follow-up|4|||
131764270|NCT00696774|474413183|FG000|Period II|Protocol Violation|0|||
131764271|NCT00696774|474413184|FG001|Period II|Protocol Violation|0|||
131764272|NCT00696774|474413185|FG002|Period II|Protocol Violation|11|||
131764273|NCT00696774|474413183|FG000|Period II|Withdrawal by Subject|0|||
131764274|NCT00696774|474413184|FG001|Period II|Withdrawal by Subject|0|||
131764275|NCT00696774|474413185|FG002|Period II|Withdrawal by Subject|4|||
131764276|NCT00696774|474413183|FG000|Period II|Sponsor Decision|0|||
131764277|NCT00696774|474413184|FG001|Period II|Sponsor Decision|0|||
131764278|NCT00696774|474413185|FG002|Period II|Sponsor Decision|0|||
131764279|NCT00696774|474413183|FG000|Period II|Lack of Efficacy|0|||
131764280|NCT00696774|474413184|FG001|Period II|Lack of Efficacy|0|||
131764281|NCT00696774|474413185|FG002|Period II|Lack of Efficacy|2|||
131764282|NCT00696774|474413183|FG000|Period III|Adverse Event|1|||
131764283|NCT00696774|474413184|FG001|Period III|Adverse Event|1|||
131764284|NCT00696774|474413185|FG002|Period III|Adverse Event|0|||
131764285|NCT00696774|474413183|FG000|Period III|Lost to Follow-up|2|||
131764286|NCT00696774|474413184|FG001|Period III|Lost to Follow-up|1|||
131764287|NCT00696774|474413185|FG002|Period III|Lost to Follow-up|0|||
131764288|NCT00696774|474413183|FG000|Period III|Protocol Violation|1|||
131764289|NCT00696774|474413184|FG001|Period III|Protocol Violation|1|||
131764290|NCT00696774|474413185|FG002|Period III|Protocol Violation|0|||
131764291|NCT00696774|474413183|FG000|Period III|Withdrawal by Subject|1|||
131764292|NCT00696774|474413184|FG001|Period III|Withdrawal by Subject|2|||
131764293|NCT00696774|474413185|FG002|Period III|Withdrawal by Subject|0|||
131764294|NCT00696774|474413183|FG000|Period III|Sponsor Decision|2|||
131764295|NCT00696774|474413184|FG001|Period III|Sponsor Decision|0|||
131764296|NCT00696774|474413185|FG002|Period III|Sponsor Decision|0|||
131764297|NCT00696774|474413183|FG000|Period III|Lack of Efficacy|0|||
131764298|NCT00696774|474413184|FG001|Period III|Lack of Efficacy|2|||
131764299|NCT00696774|474413185|FG002|Period III|Lack of Efficacy|0|||
131764300|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
131764301|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
131764302|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
131764303|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
131764304|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
131764305|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
131764306|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
131764307|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
131764308|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Death|0|||
131764309|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Death|0|||
131764310|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Death|0|||
131813909|NCT03415308|474601798|FG002|Overall Study|Lost to Follow-up|1|||
131813910|NCT03415308|474601796|FG000|Overall Study|Scheduling Conflicts|0|||
131764311|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Death|1|||
131764312|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Death|1|||
131764313|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Death|0|||
131764314|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Death|2|||
131764315|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Death|0|||
131764316|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764317|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764318|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764319|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
131764320|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764321|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764322|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764323|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131764324|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764325|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764326|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764327|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
131764328|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764329|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764330|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764331|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131764332|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131764333|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131764334|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131764335|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
131764336|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131764337|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
131764338|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131764339|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
131764340|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131764341|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131764342|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131764343|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
131764344|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131764345|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
131764346|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
131764347|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131764348|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131764349|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131764350|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131764351|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131764352|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
131764353|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131764354|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
131764355|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
131764356|NCT02442765|474413188|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131764357|NCT02442765|474413189|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131764358|NCT02442765|474413190|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131764359|NCT02442765|474413191|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131764360|NCT02442765|474413192|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
131764361|NCT02442765|474413193|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131764362|NCT02442765|474413194|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131764363|NCT02442765|474413195|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
131764364|NCT01200758|474413196|FG000|Stage I|Death|0|||
131764365|NCT01200758|474413197|FG001|Stage I|Death|1|||
131764366|NCT01200758|474413198|FG002|Stage I|Death|0|||
131764367|NCT01200758|474413199|FG003|Stage I|Death|0|||
131764368|NCT01200758|474413196|FG000|Stage I|Physician Decision|1|||
131764369|NCT01200758|474413197|FG001|Stage I|Physician Decision|1|||
131764370|NCT01200758|474413198|FG002|Stage I|Physician Decision|0|||
131764371|NCT01200758|474413199|FG003|Stage I|Physician Decision|0|||
131764372|NCT01200758|474413196|FG000|Stage I|Lack of Efficacy|2|||
131764373|NCT01200758|474413197|FG001|Stage I|Lack of Efficacy|1|||
131764374|NCT01200758|474413198|FG002|Stage I|Lack of Efficacy|0|||
131764375|NCT01200758|474413199|FG003|Stage I|Lack of Efficacy|0|||
131764376|NCT01200758|474413196|FG000|Stage I|Adverse Event|5|||
131764377|NCT01200758|474413197|FG001|Stage I|Adverse Event|5|||
131764378|NCT01200758|474413198|FG002|Stage I|Adverse Event|0|||
131764379|NCT01200758|474413199|FG003|Stage I|Adverse Event|0|||
131764380|NCT01200758|474413196|FG000|Stage I|Withdrawal by Subject|1|||
131764381|NCT01200758|474413197|FG001|Stage I|Withdrawal by Subject|2|||
131764382|NCT01200758|474413198|FG002|Stage I|Withdrawal by Subject|0|||
131764383|NCT01200758|474413199|FG003|Stage I|Withdrawal by Subject|0|||
131764384|NCT01200758|474413196|FG000|Stage I|Disease Progression|9|||
131764385|NCT01200758|474413197|FG001|Stage I|Disease Progression|7|||
131764386|NCT01200758|474413198|FG002|Stage I|Disease Progression|0|||
131764387|NCT01200758|474413199|FG003|Stage I|Disease Progression|0|||
131764388|NCT01200758|474413196|FG000|Stage 2|Disease Progression|0|||
131764389|NCT01200758|474413197|FG001|Stage 2|Disease Progression|0|||
131764390|NCT01200758|474413198|FG002|Stage 2|Disease Progression|16|||
131764391|NCT01200758|474413199|FG003|Stage 2|Disease Progression|21|||
131764392|NCT01200758|474413196|FG000|Stage 2|Lack of Efficacy|0|||
131764393|NCT01200758|474413197|FG001|Stage 2|Lack of Efficacy|0|||
131764394|NCT01200758|474413198|FG002|Stage 2|Lack of Efficacy|4|||
131764395|NCT01200758|474413199|FG003|Stage 2|Lack of Efficacy|2|||
131764396|NCT01200758|474413196|FG000|Stage 2|Physician Decision|0|||
131764397|NCT01200758|474413197|FG001|Stage 2|Physician Decision|0|||
131764398|NCT01200758|474413198|FG002|Stage 2|Physician Decision|5|||
131764399|NCT01200758|474413199|FG003|Stage 2|Physician Decision|7|||
131764400|NCT01200758|474413196|FG000|Stage 2|Adverse Event|0|||
131764401|NCT01200758|474413197|FG001|Stage 2|Adverse Event|0|||
131764402|NCT01200758|474413198|FG002|Stage 2|Adverse Event|5|||
131764403|NCT01200758|474413199|FG003|Stage 2|Adverse Event|9|||
131764404|NCT01200758|474413196|FG000|Stage 2|Withdrawal by Subject|0|||
131764405|NCT01200758|474413197|FG001|Stage 2|Withdrawal by Subject|0|||
131764406|NCT01200758|474413198|FG002|Stage 2|Withdrawal by Subject|4|||
131764407|NCT01200758|474413199|FG003|Stage 2|Withdrawal by Subject|1|||
131764408|NCT01200758|474413196|FG000|Stage 2|Lost to Follow-up|0|||
131764409|NCT01200758|474413197|FG001|Stage 2|Lost to Follow-up|0|||
131764410|NCT01200758|474413198|FG002|Stage 2|Lost to Follow-up|3|||
131764411|NCT01200758|474413199|FG003|Stage 2|Lost to Follow-up|1|||
131764412|NCT01200758|474413196|FG000|Stage 2|Protocol Violation|0|||
131764413|NCT01200758|474413197|FG001|Stage 2|Protocol Violation|0|||
131764414|NCT01200758|474413198|FG002|Stage 2|Protocol Violation|1|||
131764415|NCT01200758|474413199|FG003|Stage 2|Protocol Violation|4|||
131764416|NCT01200758|474413196|FG000|Stage 2|Death|0|||
131764417|NCT01200758|474413197|FG001|Stage 2|Death|0|||
131764418|NCT01200758|474413198|FG002|Stage 2|Death|3|||
131764419|NCT01200758|474413199|FG003|Stage 2|Death|5|||
131764420|NCT00545584|474413200|FG000|Overall Study|Only one reason for discontinuation|62|||
131764421|NCT00545584|474413201|FG001|Overall Study|Only one reason for discontinuation|61|||
131764422|NCT00545584|474413202|FG002|Overall Study|Only one reason for discontinuation|48|||
131764423|NCT00545584|474413200|FG000|Overall Study|Two or more reasons for discontinuation|17|||
131813911|NCT03415308|474601797|FG001|Overall Study|Scheduling Conflicts|0|||
131813912|NCT03415308|474601798|FG002|Overall Study|Scheduling Conflicts|7|||
131764424|NCT00545584|474413201|FG001|Overall Study|Two or more reasons for discontinuation|19|||
131764425|NCT00545584|474413202|FG002|Overall Study|Two or more reasons for discontinuation|8|||
131764426|NCT03525613|474413205|FG000|Overall Study|Adverse Event|11|||
131764427|NCT03525613|474413206|FG001|Overall Study|Adverse Event|8|||
131764428|NCT03525613|474413207|FG002|Overall Study|Adverse Event|3|||
131764429|NCT03525613|474413208|FG003|Overall Study|Adverse Event|3|||
131764430|NCT03525613|474413205|FG000|Overall Study|Lost to Follow-up|4|||
131764431|NCT03525613|474413206|FG001|Overall Study|Lost to Follow-up|5|||
131813913|NCT01471353|474601799|FG000|Overall Study|remain on study|3|||
131813914|NCT00836472|474601800|FG000|Washout|Adverse Event|1|||
131813915|NCT00836472|474601801|FG001|Washout|Adverse Event|2|||
131813916|NCT00836472|474601800|FG000|Washout|Withdrawal by Subject|1|||
131813917|NCT00836472|474601801|FG001|Washout|Withdrawal by Subject|1|||
131813918|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
131813919|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
131813920|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
131813921|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
131813922|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131813923|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131813924|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131813925|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131909513|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
131909514|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
131909515|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
131909516|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
131909517|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
131909518|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
131909519|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
131909520|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
131909521|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
131909522|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
131909523|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
131909524|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
131909525|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
131909526|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
131909527|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
131909528|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
131909529|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
131764432|NCT03525613|474413207|FG002|Overall Study|Lost to Follow-up|3|||
131764433|NCT03525613|474413208|FG003|Overall Study|Lost to Follow-up|2|||
131764434|NCT03525613|474413205|FG000|Overall Study|Physician Decision|0|||
131764435|NCT03525613|474413206|FG001|Overall Study|Physician Decision|1|||
131764436|NCT03525613|474413207|FG002|Overall Study|Physician Decision|0|||
131764437|NCT03525613|474413208|FG003|Overall Study|Physician Decision|1|||
131764438|NCT03525613|474413205|FG000|Overall Study|Consent Withdrawal|25|||
131764439|NCT03525613|474413206|FG001|Overall Study|Consent Withdrawal|16|||
131813926|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131909530|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
131764440|NCT03525613|474413207|FG002|Overall Study|Consent Withdrawal|12|||
131764441|NCT03525613|474413208|FG003|Overall Study|Consent Withdrawal|9|||
131764442|NCT03525613|474413205|FG000|Overall Study|Death|20|||
131764443|NCT03525613|474413206|FG001|Overall Study|Death|9|||
131764444|NCT03525613|474413207|FG002|Overall Study|Death|7|||
131764445|NCT03525613|474413208|FG003|Overall Study|Death|1|||
131764446|NCT03525613|474413205|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
131764447|NCT03525613|474413206|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
131764448|NCT03525613|474413207|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
131764449|NCT03525613|474413208|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
131764450|NCT02584660|474413209|FG000|Overall Study|Adverse Event|4|||
131764451|NCT02584660|474413210|FG001|Overall Study|Adverse Event|0|||
131764452|NCT02584660|474413209|FG000|Overall Study|Lost to Follow-up|3|||
131764453|NCT02584660|474413210|FG001|Overall Study|Lost to Follow-up|4|||
131764454|NCT02584660|474413209|FG000|Overall Study|Protocol Violation|0|||
131764455|NCT02584660|474413210|FG001|Overall Study|Protocol Violation|1|||
131764456|NCT02584660|474413209|FG000|Overall Study|Withdrawal by Subject|0|||
131764457|NCT02584660|474413210|FG001|Overall Study|Withdrawal by Subject|2|||
131764458|NCT02584660|474413209|FG000|Overall Study|Other|0|||
131764459|NCT02584660|474413210|FG001|Overall Study|Other|1|||
131764460|NCT02993783|474413213|FG000|Overall Study|Reason not Specified|6|||
131813927|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131764461|NCT02993783|474413214|FG001|Overall Study|Reason not Specified|9|||
131764462|NCT03049852|474413220|FG000|Overall Study|Lost to Follow-up|0|||
131764463|NCT03049852|474413221|FG001|Overall Study|Lost to Follow-up|1|||
131764464|NCT03049852|474413222|FG002|Overall Study|Lost to Follow-up|0|||
131764465|NCT01987609|474413223|FG000|Overall Study|Adverse Event|1|||
131764466|NCT02610231|474413224|FG000|Overall Study|Withdrawal by Subject|27|||
131764467|NCT02610231|474413224|FG000|Overall Study|Adverse Event|20|||
131764468|NCT02610231|474413224|FG000|Overall Study|Death|5|||
131764469|NCT02610231|474413224|FG000|Overall Study|Surgery|2|||
131764470|NCT02610231|474413224|FG000|Overall Study|Physician Decision|1|||
131764471|NCT02610231|474413224|FG000|Overall Study|Non Compliance|2|||
131764472|NCT02610231|474413224|FG000|Overall Study|Other|3|||
131764473|NCT00806494|474413225|FG000|Overall Study|Adverse Event|29|||
131764474|NCT00806494|474413225|FG000|Overall Study|Lack of Efficacy|6|||
131764475|NCT00806494|474413225|FG000|Overall Study|Lost to Follow-up|10|||
131764476|NCT00806494|474413225|FG000|Overall Study|Other|30|||
131764477|NCT00806494|474413225|FG000|Overall Study|Withdrawal by Subject|5|||
131764478|NCT01279954|474413226|FG000|Overall Study|Lack of Efficacy|3|||
131764479|NCT01279954|474413227|FG001|Overall Study|Lack of Efficacy|4|||
131764480|NCT02709889|474413228|FG000|Overall Study|Withdrawal by Subject|11|||
131764481|NCT02709889|474413229|FG001|Overall Study|Withdrawal by Subject|10|||
131764482|NCT02709889|474413230|FG002|Overall Study|Withdrawal by Subject|2|||
131764483|NCT02709889|474413231|FG003|Overall Study|Withdrawal by Subject|12|||
131764484|NCT02709889|474413228|FG000|Overall Study|Death|25|||
131764485|NCT02709889|474413229|FG001|Overall Study|Death|38|||
131764486|NCT02709889|474413230|FG002|Overall Study|Death|4|||
131764487|NCT02709889|474413231|FG003|Overall Study|Death|44|||
131764488|NCT02709889|474413228|FG000|Overall Study|Physician Decision|1|||
131764489|NCT02709889|474413229|FG001|Overall Study|Physician Decision|2|||
131764490|NCT02709889|474413230|FG002|Overall Study|Physician Decision|3|||
131764491|NCT02709889|474413231|FG003|Overall Study|Physician Decision|5|||
131764492|NCT02709889|474413228|FG000|Overall Study|Lost to Follow-up|2|||
131764493|NCT02709889|474413229|FG001|Overall Study|Lost to Follow-up|0|||
131764494|NCT02709889|474413230|FG002|Overall Study|Lost to Follow-up|0|||
131764495|NCT02709889|474413231|FG003|Overall Study|Lost to Follow-up|4|||
131764496|NCT02709889|474413228|FG000|Overall Study|Study Terminated by Sponsor|4|||
131764497|NCT02709889|474413229|FG001|Overall Study|Study Terminated by Sponsor|6|||
131764498|NCT02709889|474413230|FG002|Overall Study|Study Terminated by Sponsor|2|||
131764499|NCT02709889|474413231|FG003|Overall Study|Study Terminated by Sponsor|17|||
131764500|NCT02709889|474413228|FG000|Overall Study|Other, Not Specified|0|||
131764501|NCT02709889|474413229|FG001|Overall Study|Other, Not Specified|1|||
131764502|NCT02709889|474413230|FG002|Overall Study|Other, Not Specified|1|||
131764503|NCT02709889|474413231|FG003|Overall Study|Other, Not Specified|6|||
131764504|NCT00537810|474413232|FG000|Overall Study|Withdrawal by Subject|4|||
131764505|NCT00537810|474413233|FG001|Overall Study|Withdrawal by Subject|11|||
131764506|NCT00537810|474413234|FG002|Overall Study|Withdrawal by Subject|4|||
131764507|NCT00537810|474413235|FG003|Overall Study|Withdrawal by Subject|3|||
131764508|NCT00537810|474413232|FG000|Overall Study|Medically withdrawn|2|||
131764509|NCT00537810|474413233|FG001|Overall Study|Medically withdrawn|2|||
131764510|NCT00537810|474413234|FG002|Overall Study|Medically withdrawn|0|||
131764511|NCT00537810|474413235|FG003|Overall Study|Medically withdrawn|1|||
131764512|NCT03258762|474413240|FG000|Overall Study|Lost to Follow-up|0|||
131764513|NCT03258762|474413241|FG001|Overall Study|Lost to Follow-up|1|||
131764514|NCT01711359|474413242|FG000|Treatment Period|Withdrawal by Subject|18|||
131764515|NCT01711359|474413243|FG001|Treatment Period|Withdrawal by Subject|7|||
131764516|NCT01711359|474413244|FG002|Treatment Period|Withdrawal by Subject|13|||
131764517|NCT01711359|474413242|FG000|Treatment Period|Lack of Efficacy|13|||
131764518|NCT01711359|474413243|FG001|Treatment Period|Lack of Efficacy|2|||
131764519|NCT01711359|474413244|FG002|Treatment Period|Lack of Efficacy|2|||
131764520|NCT01711359|474413242|FG000|Treatment Period|Adverse Event|8|||
131764521|NCT01711359|474413243|FG001|Treatment Period|Adverse Event|10|||
131400554|NCT00526656|473087775|FG000|Overall Study|Death|1|||
131400555|NCT00526656|473087775|FG000|Overall Study|Refused surgery|1|||
131400556|NCT03372551|473089526|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
131400557|NCT03372551|473089527|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
131400558|NCT03727646|473089528|FG000|Overall Study|Adverse Event|1|||
131400559|NCT03727646|473089529|FG001|Overall Study|Adverse Event|0|||
131764522|NCT01711359|474413244|FG002|Treatment Period|Adverse Event|24|||
131764523|NCT01711359|474413242|FG000|Treatment Period|Physician Decision|4|||
131764524|NCT01711359|474413243|FG001|Treatment Period|Physician Decision|3|||
131764525|NCT01711359|474413244|FG002|Treatment Period|Physician Decision|2|||
131764526|NCT01711359|474413242|FG000|Treatment Period|Death|3|||
131764527|NCT01711359|474413243|FG001|Treatment Period|Death|0|||
131764528|NCT01711359|474413244|FG002|Treatment Period|Death|0|||
131764529|NCT01711359|474413242|FG000|Treatment Period|Entry Criteria Not Met|1|||
131764530|NCT01711359|474413243|FG001|Treatment Period|Entry Criteria Not Met|0|||
131764531|NCT01711359|474413244|FG002|Treatment Period|Entry Criteria Not Met|0|||
131764532|NCT01711359|474413242|FG000|Treatment Period|Sponsor Decision|1|||
131764533|NCT01711359|474413243|FG001|Treatment Period|Sponsor Decision|0|||
131764534|NCT01711359|474413244|FG002|Treatment Period|Sponsor Decision|0|||
131764535|NCT01711359|474413242|FG000|Treatment Period|Lost to Follow-up|1|||
131764536|NCT01711359|474413243|FG001|Treatment Period|Lost to Follow-up|1|||
131764537|NCT01711359|474413244|FG002|Treatment Period|Lost to Follow-up|1|||
131764538|NCT01711359|474413242|FG000|Treatment Period|Randomized, Not Treated|3|||
131764539|NCT01711359|474413243|FG001|Treatment Period|Randomized, Not Treated|1|||
131764540|NCT01711359|474413244|FG002|Treatment Period|Randomized, Not Treated|0|||
131764541|NCT01385098|474413245|FG000|Overall Study|Adverse Event|10|||
131764542|NCT01385098|474413245|FG000|Overall Study|Lost to Follow-up|4|||
131764543|NCT02698176|474413246|FG000|Overall Study|Progressive disease|4|||
131764544|NCT02698176|474413247|FG001|Overall Study|Progressive disease|3|||
131764545|NCT02698176|474413248|FG002|Overall Study|Progressive disease|1|||
131764546|NCT02698176|474413249|FG003|Overall Study|Progressive disease|0|||
131764547|NCT02698176|474413246|FG000|Overall Study|Adverse Event|2|||
131764548|NCT02698176|474413247|FG001|Overall Study|Adverse Event|0|||
131764549|NCT02698176|474413248|FG002|Overall Study|Adverse Event|0|||
131764550|NCT02698176|474413249|FG003|Overall Study|Adverse Event|0|||
131764551|NCT02698176|474413246|FG000|Overall Study|Clinical progression|3|||
131764552|NCT02698176|474413247|FG001|Overall Study|Clinical progression|0|||
131764553|NCT02698176|474413248|FG002|Overall Study|Clinical progression|0|||
131764554|NCT02698176|474413249|FG003|Overall Study|Clinical progression|0|||
131764555|NCT00925522|474413250|FG000|Overall Study|study closed -- business decision|20|||
131764556|NCT02561572|474413255|FG000|Overall Study|Inadequate time before surgery|2|||
131764557|NCT02561572|474413256|FG001|Overall Study|Inadequate time before surgery|1|||
131764558|NCT02561572|474413255|FG000|Overall Study|Protocol Violation|0|||
131764559|NCT02561572|474413256|FG001|Overall Study|Protocol Violation|1|||
131764560|NCT00795717|474413257|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
131764561|NCT00795717|474413258|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
131764562|NCT00795717|474413257|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
131764563|NCT00795717|474413258|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
131764564|NCT00795717|474413257|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
131764565|NCT00795717|474413258|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
131764566|NCT00795717|474413257|FG000|Phase II|too busy|0|||
131764567|NCT00795717|474413258|FG001|Phase II|too busy|1|||
131764568|NCT00410514|474413259|FG000|Overall Study|Adverse Event|2|||
131400560|NCT00327015|473089532|FG000|Overall Study|Lack of Efficacy|18|||
131400561|NCT00327015|473089533|FG001|Overall Study|Lack of Efficacy|18|||
131400562|NCT00327015|473089534|FG002|Overall Study|Lack of Efficacy|35|||
131400563|NCT00327015|473089535|FG003|Overall Study|Lack of Efficacy|29|||
131400564|NCT00327015|473089532|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
131400565|NCT00327015|473089533|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
131764569|NCT00410514|474413260|FG001|Overall Study|Adverse Event|2|||
131764570|NCT00410514|474413261|FG002|Overall Study|Adverse Event|2|||
131764571|NCT00410514|474413259|FG000|Overall Study|Protocol Violation|0|||
131764572|NCT00410514|474413260|FG001|Overall Study|Protocol Violation|1|||
131764573|NCT00410514|474413261|FG002|Overall Study|Protocol Violation|1|||
131764574|NCT00410514|474413259|FG000|Overall Study|Lost to Follow-up|0|||
131764575|NCT00410514|474413260|FG001|Overall Study|Lost to Follow-up|0|||
131764576|NCT00410514|474413261|FG002|Overall Study|Lost to Follow-up|2|||
131764577|NCT00410514|474413259|FG000|Overall Study|Non-compliant with study procedures|0|||
131764578|NCT00410514|474413260|FG001|Overall Study|Non-compliant with study procedures|0|||
131764579|NCT00410514|474413261|FG002|Overall Study|Non-compliant with study procedures|2|||
131764580|NCT01021423|474413262|FG000|Overall Study|Study terminated|4|||
131764581|NCT01021423|474413263|FG001|Overall Study|Study terminated|5|||
131764582|NCT02985684|474413267|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
131400566|NCT00327015|473089534|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
131400567|NCT00327015|473089535|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
131764583|NCT02985684|474413267|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
131764584|NCT02985684|474413267|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
131764585|NCT00959192|474415241|FG000|Overall Study|Adverse Event|1|||
131764586|NCT00959192|474415242|FG001|Overall Study|Adverse Event|1|||
131764587|NCT00959192|474415243|FG002|Overall Study|Adverse Event|1|||
131764588|NCT00959192|474415244|FG003|Overall Study|Adverse Event|0|||
131764589|NCT00959192|474415241|FG000|Overall Study|Investigator Request|1|||
131764590|NCT00959192|474415242|FG001|Overall Study|Investigator Request|0|||
131764591|NCT00959192|474415243|FG002|Overall Study|Investigator Request|0|||
131764592|NCT00959192|474415244|FG003|Overall Study|Investigator Request|0|||
131764593|NCT00959192|474415241|FG000|Overall Study|Caregiver Request|0|||
131764594|NCT00959192|474415242|FG001|Overall Study|Caregiver Request|0|||
131764595|NCT00959192|474415243|FG002|Overall Study|Caregiver Request|2|||
131764596|NCT00959192|474415244|FG003|Overall Study|Caregiver Request|1|||
131764597|NCT00532441|474415245|FG000|Overall Study|Death|1|||
131764598|NCT00532441|474415246|FG001|Overall Study|Death|0|||
131764599|NCT01967134|474415247|FG000|Overall Study|Lost to Follow-up|0|||
131764600|NCT01967134|474415248|FG001|Overall Study|Lost to Follow-up|1|||
131764601|NCT01967134|474415249|FG002|Overall Study|Lost to Follow-up|0|||
131764602|NCT00443534|474415250|FG000|Overall Study|Lack of Efficacy|67|||
131764603|NCT00443534|474415250|FG000|Overall Study|Adverse Event|16|||
131764604|NCT00443534|474415250|FG000|Overall Study|Death|9|||
131764605|NCT00443534|474415250|FG000|Overall Study|Withdrawal by Subject|8|||
131764606|NCT00443534|474415250|FG000|Overall Study|Study Terminated by Sponsor|12|||
131764607|NCT00443534|474415250|FG000|Overall Study|Other|10|||
131764608|NCT00443534|474415250|FG000|Overall Study|Enrolled, Not Treated|1|||
131764609|NCT04097925|474415252|FG000|Overall Study|Withdrawal by Subject|1|||
131764610|NCT04735432|474415256|FG000|Overall Study|Other - due to personal reason|1|||
131764611|NCT04735432|474415257|FG001|Overall Study|Other - due to personal reason|0|||
131764612|NCT04735432|474415256|FG000|Overall Study|Adverse Event|2|||
131764613|NCT04735432|474415257|FG001|Overall Study|Adverse Event|0|||
131764614|NCT00626327|474415258|FG000|Overall Study|Withdrawal by Subject|21|||
131764615|NCT00626327|474415259|FG001|Overall Study|Withdrawal by Subject|29|||
131764616|NCT00626327|474415260|FG002|Overall Study|Withdrawal by Subject|30|||
131764617|NCT00626327|474415258|FG000|Overall Study|Adverse Event|1|||
131764618|NCT00626327|474415259|FG001|Overall Study|Adverse Event|0|||
131764619|NCT00626327|474415260|FG002|Overall Study|Adverse Event|0|||
131764620|NCT00626327|474415258|FG000|Overall Study|Lost to Follow-up|24|||
131764621|NCT00626327|474415259|FG001|Overall Study|Lost to Follow-up|21|||
131764622|NCT00626327|474415260|FG002|Overall Study|Lost to Follow-up|23|||
131764623|NCT00626327|474415258|FG000|Overall Study|Inappropriate enrollment|4|||
131764624|NCT00626327|474415259|FG001|Overall Study|Inappropriate enrollment|5|||
131764625|NCT00626327|474415260|FG002|Overall Study|Inappropriate enrollment|3|||
131764626|NCT00626327|474415258|FG000|Overall Study|Administrative Reason|2|||
131764627|NCT00626327|474415259|FG001|Overall Study|Administrative Reason|0|||
131764628|NCT00626327|474415260|FG002|Overall Study|Administrative Reason|6|||
131764629|NCT00626327|474415258|FG000|Overall Study|Protocol Violation|26|||
131764630|NCT00626327|474415259|FG001|Overall Study|Protocol Violation|4|||
131764631|NCT00626327|474415260|FG002|Overall Study|Protocol Violation|26|||
131764632|NCT01823991|474415261|FG000|Overall Study|Withdrawal by Subject|8|||
131764633|NCT01823991|474415262|FG001|Overall Study|Withdrawal by Subject|5|||
131764634|NCT05158244|474415263|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
131764635|NCT05158244|474415264|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131764636|NCT05158244|474415265|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131764637|NCT05158244|474415266|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131764638|NCT05158244|474415267|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131764639|NCT05158244|474415263|FG000|Overall Study|Withdrawal by Subject|0|||
131764640|NCT05158244|474415264|FG001|Overall Study|Withdrawal by Subject|0|||
131764641|NCT05158244|474415265|FG002|Overall Study|Withdrawal by Subject|1|||
131764642|NCT05158244|474415266|FG003|Overall Study|Withdrawal by Subject|0|||
131764643|NCT05158244|474415267|FG004|Overall Study|Withdrawal by Subject|0|||
131764644|NCT01066819|474415268|FG000|Overall Study|Adverse Event|18|||
131764645|NCT01066819|474415269|FG001|Overall Study|Adverse Event|1|||
131764646|NCT01066819|474415270|FG002|Overall Study|Adverse Event|6|||
131764647|NCT01066819|474415271|FG003|Overall Study|Adverse Event|0|||
131764648|NCT01066819|474415272|FG004|Overall Study|Adverse Event|0|||
131764649|NCT01066819|474415273|FG005|Overall Study|Adverse Event|0|||
131764650|NCT01066819|474415268|FG000|Overall Study|Death|5|||
131764651|NCT01066819|474415269|FG001|Overall Study|Death|0|||
131813928|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131813929|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131764652|NCT01066819|474415270|FG002|Overall Study|Death|1|||
131764653|NCT01066819|474415271|FG003|Overall Study|Death|0|||
131764654|NCT01066819|474415272|FG004|Overall Study|Death|0|||
131764655|NCT01066819|474415273|FG005|Overall Study|Death|0|||
131764656|NCT01066819|474415268|FG000|Overall Study|Lack of Efficacy|22|||
131764657|NCT01066819|474415269|FG001|Overall Study|Lack of Efficacy|1|||
131764658|NCT01066819|474415270|FG002|Overall Study|Lack of Efficacy|2|||
131764659|NCT01066819|474415271|FG003|Overall Study|Lack of Efficacy|1|||
131764660|NCT01066819|474415272|FG004|Overall Study|Lack of Efficacy|0|||
131764661|NCT01066819|474415273|FG005|Overall Study|Lack of Efficacy|0|||
131764662|NCT01066819|474415268|FG000|Overall Study|Physician Decision|6|||
131764663|NCT01066819|474415269|FG001|Overall Study|Physician Decision|2|||
131764664|NCT01066819|474415270|FG002|Overall Study|Physician Decision|3|||
131764665|NCT01066819|474415271|FG003|Overall Study|Physician Decision|0|||
131764666|NCT01066819|474415272|FG004|Overall Study|Physician Decision|0|||
131764667|NCT01066819|474415273|FG005|Overall Study|Physician Decision|0|||
131764668|NCT01066819|474415268|FG000|Overall Study|Protocol Violation|12|||
131764669|NCT01066819|474415269|FG001|Overall Study|Protocol Violation|6|||
131764670|NCT01066819|474415270|FG002|Overall Study|Protocol Violation|0|||
131764671|NCT01066819|474415271|FG003|Overall Study|Protocol Violation|0|||
131764672|NCT01066819|474415272|FG004|Overall Study|Protocol Violation|0|||
131764673|NCT01066819|474415273|FG005|Overall Study|Protocol Violation|0|||
131764674|NCT01066819|474415268|FG000|Overall Study|Withdrawal by Subject|29|||
131764675|NCT01066819|474415269|FG001|Overall Study|Withdrawal by Subject|11|||
131764676|NCT01066819|474415270|FG002|Overall Study|Withdrawal by Subject|6|||
131764677|NCT01066819|474415271|FG003|Overall Study|Withdrawal by Subject|0|||
131764678|NCT01066819|474415272|FG004|Overall Study|Withdrawal by Subject|0|||
131764679|NCT01066819|474415273|FG005|Overall Study|Withdrawal by Subject|0|||
131764680|NCT01066819|474415268|FG000|Overall Study|Administrative|6|||
131764681|NCT01066819|474415269|FG001|Overall Study|Administrative|4|||
131764682|NCT01066819|474415270|FG002|Overall Study|Administrative|2|||
131764683|NCT01066819|474415271|FG003|Overall Study|Administrative|0|||
131764684|NCT01066819|474415272|FG004|Overall Study|Administrative|0|||
131764685|NCT01066819|474415273|FG005|Overall Study|Administrative|0|||
131764686|NCT01066819|474415268|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
131764687|NCT01066819|474415269|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
131764688|NCT01066819|474415270|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
131764689|NCT01066819|474415271|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
131764690|NCT01066819|474415272|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
131764691|NCT01066819|474415273|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
131764692|NCT01066819|474415268|FG000|Overall Study|Early termination|2|||
131764693|NCT01066819|474415269|FG001|Overall Study|Early termination|0|||
131764694|NCT01066819|474415270|FG002|Overall Study|Early termination|0|||
131764695|NCT01066819|474415271|FG003|Overall Study|Early termination|0|||
131764696|NCT01066819|474415272|FG004|Overall Study|Early termination|0|||
131764697|NCT01066819|474415273|FG005|Overall Study|Early termination|0|||
131764698|NCT01066819|474415268|FG000|Overall Study|Failed to return|298|||
131764699|NCT01066819|474415269|FG001|Overall Study|Failed to return|107|||
131764700|NCT01066819|474415270|FG002|Overall Study|Failed to return|68|||
131764701|NCT01066819|474415271|FG003|Overall Study|Failed to return|7|||
131764702|NCT01066819|474415272|FG004|Overall Study|Failed to return|2|||
131764703|NCT01066819|474415273|FG005|Overall Study|Failed to return|3|||
131764704|NCT01066819|474415268|FG000|Overall Study|Lab test not done|9|||
131764705|NCT01066819|474415269|FG001|Overall Study|Lab test not done|0|||
131764706|NCT01066819|474415270|FG002|Overall Study|Lab test not done|2|||
131764707|NCT01066819|474415271|FG003|Overall Study|Lab test not done|1|||
131764708|NCT01066819|474415272|FG004|Overall Study|Lab test not done|0|||
131764709|NCT01066819|474415273|FG005|Overall Study|Lab test not done|0|||
131764710|NCT01066819|474415268|FG000|Overall Study|Miscellaneous|28|||
131764711|NCT01066819|474415269|FG001|Overall Study|Miscellaneous|10|||
131764712|NCT01066819|474415270|FG002|Overall Study|Miscellaneous|18|||
131764713|NCT01066819|474415271|FG003|Overall Study|Miscellaneous|1|||
131764714|NCT01066819|474415272|FG004|Overall Study|Miscellaneous|0|||
131764715|NCT01066819|474415273|FG005|Overall Study|Miscellaneous|0|||
131764716|NCT01066819|474415268|FG000|Overall Study|Non responders|123|||
131400568|NCT00327015|473089532|FG000|Overall Study|Lost to Follow-up|22|||
131400569|NCT00327015|473089533|FG001|Overall Study|Lost to Follow-up|23|||
131764717|NCT01066819|474415269|FG001|Overall Study|Non responders|2|||
131764718|NCT01066819|474415270|FG002|Overall Study|Non responders|7|||
131400570|NCT00327015|473089534|FG002|Overall Study|Lost to Follow-up|29|||
131400571|NCT00327015|473089535|FG003|Overall Study|Lost to Follow-up|22|||
131400572|NCT00327015|473089532|FG000|Overall Study|Adverse Event|14|||
131400573|NCT00327015|473089533|FG001|Overall Study|Adverse Event|10|||
131764719|NCT01066819|474415271|FG003|Overall Study|Non responders|2|||
131764720|NCT01066819|474415272|FG004|Overall Study|Non responders|0|||
131764721|NCT01066819|474415273|FG005|Overall Study|Non responders|1|||
131764722|NCT01066819|474415268|FG000|Overall Study|Not categorised|9|||
131764723|NCT01066819|474415269|FG001|Overall Study|Not categorised|2|||
131764724|NCT01066819|474415270|FG002|Overall Study|Not categorised|6|||
131764725|NCT01066819|474415271|FG003|Overall Study|Not categorised|1|||
131764726|NCT01066819|474415272|FG004|Overall Study|Not categorised|0|||
131764727|NCT01066819|474415273|FG005|Overall Study|Not categorised|0|||
131764728|NCT01066819|474415268|FG000|Overall Study|Relapse|16|||
131764729|NCT01066819|474415269|FG001|Overall Study|Relapse|4|||
131764730|NCT01066819|474415270|FG002|Overall Study|Relapse|3|||
131764731|NCT01066819|474415271|FG003|Overall Study|Relapse|0|||
131764732|NCT01066819|474415272|FG004|Overall Study|Relapse|0|||
131764733|NCT01066819|474415273|FG005|Overall Study|Relapse|0|||
131764734|NCT01066819|474415268|FG000|Overall Study|Results not available|1|||
131764735|NCT01066819|474415269|FG001|Overall Study|Results not available|0|||
131764736|NCT01066819|474415270|FG002|Overall Study|Results not available|0|||
131764737|NCT01066819|474415271|FG003|Overall Study|Results not available|0|||
131764738|NCT01066819|474415272|FG004|Overall Study|Results not available|0|||
131764739|NCT01066819|474415273|FG005|Overall Study|Results not available|0|||
131764740|NCT01066819|474415268|FG000|Overall Study|Screen failure|1|||
131764741|NCT01066819|474415269|FG001|Overall Study|Screen failure|0|||
131764742|NCT01066819|474415270|FG002|Overall Study|Screen failure|0|||
131764743|NCT01066819|474415271|FG003|Overall Study|Screen failure|0|||
131764744|NCT01066819|474415272|FG004|Overall Study|Screen failure|0|||
131764745|NCT01066819|474415273|FG005|Overall Study|Screen failure|0|||
131764746|NCT01066819|474415268|FG000|Overall Study|Spontaneous cure|1|||
131764747|NCT01066819|474415269|FG001|Overall Study|Spontaneous cure|0|||
131764748|NCT01066819|474415270|FG002|Overall Study|Spontaneous cure|0|||
131764749|NCT01066819|474415271|FG003|Overall Study|Spontaneous cure|0|||
131764750|NCT01066819|474415272|FG004|Overall Study|Spontaneous cure|0|||
131764751|NCT01066819|474415273|FG005|Overall Study|Spontaneous cure|0|||
131764752|NCT01066819|474415268|FG000|Overall Study|Treatment never started|85|||
131764753|NCT01066819|474415269|FG001|Overall Study|Treatment never started|19|||
131764754|NCT01066819|474415270|FG002|Overall Study|Treatment never started|19|||
131764755|NCT01066819|474415271|FG003|Overall Study|Treatment never started|3|||
131764756|NCT01066819|474415272|FG004|Overall Study|Treatment never started|2|||
131764757|NCT01066819|474415273|FG005|Overall Study|Treatment never started|2|||
131764758|NCT01066819|474415268|FG000|Overall Study|Treatment stopped|12|||
131764759|NCT01066819|474415269|FG001|Overall Study|Treatment stopped|1|||
131764760|NCT01066819|474415270|FG002|Overall Study|Treatment stopped|2|||
131764761|NCT01066819|474415271|FG003|Overall Study|Treatment stopped|1|||
131764762|NCT01066819|474415272|FG004|Overall Study|Treatment stopped|0|||
131764763|NCT01066819|474415273|FG005|Overall Study|Treatment stopped|0|||
131764764|NCT01066819|474415268|FG000|Overall Study|Other|5|||
131764765|NCT01066819|474415269|FG001|Overall Study|Other|1|||
131764766|NCT01066819|474415270|FG002|Overall Study|Other|1|||
131764767|NCT01066819|474415271|FG003|Overall Study|Other|0|||
131764768|NCT01066819|474415272|FG004|Overall Study|Other|0|||
131764769|NCT01066819|474415273|FG005|Overall Study|Other|0|||
131764770|NCT01797302|474415275|FG000|Overall Study|Lost to Follow-up|16|||
131764771|NCT01797302|474415276|FG001|Overall Study|Lost to Follow-up|23|||
131764772|NCT01797302|474415277|FG002|Overall Study|Lost to Follow-up|22|||
131764773|NCT01797302|474415275|FG000|Overall Study|Withdrawal by Subject|1|||
131764774|NCT01797302|474415276|FG001|Overall Study|Withdrawal by Subject|3|||
131764775|NCT01797302|474415277|FG002|Overall Study|Withdrawal by Subject|4|||
131764776|NCT03228836|474415278|FG000|Overall Study|Adverse Event|3|||
131764777|NCT03228836|474415278|FG000|Overall Study|Withdrawal by Subject|1|||
131764778|NCT03228836|474415278|FG000|Overall Study|Death|1|||
131764779|NCT03228836|474415278|FG000|Overall Study|Physician Decision|1|||
131764780|NCT03228836|474415278|FG000|Overall Study|Disease Progression|7|||
131764781|NCT03228836|474415278|FG000|Overall Study|Other|4|||
131764782|NCT02773849|474415280|FG000|Overall Study|Lost to Follow-up|11|||
131764783|NCT02773849|474415280|FG000|Overall Study|Death|26|||
131764784|NCT02773849|474415280|FG000|Overall Study|Withdrawal by Subject|5|||
131764785|NCT02773849|474415280|FG000|Overall Study|Withdrawal of Consent|9|||
131764786|NCT02773849|474415280|FG000|Overall Study|Other: not due to lack of tolerability|11|||
131764787|NCT02418000|474415285|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
131764788|NCT02418000|474415286|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764789|NCT02418000|474415287|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764790|NCT02418000|474415288|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764791|NCT02418000|474415289|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764792|NCT02418000|474415285|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
131764793|NCT02418000|474415286|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131764794|NCT02418000|474415287|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131764795|NCT02418000|474415288|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131764796|NCT02418000|474415289|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131764797|NCT02418000|474415285|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
131400574|NCT00327015|473089534|FG002|Overall Study|Adverse Event|14|||
131400575|NCT00327015|473089535|FG003|Overall Study|Adverse Event|14|||
131764798|NCT02418000|474415286|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131764799|NCT02418000|474415287|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131764800|NCT02418000|474415288|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131764801|NCT02418000|474415289|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131764802|NCT02418000|474415285|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764803|NCT02418000|474415286|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
131764804|NCT02418000|474415287|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764805|NCT02418000|474415288|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764806|NCT02418000|474415289|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131764807|NCT02418000|474415285|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131764808|NCT02418000|474415286|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
131764809|NCT02418000|474415287|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131764810|NCT02418000|474415288|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131764811|NCT02418000|474415289|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131764812|NCT02418000|474415285|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764813|NCT02418000|474415286|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764814|NCT02418000|474415287|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
131764815|NCT02418000|474415288|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764816|NCT02418000|474415289|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764817|NCT02418000|474415285|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764818|NCT02418000|474415286|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764819|NCT02418000|474415287|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764820|NCT02418000|474415288|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
131764821|NCT02418000|474415289|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764822|NCT02418000|474415285|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131764823|NCT02418000|474415286|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131764824|NCT02418000|474415287|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131764825|NCT02418000|474415288|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131764826|NCT02418000|474415289|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
131764827|NCT02418000|474415285|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764828|NCT02418000|474415286|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764829|NCT02418000|474415287|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764830|NCT02418000|474415288|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131764831|NCT02418000|474415289|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
131764832|NCT02870348|474415297|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
131764833|NCT01051856|474415298|FG000|Overall Study|Withdrawal by Subject|1|||
131764834|NCT01051856|474415299|FG001|Overall Study|Withdrawal by Subject|0|||
131764835|NCT02381795|474415300|FG000|Overall Study|Withdrawal by Subject|1|||
131764836|NCT02381795|474415300|FG000|Overall Study|Study Terminated|2|||
131764837|NCT02176226|474415301|FG000|Overall Study|Lost to Follow-up|3|||
131764838|NCT02176226|474415301|FG000|Overall Study|Withdrew prior to treatment|6|||
131764839|NCT02908841|474415308|FG000|Overall Study|Physician Decision|4|||
131764840|NCT02908841|474415309|FG001|Overall Study|Physician Decision|0|||
131764841|NCT01611558|474415310|FG000|Induction Phase|Study drug toxicity|15|||
131764842|NCT01611558|474415310|FG000|Induction Phase|Disease progression|18|||
131764843|NCT01611558|474415310|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
131764844|NCT01611558|474415310|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
131764845|NCT01611558|474415310|FG000|Induction Phase|Death|1|||
131764846|NCT01611558|474415310|FG000|Maintenance Phase|Withdrawal by Subject|1|||
131764847|NCT01611558|474415310|FG000|Maintenance Phase|Elevated Uric acid|1|||
131764848|NCT04005885|474415316|FG000|First Intervention|Withdrawal by Subject|1|||
131764849|NCT04005885|474415317|FG001|First Intervention|Withdrawal by Subject|1|||
131764850|NCT04005885|474415316|FG000|Second Intervention|Withdrawal by Subject|0|||
131764851|NCT04005885|474415317|FG001|Second Intervention|Withdrawal by Subject|2|||
131764852|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Adverse Event|30|||
131813930|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131813931|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
131813932|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
131813933|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
131813934|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
131813935|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
131813936|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131813937|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131813938|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131909531|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
131909532|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
131909533|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
131909534|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
131909535|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
131909536|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
131764853|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Adverse Event|25|||
131813939|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131813940|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131764854|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Adverse Event|23|||
131764855|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Adverse Event|14|||
131764856|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Death|0|||
131909537|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
131909538|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
131764857|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Death|0|||
131764858|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Death|1|||
131764859|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Death|0|||
131764860|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Physician Decision|0|||
131764861|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Physician Decision|1|||
131764862|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Physician Decision|0|||
131764863|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Physician Decision|1|||
131764864|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
131764865|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
131764866|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
131764867|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
131764868|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Other|6|||
131764869|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Other|1|||
131764870|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Other|0|||
131764871|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Other|2|||
131764872|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
131764873|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
131764874|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
131764875|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
131764876|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
131764877|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
131764878|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
131764879|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
131764880|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
131764881|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
131764882|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
131764883|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
131764884|NCT00242710|474415320|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
131764885|NCT00242710|474415321|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
131764886|NCT00242710|474415322|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
131764887|NCT00242710|474415323|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
131764888|NCT00242710|474415320|FG000|Period Between Core Study and Extension|Adverse Event|2|||
131764889|NCT00242710|474415321|FG001|Period Between Core Study and Extension|Adverse Event|3|||
131764890|NCT00242710|474415322|FG002|Period Between Core Study and Extension|Adverse Event|5|||
131764891|NCT00242710|474415323|FG003|Period Between Core Study and Extension|Adverse Event|2|||
131764892|NCT00242710|474415320|FG000|Period Between Core Study and Extension|Physician Decision|1|||
131764893|NCT00242710|474415321|FG001|Period Between Core Study and Extension|Physician Decision|1|||
131764894|NCT00242710|474415322|FG002|Period Between Core Study and Extension|Physician Decision|0|||
131764895|NCT00242710|474415323|FG003|Period Between Core Study and Extension|Physician Decision|0|||
131764896|NCT00242710|474415320|FG000|Period Between Core Study and Extension|Other|24|||
131764897|NCT00242710|474415321|FG001|Period Between Core Study and Extension|Other|24|||
131764898|NCT00242710|474415322|FG002|Period Between Core Study and Extension|Other|9|||
131764899|NCT00242710|474415323|FG003|Period Between Core Study and Extension|Other|11|||
131764900|NCT00242710|474415320|FG000|Period Between Core Study and Extension|Extension not Available|17|||
131764901|NCT00242710|474415321|FG001|Period Between Core Study and Extension|Extension not Available|21|||
131764902|NCT00242710|474415322|FG002|Period Between Core Study and Extension|Extension not Available|8|||
131764903|NCT00242710|474415323|FG003|Period Between Core Study and Extension|Extension not Available|7|||
131764904|NCT00242710|474415320|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
131764905|NCT00242710|474415321|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
131764906|NCT00242710|474415322|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
131764907|NCT00242710|474415323|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
131764908|NCT00242710|474415320|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
131764909|NCT00242710|474415321|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
131764910|NCT00242710|474415322|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
131909539|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
131909540|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
131400576|NCT00327015|473089532|FG000|Overall Study|Subject no longer meets study criteria|4|||
131400577|NCT00327015|473089533|FG001|Overall Study|Subject no longer meets study criteria|2|||
131400578|NCT00327015|473089534|FG002|Overall Study|Subject no longer meets study criteria|8|||
131400579|NCT00327015|473089535|FG003|Overall Study|Subject no longer meets study criteria|7|||
131764911|NCT00242710|474415323|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
131764912|NCT00242710|474415320|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
131764913|NCT00242710|474415321|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
131764914|NCT00242710|474415322|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
131764915|NCT00242710|474415323|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
131764916|NCT00242710|474415320|FG000|Study Extension (up to Year 2)|Death|0|||
131764917|NCT00242710|474415321|FG001|Study Extension (up to Year 2)|Death|0|||
131764918|NCT00242710|474415322|FG002|Study Extension (up to Year 2)|Death|0|||
131764919|NCT00242710|474415323|FG003|Study Extension (up to Year 2)|Death|1|||
131764920|NCT00242710|474415320|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
131764921|NCT00242710|474415321|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
131764922|NCT00242710|474415322|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
131764923|NCT00242710|474415323|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
131764924|NCT00242710|474415320|FG000|Study Extension (up to Year 2)|Other|3|||
131764925|NCT00242710|474415321|FG001|Study Extension (up to Year 2)|Other|5|||
131764926|NCT00242710|474415322|FG002|Study Extension (up to Year 2)|Other|4|||
131764927|NCT00242710|474415323|FG003|Study Extension (up to Year 2)|Other|3|||
131764928|NCT00242710|474415320|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
131764929|NCT00242710|474415321|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
131764930|NCT00242710|474415322|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
131764931|NCT00242710|474415323|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
131764932|NCT00242710|474415320|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
131764933|NCT00242710|474415321|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
131764934|NCT00242710|474415322|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
131764935|NCT00242710|474415323|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
131764936|NCT00579527|474415324|FG000|Overall Study|Death|4|||
131764937|NCT00808132|474415327|FG000|Overall Study|Adverse Event|34|||
131764938|NCT00808132|474415328|FG001|Overall Study|Adverse Event|33|||
131764939|NCT00808132|474415329|FG002|Overall Study|Adverse Event|16|||
131764940|NCT00808132|474415330|FG003|Overall Study|Adverse Event|31|||
131764941|NCT00808132|474415331|FG004|Overall Study|Adverse Event|33|||
131764942|NCT00808132|474415327|FG000|Overall Study|Death|0|||
131764943|NCT00808132|474415328|FG001|Overall Study|Death|0|||
131764944|NCT00808132|474415329|FG002|Overall Study|Death|0|||
131764945|NCT00808132|474415330|FG003|Overall Study|Death|0|||
131764946|NCT00808132|474415331|FG004|Overall Study|Death|1|||
131764947|NCT00808132|474415327|FG000|Overall Study|Physician Decision|0|||
131764948|NCT00808132|474415328|FG001|Overall Study|Physician Decision|1|||
131764949|NCT00808132|474415329|FG002|Overall Study|Physician Decision|0|||
131764950|NCT00808132|474415330|FG003|Overall Study|Physician Decision|0|||
131764951|NCT00808132|474415331|FG004|Overall Study|Physician Decision|0|||
131764952|NCT00808132|474415327|FG000|Overall Study|Lost to Follow-up|8|||
131764953|NCT00808132|474415328|FG001|Overall Study|Lost to Follow-up|10|||
131764954|NCT00808132|474415329|FG002|Overall Study|Lost to Follow-up|11|||
131764955|NCT00808132|474415330|FG003|Overall Study|Lost to Follow-up|8|||
131764956|NCT00808132|474415331|FG004|Overall Study|Lost to Follow-up|9|||
131764957|NCT00808132|474415327|FG000|Overall Study|Protocol Violation|8|||
131764958|NCT00808132|474415328|FG001|Overall Study|Protocol Violation|9|||
131764959|NCT00808132|474415329|FG002|Overall Study|Protocol Violation|4|||
131764960|NCT00808132|474415330|FG003|Overall Study|Protocol Violation|9|||
131764961|NCT00808132|474415331|FG004|Overall Study|Protocol Violation|5|||
131764962|NCT00808132|474415327|FG000|Overall Study|Withdrawal by Subject|27|||
131764963|NCT00808132|474415328|FG001|Overall Study|Withdrawal by Subject|18|||
131764964|NCT00808132|474415329|FG002|Overall Study|Withdrawal by Subject|2|||
131764965|NCT00808132|474415330|FG003|Overall Study|Withdrawal by Subject|7|||
131764966|NCT00808132|474415331|FG004|Overall Study|Withdrawal by Subject|16|||
131764967|NCT00808132|474415327|FG000|Overall Study|Other|6|||
131764968|NCT00808132|474415328|FG001|Overall Study|Other|4|||
131764969|NCT00808132|474415329|FG002|Overall Study|Other|6|||
131764970|NCT00808132|474415330|FG003|Overall Study|Other|2|||
131764971|NCT00808132|474415331|FG004|Overall Study|Other|15|||
131764972|NCT00808132|474415327|FG000|Overall Study|Randomized, but not treated|10|||
131764973|NCT00808132|474415328|FG001|Overall Study|Randomized, but not treated|7|||
131813941|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131813942|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131400580|NCT00327015|473089532|FG000|Overall Study|Poor/Noncompliance|11|||
131400581|NCT00327015|473089533|FG001|Overall Study|Poor/Noncompliance|8|||
131764974|NCT00808132|474415329|FG002|Overall Study|Randomized, but not treated|9|||
131764975|NCT00808132|474415330|FG003|Overall Study|Randomized, but not treated|8|||
131813943|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131813944|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131764976|NCT00808132|474415331|FG004|Overall Study|Randomized, but not treated|9|||
131764977|NCT00808132|474415327|FG000|Overall Study|Unsatisfactory response|5|||
131764978|NCT00808132|474415328|FG001|Overall Study|Unsatisfactory response|6|||
131764979|NCT00808132|474415329|FG002|Overall Study|Unsatisfactory response|6|||
131764980|NCT00808132|474415330|FG003|Overall Study|Unsatisfactory response|4|||
131813945|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131400582|NCT00327015|473089534|FG002|Overall Study|Poor/Noncompliance|4|||
131764981|NCT00808132|474415331|FG004|Overall Study|Unsatisfactory response|12|||
131764982|NCT01948791|474415340|FG000|Overall Study|Adverse Event|12|||
131764983|NCT01948791|474415340|FG000|Overall Study|Lack of Efficacy|3|||
131764984|NCT01948791|474415340|FG000|Overall Study|Protocol Violation|2|||
131764985|NCT01948791|474415340|FG000|Overall Study|Withdrawal by Subject|5|||
131764986|NCT01948791|474415340|FG000|Overall Study|Lost to Follow-up|6|||
131764987|NCT01948791|474415340|FG000|Overall Study|Management issues|1|||
131764988|NCT01948791|474415340|FG000|Overall Study|Others|7|||
131764989|NCT01948791|474415340|FG000|Overall Study|Screening failure|35|||
131764990|NCT03490734|474415344|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
131764991|NCT03490734|474415345|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
131764992|NCT03490734|474415346|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
131764993|NCT03490734|474415347|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
131764994|NCT03490734|474415344|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
131764995|NCT03490734|474415345|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
131764996|NCT03490734|474415346|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
131764997|NCT03490734|474415347|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
131764998|NCT03490734|474415344|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
131764999|NCT03490734|474415345|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
131765000|NCT03490734|474415346|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
131765001|NCT03490734|474415347|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
131765002|NCT03490734|474415344|FG000|Post-intervention Scan Visit|Adverse Event|2|||
131765003|NCT03490734|474415345|FG001|Post-intervention Scan Visit|Adverse Event|0|||
131765004|NCT03490734|474415346|FG002|Post-intervention Scan Visit|Adverse Event|0|||
131765005|NCT03490734|474415347|FG003|Post-intervention Scan Visit|Adverse Event|0|||
131765006|NCT03490734|474415344|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
131765007|NCT03490734|474415345|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
131765008|NCT03490734|474415346|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
131765009|NCT03490734|474415347|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
131765010|NCT03490734|474415344|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
131765011|NCT03490734|474415345|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
131765012|NCT03490734|474415346|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
131765013|NCT03490734|474415347|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
131765014|NCT01955005|474415354|FG000|Overall Study|Withdrawal by Subject|3|||
131765015|NCT01955005|474415355|FG001|Overall Study|Withdrawal by Subject|5|||
131765016|NCT00702949|474415360|FG000|Overall Study|Refusal|3|||
131765017|NCT00702949|474415361|FG001|Overall Study|Refusal|2|||
131765018|NCT00702949|474415362|FG002|Overall Study|Refusal|2|||
131765019|NCT00702949|474415360|FG000|Overall Study|Adverse Event|1|||
131765020|NCT00702949|474415361|FG001|Overall Study|Adverse Event|6|||
131765021|NCT00702949|474415362|FG002|Overall Study|Adverse Event|3|||
131765022|NCT00702949|474415360|FG000|Overall Study|Other Medical Reason/unknown|1|||
131765023|NCT00702949|474415361|FG001|Overall Study|Other Medical Reason/unknown|1|||
131765024|NCT00702949|474415362|FG002|Overall Study|Other Medical Reason/unknown|3|||
131765025|NCT00887913|474415363|FG000|Overall Study|Withdrawal by Subject|6|||
131765026|NCT01371721|474415364|FG000|Overall Study|Adverse Event|5|||
131765027|NCT01371721|474415365|FG001|Overall Study|Adverse Event|4|||
131765028|NCT01371721|474415366|FG002|Overall Study|Adverse Event|5|||
131765029|NCT01371721|474415364|FG000|Overall Study|Protocol Violation|6|||
131765030|NCT01371721|474415365|FG001|Overall Study|Protocol Violation|4|||
131765031|NCT01371721|474415366|FG002|Overall Study|Protocol Violation|5|||
131765032|NCT01371721|474415364|FG000|Overall Study|Lost to Follow-up|8|||
131765033|NCT01371721|474415365|FG001|Overall Study|Lost to Follow-up|2|||
131765034|NCT01371721|474415366|FG002|Overall Study|Lost to Follow-up|6|||
131765035|NCT01371721|474415364|FG000|Overall Study|Withdrawal by Subject|5|||
131765036|NCT01371721|474415365|FG001|Overall Study|Withdrawal by Subject|7|||
131765037|NCT01371721|474415366|FG002|Overall Study|Withdrawal by Subject|11|||
131765038|NCT01371721|474415364|FG000|Overall Study|Other|2|||
131765039|NCT01371721|474415365|FG001|Overall Study|Other|3|||
131765040|NCT01371721|474415366|FG002|Overall Study|Other|0|||
131765041|NCT01371721|474415364|FG000|Overall Study|Lack of Efficacy|2|||
131765042|NCT01371721|474415365|FG001|Overall Study|Lack of Efficacy|4|||
131765043|NCT01371721|474415366|FG002|Overall Study|Lack of Efficacy|3|||
131765044|NCT01371721|474415364|FG000|Overall Study|Randomized but not treated|1|||
131765045|NCT01371721|474415365|FG001|Overall Study|Randomized but not treated|0|||
131765046|NCT01371721|474415366|FG002|Overall Study|Randomized but not treated|0|||
131765047|NCT04491591|474415368|FG000|Overall Study|Accidently randomized|3|||
131765048|NCT04491591|474415369|FG001|Overall Study|Accidently randomized|1|||
131765049|NCT04491591|474415370|FG002|Overall Study|Accidently randomized|0|||
131765050|NCT04491591|474415368|FG000|Overall Study|Did not complete survey|28|||
131765051|NCT04491591|474415369|FG001|Overall Study|Did not complete survey|20|||
131765052|NCT04491591|474415370|FG002|Overall Study|Did not complete survey|3|||
131765053|NCT00135694|474415371|FG000|Overall Study|Adverse Event|17|||
131765054|NCT00135694|474415372|FG001|Overall Study|Adverse Event|4|||
131765055|NCT00135694|474415373|FG002|Overall Study|Adverse Event|0|||
131765056|NCT00135694|474415371|FG000|Overall Study|Death|14|||
131765057|NCT00135694|474415372|FG001|Overall Study|Death|1|||
131765058|NCT00135694|474415373|FG002|Overall Study|Death|2|||
131765059|NCT00135694|474415371|FG000|Overall Study|Lost to Follow-up|8|||
131909541|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
131765060|NCT00135694|474415372|FG001|Overall Study|Lost to Follow-up|7|||
131765061|NCT00135694|474415373|FG002|Overall Study|Lost to Follow-up|1|||
131765062|NCT00135694|474415371|FG000|Overall Study|Withdrawal by Subject|41|||
131765063|NCT00135694|474415372|FG001|Overall Study|Withdrawal by Subject|7|||
131765064|NCT00135694|474415373|FG002|Overall Study|Withdrawal by Subject|4|||
131765065|NCT00135694|474415371|FG000|Overall Study|Protocol Violation|19|||
131765066|NCT00135694|474415372|FG001|Overall Study|Protocol Violation|1|||
131765067|NCT00135694|474415373|FG002|Overall Study|Protocol Violation|0|||
131765068|NCT00135694|474415371|FG000|Overall Study|Hepatitis C related reasons|39|||
131765069|NCT00135694|474415372|FG001|Overall Study|Hepatitis C related reasons|1|||
131765070|NCT00135694|474415373|FG002|Overall Study|Hepatitis C related reasons|0|||
131765071|NCT00135694|474415371|FG000|Overall Study|Ineligible for Random assignment|42|||
131765072|NCT00135694|474415372|FG001|Overall Study|Ineligible for Random assignment|0|||
131765073|NCT00135694|474415373|FG002|Overall Study|Ineligible for Random assignment|0|||
131765074|NCT00472043|474415374|FG000|Overall Study|Withdrawal by Subject|1|||
131765075|NCT00472043|474415375|FG001|Overall Study|Withdrawal by Subject|0|||
131765076|NCT00472043|474415374|FG000|Overall Study|Death|1|||
131765077|NCT00472043|474415375|FG001|Overall Study|Death|0|||
131765078|NCT02802735|474415376|FG000|Overall Study|Withdrawal by Subject|0|||
131765079|NCT02802735|474415377|FG001|Overall Study|Withdrawal by Subject|1|||
131765080|NCT02802735|474415378|FG002|Overall Study|Withdrawal by Subject|0|||
131765081|NCT02802735|474415379|FG003|Overall Study|Withdrawal by Subject|0|||
131765082|NCT02802735|474415380|FG004|Overall Study|Withdrawal by Subject|0|||
131765083|NCT00420212|474415383|FG000|Overall Study|Adverse Event|22|||
131765084|NCT00420212|474415384|FG001|Overall Study|Adverse Event|40|||
131765085|NCT00420212|474415385|FG002|Overall Study|Adverse Event|36|||
131765086|NCT00420212|474415383|FG000|Overall Study|Lost to Follow-up|9|||
131765087|NCT00420212|474415384|FG001|Overall Study|Lost to Follow-up|11|||
131765088|NCT00420212|474415385|FG002|Overall Study|Lost to Follow-up|11|||
131765089|NCT00420212|474415383|FG000|Overall Study|Withdrawal by Subject|31|||
131765090|NCT00420212|474415384|FG001|Overall Study|Withdrawal by Subject|22|||
131765091|NCT00420212|474415385|FG002|Overall Study|Withdrawal by Subject|19|||
131765092|NCT00420212|474415383|FG000|Overall Study|Physician Decision|4|||
131765093|NCT00420212|474415384|FG001|Overall Study|Physician Decision|4|||
131765094|NCT00420212|474415385|FG002|Overall Study|Physician Decision|3|||
131765095|NCT00420212|474415383|FG000|Overall Study|Protocol Violation|4|||
131765096|NCT00420212|474415384|FG001|Overall Study|Protocol Violation|4|||
131765097|NCT00420212|474415385|FG002|Overall Study|Protocol Violation|8|||
131765098|NCT00420212|474415383|FG000|Overall Study|Death|0|||
131765099|NCT00420212|474415384|FG001|Overall Study|Death|0|||
131765100|NCT00420212|474415385|FG002|Overall Study|Death|1|||
131765101|NCT00420212|474415383|FG000|Overall Study|Other-Unspecified|21|||
131765102|NCT00420212|474415384|FG001|Overall Study|Other-Unspecified|14|||
131765103|NCT00420212|474415385|FG002|Overall Study|Other-Unspecified|18|||
131765104|NCT00877890|474415386|FG000|Overall Study|Adverse Event|6|||
131765105|NCT00877890|474415387|FG001|Overall Study|Adverse Event|6|||
131765106|NCT00877890|474415386|FG000|Overall Study|Lost to Follow-up|5|||
131765107|NCT00877890|474415387|FG001|Overall Study|Lost to Follow-up|5|||
131765108|NCT00877890|474415386|FG000|Overall Study|Protocol Violation|0|||
131765109|NCT00877890|474415387|FG001|Overall Study|Protocol Violation|1|||
131765110|NCT00877890|474415386|FG000|Overall Study|Withdrawal of Consent|6|||
131765111|NCT00877890|474415387|FG001|Overall Study|Withdrawal of Consent|12|||
131765112|NCT00877890|474415386|FG000|Overall Study|Investigator Decision|0|||
131765113|NCT00877890|474415387|FG001|Overall Study|Investigator Decision|2|||
131765114|NCT00877890|474415386|FG000|Overall Study|Loss of Glucose Control|3|||
131765115|NCT00877890|474415387|FG001|Overall Study|Loss of Glucose Control|4|||
131765116|NCT01225211|474415389|FG000|Overall Study|Adverse Event|0|||
131400583|NCT00327015|473089535|FG003|Overall Study|Poor/Noncompliance|5|||
131400584|NCT00327015|473089532|FG000|Overall Study|Physician Decision|0|||
131765117|NCT01225211|474415390|FG001|Overall Study|Adverse Event|0|||
131765118|NCT01225211|474415391|FG002|Overall Study|Adverse Event|1|||
131765119|NCT01225211|474415392|FG003|Overall Study|Adverse Event|0|||
131813946|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
131813947|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131400585|NCT00327015|473089533|FG001|Overall Study|Physician Decision|1|||
131765120|NCT01225211|474415393|FG004|Overall Study|Adverse Event|0|||
131765121|NCT01225211|474415394|FG005|Overall Study|Adverse Event|0|||
131765122|NCT01225211|474415395|FG006|Overall Study|Adverse Event|0|||
131765123|NCT01225211|474415396|FG007|Overall Study|Adverse Event|0|||
131813948|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
131765124|NCT01225211|474415397|FG008|Overall Study|Adverse Event|0|||
131765125|NCT01225211|474415398|FG009|Overall Study|Adverse Event|1|||
131813949|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131400586|NCT00327015|473089534|FG002|Overall Study|Physician Decision|3|||
131400587|NCT00327015|473089535|FG003|Overall Study|Physician Decision|2|||
131400588|NCT00327015|473089532|FG000|Overall Study|Death|1|||
131400589|NCT00327015|473089533|FG001|Overall Study|Death|2|||
131765126|NCT01225211|474415389|FG000|Overall Study|Withdrawal by Subject|0|||
131765127|NCT01225211|474415390|FG001|Overall Study|Withdrawal by Subject|0|||
131765128|NCT01225211|474415391|FG002|Overall Study|Withdrawal by Subject|0|||
131765129|NCT01225211|474415392|FG003|Overall Study|Withdrawal by Subject|0|||
131765130|NCT01225211|474415393|FG004|Overall Study|Withdrawal by Subject|0|||
131765131|NCT01225211|474415394|FG005|Overall Study|Withdrawal by Subject|0|||
131765132|NCT01225211|474415395|FG006|Overall Study|Withdrawal by Subject|1|||
131765133|NCT01225211|474415396|FG007|Overall Study|Withdrawal by Subject|0|||
131765134|NCT01225211|474415397|FG008|Overall Study|Withdrawal by Subject|1|||
131765135|NCT01225211|474415398|FG009|Overall Study|Withdrawal by Subject|3|||
131765136|NCT01225211|474415389|FG000|Overall Study|Other|0|||
131765137|NCT01225211|474415390|FG001|Overall Study|Other|0|||
131765138|NCT01225211|474415391|FG002|Overall Study|Other|0|||
131765139|NCT01225211|474415392|FG003|Overall Study|Other|0|||
131765140|NCT01225211|474415393|FG004|Overall Study|Other|0|||
131765141|NCT01225211|474415394|FG005|Overall Study|Other|0|||
131765142|NCT01225211|474415395|FG006|Overall Study|Other|0|||
131765143|NCT01225211|474415396|FG007|Overall Study|Other|0|||
131765144|NCT01225211|474415397|FG008|Overall Study|Other|0|||
131765145|NCT01225211|474415398|FG009|Overall Study|Other|1|||
131765146|NCT00606021|474415406|FG000|Induction Phase|Death|73|||
131765147|NCT00606021|474415407|FG001|Induction Phase|Death|0|||
131765148|NCT00606021|474415408|FG002|Induction Phase|Death|0|||
131765149|NCT00606021|474415406|FG000|Induction Phase|Physician Decision|2|||
131765150|NCT00606021|474415407|FG001|Induction Phase|Physician Decision|0|||
131765151|NCT00606021|474415408|FG002|Induction Phase|Physician Decision|0|||
131765152|NCT00606021|474415406|FG000|Induction Phase|Withdrawal by Subject|2|||
131765153|NCT00606021|474415407|FG001|Induction Phase|Withdrawal by Subject|0|||
131765154|NCT00606021|474415408|FG002|Induction Phase|Withdrawal by Subject|0|||
131765155|NCT00606021|474415406|FG000|Induction Phase|Lost to Follow-up|10|||
131765156|NCT00606021|474415407|FG001|Induction Phase|Lost to Follow-up|0|||
131765157|NCT00606021|474415408|FG002|Induction Phase|Lost to Follow-up|0|||
131765158|NCT00606021|474415406|FG000|Maintenance Phase|Death|0|||
131765159|NCT00606021|474415407|FG001|Maintenance Phase|Death|17|||
131765160|NCT00606021|474415408|FG002|Maintenance Phase|Death|15|||
131765161|NCT00606021|474415406|FG000|Maintenance Phase|Physician Decision|0|||
131765162|NCT00606021|474415407|FG001|Maintenance Phase|Physician Decision|1|||
131765163|NCT00606021|474415408|FG002|Maintenance Phase|Physician Decision|0|||
131765164|NCT00606021|474415406|FG000|Maintenance Phase|Lost to Follow-up|0|||
131765165|NCT00606021|474415407|FG001|Maintenance Phase|Lost to Follow-up|5|||
131765166|NCT00606021|474415408|FG002|Maintenance Phase|Lost to Follow-up|2|||
131765167|NCT00392210|474415411|FG000|First Voiding Trial|Physician Decision|2|||
131765168|NCT00392210|474415412|FG001|First Voiding Trial|Physician Decision|2|||
131765169|NCT00554840|474415413|FG000|Overall Study|Physician Decision|0|||
131765170|NCT00554840|474415414|FG001|Overall Study|Physician Decision|1|||
131765171|NCT00805142|474415417|FG000|Titration Period|Adverse Event|3|||
131765172|NCT00805142|474415418|FG001|Titration Period|Adverse Event|3|||
131765173|NCT00805142|474415417|FG000|Titration Period|Lack of Efficacy|1|||
131765174|NCT00805142|474415418|FG001|Titration Period|Lack of Efficacy|1|||
131765175|NCT00805142|474415417|FG000|Titration Period|Lost to Follow-up|0|||
131765176|NCT00805142|474415418|FG001|Titration Period|Lost to Follow-up|1|||
131765177|NCT00805142|474415417|FG000|Titration Period|Disease Progression|2|||
131765178|NCT00805142|474415418|FG001|Titration Period|Disease Progression|1|||
131765179|NCT00805142|474415417|FG000|Titration Period|Withdrawal of consent|0|||
131765180|NCT00805142|474415418|FG001|Titration Period|Withdrawal of consent|1|||
131765181|NCT00805142|474415417|FG000|Titration Period|Other|0|||
131765182|NCT00805142|474415418|FG001|Titration Period|Other|3|||
131765183|NCT00805142|474415417|FG000|Maintenance Period|Adverse Event|0|||
131765184|NCT00805142|474415418|FG001|Maintenance Period|Adverse Event|1|||
131765185|NCT00805142|474415417|FG000|Maintenance Period|Other|0|||
131813950|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813951|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813952|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813953|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131765186|NCT00805142|474415418|FG001|Maintenance Period|Other|1|||
131765187|NCT02886338|474415420|FG000|Overall Study|Withdrawal by Subject|1|||
131765188|NCT00394654|474415421|FG000|Overall Study|Lost to Follow-up|1|||
131765189|NCT00394654|474415422|FG001|Overall Study|Lost to Follow-up|0|||
131765190|NCT00394654|474415421|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
131765191|NCT00394654|474415422|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
131765192|NCT00122317|474415423|FG000|Overall Study|Death|3|||
131765193|NCT00122317|474415423|FG000|Overall Study|Adverse Event|4|||
131765194|NCT00122317|474415423|FG000|Overall Study|Physician Decision|2|||
131765195|NCT00122317|474415423|FG000|Overall Study|patient non-compliance|1|||
131813954|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131765196|NCT00122317|474415423|FG000|Overall Study|Withdrawal by Subject|1|||
131765197|NCT03756285|474415425|FG000|Overall Study|Lost to Follow-up|0|||
131765198|NCT03756285|474415426|FG001|Overall Study|Lost to Follow-up|1|||
131765199|NCT03756285|474415425|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
131909542|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
131909543|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
131909544|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
131909545|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
131909546|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
131909547|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
131909548|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
131909549|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
131909550|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
131909551|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
131909552|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
131909553|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
131909554|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
131909555|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
131909556|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
131909557|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
131909558|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
131909559|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
131909560|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
131909561|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
131909562|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
131909563|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
131909564|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
131909565|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
131909566|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
131909567|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
131909568|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
131909569|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
131909570|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
131909571|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
131909572|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
131909573|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
131909574|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
131909575|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
131909576|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
131909577|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
131909578|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
131909579|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
131909580|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
131909581|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
131765200|NCT03756285|474415426|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
131765201|NCT03756285|474415425|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
131765202|NCT03756285|474415426|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
131765203|NCT04728815|474415428|FG000|Overall Study|Lost to Follow-up|3|||
131765204|NCT04728815|474415429|FG001|Overall Study|Lost to Follow-up|0|||
131765205|NCT04728815|474415430|FG002|Overall Study|Lost to Follow-up|0|||
131765206|NCT04728815|474415431|FG003|Overall Study|Lost to Follow-up|1|||
131765207|NCT04728815|474415432|FG004|Overall Study|Lost to Follow-up|1|||
131765208|NCT04728815|474415433|FG005|Overall Study|Lost to Follow-up|0|||
131765209|NCT04728815|474415434|FG006|Overall Study|Lost to Follow-up|2|||
131765210|NCT04728815|474415435|FG007|Overall Study|Lost to Follow-up|0|||
131765211|NCT04728815|474415428|FG000|Overall Study|Physician Decision|0|||
131765212|NCT04728815|474415429|FG001|Overall Study|Physician Decision|0|||
131765213|NCT04728815|474415430|FG002|Overall Study|Physician Decision|1|||
131765214|NCT04728815|474415431|FG003|Overall Study|Physician Decision|0|||
131765215|NCT04728815|474415432|FG004|Overall Study|Physician Decision|0|||
131765216|NCT04728815|474415433|FG005|Overall Study|Physician Decision|0|||
131765217|NCT04728815|474415434|FG006|Overall Study|Physician Decision|0|||
131765218|NCT04728815|474415435|FG007|Overall Study|Physician Decision|0|||
131765219|NCT04728815|474415428|FG000|Overall Study|Treatment drop|0|||
131765220|NCT04728815|474415429|FG001|Overall Study|Treatment drop|2|||
131765221|NCT04728815|474415430|FG002|Overall Study|Treatment drop|1|||
131765222|NCT04728815|474415431|FG003|Overall Study|Treatment drop|0|||
131765223|NCT04728815|474415432|FG004|Overall Study|Treatment drop|3|||
131765224|NCT04728815|474415433|FG005|Overall Study|Treatment drop|1|||
131765225|NCT04728815|474415434|FG006|Overall Study|Treatment drop|3|||
131765226|NCT04728815|474415435|FG007|Overall Study|Treatment drop|0|||
131765227|NCT04728815|474415428|FG000|Overall Study|Study drop|0|||
131765228|NCT04728815|474415429|FG001|Overall Study|Study drop|3|||
131765229|NCT04728815|474415430|FG002|Overall Study|Study drop|3|||
131765230|NCT04728815|474415431|FG003|Overall Study|Study drop|0|||
131765231|NCT04728815|474415432|FG004|Overall Study|Study drop|0|||
131765232|NCT04728815|474415433|FG005|Overall Study|Study drop|0|||
131765233|NCT04728815|474415434|FG006|Overall Study|Study drop|7|||
131765234|NCT04728815|474415435|FG007|Overall Study|Study drop|0|||
131765235|NCT00957034|474415438|FG000|Overall Study|Adverse Event|0|||
131765236|NCT00957034|474415439|FG001|Overall Study|Adverse Event|1|||
131765237|NCT00957034|474415440|FG002|Overall Study|Adverse Event|1|||
131909582|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
131909583|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
131909584|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
131909585|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
131909586|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
131765238|NCT00957034|474415438|FG000|Overall Study|Sponsor Terminated Study|6|||
131765239|NCT00957034|474415439|FG001|Overall Study|Sponsor Terminated Study|1|||
131765240|NCT00957034|474415440|FG002|Overall Study|Sponsor Terminated Study|5|||
131765241|NCT00957034|474415438|FG000|Overall Study|Withdrawal by Subject|0|||
131765242|NCT00957034|474415439|FG001|Overall Study|Withdrawal by Subject|2|||
131765243|NCT00957034|474415440|FG002|Overall Study|Withdrawal by Subject|0|||
131765244|NCT02390167|474417828|FG000|Overall Study|Lost to Follow-up|1|||
131765245|NCT00027846|474417829|FG000|Overall Study|Lost to Follow-up|0|||
131765246|NCT00027846|474417830|FG001|Overall Study|Lost to Follow-up|41|||
131765247|NCT00027846|474417831|FG002|Overall Study|Lost to Follow-up|9|||
131765248|NCT00027846|474417829|FG000|Overall Study|Withdrawal by Subject|0|||
131765249|NCT00027846|474417830|FG001|Overall Study|Withdrawal by Subject|14|||
131765250|NCT00027846|474417831|FG002|Overall Study|Withdrawal by Subject|7|||
131765251|NCT00027846|474417829|FG000|Overall Study|Ineligible for study|2|||
131765252|NCT00027846|474417830|FG001|Overall Study|Ineligible for study|6|||
131765253|NCT00027846|474417831|FG002|Overall Study|Ineligible for study|14|||
131765254|NCT00027846|474417829|FG000|Overall Study|Entry into another COG therapeutic study|0|||
131765255|NCT00027846|474417830|FG001|Overall Study|Entry into another COG therapeutic study|5|||
131765256|NCT00027846|474417831|FG002|Overall Study|Entry into another COG therapeutic study|2|||
131765257|NCT00027846|474417829|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
131765258|NCT00027846|474417830|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
131765259|NCT00027846|474417831|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
131765260|NCT02033369|474417832|FG000|Overall Study|Physician Decision|1|||
131765261|NCT02033369|474417833|FG001|Overall Study|Physician Decision|2|||
131765262|NCT02033369|474417832|FG000|Overall Study|Not a good demographic match|0|||
131765263|NCT02033369|474417833|FG001|Overall Study|Not a good demographic match|2|||
131765264|NCT02033369|474417832|FG000|Overall Study|Withdrawal by Subject|1|||
131765265|NCT02033369|474417833|FG001|Overall Study|Withdrawal by Subject|1|||
131765266|NCT02033369|474417832|FG000|Overall Study|Lost to Follow-up|1|||
131765267|NCT02033369|474417833|FG001|Overall Study|Lost to Follow-up|0|||
131765268|NCT02033369|474417832|FG000|Overall Study|Protocol Violation|2|||
131765269|NCT02033369|474417833|FG001|Overall Study|Protocol Violation|0|||
131765270|NCT01265719|474417834|FG000|Overall Study|Does not meet entrance criteria|0|||
131765271|NCT01265719|474417835|FG001|Overall Study|Does not meet entrance criteria|3|||
131765272|NCT01265719|474417834|FG000|Overall Study|Other reasons|2|||
131765273|NCT01265719|474417835|FG001|Overall Study|Other reasons|0|||
131765274|NCT01265719|474417834|FG000|Overall Study|Withdrawal by Subject|8|||
131765275|NCT01265719|474417835|FG001|Overall Study|Withdrawal by Subject|3|||
131765276|NCT01265719|474417834|FG000|Overall Study|Lost to Follow-up|2|||
131765277|NCT01265719|474417835|FG001|Overall Study|Lost to Follow-up|7|||
131765278|NCT01265719|474417834|FG000|Overall Study|Adverse Event|2|||
131765279|NCT01265719|474417835|FG001|Overall Study|Adverse Event|0|||
131765280|NCT04335929|474417836|FG000|Overall Study|Lost to Follow-up|10|||
131765281|NCT05604781|474417838|FG000|Overall Study|Lost to Follow-up|3|||
131765282|NCT05604781|474417838|FG000|Overall Study|Adverse Event|1|||
131765283|NCT01005966|474417839|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
131765284|NCT01005966|474417840|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
131765285|NCT01005966|474417841|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
131765286|NCT01005966|474417842|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
131765287|NCT01005966|474417843|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
131765288|NCT01005966|474417839|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131765289|NCT01005966|474417840|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
131765290|NCT01005966|474417841|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131765291|NCT01005966|474417842|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
131765292|NCT01005966|474417843|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
131765293|NCT01005966|474417839|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131765294|NCT01005966|474417840|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131765295|NCT01005966|474417841|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131765296|NCT01005966|474417842|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
131765297|NCT01005966|474417843|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131765298|NCT01005966|474417839|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
131765299|NCT01005966|474417840|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
131765300|NCT01005966|474417841|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
131765301|NCT01005966|474417842|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
131765302|NCT01005966|474417843|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
131765303|NCT01005966|474417839|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131765304|NCT01005966|474417840|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131765305|NCT01005966|474417841|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131765306|NCT01005966|474417842|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
131765307|NCT01005966|474417843|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131765308|NCT01005966|474417839|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131765309|NCT01005966|474417840|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131765310|NCT01005966|474417841|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
131765311|NCT01005966|474417842|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131765312|NCT01005966|474417843|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131765313|NCT01005966|474417839|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
131765314|NCT01005966|474417840|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
131765315|NCT01005966|474417841|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
131765316|NCT01005966|474417842|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
131765317|NCT01005966|474417843|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
131765318|NCT01005966|474417839|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131765319|NCT01005966|474417840|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
131813955|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813956|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813957|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813958|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813959|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131813960|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
131813961|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
131813962|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
131813963|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813964|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813965|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813966|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813967|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813968|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813969|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813970|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813971|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813972|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813973|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131813974|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
131813975|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813976|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
131813977|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813978|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813979|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813980|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813981|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813982|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813983|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813984|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813985|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813986|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813987|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131813988|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
131813989|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131765320|NCT01005966|474417841|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131765321|NCT01005966|474417842|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131765322|NCT01005966|474417843|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131765323|NCT01005966|474417839|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
131765324|NCT01005966|474417840|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
131813990|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
131813991|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131813992|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131909587|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
131909588|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
131909589|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
131909590|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
131909591|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
131909592|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
131765325|NCT01005966|474417841|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
131765326|NCT01005966|474417842|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
131765327|NCT01005966|474417843|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
131765328|NCT01451203|474417844|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
131765329|NCT01451203|474417845|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
131765330|NCT01451203|474417844|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
131765331|NCT01451203|474417845|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
131765332|NCT01451203|474417844|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
131765333|NCT01451203|474417845|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
131765334|NCT01451203|474417844|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
131765335|NCT01451203|474417845|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
131765336|NCT01451203|474417844|FG000|Double-blind Treatment Period|Adverse Event|6|||
131765337|NCT01451203|474417845|FG001|Double-blind Treatment Period|Adverse Event|9|||
131765338|NCT01451203|474417844|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
131765339|NCT01451203|474417845|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
131909593|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
131909594|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
131909595|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
131909596|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
131909597|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
131909598|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
131909599|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
131909600|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
131909601|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
131909602|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
131909603|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
131909604|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
131909605|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
131909606|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
131909607|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
131909608|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
131909609|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
131909610|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
131909611|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
131909612|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
131909613|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
131909614|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
131909615|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
131909616|NCT02717195|474956797|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
131909617|NCT02717195|474956798|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
131909618|NCT02717195|474956799|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
131909619|NCT02717195|474956800|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
131909620|NCT02717195|474956801|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
131909621|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
131909622|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
131909623|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
131909624|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
131909625|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
131909626|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
131909627|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
131909628|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
131909629|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
131909630|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
131909631|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
131909632|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
131909633|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
131765340|NCT01451203|474417844|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
131765341|NCT01451203|474417845|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
131765342|NCT01451203|474417844|FG000|Double-blind Treatment Period|Investigator decision|2|||
131765343|NCT01451203|474417845|FG001|Double-blind Treatment Period|Investigator decision|0|||
131765344|NCT01451203|474417844|FG000|Post-treatment Period|Consent withdrawn|2|||
131765345|NCT01451203|474417845|FG001|Post-treatment Period|Consent withdrawn|4|||
131765346|NCT01451203|474417844|FG000|Post-treatment Period|Lack of Efficacy|12|||
131765347|NCT01451203|474417845|FG001|Post-treatment Period|Lack of Efficacy|28|||
131765348|NCT01451203|474417844|FG000|Post-treatment Period|Adverse Event|0|||
131765349|NCT01451203|474417845|FG001|Post-treatment Period|Adverse Event|1|||
131765350|NCT01451203|474417844|FG000|Post-treatment Period|Investigator decision|0|||
131765351|NCT01451203|474417845|FG001|Post-treatment Period|Investigator decision|1|||
131765352|NCT00027027|474417846|FG000|Overall Study|Adverse Event|0|||
131765353|NCT00027027|474417847|FG001|Overall Study|Adverse Event|0|||
131765354|NCT00027027|474417848|FG002|Overall Study|Adverse Event|1|||
131765355|NCT00027027|474417849|FG003|Overall Study|Adverse Event|0|||
131765356|NCT00027027|474417850|FG004|Overall Study|Adverse Event|1|||
131765357|NCT00027027|474417846|FG000|Overall Study|Admitted for Signs of PD|0|||
131765358|NCT00027027|474417847|FG001|Overall Study|Admitted for Signs of PD|0|||
131765359|NCT00027027|474417848|FG002|Overall Study|Admitted for Signs of PD|0|||
131765360|NCT00027027|474417849|FG003|Overall Study|Admitted for Signs of PD|0|||
131765361|NCT00027027|474417850|FG004|Overall Study|Admitted for Signs of PD|1|||
131765362|NCT00027027|474417846|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
131765363|NCT00027027|474417847|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
131765364|NCT00027027|474417848|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
131765365|NCT00027027|474417849|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
131765366|NCT00027027|474417850|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
131765367|NCT00027027|474417846|FG000|Overall Study|PD Requiring Surgery|0|||
131765368|NCT00027027|474417847|FG001|Overall Study|PD Requiring Surgery|0|||
131765369|NCT00027027|474417848|FG002|Overall Study|PD Requiring Surgery|1|||
131765370|NCT00027027|474417849|FG003|Overall Study|PD Requiring Surgery|0|||
131765371|NCT00027027|474417850|FG004|Overall Study|PD Requiring Surgery|0|||
131765372|NCT00027027|474417846|FG000|Overall Study|Physician Decision Due To PD|2|||
131765373|NCT00027027|474417847|FG001|Overall Study|Physician Decision Due To PD|3|||
131765374|NCT00027027|474417848|FG002|Overall Study|Physician Decision Due To PD|2|||
131765375|NCT00027027|474417849|FG003|Overall Study|Physician Decision Due To PD|3|||
131765376|NCT00027027|474417850|FG004|Overall Study|Physician Decision Due To PD|5|||
131765377|NCT00027027|474417846|FG000|Overall Study|Withdrawal by Subject|0|||
131765378|NCT00027027|474417847|FG001|Overall Study|Withdrawal by Subject|0|||
131765379|NCT00027027|474417848|FG002|Overall Study|Withdrawal by Subject|0|||
131765380|NCT00027027|474417849|FG003|Overall Study|Withdrawal by Subject|0|||
131765381|NCT00027027|474417850|FG004|Overall Study|Withdrawal by Subject|1|||
131765382|NCT05466240|474417854|FG000|Overall Study|Adverse Event|1|||
131765383|NCT05466240|474417855|FG001|Overall Study|Adverse Event|0|||
131765384|NCT05466240|474417854|FG000|Overall Study|Withdrawal by Subject|1|||
131765385|NCT05466240|474417855|FG001|Overall Study|Withdrawal by Subject|0|||
131765386|NCT00305773|474417856|FG000|Overall Study|Death|3|||
131765387|NCT00305773|474417857|FG001|Overall Study|Death|2|||
131765388|NCT00305773|474417856|FG000|Overall Study|Adverse Event|1|||
131765389|NCT00305773|474417857|FG001|Overall Study|Adverse Event|2|||
131765390|NCT00305773|474417856|FG000|Overall Study|Alternative Treatment|4|||
131765391|NCT00305773|474417857|FG001|Overall Study|Alternative Treatment|4|||
131765392|NCT00305773|474417856|FG000|Overall Study|Physician Decision|1|||
131765393|NCT00305773|474417857|FG001|Overall Study|Physician Decision|1|||
131765394|NCT00305773|474417856|FG000|Overall Study|Withdrawal by Subject|1|||
131765395|NCT00305773|474417857|FG001|Overall Study|Withdrawal by Subject|4|||
131765396|NCT00305773|474417856|FG000|Overall Study|Disease Progression|1|||
131813993|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131813994|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131813995|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131813996|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131813997|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131400590|NCT00327015|473089534|FG002|Overall Study|Death|2|||
131765397|NCT00305773|474417857|FG001|Overall Study|Disease Progression|3|||
131765398|NCT00305773|474417856|FG000|Overall Study|All other reasons|3|||
131765399|NCT00305773|474417857|FG001|Overall Study|All other reasons|2|||
131813998|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131813999|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131400591|NCT00327015|473089535|FG003|Overall Study|Death|3|||
131765400|NCT02679222|474417858|FG000|Overall Study|No time for project|1|||
131765401|NCT00413231|474417859|FG000|0 to 30-day Post Treatment|Death|5|||
131765402|NCT00413231|474417859|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
131765403|NCT00413231|474417859|FG000|30-day to 365-day Post Treatment|Death|13|||
131765404|NCT00413231|474417859|FG000|365-day to 60-month Post Treatment|Death|36|||
131765405|NCT00413231|474417859|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
131765406|NCT00413231|474417859|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
131765407|NCT00413231|474417859|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
131765408|NCT00945945|474417864|FG000|Overall Study|Adverse Event|15|||
131765409|NCT00945945|474417865|FG001|Overall Study|Adverse Event|35|||
131765410|NCT00945945|474417864|FG000|Overall Study|Withdrawal by Subject|7|||
131765411|NCT00945945|474417865|FG001|Overall Study|Withdrawal by Subject|10|||
131765412|NCT00945945|474417864|FG000|Overall Study|Lost to Follow-up|4|||
131765413|NCT00945945|474417865|FG001|Overall Study|Lost to Follow-up|5|||
131765414|NCT00945945|474417864|FG000|Overall Study|Lack of Efficacy|6|||
131765415|NCT00945945|474417865|FG001|Overall Study|Lack of Efficacy|2|||
131765416|NCT00945945|474417864|FG000|Overall Study|Protocol Violation|4|||
131765417|NCT00945945|474417865|FG001|Overall Study|Protocol Violation|2|||
131765418|NCT00945945|474417864|FG000|Overall Study|Entry Criteria Not Met|0|||
131765419|NCT00945945|474417865|FG001|Overall Study|Entry Criteria Not Met|1|||
131765420|NCT02408016|474417867|FG000|Overall Study|Death|6|||
131765421|NCT02408016|474417868|FG001|Overall Study|Death|1|||
131765422|NCT02408016|474417869|FG002|Overall Study|Death|0|||
131765423|NCT02408016|474417867|FG000|Overall Study|Physician Decision|0|||
131765424|NCT02408016|474417868|FG001|Overall Study|Physician Decision|2|||
131765425|NCT02408016|474417869|FG002|Overall Study|Physician Decision|0|||
131765426|NCT00805194|474417870|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
131765427|NCT00805194|474417871|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
131765428|NCT00805194|474417870|FG000|Overall Study|Worsening or AE of underlying disease|64|||
131765429|NCT00805194|474417871|FG001|Overall Study|Worsening or AE of underlying disease|70|||
131765430|NCT00805194|474417870|FG000|Overall Study|Other AE|84|||
131765431|NCT00805194|474417871|FG001|Overall Study|Other AE|73|||
131814000|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131814001|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131814002|NCT01695239|474601802|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
131814003|NCT01695239|474601803|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814004|NCT01695239|474601804|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814005|NCT01695239|474601805|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814006|NCT01695239|474601806|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814007|NCT01695239|474601807|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814008|NCT01695239|474601808|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814009|NCT01695239|474601809|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814010|NCT01695239|474601810|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814011|NCT01695239|474601811|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814012|NCT01695239|474601812|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131765432|NCT00805194|474417870|FG000|Overall Study|Protocol Violation|9|||
131765433|NCT00805194|474417871|FG001|Overall Study|Protocol Violation|9|||
131765434|NCT00805194|474417870|FG000|Overall Study|Lost to Follow-up|5|||
131765435|NCT00805194|474417871|FG001|Overall Study|Lost to Follow-up|5|||
131765436|NCT00805194|474417870|FG000|Overall Study|Withdrawal by Subject|60|||
131765437|NCT00805194|474417871|FG001|Overall Study|Withdrawal by Subject|42|||
131765438|NCT00805194|474417870|FG000|Overall Study|Not treated|3|||
131765439|NCT00805194|474417871|FG001|Overall Study|Not treated|4|||
131765440|NCT00805194|474417870|FG000|Overall Study|Reasons other than stated above|20|||
131765441|NCT00805194|474417871|FG001|Overall Study|Reasons other than stated above|16|||
131765442|NCT02275052|474417875|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131765443|NCT02275052|474417876|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131765444|NCT02275052|474417877|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131765445|NCT02275052|474417878|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131814013|NCT01695239|474601813|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131765446|NCT02275052|474417875|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
131814014|NCT01695239|474601814|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814015|NCT01695239|474601815|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131814016|NCT01695239|474601802|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814017|NCT01695239|474601803|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814018|NCT01695239|474601804|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814019|NCT01695239|474601805|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814020|NCT01695239|474601806|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131909634|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
131765447|NCT02275052|474417876|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
131765448|NCT02275052|474417877|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
131765449|NCT02275052|474417878|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
131765450|NCT02275052|474417875|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
131765451|NCT02275052|474417876|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
131814021|NCT01695239|474601807|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814022|NCT01695239|474601808|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131765452|NCT02275052|474417877|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131765453|NCT02275052|474417878|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131765454|NCT02275052|474417875|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
131765455|NCT02275052|474417876|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
131765456|NCT02275052|474417877|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
131765457|NCT02275052|474417878|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
131765458|NCT02275052|474417875|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
131765459|NCT02275052|474417876|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
131765460|NCT02275052|474417877|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
131765461|NCT02275052|474417878|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
131765462|NCT02275052|474417875|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
131765463|NCT02275052|474417876|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
131765464|NCT02275052|474417877|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
131765465|NCT02275052|474417878|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
131765466|NCT02275052|474417875|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
131765467|NCT02275052|474417876|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
131765468|NCT02275052|474417877|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
131765469|NCT02275052|474417878|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
131765470|NCT02275052|474417875|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131765471|NCT02275052|474417876|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131765472|NCT02275052|474417877|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
131765473|NCT02275052|474417878|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
131765474|NCT02275052|474417875|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131765475|NCT02275052|474417876|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131765476|NCT02275052|474417877|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131765477|NCT02275052|474417878|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
131765478|NCT02275052|474417875|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131765479|NCT02275052|474417876|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131765480|NCT02275052|474417877|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131765481|NCT02275052|474417878|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
131765482|NCT02275052|474417875|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131765483|NCT02275052|474417876|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131765484|NCT02275052|474417877|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131765485|NCT02275052|474417878|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
131765486|NCT00846027|474417881|FG000|Overall Study|Death|3|||
131765487|NCT00846027|474417881|FG000|Overall Study|Disease Progression|30|||
131765488|NCT00846027|474417881|FG000|Overall Study|Toxicity|12|||
131765489|NCT00846027|474417881|FG000|Overall Study|Patient Decision|7|||
131765490|NCT00846027|474417881|FG000|Overall Study|Investigator Discretion|29|||
131765491|NCT00846027|474417881|FG000|Overall Study|Protocol Violation|2|||
131765492|NCT00846027|474417881|FG000|Overall Study|Subject Not Treated|7|||
131765493|NCT01412333|474417887|FG000|Overall Study|Adverse Event|40|||
131765494|NCT01412333|474417888|FG001|Overall Study|Adverse Event|42|||
131765495|NCT01412333|474417887|FG000|Overall Study|Death|5|||
131765496|NCT01412333|474417888|FG001|Overall Study|Death|6|||
131765497|NCT01412333|474417887|FG000|Overall Study|Lack of Efficacy|22|||
131765498|NCT01412333|474417888|FG001|Overall Study|Lack of Efficacy|10|||
131765499|NCT01412333|474417887|FG000|Overall Study|Lost to Follow-up|15|||
131765500|NCT01412333|474417888|FG001|Overall Study|Lost to Follow-up|12|||
131765501|NCT01412333|474417887|FG000|Overall Study|Non-Compliance|3|||
131765502|NCT01412333|474417888|FG001|Overall Study|Non-Compliance|7|||
131765503|NCT01412333|474417887|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131765504|NCT01412333|474417888|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131765505|NCT01412333|474417887|FG000|Overall Study|Other|30|||
131765506|NCT01412333|474417888|FG001|Overall Study|Other|33|||
131765507|NCT01412333|474417887|FG000|Overall Study|Physician Decision|11|||
131765508|NCT01412333|474417888|FG001|Overall Study|Physician Decision|16|||
131765509|NCT01412333|474417887|FG000|Overall Study|Pregnancy|6|||
131765510|NCT01412333|474417888|FG001|Overall Study|Pregnancy|4|||
131814023|NCT01695239|474601809|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
131814024|NCT01695239|474601810|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131765511|NCT01412333|474417887|FG000|Overall Study|Protocol Violation|1|||
131765512|NCT01412333|474417888|FG001|Overall Study|Protocol Violation|2|||
131765513|NCT01412333|474417887|FG000|Overall Study|Study Terminated By Sponsor|3|||
131765514|NCT01412333|474417888|FG001|Overall Study|Study Terminated By Sponsor|2|||
131765515|NCT01412333|474417887|FG000|Overall Study|Withdrawal by Subject|51|||
131765516|NCT01412333|474417888|FG001|Overall Study|Withdrawal by Subject|54|||
131765517|NCT01412333|474417887|FG000|Overall Study|Missing|1|||
131765518|NCT01412333|474417888|FG001|Overall Study|Missing|3|||
131765519|NCT00750867|474417890|FG000|Overall Study|Adverse Event|2|||
131814025|NCT01695239|474601811|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131765520|NCT01562327|474417891|FG000|Overall Study|Adverse Event|2|||
131765521|NCT01562327|474417891|FG000|Overall Study|Lack of Efficacy|1|||
131814026|NCT01695239|474601812|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814027|NCT01695239|474601813|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814028|NCT01695239|474601814|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131814029|NCT01695239|474601815|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
131765522|NCT01562327|474417891|FG000|Overall Study|Participant drop-out|1|||
131765523|NCT01562327|474417891|FG000|Overall Study|Infusion not received at 6 month window|4|||
131765524|NCT03018340|474417892|FG000|Overall Study|Adverse Event|1|||
131765525|NCT03018340|474417893|FG001|Overall Study|Adverse Event|2|||
131765526|NCT03018340|474417892|FG000|Overall Study|Withdrawal by Subject|0|||
131765527|NCT03018340|474417893|FG001|Overall Study|Withdrawal by Subject|8|||
131765528|NCT03018340|474417892|FG000|Overall Study|Lack of Efficacy|0|||
131765529|NCT03018340|474417893|FG001|Overall Study|Lack of Efficacy|1|||
131765530|NCT03018340|474417892|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
131765531|NCT03018340|474417893|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
131765532|NCT03018340|474417892|FG000|Overall Study|Lost to Follow-up|1|||
131765533|NCT03018340|474417893|FG001|Overall Study|Lost to Follow-up|7|||
131765534|NCT03018340|474417892|FG000|Overall Study|Protocol Violation|3|||
131765535|NCT03018340|474417893|FG001|Overall Study|Protocol Violation|7|||
131765536|NCT03018340|474417892|FG000|Overall Study|Not further specified|0|||
131765537|NCT03018340|474417893|FG001|Overall Study|Not further specified|1|||
131765538|NCT02516306|474417894|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
131765539|NCT02516306|474417895|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
131765540|NCT01195636|474417896|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
131765541|NCT01195636|474417897|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
131765542|NCT01195636|474417896|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
131765543|NCT01195636|474417897|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
131765544|NCT01195636|474417896|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131765545|NCT01195636|474417897|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131765546|NCT01195636|474417896|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
131765547|NCT01195636|474417897|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
131765548|NCT01195636|474417896|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
131765549|NCT01195636|474417897|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
131765550|NCT01195636|474417896|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
131765551|NCT01195636|474417897|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
131765552|NCT01195636|474417896|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
131765553|NCT01195636|474417897|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
131765554|NCT01195636|474417896|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131765555|NCT01195636|474417897|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
131765556|NCT03961529|474417898|FG000|Overall Study|Adverse Event|13|||
131765557|NCT03961529|474417899|FG001|Overall Study|Adverse Event|5|||
131765558|NCT03961529|474417900|FG002|Overall Study|Adverse Event|2|||
131765559|NCT03961529|474417898|FG000|Overall Study|Withdrawal by Subject|17|||
131765560|NCT03961529|474417899|FG001|Overall Study|Withdrawal by Subject|2|||
131765561|NCT03961529|474417900|FG002|Overall Study|Withdrawal by Subject|1|||
131765562|NCT03961529|474417898|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131765563|NCT03961529|474417899|FG001|Overall Study|Withdrawal by parent/guardian|7|||
131765564|NCT03961529|474417900|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131765565|NCT03961529|474417898|FG000|Overall Study|Physician Decision|2|||
131765566|NCT03961529|474417899|FG001|Overall Study|Physician Decision|1|||
131765567|NCT03961529|474417900|FG002|Overall Study|Physician Decision|1|||
131765568|NCT03961529|474417898|FG000|Overall Study|Lost to Follow-up|2|||
131765569|NCT03961529|474417899|FG001|Overall Study|Lost to Follow-up|1|||
131765570|NCT03961529|474417900|FG002|Overall Study|Lost to Follow-up|0|||
131765571|NCT03961529|474417898|FG000|Overall Study|Lack of Efficacy|2|||
131765572|NCT03961529|474417899|FG001|Overall Study|Lack of Efficacy|0|||
131814030|NCT01695239|474601802|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814031|NCT01695239|474601803|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814032|NCT01695239|474601804|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814033|NCT01695239|474601805|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131765573|NCT03961529|474417900|FG002|Overall Study|Lack of Efficacy|1|||
131765574|NCT03961529|474417898|FG000|Overall Study|Other|6|||
131765575|NCT03961529|474417899|FG001|Overall Study|Other|1|||
131765576|NCT03961529|474417900|FG002|Overall Study|Other|0|||
131765577|NCT03644173|474417903|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
131765578|NCT03644173|474417903|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
131765579|NCT03644173|474417903|FG000|Participants at the 1-month Follow up|Death|2|||
131765580|NCT03644173|474417903|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
131765581|NCT00381706|474417904|FG000|Overall Study|Never treated|7|||
131765582|NCT00381706|474417905|FG001|Overall Study|Never treated|2|||
131765583|NCT00381706|474417906|FG002|Overall Study|Never treated|1|||
131765584|NCT00203294|474417908|FG000|Overall Study|Withdrawal by Subject|8|||
131814034|NCT01695239|474601806|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131765585|NCT00203294|474417909|FG001|Overall Study|Withdrawal by Subject|13|||
131765586|NCT02555722|474417910|FG000|Week 2|Adverse Event|0|||
131765587|NCT02555722|474417911|FG001|Week 2|Adverse Event|1|||
131765588|NCT02555722|474417910|FG000|Week 2|Withdrawal by Subject|1|||
131765589|NCT02555722|474417911|FG001|Week 2|Withdrawal by Subject|0|||
131765590|NCT02555722|474417910|FG000|Month 1|Lens Discomfort|1|||
131765591|NCT02555722|474417911|FG001|Month 1|Lens Discomfort|0|||
131765592|NCT02555722|474417910|FG000|Month 2|Withdrawal by Subject|3|||
131765593|NCT02555722|474417911|FG001|Month 2|Withdrawal by Subject|0|||
131765594|NCT02555722|474417910|FG000|Month 2|Lost to Follow-up|1|||
131765595|NCT02555722|474417911|FG001|Month 2|Lost to Follow-up|0|||
131765596|NCT00352027|474417912|FG000|Overall Study|Progressive disease|3|||
131765597|NCT01469637|474417913|FG000|First Intervention|Unacceptable behavior|0|||
131765598|NCT01469637|474417914|FG001|First Intervention|Unacceptable behavior|1|||
131765599|NCT01469637|474417913|FG000|Second Intervention|Incarcerated|1|||
131765600|NCT01469637|474417914|FG001|Second Intervention|Incarcerated|0|||
131765601|NCT00598585|474417915|FG000|Overall Study|Lost to Follow-up|1|||
131765602|NCT00598585|474417916|FG001|Overall Study|Lost to Follow-up|0|||
131765603|NCT03922711|474417923|FG000|Overall Study|Adverse Event|3|||
131765604|NCT03922711|474417924|FG001|Overall Study|Adverse Event|2|||
131765605|NCT03922711|474417925|FG002|Overall Study|Adverse Event|2|||
131765606|NCT03922711|474417923|FG000|Overall Study|Protocol Violation|1|||
131765607|NCT03922711|474417924|FG001|Overall Study|Protocol Violation|0|||
131765608|NCT03922711|474417925|FG002|Overall Study|Protocol Violation|0|||
131765609|NCT03922711|474417923|FG000|Overall Study|Withdrawal by Subject|0|||
131765610|NCT03922711|474417924|FG001|Overall Study|Withdrawal by Subject|3|||
131765611|NCT03922711|474417925|FG002|Overall Study|Withdrawal by Subject|1|||
131765612|NCT03922711|474417923|FG000|Overall Study|Not further specified|0|||
131765613|NCT03922711|474417924|FG001|Overall Study|Not further specified|0|||
131765614|NCT03922711|474417925|FG002|Overall Study|Not further specified|1|||
131765615|NCT03147495|474417926|FG000|Overall Study|Physician Decision|0|||
131765616|NCT03147495|474417927|FG001|Overall Study|Physician Decision|6|||
131765617|NCT00742391|474417934|FG000|Overall Study|Adverse Event|2|||
131765618|NCT00742391|474417935|FG001|Overall Study|Adverse Event|1|||
131765619|NCT00742391|474417934|FG000|Overall Study|Lost to Follow-up|1|||
131765620|NCT00742391|474417935|FG001|Overall Study|Lost to Follow-up|0|||
131765621|NCT00742391|474417934|FG000|Overall Study|Protocol Violation|1|||
131765622|NCT00742391|474417935|FG001|Overall Study|Protocol Violation|0|||
131765623|NCT02975206|474417942|FG000|Overall Study|Withdrawal by Subject|14|||
131765624|NCT02975206|474417943|FG001|Overall Study|Withdrawal by Subject|11|||
131765625|NCT02975206|474417944|FG002|Overall Study|Withdrawal by Subject|11|||
131765626|NCT02975206|474417942|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
131765627|NCT02975206|474417943|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
131765628|NCT02975206|474417944|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
131765629|NCT01981096|474417945|FG000|Overall Study|Parent illness|1|||
131765630|NCT01981096|474417946|FG001|Overall Study|Parent illness|0|||
131765631|NCT01981096|474417945|FG000|Overall Study|Withdrawal by Subject|0|||
131765632|NCT01981096|474417946|FG001|Overall Study|Withdrawal by Subject|1|||
131765633|NCT01981096|474417945|FG000|Overall Study|Lost to Follow-up|2|||
131765634|NCT01981096|474417946|FG001|Overall Study|Lost to Follow-up|0|||
131765635|NCT00866606|474417947|FG000|Overall Study|Lost to Follow-up|3|||
131765636|NCT00866606|474417947|FG000|Overall Study|Adverse Event|1|||
131765637|NCT01058356|474417963|FG000|Overall Study|Adverse Event|5|||
131765638|NCT01058356|474417963|FG000|Overall Study|Administration of contraindicated drugs|12|||
131765639|NCT01058356|474417963|FG000|Overall Study|Withdrawal by Subject|21|||
131814035|NCT01695239|474601807|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814036|NCT01695239|474601808|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814037|NCT01695239|474601809|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
131814038|NCT01695239|474601810|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814039|NCT01695239|474601811|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814040|NCT01695239|474601812|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131765640|NCT01058356|474417963|FG000|Overall Study|Lost to Follow-up|4|||
131765641|NCT02067104|474417964|FG000|Overall Study|Study termination due to low accrual|4|||
131765642|NCT02067104|474417965|FG001|Overall Study|Study termination due to low accrual|5|||
131765643|NCT04815291|474417977|FG000|Overall Study|Lost to Follow-up|1|||
131765644|NCT04815291|474417977|FG000|Overall Study|Physician Decision|4|||
131765645|NCT04815291|474417977|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
131765646|NCT02140762|474417978|FG000|Overall Study|Adverse Event|1|||
131765647|NCT02140762|474417979|FG001|Overall Study|Adverse Event|1|||
131765648|NCT02140762|474417978|FG000|Overall Study|Lost to Follow-up|9|||
131765649|NCT02140762|474417979|FG001|Overall Study|Lost to Follow-up|5|||
131765650|NCT02140762|474417978|FG000|Overall Study|Protocol Violation|1|||
131814041|NCT01695239|474601813|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131765651|NCT02140762|474417979|FG001|Overall Study|Protocol Violation|1|||
131765652|NCT02140762|474417978|FG000|Overall Study|Withdrawal by Subject|6|||
131765653|NCT02140762|474417979|FG001|Overall Study|Withdrawal by Subject|4|||
131765654|NCT02140762|474417978|FG000|Overall Study|Other|0|||
131765655|NCT02140762|474417979|FG001|Overall Study|Other|1|||
131765656|NCT00989664|474417983|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
131765657|NCT00989664|474417983|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
131765658|NCT00989664|474417983|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
131765659|NCT00989664|474417983|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
131765660|NCT00989664|474417983|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
131765661|NCT00989664|474417983|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
131765662|NCT00989664|474417983|FG000|Long-Term Follow-Up|Death|3|||
131765663|NCT00095836|474417984|FG000|Overall Study|Lost to Follow-up|1|||
131765664|NCT00095836|474417984|FG000|Overall Study|Adverse Event|1|||
131765665|NCT00095836|474417984|FG000|Overall Study|Death|2|||
131765666|NCT00962780|474417986|FG000|Overall Study|Death|0|||
131765667|NCT00962780|474417987|FG001|Overall Study|Death|1|||
131765668|NCT00962780|474417986|FG000|Overall Study|Protocol Violation|9|||
131765669|NCT00962780|474417987|FG001|Overall Study|Protocol Violation|4|||
131765670|NCT00962780|474417986|FG000|Overall Study|Withdrawal by Subject|1|||
131765671|NCT00962780|474417987|FG001|Overall Study|Withdrawal by Subject|8|||
131765672|NCT00962780|474417986|FG000|Overall Study|Other|0|||
131765673|NCT00962780|474417987|FG001|Overall Study|Other|1|||
131765674|NCT02363322|474417988|FG000|Overall Study|Lost to Follow-up|1|||
131765675|NCT02363322|474417989|FG001|Overall Study|Lost to Follow-up|0|||
131765676|NCT02055976|474417990|FG000|Overall Study|Other|0|||
131765677|NCT02055976|474417991|FG001|Overall Study|Other|0|||
131765678|NCT02055976|474417992|FG002|Overall Study|Other|1|||
131765679|NCT02055976|474417993|FG003|Overall Study|Other|0|||
131765680|NCT02055976|474417994|FG004|Overall Study|Other|0|||
131765681|NCT02055976|474417995|FG005|Overall Study|Other|0|||
131765682|NCT02055976|474417996|FG006|Overall Study|Other|0|||
131765683|NCT02055976|474417997|FG007|Overall Study|Other|0|||
131765684|NCT02055976|474417998|FG008|Overall Study|Other|0|||
131765685|NCT02055976|474417990|FG000|Overall Study|Adverse Event|0|||
131765686|NCT02055976|474417991|FG001|Overall Study|Adverse Event|0|||
131765687|NCT02055976|474417992|FG002|Overall Study|Adverse Event|0|||
131765688|NCT02055976|474417993|FG003|Overall Study|Adverse Event|0|||
131765689|NCT02055976|474417994|FG004|Overall Study|Adverse Event|0|||
131765690|NCT02055976|474417995|FG005|Overall Study|Adverse Event|1|||
131765691|NCT02055976|474417996|FG006|Overall Study|Adverse Event|1|||
131765692|NCT02055976|474417997|FG007|Overall Study|Adverse Event|0|||
131765693|NCT02055976|474417998|FG008|Overall Study|Adverse Event|0|||
131765694|NCT02055976|474417990|FG000|Overall Study|Does not meet entrance criteria|0|||
131765695|NCT02055976|474417991|FG001|Overall Study|Does not meet entrance criteria|0|||
131765696|NCT02055976|474417992|FG002|Overall Study|Does not meet entrance criteria|0|||
131765697|NCT02055976|474417993|FG003|Overall Study|Does not meet entrance criteria|0|||
131765698|NCT02055976|474417994|FG004|Overall Study|Does not meet entrance criteria|0|||
131765699|NCT02055976|474417995|FG005|Overall Study|Does not meet entrance criteria|0|||
131765700|NCT02055976|474417996|FG006|Overall Study|Does not meet entrance criteria|1|||
131765701|NCT02055976|474417997|FG007|Overall Study|Does not meet entrance criteria|0|||
131765702|NCT02055976|474417998|FG008|Overall Study|Does not meet entrance criteria|0|||
131765703|NCT02055976|474417990|FG000|Overall Study|Lost to Follow-up|0|||
131765704|NCT02055976|474417991|FG001|Overall Study|Lost to Follow-up|0|||
131765705|NCT02055976|474417992|FG002|Overall Study|Lost to Follow-up|0|||
131765706|NCT02055976|474417993|FG003|Overall Study|Lost to Follow-up|1|||
131765707|NCT02055976|474417994|FG004|Overall Study|Lost to Follow-up|0|||
131814042|NCT01695239|474601814|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814043|NCT01695239|474601815|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
131814044|NCT01695239|474601802|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814045|NCT01695239|474601803|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814046|NCT01695239|474601804|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131765708|NCT02055976|474417995|FG005|Overall Study|Lost to Follow-up|0|||
131765709|NCT02055976|474417996|FG006|Overall Study|Lost to Follow-up|0|||
131765710|NCT02055976|474417997|FG007|Overall Study|Lost to Follow-up|0|||
131765711|NCT02055976|474417998|FG008|Overall Study|Lost to Follow-up|0|||
131765712|NCT01230827|474417999|FG000|Overall Study|Lost to Follow-up|0|||
131765713|NCT01230827|474418000|FG001|Overall Study|Lost to Follow-up|0|||
131765714|NCT01230827|474418001|FG002|Overall Study|Lost to Follow-up|1|||
131765715|NCT01230827|474418002|FG003|Overall Study|Lost to Follow-up|3|||
131765716|NCT01230827|474417999|FG000|Overall Study|Withdrawal by Subject|1|||
131765717|NCT01230827|474418000|FG001|Overall Study|Withdrawal by Subject|0|||
131765718|NCT01230827|474418001|FG002|Overall Study|Withdrawal by Subject|3|||
131765719|NCT01230827|474418002|FG003|Overall Study|Withdrawal by Subject|2|||
131765720|NCT01230827|474417999|FG000|Overall Study|Lack of Efficacy|14|||
131765721|NCT01230827|474418000|FG001|Overall Study|Lack of Efficacy|1|||
131765722|NCT01230827|474418001|FG002|Overall Study|Lack of Efficacy|2|||
131814047|NCT01695239|474601805|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131765723|NCT01230827|474418002|FG003|Overall Study|Lack of Efficacy|3|||
131765724|NCT01230827|474417999|FG000|Overall Study|Adverse Event|4|||
131765725|NCT01230827|474418000|FG001|Overall Study|Adverse Event|2|||
131765726|NCT01230827|474418001|FG002|Overall Study|Adverse Event|3|||
131765727|NCT01230827|474418002|FG003|Overall Study|Adverse Event|7|||
131765728|NCT01230827|474417999|FG000|Overall Study|Recovery|0|||
131765729|NCT01230827|474418000|FG001|Overall Study|Recovery|6|||
131765730|NCT01230827|474418001|FG002|Overall Study|Recovery|0|||
131765731|NCT01230827|474418002|FG003|Overall Study|Recovery|0|||
131765732|NCT01230827|474417999|FG000|Overall Study|Study terminated by Sponsor|0|||
131765733|NCT01230827|474418000|FG001|Overall Study|Study terminated by Sponsor|2|||
131765734|NCT01230827|474418001|FG002|Overall Study|Study terminated by Sponsor|56|||
131765735|NCT01230827|474418002|FG003|Overall Study|Study terminated by Sponsor|63|||
131765736|NCT03458234|474418005|FG000|Overall Study|Withdrawal by Subject|1|||
131765737|NCT01021293|474418010|FG000|Overall Study|Serious Adverse Event|2|||
131765738|NCT01021293|474418011|FG001|Overall Study|Serious Adverse Event|1|||
131765739|NCT01021293|474418010|FG000|Overall Study|Adverse Event|2|||
131765740|NCT01021293|474418011|FG001|Overall Study|Adverse Event|1|||
131765741|NCT01021293|474418010|FG000|Overall Study|Withdrawal by Subject|1|||
131765742|NCT01021293|474418011|FG001|Overall Study|Withdrawal by Subject|3|||
131765743|NCT01021293|474418010|FG000|Overall Study|Migrated/moved from study area|6|||
131765744|NCT01021293|474418011|FG001|Overall Study|Migrated/moved from study area|18|||
131765745|NCT01021293|474418010|FG000|Overall Study|Lost to Follow-up|1|||
131765746|NCT01021293|474418011|FG001|Overall Study|Lost to Follow-up|1|||
131765747|NCT02889861|474419810|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
131765748|NCT01864746|474419811|FG000|Overall Study|Disease recurrence|25|||
131765749|NCT01864746|474419812|FG001|Overall Study|Disease recurrence|40|||
131765750|NCT01864746|474419811|FG000|Overall Study|Second primary invasive nonbreast|2|||
131765751|NCT01864746|474419812|FG001|Overall Study|Second primary invasive nonbreast|3|||
131765752|NCT01864746|474419811|FG000|Overall Study|Death|2|||
131765753|NCT01864746|474419812|FG001|Overall Study|Death|1|||
131765754|NCT01864746|474419811|FG000|Overall Study|Adverse Event|33|||
131765755|NCT01864746|474419812|FG001|Overall Study|Adverse Event|5|||
131765756|NCT01864746|474419811|FG000|Overall Study|Withdrawal by Subject|56|||
131765757|NCT01864746|474419812|FG001|Overall Study|Withdrawal by Subject|41|||
131765758|NCT01864746|474419811|FG000|Overall Study|Physician Decision|5|||
131765759|NCT01864746|474419812|FG001|Overall Study|Physician Decision|6|||
131765760|NCT03890731|474419813|FG000|Overall Study|Progressive disease|1|||
131765761|NCT03890731|474419813|FG000|Overall Study|Patient's decision|1|||
131765762|NCT03890731|474419813|FG000|Overall Study|Adverse Event|4|||
131765763|NCT02039687|474419817|FG000|Overall Study|Adverse Event|0|||
131765764|NCT02039687|474419818|FG001|Overall Study|Adverse Event|0|||
131765765|NCT02039687|474419819|FG002|Overall Study|Adverse Event|1|||
131765766|NCT02039687|474419820|FG003|Overall Study|Adverse Event|0|||
131765767|NCT02039687|474419817|FG000|Overall Study|Withdrawal by Subject|0|||
131765768|NCT02039687|474419818|FG001|Overall Study|Withdrawal by Subject|1|||
131765769|NCT02039687|474419819|FG002|Overall Study|Withdrawal by Subject|0|||
131765770|NCT02039687|474419820|FG003|Overall Study|Withdrawal by Subject|0|||
131765771|NCT02039687|474419817|FG000|Overall Study|treatment assignment could not be confir|0|||
131765772|NCT02039687|474419818|FG001|Overall Study|treatment assignment could not be confir|0|||
131765773|NCT02039687|474419819|FG002|Overall Study|treatment assignment could not be confir|2|||
131765774|NCT02039687|474419820|FG003|Overall Study|treatment assignment could not be confir|0|||
131765775|NCT00303329|474419830|FG000|Overall Study|Adverse Event|7|||
131765776|NCT00303329|474419831|FG001|Overall Study|Adverse Event|14|||
131765777|NCT00303329|474419830|FG000|Overall Study|Abnormal Laboratory Values|0|||
131765778|NCT00303329|474419831|FG001|Overall Study|Abnormal Laboratory Values|1|||
131765779|NCT00303329|474419830|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
131765780|NCT00303329|474419831|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131765781|NCT00303329|474419830|FG000|Overall Study|Condition no longer requires study drug|0|||
131765782|NCT00303329|474419831|FG001|Overall Study|Condition no longer requires study drug|8|||
131765783|NCT00303329|474419830|FG000|Overall Study|Protocol Violation|3|||
131765784|NCT00303329|474419831|FG001|Overall Study|Protocol Violation|0|||
131765785|NCT00303329|474419830|FG000|Overall Study|Withdrawal by Subject|9|||
131765786|NCT00303329|474419831|FG001|Overall Study|Withdrawal by Subject|15|||
131765787|NCT00303329|474419830|FG000|Overall Study|Lost to Follow-up|0|||
131765788|NCT00303329|474419831|FG001|Overall Study|Lost to Follow-up|1|||
131765789|NCT00303329|474419830|FG000|Overall Study|Administrative problems|1|||
131765790|NCT00303329|474419831|FG001|Overall Study|Administrative problems|0|||
131765791|NCT00303329|474419830|FG000|Overall Study|Death|2|||
131765792|NCT00303329|474419831|FG001|Overall Study|Death|12|||
131765793|NCT00303329|474419830|FG000|Overall Study|Stopped at end of core|3|||
131765794|NCT00303329|474419831|FG001|Overall Study|Stopped at end of core|9|||
131765795|NCT00303329|474419830|FG000|Overall Study|Stopped at end of extension 1|1|||
131765796|NCT00303329|474419831|FG001|Overall Study|Stopped at end of extension 1|0|||
131765797|NCT00542321|474419832|FG000|Overall Study|Death|0|||
131765798|NCT00542321|474419833|FG001|Overall Study|Death|1|||
131765799|NCT00253747|474419836|FG000|Overall Study|Lost to Follow-up|13|||
131765800|NCT00253747|474419837|FG001|Overall Study|Lost to Follow-up|14|||
131765801|NCT00253747|474419836|FG000|Overall Study|Withdrawal by Subject|10|||
131909635|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
131765802|NCT00253747|474419837|FG001|Overall Study|Withdrawal by Subject|11|||
131765803|NCT00253747|474419836|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
131909636|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
131765804|NCT00253747|474419837|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
131765805|NCT00718887|474419839|FG000|Overall Study|Withdrawal by Subject|3|||
131765806|NCT00718887|474419840|FG001|Overall Study|Withdrawal by Subject|2|||
131765807|NCT00718887|474419839|FG000|Overall Study|Not identified|2|||
131765808|NCT00718887|474419840|FG001|Overall Study|Not identified|7|||
131765809|NCT04235959|474419842|FG000|Overall Study|Protocol Violation|0|||
131765810|NCT04235959|474419843|FG001|Overall Study|Protocol Violation|1|||
131765811|NCT04235959|474419844|FG002|Overall Study|Protocol Violation|0|||
131765812|NCT04235959|474419842|FG000|Overall Study|Adverse Event|1|||
131765813|NCT04235959|474419843|FG001|Overall Study|Adverse Event|0|||
131765814|NCT04235959|474419844|FG002|Overall Study|Adverse Event|0|||
131765815|NCT00608426|474419845|FG000|Overall Study|Death|32|||
131765816|NCT00608426|474419846|FG001|Overall Study|Death|36|||
131765817|NCT00608426|474419845|FG000|Overall Study|Lost to Follow-up|485|||
131765818|NCT00608426|474419846|FG001|Overall Study|Lost to Follow-up|521|||
131765819|NCT00608426|474419845|FG000|Overall Study|refused, health issues, wrong address|319|||
131765820|NCT00608426|474419846|FG001|Overall Study|refused, health issues, wrong address|348|||
131765821|NCT00348686|474419856|FG000|Overall Study|Withdrawal by Subject|45|||
131765822|NCT00348686|474419856|FG000|Overall Study|Adverse Event|5|||
131765823|NCT00348686|474419856|FG000|Overall Study|Protocol Violation|6|||
131765824|NCT00348686|474419856|FG000|Overall Study|Lost to Follow-up|2|||
131765825|NCT00348686|474419856|FG000|Overall Study|Multiple Reasons|8|||
131765826|NCT01258738|474419857|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
131765827|NCT01258738|474419858|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
131765828|NCT01258738|474419857|FG000|Double-blind Period|Withdrawal by Subject|2|||
131765829|NCT01258738|474419858|FG001|Double-blind Period|Withdrawal by Subject|2|||
131765830|NCT01258738|474419857|FG000|Double-blind Period|Protocol Violation|1|||
131765831|NCT01258738|474419858|FG001|Double-blind Period|Protocol Violation|1|||
131765832|NCT01258738|474419857|FG000|Double-blind Period|Adverse Event|3|||
131765833|NCT01258738|474419858|FG001|Double-blind Period|Adverse Event|1|||
131765834|NCT01258738|474419857|FG000|Open-label Period|Did not meet inclusion criteria|0|||
131765835|NCT01258738|474419858|FG001|Open-label Period|Did not meet inclusion criteria|1|||
131765836|NCT01258738|474419857|FG000|Open-label Period|Insufficient clinical response|5|||
131765837|NCT01258738|474419858|FG001|Open-label Period|Insufficient clinical response|3|||
131765838|NCT01258738|474419857|FG000|Open-label Period|Lost to Follow-up|0|||
131765839|NCT01258738|474419858|FG001|Open-label Period|Lost to Follow-up|2|||
131765840|NCT01258738|474419857|FG000|Open-label Period|Withdrawal by Subject|5|||
131765841|NCT01258738|474419858|FG001|Open-label Period|Withdrawal by Subject|6|||
131765842|NCT01258738|474419857|FG000|Open-label Period|Protocol Violation|2|||
131765843|NCT01258738|474419858|FG001|Open-label Period|Protocol Violation|2|||
131765844|NCT01258738|474419857|FG000|Open-label Period|Adverse Event|4|||
131765845|NCT01258738|474419858|FG001|Open-label Period|Adverse Event|5|||
131814048|NCT01695239|474601806|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814049|NCT01695239|474601807|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814050|NCT01695239|474601808|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814051|NCT01695239|474601809|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
131814052|NCT01695239|474601810|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814053|NCT01695239|474601811|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814054|NCT01695239|474601812|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814055|NCT01695239|474601813|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814056|NCT01695239|474601814|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814057|NCT01695239|474601815|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
131814058|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814059|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814060|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131909637|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
131765846|NCT01258738|474419857|FG000|Open-label Period|Other Reasons|0|||
131765847|NCT01258738|474419858|FG001|Open-label Period|Other Reasons|1|||
131765848|NCT01258738|474419857|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
131909638|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
131909639|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
131765849|NCT01258738|474419858|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
131765850|NCT00689611|474419859|FG000|Overall Study|Death|6|||
131765851|NCT00689611|474419860|FG001|Overall Study|Death|9|||
131765852|NCT00689611|474419859|FG000|Overall Study|Withdrawal by Subject|8|||
131765853|NCT00689611|474419860|FG001|Overall Study|Withdrawal by Subject|9|||
131765854|NCT00689611|474419859|FG000|Overall Study|Lost to Follow-up|27|||
131765855|NCT00689611|474419860|FG001|Overall Study|Lost to Follow-up|28|||
131765856|NCT00568399|474419861|FG000|Overall Study|Death|2|||
131814061|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814062|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814063|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814064|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814065|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814066|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
131814067|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
131814068|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814069|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814070|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814071|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
131814072|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
131814073|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
131814074|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
131814075|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
131814076|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
131814077|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
131814078|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
131814079|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
131814080|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
131814081|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
131814082|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
131814083|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
131814084|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
131814085|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
131814086|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814087|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814088|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814089|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814090|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814091|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814092|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814093|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814094|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
131814095|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
131814096|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814097|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814098|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814099|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
131814100|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
131814101|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
131814102|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
131814103|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
131814104|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
131814105|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
131814106|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
131814107|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
131814108|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
131814109|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
131814110|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
131814111|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
131814112|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
131814113|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
131814114|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814115|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131909640|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
131909641|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131909642|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131909643|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
131909644|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
131909645|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
131909646|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
131909647|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
131909648|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
131765857|NCT00568399|474419861|FG000|Overall Study|Adverse Event|5|||
131765858|NCT00568399|474419861|FG000|Overall Study|Withdrawal by Subject|8|||
131765859|NCT02967562|474419862|FG000|Overall Study|Consent not obtained|1|||
131765860|NCT02967562|474419863|FG001|Overall Study|Consent not obtained|0|||
131765861|NCT02967562|474419862|FG000|Overall Study|High leak precluding analysis|1|||
131765862|NCT02967562|474419863|FG001|Overall Study|High leak precluding analysis|1|||
131765863|NCT00672139|474419864|FG000|Overall Study|Death|14|||
131765864|NCT00672139|474419865|FG001|Overall Study|Death|23|||
131765865|NCT00672139|474419864|FG000|Overall Study|Withdrawal by Subject|2|||
131765866|NCT00672139|474419865|FG001|Overall Study|Withdrawal by Subject|11|||
131765867|NCT00672139|474419864|FG000|Overall Study|Adverse Event|4|||
131765868|NCT00672139|474419865|FG001|Overall Study|Adverse Event|7|||
131765869|NCT00672139|474419864|FG000|Overall Study|Physician Decision|2|||
131765870|NCT00672139|474419865|FG001|Overall Study|Physician Decision|0|||
131765871|NCT00672139|474419864|FG000|Overall Study|Lack of Efficacy|4|||
131765872|NCT00672139|474419865|FG001|Overall Study|Lack of Efficacy|1|||
131765873|NCT00672139|474419864|FG000|Overall Study|Protocol Violation|1|||
131765874|NCT00672139|474419865|FG001|Overall Study|Protocol Violation|1|||
131765875|NCT00672139|474419864|FG000|Overall Study|hospice discharge, caregiver requests|3|||
131765876|NCT00672139|474419865|FG001|Overall Study|hospice discharge, caregiver requests|2|||
131765877|NCT01038635|474419866|FG000|Overall Study|Disease Progression|2|||
131765878|NCT01038635|474419867|FG001|Overall Study|Disease Progression|0|||
131765879|NCT01038635|474419868|FG002|Overall Study|Disease Progression|0|||
131765880|NCT01038635|474419869|FG003|Overall Study|Disease Progression|0|||
131765881|NCT01038635|474419870|FG004|Overall Study|Disease Progression|0|||
131765882|NCT01038635|474419871|FG005|Overall Study|Disease Progression|0|||
131765883|NCT01038635|474419872|FG006|Overall Study|Disease Progression|1|||
131765884|NCT01038635|474419873|FG007|Overall Study|Disease Progression|4|||
131765885|NCT01038635|474419874|FG008|Overall Study|Disease Progression|0|||
131765886|NCT01038635|474419866|FG000|Overall Study|Death|0|||
131765887|NCT01038635|474419867|FG001|Overall Study|Death|0|||
131765888|NCT01038635|474419868|FG002|Overall Study|Death|0|||
131765889|NCT01038635|474419869|FG003|Overall Study|Death|0|||
131765890|NCT01038635|474419870|FG004|Overall Study|Death|1|||
131765891|NCT01038635|474419871|FG005|Overall Study|Death|0|||
131765892|NCT01038635|474419872|FG006|Overall Study|Death|1|||
131765893|NCT01038635|474419873|FG007|Overall Study|Death|1|||
131765894|NCT01038635|474419874|FG008|Overall Study|Death|2|||
131765895|NCT01060150|474419875|FG000|Overall Study|Adverse Event|6|||
131765896|NCT01060150|474419875|FG000|Overall Study|Lost to Follow-up|1|||
131765897|NCT01060150|474419875|FG000|Overall Study|Protocol Violation|6|||
131765898|NCT01060150|474419875|FG000|Overall Study|Withdrawal by Subject|8|||
131765899|NCT01060150|474419875|FG000|Overall Study|Enrolled, but not treated|2|||
131765900|NCT00256204|474419879|FG000|Overall Study|Adverse Event|10|||
131765901|NCT00256204|474419880|FG001|Overall Study|Adverse Event|14|||
131765902|NCT00256204|474419881|FG002|Overall Study|Adverse Event|16|||
131765903|NCT00256204|474419882|FG003|Overall Study|Adverse Event|14|||
131765904|NCT00256204|474419879|FG000|Overall Study|Death|0|||
131765905|NCT00256204|474419880|FG001|Overall Study|Death|1|||
131814116|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814117|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814118|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814119|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814120|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814121|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814122|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
131814123|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
131765906|NCT00256204|474419881|FG002|Overall Study|Death|0|||
131765907|NCT00256204|474419882|FG003|Overall Study|Death|0|||
131765908|NCT00256204|474419879|FG000|Overall Study|Lost to Follow-up|1|||
131765909|NCT00256204|474419880|FG001|Overall Study|Lost to Follow-up|1|||
131765910|NCT00256204|474419881|FG002|Overall Study|Lost to Follow-up|1|||
131765911|NCT00256204|474419882|FG003|Overall Study|Lost to Follow-up|2|||
131765912|NCT00256204|474419879|FG000|Overall Study|Protocol Violation|1|||
131765913|NCT00256204|474419880|FG001|Overall Study|Protocol Violation|0|||
131765914|NCT00256204|474419881|FG002|Overall Study|Protocol Violation|2|||
131765915|NCT00256204|474419882|FG003|Overall Study|Protocol Violation|1|||
131814124|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131765916|NCT00256204|474419879|FG000|Overall Study|Physician Decision|0|||
131765917|NCT00256204|474419880|FG001|Overall Study|Physician Decision|0|||
131765918|NCT00256204|474419881|FG002|Overall Study|Physician Decision|1|||
131765919|NCT00256204|474419882|FG003|Overall Study|Physician Decision|2|||
131765920|NCT00256204|474419879|FG000|Overall Study|Withdrawal by Subject|17|||
131765921|NCT00256204|474419880|FG001|Overall Study|Withdrawal by Subject|6|||
131765922|NCT00256204|474419881|FG002|Overall Study|Withdrawal by Subject|7|||
131765923|NCT00256204|474419882|FG003|Overall Study|Withdrawal by Subject|5|||
131765924|NCT00256204|474419879|FG000|Overall Study|Need for additional prohibited treatment|38|||
131814125|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131765925|NCT00256204|474419880|FG001|Overall Study|Need for additional prohibited treatment|28|||
131765926|NCT00256204|474419881|FG002|Overall Study|Need for additional prohibited treatment|27|||
131765927|NCT00256204|474419882|FG003|Overall Study|Need for additional prohibited treatment|25|||
131765928|NCT00550615|474419884|FG000|Overall Study|Withdrawal by Subject|0|||
131765929|NCT00550615|474419885|FG001|Overall Study|Withdrawal by Subject|0|||
131765930|NCT00550615|474419886|FG002|Overall Study|Withdrawal by Subject|2|||
131765931|NCT00550615|474419887|FG003|Overall Study|Withdrawal by Subject|3|||
131814126|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814127|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
131814128|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814129|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814130|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814131|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814132|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814133|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814134|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814135|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814136|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
131909649|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
131909650|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
131909651|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
131814137|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
131814138|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814139|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814140|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814141|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
131814142|NCT01695239|474601802|FG000|Extension Long-Term Extension Periods|Death|0|||
131814143|NCT01695239|474601803|FG001|Extension Long-Term Extension Periods|Death|0|||
131814144|NCT01695239|474601804|FG002|Extension Long-Term Extension Periods|Death|0|||
131814145|NCT01695239|474601805|FG003|Extension Long-Term Extension Periods|Death|0|||
131814146|NCT01695239|474601806|FG004|Extension Long-Term Extension Periods|Death|0|||
131814147|NCT01695239|474601807|FG005|Extension Long-Term Extension Periods|Death|0|||
131814148|NCT01695239|474601808|FG006|Extension Long-Term Extension Periods|Death|0|||
131814149|NCT01695239|474601809|FG007|Extension Long-Term Extension Periods|Death|0|||
131814150|NCT01695239|474601810|FG008|Extension Long-Term Extension Periods|Death|1|||
131814151|NCT01695239|474601811|FG009|Extension Long-Term Extension Periods|Death|0|||
131814152|NCT01695239|474601812|FG010|Extension Long-Term Extension Periods|Death|0|||
131814153|NCT01695239|474601813|FG011|Extension Long-Term Extension Periods|Death|0|||
131814154|NCT01695239|474601814|FG012|Extension Long-Term Extension Periods|Death|0|||
131814155|NCT01695239|474601815|FG013|Extension Long-Term Extension Periods|Death|0|||
131814156|NCT01695239|474601802|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814157|NCT01695239|474601803|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814158|NCT01695239|474601804|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814159|NCT01695239|474601805|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814160|NCT01695239|474601806|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814161|NCT01695239|474601807|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814162|NCT01695239|474601808|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814163|NCT01695239|474601809|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814164|NCT01695239|474601810|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814165|NCT01695239|474601811|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814166|NCT01695239|474601812|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131814167|NCT01695239|474601813|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
131909652|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
131909653|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
131909654|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
131909655|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
131909656|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
131909657|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
131765932|NCT00550615|474419884|FG000|Overall Study|Not evaluable|0|||
131765933|NCT00550615|474419885|FG001|Overall Study|Not evaluable|0|||
131765934|NCT00550615|474419886|FG002|Overall Study|Not evaluable|2|||
131814168|NCT01695239|474601814|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
131909658|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
131909659|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
131765935|NCT00550615|474419887|FG003|Overall Study|Not evaluable|7|||
131765936|NCT02405091|474419890|FG000|Overall Study|Adverse Event|16|||
131765937|NCT02405091|474419891|FG001|Overall Study|Adverse Event|10|||
131765938|NCT02405091|474419892|FG002|Overall Study|Adverse Event|0|||
131765939|NCT02405091|474419890|FG000|Overall Study|Protocol Violation|1|||
131765940|NCT02405091|474419891|FG001|Overall Study|Protocol Violation|0|||
131765941|NCT02405091|474419892|FG002|Overall Study|Protocol Violation|0|||
131765942|NCT02405091|474419890|FG000|Overall Study|Noncompliance|1|||
131765943|NCT02405091|474419891|FG001|Overall Study|Noncompliance|6|||
131765944|NCT02405091|474419892|FG002|Overall Study|Noncompliance|2|||
131765945|NCT02405091|474419890|FG000|Overall Study|Withdrawal by Subject|4|||
131765946|NCT02405091|474419891|FG001|Overall Study|Withdrawal by Subject|8|||
131765947|NCT02405091|474419892|FG002|Overall Study|Withdrawal by Subject|0|||
131765948|NCT02405091|474419890|FG000|Overall Study|Death|0|||
131765949|NCT02405091|474419891|FG001|Overall Study|Death|1|||
131765950|NCT02405091|474419892|FG002|Overall Study|Death|0|||
131765951|NCT02405091|474419890|FG000|Overall Study|Lost to Follow-up|5|||
131765952|NCT02405091|474419891|FG001|Overall Study|Lost to Follow-up|6|||
131765953|NCT02405091|474419892|FG002|Overall Study|Lost to Follow-up|0|||
131765954|NCT02405091|474419890|FG000|Overall Study|Physician Decision|2|||
131765955|NCT02405091|474419891|FG001|Overall Study|Physician Decision|2|||
131765956|NCT02405091|474419892|FG002|Overall Study|Physician Decision|0|||
131765957|NCT01234337|474419896|FG000|Overall Study|Adverse Event|58|||
131765958|NCT01234337|474419897|FG001|Overall Study|Adverse Event|21|||
131765959|NCT01234337|474419896|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
131765960|NCT01234337|474419897|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
131765961|NCT01234337|474419896|FG000|Overall Study|Investi. decision not protocol driven|5|||
131765962|NCT01234337|474419897|FG001|Overall Study|Investi. decision not protocol driven|6|||
131765963|NCT01234337|474419896|FG000|Overall Study|Non-compliant with study medication|3|||
131765964|NCT01234337|474419897|FG001|Overall Study|Non-compliant with study medication|2|||
131765965|NCT01234337|474419896|FG000|Overall Study|Randomized but not treated|6|||
131765966|NCT01234337|474419897|FG001|Overall Study|Randomized but not treated|4|||
131765967|NCT01234337|474419896|FG000|Overall Study|Lost to Follow-up|0|||
131765968|NCT01234337|474419897|FG001|Overall Study|Lost to Follow-up|1|||
131765969|NCT01234337|474419896|FG000|Overall Study|Protocol Violation|2|||
131765970|NCT01234337|474419897|FG001|Overall Study|Protocol Violation|3|||
131765971|NCT01234337|474419896|FG000|Overall Study|Withdrawal by Subject|11|||
131765972|NCT01234337|474419897|FG001|Overall Study|Withdrawal by Subject|9|||
131765973|NCT01234337|474419896|FG000|Overall Study|Death|0|||
131765974|NCT01234337|474419897|FG001|Overall Study|Death|1|||
131765975|NCT01234337|474419896|FG000|Overall Study|Switch to commercial drug|0|||
131765976|NCT01234337|474419897|FG001|Overall Study|Switch to commercial drug|1|||
131765977|NCT03481634|474419900|FG000|Overall Study|Withdrawal by Subject|16|||
131765978|NCT03481634|474419901|FG001|Overall Study|Withdrawal by Subject|19|||
131765979|NCT03481634|474419902|FG002|Overall Study|Withdrawal by Subject|14|||
131765980|NCT03481634|474419900|FG000|Overall Study|Protocol Violation|1|||
131765981|NCT03481634|474419901|FG001|Overall Study|Protocol Violation|0|||
131765982|NCT03481634|474419902|FG002|Overall Study|Protocol Violation|1|||
131765983|NCT03481634|474419900|FG000|Overall Study|Progressive disease|0|||
131765984|NCT03481634|474419901|FG001|Overall Study|Progressive disease|1|||
131765985|NCT03481634|474419902|FG002|Overall Study|Progressive disease|0|||
131765986|NCT03481634|474419900|FG000|Overall Study|Physician Decision|3|||
131765987|NCT03481634|474419901|FG001|Overall Study|Physician Decision|0|||
131765988|NCT03481634|474419902|FG002|Overall Study|Physician Decision|1|||
131814169|NCT01695239|474601815|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
131814170|NCT01695239|474601802|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814171|NCT01695239|474601803|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814172|NCT01695239|474601804|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131765989|NCT03481634|474419900|FG000|Overall Study|Lost to Follow-up|3|||
131765990|NCT03481634|474419901|FG001|Overall Study|Lost to Follow-up|4|||
131765991|NCT03481634|474419902|FG002|Overall Study|Lost to Follow-up|4|||
131765992|NCT03481634|474419900|FG000|Overall Study|Death|4|||
131765993|NCT03481634|474419901|FG001|Overall Study|Death|8|||
131765994|NCT03481634|474419902|FG002|Overall Study|Death|7|||
131765995|NCT03481634|474419900|FG000|Overall Study|Adverse Event|6|||
131765996|NCT03481634|474419901|FG001|Overall Study|Adverse Event|3|||
131765997|NCT03481634|474419902|FG002|Overall Study|Adverse Event|7|||
131765998|NCT00994890|474419912|FG000|Overall Study|Adverse Event|13|||
131765999|NCT00994890|474419913|FG001|Overall Study|Adverse Event|9|||
131766000|NCT00994890|474419914|FG002|Overall Study|Adverse Event|11|||
131766001|NCT00994890|474419912|FG000|Overall Study|Lack of Efficacy|0|||
131766002|NCT00994890|474419913|FG001|Overall Study|Lack of Efficacy|0|||
131766003|NCT00994890|474419914|FG002|Overall Study|Lack of Efficacy|1|||
131766004|NCT00994890|474419912|FG000|Overall Study|Lost to Follow-up|6|||
131766005|NCT00994890|474419913|FG001|Overall Study|Lost to Follow-up|1|||
131766006|NCT00994890|474419914|FG002|Overall Study|Lost to Follow-up|3|||
131766007|NCT00994890|474419912|FG000|Overall Study|No longer willing to participate|8|||
131766008|NCT00994890|474419913|FG001|Overall Study|No longer willing to participate|5|||
131766009|NCT00994890|474419914|FG002|Overall Study|No longer willing to participate|13|||
131766010|NCT00994890|474419912|FG000|Overall Study|Protocol Violation|2|||
131766011|NCT00994890|474419913|FG001|Overall Study|Protocol Violation|4|||
131766012|NCT00994890|474419914|FG002|Overall Study|Protocol Violation|0|||
131766013|NCT00994890|474419912|FG000|Overall Study|Study terminated by sponsor|199|||
131766014|NCT00994890|474419913|FG001|Overall Study|Study terminated by sponsor|201|||
131766015|NCT00994890|474419914|FG002|Overall Study|Study terminated by sponsor|197|||
131766016|NCT00994890|474419912|FG000|Overall Study|Randomized, but not treated|1|||
131766017|NCT00994890|474419913|FG001|Overall Study|Randomized, but not treated|0|||
131766018|NCT00994890|474419914|FG002|Overall Study|Randomized, but not treated|0|||
131766019|NCT00994890|474419912|FG000|Overall Study|Other|2|||
131766020|NCT00994890|474419913|FG001|Overall Study|Other|2|||
131766021|NCT00994890|474419914|FG002|Overall Study|Other|1|||
131766022|NCT03323385|474419919|FG000|Overall Study|Withdrawal by Subject|1|||
131766023|NCT03323385|474419920|FG001|Overall Study|Withdrawal by Subject|2|||
131766024|NCT03323385|474419919|FG000|Overall Study|Noncompliance|0|||
131766025|NCT03323385|474419920|FG001|Overall Study|Noncompliance|1|||
131766026|NCT00247962|474419921|FG000|Overall Study|Adverse Event|15|||
131766027|NCT00247962|474419922|FG001|Overall Study|Adverse Event|12|||
131766028|NCT00247962|474419921|FG000|Overall Study|Lost to Follow-up|3|||
131766029|NCT00247962|474419922|FG001|Overall Study|Lost to Follow-up|1|||
131766030|NCT00247962|474419921|FG000|Overall Study|Physician Decision|0|||
131766031|NCT00247962|474419922|FG001|Overall Study|Physician Decision|1|||
131766032|NCT00247962|474419921|FG000|Overall Study|Protocol Violation|1|||
131766033|NCT00247962|474419922|FG001|Overall Study|Protocol Violation|1|||
131766034|NCT00247962|474419921|FG000|Overall Study|Withdrawal by Subject|3|||
131766035|NCT00247962|474419922|FG001|Overall Study|Withdrawal by Subject|2|||
131766036|NCT00247962|474419921|FG000|Overall Study|Lack of Efficacy|4|||
131766037|NCT00247962|474419922|FG001|Overall Study|Lack of Efficacy|2|||
131766038|NCT01849289|474419923|FG000|Overall Study|Adverse Event|3|||
131766039|NCT01849289|474419924|FG001|Overall Study|Adverse Event|3|||
131766040|NCT01849289|474419923|FG000|Overall Study|Protocol Violation|3|||
131766041|NCT01849289|474419924|FG001|Overall Study|Protocol Violation|3|||
131766042|NCT01849289|474419923|FG000|Overall Study|Withdrawal criteria|1|||
131766043|NCT01849289|474419924|FG001|Overall Study|Withdrawal criteria|0|||
131766044|NCT01849289|474419923|FG000|Overall Study|Unclassified|25|||
131766045|NCT01849289|474419924|FG001|Overall Study|Unclassified|18|||
131766046|NCT03480360|474419925|FG000|Overall Study|Death|2|||
131766047|NCT01326910|474419928|FG000|Overall Study|Withdrawal by Subject|3|||
131766048|NCT01326910|474419929|FG001|Overall Study|Withdrawal by Subject|2|||
131766049|NCT01326910|474419928|FG000|Overall Study|Protocol Violation|1|||
131766050|NCT01326910|474419929|FG001|Overall Study|Protocol Violation|1|||
131766051|NCT02607735|474419930|FG000|Primary Study|Randomized but Never Treated|1|||
131766052|NCT02607735|474419931|FG001|Primary Study|Randomized but Never Treated|0|||
131766053|NCT02607735|474419932|FG002|Primary Study|Randomized but Never Treated|0|||
131766054|NCT02607735|474419930|FG000|Primary Study|Lost to Follow-up|4|||
131766055|NCT02607735|474419931|FG001|Primary Study|Lost to Follow-up|0|||
131766056|NCT02607735|474419932|FG002|Primary Study|Lost to Follow-up|0|||
131766057|NCT02607735|474419930|FG000|Primary Study|Withdrew Consent|2|||
131766058|NCT02607735|474419931|FG001|Primary Study|Withdrew Consent|0|||
131766059|NCT02607735|474419932|FG002|Primary Study|Withdrew Consent|0|||
131766060|NCT02607735|474419930|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
131766061|NCT02607735|474419931|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
131766062|NCT02607735|474419932|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
131766063|NCT02607735|474419930|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
131766064|NCT02607735|474419931|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
131766065|NCT02607735|474419932|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
131766066|NCT01681836|474419935|FG000|Second Intervention|Withdrawal by Subject|0|||
131766067|NCT01681836|474419936|FG001|Second Intervention|Withdrawal by Subject|1|||
131766068|NCT02355665|474419941|FG000|Overall Study|Adverse Event|16|||
131766069|NCT02355665|474419942|FG001|Overall Study|Adverse Event|24|||
131766070|NCT02355665|474419941|FG000|Overall Study|Protocol Violation|2|||
131766071|NCT02355665|474419942|FG001|Overall Study|Protocol Violation|0|||
131766072|NCT02355665|474419941|FG000|Overall Study|Withdrawal by Subject|90|||
131766073|NCT02355665|474419942|FG001|Overall Study|Withdrawal by Subject|100|||
131766074|NCT02355665|474419941|FG000|Overall Study|Lost to Follow-up|131|||
131766075|NCT02355665|474419942|FG001|Overall Study|Lost to Follow-up|103|||
131766076|NCT02355665|474419941|FG000|Overall Study|Death|4|||
131766077|NCT02355665|474419942|FG001|Overall Study|Death|2|||
131766078|NCT02355665|474419941|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
131766079|NCT02355665|474419942|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
131766080|NCT01454531|474419943|FG000|Overall Study|Adverse Event|14|||
131766081|NCT01454531|474419943|FG000|Overall Study|Withdrawal by Subject|5|||
131766082|NCT01454531|474419943|FG000|Overall Study|Lost to Follow-up|1|||
131766083|NCT01454531|474419943|FG000|Overall Study|Physician Decision|1|||
131766084|NCT01454531|474419943|FG000|Overall Study|Delay in IMP administration|1|||
131766085|NCT01454531|474419943|FG000|Overall Study|Other|1|||
131766086|NCT00303719|474421899|FG000|Overall Study|Not evaluable, prior therapies|0|||
131766087|NCT00303719|474421900|FG001|Overall Study|Not evaluable, prior therapies|30|||
131766088|NCT00303719|474421899|FG000|Overall Study|Lost to Follow-up|0|||
131766089|NCT00303719|474421900|FG001|Overall Study|Lost to Follow-up|7|||
131766090|NCT00561912|474421910|FG000|Overall Study|ineligible|1|||
131909660|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
131909661|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
131909662|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
131766091|NCT02516605|474421912|FG000|Overall Study|Protocol Violation|0|||
131766092|NCT02516605|474421913|FG001|Overall Study|Protocol Violation|0|||
131766093|NCT02516605|474421914|FG002|Overall Study|Protocol Violation|0|||
131766094|NCT02516605|474421915|FG003|Overall Study|Protocol Violation|0|||
131766095|NCT02516605|474421916|FG004|Overall Study|Protocol Violation|1|||
131766096|NCT02516605|474421912|FG000|Overall Study|Withdrawal by Subject|0|||
131766097|NCT02516605|474421913|FG001|Overall Study|Withdrawal by Subject|0|||
131766098|NCT02516605|474421914|FG002|Overall Study|Withdrawal by Subject|0|||
131766099|NCT02516605|474421915|FG003|Overall Study|Withdrawal by Subject|1|||
131766100|NCT02516605|474421916|FG004|Overall Study|Withdrawal by Subject|0|||
131766101|NCT02577107|474421917|FG000|Overall Study|Protocol deviation|0|||
131766102|NCT02577107|474421918|FG001|Overall Study|Protocol deviation|1|||
131766103|NCT00577382|474421919|FG000|Overall Study|Adverse Event|0|||
131766104|NCT00577382|474421920|FG001|Overall Study|Adverse Event|6|||
131766105|NCT00577382|474421919|FG000|Overall Study|Withdrawal by Subject|0|||
131766106|NCT00577382|474421920|FG001|Overall Study|Withdrawal by Subject|1|||
131766107|NCT00577382|474421919|FG000|Overall Study|Progressive Disease|17|||
131766108|NCT00577382|474421920|FG001|Overall Study|Progressive Disease|19|||
131766109|NCT00577382|474421919|FG000|Overall Study|Intercurrent Illness|1|||
131766110|NCT00577382|474421920|FG001|Overall Study|Intercurrent Illness|2|||
131766111|NCT00577382|474421919|FG000|Overall Study|Death|1|||
131766112|NCT00577382|474421920|FG001|Overall Study|Death|1|||
131766113|NCT00577382|474421919|FG000|Overall Study|Lost to Follow-up|2|||
131766114|NCT00577382|474421920|FG001|Overall Study|Lost to Follow-up|2|||
131766115|NCT02643420|474421921|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
131766116|NCT02643420|474421922|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
131766117|NCT02643420|474421921|FG000|Overall Study|Withdrawal by Subject|25|||
131766118|NCT02643420|474421922|FG001|Overall Study|Withdrawal by Subject|19|||
131766119|NCT02643420|474421921|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
131766120|NCT02643420|474421922|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
131766121|NCT02643420|474421921|FG000|Overall Study|Lost to Follow-up|6|||
131766122|NCT02643420|474421922|FG001|Overall Study|Lost to Follow-up|10|||
131766123|NCT02643420|474421921|FG000|Overall Study|Investigator Decision|2|||
131766124|NCT02643420|474421922|FG001|Overall Study|Investigator Decision|4|||
131766125|NCT02643420|474421921|FG000|Overall Study|Sponsor decision|1|||
131766126|NCT02643420|474421922|FG001|Overall Study|Sponsor decision|1|||
131766127|NCT02643420|474421921|FG000|Overall Study|Death|0|||
131766128|NCT02643420|474421922|FG001|Overall Study|Death|2|||
131766129|NCT02643420|474421921|FG000|Overall Study|Reason not Specified|8|||
131766130|NCT02643420|474421922|FG001|Overall Study|Reason not Specified|7|||
131766131|NCT02127970|474421923|FG000|Overall Study|Adverse Event|2|||
131766132|NCT02127970|474421924|FG001|Overall Study|Adverse Event|1|||
131766133|NCT02127970|474421923|FG000|Overall Study|Death|1|||
131766134|NCT02127970|474421924|FG001|Overall Study|Death|1|||
131766135|NCT02127970|474421923|FG000|Overall Study|Lost to Follow-up|14|||
131766136|NCT02127970|474421924|FG001|Overall Study|Lost to Follow-up|14|||
131766137|NCT02127970|474421923|FG000|Overall Study|Reason not Specified|4|||
131766138|NCT02127970|474421924|FG001|Overall Study|Reason not Specified|7|||
131766139|NCT02127970|474421923|FG000|Overall Study|Pregnancy|0|||
131766140|NCT02127970|474421924|FG001|Overall Study|Pregnancy|1|||
131766141|NCT02127970|474421923|FG000|Overall Study|Subject Withdrew Consent|5|||
131766142|NCT02127970|474421924|FG001|Overall Study|Subject Withdrew Consent|3|||
131766143|NCT01710709|474421925|FG000|Overall Study|Lost to Follow-up|29|||
131766144|NCT01710709|474421925|FG000|Overall Study|Adverse Event|48|||
131766145|NCT01710709|474421925|FG000|Overall Study|Participant met withdrawal criteria|33|||
131766146|NCT01710709|474421925|FG000|Overall Study|Participant withdrawn by investigator|2|||
131766147|NCT01710709|474421925|FG000|Overall Study|Withdrawal by Subject|53|||
131766148|NCT01710709|474421925|FG000|Overall Study|Protocol Violation|5|||
131766149|NCT01710709|474421925|FG000|Overall Study|Lack of Efficacy|3|||
131766150|NCT01398176|474421927|FG000|Overall Study|Lost to Follow-up|1|||
131766151|NCT01398176|474421928|FG001|Overall Study|Lost to Follow-up|3|||
131766152|NCT01398176|474421927|FG000|Overall Study|Physician Decision|2|||
131766153|NCT01398176|474421928|FG001|Overall Study|Physician Decision|3|||
131766154|NCT02988115|474421933|FG000|Overall Study|Adverse Event|6|||
131766155|NCT02988115|474421934|FG001|Overall Study|Adverse Event|1|||
131766156|NCT02988115|474421933|FG000|Overall Study|Sponsor Decision|5|||
131766157|NCT02988115|474421934|FG001|Overall Study|Sponsor Decision|2|||
131766158|NCT02988115|474421933|FG000|Overall Study|Withdrawal by Subject|1|||
131766159|NCT02988115|474421934|FG001|Overall Study|Withdrawal by Subject|1|||
131766160|NCT02988115|474421933|FG000|Overall Study|Withdrawn by Mistake|1|||
131766161|NCT02988115|474421934|FG001|Overall Study|Withdrawn by Mistake|0|||
131766162|NCT02988115|474421933|FG000|Overall Study|Lost to Follow-up|1|||
131766163|NCT02988115|474421934|FG001|Overall Study|Lost to Follow-up|0|||
131766164|NCT01731951|474421935|FG000|Overall Study|Documented Disease Progression|1|||
131766165|NCT01731951|474421936|FG001|Overall Study|Documented Disease Progression|0|||
131766166|NCT01731951|474421937|FG002|Overall Study|Documented Disease Progression|0|||
131766167|NCT01731951|474421938|FG003|Overall Study|Documented Disease Progression|0|||
131766168|NCT01731951|474421939|FG004|Overall Study|Documented Disease Progression|0|||
131766169|NCT01731951|474421940|FG005|Overall Study|Documented Disease Progression|0|||
131766170|NCT01731951|474421935|FG000|Overall Study|Lost to Follow-up|2|||
131766171|NCT01731951|474421936|FG001|Overall Study|Lost to Follow-up|0|||
131766172|NCT01731951|474421937|FG002|Overall Study|Lost to Follow-up|0|||
131766173|NCT01731951|474421938|FG003|Overall Study|Lost to Follow-up|1|||
131766174|NCT01731951|474421939|FG004|Overall Study|Lost to Follow-up|3|||
131766175|NCT01731951|474421940|FG005|Overall Study|Lost to Follow-up|1|||
131766176|NCT01731951|474421935|FG000|Overall Study|Withdrawal of Consent|1|||
131766177|NCT01731951|474421936|FG001|Overall Study|Withdrawal of Consent|0|||
131766178|NCT01731951|474421937|FG002|Overall Study|Withdrawal of Consent|0|||
131766179|NCT01731951|474421938|FG003|Overall Study|Withdrawal of Consent|0|||
131766180|NCT01731951|474421939|FG004|Overall Study|Withdrawal of Consent|0|||
131766181|NCT01731951|474421940|FG005|Overall Study|Withdrawal of Consent|2|||
131766182|NCT01731951|474421935|FG000|Overall Study|Death|13|||
131766183|NCT01731951|474421936|FG001|Overall Study|Death|15|||
131766184|NCT01731951|474421937|FG002|Overall Study|Death|9|||
131766185|NCT01731951|474421938|FG003|Overall Study|Death|8|||
131766186|NCT01731951|474421939|FG004|Overall Study|Death|9|||
131766187|NCT01731951|474421940|FG005|Overall Study|Death|6|||
131766188|NCT03287089|474421941|FG000|Overall Study|Lost to Follow-up|0|||
131766189|NCT03287089|474421942|FG001|Overall Study|Lost to Follow-up|2|||
131766190|NCT03287089|474421941|FG000|Overall Study|Physician Decision|0|||
131766191|NCT03287089|474421942|FG001|Overall Study|Physician Decision|2|||
131766192|NCT03287089|474421941|FG000|Overall Study|Withdrawal by Subject|0|||
131766193|NCT03287089|474421942|FG001|Overall Study|Withdrawal by Subject|2|||
131766194|NCT00775138|474421943|FG000|Overall Study|Withdrawal by Subject|0|||
131766195|NCT00775138|474421944|FG001|Overall Study|Withdrawal by Subject|0|||
131766196|NCT00775138|474421945|FG002|Overall Study|Withdrawal by Subject|2|||
131766197|NCT00775138|474421946|FG003|Overall Study|Withdrawal by Subject|2|||
131766198|NCT00775138|474421943|FG000|Overall Study|Adverse Event|0|||
131766199|NCT00775138|474421944|FG001|Overall Study|Adverse Event|0|||
131766200|NCT00775138|474421945|FG002|Overall Study|Adverse Event|1|||
131766201|NCT00775138|474421946|FG003|Overall Study|Adverse Event|0|||
131766202|NCT04880642|474421947|FG000|Randomization|Withdrawal by Subject|2|||
131766203|NCT04880642|474421948|FG001|Randomization|Withdrawal by Subject|3|||
131766204|NCT04880642|474421947|FG000|Treatment Period|Adverse Event|0|||
131766205|NCT04880642|474421948|FG001|Treatment Period|Adverse Event|1|||
131766206|NCT04880642|474421947|FG000|Treatment Period|Death|6|||
131766207|NCT04880642|474421948|FG001|Treatment Period|Death|6|||
131766208|NCT04880642|474421947|FG000|Treatment Period|Lost to Follow-up|1|||
131766209|NCT04880642|474421948|FG001|Treatment Period|Lost to Follow-up|0|||
131766210|NCT04880642|474421947|FG000|Treatment Period|Protocol Violation|0|||
131766211|NCT04880642|474421948|FG001|Treatment Period|Protocol Violation|1|||
131766212|NCT04880642|474421947|FG000|Treatment Period|Withdrawal by Subject|5|||
131766213|NCT04880642|474421948|FG001|Treatment Period|Withdrawal by Subject|3|||
131766214|NCT04880642|474421947|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
131766215|NCT04880642|474421948|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
131766216|NCT04880642|474421947|FG000|Follow-up|Death|4|||
131766217|NCT04880642|474421948|FG001|Follow-up|Death|3|||
131766218|NCT04880642|474421947|FG000|Follow-up|Withdrawal by Subject|1|||
131766219|NCT04880642|474421948|FG001|Follow-up|Withdrawal by Subject|0|||
131766220|NCT00104299|474421949|FG000|Overall Study|Adverse Event|3|||
131766221|NCT00104299|474421950|FG001|Overall Study|Adverse Event|1|||
131766222|NCT00104299|474421949|FG000|Overall Study|Death|2|||
131766223|NCT00104299|474421950|FG001|Overall Study|Death|2|||
131766224|NCT00104299|474421949|FG000|Overall Study|Withdrawal by Subject|2|||
131766225|NCT00104299|474421950|FG001|Overall Study|Withdrawal by Subject|6|||
131766226|NCT00104299|474421949|FG000|Overall Study|Physician Decision|1|||
131766227|NCT00104299|474421950|FG001|Overall Study|Physician Decision|1|||
131766228|NCT00104299|474421949|FG000|Overall Study|To have renal transplant|1|||
131766229|NCT00104299|474421950|FG001|Overall Study|To have renal transplant|0|||
131766230|NCT02452034|474421951|FG000|Overall Study|Adverse Event|0|||
131766231|NCT02452034|474421952|FG001|Overall Study|Adverse Event|0|||
131766232|NCT02452034|474421953|FG002|Overall Study|Adverse Event|0|||
131766233|NCT02452034|474421954|FG003|Overall Study|Adverse Event|0|||
131766234|NCT02452034|474421955|FG004|Overall Study|Adverse Event|0|||
131766235|NCT02452034|474421956|FG005|Overall Study|Adverse Event|1|||
131766236|NCT02452034|474421951|FG000|Overall Study|Death|0|||
131766237|NCT02452034|474421952|FG001|Overall Study|Death|0|||
131766238|NCT02452034|474421953|FG002|Overall Study|Death|0|||
131766239|NCT02452034|474421954|FG003|Overall Study|Death|0|||
131766240|NCT02452034|474421955|FG004|Overall Study|Death|1|||
131766241|NCT02452034|474421956|FG005|Overall Study|Death|1|||
131766242|NCT02452034|474421951|FG000|Overall Study|Physician Decision|0|||
131766243|NCT02452034|474421952|FG001|Overall Study|Physician Decision|1|||
131766244|NCT02452034|474421953|FG002|Overall Study|Physician Decision|1|||
131766245|NCT02452034|474421954|FG003|Overall Study|Physician Decision|0|||
131766246|NCT02452034|474421955|FG004|Overall Study|Physician Decision|0|||
131766247|NCT02452034|474421956|FG005|Overall Study|Physician Decision|0|||
131400592|NCT00327015|473089532|FG000|Overall Study|Pregnancy|0|||
131766248|NCT02452034|474421951|FG000|Overall Study|Protocol Violation|0|||
131766249|NCT02452034|474421952|FG001|Overall Study|Protocol Violation|0|||
131766250|NCT02452034|474421953|FG002|Overall Study|Protocol Violation|0|||
131766251|NCT02452034|474421954|FG003|Overall Study|Protocol Violation|0|||
131766252|NCT02452034|474421955|FG004|Overall Study|Protocol Violation|0|||
131766253|NCT02452034|474421956|FG005|Overall Study|Protocol Violation|1|||
131766254|NCT02452034|474421951|FG000|Overall Study|Screen Failure|1|||
131766255|NCT02452034|474421952|FG001|Overall Study|Screen Failure|0|||
131766256|NCT02452034|474421953|FG002|Overall Study|Screen Failure|0|||
131766257|NCT02452034|474421954|FG003|Overall Study|Screen Failure|1|||
131766258|NCT02452034|474421955|FG004|Overall Study|Screen Failure|0|||
131766259|NCT02452034|474421956|FG005|Overall Study|Screen Failure|0|||
131766260|NCT02452034|474421951|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
131766261|NCT02452034|474421952|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
131766262|NCT02452034|474421953|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
131766263|NCT02452034|474421954|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
131766264|NCT02452034|474421955|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
131766265|NCT02452034|474421956|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
131766266|NCT00561795|474421957|FG000|Overall Study|Adverse Event|3|||
131766267|NCT00561795|474421958|FG001|Overall Study|Adverse Event|3|||
131766268|NCT00561795|474421959|FG002|Overall Study|Adverse Event|0|||
131766269|NCT00561795|474421960|FG003|Overall Study|Adverse Event|0|||
131766270|NCT00561795|474421957|FG000|Overall Study|Study Closed/Terminated|0|||
131766271|NCT00561795|474421958|FG001|Overall Study|Study Closed/Terminated|3|||
131766272|NCT00561795|474421959|FG002|Overall Study|Study Closed/Terminated|0|||
131766273|NCT00561795|474421960|FG003|Overall Study|Study Closed/Terminated|0|||
131766274|NCT00561795|474421957|FG000|Overall Study|Physician Decision|1|||
131766275|NCT00561795|474421958|FG001|Overall Study|Physician Decision|0|||
131766276|NCT00561795|474421959|FG002|Overall Study|Physician Decision|0|||
131814173|NCT01695239|474601805|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814174|NCT01695239|474601806|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814175|NCT01695239|474601807|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814176|NCT01695239|474601808|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814177|NCT01695239|474601809|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814178|NCT01695239|474601810|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814179|NCT01695239|474601811|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814180|NCT01695239|474601812|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814181|NCT01695239|474601813|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131814182|NCT01695239|474601814|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
131814183|NCT01695239|474601815|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
131814184|NCT01695239|474601802|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814185|NCT01695239|474601803|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814186|NCT01695239|474601804|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814187|NCT01695239|474601805|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814188|NCT01695239|474601806|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
131766277|NCT00561795|474421960|FG003|Overall Study|Physician Decision|0|||
131766278|NCT05102734|474421962|FG000|Overall Study|Did not require vasopressors|1|||
131766279|NCT05102734|474421963|FG001|Overall Study|Did not require vasopressors|0|||
131766280|NCT05102734|474421962|FG000|Overall Study|Did not have functioning PA catheter|1|||
131766281|NCT05102734|474421963|FG001|Overall Study|Did not have functioning PA catheter|0|||
131766282|NCT05102734|474421962|FG000|Overall Study|Inadequate video quality|2|||
131814189|NCT01695239|474601807|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
131400593|NCT00327015|473089533|FG001|Overall Study|Pregnancy|2|||
131766283|NCT05102734|474421963|FG001|Overall Study|Inadequate video quality|0|||
131766284|NCT03055806|474421964|FG000|Overall Study|Adverse Event|0|||
131766285|NCT03055806|474421965|FG001|Overall Study|Adverse Event|0|||
131766286|NCT03055806|474421966|FG002|Overall Study|Adverse Event|1|||
131766287|NCT03055806|474421967|FG003|Overall Study|Adverse Event|1|||
131766288|NCT03055806|474421964|FG000|Overall Study|Lost to Follow-up|0|||
131766289|NCT03055806|474421965|FG001|Overall Study|Lost to Follow-up|3|||
131814190|NCT01695239|474601808|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814191|NCT01695239|474601809|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
131400594|NCT00327015|473089534|FG002|Overall Study|Pregnancy|1|||
131766290|NCT03055806|474421966|FG002|Overall Study|Lost to Follow-up|6|||
131766291|NCT03055806|474421967|FG003|Overall Study|Lost to Follow-up|7|||
131766292|NCT03055806|474421964|FG000|Overall Study|Physician Decision|1|||
131400595|NCT00327015|473089535|FG003|Overall Study|Pregnancy|1|||
131766293|NCT03055806|474421965|FG001|Overall Study|Physician Decision|0|||
131766294|NCT03055806|474421966|FG002|Overall Study|Physician Decision|0|||
131766295|NCT03055806|474421967|FG003|Overall Study|Physician Decision|1|||
131766296|NCT03055806|474421964|FG000|Overall Study|Protocol Violation|1|||
131814192|NCT01695239|474601810|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814193|NCT01695239|474601811|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814194|NCT01695239|474601812|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814195|NCT01695239|474601813|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814196|NCT01695239|474601814|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
131814197|NCT01695239|474601815|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
131814198|NCT01695239|474601802|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814199|NCT01695239|474601803|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814200|NCT01695239|474601804|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814201|NCT01695239|474601805|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814202|NCT01695239|474601806|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131400596|NCT00327015|473089532|FG000|Overall Study|Administrative Reason by Sponsor|1|||
131766297|NCT03055806|474421965|FG001|Overall Study|Protocol Violation|0|||
131766298|NCT03055806|474421966|FG002|Overall Study|Protocol Violation|0|||
131766299|NCT03055806|474421967|FG003|Overall Study|Protocol Violation|0|||
131766300|NCT03055806|474421964|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
131766301|NCT03055806|474421965|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
131766302|NCT03055806|474421966|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
131766303|NCT03055806|474421967|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
131766304|NCT03055806|474421964|FG000|Overall Study|Withdrawal of consent to continue study|2|||
131766305|NCT03055806|474421965|FG001|Overall Study|Withdrawal of consent to continue study|3|||
131766306|NCT03055806|474421966|FG002|Overall Study|Withdrawal of consent to continue study|4|||
131766307|NCT03055806|474421967|FG003|Overall Study|Withdrawal of consent to continue study|6|||
131766308|NCT03055806|474421964|FG000|Overall Study|Partner not willing to try intercourse|1|||
131766309|NCT03055806|474421965|FG001|Overall Study|Partner not willing to try intercourse|0|||
131766310|NCT03055806|474421966|FG002|Overall Study|Partner not willing to try intercourse|0|||
131766311|NCT03055806|474421967|FG003|Overall Study|Partner not willing to try intercourse|0|||
131766312|NCT04601194|474421968|FG000|Overall Study|Lost to Follow-up|7|||
131766313|NCT02630459|474421969|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131766314|NCT02630459|474421970|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
131766315|NCT02630459|474421971|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131766316|NCT02630459|474421972|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
131766317|NCT02630459|474421973|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131766318|NCT02630459|474421974|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131814203|NCT01695239|474601807|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814204|NCT01695239|474601808|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814205|NCT01695239|474601809|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814206|NCT01695239|474601810|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814207|NCT01695239|474601811|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814208|NCT01695239|474601812|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814209|NCT01695239|474601813|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814210|NCT01695239|474601814|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131814211|NCT01695239|474601815|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
131814212|NCT03913377|474601817|FG000|Period 1|Test Article no longer available|0|||
131814213|NCT03913377|474601818|FG001|Period 1|Test Article no longer available|1|||
131814214|NCT03913377|474601819|FG002|Period 1|Test Article no longer available|0|||
131814215|NCT03913377|474601817|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
131814216|NCT03913377|474601818|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
131814217|NCT03913377|474601819|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
131814218|NCT05239195|474601820|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
131814219|NCT05239195|474601821|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
131814220|NCT05014828|474601822|FG000|Overall Study|Study Completed by Sponsor|16|||
131814221|NCT05014828|474601823|FG001|Overall Study|Study Completed by Sponsor|16|||
131814222|NCT05014828|474601824|FG002|Overall Study|Study Completed by Sponsor|3|||
131814223|NCT05014828|474601825|FG003|Overall Study|Study Completed by Sponsor|3|||
131814224|NCT05014828|474601822|FG000|Overall Study|Death|11|||
131814225|NCT05014828|474601823|FG001|Overall Study|Death|6|||
131814226|NCT05014828|474601824|FG002|Overall Study|Death|0|||
131814227|NCT05014828|474601825|FG003|Overall Study|Death|0|||
131814228|NCT05014828|474601822|FG000|Overall Study|Lost to Follow-up|0|||
131766319|NCT02630459|474421975|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131814229|NCT05014828|474601823|FG001|Overall Study|Lost to Follow-up|0|||
131814230|NCT05014828|474601824|FG002|Overall Study|Lost to Follow-up|2|||
131814231|NCT05014828|474601825|FG003|Overall Study|Lost to Follow-up|0|||
131814232|NCT05014828|474601822|FG000|Overall Study|Miscellaneous.|0|||
131814233|NCT05014828|474601823|FG001|Overall Study|Miscellaneous.|1|||
131814234|NCT05014828|474601824|FG002|Overall Study|Miscellaneous.|0|||
131814235|NCT05014828|474601825|FG003|Overall Study|Miscellaneous.|0|||
131766320|NCT02630459|474421976|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131766321|NCT02630459|474421969|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766322|NCT02630459|474421970|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766323|NCT02630459|474421971|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
131766324|NCT02630459|474421972|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766325|NCT02630459|474421973|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766326|NCT02630459|474421974|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766327|NCT02630459|474421975|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766328|NCT02630459|474421976|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131766329|NCT02630459|474421969|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
131766330|NCT02630459|474421970|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
131766331|NCT02630459|474421971|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
131766332|NCT02630459|474421972|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
131766333|NCT02630459|474421973|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131766334|NCT02630459|474421974|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131766335|NCT02630459|474421975|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131766336|NCT02630459|474421976|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131766337|NCT02630459|474421969|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
131766338|NCT02630459|474421970|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766339|NCT02630459|474421971|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766340|NCT02630459|474421972|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766341|NCT02630459|474421973|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766342|NCT02630459|474421974|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766343|NCT02630459|474421975|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766344|NCT02630459|474421976|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131766345|NCT02630459|474421969|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131766346|NCT02630459|474421970|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131766347|NCT02630459|474421971|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131766348|NCT02630459|474421972|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131766349|NCT02630459|474421973|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
131766350|NCT02630459|474421974|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
131766351|NCT02630459|474421975|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131766352|NCT02630459|474421976|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131766353|NCT02630459|474421969|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131766354|NCT02630459|474421970|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131766355|NCT02630459|474421971|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131766356|NCT02630459|474421972|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131766357|NCT02630459|474421973|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
131766358|NCT02630459|474421974|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
131766359|NCT02630459|474421975|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131766360|NCT02630459|474421976|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131766361|NCT02630459|474421969|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766362|NCT02630459|474421970|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766363|NCT02630459|474421971|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766364|NCT02630459|474421972|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766365|NCT02630459|474421973|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
131766366|NCT02630459|474421974|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766367|NCT02630459|474421975|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766368|NCT02630459|474421976|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131766369|NCT00125138|474421977|FG000|Overall Study|Adverse Event|1|||
131766370|NCT00125138|474421978|FG001|Overall Study|Adverse Event|0|||
131766371|NCT00125138|474421979|FG002|Overall Study|Adverse Event|3|||
131766372|NCT00125138|474421980|FG003|Overall Study|Adverse Event|2|||
131766373|NCT00125138|474421977|FG000|Overall Study|Withdrawal by Subject|2|||
131766374|NCT00125138|474421978|FG001|Overall Study|Withdrawal by Subject|3|||
131766375|NCT00125138|474421979|FG002|Overall Study|Withdrawal by Subject|1|||
131766376|NCT00125138|474421980|FG003|Overall Study|Withdrawal by Subject|1|||
131766377|NCT00125138|474421977|FG000|Overall Study|Lack of Efficacy|0|||
131766378|NCT00125138|474421978|FG001|Overall Study|Lack of Efficacy|0|||
131766379|NCT00125138|474421979|FG002|Overall Study|Lack of Efficacy|0|||
131766380|NCT00125138|474421980|FG003|Overall Study|Lack of Efficacy|1|||
131766381|NCT00125138|474421977|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
131766382|NCT00125138|474421978|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
131766383|NCT00125138|474421979|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
131766384|NCT00125138|474421980|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
131766385|NCT00490815|474421985|FG000|Overall Study|Adverse Event|2|||
131766386|NCT00490815|474421986|FG001|Overall Study|Adverse Event|3|||
131766387|NCT00490815|474421985|FG000|Overall Study|Withdrawal by Subject|4|||
131766388|NCT00490815|474421986|FG001|Overall Study|Withdrawal by Subject|0|||
131766389|NCT00490815|474421985|FG000|Overall Study|Lost to Follow-up|1|||
131766390|NCT00490815|474421986|FG001|Overall Study|Lost to Follow-up|3|||
131766391|NCT00490815|474421985|FG000|Overall Study|Death|1|||
131766392|NCT00490815|474421986|FG001|Overall Study|Death|3|||
131766393|NCT01904760|474421994|FG000|Overall Study|Protocol Violation|1|||
131766394|NCT01904760|474421995|FG001|Overall Study|Protocol Violation|0|||
131766395|NCT04249076|474422005|FG000|Overall Study|Adverse Event|1|||
131766396|NCT04249076|474422006|FG001|Overall Study|Adverse Event|1|||
131766397|NCT04249076|474422005|FG000|Overall Study|Protocol Violation|1|||
131766398|NCT04249076|474422006|FG001|Overall Study|Protocol Violation|2|||
131766399|NCT04249076|474422005|FG000|Overall Study|Lack of Efficacy|0|||
131766400|NCT04249076|474422006|FG001|Overall Study|Lack of Efficacy|1|||
131766401|NCT04249076|474422005|FG000|Overall Study|Withdrawal by Subject|0|||
131766402|NCT04249076|474422006|FG001|Overall Study|Withdrawal by Subject|1|||
131766403|NCT00783263|474422007|FG000|Overall Study|Adverse Event|3|||
131766404|NCT00783263|474422008|FG001|Overall Study|Adverse Event|0|||
131766405|NCT00783263|474422009|FG002|Overall Study|Adverse Event|2|||
131766406|NCT00783263|474422010|FG003|Overall Study|Adverse Event|1|||
131766407|NCT00783263|474422007|FG000|Overall Study|Lost to Follow-up|1|||
131766408|NCT00783263|474422008|FG001|Overall Study|Lost to Follow-up|1|||
131766409|NCT00783263|474422009|FG002|Overall Study|Lost to Follow-up|0|||
131766410|NCT00783263|474422010|FG003|Overall Study|Lost to Follow-up|0|||
131766411|NCT00783263|474422007|FG000|Overall Study|Withdrawal by Subject|0|||
131766412|NCT00783263|474422008|FG001|Overall Study|Withdrawal by Subject|1|||
131766413|NCT00783263|474422009|FG002|Overall Study|Withdrawal by Subject|1|||
131766414|NCT00783263|474422010|FG003|Overall Study|Withdrawal by Subject|2|||
131766415|NCT00106626|474422011|FG000|Overall Study|Adverse Event|5|||
131766416|NCT00106626|474422012|FG001|Overall Study|Adverse Event|4|||
131766417|NCT00106626|474422013|FG002|Overall Study|Adverse Event|3|||
131766418|NCT00106626|474422014|FG003|Overall Study|Adverse Event|3|||
131766419|NCT00106626|474422011|FG000|Overall Study|Progressive Disease|4|||
131766420|NCT00106626|474422012|FG001|Overall Study|Progressive Disease|1|||
131766421|NCT00106626|474422013|FG002|Overall Study|Progressive Disease|9|||
131766422|NCT00106626|474422014|FG003|Overall Study|Progressive Disease|10|||
131766423|NCT00106626|474422011|FG000|Overall Study|Received radiation on new therapy|1|||
131766424|NCT00106626|474422012|FG001|Overall Study|Received radiation on new therapy|0|||
131766425|NCT00106626|474422013|FG002|Overall Study|Received radiation on new therapy|0|||
131766426|NCT00106626|474422014|FG003|Overall Study|Received radiation on new therapy|0|||
131766427|NCT00106626|474422011|FG000|Overall Study|> 14 day delay in therapy start|0|||
131766428|NCT00106626|474422012|FG001|Overall Study|> 14 day delay in therapy start|1|||
131766429|NCT00106626|474422013|FG002|Overall Study|> 14 day delay in therapy start|0|||
131766430|NCT00106626|474422014|FG003|Overall Study|> 14 day delay in therapy start|0|||
131766431|NCT00405756|474422019|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
131766432|NCT00405756|474422020|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
131766433|NCT00405756|474422021|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
131766434|NCT00405756|474422019|FG000|Double-blind Treatment|Adverse Event|31|||
131766435|NCT00405756|474422020|FG001|Double-blind Treatment|Adverse Event|27|||
131766436|NCT00405756|474422021|FG002|Double-blind Treatment|Adverse Event|12|||
131766437|NCT00405756|474422019|FG000|Double-blind Treatment|Disease Progression|47|||
131766438|NCT00405756|474422020|FG001|Double-blind Treatment|Disease Progression|81|||
131766439|NCT00405756|474422021|FG002|Double-blind Treatment|Disease Progression|102|||
131766440|NCT00405756|474422019|FG000|Double-blind Treatment|Lack of Efficacy|1|||
131766441|NCT00405756|474422020|FG001|Double-blind Treatment|Lack of Efficacy|4|||
131766442|NCT00405756|474422021|FG002|Double-blind Treatment|Lack of Efficacy|2|||
131766443|NCT00405756|474422019|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
131766444|NCT00405756|474422020|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
131766445|NCT00405756|474422021|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
131766446|NCT00405756|474422019|FG000|Double-blind Treatment|Lost to Follow-up|1|||
131766447|NCT00405756|474422020|FG001|Double-blind Treatment|Lost to Follow-up|0|||
131766448|NCT00405756|474422021|FG002|Double-blind Treatment|Lost to Follow-up|0|||
131766449|NCT00405756|474422019|FG000|Double-blind Treatment|Death|4|||
131766450|NCT00405756|474422020|FG001|Double-blind Treatment|Death|4|||
131766451|NCT00405756|474422021|FG002|Double-blind Treatment|Death|4|||
131766452|NCT00405756|474422019|FG000|Double-blind Treatment|Protocol Violation|1|||
131766453|NCT00405756|474422020|FG001|Double-blind Treatment|Protocol Violation|0|||
131766454|NCT00405756|474422021|FG002|Double-blind Treatment|Protocol Violation|2|||
131766455|NCT00405756|474422019|FG000|Double-blind Treatment|Other|7|||
131766456|NCT00405756|474422020|FG001|Double-blind Treatment|Other|4|||
131766457|NCT00405756|474422021|FG002|Double-blind Treatment|Other|4|||
131766458|NCT00405756|474422019|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
131766459|NCT00405756|474422020|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
131766460|NCT00405756|474422021|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
131766461|NCT00405756|474422019|FG000|Open-label Extension|Adverse Event|1|||
131766462|NCT00405756|474422020|FG001|Open-label Extension|Adverse Event|3|||
131766463|NCT00405756|474422021|FG002|Open-label Extension|Adverse Event|7|||
131766464|NCT00405756|474422019|FG000|Open-label Extension|Disease Progression|8|||
131766465|NCT00405756|474422020|FG001|Open-label Extension|Disease Progression|23|||
131766466|NCT00405756|474422021|FG002|Open-label Extension|Disease Progression|26|||
131766467|NCT00405756|474422019|FG000|Open-label Extension|Withdrawal by Subject|2|||
131766468|NCT00405756|474422020|FG001|Open-label Extension|Withdrawal by Subject|3|||
131766469|NCT00405756|474422021|FG002|Open-label Extension|Withdrawal by Subject|3|||
131766470|NCT00405756|474422019|FG000|Open-label Extension|Death|1|||
131766471|NCT00405756|474422020|FG001|Open-label Extension|Death|2|||
131766472|NCT00405756|474422021|FG002|Open-label Extension|Death|4|||
131766473|NCT00405756|474422019|FG000|Open-label Extension|Other|0|||
131766474|NCT00405756|474422020|FG001|Open-label Extension|Other|1|||
131766475|NCT00405756|474422021|FG002|Open-label Extension|Other|7|||
131766476|NCT00405756|474422019|FG000|Follow-up|Ongoing in Follow-up Period|52|||
131766477|NCT00405756|474422020|FG001|Follow-up|Ongoing in Follow-up Period|51|||
131766478|NCT00405756|474422021|FG002|Follow-up|Ongoing in Follow-up Period|60|||
131766479|NCT00405756|474422019|FG000|Follow-up|Death|21|||
131766480|NCT00405756|474422020|FG001|Follow-up|Death|31|||
131766481|NCT00405756|474422021|FG002|Follow-up|Death|24|||
131766482|NCT00405756|474422019|FG000|Follow-up|Lost to Follow-up|2|||
131766483|NCT00405756|474422020|FG001|Follow-up|Lost to Follow-up|8|||
131766484|NCT00405756|474422021|FG002|Follow-up|Lost to Follow-up|4|||
131766485|NCT01117428|474422027|FG000|Overall Study|Lack of Efficacy|1|||
131766486|NCT01117428|474422028|FG001|Overall Study|Lack of Efficacy|0|||
131766487|NCT01117428|474422029|FG002|Overall Study|Lack of Efficacy|0|||
131766488|NCT01117428|474422030|FG003|Overall Study|Lack of Efficacy|0|||
131766489|NCT01117428|474422031|FG004|Overall Study|Lack of Efficacy|0|||
131766490|NCT01117428|474422032|FG005|Overall Study|Lack of Efficacy|0|||
131766491|NCT01117428|474422027|FG000|Overall Study|Adverse Event|4|||
131766492|NCT01117428|474422028|FG001|Overall Study|Adverse Event|0|||
131766493|NCT01117428|474422029|FG002|Overall Study|Adverse Event|0|||
131766494|NCT01117428|474422030|FG003|Overall Study|Adverse Event|0|||
131766495|NCT01117428|474422031|FG004|Overall Study|Adverse Event|1|||
131766496|NCT01117428|474422032|FG005|Overall Study|Adverse Event|2|||
131766497|NCT01117428|474422027|FG000|Overall Study|Death|0|||
131766498|NCT01117428|474422028|FG001|Overall Study|Death|1|||
131766499|NCT01117428|474422029|FG002|Overall Study|Death|2|||
131766500|NCT01117428|474422030|FG003|Overall Study|Death|0|||
131766501|NCT01117428|474422031|FG004|Overall Study|Death|0|||
131766502|NCT01117428|474422032|FG005|Overall Study|Death|1|||
131766503|NCT01117428|474422027|FG000|Overall Study|Physician Decision|0|||
131766504|NCT01117428|474422028|FG001|Overall Study|Physician Decision|1|||
131766505|NCT01117428|474422029|FG002|Overall Study|Physician Decision|0|||
131766506|NCT01117428|474422030|FG003|Overall Study|Physician Decision|0|||
131766507|NCT01117428|474422031|FG004|Overall Study|Physician Decision|0|||
131766508|NCT01117428|474422032|FG005|Overall Study|Physician Decision|0|||
131766509|NCT01117428|474422027|FG000|Overall Study|Withdrawal by Subject|0|||
131766510|NCT01117428|474422028|FG001|Overall Study|Withdrawal by Subject|0|||
131766511|NCT01117428|474422029|FG002|Overall Study|Withdrawal by Subject|1|||
131766512|NCT01117428|474422030|FG003|Overall Study|Withdrawal by Subject|0|||
131766513|NCT01117428|474422031|FG004|Overall Study|Withdrawal by Subject|0|||
131766514|NCT01117428|474422032|FG005|Overall Study|Withdrawal by Subject|0|||
131766515|NCT01117428|474422027|FG000|Overall Study|Progressive disease|15|||
131766516|NCT01117428|474422028|FG001|Overall Study|Progressive disease|27|||
131766517|NCT01117428|474422029|FG002|Overall Study|Progressive disease|10|||
131766518|NCT01117428|474422030|FG003|Overall Study|Progressive disease|12|||
131766519|NCT01117428|474422031|FG004|Overall Study|Progressive disease|16|||
131766520|NCT01117428|474422032|FG005|Overall Study|Progressive disease|17|||
131400597|NCT00327015|473089533|FG001|Overall Study|Administrative Reason by Sponsor|2|||
131400598|NCT00327015|473089534|FG002|Overall Study|Administrative Reason by Sponsor|2|||
131400599|NCT00327015|473089535|FG003|Overall Study|Administrative Reason by Sponsor|1|||
131400600|NCT01289353|473089539|FG000|Overall Study|Lost to Follow-up|2|||
131400601|NCT01549886|473089540|FG000|Overall Study|Sponsor's decision|2|||
131766521|NCT03018028|474422033|FG000|Overall Study|Withdrawal by Subject|3|||
131766522|NCT03018028|474422034|FG001|Overall Study|Withdrawal by Subject|0|||
131766523|NCT03018028|474422035|FG002|Overall Study|Withdrawal by Subject|1|||
131766524|NCT03018028|474422036|FG003|Overall Study|Withdrawal by Subject|2|||
131766525|NCT03018028|474422037|FG004|Overall Study|Withdrawal by Subject|0|||
131766526|NCT02519777|474422041|FG000|Overall Study|Death|1|||
131766527|NCT02519777|474422042|FG001|Overall Study|Death|0|||
131766528|NCT02519777|474422043|FG002|Overall Study|Death|0|||
131766529|NCT02519777|474422041|FG000|Overall Study|Lost to Follow-up|0|||
131766530|NCT02519777|474422042|FG001|Overall Study|Lost to Follow-up|4|||
131766531|NCT02519777|474422043|FG002|Overall Study|Lost to Follow-up|2|||
131766532|NCT02519777|474422041|FG000|Overall Study|Withdrawal by Subject|3|||
131766533|NCT02519777|474422042|FG001|Overall Study|Withdrawal by Subject|1|||
131400602|NCT01549886|473089541|FG001|Overall Study|Sponsor's decision|3|||
131400603|NCT00473668|473089542|FG000|Overall Study|Withdrawal by Subject|0|||
131766534|NCT02519777|474422043|FG002|Overall Study|Withdrawal by Subject|0|||
131766535|NCT02519777|474422041|FG000|Overall Study|Severe Debilitation|1|||
131766536|NCT02519777|474422042|FG001|Overall Study|Severe Debilitation|1|||
131814236|NCT00918645|474601826|FG000|Overall Study|Withdrawal by Subject|1|||
131814237|NCT05133180|474601827|FG000|Overall Study|Withdrawal of consent|1|||
131814238|NCT05133180|474601828|FG001|Overall Study|Withdrawal of consent|1|||
131814239|NCT05133180|474601827|FG000|Overall Study|Lost to Follow-up|1|||
131814240|NCT05133180|474601828|FG001|Overall Study|Lost to Follow-up|1|||
131814241|NCT05133180|474601827|FG000|Overall Study|Documented disease progression|0|||
131814242|NCT05133180|474601828|FG001|Overall Study|Documented disease progression|1|||
131814243|NCT03446768|474601829|FG000|Overall Study|Withdrawal by Subject|0|||
131814244|NCT03446768|474601830|FG001|Overall Study|Withdrawal by Subject|1|||
131814245|NCT01535222|474601831|FG000|Overall Study|Inclusion/exclusion|0|||
131814246|NCT01535222|474601832|FG001|Overall Study|Inclusion/exclusion|0|||
131814247|NCT01535222|474601833|FG002|Overall Study|Inclusion/exclusion|1|||
131814248|NCT01535222|474601834|FG003|Overall Study|Inclusion/exclusion|0|||
131814249|NCT01535222|474601835|FG004|Overall Study|Inclusion/exclusion|0|||
131814250|NCT01535222|474601836|FG005|Overall Study|Inclusion/exclusion|0|||
131814251|NCT00935012|474601837|FG000|Overall Study|Death|19|||
131814252|NCT00935012|474601837|FG000|Overall Study|Withdrawal by Subject|3|||
131814253|NCT00935012|474601837|FG000|Overall Study|Other|5|||
131814254|NCT00935012|474601837|FG000|Overall Study|Adverse Event|2|||
131814255|NCT01442155|474601838|FG000|Overall Study|Complete remission|35|||
131814256|NCT01442155|474601838|FG000|Overall Study|Recurrence|26|||
131814257|NCT01442155|474601838|FG000|Overall Study|Adverse Event|2|||
131814258|NCT01442155|474601838|FG000|Overall Study|Lost to Follow-up|2|||
131814259|NCT01590563|474601839|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
131814260|NCT02699463|474601842|FG000|Overall Study|Lost to Follow-up|11|||
131814261|NCT02699463|474601843|FG001|Overall Study|Lost to Follow-up|8|||
131814262|NCT02699463|474601842|FG000|Overall Study|Withdrawal by Subject|4|||
131814263|NCT02699463|474601843|FG001|Overall Study|Withdrawal by Subject|1|||
131814264|NCT01808651|474601844|FG000|Study Period 1|Lost to Follow-up|1|||
131814265|NCT01808651|474601845|FG001|Study Period 1|Lost to Follow-up|3|||
131814266|NCT01808651|474601846|FG002|Study Period 1|Lost to Follow-up|0|||
131814267|NCT01808651|474601844|FG000|Study Period 1|Protocol Violation|1|||
131814268|NCT01808651|474601845|FG001|Study Period 1|Protocol Violation|0|||
131814269|NCT01808651|474601846|FG002|Study Period 1|Protocol Violation|1|||
131814270|NCT01808651|474601844|FG000|Study Period 1|Physician Decision|3|||
131814271|NCT01808651|474601845|FG001|Study Period 1|Physician Decision|2|||
131814272|NCT01808651|474601846|FG002|Study Period 1|Physician Decision|0|||
131814273|NCT01808651|474601844|FG000|Study Period 1|Lack of Efficacy|2|||
131814274|NCT01808651|474601845|FG001|Study Period 1|Lack of Efficacy|1|||
131814275|NCT01808651|474601846|FG002|Study Period 1|Lack of Efficacy|0|||
131814276|NCT01808651|474601844|FG000|Study Period 1|Adverse Event|10|||
131814277|NCT01808651|474601845|FG001|Study Period 1|Adverse Event|4|||
131814278|NCT01808651|474601846|FG002|Study Period 1|Adverse Event|1|||
131814279|NCT01808651|474601844|FG000|Study Period 1|Participant Decision|9|||
131814280|NCT01808651|474601845|FG001|Study Period 1|Participant Decision|7|||
131814281|NCT01808651|474601846|FG002|Study Period 1|Participant Decision|3|||
131814282|NCT00829712|474601851|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
131814283|NCT00829712|474601852|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
131814284|NCT02294981|474601853|FG000|Overall Study|Lost to Follow-up|1|||
131814285|NCT00606281|474601854|FG000|Overall Study|Adverse Event|11|||
131814286|NCT00606281|474601855|FG001|Overall Study|Adverse Event|12|||
131814287|NCT00606281|474601854|FG000|Overall Study|Death|1|||
131814288|NCT00606281|474601855|FG001|Overall Study|Death|0|||
131814289|NCT00606281|474601854|FG000|Overall Study|Lack of Efficacy|28|||
131814290|NCT00606281|474601855|FG001|Overall Study|Lack of Efficacy|35|||
131814291|NCT00606281|474601854|FG000|Overall Study|Physician Decision|0|||
131814292|NCT00606281|474601855|FG001|Overall Study|Physician Decision|1|||
131814293|NCT00606281|474601854|FG000|Overall Study|Protocol Violation|3|||
131814294|NCT00606281|474601855|FG001|Overall Study|Protocol Violation|3|||
131814295|NCT00606281|474601854|FG000|Overall Study|Withdrawal by Subject|11|||
131814296|NCT00606281|474601855|FG001|Overall Study|Withdrawal by Subject|13|||
131814297|NCT00606281|474601854|FG000|Overall Study|Progression to depressive phase|1|||
131814298|NCT00606281|474601855|FG001|Overall Study|Progression to depressive phase|1|||
131814299|NCT00606281|474601854|FG000|Overall Study|Change of residence or other commitments|1|||
131814300|NCT00606281|474601855|FG001|Overall Study|Change of residence or other commitments|1|||
131814301|NCT01188681|474601856|FG000|Overall Study|bladder cancer|0|||
131814302|NCT01188681|474601857|FG001|Overall Study|bladder cancer|0|||
131400604|NCT00473668|473089543|FG001|Overall Study|Withdrawal by Subject|2|||
131814303|NCT01188681|474601858|FG002|Overall Study|bladder cancer|1|||
131400605|NCT00473668|473089544|FG002|Overall Study|Withdrawal by Subject|0|||
131400606|NCT00473668|473089542|FG000|Overall Study|Migrated/moved from study area|3|||
131814304|NCT01188681|474601859|FG003|Overall Study|bladder cancer|0|||
131814305|NCT01188681|474601856|FG000|Overall Study|Withdrawal by Subject|0|||
131814306|NCT01188681|474601857|FG001|Overall Study|Withdrawal by Subject|0|||
131814307|NCT01188681|474601858|FG002|Overall Study|Withdrawal by Subject|0|||
131814308|NCT01188681|474601859|FG003|Overall Study|Withdrawal by Subject|1|||
131814309|NCT05752721|474601860|FG000|Overall Study|Lost to Follow-up|22|||
131814310|NCT05752721|474601861|FG001|Overall Study|Lost to Follow-up|20|||
131766537|NCT02519777|474422043|FG002|Overall Study|Severe Debilitation|1|||
131766538|NCT02519777|474422041|FG000|Overall Study|Not able to get to clinic|1|||
131766539|NCT02519777|474422042|FG001|Overall Study|Not able to get to clinic|2|||
131766540|NCT02519777|474422043|FG002|Overall Study|Not able to get to clinic|1|||
131766541|NCT02195531|474422044|FG000|Overall Study|Withdrawal by Subject|1|||
131766542|NCT02195531|474422045|FG001|Overall Study|Withdrawal by Subject|1|||
131766543|NCT02195531|474422046|FG002|Overall Study|Withdrawal by Subject|1|||
131766544|NCT02543801|474422048|FG000|Overall Study|Protocol Violation|1|||
131766545|NCT02543801|474422049|FG001|Overall Study|Protocol Violation|2|||
131766546|NCT02543801|474422050|FG002|Overall Study|Protocol Violation|0|||
131766547|NCT02543801|474422051|FG003|Overall Study|Protocol Violation|0|||
131766548|NCT01034709|474422054|FG000|Overall Study|Protocol Violation|9|||
131766549|NCT01034709|474422055|FG001|Overall Study|Protocol Violation|16|||
131766550|NCT01683058|474422057|FG000|Overall Study|Lost to Follow-up|9|||
131766551|NCT01683058|474422057|FG000|Overall Study|Adverse Event|6|||
131766552|NCT01683058|474422057|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
131766553|NCT01683058|474422057|FG000|Overall Study|Withdrawal by Subject|7|||
131766554|NCT01683058|474422057|FG000|Overall Study|Lack of Efficacy|2|||
131766555|NCT04062240|474422061|FG000|Overall Study|equipment malfunction|1|||
131766556|NCT01957111|474422062|FG000|Overall Study|Withdrawal by Subject|1|||
131766557|NCT01957111|474422063|FG001|Overall Study|Withdrawal by Subject|1|||
131766558|NCT01057394|474422064|FG000|Overall Study|Not eligible|0|||
131766559|NCT01057394|474422065|FG001|Overall Study|Not eligible|2|||
131766560|NCT03500419|474422066|FG000|Overall Study|Withdrawal by Subject|2|||
131766561|NCT03500419|474422067|FG001|Overall Study|Withdrawal by Subject|25|||
131766562|NCT00082628|474422068|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131766563|NCT00082628|474422069|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
131766564|NCT00082628|474422070|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131766565|NCT00082628|474422071|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131766566|NCT00082628|474422072|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131766567|NCT00082628|474422068|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
131766568|NCT00082628|474422069|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
131766569|NCT00082628|474422070|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
131766570|NCT00082628|474422071|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
131766571|NCT00082628|474422072|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
131766572|NCT00082628|474422068|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
131766573|NCT00082628|474422069|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
131766574|NCT00082628|474422070|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
131766575|NCT00082628|474422071|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
131766576|NCT00082628|474422072|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
131766577|NCT00082628|474422068|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
131766578|NCT00082628|474422069|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
131766579|NCT00082628|474422070|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
131766580|NCT00082628|474422071|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
131766581|NCT00082628|474422072|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
131766582|NCT00082628|474422068|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131766583|NCT00082628|474422069|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131909663|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
131909664|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
131766584|NCT00082628|474422070|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131766585|NCT00082628|474422071|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131766586|NCT00082628|474422072|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
131766587|NCT00082628|474422068|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131766588|NCT00082628|474422069|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131766589|NCT00082628|474422070|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131766590|NCT00082628|474422071|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
131766591|NCT00082628|474422072|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131766592|NCT00082628|474422068|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
131766593|NCT00082628|474422069|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
131909665|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
131909666|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
131909667|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
131909668|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
131766594|NCT00082628|474422070|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
131766595|NCT00082628|474422071|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
131766596|NCT00082628|474422072|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
131766597|NCT02364999|474422077|FG000|Overall Study|Death|136|||
131766598|NCT02364999|474422078|FG001|Overall Study|Death|138|||
131766599|NCT02364999|474422077|FG000|Overall Study|Lost to Follow-up|10|||
131766600|NCT02364999|474422078|FG001|Overall Study|Lost to Follow-up|15|||
131766601|NCT02364999|474422077|FG000|Overall Study|Protocol Violation|3|||
131766602|NCT02364999|474422078|FG001|Overall Study|Protocol Violation|2|||
131766603|NCT02364999|474422077|FG000|Overall Study|Withdrawal by Subject|14|||
131766604|NCT02364999|474422078|FG001|Overall Study|Withdrawal by Subject|14|||
131766605|NCT02364999|474422077|FG000|Overall Study|Other|0|||
131766606|NCT02364999|474422078|FG001|Overall Study|Other|1|||
131766607|NCT02364999|474422077|FG000|Overall Study|Randomized but did not receive treatment|2|||
131766608|NCT02364999|474422078|FG001|Overall Study|Randomized but did not receive treatment|3|||
131766609|NCT01566981|474422079|FG000|Overall Study|Lost to Follow-up|5|||
131766610|NCT01566981|474422080|FG001|Overall Study|Lost to Follow-up|8|||
131766611|NCT02177942|474422081|FG000|Overall Study|Adverse Event|1|||
131766612|NCT02177942|474422082|FG001|Overall Study|Adverse Event|0|||
131766613|NCT02177942|474422081|FG000|Overall Study|Lost to Follow-up|1|||
131766614|NCT02177942|474422082|FG001|Overall Study|Lost to Follow-up|1|||
131766615|NCT02177942|474422081|FG000|Overall Study|Protocol Violation|4|||
131766616|NCT02177942|474422082|FG001|Overall Study|Protocol Violation|6|||
131766617|NCT02177942|474422081|FG000|Overall Study|Withdrawal by Subject|71|||
131766618|NCT02177942|474422082|FG001|Overall Study|Withdrawal by Subject|81|||
131766619|NCT00699582|474422085|FG000|Overall Study|Adverse Event|4|||
131766620|NCT00699582|474422086|FG001|Overall Study|Adverse Event|11|||
131766621|NCT00699582|474422087|FG002|Overall Study|Adverse Event|23|||
131766622|NCT00699582|474422085|FG000|Overall Study|Withdrawal by Subject|6|||
131766623|NCT00699582|474422086|FG001|Overall Study|Withdrawal by Subject|7|||
131766624|NCT00699582|474422087|FG002|Overall Study|Withdrawal by Subject|4|||
131766625|NCT00699582|474422085|FG000|Overall Study|Lack of Efficacy|1|||
131766626|NCT00699582|474422086|FG001|Overall Study|Lack of Efficacy|0|||
131766627|NCT00699582|474422087|FG002|Overall Study|Lack of Efficacy|1|||
131766628|NCT00699582|474422085|FG000|Overall Study|Progressive Disease|1|||
131766629|NCT00699582|474422086|FG001|Overall Study|Progressive Disease|0|||
131766630|NCT00699582|474422087|FG002|Overall Study|Progressive Disease|0|||
131766631|NCT00699582|474422085|FG000|Overall Study|Administrative/Other|4|||
131766632|NCT00699582|474422086|FG001|Overall Study|Administrative/Other|3|||
131766633|NCT00699582|474422087|FG002|Overall Study|Administrative/Other|0|||
131766634|NCT00699582|474422085|FG000|Overall Study|Randomized, Not Treated|2|||
131766635|NCT00699582|474422086|FG001|Overall Study|Randomized, Not Treated|1|||
131766636|NCT00699582|474422087|FG002|Overall Study|Randomized, Not Treated|0|||
131766637|NCT02692560|474422090|FG000|Overall Study|Withdrawal by Subject|0|||
131766638|NCT02692560|474422091|FG001|Overall Study|Withdrawal by Subject|6|||
131766639|NCT01241318|474422092|FG000|Overall Study|Woman: false pregnancies|27|||
131766640|NCT01241318|474422093|FG001|Overall Study|Woman: false pregnancies|15|||
131766641|NCT01241318|474422092|FG000|Overall Study|Woman: miscarriage/abortion|46|||
131766642|NCT01241318|474422093|FG001|Overall Study|Woman: miscarriage/abortion|38|||
131766643|NCT01241318|474422092|FG000|Overall Study|Withdrawal by Subject|175|||
131766644|NCT01241318|474422093|FG001|Overall Study|Withdrawal by Subject|46|||
131766645|NCT01241318|474422092|FG000|Overall Study|Lost to Follow-up|740|||
131766646|NCT01241318|474422093|FG001|Overall Study|Lost to Follow-up|455|||
131766647|NCT01241318|474422092|FG000|Overall Study|Death|2|||
131766648|NCT01241318|474422093|FG001|Overall Study|Death|4|||
131766649|NCT01241318|474422092|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
131766650|NCT01241318|474422093|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
131766651|NCT01241318|474422092|FG000|Overall Study|Woman: Stillborn infant|129|||
131766652|NCT01241318|474422093|FG001|Overall Study|Woman: Stillborn infant|146|||
131766653|NCT04129242|474422094|FG000|Overall Study|Physician Decision|1|||
131766654|NCT04129242|474422095|FG001|Overall Study|Physician Decision|1|||
131766655|NCT04129242|474422094|FG000|Overall Study|Protocol Violation|0|||
131766656|NCT04129242|474422095|FG001|Overall Study|Protocol Violation|1|||
131766657|NCT02728804|474422099|FG000|Overall Study|Ineligible|3|||
131814311|NCT05752721|474601860|FG000|Overall Study|Withdrawal by Subject|15|||
131766658|NCT02728804|474422099|FG000|Overall Study|Did not complete baseline questionnaire|9|||
131814312|NCT05752721|474601861|FG001|Overall Study|Withdrawal by Subject|12|||
131766659|NCT02728804|474422099|FG000|Overall Study|Death|99|||
131766660|NCT01084096|474424036|FG000|Overall Study|Lost to Follow-up|1501|||
131814313|NCT00263588|474601862|FG000|Overall Study|Death|54|||
131766661|NCT01084096|474424037|FG001|Overall Study|Lost to Follow-up|1833|||
131766662|NCT01084096|474424036|FG000|Overall Study|Withdrawal by Subject|3|||
131766663|NCT01084096|474424037|FG001|Overall Study|Withdrawal by Subject|0|||
131766664|NCT01084096|474424036|FG000|Overall Study|Woman had a miscarriage|21|||
131766665|NCT01084096|474424037|FG001|Overall Study|Woman had a miscarriage|17|||
131766666|NCT01354964|474424038|FG000|Overall Study|Lost to Follow-up|2|||
131766667|NCT01354964|474424039|FG001|Overall Study|Lost to Follow-up|0|||
131766668|NCT01354964|474424038|FG000|Overall Study|IV access issues|1|||
131766669|NCT01354964|474424039|FG001|Overall Study|IV access issues|1|||
131814314|NCT00263588|474601863|FG001|Overall Study|Death|90|||
131766670|NCT01354964|474424038|FG000|Overall Study|Physician Decision|1|||
131766671|NCT01354964|474424039|FG001|Overall Study|Physician Decision|0|||
131766672|NCT02551874|474424040|FG000|Overall Study|Lost to Follow-up|0|||
131766673|NCT02551874|474424041|FG001|Overall Study|Lost to Follow-up|2|||
131766674|NCT02551874|474424040|FG000|Overall Study|Pregnancy|0|||
131766675|NCT02551874|474424041|FG001|Overall Study|Pregnancy|1|||
131766676|NCT02551874|474424040|FG000|Overall Study|Reason not reported|10|||
131766677|NCT02551874|474424041|FG001|Overall Study|Reason not reported|4|||
131766678|NCT02551874|474424040|FG000|Overall Study|Did not receive randomized treatment|0|||
131766679|NCT02551874|474424041|FG001|Overall Study|Did not receive randomized treatment|7|||
131766680|NCT02551874|474424040|FG000|Overall Study|Did not enter long-term study|18|||
131766681|NCT02551874|474424041|FG001|Overall Study|Did not enter long-term study|25|||
131766682|NCT01640353|474424052|FG000|Overall Study|Withdrew prior to treatment|10|||
131766683|NCT01640353|474424052|FG000|Overall Study|Withdrawn from analysis at term site|12|||
131766684|NCT01640353|474424052|FG000|Overall Study|Withdrawal by Subject|5|||
131766685|NCT01640353|474424052|FG000|Overall Study|Death|2|||
131766686|NCT01640353|474424052|FG000|Overall Study|Early site termination|3|||
131766687|NCT01640353|474424052|FG000|Overall Study|Lost to Follow-up|12|||
131766688|NCT01640353|474424052|FG000|Overall Study|Physician Decision|1|||
131766689|NCT01524900|474424057|FG000|Overall Study|Lost to Follow-up|3|||
131766690|NCT01524900|474424058|FG001|Overall Study|Lost to Follow-up|12|||
131766691|NCT01524900|474424059|FG002|Overall Study|Lost to Follow-up|1|||
131766692|NCT01524900|474424060|FG003|Overall Study|Lost to Follow-up|0|||
131766693|NCT01524900|474424061|FG004|Overall Study|Lost to Follow-up|0|||
131766694|NCT01524900|474424057|FG000|Overall Study|Other reason than stated above|1|||
131766695|NCT01524900|474424058|FG001|Overall Study|Other reason than stated above|1|||
131766696|NCT01524900|474424059|FG002|Overall Study|Other reason than stated above|0|||
131766697|NCT01524900|474424060|FG003|Overall Study|Other reason than stated above|0|||
131766698|NCT01524900|474424061|FG004|Overall Study|Other reason than stated above|0|||
131766699|NCT01524900|474424057|FG000|Overall Study|No reason documented|2|||
131766700|NCT01524900|474424058|FG001|Overall Study|No reason documented|1|||
131766701|NCT01524900|474424059|FG002|Overall Study|No reason documented|0|||
131766702|NCT01524900|474424060|FG003|Overall Study|No reason documented|1|||
131766703|NCT01524900|474424061|FG004|Overall Study|No reason documented|0|||
131766704|NCT03758612|474424062|FG000|Washout Period|Withdrawal by Subject|0|||
131766705|NCT03758612|474424063|FG001|Washout Period|Withdrawal by Subject|0|||
131766706|NCT03758612|474424064|FG002|Washout Period|Withdrawal by Subject|2|||
131766707|NCT03758612|474424065|FG003|Washout Period|Withdrawal by Subject|0|||
131766708|NCT03758612|474424066|FG004|Washout Period|Withdrawal by Subject|0|||
131766709|NCT03758612|474424067|FG005|Washout Period|Withdrawal by Subject|0|||
131766710|NCT03758612|474424068|FG006|Washout Period|Withdrawal by Subject|0|||
131766711|NCT03758612|474424069|FG007|Washout Period|Withdrawal by Subject|0|||
131766712|NCT03758612|474424070|FG008|Washout Period|Withdrawal by Subject|0|||
131766713|NCT03758612|474424071|FG009|Washout Period|Withdrawal by Subject|0|||
131766714|NCT03758612|474424072|FG010|Washout Period|Withdrawal by Subject|0|||
131766715|NCT03758612|474424073|FG011|Washout Period|Withdrawal by Subject|0|||
131766716|NCT03758612|474424062|FG000|Period 2|Protocol Violation|0|||
131766717|NCT03758612|474424063|FG001|Period 2|Protocol Violation|0|||
131766718|NCT03758612|474424064|FG002|Period 2|Protocol Violation|0|||
131766719|NCT03758612|474424065|FG003|Period 2|Protocol Violation|0|||
131766720|NCT03758612|474424066|FG004|Period 2|Protocol Violation|1|||
131766721|NCT03758612|474424067|FG005|Period 2|Protocol Violation|0|||
131766722|NCT03758612|474424068|FG006|Period 2|Protocol Violation|0|||
131766723|NCT03758612|474424069|FG007|Period 2|Protocol Violation|0|||
131766724|NCT03758612|474424070|FG008|Period 2|Protocol Violation|0|||
131766725|NCT03758612|474424071|FG009|Period 2|Protocol Violation|0|||
131766726|NCT03758612|474424072|FG010|Period 2|Protocol Violation|0|||
131766727|NCT03758612|474424073|FG011|Period 2|Protocol Violation|0|||
131766728|NCT01603615|474424075|FG000|Overall Study|Did not Receive Treatment|7|||
131766729|NCT01603615|474424075|FG000|Overall Study|Lost to Follow-up|9|||
131766730|NCT01603615|474424075|FG000|Overall Study|Personal Reasons|17|||
131766731|NCT01603615|474424075|FG000|Overall Study|Other Miscellaneous|1|||
131766732|NCT03419741|474424076|FG000|Overall Study|Adverse Event|1|||
131766733|NCT03419741|474424077|FG001|Overall Study|Adverse Event|0|||
131766734|NCT03419741|474424076|FG000|Overall Study|Withdrawal by Subject|1|||
131766735|NCT03419741|474424077|FG001|Overall Study|Withdrawal by Subject|2|||
131766736|NCT04354870|474424078|FG000|Overall Study|Lost to Follow-up|32|||
131766737|NCT04354870|474424079|FG001|Overall Study|Lost to Follow-up|12|||
131766738|NCT04354870|474424078|FG000|Overall Study|Withdrawal by Subject|10|||
131766739|NCT04354870|474424079|FG001|Overall Study|Withdrawal by Subject|16|||
131766740|NCT04354870|474424078|FG000|Overall Study|Did not complete all study visits|6|||
131766741|NCT04354870|474424079|FG001|Overall Study|Did not complete all study visits|5|||
131766742|NCT03384316|474424080|FG000|Overall Study|Screen failure|0|||
131766743|NCT03384316|474424081|FG001|Overall Study|Screen failure|1|||
131766744|NCT04450394|474424092|FG000|Overall Study|Adverse Event|2|||
131766745|NCT04450394|474424093|FG001|Overall Study|Adverse Event|0|||
131766746|NCT04450394|474424094|FG002|Overall Study|Adverse Event|0|||
131766747|NCT04450394|474424092|FG000|Overall Study|Death|0|||
131766748|NCT04450394|474424093|FG001|Overall Study|Death|1|||
131766749|NCT04450394|474424094|FG002|Overall Study|Death|0|||
131766750|NCT04450394|474424092|FG000|Overall Study|Lost to Follow-up|0|||
131766751|NCT04450394|474424093|FG001|Overall Study|Lost to Follow-up|3|||
131766752|NCT04450394|474424094|FG002|Overall Study|Lost to Follow-up|0|||
131766753|NCT04450394|474424092|FG000|Overall Study|Physician Decision|0|||
131766754|NCT04450394|474424093|FG001|Overall Study|Physician Decision|1|||
131766755|NCT04450394|474424094|FG002|Overall Study|Physician Decision|0|||
131766756|NCT04450394|474424092|FG000|Overall Study|Protocol Violation|2|||
131766757|NCT04450394|474424093|FG001|Overall Study|Protocol Violation|0|||
131766758|NCT04450394|474424094|FG002|Overall Study|Protocol Violation|0|||
131766759|NCT04450394|474424092|FG000|Overall Study|Withdrawal by Subject|6|||
131766760|NCT04450394|474424093|FG001|Overall Study|Withdrawal by Subject|9|||
131766761|NCT04450394|474424094|FG002|Overall Study|Withdrawal by Subject|0|||
131766762|NCT02194699|474424095|FG000|Randomised|Did not receive treatment|1|||
131766763|NCT02194699|474424096|FG001|Randomised|Did not receive treatment|5|||
131766764|NCT02194699|474424095|FG000|Randomised|Without potential for 52 weeks of IP|5|||
131766765|NCT02194699|474424096|FG001|Randomised|Without potential for 52 weeks of IP|5|||
131814315|NCT00263588|474601862|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
131814316|NCT00263588|474601863|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
131814317|NCT00263588|474601862|FG000|Overall Study|Lost to Follow-up|7|||
131814318|NCT00263588|474601863|FG001|Overall Study|Lost to Follow-up|10|||
131814319|NCT00263588|474601862|FG000|Overall Study|Withdrawal by Subject|3|||
131814320|NCT00263588|474601863|FG001|Overall Study|Withdrawal by Subject|4|||
131814321|NCT00263588|474601862|FG000|Overall Study|Protocol Violation|0|||
131814322|NCT00263588|474601863|FG001|Overall Study|Protocol Violation|1|||
131814323|NCT00263588|474601862|FG000|Overall Study|Investigator decision|7|||
131814324|NCT00263588|474601863|FG001|Overall Study|Investigator decision|15|||
131814325|NCT00263588|474601862|FG000|Overall Study|Sponsor terminated study|0|||
131814326|NCT00263588|474601863|FG001|Overall Study|Sponsor terminated study|1|||
131814327|NCT00484679|474601864|FG000|Overall Study|Withdrawal by Subject|3|||
131814328|NCT00835692|474601865|FG000|First Intervention|Withdrawal by Subject|1|||
131814329|NCT00835692|474601866|FG001|First Intervention|Withdrawal by Subject|0|||
131814330|NCT04078022|474601869|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
131814331|NCT04078022|474601870|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
131814332|NCT01348789|474601871|FG000|Overall Study|Protocol Violation|2|||
131814333|NCT01348789|474601871|FG000|Overall Study|Withdrawal by Subject|2|||
131814334|NCT01825798|474601874|FG000|Overall Study|Adverse Event|1|||
131814335|NCT01825798|474601875|FG001|Overall Study|Adverse Event|5|||
131814336|NCT01825798|474601874|FG000|Overall Study|Lost to Follow-up|1|||
131814337|NCT01825798|474601875|FG001|Overall Study|Lost to Follow-up|0|||
131814338|NCT00834873|474601876|FG000|First Intervention|Adverse Event|0|||
131814339|NCT00834873|474601877|FG001|First Intervention|Adverse Event|1|||
131814340|NCT05098743|474601879|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
131814341|NCT05098743|474601880|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
131814342|NCT05098743|474601879|FG000|Overall Study|Lost to Follow-up|1|||
131814343|NCT05098743|474601880|FG001|Overall Study|Lost to Follow-up|2|||
131814344|NCT02911025|474601881|FG000|Overall Study|Lost to Follow-up|3|||
131814345|NCT04063878|474601882|FG000|Overall Study|Withdrawal by Subject|2|||
131814346|NCT04063878|474601882|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
131814347|NCT01473953|474601885|FG000|Overall Study|Other|1|||
131814348|NCT01473953|474601886|FG001|Overall Study|Other|0|||
131814349|NCT01473953|474601887|FG002|Overall Study|Other|0|||
131814350|NCT01473953|474601888|FG003|Overall Study|Other|0|||
131814351|NCT01473953|474601889|FG004|Overall Study|Other|0|||
131814352|NCT02358538|474601890|FG000|Through Week 26|Adverse Event|0|||
131814353|NCT02358538|474601891|FG001|Through Week 26|Adverse Event|1|||
131814354|NCT02358538|474601892|FG002|Through Week 26|Adverse Event|1|||
131909669|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
131766766|NCT02194699|474424095|FG000|Randomised|Duplicate patient|2|||
131766767|NCT02194699|474424096|FG001|Randomised|Duplicate patient|1|||
131766768|NCT02194699|474424095|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
131766769|NCT02194699|474424096|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
131766770|NCT02194699|474424095|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
131766771|NCT02194699|474424096|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
131766772|NCT02194699|474424095|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
131814355|NCT02358538|474601893|FG003|Through Week 26|Adverse Event|2|||
131814356|NCT02358538|474601890|FG000|Through Week 26|Lack of Efficacy|1|||
131814357|NCT02358538|474601891|FG001|Through Week 26|Lack of Efficacy|1|||
131814358|NCT02358538|474601892|FG002|Through Week 26|Lack of Efficacy|3|||
131814359|NCT02358538|474601893|FG003|Through Week 26|Lack of Efficacy|3|||
131814360|NCT02358538|474601890|FG000|Through Week 26|Withdrawal by Subject|1|||
131814361|NCT02358538|474601891|FG001|Through Week 26|Withdrawal by Subject|0|||
131814362|NCT02358538|474601892|FG002|Through Week 26|Withdrawal by Subject|0|||
131814363|NCT02358538|474601893|FG003|Through Week 26|Withdrawal by Subject|0|||
131766773|NCT02194699|474424096|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
131766774|NCT02194699|474424095|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
131766775|NCT02194699|474424096|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
131766776|NCT02194699|474424095|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
131766777|NCT02194699|474424096|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
131766778|NCT02194699|474424095|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
131766779|NCT02194699|474424096|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
131766780|NCT02719028|474424100|FG000|Overall Study|Adverse Event|2|||
131766781|NCT02719028|474424101|FG001|Overall Study|Adverse Event|1|||
131766782|NCT02719028|474424102|FG002|Overall Study|Adverse Event|4|||
131766783|NCT02719028|474424103|FG003|Overall Study|Adverse Event|8|||
131766784|NCT02719028|474424100|FG000|Overall Study|Physician Decision|0|||
131766785|NCT02719028|474424101|FG001|Overall Study|Physician Decision|1|||
131766786|NCT02719028|474424102|FG002|Overall Study|Physician Decision|1|||
131766787|NCT02719028|474424103|FG003|Overall Study|Physician Decision|1|||
131766788|NCT02719028|474424100|FG000|Overall Study|Use of prohibited medication|0|||
131766789|NCT02719028|474424101|FG001|Overall Study|Use of prohibited medication|0|||
131766790|NCT02719028|474424102|FG002|Overall Study|Use of prohibited medication|1|||
131766791|NCT02719028|474424103|FG003|Overall Study|Use of prohibited medication|0|||
131766792|NCT02719028|474424100|FG000|Overall Study|Protocol Violation|0|||
131766793|NCT02719028|474424101|FG001|Overall Study|Protocol Violation|0|||
131766794|NCT02719028|474424102|FG002|Overall Study|Protocol Violation|0|||
131766795|NCT02719028|474424103|FG003|Overall Study|Protocol Violation|1|||
131766796|NCT01539720|474424105|FG000|Overall Study|Screen Fail|15|||
131766797|NCT01539720|474424106|FG001|Overall Study|Screen Fail|3|||
131766798|NCT01539720|474424105|FG000|Overall Study|Lost to Follow-up|14|||
131766799|NCT01539720|474424106|FG001|Overall Study|Lost to Follow-up|7|||
131766800|NCT00298766|474424107|FG000|Overall Study|Adverse Event|18|||
131766801|NCT00298766|474424107|FG000|Overall Study|Death|2|||
131766802|NCT00298766|474424107|FG000|Overall Study|Withdrawal by Subject|9|||
131766803|NCT00298766|474424107|FG000|Overall Study|Treatment ongoing|4|||
131766804|NCT00298766|474424107|FG000|Overall Study|Progression of amyloid markers|4|||
131766805|NCT00298766|474424107|FG000|Overall Study|Deterioration in KPS and organ function|1|||
131766806|NCT00298766|474424107|FG000|Overall Study|Subjects overall condition deterioration|4|||
131766807|NCT00298766|474424107|FG000|Overall Study|Other|4|||
131766808|NCT02155660|474424108|FG000|Overall Study|Other Reason|8|||
131766809|NCT02155660|474424109|FG001|Overall Study|Other Reason|6|||
131766810|NCT02155660|474424110|FG002|Overall Study|Other Reason|10|||
131766811|NCT02155660|474424111|FG003|Overall Study|Other Reason|10|||
131766812|NCT02155660|474424108|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131766813|NCT02155660|474424109|FG001|Overall Study|Study-specific withdrawal criteria|1|||
131766814|NCT02155660|474424110|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131766815|NCT02155660|474424111|FG003|Overall Study|Study-specific withdrawal criteria|1|||
131766816|NCT02155660|474424108|FG000|Overall Study|Severe non-compliance|0|||
131766817|NCT02155660|474424109|FG001|Overall Study|Severe non-compliance|4|||
131766818|NCT02155660|474424110|FG002|Overall Study|Severe non-compliance|0|||
131766819|NCT02155660|474424111|FG003|Overall Study|Severe non-compliance|1|||
131766820|NCT02155660|474424108|FG000|Overall Study|Adverse Event|2|||
131766821|NCT02155660|474424109|FG001|Overall Study|Adverse Event|6|||
131766822|NCT02155660|474424110|FG002|Overall Study|Adverse Event|3|||
131766823|NCT02155660|474424111|FG003|Overall Study|Adverse Event|1|||
131766824|NCT02155660|474424108|FG000|Overall Study|Lost to Follow-up|3|||
131766825|NCT02155660|474424109|FG001|Overall Study|Lost to Follow-up|6|||
131766826|NCT02155660|474424110|FG002|Overall Study|Lost to Follow-up|5|||
131766827|NCT02155660|474424111|FG003|Overall Study|Lost to Follow-up|8|||
131766828|NCT02155660|474424108|FG000|Overall Study|Death|17|||
131766829|NCT02155660|474424109|FG001|Overall Study|Death|19|||
131766830|NCT02155660|474424110|FG002|Overall Study|Death|17|||
131766831|NCT02155660|474424111|FG003|Overall Study|Death|19|||
131766832|NCT02155660|474424108|FG000|Overall Study|Withdrawal by Subject|28|||
131766833|NCT02155660|474424109|FG001|Overall Study|Withdrawal by Subject|31|||
131766834|NCT02155660|474424110|FG002|Overall Study|Withdrawal by Subject|24|||
131766835|NCT02155660|474424111|FG003|Overall Study|Withdrawal by Subject|21|||
131766836|NCT03812224|474424118|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
131766837|NCT03812224|474424119|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131766838|NCT03812224|474424118|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
131766839|NCT03812224|474424119|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
131766840|NCT03812224|474424118|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
131814364|NCT02358538|474601890|FG000|Through Week 26|Non-Compliance|0|||
131814365|NCT02358538|474601891|FG001|Through Week 26|Non-Compliance|0|||
131814366|NCT02358538|474601892|FG002|Through Week 26|Non-Compliance|1|||
131814367|NCT02358538|474601893|FG003|Through Week 26|Non-Compliance|0|||
131814368|NCT02358538|474601890|FG000|Through Week 26|Family did not see benefit from IP|1|||
131766841|NCT03812224|474424119|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
131814369|NCT02358538|474601891|FG001|Through Week 26|Family did not see benefit from IP|0|||
131766842|NCT03812224|474424118|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
131766843|NCT03812224|474424119|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
131766844|NCT01641952|474424120|FG000|Overall Study|Lost to Follow-up|28|||
131766845|NCT01641952|474424120|FG000|Overall Study|Adverse Event|6|||
131766846|NCT02500901|474424121|FG000|Overall Study|Disease ProgressionDD|2|||
131766847|NCT00386152|474424123|FG000|Overall Study|Adverse Event|6|||
131766848|NCT00386152|474424124|FG001|Overall Study|Adverse Event|5|||
131766849|NCT00386152|474424125|FG002|Overall Study|Adverse Event|4|||
131766850|NCT00386152|474424123|FG000|Overall Study|Chang from original chemo stratification|4|||
131766851|NCT00386152|474424124|FG001|Overall Study|Chang from original chemo stratification|5|||
131766852|NCT00386152|474424125|FG002|Overall Study|Chang from original chemo stratification|6|||
131766853|NCT00386152|474424123|FG000|Overall Study|Death|3|||
131766854|NCT00386152|474424124|FG001|Overall Study|Death|0|||
131766855|NCT00386152|474424125|FG002|Overall Study|Death|1|||
131766856|NCT00386152|474424123|FG000|Overall Study|Disease progression|7|||
131766857|NCT00386152|474424124|FG001|Overall Study|Disease progression|4|||
131766858|NCT00386152|474424125|FG002|Overall Study|Disease progression|5|||
131766859|NCT00386152|474424123|FG000|Overall Study|Physician Decision|13|||
131766860|NCT00386152|474424124|FG001|Overall Study|Physician Decision|10|||
131766861|NCT00386152|474424125|FG002|Overall Study|Physician Decision|4|||
131766862|NCT00386152|474424123|FG000|Overall Study|Lost to Follow-up|1|||
131766863|NCT00386152|474424124|FG001|Overall Study|Lost to Follow-up|0|||
131766864|NCT00386152|474424125|FG002|Overall Study|Lost to Follow-up|0|||
131766865|NCT00386152|474424123|FG000|Overall Study|Completed chemotherapy|4|||
131766866|NCT00386152|474424124|FG001|Overall Study|Completed chemotherapy|5|||
131766867|NCT00386152|474424125|FG002|Overall Study|Completed chemotherapy|1|||
131766868|NCT00386152|474424123|FG000|Overall Study|Protocol Violation|3|||
131766869|NCT00386152|474424124|FG001|Overall Study|Protocol Violation|5|||
131766870|NCT00386152|474424125|FG002|Overall Study|Protocol Violation|2|||
131766871|NCT00386152|474424123|FG000|Overall Study|Withdrawal by Subject|3|||
131766872|NCT00386152|474424124|FG001|Overall Study|Withdrawal by Subject|6|||
131766873|NCT00386152|474424125|FG002|Overall Study|Withdrawal by Subject|10|||
131766874|NCT03633461|474424140|FG000|Overall Study|Lost to Follow-up|0|||
131766875|NCT03633461|474424141|FG001|Overall Study|Lost to Follow-up|1|||
131766876|NCT03938857|474424144|FG000|Overall Study|Physician Decision|1|||
131766877|NCT03938857|474424145|FG001|Overall Study|Physician Decision|0|||
131814370|NCT02358538|474601892|FG002|Through Week 26|Family did not see benefit from IP|0|||
131814371|NCT02358538|474601893|FG003|Through Week 26|Family did not see benefit from IP|0|||
131814372|NCT02358538|474601890|FG000|52 Week Extension Period|Lack of Efficacy|0|||
131814373|NCT02358538|474601891|FG001|52 Week Extension Period|Lack of Efficacy|0|||
131814374|NCT02358538|474601892|FG002|52 Week Extension Period|Lack of Efficacy|2|||
131814375|NCT02358538|474601893|FG003|52 Week Extension Period|Lack of Efficacy|4|||
131814376|NCT03500094|474601896|FG000|Overall Study|Withdrawal by Subject|1|||
131814377|NCT03500094|474601896|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
131814378|NCT03500094|474601896|FG000|Overall Study|Lost to Follow-up|1|||
131814379|NCT01030133|474601899|FG000|Overall Study|failed to experience pain at level 7/10|2|||
131814380|NCT01030133|474601900|FG001|Overall Study|failed to experience pain at level 7/10|2|||
131814381|NCT00477594|474601901|FG000|Year 1 and Year 2|Adverse Event|4|||
131814382|NCT00477594|474601902|FG001|Year 1 and Year 2|Adverse Event|2|||
131814383|NCT00477594|474601901|FG000|Year 1 and Year 2|Physician Decision|2|||
131814384|NCT00477594|474601902|FG001|Year 1 and Year 2|Physician Decision|1|||
131814385|NCT00477594|474601901|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
131814386|NCT00477594|474601902|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
131814387|NCT00477594|474601901|FG000|Year 1 and Year 2|Other|1|||
131814388|NCT00477594|474601902|FG001|Year 1 and Year 2|Other|0|||
131814389|NCT00477594|474601901|FG000|Year 3|Adverse Event|1|||
131814390|NCT00477594|474601902|FG001|Year 3|Adverse Event|0|||
131814391|NCT00477594|474601901|FG000|Year 3|Withdrawal by Subject|1|||
131814392|NCT00477594|474601902|FG001|Year 3|Withdrawal by Subject|0|||
131766878|NCT03938857|474424146|FG002|Overall Study|Physician Decision|0|||
131766879|NCT03938857|474424147|FG003|Overall Study|Physician Decision|0|||
131814393|NCT00477594|474601901|FG000|Follow-up Period|Withdrawal by Subject|2|||
131766880|NCT01977651|474424148|FG000|4 Month Treatment Period|Adverse Event|34|||
131766881|NCT01977651|474424148|FG000|4 Month Treatment Period|Death|3|||
131766882|NCT01977651|474424148|FG000|4 Month Treatment Period|Progressive Disease|43|||
131766883|NCT01977651|474424148|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
131766884|NCT01977651|474424148|FG000|4 Month Treatment Period|Physician Decision|4|||
131766885|NCT01977651|474424148|FG000|1 Year Extension Period|Adverse Event|14|||
131766886|NCT01977651|474424148|FG000|1 Year Extension Period|Death|10|||
131766887|NCT01977651|474424148|FG000|1 Year Extension Period|Lost to Follow-up|2|||
131766888|NCT01977651|474424148|FG000|1 Year Extension Period|Progressive Disease|86|||
131766889|NCT01977651|474424148|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
131814394|NCT00477594|474601902|FG001|Follow-up Period|Withdrawal by Subject|1|||
131814395|NCT00477594|474601901|FG000|Follow-up Period|Other|1|||
131814396|NCT00477594|474601902|FG001|Follow-up Period|Other|0|||
131814397|NCT02316548|474604426|FG000|Overall Study|Protocol Violation|0|||
131814398|NCT02316548|474604427|FG001|Overall Study|Protocol Violation|1|||
131814399|NCT02566850|474604429|FG000|Overall Study|Protocol Violation|1|||
131814400|NCT02635750|474604430|FG000|Part 1, Period 2|Adverse Event|1|||
131766890|NCT01977651|474424148|FG000|1 Year Extension Period|Physician Decision|6|||
131766891|NCT01977651|474424148|FG000|1 Year Extension Period|Miscellaneous|1|||
131766892|NCT01977651|474424148|FG000|Post 1 Year Extension Period|Adverse Event|5|||
131766893|NCT01977651|474424148|FG000|Post 1 Year Extension Period|Death|13|||
131766894|NCT01977651|474424148|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
131766895|NCT01977651|474424148|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
131766896|NCT01977651|474424148|FG000|Post 1 Year Extension Period|Physician Decision|4|||
131766897|NCT01977651|474424148|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
131766898|NCT00661362|474424149|FG000|Overall Study|Adverse Event|5|||
131766899|NCT00661362|474424150|FG001|Overall Study|Adverse Event|4|||
131766900|NCT00661362|474424149|FG000|Overall Study|Incorrect enrollment|2|||
131766901|NCT00661362|474424150|FG001|Overall Study|Incorrect enrollment|0|||
131766902|NCT00661362|474424149|FG000|Overall Study|Study specific discontinuation criteria|4|||
131766903|NCT00661362|474424150|FG001|Overall Study|Study specific discontinuation criteria|11|||
131766904|NCT00661362|474424149|FG000|Overall Study|Withdrawal by Subject|13|||
131766905|NCT00661362|474424150|FG001|Overall Study|Withdrawal by Subject|23|||
131766906|NCT00661362|474424149|FG000|Overall Study|Lost to Follow-up|3|||
131766907|NCT00661362|474424150|FG001|Overall Study|Lost to Follow-up|1|||
131766908|NCT00661362|474424149|FG000|Overall Study|Severe non-compliance to protocol|0|||
131766909|NCT00661362|474424150|FG001|Overall Study|Severe non-compliance to protocol|1|||
131766910|NCT00661362|474424149|FG000|Overall Study|Safety reasons|1|||
131766911|NCT00661362|474424150|FG001|Overall Study|Safety reasons|0|||
131766912|NCT00661362|474424149|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
131766913|NCT00661362|474424150|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
131766914|NCT02906644|474424151|FG000|First 2 Weeks|Withdrawal by Subject|0|||
131766915|NCT02906644|474424152|FG001|First 2 Weeks|Withdrawal by Subject|2|||
131766916|NCT02906644|474424151|FG000|First 2 Weeks|Physician Decision|1|||
131766917|NCT02906644|474424152|FG001|First 2 Weeks|Physician Decision|1|||
131766918|NCT02906644|474424151|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
131766919|NCT02906644|474424152|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
131766920|NCT02906644|474424151|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
131766921|NCT02906644|474424152|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
131766922|NCT01351415|474424164|FG000|Overall Study|Withdrawal by Subject|15|||
131766923|NCT01351415|474424165|FG001|Overall Study|Withdrawal by Subject|17|||
131766924|NCT01351415|474424164|FG000|Overall Study|Trial termination by the Sponsor|28|||
131766925|NCT01351415|474424165|FG001|Overall Study|Trial termination by the Sponsor|19|||
131766926|NCT01351415|474424164|FG000|Overall Study|Lost to Follow-up|5|||
131766927|NCT01351415|474424165|FG001|Overall Study|Lost to Follow-up|7|||
131766928|NCT01351415|474424164|FG000|Overall Study|Death|190|||
131766929|NCT01351415|474424165|FG001|Overall Study|Death|187|||
131766930|NCT01351415|474424164|FG000|Overall Study|Physician Decision|2|||
131766931|NCT01351415|474424165|FG001|Overall Study|Physician Decision|3|||
131766932|NCT01351415|474424164|FG000|Overall Study|Reason unknown|0|||
131766933|NCT01351415|474424165|FG001|Overall Study|Reason unknown|2|||
131766934|NCT01351415|474424164|FG000|Overall Study|Never Started|5|||
131766935|NCT01351415|474424165|FG001|Overall Study|Never Started|5|||
131766936|NCT04118127|474424170|FG000|Overall Study|Trial terminated by sponsor|0|||
131766937|NCT04118127|474424171|FG001|Overall Study|Trial terminated by sponsor|12|||
131766938|NCT04118127|474424170|FG000|Overall Study|Adverse Event|1|||
131766939|NCT04118127|474424171|FG001|Overall Study|Adverse Event|2|||
131766940|NCT04118127|474424170|FG000|Overall Study|Physician Decision|0|||
131814401|NCT02635750|474604431|FG001|Part 1, Period 2|Adverse Event|0|||
131814402|NCT02635750|474604432|FG002|Part 1, Period 2|Adverse Event|0|||
131814403|NCT00830258|474604435|FG000|First Intervention|Adverse Event|1|||
131814404|NCT00830258|474604436|FG001|First Intervention|Adverse Event|0|||
131814405|NCT00830258|474604435|FG000|Washout: 7 Days|Protocol Violation|1|||
131814406|NCT00830258|474604436|FG001|Washout: 7 Days|Protocol Violation|0|||
131814407|NCT03599193|474604438|FG000|Overall Study|Adverse Event|0|||
131814408|NCT03599193|474604439|FG001|Overall Study|Adverse Event|2|||
131766941|NCT04118127|474424171|FG001|Overall Study|Physician Decision|1|||
131766942|NCT04118127|474424170|FG000|Overall Study|Withdrawal by Subject|2|||
131766943|NCT04118127|474424171|FG001|Overall Study|Withdrawal by Subject|1|||
131766944|NCT00660816|474424172|FG000|Overall Study|Adverse Event|1|||
131766945|NCT00660816|474424173|FG001|Overall Study|Adverse Event|2|||
131766946|NCT00660816|474424172|FG000|Overall Study|Withdrawal by Subject|1|||
131766947|NCT00660816|474424173|FG001|Overall Study|Withdrawal by Subject|0|||
131766948|NCT00660816|474424172|FG000|Overall Study|Death|0|||
131766949|NCT00660816|474424173|FG001|Overall Study|Death|2|||
131766950|NCT00660816|474424172|FG000|Overall Study|Lack of Efficacy|1|||
131766951|NCT00660816|474424173|FG001|Overall Study|Lack of Efficacy|0|||
131766952|NCT00660816|474424172|FG000|Overall Study|Physician Decision|0|||
131766953|NCT00660816|474424173|FG001|Overall Study|Physician Decision|2|||
131766954|NCT00660816|474424172|FG000|Overall Study|Protocol Violation|1|||
131814409|NCT03599193|474604438|FG000|Overall Study|Withdrawal by Subject|1|||
131814410|NCT03599193|474604439|FG001|Overall Study|Withdrawal by Subject|0|||
131766955|NCT00660816|474424173|FG001|Overall Study|Protocol Violation|0|||
131766956|NCT00660816|474424172|FG000|Overall Study|Disease Progression|16|||
131766957|NCT00660816|474424173|FG001|Overall Study|Disease Progression|12|||
131766958|NCT00660816|474424172|FG000|Overall Study|Complicating Disease|0|||
131766959|NCT00660816|474424173|FG001|Overall Study|Complicating Disease|1|||
131766960|NCT02394028|474424174|FG000|Induction Phase|Adverse Event|2|||
131766961|NCT02394028|474424175|FG001|Induction Phase|Adverse Event|4|||
131766962|NCT02394028|474424176|FG002|Induction Phase|Adverse Event|1|||
131766963|NCT02394028|474424177|FG003|Induction Phase|Adverse Event|2|||
131766964|NCT02394028|474424178|FG004|Induction Phase|Adverse Event|5|||
131766965|NCT02394028|474424179|FG005|Induction Phase|Adverse Event|2|||
131766966|NCT02394028|474424180|FG006|Induction Phase|Adverse Event|0|||
131766967|NCT02394028|474424181|FG007|Induction Phase|Adverse Event|0|||
131766968|NCT02394028|474424182|FG008|Induction Phase|Adverse Event|0|||
131766969|NCT02394028|474424183|FG009|Induction Phase|Adverse Event|0|||
131766970|NCT02394028|474424184|FG010|Induction Phase|Adverse Event|0|||
131766971|NCT02394028|474424174|FG000|Induction Phase|Lack of Efficacy|3|||
131766972|NCT02394028|474424175|FG001|Induction Phase|Lack of Efficacy|6|||
131766973|NCT02394028|474424176|FG002|Induction Phase|Lack of Efficacy|2|||
131766974|NCT02394028|474424177|FG003|Induction Phase|Lack of Efficacy|17|||
131766975|NCT02394028|474424178|FG004|Induction Phase|Lack of Efficacy|14|||
131766976|NCT02394028|474424179|FG005|Induction Phase|Lack of Efficacy|8|||
131766977|NCT02394028|474424180|FG006|Induction Phase|Lack of Efficacy|17|||
131766978|NCT02394028|474424181|FG007|Induction Phase|Lack of Efficacy|23|||
131766979|NCT02394028|474424182|FG008|Induction Phase|Lack of Efficacy|0|||
131766980|NCT02394028|474424183|FG009|Induction Phase|Lack of Efficacy|0|||
131766981|NCT02394028|474424184|FG010|Induction Phase|Lack of Efficacy|0|||
131766982|NCT02394028|474424174|FG000|Induction Phase|Lost to Follow-up|1|||
131766983|NCT02394028|474424175|FG001|Induction Phase|Lost to Follow-up|0|||
131766984|NCT02394028|474424176|FG002|Induction Phase|Lost to Follow-up|0|||
131766985|NCT02394028|474424177|FG003|Induction Phase|Lost to Follow-up|1|||
131766986|NCT02394028|474424178|FG004|Induction Phase|Lost to Follow-up|0|||
131766987|NCT02394028|474424179|FG005|Induction Phase|Lost to Follow-up|0|||
131766988|NCT02394028|474424180|FG006|Induction Phase|Lost to Follow-up|1|||
131766989|NCT02394028|474424181|FG007|Induction Phase|Lost to Follow-up|0|||
131766990|NCT02394028|474424182|FG008|Induction Phase|Lost to Follow-up|0|||
131766991|NCT02394028|474424183|FG009|Induction Phase|Lost to Follow-up|0|||
131766992|NCT02394028|474424184|FG010|Induction Phase|Lost to Follow-up|0|||
131766993|NCT02394028|474424174|FG000|Induction Phase|Non-compliance|0|||
131766994|NCT02394028|474424175|FG001|Induction Phase|Non-compliance|1|||
131766995|NCT02394028|474424176|FG002|Induction Phase|Non-compliance|3|||
131766996|NCT02394028|474424177|FG003|Induction Phase|Non-compliance|1|||
131766997|NCT02394028|474424178|FG004|Induction Phase|Non-compliance|3|||
131766998|NCT02394028|474424179|FG005|Induction Phase|Non-compliance|0|||
131766999|NCT02394028|474424180|FG006|Induction Phase|Non-compliance|1|||
131767000|NCT02394028|474424181|FG007|Induction Phase|Non-compliance|1|||
131767001|NCT02394028|474424182|FG008|Induction Phase|Non-compliance|0|||
131767002|NCT02394028|474424183|FG009|Induction Phase|Non-compliance|0|||
131767003|NCT02394028|474424184|FG010|Induction Phase|Non-compliance|0|||
131767004|NCT02394028|474424174|FG000|Induction Phase|Physician Decision|0|||
131767005|NCT02394028|474424175|FG001|Induction Phase|Physician Decision|0|||
131767006|NCT02394028|474424176|FG002|Induction Phase|Physician Decision|1|||
131767007|NCT02394028|474424177|FG003|Induction Phase|Physician Decision|4|||
131767008|NCT02394028|474424178|FG004|Induction Phase|Physician Decision|0|||
131767009|NCT02394028|474424179|FG005|Induction Phase|Physician Decision|2|||
131767010|NCT02394028|474424180|FG006|Induction Phase|Physician Decision|1|||
131767011|NCT02394028|474424181|FG007|Induction Phase|Physician Decision|0|||
131767012|NCT02394028|474424182|FG008|Induction Phase|Physician Decision|0|||
131767013|NCT02394028|474424183|FG009|Induction Phase|Physician Decision|0|||
131909670|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
131909671|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
131909672|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
131909673|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
131909674|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
131767014|NCT02394028|474424184|FG010|Induction Phase|Physician Decision|0|||
131767015|NCT02394028|474424174|FG000|Induction Phase|Protocol Violation|0|||
131767016|NCT02394028|474424175|FG001|Induction Phase|Protocol Violation|2|||
131767017|NCT02394028|474424176|FG002|Induction Phase|Protocol Violation|0|||
131767018|NCT02394028|474424177|FG003|Induction Phase|Protocol Violation|3|||
131767019|NCT02394028|474424178|FG004|Induction Phase|Protocol Violation|0|||
131909675|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
131400607|NCT00473668|473089543|FG001|Overall Study|Migrated/moved from study area|2|||
131767020|NCT02394028|474424179|FG005|Induction Phase|Protocol Violation|1|||
131767021|NCT02394028|474424180|FG006|Induction Phase|Protocol Violation|1|||
131767022|NCT02394028|474424181|FG007|Induction Phase|Protocol Violation|0|||
131767023|NCT02394028|474424182|FG008|Induction Phase|Protocol Violation|0|||
131767024|NCT02394028|474424183|FG009|Induction Phase|Protocol Violation|0|||
131767025|NCT02394028|474424184|FG010|Induction Phase|Protocol Violation|0|||
131767026|NCT02394028|474424174|FG000|Induction Phase|Withdrawal by Subject|1|||
131767027|NCT02394028|474424175|FG001|Induction Phase|Withdrawal by Subject|2|||
131767028|NCT02394028|474424176|FG002|Induction Phase|Withdrawal by Subject|4|||
131767029|NCT02394028|474424177|FG003|Induction Phase|Withdrawal by Subject|6|||
131767030|NCT02394028|474424178|FG004|Induction Phase|Withdrawal by Subject|7|||
131767031|NCT02394028|474424179|FG005|Induction Phase|Withdrawal by Subject|4|||
131767032|NCT02394028|474424180|FG006|Induction Phase|Withdrawal by Subject|3|||
131767033|NCT02394028|474424181|FG007|Induction Phase|Withdrawal by Subject|6|||
131767034|NCT02394028|474424182|FG008|Induction Phase|Withdrawal by Subject|0|||
131767035|NCT02394028|474424183|FG009|Induction Phase|Withdrawal by Subject|0|||
131767036|NCT02394028|474424184|FG010|Induction Phase|Withdrawal by Subject|0|||
131767037|NCT02394028|474424174|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767038|NCT02394028|474424175|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767039|NCT02394028|474424176|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767040|NCT02394028|474424177|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767041|NCT02394028|474424178|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767042|NCT02394028|474424179|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767043|NCT02394028|474424180|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
131767044|NCT02394028|474424181|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767045|NCT02394028|474424182|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767046|NCT02394028|474424183|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767047|NCT02394028|474424184|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
131767048|NCT02394028|474424174|FG000|Induction Phase|Sponsor decision|0|||
131767049|NCT02394028|474424175|FG001|Induction Phase|Sponsor decision|1|||
131767050|NCT02394028|474424176|FG002|Induction Phase|Sponsor decision|2|||
131767051|NCT02394028|474424177|FG003|Induction Phase|Sponsor decision|0|||
131767052|NCT02394028|474424178|FG004|Induction Phase|Sponsor decision|0|||
131767053|NCT02394028|474424179|FG005|Induction Phase|Sponsor decision|0|||
131767054|NCT02394028|474424180|FG006|Induction Phase|Sponsor decision|0|||
131767055|NCT02394028|474424181|FG007|Induction Phase|Sponsor decision|0|||
131767056|NCT02394028|474424182|FG008|Induction Phase|Sponsor decision|0|||
131767057|NCT02394028|474424183|FG009|Induction Phase|Sponsor decision|0|||
131767058|NCT02394028|474424184|FG010|Induction Phase|Sponsor decision|0|||
131767059|NCT02394028|474424174|FG000|Induction Phase|Technical reason|0|||
131767060|NCT02394028|474424175|FG001|Induction Phase|Technical reason|0|||
131767061|NCT02394028|474424176|FG002|Induction Phase|Technical reason|0|||
131767062|NCT02394028|474424177|FG003|Induction Phase|Technical reason|1|||
131767063|NCT02394028|474424178|FG004|Induction Phase|Technical reason|0|||
131767064|NCT02394028|474424179|FG005|Induction Phase|Technical reason|0|||
131767065|NCT02394028|474424180|FG006|Induction Phase|Technical reason|0|||
131767066|NCT02394028|474424181|FG007|Induction Phase|Technical reason|0|||
131767067|NCT02394028|474424182|FG008|Induction Phase|Technical reason|0|||
131767068|NCT02394028|474424183|FG009|Induction Phase|Technical reason|0|||
131767069|NCT02394028|474424184|FG010|Induction Phase|Technical reason|0|||
131767070|NCT02394028|474424174|FG000|Induction Phase|:ack of calculation|0|||
131767071|NCT02394028|474424175|FG001|Induction Phase|:ack of calculation|0|||
131767072|NCT02394028|474424176|FG002|Induction Phase|:ack of calculation|0|||
131767073|NCT02394028|474424177|FG003|Induction Phase|:ack of calculation|0|||
131767074|NCT02394028|474424178|FG004|Induction Phase|:ack of calculation|0|||
131767075|NCT02394028|474424179|FG005|Induction Phase|:ack of calculation|0|||
131767076|NCT02394028|474424180|FG006|Induction Phase|:ack of calculation|0|||
131767077|NCT02394028|474424181|FG007|Induction Phase|:ack of calculation|1|||
131767078|NCT02394028|474424182|FG008|Induction Phase|:ack of calculation|0|||
131767079|NCT02394028|474424183|FG009|Induction Phase|:ack of calculation|0|||
131767080|NCT02394028|474424184|FG010|Induction Phase|:ack of calculation|0|||
131767081|NCT02394028|474424174|FG000|Maintenance Phase|Protocol Violation|0|||
131767082|NCT02394028|474424175|FG001|Maintenance Phase|Protocol Violation|0|||
131767083|NCT02394028|474424176|FG002|Maintenance Phase|Protocol Violation|0|||
131767084|NCT02394028|474424177|FG003|Maintenance Phase|Protocol Violation|0|||
131767085|NCT02394028|474424178|FG004|Maintenance Phase|Protocol Violation|0|||
131767086|NCT02394028|474424179|FG005|Maintenance Phase|Protocol Violation|0|||
131767087|NCT02394028|474424180|FG006|Maintenance Phase|Protocol Violation|0|||
131767088|NCT02394028|474424181|FG007|Maintenance Phase|Protocol Violation|0|||
131767089|NCT02394028|474424182|FG008|Maintenance Phase|Protocol Violation|0|||
131767090|NCT02394028|474424183|FG009|Maintenance Phase|Protocol Violation|0|||
131449834|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
131767091|NCT02394028|474424184|FG010|Maintenance Phase|Protocol Violation|1|||
131767092|NCT02394028|474424174|FG000|Maintenance Phase|Physician Decision|0|||
131767093|NCT02394028|474424175|FG001|Maintenance Phase|Physician Decision|0|||
131767094|NCT02394028|474424176|FG002|Maintenance Phase|Physician Decision|0|||
131767095|NCT02394028|474424177|FG003|Maintenance Phase|Physician Decision|0|||
131767096|NCT02394028|474424178|FG004|Maintenance Phase|Physician Decision|0|||
131767097|NCT02394028|474424179|FG005|Maintenance Phase|Physician Decision|0|||
131400608|NCT00473668|473089544|FG002|Overall Study|Migrated/moved from study area|0|||
131400609|NCT00473668|473089542|FG000|Overall Study|Lost to Follow-up|0|||
131400610|NCT00473668|473089543|FG001|Overall Study|Lost to Follow-up|4|||
131400611|NCT00473668|473089544|FG002|Overall Study|Lost to Follow-up|6|||
131400612|NCT00473668|473089542|FG000|Overall Study|Other|2|||
131767098|NCT02394028|474424180|FG006|Maintenance Phase|Physician Decision|0|||
131767099|NCT02394028|474424181|FG007|Maintenance Phase|Physician Decision|0|||
131767100|NCT02394028|474424182|FG008|Maintenance Phase|Physician Decision|1|||
131767101|NCT02394028|474424183|FG009|Maintenance Phase|Physician Decision|3|||
131767102|NCT02394028|474424184|FG010|Maintenance Phase|Physician Decision|2|||
131767103|NCT02394028|474424174|FG000|Maintenance Phase|Lack of Efficacy|0|||
131767104|NCT02394028|474424175|FG001|Maintenance Phase|Lack of Efficacy|0|||
131767105|NCT02394028|474424176|FG002|Maintenance Phase|Lack of Efficacy|0|||
131767106|NCT02394028|474424177|FG003|Maintenance Phase|Lack of Efficacy|0|||
131767107|NCT02394028|474424178|FG004|Maintenance Phase|Lack of Efficacy|0|||
131767108|NCT02394028|474424179|FG005|Maintenance Phase|Lack of Efficacy|0|||
131767109|NCT02394028|474424180|FG006|Maintenance Phase|Lack of Efficacy|0|||
131767110|NCT02394028|474424181|FG007|Maintenance Phase|Lack of Efficacy|0|||
131767111|NCT02394028|474424182|FG008|Maintenance Phase|Lack of Efficacy|7|||
131767112|NCT02394028|474424183|FG009|Maintenance Phase|Lack of Efficacy|25|||
131767113|NCT02394028|474424184|FG010|Maintenance Phase|Lack of Efficacy|33|||
131767114|NCT02394028|474424174|FG000|Maintenance Phase|Death|0|||
131767115|NCT02394028|474424175|FG001|Maintenance Phase|Death|0|||
131767116|NCT02394028|474424176|FG002|Maintenance Phase|Death|0|||
131767117|NCT02394028|474424177|FG003|Maintenance Phase|Death|0|||
131767118|NCT02394028|474424178|FG004|Maintenance Phase|Death|0|||
131767119|NCT02394028|474424179|FG005|Maintenance Phase|Death|0|||
131767120|NCT02394028|474424180|FG006|Maintenance Phase|Death|0|||
131767121|NCT02394028|474424181|FG007|Maintenance Phase|Death|0|||
131767122|NCT02394028|474424182|FG008|Maintenance Phase|Death|0|||
131767123|NCT02394028|474424183|FG009|Maintenance Phase|Death|0|||
131767124|NCT02394028|474424184|FG010|Maintenance Phase|Death|1|||
131767125|NCT02394028|474424174|FG000|Maintenance Phase|Adverse Event|0|||
131767126|NCT02394028|474424175|FG001|Maintenance Phase|Adverse Event|0|||
131767127|NCT02394028|474424176|FG002|Maintenance Phase|Adverse Event|0|||
131767128|NCT02394028|474424177|FG003|Maintenance Phase|Adverse Event|0|||
131767129|NCT02394028|474424178|FG004|Maintenance Phase|Adverse Event|0|||
131767130|NCT02394028|474424179|FG005|Maintenance Phase|Adverse Event|0|||
131767131|NCT02394028|474424180|FG006|Maintenance Phase|Adverse Event|0|||
131767132|NCT02394028|474424181|FG007|Maintenance Phase|Adverse Event|0|||
131767133|NCT02394028|474424182|FG008|Maintenance Phase|Adverse Event|1|||
131767134|NCT02394028|474424183|FG009|Maintenance Phase|Adverse Event|1|||
131767135|NCT02394028|474424184|FG010|Maintenance Phase|Adverse Event|3|||
131767136|NCT02394028|474424174|FG000|Maintenance Phase|Site closure|0|||
131767137|NCT02394028|474424175|FG001|Maintenance Phase|Site closure|0|||
131767138|NCT02394028|474424176|FG002|Maintenance Phase|Site closure|0|||
131767139|NCT02394028|474424177|FG003|Maintenance Phase|Site closure|0|||
131767140|NCT02394028|474424178|FG004|Maintenance Phase|Site closure|0|||
131767141|NCT02394028|474424179|FG005|Maintenance Phase|Site closure|0|||
131767142|NCT02394028|474424180|FG006|Maintenance Phase|Site closure|0|||
131767143|NCT02394028|474424181|FG007|Maintenance Phase|Site closure|0|||
131767144|NCT02394028|474424182|FG008|Maintenance Phase|Site closure|0|||
131767145|NCT02394028|474424183|FG009|Maintenance Phase|Site closure|1|||
131767146|NCT02394028|474424184|FG010|Maintenance Phase|Site closure|0|||
131767147|NCT02394028|474424174|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131767148|NCT02394028|474424175|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131767149|NCT02394028|474424176|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131767150|NCT02394028|474424177|FG003|Maintenance Phase|Withdrawal by Subject|0|||
131400613|NCT00473668|473089543|FG001|Overall Study|Other|3|||
131767151|NCT02394028|474424178|FG004|Maintenance Phase|Withdrawal by Subject|0|||
131400614|NCT00473668|473089544|FG002|Overall Study|Other|4|||
131400615|NCT02226562|473089545|FG000|Overall Study|Lost to Follow-up|0|||
131400616|NCT02226562|473089546|FG001|Overall Study|Lost to Follow-up|1|||
131767152|NCT02394028|474424179|FG005|Maintenance Phase|Withdrawal by Subject|0|||
131767153|NCT02394028|474424180|FG006|Maintenance Phase|Withdrawal by Subject|0|||
131767154|NCT02394028|474424181|FG007|Maintenance Phase|Withdrawal by Subject|0|||
131767155|NCT02394028|474424182|FG008|Maintenance Phase|Withdrawal by Subject|3|||
131767156|NCT02394028|474424183|FG009|Maintenance Phase|Withdrawal by Subject|12|||
131400617|NCT06004895|473089547|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
131767157|NCT02394028|474424184|FG010|Maintenance Phase|Withdrawal by Subject|12|||
131767158|NCT01775995|474424185|FG000|Overall Study|Lost to Follow-up|1|||
131767159|NCT01775995|474424186|FG001|Overall Study|Lost to Follow-up|1|||
131767160|NCT00440232|474424187|FG000|Overall Study|Lost to Follow-up|1|||
131767161|NCT00440232|474424188|FG001|Overall Study|Lost to Follow-up|1|||
131767162|NCT00440232|474424187|FG000|Overall Study|Unable to treat within allowed time|0|||
131767163|NCT00440232|474424188|FG001|Overall Study|Unable to treat within allowed time|1|||
131433997|NCT04276233|473214590|FG000|Overall Study|Withdrawal by Subject|2|||
131433998|NCT00985465|473214593|FG000|Overall Study|Withdrawal by Subject|1|||
131433999|NCT00985465|473214594|FG001|Overall Study|Withdrawal by Subject|2|||
131400618|NCT06004895|473089547|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
131400619|NCT00967694|473089548|FG000|Overall Study|Withdrawal by Subject|6|||
131400620|NCT00695955|473089551|FG000|Cohort 1|Adverse Event|26|||
131400621|NCT00695955|473089551|FG000|Cohort 1|Protocol Violation|2|||
131400622|NCT00695955|473089551|FG000|Cohort 1|Lost to Follow-up|30|||
131400623|NCT00695955|473089551|FG000|Cohort 1|Withdrawal by Subject|25|||
131767164|NCT00440232|474424187|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
131767165|NCT00440232|474424188|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
131767166|NCT00426842|474424189|FG000|Overall Study|Lost to Follow-up|1|||
131767167|NCT01277666|474424192|FG000|Overall Study|Adverse Event|26|||
131767168|NCT01277666|474424193|FG001|Overall Study|Adverse Event|25|||
131767169|NCT01277666|474424194|FG002|Overall Study|Adverse Event|20|||
131767170|NCT01277666|474424192|FG000|Overall Study|Lack of Efficacy|8|||
131767171|NCT01277666|474424193|FG001|Overall Study|Lack of Efficacy|20|||
131767172|NCT01277666|474424194|FG002|Overall Study|Lack of Efficacy|12|||
131767173|NCT01277666|474424192|FG000|Overall Study|Protocol Violation|2|||
131767174|NCT01277666|474424193|FG001|Overall Study|Protocol Violation|3|||
131767175|NCT01277666|474424194|FG002|Overall Study|Protocol Violation|2|||
131767176|NCT01277666|474424192|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
131767177|NCT01277666|474424193|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
131767178|NCT01277666|474424194|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
131767179|NCT01277666|474424192|FG000|Overall Study|Lost to Follow-up|1|||
131767180|NCT01277666|474424193|FG001|Overall Study|Lost to Follow-up|1|||
131767181|NCT01277666|474424194|FG002|Overall Study|Lost to Follow-up|2|||
131767182|NCT01277666|474424192|FG000|Overall Study|Withdrawal by Subject|7|||
131767183|NCT01277666|474424193|FG001|Overall Study|Withdrawal by Subject|8|||
131767184|NCT01277666|474424194|FG002|Overall Study|Withdrawal by Subject|6|||
131767185|NCT01277666|474424192|FG000|Overall Study|Death|0|||
131767186|NCT01277666|474424193|FG001|Overall Study|Death|0|||
131767187|NCT01277666|474424194|FG002|Overall Study|Death|1|||
131767188|NCT02918006|474424205|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
131767189|NCT02918006|474424206|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
131767190|NCT02918006|474424207|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
131767191|NCT02918006|474424205|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
131767192|NCT02918006|474424206|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
131767193|NCT02918006|474424207|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
131767194|NCT02918006|474424205|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
131767195|NCT02918006|474424206|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
131767196|NCT02918006|474424207|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
131767197|NCT02918006|474424205|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
131767198|NCT02918006|474424206|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
131767199|NCT02918006|474424207|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
131767200|NCT02918006|474424205|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
131767201|NCT02918006|474424206|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
131767202|NCT02918006|474424207|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
131767203|NCT02918006|474424205|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
131767204|NCT02918006|474424206|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
131767205|NCT02918006|474424207|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
131767206|NCT02918006|474424205|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
131767207|NCT02918006|474424206|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
131767208|NCT02918006|474424207|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
131767209|NCT02918006|474424205|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
131767210|NCT02918006|474424206|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
131767211|NCT02918006|474424207|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
131767212|NCT02918006|474424205|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
131767213|NCT02918006|474424206|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
131767214|NCT02918006|474424207|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
131767215|NCT02475564|474424211|FG000|Overall Study|Withdrawal by Subject|1|||
131767216|NCT02475564|474424212|FG001|Overall Study|Withdrawal by Subject|0|||
131767217|NCT02475564|474424211|FG000|Overall Study|Lost to Follow-up|2|||
131767218|NCT02475564|474424212|FG001|Overall Study|Lost to Follow-up|1|||
131767219|NCT02475564|474424211|FG000|Overall Study|Intense Menstrual bleeding|1|||
131767220|NCT02475564|474424212|FG001|Overall Study|Intense Menstrual bleeding|0|||
131767221|NCT01156012|474424213|FG000|Overall Study|Adverse Event|3|||
131767222|NCT01156012|474424214|FG001|Overall Study|Adverse Event|1|||
131767223|NCT01156012|474424213|FG000|Overall Study|Lost to Follow-up|1|||
131767224|NCT01156012|474424214|FG001|Overall Study|Lost to Follow-up|0|||
131767225|NCT01156012|474424213|FG000|Overall Study|Withdrawal by Subject|1|||
131767226|NCT01156012|474424214|FG001|Overall Study|Withdrawal by Subject|0|||
131767227|NCT01156012|474424213|FG000|Overall Study|use of commercial drug instead of study|0|||
131767228|NCT01156012|474424214|FG001|Overall Study|use of commercial drug instead of study|1|||
131767229|NCT01156012|474424213|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
131767230|NCT01156012|474424214|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
131814411|NCT03599193|474604438|FG000|Overall Study|Protocol Violation|1|||
131814412|NCT03599193|474604439|FG001|Overall Study|Protocol Violation|0|||
131814413|NCT03599193|474604438|FG000|Overall Study|Lost to Follow-up|0|||
131814414|NCT03599193|474604439|FG001|Overall Study|Lost to Follow-up|1|||
131814415|NCT00835705|474604440|FG000|First Intervention|Difficulty with vein|1|||
131814416|NCT00835705|474604441|FG001|First Intervention|Difficulty with vein|0|||
131814417|NCT00835705|474604440|FG000|Second Intervention|Difficulty with vein|1|||
131814418|NCT00835705|474604441|FG001|Second Intervention|Difficulty with vein|0|||
131814419|NCT01750294|474604442|FG000|Overall Study|Withdrawal by Subject|1|||
131814420|NCT01750294|474604442|FG000|Overall Study|Safety Endpoint|1|||
131814421|NCT00665925|474604443|FG000|Overall Study|Lack of Efficacy|10|||
131814422|NCT00665925|474604444|FG001|Overall Study|Lack of Efficacy|8|||
131814423|NCT00665925|474604445|FG002|Overall Study|Lack of Efficacy|9|||
131814424|NCT00665925|474604446|FG003|Overall Study|Lack of Efficacy|8|||
131909676|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
131909677|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
131909678|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
131909679|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
131909680|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
131909681|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
131909682|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
131767231|NCT02705755|474424216|FG000|Part A (6 Days)|Adverse Event|1|||
131767232|NCT02705755|474424217|FG001|Part A (6 Days)|Adverse Event|0|||
131767233|NCT02705755|474424218|FG002|Part A (6 Days)|Adverse Event|0|||
131767234|NCT02705755|474424219|FG003|Part A (6 Days)|Adverse Event|0|||
131767235|NCT02705755|474424216|FG000|Part A (6 Days)|Physician Decision|3|||
131767236|NCT02705755|474424217|FG001|Part A (6 Days)|Physician Decision|0|||
131767237|NCT02705755|474424218|FG002|Part A (6 Days)|Physician Decision|0|||
131767238|NCT02705755|474424219|FG003|Part A (6 Days)|Physician Decision|0|||
131767239|NCT02705755|474424216|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
131767240|NCT02705755|474424217|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
131767241|NCT02705755|474424218|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
131767242|NCT02705755|474424219|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
131767243|NCT02705755|474424216|FG000|Part C (20 Weeks)|Physician Decision|0|||
131767244|NCT02705755|474424217|FG001|Part C (20 Weeks)|Physician Decision|0|||
131767245|NCT02705755|474424218|FG002|Part C (20 Weeks)|Physician Decision|0|||
131767246|NCT02705755|474424219|FG003|Part C (20 Weeks)|Physician Decision|2|||
131767247|NCT02705755|474424216|FG000|Part C (20 Weeks)|Adverse Event|0|||
131767248|NCT02705755|474424217|FG001|Part C (20 Weeks)|Adverse Event|0|||
131767249|NCT02705755|474424218|FG002|Part C (20 Weeks)|Adverse Event|0|||
131767250|NCT02705755|474424219|FG003|Part C (20 Weeks)|Adverse Event|6|||
131767251|NCT02705755|474424216|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
131767252|NCT02705755|474424217|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
131767253|NCT02705755|474424218|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
131767254|NCT02705755|474424219|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
131767255|NCT01345162|474426104|FG000|Overall Study|Protocol Violation|2|||
131767256|NCT01345162|474426105|FG001|Overall Study|Protocol Violation|4|||
131767257|NCT00508872|474426106|FG000|Overall Study|Lost to Follow-up|1|||
131767258|NCT00508872|474426106|FG000|Overall Study|Physician Decision|1|||
131767259|NCT01871870|474426107|FG000|Overall Study|Hardware issues|7|||
131767260|NCT01871870|474426107|FG000|Overall Study|hyperglycemia|2|||
131767261|NCT03007472|474426109|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
131767262|NCT03007472|474426109|FG000|Overall Study|Death|2|||
131767263|NCT03007472|474426109|FG000|Overall Study|Loss to Follow Up|1|||
131767264|NCT00883896|474426110|FG000|Overall Study|Lost to Follow-up|0|||
131767265|NCT00883896|474426111|FG001|Overall Study|Lost to Follow-up|0|||
131767266|NCT00883896|474426112|FG002|Overall Study|Lost to Follow-up|0|||
131767267|NCT00883896|474426113|FG003|Overall Study|Lost to Follow-up|2|||
131767268|NCT00883896|474426110|FG000|Overall Study|Withdrawal by Subject|5|||
131909683|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
131767269|NCT00883896|474426111|FG001|Overall Study|Withdrawal by Subject|0|||
131767270|NCT00883896|474426112|FG002|Overall Study|Withdrawal by Subject|1|||
131767271|NCT00883896|474426113|FG003|Overall Study|Withdrawal by Subject|3|||
131767272|NCT00883896|474426110|FG000|Overall Study|Lack of Efficacy|0|||
131767273|NCT00883896|474426111|FG001|Overall Study|Lack of Efficacy|0|||
131767274|NCT00883896|474426112|FG002|Overall Study|Lack of Efficacy|0|||
131767275|NCT00883896|474426113|FG003|Overall Study|Lack of Efficacy|2|||
131767276|NCT00883896|474426110|FG000|Overall Study|Other|1|||
131767277|NCT00883896|474426111|FG001|Overall Study|Other|0|||
131767278|NCT00883896|474426112|FG002|Overall Study|Other|0|||
131767279|NCT00883896|474426113|FG003|Overall Study|Other|0|||
131767280|NCT01716585|474426124|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
131814425|NCT00665925|474604443|FG000|Overall Study|Lost to Follow-up|1|||
131814426|NCT00665925|474604444|FG001|Overall Study|Lost to Follow-up|2|||
131814427|NCT00665925|474604445|FG002|Overall Study|Lost to Follow-up|2|||
131814428|NCT00665925|474604446|FG003|Overall Study|Lost to Follow-up|2|||
131767281|NCT01716585|474426125|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
131767282|NCT01716585|474426124|FG000|Double-blind Treatment|Adverse Event|2|||
131767283|NCT01716585|474426125|FG001|Double-blind Treatment|Adverse Event|1|||
131767284|NCT01716585|474426124|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
131767285|NCT01716585|474426125|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
131767286|NCT01716585|474426124|FG000|Double-blind Treatment|Lost to Follow-up|2|||
131767287|NCT01716585|474426125|FG001|Double-blind Treatment|Lost to Follow-up|0|||
131767288|NCT01716585|474426124|FG000|Double-blind Treatment|Subject Noncompliant|1|||
131767289|NCT01716585|474426125|FG001|Double-blind Treatment|Subject Noncompliant|0|||
131767290|NCT01716585|474426124|FG000|Double-blind Treatment|Other|1|||
131767291|NCT01716585|474426125|FG001|Double-blind Treatment|Other|0|||
131767292|NCT01716585|474426124|FG000|Open-label Treatment|Adverse Event|0|||
131767293|NCT01716585|474426125|FG001|Open-label Treatment|Adverse Event|2|||
131767294|NCT01716585|474426124|FG000|Open-label Treatment|Virologic Failure|0|||
131767295|NCT01716585|474426125|FG001|Open-label Treatment|Virologic Failure|2|||
131767296|NCT01716585|474426124|FG000|Open-label Treatment|Withdrawal by Subject|0|||
131767297|NCT01716585|474426125|FG001|Open-label Treatment|Withdrawal by Subject|3|||
131767298|NCT03672006|474426126|FG000|Overall Study|exclusion criteria met|0|||
131767299|NCT03672006|474426127|FG001|Overall Study|exclusion criteria met|1|||
131767300|NCT01453439|474426128|FG000|Treatment Phase|Withdrawal by Subject|13|||
131767301|NCT01453439|474426129|FG001|Treatment Phase|Withdrawal by Subject|10|||
131767302|NCT01453439|474426128|FG000|Treatment Phase|Suicidal Ideation|2|||
131767303|NCT01453439|474426129|FG001|Treatment Phase|Suicidal Ideation|0|||
131767304|NCT01453439|474426128|FG000|Treatment Phase|Need for higher level of care|1|||
131767305|NCT01453439|474426129|FG001|Treatment Phase|Need for higher level of care|1|||
131767306|NCT01453439|474426128|FG000|Treatment Phase|Therapist conflict of interest|1|||
131767307|NCT01453439|474426129|FG001|Treatment Phase|Therapist conflict of interest|0|||
131767308|NCT01453439|474426128|FG000|Follow-up|Withdrawal by Subject|0|||
131767309|NCT01453439|474426129|FG001|Follow-up|Withdrawal by Subject|1|||
131767310|NCT01453439|474426128|FG000|Follow-up|Lost to Follow-up|5|||
131767311|NCT01453439|474426129|FG001|Follow-up|Lost to Follow-up|10|||
131767312|NCT01014442|474426130|FG000|Overall Study|Adverse Event|0|||
131767313|NCT01014442|474426131|FG001|Overall Study|Adverse Event|8|||
131767314|NCT01014442|474426130|FG000|Overall Study|Withdrawal by Subject|4|||
131767315|NCT01014442|474426131|FG001|Overall Study|Withdrawal by Subject|4|||
131767316|NCT01014442|474426130|FG000|Overall Study|Protocol Violation|2|||
131767317|NCT01014442|474426131|FG001|Overall Study|Protocol Violation|5|||
131767318|NCT01014442|474426130|FG000|Overall Study|Lack of Compliance|0|||
131767319|NCT01014442|474426131|FG001|Overall Study|Lack of Compliance|1|||
131767320|NCT01014442|474426130|FG000|Overall Study|Unspecified Reason|1|||
131767321|NCT01014442|474426131|FG001|Overall Study|Unspecified Reason|1|||
131767322|NCT02135848|474426139|FG000|Overall Study|Adverse Event|2|||
131767323|NCT02135848|474426140|FG001|Overall Study|Adverse Event|0|||
131767324|NCT02135848|474426139|FG000|Overall Study|Withdrawal by Subject|1|||
131767325|NCT02135848|474426140|FG001|Overall Study|Withdrawal by Subject|1|||
131767326|NCT00089505|474426141|FG000|Overall Study|Death|4|||
131767327|NCT00089505|474426142|FG001|Overall Study|Death|1|||
131767328|NCT00089505|474426143|FG002|Overall Study|Death|5|||
131767329|NCT00089505|474426144|FG003|Overall Study|Death|8|||
131767330|NCT00089505|474426141|FG000|Overall Study|Withdrawal by Subject|3|||
131767331|NCT00089505|474426142|FG001|Overall Study|Withdrawal by Subject|0|||
131767332|NCT00089505|474426143|FG002|Overall Study|Withdrawal by Subject|6|||
131767333|NCT00089505|474426144|FG003|Overall Study|Withdrawal by Subject|6|||
131767334|NCT00089505|474426141|FG000|Overall Study|Lost to Follow-up|1|||
131767335|NCT00089505|474426142|FG001|Overall Study|Lost to Follow-up|1|||
131767336|NCT00089505|474426143|FG002|Overall Study|Lost to Follow-up|9|||
131767337|NCT00089505|474426144|FG003|Overall Study|Lost to Follow-up|7|||
131767338|NCT00089505|474426141|FG000|Overall Study|Physician Decision|1|||
131767339|NCT00089505|474426142|FG001|Overall Study|Physician Decision|0|||
131767340|NCT00089505|474426143|FG002|Overall Study|Physician Decision|0|||
131767341|NCT00089505|474426144|FG003|Overall Study|Physician Decision|0|||
131767342|NCT00089505|474426141|FG000|Overall Study|Protocol Violation|0|||
131767343|NCT00089505|474426142|FG001|Overall Study|Protocol Violation|0|||
131767344|NCT00089505|474426143|FG002|Overall Study|Protocol Violation|1|||
131767345|NCT00089505|474426144|FG003|Overall Study|Protocol Violation|0|||
131767346|NCT01284127|474426146|FG000|Overall Study|Adverse Event|2|||
131767347|NCT01284127|474426146|FG000|Overall Study|Withdrawal by Subject|4|||
131767348|NCT01284127|474426146|FG000|Overall Study|Physician Decision|1|||
131767349|NCT04212221|474426151|FG000|Overall Study|Remained on Treatment|0|||
131767350|NCT04212221|474426152|FG001|Overall Study|Remained on Treatment|0|||
131767351|NCT04212221|474426153|FG002|Overall Study|Remained on Treatment|0|||
131767352|NCT04212221|474426154|FG003|Overall Study|Remained on Treatment|1|||
131767353|NCT04212221|474426155|FG004|Overall Study|Remained on Treatment|0|||
131767354|NCT04212221|474426156|FG005|Overall Study|Remained on Treatment|0|||
131767355|NCT04212221|474426157|FG006|Overall Study|Remained on Treatment|3|||
131767356|NCT04212221|474426158|FG007|Overall Study|Remained on Treatment|9|||
131767357|NCT04212221|474426151|FG000|Overall Study|Adverse Event|0|||
131767358|NCT04212221|474426152|FG001|Overall Study|Adverse Event|0|||
131767359|NCT04212221|474426153|FG002|Overall Study|Adverse Event|0|||
131767360|NCT04212221|474426154|FG003|Overall Study|Adverse Event|0|||
131767361|NCT04212221|474426155|FG004|Overall Study|Adverse Event|0|||
131767362|NCT04212221|474426156|FG005|Overall Study|Adverse Event|0|||
131767363|NCT04212221|474426157|FG006|Overall Study|Adverse Event|2|||
131767364|NCT04212221|474426158|FG007|Overall Study|Adverse Event|3|||
131767365|NCT04212221|474426151|FG000|Overall Study|Death|0|||
131767366|NCT04212221|474426152|FG001|Overall Study|Death|0|||
131767367|NCT04212221|474426153|FG002|Overall Study|Death|0|||
131767368|NCT04212221|474426154|FG003|Overall Study|Death|0|||
131767369|NCT04212221|474426155|FG004|Overall Study|Death|0|||
131767370|NCT04212221|474426156|FG005|Overall Study|Death|0|||
131767371|NCT04212221|474426157|FG006|Overall Study|Death|0|||
131767372|NCT04212221|474426158|FG007|Overall Study|Death|2|||
131767373|NCT04212221|474426151|FG000|Overall Study|Disease progression according to irRECIST|1|||
131767374|NCT04212221|474426152|FG001|Overall Study|Disease progression according to irRECIST|2|||
131767375|NCT04212221|474426153|FG002|Overall Study|Disease progression according to irRECIST|3|||
131767376|NCT04212221|474426154|FG003|Overall Study|Disease progression according to irRECIST|3|||
131767377|NCT04212221|474426155|FG004|Overall Study|Disease progression according to irRECIST|2|||
131767378|NCT04212221|474426156|FG005|Overall Study|Disease progression according to irRECIST|2|||
131767379|NCT04212221|474426157|FG006|Overall Study|Disease progression according to irRECIST|21|||
131767380|NCT04212221|474426158|FG007|Overall Study|Disease progression according to irRECIST|17|||
131767381|NCT04212221|474426151|FG000|Overall Study|Global Deterioration of Health Status|0|||
131767382|NCT04212221|474426152|FG001|Overall Study|Global Deterioration of Health Status|0|||
131767383|NCT04212221|474426153|FG002|Overall Study|Global Deterioration of Health Status|0|||
131767384|NCT04212221|474426154|FG003|Overall Study|Global Deterioration of Health Status|0|||
131767385|NCT04212221|474426155|FG004|Overall Study|Global Deterioration of Health Status|0|||
131767386|NCT04212221|474426156|FG005|Overall Study|Global Deterioration of Health Status|0|||
131767387|NCT04212221|474426157|FG006|Overall Study|Global Deterioration of Health Status|0|||
131767388|NCT04212221|474426158|FG007|Overall Study|Global Deterioration of Health Status|2|||
131767389|NCT04212221|474426151|FG000|Overall Study|Investigator's Decision|0|||
131767390|NCT04212221|474426152|FG001|Overall Study|Investigator's Decision|0|||
131767391|NCT04212221|474426153|FG002|Overall Study|Investigator's Decision|0|||
131767392|NCT04212221|474426154|FG003|Overall Study|Investigator's Decision|1|||
131767393|NCT04212221|474426155|FG004|Overall Study|Investigator's Decision|0|||
131767394|NCT04212221|474426156|FG005|Overall Study|Investigator's Decision|0|||
131767395|NCT04212221|474426157|FG006|Overall Study|Investigator's Decision|3|||
131767396|NCT04212221|474426158|FG007|Overall Study|Investigator's Decision|0|||
131767397|NCT04212221|474426151|FG000|Overall Study|Participant refused to continue treatment|0|||
131767398|NCT04212221|474426152|FG001|Overall Study|Participant refused to continue treatment|1|||
131767399|NCT04212221|474426153|FG002|Overall Study|Participant refused to continue treatment|0|||
131767400|NCT04212221|474426154|FG003|Overall Study|Participant refused to continue treatment|1|||
131767401|NCT04212221|474426155|FG004|Overall Study|Participant refused to continue treatment|1|||
131767402|NCT04212221|474426156|FG005|Overall Study|Participant refused to continue treatment|2|||
131767403|NCT04212221|474426157|FG006|Overall Study|Participant refused to continue treatment|4|||
131767404|NCT04212221|474426158|FG007|Overall Study|Participant refused to continue treatment|2|||
131767405|NCT04212221|474426151|FG000|Overall Study|Protocol Violation|0|||
131814429|NCT00665925|474604443|FG000|Overall Study|Withdrawal by Subject|2|||
131814430|NCT00665925|474604444|FG001|Overall Study|Withdrawal by Subject|2|||
131814431|NCT00665925|474604445|FG002|Overall Study|Withdrawal by Subject|3|||
131814432|NCT00665925|474604446|FG003|Overall Study|Withdrawal by Subject|2|||
131814433|NCT00665925|474604443|FG000|Overall Study|Physician Decision|0|||
131814434|NCT00665925|474604444|FG001|Overall Study|Physician Decision|0|||
131814435|NCT00665925|474604445|FG002|Overall Study|Physician Decision|1|||
131814436|NCT00665925|474604446|FG003|Overall Study|Physician Decision|2|||
131814437|NCT00665925|474604443|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
131814438|NCT00665925|474604444|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
131814439|NCT00665925|474604445|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
131767406|NCT04212221|474426152|FG001|Overall Study|Protocol Violation|0|||
131767407|NCT04212221|474426153|FG002|Overall Study|Protocol Violation|0|||
131767408|NCT04212221|474426154|FG003|Overall Study|Protocol Violation|0|||
131767409|NCT04212221|474426155|FG004|Overall Study|Protocol Violation|0|||
131767410|NCT04212221|474426156|FG005|Overall Study|Protocol Violation|0|||
131767411|NCT04212221|474426157|FG006|Overall Study|Protocol Violation|0|||
131767412|NCT04212221|474426158|FG007|Overall Study|Protocol Violation|1|||
131767413|NCT01646255|474426164|FG000|Overall Study|Adverse Event|7|||
131767414|NCT01646255|474426165|FG001|Overall Study|Adverse Event|8|||
131767415|NCT01646255|474426164|FG000|Overall Study|Lack of Efficacy|2|||
131767416|NCT01646255|474426165|FG001|Overall Study|Lack of Efficacy|0|||
131767417|NCT01646255|474426164|FG000|Overall Study|Withdrawal by Subject|10|||
131767418|NCT01646255|474426165|FG001|Overall Study|Withdrawal by Subject|6|||
131814440|NCT00665925|474604446|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
131814441|NCT00665925|474604443|FG000|Overall Study|Adverse Event|1|||
131767419|NCT01646255|474426164|FG000|Overall Study|Compliance is not well|1|||
131767420|NCT01646255|474426165|FG001|Overall Study|Compliance is not well|0|||
131767421|NCT01646255|474426164|FG000|Overall Study|Inclusion Criteria Deviation|1|||
131767422|NCT01646255|474426165|FG001|Overall Study|Inclusion Criteria Deviation|0|||
131767423|NCT02142712|474426166|FG000|Overall Study|Lost to Follow-up|1|||
131767424|NCT02142712|474426167|FG001|Overall Study|Lost to Follow-up|1|||
131767425|NCT02142712|474426168|FG002|Overall Study|Lost to Follow-up|1|||
131767426|NCT02142712|474426169|FG003|Overall Study|Lost to Follow-up|0|||
131767427|NCT03480841|474426172|FG000|Overall Study|Lost to Follow-up|2|||
131767428|NCT02380703|474426173|FG000|Overall Study|Withdrawal by Subject|12|||
131767429|NCT02380703|474426174|FG001|Overall Study|Withdrawal by Subject|9|||
131767430|NCT02380703|474426173|FG000|Overall Study|Lost to Follow-up|12|||
131767431|NCT02380703|474426174|FG001|Overall Study|Lost to Follow-up|12|||
131767432|NCT02380703|474426173|FG000|Overall Study|Caregiver death|1|||
131767433|NCT02380703|474426174|FG001|Overall Study|Caregiver death|0|||
131767434|NCT02380703|474426173|FG000|Overall Study|Person with dementia (PWD) death|7|||
131767435|NCT02380703|474426174|FG001|Overall Study|Person with dementia (PWD) death|8|||
131767436|NCT02380703|474426173|FG000|Overall Study|Entered Long-term Care|4|||
131767437|NCT02380703|474426174|FG001|Overall Study|Entered Long-term Care|7|||
131767438|NCT01362049|474426175|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
131767439|NCT01362049|474426176|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
131767440|NCT01362049|474426177|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
131767441|NCT01362049|474426178|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
131767442|NCT01362049|474426175|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
131767443|NCT01362049|474426176|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
131767444|NCT01362049|474426177|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
131767445|NCT01362049|474426178|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
131767446|NCT03607994|474426179|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
131767447|NCT03607994|474426180|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
131767448|NCT02850276|474426185|FG000|Overall Study|screen failure|43|||
131767449|NCT02850276|474426185|FG000|Overall Study|Withdrawal by Subject|14|||
131767450|NCT02850276|474426185|FG000|Overall Study|Physician Decision|2|||
131767451|NCT02850276|474426185|FG000|Overall Study|Lost to Follow-up|2|||
131767452|NCT02853318|474426189|FG000|Overall Study|Withdrawal by Subject|1|||
131767453|NCT00252499|474426190|FG000|Overall Study|Lost to Follow-up|1|||
131767454|NCT00252499|474426191|FG001|Overall Study|Lost to Follow-up|0|||
131767455|NCT00252499|474426192|FG002|Overall Study|Lost to Follow-up|0|||
131767456|NCT01882439|474426200|FG000|Overall Study|Adverse event related to study drug|3|||
131767457|NCT01882439|474426201|FG001|Overall Study|Adverse event related to study drug|8|||
131767458|NCT01882439|474426202|FG002|Overall Study|Adverse event related to study drug|1|||
131767459|NCT01882439|474426203|FG003|Overall Study|Adverse event related to study drug|2|||
131767460|NCT01882439|474426200|FG000|Overall Study|Pregnancy|0|||
131767461|NCT01882439|474426201|FG001|Overall Study|Pregnancy|1|||
131767462|NCT01882439|474426202|FG002|Overall Study|Pregnancy|0|||
131767463|NCT01882439|474426203|FG003|Overall Study|Pregnancy|0|||
131767464|NCT01882439|474426200|FG000|Overall Study|Protocol Violation|2|||
131767465|NCT01882439|474426201|FG001|Overall Study|Protocol Violation|2|||
131767466|NCT01882439|474426202|FG002|Overall Study|Protocol Violation|0|||
131767467|NCT01882439|474426203|FG003|Overall Study|Protocol Violation|1|||
131767468|NCT01882439|474426200|FG000|Overall Study|No longer willing to participate|1|||
131767469|NCT01882439|474426201|FG001|Overall Study|No longer willing to participate|4|||
131767470|NCT01882439|474426202|FG002|Overall Study|No longer willing to participate|2|||
131767471|NCT01882439|474426203|FG003|Overall Study|No longer willing to participate|3|||
131767472|NCT01882439|474426200|FG000|Overall Study|Medication error with no associated AE|0|||
131767473|NCT01882439|474426201|FG001|Overall Study|Medication error with no associated AE|0|||
131767474|NCT01882439|474426202|FG002|Overall Study|Medication error with no associated AE|2|||
131767475|NCT01882439|474426203|FG003|Overall Study|Medication error with no associated AE|0|||
131767476|NCT01882439|474426200|FG000|Overall Study|Insufficient clinical response|1|||
131814442|NCT00665925|474604444|FG001|Overall Study|Adverse Event|5|||
131767477|NCT01882439|474426201|FG001|Overall Study|Insufficient clinical response|4|||
131767478|NCT01882439|474426202|FG002|Overall Study|Insufficient clinical response|4|||
131767479|NCT01882439|474426203|FG003|Overall Study|Insufficient clinical response|2|||
131767480|NCT01882439|474426200|FG000|Overall Study|Adverse event unrelated to study drug|2|||
131767481|NCT01882439|474426201|FG001|Overall Study|Adverse event unrelated to study drug|2|||
131767482|NCT01882439|474426202|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131767483|NCT01882439|474426203|FG003|Overall Study|Adverse event unrelated to study drug|1|||
131767484|NCT01997333|474426206|FG000|Randomization and Treatment|Disease Progression|70|||
131767485|NCT01997333|474426207|FG001|Randomization and Treatment|Disease Progression|159|||
131767486|NCT01997333|474426206|FG000|Randomization and Treatment|Adverse Event|10|||
131767487|NCT01997333|474426207|FG001|Randomization and Treatment|Adverse Event|32|||
131767488|NCT01997333|474426206|FG000|Randomization and Treatment|Physician Decision|0|||
131767489|NCT01997333|474426207|FG001|Randomization and Treatment|Physician Decision|4|||
131814443|NCT00665925|474604445|FG002|Overall Study|Adverse Event|10|||
131814444|NCT00665925|474604446|FG003|Overall Study|Adverse Event|5|||
131814445|NCT00665925|474604443|FG000|Overall Study|Enrolled by mistake|0|||
131814446|NCT00665925|474604444|FG001|Overall Study|Enrolled by mistake|0|||
131814447|NCT00665925|474604445|FG002|Overall Study|Enrolled by mistake|0|||
131814448|NCT00665925|474604446|FG003|Overall Study|Enrolled by mistake|1|||
131767490|NCT01997333|474426206|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
131767491|NCT01997333|474426207|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
131767492|NCT01997333|474426206|FG000|Randomization and Treatment|Did not receive treatment|17|||
131767493|NCT01997333|474426207|FG001|Randomization and Treatment|Did not receive treatment|5|||
131767494|NCT01997333|474426206|FG000|Survival Follow up|Withdrawal by Subject|15|||
131767495|NCT01997333|474426207|FG001|Survival Follow up|Withdrawal by Subject|6|||
131767496|NCT01997333|474426206|FG000|Survival Follow up|Lost to Follow-up|0|||
131767497|NCT01997333|474426207|FG001|Survival Follow up|Lost to Follow-up|6|||
131767498|NCT01997333|474426206|FG000|Survival Follow up|Various|1|||
131767499|NCT01997333|474426207|FG001|Survival Follow up|Various|2|||
131767500|NCT02269709|474426208|FG000|Time of Enrollment|Withdrawal by Subject|3|||
131767501|NCT02269709|474426208|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
131767502|NCT02269709|474426208|FG000|Six Month Follow-up|Lost to Follow-up|12|||
131767503|NCT02909504|474426209|FG000|Overall Study|Adverse Event|2|||
131767504|NCT02909504|474426209|FG000|Overall Study|Lack of Efficacy|3|||
131767505|NCT02909504|474426209|FG000|Overall Study|Withdrawal by Subject|4|||
131767506|NCT02909504|474426209|FG000|Overall Study|Pregnancy|1|||
131767507|NCT02909504|474426209|FG000|Overall Study|Subject moved|1|||
131767508|NCT02909504|474426209|FG000|Overall Study|Lost to Follow-up|1|||
131767509|NCT04411472|474426212|FG000|Overall Study|Adverse Event|5|||
131767510|NCT04411472|474426213|FG001|Overall Study|Adverse Event|10|||
131767511|NCT04411472|474426214|FG002|Overall Study|Adverse Event|1|||
131767512|NCT04411472|474426215|FG003|Overall Study|Adverse Event|0|||
131767513|NCT04411472|474426216|FG004|Overall Study|Adverse Event|0|||
131767514|NCT04411472|474426217|FG005|Overall Study|Adverse Event|0|||
131767515|NCT04411472|474426212|FG000|Overall Study|Protocol Violation|1|||
131767516|NCT04411472|474426213|FG001|Overall Study|Protocol Violation|0|||
131767517|NCT04411472|474426214|FG002|Overall Study|Protocol Violation|0|||
131767518|NCT04411472|474426215|FG003|Overall Study|Protocol Violation|0|||
131767519|NCT04411472|474426216|FG004|Overall Study|Protocol Violation|0|||
131767520|NCT04411472|474426217|FG005|Overall Study|Protocol Violation|0|||
131767521|NCT04411472|474426212|FG000|Overall Study|Withdrawal by Subject|0|||
131767522|NCT04411472|474426213|FG001|Overall Study|Withdrawal by Subject|1|||
131767523|NCT04411472|474426214|FG002|Overall Study|Withdrawal by Subject|0|||
131767524|NCT04411472|474426215|FG003|Overall Study|Withdrawal by Subject|1|||
131767525|NCT04411472|474426216|FG004|Overall Study|Withdrawal by Subject|0|||
131767526|NCT04411472|474426217|FG005|Overall Study|Withdrawal by Subject|0|||
131814449|NCT00665925|474604443|FG000|Overall Study|Due to exclusion criteria|1|||
131814450|NCT00665925|474604444|FG001|Overall Study|Due to exclusion criteria|0|||
131814451|NCT00665925|474604445|FG002|Overall Study|Due to exclusion criteria|0|||
131814452|NCT00665925|474604446|FG003|Overall Study|Due to exclusion criteria|0|||
131814453|NCT04035187|474604449|FG000|Overall Study|Withdrawal by Subject|2|||
131814454|NCT04035187|474604450|FG001|Overall Study|Withdrawal by Subject|1|||
131814455|NCT04035187|474604451|FG002|Overall Study|Withdrawal by Subject|0|||
131814456|NCT04035187|474604452|FG003|Overall Study|Withdrawal by Subject|0|||
131814457|NCT04035187|474604449|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
131814458|NCT04035187|474604450|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
131814459|NCT04035187|474604451|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
131814460|NCT04035187|474604452|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
131814461|NCT01116739|474604453|FG000|Overall Study|Child had 2 years of HS|110|||
131814462|NCT01116739|474604454|FG001|Overall Study|Child had 2 years of HS|128|||
131814463|NCT01116739|474604453|FG000|Overall Study|Withdrawal by Subject|6|||
131814464|NCT01116739|474604454|FG001|Overall Study|Withdrawal by Subject|0|||
131814465|NCT01116739|474604453|FG000|Overall Study|child too young|2|||
131814466|NCT01116739|474604454|FG001|Overall Study|child too young|6|||
131814467|NCT01116739|474604453|FG000|Overall Study|child not enrolled in head start|10|||
131814468|NCT01116739|474604454|FG001|Overall Study|child not enrolled in head start|2|||
131909684|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
131767527|NCT04411472|474426212|FG000|Overall Study|Physician Decision|1|||
131767528|NCT04411472|474426213|FG001|Overall Study|Physician Decision|0|||
131909685|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
131767529|NCT04411472|474426214|FG002|Overall Study|Physician Decision|0|||
131767530|NCT04411472|474426215|FG003|Overall Study|Physician Decision|0|||
131767531|NCT04411472|474426216|FG004|Overall Study|Physician Decision|0|||
131767532|NCT04411472|474426217|FG005|Overall Study|Physician Decision|0|||
131767533|NCT04411472|474426212|FG000|Overall Study|Study terminated by sponsor|17|||
131767534|NCT04411472|474426213|FG001|Overall Study|Study terminated by sponsor|20|||
131767535|NCT04411472|474426214|FG002|Overall Study|Study terminated by sponsor|3|||
131814469|NCT01116739|474604453|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
131909686|NCT02717195|474956797|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
131909687|NCT02717195|474956798|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
131909688|NCT02717195|474956799|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
131909689|NCT02717195|474956800|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
131909690|NCT02717195|474956801|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
131400624|NCT00695955|473089551|FG000|Cohort 1|Lack of Efficacy|3|||
131400625|NCT00695955|473089551|FG000|Cohort 1|Other|16|||
131767536|NCT04411472|474426215|FG003|Overall Study|Study terminated by sponsor|0|||
131767537|NCT04411472|474426216|FG004|Overall Study|Study terminated by sponsor|0|||
131767538|NCT04411472|474426217|FG005|Overall Study|Study terminated by sponsor|0|||
131767539|NCT02504424|474426219|FG000|Overall Study|Withdrawal by Subject|2|||
131767540|NCT05060003|474426222|FG000|Overall Study|ctDNA negative|7|||
131767541|NCT00819052|474426223|FG000|Overall Study|Adverse Event|0|||
131767542|NCT00819052|474426224|FG001|Overall Study|Adverse Event|5|||
131767543|NCT00819052|474426223|FG000|Overall Study|Protocol Violation|1|||
131767544|NCT00819052|474426224|FG001|Overall Study|Protocol Violation|2|||
131767545|NCT00819052|474426223|FG000|Overall Study|Lost to Follow-up|1|||
131767546|NCT00819052|474426224|FG001|Overall Study|Lost to Follow-up|2|||
131767547|NCT00819052|474426223|FG000|Overall Study|Withdrawal by Subject|1|||
131767548|NCT00819052|474426224|FG001|Overall Study|Withdrawal by Subject|2|||
131767549|NCT00819052|474426223|FG000|Overall Study|Lack of Efficacy|1|||
131767550|NCT00819052|474426224|FG001|Overall Study|Lack of Efficacy|1|||
131767551|NCT00819052|474426223|FG000|Overall Study|Pregnancy|1|||
131767552|NCT00819052|474426224|FG001|Overall Study|Pregnancy|2|||
131767553|NCT00819052|474426223|FG000|Overall Study|Death or events leading to death|1|||
131767554|NCT00819052|474426224|FG001|Overall Study|Death or events leading to death|0|||
131767555|NCT00362297|474426225|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
131767556|NCT00362297|474426226|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
131767557|NCT01747655|474426229|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
131767558|NCT01747655|474426230|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
131767559|NCT01747655|474426229|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
131767560|NCT01747655|474426230|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
131767561|NCT01747655|474426229|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
131767562|NCT01747655|474426230|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
131767563|NCT00982111|474426231|FG000|Overall Study|Adverse Event|1|||
131767564|NCT00982111|474426232|FG001|Overall Study|Adverse Event|1|||
131767565|NCT00982111|474426231|FG000|Overall Study|Progressive Disease|46|||
131767566|NCT00982111|474426232|FG001|Overall Study|Progressive Disease|39|||
131767567|NCT00982111|474426231|FG000|Overall Study|Lost to Follow-up|9|||
131767568|NCT00982111|474426232|FG001|Overall Study|Lost to Follow-up|6|||
131767569|NCT00982111|474426231|FG000|Overall Study|New Anti-Cancer Therapy|5|||
131767570|NCT00982111|474426232|FG001|Overall Study|New Anti-Cancer Therapy|5|||
131767571|NCT00982111|474426231|FG000|Overall Study|Medical Decision|1|||
131767572|NCT00982111|474426232|FG001|Overall Study|Medical Decision|0|||
131767573|NCT00982111|474426231|FG000|Overall Study|Withdrawal by Subject|17|||
131767574|NCT00982111|474426232|FG001|Overall Study|Withdrawal by Subject|19|||
131767575|NCT00982111|474426231|FG000|Overall Study|Global Study End|0|||
131767576|NCT00982111|474426232|FG001|Overall Study|Global Study End|1|||
131767577|NCT00982111|474426231|FG000|Overall Study|Sponsor's Decision|0|||
131767578|NCT00982111|474426232|FG001|Overall Study|Sponsor's Decision|1|||
131767579|NCT03769753|474426233|FG000|Overall Study|Not Treated|6|||
131767580|NCT03769753|474426233|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
131767581|NCT03702166|474426234|FG000|Overall Study|Lost to Follow-up|1|||
131767582|NCT03702166|474426234|FG000|Overall Study|Withdrawal by Subject|1|||
131767583|NCT01070381|474426235|FG000|Period 2, 1 Week of Wear|Handling|0|||
131767584|NCT01070381|474426236|FG001|Period 2, 1 Week of Wear|Handling|1|||
131767585|NCT01070381|474426235|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
131767586|NCT01070381|474426236|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
131767587|NCT00684073|474426237|FG000|Selection|Selection/non-selection criteria|3|||
131767588|NCT00684073|474426237|FG000|Selection|Death|1|||
131767589|NCT00684073|474426237|FG000|Selection|noncompliance|1|||
131767590|NCT00684073|474426237|FG000|Selection|Lost to Follow-up|1|||
131767591|NCT00684073|474426237|FG000|Selection|request of the sponsor|1|||
131767592|NCT00684073|474426237|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
131400626|NCT00695955|473089551|FG000|Cohort 2|Adverse Event|24|||
131400627|NCT00695955|473089551|FG000|Cohort 2|Protocol Violation|5|||
131400628|NCT00695955|473089551|FG000|Cohort 2|Lost to Follow-up|38|||
131767593|NCT03512028|474426240|FG000|Overall Study|Withdrawal by Subject|2|||
131767594|NCT03512028|474426241|FG001|Overall Study|Withdrawal by Subject|0|||
131767595|NCT03512028|474426240|FG000|Overall Study|Protocol Violation|2|||
131767596|NCT03512028|474426241|FG001|Overall Study|Protocol Violation|0|||
131767597|NCT03529162|474426244|FG000|Overall Study|Lost to Follow-up|2|||
131767598|NCT03529162|474426245|FG001|Overall Study|Lost to Follow-up|2|||
131400629|NCT00695955|473089551|FG000|Cohort 2|Withdrawal by Subject|28|||
131767599|NCT00983827|474426246|FG000|Overall Study|Withdrawal by Subject|1|||
131767600|NCT01888367|474426249|FG000|Overall Study|Physician Decision|3|||
131767601|NCT01888367|474426250|FG001|Overall Study|Physician Decision|4|||
131767602|NCT01888367|474426251|FG002|Overall Study|Physician Decision|2|||
131767603|NCT01888367|474426249|FG000|Overall Study|Death|2|||
131814470|NCT01116739|474604454|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
131814471|NCT05511935|474604457|FG000|Overall Study|Lost to Follow-up|9|||
131814472|NCT05511935|474604458|FG001|Overall Study|Lost to Follow-up|27|||
131814473|NCT05090839|474604461|FG000|Overall Study|Lost to Follow-up|2|||
131814474|NCT05090839|474604462|FG001|Overall Study|Lost to Follow-up|3|||
131814475|NCT05090839|474604463|FG002|Overall Study|Lost to Follow-up|1|||
131814476|NCT05090839|474604464|FG003|Overall Study|Lost to Follow-up|1|||
131814477|NCT04372238|474604465|FG000|Overall Study|Duplicate|3|||
131909691|NCT03087058|474956802|FG000|Overall Study|Withdrawal by Subject|2|||
131909692|NCT03087058|474956803|FG001|Overall Study|Withdrawal by Subject|0|||
131909693|NCT03087058|474956804|FG002|Overall Study|Withdrawal by Subject|0|||
131909694|NCT02577029|474956805|FG000|Overall Study|Adverse Event|1|||
131909695|NCT02577029|474956806|FG001|Overall Study|Adverse Event|0|||
131909696|NCT02577029|474956807|FG002|Overall Study|Adverse Event|2|||
131909697|NCT02577029|474956808|FG003|Overall Study|Adverse Event|0|||
131909698|NCT02577029|474956809|FG004|Overall Study|Adverse Event|1|||
131909699|NCT02577029|474956810|FG005|Overall Study|Adverse Event|0|||
131909700|NCT02577029|474956811|FG006|Overall Study|Adverse Event|0|||
131909701|NCT02577029|474956812|FG007|Overall Study|Adverse Event|0|||
131909702|NCT02577029|474956805|FG000|Overall Study|Withdrawal by Subject|0|||
131909703|NCT02577029|474956806|FG001|Overall Study|Withdrawal by Subject|0|||
131909704|NCT02577029|474956807|FG002|Overall Study|Withdrawal by Subject|0|||
131909705|NCT02577029|474956808|FG003|Overall Study|Withdrawal by Subject|0|||
131909706|NCT02577029|474956809|FG004|Overall Study|Withdrawal by Subject|0|||
131909707|NCT02577029|474956810|FG005|Overall Study|Withdrawal by Subject|1|||
131909708|NCT02577029|474956811|FG006|Overall Study|Withdrawal by Subject|0|||
131909709|NCT02577029|474956812|FG007|Overall Study|Withdrawal by Subject|0|||
131909710|NCT02577029|474956805|FG000|Overall Study|Sponsor Termination of the Study|9|||
131909711|NCT02577029|474956806|FG001|Overall Study|Sponsor Termination of the Study|2|||
131909712|NCT02577029|474956807|FG002|Overall Study|Sponsor Termination of the Study|5|||
131909713|NCT02577029|474956808|FG003|Overall Study|Sponsor Termination of the Study|12|||
131909714|NCT02577029|474956809|FG004|Overall Study|Sponsor Termination of the Study|10|||
131909715|NCT02577029|474956810|FG005|Overall Study|Sponsor Termination of the Study|12|||
131909716|NCT02577029|474956811|FG006|Overall Study|Sponsor Termination of the Study|12|||
131909717|NCT02577029|474956812|FG007|Overall Study|Sponsor Termination of the Study|12|||
131909718|NCT02078817|474956813|FG000|Overall Study|Withdrawal by Subject|1|||
131767604|NCT01888367|474426250|FG001|Overall Study|Death|0|||
131767605|NCT01888367|474426251|FG002|Overall Study|Death|1|||
131767606|NCT01888367|474426249|FG000|Overall Study|Withdrawal by Subject|1|||
131767607|NCT01888367|474426250|FG001|Overall Study|Withdrawal by Subject|0|||
131767608|NCT01888367|474426251|FG002|Overall Study|Withdrawal by Subject|1|||
131767609|NCT01888367|474426249|FG000|Overall Study|Lost to Follow-up|1|||
131767610|NCT01888367|474426250|FG001|Overall Study|Lost to Follow-up|1|||
131767611|NCT01888367|474426251|FG002|Overall Study|Lost to Follow-up|0|||
131767612|NCT01888367|474426249|FG000|Overall Study|Protocol Violation|0|||
131767613|NCT01888367|474426250|FG001|Overall Study|Protocol Violation|0|||
131767614|NCT01888367|474426251|FG002|Overall Study|Protocol Violation|1|||
131767615|NCT01888367|474426249|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
131767616|NCT01888367|474426250|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
131767617|NCT01888367|474426251|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
131767618|NCT01854918|474426252|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
131767619|NCT01854918|474426253|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
131767620|NCT01854918|474426252|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
131814478|NCT04372238|474604466|FG001|Overall Study|Duplicate|3|||
131814479|NCT04372238|474604465|FG000|Overall Study|Did not consent for data linkage|6|||
131814480|NCT04372238|474604466|FG001|Overall Study|Did not consent for data linkage|10|||
131909719|NCT01420536|474956814|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
131400630|NCT00695955|473089551|FG000|Cohort 2|Lack of Efficacy|4|||
131767621|NCT01854918|474426253|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
131814481|NCT00334815|474604467|FG000|Overall Study|Adverse Event|3|||
131814482|NCT00334815|474604468|FG001|Overall Study|Adverse Event|2|||
131814483|NCT00334815|474604467|FG000|Overall Study|Death|0|||
131909720|NCT01420536|474956815|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
131909721|NCT01265498|474956820|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
131909722|NCT01265498|474956821|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
131909723|NCT01652690|474956823|FG000|Overall Study|Withdrawal by Subject|16|||
131400631|NCT00695955|473089551|FG000|Cohort 2|Other|5|||
131767622|NCT01854918|474426252|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
131767623|NCT01854918|474426253|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
131767624|NCT01854918|474426252|FG000|SOC-controlled Period (Year 1)|Death|5|||
131814484|NCT00334815|474604468|FG001|Overall Study|Death|2|||
131814485|NCT00334815|474604467|FG000|Overall Study|Progression|1|||
131814486|NCT00334815|474604468|FG001|Overall Study|Progression|0|||
131814487|NCT00334815|474604467|FG000|Overall Study|ineligible|1|||
131814488|NCT00334815|474604468|FG001|Overall Study|ineligible|1|||
131814489|NCT00334815|474604467|FG000|Overall Study|patient refused treatment|0|||
131814490|NCT00334815|474604468|FG001|Overall Study|patient refused treatment|1|||
131814491|NCT00334815|474604467|FG000|Overall Study|Physician Decision|2|||
131814492|NCT00334815|474604468|FG001|Overall Study|Physician Decision|4|||
131814493|NCT03499353|474604469|FG000|Treatment|Adverse Event|3|||
131814494|NCT03499353|474604469|FG000|Treatment|Progressive Disease|10|||
131814495|NCT03499353|474604469|FG000|Treatment|Other|1|||
131814496|NCT03499353|474604469|FG000|Treatment|Withdrawal by Subject|2|||
131400632|NCT04154605|473089556|FG000|Overall Study|Procedure Canceled|1|||
131767625|NCT01854918|474426253|FG001|SOC-controlled Period (Year 1)|Death|5|||
131767626|NCT01854918|474426252|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
131767627|NCT01854918|474426253|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
131767628|NCT01854918|474426252|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
131767629|NCT01854918|474426253|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
131767630|NCT01854918|474426252|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
131767631|NCT01854918|474426253|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
131767632|NCT01854918|474426252|FG000|All-IP Period (Years 2 and 3)|Death|5|||
131767633|NCT01854918|474426253|FG001|All-IP Period (Years 2 and 3)|Death|16|||
131767634|NCT02146352|474426254|FG000|Overall Study|Death|1|||
131767635|NCT02146352|474426254|FG000|Overall Study|Patient entered hospice care|1|||
131767636|NCT03091920|474426257|FG000|Overall Study|Adverse Event|0|||
131767637|NCT03091920|474426258|FG001|Overall Study|Adverse Event|1|||
131767638|NCT03091920|474426259|FG002|Overall Study|Adverse Event|0|||
131767639|NCT00453349|474426261|FG000|Randomized|Adverse Event|12|||
131767640|NCT00453349|474426262|FG001|Randomized|Adverse Event|11|||
131767641|NCT00453349|474426261|FG000|Randomized|Lack of Efficacy|2|||
131767642|NCT00453349|474426262|FG001|Randomized|Lack of Efficacy|1|||
131767643|NCT00453349|474426261|FG000|Randomized|Lost to Follow-up|7|||
131767644|NCT00453349|474426262|FG001|Randomized|Lost to Follow-up|5|||
131767645|NCT00453349|474426261|FG000|Randomized|Protocol Violation|1|||
131767646|NCT00453349|474426262|FG001|Randomized|Protocol Violation|1|||
131767647|NCT00453349|474426261|FG000|Randomized|Withdrawal by Subject|3|||
131767648|NCT00453349|474426262|FG001|Randomized|Withdrawal by Subject|5|||
131400633|NCT04154605|473089557|FG001|Overall Study|Procedure Canceled|1|||
131400634|NCT04154605|473089556|FG000|Overall Study|Missed follow up|1|||
131400635|NCT04154605|473089557|FG001|Overall Study|Missed follow up|1|||
131400636|NCT04154605|473089556|FG000|Overall Study|Withdrawal by Subject|1|||
131767649|NCT00453349|474426261|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
131767650|NCT00453349|474426262|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
131767651|NCT00453349|474426261|FG000|Completed Study|Adverse Event|12|||
131767652|NCT00453349|474426262|FG001|Completed Study|Adverse Event|11|||
131767653|NCT00453349|474426261|FG000|Completed Study|Lack of Efficacy|2|||
131767654|NCT00453349|474426262|FG001|Completed Study|Lack of Efficacy|1|||
131767655|NCT00453349|474426261|FG000|Completed Study|Lost to Follow-up|7|||
131767656|NCT00453349|474426262|FG001|Completed Study|Lost to Follow-up|5|||
131767657|NCT00453349|474426261|FG000|Completed Study|Protocol Violation|1|||
131767658|NCT00453349|474426262|FG001|Completed Study|Protocol Violation|1|||
131767659|NCT00453349|474426261|FG000|Completed Study|Withdrawal by Subject|3|||
131767660|NCT00453349|474426262|FG001|Completed Study|Withdrawal by Subject|5|||
131767661|NCT00453349|474426261|FG000|Completed Study|Lost to follow up after study treatment|2|||
131767662|NCT00453349|474426262|FG001|Completed Study|Lost to follow up after study treatment|11|||
131767663|NCT01513460|474426264|FG000|Overall Study|Death|0|||
131767664|NCT01513460|474426265|FG001|Overall Study|Death|0|||
131767665|NCT01513460|474426266|FG002|Overall Study|Death|1|||
131767666|NCT01513460|474426264|FG000|Overall Study|Lost to Follow-up|0|||
131767667|NCT01513460|474426265|FG001|Overall Study|Lost to Follow-up|0|||
131767668|NCT01513460|474426266|FG002|Overall Study|Lost to Follow-up|2|||
131767669|NCT01513460|474426264|FG000|Overall Study|Abnormal laboratory value|1|||
131814497|NCT03499353|474604469|FG000|Long-Term Follow-up|Death|2|||
131400637|NCT04154605|473089557|FG001|Overall Study|Withdrawal by Subject|0|||
131400638|NCT01581021|473089558|FG000|Overall Study|Lost to Follow-up|4|||
131400639|NCT01581021|473089559|FG001|Overall Study|Lost to Follow-up|6|||
131814498|NCT03499353|474604469|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
131400640|NCT01581021|473089558|FG000|Overall Study|More than 2 hooks in thoracic|3|||
131400641|NCT01581021|473089559|FG001|Overall Study|More than 2 hooks in thoracic|0|||
131400642|NCT01581021|473089558|FG000|Overall Study|Neuromuscular|2|||
131767670|NCT01513460|474426265|FG001|Overall Study|Abnormal laboratory value|0|||
131767671|NCT01513460|474426266|FG002|Overall Study|Abnormal laboratory value|1|||
131767672|NCT01513460|474426264|FG000|Overall Study|Lack of Efficacy|1|||
131767673|NCT01513460|474426265|FG001|Overall Study|Lack of Efficacy|2|||
131767674|NCT01513460|474426266|FG002|Overall Study|Lack of Efficacy|5|||
131767675|NCT01513460|474426264|FG000|Overall Study|Protocol deviations|3|||
131767676|NCT01513460|474426265|FG001|Overall Study|Protocol deviations|4|||
131767677|NCT01513460|474426266|FG002|Overall Study|Protocol deviations|3|||
131767678|NCT01513460|474426264|FG000|Overall Study|Withdrawal by Subject|7|||
131767679|NCT01513460|474426265|FG001|Overall Study|Withdrawal by Subject|8|||
131767680|NCT01513460|474426266|FG002|Overall Study|Withdrawal by Subject|21|||
131767681|NCT01513460|474426264|FG000|Overall Study|Adverse Event|16|||
131767682|NCT01513460|474426265|FG001|Overall Study|Adverse Event|18|||
131767683|NCT01513460|474426266|FG002|Overall Study|Adverse Event|23|||
131767684|NCT01513460|474426264|FG000|Overall Study|Abnormal test procedure|1|||
131767685|NCT01513460|474426265|FG001|Overall Study|Abnormal test procedure|0|||
131767686|NCT01513460|474426266|FG002|Overall Study|Abnormal test procedure|0|||
131767687|NCT00939094|474426270|FG000|Overall Study|Adverse Event|9|||
131767688|NCT00939094|474426271|FG001|Overall Study|Adverse Event|0|||
131767689|NCT00939094|474426270|FG000|Overall Study|Withdrawal by Subject|1|||
131767690|NCT00939094|474426271|FG001|Overall Study|Withdrawal by Subject|6|||
131767691|NCT00939094|474426270|FG000|Overall Study|Lost to Follow-up|1|||
131767692|NCT00939094|474426271|FG001|Overall Study|Lost to Follow-up|1|||
131767693|NCT00939094|474426270|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131767694|NCT00939094|474426271|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131767695|NCT00939094|474426270|FG000|Overall Study|Severe non-compliance to protocol|0|||
131767696|NCT00939094|474426271|FG001|Overall Study|Severe non-compliance to protocol|1|||
131767697|NCT00939094|474426270|FG000|Overall Study|Study stopped by sponsor|0|||
131767698|NCT00939094|474426271|FG001|Overall Study|Study stopped by sponsor|2|||
131767699|NCT00939094|474426270|FG000|Overall Study|Abnormal ECG findings|1|||
131767700|NCT00939094|474426271|FG001|Overall Study|Abnormal ECG findings|0|||
131767701|NCT01906489|474426272|FG000|Overall Study|Adverse Event|10|||
131767702|NCT01906489|474426273|FG001|Overall Study|Adverse Event|3|||
131767703|NCT01906489|474426272|FG000|Overall Study|Worsening of CKD|6|||
131767704|NCT01906489|474426273|FG001|Overall Study|Worsening of CKD|4|||
131767705|NCT01906489|474426272|FG000|Overall Study|Withdrawal by Subject|5|||
131767706|NCT01906489|474426273|FG001|Overall Study|Withdrawal by Subject|0|||
131767707|NCT01906489|474426272|FG000|Overall Study|Worsening of Anemia|1|||
131767708|NCT01906489|474426273|FG001|Overall Study|Worsening of Anemia|0|||
131767709|NCT01906489|474426272|FG000|Overall Study|Protocol Violation|0|||
131767710|NCT01906489|474426273|FG001|Overall Study|Protocol Violation|1|||
131767711|NCT01906489|474426272|FG000|Overall Study|Non- Compliance|1|||
131767712|NCT01906489|474426273|FG001|Overall Study|Non- Compliance|0|||
131767713|NCT01906489|474426272|FG000|Overall Study|Sponsor Decision|1|||
131767714|NCT01906489|474426273|FG001|Overall Study|Sponsor Decision|0|||
131767715|NCT01906489|474426272|FG000|Overall Study|Lost to Follow-up|1|||
131767716|NCT01906489|474426273|FG001|Overall Study|Lost to Follow-up|1|||
131767717|NCT01906489|474426272|FG000|Overall Study|Other|1|||
131767718|NCT01906489|474426273|FG001|Overall Study|Other|0|||
131767719|NCT01503229|474427783|FG000|Overall Study|Withdrew consent|1|||
131767720|NCT01884675|474427784|FG000|Overall Study|Study closed/terminated|3|||
131767721|NCT01884675|474427785|FG001|Overall Study|Study closed/terminated|2|||
131767722|NCT02361307|474427786|FG000|Overall Study|Unstable medical condition.|0|||
131767723|NCT02361307|474427787|FG001|Overall Study|Unstable medical condition.|1|||
131767724|NCT02534324|474427791|FG000|Overall Study|Protocol Violation|4|||
131767725|NCT02534324|474427792|FG001|Overall Study|Protocol Violation|1|||
131767726|NCT02534324|474427791|FG000|Overall Study|Lost to Follow-up|20|||
131767727|NCT02534324|474427792|FG001|Overall Study|Lost to Follow-up|7|||
131767728|NCT02534324|474427791|FG000|Overall Study|Adverse Event|1|||
131767729|NCT02534324|474427792|FG001|Overall Study|Adverse Event|0|||
131814499|NCT03499353|474604469|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
131814500|NCT01592240|474604470|FG000|Overall Study|Adverse Event|1|||
131814501|NCT01592240|474604471|FG001|Overall Study|Adverse Event|0|||
131814502|NCT01592240|474604472|FG002|Overall Study|Adverse Event|0|||
131814503|NCT01592240|474604473|FG003|Overall Study|Adverse Event|1|||
131814504|NCT01592240|474604474|FG004|Overall Study|Adverse Event|1|||
131814505|NCT01592240|474604475|FG005|Overall Study|Adverse Event|0|||
131909724|NCT01652690|474956824|FG001|Overall Study|Withdrawal by Subject|4|||
131909725|NCT01652690|474956823|FG000|Overall Study|Other|8|||
131767730|NCT01459016|474427795|FG000|Overall Study|Withdrawal by Subject|11|||
131767731|NCT01459016|474427795|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
131767732|NCT00303602|474427799|FG000|Overall Study|Adverse Event|2|||
131767733|NCT00303602|474427800|FG001|Overall Study|Adverse Event|2|||
131814506|NCT01592240|474604476|FG006|Overall Study|Adverse Event|0|||
131909726|NCT01652690|474956824|FG001|Overall Study|Other|9|||
131909727|NCT01652690|474956823|FG000|Overall Study|Lost to Follow-up|6|||
131814507|NCT01592240|474604470|FG000|Overall Study|Death|0|||
131909728|NCT01652690|474956824|FG001|Overall Study|Lost to Follow-up|6|||
131767734|NCT00303602|474427799|FG000|Overall Study|Withdrawal by Subject|5|||
131767735|NCT00303602|474427800|FG001|Overall Study|Withdrawal by Subject|6|||
131767736|NCT00303602|474427799|FG000|Overall Study|Lost to Follow-up|5|||
131767737|NCT00303602|474427800|FG001|Overall Study|Lost to Follow-up|2|||
131767738|NCT00303602|474427799|FG000|Overall Study|Protocol entry criteria not met|2|||
131767739|NCT00303602|474427800|FG001|Overall Study|Protocol entry criteria not met|2|||
131767740|NCT00303602|474427799|FG000|Overall Study|Physician Decision|2|||
131767741|NCT00303602|474427800|FG001|Overall Study|Physician Decision|1|||
131767742|NCT00303602|474427799|FG000|Overall Study|Noncompliance|2|||
131909729|NCT01652690|474956823|FG000|Overall Study|Death|5|||
131814508|NCT01592240|474604471|FG001|Overall Study|Death|1|||
131814509|NCT01592240|474604472|FG002|Overall Study|Death|0|||
131814510|NCT01592240|474604473|FG003|Overall Study|Death|0|||
131814511|NCT01592240|474604474|FG004|Overall Study|Death|0|||
131814512|NCT01592240|474604475|FG005|Overall Study|Death|0|||
131814513|NCT01592240|474604476|FG006|Overall Study|Death|0|||
131814514|NCT01592240|474604470|FG000|Overall Study|Lost to Follow-up|1|||
131814515|NCT01592240|474604471|FG001|Overall Study|Lost to Follow-up|3|||
131767743|NCT00303602|474427800|FG001|Overall Study|Noncompliance|2|||
131814516|NCT01592240|474604472|FG002|Overall Study|Lost to Follow-up|1|||
131767744|NCT00303602|474427799|FG000|Overall Study|Protocol Violation|1|||
131767745|NCT00303602|474427800|FG001|Overall Study|Protocol Violation|0|||
131767746|NCT00240331|474427803|FG000|Overall Study|Withdrawal by Subject|125|||
131767747|NCT00240331|474427804|FG001|Overall Study|Withdrawal by Subject|132|||
131767748|NCT00240331|474427803|FG000|Overall Study|Option selected by investigator|1|||
131767749|NCT00240331|474427804|FG001|Overall Study|Option selected by investigator|2|||
131767750|NCT00313716|474427811|FG000|Overall Study|Death|3|||
131767751|NCT00313716|474427812|FG001|Overall Study|Death|2|||
131767752|NCT00313716|474427813|FG002|Overall Study|Death|9|||
131767753|NCT00313716|474427814|FG003|Overall Study|Death|3|||
131767754|NCT00313716|474427815|FG004|Overall Study|Death|5|||
131767755|NCT00313716|474427816|FG005|Overall Study|Death|9|||
131767756|NCT00313716|474427811|FG000|Overall Study|Lost to Follow-up|2|||
131767757|NCT00313716|474427812|FG001|Overall Study|Lost to Follow-up|5|||
131767758|NCT00313716|474427813|FG002|Overall Study|Lost to Follow-up|2|||
131767759|NCT00313716|474427814|FG003|Overall Study|Lost to Follow-up|1|||
131767760|NCT00313716|474427815|FG004|Overall Study|Lost to Follow-up|0|||
131767761|NCT00313716|474427816|FG005|Overall Study|Lost to Follow-up|4|||
131767762|NCT00313716|474427811|FG000|Overall Study|Withdrawal by Subject|0|||
131767763|NCT00313716|474427812|FG001|Overall Study|Withdrawal by Subject|1|||
131767764|NCT00313716|474427813|FG002|Overall Study|Withdrawal by Subject|1|||
131767765|NCT00313716|474427814|FG003|Overall Study|Withdrawal by Subject|0|||
131767766|NCT00313716|474427815|FG004|Overall Study|Withdrawal by Subject|1|||
131767767|NCT00313716|474427816|FG005|Overall Study|Withdrawal by Subject|0|||
131767768|NCT01491802|474427817|FG000|Overall Study|Adverse Event|1|||
131767769|NCT01491802|474427818|FG001|Overall Study|Adverse Event|1|||
131767770|NCT01491802|474427817|FG000|Overall Study|Withdrawal by Subject|0|||
131767771|NCT01491802|474427818|FG001|Overall Study|Withdrawal by Subject|1|||
131767772|NCT00663208|474427819|FG000|Treatment Period|Lost to Follow-up|0|||
131767773|NCT00663208|474427820|FG001|Treatment Period|Lost to Follow-up|1|||
131767774|NCT00663208|474427821|FG002|Treatment Period|Lost to Follow-up|0|||
131767775|NCT00663208|474427822|FG003|Treatment Period|Lost to Follow-up|0|||
131767776|NCT00663208|474427823|FG004|Treatment Period|Lost to Follow-up|0|||
131767777|NCT00663208|474427824|FG005|Treatment Period|Lost to Follow-up|0|||
131767778|NCT00663208|474427825|FG006|Treatment Period|Lost to Follow-up|0|||
131767779|NCT00663208|474427819|FG000|Follow-up Period|Lost to Follow-up|2|||
131767780|NCT00663208|474427820|FG001|Follow-up Period|Lost to Follow-up|0|||
131767781|NCT00663208|474427821|FG002|Follow-up Period|Lost to Follow-up|3|||
131767782|NCT00663208|474427822|FG003|Follow-up Period|Lost to Follow-up|2|||
131767783|NCT00663208|474427823|FG004|Follow-up Period|Lost to Follow-up|0|||
131767784|NCT00663208|474427824|FG005|Follow-up Period|Lost to Follow-up|0|||
131767785|NCT00663208|474427825|FG006|Follow-up Period|Lost to Follow-up|0|||
131767786|NCT00663208|474427819|FG000|Follow-up Period|Other reason|1|||
131814517|NCT01592240|474604473|FG003|Overall Study|Lost to Follow-up|0|||
131814518|NCT01592240|474604474|FG004|Overall Study|Lost to Follow-up|3|||
131814519|NCT01592240|474604475|FG005|Overall Study|Lost to Follow-up|2|||
131814520|NCT01592240|474604476|FG006|Overall Study|Lost to Follow-up|0|||
131814521|NCT01592240|474604470|FG000|Overall Study|Protocol Violation|0|||
131814522|NCT01592240|474604471|FG001|Overall Study|Protocol Violation|0|||
131909730|NCT01652690|474956824|FG001|Overall Study|Death|2|||
131909731|NCT03225287|474956825|FG000|Overall Study|Adverse Event|0|||
131814523|NCT01592240|474604472|FG002|Overall Study|Protocol Violation|0|||
131814524|NCT01592240|474604473|FG003|Overall Study|Protocol Violation|0|||
131814525|NCT01592240|474604474|FG004|Overall Study|Protocol Violation|0|||
131400643|NCT01581021|473089559|FG001|Overall Study|Neuromuscular|1|||
131400644|NCT01581021|473089558|FG000|Overall Study|Not Randomized|1|||
131767787|NCT00663208|474427820|FG001|Follow-up Period|Other reason|0|||
131767788|NCT00663208|474427821|FG002|Follow-up Period|Other reason|0|||
131814526|NCT01592240|474604475|FG005|Overall Study|Protocol Violation|1|||
131814527|NCT01592240|474604476|FG006|Overall Study|Protocol Violation|0|||
131909732|NCT03225287|474956826|FG001|Overall Study|Adverse Event|0|||
131400645|NCT01581021|473089559|FG001|Overall Study|Not Randomized|2|||
131767789|NCT00663208|474427822|FG003|Follow-up Period|Other reason|0|||
131767790|NCT00663208|474427823|FG004|Follow-up Period|Other reason|0|||
131767791|NCT00663208|474427824|FG005|Follow-up Period|Other reason|0|||
131767792|NCT00663208|474427825|FG006|Follow-up Period|Other reason|1|||
131767793|NCT04067310|474427828|FG000|Overall Study|Physician Decision|2|||
131767794|NCT04067310|474427829|FG001|Overall Study|Physician Decision|6|||
131767795|NCT04067310|474427828|FG000|Overall Study|Lost to Follow-up|0|||
131814528|NCT01592240|474604470|FG000|Overall Study|Withdrawal by Subject|0|||
131767796|NCT04067310|474427829|FG001|Overall Study|Lost to Follow-up|1|||
131767797|NCT04067310|474427828|FG000|Overall Study|Withdrawal by Subject|3|||
131767798|NCT04067310|474427829|FG001|Overall Study|Withdrawal by Subject|0|||
131767799|NCT01041027|474427830|FG000|Overall Study|Withdrawal by Subject|2|||
131767800|NCT01041027|474427830|FG000|Overall Study|Protocol Violation|1|||
131767801|NCT01041027|474427830|FG000|Overall Study|Delayed Radiation Therapy|1|||
131767802|NCT01041027|474427830|FG000|Overall Study|Adverse Event|4|||
131767803|NCT01249404|474427831|FG000|Overall Study|Study treatment not received|0|||
131767804|NCT01249404|474427832|FG001|Overall Study|Study treatment not received|1|||
131767805|NCT01249404|474427833|FG002|Overall Study|Study treatment not received|2|||
131767806|NCT01249404|474427831|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
131767807|NCT01249404|474427832|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
131767808|NCT01249404|474427833|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
131767809|NCT01249404|474427831|FG000|Overall Study|Adverse Event|2|||
131767810|NCT01249404|474427832|FG001|Overall Study|Adverse Event|2|||
131767811|NCT01249404|474427833|FG002|Overall Study|Adverse Event|2|||
131400646|NCT01581021|473089558|FG000|Overall Study|Lenke 6 Classification|0|||
131400647|NCT01581021|473089559|FG001|Overall Study|Lenke 6 Classification|1|||
131400648|NCT01581021|473089558|FG000|Overall Study|Lack of Efficacy|0|||
131767812|NCT01249404|474427831|FG000|Overall Study|Withdrawal by Subject|2|||
131400649|NCT01581021|473089559|FG001|Overall Study|Lack of Efficacy|1|||
131767813|NCT01249404|474427832|FG001|Overall Study|Withdrawal by Subject|2|||
131767814|NCT01249404|474427833|FG002|Overall Study|Withdrawal by Subject|0|||
131767815|NCT01249404|474427831|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
131767816|NCT01249404|474427832|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
131767817|NCT01249404|474427833|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
131767818|NCT01249404|474427831|FG000|Overall Study|Non compliance to visit schedule|0|||
131767819|NCT01249404|474427832|FG001|Overall Study|Non compliance to visit schedule|1|||
131767820|NCT01249404|474427833|FG002|Overall Study|Non compliance to visit schedule|0|||
131767821|NCT03824704|474427834|FG000|Overall Study|Study Terminated by Sponsor|1|||
131767822|NCT03287960|474427835|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
131767823|NCT03287960|474427835|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
131767824|NCT01667731|474427838|FG000|Overall Study|Enrolled but not treated|0|||
131767825|NCT01667731|474427839|FG001|Overall Study|Enrolled but not treated|0|||
131767826|NCT01667731|474427840|FG002|Overall Study|Enrolled but not treated|0|||
131767827|NCT01667731|474427841|FG003|Overall Study|Enrolled but not treated|0|||
131767828|NCT01667731|474427842|FG004|Overall Study|Enrolled but not treated|1|||
131767829|NCT01667731|474427838|FG000|Overall Study|Efficacy Failure|1|||
131767830|NCT01667731|474427839|FG001|Overall Study|Efficacy Failure|12|||
131767831|NCT01667731|474427840|FG002|Overall Study|Efficacy Failure|0|||
131767832|NCT01667731|474427841|FG003|Overall Study|Efficacy Failure|1|||
131767833|NCT01667731|474427842|FG004|Overall Study|Efficacy Failure|24|||
131767834|NCT01667731|474427838|FG000|Overall Study|Lost to Follow-up|2|||
131767835|NCT01667731|474427839|FG001|Overall Study|Lost to Follow-up|3|||
131767836|NCT01667731|474427840|FG002|Overall Study|Lost to Follow-up|1|||
131767837|NCT01667731|474427841|FG003|Overall Study|Lost to Follow-up|1|||
131767838|NCT01667731|474427842|FG004|Overall Study|Lost to Follow-up|2|||
131767839|NCT01667731|474427838|FG000|Overall Study|Subject Withdrew Consent|2|||
131767840|NCT01667731|474427839|FG001|Overall Study|Subject Withdrew Consent|0|||
131814529|NCT01592240|474604471|FG001|Overall Study|Withdrawal by Subject|4|||
131814530|NCT01592240|474604472|FG002|Overall Study|Withdrawal by Subject|4|||
131814531|NCT01592240|474604473|FG003|Overall Study|Withdrawal by Subject|1|||
131814532|NCT01592240|474604474|FG004|Overall Study|Withdrawal by Subject|3|||
131814533|NCT01592240|474604475|FG005|Overall Study|Withdrawal by Subject|0|||
131814534|NCT01592240|474604476|FG006|Overall Study|Withdrawal by Subject|2|||
131814535|NCT01592240|474604470|FG000|Overall Study|Other|0|||
131814536|NCT01592240|474604471|FG001|Overall Study|Other|3|||
131814537|NCT01592240|474604472|FG002|Overall Study|Other|1|||
131814538|NCT01592240|474604473|FG003|Overall Study|Other|1|||
131814539|NCT01592240|474604474|FG004|Overall Study|Other|0|||
131814540|NCT01592240|474604475|FG005|Overall Study|Other|0|||
131767841|NCT01667731|474427840|FG002|Overall Study|Subject Withdrew Consent|1|||
131767842|NCT01667731|474427841|FG003|Overall Study|Subject Withdrew Consent|0|||
131767843|NCT01667731|474427842|FG004|Overall Study|Subject Withdrew Consent|1|||
131767844|NCT01667731|474427838|FG000|Overall Study|Death|0|||
131767845|NCT01667731|474427839|FG001|Overall Study|Death|1|||
131767846|NCT01667731|474427840|FG002|Overall Study|Death|0|||
131767847|NCT01667731|474427841|FG003|Overall Study|Death|0|||
131767848|NCT01667731|474427842|FG004|Overall Study|Death|0|||
131767849|NCT01425268|474427843|FG000|Overall Study|Withdrawal by Subject|2|||
131767850|NCT01425268|474427844|FG001|Overall Study|Withdrawal by Subject|0|||
131767851|NCT01425268|474427843|FG000|Overall Study|Sponsor Decision|5|||
131767852|NCT01425268|474427844|FG001|Overall Study|Sponsor Decision|0|||
131767853|NCT01425268|474427843|FG000|Overall Study|Physician Decision|1|||
131814541|NCT01592240|474604476|FG006|Overall Study|Other|1|||
131814542|NCT01592240|474604470|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131814543|NCT01592240|474604471|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
131767854|NCT01425268|474427844|FG001|Overall Study|Physician Decision|0|||
131767855|NCT02839330|474427845|FG000|Overall Study|Adverse Event|0|||
131767856|NCT02839330|474427846|FG001|Overall Study|Adverse Event|1|||
131767857|NCT02839330|474427847|FG002|Overall Study|Adverse Event|2|||
131767858|NCT02839330|474427848|FG003|Overall Study|Adverse Event|2|||
131767859|NCT02839330|474427845|FG000|Overall Study|Death|4|||
131767860|NCT02839330|474427846|FG001|Overall Study|Death|6|||
131767861|NCT02839330|474427847|FG002|Overall Study|Death|1|||
131767862|NCT02839330|474427848|FG003|Overall Study|Death|1|||
131767863|NCT02839330|474427845|FG000|Overall Study|Withdrawal by Subject|27|||
131767864|NCT02839330|474427846|FG001|Overall Study|Withdrawal by Subject|19|||
131767865|NCT02839330|474427847|FG002|Overall Study|Withdrawal by Subject|11|||
131767866|NCT02839330|474427848|FG003|Overall Study|Withdrawal by Subject|13|||
131767867|NCT02839330|474427845|FG000|Overall Study|Lost to Follow-up|22|||
131767868|NCT02839330|474427846|FG001|Overall Study|Lost to Follow-up|27|||
131767869|NCT02839330|474427847|FG002|Overall Study|Lost to Follow-up|29|||
131767870|NCT02839330|474427848|FG003|Overall Study|Lost to Follow-up|25|||
131767871|NCT02839330|474427845|FG000|Overall Study|Administrative Reason|0|||
131767872|NCT02839330|474427846|FG001|Overall Study|Administrative Reason|0|||
131767873|NCT02839330|474427847|FG002|Overall Study|Administrative Reason|0|||
131767874|NCT02839330|474427848|FG003|Overall Study|Administrative Reason|1|||
131767875|NCT02839330|474427845|FG000|Overall Study|Protocol Violation|1|||
131767876|NCT02839330|474427846|FG001|Overall Study|Protocol Violation|2|||
131767877|NCT02839330|474427847|FG002|Overall Study|Protocol Violation|2|||
131767878|NCT02839330|474427848|FG003|Overall Study|Protocol Violation|3|||
131767879|NCT02839330|474427845|FG000|Overall Study|Other reason, not specified|4|||
131767880|NCT02839330|474427846|FG001|Overall Study|Other reason, not specified|3|||
131767881|NCT02839330|474427847|FG002|Overall Study|Other reason, not specified|3|||
131767882|NCT02839330|474427848|FG003|Overall Study|Other reason, not specified|6|||
131767883|NCT01756846|474427849|FG000|Overall Study|Lost to Follow-up|5|||
131767884|NCT01756846|474427850|FG001|Overall Study|Lost to Follow-up|10|||
131767885|NCT01756846|474427849|FG000|Overall Study|Withdrawal by Subject|1|||
131767886|NCT01756846|474427850|FG001|Overall Study|Withdrawal by Subject|2|||
131767887|NCT00545740|474427853|FG000|Overall Study|Lack of Efficacy|34|||
131767888|NCT00545740|474427854|FG001|Overall Study|Lack of Efficacy|35|||
131767889|NCT00545740|474427855|FG002|Overall Study|Lack of Efficacy|47|||
131767890|NCT00545740|474427856|FG003|Overall Study|Lack of Efficacy|36|||
131767891|NCT00545740|474427853|FG000|Overall Study|Withdrawal by Subject|17|||
131767892|NCT00545740|474427854|FG001|Overall Study|Withdrawal by Subject|15|||
131767893|NCT00545740|474427855|FG002|Overall Study|Withdrawal by Subject|16|||
131767894|NCT00545740|474427856|FG003|Overall Study|Withdrawal by Subject|18|||
131767895|NCT00545740|474427853|FG000|Overall Study|Adverse Event|10|||
131767896|NCT00545740|474427854|FG001|Overall Study|Adverse Event|18|||
131767897|NCT00545740|474427855|FG002|Overall Study|Adverse Event|19|||
131767898|NCT00545740|474427856|FG003|Overall Study|Adverse Event|9|||
131767899|NCT00545740|474427853|FG000|Overall Study|Lost to Follow-up|7|||
131767900|NCT00545740|474427854|FG001|Overall Study|Lost to Follow-up|5|||
131767901|NCT00545740|474427855|FG002|Overall Study|Lost to Follow-up|5|||
131767902|NCT00545740|474427856|FG003|Overall Study|Lost to Follow-up|6|||
131767903|NCT00545740|474427853|FG000|Overall Study|Protocol Violation|1|||
131767904|NCT00545740|474427854|FG001|Overall Study|Protocol Violation|3|||
131767905|NCT00545740|474427855|FG002|Overall Study|Protocol Violation|1|||
131767906|NCT00545740|474427856|FG003|Overall Study|Protocol Violation|0|||
131767907|NCT00545740|474427853|FG000|Overall Study|Non-compliance|0|||
131767908|NCT00545740|474427854|FG001|Overall Study|Non-compliance|2|||
131767909|NCT00545740|474427855|FG002|Overall Study|Non-compliance|1|||
131767910|NCT00545740|474427856|FG003|Overall Study|Non-compliance|0|||
131767911|NCT00545740|474427853|FG000|Overall Study|Moved|2|||
131767912|NCT00545740|474427854|FG001|Overall Study|Moved|0|||
131767913|NCT00545740|474427855|FG002|Overall Study|Moved|1|||
131767914|NCT00545740|474427856|FG003|Overall Study|Moved|0|||
131767915|NCT00545740|474427853|FG000|Overall Study|Diverticulitis attack|0|||
131767916|NCT00545740|474427854|FG001|Overall Study|Diverticulitis attack|0|||
131767917|NCT00545740|474427855|FG002|Overall Study|Diverticulitis attack|1|||
131767918|NCT00545740|474427856|FG003|Overall Study|Diverticulitis attack|1|||
131767919|NCT00545740|474427853|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
131767920|NCT00545740|474427854|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
131767921|NCT00545740|474427855|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
131767922|NCT00545740|474427856|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
131767923|NCT00545740|474427853|FG000|Overall Study|Site closure|1|||
131767924|NCT00545740|474427854|FG001|Overall Study|Site closure|0|||
131767925|NCT00545740|474427855|FG002|Overall Study|Site closure|0|||
131767926|NCT00545740|474427856|FG003|Overall Study|Site closure|0|||
131767927|NCT00545740|474427853|FG000|Overall Study|Missed visit|1|||
131767928|NCT00545740|474427854|FG001|Overall Study|Missed visit|0|||
131767929|NCT00545740|474427855|FG002|Overall Study|Missed visit|0|||
131767930|NCT00545740|474427856|FG003|Overall Study|Missed visit|0|||
131767931|NCT00545740|474427853|FG000|Overall Study|Physician Decision|0|||
131767932|NCT00545740|474427854|FG001|Overall Study|Physician Decision|0|||
131400650|NCT00054327|473089562|FG000|Overall Study|Engraftment failure|1|||
131400651|NCT00054327|473089563|FG001|Overall Study|Engraftment failure|0|||
131400652|NCT00054327|473089564|FG002|Overall Study|Engraftment failure|0|||
131400653|NCT00054327|473089565|FG003|Overall Study|Engraftment failure|0|||
131767933|NCT00545740|474427855|FG002|Overall Study|Physician Decision|3|||
131767934|NCT00545740|474427856|FG003|Overall Study|Physician Decision|0|||
131767935|NCT00545740|474427853|FG000|Overall Study|Accepted only monthly telephone calls|1|||
131767936|NCT00545740|474427854|FG001|Overall Study|Accepted only monthly telephone calls|0|||
131767937|NCT00545740|474427855|FG002|Overall Study|Accepted only monthly telephone calls|0|||
131767938|NCT00545740|474427856|FG003|Overall Study|Accepted only monthly telephone calls|0|||
131767939|NCT00545740|474427853|FG000|Overall Study|Sponsor decision|0|||
131767940|NCT00545740|474427854|FG001|Overall Study|Sponsor decision|1|||
131767941|NCT00545740|474427855|FG002|Overall Study|Sponsor decision|0|||
131767942|NCT00545740|474427856|FG003|Overall Study|Sponsor decision|0|||
131767943|NCT00545740|474427853|FG000|Overall Study|Lack of time|0|||
131767944|NCT00545740|474427854|FG001|Overall Study|Lack of time|1|||
131767945|NCT00545740|474427855|FG002|Overall Study|Lack of time|0|||
131767946|NCT00545740|474427856|FG003|Overall Study|Lack of time|0|||
131767947|NCT00545740|474427853|FG000|Overall Study|Non-adherence to visits|0|||
131767948|NCT00545740|474427854|FG001|Overall Study|Non-adherence to visits|1|||
131767949|NCT00545740|474427855|FG002|Overall Study|Non-adherence to visits|0|||
131767950|NCT00545740|474427856|FG003|Overall Study|Non-adherence to visits|0|||
131767951|NCT00545740|474427853|FG000|Overall Study|Patient difficulties|0|||
131767952|NCT00545740|474427854|FG001|Overall Study|Patient difficulties|1|||
131767953|NCT00545740|474427855|FG002|Overall Study|Patient difficulties|0|||
131767954|NCT00545740|474427856|FG003|Overall Study|Patient difficulties|0|||
131767955|NCT00545740|474427853|FG000|Overall Study|Husband against study|0|||
131767956|NCT00545740|474427854|FG001|Overall Study|Husband against study|0|||
131767957|NCT00545740|474427855|FG002|Overall Study|Husband against study|1|||
131767958|NCT00545740|474427856|FG003|Overall Study|Husband against study|0|||
131767959|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
131767960|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
131767961|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
131767962|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
131767963|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
131767964|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
131767965|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Death|1|||
131767966|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Death|1|||
131767967|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Death|1|||
131767968|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Death|0|||
131767969|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Death|0|||
131767970|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Death|0|||
131767971|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
131767972|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
131767973|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131767974|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131767975|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131767976|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131767977|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131767978|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131767979|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
131814544|NCT01592240|474604472|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
131814545|NCT01592240|474604473|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
131814546|NCT01592240|474604474|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
131814547|NCT01592240|474604475|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
131400654|NCT00054327|473089566|FG004|Overall Study|Engraftment failure|0|||
131400655|NCT00054327|473089567|FG005|Overall Study|Engraftment failure|0|||
131767980|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131767981|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131767982|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131767983|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131767984|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
131767985|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131767986|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131767987|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131767988|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131767989|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
131767990|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
131767991|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
131767992|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
131400656|NCT00344318|473089568|FG000|Overall Study|Adverse Event|0|||
131400657|NCT00344318|473089569|FG001|Overall Study|Adverse Event|3|||
131767993|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
131767994|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
131767995|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
131767996|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
131767997|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
131767998|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
131767999|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
131768000|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
131768001|NCT03370133|474427866|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
131768002|NCT03370133|474427867|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
131768003|NCT03370133|474427868|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
131768004|NCT03370133|474427869|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
131768005|NCT03370133|474427870|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
131768006|NCT03370133|474427871|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
131768007|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
131768008|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
131768009|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
131768010|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
131768011|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
131768012|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
131768013|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131768014|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131768015|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131768016|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131768017|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
131768018|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
131768019|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131768020|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131768021|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131768022|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
131768023|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
131768024|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131768025|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131768026|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131768027|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131768028|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131768029|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
131768030|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
131768031|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
131768032|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
131768033|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
131768034|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
131768035|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
131768036|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
131768037|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131768038|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131768039|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131768040|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131768041|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
131768042|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131768043|NCT03370133|474427866|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131768044|NCT03370133|474427867|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131768045|NCT03370133|474427868|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131768046|NCT03370133|474427869|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131768047|NCT03370133|474427870|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131768048|NCT03370133|474427871|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
131768049|NCT00636506|474427872|FG000|Overall Study|Lost to Follow-up|8|||
131814548|NCT01592240|474604476|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
131814549|NCT01896934|474604480|FG000|Overall Study|Adverse Event|1|||
131814550|NCT01896934|474604480|FG000|Overall Study|Withdrawal by Subject|1|||
131814551|NCT02751424|474604481|FG000|Part 2|Adverse Event|0|||
131814552|NCT02751424|474604482|FG001|Part 2|Adverse Event|0|||
131768050|NCT00636506|474427872|FG000|Overall Study|Explanted|1|||
131814553|NCT02751424|474604483|FG002|Part 2|Adverse Event|0|||
131814554|NCT02751424|474604484|FG003|Part 2|Adverse Event|0|||
131814555|NCT02751424|474604485|FG004|Part 2|Adverse Event|0|||
131449835|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
131400658|NCT00344318|473089570|FG002|Overall Study|Adverse Event|0|||
131400659|NCT00344318|473089571|FG003|Overall Study|Adverse Event|1|||
131400660|NCT00344318|473089568|FG000|Overall Study|Withdrawal by Subject|2|||
131400661|NCT00344318|473089569|FG001|Overall Study|Withdrawal by Subject|2|||
131400662|NCT00344318|473089570|FG002|Overall Study|Withdrawal by Subject|0|||
131400663|NCT00344318|473089571|FG003|Overall Study|Withdrawal by Subject|2|||
131768051|NCT00636506|474427872|FG000|Overall Study|Withdrawal by Subject|6|||
131768052|NCT00636506|474427872|FG000|Overall Study|Procedure aborted|1|||
131768053|NCT03742271|474427873|FG000|Overall Study|Unsatisfactory Visual Response|1|||
131768054|NCT03742271|474427873|FG000|Overall Study|Withdrawal by Subject|3|||
131768055|NCT03742271|474427873|FG000|Overall Study|Lost to Follow-up|4|||
131768056|NCT03742271|474427873|FG000|Overall Study|Failed Insertion & removal|3|||
131768057|NCT03742271|474427873|FG000|Overall Study|Protocol Violation|1|||
131768058|NCT01624974|474427874|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
131768059|NCT01624974|474427875|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
131768060|NCT01624974|474427874|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
131768061|NCT01624974|474427875|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
131768062|NCT01624974|474427874|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
131768063|NCT01624974|474427875|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
131768064|NCT01624974|474427874|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
131768065|NCT01624974|474427875|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
131768066|NCT01624974|474427874|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
131768067|NCT01624974|474427875|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
131768068|NCT01624974|474427874|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
131768069|NCT01624974|474427875|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
131768070|NCT01624974|474427874|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
131768071|NCT01624974|474427875|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
131768072|NCT01624974|474427874|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
131768073|NCT01624974|474427875|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
131768074|NCT01624974|474427874|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
131768075|NCT01624974|474427875|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
131768076|NCT01624974|474427874|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
131768077|NCT01624974|474427875|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
131768078|NCT01624974|474427874|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
131768079|NCT01624974|474427875|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
131768080|NCT01624974|474427874|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
131768081|NCT01624974|474427875|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
131768082|NCT01376908|474427876|FG000|Overall Study|Protocol Violation|1|||
131768083|NCT01376908|474427877|FG001|Overall Study|Protocol Violation|1|||
131768084|NCT01376908|474427876|FG000|Overall Study|Withdrawal by Subject|1|||
131768085|NCT01376908|474427877|FG001|Overall Study|Withdrawal by Subject|2|||
131768086|NCT01468844|474427878|FG000|Overall Study|Adverse Event|1|||
131768087|NCT01468844|474427879|FG001|Overall Study|Adverse Event|0|||
131768088|NCT01468844|474427878|FG000|Overall Study|Withdrawal by Subject|1|||
131768089|NCT01468844|474427879|FG001|Overall Study|Withdrawal by Subject|0|||
131768090|NCT00266695|474427880|FG000|Overall Study|Adverse Event|1|||
131768091|NCT00266695|474427880|FG000|Overall Study|Death|9|||
131768092|NCT00266695|474427880|FG000|Overall Study|Physician Decision|1|||
131768093|NCT00266695|474427880|FG000|Overall Study|Lost to Follow-up|3|||
131768094|NCT00266695|474427880|FG000|Overall Study|Withdrawal by Subject|15|||
131768095|NCT02417935|474427881|FG000|Treatment Period|Adverse Event|12|||
131768096|NCT02417935|474427882|FG001|Treatment Period|Adverse Event|10|||
131768097|NCT02417935|474427881|FG000|Treatment Period|Lost to Follow-up|1|||
131768098|NCT02417935|474427882|FG001|Treatment Period|Lost to Follow-up|0|||
131768099|NCT02417935|474427881|FG000|Treatment Period|Entry Criteria not met|0|||
131768100|NCT02417935|474427882|FG001|Treatment Period|Entry Criteria not met|1|||
131768101|NCT02417935|474427881|FG000|Treatment Period|Protocol Violation|2|||
131768102|NCT02417935|474427882|FG001|Treatment Period|Protocol Violation|1|||
131768103|NCT02417935|474427881|FG000|Treatment Period|Withdrawal by Subject|3|||
131768104|NCT02417935|474427882|FG001|Treatment Period|Withdrawal by Subject|3|||
131768105|NCT02417935|474427881|FG000|Treatment Period|Physician Decision|3|||
131768106|NCT02417935|474427882|FG001|Treatment Period|Physician Decision|1|||
131768107|NCT01899729|474427883|FG000|Overall Study|Adverse Event|1|||
131768108|NCT01899729|474427884|FG001|Overall Study|Adverse Event|0|||
131768109|NCT01899729|474427885|FG002|Overall Study|Adverse Event|0|||
131768110|NCT01899729|474427886|FG003|Overall Study|Adverse Event|0|||
131814556|NCT02751424|474604486|FG005|Part 2|Adverse Event|0|||
131400664|NCT00344318|473089568|FG000|Overall Study|Lost to Follow-up|2|||
131400665|NCT00344318|473089569|FG001|Overall Study|Lost to Follow-up|0|||
131400666|NCT00344318|473089570|FG002|Overall Study|Lost to Follow-up|1|||
131400667|NCT00344318|473089571|FG003|Overall Study|Lost to Follow-up|0|||
131400668|NCT01923363|473089574|FG000|Overall Study|Protocol Violation|1|||
131768111|NCT01899729|474427887|FG004|Overall Study|Adverse Event|1|||
131768112|NCT01899729|474427883|FG000|Overall Study|Withdrawal by Subject|1|||
131814557|NCT02751424|474604487|FG006|Part 2|Adverse Event|0|||
131814558|NCT02751424|474604488|FG007|Part 2|Adverse Event|5|||
131814559|NCT02751424|474604489|FG008|Part 2|Adverse Event|0|||
131814560|NCT02197416|474604490|FG000|Overall Study|Other reasons|0|||
131814561|NCT02197416|474604491|FG001|Overall Study|Other reasons|2|||
131814562|NCT02197416|474604492|FG002|Overall Study|Other reasons|5|||
131814563|NCT02197416|474604490|FG000|Overall Study|Withdrawal by Subject|0|||
131814564|NCT02197416|474604491|FG001|Overall Study|Withdrawal by Subject|2|||
131814565|NCT02197416|474604492|FG002|Overall Study|Withdrawal by Subject|1|||
131814566|NCT02197416|474604490|FG000|Overall Study|Protocol Violation|1|||
131814567|NCT02197416|474604491|FG001|Overall Study|Protocol Violation|0|||
131814568|NCT02197416|474604492|FG002|Overall Study|Protocol Violation|1|||
131814569|NCT02197416|474604490|FG000|Overall Study|Adverse Event|0|||
131814570|NCT02197416|474604491|FG001|Overall Study|Adverse Event|0|||
131814571|NCT02197416|474604492|FG002|Overall Study|Adverse Event|1|||
131814572|NCT02451696|474604493|FG000|Overall Study|Surgery postponed|1|||
131814573|NCT02451696|474604494|FG001|Overall Study|Surgery postponed|0|||
131814574|NCT05523895|474604496|FG000|Overall Study|Adverse Event|2|||
131814575|NCT05523895|474604497|FG001|Overall Study|Adverse Event|1|||
131814576|NCT05523895|474604498|FG002|Overall Study|Adverse Event|1|||
131814577|NCT05523895|474604496|FG000|Overall Study|Lost to Follow-up|0|||
131814578|NCT05523895|474604497|FG001|Overall Study|Lost to Follow-up|1|||
131814579|NCT05523895|474604498|FG002|Overall Study|Lost to Follow-up|2|||
131814580|NCT05523895|474604496|FG000|Overall Study|Noncompliance with study drug|1|||
131768113|NCT01899729|474427884|FG001|Overall Study|Withdrawal by Subject|2|||
131768114|NCT01899729|474427885|FG002|Overall Study|Withdrawal by Subject|0|||
131768115|NCT01899729|474427886|FG003|Overall Study|Withdrawal by Subject|0|||
131768116|NCT01899729|474427887|FG004|Overall Study|Withdrawal by Subject|0|||
131768117|NCT01899729|474427883|FG000|Overall Study|Lack of Efficacy|0|||
131768118|NCT01899729|474427884|FG001|Overall Study|Lack of Efficacy|0|||
131768119|NCT01899729|474427885|FG002|Overall Study|Lack of Efficacy|2|||
131768120|NCT01899729|474427886|FG003|Overall Study|Lack of Efficacy|0|||
131768121|NCT01899729|474427887|FG004|Overall Study|Lack of Efficacy|1|||
131768122|NCT02646332|474427890|FG000|Overall Study|Lost to Follow-up|0|||
131768123|NCT02646332|474427891|FG001|Overall Study|Lost to Follow-up|3|||
131768124|NCT04490499|474427892|FG000|Overall Study|Withdrawal by Subject|2|||
131768125|NCT03125902|474427893|FG000|Overall Study|Adverse Event|0|||
131768126|NCT03125902|474427894|FG001|Overall Study|Adverse Event|1|||
131768127|NCT03125902|474427893|FG000|Overall Study|Death|119|||
131768128|NCT03125902|474427894|FG001|Overall Study|Death|229|||
131768129|NCT03125902|474427893|FG000|Overall Study|Lost to Follow-up|4|||
131768130|NCT03125902|474427894|FG001|Overall Study|Lost to Follow-up|13|||
131768131|NCT03125902|474427893|FG000|Overall Study|Other|0|||
131768132|NCT03125902|474427894|FG001|Overall Study|Other|4|||
131768133|NCT03125902|474427893|FG000|Overall Study|Physician Decision|2|||
131768134|NCT03125902|474427894|FG001|Overall Study|Physician Decision|1|||
131768135|NCT03125902|474427893|FG000|Overall Study|Progressive Disease|0|||
131768136|NCT03125902|474427894|FG001|Overall Study|Progressive Disease|3|||
131768137|NCT03125902|474427893|FG000|Overall Study|Study Terminated By Sponsor|74|||
131768138|NCT03125902|474427894|FG001|Overall Study|Study Terminated By Sponsor|143|||
131768139|NCT03125902|474427893|FG000|Overall Study|Withdrawal by Subject|21|||
131768140|NCT03125902|474427894|FG001|Overall Study|Withdrawal by Subject|37|||
131768141|NCT01657903|474427895|FG000|Overall Study|Lost to Follow-up|1|||
131768142|NCT01657903|474427895|FG000|Overall Study|Withdrawal by Subject|1|||
131768143|NCT01259388|474427896|FG000|Overall Study|Adverse Event|3|||
131768144|NCT01259388|474427897|FG001|Overall Study|Adverse Event|0|||
131768145|NCT01259388|474427896|FG000|Overall Study|Withdrawal by Subject|1|||
131768146|NCT01259388|474427897|FG001|Overall Study|Withdrawal by Subject|1|||
131768147|NCT01259388|474427896|FG000|Overall Study|Physician Decision|1|||
131814581|NCT05523895|474604497|FG001|Overall Study|Noncompliance with study drug|1|||
131814582|NCT05523895|474604498|FG002|Overall Study|Noncompliance with study drug|1|||
131814583|NCT05523895|474604496|FG000|Overall Study|Protocol Violation|0|||
131814584|NCT05523895|474604497|FG001|Overall Study|Protocol Violation|2|||
131814585|NCT05523895|474604498|FG002|Overall Study|Protocol Violation|0|||
131814586|NCT05523895|474604496|FG000|Overall Study|Withdrawal by Subject|1|||
131814587|NCT05523895|474604497|FG001|Overall Study|Withdrawal by Subject|3|||
131814588|NCT05523895|474604498|FG002|Overall Study|Withdrawal by Subject|1|||
131400669|NCT00290771|473089581|FG000|Overall Study|Disease progression|95|||
131768148|NCT01259388|474427897|FG001|Overall Study|Physician Decision|0|||
131768149|NCT02743494|474427898|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
131768150|NCT02743494|474427899|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
131768151|NCT02743494|474427898|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
131768152|NCT02743494|474427899|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
131814589|NCT05523895|474604496|FG000|Overall Study|Not further specified|0|||
131814590|NCT05523895|474604497|FG001|Overall Study|Not further specified|3|||
131814591|NCT05523895|474604498|FG002|Overall Study|Not further specified|1|||
131768153|NCT02743494|474427898|FG000|Treatment Period|Completed treatment|229|||
131768154|NCT02743494|474427899|FG001|Treatment Period|Completed treatment|99|||
131909733|NCT03225287|474956827|FG002|Overall Study|Adverse Event|1|||
131909734|NCT03225287|474956825|FG000|Overall Study|Protocol non-compliance|0|||
131909735|NCT03225287|474956826|FG001|Overall Study|Protocol non-compliance|0|||
131909736|NCT03225287|474956827|FG002|Overall Study|Protocol non-compliance|1|||
131768155|NCT02743494|474427898|FG000|Treatment Period|Disease recurrence|149|||
131768156|NCT02743494|474427899|FG001|Treatment Period|Disease recurrence|113|||
131768157|NCT02743494|474427898|FG000|Treatment Period|Study drug toxicity|57|||
131768158|NCT02743494|474427899|FG001|Treatment Period|Study drug toxicity|8|||
131768159|NCT02743494|474427898|FG000|Treatment Period|Death|1|||
131768160|NCT02743494|474427899|FG001|Treatment Period|Death|0|||
131768161|NCT02743494|474427898|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
131768162|NCT02743494|474427899|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
131768163|NCT02743494|474427898|FG000|Treatment Period|Participant request to discontinue treatment|30|||
131768164|NCT02743494|474427899|FG001|Treatment Period|Participant request to discontinue treatment|5|||
131768165|NCT02743494|474427898|FG000|Treatment Period|Participant withdrew consent|12|||
131768166|NCT02743494|474427899|FG001|Treatment Period|Participant withdrew consent|4|||
131768167|NCT02743494|474427898|FG000|Treatment Period|Lost to Follow-up|0|||
131768168|NCT02743494|474427899|FG001|Treatment Period|Lost to Follow-up|1|||
131768169|NCT02743494|474427898|FG000|Treatment Period|Poor/Non-compliance|1|||
131768170|NCT02743494|474427899|FG001|Treatment Period|Poor/Non-compliance|0|||
131768171|NCT02743494|474427898|FG000|Treatment Period|Other reasons|7|||
131768172|NCT02743494|474427899|FG001|Treatment Period|Other reasons|2|||
131768173|NCT01521494|474427902|FG000|Overall Study|Adverse Event|1|||
131768174|NCT01521494|474427903|FG001|Overall Study|Adverse Event|2|||
131768175|NCT01521494|474427904|FG002|Overall Study|Adverse Event|9|||
131768176|NCT01521494|474427905|FG003|Overall Study|Adverse Event|6|||
131768177|NCT01521494|474427906|FG004|Overall Study|Adverse Event|2|||
131768178|NCT01521494|474427902|FG000|Overall Study|Lack of Efficacy|0|||
131768179|NCT01521494|474427903|FG001|Overall Study|Lack of Efficacy|0|||
131768180|NCT01521494|474427904|FG002|Overall Study|Lack of Efficacy|0|||
131768181|NCT01521494|474427905|FG003|Overall Study|Lack of Efficacy|0|||
131768182|NCT01521494|474427906|FG004|Overall Study|Lack of Efficacy|2|||
131768183|NCT01521494|474427902|FG000|Overall Study|Withdrawal by Subject|1|||
131768184|NCT01521494|474427903|FG001|Overall Study|Withdrawal by Subject|1|||
131768185|NCT01521494|474427904|FG002|Overall Study|Withdrawal by Subject|0|||
131768186|NCT01521494|474427905|FG003|Overall Study|Withdrawal by Subject|2|||
131768187|NCT01521494|474427906|FG004|Overall Study|Withdrawal by Subject|0|||
131768188|NCT01521494|474427902|FG000|Overall Study|Decrease in serum phosphate|0|||
131768189|NCT01521494|474427903|FG001|Overall Study|Decrease in serum phosphate|2|||
131768190|NCT01521494|474427904|FG002|Overall Study|Decrease in serum phosphate|3|||
131768191|NCT01521494|474427905|FG003|Overall Study|Decrease in serum phosphate|12|||
131768192|NCT01521494|474427906|FG004|Overall Study|Decrease in serum phosphate|0|||
131768193|NCT01521494|474427902|FG000|Overall Study|Decrease in serum calcium|0|||
131768194|NCT01521494|474427903|FG001|Overall Study|Decrease in serum calcium|0|||
131768195|NCT01521494|474427904|FG002|Overall Study|Decrease in serum calcium|0|||
131768196|NCT01521494|474427905|FG003|Overall Study|Decrease in serum calcium|1|||
131768197|NCT01521494|474427906|FG004|Overall Study|Decrease in serum calcium|1|||
131768198|NCT01521494|474427902|FG000|Overall Study|Physician Decision|0|||
131768199|NCT01521494|474427903|FG001|Overall Study|Physician Decision|0|||
131768200|NCT01521494|474427904|FG002|Overall Study|Physician Decision|0|||
131768201|NCT01521494|474427905|FG003|Overall Study|Physician Decision|0|||
131768202|NCT01521494|474427906|FG004|Overall Study|Physician Decision|2|||
131768203|NCT03969589|474427909|FG000|Overall Study|Lost to Follow-up|3|||
131768204|NCT03969589|474427910|FG001|Overall Study|Lost to Follow-up|2|||
131768205|NCT03969589|474427909|FG000|Overall Study|Declined Follow-Up|0|||
131768206|NCT03969589|474427910|FG001|Overall Study|Declined Follow-Up|1|||
131768207|NCT00517634|474427911|FG000|Second Treatment Period|Withdrawal by Subject|0|||
131768208|NCT00517634|474427912|FG001|Second Treatment Period|Withdrawal by Subject|0|||
131768209|NCT00517634|474427913|FG002|Second Treatment Period|Withdrawal by Subject|0|||
131768210|NCT00517634|474427914|FG003|Second Treatment Period|Withdrawal by Subject|0|||
131768211|NCT00517634|474427915|FG004|Second Treatment Period|Withdrawal by Subject|1|||
131768212|NCT00517634|474427916|FG005|Second Treatment Period|Withdrawal by Subject|0|||
131768213|NCT03143855|474427917|FG000|Overall Study|Withdrawal by Subject|4|||
131768214|NCT03143855|474427918|FG001|Overall Study|Withdrawal by Subject|3|||
131909737|NCT03225287|474956825|FG000|Overall Study|Subject withdraws consent|3|||
131909738|NCT03225287|474956826|FG001|Overall Study|Subject withdraws consent|0|||
131909739|NCT03225287|474956827|FG002|Overall Study|Subject withdraws consent|0|||
131909740|NCT03225287|474956825|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
131768215|NCT03143855|474427917|FG000|Overall Study|Protocol Violation|1|||
131768216|NCT03143855|474427918|FG001|Overall Study|Protocol Violation|0|||
131768217|NCT03143855|474427917|FG000|Overall Study|Participant experienced withdrawal|0|||
131768218|NCT03143855|474427918|FG001|Overall Study|Participant experienced withdrawal|1|||
131768219|NCT00489216|474427919|FG000|Overall Study|Adverse Event|1|||
131768220|NCT02539160|474427920|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
131768221|NCT02539160|474427921|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
131909741|NCT03225287|474956826|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
131768222|NCT02539160|474427922|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
131768223|NCT02539160|474427923|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
131768224|NCT02539160|474427920|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
131768225|NCT02539160|474427921|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
131768226|NCT02539160|474427922|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
131768227|NCT02539160|474427923|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
131768228|NCT02539160|474427920|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
131768229|NCT02539160|474427921|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
131768230|NCT02539160|474427922|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
131768231|NCT02539160|474427923|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
131768232|NCT01681004|474427924|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
131768233|NCT01681004|474427925|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
131768234|NCT01681004|474427924|FG000|Study Completion|Lost to Follow-up|8|||
131768235|NCT01681004|474427925|FG001|Study Completion|Lost to Follow-up|3|||
131768236|NCT01681004|474427924|FG000|Study Completion|Physician Decision|1|||
131768237|NCT01681004|474427925|FG001|Study Completion|Physician Decision|3|||
131768238|NCT01681004|474427924|FG000|Study Completion|Site Termination|2|||
131768239|NCT01681004|474427925|FG001|Study Completion|Site Termination|1|||
131768240|NCT01681004|474427924|FG000|Study Completion|Death|1|||
131768241|NCT01681004|474427925|FG001|Study Completion|Death|1|||
131768242|NCT02828982|474427926|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131768243|NCT02828982|474427927|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131768244|NCT00701064|474427928|FG000|Overall Study|Protocol Violation|1|||
131768245|NCT00701064|474427929|FG001|Overall Study|Protocol Violation|1|||
131768246|NCT00701064|474427928|FG000|Overall Study|Withdrawal by Subject|1|||
131768247|NCT00701064|474427929|FG001|Overall Study|Withdrawal by Subject|1|||
131768248|NCT00701064|474427928|FG000|Overall Study|initiated other PTSD treatment|2|||
131768249|NCT00701064|474427929|FG001|Overall Study|initiated other PTSD treatment|2|||
131768250|NCT00695318|474427930|FG000|Overall Study|Lost to Follow-up|1|||
131768251|NCT00695318|474427931|FG001|Overall Study|Lost to Follow-up|0|||
131768252|NCT00695318|474427930|FG000|Overall Study|Withdrawal by Subject|2|||
131768253|NCT00695318|474427931|FG001|Overall Study|Withdrawal by Subject|0|||
131768254|NCT00695318|474427930|FG000|Overall Study|Death|1|||
131768255|NCT00695318|474427931|FG001|Overall Study|Death|1|||
131768256|NCT00695318|474427930|FG000|Overall Study|Study Terminated|1|||
131768257|NCT00695318|474427931|FG001|Overall Study|Study Terminated|0|||
131768258|NCT00758394|474427932|FG000|2nd Intervention Order|Lost to Follow-up|0|||
131768259|NCT00758394|474427933|FG001|2nd Intervention Order|Lost to Follow-up|1|||
131768260|NCT00758394|474427934|FG002|2nd Intervention Order|Lost to Follow-up|0|||
131400670|NCT00290771|473089582|FG001|Overall Study|Disease progression|73|||
131400671|NCT00290771|473089581|FG000|Overall Study|Death|11|||
131400672|NCT00290771|473089582|FG001|Overall Study|Death|10|||
131400673|NCT00290771|473089581|FG000|Overall Study|Adverse Event|12|||
131400674|NCT00290771|473089582|FG001|Overall Study|Adverse Event|6|||
131400675|NCT00290771|473089581|FG000|Overall Study|Withdrawal by Subject|5|||
131400676|NCT00290771|473089582|FG001|Overall Study|Withdrawal by Subject|6|||
131400677|NCT00290771|473089581|FG000|Overall Study|Administrative problems|2|||
131400678|NCT00290771|473089582|FG001|Overall Study|Administrative problems|1|||
131400679|NCT00290771|473089581|FG000|Overall Study|Protocol Violation|2|||
131768261|NCT00758394|474427935|FG003|2nd Intervention Order|Lost to Follow-up|0|||
131768262|NCT00758394|474427932|FG000|3rd Intervention|Lost to Follow-up|1|||
131768263|NCT00758394|474427933|FG001|3rd Intervention|Lost to Follow-up|0|||
131768264|NCT00758394|474427934|FG002|3rd Intervention|Lost to Follow-up|0|||
131768265|NCT00758394|474427935|FG003|3rd Intervention|Lost to Follow-up|1|||
131768266|NCT01078389|474429722|FG000|Overall Study|Adverse Event|10|||
131768267|NCT01078389|474429723|FG001|Overall Study|Adverse Event|6|||
131768268|NCT01078389|474429722|FG000|Overall Study|Major Protocol Deviation|2|||
131768269|NCT01078389|474429723|FG001|Overall Study|Major Protocol Deviation|0|||
131768270|NCT01078389|474429722|FG000|Overall Study|Lost to Follow-up|23|||
131768271|NCT01078389|474429723|FG001|Overall Study|Lost to Follow-up|23|||
131768272|NCT01078389|474429722|FG000|Overall Study|Voluntary Withdrawal|20|||
131768273|NCT01078389|474429723|FG001|Overall Study|Voluntary Withdrawal|36|||
131400680|NCT00290771|473089582|FG001|Overall Study|Protocol Violation|0|||
131400681|NCT00290771|473089581|FG000|Overall Study|Lost to Follow-up|0|||
131400682|NCT00290771|473089582|FG001|Overall Study|Lost to Follow-up|1|||
131400683|NCT00244933|473089585|FG000|Overall Study|Not response evaluable|2|||
131768274|NCT01078389|474429722|FG000|Overall Study|Other|9|||
131768275|NCT01078389|474429723|FG001|Overall Study|Other|2|||
131768276|NCT04823494|474429724|FG000|Overall Study|Programming software malfunction.|1|||
131768277|NCT04823494|474429725|FG001|Overall Study|Programming software malfunction.|0|||
131768278|NCT04823494|474429724|FG000|Overall Study|Withdrawal by Subject|1|||
131768279|NCT04823494|474429725|FG001|Overall Study|Withdrawal by Subject|0|||
131768280|NCT04823494|474429724|FG000|Overall Study|Devices lost|0|||
131768281|NCT04823494|474429725|FG001|Overall Study|Devices lost|1|||
131768282|NCT03726320|474429726|FG000|Overall Study|Lost to Follow-up|2|||
131768283|NCT03726320|474429727|FG001|Overall Study|Lost to Follow-up|4|||
131768284|NCT03726320|474429728|FG002|Overall Study|Lost to Follow-up|0|||
131768285|NCT03726320|474429726|FG000|Overall Study|Time Constraints|4|||
131768286|NCT03726320|474429727|FG001|Overall Study|Time Constraints|1|||
131768287|NCT03726320|474429728|FG002|Overall Study|Time Constraints|0|||
131768288|NCT03726320|474429726|FG000|Overall Study|Ineligible after enrollment|3|||
131768289|NCT03726320|474429727|FG001|Overall Study|Ineligible after enrollment|3|||
131768290|NCT03726320|474429728|FG002|Overall Study|Ineligible after enrollment|0|||
131768291|NCT03726320|474429726|FG000|Overall Study|Clinic / insurance issue|2|||
131768292|NCT03726320|474429727|FG001|Overall Study|Clinic / insurance issue|0|||
131768293|NCT03726320|474429728|FG002|Overall Study|Clinic / insurance issue|0|||
131768294|NCT03726320|474429726|FG000|Overall Study|Language barrier|1|||
131768295|NCT03726320|474429727|FG001|Overall Study|Language barrier|0|||
131768296|NCT03726320|474429728|FG002|Overall Study|Language barrier|0|||
131768297|NCT03726320|474429726|FG000|Overall Study|Provider left the clinic|0|||
131768298|NCT03726320|474429727|FG001|Overall Study|Provider left the clinic|0|||
131768299|NCT03726320|474429728|FG002|Overall Study|Provider left the clinic|1|||
131768300|NCT03691831|474429731|FG000|Overall Study|Lost to Follow-up|16|||
131768301|NCT03691831|474429732|FG001|Overall Study|Lost to Follow-up|12|||
131768302|NCT03691831|474429731|FG000|Overall Study|Withdrawal by Subject|9|||
131768303|NCT03691831|474429732|FG001|Overall Study|Withdrawal by Subject|17|||
131768304|NCT03691831|474429731|FG000|Overall Study|Investigator Decision|2|||
131768305|NCT03691831|474429732|FG001|Overall Study|Investigator Decision|2|||
131768306|NCT02028182|474429733|FG000|Overall Study|Protocol Violation|2|||
131768307|NCT01684930|474429736|FG000|Overall Study|Withdrawal by Subject|3|||
131768308|NCT01684930|474429737|FG001|Overall Study|Withdrawal by Subject|1|||
131768309|NCT02198040|474429738|FG000|Overall Study|Work reasons|0|||
131768310|NCT02198040|474429739|FG001|Overall Study|Work reasons|1|||
131768311|NCT02198040|474429740|FG002|Overall Study|Work reasons|0|||
131768312|NCT02198040|474429738|FG000|Overall Study|Withdrawal by Subject|0|||
131768313|NCT02198040|474429739|FG001|Overall Study|Withdrawal by Subject|0|||
131768314|NCT02198040|474429740|FG002|Overall Study|Withdrawal by Subject|1|||
131768315|NCT04524663|474429741|FG000|Overall Study|Withdrawal by Subject|0|||
131768316|NCT04524663|474429742|FG001|Overall Study|Withdrawal by Subject|2|||
131768317|NCT00337935|474429743|FG000|Overall Study|Adverse Event|2|||
131768318|NCT00337935|474429744|FG001|Overall Study|Adverse Event|5|||
131768319|NCT00337935|474429743|FG000|Overall Study|Death|2|||
131768320|NCT00337935|474429744|FG001|Overall Study|Death|8|||
131768321|NCT00337935|474429743|FG000|Overall Study|Physician Decision|1|||
131768322|NCT00337935|474429744|FG001|Overall Study|Physician Decision|1|||
131768323|NCT00337935|474429743|FG000|Overall Study|Lost to Follow-up|0|||
131768324|NCT00337935|474429744|FG001|Overall Study|Lost to Follow-up|1|||
131768325|NCT00337935|474429743|FG000|Overall Study|Protocol Violation|4|||
131768326|NCT00337935|474429744|FG001|Overall Study|Protocol Violation|3|||
131768327|NCT00337935|474429743|FG000|Overall Study|Withdrawal by Subject|1|||
131768328|NCT00337935|474429744|FG001|Overall Study|Withdrawal by Subject|7|||
131768329|NCT00337935|474429743|FG000|Overall Study|Other|0|||
131768330|NCT00337935|474429744|FG001|Overall Study|Other|1|||
131768331|NCT00337935|474429743|FG000|Overall Study|Lack of Efficacy|0|||
131768332|NCT00337935|474429744|FG001|Overall Study|Lack of Efficacy|1|||
131768333|NCT00711009|474429745|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
131768334|NCT00711009|474429746|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
131768335|NCT00711009|474429745|FG000|Overall Study|Withdrawal by Subject|4|||
131768336|NCT00711009|474429746|FG001|Overall Study|Withdrawal by Subject|2|||
131768337|NCT00711009|474429745|FG000|Overall Study|Lost to Follow-up|3|||
131768338|NCT00711009|474429746|FG001|Overall Study|Lost to Follow-up|9|||
131768339|NCT00711009|474429745|FG000|Overall Study|Participant Noncompliant|0|||
131768340|NCT00711009|474429746|FG001|Overall Study|Participant Noncompliant|1|||
131768341|NCT00711009|474429745|FG000|Overall Study|Virologic Failure|2|||
131768342|NCT00711009|474429746|FG001|Overall Study|Virologic Failure|1|||
131768343|NCT00711009|474429745|FG000|Overall Study|Pregnancy|1|||
131768344|NCT00711009|474429746|FG001|Overall Study|Pregnancy|0|||
131768345|NCT00711009|474429745|FG000|Overall Study|Site closing|0|||
131768346|NCT00711009|474429746|FG001|Overall Study|Site closing|1|||
131768347|NCT00711009|474429745|FG000|Overall Study|Dose adjustment|1|||
131768348|NCT00711009|474429746|FG001|Overall Study|Dose adjustment|0|||
131768349|NCT03359811|474429747|FG000|Overall Study|Protocol Violation|2|||
131768350|NCT03359811|474429748|FG001|Overall Study|Protocol Violation|0|||
131768351|NCT01682876|474429750|FG000|Overall Study|Administrative reason|4|||
131768352|NCT01682876|474429751|FG001|Overall Study|Administrative reason|4|||
131768353|NCT01682876|474429752|FG002|Overall Study|Administrative reason|0|||
131768354|NCT01682876|474429753|FG003|Overall Study|Administrative reason|3|||
131768355|NCT01682876|474429750|FG000|Overall Study|Adverse Event|0|||
131768356|NCT01682876|474429751|FG001|Overall Study|Adverse Event|0|||
131768357|NCT01682876|474429752|FG002|Overall Study|Adverse Event|0|||
131768358|NCT01682876|474429753|FG003|Overall Study|Adverse Event|1|||
131768359|NCT01682876|474429750|FG000|Overall Study|Lost to Follow-up|11|||
131768360|NCT01682876|474429751|FG001|Overall Study|Lost to Follow-up|15|||
131768361|NCT01682876|474429752|FG002|Overall Study|Lost to Follow-up|9|||
131814592|NCT03674892|474604499|FG000|Overall Study|Lack of Efficacy|5|||
131768362|NCT01682876|474429753|FG003|Overall Study|Lost to Follow-up|11|||
131768363|NCT01682876|474429750|FG000|Overall Study|Protocol Violation|1|||
131768364|NCT01682876|474429751|FG001|Overall Study|Protocol Violation|1|||
131768365|NCT01682876|474429752|FG002|Overall Study|Protocol Violation|1|||
131768366|NCT01682876|474429753|FG003|Overall Study|Protocol Violation|1|||
131768367|NCT01682876|474429750|FG000|Overall Study|Withdrawal by Subject|4|||
131768368|NCT01682876|474429751|FG001|Overall Study|Withdrawal by Subject|0|||
131768369|NCT01682876|474429752|FG002|Overall Study|Withdrawal by Subject|0|||
131768370|NCT01682876|474429753|FG003|Overall Study|Withdrawal by Subject|2|||
131768371|NCT01682876|474429750|FG000|Overall Study|Other|1|||
131768372|NCT01682876|474429751|FG001|Overall Study|Other|0|||
131768373|NCT01682876|474429752|FG002|Overall Study|Other|1|||
131768374|NCT01682876|474429753|FG003|Overall Study|Other|1|||
131768375|NCT03922945|474429754|FG000|Overall Study|Adverse Event|1|||
131768376|NCT03922945|474429755|FG001|Overall Study|Adverse Event|1|||
131768377|NCT03922945|474429756|FG002|Overall Study|Adverse Event|2|||
131768378|NCT03922945|474429754|FG000|Overall Study|Lost to Follow-up|13|||
131768379|NCT03922945|474429755|FG001|Overall Study|Lost to Follow-up|9|||
131768380|NCT03922945|474429756|FG002|Overall Study|Lost to Follow-up|20|||
131768381|NCT03922945|474429754|FG000|Overall Study|Lack of Efficacy|2|||
131768382|NCT03922945|474429755|FG001|Overall Study|Lack of Efficacy|0|||
131768383|NCT03922945|474429756|FG002|Overall Study|Lack of Efficacy|1|||
131768384|NCT03922945|474429754|FG000|Overall Study|Protocol Non-Compliance|0|||
131768385|NCT03922945|474429755|FG001|Overall Study|Protocol Non-Compliance|0|||
131768386|NCT03922945|474429756|FG002|Overall Study|Protocol Non-Compliance|1|||
131768387|NCT03922945|474429754|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
131768388|NCT03922945|474429755|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
131768389|NCT03922945|474429756|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
131768390|NCT03922945|474429754|FG000|Overall Study|All Other Personal Reasons|1|||
131768391|NCT03922945|474429755|FG001|Overall Study|All Other Personal Reasons|1|||
131768392|NCT03922945|474429756|FG002|Overall Study|All Other Personal Reasons|2|||
131768393|NCT02491463|474429757|FG000|Overall Study|Withdrawal by Subject|1|||
131768394|NCT02491463|474429758|FG001|Overall Study|Withdrawal by Subject|2|||
131768395|NCT02491463|474429759|FG002|Overall Study|Withdrawal by Subject|0|||
131768396|NCT02491463|474429760|FG003|Overall Study|Withdrawal by Subject|0|||
131768397|NCT02491463|474429757|FG000|Overall Study|Migrated/moved from study area|1|||
131768398|NCT02491463|474429758|FG001|Overall Study|Migrated/moved from study area|5|||
131768399|NCT02491463|474429759|FG002|Overall Study|Migrated/moved from study area|1|||
131768400|NCT02491463|474429760|FG003|Overall Study|Migrated/moved from study area|1|||
131768401|NCT02491463|474429757|FG000|Overall Study|Lost to Follow-up|0|||
131768402|NCT02491463|474429758|FG001|Overall Study|Lost to Follow-up|3|||
131768403|NCT02491463|474429759|FG002|Overall Study|Lost to Follow-up|3|||
131768404|NCT02491463|474429760|FG003|Overall Study|Lost to Follow-up|0|||
131768405|NCT00039377|474429763|FG000|Initial Registration|Adverse Event|2|||
131768406|NCT00039377|474429764|FG001|Initial Registration|Adverse Event|0|||
131768407|NCT00039377|474429765|FG002|Initial Registration|Adverse Event|0|||
131768408|NCT00039377|474429766|FG003|Initial Registration|Adverse Event|0|||
131768409|NCT00039377|474429763|FG000|Initial Registration|Relapsed|6|||
131768410|NCT00039377|474429764|FG001|Initial Registration|Relapsed|0|||
131768411|NCT00039377|474429765|FG002|Initial Registration|Relapsed|0|||
131768412|NCT00039377|474429766|FG003|Initial Registration|Relapsed|0|||
131768413|NCT00039377|474429763|FG000|Initial Registration|Received non-protocol therapy|11|||
131768414|NCT00039377|474429764|FG001|Initial Registration|Received non-protocol therapy|0|||
131768415|NCT00039377|474429765|FG002|Initial Registration|Received non-protocol therapy|0|||
131768416|NCT00039377|474429766|FG003|Initial Registration|Received non-protocol therapy|0|||
131768417|NCT00039377|474429763|FG000|Initial Registration|Withdrawal by Subject|3|||
131768418|NCT00039377|474429764|FG001|Initial Registration|Withdrawal by Subject|0|||
131768419|NCT00039377|474429765|FG002|Initial Registration|Withdrawal by Subject|0|||
131814593|NCT03674892|474604499|FG000|Overall Study|Lost to Follow-up|3|||
131814594|NCT03674892|474604499|FG000|Overall Study|Migraine|2|||
131814595|NCT03674892|474604499|FG000|Overall Study|Excessive Tearing|1|||
131814596|NCT03674892|474604499|FG000|Overall Study|Increased Eye Pain|1|||
131814597|NCT03674892|474604499|FG000|Overall Study|Increased Facial Pain|1|||
131768420|NCT00039377|474429766|FG003|Initial Registration|Withdrawal by Subject|0|||
131768421|NCT01347931|474429770|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
131768422|NCT02493712|474429771|FG000|Overall Study|Withdrawal by Subject|1|||
131768423|NCT02493712|474429772|FG001|Overall Study|Withdrawal by Subject|0|||
131768424|NCT02493712|474429773|FG002|Overall Study|Withdrawal by Subject|2|||
131768425|NCT02493712|474429771|FG000|Overall Study|Protocol Violation|0|||
131814598|NCT03674892|474604499|FG000|Overall Study|Sinus Irritation|1|||
131768426|NCT02493712|474429772|FG001|Overall Study|Protocol Violation|0|||
131814599|NCT03674892|474604499|FG000|Overall Study|Sinus Infection|1|||
131768427|NCT02493712|474429773|FG002|Overall Study|Protocol Violation|1|||
131768428|NCT02493712|474429771|FG000|Overall Study|Lost to Follow-up|1|||
131768429|NCT02493712|474429772|FG001|Overall Study|Lost to Follow-up|0|||
131768430|NCT02493712|474429773|FG002|Overall Study|Lost to Follow-up|0|||
131768431|NCT02493712|474429771|FG000|Overall Study|Physician Decision|0|||
131814600|NCT01959672|474604504|FG000|Overall Study|Death|1|||
131814601|NCT05041361|474604507|FG000|Overall Study|Lost to Follow-up|1|||
131814602|NCT05041361|474604508|FG001|Overall Study|Lost to Follow-up|3|||
131814603|NCT01642277|474604509|FG000|Overall Study|Adverse Event|10|||
131814604|NCT01642277|474604510|FG001|Overall Study|Adverse Event|0|||
131814605|NCT01642277|474604509|FG000|Overall Study|Physician Decision|2|||
131814606|NCT01642277|474604510|FG001|Overall Study|Physician Decision|0|||
131814607|NCT01642277|474604509|FG000|Overall Study|Protocol Violation|1|||
131814608|NCT01642277|474604510|FG001|Overall Study|Protocol Violation|0|||
131814609|NCT01642277|474604509|FG000|Overall Study|Withdrawal by Subject|11|||
131814610|NCT01642277|474604510|FG001|Overall Study|Withdrawal by Subject|0|||
131814611|NCT03605342|474604511|FG000|Overall Study|Withdrawal by Subject|9|||
131814612|NCT03605342|474604512|FG001|Overall Study|Withdrawal by Subject|7|||
131814613|NCT03605342|474604511|FG000|Overall Study|Lost to Follow-up|1|||
131814614|NCT03605342|474604512|FG001|Overall Study|Lost to Follow-up|1|||
131814615|NCT03366792|474604513|FG000|Overall Study|Withdrawal by Subject|7|||
131814616|NCT03366792|474604513|FG000|Overall Study|Lost to Follow-up|2|||
131814617|NCT03366792|474604513|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
131814618|NCT03366792|474604513|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
131814619|NCT02450539|474604514|FG000|Overall Study|Withdrawal by Subject|12|||
131814620|NCT02450539|474604515|FG001|Overall Study|Withdrawal by Subject|6|||
131814621|NCT02450539|474604514|FG000|Overall Study|Lost to Follow-up|4|||
131814622|NCT02450539|474604515|FG001|Overall Study|Lost to Follow-up|1|||
131814623|NCT00585286|474604518|FG000|Overall Study|Lost to Follow-up|1|||
131814624|NCT00918684|474604523|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
131814625|NCT00918684|474604523|FG000|Treatment Phase|Lack of Efficacy|6|||
131814626|NCT00918684|474604523|FG000|Treatment Phase|Lost to Follow-up|2|||
131814627|NCT00918684|474604523|FG000|Treatment Phase|Physician Decision|8|||
131814628|NCT00918684|474604523|FG000|Treatment Phase|Protocol Violation|1|||
131814629|NCT00918684|474604523|FG000|Treatment Phase|Withdrawal by Subject|8|||
131814630|NCT00909038|474604524|FG000|Overall Study|Protocol Violation|187|||
131814631|NCT00909038|474604524|FG000|Overall Study|Non-evaluable Subjects|230|||
131768432|NCT02493712|474429772|FG001|Overall Study|Physician Decision|1|||
131768433|NCT02493712|474429773|FG002|Overall Study|Physician Decision|0|||
131768434|NCT02493712|474429771|FG000|Overall Study|Lack of Efficacy|0|||
131768435|NCT02493712|474429772|FG001|Overall Study|Lack of Efficacy|5|||
131768436|NCT02493712|474429773|FG002|Overall Study|Lack of Efficacy|3|||
131768437|NCT04563845|474429774|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768438|NCT04563845|474429775|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768439|NCT04563845|474429776|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768440|NCT04563845|474429777|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768441|NCT04563845|474429778|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768442|NCT04563845|474429779|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768443|NCT04563845|474429780|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768444|NCT04563845|474429781|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
131768445|NCT04563845|474429782|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768446|NCT04563845|474429783|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768447|NCT04563845|474429784|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768448|NCT04563845|474429785|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768449|NCT04563845|474429786|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768450|NCT04563845|474429787|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131768451|NCT04563845|474429774|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768452|NCT04563845|474429775|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768453|NCT04563845|474429776|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768454|NCT04563845|474429777|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768455|NCT04563845|474429778|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
131768456|NCT04563845|474429779|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768457|NCT04563845|474429780|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131909742|NCT03225287|474956827|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
131909743|NCT03225287|474956825|FG000|Overall Study|Trial drug not effective|0|||
131768458|NCT04563845|474429781|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768459|NCT04563845|474429782|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768460|NCT04563845|474429783|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768461|NCT04563845|474429784|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768462|NCT04563845|474429785|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768463|NCT04563845|474429786|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131768464|NCT04563845|474429787|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131814632|NCT00402103|474604527|FG000|Overall Study|Adverse Event|60|||
131814633|NCT00402103|474604528|FG001|Overall Study|Adverse Event|7|||
131814634|NCT00402103|474604527|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131814635|NCT00402103|474604528|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131814636|NCT00402103|474604527|FG000|Overall Study|Condition no longer requires study drug|2|||
131814637|NCT00402103|474604528|FG001|Overall Study|Condition no longer requires study drug|0|||
131814638|NCT00402103|474604527|FG000|Overall Study|Protocol Deviation|8|||
131814639|NCT00402103|474604528|FG001|Overall Study|Protocol Deviation|0|||
131814640|NCT00402103|474604527|FG000|Overall Study|Patient withdrew consent|12|||
131814641|NCT00402103|474604528|FG001|Overall Study|Patient withdrew consent|1|||
131814642|NCT00402103|474604527|FG000|Overall Study|Lost to Follow-up|6|||
131814643|NCT00402103|474604528|FG001|Overall Study|Lost to Follow-up|3|||
131814644|NCT00402103|474604527|FG000|Overall Study|Administrative problems|2|||
131814645|NCT00402103|474604528|FG001|Overall Study|Administrative problems|0|||
131814646|NCT04345653|474604529|FG000|Overall Study|Withdrawal by Subject|2|||
131814647|NCT01895335|474604534|FG000|Overall Study|Adverse Event|106|||
131814648|NCT01895335|474604534|FG000|Overall Study|Lack of Efficacy|53|||
131814649|NCT01895335|474604534|FG000|Overall Study|Poor Compliance to Protocol|11|||
131814650|NCT01895335|474604534|FG000|Overall Study|Included But Not treated|1|||
131814651|NCT01895335|474604534|FG000|Overall Study|Other than Specified Above|44|||
131814652|NCT00418938|474604535|FG000|Overall Study|Reimbursement|1|||
131814653|NCT00418938|474604536|FG001|Overall Study|Reimbursement|0|||
131814654|NCT00418938|474604535|FG000|Overall Study|Administrative decision|3|||
131814655|NCT00418938|474604536|FG001|Overall Study|Administrative decision|3|||
131814656|NCT00418938|474604535|FG000|Overall Study|Withdrawal by Subject|16|||
131814657|NCT00418938|474604536|FG001|Overall Study|Withdrawal by Subject|15|||
131814658|NCT00418938|474604535|FG000|Overall Study|Lost to Follow-up|1|||
131814659|NCT00418938|474604536|FG001|Overall Study|Lost to Follow-up|3|||
131814660|NCT00418938|474604535|FG000|Overall Study|Adverse Event|1|||
131814661|NCT00418938|474604536|FG001|Overall Study|Adverse Event|1|||
131814662|NCT00418938|474604535|FG000|Overall Study|On-going|1|||
131814663|NCT00418938|474604536|FG001|Overall Study|On-going|1|||
131814664|NCT00418938|474604535|FG000|Overall Study|Ineligibility Determined|1|||
131814665|NCT00418938|474604536|FG001|Overall Study|Ineligibility Determined|0|||
131814666|NCT00115063|474604537|FG000|Overall Study|Lost to Follow-up|98|||
131814667|NCT00115063|474604538|FG001|Overall Study|Lost to Follow-up|104|||
131814668|NCT00115063|474604537|FG000|Overall Study|Death|1|||
131814669|NCT00115063|474604538|FG001|Overall Study|Death|0|||
131814670|NCT01075282|474604539|FG000|Overall Study|Withdrawal by Subject|11|||
131814671|NCT01075282|474604540|FG001|Overall Study|Withdrawal by Subject|7|||
131814672|NCT01075282|474604541|FG002|Overall Study|Withdrawal by Subject|11|||
131814673|NCT01075282|474604539|FG000|Overall Study|Adverse Event|9|||
131814674|NCT01075282|474604540|FG001|Overall Study|Adverse Event|8|||
131814675|NCT01075282|474604541|FG002|Overall Study|Adverse Event|5|||
131814676|NCT01075282|474604539|FG000|Overall Study|Entry Criteria Not Met|3|||
131814677|NCT01075282|474604540|FG001|Overall Study|Entry Criteria Not Met|2|||
131814678|NCT01075282|474604541|FG002|Overall Study|Entry Criteria Not Met|0|||
131814679|NCT01075282|474604539|FG000|Overall Study|Lost to Follow-up|3|||
131814680|NCT01075282|474604540|FG001|Overall Study|Lost to Follow-up|3|||
131814681|NCT01075282|474604541|FG002|Overall Study|Lost to Follow-up|3|||
131814682|NCT01075282|474604539|FG000|Overall Study|Physician Decision|3|||
131814683|NCT01075282|474604540|FG001|Overall Study|Physician Decision|3|||
131814684|NCT01075282|474604541|FG002|Overall Study|Physician Decision|3|||
131814685|NCT01075282|474604539|FG000|Overall Study|Lack of Efficacy|1|||
131814686|NCT01075282|474604540|FG001|Overall Study|Lack of Efficacy|1|||
131814687|NCT01075282|474604541|FG002|Overall Study|Lack of Efficacy|0|||
131814688|NCT01075282|474604539|FG000|Overall Study|Treatment Non-compliance|1|||
131814689|NCT01075282|474604540|FG001|Overall Study|Treatment Non-compliance|2|||
131814690|NCT01075282|474604541|FG002|Overall Study|Treatment Non-compliance|2|||
131814691|NCT01075282|474604539|FG000|Overall Study|Protocol Violation|0|||
131814692|NCT01075282|474604540|FG001|Overall Study|Protocol Violation|2|||
131909744|NCT03225287|474956826|FG001|Overall Study|Trial drug not effective|1|||
131909745|NCT03225287|474956827|FG002|Overall Study|Trial drug not effective|0|||
131909746|NCT03225287|474956825|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
131909747|NCT03225287|474956826|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
131909748|NCT03225287|474956827|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
131909749|NCT03225287|474956825|FG000|Overall Study|Stem cell transplantation|0|||
131909750|NCT03225287|474956826|FG001|Overall Study|Stem cell transplantation|1|||
131400684|NCT02487654|473089588|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
131814693|NCT01075282|474604541|FG002|Overall Study|Protocol Violation|1|||
131814694|NCT01075282|474604539|FG000|Overall Study|Death|0|||
131814695|NCT01075282|474604540|FG001|Overall Study|Death|1|||
131814696|NCT01075282|474604541|FG002|Overall Study|Death|2|||
131814697|NCT00700739|474604542|FG000|Overall Study|Lost to Follow-up|4|||
131814698|NCT00700739|474604543|FG001|Overall Study|Lost to Follow-up|4|||
131814699|NCT01316055|474604551|FG000|Overall Study|Lost to Follow-up|1|||
131814700|NCT01316055|474604552|FG001|Overall Study|Lost to Follow-up|0|||
131909751|NCT03225287|474956827|FG002|Overall Study|Stem cell transplantation|0|||
131400685|NCT02487654|473089589|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
131400686|NCT02487654|473089588|FG000|Overall Study|Withdrawal by Subject|3|||
131814701|NCT01316055|474604553|FG002|Overall Study|Lost to Follow-up|0|||
131814702|NCT00003470|474604554|FG000|Overall Study|Not evaluable|6|||
131814703|NCT02679729|474604555|FG000|Overall Study|Lost to Follow-up|0|||
131814704|NCT02679729|474604556|FG001|Overall Study|Lost to Follow-up|1|||
131814705|NCT02679729|474604557|FG002|Overall Study|Lost to Follow-up|0|||
131814706|NCT02679729|474604558|FG003|Overall Study|Lost to Follow-up|0|||
131814707|NCT02679729|474604559|FG004|Overall Study|Lost to Follow-up|1|||
131814708|NCT02679729|474604560|FG005|Overall Study|Lost to Follow-up|0|||
131814709|NCT02679729|474604561|FG006|Overall Study|Lost to Follow-up|0|||
131814710|NCT02679729|474604562|FG007|Overall Study|Lost to Follow-up|0|||
131814711|NCT02679729|474604563|FG008|Overall Study|Lost to Follow-up|0|||
131814712|NCT02679729|474604555|FG000|Overall Study|Participant decision|0|||
131814713|NCT02679729|474604556|FG001|Overall Study|Participant decision|1|||
131814714|NCT02679729|474604557|FG002|Overall Study|Participant decision|0|||
131814715|NCT02679729|474604558|FG003|Overall Study|Participant decision|0|||
131814716|NCT02679729|474604559|FG004|Overall Study|Participant decision|0|||
131814717|NCT02679729|474604560|FG005|Overall Study|Participant decision|0|||
131814718|NCT02679729|474604561|FG006|Overall Study|Participant decision|1|||
131814719|NCT02679729|474604562|FG007|Overall Study|Participant decision|0|||
131814720|NCT02679729|474604563|FG008|Overall Study|Participant decision|0|||
131814721|NCT03488108|474604570|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
131814722|NCT03488108|474604571|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131814723|NCT03488108|474604570|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
131814724|NCT03488108|474604571|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
131814725|NCT03503318|474604575|FG000|Overall Study|Death|1|||
131814726|NCT03503318|474604576|FG001|Overall Study|Death|0|||
131814727|NCT03503318|474604577|FG002|Overall Study|Death|4|||
131814728|NCT03503318|474604575|FG000|Overall Study|Adverse Event|3|||
131814729|NCT03503318|474604576|FG001|Overall Study|Adverse Event|4|||
131814730|NCT03503318|474604577|FG002|Overall Study|Adverse Event|2|||
131814731|NCT03503318|474604575|FG000|Overall Study|Withdrawal by Subject|12|||
131814732|NCT03503318|474604576|FG001|Overall Study|Withdrawal by Subject|17|||
131814733|NCT03503318|474604577|FG002|Overall Study|Withdrawal by Subject|16|||
131814734|NCT03503318|474604575|FG000|Overall Study|Protocol Violation|5|||
131814735|NCT03503318|474604576|FG001|Overall Study|Protocol Violation|0|||
131814736|NCT03503318|474604577|FG002|Overall Study|Protocol Violation|3|||
131814737|NCT03503318|474604575|FG000|Overall Study|Lost to Follow-up|17|||
131814738|NCT03503318|474604576|FG001|Overall Study|Lost to Follow-up|15|||
131814739|NCT03503318|474604577|FG002|Overall Study|Lost to Follow-up|12|||
131814740|NCT03503318|474604575|FG000|Overall Study|Other than specified|1|||
131814741|NCT03503318|474604576|FG001|Overall Study|Other than specified|3|||
131814742|NCT03503318|474604577|FG002|Overall Study|Other than specified|3|||
131814743|NCT02139826|474604582|FG000|Overall Study|Adverse Event|1|||
131814744|NCT01494532|474604590|FG000|Overall Study|Adverse Event|4|||
131814745|NCT01494532|474604591|FG001|Overall Study|Adverse Event|1|||
131909752|NCT06996301|474956828|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
131909753|NCT06996301|474956829|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
131909754|NCT06996301|474956828|FG000|Overall Study|Patients with discordant diagnostic results|107|||
131909755|NCT06996301|474956829|FG001|Overall Study|Patients with discordant diagnostic results|90|||
131909756|NCT06996301|474956828|FG000|Overall Study|Lost to Follow-up|31|||
131909757|NCT06996301|474956829|FG001|Overall Study|Lost to Follow-up|56|||
131909758|NCT06996301|474956828|FG000|Overall Study|Withdrawal by Subject|12|||
131814746|NCT01494532|474604592|FG002|Overall Study|Adverse Event|8|||
131814747|NCT01494532|474604593|FG003|Overall Study|Adverse Event|6|||
131814748|NCT01494532|474604594|FG004|Overall Study|Adverse Event|5|||
131814749|NCT01494532|474604595|FG005|Overall Study|Adverse Event|0|||
131814750|NCT01494532|474604590|FG000|Overall Study|Lack of Efficacy|0|||
131814751|NCT01494532|474604591|FG001|Overall Study|Lack of Efficacy|0|||
131814752|NCT01494532|474604592|FG002|Overall Study|Lack of Efficacy|0|||
131909759|NCT06996301|474956829|FG001|Overall Study|Withdrawal by Subject|7|||
131909760|NCT04030598|474956830|FG000|Overall Study|Voluntary Withdrawal|0|||
131909761|NCT04030598|474956831|FG001|Overall Study|Voluntary Withdrawal|1|||
131814753|NCT01494532|474604593|FG003|Overall Study|Lack of Efficacy|0|||
131814754|NCT01494532|474604594|FG004|Overall Study|Lack of Efficacy|2|||
131814755|NCT01494532|474604595|FG005|Overall Study|Lack of Efficacy|0|||
131814756|NCT01494532|474604590|FG000|Overall Study|Protocol deviation|2|||
131814757|NCT01494532|474604591|FG001|Overall Study|Protocol deviation|1|||
131909762|NCT04030598|474956832|FG002|Overall Study|Voluntary Withdrawal|0|||
131909763|NCT00666237|474956836|FG000|Overall Study|Death|5|||
131909764|NCT00666237|474956837|FG001|Overall Study|Death|5|||
131909765|NCT00666237|474956836|FG000|Overall Study|Lost to Follow-up|29|||
131909766|NCT00666237|474956837|FG001|Overall Study|Lost to Follow-up|25|||
131909767|NCT00753519|474958647|FG000|Overall Study|Withdrawal by Subject|0|||
131814758|NCT01494532|474604592|FG002|Overall Study|Protocol deviation|3|||
131814759|NCT01494532|474604593|FG003|Overall Study|Protocol deviation|2|||
131814760|NCT01494532|474604594|FG004|Overall Study|Protocol deviation|3|||
131814761|NCT01494532|474604595|FG005|Overall Study|Protocol deviation|0|||
131814762|NCT01494532|474604590|FG000|Overall Study|Protocol-defined stopping criteria|0|||
131814763|NCT01494532|474604591|FG001|Overall Study|Protocol-defined stopping criteria|0|||
131768465|NCT01020812|474429788|FG000|Overall Study|Physician Decision|1|||
131768466|NCT01020812|474429788|FG000|Overall Study|Withdrawal by Subject|1|||
131768467|NCT01020812|474429788|FG000|Overall Study|Protocol Violation|1|||
131768468|NCT02528643|474429789|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
131768469|NCT02528643|474429790|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
131768470|NCT02528643|474429789|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
131768471|NCT02528643|474429790|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
131768472|NCT02528643|474429789|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
131768473|NCT02528643|474429790|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
131768474|NCT02528643|474429789|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
131768475|NCT02528643|474429790|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
131768476|NCT02528643|474429789|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
131768477|NCT02528643|474429790|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
131768478|NCT02528643|474429789|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
131768479|NCT02528643|474429790|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
131768480|NCT02528643|474429789|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
131768481|NCT02528643|474429790|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
131768482|NCT02927990|474429791|FG000|Overall Study|Protocol Violation|4|||
131768483|NCT02927990|474429791|FG000|Overall Study|Physician Decision|9|||
131768484|NCT02927990|474429791|FG000|Overall Study|Room switched and therefore no study device available|15|||
131768485|NCT02927990|474429791|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
131768486|NCT00960323|474429792|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
131768487|NCT02146274|474429793|FG000|Overall Study|Protocol Violation|73|||
131768488|NCT03730987|474429800|FG000|Overall Study|Lost to Follow-up|2|||
131768489|NCT03730987|474429801|FG001|Overall Study|Lost to Follow-up|0|||
131768490|NCT03730987|474429802|FG002|Overall Study|Lost to Follow-up|2|||
131768491|NCT03730987|474429803|FG003|Overall Study|Lost to Follow-up|0|||
131768492|NCT01191190|474429804|FG000|Overall Study|Withdrawal by Subject|1|||
131768493|NCT01856920|474429822|FG000|Overall Study|Disease Progression On Study|3|||
131768494|NCT01856920|474429823|FG001|Overall Study|Disease Progression On Study|4|||
131768495|NCT01856920|474429822|FG000|Overall Study|Disease Progression before Treatment|1|||
131768496|NCT01856920|474429823|FG001|Overall Study|Disease Progression before Treatment|0|||
131768497|NCT01856920|474429822|FG000|Overall Study|Ineligible|0|||
131768498|NCT01856920|474429823|FG001|Overall Study|Ineligible|1|||
131768499|NCT01856920|474429822|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
131768500|NCT01856920|474429823|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
131768501|NCT01856920|474429822|FG000|Overall Study|Refused further Treatment|5|||
131768502|NCT01856920|474429823|FG001|Overall Study|Refused further Treatment|1|||
131768503|NCT01856920|474429822|FG000|Overall Study|Other Reasons|0|||
131768504|NCT01856920|474429823|FG001|Overall Study|Other Reasons|1|||
131768505|NCT01856920|474429822|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
131768506|NCT01856920|474429823|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
131768507|NCT02545270|474429825|FG000|Overall Study|technical difficulties|0|||
131768508|NCT02545270|474429826|FG001|Overall Study|technical difficulties|1|||
131768509|NCT02545270|474429827|FG002|Overall Study|technical difficulties|0|||
131768510|NCT02545270|474429825|FG000|Overall Study|Videos being too similar to other|0|||
131768511|NCT02545270|474429826|FG001|Overall Study|Videos being too similar to other|0|||
131768512|NCT02545270|474429827|FG002|Overall Study|Videos being too similar to other|2|||
131768513|NCT01729559|474429828|FG000|Overall Study|Protocol Violation|31|||
131768514|NCT01729559|474429829|FG001|Overall Study|Protocol Violation|28|||
131768515|NCT03764813|474429834|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
131768516|NCT03764813|474429835|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
131768517|NCT03764813|474429836|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
131768518|NCT03764813|474429837|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
131768519|NCT00761891|474429840|FG000|Overall Study|Withdrawal by Subject|10|||
131768520|NCT01707667|474429841|FG000|Period 1|expulsion of colonic sensor catheter|1|||
131768521|NCT01707667|474429842|FG001|Period 1|expulsion of colonic sensor catheter|0|||
131400687|NCT02487654|473089589|FG001|Overall Study|Withdrawal by Subject|7|||
131768522|NCT02074059|474429848|FG000|Overall Study|Death|0|||
131768523|NCT02074059|474429849|FG001|Overall Study|Death|0|||
131768524|NCT02074059|474429850|FG002|Overall Study|Death|0|||
131768525|NCT02074059|474429851|FG003|Overall Study|Death|0|||
131768526|NCT02074059|474429852|FG004|Overall Study|Death|1|||
131768527|NCT02074059|474429853|FG005|Overall Study|Death|1|||
131768528|NCT03432819|474429855|FG000|Overall Study|Lost to Follow-up|2|||
131768529|NCT03432819|474429856|FG001|Overall Study|Lost to Follow-up|2|||
131768530|NCT03432819|474429855|FG000|Overall Study|Withdrawal by Subject|5|||
131768531|NCT03432819|474429856|FG001|Overall Study|Withdrawal by Subject|3|||
131768532|NCT01220024|474429862|FG000|Overall Study|Lost to Follow-up|1|||
131768533|NCT01220024|474429863|FG001|Overall Study|Lost to Follow-up|1|||
131768534|NCT00174460|474429866|FG000|Overall Study|Withdrawal by Subject|0|||
131814764|NCT01494532|474604592|FG002|Overall Study|Protocol-defined stopping criteria|1|||
131814765|NCT01494532|474604593|FG003|Overall Study|Protocol-defined stopping criteria|0|||
131814766|NCT01494532|474604594|FG004|Overall Study|Protocol-defined stopping criteria|0|||
131814767|NCT01494532|474604595|FG005|Overall Study|Protocol-defined stopping criteria|0|||
131814768|NCT01494532|474604590|FG000|Overall Study|Lost to Follow-up|1|||
131814769|NCT01494532|474604591|FG001|Overall Study|Lost to Follow-up|0|||
131814770|NCT01494532|474604592|FG002|Overall Study|Lost to Follow-up|0|||
131814771|NCT01494532|474604593|FG003|Overall Study|Lost to Follow-up|2|||
131814772|NCT01494532|474604594|FG004|Overall Study|Lost to Follow-up|0|||
131814773|NCT01494532|474604595|FG005|Overall Study|Lost to Follow-up|0|||
131814774|NCT01494532|474604590|FG000|Overall Study|Physician Decision|0|||
131814775|NCT01494532|474604591|FG001|Overall Study|Physician Decision|1|||
131814776|NCT01494532|474604592|FG002|Overall Study|Physician Decision|1|||
131814777|NCT01494532|474604593|FG003|Overall Study|Physician Decision|2|||
131814778|NCT01494532|474604594|FG004|Overall Study|Physician Decision|0|||
131814779|NCT01494532|474604595|FG005|Overall Study|Physician Decision|0|||
131814780|NCT01494532|474604590|FG000|Overall Study|Withdrawal by Subject|3|||
131814781|NCT01494532|474604591|FG001|Overall Study|Withdrawal by Subject|1|||
131814782|NCT01494532|474604592|FG002|Overall Study|Withdrawal by Subject|4|||
131909768|NCT00753519|474958648|FG001|Overall Study|Withdrawal by Subject|2|||
131909769|NCT00959751|474958649|FG000|Overall Study|Lost to Follow-up|2|||
131909770|NCT00959751|474958650|FG001|Overall Study|Lost to Follow-up|3|||
131768535|NCT00174460|474429867|FG001|Overall Study|Withdrawal by Subject|1|||
131768536|NCT00579059|474429868|FG000|Overall Study|Study Canceled at 1 Year|21|||
131768537|NCT00579059|474429869|FG001|Overall Study|Study Canceled at 1 Year|10|||
131768538|NCT02764229|474429870|FG000|Overall Study|Withdrawal by Subject|15|||
131768539|NCT02764229|474429870|FG000|Overall Study|Adverse Event|9|||
131768540|NCT02764229|474429870|FG000|Overall Study|Physician Decision|5|||
131768541|NCT02764229|474429870|FG000|Overall Study|Lost to Follow-up|3|||
131768542|NCT02764229|474429870|FG000|Overall Study|Lack of Efficacy|1|||
131768543|NCT02764229|474429870|FG000|Overall Study|Study Stopped by Sponsor|69|||
131768544|NCT00779506|474429872|FG000|Overall Study|Screening Failed|2|||
131768545|NCT00779506|474429872|FG000|Overall Study|Adverse Event|4|||
131768546|NCT00779506|474429872|FG000|Overall Study|Lack of Efficacy|11|||
131768547|NCT00779506|474429872|FG000|Overall Study|Protocol Violation|5|||
131768548|NCT00779506|474429872|FG000|Overall Study|Withdrawal by Subject|6|||
131768549|NCT00779506|474429872|FG000|Overall Study|Lost to Follow-up|1|||
131768550|NCT04047472|474429873|FG000|Overall Study|Adverse Event|3|||
131768551|NCT04047472|474429874|FG001|Overall Study|Adverse Event|3|||
131768552|NCT04047472|474429873|FG000|Overall Study|Death|0|||
131768553|NCT04047472|474429874|FG001|Overall Study|Death|1|||
131768554|NCT04047472|474429873|FG000|Overall Study|Lost to Follow-up|1|||
131768555|NCT04047472|474429874|FG001|Overall Study|Lost to Follow-up|0|||
131768556|NCT04047472|474429873|FG000|Overall Study|Physician Decision|1|||
131768557|NCT04047472|474429874|FG001|Overall Study|Physician Decision|2|||
131768558|NCT04047472|474429873|FG000|Overall Study|Protocol Violation|1|||
131768559|NCT04047472|474429874|FG001|Overall Study|Protocol Violation|0|||
131768560|NCT04047472|474429873|FG000|Overall Study|Withdrawal by Subject|10|||
131768561|NCT04047472|474429874|FG001|Overall Study|Withdrawal by Subject|10|||
131768562|NCT02030067|474429877|FG000|Overall Study|Disease Progression|1|||
131768563|NCT02030067|474429878|FG001|Overall Study|Disease Progression|1|||
131768564|NCT02030067|474429879|FG002|Overall Study|Disease Progression|2|||
131768565|NCT02030067|474429880|FG003|Overall Study|Disease Progression|2|||
131768566|NCT02030067|474429881|FG004|Overall Study|Disease Progression|3|||
131768567|NCT02030067|474429882|FG005|Overall Study|Disease Progression|2|||
131768568|NCT02030067|474429883|FG006|Overall Study|Disease Progression|3|||
131768569|NCT02030067|474429884|FG007|Overall Study|Disease Progression|3|||
131768570|NCT02030067|474429885|FG008|Overall Study|Disease Progression|4|||
131768571|NCT02030067|474429886|FG009|Overall Study|Disease Progression|3|||
131768572|NCT02030067|474429887|FG010|Overall Study|Disease Progression|7|||
131768573|NCT02030067|474429888|FG011|Overall Study|Disease Progression|2|||
131768574|NCT02030067|474429889|FG012|Overall Study|Disease Progression|59|||
131768575|NCT02030067|474429877|FG000|Overall Study|Withdrawal by Subject|0|||
131768576|NCT02030067|474429878|FG001|Overall Study|Withdrawal by Subject|0|||
131768577|NCT02030067|474429879|FG002|Overall Study|Withdrawal by Subject|0|||
131909771|NCT00959751|474958649|FG000|Overall Study|Consent Withdrawn|0|||
131909772|NCT00959751|474958650|FG001|Overall Study|Consent Withdrawn|1|||
131400688|NCT00656058|473089590|FG000|Overall Study|Withdrawal by Subject|2|||
131768578|NCT02030067|474429880|FG003|Overall Study|Withdrawal by Subject|1|||
131768579|NCT02030067|474429881|FG004|Overall Study|Withdrawal by Subject|0|||
131768580|NCT02030067|474429882|FG005|Overall Study|Withdrawal by Subject|0|||
131768581|NCT02030067|474429883|FG006|Overall Study|Withdrawal by Subject|0|||
131768582|NCT02030067|474429884|FG007|Overall Study|Withdrawal by Subject|1|||
131768583|NCT02030067|474429885|FG008|Overall Study|Withdrawal by Subject|0|||
131768584|NCT02030067|474429886|FG009|Overall Study|Withdrawal by Subject|0|||
131768585|NCT02030067|474429887|FG010|Overall Study|Withdrawal by Subject|3|||
131814783|NCT01494532|474604593|FG003|Overall Study|Withdrawal by Subject|3|||
131814784|NCT01494532|474604594|FG004|Overall Study|Withdrawal by Subject|2|||
131814785|NCT01494532|474604595|FG005|Overall Study|Withdrawal by Subject|0|||
131814786|NCT04827394|474604597|FG000|Overall Study|Physician Decision|0|||
131814787|NCT04827394|474604598|FG001|Overall Study|Physician Decision|2|||
131814788|NCT02875392|474606346|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
131814789|NCT02875392|474606347|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
131814790|NCT03206749|474606354|FG000|Overall Study|Withdrawal of consent|5|||
131814791|NCT03206749|474606355|FG001|Overall Study|Withdrawal of consent|3|||
131814792|NCT03206749|474606356|FG002|Overall Study|Withdrawal of consent|6|||
131814793|NCT03206749|474606354|FG000|Overall Study|Lost to Follow-up|0|||
131814794|NCT03206749|474606355|FG001|Overall Study|Lost to Follow-up|0|||
131814795|NCT03206749|474606356|FG002|Overall Study|Lost to Follow-up|1|||
131814796|NCT03779334|474606359|FG000|Overall Study|Withdrawal by Subject|3|||
131814797|NCT03779334|474606360|FG001|Overall Study|Withdrawal by Subject|0|||
131814798|NCT03779334|474606361|FG002|Overall Study|Withdrawal by Subject|0|||
131814799|NCT03779334|474606359|FG000|Overall Study|Ongoing in Study|5|||
131814800|NCT03779334|474606360|FG001|Overall Study|Ongoing in Study|13|||
131814801|NCT03779334|474606361|FG002|Overall Study|Ongoing in Study|5|||
131814802|NCT00796328|474606364|FG000|Overall Study|experienced hypotension requiring tx|6|||
131814803|NCT02842853|474606365|FG000|Overall Study|Non-compliance with the protocol|3|||
131814804|NCT02842853|474606366|FG001|Overall Study|Non-compliance with the protocol|7|||
131814805|NCT02842853|474606367|FG002|Overall Study|Non-compliance with the protocol|2|||
131814806|NCT02842853|474606368|FG003|Overall Study|Non-compliance with the protocol|5|||
131814807|NCT02842853|474606365|FG000|Overall Study|Subject met exclusion criteria|0|||
131814808|NCT02842853|474606366|FG001|Overall Study|Subject met exclusion criteria|1|||
131814809|NCT02842853|474606367|FG002|Overall Study|Subject met exclusion criteria|0|||
131814810|NCT02842853|474606368|FG003|Overall Study|Subject met exclusion criteria|0|||
131814811|NCT02842853|474606365|FG000|Overall Study|Withdrawal by Subject|11|||
131814812|NCT02842853|474606366|FG001|Overall Study|Withdrawal by Subject|13|||
131814813|NCT02842853|474606367|FG002|Overall Study|Withdrawal by Subject|9|||
131814814|NCT02842853|474606368|FG003|Overall Study|Withdrawal by Subject|8|||
131814815|NCT02842853|474606365|FG000|Overall Study|Lost to Follow-up|9|||
131814816|NCT02842853|474606366|FG001|Overall Study|Lost to Follow-up|13|||
131814817|NCT02842853|474606367|FG002|Overall Study|Lost to Follow-up|10|||
131814818|NCT02842853|474606368|FG003|Overall Study|Lost to Follow-up|11|||
131814819|NCT04089553|474606369|FG000|Overall Study|Death|1|||
131814820|NCT04089553|474606370|FG001|Overall Study|Death|1|||
131814821|NCT04089553|474606369|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
131814822|NCT04089553|474606370|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
131814823|NCT04089553|474606369|FG000|Overall Study|Withdrawal by Subject|3|||
131814824|NCT04089553|474606370|FG001|Overall Study|Withdrawal by Subject|3|||
131814825|NCT04089553|474606369|FG000|Overall Study|Physician Decision|1|||
131814826|NCT04089553|474606370|FG001|Overall Study|Physician Decision|0|||
131814827|NCT04089553|474606369|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
131814828|NCT04089553|474606370|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
131814829|NCT04089553|474606369|FG000|Overall Study|Other|1|||
131814830|NCT04089553|474606370|FG001|Overall Study|Other|0|||
131814831|NCT04089553|474606369|FG000|Overall Study|Adverse Event|1|||
131814832|NCT04089553|474606370|FG001|Overall Study|Adverse Event|1|||
131814833|NCT01403194|474606378|FG000|Overall Study|Screen Failure|2|||
131814834|NCT01403194|474606378|FG000|Overall Study|Lost to Follow-up|8|||
131814835|NCT01175135|474606379|FG000|Overall Study|Adverse Event|2|||
131814836|NCT01175135|474606380|FG001|Overall Study|Adverse Event|5|||
131814837|NCT01175135|474606381|FG002|Overall Study|Adverse Event|3|||
131814838|NCT01175135|474606382|FG003|Overall Study|Adverse Event|4|||
131814839|NCT01175135|474606379|FG000|Overall Study|Death|1|||
131814840|NCT01175135|474606380|FG001|Overall Study|Death|0|||
131814841|NCT01175135|474606381|FG002|Overall Study|Death|0|||
131814842|NCT01175135|474606382|FG003|Overall Study|Death|0|||
131814843|NCT01175135|474606379|FG000|Overall Study|Lack of Efficacy|4|||
131814844|NCT01175135|474606380|FG001|Overall Study|Lack of Efficacy|5|||
131814845|NCT01175135|474606381|FG002|Overall Study|Lack of Efficacy|0|||
131814846|NCT01175135|474606382|FG003|Overall Study|Lack of Efficacy|5|||
131814847|NCT01175135|474606379|FG000|Overall Study|Lost to Follow-up|1|||
131814848|NCT01175135|474606380|FG001|Overall Study|Lost to Follow-up|2|||
131814849|NCT01175135|474606381|FG002|Overall Study|Lost to Follow-up|0|||
131814850|NCT01175135|474606382|FG003|Overall Study|Lost to Follow-up|0|||
131814851|NCT01175135|474606379|FG000|Overall Study|Protocol Violation|1|||
131814852|NCT01175135|474606380|FG001|Overall Study|Protocol Violation|1|||
131814853|NCT01175135|474606381|FG002|Overall Study|Protocol Violation|0|||
131909773|NCT00959751|474958649|FG000|Overall Study|Non-compliance to Study Procedures|0|||
131814854|NCT01175135|474606382|FG003|Overall Study|Protocol Violation|0|||
131814855|NCT01175135|474606379|FG000|Overall Study|Withdrawal by Subject|4|||
131814856|NCT01175135|474606380|FG001|Overall Study|Withdrawal by Subject|8|||
131814857|NCT01175135|474606381|FG002|Overall Study|Withdrawal by Subject|5|||
131814858|NCT01175135|474606382|FG003|Overall Study|Withdrawal by Subject|5|||
131814859|NCT01175135|474606379|FG000|Overall Study|Other|3|||
131814860|NCT01175135|474606380|FG001|Overall Study|Other|1|||
131768586|NCT02030067|474429888|FG011|Overall Study|Withdrawal by Subject|0|||
131768587|NCT02030067|474429889|FG012|Overall Study|Withdrawal by Subject|6|||
131768588|NCT02030067|474429877|FG000|Overall Study|Physician Decision|0|||
131768589|NCT02030067|474429878|FG001|Overall Study|Physician Decision|0|||
131768590|NCT02030067|474429879|FG002|Overall Study|Physician Decision|0|||
131768591|NCT02030067|474429880|FG003|Overall Study|Physician Decision|0|||
131768592|NCT02030067|474429881|FG004|Overall Study|Physician Decision|0|||
131768593|NCT02030067|474429882|FG005|Overall Study|Physician Decision|0|||
131768594|NCT02030067|474429883|FG006|Overall Study|Physician Decision|0|||
131768595|NCT02030067|474429884|FG007|Overall Study|Physician Decision|0|||
131768596|NCT02030067|474429885|FG008|Overall Study|Physician Decision|0|||
131768597|NCT02030067|474429886|FG009|Overall Study|Physician Decision|0|||
131814861|NCT01175135|474606381|FG002|Overall Study|Other|3|||
131814862|NCT01175135|474606382|FG003|Overall Study|Other|0|||
131814863|NCT01175135|474606379|FG000|Overall Study|Randomized But Not Treated|0|||
131814864|NCT01175135|474606380|FG001|Overall Study|Randomized But Not Treated|0|||
131814865|NCT01175135|474606381|FG002|Overall Study|Randomized But Not Treated|1|||
131814866|NCT01175135|474606382|FG003|Overall Study|Randomized But Not Treated|0|||
131814867|NCT04692155|474606390|FG000|Overall Study|Death|1|||
131814868|NCT00107991|474606391|FG000|Eligibility Assessment|Disease not severe enough|7|||
131814869|NCT00107991|474606391|FG000|Eligibility Assessment|Unwilling to participate|7|||
131814870|NCT00107991|474606391|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
131814871|NCT00107991|474606391|FG000|Eligibility Assessment|Abnormal labs|2|||
131814872|NCT00107991|474606391|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
131814873|NCT00107991|474606391|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
131814874|NCT00107991|474606391|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
131814875|NCT00107991|474606391|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
131814876|NCT00107991|474606391|FG000|12 Week Treatment Period|Adverse Event|1|||
131814877|NCT00107991|474606391|FG000|12 Week Treatment Period|Protocol Violation|1|||
131814878|NCT00107991|474606391|FG000|12 Week Treatment Period|Incarcerated|1|||
131814879|NCT00107991|474606391|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
131814880|NCT00506831|474606398|FG000|Overall Study|Death|1|||
131814881|NCT00506831|474606398|FG000|Overall Study|Withdrawal by Subject|1|||
131814882|NCT02488239|474606403|FG000|Overall Study|Death|3|||
131814883|NCT02488239|474606403|FG000|Overall Study|Withdrawal by Subject|3|||
131814884|NCT02488239|474606403|FG000|Overall Study|Physician Decision|2|||
131814885|NCT02488239|474606403|FG000|Overall Study|Consent ineligible|1|||
131814886|NCT02488239|474606403|FG000|Overall Study|Did not undergo implant procedure|1|||
131814887|NCT00608322|474606406|FG000|Overall Study|Death|2|||
131814888|NCT00608322|474606407|FG001|Overall Study|Death|1|||
131814889|NCT00834444|474606408|FG000|First Intervention|Adverse Event|1|||
131814890|NCT00834444|474606409|FG001|First Intervention|Adverse Event|0|||
131814891|NCT00834444|474606408|FG000|First Intervention|Intolerance to Venopuncture|0|||
131814892|NCT00834444|474606409|FG001|First Intervention|Intolerance to Venopuncture|1|||
131814893|NCT00834444|474606408|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
131814894|NCT00834444|474606409|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
131814895|NCT00834444|474606408|FG000|Second Intervention|Adverse Event|1|||
131814896|NCT00834444|474606409|FG001|Second Intervention|Adverse Event|0|||
131814897|NCT03325881|474606412|FG000|Overall Study|Protocol Violation|0|||
131814898|NCT03325881|474606413|FG001|Overall Study|Protocol Violation|1|||
131814899|NCT03325881|474606412|FG000|Overall Study|Withdrawal by Subject|0|||
131814900|NCT03325881|474606413|FG001|Overall Study|Withdrawal by Subject|2|||
131814901|NCT03325881|474606412|FG000|Overall Study|Lack of Efficacy|2|||
131814902|NCT03325881|474606413|FG001|Overall Study|Lack of Efficacy|0|||
131814903|NCT03325881|474606412|FG000|Overall Study|Not treated|1|||
131814904|NCT03325881|474606413|FG001|Overall Study|Not treated|0|||
131814905|NCT03676634|474606414|FG000|Overall Study|Red blood cell loss|1|||
131814906|NCT03676634|474606414|FG000|Overall Study|Out-of-limit pulse|2|||
131814907|NCT03131895|474606423|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
131814908|NCT03131895|474606424|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
131814909|NCT03131895|474606425|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
131814910|NCT03131895|474606426|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
131814911|NCT03131895|474606423|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131814912|NCT03131895|474606424|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
131814913|NCT03131895|474606425|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
131814914|NCT03131895|474606426|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
131814915|NCT03131895|474606423|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131814916|NCT03131895|474606424|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
131814917|NCT03131895|474606425|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131814918|NCT03131895|474606426|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
131814919|NCT03131895|474606423|FG000|Washout Period (at Least 5 Days)|Other|0|||
131814920|NCT03131895|474606424|FG001|Washout Period (at Least 5 Days)|Other|0|||
131814921|NCT03131895|474606425|FG002|Washout Period (at Least 5 Days)|Other|2|||
131814922|NCT03131895|474606426|FG003|Washout Period (at Least 5 Days)|Other|0|||
131814923|NCT03131895|474606423|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
131814924|NCT03131895|474606424|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
131814925|NCT03131895|474606425|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
131814926|NCT03131895|474606426|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
131814927|NCT03131895|474606423|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
131814928|NCT03131895|474606424|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
131814929|NCT03131895|474606425|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
131814930|NCT03131895|474606426|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
131814931|NCT00540423|474606427|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131814932|NCT00540423|474606428|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131814933|NCT00540423|474606429|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131814934|NCT00540423|474606427|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
131814935|NCT00540423|474606428|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
131814936|NCT00540423|474606429|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
131814937|NCT02213263|474606435|FG000|Overall Study|Insufficient clinical response|4|||
131814938|NCT02213263|474606436|FG001|Overall Study|Insufficient clinical response|3|||
131814939|NCT02213263|474606435|FG000|Overall Study|Lost to Follow-up|0|||
131814940|NCT02213263|474606436|FG001|Overall Study|Lost to Follow-up|1|||
131814941|NCT02213263|474606435|FG000|Overall Study|No longer willing to participate|3|||
131814942|NCT02213263|474606436|FG001|Overall Study|No longer willing to participate|4|||
131814943|NCT02213263|474606435|FG000|Overall Study|Progressive disease|20|||
131814944|NCT02213263|474606436|FG001|Overall Study|Progressive disease|14|||
131814945|NCT02213263|474606435|FG000|Overall Study|Protocol Violation|0|||
131814946|NCT02213263|474606436|FG001|Overall Study|Protocol Violation|1|||
131814947|NCT02213263|474606435|FG000|Overall Study|Adverse Event|1|||
131814948|NCT02213263|474606436|FG001|Overall Study|Adverse Event|3|||
131814949|NCT02280863|474606437|FG000|Integrated Platform|Met stopping criteria|0|||
131814950|NCT02280863|474606438|FG001|Integrated Platform|Met stopping criteria|1|||
131814951|NCT00216736|474606444|FG000|Overall Study|Lost to Follow-up|1|||
131814952|NCT00216736|474606445|FG001|Overall Study|Lost to Follow-up|1|||
131814953|NCT02890992|474606446|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814954|NCT02890992|474606447|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
131814955|NCT02890992|474606448|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814956|NCT02890992|474606449|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814957|NCT02890992|474606450|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814958|NCT02890992|474606451|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814959|NCT02890992|474606452|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814960|NCT02890992|474606453|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
131814961|NCT02890992|474606446|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
131814962|NCT02890992|474606447|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
131814963|NCT02890992|474606448|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
131814964|NCT02890992|474606449|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
131814965|NCT02890992|474606450|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
131814966|NCT02890992|474606451|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
131814967|NCT02890992|474606452|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
131814968|NCT02890992|474606453|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
131814969|NCT02890992|474606446|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814970|NCT02890992|474606447|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
131814971|NCT02890992|474606448|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814972|NCT02890992|474606449|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814973|NCT02890992|474606450|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814974|NCT02890992|474606451|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814975|NCT02890992|474606452|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814976|NCT02890992|474606453|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
131814977|NCT02622386|474606454|FG000|First Assignment|Withdrawal by Subject|3|||
131814978|NCT02622386|474606455|FG001|First Assignment|Withdrawal by Subject|2|||
131814979|NCT02622386|474606454|FG000|Washout|Withdrawal by Subject|4|||
131814980|NCT02622386|474606455|FG001|Washout|Withdrawal by Subject|4|||
131814981|NCT02622386|474606454|FG000|Second Assignment|Withdrawal by Subject|0|||
131814982|NCT02622386|474606455|FG001|Second Assignment|Withdrawal by Subject|2|||
131814983|NCT03236311|474606456|FG000|Overall Study|Study terminated by sponsor|0|||
131814984|NCT03236311|474606457|FG001|Overall Study|Study terminated by sponsor|2|||
131814985|NCT03236311|474606456|FG000|Overall Study|Adverse Event|0|||
131814986|NCT03236311|474606457|FG001|Overall Study|Adverse Event|1|||
131814987|NCT00669162|474606458|FG000|Overall Study|Withdrawal by Subject|1|||
131814988|NCT00807495|474606461|FG000|Overall Study|Adverse Event|6|||
131814989|NCT00807495|474606462|FG001|Overall Study|Adverse Event|3|||
131814990|NCT00807495|474606463|FG002|Overall Study|Adverse Event|1|||
131814991|NCT00807495|474606464|FG003|Overall Study|Adverse Event|1|||
131814992|NCT00807495|474606465|FG004|Overall Study|Adverse Event|2|||
131814993|NCT00807495|474606461|FG000|Overall Study|Withdrawal by Patient|2|||
131814994|NCT00807495|474606462|FG001|Overall Study|Withdrawal by Patient|0|||
131814995|NCT00807495|474606463|FG002|Overall Study|Withdrawal by Patient|1|||
131814996|NCT00807495|474606464|FG003|Overall Study|Withdrawal by Patient|0|||
131814997|NCT00807495|474606465|FG004|Overall Study|Withdrawal by Patient|0|||
131814998|NCT00807495|474606461|FG000|Overall Study|Reason Not Specified|0|||
131814999|NCT00807495|474606462|FG001|Overall Study|Reason Not Specified|3|||
131815000|NCT00807495|474606463|FG002|Overall Study|Reason Not Specified|2|||
131815001|NCT00807495|474606464|FG003|Overall Study|Reason Not Specified|0|||
131815002|NCT00807495|474606465|FG004|Overall Study|Reason Not Specified|3|||
131815003|NCT05274763|474606467|FG000|Overall Study|Lost to Follow-up|1|||
131815004|NCT01174186|474606468|FG000|Overall Study|Lost to Follow-up|0|||
131815005|NCT01174186|474606469|FG001|Overall Study|Lost to Follow-up|1|||
131815006|NCT01174186|474606468|FG000|Overall Study|Withdrawal by Subject|0|||
131815007|NCT01174186|474606469|FG001|Overall Study|Withdrawal by Subject|2|||
131815008|NCT00909753|474606471|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
131815009|NCT00909753|474606472|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
131815010|NCT00909753|474606471|FG000|Period: Second Intervention|Protocol Violation|1|||
131815011|NCT00909753|474606472|FG001|Period: Second Intervention|Protocol Violation|0|||
131815012|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
131815013|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
131815014|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
131815015|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
131815016|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
131815017|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
131815018|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Death|9|||
131815019|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Death|7|||
131815020|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Death|14|||
131815021|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Death|7|||
131815022|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Death|0|||
131815023|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Death|0|||
131815024|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
131815025|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
131815026|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
131815027|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
131815028|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
131815029|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
131815030|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Other Event|49|||
131815031|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Other Event|52|||
131815032|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Other Event|41|||
131815033|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Other Event|58|||
131815034|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Other Event|0|||
131815035|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Other Event|0|||
131815036|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
131815037|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
131815038|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
131815039|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
131815040|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
131815041|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
131815042|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
131815043|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
131815044|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
131909774|NCT00959751|474958650|FG001|Overall Study|Non-compliance to Study Procedures|1|||
131909775|NCT00959751|474958649|FG000|Overall Study|No migraine headache without aura|7|||
131909776|NCT00959751|474958650|FG001|Overall Study|No migraine headache without aura|7|||
131909777|NCT02807259|474958653|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
131909778|NCT02807259|474958654|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
131909779|NCT02807259|474958653|FG000|Midline (3 Months)|migration, refusal, not available|30|||
131909780|NCT02807259|474958654|FG001|Midline (3 Months)|migration, refusal, not available|34|||
131909781|NCT02807259|474958653|FG000|Endline (3 Months)|migration, refusal, not available|35|||
131909782|NCT02807259|474958654|FG001|Endline (3 Months)|migration, refusal, not available|87|||
131909783|NCT03861039|474958655|FG000|Overall Study|Adverse Event|2|||
131909784|NCT03861039|474958656|FG001|Overall Study|Adverse Event|5|||
131909785|NCT03861039|474958657|FG002|Overall Study|Adverse Event|11|||
131400689|NCT00656058|473089590|FG000|Overall Study|Withdrawal by Subject|4|||
131909786|NCT03861039|474958655|FG000|Overall Study|Withdrawal by Subject|1|||
131909787|NCT03861039|474958656|FG001|Overall Study|Withdrawal by Subject|3|||
131400690|NCT00616018|473089591|FG000|Overall Study|Protocol Violation|3|||
131909788|NCT03861039|474958657|FG002|Overall Study|Withdrawal by Subject|4|||
131400691|NCT03718884|473089592|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
131400692|NCT03718884|473089593|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
131815045|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
131815046|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
131815047|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
131909789|NCT00900562|474958663|FG000|Overall Study|Progressive disease|9|||
131909790|NCT00900562|474958664|FG001|Overall Study|Progressive disease|5|||
131400693|NCT03718884|473089592|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
131815048|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
131815049|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
131815050|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
131815051|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
131815052|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
131815053|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
131815054|NCT00205777|474606479|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
131815055|NCT00205777|474606480|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
131815056|NCT00205777|474606481|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
131815057|NCT00205777|474606482|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
131815058|NCT00205777|474606483|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
131815059|NCT00205777|474606484|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
131815060|NCT00205777|474606479|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
131815061|NCT00205777|474606480|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
131815062|NCT00205777|474606481|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
131815063|NCT00205777|474606482|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
131815064|NCT00205777|474606483|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
131815065|NCT00205777|474606484|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
131815066|NCT00205777|474606479|FG000|Completed Core Study, Entered SE I|Other Event|52|||
131815067|NCT00205777|474606480|FG001|Completed Core Study, Entered SE I|Other Event|46|||
131815068|NCT00205777|474606481|FG002|Completed Core Study, Entered SE I|Other Event|47|||
131815069|NCT00205777|474606482|FG003|Completed Core Study, Entered SE I|Other Event|50|||
131815070|NCT00205777|474606483|FG004|Completed Core Study, Entered SE I|Other Event|0|||
131815071|NCT00205777|474606484|FG005|Completed Core Study, Entered SE I|Other Event|0|||
131815072|NCT00205777|474606479|FG000|Study Extension I|Adverse Event|57|||
131815073|NCT00205777|474606480|FG001|Study Extension I|Adverse Event|0|||
131815074|NCT00205777|474606481|FG002|Study Extension I|Adverse Event|0|||
131815075|NCT00205777|474606482|FG003|Study Extension I|Adverse Event|61|||
131815076|NCT00205777|474606483|FG004|Study Extension I|Adverse Event|58|||
131815077|NCT00205777|474606484|FG005|Study Extension I|Adverse Event|0|||
131815078|NCT00205777|474606479|FG000|Study Extension I|Death|5|||
131815079|NCT00205777|474606480|FG001|Study Extension I|Death|0|||
131815080|NCT00205777|474606481|FG002|Study Extension I|Death|0|||
131815081|NCT00205777|474606482|FG003|Study Extension I|Death|1|||
131815082|NCT00205777|474606483|FG004|Study Extension I|Death|2|||
131815083|NCT00205777|474606484|FG005|Study Extension I|Death|0|||
131815084|NCT00205777|474606479|FG000|Study Extension I|Withdrawal by Subject|99|||
131815085|NCT00205777|474606480|FG001|Study Extension I|Withdrawal by Subject|0|||
131815086|NCT00205777|474606481|FG002|Study Extension I|Withdrawal by Subject|0|||
131815087|NCT00205777|474606482|FG003|Study Extension I|Withdrawal by Subject|106|||
131815088|NCT00205777|474606483|FG004|Study Extension I|Withdrawal by Subject|89|||
131815089|NCT00205777|474606484|FG005|Study Extension I|Withdrawal by Subject|0|||
131815090|NCT00205777|474606479|FG000|Study Extension I|Protocol Violation|4|||
131815091|NCT00205777|474606480|FG001|Study Extension I|Protocol Violation|0|||
131815092|NCT00205777|474606481|FG002|Study Extension I|Protocol Violation|0|||
131815093|NCT00205777|474606482|FG003|Study Extension I|Protocol Violation|8|||
131815094|NCT00205777|474606483|FG004|Study Extension I|Protocol Violation|8|||
131815095|NCT00205777|474606484|FG005|Study Extension I|Protocol Violation|0|||
131815096|NCT00205777|474606479|FG000|Study Extension I|Lack of Efficacy|0|||
131815097|NCT00205777|474606480|FG001|Study Extension I|Lack of Efficacy|0|||
131815098|NCT00205777|474606481|FG002|Study Extension I|Lack of Efficacy|0|||
131815099|NCT00205777|474606482|FG003|Study Extension I|Lack of Efficacy|1|||
131815100|NCT00205777|474606483|FG004|Study Extension I|Lack of Efficacy|2|||
131815101|NCT00205777|474606484|FG005|Study Extension I|Lack of Efficacy|0|||
131815102|NCT00205777|474606479|FG000|Study Extension I|Failed to return|15|||
131815103|NCT00205777|474606480|FG001|Study Extension I|Failed to return|0|||
131815104|NCT00205777|474606481|FG002|Study Extension I|Failed to return|0|||
131815105|NCT00205777|474606482|FG003|Study Extension I|Failed to return|17|||
131815106|NCT00205777|474606483|FG004|Study Extension I|Failed to return|13|||
131815107|NCT00205777|474606484|FG005|Study Extension I|Failed to return|0|||
131815108|NCT00205777|474606479|FG000|Study Extension I|Other Event|34|||
131815109|NCT00205777|474606480|FG001|Study Extension I|Other Event|0|||
131815110|NCT00205777|474606481|FG002|Study Extension I|Other Event|0|||
131815111|NCT00205777|474606482|FG003|Study Extension I|Other Event|34|||
131815112|NCT00205777|474606483|FG004|Study Extension I|Other Event|29|||
131815113|NCT00205777|474606484|FG005|Study Extension I|Other Event|0|||
131815114|NCT00205777|474606479|FG000|Study Extension I|Withdrawn as per protocol|0|||
131815115|NCT00205777|474606480|FG001|Study Extension I|Withdrawn as per protocol|0|||
131815116|NCT00205777|474606481|FG002|Study Extension I|Withdrawn as per protocol|1070|||
131815117|NCT00205777|474606482|FG003|Study Extension I|Withdrawn as per protocol|0|||
131815118|NCT00205777|474606483|FG004|Study Extension I|Withdrawn as per protocol|0|||
131400694|NCT03718884|473089593|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
131400695|NCT00349921|473089594|FG000|First Spinal Injection|Physician Decision|1|||
131815119|NCT00205777|474606484|FG005|Study Extension I|Withdrawn as per protocol|0|||
131400696|NCT00349921|473089595|FG001|First Spinal Injection|Physician Decision|0|||
131400697|NCT00349921|473089596|FG002|First Spinal Injection|Physician Decision|0|||
131400698|NCT00349921|473089597|FG003|First Spinal Injection|Physician Decision|0|||
131400699|NCT00349921|473089594|FG000|First Spinal Injection|Adverse Event|0|||
131400700|NCT00349921|473089595|FG001|First Spinal Injection|Adverse Event|0|||
131400701|NCT00349921|473089596|FG002|First Spinal Injection|Adverse Event|1|||
131815120|NCT00205777|474606479|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
131815121|NCT00205777|474606480|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
131815122|NCT00205777|474606481|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
131815123|NCT00205777|474606482|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
131815124|NCT00205777|474606483|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
131815125|NCT00205777|474606484|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
131815126|NCT00205777|474606479|FG000|Study Extension II|Adverse Event|0|||
131815127|NCT00205777|474606480|FG001|Study Extension II|Adverse Event|0|||
131815128|NCT00205777|474606481|FG002|Study Extension II|Adverse Event|0|||
131815129|NCT00205777|474606482|FG003|Study Extension II|Adverse Event|14|||
131815130|NCT00205777|474606483|FG004|Study Extension II|Adverse Event|0|||
131815131|NCT00205777|474606484|FG005|Study Extension II|Adverse Event|30|||
131815132|NCT00205777|474606479|FG000|Study Extension II|Death|0|||
131815133|NCT00205777|474606480|FG001|Study Extension II|Death|0|||
131815134|NCT00205777|474606481|FG002|Study Extension II|Death|0|||
131815135|NCT00205777|474606482|FG003|Study Extension II|Death|2|||
131815136|NCT00205777|474606483|FG004|Study Extension II|Death|0|||
131815137|NCT00205777|474606484|FG005|Study Extension II|Death|5|||
131815138|NCT00205777|474606479|FG000|Study Extension II|Withdrawal by Subject|0|||
131815139|NCT00205777|474606480|FG001|Study Extension II|Withdrawal by Subject|0|||
131815140|NCT00205777|474606481|FG002|Study Extension II|Withdrawal by Subject|0|||
131815141|NCT00205777|474606482|FG003|Study Extension II|Withdrawal by Subject|35|||
131815142|NCT00205777|474606483|FG004|Study Extension II|Withdrawal by Subject|0|||
131815143|NCT00205777|474606484|FG005|Study Extension II|Withdrawal by Subject|59|||
131815144|NCT00205777|474606479|FG000|Study Extension II|Protocol Violation|0|||
131815145|NCT00205777|474606480|FG001|Study Extension II|Protocol Violation|0|||
131815146|NCT00205777|474606481|FG002|Study Extension II|Protocol Violation|0|||
131815147|NCT00205777|474606482|FG003|Study Extension II|Protocol Violation|1|||
131815148|NCT00205777|474606483|FG004|Study Extension II|Protocol Violation|0|||
131815149|NCT00205777|474606484|FG005|Study Extension II|Protocol Violation|10|||
131815150|NCT00205777|474606479|FG000|Study Extension II|Lack of Efficacy|0|||
131815151|NCT00205777|474606480|FG001|Study Extension II|Lack of Efficacy|0|||
131815152|NCT00205777|474606481|FG002|Study Extension II|Lack of Efficacy|0|||
131815153|NCT00205777|474606482|FG003|Study Extension II|Lack of Efficacy|0|||
131815154|NCT00205777|474606483|FG004|Study Extension II|Lack of Efficacy|0|||
131815155|NCT00205777|474606484|FG005|Study Extension II|Lack of Efficacy|1|||
131815156|NCT00205777|474606479|FG000|Study Extension II|Failed to return|0|||
131815157|NCT00205777|474606480|FG001|Study Extension II|Failed to return|0|||
131815158|NCT00205777|474606481|FG002|Study Extension II|Failed to return|0|||
131815159|NCT00205777|474606482|FG003|Study Extension II|Failed to return|14|||
131815160|NCT00205777|474606483|FG004|Study Extension II|Failed to return|0|||
131815161|NCT00205777|474606484|FG005|Study Extension II|Failed to return|26|||
131815162|NCT00205777|474606479|FG000|Study Extension II|Other Event|0|||
131815163|NCT00205777|474606480|FG001|Study Extension II|Other Event|0|||
131815164|NCT00205777|474606481|FG002|Study Extension II|Other Event|0|||
131815165|NCT00205777|474606482|FG003|Study Extension II|Other Event|12|||
131815166|NCT00205777|474606483|FG004|Study Extension II|Other Event|0|||
131815167|NCT00205777|474606484|FG005|Study Extension II|Other Event|20|||
131815168|NCT00205777|474606479|FG000|Study Extension II|Enrolled but not treated|0|||
131815169|NCT00205777|474606480|FG001|Study Extension II|Enrolled but not treated|0|||
131815170|NCT00205777|474606481|FG002|Study Extension II|Enrolled but not treated|0|||
131815171|NCT00205777|474606482|FG003|Study Extension II|Enrolled but not treated|71|||
131815172|NCT00205777|474606483|FG004|Study Extension II|Enrolled but not treated|0|||
131815173|NCT00205777|474606484|FG005|Study Extension II|Enrolled but not treated|131|||
131815174|NCT00858780|474606487|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
131815175|NCT00858780|474606488|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
131815176|NCT00858780|474606489|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
131815177|NCT00858780|474606490|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
131815178|NCT00858780|474606491|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
131815179|NCT00858780|474606487|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
131815180|NCT00858780|474606488|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
131909791|NCT00900562|474958663|FG000|Overall Study|Toxicity|1|||
131909792|NCT00900562|474958664|FG001|Overall Study|Toxicity|0|||
131815181|NCT00858780|474606489|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
131815182|NCT00858780|474606490|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
131815183|NCT00858780|474606491|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
131815184|NCT00858780|474606487|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
131815185|NCT00858780|474606488|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
131815186|NCT00858780|474606489|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
131815187|NCT00858780|474606490|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
131815188|NCT00858780|474606491|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
131815189|NCT00858780|474606487|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
131815190|NCT00858780|474606488|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
131815191|NCT00858780|474606489|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
131815192|NCT00858780|474606490|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
131815193|NCT00858780|474606491|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
131815194|NCT00858780|474606487|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
131815195|NCT00858780|474606488|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
131815196|NCT00858780|474606489|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
131815197|NCT00858780|474606490|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
131815198|NCT00858780|474606491|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
131815199|NCT00858780|474606487|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
131815200|NCT00858780|474606488|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
131815201|NCT00858780|474606489|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
131815202|NCT00858780|474606490|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
131815203|NCT00858780|474606491|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
131815204|NCT00863330|474606492|FG000|Overall Study|study terminated early due to administra|6|||
131815205|NCT01297504|474606493|FG000|Overall Study|Invalid Consent|1|||
131815206|NCT01297504|474606493|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
131815207|NCT01297504|474606493|FG000|Overall Study|No Study Visits|4|||
131815208|NCT01297504|474606493|FG000|Overall Study|Death|3|||
131815209|NCT01297504|474606493|FG000|Overall Study|Lost to Follow-up|43|||
131815210|NCT01297504|474606493|FG000|Overall Study|Withdrawal by Subject|9|||
131815211|NCT01297504|474606493|FG000|Overall Study|Site Closure|3|||
131815212|NCT01297504|474606493|FG000|Overall Study|Protocol Violation|3|||
131815213|NCT03602339|474606494|FG000|Overall Study|Withdrawal by Subject|9|||
131815214|NCT03602339|474606494|FG000|Overall Study|Physician Decision|2|||
131815215|NCT03602339|474606494|FG000|Overall Study|Other reason|4|||
131815216|NCT02615249|474606495|FG000|Overall Study|Withdrawal by Subject|1|||
131815217|NCT02923349|474606502|FG000|Overall Study|Other|1|||
131815218|NCT02923349|474606503|FG001|Overall Study|Other|2|||
131815219|NCT02923349|474606504|FG002|Overall Study|Other|4|||
131815220|NCT02923349|474606505|FG003|Overall Study|Other|1|||
131815221|NCT02923349|474606506|FG004|Overall Study|Other|3|||
131815222|NCT02923349|474606507|FG005|Overall Study|Other|0|||
131815223|NCT02923349|474606508|FG006|Overall Study|Other|1|||
131815224|NCT02923349|474606502|FG000|Overall Study|Withdrawal by Subject|2|||
131815225|NCT02923349|474606503|FG001|Overall Study|Withdrawal by Subject|2|||
131815226|NCT02923349|474606504|FG002|Overall Study|Withdrawal by Subject|8|||
131815227|NCT02923349|474606505|FG003|Overall Study|Withdrawal by Subject|10|||
131815228|NCT02923349|474606506|FG004|Overall Study|Withdrawal by Subject|12|||
131815229|NCT02923349|474606507|FG005|Overall Study|Withdrawal by Subject|3|||
131815230|NCT02923349|474606508|FG006|Overall Study|Withdrawal by Subject|0|||
131815231|NCT02923349|474606502|FG000|Overall Study|Physician Decision|0|||
131815232|NCT02923349|474606503|FG001|Overall Study|Physician Decision|0|||
131815233|NCT02923349|474606504|FG002|Overall Study|Physician Decision|0|||
131815234|NCT02923349|474606505|FG003|Overall Study|Physician Decision|1|||
131815235|NCT02923349|474606506|FG004|Overall Study|Physician Decision|1|||
131815236|NCT02923349|474606507|FG005|Overall Study|Physician Decision|0|||
131815237|NCT02923349|474606508|FG006|Overall Study|Physician Decision|2|||
131815238|NCT02923349|474606502|FG000|Overall Study|Lost to Follow-up|0|||
131815239|NCT02923349|474606503|FG001|Overall Study|Lost to Follow-up|0|||
131815240|NCT02923349|474606504|FG002|Overall Study|Lost to Follow-up|3|||
131815241|NCT02923349|474606505|FG003|Overall Study|Lost to Follow-up|0|||
131815242|NCT02923349|474606506|FG004|Overall Study|Lost to Follow-up|1|||
131815243|NCT02923349|474606507|FG005|Overall Study|Lost to Follow-up|1|||
131815244|NCT02923349|474606508|FG006|Overall Study|Lost to Follow-up|0|||
131815245|NCT02923349|474606502|FG000|Overall Study|Death|1|||
131815246|NCT02923349|474606503|FG001|Overall Study|Death|0|||
131815247|NCT02923349|474606504|FG002|Overall Study|Death|2|||
131815248|NCT02923349|474606505|FG003|Overall Study|Death|4|||
131815249|NCT02923349|474606506|FG004|Overall Study|Death|2|||
131815250|NCT02923349|474606507|FG005|Overall Study|Death|3|||
131815251|NCT02923349|474606508|FG006|Overall Study|Death|0|||
131815252|NCT02751827|474606509|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
131815253|NCT02751827|474606510|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
131815254|NCT02751827|474606511|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
131815255|NCT03578809|474607993|FG000|Overall Study|Death|0|||
131815256|NCT03578809|474607994|FG001|Overall Study|Death|2|||
131815257|NCT03578809|474607995|FG002|Overall Study|Death|0|||
131815258|NCT03578809|474607996|FG003|Overall Study|Death|1|||
131815259|NCT03578809|474607993|FG000|Overall Study|Lost to Follow-up|0|||
131815260|NCT03578809|474607994|FG001|Overall Study|Lost to Follow-up|1|||
131815261|NCT03578809|474607995|FG002|Overall Study|Lost to Follow-up|0|||
131815262|NCT03578809|474607996|FG003|Overall Study|Lost to Follow-up|0|||
131815263|NCT03578809|474607993|FG000|Overall Study|Withdrawal by Subject|3|||
131815264|NCT03578809|474607994|FG001|Overall Study|Withdrawal by Subject|5|||
131815265|NCT03578809|474607995|FG002|Overall Study|Withdrawal by Subject|2|||
131815266|NCT03578809|474607996|FG003|Overall Study|Withdrawal by Subject|0|||
131815267|NCT03578809|474607993|FG000|Overall Study|Other|3|||
131815268|NCT03578809|474607994|FG001|Overall Study|Other|6|||
131815269|NCT03578809|474607995|FG002|Overall Study|Other|2|||
131815270|NCT03578809|474607996|FG003|Overall Study|Other|8|||
131815271|NCT01952691|474607997|FG000|Overall Study|Lost to Follow-up|2|||
131815272|NCT00199901|474607998|FG000|Overall Study|Protocol Violation|2|||
131815273|NCT00199901|474607999|FG001|Overall Study|Protocol Violation|0|||
131815274|NCT00199901|474607998|FG000|Overall Study|Withdrawal by Subject|1|||
131815275|NCT00199901|474607999|FG001|Overall Study|Withdrawal by Subject|0|||
131815276|NCT00199901|474607998|FG000|Overall Study|Progressive Disease|24|||
131815277|NCT00199901|474607999|FG001|Overall Study|Progressive Disease|24|||
131815278|NCT03428750|474608004|FG000|Overall Study|Withdrawal by Subject|11|||
131815279|NCT03428750|474608005|FG001|Overall Study|Withdrawal by Subject|10|||
131815280|NCT03428750|474608004|FG000|Overall Study|Lost to Follow-up|3|||
131815281|NCT03428750|474608005|FG001|Overall Study|Lost to Follow-up|9|||
131815282|NCT03428750|474608004|FG000|Overall Study|Adverse Event|9|||
131815283|NCT03428750|474608005|FG001|Overall Study|Adverse Event|1|||
131815284|NCT03428750|474608004|FG000|Overall Study|Protocol Violation|1|||
131815285|NCT03428750|474608005|FG001|Overall Study|Protocol Violation|0|||
131815286|NCT03428750|474608004|FG000|Overall Study|Administrative|0|||
131815287|NCT03428750|474608005|FG001|Overall Study|Administrative|1|||
131815288|NCT02554877|474608006|FG000|Overall Study|Adverse Event|2|||
131815289|NCT02554877|474608007|FG001|Overall Study|Adverse Event|0|||
131815290|NCT02554877|474608008|FG002|Overall Study|Adverse Event|0|||
131815291|NCT02554877|474608009|FG003|Overall Study|Adverse Event|1|||
131815292|NCT02554877|474608006|FG000|Overall Study|Lost to Follow-up|1|||
131815293|NCT02554877|474608007|FG001|Overall Study|Lost to Follow-up|1|||
131815294|NCT02554877|474608008|FG002|Overall Study|Lost to Follow-up|1|||
131815295|NCT02554877|474608009|FG003|Overall Study|Lost to Follow-up|2|||
131815296|NCT02554877|474608006|FG000|Overall Study|Did not meet entrance criteria|0|||
131815297|NCT02554877|474608007|FG001|Overall Study|Did not meet entrance criteria|0|||
131815298|NCT02554877|474608008|FG002|Overall Study|Did not meet entrance criteria|1|||
131815299|NCT02554877|474608009|FG003|Overall Study|Did not meet entrance criteria|0|||
131815300|NCT02554877|474608006|FG000|Overall Study|No longer met eligibility criteria|1|||
131815301|NCT02554877|474608007|FG001|Overall Study|No longer met eligibility criteria|0|||
131815302|NCT02554877|474608008|FG002|Overall Study|No longer met eligibility criteria|1|||
131815303|NCT02554877|474608009|FG003|Overall Study|No longer met eligibility criteria|1|||
131815304|NCT02554877|474608006|FG000|Overall Study|Protocol Violation|3|||
131815305|NCT02554877|474608007|FG001|Overall Study|Protocol Violation|1|||
131815306|NCT02554877|474608008|FG002|Overall Study|Protocol Violation|1|||
131815307|NCT02554877|474608009|FG003|Overall Study|Protocol Violation|0|||
131815308|NCT02554877|474608006|FG000|Overall Study|Other|1|||
131815309|NCT02554877|474608007|FG001|Overall Study|Other|3|||
131815310|NCT02554877|474608008|FG002|Overall Study|Other|0|||
131815311|NCT02554877|474608009|FG003|Overall Study|Other|3|||
131815312|NCT02554877|474608006|FG000|Overall Study|Insufficient clinical response|4|||
131815313|NCT02554877|474608007|FG001|Overall Study|Insufficient clinical response|0|||
131815314|NCT02554877|474608008|FG002|Overall Study|Insufficient clinical response|0|||
131815315|NCT02554877|474608009|FG003|Overall Study|Insufficient clinical response|0|||
131815316|NCT02554877|474608006|FG000|Overall Study|No longer willing to participate|0|||
131815317|NCT02554877|474608007|FG001|Overall Study|No longer willing to participate|2|||
131815318|NCT02554877|474608008|FG002|Overall Study|No longer willing to participate|2|||
131815319|NCT02554877|474608009|FG003|Overall Study|No longer willing to participate|0|||
131815320|NCT04474405|474608010|FG000|Overall Study|Withdrawal by Subject|0|||
131815321|NCT04474405|474608011|FG001|Overall Study|Withdrawal by Subject|0|||
131815322|NCT04474405|474608012|FG002|Overall Study|Withdrawal by Subject|1|||
131815323|NCT04474405|474608013|FG003|Overall Study|Withdrawal by Subject|0|||
131815324|NCT04474405|474608014|FG004|Overall Study|Withdrawal by Subject|1|||
131815325|NCT04474405|474608015|FG005|Overall Study|Withdrawal by Subject|0|||
131815326|NCT04474405|474608010|FG000|Overall Study|Other|0|||
131815327|NCT04474405|474608011|FG001|Overall Study|Other|0|||
131815328|NCT04474405|474608012|FG002|Overall Study|Other|0|||
131815329|NCT04474405|474608013|FG003|Overall Study|Other|0|||
131815330|NCT04474405|474608014|FG004|Overall Study|Other|3|||
131815331|NCT04474405|474608015|FG005|Overall Study|Other|0|||
131815332|NCT00274651|474608016|FG000|Overall Study|Adverse Event|6|||
131815333|NCT00274651|474608017|FG001|Overall Study|Adverse Event|3|||
131909793|NCT00900562|474958663|FG000|Overall Study|Death|1|||
131400702|NCT00349921|473089597|FG003|First Spinal Injection|Adverse Event|0|||
131400703|NCT06359028|473089598|FG000|Overall Study|Adverse Event|1|||
131815334|NCT00274651|474608016|FG000|Overall Study|Lack of Efficacy|13|||
131815335|NCT00274651|474608017|FG001|Overall Study|Lack of Efficacy|6|||
131815336|NCT00274651|474608016|FG000|Overall Study|Death|1|||
131815337|NCT00274651|474608017|FG001|Overall Study|Death|3|||
131815338|NCT00274651|474608016|FG000|Overall Study|Withdrawal by Subject|0|||
131815339|NCT00274651|474608017|FG001|Overall Study|Withdrawal by Subject|1|||
131815340|NCT00274651|474608016|FG000|Overall Study|Physician Decision|8|||
131815341|NCT00274651|474608017|FG001|Overall Study|Physician Decision|7|||
131815342|NCT04547192|474608018|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
131815343|NCT04547192|474608019|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
131815344|NCT04547192|474608020|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
131815345|NCT04547192|474608021|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
131815346|NCT04547192|474608018|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
131815347|NCT04547192|474608019|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
131815348|NCT04547192|474608020|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
131815349|NCT04547192|474608021|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
131815350|NCT04547192|474608018|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
131815351|NCT04547192|474608019|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
131815352|NCT04547192|474608020|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
131815353|NCT04547192|474608021|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
131815354|NCT04547192|474608018|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
131815355|NCT04547192|474608019|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
131815356|NCT04547192|474608020|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
131815357|NCT04547192|474608021|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
131815358|NCT04547192|474608018|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
131815359|NCT04547192|474608019|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
131815360|NCT04547192|474608020|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
131815361|NCT04547192|474608021|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
131815362|NCT04723693|474608022|FG000|Overall Study|Withdrawal by Subject|2|||
131815363|NCT02157974|474608023|FG000|Overall Study|Withdrawal by Subject|0|||
131815364|NCT02157974|474608024|FG001|Overall Study|Withdrawal by Subject|1|||
131815365|NCT02157974|474608025|FG002|Overall Study|Withdrawal by Subject|0|||
131815366|NCT02157974|474608026|FG003|Overall Study|Withdrawal by Subject|0|||
131815367|NCT02157974|474608027|FG004|Overall Study|Withdrawal by Subject|0|||
131815368|NCT02157974|474608023|FG000|Overall Study|Screen Failure|0|||
131815369|NCT02157974|474608024|FG001|Overall Study|Screen Failure|1|||
131815370|NCT02157974|474608025|FG002|Overall Study|Screen Failure|0|||
131815371|NCT02157974|474608026|FG003|Overall Study|Screen Failure|0|||
131815372|NCT02157974|474608027|FG004|Overall Study|Screen Failure|0|||
131815373|NCT02157974|474608023|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
131815374|NCT02157974|474608024|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
131815375|NCT02157974|474608025|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
131815376|NCT02157974|474608026|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
131815377|NCT02157974|474608027|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
131815378|NCT01410227|474608028|FG000|Overall Study|Adverse Event|1|||
131815379|NCT01410227|474608029|FG001|Overall Study|Adverse Event|0|||
131815380|NCT01410227|474608030|FG002|Overall Study|Adverse Event|0|||
131815381|NCT01410227|474608031|FG003|Overall Study|Adverse Event|0|||
131815382|NCT01410227|474608028|FG000|Overall Study|Withdrawal by Subject|3|||
131815383|NCT01410227|474608029|FG001|Overall Study|Withdrawal by Subject|0|||
131815384|NCT01410227|474608030|FG002|Overall Study|Withdrawal by Subject|1|||
131815385|NCT01410227|474608031|FG003|Overall Study|Withdrawal by Subject|0|||
131815386|NCT01410227|474608028|FG000|Overall Study|Pregnancy|0|||
131815387|NCT01410227|474608029|FG001|Overall Study|Pregnancy|0|||
131815388|NCT01410227|474608030|FG002|Overall Study|Pregnancy|0|||
131815389|NCT01410227|474608031|FG003|Overall Study|Pregnancy|1|||
131815390|NCT01410227|474608028|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
131815391|NCT01410227|474608029|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
131815392|NCT01410227|474608030|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
131815393|NCT01410227|474608031|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
131815394|NCT03497130|474608032|FG000|Overall Study|Lost to Follow-up|1|||
131815395|NCT03497130|474608033|FG001|Overall Study|Lost to Follow-up|1|||
131815396|NCT04002648|474608034|FG000|Overall Study|Lost to Follow-up|2|||
131815397|NCT04002648|474608035|FG001|Overall Study|Lost to Follow-up|0|||
131815398|NCT01484912|474608037|FG000|Overall Study|Withdrawal by Subject|1|||
131815399|NCT01484912|474608038|FG001|Overall Study|Withdrawal by Subject|0|||
131815400|NCT01484912|474608037|FG000|Overall Study|Physician Decision|0|||
131815401|NCT01484912|474608038|FG001|Overall Study|Physician Decision|1|||
131815402|NCT03158727|474608041|FG000|Overall Study|Withdrawal by Subject|2|||
131815403|NCT03158727|474608042|FG001|Overall Study|Withdrawal by Subject|6|||
131815404|NCT03158727|474608041|FG000|Overall Study|Death|11|||
131815405|NCT03158727|474608042|FG001|Overall Study|Death|12|||
131815406|NCT03158727|474608041|FG000|Overall Study|Lost to Follow-up|1|||
131815407|NCT03158727|474608042|FG001|Overall Study|Lost to Follow-up|0|||
131815408|NCT03158727|474608041|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
131815409|NCT03158727|474608042|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
131815410|NCT03158727|474608041|FG000|Overall Study|Visit 11 not done by mistake|0|||
131815411|NCT03158727|474608042|FG001|Overall Study|Visit 11 not done by mistake|1|||
131815412|NCT03158727|474608041|FG000|Overall Study|Enrolled, not treated|1|||
131815413|NCT03158727|474608042|FG001|Overall Study|Enrolled, not treated|0|||
131815414|NCT02412852|474608043|FG000|Overall Study|Withdrawal by Subject|0|||
131815415|NCT02412852|474608044|FG001|Overall Study|Withdrawal by Subject|1|||
131815416|NCT02412852|474608045|FG002|Overall Study|Withdrawal by Subject|0|||
131815417|NCT02412852|474608046|FG003|Overall Study|Withdrawal by Subject|0|||
131815418|NCT02412852|474608043|FG000|Overall Study|Physician Decision|0|||
131815419|NCT02412852|474608044|FG001|Overall Study|Physician Decision|0|||
131815420|NCT02412852|474608045|FG002|Overall Study|Physician Decision|0|||
131815421|NCT02412852|474608046|FG003|Overall Study|Physician Decision|1|||
131815422|NCT00985439|474608047|FG000|Overall Study|Adverse Event|0|||
131815423|NCT00985439|474608048|FG001|Overall Study|Adverse Event|0|||
131815424|NCT00985439|474608049|FG002|Overall Study|Adverse Event|1|||
131815425|NCT00985439|474608050|FG003|Overall Study|Adverse Event|0|||
131815426|NCT01051349|474608051|FG000|Overall Study|Adverse Event|88|||
131815427|NCT01051349|474608051|FG000|Overall Study|Consent Withdrawn|54|||
131815428|NCT01051349|474608051|FG000|Overall Study|Investigator Decision|6|||
131815429|NCT01051349|474608051|FG000|Overall Study|Lost to Follow-up|6|||
131815430|NCT01051349|474608051|FG000|Overall Study|Subject non-compliance|7|||
131815431|NCT01051349|474608051|FG000|Overall Study|Reason not Specified|12|||
131815432|NCT00841542|474608052|FG000|Period 1|Adverse Event|1|||
131815433|NCT00841542|474608053|FG001|Period 1|Adverse Event|0|||
131815434|NCT00418145|474608054|FG000|Overall Study|study terminated|6|||
131815435|NCT03214588|474608055|FG000|Overall Study|Adverse Event|1|||
131815436|NCT03214588|474608056|FG001|Overall Study|Adverse Event|0|||
131815437|NCT03214588|474608057|FG002|Overall Study|Adverse Event|2|||
131815438|NCT03214588|474608055|FG000|Overall Study|Reason Not Specified|0|||
131815439|NCT03214588|474608056|FG001|Overall Study|Reason Not Specified|1|||
131815440|NCT03214588|474608057|FG002|Overall Study|Reason Not Specified|0|||
131815441|NCT00472212|474608058|FG000|Overall Study|Lost to Follow-up|6|||
131815442|NCT00472212|474608059|FG001|Overall Study|Lost to Follow-up|4|||
131815443|NCT01906372|474608060|FG000|Overall Study|Withdrawal by Subject|2|||
131815444|NCT02462837|474608061|FG000|Overall Study|pt developed hives|1|||
131815445|NCT02462837|474608062|FG001|Overall Study|pt developed hives|0|||
131815446|NCT02462837|474608061|FG000|Overall Study|Withdrawal by Subject|1|||
131815447|NCT02462837|474608062|FG001|Overall Study|Withdrawal by Subject|0|||
131815448|NCT00367133|474608063|FG000|2 Years|Death|20|||
131815449|NCT00367133|474608064|FG001|2 Years|Death|12|||
131815450|NCT00367133|474608065|FG002|2 Years|Death|12|||
131815451|NCT00367133|474608063|FG000|2 Years|Dropped|34|||
131815452|NCT00367133|474608064|FG001|2 Years|Dropped|19|||
131815453|NCT00367133|474608065|FG002|2 Years|Dropped|33|||
131815454|NCT00367133|474608063|FG000|2 Years|Missed visit|4|||
131815455|NCT00367133|474608064|FG001|2 Years|Missed visit|5|||
131815456|NCT00367133|474608065|FG002|2 Years|Missed visit|4|||
131815457|NCT02336074|474608066|FG000|Overall Study|Adverse Event|0|||
131815458|NCT02336074|474608067|FG001|Overall Study|Adverse Event|2|||
131815459|NCT00906399|474608069|FG000|Year 1|Randomized But Not Treated|0|||
131815460|NCT00906399|474608070|FG001|Year 1|Randomized But Not Treated|1|||
131815461|NCT00906399|474608071|FG002|Year 1|Randomized But Not Treated|3|||
131815462|NCT00906399|474608072|FG003|Year 1|Randomized But Not Treated|0|||
131815463|NCT00906399|474608073|FG004|Year 1|Randomized But Not Treated|0|||
131815464|NCT00906399|474608074|FG005|Year 1|Randomized But Not Treated|0|||
131815465|NCT00906399|474608075|FG006|Year 1|Randomized But Not Treated|0|||
131815466|NCT00906399|474608069|FG000|Year 1|Adverse Event|4|||
131815467|NCT00906399|474608070|FG001|Year 1|Adverse Event|22|||
131815468|NCT00906399|474608071|FG002|Year 1|Adverse Event|24|||
131815469|NCT00906399|474608072|FG003|Year 1|Adverse Event|0|||
131815470|NCT00906399|474608073|FG004|Year 1|Adverse Event|0|||
131815471|NCT00906399|474608074|FG005|Year 1|Adverse Event|0|||
131815472|NCT00906399|474608075|FG006|Year 1|Adverse Event|0|||
131815473|NCT00906399|474608069|FG000|Year 1|Lost to Follow-up|4|||
131815474|NCT00906399|474608070|FG001|Year 1|Lost to Follow-up|4|||
131815475|NCT00906399|474608071|FG002|Year 1|Lost to Follow-up|2|||
131815476|NCT00906399|474608072|FG003|Year 1|Lost to Follow-up|0|||
131815477|NCT00906399|474608073|FG004|Year 1|Lost to Follow-up|0|||
131815478|NCT00906399|474608074|FG005|Year 1|Lost to Follow-up|0|||
131815479|NCT00906399|474608075|FG006|Year 1|Lost to Follow-up|0|||
131815480|NCT00906399|474608069|FG000|Year 1|Withdrawal by Subject|30|||
131815481|NCT00906399|474608070|FG001|Year 1|Withdrawal by Subject|32|||
131815482|NCT00906399|474608071|FG002|Year 1|Withdrawal by Subject|36|||
131815483|NCT00906399|474608072|FG003|Year 1|Withdrawal by Subject|0|||
131815484|NCT00906399|474608073|FG004|Year 1|Withdrawal by Subject|0|||
131815485|NCT00906399|474608074|FG005|Year 1|Withdrawal by Subject|0|||
131815486|NCT00906399|474608075|FG006|Year 1|Withdrawal by Subject|0|||
131815487|NCT00906399|474608069|FG000|Year 1|Physician Decision|0|||
131815488|NCT00906399|474608070|FG001|Year 1|Physician Decision|1|||
131815489|NCT00906399|474608071|FG002|Year 1|Physician Decision|3|||
131400704|NCT06359028|473089599|FG001|Overall Study|Adverse Event|0|||
131400705|NCT06359028|473089598|FG000|Overall Study|Withdrawal by Subject|1|||
131400706|NCT06359028|473089599|FG001|Overall Study|Withdrawal by Subject|0|||
131400707|NCT04700540|473089600|FG000|Overall Study|Withdrawal by Subject|12|||
131400708|NCT04700540|473089601|FG001|Overall Study|Withdrawal by Subject|8|||
131400709|NCT04700540|473089600|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
131815490|NCT00906399|474608072|FG003|Year 1|Physician Decision|0|||
131815491|NCT00906399|474608073|FG004|Year 1|Physician Decision|0|||
131815492|NCT00906399|474608074|FG005|Year 1|Physician Decision|0|||
131815493|NCT00906399|474608075|FG006|Year 1|Physician Decision|0|||
131815494|NCT00906399|474608069|FG000|Year 1|Death|2|||
131815495|NCT00906399|474608070|FG001|Year 1|Death|1|||
131815496|NCT00906399|474608071|FG002|Year 1|Death|1|||
131815497|NCT00906399|474608072|FG003|Year 1|Death|0|||
131815498|NCT00906399|474608073|FG004|Year 1|Death|0|||
131815499|NCT00906399|474608074|FG005|Year 1|Death|0|||
131815500|NCT00906399|474608075|FG006|Year 1|Death|0|||
131815501|NCT00906399|474608069|FG000|Year 1|Other|4|||
131815502|NCT00906399|474608070|FG001|Year 1|Other|2|||
131815503|NCT00906399|474608071|FG002|Year 1|Other|7|||
131815504|NCT00906399|474608072|FG003|Year 1|Other|0|||
131815505|NCT00906399|474608073|FG004|Year 1|Other|0|||
131815506|NCT00906399|474608074|FG005|Year 1|Other|0|||
131815507|NCT00906399|474608075|FG006|Year 1|Other|0|||
131815508|NCT00906399|474608069|FG000|Year 2|Adverse Event|0|||
131815509|NCT00906399|474608070|FG001|Year 2|Adverse Event|0|||
131815510|NCT00906399|474608071|FG002|Year 2|Adverse Event|0|||
131815511|NCT00906399|474608072|FG003|Year 2|Adverse Event|9|||
131815512|NCT00906399|474608073|FG004|Year 2|Adverse Event|8|||
131815513|NCT00906399|474608074|FG005|Year 2|Adverse Event|11|||
131815514|NCT00906399|474608075|FG006|Year 2|Adverse Event|6|||
131815515|NCT00906399|474608069|FG000|Year 2|Lost to Follow-up|0|||
131815516|NCT00906399|474608070|FG001|Year 2|Lost to Follow-up|0|||
131815517|NCT00906399|474608071|FG002|Year 2|Lost to Follow-up|0|||
131815518|NCT00906399|474608072|FG003|Year 2|Lost to Follow-up|1|||
131815519|NCT00906399|474608073|FG004|Year 2|Lost to Follow-up|4|||
131815520|NCT00906399|474608074|FG005|Year 2|Lost to Follow-up|2|||
131815521|NCT00906399|474608075|FG006|Year 2|Lost to Follow-up|4|||
131815522|NCT00906399|474608069|FG000|Year 2|Withdrawal by Subject|0|||
131815523|NCT00906399|474608070|FG001|Year 2|Withdrawal by Subject|0|||
131815524|NCT00906399|474608071|FG002|Year 2|Withdrawal by Subject|0|||
131815525|NCT00906399|474608072|FG003|Year 2|Withdrawal by Subject|17|||
131815526|NCT00906399|474608073|FG004|Year 2|Withdrawal by Subject|18|||
131815527|NCT00906399|474608074|FG005|Year 2|Withdrawal by Subject|27|||
131815528|NCT00906399|474608075|FG006|Year 2|Withdrawal by Subject|13|||
131815529|NCT00906399|474608069|FG000|Year 2|Physician Decision|0|||
131815530|NCT00906399|474608070|FG001|Year 2|Physician Decision|0|||
131815531|NCT00906399|474608071|FG002|Year 2|Physician Decision|0|||
131815532|NCT00906399|474608072|FG003|Year 2|Physician Decision|0|||
131815533|NCT00906399|474608073|FG004|Year 2|Physician Decision|2|||
131815534|NCT00906399|474608074|FG005|Year 2|Physician Decision|6|||
131815535|NCT00906399|474608075|FG006|Year 2|Physician Decision|3|||
131815536|NCT00906399|474608069|FG000|Year 2|Death|0|||
131815537|NCT00906399|474608070|FG001|Year 2|Death|0|||
131815538|NCT00906399|474608071|FG002|Year 2|Death|0|||
131815539|NCT00906399|474608072|FG003|Year 2|Death|1|||
131815540|NCT00906399|474608073|FG004|Year 2|Death|0|||
131815541|NCT00906399|474608074|FG005|Year 2|Death|0|||
131400710|NCT04700540|473089601|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
131815542|NCT00906399|474608075|FG006|Year 2|Death|3|||
131815543|NCT00906399|474608069|FG000|Year 2|Other|0|||
131815544|NCT00906399|474608070|FG001|Year 2|Other|0|||
131400711|NCT03515551|473089602|FG000|Overall Study|Death|4|||
131815545|NCT00906399|474608071|FG002|Year 2|Other|0|||
131815546|NCT00906399|474608072|FG003|Year 2|Other|2|||
131815547|NCT00906399|474608073|FG004|Year 2|Other|3|||
131815548|NCT00906399|474608074|FG005|Year 2|Other|1|||
131815549|NCT00906399|474608075|FG006|Year 2|Other|0|||
131815550|NCT00624286|474608086|FG000|Overall Study|Protocol Deviation|7|||
131815551|NCT00624286|474608087|FG001|Overall Study|Protocol Deviation|9|||
131815552|NCT00624286|474608086|FG000|Overall Study|Adverse Event|6|||
131815553|NCT00624286|474608087|FG001|Overall Study|Adverse Event|3|||
131815554|NCT00624286|474608086|FG000|Overall Study|Withdrawal by Subject|5|||
131815555|NCT00624286|474608087|FG001|Overall Study|Withdrawal by Subject|4|||
131815556|NCT00624286|474608086|FG000|Overall Study|Lost to Follow-up|3|||
131815557|NCT00624286|474608087|FG001|Overall Study|Lost to Follow-up|2|||
131815558|NCT00624286|474608086|FG000|Overall Study|Administrative problems|3|||
131815559|NCT00624286|474608087|FG001|Overall Study|Administrative problems|0|||
131815560|NCT00624286|474608086|FG000|Overall Study|Lack of Efficacy|1|||
131815561|NCT00624286|474608087|FG001|Overall Study|Lack of Efficacy|6|||
131815562|NCT00624286|474608086|FG000|Overall Study|Not stated|0|||
131815563|NCT00624286|474608087|FG001|Overall Study|Not stated|1|||
131815564|NCT00624286|474608086|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131815565|NCT00624286|474608087|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131815566|NCT00624286|474608086|FG000|Overall Study|Death|0|||
131815567|NCT00624286|474608087|FG001|Overall Study|Death|1|||
131815568|NCT04404725|474608097|FG000|First Intervention|Withdrawal by Subject|0|||
131400712|NCT03515551|473089603|FG001|Overall Study|Death|1|||
131400713|NCT03515551|473089604|FG002|Overall Study|Death|2|||
131400714|NCT03515551|473089605|FG003|Overall Study|Death|2|||
131400715|NCT03515551|473089606|FG004|Overall Study|Death|2|||
131815569|NCT04404725|474608098|FG001|First Intervention|Withdrawal by Subject|2|||
131815570|NCT04404725|474608097|FG000|Second Intervention|Adverse Event|1|||
131815571|NCT04404725|474608098|FG001|Second Intervention|Adverse Event|1|||
131815572|NCT04404725|474608097|FG000|Second Intervention|Withdrawal by Subject|0|||
131815573|NCT04404725|474608098|FG001|Second Intervention|Withdrawal by Subject|1|||
131815574|NCT01075516|474608099|FG000|Overall Study|Death|5|||
131815575|NCT01075516|474608100|FG001|Overall Study|Death|9|||
131815576|NCT01075516|474608099|FG000|Overall Study|Lost to Follow-up|10|||
131815577|NCT01075516|474608100|FG001|Overall Study|Lost to Follow-up|2|||
131815578|NCT01075516|474608099|FG000|Overall Study|Withdrawal by Subject|3|||
131815579|NCT01075516|474608100|FG001|Overall Study|Withdrawal by Subject|5|||
131815580|NCT02252016|474608101|FG000|Overall Study|Lost to Follow-up|2|||
131815581|NCT02252016|474608102|FG001|Overall Study|Lost to Follow-up|1|||
131815582|NCT02252016|474608101|FG000|Overall Study|Physician Decision|1|||
131815583|NCT02252016|474608102|FG001|Overall Study|Physician Decision|0|||
131815584|NCT02252016|474608101|FG000|Overall Study|Withdrawal by Subject|0|||
131815585|NCT02252016|474608102|FG001|Overall Study|Withdrawal by Subject|2|||
131815586|NCT01190865|474608103|FG000|Overall Study|Withdrawal by Subject|1|||
131815587|NCT01190865|474608103|FG000|Overall Study|Non-compliance|2|||
131815588|NCT00574847|474608104|FG000|Overall Study|Adverse Event|2|||
131815589|NCT00574847|474608105|FG001|Overall Study|Adverse Event|0|||
131815590|NCT00574847|474608104|FG000|Overall Study|Death|1|||
131815591|NCT00574847|474608105|FG001|Overall Study|Death|0|||
131815592|NCT00574847|474608104|FG000|Overall Study|Withdrawal by Subject|2|||
131815593|NCT00574847|474608105|FG001|Overall Study|Withdrawal by Subject|2|||
131815594|NCT00574847|474608104|FG000|Overall Study|Physician Decision|1|||
131815595|NCT00574847|474608105|FG001|Overall Study|Physician Decision|0|||
131815596|NCT00574847|474608104|FG000|Overall Study|Did not receive medication (declined)|2|||
131815597|NCT00574847|474608105|FG001|Overall Study|Did not receive medication (declined)|5|||
131815598|NCT02055547|474608113|FG000|Overall Study|Protocol Violation|0|||
131815599|NCT02055547|474608114|FG001|Overall Study|Protocol Violation|0|||
131815600|NCT02055547|474608115|FG002|Overall Study|Protocol Violation|1|||
131815601|NCT02055547|474608116|FG003|Overall Study|Protocol Violation|0|||
131815602|NCT02055547|474608117|FG004|Overall Study|Protocol Violation|0|||
131815603|NCT02055547|474608118|FG005|Overall Study|Protocol Violation|0|||
131815604|NCT02055547|474608119|FG006|Overall Study|Protocol Violation|1|||
131815605|NCT02055547|474608120|FG007|Overall Study|Protocol Violation|0|||
131815606|NCT02055547|474608121|FG008|Overall Study|Protocol Violation|0|||
131815607|NCT02055547|474608122|FG009|Overall Study|Protocol Violation|0|||
131815608|NCT02055547|474608123|FG010|Overall Study|Protocol Violation|0|||
131815609|NCT02055547|474608124|FG011|Overall Study|Protocol Violation|0|||
131815610|NCT02055547|474608125|FG012|Overall Study|Protocol Violation|0|||
131815611|NCT02055547|474608126|FG013|Overall Study|Protocol Violation|0|||
131815612|NCT02055547|474608127|FG014|Overall Study|Protocol Violation|0|||
131815613|NCT02055547|474608128|FG015|Overall Study|Protocol Violation|0|||
131815614|NCT02055547|474608129|FG016|Overall Study|Protocol Violation|0|||
131815615|NCT02055547|474608130|FG017|Overall Study|Protocol Violation|0|||
131815616|NCT02055547|474608131|FG018|Overall Study|Protocol Violation|0|||
131815617|NCT02055547|474608113|FG000|Overall Study|Physician Decision|0|||
131400716|NCT03515551|473089607|FG005|Overall Study|Death|4|||
131400717|NCT03515551|473089608|FG006|Overall Study|Death|1|||
131815618|NCT02055547|474608114|FG001|Overall Study|Physician Decision|1|||
131815619|NCT02055547|474608115|FG002|Overall Study|Physician Decision|1|||
131815620|NCT02055547|474608116|FG003|Overall Study|Physician Decision|0|||
131815621|NCT02055547|474608117|FG004|Overall Study|Physician Decision|1|||
131815622|NCT02055547|474608118|FG005|Overall Study|Physician Decision|0|||
131815623|NCT02055547|474608119|FG006|Overall Study|Physician Decision|0|||
131815624|NCT02055547|474608120|FG007|Overall Study|Physician Decision|0|||
131815625|NCT02055547|474608121|FG008|Overall Study|Physician Decision|0|||
131815626|NCT02055547|474608122|FG009|Overall Study|Physician Decision|1|||
131815627|NCT02055547|474608123|FG010|Overall Study|Physician Decision|1|||
131815628|NCT02055547|474608124|FG011|Overall Study|Physician Decision|0|||
131815629|NCT02055547|474608125|FG012|Overall Study|Physician Decision|0|||
131815630|NCT02055547|474608126|FG013|Overall Study|Physician Decision|0|||
131815631|NCT02055547|474608127|FG014|Overall Study|Physician Decision|0|||
131815632|NCT02055547|474608128|FG015|Overall Study|Physician Decision|0|||
131815633|NCT02055547|474608129|FG016|Overall Study|Physician Decision|0|||
131400718|NCT03515551|473089602|FG000|Overall Study|Lost to Follow-up|0|||
131815634|NCT02055547|474608130|FG017|Overall Study|Physician Decision|0|||
131815635|NCT02055547|474608131|FG018|Overall Study|Physician Decision|0|||
131815636|NCT02055547|474608113|FG000|Overall Study|Adverse Event|0|||
131815637|NCT02055547|474608114|FG001|Overall Study|Adverse Event|0|||
131815638|NCT02055547|474608115|FG002|Overall Study|Adverse Event|0|||
131815639|NCT02055547|474608116|FG003|Overall Study|Adverse Event|0|||
131815640|NCT02055547|474608117|FG004|Overall Study|Adverse Event|0|||
131815641|NCT02055547|474608118|FG005|Overall Study|Adverse Event|0|||
131815642|NCT02055547|474608119|FG006|Overall Study|Adverse Event|1|||
131815643|NCT02055547|474608120|FG007|Overall Study|Adverse Event|0|||
131815644|NCT02055547|474608121|FG008|Overall Study|Adverse Event|1|||
131815645|NCT02055547|474608122|FG009|Overall Study|Adverse Event|0|||
131815646|NCT02055547|474608123|FG010|Overall Study|Adverse Event|0|||
131815647|NCT02055547|474608124|FG011|Overall Study|Adverse Event|0|||
131815648|NCT02055547|474608125|FG012|Overall Study|Adverse Event|0|||
131815649|NCT02055547|474608126|FG013|Overall Study|Adverse Event|0|||
131815650|NCT02055547|474608127|FG014|Overall Study|Adverse Event|0|||
131815651|NCT02055547|474608128|FG015|Overall Study|Adverse Event|0|||
131815652|NCT02055547|474608129|FG016|Overall Study|Adverse Event|0|||
131815653|NCT02055547|474608130|FG017|Overall Study|Adverse Event|0|||
131815654|NCT02055547|474608131|FG018|Overall Study|Adverse Event|0|||
131815655|NCT02055547|474608113|FG000|Overall Study|Withdrawal by Subject|0|||
131815656|NCT02055547|474608114|FG001|Overall Study|Withdrawal by Subject|0|||
131815657|NCT02055547|474608115|FG002|Overall Study|Withdrawal by Subject|0|||
131815658|NCT02055547|474608116|FG003|Overall Study|Withdrawal by Subject|0|||
131815659|NCT02055547|474608117|FG004|Overall Study|Withdrawal by Subject|0|||
131815660|NCT02055547|474608118|FG005|Overall Study|Withdrawal by Subject|1|||
131815661|NCT02055547|474608119|FG006|Overall Study|Withdrawal by Subject|0|||
131815662|NCT02055547|474608120|FG007|Overall Study|Withdrawal by Subject|0|||
131815663|NCT02055547|474608121|FG008|Overall Study|Withdrawal by Subject|1|||
131815664|NCT02055547|474608122|FG009|Overall Study|Withdrawal by Subject|0|||
131815665|NCT02055547|474608123|FG010|Overall Study|Withdrawal by Subject|0|||
131815666|NCT02055547|474608124|FG011|Overall Study|Withdrawal by Subject|0|||
131815667|NCT02055547|474608125|FG012|Overall Study|Withdrawal by Subject|0|||
131815668|NCT02055547|474608126|FG013|Overall Study|Withdrawal by Subject|1|||
131815669|NCT02055547|474608127|FG014|Overall Study|Withdrawal by Subject|0|||
131815670|NCT02055547|474608128|FG015|Overall Study|Withdrawal by Subject|1|||
131815671|NCT02055547|474608129|FG016|Overall Study|Withdrawal by Subject|0|||
131815672|NCT02055547|474608130|FG017|Overall Study|Withdrawal by Subject|0|||
131815673|NCT02055547|474608131|FG018|Overall Study|Withdrawal by Subject|0|||
131815674|NCT02055547|474608113|FG000|Overall Study|Lost to Follow-up|0|||
131815675|NCT02055547|474608114|FG001|Overall Study|Lost to Follow-up|0|||
131815676|NCT02055547|474608115|FG002|Overall Study|Lost to Follow-up|1|||
131815677|NCT02055547|474608116|FG003|Overall Study|Lost to Follow-up|0|||
131815678|NCT02055547|474608117|FG004|Overall Study|Lost to Follow-up|0|||
131815679|NCT02055547|474608118|FG005|Overall Study|Lost to Follow-up|0|||
131815680|NCT02055547|474608119|FG006|Overall Study|Lost to Follow-up|0|||
131815681|NCT02055547|474608120|FG007|Overall Study|Lost to Follow-up|0|||
131815682|NCT02055547|474608121|FG008|Overall Study|Lost to Follow-up|0|||
131815683|NCT02055547|474608122|FG009|Overall Study|Lost to Follow-up|0|||
131815684|NCT02055547|474608123|FG010|Overall Study|Lost to Follow-up|0|||
131815685|NCT02055547|474608124|FG011|Overall Study|Lost to Follow-up|0|||
131815686|NCT02055547|474608125|FG012|Overall Study|Lost to Follow-up|0|||
131815687|NCT02055547|474608126|FG013|Overall Study|Lost to Follow-up|0|||
131815688|NCT02055547|474608127|FG014|Overall Study|Lost to Follow-up|0|||
131815689|NCT02055547|474608128|FG015|Overall Study|Lost to Follow-up|0|||
131815690|NCT02055547|474608129|FG016|Overall Study|Lost to Follow-up|0|||
131815691|NCT02055547|474608130|FG017|Overall Study|Lost to Follow-up|0|||
131815692|NCT02055547|474608131|FG018|Overall Study|Lost to Follow-up|0|||
131815693|NCT00868998|474608140|FG000|Overall Study|Screen Failure|1|||
131815694|NCT00868998|474608140|FG000|Overall Study|Withdrawal by Subject|1|||
131400719|NCT03515551|473089603|FG001|Overall Study|Lost to Follow-up|0|||
131400720|NCT03515551|473089604|FG002|Overall Study|Lost to Follow-up|1|||
131400721|NCT03515551|473089605|FG003|Overall Study|Lost to Follow-up|0|||
131400722|NCT03515551|473089606|FG004|Overall Study|Lost to Follow-up|0|||
131400723|NCT03515551|473089607|FG005|Overall Study|Lost to Follow-up|0|||
131400724|NCT03515551|473089608|FG006|Overall Study|Lost to Follow-up|0|||
131400725|NCT03515551|473089602|FG000|Overall Study|Withdrawal by Subject|0|||
131400726|NCT03515551|473089603|FG001|Overall Study|Withdrawal by Subject|1|||
131400727|NCT03515551|473089604|FG002|Overall Study|Withdrawal by Subject|0|||
131400728|NCT03515551|473089605|FG003|Overall Study|Withdrawal by Subject|0|||
131815695|NCT00868998|474608140|FG000|Overall Study|Progression of disease|2|||
131815696|NCT00868998|474608140|FG000|Overall Study|Death|1|||
131815697|NCT03719040|474608141|FG000|Overall Study|Withdrawal by Subject|177|||
131815698|NCT03719040|474608141|FG000|Overall Study|Lost to Follow-up|26|||
131815699|NCT00849797|474608142|FG000|First Intervention|bad veins|1|||
131815700|NCT00849797|474608143|FG001|First Intervention|bad veins|0|||
131815701|NCT00849797|474608142|FG000|First Intervention|Adverse Event|0|||
131815702|NCT00849797|474608143|FG001|First Intervention|Adverse Event|1|||
131815703|NCT00849797|474608142|FG000|Washout: One Week|Withdrawal by Subject|0|||
131815704|NCT00849797|474608143|FG001|Washout: One Week|Withdrawal by Subject|2|||
131815705|NCT00679081|474608144|FG000|Overall Study|Lost to Follow-up|1|||
131815706|NCT00725322|474608145|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
131815707|NCT00725322|474608146|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
131815708|NCT00725322|474608145|FG000|Washout (28 Days)|Protocol Violation|0|||
131815709|NCT00725322|474608146|FG001|Washout (28 Days)|Protocol Violation|1|||
131815710|NCT01279486|474608147|FG000|Overall Study|Lost to Follow-up|1|||
131815711|NCT04198363|474608150|FG000|Overall Study|Adverse Event|1|||
131815712|NCT04198363|474608151|FG001|Overall Study|Adverse Event|1|||
131815713|NCT04198363|474608150|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
131815714|NCT04198363|474608151|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
131815715|NCT04198363|474608150|FG000|Overall Study|Reason not Specified|1|||
131815716|NCT04198363|474608151|FG001|Overall Study|Reason not Specified|0|||
131815717|NCT03067987|474608154|FG000|Overall Study|Lost to Follow-up|7|||
131815718|NCT03067987|474608155|FG001|Overall Study|Lost to Follow-up|10|||
131815719|NCT03067987|474608154|FG000|Overall Study|Protocol Violation|1|||
131815720|NCT03067987|474608155|FG001|Overall Study|Protocol Violation|2|||
131815721|NCT03067987|474608154|FG000|Overall Study|Withdrawal by Subject|2|||
131815722|NCT03067987|474608155|FG001|Overall Study|Withdrawal by Subject|1|||
131815723|NCT00829764|474608158|FG000|First Intervention|Adverse Event|1|||
131815724|NCT00829764|474608159|FG001|First Intervention|Adverse Event|0|||
131815725|NCT00829764|474608158|FG000|First Intervention|Withdrawal by Subject|1|||
131815726|NCT00829764|474608159|FG001|First Intervention|Withdrawal by Subject|1|||
131815727|NCT04594252|474608160|FG000|Overall Study|Adverse Event|0|||
131815728|NCT04594252|474608161|FG001|Overall Study|Adverse Event|2|||
131815729|NCT05776901|474609885|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
131815730|NCT02997176|474609890|FG000|Overall Study|Adverse Event|0|||
131815731|NCT02997176|474609891|FG001|Overall Study|Adverse Event|0|||
131815732|NCT02997176|474609892|FG002|Overall Study|Adverse Event|0|||
131815733|NCT02997176|474609893|FG003|Overall Study|Adverse Event|8|||
131815734|NCT02997176|474609890|FG000|Overall Study|Progressive Disease|1|||
131815735|NCT02997176|474609891|FG001|Overall Study|Progressive Disease|0|||
131815736|NCT02997176|474609892|FG002|Overall Study|Progressive Disease|1|||
131815737|NCT02997176|474609893|FG003|Overall Study|Progressive Disease|1|||
131815738|NCT02997176|474609890|FG000|Overall Study|Death|0|||
131815739|NCT02997176|474609891|FG001|Overall Study|Death|0|||
131815740|NCT02997176|474609892|FG002|Overall Study|Death|1|||
131815741|NCT02997176|474609893|FG003|Overall Study|Death|1|||
131815742|NCT02997176|474609890|FG000|Overall Study|Withdrawal by Subject|0|||
131815743|NCT02997176|474609891|FG001|Overall Study|Withdrawal by Subject|2|||
131815744|NCT02997176|474609892|FG002|Overall Study|Withdrawal by Subject|0|||
131815745|NCT02997176|474609893|FG003|Overall Study|Withdrawal by Subject|1|||
131815746|NCT01624233|474609894|FG000|Period 2 - Induction|Adverse Event|1|||
131815747|NCT01624233|474609894|FG000|Period 3 - Maintenance|Adverse Event|2|||
131815748|NCT01624233|474609894|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
131815749|NCT01624233|474609894|FG000|Period 3 - Maintenance|Physician Decision|2|||
131815750|NCT01624233|474609894|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
131815751|NCT01624233|474609894|FG000|Period 4 - Drug Free Period|Relapsed|61|||
131815752|NCT01624233|474609894|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
131815753|NCT01624233|474609894|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
131815754|NCT01624233|474609894|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
131815755|NCT01624233|474609894|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
131815756|NCT01624233|474609894|FG000|Period 6: Follow-up|Adverse Event|3|||
131815757|NCT01624233|474609894|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
131815758|NCT01624233|474609894|FG000|Period 6: Follow-up|Physician Decision|1|||
131815759|NCT01624233|474609894|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
131815760|NCT00373256|474609895|FG000|Overall Study|Adverse Event (AE)|1|||
131815761|NCT00373256|474609896|FG001|Overall Study|Adverse Event (AE)|5|||
131815762|NCT00373256|474609895|FG000|Overall Study|Lost to Follow-up|2|||
131815763|NCT00373256|474609896|FG001|Overall Study|Lost to Follow-up|1|||
131815764|NCT00373256|474609895|FG000|Overall Study|Death|9|||
131815765|NCT00373256|474609896|FG001|Overall Study|Death|8|||
131815766|NCT00373256|474609895|FG000|Overall Study|Objective Progression or Relapse|111|||
131815767|NCT00373256|474609896|FG001|Overall Study|Objective Progression or Relapse|104|||
131815768|NCT00373256|474609895|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
131815769|NCT00373256|474609896|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
131815770|NCT00373256|474609895|FG000|Overall Study|Other|73|||
131815771|NCT00373256|474609896|FG001|Overall Study|Other|107|||
131815772|NCT00373256|474609895|FG000|Overall Study|Protocol Violation|0|||
131815773|NCT00373256|474609896|FG001|Overall Study|Protocol Violation|2|||
131815774|NCT00373256|474609895|FG000|Overall Study|Study Terminated by Sponsor|41|||
131815775|NCT00373256|474609896|FG001|Overall Study|Study Terminated by Sponsor|13|||
131815776|NCT04241458|474609897|FG000|Overall Study|Withdrawal by Subject|0|||
131815777|NCT04241458|474609898|FG001|Overall Study|Withdrawal by Subject|0|||
131815778|NCT04241458|474609899|FG002|Overall Study|Withdrawal by Subject|0|||
131815779|NCT04241458|474609900|FG003|Overall Study|Withdrawal by Subject|0|||
131815780|NCT04241458|474609901|FG004|Overall Study|Withdrawal by Subject|1|||
131815781|NCT06144424|474609902|FG000|Overall Study|Withdrawal by Subject|2|||
131815782|NCT06144424|474609903|FG001|Overall Study|Withdrawal by Subject|0|||
131815783|NCT06144424|474609902|FG000|Overall Study|Incarceration|1|||
131815784|NCT06144424|474609903|FG001|Overall Study|Incarceration|0|||
131815785|NCT02727192|474609911|FG000|Overall Study|Lost to Follow-up|1|||
131815786|NCT02727192|474609912|FG001|Overall Study|Lost to Follow-up|0|||
131815787|NCT02727192|474609913|FG002|Overall Study|Lost to Follow-up|0|||
131815788|NCT00928057|474609914|FG000|Overall Study|Adverse Event|1|||
131815789|NCT00928057|474609915|FG001|Overall Study|Adverse Event|2|||
131815790|NCT00928057|474609914|FG000|Overall Study|Withdrawal by Subject|1|||
131815791|NCT00928057|474609915|FG001|Overall Study|Withdrawal by Subject|0|||
131815792|NCT00928057|474609914|FG000|Overall Study|Lost to Follow-up|0|||
131815793|NCT00928057|474609915|FG001|Overall Study|Lost to Follow-up|1|||
131815794|NCT00928057|474609914|FG000|Overall Study|Protocol Violation|0|||
131815795|NCT00928057|474609915|FG001|Overall Study|Protocol Violation|1|||
131815796|NCT05497557|474609916|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
131815797|NCT05497557|474609917|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
131815798|NCT05497557|474609918|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
131815799|NCT02752074|474609921|FG000|Overall Study|Lost to Follow-up|1|||
131815800|NCT02752074|474609922|FG001|Overall Study|Lost to Follow-up|4|||
131815801|NCT02752074|474609921|FG000|Overall Study|Death|146|||
131815802|NCT02752074|474609922|FG001|Overall Study|Death|129|||
131815803|NCT02752074|474609921|FG000|Overall Study|Withdrawal by Subject|9|||
131815804|NCT02752074|474609922|FG001|Overall Study|Withdrawal by Subject|10|||
131815805|NCT02392195|474609925|FG000|Overall Study|Lost to Follow-up|4|||
131815806|NCT02392195|474609925|FG000|Overall Study|Withdrawal by Subject|4|||
131815807|NCT00545792|474609928|FG000|Overall Study|Withdrawal by Subject|1|||
131815808|NCT01380782|474609931|FG000|Overall Study|Adverse Event|0|||
131815809|NCT01380782|474609932|FG001|Overall Study|Adverse Event|1|||
131815810|NCT01380782|474609933|FG002|Overall Study|Adverse Event|0|||
131815811|NCT01380782|474609934|FG003|Overall Study|Adverse Event|0|||
131815812|NCT01380782|474609931|FG000|Overall Study|Death|1|||
131815813|NCT01380782|474609932|FG001|Overall Study|Death|0|||
131815814|NCT01380782|474609933|FG002|Overall Study|Death|0|||
131815815|NCT01380782|474609934|FG003|Overall Study|Death|0|||
131815816|NCT01380782|474609931|FG000|Overall Study|Lack of Efficacy|10|||
131815817|NCT01380782|474609932|FG001|Overall Study|Lack of Efficacy|9|||
131815818|NCT01380782|474609933|FG002|Overall Study|Lack of Efficacy|10|||
131815819|NCT01380782|474609934|FG003|Overall Study|Lack of Efficacy|3|||
131815820|NCT01380782|474609931|FG000|Overall Study|Physician Decision|1|||
131815821|NCT01380782|474609932|FG001|Overall Study|Physician Decision|0|||
131815822|NCT01380782|474609933|FG002|Overall Study|Physician Decision|0|||
131815823|NCT01380782|474609934|FG003|Overall Study|Physician Decision|0|||
131815824|NCT01380782|474609931|FG000|Overall Study|Withdrawal by Subject|0|||
131815825|NCT01380782|474609932|FG001|Overall Study|Withdrawal by Subject|0|||
131815826|NCT01380782|474609933|FG002|Overall Study|Withdrawal by Subject|1|||
131815827|NCT01380782|474609934|FG003|Overall Study|Withdrawal by Subject|1|||
131815828|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
131815829|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
131815830|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
131815831|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
131815832|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
131815833|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
131815834|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
131815835|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
131815836|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
131815837|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
131815838|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
131815839|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
131815840|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
131815841|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
131815842|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
131815843|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
131815844|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
131815845|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
131815846|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
131815847|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
131815848|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
131815849|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
131815850|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
131815851|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
131815852|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
131815853|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
131815854|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
131815855|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
131815856|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
131815857|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
131909794|NCT00900562|474958664|FG001|Overall Study|Death|1|||
131815858|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
131815859|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
131815860|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
131815861|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
131815862|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
131815863|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
131815864|NCT04194801|474609935|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
131815865|NCT04194801|474609936|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
131815866|NCT04194801|474609937|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
131815867|NCT04194801|474609935|FG000|Part Ib/II End of Study|Death|2|||
131815868|NCT04194801|474609936|FG001|Part Ib/II End of Study|Death|3|||
131815869|NCT04194801|474609937|FG002|Part Ib/II End of Study|Death|3|||
131815870|NCT04194801|474609935|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
131815871|NCT04194801|474609936|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
131815872|NCT04194801|474609937|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
131815873|NCT04194801|474609935|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
131815874|NCT04194801|474609936|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
131815875|NCT04194801|474609937|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
131815876|NCT04194801|474609935|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
131815877|NCT04194801|474609936|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
131815878|NCT04194801|474609937|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
131815879|NCT04194801|474609935|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
131815880|NCT04194801|474609936|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
131815881|NCT04194801|474609937|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
131815882|NCT03480763|474609938|FG000|Overall Study|Withdrawal by Subject|18|||
131815883|NCT03480763|474609939|FG001|Overall Study|Withdrawal by Subject|10|||
131815884|NCT03480763|474609938|FG000|Overall Study|Lost to Follow-up|4|||
131815885|NCT03480763|474609939|FG001|Overall Study|Lost to Follow-up|7|||
131815886|NCT03480763|474609938|FG000|Overall Study|non-study pneumococcal vaccine|1|||
131815887|NCT03480763|474609939|FG001|Overall Study|non-study pneumococcal vaccine|0|||
131815888|NCT03480763|474609938|FG000|Overall Study|oncological treatment|0|||
131815889|NCT03480763|474609939|FG001|Overall Study|oncological treatment|2|||
131815890|NCT03480763|474609938|FG000|Overall Study|pain with vaccination|1|||
131815891|NCT03480763|474609939|FG001|Overall Study|pain with vaccination|0|||
131815892|NCT01647828|474609944|FG000|Overall Study|Death|3|||
131815893|NCT01647828|474609945|FG001|Overall Study|Death|4|||
131815894|NCT01647828|474609946|FG002|Overall Study|Death|4|||
131815895|NCT01647828|474609947|FG003|Overall Study|Death|5|||
131815896|NCT01647828|474609948|FG004|Overall Study|Death|6|||
131815897|NCT01647828|474609949|FG005|Overall Study|Death|3|||
131815898|NCT01647828|474609950|FG006|Overall Study|Death|10|||
131815899|NCT01647828|474609951|FG007|Overall Study|Death|60|||
131815900|NCT01647828|474609952|FG008|Overall Study|Death|71|||
131815901|NCT01647828|474609944|FG000|Overall Study|Withdrawal by Subject|2|||
131815902|NCT01647828|474609945|FG001|Overall Study|Withdrawal by Subject|0|||
131815903|NCT01647828|474609946|FG002|Overall Study|Withdrawal by Subject|0|||
131815904|NCT01647828|474609947|FG003|Overall Study|Withdrawal by Subject|1|||
131815905|NCT01647828|474609948|FG004|Overall Study|Withdrawal by Subject|0|||
131815906|NCT01647828|474609949|FG005|Overall Study|Withdrawal by Subject|0|||
131815907|NCT01647828|474609950|FG006|Overall Study|Withdrawal by Subject|1|||
131815908|NCT01647828|474609951|FG007|Overall Study|Withdrawal by Subject|0|||
131815909|NCT01647828|474609952|FG008|Overall Study|Withdrawal by Subject|2|||
131815910|NCT01647828|474609944|FG000|Overall Study|Study terminated by Sponsor|0|||
131815911|NCT01647828|474609945|FG001|Overall Study|Study terminated by Sponsor|0|||
131815912|NCT01647828|474609946|FG002|Overall Study|Study terminated by Sponsor|0|||
131815913|NCT01647828|474609947|FG003|Overall Study|Study terminated by Sponsor|0|||
131815914|NCT01647828|474609948|FG004|Overall Study|Study terminated by Sponsor|0|||
131815915|NCT01647828|474609949|FG005|Overall Study|Study terminated by Sponsor|0|||
131815916|NCT01647828|474609950|FG006|Overall Study|Study terminated by Sponsor|1|||
131815917|NCT01647828|474609951|FG007|Overall Study|Study terminated by Sponsor|26|||
131815918|NCT01647828|474609952|FG008|Overall Study|Study terminated by Sponsor|16|||
131815919|NCT01647828|474609944|FG000|Overall Study|Lost to Follow-up|0|||
131815920|NCT01647828|474609945|FG001|Overall Study|Lost to Follow-up|0|||
131815921|NCT01647828|474609946|FG002|Overall Study|Lost to Follow-up|0|||
131815922|NCT01647828|474609947|FG003|Overall Study|Lost to Follow-up|0|||
131815923|NCT01647828|474609948|FG004|Overall Study|Lost to Follow-up|0|||
131815924|NCT01647828|474609949|FG005|Overall Study|Lost to Follow-up|0|||
131815925|NCT01647828|474609950|FG006|Overall Study|Lost to Follow-up|0|||
131815926|NCT01647828|474609951|FG007|Overall Study|Lost to Follow-up|2|||
131815927|NCT01647828|474609952|FG008|Overall Study|Lost to Follow-up|0|||
131815928|NCT03629054|474609954|FG000|Period 2 (4 Days)|Not treated|0|||
131815929|NCT03629054|474609955|FG001|Period 2 (4 Days)|Not treated|1|||
131815930|NCT00924638|474609959|FG000|Overall Study|Death|3|||
131815931|NCT00924638|474609960|FG001|Overall Study|Death|2|||
131815932|NCT00924638|474609959|FG000|Overall Study|Lost to Follow-up|1|||
131815933|NCT00924638|474609960|FG001|Overall Study|Lost to Follow-up|1|||
131400729|NCT03515551|473089606|FG004|Overall Study|Withdrawal by Subject|0|||
131400730|NCT03515551|473089607|FG005|Overall Study|Withdrawal by Subject|0|||
131400731|NCT03515551|473089608|FG006|Overall Study|Withdrawal by Subject|1|||
131400732|NCT03515551|473089602|FG000|Overall Study|Study ended by sponsor|0|||
131400733|NCT03515551|473089603|FG001|Overall Study|Study ended by sponsor|0|||
131400734|NCT03515551|473089604|FG002|Overall Study|Study ended by sponsor|2|||
131400735|NCT03515551|473089605|FG003|Overall Study|Study ended by sponsor|1|||
131815934|NCT00924638|474609959|FG000|Overall Study|Withdrawal by Subject|5|||
131815935|NCT00924638|474609960|FG001|Overall Study|Withdrawal by Subject|7|||
131815936|NCT00924638|474609959|FG000|Overall Study|Physician Decision|3|||
131815937|NCT00924638|474609960|FG001|Overall Study|Physician Decision|3|||
131815938|NCT00958724|474609963|FG000|Overall Study|Disease Progression|6|||
131815939|NCT05604014|474609964|FG000|Overall Study|Lost to Follow-up|13|||
131815940|NCT00840203|474609965|FG000|First Intervention|Protocol Violation|1|||
131815941|NCT00840203|474609966|FG001|First Intervention|Protocol Violation|1|||
131815942|NCT00840203|474609965|FG000|Washout|Protocol Violation|1|||
131815943|NCT00840203|474609966|FG001|Washout|Protocol Violation|0|||
131815944|NCT05562011|474609970|FG000|Overall Study|Withdrawal by Subject|3|||
131815945|NCT05562011|474609970|FG000|Overall Study|Lost to Follow-up|1|||
131815946|NCT05562011|474609970|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
131815947|NCT05562011|474609970|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
131815948|NCT05562011|474609970|FG000|Overall Study|Device malfunction|13|||
131815949|NCT04411680|474609973|FG000|Treatment Period|Adverse Event|3|||
131815950|NCT04411680|474609974|FG001|Treatment Period|Adverse Event|0|||
131815951|NCT04411680|474609973|FG000|Treatment Period|Discharged from hospital|18|||
131815952|NCT04411680|474609974|FG001|Treatment Period|Discharged from hospital|7|||
131815953|NCT04411680|474609973|FG000|Treatment Period|Missed 1 or more doses|8|||
131815954|NCT04411680|474609974|FG001|Treatment Period|Missed 1 or more doses|0|||
131815955|NCT04411680|474609973|FG000|Treatment Period|Transferred to another hospital|0|||
131815956|NCT04411680|474609974|FG001|Treatment Period|Transferred to another hospital|1|||
131815957|NCT04411680|474609973|FG000|Follow up Period|Withdrawal by Subject|2|||
131815958|NCT04411680|474609974|FG001|Follow up Period|Withdrawal by Subject|0|||
131815959|NCT04411680|474609973|FG000|Follow up Period|Lost to Follow-up|5|||
131815960|NCT04411680|474609974|FG001|Follow up Period|Lost to Follow-up|6|||
131815961|NCT04411680|474609973|FG000|Follow up Period|Death|11|||
131815962|NCT04411680|474609974|FG001|Follow up Period|Death|8|||
131815963|NCT00748566|474609975|FG000|Overall Study|Adverse Event|49|||
131815964|NCT00748566|474609975|FG000|Overall Study|Death|1|||
131815965|NCT00748566|474609975|FG000|Overall Study|Lack of Efficacy|12|||
131815966|NCT00748566|474609975|FG000|Overall Study|Lost to Follow-up|1|||
131815967|NCT00748566|474609975|FG000|Overall Study|Protocol Violation|13|||
131815968|NCT00748566|474609975|FG000|Overall Study|Withdrawal by Subject|22|||
131815969|NCT00748566|474609975|FG000|Overall Study|Study terminated by sponsor|5|||
131815970|NCT00748566|474609975|FG000|Overall Study|Other|9|||
131815971|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Refused|1|||
131815972|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Refused|3|||
131815973|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Medical|0|||
131815974|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Medical|1|||
131815975|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
131815976|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
131815977|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
131815978|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
131815979|NCT02054715|474609976|FG000|Baseline/Follow-up 1|No Reason|0|||
131815980|NCT02054715|474609977|FG001|Baseline/Follow-up 1|No Reason|1|||
131815981|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
131815982|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
131815983|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Ineligible|3|||
131815984|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Ineligible|0|||
131815985|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Hospitalization|1|||
131815986|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Hospitalization|0|||
131815987|NCT02054715|474609976|FG000|Baseline/Follow-up 1|Changed Mind|1|||
131400736|NCT03515551|473089606|FG004|Overall Study|Study ended by sponsor|3|||
131400737|NCT03515551|473089607|FG005|Overall Study|Study ended by sponsor|0|||
131400738|NCT03515551|473089608|FG006|Overall Study|Study ended by sponsor|3|||
131400739|NCT03515551|473089602|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
131400740|NCT03515551|473089603|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
131815988|NCT02054715|474609977|FG001|Baseline/Follow-up 1|Changed Mind|0|||
131815989|NCT02054715|474609976|FG000|Follow-up 2|Lost to Followup|3|||
131815990|NCT02054715|474609977|FG001|Follow-up 2|Lost to Followup|1|||
131815991|NCT02054715|474609976|FG000|Follow-up 2|Refused|3|||
131815992|NCT02054715|474609977|FG001|Follow-up 2|Refused|2|||
131815993|NCT02054715|474609976|FG000|Follow-up 2|Followup Not Completed|3|||
131815994|NCT02054715|474609977|FG001|Follow-up 2|Followup Not Completed|4|||
131815995|NCT02054715|474609976|FG000|Follow-up 2|Ineligible|4|||
131815996|NCT02054715|474609977|FG001|Follow-up 2|Ineligible|5|||
131815997|NCT02054715|474609976|FG000|Follow-up 2|Death|3|||
131815998|NCT02054715|474609977|FG001|Follow-up 2|Death|3|||
131815999|NCT02054715|474609976|FG000|Follow-up 2|Hospitalization|0|||
131816000|NCT02054715|474609977|FG001|Follow-up 2|Hospitalization|2|||
131816001|NCT02054715|474609976|FG000|Follow-up 2|Changed MD/Facility|0|||
131816002|NCT02054715|474609977|FG001|Follow-up 2|Changed MD/Facility|1|||
131816003|NCT02054715|474609976|FG000|Follow-up 2|Changed Mind|0|||
131816004|NCT02054715|474609977|FG001|Follow-up 2|Changed Mind|1|||
131816005|NCT02054715|474609976|FG000|Follow-up 2|No Reason|2|||
131816006|NCT02054715|474609977|FG001|Follow-up 2|No Reason|0|||
131816007|NCT02054715|474609976|FG000|Follow-up 2|Treatment Change or Delay|1|||
131816008|NCT02054715|474609977|FG001|Follow-up 2|Treatment Change or Delay|0|||
131816009|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
131816010|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
131816011|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
131816012|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
131816013|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
131816014|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
131816015|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
131816016|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
131816017|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
131816018|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
131816019|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
131816020|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
131816021|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
131816022|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
131816023|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
131816024|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
131816025|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
131816026|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
131816027|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
131816028|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
131816029|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
131816030|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
131816031|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
131816032|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
131400741|NCT03515551|473089604|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
131400742|NCT03515551|473089605|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
131816033|NCT00073307|474609983|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
131816034|NCT00073307|474609984|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
131816035|NCT00073307|474609985|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
131816036|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
131816037|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
131816038|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
131816039|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
131816040|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
131816041|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
131816042|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
131816043|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
131816044|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
131816045|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
131816046|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
131816047|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
131816048|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
131816049|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
131816050|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
131816051|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
131816052|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
131816053|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
131816054|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
131816055|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
131816056|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
131816057|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
131816058|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
131816059|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
131400743|NCT03515551|473089606|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
131909795|NCT00900562|474958663|FG000|Overall Study|Withdrawal by Subject|0|||
131909796|NCT00900562|474958664|FG001|Overall Study|Withdrawal by Subject|1|||
131909797|NCT00900562|474958663|FG000|Overall Study|Unrelated adverse event|1|||
131909798|NCT00900562|474958664|FG001|Overall Study|Unrelated adverse event|0|||
131816060|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
131816061|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
131816062|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
131816063|NCT00073307|474609983|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
131816064|NCT00073307|474609984|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
131816065|NCT00073307|474609985|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
131816066|NCT01438060|474609986|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
131816067|NCT01438060|474609987|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
131816068|NCT01438060|474609986|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
131816069|NCT01438060|474609987|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
131816070|NCT01438060|474609986|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
131816071|NCT01438060|474609987|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
131816072|NCT01438060|474609986|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
131816073|NCT01438060|474609987|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
131816074|NCT01438060|474609986|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
131816075|NCT01438060|474609987|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
131816076|NCT01438060|474609986|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
131816077|NCT01438060|474609987|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
131816078|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
131816079|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
131816080|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
131816081|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
131816082|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
131816083|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
131816084|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
131816085|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
131816086|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
131816087|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
131816088|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
131816089|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
131816090|NCT01438060|474609986|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
131816091|NCT01438060|474609987|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
131816092|NCT01438060|474609986|FG000|On Study Beyond Week 140|Adverse Event|0|||
131816093|NCT01438060|474609987|FG001|On Study Beyond Week 140|Adverse Event|2|||
131816094|NCT01438060|474609986|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
131816095|NCT01438060|474609987|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
131816096|NCT01438060|474609986|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
131816097|NCT01438060|474609987|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
131816098|NCT01438060|474609986|FG000|On Study Beyond Week 140|Death|0|||
131816099|NCT01438060|474609987|FG001|On Study Beyond Week 140|Death|1|||
131816100|NCT01438060|474609986|FG000|On Study Beyond Week 140|Other Reason|0|||
131816101|NCT01438060|474609987|FG001|On Study Beyond Week 140|Other Reason|3|||
131816102|NCT01442376|474609988|FG000|Overall Study|Adverse Event|0|||
131816103|NCT01442376|474609989|FG001|Overall Study|Adverse Event|3|||
131816104|NCT01442376|474609990|FG002|Overall Study|Adverse Event|2|||
131816105|NCT01442376|474609988|FG000|Overall Study|Death|0|||
131816106|NCT01442376|474609989|FG001|Overall Study|Death|1|||
131816107|NCT01442376|474609990|FG002|Overall Study|Death|1|||
131816108|NCT01442376|474609988|FG000|Overall Study|Withdrawal of consent|0|||
131909799|NCT04459338|474958665|FG000|Overall Study|Loss of IV during study|1|||
131909800|NCT04459338|474958666|FG001|Overall Study|Loss of IV during study|0|||
131909801|NCT01259245|474958669|FG000|Overall Study|Withdrawal by Subject|27|||
131816109|NCT01442376|474609989|FG001|Overall Study|Withdrawal of consent|0|||
131816110|NCT01442376|474609990|FG002|Overall Study|Withdrawal of consent|1|||
131816111|NCT01442376|474609988|FG000|Overall Study|Patients not treated|2|||
131816112|NCT01442376|474609989|FG001|Overall Study|Patients not treated|3|||
131909802|NCT01259245|474958670|FG001|Overall Study|Withdrawal by Subject|24|||
131909803|NCT01259245|474958669|FG000|Overall Study|Death|1|||
131816113|NCT01442376|474609990|FG002|Overall Study|Patients not treated|1|||
131816114|NCT01442376|474609988|FG000|Overall Study|Not eligible for subsequent cycles|1|||
131816115|NCT01442376|474609989|FG001|Overall Study|Not eligible for subsequent cycles|2|||
131816116|NCT01442376|474609990|FG002|Overall Study|Not eligible for subsequent cycles|0|||
131816117|NCT03499873|474609991|FG000|Overall Study|Withdrawal by Subject|4|||
131816118|NCT03499873|474609992|FG001|Overall Study|Withdrawal by Subject|6|||
131816119|NCT03499873|474609993|FG002|Overall Study|Withdrawal by Subject|1|||
131909804|NCT01259245|474958670|FG001|Overall Study|Death|2|||
131816120|NCT03499873|474609991|FG000|Overall Study|Subjects condition worsened|0|||
131816121|NCT03499873|474609992|FG001|Overall Study|Subjects condition worsened|3|||
131816122|NCT03499873|474609993|FG002|Overall Study|Subjects condition worsened|11|||
131816123|NCT03499873|474609991|FG000|Overall Study|Adverse Event|8|||
131816124|NCT03499873|474609992|FG001|Overall Study|Adverse Event|3|||
131816125|NCT03499873|474609993|FG002|Overall Study|Adverse Event|6|||
131816126|NCT03499873|474609991|FG000|Overall Study|Physician Decision|1|||
131816127|NCT03499873|474609992|FG001|Overall Study|Physician Decision|0|||
131816128|NCT03499873|474609993|FG002|Overall Study|Physician Decision|0|||
131816129|NCT03499873|474609991|FG000|Overall Study|Administrative reasons|0|||
131816130|NCT03499873|474609992|FG001|Overall Study|Administrative reasons|1|||
131816131|NCT03499873|474609993|FG002|Overall Study|Administrative reasons|0|||
131816132|NCT03499873|474609991|FG000|Overall Study|Concomitant therapy|5|||
131816133|NCT03499873|474609992|FG001|Overall Study|Concomitant therapy|4|||
131816134|NCT03499873|474609993|FG002|Overall Study|Concomitant therapy|7|||
131816135|NCT03499873|474609991|FG000|Overall Study|Miscellaneous|1|||
131816136|NCT03499873|474609992|FG001|Overall Study|Miscellaneous|2|||
131816137|NCT03499873|474609993|FG002|Overall Study|Miscellaneous|2|||
131816138|NCT03499873|474609991|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
131816139|NCT03499873|474609992|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
131816140|NCT03499873|474609993|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
131816141|NCT01483820|474610004|FG000|Overall Study|Lack of Efficacy|6|||
131816142|NCT01483820|474610004|FG000|Overall Study|Adverse Event|1|||
131816143|NCT01483820|474610004|FG000|Overall Study|Death|1|||
131816144|NCT00867360|474610005|FG000|Overall Study|Withdrawal by Subject|1|||
131816145|NCT00867360|474610006|FG001|Overall Study|Withdrawal by Subject|0|||
131816146|NCT00867360|474610005|FG000|Overall Study|Physician Decision|0|||
131816147|NCT00867360|474610006|FG001|Overall Study|Physician Decision|1|||
131816148|NCT00842309|474610008|FG000|Overall Study|Withdrawal by Subject|3|||
131816149|NCT00842309|474610009|FG001|Overall Study|Withdrawal by Subject|1|||
131816150|NCT03218787|474610010|FG000|Overall Study|Lost to Follow-up|12|||
131816151|NCT03218787|474610010|FG000|Overall Study|Withdrawal by Subject|72|||
131816152|NCT03218787|474610010|FG000|Overall Study|Physician Decision|11|||
131816153|NCT03218787|474610010|FG000|Overall Study|Death|111|||
131816154|NCT02264977|474610011|FG000|Overall Study|Death|3|||
131909805|NCT03451071|474958671|FG000|First Vaccine|Withdrawal by Subject|1|||
131909806|NCT03451071|474958671|FG000|Second Vaccine|Lost to Follow-up|19|||
131909807|NCT03451071|474958671|FG000|Third Vaccine|Lost to Follow-up|22|||
131816155|NCT02264977|474610011|FG000|Overall Study|Physician Decision|1|||
131816156|NCT02264977|474610011|FG000|Overall Study|Refuse to return|1|||
131816157|NCT03573544|474610012|FG000|Overall Study|Adverse Event|0|||
131816158|NCT03573544|474610013|FG001|Overall Study|Adverse Event|0|||
131816159|NCT03573544|474610014|FG002|Overall Study|Adverse Event|0|||
131816160|NCT03573544|474610015|FG003|Overall Study|Adverse Event|3|||
131816161|NCT03573544|474610016|FG004|Overall Study|Adverse Event|1|||
131816162|NCT03573544|474610017|FG005|Overall Study|Adverse Event|0|||
131816163|NCT03573544|474610018|FG006|Overall Study|Adverse Event|2|||
131816164|NCT03573544|474610019|FG007|Overall Study|Adverse Event|0|||
131816165|NCT03573544|474610012|FG000|Overall Study|Physician Decision|0|||
131816166|NCT03573544|474610013|FG001|Overall Study|Physician Decision|0|||
131816167|NCT03573544|474610014|FG002|Overall Study|Physician Decision|0|||
131816168|NCT03573544|474610015|FG003|Overall Study|Physician Decision|0|||
131816169|NCT03573544|474610016|FG004|Overall Study|Physician Decision|0|||
131816170|NCT03573544|474610017|FG005|Overall Study|Physician Decision|0|||
131816171|NCT03573544|474610018|FG006|Overall Study|Physician Decision|1|||
131816172|NCT03573544|474610019|FG007|Overall Study|Physician Decision|0|||
131816173|NCT03573544|474610012|FG000|Overall Study|Withdrawal by Subject|2|||
131816174|NCT03573544|474610013|FG001|Overall Study|Withdrawal by Subject|0|||
131816175|NCT03573544|474610014|FG002|Overall Study|Withdrawal by Subject|0|||
131816176|NCT03573544|474610015|FG003|Overall Study|Withdrawal by Subject|1|||
131816177|NCT03573544|474610016|FG004|Overall Study|Withdrawal by Subject|1|||
131816178|NCT03573544|474610017|FG005|Overall Study|Withdrawal by Subject|1|||
131816179|NCT03573544|474610018|FG006|Overall Study|Withdrawal by Subject|0|||
131816180|NCT03573544|474610019|FG007|Overall Study|Withdrawal by Subject|1|||
131816181|NCT03573544|474610012|FG000|Overall Study|Disease progression|3|||
131816182|NCT03573544|474610013|FG001|Overall Study|Disease progression|3|||
131816183|NCT03573544|474610014|FG002|Overall Study|Disease progression|6|||
131816184|NCT03573544|474610015|FG003|Overall Study|Disease progression|4|||
131816185|NCT03573544|474610016|FG004|Overall Study|Disease progression|5|||
131816186|NCT03573544|474610017|FG005|Overall Study|Disease progression|7|||
131816187|NCT03573544|474610018|FG006|Overall Study|Disease progression|6|||
131816188|NCT03573544|474610019|FG007|Overall Study|Disease progression|7|||
131816189|NCT01248728|474610023|FG000|Overall Study|Adverse Event|1|||
131816190|NCT01248728|474610024|FG001|Overall Study|Adverse Event|1|||
131816191|NCT01248728|474610023|FG000|Overall Study|Withdrawal by Subject|2|||
131816192|NCT01248728|474610024|FG001|Overall Study|Withdrawal by Subject|1|||
131909808|NCT03451071|474958671|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
131816193|NCT01248728|474610023|FG000|Overall Study|Lack of Efficacy|1|||
131816194|NCT01248728|474610024|FG001|Overall Study|Lack of Efficacy|0|||
131816195|NCT00147498|474610025|FG000|Overall Study|Adverse Event|1|||
131816196|NCT00147498|474610026|FG001|Overall Study|Adverse Event|6|||
131816197|NCT00147498|474610027|FG002|Overall Study|Adverse Event|7|||
131816198|NCT00147498|474610028|FG003|Overall Study|Adverse Event|3|||
131816199|NCT00147498|474610025|FG000|Overall Study|Lack of Efficacy|1|||
131816200|NCT00147498|474610026|FG001|Overall Study|Lack of Efficacy|1|||
131816201|NCT00147498|474610027|FG002|Overall Study|Lack of Efficacy|1|||
131816202|NCT00147498|474610028|FG003|Overall Study|Lack of Efficacy|8|||
131816203|NCT00147498|474610025|FG000|Overall Study|Laboratory abnormality|0|||
131816204|NCT00147498|474610026|FG001|Overall Study|Laboratory abnormality|0|||
131816205|NCT00147498|474610027|FG002|Overall Study|Laboratory abnormality|2|||
131816206|NCT00147498|474610028|FG003|Overall Study|Laboratory abnormality|0|||
131816207|NCT00147498|474610025|FG000|Overall Study|Participant defaulted|0|||
131816208|NCT00147498|474610026|FG001|Overall Study|Participant defaulted|1|||
131816209|NCT00147498|474610027|FG002|Overall Study|Participant defaulted|4|||
131816210|NCT00147498|474610028|FG003|Overall Study|Participant defaulted|3|||
131816211|NCT00147498|474610025|FG000|Overall Study|Other|1|||
131816212|NCT00147498|474610026|FG001|Overall Study|Other|1|||
131816213|NCT00147498|474610027|FG002|Overall Study|Other|3|||
131816214|NCT00147498|474610028|FG003|Overall Study|Other|3|||
131816215|NCT01838681|474610029|FG000|Period A|Adverse Event|39|||
131816216|NCT01838681|474610030|FG001|Period A|Adverse Event|0|||
131816217|NCT01838681|474610031|FG002|Period A|Adverse Event|0|||
131816218|NCT01838681|474610032|FG003|Period A|Adverse Event|0|||
131816219|NCT01838681|474610029|FG000|Period A|Lack of Efficacy|21|||
131816220|NCT01838681|474610030|FG001|Period A|Lack of Efficacy|0|||
131816221|NCT01838681|474610031|FG002|Period A|Lack of Efficacy|0|||
131816222|NCT01838681|474610032|FG003|Period A|Lack of Efficacy|0|||
131816223|NCT01838681|474610029|FG000|Period A|Early response|148|||
131816224|NCT01838681|474610030|FG001|Period A|Early response|0|||
131816225|NCT01838681|474610031|FG002|Period A|Early response|0|||
131816226|NCT01838681|474610032|FG003|Period A|Early response|0|||
131816227|NCT01838681|474610029|FG000|Period A|Withdrawal by Subject|70|||
131816228|NCT01838681|474610030|FG001|Period A|Withdrawal by Subject|0|||
131816229|NCT01838681|474610031|FG002|Period A|Withdrawal by Subject|0|||
131816230|NCT01838681|474610032|FG003|Period A|Withdrawal by Subject|0|||
131816231|NCT01838681|474610029|FG000|Period A|Protocol Violation|16|||
131816232|NCT01838681|474610030|FG001|Period A|Protocol Violation|0|||
131816233|NCT01838681|474610031|FG002|Period A|Protocol Violation|0|||
131816234|NCT01838681|474610032|FG003|Period A|Protocol Violation|0|||
131816235|NCT01838681|474610029|FG000|Period A|Non-compliance with IMP|6|||
131816236|NCT01838681|474610030|FG001|Period A|Non-compliance with IMP|0|||
131816237|NCT01838681|474610031|FG002|Period A|Non-compliance with IMP|0|||
131816238|NCT01838681|474610032|FG003|Period A|Non-compliance with IMP|0|||
131816239|NCT01838681|474610029|FG000|Period A|Lost to Follow-up|4|||
131816240|NCT01838681|474610030|FG001|Period A|Lost to Follow-up|0|||
131816241|NCT01838681|474610031|FG002|Period A|Lost to Follow-up|0|||
131816242|NCT01838681|474610032|FG003|Period A|Lost to Follow-up|0|||
131816243|NCT01838681|474610029|FG000|Period A|Withdrawal before treatment|4|||
131816244|NCT01838681|474610030|FG001|Period A|Withdrawal before treatment|0|||
131816245|NCT01838681|474610031|FG002|Period A|Withdrawal before treatment|0|||
131816246|NCT01838681|474610032|FG003|Period A|Withdrawal before treatment|0|||
131816247|NCT01838681|474610029|FG000|Period A|Administrative or other reasons|17|||
131816248|NCT01838681|474610030|FG001|Period A|Administrative or other reasons|0|||
131816249|NCT01838681|474610031|FG002|Period A|Administrative or other reasons|0|||
131816250|NCT01838681|474610032|FG003|Period A|Administrative or other reasons|0|||
131816251|NCT01838681|474610029|FG000|Period B/A+|Adverse Event|0|||
131816252|NCT01838681|474610030|FG001|Period B/A+|Adverse Event|13|||
131816253|NCT01838681|474610031|FG002|Period B/A+|Adverse Event|27|||
131816254|NCT01838681|474610032|FG003|Period B/A+|Adverse Event|16|||
131816255|NCT01838681|474610029|FG000|Period B/A+|Lack of Efficacy|0|||
131816256|NCT01838681|474610030|FG001|Period B/A+|Lack of Efficacy|9|||
131816257|NCT01838681|474610031|FG002|Period B/A+|Lack of Efficacy|11|||
131816258|NCT01838681|474610032|FG003|Period B/A+|Lack of Efficacy|6|||
131816259|NCT01838681|474610029|FG000|Period B/A+|Withdrawal by Subject|0|||
131816260|NCT01838681|474610030|FG001|Period B/A+|Withdrawal by Subject|28|||
131816261|NCT01838681|474610031|FG002|Period B/A+|Withdrawal by Subject|35|||
131816262|NCT01838681|474610032|FG003|Period B/A+|Withdrawal by Subject|47|||
131816263|NCT01838681|474610029|FG000|Period B/A+|Protocol Violation|0|||
131816264|NCT01838681|474610030|FG001|Period B/A+|Protocol Violation|1|||
131816265|NCT01838681|474610031|FG002|Period B/A+|Protocol Violation|4|||
131816266|NCT01838681|474610032|FG003|Period B/A+|Protocol Violation|6|||
131816267|NCT01838681|474610029|FG000|Period B/A+|Non-compliance with IMP|0|||
131816268|NCT01838681|474610030|FG001|Period B/A+|Non-compliance with IMP|2|||
131816269|NCT01838681|474610031|FG002|Period B/A+|Non-compliance with IMP|3|||
131816270|NCT01838681|474610032|FG003|Period B/A+|Non-compliance with IMP|3|||
131816271|NCT01838681|474610029|FG000|Period B/A+|Lost to Follow-up|0|||
131816272|NCT01838681|474610030|FG001|Period B/A+|Lost to Follow-up|2|||
131816273|NCT01838681|474610031|FG002|Period B/A+|Lost to Follow-up|5|||
131816274|NCT01838681|474610032|FG003|Period B/A+|Lost to Follow-up|11|||
131816275|NCT01838681|474610029|FG000|Period B/A+|Withdrawal before treatment|0|||
131816276|NCT01838681|474610030|FG001|Period B/A+|Withdrawal before treatment|1|||
131816277|NCT01838681|474610031|FG002|Period B/A+|Withdrawal before treatment|0|||
131816278|NCT01838681|474610032|FG003|Period B/A+|Withdrawal before treatment|0|||
131816279|NCT01838681|474610029|FG000|Period B/A+|Administrative or other reasons|0|||
131816280|NCT01838681|474610030|FG001|Period B/A+|Administrative or other reasons|6|||
131816281|NCT01838681|474610031|FG002|Period B/A+|Administrative or other reasons|10|||
131816282|NCT01838681|474610032|FG003|Period B/A+|Administrative or other reasons|28|||
131816283|NCT01229150|474610033|FG000|Overall Study|Toxicity|2|||
131816284|NCT01229150|474610034|FG001|Overall Study|Toxicity|2|||
131816285|NCT01229150|474610035|FG002|Overall Study|Toxicity|0|||
131816286|NCT01229150|474610036|FG003|Overall Study|Toxicity|0|||
131816287|NCT02011945|474610037|FG000|Overall Study|Participant requested to Discontinue|0|||
131816288|NCT02011945|474610038|FG001|Overall Study|Participant requested to Discontinue|1|||
131816289|NCT02011945|474610039|FG002|Overall Study|Participant requested to Discontinue|1|||
131816290|NCT02011945|474610037|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
131816291|NCT02011945|474610038|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
131816292|NCT02011945|474610039|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
131816293|NCT02011945|474610037|FG000|Overall Study|Study Drug Toxicity|0|||
131816294|NCT02011945|474610038|FG001|Overall Study|Study Drug Toxicity|0|||
131816295|NCT02011945|474610039|FG002|Overall Study|Study Drug Toxicity|1|||
131816296|NCT02011945|474610037|FG000|Overall Study|Treatment Failure|0|||
131816297|NCT02011945|474610038|FG001|Overall Study|Treatment Failure|7|||
131816298|NCT02011945|474610039|FG002|Overall Study|Treatment Failure|6|||
131816299|NCT02011945|474610037|FG000|Overall Study|No Longer Meets Study Criteria|1|||
131816300|NCT02011945|474610038|FG001|Overall Study|No Longer Meets Study Criteria|0|||
131816301|NCT02011945|474610039|FG002|Overall Study|No Longer Meets Study Criteria|0|||
131816302|NCT02011945|474610037|FG000|Overall Study|Proceeded to stem cell transplant|0|||
131816303|NCT02011945|474610038|FG001|Overall Study|Proceeded to stem cell transplant|0|||
131816304|NCT02011945|474610039|FG002|Overall Study|Proceeded to stem cell transplant|1|||
131816305|NCT02011945|474610037|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
131816306|NCT02011945|474610038|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
131816307|NCT02011945|474610039|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
131816308|NCT00902538|474610040|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
131816309|NCT00902538|474610041|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
131816310|NCT00902538|474610042|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
131816311|NCT00902538|474610043|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
131816312|NCT00902538|474610044|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
131816313|NCT00902538|474610045|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
131816314|NCT00902538|474610040|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
131816315|NCT00902538|474610041|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
131816316|NCT00902538|474610042|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
131816317|NCT00902538|474610043|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
131816318|NCT00902538|474610044|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
131816319|NCT00902538|474610045|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
131816320|NCT00902538|474610040|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
131816321|NCT00902538|474610041|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
131816322|NCT00902538|474610042|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
131816323|NCT00902538|474610043|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
131816324|NCT00902538|474610044|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
131816325|NCT00902538|474610045|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
131816326|NCT00902538|474610040|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
131816327|NCT00902538|474610041|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
131816328|NCT00902538|474610042|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
131816329|NCT00902538|474610043|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
131816330|NCT00902538|474610044|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
131816331|NCT00902538|474610045|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
131816332|NCT00902538|474610040|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
131816333|NCT00902538|474610041|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
131816334|NCT00902538|474610042|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
131816335|NCT00902538|474610043|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
131816336|NCT00902538|474610044|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
131816337|NCT00902538|474610045|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
131816338|NCT00902538|474610040|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
131816339|NCT00902538|474610041|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
131816340|NCT00902538|474610042|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
131816341|NCT00902538|474610043|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
131816342|NCT00902538|474610044|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
131816343|NCT00902538|474610045|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
131816344|NCT00902538|474610040|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
131816345|NCT00902538|474610041|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
131816346|NCT00902538|474610042|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
131816347|NCT00902538|474610043|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
131816348|NCT00902538|474610044|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
131816349|NCT00902538|474610045|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
131816350|NCT00902538|474610040|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
131816351|NCT00902538|474610041|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
131816352|NCT00902538|474610042|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
131816353|NCT00902538|474610043|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
131816354|NCT00902538|474610044|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
131816355|NCT00902538|474610045|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
131816356|NCT00902538|474610040|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
131816357|NCT00902538|474610041|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
131816358|NCT00902538|474610042|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
131816359|NCT00902538|474610043|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
131816360|NCT00902538|474610044|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
131816361|NCT00902538|474610045|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
131816362|NCT00902538|474610040|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
131816363|NCT00902538|474610041|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
131816364|NCT00902538|474610042|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
131816365|NCT00902538|474610043|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
131816366|NCT00902538|474610044|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
131816367|NCT00902538|474610045|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
131816368|NCT00902538|474610040|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
131816369|NCT00902538|474610041|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
131816370|NCT00902538|474610042|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
131816371|NCT00902538|474610043|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
131816372|NCT00902538|474610044|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
131816373|NCT00902538|474610045|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
131816374|NCT00902538|474610040|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
131816375|NCT00902538|474610041|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
131816376|NCT00902538|474610042|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
131816377|NCT00902538|474610043|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
131816378|NCT00902538|474610044|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
131816379|NCT00902538|474610045|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
131816380|NCT00902538|474610040|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
131816381|NCT00902538|474610041|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
131816382|NCT00902538|474610042|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
131816383|NCT00902538|474610043|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
131816384|NCT00902538|474610044|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
131816385|NCT00902538|474610045|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
131816386|NCT00902538|474610040|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
131816387|NCT00902538|474610041|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
131816388|NCT00902538|474610042|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
131816389|NCT00902538|474610043|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
131816390|NCT00902538|474610044|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
131816391|NCT00902538|474610045|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
131816392|NCT00902538|474610040|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
131816393|NCT00902538|474610041|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
131816394|NCT00902538|474610042|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
131816395|NCT00902538|474610043|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
131816396|NCT00902538|474610044|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
131816397|NCT00902538|474610045|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
131816398|NCT00902538|474610040|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
131816399|NCT00902538|474610041|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
131816400|NCT00902538|474610042|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
131816401|NCT00902538|474610043|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
131816402|NCT00902538|474610044|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
131816403|NCT00902538|474610045|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
131816404|NCT00902538|474610040|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
131816405|NCT00902538|474610041|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
131816406|NCT00902538|474610042|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
131816407|NCT00902538|474610043|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
131816408|NCT00902538|474610044|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
131816409|NCT00902538|474610045|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
131816410|NCT03531827|474610046|FG000|Overall Study|Adverse Event|2|||
131816411|NCT03531827|474610047|FG001|Overall Study|Adverse Event|0|||
131816412|NCT03531827|474610046|FG000|Overall Study|Progressive disease|1|||
131816413|NCT03531827|474610047|FG001|Overall Study|Progressive disease|0|||
131816414|NCT01404988|474610048|FG000|Overall Study|Death|2|||
131816415|NCT01404988|474610049|FG001|Overall Study|Death|0|||
131816416|NCT01404988|474610050|FG002|Overall Study|Death|2|||
131816417|NCT01404988|474610048|FG000|Overall Study|Adverse Event|1|||
131816418|NCT01404988|474610049|FG001|Overall Study|Adverse Event|0|||
131816419|NCT01404988|474610050|FG002|Overall Study|Adverse Event|0|||
131816420|NCT01404988|474610048|FG000|Overall Study|Withdrawal by Subject|2|||
131816421|NCT01404988|474610049|FG001|Overall Study|Withdrawal by Subject|2|||
131816422|NCT01404988|474610050|FG002|Overall Study|Withdrawal by Subject|0|||
131816423|NCT01404988|474610048|FG000|Overall Study|Lost to Follow-up|1|||
131816424|NCT01404988|474610049|FG001|Overall Study|Lost to Follow-up|2|||
131816425|NCT01404988|474610050|FG002|Overall Study|Lost to Follow-up|1|||
131816426|NCT02302716|474612179|FG000|Overall Study|Adverse Event|1|||
131816427|NCT02302716|474612180|FG001|Overall Study|Adverse Event|1|||
131816428|NCT02302716|474612179|FG000|Overall Study|Death|0|||
131816429|NCT02302716|474612180|FG001|Overall Study|Death|1|||
131816430|NCT02302716|474612179|FG000|Overall Study|Lack of Efficacy|0|||
131816431|NCT02302716|474612180|FG001|Overall Study|Lack of Efficacy|1|||
131816432|NCT02302716|474612179|FG000|Overall Study|Lost to Follow-up|2|||
131816433|NCT02302716|474612180|FG001|Overall Study|Lost to Follow-up|4|||
131816434|NCT02302716|474612179|FG000|Overall Study|Physician Decision|3|||
131816435|NCT02302716|474612180|FG001|Overall Study|Physician Decision|4|||
131816436|NCT02302716|474612179|FG000|Overall Study|Withdrawal by Subject|13|||
131816437|NCT02302716|474612180|FG001|Overall Study|Withdrawal by Subject|7|||
131816438|NCT02302716|474612179|FG000|Overall Study|Protocol Violation|0|||
131816439|NCT02302716|474612180|FG001|Overall Study|Protocol Violation|1|||
131816440|NCT00557245|474612184|FG000|Overall Study|Lost to Follow-up|7|||
131816441|NCT00557245|474612185|FG001|Overall Study|Lost to Follow-up|8|||
131816442|NCT00557245|474612186|FG002|Overall Study|Lost to Follow-up|10|||
131816443|NCT00557245|474612184|FG000|Overall Study|Ineligible|5|||
131816444|NCT00557245|474612185|FG001|Overall Study|Ineligible|4|||
131816445|NCT00557245|474612186|FG002|Overall Study|Ineligible|2|||
131816446|NCT00798603|474612189|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
131816447|NCT00798603|474612189|FG000|Overall Study|Withdrawal by Subject|10|||
131816448|NCT00798603|474612189|FG000|Overall Study|Adverse Event|22|||
131816449|NCT00798603|474612189|FG000|Overall Study|Physician Decision|1|||
131816450|NCT00798603|474612189|FG000|Overall Study|Lack of insurance coverage|1|||
131816451|NCT04158687|474612193|FG000|Overall Study|Adverse Event|2|||
131816452|NCT04158687|474612194|FG001|Overall Study|Adverse Event|3|||
131816453|NCT04158687|474612195|FG002|Overall Study|Adverse Event|0|||
131816454|NCT04158687|474612196|FG003|Overall Study|Adverse Event|3|||
131816455|NCT04158687|474612193|FG000|Overall Study|Lost to Follow-up|5|||
131816456|NCT04158687|474612194|FG001|Overall Study|Lost to Follow-up|12|||
131816457|NCT04158687|474612195|FG002|Overall Study|Lost to Follow-up|4|||
131816458|NCT04158687|474612196|FG003|Overall Study|Lost to Follow-up|5|||
131816459|NCT04158687|474612193|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
131816460|NCT04158687|474612194|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
131816461|NCT04158687|474612195|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
131816462|NCT04158687|474612196|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
131816463|NCT04158687|474612193|FG000|Overall Study|Non-Compliance with Study Medication|2|||
131816464|NCT04158687|474612194|FG001|Overall Study|Non-Compliance with Study Medication|2|||
131816465|NCT04158687|474612195|FG002|Overall Study|Non-Compliance with Study Medication|3|||
131816466|NCT04158687|474612196|FG003|Overall Study|Non-Compliance with Study Medication|0|||
131816467|NCT04158687|474612193|FG000|Overall Study|Investigator Decision|0|||
131816468|NCT04158687|474612194|FG001|Overall Study|Investigator Decision|0|||
131909809|NCT02065557|474958672|FG000|Induction Period|Withdrawal by Subject|2|||
131909810|NCT02065557|474958673|FG001|Induction Period|Withdrawal by Subject|1|||
131909811|NCT02065557|474958674|FG002|Induction Period|Withdrawal by Subject|0|||
131816469|NCT04158687|474612195|FG002|Overall Study|Investigator Decision|2|||
131816470|NCT04158687|474612196|FG003|Overall Study|Investigator Decision|0|||
131816471|NCT04158687|474612193|FG000|Overall Study|Protocol Violation|0|||
131816472|NCT04158687|474612194|FG001|Overall Study|Protocol Violation|2|||
131816473|NCT04158687|474612195|FG002|Overall Study|Protocol Violation|1|||
131816474|NCT04158687|474612196|FG003|Overall Study|Protocol Violation|0|||
131909812|NCT02065557|474958675|FG003|Induction Period|Withdrawal by Subject|0|||
131449836|NCT02968004|473276718|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
131816475|NCT04158687|474612193|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
131816476|NCT04158687|474612194|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
131816477|NCT04158687|474612195|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
131816478|NCT04158687|474612196|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
131816479|NCT04158687|474612193|FG000|Overall Study|Reason not Specified|3|||
131816480|NCT04158687|474612194|FG001|Overall Study|Reason not Specified|2|||
131816481|NCT04158687|474612195|FG002|Overall Study|Reason not Specified|4|||
131816482|NCT04158687|474612196|FG003|Overall Study|Reason not Specified|4|||
131816483|NCT04523480|474612199|FG000|Overall Study|Lost to Follow-up|30|||
131816484|NCT04523480|474612200|FG001|Overall Study|Lost to Follow-up|35|||
131816485|NCT04523480|474612201|FG002|Overall Study|Lost to Follow-up|0|||
131816486|NCT00081653|474612204|FG000|Overall Study|Adverse Event|23|||
131816487|NCT00081653|474612205|FG001|Overall Study|Adverse Event|17|||
131816488|NCT00081653|474612204|FG000|Overall Study|Lost to Follow-up|2|||
131816489|NCT00081653|474612205|FG001|Overall Study|Lost to Follow-up|4|||
131816490|NCT00081653|474612204|FG000|Overall Study|Refused Treatment|18|||
131816491|NCT00081653|474612205|FG001|Overall Study|Refused Treatment|14|||
131816492|NCT00081653|474612204|FG000|Overall Study|Low bone mineral density|1|||
131816493|NCT00081653|474612205|FG001|Overall Study|Low bone mineral density|0|||
131816494|NCT00081653|474612204|FG000|Overall Study|Bone loss|2|||
131816495|NCT00081653|474612205|FG001|Overall Study|Bone loss|0|||
131816496|NCT00081653|474612204|FG000|Overall Study|Participant leaving country|1|||
131816497|NCT00081653|474612205|FG001|Overall Study|Participant leaving country|0|||
131816498|NCT00081653|474612204|FG000|Overall Study|Loss of bone mass|0|||
131816499|NCT00081653|474612205|FG001|Overall Study|Loss of bone mass|2|||
131816500|NCT02694536|474612211|FG000|Overall Study|Progressive Disease|40|||
131816501|NCT02694536|474612211|FG000|Overall Study|Lost to Follow-up|1|||
131816502|NCT02694536|474612211|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
131816503|NCT02694536|474612211|FG000|Overall Study|Withdrawal by Subject|8|||
131816504|NCT02694536|474612211|FG000|Overall Study|Death|8|||
131816505|NCT02694536|474612211|FG000|Overall Study|Other|22|||
131816506|NCT01911429|474612216|FG000|Overall Study|Adverse Event|5|||
131816507|NCT01911429|474612217|FG001|Overall Study|Adverse Event|3|||
131816508|NCT01911429|474612218|FG002|Overall Study|Adverse Event|9|||
131816509|NCT01911429|474612216|FG000|Overall Study|Lack of Efficacy|1|||
131816510|NCT01911429|474612217|FG001|Overall Study|Lack of Efficacy|2|||
131816511|NCT01911429|474612218|FG002|Overall Study|Lack of Efficacy|4|||
131816512|NCT01911429|474612216|FG000|Overall Study|Lost to Follow-up|0|||
131816513|NCT01911429|474612217|FG001|Overall Study|Lost to Follow-up|0|||
131816514|NCT01911429|474612218|FG002|Overall Study|Lost to Follow-up|1|||
131816515|NCT01911429|474612216|FG000|Overall Study|Protocol Violation|0|||
131816516|NCT01911429|474612217|FG001|Overall Study|Protocol Violation|0|||
131816517|NCT01911429|474612218|FG002|Overall Study|Protocol Violation|1|||
131816518|NCT01911429|474612216|FG000|Overall Study|Withdrawal by Subject|5|||
131816519|NCT01911429|474612217|FG001|Overall Study|Withdrawal by Subject|5|||
131816520|NCT01911429|474612218|FG002|Overall Study|Withdrawal by Subject|4|||
131816521|NCT01911429|474612216|FG000|Overall Study|Accidental randomization|0|||
131816522|NCT01911429|474612217|FG001|Overall Study|Accidental randomization|0|||
131816523|NCT01911429|474612218|FG002|Overall Study|Accidental randomization|1|||
131816524|NCT01911429|474612216|FG000|Overall Study|subject left study|1|||
131816525|NCT01911429|474612217|FG001|Overall Study|subject left study|0|||
131816526|NCT01911429|474612218|FG002|Overall Study|subject left study|0|||
131816527|NCT01557751|474612224|FG000|Overall Study|Physician Decision|3|||
131816528|NCT03679598|474612226|FG000|Overall Study|Adverse Event|2|||
131816529|NCT03679598|474612227|FG001|Overall Study|Adverse Event|0|||
131816530|NCT01701063|474612230|FG000|Overall Study|Lost to Follow-up|0|||
131816531|NCT01701063|474612231|FG001|Overall Study|Lost to Follow-up|1|||
131816532|NCT01701063|474612232|FG002|Overall Study|Lost to Follow-up|0|||
131816533|NCT01701063|474612230|FG000|Overall Study|Withdrawal by Subject|0|||
131816534|NCT01701063|474612231|FG001|Overall Study|Withdrawal by Subject|0|||
131816535|NCT01701063|474612232|FG002|Overall Study|Withdrawal by Subject|1|||
131816536|NCT01701063|474612230|FG000|Overall Study|Other|0|||
131816537|NCT01701063|474612231|FG001|Overall Study|Other|0|||
131816538|NCT01701063|474612232|FG002|Overall Study|Other|1|||
131816539|NCT05387408|474612233|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
131816540|NCT01919112|474612234|FG000|Secondary Analysis-day 30|Death|1|||
131816541|NCT01919112|474612235|FG001|Secondary Analysis-day 30|Death|1|||
131816542|NCT01919112|474612236|FG002|Secondary Analysis-day 30|Death|1|||
131816543|NCT01919112|474612234|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
131816544|NCT01919112|474612235|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
131816545|NCT01919112|474612236|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
131816546|NCT02043132|474612237|FG000|Overall Study|Lost to Follow-up|1|||
131816547|NCT02043132|474612238|FG001|Overall Study|Lost to Follow-up|1|||
131816548|NCT02043132|474612237|FG000|Overall Study|screen failures|4|||
131816549|NCT02043132|474612238|FG001|Overall Study|screen failures|8|||
131816550|NCT00635648|474612239|FG000|Overall Study|Adverse Event|12|||
131816551|NCT00635648|474612239|FG000|Overall Study|Withdrawal by Subject|9|||
131816552|NCT00635648|474612239|FG000|Overall Study|Physician Decision|4|||
131816553|NCT00635648|474612239|FG000|Overall Study|Rapid progression of baseline disease|4|||
131816554|NCT00635648|474612239|FG000|Overall Study|Use of other antifungal agent needed|1|||
131816555|NCT00635648|474612239|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
131816556|NCT00635648|474612239|FG000|Overall Study|Noncompliance with protocol|1|||
131816557|NCT00635648|474612239|FG000|Overall Study|Other reason|2|||
131816558|NCT03827395|474612240|FG000|Overall Study|Lost to Follow-up|1|||
131816559|NCT03827395|474612241|FG001|Overall Study|Lost to Follow-up|0|||
131816560|NCT03827395|474612240|FG000|Overall Study|Protocol Violation|1|||
131816561|NCT03827395|474612241|FG001|Overall Study|Protocol Violation|0|||
131816562|NCT03827395|474612240|FG000|Overall Study|Became ineligible after enrollment|1|||
131816563|NCT03827395|474612241|FG001|Overall Study|Became ineligible after enrollment|2|||
131816564|NCT01923740|474612242|FG000|Overall Study|Lost to Follow-up|4|||
131816565|NCT01923740|474612243|FG001|Overall Study|Lost to Follow-up|9|||
131816566|NCT01923740|474612242|FG000|Overall Study|Withdrawal by Subject|2|||
131816567|NCT01923740|474612243|FG001|Overall Study|Withdrawal by Subject|0|||
131816568|NCT00294047|474612244|FG000|Month 48|Adverse Event|28|||
131816569|NCT00294047|474612245|FG001|Month 48|Adverse Event|13|||
131816570|NCT00294047|474612244|FG000|Month 48|Protocol Violation|4|||
131816571|NCT00294047|474612245|FG001|Month 48|Protocol Violation|4|||
131816572|NCT00294047|474612244|FG000|Month 48|Withdrawal by Subject|111|||
131816573|NCT00294047|474612245|FG001|Month 48|Withdrawal by Subject|115|||
131816574|NCT00294047|474612244|FG000|Month 48|Lost to Follow-up|272|||
131816575|NCT00294047|474612245|FG001|Month 48|Lost to Follow-up|287|||
131816576|NCT00294047|474612244|FG000|Month 48|Other|10|||
131816577|NCT00294047|474612245|FG001|Month 48|Other|14|||
131816578|NCT00294047|474612244|FG000|Month 84|Adverse Event|4|||
131816579|NCT00294047|474612245|FG001|Month 84|Adverse Event|2|||
131816580|NCT00294047|474612244|FG000|Month 84|Protocol Violation|1|||
131816581|NCT00294047|474612245|FG001|Month 84|Protocol Violation|1|||
131816582|NCT00294047|474612244|FG000|Month 84|Withdrawal by Subject|33|||
131816583|NCT00294047|474612245|FG001|Month 84|Withdrawal by Subject|31|||
131816584|NCT00294047|474612244|FG000|Month 84|Lost to Follow-up|187|||
131816585|NCT00294047|474612245|FG001|Month 84|Lost to Follow-up|190|||
131816586|NCT00294047|474612244|FG000|Month 84|Absent Cervix|2|||
131816587|NCT00294047|474612245|FG001|Month 84|Absent Cervix|0|||
131816588|NCT00294047|474612244|FG000|Month 84|Work related reasons|4|||
131816589|NCT00294047|474612245|FG001|Month 84|Work related reasons|2|||
131816590|NCT00294047|474612244|FG000|Month 84|Center closed, subject did not transfer|1|||
131816591|NCT00294047|474612245|FG001|Month 84|Center closed, subject did not transfer|0|||
131816592|NCT00294047|474612244|FG000|Month 84|Family problems|2|||
131816593|NCT00294047|474612245|FG001|Month 84|Family problems|2|||
131816594|NCT00294047|474612244|FG000|Month 84|Lack of time|3|||
131816595|NCT00294047|474612245|FG001|Month 84|Lack of time|1|||
131816596|NCT00294047|474612244|FG000|Month 84|Personal reason|2|||
131816597|NCT00294047|474612245|FG001|Month 84|Personal reason|4|||
131816598|NCT00294047|474612244|FG000|Month 84|Subject does not want male physician|1|||
131816599|NCT00294047|474612245|FG001|Month 84|Subject does not want male physician|0|||
131816600|NCT00294047|474612244|FG000|Month 84|Transport reimbursement delayed|0|||
131816601|NCT00294047|474612245|FG001|Month 84|Transport reimbursement delayed|1|||
131816602|NCT00294047|474612244|FG000|Month 84|Unable to reach study site|1|||
131816603|NCT00294047|474612245|FG001|Month 84|Unable to reach study site|0|||
131816604|NCT00294047|474612244|FG000|Month 84|Under investigation locally|1|||
131816605|NCT00294047|474612245|FG001|Month 84|Under investigation locally|0|||
131816606|NCT00294047|474612244|FG000|Month 84|Visit missed|0|||
131400744|NCT03515551|473089607|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
131816607|NCT00294047|474612245|FG001|Month 84|Visit missed|1|||
131816608|NCT00294047|474612244|FG000|Month 84|No consent for Month 84 Follow-up|731|||
131816609|NCT00294047|474612245|FG001|Month 84|No consent for Month 84 Follow-up|754|||
131816610|NCT00847535|474612250|FG000|Overall Study|Withdrawal by Subject|2|||
131816611|NCT00847535|474612251|FG001|Overall Study|Withdrawal by Subject|1|||
131816612|NCT00847535|474612252|FG002|Overall Study|Withdrawal by Subject|1|||
131816613|NCT00847535|474612250|FG000|Overall Study|Lost to Follow-up|0|||
131816614|NCT00847535|474612251|FG001|Overall Study|Lost to Follow-up|1|||
131816615|NCT00847535|474612252|FG002|Overall Study|Lost to Follow-up|0|||
131816616|NCT01252953|474612253|FG000|Overall Study|Withdrawal by Subject|16|||
131816617|NCT01252953|474612254|FG001|Overall Study|Withdrawal by Subject|17|||
131816618|NCT01252953|474612253|FG000|Overall Study|Lost to Follow-up|22|||
131816619|NCT01252953|474612254|FG001|Overall Study|Lost to Follow-up|21|||
131816620|NCT02121184|474612274|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
131816621|NCT02121184|474612275|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
131816622|NCT02121184|474612274|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
131816623|NCT02121184|474612275|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
131816624|NCT02121184|474612274|FG000|Overall Study|Emergency cesarean section required|0|||
131816625|NCT02121184|474612275|FG001|Overall Study|Emergency cesarean section required|2|||
131816626|NCT02121184|474612274|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
131816627|NCT02121184|474612275|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
131816628|NCT00841659|474612278|FG000|Washout: 2 Weeks|Protocol Violation|1|||
131816629|NCT00841659|474612279|FG001|Washout: 2 Weeks|Protocol Violation|0|||
131816630|NCT01964950|474612283|FG000|Overall Study|Protocol Violation|25|||
131816631|NCT00674128|474612286|FG000|Overall Study|Withdrawal by Subject|25|||
131816632|NCT00674128|474612287|FG001|Overall Study|Withdrawal by Subject|23|||
131400745|NCT03515551|473089608|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
131400746|NCT00920387|473089615|FG000|Stage 1|Adverse Event|1|||
131400747|NCT00920387|473089616|FG001|Stage 1|Adverse Event|0|||
131400748|NCT00920387|473089617|FG002|Stage 1|Adverse Event|0|||
131400749|NCT02265536|473089628|FG000|Overall Study|Adverse Event|1|||
131400750|NCT02265536|473089629|FG001|Overall Study|Adverse Event|0|||
131400751|NCT02265536|473089630|FG002|Overall Study|Adverse Event|0|||
131400752|NCT02265536|473089631|FG003|Overall Study|Adverse Event|0|||
131400753|NCT02265536|473089632|FG004|Overall Study|Adverse Event|1|||
131400754|NCT02265536|473089633|FG005|Overall Study|Adverse Event|0|||
131400755|NCT02265536|473089628|FG000|Overall Study|Physician Decision|0|||
131400756|NCT02265536|473089629|FG001|Overall Study|Physician Decision|0|||
131400757|NCT02265536|473089630|FG002|Overall Study|Physician Decision|0|||
131816633|NCT04631562|474612294|FG000|Overall Study|Withdrawal by Subject|0|||
131816634|NCT04631562|474612295|FG001|Overall Study|Withdrawal by Subject|0|||
131816635|NCT04631562|474612296|FG002|Overall Study|Withdrawal by Subject|0|||
131816636|NCT04631562|474612297|FG003|Overall Study|Withdrawal by Subject|0|||
131400758|NCT02265536|473089631|FG003|Overall Study|Physician Decision|0|||
131400759|NCT02265536|473089632|FG004|Overall Study|Physician Decision|2|||
131400760|NCT02265536|473089633|FG005|Overall Study|Physician Decision|0|||
131400761|NCT02265536|473089628|FG000|Overall Study|Withdrawal by Subject|0|||
131816637|NCT04631562|474612298|FG004|Overall Study|Withdrawal by Subject|0|||
131816638|NCT04631562|474612299|FG005|Overall Study|Withdrawal by Subject|0|||
131816639|NCT04631562|474612300|FG006|Overall Study|Withdrawal by Subject|0|||
131816640|NCT04631562|474612301|FG007|Overall Study|Withdrawal by Subject|1|||
131816641|NCT04631562|474612302|FG008|Overall Study|Withdrawal by Subject|0|||
131816642|NCT04631562|474612294|FG000|Overall Study|Other|0|||
131816643|NCT04631562|474612295|FG001|Overall Study|Other|0|||
131816644|NCT04631562|474612296|FG002|Overall Study|Other|0|||
131816645|NCT04631562|474612297|FG003|Overall Study|Other|0|||
131400762|NCT02265536|473089629|FG001|Overall Study|Withdrawal by Subject|3|||
131816646|NCT04631562|474612298|FG004|Overall Study|Other|0|||
131816647|NCT04631562|474612299|FG005|Overall Study|Other|0|||
131816648|NCT04631562|474612300|FG006|Overall Study|Other|0|||
131816649|NCT04631562|474612301|FG007|Overall Study|Other|0|||
131816650|NCT04631562|474612302|FG008|Overall Study|Other|1|||
131816651|NCT04631562|474612294|FG000|Overall Study|Lost to Follow-up|0|||
131816652|NCT04631562|474612295|FG001|Overall Study|Lost to Follow-up|0|||
131816653|NCT04631562|474612296|FG002|Overall Study|Lost to Follow-up|0|||
131816654|NCT04631562|474612297|FG003|Overall Study|Lost to Follow-up|1|||
131816655|NCT04631562|474612298|FG004|Overall Study|Lost to Follow-up|0|||
131816656|NCT04631562|474612299|FG005|Overall Study|Lost to Follow-up|0|||
131816657|NCT04631562|474612300|FG006|Overall Study|Lost to Follow-up|0|||
131816658|NCT04631562|474612301|FG007|Overall Study|Lost to Follow-up|0|||
131400763|NCT02265536|473089630|FG002|Overall Study|Withdrawal by Subject|0|||
131400764|NCT02265536|473089631|FG003|Overall Study|Withdrawal by Subject|0|||
131400765|NCT02265536|473089632|FG004|Overall Study|Withdrawal by Subject|0|||
131816659|NCT04631562|474612302|FG008|Overall Study|Lost to Follow-up|0|||
131816660|NCT04631562|474612294|FG000|Overall Study|Adverse Event|0|||
131816661|NCT04631562|474612295|FG001|Overall Study|Adverse Event|0|||
131816662|NCT04631562|474612296|FG002|Overall Study|Adverse Event|0|||
131816663|NCT04631562|474612297|FG003|Overall Study|Adverse Event|0|||
131816664|NCT04631562|474612298|FG004|Overall Study|Adverse Event|0|||
131816665|NCT04631562|474612299|FG005|Overall Study|Adverse Event|0|||
131816666|NCT04631562|474612300|FG006|Overall Study|Adverse Event|1|||
131816667|NCT04631562|474612301|FG007|Overall Study|Adverse Event|0|||
131816668|NCT04631562|474612302|FG008|Overall Study|Adverse Event|0|||
131816669|NCT00829452|474612309|FG000|First Intervention|Withdrawal by Subject|0|||
131816670|NCT00829452|474612310|FG001|First Intervention|Withdrawal by Subject|1|||
131816671|NCT00829452|474612309|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
131816672|NCT00829452|474612310|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
131816673|NCT00829452|474612309|FG000|Second Intervention|Physician Decision|0|||
131816674|NCT00829452|474612310|FG001|Second Intervention|Physician Decision|1|||
131816675|NCT02436200|474612313|FG000|Overall Study|Significant outlier|1|||
131816676|NCT02471807|474612314|FG000|Overall Study|Death|14|||
131816677|NCT02471807|474612314|FG000|Overall Study|Withdrawal by Subject|2|||
131816678|NCT02471807|474612314|FG000|Overall Study|Explant|5|||
131816679|NCT02471807|474612314|FG000|Overall Study|Lost to Follow-up|1|||
131816680|NCT00957021|474612317|FG000|Overall Study|Death|5|||
131816681|NCT00957021|474612317|FG000|Overall Study|Lost to Follow-up|8|||
131816682|NCT00957021|474612317|FG000|Overall Study|Withdrawal by Subject|34|||
131400766|NCT02265536|473089633|FG005|Overall Study|Withdrawal by Subject|0|||
131400767|NCT02602275|473089636|FG000|Day 1|Physician Decision|0|||
131400768|NCT02602275|473089637|FG001|Day 1|Physician Decision|1|||
131816683|NCT00957021|474612317|FG000|Overall Study|No 2 yr ROM data|35|||
131816684|NCT00957021|474612317|FG000|Overall Study|Revised study component by 2 yr visit|8|||
131816685|NCT00957021|474612317|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
131816686|NCT00957021|474612317|FG000|Overall Study|Surgery Cancelled|9|||
131816687|NCT00957021|474612317|FG000|Overall Study|Termination due to language issue|2|||
131816688|NCT04025021|474612318|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
131816689|NCT04025021|474612319|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
131816690|NCT01986647|474612320|FG000|Overall Study|Lost to Follow-up|4|||
131816691|NCT01986647|474612321|FG001|Overall Study|Lost to Follow-up|1|||
131816692|NCT01986647|474612322|FG002|Overall Study|Lost to Follow-up|4|||
131816693|NCT01986647|474612323|FG003|Overall Study|Lost to Follow-up|4|||
131816694|NCT01986647|474612320|FG000|Overall Study|Withdrawal by Subject|1|||
131816695|NCT01986647|474612321|FG001|Overall Study|Withdrawal by Subject|3|||
131816696|NCT01986647|474612322|FG002|Overall Study|Withdrawal by Subject|2|||
131816697|NCT01986647|474612323|FG003|Overall Study|Withdrawal by Subject|3|||
131816698|NCT01986647|474612320|FG000|Overall Study|Health|5|||
131816699|NCT01986647|474612321|FG001|Overall Study|Health|3|||
131816700|NCT01986647|474612322|FG002|Overall Study|Health|6|||
131816701|NCT01986647|474612323|FG003|Overall Study|Health|4|||
131816702|NCT02905435|474612324|FG000|Overall Study|Death|2|||
131816703|NCT02905435|474612324|FG000|Overall Study|Physician Decision|1|||
131816704|NCT02905435|474612324|FG000|Overall Study|Lost to Follow-up|4|||
131816705|NCT01395017|474612328|FG000|Overall Study|Lost to Follow-up|1|||
131816706|NCT01395017|474612329|FG001|Overall Study|Lost to Follow-up|0|||
131816707|NCT01395017|474612328|FG000|Overall Study|Adverse Event|26|||
131816708|NCT01395017|474612329|FG001|Overall Study|Adverse Event|12|||
131816709|NCT01395017|474612328|FG000|Overall Study|Physician Decision|11|||
131816710|NCT01395017|474612329|FG001|Overall Study|Physician Decision|15|||
131816711|NCT01395017|474612328|FG000|Overall Study|Withdrawal by Subject|14|||
131816712|NCT01395017|474612329|FG001|Overall Study|Withdrawal by Subject|8|||
131816713|NCT01395017|474612328|FG000|Overall Study|Protocol deviation|1|||
131816714|NCT01395017|474612329|FG001|Overall Study|Protocol deviation|2|||
131816715|NCT01395017|474612328|FG000|Overall Study|Death|4|||
131816716|NCT01395017|474612329|FG001|Overall Study|Death|3|||
131816717|NCT01395017|474612328|FG000|Overall Study|Disease progression|42|||
131768598|NCT02030067|474429887|FG010|Overall Study|Physician Decision|1|||
131768599|NCT02030067|474429888|FG011|Overall Study|Physician Decision|0|||
131768600|NCT02030067|474429889|FG012|Overall Study|Physician Decision|3|||
131768601|NCT02030067|474429877|FG000|Overall Study|other reasons|0|||
131768602|NCT02030067|474429878|FG001|Overall Study|other reasons|0|||
131768603|NCT02030067|474429879|FG002|Overall Study|other reasons|0|||
131768604|NCT02030067|474429880|FG003|Overall Study|other reasons|0|||
131768605|NCT02030067|474429881|FG004|Overall Study|other reasons|0|||
131768606|NCT02030067|474429882|FG005|Overall Study|other reasons|1|||
131768607|NCT02030067|474429883|FG006|Overall Study|other reasons|0|||
131768608|NCT02030067|474429884|FG007|Overall Study|other reasons|0|||
131768609|NCT02030067|474429885|FG008|Overall Study|other reasons|2|||
131768610|NCT02030067|474429886|FG009|Overall Study|other reasons|0|||
131768611|NCT02030067|474429887|FG010|Overall Study|other reasons|0|||
131768612|NCT02030067|474429888|FG011|Overall Study|other reasons|0|||
131768613|NCT02030067|474429889|FG012|Overall Study|other reasons|4|||
131768614|NCT02030067|474429877|FG000|Overall Study|Adverse Event|0|||
131768615|NCT02030067|474429878|FG001|Overall Study|Adverse Event|0|||
131768616|NCT02030067|474429879|FG002|Overall Study|Adverse Event|0|||
131768617|NCT02030067|474429880|FG003|Overall Study|Adverse Event|0|||
131768618|NCT02030067|474429881|FG004|Overall Study|Adverse Event|0|||
131768619|NCT02030067|474429882|FG005|Overall Study|Adverse Event|0|||
131768620|NCT02030067|474429883|FG006|Overall Study|Adverse Event|0|||
131768621|NCT02030067|474429884|FG007|Overall Study|Adverse Event|0|||
131768622|NCT02030067|474429885|FG008|Overall Study|Adverse Event|0|||
131768623|NCT02030067|474429886|FG009|Overall Study|Adverse Event|0|||
131768624|NCT02030067|474429887|FG010|Overall Study|Adverse Event|0|||
131768625|NCT02030067|474429888|FG011|Overall Study|Adverse Event|1|||
131768626|NCT02030067|474429889|FG012|Overall Study|Adverse Event|8|||
131768627|NCT01632345|474429890|FG000|Treatment: Part I|Adverse Event|1|||
131768628|NCT01632345|474429891|FG001|Treatment: Part I|Adverse Event|4|||
131768629|NCT01632345|474429892|FG002|Treatment: Part I|Adverse Event|2|||
131768630|NCT01632345|474429893|FG003|Treatment: Part I|Adverse Event|1|||
131768631|NCT01632345|474429894|FG004|Treatment: Part I|Adverse Event|3|||
131768632|NCT01632345|474429895|FG005|Treatment: Part I|Adverse Event|0|||
131768633|NCT01632345|474429896|FG006|Treatment: Part I|Adverse Event|0|||
131768634|NCT01632345|474429890|FG000|Treatment: Part I|Lack of Efficacy|0|||
131768635|NCT01632345|474429891|FG001|Treatment: Part I|Lack of Efficacy|1|||
131768636|NCT01632345|474429892|FG002|Treatment: Part I|Lack of Efficacy|0|||
131768637|NCT01632345|474429893|FG003|Treatment: Part I|Lack of Efficacy|1|||
131768638|NCT01632345|474429894|FG004|Treatment: Part I|Lack of Efficacy|1|||
131768639|NCT01632345|474429895|FG005|Treatment: Part I|Lack of Efficacy|0|||
131768640|NCT01632345|474429896|FG006|Treatment: Part I|Lack of Efficacy|0|||
131768641|NCT01632345|474429890|FG000|Treatment: Part I|Lost to Follow-up|3|||
131768642|NCT01632345|474429891|FG001|Treatment: Part I|Lost to Follow-up|2|||
131768643|NCT01632345|474429892|FG002|Treatment: Part I|Lost to Follow-up|1|||
131768644|NCT01632345|474429893|FG003|Treatment: Part I|Lost to Follow-up|3|||
131768645|NCT01632345|474429894|FG004|Treatment: Part I|Lost to Follow-up|4|||
131768646|NCT01632345|474429895|FG005|Treatment: Part I|Lost to Follow-up|0|||
131816718|NCT01395017|474612329|FG001|Overall Study|Disease progression|58|||
131816719|NCT01395017|474612328|FG000|Overall Study|Sponsor discontinued study|1|||
131816720|NCT01395017|474612329|FG001|Overall Study|Sponsor discontinued study|4|||
131816721|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
131816722|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
131816723|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
131816724|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
131816725|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
131816726|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816727|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816728|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816729|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816730|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816731|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816732|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816733|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816734|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816735|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816736|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816737|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816738|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816739|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816740|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816741|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816742|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816743|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816744|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816745|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816746|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
131816747|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816748|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
131816749|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816750|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816751|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816752|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816753|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816754|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816755|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816756|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816757|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816758|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816759|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816760|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816761|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816762|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816763|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816764|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816765|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816766|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816767|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816768|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816769|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816770|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816771|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816772|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131816773|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816774|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
131816775|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816776|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816777|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816778|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816779|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816780|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816781|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131449837|NCT02968004|473276719|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
131816782|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816783|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816784|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131449838|NCT03722238|473276722|FG000|Overall Study|Protocol Violation|1|||
131816785|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131400769|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
131400770|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
131816786|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816787|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816788|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816789|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816790|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816791|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816792|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816793|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816794|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816795|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816796|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816797|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816798|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131816799|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
131816800|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816801|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
131816802|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
131816803|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
131816804|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816805|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816806|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816807|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816808|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816809|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816810|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816811|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816812|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816813|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816814|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816815|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816816|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816817|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816818|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816819|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816820|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131400771|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
131400772|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
131400773|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
131400774|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
131400775|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
131400776|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
131400777|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
131400778|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
131400779|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
131400780|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
131400781|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
131400782|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
131400783|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
131400784|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
131400785|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
131400786|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
131816821|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816822|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816823|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816824|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131816825|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
131816826|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
131816827|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
131816828|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
131816829|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
131816830|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816831|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816832|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816833|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131449839|NCT03722238|473276723|FG001|Overall Study|Protocol Violation|0|||
131816834|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816835|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816836|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816837|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816838|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131909813|NCT02065557|474958676|FG004|Induction Period|Withdrawal by Subject|0|||
131909814|NCT02065557|474958677|FG005|Induction Period|Withdrawal by Subject|0|||
131909815|NCT02065557|474958672|FG000|Induction Period|Lack of Efficacy|2|||
131909816|NCT02065557|474958673|FG001|Induction Period|Lack of Efficacy|1|||
131909817|NCT02065557|474958674|FG002|Induction Period|Lack of Efficacy|1|||
131909818|NCT02065557|474958675|FG003|Induction Period|Lack of Efficacy|0|||
131909819|NCT02065557|474958676|FG004|Induction Period|Lack of Efficacy|0|||
131909820|NCT02065557|474958677|FG005|Induction Period|Lack of Efficacy|0|||
131909821|NCT02065557|474958672|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
131909822|NCT02065557|474958673|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
131909823|NCT02065557|474958674|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
131909824|NCT02065557|474958675|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
131909825|NCT02065557|474958676|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
131909826|NCT02065557|474958677|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
131909827|NCT02065557|474958672|FG000|Induction Period|Non-Responder at Week 8|4|||
131909828|NCT02065557|474958673|FG001|Induction Period|Non-Responder at Week 8|4|||
131909829|NCT02065557|474958674|FG002|Induction Period|Non-Responder at Week 8|0|||
131909830|NCT02065557|474958675|FG003|Induction Period|Non-Responder at Week 8|0|||
131909831|NCT02065557|474958676|FG004|Induction Period|Non-Responder at Week 8|0|||
131909832|NCT02065557|474958677|FG005|Induction Period|Non-Responder at Week 8|0|||
131909833|NCT02065557|474958672|FG000|Induction Period|Adverse Event|1|||
131909834|NCT02065557|474958673|FG001|Induction Period|Adverse Event|1|||
131909835|NCT02065557|474958674|FG002|Induction Period|Adverse Event|0|||
131909836|NCT02065557|474958675|FG003|Induction Period|Adverse Event|0|||
131909837|NCT02065557|474958676|FG004|Induction Period|Adverse Event|0|||
131909838|NCT02065557|474958677|FG005|Induction Period|Adverse Event|0|||
131909839|NCT02065557|474958672|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
131909840|NCT02065557|474958673|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
131909841|NCT02065557|474958674|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
131909842|NCT02065557|474958675|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
131400787|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
131400788|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
131400789|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
131400790|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
131400791|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
131816839|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816840|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816841|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816842|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816843|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816844|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816845|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816846|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816847|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816848|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816849|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816850|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131816851|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|moved|0|||
131816852|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|moved|1|||
131816853|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|moved|1|||
131816854|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|moved|0|||
131816855|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|moved|0|||
131816856|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|moved|0|||
131816857|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|moved|0|||
131816858|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|moved|0|||
131816859|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|moved|0|||
131816860|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|moved|0|||
131816861|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|moved|0|||
131816862|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|moved|0|||
131816863|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|moved|0|||
131816864|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|moved|0|||
131400792|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
131909843|NCT02065557|474958676|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
131909844|NCT02065557|474958677|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
131909845|NCT02065557|474958672|FG000|Maintenance Period|Withdrawal by Subject|0|||
131816865|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|moved|0|||
131816866|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|moved|0|||
131816867|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|moved|0|||
131816868|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|moved|0|||
131816869|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|moved|0|||
131816870|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|moved|0|||
131816871|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|moved|0|||
131816872|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|moved|0|||
131816873|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|moved|0|||
131816874|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|moved|0|||
131816875|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|moved|0|||
131816876|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|moved|0|||
131816877|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816878|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816879|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816880|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
131816881|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816882|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816883|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816884|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816885|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816886|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816887|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816888|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816889|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816890|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816891|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816892|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816893|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816894|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816895|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816896|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816897|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816898|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816899|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816900|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816901|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816902|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131816903|NCT00112437|474612335|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816904|NCT00112437|474612336|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816905|NCT00112437|474612337|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816906|NCT00112437|474612338|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816907|NCT00112437|474612339|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
131816908|NCT00112437|474612340|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816909|NCT00112437|474612341|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816910|NCT00112437|474612342|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816911|NCT00112437|474612343|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816912|NCT00112437|474612344|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816913|NCT00112437|474612345|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816914|NCT00112437|474612346|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816915|NCT00112437|474612347|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816916|NCT00112437|474612348|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816917|NCT00112437|474612349|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816918|NCT00112437|474612350|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816919|NCT00112437|474612351|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816920|NCT00112437|474612352|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131909846|NCT02065557|474958673|FG001|Maintenance Period|Withdrawal by Subject|0|||
131909847|NCT02065557|474958674|FG002|Maintenance Period|Withdrawal by Subject|0|||
131909848|NCT02065557|474958675|FG003|Maintenance Period|Withdrawal by Subject|0|||
131909849|NCT02065557|474958676|FG004|Maintenance Period|Withdrawal by Subject|2|||
131400793|NCT01866111|473089638|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
131400794|NCT01866111|473089639|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
131400795|NCT01866111|473089640|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
131816921|NCT00112437|474612353|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816922|NCT00112437|474612354|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816923|NCT00112437|474612355|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816924|NCT00112437|474612356|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816925|NCT00112437|474612357|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816926|NCT00112437|474612358|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816927|NCT00112437|474612359|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816928|NCT00112437|474612360|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131816929|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
131816930|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
131816931|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
131816932|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
131816933|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
131816934|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
131816935|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
131816936|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
131816937|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
131816938|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
131816939|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
131816940|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
131816941|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
131816942|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
131816943|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
131816944|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
131816945|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
131816946|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
131816947|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
131816948|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
131816949|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
131816950|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
131816951|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
131816952|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
131816953|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
131816954|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
131816955|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816956|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816957|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816958|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816959|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816960|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
131816961|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
131816962|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816963|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816964|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
131816965|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816966|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816967|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816968|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816969|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816970|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816971|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816972|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816973|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816974|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816975|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816976|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816977|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816978|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816979|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816980|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
131816981|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816982|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816983|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816984|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816985|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816986|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816987|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816988|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816989|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
131816990|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816991|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816992|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816993|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816994|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816995|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816996|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816997|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816998|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131816999|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817000|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817001|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817002|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817003|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817004|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817005|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817006|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131817007|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817008|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817009|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817010|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817011|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817012|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817013|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817014|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817015|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
131817016|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817017|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817018|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817019|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817020|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817021|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817022|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817023|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817024|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817025|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817026|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817027|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817028|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817029|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817030|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817031|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817032|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
131817033|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817034|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817035|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817036|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817037|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817038|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
131817039|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
131817040|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
131817041|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
131817042|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
131817043|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817044|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817045|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817046|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817047|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817048|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817049|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817050|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817051|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131909850|NCT02065557|474958677|FG005|Maintenance Period|Withdrawal by Subject|1|||
131909851|NCT02065557|474958672|FG000|Maintenance Period|Lack of Efficacy|0|||
131817052|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817053|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817054|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131909852|NCT02065557|474958673|FG001|Maintenance Period|Lack of Efficacy|0|||
131817055|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817056|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817057|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817058|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
131817059|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817060|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817061|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817062|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817063|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817064|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817065|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817066|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817067|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817068|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
131817069|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817070|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817071|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817072|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817073|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817074|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817075|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817076|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817077|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817078|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817079|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817080|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817081|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817082|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817083|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817084|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
131817085|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817086|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817087|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817088|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817089|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817090|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817091|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817092|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817093|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817094|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
131817095|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817096|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817097|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817098|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817099|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817100|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817101|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817102|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817103|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817104|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817105|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817106|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817107|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817108|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817109|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
131817110|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
131909853|NCT02065557|474958674|FG002|Maintenance Period|Lack of Efficacy|0|||
131817111|NCT00112437|474612335|FG000|Year 2 (12-Month Extension)|Moved|0|||
131817112|NCT00112437|474612336|FG001|Year 2 (12-Month Extension)|Moved|0|||
131817113|NCT00112437|474612337|FG002|Year 2 (12-Month Extension)|Moved|0|||
131817114|NCT00112437|474612338|FG003|Year 2 (12-Month Extension)|Moved|0|||
131817115|NCT00112437|474612339|FG004|Year 2 (12-Month Extension)|Moved|0|||
131817116|NCT00112437|474612340|FG005|Year 2 (12-Month Extension)|Moved|0|||
131817117|NCT00112437|474612341|FG006|Year 2 (12-Month Extension)|Moved|0|||
131817118|NCT00112437|474612342|FG007|Year 2 (12-Month Extension)|Moved|0|||
131817119|NCT00112437|474612343|FG008|Year 2 (12-Month Extension)|Moved|0|||
131817120|NCT00112437|474612344|FG009|Year 2 (12-Month Extension)|Moved|1|||
131817121|NCT00112437|474612345|FG010|Year 2 (12-Month Extension)|Moved|0|||
131817122|NCT00112437|474612346|FG011|Year 2 (12-Month Extension)|Moved|0|||
131400796|NCT01866111|473089641|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
131400797|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
131400798|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
131400799|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
131400800|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
131400801|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
131400802|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
131817123|NCT00112437|474612347|FG012|Year 2 (12-Month Extension)|Moved|0|||
131817124|NCT00112437|474612348|FG013|Year 2 (12-Month Extension)|Moved|0|||
131817125|NCT00112437|474612349|FG014|Year 2 (12-Month Extension)|Moved|0|||
131817126|NCT00112437|474612350|FG015|Year 2 (12-Month Extension)|Moved|0|||
131817127|NCT00112437|474612351|FG016|Year 2 (12-Month Extension)|Moved|0|||
131817128|NCT00112437|474612352|FG017|Year 2 (12-Month Extension)|Moved|0|||
131817129|NCT00112437|474612353|FG018|Year 2 (12-Month Extension)|Moved|0|||
131817130|NCT00112437|474612354|FG019|Year 2 (12-Month Extension)|Moved|0|||
131817131|NCT00112437|474612355|FG020|Year 2 (12-Month Extension)|Moved|0|||
131817132|NCT00112437|474612356|FG021|Year 2 (12-Month Extension)|Moved|0|||
131817133|NCT00112437|474612357|FG022|Year 2 (12-Month Extension)|Moved|0|||
131817134|NCT00112437|474612358|FG023|Year 2 (12-Month Extension)|Moved|0|||
131817135|NCT00112437|474612359|FG024|Year 2 (12-Month Extension)|Moved|0|||
131817136|NCT00112437|474612360|FG025|Year 2 (12-Month Extension)|Moved|0|||
131817137|NCT00112437|474612335|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
131817138|NCT00112437|474612336|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
131817139|NCT00112437|474612337|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
131817140|NCT00112437|474612338|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
131817141|NCT00112437|474612339|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
131817142|NCT00112437|474612340|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
131817143|NCT00112437|474612341|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
131817144|NCT00112437|474612342|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
131817145|NCT00112437|474612343|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
131817146|NCT00112437|474612344|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
131817147|NCT00112437|474612345|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
131817148|NCT00112437|474612346|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
131817149|NCT00112437|474612347|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
131817150|NCT00112437|474612348|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
131817151|NCT00112437|474612349|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
131817152|NCT00112437|474612350|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
131817153|NCT00112437|474612351|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
131817154|NCT00112437|474612352|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
131817155|NCT00112437|474612353|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
131817156|NCT00112437|474612354|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
131817157|NCT00112437|474612355|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
131817158|NCT00112437|474612356|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
131817159|NCT00112437|474612357|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
131817160|NCT00112437|474612358|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
131817161|NCT00112437|474612359|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
131817162|NCT00112437|474612360|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
131817163|NCT00112437|474612335|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817164|NCT00112437|474612336|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817165|NCT00112437|474612337|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817166|NCT00112437|474612338|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817167|NCT00112437|474612339|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817168|NCT00112437|474612340|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817169|NCT00112437|474612341|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817170|NCT00112437|474612342|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817171|NCT00112437|474612343|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817172|NCT00112437|474612344|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817173|NCT00112437|474612345|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817174|NCT00112437|474612346|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
131817175|NCT00112437|474612347|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817176|NCT00112437|474612348|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
131817177|NCT00112437|474612349|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817178|NCT00112437|474612350|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
131817179|NCT00112437|474612351|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817180|NCT00112437|474612352|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817181|NCT00112437|474612353|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
131817182|NCT00112437|474612354|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131909854|NCT02065557|474958675|FG003|Maintenance Period|Lack of Efficacy|0|||
131817183|NCT00112437|474612355|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817184|NCT00112437|474612356|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817185|NCT00112437|474612357|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817186|NCT00112437|474612358|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131909855|NCT02065557|474958676|FG004|Maintenance Period|Lack of Efficacy|5|||
131817187|NCT00112437|474612359|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817188|NCT00112437|474612360|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
131817189|NCT00112437|474612335|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817190|NCT00112437|474612336|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817191|NCT00112437|474612337|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817192|NCT00112437|474612338|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817193|NCT00112437|474612339|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817194|NCT00112437|474612340|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817195|NCT00112437|474612341|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817196|NCT00112437|474612342|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817197|NCT00112437|474612343|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817198|NCT00112437|474612344|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817199|NCT00112437|474612345|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817200|NCT00112437|474612346|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817201|NCT00112437|474612347|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817202|NCT00112437|474612348|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817203|NCT00112437|474612349|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817204|NCT00112437|474612350|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
131817205|NCT00112437|474612351|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817206|NCT00112437|474612352|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817207|NCT00112437|474612353|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817208|NCT00112437|474612354|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817209|NCT00112437|474612355|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817210|NCT00112437|474612356|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817211|NCT00112437|474612357|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817212|NCT00112437|474612358|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817213|NCT00112437|474612359|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817214|NCT00112437|474612360|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
131817215|NCT00112437|474612335|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817216|NCT00112437|474612336|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817217|NCT00112437|474612337|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817218|NCT00112437|474612338|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817219|NCT00112437|474612339|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817220|NCT00112437|474612340|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817221|NCT00112437|474612341|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817222|NCT00112437|474612342|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817223|NCT00112437|474612343|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817224|NCT00112437|474612344|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817225|NCT00112437|474612345|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817226|NCT00112437|474612346|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817227|NCT00112437|474612347|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817228|NCT00112437|474612348|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817229|NCT00112437|474612349|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817230|NCT00112437|474612350|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
131817231|NCT00112437|474612351|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817232|NCT00112437|474612352|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817233|NCT00112437|474612353|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817234|NCT00112437|474612354|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817235|NCT00112437|474612355|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817236|NCT00112437|474612356|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817237|NCT00112437|474612357|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817238|NCT00112437|474612358|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817239|NCT00112437|474612359|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817240|NCT00112437|474612360|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
131817241|NCT00112437|474612335|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817242|NCT00112437|474612336|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817243|NCT00112437|474612337|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817244|NCT00112437|474612338|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817245|NCT00112437|474612339|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817246|NCT00112437|474612340|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817247|NCT00112437|474612341|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131909856|NCT02065557|474958677|FG005|Maintenance Period|Lack of Efficacy|2|||
131909857|NCT02065557|474958672|FG000|Maintenance Period|Subject Non-Compliance|0|||
131909858|NCT02065557|474958673|FG001|Maintenance Period|Subject Non-Compliance|0|||
131817248|NCT00112437|474612342|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817249|NCT00112437|474612343|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817250|NCT00112437|474612344|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817251|NCT00112437|474612345|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817252|NCT00112437|474612346|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
131909859|NCT02065557|474958674|FG002|Maintenance Period|Subject Non-Compliance|0|||
131817253|NCT00112437|474612347|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817254|NCT00112437|474612348|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817255|NCT00112437|474612349|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
131817256|NCT00112437|474612350|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817257|NCT00112437|474612351|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817258|NCT00112437|474612352|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817259|NCT00112437|474612353|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817260|NCT00112437|474612354|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817261|NCT00112437|474612355|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817262|NCT00112437|474612356|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817263|NCT00112437|474612357|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817264|NCT00112437|474612358|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817265|NCT00112437|474612359|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817266|NCT00112437|474612360|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131817267|NCT00112437|474612335|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817268|NCT00112437|474612336|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817269|NCT00112437|474612337|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817270|NCT00112437|474612338|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817271|NCT00112437|474612339|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817272|NCT00112437|474612340|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817273|NCT00112437|474612341|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817274|NCT00112437|474612342|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817275|NCT00112437|474612343|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817276|NCT00112437|474612344|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817277|NCT00112437|474612345|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
131817278|NCT00112437|474612346|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
131817279|NCT00112437|474612347|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817280|NCT00112437|474612348|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817281|NCT00112437|474612349|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817282|NCT00112437|474612350|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817283|NCT00112437|474612351|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817284|NCT00112437|474612352|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817285|NCT00112437|474612353|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817286|NCT00112437|474612354|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817287|NCT00112437|474612355|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817288|NCT00112437|474612356|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817289|NCT00112437|474612357|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817290|NCT00112437|474612358|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817291|NCT00112437|474612359|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817292|NCT00112437|474612360|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
131817293|NCT00112437|474612335|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817294|NCT00112437|474612336|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817295|NCT00112437|474612337|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817296|NCT00112437|474612338|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817297|NCT00112437|474612339|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817298|NCT00112437|474612340|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817299|NCT00112437|474612341|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817300|NCT00112437|474612342|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131909860|NCT02065557|474958675|FG003|Maintenance Period|Subject Non-Compliance|0|||
131400803|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
131817301|NCT00112437|474612343|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817302|NCT00112437|474612344|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817303|NCT00112437|474612345|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817304|NCT00112437|474612346|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817305|NCT00112437|474612347|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817306|NCT00112437|474612348|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817307|NCT00112437|474612349|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817308|NCT00112437|474612350|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817309|NCT00112437|474612351|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817310|NCT00112437|474612352|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817311|NCT00112437|474612353|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817312|NCT00112437|474612354|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817313|NCT00112437|474612355|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
131817314|NCT00112437|474612356|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
131909861|NCT02065557|474958676|FG004|Maintenance Period|Subject Non-Compliance|0|||
131909862|NCT02065557|474958677|FG005|Maintenance Period|Subject Non-Compliance|1|||
131817315|NCT00112437|474612357|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817316|NCT00112437|474612358|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131449840|NCT03722238|473276722|FG000|Overall Study|Physician Decision|1|||
131817317|NCT00112437|474612359|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817318|NCT00112437|474612360|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
131817319|NCT00112437|474612335|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817320|NCT00112437|474612336|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817321|NCT00112437|474612337|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817322|NCT00112437|474612338|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817323|NCT00112437|474612339|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817324|NCT00112437|474612340|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817325|NCT00112437|474612341|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817326|NCT00112437|474612342|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817327|NCT00112437|474612343|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817328|NCT00112437|474612344|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817329|NCT00112437|474612345|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817330|NCT00112437|474612346|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817331|NCT00112437|474612347|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817332|NCT00112437|474612348|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817333|NCT00112437|474612349|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817334|NCT00112437|474612350|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817335|NCT00112437|474612351|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817336|NCT00112437|474612352|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817337|NCT00112437|474612353|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817338|NCT00112437|474612354|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817339|NCT00112437|474612355|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
131817340|NCT00112437|474612356|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817341|NCT00112437|474612357|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817342|NCT00112437|474612358|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817343|NCT00112437|474612359|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817344|NCT00112437|474612360|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131817345|NCT00112437|474612335|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817346|NCT00112437|474612336|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817347|NCT00112437|474612337|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817348|NCT00112437|474612338|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817349|NCT00112437|474612339|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817350|NCT00112437|474612340|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817351|NCT00112437|474612341|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817352|NCT00112437|474612342|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817353|NCT00112437|474612343|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817354|NCT00112437|474612344|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817355|NCT00112437|474612345|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817356|NCT00112437|474612346|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817357|NCT00112437|474612347|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817358|NCT00112437|474612348|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817359|NCT00112437|474612349|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817360|NCT00112437|474612350|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817361|NCT00112437|474612351|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817362|NCT00112437|474612352|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817363|NCT00112437|474612353|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817364|NCT00112437|474612354|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817365|NCT00112437|474612355|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817366|NCT00112437|474612356|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
131817367|NCT00112437|474612357|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817368|NCT00112437|474612358|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817369|NCT00112437|474612359|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817370|NCT00112437|474612360|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131817371|NCT00112437|474612335|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817372|NCT00112437|474612336|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817373|NCT00112437|474612337|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817374|NCT00112437|474612338|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817375|NCT00112437|474612339|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817376|NCT00112437|474612340|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817377|NCT00112437|474612341|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817378|NCT00112437|474612342|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817379|NCT00112437|474612343|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817380|NCT00112437|474612344|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817381|NCT00112437|474612345|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817382|NCT00112437|474612346|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817383|NCT00112437|474612347|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817384|NCT00112437|474612348|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817385|NCT00112437|474612349|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817386|NCT00112437|474612350|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817387|NCT00112437|474612351|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817388|NCT00112437|474612352|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817389|NCT00112437|474612353|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817390|NCT00112437|474612354|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817391|NCT00112437|474612355|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817392|NCT00112437|474612356|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
131817393|NCT00112437|474612357|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817394|NCT00112437|474612358|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817395|NCT00112437|474612359|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817396|NCT00112437|474612360|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
131817397|NCT00112437|474612335|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817398|NCT00112437|474612336|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817399|NCT00112437|474612337|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817400|NCT00112437|474612338|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817401|NCT00112437|474612339|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817402|NCT00112437|474612340|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817403|NCT00112437|474612341|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817404|NCT00112437|474612342|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817405|NCT00112437|474612343|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817406|NCT00112437|474612344|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817407|NCT00112437|474612345|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817408|NCT00112437|474612346|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817409|NCT00112437|474612347|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817410|NCT00112437|474612348|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817411|NCT00112437|474612349|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817412|NCT00112437|474612350|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817413|NCT00112437|474612351|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817414|NCT00112437|474612352|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817415|NCT00112437|474612353|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817416|NCT00112437|474612354|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817417|NCT00112437|474612355|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
131817418|NCT00112437|474612356|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
131817419|NCT00112437|474612357|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817420|NCT00112437|474612358|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817421|NCT00112437|474612359|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817422|NCT00112437|474612360|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
131817423|NCT00112437|474612335|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817424|NCT00112437|474612336|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817425|NCT00112437|474612337|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817426|NCT00112437|474612338|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817427|NCT00112437|474612339|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817428|NCT00112437|474612340|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817429|NCT00112437|474612341|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817430|NCT00112437|474612342|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817431|NCT00112437|474612343|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817432|NCT00112437|474612344|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817433|NCT00112437|474612345|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817434|NCT00112437|474612346|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817435|NCT00112437|474612347|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817436|NCT00112437|474612348|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817437|NCT00112437|474612349|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817438|NCT00112437|474612350|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817439|NCT00112437|474612351|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817440|NCT00112437|474612352|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817441|NCT00112437|474612353|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817442|NCT00112437|474612354|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817443|NCT00112437|474612355|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817444|NCT00112437|474612356|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817445|NCT00112437|474612357|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
131817446|NCT00112437|474612358|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
131817447|NCT00112437|474612359|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131817448|NCT00112437|474612360|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
131817449|NCT00112437|474612335|FG000|Years 6-10 (60-Month Extension)|Death|0|||
131817450|NCT00112437|474612336|FG001|Years 6-10 (60-Month Extension)|Death|0|||
131817451|NCT00112437|474612337|FG002|Years 6-10 (60-Month Extension)|Death|0|||
131817452|NCT00112437|474612338|FG003|Years 6-10 (60-Month Extension)|Death|0|||
131817453|NCT00112437|474612339|FG004|Years 6-10 (60-Month Extension)|Death|0|||
131817454|NCT00112437|474612340|FG005|Years 6-10 (60-Month Extension)|Death|0|||
131817455|NCT00112437|474612341|FG006|Years 6-10 (60-Month Extension)|Death|0|||
131817456|NCT00112437|474612342|FG007|Years 6-10 (60-Month Extension)|Death|0|||
131817457|NCT00112437|474612343|FG008|Years 6-10 (60-Month Extension)|Death|0|||
131817458|NCT00112437|474612344|FG009|Years 6-10 (60-Month Extension)|Death|0|||
131817459|NCT00112437|474612345|FG010|Years 6-10 (60-Month Extension)|Death|0|||
131817460|NCT00112437|474612346|FG011|Years 6-10 (60-Month Extension)|Death|0|||
131817461|NCT00112437|474612347|FG012|Years 6-10 (60-Month Extension)|Death|0|||
131817462|NCT00112437|474612348|FG013|Years 6-10 (60-Month Extension)|Death|0|||
131817463|NCT00112437|474612349|FG014|Years 6-10 (60-Month Extension)|Death|0|||
131817464|NCT00112437|474612350|FG015|Years 6-10 (60-Month Extension)|Death|0|||
131817465|NCT00112437|474612351|FG016|Years 6-10 (60-Month Extension)|Death|0|||
131817466|NCT00112437|474612352|FG017|Years 6-10 (60-Month Extension)|Death|0|||
131817467|NCT00112437|474612353|FG018|Years 6-10 (60-Month Extension)|Death|0|||
131817468|NCT00112437|474612354|FG019|Years 6-10 (60-Month Extension)|Death|0|||
131817469|NCT00112437|474612355|FG020|Years 6-10 (60-Month Extension)|Death|0|||
131817470|NCT00112437|474612356|FG021|Years 6-10 (60-Month Extension)|Death|0|||
131817471|NCT00112437|474612357|FG022|Years 6-10 (60-Month Extension)|Death|0|||
131817472|NCT00112437|474612358|FG023|Years 6-10 (60-Month Extension)|Death|2|||
131817473|NCT00112437|474612359|FG024|Years 6-10 (60-Month Extension)|Death|0|||
131817474|NCT00112437|474612360|FG025|Years 6-10 (60-Month Extension)|Death|0|||
131817475|NCT00112437|474612335|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817476|NCT00112437|474612336|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817477|NCT00112437|474612337|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817478|NCT00112437|474612338|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817479|NCT00112437|474612339|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817480|NCT00112437|474612340|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817481|NCT00112437|474612341|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817482|NCT00112437|474612342|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817483|NCT00112437|474612343|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817484|NCT00112437|474612344|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817485|NCT00112437|474612345|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817486|NCT00112437|474612346|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817487|NCT00112437|474612347|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817488|NCT00112437|474612348|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817489|NCT00112437|474612349|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817490|NCT00112437|474612350|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817491|NCT00112437|474612351|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817492|NCT00112437|474612352|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817493|NCT00112437|474612353|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817494|NCT00112437|474612354|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817495|NCT00112437|474612355|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817496|NCT00112437|474612356|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817497|NCT00112437|474612357|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817498|NCT00112437|474612358|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817499|NCT00112437|474612359|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
131817500|NCT00112437|474612360|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
131817501|NCT00112437|474612335|FG000|Years 6-10 (60-Month Extension)|Other|0|||
131817502|NCT00112437|474612336|FG001|Years 6-10 (60-Month Extension)|Other|0|||
131817503|NCT00112437|474612337|FG002|Years 6-10 (60-Month Extension)|Other|0|||
131817504|NCT00112437|474612338|FG003|Years 6-10 (60-Month Extension)|Other|0|||
131817505|NCT00112437|474612339|FG004|Years 6-10 (60-Month Extension)|Other|0|||
131817506|NCT00112437|474612340|FG005|Years 6-10 (60-Month Extension)|Other|0|||
131817507|NCT00112437|474612341|FG006|Years 6-10 (60-Month Extension)|Other|0|||
131817508|NCT00112437|474612342|FG007|Years 6-10 (60-Month Extension)|Other|0|||
131817509|NCT00112437|474612343|FG008|Years 6-10 (60-Month Extension)|Other|0|||
131817510|NCT00112437|474612344|FG009|Years 6-10 (60-Month Extension)|Other|0|||
131817511|NCT00112437|474612345|FG010|Years 6-10 (60-Month Extension)|Other|0|||
131817512|NCT00112437|474612346|FG011|Years 6-10 (60-Month Extension)|Other|0|||
131817513|NCT00112437|474612347|FG012|Years 6-10 (60-Month Extension)|Other|0|||
131400804|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
131817514|NCT00112437|474612348|FG013|Years 6-10 (60-Month Extension)|Other|0|||
131817515|NCT00112437|474612349|FG014|Years 6-10 (60-Month Extension)|Other|0|||
131817516|NCT00112437|474612350|FG015|Years 6-10 (60-Month Extension)|Other|0|||
131817517|NCT00112437|474612351|FG016|Years 6-10 (60-Month Extension)|Other|0|||
131817518|NCT00112437|474612352|FG017|Years 6-10 (60-Month Extension)|Other|0|||
131817519|NCT00112437|474612353|FG018|Years 6-10 (60-Month Extension)|Other|0|||
131817520|NCT00112437|474612354|FG019|Years 6-10 (60-Month Extension)|Other|0|||
131817521|NCT00112437|474612355|FG020|Years 6-10 (60-Month Extension)|Other|0|||
131817522|NCT00112437|474612356|FG021|Years 6-10 (60-Month Extension)|Other|0|||
131817523|NCT00112437|474612357|FG022|Years 6-10 (60-Month Extension)|Other|0|||
131817524|NCT00112437|474612358|FG023|Years 6-10 (60-Month Extension)|Other|0|||
131817525|NCT00112437|474612359|FG024|Years 6-10 (60-Month Extension)|Other|1|||
131817526|NCT00112437|474612360|FG025|Years 6-10 (60-Month Extension)|Other|0|||
131817527|NCT00112437|474612335|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817528|NCT00112437|474612336|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817529|NCT00112437|474612337|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817530|NCT00112437|474612338|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817531|NCT00112437|474612339|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817532|NCT00112437|474612340|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817533|NCT00112437|474612341|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817534|NCT00112437|474612342|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817535|NCT00112437|474612343|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817536|NCT00112437|474612344|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817537|NCT00112437|474612345|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817538|NCT00112437|474612346|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817539|NCT00112437|474612347|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817540|NCT00112437|474612348|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817541|NCT00112437|474612349|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817542|NCT00112437|474612350|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817543|NCT00112437|474612351|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817544|NCT00112437|474612352|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817545|NCT00112437|474612353|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817546|NCT00112437|474612354|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817547|NCT00112437|474612355|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817548|NCT00112437|474612356|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817549|NCT00112437|474612357|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817550|NCT00112437|474612358|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
131817551|NCT00112437|474612359|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817552|NCT00112437|474612360|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
131817553|NCT00112437|474612335|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817554|NCT00112437|474612336|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817555|NCT00112437|474612337|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817556|NCT00112437|474612338|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817557|NCT00112437|474612339|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817558|NCT00112437|474612340|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817559|NCT00112437|474612341|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817560|NCT00112437|474612342|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817561|NCT00112437|474612343|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817562|NCT00112437|474612344|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817563|NCT00112437|474612345|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817564|NCT00112437|474612346|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817565|NCT00112437|474612347|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817566|NCT00112437|474612348|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817567|NCT00112437|474612349|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817568|NCT00112437|474612350|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817569|NCT00112437|474612351|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817570|NCT00112437|474612352|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817571|NCT00112437|474612353|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817572|NCT00112437|474612354|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817573|NCT00112437|474612355|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817574|NCT00112437|474612356|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817575|NCT00112437|474612357|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
131817576|NCT00112437|474612358|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
131817577|NCT00112437|474612359|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
131817578|NCT00112437|474612360|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
131817579|NCT03541252|474612361|FG000|Overall Study|Withdrawal by Subject|1|||
131817580|NCT00227370|474612362|FG000|Overall Study|Withdrawal by Subject|1|||
131817581|NCT00227370|474612363|FG001|Overall Study|Withdrawal by Subject|2|||
131817582|NCT00227370|474612362|FG000|Overall Study|Death|3|||
131817583|NCT00227370|474612363|FG001|Overall Study|Death|4|||
131817584|NCT00227370|474612362|FG000|Overall Study|Adverse Event|6|||
131817585|NCT00227370|474612363|FG001|Overall Study|Adverse Event|11|||
131817586|NCT00227370|474612362|FG000|Overall Study|Physician Decision|9|||
131817587|NCT00227370|474612363|FG001|Overall Study|Physician Decision|6|||
131817588|NCT00227370|474612362|FG000|Overall Study|Other reasons|2|||
131817589|NCT00227370|474612363|FG001|Overall Study|Other reasons|1|||
131817590|NCT03846193|474612364|FG000|Overall Study|Physician Decision|0|||
131817591|NCT03846193|474612365|FG001|Overall Study|Physician Decision|0|||
131817592|NCT03846193|474612366|FG002|Overall Study|Physician Decision|1|||
131817593|NCT03846193|474612367|FG003|Overall Study|Physician Decision|0|||
131817594|NCT03846193|474612368|FG004|Overall Study|Physician Decision|0|||
131817595|NCT03846193|474612364|FG000|Overall Study|Lost to Follow-up|0|||
131817596|NCT03846193|474612365|FG001|Overall Study|Lost to Follow-up|0|||
131817597|NCT03846193|474612366|FG002|Overall Study|Lost to Follow-up|0|||
131817598|NCT03846193|474612367|FG003|Overall Study|Lost to Follow-up|0|||
131817599|NCT03846193|474612368|FG004|Overall Study|Lost to Follow-up|1|||
131817600|NCT03846193|474612364|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
131817601|NCT03846193|474612365|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
131817602|NCT03846193|474612366|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
131817603|NCT03846193|474612367|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
131817604|NCT03846193|474612368|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
131817605|NCT02588339|474612370|FG000|Overall Study|Withdrawal by Subject|1|||
131817606|NCT02588339|474612370|FG000|Overall Study|GVHD Progression prior to treatment|2|||
131817607|NCT02316223|474613602|FG000|Overall Study|Lack of Efficacy|0|||
131817608|NCT02316223|474613603|FG001|Overall Study|Lack of Efficacy|1|||
131817609|NCT02316223|474613604|FG002|Overall Study|Lack of Efficacy|1|||
131817610|NCT02316223|474613602|FG000|Overall Study|Lost to Follow-up|27|||
131817611|NCT02316223|474613603|FG001|Overall Study|Lost to Follow-up|34|||
131817612|NCT02316223|474613604|FG002|Overall Study|Lost to Follow-up|36|||
131817613|NCT02316223|474613602|FG000|Overall Study|COPD Diagnosis|3|||
131817614|NCT02316223|474613603|FG001|Overall Study|COPD Diagnosis|2|||
131817615|NCT02316223|474613604|FG002|Overall Study|COPD Diagnosis|3|||
131817616|NCT02316223|474613602|FG000|Overall Study|Reside outside study area|1|||
131817617|NCT02316223|474613603|FG001|Overall Study|Reside outside study area|1|||
131817618|NCT02316223|474613604|FG002|Overall Study|Reside outside study area|1|||
131817619|NCT02316223|474613602|FG000|Overall Study|No asthma|2|||
131817620|NCT02316223|474613603|FG001|Overall Study|No asthma|0|||
131817621|NCT02316223|474613604|FG002|Overall Study|No asthma|0|||
131817622|NCT02316223|474613602|FG000|Overall Study|Discontinued by PI|11|||
131817623|NCT02316223|474613603|FG001|Overall Study|Discontinued by PI|19|||
131817624|NCT02316223|474613604|FG002|Overall Study|Discontinued by PI|3|||
131817625|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Subject request|8|||
131817626|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Subject request|11|||
131817627|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
131817628|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
131817629|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
131817630|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
131817631|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
131817632|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
131817633|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
131817634|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
131817635|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
131817636|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
131817637|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Death|1|||
131817638|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Death|0|||
131817639|NCT00521586|474613606|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
131817640|NCT00521586|474613607|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
131817641|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
131817642|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
131817643|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
131817644|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
131817645|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
131817646|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
131909863|NCT00250588|474958678|FG000|Overall Study|Withdrawal by Subject|3|||
131400805|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
131400806|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
131400807|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
131817647|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
131817648|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
131817649|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
131817650|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
131817651|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
131817652|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
131817653|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
131817654|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
131817655|NCT00521586|474613606|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
131817656|NCT00521586|474613607|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
131817657|NCT00521586|474613606|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
131817658|NCT00521586|474613607|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
131817659|NCT00521586|474613606|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
131817660|NCT00521586|474613607|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
131817661|NCT00521586|474613606|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
131817662|NCT00521586|474613607|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
131817663|NCT00529763|474613608|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
131817664|NCT00529763|474613609|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
131817665|NCT00529763|474613610|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
131817666|NCT00529763|474613608|FG000|Overall Study|Death|1|||
131817667|NCT00529763|474613609|FG001|Overall Study|Death|1|||
131817668|NCT00529763|474613610|FG002|Overall Study|Death|1|||
131817669|NCT00529763|474613608|FG000|Overall Study|Disease Progression|10|||
131817670|NCT00529763|474613609|FG001|Overall Study|Disease Progression|16|||
131817671|NCT00529763|474613610|FG002|Overall Study|Disease Progression|11|||
131817672|NCT00529763|474613608|FG000|Overall Study|Lost to Follow-up|1|||
131817673|NCT00529763|474613609|FG001|Overall Study|Lost to Follow-up|2|||
131817674|NCT00529763|474613610|FG002|Overall Study|Lost to Follow-up|3|||
131817675|NCT00529763|474613608|FG000|Overall Study|Stem Cell Transplant|0|||
131817676|NCT00529763|474613609|FG001|Overall Study|Stem Cell Transplant|3|||
131817677|NCT00529763|474613610|FG002|Overall Study|Stem Cell Transplant|1|||
131817678|NCT00529763|474613608|FG000|Overall Study|Study Drug Toxicity|3|||
131817679|NCT00529763|474613609|FG001|Overall Study|Study Drug Toxicity|6|||
131817680|NCT00529763|474613610|FG002|Overall Study|Study Drug Toxicity|4|||
131817681|NCT00529763|474613608|FG000|Overall Study|Participant Withdrew Consent|2|||
131817682|NCT00529763|474613609|FG001|Overall Study|Participant Withdrew Consent|3|||
131817683|NCT00529763|474613610|FG002|Overall Study|Participant Withdrew Consent|4|||
131817684|NCT00529763|474613608|FG000|Overall Study|Other reasons|2|||
131817685|NCT00529763|474613609|FG001|Overall Study|Other reasons|0|||
131817686|NCT00529763|474613610|FG002|Overall Study|Other reasons|2|||
131817687|NCT00529763|474613608|FG000|Overall Study|Participant request to discontinue treatment|1|||
131817688|NCT00529763|474613609|FG001|Overall Study|Participant request to discontinue treatment|1|||
131817689|NCT00529763|474613610|FG002|Overall Study|Participant request to discontinue treatment|3|||
131817690|NCT03669250|474613611|FG000|Overall Study|Adverse Event|0|||
131817691|NCT03669250|474613612|FG001|Overall Study|Adverse Event|0|||
131817692|NCT03669250|474613613|FG002|Overall Study|Adverse Event|0|||
131817693|NCT03669250|474613614|FG003|Overall Study|Adverse Event|0|||
131817694|NCT03669250|474613615|FG004|Overall Study|Adverse Event|1|||
131817695|NCT03669250|474613616|FG005|Overall Study|Adverse Event|0|||
131817696|NCT03669250|474613611|FG000|Overall Study|Withdrawal by Subject|0|||
131817697|NCT03669250|474613612|FG001|Overall Study|Withdrawal by Subject|1|||
131817698|NCT03669250|474613613|FG002|Overall Study|Withdrawal by Subject|0|||
131817699|NCT03669250|474613614|FG003|Overall Study|Withdrawal by Subject|1|||
131817700|NCT03669250|474613615|FG004|Overall Study|Withdrawal by Subject|0|||
131817701|NCT03669250|474613616|FG005|Overall Study|Withdrawal by Subject|0|||
131817702|NCT00828321|474613617|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
131817703|NCT00828321|474613618|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
131817704|NCT00828321|474613617|FG000|Second Intervention|Protocol Violation|0|||
131817705|NCT00828321|474613618|FG001|Second Intervention|Protocol Violation|1|||
131400808|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
131400809|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
131817706|NCT03234907|474613619|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
131817707|NCT03234907|474613620|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
131817708|NCT03234907|474613621|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
131817709|NCT03234907|474613622|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
131817710|NCT03234907|474613623|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
131817711|NCT03234907|474613624|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
131817712|NCT03234907|474613619|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
131817713|NCT03234907|474613620|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
131817714|NCT03234907|474613621|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
131817715|NCT03234907|474613622|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
131817716|NCT03234907|474613623|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
131817717|NCT03234907|474613624|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
131817718|NCT03234907|474613619|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
131817719|NCT03234907|474613620|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
131817720|NCT03234907|474613621|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
131817721|NCT03234907|474613622|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
131817722|NCT03234907|474613623|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
131817723|NCT03234907|474613624|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
131817724|NCT03234907|474613619|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
131909864|NCT00250588|474958679|FG001|Overall Study|Withdrawal by Subject|6|||
131909865|NCT00250588|474958680|FG002|Overall Study|Withdrawal by Subject|0|||
131909866|NCT00250588|474958678|FG000|Overall Study|Lost to Follow-up|6|||
131909867|NCT00250588|474958679|FG001|Overall Study|Lost to Follow-up|13|||
131817725|NCT03234907|474613620|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
131817726|NCT03234907|474613621|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
131817727|NCT03234907|474613622|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
131817728|NCT03234907|474613623|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
131817729|NCT03234907|474613624|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
131817730|NCT03234907|474613619|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
131817731|NCT03234907|474613620|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
131817732|NCT03234907|474613621|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
131817733|NCT03234907|474613622|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
131817734|NCT03234907|474613623|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
131817735|NCT03234907|474613624|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
131817736|NCT03234907|474613619|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
131817737|NCT03234907|474613620|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
131817738|NCT03234907|474613621|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
131817739|NCT03234907|474613622|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
131817740|NCT03234907|474613623|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
131817741|NCT03234907|474613624|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
131817742|NCT03234907|474613619|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
131817743|NCT03234907|474613620|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
131817744|NCT03234907|474613621|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
131817745|NCT03234907|474613622|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
131817746|NCT03234907|474613623|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
131817747|NCT03234907|474613624|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
131817748|NCT02664415|474613625|FG000|Overall Study|Adverse Event|1|||
131817749|NCT02664415|474613626|FG001|Overall Study|Adverse Event|0|||
131817750|NCT00642993|474613627|FG000|Overall Study|Adverse Event|85|||
131817751|NCT00642993|474613628|FG001|Overall Study|Adverse Event|4|||
131817752|NCT00642993|474613627|FG000|Overall Study|Lost to Follow-up|8|||
131817753|NCT00642993|474613628|FG001|Overall Study|Lost to Follow-up|4|||
131817754|NCT00642993|474613627|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
131817755|NCT00642993|474613628|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
131817756|NCT00642993|474613627|FG000|Overall Study|Protocol Violation|1|||
131817757|NCT00642993|474613628|FG001|Overall Study|Protocol Violation|4|||
131817758|NCT00642993|474613627|FG000|Overall Study|Did not meet protocol eligibility|0|||
131817759|NCT00642993|474613628|FG001|Overall Study|Did not meet protocol eligibility|1|||
131817760|NCT00642993|474613627|FG000|Overall Study|Administrative|1|||
131817761|NCT00642993|474613628|FG001|Overall Study|Administrative|0|||
131817762|NCT02986139|474613632|FG000|Overall Study|Sponsor Decision|1|||
131817763|NCT02986139|474613633|FG001|Overall Study|Sponsor Decision|2|||
131817764|NCT02986139|474613632|FG000|Overall Study|Withdrawal by Subject|0|||
131817765|NCT02986139|474613633|FG001|Overall Study|Withdrawal by Subject|1|||
131817766|NCT02986139|474613632|FG000|Overall Study|Lost to Follow-up|0|||
131817767|NCT02986139|474613633|FG001|Overall Study|Lost to Follow-up|1|||
131817768|NCT00414726|474613634|FG000|Overall Study|Withdrawal by Subject|0|||
131817769|NCT00414726|474613635|FG001|Overall Study|Withdrawal by Subject|1|||
131817770|NCT02107196|474613636|FG000|12-week Treatment Period|Adverse Event|6|||
131817771|NCT02107196|474613637|FG001|12-week Treatment Period|Adverse Event|3|||
131817772|NCT02107196|474613636|FG000|12-week Treatment Period|Lack of Efficacy|2|||
131817773|NCT02107196|474613637|FG001|12-week Treatment Period|Lack of Efficacy|1|||
131817774|NCT02107196|474613636|FG000|12-week Treatment Period|Lost to Follow-up|3|||
131817775|NCT02107196|474613637|FG001|12-week Treatment Period|Lost to Follow-up|6|||
131817776|NCT02107196|474613636|FG000|12-week Treatment Period|Physician Decision|0|||
131817777|NCT02107196|474613637|FG001|12-week Treatment Period|Physician Decision|1|||
131817778|NCT02107196|474613636|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
131817779|NCT02107196|474613637|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
131817780|NCT02107196|474613636|FG000|12-week Treatment Period|Protocol Violation|7|||
131817781|NCT02107196|474613637|FG001|12-week Treatment Period|Protocol Violation|8|||
131909868|NCT00250588|474958680|FG002|Overall Study|Lost to Follow-up|13|||
131817782|NCT02107196|474613636|FG000|12-week Treatment Period|Reason Missing|11|||
131909869|NCT03502798|474958681|FG000|Overall Study|equipment failure|0|||
131817783|NCT02107196|474613637|FG001|12-week Treatment Period|Reason Missing|8|||
131817784|NCT02107196|474613636|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
131817785|NCT02107196|474613637|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
131909870|NCT03502798|474958682|FG001|Overall Study|equipment failure|7|||
131400810|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
131909871|NCT00485303|474958684|FG000|Overall Study|Adverse Event|5|||
131909872|NCT00485303|474958684|FG000|Overall Study|Progressive Disease|44|||
131817786|NCT02107196|474613636|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
131817787|NCT02107196|474613637|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131817788|NCT02107196|474613636|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
131817789|NCT02107196|474613637|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
131817790|NCT02107196|474613636|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
131817791|NCT02107196|474613637|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
131817792|NCT00516295|474613638|FG000|Overall Study|Lack of Efficacy|2|||
131817793|NCT00516295|474613639|FG001|Overall Study|Lack of Efficacy|0|||
131817794|NCT00516295|474613640|FG002|Overall Study|Lack of Efficacy|0|||
131817795|NCT00516295|474613638|FG000|Overall Study|Ineligible|1|||
131817796|NCT00516295|474613639|FG001|Overall Study|Ineligible|0|||
131817797|NCT00516295|474613640|FG002|Overall Study|Ineligible|0|||
131817798|NCT02034513|474613641|FG000|Overall Study|Adverse Event|11|||
131817799|NCT02034513|474613642|FG001|Overall Study|Adverse Event|10|||
131817800|NCT02034513|474613641|FG000|Overall Study|Lack of Efficacy|0|||
131817801|NCT02034513|474613642|FG001|Overall Study|Lack of Efficacy|1|||
131817802|NCT02034513|474613641|FG000|Overall Study|Lost to Follow-up|6|||
131817803|NCT02034513|474613642|FG001|Overall Study|Lost to Follow-up|7|||
131817804|NCT02034513|474613641|FG000|Overall Study|Pregnancy|0|||
131817805|NCT02034513|474613642|FG001|Overall Study|Pregnancy|3|||
131817806|NCT02034513|474613641|FG000|Overall Study|Protocol Violation|7|||
131817807|NCT02034513|474613642|FG001|Overall Study|Protocol Violation|10|||
131817808|NCT02034513|474613641|FG000|Overall Study|Withdrawal by Subject|25|||
131817809|NCT02034513|474613642|FG001|Overall Study|Withdrawal by Subject|25|||
131817810|NCT02034513|474613641|FG000|Overall Study|Unclassified|0|||
131817811|NCT02034513|474613642|FG001|Overall Study|Unclassified|1|||
131817812|NCT01168856|474613653|FG000|Overall Study|Lost to Follow-up|4|||
131817813|NCT01168856|474613654|FG001|Overall Study|Lost to Follow-up|34|||
131817814|NCT01168856|474613653|FG000|Overall Study|Withdrawal by Subject|6|||
131817815|NCT01168856|474613654|FG001|Overall Study|Withdrawal by Subject|8|||
131817816|NCT01168856|474613653|FG000|Overall Study|Physician Decision|2|||
131817817|NCT01168856|474613654|FG001|Overall Study|Physician Decision|1|||
131817818|NCT01168856|474613653|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
131817819|NCT01168856|474613654|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
131817820|NCT01168856|474613653|FG000|Overall Study|Participant received anti-HCV treatment|1|||
131817821|NCT01168856|474613654|FG001|Overall Study|Participant received anti-HCV treatment|0|||
131817822|NCT01168856|474613653|FG000|Overall Study|Death|0|||
131817823|NCT01168856|474613654|FG001|Overall Study|Death|2|||
131817824|NCT01168856|474613653|FG000|Overall Study|Other|1|||
131817825|NCT01168856|474613654|FG001|Overall Study|Other|291|||
131817826|NCT01168856|474613653|FG000|Overall Study|Protocol Violation|4|||
131817827|NCT01168856|474613654|FG001|Overall Study|Protocol Violation|6|||
131817828|NCT04567329|474613659|FG000|Overall Study|Withdrawal by Subject|5|||
131817829|NCT04567329|474613660|FG001|Overall Study|Withdrawal by Subject|6|||
131817830|NCT04567329|474613659|FG000|Overall Study|Protocol Violation|2|||
131817831|NCT04567329|474613660|FG001|Overall Study|Protocol Violation|3|||
131817832|NCT04567329|474613659|FG000|Overall Study|Discontinued|2|||
131817833|NCT04567329|474613660|FG001|Overall Study|Discontinued|2|||
131817834|NCT04567329|474613659|FG000|Overall Study|Lost to Follow-up|0|||
131817835|NCT04567329|474613660|FG001|Overall Study|Lost to Follow-up|1|||
131817836|NCT04567329|474613659|FG000|Overall Study|Lack of Efficacy|0|||
131817837|NCT04567329|474613660|FG001|Overall Study|Lack of Efficacy|1|||
131817838|NCT01559363|474613678|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
131817839|NCT01559363|474613679|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
131817840|NCT01559363|474613680|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
131817841|NCT01559363|474613681|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
131817842|NCT01559363|474613682|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
131817843|NCT01559363|474613683|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
131817844|NCT01559363|474613678|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
131817845|NCT01559363|474613679|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
131817846|NCT01559363|474613680|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
131817847|NCT01559363|474613681|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
131817848|NCT01559363|474613682|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
131400811|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
131817849|NCT01559363|474613683|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
131817850|NCT01559363|474613678|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
131817851|NCT01559363|474613679|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
131817852|NCT01559363|474613680|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
131817853|NCT01559363|474613681|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
131817854|NCT01559363|474613682|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
131817855|NCT01559363|474613683|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
131817856|NCT01559363|474613678|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
131817857|NCT01559363|474613679|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
131817858|NCT01559363|474613680|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
131909873|NCT00485303|474958684|FG000|Overall Study|Other|3|||
131817859|NCT01559363|474613681|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
131817860|NCT01559363|474613682|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
131817861|NCT01559363|474613683|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
131817862|NCT01559363|474613678|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
131817863|NCT01559363|474613679|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
131817864|NCT01559363|474613680|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
131817865|NCT01559363|474613681|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
131817866|NCT01559363|474613682|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
131817867|NCT01559363|474613683|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
131817868|NCT01559363|474613678|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
131817869|NCT01559363|474613679|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
131817870|NCT01559363|474613680|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
131817871|NCT01559363|474613681|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
131817872|NCT01559363|474613682|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
131817873|NCT01559363|474613683|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
131817874|NCT01559363|474613678|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
131817875|NCT01559363|474613679|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
131817876|NCT01559363|474613680|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
131817877|NCT01559363|474613681|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
131817878|NCT01559363|474613682|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
131817879|NCT01559363|474613683|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
131817880|NCT00672984|474613684|FG000|First Intervention|Adverse Event|5|||
131817881|NCT00672984|474613685|FG001|First Intervention|Adverse Event|0|||
131817882|NCT00672984|474613686|FG002|First Intervention|Adverse Event|0|||
131817883|NCT00672984|474613684|FG000|First Intervention|Withdrawal by Subject|1|||
131817884|NCT00672984|474613685|FG001|First Intervention|Withdrawal by Subject|2|||
131817885|NCT00672984|474613686|FG002|First Intervention|Withdrawal by Subject|2|||
131817886|NCT00672984|474613684|FG000|First Intervention|Sponsor decision|3|||
131817887|NCT00672984|474613685|FG001|First Intervention|Sponsor decision|0|||
131817888|NCT00672984|474613686|FG002|First Intervention|Sponsor decision|0|||
131817889|NCT00672984|474613684|FG000|Second Intervention|Non-compliance with facility policies|0|||
131817890|NCT00672984|474613685|FG001|Second Intervention|Non-compliance with facility policies|2|||
131817891|NCT00672984|474613686|FG002|Second Intervention|Non-compliance with facility policies|0|||
131817892|NCT00672984|474613684|FG000|Second Intervention|Withdrawal by Subject|0|||
131817893|NCT00672984|474613685|FG001|Second Intervention|Withdrawal by Subject|3|||
131817894|NCT00672984|474613686|FG002|Second Intervention|Withdrawal by Subject|0|||
131817895|NCT00672984|474613684|FG000|Second Intervention|Protocol Violation|0|||
131817896|NCT00672984|474613685|FG001|Second Intervention|Protocol Violation|1|||
131817897|NCT00672984|474613686|FG002|Second Intervention|Protocol Violation|1|||
131817898|NCT00672984|474613684|FG000|Third Intervention|Adverse Event|1|||
131817899|NCT00672984|474613685|FG001|Third Intervention|Adverse Event|0|||
131817900|NCT00672984|474613686|FG002|Third Intervention|Adverse Event|1|||
131817901|NCT04060251|474613687|FG000|Overall Study|Study terminated due to low enrollment.|7|||
131817902|NCT04060251|474613688|FG001|Overall Study|Study terminated due to low enrollment.|5|||
131817903|NCT04060251|474613689|FG002|Overall Study|Study terminated due to low enrollment.|7|||
131817904|NCT04060251|474613687|FG000|Overall Study|Adverse Event|1|||
131817905|NCT04060251|474613688|FG001|Overall Study|Adverse Event|1|||
131817906|NCT04060251|474613689|FG002|Overall Study|Adverse Event|0|||
131817907|NCT00487435|474613690|FG000|Overall Study|Adverse Event|146|||
131817908|NCT00487435|474613690|FG000|Overall Study|Death|2|||
131817909|NCT00487435|474613690|FG000|Overall Study|Lack of Efficacy|33|||
131817910|NCT00487435|474613690|FG000|Overall Study|Lost to Follow-up|54|||
131817911|NCT00487435|474613690|FG000|Overall Study|Pregnancy|2|||
131817912|NCT00487435|474613690|FG000|Overall Study|Withdrawal by Subject|132|||
131817913|NCT00487435|474613690|FG000|Overall Study|Resolution Of Pain|1|||
131817914|NCT00487435|474613690|FG000|Overall Study|Study Medication Non-Compliant|32|||
131817915|NCT00487435|474613690|FG000|Overall Study|Other|83|||
131817916|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
131817917|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
131817918|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
131817919|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
131817920|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
131817921|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
131817922|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
131400812|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
131817923|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
131817924|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
131817925|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
131817926|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
131817927|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
131817928|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
131817929|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
131817930|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
131817931|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
131817932|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
131817933|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
131817934|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
131817935|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
131817936|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
131817937|NCT02227238|474613691|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
131817938|NCT02227238|474613692|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
131400813|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Death|1|||
131400814|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Death|1|||
131400815|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Death|3|||
131400816|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Death|2|||
131400817|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
131400818|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
131400819|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
131449841|NCT03722238|473276723|FG001|Overall Study|Physician Decision|0|||
131817939|NCT02227238|474613693|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
131817940|NCT02227238|474613691|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
131817941|NCT02227238|474613692|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
131817942|NCT02227238|474613693|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
131817943|NCT02227238|474613691|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
131817944|NCT02227238|474613692|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
131817945|NCT02227238|474613693|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
131817946|NCT02227238|474613691|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
131817947|NCT02227238|474613692|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
131817948|NCT02227238|474613693|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
131817949|NCT02227238|474613691|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
131817950|NCT02227238|474613692|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
131817951|NCT02227238|474613693|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
131817952|NCT02227238|474613691|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
131817953|NCT02227238|474613692|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
131817954|NCT02227238|474613693|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
131817955|NCT02227238|474613691|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
131817956|NCT02227238|474613692|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
131817957|NCT02227238|474613693|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
131817958|NCT03966911|474613695|FG000|Overall Study|Adverse Event|1|||
131817959|NCT03966911|474613696|FG001|Overall Study|Adverse Event|1|||
131817960|NCT03966911|474613695|FG000|Overall Study|Withdrawal by Subject|8|||
131817961|NCT03966911|474613696|FG001|Overall Study|Withdrawal by Subject|2|||
131817962|NCT03966911|474613695|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
131817963|NCT03966911|474613696|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
131817964|NCT03498560|474613697|FG000|Overall Study|Found Ineligible|2|||
131817965|NCT03498560|474613697|FG000|Overall Study|Withdrawal by Subject|14|||
131817966|NCT03498560|474613697|FG000|Overall Study|Lost to Follow-up|4|||
131817967|NCT03498560|474613697|FG000|Overall Study|Death|1|||
131817968|NCT01507662|474613698|FG000|Overall Study|Death|26|||
131817969|NCT01507662|474613699|FG001|Overall Study|Death|18|||
131817970|NCT01507662|474613698|FG000|Overall Study|Withdrawal by Subject|290|||
131817971|NCT01507662|474613699|FG001|Overall Study|Withdrawal by Subject|287|||
131817972|NCT01507662|474613698|FG000|Overall Study|Lost to Follow-up|498|||
131817973|NCT01507662|474613699|FG001|Overall Study|Lost to Follow-up|523|||
131817974|NCT01507662|474613698|FG000|Overall Study|Proxy interview done|2|||
131817975|NCT01507662|474613699|FG001|Overall Study|Proxy interview done|3|||
131817976|NCT01004510|474613706|FG000|Overall Study|Adverse Event|1|||
131817977|NCT00474188|474613709|FG000|Overall Study|Withdrawal by Subject|1|||
131817978|NCT00474188|474613709|FG000|Overall Study|Study discontinued by sponsor|5|||
131817979|NCT01960296|474613711|FG000|Overall Study|Postponed surgery|1|||
131817980|NCT01960296|474613712|FG001|Overall Study|Postponed surgery|0|||
131817981|NCT01960296|474613711|FG000|Overall Study|Received different procedure|1|||
131817982|NCT01960296|474613712|FG001|Overall Study|Received different procedure|3|||
131817983|NCT02003391|474613713|FG000|Overall Study|Withdrawal by Subject|2|||
131817984|NCT02003391|474613714|FG001|Overall Study|Withdrawal by Subject|1|||
131817985|NCT02003391|474613713|FG000|Overall Study|Protocol Violation|0|||
131817986|NCT02003391|474613714|FG001|Overall Study|Protocol Violation|1|||
131817987|NCT02003391|474613713|FG000|Overall Study|Adverse Event|1|||
131817988|NCT02003391|474613714|FG001|Overall Study|Adverse Event|0|||
131817989|NCT02272803|474613715|FG000|Overall Study|Disease progression|16|||
131817990|NCT02272803|474613716|FG001|Overall Study|Disease progression|8|||
131817991|NCT02272803|474613715|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
131817992|NCT02272803|474613716|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
131817993|NCT02272803|474613715|FG000|Overall Study|Study drug toxicity|4|||
131817994|NCT02272803|474613716|FG001|Overall Study|Study drug toxicity|9|||
131817995|NCT02272803|474613715|FG000|Overall Study|Participant request to discontinue study treatment|3|||
131817996|NCT02272803|474613716|FG001|Overall Study|Participant request to discontinue study treatment|7|||
131817997|NCT02272803|474613715|FG000|Overall Study|Maximum clinical benefit|4|||
131817998|NCT02272803|474613716|FG001|Overall Study|Maximum clinical benefit|2|||
131817999|NCT02272803|474613715|FG000|Overall Study|Poor/non-compliance|2|||
131818000|NCT02272803|474613716|FG001|Overall Study|Poor/non-compliance|2|||
131818001|NCT02272803|474613715|FG000|Overall Study|Withdrawal by Subject|2|||
131818002|NCT02272803|474613716|FG001|Overall Study|Withdrawal by Subject|1|||
131818003|NCT02272803|474613715|FG000|Overall Study|Death|0|||
131818004|NCT02272803|474613716|FG001|Overall Study|Death|1|||
131818005|NCT02272803|474613715|FG000|Overall Study|Other reasons|1|||
131818006|NCT02272803|474613716|FG001|Overall Study|Other reasons|3|||
131818007|NCT02272803|474613715|FG000|Overall Study|Administrative reason by sponsor|5|||
131818008|NCT02272803|474613716|FG001|Overall Study|Administrative reason by sponsor|4|||
131818009|NCT00858403|474613717|FG000|Overall Study|Withdrawal by Subject|1|||
131818010|NCT00858403|474613717|FG000|Overall Study|Death|3|||
131818011|NCT00858403|474613717|FG000|Overall Study|Disease Progression|1|||
131818012|NCT03961204|474613722|FG000|Overall Study|Withdrawal by Subject|2|||
131818013|NCT03961204|474613722|FG000|Overall Study|Lost to Follow-up|3|||
131400820|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
131400821|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
131400822|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
131818014|NCT03961204|474613722|FG000|Overall Study|Other|1|||
131818015|NCT03961204|474613722|FG000|Overall Study|Missing|1|||
131818016|NCT01566435|474613726|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
131818017|NCT03684928|474613727|FG000|First Intervention|Lost to Follow-up|0|||
131818018|NCT03684928|474613728|FG001|First Intervention|Lost to Follow-up|1|||
131818019|NCT03684928|474613727|FG000|First Intervention|Withdrawal by Subject|0|||
131818020|NCT03684928|474613728|FG001|First Intervention|Withdrawal by Subject|2|||
131818021|NCT03684928|474613727|FG000|Second Intervention|Soft Tissue Injury|1|||
131818022|NCT03684928|474613728|FG001|Second Intervention|Soft Tissue Injury|0|||
131818023|NCT03733145|474613732|FG000|Overall Study|screenfail|3|||
131818024|NCT03733145|474613733|FG001|Overall Study|screenfail|3|||
131818025|NCT03733145|474613734|FG002|Overall Study|screenfail|2|||
131818026|NCT03119662|474615142|FG000|Overall Study|Withdrawal by Subject|0|||
131818027|NCT03119662|474615143|FG001|Overall Study|Withdrawal by Subject|1|||
131818028|NCT00660660|474615145|FG000|Overall Study|Adverse Event|1|||
131818029|NCT00660660|474615146|FG001|Overall Study|Adverse Event|0|||
131818030|NCT00660660|474615145|FG000|Overall Study|Lost to Follow-up|0|||
131818031|NCT00660660|474615146|FG001|Overall Study|Lost to Follow-up|6|||
131818032|NCT00660660|474615145|FG000|Overall Study|Lack of Efficacy|0|||
131818033|NCT00660660|474615146|FG001|Overall Study|Lack of Efficacy|2|||
131818034|NCT00660660|474615145|FG000|Overall Study|Withdrawal by Subject|3|||
131818035|NCT00660660|474615146|FG001|Overall Study|Withdrawal by Subject|0|||
131818036|NCT00660660|474615145|FG000|Overall Study|Incorrect enrollment and other|0|||
131818037|NCT00660660|474615146|FG001|Overall Study|Incorrect enrollment and other|1|||
131818038|NCT00660660|474615145|FG000|Overall Study|New medication after randomization|1|||
131818039|NCT00660660|474615146|FG001|Overall Study|New medication after randomization|0|||
131818040|NCT01630616|474615150|FG000|Overall Study|Adverse Event|0|||
131818041|NCT01630616|474615151|FG001|Overall Study|Adverse Event|0|||
131818042|NCT01630616|474615152|FG002|Overall Study|Adverse Event|0|||
131818043|NCT01630616|474615153|FG003|Overall Study|Adverse Event|1|||
131818044|NCT01630616|474615154|FG004|Overall Study|Adverse Event|0|||
131818045|NCT01630616|474615155|FG005|Overall Study|Adverse Event|0|||
131818046|NCT01630616|474615150|FG000|Overall Study|Withdrawal by Subject|0|||
131818047|NCT01630616|474615151|FG001|Overall Study|Withdrawal by Subject|0|||
131818048|NCT01630616|474615152|FG002|Overall Study|Withdrawal by Subject|0|||
131818049|NCT01630616|474615153|FG003|Overall Study|Withdrawal by Subject|2|||
131400823|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
131818050|NCT01630616|474615154|FG004|Overall Study|Withdrawal by Subject|0|||
131818051|NCT01630616|474615155|FG005|Overall Study|Withdrawal by Subject|0|||
131818052|NCT02218541|474615156|FG000|Overall Study|Lost to Follow-up|2|||
131818053|NCT02218541|474615157|FG001|Overall Study|Lost to Follow-up|1|||
131818054|NCT02218541|474615156|FG000|Overall Study|Implant Failure|4|||
131818055|NCT02218541|474615157|FG001|Overall Study|Implant Failure|1|||
131818056|NCT01993186|474615159|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
131818057|NCT01993186|474615160|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
131818058|NCT01993186|474615159|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
131818059|NCT01993186|474615160|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
131818060|NCT01993186|474615159|FG000|Open-Label Extension Period|Other, Not Specified|0|||
131818061|NCT01993186|474615160|FG001|Open-Label Extension Period|Other, Not Specified|1|||
131818062|NCT01993186|474615159|FG000|Open-Label Extension Period|Adverse Event|1|||
131818063|NCT01993186|474615160|FG001|Open-Label Extension Period|Adverse Event|0|||
131818064|NCT01993186|474615159|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
131818065|NCT01993186|474615160|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
131818066|NCT01993186|474615159|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
131818067|NCT01993186|474615160|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
131818068|NCT01993186|474615159|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
131818069|NCT01993186|474615160|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
131818070|NCT00691704|474615161|FG000|Induction Therapy|Disease Progression|1|||
131818071|NCT00691704|474615161|FG000|Induction Therapy|Active Hepatitis|1|||
131818072|NCT00691704|474615161|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
131818073|NCT00691704|474615161|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
131818074|NCT00691704|474615161|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
131818075|NCT04661202|474615162|FG000|Overall Study|Withdrawal by Subject|1|||
131818076|NCT04661202|474615163|FG001|Overall Study|Withdrawal by Subject|1|||
131818077|NCT04661202|474615162|FG000|Overall Study|Lack of Efficacy|2|||
131818078|NCT04661202|474615163|FG001|Overall Study|Lack of Efficacy|0|||
131818079|NCT02313558|474615167|FG000|Overall Study|Withdrawal by Subject|2|||
131818080|NCT02313558|474615168|FG001|Overall Study|Withdrawal by Subject|0|||
131818081|NCT02313558|474615167|FG000|Overall Study|Lost to Follow-up|4|||
131818082|NCT02313558|474615168|FG001|Overall Study|Lost to Follow-up|4|||
131818083|NCT00084864|474615171|FG000|Overall Study|Adverse Event|1|||
131818084|NCT00084864|474615172|FG001|Overall Study|Adverse Event|0|||
131818085|NCT00084864|474615173|FG002|Overall Study|Adverse Event|0|||
131818086|NCT00084864|474615174|FG003|Overall Study|Adverse Event|0|||
131818087|NCT04102345|474615175|FG000|Overall Study|Withdrawal by Subject|1|||
131818088|NCT04102345|474615176|FG001|Overall Study|Withdrawal by Subject|0|||
131818089|NCT03599362|474615179|FG000|Overall Study|Screen Failure|3|||
131818090|NCT01537887|474615180|FG000|Period 1|Physician Decision|0|||
131818091|NCT01537887|474615181|FG001|Period 1|Physician Decision|0|||
131818092|NCT01537887|474615182|FG002|Period 1|Physician Decision|0|||
131818093|NCT01537887|474615183|FG003|Period 1|Physician Decision|0|||
131818094|NCT01537887|474615184|FG004|Period 1|Physician Decision|1|||
131818095|NCT01537887|474615185|FG005|Period 1|Physician Decision|1|||
131818096|NCT01537887|474615180|FG000|Period 1|Did not receive treatment|0|||
131818097|NCT01537887|474615181|FG001|Period 1|Did not receive treatment|0|||
131818098|NCT01537887|474615182|FG002|Period 1|Did not receive treatment|1|||
131818099|NCT01537887|474615183|FG003|Period 1|Did not receive treatment|0|||
131818100|NCT01537887|474615184|FG004|Period 1|Did not receive treatment|0|||
131818101|NCT01537887|474615185|FG005|Period 1|Did not receive treatment|0|||
131818102|NCT01537887|474615180|FG000|Period 2|Withdrawal by Subject|0|||
131818103|NCT01537887|474615181|FG001|Period 2|Withdrawal by Subject|1|||
131818104|NCT01537887|474615182|FG002|Period 2|Withdrawal by Subject|0|||
131818105|NCT01537887|474615183|FG003|Period 2|Withdrawal by Subject|0|||
131818106|NCT01537887|474615184|FG004|Period 2|Withdrawal by Subject|0|||
131400824|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
131400825|NCT01866111|473089638|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
131818107|NCT01537887|474615185|FG005|Period 2|Withdrawal by Subject|0|||
131818108|NCT01537887|474615180|FG000|Period 3|Adverse Event|0|||
131818109|NCT01537887|474615181|FG001|Period 3|Adverse Event|0|||
131818110|NCT01537887|474615182|FG002|Period 3|Adverse Event|1|||
131818111|NCT01537887|474615183|FG003|Period 3|Adverse Event|0|||
131818112|NCT01537887|474615184|FG004|Period 3|Adverse Event|0|||
131818113|NCT01537887|474615185|FG005|Period 3|Adverse Event|0|||
131818114|NCT01537887|474615180|FG000|Period 3|Withdrawal by Subject|0|||
131818115|NCT01537887|474615181|FG001|Period 3|Withdrawal by Subject|1|||
131818116|NCT01537887|474615182|FG002|Period 3|Withdrawal by Subject|0|||
131818117|NCT01537887|474615183|FG003|Period 3|Withdrawal by Subject|0|||
131818118|NCT01537887|474615184|FG004|Period 3|Withdrawal by Subject|0|||
131818119|NCT01537887|474615185|FG005|Period 3|Withdrawal by Subject|0|||
131400826|NCT01866111|473089639|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
131400827|NCT01866111|473089640|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
131400828|NCT01866111|473089641|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
131818120|NCT01370083|474615187|FG000|Overall Study|Lost to Follow-up|2|||
131818121|NCT01370083|474615188|FG001|Overall Study|Lost to Follow-up|0|||
131818122|NCT01370083|474615187|FG000|Overall Study|Adverse Event|0|||
131818123|NCT01370083|474615188|FG001|Overall Study|Adverse Event|1|||
131818124|NCT02072096|474615190|FG000|Overall Study|Lack of Efficacy|18|||
131818125|NCT02072096|474615191|FG001|Overall Study|Lack of Efficacy|29|||
131818126|NCT02072096|474615190|FG000|Overall Study|Protocol Violation|7|||
131818127|NCT02072096|474615191|FG001|Overall Study|Protocol Violation|7|||
131818128|NCT02072096|474615190|FG000|Overall Study|Withdrawal by Subject|5|||
131818129|NCT02072096|474615191|FG001|Overall Study|Withdrawal by Subject|7|||
131818130|NCT02072096|474615190|FG000|Overall Study|Adverse Event|5|||
131818131|NCT02072096|474615191|FG001|Overall Study|Adverse Event|2|||
131818132|NCT02072096|474615190|FG000|Overall Study|No Reason Provided|4|||
131818133|NCT02072096|474615191|FG001|Overall Study|No Reason Provided|2|||
131818134|NCT02072096|474615190|FG000|Overall Study|Death|2|||
131818135|NCT02072096|474615191|FG001|Overall Study|Death|0|||
131818136|NCT02072096|474615190|FG000|Overall Study|Physician Decision|0|||
131818137|NCT02072096|474615191|FG001|Overall Study|Physician Decision|1|||
131818138|NCT02072096|474615190|FG000|Overall Study|Study Terminated by Sponsor|43|||
131818139|NCT02072096|474615191|FG001|Overall Study|Study Terminated by Sponsor|30|||
131818140|NCT02072096|474615190|FG000|Overall Study|Lost to Follow-up|1|||
131818141|NCT02072096|474615191|FG001|Overall Study|Lost to Follow-up|0|||
131818142|NCT00425308|474615199|FG000|Overall Study|Adverse Event|2|||
131818143|NCT00425308|474615200|FG001|Overall Study|Adverse Event|1|||
131818144|NCT00425308|474615199|FG000|Overall Study|Withdrawal by Subject|1|||
131818145|NCT00425308|474615200|FG001|Overall Study|Withdrawal by Subject|0|||
131818146|NCT00425308|474615199|FG000|Overall Study|Death|1|||
131818147|NCT00425308|474615200|FG001|Overall Study|Death|0|||
131818148|NCT04442503|474615201|FG000|Overall Study|Adverse Event|1|||
131818149|NCT04442503|474615202|FG001|Overall Study|Adverse Event|1|||
131818150|NCT04442503|474615201|FG000|Overall Study|Lost to Follow-up|8|||
131818151|NCT04442503|474615202|FG001|Overall Study|Lost to Follow-up|6|||
131818152|NCT04442503|474615201|FG000|Overall Study|Physician Decision|0|||
131818153|NCT04442503|474615202|FG001|Overall Study|Physician Decision|2|||
131818154|NCT04442503|474615201|FG000|Overall Study|Withdrawal by Subject|3|||
131818155|NCT04442503|474615202|FG001|Overall Study|Withdrawal by Subject|4|||
131818156|NCT04442503|474615201|FG000|Overall Study|Reason not Specified|0|||
131818157|NCT04442503|474615202|FG001|Overall Study|Reason not Specified|1|||
131818158|NCT04442503|474615201|FG000|Overall Study|Randomized but not Treated|3|||
131818159|NCT04442503|474615202|FG001|Overall Study|Randomized but not Treated|1|||
131818160|NCT01945580|474615203|FG000|Overall Study|Withdrawal by Subject|13|||
131818161|NCT01945580|474615204|FG001|Overall Study|Withdrawal by Subject|35|||
131818162|NCT01945580|474615203|FG000|Overall Study|Physician Decision|3|||
131818163|NCT01945580|474615204|FG001|Overall Study|Physician Decision|2|||
131818164|NCT01945580|474615203|FG000|Overall Study|Lost to Follow-up|26|||
131818165|NCT01945580|474615204|FG001|Overall Study|Lost to Follow-up|39|||
131818166|NCT01945580|474615203|FG000|Overall Study|Death|7|||
131818167|NCT01945580|474615204|FG001|Overall Study|Death|2|||
131818168|NCT01945580|474615203|FG000|Overall Study|Patient moved out of state|0|||
131818169|NCT01945580|474615204|FG001|Overall Study|Patient moved out of state|1|||
131818170|NCT01945580|474615203|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
131818171|NCT01945580|474615204|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
131818172|NCT01945580|474615203|FG000|Overall Study|Family illness - unable to return|0|||
131818173|NCT01945580|474615204|FG001|Overall Study|Family illness - unable to return|1|||
131818174|NCT01945580|474615203|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
131818175|NCT01945580|474615204|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
131818176|NCT01945580|474615203|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
131818177|NCT01945580|474615204|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
131818178|NCT01945580|474615203|FG000|Overall Study|Noncompliance with 36 month visit|1|||
131818179|NCT01945580|474615204|FG001|Overall Study|Noncompliance with 36 month visit|0|||
131818180|NCT01945580|474615203|FG000|Overall Study|The patient moved.|1|||
131818181|NCT01945580|474615204|FG001|Overall Study|The patient moved.|0|||
131818182|NCT01945580|474615203|FG000|Overall Study|No data available|0|||
131818183|NCT01945580|474615204|FG001|Overall Study|No data available|2|||
131818184|NCT00474058|474615207|FG000|Overall Study|Adverse Event|11|||
131818185|NCT00474058|474615208|FG001|Overall Study|Adverse Event|6|||
131818186|NCT00474058|474615207|FG000|Overall Study|Lack of Efficacy|0|||
131818187|NCT00474058|474615208|FG001|Overall Study|Lack of Efficacy|4|||
131818188|NCT00474058|474615207|FG000|Overall Study|Withdrawal by Subject|11|||
131818189|NCT00474058|474615208|FG001|Overall Study|Withdrawal by Subject|7|||
131818190|NCT00474058|474615207|FG000|Overall Study|Other|2|||
131818191|NCT00474058|474615208|FG001|Overall Study|Other|0|||
131818192|NCT03101358|474615209|FG000|Overall Study|Non-compliance with study schedule|1|||
131818193|NCT03101358|474615210|FG001|Overall Study|Non-compliance with study schedule|0|||
131818194|NCT03101358|474615211|FG002|Overall Study|Non-compliance with study schedule|0|||
131818195|NCT03101358|474615212|FG003|Overall Study|Non-compliance with study schedule|1|||
131818196|NCT03101358|474615209|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
131818197|NCT03101358|474615210|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
131818198|NCT03101358|474615211|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
131818199|NCT03101358|474615212|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
131818200|NCT03101358|474615209|FG000|Overall Study|Physician Decision|1|||
131818201|NCT03101358|474615210|FG001|Overall Study|Physician Decision|0|||
131818202|NCT03101358|474615211|FG002|Overall Study|Physician Decision|0|||
131818203|NCT03101358|474615212|FG003|Overall Study|Physician Decision|3|||
131818204|NCT03101358|474615209|FG000|Overall Study|Adverse Event|0|||
131818205|NCT03101358|474615210|FG001|Overall Study|Adverse Event|0|||
131818206|NCT03101358|474615211|FG002|Overall Study|Adverse Event|1|||
131818207|NCT03101358|474615212|FG003|Overall Study|Adverse Event|0|||
131818208|NCT03101358|474615209|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
131818209|NCT03101358|474615210|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
131818210|NCT03101358|474615211|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
131818211|NCT03101358|474615212|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
131818212|NCT03101358|474615209|FG000|Overall Study|Lost to Follow-up|1|||
131818213|NCT03101358|474615210|FG001|Overall Study|Lost to Follow-up|0|||
131818214|NCT03101358|474615211|FG002|Overall Study|Lost to Follow-up|0|||
131818215|NCT03101358|474615212|FG003|Overall Study|Lost to Follow-up|1|||
131818216|NCT02845336|474615213|FG000|Overall Study|Lost to Follow-up|3|||
131818217|NCT02845336|474615214|FG001|Overall Study|Lost to Follow-up|1|||
131818218|NCT02845336|474615213|FG000|Overall Study|Inability to get medication|2|||
131818219|NCT02845336|474615214|FG001|Overall Study|Inability to get medication|0|||
131818220|NCT01496118|474615215|FG000|Overall Study|Disease progression|3|||
131818221|NCT01496118|474615216|FG001|Overall Study|Disease progression|2|||
131818222|NCT01496118|474615217|FG002|Overall Study|Disease progression|3|||
131818223|NCT01496118|474615218|FG003|Overall Study|Disease progression|1|||
131818224|NCT01496118|474615219|FG004|Overall Study|Disease progression|2|||
131818225|NCT01496118|474615220|FG005|Overall Study|Disease progression|2|||
131818226|NCT01496118|474615221|FG006|Overall Study|Disease progression|14|||
131818227|NCT01496118|474615222|FG007|Overall Study|Disease progression|10|||
131818228|NCT01496118|474615215|FG000|Overall Study|Physician Decision|0|||
131818229|NCT01496118|474615216|FG001|Overall Study|Physician Decision|0|||
131818230|NCT01496118|474615217|FG002|Overall Study|Physician Decision|0|||
131818231|NCT01496118|474615218|FG003|Overall Study|Physician Decision|0|||
131818232|NCT01496118|474615219|FG004|Overall Study|Physician Decision|1|||
131818233|NCT01496118|474615220|FG005|Overall Study|Physician Decision|0|||
131818234|NCT01496118|474615221|FG006|Overall Study|Physician Decision|3|||
131818235|NCT01496118|474615222|FG007|Overall Study|Physician Decision|6|||
131818236|NCT01496118|474615215|FG000|Overall Study|Adverse Event|1|||
131818237|NCT01496118|474615216|FG001|Overall Study|Adverse Event|1|||
131818238|NCT01496118|474615217|FG002|Overall Study|Adverse Event|0|||
131818239|NCT01496118|474615218|FG003|Overall Study|Adverse Event|0|||
131818240|NCT01496118|474615219|FG004|Overall Study|Adverse Event|0|||
131818241|NCT01496118|474615220|FG005|Overall Study|Adverse Event|0|||
131818242|NCT01496118|474615221|FG006|Overall Study|Adverse Event|6|||
131818243|NCT01496118|474615222|FG007|Overall Study|Adverse Event|10|||
131818244|NCT01496118|474615215|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818245|NCT01496118|474615216|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818246|NCT01496118|474615217|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818247|NCT01496118|474615218|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818248|NCT01496118|474615219|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818249|NCT01496118|474615220|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818250|NCT01496118|474615221|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
131818251|NCT01496118|474615222|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
131818252|NCT01496118|474615215|FG000|Overall Study|Death|0|||
131818253|NCT01496118|474615216|FG001|Overall Study|Death|0|||
131818254|NCT01496118|474615217|FG002|Overall Study|Death|0|||
131818255|NCT01496118|474615218|FG003|Overall Study|Death|0|||
131818256|NCT01496118|474615219|FG004|Overall Study|Death|0|||
131818257|NCT01496118|474615220|FG005|Overall Study|Death|0|||
131818258|NCT01496118|474615221|FG006|Overall Study|Death|1|||
131818259|NCT01496118|474615222|FG007|Overall Study|Death|1|||
131818260|NCT01496118|474615215|FG000|Overall Study|Withdrawal by Subject|0|||
131818261|NCT01496118|474615216|FG001|Overall Study|Withdrawal by Subject|0|||
131818262|NCT01496118|474615217|FG002|Overall Study|Withdrawal by Subject|0|||
131818263|NCT01496118|474615218|FG003|Overall Study|Withdrawal by Subject|2|||
131818264|NCT01496118|474615219|FG004|Overall Study|Withdrawal by Subject|0|||
131818265|NCT01496118|474615220|FG005|Overall Study|Withdrawal by Subject|1|||
131818266|NCT01496118|474615221|FG006|Overall Study|Withdrawal by Subject|6|||
131818267|NCT01496118|474615222|FG007|Overall Study|Withdrawal by Subject|3|||
131818268|NCT00881751|474615223|FG000|Overall Study|Physician Decision|0|||
131818269|NCT00881751|474615224|FG001|Overall Study|Physician Decision|1|||
131818270|NCT00881751|474615223|FG000|Overall Study|Adverse Event|0|||
131818271|NCT00881751|474615224|FG001|Overall Study|Adverse Event|2|||
131818272|NCT00881751|474615223|FG000|Overall Study|Withdrawal by Subject|0|||
131818273|NCT00881751|474615224|FG001|Overall Study|Withdrawal by Subject|2|||
131818274|NCT02385708|474615225|FG000|Overall Study|Withdrawal by Subject|0|||
131818275|NCT02385708|474615226|FG001|Overall Study|Withdrawal by Subject|2|||
131818276|NCT02385708|474615225|FG000|Overall Study|Withdrawn - surgery canceled|2|||
131818277|NCT02385708|474615226|FG001|Overall Study|Withdrawn - surgery canceled|5|||
131818278|NCT02385708|474615225|FG000|Overall Study|Investigator decision|5|||
131818279|NCT02385708|474615226|FG001|Overall Study|Investigator decision|7|||
131818280|NCT02385708|474615225|FG000|Overall Study|Protocol Violation|1|||
131818281|NCT02385708|474615226|FG001|Overall Study|Protocol Violation|1|||
131818282|NCT02761915|474615227|FG000|Overall Study|Death|3|||
131818283|NCT02761915|474615228|FG001|Overall Study|Death|1|||
131818284|NCT02761915|474615229|FG002|Overall Study|Death|1|||
131818285|NCT02761915|474615230|FG003|Overall Study|Death|1|||
131818286|NCT02761915|474615231|FG004|Overall Study|Death|0|||
131818287|NCT02761915|474615232|FG005|Overall Study|Death|1|||
131818288|NCT02761915|474615227|FG000|Overall Study|Withdrawal by Subject|1|||
131818289|NCT02761915|474615228|FG001|Overall Study|Withdrawal by Subject|0|||
131818290|NCT02761915|474615229|FG002|Overall Study|Withdrawal by Subject|0|||
131818291|NCT02761915|474615230|FG003|Overall Study|Withdrawal by Subject|0|||
131818292|NCT02761915|474615231|FG004|Overall Study|Withdrawal by Subject|1|||
131818293|NCT02761915|474615232|FG005|Overall Study|Withdrawal by Subject|2|||
131818294|NCT02761915|474615227|FG000|Overall Study|Disease Progression|0|||
131818295|NCT02761915|474615228|FG001|Overall Study|Disease Progression|0|||
131818296|NCT02761915|474615229|FG002|Overall Study|Disease Progression|0|||
131818297|NCT02761915|474615230|FG003|Overall Study|Disease Progression|2|||
131818298|NCT02761915|474615231|FG004|Overall Study|Disease Progression|2|||
131818299|NCT02761915|474615232|FG005|Overall Study|Disease Progression|2|||
131818300|NCT00645853|474615237|FG000|Overall Study|Adverse Event|18|||
131818301|NCT00645853|474615238|FG001|Overall Study|Adverse Event|7|||
131818302|NCT00645853|474615237|FG000|Overall Study|AZ study closure in Hungary|60|||
131818303|NCT00645853|474615238|FG001|Overall Study|AZ study closure in Hungary|40|||
131818304|NCT00645853|474615237|FG000|Overall Study|Withdrawal by Subject|5|||
131818305|NCT00645853|474615238|FG001|Overall Study|Withdrawal by Subject|2|||
131818306|NCT00645853|474615237|FG000|Overall Study|Protocol Violation|0|||
131818307|NCT00645853|474615238|FG001|Overall Study|Protocol Violation|2|||
131818308|NCT00645853|474615237|FG000|Overall Study|Discontinuation criteria|2|||
131818309|NCT00645853|474615238|FG001|Overall Study|Discontinuation criteria|2|||
131818310|NCT00645853|474615237|FG000|Overall Study|recall of ICF, planned operation, death|7|||
131818311|NCT00645853|474615238|FG001|Overall Study|recall of ICF, planned operation, death|4|||
131818312|NCT02705716|474615239|FG000|Overall Study|Adverse Event|0|||
131818313|NCT02705716|474615240|FG001|Overall Study|Adverse Event|1|||
131818314|NCT02705716|474615239|FG000|Overall Study|Protocol Violation|3|||
131818315|NCT02705716|474615240|FG001|Overall Study|Protocol Violation|0|||
131818316|NCT02705716|474615239|FG000|Overall Study|Withdrawal of Consent|1|||
131818317|NCT02705716|474615240|FG001|Overall Study|Withdrawal of Consent|1|||
131818318|NCT00562718|474615241|FG000|Overall Study|Death|1|||
131818319|NCT00562718|474615241|FG000|Overall Study|Withdrawal by Subject|3|||
131818320|NCT00562718|474615241|FG000|Overall Study|Adverse Event|4|||
131818321|NCT00562718|474615241|FG000|Overall Study|Lack of Efficacy|2|||
131818322|NCT00562718|474615241|FG000|Overall Study|not stated|1|||
131818323|NCT01868243|474615242|FG000|Overall Study|Death|0|||
131818324|NCT01868243|474615243|FG001|Overall Study|Death|1|||
131818325|NCT00985751|474615244|FG000|Overall Study|Adverse Event|0|||
131818326|NCT00985751|474615245|FG001|Overall Study|Adverse Event|0|||
131818327|NCT00985751|474615246|FG002|Overall Study|Adverse Event|0|||
131818328|NCT00985751|474615247|FG003|Overall Study|Adverse Event|0|||
131818329|NCT00985751|474615248|FG004|Overall Study|Adverse Event|1|||
131818330|NCT00380588|474615249|FG000|Overall Study|Unequivocal Disease Progression|25|||
131818331|NCT00380588|474615250|FG001|Overall Study|Unequivocal Disease Progression|34|||
131818332|NCT00380588|474615249|FG000|Overall Study|Next Cycle Not Started|4|||
131818333|NCT00380588|474615250|FG001|Overall Study|Next Cycle Not Started|0|||
131818334|NCT00380588|474615249|FG000|Overall Study|Adverse Event|7|||
131818335|NCT00380588|474615250|FG001|Overall Study|Adverse Event|3|||
131818336|NCT00380588|474615249|FG000|Overall Study|Withdrawal by Subject|1|||
131818337|NCT00380588|474615250|FG001|Overall Study|Withdrawal by Subject|3|||
131818338|NCT00380588|474615249|FG000|Overall Study|Physician Decision|2|||
131818339|NCT00380588|474615250|FG001|Overall Study|Physician Decision|0|||
131818340|NCT00999687|474615256|FG000|First Intervention|Withdrawal by Subject|1|||
131818341|NCT00999687|474615256|FG000|Second Intervention|Withdrawal by Subject|2|||
131818342|NCT00999687|474615256|FG000|Second Intervention|Lack of Efficacy|1|||
131818343|NCT03727139|474615259|FG000|Overall Study|Protocol Violation|60|||
131818344|NCT01120028|474615260|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
131818345|NCT01120028|474615261|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
131818346|NCT01120028|474615262|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
131818347|NCT01120028|474615263|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
131818348|NCT01120028|474615260|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
131818349|NCT01120028|474615261|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
131818350|NCT01120028|474615262|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
131818351|NCT01120028|474615263|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
131818352|NCT03867760|474615264|FG000|Overall Study|Lost to Follow-up|2|||
131818353|NCT03867760|474615265|FG001|Overall Study|Lost to Follow-up|3|||
131818354|NCT03867760|474615264|FG000|Overall Study|Withdrawal by Subject|1|||
131818355|NCT03867760|474615265|FG001|Overall Study|Withdrawal by Subject|2|||
131818356|NCT03867760|474615264|FG000|Overall Study|subject could not meet study logistics|3|||
131818357|NCT03867760|474615265|FG001|Overall Study|subject could not meet study logistics|3|||
131818358|NCT01401062|474615268|FG000|Overall Study|Death|9|||
131818359|NCT01401062|474615269|FG001|Overall Study|Death|7|||
131818360|NCT01401062|474615268|FG000|Overall Study|Physician Decision|1|||
131818361|NCT01401062|474615269|FG001|Overall Study|Physician Decision|0|||
131818362|NCT01401062|474615268|FG000|Overall Study|Withdrawal by Subject|1|||
131818363|NCT01401062|474615269|FG001|Overall Study|Withdrawal by Subject|1|||
131818364|NCT01131260|474615270|FG000|Overall Study|Randomization error|5|||
131818365|NCT01131260|474615271|FG001|Overall Study|Randomization error|1|||
131818366|NCT01131260|474615270|FG000|Overall Study|Declined to continue participation|8|||
131818367|NCT01131260|474615271|FG001|Overall Study|Declined to continue participation|13|||
131818368|NCT01131260|474615270|FG000|Overall Study|Physician Decision|22|||
131400829|NCT05596734|473089642|FG000|Substudy A|Withdrawal by Subject|1|||
131400830|NCT05596734|473089643|FG001|Substudy A|Withdrawal by Subject|0|||
131818369|NCT01131260|474615271|FG001|Overall Study|Physician Decision|24|||
131818370|NCT01131260|474615270|FG000|Overall Study|Technical problems|7|||
131818371|NCT01131260|474615271|FG001|Overall Study|Technical problems|6|||
131818372|NCT01131260|474615270|FG000|Overall Study|Staff error|2|||
131818373|NCT01131260|474615271|FG001|Overall Study|Staff error|1|||
131818374|NCT01131260|474615270|FG000|Overall Study|Ineligible|0|||
131818375|NCT01131260|474615271|FG001|Overall Study|Ineligible|2|||
131818376|NCT00757172|474615272|FG000|Overall Study|Withdrawal by Subject|4|||
131818377|NCT00757172|474615272|FG000|Overall Study|Physician Decision|3|||
131818378|NCT00757172|474615272|FG000|Overall Study|Progression|4|||
131818379|NCT01018862|474615284|FG000|Overall Study|Adverse Event|2|||
131818380|NCT01018862|474615285|FG001|Overall Study|Adverse Event|0|||
131818381|NCT01018862|474615286|FG002|Overall Study|Adverse Event|6|||
131818382|NCT01018862|474615284|FG000|Overall Study|Lack of Efficacy|1|||
131818383|NCT01018862|474615285|FG001|Overall Study|Lack of Efficacy|0|||
131818384|NCT01018862|474615286|FG002|Overall Study|Lack of Efficacy|2|||
131818385|NCT01018862|474615284|FG000|Overall Study|Lost to Follow-up|3|||
131818386|NCT01018862|474615285|FG001|Overall Study|Lost to Follow-up|1|||
131818387|NCT01018862|474615286|FG002|Overall Study|Lost to Follow-up|0|||
131818388|NCT01018862|474615284|FG000|Overall Study|Protocol Violation|1|||
131818389|NCT01018862|474615285|FG001|Overall Study|Protocol Violation|3|||
131818390|NCT01018862|474615286|FG002|Overall Study|Protocol Violation|3|||
131818391|NCT01018862|474615284|FG000|Overall Study|Withdrawal by Subject|1|||
131818392|NCT01018862|474615285|FG001|Overall Study|Withdrawal by Subject|2|||
131818393|NCT01018862|474615286|FG002|Overall Study|Withdrawal by Subject|1|||
131818394|NCT01018862|474615284|FG000|Overall Study|administrative problems|5|||
131818395|NCT01018862|474615285|FG001|Overall Study|administrative problems|4|||
131818396|NCT01018862|474615286|FG002|Overall Study|administrative problems|4|||
131818397|NCT01968031|474615287|FG000|Overall Study|Adverse Event|13|||
131818398|NCT01968031|474615288|FG001|Overall Study|Adverse Event|10|||
131818399|NCT01968031|474615289|FG002|Overall Study|Adverse Event|22|||
131818400|NCT01968031|474615287|FG000|Overall Study|Withdrawal by Subject|3|||
131818401|NCT01968031|474615288|FG001|Overall Study|Withdrawal by Subject|7|||
131818402|NCT01968031|474615289|FG002|Overall Study|Withdrawal by Subject|3|||
131818403|NCT01968031|474615287|FG000|Overall Study|Did not meet entry criteria|1|||
131818404|NCT01968031|474615288|FG001|Overall Study|Did not meet entry criteria|1|||
131818405|NCT01968031|474615289|FG002|Overall Study|Did not meet entry criteria|1|||
131818406|NCT01968031|474615287|FG000|Overall Study|Noncompliance|0|||
131818407|NCT01968031|474615288|FG001|Overall Study|Noncompliance|0|||
131818408|NCT01968031|474615289|FG002|Overall Study|Noncompliance|2|||
131818409|NCT01968031|474615287|FG000|Overall Study|Failed inclusion criteria|0|||
131818410|NCT01968031|474615288|FG001|Overall Study|Failed inclusion criteria|2|||
131818411|NCT01968031|474615289|FG002|Overall Study|Failed inclusion criteria|0|||
131818412|NCT01968031|474615287|FG000|Overall Study|Death|0|||
131818413|NCT01968031|474615288|FG001|Overall Study|Death|0|||
131818414|NCT01968031|474615289|FG002|Overall Study|Death|1|||
131818415|NCT01968031|474615287|FG000|Overall Study|Prohibited concomitant medication|1|||
131818416|NCT01968031|474615288|FG001|Overall Study|Prohibited concomitant medication|0|||
131818417|NCT01968031|474615289|FG002|Overall Study|Prohibited concomitant medication|0|||
131818418|NCT00840879|474615290|FG000|Second Intervention|Withdrawal by Subject|1|||
131818419|NCT00840879|474615291|FG001|Second Intervention|Withdrawal by Subject|0|||
131818420|NCT04236596|474615292|FG000|Overall Study|Withdrawal by Subject|1|||
131818421|NCT04236596|474615292|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
131818422|NCT04236596|474615292|FG000|Overall Study|Participants did not receive implant at all|4|||
131818423|NCT02957331|474615295|FG000|Overall Study|Protocol Violation|1|||
131818424|NCT02957331|474615296|FG001|Overall Study|Protocol Violation|0|||
131818425|NCT02308241|474616928|FG000|Overall Study|Withdrawal by Subject|3|||
131818426|NCT04408924|474616929|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
131818427|NCT04408924|474616929|FG000|Overall Study|Lost to Follow-up|3|||
131818428|NCT04408924|474616929|FG000|Overall Study|Withdrawal by Subject|5|||
131818429|NCT04408924|474616929|FG000|Overall Study|Sponsor Decision|2|||
131818430|NCT02578641|474616930|FG000|Overall Study|Adverse Event|5|||
131818431|NCT02578641|474616931|FG001|Overall Study|Adverse Event|15|||
131818432|NCT02578641|474616930|FG000|Overall Study|Death|16|||
131818433|NCT02578641|474616931|FG001|Overall Study|Death|8|||
131818434|NCT02578641|474616930|FG000|Overall Study|Lost to Follow-up|0|||
131818435|NCT02578641|474616931|FG001|Overall Study|Lost to Follow-up|1|||
131818436|NCT02578641|474616930|FG000|Overall Study|Withdrawal by Subject|14|||
131818437|NCT02578641|474616931|FG001|Overall Study|Withdrawal by Subject|7|||
131818438|NCT02578641|474616930|FG000|Overall Study|Progressive Disease|69|||
131818439|NCT02578641|474616931|FG001|Overall Study|Progressive Disease|21|||
131818440|NCT02578641|474616930|FG000|Overall Study|No Study Drug|2|||
131818441|NCT02578641|474616931|FG001|Overall Study|No Study Drug|0|||
131818442|NCT02578641|474616930|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
131818443|NCT02578641|474616931|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
131818444|NCT02578641|474616930|FG000|Overall Study|Non-compliance with Study Schedule|1|||
131818445|NCT02578641|474616931|FG001|Overall Study|Non-compliance with Study Schedule|0|||
131818446|NCT02578641|474616930|FG000|Overall Study|Other|1|||
131818447|NCT02578641|474616931|FG001|Overall Study|Other|10|||
131818448|NCT02578641|474616930|FG000|Overall Study|Not treated|1|||
131818449|NCT02578641|474616931|FG001|Overall Study|Not treated|4|||
131818450|NCT00640393|474616932|FG000|Part 1|Lost to Follow-up|2|||
131818451|NCT00640393|474616933|FG001|Part 1|Lost to Follow-up|0|||
131818452|NCT00640393|474616934|FG002|Part 1|Lost to Follow-up|0|||
131818453|NCT00640393|474616932|FG000|Part 1|Withdrawal by Subject|3|||
131818454|NCT00640393|474616933|FG001|Part 1|Withdrawal by Subject|0|||
131818455|NCT00640393|474616934|FG002|Part 1|Withdrawal by Subject|0|||
131818456|NCT00640393|474616932|FG000|Randomization|Withdrawn per protocol|17|||
131818457|NCT00640393|474616933|FG001|Randomization|Withdrawn per protocol|0|||
131818458|NCT00640393|474616934|FG002|Randomization|Withdrawn per protocol|0|||
131818459|NCT00640393|474616932|FG000|Randomization|Never randomized by site|2|||
131818460|NCT00640393|474616933|FG001|Randomization|Never randomized by site|0|||
131818461|NCT00640393|474616934|FG002|Randomization|Never randomized by site|0|||
131818462|NCT00640393|474616932|FG000|Part 2|Lost to Follow-up|0|||
131818463|NCT00640393|474616933|FG001|Part 2|Lost to Follow-up|2|||
131818464|NCT00640393|474616934|FG002|Part 2|Lost to Follow-up|2|||
131818465|NCT00640393|474616932|FG000|Part 2|Withdrawal by Subject|0|||
131818466|NCT00640393|474616933|FG001|Part 2|Withdrawal by Subject|6|||
131818467|NCT00640393|474616934|FG002|Part 2|Withdrawal by Subject|1|||
131818468|NCT00640393|474616932|FG000|Part 2|Non-adherence|0|||
131818469|NCT00640393|474616933|FG001|Part 2|Non-adherence|1|||
131818470|NCT00640393|474616934|FG002|Part 2|Non-adherence|0|||
131818471|NCT00640393|474616932|FG000|Part 2|Adverse Event|0|||
131818472|NCT00640393|474616933|FG001|Part 2|Adverse Event|1|||
131818473|NCT00640393|474616934|FG002|Part 2|Adverse Event|0|||
131818474|NCT04406194|474616935|FG000|Period 1|Withdrawal by Subject|0|||
131818475|NCT04406194|474616936|FG001|Period 1|Withdrawal by Subject|1|||
131818476|NCT00385736|474616937|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
131818477|NCT00385736|474616938|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
131818478|NCT00385736|474616939|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
131818479|NCT00385736|474616937|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
131818480|NCT00385736|474616938|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
131818481|NCT00385736|474616939|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
131818482|NCT00385736|474616937|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
131818483|NCT00385736|474616938|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
131818484|NCT00385736|474616939|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
131818485|NCT00385736|474616937|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
131818486|NCT00385736|474616938|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
131818487|NCT00385736|474616939|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
131818488|NCT00385736|474616937|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
131818489|NCT00385736|474616938|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
131818490|NCT00385736|474616939|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
131818491|NCT00385736|474616937|FG000|Efficacy Analysis Set - Induction|Other|0|||
131818492|NCT00385736|474616938|FG001|Efficacy Analysis Set - Induction|Other|0|||
131818493|NCT00385736|474616939|FG002|Efficacy Analysis Set - Induction|Other|1|||
131818494|NCT00385736|474616937|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
131818495|NCT00385736|474616938|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
131818496|NCT00385736|474616939|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
131818497|NCT00385736|474616937|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
131818498|NCT00385736|474616938|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
131400831|NCT05596734|473089644|FG002|Substudy A|Withdrawal by Subject|0|||
131818499|NCT00385736|474616939|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
131818500|NCT00385736|474616937|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
131818501|NCT00385736|474616938|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
131818502|NCT00385736|474616939|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
131818503|NCT00385736|474616937|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
131818504|NCT00385736|474616938|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
131818505|NCT00385736|474616939|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
131400832|NCT05596734|473089645|FG003|Substudy A|Withdrawal by Subject|0|||
131818506|NCT00385736|474616937|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
131818507|NCT00385736|474616938|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
131818508|NCT00385736|474616939|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
131818509|NCT00385736|474616937|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
131818510|NCT00385736|474616938|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
131818511|NCT00385736|474616939|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
131818512|NCT00385736|474616937|FG000|Safety Analysis Set|Adverse Event|23|||
131818513|NCT00385736|474616938|FG001|Safety Analysis Set|Adverse Event|15|||
131818514|NCT00385736|474616939|FG002|Safety Analysis Set|Adverse Event|23|||
131818515|NCT00385736|474616937|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
131818516|NCT00385736|474616938|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
131818517|NCT00385736|474616939|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
131818518|NCT00385736|474616937|FG000|Safety Analysis Set|Lost to Follow-up|0|||
131818519|NCT00385736|474616938|FG001|Safety Analysis Set|Lost to Follow-up|2|||
131818520|NCT00385736|474616939|FG002|Safety Analysis Set|Lost to Follow-up|2|||
131818521|NCT00385736|474616937|FG000|Safety Analysis Set|Lack of Efficacy|38|||
131818522|NCT00385736|474616938|FG001|Safety Analysis Set|Lack of Efficacy|16|||
131818523|NCT00385736|474616939|FG002|Safety Analysis Set|Lack of Efficacy|31|||
131818524|NCT00385736|474616937|FG000|Safety Analysis Set|Protocol Violation|2|||
131818525|NCT00385736|474616938|FG001|Safety Analysis Set|Protocol Violation|1|||
131818526|NCT00385736|474616939|FG002|Safety Analysis Set|Protocol Violation|6|||
131818527|NCT00385736|474616937|FG000|Safety Analysis Set|Other|1|||
131818528|NCT00385736|474616938|FG001|Safety Analysis Set|Other|4|||
131818529|NCT00385736|474616939|FG002|Safety Analysis Set|Other|4|||
131818530|NCT01456962|474616940|FG000|Overall Study|Lost to Follow-up|2|||
131818531|NCT01456962|474616941|FG001|Overall Study|Lost to Follow-up|1|||
131818532|NCT01853176|474616943|FG000|Overall Study|Study terminated|4|||
131818533|NCT01853176|474616944|FG001|Overall Study|Study terminated|0|||
131818534|NCT00198133|474616945|FG000|Overall Study|Disease progression|2|||
131818535|NCT00198133|474616946|FG001|Overall Study|Disease progression|5|||
131818536|NCT00198133|474616945|FG000|Overall Study|Adverse Event|1|||
131818537|NCT00198133|474616946|FG001|Overall Study|Adverse Event|3|||
131818538|NCT00198133|474616945|FG000|Overall Study|Withdrawal by Subject|1|||
131818539|NCT00198133|474616946|FG001|Overall Study|Withdrawal by Subject|0|||
131818540|NCT00198133|474616945|FG000|Overall Study|Physician Decision|1|||
131818541|NCT00198133|474616946|FG001|Overall Study|Physician Decision|0|||
131818542|NCT00835666|474616950|FG000|Washout|Protocol Violation|1|||
131818543|NCT00835666|474616951|FG001|Washout|Protocol Violation|0|||
131818544|NCT00835666|474616950|FG000|Washout|Withdrawal by Subject|1|||
131818545|NCT00835666|474616951|FG001|Washout|Withdrawal by Subject|0|||
131818546|NCT03707587|474616955|FG000|Overall Study|Death|0|||
131818547|NCT03707587|474616956|FG001|Overall Study|Death|1|||
131818548|NCT03358147|474616957|FG000|Overall Study|Withdrawal by Subject|13|||
131818549|NCT03358147|474616958|FG001|Overall Study|Withdrawal by Subject|19|||
131818550|NCT03358147|474616959|FG002|Overall Study|Withdrawal by Subject|16|||
131818551|NCT03358147|474616960|FG003|Overall Study|Withdrawal by Subject|10|||
131818552|NCT03358147|474616961|FG004|Overall Study|Withdrawal by Subject|5|||
131818553|NCT03358147|474616957|FG000|Overall Study|Adverse Event|3|||
131818554|NCT03358147|474616958|FG001|Overall Study|Adverse Event|9|||
131818555|NCT03358147|474616959|FG002|Overall Study|Adverse Event|7|||
131818556|NCT03358147|474616960|FG003|Overall Study|Adverse Event|5|||
131818557|NCT03358147|474616961|FG004|Overall Study|Adverse Event|2|||
131818558|NCT03358147|474616957|FG000|Overall Study|Lost to Follow-up|4|||
131818559|NCT03358147|474616958|FG001|Overall Study|Lost to Follow-up|3|||
131818560|NCT03358147|474616959|FG002|Overall Study|Lost to Follow-up|7|||
131818561|NCT03358147|474616960|FG003|Overall Study|Lost to Follow-up|6|||
131818562|NCT03358147|474616961|FG004|Overall Study|Lost to Follow-up|4|||
131818563|NCT03358147|474616957|FG000|Overall Study|Major Protocol Deviation|11|||
131818564|NCT03358147|474616958|FG001|Overall Study|Major Protocol Deviation|3|||
131818565|NCT03358147|474616959|FG002|Overall Study|Major Protocol Deviation|2|||
131818566|NCT03358147|474616960|FG003|Overall Study|Major Protocol Deviation|3|||
131818567|NCT03358147|474616961|FG004|Overall Study|Major Protocol Deviation|1|||
131818568|NCT03358147|474616957|FG000|Overall Study|Protocol specified criteria|2|||
131400833|NCT05596734|473089646|FG004|Substudy A|Withdrawal by Subject|0|||
131400834|NCT05596734|473089647|FG005|Substudy A|Withdrawal by Subject|0|||
131400835|NCT05596734|473089648|FG006|Substudy A|Withdrawal by Subject|1|||
131400836|NCT05596734|473089649|FG007|Substudy A|Withdrawal by Subject|0|||
131818569|NCT03358147|474616958|FG001|Overall Study|Protocol specified criteria|3|||
131818570|NCT03358147|474616959|FG002|Overall Study|Protocol specified criteria|0|||
131818571|NCT03358147|474616960|FG003|Overall Study|Protocol specified criteria|3|||
131818572|NCT03358147|474616961|FG004|Overall Study|Protocol specified criteria|1|||
131818573|NCT03358147|474616957|FG000|Overall Study|Physician Decision|1|||
131818574|NCT03358147|474616958|FG001|Overall Study|Physician Decision|0|||
131818575|NCT03358147|474616959|FG002|Overall Study|Physician Decision|1|||
131818576|NCT03358147|474616960|FG003|Overall Study|Physician Decision|6|||
131818577|NCT03358147|474616961|FG004|Overall Study|Physician Decision|1|||
131818578|NCT03358147|474616957|FG000|Overall Study|Administrative reasons|0|||
131818579|NCT03358147|474616958|FG001|Overall Study|Administrative reasons|1|||
131818580|NCT03358147|474616959|FG002|Overall Study|Administrative reasons|0|||
131818581|NCT03358147|474616960|FG003|Overall Study|Administrative reasons|3|||
131818582|NCT03358147|474616961|FG004|Overall Study|Administrative reasons|0|||
131818583|NCT03358147|474616957|FG000|Overall Study|Lack of Efficacy|0|||
131818584|NCT03358147|474616958|FG001|Overall Study|Lack of Efficacy|1|||
131818585|NCT03358147|474616959|FG002|Overall Study|Lack of Efficacy|1|||
131818586|NCT03358147|474616960|FG003|Overall Study|Lack of Efficacy|0|||
131818587|NCT03358147|474616961|FG004|Overall Study|Lack of Efficacy|0|||
131818588|NCT00731939|474616962|FG000|Overall Study|Adverse Event|6|||
131818589|NCT00731939|474616962|FG000|Overall Study|Lost to Follow-up|15|||
131818590|NCT00731939|474616962|FG000|Overall Study|Not implanted with study device|9|||
131818591|NCT00731939|474616962|FG000|Overall Study|Withdrawal by Subject|2|||
131818592|NCT00731939|474616962|FG000|Overall Study|Did not meet enrollment criteria|2|||
131818593|NCT01634139|474616963|FG000|Overall Study|Non compliant with protocol|1|||
131818594|NCT01634139|474616964|FG001|Overall Study|Non compliant with protocol|0|||
131818595|NCT01634139|474616965|FG002|Overall Study|Non compliant with protocol|0|||
131818596|NCT01634139|474616963|FG000|Overall Study|Consent withdrawn not due to AE|4|||
131818597|NCT01634139|474616964|FG001|Overall Study|Consent withdrawn not due to AE|3|||
131818598|NCT01634139|474616965|FG002|Overall Study|Consent withdrawn not due to AE|2|||
131818599|NCT01634139|474616963|FG000|Overall Study|Other|4|||
131818600|NCT01634139|474616964|FG001|Overall Study|Other|0|||
131818601|NCT01634139|474616965|FG002|Overall Study|Other|3|||
131818602|NCT01634139|474616963|FG000|Overall Study|Lost to Follow-up|0|||
131818603|NCT01634139|474616964|FG001|Overall Study|Lost to Follow-up|2|||
131818604|NCT01634139|474616965|FG002|Overall Study|Lost to Follow-up|0|||
131818605|NCT01634139|474616963|FG000|Overall Study|Not treated|1|||
131818606|NCT01634139|474616964|FG001|Overall Study|Not treated|1|||
131818607|NCT01634139|474616965|FG002|Overall Study|Not treated|0|||
131818608|NCT01266902|474616969|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
131818609|NCT01266902|474616970|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
131818610|NCT01266902|474616971|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
131818611|NCT01266902|474616969|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
131818612|NCT01266902|474616970|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
131818613|NCT01266902|474616971|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
131818614|NCT01266902|474616969|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
131818615|NCT01266902|474616970|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
131818616|NCT01266902|474616971|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
131818617|NCT01266902|474616969|FG000|Period 1 (Main Study)|Adverse Event|3|||
131818618|NCT01266902|474616970|FG001|Period 1 (Main Study)|Adverse Event|11|||
131818619|NCT01266902|474616971|FG002|Period 1 (Main Study)|Adverse Event|0|||
131818620|NCT01266902|474616969|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
131818621|NCT01266902|474616970|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
131818622|NCT01266902|474616971|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
131818623|NCT01266902|474616969|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
131818624|NCT01266902|474616970|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
131818625|NCT01266902|474616971|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
131818626|NCT01266902|474616969|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
131818627|NCT01266902|474616970|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
131818628|NCT01266902|474616971|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
131818629|NCT01266902|474616969|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
131818630|NCT01266902|474616970|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
131818631|NCT01266902|474616971|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
131818632|NCT01266902|474616969|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
131818633|NCT01266902|474616970|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
131818634|NCT01266902|474616971|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
131818635|NCT01266902|474616969|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
131818636|NCT01266902|474616970|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
131818637|NCT01266902|474616971|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
131818638|NCT00387153|474616972|FG000|Overall Study|Adverse Event|1|||
131818639|NCT00387153|474616972|FG000|Overall Study|Disease Progression|3|||
131818640|NCT00387153|474616972|FG000|Overall Study|Lack of Response|4|||
131818641|NCT02933060|474616973|FG000|Overall Study|Withdrawal by Subject|0|||
131818642|NCT02933060|474616974|FG001|Overall Study|Withdrawal by Subject|1|||
131818643|NCT05034874|474616977|FG000|Overall Study|Withdrawal by Subject|6|||
131818644|NCT05034874|474616978|FG001|Overall Study|Withdrawal by Subject|6|||
131818645|NCT05034874|474616977|FG000|Overall Study|Lost to Follow-up|18|||
131818646|NCT05034874|474616978|FG001|Overall Study|Lost to Follow-up|8|||
131818647|NCT05034874|474616977|FG000|Overall Study|Physician Decision|0|||
131818648|NCT05034874|474616978|FG001|Overall Study|Physician Decision|1|||
131818649|NCT05034874|474616977|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
131818650|NCT05034874|474616978|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
131818651|NCT00989950|474616979|FG000|Randomized Phase|Protocol Violation|1|||
131818652|NCT00989950|474616980|FG001|Randomized Phase|Protocol Violation|0|||
131818653|NCT00989950|474616981|FG002|Randomized Phase|Protocol Violation|0|||
131909874|NCT00485303|474958684|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
131909875|NCT00485303|474958684|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
131909876|NCT01401322|474958685|FG000|Overall Study|Withdrawal by Subject|1|||
131818654|NCT00989950|474616982|FG003|Randomized Phase|Protocol Violation|0|||
131818655|NCT00989950|474616979|FG000|Randomized Phase|Adverse Event|0|||
131818656|NCT00989950|474616980|FG001|Randomized Phase|Adverse Event|1|||
131818657|NCT00989950|474616981|FG002|Randomized Phase|Adverse Event|0|||
131818658|NCT00989950|474616982|FG003|Randomized Phase|Adverse Event|0|||
131818659|NCT00101439|474616983|FG000|Period 2|Withdrawal by Subject|0|||
131818660|NCT00101439|474616984|FG001|Period 2|Withdrawal by Subject|2|||
131818661|NCT00840658|474616986|FG000|Overall Study|Death|2|||
131818662|NCT00840658|474616987|FG001|Overall Study|Death|2|||
131818663|NCT00840658|474616988|FG002|Overall Study|Death|3|||
131818664|NCT00840658|474616989|FG003|Overall Study|Death|3|||
131818665|NCT00840658|474616986|FG000|Overall Study|Lost to Follow-up|3|||
131818666|NCT00840658|474616987|FG001|Overall Study|Lost to Follow-up|1|||
131818667|NCT00840658|474616988|FG002|Overall Study|Lost to Follow-up|2|||
131818668|NCT00840658|474616989|FG003|Overall Study|Lost to Follow-up|1|||
131818669|NCT01867658|474616990|FG000|Overall Study|Withdrawal by Subject|6|||
131818670|NCT01867658|474616990|FG000|Overall Study|Death|2|||
131818671|NCT01867658|474616990|FG000|Overall Study|Subject could not be contacted|1|||
131818672|NCT02426918|474616995|FG000|Overall Study|Adverse Event|2|||
131818673|NCT02426918|474616996|FG001|Overall Study|Adverse Event|2|||
131818674|NCT02426918|474616997|FG002|Overall Study|Adverse Event|0|||
131818675|NCT02426918|474616995|FG000|Overall Study|Physician Decision|1|||
131818676|NCT02426918|474616996|FG001|Overall Study|Physician Decision|1|||
131818677|NCT02426918|474616997|FG002|Overall Study|Physician Decision|1|||
131818678|NCT02426918|474616995|FG000|Overall Study|Withdrawal by Subject|5|||
131818679|NCT02426918|474616996|FG001|Overall Study|Withdrawal by Subject|5|||
131818680|NCT02426918|474616997|FG002|Overall Study|Withdrawal by Subject|4|||
131818681|NCT02426918|474616995|FG000|Overall Study|Other|9|||
131818682|NCT02426918|474616996|FG001|Overall Study|Other|11|||
131818683|NCT02426918|474616997|FG002|Overall Study|Other|9|||
131818684|NCT02420353|474617004|FG000|Overall Study|Withdrawal by Subject|0|||
131818685|NCT02420353|474617005|FG001|Overall Study|Withdrawal by Subject|1|||
131818686|NCT04608448|474617006|FG000|Overall Study|Withdrawal by Subject|1|||
131818687|NCT04608448|474617006|FG000|Overall Study|Adverse Event|1|||
131818688|NCT00654186|474617007|FG000|Overall Study|Withdrawal by Subject|5|||
131818689|NCT05616728|474617008|FG000|Overall Study|Lost to Follow-up|0|||
131818690|NCT05616728|474617009|FG001|Overall Study|Lost to Follow-up|0|||
131818691|NCT05616728|474617010|FG002|Overall Study|Lost to Follow-up|1|||
131818692|NCT05616728|474617008|FG000|Overall Study|Withdrawal by Subject|1|||
131818693|NCT05616728|474617009|FG001|Overall Study|Withdrawal by Subject|1|||
131818694|NCT05616728|474617010|FG002|Overall Study|Withdrawal by Subject|0|||
131818695|NCT05616728|474617008|FG000|Overall Study|Physician Decision|1|||
131818696|NCT05616728|474617009|FG001|Overall Study|Physician Decision|1|||
131818697|NCT05616728|474617010|FG002|Overall Study|Physician Decision|1|||
131818698|NCT05616728|474617008|FG000|Overall Study|Other|0|||
131818699|NCT05616728|474617009|FG001|Overall Study|Other|2|||
131818700|NCT05616728|474617010|FG002|Overall Study|Other|0|||
131818701|NCT01024855|474617013|FG000|Overall Study|Inclusion/exclusion criteria|1|||
131818702|NCT03306277|474617018|FG000|Overall Study|Death|1|||
131818703|NCT03306277|474617018|FG000|Overall Study|Adverse Event|1|||
131818704|NCT03306277|474617018|FG000|Overall Study|Withdrawal by Subject|1|||
131818705|NCT01370863|474617019|FG000|Overall Study|Adverse Event|1|||
131818706|NCT01370863|474617020|FG001|Overall Study|Adverse Event|1|||
131818707|NCT01370863|474617019|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
131818708|NCT01370863|474617020|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
131818709|NCT01370863|474617019|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131909877|NCT01401322|474958685|FG000|Overall Study|Physician Decision|1|||
131909878|NCT00087178|474958686|FG000|Overall Study|No follow up data|5|||
131909879|NCT00087178|474958687|FG001|Overall Study|No follow up data|15|||
131818710|NCT01370863|474617020|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131818711|NCT01143337|474617021|FG000|Overall Study|Adverse Event|3|||
131818712|NCT01143337|474617022|FG001|Overall Study|Adverse Event|9|||
131818713|NCT01143337|474617023|FG002|Overall Study|Adverse Event|5|||
131818714|NCT01143337|474617021|FG000|Overall Study|Lack of Efficacy|6|||
131818715|NCT01143337|474617022|FG001|Overall Study|Lack of Efficacy|2|||
131818716|NCT01143337|474617023|FG002|Overall Study|Lack of Efficacy|1|||
131818717|NCT01143337|474617021|FG000|Overall Study|Protocol Violation|1|||
131818718|NCT01143337|474617022|FG001|Overall Study|Protocol Violation|0|||
131818719|NCT01143337|474617023|FG002|Overall Study|Protocol Violation|0|||
131818720|NCT01143337|474617021|FG000|Overall Study|Withdrawal by Subject|0|||
131818721|NCT01143337|474617022|FG001|Overall Study|Withdrawal by Subject|0|||
131818722|NCT01143337|474617023|FG002|Overall Study|Withdrawal by Subject|1|||
131818723|NCT01143337|474617021|FG000|Overall Study|Other reason|0|||
131818724|NCT01143337|474617022|FG001|Overall Study|Other reason|0|||
131818725|NCT01143337|474617023|FG002|Overall Study|Other reason|5|||
131818726|NCT00406393|474617033|FG000|Overall Study|Did not undergo transplantation|2|||
131818727|NCT00406393|474617034|FG001|Overall Study|Did not undergo transplantation|1|||
131818728|NCT01597791|474617035|FG000|Overall Study|Physician Decision|2|||
131818729|NCT01597791|474617036|FG001|Overall Study|Physician Decision|1|||
131818730|NCT01597791|474617035|FG000|Overall Study|Cesarean Section|6|||
131818731|NCT01597791|474617036|FG001|Overall Study|Cesarean Section|7|||
131818732|NCT01597791|474617035|FG000|Overall Study|Subject withdrawal|0|||
131818733|NCT01597791|474617036|FG001|Overall Study|Subject withdrawal|1|||
131818734|NCT01597791|474617035|FG000|Overall Study|Protocol Violation|0|||
131818735|NCT01597791|474617036|FG001|Overall Study|Protocol Violation|1|||
131818736|NCT01087502|474617037|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
131818737|NCT01087502|474617038|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
131818738|NCT01087502|474617037|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
131818739|NCT01087502|474617038|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
131818740|NCT01087502|474617037|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
131818741|NCT01087502|474617038|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
131818742|NCT01087502|474617037|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
131818743|NCT01087502|474617038|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
131818744|NCT01087502|474617037|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
131818745|NCT01087502|474617038|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
131818746|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
131818747|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
131818748|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
131818749|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
131818750|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
131818751|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
131818752|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
131818753|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
131818754|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
131818755|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
131818756|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
131818757|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
131818758|NCT01087502|474617037|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
131818759|NCT01087502|474617038|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
131818760|NCT01151618|474617039|FG000|Overall Study|Adverse Event|2|||
131818761|NCT01151618|474617039|FG000|Overall Study|Withdrawal by Subject|7|||
131818762|NCT01632306|474617040|FG000|Overall Study|Protocol Violation|1|||
131818763|NCT01632306|474617041|FG001|Overall Study|Protocol Violation|0|||
131818764|NCT01632306|474617042|FG002|Overall Study|Protocol Violation|0|||
131818765|NCT01663896|474617045|FG000|Overall Study|Various reasons|43|||
131818766|NCT01451541|474617046|FG000|Overall Study|Adverse Event|4|||
131818767|NCT01451541|474617047|FG001|Overall Study|Adverse Event|3|||
131818768|NCT01451541|474617048|FG002|Overall Study|Adverse Event|6|||
131818769|NCT01451541|474617046|FG000|Overall Study|Lack of Efficacy|2|||
131818770|NCT01451541|474617047|FG001|Overall Study|Lack of Efficacy|0|||
131818771|NCT01451541|474617048|FG002|Overall Study|Lack of Efficacy|0|||
131818772|NCT01451541|474617046|FG000|Overall Study|Lost to Follow-up|4|||
131818773|NCT01451541|474617047|FG001|Overall Study|Lost to Follow-up|4|||
131818774|NCT01451541|474617048|FG002|Overall Study|Lost to Follow-up|7|||
131818775|NCT01451541|474617046|FG000|Overall Study|Withdrawal by Subject|15|||
131818776|NCT01451541|474617047|FG001|Overall Study|Withdrawal by Subject|8|||
131818777|NCT01451541|474617048|FG002|Overall Study|Withdrawal by Subject|6|||
131818778|NCT01451541|474617046|FG000|Overall Study|randomization error, noncompliance|11|||
131818779|NCT01451541|474617047|FG001|Overall Study|randomization error, noncompliance|10|||
131818780|NCT01451541|474617048|FG002|Overall Study|randomization error, noncompliance|8|||
131818781|NCT03366428|474617049|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
131818782|NCT03366428|474617049|FG000|Overall Study|Adverse Event|12|||
131818783|NCT03366428|474617049|FG000|Overall Study|Clinical progression|2|||
131818784|NCT03366428|474617049|FG000|Overall Study|Withdrawal by Subject|4|||
131818785|NCT01046084|474617053|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
131818786|NCT01046084|474617054|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
131818787|NCT03614728|474617055|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
131818788|NCT03614728|474617056|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
131818789|NCT03614728|474617057|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
131818790|NCT03614728|474617058|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
131818791|NCT03614728|474617055|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
131818792|NCT03614728|474617056|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
131818793|NCT03614728|474617057|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
131818794|NCT03614728|474617058|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
131818795|NCT00379353|474617059|FG000|Overall Study|Hospitalization|3|||
131818796|NCT00379353|474617060|FG001|Overall Study|Hospitalization|3|||
131818797|NCT00379353|474617059|FG000|Overall Study|Withdrawal by Subject|5|||
131818798|NCT00379353|474617060|FG001|Overall Study|Withdrawal by Subject|2|||
131818799|NCT00379353|474617059|FG000|Overall Study|Death|1|||
131818800|NCT00379353|474617060|FG001|Overall Study|Death|0|||
131818801|NCT00379353|474617059|FG000|Overall Study|Cardiac Tamponade|1|||
131818802|NCT00379353|474617060|FG001|Overall Study|Cardiac Tamponade|0|||
131818803|NCT00379353|474617059|FG000|Overall Study|Non-compliance|1|||
131818804|NCT00379353|474617060|FG001|Overall Study|Non-compliance|0|||
131818805|NCT00379353|474617059|FG000|Overall Study|Conflicting drug treatment|0|||
131818806|NCT00379353|474617060|FG001|Overall Study|Conflicting drug treatment|1|||
131818807|NCT01824576|474617061|FG000|Overall Study|Device deficiency|2|||
131818808|NCT01958476|474617062|FG000|Overall Study|Parent requested exclusion from analysis|1|||
131818809|NCT01958476|474617063|FG001|Overall Study|Parent requested exclusion from analysis|0|||
131818810|NCT05412121|474617064|FG000|Overall Study|Withdrawal by Subject|4|||
131818811|NCT05412121|474617064|FG000|Overall Study|Physician Decision|1|||
131818812|NCT05412121|474617064|FG000|Overall Study|Lost to Follow-up|5|||
131818813|NCT03105297|474617065|FG000|Baseline Phase (Day 1)|Other|21|||
131818814|NCT03105297|474617065|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
131818815|NCT03105297|474617065|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
131818816|NCT01390948|474617066|FG000|Overall Study|End of Study|1|||
131818817|NCT01390948|474617067|FG001|Overall Study|End of Study|0|||
131818818|NCT01390948|474617068|FG002|Overall Study|End of Study|0|||
131818819|NCT01390948|474617066|FG000|Overall Study|Withdrew consent|2|||
131818820|NCT01390948|474617067|FG001|Overall Study|Withdrew consent|2|||
131818821|NCT01390948|474617068|FG002|Overall Study|Withdrew consent|0|||
131818822|NCT01390948|474617066|FG000|Overall Study|Progressive Disease|2|||
131818823|NCT01390948|474617067|FG001|Overall Study|Progressive Disease|5|||
131818824|NCT01390948|474617068|FG002|Overall Study|Progressive Disease|0|||
131818825|NCT01390948|474617066|FG000|Overall Study|Death during follow-up|10|||
131818826|NCT01390948|474617067|FG001|Overall Study|Death during follow-up|11|||
131818827|NCT01390948|474617068|FG002|Overall Study|Death during follow-up|1|||
131818828|NCT05315713|474617070|FG000|Overall Study|Death|5|||
131818829|NCT05315713|474617070|FG000|Overall Study|Progressive disease|1|||
131818830|NCT05315713|474617070|FG000|Overall Study|Withdrawal by Subject|1|||
131818831|NCT05315713|474617070|FG000|Overall Study|Study terminated by sponsor|1|||
131818832|NCT03250117|474617073|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
131400837|NCT05596734|473089650|FG008|Substudy A|Withdrawal by Subject|0|||
131400838|NCT05596734|473089651|FG009|Substudy A|Withdrawal by Subject|0|||
131400839|NCT05596734|473089652|FG010|Substudy A|Withdrawal by Subject|0|||
131400840|NCT05596734|473089653|FG011|Substudy A|Withdrawal by Subject|0|||
131818833|NCT03250117|474617074|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
131818834|NCT03250117|474617075|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
131818835|NCT03250117|474617076|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
131818836|NCT03247686|474618884|FG000|Overall Study|Withdrawal by Subject|1|||
131818837|NCT03247686|474618885|FG001|Overall Study|Withdrawal by Subject|2|||
131818838|NCT00754052|474618898|FG000|Overall Study|Study terminated by Sponsor|5|||
131818839|NCT00754052|474618899|FG001|Overall Study|Study terminated by Sponsor|3|||
131818840|NCT02658019|474618901|FG000|Overall Study|Adverse Event|1|||
131818841|NCT04364854|474618905|FG000|Overall Study|Withdrawal by Subject|1|||
131818842|NCT04364854|474618906|FG001|Overall Study|Withdrawal by Subject|0|||
131818843|NCT04364854|474618907|FG002|Overall Study|Withdrawal by Subject|1|||
131818844|NCT04364854|474618908|FG003|Overall Study|Withdrawal by Subject|3|||
131818845|NCT04364854|474618905|FG000|Overall Study|Death|1|||
131818846|NCT04364854|474618906|FG001|Overall Study|Death|0|||
131818847|NCT04364854|474618907|FG002|Overall Study|Death|0|||
131818848|NCT04364854|474618908|FG003|Overall Study|Death|0|||
131818849|NCT04364854|474618905|FG000|Overall Study|Lost to Follow-up|0|||
131818850|NCT04364854|474618906|FG001|Overall Study|Lost to Follow-up|0|||
131818851|NCT04364854|474618907|FG002|Overall Study|Lost to Follow-up|0|||
131818852|NCT04364854|474618908|FG003|Overall Study|Lost to Follow-up|1|||
131818853|NCT02583048|474618909|FG000|Overall Study|Withdrawal by Subject|0|||
131818854|NCT02583048|474618910|FG001|Overall Study|Withdrawal by Subject|1|||
131818855|NCT02583048|474618911|FG002|Overall Study|Withdrawal by Subject|0|||
131400841|NCT05596734|473089654|FG012|Substudy A|Withdrawal by Subject|0|||
131400842|NCT05596734|473089655|FG013|Substudy A|Withdrawal by Subject|0|||
131400843|NCT05596734|473089656|FG014|Substudy A|Withdrawal by Subject|0|||
131818856|NCT02583048|474618909|FG000|Overall Study|Failed to meet eligibility criterion|0|||
131818857|NCT02583048|474618910|FG001|Overall Study|Failed to meet eligibility criterion|0|||
131818858|NCT02583048|474618911|FG002|Overall Study|Failed to meet eligibility criterion|1|||
131818859|NCT01151280|474618915|FG000|Overall Study|Adverse Event|1|||
131818860|NCT01151280|474618915|FG000|Overall Study|Lack of Efficacy|3|||
131818861|NCT02435433|474618916|FG000|Overall Study|Withdrawal by Subject|2|||
131818862|NCT02435433|474618917|FG001|Overall Study|Withdrawal by Subject|3|||
131818863|NCT02435433|474618918|FG002|Overall Study|Withdrawal by Subject|1|||
131818864|NCT02435433|474618919|FG003|Overall Study|Withdrawal by Subject|0|||
131818865|NCT02435433|474618920|FG004|Overall Study|Withdrawal by Subject|0|||
131818866|NCT02435433|474618916|FG000|Overall Study|Lost to Follow-up|2|||
131818867|NCT02435433|474618917|FG001|Overall Study|Lost to Follow-up|2|||
131909880|NCT00087178|474958686|FG000|Overall Study|No clinical assessment|1|||
131818868|NCT02435433|474618918|FG002|Overall Study|Lost to Follow-up|4|||
131818869|NCT02435433|474618919|FG003|Overall Study|Lost to Follow-up|1|||
131818870|NCT02435433|474618920|FG004|Overall Study|Lost to Follow-up|0|||
131818871|NCT01243151|474618921|FG000|Overall Study|Adverse Event|0|||
131818872|NCT01243151|474618922|FG001|Overall Study|Adverse Event|1|||
131818873|NCT01243151|474618923|FG002|Overall Study|Adverse Event|0|||
131818874|NCT01243151|474618924|FG003|Overall Study|Adverse Event|0|||
131818875|NCT01243151|474618925|FG004|Overall Study|Adverse Event|0|||
131818876|NCT01243151|474618921|FG000|Overall Study|Protocol Violation|0|||
131818877|NCT01243151|474618922|FG001|Overall Study|Protocol Violation|0|||
131818878|NCT01243151|474618923|FG002|Overall Study|Protocol Violation|1|||
131818879|NCT01243151|474618924|FG003|Overall Study|Protocol Violation|0|||
131818880|NCT01243151|474618925|FG004|Overall Study|Protocol Violation|0|||
131818881|NCT01243151|474618921|FG000|Overall Study|Other|0|||
131818882|NCT01243151|474618922|FG001|Overall Study|Other|0|||
131818883|NCT01243151|474618923|FG002|Overall Study|Other|0|||
131818884|NCT01243151|474618924|FG003|Overall Study|Other|1|||
131818885|NCT01243151|474618925|FG004|Overall Study|Other|0|||
131818886|NCT01243151|474618921|FG000|Overall Study|Randomized but not treated|0|||
131818887|NCT01243151|474618922|FG001|Overall Study|Randomized but not treated|0|||
131818888|NCT01243151|474618923|FG002|Overall Study|Randomized but not treated|0|||
131818889|NCT01243151|474618924|FG003|Overall Study|Randomized but not treated|1|||
131818890|NCT01243151|474618925|FG004|Overall Study|Randomized but not treated|0|||
131818891|NCT00757705|474618926|FG000|Overall Study|Adverse Event|19|||
131818892|NCT00757705|474618926|FG000|Overall Study|Lost to Follow-up|16|||
131818893|NCT00757705|474618926|FG000|Overall Study|Withdrawal by Subject|25|||
131818894|NCT00757705|474618926|FG000|Overall Study|Insufficient Response|26|||
131818895|NCT00757705|474618926|FG000|Overall Study|Ineligible to continue|8|||
131818896|NCT00757705|474618926|FG000|Overall Study|Non-compliant|9|||
131818897|NCT00757705|474618926|FG000|Overall Study|Other|18|||
131818898|NCT00659815|474618929|FG000|Overall Study|Study related symptoms and complaints|2|||
131818899|NCT00659815|474618930|FG001|Overall Study|Study related symptoms and complaints|1|||
131818900|NCT00659815|474618929|FG000|Overall Study|Inability to maintain wearing schedule|1|||
131818901|NCT00659815|474618930|FG001|Overall Study|Inability to maintain wearing schedule|2|||
131818902|NCT00659815|474618929|FG000|Overall Study|Withdrawal by Subject|1|||
131818903|NCT00659815|474618930|FG001|Overall Study|Withdrawal by Subject|1|||
131818904|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
131818905|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
131818906|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
131818907|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
131818908|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
131818909|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
131818910|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
131818911|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
131818912|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
131818913|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
131818914|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
131818915|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
131818916|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
131818917|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
131818918|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
131818919|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
131818920|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
131818921|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
131818922|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
131818923|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
131818924|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
131818925|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
131818926|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
131818927|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
131818928|NCT01710358|474618931|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
131818929|NCT01710358|474618932|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
131818930|NCT01710358|474618933|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
131818931|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
131818932|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
131818933|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
131818934|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
131818935|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
131818936|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
131400844|NCT05596734|473089657|FG015|Substudy A|Withdrawal by Subject|0|||
131400845|NCT05596734|473089658|FG016|Substudy A|Withdrawal by Subject|0|||
131818937|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
131818938|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
131818939|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
131818940|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
131818941|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
131818942|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
131818943|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
131818944|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
131818945|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
131818946|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
131818947|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
131818948|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
131818949|NCT01710358|474618931|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
131818950|NCT01710358|474618932|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
131818951|NCT01710358|474618933|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
131818952|NCT01710358|474618931|FG000|Rescue Period|Adverse Event|0|||
131818953|NCT01710358|474618932|FG001|Rescue Period|Adverse Event|15|||
131818954|NCT01710358|474618933|FG002|Rescue Period|Adverse Event|0|||
131818955|NCT01710358|474618931|FG000|Rescue Period|Death|0|||
131818956|NCT01710358|474618932|FG001|Rescue Period|Death|1|||
131818957|NCT01710358|474618933|FG002|Rescue Period|Death|0|||
131818958|NCT01710358|474618931|FG000|Rescue Period|Lack of Efficacy|0|||
131818959|NCT01710358|474618932|FG001|Rescue Period|Lack of Efficacy|7|||
131818960|NCT01710358|474618933|FG002|Rescue Period|Lack of Efficacy|0|||
131818961|NCT01710358|474618931|FG000|Rescue Period|Withdrawal by Subject|0|||
131818962|NCT01710358|474618932|FG001|Rescue Period|Withdrawal by Subject|8|||
131818963|NCT01710358|474618933|FG002|Rescue Period|Withdrawal by Subject|0|||
131818964|NCT00396162|474618941|FG000|Overall Study|Withdrawal by Subject|2|||
131818965|NCT00396162|474618942|FG001|Overall Study|Withdrawal by Subject|3|||
131818966|NCT01741545|474618943|FG000|Treatment Period|Lack of Efficacy|0|||
131818967|NCT01741545|474618944|FG001|Treatment Period|Lack of Efficacy|1|||
131818968|NCT01741545|474618943|FG000|Treatment Period|Adverse event, non-fatal|1|||
131818969|NCT01741545|474618944|FG001|Treatment Period|Adverse event, non-fatal|3|||
131818970|NCT01741545|474618943|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
131818971|NCT01741545|474618944|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
131818972|NCT01741545|474618943|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
131818973|NCT01741545|474618944|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
131818974|NCT03540160|474618945|FG000|Overall Study|Protocol Violation|1|||
131818975|NCT03540160|474618945|FG000|Overall Study|Physician Decision|8|||
131818976|NCT03540160|474618945|FG000|Overall Study|Lack of Efficacy|60|||
131818977|NCT03540160|474618945|FG000|Overall Study|Pregnancy|1|||
131818978|NCT03540160|474618945|FG000|Overall Study|Adverse Event|20|||
131818979|NCT03540160|474618945|FG000|Overall Study|Withdrawal by Subject|68|||
131818980|NCT03540160|474618945|FG000|Overall Study|COVID-19|2|||
131818981|NCT03540160|474618945|FG000|Overall Study|Study Closure|10|||
131818982|NCT03540160|474618945|FG000|Overall Study|Lost to Follow-up|18|||
131818983|NCT03540160|474618945|FG000|Overall Study|Sponsor decision|191|||
131818984|NCT01664039|474618948|FG000|Overall Study|Adverse Event|3|||
131818985|NCT01664039|474618949|FG001|Overall Study|Adverse Event|4|||
131818986|NCT01664039|474618948|FG000|Overall Study|Lost to Follow-up|1|||
131818987|NCT01664039|474618949|FG001|Overall Study|Lost to Follow-up|1|||
131818988|NCT01664039|474618948|FG000|Overall Study|Withdrawal by Subject|1|||
131818989|NCT01664039|474618949|FG001|Overall Study|Withdrawal by Subject|3|||
131818990|NCT01664039|474618948|FG000|Overall Study|Noncompliance|1|||
131818991|NCT01664039|474618949|FG001|Overall Study|Noncompliance|1|||
131818992|NCT02704091|474618952|FG000|Overall Study|Adverse Event|4|||
131818993|NCT02704091|474618953|FG001|Overall Study|Adverse Event|3|||
131818994|NCT02704091|474618952|FG000|Overall Study|Protocol Violation|5|||
131818995|NCT02704091|474618953|FG001|Overall Study|Protocol Violation|3|||
131818996|NCT02704091|474618952|FG000|Overall Study|Consent withdrawn|4|||
131818997|NCT02704091|474618953|FG001|Overall Study|Consent withdrawn|4|||
131818998|NCT02704091|474618952|FG000|Overall Study|Lost to Follow-up|13|||
131909881|NCT00087178|474958687|FG001|Overall Study|No clinical assessment|2|||
131818999|NCT02704091|474618953|FG001|Overall Study|Lost to Follow-up|5|||
131819000|NCT02704091|474618952|FG000|Overall Study|Other|2|||
131819001|NCT02704091|474618953|FG001|Overall Study|Other|8|||
131819002|NCT01149057|474618959|FG000|Overall Study|Lack of Efficacy|16|||
131819003|NCT01149057|474618959|FG000|Overall Study|Adverse Event|13|||
131819004|NCT01149057|474618959|FG000|Overall Study|Withdrawal by Subject|9|||
131819005|NCT01149057|474618959|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
131819006|NCT01149057|474618959|FG000|Overall Study|B Cell Depletion|4|||
131819007|NCT01149057|474618959|FG000|Overall Study|Participant Non-Compliance|2|||
131819008|NCT01149057|474618959|FG000|Overall Study|Lost to Follow-up|1|||
131819009|NCT01149057|474618959|FG000|Overall Study|High Parathyroid Hormone Value|1|||
131819010|NCT01149057|474618959|FG000|Overall Study|Other|6|||
131819011|NCT00577655|474618960|FG000|Overall Study|Patient Request|0|||
131819012|NCT00577655|474618961|FG001|Overall Study|Patient Request|2|||
131819013|NCT00577655|474618960|FG000|Overall Study|Protocol Violation|0|||
131819014|NCT00577655|474618961|FG001|Overall Study|Protocol Violation|1|||
131819015|NCT00577655|474618960|FG000|Overall Study|Lost to Follow-up|1|||
131819016|NCT00577655|474618961|FG001|Overall Study|Lost to Follow-up|1|||
131819017|NCT00875524|474618963|FG000|Overall Study|Serious adverse event|0|||
131819018|NCT00875524|474618964|FG001|Overall Study|Serious adverse event|1|||
131819019|NCT00875524|474618963|FG000|Overall Study|Protocol Violation|4|||
131819020|NCT00875524|474618964|FG001|Overall Study|Protocol Violation|0|||
131819021|NCT00875524|474618963|FG000|Overall Study|Lost to Follow-up|1|||
131819022|NCT00875524|474618964|FG001|Overall Study|Lost to Follow-up|0|||
131819023|NCT00875524|474618963|FG000|Overall Study|Withdrawal by Subject|3|||
131819024|NCT00875524|474618964|FG001|Overall Study|Withdrawal by Subject|5|||
131819025|NCT02166606|474618965|FG000|Overall Study|Adverse Event|3|||
131819026|NCT02166606|474618965|FG000|Overall Study|Death|31|||
131819027|NCT02166606|474618965|FG000|Overall Study|Protocol Violation|7|||
131819028|NCT02166606|474618965|FG000|Overall Study|Lost to Follow-up|30|||
131819029|NCT02166606|474618965|FG000|Overall Study|Withdrawal by Subject|1|||
131819030|NCT02166606|474618965|FG000|Overall Study|Physician Decision|1|||
131819031|NCT02166606|474618965|FG000|Overall Study|Device upgrade|1|||
131819032|NCT02166606|474618965|FG000|Overall Study|Enrolled after End of Enrollment|4|||
131819033|NCT00537095|474618970|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
131819034|NCT00537095|474618971|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
131819035|NCT00537095|474618970|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
131819036|NCT00537095|474618971|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
131819037|NCT00537095|474618970|FG000|Randomized Treatment Period (433 Days)|Death|3|||
131819038|NCT00537095|474618971|FG001|Randomized Treatment Period (433 Days)|Death|1|||
131819039|NCT00537095|474618970|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
131819040|NCT00537095|474618971|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
131819041|NCT00537095|474618970|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
131819042|NCT00537095|474618971|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
131819043|NCT00537095|474618970|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
131819044|NCT00537095|474618971|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
131819045|NCT00537095|474618970|FG000|Open-label Period (590 Days)|Adverse Event|2|||
131819046|NCT00537095|474618971|FG001|Open-label Period (590 Days)|Adverse Event|11|||
131819047|NCT00537095|474618970|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
131819048|NCT00537095|474618971|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
131819049|NCT00537095|474618970|FG000|Open-label Period (590 Days)|Death|2|||
131819050|NCT00537095|474618971|FG001|Open-label Period (590 Days)|Death|2|||
131819051|NCT00537095|474618970|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
131819052|NCT00537095|474618971|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
131819053|NCT00537095|474618970|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
131819054|NCT00537095|474618971|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
131819055|NCT00566722|474618972|FG000|Overall Study|Adverse Event|0|||
131819056|NCT00566722|474618973|FG001|Overall Study|Adverse Event|1|||
131819057|NCT00566722|474618974|FG002|Overall Study|Adverse Event|0|||
131819058|NCT00566722|474618972|FG000|Overall Study|Withdrawal by Subject|0|||
131819059|NCT00566722|474618973|FG001|Overall Study|Withdrawal by Subject|0|||
131819060|NCT00566722|474618974|FG002|Overall Study|Withdrawal by Subject|1|||
131819061|NCT00566722|474618972|FG000|Overall Study|Lost to Follow-up|1|||
131819062|NCT00566722|474618973|FG001|Overall Study|Lost to Follow-up|1|||
131819063|NCT00566722|474618974|FG002|Overall Study|Lost to Follow-up|1|||
131819064|NCT00566722|474618972|FG000|Overall Study|Lack of Efficacy|1|||
131819065|NCT00566722|474618973|FG001|Overall Study|Lack of Efficacy|2|||
131819066|NCT00566722|474618974|FG002|Overall Study|Lack of Efficacy|4|||
131819067|NCT00566722|474618972|FG000|Overall Study|Did not meet exclusion criteria|0|||
131819068|NCT00566722|474618973|FG001|Overall Study|Did not meet exclusion criteria|0|||
131819069|NCT00566722|474618974|FG002|Overall Study|Did not meet exclusion criteria|2|||
131819070|NCT00566722|474618972|FG000|Overall Study|Serious adverse event|0|||
131819071|NCT00566722|474618973|FG001|Overall Study|Serious adverse event|1|||
131819072|NCT00566722|474618974|FG002|Overall Study|Serious adverse event|0|||
131819073|NCT00566722|474618972|FG000|Overall Study|Noncompliant with drug administration|0|||
131819074|NCT00566722|474618973|FG001|Overall Study|Noncompliant with drug administration|0|||
131819075|NCT00566722|474618974|FG002|Overall Study|Noncompliant with drug administration|1|||
131819076|NCT02611323|474618975|FG000|Overall Study|Death|3|||
131819077|NCT02611323|474618976|FG001|Overall Study|Death|1|||
131819078|NCT02611323|474618977|FG002|Overall Study|Death|0|||
131819079|NCT02611323|474618978|FG003|Overall Study|Death|0|||
131819080|NCT02611323|474618979|FG004|Overall Study|Death|1|||
131819081|NCT02611323|474618980|FG005|Overall Study|Death|1|||
131819082|NCT02611323|474618981|FG006|Overall Study|Death|8|||
131819083|NCT02611323|474618982|FG007|Overall Study|Death|0|||
131819084|NCT02611323|474618983|FG008|Overall Study|Death|4|||
131819085|NCT02611323|474618984|FG009|Overall Study|Death|6|||
131819086|NCT02611323|474618985|FG010|Overall Study|Death|26|||
131819087|NCT02611323|474618975|FG000|Overall Study|Lost to Follow-up|1|||
131819088|NCT02611323|474618976|FG001|Overall Study|Lost to Follow-up|0|||
131819089|NCT02611323|474618977|FG002|Overall Study|Lost to Follow-up|0|||
131819090|NCT02611323|474618978|FG003|Overall Study|Lost to Follow-up|0|||
131819091|NCT02611323|474618979|FG004|Overall Study|Lost to Follow-up|0|||
131819092|NCT02611323|474618980|FG005|Overall Study|Lost to Follow-up|0|||
131819093|NCT02611323|474618981|FG006|Overall Study|Lost to Follow-up|3|||
131819094|NCT02611323|474618982|FG007|Overall Study|Lost to Follow-up|0|||
131819095|NCT02611323|474618983|FG008|Overall Study|Lost to Follow-up|0|||
131819096|NCT02611323|474618984|FG009|Overall Study|Lost to Follow-up|0|||
131819097|NCT02611323|474618985|FG010|Overall Study|Lost to Follow-up|2|||
131819098|NCT02611323|474618975|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819099|NCT02611323|474618976|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819100|NCT02611323|474618977|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819101|NCT02611323|474618978|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819102|NCT02611323|474618979|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819103|NCT02611323|474618980|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819104|NCT02611323|474618981|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819105|NCT02611323|474618982|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819106|NCT02611323|474618983|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819107|NCT02611323|474618984|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
131819108|NCT02611323|474618985|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
131819109|NCT02611323|474618975|FG000|Overall Study|Progressive Disease|0|||
131819110|NCT02611323|474618976|FG001|Overall Study|Progressive Disease|0|||
131819111|NCT02611323|474618977|FG002|Overall Study|Progressive Disease|0|||
131819112|NCT02611323|474618978|FG003|Overall Study|Progressive Disease|0|||
131819113|NCT02611323|474618979|FG004|Overall Study|Progressive Disease|0|||
131819114|NCT02611323|474618980|FG005|Overall Study|Progressive Disease|0|||
131819115|NCT02611323|474618981|FG006|Overall Study|Progressive Disease|0|||
131819116|NCT02611323|474618982|FG007|Overall Study|Progressive Disease|0|||
131819117|NCT02611323|474618983|FG008|Overall Study|Progressive Disease|0|||
131819118|NCT02611323|474618984|FG009|Overall Study|Progressive Disease|0|||
131819119|NCT02611323|474618985|FG010|Overall Study|Progressive Disease|1|||
131819120|NCT02611323|474618975|FG000|Overall Study|Withdrawal by Subject|1|||
131819121|NCT02611323|474618976|FG001|Overall Study|Withdrawal by Subject|0|||
131819122|NCT02611323|474618977|FG002|Overall Study|Withdrawal by Subject|0|||
131819123|NCT02611323|474618978|FG003|Overall Study|Withdrawal by Subject|0|||
131819124|NCT02611323|474618979|FG004|Overall Study|Withdrawal by Subject|0|||
131819125|NCT02611323|474618980|FG005|Overall Study|Withdrawal by Subject|0|||
131819126|NCT02611323|474618981|FG006|Overall Study|Withdrawal by Subject|0|||
131819127|NCT02611323|474618982|FG007|Overall Study|Withdrawal by Subject|1|||
131819128|NCT02611323|474618983|FG008|Overall Study|Withdrawal by Subject|0|||
131819129|NCT02611323|474618984|FG009|Overall Study|Withdrawal by Subject|1|||
131819130|NCT02611323|474618985|FG010|Overall Study|Withdrawal by Subject|0|||
131819131|NCT02597049|474618986|FG000|Overall Study|Lost to Follow-up|0|||
131819132|NCT02597049|474618987|FG001|Overall Study|Lost to Follow-up|3|||
131819133|NCT02597049|474618988|FG002|Overall Study|Lost to Follow-up|2|||
131819134|NCT02597049|474618986|FG000|Overall Study|Withdrawal by Subject|2|||
131819135|NCT02597049|474618987|FG001|Overall Study|Withdrawal by Subject|2|||
131819136|NCT02597049|474618988|FG002|Overall Study|Withdrawal by Subject|1|||
131819137|NCT02597049|474618986|FG000|Overall Study|Adverse Event|2|||
131400846|NCT05596734|473089659|FG017|Substudy A|Withdrawal by Subject|0|||
131400847|NCT05596734|473089660|FG018|Substudy A|Withdrawal by Subject|0|||
131819138|NCT02597049|474618987|FG001|Overall Study|Adverse Event|0|||
131819139|NCT02597049|474618988|FG002|Overall Study|Adverse Event|0|||
131819140|NCT02597049|474618986|FG000|Overall Study|Death|2|||
131819141|NCT02597049|474618987|FG001|Overall Study|Death|0|||
131819142|NCT02597049|474618988|FG002|Overall Study|Death|0|||
131819143|NCT02597049|474618986|FG000|Overall Study|Noncompliant with Study Visits|1|||
131819144|NCT02597049|474618987|FG001|Overall Study|Noncompliant with Study Visits|0|||
131819145|NCT02597049|474618988|FG002|Overall Study|Noncompliant with Study Visits|0|||
131819146|NCT00243347|474618991|FG000|Overall Study|Lack of Efficacy|4|||
131819147|NCT00243347|474618991|FG000|Overall Study|Adverse Event|2|||
131819148|NCT00243347|474618991|FG000|Overall Study|Death|1|||
131819149|NCT00243347|474618991|FG000|Overall Study|Withdrawal by Subject|5|||
131819150|NCT00243347|474618991|FG000|Overall Study|Condition worsened|7|||
131819151|NCT01899053|474618994|FG000|Overall Study|Progressive Disease|4|||
131819152|NCT01899053|474618995|FG001|Overall Study|Progressive Disease|0|||
131819153|NCT01899053|474618996|FG002|Overall Study|Progressive Disease|3|||
131819154|NCT01899053|474618997|FG003|Overall Study|Progressive Disease|0|||
131819155|NCT01899053|474618998|FG004|Overall Study|Progressive Disease|3|||
131819156|NCT01899053|474618999|FG005|Overall Study|Progressive Disease|1|||
131819157|NCT01899053|474619000|FG006|Overall Study|Progressive Disease|1|||
131819158|NCT01899053|474619001|FG007|Overall Study|Progressive Disease|1|||
131819159|NCT01899053|474619002|FG008|Overall Study|Progressive Disease|4|||
131819160|NCT01899053|474619003|FG009|Overall Study|Progressive Disease|3|||
131819161|NCT01899053|474619004|FG010|Overall Study|Progressive Disease|12|||
131819162|NCT01899053|474619005|FG011|Overall Study|Progressive Disease|5|||
131819163|NCT01899053|474619006|FG012|Overall Study|Progressive Disease|8|||
131819164|NCT01899053|474619007|FG013|Overall Study|Progressive Disease|17|||
131819165|NCT01899053|474618994|FG000|Overall Study|Adverse Event|1|||
131819166|NCT01899053|474618995|FG001|Overall Study|Adverse Event|1|||
131819167|NCT01899053|474618996|FG002|Overall Study|Adverse Event|1|||
131819168|NCT01899053|474618997|FG003|Overall Study|Adverse Event|3|||
131819169|NCT01899053|474618998|FG004|Overall Study|Adverse Event|1|||
131819170|NCT01899053|474618999|FG005|Overall Study|Adverse Event|1|||
131819171|NCT01899053|474619000|FG006|Overall Study|Adverse Event|1|||
131819172|NCT01899053|474619001|FG007|Overall Study|Adverse Event|0|||
131819173|NCT01899053|474619002|FG008|Overall Study|Adverse Event|2|||
131819174|NCT01899053|474619003|FG009|Overall Study|Adverse Event|0|||
131819175|NCT01899053|474619004|FG010|Overall Study|Adverse Event|3|||
131819176|NCT01899053|474619005|FG011|Overall Study|Adverse Event|1|||
131819177|NCT01899053|474619006|FG012|Overall Study|Adverse Event|2|||
131819178|NCT01899053|474619007|FG013|Overall Study|Adverse Event|2|||
131819179|NCT01899053|474618994|FG000|Overall Study|Reason Not Specified|0|||
131819180|NCT01899053|474618995|FG001|Overall Study|Reason Not Specified|0|||
131819181|NCT01899053|474618996|FG002|Overall Study|Reason Not Specified|0|||
131819182|NCT01899053|474618997|FG003|Overall Study|Reason Not Specified|0|||
131819183|NCT01899053|474618998|FG004|Overall Study|Reason Not Specified|0|||
131819184|NCT01899053|474618999|FG005|Overall Study|Reason Not Specified|0|||
131819185|NCT01899053|474619000|FG006|Overall Study|Reason Not Specified|1|||
131819186|NCT01899053|474619001|FG007|Overall Study|Reason Not Specified|0|||
131819187|NCT01899053|474619002|FG008|Overall Study|Reason Not Specified|0|||
131819188|NCT01899053|474619003|FG009|Overall Study|Reason Not Specified|0|||
131819189|NCT01899053|474619004|FG010|Overall Study|Reason Not Specified|0|||
131819190|NCT01899053|474619005|FG011|Overall Study|Reason Not Specified|0|||
131819191|NCT01899053|474619006|FG012|Overall Study|Reason Not Specified|1|||
131819192|NCT01899053|474619007|FG013|Overall Study|Reason Not Specified|0|||
131819193|NCT01899053|474618994|FG000|Overall Study|Withdrawal by Subject|1|||
131819194|NCT01899053|474618995|FG001|Overall Study|Withdrawal by Subject|1|||
131819195|NCT01899053|474618996|FG002|Overall Study|Withdrawal by Subject|2|||
131819196|NCT01899053|474618997|FG003|Overall Study|Withdrawal by Subject|0|||
131819197|NCT01899053|474618998|FG004|Overall Study|Withdrawal by Subject|2|||
131819198|NCT01899053|474618999|FG005|Overall Study|Withdrawal by Subject|0|||
131819199|NCT01899053|474619000|FG006|Overall Study|Withdrawal by Subject|0|||
131819200|NCT01899053|474619001|FG007|Overall Study|Withdrawal by Subject|1|||
131819201|NCT01899053|474619002|FG008|Overall Study|Withdrawal by Subject|0|||
131819202|NCT01899053|474619003|FG009|Overall Study|Withdrawal by Subject|0|||
131819203|NCT01899053|474619004|FG010|Overall Study|Withdrawal by Subject|0|||
131819204|NCT01899053|474619005|FG011|Overall Study|Withdrawal by Subject|0|||
131819205|NCT01899053|474619006|FG012|Overall Study|Withdrawal by Subject|1|||
131819206|NCT01899053|474619007|FG013|Overall Study|Withdrawal by Subject|1|||
131819207|NCT01899053|474618994|FG000|Overall Study|Protocol Violation|0|||
131819208|NCT01899053|474618995|FG001|Overall Study|Protocol Violation|0|||
131819209|NCT01899053|474618996|FG002|Overall Study|Protocol Violation|1|||
131819210|NCT01899053|474618997|FG003|Overall Study|Protocol Violation|0|||
131819211|NCT01899053|474618998|FG004|Overall Study|Protocol Violation|0|||
131819212|NCT01899053|474618999|FG005|Overall Study|Protocol Violation|0|||
131819213|NCT01899053|474619000|FG006|Overall Study|Protocol Violation|0|||
131819214|NCT01899053|474619001|FG007|Overall Study|Protocol Violation|0|||
131819215|NCT01899053|474619002|FG008|Overall Study|Protocol Violation|0|||
131819216|NCT01899053|474619003|FG009|Overall Study|Protocol Violation|0|||
131819217|NCT01899053|474619004|FG010|Overall Study|Protocol Violation|0|||
131819218|NCT01899053|474619005|FG011|Overall Study|Protocol Violation|0|||
131819219|NCT01899053|474619006|FG012|Overall Study|Protocol Violation|0|||
131819220|NCT01899053|474619007|FG013|Overall Study|Protocol Violation|0|||
131819221|NCT01899053|474618994|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
131819222|NCT01899053|474618995|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
131819223|NCT01899053|474618996|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819224|NCT01899053|474618997|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819225|NCT01899053|474618998|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819226|NCT01899053|474618999|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819227|NCT01899053|474619000|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819228|NCT01899053|474619001|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819229|NCT01899053|474619002|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819230|NCT01899053|474619003|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819231|NCT01899053|474619004|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
131819232|NCT01899053|474619005|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819233|NCT01899053|474619006|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819234|NCT01899053|474619007|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
131819235|NCT01899053|474618994|FG000|Overall Study|Symptomatic Deterioration|0|||
131819236|NCT01899053|474618995|FG001|Overall Study|Symptomatic Deterioration|0|||
131819237|NCT01899053|474618996|FG002|Overall Study|Symptomatic Deterioration|0|||
131819238|NCT01899053|474618997|FG003|Overall Study|Symptomatic Deterioration|0|||
131819239|NCT01899053|474618998|FG004|Overall Study|Symptomatic Deterioration|0|||
131819240|NCT01899053|474618999|FG005|Overall Study|Symptomatic Deterioration|1|||
131819241|NCT01899053|474619000|FG006|Overall Study|Symptomatic Deterioration|0|||
131819242|NCT01899053|474619001|FG007|Overall Study|Symptomatic Deterioration|1|||
131819243|NCT01899053|474619002|FG008|Overall Study|Symptomatic Deterioration|0|||
131819244|NCT01899053|474619003|FG009|Overall Study|Symptomatic Deterioration|0|||
131819245|NCT01899053|474619004|FG010|Overall Study|Symptomatic Deterioration|0|||
131819246|NCT01899053|474619005|FG011|Overall Study|Symptomatic Deterioration|1|||
131819247|NCT01899053|474619006|FG012|Overall Study|Symptomatic Deterioration|2|||
131819248|NCT01899053|474619007|FG013|Overall Study|Symptomatic Deterioration|0|||
131819249|NCT02452463|474619008|FG000|Overall Study|Death|1|||
131819250|NCT02452463|474619009|FG001|Overall Study|Death|0|||
131819251|NCT02452463|474619010|FG002|Overall Study|Death|0|||
131819252|NCT02452463|474619008|FG000|Overall Study|Study Suspended|1|||
131819253|NCT02452463|474619009|FG001|Overall Study|Study Suspended|0|||
131819254|NCT02452463|474619010|FG002|Overall Study|Study Suspended|0|||
131819255|NCT02452463|474619008|FG000|Overall Study|Recommended by DSMB|0|||
131819256|NCT02452463|474619009|FG001|Overall Study|Recommended by DSMB|1|||
131819257|NCT02452463|474619010|FG002|Overall Study|Recommended by DSMB|0|||
131819258|NCT02452463|474619008|FG000|Overall Study|Withdrawal by Subject|0|||
131819259|NCT02452463|474619009|FG001|Overall Study|Withdrawal by Subject|1|||
131819260|NCT02452463|474619010|FG002|Overall Study|Withdrawal by Subject|0|||
131819261|NCT00556673|474619011|FG000|Overall Study|Protocol deviation|3|||
131819262|NCT00556673|474619012|FG001|Overall Study|Protocol deviation|2|||
131819263|NCT03555695|474619013|FG000|Overall Study|Withdrawal by Subject|1|||
131819264|NCT03555695|474619013|FG000|Overall Study|Lost to Follow-up|1|||
131819265|NCT03555695|474619013|FG000|Overall Study|appendicitis (unrelated)|1|||
131819266|NCT03555695|474619013|FG000|Overall Study|pre-existing sciatica|1|||
131819267|NCT00494013|474619014|FG000|Overall Study|Adverse Event|0|||
131819268|NCT00494013|474619015|FG001|Overall Study|Adverse Event|1|||
131819269|NCT00494013|474619014|FG000|Overall Study|Entry Criteria Not Met|1|||
131819270|NCT00494013|474619015|FG001|Overall Study|Entry Criteria Not Met|4|||
131819271|NCT00494013|474619014|FG000|Overall Study|Lost to Follow-up|5|||
131819272|NCT00494013|474619015|FG001|Overall Study|Lost to Follow-up|6|||
131819273|NCT00494013|474619014|FG000|Overall Study|Physician Decision|3|||
131819274|NCT00494013|474619015|FG001|Overall Study|Physician Decision|5|||
131819275|NCT00494013|474619014|FG000|Overall Study|Protocol Violation|8|||
131819276|NCT00494013|474619015|FG001|Overall Study|Protocol Violation|5|||
131819277|NCT00494013|474619014|FG000|Overall Study|Withdrawal by Subject|13|||
131819278|NCT00494013|474619015|FG001|Overall Study|Withdrawal by Subject|14|||
131819279|NCT00494013|474619014|FG000|Overall Study|Sponsor Decision|0|||
131819280|NCT00494013|474619015|FG001|Overall Study|Sponsor Decision|1|||
131819281|NCT04194151|474619016|FG000|Overall Study|Physician Decision|1|||
131819282|NCT04194151|474619017|FG001|Overall Study|Physician Decision|1|||
131819283|NCT04194151|474619018|FG002|Overall Study|Physician Decision|1|||
131819284|NCT04194151|474619019|FG003|Overall Study|Physician Decision|1|||
131819285|NCT04194151|474619020|FG004|Overall Study|Physician Decision|0|||
131819286|NCT04194151|474619021|FG005|Overall Study|Physician Decision|1|||
131819287|NCT04194151|474619016|FG000|Overall Study|Monitorization problem|0|||
131819288|NCT04194151|474619017|FG001|Overall Study|Monitorization problem|1|||
131819289|NCT04194151|474619018|FG002|Overall Study|Monitorization problem|0|||
131819290|NCT04194151|474619019|FG003|Overall Study|Monitorization problem|0|||
131819291|NCT04194151|474619020|FG004|Overall Study|Monitorization problem|0|||
131819292|NCT04194151|474619021|FG005|Overall Study|Monitorization problem|0|||
131819293|NCT04203823|474619023|FG000|Overall Study|Withdrawal by Subject|2|||
131819294|NCT04203823|474619024|FG001|Overall Study|Withdrawal by Subject|2|||
131819295|NCT04203823|474619023|FG000|Overall Study|Adverse Event|1|||
131819296|NCT04203823|474619024|FG001|Overall Study|Adverse Event|1|||
131819297|NCT04203823|474619023|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131819298|NCT04203823|474619024|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
131819299|NCT01499043|474619025|FG000|Overall Study|Progressive disease (radiographic)|2|||
131819300|NCT01499043|474619025|FG000|Overall Study|Progressive disease (clinical)|1|||
131819301|NCT01499043|474619025|FG000|Overall Study|Withdrawal by Subject|2|||
131819302|NCT01499043|474619025|FG000|Overall Study|Adverse Event|1|||
131819303|NCT00438633|474619026|FG000|Overall Study|Withdrawal by Subject|1|||
131819304|NCT00438633|474619027|FG001|Overall Study|Withdrawal by Subject|0|||
131819305|NCT00438633|474619026|FG000|Overall Study|Lost to Follow-up|15|||
131819306|NCT00438633|474619027|FG001|Overall Study|Lost to Follow-up|17|||
131819307|NCT00874276|474619028|FG000|Overall Study|Withdrawal by Subject|1|||
131819308|NCT00874276|474619029|FG001|Overall Study|Withdrawal by Subject|1|||
131819309|NCT00874822|474620610|FG000|Overall Study|excluded by criteria|8|||
131819310|NCT03073798|474620611|FG000|Overall Study|Adverse Event|1|||
131819311|NCT03073798|474620611|FG000|Overall Study|Withdrawal by Subject|1|||
131819312|NCT01186458|474620612|FG000|Overall Study|Adverse Event|1|||
131819313|NCT02640235|474620613|FG000|Overall Study|Withdrawal by Subject|7|||
131819314|NCT02640235|474620614|FG001|Overall Study|Withdrawal by Subject|6|||
131819315|NCT02640235|474620613|FG000|Overall Study|Lost to Follow-up|4|||
131819316|NCT02640235|474620614|FG001|Overall Study|Lost to Follow-up|3|||
131819317|NCT02640235|474620613|FG000|Overall Study|Death|2|||
131819318|NCT02640235|474620614|FG001|Overall Study|Death|3|||
131819319|NCT02640235|474620613|FG000|Overall Study|Other|1|||
131819320|NCT02640235|474620614|FG001|Overall Study|Other|2|||
131819321|NCT00301964|474620615|FG000|Overall Study|Second primary|2|||
131819322|NCT00301964|474620615|FG000|Overall Study|Wrong primary|1|||
131819323|NCT00301964|474620615|FG000|Overall Study|Inadequate pathology|1|||
131819324|NCT04133311|474620616|FG000|Period 1 Double Masked Treatment Period|Death|1|||
131819325|NCT04133311|474620617|FG001|Period 1 Double Masked Treatment Period|Death|0|||
131819326|NCT04133311|474620618|FG002|Period 1 Double Masked Treatment Period|Death|0|||
131819327|NCT04133311|474620619|FG003|Period 1 Double Masked Treatment Period|Death|0|||
131819328|NCT04133311|474620616|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
131819329|NCT04133311|474620617|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
131819330|NCT04133311|474620618|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
131819331|NCT04133311|474620619|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
131819332|NCT04133311|474620616|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
131819333|NCT04133311|474620617|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
131819334|NCT04133311|474620618|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
131819335|NCT04133311|474620619|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
131819336|NCT04133311|474620616|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
131819337|NCT04133311|474620617|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
131819338|NCT04133311|474620618|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
131819339|NCT04133311|474620619|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
131819340|NCT04133311|474620616|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
131819341|NCT04133311|474620617|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
131819342|NCT04133311|474620618|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
131819343|NCT04133311|474620619|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
131819344|NCT04133311|474620616|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
131819345|NCT04133311|474620617|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
131819346|NCT04133311|474620618|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
131819347|NCT04133311|474620619|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
131819348|NCT04133311|474620616|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
131819349|NCT04133311|474620617|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
131819350|NCT04133311|474620618|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
131819351|NCT04133311|474620619|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
131819352|NCT04133311|474620616|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
131819353|NCT04133311|474620617|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
131819354|NCT04133311|474620618|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
131819355|NCT04133311|474620619|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
131819356|NCT01926119|474620622|FG000|Overall Study|Withdrawal by Subject|1|||
131819357|NCT01859598|474620625|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
131819358|NCT00354835|474620626|FG000|Overall Study|Death|1|||
131819359|NCT00354835|474620627|FG001|Overall Study|Death|1|||
131819360|NCT00354835|474620626|FG000|Overall Study|Physician Decision|8|||
131819361|NCT00354835|474620627|FG001|Overall Study|Physician Decision|13|||
131819362|NCT00354835|474620626|FG000|Overall Study|Withdrawal by Subject|2|||
131819363|NCT00354835|474620627|FG001|Overall Study|Withdrawal by Subject|1|||
131819364|NCT00354835|474620626|FG000|Overall Study|Ineligible|17|||
131819365|NCT00354835|474620627|FG001|Overall Study|Ineligible|16|||
131819366|NCT00354835|474620626|FG000|Overall Study|Disease progression or relapse|15|||
131819367|NCT00354835|474620627|FG001|Overall Study|Disease progression or relapse|22|||
131819368|NCT00354835|474620626|FG000|Overall Study|Adverse Event|6|||
131819369|NCT00354835|474620627|FG001|Overall Study|Adverse Event|0|||
131819370|NCT00354835|474620626|FG000|Overall Study|Refusal of further therapy|3|||
131819371|NCT00354835|474620627|FG001|Overall Study|Refusal of further therapy|8|||
131819372|NCT01968551|474620632|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
131819373|NCT01968551|474620633|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
131819374|NCT01968551|474620634|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
131819375|NCT01968551|474620632|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
131819376|NCT01968551|474620633|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
131819377|NCT01968551|474620634|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
131819378|NCT01968551|474620632|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
131819379|NCT01968551|474620633|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
131819380|NCT01968551|474620634|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
131909882|NCT00087178|474958686|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
131400848|NCT05596734|473089661|FG019|Substudy A|Withdrawal by Subject|0|||
131400849|NCT05596734|473089662|FG020|Substudy A|Withdrawal by Subject|0|||
131400850|NCT05596734|473089663|FG021|Substudy A|Withdrawal by Subject|0|||
131400851|NCT05596734|473089664|FG022|Substudy A|Withdrawal by Subject|0|||
131400852|NCT05596734|473089665|FG023|Substudy A|Withdrawal by Subject|0|||
131819381|NCT01968551|474620632|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
131819382|NCT01968551|474620633|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
131819383|NCT01968551|474620634|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
131819384|NCT01968551|474620632|FG000|Extension Phase|Adverse Event|0|||
131819385|NCT01968551|474620633|FG001|Extension Phase|Adverse Event|0|||
131819386|NCT01968551|474620634|FG002|Extension Phase|Adverse Event|2|||
131819387|NCT01968551|474620632|FG000|Extension Phase|Death|0|||
131819388|NCT01968551|474620633|FG001|Extension Phase|Death|1|||
131819389|NCT01968551|474620634|FG002|Extension Phase|Death|0|||
131819390|NCT01968551|474620632|FG000|Extension Phase|Withdrew Consent|0|||
131819391|NCT01968551|474620633|FG001|Extension Phase|Withdrew Consent|0|||
131819392|NCT01968551|474620634|FG002|Extension Phase|Withdrew Consent|1|||
131819393|NCT01968551|474620632|FG000|Extension Phase|Lost to Follow-up|1|||
131819394|NCT01968551|474620633|FG001|Extension Phase|Lost to Follow-up|0|||
131819395|NCT01968551|474620634|FG002|Extension Phase|Lost to Follow-up|1|||
131819396|NCT00819169|474620635|FG000|Overall Study|Withdrawal by Subject|2|||
131819397|NCT00819169|474620636|FG001|Overall Study|Withdrawal by Subject|0|||
131819398|NCT00819169|474620637|FG002|Overall Study|Withdrawal by Subject|0|||
131819399|NCT00819169|474620638|FG003|Overall Study|Withdrawal by Subject|1|||
131819400|NCT00819169|474620639|FG004|Overall Study|Withdrawal by Subject|1|||
131819401|NCT00819169|474620640|FG005|Overall Study|Withdrawal by Subject|1|||
131819402|NCT00819169|474620641|FG006|Overall Study|Withdrawal by Subject|5|||
131819403|NCT00819169|474620642|FG007|Overall Study|Withdrawal by Subject|1|||
131819404|NCT00819169|474620643|FG008|Overall Study|Withdrawal by Subject|4|||
131819405|NCT00819169|474620635|FG000|Overall Study|Lost to Follow-up|0|||
131819406|NCT00819169|474620636|FG001|Overall Study|Lost to Follow-up|2|||
131819407|NCT00819169|474620637|FG002|Overall Study|Lost to Follow-up|0|||
131819408|NCT00819169|474620638|FG003|Overall Study|Lost to Follow-up|1|||
131819409|NCT00819169|474620639|FG004|Overall Study|Lost to Follow-up|0|||
131819410|NCT00819169|474620640|FG005|Overall Study|Lost to Follow-up|6|||
131819411|NCT00819169|474620641|FG006|Overall Study|Lost to Follow-up|2|||
131819412|NCT00819169|474620642|FG007|Overall Study|Lost to Follow-up|2|||
131819413|NCT00819169|474620643|FG008|Overall Study|Lost to Follow-up|1|||
131819414|NCT00819169|474620635|FG000|Overall Study|Death|1|||
131819415|NCT00819169|474620636|FG001|Overall Study|Death|1|||
131819416|NCT00819169|474620637|FG002|Overall Study|Death|3|||
131819417|NCT00819169|474620638|FG003|Overall Study|Death|8|||
131819418|NCT00819169|474620639|FG004|Overall Study|Death|5|||
131819419|NCT00819169|474620640|FG005|Overall Study|Death|7|||
131819420|NCT00819169|474620641|FG006|Overall Study|Death|9|||
131819421|NCT00819169|474620642|FG007|Overall Study|Death|4|||
131819422|NCT00819169|474620643|FG008|Overall Study|Death|7|||
131819423|NCT00819169|474620635|FG000|Overall Study|Ineligibility determined|0|||
131819424|NCT00819169|474620636|FG001|Overall Study|Ineligibility determined|0|||
131819425|NCT00819169|474620637|FG002|Overall Study|Ineligibility determined|0|||
131819426|NCT00819169|474620638|FG003|Overall Study|Ineligibility determined|2|||
131819427|NCT00819169|474620639|FG004|Overall Study|Ineligibility determined|0|||
131819428|NCT00819169|474620640|FG005|Overall Study|Ineligibility determined|0|||
131819429|NCT00819169|474620641|FG006|Overall Study|Ineligibility determined|0|||
131819430|NCT00819169|474620642|FG007|Overall Study|Ineligibility determined|0|||
131819431|NCT00819169|474620643|FG008|Overall Study|Ineligibility determined|1|||
131819432|NCT00819169|474620635|FG000|Overall Study|Adverse Event|0|||
131819433|NCT00819169|474620636|FG001|Overall Study|Adverse Event|0|||
131819434|NCT00819169|474620637|FG002|Overall Study|Adverse Event|0|||
131819435|NCT00819169|474620638|FG003|Overall Study|Adverse Event|0|||
131400853|NCT05596734|473089642|FG000|Substudy A|Lost to Follow-up|1|||
131400854|NCT05596734|473089643|FG001|Substudy A|Lost to Follow-up|0|||
131819436|NCT00819169|474620639|FG004|Overall Study|Adverse Event|1|||
131819437|NCT00819169|474620640|FG005|Overall Study|Adverse Event|0|||
131819438|NCT00819169|474620641|FG006|Overall Study|Adverse Event|0|||
131819439|NCT00819169|474620642|FG007|Overall Study|Adverse Event|0|||
131819440|NCT00819169|474620643|FG008|Overall Study|Adverse Event|0|||
131819441|NCT00819169|474620635|FG000|Overall Study|Administrative Decision|0|||
131819442|NCT00819169|474620636|FG001|Overall Study|Administrative Decision|0|||
131819443|NCT00819169|474620637|FG002|Overall Study|Administrative Decision|0|||
131819444|NCT00819169|474620638|FG003|Overall Study|Administrative Decision|0|||
131819445|NCT00819169|474620639|FG004|Overall Study|Administrative Decision|1|||
131819446|NCT00819169|474620640|FG005|Overall Study|Administrative Decision|2|||
131819447|NCT00819169|474620641|FG006|Overall Study|Administrative Decision|0|||
131819448|NCT00819169|474620642|FG007|Overall Study|Administrative Decision|2|||
131819449|NCT00819169|474620643|FG008|Overall Study|Administrative Decision|0|||
131819450|NCT00573313|474620644|FG000|Overall Study|Protocol Violation|5|||
131819451|NCT00573313|474620645|FG001|Overall Study|Protocol Violation|0|||
131819452|NCT00573313|474620646|FG002|Overall Study|Protocol Violation|6|||
131819453|NCT00573313|474620647|FG003|Overall Study|Protocol Violation|0|||
131819454|NCT01155531|474620658|FG000|Overall Study|Adverse Event|0|||
131819455|NCT01155531|474620659|FG001|Overall Study|Adverse Event|0|||
131819456|NCT01155531|474620660|FG002|Overall Study|Adverse Event|1|||
131819457|NCT01155531|474620661|FG003|Overall Study|Adverse Event|0|||
131819458|NCT01155531|474620658|FG000|Overall Study|Lost to Follow-up|0|||
131819459|NCT01155531|474620659|FG001|Overall Study|Lost to Follow-up|0|||
131819460|NCT01155531|474620660|FG002|Overall Study|Lost to Follow-up|0|||
131819461|NCT01155531|474620661|FG003|Overall Study|Lost to Follow-up|1|||
131819462|NCT01155531|474620658|FG000|Overall Study|Withdrawal by Subject|1|||
131819463|NCT01155531|474620659|FG001|Overall Study|Withdrawal by Subject|0|||
131819464|NCT01155531|474620660|FG002|Overall Study|Withdrawal by Subject|1|||
131819465|NCT01155531|474620661|FG003|Overall Study|Withdrawal by Subject|0|||
131819466|NCT00354159|474620662|FG000|Randomized Study Period|Withdrawal by Subject|5|||
131819467|NCT00354159|474620663|FG001|Randomized Study Period|Withdrawal by Subject|3|||
131819468|NCT00354159|474620662|FG000|Randomized Study Period|Physician Decision|6|||
131819469|NCT00354159|474620663|FG001|Randomized Study Period|Physician Decision|10|||
131819470|NCT00354159|474620662|FG000|Randomized Study Period|Lost to Follow-up|4|||
131819471|NCT00354159|474620663|FG001|Randomized Study Period|Lost to Follow-up|0|||
131819472|NCT00354159|474620662|FG000|Randomized Study Period|Death|7|||
131819473|NCT00354159|474620663|FG001|Randomized Study Period|Death|9|||
131819474|NCT00354159|474620662|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
131819475|NCT00354159|474620663|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
131819476|NCT00354159|474620662|FG000|Long-term Follow-up|Physician Decision|127|||
131819477|NCT00354159|474620663|FG001|Long-term Follow-up|Physician Decision|122|||
131819478|NCT00354159|474620662|FG000|Long-term Follow-up|Lost to Follow-up|1|||
131819479|NCT00354159|474620663|FG001|Long-term Follow-up|Lost to Follow-up|0|||
131819480|NCT00354159|474620662|FG000|Long-term Follow-up|Death|14|||
131819481|NCT00354159|474620663|FG001|Long-term Follow-up|Death|11|||
131819482|NCT00354159|474620662|FG000|Long-term Follow-up|Study Closed|29|||
131819483|NCT00354159|474620663|FG001|Long-term Follow-up|Study Closed|34|||
131819484|NCT01653704|474620664|FG000|Overall Study|Technical failure during recording|1|||
131819485|NCT01653704|474620665|FG001|Overall Study|Technical failure during recording|1|||
131819486|NCT01653704|474620664|FG000|Overall Study|Performance not reflective of training|1|||
131819487|NCT01653704|474620665|FG001|Overall Study|Performance not reflective of training|0|||
131819488|NCT01728116|474620668|FG000|Overall Study|Sponsor Terminated Study|106|||
131819489|NCT01728116|474620669|FG001|Overall Study|Sponsor Terminated Study|35|||
131819490|NCT01728116|474620668|FG000|Overall Study|Withdrawal by Subject|16|||
131819491|NCT01728116|474620669|FG001|Overall Study|Withdrawal by Subject|9|||
131819492|NCT01728116|474620668|FG000|Overall Study|Adverse Event|13|||
131819493|NCT01728116|474620669|FG001|Overall Study|Adverse Event|0|||
131819494|NCT01728116|474620668|FG000|Overall Study|Procedure/device failure|7|||
131819495|NCT01728116|474620669|FG001|Overall Study|Procedure/device failure|0|||
131819496|NCT01728116|474620668|FG000|Overall Study|Lost to Follow-up|9|||
131819497|NCT01728116|474620669|FG001|Overall Study|Lost to Follow-up|2|||
131819498|NCT01728116|474620668|FG000|Overall Study|Physician Decision|2|||
131819499|NCT01728116|474620669|FG001|Overall Study|Physician Decision|0|||
131819500|NCT01728116|474620668|FG000|Overall Study|Subject Non-Compliance|2|||
131819501|NCT01728116|474620669|FG001|Overall Study|Subject Non-Compliance|0|||
131819502|NCT01728116|474620668|FG000|Overall Study|Inter-current finding at procedure|1|||
131819503|NCT01728116|474620669|FG001|Overall Study|Inter-current finding at procedure|0|||
131819504|NCT01728116|474620668|FG000|Overall Study|Incorrectly enrolled in Study|0|||
131819505|NCT01728116|474620669|FG001|Overall Study|Incorrectly enrolled in Study|1|||
131819506|NCT01728116|474620668|FG000|Overall Study|various not noted previously|5|||
131819507|NCT01728116|474620669|FG001|Overall Study|various not noted previously|0|||
131819508|NCT00467597|474620670|FG000|Overall Study|Withdrawal by Subject|2|||
131819509|NCT00467597|474620671|FG001|Overall Study|Withdrawal by Subject|0|||
131819510|NCT02096705|474620672|FG000|Treatment|Adverse Event|6|||
131819511|NCT02096705|474620673|FG001|Treatment|Adverse Event|3|||
131819512|NCT02096705|474620672|FG000|Treatment|Subject request to discontinue treatment|1|||
131819513|NCT02096705|474620673|FG001|Treatment|Subject request to discontinue treatment|1|||
131819514|NCT02096705|474620672|FG000|Treatment|Withdrawal by Subject|1|||
131819515|NCT02096705|474620673|FG001|Treatment|Withdrawal by Subject|0|||
131819516|NCT02096705|474620672|FG000|Treatment|Other|1|||
131819517|NCT02096705|474620673|FG001|Treatment|Other|1|||
131819518|NCT02096705|474620672|FG000|Follow-up|Withdrawal by Subject|1|||
131819519|NCT02096705|474620673|FG001|Follow-up|Withdrawal by Subject|0|||
131819520|NCT02096705|474620672|FG000|Follow-up|Adverse Event|2|||
131819521|NCT02096705|474620673|FG001|Follow-up|Adverse Event|2|||
131819522|NCT02096705|474620672|FG000|Follow-up|Subjects not reporting status|1|||
131819523|NCT02096705|474620673|FG001|Follow-up|Subjects not reporting status|2|||
131819524|NCT02670551|474620677|FG000|Overall Study|Adverse Event|4|||
131819525|NCT02670551|474620678|FG001|Overall Study|Adverse Event|7|||
131819526|NCT02670551|474620679|FG002|Overall Study|Adverse Event|9|||
131819527|NCT02670551|474620677|FG000|Overall Study|Lack of Efficacy|2|||
131819528|NCT02670551|474620678|FG001|Overall Study|Lack of Efficacy|0|||
131819529|NCT02670551|474620679|FG002|Overall Study|Lack of Efficacy|3|||
131819530|NCT02670551|474620677|FG000|Overall Study|Withdrawal of Consent|6|||
131819531|NCT02670551|474620678|FG001|Overall Study|Withdrawal of Consent|3|||
131819532|NCT02670551|474620679|FG002|Overall Study|Withdrawal of Consent|8|||
131819533|NCT02670551|474620677|FG000|Overall Study|Lost to Follow-up|5|||
131819534|NCT02670551|474620678|FG001|Overall Study|Lost to Follow-up|7|||
131819535|NCT02670551|474620679|FG002|Overall Study|Lost to Follow-up|6|||
131819536|NCT02670551|474620677|FG000|Overall Study|Protocol Violation|1|||
131819537|NCT02670551|474620678|FG001|Overall Study|Protocol Violation|0|||
131819538|NCT02670551|474620679|FG002|Overall Study|Protocol Violation|0|||
131819539|NCT02670551|474620677|FG000|Overall Study|Noncompliance with study drug|3|||
131819540|NCT02670551|474620678|FG001|Overall Study|Noncompliance with study drug|3|||
131819541|NCT02670551|474620679|FG002|Overall Study|Noncompliance with study drug|2|||
131819542|NCT02670551|474620677|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131819543|NCT02670551|474620678|FG001|Overall Study|Other Miscellaneous Reasons|3|||
131819544|NCT02670551|474620679|FG002|Overall Study|Other Miscellaneous Reasons|3|||
131819545|NCT02670551|474620677|FG000|Overall Study|Did Not Receive Treatment|5|||
131819546|NCT02670551|474620678|FG001|Overall Study|Did Not Receive Treatment|3|||
131819547|NCT02670551|474620679|FG002|Overall Study|Did Not Receive Treatment|0|||
131819548|NCT01962298|474620680|FG000|Overall Study|Protocol Violation|1|||
131819549|NCT01962298|474620681|FG001|Overall Study|Protocol Violation|0|||
131819550|NCT01962298|474620682|FG002|Overall Study|Protocol Violation|1|||
131819551|NCT01962298|474620683|FG003|Overall Study|Protocol Violation|1|||
131819552|NCT01962298|474620684|FG004|Overall Study|Protocol Violation|0|||
131819553|NCT01962298|474620680|FG000|Overall Study|Data quality insufficient|2|||
131819554|NCT01962298|474620681|FG001|Overall Study|Data quality insufficient|0|||
131819555|NCT01962298|474620682|FG002|Overall Study|Data quality insufficient|3|||
131819556|NCT01962298|474620683|FG003|Overall Study|Data quality insufficient|1|||
131819557|NCT01962298|474620684|FG004|Overall Study|Data quality insufficient|4|||
131819558|NCT01962298|474620680|FG000|Overall Study|Insufficient data|0|||
131819559|NCT01962298|474620681|FG001|Overall Study|Insufficient data|2|||
131819560|NCT01962298|474620682|FG002|Overall Study|Insufficient data|1|||
131819561|NCT01962298|474620683|FG003|Overall Study|Insufficient data|0|||
131819562|NCT01962298|474620684|FG004|Overall Study|Insufficient data|1|||
131819563|NCT01962298|474620680|FG000|Overall Study|Incorrect data recorded|0|||
131819564|NCT01962298|474620681|FG001|Overall Study|Incorrect data recorded|1|||
131819565|NCT01962298|474620682|FG002|Overall Study|Incorrect data recorded|0|||
131819566|NCT01962298|474620683|FG003|Overall Study|Incorrect data recorded|0|||
131819567|NCT01962298|474620684|FG004|Overall Study|Incorrect data recorded|0|||
131819568|NCT01962298|474620680|FG000|Overall Study|Physician Decision|0|||
131819569|NCT01962298|474620681|FG001|Overall Study|Physician Decision|1|||
131819570|NCT01962298|474620682|FG002|Overall Study|Physician Decision|0|||
131819571|NCT01962298|474620683|FG003|Overall Study|Physician Decision|0|||
131819572|NCT01962298|474620684|FG004|Overall Study|Physician Decision|1|||
131819573|NCT04476277|474620685|FG000|Overall Study|Withdrawal by Subject|0|||
131819574|NCT04476277|474620686|FG001|Overall Study|Withdrawal by Subject|0|||
131819575|NCT04476277|474620687|FG002|Overall Study|Withdrawal by Subject|1|||
131819576|NCT04476277|474620688|FG003|Overall Study|Withdrawal by Subject|0|||
131819577|NCT01971645|474620689|FG000|Overall Study|Adverse Event|1|||
131819578|NCT01971645|474620690|FG001|Overall Study|Adverse Event|0|||
131819579|NCT01971645|474620691|FG002|Overall Study|Adverse Event|0|||
131819580|NCT01971645|474620689|FG000|Overall Study|Lost to Follow-up|1|||
131819581|NCT01971645|474620690|FG001|Overall Study|Lost to Follow-up|0|||
131819582|NCT01971645|474620691|FG002|Overall Study|Lost to Follow-up|1|||
131819583|NCT01971645|474620689|FG000|Overall Study|Protocol Violation|0|||
131819584|NCT01971645|474620690|FG001|Overall Study|Protocol Violation|0|||
131819585|NCT01971645|474620691|FG002|Overall Study|Protocol Violation|1|||
131819586|NCT00533507|474620692|FG000|Overall Study|Withdrawal by Subject|1|||
131819587|NCT01576705|474620693|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
131819588|NCT01576705|474620694|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
131819589|NCT01576705|474620695|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
131909883|NCT00087178|474958687|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
131819590|NCT01576705|474620696|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
131819591|NCT01576705|474620693|FG000|Overall Study|invalid ICF|0|||
131819592|NCT01576705|474620694|FG001|Overall Study|invalid ICF|1|||
131819593|NCT01576705|474620695|FG002|Overall Study|invalid ICF|0|||
131819594|NCT01576705|474620696|FG003|Overall Study|invalid ICF|0|||
131819595|NCT02896296|474620697|FG000|Overall Study|Adverse Event|1|||
131819596|NCT02896296|474620697|FG000|Overall Study|Lost to Follow-up|19|||
131819597|NCT02896296|474620697|FG000|Overall Study|Pregnancy|1|||
131819598|NCT02896296|474620697|FG000|Overall Study|Physician Decision|2|||
131819599|NCT02896296|474620697|FG000|Overall Study|Withdrawal by Subject|10|||
131819600|NCT02896296|474620697|FG000|Overall Study|Site closing|7|||
131909884|NCT03444584|474958703|FG000|Overall Study|Withdrawal by Subject|0|||
131449842|NCT03722238|473276722|FG000|Overall Study|Death|1|||
131819601|NCT02896296|474620697|FG000|Overall Study|Incarceration|1|||
131819602|NCT02896296|474620697|FG000|Overall Study|Relocation|1|||
131449843|NCT03722238|473276723|FG001|Overall Study|Death|0|||
131819603|NCT02943096|474620698|FG000|Overall Study|Lack of Efficacy|0|||
131819604|NCT02943096|474620699|FG001|Overall Study|Lack of Efficacy|1|||
131819605|NCT00714051|474620705|FG000|Overall Study|Withdrawal by Subject|1|||
131819606|NCT00714051|474620706|FG001|Overall Study|Withdrawal by Subject|0|||
131819607|NCT00714051|474620705|FG000|Overall Study|Death|0|||
131819608|NCT00714051|474620706|FG001|Overall Study|Death|1|||
131819609|NCT02119936|474620715|FG000|Overall Study|Lost to Follow-up|10|||
131819610|NCT00570128|474620716|FG000|Overall Study|Adverse Event|1|||
131819611|NCT00570128|474620717|FG001|Overall Study|Adverse Event|0|||
131819612|NCT00570128|474620716|FG000|Overall Study|Lost to Follow-up|1|||
131819613|NCT00570128|474620717|FG001|Overall Study|Lost to Follow-up|0|||
131819614|NCT00570128|474620716|FG000|Overall Study|Withdrawal by Subject|2|||
131819615|NCT00570128|474620717|FG001|Overall Study|Withdrawal by Subject|0|||
131819616|NCT03868631|474620718|FG000|Baseline to Week 6|Adverse Event|0|||
131819617|NCT03868631|474620719|FG001|Baseline to Week 6|Adverse Event|3|||
131819618|NCT03868631|474620718|FG000|Baseline to Week 6|Protocol Violation|1|||
131819619|NCT03868631|474620719|FG001|Baseline to Week 6|Protocol Violation|1|||
131819620|NCT03868631|474620718|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
131819621|NCT03868631|474620719|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
131819622|NCT03868631|474620718|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
131819623|NCT03868631|474620719|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
131819624|NCT03868631|474620718|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
131819625|NCT03868631|474620719|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
131819626|NCT03868631|474620718|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
131819627|NCT03868631|474620719|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
131819628|NCT05740098|474620720|FG000|Overall Study|Lost to Follow-up|26|||
131819629|NCT05740098|474620721|FG001|Overall Study|Lost to Follow-up|17|||
131819630|NCT05740098|474620722|FG002|Overall Study|Lost to Follow-up|21|||
131819631|NCT01073631|474620723|FG000|Overall Study|Death|82|||
131819632|NCT01073631|474620723|FG000|Overall Study|Adverse Event|24|||
131819633|NCT01073631|474620723|FG000|Overall Study|Other|63|||
131819634|NCT01528735|474620724|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
131819635|NCT01528735|474620725|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
131819636|NCT01528735|474620724|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
131819637|NCT01528735|474620725|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
131819638|NCT01426854|474620726|FG000|Overall Study|Adverse Event|1|||
131819639|NCT01426854|474620727|FG001|Overall Study|Adverse Event|5|||
131819640|NCT01426854|474620726|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
131819641|NCT01426854|474620727|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
131819642|NCT01426854|474620726|FG000|Overall Study|Lost to Follow-up|3|||
131819643|NCT01426854|474620727|FG001|Overall Study|Lost to Follow-up|0|||
131819644|NCT01426854|474620726|FG000|Overall Study|Noncompliance|0|||
131819645|NCT01426854|474620727|FG001|Overall Study|Noncompliance|1|||
131819646|NCT01426854|474620726|FG000|Overall Study|Treatment Failure|0|||
131819647|NCT01426854|474620727|FG001|Overall Study|Treatment Failure|16|||
131819648|NCT01426854|474620726|FG000|Overall Study|Protocol Deviation|0|||
131819649|NCT01426854|474620727|FG001|Overall Study|Protocol Deviation|1|||
131819650|NCT01426854|474620726|FG000|Overall Study|Other|3|||
131819651|NCT01426854|474620727|FG001|Overall Study|Other|2|||
131819652|NCT01971554|474620730|FG000|Overall Study|Lost to Follow-up|1|||
131819653|NCT01971554|474620731|FG001|Overall Study|Lost to Follow-up|0|||
131819654|NCT01971554|474620732|FG002|Overall Study|Lost to Follow-up|0|||
131819655|NCT01971554|474620733|FG003|Overall Study|Lost to Follow-up|0|||
131819656|NCT01942135|474620737|FG000|Overall Study|Adverse Event|21|||
131819657|NCT01942135|474620738|FG001|Overall Study|Adverse Event|7|||
131819658|NCT01942135|474620737|FG000|Overall Study|Global Deterioration of Health Status|9|||
131819659|NCT01942135|474620738|FG001|Overall Study|Global Deterioration of Health Status|6|||
131819660|NCT01942135|474620737|FG000|Overall Study|Randomized Not Treated|2|||
131819661|NCT01942135|474620738|FG001|Overall Study|Randomized Not Treated|2|||
131819662|NCT01942135|474620737|FG000|Overall Study|Death|2|||
131819663|NCT01942135|474620738|FG001|Overall Study|Death|1|||
131819664|NCT01942135|474620737|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
131819665|NCT01942135|474620738|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
131819666|NCT01942135|474620737|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
131819667|NCT01942135|474620738|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
131819668|NCT01942135|474620737|FG000|Overall Study|Withdrawal by Subject|4|||
131819669|NCT01942135|474620738|FG001|Overall Study|Withdrawal by Subject|3|||
131819670|NCT01942135|474620737|FG000|Overall Study|Protocol Violation|1|||
131819671|NCT01942135|474620738|FG001|Overall Study|Protocol Violation|0|||
131819672|NCT01942135|474620737|FG000|Overall Study|Other|19|||
131819673|NCT01942135|474620738|FG001|Overall Study|Other|4|||
131819674|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
131819675|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
131819676|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
131819677|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
131819678|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
131819679|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
131819680|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
131819681|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
131819682|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
131819683|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
131819684|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
131819685|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
131819686|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
131819687|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
131819688|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
131819689|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
131819690|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
131819691|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
131819692|NCT00950300|474620739|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
131819693|NCT00950300|474620740|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
131819694|NCT00950300|474620739|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
131819695|NCT00950300|474620740|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
131819696|NCT00950300|474620739|FG000|TFFU Period|Death|4|||
131819697|NCT00950300|474620740|FG001|TFFU Period|Death|1|||
131819698|NCT00950300|474620739|FG000|TFFU Period|Refused Treatment|10|||
131819699|NCT00950300|474620740|FG001|TFFU Period|Refused Treatment|11|||
131819700|NCT00950300|474620739|FG000|TFFU Period|Failure to Return|16|||
131819701|NCT00950300|474620740|FG001|TFFU Period|Failure to Return|16|||
131819702|NCT00950300|474620739|FG000|TFFU Period|Recurrence of Disease|63|||
131819703|NCT00950300|474620740|FG001|TFFU Period|Recurrence of Disease|72|||
131819704|NCT00950300|474620739|FG000|TFFU Period|Other|4|||
131819705|NCT00950300|474620740|FG001|TFFU Period|Other|3|||
131819706|NCT00950300|474620739|FG000|SFU Period|Death|44|||
131819707|NCT00950300|474620740|FG001|SFU Period|Death|42|||
131819708|NCT00950300|474620739|FG000|SFU Period|Lost to Follow-up|30|||
131819709|NCT00950300|474620740|FG001|SFU Period|Lost to Follow-up|28|||
131819710|NCT00950300|474620739|FG000|SFU Period|Withdrawal by Subject|4|||
131819711|NCT00950300|474620740|FG001|SFU Period|Withdrawal by Subject|8|||
131819712|NCT01717040|474620741|FG000|Overall Study|Lost to Follow-up|2|||
131819713|NCT01717040|474620742|FG001|Overall Study|Lost to Follow-up|3|||
131819714|NCT01717040|474620741|FG000|Overall Study|Lack of Efficacy|1|||
131819715|NCT01717040|474620742|FG001|Overall Study|Lack of Efficacy|1|||
131819716|NCT01717040|474620741|FG000|Overall Study|Adverse Event|1|||
131819717|NCT01717040|474620742|FG001|Overall Study|Adverse Event|0|||
131819718|NCT01717040|474620741|FG000|Overall Study|Required Medication Change|0|||
131819719|NCT01717040|474620742|FG001|Overall Study|Required Medication Change|1|||
131819720|NCT01717040|474620741|FG000|Overall Study|New Substance Use Disorder|1|||
131819721|NCT01717040|474620742|FG001|Overall Study|New Substance Use Disorder|0|||
131819722|NCT03193021|474620743|FG000|Overall Study|Lost to Follow-up|1|||
131819723|NCT03193021|474620744|FG001|Overall Study|Lost to Follow-up|1|||
131819724|NCT02286466|474620745|FG000|Overall Study|Death|1|||
131819725|NCT02286466|474620746|FG001|Overall Study|Death|3|||
131819726|NCT02286466|474620745|FG000|Overall Study|Withdrawal by Subject|5|||
131819727|NCT02286466|474620746|FG001|Overall Study|Withdrawal by Subject|2|||
131819728|NCT02286466|474620745|FG000|Overall Study|Lost to Follow-up|1|||
131819729|NCT02286466|474620746|FG001|Overall Study|Lost to Follow-up|4|||
131819730|NCT02286466|474620745|FG000|Overall Study|Declined Clinician Assessment|0|||
131819731|NCT02286466|474620746|FG001|Overall Study|Declined Clinician Assessment|1|||
131819732|NCT00835081|474620747|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131819733|NCT00835081|474620748|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131819734|NCT00421304|474620749|FG000|Overall Study|Lost to Follow-up|5|||
131819735|NCT00421304|474620750|FG001|Overall Study|Lost to Follow-up|2|||
131819736|NCT00421304|474620751|FG002|Overall Study|Lost to Follow-up|5|||
131819737|NCT00421304|474620749|FG000|Overall Study|Withdrawal by Subject|2|||
131819738|NCT00421304|474620750|FG001|Overall Study|Withdrawal by Subject|2|||
131819739|NCT00421304|474620751|FG002|Overall Study|Withdrawal by Subject|2|||
131819740|NCT00421304|474620749|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
131819741|NCT00421304|474620750|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
131819742|NCT00421304|474620751|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
131819743|NCT00421304|474620749|FG000|Overall Study|Did not attend Day 360 visit|0|||
131819744|NCT00421304|474620750|FG001|Overall Study|Did not attend Day 360 visit|0|||
131819745|NCT00421304|474620751|FG002|Overall Study|Did not attend Day 360 visit|1|||
131819746|NCT03196284|474620752|FG000|Main Part|Withdrawal by Subject|0|||
131819747|NCT03196284|474620753|FG001|Main Part|Withdrawal by Subject|1|||
131819748|NCT03196284|474620754|FG002|Main Part|Withdrawal by Subject|0|||
131819749|NCT03196284|474620752|FG000|Extension Part|Lack of Efficacy|0|||
131819750|NCT03196284|474620753|FG001|Extension Part|Lack of Efficacy|0|||
131819751|NCT03196284|474620754|FG002|Extension Part|Lack of Efficacy|1|||
131819752|NCT03196284|474620752|FG000|Extension Part|Withdrawal by Subject|0|||
131819753|NCT03196284|474620753|FG001|Extension Part|Withdrawal by Subject|0|||
131819754|NCT03196284|474620754|FG002|Extension Part|Withdrawal by Subject|1|||
131819755|NCT03196284|474620752|FG000|Extension Part|Physician Decision|0|||
131819756|NCT03196284|474620753|FG001|Extension Part|Physician Decision|0|||
131819757|NCT03196284|474620754|FG002|Extension Part|Physician Decision|1|||
131400855|NCT05596734|473089644|FG002|Substudy A|Lost to Follow-up|1|||
131400856|NCT05596734|473089645|FG003|Substudy A|Lost to Follow-up|0|||
131819758|NCT01139762|474620755|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
131819759|NCT01139762|474620756|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
131819760|NCT01139762|474620757|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
131819761|NCT01139762|474620755|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
131819762|NCT01139762|474620756|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
131819763|NCT01139762|474620757|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
131819764|NCT01139762|474620755|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
131819765|NCT01139762|474620756|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
131819766|NCT01139762|474620757|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
131819767|NCT01139762|474620755|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
131819768|NCT01139762|474620756|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
131819769|NCT01139762|474620757|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
131819770|NCT01139762|474620755|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
131819771|NCT01139762|474620756|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
131819772|NCT01139762|474620757|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
131819773|NCT01139762|474620755|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
131819774|NCT01139762|474620756|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
131819775|NCT01139762|474620757|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
131819776|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
131819777|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
131819778|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
131819779|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Death|0|||
131819780|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Death|1|||
131819781|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Death|1|||
131819782|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
131819783|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
131819784|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
131819785|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
131819786|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
131819787|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
131819788|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
131819789|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
131819790|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
131819791|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
131819792|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
131819793|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
131819794|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
131819795|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
131819796|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
131819797|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
131819798|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
131819799|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
131819800|NCT01139762|474620755|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
131819801|NCT01139762|474620756|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
131819802|NCT01139762|474620757|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
131819803|NCT01912807|474620758|FG000|Overall Study|Did not meet elegibility criteria|6|||
131819804|NCT01912807|474620759|FG001|Overall Study|Did not meet elegibility criteria|4|||
131819805|NCT01912807|474620758|FG000|Overall Study|Lost to Follow-up|36|||
131819806|NCT01912807|474620759|FG001|Overall Study|Lost to Follow-up|37|||
131819807|NCT04750239|474620760|FG000|Overall Study|Withdrawal by Subject|2|||
131819808|NCT04750239|474620760|FG000|Overall Study|Trial terminated by sponsor|1|||
131400857|NCT05596734|473089646|FG004|Substudy A|Lost to Follow-up|0|||
131400858|NCT05596734|473089647|FG005|Substudy A|Lost to Follow-up|0|||
131400859|NCT05596734|473089648|FG006|Substudy A|Lost to Follow-up|0|||
131400860|NCT05596734|473089649|FG007|Substudy A|Lost to Follow-up|0|||
131400861|NCT05596734|473089650|FG008|Substudy A|Lost to Follow-up|0|||
131400862|NCT05596734|473089651|FG009|Substudy A|Lost to Follow-up|0|||
131819809|NCT00903877|474620761|FG000|Overall Study|Did not meet study criteria|33|||
131819810|NCT00903877|474620761|FG000|Overall Study|Withdrawal by Subject|3|||
131819811|NCT00903877|474620761|FG000|Overall Study|Adverse Event|2|||
131819812|NCT00903877|474620761|FG000|Overall Study|Lost to Follow-up|1|||
131819813|NCT00903877|474620761|FG000|Overall Study|Participation put on hold|4|||
131400863|NCT05596734|473089652|FG010|Substudy A|Lost to Follow-up|0|||
131400864|NCT05596734|473089653|FG011|Substudy A|Lost to Follow-up|0|||
131819814|NCT00919711|474620762|FG000|Overall Study|Withdrawal by Subject|15|||
131819815|NCT00919711|474620763|FG001|Overall Study|Withdrawal by Subject|7|||
131819816|NCT00919711|474620762|FG000|Overall Study|Adverse Event|13|||
131819817|NCT00919711|474620763|FG001|Overall Study|Adverse Event|3|||
131819818|NCT00919711|474620762|FG000|Overall Study|Other|1|||
131819819|NCT00919711|474620763|FG001|Overall Study|Other|2|||
131819820|NCT00919711|474620762|FG000|Overall Study|Administrative Decision|0|||
131819821|NCT00919711|474620763|FG001|Overall Study|Administrative Decision|1|||
131819822|NCT00919711|474620762|FG000|Overall Study|Lost to Follow-up|2|||
131819823|NCT00919711|474620763|FG001|Overall Study|Lost to Follow-up|0|||
131819824|NCT00919711|474620762|FG000|Overall Study|Death|1|||
131819825|NCT00919711|474620763|FG001|Overall Study|Death|0|||
131819826|NCT00919711|474620762|FG000|Overall Study|Noncompliance|1|||
131819827|NCT00919711|474620763|FG001|Overall Study|Noncompliance|0|||
131819828|NCT00087529|474620765|FG000|Overall Study|Death|1|||
131819829|NCT00087529|474620766|FG001|Overall Study|Death|0|||
131819830|NCT00087529|474620765|FG000|Overall Study|Adverse Event|0|||
131819831|NCT00087529|474620766|FG001|Overall Study|Adverse Event|8|||
131819832|NCT00087529|474620765|FG000|Overall Study|Pregnancy|0|||
131819833|NCT00087529|474620766|FG001|Overall Study|Pregnancy|1|||
131819834|NCT00087529|474620765|FG000|Overall Study|Lost to Follow-up|2|||
131819835|NCT00087529|474620766|FG001|Overall Study|Lost to Follow-up|3|||
131819836|NCT00087529|474620765|FG000|Overall Study|Participant Decision|14|||
131819837|NCT00087529|474620766|FG001|Overall Study|Participant Decision|37|||
131819838|NCT00087529|474620765|FG000|Overall Study|Physician Decision|4|||
131819839|NCT00087529|474620766|FG001|Overall Study|Physician Decision|8|||
131819840|NCT00087529|474620765|FG000|Overall Study|Initiation of Excluded Therapy|0|||
131819841|NCT00087529|474620766|FG001|Overall Study|Initiation of Excluded Therapy|1|||
131819842|NCT00087529|474620765|FG000|Overall Study|Participant Noncompliance|0|||
131819843|NCT00087529|474620766|FG001|Overall Study|Participant Noncompliance|1|||
131400865|NCT05596734|473089654|FG012|Substudy A|Lost to Follow-up|0|||
131400866|NCT05596734|473089655|FG013|Substudy A|Lost to Follow-up|0|||
131400867|NCT05596734|473089656|FG014|Substudy A|Lost to Follow-up|0|||
131819844|NCT00087529|474620765|FG000|Overall Study|Disease Progression|5|||
131819845|NCT00087529|474620766|FG001|Overall Study|Disease Progression|4|||
131819846|NCT00087529|474620765|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
131819847|NCT00087529|474620766|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
131819848|NCT02535923|474620767|FG000|Overall Study|Lost to Follow-up|5|||
131819849|NCT02535923|474620768|FG001|Overall Study|Lost to Follow-up|5|||
131819850|NCT02535923|474620767|FG000|Overall Study|Withdrawal by Subject|4|||
131819851|NCT02535923|474620768|FG001|Overall Study|Withdrawal by Subject|3|||
131819852|NCT00685334|474620776|FG000|Overall Study|Withdrawal by Subject|5|||
131819853|NCT00685334|474620777|FG001|Overall Study|Withdrawal by Subject|6|||
131819854|NCT00685334|474620776|FG000|Overall Study|Lost to Follow-up|4|||
131819855|NCT00685334|474620777|FG001|Overall Study|Lost to Follow-up|0|||
131819856|NCT00685334|474620776|FG000|Overall Study|Chose to enter hospital|1|||
131819857|NCT00685334|474620777|FG001|Overall Study|Chose to enter hospital|1|||
131819858|NCT01891357|474620778|FG000|Overall Study|Protocol Violation|3|||
131400868|NCT05596734|473089657|FG015|Substudy A|Lost to Follow-up|0|||
131400869|NCT05596734|473089658|FG016|Substudy A|Lost to Follow-up|0|||
131819859|NCT01253564|474620779|FG000|Overall Study|Disease Progression|22|||
131819860|NCT01253564|474620779|FG000|Overall Study|Withdrawal by Subject|1|||
131819861|NCT01253564|474620779|FG000|Overall Study|Serious Adverse Event|1|||
131819862|NCT03694197|474620782|FG000|Overall Study|Adverse Event|9|||
131400870|NCT05596734|473089659|FG017|Substudy A|Lost to Follow-up|0|||
131400871|NCT05596734|473089660|FG018|Substudy A|Lost to Follow-up|0|||
131400872|NCT05596734|473089661|FG019|Substudy A|Lost to Follow-up|0|||
131400873|NCT05596734|473089662|FG020|Substudy A|Lost to Follow-up|0|||
131819863|NCT03694197|474620782|FG000|Overall Study|Protocol became inconvenient to participate|1|||
131819864|NCT03694197|474620782|FG000|Overall Study|Physician Decision|4|||
131819865|NCT03694197|474620782|FG000|Overall Study|Study terminated by sponsor|1350|||
131819866|NCT03694197|474620782|FG000|Overall Study|Participant moved|5|||
131819867|NCT03694197|474620782|FG000|Overall Study|Participant withdrew consent|10|||
131819868|NCT03694197|474620782|FG000|Overall Study|Related to IMP administration|1|||
131819869|NCT03694197|474620782|FG000|Overall Study|Not disclosed|5|||
131819870|NCT04573309|474622488|FG000|Overall Study|Protocol Violation|1|||
131819871|NCT04573309|474622489|FG001|Overall Study|Protocol Violation|0|||
131819872|NCT01109849|474622492|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
131819873|NCT01109849|474622493|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
131819874|NCT01109849|474622494|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
131819875|NCT01109849|474622495|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
131819876|NCT01109849|474622496|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
131819877|NCT01109849|474622492|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
131400874|NCT05596734|473089663|FG021|Substudy A|Lost to Follow-up|0|||
131400875|NCT05596734|473089664|FG022|Substudy A|Lost to Follow-up|0|||
131400876|NCT05596734|473089665|FG023|Substudy A|Lost to Follow-up|0|||
131400877|NCT05596734|473089642|FG000|Substudy B|Withdrawal by Subject|0|||
131819878|NCT01109849|474622493|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
131819879|NCT01109849|474622494|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
131819880|NCT01109849|474622495|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
131819881|NCT01109849|474622496|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
131819882|NCT01109849|474622492|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
131819883|NCT01109849|474622493|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
131819884|NCT01109849|474622494|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
131819885|NCT01109849|474622495|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
131819886|NCT01109849|474622496|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
131819887|NCT01109849|474622492|FG000|Initial Randomization: ADHD Treatment|move away|2|||
131819888|NCT01109849|474622493|FG001|Initial Randomization: ADHD Treatment|move away|7|||
131819889|NCT01109849|474622494|FG002|Initial Randomization: ADHD Treatment|move away|0|||
131819890|NCT01109849|474622495|FG003|Initial Randomization: ADHD Treatment|move away|0|||
131819891|NCT01109849|474622496|FG004|Initial Randomization: ADHD Treatment|move away|0|||
131819892|NCT01109849|474622492|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
131819893|NCT01109849|474622493|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
131819894|NCT01109849|474622494|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
131819895|NCT01109849|474622495|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
131819896|NCT01109849|474622496|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
131819897|NCT01109849|474622492|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
131819898|NCT01109849|474622493|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
131819899|NCT01109849|474622494|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
131819900|NCT01109849|474622495|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
131819901|NCT01109849|474622496|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
131819902|NCT02300987|474622497|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
131819903|NCT02300987|474622498|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
131819904|NCT02300987|474622497|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
131819905|NCT02300987|474622498|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
131819906|NCT02300987|474622497|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
131819907|NCT02300987|474622498|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
131819908|NCT02300987|474622497|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
131819909|NCT02300987|474622498|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
131819910|NCT02300987|474622497|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
131819911|NCT02300987|474622498|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
131819912|NCT02488109|474622502|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
131819913|NCT02488109|474622503|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
131819914|NCT02488109|474622502|FG000|12-month Follow-Up|Lost to Follow-up|4|||
131819915|NCT02488109|474622503|FG001|12-month Follow-Up|Lost to Follow-up|7|||
131819916|NCT00660387|474622504|FG000|Overall Study|Adverse Event|1|||
131819917|NCT00660387|474622505|FG001|Overall Study|Adverse Event|2|||
131819918|NCT00660387|474622504|FG000|Overall Study|Lack of Efficacy|0|||
131819919|NCT00660387|474622505|FG001|Overall Study|Lack of Efficacy|1|||
131819920|NCT00660387|474622504|FG000|Overall Study|Protocol Violation|1|||
131819921|NCT00660387|474622505|FG001|Overall Study|Protocol Violation|0|||
131819922|NCT03969641|474622510|FG000|Overall Study|Lost to Follow-up|5|||
131819923|NCT03969641|474622511|FG001|Overall Study|Lost to Follow-up|3|||
131819924|NCT03969641|474622510|FG000|Overall Study|Withdrawal by Subject|1|||
131819925|NCT03969641|474622511|FG001|Overall Study|Withdrawal by Subject|2|||
131819926|NCT03969641|474622510|FG000|Overall Study|Found to be ineligible|1|||
131819927|NCT03969641|474622511|FG001|Overall Study|Found to be ineligible|1|||
131819928|NCT03969641|474622510|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
131819929|NCT03969641|474622511|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
131819930|NCT03969641|474622510|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
131819931|NCT03969641|474622511|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
131819932|NCT03969641|474622510|FG000|Overall Study|Elective termination|0|||
131819933|NCT03969641|474622511|FG001|Overall Study|Elective termination|1|||
131819934|NCT01541215|474622512|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
131819935|NCT01541215|474622513|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
131819936|NCT01541215|474622512|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
131819937|NCT01541215|474622513|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
131819938|NCT01541215|474622512|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
131819939|NCT01541215|474622513|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
131400878|NCT05596734|473089643|FG001|Substudy B|Withdrawal by Subject|0|||
131400879|NCT05596734|473089644|FG002|Substudy B|Withdrawal by Subject|0|||
131400880|NCT05596734|473089645|FG003|Substudy B|Withdrawal by Subject|0|||
131400881|NCT05596734|473089646|FG004|Substudy B|Withdrawal by Subject|0|||
131400882|NCT05596734|473089647|FG005|Substudy B|Withdrawal by Subject|0|||
131400883|NCT05596734|473089648|FG006|Substudy B|Withdrawal by Subject|0|||
131400884|NCT05596734|473089649|FG007|Substudy B|Withdrawal by Subject|0|||
131400885|NCT05596734|473089650|FG008|Substudy B|Withdrawal by Subject|0|||
131400886|NCT05596734|473089651|FG009|Substudy B|Withdrawal by Subject|0|||
131819940|NCT01541215|474622512|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
131819941|NCT01541215|474622513|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
131819942|NCT01541215|474622512|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
131819943|NCT01541215|474622513|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
131819944|NCT01541215|474622512|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
131819945|NCT01541215|474622513|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
131819946|NCT02817828|474622521|FG000|Overall Study|Lost to Follow-up|41|||
131819947|NCT02817828|474622521|FG000|Overall Study|Adverse event not related to bleeding|104|||
131819948|NCT02817828|474622521|FG000|Overall Study|Adverse event related to bleeding|53|||
131819949|NCT02817828|474622521|FG000|Overall Study|Protocol Violation|11|||
131819950|NCT02817828|474622521|FG000|Overall Study|Pregnancy|7|||
131819951|NCT02817828|474622521|FG000|Overall Study|Pregnancy wish|15|||
131819952|NCT02817828|474622521|FG000|Overall Study|Withdrawal by Subject|78|||
131819953|NCT02817828|474622521|FG000|Overall Study|Other|26|||
131819954|NCT02651987|474622523|FG000|Overall Study|Adverse Event|2|||
131819955|NCT02651987|474622524|FG001|Overall Study|Adverse Event|2|||
131819956|NCT02651987|474622523|FG000|Overall Study|Consent Withdrawn|2|||
131819957|NCT02651987|474622524|FG001|Overall Study|Consent Withdrawn|0|||
131819958|NCT02651987|474622523|FG000|Overall Study|Local PD|0|||
131819959|NCT02651987|474622524|FG001|Overall Study|Local PD|2|||
131819960|NCT02651987|474622523|FG000|Overall Study|Investigator Decision|1|||
131819961|NCT02651987|474622524|FG001|Overall Study|Investigator Decision|1|||
131819962|NCT00486434|474622525|FG000|Overall Study|Withdrawal by Subject|34|||
131819963|NCT00486434|474622526|FG001|Overall Study|Withdrawal by Subject|39|||
131819964|NCT00486434|474622525|FG000|Overall Study|Adverse Event|118|||
131819965|NCT00486434|474622526|FG001|Overall Study|Adverse Event|44|||
131819966|NCT00486434|474622525|FG000|Overall Study|Protocol Violation|22|||
131819967|NCT00486434|474622526|FG001|Overall Study|Protocol Violation|21|||
131819968|NCT00486434|474622525|FG000|Overall Study|Lack of Efficacy|12|||
131819969|NCT00486434|474622526|FG001|Overall Study|Lack of Efficacy|19|||
131819970|NCT00486434|474622525|FG000|Overall Study|Lost to Follow-up|2|||
131819971|NCT00486434|474622526|FG001|Overall Study|Lost to Follow-up|3|||
131819972|NCT00486434|474622525|FG000|Overall Study|Death|1|||
131819973|NCT00486434|474622526|FG001|Overall Study|Death|2|||
131819974|NCT00486434|474622525|FG000|Overall Study|Personal reasons|5|||
131819975|NCT00486434|474622526|FG001|Overall Study|Personal reasons|6|||
131819976|NCT00522041|474622527|FG000|Overall Study|Adverse Event|9|||
131819977|NCT00522041|474622528|FG001|Overall Study|Adverse Event|3|||
131819978|NCT00522041|474622527|FG000|Overall Study|Protocol Violation|2|||
131819979|NCT00522041|474622528|FG001|Overall Study|Protocol Violation|0|||
131819980|NCT00522041|474622527|FG000|Overall Study|Lost to Follow-up|1|||
131819981|NCT00522041|474622528|FG001|Overall Study|Lost to Follow-up|4|||
131819982|NCT00522041|474622527|FG000|Overall Study|Voluntary withdrawal|5|||
131819983|NCT00522041|474622528|FG001|Overall Study|Voluntary withdrawal|4|||
131819984|NCT00522041|474622527|FG000|Overall Study|Did not receive treatment|0|||
131819985|NCT00522041|474622528|FG001|Overall Study|Did not receive treatment|1|||
131819986|NCT00544167|474622529|FG000|Overall Study|Adverse Event|21|||
131819987|NCT00544167|474622529|FG000|Overall Study|Physician Decision|8|||
131819988|NCT01944722|474622534|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
131819989|NCT01944722|474622534|FG000|Overall Study|Specimen Shipping Issues|34|||
131819990|NCT01944722|474622534|FG000|Overall Study|Improper Storage/Transport|5|||
131819991|NCT01944722|474622534|FG000|Overall Study|Insufficient Volume for Test|1|||
131819992|NCT01944722|474622534|FG000|Overall Study|Missing Specimens|3|||
131819993|NCT01944722|474622534|FG000|Overall Study|Specimens Mislabeled|2|||
131819994|NCT01944722|474622534|FG000|Overall Study|Withdrawal by Subject|8|||
131819995|NCT01944722|474622534|FG000|Overall Study|NILM Subjects <30 years old|8106|||
131819996|NCT01944722|474622534|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
131819997|NCT01944722|474622534|FG000|Overall Study|>ASCUS Cytology|1122|||
131819998|NCT02906917|474622536|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
131819999|NCT02906917|474622537|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
131820000|NCT02906917|474622536|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
131820001|NCT02906917|474622537|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
131820002|NCT02906917|474622536|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
131820003|NCT02906917|474622537|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
131820004|NCT02906917|474622536|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
131820005|NCT02906917|474622537|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
131820006|NCT02906917|474622536|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
131820007|NCT02906917|474622537|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
131820008|NCT02906917|474622536|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
131820009|NCT02906917|474622537|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
131820010|NCT02906917|474622536|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
131820011|NCT02906917|474622537|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
131820012|NCT02906917|474622536|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
131820013|NCT02906917|474622537|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
131820014|NCT00210639|474622538|FG000|Overall Study|Lost to Follow-up|37|||
131820015|NCT00210639|474622539|FG001|Overall Study|Lost to Follow-up|29|||
131820016|NCT00210639|474622538|FG000|Overall Study|Withdrawal by Subject|8|||
131820017|NCT00210639|474622539|FG001|Overall Study|Withdrawal by Subject|1|||
131820018|NCT00210639|474622538|FG000|Overall Study|Other|18|||
131820019|NCT00210639|474622539|FG001|Overall Study|Other|12|||
131820020|NCT02854800|474622543|FG000|Overall Study|Protocol Violation|16|||
131820021|NCT02854800|474622544|FG001|Overall Study|Protocol Violation|11|||
131820022|NCT02854800|474622545|FG002|Overall Study|Protocol Violation|3|||
131820023|NCT02854800|474622543|FG000|Overall Study|Withdrawal by Subject|4|||
131820024|NCT02854800|474622544|FG001|Overall Study|Withdrawal by Subject|2|||
131820025|NCT02854800|474622545|FG002|Overall Study|Withdrawal by Subject|3|||
131820026|NCT02627963|474622552|FG000|Overall Study|Randomized but not treated|2|||
131820027|NCT02627963|474622553|FG001|Overall Study|Randomized but not treated|6|||
131820028|NCT00152451|474622554|FG000|Overall Study|Adverse Event|4|||
131820029|NCT00503867|474622558|FG000|Overall Study|Lost to Follow-up|1|||
131820030|NCT00503867|474622558|FG000|Overall Study|Adverse Event|1|||
131820031|NCT04697173|474622561|FG000|Overall Study|Withdrawal by Subject|34|||
131820032|NCT04697173|474622562|FG001|Overall Study|Withdrawal by Subject|38|||
131820033|NCT03807440|474622563|FG000|Overall Study|No documentation of index date 2|320|||
131820034|NCT03807440|474622563|FG000|Overall Study|No informed consent for index date 2|117|||
131820035|NCT00323258|474622564|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
131820036|NCT00323258|474622565|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
131820037|NCT00323258|474622564|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
131820038|NCT00323258|474622565|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
131820039|NCT00323258|474622564|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
131820040|NCT00323258|474622565|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
131820041|NCT00323258|474622564|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
131820042|NCT00323258|474622565|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
131820043|NCT00323258|474622564|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
131820044|NCT00323258|474622565|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
131820045|NCT00323258|474622564|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
131820046|NCT00323258|474622565|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
131820047|NCT00323258|474622564|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
131820048|NCT00323258|474622565|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
131820049|NCT02372006|474622575|FG000|Overall Study|Progressive disease|8|||
131820050|NCT02372006|474622576|FG001|Overall Study|Progressive disease|7|||
131820051|NCT02372006|474622577|FG002|Overall Study|Progressive disease|34|||
131820052|NCT02372006|474622575|FG000|Overall Study|Dose limiting toxicity|0|||
131820053|NCT02372006|474622576|FG001|Overall Study|Dose limiting toxicity|1|||
131820054|NCT02372006|474622577|FG002|Overall Study|Dose limiting toxicity|0|||
131820055|NCT02372006|474622575|FG000|Overall Study|Adverse Event|0|||
131820056|NCT02372006|474622576|FG001|Overall Study|Adverse Event|0|||
131820057|NCT02372006|474622577|FG002|Overall Study|Adverse Event|3|||
131820058|NCT02372006|474622575|FG000|Overall Study|Withdrawal by Subject|0|||
131820059|NCT02372006|474622576|FG001|Overall Study|Withdrawal by Subject|1|||
131820060|NCT02372006|474622577|FG002|Overall Study|Withdrawal by Subject|1|||
131820061|NCT02372006|474622575|FG000|Overall Study|Other reason for not completing|0|||
131820062|NCT02372006|474622576|FG001|Overall Study|Other reason for not completing|0|||
131820063|NCT02372006|474622577|FG002|Overall Study|Other reason for not completing|1|||
131820064|NCT01055834|474622581|FG000|Treatment Period I|Adverse Event|1|||
131820065|NCT01055834|474622582|FG001|Treatment Period I|Adverse Event|0|||
131820066|NCT01717313|474622583|FG000|Phase A (Weeks 0 to 24)|Death|0|||
131820067|NCT01717313|474622584|FG001|Phase A (Weeks 0 to 24)|Death|1|||
131820068|NCT01717313|474622583|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
131820069|NCT01717313|474622584|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
131820070|NCT01717313|474622583|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
131820071|NCT01717313|474622584|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
131820072|NCT01717313|474622583|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
131820073|NCT01717313|474622584|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
131820074|NCT01717313|474622583|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
131820075|NCT01717313|474622584|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
131820076|NCT01717313|474622583|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
131820077|NCT01717313|474622584|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
131820078|NCT01717313|474622583|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
131820079|NCT01717313|474622584|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
131820080|NCT01717313|474622583|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
131820081|NCT01717313|474622584|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
131820082|NCT01717313|474622583|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
131820083|NCT01717313|474622584|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
131820084|NCT00295490|474622585|FG000|Overall Study|Protocol Violation|0|||
131820085|NCT00295490|474622586|FG001|Overall Study|Protocol Violation|0|||
131909885|NCT03444584|474958704|FG001|Overall Study|Withdrawal by Subject|1|||
131909886|NCT03444584|474958703|FG000|Overall Study|Other|0|||
131909887|NCT03444584|474958704|FG001|Overall Study|Other|1|||
131909888|NCT03704064|474958705|FG000|Overall Study|Lost to Follow-up|8|||
131909889|NCT03704064|474958706|FG001|Overall Study|Lost to Follow-up|4|||
131909890|NCT03704064|474958705|FG000|Overall Study|Withdrawal by Subject|1|||
131909891|NCT03704064|474958706|FG001|Overall Study|Withdrawal by Subject|1|||
131909892|NCT03704064|474958705|FG000|Overall Study|No longer available for study visits|0|||
131909893|NCT03704064|474958706|FG001|Overall Study|No longer available for study visits|1|||
131909894|NCT03704064|474958705|FG000|Overall Study|Censoring event|1|||
131909895|NCT03704064|474958706|FG001|Overall Study|Censoring event|0|||
131909896|NCT04142242|474958707|FG000|Stage I|Non-compliance with the protocol|1|||
131909897|NCT04142242|474958708|FG001|Stage I|Non-compliance with the protocol|0|||
131909898|NCT04142242|474958709|FG002|Stage I|Non-compliance with the protocol|0|||
131909899|NCT04142242|474958710|FG003|Stage I|Non-compliance with the protocol|0|||
131909900|NCT04142242|474958711|FG004|Stage I|Non-compliance with the protocol|0|||
131909901|NCT04142242|474958712|FG005|Stage I|Non-compliance with the protocol|1|||
131909902|NCT04142242|474958707|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
131909903|NCT04142242|474958708|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
131909904|NCT04142242|474958709|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
131909905|NCT04142242|474958710|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
131909906|NCT04142242|474958711|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
131909907|NCT04142242|474958712|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
131909908|NCT04142242|474958707|FG000|Stage II|Non-compliance with the protocol|0|||
131909909|NCT04142242|474958708|FG001|Stage II|Non-compliance with the protocol|0|||
131909910|NCT04142242|474958709|FG002|Stage II|Non-compliance with the protocol|0|||
131909911|NCT04142242|474958710|FG003|Stage II|Non-compliance with the protocol|2|||
131909912|NCT04142242|474958711|FG004|Stage II|Non-compliance with the protocol|0|||
131909913|NCT04142242|474958712|FG005|Stage II|Non-compliance with the protocol|0|||
131909914|NCT04142242|474958707|FG000|Stage II|Lost to Follow-up|0|||
131909915|NCT04142242|474958708|FG001|Stage II|Lost to Follow-up|0|||
131909916|NCT04142242|474958709|FG002|Stage II|Lost to Follow-up|1|||
131909917|NCT04142242|474958710|FG003|Stage II|Lost to Follow-up|2|||
131400887|NCT05596734|473089652|FG010|Substudy B|Withdrawal by Subject|0|||
131400888|NCT05596734|473089653|FG011|Substudy B|Withdrawal by Subject|0|||
131400889|NCT05596734|473089654|FG012|Substudy B|Withdrawal by Subject|1|||
131400890|NCT05596734|473089655|FG013|Substudy B|Withdrawal by Subject|0|||
131400891|NCT05596734|473089656|FG014|Substudy B|Withdrawal by Subject|1|||
131400892|NCT05596734|473089657|FG015|Substudy B|Withdrawal by Subject|2|||
131400893|NCT05596734|473089658|FG016|Substudy B|Withdrawal by Subject|2|||
131400894|NCT05596734|473089659|FG017|Substudy B|Withdrawal by Subject|1|||
131820086|NCT00295490|474622587|FG002|Overall Study|Protocol Violation|3|||
131820087|NCT00295490|474622588|FG003|Overall Study|Protocol Violation|3|||
131820088|NCT00295490|474622585|FG000|Overall Study|Withdrawal by Subject|0|||
131820089|NCT00295490|474622586|FG001|Overall Study|Withdrawal by Subject|2|||
131820090|NCT00295490|474622587|FG002|Overall Study|Withdrawal by Subject|0|||
131820091|NCT00295490|474622588|FG003|Overall Study|Withdrawal by Subject|1|||
131820092|NCT00295490|474622585|FG000|Overall Study|Lost to Follow-up|0|||
131820093|NCT00295490|474622586|FG001|Overall Study|Lost to Follow-up|0|||
131820094|NCT00295490|474622587|FG002|Overall Study|Lost to Follow-up|1|||
131820095|NCT00295490|474622588|FG003|Overall Study|Lost to Follow-up|0|||
131820096|NCT00295490|474622585|FG000|Overall Study|Adverse Event|1|||
131820097|NCT00295490|474622586|FG001|Overall Study|Adverse Event|0|||
131820098|NCT00295490|474622587|FG002|Overall Study|Adverse Event|0|||
131820099|NCT00295490|474622588|FG003|Overall Study|Adverse Event|0|||
131820100|NCT00295490|474622585|FG000|Overall Study|Other|0|||
131820101|NCT00295490|474622586|FG001|Overall Study|Other|2|||
131820102|NCT00295490|474622587|FG002|Overall Study|Other|0|||
131820103|NCT00295490|474622588|FG003|Overall Study|Other|1|||
131820104|NCT01617096|474622589|FG000|Overall Study|Withdrawal by Subject|96|||
131820105|NCT01617096|474622590|FG001|Overall Study|Withdrawal by Subject|81|||
131820106|NCT01617096|474622589|FG000|Overall Study|Lost to Follow-up|37|||
131820107|NCT01617096|474622590|FG001|Overall Study|Lost to Follow-up|32|||
131820108|NCT01617096|474622589|FG000|Overall Study|Physician Decision|10|||
131820109|NCT01617096|474622590|FG001|Overall Study|Physician Decision|18|||
131820110|NCT01617096|474622589|FG000|Overall Study|Death|4|||
131820111|NCT01617096|474622590|FG001|Overall Study|Death|3|||
131820112|NCT01617096|474622589|FG000|Overall Study|Other|1|||
131820113|NCT01617096|474622590|FG001|Overall Study|Other|3|||
131909918|NCT04142242|474958711|FG004|Stage II|Lost to Follow-up|0|||
131909919|NCT04142242|474958712|FG005|Stage II|Lost to Follow-up|0|||
131909920|NCT04142242|474958707|FG000|Stage II|Withdrawal by Subject|0|||
131909921|NCT04142242|474958708|FG001|Stage II|Withdrawal by Subject|0|||
131909922|NCT04142242|474958709|FG002|Stage II|Withdrawal by Subject|5|||
131909923|NCT04142242|474958710|FG003|Stage II|Withdrawal by Subject|9|||
131400895|NCT05596734|473089660|FG018|Substudy B|Withdrawal by Subject|2|||
131820114|NCT03255980|474622591|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
131400896|NCT05596734|473089661|FG019|Substudy B|Withdrawal by Subject|0|||
131820115|NCT03255980|474622592|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
131820116|NCT03255980|474622593|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
131820117|NCT03255980|474622594|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
131820118|NCT03255980|474622591|FG000|Overall Study|Adverse Event|1|||
131820119|NCT03255980|474622592|FG001|Overall Study|Adverse Event|1|||
131820120|NCT03255980|474622593|FG002|Overall Study|Adverse Event|0|||
131820121|NCT03255980|474622594|FG003|Overall Study|Adverse Event|1|||
131820122|NCT03255980|474622591|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
131820123|NCT03255980|474622592|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
131820124|NCT03255980|474622593|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
131820125|NCT03255980|474622594|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
131820126|NCT03255980|474622591|FG000|Overall Study|Lost to Follow-up|1|||
131820127|NCT03255980|474622592|FG001|Overall Study|Lost to Follow-up|1|||
131400897|NCT05596734|473089662|FG020|Substudy B|Withdrawal by Subject|0|||
131400898|NCT05596734|473089663|FG021|Substudy B|Withdrawal by Subject|0|||
131820128|NCT03255980|474622593|FG002|Overall Study|Lost to Follow-up|0|||
131820129|NCT03255980|474622594|FG003|Overall Study|Lost to Follow-up|3|||
131820130|NCT03255980|474622591|FG000|Overall Study|Withdrawal by Subject|0|||
131820131|NCT03255980|474622592|FG001|Overall Study|Withdrawal by Subject|1|||
131820132|NCT03255980|474622593|FG002|Overall Study|Withdrawal by Subject|0|||
131820133|NCT03255980|474622594|FG003|Overall Study|Withdrawal by Subject|3|||
131820134|NCT02611362|474622595|FG000|Overall Study|Withdrawal by Subject|7|||
131820135|NCT02611362|474622596|FG001|Overall Study|Withdrawal by Subject|2|||
131820136|NCT02611362|474622595|FG000|Overall Study|Lost to Follow-up|2|||
131820137|NCT02611362|474622596|FG001|Overall Study|Lost to Follow-up|4|||
131820138|NCT01196390|474622602|FG000|Overall Study|Protocol Violation|4|||
131820139|NCT01196390|474622603|FG001|Overall Study|Protocol Violation|5|||
131820140|NCT03141151|474622604|FG000|Overall Study|Lost to Follow-up|3|||
131820141|NCT03141151|474622605|FG001|Overall Study|Lost to Follow-up|2|||
131820142|NCT03141151|474622604|FG000|Overall Study|Withdrawal by Subject|3|||
131820143|NCT03141151|474622605|FG001|Overall Study|Withdrawal by Subject|2|||
131820144|NCT04610580|474622606|FG000|Two-way Crossover Period|Adverse Event|1|||
131820145|NCT04610580|474622607|FG001|Two-way Crossover Period|Adverse Event|0|||
131820146|NCT04610580|474622608|FG002|Two-way Crossover Period|Adverse Event|0|||
131820147|NCT04610580|474622609|FG003|Two-way Crossover Period|Adverse Event|0|||
131820148|NCT04610580|474622610|FG004|Two-way Crossover Period|Adverse Event|0|||
131820149|NCT04610580|474622611|FG005|Two-way Crossover Period|Adverse Event|0|||
131820150|NCT04610580|474622606|FG000|Two-way Crossover Period|Physician Decision|1|||
131820151|NCT04610580|474622607|FG001|Two-way Crossover Period|Physician Decision|0|||
131820152|NCT04610580|474622608|FG002|Two-way Crossover Period|Physician Decision|0|||
131820153|NCT04610580|474622609|FG003|Two-way Crossover Period|Physician Decision|0|||
131820154|NCT04610580|474622610|FG004|Two-way Crossover Period|Physician Decision|0|||
131820155|NCT04610580|474622611|FG005|Two-way Crossover Period|Physician Decision|0|||
131820156|NCT04610580|474622606|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
131820157|NCT04610580|474622607|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
131820158|NCT04610580|474622608|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
131820159|NCT04610580|474622609|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
131820160|NCT04610580|474622610|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
131820161|NCT04610580|474622611|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
131820162|NCT04610580|474622606|FG000|Two-way Crossover Period|Other than specified|0|||
131820163|NCT04610580|474622607|FG001|Two-way Crossover Period|Other than specified|1|||
131820164|NCT04610580|474622608|FG002|Two-way Crossover Period|Other than specified|0|||
131400899|NCT05596734|473089664|FG022|Substudy B|Withdrawal by Subject|0|||
131400900|NCT05596734|473089665|FG023|Substudy B|Withdrawal by Subject|1|||
131400901|NCT05596734|473089642|FG000|Substudy B|Physician Decision|0|||
131400902|NCT05596734|473089643|FG001|Substudy B|Physician Decision|0|||
131820165|NCT04610580|474622609|FG003|Two-way Crossover Period|Other than specified|0|||
131820166|NCT04610580|474622610|FG004|Two-way Crossover Period|Other than specified|0|||
131820167|NCT04610580|474622611|FG005|Two-way Crossover Period|Other than specified|0|||
131820168|NCT04610580|474622606|FG000|Washout Before Extension Period|Other than specified|0|||
131820169|NCT04610580|474622607|FG001|Washout Before Extension Period|Other than specified|1|||
131820170|NCT04610580|474622608|FG002|Washout Before Extension Period|Other than specified|0|||
131820171|NCT04610580|474622609|FG003|Washout Before Extension Period|Other than specified|0|||
131820172|NCT04610580|474622610|FG004|Washout Before Extension Period|Other than specified|0|||
131820173|NCT04610580|474622611|FG005|Washout Before Extension Period|Other than specified|0|||
131820174|NCT04610580|474622606|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
131820175|NCT04610580|474622607|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
131820176|NCT04610580|474622608|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
131400903|NCT05596734|473089644|FG002|Substudy B|Physician Decision|0|||
131400904|NCT05596734|473089645|FG003|Substudy B|Physician Decision|0|||
131400905|NCT05596734|473089646|FG004|Substudy B|Physician Decision|0|||
131400906|NCT05596734|473089647|FG005|Substudy B|Physician Decision|0|||
131400907|NCT05596734|473089648|FG006|Substudy B|Physician Decision|0|||
131400908|NCT05596734|473089649|FG007|Substudy B|Physician Decision|0|||
131400909|NCT05596734|473089650|FG008|Substudy B|Physician Decision|0|||
131400910|NCT05596734|473089651|FG009|Substudy B|Physician Decision|0|||
131400911|NCT05596734|473089652|FG010|Substudy B|Physician Decision|0|||
131820177|NCT04610580|474622609|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
131820178|NCT04610580|474622610|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
131820179|NCT04610580|474622611|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
131820180|NCT04610580|474622606|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
131820181|NCT04610580|474622607|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
131820182|NCT04610580|474622608|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
131820183|NCT04610580|474622609|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
131820184|NCT04610580|474622610|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
131820185|NCT04610580|474622611|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
131820186|NCT00884390|474622614|FG000|Overall Study|Adverse Event|0|||
131820187|NCT00884390|474622615|FG001|Overall Study|Adverse Event|1|||
131820188|NCT00884390|474622614|FG000|Overall Study|Lost to Follow-up|0|||
131820189|NCT00884390|474622615|FG001|Overall Study|Lost to Follow-up|1|||
131820190|NCT00884390|474622614|FG000|Overall Study|Physician Decision|2|||
131820191|NCT00884390|474622615|FG001|Overall Study|Physician Decision|1|||
131820192|NCT00884390|474622614|FG000|Overall Study|Protocol Violation|4|||
131820193|NCT00884390|474622615|FG001|Overall Study|Protocol Violation|1|||
131820194|NCT00884390|474622614|FG000|Overall Study|Withdrawal by Subject|4|||
131820195|NCT00884390|474622615|FG001|Overall Study|Withdrawal by Subject|1|||
131820196|NCT00884390|474622614|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
131820197|NCT00884390|474622615|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
131820198|NCT00884390|474622614|FG000|Overall Study|Other|11|||
131820199|NCT00884390|474622615|FG001|Overall Study|Other|1|||
131820200|NCT01691612|474622616|FG000|Overall Study|deemed ineligible after 1st visit|6|||
131820201|NCT01691612|474622616|FG000|Overall Study|Adverse Event|1|||
131820202|NCT01874535|474622617|FG000|Overall Study|Lost to Follow-up|10|||
131820203|NCT01874535|474622618|FG001|Overall Study|Lost to Follow-up|9|||
131820204|NCT01874535|474622617|FG000|Overall Study|incomplete symptom resolution|45|||
131820205|NCT01874535|474622618|FG001|Overall Study|incomplete symptom resolution|35|||
131820206|NCT01215721|474622619|FG000|Overall Study|Adverse Event|2|||
131820207|NCT00045162|474622620|FG000|Overall Study|Ineligible|12|||
131820208|NCT00045162|474622621|FG001|Overall Study|Ineligible|8|||
131820209|NCT00045162|474622620|FG000|Overall Study|Not treated|7|||
131820210|NCT00045162|474622621|FG001|Overall Study|Not treated|2|||
131820211|NCT00045162|474622620|FG000|Overall Study|Adverse Event|55|||
131820212|NCT00045162|474622621|FG001|Overall Study|Adverse Event|50|||
131820213|NCT00045162|474622620|FG000|Overall Study|Lack of Efficacy|32|||
131820214|NCT00045162|474622621|FG001|Overall Study|Lack of Efficacy|29|||
131820215|NCT00045162|474622620|FG000|Overall Study|Death|10|||
131820216|NCT00045162|474622621|FG001|Overall Study|Death|10|||
131820217|NCT00045162|474622620|FG000|Overall Study|Withdrawal by Subject|5|||
131820218|NCT00045162|474622621|FG001|Overall Study|Withdrawal by Subject|3|||
131820219|NCT00045162|474622620|FG000|Overall Study|Other|21|||
131820220|NCT00045162|474622621|FG001|Overall Study|Other|16|||
131820221|NCT01044433|474622622|FG000|Overall Study|Lost to Follow-up|3|||
131820222|NCT01044433|474622622|FG000|Overall Study|Withdrawal by Subject|3|||
131820223|NCT05065619|474622623|FG000|Up to Day 42|Lost to Follow-up|1|||
131820224|NCT05065619|474622624|FG001|Up to Day 42|Lost to Follow-up|0|||
131820225|NCT05065619|474622623|FG000|Up to Day 42|Withdrawal by Subject|1|||
131820226|NCT05065619|474622624|FG001|Up to Day 42|Withdrawal by Subject|0|||
131820227|NCT05065619|474622623|FG000|After Day 43|Lost to Follow-up|1|||
131820228|NCT05065619|474622624|FG001|After Day 43|Lost to Follow-up|0|||
131820229|NCT05065619|474622623|FG000|After Day 43|Physician Decision|3|||
131820230|NCT05065619|474622624|FG001|After Day 43|Physician Decision|0|||
131820231|NCT05065619|474622623|FG000|After Day 43|Withdrawal by Subject|1|||
131820232|NCT05065619|474622624|FG001|After Day 43|Withdrawal by Subject|2|||
131820233|NCT05065619|474622623|FG000|After Day 43|Public vaccination|6|||
131820234|NCT05065619|474622624|FG001|After Day 43|Public vaccination|8|||
131820235|NCT05065619|474622623|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
131820236|NCT05065619|474622624|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
131400912|NCT05596734|473089653|FG011|Substudy B|Physician Decision|0|||
131820237|NCT05065619|474622623|FG000|After Day 43|Study Terminated by Sponsor|88|||
131820238|NCT05065619|474622624|FG001|After Day 43|Study Terminated by Sponsor|16|||
131820239|NCT01929681|474622626|FG000|Overall Study|Withdrawal by Subject|1|||
131820240|NCT01929681|474622627|FG001|Overall Study|Withdrawal by Subject|0|||
131820241|NCT01929681|474622626|FG000|Overall Study|Physician Decision|1|||
131820242|NCT01929681|474622627|FG001|Overall Study|Physician Decision|1|||
131820243|NCT02218216|474622628|FG000|Overall Study|Study terminated before completed|6|||
131820244|NCT02218216|474622629|FG001|Overall Study|Study terminated before completed|0|||
131820245|NCT02218216|474622630|FG002|Overall Study|Study terminated before completed|0|||
131820246|NCT03506633|474623824|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
131820247|NCT03506633|474623825|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
131820248|NCT00640341|474623826|FG000|Overall Study|Adverse Event|0|||
131820249|NCT00640341|474623827|FG001|Overall Study|Adverse Event|0|||
131820250|NCT00640341|474623828|FG002|Overall Study|Adverse Event|1|||
131400913|NCT05596734|473089654|FG012|Substudy B|Physician Decision|0|||
131820251|NCT00640341|474623826|FG000|Overall Study|Positive Slit Lamp Findings|0|||
131820252|NCT00640341|474623827|FG001|Overall Study|Positive Slit Lamp Findings|0|||
131820253|NCT00640341|474623828|FG002|Overall Study|Positive Slit Lamp Findings|1|||
131820254|NCT00640341|474623826|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
131820255|NCT00640341|474623827|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
131820256|NCT00640341|474623828|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
131820257|NCT00640341|474623826|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
131820258|NCT00640341|474623827|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
131820259|NCT00640341|474623828|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
131820260|NCT00640341|474623826|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
131820261|NCT00640341|474623827|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
131820262|NCT00640341|474623828|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
131820263|NCT00640341|474623826|FG000|Overall Study|Lost to Follow-up|2|||
131820264|NCT00640341|474623827|FG001|Overall Study|Lost to Follow-up|0|||
131820265|NCT00640341|474623828|FG002|Overall Study|Lost to Follow-up|0|||
131820266|NCT00640341|474623826|FG000|Overall Study|Withdrawal by Subject|4|||
131820267|NCT00640341|474623827|FG001|Overall Study|Withdrawal by Subject|0|||
131820268|NCT00640341|474623828|FG002|Overall Study|Withdrawal by Subject|1|||
131820269|NCT00640341|474623826|FG000|Overall Study|Unacceptable Lens Movement|1|||
131820270|NCT00640341|474623827|FG001|Overall Study|Unacceptable Lens Movement|0|||
131820271|NCT00640341|474623828|FG002|Overall Study|Unacceptable Lens Movement|0|||
131820272|NCT00640341|474623826|FG000|Overall Study|Poor fit/Uncomfortable|4|||
131820273|NCT00640341|474623827|FG001|Overall Study|Poor fit/Uncomfortable|0|||
131820274|NCT00640341|474623828|FG002|Overall Study|Poor fit/Uncomfortable|0|||
131820275|NCT00640341|474623826|FG000|Overall Study|Ineligable at Baseline|5|||
131820276|NCT00640341|474623827|FG001|Overall Study|Ineligable at Baseline|3|||
131820277|NCT00640341|474623828|FG002|Overall Study|Ineligable at Baseline|2|||
131820278|NCT00640341|474623826|FG000|Overall Study|Adverse event and positive slit lamp|1|||
131820279|NCT00640341|474623827|FG001|Overall Study|Adverse event and positive slit lamp|0|||
131820280|NCT00640341|474623828|FG002|Overall Study|Adverse event and positive slit lamp|0|||
131820281|NCT01894230|474623830|FG000|Overall Study|Lost to Follow-up|2|||
131820282|NCT01894230|474623831|FG001|Overall Study|Lost to Follow-up|2|||
131820283|NCT01894230|474623830|FG000|Overall Study|Withdrawal by Subject|4|||
131820284|NCT01894230|474623831|FG001|Overall Study|Withdrawal by Subject|4|||
131820285|NCT01894230|474623830|FG000|Overall Study|Non-adherent|0|||
131820286|NCT01894230|474623831|FG001|Overall Study|Non-adherent|1|||
131820287|NCT01894230|474623830|FG000|Overall Study|Death|1|||
131820288|NCT01894230|474623831|FG001|Overall Study|Death|0|||
131820289|NCT02966340|474623832|FG000|Overall Study|Adverse Event|0|||
131820290|NCT02966340|474623833|FG001|Overall Study|Adverse Event|1|||
131820291|NCT02966340|474623832|FG000|Overall Study|Lost to Follow-up|0|||
131820292|NCT02966340|474623833|FG001|Overall Study|Lost to Follow-up|1|||
131820293|NCT02966340|474623832|FG000|Overall Study|Withdrawal by Subject|1|||
131820294|NCT02966340|474623833|FG001|Overall Study|Withdrawal by Subject|0|||
131820295|NCT02966340|474623832|FG000|Overall Study|data acquisition error|1|||
131820296|NCT02966340|474623833|FG001|Overall Study|data acquisition error|0|||
131820297|NCT02966340|474623832|FG000|Overall Study|startle non-responder|1|||
131820298|NCT02966340|474623833|FG001|Overall Study|startle non-responder|1|||
131820299|NCT04556734|474623834|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
131820300|NCT04556734|474623835|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131820301|NCT04556734|474623836|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131820302|NCT04556734|474623837|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131820303|NCT04556734|474623838|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131820304|NCT04556734|474623839|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131820305|NCT04556734|474623840|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131820306|NCT04556734|474623841|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131820307|NCT04556734|474623834|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
131820308|NCT04556734|474623835|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131820309|NCT04556734|474623836|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131820310|NCT04556734|474623837|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131400914|NCT05596734|473089655|FG013|Substudy B|Physician Decision|0|||
131400915|NCT05596734|473089656|FG014|Substudy B|Physician Decision|0|||
131820311|NCT04556734|474623838|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131820312|NCT04556734|474623839|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131820313|NCT04556734|474623840|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131820314|NCT04556734|474623841|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131820315|NCT04556734|474623834|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131820316|NCT04556734|474623835|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131820317|NCT04556734|474623836|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131400916|NCT05596734|473089657|FG015|Substudy B|Physician Decision|1|||
131820318|NCT04556734|474623837|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131820319|NCT04556734|474623838|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131820320|NCT04556734|474623839|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131820321|NCT04556734|474623840|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131820322|NCT04556734|474623841|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131820323|NCT04556734|474623834|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
131820324|NCT04556734|474623835|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820325|NCT04556734|474623836|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820326|NCT04556734|474623837|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820327|NCT04556734|474623838|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820328|NCT04556734|474623839|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820329|NCT04556734|474623840|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820330|NCT04556734|474623841|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131820331|NCT04556734|474623834|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820332|NCT04556734|474623835|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820333|NCT04556734|474623836|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
131820334|NCT04556734|474623837|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820335|NCT04556734|474623838|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820336|NCT04556734|474623839|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820337|NCT04556734|474623840|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820338|NCT04556734|474623841|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
131820339|NCT04556734|474623834|FG000|OLE Period (28 Weeks)|Not reported|0|||
131820340|NCT04556734|474623835|FG001|OLE Period (28 Weeks)|Not reported|0|||
131820341|NCT04556734|474623836|FG002|OLE Period (28 Weeks)|Not reported|0|||
131820342|NCT04556734|474623837|FG003|OLE Period (28 Weeks)|Not reported|0|||
131820343|NCT04556734|474623838|FG004|OLE Period (28 Weeks)|Not reported|0|||
131820344|NCT04556734|474623839|FG005|OLE Period (28 Weeks)|Not reported|1|||
131820345|NCT04556734|474623840|FG006|OLE Period (28 Weeks)|Not reported|0|||
131820346|NCT04556734|474623841|FG007|OLE Period (28 Weeks)|Not reported|0|||
131820347|NCT04556734|474623834|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820348|NCT04556734|474623835|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820349|NCT04556734|474623836|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820350|NCT04556734|474623837|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820351|NCT04556734|474623838|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820352|NCT04556734|474623839|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820353|NCT04556734|474623840|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131820354|NCT04556734|474623841|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
131820355|NCT04556734|474623834|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
131820356|NCT04556734|474623835|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
131820357|NCT04556734|474623836|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
131820358|NCT04556734|474623837|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
131820359|NCT04556734|474623838|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
131820360|NCT04556734|474623839|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
131820361|NCT04556734|474623840|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
131820362|NCT04556734|474623841|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
131820363|NCT04556734|474623834|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131820364|NCT04556734|474623835|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131820365|NCT04556734|474623836|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131820366|NCT04556734|474623837|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
131820367|NCT04556734|474623838|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
131820368|NCT04556734|474623839|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
131820369|NCT04556734|474623840|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
131820370|NCT04556734|474623841|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131820371|NCT01120899|474623844|FG000|Overall Study|Withdrawal by Subject|3|||
131820372|NCT00735696|474623847|FG000|Overall Study|Withdrawal by Subject|1|||
131820373|NCT00735696|474623847|FG000|Overall Study|Enrolled but never Treated|1|||
131820374|NCT02998541|474623850|FG000|Overall Study|Adverse Event|4|||
131820375|NCT02998541|474623851|FG001|Overall Study|Adverse Event|5|||
131820376|NCT02998541|474623852|FG002|Overall Study|Adverse Event|1|||
131820377|NCT02998541|474623850|FG000|Overall Study|Protocol Violation|1|||
131820378|NCT02998541|474623851|FG001|Overall Study|Protocol Violation|0|||
131820379|NCT02998541|474623852|FG002|Overall Study|Protocol Violation|0|||
131820380|NCT02998541|474623850|FG000|Overall Study|Withdrawal by Subject|3|||
131820381|NCT02998541|474623851|FG001|Overall Study|Withdrawal by Subject|1|||
131820382|NCT02998541|474623852|FG002|Overall Study|Withdrawal by Subject|0|||
131820383|NCT02998541|474623850|FG000|Overall Study|Lost to Follow-up|0|||
131820384|NCT02998541|474623851|FG001|Overall Study|Lost to Follow-up|3|||
131820385|NCT02998541|474623852|FG002|Overall Study|Lost to Follow-up|1|||
131820386|NCT02998541|474623850|FG000|Overall Study|Physician Decision|0|||
131820387|NCT02998541|474623851|FG001|Overall Study|Physician Decision|0|||
131820388|NCT02998541|474623852|FG002|Overall Study|Physician Decision|3|||
131820389|NCT02998541|474623850|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131820390|NCT02998541|474623851|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131820391|NCT02998541|474623852|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
131820392|NCT02733627|474623853|FG000|Overall Study|Adverse Event|0|||
131820393|NCT02733627|474623854|FG001|Overall Study|Adverse Event|1|||
131820394|NCT02733627|474623855|FG002|Overall Study|Adverse Event|1|||
131820395|NCT02733627|474623856|FG003|Overall Study|Adverse Event|0|||
131820396|NCT02733627|474623853|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
131820397|NCT02733627|474623854|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
131820398|NCT02733627|474623855|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
131820399|NCT02733627|474623856|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
131820400|NCT00183196|474623857|FG000|Overall Study|Withdrawal by Subject|18|||
131820401|NCT00183196|474623858|FG001|Overall Study|Withdrawal by Subject|11|||
131820402|NCT00183196|474623859|FG002|Overall Study|Withdrawal by Subject|13|||
131820403|NCT00183196|474623857|FG000|Overall Study|Adverse Event|1|||
131820404|NCT00183196|474623858|FG001|Overall Study|Adverse Event|2|||
131820405|NCT00183196|474623859|FG002|Overall Study|Adverse Event|2|||
131820406|NCT00183196|474623857|FG000|Overall Study|Legal event|1|||
131820407|NCT00183196|474623858|FG001|Overall Study|Legal event|1|||
131820408|NCT00183196|474623859|FG002|Overall Study|Legal event|1|||
131820409|NCT00183196|474623857|FG000|Overall Study|Required more intensive care|0|||
131820410|NCT00183196|474623858|FG001|Overall Study|Required more intensive care|1|||
131820411|NCT00183196|474623859|FG002|Overall Study|Required more intensive care|2|||
131820412|NCT01513239|474623865|FG000|Period 1: Main Phase|Adverse Event|1|||
131820413|NCT01513239|474623866|FG001|Period 1: Main Phase|Adverse Event|1|||
131820414|NCT01513239|474623867|FG002|Period 1: Main Phase|Adverse Event|2|||
131820415|NCT01513239|474623868|FG003|Period 1: Main Phase|Adverse Event|0|||
131820416|NCT01513239|474623869|FG004|Period 1: Main Phase|Adverse Event|0|||
131820417|NCT01513239|474623870|FG005|Period 1: Main Phase|Adverse Event|0|||
131820418|NCT01513239|474623865|FG000|Period 1: Main Phase|Death|29|||
131820419|NCT01513239|474623866|FG001|Period 1: Main Phase|Death|22|||
131820420|NCT01513239|474623867|FG002|Period 1: Main Phase|Death|32|||
131820421|NCT01513239|474623868|FG003|Period 1: Main Phase|Death|0|||
131820422|NCT01513239|474623869|FG004|Period 1: Main Phase|Death|0|||
131820423|NCT01513239|474623870|FG005|Period 1: Main Phase|Death|0|||
131820424|NCT01513239|474623865|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
131820425|NCT01513239|474623866|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
131820426|NCT01513239|474623867|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
131820427|NCT01513239|474623868|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
131820428|NCT01513239|474623869|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
131820429|NCT01513239|474623870|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
131820430|NCT01513239|474623865|FG000|Period 1: Main Phase|Physician Decision|4|||
131820431|NCT01513239|474623866|FG001|Period 1: Main Phase|Physician Decision|4|||
131820432|NCT01513239|474623867|FG002|Period 1: Main Phase|Physician Decision|4|||
131820433|NCT01513239|474623868|FG003|Period 1: Main Phase|Physician Decision|0|||
131820434|NCT01513239|474623869|FG004|Period 1: Main Phase|Physician Decision|0|||
131820435|NCT01513239|474623870|FG005|Period 1: Main Phase|Physician Decision|0|||
131820436|NCT01513239|474623865|FG000|Period 1: Main Phase|Protocol Violation|2|||
131820437|NCT01513239|474623866|FG001|Period 1: Main Phase|Protocol Violation|2|||
131820438|NCT01513239|474623867|FG002|Period 1: Main Phase|Protocol Violation|2|||
131820439|NCT01513239|474623868|FG003|Period 1: Main Phase|Protocol Violation|0|||
131820440|NCT01513239|474623869|FG004|Period 1: Main Phase|Protocol Violation|0|||
131820441|NCT01513239|474623870|FG005|Period 1: Main Phase|Protocol Violation|0|||
131820442|NCT01513239|474623865|FG000|Period 1: Main Phase|Technical Problems|1|||
131820443|NCT01513239|474623866|FG001|Period 1: Main Phase|Technical Problems|2|||
131820444|NCT01513239|474623867|FG002|Period 1: Main Phase|Technical Problems|0|||
131820445|NCT01513239|474623868|FG003|Period 1: Main Phase|Technical Problems|0|||
131820446|NCT01513239|474623869|FG004|Period 1: Main Phase|Technical Problems|0|||
131820447|NCT01513239|474623870|FG005|Period 1: Main Phase|Technical Problems|0|||
131820448|NCT01513239|474623865|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
131820449|NCT01513239|474623866|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
131820450|NCT01513239|474623867|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
131400917|NCT05596734|473089658|FG016|Substudy B|Physician Decision|0|||
131400918|NCT05596734|473089659|FG017|Substudy B|Physician Decision|0|||
131820451|NCT01513239|474623868|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
131820452|NCT01513239|474623869|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
131820453|NCT01513239|474623870|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
131820454|NCT01513239|474623865|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
131820455|NCT01513239|474623866|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
131820456|NCT01513239|474623867|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
131820457|NCT01513239|474623868|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
131820458|NCT01513239|474623869|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
131820459|NCT01513239|474623870|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
131820460|NCT01513239|474623865|FG000|Period 2: 9 Month Extension Phase|Death|0|||
131820461|NCT01513239|474623866|FG001|Period 2: 9 Month Extension Phase|Death|0|||
131820462|NCT01513239|474623867|FG002|Period 2: 9 Month Extension Phase|Death|0|||
131820463|NCT01513239|474623868|FG003|Period 2: 9 Month Extension Phase|Death|2|||
131400919|NCT05596734|473089660|FG018|Substudy B|Physician Decision|0|||
131400920|NCT05596734|473089661|FG019|Substudy B|Physician Decision|0|||
131400921|NCT05596734|473089662|FG020|Substudy B|Physician Decision|0|||
131400922|NCT05596734|473089663|FG021|Substudy B|Physician Decision|0|||
131400923|NCT05596734|473089664|FG022|Substudy B|Physician Decision|0|||
131400924|NCT05596734|473089665|FG023|Substudy B|Physician Decision|0|||
131400925|NCT05596734|473089642|FG000|Substudy B|Lost to Follow-up|0|||
131400926|NCT05596734|473089643|FG001|Substudy B|Lost to Follow-up|0|||
131820464|NCT01513239|474623869|FG004|Period 2: 9 Month Extension Phase|Death|5|||
131820465|NCT01513239|474623870|FG005|Period 2: 9 Month Extension Phase|Death|2|||
131820466|NCT01513239|474623865|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
131820467|NCT01513239|474623866|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
131820468|NCT01513239|474623867|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
131820469|NCT01513239|474623868|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
131820470|NCT01513239|474623869|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
131820471|NCT01513239|474623870|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
131820472|NCT01513239|474623865|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
131820473|NCT01513239|474623866|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
131820474|NCT01513239|474623867|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
131820475|NCT01513239|474623868|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
131820476|NCT01513239|474623869|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
131820477|NCT01513239|474623870|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
131820478|NCT01513239|474623865|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
131820479|NCT01513239|474623866|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
131820480|NCT01513239|474623867|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
131820481|NCT01513239|474623868|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
131820482|NCT01513239|474623869|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
131820483|NCT01513239|474623870|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
131820484|NCT00059332|474623873|FG000|Overall Study|Withdrawal by Subject|2|||
131820485|NCT00059332|474623874|FG001|Overall Study|Withdrawal by Subject|1|||
131820486|NCT00059332|474623873|FG000|Overall Study|Lost to Follow-up|1|||
131820487|NCT00059332|474623874|FG001|Overall Study|Lost to Follow-up|1|||
131820488|NCT03387462|474623877|FG000|Overall Study|Lost to Follow-up|1|||
131820489|NCT04281472|474623880|FG000|Stage A|Lack of Efficacy|8|||
131820490|NCT04281472|474623881|FG001|Stage A|Lack of Efficacy|0|||
131820491|NCT04281472|474623882|FG002|Stage A|Lack of Efficacy|0|||
131820492|NCT04281472|474623880|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
131820493|NCT04281472|474623881|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
131820494|NCT04281472|474623882|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
131820495|NCT04281472|474623880|FG000|Stage A|Adverse Event|20|||
131820496|NCT04281472|474623881|FG001|Stage A|Adverse Event|0|||
131820497|NCT04281472|474623882|FG002|Stage A|Adverse Event|0|||
131820498|NCT04281472|474623880|FG000|Stage A|Death|1|||
131820499|NCT04281472|474623881|FG001|Stage A|Death|0|||
131820500|NCT04281472|474623882|FG002|Stage A|Death|0|||
131820501|NCT04281472|474623880|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
131820502|NCT04281472|474623881|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
131820503|NCT04281472|474623882|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
131820504|NCT04281472|474623880|FG000|Stage A|Lost to Follow-up|2|||
131820505|NCT04281472|474623881|FG001|Stage A|Lost to Follow-up|0|||
131820506|NCT04281472|474623882|FG002|Stage A|Lost to Follow-up|0|||
131820507|NCT04281472|474623880|FG000|Stage A|Non-compliance with study drug|1|||
131820508|NCT04281472|474623881|FG001|Stage A|Non-compliance with study drug|0|||
131820509|NCT04281472|474623882|FG002|Stage A|Non-compliance with study drug|0|||
131820510|NCT04281472|474623880|FG000|Stage A|Physician Decision|1|||
131820511|NCT04281472|474623881|FG001|Stage A|Physician Decision|0|||
131820512|NCT04281472|474623882|FG002|Stage A|Physician Decision|0|||
131820513|NCT04281472|474623880|FG000|Stage A|Prohibited medications|2|||
131400927|NCT05596734|473089644|FG002|Substudy B|Lost to Follow-up|0|||
131400928|NCT05596734|473089645|FG003|Substudy B|Lost to Follow-up|0|||
131400929|NCT05596734|473089646|FG004|Substudy B|Lost to Follow-up|0|||
131400930|NCT05596734|473089647|FG005|Substudy B|Lost to Follow-up|0|||
131400931|NCT05596734|473089648|FG006|Substudy B|Lost to Follow-up|0|||
131400932|NCT05596734|473089649|FG007|Substudy B|Lost to Follow-up|0|||
131400933|NCT05596734|473089650|FG008|Substudy B|Lost to Follow-up|0|||
131400934|NCT05596734|473089651|FG009|Substudy B|Lost to Follow-up|0|||
131820514|NCT04281472|474623881|FG001|Stage A|Prohibited medications|0|||
131820515|NCT04281472|474623882|FG002|Stage A|Prohibited medications|0|||
131820516|NCT04281472|474623880|FG000|Stage A|Withdrawal by Subject|11|||
131820517|NCT04281472|474623881|FG001|Stage A|Withdrawal by Subject|0|||
131820518|NCT04281472|474623882|FG002|Stage A|Withdrawal by Subject|0|||
131820519|NCT04281472|474623880|FG000|Stage A|Other|5|||
131820520|NCT04281472|474623881|FG001|Stage A|Other|0|||
131820521|NCT04281472|474623882|FG002|Stage A|Other|0|||
131820522|NCT04281472|474623880|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
131820523|NCT04281472|474623881|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
131820524|NCT04281472|474623882|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
131820525|NCT04281472|474623880|FG000|Stage B|Adverse Event|0|||
131820526|NCT04281472|474623881|FG001|Stage B|Adverse Event|3|||
131820527|NCT04281472|474623882|FG002|Stage B|Adverse Event|0|||
131820528|NCT04281472|474623880|FG000|Stage B|Death|0|||
131820529|NCT04281472|474623881|FG001|Stage B|Death|0|||
131820530|NCT04281472|474623882|FG002|Stage B|Death|1|||
131820531|NCT04281472|474623880|FG000|Stage B|Lack of Efficacy|0|||
131820532|NCT04281472|474623881|FG001|Stage B|Lack of Efficacy|0|||
131820533|NCT04281472|474623882|FG002|Stage B|Lack of Efficacy|1|||
131820534|NCT04281472|474623880|FG000|Stage B|Lost to Follow-up|0|||
131820535|NCT04281472|474623881|FG001|Stage B|Lost to Follow-up|0|||
131820536|NCT04281472|474623882|FG002|Stage B|Lost to Follow-up|2|||
131820537|NCT04281472|474623880|FG000|Stage B|Prohibited medications|0|||
131820538|NCT04281472|474623881|FG001|Stage B|Prohibited medications|2|||
131820539|NCT04281472|474623882|FG002|Stage B|Prohibited medications|1|||
131820540|NCT04281472|474623880|FG000|Stage B|Protocol Violation|0|||
131820541|NCT04281472|474623881|FG001|Stage B|Protocol Violation|1|||
131820542|NCT04281472|474623882|FG002|Stage B|Protocol Violation|1|||
131820543|NCT04281472|474623880|FG000|Stage B|Sponsor decision|0|||
131820544|NCT04281472|474623881|FG001|Stage B|Sponsor decision|0|||
131820545|NCT04281472|474623882|FG002|Stage B|Sponsor decision|1|||
131820546|NCT04281472|474623880|FG000|Stage B|Withdrawal by Subject|0|||
131820547|NCT04281472|474623881|FG001|Stage B|Withdrawal by Subject|3|||
131820548|NCT04281472|474623882|FG002|Stage B|Withdrawal by Subject|3|||
131820549|NCT04281472|474623880|FG000|Stage B|Other|0|||
131820550|NCT04281472|474623881|FG001|Stage B|Other|3|||
131820551|NCT04281472|474623882|FG002|Stage B|Other|0|||
131820552|NCT05278858|474623883|FG000|Overall Study|Withdrawal by Subject|1|||
131820553|NCT05004649|474623891|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
131820554|NCT05004649|474623891|FG000|Overall Study|Lost to Follow-up|1|||
131820555|NCT05004649|474623891|FG000|Overall Study|Withdrawal by Subject|2|||
131820556|NCT05004649|474623891|FG000|Overall Study|COVID-19|1|||
131820557|NCT03504085|474623892|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
131820558|NCT03504085|474623893|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
131820559|NCT03504085|474623892|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
131820560|NCT03504085|474623893|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
131820561|NCT00728754|474623894|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
131820562|NCT00728754|474623895|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
131820563|NCT00728754|474623894|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
131820564|NCT00728754|474623895|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
131820565|NCT00728754|474623894|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
131820566|NCT00728754|474623895|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
131820567|NCT00009945|474623896|FG000|Overall Study|no follow up data|7|||
131820568|NCT00009945|474623897|FG001|Overall Study|no follow up data|5|||
131820569|NCT02654145|474623898|FG000|Overall Study|Lack of Efficacy|1|||
131820570|NCT02654145|474623898|FG000|Overall Study|Protocol Violation|1|||
131820571|NCT02654145|474623898|FG000|Overall Study|Withdrawal by Subject|5|||
131820572|NCT02637141|474623903|FG000|Overall Study|Adverse Event|1|||
131820573|NCT02637141|474623904|FG001|Overall Study|Adverse Event|1|||
131820574|NCT02637141|474623905|FG002|Overall Study|Adverse Event|0|||
131820575|NCT02637141|474623903|FG000|Overall Study|Withdrawal by Subject|1|||
131820576|NCT02637141|474623904|FG001|Overall Study|Withdrawal by Subject|1|||
131820577|NCT02637141|474623905|FG002|Overall Study|Withdrawal by Subject|1|||
131820578|NCT01943435|474623909|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
131820579|NCT01943435|474623910|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
131820580|NCT01943435|474623911|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
131820581|NCT01943435|474623909|FG000|Intervention Period|Withdrawal by Subject|3|||
131820582|NCT01943435|474623910|FG001|Intervention Period|Withdrawal by Subject|3|||
131820583|NCT01943435|474623911|FG002|Intervention Period|Withdrawal by Subject|4|||
131820584|NCT01943435|474623909|FG000|2 Month Follow up|Lost to Follow-up|2|||
131820585|NCT01943435|474623910|FG001|2 Month Follow up|Lost to Follow-up|3|||
131820586|NCT01943435|474623911|FG002|2 Month Follow up|Lost to Follow-up|0|||
131820587|NCT01943435|474623909|FG000|6 Month Follow up|Lost to Follow-up|12|||
131820588|NCT01943435|474623910|FG001|6 Month Follow up|Lost to Follow-up|7|||
131820589|NCT01943435|474623911|FG002|6 Month Follow up|Lost to Follow-up|15|||
131820590|NCT03885934|474623916|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
131820591|NCT03885934|474623917|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
131820592|NCT03885934|474623918|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
131820593|NCT03885934|474623919|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
131820594|NCT03885934|474623920|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
131820595|NCT03885934|474623921|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
131820596|NCT01097694|474623932|FG000|Overall Study|Adverse Event|5|||
131820597|NCT01097694|474623933|FG001|Overall Study|Adverse Event|0|||
131820598|NCT01097694|474623932|FG000|Overall Study|Lost to Follow-up|0|||
131820599|NCT01097694|474623933|FG001|Overall Study|Lost to Follow-up|3|||
131820600|NCT01097694|474623932|FG000|Overall Study|Withdrawal by Subject|3|||
131820601|NCT01097694|474623933|FG001|Overall Study|Withdrawal by Subject|1|||
131820602|NCT02179190|474623934|FG000|Enrollment|Exit Prior to Device Attempt|11|||
131820603|NCT02179190|474623934|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
131820604|NCT02179190|474623934|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
131820605|NCT02179190|474623934|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
131820606|NCT02179190|474623934|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
131820607|NCT02179190|474623934|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
131820608|NCT02377349|474623935|FG000|Overall Study|Serious Adverse Event|1|||
131820609|NCT02377349|474623936|FG001|Overall Study|Serious Adverse Event|0|||
131820610|NCT02377349|474623935|FG000|Overall Study|Protocol Violation|3|||
131820611|NCT02377349|474623936|FG001|Overall Study|Protocol Violation|2|||
131820612|NCT02377349|474623935|FG000|Overall Study|Withdrawal by Subject|5|||
131820613|NCT02377349|474623936|FG001|Overall Study|Withdrawal by Subject|3|||
131820614|NCT02377349|474623935|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
131820615|NCT02377349|474623936|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
131820616|NCT02377349|474623935|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
131820617|NCT02377349|474623936|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
131820618|NCT02377349|474623935|FG000|Overall Study|Other|0|||
131820619|NCT02377349|474623936|FG001|Overall Study|Other|1|||
131820620|NCT03277248|474623939|FG000|Overall Study|Adverse Event|3|||
131820621|NCT03277248|474623940|FG001|Overall Study|Adverse Event|1|||
131820622|NCT03277248|474623939|FG000|Overall Study|Subject Withdrawal of Consent|6|||
131820623|NCT03277248|474623940|FG001|Overall Study|Subject Withdrawal of Consent|23|||
131820624|NCT03277248|474623939|FG000|Overall Study|Investigator/Sponsor Decision|2|||
131820625|NCT03277248|474623940|FG001|Overall Study|Investigator/Sponsor Decision|2|||
131820626|NCT03277248|474623939|FG000|Overall Study|Pregnancy|4|||
131820627|NCT03277248|474623940|FG001|Overall Study|Pregnancy|1|||
131820628|NCT03277248|474623939|FG000|Overall Study|Lost to Follow-up|0|||
131820629|NCT03277248|474623940|FG001|Overall Study|Lost to Follow-up|2|||
131820630|NCT03277248|474623939|FG000|Overall Study|Lack of Efficacy|0|||
131820631|NCT03277248|474623940|FG001|Overall Study|Lack of Efficacy|2|||
131820632|NCT03277248|474623939|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
131820633|NCT03277248|474623940|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
131820634|NCT01993940|474623941|FG000|Overall Study|Adverse Event|16|||
131820635|NCT01993940|474623942|FG001|Overall Study|Adverse Event|11|||
131820636|NCT01993940|474623941|FG000|Overall Study|Withdrawal by Subject|15|||
131820637|NCT01993940|474623942|FG001|Overall Study|Withdrawal by Subject|19|||
131820638|NCT01993940|474623941|FG000|Overall Study|Lost to Follow-up|2|||
131820639|NCT01993940|474623942|FG001|Overall Study|Lost to Follow-up|5|||
131820640|NCT01993940|474623941|FG000|Overall Study|Protocol Violation|5|||
131820641|NCT01993940|474623942|FG001|Overall Study|Protocol Violation|8|||
131820642|NCT01993940|474623941|FG000|Overall Study|Death|1|||
131820643|NCT01993940|474623942|FG001|Overall Study|Death|0|||
131820644|NCT01993940|474623941|FG000|Overall Study|Other - Miscellaneous|1|||
131820645|NCT01993940|474623942|FG001|Overall Study|Other - Miscellaneous|1|||
131820646|NCT03259165|474623943|FG000|Overall Study|COVID 19 pandemic|1|||
131820647|NCT03259165|474623944|FG001|Overall Study|COVID 19 pandemic|1|||
131820648|NCT01949532|474623945|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
131820649|NCT01949532|474623946|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
131820650|NCT00021541|474623949|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
131820651|NCT00021541|474623950|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
131820652|NCT00021541|474623949|FG000|Period 1-First Treatment|Adverse Event|2|||
131820653|NCT00021541|474623950|FG001|Period 1-First Treatment|Adverse Event|1|||
131820654|NCT00021541|474623949|FG000|Period 1-First Treatment|non-adherence|3|||
131820655|NCT00021541|474623950|FG001|Period 1-First Treatment|non-adherence|0|||
131820656|NCT00021541|474623949|FG000|Period 1-First Treatment|Death|1|||
131820657|NCT00021541|474623950|FG001|Period 1-First Treatment|Death|0|||
131820658|NCT00021541|474623949|FG000|Period 1-First Treatment|Pts that did not progress|2|||
131820659|NCT00021541|474623950|FG001|Period 1-First Treatment|Pts that did not progress|2|||
131820660|NCT00021541|474623949|FG000|Period 1-First Treatment|Ineligible|0|||
131820661|NCT00021541|474623950|FG001|Period 1-First Treatment|Ineligible|2|||
131820662|NCT00021541|474623949|FG000|Period 2-crossover|refused phase B|2|||
131820663|NCT00021541|474623950|FG001|Period 2-crossover|refused phase B|2|||
131820664|NCT00021541|474623949|FG000|Period 2-crossover|Withdrawal by Subject|3|||
131820665|NCT00021541|474623950|FG001|Period 2-crossover|Withdrawal by Subject|4|||
131820666|NCT00021541|474623949|FG000|Period 2-crossover|Adverse Event|2|||
131909924|NCT04142242|474958711|FG004|Stage II|Withdrawal by Subject|0|||
131400935|NCT05596734|473089652|FG010|Substudy B|Lost to Follow-up|0|||
131820667|NCT00021541|474623950|FG001|Period 2-crossover|Adverse Event|2|||
131820668|NCT00021541|474623949|FG000|Period 2-crossover|non-adherence|1|||
131820669|NCT00021541|474623950|FG001|Period 2-crossover|non-adherence|0|||
131820670|NCT00021541|474623949|FG000|Period 2-crossover|Pts that did not progress|2|||
131820671|NCT00021541|474623950|FG001|Period 2-crossover|Pts that did not progress|3|||
131820672|NCT00826241|474623951|FG000|Overall Study|Withdrawal from Follow-up|1|||
131820673|NCT00826241|474623951|FG000|Overall Study|Withdrew consent|2|||
131820674|NCT00826241|474623951|FG000|Overall Study|Death|4|||
131820675|NCT00826241|474623951|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
131820676|NCT00826241|474623951|FG000|Overall Study|Non-compliance|1|||
131820677|NCT00826241|474623951|FG000|Overall Study|Progression of disease|1|||
131820678|NCT00826241|474623951|FG000|Overall Study|Patient refused follow-up|3|||
131820679|NCT00826241|474623951|FG000|Overall Study|Lost to Follow-up|9|||
131820680|NCT00826241|474623951|FG000|Overall Study|Could not obtain records|1|||
131820681|NCT00826241|474623951|FG000|Overall Study|Screen failure|2|||
131820682|NCT00826241|474623951|FG000|Overall Study|Pt unable to proceed to registration|1|||
131820683|NCT00826241|474623951|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
131820684|NCT00939523|474623956|FG000|Overall Study|Lack of Efficacy|1|||
131820685|NCT00939523|474623956|FG000|Overall Study|Physician Decision|2|||
131820686|NCT00024258|474623957|FG000|Overall Study|Withdrawal by Subject|1|||
131820687|NCT00024258|474623957|FG000|Overall Study|Disease Progression|8|||
131820688|NCT01050764|474623958|FG000|Overall Study|Death, before HSCT|1|||
131820689|NCT01050764|474623958|FG000|Overall Study|Donor mobilization failure, death|1|||
131820690|NCT01050764|474623958|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
131820691|NCT00258856|474625397|FG000|Overall Study|Lost to Follow-up|1|||
131820692|NCT00258856|474625398|FG001|Overall Study|Lost to Follow-up|0|||
131820693|NCT00258856|474625399|FG002|Overall Study|Lost to Follow-up|2|||
131820694|NCT00258856|474625400|FG003|Overall Study|Lost to Follow-up|0|||
131820695|NCT00258856|474625397|FG000|Overall Study|Non-compliance|2|||
131820696|NCT00258856|474625398|FG001|Overall Study|Non-compliance|0|||
131820697|NCT00258856|474625399|FG002|Overall Study|Non-compliance|0|||
131820698|NCT00258856|474625400|FG003|Overall Study|Non-compliance|1|||
131820699|NCT01691430|474625401|FG000|Overall Study|Death|17|||
131820700|NCT01691430|474625402|FG001|Overall Study|Death|16|||
131820701|NCT01691430|474625401|FG000|Overall Study|Withdrawal by Subject|5|||
131820702|NCT01691430|474625402|FG001|Overall Study|Withdrawal by Subject|1|||
131820703|NCT01691430|474625401|FG000|Overall Study|Lost to Follow-up|0|||
131820704|NCT01691430|474625402|FG001|Overall Study|Lost to Follow-up|3|||
131820705|NCT02219009|474625405|FG000|Overall Study|Withdrawal by Subject|5|||
131820706|NCT02219009|474625406|FG001|Overall Study|Withdrawal by Subject|1|||
131820707|NCT02219009|474625405|FG000|Overall Study|Adverse Event|2|||
131820708|NCT02219009|474625406|FG001|Overall Study|Adverse Event|4|||
131820709|NCT02219009|474625405|FG000|Overall Study|Lost to Follow-up|2|||
131820710|NCT02219009|474625406|FG001|Overall Study|Lost to Follow-up|2|||
131820711|NCT02219009|474625405|FG000|Overall Study|Protocol deviation|1|||
131820712|NCT02219009|474625406|FG001|Overall Study|Protocol deviation|0|||
131820713|NCT02219009|474625405|FG000|Overall Study|Physician Decision|0|||
131820714|NCT02219009|474625406|FG001|Overall Study|Physician Decision|1|||
131820715|NCT03086135|474625407|FG000|Overall Study|Adverse Event|1|||
131820716|NCT03086135|474625407|FG000|Overall Study|Lost to Follow-up|2|||
131820717|NCT00762411|474625410|FG000|Initial Treatment|Death|7|||
131820718|NCT00762411|474625411|FG001|Initial Treatment|Death|6|||
131820719|NCT00762411|474625410|FG000|Initial Treatment|Adverse Event|132|||
131820720|NCT00762411|474625411|FG001|Initial Treatment|Adverse Event|40|||
131820721|NCT00762411|474625410|FG000|Initial Treatment|Protocol Violation|4|||
131820722|NCT00762411|474625411|FG001|Initial Treatment|Protocol Violation|1|||
131820723|NCT00762411|474625410|FG000|Initial Treatment|Withdrawal by Subject|65|||
131820724|NCT00762411|474625411|FG001|Initial Treatment|Withdrawal by Subject|52|||
131820725|NCT00762411|474625410|FG000|Initial Treatment|Physician Decision|1|||
131820726|NCT00762411|474625411|FG001|Initial Treatment|Physician Decision|0|||
131820727|NCT00762411|474625410|FG000|Initial Treatment|Sponsor Decision|293|||
131820728|NCT00762411|474625411|FG001|Initial Treatment|Sponsor Decision|401|||
131820729|NCT00762411|474625410|FG000|Initial Treatment|Lost to Follow-up|5|||
131820730|NCT00762411|474625411|FG001|Initial Treatment|Lost to Follow-up|0|||
131820731|NCT00762411|474625410|FG000|Initial Treatment|Caregiver Decision|21|||
131820732|NCT00762411|474625411|FG001|Initial Treatment|Caregiver Decision|16|||
131820733|NCT00762411|474625410|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
131820734|NCT00762411|474625411|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
131820735|NCT00762411|474625410|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
131820736|NCT00762411|474625411|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
131820737|NCT00762411|474625410|FG000|Delayed Start|Adverse Event|0|||
131820738|NCT00762411|474625411|FG001|Delayed Start|Adverse Event|4|||
131820739|NCT00762411|474625410|FG000|Delayed Start|Protocol Violation|0|||
131820740|NCT00762411|474625411|FG001|Delayed Start|Protocol Violation|1|||
131820741|NCT00762411|474625410|FG000|Delayed Start|Sponsor Decision|16|||
131820742|NCT00762411|474625411|FG001|Delayed Start|Sponsor Decision|20|||
131820743|NCT00762411|474625410|FG000|Delayed Start|Caregiver Decision|1|||
131820744|NCT00762411|474625411|FG001|Delayed Start|Caregiver Decision|1|||
131820745|NCT00762411|474625410|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
131820746|NCT00762411|474625411|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
131820747|NCT00762411|474625410|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
131820748|NCT00762411|474625411|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
131820749|NCT00762411|474625410|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
131820750|NCT00762411|474625411|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
131820751|NCT00762411|474625410|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
131820752|NCT00762411|474625411|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
131820753|NCT00762411|474625410|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
131820754|NCT00762411|474625411|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
131820755|NCT00762411|474625410|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
131820756|NCT00762411|474625411|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
131820757|NCT01023061|474625412|FG000|Overall Study|Withdrawal prior to treatment|2|||
131820758|NCT01622660|474625415|FG000|Overall Study|Adverse Event|1|||
131820759|NCT02259348|474625416|FG000|Overall Study|Donors|6|||
131820760|NCT02259348|474625416|FG000|Overall Study|Death|4|||
131820761|NCT04211766|474625417|FG000|Overall Study|Withdrawal by Subject|5|||
131820762|NCT04211766|474625418|FG001|Overall Study|Withdrawal by Subject|1|||
131820763|NCT04590781|474625420|FG000|Overall Study|Death|0|||
131820764|NCT04590781|474625421|FG001|Overall Study|Death|2|||
131820765|NCT04590781|474625420|FG000|Overall Study|Withdrawal by Subject|2|||
131820766|NCT04590781|474625421|FG001|Overall Study|Withdrawal by Subject|0|||
131820767|NCT01680016|474625424|FG000|Overall Study|Adverse Event|0|||
131820768|NCT01680016|474625425|FG001|Overall Study|Adverse Event|0|||
131820769|NCT01680016|474625426|FG002|Overall Study|Adverse Event|1|||
131820770|NCT01680016|474625427|FG003|Overall Study|Adverse Event|4|||
131820771|NCT01680016|474625424|FG000|Overall Study|The Subject went out of The Trial|1|||
131820772|NCT01680016|474625425|FG001|Overall Study|The Subject went out of The Trial|0|||
131820773|NCT01680016|474625426|FG002|Overall Study|The Subject went out of The Trial|3|||
131820774|NCT01680016|474625427|FG003|Overall Study|The Subject went out of The Trial|0|||
131820775|NCT01680016|474625424|FG000|Overall Study|Protocol Violation|0|||
131820776|NCT01680016|474625425|FG001|Overall Study|Protocol Violation|1|||
131820777|NCT01680016|474625426|FG002|Overall Study|Protocol Violation|0|||
131820778|NCT01680016|474625427|FG003|Overall Study|Protocol Violation|0|||
131820779|NCT01680016|474625424|FG000|Overall Study|Withdrawal by Subject|5|||
131820780|NCT01680016|474625425|FG001|Overall Study|Withdrawal by Subject|7|||
131820781|NCT01680016|474625426|FG002|Overall Study|Withdrawal by Subject|1|||
131820782|NCT01680016|474625427|FG003|Overall Study|Withdrawal by Subject|1|||
131820783|NCT00820599|474625428|FG000|Overall Study|Death|129|||
131820784|NCT00820599|474625428|FG000|Overall Study|Withdrawal by Subject|2|||
131820785|NCT03686215|474625429|FG000|Overall Study|Adverse Event|0|||
131820786|NCT03686215|474625430|FG001|Overall Study|Adverse Event|0|||
131820787|NCT03686215|474625431|FG002|Overall Study|Adverse Event|7|||
131820788|NCT03686215|474625429|FG000|Overall Study|Physician Decision|0|||
131820789|NCT03686215|474625430|FG001|Overall Study|Physician Decision|0|||
131820790|NCT03686215|474625431|FG002|Overall Study|Physician Decision|1|||
131820791|NCT03686215|474625429|FG000|Overall Study|Protocol Violation|0|||
131820792|NCT03686215|474625430|FG001|Overall Study|Protocol Violation|0|||
131820793|NCT03686215|474625431|FG002|Overall Study|Protocol Violation|4|||
131820794|NCT03686215|474625429|FG000|Overall Study|Device issue|1|||
131820795|NCT03686215|474625430|FG001|Overall Study|Device issue|0|||
131820796|NCT03686215|474625431|FG002|Overall Study|Device issue|2|||
131820797|NCT02485158|474625434|FG000|Overall Study|Withdrawal by Subject|3|||
131820798|NCT02485158|474625434|FG000|Overall Study|expected drug side effect|1|||
131820799|NCT00202839|474625435|FG000|Overall Study|Adverse Event|1|||
131820800|NCT00202839|474625436|FG001|Overall Study|Adverse Event|5|||
131820801|NCT00202839|474625435|FG000|Overall Study|Physician Decision|12|||
131820802|NCT00202839|474625436|FG001|Overall Study|Physician Decision|0|||
131820803|NCT00202839|474625435|FG000|Overall Study|Withdrawal by Subject|6|||
131820804|NCT00202839|474625436|FG001|Overall Study|Withdrawal by Subject|2|||
131820805|NCT00202839|474625435|FG000|Overall Study|Protocol Violation|2|||
131820806|NCT00202839|474625436|FG001|Overall Study|Protocol Violation|1|||
131820807|NCT00202839|474625435|FG000|Overall Study|Lost to Follow-up|3|||
131820808|NCT00202839|474625436|FG001|Overall Study|Lost to Follow-up|2|||
131820809|NCT02846883|474625439|FG000|Overall Study|Death|0|||
131820810|NCT02846883|474625440|FG001|Overall Study|Death|1|||
131820811|NCT02846883|474625441|FG002|Overall Study|Death|1|||
131820812|NCT02846883|474625439|FG000|Overall Study|Lost to Follow-up|0|||
131820813|NCT02846883|474625440|FG001|Overall Study|Lost to Follow-up|0|||
131820814|NCT02846883|474625441|FG002|Overall Study|Lost to Follow-up|1|||
131820815|NCT02846883|474625439|FG000|Overall Study|Withdrawal by Subject|1|||
131820816|NCT02846883|474625440|FG001|Overall Study|Withdrawal by Subject|0|||
131820817|NCT02846883|474625441|FG002|Overall Study|Withdrawal by Subject|0|||
131820818|NCT02846883|474625439|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
131820819|NCT02846883|474625440|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
131820820|NCT02846883|474625441|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
131820821|NCT02846883|474625439|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
131820822|NCT02846883|474625440|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
131820823|NCT02846883|474625441|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
131820824|NCT00927251|474625442|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
131820825|NCT01098851|474625443|FG000|Overall Study|Equipment failure|1|||
131820826|NCT01098851|474625444|FG001|Overall Study|Equipment failure|0|||
131820827|NCT00442351|474625447|FG000|Overall Study|Administrative|6|||
131820828|NCT00442351|474625448|FG001|Overall Study|Administrative|5|||
131820829|NCT00442351|474625447|FG000|Overall Study|Did not meet protocol eligibility|1|||
131820830|NCT00442351|474625448|FG001|Overall Study|Did not meet protocol eligibility|0|||
131820831|NCT00442351|474625447|FG000|Overall Study|Other|0|||
131820832|NCT00442351|474625448|FG001|Overall Study|Other|1|||
131820833|NCT01813435|474625454|FG000|Overall Study|did not finish experimental regimen|1902|||
131820834|NCT01813435|474625455|FG001|Overall Study|did not finish experimental regimen|770|||
131820835|NCT01813435|474625454|FG000|Overall Study|Lost to Follow-up|268|||
131820836|NCT01813435|474625455|FG001|Overall Study|Lost to Follow-up|237|||
131820837|NCT03035890|474625456|FG000|Overall Study|Death|1|||
131820838|NCT00452348|474625458|FG000|Overall Study|Adverse Event|6|||
131820839|NCT00452348|474625459|FG001|Overall Study|Adverse Event|9|||
131820840|NCT00452348|474625458|FG000|Overall Study|Lack of Efficacy|10|||
131820841|NCT00452348|474625459|FG001|Overall Study|Lack of Efficacy|9|||
131820842|NCT00452348|474625458|FG000|Overall Study|Lost to Follow-up|14|||
131820843|NCT00452348|474625459|FG001|Overall Study|Lost to Follow-up|8|||
131820844|NCT00452348|474625458|FG000|Overall Study|Protocol Violation|22|||
131820845|NCT00452348|474625459|FG001|Overall Study|Protocol Violation|28|||
131820846|NCT00452348|474625458|FG000|Overall Study|Withdrawal by Subject|18|||
131820847|NCT00452348|474625459|FG001|Overall Study|Withdrawal by Subject|21|||
131820848|NCT00452348|474625458|FG000|Overall Study|Other|9|||
131820849|NCT00452348|474625459|FG001|Overall Study|Other|9|||
131820850|NCT00413049|474625460|FG000|Overall Study|Adverse Event|10|||
131820851|NCT00413049|474625461|FG001|Overall Study|Adverse Event|8|||
131820852|NCT00413049|474625460|FG000|Overall Study|Withdrawal by Subject|7|||
131820853|NCT00413049|474625461|FG001|Overall Study|Withdrawal by Subject|5|||
131820854|NCT00413049|474625460|FG000|Overall Study|Lost to Follow-up|2|||
131820855|NCT00413049|474625461|FG001|Overall Study|Lost to Follow-up|3|||
131820856|NCT00413049|474625460|FG000|Overall Study|Protocol Violation|3|||
131820857|NCT00413049|474625461|FG001|Overall Study|Protocol Violation|1|||
131820858|NCT00413049|474625460|FG000|Overall Study|Subject no longer requires study drug|0|||
131820859|NCT00413049|474625461|FG001|Overall Study|Subject no longer requires study drug|1|||
131820860|NCT00413049|474625460|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131820861|NCT00413049|474625461|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131820862|NCT00413049|474625460|FG000|Overall Study|Lack of Efficacy|1|||
131820863|NCT00413049|474625461|FG001|Overall Study|Lack of Efficacy|0|||
131820864|NCT02587143|474625462|FG000|Overall Study|Adverse Event|1|||
131820865|NCT02587143|474625463|FG001|Overall Study|Adverse Event|0|||
131820866|NCT01119625|474625464|FG000|Overall Study|Lost to Follow-up|1|||
131820867|NCT01119625|474625465|FG001|Overall Study|Lost to Follow-up|2|||
131820868|NCT01119625|474625464|FG000|Overall Study|Withdrawal by Subject|2|||
131820869|NCT01119625|474625465|FG001|Overall Study|Withdrawal by Subject|1|||
131820870|NCT01119625|474625464|FG000|Overall Study|Other|0|||
131820871|NCT01119625|474625465|FG001|Overall Study|Other|1|||
131820872|NCT00397254|474625478|FG000|Overall Study|Lost to Follow-up|2|||
131820873|NCT00397254|474625479|FG001|Overall Study|Lost to Follow-up|2|||
131820874|NCT02340780|474625480|FG000|Overall Study|Ineligible|1|||
131820875|NCT04473326|474625486|FG000|Overall Study|Death|0|||
131820876|NCT04473326|474625487|FG001|Overall Study|Death|1|||
131820877|NCT04473326|474625486|FG000|Overall Study|Withdrawal by Subject|1|||
131820878|NCT04473326|474625487|FG001|Overall Study|Withdrawal by Subject|2|||
131820879|NCT02046122|474625488|FG000|Overall Study|Physician Decision|8|||
131820880|NCT02046122|474625488|FG000|Overall Study|Withdrawal by Subject|1|||
131820881|NCT02229084|474625489|FG000|Overall Study|Adverse Event|1|||
131820882|NCT02229084|474625490|FG001|Overall Study|Adverse Event|0|||
131820883|NCT02229084|474625491|FG002|Overall Study|Adverse Event|0|||
131820884|NCT02229084|474625492|FG003|Overall Study|Adverse Event|0|||
131820885|NCT02229084|474625493|FG004|Overall Study|Adverse Event|0|||
131820886|NCT02229084|474625494|FG005|Overall Study|Adverse Event|0|||
131820887|NCT02229084|474625495|FG006|Overall Study|Adverse Event|0|||
131820888|NCT02229084|474625489|FG000|Overall Study|Lost to Follow-up|0|||
131820889|NCT02229084|474625490|FG001|Overall Study|Lost to Follow-up|0|||
131820890|NCT02229084|474625491|FG002|Overall Study|Lost to Follow-up|1|||
131820891|NCT02229084|474625492|FG003|Overall Study|Lost to Follow-up|1|||
131820892|NCT02229084|474625493|FG004|Overall Study|Lost to Follow-up|0|||
131820893|NCT02229084|474625494|FG005|Overall Study|Lost to Follow-up|0|||
131820894|NCT02229084|474625495|FG006|Overall Study|Lost to Follow-up|1|||
131820895|NCT02229084|474625489|FG000|Overall Study|Physician Decision|0|||
131820896|NCT02229084|474625490|FG001|Overall Study|Physician Decision|0|||
131820897|NCT02229084|474625491|FG002|Overall Study|Physician Decision|0|||
131820898|NCT02229084|474625492|FG003|Overall Study|Physician Decision|1|||
131820899|NCT02229084|474625493|FG004|Overall Study|Physician Decision|3|||
131820900|NCT02229084|474625494|FG005|Overall Study|Physician Decision|0|||
131820901|NCT02229084|474625495|FG006|Overall Study|Physician Decision|1|||
131820902|NCT02229084|474625489|FG000|Overall Study|Withdrawal by Subject|0|||
131820903|NCT02229084|474625490|FG001|Overall Study|Withdrawal by Subject|0|||
131820904|NCT02229084|474625491|FG002|Overall Study|Withdrawal by Subject|1|||
131820905|NCT02229084|474625492|FG003|Overall Study|Withdrawal by Subject|0|||
131909925|NCT04142242|474958712|FG005|Stage II|Withdrawal by Subject|0|||
131820906|NCT02229084|474625493|FG004|Overall Study|Withdrawal by Subject|1|||
131820907|NCT02229084|474625494|FG005|Overall Study|Withdrawal by Subject|1|||
131820908|NCT02229084|474625495|FG006|Overall Study|Withdrawal by Subject|1|||
131820909|NCT02229084|474625489|FG000|Overall Study|Death|0|||
131820910|NCT02229084|474625490|FG001|Overall Study|Death|0|||
131820911|NCT02229084|474625491|FG002|Overall Study|Death|0|||
131820912|NCT02229084|474625492|FG003|Overall Study|Death|0|||
131820913|NCT02229084|474625493|FG004|Overall Study|Death|0|||
131820914|NCT02229084|474625494|FG005|Overall Study|Death|0|||
131820915|NCT02229084|474625495|FG006|Overall Study|Death|1|||
131820916|NCT01532908|474625499|FG000|Overall Study|Not Transplanted|1|||
131820917|NCT01532908|474625500|FG001|Overall Study|Not Transplanted|0|||
131820918|NCT01559116|474625501|FG000|Overall Study|Adverse Event|10|||
131820919|NCT01559116|474625501|FG000|Overall Study|Lack of Efficacy|1|||
131820920|NCT01559116|474625501|FG000|Overall Study|Lost to Follow-up|1|||
131820921|NCT01559116|474625501|FG000|Overall Study|Protocol Violation|1|||
131820922|NCT01559116|474625501|FG000|Overall Study|Withdrawal by Subject|4|||
131820923|NCT01559116|474625501|FG000|Overall Study|other than stated above|9|||
131820924|NCT04561115|474625502|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
131820925|NCT04561115|474625503|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
131820926|NCT04561115|474625502|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
131820927|NCT04561115|474625503|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
131820928|NCT04561115|474625502|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
131820929|NCT04561115|474625503|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
131820930|NCT01745094|474625504|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
131820931|NCT01745094|474625505|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
131820932|NCT01745094|474625506|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
131820933|NCT01745094|474625507|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
131820934|NCT01745094|474625504|FG000|Overall Study|Adverse Event|0|||
131820935|NCT01745094|474625505|FG001|Overall Study|Adverse Event|0|||
131820936|NCT01745094|474625506|FG002|Overall Study|Adverse Event|3|||
131820937|NCT01745094|474625507|FG003|Overall Study|Adverse Event|0|||
131820938|NCT01745094|474625504|FG000|Overall Study|Withdrawal by Subject|2|||
131820939|NCT01745094|474625505|FG001|Overall Study|Withdrawal by Subject|0|||
131820940|NCT01745094|474625506|FG002|Overall Study|Withdrawal by Subject|1|||
131820941|NCT01745094|474625507|FG003|Overall Study|Withdrawal by Subject|2|||
131820942|NCT01745094|474625504|FG000|Overall Study|Protocol Violation|1|||
131820943|NCT01745094|474625505|FG001|Overall Study|Protocol Violation|0|||
131820944|NCT01745094|474625506|FG002|Overall Study|Protocol Violation|3|||
131820945|NCT01745094|474625507|FG003|Overall Study|Protocol Violation|1|||
131820946|NCT01745094|474625504|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
131820947|NCT01745094|474625505|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
131820948|NCT01745094|474625506|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
131820949|NCT01745094|474625507|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
131820950|NCT01745094|474625504|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
131820951|NCT01745094|474625505|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
131820952|NCT01745094|474625506|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
131820953|NCT01745094|474625507|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
131820954|NCT01745094|474625504|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
131820955|NCT01745094|474625505|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
131820956|NCT01745094|474625506|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
131820957|NCT01745094|474625507|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
131820958|NCT00881569|474625509|FG000|Overall Study|Disease progression|1|||
131820959|NCT00881569|474625510|FG001|Overall Study|Disease progression|1|||
131820960|NCT02004691|474625521|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
131820961|NCT02004691|474625522|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
131820962|NCT02004691|474625521|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
131820963|NCT02004691|474625522|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
131820964|NCT02004691|474625521|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
131820965|NCT02004691|474625522|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
131820966|NCT02004691|474625521|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
131820967|NCT02004691|474625522|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
131820968|NCT02004691|474625521|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
131820969|NCT02004691|474625522|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
131820970|NCT02004691|474625521|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
131820971|NCT02004691|474625522|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
131820972|NCT02623218|474625523|FG000|Overall Study|Lost to Follow-up|0|||
131820973|NCT02623218|474625524|FG001|Overall Study|Lost to Follow-up|1|||
131820974|NCT02623218|474625525|FG002|Overall Study|Lost to Follow-up|0|||
131400936|NCT05596734|473089653|FG011|Substudy B|Lost to Follow-up|0|||
131820975|NCT02623218|474625526|FG003|Overall Study|Lost to Follow-up|0|||
131820976|NCT02623218|474625527|FG004|Overall Study|Lost to Follow-up|0|||
131820977|NCT01675596|474625533|FG000|Overall Study|Death|6|||
131820978|NCT01675596|474625533|FG000|Overall Study|Exit with other reason|1|||
131820979|NCT01675596|474625533|FG000|Overall Study|Missed Visit|1|||
131820980|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Adverse Event|8|||
131820981|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Adverse Event|5|||
131820982|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Adverse Event|9|||
131820983|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Adverse Event|0|||
131820984|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Adverse Event|0|||
131820985|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Adverse Event|0|||
131820986|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
131820987|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
131820988|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
131820989|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
131820990|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
131820991|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
131820992|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
131820993|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
131820994|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
131820995|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
131820996|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
131820997|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
131820998|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Physician Decision|4|||
131820999|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Physician Decision|0|||
131821000|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Physician Decision|2|||
131821001|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Physician Decision|0|||
131821002|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Physician Decision|0|||
131821003|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Physician Decision|0|||
131821004|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Pregnancy|1|||
131821005|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Pregnancy|2|||
131821006|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Pregnancy|0|||
131821007|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Pregnancy|0|||
131821008|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Pregnancy|0|||
131821009|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Pregnancy|0|||
131821010|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
131821011|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
131821012|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
131821013|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
131821014|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
131821015|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
131821016|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
131821017|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
131821018|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
131821019|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
131821020|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
131821021|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
131821022|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
131821023|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
131821024|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
131821025|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
131821026|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
131821027|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
131821028|NCT02614196|474625534|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
131821029|NCT02614196|474625535|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
131821030|NCT02614196|474625536|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
131821031|NCT02614196|474625537|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
131821032|NCT02614196|474625538|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
131821033|NCT02614196|474625539|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
131821034|NCT02614196|474625534|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
131821035|NCT02614196|474625535|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
131821036|NCT02614196|474625536|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
131821037|NCT02614196|474625537|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
131821038|NCT02614196|474625538|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
131821039|NCT02614196|474625539|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
131821040|NCT02614196|474625534|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
131821041|NCT02614196|474625535|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
131821042|NCT02614196|474625536|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
131821043|NCT02614196|474625537|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
131400937|NCT05596734|473089654|FG012|Substudy B|Lost to Follow-up|1|||
131821044|NCT02614196|474625538|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
131821045|NCT02614196|474625539|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
131821046|NCT02614196|474625534|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
131821047|NCT02614196|474625535|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
131821048|NCT02614196|474625536|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
131821049|NCT02614196|474625537|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
131821050|NCT02614196|474625538|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
131821051|NCT02614196|474625539|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
131821052|NCT02614196|474625534|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
131821053|NCT02614196|474625535|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
131821054|NCT02614196|474625536|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
131821055|NCT02614196|474625537|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
131821056|NCT02614196|474625538|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
131821057|NCT02614196|474625539|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
131821058|NCT01539239|474625540|FG000|Overall Study|Death|5|||
131821059|NCT01539239|474625541|FG001|Overall Study|Death|5|||
131821060|NCT01539239|474625540|FG000|Overall Study|Lost to Follow-up|7|||
131821061|NCT01539239|474625541|FG001|Overall Study|Lost to Follow-up|12|||
131821062|NCT03201003|474625549|FG000|Overall Study|Adverse Event|14|||
131821063|NCT03201003|474625550|FG001|Overall Study|Adverse Event|1|||
131821064|NCT03201003|474625549|FG000|Overall Study|Other reasons|5|||
131821065|NCT03201003|474625550|FG001|Overall Study|Other reasons|1|||
131821066|NCT03201003|474625549|FG000|Overall Study|Withdrawal by Subject|4|||
131821067|NCT03201003|474625550|FG001|Overall Study|Withdrawal by Subject|1|||
131821068|NCT03201003|474625549|FG000|Overall Study|Lost to Follow-up|2|||
131821069|NCT03201003|474625550|FG001|Overall Study|Lost to Follow-up|0|||
131821070|NCT03201003|474625549|FG000|Overall Study|Protocol Violation|1|||
131821071|NCT03201003|474625550|FG001|Overall Study|Protocol Violation|0|||
131821072|NCT00834613|474625551|FG000|First Intervention|Protocol Violation|1|||
131821073|NCT00834613|474625552|FG001|First Intervention|Protocol Violation|0|||
131821074|NCT01751087|474625553|FG000|Overall Study|Withdrawal by Subject|1|||
131821075|NCT01751087|474625554|FG001|Overall Study|Withdrawal by Subject|0|||
131821076|NCT01751087|474625555|FG002|Overall Study|Withdrawal by Subject|0|||
131821077|NCT01751087|474625553|FG000|Overall Study|Physician Decision|0|||
131821078|NCT01751087|474625554|FG001|Overall Study|Physician Decision|0|||
131821079|NCT01751087|474625555|FG002|Overall Study|Physician Decision|1|||
131821080|NCT00697619|474625556|FG000|Overall Study|Lack of Efficacy|2|||
131821081|NCT00697619|474625557|FG001|Overall Study|Lack of Efficacy|2|||
131821082|NCT00697619|474625556|FG000|Overall Study|Adverse Event|4|||
131821083|NCT00697619|474625557|FG001|Overall Study|Adverse Event|6|||
131821084|NCT01490190|474627342|FG000|Overall Study|Withdrawal by Subject|9|||
131821085|NCT01490190|474627342|FG000|Overall Study|Adverse Event|17|||
131821086|NCT01490190|474627342|FG000|Overall Study|Protocol Violation|5|||
131821087|NCT01490190|474627342|FG000|Overall Study|Lost to Follow-up|13|||
131821088|NCT01490190|474627342|FG000|Overall Study|Relocation|1|||
131821089|NCT01490190|474627342|FG000|Overall Study|Inconvenience|1|||
131821090|NCT01490190|474627342|FG000|Overall Study|Ring expulsion|2|||
131821091|NCT00960154|474627348|FG000|Overall Study|Study termination|25|||
131821092|NCT00960154|474627349|FG001|Overall Study|Study termination|25|||
131821093|NCT00377156|474627350|FG000|Overall Study|Death|23|||
131821094|NCT00377156|474627351|FG001|Overall Study|Death|19|||
131821095|NCT00377156|474627350|FG000|Overall Study|Withdrawal by Subject|16|||
131821096|NCT00377156|474627351|FG001|Overall Study|Withdrawal by Subject|24|||
131821097|NCT00377156|474627350|FG000|Overall Study|Had follow-up <90 d|3|||
131821098|NCT00377156|474627351|FG001|Overall Study|Had follow-up <90 d|6|||
131821099|NCT00377156|474627350|FG000|Overall Study|Cancellation|1|||
131821100|NCT00377156|474627351|FG001|Overall Study|Cancellation|0|||
131821101|NCT00377156|474627350|FG000|Overall Study|Refused testing|0|||
131821102|NCT00377156|474627351|FG001|Overall Study|Refused testing|1|||
131821103|NCT00377156|474627350|FG000|Overall Study|Ineligible|0|||
131821104|NCT00377156|474627351|FG001|Overall Study|Ineligible|1|||
131821105|NCT00377156|474627350|FG000|Overall Study|Disability or language problem|0|||
131821106|NCT00377156|474627351|FG001|Overall Study|Disability or language problem|1|||
131821107|NCT00377156|474627350|FG000|Overall Study|Other|5|||
131821108|NCT00377156|474627351|FG001|Overall Study|Other|2|||
131821109|NCT00856349|474627352|FG000|Overall Study|Death|418|||
131821110|NCT00856349|474627352|FG000|Overall Study|Withdrawal by Subject|116|||
131821111|NCT00856349|474627352|FG000|Overall Study|Lost to Follow-up|91|||
131821112|NCT00856349|474627352|FG000|Overall Study|Protocol Violation|38|||
131821113|NCT00856349|474627352|FG000|Overall Study|Physician Decision|13|||
131821114|NCT00856349|474627352|FG000|Overall Study|Subject relocation|104|||
131821115|NCT00856349|474627352|FG000|Overall Study|Device explant|33|||
131821116|NCT00856349|474627352|FG000|Overall Study|Site closure|78|||
131821117|NCT00856349|474627352|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
131821118|NCT02725515|474627353|FG000|Overall Study|Refused infusion (no study treatment)|1|||
131821119|NCT02725515|474627354|FG001|Overall Study|Refused infusion (no study treatment)|0|||
131821120|NCT02725515|474627353|FG000|Overall Study|Loss of Improvement per Protocol|14|||
131821121|NCT02725515|474627354|FG001|Overall Study|Loss of Improvement per Protocol|25|||
131821122|NCT02725515|474627353|FG000|Overall Study|Withdrawal by Subject|2|||
131821123|NCT02725515|474627354|FG001|Overall Study|Withdrawal by Subject|1|||
131821124|NCT02725515|474627353|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131821125|NCT02725515|474627354|FG001|Overall Study|Non-Compliance With Study Drug|3|||
131821126|NCT02725515|474627353|FG000|Overall Study|Lost to Follow-up|1|||
131821127|NCT02725515|474627354|FG001|Overall Study|Lost to Follow-up|1|||
131821128|NCT02725515|474627353|FG000|Overall Study|Adverse Event|7|||
131821129|NCT02725515|474627354|FG001|Overall Study|Adverse Event|2|||
131821130|NCT02725515|474627353|FG000|Overall Study|No Documented Disease Improvement|0|||
131821131|NCT02725515|474627354|FG001|Overall Study|No Documented Disease Improvement|1|||
131821132|NCT02725515|474627353|FG000|Overall Study|Completed Study Under Original Protocol|0|||
131821133|NCT02725515|474627354|FG001|Overall Study|Completed Study Under Original Protocol|1|||
131821134|NCT02725515|474627353|FG000|Overall Study|Lack of Response|0|||
131821135|NCT02725515|474627354|FG001|Overall Study|Lack of Response|1|||
131821136|NCT00874549|474627355|FG000|Overall Study|Adverse Event|0|||
131821137|NCT00874549|474627356|FG001|Overall Study|Adverse Event|0|||
131821138|NCT00874549|474627357|FG002|Overall Study|Adverse Event|1|||
131821139|NCT00874549|474627358|FG003|Overall Study|Adverse Event|0|||
131821140|NCT00874549|474627355|FG000|Overall Study|Protocol Violation|1|||
131821141|NCT00874549|474627356|FG001|Overall Study|Protocol Violation|0|||
131821142|NCT00874549|474627357|FG002|Overall Study|Protocol Violation|2|||
131821143|NCT00874549|474627358|FG003|Overall Study|Protocol Violation|1|||
131821144|NCT00874549|474627355|FG000|Overall Study|Lost to Follow-up|0|||
131821145|NCT00874549|474627356|FG001|Overall Study|Lost to Follow-up|0|||
131821146|NCT00874549|474627357|FG002|Overall Study|Lost to Follow-up|1|||
131821147|NCT00874549|474627358|FG003|Overall Study|Lost to Follow-up|0|||
131821148|NCT00874549|474627355|FG000|Overall Study|Withdrawal by Subject|0|||
131821149|NCT00874549|474627356|FG001|Overall Study|Withdrawal by Subject|1|||
131821150|NCT00874549|474627357|FG002|Overall Study|Withdrawal by Subject|0|||
131821151|NCT00874549|474627358|FG003|Overall Study|Withdrawal by Subject|1|||
131821152|NCT00517192|474627365|FG000|Overall Study|Adverse Event|1|||
131821153|NCT00517192|474627366|FG001|Overall Study|Adverse Event|1|||
131821154|NCT00517192|474627365|FG000|Overall Study|Lost to Follow-up|1|||
131821155|NCT00517192|474627366|FG001|Overall Study|Lost to Follow-up|1|||
131821156|NCT00517192|474627365|FG000|Overall Study|Withdrawal by Subject|1|||
131821157|NCT00517192|474627366|FG001|Overall Study|Withdrawal by Subject|0|||
131821158|NCT00517192|474627365|FG000|Overall Study|Early termination of the trial|16|||
131821159|NCT00517192|474627366|FG001|Overall Study|Early termination of the trial|18|||
131821160|NCT03167606|474627368|FG000|Overall Study|Lost to Follow-up|73|||
131821161|NCT03167606|474627369|FG001|Overall Study|Lost to Follow-up|64|||
131821162|NCT03167606|474627368|FG000|Overall Study|Withdrawal by Subject|6|||
131821163|NCT03167606|474627369|FG001|Overall Study|Withdrawal by Subject|5|||
131821164|NCT03167606|474627368|FG000|Overall Study|Withdrawal by Investigator|0|||
131821165|NCT03167606|474627369|FG001|Overall Study|Withdrawal by Investigator|2|||
131821166|NCT01460628|474627371|FG000|Overall Study|Adverse Event|3|||
131821167|NCT01460628|474627371|FG000|Overall Study|Withdrawal by Subject|2|||
131821168|NCT03314857|474627374|FG000|Overall Study|Death|4|||
131821169|NCT03314857|474627374|FG000|Overall Study|Physician Decision|1|||
131821170|NCT01721772|474627375|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
131821171|NCT01721772|474627376|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
131821172|NCT01721772|474627375|FG000|Pre-Treatment|Poor/non-compliance|0|||
131821173|NCT01721772|474627376|FG001|Pre-Treatment|Poor/non-compliance|1|||
131821174|NCT01721772|474627375|FG000|Pre-Treatment|Participant withdrew consent|0|||
131821175|NCT01721772|474627376|FG001|Pre-Treatment|Participant withdrew consent|1|||
131821176|NCT01721772|474627375|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
131821177|NCT01721772|474627376|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
131821178|NCT01721772|474627375|FG000|Treatment|Disease progression|119|||
131821179|NCT01721772|474627376|FG001|Treatment|Disease progression|168|||
131821180|NCT01721772|474627375|FG000|Treatment|Study drug toxicity|19|||
131821181|NCT01721772|474627376|FG001|Treatment|Study drug toxicity|10|||
131821182|NCT01721772|474627375|FG000|Treatment|Adverse event unrelated to study drug|7|||
131821183|NCT01721772|474627376|FG001|Treatment|Adverse event unrelated to study drug|7|||
131821184|NCT01721772|474627375|FG000|Treatment|Maximum clinical benefit|16|||
131821185|NCT01721772|474627376|FG001|Treatment|Maximum clinical benefit|4|||
131821186|NCT01721772|474627375|FG000|Treatment|Other|19|||
131821187|NCT01721772|474627376|FG001|Treatment|Other|2|||
131821188|NCT01721772|474627375|FG000|Treatment|Participant withdrew consent|2|||
131821189|NCT01721772|474627376|FG001|Treatment|Participant withdrew consent|5|||
131821190|NCT01721772|474627375|FG000|Treatment|Participant request to discontinue study treatment|21|||
131400938|NCT05596734|473089655|FG013|Substudy B|Lost to Follow-up|0|||
131821191|NCT01721772|474627376|FG001|Treatment|Participant request to discontinue study treatment|8|||
131821192|NCT01721772|474627375|FG000|Treatment|Death|1|||
131821193|NCT01721772|474627376|FG001|Treatment|Death|0|||
131821194|NCT01721772|474627375|FG000|Treatment|Not reported|1|||
131821195|NCT01721772|474627376|FG001|Treatment|Not reported|0|||
131821196|NCT01721772|474627375|FG000|Treatment|Poor/non-compliance|1|||
131821197|NCT01721772|474627376|FG001|Treatment|Poor/non-compliance|0|||
131821198|NCT01721772|474627375|FG000|Treatment|Lost to Follow-up|0|||
131821199|NCT01721772|474627376|FG001|Treatment|Lost to Follow-up|1|||
131821200|NCT04535986|474627386|FG000|Overall Study|Death|4|||
131821201|NCT04535986|474627387|FG001|Overall Study|Death|5|||
131821202|NCT04535986|474627386|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
131821203|NCT04535986|474627387|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
131821204|NCT04535986|474627386|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
131821205|NCT04535986|474627387|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
131821206|NCT04535986|474627386|FG000|Overall Study|Adverse Event|10|||
131821207|NCT04535986|474627387|FG001|Overall Study|Adverse Event|1|||
131821208|NCT04535986|474627386|FG000|Overall Study|Lack of Efficacy|3|||
131821209|NCT04535986|474627387|FG001|Overall Study|Lack of Efficacy|2|||
131821210|NCT04535986|474627386|FG000|Overall Study|Investigator discretion|3|||
131821211|NCT04535986|474627387|FG001|Overall Study|Investigator discretion|0|||
131821212|NCT04535986|474627386|FG000|Overall Study|Withdrawal by Subject|32|||
131821213|NCT04535986|474627387|FG001|Overall Study|Withdrawal by Subject|14|||
131821214|NCT04535986|474627386|FG000|Overall Study|Lost to Follow-up|5|||
131821215|NCT04535986|474627387|FG001|Overall Study|Lost to Follow-up|3|||
131821216|NCT04535986|474627386|FG000|Overall Study|Other|7|||
131821217|NCT04535986|474627387|FG001|Overall Study|Other|3|||
131821218|NCT00743145|474627390|FG000|Overall Study|Withdrawal by Subject|1|||
131821219|NCT00743145|474627390|FG000|Overall Study|Adverse Event|2|||
131821220|NCT00743145|474627390|FG000|Overall Study|Pregnancy|1|||
131821221|NCT02416180|474627391|FG000|Overall Study|Withdrawal by Subject|1|||
131821222|NCT03922750|474627394|FG000|Overall Study|Unclassified|0|||
131821223|NCT03922750|474627395|FG001|Overall Study|Unclassified|0|||
131821224|NCT03922750|474627396|FG002|Overall Study|Unclassified|1|||
131821225|NCT03922750|474627394|FG000|Overall Study|Adverse Event|0|||
131821226|NCT03922750|474627395|FG001|Overall Study|Adverse Event|1|||
131821227|NCT03922750|474627396|FG002|Overall Study|Adverse Event|0|||
131821228|NCT01670097|474627401|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
131821229|NCT01670097|474627402|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
131821230|NCT01670097|474627401|FG000|Overall Study|Study burden|1|||
131821231|NCT01670097|474627402|FG001|Overall Study|Study burden|0|||
131821232|NCT01670097|474627401|FG000|Overall Study|COPD exacerbation|0|||
131821233|NCT01670097|474627402|FG001|Overall Study|COPD exacerbation|1|||
131821234|NCT01670097|474627401|FG000|Overall Study|Neutropenia|0|||
131821235|NCT01670097|474627402|FG001|Overall Study|Neutropenia|1|||
131821236|NCT01670097|474627401|FG000|Overall Study|Clinical deterioration|0|||
131821237|NCT01670097|474627402|FG001|Overall Study|Clinical deterioration|1|||
131821238|NCT01670097|474627401|FG000|Overall Study|Disease progression|0|||
131821239|NCT01670097|474627402|FG001|Overall Study|Disease progression|1|||
131821240|NCT00550147|474627403|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
131821241|NCT00550147|474627403|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
131821242|NCT00550147|474627403|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
131821243|NCT00550147|474627403|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
131821244|NCT00550147|474627403|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
131821245|NCT01567527|474627404|FG000|Conversion Phase.|Protocol deviation|3|||
131821246|NCT01567527|474627405|FG001|Conversion Phase.|Protocol deviation|0|||
131821247|NCT01567527|474627406|FG002|Conversion Phase.|Protocol deviation|0|||
131821248|NCT01567527|474627407|FG003|Conversion Phase.|Protocol deviation|0|||
131821249|NCT01567527|474627408|FG004|Conversion Phase.|Protocol deviation|0|||
131821250|NCT01567527|474627404|FG000|Conversion Phase.|Met withdrawal criteria|10|||
131821251|NCT01567527|474627405|FG001|Conversion Phase.|Met withdrawal criteria|0|||
131821252|NCT01567527|474627406|FG002|Conversion Phase.|Met withdrawal criteria|0|||
131821253|NCT01567527|474627407|FG003|Conversion Phase.|Met withdrawal criteria|0|||
131821254|NCT01567527|474627408|FG004|Conversion Phase.|Met withdrawal criteria|0|||
131821255|NCT01567527|474627404|FG000|Conversion Phase.|Withdrawal by Subject|32|||
131821256|NCT01567527|474627405|FG001|Conversion Phase.|Withdrawal by Subject|0|||
131821257|NCT01567527|474627406|FG002|Conversion Phase.|Withdrawal by Subject|0|||
131821258|NCT01567527|474627407|FG003|Conversion Phase.|Withdrawal by Subject|0|||
131821259|NCT01567527|474627408|FG004|Conversion Phase.|Withdrawal by Subject|0|||
131821260|NCT01567527|474627404|FG000|Conversion Phase.|Lost to Follow-up|16|||
131821261|NCT01567527|474627405|FG001|Conversion Phase.|Lost to Follow-up|0|||
131821262|NCT01567527|474627406|FG002|Conversion Phase.|Lost to Follow-up|0|||
131821263|NCT01567527|474627407|FG003|Conversion Phase.|Lost to Follow-up|0|||
131821264|NCT01567527|474627408|FG004|Conversion Phase.|Lost to Follow-up|0|||
131821265|NCT01567527|474627404|FG000|Conversion Phase.|Lack of Efficacy|2|||
131821266|NCT01567527|474627405|FG001|Conversion Phase.|Lack of Efficacy|0|||
131821267|NCT01567527|474627406|FG002|Conversion Phase.|Lack of Efficacy|0|||
131821268|NCT01567527|474627407|FG003|Conversion Phase.|Lack of Efficacy|0|||
131821269|NCT01567527|474627408|FG004|Conversion Phase.|Lack of Efficacy|0|||
131821270|NCT01567527|474627404|FG000|Conversion Phase.|Adverse Event|33|||
131821271|NCT01567527|474627405|FG001|Conversion Phase.|Adverse Event|0|||
131821272|NCT01567527|474627406|FG002|Conversion Phase.|Adverse Event|0|||
131821273|NCT01567527|474627407|FG003|Conversion Phase.|Adverse Event|0|||
131821274|NCT01567527|474627408|FG004|Conversion Phase.|Adverse Event|0|||
131821275|NCT01567527|474627404|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
131821276|NCT01567527|474627405|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
131821277|NCT01567527|474627406|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
131821278|NCT01567527|474627407|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
131821279|NCT01567527|474627408|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
131821280|NCT01567527|474627404|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
131821281|NCT01567527|474627405|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
131821282|NCT01567527|474627406|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
131821283|NCT01567527|474627407|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
131821284|NCT01567527|474627408|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
131821285|NCT01567527|474627404|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
131821286|NCT01567527|474627405|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
131821287|NCT01567527|474627406|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
131821288|NCT01567527|474627407|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
131821289|NCT01567527|474627408|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
131821290|NCT01567527|474627404|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
131821291|NCT01567527|474627405|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
131821292|NCT01567527|474627406|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
131821293|NCT01567527|474627407|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
131821294|NCT01567527|474627408|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
131821295|NCT01567527|474627404|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
131821296|NCT01567527|474627405|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
131821297|NCT01567527|474627406|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
131821298|NCT01567527|474627407|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
131821299|NCT01567527|474627408|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
131821300|NCT01567527|474627404|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
131821301|NCT01567527|474627405|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
131821302|NCT01567527|474627406|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
131821303|NCT01567527|474627407|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
131821304|NCT01567527|474627408|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
131821305|NCT01567527|474627404|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
131821306|NCT01567527|474627405|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
131821307|NCT01567527|474627406|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
131821308|NCT01567527|474627407|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
131821309|NCT01567527|474627408|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
131821310|NCT01567527|474627404|FG000|IM Depot Stabilization.|Protocol deviation|0|||
131821311|NCT01567527|474627405|FG001|IM Depot Stabilization.|Protocol deviation|0|||
131821312|NCT01567527|474627406|FG002|IM Depot Stabilization.|Protocol deviation|5|||
131821313|NCT01567527|474627407|FG003|IM Depot Stabilization.|Protocol deviation|0|||
131821314|NCT01567527|474627408|FG004|IM Depot Stabilization.|Protocol deviation|0|||
131821315|NCT01567527|474627404|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
131821316|NCT01567527|474627405|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
131821317|NCT01567527|474627406|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
131821318|NCT01567527|474627407|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
131821319|NCT01567527|474627408|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
131821320|NCT01567527|474627404|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
131821321|NCT01567527|474627405|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
131821322|NCT01567527|474627406|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
131821323|NCT01567527|474627407|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
131821324|NCT01567527|474627408|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
131821325|NCT01567527|474627404|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
131821326|NCT01567527|474627405|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
131821327|NCT01567527|474627406|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
131821328|NCT01567527|474627407|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
131821329|NCT01567527|474627408|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
131821330|NCT01567527|474627404|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
131821331|NCT01567527|474627405|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
131821332|NCT01567527|474627406|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
131821333|NCT01567527|474627407|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
131821334|NCT01567527|474627408|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
131821335|NCT01567527|474627404|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
131821336|NCT01567527|474627405|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
131821337|NCT01567527|474627406|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
131821338|NCT01567527|474627407|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
131821339|NCT01567527|474627408|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
131821340|NCT01567527|474627404|FG000|IM Depot Stabilization.|Adverse Event|0|||
131821341|NCT01567527|474627405|FG001|IM Depot Stabilization.|Adverse Event|0|||
131821342|NCT01567527|474627406|FG002|IM Depot Stabilization.|Adverse Event|37|||
131821343|NCT01567527|474627407|FG003|IM Depot Stabilization.|Adverse Event|0|||
131821344|NCT01567527|474627408|FG004|IM Depot Stabilization.|Adverse Event|0|||
131821345|NCT01567527|474627404|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
131821346|NCT01567527|474627405|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
131821347|NCT01567527|474627406|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
131821348|NCT01567527|474627407|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
131821349|NCT01567527|474627408|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
131821350|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
131821351|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
131821352|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
131821353|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
131821354|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
131821355|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
131821356|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
131821357|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
131821358|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
131821359|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
131821360|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
131821361|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
131821362|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
131821363|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
131821364|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
131821365|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
131821366|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
131821367|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
131821368|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
131821369|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
131821370|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131821371|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131821372|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131821373|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
131821374|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
131821375|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
131821376|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
131821377|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
131821378|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
131821379|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
131821380|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
131821381|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
131821382|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
131821383|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
131821384|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
131821385|NCT01567527|474627404|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131821386|NCT01567527|474627405|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131821387|NCT01567527|474627406|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131821388|NCT01567527|474627407|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
131821389|NCT01567527|474627408|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
131821390|NCT02311894|474627410|FG000|Overall Study|Discontinued in error|1|||
131821391|NCT02311894|474627410|FG000|Overall Study|Lost to Follow-up|1|||
131821392|NCT02311894|474627410|FG000|Overall Study|Adverse Event|1|||
131400939|NCT05596734|473089656|FG014|Substudy B|Lost to Follow-up|1|||
131400940|NCT05596734|473089657|FG015|Substudy B|Lost to Follow-up|1|||
131400941|NCT05596734|473089658|FG016|Substudy B|Lost to Follow-up|0|||
131400942|NCT05596734|473089659|FG017|Substudy B|Lost to Follow-up|0|||
131400943|NCT05596734|473089660|FG018|Substudy B|Lost to Follow-up|0|||
131400944|NCT05596734|473089661|FG019|Substudy B|Lost to Follow-up|0|||
131400945|NCT05596734|473089662|FG020|Substudy B|Lost to Follow-up|0|||
131400946|NCT05596734|473089663|FG021|Substudy B|Lost to Follow-up|0|||
131400947|NCT05596734|473089664|FG022|Substudy B|Lost to Follow-up|0|||
131400948|NCT05596734|473089665|FG023|Substudy B|Lost to Follow-up|0|||
131400949|NCT05005013|473089666|FG000|Overall Study|Withdrawal by Subject|5|||
131400950|NCT05005013|473089667|FG001|Overall Study|Withdrawal by Subject|1|||
131400951|NCT05005013|473089666|FG000|Overall Study|Lost to Follow-up|3|||
131821393|NCT02311894|474627410|FG000|Overall Study|Withdrawal by Subject|1|||
131821394|NCT00751023|474627411|FG000|Overall Study|Lost to Follow-up|11|||
131821395|NCT00751023|474627412|FG001|Overall Study|Lost to Follow-up|7|||
131821396|NCT01726803|474627414|FG000|Overall Study|Lost to Follow-up|6|||
131821397|NCT01726803|474627415|FG001|Overall Study|Lost to Follow-up|1|||
131821398|NCT01726803|474627414|FG000|Overall Study|Withdrawal by Subject|1|||
131821399|NCT01726803|474627415|FG001|Overall Study|Withdrawal by Subject|0|||
131821400|NCT01685008|474627417|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
131821401|NCT01685008|474627418|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
131821402|NCT01685008|474627419|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
131821403|NCT01685008|474627420|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
131821404|NCT01685008|474627417|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
131821405|NCT01685008|474627418|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
131821406|NCT01685008|474627419|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
131821407|NCT01685008|474627420|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
131821408|NCT01685008|474627417|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
131821409|NCT01685008|474627418|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
131821410|NCT01685008|474627419|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
131821411|NCT01685008|474627420|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
131821412|NCT01685008|474627417|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
131821413|NCT01685008|474627418|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
131821414|NCT01685008|474627419|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
131821415|NCT01685008|474627420|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
131821416|NCT01685008|474627417|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
131821417|NCT01685008|474627418|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
131821418|NCT01685008|474627419|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
131821419|NCT01685008|474627420|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
131821420|NCT01970592|474627421|FG000|Overall Study|Withdrawal by Subject|4|||
131821421|NCT01970592|474627421|FG000|Overall Study|Physician Decision|1|||
131821422|NCT01970592|474627421|FG000|Overall Study|Adverse Event|1|||
131821423|NCT01320722|474627424|FG000|Overall Study|Did not Receive Intervention|3|||
131821424|NCT01320722|474627425|FG001|Overall Study|Did not Receive Intervention|2|||
131821425|NCT01320722|474627426|FG002|Overall Study|Did not Receive Intervention|1|||
131821426|NCT01320722|474627427|FG003|Overall Study|Did not Receive Intervention|1|||
131821427|NCT01320722|474627428|FG004|Overall Study|Did not Receive Intervention|2|||
131821428|NCT01320722|474627424|FG000|Overall Study|Lost to Follow-up|0|||
131821429|NCT01320722|474627425|FG001|Overall Study|Lost to Follow-up|1|||
131821430|NCT01320722|474627426|FG002|Overall Study|Lost to Follow-up|0|||
131821431|NCT01320722|474627427|FG003|Overall Study|Lost to Follow-up|1|||
131821432|NCT01320722|474627428|FG004|Overall Study|Lost to Follow-up|3|||
131821433|NCT01320722|474627424|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
131821434|NCT01320722|474627425|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
131821435|NCT01320722|474627426|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
131821436|NCT01320722|474627427|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
131821437|NCT01320722|474627428|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
131821438|NCT01320722|474627424|FG000|Overall Study|Participant Developed a Rash|0|||
131821439|NCT01320722|474627425|FG001|Overall Study|Participant Developed a Rash|0|||
131821440|NCT01320722|474627426|FG002|Overall Study|Participant Developed a Rash|2|||
131821441|NCT01320722|474627427|FG003|Overall Study|Participant Developed a Rash|1|||
131821442|NCT01320722|474627428|FG004|Overall Study|Participant Developed a Rash|1|||
131821443|NCT01320722|474627424|FG000|Overall Study|Non-compliant with Medication|0|||
131821444|NCT01320722|474627425|FG001|Overall Study|Non-compliant with Medication|0|||
131821445|NCT01320722|474627426|FG002|Overall Study|Non-compliant with Medication|1|||
131821446|NCT01320722|474627427|FG003|Overall Study|Non-compliant with Medication|0|||
131821447|NCT01320722|474627428|FG004|Overall Study|Non-compliant with Medication|0|||
131821448|NCT01320722|474627424|FG000|Overall Study|Adverse Event|0|||
131821449|NCT01320722|474627425|FG001|Overall Study|Adverse Event|0|||
131821450|NCT01320722|474627426|FG002|Overall Study|Adverse Event|3|||
131821451|NCT01320722|474627427|FG003|Overall Study|Adverse Event|6|||
131821452|NCT01320722|474627428|FG004|Overall Study|Adverse Event|0|||
131821453|NCT01320722|474627424|FG000|Overall Study|Not Compliant with Study Procedures|0|||
131821454|NCT01320722|474627425|FG001|Overall Study|Not Compliant with Study Procedures|0|||
131821455|NCT01320722|474627426|FG002|Overall Study|Not Compliant with Study Procedures|0|||
131821456|NCT01320722|474627427|FG003|Overall Study|Not Compliant with Study Procedures|4|||
131821457|NCT01320722|474627428|FG004|Overall Study|Not Compliant with Study Procedures|0|||
131821458|NCT01320722|474627424|FG000|Overall Study|Pregnancy|0|||
131821459|NCT01320722|474627425|FG001|Overall Study|Pregnancy|0|||
131821460|NCT01320722|474627426|FG002|Overall Study|Pregnancy|0|||
131821461|NCT01320722|474627427|FG003|Overall Study|Pregnancy|1|||
131821462|NCT01320722|474627428|FG004|Overall Study|Pregnancy|0|||
131821463|NCT01320722|474627424|FG000|Overall Study|Started an Exclusionary Medication|0|||
131821464|NCT01320722|474627425|FG001|Overall Study|Started an Exclusionary Medication|0|||
131821465|NCT01320722|474627426|FG002|Overall Study|Started an Exclusionary Medication|0|||
131821466|NCT01320722|474627427|FG003|Overall Study|Started an Exclusionary Medication|0|||
131821467|NCT01320722|474627428|FG004|Overall Study|Started an Exclusionary Medication|1|||
131821468|NCT01320722|474627424|FG000|Overall Study|Withdrew due to Health Condition|0|||
131821469|NCT01320722|474627425|FG001|Overall Study|Withdrew due to Health Condition|0|||
131821470|NCT01320722|474627426|FG002|Overall Study|Withdrew due to Health Condition|0|||
131821471|NCT01320722|474627427|FG003|Overall Study|Withdrew due to Health Condition|0|||
131821472|NCT01320722|474627428|FG004|Overall Study|Withdrew due to Health Condition|1|||
131821473|NCT00160524|474627429|FG000|Overall Study|Adverse Event|119|||
131821474|NCT00160524|474627429|FG000|Overall Study|Adverse Event and Other|94|||
131821475|NCT00160524|474627429|FG000|Overall Study|Protocol Violation|16|||
131821476|NCT00160524|474627429|FG000|Overall Study|Protocol Violation and Other|2|||
131821477|NCT00160524|474627429|FG000|Overall Study|Withdrawal by Subject|141|||
131821478|NCT00160524|474627429|FG000|Overall Study|Withdrawal by Subject and Other|17|||
131821479|NCT00160524|474627429|FG000|Overall Study|Physician Decision|27|||
131821480|NCT00160524|474627429|FG000|Overall Study|Physician Decision and Other|6|||
131821481|NCT00160524|474627429|FG000|Overall Study|Lost to Follow-up|13|||
131821482|NCT00160524|474627429|FG000|Overall Study|Lost to Follow-up and Other|1|||
131821483|NCT00160524|474627429|FG000|Overall Study|Lack of Efficacy|21|||
131821484|NCT00160524|474627429|FG000|Overall Study|Lack of Efficacy and Other|1|||
131821485|NCT00160524|474627429|FG000|Overall Study|Other|20|||
131821486|NCT01547728|474627437|FG000|Overall Study|Change in procedure and equipment|1|||
131821487|NCT01547728|474627437|FG000|Overall Study|Drug not ready for subject|1|||
131821488|NCT01547728|474627437|FG000|Overall Study|Screen failure|39|||
131821489|NCT03828539|474627438|FG000|Overall Study|Adverse Event|3|||
131821490|NCT03828539|474627439|FG001|Overall Study|Adverse Event|12|||
131821491|NCT03828539|474627438|FG000|Overall Study|Patient's/guardian's decision|3|||
131821492|NCT03828539|474627439|FG001|Overall Study|Patient's/guardian's decision|5|||
131821493|NCT03828539|474627438|FG000|Overall Study|Lost to Follow-up|4|||
131821494|NCT03828539|474627439|FG001|Overall Study|Lost to Follow-up|2|||
131821495|NCT03828539|474627438|FG000|Overall Study|Protocol Violation|3|||
131821496|NCT03828539|474627439|FG001|Overall Study|Protocol Violation|2|||
131821497|NCT03828539|474627438|FG000|Overall Study|Withdrawal of informed consent|2|||
131821498|NCT03828539|474627439|FG001|Overall Study|Withdrawal of informed consent|1|||
131821499|NCT03828539|474627438|FG000|Overall Study|New therapy for study indication|1|||
131821500|NCT03828539|474627439|FG001|Overall Study|New therapy for study indication|0|||
131821501|NCT01341405|474627440|FG000|Overall Study|Adverse Event|0|||
131821502|NCT01341405|474627441|FG001|Overall Study|Adverse Event|1|||
131821503|NCT01341405|474627442|FG002|Overall Study|Adverse Event|1|||
131821504|NCT01341405|474627440|FG000|Overall Study|Withdrawal by Subject|3|||
131821505|NCT01341405|474627441|FG001|Overall Study|Withdrawal by Subject|2|||
131821506|NCT01341405|474627442|FG002|Overall Study|Withdrawal by Subject|1|||
131821507|NCT02616380|474627443|FG000|Overall Study|Lost to Follow-up|1|||
131821508|NCT02616380|474627443|FG000|Overall Study|Other|2|||
131821509|NCT00057941|474627444|FG000|Overall Study|Death|1|||
131821510|NCT00057941|474627445|FG001|Overall Study|Death|2|||
131821511|NCT00057941|474627444|FG000|Overall Study|Adverse Event|7|||
131821512|NCT00057941|474627445|FG001|Overall Study|Adverse Event|9|||
131821513|NCT00057941|474627444|FG000|Overall Study|Lack of Efficacy|54|||
131821514|NCT00057941|474627445|FG001|Overall Study|Lack of Efficacy|53|||
131821515|NCT00057941|474627444|FG000|Overall Study|Withdrawal by Subject|6|||
131821516|NCT00057941|474627445|FG001|Overall Study|Withdrawal by Subject|1|||
131821517|NCT00057941|474627444|FG000|Overall Study|still on treatment|3|||
131821518|NCT00057941|474627445|FG001|Overall Study|still on treatment|1|||
131821519|NCT00057941|474627444|FG000|Overall Study|insurance, symptomatic deterioration|1|||
131821520|NCT00057941|474627445|FG001|Overall Study|insurance, symptomatic deterioration|3|||
131821521|NCT00057941|474627444|FG000|Overall Study|Ineligible|2|||
131821522|NCT00057941|474627445|FG001|Overall Study|Ineligible|5|||
131821523|NCT03407729|474627447|FG000|Overall Study|Lost to Follow-up|2|||
131821524|NCT03407729|474627448|FG001|Overall Study|Lost to Follow-up|0|||
131821525|NCT03407729|474627447|FG000|Overall Study|Unable to schedule|0|||
131821526|NCT03407729|474627448|FG001|Overall Study|Unable to schedule|3|||
131821527|NCT04142658|474627449|FG000|Overall Study|Death|2|||
131821528|NCT04142658|474627450|FG001|Overall Study|Death|1|||
131821529|NCT04142658|474627449|FG000|Overall Study|Lost to Follow-up|4|||
131821530|NCT04142658|474627450|FG001|Overall Study|Lost to Follow-up|13|||
131821531|NCT04142658|474627449|FG000|Overall Study|Withdrawal by Subject|9|||
131821532|NCT04142658|474627450|FG001|Overall Study|Withdrawal by Subject|16|||
131821533|NCT03950674|474627455|FG000|Overall Study|Death|16|||
131821534|NCT03950674|474627456|FG001|Overall Study|Death|15|||
131821535|NCT03950674|474627455|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
131821536|NCT03950674|474627456|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
131821537|NCT00830167|474627459|FG000|Overall Study|Lack of Efficacy|26|||
131821538|NCT00830167|474627460|FG001|Overall Study|Lack of Efficacy|10|||
131821539|NCT00830167|474627459|FG000|Overall Study|Adverse Event|8|||
131821540|NCT00830167|474627460|FG001|Overall Study|Adverse Event|24|||
131821541|NCT00830167|474627459|FG000|Overall Study|Not meeting entrance criteria|2|||
131821542|NCT00830167|474627460|FG001|Overall Study|Not meeting entrance criteria|5|||
131821543|NCT00830167|474627459|FG000|Overall Study|Withdrawal by Subject|2|||
131821544|NCT00830167|474627460|FG001|Overall Study|Withdrawal by Subject|0|||
131821545|NCT00830167|474627459|FG000|Overall Study|Lost to Follow-up|0|||
131821546|NCT00830167|474627460|FG001|Overall Study|Lost to Follow-up|1|||
131821547|NCT00830167|474627459|FG000|Overall Study|Protocol Violation|0|||
131821548|NCT00830167|474627460|FG001|Overall Study|Protocol Violation|1|||
131821549|NCT00830167|474627459|FG000|Overall Study|Other|2|||
131821550|NCT00830167|474627460|FG001|Overall Study|Other|2|||
131821551|NCT02224053|474627461|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
131821552|NCT02224053|474627461|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
131821553|NCT02224053|474627461|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
131821554|NCT02224053|474627461|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
131821555|NCT02224053|474627461|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
131821556|NCT01898598|474627465|FG000|Overall Study|Adverse Event|1|||
131821557|NCT01898598|474627466|FG001|Overall Study|Adverse Event|0|||
131821558|NCT01898598|474627465|FG000|Overall Study|Withdrawal by Subject|3|||
131821559|NCT01898598|474627466|FG001|Overall Study|Withdrawal by Subject|0|||
131821560|NCT01898598|474627465|FG000|Overall Study|Lost to Follow-up|0|||
131821561|NCT01898598|474627466|FG001|Overall Study|Lost to Follow-up|1|||
131821562|NCT01898598|474627465|FG000|Overall Study|Other|0|||
131821563|NCT01898598|474627466|FG001|Overall Study|Other|1|||
131821564|NCT03833427|474627467|FG000|Overall Study|Death|4|||
131821565|NCT03833427|474627468|FG001|Overall Study|Death|2|||
131821566|NCT03833427|474627469|FG002|Overall Study|Death|9|||
131821567|NCT03833427|474627470|FG003|Overall Study|Death|11|||
131821568|NCT03833427|474627471|FG004|Overall Study|Death|0|||
131821569|NCT03833427|474627472|FG005|Overall Study|Death|0|||
131821570|NCT03833427|474627473|FG006|Overall Study|Death|0|||
131821571|NCT03833427|474627467|FG000|Overall Study|Withdrawal by Subject|0|||
131821572|NCT03833427|474627468|FG001|Overall Study|Withdrawal by Subject|1|||
131821573|NCT03833427|474627469|FG002|Overall Study|Withdrawal by Subject|1|||
131821574|NCT03833427|474627470|FG003|Overall Study|Withdrawal by Subject|0|||
131821575|NCT03833427|474627471|FG004|Overall Study|Withdrawal by Subject|0|||
131821576|NCT03833427|474627472|FG005|Overall Study|Withdrawal by Subject|0|||
131821577|NCT03833427|474627473|FG006|Overall Study|Withdrawal by Subject|0|||
131821578|NCT03833427|474627467|FG000|Overall Study|Sponsor Decision|0|||
131821579|NCT03833427|474627468|FG001|Overall Study|Sponsor Decision|0|||
131821580|NCT03833427|474627469|FG002|Overall Study|Sponsor Decision|1|||
131821581|NCT03833427|474627470|FG003|Overall Study|Sponsor Decision|3|||
131821582|NCT03833427|474627471|FG004|Overall Study|Sponsor Decision|0|||
131821583|NCT03833427|474627472|FG005|Overall Study|Sponsor Decision|0|||
131821584|NCT03833427|474627473|FG006|Overall Study|Sponsor Decision|0|||
131821585|NCT03448692|474627474|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
131821586|NCT03448692|474627475|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
131821587|NCT03448692|474627474|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
131821588|NCT03448692|474627475|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
131821589|NCT03448692|474627474|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
131821590|NCT03448692|474627475|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
131821591|NCT03448692|474627474|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
131821592|NCT03448692|474627475|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
131821593|NCT03448692|474627474|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
131821594|NCT03448692|474627475|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
131821595|NCT04194008|474627477|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
131821596|NCT04194008|474627477|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
131821597|NCT04194008|474627477|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
131821598|NCT04194008|474627477|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
131821599|NCT04194008|474627477|FG000|Treatment Phase With Nerivio|Missing data|4|||
131821600|NCT04194008|474627477|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
131821601|NCT00860262|474627478|FG000|Overall Study|Adverse Event|9|||
131821602|NCT00860262|474627479|FG001|Overall Study|Adverse Event|6|||
131821603|NCT00860262|474627480|FG002|Overall Study|Adverse Event|7|||
131821604|NCT00860262|474627478|FG000|Overall Study|Protocol Violation|0|||
131821605|NCT00860262|474627479|FG001|Overall Study|Protocol Violation|1|||
131821606|NCT00860262|474627480|FG002|Overall Study|Protocol Violation|0|||
131821607|NCT00860262|474627478|FG000|Overall Study|Lost to Follow-up|2|||
131821608|NCT00860262|474627479|FG001|Overall Study|Lost to Follow-up|0|||
131821609|NCT00860262|474627480|FG002|Overall Study|Lost to Follow-up|1|||
131821610|NCT00860262|474627478|FG000|Overall Study|Withdrawal by Subject|4|||
131821611|NCT00860262|474627479|FG001|Overall Study|Withdrawal by Subject|8|||
131821612|NCT00860262|474627480|FG002|Overall Study|Withdrawal by Subject|6|||
131821613|NCT00860262|474627478|FG000|Overall Study|Lack of Efficacy|0|||
131821614|NCT00860262|474627479|FG001|Overall Study|Lack of Efficacy|4|||
131821615|NCT00860262|474627480|FG002|Overall Study|Lack of Efficacy|3|||
131821616|NCT00860262|474627478|FG000|Overall Study|Other|5|||
131821617|NCT00860262|474627479|FG001|Overall Study|Other|3|||
131821618|NCT00860262|474627480|FG002|Overall Study|Other|1|||
131821619|NCT00124618|474627481|FG000|Overall Study|Ineligible|1|||
131821620|NCT00593827|474627482|FG000|Overall Study|On Active Treatment/Pending|0|||
131821621|NCT00593827|474627483|FG001|Overall Study|On Active Treatment/Pending|2|||
131821622|NCT01596127|474627484|FG000|Overall Study|Patient Ineligible|1|||
131821623|NCT00633022|474627485|FG000|Overall Study|Adverse Event|1|||
131821624|NCT00633022|474627486|FG001|Overall Study|Adverse Event|0|||
131821625|NCT00633022|474627487|FG002|Overall Study|Adverse Event|5|||
131821626|NCT00633022|474627485|FG000|Overall Study|Physician Decision|0|||
131821627|NCT00633022|474627486|FG001|Overall Study|Physician Decision|1|||
131821628|NCT00633022|474627487|FG002|Overall Study|Physician Decision|0|||
131821629|NCT04388787|474627488|FG000|Blinded Period|Patient could not follow instructions|1|||
131821630|NCT04388787|474627488|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
131821631|NCT00688844|474627489|FG000|Overall Study|Lost to Follow-up|10|||
131821632|NCT01223027|474627490|FG000|Overall Study|Adverse Event|20|||
131821633|NCT01223027|474627491|FG001|Overall Study|Adverse Event|10|||
131821634|NCT01223027|474627490|FG000|Overall Study|Death|42|||
131821635|NCT01223027|474627491|FG001|Overall Study|Death|42|||
131821636|NCT01223027|474627490|FG000|Overall Study|Lost to Follow-up|2|||
131821637|NCT01223027|474627491|FG001|Overall Study|Lost to Follow-up|1|||
131821638|NCT01223027|474627490|FG000|Overall Study|Physician Decision|4|||
131821639|NCT01223027|474627491|FG001|Overall Study|Physician Decision|8|||
131821640|NCT01223027|474627490|FG000|Overall Study|Progressive Disease|167|||
131821641|NCT01223027|474627491|FG001|Overall Study|Progressive Disease|183|||
131821642|NCT01223027|474627490|FG000|Overall Study|Protocol Violation|2|||
131821643|NCT01223027|474627491|FG001|Overall Study|Protocol Violation|1|||
131821644|NCT01223027|474627490|FG000|Overall Study|Subject/guardian decicion|18|||
131821645|NCT01223027|474627491|FG001|Overall Study|Subject/guardian decicion|16|||
131821646|NCT01223027|474627490|FG000|Overall Study|New therapy for study indication|17|||
131821647|NCT01223027|474627491|FG001|Overall Study|New therapy for study indication|8|||
131821648|NCT01223027|474627490|FG000|Overall Study|Study terminated by sponsor|2|||
131821649|NCT01223027|474627491|FG001|Overall Study|Study terminated by sponsor|8|||
131821650|NCT01709903|474627495|FG000|Overall Study|administrative problems|2|||
131821651|NCT01709903|474627496|FG001|Overall Study|administrative problems|6|||
131821652|NCT01709903|474627495|FG000|Overall Study|Abnormal test procedure results|1|||
131821653|NCT01709903|474627496|FG001|Overall Study|Abnormal test procedure results|0|||
131821654|NCT01709903|474627495|FG000|Overall Study|In ability to use device|1|||
131821655|NCT01709903|474627496|FG001|Overall Study|In ability to use device|1|||
131821656|NCT01709903|474627495|FG000|Overall Study|no longer needed study drug|0|||
131821657|NCT01709903|474627496|FG001|Overall Study|no longer needed study drug|1|||
131821658|NCT01709903|474627495|FG000|Overall Study|Lost to Follow-up|0|||
131821659|NCT01709903|474627496|FG001|Overall Study|Lost to Follow-up|2|||
131821660|NCT01709903|474627495|FG000|Overall Study|Death|2|||
131821661|NCT01709903|474627496|FG001|Overall Study|Death|0|||
131821662|NCT01709903|474627495|FG000|Overall Study|Protocol Violation|3|||
131821663|NCT01709903|474627496|FG001|Overall Study|Protocol Violation|2|||
131821664|NCT01709903|474627495|FG000|Overall Study|Lack of Efficacy|3|||
131821665|NCT01709903|474627496|FG001|Overall Study|Lack of Efficacy|3|||
131821666|NCT01709903|474627495|FG000|Overall Study|Withdrawal by Subject|6|||
131821667|NCT01709903|474627496|FG001|Overall Study|Withdrawal by Subject|6|||
131821668|NCT01709903|474627495|FG000|Overall Study|Adverse Event|11|||
131821669|NCT01709903|474627496|FG001|Overall Study|Adverse Event|18|||
131821670|NCT02061280|474627497|FG000|Overall Study|Protocol Violation|12|||
131821671|NCT02061280|474627498|FG001|Overall Study|Protocol Violation|8|||
131821672|NCT02061280|474627497|FG000|Overall Study|moved out of state|0|||
131821673|NCT02061280|474627498|FG001|Overall Study|moved out of state|1|||
131821674|NCT02061280|474627497|FG000|Overall Study|Withdrawal by Subject|1|||
131821675|NCT02061280|474627498|FG001|Overall Study|Withdrawal by Subject|2|||
131821676|NCT02061280|474627497|FG000|Overall Study|Lost to Follow-up|5|||
131821677|NCT02061280|474627498|FG001|Overall Study|Lost to Follow-up|1|||
131821678|NCT00724958|474627499|FG000|Overall Study|Adverse Event|28|||
131821679|NCT00724958|474627499|FG000|Overall Study|Loss of Response|40|||
131821680|NCT00724958|474627499|FG000|Overall Study|No Response|18|||
131821681|NCT00724958|474627499|FG000|Overall Study|Remission|7|||
131821682|NCT00724958|474627499|FG000|Overall Study|Other Reason|76|||
131821683|NCT00724958|474627499|FG000|Overall Study|No documentation for end of therapy|13|||
131821684|NCT01520987|474629067|FG000|Overall Study|Withdrawal by Subject|1|||
131821685|NCT01520987|474629068|FG001|Overall Study|Withdrawal by Subject|0|||
131821686|NCT01520987|474629069|FG002|Overall Study|Withdrawal by Subject|0|||
131821687|NCT01520987|474629070|FG003|Overall Study|Withdrawal by Subject|0|||
131821688|NCT01520987|474629071|FG004|Overall Study|Withdrawal by Subject|0|||
131821689|NCT01520987|474629072|FG005|Overall Study|Withdrawal by Subject|1|||
131821690|NCT01520987|474629073|FG006|Overall Study|Withdrawal by Subject|0|||
131821691|NCT01520987|474629074|FG007|Overall Study|Withdrawal by Subject|0|||
131821692|NCT02005562|474629075|FG000|Overall Study|Death|2|||
131821693|NCT02005562|474629076|FG001|Overall Study|Death|2|||
131821694|NCT02005562|474629075|FG000|Overall Study|Graft loss|7|||
131821695|NCT02005562|474629076|FG001|Overall Study|Graft loss|6|||
131821696|NCT02005562|474629075|FG000|Overall Study|Withdrawal by Subject|2|||
131821697|NCT02005562|474629076|FG001|Overall Study|Withdrawal by Subject|2|||
131821698|NCT02005562|474629075|FG000|Overall Study|No transplant|1|||
131821699|NCT02005562|474629076|FG001|Overall Study|No transplant|4|||
131821700|NCT02005562|474629075|FG000|Overall Study|Physician Decision|0|||
131821701|NCT02005562|474629076|FG001|Overall Study|Physician Decision|1|||
131821702|NCT01188226|474629077|FG000|Overall Study|Withdrawal by Subject|4|||
131821703|NCT03087786|474629078|FG000|Overall Study|Withdrawal by Subject|2|||
131821704|NCT03087786|474629079|FG001|Overall Study|Withdrawal by Subject|0|||
131821705|NCT00288704|474629083|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
131821706|NCT00288704|474629084|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
131821707|NCT00288704|474629085|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
131821708|NCT00288704|474629083|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
131821709|NCT00288704|474629084|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
131821710|NCT00288704|474629085|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
131821711|NCT00288704|474629083|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
131821712|NCT00288704|474629084|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
131821713|NCT00288704|474629085|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
131821714|NCT00288704|474629083|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
131821715|NCT00288704|474629084|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
131821716|NCT00288704|474629085|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
131821717|NCT00288704|474629083|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
131821718|NCT00288704|474629084|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
131821719|NCT00288704|474629085|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
131821720|NCT00288704|474629083|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
131821721|NCT00288704|474629084|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
131821722|NCT00288704|474629085|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
131821723|NCT00288704|474629083|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
131821724|NCT00288704|474629084|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
131821725|NCT00288704|474629085|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
131821726|NCT01579006|474629086|FG000|Overall Study|Lack of Efficacy|10|||
131821727|NCT01579006|474629086|FG000|Overall Study|Adverse Event|13|||
131821728|NCT01579006|474629086|FG000|Overall Study|Withdrawal by Subject|5|||
131821729|NCT01579006|474629086|FG000|Overall Study|Non-compliance|3|||
131821730|NCT01579006|474629086|FG000|Overall Study|Due to participant's health fund|1|||
131821731|NCT01579006|474629086|FG000|Overall Study|Scheduled surgery|1|||
131821732|NCT00799708|474629089|FG000|Overall Study|non-compliance|1|||
131821733|NCT00799708|474629090|FG001|Overall Study|non-compliance|0|||
131821734|NCT00799708|474629091|FG002|Overall Study|non-compliance|0|||
131821735|NCT03343639|474629092|FG000|Overall Study|Withdrawal by Subject|10|||
131821736|NCT03343639|474629093|FG001|Overall Study|Withdrawal by Subject|6|||
131821737|NCT03343639|474629092|FG000|Overall Study|Lost to Follow-up|4|||
131821738|NCT03343639|474629093|FG001|Overall Study|Lost to Follow-up|5|||
131821739|NCT03343639|474629092|FG000|Overall Study|Protocol Violation|0|||
131821740|NCT03343639|474629093|FG001|Overall Study|Protocol Violation|1|||
131821741|NCT05061992|474629096|FG000|Overall Study|Excess bowel movements|1|||
131821742|NCT05061992|474629097|FG001|Overall Study|Excess bowel movements|0|||
131821743|NCT05061992|474629096|FG000|Overall Study|Complications of Medical Care|1|||
131821744|NCT05061992|474629097|FG001|Overall Study|Complications of Medical Care|0|||
131821745|NCT05061992|474629096|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
131821746|NCT05061992|474629097|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
131821747|NCT05061992|474629096|FG000|Overall Study|Withdrawal by Subject|0|||
131821748|NCT05061992|474629097|FG001|Overall Study|Withdrawal by Subject|1|||
131821749|NCT02697617|474629099|FG000|Overall Study|Withdrawal by Subject|0|||
131821750|NCT02697617|474629100|FG001|Overall Study|Withdrawal by Subject|2|||
131821751|NCT02697617|474629099|FG000|Overall Study|Pregnancy|1|||
131821752|NCT02697617|474629100|FG001|Overall Study|Pregnancy|0|||
131821753|NCT02460835|474629103|FG000|Overall Study|Disease progression prior to treatment|3|||
131821754|NCT02460835|474629103|FG000|Overall Study|Unable to complete planning scans|2|||
131821755|NCT02460835|474629103|FG000|Overall Study|Decrease in performance status|1|||
131821756|NCT02460835|474629103|FG000|Overall Study|Withdrawal by Subject|3|||
131821757|NCT02460835|474629103|FG000|Overall Study|Underwent fractionated RT|10|||
131821758|NCT02460835|474629103|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
131821759|NCT01157234|474629104|FG000|Overall Study|Withdrawal by Subject|1|||
131821760|NCT01157234|474629105|FG001|Overall Study|Withdrawal by Subject|0|||
131821761|NCT02483416|474629112|FG000|Overall Study|Other reason|0|||
131821762|NCT02483416|474629113|FG001|Overall Study|Other reason|1|||
131821763|NCT02483416|474629112|FG000|Overall Study|Treatment stop|3|||
131821764|NCT02483416|474629113|FG001|Overall Study|Treatment stop|0|||
131821765|NCT04968925|474629114|FG000|Phase I- Period 1|COVID-19 related|0|||
131821766|NCT04968925|474629115|FG001|Phase I- Period 1|COVID-19 related|1|||
131821767|NCT04968925|474629116|FG002|Phase I- Period 1|COVID-19 related|0|||
131909926|NCT03040726|474958715|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
131821768|NCT04968925|474629117|FG003|Phase I- Period 1|COVID-19 related|0|||
131821769|NCT04968925|474629114|FG000|Phase I- Period 1|Subject enrolled in error|1|||
131821770|NCT04968925|474629115|FG001|Phase I- Period 1|Subject enrolled in error|1|||
131821771|NCT04968925|474629116|FG002|Phase I- Period 1|Subject enrolled in error|0|||
131821772|NCT04968925|474629117|FG003|Phase I- Period 1|Subject enrolled in error|0|||
131821773|NCT04968925|474629114|FG000|Phase II- Period 1|COVID-19 Related|0|||
131821774|NCT04968925|474629115|FG001|Phase II- Period 1|COVID-19 Related|0|||
131821775|NCT04968925|474629116|FG002|Phase II- Period 1|COVID-19 Related|6|||
131821776|NCT04968925|474629117|FG003|Phase II- Period 1|COVID-19 Related|6|||
131821777|NCT04968925|474629114|FG000|Phase II- Period 1|Subject enrolled in error|0|||
131821778|NCT04968925|474629115|FG001|Phase II- Period 1|Subject enrolled in error|0|||
131821779|NCT04968925|474629116|FG002|Phase II- Period 1|Subject enrolled in error|1|||
131821780|NCT04968925|474629117|FG003|Phase II- Period 1|Subject enrolled in error|0|||
131821781|NCT04968925|474629114|FG000|Phase II -Period 2|COVID-19 related|0|||
131821782|NCT04968925|474629115|FG001|Phase II -Period 2|COVID-19 related|0|||
131821783|NCT04968925|474629116|FG002|Phase II -Period 2|COVID-19 related|4|||
131821784|NCT04968925|474629117|FG003|Phase II -Period 2|COVID-19 related|3|||
131821785|NCT04968925|474629114|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
131821786|NCT04968925|474629115|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
131821787|NCT04968925|474629116|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
131821788|NCT04968925|474629117|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
131821789|NCT00876265|474629122|FG000|Overall Study|Miscellaneous reasons|4|||
131821790|NCT00876265|474629122|FG000|Overall Study|Lost to Follow-up|6|||
131821791|NCT00876265|474629122|FG000|Overall Study|Withdrawal by Subject|2|||
131821792|NCT01408888|474629123|FG000|First Intervention|Adverse Event|0|||
131821793|NCT01408888|474629124|FG001|First Intervention|Adverse Event|1|||
131821794|NCT01408888|474629123|FG000|First Intervention|Withdrawal by Subject|0|||
131821795|NCT01408888|474629124|FG001|First Intervention|Withdrawal by Subject|2|||
131821796|NCT01408888|474629123|FG000|Second Intervention|Withdrawal by Subject|1|||
131821797|NCT01408888|474629124|FG001|Second Intervention|Withdrawal by Subject|0|||
131821798|NCT01408888|474629123|FG000|Second Intervention|Adverse Event|1|||
131449844|NCT03722238|473276722|FG000|Overall Study|Lost to Follow-up|6|||
131449845|NCT03722238|473276723|FG001|Overall Study|Lost to Follow-up|0|||
131449846|NCT03722238|473276722|FG000|Overall Study|Partial missing data|44|||
131449847|NCT03722238|473276723|FG001|Overall Study|Partial missing data|1|||
131449848|NCT03722238|473276722|FG000|Overall Study|Withdrawal by Subject|2|||
131449849|NCT03722238|473276723|FG001|Overall Study|Withdrawal by Subject|0|||
131449850|NCT03722238|473276722|FG000|Overall Study|Other|4|||
131449851|NCT03722238|473276723|FG001|Overall Study|Other|0|||
131449852|NCT03722238|473276722|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
131449853|NCT03722238|473276723|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
131449854|NCT03722238|473276722|FG000|Overall Study|Did not meet risk classification group criteria|90|||
131449855|NCT03722238|473276723|FG001|Overall Study|Did not meet risk classification group criteria|0|||
131449856|NCT03722238|473276722|FG000|Overall Study|Did not sign consent|17|||
131449857|NCT03722238|473276723|FG001|Overall Study|Did not sign consent|0|||
131449858|NCT03722238|473276722|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
131821799|NCT01408888|474629124|FG001|Second Intervention|Adverse Event|0|||
131821800|NCT00695110|474629125|FG000|Treatment Period 1|Adverse Event|1|||
131821801|NCT00695110|474629125|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131821802|NCT00695110|474629125|FG000|Treatment Period 3|Withdrawal by Subject|1|||
131821803|NCT00695110|474629125|FG000|Treatment Period 4|Adverse Event|1|||
131821804|NCT00487695|474629126|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
131821805|NCT00487695|474629127|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
131821806|NCT00487695|474629126|FG000|First Procedure|active wheezing (did not have procedure)|1|||
131821807|NCT00487695|474629127|FG001|First Procedure|active wheezing (did not have procedure)|0|||
131821808|NCT00487695|474629126|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
131821809|NCT00487695|474629127|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
131821810|NCT00487695|474629126|FG000|Second Procedure|active wheezing|0|||
131821811|NCT00487695|474629127|FG001|Second Procedure|active wheezing|1|||
131821812|NCT00487695|474629126|FG000|Second Procedure|Withdrawal by Subject|1|||
131821813|NCT00487695|474629127|FG001|Second Procedure|Withdrawal by Subject|2|||
131821814|NCT04542694|474629128|FG000|Overall Study|The need for prohibited therapy|2|||
131821815|NCT04542694|474629129|FG001|Overall Study|The need for prohibited therapy|0|||
131821816|NCT04542694|474629128|FG000|Overall Study|Adverse Event|1|||
131821817|NCT04542694|474629129|FG001|Overall Study|Adverse Event|0|||
131821818|NCT04542694|474629128|FG000|Overall Study|Protocol Violation|1|||
131821819|NCT04542694|474629129|FG001|Overall Study|Protocol Violation|0|||
131821820|NCT00969124|474629134|FG000|Overall Study|Protocol Violation|2|||
131821821|NCT00969124|474629134|FG000|Overall Study|Inadequate bowel preparation|15|||
131821822|NCT00969124|474629134|FG000|Overall Study|Inability to reach cecum|9|||
131449859|NCT03722238|473276723|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
131821823|NCT00969124|474629134|FG000|Overall Study|Previously unrecognized disease|3|||
131821824|NCT00969124|474629134|FG000|Overall Study|Technical error|1|||
131821825|NCT00981799|474629135|FG000|Overall Study|Adverse Event|1|||
131821826|NCT00981799|474629136|FG001|Overall Study|Adverse Event|1|||
131821827|NCT00981799|474629137|FG002|Overall Study|Adverse Event|0|||
131821828|NCT00981799|474629138|FG003|Overall Study|Adverse Event|0|||
131821829|NCT00687739|474629139|FG000|Overall Study|Lost to Follow-up|2|||
131821830|NCT00687739|474629140|FG001|Overall Study|Lost to Follow-up|2|||
131821831|NCT00687739|474629141|FG002|Overall Study|Lost to Follow-up|1|||
131821832|NCT00687739|474629142|FG003|Overall Study|Lost to Follow-up|2|||
131821833|NCT00687739|474629139|FG000|Overall Study|Adverse Event|0|||
131821834|NCT00687739|474629140|FG001|Overall Study|Adverse Event|1|||
131821835|NCT00687739|474629141|FG002|Overall Study|Adverse Event|1|||
131821836|NCT00687739|474629142|FG003|Overall Study|Adverse Event|0|||
131821837|NCT03433703|474629143|FG000|Overall Study|Study terminated by Sponsor|2|||
131821838|NCT02786953|474629146|FG000|Overall Study|Withdrawal by Subject|3|||
131821839|NCT02786953|474629147|FG001|Overall Study|Withdrawal by Subject|0|||
131821840|NCT02786953|474629146|FG000|Overall Study|Physician Decision|0|||
131821841|NCT02786953|474629147|FG001|Overall Study|Physician Decision|1|||
131821842|NCT01698554|474629148|FG000|Overall Study|Adverse Event|2|||
131821843|NCT01698554|474629149|FG001|Overall Study|Adverse Event|5|||
131821844|NCT01698554|474629150|FG002|Overall Study|Adverse Event|0|||
131821845|NCT01698554|474629151|FG003|Overall Study|Adverse Event|1|||
131821846|NCT01698554|474629148|FG000|Overall Study|Lost to Follow-up|1|||
131821847|NCT01698554|474629149|FG001|Overall Study|Lost to Follow-up|0|||
131821848|NCT01698554|474629150|FG002|Overall Study|Lost to Follow-up|0|||
131821849|NCT01698554|474629151|FG003|Overall Study|Lost to Follow-up|0|||
131821850|NCT01698554|474629148|FG000|Overall Study|Personal Reasons|0|||
131821851|NCT01698554|474629149|FG001|Overall Study|Personal Reasons|5|||
131821852|NCT01698554|474629150|FG002|Overall Study|Personal Reasons|1|||
131821853|NCT01698554|474629151|FG003|Overall Study|Personal Reasons|1|||
131821854|NCT01698554|474629148|FG000|Overall Study|Protocol Violation|2|||
131821855|NCT01698554|474629149|FG001|Overall Study|Protocol Violation|0|||
131821856|NCT01698554|474629150|FG002|Overall Study|Protocol Violation|1|||
131821857|NCT01698554|474629151|FG003|Overall Study|Protocol Violation|0|||
131821858|NCT01698554|474629148|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131821859|NCT01698554|474629149|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131821860|NCT01698554|474629150|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131821861|NCT01698554|474629151|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131821862|NCT01332968|474629155|FG000|Induction Period|Adverse Event|23|||
131821863|NCT01332968|474629156|FG001|Induction Period|Adverse Event|26|||
131821864|NCT01332968|474629157|FG002|Induction Period|Adverse Event|0|||
131821865|NCT01332968|474629158|FG003|Induction Period|Adverse Event|0|||
131821866|NCT01332968|474629159|FG004|Induction Period|Adverse Event|0|||
131821867|NCT01332968|474629160|FG005|Induction Period|Adverse Event|0|||
131821868|NCT01332968|474629161|FG006|Induction Period|Adverse Event|0|||
131821869|NCT01332968|474629162|FG007|Induction Period|Adverse Event|0|||
131821870|NCT01332968|474629155|FG000|Induction Period|Death|1|||
131821871|NCT01332968|474629156|FG001|Induction Period|Death|4|||
131821872|NCT01332968|474629157|FG002|Induction Period|Death|0|||
131821873|NCT01332968|474629158|FG003|Induction Period|Death|0|||
131821874|NCT01332968|474629159|FG004|Induction Period|Death|0|||
131821875|NCT01332968|474629160|FG005|Induction Period|Death|0|||
131821876|NCT01332968|474629161|FG006|Induction Period|Death|0|||
131821877|NCT01332968|474629162|FG007|Induction Period|Death|0|||
131821878|NCT01332968|474629155|FG000|Induction Period|Non-compliance|1|||
131821879|NCT01332968|474629156|FG001|Induction Period|Non-compliance|0|||
131821880|NCT01332968|474629157|FG002|Induction Period|Non-compliance|0|||
131821881|NCT01332968|474629158|FG003|Induction Period|Non-compliance|0|||
131821882|NCT01332968|474629159|FG004|Induction Period|Non-compliance|0|||
131821883|NCT01332968|474629160|FG005|Induction Period|Non-compliance|0|||
131821884|NCT01332968|474629161|FG006|Induction Period|Non-compliance|0|||
131821885|NCT01332968|474629162|FG007|Induction Period|Non-compliance|0|||
131821886|NCT01332968|474629155|FG000|Induction Period|Other|2|||
131821887|NCT01332968|474629156|FG001|Induction Period|Other|2|||
131821888|NCT01332968|474629157|FG002|Induction Period|Other|0|||
131821889|NCT01332968|474629158|FG003|Induction Period|Other|0|||
131821890|NCT01332968|474629159|FG004|Induction Period|Other|0|||
131449860|NCT03722238|473276722|FG000|Overall Study|Not willing to purchase study medication|142|||
131821891|NCT01332968|474629160|FG005|Induction Period|Other|0|||
131821892|NCT01332968|474629161|FG006|Induction Period|Other|0|||
131821893|NCT01332968|474629162|FG007|Induction Period|Other|0|||
131821894|NCT01332968|474629155|FG000|Induction Period|Physician Decision|6|||
131821895|NCT01332968|474629156|FG001|Induction Period|Physician Decision|1|||
131449861|NCT03722238|473276723|FG001|Overall Study|Not willing to purchase study medication|0|||
131821896|NCT01332968|474629157|FG002|Induction Period|Physician Decision|0|||
131821897|NCT01332968|474629158|FG003|Induction Period|Physician Decision|0|||
131821898|NCT01332968|474629159|FG004|Induction Period|Physician Decision|0|||
131821899|NCT01332968|474629160|FG005|Induction Period|Physician Decision|0|||
131821900|NCT01332968|474629161|FG006|Induction Period|Physician Decision|0|||
131821901|NCT01332968|474629162|FG007|Induction Period|Physician Decision|0|||
131821902|NCT01332968|474629155|FG000|Induction Period|Progressive Disease|15|||
131821903|NCT01332968|474629156|FG001|Induction Period|Progressive Disease|7|||
131821904|NCT01332968|474629157|FG002|Induction Period|Progressive Disease|0|||
131821905|NCT01332968|474629158|FG003|Induction Period|Progressive Disease|0|||
131821906|NCT01332968|474629159|FG004|Induction Period|Progressive Disease|0|||
131821907|NCT01332968|474629160|FG005|Induction Period|Progressive Disease|0|||
131821908|NCT01332968|474629161|FG006|Induction Period|Progressive Disease|0|||
131821909|NCT01332968|474629162|FG007|Induction Period|Progressive Disease|0|||
131821910|NCT01332968|474629155|FG000|Induction Period|Protocol Violation|3|||
131821911|NCT01332968|474629156|FG001|Induction Period|Protocol Violation|4|||
131821912|NCT01332968|474629157|FG002|Induction Period|Protocol Violation|0|||
131821913|NCT01332968|474629158|FG003|Induction Period|Protocol Violation|0|||
131821914|NCT01332968|474629159|FG004|Induction Period|Protocol Violation|0|||
131821915|NCT01332968|474629160|FG005|Induction Period|Protocol Violation|0|||
131821916|NCT01332968|474629161|FG006|Induction Period|Protocol Violation|0|||
131821917|NCT01332968|474629162|FG007|Induction Period|Protocol Violation|0|||
131821918|NCT01332968|474629155|FG000|Induction Period|Withdrawal by Subject|3|||
131821919|NCT01332968|474629156|FG001|Induction Period|Withdrawal by Subject|5|||
131821920|NCT01332968|474629157|FG002|Induction Period|Withdrawal by Subject|0|||
131821921|NCT01332968|474629158|FG003|Induction Period|Withdrawal by Subject|0|||
131821922|NCT01332968|474629159|FG004|Induction Period|Withdrawal by Subject|0|||
131821923|NCT01332968|474629160|FG005|Induction Period|Withdrawal by Subject|0|||
131821924|NCT01332968|474629161|FG006|Induction Period|Withdrawal by Subject|0|||
131821925|NCT01332968|474629162|FG007|Induction Period|Withdrawal by Subject|0|||
131821926|NCT01332968|474629155|FG000|Induction Period|Randomised but not treated|4|||
131821927|NCT01332968|474629156|FG001|Induction Period|Randomised but not treated|7|||
131821928|NCT01332968|474629157|FG002|Induction Period|Randomised but not treated|0|||
131821929|NCT01332968|474629158|FG003|Induction Period|Randomised but not treated|0|||
131821930|NCT01332968|474629159|FG004|Induction Period|Randomised but not treated|0|||
131821931|NCT01332968|474629160|FG005|Induction Period|Randomised but not treated|0|||
131821932|NCT01332968|474629161|FG006|Induction Period|Randomised but not treated|0|||
131821933|NCT01332968|474629162|FG007|Induction Period|Randomised but not treated|0|||
131821934|NCT01332968|474629155|FG000|Maintenance/Observation Period|Adverse Event|0|||
131821935|NCT01332968|474629156|FG001|Maintenance/Observation Period|Adverse Event|0|||
131821936|NCT01332968|474629157|FG002|Maintenance/Observation Period|Adverse Event|53|||
131821937|NCT01332968|474629158|FG003|Maintenance/Observation Period|Adverse Event|66|||
131821938|NCT01332968|474629159|FG004|Maintenance/Observation Period|Adverse Event|0|||
131821939|NCT01332968|474629160|FG005|Maintenance/Observation Period|Adverse Event|0|||
131821940|NCT01332968|474629161|FG006|Maintenance/Observation Period|Adverse Event|0|||
131821941|NCT01332968|474629162|FG007|Maintenance/Observation Period|Adverse Event|0|||
131821942|NCT01332968|474629155|FG000|Maintenance/Observation Period|Death|0|||
131821943|NCT01332968|474629156|FG001|Maintenance/Observation Period|Death|0|||
131821944|NCT01332968|474629157|FG002|Maintenance/Observation Period|Death|5|||
131821945|NCT01332968|474629158|FG003|Maintenance/Observation Period|Death|6|||
131821946|NCT01332968|474629159|FG004|Maintenance/Observation Period|Death|0|||
131821947|NCT01332968|474629160|FG005|Maintenance/Observation Period|Death|0|||
131821948|NCT01332968|474629161|FG006|Maintenance/Observation Period|Death|0|||
131821949|NCT01332968|474629162|FG007|Maintenance/Observation Period|Death|0|||
131821950|NCT01332968|474629155|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
131821951|NCT01332968|474629156|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
131821952|NCT01332968|474629157|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
131821953|NCT01332968|474629158|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
131821954|NCT01332968|474629159|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
131821955|NCT01332968|474629160|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
131821956|NCT01332968|474629161|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
131821957|NCT01332968|474629162|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
131821958|NCT01332968|474629155|FG000|Maintenance/Observation Period|Non-compliance|0|||
131821959|NCT01332968|474629156|FG001|Maintenance/Observation Period|Non-compliance|0|||
131821960|NCT01332968|474629157|FG002|Maintenance/Observation Period|Non-compliance|4|||
131821961|NCT01332968|474629158|FG003|Maintenance/Observation Period|Non-compliance|3|||
131821962|NCT01332968|474629159|FG004|Maintenance/Observation Period|Non-compliance|0|||
131821963|NCT01332968|474629160|FG005|Maintenance/Observation Period|Non-compliance|0|||
131821964|NCT01332968|474629161|FG006|Maintenance/Observation Period|Non-compliance|0|||
131821965|NCT01332968|474629162|FG007|Maintenance/Observation Period|Non-compliance|0|||
131821966|NCT01332968|474629155|FG000|Maintenance/Observation Period|Other|0|||
131821967|NCT01332968|474629156|FG001|Maintenance/Observation Period|Other|0|||
131821968|NCT01332968|474629157|FG002|Maintenance/Observation Period|Other|4|||
131821969|NCT01332968|474629158|FG003|Maintenance/Observation Period|Other|7|||
131821970|NCT01332968|474629159|FG004|Maintenance/Observation Period|Other|0|||
131821971|NCT01332968|474629160|FG005|Maintenance/Observation Period|Other|0|||
131821972|NCT01332968|474629161|FG006|Maintenance/Observation Period|Other|0|||
131821973|NCT01332968|474629162|FG007|Maintenance/Observation Period|Other|0|||
131821974|NCT01332968|474629155|FG000|Maintenance/Observation Period|Physician Decision|0|||
131821975|NCT01332968|474629156|FG001|Maintenance/Observation Period|Physician Decision|0|||
131821976|NCT01332968|474629157|FG002|Maintenance/Observation Period|Physician Decision|14|||
131821977|NCT01332968|474629158|FG003|Maintenance/Observation Period|Physician Decision|19|||
131821978|NCT01332968|474629159|FG004|Maintenance/Observation Period|Physician Decision|0|||
131821979|NCT01332968|474629160|FG005|Maintenance/Observation Period|Physician Decision|1|||
131821980|NCT01332968|474629161|FG006|Maintenance/Observation Period|Physician Decision|0|||
131821981|NCT01332968|474629162|FG007|Maintenance/Observation Period|Physician Decision|0|||
131821982|NCT01332968|474629155|FG000|Maintenance/Observation Period|Progressive Disease|0|||
131821983|NCT01332968|474629156|FG001|Maintenance/Observation Period|Progressive Disease|0|||
131821984|NCT01332968|474629157|FG002|Maintenance/Observation Period|Progressive Disease|72|||
131821985|NCT01332968|474629158|FG003|Maintenance/Observation Period|Progressive Disease|40|||
131821986|NCT01332968|474629159|FG004|Maintenance/Observation Period|Progressive Disease|0|||
131821987|NCT01332968|474629160|FG005|Maintenance/Observation Period|Progressive Disease|0|||
131821988|NCT01332968|474629161|FG006|Maintenance/Observation Period|Progressive Disease|0|||
131821989|NCT01332968|474629162|FG007|Maintenance/Observation Period|Progressive Disease|0|||
131821990|NCT01332968|474629155|FG000|Maintenance/Observation Period|Protocol Violation|0|||
131821991|NCT01332968|474629156|FG001|Maintenance/Observation Period|Protocol Violation|0|||
131821992|NCT01332968|474629157|FG002|Maintenance/Observation Period|Protocol Violation|1|||
131821993|NCT01332968|474629158|FG003|Maintenance/Observation Period|Protocol Violation|1|||
131821994|NCT01332968|474629159|FG004|Maintenance/Observation Period|Protocol Violation|0|||
131821995|NCT01332968|474629160|FG005|Maintenance/Observation Period|Protocol Violation|0|||
131909927|NCT03040726|474958716|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
131909928|NCT03040726|474958715|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
131909929|NCT03040726|474958716|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
131909930|NCT03040726|474958715|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
131821996|NCT01332968|474629161|FG006|Maintenance/Observation Period|Protocol Violation|0|||
131821997|NCT01332968|474629162|FG007|Maintenance/Observation Period|Protocol Violation|0|||
131821998|NCT01332968|474629155|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
131821999|NCT01332968|474629156|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
131822000|NCT01332968|474629157|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
131822001|NCT01332968|474629158|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
131822002|NCT01332968|474629159|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
131822003|NCT01332968|474629160|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
131822004|NCT01332968|474629161|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
131822005|NCT01332968|474629162|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
131822006|NCT01332968|474629155|FG000|Follow-Up Period|Adverse Event|0|||
131822007|NCT01332968|474629156|FG001|Follow-Up Period|Adverse Event|0|||
131822008|NCT01332968|474629157|FG002|Follow-Up Period|Adverse Event|0|||
131822009|NCT01332968|474629158|FG003|Follow-Up Period|Adverse Event|0|||
131822010|NCT01332968|474629159|FG004|Follow-Up Period|Adverse Event|0|||
131822011|NCT01332968|474629160|FG005|Follow-Up Period|Adverse Event|0|||
131822012|NCT01332968|474629161|FG006|Follow-Up Period|Adverse Event|0|||
131822013|NCT01332968|474629162|FG007|Follow-Up Period|Adverse Event|4|||
131822014|NCT01332968|474629155|FG000|Follow-Up Period|Death|0|||
131822015|NCT01332968|474629156|FG001|Follow-Up Period|Death|0|||
131822016|NCT01332968|474629157|FG002|Follow-Up Period|Death|0|||
131822017|NCT01332968|474629158|FG003|Follow-Up Period|Death|0|||
131822018|NCT01332968|474629159|FG004|Follow-Up Period|Death|0|||
131822019|NCT01332968|474629160|FG005|Follow-Up Period|Death|0|||
131822020|NCT01332968|474629161|FG006|Follow-Up Period|Death|27|||
131822021|NCT01332968|474629162|FG007|Follow-Up Period|Death|30|||
131822022|NCT01332968|474629155|FG000|Follow-Up Period|Lost to Follow-up|0|||
131822023|NCT01332968|474629156|FG001|Follow-Up Period|Lost to Follow-up|0|||
131822024|NCT01332968|474629157|FG002|Follow-Up Period|Lost to Follow-up|0|||
131822025|NCT01332968|474629158|FG003|Follow-Up Period|Lost to Follow-up|0|||
131822026|NCT01332968|474629159|FG004|Follow-Up Period|Lost to Follow-up|0|||
131822027|NCT01332968|474629160|FG005|Follow-Up Period|Lost to Follow-up|0|||
131822028|NCT01332968|474629161|FG006|Follow-Up Period|Lost to Follow-up|11|||
131822029|NCT01332968|474629162|FG007|Follow-Up Period|Lost to Follow-up|15|||
131822030|NCT01332968|474629155|FG000|Follow-Up Period|Non-compliance|0|||
131822031|NCT01332968|474629156|FG001|Follow-Up Period|Non-compliance|0|||
131822032|NCT01332968|474629157|FG002|Follow-Up Period|Non-compliance|0|||
131822033|NCT01332968|474629158|FG003|Follow-Up Period|Non-compliance|0|||
131909931|NCT03040726|474958716|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
131909932|NCT03040726|474958715|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
131909933|NCT03040726|474958716|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
131909934|NCT03040726|474958715|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
131909935|NCT03040726|474958716|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
131909936|NCT01123655|474958717|FG000|Overall Study|Medication for RA had to be changed|1|||
131822034|NCT01332968|474629159|FG004|Follow-Up Period|Non-compliance|0|||
131822035|NCT01332968|474629160|FG005|Follow-Up Period|Non-compliance|0|||
131822036|NCT01332968|474629161|FG006|Follow-Up Period|Non-compliance|4|||
131822037|NCT01332968|474629162|FG007|Follow-Up Period|Non-compliance|9|||
131822038|NCT01332968|474629155|FG000|Follow-Up Period|Other|0|||
131822039|NCT01332968|474629156|FG001|Follow-Up Period|Other|0|||
131822040|NCT01332968|474629157|FG002|Follow-Up Period|Other|0|||
131822041|NCT01332968|474629158|FG003|Follow-Up Period|Other|0|||
131822042|NCT01332968|474629159|FG004|Follow-Up Period|Other|0|||
131822043|NCT01332968|474629160|FG005|Follow-Up Period|Other|0|||
131822044|NCT01332968|474629161|FG006|Follow-Up Period|Other|18|||
131822045|NCT01332968|474629162|FG007|Follow-Up Period|Other|21|||
131822046|NCT01332968|474629155|FG000|Follow-Up Period|Physician Decision|0|||
131822047|NCT01332968|474629156|FG001|Follow-Up Period|Physician Decision|0|||
131822048|NCT01332968|474629157|FG002|Follow-Up Period|Physician Decision|0|||
131822049|NCT01332968|474629158|FG003|Follow-Up Period|Physician Decision|0|||
131822050|NCT01332968|474629159|FG004|Follow-Up Period|Physician Decision|0|||
131822051|NCT01332968|474629160|FG005|Follow-Up Period|Physician Decision|0|||
131822052|NCT01332968|474629161|FG006|Follow-Up Period|Physician Decision|12|||
131822053|NCT01332968|474629162|FG007|Follow-Up Period|Physician Decision|15|||
131822054|NCT01332968|474629155|FG000|Follow-Up Period|Progressive Disease|0|||
131822055|NCT01332968|474629156|FG001|Follow-Up Period|Progressive Disease|0|||
131822056|NCT01332968|474629157|FG002|Follow-Up Period|Progressive Disease|0|||
131822057|NCT01332968|474629158|FG003|Follow-Up Period|Progressive Disease|0|||
131822058|NCT01332968|474629159|FG004|Follow-Up Period|Progressive Disease|0|||
131822059|NCT01332968|474629160|FG005|Follow-Up Period|Progressive Disease|0|||
131822060|NCT01332968|474629161|FG006|Follow-Up Period|Progressive Disease|126|||
131822061|NCT01332968|474629162|FG007|Follow-Up Period|Progressive Disease|106|||
131822062|NCT01332968|474629155|FG000|Follow-Up Period|Protocol Violation|0|||
131822063|NCT01332968|474629156|FG001|Follow-Up Period|Protocol Violation|0|||
131822064|NCT01332968|474629157|FG002|Follow-Up Period|Protocol Violation|0|||
131822065|NCT01332968|474629158|FG003|Follow-Up Period|Protocol Violation|0|||
131822066|NCT01332968|474629159|FG004|Follow-Up Period|Protocol Violation|0|||
131822067|NCT01332968|474629160|FG005|Follow-Up Period|Protocol Violation|0|||
131822068|NCT01332968|474629161|FG006|Follow-Up Period|Protocol Violation|1|||
131822069|NCT01332968|474629162|FG007|Follow-Up Period|Protocol Violation|0|||
131822070|NCT01332968|474629155|FG000|Follow-Up Period|Withdrawal by Subject|0|||
131822071|NCT01332968|474629156|FG001|Follow-Up Period|Withdrawal by Subject|0|||
131822072|NCT01332968|474629157|FG002|Follow-Up Period|Withdrawal by Subject|0|||
131822073|NCT01332968|474629158|FG003|Follow-Up Period|Withdrawal by Subject|0|||
131822074|NCT01332968|474629159|FG004|Follow-Up Period|Withdrawal by Subject|0|||
131822075|NCT01332968|474629160|FG005|Follow-Up Period|Withdrawal by Subject|0|||
131822076|NCT01332968|474629161|FG006|Follow-Up Period|Withdrawal by Subject|29|||
131822077|NCT01332968|474629162|FG007|Follow-Up Period|Withdrawal by Subject|32|||
131822078|NCT01332968|474629155|FG000|Follow-Up Period|No reason provided|0|||
131822079|NCT01332968|474629156|FG001|Follow-Up Period|No reason provided|0|||
131822080|NCT01332968|474629157|FG002|Follow-Up Period|No reason provided|0|||
131822081|NCT01332968|474629158|FG003|Follow-Up Period|No reason provided|0|||
131822082|NCT01332968|474629159|FG004|Follow-Up Period|No reason provided|0|||
131822083|NCT01332968|474629160|FG005|Follow-Up Period|No reason provided|0|||
131822084|NCT01332968|474629161|FG006|Follow-Up Period|No reason provided|2|||
131822085|NCT01332968|474629162|FG007|Follow-Up Period|No reason provided|3|||
131822086|NCT03480022|474629163|FG000|Overall Study|Pregnancy|2|||
131822087|NCT03480022|474629164|FG001|Overall Study|Pregnancy|0|||
131822088|NCT03480022|474629163|FG000|Overall Study|Adverse Event|6|||
131822089|NCT03480022|474629164|FG001|Overall Study|Adverse Event|0|||
131822090|NCT03480022|474629163|FG000|Overall Study|Lack of Efficacy|0|||
131822091|NCT03480022|474629164|FG001|Overall Study|Lack of Efficacy|2|||
131822092|NCT03480022|474629163|FG000|Overall Study|Physician Decision|0|||
131822093|NCT03480022|474629164|FG001|Overall Study|Physician Decision|1|||
131822094|NCT03480022|474629163|FG000|Overall Study|Withdrawal by Subject|2|||
131822095|NCT03480022|474629164|FG001|Overall Study|Withdrawal by Subject|0|||
131822096|NCT03480022|474629163|FG000|Overall Study|Medication concerns|1|||
131822097|NCT03480022|474629164|FG001|Overall Study|Medication concerns|0|||
131822098|NCT03480022|474629163|FG000|Overall Study|Family member COVID exposure|0|||
131822099|NCT03480022|474629164|FG001|Overall Study|Family member COVID exposure|1|||
131822100|NCT02985398|474629165|FG000|Overall Study|Adverse Event|1|||
131822101|NCT02985398|474629165|FG000|Overall Study|Lost to Follow-up|4|||
131822102|NCT02985398|474629165|FG000|Overall Study|Withdrawal by Subject|8|||
131822103|NCT02985398|474629165|FG000|Overall Study|Study Burden|9|||
131822104|NCT04164758|474629166|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
131822105|NCT04164758|474629167|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
131822106|NCT04164758|474629168|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
131822107|NCT04164758|474629166|FG000|Overall Study|Adverse Event|0|||
131822108|NCT04164758|474629167|FG001|Overall Study|Adverse Event|1|||
131822109|NCT04164758|474629168|FG002|Overall Study|Adverse Event|0|||
131822110|NCT00697827|474629169|FG000|Overall Study|enrolled but not treated|2|||
131822111|NCT00697827|474629170|FG001|Overall Study|enrolled but not treated|1|||
131822112|NCT00283842|474629177|FG000|Overall Study|Adverse Event|8|||
131822113|NCT00283842|474629178|FG001|Overall Study|Adverse Event|7|||
131822114|NCT00283842|474629179|FG002|Overall Study|Adverse Event|21|||
131822115|NCT00283842|474629180|FG003|Overall Study|Adverse Event|21|||
131822116|NCT00283842|474629181|FG004|Overall Study|Adverse Event|5|||
131822117|NCT00283842|474629177|FG000|Overall Study|Protocol Violation|1|||
131822118|NCT00283842|474629178|FG001|Overall Study|Protocol Violation|5|||
131822119|NCT00283842|474629179|FG002|Overall Study|Protocol Violation|4|||
131822120|NCT00283842|474629180|FG003|Overall Study|Protocol Violation|0|||
131822121|NCT00283842|474629181|FG004|Overall Study|Protocol Violation|0|||
131822122|NCT00283842|474629177|FG000|Overall Study|Protocol deviation|0|||
131822123|NCT00283842|474629178|FG001|Overall Study|Protocol deviation|0|||
131822124|NCT00283842|474629179|FG002|Overall Study|Protocol deviation|0|||
131822125|NCT00283842|474629180|FG003|Overall Study|Protocol deviation|0|||
131822126|NCT00283842|474629181|FG004|Overall Study|Protocol deviation|2|||
131822127|NCT00283842|474629177|FG000|Overall Study|Withdrawal by Subject|2|||
131822128|NCT00283842|474629178|FG001|Overall Study|Withdrawal by Subject|1|||
131822129|NCT00283842|474629179|FG002|Overall Study|Withdrawal by Subject|1|||
131822130|NCT00283842|474629180|FG003|Overall Study|Withdrawal by Subject|5|||
131822131|NCT00283842|474629181|FG004|Overall Study|Withdrawal by Subject|4|||
131822132|NCT00283842|474629177|FG000|Overall Study|Lack of Efficacy|1|||
131822133|NCT00283842|474629178|FG001|Overall Study|Lack of Efficacy|3|||
131822134|NCT00283842|474629179|FG002|Overall Study|Lack of Efficacy|1|||
131822135|NCT00283842|474629180|FG003|Overall Study|Lack of Efficacy|0|||
131822136|NCT00283842|474629181|FG004|Overall Study|Lack of Efficacy|3|||
131822137|NCT00283842|474629177|FG000|Overall Study|Lost to Follow-up|0|||
131822138|NCT00283842|474629178|FG001|Overall Study|Lost to Follow-up|2|||
131822139|NCT00283842|474629179|FG002|Overall Study|Lost to Follow-up|4|||
131822140|NCT00283842|474629180|FG003|Overall Study|Lost to Follow-up|1|||
131822141|NCT00283842|474629181|FG004|Overall Study|Lost to Follow-up|1|||
131822142|NCT05665387|474629182|FG000|Overall Study|Withdrawal by Subject|1|||
131822143|NCT05665387|474629183|FG001|Overall Study|Withdrawal by Subject|0|||
131822144|NCT05665387|474629184|FG002|Overall Study|Withdrawal by Subject|1|||
131822145|NCT03732833|474629185|FG000|Overall Study|Adverse Event|0|||
131822146|NCT03732833|474629186|FG001|Overall Study|Adverse Event|3|||
131822147|NCT03732833|474629187|FG002|Overall Study|Adverse Event|1|||
131822148|NCT03732833|474629185|FG000|Overall Study|Withdrawal by Subject|11|||
131822149|NCT03732833|474629186|FG001|Overall Study|Withdrawal by Subject|13|||
131822150|NCT03732833|474629187|FG002|Overall Study|Withdrawal by Subject|8|||
131822151|NCT03732833|474629185|FG000|Overall Study|Lost to Follow-up|3|||
131822152|NCT03732833|474629186|FG001|Overall Study|Lost to Follow-up|5|||
131822153|NCT03732833|474629187|FG002|Overall Study|Lost to Follow-up|4|||
131822154|NCT03732833|474629185|FG000|Overall Study|Pregnancy|0|||
131822155|NCT03732833|474629186|FG001|Overall Study|Pregnancy|2|||
131822156|NCT03732833|474629187|FG002|Overall Study|Pregnancy|0|||
131822157|NCT03732833|474629185|FG000|Overall Study|Physician Decision|2|||
131822158|NCT03732833|474629186|FG001|Overall Study|Physician Decision|3|||
131822159|NCT03732833|474629187|FG002|Overall Study|Physician Decision|1|||
131822160|NCT03732833|474629185|FG000|Overall Study|Covid-19 related and other reasons|2|||
131822161|NCT03732833|474629186|FG001|Overall Study|Covid-19 related and other reasons|7|||
131822162|NCT03732833|474629187|FG002|Overall Study|Covid-19 related and other reasons|3|||
131822163|NCT01824498|474629190|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
131822164|NCT01824498|474629191|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
131822165|NCT01824498|474629192|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
131822166|NCT01824498|474629193|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
131822167|NCT01824498|474629194|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
131822168|NCT01824498|474629195|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
131822169|NCT03980522|474629199|FG000|Treatment Period|Adverse Event|1|||
131822170|NCT03980522|474629200|FG001|Treatment Period|Adverse Event|0|||
131822171|NCT03980522|474629201|FG002|Treatment Period|Adverse Event|0|||
131822172|NCT03980522|474629202|FG003|Treatment Period|Adverse Event|0|||
131822173|NCT03980522|474629203|FG004|Treatment Period|Adverse Event|0|||
131822174|NCT04892147|474629204|FG000|Overall Study|Withdrawal by Subject|2|||
131822175|NCT04892147|474629205|FG001|Overall Study|Withdrawal by Subject|0|||
131822176|NCT05263505|474629206|FG000|Overall Study|Adverse Event|0|||
131822177|NCT05263505|474629207|FG001|Overall Study|Adverse Event|1|||
131822178|NCT00609154|474629208|FG000|Overall Study|Protocol Violation|1|||
131822179|NCT00609154|474629209|FG001|Overall Study|Protocol Violation|2|||
131822180|NCT00609154|474629208|FG000|Overall Study|Unable to establish IV access|0|||
131822181|NCT00609154|474629209|FG001|Overall Study|Unable to establish IV access|4|||
131822182|NCT00609154|474629208|FG000|Overall Study|Adverse Event|0|||
131822183|NCT00609154|474629209|FG001|Overall Study|Adverse Event|2|||
131400952|NCT05005013|473089667|FG001|Overall Study|Lost to Follow-up|1|||
131822184|NCT01499160|474629211|FG000|Overall Study|Adverse Event|1|||
131822185|NCT01499160|474629211|FG000|Overall Study|Withdrawal by Subject|1|||
131822186|NCT03428945|474629216|FG000|Overall Study|Lost to Follow-up|5|||
131822187|NCT03428945|474629217|FG001|Overall Study|Lost to Follow-up|3|||
131822188|NCT03428945|474629216|FG000|Overall Study|Withdrawal by Subject|10|||
131822189|NCT03428945|474629217|FG001|Overall Study|Withdrawal by Subject|10|||
131822190|NCT01562613|474629218|FG000|Overall Study|Lost to Follow-up|2|||
131822191|NCT01562613|474629218|FG000|Overall Study|Withdrawal by Subject|2|||
131822192|NCT01374451|474629223|FG000|Overall Study|Administrative problems|1|||
131822193|NCT01374451|474629224|FG001|Overall Study|Administrative problems|0|||
131822194|NCT04640194|474629225|FG000|Overall Study|Adverse Event|3|||
131822195|NCT04640194|474629226|FG001|Overall Study|Adverse Event|7|||
131822196|NCT04640194|474629227|FG002|Overall Study|Adverse Event|0|||
131822197|NCT04640194|474629228|FG003|Overall Study|Adverse Event|5|||
131822198|NCT04640194|474629229|FG004|Overall Study|Adverse Event|0|||
131822199|NCT04640194|474629230|FG005|Overall Study|Adverse Event|4|||
131822200|NCT04640194|474629231|FG006|Overall Study|Adverse Event|0|||
131822201|NCT04640194|474629225|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
131822202|NCT04640194|474629226|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
131822203|NCT04640194|474629227|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
131822204|NCT04640194|474629228|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
131822205|NCT04640194|474629229|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
131822206|NCT04640194|474629230|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
131822207|NCT04640194|474629231|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
131822208|NCT04640194|474629225|FG000|Overall Study|fibrinogen level too low|0|||
131822209|NCT04640194|474629226|FG001|Overall Study|fibrinogen level too low|0|||
131822210|NCT04640194|474629227|FG002|Overall Study|fibrinogen level too low|0|||
131822211|NCT04640194|474629228|FG003|Overall Study|fibrinogen level too low|1|||
131822212|NCT04640194|474629229|FG004|Overall Study|fibrinogen level too low|0|||
131822213|NCT04640194|474629230|FG005|Overall Study|fibrinogen level too low|0|||
131822214|NCT04640194|474629231|FG006|Overall Study|fibrinogen level too low|0|||
131822215|NCT04640194|474629225|FG000|Overall Study|mild bleeding|0|||
131822216|NCT04640194|474629226|FG001|Overall Study|mild bleeding|0|||
131822217|NCT04640194|474629227|FG002|Overall Study|mild bleeding|0|||
131822218|NCT04640194|474629228|FG003|Overall Study|mild bleeding|1|||
131822219|NCT04640194|474629229|FG004|Overall Study|mild bleeding|0|||
131822220|NCT04640194|474629230|FG005|Overall Study|mild bleeding|0|||
131822221|NCT04640194|474629231|FG006|Overall Study|mild bleeding|0|||
131822222|NCT04640194|474629225|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
131822223|NCT04640194|474629226|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
131822224|NCT04640194|474629227|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
131822225|NCT04640194|474629228|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
131822226|NCT04640194|474629229|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
131822227|NCT04640194|474629230|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
131822228|NCT04640194|474629231|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
131822229|NCT00663234|474629232|FG000|Overall Study|Not willing to adhere to requirements|1|||
131822230|NCT04773600|474629249|FG000|Overall Study|Withdrawal by Subject|15|||
131822231|NCT04773600|474629250|FG001|Overall Study|Withdrawal by Subject|9|||
131822232|NCT04773600|474629249|FG000|Overall Study|Lost to Follow-up|10|||
131822233|NCT04773600|474629250|FG001|Overall Study|Lost to Follow-up|6|||
131822234|NCT04773600|474629249|FG000|Overall Study|Adverse Event|8|||
131822235|NCT04773600|474629250|FG001|Overall Study|Adverse Event|2|||
131822236|NCT04773600|474629249|FG000|Overall Study|Lack of Efficacy|2|||
131822237|NCT04773600|474629250|FG001|Overall Study|Lack of Efficacy|3|||
131822238|NCT04773600|474629249|FG000|Overall Study|Noncompliance|2|||
131822239|NCT04773600|474629250|FG001|Overall Study|Noncompliance|0|||
131822240|NCT04773600|474629249|FG000|Overall Study|Protocol Violation|2|||
131822241|NCT04773600|474629250|FG001|Overall Study|Protocol Violation|0|||
131822242|NCT04773600|474629249|FG000|Overall Study|Physician Decision|0|||
131822243|NCT04773600|474629250|FG001|Overall Study|Physician Decision|1|||
131822244|NCT04773600|474629249|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
131822245|NCT04773600|474629250|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
131822246|NCT04773600|474629249|FG000|Overall Study|Emergency Travel Out of Country|1|||
131822247|NCT04773600|474629250|FG001|Overall Study|Emergency Travel Out of Country|0|||
131822248|NCT04729101|474630976|FG000|Overall Study|Adverse Event|1|||
131822249|NCT04729101|474630977|FG001|Overall Study|Adverse Event|0|||
131822250|NCT04729101|474630976|FG000|Overall Study|Physician Decision|1|||
131822251|NCT04729101|474630977|FG001|Overall Study|Physician Decision|0|||
131822252|NCT04729101|474630976|FG000|Overall Study|Withdrawal by Subject|1|||
131822253|NCT04729101|474630977|FG001|Overall Study|Withdrawal by Subject|0|||
131822254|NCT02940522|474630978|FG000|Overall Study|Lost to Follow-up|1|||
131822255|NCT02940522|474630979|FG001|Overall Study|Lost to Follow-up|2|||
131822256|NCT02940522|474630978|FG000|Overall Study|Withdrawal by Subject|1|||
131822257|NCT02940522|474630979|FG001|Overall Study|Withdrawal by Subject|0|||
131822258|NCT00274625|474630980|FG000|Overall Study|Lost to Follow-up|46|||
131822259|NCT00274625|474630981|FG001|Overall Study|Lost to Follow-up|54|||
131909937|NCT01123655|474958718|FG001|Overall Study|Medication for RA had to be changed|0|||
131822260|NCT00274625|474630980|FG000|Overall Study|Excluded from analysis|14|||
131822261|NCT00274625|474630981|FG001|Overall Study|Excluded from analysis|8|||
131822262|NCT01754376|474630985|FG000|Overall Study|Adverse Event|1|||
131822263|NCT01754376|474630985|FG000|Overall Study|Lack of Efficacy|2|||
131822264|NCT04264819|474630991|FG000|Overall Study|Physician Decision|19|||
131822265|NCT04264819|474630991|FG000|Overall Study|Adverse Event|12|||
131822266|NCT04264819|474630991|FG000|Overall Study|Withdrawal by Subject|11|||
131822267|NCT04264819|474630991|FG000|Overall Study|Lost to Follow-up|2|||
131400953|NCT05005013|473089666|FG000|Overall Study|Ineligibility|1|||
131822268|NCT04264819|474630991|FG000|Overall Study|Death|2|||
131822269|NCT01662024|474630994|FG000|Overall Study|Pregnancy|2|||
131822270|NCT01662024|474630994|FG000|Overall Study|Withdrawal by Subject|3|||
131822271|NCT04832971|474630995|FG000|Overall Study|Death|1|||
131822272|NCT04832971|474630996|FG001|Overall Study|Death|0|||
131822273|NCT04832971|474630997|FG002|Overall Study|Death|0|||
131822274|NCT04832971|474630998|FG003|Overall Study|Death|0|||
131822275|NCT04832971|474630995|FG000|Overall Study|Lost to Follow-up|1|||
131822276|NCT04832971|474630996|FG001|Overall Study|Lost to Follow-up|1|||
131822277|NCT04832971|474630997|FG002|Overall Study|Lost to Follow-up|1|||
131822278|NCT04832971|474630998|FG003|Overall Study|Lost to Follow-up|0|||
131822279|NCT04832971|474630995|FG000|Overall Study|Withdrawal by Subject|1|||
131822280|NCT04832971|474630996|FG001|Overall Study|Withdrawal by Subject|3|||
131822281|NCT04832971|474630997|FG002|Overall Study|Withdrawal by Subject|2|||
131822282|NCT04832971|474630998|FG003|Overall Study|Withdrawal by Subject|2|||
131822283|NCT04832971|474630995|FG000|Overall Study|Other, Not Specified|0|||
131822284|NCT04832971|474630996|FG001|Overall Study|Other, Not Specified|0|||
131822285|NCT04832971|474630997|FG002|Overall Study|Other, Not Specified|1|||
131822286|NCT04832971|474630998|FG003|Overall Study|Other, Not Specified|0|||
131822287|NCT04768296|474630999|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
131822288|NCT04768296|474631000|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
131822289|NCT01453153|474631005|FG000|Overall Study|Physician Decision|0|||
131822290|NCT01453153|474631006|FG001|Overall Study|Physician Decision|0|||
131822291|NCT01453153|474631007|FG002|Overall Study|Physician Decision|1|||
131822292|NCT01453153|474631005|FG000|Overall Study|Progressive Disease|3|||
131822293|NCT01453153|474631006|FG001|Overall Study|Progressive Disease|2|||
131400954|NCT05005013|473089667|FG001|Overall Study|Ineligibility|1|||
131400955|NCT02791516|473089668|FG000|Overall Study|Withdrawal by Subject|1|||
131400956|NCT02791516|473089669|FG001|Overall Study|Withdrawal by Subject|1|||
131400957|NCT02524275|473089670|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
131400958|NCT04283994|473089672|FG000|Overall Study|Death|11|||
131400959|NCT04283994|473089673|FG001|Overall Study|Death|20|||
131400960|NCT04283994|473089674|FG002|Overall Study|Death|11|||
131400961|NCT04283994|473089675|FG003|Overall Study|Death|0|||
131400962|NCT04283994|473089676|FG004|Overall Study|Death|0|||
131822294|NCT01453153|474631007|FG002|Overall Study|Progressive Disease|16|||
131822295|NCT01453153|474631005|FG000|Overall Study|Withdrawal by Subject|0|||
131822296|NCT01453153|474631006|FG001|Overall Study|Withdrawal by Subject|1|||
131822297|NCT01453153|474631007|FG002|Overall Study|Withdrawal by Subject|2|||
131400963|NCT04283994|473089677|FG005|Overall Study|Death|0|||
131400964|NCT04283994|473089678|FG006|Overall Study|Death|0|||
131400965|NCT04283994|473089672|FG000|Overall Study|Withdrawal by Subject|16|||
131400966|NCT04283994|473089673|FG001|Overall Study|Withdrawal by Subject|4|||
131400967|NCT04283994|473089674|FG002|Overall Study|Withdrawal by Subject|6|||
131400968|NCT04283994|473089675|FG003|Overall Study|Withdrawal by Subject|1|||
131400969|NCT04283994|473089676|FG004|Overall Study|Withdrawal by Subject|0|||
131822298|NCT01453153|474631005|FG000|Overall Study|Adverse Event|1|||
131822299|NCT01453153|474631006|FG001|Overall Study|Adverse Event|1|||
131822300|NCT01453153|474631007|FG002|Overall Study|Adverse Event|1|||
131822301|NCT03243396|474631008|FG000|Overall Study|Lost to Follow-up|2|||
131822302|NCT03243396|474631009|FG001|Overall Study|Lost to Follow-up|3|||
131822303|NCT03243396|474631010|FG002|Overall Study|Lost to Follow-up|15|||
131822304|NCT03243396|474631011|FG003|Overall Study|Lost to Follow-up|8|||
131822305|NCT03243396|474631012|FG004|Overall Study|Lost to Follow-up|1|||
131822306|NCT03243396|474631013|FG005|Overall Study|Lost to Follow-up|4|||
131822307|NCT03243396|474631014|FG006|Overall Study|Lost to Follow-up|9|||
131822308|NCT03687242|474631015|FG000|Overall Study|Adverse Event|1|||
131822309|NCT01802216|474631016|FG000|4 Month Visit|Participant did not show to visit|3|||
131400970|NCT04283994|473089677|FG005|Overall Study|Withdrawal by Subject|1|||
131400971|NCT04283994|473089678|FG006|Overall Study|Withdrawal by Subject|0|||
131400972|NCT03763656|473089679|FG000|Overall Study|Physician Decision|1|||
131400973|NCT03763656|473089679|FG000|Overall Study|Protocol Violation|1|||
131822310|NCT01802216|474631017|FG001|4 Month Visit|Participant did not show to visit|4|||
131822311|NCT01802216|474631016|FG000|8 Month Visit|Participant did not show to visit|3|||
131822312|NCT01802216|474631017|FG001|8 Month Visit|Participant did not show to visit|5|||
131822313|NCT01802216|474631016|FG000|12 Month Visit|Participant did not show to visit|3|||
131822314|NCT01802216|474631017|FG001|12 Month Visit|Participant did not show to visit|4|||
131822315|NCT00880334|474631018|FG000|Randomized Phase|Physician Decision|1|||
131822316|NCT00880334|474631019|FG001|Randomized Phase|Physician Decision|0|||
131822317|NCT00880334|474631018|FG000|Randomized Phase|Withdrawal by Subject|2|||
131822318|NCT00880334|474631019|FG001|Randomized Phase|Withdrawal by Subject|1|||
131822319|NCT00880334|474631018|FG000|Randomized Phase|Inadequate Labs|1|||
131822320|NCT00880334|474631019|FG001|Randomized Phase|Inadequate Labs|1|||
131400974|NCT03763656|473089679|FG000|Overall Study|Withdrawal by Subject|7|||
131400975|NCT00211757|473089680|FG000|Overall Study|Withdrawal by Subject|1|||
131400976|NCT00211757|473089681|FG001|Overall Study|Withdrawal by Subject|1|||
131822321|NCT00880334|474631018|FG000|Randomized Phase|Brain Metastasis|0|||
131400977|NCT00211757|473089680|FG000|Overall Study|Lack of Efficacy|0|||
131400978|NCT00211757|473089681|FG001|Overall Study|Lack of Efficacy|1|||
131400979|NCT00322452|473089684|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131400980|NCT00322452|473089685|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131400981|NCT00322452|473089684|FG000|Overall Study|Lost to Follow-up|5|||
131400982|NCT00322452|473089685|FG001|Overall Study|Lost to Follow-up|2|||
131400983|NCT00322452|473089684|FG000|Overall Study|Withdrawal by Subject|19|||
131400984|NCT00322452|473089685|FG001|Overall Study|Withdrawal by Subject|46|||
131400985|NCT00322452|473089684|FG000|Overall Study|Death|223|||
131400986|NCT00322452|473089685|FG001|Overall Study|Death|227|||
131400987|NCT04091581|473089686|FG000|Overall Study|Lost to Follow-up|0|||
131400988|NCT04091581|473089687|FG001|Overall Study|Lost to Follow-up|1|||
131400989|NCT01795495|473089688|FG000|Overall Study|Protocol Violation|1|||
131400990|NCT01795495|473089689|FG001|Overall Study|Protocol Violation|0|||
131400991|NCT01795495|473089690|FG002|Overall Study|Protocol Violation|1|||
131400992|NCT01795495|473089688|FG000|Overall Study|Physician Decision|0|||
131400993|NCT01795495|473089689|FG001|Overall Study|Physician Decision|0|||
131400994|NCT01795495|473089690|FG002|Overall Study|Physician Decision|1|||
131400995|NCT01331837|473089691|FG000|Overall Study|Death|30|||
131400996|NCT01331837|473089692|FG001|Overall Study|Death|34|||
131400997|NCT01331837|473089691|FG000|Overall Study|Lost to Follow-up|3|||
131400998|NCT01331837|473089692|FG001|Overall Study|Lost to Follow-up|1|||
131400999|NCT01331837|473089691|FG000|Overall Study|Info not recorded|10|||
131401000|NCT01331837|473089692|FG001|Overall Study|Info not recorded|16|||
131401001|NCT01331837|473089691|FG000|Overall Study|Withdrawal by Subject|13|||
131401002|NCT01331837|473089692|FG001|Overall Study|Withdrawal by Subject|16|||
131401003|NCT02578680|473091445|FG000|Overall Study|Death|329|||
131401004|NCT02578680|473091446|FG001|Overall Study|Death|181|||
131401005|NCT02578680|473091445|FG000|Overall Study|Lost to Follow-up|3|||
131401006|NCT02578680|473091446|FG001|Overall Study|Lost to Follow-up|1|||
131401007|NCT02578680|473091445|FG000|Overall Study|Physician Decision|0|||
131401008|NCT02578680|473091446|FG001|Overall Study|Physician Decision|1|||
131401009|NCT02578680|473091445|FG000|Overall Study|Protocol Violation|1|||
131401010|NCT02578680|473091446|FG001|Overall Study|Protocol Violation|1|||
131401011|NCT02578680|473091445|FG000|Overall Study|Sponsor Decision|64|||
131401012|NCT02578680|473091446|FG001|Overall Study|Sponsor Decision|13|||
131401013|NCT02578680|473091445|FG000|Overall Study|Withdrawal by Subject|13|||
131401014|NCT02578680|473091446|FG001|Overall Study|Withdrawal by Subject|9|||
131401015|NCT00734604|473091450|FG000|Overall Study|Adverse Event|0|||
131401016|NCT00734604|473091451|FG001|Overall Study|Adverse Event|2|||
131401017|NCT00734604|473091452|FG002|Overall Study|Adverse Event|0|||
131401018|NCT00734604|473091453|FG003|Overall Study|Adverse Event|2|||
131401019|NCT00734604|473091454|FG004|Overall Study|Adverse Event|1|||
131401020|NCT00734604|473091455|FG005|Overall Study|Adverse Event|1|||
131401021|NCT00734604|473091450|FG000|Overall Study|Serious Adverse Event|1|||
131401022|NCT00734604|473091451|FG001|Overall Study|Serious Adverse Event|0|||
131401023|NCT00734604|473091452|FG002|Overall Study|Serious Adverse Event|1|||
131401024|NCT00734604|473091453|FG003|Overall Study|Serious Adverse Event|2|||
131401025|NCT00734604|473091454|FG004|Overall Study|Serious Adverse Event|0|||
131401026|NCT00734604|473091455|FG005|Overall Study|Serious Adverse Event|1|||
131401027|NCT00734604|473091450|FG000|Overall Study|Lost to Follow-up|1|||
131401028|NCT00734604|473091451|FG001|Overall Study|Lost to Follow-up|2|||
131401029|NCT00734604|473091452|FG002|Overall Study|Lost to Follow-up|2|||
131401030|NCT00734604|473091453|FG003|Overall Study|Lost to Follow-up|4|||
131401031|NCT00734604|473091454|FG004|Overall Study|Lost to Follow-up|2|||
131401032|NCT00734604|473091455|FG005|Overall Study|Lost to Follow-up|3|||
131401033|NCT00734604|473091450|FG000|Overall Study|Physician Decision|0|||
131401034|NCT00734604|473091451|FG001|Overall Study|Physician Decision|1|||
131401035|NCT00734604|473091452|FG002|Overall Study|Physician Decision|1|||
131401036|NCT00734604|473091453|FG003|Overall Study|Physician Decision|0|||
131401037|NCT00734604|473091454|FG004|Overall Study|Physician Decision|0|||
131401038|NCT00734604|473091455|FG005|Overall Study|Physician Decision|0|||
131401039|NCT00734604|473091450|FG000|Overall Study|Protocol Violation|0|||
131401040|NCT00734604|473091451|FG001|Overall Study|Protocol Violation|2|||
131401041|NCT00734604|473091452|FG002|Overall Study|Protocol Violation|0|||
131401042|NCT00734604|473091453|FG003|Overall Study|Protocol Violation|0|||
131401043|NCT00734604|473091454|FG004|Overall Study|Protocol Violation|1|||
131401044|NCT00734604|473091455|FG005|Overall Study|Protocol Violation|0|||
131401045|NCT00734604|473091450|FG000|Overall Study|Sponsor Decision|1|||
131401046|NCT00734604|473091451|FG001|Overall Study|Sponsor Decision|2|||
131401047|NCT00734604|473091452|FG002|Overall Study|Sponsor Decision|1|||
131401048|NCT00734604|473091453|FG003|Overall Study|Sponsor Decision|0|||
131401049|NCT00734604|473091454|FG004|Overall Study|Sponsor Decision|2|||
131401050|NCT00734604|473091455|FG005|Overall Study|Sponsor Decision|0|||
131401051|NCT00734604|473091450|FG000|Overall Study|Withdrawal by Subject|0|||
131401052|NCT00734604|473091451|FG001|Overall Study|Withdrawal by Subject|2|||
131401053|NCT00734604|473091452|FG002|Overall Study|Withdrawal by Subject|0|||
131401054|NCT00734604|473091453|FG003|Overall Study|Withdrawal by Subject|1|||
131401055|NCT00734604|473091454|FG004|Overall Study|Withdrawal by Subject|2|||
131401056|NCT00734604|473091455|FG005|Overall Study|Withdrawal by Subject|1|||
131822322|NCT00880334|474631019|FG001|Randomized Phase|Brain Metastasis|1|||
131822323|NCT00880334|474631018|FG000|Randomized Phase|Crossover Participants|0|||
131822324|NCT00880334|474631019|FG001|Randomized Phase|Crossover Participants|37|||
131822325|NCT02473393|474631024|FG000|Overall Study|Adverse Event|0|||
131822326|NCT02473393|474631025|FG001|Overall Study|Adverse Event|0|||
131822327|NCT02473393|474631026|FG002|Overall Study|Adverse Event|1|||
131822328|NCT02473393|474631027|FG003|Overall Study|Adverse Event|0|||
131822329|NCT02473393|474631024|FG000|Overall Study|Withdrawal by Subject|0|||
131822330|NCT02473393|474631025|FG001|Overall Study|Withdrawal by Subject|0|||
131822331|NCT02473393|474631026|FG002|Overall Study|Withdrawal by Subject|1|||
131822332|NCT02473393|474631027|FG003|Overall Study|Withdrawal by Subject|1|||
131822333|NCT02274558|474631028|FG000|Overall Study|Adverse Event|2|||
131822334|NCT02274558|474631029|FG001|Overall Study|Adverse Event|4|||
131909938|NCT01123655|474958719|FG002|Overall Study|Medication for RA had to be changed|0|||
131909939|NCT01123655|474958717|FG000|Overall Study|new illness|0|||
131909940|NCT01123655|474958718|FG001|Overall Study|new illness|1|||
131909941|NCT01123655|474958719|FG002|Overall Study|new illness|0|||
131909942|NCT01123655|474958717|FG000|Overall Study|began prohibitive drug|0|||
131822335|NCT02274558|474631030|FG002|Overall Study|Adverse Event|2|||
131822336|NCT02274558|474631028|FG000|Overall Study|Non-compliance|2|||
131822337|NCT02274558|474631029|FG001|Overall Study|Non-compliance|1|||
131822338|NCT02274558|474631030|FG002|Overall Study|Non-compliance|0|||
131909943|NCT01123655|474958718|FG001|Overall Study|began prohibitive drug|0|||
131909944|NCT01123655|474958719|FG002|Overall Study|began prohibitive drug|1|||
131909945|NCT00171249|474958722|FG000|Overall Study|Withdrawal by Subject|2|||
131909946|NCT00171249|474958723|FG001|Overall Study|Withdrawal by Subject|0|||
131909947|NCT00171249|474958724|FG002|Overall Study|Withdrawal by Subject|0|||
131909948|NCT00171249|474958725|FG003|Overall Study|Withdrawal by Subject|6|||
131909949|NCT00171249|474958726|FG004|Overall Study|Withdrawal by Subject|0|||
131909950|NCT00171249|474958727|FG005|Overall Study|Withdrawal by Subject|0|||
131909951|NCT00171249|474958728|FG006|Overall Study|Withdrawal by Subject|0|||
131909952|NCT00171249|474958722|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
131909953|NCT00171249|474958723|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131909954|NCT00171249|474958724|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
131909955|NCT00171249|474958725|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
131909956|NCT00171249|474958726|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131909957|NCT00171249|474958727|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
131909958|NCT00171249|474958728|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131909959|NCT00171249|474958722|FG000|Overall Study|Death|7|||
131909960|NCT00171249|474958723|FG001|Overall Study|Death|1|||
131909961|NCT00171249|474958724|FG002|Overall Study|Death|0|||
131909962|NCT00171249|474958725|FG003|Overall Study|Death|4|||
131909963|NCT00171249|474958726|FG004|Overall Study|Death|0|||
131909964|NCT00171249|474958727|FG005|Overall Study|Death|3|||
131909965|NCT00171249|474958728|FG006|Overall Study|Death|1|||
131909966|NCT00171249|474958722|FG000|Overall Study|Other|10|||
131909967|NCT00171249|474958723|FG001|Overall Study|Other|0|||
131909968|NCT00171249|474958724|FG002|Overall Study|Other|0|||
131909969|NCT00171249|474958725|FG003|Overall Study|Other|43|||
131909970|NCT00171249|474958726|FG004|Overall Study|Other|0|||
131909971|NCT00171249|474958727|FG005|Overall Study|Other|2|||
131909972|NCT00171249|474958728|FG006|Overall Study|Other|0|||
131822339|NCT02274558|474631028|FG000|Overall Study|Withdrawal by Subject|1|||
131822340|NCT02274558|474631029|FG001|Overall Study|Withdrawal by Subject|5|||
131822341|NCT02274558|474631030|FG002|Overall Study|Withdrawal by Subject|4|||
131822342|NCT02274558|474631028|FG000|Overall Study|Death|0|||
131822343|NCT02274558|474631029|FG001|Overall Study|Death|0|||
131822344|NCT02274558|474631030|FG002|Overall Study|Death|1|||
131822345|NCT02274558|474631028|FG000|Overall Study|Lost to Follow-up|2|||
131822346|NCT02274558|474631029|FG001|Overall Study|Lost to Follow-up|1|||
131822347|NCT02274558|474631030|FG002|Overall Study|Lost to Follow-up|1|||
131909973|NCT00171249|474958722|FG000|Overall Study|No Longer Requires Study Drug|4|||
131909974|NCT00171249|474958723|FG001|Overall Study|No Longer Requires Study Drug|0|||
131909975|NCT00171249|474958724|FG002|Overall Study|No Longer Requires Study Drug|0|||
131909976|NCT00171249|474958725|FG003|Overall Study|No Longer Requires Study Drug|3|||
131909977|NCT00171249|474958726|FG004|Overall Study|No Longer Requires Study Drug|0|||
131909978|NCT00171249|474958727|FG005|Overall Study|No Longer Requires Study Drug|5|||
131909979|NCT00171249|474958728|FG006|Overall Study|No Longer Requires Study Drug|0|||
131401057|NCT00734604|473091450|FG000|Overall Study|Lack of Efficacy|0|||
131401058|NCT00734604|473091451|FG001|Overall Study|Lack of Efficacy|1|||
131822348|NCT02274558|474631028|FG000|Overall Study|Physician Decision|0|||
131822349|NCT02274558|474631029|FG001|Overall Study|Physician Decision|2|||
131822350|NCT02274558|474631030|FG002|Overall Study|Physician Decision|1|||
131822351|NCT02246764|474631040|FG000|Overall Study|Adverse Event|15|||
131822352|NCT02246764|474631041|FG001|Overall Study|Adverse Event|29|||
131822353|NCT02246764|474631042|FG002|Overall Study|Adverse Event|1|||
131822354|NCT02246764|474631040|FG000|Overall Study|Withdrawal by Subject|0|||
131909980|NCT00171249|474958722|FG000|Overall Study|Administrative Problems|1|||
131909981|NCT00171249|474958723|FG001|Overall Study|Administrative Problems|0|||
131822355|NCT02246764|474631041|FG001|Overall Study|Withdrawal by Subject|0|||
131822356|NCT02246764|474631042|FG002|Overall Study|Withdrawal by Subject|1|||
131822357|NCT02246764|474631040|FG000|Overall Study|Disallowed Concomitant Medication|1|||
131822358|NCT02246764|474631041|FG001|Overall Study|Disallowed Concomitant Medication|0|||
131822359|NCT02246764|474631042|FG002|Overall Study|Disallowed Concomitant Medication|0|||
131822360|NCT02246764|474631040|FG000|Overall Study|Physician Decision|0|||
131822361|NCT02246764|474631041|FG001|Overall Study|Physician Decision|2|||
131822362|NCT02246764|474631042|FG002|Overall Study|Physician Decision|1|||
131822363|NCT02246764|474631040|FG000|Overall Study|Protocol Violation|2|||
131822364|NCT02246764|474631041|FG001|Overall Study|Protocol Violation|1|||
131822365|NCT02246764|474631042|FG002|Overall Study|Protocol Violation|1|||
131822366|NCT05393271|474631043|FG000|Overall Study|Physician Decision|0|||
131822367|NCT05393271|474631044|FG001|Overall Study|Physician Decision|0|||
131822368|NCT05393271|474631045|FG002|Overall Study|Physician Decision|0|||
131822369|NCT05393271|474631046|FG003|Overall Study|Physician Decision|0|||
131822370|NCT05393271|474631047|FG004|Overall Study|Physician Decision|0|||
131822371|NCT05393271|474631048|FG005|Overall Study|Physician Decision|0|||
131822372|NCT05393271|474631049|FG006|Overall Study|Physician Decision|1|||
131822373|NCT05393271|474631050|FG007|Overall Study|Physician Decision|0|||
131822374|NCT05393271|474631051|FG008|Overall Study|Physician Decision|0|||
131822375|NCT05393271|474631052|FG009|Overall Study|Physician Decision|0|||
131822376|NCT05393271|474631053|FG010|Overall Study|Physician Decision|0|||
131822377|NCT02943993|474631054|FG000|Overall Study|Withdrawal by Subject|52|||
131822378|NCT02943993|474631054|FG000|Overall Study|Transfer to another institution|6|||
131822379|NCT02943993|474631054|FG000|Overall Study|Lost to Follow-up|135|||
131822380|NCT02943993|474631054|FG000|Overall Study|Death|98|||
131822381|NCT02943993|474631054|FG000|Overall Study|Other reason for premature termination|32|||
131822382|NCT02943993|474631054|FG000|Overall Study|Missing reason for termination|7|||
131822383|NCT02754492|474631060|FG000|Overall Study|Protocol Violation|2|||
131822384|NCT02754492|474631061|FG001|Overall Study|Protocol Violation|2|||
131822385|NCT02754492|474631062|FG002|Overall Study|Protocol Violation|0|||
131822386|NCT02754492|474631063|FG003|Overall Study|Protocol Violation|1|||
131822387|NCT02754492|474631060|FG000|Overall Study|Withdrawal by Subject|2|||
131822388|NCT02754492|474631061|FG001|Overall Study|Withdrawal by Subject|0|||
131822389|NCT02754492|474631062|FG002|Overall Study|Withdrawal by Subject|0|||
131822390|NCT02754492|474631063|FG003|Overall Study|Withdrawal by Subject|0|||
131822391|NCT02754492|474631060|FG000|Overall Study|Equipment malfuntion|0|||
131822392|NCT02754492|474631061|FG001|Overall Study|Equipment malfuntion|0|||
131822393|NCT02754492|474631062|FG002|Overall Study|Equipment malfuntion|2|||
131822394|NCT02754492|474631063|FG003|Overall Study|Equipment malfuntion|5|||
131822395|NCT02754492|474631060|FG000|Overall Study|Adverse Event|0|||
131822396|NCT02754492|474631061|FG001|Overall Study|Adverse Event|0|||
131822397|NCT02754492|474631062|FG002|Overall Study|Adverse Event|0|||
131822398|NCT02754492|474631063|FG003|Overall Study|Adverse Event|13|||
131822399|NCT02754492|474631060|FG000|Overall Study|Venous access issues not resulting in AE|0|||
131822400|NCT02754492|474631061|FG001|Overall Study|Venous access issues not resulting in AE|0|||
131822401|NCT02754492|474631062|FG002|Overall Study|Venous access issues not resulting in AE|0|||
131822402|NCT02754492|474631063|FG003|Overall Study|Venous access issues not resulting in AE|4|||
131822403|NCT02104817|474631066|FG000|Overall Study|Death|363|||
131822404|NCT02104817|474631067|FG001|Overall Study|Death|330|||
131822405|NCT02104817|474631066|FG000|Overall Study|Lost to Follow-up|3|||
131822406|NCT02104817|474631067|FG001|Overall Study|Lost to Follow-up|2|||
131822407|NCT02104817|474631066|FG000|Overall Study|Protocol Violation|0|||
131822408|NCT02104817|474631067|FG001|Overall Study|Protocol Violation|1|||
131822409|NCT02104817|474631066|FG000|Overall Study|Study terminated by sponsor|5854|||
131822410|NCT02104817|474631067|FG001|Overall Study|Study terminated by sponsor|5901|||
131822411|NCT02104817|474631066|FG000|Overall Study|Withdrawal by Subject|111|||
131822412|NCT02104817|474631067|FG001|Overall Study|Withdrawal by Subject|78|||
131822413|NCT02104817|474631066|FG000|Overall Study|Other reasons|128|||
131822414|NCT02104817|474631067|FG001|Overall Study|Other reasons|135|||
131822415|NCT02575339|474631071|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
131822416|NCT02575339|474631072|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
131822417|NCT02575339|474631073|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
131822418|NCT02575339|474631071|FG000|Study Treatment|Disease Progression|5|||
131822419|NCT02575339|474631072|FG001|Study Treatment|Disease Progression|2|||
131822420|NCT02575339|474631073|FG002|Study Treatment|Disease Progression|0|||
131822421|NCT02575339|474631071|FG000|Study Treatment|Adverse Event|1|||
131822422|NCT02575339|474631072|FG001|Study Treatment|Adverse Event|2|||
131822423|NCT02575339|474631073|FG002|Study Treatment|Adverse Event|0|||
131822424|NCT02575339|474631071|FG000|Follow up|Death|6|||
131822425|NCT02575339|474631072|FG001|Follow up|Death|2|||
131822426|NCT02575339|474631073|FG002|Follow up|Death|0|||
131822427|NCT02575339|474631071|FG000|Follow up|Study Terminated|0|||
131822428|NCT02575339|474631072|FG001|Follow up|Study Terminated|2|||
131822429|NCT02575339|474631073|FG002|Follow up|Study Terminated|0|||
131822430|NCT02575339|474631071|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
131822431|NCT02575339|474631072|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
131822432|NCT02575339|474631073|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
131822433|NCT00611884|474631074|FG000|Overall Study|Adverse Event|1|||
131822434|NCT00611884|474631075|FG001|Overall Study|Adverse Event|0|||
131822435|NCT00611884|474631076|FG002|Overall Study|Adverse Event|0|||
131822436|NCT00611884|474631077|FG003|Overall Study|Adverse Event|1|||
131822437|NCT00611884|474631074|FG000|Overall Study|Non-Compliance|1|||
131822438|NCT00611884|474631075|FG001|Overall Study|Non-Compliance|4|||
131822439|NCT00611884|474631076|FG002|Overall Study|Non-Compliance|2|||
131822440|NCT00611884|474631077|FG003|Overall Study|Non-Compliance|2|||
131822441|NCT00611884|474631074|FG000|Overall Study|Lack of Efficacy|0|||
131822442|NCT00611884|474631075|FG001|Overall Study|Lack of Efficacy|1|||
131822443|NCT00611884|474631076|FG002|Overall Study|Lack of Efficacy|0|||
131822444|NCT00611884|474631077|FG003|Overall Study|Lack of Efficacy|0|||
131822445|NCT00611884|474631074|FG000|Overall Study|Unclassified|7|||
131822446|NCT00611884|474631075|FG001|Overall Study|Unclassified|4|||
131822447|NCT00611884|474631076|FG002|Overall Study|Unclassified|2|||
131822448|NCT00611884|474631077|FG003|Overall Study|Unclassified|3|||
131822449|NCT02167594|474631079|FG000|Overall Study|Withdrawal by Subject|2|||
131822450|NCT02167594|474631080|FG001|Overall Study|Withdrawal by Subject|0|||
131822451|NCT02167594|474631081|FG002|Overall Study|Withdrawal by Subject|0|||
131822452|NCT02167594|474631079|FG000|Overall Study|Death|0|||
131822453|NCT02167594|474631080|FG001|Overall Study|Death|1|||
131822454|NCT02167594|474631081|FG002|Overall Study|Death|0|||
131822455|NCT01957150|474631082|FG000|Overall Study|Adverse Event|23|||
131822456|NCT01957150|474631083|FG001|Overall Study|Adverse Event|20|||
131822457|NCT01957150|474631082|FG000|Overall Study|Withdrawal by Subject|13|||
131822458|NCT01957150|474631083|FG001|Overall Study|Withdrawal by Subject|17|||
131822459|NCT01957150|474631082|FG000|Overall Study|Physician Decision|3|||
131822460|NCT01957150|474631083|FG001|Overall Study|Physician Decision|6|||
131822461|NCT01957150|474631082|FG000|Overall Study|Lost to Follow-up|4|||
131822462|NCT01957150|474631083|FG001|Overall Study|Lost to Follow-up|4|||
131822463|NCT01957150|474631082|FG000|Overall Study|Protocol Violation|1|||
131822464|NCT01957150|474631083|FG001|Overall Study|Protocol Violation|0|||
131822465|NCT01957150|474631082|FG000|Overall Study|Lack of Efficacy|11|||
131822466|NCT01957150|474631083|FG001|Overall Study|Lack of Efficacy|11|||
131822467|NCT02451358|474631086|FG000|Overall Study|Withdrawal by Subject|1|||
131822468|NCT02451358|474631087|FG001|Overall Study|Withdrawal by Subject|1|||
131822469|NCT02451358|474631088|FG002|Overall Study|Withdrawal by Subject|0|||
131822470|NCT02451358|474631089|FG003|Overall Study|Withdrawal by Subject|0|||
131822471|NCT02451358|474631086|FG000|Overall Study|Protocol Violation|0|||
131822472|NCT02451358|474631087|FG001|Overall Study|Protocol Violation|1|||
131822473|NCT02451358|474631088|FG002|Overall Study|Protocol Violation|1|||
131822474|NCT02451358|474631089|FG003|Overall Study|Protocol Violation|0|||
131822475|NCT00252564|474631094|FG000|Overall Study|Adverse Event|17|||
131822476|NCT00252564|474631095|FG001|Overall Study|Adverse Event|13|||
131822477|NCT00252564|474631094|FG000|Overall Study|Unrelated Complication|2|||
131822478|NCT00252564|474631095|FG001|Overall Study|Unrelated Complication|1|||
131822479|NCT00252564|474631094|FG000|Overall Study|Disease Progression|14|||
131822480|NCT00252564|474631095|FG001|Overall Study|Disease Progression|20|||
131822481|NCT00252564|474631094|FG000|Overall Study|Death|0|||
131822482|NCT00252564|474631095|FG001|Overall Study|Death|3|||
131822483|NCT00252564|474631094|FG000|Overall Study|Physician Decision|1|||
131822484|NCT00252564|474631095|FG001|Overall Study|Physician Decision|0|||
131822485|NCT00252564|474631094|FG000|Overall Study|Lost to Follow-up|1|||
131401059|NCT00734604|473091452|FG002|Overall Study|Lack of Efficacy|1|||
131401060|NCT00734604|473091453|FG003|Overall Study|Lack of Efficacy|0|||
131401061|NCT00734604|473091454|FG004|Overall Study|Lack of Efficacy|0|||
131401062|NCT00734604|473091455|FG005|Overall Study|Lack of Efficacy|0|||
131401063|NCT02589665|473091456|FG000|Induction Period|Did not receive drug|0|||
131401064|NCT02589665|473091457|FG001|Induction Period|Did not receive drug|0|||
131822486|NCT00252564|474631095|FG001|Overall Study|Lost to Follow-up|0|||
131822487|NCT00252564|474631094|FG000|Overall Study|Patient Request|4|||
131822488|NCT00252564|474631095|FG001|Overall Study|Patient Request|5|||
131822489|NCT00252564|474631094|FG000|Overall Study|Withdrawal by Subject|0|||
131822490|NCT00252564|474631095|FG001|Overall Study|Withdrawal by Subject|2|||
131822491|NCT01583530|474631096|FG000|Overall Study|Adverse Event|0|||
131822492|NCT01583530|474631097|FG001|Overall Study|Adverse Event|0|||
131822493|NCT01583530|474631098|FG002|Overall Study|Adverse Event|0|||
131822494|NCT01583530|474631099|FG003|Overall Study|Adverse Event|0|||
131822495|NCT01583530|474631100|FG004|Overall Study|Adverse Event|0|||
131822496|NCT01583530|474631101|FG005|Overall Study|Adverse Event|1|||
131822497|NCT01583530|474631096|FG000|Overall Study|Withdrawal by Subject|0|||
131822498|NCT01583530|474631097|FG001|Overall Study|Withdrawal by Subject|3|||
131822499|NCT01583530|474631098|FG002|Overall Study|Withdrawal by Subject|0|||
131822500|NCT01583530|474631099|FG003|Overall Study|Withdrawal by Subject|1|||
131822501|NCT01583530|474631100|FG004|Overall Study|Withdrawal by Subject|1|||
131822502|NCT01583530|474631101|FG005|Overall Study|Withdrawal by Subject|2|||
131822503|NCT01583530|474631096|FG000|Overall Study|Lost to Follow-up|0|||
131822504|NCT01583530|474631097|FG001|Overall Study|Lost to Follow-up|0|||
131822505|NCT01583530|474631098|FG002|Overall Study|Lost to Follow-up|0|||
131822506|NCT01583530|474631099|FG003|Overall Study|Lost to Follow-up|0|||
131822507|NCT01583530|474631100|FG004|Overall Study|Lost to Follow-up|3|||
131822508|NCT01583530|474631101|FG005|Overall Study|Lost to Follow-up|0|||
131822509|NCT01583530|474631096|FG000|Overall Study|Lack of compliance|0|||
131822510|NCT01583530|474631097|FG001|Overall Study|Lack of compliance|0|||
131822511|NCT01583530|474631098|FG002|Overall Study|Lack of compliance|0|||
131822512|NCT01583530|474631099|FG003|Overall Study|Lack of compliance|0|||
131822513|NCT01583530|474631100|FG004|Overall Study|Lack of compliance|1|||
131822514|NCT01583530|474631101|FG005|Overall Study|Lack of compliance|0|||
131822515|NCT03414034|474631102|FG000|Overall Study|Adverse Event|6|||
131822516|NCT03414034|474631103|FG001|Overall Study|Adverse Event|1|||
131822517|NCT03414034|474631104|FG002|Overall Study|Adverse Event|1|||
131822518|NCT03414034|474631102|FG000|Overall Study|Death|0|||
131401065|NCT02589665|473091458|FG002|Induction Period|Did not receive drug|0|||
131401066|NCT02589665|473091459|FG003|Induction Period|Did not receive drug|1|||
131401067|NCT02589665|473091460|FG004|Induction Period|Did not receive drug|0|||
131401068|NCT02589665|473091461|FG005|Induction Period|Did not receive drug|0|||
131401069|NCT02589665|473091462|FG006|Induction Period|Did not receive drug|0|||
131401070|NCT02589665|473091463|FG007|Induction Period|Did not receive drug|0|||
131401071|NCT02589665|473091464|FG008|Induction Period|Did not receive drug|0|||
131401072|NCT02589665|473091465|FG009|Induction Period|Did not receive drug|0|||
131401073|NCT02589665|473091456|FG000|Induction Period|Adverse Event|3|||
131401074|NCT02589665|473091457|FG001|Induction Period|Adverse Event|0|||
131401075|NCT02589665|473091458|FG002|Induction Period|Adverse Event|2|||
131401076|NCT02589665|473091459|FG003|Induction Period|Adverse Event|2|||
131401077|NCT02589665|473091460|FG004|Induction Period|Adverse Event|0|||
131401078|NCT02589665|473091461|FG005|Induction Period|Adverse Event|0|||
131401079|NCT02589665|473091462|FG006|Induction Period|Adverse Event|0|||
131401080|NCT02589665|473091463|FG007|Induction Period|Adverse Event|0|||
131822519|NCT03414034|474631103|FG001|Overall Study|Death|0|||
131822520|NCT03414034|474631104|FG002|Overall Study|Death|1|||
131822521|NCT03414034|474631102|FG000|Overall Study|Non-compliance With Study Drug|0|||
131822522|NCT03414034|474631103|FG001|Overall Study|Non-compliance With Study Drug|0|||
131822523|NCT03414034|474631104|FG002|Overall Study|Non-compliance With Study Drug|1|||
131822524|NCT03414034|474631102|FG000|Overall Study|Physician Decision|1|||
131822525|NCT03414034|474631103|FG001|Overall Study|Physician Decision|3|||
131822526|NCT03414034|474631104|FG002|Overall Study|Physician Decision|2|||
131822527|NCT03414034|474631102|FG000|Overall Study|Withdrawal of Informed Consent|2|||
131822528|NCT03414034|474631103|FG001|Overall Study|Withdrawal of Informed Consent|1|||
131822529|NCT03414034|474631104|FG002|Overall Study|Withdrawal of Informed Consent|4|||
131822530|NCT03414034|474631102|FG000|Overall Study|Progressive Disease|15|||
131822531|NCT03414034|474631103|FG001|Overall Study|Progressive Disease|15|||
131822532|NCT03414034|474631104|FG002|Overall Study|Progressive Disease|17|||
131822533|NCT03414034|474631102|FG000|Overall Study|Miscellaneous|0|||
131822534|NCT03414034|474631103|FG001|Overall Study|Miscellaneous|0|||
131822535|NCT03414034|474631104|FG002|Overall Study|Miscellaneous|2|||
131822536|NCT04010227|474631105|FG000|Overall Study|Death|1|||
131822537|NCT04010227|474631106|FG001|Overall Study|Death|2|||
131822538|NCT04010227|474631105|FG000|Overall Study|Medical Reasons|4|||
131822539|NCT04010227|474631106|FG001|Overall Study|Medical Reasons|3|||
131822540|NCT04010227|474631105|FG000|Overall Study|Withdrawal by Subject|2|||
131822541|NCT04010227|474631106|FG001|Overall Study|Withdrawal by Subject|0|||
131822542|NCT04010227|474631105|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
131822543|NCT04010227|474631106|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
131822544|NCT00640926|474631107|FG000|Overall Study|Adverse Event|2|||
131822545|NCT00640926|474631108|FG001|Overall Study|Adverse Event|3|||
131822546|NCT00640926|474631109|FG002|Overall Study|Adverse Event|2|||
131822547|NCT00640926|474631107|FG000|Overall Study|Lack of Efficacy|0|||
131822548|NCT00640926|474631108|FG001|Overall Study|Lack of Efficacy|2|||
131822549|NCT00640926|474631109|FG002|Overall Study|Lack of Efficacy|1|||
131909982|NCT00171249|474958724|FG002|Overall Study|Administrative Problems|0|||
131401081|NCT02589665|473091464|FG008|Induction Period|Adverse Event|0|||
131401082|NCT02589665|473091465|FG009|Induction Period|Adverse Event|0|||
131401083|NCT02589665|473091456|FG000|Induction Period|Withdrawal by Subject|0|||
131822550|NCT00640926|474631107|FG000|Overall Study|Protocol Violation|2|||
131822551|NCT00640926|474631108|FG001|Overall Study|Protocol Violation|0|||
131822552|NCT00640926|474631109|FG002|Overall Study|Protocol Violation|2|||
131909983|NCT00171249|474958725|FG003|Overall Study|Administrative Problems|2|||
131401084|NCT02589665|473091457|FG001|Induction Period|Withdrawal by Subject|1|||
131401085|NCT02589665|473091458|FG002|Induction Period|Withdrawal by Subject|0|||
131401086|NCT02589665|473091459|FG003|Induction Period|Withdrawal by Subject|1|||
131401087|NCT02589665|473091460|FG004|Induction Period|Withdrawal by Subject|0|||
131401088|NCT02589665|473091461|FG005|Induction Period|Withdrawal by Subject|0|||
131822553|NCT00640926|474631107|FG000|Overall Study|Lost to Follow-up|3|||
131822554|NCT00640926|474631108|FG001|Overall Study|Lost to Follow-up|1|||
131822555|NCT00640926|474631109|FG002|Overall Study|Lost to Follow-up|2|||
131822556|NCT00640926|474631107|FG000|Overall Study|Withdrawal by Subject|1|||
131822557|NCT00640926|474631108|FG001|Overall Study|Withdrawal by Subject|0|||
131822558|NCT00640926|474631109|FG002|Overall Study|Withdrawal by Subject|1|||
131822559|NCT01277510|474631110|FG000|Double-blind Phase|Non-compliance|0|||
131822560|NCT01277510|474631111|FG001|Double-blind Phase|Non-compliance|1|||
131822561|NCT01277510|474631110|FG000|Double-blind Phase|Adverse Event|1|||
131822562|NCT01277510|474631111|FG001|Double-blind Phase|Adverse Event|0|||
131822563|NCT01277510|474631110|FG000|Double-blind Phase|Withdrawal by Subject|2|||
131822564|NCT01277510|474631111|FG001|Double-blind Phase|Withdrawal by Subject|0|||
131822565|NCT01277510|474631110|FG000|Double-blind Phase|Administrative decision|7|||
131822566|NCT01277510|474631111|FG001|Double-blind Phase|Administrative decision|9|||
131822567|NCT01277510|474631110|FG000|Double-blind Phase|Death|0|||
131822568|NCT01277510|474631111|FG001|Double-blind Phase|Death|1|||
131822569|NCT01277510|474631110|FG000|Double-blind Phase|Protocol-specified criteria|2|||
131822570|NCT01277510|474631111|FG001|Double-blind Phase|Protocol-specified criteria|6|||
131822571|NCT01277510|474631110|FG000|Double-blind Phase|Other|1|||
131822572|NCT01277510|474631111|FG001|Double-blind Phase|Other|1|||
131822573|NCT01277510|474631110|FG000|Open-label Phase|Administrative decision|4|||
131822574|NCT01277510|474631111|FG001|Open-label Phase|Administrative decision|3|||
131822575|NCT01277510|474631110|FG000|Open-label Phase|Protocol-specified criteria|1|||
131822576|NCT01277510|474631111|FG001|Open-label Phase|Protocol-specified criteria|0|||
131822577|NCT01277510|474631110|FG000|Open-label Phase|Never received investigational product|2|||
131822578|NCT01277510|474631111|FG001|Open-label Phase|Never received investigational product|0|||
131822579|NCT03919695|474631113|FG000|3-month Follow-up|Death|1|||
131822580|NCT03919695|474631114|FG001|3-month Follow-up|Death|1|||
131822581|NCT03919695|474631113|FG000|3-month Follow-up|unable to contact|0|||
131822582|NCT03919695|474631114|FG001|3-month Follow-up|unable to contact|3|||
131822583|NCT03919695|474631113|FG000|3-month Follow-up|in prison|0|||
131822584|NCT03919695|474631114|FG001|3-month Follow-up|in prison|1|||
131822585|NCT03919695|474631113|FG000|6-month Follow-up|Death|0|||
131822586|NCT03919695|474631114|FG001|6-month Follow-up|Death|1|||
131822587|NCT03919695|474631113|FG000|6-month Follow-up|Lost to Follow-up|1|||
131822588|NCT03919695|474631114|FG001|6-month Follow-up|Lost to Follow-up|2|||
131822589|NCT03919695|474631113|FG000|6-month Follow-up|in prison|0|||
131822590|NCT03919695|474631114|FG001|6-month Follow-up|in prison|2|||
131822591|NCT03919695|474631113|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
131822592|NCT03919695|474631114|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
131822593|NCT03919695|474631113|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
131822594|NCT03919695|474631114|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
131822595|NCT01688882|474631115|FG000|Overall Study|Adverse Event|1|||
131822596|NCT01688882|474631116|FG001|Overall Study|Adverse Event|0|||
131822597|NCT01688882|474631115|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131822598|NCT01688882|474631116|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131822599|NCT01688882|474631115|FG000|Overall Study|Administrative problems|1|||
131822600|NCT01688882|474631116|FG001|Overall Study|Administrative problems|0|||
131822601|NCT02387762|474631118|FG000|Overall Study|Withdrawal by Subject|1|||
131822602|NCT02387762|474631119|FG001|Overall Study|Withdrawal by Subject|0|||
131822603|NCT01598896|474631128|FG000|Overall Study|Withdrawal by Subject|0|||
131822604|NCT01598896|474631129|FG001|Overall Study|Withdrawal by Subject|1|||
131822605|NCT01598896|474631128|FG000|Overall Study|Lack of Efficacy|0|||
131822606|NCT01598896|474631129|FG001|Overall Study|Lack of Efficacy|1|||
131822607|NCT00642811|474631132|FG000|Overall Study|Adverse Event|2|||
131822608|NCT00642811|474631133|FG001|Overall Study|Adverse Event|3|||
131822609|NCT00642811|474631134|FG002|Overall Study|Adverse Event|0|||
131822610|NCT00642811|474631135|FG003|Overall Study|Adverse Event|0|||
131822611|NCT00642811|474631136|FG004|Overall Study|Adverse Event|0|||
131822612|NCT00642811|474631137|FG005|Overall Study|Adverse Event|1|||
131822613|NCT00642811|474631132|FG000|Overall Study|Developement of discontinuation criteria|0|||
131822614|NCT00642811|474631133|FG001|Overall Study|Developement of discontinuation criteria|0|||
131822615|NCT00642811|474631134|FG002|Overall Study|Developement of discontinuation criteria|0|||
131822616|NCT00642811|474631135|FG003|Overall Study|Developement of discontinuation criteria|0|||
131822617|NCT00642811|474631136|FG004|Overall Study|Developement of discontinuation criteria|1|||
131822618|NCT00642811|474631137|FG005|Overall Study|Developement of discontinuation criteria|0|||
131822619|NCT00642811|474631132|FG000|Overall Study|Severe Non-compliance to protocol|1|||
131822620|NCT00642811|474631133|FG001|Overall Study|Severe Non-compliance to protocol|0|||
131822621|NCT00642811|474631134|FG002|Overall Study|Severe Non-compliance to protocol|0|||
131822622|NCT00642811|474631135|FG003|Overall Study|Severe Non-compliance to protocol|0|||
131822623|NCT00642811|474631136|FG004|Overall Study|Severe Non-compliance to protocol|0|||
131822624|NCT00642811|474631137|FG005|Overall Study|Severe Non-compliance to protocol|0|||
131822625|NCT00642811|474631132|FG000|Overall Study|Other|0|||
131822626|NCT00642811|474631133|FG001|Overall Study|Other|1|||
131822627|NCT00642811|474631134|FG002|Overall Study|Other|0|||
131822628|NCT00642811|474631135|FG003|Overall Study|Other|1|||
131822629|NCT00642811|474631136|FG004|Overall Study|Other|0|||
131822630|NCT00642811|474631137|FG005|Overall Study|Other|0|||
131822631|NCT01120691|474631138|FG000|Overall Study|Adverse Event|59|||
131822632|NCT01120691|474631139|FG001|Overall Study|Adverse Event|67|||
131822633|NCT01120691|474631140|FG002|Overall Study|Adverse Event|47|||
131822634|NCT01120691|474631138|FG000|Overall Study|Subject withdrew consent|33|||
131822635|NCT01120691|474631139|FG001|Overall Study|Subject withdrew consent|50|||
131822636|NCT01120691|474631140|FG002|Overall Study|Subject withdrew consent|44|||
131822637|NCT01120691|474631138|FG000|Overall Study|Death|21|||
131401089|NCT02589665|473091462|FG006|Induction Period|Withdrawal by Subject|0|||
131401090|NCT02589665|473091463|FG007|Induction Period|Withdrawal by Subject|0|||
131401091|NCT02589665|473091464|FG008|Induction Period|Withdrawal by Subject|0|||
131401092|NCT02589665|473091465|FG009|Induction Period|Withdrawal by Subject|0|||
131401093|NCT02589665|473091456|FG000|Induction Period|Protocol Violation|0|||
131401094|NCT02589665|473091457|FG001|Induction Period|Protocol Violation|1|||
131401095|NCT02589665|473091458|FG002|Induction Period|Protocol Violation|0|||
131822638|NCT01120691|474631139|FG001|Overall Study|Death|22|||
131822639|NCT01120691|474631140|FG002|Overall Study|Death|24|||
131822640|NCT01120691|474631138|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
131401096|NCT02589665|473091459|FG003|Induction Period|Protocol Violation|0|||
131822641|NCT01120691|474631139|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
131822642|NCT01120691|474631140|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
131822643|NCT01120691|474631138|FG000|Overall Study|Administrative problems|15|||
131822644|NCT01120691|474631139|FG001|Overall Study|Administrative problems|8|||
131822645|NCT01120691|474631140|FG002|Overall Study|Administrative problems|9|||
131822646|NCT01120691|474631138|FG000|Overall Study|Protocol deviation|13|||
131822647|NCT01120691|474631139|FG001|Overall Study|Protocol deviation|12|||
131822648|NCT01120691|474631140|FG002|Overall Study|Protocol deviation|12|||
131822649|NCT01120691|474631138|FG000|Overall Study|Lost to Follow-up|5|||
131822650|NCT01120691|474631139|FG001|Overall Study|Lost to Follow-up|6|||
131822651|NCT01120691|474631140|FG002|Overall Study|Lost to Follow-up|4|||
131822652|NCT01120691|474631138|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131822653|NCT01120691|474631139|FG001|Overall Study|Abnormal test procedure result(s)|2|||
131822654|NCT01120691|474631140|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131822655|NCT01120691|474631138|FG000|Overall Study|Patient's inability to use the device|3|||
131822656|NCT01120691|474631139|FG001|Overall Study|Patient's inability to use the device|1|||
131822657|NCT01120691|474631140|FG002|Overall Study|Patient's inability to use the device|0|||
131822658|NCT01120691|474631138|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131822659|NCT01120691|474631139|FG001|Overall Study|Abnormal laboratory value(s)|3|||
131822660|NCT01120691|474631140|FG002|Overall Study|Abnormal laboratory value(s)|4|||
131822661|NCT04553406|474631143|FG000|Overall Study|Study Discontinuation|0|||
131822662|NCT04553406|474631144|FG001|Overall Study|Study Discontinuation|1|||
131822663|NCT03370510|474631145|FG000|Overall Study|COVID-19|2|||
131822664|NCT03370510|474631146|FG001|Overall Study|COVID-19|0|||
131822665|NCT00772148|474631147|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
131822666|NCT00772148|474631148|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
131822667|NCT00772148|474631147|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
131822668|NCT00772148|474631148|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
131822669|NCT00772148|474631147|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
131822670|NCT00772148|474631148|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
131822671|NCT00772148|474631147|FG000|Maintenance Phase (Week 52)|Death|2|||
131822672|NCT00772148|474631148|FG001|Maintenance Phase (Week 52)|Death|2|||
131822673|NCT00772148|474631147|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
131822674|NCT00772148|474631148|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
131822675|NCT00772148|474631147|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
131822676|NCT00772148|474631148|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
131822677|NCT00772148|474631147|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
131822678|NCT00772148|474631148|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
131822679|NCT01525628|474631151|FG000|Overall Study|Adverse Event|1|||
131822680|NCT01525628|474631152|FG001|Overall Study|Adverse Event|1|||
131822681|NCT01525628|474631153|FG002|Overall Study|Adverse Event|2|||
131822682|NCT01525628|474631154|FG003|Overall Study|Adverse Event|0|||
131822683|NCT01525628|474631155|FG004|Overall Study|Adverse Event|1|||
131822684|NCT01525628|474631151|FG000|Overall Study|Lack of Efficacy|0|||
131401097|NCT02589665|473091460|FG004|Induction Period|Protocol Violation|0|||
131401098|NCT02589665|473091461|FG005|Induction Period|Protocol Violation|0|||
131822685|NCT01525628|474631152|FG001|Overall Study|Lack of Efficacy|2|||
131822686|NCT01525628|474631153|FG002|Overall Study|Lack of Efficacy|2|||
131822687|NCT01525628|474631154|FG003|Overall Study|Lack of Efficacy|1|||
131822688|NCT01525628|474631155|FG004|Overall Study|Lack of Efficacy|2|||
131822689|NCT01525628|474631151|FG000|Overall Study|Protocol Violation|0|||
131401099|NCT02589665|473091462|FG006|Induction Period|Protocol Violation|0|||
131401100|NCT02589665|473091463|FG007|Induction Period|Protocol Violation|0|||
131401101|NCT02589665|473091464|FG008|Induction Period|Protocol Violation|0|||
131822690|NCT01525628|474631152|FG001|Overall Study|Protocol Violation|0|||
131822691|NCT01525628|474631153|FG002|Overall Study|Protocol Violation|1|||
131822692|NCT01525628|474631154|FG003|Overall Study|Protocol Violation|0|||
131822693|NCT01525628|474631155|FG004|Overall Study|Protocol Violation|0|||
131822694|NCT01525628|474631151|FG000|Overall Study|Lost to Follow-up|1|||
131822695|NCT01525628|474631152|FG001|Overall Study|Lost to Follow-up|1|||
131822696|NCT01525628|474631153|FG002|Overall Study|Lost to Follow-up|0|||
131822697|NCT01525628|474631154|FG003|Overall Study|Lost to Follow-up|0|||
131822698|NCT01525628|474631155|FG004|Overall Study|Lost to Follow-up|0|||
131822699|NCT01525628|474631151|FG000|Overall Study|Withdrawal by Subject|0|||
131822700|NCT01525628|474631152|FG001|Overall Study|Withdrawal by Subject|1|||
131822701|NCT01525628|474631153|FG002|Overall Study|Withdrawal by Subject|0|||
131822702|NCT01525628|474631154|FG003|Overall Study|Withdrawal by Subject|0|||
131822703|NCT01525628|474631155|FG004|Overall Study|Withdrawal by Subject|0|||
131822704|NCT01525628|474631151|FG000|Overall Study|Other reason not defined above|0|||
131822705|NCT01525628|474631152|FG001|Overall Study|Other reason not defined above|0|||
131822706|NCT01525628|474631153|FG002|Overall Study|Other reason not defined above|0|||
131822707|NCT01525628|474631154|FG003|Overall Study|Other reason not defined above|3|||
131822708|NCT01525628|474631155|FG004|Overall Study|Other reason not defined above|0|||
131822709|NCT03573336|474631156|FG000|Overall Study|Study terminated|2|||
131822710|NCT03573336|474631157|FG001|Overall Study|Study terminated|4|||
131822711|NCT03573336|474631158|FG002|Overall Study|Study terminated|2|||
131822712|NCT00239005|474631159|FG000|Overall Study|Adverse Event|6|||
131822713|NCT00239005|474631160|FG001|Overall Study|Adverse Event|6|||
131822714|NCT00239005|474631159|FG000|Overall Study|Withdrawal by Subject|3|||
131822715|NCT00239005|474631160|FG001|Overall Study|Withdrawal by Subject|4|||
131822716|NCT00239005|474631159|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
131822717|NCT00239005|474631160|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
131822718|NCT00239005|474631159|FG000|Overall Study|Protocol Violation|1|||
131822719|NCT00239005|474631160|FG001|Overall Study|Protocol Violation|0|||
131822720|NCT00239005|474631159|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
131822721|NCT00239005|474631160|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
131822722|NCT00239005|474631159|FG000|Overall Study|Lost to Follow-up|0|||
131822723|NCT00239005|474631160|FG001|Overall Study|Lost to Follow-up|1|||
131822724|NCT02614898|474631161|FG000|Overall Study|Participated until study termination|10|||
131822725|NCT02614898|474631162|FG001|Overall Study|Participated until study termination|26|||
131822726|NCT02614898|474631161|FG000|Overall Study|Lost to Follow-up|0|||
131822727|NCT02614898|474631162|FG001|Overall Study|Lost to Follow-up|2|||
131822728|NCT02614898|474631161|FG000|Overall Study|Physician Decision|1|||
131822729|NCT02614898|474631162|FG001|Overall Study|Physician Decision|8|||
131822730|NCT02614898|474631161|FG000|Overall Study|Study Terminated by Sponsor|3|||
131822731|NCT02614898|474631162|FG001|Overall Study|Study Terminated by Sponsor|0|||
131822732|NCT02614898|474631161|FG000|Overall Study|Withdrawal by Subject|0|||
131822733|NCT02614898|474631162|FG001|Overall Study|Withdrawal by Subject|2|||
131822734|NCT02614898|474631161|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131822735|NCT02614898|474631162|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131822736|NCT02614898|474631161|FG000|Overall Study|Other-Additional Information Unavailable|0|||
131822737|NCT02614898|474631162|FG001|Overall Study|Other-Additional Information Unavailable|11|||
131822738|NCT02614898|474631161|FG000|Overall Study|Missing|0|||
131822739|NCT02614898|474631162|FG001|Overall Study|Missing|1|||
131822740|NCT00787605|474631163|FG000|Overall Study|Administrative Problems|3|||
131822741|NCT00787605|474631164|FG001|Overall Study|Administrative Problems|0|||
131822742|NCT00787605|474631163|FG000|Overall Study|Adverse Event|14|||
131822743|NCT00787605|474631164|FG001|Overall Study|Adverse Event|25|||
131822744|NCT00787605|474631163|FG000|Overall Study|Lost to Follow-up|3|||
131449862|NCT03722238|473276722|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
131822745|NCT00787605|474631164|FG001|Overall Study|Lost to Follow-up|6|||
131822746|NCT00787605|474631163|FG000|Overall Study|Protocol Violation|7|||
131822747|NCT00787605|474631164|FG001|Overall Study|Protocol Violation|3|||
131822748|NCT00787605|474631163|FG000|Overall Study|Withdrawal by Subject|6|||
131822749|NCT00787605|474631164|FG001|Overall Study|Withdrawal by Subject|13|||
131822750|NCT00787605|474631163|FG000|Overall Study|Lack of Efficacy|13|||
131822751|NCT00787605|474631164|FG001|Overall Study|Lack of Efficacy|9|||
131822752|NCT03382041|474631165|FG000|Overall Study|Consent Form Lost|2|||
131822753|NCT03382041|474631166|FG001|Overall Study|Consent Form Lost|1|||
131822754|NCT03382041|474631165|FG000|Overall Study|Withdrawal by Subject|1|||
131822755|NCT03382041|474631166|FG001|Overall Study|Withdrawal by Subject|4|||
131822756|NCT03382041|474631165|FG000|Overall Study|Lost to Follow-up|1|||
131822757|NCT03382041|474631166|FG001|Overall Study|Lost to Follow-up|4|||
131822758|NCT03493919|474631171|FG000|Overall Study|Other|2|||
131822759|NCT03493919|474631172|FG001|Overall Study|Other|0|||
131822760|NCT03493919|474631173|FG002|Overall Study|Other|1|||
131822761|NCT03493919|474631174|FG003|Overall Study|Other|0|||
131822762|NCT03493919|474631171|FG000|Overall Study|Withdrawal by Subject|9|||
131822763|NCT03493919|474631172|FG001|Overall Study|Withdrawal by Subject|3|||
131822764|NCT03493919|474631173|FG002|Overall Study|Withdrawal by Subject|1|||
131909984|NCT00171249|474958726|FG004|Overall Study|Administrative Problems|0|||
131909985|NCT00171249|474958727|FG005|Overall Study|Administrative Problems|0|||
131822765|NCT03493919|474631174|FG003|Overall Study|Withdrawal by Subject|1|||
131822766|NCT03493919|474631171|FG000|Overall Study|Lost to Follow-up|5|||
131822767|NCT03493919|474631172|FG001|Overall Study|Lost to Follow-up|0|||
131822768|NCT03493919|474631173|FG002|Overall Study|Lost to Follow-up|0|||
131401102|NCT02589665|473091465|FG009|Induction Period|Protocol Violation|0|||
131401103|NCT02589665|473091456|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401104|NCT02589665|473091457|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131822769|NCT03493919|474631174|FG003|Overall Study|Lost to Follow-up|3|||
131822770|NCT03493919|474631171|FG000|Overall Study|Adverse Event|0|||
131822771|NCT03493919|474631172|FG001|Overall Study|Adverse Event|1|||
131822772|NCT03493919|474631173|FG002|Overall Study|Adverse Event|0|||
131822773|NCT03493919|474631174|FG003|Overall Study|Adverse Event|0|||
131822774|NCT05135273|474632812|FG000|Overall Study|Recruited into the army|0|||
131822775|NCT05135273|474632813|FG001|Overall Study|Recruited into the army|0|||
131822776|NCT05135273|474632814|FG002|Overall Study|Recruited into the army|0|||
131822777|NCT05135273|474632815|FG003|Overall Study|Recruited into the army|0|||
131822778|NCT05135273|474632816|FG004|Overall Study|Recruited into the army|1|||
131822779|NCT05135273|474632817|FG005|Overall Study|Recruited into the army|0|||
131822780|NCT05135273|474632818|FG006|Overall Study|Recruited into the army|0|||
131822781|NCT05135273|474632819|FG007|Overall Study|Recruited into the army|0|||
131822782|NCT05135273|474632812|FG000|Overall Study|Moved away from study site|0|||
131822783|NCT05135273|474632813|FG001|Overall Study|Moved away from study site|0|||
131822784|NCT05135273|474632814|FG002|Overall Study|Moved away from study site|0|||
131822785|NCT05135273|474632815|FG003|Overall Study|Moved away from study site|0|||
131822786|NCT05135273|474632816|FG004|Overall Study|Moved away from study site|0|||
131822787|NCT05135273|474632817|FG005|Overall Study|Moved away from study site|1|||
131822788|NCT05135273|474632818|FG006|Overall Study|Moved away from study site|1|||
131822789|NCT05135273|474632819|FG007|Overall Study|Moved away from study site|0|||
131822790|NCT05135273|474632812|FG000|Overall Study|Travel|0|||
131822791|NCT05135273|474632813|FG001|Overall Study|Travel|0|||
131822792|NCT05135273|474632814|FG002|Overall Study|Travel|0|||
131822793|NCT05135273|474632815|FG003|Overall Study|Travel|0|||
131822794|NCT05135273|474632816|FG004|Overall Study|Travel|0|||
131822795|NCT05135273|474632817|FG005|Overall Study|Travel|0|||
131822796|NCT05135273|474632818|FG006|Overall Study|Travel|0|||
131822797|NCT05135273|474632819|FG007|Overall Study|Travel|1|||
131822798|NCT02710214|474632820|FG000|Overall Study|Lost to Follow-up|1|||
131822799|NCT02710214|474632821|FG001|Overall Study|Lost to Follow-up|0|||
131822800|NCT02710214|474632820|FG000|Overall Study|Lack of Efficacy|0|||
131822801|NCT02710214|474632821|FG001|Overall Study|Lack of Efficacy|1|||
131822802|NCT02710214|474632820|FG000|Overall Study|Death|0|||
131822803|NCT02710214|474632821|FG001|Overall Study|Death|1|||
131822804|NCT00559637|474632822|FG000|Overall Study|Adverse Event|22|||
131822805|NCT00559637|474632822|FG000|Overall Study|Withdrawal by Subject|4|||
131822806|NCT00559637|474632822|FG000|Overall Study|Protocol Violation|6|||
131822807|NCT00559637|474632822|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
131822808|NCT00559637|474632822|FG000|Overall Study|Failure to return|6|||
131822809|NCT00559637|474632822|FG000|Overall Study|Insufficient response|3|||
131822810|NCT00559637|474632822|FG000|Overall Study|Started requiring dialysis after month 7|2|||
131822811|NCT00559637|474632822|FG000|Overall Study|Suspected lung cancer|1|||
131822812|NCT00559637|474632822|FG000|Overall Study|Participation in another study|1|||
131822813|NCT00559637|474632822|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
131822814|NCT00559637|474632822|FG000|Overall Study|Change of center|1|||
131822815|NCT00559637|474632822|FG000|Overall Study|Change of home|1|||
131822816|NCT00559637|474632822|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
131822817|NCT01705717|474632827|FG000|Overall Study|Adverse Event|2|||
131822818|NCT01705717|474632828|FG001|Overall Study|Adverse Event|2|||
131822819|NCT01705717|474632827|FG000|Overall Study|Lack of Efficacy|0|||
131822820|NCT01705717|474632828|FG001|Overall Study|Lack of Efficacy|1|||
131822821|NCT01705717|474632827|FG000|Overall Study|Other|0|||
131822822|NCT01705717|474632828|FG001|Overall Study|Other|2|||
131822823|NCT04980456|474632832|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
131822824|NCT04980456|474632833|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
131822825|NCT04980456|474632832|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
131822826|NCT04980456|474632833|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
131401105|NCT02589665|473091458|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401106|NCT02589665|473091459|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401107|NCT02589665|473091460|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
131401108|NCT02589665|473091461|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
131822827|NCT04980456|474632832|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
131822828|NCT04980456|474632833|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
131822829|NCT04980456|474632832|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
131822830|NCT04980456|474632833|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
131822831|NCT02293460|474632834|FG000|Overall Study|Protocol Violation|1|||
131822832|NCT02293460|474632834|FG000|Overall Study|Lack of Efficacy|2|||
131822833|NCT02293460|474632834|FG000|Overall Study|Adverse Event|2|||
131822834|NCT02293460|474632834|FG000|Overall Study|Withdrawal by Subject|1|||
131822835|NCT00500318|474632836|FG000|Overall Study|Adverse Event|3|||
131822836|NCT00500318|474632837|FG001|Overall Study|Adverse Event|8|||
131822837|NCT00500318|474632836|FG000|Overall Study|Protocol Violation|1|||
131822838|NCT00500318|474632837|FG001|Overall Study|Protocol Violation|3|||
131822839|NCT00500318|474632836|FG000|Overall Study|Withdrawal by Subject|1|||
131822840|NCT00500318|474632837|FG001|Overall Study|Withdrawal by Subject|2|||
131822841|NCT00500318|474632836|FG000|Overall Study|Lack of Efficacy|0|||
131822842|NCT00500318|474632837|FG001|Overall Study|Lack of Efficacy|3|||
131822843|NCT00500318|474632836|FG000|Overall Study|Other Reason|0|||
131822844|NCT00500318|474632837|FG001|Overall Study|Other Reason|1|||
131822845|NCT01257581|474632843|FG000|Overall Study|Early Termination|3|||
131822846|NCT01257581|474632844|FG001|Overall Study|Early Termination|1|||
131822847|NCT01257581|474632845|FG002|Overall Study|Early Termination|2|||
131822848|NCT01257581|474632843|FG000|Overall Study|Death|2|||
131822849|NCT01257581|474632844|FG001|Overall Study|Death|2|||
131822850|NCT01257581|474632845|FG002|Overall Study|Death|4|||
131822851|NCT02655224|474632846|FG000|Overall Study|Adverse Event|1|||
131822852|NCT02655224|474632847|FG001|Overall Study|Adverse Event|1|||
131822853|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
131822854|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
131822855|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
131822856|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
131822857|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
131822858|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
131822859|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
131822860|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
131822861|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
131822862|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
131822863|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
131822864|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
131822865|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
131822866|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
131822867|NCT04592419|474632848|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
131822868|NCT04592419|474632849|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
131822869|NCT04592419|474632848|FG000|Open-Label Extension Period|Adverse Event|1|||
131822870|NCT04592419|474632849|FG001|Open-Label Extension Period|Adverse Event|2|||
131401109|NCT02589665|473091462|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
131822871|NCT04592419|474632848|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
131822872|NCT04592419|474632849|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
131822873|NCT04592419|474632848|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
131822874|NCT04592419|474632849|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
131822875|NCT04592419|474632848|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
131822876|NCT04592419|474632849|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
131822877|NCT04592419|474632848|FG000|Open-Label Extension Period|Sponsor Request|73|||
131822878|NCT04592419|474632849|FG001|Open-Label Extension Period|Sponsor Request|84|||
131822879|NCT04129944|474632855|FG000|Overall Study|Death|0|||
131822880|NCT04129944|474632856|FG001|Overall Study|Death|0|||
131822881|NCT04129944|474632857|FG002|Overall Study|Death|0|||
131822882|NCT04129944|474632858|FG003|Overall Study|Death|1|||
131822883|NCT04129944|474632855|FG000|Overall Study|Lost to Follow-up|1|||
131822884|NCT04129944|474632856|FG001|Overall Study|Lost to Follow-up|0|||
131822885|NCT04129944|474632857|FG002|Overall Study|Lost to Follow-up|0|||
131822886|NCT04129944|474632858|FG003|Overall Study|Lost to Follow-up|0|||
131822887|NCT04129944|474632855|FG000|Overall Study|Withdrawal by Subject|1|||
131822888|NCT04129944|474632856|FG001|Overall Study|Withdrawal by Subject|0|||
131822889|NCT04129944|474632857|FG002|Overall Study|Withdrawal by Subject|1|||
131822890|NCT04129944|474632858|FG003|Overall Study|Withdrawal by Subject|2|||
131822891|NCT02419573|474632859|FG000|Overall Study|Lost to Follow-up|3|||
131822892|NCT02419573|474632860|FG001|Overall Study|Lost to Follow-up|0|||
131822893|NCT02419573|474632859|FG000|Overall Study|Withdrawal by Subject|1|||
131822894|NCT02419573|474632860|FG001|Overall Study|Withdrawal by Subject|0|||
131822895|NCT00493792|474632861|FG000|Overall Study|Death|55|||
131822896|NCT00493792|474632862|FG001|Overall Study|Death|50|||
131909986|NCT00171249|474958728|FG006|Overall Study|Administrative Problems|0|||
131401110|NCT02589665|473091463|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131822897|NCT00493792|474632861|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
131822898|NCT00493792|474632862|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
131822899|NCT01190930|474632871|FG000|Induction|Adverse Event|17|||
131822900|NCT01190930|474632872|FG001|Induction|Adverse Event|0|||
131822901|NCT01190930|474632873|FG002|Induction|Adverse Event|0|||
131822902|NCT01190930|474632874|FG003|Induction|Adverse Event|0|||
131822903|NCT01190930|474632875|FG004|Induction|Adverse Event|0|||
131822904|NCT01190930|474632876|FG005|Induction|Adverse Event|0|||
131822905|NCT01190930|474632877|FG006|Induction|Adverse Event|0|||
131822906|NCT01190930|474632878|FG007|Induction|Adverse Event|0|||
131822907|NCT01190930|474632879|FG008|Induction|Adverse Event|0|||
131822908|NCT01190930|474632880|FG009|Induction|Adverse Event|0|||
131822909|NCT01190930|474632871|FG000|Induction|Death|34|||
131822910|NCT01190930|474632872|FG001|Induction|Death|0|||
131822911|NCT01190930|474632873|FG002|Induction|Death|0|||
131822912|NCT01190930|474632874|FG003|Induction|Death|0|||
131822913|NCT01190930|474632875|FG004|Induction|Death|0|||
131822914|NCT01190930|474632876|FG005|Induction|Death|0|||
131822915|NCT01190930|474632877|FG006|Induction|Death|0|||
131822916|NCT01190930|474632878|FG007|Induction|Death|0|||
131822917|NCT01190930|474632879|FG008|Induction|Death|0|||
131822918|NCT01190930|474632880|FG009|Induction|Death|0|||
131822919|NCT01190930|474632871|FG000|Induction|Lost to Follow-up|1|||
131822920|NCT01190930|474632872|FG001|Induction|Lost to Follow-up|0|||
131822921|NCT01190930|474632873|FG002|Induction|Lost to Follow-up|0|||
131822922|NCT01190930|474632874|FG003|Induction|Lost to Follow-up|0|||
131822923|NCT01190930|474632875|FG004|Induction|Lost to Follow-up|0|||
131822924|NCT01190930|474632876|FG005|Induction|Lost to Follow-up|0|||
131822925|NCT01190930|474632877|FG006|Induction|Lost to Follow-up|0|||
131822926|NCT01190930|474632878|FG007|Induction|Lost to Follow-up|0|||
131822927|NCT01190930|474632879|FG008|Induction|Lost to Follow-up|0|||
131822928|NCT01190930|474632880|FG009|Induction|Lost to Follow-up|0|||
131822929|NCT01190930|474632871|FG000|Induction|Physician Decision|125|||
131822930|NCT01190930|474632872|FG001|Induction|Physician Decision|3|||
131822931|NCT01190930|474632873|FG002|Induction|Physician Decision|0|||
131822932|NCT01190930|474632874|FG003|Induction|Physician Decision|0|||
131822933|NCT01190930|474632875|FG004|Induction|Physician Decision|0|||
131822934|NCT01190930|474632876|FG005|Induction|Physician Decision|0|||
131822935|NCT01190930|474632877|FG006|Induction|Physician Decision|0|||
131822936|NCT01190930|474632878|FG007|Induction|Physician Decision|0|||
131822937|NCT01190930|474632879|FG008|Induction|Physician Decision|0|||
131822938|NCT01190930|474632880|FG009|Induction|Physician Decision|0|||
131822939|NCT01190930|474632871|FG000|Induction|Withdrawal by Subject|9|||
131822940|NCT01190930|474632872|FG001|Induction|Withdrawal by Subject|0|||
131822941|NCT01190930|474632873|FG002|Induction|Withdrawal by Subject|0|||
131822942|NCT01190930|474632874|FG003|Induction|Withdrawal by Subject|0|||
131822943|NCT01190930|474632875|FG004|Induction|Withdrawal by Subject|0|||
131822944|NCT01190930|474632876|FG005|Induction|Withdrawal by Subject|0|||
131822945|NCT01190930|474632877|FG006|Induction|Withdrawal by Subject|0|||
131822946|NCT01190930|474632878|FG007|Induction|Withdrawal by Subject|0|||
131822947|NCT01190930|474632879|FG008|Induction|Withdrawal by Subject|0|||
131822948|NCT01190930|474632880|FG009|Induction|Withdrawal by Subject|0|||
131822949|NCT01190930|474632871|FG000|Induction|Refusal|235|||
131822950|NCT01190930|474632872|FG001|Induction|Refusal|0|||
131822951|NCT01190930|474632873|FG002|Induction|Refusal|0|||
131822952|NCT01190930|474632874|FG003|Induction|Refusal|0|||
131822953|NCT01190930|474632875|FG004|Induction|Refusal|0|||
131822954|NCT01190930|474632876|FG005|Induction|Refusal|0|||
131822955|NCT01190930|474632877|FG006|Induction|Refusal|0|||
131822956|NCT01190930|474632878|FG007|Induction|Refusal|0|||
131822957|NCT01190930|474632879|FG008|Induction|Refusal|0|||
131822958|NCT01190930|474632880|FG009|Induction|Refusal|0|||
131822959|NCT01190930|474632871|FG000|Induction|Inevaluable|23|||
131822960|NCT01190930|474632872|FG001|Induction|Inevaluable|1|||
131822961|NCT01190930|474632873|FG002|Induction|Inevaluable|0|||
131822962|NCT01190930|474632874|FG003|Induction|Inevaluable|0|||
131822963|NCT01190930|474632875|FG004|Induction|Inevaluable|0|||
131822964|NCT01190930|474632876|FG005|Induction|Inevaluable|0|||
131822965|NCT01190930|474632877|FG006|Induction|Inevaluable|0|||
131822966|NCT01190930|474632878|FG007|Induction|Inevaluable|0|||
131822967|NCT01190930|474632879|FG008|Induction|Inevaluable|0|||
131822968|NCT01190930|474632880|FG009|Induction|Inevaluable|0|||
131822969|NCT01190930|474632871|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
131822970|NCT01190930|474632872|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822971|NCT01190930|474632873|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822972|NCT01190930|474632874|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822973|NCT01190930|474632875|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822974|NCT01190930|474632876|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822975|NCT01190930|474632877|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822976|NCT01190930|474632878|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822977|NCT01190930|474632879|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822978|NCT01190930|474632880|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
131822979|NCT01190930|474632871|FG000|Induction|High Risk Downs|80|||
131822980|NCT01190930|474632872|FG001|Induction|High Risk Downs|0|||
131822981|NCT01190930|474632873|FG002|Induction|High Risk Downs|0|||
131822982|NCT01190930|474632874|FG003|Induction|High Risk Downs|0|||
131822983|NCT01190930|474632875|FG004|Induction|High Risk Downs|0|||
131822984|NCT01190930|474632876|FG005|Induction|High Risk Downs|0|||
131822985|NCT01190930|474632877|FG006|Induction|High Risk Downs|0|||
131822986|NCT01190930|474632878|FG007|Induction|High Risk Downs|0|||
131822987|NCT01190930|474632879|FG008|Induction|High Risk Downs|0|||
131822988|NCT01190930|474632880|FG009|Induction|High Risk Downs|0|||
131822989|NCT01190930|474632871|FG000|Induction|Enrollment onto another COG Protocol|1|||
131822990|NCT01190930|474632872|FG001|Induction|Enrollment onto another COG Protocol|0|||
131822991|NCT01190930|474632873|FG002|Induction|Enrollment onto another COG Protocol|0|||
131822992|NCT01190930|474632874|FG003|Induction|Enrollment onto another COG Protocol|0|||
131909987|NCT00171249|474958722|FG000|Overall Study|Adverse Event|3|||
131822993|NCT01190930|474632875|FG004|Induction|Enrollment onto another COG Protocol|0|||
131822994|NCT01190930|474632876|FG005|Induction|Enrollment onto another COG Protocol|0|||
131822995|NCT01190930|474632877|FG006|Induction|Enrollment onto another COG Protocol|0|||
131822996|NCT01190930|474632878|FG007|Induction|Enrollment onto another COG Protocol|0|||
131822997|NCT01190930|474632879|FG008|Induction|Enrollment onto another COG Protocol|0|||
131822998|NCT01190930|474632880|FG009|Induction|Enrollment onto another COG Protocol|0|||
131822999|NCT01190930|474632871|FG000|Induction|Average Risk|1847|||
131823000|NCT01190930|474632872|FG001|Induction|Average Risk|0|||
131823001|NCT01190930|474632873|FG002|Induction|Average Risk|0|||
131823002|NCT01190930|474632874|FG003|Induction|Average Risk|0|||
131823003|NCT01190930|474632875|FG004|Induction|Average Risk|0|||
131823004|NCT01190930|474632876|FG005|Induction|Average Risk|0|||
131823005|NCT01190930|474632877|FG006|Induction|Average Risk|0|||
131823006|NCT01190930|474632878|FG007|Induction|Average Risk|0|||
131823007|NCT01190930|474632879|FG008|Induction|Average Risk|0|||
131823008|NCT01190930|474632880|FG009|Induction|Average Risk|0|||
131823009|NCT01190930|474632871|FG000|Induction|High Risk|1227|||
131823010|NCT01190930|474632872|FG001|Induction|High Risk|0|||
131823011|NCT01190930|474632873|FG002|Induction|High Risk|0|||
131823012|NCT01190930|474632874|FG003|Induction|High Risk|0|||
131823013|NCT01190930|474632875|FG004|Induction|High Risk|0|||
131823014|NCT01190930|474632876|FG005|Induction|High Risk|0|||
131823015|NCT01190930|474632877|FG006|Induction|High Risk|0|||
131823016|NCT01190930|474632878|FG007|Induction|High Risk|0|||
131823017|NCT01190930|474632879|FG008|Induction|High Risk|0|||
131823018|NCT01190930|474632880|FG009|Induction|High Risk|0|||
131823019|NCT01190930|474632871|FG000|Induction|Low Risk|443|||
131823020|NCT01190930|474632872|FG001|Induction|Low Risk|0|||
131823021|NCT01190930|474632873|FG002|Induction|Low Risk|0|||
131823022|NCT01190930|474632874|FG003|Induction|Low Risk|0|||
131823023|NCT01190930|474632875|FG004|Induction|Low Risk|0|||
131823024|NCT01190930|474632876|FG005|Induction|Low Risk|0|||
131823025|NCT01190930|474632877|FG006|Induction|Low Risk|0|||
131823026|NCT01190930|474632878|FG007|Induction|Low Risk|0|||
131823027|NCT01190930|474632879|FG008|Induction|Low Risk|0|||
131823028|NCT01190930|474632880|FG009|Induction|Low Risk|0|||
131823029|NCT01190930|474632871|FG000|Induction|Very High Risk|1012|||
131823030|NCT01190930|474632872|FG001|Induction|Very High Risk|0|||
131823031|NCT01190930|474632873|FG002|Induction|Very High Risk|0|||
131823032|NCT01190930|474632874|FG003|Induction|Very High Risk|0|||
131823033|NCT01190930|474632875|FG004|Induction|Very High Risk|0|||
131823034|NCT01190930|474632876|FG005|Induction|Very High Risk|0|||
131823035|NCT01190930|474632877|FG006|Induction|Very High Risk|0|||
131823036|NCT01190930|474632878|FG007|Induction|Very High Risk|0|||
131823037|NCT01190930|474632879|FG008|Induction|Very High Risk|0|||
131823038|NCT01190930|474632880|FG009|Induction|Very High Risk|0|||
131823039|NCT01190930|474632871|FG000|Induction|Philadelphia chromosome-positive|99|||
131823040|NCT01190930|474632872|FG001|Induction|Philadelphia chromosome-positive|0|||
131823041|NCT01190930|474632873|FG002|Induction|Philadelphia chromosome-positive|0|||
131823042|NCT01190930|474632874|FG003|Induction|Philadelphia chromosome-positive|0|||
131823043|NCT01190930|474632875|FG004|Induction|Philadelphia chromosome-positive|0|||
131823044|NCT01190930|474632876|FG005|Induction|Philadelphia chromosome-positive|0|||
131823045|NCT01190930|474632877|FG006|Induction|Philadelphia chromosome-positive|0|||
131823046|NCT01190930|474632878|FG007|Induction|Philadelphia chromosome-positive|0|||
131823047|NCT01190930|474632879|FG008|Induction|Philadelphia chromosome-positive|0|||
131823048|NCT01190930|474632880|FG009|Induction|Philadelphia chromosome-positive|0|||
131823049|NCT01190930|474632871|FG000|Induction|Incomplete Induction data|63|||
131823050|NCT01190930|474632872|FG001|Induction|Incomplete Induction data|0|||
131823051|NCT01190930|474632873|FG002|Induction|Incomplete Induction data|0|||
131823052|NCT01190930|474632874|FG003|Induction|Incomplete Induction data|0|||
131909988|NCT00171249|474958723|FG001|Overall Study|Adverse Event|1|||
131823053|NCT01190930|474632875|FG004|Induction|Incomplete Induction data|0|||
131823054|NCT01190930|474632876|FG005|Induction|Incomplete Induction data|0|||
131823055|NCT01190930|474632877|FG006|Induction|Incomplete Induction data|0|||
131823056|NCT01190930|474632878|FG007|Induction|Incomplete Induction data|0|||
131823057|NCT01190930|474632879|FG008|Induction|Incomplete Induction data|0|||
131823058|NCT01190930|474632880|FG009|Induction|Incomplete Induction data|0|||
131823059|NCT01190930|474632871|FG000|Induction|Progressive disease|0|||
131823060|NCT01190930|474632872|FG001|Induction|Progressive disease|1|||
131909989|NCT00171249|474958724|FG002|Overall Study|Adverse Event|0|||
131823061|NCT01190930|474632873|FG002|Induction|Progressive disease|0|||
131823062|NCT01190930|474632874|FG003|Induction|Progressive disease|0|||
131823063|NCT01190930|474632875|FG004|Induction|Progressive disease|0|||
131823064|NCT01190930|474632876|FG005|Induction|Progressive disease|0|||
131823065|NCT01190930|474632877|FG006|Induction|Progressive disease|0|||
131823066|NCT01190930|474632878|FG007|Induction|Progressive disease|0|||
131823067|NCT01190930|474632879|FG008|Induction|Progressive disease|0|||
131823068|NCT01190930|474632880|FG009|Induction|Progressive disease|0|||
131909990|NCT00171249|474958725|FG003|Overall Study|Adverse Event|15|||
131823069|NCT01190930|474632871|FG000|Induction|No treatment|3|||
131823070|NCT01190930|474632872|FG001|Induction|No treatment|0|||
131823071|NCT01190930|474632873|FG002|Induction|No treatment|0|||
131823072|NCT01190930|474632874|FG003|Induction|No treatment|0|||
131823073|NCT01190930|474632875|FG004|Induction|No treatment|0|||
131823074|NCT01190930|474632876|FG005|Induction|No treatment|0|||
131823075|NCT01190930|474632877|FG006|Induction|No treatment|0|||
131823076|NCT01190930|474632878|FG007|Induction|No treatment|0|||
131823077|NCT01190930|474632879|FG008|Induction|No treatment|0|||
131823078|NCT01190930|474632880|FG009|Induction|No treatment|0|||
131823079|NCT01190930|474632871|FG000|Induction|Ineligible|69|||
131823080|NCT01190930|474632872|FG001|Induction|Ineligible|4|||
131823081|NCT01190930|474632873|FG002|Induction|Ineligible|0|||
131823082|NCT01190930|474632874|FG003|Induction|Ineligible|0|||
131823083|NCT01190930|474632875|FG004|Induction|Ineligible|0|||
131823084|NCT01190930|474632876|FG005|Induction|Ineligible|0|||
131823085|NCT01190930|474632877|FG006|Induction|Ineligible|0|||
131823086|NCT01190930|474632878|FG007|Induction|Ineligible|0|||
131823087|NCT01190930|474632879|FG008|Induction|Ineligible|0|||
131823088|NCT01190930|474632880|FG009|Induction|Ineligible|0|||
131823089|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
131823090|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
131823091|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
131823092|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
131823093|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
131823094|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
131823095|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
131823096|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
131823097|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
131823098|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
131823099|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Death|0|||
131823100|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Death|0|||
131823101|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Death|8|||
131823102|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Death|4|||
131823103|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Death|0|||
131823104|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Death|0|||
131823105|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Death|0|||
131823106|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Death|0|||
131823107|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Death|0|||
131823108|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Death|0|||
131823109|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
131823110|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
131823111|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
131823112|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
131823113|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
131823114|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
131823115|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
131823116|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
131823117|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
131823118|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
131823119|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823120|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
131823121|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
131823122|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
131823123|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823124|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823125|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823126|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823127|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823128|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
131823129|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Refusal|0|||
131823130|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Refusal|2|||
131823131|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Refusal|694|||
131823132|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Refusal|4|||
131823133|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Refusal|0|||
131823134|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Refusal|3|||
131823135|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Refusal|0|||
131909991|NCT00171249|474958726|FG004|Overall Study|Adverse Event|0|||
131909992|NCT00171249|474958727|FG005|Overall Study|Adverse Event|2|||
131823136|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Refusal|0|||
131823137|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Refusal|0|||
131823138|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Refusal|0|||
131823139|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
131823140|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
131823141|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
131823142|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
131909993|NCT00171249|474958728|FG006|Overall Study|Adverse Event|0|||
131823143|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
131823144|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
131823145|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
131823146|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
131823147|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
131823148|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
131823149|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823150|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
131823151|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823152|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823153|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823154|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823155|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823156|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823157|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823158|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
131823159|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
131823160|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
131823161|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
131823162|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
131823163|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
131823164|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
131823165|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
131823166|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
131823167|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
131823168|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
131823169|NCT01190930|474632871|FG000|Post Induction Pre-Maintenance|Relapse|0|||
131823170|NCT01190930|474632872|FG001|Post Induction Pre-Maintenance|Relapse|0|||
131823171|NCT01190930|474632873|FG002|Post Induction Pre-Maintenance|Relapse|1|||
131823172|NCT01190930|474632874|FG003|Post Induction Pre-Maintenance|Relapse|0|||
131823173|NCT01190930|474632875|FG004|Post Induction Pre-Maintenance|Relapse|0|||
131823174|NCT01190930|474632876|FG005|Post Induction Pre-Maintenance|Relapse|0|||
131823175|NCT01190930|474632877|FG006|Post Induction Pre-Maintenance|Relapse|0|||
131823176|NCT01190930|474632878|FG007|Post Induction Pre-Maintenance|Relapse|0|||
131823177|NCT01190930|474632879|FG008|Post Induction Pre-Maintenance|Relapse|0|||
131823178|NCT01190930|474632880|FG009|Post Induction Pre-Maintenance|Relapse|0|||
131823179|NCT01190930|474632871|FG000|Maintenance|Adverse Event|0|||
131823180|NCT01190930|474632872|FG001|Maintenance|Adverse Event|0|||
131823181|NCT01190930|474632873|FG002|Maintenance|Adverse Event|0|||
131823182|NCT01190930|474632874|FG003|Maintenance|Adverse Event|0|||
131823183|NCT01190930|474632875|FG004|Maintenance|Adverse Event|0|||
131823184|NCT01190930|474632876|FG005|Maintenance|Adverse Event|1|||
131823185|NCT01190930|474632877|FG006|Maintenance|Adverse Event|1|||
131823186|NCT01190930|474632878|FG007|Maintenance|Adverse Event|3|||
131823187|NCT01190930|474632879|FG008|Maintenance|Adverse Event|3|||
131823188|NCT01190930|474632880|FG009|Maintenance|Adverse Event|0|||
131823189|NCT01190930|474632871|FG000|Maintenance|Death|0|||
131823190|NCT01190930|474632872|FG001|Maintenance|Death|0|||
131823191|NCT01190930|474632873|FG002|Maintenance|Death|0|||
131823192|NCT01190930|474632874|FG003|Maintenance|Death|1|||
131823193|NCT01190930|474632875|FG004|Maintenance|Death|0|||
131823194|NCT01190930|474632876|FG005|Maintenance|Death|0|||
131823195|NCT01190930|474632877|FG006|Maintenance|Death|2|||
131823196|NCT01190930|474632878|FG007|Maintenance|Death|2|||
131823197|NCT01190930|474632879|FG008|Maintenance|Death|2|||
131823198|NCT01190930|474632880|FG009|Maintenance|Death|2|||
131823199|NCT01190930|474632871|FG000|Maintenance|Lost to Follow-up|0|||
131823200|NCT01190930|474632872|FG001|Maintenance|Lost to Follow-up|0|||
131823201|NCT01190930|474632873|FG002|Maintenance|Lost to Follow-up|0|||
131823202|NCT01190930|474632874|FG003|Maintenance|Lost to Follow-up|0|||
131823203|NCT01190930|474632875|FG004|Maintenance|Lost to Follow-up|0|||
131823204|NCT01190930|474632876|FG005|Maintenance|Lost to Follow-up|0|||
131823205|NCT01190930|474632877|FG006|Maintenance|Lost to Follow-up|1|||
131823206|NCT01190930|474632878|FG007|Maintenance|Lost to Follow-up|1|||
131823207|NCT01190930|474632879|FG008|Maintenance|Lost to Follow-up|1|||
131823208|NCT01190930|474632880|FG009|Maintenance|Lost to Follow-up|0|||
131823209|NCT01190930|474632871|FG000|Maintenance|Physician Decision|0|||
131823210|NCT01190930|474632872|FG001|Maintenance|Physician Decision|1|||
131823211|NCT01190930|474632873|FG002|Maintenance|Physician Decision|0|||
131823212|NCT01190930|474632874|FG003|Maintenance|Physician Decision|5|||
131823213|NCT01190930|474632875|FG004|Maintenance|Physician Decision|9|||
131823214|NCT01190930|474632876|FG005|Maintenance|Physician Decision|4|||
131823215|NCT01190930|474632877|FG006|Maintenance|Physician Decision|8|||
131823216|NCT01190930|474632878|FG007|Maintenance|Physician Decision|8|||
131823217|NCT01190930|474632879|FG008|Maintenance|Physician Decision|10|||
131823218|NCT01190930|474632880|FG009|Maintenance|Physician Decision|17|||
131823219|NCT01190930|474632871|FG000|Maintenance|Withdrawal by Subject|0|||
131823220|NCT01190930|474632872|FG001|Maintenance|Withdrawal by Subject|0|||
131823221|NCT01190930|474632873|FG002|Maintenance|Withdrawal by Subject|0|||
131823222|NCT01190930|474632874|FG003|Maintenance|Withdrawal by Subject|0|||
131823223|NCT01190930|474632875|FG004|Maintenance|Withdrawal by Subject|0|||
131823224|NCT01190930|474632876|FG005|Maintenance|Withdrawal by Subject|0|||
131823225|NCT01190930|474632877|FG006|Maintenance|Withdrawal by Subject|2|||
131823226|NCT01190930|474632878|FG007|Maintenance|Withdrawal by Subject|1|||
131823227|NCT01190930|474632879|FG008|Maintenance|Withdrawal by Subject|4|||
131823228|NCT01190930|474632880|FG009|Maintenance|Withdrawal by Subject|1|||
131823229|NCT01190930|474632871|FG000|Maintenance|Refusal|0|||
131823230|NCT01190930|474632872|FG001|Maintenance|Refusal|1|||
131823231|NCT01190930|474632873|FG002|Maintenance|Refusal|0|||
131823232|NCT01190930|474632874|FG003|Maintenance|Refusal|2|||
131823233|NCT01190930|474632875|FG004|Maintenance|Refusal|0|||
131823234|NCT01190930|474632876|FG005|Maintenance|Refusal|4|||
131823235|NCT01190930|474632877|FG006|Maintenance|Refusal|5|||
131823236|NCT01190930|474632878|FG007|Maintenance|Refusal|17|||
131823237|NCT01190930|474632879|FG008|Maintenance|Refusal|13|||
131823238|NCT01190930|474632880|FG009|Maintenance|Refusal|6|||
131823239|NCT01190930|474632871|FG000|Maintenance|second malignant neoplasm|0|||
131823240|NCT01190930|474632872|FG001|Maintenance|second malignant neoplasm|0|||
131823241|NCT01190930|474632873|FG002|Maintenance|second malignant neoplasm|0|||
131823242|NCT01190930|474632874|FG003|Maintenance|second malignant neoplasm|1|||
131823243|NCT01190930|474632875|FG004|Maintenance|second malignant neoplasm|0|||
131823244|NCT01190930|474632876|FG005|Maintenance|second malignant neoplasm|1|||
131823245|NCT01190930|474632877|FG006|Maintenance|second malignant neoplasm|0|||
131823246|NCT01190930|474632878|FG007|Maintenance|second malignant neoplasm|0|||
131823247|NCT01190930|474632879|FG008|Maintenance|second malignant neoplasm|1|||
131823248|NCT01190930|474632880|FG009|Maintenance|second malignant neoplasm|0|||
131823249|NCT01190930|474632871|FG000|Maintenance|Inevaluable|0|||
131823250|NCT01190930|474632872|FG001|Maintenance|Inevaluable|0|||
131823251|NCT01190930|474632873|FG002|Maintenance|Inevaluable|0|||
131823252|NCT01190930|474632874|FG003|Maintenance|Inevaluable|0|||
131823253|NCT01190930|474632875|FG004|Maintenance|Inevaluable|0|||
131823254|NCT01190930|474632876|FG005|Maintenance|Inevaluable|1|||
131823255|NCT01190930|474632877|FG006|Maintenance|Inevaluable|1|||
131823256|NCT01190930|474632878|FG007|Maintenance|Inevaluable|1|||
131823257|NCT01190930|474632879|FG008|Maintenance|Inevaluable|0|||
131823258|NCT01190930|474632880|FG009|Maintenance|Inevaluable|0|||
131823259|NCT01190930|474632871|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
131823260|NCT01190930|474632872|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
131823261|NCT01190930|474632873|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
131823262|NCT01190930|474632874|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
131823263|NCT01190930|474632875|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
131823264|NCT01190930|474632876|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
131823265|NCT01190930|474632877|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
131823266|NCT01190930|474632878|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
131823267|NCT01190930|474632879|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
131823268|NCT01190930|474632880|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
131823269|NCT01190930|474632871|FG000|Maintenance|Relapse|0|||
131823270|NCT01190930|474632872|FG001|Maintenance|Relapse|0|||
131823271|NCT01190930|474632873|FG002|Maintenance|Relapse|0|||
131823272|NCT01190930|474632874|FG003|Maintenance|Relapse|2|||
131823273|NCT01190930|474632875|FG004|Maintenance|Relapse|0|||
131823274|NCT01190930|474632876|FG005|Maintenance|Relapse|1|||
131823275|NCT01190930|474632877|FG006|Maintenance|Relapse|6|||
131823276|NCT01190930|474632878|FG007|Maintenance|Relapse|13|||
131823277|NCT01190930|474632879|FG008|Maintenance|Relapse|11|||
131823278|NCT01190930|474632880|FG009|Maintenance|Relapse|11|||
131823279|NCT01190930|474632871|FG000|Maintenance|Still on therapy|0|||
131823280|NCT01190930|474632872|FG001|Maintenance|Still on therapy|8|||
131823281|NCT01190930|474632873|FG002|Maintenance|Still on therapy|0|||
131823282|NCT01190930|474632874|FG003|Maintenance|Still on therapy|29|||
131823283|NCT01190930|474632875|FG004|Maintenance|Still on therapy|0|||
131823284|NCT01190930|474632876|FG005|Maintenance|Still on therapy|0|||
131823285|NCT01190930|474632877|FG006|Maintenance|Still on therapy|0|||
131823286|NCT01190930|474632878|FG007|Maintenance|Still on therapy|0|||
131823287|NCT01190930|474632879|FG008|Maintenance|Still on therapy|0|||
131823288|NCT01190930|474632880|FG009|Maintenance|Still on therapy|0|||
131823289|NCT02161549|474632881|FG000|Overall Study|Physician Decision|6|||
131823290|NCT02161549|474632882|FG001|Overall Study|Physician Decision|2|||
131823291|NCT01628549|474632883|FG000|Overall Study|Adverse Event|1|||
131823292|NCT01628549|474632884|FG001|Overall Study|Adverse Event|1|||
131823293|NCT01628549|474632885|FG002|Overall Study|Adverse Event|0|||
131823294|NCT01628549|474632886|FG003|Overall Study|Adverse Event|4|||
131823295|NCT01628549|474632883|FG000|Overall Study|Lost to Follow-up|3|||
131823296|NCT01628549|474632884|FG001|Overall Study|Lost to Follow-up|4|||
131823297|NCT01628549|474632885|FG002|Overall Study|Lost to Follow-up|3|||
131823298|NCT01628549|474632886|FG003|Overall Study|Lost to Follow-up|3|||
131823299|NCT01628549|474632883|FG000|Overall Study|Withdrawal by Subject|3|||
131823300|NCT01628549|474632884|FG001|Overall Study|Withdrawal by Subject|4|||
131823301|NCT01628549|474632885|FG002|Overall Study|Withdrawal by Subject|4|||
131823302|NCT01628549|474632886|FG003|Overall Study|Withdrawal by Subject|1|||
131823303|NCT01628549|474632883|FG000|Overall Study|Protocol Violation|2|||
131823304|NCT01628549|474632884|FG001|Overall Study|Protocol Violation|1|||
131823305|NCT01628549|474632885|FG002|Overall Study|Protocol Violation|1|||
131823306|NCT01628549|474632886|FG003|Overall Study|Protocol Violation|0|||
131823307|NCT01628549|474632883|FG000|Overall Study|withdrawn for noncompliance|0|||
131823308|NCT01628549|474632884|FG001|Overall Study|withdrawn for noncompliance|2|||
131823309|NCT01628549|474632885|FG002|Overall Study|withdrawn for noncompliance|1|||
131823310|NCT01628549|474632886|FG003|Overall Study|withdrawn for noncompliance|0|||
131823311|NCT01628549|474632883|FG000|Overall Study|abnormal laboratory test results|0|||
131823312|NCT01628549|474632884|FG001|Overall Study|abnormal laboratory test results|0|||
131823313|NCT01628549|474632885|FG002|Overall Study|abnormal laboratory test results|1|||
131823314|NCT01628549|474632886|FG003|Overall Study|abnormal laboratory test results|0|||
131823315|NCT01628549|474632883|FG000|Overall Study|positive pregnancy test|0|||
131823316|NCT01628549|474632884|FG001|Overall Study|positive pregnancy test|0|||
131823317|NCT01628549|474632885|FG002|Overall Study|positive pregnancy test|0|||
131823318|NCT01628549|474632886|FG003|Overall Study|positive pregnancy test|1|||
131823319|NCT01841073|474632889|FG000|Overall Study|Adverse Event|1|||
131823320|NCT01841073|474632890|FG001|Overall Study|Adverse Event|1|||
131823321|NCT01841073|474632889|FG000|Overall Study|Physician Decision|1|||
131823322|NCT01841073|474632890|FG001|Overall Study|Physician Decision|0|||
131823323|NCT01841073|474632889|FG000|Overall Study|Lost to Follow-up|0|||
131823324|NCT01841073|474632890|FG001|Overall Study|Lost to Follow-up|2|||
131823325|NCT04320745|474632891|FG000|Overall Study|Adverse Event|26|||
131823326|NCT04320745|474632891|FG000|Overall Study|Withdrawal by Subject|4|||
131823327|NCT04320745|474632891|FG000|Overall Study|Lost to Follow-up|12|||
131823328|NCT04320745|474632891|FG000|Overall Study|Protocol Deviation|2|||
131823329|NCT04320745|474632891|FG000|Overall Study|Non-compliance With Study Drug|2|||
131823330|NCT04320745|474632891|FG000|Overall Study|Reason Not Specified|1|||
131823331|NCT00046839|474632892|FG000|Overall Study|Ineligible / No protocol treatment|0|||
131823332|NCT00046839|474632893|FG001|Overall Study|Ineligible / No protocol treatment|2|||
131823333|NCT00046839|474632892|FG000|Overall Study|Withdrawal of consent|1|||
131823334|NCT00046839|474632893|FG001|Overall Study|Withdrawal of consent|0|||
131823335|NCT02472639|474632894|FG000|Overall Study|Physician Decision|4|||
131823336|NCT02472639|474632895|FG001|Overall Study|Physician Decision|3|||
131823337|NCT00702507|474632899|FG000|Initial Treatment Phase|Adverse Event|2|||
131823338|NCT00702507|474632899|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
131823339|NCT00702507|474632899|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
131823340|NCT00702507|474632899|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
131823341|NCT00702507|474632899|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
131823342|NCT00702507|474632899|FG000|Follow-up Phase|Protocol Violation|2|||
131823343|NCT00702507|474632899|FG000|Follow-up Phase|Lost to Follow-up|23|||
131823344|NCT00702507|474632899|FG000|Follow-up Phase|Late Enrollment|1|||
131823345|NCT02308696|474632901|FG000|Overall Study|Lost to Follow-up|28|||
131823346|NCT02308696|474632902|FG001|Overall Study|Lost to Follow-up|21|||
131823347|NCT02308696|474632901|FG000|Overall Study|Death|8|||
131823348|NCT02308696|474632902|FG001|Overall Study|Death|4|||
131823349|NCT02308696|474632901|FG000|Overall Study|Moved to a Higher Level of Care|17|||
131823350|NCT02308696|474632902|FG001|Overall Study|Moved to a Higher Level of Care|6|||
131823351|NCT01211262|474632903|FG000|Overall Study|Progressive Disease|18|||
131823352|NCT01211262|474632904|FG001|Overall Study|Progressive Disease|9|||
131823353|NCT01211262|474632903|FG000|Overall Study|Adverse Event|4|||
131823354|NCT01211262|474632904|FG001|Overall Study|Adverse Event|0|||
131823355|NCT01211262|474632903|FG000|Overall Study|Withdrawal of Consent|1|||
131823356|NCT01211262|474632904|FG001|Overall Study|Withdrawal of Consent|0|||
131823357|NCT01211262|474632903|FG000|Overall Study|Other|0|||
131823358|NCT01211262|474632904|FG001|Overall Study|Other|1|||
131823359|NCT04768114|474632905|FG000|Overall Study|Lost to Follow-up|5|||
131823360|NCT04768114|474632906|FG001|Overall Study|Lost to Follow-up|10|||
131823361|NCT04768114|474632905|FG000|Overall Study|Withdrawal by Subject|0|||
131823362|NCT04768114|474632906|FG001|Overall Study|Withdrawal by Subject|1|||
131823363|NCT04049097|474632907|FG000|Overall Study|Adverse Event|18|||
131823364|NCT04049097|474632907|FG000|Overall Study|Death|2|||
131823365|NCT04049097|474632907|FG000|Overall Study|Lost to Follow-up|1|||
131823366|NCT04049097|474632907|FG000|Overall Study|Physician Decision|2|||
131823367|NCT04049097|474632907|FG000|Overall Study|Withdrawal by Subject|9|||
131823368|NCT04049097|474632907|FG000|Overall Study|Protocol Violation|2|||
131823369|NCT04049097|474632907|FG000|Overall Study|Other|1|||
131823370|NCT04049097|474632907|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
131823371|NCT01963260|474632918|FG000|Overall Study|Withdrawal by Subject|2|||
131823372|NCT01963260|474632919|FG001|Overall Study|Withdrawal by Subject|0|||
131823373|NCT01963260|474632920|FG002|Overall Study|Withdrawal by Subject|0|||
131823374|NCT01963260|474632921|FG003|Overall Study|Withdrawal by Subject|1|||
131823375|NCT01963260|474632922|FG004|Overall Study|Withdrawal by Subject|2|||
131823376|NCT01963260|474632923|FG005|Overall Study|Withdrawal by Subject|0|||
131823377|NCT01963260|474632924|FG006|Overall Study|Withdrawal by Subject|0|||
131823378|NCT01963260|474632925|FG007|Overall Study|Withdrawal by Subject|0|||
131823379|NCT01963260|474632926|FG008|Overall Study|Withdrawal by Subject|0|||
131823380|NCT01963260|474632927|FG009|Overall Study|Withdrawal by Subject|0|||
131823381|NCT04994431|474632928|FG000|Overall Study|Adverse Event|1|||
131823382|NCT04994431|474632929|FG001|Overall Study|Adverse Event|0|||
131823383|NCT01091363|474632930|FG000|Overall Study|Withdrawal by Subject|11|||
131823384|NCT01091363|474632931|FG001|Overall Study|Withdrawal by Subject|15|||
131823385|NCT01091363|474632930|FG000|Overall Study|Lost to Follow-up|2|||
131823386|NCT01091363|474632931|FG001|Overall Study|Lost to Follow-up|2|||
131823387|NCT02151149|474632934|FG000|Treatment Period|Death|2|||
131823388|NCT02151149|474632935|FG001|Treatment Period|Death|3|||
131823389|NCT02151149|474632934|FG000|Treatment Period|Adverse Event|17|||
131823390|NCT02151149|474632935|FG001|Treatment Period|Adverse Event|14|||
131823391|NCT02151149|474632934|FG000|Treatment Period|Progressive Disease|25|||
131823392|NCT02151149|474632935|FG001|Treatment Period|Progressive Disease|24|||
131823393|NCT02151149|474632934|FG000|Treatment Period|Symptomatic Deterioration|2|||
131823394|NCT02151149|474632935|FG001|Treatment Period|Symptomatic Deterioration|10|||
131823395|NCT02151149|474632934|FG000|Treatment Period|Withdrawal by Subject|13|||
131823396|NCT02151149|474632935|FG001|Treatment Period|Withdrawal by Subject|11|||
131823397|NCT02151149|474632934|FG000|Treatment Period|Miscellaneous|8|||
131823398|NCT02151149|474632935|FG001|Treatment Period|Miscellaneous|7|||
131823399|NCT02151149|474632934|FG000|Treatment Period|Participants randomized but not treated|3|||
131823400|NCT02151149|474632935|FG001|Treatment Period|Participants randomized but not treated|2|||
131823401|NCT02151149|474632934|FG000|Follow-Up Period|Lost to Follow-up|2|||
131823402|NCT02151149|474632935|FG001|Follow-Up Period|Lost to Follow-up|3|||
131823403|NCT02151149|474632934|FG000|Follow-Up Period|Death|37|||
131823404|NCT02151149|474632935|FG001|Follow-Up Period|Death|34|||
131823405|NCT02760433|474632936|FG000|Overall Study|Lost to Follow-up|1|||
131823406|NCT02760433|474632937|FG001|Overall Study|Lost to Follow-up|0|||
131823407|NCT02760433|474632938|FG002|Overall Study|Lost to Follow-up|1|||
131823408|NCT02760433|474632939|FG003|Overall Study|Lost to Follow-up|0|||
131823409|NCT02760433|474632940|FG004|Overall Study|Lost to Follow-up|0|||
131823410|NCT02760433|474632936|FG000|Overall Study|Withdrawal by Subject|23|||
131823411|NCT02760433|474632937|FG001|Overall Study|Withdrawal by Subject|9|||
131823412|NCT02760433|474632938|FG002|Overall Study|Withdrawal by Subject|0|||
131823413|NCT02760433|474632939|FG003|Overall Study|Withdrawal by Subject|2|||
131823414|NCT02760433|474632940|FG004|Overall Study|Withdrawal by Subject|9|||
131823415|NCT02760433|474632936|FG000|Overall Study|Lack of Response At Week 14|0|||
131823416|NCT02760433|474632937|FG001|Overall Study|Lack of Response At Week 14|0|||
131823417|NCT02760433|474632938|FG002|Overall Study|Lack of Response At Week 14|0|||
131823418|NCT02760433|474632939|FG003|Overall Study|Lack of Response At Week 14|0|||
131823419|NCT02760433|474632940|FG004|Overall Study|Lack of Response At Week 14|1|||
131823420|NCT02760433|474632936|FG000|Overall Study|Subject refused to continue the study|1|||
131823421|NCT02760433|474632937|FG001|Overall Study|Subject refused to continue the study|0|||
131823422|NCT02760433|474632938|FG002|Overall Study|Subject refused to continue the study|0|||
131823423|NCT02760433|474632939|FG003|Overall Study|Subject refused to continue the study|0|||
131823424|NCT02760433|474632940|FG004|Overall Study|Subject refused to continue the study|0|||
131823425|NCT02760433|474632936|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
131823426|NCT02760433|474632937|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
131823427|NCT02760433|474632938|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
131823428|NCT02760433|474632939|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
131823429|NCT02760433|474632940|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
131823430|NCT02760433|474632936|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
131823431|NCT02760433|474632937|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
131823432|NCT02760433|474632938|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
131909994|NCT00171249|474958722|FG000|Overall Study|Lost to Follow-up|5|||
131823433|NCT02760433|474632939|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
131823434|NCT02760433|474632940|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
131823435|NCT00766493|474632941|FG000|30 Days Post-Procedure|Discontinued|7|||
131823436|NCT00766493|474632941|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
131823437|NCT00766493|474632941|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
131909995|NCT00171249|474958723|FG001|Overall Study|Lost to Follow-up|0|||
131909996|NCT00171249|474958724|FG002|Overall Study|Lost to Follow-up|0|||
131909997|NCT00171249|474958725|FG003|Overall Study|Lost to Follow-up|9|||
131909998|NCT00171249|474958726|FG004|Overall Study|Lost to Follow-up|0|||
131823438|NCT00982228|474632946|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
131823439|NCT00982228|474632947|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
131823440|NCT00982228|474632946|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
131823441|NCT00982228|474632947|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
131823442|NCT00982228|474632946|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
131823443|NCT00982228|474632947|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
131823444|NCT00982228|474632946|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
131823445|NCT00982228|474632947|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
131823446|NCT00982228|474632946|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
131823447|NCT00982228|474632947|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
131823448|NCT00982228|474632946|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
131823449|NCT00982228|474632947|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
131823450|NCT00982228|474632946|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
131823451|NCT00982228|474632947|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
131823452|NCT00982228|474632946|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
131823453|NCT00982228|474632947|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
131823454|NCT00982228|474632946|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
131823455|NCT00982228|474632947|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
131823456|NCT00982228|474632946|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
131823457|NCT00982228|474632947|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
131823458|NCT01438476|474632948|FG000|Overall Study|Protocol Violation|1|||
131823459|NCT01438476|474632949|FG001|Overall Study|Protocol Violation|0|||
131823460|NCT01438476|474632948|FG000|Overall Study|Withdrawal by Subject|1|||
131823461|NCT01438476|474632949|FG001|Overall Study|Withdrawal by Subject|0|||
131823462|NCT01438476|474632948|FG000|Overall Study|No Surgery- Disease|8|||
131823463|NCT01438476|474632949|FG001|Overall Study|No Surgery- Disease|10|||
131823464|NCT01438476|474632948|FG000|Overall Study|Communication barrier|0|||
131823465|NCT01438476|474632949|FG001|Overall Study|Communication barrier|1|||
131823466|NCT02522780|474632950|FG000|Overall Study|Consent withdrawn by subject|5|||
131823467|NCT02522780|474632951|FG001|Overall Study|Consent withdrawn by subject|7|||
131823468|NCT02522780|474632950|FG000|Overall Study|Protocol deviation|1|||
131823469|NCT02522780|474632951|FG001|Overall Study|Protocol deviation|3|||
131823470|NCT02522780|474632950|FG000|Overall Study|Subject refused endoscopic procedure|0|||
131823471|NCT02522780|474632951|FG001|Overall Study|Subject refused endoscopic procedure|1|||
131823472|NCT02522780|474632950|FG000|Overall Study|Adverse event, non-fatal|11|||
131823473|NCT02522780|474632951|FG001|Overall Study|Adverse event, non-fatal|16|||
131823474|NCT02058160|474632952|FG000|Overall Study|Randomized but not treated|2|||
131823475|NCT02058160|474632953|FG001|Overall Study|Randomized but not treated|4|||
131823476|NCT02058160|474632952|FG000|Overall Study|Poor compliance to protocol|4|||
131823477|NCT02058160|474632953|FG001|Overall Study|Poor compliance to protocol|1|||
131823478|NCT02058160|474632952|FG000|Overall Study|Adverse Event|12|||
131823479|NCT02058160|474632953|FG001|Overall Study|Adverse Event|3|||
131823480|NCT02058160|474632952|FG000|Overall Study|Lost to Follow-up|1|||
131823481|NCT02058160|474632953|FG001|Overall Study|Lost to Follow-up|0|||
131823482|NCT02058160|474632952|FG000|Overall Study|Other than specified above|12|||
131823483|NCT02058160|474632953|FG001|Overall Study|Other than specified above|6|||
131823484|NCT02260635|474632956|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
131823485|NCT02260635|474632957|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
131823486|NCT02260635|474632956|FG000|Open-Label Extension|Study Termination|25|||
131823487|NCT02260635|474632957|FG001|Open-Label Extension|Study Termination|25|||
131823488|NCT02260635|474632956|FG000|Open-Label Extension|Withdrawal by Subject|1|||
131823489|NCT02260635|474632957|FG001|Open-Label Extension|Withdrawal by Subject|0|||
131823490|NCT04106817|474632958|FG000|Overall Study|Lost to Follow-up|1|||
131823491|NCT04106817|474632959|FG001|Overall Study|Lost to Follow-up|0|||
131823492|NCT04106817|474632960|FG002|Overall Study|Lost to Follow-up|0|||
131823493|NCT03310619|474632961|FG000|Pre-Treatment Period|Death|1|||
131823494|NCT03310619|474632962|FG001|Pre-Treatment Period|Death|0|||
131823495|NCT03310619|474632963|FG002|Pre-Treatment Period|Death|0|||
131823496|NCT03310619|474632964|FG003|Pre-Treatment Period|Death|0|||
131823497|NCT03310619|474632965|FG004|Pre-Treatment Period|Death|1|||
131823498|NCT03310619|474632966|FG005|Pre-Treatment Period|Death|0|||
131823499|NCT03310619|474632967|FG006|Pre-Treatment Period|Death|0|||
131823500|NCT03310619|474632968|FG007|Pre-Treatment Period|Death|0|||
131823501|NCT03310619|474632961|FG000|Pre-Treatment Period|Other reasons|2|||
131823502|NCT03310619|474632962|FG001|Pre-Treatment Period|Other reasons|1|||
131823503|NCT03310619|474632963|FG002|Pre-Treatment Period|Other reasons|2|||
131823504|NCT03310619|474632964|FG003|Pre-Treatment Period|Other reasons|0|||
131401111|NCT02589665|473091464|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131823505|NCT03310619|474632965|FG004|Pre-Treatment Period|Other reasons|0|||
131823506|NCT03310619|474632966|FG005|Pre-Treatment Period|Other reasons|0|||
131823507|NCT03310619|474632967|FG006|Pre-Treatment Period|Other reasons|2|||
131823508|NCT03310619|474632968|FG007|Pre-Treatment Period|Other reasons|0|||
131823509|NCT03310619|474632961|FG000|Treatment Period|Death|1|||
131823510|NCT03310619|474632962|FG001|Treatment Period|Death|2|||
131823511|NCT03310619|474632963|FG002|Treatment Period|Death|0|||
131823512|NCT03310619|474632964|FG003|Treatment Period|Death|0|||
131823513|NCT03310619|474632965|FG004|Treatment Period|Death|1|||
131823514|NCT03310619|474632966|FG005|Treatment Period|Death|0|||
131823515|NCT03310619|474632967|FG006|Treatment Period|Death|2|||
131823516|NCT03310619|474632968|FG007|Treatment Period|Death|0|||
131823517|NCT03310619|474632961|FG000|Treatment Period|Adverse Event|0|||
131823518|NCT03310619|474632962|FG001|Treatment Period|Adverse Event|1|||
131823519|NCT03310619|474632963|FG002|Treatment Period|Adverse Event|4|||
131823520|NCT03310619|474632964|FG003|Treatment Period|Adverse Event|1|||
131823521|NCT03310619|474632965|FG004|Treatment Period|Adverse Event|0|||
131823522|NCT03310619|474632966|FG005|Treatment Period|Adverse Event|0|||
131823523|NCT03310619|474632967|FG006|Treatment Period|Adverse Event|0|||
131823524|NCT03310619|474632968|FG007|Treatment Period|Adverse Event|0|||
131823525|NCT03310619|474632961|FG000|Treatment Period|Withdrawal by participant|0|||
131823526|NCT03310619|474632962|FG001|Treatment Period|Withdrawal by participant|0|||
131823527|NCT03310619|474632963|FG002|Treatment Period|Withdrawal by participant|1|||
131823528|NCT03310619|474632964|FG003|Treatment Period|Withdrawal by participant|0|||
131823529|NCT03310619|474632965|FG004|Treatment Period|Withdrawal by participant|0|||
131823530|NCT03310619|474632966|FG005|Treatment Period|Withdrawal by participant|0|||
131823531|NCT03310619|474632967|FG006|Treatment Period|Withdrawal by participant|0|||
131823532|NCT03310619|474632968|FG007|Treatment Period|Withdrawal by participant|0|||
131823533|NCT03310619|474632961|FG000|Treatment Period|Lost to Follow-up|0|||
131823534|NCT03310619|474632962|FG001|Treatment Period|Lost to Follow-up|0|||
131823535|NCT03310619|474632963|FG002|Treatment Period|Lost to Follow-up|0|||
131823536|NCT03310619|474632964|FG003|Treatment Period|Lost to Follow-up|0|||
131823537|NCT03310619|474632965|FG004|Treatment Period|Lost to Follow-up|0|||
131823538|NCT03310619|474632966|FG005|Treatment Period|Lost to Follow-up|0|||
131823539|NCT03310619|474632967|FG006|Treatment Period|Lost to Follow-up|0|||
131823540|NCT03310619|474632968|FG007|Treatment Period|Lost to Follow-up|1|||
131823541|NCT03310619|474632961|FG000|Treatment Period|Study terminated by sponsor|0|||
131823542|NCT03310619|474632962|FG001|Treatment Period|Study terminated by sponsor|0|||
131823543|NCT03310619|474632963|FG002|Treatment Period|Study terminated by sponsor|0|||
131823544|NCT03310619|474632964|FG003|Treatment Period|Study terminated by sponsor|0|||
131823545|NCT03310619|474632965|FG004|Treatment Period|Study terminated by sponsor|0|||
131823546|NCT03310619|474632966|FG005|Treatment Period|Study terminated by sponsor|0|||
131823547|NCT03310619|474632967|FG006|Treatment Period|Study terminated by sponsor|0|||
131823548|NCT03310619|474632968|FG007|Treatment Period|Study terminated by sponsor|1|||
131823549|NCT03310619|474632961|FG000|Treatment Period|Physician Decision|0|||
131823550|NCT03310619|474632962|FG001|Treatment Period|Physician Decision|0|||
131823551|NCT03310619|474632963|FG002|Treatment Period|Physician Decision|0|||
131823552|NCT03310619|474632964|FG003|Treatment Period|Physician Decision|0|||
131823553|NCT03310619|474632965|FG004|Treatment Period|Physician Decision|3|||
131823554|NCT03310619|474632966|FG005|Treatment Period|Physician Decision|0|||
131823555|NCT03310619|474632967|FG006|Treatment Period|Physician Decision|0|||
131823556|NCT03310619|474632968|FG007|Treatment Period|Physician Decision|0|||
131823557|NCT03310619|474632961|FG000|Treatment Period|Other reasons|1|||
131823558|NCT03310619|474632962|FG001|Treatment Period|Other reasons|0|||
131823559|NCT03310619|474632963|FG002|Treatment Period|Other reasons|2|||
131823560|NCT03310619|474632964|FG003|Treatment Period|Other reasons|0|||
131823561|NCT03310619|474632965|FG004|Treatment Period|Other reasons|0|||
131823562|NCT03310619|474632966|FG005|Treatment Period|Other reasons|0|||
131823563|NCT03310619|474632967|FG006|Treatment Period|Other reasons|0|||
131823564|NCT03310619|474632968|FG007|Treatment Period|Other reasons|0|||
131823565|NCT00152516|474632969|FG000|Overall Study|Adverse Event|18|||
131823566|NCT00152516|474632969|FG000|Overall Study|Lack and Loss of Efficacy|30|||
131823567|NCT00152516|474632969|FG000|Overall Study|Lost to Follow-up|5|||
131823568|NCT00152516|474632969|FG000|Overall Study|Withdrawal by Subject|8|||
131823569|NCT00152516|474632969|FG000|Overall Study|Protocol Violation|3|||
131823570|NCT00152516|474632969|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
131823571|NCT00152516|474632969|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
131823572|NCT00152516|474632969|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
131823573|NCT00152516|474632969|FG000|Overall Study|Other: Non-Compliance|2|||
131823574|NCT00152516|474632969|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
131823575|NCT00152516|474632969|FG000|Overall Study|Other: Moved Out Of State|1|||
131823576|NCT00152516|474632969|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
131823577|NCT00152516|474632969|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
131823578|NCT00360490|474632970|FG000|Overall Study|Adverse Event|4|||
131823579|NCT00360490|474632971|FG001|Overall Study|Adverse Event|2|||
131823580|NCT00360490|474632970|FG000|Overall Study|Lost to Follow-up|2|||
131909999|NCT00171249|474958727|FG005|Overall Study|Lost to Follow-up|0|||
131823581|NCT00360490|474632971|FG001|Overall Study|Lost to Follow-up|1|||
131823582|NCT00360490|474632970|FG000|Overall Study|Physician Decision|2|||
131823583|NCT00360490|474632971|FG001|Overall Study|Physician Decision|1|||
131823584|NCT00360490|474632970|FG000|Overall Study|Protocol Violation|0|||
131823585|NCT00360490|474632971|FG001|Overall Study|Protocol Violation|4|||
131823586|NCT00360490|474632970|FG000|Overall Study|Withdrawal by Subject|1|||
131823587|NCT00360490|474632971|FG001|Overall Study|Withdrawal by Subject|3|||
131823588|NCT01517867|474632973|FG000|Overall Study|never started treatment|29|||
131823589|NCT01517867|474632974|FG001|Overall Study|never started treatment|32|||
131823590|NCT01517867|474632973|FG000|Overall Study|Withdrawal by Subject|34|||
131823591|NCT01517867|474632974|FG001|Overall Study|Withdrawal by Subject|30|||
131823592|NCT01517867|474632973|FG000|Overall Study|Still in treatment at study end|0|||
131823593|NCT01517867|474632974|FG001|Overall Study|Still in treatment at study end|3|||
131823594|NCT01266603|474632976|FG000|Overall Study|Adverse Event|1|||
131823595|NCT01266603|474632976|FG000|Overall Study|Lack of Efficacy|14|||
131823596|NCT01266603|474632976|FG000|Overall Study|Withdrawal by Subject|1|||
131823597|NCT01266603|474632976|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
131823598|NCT01924364|474632977|FG000|Overall Study|Physician Decision|3|||
131823599|NCT02654015|474632978|FG000|Overall Study|Death|12|||
131823600|NCT02654015|474632978|FG000|Overall Study|Lost to Follow-up|3|||
131823601|NCT02466386|474632981|FG000|Overall Study|Adverse Event|5|||
131823602|NCT02466386|474632981|FG000|Overall Study|Protocol Violation|2|||
131823603|NCT02466386|474632981|FG000|Overall Study|Withdrawal by Subject|14|||
131823604|NCT02466386|474632981|FG000|Overall Study|Lost to Follow-up|5|||
131823605|NCT02466386|474632981|FG000|Overall Study|Lack of Efficacy|8|||
131823606|NCT02466386|474632981|FG000|Overall Study|Other|10|||
131823607|NCT03259789|474632982|FG000|Overall Study|Adverse Event|3|||
131823608|NCT03259789|474632983|FG001|Overall Study|Adverse Event|2|||
131823609|NCT03259789|474632984|FG002|Overall Study|Adverse Event|1|||
131823610|NCT03259789|474632982|FG000|Overall Study|Withdrawal by Subject|9|||
131823611|NCT03259789|474632983|FG001|Overall Study|Withdrawal by Subject|5|||
131823612|NCT03259789|474632984|FG002|Overall Study|Withdrawal by Subject|1|||
131823613|NCT03259789|474632982|FG000|Overall Study|Lost to Follow-up|5|||
131823614|NCT03259789|474632983|FG001|Overall Study|Lost to Follow-up|9|||
131823615|NCT03259789|474632984|FG002|Overall Study|Lost to Follow-up|4|||
131823616|NCT03259789|474632982|FG000|Overall Study|Physician Decision|0|||
131823617|NCT03259789|474632983|FG001|Overall Study|Physician Decision|1|||
131823618|NCT03259789|474632984|FG002|Overall Study|Physician Decision|0|||
131823619|NCT02832167|474634755|FG000|Treatment Period 1|Disease progression|90|||
131823620|NCT02832167|474634755|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
131823621|NCT02832167|474634755|FG000|Treatment Period 1|Death|2|||
131823622|NCT02832167|474634755|FG000|Treatment Period 1|Study Drug Toxicity|6|||
131823623|NCT02832167|474634755|FG000|Treatment Period 1|Participant request to discontinue|9|||
131823624|NCT02832167|474634755|FG000|Treatment Period 1|No longer meet study criteria|1|||
131823625|NCT02832167|474634755|FG000|Treatment Period 1|Participant withdrew consent|3|||
131823626|NCT02832167|474634755|FG000|Treatment Period 1|Other reasons|6|||
131823627|NCT02832167|474634755|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
131823628|NCT02832167|474634755|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
131823629|NCT02832167|474634755|FG000|Transition From Period 1 to Period 2|Death|2|||
131401112|NCT02589665|473091465|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131823630|NCT02832167|474634755|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
131823631|NCT02832167|474634755|FG000|Treatment Period 2|Disease progression|69|||
131823632|NCT02832167|474634755|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
131823633|NCT02832167|474634755|FG000|Treatment Period 2|Maximum clinical benefit|1|||
131823634|NCT02832167|474634755|FG000|Treatment Period 2|Study Drug Toxicity|5|||
131823635|NCT02832167|474634755|FG000|Treatment Period 2|Participant request to discontinue|2|||
131823636|NCT02832167|474634755|FG000|Treatment Period 2|Participant withdrew consent|3|||
131823637|NCT02832167|474634755|FG000|Treatment Period 2|Other reasons|3|||
131823638|NCT00224484|474634756|FG000|Overall Study|Serious Adverse Event|1|||
131823639|NCT00224484|474634757|FG001|Overall Study|Serious Adverse Event|1|||
131823640|NCT00224484|474634758|FG002|Overall Study|Serious Adverse Event|0|||
131823641|NCT00224484|474634756|FG000|Overall Study|Non-Serious Adverse Event|5|||
131823642|NCT00224484|474634757|FG001|Overall Study|Non-Serious Adverse Event|7|||
131823643|NCT00224484|474634758|FG002|Overall Study|Non-Serious Adverse Event|3|||
131823644|NCT00224484|474634756|FG000|Overall Study|Protocol Violation|2|||
131823645|NCT00224484|474634757|FG001|Overall Study|Protocol Violation|2|||
131823646|NCT00224484|474634758|FG002|Overall Study|Protocol Violation|0|||
131823647|NCT00224484|474634756|FG000|Overall Study|Withdrawal by Subject|49|||
131823648|NCT00224484|474634757|FG001|Overall Study|Withdrawal by Subject|18|||
131823649|NCT00224484|474634758|FG002|Overall Study|Withdrawal by Subject|16|||
131823650|NCT00224484|474634756|FG000|Overall Study|Migrated/moved from study area|18|||
131823651|NCT00224484|474634757|FG001|Overall Study|Migrated/moved from study area|5|||
131823652|NCT00224484|474634758|FG002|Overall Study|Migrated/moved from study area|5|||
131823653|NCT00224484|474634756|FG000|Overall Study|Lost to Follow-up|66|||
131823654|NCT00224484|474634757|FG001|Overall Study|Lost to Follow-up|28|||
131823655|NCT00224484|474634758|FG002|Overall Study|Lost to Follow-up|36|||
131823656|NCT00224484|474634756|FG000|Overall Study|Reason not specified|5|||
131823657|NCT00224484|474634757|FG001|Overall Study|Reason not specified|4|||
131823658|NCT00224484|474634758|FG002|Overall Study|Reason not specified|2|||
131401113|NCT02589665|473091456|FG000|Maintenance Period|Withdrawal by Subject|0|||
131823659|NCT04633642|474634759|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
131823660|NCT04633642|474634760|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
131823661|NCT03223909|474634761|FG000|Overall Study|Protocol Violation|48|||
131823662|NCT03223909|474634762|FG001|Overall Study|Protocol Violation|45|||
131823663|NCT03223909|474634763|FG002|Overall Study|Protocol Violation|16|||
131823664|NCT00177164|474634765|FG000|Overall Study|Protocol Violation|0|||
131823665|NCT00177164|474634766|FG001|Overall Study|Protocol Violation|7|||
131823666|NCT00177164|474634765|FG000|Overall Study|Lost to Follow-up|4|||
131823667|NCT00177164|474634766|FG001|Overall Study|Lost to Follow-up|5|||
131823668|NCT00177164|474634765|FG000|Overall Study|increase in alcohol and drug use|1|||
131823669|NCT00177164|474634766|FG001|Overall Study|increase in alcohol and drug use|2|||
131823670|NCT00177164|474634765|FG000|Overall Study|Adverse Event|1|||
131823671|NCT00177164|474634766|FG001|Overall Study|Adverse Event|0|||
131823672|NCT00177164|474634765|FG000|Overall Study|discharge from hospital|1|||
131823673|NCT00177164|474634766|FG001|Overall Study|discharge from hospital|0|||
131823674|NCT00177164|474634765|FG000|Overall Study|Lack of Efficacy|2|||
131823675|NCT00177164|474634766|FG001|Overall Study|Lack of Efficacy|1|||
131823676|NCT00177164|474634765|FG000|Overall Study|Pregnancy|0|||
131823677|NCT00177164|474634766|FG001|Overall Study|Pregnancy|1|||
131823678|NCT00965757|474634767|FG000|Double-blind Phase|Progression of concomitant disease|1|||
131823679|NCT00965757|474634768|FG001|Double-blind Phase|Progression of concomitant disease|2|||
131823680|NCT00965757|474634769|FG002|Double-blind Phase|Progression of concomitant disease|0|||
131823681|NCT00965757|474634770|FG003|Double-blind Phase|Progression of concomitant disease|0|||
131823682|NCT00965757|474634767|FG000|Double-blind Phase|Adverse drug reaction|2|||
131823683|NCT00965757|474634768|FG001|Double-blind Phase|Adverse drug reaction|1|||
131823684|NCT00965757|474634769|FG002|Double-blind Phase|Adverse drug reaction|0|||
131823685|NCT00965757|474634770|FG003|Double-blind Phase|Adverse drug reaction|0|||
131823686|NCT00965757|474634767|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
131823687|NCT00965757|474634768|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
131823688|NCT00965757|474634769|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
131823689|NCT00965757|474634770|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
131823690|NCT00965757|474634767|FG000|Double-blind Phase|Lack of Efficacy|7|||
131823691|NCT00965757|474634768|FG001|Double-blind Phase|Lack of Efficacy|11|||
131823692|NCT00965757|474634769|FG002|Double-blind Phase|Lack of Efficacy|0|||
131823693|NCT00965757|474634770|FG003|Double-blind Phase|Lack of Efficacy|0|||
131823694|NCT00965757|474634767|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
131823695|NCT00965757|474634768|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
131823696|NCT00965757|474634769|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
131823697|NCT00965757|474634770|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
131823698|NCT00965757|474634767|FG000|Double-blind Phase|Lost to Follow-up|0|||
131823699|NCT00965757|474634768|FG001|Double-blind Phase|Lost to Follow-up|1|||
131823700|NCT00965757|474634769|FG002|Double-blind Phase|Lost to Follow-up|0|||
131823701|NCT00965757|474634770|FG003|Double-blind Phase|Lost to Follow-up|0|||
131823702|NCT00965757|474634767|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
131823703|NCT00965757|474634768|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
131823704|NCT00965757|474634769|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
131823705|NCT00965757|474634770|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
131823706|NCT00965757|474634767|FG000|Double-blind Phase|Other|1|||
131823707|NCT00965757|474634768|FG001|Double-blind Phase|Other|0|||
131823708|NCT00965757|474634769|FG002|Double-blind Phase|Other|0|||
131823709|NCT00965757|474634770|FG003|Double-blind Phase|Other|0|||
131823710|NCT00965757|474634767|FG000|Extension Phase|Progression of concomitant disease|0|||
131823711|NCT00965757|474634768|FG001|Extension Phase|Progression of concomitant disease|0|||
131823712|NCT00965757|474634769|FG002|Extension Phase|Progression of concomitant disease|4|||
131823713|NCT00965757|474634770|FG003|Extension Phase|Progression of concomitant disease|2|||
131823714|NCT00965757|474634767|FG000|Extension Phase|Adverse drug reaction|0|||
131823715|NCT00965757|474634768|FG001|Extension Phase|Adverse drug reaction|0|||
131823716|NCT00965757|474634769|FG002|Extension Phase|Adverse drug reaction|6|||
131823717|NCT00965757|474634770|FG003|Extension Phase|Adverse drug reaction|3|||
131823718|NCT00965757|474634767|FG000|Extension Phase|Abnormal Laboratory Value|0|||
131823719|NCT00965757|474634768|FG001|Extension Phase|Abnormal Laboratory Value|0|||
131823720|NCT00965757|474634769|FG002|Extension Phase|Abnormal Laboratory Value|6|||
131823721|NCT00965757|474634770|FG003|Extension Phase|Abnormal Laboratory Value|1|||
131823722|NCT00965757|474634767|FG000|Extension Phase|Lack of Efficacy|0|||
131823723|NCT00965757|474634768|FG001|Extension Phase|Lack of Efficacy|0|||
131823724|NCT00965757|474634769|FG002|Extension Phase|Lack of Efficacy|8|||
131823725|NCT00965757|474634770|FG003|Extension Phase|Lack of Efficacy|12|||
131823726|NCT00965757|474634767|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
131823727|NCT00965757|474634768|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
131823728|NCT00965757|474634769|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
131823729|NCT00965757|474634770|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
131823730|NCT00965757|474634767|FG000|Extension Phase|Lost to Follow-up|0|||
131823731|NCT00965757|474634768|FG001|Extension Phase|Lost to Follow-up|0|||
131823732|NCT00965757|474634769|FG002|Extension Phase|Lost to Follow-up|0|||
131823733|NCT00965757|474634770|FG003|Extension Phase|Lost to Follow-up|1|||
131823734|NCT00965757|474634767|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
131401114|NCT02589665|473091457|FG001|Maintenance Period|Withdrawal by Subject|0|||
131401115|NCT02589665|473091458|FG002|Maintenance Period|Withdrawal by Subject|0|||
131401116|NCT02589665|473091459|FG003|Maintenance Period|Withdrawal by Subject|0|||
131401117|NCT02589665|473091460|FG004|Maintenance Period|Withdrawal by Subject|4|||
131401118|NCT02589665|473091461|FG005|Maintenance Period|Withdrawal by Subject|2|||
131823735|NCT00965757|474634768|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
131823736|NCT00965757|474634769|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
131823737|NCT00965757|474634770|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
131823738|NCT00965757|474634767|FG000|Extension Phase|Protocol Violation|0|||
131823739|NCT00965757|474634768|FG001|Extension Phase|Protocol Violation|0|||
131823740|NCT00965757|474634769|FG002|Extension Phase|Protocol Violation|0|||
131823741|NCT00965757|474634770|FG003|Extension Phase|Protocol Violation|1|||
131823742|NCT00965757|474634767|FG000|Extension Phase|Other|0|||
131823743|NCT00965757|474634768|FG001|Extension Phase|Other|0|||
131823744|NCT00965757|474634769|FG002|Extension Phase|Other|2|||
131823745|NCT00965757|474634770|FG003|Extension Phase|Other|1|||
131823746|NCT01344018|474634776|FG000|Overall Study|Death|22|||
131823747|NCT01344018|474634777|FG001|Overall Study|Death|25|||
131823748|NCT01344018|474634776|FG000|Overall Study|Lost to Follow-up|4|||
131823749|NCT01344018|474634777|FG001|Overall Study|Lost to Follow-up|7|||
131823750|NCT05070754|474634778|FG000|Overall Study|Withdrawal by Subject|0|||
131823751|NCT05070754|474634779|FG001|Overall Study|Withdrawal by Subject|0|||
131823752|NCT05070754|474634780|FG002|Overall Study|Withdrawal by Subject|0|||
131823753|NCT05070754|474634781|FG003|Overall Study|Withdrawal by Subject|1|||
131823754|NCT05070754|474634778|FG000|Overall Study|Protocol Violation|0|||
131823755|NCT05070754|474634779|FG001|Overall Study|Protocol Violation|0|||
131823756|NCT05070754|474634780|FG002|Overall Study|Protocol Violation|0|||
131823757|NCT05070754|474634781|FG003|Overall Study|Protocol Violation|1|||
131823758|NCT01398787|474634782|FG000|Overall Study|Adverse Event|1|||
131823759|NCT02351167|474634783|FG000|Overall Study|Withdrawal by Subject|19|||
131823760|NCT02351167|474634784|FG001|Overall Study|Withdrawal by Subject|18|||
131823761|NCT02351167|474634785|FG002|Overall Study|Withdrawal by Subject|21|||
131823762|NCT00668395|474634788|FG000|Overall Study|Withdrawal by Subject|4|||
131823763|NCT00668395|474634789|FG001|Overall Study|Withdrawal by Subject|4|||
131823764|NCT00668395|474634790|FG002|Overall Study|Withdrawal by Subject|1|||
131823765|NCT00668395|474634788|FG000|Overall Study|Adverse Event|1|||
131823766|NCT00668395|474634789|FG001|Overall Study|Adverse Event|1|||
131823767|NCT00668395|474634790|FG002|Overall Study|Adverse Event|0|||
131823768|NCT00668395|474634788|FG000|Overall Study|Physician Decision|1|||
131823769|NCT00668395|474634789|FG001|Overall Study|Physician Decision|1|||
131823770|NCT00668395|474634790|FG002|Overall Study|Physician Decision|0|||
131823771|NCT02858037|474634793|FG000|Overall Study|Death|1|||
131823772|NCT02858037|474634793|FG000|Overall Study|Withdrawal by Subject|18|||
131823773|NCT02858037|474634793|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
131823774|NCT02858037|474634793|FG000|Overall Study|Lost to Follow-up|3|||
131823775|NCT02858037|474634793|FG000|Overall Study|Other|4|||
131823776|NCT02050321|474634798|FG000|Overall Study|Withdrawal by Subject|1|||
131823777|NCT02050321|474634798|FG000|Overall Study|Adverse Event|1|||
131823778|NCT00113919|474634799|FG000|Overall Study|Physician Decision|8|||
131823779|NCT00113919|474634799|FG000|Overall Study|Death|6|||
131823780|NCT00715676|474634800|FG000|Overall Study|Adverse Event|3|||
131823781|NCT00715676|474634801|FG001|Overall Study|Adverse Event|5|||
131823782|NCT00715676|474634802|FG002|Overall Study|Adverse Event|21|||
131823783|NCT00715676|474634800|FG000|Overall Study|Withdrawal by Subject|1|||
131823784|NCT00715676|474634801|FG001|Overall Study|Withdrawal by Subject|3|||
131823785|NCT00715676|474634802|FG002|Overall Study|Withdrawal by Subject|8|||
131823786|NCT00715676|474634800|FG000|Overall Study|Lost to Follow-up|1|||
131823787|NCT00715676|474634801|FG001|Overall Study|Lost to Follow-up|2|||
131823788|NCT00715676|474634802|FG002|Overall Study|Lost to Follow-up|1|||
131823789|NCT00715676|474634800|FG000|Overall Study|Terminated by Sponsor|1|||
131823790|NCT00715676|474634801|FG001|Overall Study|Terminated by Sponsor|0|||
131823791|NCT00715676|474634802|FG002|Overall Study|Terminated by Sponsor|0|||
131823792|NCT00715676|474634800|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
131401119|NCT02589665|473091462|FG006|Maintenance Period|Withdrawal by Subject|4|||
131401120|NCT02589665|473091463|FG007|Maintenance Period|Withdrawal by Subject|0|||
131401121|NCT02589665|473091464|FG008|Maintenance Period|Withdrawal by Subject|0|||
131823793|NCT00715676|474634801|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
131823794|NCT00715676|474634802|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
131823795|NCT00715676|474634800|FG000|Overall Study|Use of Exclusionary Medication|0|||
131823796|NCT00715676|474634801|FG001|Overall Study|Use of Exclusionary Medication|0|||
131823797|NCT00715676|474634802|FG002|Overall Study|Use of Exclusionary Medication|1|||
131823798|NCT00715676|474634800|FG000|Overall Study|Elevated Blood Glucose|0|||
131823799|NCT00715676|474634801|FG001|Overall Study|Elevated Blood Glucose|1|||
131823800|NCT00715676|474634802|FG002|Overall Study|Elevated Blood Glucose|0|||
131823801|NCT02005276|474634803|FG000|Overall Study|No longer interested|5|||
131823802|NCT02005276|474634804|FG001|Overall Study|No longer interested|2|||
131401122|NCT02589665|473091465|FG009|Maintenance Period|Withdrawal by Subject|0|||
131823803|NCT02005276|474634805|FG002|Overall Study|No longer interested|3|||
131823804|NCT02005276|474634806|FG003|Overall Study|No longer interested|3|||
131823805|NCT00372996|474634807|FG000|Overall Study|Death|11|||
131823806|NCT00372996|474634808|FG001|Overall Study|Death|4|||
131823807|NCT00372996|474634809|FG002|Overall Study|Death|8|||
131823808|NCT00372996|474634810|FG003|Overall Study|Death|7|||
131823809|NCT00372996|474634807|FG000|Overall Study|Lost to Follow-up|0|||
131823810|NCT00372996|474634808|FG001|Overall Study|Lost to Follow-up|2|||
131823811|NCT00372996|474634809|FG002|Overall Study|Lost to Follow-up|0|||
131823812|NCT00372996|474634810|FG003|Overall Study|Lost to Follow-up|1|||
131823813|NCT00372996|474634807|FG000|Overall Study|Withdrawal by Subject|12|||
131823814|NCT00372996|474634808|FG001|Overall Study|Withdrawal by Subject|6|||
131823815|NCT00372996|474634809|FG002|Overall Study|Withdrawal by Subject|9|||
131823816|NCT00372996|474634810|FG003|Overall Study|Withdrawal by Subject|5|||
131823817|NCT00372996|474634807|FG000|Overall Study|Study Terminated by Sponsor|4|||
131823818|NCT00372996|474634808|FG001|Overall Study|Study Terminated by Sponsor|0|||
131823819|NCT00372996|474634809|FG002|Overall Study|Study Terminated by Sponsor|4|||
131823820|NCT00372996|474634810|FG003|Overall Study|Study Terminated by Sponsor|0|||
131823821|NCT00372996|474634807|FG000|Overall Study|Other|10|||
131823822|NCT00372996|474634808|FG001|Overall Study|Other|2|||
131823823|NCT00372996|474634809|FG002|Overall Study|Other|7|||
131823824|NCT00372996|474634810|FG003|Overall Study|Other|7|||
131823825|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
131823826|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
131823827|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
131823828|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
131823829|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
131823830|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
131823831|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
131823832|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
131823833|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
131823834|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
131823835|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
131823836|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
131823837|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
131823838|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
131823839|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
131823840|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
131823841|NCT01067521|474634812|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
131823842|NCT01067521|474634813|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
131823843|NCT01067521|474634812|FG000|Open-Label Period|Death|3|||
131823844|NCT01067521|474634813|FG001|Open-Label Period|Death|1|||
131823845|NCT01067521|474634812|FG000|Open-Label Period|Adverse Event|30|||
131823846|NCT01067521|474634813|FG001|Open-Label Period|Adverse Event|28|||
131823847|NCT01067521|474634812|FG000|Open-Label Period|Withdrawal by Subject|160|||
131823848|NCT01067521|474634813|FG001|Open-Label Period|Withdrawal by Subject|88|||
131823849|NCT01067521|474634812|FG000|Open-Label Period|Physician Decision|13|||
131823850|NCT01067521|474634813|FG001|Open-Label Period|Physician Decision|11|||
131823851|NCT01067521|474634812|FG000|Open-Label Period|Non-compliance with study drug|5|||
131823852|NCT01067521|474634813|FG001|Open-Label Period|Non-compliance with study drug|0|||
131823853|NCT01067521|474634812|FG000|Open-Label Period|Protocol Violation|3|||
131823854|NCT01067521|474634813|FG001|Open-Label Period|Protocol Violation|0|||
131823855|NCT01067521|474634812|FG000|Open-Label Period|Pregnancy|14|||
131823856|NCT01067521|474634813|FG001|Open-Label Period|Pregnancy|8|||
131823857|NCT01067521|474634812|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
131823858|NCT01067521|474634813|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
131823859|NCT01067521|474634812|FG000|Open-Label Period|Lost to Follow-up|21|||
131823860|NCT01067521|474634813|FG001|Open-Label Period|Lost to Follow-up|20|||
131823861|NCT03419962|474634815|FG000|Overall Study|Change to other medication|1|||
131823862|NCT03419962|474634815|FG000|Overall Study|Refusal of continuing with trial drug|1|||
131823863|NCT03419962|474634815|FG000|Overall Study|Lost to Follow-up|3|||
131823864|NCT03419962|474634815|FG000|Overall Study|Difficulty in inhaling the doses|1|||
131823865|NCT03419962|474634815|FG000|Overall Study|Missing completion data|31|||
131823866|NCT01849458|474634818|FG000|Overall Study|Lost to Follow-up|4|||
131823867|NCT01781234|474634819|FG000|Overall Study|Adverse Event|2|||
131823868|NCT01781234|474634820|FG001|Overall Study|Adverse Event|0|||
131823869|NCT01781234|474634819|FG000|Overall Study|Protocol Violation|3|||
131823870|NCT01781234|474634820|FG001|Overall Study|Protocol Violation|0|||
131823871|NCT01781234|474634819|FG000|Overall Study|Withdrawal by Subject|4|||
131823872|NCT01781234|474634820|FG001|Overall Study|Withdrawal by Subject|3|||
131823873|NCT03439085|474634821|FG000|Overall Study|Death|2|||
131823874|NCT03439085|474634821|FG000|Overall Study|Screen Failure|20|||
131823875|NCT01863433|474634822|FG000|Overall Study|Protocol Violation|1|||
131823876|NCT02661022|474634825|FG000|Overall Study|Withdrawal by Subject|3|||
131823877|NCT02661022|474634826|FG001|Overall Study|Withdrawal by Subject|0|||
131823878|NCT02661022|474634825|FG000|Overall Study|Adverse Event|1|||
131823879|NCT02661022|474634826|FG001|Overall Study|Adverse Event|1|||
131823880|NCT02661022|474634825|FG000|Overall Study|Physician Decision|1|||
131823881|NCT02661022|474634826|FG001|Overall Study|Physician Decision|0|||
131823882|NCT02661022|474634825|FG000|Overall Study|Progressive Disease|2|||
131823883|NCT02661022|474634826|FG001|Overall Study|Progressive Disease|1|||
131823884|NCT05889039|474634827|FG000|Overall Study|error in completing survey|0|||
131823885|NCT05889039|474634828|FG001|Overall Study|error in completing survey|2|||
131823886|NCT05889039|474634829|FG002|Overall Study|error in completing survey|0|||
131823887|NCT05889039|474634830|FG003|Overall Study|error in completing survey|0|||
131823888|NCT05889039|474634827|FG000|Overall Study|Lost to Follow-up|4|||
131823889|NCT05889039|474634828|FG001|Overall Study|Lost to Follow-up|0|||
131823890|NCT05889039|474634829|FG002|Overall Study|Lost to Follow-up|0|||
131823891|NCT05889039|474634830|FG003|Overall Study|Lost to Follow-up|0|||
131823892|NCT01785615|474634838|FG000|Dietary Phase|Lost to Follow-up|0|||
131823893|NCT01785615|474634839|FG001|Dietary Phase|Lost to Follow-up|0|||
131823894|NCT01785615|474634840|FG002|Dietary Phase|Lost to Follow-up|0|||
131823895|NCT01785615|474634841|FG003|Dietary Phase|Lost to Follow-up|24|||
131823896|NCT01881737|474634842|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
131823897|NCT01881737|474634842|FG000|Overall Study|Withdrawal by Subject|1|||
131823898|NCT01881737|474634842|FG000|Overall Study|Worsening of baseline behavior|1|||
131823899|NCT02250651|474634853|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
131823900|NCT02250651|474634854|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
131823901|NCT02250651|474634855|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
131823902|NCT02250651|474634853|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
131823903|NCT02250651|474634854|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
131823904|NCT02250651|474634855|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
131823905|NCT02250651|474634853|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
131823906|NCT02250651|474634854|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
131823907|NCT02250651|474634855|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
131823908|NCT02250651|474634853|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
131823909|NCT02250651|474634854|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
131823910|NCT02250651|474634855|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
131823911|NCT02250651|474634853|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
131823912|NCT02250651|474634854|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
131823913|NCT02250651|474634855|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
131823914|NCT02250651|474634853|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
131823915|NCT02250651|474634854|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
131823916|NCT02250651|474634855|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
131823917|NCT02250651|474634853|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
131823918|NCT02250651|474634854|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
131823919|NCT02250651|474634855|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
131823920|NCT02250651|474634853|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
131823921|NCT02250651|474634854|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
131823922|NCT02250651|474634855|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
131823923|NCT02250651|474634853|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
131823924|NCT02250651|474634854|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
131823925|NCT02250651|474634855|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
131823926|NCT02250651|474634853|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
131823927|NCT02250651|474634854|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
131823928|NCT02250651|474634855|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
131823929|NCT02250651|474634853|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
131823930|NCT02250651|474634854|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
131823931|NCT02250651|474634855|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
131823932|NCT02250651|474634853|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
131823933|NCT02250651|474634854|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
131823934|NCT02250651|474634855|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
131823935|NCT02250651|474634853|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
131823936|NCT02250651|474634854|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
131823937|NCT02250651|474634855|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
131823938|NCT02250651|474634853|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
131823939|NCT02250651|474634854|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
131823940|NCT02250651|474634855|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
131823941|NCT02250651|474634853|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
131823942|NCT02250651|474634854|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
131823943|NCT02250651|474634855|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
131823944|NCT03496298|474634856|FG000|Overall Study|Adverse Event|49|||
131823945|NCT03496298|474634857|FG001|Overall Study|Adverse Event|68|||
131823946|NCT03496298|474634858|FG002|Overall Study|Adverse Event|79|||
131823947|NCT03496298|474634856|FG000|Overall Study|Study terminated by Sponsor|1050|||
131823948|NCT03496298|474634857|FG001|Overall Study|Study terminated by Sponsor|1063|||
131823949|NCT03496298|474634858|FG002|Overall Study|Study terminated by Sponsor|1071|||
131823950|NCT03496298|474634856|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
131823951|NCT03496298|474634857|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
131823952|NCT03496298|474634858|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
131823953|NCT03496298|474634856|FG000|Overall Study|Withdrawal by Subject|176|||
131823954|NCT03496298|474634857|FG001|Overall Study|Withdrawal by Subject|154|||
131823955|NCT03496298|474634858|FG002|Overall Study|Withdrawal by Subject|151|||
131823956|NCT03496298|474634856|FG000|Overall Study|Other|29|||
131823957|NCT03496298|474634857|FG001|Overall Study|Other|20|||
131823958|NCT03496298|474634858|FG002|Overall Study|Other|23|||
131823959|NCT03496298|474634856|FG000|Overall Study|Randomized and not treated|1|||
131823960|NCT03496298|474634857|FG001|Overall Study|Randomized and not treated|1|||
131823961|NCT03496298|474634858|FG002|Overall Study|Randomized and not treated|1|||
131823962|NCT02289820|474634865|FG000|Overall Study|Withdrawal by Subject|2|||
131823963|NCT02289820|474634866|FG001|Overall Study|Withdrawal by Subject|1|||
131823964|NCT02289820|474634867|FG002|Overall Study|Withdrawal by Subject|2|||
131823965|NCT02289820|474634868|FG003|Overall Study|Withdrawal by Subject|1|||
131823966|NCT02289820|474634869|FG004|Overall Study|Withdrawal by Subject|0|||
131823967|NCT02289820|474634870|FG005|Overall Study|Withdrawal by Subject|0|||
131823968|NCT02289820|474634871|FG006|Overall Study|Withdrawal by Subject|1|||
131823969|NCT02289820|474634865|FG000|Overall Study|Death|0|||
131823970|NCT02289820|474634866|FG001|Overall Study|Death|0|||
131823971|NCT02289820|474634867|FG002|Overall Study|Death|1|||
131823972|NCT02289820|474634868|FG003|Overall Study|Death|0|||
131823973|NCT02289820|474634869|FG004|Overall Study|Death|0|||
131823974|NCT02289820|474634870|FG005|Overall Study|Death|0|||
131823975|NCT02289820|474634871|FG006|Overall Study|Death|0|||
131823976|NCT02289820|474634865|FG000|Overall Study|Lost to Follow-up|0|||
131823977|NCT02289820|474634866|FG001|Overall Study|Lost to Follow-up|0|||
131823978|NCT02289820|474634867|FG002|Overall Study|Lost to Follow-up|3|||
131823979|NCT02289820|474634868|FG003|Overall Study|Lost to Follow-up|1|||
131823980|NCT02289820|474634869|FG004|Overall Study|Lost to Follow-up|0|||
131823981|NCT02289820|474634870|FG005|Overall Study|Lost to Follow-up|1|||
131823982|NCT02289820|474634871|FG006|Overall Study|Lost to Follow-up|1|||
131823983|NCT02289820|474634865|FG000|Overall Study|withdrawal of consent|0|||
131823984|NCT02289820|474634866|FG001|Overall Study|withdrawal of consent|1|||
131823985|NCT02289820|474634867|FG002|Overall Study|withdrawal of consent|0|||
131823986|NCT02289820|474634868|FG003|Overall Study|withdrawal of consent|0|||
131823987|NCT02289820|474634869|FG004|Overall Study|withdrawal of consent|0|||
131823988|NCT02289820|474634870|FG005|Overall Study|withdrawal of consent|0|||
131823989|NCT02289820|474634871|FG006|Overall Study|withdrawal of consent|0|||
131823990|NCT00926367|474634872|FG000|Overall Study|Withdrawal by Subject|0|||
131823991|NCT00926367|474634873|FG001|Overall Study|Withdrawal by Subject|1|||
131823992|NCT00926367|474634872|FG000|Overall Study|Lost to Follow-up|1|||
131823993|NCT00926367|474634873|FG001|Overall Study|Lost to Follow-up|0|||
131823994|NCT00926367|474634872|FG000|Overall Study|Skin Irritation|1|||
131823995|NCT00926367|474634873|FG001|Overall Study|Skin Irritation|2|||
131823996|NCT03294317|474634874|FG000|Overall Study|Physician Decision|1|||
131823997|NCT03294317|474634874|FG000|Overall Study|Withdrawal by Subject|6|||
131823998|NCT03294317|474634874|FG000|Overall Study|Lost to Follow-up|1|||
131823999|NCT03294317|474634874|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
131824000|NCT03294317|474634874|FG000|Overall Study|Failed HB lead implant|8|||
131824001|NCT03294317|474634874|FG000|Overall Study|Received CRT instead|1|||
131824002|NCT03294317|474634874|FG000|Overall Study|Exited after lead revision|2|||
131824003|NCT02725411|474634881|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
131824004|NCT02725411|474634882|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
131824005|NCT02725411|474634883|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
131824006|NCT02725411|474634881|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
131824007|NCT02725411|474634882|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
131824008|NCT02725411|474634883|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
131824009|NCT02725411|474634881|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
131824010|NCT02725411|474634882|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
131824011|NCT02725411|474634883|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
131824012|NCT02725411|474634881|FG000|Treatment Period (56 Weeks)|Other|1|||
131824013|NCT02725411|474634882|FG001|Treatment Period (56 Weeks)|Other|4|||
131824014|NCT02725411|474634883|FG002|Treatment Period (56 Weeks)|Other|5|||
131824015|NCT02725411|474634881|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
131824016|NCT02725411|474634882|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
131824017|NCT02725411|474634883|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
131824018|NCT02725411|474634881|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
131824019|NCT02725411|474634882|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
131824020|NCT02725411|474634883|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
131824021|NCT02725411|474634881|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
131824022|NCT02725411|474634882|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
131824023|NCT02725411|474634883|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
131824024|NCT02725411|474634881|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
131824025|NCT02725411|474634882|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
131824026|NCT02725411|474634883|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
131824027|NCT02725411|474634881|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
131824028|NCT02725411|474634882|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
131824029|NCT02725411|474634883|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
131824030|NCT02725411|474634881|FG000|Follow-up Period (24 Weeks)|Other|1|||
131824031|NCT02725411|474634882|FG001|Follow-up Period (24 Weeks)|Other|4|||
131824032|NCT02725411|474634883|FG002|Follow-up Period (24 Weeks)|Other|2|||
131824033|NCT02725411|474634881|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
131824034|NCT02725411|474634882|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
131824035|NCT02725411|474634883|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
131824036|NCT02911935|474634884|FG000|Overall Study|Lost to Follow-up|5|||
131824037|NCT02911935|474634885|FG001|Overall Study|Lost to Follow-up|7|||
131824038|NCT00756717|474634886|FG000|Overall Study|Withdrawal by Subject|2|||
131824039|NCT04979858|474634887|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
131824040|NCT04979858|474634888|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
131824041|NCT01896505|474634889|FG000|Overall Study|Adverse Event|1|||
131824042|NCT01896505|474634890|FG001|Overall Study|Adverse Event|0|||
131824043|NCT01896505|474634891|FG002|Overall Study|Adverse Event|2|||
131824044|NCT01896505|474634892|FG003|Overall Study|Adverse Event|1|||
131824045|NCT01896505|474634893|FG004|Overall Study|Adverse Event|1|||
131824046|NCT01896505|474634894|FG005|Overall Study|Adverse Event|0|||
131824047|NCT01896505|474634889|FG000|Overall Study|Physician Decision|1|||
131824048|NCT01896505|474634890|FG001|Overall Study|Physician Decision|3|||
131824049|NCT01896505|474634891|FG002|Overall Study|Physician Decision|2|||
131824050|NCT01896505|474634892|FG003|Overall Study|Physician Decision|0|||
131824051|NCT01896505|474634893|FG004|Overall Study|Physician Decision|0|||
131824052|NCT01896505|474634894|FG005|Overall Study|Physician Decision|1|||
131824053|NCT01896505|474634889|FG000|Overall Study|Withdrawal by Subject|1|||
131824054|NCT01896505|474634890|FG001|Overall Study|Withdrawal by Subject|0|||
131824055|NCT01896505|474634891|FG002|Overall Study|Withdrawal by Subject|3|||
131824056|NCT01896505|474634892|FG003|Overall Study|Withdrawal by Subject|1|||
131824057|NCT01896505|474634893|FG004|Overall Study|Withdrawal by Subject|0|||
131824058|NCT01896505|474634894|FG005|Overall Study|Withdrawal by Subject|0|||
131824059|NCT01896505|474634889|FG000|Overall Study|Disease Progression|7|||
131824060|NCT01896505|474634890|FG001|Overall Study|Disease Progression|5|||
131824061|NCT01896505|474634891|FG002|Overall Study|Disease Progression|8|||
131824062|NCT01896505|474634892|FG003|Overall Study|Disease Progression|4|||
131824063|NCT01896505|474634893|FG004|Overall Study|Disease Progression|4|||
131824064|NCT01896505|474634894|FG005|Overall Study|Disease Progression|4|||
131824065|NCT01896505|474634889|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
131824066|NCT01896505|474634890|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
131824067|NCT01896505|474634891|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
131824068|NCT01896505|474634892|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
131824069|NCT01896505|474634893|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
131824070|NCT01896505|474634894|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
131824071|NCT01896505|474634889|FG000|Overall Study|Intercurrent illness|0|||
131824072|NCT01896505|474634890|FG001|Overall Study|Intercurrent illness|1|||
131824073|NCT01896505|474634891|FG002|Overall Study|Intercurrent illness|0|||
131824074|NCT01896505|474634892|FG003|Overall Study|Intercurrent illness|0|||
131824075|NCT01896505|474634893|FG004|Overall Study|Intercurrent illness|0|||
131824076|NCT01896505|474634894|FG005|Overall Study|Intercurrent illness|0|||
131824077|NCT01896505|474634889|FG000|Overall Study|Death|0|||
131824078|NCT01896505|474634890|FG001|Overall Study|Death|0|||
131824079|NCT01896505|474634891|FG002|Overall Study|Death|1|||
131824080|NCT01896505|474634892|FG003|Overall Study|Death|1|||
131910000|NCT00171249|474958728|FG006|Overall Study|Lost to Follow-up|0|||
131910001|NCT01041859|474958729|FG000|Open-Label Titration|Adverse Event|69|||
131910002|NCT01041859|474958730|FG001|Open-Label Titration|Adverse Event|0|||
131824081|NCT01896505|474634893|FG004|Overall Study|Death|0|||
131824082|NCT01896505|474634894|FG005|Overall Study|Death|1|||
131824083|NCT05317195|474634895|FG000|Randomization|Withdrawal by Subject|1|||
131824084|NCT05317195|474634895|FG000|Randomization|Discontinued|6|||
131824085|NCT05317195|474634895|FG000|Admission|Withdrawal by Subject|2|||
131824086|NCT02063217|474634896|FG000|Overall Study|Withdrawal by Subject|1|||
131824087|NCT02063217|474634897|FG001|Overall Study|Withdrawal by Subject|0|||
131824088|NCT02063217|474634898|FG002|Overall Study|Withdrawal by Subject|0|||
131824089|NCT00889252|474634899|FG000|Overall Study|Adverse Event|2|||
131824090|NCT00889252|474634900|FG001|Overall Study|Adverse Event|4|||
131824091|NCT00889252|474634899|FG000|Overall Study|Withdrawal by Subject|3|||
131824092|NCT00889252|474634900|FG001|Overall Study|Withdrawal by Subject|0|||
131824093|NCT00889252|474634899|FG000|Overall Study|Protocol Violation|2|||
131824094|NCT00889252|474634900|FG001|Overall Study|Protocol Violation|0|||
131824095|NCT02416934|474634901|FG000|Overall Study|given steroids|1|||
131824096|NCT02416934|474634902|FG001|Overall Study|given steroids|2|||
131824097|NCT02416934|474634901|FG000|Overall Study|Lost to Follow-up|0|||
131824098|NCT02416934|474634902|FG001|Overall Study|Lost to Follow-up|2|||
131824099|NCT02416934|474634901|FG000|Overall Study|Withdrawal by Subject|1|||
131824100|NCT02416934|474634902|FG001|Overall Study|Withdrawal by Subject|0|||
131824101|NCT02416934|474634901|FG000|Overall Study|recruited during continuing renewal proc|0|||
131824102|NCT02416934|474634902|FG001|Overall Study|recruited during continuing renewal proc|1|||
131824103|NCT02416934|474634901|FG000|Overall Study|Protocol Violation|0|||
131824104|NCT02416934|474634902|FG001|Overall Study|Protocol Violation|1|||
131824105|NCT02416934|474634901|FG000|Overall Study|surgery started late|0|||
131824106|NCT02416934|474634902|FG001|Overall Study|surgery started late|1|||
131824107|NCT02416934|474634901|FG000|Overall Study|re-operation|1|||
131824108|NCT02416934|474634902|FG001|Overall Study|re-operation|0|||
131824109|NCT01160640|474634906|FG000|Overall Study|Physician Decision|3|||
131824110|NCT01160640|474634907|FG001|Overall Study|Physician Decision|3|||
131824111|NCT01160640|474634906|FG000|Overall Study|Incarceration|1|||
131824112|NCT01160640|474634907|FG001|Overall Study|Incarceration|0|||
131824113|NCT01160640|474634906|FG000|Overall Study|Withdrawal by Subject|0|||
131824114|NCT01160640|474634907|FG001|Overall Study|Withdrawal by Subject|3|||
131824115|NCT02169336|474634908|FG000|Overall Study|Lack of Efficacy|1|||
131824116|NCT02169336|474634909|FG001|Overall Study|Lack of Efficacy|1|||
131824117|NCT02169336|474634910|FG002|Overall Study|Lack of Efficacy|0|||
131824118|NCT02169336|474634908|FG000|Overall Study|Adverse Event|2|||
131824119|NCT02169336|474634909|FG001|Overall Study|Adverse Event|3|||
131824120|NCT02169336|474634910|FG002|Overall Study|Adverse Event|1|||
131824121|NCT02169336|474634908|FG000|Overall Study|Withdrawal by Subject|1|||
131824122|NCT02169336|474634909|FG001|Overall Study|Withdrawal by Subject|0|||
131824123|NCT02169336|474634910|FG002|Overall Study|Withdrawal by Subject|0|||
131824124|NCT02169336|474634908|FG000|Overall Study|Physician Decision|0|||
131824125|NCT02169336|474634909|FG001|Overall Study|Physician Decision|0|||
131824126|NCT02169336|474634910|FG002|Overall Study|Physician Decision|1|||
131824127|NCT02169336|474634908|FG000|Overall Study|Subject declined to continue dosing|0|||
131824128|NCT02169336|474634909|FG001|Overall Study|Subject declined to continue dosing|0|||
131824129|NCT02169336|474634910|FG002|Overall Study|Subject declined to continue dosing|1|||
131824130|NCT03108820|474634912|FG000|Overall Study|Lost to Follow-up|30|||
131824131|NCT03108820|474634913|FG001|Overall Study|Lost to Follow-up|28|||
131824132|NCT03108820|474634912|FG000|Overall Study|Withdrawal by Subject|32|||
131824133|NCT03108820|474634913|FG001|Overall Study|Withdrawal by Subject|24|||
131824134|NCT03108820|474634912|FG000|Overall Study|Death|6|||
131824135|NCT03108820|474634913|FG001|Overall Study|Death|11|||
131824136|NCT00089973|474634917|FG000|Overall Study|Adverse Event|3|||
131824137|NCT00089973|474634917|FG000|Overall Study|Withdrawal by Subject|1|||
131824138|NCT00089973|474634917|FG000|Overall Study|Disease progression|45|||
131824139|NCT00089973|474634917|FG000|Overall Study|Death|1|||
131824140|NCT00965731|474634918|FG000|Overall Study|Death|0|||
131824141|NCT00965731|474634919|FG001|Overall Study|Death|4|||
131824142|NCT00965731|474634918|FG000|Overall Study|Withdrawal by Subject|0|||
131910003|NCT01041859|474958731|FG002|Open-Label Titration|Adverse Event|0|||
131824143|NCT00965731|474634919|FG001|Overall Study|Withdrawal by Subject|1|||
131824144|NCT00965731|474634918|FG000|Overall Study|Other|7|||
131824145|NCT00965731|474634919|FG001|Overall Study|Other|15|||
131824146|NCT01958060|474636602|FG000|Overall Study|Not treated|2|||
131910004|NCT01041859|474958729|FG000|Open-Label Titration|Lack of Efficacy|3|||
131910005|NCT01041859|474958730|FG001|Open-Label Titration|Lack of Efficacy|0|||
131910006|NCT01041859|474958731|FG002|Open-Label Titration|Lack of Efficacy|0|||
131910007|NCT01041859|474958729|FG000|Open-Label Titration|Lost to Follow-up|1|||
131824147|NCT01958060|474636603|FG001|Overall Study|Not treated|0|||
131824148|NCT01958060|474636604|FG002|Overall Study|Not treated|0|||
131824149|NCT01958060|474636605|FG003|Overall Study|Not treated|0|||
131824150|NCT01958060|474636606|FG004|Overall Study|Not treated|1|||
131824151|NCT01958060|474636607|FG005|Overall Study|Not treated|0|||
131824152|NCT01074008|474636612|FG000|Overall Study|Adverse Event|0|||
131824153|NCT01074008|474636613|FG001|Overall Study|Adverse Event|1|||
131824154|NCT01074008|474636614|FG002|Overall Study|Adverse Event|0|||
131824155|NCT01074008|474636615|FG003|Overall Study|Adverse Event|0|||
131910008|NCT01041859|474958730|FG001|Open-Label Titration|Lost to Follow-up|0|||
131824156|NCT01074008|474636616|FG004|Overall Study|Adverse Event|0|||
131824157|NCT01074008|474636617|FG005|Overall Study|Adverse Event|0|||
131824158|NCT01074008|474636618|FG006|Overall Study|Adverse Event|0|||
131824159|NCT01074008|474636619|FG007|Overall Study|Adverse Event|0|||
131824160|NCT01074008|474636620|FG008|Overall Study|Adverse Event|0|||
131824161|NCT01074008|474636612|FG000|Overall Study|Withdrawal by Subject|1|||
131824162|NCT01074008|474636613|FG001|Overall Study|Withdrawal by Subject|1|||
131824163|NCT01074008|474636614|FG002|Overall Study|Withdrawal by Subject|1|||
131824164|NCT01074008|474636615|FG003|Overall Study|Withdrawal by Subject|0|||
131824165|NCT01074008|474636616|FG004|Overall Study|Withdrawal by Subject|1|||
131824166|NCT01074008|474636617|FG005|Overall Study|Withdrawal by Subject|0|||
131824167|NCT01074008|474636618|FG006|Overall Study|Withdrawal by Subject|0|||
131824168|NCT01074008|474636619|FG007|Overall Study|Withdrawal by Subject|0|||
131824169|NCT01074008|474636620|FG008|Overall Study|Withdrawal by Subject|0|||
131824170|NCT01074008|474636612|FG000|Overall Study|Lost to Follow-up|0|||
131824171|NCT01074008|474636613|FG001|Overall Study|Lost to Follow-up|1|||
131824172|NCT01074008|474636614|FG002|Overall Study|Lost to Follow-up|1|||
131824173|NCT01074008|474636615|FG003|Overall Study|Lost to Follow-up|1|||
131824174|NCT01074008|474636616|FG004|Overall Study|Lost to Follow-up|1|||
131824175|NCT01074008|474636617|FG005|Overall Study|Lost to Follow-up|0|||
131824176|NCT01074008|474636618|FG006|Overall Study|Lost to Follow-up|1|||
131824177|NCT01074008|474636619|FG007|Overall Study|Lost to Follow-up|0|||
131824178|NCT01074008|474636620|FG008|Overall Study|Lost to Follow-up|4|||
131824179|NCT02805309|474636621|FG000|Overall Study|Lost to Follow-up|2|||
131824180|NCT02805309|474636622|FG001|Overall Study|Lost to Follow-up|2|||
131824181|NCT02805309|474636623|FG002|Overall Study|Lost to Follow-up|2|||
131824182|NCT02805309|474636621|FG000|Overall Study|Post-Randomization Exclusion|0|||
131824183|NCT02805309|474636622|FG001|Overall Study|Post-Randomization Exclusion|2|||
131824184|NCT02805309|474636623|FG002|Overall Study|Post-Randomization Exclusion|1|||
131824185|NCT00108628|474636631|FG000|Overall Study|Withdrawal by Subject|17|||
131824186|NCT00108628|474636632|FG001|Overall Study|Withdrawal by Subject|9|||
131824187|NCT00108628|474636631|FG000|Overall Study|Lack of Efficacy|2|||
131824188|NCT00108628|474636632|FG001|Overall Study|Lack of Efficacy|1|||
131824189|NCT00108628|474636631|FG000|Overall Study|Death|1|||
131824190|NCT00108628|474636632|FG001|Overall Study|Death|0|||
131824191|NCT01350934|474636635|FG000|Base Study|Adverse Event|6|||
131824192|NCT01350934|474636636|FG001|Base Study|Adverse Event|0|||
131824193|NCT01350934|474636635|FG000|Base Study|Lost to Follow-up|1|||
131824194|NCT01350934|474636636|FG001|Base Study|Lost to Follow-up|0|||
131824195|NCT01350934|474636635|FG000|Base Study|Protocol Violation|1|||
131824196|NCT01350934|474636636|FG001|Base Study|Protocol Violation|1|||
131824197|NCT01350934|474636635|FG000|Base Study|Withdrawal by Subject|1|||
131824198|NCT01350934|474636636|FG001|Base Study|Withdrawal by Subject|2|||
131824199|NCT01350934|474636635|FG000|Base Study|Non-Compliance With Study Drug|2|||
131824200|NCT01350934|474636636|FG001|Base Study|Non-Compliance With Study Drug|0|||
131824201|NCT01350934|474636635|FG000|Extension Study|Adverse Event|2|||
131824202|NCT01350934|474636636|FG001|Extension Study|Adverse Event|1|||
131824203|NCT01350934|474636635|FG000|Extension Study|Lost to Follow-up|2|||
131824204|NCT01350934|474636636|FG001|Extension Study|Lost to Follow-up|0|||
131824205|NCT01350934|474636635|FG000|Extension Study|Protocol Violation|1|||
131824206|NCT01350934|474636636|FG001|Extension Study|Protocol Violation|1|||
131824207|NCT01350934|474636635|FG000|Extension Study|Lack of Efficacy|0|||
131824208|NCT01350934|474636636|FG001|Extension Study|Lack of Efficacy|1|||
131824209|NCT01350934|474636635|FG000|Extension Study|Withdrawal by Subject|0|||
131824210|NCT01350934|474636636|FG001|Extension Study|Withdrawal by Subject|1|||
131824211|NCT03547635|474636637|FG000|Overall Study|Adverse Event|5|||
131824212|NCT03547635|474636638|FG001|Overall Study|Adverse Event|2|||
131824213|NCT03547635|474636639|FG002|Overall Study|Adverse Event|3|||
131824214|NCT03547635|474636637|FG000|Overall Study|Lost to Follow-up|1|||
131824215|NCT03547635|474636638|FG001|Overall Study|Lost to Follow-up|3|||
131824216|NCT03547635|474636639|FG002|Overall Study|Lost to Follow-up|4|||
131824217|NCT03547635|474636637|FG000|Overall Study|Withdrawal by Subject|1|||
131824218|NCT03547635|474636638|FG001|Overall Study|Withdrawal by Subject|0|||
131824219|NCT03547635|474636639|FG002|Overall Study|Withdrawal by Subject|0|||
131824220|NCT03547635|474636637|FG000|Overall Study|Withdrawal By PI|0|||
131824221|NCT03547635|474636638|FG001|Overall Study|Withdrawal By PI|1|||
131824222|NCT03547635|474636639|FG002|Overall Study|Withdrawal By PI|0|||
131824223|NCT03547635|474636637|FG000|Overall Study|Withdrawal by Sponsor|0|||
131824224|NCT03547635|474636638|FG001|Overall Study|Withdrawal by Sponsor|0|||
131824225|NCT03547635|474636639|FG002|Overall Study|Withdrawal by Sponsor|1|||
131824226|NCT03547635|474636637|FG000|Overall Study|Errant Randomization before Treatment|0|||
131824227|NCT03547635|474636638|FG001|Overall Study|Errant Randomization before Treatment|1|||
131824228|NCT03547635|474636639|FG002|Overall Study|Errant Randomization before Treatment|0|||
131824229|NCT03547635|474636637|FG000|Overall Study|Withdrawal by Subject|1|||
131824230|NCT03547635|474636638|FG001|Overall Study|Withdrawal by Subject|0|||
131824231|NCT03547635|474636639|FG002|Overall Study|Withdrawal by Subject|0|||
131824232|NCT00676650|474636642|FG000|Overall Study|Death|45|||
131824233|NCT00676650|474636643|FG001|Overall Study|Death|14|||
131824234|NCT00676650|474636642|FG000|Overall Study|Adverse Event|159|||
131824235|NCT00676650|474636643|FG001|Overall Study|Adverse Event|21|||
131824236|NCT00676650|474636642|FG000|Overall Study|Global deterioration of health status|66|||
131824237|NCT00676650|474636643|FG001|Overall Study|Global deterioration of health status|31|||
131824238|NCT00676650|474636642|FG000|Overall Study|Lost to Follow-up|0|||
131824239|NCT00676650|474636643|FG001|Overall Study|Lost to Follow-up|1|||
131824240|NCT00676650|474636642|FG000|Overall Study|Objective progression or relapse|189|||
131824241|NCT00676650|474636643|FG001|Overall Study|Objective progression or relapse|140|||
131824242|NCT00676650|474636642|FG000|Overall Study|Other|14|||
131824243|NCT00676650|474636643|FG001|Overall Study|Other|10|||
131824244|NCT00676650|474636642|FG000|Overall Study|Protocol Violation|3|||
131824245|NCT00676650|474636643|FG001|Overall Study|Protocol Violation|1|||
131824246|NCT00676650|474636642|FG000|Overall Study|Study terminated by sponsor|57|||
131824247|NCT00676650|474636643|FG001|Overall Study|Study terminated by sponsor|43|||
131824248|NCT00676650|474636642|FG000|Overall Study|Withdrawal by Subject|48|||
131824249|NCT00676650|474636643|FG001|Overall Study|Withdrawal by Subject|24|||
131824250|NCT00676650|474636642|FG000|Overall Study|Randomized but not treated|3|||
131824251|NCT00676650|474636643|FG001|Overall Study|Randomized but not treated|4|||
131824252|NCT01872715|474636647|FG000|Overall Study|Adverse Event|1|||
131824253|NCT01872715|474636647|FG000|Overall Study|Protocol Violation|1|||
131824254|NCT01872715|474636647|FG000|Overall Study|Withdrawal by Subject|2|||
131824255|NCT00683592|474636648|FG000|Overall Study|Adverse Event|12|||
131824256|NCT00683592|474636649|FG001|Overall Study|Adverse Event|4|||
131824257|NCT00683592|474636648|FG000|Overall Study|Withdrawal by Subject|11|||
131824258|NCT00683592|474636649|FG001|Overall Study|Withdrawal by Subject|11|||
131824259|NCT00683592|474636648|FG000|Overall Study|Lost to Follow-up|17|||
131824260|NCT00683592|474636649|FG001|Overall Study|Lost to Follow-up|17|||
131824261|NCT00683592|474636648|FG000|Overall Study|Lack of Efficacy|3|||
131824262|NCT00683592|474636649|FG001|Overall Study|Lack of Efficacy|7|||
131824263|NCT00683592|474636648|FG000|Overall Study|Physician Decision|0|||
131824264|NCT00683592|474636649|FG001|Overall Study|Physician Decision|1|||
131824265|NCT00683592|474636648|FG000|Overall Study|Non-compliance|3|||
131824266|NCT00683592|474636649|FG001|Overall Study|Non-compliance|5|||
131824267|NCT00683592|474636648|FG000|Overall Study|Other|1|||
131824268|NCT00683592|474636649|FG001|Overall Study|Other|1|||
131824269|NCT00329160|474636654|FG000|Overall Study|Adverse Event|27|||
131824270|NCT00329160|474636654|FG000|Overall Study|Withdrawal by Subject|13|||
131824271|NCT00329160|474636654|FG000|Overall Study|Protocol Violation|2|||
131824272|NCT00329160|474636654|FG000|Overall Study|Did not Receive Study Drug|1|||
131824273|NCT00329160|474636654|FG000|Overall Study|Incomplete IVUS|45|||
131824274|NCT00063258|474636655|FG000|Overall Study|Physician Decision|2|||
131824275|NCT00063258|474636656|FG001|Overall Study|Physician Decision|0|||
131824276|NCT00063258|474636655|FG000|Overall Study|Lack of Efficacy|2|||
131824277|NCT00063258|474636656|FG001|Overall Study|Lack of Efficacy|0|||
131824278|NCT00396630|474636659|FG000|Overall Study|Lost to Follow-up|1|||
131824279|NCT00396630|474636660|FG001|Overall Study|Lost to Follow-up|1|||
131824280|NCT00396630|474636659|FG000|Overall Study|Withdrawal by Subject|1|||
131824281|NCT00396630|474636660|FG001|Overall Study|Withdrawal by Subject|1|||
131824282|NCT00396630|474636659|FG000|Overall Study|Not vaccinated at Visit 3|3|||
131824283|NCT00396630|474636660|FG001|Overall Study|Not vaccinated at Visit 3|3|||
131824284|NCT02327325|474636661|FG000|Overall Study|Withdrawal by Subject|1|||
131824285|NCT02327325|474636662|FG001|Overall Study|Withdrawal by Subject|4|||
131824286|NCT02327325|474636663|FG002|Overall Study|Withdrawal by Subject|4|||
131824287|NCT02327325|474636661|FG000|Overall Study|Excluded by Study Team|0|||
131824288|NCT02327325|474636662|FG001|Overall Study|Excluded by Study Team|0|||
131824289|NCT02327325|474636663|FG002|Overall Study|Excluded by Study Team|1|||
131824290|NCT01755975|474636666|FG000|Overall Study|Adverse Event|0|||
131824291|NCT01755975|474636667|FG001|Overall Study|Adverse Event|0|||
131824292|NCT01755975|474636668|FG002|Overall Study|Adverse Event|1|||
131824293|NCT01755975|474636669|FG003|Overall Study|Adverse Event|0|||
131824294|NCT01755975|474636670|FG004|Overall Study|Adverse Event|2|||
131824295|NCT03653026|474636671|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
131824296|NCT03653026|474636672|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
131824297|NCT03653026|474636673|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
131824298|NCT03653026|474636674|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
131824299|NCT03653026|474636671|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
131824300|NCT03653026|474636672|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
131824301|NCT03653026|474636673|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131824302|NCT03653026|474636674|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131824303|NCT03653026|474636671|FG000|Part 1: Placebo-controlled Period|Other|0|||
131824304|NCT03653026|474636672|FG001|Part 1: Placebo-controlled Period|Other|3|||
131824305|NCT03653026|474636673|FG002|Part 1: Placebo-controlled Period|Other|0|||
131824306|NCT03653026|474636674|FG003|Part 1: Placebo-controlled Period|Other|0|||
131824307|NCT03653026|474636671|FG000|Part 2: Open-label Extension|Adverse Event|0|||
131824308|NCT03653026|474636672|FG001|Part 2: Open-label Extension|Adverse Event|0|||
131824309|NCT03653026|474636673|FG002|Part 2: Open-label Extension|Adverse Event|1|||
131824310|NCT03653026|474636674|FG003|Part 2: Open-label Extension|Adverse Event|1|||
131824311|NCT03653026|474636671|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
131824312|NCT03653026|474636672|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
131824313|NCT03653026|474636673|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
131824314|NCT03653026|474636674|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
131824315|NCT03653026|474636671|FG000|Part 2: Open-label Extension|Other|0|||
131824316|NCT03653026|474636672|FG001|Part 2: Open-label Extension|Other|0|||
131824317|NCT03653026|474636673|FG002|Part 2: Open-label Extension|Other|1|||
131824318|NCT03653026|474636674|FG003|Part 2: Open-label Extension|Other|2|||
131824319|NCT02457819|474636680|FG000|Overall Study|reason not given|8|||
131824320|NCT02457819|474636680|FG000|Overall Study|Withdrawal by Subject|24|||
131824321|NCT02457819|474636680|FG000|Overall Study|Protocol Violation|1|||
131824322|NCT02457819|474636680|FG000|Overall Study|non compliance with study drug|4|||
131824323|NCT02457819|474636680|FG000|Overall Study|Lost to Follow-up|10|||
131824324|NCT02457819|474636680|FG000|Overall Study|Lack of Efficacy|19|||
131824325|NCT02457819|474636680|FG000|Overall Study|Adverse Event|33|||
131824326|NCT01901848|474636682|FG000|Randomized and Treated|Lost to Follow-up|3|||
131824327|NCT01901848|474636683|FG001|Randomized and Treated|Lost to Follow-up|6|||
131824328|NCT01901848|474636682|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
131824329|NCT01901848|474636683|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
131824330|NCT01729026|474636684|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
131824331|NCT01729026|474636685|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
131824332|NCT01729026|474636684|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
131824333|NCT01729026|474636685|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
131824334|NCT03710590|474636686|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
131824335|NCT03710590|474636687|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
131824336|NCT00852917|474636688|FG000|Overall Study|Adverse Event|13|||
131824337|NCT00852917|474636689|FG001|Overall Study|Adverse Event|20|||
131824338|NCT00852917|474636690|FG002|Overall Study|Adverse Event|35|||
131824339|NCT00852917|474636691|FG003|Overall Study|Adverse Event|17|||
131824340|NCT00852917|474636688|FG000|Overall Study|Lack of Efficacy|21|||
131824341|NCT00852917|474636689|FG001|Overall Study|Lack of Efficacy|11|||
131824342|NCT00852917|474636690|FG002|Overall Study|Lack of Efficacy|11|||
131824343|NCT00852917|474636691|FG003|Overall Study|Lack of Efficacy|47|||
131824344|NCT00852917|474636688|FG000|Overall Study|Withdrawal by Subject|4|||
131824345|NCT00852917|474636689|FG001|Overall Study|Withdrawal by Subject|8|||
131824346|NCT00852917|474636690|FG002|Overall Study|Withdrawal by Subject|10|||
131824347|NCT00852917|474636691|FG003|Overall Study|Withdrawal by Subject|9|||
131824348|NCT00852917|474636688|FG000|Overall Study|Physician Decision|6|||
131824349|NCT00852917|474636689|FG001|Overall Study|Physician Decision|7|||
131824350|NCT00852917|474636690|FG002|Overall Study|Physician Decision|2|||
131824351|NCT00852917|474636691|FG003|Overall Study|Physician Decision|19|||
131401123|NCT02589665|473091456|FG000|Maintenance Period|Lack of Efficacy|0|||
131401124|NCT02589665|473091457|FG001|Maintenance Period|Lack of Efficacy|0|||
131401125|NCT02589665|473091458|FG002|Maintenance Period|Lack of Efficacy|0|||
131824352|NCT00852917|474636688|FG000|Overall Study|Death|0|||
131824353|NCT00852917|474636689|FG001|Overall Study|Death|0|||
131824354|NCT00852917|474636690|FG002|Overall Study|Death|0|||
131824355|NCT00852917|474636691|FG003|Overall Study|Death|1|||
131824356|NCT04675775|474636693|FG000|Overall Study|Withdrawal by Subject|7|||
131824357|NCT01045707|474636695|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
131824358|NCT01045707|474636696|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
131824359|NCT01045707|474636695|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
131824360|NCT01045707|474636696|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
131824361|NCT01045707|474636695|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
131824362|NCT01045707|474636696|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
131824363|NCT01045707|474636695|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
131824364|NCT01045707|474636696|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
131824365|NCT01045707|474636695|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
131824366|NCT01045707|474636696|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
131824367|NCT01045707|474636695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
131824368|NCT01045707|474636696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
131824369|NCT01045707|474636695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
131824370|NCT01045707|474636696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
131824371|NCT01045707|474636695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
131824372|NCT01045707|474636696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
131824373|NCT01045707|474636695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
131824374|NCT01045707|474636696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
131824375|NCT00348816|474636697|FG000|Overall Study|Noncompliance with radiation treatment|1|||
131824376|NCT04886063|474636706|FG000|Overall Study|Adverse Event|50|||
131824377|NCT04886063|474636706|FG000|Overall Study|Lack of Efficacy|31|||
131824378|NCT04886063|474636706|FG000|Overall Study|Withdrawal by Subject|45|||
131824379|NCT04886063|474636706|FG000|Overall Study|Physician Decision|3|||
131824380|NCT04886063|474636706|FG000|Overall Study|Protocol Violation|3|||
131824381|NCT04886063|474636706|FG000|Overall Study|Site closure|4|||
131824382|NCT04886063|474636706|FG000|Overall Study|Nursing home replacement|3|||
131910009|NCT01041859|474958731|FG002|Open-Label Titration|Lost to Follow-up|0|||
131910010|NCT01041859|474958729|FG000|Open-Label Titration|Physician Decision|1|||
131401126|NCT02589665|473091459|FG003|Maintenance Period|Lack of Efficacy|0|||
131824383|NCT04886063|474636706|FG000|Overall Study|Lost to Follow-up|5|||
131824384|NCT04886063|474636706|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
131824385|NCT04886063|474636706|FG000|Overall Study|>1 reason|20|||
131824386|NCT02448563|474636709|FG000|Overall Study|Lost to Follow-up|16|||
131824387|NCT02448563|474636710|FG001|Overall Study|Lost to Follow-up|10|||
131824388|NCT02448563|474636709|FG000|Overall Study|Withdrawal by Subject|0|||
131824389|NCT02448563|474636710|FG001|Overall Study|Withdrawal by Subject|1|||
131824390|NCT02914457|474636714|FG000|Overall Study|Withdrawal by Subject|1|||
131824391|NCT02914457|474636714|FG000|Overall Study|Physician Decision|1|||
131824392|NCT02914457|474636714|FG000|Overall Study|No veins available for lead placement|1|||
131824393|NCT02914457|474636714|FG000|Overall Study|Electrical instability of patient|1|||
131824394|NCT02914457|474636714|FG000|Overall Study|ECG acquisition error due to sweating|1|||
131824395|NCT02914457|474636714|FG000|Overall Study|Protocol Violation|1|||
131824396|NCT01292837|474636718|FG000|Overall Study|Adverse Event|1|||
131824397|NCT01292837|474636718|FG000|Overall Study|Further treatment determined|1|||
131824398|NCT02174276|474636719|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
131824399|NCT02174276|474636720|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
131824400|NCT02174276|474636721|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
131824401|NCT02174276|474636722|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
131824402|NCT02174276|474636719|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
131824403|NCT02174276|474636720|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
131824404|NCT02174276|474636721|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
131824405|NCT02174276|474636722|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
131824406|NCT02174276|474636719|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
131824407|NCT02174276|474636720|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
131824408|NCT02174276|474636721|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
131824409|NCT02174276|474636722|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
131824410|NCT02174276|474636719|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
131824411|NCT02174276|474636720|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
131824412|NCT02174276|474636721|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
131824413|NCT02174276|474636722|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
131824414|NCT02174276|474636719|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
131824415|NCT02174276|474636720|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
131824416|NCT02174276|474636721|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
131824417|NCT02174276|474636722|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
131824418|NCT02174276|474636719|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
131824419|NCT02174276|474636720|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
131824420|NCT02174276|474636721|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
131824421|NCT02174276|474636722|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
131824422|NCT01206439|474636723|FG000|Overall Study|subject did not meet inclusion criteria|1|||
131824423|NCT04531527|474636726|FG000|Overall Study|Found to be Ineligible|3|||
131824424|NCT02427399|474636730|FG000|Overall Study|Protocol Violation|14|||
131824425|NCT02427399|474636731|FG001|Overall Study|Protocol Violation|16|||
131824426|NCT02427399|474636732|FG002|Overall Study|Protocol Violation|12|||
131824427|NCT02427399|474636733|FG003|Overall Study|Protocol Violation|18|||
131824428|NCT02427399|474636734|FG004|Overall Study|Protocol Violation|15|||
131824429|NCT01115933|474636735|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
131824430|NCT03847974|474636738|FG000|Overall Study|relocated out of region|3|||
131824431|NCT03847974|474636738|FG000|Overall Study|Withdrawal by Subject|2|||
131824432|NCT03847974|474636738|FG000|Overall Study|Adverse Event|1|||
131824433|NCT01685216|474636739|FG000|Overall Study|Did not receive study drug|1|||
131824434|NCT01294449|474636740|FG000|Overall Study|Death|11|||
131824435|NCT01294449|474636741|FG001|Overall Study|Death|12|||
131824436|NCT01294449|474636740|FG000|Overall Study|Withdrawal by Subject|1|||
131824437|NCT01294449|474636741|FG001|Overall Study|Withdrawal by Subject|3|||
131824438|NCT00603512|474636744|FG000|Overall Study|Adverse Event|0|||
131824439|NCT00603512|474636745|FG001|Overall Study|Adverse Event|2|||
131401127|NCT02589665|473091460|FG004|Maintenance Period|Lack of Efficacy|2|||
131824440|NCT00603512|474636746|FG002|Overall Study|Adverse Event|4|||
131824441|NCT00603512|474636747|FG003|Overall Study|Adverse Event|4|||
131824442|NCT00603512|474636748|FG004|Overall Study|Adverse Event|2|||
131824443|NCT00603512|474636744|FG000|Overall Study|Lack of Efficacy|0|||
131824444|NCT00603512|474636745|FG001|Overall Study|Lack of Efficacy|1|||
131824445|NCT00603512|474636746|FG002|Overall Study|Lack of Efficacy|0|||
131824446|NCT00603512|474636747|FG003|Overall Study|Lack of Efficacy|0|||
131824447|NCT00603512|474636748|FG004|Overall Study|Lack of Efficacy|1|||
131824448|NCT00603512|474636744|FG000|Overall Study|Other|2|||
131824449|NCT00603512|474636745|FG001|Overall Study|Other|1|||
131824450|NCT00603512|474636746|FG002|Overall Study|Other|0|||
131824451|NCT00603512|474636747|FG003|Overall Study|Other|1|||
131824452|NCT00603512|474636748|FG004|Overall Study|Other|1|||
131401128|NCT02589665|473091461|FG005|Maintenance Period|Lack of Efficacy|1|||
131824453|NCT00603512|474636744|FG000|Overall Study|Withdrawal by Subject|0|||
131824454|NCT00603512|474636745|FG001|Overall Study|Withdrawal by Subject|0|||
131824455|NCT00603512|474636746|FG002|Overall Study|Withdrawal by Subject|0|||
131824456|NCT00603512|474636747|FG003|Overall Study|Withdrawal by Subject|0|||
131824457|NCT00603512|474636748|FG004|Overall Study|Withdrawal by Subject|1|||
131824458|NCT00603512|474636744|FG000|Overall Study|Randomized but not treated|0|||
131824459|NCT00603512|474636745|FG001|Overall Study|Randomized but not treated|1|||
131824460|NCT00603512|474636746|FG002|Overall Study|Randomized but not treated|1|||
131824461|NCT00603512|474636747|FG003|Overall Study|Randomized but not treated|2|||
131824462|NCT00603512|474636748|FG004|Overall Study|Randomized but not treated|0|||
131824463|NCT00685750|474636749|FG000|Overall Study|Tumor sampling failure|0|||
131824464|NCT00685750|474636750|FG001|Overall Study|Tumor sampling failure|0|||
131824465|NCT00685750|474636751|FG002|Overall Study|Tumor sampling failure|1|||
131824466|NCT00685750|474636752|FG003|Overall Study|Tumor sampling failure|0|||
131824467|NCT00685750|474636753|FG004|Overall Study|Tumor sampling failure|0|||
131824468|NCT00685750|474636754|FG005|Overall Study|Tumor sampling failure|0|||
131824469|NCT00685750|474636755|FG006|Overall Study|Tumor sampling failure|0|||
131824470|NCT00685750|474636749|FG000|Overall Study|Patient didn't receive the treatment|0|||
131824471|NCT00685750|474636750|FG001|Overall Study|Patient didn't receive the treatment|0|||
131824472|NCT00685750|474636751|FG002|Overall Study|Patient didn't receive the treatment|0|||
131824473|NCT00685750|474636752|FG003|Overall Study|Patient didn't receive the treatment|0|||
131824474|NCT00685750|474636753|FG004|Overall Study|Patient didn't receive the treatment|0|||
131824475|NCT00685750|474636754|FG005|Overall Study|Patient didn't receive the treatment|0|||
131824476|NCT00685750|474636755|FG006|Overall Study|Patient didn't receive the treatment|1|||
131824477|NCT00685750|474636749|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131824478|NCT00685750|474636750|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131824479|NCT00685750|474636751|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
131824480|NCT00685750|474636752|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
131824481|NCT00685750|474636753|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
131824482|NCT00685750|474636754|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
131824483|NCT00685750|474636755|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
131824484|NCT04428645|474636760|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
131824485|NCT01049581|474636761|FG000|Overall Study|Lost to Follow-up|2|||
131824486|NCT01049581|474636762|FG001|Overall Study|Lost to Follow-up|1|||
131824487|NCT02722616|474638642|FG000|Overall Study|Sponsor closed study after one month|2|||
131824488|NCT02722616|474638643|FG001|Overall Study|Sponsor closed study after one month|0|||
131824489|NCT02722616|474638644|FG002|Overall Study|Sponsor closed study after one month|0|||
131824490|NCT02031237|474638647|FG000|Overall Study|Death|1|||
131824491|NCT02031237|474638648|FG001|Overall Study|Death|5|||
131910011|NCT01041859|474958730|FG001|Open-Label Titration|Physician Decision|0|||
131824492|NCT02031237|474638649|FG002|Overall Study|Death|0|||
131824493|NCT02031237|474638647|FG000|Overall Study|Physician Decision|0|||
131824494|NCT02031237|474638648|FG001|Overall Study|Physician Decision|1|||
131824495|NCT02031237|474638649|FG002|Overall Study|Physician Decision|0|||
131824496|NCT02031237|474638647|FG000|Overall Study|Withdrawal by Subject|2|||
131824497|NCT02031237|474638648|FG001|Overall Study|Withdrawal by Subject|2|||
131824498|NCT02031237|474638649|FG002|Overall Study|Withdrawal by Subject|0|||
131824499|NCT02031237|474638647|FG000|Overall Study|Protocol Violation|2|||
131824500|NCT02031237|474638648|FG001|Overall Study|Protocol Violation|6|||
131824501|NCT02031237|474638649|FG002|Overall Study|Protocol Violation|0|||
131824502|NCT02031237|474638647|FG000|Overall Study|Alternate Treatment Given|0|||
131824503|NCT02031237|474638648|FG001|Overall Study|Alternate Treatment Given|0|||
131824504|NCT02031237|474638649|FG002|Overall Study|Alternate Treatment Given|3|||
131824505|NCT01011335|474638668|FG000|Overall Study|Lost to Follow-up|0|||
131824506|NCT01011335|474638669|FG001|Overall Study|Lost to Follow-up|0|||
131824507|NCT01011335|474638670|FG002|Overall Study|Lost to Follow-up|1|||
131824508|NCT01011335|474638671|FG003|Overall Study|Lost to Follow-up|1|||
131824509|NCT01011335|474638672|FG004|Overall Study|Lost to Follow-up|1|||
131824510|NCT01011335|474638673|FG005|Overall Study|Lost to Follow-up|1|||
131824511|NCT01011335|474638674|FG006|Overall Study|Lost to Follow-up|2|||
131824512|NCT01011335|474638675|FG007|Overall Study|Lost to Follow-up|2|||
131824513|NCT01011335|474638676|FG008|Overall Study|Lost to Follow-up|1|||
131824514|NCT01011335|474638677|FG009|Overall Study|Lost to Follow-up|0|||
131824515|NCT01011335|474638678|FG010|Overall Study|Lost to Follow-up|0|||
131824516|NCT01011335|474638679|FG011|Overall Study|Lost to Follow-up|1|||
131910012|NCT01041859|474958731|FG002|Open-Label Titration|Physician Decision|0|||
131910013|NCT01041859|474958729|FG000|Open-Label Titration|Protocol Violation|1|||
131910014|NCT01041859|474958730|FG001|Open-Label Titration|Protocol Violation|0|||
131910015|NCT01041859|474958731|FG002|Open-Label Titration|Protocol Violation|0|||
131910016|NCT01041859|474958729|FG000|Open-Label Titration|Other|7|||
131910017|NCT01041859|474958730|FG001|Open-Label Titration|Other|0|||
131910018|NCT01041859|474958731|FG002|Open-Label Titration|Other|0|||
131910019|NCT01041859|474958729|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
131910020|NCT01041859|474958730|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
131824517|NCT01011335|474638680|FG012|Overall Study|Lost to Follow-up|2|||
131824518|NCT01011335|474638668|FG000|Overall Study|Protocol Violation|0|||
131824519|NCT01011335|474638669|FG001|Overall Study|Protocol Violation|1|||
131824520|NCT01011335|474638670|FG002|Overall Study|Protocol Violation|0|||
131824521|NCT01011335|474638671|FG003|Overall Study|Protocol Violation|0|||
131824522|NCT01011335|474638672|FG004|Overall Study|Protocol Violation|0|||
131824523|NCT01011335|474638673|FG005|Overall Study|Protocol Violation|0|||
131824524|NCT01011335|474638674|FG006|Overall Study|Protocol Violation|0|||
131824525|NCT01011335|474638675|FG007|Overall Study|Protocol Violation|0|||
131824526|NCT01011335|474638676|FG008|Overall Study|Protocol Violation|0|||
131824527|NCT01011335|474638677|FG009|Overall Study|Protocol Violation|0|||
131824528|NCT01011335|474638678|FG010|Overall Study|Protocol Violation|0|||
131824529|NCT01011335|474638679|FG011|Overall Study|Protocol Violation|0|||
131824530|NCT01011335|474638680|FG012|Overall Study|Protocol Violation|0|||
131824531|NCT01011335|474638668|FG000|Overall Study|Moved/deployed or no booster|1|||
131824532|NCT01011335|474638669|FG001|Overall Study|Moved/deployed or no booster|0|||
131824533|NCT01011335|474638670|FG002|Overall Study|Moved/deployed or no booster|0|||
131824534|NCT01011335|474638671|FG003|Overall Study|Moved/deployed or no booster|1|||
131824535|NCT01011335|474638672|FG004|Overall Study|Moved/deployed or no booster|0|||
131824536|NCT01011335|474638673|FG005|Overall Study|Moved/deployed or no booster|0|||
131824537|NCT01011335|474638674|FG006|Overall Study|Moved/deployed or no booster|1|||
131824538|NCT01011335|474638675|FG007|Overall Study|Moved/deployed or no booster|0|||
131824539|NCT01011335|474638676|FG008|Overall Study|Moved/deployed or no booster|1|||
131824540|NCT01011335|474638677|FG009|Overall Study|Moved/deployed or no booster|0|||
131824541|NCT01011335|474638678|FG010|Overall Study|Moved/deployed or no booster|2|||
131824542|NCT01011335|474638679|FG011|Overall Study|Moved/deployed or no booster|0|||
131824543|NCT01011335|474638680|FG012|Overall Study|Moved/deployed or no booster|0|||
131824544|NCT01011335|474638668|FG000|Overall Study|Adverse Event|0|||
131824545|NCT01011335|474638669|FG001|Overall Study|Adverse Event|0|||
131824546|NCT01011335|474638670|FG002|Overall Study|Adverse Event|0|||
131824547|NCT01011335|474638671|FG003|Overall Study|Adverse Event|0|||
131824548|NCT01011335|474638672|FG004|Overall Study|Adverse Event|0|||
131824549|NCT01011335|474638673|FG005|Overall Study|Adverse Event|0|||
131824550|NCT01011335|474638674|FG006|Overall Study|Adverse Event|0|||
131824551|NCT01011335|474638675|FG007|Overall Study|Adverse Event|0|||
131824552|NCT01011335|474638676|FG008|Overall Study|Adverse Event|0|||
131824553|NCT01011335|474638677|FG009|Overall Study|Adverse Event|0|||
131824554|NCT01011335|474638678|FG010|Overall Study|Adverse Event|4|||
131824555|NCT01011335|474638679|FG011|Overall Study|Adverse Event|0|||
131824556|NCT01011335|474638680|FG012|Overall Study|Adverse Event|1|||
131824557|NCT01636934|474638681|FG000|Overall Study|Withdrawal by Subject|3|||
131824558|NCT01636934|474638682|FG001|Overall Study|Withdrawal by Subject|2|||
131824559|NCT01636934|474638681|FG000|Overall Study|Chemo cancel|1|||
131824560|NCT01636934|474638682|FG001|Overall Study|Chemo cancel|0|||
131824561|NCT01636934|474638681|FG000|Overall Study|Too ill to continue|1|||
131824562|NCT01636934|474638682|FG001|Overall Study|Too ill to continue|0|||
131824563|NCT01636934|474638681|FG000|Overall Study|Never started study medication|1|||
131824564|NCT01636934|474638682|FG001|Overall Study|Never started study medication|1|||
131824565|NCT02415387|474638694|FG000|Overall Study|Withdrawal by Subject|6|||
131824566|NCT02415387|474638695|FG001|Overall Study|Withdrawal by Subject|1|||
131824567|NCT02415387|474638694|FG000|Overall Study|blood draw problem|0|||
131824568|NCT02415387|474638695|FG001|Overall Study|blood draw problem|1|||
131824569|NCT02415387|474638694|FG000|Overall Study|Protocol Violation|1|||
131824570|NCT02415387|474638695|FG001|Overall Study|Protocol Violation|0|||
131824571|NCT01765751|474638702|FG000|Overall Study|Lost to Follow-up|0|||
131824572|NCT01765751|474638703|FG001|Overall Study|Lost to Follow-up|2|||
131824573|NCT01765751|474638704|FG002|Overall Study|Lost to Follow-up|1|||
131824574|NCT02297841|474638709|FG000|Overall Study|Withdrawal by Subject|1|||
131824575|NCT02297841|474638709|FG000|Overall Study|Protocol Violation|7|||
131824576|NCT03429049|474638710|FG000|Overall Study|Adverse Event|2|||
131824577|NCT03429049|474638711|FG001|Overall Study|Adverse Event|3|||
131824578|NCT03429049|474638710|FG000|Overall Study|Death|0|||
131824579|NCT03429049|474638711|FG001|Overall Study|Death|1|||
131824580|NCT03429049|474638710|FG000|Overall Study|Lack of Efficacy|4|||
131824581|NCT03429049|474638711|FG001|Overall Study|Lack of Efficacy|2|||
131824582|NCT03429049|474638710|FG000|Overall Study|Lost to Follow-up|9|||
131824583|NCT03429049|474638711|FG001|Overall Study|Lost to Follow-up|8|||
131824584|NCT03429049|474638710|FG000|Overall Study|Physician Decision|1|||
131824585|NCT03429049|474638711|FG001|Overall Study|Physician Decision|0|||
131824586|NCT03429049|474638710|FG000|Overall Study|Protocol Violation|3|||
131824587|NCT03429049|474638711|FG001|Overall Study|Protocol Violation|0|||
131824588|NCT03429049|474638710|FG000|Overall Study|Sponsor Decision|2|||
131824589|NCT03429049|474638711|FG001|Overall Study|Sponsor Decision|0|||
131824590|NCT03429049|474638710|FG000|Overall Study|Withdrawal by Subject|4|||
131401129|NCT02589665|473091462|FG006|Maintenance Period|Lack of Efficacy|0|||
131824591|NCT03429049|474638711|FG001|Overall Study|Withdrawal by Subject|20|||
131824592|NCT03429049|474638710|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
131824593|NCT03429049|474638711|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
131824594|NCT02459418|474638714|FG000|Overall Study|Exclusion Criteria|4|||
131824595|NCT02459418|474638715|FG001|Overall Study|Exclusion Criteria|0|||
131824596|NCT02459418|474638714|FG000|Overall Study|Protocol Violation|0|||
131824597|NCT02459418|474638715|FG001|Overall Study|Protocol Violation|2|||
131824598|NCT02459418|474638714|FG000|Overall Study|Physician Decision|0|||
131824599|NCT02459418|474638715|FG001|Overall Study|Physician Decision|2|||
131824600|NCT02459418|474638714|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
131824601|NCT02459418|474638715|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
131824602|NCT02459418|474638714|FG000|Overall Study|Adverse Event|0|||
131824603|NCT02459418|474638715|FG001|Overall Study|Adverse Event|1|||
131824604|NCT02459418|474638714|FG000|Overall Study|Withdrawal by Subject|1|||
131824605|NCT02459418|474638715|FG001|Overall Study|Withdrawal by Subject|1|||
131824606|NCT02459418|474638714|FG000|Overall Study|Elevated Creatine Kinase|1|||
131910021|NCT01041859|474958731|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
131910022|NCT01041859|474958729|FG000|Open-Label Titration|Withdrawal by Subject|11|||
131910023|NCT01041859|474958730|FG001|Open-Label Titration|Withdrawal by Subject|0|||
131910024|NCT01041859|474958731|FG002|Open-Label Titration|Withdrawal by Subject|0|||
131910025|NCT01041859|474958729|FG000|Double-Blind Maintenance|Adverse Event|0|||
131824607|NCT02459418|474638715|FG001|Overall Study|Elevated Creatine Kinase|0|||
131824608|NCT02459418|474638714|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
131824609|NCT02459418|474638715|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
131824610|NCT03303417|474638723|FG000|Overall Study|Withdrawal by Subject|1|||
131824611|NCT03303417|474638724|FG001|Overall Study|Withdrawal by Subject|1|||
131824612|NCT01765270|474638725|FG000|Overall Study|Physician Decision|1|||
131824613|NCT01765270|474638726|FG001|Overall Study|Physician Decision|0|||
131824614|NCT01765270|474638725|FG000|Overall Study|Withdrawal by Subject|0|||
131824615|NCT01765270|474638726|FG001|Overall Study|Withdrawal by Subject|1|||
131824616|NCT03431337|474638727|FG000|Overall Study|Lost to Follow-up|21|||
131824617|NCT03431337|474638728|FG001|Overall Study|Lost to Follow-up|19|||
131824618|NCT03431337|474638727|FG000|Overall Study|Withdrawal by Subject|8|||
131824619|NCT03431337|474638728|FG001|Overall Study|Withdrawal by Subject|3|||
131824620|NCT04501094|474638729|FG000|Overall Study|Death (unrelated to research)|1|||
131824621|NCT04501094|474638730|FG001|Overall Study|Death (unrelated to research)|0|||
131824622|NCT00685035|474638734|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
131824623|NCT00685035|474638735|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
131824624|NCT00784979|474638738|FG000|Overall Study|incomplete data|6|||
131824625|NCT04241133|474638740|FG000|Overall Study|COVID19 Precautions|14|||
131824626|NCT04241133|474638741|FG001|Overall Study|COVID19 Precautions|34|||
131824627|NCT01235715|474638743|FG000|Overall Study|Physician Decision|0|||
131824628|NCT01235715|474638744|FG001|Overall Study|Physician Decision|2|||
131824629|NCT03619876|474638745|FG000|Overall Study|Withdrawal by Subject|1|||
131824630|NCT03619876|474638746|FG001|Overall Study|Withdrawal by Subject|2|||
131824631|NCT03619876|474638745|FG000|Overall Study|Withdrawal due to incidental finding|0|||
131824632|NCT03619876|474638746|FG001|Overall Study|Withdrawal due to incidental finding|2|||
131824633|NCT02994394|474638747|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
131824634|NCT02994394|474638748|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
131824635|NCT02994394|474638749|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
131824636|NCT02994394|474638750|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
131824637|NCT02994394|474638751|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
131824638|NCT02994394|474638752|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
131824639|NCT02994394|474638747|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
131824640|NCT02994394|474638748|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
131824641|NCT02994394|474638749|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
131824642|NCT02994394|474638750|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
131824643|NCT02994394|474638751|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
131824644|NCT02994394|474638752|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
131824645|NCT04982445|474638753|FG000|Overall Study|Protocol Violation|1|||
131824646|NCT04982445|474638753|FG000|Overall Study|Withdrawal by Subject|4|||
131824647|NCT04982445|474638753|FG000|Overall Study|Lost to Follow-up|1|||
131824648|NCT00979212|474638758|FG000|Overall Study|Protocol Violation|1|||
131824649|NCT00979212|474638759|FG001|Overall Study|Protocol Violation|8|||
131824650|NCT00979212|474638758|FG000|Overall Study|No protocol therapy received|1|||
131824651|NCT00979212|474638759|FG001|Overall Study|No protocol therapy received|0|||
131824652|NCT02340962|474638762|FG000|Overall Study|Lost to Follow-up|1|||
131824653|NCT02340962|474638763|FG001|Overall Study|Lost to Follow-up|0|||
131824654|NCT01055886|474638764|FG000|Overall Study|Withdrawal by Subject|4|||
131824655|NCT01055886|474638765|FG001|Overall Study|Withdrawal by Subject|9|||
131824656|NCT01055886|474638764|FG000|Overall Study|Lost to Follow-up|1|||
131824657|NCT01055886|474638765|FG001|Overall Study|Lost to Follow-up|1|||
131824658|NCT01055886|474638764|FG000|Overall Study|Withdrawal by PI|0|||
131824659|NCT01055886|474638765|FG001|Overall Study|Withdrawal by PI|1|||
131824660|NCT00434837|474638772|FG000|Overall Study|Lost to Follow-up|20|||
131824661|NCT00434837|474638773|FG001|Overall Study|Lost to Follow-up|23|||
131824662|NCT00434837|474638774|FG002|Overall Study|Lost to Follow-up|30|||
131824663|NCT01077258|474638775|FG000|Overall Study|Lost to Follow-up|1390|||
131824664|NCT01077258|474638775|FG000|Overall Study|Adverse drug reaction|218|||
131824665|NCT01077258|474638775|FG000|Overall Study|Lack of Efficacy|663|||
131824666|NCT01077258|474638775|FG000|Overall Study|Clinical remission|37|||
131824667|NCT01077258|474638775|FG000|Overall Study|Other reasons|260|||
131824668|NCT00515216|474638776|FG000|Overall Study|Withdrawal by Subject|1|||
131824669|NCT02786927|474638780|FG000|Overall Study|Adverse Event|1|||
131824670|NCT02786927|474638780|FG000|Overall Study|Protocol Violation|4|||
131824671|NCT01801917|474638781|FG000|Period 1 - Randomized|Adverse Event|1|||
131824672|NCT01801917|474638782|FG001|Period 1 - Randomized|Adverse Event|0|||
131824673|NCT01801917|474638783|FG002|Period 1 - Randomized|Adverse Event|1|||
131401130|NCT02589665|473091463|FG007|Maintenance Period|Lack of Efficacy|0|||
131401131|NCT02589665|473091464|FG008|Maintenance Period|Lack of Efficacy|0|||
131401132|NCT02589665|473091465|FG009|Maintenance Period|Lack of Efficacy|0|||
131401133|NCT02589665|473091456|FG000|Maintenance Period|Adverse Event|0|||
131824674|NCT01801917|474638784|FG003|Period 1 - Randomized|Adverse Event|0|||
131824675|NCT04307849|474638785|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
131824676|NCT04307849|474638786|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
131824677|NCT04307849|474638787|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
131824678|NCT04307849|474638788|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
131824679|NCT04307849|474638789|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
131824680|NCT04307849|474638790|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
131824681|NCT04307849|474638785|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
131824682|NCT04307849|474638786|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
131824683|NCT04307849|474638787|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
131824684|NCT04307849|474638788|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
131824685|NCT04307849|474638789|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
131824686|NCT04307849|474638790|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
131824687|NCT04307849|474638785|FG000|Overall Study|Family member did not want them to continue|0|||
131824688|NCT04307849|474638786|FG001|Overall Study|Family member did not want them to continue|0|||
131824689|NCT04307849|474638787|FG002|Overall Study|Family member did not want them to continue|1|||
131824690|NCT04307849|474638788|FG003|Overall Study|Family member did not want them to continue|0|||
131824691|NCT04307849|474638789|FG004|Overall Study|Family member did not want them to continue|0|||
131824692|NCT04307849|474638790|FG005|Overall Study|Family member did not want them to continue|0|||
131824693|NCT04307849|474638785|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
131824694|NCT04307849|474638786|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
131824695|NCT04307849|474638787|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
131824696|NCT04307849|474638788|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
131824697|NCT04307849|474638789|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
131824698|NCT04307849|474638790|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
131824699|NCT02418754|474638795|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
131824700|NCT02418754|474638796|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
131824701|NCT02418754|474638797|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
131824702|NCT02418754|474638798|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
131824703|NCT02418754|474638799|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
131824704|NCT02418754|474638795|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
131824705|NCT02418754|474638796|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
131824706|NCT02418754|474638797|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
131824707|NCT02418754|474638798|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
131824708|NCT02418754|474638799|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
131824709|NCT02418754|474638795|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
131824710|NCT02418754|474638796|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
131824711|NCT02418754|474638797|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
131824712|NCT02418754|474638798|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
131824713|NCT02418754|474638799|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
131824714|NCT02418754|474638795|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
131824715|NCT02418754|474638796|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
131824716|NCT02418754|474638797|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
131824717|NCT02418754|474638798|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
131824718|NCT02418754|474638799|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
131824719|NCT02418754|474638795|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
131824720|NCT02418754|474638796|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
131824721|NCT02418754|474638797|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
131824722|NCT02418754|474638798|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
131824723|NCT02418754|474638799|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
131824724|NCT02418754|474638795|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
131824725|NCT02418754|474638796|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
131824726|NCT02418754|474638797|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
131824727|NCT02418754|474638798|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
131824728|NCT02418754|474638799|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
131824729|NCT02418754|474638795|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
131824730|NCT02418754|474638796|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
131824731|NCT02418754|474638797|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
131824732|NCT02418754|474638798|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
131824733|NCT02418754|474638799|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
131401134|NCT02589665|473091457|FG001|Maintenance Period|Adverse Event|0|||
131401135|NCT02589665|473091458|FG002|Maintenance Period|Adverse Event|0|||
131824734|NCT02418754|474638795|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
131824735|NCT02418754|474638796|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
131824736|NCT02418754|474638797|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
131824737|NCT02418754|474638798|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
131824738|NCT02418754|474638799|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
131824739|NCT02418754|474638795|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
131824740|NCT02418754|474638796|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
131824741|NCT02418754|474638797|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
131824742|NCT02418754|474638798|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
131824743|NCT02418754|474638799|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
131824744|NCT02418754|474638795|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
131824745|NCT02418754|474638796|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
131824746|NCT02418754|474638797|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
131824747|NCT02418754|474638798|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
131824748|NCT02418754|474638799|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
131824749|NCT02418754|474638795|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
131824750|NCT02418754|474638796|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
131824751|NCT02418754|474638797|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
131824752|NCT02418754|474638798|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
131824753|NCT02418754|474638799|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
131824754|NCT04974580|474638800|FG000|Overall Study|Lost to Follow-up|33|||
131824755|NCT04974580|474638801|FG001|Overall Study|Lost to Follow-up|39|||
131824756|NCT04974580|474638802|FG002|Overall Study|Lost to Follow-up|30|||
131824757|NCT04974580|474638803|FG003|Overall Study|Lost to Follow-up|29|||
131824758|NCT00250705|474638804|FG000|Overall Study|Lack of Efficacy|2|||
131824759|NCT05467982|474638805|FG000|Overall Study|Death|0|||
131824760|NCT05467982|474638806|FG001|Overall Study|Death|1|||
131824761|NCT05467982|474638805|FG000|Overall Study|Lost to Follow-up|3|||
131824762|NCT05467982|474638806|FG001|Overall Study|Lost to Follow-up|1|||
131824763|NCT00585312|474638835|FG000|Overall Study|Adverse Event|3|||
131824764|NCT00585312|474638836|FG001|Overall Study|Adverse Event|0|||
131824765|NCT00585312|474638835|FG000|Overall Study|Lack of Efficacy|6|||
131824766|NCT00585312|474638836|FG001|Overall Study|Lack of Efficacy|11|||
131824767|NCT00585312|474638835|FG000|Overall Study|Lost to Follow-up|1|||
131824768|NCT00585312|474638836|FG001|Overall Study|Lost to Follow-up|1|||
131824769|NCT00585312|474638835|FG000|Overall Study|Reason not specified|2|||
131824770|NCT00585312|474638836|FG001|Overall Study|Reason not specified|0|||
131824771|NCT00585312|474638835|FG000|Overall Study|Withdrawal by Subject|5|||
131824772|NCT00585312|474638836|FG001|Overall Study|Withdrawal by Subject|1|||
131824773|NCT00585312|474638835|FG000|Overall Study|Study terminated by the sponsor|34|||
131824774|NCT00585312|474638836|FG001|Overall Study|Study terminated by the sponsor|31|||
131824775|NCT01020526|474638837|FG000|Overall Study|Withdrawal by Subject|5|||
131824776|NCT01020526|474638837|FG000|Overall Study|Other reasons|3|||
131824777|NCT01020526|474638837|FG000|Overall Study|Insufficient clinical response|3|||
131824778|NCT01020526|474638837|FG000|Overall Study|Lost to Follow-up|1|||
131824779|NCT01020526|474638837|FG000|Overall Study|Adverse Event|2|||
131824780|NCT00398073|474638840|FG000|Overall Study|Withdrawal by Subject|1|||
131824781|NCT00398073|474638841|FG001|Overall Study|Withdrawal by Subject|0|||
131824782|NCT01148225|474638842|FG000|Overall Study|Other|185|||
131824783|NCT02490800|474638843|FG000|Overall Study|Adverse Event|0|||
131824784|NCT02490800|474638844|FG001|Overall Study|Adverse Event|0|||
131824785|NCT02490800|474638845|FG002|Overall Study|Adverse Event|0|||
131824786|NCT02490800|474638846|FG003|Overall Study|Adverse Event|2|||
131824787|NCT02490800|474638847|FG004|Overall Study|Adverse Event|3|||
131824788|NCT02490800|474638848|FG005|Overall Study|Adverse Event|2|||
131824789|NCT02490800|474638849|FG006|Overall Study|Adverse Event|0|||
131824790|NCT02490800|474638850|FG007|Overall Study|Adverse Event|0|||
131824791|NCT02490800|474638851|FG008|Overall Study|Adverse Event|0|||
131824792|NCT02490800|474638852|FG009|Overall Study|Adverse Event|0|||
131824793|NCT02490800|474638853|FG010|Overall Study|Adverse Event|0|||
131824794|NCT02490800|474638854|FG011|Overall Study|Adverse Event|2|||
131824795|NCT02490800|474638855|FG012|Overall Study|Adverse Event|2|||
131824796|NCT02490800|474638843|FG000|Overall Study|Withdrawal by Subject|0|||
131824797|NCT02490800|474638844|FG001|Overall Study|Withdrawal by Subject|0|||
131824798|NCT02490800|474638845|FG002|Overall Study|Withdrawal by Subject|0|||
131824799|NCT02490800|474638846|FG003|Overall Study|Withdrawal by Subject|1|||
131824800|NCT02490800|474638847|FG004|Overall Study|Withdrawal by Subject|0|||
131824801|NCT02490800|474638848|FG005|Overall Study|Withdrawal by Subject|0|||
131824802|NCT02490800|474638849|FG006|Overall Study|Withdrawal by Subject|0|||
131910026|NCT01041859|474958730|FG001|Double-Blind Maintenance|Adverse Event|23|||
131910027|NCT01041859|474958731|FG002|Double-Blind Maintenance|Adverse Event|13|||
131824803|NCT02490800|474638850|FG007|Overall Study|Withdrawal by Subject|0|||
131824804|NCT02490800|474638851|FG008|Overall Study|Withdrawal by Subject|1|||
131824805|NCT02490800|474638852|FG009|Overall Study|Withdrawal by Subject|0|||
131824806|NCT02490800|474638853|FG010|Overall Study|Withdrawal by Subject|0|||
131824807|NCT02490800|474638854|FG011|Overall Study|Withdrawal by Subject|0|||
131824808|NCT02490800|474638855|FG012|Overall Study|Withdrawal by Subject|0|||
131824809|NCT02490800|474638843|FG000|Overall Study|Progressive disease|3|||
131824810|NCT02490800|474638844|FG001|Overall Study|Progressive disease|3|||
131824811|NCT02490800|474638845|FG002|Overall Study|Progressive disease|3|||
131824812|NCT02490800|474638846|FG003|Overall Study|Progressive disease|4|||
131824813|NCT02490800|474638847|FG004|Overall Study|Progressive disease|4|||
131824814|NCT02490800|474638848|FG005|Overall Study|Progressive disease|1|||
131824815|NCT02490800|474638849|FG006|Overall Study|Progressive disease|4|||
131824816|NCT02490800|474638850|FG007|Overall Study|Progressive disease|3|||
131824817|NCT02490800|474638851|FG008|Overall Study|Progressive disease|6|||
131824818|NCT02490800|474638852|FG009|Overall Study|Progressive disease|2|||
131824819|NCT02490800|474638853|FG010|Overall Study|Progressive disease|7|||
131824820|NCT02490800|474638854|FG011|Overall Study|Progressive disease|1|||
131824821|NCT02490800|474638855|FG012|Overall Study|Progressive disease|10|||
131824822|NCT02490800|474638843|FG000|Overall Study|Patient enrolled in post-trial access|0|||
131824823|NCT02490800|474638844|FG001|Overall Study|Patient enrolled in post-trial access|0|||
131824824|NCT02490800|474638845|FG002|Overall Study|Patient enrolled in post-trial access|0|||
131824825|NCT02490800|474638846|FG003|Overall Study|Patient enrolled in post-trial access|0|||
131824826|NCT02490800|474638847|FG004|Overall Study|Patient enrolled in post-trial access|0|||
131824827|NCT02490800|474638848|FG005|Overall Study|Patient enrolled in post-trial access|0|||
131824828|NCT02490800|474638849|FG006|Overall Study|Patient enrolled in post-trial access|0|||
131824829|NCT02490800|474638850|FG007|Overall Study|Patient enrolled in post-trial access|0|||
131824830|NCT02490800|474638851|FG008|Overall Study|Patient enrolled in post-trial access|0|||
131824831|NCT02490800|474638852|FG009|Overall Study|Patient enrolled in post-trial access|1|||
131824832|NCT02490800|474638853|FG010|Overall Study|Patient enrolled in post-trial access|1|||
131824833|NCT02490800|474638854|FG011|Overall Study|Patient enrolled in post-trial access|0|||
131824834|NCT02490800|474638855|FG012|Overall Study|Patient enrolled in post-trial access|6|||
131824835|NCT01337596|474638856|FG000|Overall Study|Withdrawal by Subject|0|||
131824836|NCT01337596|474638857|FG001|Overall Study|Withdrawal by Subject|0|||
131824837|NCT01337596|474638858|FG002|Overall Study|Withdrawal by Subject|0|||
131824838|NCT01337596|474638859|FG003|Overall Study|Withdrawal by Subject|0|||
131824839|NCT01337596|474638860|FG004|Overall Study|Withdrawal by Subject|2|||
131824840|NCT01337596|474638861|FG005|Overall Study|Withdrawal by Subject|0|||
131824841|NCT01337596|474638862|FG006|Overall Study|Withdrawal by Subject|0|||
131824842|NCT01337596|474638863|FG007|Overall Study|Withdrawal by Subject|0|||
131824843|NCT01337596|474638864|FG008|Overall Study|Withdrawal by Subject|0|||
131824844|NCT03365791|474638865|FG000|Overall Study|Adverse Event|5|||
131824845|NCT03365791|474638865|FG000|Overall Study|Death|1|||
131824846|NCT03365791|474638865|FG000|Overall Study|Lost to Follow-up|1|||
131824847|NCT03365791|474638865|FG000|Overall Study|Physician Decision|9|||
131824848|NCT03365791|474638865|FG000|Overall Study|Progressive disease|51|||
131824849|NCT03365791|474638865|FG000|Overall Study|Subject/guardian decision|5|||
131824850|NCT03693950|474638866|FG000|Overall Study|Withdrawal by Subject|1|||
131824851|NCT03693950|474638867|FG001|Overall Study|Withdrawal by Subject|0|||
131824852|NCT01992094|474638868|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
131824853|NCT01992094|474638869|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
131824854|NCT01992094|474638870|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
131824855|NCT01992094|474638868|FG000|Overall Study|Adverse Event|1|||
131824856|NCT01992094|474638869|FG001|Overall Study|Adverse Event|0|||
131824857|NCT01992094|474638870|FG002|Overall Study|Adverse Event|0|||
131824858|NCT01992094|474638868|FG000|Overall Study|Death|5|||
131824859|NCT01992094|474638869|FG001|Overall Study|Death|5|||
131824860|NCT01992094|474638870|FG002|Overall Study|Death|2|||
131824861|NCT01992094|474638868|FG000|Overall Study|Lost to Follow-up|26|||
131824862|NCT01992094|474638869|FG001|Overall Study|Lost to Follow-up|9|||
131824863|NCT01992094|474638870|FG002|Overall Study|Lost to Follow-up|13|||
131824864|NCT01992094|474638868|FG000|Overall Study|OTHER|4|||
131824865|NCT01992094|474638869|FG001|Overall Study|OTHER|0|||
131401136|NCT02589665|473091459|FG003|Maintenance Period|Adverse Event|0|||
131824866|NCT01992094|474638870|FG002|Overall Study|OTHER|0|||
131824867|NCT01992094|474638868|FG000|Overall Study|Protocol Violation|1|||
131824868|NCT01992094|474638869|FG001|Overall Study|Protocol Violation|0|||
131824869|NCT01992094|474638870|FG002|Overall Study|Protocol Violation|1|||
131824870|NCT01992094|474638868|FG000|Overall Study|Withdrawal by Subject|7|||
131824871|NCT01992094|474638869|FG001|Overall Study|Withdrawal by Subject|3|||
131824872|NCT01992094|474638870|FG002|Overall Study|Withdrawal by Subject|4|||
131824873|NCT01214239|474638871|FG000|Overall Study|Adverse Event|3|||
131824874|NCT01214239|474638872|FG001|Overall Study|Adverse Event|4|||
131824875|NCT01214239|474638871|FG000|Overall Study|Protocol Violation|2|||
131824876|NCT01214239|474638872|FG001|Overall Study|Protocol Violation|1|||
131824877|NCT01214239|474638871|FG000|Overall Study|Lost to Follow-up|1|||
131824878|NCT01214239|474638872|FG001|Overall Study|Lost to Follow-up|1|||
131824879|NCT01214239|474638871|FG000|Overall Study|Withdrawal by Subject|4|||
131824880|NCT01214239|474638872|FG001|Overall Study|Withdrawal by Subject|9|||
131824881|NCT01214239|474638871|FG000|Overall Study|Lack of Efficacy|1|||
131824882|NCT01214239|474638872|FG001|Overall Study|Lack of Efficacy|2|||
131824883|NCT01214239|474638871|FG000|Overall Study|patient's private reason|1|||
131824884|NCT01214239|474638872|FG001|Overall Study|patient's private reason|1|||
131824885|NCT03203642|474638873|FG000|Overall Study|Adverse Event|3|||
131824886|NCT03203642|474638874|FG001|Overall Study|Adverse Event|1|||
131824887|NCT03203642|474638873|FG000|Overall Study|Withdrawal by Subject|6|||
131824888|NCT03203642|474638874|FG001|Overall Study|Withdrawal by Subject|6|||
131824889|NCT03203642|474638873|FG000|Overall Study|Lost to Follow-up|2|||
131824890|NCT03203642|474638874|FG001|Overall Study|Lost to Follow-up|1|||
131824891|NCT03203642|474638873|FG000|Overall Study|Termination of the study by sponsor|1|||
131824892|NCT03203642|474638874|FG001|Overall Study|Termination of the study by sponsor|1|||
131824893|NCT03203642|474638873|FG000|Overall Study|Participant moved|0|||
131824894|NCT03203642|474638874|FG001|Overall Study|Participant moved|1|||
131824895|NCT03203642|474638873|FG000|Overall Study|Investigator's decision|3|||
131824896|NCT03203642|474638874|FG001|Overall Study|Investigator's decision|0|||
131824897|NCT03203642|474638873|FG000|Overall Study|Other than above specified|0|||
131824898|NCT03203642|474638874|FG001|Overall Study|Other than above specified|1|||
131824899|NCT05068284|474638877|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
131824900|NCT05068284|474638878|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
131824901|NCT05068284|474638879|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
131824902|NCT05068284|474638880|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
131824903|NCT05068284|474638881|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
131824904|NCT05068284|474638882|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
131824905|NCT05068284|474638883|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
131824906|NCT05068284|474638884|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
131824907|NCT05068284|474638877|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824908|NCT05068284|474638878|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824909|NCT05068284|474638879|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
131824910|NCT05068284|474638880|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824911|NCT05068284|474638881|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824912|NCT05068284|474638882|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824913|NCT05068284|474638883|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824914|NCT05068284|474638884|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
131824915|NCT05068284|474638877|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
131824916|NCT05068284|474638878|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
131824917|NCT05068284|474638879|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
131824918|NCT05068284|474638880|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
131824919|NCT05068284|474638881|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
131824920|NCT05068284|474638882|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
131824921|NCT05068284|474638883|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
131824922|NCT05068284|474638884|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
131824923|NCT05068284|474638877|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
131824924|NCT05068284|474638878|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
131824925|NCT05068284|474638879|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
131824926|NCT05068284|474638880|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
131824927|NCT05068284|474638881|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
131824928|NCT05068284|474638882|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
131824929|NCT05068284|474638883|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
131824930|NCT05068284|474638884|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
131824931|NCT05068284|474638877|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824932|NCT05068284|474638878|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824933|NCT05068284|474638879|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824934|NCT05068284|474638880|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
131824935|NCT05068284|474638881|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824936|NCT05068284|474638882|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824937|NCT05068284|474638883|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824938|NCT05068284|474638884|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
131824939|NCT05068284|474638877|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
131824940|NCT05068284|474638878|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
131824941|NCT05068284|474638879|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
131824942|NCT05068284|474638880|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
131824943|NCT05068284|474638881|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
131824944|NCT05068284|474638882|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
131824945|NCT05068284|474638883|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
131824946|NCT05068284|474638884|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
131824947|NCT05068284|474638877|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824948|NCT05068284|474638878|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824949|NCT05068284|474638879|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
131824950|NCT05068284|474638880|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824951|NCT05068284|474638881|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824952|NCT05068284|474638882|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824953|NCT05068284|474638883|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824954|NCT05068284|474638884|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
131824955|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
131824956|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131824957|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131401137|NCT02589665|473091460|FG004|Maintenance Period|Adverse Event|0|||
131824958|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131824959|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131824960|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131824961|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131824962|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
131824963|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
131824964|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
131824965|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
131824966|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
131824967|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
131824968|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
131824969|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
131824970|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
131824971|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
131824972|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
131824973|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
131824974|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
131824975|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
131824976|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
131824977|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
131824978|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
131824979|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
131824980|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824981|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824982|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824983|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824984|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824985|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824986|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
131824987|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
131824988|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824989|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824990|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824991|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824992|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824993|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824994|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
131824995|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
131824996|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
131824997|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
131824998|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
131824999|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
131825000|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
131825001|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
131825002|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
131401138|NCT02589665|473091461|FG005|Maintenance Period|Adverse Event|0|||
131401139|NCT02589665|473091462|FG006|Maintenance Period|Adverse Event|2|||
131401140|NCT02589665|473091463|FG007|Maintenance Period|Adverse Event|0|||
131401141|NCT02589665|473091464|FG008|Maintenance Period|Adverse Event|0|||
131401142|NCT02589665|473091465|FG009|Maintenance Period|Adverse Event|0|||
131401143|NCT02589665|473091456|FG000|Maintenance Period|Lost to Follow-up|0|||
131401144|NCT02589665|473091457|FG001|Maintenance Period|Lost to Follow-up|0|||
131401145|NCT02589665|473091458|FG002|Maintenance Period|Lost to Follow-up|0|||
131401146|NCT02589665|473091459|FG003|Maintenance Period|Lost to Follow-up|0|||
131401147|NCT02589665|473091460|FG004|Maintenance Period|Lost to Follow-up|0|||
131401148|NCT02589665|473091461|FG005|Maintenance Period|Lost to Follow-up|1|||
131401149|NCT02589665|473091462|FG006|Maintenance Period|Lost to Follow-up|0|||
131401150|NCT02589665|473091463|FG007|Maintenance Period|Lost to Follow-up|0|||
131401151|NCT02589665|473091464|FG008|Maintenance Period|Lost to Follow-up|0|||
131401152|NCT02589665|473091465|FG009|Maintenance Period|Lost to Follow-up|0|||
131401153|NCT02589665|473091456|FG000|Maintenance Period|Physician Decision|0|||
131401154|NCT02589665|473091457|FG001|Maintenance Period|Physician Decision|0|||
131401155|NCT02589665|473091458|FG002|Maintenance Period|Physician Decision|0|||
131401156|NCT02589665|473091459|FG003|Maintenance Period|Physician Decision|0|||
131825003|NCT05068284|474638877|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825004|NCT05068284|474638878|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825005|NCT05068284|474638879|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825006|NCT05068284|474638880|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825007|NCT05068284|474638881|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825008|NCT05068284|474638882|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825009|NCT05068284|474638883|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
131825010|NCT05068284|474638884|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
131825011|NCT02129062|474640430|FG000|Overall Study|Death|1|||
131825012|NCT02129062|474640430|FG000|Overall Study|Disease Progression|2|||
131825013|NCT01923311|474640431|FG000|Overall Study|Pregnancy|1|||
131825014|NCT01923311|474640432|FG001|Overall Study|Pregnancy|0|||
131825015|NCT01923311|474640431|FG000|Overall Study|Investigator's Discretion|1|||
131825016|NCT01923311|474640432|FG001|Overall Study|Investigator's Discretion|0|||
131825017|NCT01923311|474640431|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131825018|NCT01923311|474640432|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131825019|NCT01923311|474640431|FG000|Overall Study|Withdrew Consent|1|||
131825020|NCT01923311|474640432|FG001|Overall Study|Withdrew Consent|0|||
131825021|NCT01923311|474640431|FG000|Overall Study|Study Terminated by Sponsor|12|||
131825022|NCT01923311|474640432|FG001|Overall Study|Study Terminated by Sponsor|0|||
131825023|NCT01841060|474640435|FG000|Overall Study|Protocol Violation|10|||
131825024|NCT00653159|474640436|FG000|Overall Study|Adverse Event|4|||
131825025|NCT00653159|474640437|FG001|Overall Study|Adverse Event|1|||
131825026|NCT00653159|474640436|FG000|Overall Study|Lost to Follow-up|1|||
131825027|NCT00653159|474640437|FG001|Overall Study|Lost to Follow-up|2|||
131825028|NCT05258630|474640438|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
131825029|NCT05258630|474640439|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
131825030|NCT05258630|474640438|FG000|Overall Study|Lost to Follow-up|0|||
131825031|NCT05258630|474640439|FG001|Overall Study|Lost to Follow-up|2|||
131825032|NCT00109837|474640440|FG000|Overall Study|Adverse Event|2|||
131825033|NCT00109837|474640440|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
131825034|NCT00109837|474640440|FG000|Overall Study|Death|1|||
131825035|NCT00109837|474640440|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
131825036|NCT00109837|474640440|FG000|Overall Study|Not treated|1|||
131825037|NCT00109837|474640440|FG000|Overall Study|Ineligible|1|||
131825038|NCT01848210|474640441|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
131825039|NCT01848210|474640442|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
131825040|NCT01848210|474640441|FG000|Overall Study|Lost to Follow-up|24|||
131825041|NCT01848210|474640442|FG001|Overall Study|Lost to Follow-up|12|||
131825042|NCT01848210|474640441|FG000|Overall Study|Protocol Violation|3|||
131825043|NCT01848210|474640442|FG001|Overall Study|Protocol Violation|5|||
131825044|NCT01848210|474640441|FG000|Overall Study|Use of Forbidden Drugs|9|||
131825045|NCT01848210|474640442|FG001|Overall Study|Use of Forbidden Drugs|10|||
131825046|NCT01848210|474640441|FG000|Overall Study|Impedition Condition|5|||
131825047|NCT01848210|474640442|FG001|Overall Study|Impedition Condition|9|||
131825048|NCT01848210|474640441|FG000|Overall Study|Adverse Event|7|||
131825049|NCT01848210|474640442|FG001|Overall Study|Adverse Event|9|||
131825050|NCT01848210|474640441|FG000|Overall Study|Discontinuation Criterion|5|||
131825051|NCT01848210|474640442|FG001|Overall Study|Discontinuation Criterion|7|||
131825052|NCT01848210|474640441|FG000|Overall Study|Hypesensitivity|1|||
131825053|NCT01848210|474640442|FG001|Overall Study|Hypesensitivity|0|||
131401157|NCT02589665|473091460|FG004|Maintenance Period|Physician Decision|0|||
131825054|NCT01848210|474640441|FG000|Overall Study|Hepatic Function Alteration|4|||
131825055|NCT01848210|474640442|FG001|Overall Study|Hepatic Function Alteration|0|||
131825056|NCT01848210|474640441|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
131401158|NCT02589665|473091461|FG005|Maintenance Period|Physician Decision|1|||
131401159|NCT02589665|473091462|FG006|Maintenance Period|Physician Decision|0|||
131825057|NCT01848210|474640442|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
131825058|NCT01848210|474640441|FG000|Overall Study|Administrative|1|||
131825059|NCT01848210|474640442|FG001|Overall Study|Administrative|0|||
131825060|NCT00381849|474640443|FG000|Wash Out|Withdrawal by Subject|0|||
131825061|NCT00381849|474640444|FG001|Wash Out|Withdrawal by Subject|1|||
131825062|NCT00894933|474640450|FG000|Overall Study|Lost to Follow-up|2|||
131825063|NCT00894933|474640450|FG000|Overall Study|Cancelled Procedure|1|||
131825064|NCT00894933|474640450|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
131825065|NCT00631007|474640451|FG000|Overall Study|Adverse Event|0|||
131825066|NCT00631007|474640452|FG001|Overall Study|Adverse Event|2|||
131825067|NCT00631007|474640453|FG002|Overall Study|Adverse Event|0|||
131825068|NCT00631007|474640454|FG003|Overall Study|Adverse Event|2|||
131825069|NCT00631007|474640455|FG004|Overall Study|Adverse Event|3|||
131825070|NCT00631007|474640456|FG005|Overall Study|Adverse Event|2|||
131825071|NCT00631007|474640451|FG000|Overall Study|Lost to Follow-up|2|||
131825072|NCT00631007|474640452|FG001|Overall Study|Lost to Follow-up|1|||
131825073|NCT00631007|474640453|FG002|Overall Study|Lost to Follow-up|2|||
131825074|NCT00631007|474640454|FG003|Overall Study|Lost to Follow-up|4|||
131825075|NCT00631007|474640455|FG004|Overall Study|Lost to Follow-up|5|||
131825076|NCT00631007|474640456|FG005|Overall Study|Lost to Follow-up|3|||
131825077|NCT00631007|474640451|FG000|Overall Study|Physician Decision|1|||
131825078|NCT00631007|474640452|FG001|Overall Study|Physician Decision|0|||
131825079|NCT00631007|474640453|FG002|Overall Study|Physician Decision|1|||
131825080|NCT00631007|474640454|FG003|Overall Study|Physician Decision|0|||
131825081|NCT00631007|474640455|FG004|Overall Study|Physician Decision|0|||
131825082|NCT00631007|474640456|FG005|Overall Study|Physician Decision|2|||
131825083|NCT00631007|474640451|FG000|Overall Study|Persistent Hyperglycemia|2|||
131825084|NCT00631007|474640452|FG001|Overall Study|Persistent Hyperglycemia|2|||
131825085|NCT00631007|474640453|FG002|Overall Study|Persistent Hyperglycemia|5|||
131825086|NCT00631007|474640454|FG003|Overall Study|Persistent Hyperglycemia|1|||
131825087|NCT00631007|474640455|FG004|Overall Study|Persistent Hyperglycemia|2|||
131825088|NCT00631007|474640456|FG005|Overall Study|Persistent Hyperglycemia|5|||
131825089|NCT00631007|474640451|FG000|Overall Study|Withdrawal by Subject|4|||
131825090|NCT00631007|474640452|FG001|Overall Study|Withdrawal by Subject|5|||
131825091|NCT00631007|474640453|FG002|Overall Study|Withdrawal by Subject|2|||
131825092|NCT00631007|474640454|FG003|Overall Study|Withdrawal by Subject|2|||
131825093|NCT00631007|474640455|FG004|Overall Study|Withdrawal by Subject|1|||
131825094|NCT00631007|474640456|FG005|Overall Study|Withdrawal by Subject|3|||
131825095|NCT00631007|474640451|FG000|Overall Study|Other|2|||
131825096|NCT00631007|474640452|FG001|Overall Study|Other|1|||
131825097|NCT00631007|474640453|FG002|Overall Study|Other|0|||
131825098|NCT00631007|474640454|FG003|Overall Study|Other|0|||
131825099|NCT00631007|474640455|FG004|Overall Study|Other|1|||
131825100|NCT00631007|474640456|FG005|Overall Study|Other|0|||
131825101|NCT00683787|474640457|FG000|Overall Study|Progression|3|||
131825102|NCT00683787|474640458|FG001|Overall Study|Progression|3|||
131825103|NCT00683787|474640459|FG002|Overall Study|Progression|0|||
131825104|NCT00683787|474640457|FG000|Overall Study|Adverse Event|0|||
131825105|NCT00683787|474640458|FG001|Overall Study|Adverse Event|0|||
131825106|NCT00683787|474640459|FG002|Overall Study|Adverse Event|2|||
131825107|NCT04167618|474640460|FG000|Overall Study|Trial terminated by sponsor|1|||
131825108|NCT04167618|474640461|FG001|Overall Study|Trial terminated by sponsor|1|||
131825109|NCT00835796|474640463|FG000|First Intervention|Withdrawal by Subject|0|||
131825110|NCT00835796|474640464|FG001|First Intervention|Withdrawal by Subject|1|||
131825111|NCT00651183|474640469|FG000|Overall Study|Lack of Efficacy|1|||
131825112|NCT00651183|474640470|FG001|Overall Study|Lack of Efficacy|0|||
131825113|NCT00651183|474640469|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
131825114|NCT00651183|474640470|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
131825115|NCT00651183|474640469|FG000|Overall Study|Tolerability insufficient|5|||
131825116|NCT00651183|474640470|FG001|Overall Study|Tolerability insufficient|2|||
131825117|NCT00651183|474640469|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
131825118|NCT00651183|474640470|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
131825119|NCT00651183|474640469|FG000|Overall Study|Withdrawal by Subject|6|||
131825120|NCT00651183|474640470|FG001|Overall Study|Withdrawal by Subject|3|||
131825121|NCT00651183|474640469|FG000|Overall Study|Lost to Follow-up|3|||
131825122|NCT00651183|474640470|FG001|Overall Study|Lost to Follow-up|1|||
131825123|NCT00651183|474640469|FG000|Overall Study|Other reasons|4|||
131825124|NCT00651183|474640470|FG001|Overall Study|Other reasons|2|||
131825125|NCT00651183|474640469|FG000|Overall Study|missing|1|||
131825126|NCT00651183|474640470|FG001|Overall Study|missing|0|||
131825127|NCT03330236|474640474|FG000|Overall Study|Death|2|||
131825128|NCT03330236|474640475|FG001|Overall Study|Death|1|||
131825129|NCT03330236|474640474|FG000|Overall Study|Withdrawal by Subject|2|||
131825130|NCT03330236|474640475|FG001|Overall Study|Withdrawal by Subject|4|||
131825131|NCT03330236|474640474|FG000|Overall Study|Lost to Follow-up|0|||
131825132|NCT03330236|474640475|FG001|Overall Study|Lost to Follow-up|2|||
131825133|NCT03330236|474640474|FG000|Overall Study|Physician Decision|2|||
131825134|NCT03330236|474640475|FG001|Overall Study|Physician Decision|0|||
131825135|NCT03330236|474640474|FG000|Overall Study|Protocol Violation|4|||
131825136|NCT03330236|474640475|FG001|Overall Study|Protocol Violation|3|||
131825137|NCT03330236|474640474|FG000|Overall Study|SedLine malfunction/blinding|19|||
131825138|NCT03330236|474640475|FG001|Overall Study|SedLine malfunction/blinding|14|||
131825139|NCT03330236|474640474|FG000|Overall Study|Volatile anesthetics used|11|||
131825140|NCT03330236|474640475|FG001|Overall Study|Volatile anesthetics used|8|||
131825141|NCT03330236|474640474|FG000|Overall Study|Surgery aborted/converted to open|60|||
131825142|NCT03330236|474640475|FG001|Overall Study|Surgery aborted/converted to open|52|||
131825143|NCT00763555|474640476|FG000|Overall Study|Adverse Event|2|||
131825144|NCT00763555|474640477|FG001|Overall Study|Adverse Event|1|||
131825145|NCT00763555|474640476|FG000|Overall Study|Withdrawal by Subject|2|||
131825146|NCT00763555|474640477|FG001|Overall Study|Withdrawal by Subject|6|||
131825147|NCT00763555|474640476|FG000|Overall Study|Lost to Follow-up|0|||
131825148|NCT00763555|474640477|FG001|Overall Study|Lost to Follow-up|3|||
131825149|NCT02488824|474640478|FG000|Overall Study|Adverse Event|1|||
131825150|NCT02488824|474640479|FG001|Overall Study|Adverse Event|1|||
131825151|NCT00407745|474640480|FG000|Overall Study|Lack of Efficacy|1|||
131825152|NCT00407745|474640481|FG001|Overall Study|Lack of Efficacy|2|||
131825153|NCT00407745|474640480|FG000|Overall Study|Withdrawal by Subject|3|||
131825154|NCT00407745|474640481|FG001|Overall Study|Withdrawal by Subject|3|||
131825155|NCT00407745|474640480|FG000|Overall Study|Protocol Violation|5|||
131825156|NCT00407745|474640481|FG001|Overall Study|Protocol Violation|3|||
131825157|NCT00407745|474640480|FG000|Overall Study|Adverse Event|8|||
131825158|NCT00407745|474640481|FG001|Overall Study|Adverse Event|8|||
131825159|NCT00407745|474640480|FG000|Overall Study|Other|2|||
131825160|NCT00407745|474640481|FG001|Overall Study|Other|0|||
131825161|NCT00407745|474640480|FG000|Overall Study|Randomized, unknown if treated|0|||
131825162|NCT00407745|474640481|FG001|Overall Study|Randomized, unknown if treated|1|||
131825163|NCT00848042|474640482|FG000|Overall Study|Death|1|||
131825164|NCT00848042|474640483|FG001|Overall Study|Death|2|||
131825165|NCT00848042|474640484|FG002|Overall Study|Death|0|||
131825166|NCT00848042|474640482|FG000|Overall Study|Other Therapy|3|||
131825167|NCT00848042|474640483|FG001|Overall Study|Other Therapy|0|||
131825168|NCT00848042|474640484|FG002|Overall Study|Other Therapy|0|||
131825169|NCT02972515|474640485|FG000|Overall Study|Lost to Follow-up|78|||
131825170|NCT04253236|474640488|FG000|Overall Study|Adverse Event|1|||
131825171|NCT04253236|474640489|FG001|Overall Study|Adverse Event|0|||
131825172|NCT04253236|474640488|FG000|Overall Study|Safety Concerns|1|||
131825173|NCT04253236|474640489|FG001|Overall Study|Safety Concerns|0|||
131825174|NCT04253236|474640488|FG000|Overall Study|Study Terminated by Sponsor|1|||
131825175|NCT04253236|474640489|FG001|Overall Study|Study Terminated by Sponsor|0|||
131825176|NCT01833169|474640510|FG000|Overall Study|Disease Progression|99|||
131825177|NCT01833169|474640510|FG000|Overall Study|Adverse Event|33|||
131825178|NCT01833169|474640510|FG000|Overall Study|Withdrawal by Subject|9|||
131825179|NCT01833169|474640510|FG000|Overall Study|Death|3|||
131825180|NCT01833169|474640510|FG000|Overall Study|Physician Decision|2|||
131825181|NCT01183884|474640511|FG000|Overall Study|Progressive Disease|26|||
131825182|NCT01183884|474640511|FG000|Overall Study|Adverse Event|3|||
131825183|NCT01183884|474640511|FG000|Overall Study|Withdrawal by Subject|1|||
131825184|NCT01183884|474640511|FG000|Overall Study|Other Complicating Disease|3|||
131825185|NCT01183884|474640511|FG000|Overall Study|Not Treated|1|||
131825186|NCT01183884|474640511|FG000|Overall Study|Other|4|||
131825187|NCT00879684|474640512|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
131825188|NCT00879684|474640513|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
131825189|NCT00879684|474640514|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
131825190|NCT00879684|474640515|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
131825191|NCT00879684|474640516|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
131825192|NCT00879684|474640517|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
131825193|NCT00879684|474640518|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
131825194|NCT00879684|474640512|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
131825195|NCT00879684|474640513|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
131825196|NCT00879684|474640514|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
131825197|NCT00879684|474640515|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
131910028|NCT01041859|474958729|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
131910029|NCT01041859|474958730|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
131910030|NCT01041859|474958731|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
131910031|NCT01041859|474958729|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
131910032|NCT01041859|474958730|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
131910033|NCT01041859|474958731|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
131910034|NCT01041859|474958729|FG000|Double-Blind Maintenance|Physician Decision|0|||
131910035|NCT01041859|474958730|FG001|Double-Blind Maintenance|Physician Decision|2|||
131825198|NCT00879684|474640516|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
131825199|NCT00879684|474640517|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
131825200|NCT00879684|474640518|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
131825201|NCT00879684|474640512|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
131825202|NCT00879684|474640513|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
131825203|NCT00879684|474640514|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
131825204|NCT00879684|474640515|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
131825205|NCT00879684|474640516|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
131825206|NCT00879684|474640517|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
131825207|NCT00879684|474640518|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
131825208|NCT00879684|474640512|FG000|Stage 1: Dose Escalation|Death|0|||
131825209|NCT00879684|474640513|FG001|Stage 1: Dose Escalation|Death|0|||
131825210|NCT00879684|474640514|FG002|Stage 1: Dose Escalation|Death|1|||
131825211|NCT00879684|474640515|FG003|Stage 1: Dose Escalation|Death|0|||
131825212|NCT00879684|474640516|FG004|Stage 1: Dose Escalation|Death|0|||
131825213|NCT00879684|474640517|FG005|Stage 1: Dose Escalation|Death|0|||
131825214|NCT00879684|474640518|FG006|Stage 1: Dose Escalation|Death|0|||
131825215|NCT00879684|474640512|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
131825216|NCT00879684|474640513|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
131825217|NCT00879684|474640514|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
131825218|NCT00879684|474640515|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
131825219|NCT00879684|474640516|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
131825220|NCT00879684|474640517|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
131825221|NCT00879684|474640518|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
131825222|NCT00879684|474640512|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
131825223|NCT00879684|474640513|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
131825224|NCT00879684|474640514|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
131825225|NCT00879684|474640515|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
131825226|NCT00879684|474640516|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
131825227|NCT00879684|474640517|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
131825228|NCT00879684|474640518|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
131825229|NCT00879684|474640512|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
131825230|NCT00879684|474640513|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
131825231|NCT00879684|474640514|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
131825232|NCT00879684|474640515|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
131825233|NCT00879684|474640516|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
131825234|NCT00879684|474640517|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
131825235|NCT00879684|474640518|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
131825236|NCT00105157|474640519|FG000|Double-Blind (DB)|Never Treated|1|||
131825237|NCT00105157|474640520|FG001|Double-Blind (DB)|Never Treated|0|||
131825238|NCT00105157|474640521|FG002|Double-Blind (DB)|Never Treated|0|||
131825239|NCT00105157|474640522|FG003|Double-Blind (DB)|Never Treated|0|||
131825240|NCT00105157|474640519|FG000|Double-Blind (DB)|Adverse Event|2|||
131825241|NCT00105157|474640520|FG001|Double-Blind (DB)|Adverse Event|0|||
131825242|NCT00105157|474640521|FG002|Double-Blind (DB)|Adverse Event|1|||
131825243|NCT00105157|474640522|FG003|Double-Blind (DB)|Adverse Event|1|||
131825244|NCT00105157|474640519|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
131825245|NCT00105157|474640520|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
131825246|NCT00105157|474640521|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
131825247|NCT00105157|474640522|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
131825248|NCT00105157|474640519|FG000|Open-Label Continuation of DB|Adverse Event|3|||
131825249|NCT00105157|474640520|FG001|Open-Label Continuation of DB|Adverse Event|1|||
131825250|NCT00105157|474640521|FG002|Open-Label Continuation of DB|Adverse Event|0|||
131825251|NCT00105157|474640522|FG003|Open-Label Continuation of DB|Adverse Event|0|||
131825252|NCT00105157|474640519|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
131825253|NCT00105157|474640520|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
131825254|NCT00105157|474640521|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
131825255|NCT00105157|474640522|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
131825256|NCT00105157|474640519|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
131825257|NCT00105157|474640520|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
131825258|NCT00105157|474640521|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
131825259|NCT00105157|474640522|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
131825260|NCT00105157|474640519|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
131825261|NCT00105157|474640520|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
131825262|NCT00105157|474640521|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
131825263|NCT00105157|474640522|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
131825264|NCT00105157|474640519|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
131825265|NCT00105157|474640520|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
131825266|NCT00105157|474640521|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
131825267|NCT00105157|474640522|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
131825268|NCT00105157|474640519|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
131825269|NCT00105157|474640520|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
131825270|NCT00105157|474640521|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
131825271|NCT00105157|474640522|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
131825272|NCT00105157|474640519|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
131825273|NCT00105157|474640520|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
131825274|NCT00105157|474640521|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
131825275|NCT00105157|474640522|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
131825276|NCT00105157|474640519|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
131825277|NCT00105157|474640520|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
131825278|NCT00105157|474640521|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
131825279|NCT00105157|474640522|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
131825280|NCT00105157|474640519|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
131825281|NCT00105157|474640520|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
131825282|NCT00105157|474640521|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
131825283|NCT00105157|474640522|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
131825284|NCT00105157|474640519|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
131825285|NCT00105157|474640520|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
131825286|NCT00105157|474640521|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
131825287|NCT00105157|474640522|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
131825288|NCT00105157|474640519|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
131825289|NCT00105157|474640520|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
131825290|NCT00105157|474640521|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
131825291|NCT00105157|474640522|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
131825292|NCT00127166|474640523|FG000|Period I|Protocol Violation|0|||
131825293|NCT00127166|474640524|FG001|Period I|Protocol Violation|2|||
131825294|NCT00127166|474640523|FG000|Period I|Withdrawal by Subject|2|||
131825295|NCT00127166|474640524|FG001|Period I|Withdrawal by Subject|0|||
131825296|NCT00127166|474640523|FG000|Period I|Patient did not meet inclusion criteria|1|||
131825297|NCT00127166|474640524|FG001|Period I|Patient did not meet inclusion criteria|0|||
131825298|NCT00127166|474640523|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
131825299|NCT00127166|474640524|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
131825300|NCT00127166|474640523|FG000|Period II|Withdrawal by Subject|2|||
131825301|NCT00127166|474640524|FG001|Period II|Withdrawal by Subject|0|||
131825302|NCT00127166|474640523|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
131825303|NCT00127166|474640524|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
131825304|NCT04718129|474640531|FG000|Overall Study|Lost to Follow-up|6|||
131825305|NCT04718129|474640532|FG001|Overall Study|Lost to Follow-up|7|||
131825306|NCT02212457|474640533|FG000|Overall Study|Adverse Event|1|||
131825307|NCT02212457|474640534|FG001|Overall Study|Adverse Event|2|||
131825308|NCT02212457|474640535|FG002|Overall Study|Adverse Event|2|||
131825309|NCT02212457|474640536|FG003|Overall Study|Adverse Event|2|||
131825310|NCT02212457|474640537|FG004|Overall Study|Adverse Event|0|||
131825311|NCT02212457|474640538|FG005|Overall Study|Adverse Event|1|||
131825312|NCT02212457|474640533|FG000|Overall Study|Withdrawal by Subject|8|||
131825313|NCT02212457|474640534|FG001|Overall Study|Withdrawal by Subject|10|||
131825314|NCT02212457|474640535|FG002|Overall Study|Withdrawal by Subject|8|||
131825315|NCT02212457|474640536|FG003|Overall Study|Withdrawal by Subject|6|||
131825316|NCT02212457|474640537|FG004|Overall Study|Withdrawal by Subject|5|||
131825317|NCT02212457|474640538|FG005|Overall Study|Withdrawal by Subject|4|||
131825318|NCT02212457|474640533|FG000|Overall Study|Lost to Follow-up|6|||
131825319|NCT02212457|474640534|FG001|Overall Study|Lost to Follow-up|7|||
131825320|NCT02212457|474640535|FG002|Overall Study|Lost to Follow-up|4|||
131825321|NCT02212457|474640536|FG003|Overall Study|Lost to Follow-up|1|||
131825322|NCT02212457|474640537|FG004|Overall Study|Lost to Follow-up|8|||
131825323|NCT02212457|474640538|FG005|Overall Study|Lost to Follow-up|4|||
131825324|NCT02212457|474640533|FG000|Overall Study|Protocol Violation|2|||
131825325|NCT02212457|474640534|FG001|Overall Study|Protocol Violation|1|||
131825326|NCT02212457|474640535|FG002|Overall Study|Protocol Violation|0|||
131825327|NCT02212457|474640536|FG003|Overall Study|Protocol Violation|1|||
131825328|NCT02212457|474640537|FG004|Overall Study|Protocol Violation|2|||
131825329|NCT02212457|474640538|FG005|Overall Study|Protocol Violation|3|||
131825330|NCT02212457|474640533|FG000|Overall Study|Other|2|||
131825331|NCT02212457|474640534|FG001|Overall Study|Other|1|||
131825332|NCT02212457|474640535|FG002|Overall Study|Other|2|||
131825333|NCT02212457|474640536|FG003|Overall Study|Other|1|||
131825334|NCT02212457|474640537|FG004|Overall Study|Other|0|||
131825335|NCT02212457|474640538|FG005|Overall Study|Other|1|||
131825336|NCT00420095|474640542|FG000|Overall Study|Adverse Event|1|||
131910036|NCT01041859|474958731|FG002|Double-Blind Maintenance|Physician Decision|1|||
131910037|NCT01041859|474958729|FG000|Double-Blind Maintenance|Protocol Violation|0|||
131910038|NCT01041859|474958730|FG001|Double-Blind Maintenance|Protocol Violation|1|||
131910039|NCT01041859|474958731|FG002|Double-Blind Maintenance|Protocol Violation|3|||
131825337|NCT00420095|474640543|FG001|Overall Study|Adverse Event|0|||
131825338|NCT00420095|474640542|FG000|Overall Study|Protocol Violation|1|||
131825339|NCT00420095|474640543|FG001|Overall Study|Protocol Violation|1|||
131825340|NCT00420095|474640542|FG000|Overall Study|Lost to Follow-up|1|||
131825341|NCT00420095|474640543|FG001|Overall Study|Lost to Follow-up|0|||
131825342|NCT00393705|474640544|FG000|Overall Study|Adverse Event|0|||
131825343|NCT00393705|474640545|FG001|Overall Study|Adverse Event|2|||
131825344|NCT00393705|474640544|FG000|Overall Study|Death|0|||
131825345|NCT00393705|474640545|FG001|Overall Study|Death|1|||
131825346|NCT00393705|474640544|FG000|Overall Study|Lost to Follow-up|2|||
131825347|NCT00393705|474640545|FG001|Overall Study|Lost to Follow-up|2|||
131825348|NCT00393705|474640544|FG000|Overall Study|Entry Criteria Not Met|10|||
131825349|NCT00393705|474640545|FG001|Overall Study|Entry Criteria Not Met|10|||
131825350|NCT00393705|474640544|FG000|Overall Study|Protocol Violation|4|||
131825351|NCT00393705|474640545|FG001|Overall Study|Protocol Violation|3|||
131825352|NCT00393705|474640544|FG000|Overall Study|Withdrawal by Subject|5|||
131825353|NCT00393705|474640545|FG001|Overall Study|Withdrawal by Subject|3|||
131825354|NCT00393705|474640544|FG000|Overall Study|Physician Decision|2|||
131825355|NCT00393705|474640545|FG001|Overall Study|Physician Decision|2|||
131825356|NCT03185741|474640550|FG000|Baseline|Withdrawal by Subject|1|||
131825357|NCT03185741|474640551|FG001|Baseline|Withdrawal by Subject|3|||
131825358|NCT03185741|474640552|FG002|Baseline|Withdrawal by Subject|2|||
131825359|NCT03185741|474640550|FG000|Baseline|Lost to Follow-up|1|||
131825360|NCT03185741|474640551|FG001|Baseline|Lost to Follow-up|2|||
131825361|NCT03185741|474640552|FG002|Baseline|Lost to Follow-up|3|||
131825362|NCT03185741|474640550|FG000|3Month|Death|1|||
131825363|NCT03185741|474640551|FG001|3Month|Death|1|||
131825364|NCT03185741|474640552|FG002|3Month|Death|2|||
131825365|NCT03185741|474640550|FG000|3Month|Withdrawal by Subject|1|||
131825366|NCT03185741|474640551|FG001|3Month|Withdrawal by Subject|5|||
131825367|NCT03185741|474640552|FG002|3Month|Withdrawal by Subject|1|||
131825368|NCT03185741|474640550|FG000|3Month|Lost to Follow-up|7|||
131825369|NCT03185741|474640551|FG001|3Month|Lost to Follow-up|9|||
131825370|NCT03185741|474640552|FG002|3Month|Lost to Follow-up|8|||
131825371|NCT03185741|474640550|FG000|3Month|Unavailable for 3Month|11|||
131825372|NCT03185741|474640551|FG001|3Month|Unavailable for 3Month|10|||
131825373|NCT03185741|474640552|FG002|3Month|Unavailable for 3Month|11|||
131825374|NCT03185741|474640550|FG000|3Month|Protocol Violation|0|||
131825375|NCT03185741|474640551|FG001|3Month|Protocol Violation|0|||
131825376|NCT03185741|474640552|FG002|3Month|Protocol Violation|3|||
131825377|NCT03185741|474640550|FG000|6Month|Death|1|||
131825378|NCT03185741|474640551|FG001|6Month|Death|1|||
131825379|NCT03185741|474640552|FG002|6Month|Death|2|||
131825380|NCT03185741|474640550|FG000|6Month|Withdrawal by Subject|2|||
131825381|NCT03185741|474640551|FG001|6Month|Withdrawal by Subject|3|||
131825382|NCT03185741|474640552|FG002|6Month|Withdrawal by Subject|1|||
131825383|NCT03185741|474640550|FG000|6Month|Lost to Follow-up|16|||
131825384|NCT03185741|474640551|FG001|6Month|Lost to Follow-up|15|||
131825385|NCT03185741|474640552|FG002|6Month|Lost to Follow-up|16|||
131825386|NCT01835548|474640554|FG000|Dose Optimization Period|Adverse Event|0|||
131825387|NCT01835548|474640555|FG001|Dose Optimization Period|Adverse Event|0|||
131825388|NCT01835548|474640556|FG002|Dose Optimization Period|Adverse Event|1|||
131825389|NCT01835548|474640554|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
131825390|NCT01835548|474640555|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
131825391|NCT01835548|474640556|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
131825392|NCT01835548|474640554|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131825393|NCT01835548|474640555|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131825394|NCT01835548|474640556|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131825395|NCT01835548|474640554|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131825396|NCT01835548|474640555|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131401160|NCT02589665|473091463|FG007|Maintenance Period|Physician Decision|0|||
131401161|NCT02589665|473091464|FG008|Maintenance Period|Physician Decision|0|||
131401162|NCT02589665|473091465|FG009|Maintenance Period|Physician Decision|0|||
131401163|NCT02589665|473091456|FG000|Maintenance Period|Reason Not Collected|0|||
131401164|NCT02589665|473091457|FG001|Maintenance Period|Reason Not Collected|0|||
131401165|NCT02589665|473091458|FG002|Maintenance Period|Reason Not Collected|0|||
131401166|NCT02589665|473091459|FG003|Maintenance Period|Reason Not Collected|0|||
131401167|NCT02589665|473091460|FG004|Maintenance Period|Reason Not Collected|0|||
131825397|NCT01835548|474640556|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131825398|NCT01634854|474640557|FG000|Overall Study|Cesarean delivery|2|||
131825399|NCT01634854|474640558|FG001|Overall Study|Cesarean delivery|7|||
131825400|NCT01169038|474640559|FG000|Overall Study|Death|1|||
131825401|NCT01169038|474640559|FG000|Overall Study|Adverse Event|5|||
131825402|NCT01169038|474640559|FG000|Overall Study|Required antibiotic administration|1|||
131825403|NCT01488448|474640560|FG000|Overall Study|Withdrawal by Subject|3|||
131825404|NCT01488448|474640561|FG001|Overall Study|Withdrawal by Subject|1|||
131825405|NCT01488448|474640560|FG000|Overall Study|Adverse Event|9|||
131401168|NCT02589665|473091461|FG005|Maintenance Period|Reason Not Collected|1|||
131401169|NCT02589665|473091462|FG006|Maintenance Period|Reason Not Collected|1|||
131401170|NCT02589665|473091463|FG007|Maintenance Period|Reason Not Collected|0|||
131825406|NCT01488448|474640561|FG001|Overall Study|Adverse Event|4|||
131825407|NCT01488448|474640560|FG000|Overall Study|Physician Decision|4|||
131825408|NCT01488448|474640561|FG001|Overall Study|Physician Decision|9|||
131825409|NCT01488448|474640560|FG000|Overall Study|Protocol Violation|4|||
131825410|NCT01488448|474640561|FG001|Overall Study|Protocol Violation|3|||
131825411|NCT03257254|474640562|FG000|Overall Study|Withdrawal by Subject|7|||
131825412|NCT03257254|474640562|FG000|Overall Study|Lost to Follow-up|9|||
131825413|NCT03257254|474640562|FG000|Overall Study|Study discontinued by sponsor|5|||
131825414|NCT00654641|474640564|FG000|Overall Study|Lost to Follow-up|2|||
131825415|NCT00654641|474640565|FG001|Overall Study|Lost to Follow-up|3|||
131825416|NCT02329431|474640566|FG000|Overall Study|Lost to Follow-up|20|||
131825417|NCT02329431|474640567|FG001|Overall Study|Lost to Follow-up|13|||
131825418|NCT01475487|474640568|FG000|Overall Study|had to leave early for personal reasons|2|||
131825419|NCT01475487|474640569|FG001|Overall Study|had to leave early for personal reasons|1|||
131825420|NCT03168906|474640570|FG000|Overall Study|Lack of Efficacy|6|||
131825421|NCT03168906|474640571|FG001|Overall Study|Lack of Efficacy|6|||
131825422|NCT01321697|474640572|FG000|Overall Study|Study Terminated|7|||
131825423|NCT01977456|474640573|FG000|Overall Study|Death|5|||
131825424|NCT01142661|474640574|FG000|Overall Study|Adverse Event|2|||
131825425|NCT01142661|474640574|FG000|Overall Study|Withdrawal by Subject|1|||
131825426|NCT01142661|474640574|FG000|Overall Study|Physician Decision|1|||
131825427|NCT02674633|474642552|FG000|Overall Study|Lost to Follow-up|3|||
131825428|NCT02674633|474642553|FG001|Overall Study|Lost to Follow-up|2|||
131825429|NCT02674633|474642552|FG000|Overall Study|Physician Decision|1|||
131825430|NCT02674633|474642553|FG001|Overall Study|Physician Decision|0|||
131825431|NCT02674633|474642552|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131825432|NCT02674633|474642553|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131825433|NCT00460109|474642554|FG000|Overall Study|Death|1|||
131825434|NCT02014441|474642555|FG000|Overall Study|Withdrawal by Subject|12|||
131825435|NCT00996437|474642557|FG000|Overall Study|Death|1|||
131825436|NCT00996437|474642558|FG001|Overall Study|Death|0|||
131825437|NCT00996437|474642557|FG000|Overall Study|Dropped|2|||
131825438|NCT00996437|474642558|FG001|Overall Study|Dropped|2|||
131825439|NCT00996437|474642557|FG000|Overall Study|Missed|2|||
131825440|NCT00996437|474642558|FG001|Overall Study|Missed|5|||
131825441|NCT02576717|474642559|FG000|Overall Study|Other Reasons|16|||
131825442|NCT02576717|474642560|FG001|Overall Study|Other Reasons|18|||
131825443|NCT02576717|474642561|FG002|Overall Study|Other Reasons|15|||
131825444|NCT02576717|474642559|FG000|Overall Study|Covid-19 Pandemic|0|||
131825445|NCT02576717|474642560|FG001|Overall Study|Covid-19 Pandemic|1|||
131825446|NCT02576717|474642561|FG002|Overall Study|Covid-19 Pandemic|1|||
131825447|NCT02576717|474642559|FG000|Overall Study|Sponsor Decision|0|||
131825448|NCT02576717|474642560|FG001|Overall Study|Sponsor Decision|0|||
131825449|NCT02576717|474642561|FG002|Overall Study|Sponsor Decision|1|||
131825450|NCT02576717|474642559|FG000|Overall Study|Physician Decision|3|||
131825451|NCT02576717|474642560|FG001|Overall Study|Physician Decision|8|||
131825452|NCT02576717|474642561|FG002|Overall Study|Physician Decision|9|||
131825453|NCT02576717|474642559|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
131825454|NCT02576717|474642560|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
131825455|NCT02576717|474642561|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
131825456|NCT02576717|474642559|FG000|Overall Study|Death|3|||
131825457|NCT02576717|474642560|FG001|Overall Study|Death|5|||
131825458|NCT02576717|474642561|FG002|Overall Study|Death|3|||
131825459|NCT02576717|474642559|FG000|Overall Study|Lost to Follow-up|9|||
131825460|NCT02576717|474642560|FG001|Overall Study|Lost to Follow-up|10|||
131825461|NCT02576717|474642561|FG002|Overall Study|Lost to Follow-up|19|||
131825462|NCT02576717|474642559|FG000|Overall Study|Protocol Violation|4|||
131825463|NCT02576717|474642560|FG001|Overall Study|Protocol Violation|0|||
131825464|NCT02576717|474642561|FG002|Overall Study|Protocol Violation|5|||
131825465|NCT02576717|474642559|FG000|Overall Study|Lack of Efficacy|24|||
131825466|NCT02576717|474642560|FG001|Overall Study|Lack of Efficacy|28|||
131825467|NCT02576717|474642561|FG002|Overall Study|Lack of Efficacy|20|||
131825468|NCT02576717|474642559|FG000|Overall Study|Adverse Event|26|||
131825469|NCT02576717|474642560|FG001|Overall Study|Adverse Event|32|||
131825470|NCT02576717|474642561|FG002|Overall Study|Adverse Event|26|||
131825471|NCT01363011|474642562|FG000|Main Study|Adverse Event|2|||
131825472|NCT01363011|474642563|FG001|Main Study|Adverse Event|3|||
131825473|NCT01363011|474642562|FG000|Main Study|Investigator's Discretion|1|||
131825474|NCT01363011|474642563|FG001|Main Study|Investigator's Discretion|1|||
131825475|NCT01363011|474642562|FG000|Main Study|Withdrew Consent|1|||
131825476|NCT01363011|474642563|FG001|Main Study|Withdrew Consent|4|||
131825477|NCT01363011|474642562|FG000|Main Study|Protocol Violation|0|||
131825478|NCT01363011|474642563|FG001|Main Study|Protocol Violation|1|||
131825479|NCT01363011|474642562|FG000|Extension Phase|Adverse Event|1|||
131825480|NCT01363011|474642563|FG001|Extension Phase|Adverse Event|1|||
131825481|NCT01363011|474642562|FG000|Extension Phase|Lack of Efficacy|0|||
131825482|NCT01363011|474642563|FG001|Extension Phase|Lack of Efficacy|1|||
131825483|NCT01363011|474642562|FG000|Extension Phase|Investigator's Discretion|2|||
131825484|NCT01363011|474642563|FG001|Extension Phase|Investigator's Discretion|2|||
131825485|NCT01363011|474642562|FG000|Extension Phase|Withdrew Consent|0|||
131825486|NCT01363011|474642563|FG001|Extension Phase|Withdrew Consent|1|||
131825487|NCT01363011|474642562|FG000|Extension Phase|Lost to Follow-up|0|||
131825488|NCT01363011|474642563|FG001|Extension Phase|Lost to Follow-up|2|||
131825489|NCT01363011|474642562|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
131825490|NCT01363011|474642563|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
131825491|NCT00399893|474642564|FG000|Overall Study|Withdrawal by Subject|1|||
131910040|NCT01041859|474958729|FG000|Double-Blind Maintenance|Other|0|||
131825492|NCT00399893|474642565|FG001|Overall Study|Withdrawal by Subject|0|||
131825493|NCT04412057|474642566|FG000|Overall Study|Death|3|||
131825494|NCT04412057|474642567|FG001|Overall Study|Death|7|||
131825495|NCT04412057|474642566|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
131825496|NCT04412057|474642567|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
131825497|NCT02510261|474642571|FG000|Overall Study|Adverse Event|5|||
131825498|NCT02510261|474642572|FG001|Overall Study|Adverse Event|8|||
131825499|NCT02510261|474642573|FG002|Overall Study|Adverse Event|0|||
131825500|NCT02510261|474642571|FG000|Overall Study|Physician Decision|1|||
131825501|NCT02510261|474642572|FG001|Overall Study|Physician Decision|5|||
131825502|NCT02510261|474642573|FG002|Overall Study|Physician Decision|0|||
131825503|NCT02510261|474642571|FG000|Overall Study|Death|19|||
131825504|NCT02510261|474642572|FG001|Overall Study|Death|19|||
131825505|NCT02510261|474642573|FG002|Overall Study|Death|0|||
131825506|NCT02510261|474642571|FG000|Overall Study|Withdrawal by Subject|3|||
131825507|NCT02510261|474642572|FG001|Overall Study|Withdrawal by Subject|10|||
131825508|NCT02510261|474642573|FG002|Overall Study|Withdrawal by Subject|3|||
131825509|NCT00108082|474642574|FG000|Overall Study|Adverse Event|14|||
131825510|NCT00108082|474642575|FG001|Overall Study|Adverse Event|12|||
131825511|NCT00108082|474642576|FG002|Overall Study|Adverse Event|17|||
131825512|NCT00108082|474642574|FG000|Overall Study|Lost to Follow-up|6|||
131825513|NCT00108082|474642575|FG001|Overall Study|Lost to Follow-up|3|||
131825514|NCT00108082|474642576|FG002|Overall Study|Lost to Follow-up|7|||
131825515|NCT00108082|474642574|FG000|Overall Study|Consent Withdrawn|3|||
131825516|NCT00108082|474642575|FG001|Overall Study|Consent Withdrawn|3|||
131825517|NCT00108082|474642576|FG002|Overall Study|Consent Withdrawn|5|||
131825518|NCT00108082|474642574|FG000|Overall Study|Protocol Violation|1|||
131825519|NCT00108082|474642575|FG001|Overall Study|Protocol Violation|2|||
131825520|NCT00108082|474642576|FG002|Overall Study|Protocol Violation|0|||
131825521|NCT00108082|474642574|FG000|Overall Study|Lack of Efficacy|3|||
131825522|NCT00108082|474642575|FG001|Overall Study|Lack of Efficacy|1|||
131825523|NCT00108082|474642576|FG002|Overall Study|Lack of Efficacy|2|||
131825524|NCT00108082|474642574|FG000|Overall Study|Amendment 4: > Month 12|5|||
131825525|NCT00108082|474642575|FG001|Overall Study|Amendment 4: > Month 12|7|||
131825526|NCT00108082|474642576|FG002|Overall Study|Amendment 4: > Month 12|5|||
131825527|NCT00108082|474642574|FG000|Overall Study|Woman of Child-bearing Potential|2|||
131825528|NCT00108082|474642575|FG001|Overall Study|Woman of Child-bearing Potential|0|||
131825529|NCT00108082|474642576|FG002|Overall Study|Woman of Child-bearing Potential|2|||
131825530|NCT00108082|474642574|FG000|Overall Study|Incorrectly Randomized|0|||
131825531|NCT00108082|474642575|FG001|Overall Study|Incorrectly Randomized|0|||
131825532|NCT00108082|474642576|FG002|Overall Study|Incorrectly Randomized|2|||
131825533|NCT00108082|474642574|FG000|Overall Study|Non-compliance|1|||
131825534|NCT00108082|474642575|FG001|Overall Study|Non-compliance|0|||
131825535|NCT00108082|474642576|FG002|Overall Study|Non-compliance|2|||
131825536|NCT00108082|474642574|FG000|Overall Study|Stopped Study Medication|0|||
131825537|NCT00108082|474642575|FG001|Overall Study|Stopped Study Medication|0|||
131825538|NCT00108082|474642576|FG002|Overall Study|Stopped Study Medication|1|||
131825539|NCT00108082|474642574|FG000|Overall Study|Site Closed Study|0|||
131825540|NCT00108082|474642575|FG001|Overall Study|Site Closed Study|2|||
131825541|NCT00108082|474642576|FG002|Overall Study|Site Closed Study|0|||
131825542|NCT00108082|474642574|FG000|Overall Study|Protocol Amendment|0|||
131825543|NCT00108082|474642575|FG001|Overall Study|Protocol Amendment|1|||
131825544|NCT00108082|474642576|FG002|Overall Study|Protocol Amendment|0|||
131825545|NCT00108082|474642574|FG000|Overall Study|Study Medication Not Tapered|0|||
131825546|NCT00108082|474642575|FG001|Overall Study|Study Medication Not Tapered|1|||
131825547|NCT00108082|474642576|FG002|Overall Study|Study Medication Not Tapered|0|||
131825548|NCT00108082|474642574|FG000|Overall Study|Subject Left Site Location|1|||
131825549|NCT00108082|474642575|FG001|Overall Study|Subject Left Site Location|0|||
131401171|NCT02589665|473091464|FG008|Maintenance Period|Reason Not Collected|0|||
131825550|NCT00108082|474642576|FG002|Overall Study|Subject Left Site Location|0|||
131825551|NCT00108082|474642574|FG000|Overall Study|Investigator Not at Site|1|||
131825552|NCT00108082|474642575|FG001|Overall Study|Investigator Not at Site|0|||
131825553|NCT00108082|474642576|FG002|Overall Study|Investigator Not at Site|0|||
131825554|NCT00108082|474642574|FG000|Overall Study|Blood Pressure Not Controlled|1|||
131825555|NCT00108082|474642575|FG001|Overall Study|Blood Pressure Not Controlled|0|||
131825556|NCT00108082|474642576|FG002|Overall Study|Blood Pressure Not Controlled|0|||
131825557|NCT02940730|474642582|FG000|Intervention 2|Physician Decision|7|||
131825558|NCT02940730|474642583|FG001|Intervention 2|Physician Decision|0|||
131825559|NCT03036839|474642587|FG000|Overall Study|Adverse Event|0|||
131825560|NCT03036839|474642588|FG001|Overall Study|Adverse Event|0|||
131825561|NCT03036839|474642589|FG002|Overall Study|Adverse Event|1|||
131825562|NCT03036839|474642587|FG000|Overall Study|Death|3|||
131825563|NCT03036839|474642588|FG001|Overall Study|Death|0|||
131825564|NCT03036839|474642589|FG002|Overall Study|Death|3|||
131825565|NCT03036839|474642587|FG000|Overall Study|Withdrew Consent|0|||
131825566|NCT03036839|474642588|FG001|Overall Study|Withdrew Consent|0|||
131825567|NCT03036839|474642589|FG002|Overall Study|Withdrew Consent|1|||
131825568|NCT00412737|474642591|FG000|Overall Study|Death|1|||
131825569|NCT00412737|474642592|FG001|Overall Study|Death|0|||
131825570|NCT00412737|474642591|FG000|Overall Study|Adverse Event|3|||
131825571|NCT00412737|474642592|FG001|Overall Study|Adverse Event|2|||
131825572|NCT00412737|474642591|FG000|Overall Study|Refused Treatment|6|||
131825573|NCT00412737|474642592|FG001|Overall Study|Refused Treatment|2|||
131825574|NCT00412737|474642591|FG000|Overall Study|Failure to Return|6|||
131825575|NCT00412737|474642592|FG001|Overall Study|Failure to Return|2|||
131825576|NCT01064531|474642596|FG000|Overall Study|Lost to Follow-up|0|||
131825577|NCT01064531|474642597|FG001|Overall Study|Lost to Follow-up|2|||
131825578|NCT01064531|474642596|FG000|Overall Study|Physician Decision|0|||
131825579|NCT01064531|474642597|FG001|Overall Study|Physician Decision|1|||
131825580|NCT01064531|474642596|FG000|Overall Study|Withdrawal by Subject|2|||
131825581|NCT01064531|474642597|FG001|Overall Study|Withdrawal by Subject|2|||
131825582|NCT01064531|474642596|FG000|Overall Study|Revision due to femoral stem loosening|1|||
131825583|NCT01064531|474642597|FG001|Overall Study|Revision due to femoral stem loosening|0|||
131825584|NCT01064531|474642596|FG000|Overall Study|Revision due to dislocation|0|||
131825585|NCT01064531|474642597|FG001|Overall Study|Revision due to dislocation|1|||
131825586|NCT01064531|474642596|FG000|Overall Study|Death|0|||
131825587|NCT01064531|474642597|FG001|Overall Study|Death|1|||
131825588|NCT01201759|474642599|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
131825589|NCT01201759|474642600|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
131825590|NCT01201759|474642599|FG000|Visit 3 - Washout|Adverse Event|0|||
131825591|NCT01201759|474642600|FG001|Visit 3 - Washout|Adverse Event|3|||
131825592|NCT01201759|474642599|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
131825593|NCT01201759|474642600|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
131825594|NCT01201759|474642599|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
131825595|NCT01201759|474642600|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
131825596|NCT04317599|474642603|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
131825597|NCT04317599|474642603|FG000|Overall Study|treatment outside standard of care|4|||
131825598|NCT00809965|474642604|FG000|Overall Study|Death|194|||
131825599|NCT00809965|474642605|FG001|Overall Study|Death|147|||
131825600|NCT00809965|474642606|FG002|Overall Study|Death|196|||
131825601|NCT00809965|474642604|FG000|Overall Study|Lost to Follow-up|17|||
131825602|NCT00809965|474642605|FG001|Overall Study|Lost to Follow-up|10|||
131825603|NCT00809965|474642606|FG002|Overall Study|Lost to Follow-up|18|||
131825604|NCT00809965|474642604|FG000|Overall Study|Withdrawal by Subject|405|||
131825605|NCT00809965|474642605|FG001|Overall Study|Withdrawal by Subject|448|||
131825606|NCT00809965|474642606|FG002|Overall Study|Withdrawal by Subject|441|||
131825607|NCT00809965|474642604|FG000|Overall Study|Other Reason|167|||
131825608|NCT00809965|474642605|FG001|Overall Study|Other Reason|170|||
131825609|NCT00809965|474642606|FG002|Overall Study|Other Reason|189|||
131825610|NCT02315066|474642607|FG000|Overall Study|Lost to Follow-up|0|||
131825611|NCT02315066|474642608|FG001|Overall Study|Lost to Follow-up|1|||
131825612|NCT02315066|474642609|FG002|Overall Study|Lost to Follow-up|1|||
131825613|NCT02315066|474642610|FG003|Overall Study|Lost to Follow-up|0|||
131825614|NCT02315066|474642611|FG004|Overall Study|Lost to Follow-up|1|||
131825615|NCT02315066|474642612|FG005|Overall Study|Lost to Follow-up|0|||
131825616|NCT02315066|474642613|FG006|Overall Study|Lost to Follow-up|2|||
131825617|NCT02315066|474642614|FG007|Overall Study|Lost to Follow-up|1|||
131825618|NCT02315066|474642615|FG008|Overall Study|Lost to Follow-up|0|||
131825619|NCT02315066|474642616|FG009|Overall Study|Lost to Follow-up|0|||
131825620|NCT02315066|474642617|FG010|Overall Study|Lost to Follow-up|1|||
131825621|NCT02315066|474642618|FG011|Overall Study|Lost to Follow-up|2|||
131825622|NCT02315066|474642619|FG012|Overall Study|Lost to Follow-up|0|||
131825623|NCT02315066|474642620|FG013|Overall Study|Lost to Follow-up|4|||
131825624|NCT02315066|474642607|FG000|Overall Study|Death|2|||
131825625|NCT02315066|474642608|FG001|Overall Study|Death|7|||
131825626|NCT02315066|474642609|FG002|Overall Study|Death|6|||
131825627|NCT02315066|474642610|FG003|Overall Study|Death|11|||
131825628|NCT02315066|474642611|FG004|Overall Study|Death|10|||
131825629|NCT02315066|474642612|FG005|Overall Study|Death|3|||
131825630|NCT02315066|474642613|FG006|Overall Study|Death|9|||
131825631|NCT02315066|474642614|FG007|Overall Study|Death|9|||
131825632|NCT02315066|474642615|FG008|Overall Study|Death|10|||
131825633|NCT02315066|474642616|FG009|Overall Study|Death|8|||
131825634|NCT02315066|474642617|FG010|Overall Study|Death|10|||
131825635|NCT02315066|474642618|FG011|Overall Study|Death|7|||
131825636|NCT02315066|474642619|FG012|Overall Study|Death|8|||
131825637|NCT02315066|474642620|FG013|Overall Study|Death|21|||
131825638|NCT02315066|474642607|FG000|Overall Study|Other|0|||
131825639|NCT02315066|474642608|FG001|Overall Study|Other|0|||
131825640|NCT02315066|474642609|FG002|Overall Study|Other|0|||
131825641|NCT02315066|474642610|FG003|Overall Study|Other|0|||
131825642|NCT02315066|474642611|FG004|Overall Study|Other|0|||
131825643|NCT02315066|474642612|FG005|Overall Study|Other|0|||
131825644|NCT02315066|474642613|FG006|Overall Study|Other|0|||
131825645|NCT02315066|474642614|FG007|Overall Study|Other|1|||
131825646|NCT02315066|474642615|FG008|Overall Study|Other|1|||
131825647|NCT02315066|474642616|FG009|Overall Study|Other|2|||
131825648|NCT02315066|474642617|FG010|Overall Study|Other|0|||
131825649|NCT02315066|474642618|FG011|Overall Study|Other|0|||
131825650|NCT02315066|474642619|FG012|Overall Study|Other|0|||
131825651|NCT02315066|474642620|FG013|Overall Study|Other|0|||
131825652|NCT02315066|474642607|FG000|Overall Study|Subject refused further follow-up|0|||
131825653|NCT02315066|474642608|FG001|Overall Study|Subject refused further follow-up|2|||
131825654|NCT02315066|474642609|FG002|Overall Study|Subject refused further follow-up|2|||
131825655|NCT02315066|474642610|FG003|Overall Study|Subject refused further follow-up|0|||
131825656|NCT02315066|474642611|FG004|Overall Study|Subject refused further follow-up|0|||
131825657|NCT02315066|474642612|FG005|Overall Study|Subject refused further follow-up|0|||
131825658|NCT02315066|474642613|FG006|Overall Study|Subject refused further follow-up|2|||
131825659|NCT02315066|474642614|FG007|Overall Study|Subject refused further follow-up|3|||
131825660|NCT02315066|474642615|FG008|Overall Study|Subject refused further follow-up|0|||
131825661|NCT02315066|474642616|FG009|Overall Study|Subject refused further follow-up|1|||
131825662|NCT02315066|474642617|FG010|Overall Study|Subject refused further follow-up|1|||
131825663|NCT02315066|474642618|FG011|Overall Study|Subject refused further follow-up|2|||
131825664|NCT02315066|474642619|FG012|Overall Study|Subject refused further follow-up|2|||
131825665|NCT02315066|474642620|FG013|Overall Study|Subject refused further follow-up|4|||
131825666|NCT02315066|474642607|FG000|Overall Study|Study ongoing at date of cut-off|0|||
131825667|NCT02315066|474642608|FG001|Overall Study|Study ongoing at date of cut-off|0|||
131825668|NCT02315066|474642609|FG002|Overall Study|Study ongoing at date of cut-off|0|||
131825669|NCT02315066|474642610|FG003|Overall Study|Study ongoing at date of cut-off|0|||
131825670|NCT02315066|474642611|FG004|Overall Study|Study ongoing at date of cut-off|0|||
131825671|NCT02315066|474642612|FG005|Overall Study|Study ongoing at date of cut-off|0|||
131825672|NCT02315066|474642613|FG006|Overall Study|Study ongoing at date of cut-off|0|||
131825673|NCT02315066|474642614|FG007|Overall Study|Study ongoing at date of cut-off|0|||
131825674|NCT02315066|474642615|FG008|Overall Study|Study ongoing at date of cut-off|0|||
131825675|NCT02315066|474642616|FG009|Overall Study|Study ongoing at date of cut-off|0|||
131825676|NCT02315066|474642617|FG010|Overall Study|Study ongoing at date of cut-off|0|||
131825677|NCT02315066|474642618|FG011|Overall Study|Study ongoing at date of cut-off|0|||
131825678|NCT02315066|474642619|FG012|Overall Study|Study ongoing at date of cut-off|0|||
131825679|NCT02315066|474642620|FG013|Overall Study|Study ongoing at date of cut-off|1|||
131825680|NCT01142908|474642621|FG000|Overall Study|Lost to Follow-up|19|||
131825681|NCT01142908|474642622|FG001|Overall Study|Lost to Follow-up|13|||
131825682|NCT01142908|474642621|FG000|Overall Study|Death|1|||
131825683|NCT01142908|474642622|FG001|Overall Study|Death|4|||
131401172|NCT02589665|473091465|FG009|Maintenance Period|Reason Not Collected|0|||
131401173|NCT02589665|473091456|FG000|Induction Extension Period|Adverse Event|0|||
131401174|NCT02589665|473091457|FG001|Induction Extension Period|Adverse Event|0|||
131401175|NCT02589665|473091458|FG002|Induction Extension Period|Adverse Event|0|||
131401176|NCT02589665|473091459|FG003|Induction Extension Period|Adverse Event|0|||
131825684|NCT01142908|474642621|FG000|Overall Study|Excluded - did not meet criteria|9|||
131825685|NCT01142908|474642622|FG001|Overall Study|Excluded - did not meet criteria|5|||
131825686|NCT01142908|474642621|FG000|Overall Study|Withdrawal by Subject|3|||
131825687|NCT01142908|474642622|FG001|Overall Study|Withdrawal by Subject|0|||
131825688|NCT00035555|474642623|FG000|Overall Study|Adverse Event|5|||
131825689|NCT00035555|474642624|FG001|Overall Study|Adverse Event|8|||
131825690|NCT00035555|474642625|FG002|Overall Study|Adverse Event|9|||
131825691|NCT00035555|474642623|FG000|Overall Study|Allograft loss|1|||
131825692|NCT00035555|474642624|FG001|Overall Study|Allograft loss|1|||
131825693|NCT00035555|474642625|FG002|Overall Study|Allograft loss|2|||
131825694|NCT00035555|474642623|FG000|Overall Study|Death|0|||
131825695|NCT00035555|474642624|FG001|Overall Study|Death|0|||
131825696|NCT00035555|474642625|FG002|Overall Study|Death|2|||
131825697|NCT00035555|474642623|FG000|Overall Study|Lost to Follow-up|0|||
131825698|NCT00035555|474642624|FG001|Overall Study|Lost to Follow-up|0|||
131825699|NCT00035555|474642625|FG002|Overall Study|Lost to Follow-up|1|||
131825700|NCT00035555|474642623|FG000|Overall Study|Noncompliance|0|||
131825701|NCT00035555|474642624|FG001|Overall Study|Noncompliance|1|||
131825702|NCT00035555|474642625|FG002|Overall Study|Noncompliance|1|||
131825703|NCT00035555|474642623|FG000|Overall Study|Prohibited medication|1|||
131825704|NCT00035555|474642624|FG001|Overall Study|Prohibited medication|1|||
131825705|NCT00035555|474642625|FG002|Overall Study|Prohibited medication|0|||
131825706|NCT00035555|474642623|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
131825707|NCT00035555|474642624|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
131825708|NCT00035555|474642625|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
131825709|NCT00035555|474642623|FG000|Overall Study|Withdrawal by Subject|2|||
131825710|NCT00035555|474642624|FG001|Overall Study|Withdrawal by Subject|0|||
131825711|NCT00035555|474642625|FG002|Overall Study|Withdrawal by Subject|2|||
131825712|NCT00035555|474642623|FG000|Overall Study|Investigator deemed not a good candidate|0|||
131825713|NCT00035555|474642624|FG001|Overall Study|Investigator deemed not a good candidate|0|||
131401177|NCT02589665|473091460|FG004|Induction Extension Period|Adverse Event|0|||
131825714|NCT00035555|474642625|FG002|Overall Study|Investigator deemed not a good candidate|1|||
131825715|NCT00035555|474642623|FG000|Overall Study|Received cyclosporin in error|0|||
131401178|NCT02589665|473091461|FG005|Induction Extension Period|Adverse Event|0|||
131825716|NCT00035555|474642624|FG001|Overall Study|Received cyclosporin in error|0|||
131825717|NCT00035555|474642625|FG002|Overall Study|Received cyclosporin in error|1|||
131910041|NCT01041859|474958730|FG001|Double-Blind Maintenance|Other|6|||
131910042|NCT01041859|474958731|FG002|Double-Blind Maintenance|Other|2|||
131825718|NCT01186016|474642626|FG000|Overall Study|Withdrawal by Subject|46|||
131825719|NCT01186016|474642627|FG001|Overall Study|Withdrawal by Subject|29|||
131825720|NCT01098539|474642628|FG000|Overall Study|Adverse Event|26|||
131825721|NCT01098539|474642629|FG001|Overall Study|Adverse Event|26|||
131825722|NCT01098539|474642628|FG000|Overall Study|Protocol Violation|1|||
131825723|NCT01098539|474642629|FG001|Overall Study|Protocol Violation|4|||
131825724|NCT01098539|474642628|FG000|Overall Study|Noncompliance|3|||
131825725|NCT01098539|474642629|FG001|Overall Study|Noncompliance|5|||
131825726|NCT01098539|474642628|FG000|Overall Study|Lost to Follow-up|4|||
131825727|NCT01098539|474642629|FG001|Overall Study|Lost to Follow-up|4|||
131825728|NCT01098539|474642628|FG000|Overall Study|Withdrawal by Subject|12|||
131825729|NCT01098539|474642629|FG001|Overall Study|Withdrawal by Subject|26|||
131825730|NCT01098539|474642628|FG000|Overall Study|Physician Decision|5|||
131825731|NCT01098539|474642629|FG001|Overall Study|Physician Decision|3|||
131825732|NCT00721955|474642630|FG000|Overall Study|Adverse Event|0|||
131825733|NCT00721955|474642631|FG001|Overall Study|Adverse Event|0|||
131825734|NCT00721955|474642632|FG002|Overall Study|Adverse Event|2|||
131825735|NCT00726895|474642636|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131825736|NCT00726895|474642637|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131825737|NCT01450800|474642638|FG000|Overall Study|Protocol Violation|1|||
131825738|NCT01450800|474642639|FG001|Overall Study|Protocol Violation|3|||
131825739|NCT01086969|474642647|FG000|Overall Study|Withdrawal by Subject|1|||
131825740|NCT01086969|474642648|FG001|Overall Study|Withdrawal by Subject|2|||
131825741|NCT01086969|474642649|FG002|Overall Study|Withdrawal by Subject|0|||
131825742|NCT00265785|474642650|FG000|Overall Study|Adverse Event|4|||
131825743|NCT00265785|474642650|FG000|Overall Study|Withdrawal by Subject|3|||
131825744|NCT00265785|474642650|FG000|Overall Study|Progression/Relapse|15|||
131825745|NCT00265785|474642650|FG000|Overall Study|Not protocol specified|2|||
131825746|NCT00265785|474642650|FG000|Overall Study|Ineligible|1|||
131825747|NCT00265785|474642650|FG000|Overall Study|Did not receive protocol treatment|2|||
131825748|NCT04291508|474642652|FG000|Overall Study|Withdrawal by Subject|1|||
131825749|NCT04291508|474642653|FG001|Overall Study|Withdrawal by Subject|0|||
131825750|NCT04291508|474642654|FG002|Overall Study|Withdrawal by Subject|1|||
131825751|NCT04291508|474642655|FG003|Overall Study|Withdrawal by Subject|0|||
131825752|NCT04291508|474642652|FG000|Overall Study|lost to follow up|4|||
131825753|NCT04291508|474642653|FG001|Overall Study|lost to follow up|0|||
131825754|NCT04291508|474642654|FG002|Overall Study|lost to follow up|1|||
131825755|NCT04291508|474642655|FG003|Overall Study|lost to follow up|0|||
131825756|NCT04203667|474642657|FG000|Overall Study|Withdrawal by Subject|1|||
131825757|NCT04203667|474642657|FG000|Overall Study|Lost to Follow-up|1|||
131825758|NCT04203667|474642657|FG000|Overall Study|Death|1|||
131825759|NCT04203667|474642657|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
131825760|NCT00708682|474642658|FG000|Infant Series|Adverse Event|1|||
131825761|NCT00708682|474642658|FG000|Infant Series|Lost to Follow-up|4|||
131825762|NCT00708682|474642658|FG000|Infant Series|Protocol Violation|1|||
131825763|NCT00708682|474642658|FG000|Infant Series|Parent/legal guardian request|6|||
131825764|NCT00708682|474642658|FG000|Infant Series|Failed to return|2|||
131825765|NCT00708682|474642658|FG000|Infant Series|Other|19|||
131825766|NCT00708682|474642658|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
131825767|NCT00708682|474642658|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
131825768|NCT00708682|474642658|FG000|Toddler Dose|Lost to Follow-up|3|||
131825769|NCT00708682|474642658|FG000|Toddler Dose|Failed to Return|4|||
131825770|NCT02030535|474642659|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
131825771|NCT01588548|474642660|FG000|Overall Study|Withdrawal by Subject|0|||
131825772|NCT01588548|474642661|FG001|Overall Study|Withdrawal by Subject|1|||
131825773|NCT01588548|474642662|FG002|Overall Study|Withdrawal by Subject|1|||
131825774|NCT01588548|474642663|FG003|Overall Study|Withdrawal by Subject|1|||
131825775|NCT01588548|474642664|FG004|Overall Study|Withdrawal by Subject|2|||
131825776|NCT01588548|474642665|FG005|Overall Study|Withdrawal by Subject|3|||
131825777|NCT01588548|474642660|FG000|Overall Study|Adverse Event|0|||
131825778|NCT01588548|474642661|FG001|Overall Study|Adverse Event|0|||
131825779|NCT01588548|474642662|FG002|Overall Study|Adverse Event|1|||
131825780|NCT01588548|474642663|FG003|Overall Study|Adverse Event|2|||
131825781|NCT01588548|474642664|FG004|Overall Study|Adverse Event|1|||
131825782|NCT01588548|474642665|FG005|Overall Study|Adverse Event|0|||
131825783|NCT01588548|474642660|FG000|Overall Study|Condition Under Investigation Worsened|3|||
131825784|NCT01588548|474642661|FG001|Overall Study|Condition Under Investigation Worsened|6|||
131825785|NCT01588548|474642662|FG002|Overall Study|Condition Under Investigation Worsened|4|||
131825786|NCT01588548|474642663|FG003|Overall Study|Condition Under Investigation Worsened|4|||
131825787|NCT01588548|474642664|FG004|Overall Study|Condition Under Investigation Worsened|3|||
131825788|NCT01588548|474642665|FG005|Overall Study|Condition Under Investigation Worsened|3|||
131825789|NCT00537017|474642666|FG000|Treatment Phase|Adverse Event|19|||
131825790|NCT00537017|474642666|FG000|Treatment Phase|Withdrawal by Subject|13|||
131825791|NCT00537017|474642666|FG000|Treatment Phase|Protocol Violation|2|||
131825792|NCT00537017|474642666|FG000|Follow-up Phase|Withdrawal by Subject|9|||
131825793|NCT01362296|474642667|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
131825794|NCT01362296|474642668|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
131825795|NCT01362296|474642669|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
131825796|NCT01362296|474642670|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
131825797|NCT01362296|474642667|FG000|Randomized Phase (RP)|Physician Decision|1|||
131825798|NCT01362296|474642668|FG001|Randomized Phase (RP)|Physician Decision|9|||
131825799|NCT01362296|474642669|FG002|Randomized Phase (RP)|Physician Decision|0|||
131825800|NCT01362296|474642670|FG003|Randomized Phase (RP)|Physician Decision|0|||
131825801|NCT01362296|474642667|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
131825802|NCT01362296|474642668|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
131825803|NCT01362296|474642669|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
131825804|NCT01362296|474642670|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
131825805|NCT01362296|474642667|FG000|Randomized Phase (RP)|Adverse Event|20|||
131825806|NCT01362296|474642668|FG001|Randomized Phase (RP)|Adverse Event|4|||
131825807|NCT01362296|474642669|FG002|Randomized Phase (RP)|Adverse Event|0|||
131825808|NCT01362296|474642670|FG003|Randomized Phase (RP)|Adverse Event|0|||
131825809|NCT01362296|474642667|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
131825810|NCT01362296|474642668|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
131825811|NCT01362296|474642669|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
131825812|NCT01362296|474642670|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
131825813|NCT01362296|474642667|FG000|Crossover Phase|PD including Death due to PD|0|||
131825814|NCT01362296|474642668|FG001|Crossover Phase|PD including Death due to PD|0|||
131825815|NCT01362296|474642669|FG002|Crossover Phase|PD including Death due to PD|16|||
131825816|NCT01362296|474642670|FG003|Crossover Phase|PD including Death due to PD|1|||
131825817|NCT01362296|474642667|FG000|Crossover Phase|Withdrawal by Subject|0|||
131825818|NCT01362296|474642668|FG001|Crossover Phase|Withdrawal by Subject|0|||
131825819|NCT01362296|474642669|FG002|Crossover Phase|Withdrawal by Subject|2|||
131825820|NCT01362296|474642670|FG003|Crossover Phase|Withdrawal by Subject|1|||
131825821|NCT01362296|474642667|FG000|Crossover Phase|Adverse Event|0|||
131825822|NCT01362296|474642668|FG001|Crossover Phase|Adverse Event|0|||
131825823|NCT01362296|474642669|FG002|Crossover Phase|Adverse Event|4|||
131825824|NCT01362296|474642670|FG003|Crossover Phase|Adverse Event|0|||
131825825|NCT01362296|474642667|FG000|Crossover Phase|Study Closed/Terminated|0|||
131825826|NCT01362296|474642668|FG001|Crossover Phase|Study Closed/Terminated|0|||
131825827|NCT01362296|474642669|FG002|Crossover Phase|Study Closed/Terminated|1|||
131825828|NCT01362296|474642670|FG003|Crossover Phase|Study Closed/Terminated|0|||
131825829|NCT00857818|474642677|FG000|Overall Study|Lack of Efficacy|1|||
131825830|NCT00857818|474642678|FG001|Overall Study|Lack of Efficacy|0|||
131825831|NCT00857818|474642677|FG000|Overall Study|Adverse Event|3|||
131825832|NCT00857818|474642678|FG001|Overall Study|Adverse Event|0|||
131825833|NCT00857818|474642677|FG000|Overall Study|Withdrawal by Subject|0|||
131825834|NCT00857818|474642678|FG001|Overall Study|Withdrawal by Subject|4|||
131825835|NCT00857818|474642677|FG000|Overall Study|Sponsor terminated study|6|||
131825836|NCT00857818|474642678|FG001|Overall Study|Sponsor terminated study|4|||
131825837|NCT00857818|474642677|FG000|Overall Study|Investigator decision|1|||
131825838|NCT00857818|474642678|FG001|Overall Study|Investigator decision|0|||
131825839|NCT02625974|474642680|FG000|Part 1|Lost to Follow-up|9|||
131825840|NCT02625974|474642681|FG001|Part 1|Lost to Follow-up|3|||
131825841|NCT02625974|474642680|FG000|Part 2|Lost to Follow-up|4|||
131910043|NCT01041859|474958729|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
131910044|NCT01041859|474958730|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
131910045|NCT01041859|474958731|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
131910046|NCT01041859|474958729|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
131910047|NCT01041859|474958730|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
131910048|NCT01041859|474958731|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
131910049|NCT02908347|474958734|FG000|Overall Study|Adverse Event|0|||
131910050|NCT02908347|474958735|FG001|Overall Study|Adverse Event|1|||
131910051|NCT02908347|474958734|FG000|Overall Study|Lost to Follow-up|1|||
131910052|NCT02908347|474958735|FG001|Overall Study|Lost to Follow-up|0|||
131910053|NCT00885118|474958736|FG000|Overall Study|Adverse Event|1|||
131825842|NCT02625974|474642681|FG001|Part 2|Lost to Follow-up|6|||
131825843|NCT02625974|474642680|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
131825844|NCT02625974|474642681|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
131825845|NCT00434590|474642682|FG000|Overall Study|Administrative problems|5|||
131825846|NCT00434590|474642683|FG001|Overall Study|Administrative problems|5|||
131825847|NCT04149535|474642685|FG000|Overall Study|Death|11|||
131825848|NCT04149535|474642686|FG001|Overall Study|Death|7|||
131825849|NCT04149535|474642685|FG000|Overall Study|Physician Decision|10|||
131825850|NCT04149535|474642686|FG001|Overall Study|Physician Decision|4|||
131825851|NCT04149535|474642685|FG000|Overall Study|Withdrawal by Subject|6|||
131825852|NCT04149535|474642686|FG001|Overall Study|Withdrawal by Subject|7|||
131825853|NCT04149535|474642685|FG000|Overall Study|Not described|2|||
131825854|NCT04149535|474642686|FG001|Overall Study|Not described|0|||
131910054|NCT00885118|474958737|FG001|Overall Study|Adverse Event|0|||
131910055|NCT00885118|474958738|FG002|Overall Study|Adverse Event|0|||
131825855|NCT02175368|474642687|FG000|Overall Study|Lost to Follow-up|1|||
131825856|NCT02875028|474642688|FG000|Washout Period|Withdrawal by Subject|0|||
131825857|NCT02875028|474642689|FG001|Washout Period|Withdrawal by Subject|1|||
131825858|NCT02447887|474644069|FG000|Overall Study|Study was terminated|3|||
131825859|NCT03180528|474644070|FG000|Overall Study|Adverse Event|1|||
131825860|NCT03180528|474644070|FG000|Overall Study|Withdrawal by Subject|1|||
131825861|NCT03180528|474644070|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
131825862|NCT02426541|474644073|FG000|Overall Study|Protocol Violation|1|||
131825863|NCT02426541|474644074|FG001|Overall Study|Protocol Violation|0|||
131825864|NCT01560819|474644075|FG000|Overall Study|Physician Decision|1|||
131825865|NCT01560819|474644076|FG001|Overall Study|Physician Decision|0|||
131825866|NCT02344745|474644077|FG000|Overall Study|Data collection sheets were lost|2|||
131825867|NCT02344745|474644078|FG001|Overall Study|Data collection sheets were lost|0|||
131825868|NCT02788513|474644079|FG000|Overall Study|Withdrawal by Subject|3|||
131825869|NCT02788513|474644080|FG001|Overall Study|Withdrawal by Subject|0|||
131825870|NCT02788513|474644081|FG002|Overall Study|Withdrawal by Subject|2|||
131825871|NCT02788513|474644082|FG003|Overall Study|Withdrawal by Subject|3|||
131825872|NCT02788513|474644083|FG004|Overall Study|Withdrawal by Subject|1|||
131825873|NCT02788513|474644079|FG000|Overall Study|Lost to Follow-up|1|||
131825874|NCT02788513|474644080|FG001|Overall Study|Lost to Follow-up|0|||
131825875|NCT02788513|474644081|FG002|Overall Study|Lost to Follow-up|0|||
131825876|NCT02788513|474644082|FG003|Overall Study|Lost to Follow-up|0|||
131825877|NCT02788513|474644083|FG004|Overall Study|Lost to Follow-up|1|||
131825878|NCT02788513|474644079|FG000|Overall Study|Adverse Event|5|||
131825879|NCT02788513|474644080|FG001|Overall Study|Adverse Event|8|||
131825880|NCT02788513|474644081|FG002|Overall Study|Adverse Event|4|||
131825881|NCT02788513|474644082|FG003|Overall Study|Adverse Event|2|||
131825882|NCT02788513|474644083|FG004|Overall Study|Adverse Event|2|||
131825883|NCT02788513|474644079|FG000|Overall Study|Protocol Violation|0|||
131825884|NCT02788513|474644080|FG001|Overall Study|Protocol Violation|0|||
131825885|NCT02788513|474644081|FG002|Overall Study|Protocol Violation|1|||
131825886|NCT02788513|474644082|FG003|Overall Study|Protocol Violation|1|||
131825887|NCT02788513|474644083|FG004|Overall Study|Protocol Violation|0|||
131825888|NCT02788513|474644079|FG000|Overall Study|Subject decided to stop taking treatment|0|||
131825889|NCT02788513|474644080|FG001|Overall Study|Subject decided to stop taking treatment|0|||
131825890|NCT02788513|474644081|FG002|Overall Study|Subject decided to stop taking treatment|1|||
131825891|NCT02788513|474644082|FG003|Overall Study|Subject decided to stop taking treatment|0|||
131825892|NCT02788513|474644083|FG004|Overall Study|Subject decided to stop taking treatment|0|||
131825893|NCT02788513|474644079|FG000|Overall Study|Decision by the study team|0|||
131825894|NCT02788513|474644080|FG001|Overall Study|Decision by the study team|0|||
131825895|NCT02788513|474644081|FG002|Overall Study|Decision by the study team|0|||
131825896|NCT02788513|474644082|FG003|Overall Study|Decision by the study team|0|||
131825897|NCT02788513|474644083|FG004|Overall Study|Decision by the study team|1|||
131825898|NCT05996198|474644084|FG000|Overall Study|Withdrawal by Subject|1|||
131825899|NCT05996198|474644085|FG001|Overall Study|Withdrawal by Subject|0|||
131825900|NCT00114231|474644087|FG000|Overall Study|No consent|2|||
131825901|NCT00114231|474644088|FG001|Overall Study|No consent|0|||
131825902|NCT00114231|474644087|FG000|Overall Study|QARC requirement not met|1|||
131825903|NCT00114231|474644088|FG001|Overall Study|QARC requirement not met|0|||
131825904|NCT00114231|474644087|FG000|Overall Study|Suspected metastatic disease|1|||
131825905|NCT00114231|474644088|FG001|Overall Study|Suspected metastatic disease|0|||
131825906|NCT00114231|474644087|FG000|Overall Study|No adenocarcinoma|1|||
131825907|NCT00114231|474644088|FG001|Overall Study|No adenocarcinoma|0|||
131825908|NCT00114231|474644087|FG000|Overall Study|Low creatinine clearance|0|||
131825909|NCT00114231|474644088|FG001|Overall Study|Low creatinine clearance|1|||
131825910|NCT00114231|474644087|FG000|Overall Study|Tumor size > 4cm|1|||
131825911|NCT00114231|474644088|FG001|Overall Study|Tumor size > 4cm|0|||
131825912|NCT00114231|474644087|FG000|Overall Study|Tumor fixed on digital exam|0|||
131825913|NCT00114231|474644088|FG001|Overall Study|Tumor fixed on digital exam|1|||
131825914|NCT00114231|474644087|FG000|Overall Study|No Absolute Neutrophil Count|2|||
131825915|NCT00114231|474644088|FG001|Overall Study|No Absolute Neutrophil Count|0|||
131825916|NCT00114231|474644087|FG000|Overall Study|Biopsy done after registration|1|||
131825917|NCT00114231|474644088|FG001|Overall Study|Biopsy done after registration|0|||
131825918|NCT01933919|474644091|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
131910056|NCT00885118|474958739|FG003|Overall Study|Adverse Event|0|||
131825919|NCT01933919|474644092|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
131825920|NCT01933919|474644091|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
131825921|NCT01933919|474644092|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
131825922|NCT01933919|474644091|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
131825923|NCT01933919|474644092|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
131825924|NCT01933919|474644091|FG000|Open-label Long-term Phase|Adverse Event|2|||
131825925|NCT01933919|474644092|FG001|Open-label Long-term Phase|Adverse Event|0|||
131825926|NCT01933919|474644091|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
131825927|NCT01933919|474644092|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
131825928|NCT01933919|474644091|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
131825929|NCT01933919|474644092|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
131825930|NCT01933919|474644091|FG000|Open-label Long-term Phase|Other|1|||
131825931|NCT01933919|474644092|FG001|Open-label Long-term Phase|Other|2|||
131825932|NCT01961882|474644096|FG000|Overall Study|Adverse Event|3|||
131825933|NCT01961882|474644097|FG001|Overall Study|Adverse Event|2|||
131825934|NCT01961882|474644096|FG000|Overall Study|Physician Decision|1|||
131825935|NCT01961882|474644097|FG001|Overall Study|Physician Decision|0|||
131825936|NCT01961882|474644096|FG000|Overall Study|Withdrawal by Subject|4|||
131825937|NCT01961882|474644097|FG001|Overall Study|Withdrawal by Subject|1|||
131825938|NCT01961882|474644096|FG000|Overall Study|Relapse of AML|39|||
131825939|NCT01961882|474644097|FG001|Overall Study|Relapse of AML|37|||
131825940|NCT01961882|474644096|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
131825941|NCT01961882|474644097|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
131825942|NCT01961882|474644096|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
131825943|NCT01961882|474644097|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
131825944|NCT01091103|474644105|FG000|Overall Study|Adverse Event|1|||
131825945|NCT01091103|474644105|FG000|Overall Study|Progressive Disease|3|||
131825946|NCT01270620|474644106|FG000|Overall Study|Withdrawal by Subject|1|||
131825947|NCT01270620|474644107|FG001|Overall Study|Withdrawal by Subject|3|||
131825948|NCT00988208|474644108|FG000|Overall Study|Adverse Event|71|||
131825949|NCT00988208|474644109|FG001|Overall Study|Adverse Event|122|||
131825950|NCT00988208|474644108|FG000|Overall Study|Disease Progression|103|||
131825951|NCT00988208|474644109|FG001|Overall Study|Disease Progression|89|||
131825952|NCT00988208|474644108|FG000|Overall Study|Withdrawal by Subject|50|||
131825953|NCT00988208|474644109|FG001|Overall Study|Withdrawal by Subject|57|||
131825954|NCT00988208|474644108|FG000|Overall Study|Death|9|||
131825955|NCT00988208|474644109|FG001|Overall Study|Death|15|||
131825956|NCT00988208|474644108|FG000|Overall Study|Lost to Follow-up|2|||
131825957|NCT00988208|474644109|FG001|Overall Study|Lost to Follow-up|3|||
131825958|NCT00988208|474644108|FG000|Overall Study|Protocol Violation|9|||
131825959|NCT00988208|474644109|FG001|Overall Study|Protocol Violation|2|||
131825960|NCT00988208|474644108|FG000|Overall Study|Sponsor Decision|102|||
131825961|NCT00988208|474644109|FG001|Overall Study|Sponsor Decision|78|||
131825962|NCT00988208|474644108|FG000|Overall Study|Clinical Progression|17|||
131825963|NCT00988208|474644109|FG001|Overall Study|Clinical Progression|16|||
131825964|NCT00988208|474644108|FG000|Overall Study|Biochemical Progression|21|||
131825965|NCT00988208|474644109|FG001|Overall Study|Biochemical Progression|7|||
131825966|NCT00988208|474644108|FG000|Overall Study|Clinical Deterioration|7|||
131825967|NCT00988208|474644109|FG001|Overall Study|Clinical Deterioration|14|||
131825968|NCT00988208|474644108|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
131825969|NCT00988208|474644109|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
131825970|NCT00988208|474644108|FG000|Overall Study|Other|8|||
131825971|NCT00988208|474644109|FG001|Overall Study|Other|3|||
131825972|NCT00906373|474644112|FG000|Overall Study|Withdrawal by Subject|0|||
131825973|NCT00906373|474644113|FG001|Overall Study|Withdrawal by Subject|5|||
131825974|NCT00906373|474644112|FG000|Overall Study|Other|0|||
131825975|NCT00906373|474644113|FG001|Overall Study|Other|1|||
131825976|NCT00906373|474644112|FG000|Overall Study|Still on treatment at cutoff date|0|||
131825977|NCT00906373|474644113|FG001|Overall Study|Still on treatment at cutoff date|2|||
131825978|NCT01597479|474644114|FG000|Overall Study|Protocol Violation|1|||
131825979|NCT01597479|474644115|FG001|Overall Study|Protocol Violation|0|||
131825980|NCT01597479|474644114|FG000|Overall Study|Lost to Follow-up|1|||
131825981|NCT01597479|474644115|FG001|Overall Study|Lost to Follow-up|0|||
131825982|NCT02780167|474644120|FG000|Overall Study|Adverse Event|9|||
131825983|NCT02780167|474644121|FG001|Overall Study|Adverse Event|8|||
131825984|NCT02780167|474644122|FG002|Overall Study|Adverse Event|8|||
131825985|NCT02780167|474644123|FG003|Overall Study|Adverse Event|12|||
131825986|NCT02780167|474644124|FG004|Overall Study|Adverse Event|8|||
131401179|NCT02589665|473091462|FG006|Induction Extension Period|Adverse Event|0|||
131401180|NCT02589665|473091463|FG007|Induction Extension Period|Adverse Event|0|||
131401181|NCT02589665|473091464|FG008|Induction Extension Period|Adverse Event|4|||
131401182|NCT02589665|473091465|FG009|Induction Extension Period|Adverse Event|0|||
131401183|NCT02589665|473091456|FG000|Induction Extension Period|Lack of Efficacy|0|||
131825987|NCT02780167|474644120|FG000|Overall Study|Lack of Efficacy|6|||
131825988|NCT02780167|474644121|FG001|Overall Study|Lack of Efficacy|5|||
131825989|NCT02780167|474644122|FG002|Overall Study|Lack of Efficacy|6|||
131825990|NCT02780167|474644123|FG003|Overall Study|Lack of Efficacy|1|||
131825991|NCT02780167|474644124|FG004|Overall Study|Lack of Efficacy|0|||
131825992|NCT02780167|474644120|FG000|Overall Study|Lost to Follow-up|2|||
131825993|NCT02780167|474644121|FG001|Overall Study|Lost to Follow-up|0|||
131825994|NCT02780167|474644122|FG002|Overall Study|Lost to Follow-up|1|||
131825995|NCT02780167|474644123|FG003|Overall Study|Lost to Follow-up|0|||
131825996|NCT02780167|474644124|FG004|Overall Study|Lost to Follow-up|0|||
131825997|NCT02780167|474644120|FG000|Overall Study|Does not meet entrance criteria|0|||
131825998|NCT02780167|474644121|FG001|Overall Study|Does not meet entrance criteria|0|||
131825999|NCT02780167|474644122|FG002|Overall Study|Does not meet entrance criteria|1|||
131826000|NCT02780167|474644123|FG003|Overall Study|Does not meet entrance criteria|0|||
131826001|NCT02780167|474644124|FG004|Overall Study|Does not meet entrance criteria|0|||
131826002|NCT02780167|474644120|FG000|Overall Study|No longer meets eligibility criteria|0|||
131826003|NCT02780167|474644121|FG001|Overall Study|No longer meets eligibility criteria|0|||
131826004|NCT02780167|474644122|FG002|Overall Study|No longer meets eligibility criteria|0|||
131826005|NCT02780167|474644123|FG003|Overall Study|No longer meets eligibility criteria|1|||
131826006|NCT02780167|474644124|FG004|Overall Study|No longer meets eligibility criteria|1|||
131826007|NCT02780167|474644120|FG000|Overall Study|Protocol Violation|5|||
131826008|NCT02780167|474644121|FG001|Overall Study|Protocol Violation|5|||
131826009|NCT02780167|474644122|FG002|Overall Study|Protocol Violation|1|||
131826010|NCT02780167|474644123|FG003|Overall Study|Protocol Violation|1|||
131826011|NCT02780167|474644124|FG004|Overall Study|Protocol Violation|2|||
131826012|NCT02780167|474644120|FG000|Overall Study|Withdrawal by Subject|6|||
131826013|NCT02780167|474644121|FG001|Overall Study|Withdrawal by Subject|4|||
131826014|NCT02780167|474644122|FG002|Overall Study|Withdrawal by Subject|4|||
131826015|NCT02780167|474644123|FG003|Overall Study|Withdrawal by Subject|3|||
131826016|NCT02780167|474644124|FG004|Overall Study|Withdrawal by Subject|4|||
131826017|NCT02780167|474644120|FG000|Overall Study|Other|0|||
131826018|NCT02780167|474644121|FG001|Overall Study|Other|0|||
131826019|NCT02780167|474644122|FG002|Overall Study|Other|3|||
131826020|NCT02780167|474644123|FG003|Overall Study|Other|1|||
131826021|NCT02780167|474644124|FG004|Overall Study|Other|2|||
131826022|NCT03180801|474644125|FG000|Overall Study|Physician Decision|3|||
131826023|NCT03180801|474644126|FG001|Overall Study|Physician Decision|3|||
131826024|NCT03180801|474644127|FG002|Overall Study|Physician Decision|1|||
131826025|NCT03180801|474644125|FG000|Overall Study|Non-compliance|1|||
131826026|NCT03180801|474644126|FG001|Overall Study|Non-compliance|4|||
131826027|NCT03180801|474644127|FG002|Overall Study|Non-compliance|0|||
131826028|NCT03180801|474644125|FG000|Overall Study|Inoculation Target Reached|1|||
131826029|NCT03180801|474644126|FG001|Overall Study|Inoculation Target Reached|1|||
131826030|NCT03180801|474644127|FG002|Overall Study|Inoculation Target Reached|3|||
131826031|NCT03180801|474644125|FG000|Overall Study|Adverse Event|1|||
131826032|NCT03180801|474644126|FG001|Overall Study|Adverse Event|0|||
131826033|NCT03180801|474644127|FG002|Overall Study|Adverse Event|2|||
131826034|NCT03180801|474644125|FG000|Overall Study|Withdrawal by Subject|2|||
131826035|NCT03180801|474644126|FG001|Overall Study|Withdrawal by Subject|2|||
131826036|NCT03180801|474644127|FG002|Overall Study|Withdrawal by Subject|1|||
131826037|NCT03180801|474644125|FG000|Overall Study|Lost to Follow-up|0|||
131826038|NCT03180801|474644126|FG001|Overall Study|Lost to Follow-up|2|||
131826039|NCT03180801|474644127|FG002|Overall Study|Lost to Follow-up|3|||
131826040|NCT00112294|474644129|FG000|Overall Study|Still on study|5|||
131826041|NCT00112294|474644130|FG001|Overall Study|Still on study|0|||
131826042|NCT03235479|474644134|FG000|Overall Study|Lost to Follow-up|8|||
131826043|NCT03235479|474644135|FG001|Overall Study|Lost to Follow-up|11|||
131826044|NCT03235479|474644134|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
131826045|NCT03235479|474644135|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
131826046|NCT03235479|474644134|FG000|Overall Study|Pregnancy|1|||
131826047|NCT03235479|474644135|FG001|Overall Study|Pregnancy|0|||
131826048|NCT03235479|474644134|FG000|Overall Study|Protocol Deviation|1|||
131826049|NCT03235479|474644135|FG001|Overall Study|Protocol Deviation|3|||
131826050|NCT03235479|474644134|FG000|Overall Study|Technical Problems|3|||
131826051|NCT03235479|474644135|FG001|Overall Study|Technical Problems|2|||
131826052|NCT03235479|474644134|FG000|Overall Study|Withdrawal by Subject|2|||
131826053|NCT03235479|474644135|FG001|Overall Study|Withdrawal by Subject|2|||
131826054|NCT03235479|474644134|FG000|Overall Study|Other Reasons|3|||
131826055|NCT03235479|474644135|FG001|Overall Study|Other Reasons|5|||
131826056|NCT00309985|474644138|FG000|Overall Study|Disease progression|12|||
131826057|NCT00309985|474644139|FG001|Overall Study|Disease progression|0|||
131826058|NCT00309985|474644138|FG000|Overall Study|Adverse Event|30|||
131826059|NCT00309985|474644139|FG001|Overall Study|Adverse Event|0|||
131826060|NCT00309985|474644138|FG000|Overall Study|Death|2|||
131826061|NCT00309985|474644139|FG001|Overall Study|Death|0|||
131826062|NCT00309985|474644138|FG000|Overall Study|Withdrawal by Subject|5|||
131826063|NCT00309985|474644139|FG001|Overall Study|Withdrawal by Subject|1|||
131826064|NCT00309985|474644138|FG000|Overall Study|Physician Decision|3|||
131826065|NCT00309985|474644139|FG001|Overall Study|Physician Decision|0|||
131826066|NCT00309985|474644138|FG000|Overall Study|Never started treatment|7|||
131826067|NCT00309985|474644139|FG001|Overall Study|Never started treatment|0|||
131826068|NCT00309985|474644138|FG000|Overall Study|Complicating disease|1|||
131826069|NCT00309985|474644139|FG001|Overall Study|Complicating disease|0|||
131826070|NCT00309985|474644138|FG000|Overall Study|Non-compliance|1|||
131826071|NCT00309985|474644139|FG001|Overall Study|Non-compliance|0|||
131826072|NCT00309985|474644138|FG000|Overall Study|Chemotherapy discontinued only|1|||
131826073|NCT00309985|474644139|FG001|Overall Study|Chemotherapy discontinued only|0|||
131826074|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
131826075|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
131826076|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
131910057|NCT00885118|474958740|FG004|Overall Study|Adverse Event|0|||
131401184|NCT02589665|473091457|FG001|Induction Extension Period|Lack of Efficacy|0|||
131401185|NCT02589665|473091458|FG002|Induction Extension Period|Lack of Efficacy|0|||
131401186|NCT02589665|473091459|FG003|Induction Extension Period|Lack of Efficacy|0|||
131401187|NCT02589665|473091460|FG004|Induction Extension Period|Lack of Efficacy|0|||
131401188|NCT02589665|473091461|FG005|Induction Extension Period|Lack of Efficacy|0|||
131401189|NCT02589665|473091462|FG006|Induction Extension Period|Lack of Efficacy|0|||
131401190|NCT02589665|473091463|FG007|Induction Extension Period|Lack of Efficacy|0|||
131401191|NCT02589665|473091464|FG008|Induction Extension Period|Lack of Efficacy|3|||
131826077|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
131826078|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
131826079|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
131826080|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131826081|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131826082|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
131826083|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
131826084|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
131826085|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131826086|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
131826087|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
131826088|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
131826089|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
131826090|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Death|2|||
131826091|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Death|1|||
131826092|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Death|0|||
131826093|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Death|0|||
131826094|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
131826095|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
131826096|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
131826097|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
131826098|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
131826099|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
131826100|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
131826101|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
131826102|NCT03110380|474644149|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
131826103|NCT03110380|474644150|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
131826104|NCT03110380|474644151|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
131826105|NCT03110380|474644152|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
131826106|NCT03110380|474644149|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
131826107|NCT03110380|474644150|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
131826108|NCT03110380|474644151|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
131826109|NCT03110380|474644152|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
131826110|NCT03110380|474644149|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
131826111|NCT03110380|474644150|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
131826112|NCT03110380|474644151|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
131826113|NCT03110380|474644152|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
131826114|NCT03110380|474644149|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
131826115|NCT03110380|474644150|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
131826116|NCT03110380|474644151|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
131826117|NCT03110380|474644152|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
131826118|NCT02531594|474644153|FG000|Overall Study|Withdrawal by Subject|7|||
131826119|NCT02531594|474644154|FG001|Overall Study|Withdrawal by Subject|8|||
131826120|NCT03750695|474644158|FG000|Overall Study|Lost to Follow-up|0|||
131826121|NCT03750695|474644159|FG001|Overall Study|Lost to Follow-up|1|||
131826122|NCT03843125|474644160|FG000|Overall Study|Adverse Event|17|||
131826123|NCT03843125|474644161|FG001|Overall Study|Adverse Event|13|||
131826124|NCT03843125|474644162|FG002|Overall Study|Adverse Event|5|||
131826125|NCT03843125|474644163|FG003|Overall Study|Adverse Event|9|||
131826126|NCT03843125|474644160|FG000|Overall Study|Death|0|||
131826127|NCT03843125|474644161|FG001|Overall Study|Death|6|||
131826128|NCT03843125|474644162|FG002|Overall Study|Death|2|||
131826129|NCT03843125|474644163|FG003|Overall Study|Death|0|||
131401192|NCT02589665|473091465|FG009|Induction Extension Period|Lack of Efficacy|0|||
131401193|NCT02589665|473091456|FG000|Induction Extension Period|Withdrawal by Subject|0|||
131401194|NCT02589665|473091457|FG001|Induction Extension Period|Withdrawal by Subject|0|||
131826130|NCT03843125|474644160|FG000|Overall Study|Lack of Efficacy|14|||
131826131|NCT03843125|474644161|FG001|Overall Study|Lack of Efficacy|11|||
131826132|NCT03843125|474644162|FG002|Overall Study|Lack of Efficacy|9|||
131401195|NCT02589665|473091458|FG002|Induction Extension Period|Withdrawal by Subject|0|||
131826133|NCT03843125|474644163|FG003|Overall Study|Lack of Efficacy|4|||
131826134|NCT03843125|474644160|FG000|Overall Study|Lost to Follow-up|3|||
131826135|NCT03843125|474644161|FG001|Overall Study|Lost to Follow-up|4|||
131826136|NCT03843125|474644162|FG002|Overall Study|Lost to Follow-up|0|||
131826137|NCT03843125|474644163|FG003|Overall Study|Lost to Follow-up|2|||
131826138|NCT03843125|474644160|FG000|Overall Study|Other|12|||
131826139|NCT03843125|474644161|FG001|Overall Study|Other|14|||
131826140|NCT03843125|474644162|FG002|Overall Study|Other|3|||
131826141|NCT03843125|474644163|FG003|Overall Study|Other|4|||
131826142|NCT03843125|474644160|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
131826143|NCT03843125|474644161|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
131826144|NCT03843125|474644162|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
131401196|NCT02589665|473091459|FG003|Induction Extension Period|Withdrawal by Subject|0|||
131826145|NCT03843125|474644163|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
131826146|NCT03843125|474644160|FG000|Overall Study|Study Terminated by Sponsor|318|||
131826147|NCT03843125|474644161|FG001|Overall Study|Study Terminated by Sponsor|318|||
131826148|NCT03843125|474644162|FG002|Overall Study|Study Terminated by Sponsor|163|||
131826149|NCT03843125|474644163|FG003|Overall Study|Study Terminated by Sponsor|163|||
131826150|NCT03843125|474644160|FG000|Overall Study|Withdrawal by Subject|23|||
131826151|NCT03843125|474644161|FG001|Overall Study|Withdrawal by Subject|12|||
131826152|NCT03843125|474644162|FG002|Overall Study|Withdrawal by Subject|6|||
131826153|NCT03843125|474644163|FG003|Overall Study|Withdrawal by Subject|9|||
131826154|NCT03843125|474644160|FG000|Overall Study|Missing data|0|||
131826155|NCT03843125|474644161|FG001|Overall Study|Missing data|1|||
131826156|NCT03843125|474644162|FG002|Overall Study|Missing data|1|||
131826157|NCT03843125|474644163|FG003|Overall Study|Missing data|0|||
131826158|NCT03173560|474644164|FG000|Overall Study|Death|70|||
131826159|NCT03173560|474644165|FG001|Overall Study|Death|60|||
131826160|NCT03173560|474644164|FG000|Overall Study|Lost to Follow-up|1|||
131826161|NCT03173560|474644165|FG001|Overall Study|Lost to Follow-up|4|||
131826162|NCT03173560|474644164|FG000|Overall Study|Withdrawal by Subject|10|||
131826163|NCT03173560|474644165|FG001|Overall Study|Withdrawal by Subject|5|||
131826164|NCT03173560|474644164|FG000|Overall Study|Other|0|||
131826165|NCT03173560|474644165|FG001|Overall Study|Other|1|||
131826166|NCT00725764|474644168|FG000|Overall Study|Withdrawal by Subject|2|||
131826167|NCT00725764|474644168|FG000|Overall Study|Physician Decision|1|||
131826168|NCT00725764|474644168|FG000|Overall Study|Progressive Disease|7|||
131826169|NCT00725764|474644168|FG000|Overall Study|Lost to Follow-up|1|||
131826170|NCT00725764|474644168|FG000|Overall Study|Death|1|||
131826171|NCT00725764|474644168|FG000|Overall Study|Participant non compliant with protocol|1|||
131826172|NCT00725764|474644168|FG000|Overall Study|Decline in performance status|1|||
131826173|NCT01203917|474644170|FG000|Overall Study|Death|29|||
131826174|NCT01203917|474644170|FG000|Overall Study|Lost to Follow-up|2|||
131826175|NCT01203917|474644170|FG000|Overall Study|Withdrawal by Subject|3|||
131826176|NCT01203917|474644170|FG000|Overall Study|Due to objective disease progression|1|||
131826177|NCT01203917|474644170|FG000|Overall Study|Due to EGFR M+I patient|1|||
131826178|NCT04660032|474644175|FG000|Overall Study|Protocol Violation|1|||
131826179|NCT04660032|474644176|FG001|Overall Study|Protocol Violation|1|||
131826180|NCT01609582|474644187|FG000|Overall Study|Adverse Event|20|||
131826181|NCT01609582|474644188|FG001|Overall Study|Adverse Event|18|||
131826182|NCT01609582|474644187|FG000|Overall Study|Lost to Follow-up|10|||
131826183|NCT01609582|474644188|FG001|Overall Study|Lost to Follow-up|10|||
131826184|NCT01609582|474644187|FG000|Overall Study|Withdrawal by Subject|21|||
131826185|NCT01609582|474644188|FG001|Overall Study|Withdrawal by Subject|15|||
131826186|NCT01609582|474644187|FG000|Overall Study|Study Terminated by Sponsor|1543|||
131826187|NCT01609582|474644188|FG001|Overall Study|Study Terminated by Sponsor|1548|||
131826188|NCT01609582|474644187|FG000|Overall Study|Other|9|||
131826189|NCT01609582|474644188|FG001|Overall Study|Other|10|||
131826190|NCT01609582|474644187|FG000|Overall Study|Randomized, but not treated|0|||
131826191|NCT01609582|474644188|FG001|Overall Study|Randomized, but not treated|3|||
131826192|NCT00819767|474644189|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131826193|NCT00819767|474644190|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131826194|NCT03566238|474644193|FG000|Overall Study|Adverse Event|0|||
131826195|NCT03566238|474644194|FG001|Overall Study|Adverse Event|1|||
131910058|NCT00885118|474958736|FG000|Overall Study|Withdrawal by Subject|0|||
131401197|NCT02589665|473091460|FG004|Induction Extension Period|Withdrawal by Subject|0|||
131401198|NCT02589665|473091461|FG005|Induction Extension Period|Withdrawal by Subject|0|||
131826196|NCT03566238|474644195|FG002|Overall Study|Adverse Event|0|||
131826197|NCT03566238|474644193|FG000|Overall Study|Lack of Efficacy|4|||
131826198|NCT03566238|474644194|FG001|Overall Study|Lack of Efficacy|2|||
131826199|NCT03566238|474644195|FG002|Overall Study|Lack of Efficacy|5|||
131826200|NCT03566238|474644193|FG000|Overall Study|Other|1|||
131826201|NCT03566238|474644194|FG001|Overall Study|Other|0|||
131826202|NCT03566238|474644195|FG002|Overall Study|Other|0|||
131826203|NCT01083680|474644198|FG000|Overall Study|Lost to Follow-up|2758|||
131826204|NCT01083680|474644198|FG000|Overall Study|Withdrawal by Subject|1086|||
131826205|NCT01263561|474644199|FG000|Overall Study|Death|1|||
131826206|NCT01263561|474644200|FG001|Overall Study|Death|2|||
131826207|NCT03942211|474644201|FG000|Overall Study|Death|1|||
131826208|NCT03942211|474644202|FG001|Overall Study|Death|0|||
131826209|NCT03942211|474644201|FG000|Overall Study|Study terminated by sponsor|5|||
131826210|NCT03942211|474644202|FG001|Overall Study|Study terminated by sponsor|3|||
131826211|NCT03942211|474644201|FG000|Overall Study|Adverse Event|0|||
131826212|NCT03942211|474644202|FG001|Overall Study|Adverse Event|1|||
131826213|NCT01396421|474644203|FG000|Overall Study|Lost to Follow-up|0|||
131826214|NCT01396421|474644204|FG001|Overall Study|Lost to Follow-up|0|||
131826215|NCT01396421|474644205|FG002|Overall Study|Lost to Follow-up|0|||
131826216|NCT01396421|474644206|FG003|Overall Study|Lost to Follow-up|1|||
131826217|NCT01396421|474644203|FG000|Overall Study|Adverse Event|17|||
131826218|NCT01396421|474644204|FG001|Overall Study|Adverse Event|15|||
131826219|NCT01396421|474644205|FG002|Overall Study|Adverse Event|12|||
131826220|NCT01396421|474644206|FG003|Overall Study|Adverse Event|32|||
131826221|NCT01396421|474644203|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
131826222|NCT01396421|474644204|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
131826223|NCT01396421|474644205|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
131826224|NCT01396421|474644206|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
131826225|NCT01396421|474644203|FG000|Overall Study|Physician Decision|1|||
131826226|NCT01396421|474644204|FG001|Overall Study|Physician Decision|1|||
131826227|NCT01396421|474644205|FG002|Overall Study|Physician Decision|0|||
131826228|NCT01396421|474644206|FG003|Overall Study|Physician Decision|3|||
131826229|NCT01396421|474644203|FG000|Overall Study|Withdrawal by Subject|31|||
131826230|NCT01396421|474644204|FG001|Overall Study|Withdrawal by Subject|24|||
131826231|NCT01396421|474644205|FG002|Overall Study|Withdrawal by Subject|13|||
131826232|NCT01396421|474644206|FG003|Overall Study|Withdrawal by Subject|21|||
131826233|NCT01396421|474644203|FG000|Overall Study|Protocol Deviation|2|||
131826234|NCT01396421|474644204|FG001|Overall Study|Protocol Deviation|1|||
131826235|NCT01396421|474644205|FG002|Overall Study|Protocol Deviation|1|||
131826236|NCT01396421|474644206|FG003|Overall Study|Protocol Deviation|0|||
131826237|NCT01396421|474644203|FG000|Overall Study|Lack of Efficacy|7|||
131826238|NCT01396421|474644204|FG001|Overall Study|Lack of Efficacy|17|||
131826239|NCT01396421|474644205|FG002|Overall Study|Lack of Efficacy|7|||
131826240|NCT01396421|474644206|FG003|Overall Study|Lack of Efficacy|18|||
131826241|NCT03689894|474644211|FG000|Overall Study|Adverse Event|1|||
131826242|NCT00569777|474644212|FG000|Overall Study|Withdrawal by Subject|4|||
131826243|NCT00569777|474644213|FG001|Overall Study|Withdrawal by Subject|0|||
131826244|NCT00569777|474644212|FG000|Overall Study|Adverse Event|3|||
131826245|NCT00569777|474644213|FG001|Overall Study|Adverse Event|0|||
131826246|NCT00569777|474644212|FG000|Overall Study|Lost to Follow-up|1|||
131826247|NCT00569777|474644213|FG001|Overall Study|Lost to Follow-up|0|||
131826248|NCT00569777|474644212|FG000|Overall Study|scheduled eye surgery|0|||
131826249|NCT00569777|474644213|FG001|Overall Study|scheduled eye surgery|1|||
131826250|NCT00569777|474644212|FG000|Overall Study|did not meet exclusion criteria|1|||
131826251|NCT00569777|474644213|FG001|Overall Study|did not meet exclusion criteria|2|||
131826252|NCT00569777|474644212|FG000|Overall Study|pregnant|1|||
131826253|NCT00569777|474644213|FG001|Overall Study|pregnant|0|||
131826254|NCT02839798|474645641|FG000|Overall Study|Withdrawal by Subject|2|||
131826255|NCT04703855|474645642|FG000|Overall Study|Heart Transplant|1|||
131826256|NCT00401245|474645643|FG000|Double Blind Titration Phase|Adverse Event|3|||
131826257|NCT00401245|474645644|FG001|Double Blind Titration Phase|Adverse Event|2|||
131826258|NCT00401245|474645645|FG002|Double Blind Titration Phase|Adverse Event|5|||
131826259|NCT00401245|474645646|FG003|Double Blind Titration Phase|Adverse Event|12|||
131826260|NCT00401245|474645647|FG004|Double Blind Titration Phase|Adverse Event|0|||
131826261|NCT00401245|474645648|FG005|Double Blind Titration Phase|Adverse Event|0|||
131401199|NCT02589665|473091462|FG006|Induction Extension Period|Withdrawal by Subject|0|||
131401200|NCT02589665|473091463|FG007|Induction Extension Period|Withdrawal by Subject|2|||
131401201|NCT02589665|473091464|FG008|Induction Extension Period|Withdrawal by Subject|3|||
131401202|NCT02589665|473091465|FG009|Induction Extension Period|Withdrawal by Subject|0|||
131401203|NCT02589665|473091456|FG000|Induction Extension Period|Physician Decision|0|||
131401204|NCT02589665|473091457|FG001|Induction Extension Period|Physician Decision|0|||
131401205|NCT02589665|473091458|FG002|Induction Extension Period|Physician Decision|0|||
131401206|NCT02589665|473091459|FG003|Induction Extension Period|Physician Decision|0|||
131401207|NCT02589665|473091460|FG004|Induction Extension Period|Physician Decision|0|||
131401208|NCT02589665|473091461|FG005|Induction Extension Period|Physician Decision|0|||
131401209|NCT02589665|473091462|FG006|Induction Extension Period|Physician Decision|0|||
131826262|NCT00401245|474645649|FG006|Double Blind Titration Phase|Adverse Event|0|||
131826263|NCT00401245|474645650|FG007|Double Blind Titration Phase|Adverse Event|0|||
131826264|NCT00401245|474645643|FG000|Double Blind Titration Phase|Other|0|||
131910059|NCT00885118|474958737|FG001|Overall Study|Withdrawal by Subject|0|||
131910060|NCT00885118|474958738|FG002|Overall Study|Withdrawal by Subject|0|||
131401210|NCT02589665|473091463|FG007|Induction Extension Period|Physician Decision|0|||
131826265|NCT00401245|474645644|FG001|Double Blind Titration Phase|Other|0|||
131826266|NCT00401245|474645645|FG002|Double Blind Titration Phase|Other|1|||
131826267|NCT00401245|474645646|FG003|Double Blind Titration Phase|Other|0|||
131826268|NCT00401245|474645647|FG004|Double Blind Titration Phase|Other|0|||
131826269|NCT00401245|474645648|FG005|Double Blind Titration Phase|Other|0|||
131826270|NCT00401245|474645649|FG006|Double Blind Titration Phase|Other|0|||
131826271|NCT00401245|474645650|FG007|Double Blind Titration Phase|Other|0|||
131910061|NCT00885118|474958739|FG003|Overall Study|Withdrawal by Subject|0|||
131826272|NCT00401245|474645643|FG000|Double Blind Titration Phase|Protocol Violation|0|||
131826273|NCT00401245|474645644|FG001|Double Blind Titration Phase|Protocol Violation|0|||
131826274|NCT00401245|474645645|FG002|Double Blind Titration Phase|Protocol Violation|0|||
131826275|NCT00401245|474645646|FG003|Double Blind Titration Phase|Protocol Violation|1|||
131826276|NCT00401245|474645647|FG004|Double Blind Titration Phase|Protocol Violation|0|||
131826277|NCT00401245|474645648|FG005|Double Blind Titration Phase|Protocol Violation|0|||
131826278|NCT00401245|474645649|FG006|Double Blind Titration Phase|Protocol Violation|0|||
131826279|NCT00401245|474645650|FG007|Double Blind Titration Phase|Protocol Violation|0|||
131826280|NCT00401245|474645643|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
131826281|NCT00401245|474645644|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
131826282|NCT00401245|474645645|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
131826283|NCT00401245|474645646|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
131826284|NCT00401245|474645647|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
131826285|NCT00401245|474645648|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
131826286|NCT00401245|474645649|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
131826287|NCT00401245|474645650|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
131826288|NCT00401245|474645643|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
131826289|NCT00401245|474645644|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
131826290|NCT00401245|474645645|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
131826291|NCT00401245|474645646|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
131826292|NCT00401245|474645647|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
131826293|NCT00401245|474645648|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
131826294|NCT00401245|474645649|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
131826295|NCT00401245|474645650|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
131826296|NCT00401245|474645643|FG000|Open Label Phase|Adverse Event|5|||
131826297|NCT00401245|474645644|FG001|Open Label Phase|Adverse Event|14|||
131826298|NCT00401245|474645645|FG002|Open Label Phase|Adverse Event|6|||
131826299|NCT00401245|474645646|FG003|Open Label Phase|Adverse Event|7|||
131826300|NCT00401245|474645647|FG004|Open Label Phase|Adverse Event|0|||
131826301|NCT00401245|474645648|FG005|Open Label Phase|Adverse Event|0|||
131826302|NCT00401245|474645649|FG006|Open Label Phase|Adverse Event|0|||
131826303|NCT00401245|474645650|FG007|Open Label Phase|Adverse Event|0|||
131826304|NCT00401245|474645643|FG000|Open Label Phase|Lost to Follow-up|5|||
131826305|NCT00401245|474645644|FG001|Open Label Phase|Lost to Follow-up|7|||
131826306|NCT00401245|474645645|FG002|Open Label Phase|Lost to Follow-up|5|||
131826307|NCT00401245|474645646|FG003|Open Label Phase|Lost to Follow-up|4|||
131826308|NCT00401245|474645647|FG004|Open Label Phase|Lost to Follow-up|0|||
131826309|NCT00401245|474645648|FG005|Open Label Phase|Lost to Follow-up|0|||
131826310|NCT00401245|474645649|FG006|Open Label Phase|Lost to Follow-up|0|||
131826311|NCT00401245|474645650|FG007|Open Label Phase|Lost to Follow-up|0|||
131826312|NCT00401245|474645643|FG000|Open Label Phase|Other|4|||
131826313|NCT00401245|474645644|FG001|Open Label Phase|Other|8|||
131826314|NCT00401245|474645645|FG002|Open Label Phase|Other|7|||
131826315|NCT00401245|474645646|FG003|Open Label Phase|Other|8|||
131826316|NCT00401245|474645647|FG004|Open Label Phase|Other|0|||
131826317|NCT00401245|474645648|FG005|Open Label Phase|Other|0|||
131826318|NCT00401245|474645649|FG006|Open Label Phase|Other|0|||
131826319|NCT00401245|474645650|FG007|Open Label Phase|Other|0|||
131826320|NCT00401245|474645643|FG000|Open Label Phase|Protocol Violation|0|||
131826321|NCT00401245|474645644|FG001|Open Label Phase|Protocol Violation|1|||
131826322|NCT00401245|474645645|FG002|Open Label Phase|Protocol Violation|0|||
131826323|NCT00401245|474645646|FG003|Open Label Phase|Protocol Violation|1|||
131826324|NCT00401245|474645647|FG004|Open Label Phase|Protocol Violation|0|||
131826325|NCT00401245|474645648|FG005|Open Label Phase|Protocol Violation|0|||
131826326|NCT00401245|474645649|FG006|Open Label Phase|Protocol Violation|0|||
131826327|NCT00401245|474645650|FG007|Open Label Phase|Protocol Violation|0|||
131826328|NCT00401245|474645643|FG000|Open Label Phase|Withdrawal by Subject|3|||
131826329|NCT00401245|474645644|FG001|Open Label Phase|Withdrawal by Subject|3|||
131826330|NCT00401245|474645645|FG002|Open Label Phase|Withdrawal by Subject|2|||
131826331|NCT00401245|474645646|FG003|Open Label Phase|Withdrawal by Subject|1|||
131826332|NCT00401245|474645647|FG004|Open Label Phase|Withdrawal by Subject|0|||
131826333|NCT00401245|474645648|FG005|Open Label Phase|Withdrawal by Subject|0|||
131826334|NCT00401245|474645649|FG006|Open Label Phase|Withdrawal by Subject|0|||
131910062|NCT00885118|474958740|FG004|Overall Study|Withdrawal by Subject|1|||
131826335|NCT00401245|474645650|FG007|Open Label Phase|Withdrawal by Subject|0|||
131826336|NCT00401245|474645643|FG000|Open Label Phase|Lack of Efficacy|4|||
131826337|NCT00401245|474645644|FG001|Open Label Phase|Lack of Efficacy|2|||
131826338|NCT00401245|474645645|FG002|Open Label Phase|Lack of Efficacy|3|||
131826339|NCT00401245|474645646|FG003|Open Label Phase|Lack of Efficacy|0|||
131826340|NCT00401245|474645647|FG004|Open Label Phase|Lack of Efficacy|0|||
131826341|NCT00401245|474645648|FG005|Open Label Phase|Lack of Efficacy|0|||
131826342|NCT00401245|474645649|FG006|Open Label Phase|Lack of Efficacy|0|||
131826343|NCT00401245|474645650|FG007|Open Label Phase|Lack of Efficacy|0|||
131826344|NCT00401245|474645643|FG000|Double Blind Tapering Phase|Adverse Event|0|||
131826345|NCT00401245|474645644|FG001|Double Blind Tapering Phase|Adverse Event|0|||
131826346|NCT00401245|474645645|FG002|Double Blind Tapering Phase|Adverse Event|0|||
131826347|NCT00401245|474645646|FG003|Double Blind Tapering Phase|Adverse Event|0|||
131826348|NCT00401245|474645647|FG004|Double Blind Tapering Phase|Adverse Event|1|||
131826349|NCT00401245|474645648|FG005|Double Blind Tapering Phase|Adverse Event|1|||
131826350|NCT00401245|474645649|FG006|Double Blind Tapering Phase|Adverse Event|2|||
131826351|NCT00401245|474645650|FG007|Double Blind Tapering Phase|Adverse Event|4|||
131826352|NCT00401245|474645643|FG000|Double Blind Tapering Phase|Investigator request|0|||
131826353|NCT00401245|474645644|FG001|Double Blind Tapering Phase|Investigator request|0|||
131826354|NCT00401245|474645645|FG002|Double Blind Tapering Phase|Investigator request|0|||
131826355|NCT00401245|474645646|FG003|Double Blind Tapering Phase|Investigator request|0|||
131826356|NCT00401245|474645647|FG004|Double Blind Tapering Phase|Investigator request|0|||
131826357|NCT00401245|474645648|FG005|Double Blind Tapering Phase|Investigator request|0|||
131826358|NCT00401245|474645649|FG006|Double Blind Tapering Phase|Investigator request|0|||
131826359|NCT00401245|474645650|FG007|Double Blind Tapering Phase|Investigator request|1|||
131826360|NCT00401245|474645643|FG000|Double Blind Tapering Phase|Other|0|||
131826361|NCT00401245|474645644|FG001|Double Blind Tapering Phase|Other|0|||
131826362|NCT00401245|474645645|FG002|Double Blind Tapering Phase|Other|0|||
131910063|NCT00885118|474958736|FG000|Overall Study|Other reason not defined above|0|||
131910064|NCT00885118|474958737|FG001|Overall Study|Other reason not defined above|0|||
131910065|NCT00885118|474958738|FG002|Overall Study|Other reason not defined above|1|||
131910066|NCT00885118|474958739|FG003|Overall Study|Other reason not defined above|0|||
131910067|NCT00885118|474958740|FG004|Overall Study|Other reason not defined above|0|||
131910068|NCT03883386|474958743|FG000|First Assignment|Lost to Follow-up|1|||
131910069|NCT03883386|474958744|FG001|First Assignment|Lost to Follow-up|0|||
131910070|NCT03883386|474958743|FG000|First Assignment|Withdrawal by Subject|1|||
131910071|NCT03883386|474958744|FG001|First Assignment|Withdrawal by Subject|1|||
131910072|NCT01326871|474958745|FG000|Overall Study|Major surgery|0|||
131910073|NCT01326871|474958746|FG001|Overall Study|Major surgery|1|||
131910074|NCT01326871|474958747|FG002|Overall Study|Major surgery|0|||
131910075|NCT01326871|474958745|FG000|Overall Study|SAE and death|0|||
131910076|NCT01326871|474958746|FG001|Overall Study|SAE and death|2|||
131910077|NCT01326871|474958747|FG002|Overall Study|SAE and death|0|||
131910078|NCT01326871|474958745|FG000|Overall Study|Physician decision and decreased performance status|0|||
131910079|NCT01326871|474958746|FG001|Overall Study|Physician decision and decreased performance status|1|||
131910080|NCT01326871|474958747|FG002|Overall Study|Physician decision and decreased performance status|0|||
131910081|NCT01326871|474958745|FG000|Overall Study|Disease progression|0|||
131910082|NCT01326871|474958746|FG001|Overall Study|Disease progression|11|||
131910083|NCT01326871|474958747|FG002|Overall Study|Disease progression|5|||
131910084|NCT01326871|474958745|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
131910085|NCT01326871|474958746|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
131910086|NCT01326871|474958747|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
131910087|NCT01326871|474958745|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
131910088|NCT01326871|474958746|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
131910089|NCT01326871|474958747|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
131910090|NCT01326871|474958745|FG000|Overall Study|Withdrawal by Subject|0|||
131910091|NCT01326871|474958746|FG001|Overall Study|Withdrawal by Subject|1|||
131910092|NCT01326871|474958747|FG002|Overall Study|Withdrawal by Subject|0|||
131910093|NCT01326871|474958745|FG000|Overall Study|DLT|0|||
131910094|NCT01326871|474958746|FG001|Overall Study|DLT|2|||
131910095|NCT01326871|474958747|FG002|Overall Study|DLT|0|||
131910096|NCT01326871|474958745|FG000|Overall Study|SAE, disease progression and subject decision|0|||
131910097|NCT01326871|474958746|FG001|Overall Study|SAE, disease progression and subject decision|1|||
131910098|NCT01326871|474958747|FG002|Overall Study|SAE, disease progression and subject decision|0|||
131910099|NCT01326871|474958745|FG000|Overall Study|Death|0|||
131826363|NCT00401245|474645646|FG003|Double Blind Tapering Phase|Other|0|||
131826364|NCT00401245|474645647|FG004|Double Blind Tapering Phase|Other|1|||
131826365|NCT00401245|474645648|FG005|Double Blind Tapering Phase|Other|0|||
131826366|NCT00401245|474645649|FG006|Double Blind Tapering Phase|Other|2|||
131826367|NCT00401245|474645650|FG007|Double Blind Tapering Phase|Other|2|||
131826368|NCT00401245|474645643|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
131826369|NCT00401245|474645644|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
131826370|NCT00401245|474645645|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
131826371|NCT00401245|474645646|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
131910100|NCT01326871|474958746|FG001|Overall Study|Death|1|||
131910101|NCT01326871|474958747|FG002|Overall Study|Death|0|||
131910102|NCT01326871|474958745|FG000|Overall Study|Other|0|||
131826372|NCT00401245|474645647|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
131826373|NCT00401245|474645648|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
131826374|NCT00401245|474645649|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
131826375|NCT00401245|474645650|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
131826376|NCT00401245|474645643|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826377|NCT00401245|474645644|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826378|NCT00401245|474645645|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826379|NCT00401245|474645646|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826380|NCT00401245|474645647|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826381|NCT00401245|474645648|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
131826382|NCT00401245|474645649|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826383|NCT00401245|474645650|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
131826384|NCT01563237|474645656|FG000|Overall Study|Lost to Follow-up|6|||
131826385|NCT01563237|474645657|FG001|Overall Study|Lost to Follow-up|0|||
131826386|NCT01563237|474645656|FG000|Overall Study|Withdrawal by Subject|1|||
131826387|NCT01563237|474645657|FG001|Overall Study|Withdrawal by Subject|0|||
131826388|NCT01563237|474645656|FG000|Overall Study|Adverse Event|1|||
131826389|NCT01563237|474645657|FG001|Overall Study|Adverse Event|0|||
131826390|NCT01563237|474645656|FG000|Overall Study|Medical Reasons|1|||
131826391|NCT01563237|474645657|FG001|Overall Study|Medical Reasons|0|||
131826392|NCT01563237|474645656|FG000|Overall Study|Death|1|||
131826393|NCT01563237|474645657|FG001|Overall Study|Death|0|||
131826394|NCT00966381|474645658|FG000|Overall Study|Withdrawal by Subject|2|||
131826395|NCT00966381|474645659|FG001|Overall Study|Withdrawal by Subject|2|||
131826396|NCT02668822|474645663|FG000|Overall Study|Protocol Violation|2|||
131826397|NCT02668822|474645664|FG001|Overall Study|Protocol Violation|0|||
131826398|NCT02668822|474645663|FG000|Overall Study|Study Terminated by Sponsor|7|||
131826399|NCT02668822|474645664|FG001|Overall Study|Study Terminated by Sponsor|9|||
131826400|NCT03449199|474645665|FG000|Overall Study|Lost to Follow-up|1|||
131826401|NCT03449199|474645666|FG001|Overall Study|Lost to Follow-up|1|||
131826402|NCT03449199|474645667|FG002|Overall Study|Lost to Follow-up|0|||
131826403|NCT03449199|474645665|FG000|Overall Study|Protocol Deviation|0|||
131826404|NCT03449199|474645666|FG001|Overall Study|Protocol Deviation|0|||
131826405|NCT03449199|474645667|FG002|Overall Study|Protocol Deviation|1|||
131826406|NCT03449199|474645665|FG000|Overall Study|Withdrawal by Subject|0|||
131826407|NCT03449199|474645666|FG001|Overall Study|Withdrawal by Subject|0|||
131826408|NCT03449199|474645667|FG002|Overall Study|Withdrawal by Subject|1|||
131826409|NCT03136406|474645668|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
131826410|NCT01844531|474645671|FG000|Overall Study|Withdrawal by Subject|0|||
131826411|NCT01844531|474645672|FG001|Overall Study|Withdrawal by Subject|1|||
131826412|NCT01844531|474645673|FG002|Overall Study|Withdrawal by Subject|0|||
131826413|NCT01844531|474645674|FG003|Overall Study|Withdrawal by Subject|0|||
131826414|NCT02000531|474645675|FG000|Overall Study|Lost to Follow-up|1|||
131826415|NCT02000531|474645676|FG001|Overall Study|Lost to Follow-up|0|||
131826416|NCT02000531|474645675|FG000|Overall Study|Discontinued due to data cut-off|3|||
131826417|NCT02000531|474645676|FG001|Overall Study|Discontinued due to data cut-off|8|||
131826418|NCT01280617|474645677|FG000|Overall Study|Adverse Event|0|||
131826419|NCT01280617|474645678|FG001|Overall Study|Adverse Event|1|||
131826420|NCT05966090|474645679|FG000|Overall Study|Lost to Follow-up|6|||
131826421|NCT05966090|474645680|FG001|Overall Study|Lost to Follow-up|6|||
131826422|NCT05966090|474645679|FG000|Overall Study|Adverse Event|1|||
131826423|NCT05966090|474645680|FG001|Overall Study|Adverse Event|1|||
131826424|NCT05966090|474645679|FG000|Overall Study|Withdrawal by Subject|1|||
131826425|NCT05966090|474645680|FG001|Overall Study|Withdrawal by Subject|1|||
131826426|NCT05966090|474645679|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131826427|NCT05966090|474645680|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131826428|NCT05966090|474645679|FG000|Overall Study|Other|1|||
131826429|NCT05966090|474645680|FG001|Overall Study|Other|1|||
131826430|NCT03756883|474645681|FG000|Overall Study|Adverse Event|2|||
131826431|NCT03756883|474645682|FG001|Overall Study|Adverse Event|2|||
131826432|NCT03756883|474645683|FG002|Overall Study|Adverse Event|2|||
131826433|NCT03756883|474645681|FG000|Overall Study|Lack of Efficacy|0|||
131826434|NCT03756883|474645682|FG001|Overall Study|Lack of Efficacy|1|||
131826435|NCT03756883|474645683|FG002|Overall Study|Lack of Efficacy|2|||
131826436|NCT03756883|474645681|FG000|Overall Study|Lost to Follow-up|3|||
131826437|NCT03756883|474645682|FG001|Overall Study|Lost to Follow-up|3|||
131826438|NCT03756883|474645683|FG002|Overall Study|Lost to Follow-up|0|||
131826439|NCT03756883|474645681|FG000|Overall Study|Protocol Violation|2|||
131826440|NCT03756883|474645682|FG001|Overall Study|Protocol Violation|0|||
131826441|NCT03756883|474645683|FG002|Overall Study|Protocol Violation|1|||
131826442|NCT03756883|474645681|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
131826443|NCT03756883|474645682|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
131826444|NCT03756883|474645683|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
131826445|NCT03756883|474645681|FG000|Overall Study|Withdrawal by Subject|4|||
131826446|NCT03756883|474645682|FG001|Overall Study|Withdrawal by Subject|1|||
131826447|NCT03756883|474645683|FG002|Overall Study|Withdrawal by Subject|0|||
131826448|NCT03756883|474645681|FG000|Overall Study|Other Reasons|2|||
131826449|NCT03756883|474645682|FG001|Overall Study|Other Reasons|4|||
131826450|NCT03756883|474645683|FG002|Overall Study|Other Reasons|0|||
131826451|NCT00337428|474645684|FG000|Overall Study|Withdrawal by Subject|1|||
131826452|NCT00337428|474645685|FG001|Overall Study|Withdrawal by Subject|2|||
131826453|NCT00337428|474645684|FG000|Overall Study|Lack of Time|1|||
131826454|NCT00337428|474645685|FG001|Overall Study|Lack of Time|1|||
131826455|NCT00337428|474645684|FG000|Overall Study|Unwilling to Continue|1|||
131826456|NCT00337428|474645685|FG001|Overall Study|Unwilling to Continue|0|||
131826457|NCT00337428|474645684|FG000|Overall Study|Anorexia|1|||
131826458|NCT00337428|474645685|FG001|Overall Study|Anorexia|0|||
131826459|NCT02618382|474645686|FG000|Overall Study|Physician Decision|1|||
131826460|NCT02618382|474645686|FG000|Overall Study|Withdrawal by Subject|1|||
131826461|NCT02618382|474645686|FG000|Overall Study|Protocol Violation|1|||
131826462|NCT00529217|474645690|FG000|Overall Study|Lack of Efficacy|2|||
131826463|NCT00529217|474645690|FG000|Overall Study|Unable to adhere to study schedule|2|||
131826464|NCT01999894|474645691|FG000|Overall Study|Adverse Event|9|||
131826465|NCT01999894|474645691|FG000|Overall Study|Lack of Efficacy|5|||
131826466|NCT01999894|474645691|FG000|Overall Study|Protocol Violation|1|||
131826467|NCT01999894|474645691|FG000|Overall Study|Withdrawal by Subject|7|||
131826468|NCT01999894|474645691|FG000|Overall Study|Lost to Follow-up|10|||
131826469|NCT01999894|474645691|FG000|Overall Study|Other Reason|3|||
131826470|NCT01999894|474645691|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
131826471|NCT01355302|474645693|FG000|Phase 1b|Death|4|||
131826472|NCT01355302|474645694|FG001|Phase 1b|Death|0|||
131826473|NCT01355302|474645695|FG002|Phase 1b|Death|0|||
131826474|NCT01355302|474645693|FG000|Phase 1b|Study terminated by sponsor|2|||
131826475|NCT01355302|474645694|FG001|Phase 1b|Study terminated by sponsor|0|||
131826476|NCT01355302|474645695|FG002|Phase 1b|Study terminated by sponsor|0|||
131826477|NCT01546519|474645696|FG000|Overall Study|Adverse Event|0|||
131826478|NCT01546519|474645697|FG001|Overall Study|Adverse Event|0|||
131826479|NCT01546519|474645698|FG002|Overall Study|Adverse Event|1|||
131826480|NCT01546519|474645699|FG003|Overall Study|Adverse Event|1|||
131826481|NCT01546519|474645696|FG000|Overall Study|Death|0|||
131826482|NCT01546519|474645697|FG001|Overall Study|Death|1|||
131826483|NCT01546519|474645698|FG002|Overall Study|Death|3|||
131826484|NCT01546519|474645699|FG003|Overall Study|Death|1|||
131826485|NCT01546519|474645696|FG000|Overall Study|related to disease progression|2|||
131826486|NCT01546519|474645697|FG001|Overall Study|related to disease progression|2|||
131826487|NCT01546519|474645698|FG002|Overall Study|related to disease progression|2|||
131826488|NCT01546519|474645699|FG003|Overall Study|related to disease progression|1|||
131826489|NCT01546519|474645696|FG000|Overall Study|Physician Decision|6|||
131826490|NCT01546519|474645697|FG001|Overall Study|Physician Decision|5|||
131826491|NCT01546519|474645698|FG002|Overall Study|Physician Decision|2|||
131826492|NCT01546519|474645699|FG003|Overall Study|Physician Decision|3|||
131826493|NCT01546519|474645696|FG000|Overall Study|Withdrawal by Subject|1|||
131826494|NCT01546519|474645697|FG001|Overall Study|Withdrawal by Subject|0|||
131826495|NCT01546519|474645698|FG002|Overall Study|Withdrawal by Subject|0|||
131826496|NCT01546519|474645699|FG003|Overall Study|Withdrawal by Subject|0|||
131826497|NCT00779402|474645702|FG000|Treatment Phase 1|Disease Progression|1|||
131826498|NCT00779402|474645703|FG001|Treatment Phase 1|Disease Progression|0|||
131826499|NCT00779402|474645702|FG000|Treatment Phase 1|Adverse Event|2|||
131826500|NCT00779402|474645703|FG001|Treatment Phase 1|Adverse Event|0|||
131826501|NCT00779402|474645702|FG000|Treatment Phase 1|Protocol Violation|1|||
131826502|NCT00779402|474645703|FG001|Treatment Phase 1|Protocol Violation|0|||
131826503|NCT00779402|474645702|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
131826504|NCT00779402|474645703|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
131826505|NCT00779402|474645702|FG000|Treatment Phase 1|Lost to Follow-up|0|||
131826506|NCT00779402|474645703|FG001|Treatment Phase 1|Lost to Follow-up|1|||
131826507|NCT00779402|474645702|FG000|Treatment Phase 1|Death|0|||
131826508|NCT00779402|474645703|FG001|Treatment Phase 1|Death|1|||
131826509|NCT00779402|474645702|FG000|Treatment Phase 1|Intercurrent Illness|1|||
131826510|NCT00779402|474645703|FG001|Treatment Phase 1|Intercurrent Illness|1|||
131826511|NCT00779402|474645702|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
131826512|NCT00779402|474645703|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
131826513|NCT00779402|474645702|FG000|Treatment Phase 1|Other|4|||
131826514|NCT00779402|474645703|FG001|Treatment Phase 1|Other|2|||
131826515|NCT00779402|474645702|FG000|Treatment Phase 1|Closure of Study|3|||
131826516|NCT00779402|474645703|FG001|Treatment Phase 1|Closure of Study|2|||
131826517|NCT00779402|474645702|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
131826518|NCT00779402|474645703|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
131826519|NCT00779402|474645702|FG000|Surveillance Phase|Protocol Violation|0|||
131826520|NCT00779402|474645703|FG001|Surveillance Phase|Protocol Violation|1|||
131826521|NCT00779402|474645702|FG000|Surveillance Phase|Patient refused to continue|22|||
131826522|NCT00779402|474645703|FG001|Surveillance Phase|Patient refused to continue|14|||
131826523|NCT00779402|474645702|FG000|Surveillance Phase|Lost to Follow-up|2|||
131826524|NCT00779402|474645703|FG001|Surveillance Phase|Lost to Follow-up|1|||
131826525|NCT00779402|474645702|FG000|Surveillance Phase|Death|0|||
131826526|NCT00779402|474645703|FG001|Surveillance Phase|Death|1|||
131826527|NCT00779402|474645702|FG000|Surveillance Phase|Intercurrent Illness|2|||
131826528|NCT00779402|474645703|FG001|Surveillance Phase|Intercurrent Illness|0|||
131826529|NCT00779402|474645702|FG000|Surveillance Phase|Other|5|||
131826530|NCT00779402|474645703|FG001|Surveillance Phase|Other|5|||
131401211|NCT02589665|473091464|FG008|Induction Extension Period|Physician Decision|1|||
131401212|NCT02589665|473091465|FG009|Induction Extension Period|Physician Decision|0|||
131401213|NCT02589665|473091456|FG000|Induction Extension Period|Reason Not Collected|0|||
131401214|NCT02589665|473091457|FG001|Induction Extension Period|Reason Not Collected|0|||
131401215|NCT02589665|473091458|FG002|Induction Extension Period|Reason Not Collected|0|||
131401216|NCT02589665|473091459|FG003|Induction Extension Period|Reason Not Collected|0|||
131826531|NCT00779402|474645702|FG000|Surveillance Phase|Withdrawal by Subject|4|||
131826532|NCT00779402|474645703|FG001|Surveillance Phase|Withdrawal by Subject|1|||
131401217|NCT02589665|473091460|FG004|Induction Extension Period|Reason Not Collected|0|||
131401218|NCT02589665|473091461|FG005|Induction Extension Period|Reason Not Collected|0|||
131401219|NCT02589665|473091462|FG006|Induction Extension Period|Reason Not Collected|0|||
131401220|NCT02589665|473091463|FG007|Induction Extension Period|Reason Not Collected|0|||
131826533|NCT00779402|474645702|FG000|Surveillance Phase|Closure of study|5|||
131826534|NCT00779402|474645703|FG001|Surveillance Phase|Closure of study|6|||
131826535|NCT00779402|474645702|FG000|Surveillance Phase|Completed Protocol Visits|3|||
131826536|NCT00779402|474645703|FG001|Surveillance Phase|Completed Protocol Visits|2|||
131826537|NCT00779402|474645702|FG000|Long-term Follow-up|Patient refused to continue|2|||
131826538|NCT00779402|474645703|FG001|Long-term Follow-up|Patient refused to continue|0|||
131826539|NCT00779402|474645702|FG000|Long-term Follow-up|Other|5|||
131826540|NCT00779402|474645703|FG001|Long-term Follow-up|Other|0|||
131826541|NCT00779402|474645702|FG000|Long-term Follow-up|Closure of Study|8|||
131826542|NCT00779402|474645703|FG001|Long-term Follow-up|Closure of Study|4|||
131826543|NCT00779402|474645702|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
131826544|NCT00779402|474645703|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
131826545|NCT00693225|474645704|FG000|Overall Study|Lost to Follow-up|1|||
131826546|NCT00693225|474645705|FG001|Overall Study|Lost to Follow-up|2|||
131826547|NCT00693225|474645704|FG000|Overall Study|Adverse Event|1|||
131826548|NCT00693225|474645705|FG001|Overall Study|Adverse Event|3|||
131826549|NCT01315028|474645706|FG000|Overall Study|Lost to Follow-up|1|||
131826550|NCT01315028|474645707|FG001|Overall Study|Lost to Follow-up|0|||
131826551|NCT01315028|474645706|FG000|Overall Study|Death|0|||
131826552|NCT01315028|474645707|FG001|Overall Study|Death|1|||
131826553|NCT00707434|474645710|FG000|Overall Study|Adverse Event|1|||
131826554|NCT04254809|474645712|FG000|Overall Study|Lost to Follow-up|5|||
131826555|NCT04254809|474645713|FG001|Overall Study|Lost to Follow-up|10|||
131826556|NCT04480307|474645714|FG000|Overall Study|Withdrawal by Subject|0|||
131826557|NCT04480307|474645715|FG001|Overall Study|Withdrawal by Subject|1|||
131826558|NCT04480307|474645716|FG002|Overall Study|Withdrawal by Subject|0|||
131826559|NCT04480307|474645717|FG003|Overall Study|Withdrawal by Subject|0|||
131826560|NCT04480307|474645714|FG000|Overall Study|Adverse Event|0|||
131826561|NCT04480307|474645715|FG001|Overall Study|Adverse Event|0|||
131826562|NCT04480307|474645716|FG002|Overall Study|Adverse Event|0|||
131826563|NCT04480307|474645717|FG003|Overall Study|Adverse Event|1|||
131826564|NCT01928615|474645718|FG000|Overall Study|Study Terminated by Sponsor|2|||
131826565|NCT03023137|474645719|FG000|Overall Study|Multiple pregnancy|2|||
131826566|NCT03023137|474645720|FG001|Overall Study|Multiple pregnancy|4|||
131826567|NCT03023137|474645719|FG000|Overall Study|Lost to Follow-up|1|||
131826568|NCT03023137|474645720|FG001|Overall Study|Lost to Follow-up|1|||
131826569|NCT03023137|474645719|FG000|Overall Study|Protocol Violation|0|||
131826570|NCT03023137|474645720|FG001|Overall Study|Protocol Violation|4|||
131826571|NCT03023137|474645719|FG000|Overall Study|Lost the baby in a car accident|1|||
131826572|NCT03023137|474645720|FG001|Overall Study|Lost the baby in a car accident|0|||
131826573|NCT00676494|474645724|FG000|Overall Study|Missed Visit|8|||
131826574|NCT00676494|474645724|FG000|Overall Study|Withdrawal by Subject|6|||
131826575|NCT02795676|474645725|FG000|Overall Study|Adverse Event|2|||
131826576|NCT02795676|474645726|FG001|Overall Study|Adverse Event|0|||
131826577|NCT02795676|474645725|FG000|Overall Study|Withdrawal by Subject|3|||
131826578|NCT02795676|474645726|FG001|Overall Study|Withdrawal by Subject|1|||
131826579|NCT02608476|474645727|FG000|Overall Study|Withdrawal by Subject|30|||
131826580|NCT02608476|474645728|FG001|Overall Study|Withdrawal by Subject|37|||
131826581|NCT02608476|474645727|FG000|Overall Study|Lost to Follow-up|24|||
131826582|NCT02608476|474645728|FG001|Overall Study|Lost to Follow-up|24|||
131910103|NCT01326871|474958746|FG001|Overall Study|Other|3|||
131826583|NCT02608476|474645727|FG000|Overall Study|Adverse Event|2|||
131826584|NCT02608476|474645728|FG001|Overall Study|Adverse Event|8|||
131826585|NCT02608476|474645727|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
131826586|NCT02608476|474645728|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
131826587|NCT02608476|474645727|FG000|Overall Study|Noncompliance with treatment|1|||
131826588|NCT02608476|474645728|FG001|Overall Study|Noncompliance with treatment|5|||
131826589|NCT02608476|474645727|FG000|Overall Study|Lack of Efficacy|3|||
131826590|NCT02608476|474645728|FG001|Overall Study|Lack of Efficacy|1|||
131826591|NCT02608476|474645727|FG000|Overall Study|Other|0|||
131826592|NCT02608476|474645728|FG001|Overall Study|Other|1|||
131826593|NCT02608476|474645727|FG000|Overall Study|Physician Decision|1|||
131401221|NCT02589665|473091464|FG008|Induction Extension Period|Reason Not Collected|1|||
131826594|NCT02608476|474645728|FG001|Overall Study|Physician Decision|0|||
131826595|NCT02608476|474645727|FG000|Overall Study|Pregnancy|0|||
131826596|NCT02608476|474645728|FG001|Overall Study|Pregnancy|1|||
131826597|NCT02608476|474645727|FG000|Overall Study|Progressive disease|1|||
131826598|NCT02608476|474645728|FG001|Overall Study|Progressive disease|0|||
131826599|NCT01264835|474645729|FG000|Overall Study|Lost to Follow-up|1|||
131826600|NCT00090753|474645736|FG000|First Treatment Period|Adverse Event|20|||
131826601|NCT00090753|474645737|FG001|First Treatment Period|Adverse Event|8|||
131826602|NCT00090753|474645736|FG000|First Treatment Period|Death|88|||
131826603|NCT00090753|474645737|FG001|First Treatment Period|Death|62|||
131826604|NCT00090753|474645736|FG000|First Treatment Period|Lack of Efficacy|2|||
131826605|NCT00090753|474645737|FG001|First Treatment Period|Lack of Efficacy|1|||
131826606|NCT00090753|474645736|FG000|First Treatment Period|Refused Treatment|32|||
131826607|NCT00090753|474645737|FG001|First Treatment Period|Refused Treatment|25|||
131826608|NCT00090753|474645736|FG000|First Treatment Period|Lost to Follow-up|4|||
131826609|NCT00090753|474645737|FG001|First Treatment Period|Lost to Follow-up|4|||
131768647|NCT01632345|474429896|FG006|Treatment: Part I|Lost to Follow-up|0|||
131768648|NCT01632345|474429890|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
131768649|NCT01632345|474429891|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
131768650|NCT01632345|474429892|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
131768651|NCT01632345|474429893|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
131401222|NCT02589665|473091465|FG009|Induction Extension Period|Reason Not Collected|0|||
131401223|NCT02589665|473091456|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401224|NCT02589665|473091457|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401225|NCT02589665|473091458|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401226|NCT02589665|473091459|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401227|NCT02589665|473091460|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401228|NCT02589665|473091461|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401229|NCT02589665|473091462|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401230|NCT02589665|473091463|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401231|NCT02589665|473091464|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
131401232|NCT02589665|473091465|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
131401233|NCT02589665|473091456|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
131401234|NCT02589665|473091457|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
131401235|NCT02589665|473091458|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
131401236|NCT02589665|473091459|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
131401237|NCT02589665|473091460|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
131401238|NCT02589665|473091461|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
131768652|NCT01632345|474429894|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
131768653|NCT01632345|474429895|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
131768654|NCT01632345|474429896|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
131768655|NCT01632345|474429890|FG000|Treatment: Part I|Physician Decision|2|||
131768656|NCT01632345|474429891|FG001|Treatment: Part I|Physician Decision|1|||
131768657|NCT01632345|474429892|FG002|Treatment: Part I|Physician Decision|0|||
131768658|NCT01632345|474429893|FG003|Treatment: Part I|Physician Decision|0|||
131768659|NCT01632345|474429894|FG004|Treatment: Part I|Physician Decision|1|||
131768660|NCT01632345|474429895|FG005|Treatment: Part I|Physician Decision|0|||
131768661|NCT01632345|474429896|FG006|Treatment: Part I|Physician Decision|0|||
131768662|NCT01632345|474429890|FG000|Treatment: Part I|Pregnancy|0|||
131768663|NCT01632345|474429891|FG001|Treatment: Part I|Pregnancy|1|||
131768664|NCT01632345|474429892|FG002|Treatment: Part I|Pregnancy|0|||
131768665|NCT01632345|474429893|FG003|Treatment: Part I|Pregnancy|0|||
131768666|NCT01632345|474429894|FG004|Treatment: Part I|Pregnancy|0|||
131768667|NCT01632345|474429895|FG005|Treatment: Part I|Pregnancy|0|||
131768668|NCT01632345|474429896|FG006|Treatment: Part I|Pregnancy|0|||
131768669|NCT01632345|474429890|FG000|Treatment: Part I|Protocol Deviation|0|||
131768670|NCT01632345|474429891|FG001|Treatment: Part I|Protocol Deviation|0|||
131768671|NCT01632345|474429892|FG002|Treatment: Part I|Protocol Deviation|1|||
131768672|NCT01632345|474429893|FG003|Treatment: Part I|Protocol Deviation|1|||
131768673|NCT01632345|474429894|FG004|Treatment: Part I|Protocol Deviation|0|||
131768674|NCT01632345|474429895|FG005|Treatment: Part I|Protocol Deviation|0|||
131768675|NCT01632345|474429896|FG006|Treatment: Part I|Protocol Deviation|0|||
131768676|NCT01632345|474429890|FG000|Treatment: Part I|Withdrawal by Subject|3|||
131768677|NCT01632345|474429891|FG001|Treatment: Part I|Withdrawal by Subject|4|||
131768678|NCT01632345|474429892|FG002|Treatment: Part I|Withdrawal by Subject|4|||
131768679|NCT01632345|474429893|FG003|Treatment: Part I|Withdrawal by Subject|1|||
131768680|NCT01632345|474429894|FG004|Treatment: Part I|Withdrawal by Subject|4|||
131768681|NCT01632345|474429895|FG005|Treatment: Part I|Withdrawal by Subject|0|||
131768682|NCT01632345|474429896|FG006|Treatment: Part I|Withdrawal by Subject|0|||
131768683|NCT01632345|474429890|FG000|Treatment: Part II|Adverse Event|0|||
131768684|NCT01632345|474429891|FG001|Treatment: Part II|Adverse Event|0|||
131768685|NCT01632345|474429892|FG002|Treatment: Part II|Adverse Event|0|||
131768686|NCT01632345|474429893|FG003|Treatment: Part II|Adverse Event|0|||
131826610|NCT00090753|474645736|FG000|First Treatment Period|Renal Transplant|70|||
131826611|NCT00090753|474645737|FG001|First Treatment Period|Renal Transplant|50|||
131826612|NCT00090753|474645736|FG000|First Treatment Period|Mircera Commercialization|1|||
131826613|NCT00090753|474645737|FG001|First Treatment Period|Mircera Commercialization|0|||
131826614|NCT00090753|474645736|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
131826615|NCT00090753|474645737|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
131826616|NCT00090753|474645736|FG000|Extended Treatment Period|Adverse Event|11|||
131401239|NCT02589665|473091462|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
131401240|NCT02589665|473091463|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
131401241|NCT02589665|473091464|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
131401242|NCT02589665|473091465|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
131826617|NCT00090753|474645737|FG001|Extended Treatment Period|Adverse Event|0|||
131826618|NCT00090753|474645736|FG000|Extended Treatment Period|Death|58|||
131826619|NCT00090753|474645737|FG001|Extended Treatment Period|Death|30|||
131826620|NCT00090753|474645736|FG000|Extended Treatment Period|Lack of Efficacy|1|||
131826621|NCT00090753|474645737|FG001|Extended Treatment Period|Lack of Efficacy|0|||
131826622|NCT00090753|474645736|FG000|Extended Treatment Period|Refused Treatment|18|||
131826623|NCT00090753|474645737|FG001|Extended Treatment Period|Refused Treatment|12|||
131826624|NCT00090753|474645736|FG000|Extended Treatment Period|Lost to Follow-up|3|||
131826625|NCT00090753|474645737|FG001|Extended Treatment Period|Lost to Follow-up|1|||
131826626|NCT00090753|474645736|FG000|Extended Treatment Period|Renal Transplant|15|||
131826627|NCT00090753|474645737|FG001|Extended Treatment Period|Renal Transplant|12|||
131826628|NCT00090753|474645736|FG000|Extended Treatment Period|Mircera Commercialization|188|||
131826629|NCT00090753|474645737|FG001|Extended Treatment Period|Mircera Commercialization|93|||
131826630|NCT00090753|474645736|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
131826631|NCT00090753|474645737|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
131826632|NCT00605176|474645740|FG000|Overall Study|Adverse Event|2|||
131826633|NCT00605176|474645741|FG001|Overall Study|Adverse Event|1|||
131826634|NCT00605176|474645742|FG002|Overall Study|Adverse Event|3|||
131826635|NCT00605176|474645740|FG000|Overall Study|Withdrawal by Subject|4|||
131826636|NCT00605176|474645741|FG001|Overall Study|Withdrawal by Subject|2|||
131826637|NCT00605176|474645742|FG002|Overall Study|Withdrawal by Subject|4|||
131826638|NCT00605176|474645740|FG000|Overall Study|Lost to Follow-up|2|||
131826639|NCT00605176|474645741|FG001|Overall Study|Lost to Follow-up|2|||
131826640|NCT00605176|474645742|FG002|Overall Study|Lost to Follow-up|1|||
131826641|NCT00605176|474645740|FG000|Overall Study|Non-complicance with study procedures|1|||
131826642|NCT00605176|474645741|FG001|Overall Study|Non-complicance with study procedures|0|||
131826643|NCT00605176|474645742|FG002|Overall Study|Non-complicance with study procedures|0|||
131826644|NCT00605176|474645740|FG000|Overall Study|Use of concomitant therapy|1|||
131826645|NCT00605176|474645741|FG001|Overall Study|Use of concomitant therapy|0|||
131826646|NCT00605176|474645742|FG002|Overall Study|Use of concomitant therapy|1|||
131826647|NCT00605176|474645740|FG000|Overall Study|Other (not due to AE)|1|||
131826648|NCT00605176|474645741|FG001|Overall Study|Other (not due to AE)|1|||
131826649|NCT00605176|474645742|FG002|Overall Study|Other (not due to AE)|0|||
131826650|NCT01256060|474645743|FG000|Overall Study|Lost to Follow-up|0|||
131826651|NCT01256060|474645744|FG001|Overall Study|Lost to Follow-up|1|||
131826652|NCT01256060|474645745|FG002|Overall Study|Lost to Follow-up|0|||
131826653|NCT01256060|474645746|FG003|Overall Study|Lost to Follow-up|0|||
131826654|NCT00587431|474645753|FG000|Overall Study|Adverse Event|1|||
131826655|NCT00587431|474645754|FG001|Overall Study|Adverse Event|0|||
131826656|NCT00587431|474645753|FG000|Overall Study|Withdrawal by Subject|0|||
131826657|NCT00587431|474645754|FG001|Overall Study|Withdrawal by Subject|1|||
131826658|NCT00220727|474645757|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
131826659|NCT00220727|474645758|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
131826660|NCT00761176|474645759|FG000|Overall Study|Death|1|||
131826661|NCT00761176|474645760|FG001|Overall Study|Death|0|||
131826662|NCT00761176|474645759|FG000|Overall Study|Withdrawal by Subject|1|||
131826663|NCT00761176|474645760|FG001|Overall Study|Withdrawal by Subject|1|||
131826664|NCT02762994|474645761|FG000|Overall Study|Withdrawal by Subject|0|||
131401243|NCT02589665|473091456|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
131826665|NCT02762994|474645762|FG001|Overall Study|Withdrawal by Subject|1|||
131826666|NCT02762994|474645763|FG002|Overall Study|Withdrawal by Subject|2|||
131826667|NCT02762994|474645764|FG003|Overall Study|Withdrawal by Subject|0|||
131826668|NCT02762994|474645761|FG000|Overall Study|Protocol Violation|1|||
131826669|NCT02762994|474645762|FG001|Overall Study|Protocol Violation|0|||
131826670|NCT02762994|474645763|FG002|Overall Study|Protocol Violation|0|||
131826671|NCT02762994|474645764|FG003|Overall Study|Protocol Violation|2|||
131826672|NCT05103657|474645765|FG000|Overall Study|Other reasons than listed|9|||
131826673|NCT05103657|474645766|FG001|Overall Study|Other reasons than listed|8|||
131826674|NCT05103657|474645765|FG000|Overall Study|Protocol deviation|2|||
131826675|NCT05103657|474645766|FG001|Overall Study|Protocol deviation|2|||
131826676|NCT05103657|474645765|FG000|Overall Study|No reason available|5|||
131826677|NCT05103657|474645766|FG001|Overall Study|No reason available|4|||
131826678|NCT05103657|474645765|FG000|Overall Study|Burden of study procedures|3|||
131826679|NCT05103657|474645766|FG001|Overall Study|Burden of study procedures|1|||
131826680|NCT05103657|474645765|FG000|Overall Study|Perceived lack of efficacy|1|||
131826681|NCT05103657|474645766|FG001|Overall Study|Perceived lack of efficacy|1|||
131826682|NCT05103657|474645765|FG000|Overall Study|Adverse Event|6|||
131826683|NCT05103657|474645766|FG001|Overall Study|Adverse Event|14|||
131826684|NCT05103657|474645765|FG000|Overall Study|Not Treated|1|||
131826685|NCT05103657|474645766|FG001|Overall Study|Not Treated|1|||
131826686|NCT04234464|474645770|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
131826687|NCT04234464|474645771|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
131826688|NCT03635983|474645774|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
131826689|NCT03635983|474645775|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
131826690|NCT03635983|474645774|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131826691|NCT03635983|474645775|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131826692|NCT03635983|474645774|FG000|Pre-Treatment Period|Other reasons|0|||
131826693|NCT03635983|474645775|FG001|Pre-Treatment Period|Other reasons|1|||
131826694|NCT03635983|474645774|FG000|Pre-Treatment Period|Disease Progression|0|||
131826695|NCT03635983|474645775|FG001|Pre-Treatment Period|Disease Progression|1|||
131826696|NCT03635983|474645774|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
131826697|NCT03635983|474645775|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
131826698|NCT03635983|474645774|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
131826699|NCT03635983|474645775|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
131826700|NCT03635983|474645774|FG000|Treatment Period|Withdrawal by Subject|3|||
131826701|NCT03635983|474645775|FG001|Treatment Period|Withdrawal by Subject|5|||
131826702|NCT03635983|474645774|FG000|Treatment Period|Death|3|||
131826703|NCT03635983|474645775|FG001|Treatment Period|Death|5|||
131826704|NCT03635983|474645774|FG000|Treatment Period|Poor/Non-compliance|2|||
131826705|NCT03635983|474645775|FG001|Treatment Period|Poor/Non-compliance|1|||
131826706|NCT03635983|474645774|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
131826707|NCT03635983|474645775|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
131826708|NCT03635983|474645774|FG000|Treatment Period|Other reasons|7|||
131826709|NCT03635983|474645775|FG001|Treatment Period|Other reasons|4|||
131826710|NCT03635983|474645774|FG000|Treatment Period|Disease progression|230|||
131826711|NCT03635983|474645775|FG001|Treatment Period|Disease progression|201|||
131826712|NCT03635983|474645774|FG000|Treatment Period|Study drug toxicity|35|||
131826713|NCT03635983|474645775|FG001|Treatment Period|Study drug toxicity|36|||
131826714|NCT03635983|474645774|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
131826715|NCT03635983|474645775|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
131826716|NCT03635983|474645774|FG000|Treatment Period|Maximum clinical benefit|3|||
131826717|NCT03635983|474645775|FG001|Treatment Period|Maximum clinical benefit|5|||
131826718|NCT03635983|474645774|FG000|Treatment Period|Administrative reason by the sponsor|1|||
131826719|NCT03635983|474645775|FG001|Treatment Period|Administrative reason by the sponsor|2|||
131826720|NCT03635983|474645774|FG000|Treatment Period|Lost to Follow-up|0|||
131826721|NCT03635983|474645775|FG001|Treatment Period|Lost to Follow-up|1|||
131826722|NCT03430011|474645776|FG000|Pre-Treatment|Death|1|||
131826723|NCT03430011|474645777|FG001|Pre-Treatment|Death|0|||
131826724|NCT03430011|474645778|FG002|Pre-Treatment|Death|0|||
131826725|NCT03430011|474645779|FG003|Pre-Treatment|Death|0|||
131826726|NCT03430011|474645780|FG004|Pre-Treatment|Death|1|||
131826727|NCT03430011|474645781|FG005|Pre-Treatment|Death|0|||
131826728|NCT03430011|474645782|FG006|Pre-Treatment|Death|1|||
131826729|NCT03430011|474645783|FG007|Pre-Treatment|Death|0|||
131826730|NCT03430011|474645776|FG000|Pre-Treatment|Screen Fail|0|||
131826731|NCT03430011|474645777|FG001|Pre-Treatment|Screen Fail|0|||
131826732|NCT03430011|474645778|FG002|Pre-Treatment|Screen Fail|0|||
131910104|NCT01326871|474958747|FG002|Overall Study|Other|0|||
131910105|NCT01326871|474958745|FG000|Overall Study|SAE and disease progression|0|||
131401244|NCT02589665|473091457|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
131401245|NCT02589665|473091458|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
131826733|NCT03430011|474645779|FG003|Pre-Treatment|Screen Fail|0|||
131826734|NCT03430011|474645780|FG004|Pre-Treatment|Screen Fail|1|||
131826735|NCT03430011|474645781|FG005|Pre-Treatment|Screen Fail|0|||
131826736|NCT03430011|474645782|FG006|Pre-Treatment|Screen Fail|0|||
131826737|NCT03430011|474645783|FG007|Pre-Treatment|Screen Fail|0|||
131826738|NCT03430011|474645776|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
131826739|NCT03430011|474645777|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
131826740|NCT03430011|474645778|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
131826741|NCT03430011|474645779|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
131826742|NCT03430011|474645780|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
131826743|NCT03430011|474645781|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
131910106|NCT01326871|474958746|FG001|Overall Study|SAE and disease progression|0|||
131910107|NCT01326871|474958747|FG002|Overall Study|SAE and disease progression|1|||
131910108|NCT01326871|474958745|FG000|Overall Study|SAE and physician decision|0|||
131910109|NCT01326871|474958746|FG001|Overall Study|SAE and physician decision|0|||
131826744|NCT03430011|474645782|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
131826745|NCT03430011|474645783|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
131826746|NCT03430011|474645776|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
131826747|NCT03430011|474645777|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
131826748|NCT03430011|474645778|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
131826749|NCT03430011|474645779|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
131826750|NCT03430011|474645780|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
131826751|NCT03430011|474645781|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
131826752|NCT03430011|474645782|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
131826753|NCT03430011|474645783|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
131826754|NCT03430011|474645776|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
131826755|NCT03430011|474645777|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
131826756|NCT03430011|474645778|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
131826757|NCT03430011|474645779|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
131401246|NCT02589665|473091459|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
131401247|NCT02589665|473091460|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
131401248|NCT02589665|473091461|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
131401249|NCT02589665|473091462|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
131826758|NCT03430011|474645780|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
131826759|NCT03430011|474645781|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
131826760|NCT03430011|474645782|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
131826761|NCT03430011|474645783|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
131826762|NCT03430011|474645776|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
131826763|NCT03430011|474645777|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
131401250|NCT02589665|473091463|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
131401251|NCT02589665|473091464|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
131401252|NCT02589665|473091465|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
131401253|NCT02589665|473091456|FG000|Maintenance Extension Period|Adverse Event|0|||
131401254|NCT02589665|473091457|FG001|Maintenance Extension Period|Adverse Event|0|||
131401255|NCT02589665|473091458|FG002|Maintenance Extension Period|Adverse Event|0|||
131401256|NCT02589665|473091459|FG003|Maintenance Extension Period|Adverse Event|0|||
131401257|NCT02589665|473091460|FG004|Maintenance Extension Period|Adverse Event|0|||
131401258|NCT02589665|473091461|FG005|Maintenance Extension Period|Adverse Event|0|||
131401259|NCT02589665|473091462|FG006|Maintenance Extension Period|Adverse Event|0|||
131401260|NCT02589665|473091463|FG007|Maintenance Extension Period|Adverse Event|0|||
131401261|NCT02589665|473091464|FG008|Maintenance Extension Period|Adverse Event|0|||
131401262|NCT02589665|473091465|FG009|Maintenance Extension Period|Adverse Event|2|||
131401263|NCT02589665|473091456|FG000|Maintenance Extension Period|Non-responder|0|||
131401264|NCT02589665|473091457|FG001|Maintenance Extension Period|Non-responder|0|||
131401265|NCT02589665|473091458|FG002|Maintenance Extension Period|Non-responder|0|||
131401266|NCT02589665|473091459|FG003|Maintenance Extension Period|Non-responder|0|||
131401267|NCT02589665|473091460|FG004|Maintenance Extension Period|Non-responder|0|||
131401268|NCT02589665|473091461|FG005|Maintenance Extension Period|Non-responder|0|||
131401269|NCT02589665|473091462|FG006|Maintenance Extension Period|Non-responder|0|||
131401270|NCT02589665|473091463|FG007|Maintenance Extension Period|Non-responder|0|||
131401271|NCT02589665|473091464|FG008|Maintenance Extension Period|Non-responder|0|||
131401272|NCT02589665|473091465|FG009|Maintenance Extension Period|Non-responder|1|||
131401273|NCT00978380|473091466|FG000|Overall Study|Protocol Violation|2|||
131401274|NCT00978380|473091466|FG000|Overall Study|Withdrawal criteria|9|||
131401275|NCT00978380|473091466|FG000|Overall Study|Unclassified|8|||
131401276|NCT00837265|473091467|FG000|Pilot Phase|Withdrawal by Subject|0|||
131401277|NCT00837265|473091468|FG001|Pilot Phase|Withdrawal by Subject|2|||
131401278|NCT00837265|473091469|FG002|Pilot Phase|Withdrawal by Subject|3|||
131401279|NCT00837265|473091470|FG003|Pilot Phase|Withdrawal by Subject|2|||
131401280|NCT00837265|473091471|FG004|Pilot Phase|Withdrawal by Subject|0|||
131401281|NCT00837265|473091472|FG005|Pilot Phase|Withdrawal by Subject|0|||
131401282|NCT00837265|473091473|FG006|Pilot Phase|Withdrawal by Subject|0|||
131401283|NCT00837265|473091467|FG000|Pilot Phase|Decision of the investigator|2|||
131401284|NCT00837265|473091468|FG001|Pilot Phase|Decision of the investigator|1|||
131401285|NCT00837265|473091469|FG002|Pilot Phase|Decision of the investigator|0|||
131826764|NCT03430011|474645778|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
131826765|NCT03430011|474645779|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
131826766|NCT03430011|474645780|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
131826767|NCT03430011|474645781|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
131401286|NCT00837265|473091470|FG003|Pilot Phase|Decision of the investigator|0|||
131826768|NCT03430011|474645782|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
131826769|NCT03430011|474645783|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
131826770|NCT03430011|474645776|FG000|JCARH125 Treatment|Death|4|||
131826771|NCT03430011|474645777|FG001|JCARH125 Treatment|Death|19|||
131826772|NCT03430011|474645778|FG002|JCARH125 Treatment|Death|10|||
131826773|NCT03430011|474645779|FG003|JCARH125 Treatment|Death|8|||
131826774|NCT03430011|474645780|FG004|JCARH125 Treatment|Death|5|||
131826775|NCT03430011|474645781|FG005|JCARH125 Treatment|Death|3|||
131826776|NCT03430011|474645782|FG006|JCARH125 Treatment|Death|4|||
131401287|NCT00837265|473091471|FG004|Pilot Phase|Decision of the investigator|0|||
131401288|NCT00837265|473091472|FG005|Pilot Phase|Decision of the investigator|0|||
131401289|NCT00837265|473091473|FG006|Pilot Phase|Decision of the investigator|0|||
131401290|NCT00837265|473091467|FG000|Pilot Phase|Adverse Event|1|||
131401291|NCT00837265|473091468|FG001|Pilot Phase|Adverse Event|0|||
131826777|NCT03430011|474645783|FG007|JCARH125 Treatment|Death|2|||
131826778|NCT03430011|474645776|FG000|JCARH125 Treatment|Other reasons|1|||
131826779|NCT03430011|474645777|FG001|JCARH125 Treatment|Other reasons|0|||
131826780|NCT03430011|474645778|FG002|JCARH125 Treatment|Other reasons|4|||
131826781|NCT03430011|474645779|FG003|JCARH125 Treatment|Other reasons|2|||
131826782|NCT03430011|474645780|FG004|JCARH125 Treatment|Other reasons|2|||
131826783|NCT03430011|474645781|FG005|JCARH125 Treatment|Other reasons|1|||
131826784|NCT03430011|474645782|FG006|JCARH125 Treatment|Other reasons|3|||
131826785|NCT03430011|474645783|FG007|JCARH125 Treatment|Other reasons|2|||
131826786|NCT01235442|474645786|FG000|Overall Study|Lost to Follow-up|12|||
131826787|NCT01235442|474645787|FG001|Overall Study|Lost to Follow-up|10|||
131826788|NCT01235442|474645786|FG000|Overall Study|Death|0|||
131826789|NCT01235442|474645787|FG001|Overall Study|Death|2|||
131826790|NCT01235442|474645786|FG000|Overall Study|Pregnancy|1|||
131826791|NCT01235442|474645787|FG001|Overall Study|Pregnancy|1|||
131826792|NCT01235442|474645786|FG000|Overall Study|Ineligibility determined|5|||
131826793|NCT01235442|474645787|FG001|Overall Study|Ineligibility determined|4|||
131826794|NCT01235442|474645786|FG000|Overall Study|Protocol Violation|3|||
131826795|NCT01235442|474645787|FG001|Overall Study|Protocol Violation|3|||
131826796|NCT01235442|474645786|FG000|Overall Study|Adverse Event|4|||
131826797|NCT01235442|474645787|FG001|Overall Study|Adverse Event|6|||
131826798|NCT01235442|474645786|FG000|Overall Study|Withdrawal by Subject|15|||
131826799|NCT01235442|474645787|FG001|Overall Study|Withdrawal by Subject|9|||
131826800|NCT01235442|474645786|FG000|Overall Study|Lack of Efficacy|1|||
131826801|NCT01235442|474645787|FG001|Overall Study|Lack of Efficacy|3|||
131826802|NCT01235442|474645786|FG000|Overall Study|Noncompliance|1|||
131826803|NCT01235442|474645787|FG001|Overall Study|Noncompliance|2|||
131826804|NCT01235442|474645786|FG000|Overall Study|Administrative decision|1|||
131826805|NCT01235442|474645787|FG001|Overall Study|Administrative decision|2|||
131826806|NCT01235442|474645786|FG000|Overall Study|Other unspecified|1|||
131826807|NCT01235442|474645787|FG001|Overall Study|Other unspecified|2|||
131826808|NCT01701973|474645788|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826809|NCT01701973|474645789|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
131826810|NCT01701973|474645790|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826811|NCT01701973|474645791|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826812|NCT01701973|474645792|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826813|NCT01701973|474645793|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826814|NCT01701973|474645794|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826815|NCT01701973|474645795|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
131826816|NCT02941523|474645799|FG000|Monotherapy|Withdrawal by Subject|0|||
131826817|NCT02941523|474645800|FG001|Monotherapy|Withdrawal by Subject|1|||
131826818|NCT02941523|474645799|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
131826819|NCT02941523|474645800|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
131826820|NCT02941523|474645799|FG000|Carboplatin Combination Therapy|Death|1|||
131826821|NCT02941523|474645800|FG001|Carboplatin Combination Therapy|Death|2|||
131826822|NCT02941523|474645799|FG000|Carboplatin Combination Therapy|Disease progression|2|||
131826823|NCT02941523|474645800|FG001|Carboplatin Combination Therapy|Disease progression|0|||
131826824|NCT02941523|474645799|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
131826825|NCT02941523|474645800|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
131826826|NCT04330157|474645801|FG000|Overall Study|Protocol Violation|4|||
131826827|NCT04330157|474645801|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
131826828|NCT04499482|474645802|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
131401292|NCT00837265|473091469|FG002|Pilot Phase|Adverse Event|0|||
131401293|NCT00837265|473091470|FG003|Pilot Phase|Adverse Event|0|||
131401294|NCT00837265|473091471|FG004|Pilot Phase|Adverse Event|0|||
131826829|NCT01899326|474645803|FG000|Overall Study|Withdrawal by Subject|1|||
131826830|NCT01899326|474645803|FG000|Overall Study|Adverse Event|2|||
131826831|NCT01899326|474645803|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
131401295|NCT00837265|473091472|FG005|Pilot Phase|Adverse Event|0|||
131401296|NCT00837265|473091473|FG006|Pilot Phase|Adverse Event|0|||
131826832|NCT00373425|474645804|FG000|Overall Study|Relapse of NSCLC|116|||
131826833|NCT00373425|474645805|FG001|Overall Study|Relapse of NSCLC|104|||
131826834|NCT00373425|474645806|FG002|Overall Study|Relapse of NSCLC|19|||
131826835|NCT00373425|474645807|FG003|Overall Study|Relapse of NSCLC|2|||
131826836|NCT00373425|474645808|FG004|Overall Study|Relapse of NSCLC|26|||
131826837|NCT00373425|474645804|FG000|Overall Study|Adverse Event|191|||
131826838|NCT00373425|474645805|FG001|Overall Study|Adverse Event|22|||
131826839|NCT00373425|474645806|FG002|Overall Study|Adverse Event|59|||
131401297|NCT00837265|473091467|FG000|Pilot Phase|Disease progression|0|||
131401298|NCT00837265|473091468|FG001|Pilot Phase|Disease progression|0|||
131401299|NCT00837265|473091469|FG002|Pilot Phase|Disease progression|0|||
131826840|NCT00373425|474645807|FG003|Overall Study|Adverse Event|0|||
131826841|NCT00373425|474645808|FG004|Overall Study|Adverse Event|34|||
131826842|NCT00373425|474645804|FG000|Overall Study|Patient request|35|||
131826843|NCT00373425|474645805|FG001|Overall Study|Patient request|18|||
131826844|NCT00373425|474645806|FG002|Overall Study|Patient request|43|||
131826845|NCT00373425|474645807|FG003|Overall Study|Patient request|6|||
131826846|NCT00373425|474645808|FG004|Overall Study|Patient request|7|||
131826847|NCT00373425|474645804|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
131826848|NCT00373425|474645805|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
131826849|NCT00373425|474645806|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
131826850|NCT00373425|474645807|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
131826851|NCT00373425|474645808|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
131826852|NCT00373425|474645804|FG000|Overall Study|Death|7|||
131826853|NCT00373425|474645805|FG001|Overall Study|Death|0|||
131826854|NCT00373425|474645806|FG002|Overall Study|Death|3|||
131826855|NCT00373425|474645807|FG003|Overall Study|Death|1|||
131826856|NCT00373425|474645808|FG004|Overall Study|Death|0|||
131826857|NCT00551616|474645811|FG000|Overall Study|Lost to Follow-up|48|||
131826858|NCT00551616|474645812|FG001|Overall Study|Lost to Follow-up|40|||
131826859|NCT02219308|474645813|FG000|Overall Study|Withdrawal by Subject|1|||
131826860|NCT02219308|474645814|FG001|Overall Study|Withdrawal by Subject|2|||
131826861|NCT01557582|474645815|FG000|Overall Study|Protocol Violation|4|||
131826862|NCT01557582|474645815|FG000|Overall Study|Operator error|2|||
131826863|NCT03840382|474645816|FG000|Overall Study|Lost to Follow-up|11|||
131826864|NCT02843659|474645817|FG000|Overall Study|Subject Withdrew Consent|0|||
131826865|NCT02843659|474645818|FG001|Overall Study|Subject Withdrew Consent|0|||
131826866|NCT02843659|474645819|FG002|Overall Study|Subject Withdrew Consent|1|||
131826867|NCT02843659|474645817|FG000|Overall Study|Administrative Reason by Sponsor|4|||
131826868|NCT02843659|474645818|FG001|Overall Study|Administrative Reason by Sponsor|5|||
131826869|NCT02843659|474645819|FG002|Overall Study|Administrative Reason by Sponsor|4|||
131826870|NCT02843659|474645817|FG000|Overall Study|Adverse Event|0|||
131826871|NCT02843659|474645818|FG001|Overall Study|Adverse Event|1|||
131826872|NCT02843659|474645819|FG002|Overall Study|Adverse Event|0|||
131826873|NCT02413294|474645820|FG000|Overall Study|Withdrawal by Subject|1|||
131910110|NCT01326871|474958747|FG002|Overall Study|SAE and physician decision|1|||
131910111|NCT01326871|474958745|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
131910112|NCT01326871|474958746|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
131910113|NCT01326871|474958747|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
131910114|NCT01326871|474958745|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
131910115|NCT01326871|474958746|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
131910116|NCT01326871|474958747|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
131910117|NCT01326871|474958745|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
131910118|NCT01326871|474958746|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
131910119|NCT01326871|474958747|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
131910120|NCT01326871|474958745|FG000|Overall Study|Physician Decision|0|||
131910121|NCT01326871|474958746|FG001|Overall Study|Physician Decision|0|||
131910122|NCT01326871|474958747|FG002|Overall Study|Physician Decision|1|||
131910123|NCT01326871|474958745|FG000|Overall Study|SAE|0|||
131910124|NCT01326871|474958746|FG001|Overall Study|SAE|0|||
131910125|NCT01326871|474958747|FG002|Overall Study|SAE|1|||
131910126|NCT01326871|474958745|FG000|Overall Study|Disease progression and death|0|||
131910127|NCT01326871|474958746|FG001|Overall Study|Disease progression and death|0|||
131910128|NCT01326871|474958747|FG002|Overall Study|Disease progression and death|1|||
131910129|NCT01326871|474958745|FG000|Overall Study|Subject decision|0|||
131910130|NCT01326871|474958746|FG001|Overall Study|Subject decision|0|||
131910131|NCT01326871|474958747|FG002|Overall Study|Subject decision|1|||
131910132|NCT00251758|474958748|FG000|Overall Study|Adverse Event|7|||
131910133|NCT00251758|474958749|FG001|Overall Study|Adverse Event|9|||
131910134|NCT00251758|474958750|FG002|Overall Study|Adverse Event|11|||
131910135|NCT00251758|474958748|FG000|Overall Study|Lost to Follow-up|4|||
131910136|NCT00251758|474958749|FG001|Overall Study|Lost to Follow-up|2|||
131910137|NCT00251758|474958750|FG002|Overall Study|Lost to Follow-up|5|||
131910138|NCT00251758|474958748|FG000|Overall Study|Withdrawal by Subject|13|||
131910139|NCT00251758|474958749|FG001|Overall Study|Withdrawal by Subject|7|||
131910140|NCT00251758|474958750|FG002|Overall Study|Withdrawal by Subject|3|||
131910141|NCT00251758|474958748|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
131910142|NCT00251758|474958749|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
131910143|NCT00251758|474958750|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
131401300|NCT00837265|473091470|FG003|Pilot Phase|Disease progression|1|||
131401301|NCT00837265|473091471|FG004|Pilot Phase|Disease progression|0|||
131401302|NCT00837265|473091472|FG005|Pilot Phase|Disease progression|0|||
131910144|NCT00251758|474958748|FG000|Overall Study|Lack of Efficacy|3|||
131910145|NCT00251758|474958749|FG001|Overall Study|Lack of Efficacy|0|||
131910146|NCT00251758|474958750|FG002|Overall Study|Lack of Efficacy|0|||
131826874|NCT01989676|474647338|FG000|Overall Study|Death|52|||
131826875|NCT01989676|474647339|FG001|Overall Study|Death|60|||
131826876|NCT01989676|474647338|FG000|Overall Study|Protocol Violation|2|||
131826877|NCT01989676|474647339|FG001|Overall Study|Protocol Violation|1|||
131826878|NCT01989676|474647338|FG000|Overall Study|Lost to Follow-up|8|||
131826879|NCT01989676|474647339|FG001|Overall Study|Lost to Follow-up|18|||
131826880|NCT01989676|474647338|FG000|Overall Study|No longer willing to participate in study|26|||
131826881|NCT01989676|474647339|FG001|Overall Study|No longer willing to participate in study|26|||
131826882|NCT01989676|474647338|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
131826883|NCT01989676|474647339|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
131826884|NCT01989676|474647338|FG000|Overall Study|Other|4|||
131826885|NCT01989676|474647339|FG001|Overall Study|Other|3|||
131826886|NCT03941834|474647340|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
131826887|NCT03941834|474647341|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
131826888|NCT03941834|474647342|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
131826889|NCT03941834|474647340|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
131826890|NCT03941834|474647341|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
131826891|NCT03941834|474647342|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
131826892|NCT03941834|474647340|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
131826893|NCT03941834|474647341|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
131826894|NCT03941834|474647342|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
131826895|NCT03941834|474647340|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
131826896|NCT03941834|474647341|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
131826897|NCT03941834|474647342|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
131826898|NCT03941834|474647340|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
131826899|NCT03941834|474647341|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
131826900|NCT03941834|474647342|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
131826901|NCT03941834|474647340|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
131826902|NCT03941834|474647341|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
131826903|NCT03941834|474647342|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
131826904|NCT00991510|474647343|FG000|Period I (Days 1-14)|Adverse Event|1|||
131826905|NCT00991510|474647344|FG001|Period I (Days 1-14)|Adverse Event|0|||
131826906|NCT00991510|474647343|FG000|Period III (Days 29-112)|Adverse Event|1|||
131826907|NCT00991510|474647344|FG001|Period III (Days 29-112)|Adverse Event|1|||
131826908|NCT01976728|474647345|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
131826909|NCT01976728|474647346|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
131826910|NCT01976728|474647347|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
131826911|NCT01976728|474647348|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
131826912|NCT01124695|474647349|FG000|Overall Study|Disease progression|77|||
131826913|NCT01124695|474647349|FG000|Overall Study|Adverse Event|11|||
131826914|NCT01124695|474647349|FG000|Overall Study|Death|1|||
131826915|NCT01124695|474647349|FG000|Overall Study|Withdrawal by Subject|7|||
131826916|NCT01124695|474647349|FG000|Overall Study|Physician Decision|3|||
131826917|NCT01124695|474647349|FG000|Overall Study|Alternative therapy|9|||
131826918|NCT01124695|474647349|FG000|Overall Study|No documentation that patient went off treatment|4|||
131826919|NCT01124695|474647349|FG000|Overall Study|Ineligible|9|||
131826920|NCT01124695|474647349|FG000|Overall Study|Ineligible and never start treatment|2|||
131826921|NCT01522950|474647351|FG000|Overall Study|Withdrawal by Subject|3|||
131826922|NCT01522950|474647352|FG001|Overall Study|Withdrawal by Subject|2|||
131826923|NCT01522950|474647353|FG002|Overall Study|Withdrawal by Subject|1|||
131826924|NCT01522950|474647351|FG000|Overall Study|Adverse Event|3|||
131826925|NCT01522950|474647352|FG001|Overall Study|Adverse Event|1|||
131826926|NCT01522950|474647353|FG002|Overall Study|Adverse Event|1|||
131826927|NCT01522950|474647351|FG000|Overall Study|Protocol Violation|0|||
131826928|NCT01522950|474647352|FG001|Overall Study|Protocol Violation|0|||
131401303|NCT00837265|473091473|FG006|Pilot Phase|Disease progression|0|||
131401304|NCT00837265|473091467|FG000|Pilot Phase|Participant left the city|0|||
131401305|NCT00837265|473091468|FG001|Pilot Phase|Participant left the city|0|||
131401306|NCT00837265|473091469|FG002|Pilot Phase|Participant left the city|0|||
131826929|NCT01522950|474647353|FG002|Overall Study|Protocol Violation|2|||
131826930|NCT01522950|474647351|FG000|Overall Study|Death|0|||
131826931|NCT01522950|474647352|FG001|Overall Study|Death|1|||
131826932|NCT01522950|474647353|FG002|Overall Study|Death|1|||
131826933|NCT01522950|474647351|FG000|Overall Study|Study Medication Sensitivity|0|||
131826934|NCT01522950|474647352|FG001|Overall Study|Study Medication Sensitivity|1|||
131401307|NCT00837265|473091470|FG003|Pilot Phase|Participant left the city|1|||
131401308|NCT00837265|473091471|FG004|Pilot Phase|Participant left the city|0|||
131826935|NCT01522950|474647353|FG002|Overall Study|Study Medication Sensitivity|0|||
131826936|NCT02443324|474647356|FG000|Overall Study|Death|4|||
131826937|NCT02443324|474647357|FG001|Overall Study|Death|1|||
131826938|NCT02443324|474647358|FG002|Overall Study|Death|0|||
131826939|NCT02443324|474647359|FG003|Overall Study|Death|3|||
131826940|NCT02443324|474647360|FG004|Overall Study|Death|1|||
131826941|NCT02443324|474647361|FG005|Overall Study|Death|3|||
131826942|NCT02443324|474647362|FG006|Overall Study|Death|2|||
131826943|NCT02443324|474647356|FG000|Overall Study|Lost to Follow-up|0|||
131826944|NCT02443324|474647357|FG001|Overall Study|Lost to Follow-up|0|||
131826945|NCT02443324|474647358|FG002|Overall Study|Lost to Follow-up|0|||
131826946|NCT02443324|474647359|FG003|Overall Study|Lost to Follow-up|1|||
131826947|NCT02443324|474647360|FG004|Overall Study|Lost to Follow-up|0|||
131826948|NCT02443324|474647361|FG005|Overall Study|Lost to Follow-up|1|||
131826949|NCT02443324|474647362|FG006|Overall Study|Lost to Follow-up|0|||
131826950|NCT02443324|474647356|FG000|Overall Study|Physician Decision|0|||
131826951|NCT02443324|474647357|FG001|Overall Study|Physician Decision|3|||
131826952|NCT02443324|474647358|FG002|Overall Study|Physician Decision|5|||
131826953|NCT02443324|474647359|FG003|Overall Study|Physician Decision|1|||
131826954|NCT02443324|474647360|FG004|Overall Study|Physician Decision|1|||
131826955|NCT02443324|474647361|FG005|Overall Study|Physician Decision|0|||
131826956|NCT02443324|474647362|FG006|Overall Study|Physician Decision|2|||
131826957|NCT02443324|474647356|FG000|Overall Study|Progressive Disease|20|||
131449863|NCT03722238|473276723|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
131449864|NCT01532986|473276730|FG000|Overall Study|Death|9|||
131449865|NCT01532986|473276731|FG001|Overall Study|Death|9|||
131449866|NCT01532986|473276730|FG000|Overall Study|Withdrawal by Subject|7|||
131449867|NCT01532986|473276731|FG001|Overall Study|Withdrawal by Subject|10|||
131449868|NCT01532986|473276730|FG000|Overall Study|Physician Decision|7|||
131449869|NCT01532986|473276731|FG001|Overall Study|Physician Decision|5|||
131449870|NCT00885170|473276734|FG000|Overall Study|Adverse Event|12|||
131449871|NCT00885170|473276735|FG001|Overall Study|Adverse Event|4|||
131449872|NCT00885170|473276734|FG000|Overall Study|Excessive bone loss|6|||
131449873|NCT00885170|473276735|FG001|Overall Study|Excessive bone loss|3|||
131826958|NCT02443324|474647357|FG001|Overall Study|Progressive Disease|20|||
131826959|NCT02443324|474647358|FG002|Overall Study|Progressive Disease|13|||
131826960|NCT02443324|474647359|FG003|Overall Study|Progressive Disease|10|||
131826961|NCT02443324|474647360|FG004|Overall Study|Progressive Disease|13|||
131826962|NCT02443324|474647361|FG005|Overall Study|Progressive Disease|17|||
131826963|NCT02443324|474647362|FG006|Overall Study|Progressive Disease|10|||
131826964|NCT02443324|474647356|FG000|Overall Study|Withdrawal by Subject|0|||
131826965|NCT02443324|474647357|FG001|Overall Study|Withdrawal by Subject|0|||
131826966|NCT02443324|474647358|FG002|Overall Study|Withdrawal by Subject|3|||
131826967|NCT02443324|474647359|FG003|Overall Study|Withdrawal by Subject|1|||
131826968|NCT02443324|474647360|FG004|Overall Study|Withdrawal by Subject|1|||
131826969|NCT02443324|474647361|FG005|Overall Study|Withdrawal by Subject|0|||
131826970|NCT02443324|474647362|FG006|Overall Study|Withdrawal by Subject|1|||
131826971|NCT02443324|474647356|FG000|Overall Study|Adverse Event|0|||
131826972|NCT02443324|474647357|FG001|Overall Study|Adverse Event|1|||
131826973|NCT02443324|474647358|FG002|Overall Study|Adverse Event|3|||
131826974|NCT02443324|474647359|FG003|Overall Study|Adverse Event|0|||
131826975|NCT02443324|474647360|FG004|Overall Study|Adverse Event|4|||
131826976|NCT02443324|474647361|FG005|Overall Study|Adverse Event|3|||
131826977|NCT02443324|474647362|FG006|Overall Study|Adverse Event|3|||
131826978|NCT02443324|474647356|FG000|Overall Study|Enrolled but Never Treated|0|||
131826979|NCT02443324|474647357|FG001|Overall Study|Enrolled but Never Treated|0|||
131826980|NCT02443324|474647358|FG002|Overall Study|Enrolled but Never Treated|1|||
131826981|NCT02443324|474647359|FG003|Overall Study|Enrolled but Never Treated|0|||
131826982|NCT02443324|474647360|FG004|Overall Study|Enrolled but Never Treated|1|||
131826983|NCT02443324|474647361|FG005|Overall Study|Enrolled but Never Treated|0|||
131826984|NCT02443324|474647362|FG006|Overall Study|Enrolled but Never Treated|1|||
131826985|NCT00298740|474647363|FG000|Overall Study|Lack of Efficacy|6|||
131826986|NCT00298740|474647363|FG000|Overall Study|Withdrawal by Subject|3|||
131826987|NCT00684567|474647364|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
131826988|NCT00684567|474647364|FG000|Monotherapy Period|Adverse Event|2|||
131826989|NCT00684567|474647364|FG000|Monotherapy Period|Death|1|||
131826990|NCT00684567|474647364|FG000|Monotherapy Period|Progression of primary disease|11|||
131826991|NCT01345318|474647370|FG000|Overall Study|Adverse Event|16|||
131826992|NCT01345318|474647370|FG000|Overall Study|Lack of Efficacy|17|||
131826993|NCT01345318|474647370|FG000|Overall Study|Lost to Follow-up|2|||
131826994|NCT01345318|474647370|FG000|Overall Study|Protocol Violation|1|||
131826995|NCT01345318|474647370|FG000|Overall Study|Withdrawal by Subject|41|||
131826996|NCT01345318|474647370|FG000|Overall Study|Other|3|||
131826997|NCT00317642|474647371|FG000|Overall Study|Not Received Either Study Drug|1|||
131826998|NCT00317642|474647372|FG001|Overall Study|Not Received Either Study Drug|3|||
131826999|NCT00317642|474647371|FG000|Overall Study|Physician Decision|15|||
131827000|NCT00317642|474647372|FG001|Overall Study|Physician Decision|7|||
131827001|NCT00317642|474647371|FG000|Overall Study|Participant declined treatment|14|||
131827002|NCT00317642|474647372|FG001|Overall Study|Participant declined treatment|3|||
131827003|NCT00317642|474647371|FG000|Overall Study|Adverse Event|17|||
131827004|NCT00317642|474647372|FG001|Overall Study|Adverse Event|5|||
131827005|NCT00317642|474647371|FG000|Overall Study|Treatment Failure|56|||
131827006|NCT00317642|474647372|FG001|Overall Study|Treatment Failure|102|||
131827007|NCT00317642|474647371|FG000|Overall Study|Disease Recurrence|1|||
131827008|NCT00317642|474647372|FG001|Overall Study|Disease Recurrence|2|||
131827009|NCT00317642|474647371|FG000|Overall Study|Death|14|||
131827010|NCT00317642|474647372|FG001|Overall Study|Death|7|||
131827011|NCT00317642|474647371|FG000|Overall Study|Not Continue to Consolidation|2|||
131827012|NCT00317642|474647372|FG001|Overall Study|Not Continue to Consolidation|0|||
131827013|NCT00317642|474647371|FG000|Overall Study|Withdrawal by Subject|0|||
131827014|NCT00317642|474647372|FG001|Overall Study|Withdrawal by Subject|1|||
131827015|NCT00317642|474647371|FG000|Overall Study|Referred For Transplantation|1|||
131827016|NCT00317642|474647372|FG001|Overall Study|Referred For Transplantation|0|||
131827017|NCT00317642|474647371|FG000|Overall Study|AML Not Centrally Confirmed|1|||
131827018|NCT00317642|474647372|FG001|Overall Study|AML Not Centrally Confirmed|5|||
131827019|NCT01239472|474647377|FG000|Overall Study|Withdrawal by Subject|5|||
131827020|NCT01239472|474647378|FG001|Overall Study|Withdrawal by Subject|1|||
131827021|NCT01239472|474647377|FG000|Overall Study|Adverse Event|0|||
131827022|NCT01239472|474647378|FG001|Overall Study|Adverse Event|1|||
131827023|NCT01239472|474647377|FG000|Overall Study|Lack of Efficacy|0|||
131827024|NCT01239472|474647378|FG001|Overall Study|Lack of Efficacy|1|||
131827025|NCT02916693|474647382|FG000|Overall Study|Lost to Follow-up|7|||
131827026|NCT01049412|474647383|FG000|Period I|Withdrawal by Subject|4|||
131827027|NCT01049412|474647384|FG001|Period I|Withdrawal by Subject|6|||
131827028|NCT01049412|474647383|FG000|Period I|Lost to Follow-up|2|||
131827029|NCT01049412|474647384|FG001|Period I|Lost to Follow-up|2|||
131827030|NCT01049412|474647383|FG000|Period I|Physician Decision|0|||
131827031|NCT01049412|474647384|FG001|Period I|Physician Decision|3|||
131827032|NCT01049412|474647383|FG000|Period I|Protocol Violation|1|||
131827033|NCT01049412|474647384|FG001|Period I|Protocol Violation|2|||
131910147|NCT00251758|474958748|FG000|Overall Study|Noncompliant|0|||
131910148|NCT00251758|474958749|FG001|Overall Study|Noncompliant|2|||
131910149|NCT00251758|474958750|FG002|Overall Study|Noncompliant|2|||
131910150|NCT00251758|474958748|FG000|Overall Study|Pregnancy|0|||
131910151|NCT00251758|474958749|FG001|Overall Study|Pregnancy|1|||
131910152|NCT00251758|474958750|FG002|Overall Study|Pregnancy|0|||
131910153|NCT00251758|474958748|FG000|Overall Study|Per Subject Request|0|||
131910154|NCT00251758|474958749|FG001|Overall Study|Per Subject Request|0|||
131910155|NCT00251758|474958750|FG002|Overall Study|Per Subject Request|1|||
131910156|NCT00251758|474958748|FG000|Overall Study|Per Investigator Request|1|||
131910157|NCT00251758|474958749|FG001|Overall Study|Per Investigator Request|0|||
131910158|NCT00251758|474958750|FG002|Overall Study|Per Investigator Request|0|||
131910159|NCT01387269|474958753|FG000|Overall Study|Death|38|||
131910160|NCT01387269|474958754|FG001|Overall Study|Death|20|||
131910161|NCT01387269|474958753|FG000|Overall Study|Other|8|||
131910162|NCT01387269|474958754|FG001|Overall Study|Other|7|||
131910163|NCT01387269|474958753|FG000|Overall Study|Unrelated AE|12|||
131910164|NCT01387269|474958754|FG001|Overall Study|Unrelated AE|3|||
131910165|NCT01387269|474958753|FG000|Overall Study|Withdrawal by patient|32|||
131910166|NCT01387269|474958754|FG001|Overall Study|Withdrawal by patient|10|||
131910167|NCT01387269|474958753|FG000|Overall Study|Study drug-related AE|1|||
131910168|NCT01387269|474958754|FG001|Overall Study|Study drug-related AE|0|||
131910169|NCT01387269|474958753|FG000|Overall Study|Lost to Follow-up|1|||
131910170|NCT01387269|474958754|FG001|Overall Study|Lost to Follow-up|0|||
131910171|NCT03824561|474958757|FG000|Overall Study|Protocol Violation|19|||
131910172|NCT01773928|474958758|FG000|Overall Study|Adverse Event|0|||
131910173|NCT01773928|474958759|FG001|Overall Study|Adverse Event|0|||
131910174|NCT01773928|474958760|FG002|Overall Study|Adverse Event|0|||
131910175|NCT01773928|474958761|FG003|Overall Study|Adverse Event|0|||
131910176|NCT01773928|474958762|FG004|Overall Study|Adverse Event|0|||
131910177|NCT01773928|474958763|FG005|Overall Study|Adverse Event|0|||
131910178|NCT01773928|474958764|FG006|Overall Study|Adverse Event|0|||
131910179|NCT01773928|474958765|FG007|Overall Study|Adverse Event|1|||
131827034|NCT01049412|474647383|FG000|Period I|Adverse Event|1|||
131827035|NCT01049412|474647384|FG001|Period I|Adverse Event|0|||
131910180|NCT01773928|474958766|FG008|Overall Study|Adverse Event|0|||
131910181|NCT01773928|474958758|FG000|Overall Study|Physician Decision|0|||
131910182|NCT01773928|474958759|FG001|Overall Study|Physician Decision|0|||
131910183|NCT01773928|474958760|FG002|Overall Study|Physician Decision|0|||
131910184|NCT01773928|474958761|FG003|Overall Study|Physician Decision|1|||
131910185|NCT01773928|474958762|FG004|Overall Study|Physician Decision|0|||
131910186|NCT01773928|474958763|FG005|Overall Study|Physician Decision|0|||
131910187|NCT01773928|474958764|FG006|Overall Study|Physician Decision|0|||
131910188|NCT01773928|474958765|FG007|Overall Study|Physician Decision|0|||
131910189|NCT01773928|474958766|FG008|Overall Study|Physician Decision|0|||
131910190|NCT01773928|474958758|FG000|Overall Study|Withdrawal by Subject|5|||
131910191|NCT01773928|474958759|FG001|Overall Study|Withdrawal by Subject|4|||
131910192|NCT01773928|474958760|FG002|Overall Study|Withdrawal by Subject|4|||
131910193|NCT01773928|474958761|FG003|Overall Study|Withdrawal by Subject|4|||
131910194|NCT01773928|474958762|FG004|Overall Study|Withdrawal by Subject|7|||
131910195|NCT01773928|474958763|FG005|Overall Study|Withdrawal by Subject|1|||
131910196|NCT01773928|474958764|FG006|Overall Study|Withdrawal by Subject|0|||
131910197|NCT01773928|474958765|FG007|Overall Study|Withdrawal by Subject|0|||
131827036|NCT01049412|474647383|FG000|Period II|Withdrawal by Subject|2|||
131827037|NCT01049412|474647384|FG001|Period II|Withdrawal by Subject|3|||
131827038|NCT01049412|474647383|FG000|Period II|Adverse Event|1|||
131827039|NCT01049412|474647384|FG001|Period II|Adverse Event|0|||
131827040|NCT01049412|474647383|FG000|Period II|Lost to Follow-up|1|||
131827041|NCT01049412|474647384|FG001|Period II|Lost to Follow-up|0|||
131827042|NCT01519947|474647386|FG000|Overall Study|Death|0|||
131827043|NCT01519947|474647387|FG001|Overall Study|Death|0|||
131827044|NCT01519947|474647388|FG002|Overall Study|Death|0|||
131827045|NCT01519947|474647389|FG003|Overall Study|Death|1|||
131827046|NCT01519947|474647386|FG000|Overall Study|Protocol Violation|0|||
131827047|NCT01519947|474647387|FG001|Overall Study|Protocol Violation|0|||
131827048|NCT01519947|474647388|FG002|Overall Study|Protocol Violation|2|||
131827049|NCT01519947|474647389|FG003|Overall Study|Protocol Violation|1|||
131827050|NCT01519947|474647386|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
131827051|NCT01519947|474647387|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
131827052|NCT01519947|474647388|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
131827053|NCT01519947|474647389|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
131827054|NCT01519947|474647386|FG000|Overall Study|Development of Anemia|0|||
131827055|NCT01519947|474647387|FG001|Overall Study|Development of Anemia|1|||
131827056|NCT01519947|474647388|FG002|Overall Study|Development of Anemia|0|||
131827057|NCT01519947|474647389|FG003|Overall Study|Development of Anemia|1|||
131827058|NCT01519947|474647386|FG000|Overall Study|Blood Transfusion|0|||
131827059|NCT01519947|474647387|FG001|Overall Study|Blood Transfusion|1|||
131827060|NCT01519947|474647388|FG002|Overall Study|Blood Transfusion|1|||
131827061|NCT01519947|474647389|FG003|Overall Study|Blood Transfusion|0|||
131827062|NCT01519947|474647386|FG000|Overall Study|Withdrawal by Subject|0|||
131827063|NCT01519947|474647387|FG001|Overall Study|Withdrawal by Subject|1|||
131827064|NCT01519947|474647388|FG002|Overall Study|Withdrawal by Subject|0|||
131827065|NCT01519947|474647389|FG003|Overall Study|Withdrawal by Subject|1|||
131827066|NCT01519947|474647386|FG000|Overall Study|Lost to Follow-up|0|||
131827067|NCT01519947|474647387|FG001|Overall Study|Lost to Follow-up|0|||
131827068|NCT01519947|474647388|FG002|Overall Study|Lost to Follow-up|3|||
131827069|NCT01519947|474647389|FG003|Overall Study|Lost to Follow-up|2|||
131827070|NCT01519947|474647386|FG000|Overall Study|Poor Response|1|||
131827071|NCT01519947|474647387|FG001|Overall Study|Poor Response|0|||
131827072|NCT01519947|474647388|FG002|Overall Study|Poor Response|0|||
131827073|NCT01519947|474647389|FG003|Overall Study|Poor Response|1|||
131827074|NCT01519947|474647386|FG000|Overall Study|Adverse Event|1|||
131827075|NCT01519947|474647387|FG001|Overall Study|Adverse Event|0|||
131827076|NCT01519947|474647388|FG002|Overall Study|Adverse Event|1|||
131827077|NCT01519947|474647389|FG003|Overall Study|Adverse Event|1|||
131827078|NCT02274948|474647394|FG000|Overall Study|Lost to Follow-up|28|||
131827079|NCT02274948|474647395|FG001|Overall Study|Lost to Follow-up|25|||
131827080|NCT02274948|474647394|FG000|Overall Study|Withdrawal by Subject|64|||
131827081|NCT02274948|474647395|FG001|Overall Study|Withdrawal by Subject|58|||
131827082|NCT02274948|474647394|FG000|Overall Study|Stopped on family Practitioner advice|2|||
131827083|NCT02274948|474647395|FG001|Overall Study|Stopped on family Practitioner advice|5|||
131827084|NCT02274948|474647394|FG000|Overall Study|Left the area|4|||
131827085|NCT02274948|474647395|FG001|Overall Study|Left the area|3|||
131827086|NCT01386125|474647396|FG000|Overall Study|Lost to Follow-up|3|||
131827087|NCT01386125|474647397|FG001|Overall Study|Lost to Follow-up|9|||
131827088|NCT01386125|474647396|FG000|Overall Study|Physician Decision|0|||
131827089|NCT01386125|474647397|FG001|Overall Study|Physician Decision|1|||
131827090|NCT01386125|474647396|FG000|Overall Study|Protocol Violation|5|||
131827091|NCT01386125|474647397|FG001|Overall Study|Protocol Violation|7|||
131827092|NCT01386125|474647396|FG000|Overall Study|Disease Progress|1|||
131827093|NCT01386125|474647397|FG001|Overall Study|Disease Progress|2|||
131827094|NCT01386125|474647396|FG000|Overall Study|Withdrawal by Subject|13|||
131827095|NCT01386125|474647397|FG001|Overall Study|Withdrawal by Subject|12|||
131827096|NCT01386125|474647396|FG000|Overall Study|Adverse Event|2|||
131827097|NCT01386125|474647397|FG001|Overall Study|Adverse Event|5|||
131827098|NCT01386125|474647396|FG000|Overall Study|Lack of Efficacy|0|||
131827099|NCT01386125|474647397|FG001|Overall Study|Lack of Efficacy|1|||
131827100|NCT01386125|474647396|FG000|Overall Study|Participant Leaving Country|1|||
131827101|NCT01386125|474647397|FG001|Overall Study|Participant Leaving Country|0|||
131827102|NCT02359864|474647398|FG000|Overall Study|Withdrawal by Subject|1|||
131827103|NCT02359864|474647399|FG001|Overall Study|Withdrawal by Subject|0|||
131827104|NCT00732160|474647400|FG000|Overall Study|Adverse Event|1|||
131827105|NCT00732160|474647401|FG001|Overall Study|Adverse Event|0|||
131827106|NCT00732160|474647402|FG002|Overall Study|Adverse Event|1|||
131827107|NCT00732160|474647403|FG003|Overall Study|Adverse Event|1|||
131827108|NCT00732160|474647400|FG000|Overall Study|scheduling|4|||
131827109|NCT00732160|474647401|FG001|Overall Study|scheduling|4|||
131827110|NCT00732160|474647402|FG002|Overall Study|scheduling|2|||
131827111|NCT00732160|474647403|FG003|Overall Study|scheduling|1|||
131827112|NCT01466036|474647406|FG000|Overall Study|Death|1|||
131827113|NCT01466036|474647407|FG001|Overall Study|Death|1|||
131827114|NCT01466036|474647406|FG000|Overall Study|Physician Decision|0|||
131827115|NCT01466036|474647407|FG001|Overall Study|Physician Decision|4|||
131827116|NCT01466036|474647406|FG000|Overall Study|Adverse Event|2|||
131827117|NCT01466036|474647407|FG001|Overall Study|Adverse Event|6|||
131827118|NCT01466036|474647406|FG000|Overall Study|Withdrawal by Subject|2|||
131827119|NCT01466036|474647407|FG001|Overall Study|Withdrawal by Subject|8|||
131827120|NCT01466036|474647406|FG000|Overall Study|progression/relapse|14|||
131827121|NCT01466036|474647407|FG001|Overall Study|progression/relapse|21|||
131401309|NCT00837265|473091472|FG005|Pilot Phase|Participant left the city|0|||
131401310|NCT00837265|473091473|FG006|Pilot Phase|Participant left the city|0|||
131401311|NCT00837265|473091467|FG000|Main Phase|Withdrawal by Subject|0|||
131401312|NCT00837265|473091468|FG001|Main Phase|Withdrawal by Subject|0|||
131401313|NCT00837265|473091469|FG002|Main Phase|Withdrawal by Subject|0|||
131401314|NCT00837265|473091470|FG003|Main Phase|Withdrawal by Subject|0|||
131827122|NCT01466036|474647406|FG000|Overall Study|prolonged treatment delay|1|||
131827123|NCT01466036|474647407|FG001|Overall Study|prolonged treatment delay|1|||
131827124|NCT00985231|474647414|FG000|Overall Study|ineligible|1|||
131827125|NCT00985231|474647415|FG001|Overall Study|ineligible|0|||
131827126|NCT00985231|474647414|FG000|Overall Study|Protocol Violation|1|||
131827127|NCT00985231|474647415|FG001|Overall Study|Protocol Violation|0|||
131827128|NCT00985231|474647414|FG000|Overall Study|Withdrawal by Subject|1|||
131827129|NCT00985231|474647415|FG001|Overall Study|Withdrawal by Subject|0|||
131827130|NCT00985231|474647414|FG000|Overall Study|Lost to Follow-up|0|||
131827131|NCT00985231|474647415|FG001|Overall Study|Lost to Follow-up|1|||
131827132|NCT00985231|474647414|FG000|Overall Study|Study related symptoms & complaints|0|||
131827133|NCT00985231|474647415|FG001|Overall Study|Study related symptoms & complaints|2|||
131827134|NCT01808248|474647416|FG000|Overall Study|Lack of Efficacy|3|||
131827135|NCT01808248|474647416|FG000|Overall Study|Withdrawal by Subject|1|||
131827136|NCT01808248|474647416|FG000|Overall Study|Lost to Follow-up|1|||
131827137|NCT00436917|474647420|FG000|Overall Study|Withdrawal by Subject|13|||
131827138|NCT00436917|474647420|FG000|Overall Study|Adverse Event|2|||
131827139|NCT00436917|474647420|FG000|Overall Study|Physician Decision|1|||
131827140|NCT00436917|474647420|FG000|Overall Study|Death|1|||
131827141|NCT00436917|474647420|FG000|Overall Study|Lost to Follow-up|1|||
131827142|NCT00436917|474647420|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
131827143|NCT00436917|474647420|FG000|Overall Study|Increased creatinine|1|||
131827144|NCT00436917|474647420|FG000|Overall Study|Personal conflicts of patient|1|||
131827145|NCT00808509|474647421|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
131827146|NCT00808509|474647422|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
131827147|NCT00808509|474647421|FG000|Randomized Phase|Reduced methotrexate dose|1|||
131827148|NCT00808509|474647422|FG001|Randomized Phase|Reduced methotrexate dose|2|||
131827149|NCT00808509|474647421|FG000|Randomized Phase|Patient refused rescue therapy|0|||
131827150|NCT00808509|474647422|FG001|Randomized Phase|Patient refused rescue therapy|3|||
131827151|NCT02169791|474647423|FG000|Overall Study|Death|6|||
131827152|NCT02169791|474647423|FG000|Overall Study|patient withdrew consent|1|||
131827153|NCT02020967|474647431|FG000|Overall Study|Withdrawal by Subject|51|||
131827154|NCT03507686|474647432|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
131827155|NCT03507686|474647433|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
131827156|NCT03507686|474647432|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
131827157|NCT03507686|474647433|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
131827158|NCT03507686|474647432|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
131827159|NCT03507686|474647433|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
131827160|NCT03507686|474647432|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
131827161|NCT03507686|474647433|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
131827162|NCT03507686|474647432|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
131827163|NCT03507686|474647433|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
131827164|NCT03507686|474647432|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
131827165|NCT03507686|474647433|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
131827166|NCT02508116|474647434|FG000|Overall Study|Lost to Follow-up|2|||
131827167|NCT02508116|474647435|FG001|Overall Study|Lost to Follow-up|3|||
131827168|NCT02508116|474647434|FG000|Overall Study|Withdrawal by Subject|3|||
131827169|NCT02508116|474647435|FG001|Overall Study|Withdrawal by Subject|2|||
131827170|NCT02508116|474647434|FG000|Overall Study|Protocol Violation|1|||
131827171|NCT02508116|474647435|FG001|Overall Study|Protocol Violation|2|||
131827172|NCT02508116|474647434|FG000|Overall Study|Physician Decision|2|||
131827173|NCT02508116|474647435|FG001|Overall Study|Physician Decision|0|||
131827174|NCT00109850|474647438|FG000|Overall Study|Adverse Event|1|||
131827175|NCT00109850|474647438|FG000|Overall Study|Death|2|||
131827176|NCT00109850|474647438|FG000|Overall Study|Ineligible|1|||
131827177|NCT00476593|474647439|FG000|Overall Study|Lost to Follow-up|10|||
131827178|NCT00476593|474647440|FG001|Overall Study|Lost to Follow-up|2|||
131827179|NCT00476593|474647441|FG002|Overall Study|Lost to Follow-up|8|||
131827180|NCT00476593|474647442|FG003|Overall Study|Lost to Follow-up|22|||
131827181|NCT00983528|474647443|FG000|Overall Study|Death|4|||
131827182|NCT00983528|474647443|FG000|Overall Study|Lost to Follow-up|1|||
131827183|NCT00983528|474647443|FG000|Overall Study|Study Terminated|1|||
131827184|NCT00575380|474647444|FG000|Overall Study|Withdrawal by Subject|1|||
131910198|NCT01773928|474958766|FG008|Overall Study|Withdrawal by Subject|1|||
131401315|NCT00837265|473091471|FG004|Main Phase|Withdrawal by Subject|4|||
131401316|NCT00837265|473091472|FG005|Main Phase|Withdrawal by Subject|2|||
131401317|NCT00837265|473091473|FG006|Main Phase|Withdrawal by Subject|1|||
131827185|NCT00575380|474647445|FG001|Overall Study|Withdrawal by Subject|0|||
131827186|NCT00575380|474647444|FG000|Overall Study|Adverse Event|0|||
131827187|NCT00575380|474647445|FG001|Overall Study|Adverse Event|1|||
131827188|NCT00575380|474647444|FG000|Overall Study|Various|0|||
131827189|NCT00575380|474647445|FG001|Overall Study|Various|2|||
131827190|NCT04126343|474647446|FG000|Overall Study|Adverse Event|0|||
131827191|NCT04126343|474647447|FG001|Overall Study|Adverse Event|0|||
131827192|NCT04126343|474647448|FG002|Overall Study|Adverse Event|0|||
131827193|NCT04126343|474647449|FG003|Overall Study|Adverse Event|0|||
131827194|NCT04126343|474647450|FG004|Overall Study|Adverse Event|0|||
131827195|NCT04126343|474647451|FG005|Overall Study|Adverse Event|1|||
131827196|NCT04126343|474647446|FG000|Overall Study|Withdrawal by Subject|0|||
131827197|NCT04126343|474647447|FG001|Overall Study|Withdrawal by Subject|0|||
131827198|NCT04126343|474647448|FG002|Overall Study|Withdrawal by Subject|0|||
131827199|NCT04126343|474647449|FG003|Overall Study|Withdrawal by Subject|1|||
131827200|NCT04126343|474647450|FG004|Overall Study|Withdrawal by Subject|0|||
131827201|NCT04126343|474647451|FG005|Overall Study|Withdrawal by Subject|0|||
131827202|NCT04126343|474647446|FG000|Overall Study|Related to COVID-19 pandemic|3|||
131827203|NCT04126343|474647447|FG001|Overall Study|Related to COVID-19 pandemic|4|||
131827204|NCT04126343|474647448|FG002|Overall Study|Related to COVID-19 pandemic|3|||
131827205|NCT04126343|474647449|FG003|Overall Study|Related to COVID-19 pandemic|3|||
131827206|NCT04126343|474647450|FG004|Overall Study|Related to COVID-19 pandemic|3|||
131827207|NCT04126343|474647451|FG005|Overall Study|Related to COVID-19 pandemic|3|||
131827208|NCT00559364|474647452|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
131827209|NCT00559364|474647453|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
131827210|NCT00084799|474647454|FG000|Overall Study|Disease Progression|1|||
131827211|NCT00084799|474647455|FG001|Overall Study|Disease Progression|0|||
131827212|NCT00330460|474647460|FG000|Overall Study|Physician Decision|1|||
131827213|NCT00330460|474647461|FG001|Overall Study|Physician Decision|0|||
131827214|NCT00330460|474647460|FG000|Overall Study|Adverse Event|10|||
131827215|NCT00330460|474647461|FG001|Overall Study|Adverse Event|8|||
131827216|NCT00330460|474647460|FG000|Overall Study|Withdrawal by Subject|18|||
131827217|NCT00330460|474647461|FG001|Overall Study|Withdrawal by Subject|17|||
131827218|NCT00330460|474647460|FG000|Overall Study|Death|1|||
131827219|NCT00330460|474647461|FG001|Overall Study|Death|1|||
131827220|NCT00330460|474647460|FG000|Overall Study|Ineligibility determined|1|||
131827221|NCT00330460|474647461|FG001|Overall Study|Ineligibility determined|3|||
131827222|NCT00330460|474647460|FG000|Overall Study|Lost to Follow-up|8|||
131827223|NCT00330460|474647461|FG001|Overall Study|Lost to Follow-up|3|||
131827224|NCT00330460|474647460|FG000|Overall Study|Noncompliance|2|||
131827225|NCT00330460|474647461|FG001|Overall Study|Noncompliance|1|||
131827226|NCT00330460|474647460|FG000|Overall Study|Other|1|||
131827227|NCT00330460|474647461|FG001|Overall Study|Other|0|||
131827228|NCT02663882|474647466|FG000|Overall Study|Lost to Follow-up|4|||
131827229|NCT02663882|474647467|FG001|Overall Study|Lost to Follow-up|2|||
131827230|NCT03712124|474647470|FG000|Overall Study|Protocol Violation|1|||
131827231|NCT03712124|474647471|FG001|Overall Study|Protocol Violation|0|||
131827232|NCT02412722|474647474|FG000|Overall Study|Adverse Event|0|||
131827233|NCT02412722|474647475|FG001|Overall Study|Adverse Event|2|||
131827234|NCT02412722|474647476|FG002|Overall Study|Adverse Event|0|||
131827235|NCT02412722|474647477|FG003|Overall Study|Adverse Event|3|||
131827236|NCT02412722|474647478|FG004|Overall Study|Adverse Event|0|||
131827237|NCT02412722|474647479|FG005|Overall Study|Adverse Event|3|||
131827238|NCT02412722|474647474|FG000|Overall Study|Progressive Disease|6|||
131827239|NCT02412722|474647475|FG001|Overall Study|Progressive Disease|4|||
131827240|NCT02412722|474647476|FG002|Overall Study|Progressive Disease|4|||
131827241|NCT02412722|474647477|FG003|Overall Study|Progressive Disease|9|||
131827242|NCT02412722|474647478|FG004|Overall Study|Progressive Disease|3|||
131827243|NCT02412722|474647479|FG005|Overall Study|Progressive Disease|3|||
131827244|NCT02412722|474647474|FG000|Overall Study|Withdrawal by Subject|2|||
131827245|NCT02412722|474647475|FG001|Overall Study|Withdrawal by Subject|0|||
131827246|NCT02412722|474647476|FG002|Overall Study|Withdrawal by Subject|1|||
131827247|NCT02412722|474647477|FG003|Overall Study|Withdrawal by Subject|2|||
131827248|NCT02412722|474647478|FG004|Overall Study|Withdrawal by Subject|1|||
131827249|NCT02412722|474647479|FG005|Overall Study|Withdrawal by Subject|1|||
131827250|NCT02412722|474647474|FG000|Overall Study|Lost to Follow-up|0|||
131827251|NCT02412722|474647475|FG001|Overall Study|Lost to Follow-up|0|||
131827252|NCT02412722|474647476|FG002|Overall Study|Lost to Follow-up|0|||
131827253|NCT02412722|474647477|FG003|Overall Study|Lost to Follow-up|0|||
131827254|NCT02412722|474647478|FG004|Overall Study|Lost to Follow-up|1|||
131827255|NCT02412722|474647479|FG005|Overall Study|Lost to Follow-up|0|||
131827256|NCT02412722|474647474|FG000|Overall Study|Received drug in run-in and discontinued|0|||
131827257|NCT02412722|474647475|FG001|Overall Study|Received drug in run-in and discontinued|2|||
131827258|NCT02412722|474647476|FG002|Overall Study|Received drug in run-in and discontinued|0|||
131827259|NCT02412722|474647477|FG003|Overall Study|Received drug in run-in and discontinued|0|||
131827260|NCT02412722|474647478|FG004|Overall Study|Received drug in run-in and discontinued|0|||
131827261|NCT02412722|474647479|FG005|Overall Study|Received drug in run-in and discontinued|0|||
131827262|NCT02412722|474647474|FG000|Overall Study|Reason not Specified|3|||
131827263|NCT02412722|474647475|FG001|Overall Study|Reason not Specified|0|||
131827264|NCT02412722|474647476|FG002|Overall Study|Reason not Specified|2|||
131827265|NCT02412722|474647477|FG003|Overall Study|Reason not Specified|1|||
131827266|NCT02412722|474647478|FG004|Overall Study|Reason not Specified|2|||
131827267|NCT02412722|474647479|FG005|Overall Study|Reason not Specified|6|||
131827268|NCT04449341|474647480|FG000|Overall Study|Protocol Violation|1|||
131827269|NCT04449341|474647481|FG001|Overall Study|Protocol Violation|0|||
131827270|NCT04314843|474647482|FG000|Overall Study|Death|2|||
131827271|NCT04314843|474647483|FG001|Overall Study|Death|2|||
131827272|NCT04314843|474647482|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
131827273|NCT04314843|474647483|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
131827274|NCT00831233|474649199|FG000|Overall Study|Adverse Event|0|||
131827275|NCT00831233|474649200|FG001|Overall Study|Adverse Event|1|||
131827276|NCT00831233|474649199|FG000|Overall Study|Protocol Violation|1|||
131827277|NCT00831233|474649200|FG001|Overall Study|Protocol Violation|0|||
131827278|NCT00831233|474649199|FG000|Overall Study|Selection Criteria Not Met|2|||
131827279|NCT00831233|474649200|FG001|Overall Study|Selection Criteria Not Met|0|||
131827280|NCT02356211|474649201|FG000|Overall Study|Withdrawal by Subject|2|||
131827281|NCT02356211|474649202|FG001|Overall Study|Withdrawal by Subject|2|||
131827282|NCT02356211|474649201|FG000|Overall Study|ineligible|1|||
131827283|NCT02356211|474649202|FG001|Overall Study|ineligible|8|||
131827284|NCT00097786|474649203|FG000|Overall Study|lost to follow-up for all-cause death|296|||
131827285|NCT00097786|474649204|FG001|Overall Study|lost to follow-up for all-cause death|292|||
131827286|NCT00097786|474649205|FG002|Overall Study|lost to follow-up for all-cause death|313|||
131827287|NCT00097786|474649206|FG003|Overall Study|lost to follow-up for all-cause death|310|||
131827288|NCT02001051|474649213|FG000|Overall Study|Deemed not eligible following enrollment|0|||
131827289|NCT02001051|474649214|FG001|Overall Study|Deemed not eligible following enrollment|1|||
131827290|NCT04205162|474649220|FG000|Overall Study|Lost to Follow-up|1|||
131827291|NCT04205162|474649221|FG001|Overall Study|Lost to Follow-up|0|||
131827292|NCT04205162|474649220|FG000|Overall Study|Withdrawal by Subject|2|||
131827293|NCT04205162|474649221|FG001|Overall Study|Withdrawal by Subject|0|||
131827294|NCT04205162|474649220|FG000|Overall Study|University closure due to COVID-19|1|||
131827295|NCT04205162|474649221|FG001|Overall Study|University closure due to COVID-19|0|||
131827296|NCT01098110|474649225|FG000|Overall Study|Withdrawal by Subject|14|||
131827297|NCT01098110|474649226|FG001|Overall Study|Withdrawal by Subject|24|||
131827298|NCT01098110|474649227|FG002|Overall Study|Withdrawal by Subject|19|||
131827299|NCT01098110|474649225|FG000|Overall Study|Adverse Event|30|||
131827300|NCT01098110|474649226|FG001|Overall Study|Adverse Event|32|||
131910199|NCT01773928|474958758|FG000|Overall Study|Lost to Follow-up|0|||
131910200|NCT01773928|474958759|FG001|Overall Study|Lost to Follow-up|0|||
131910201|NCT01773928|474958760|FG002|Overall Study|Lost to Follow-up|0|||
131910202|NCT01773928|474958761|FG003|Overall Study|Lost to Follow-up|0|||
131910203|NCT01773928|474958762|FG004|Overall Study|Lost to Follow-up|0|||
131910204|NCT01773928|474958763|FG005|Overall Study|Lost to Follow-up|1|||
131910205|NCT01773928|474958764|FG006|Overall Study|Lost to Follow-up|0|||
131910206|NCT01773928|474958765|FG007|Overall Study|Lost to Follow-up|0|||
131910207|NCT01773928|474958766|FG008|Overall Study|Lost to Follow-up|0|||
131910208|NCT01773928|474958758|FG000|Overall Study|Subject misrepresented age|0|||
131910209|NCT01773928|474958759|FG001|Overall Study|Subject misrepresented age|1|||
131910210|NCT01773928|474958760|FG002|Overall Study|Subject misrepresented age|0|||
131910211|NCT01773928|474958761|FG003|Overall Study|Subject misrepresented age|0|||
131910212|NCT01773928|474958762|FG004|Overall Study|Subject misrepresented age|0|||
131910213|NCT01773928|474958763|FG005|Overall Study|Subject misrepresented age|0|||
131910214|NCT01773928|474958764|FG006|Overall Study|Subject misrepresented age|0|||
131910215|NCT01773928|474958765|FG007|Overall Study|Subject misrepresented age|0|||
131910216|NCT01773928|474958766|FG008|Overall Study|Subject misrepresented age|0|||
131910217|NCT01773928|474958758|FG000|Overall Study|Subject met exclusion criteria|0|||
131910218|NCT01773928|474958759|FG001|Overall Study|Subject met exclusion criteria|0|||
131910219|NCT01773928|474958760|FG002|Overall Study|Subject met exclusion criteria|0|||
131910220|NCT01773928|474958761|FG003|Overall Study|Subject met exclusion criteria|0|||
131910221|NCT01773928|474958762|FG004|Overall Study|Subject met exclusion criteria|0|||
131910222|NCT01773928|474958763|FG005|Overall Study|Subject met exclusion criteria|0|||
131910223|NCT01773928|474958764|FG006|Overall Study|Subject met exclusion criteria|0|||
131910224|NCT01773928|474958765|FG007|Overall Study|Subject met exclusion criteria|0|||
131910225|NCT01773928|474958766|FG008|Overall Study|Subject met exclusion criteria|1|||
131827301|NCT01098110|474649227|FG002|Overall Study|Adverse Event|43|||
131827302|NCT01098110|474649225|FG000|Overall Study|Lack of Efficacy|13|||
131827303|NCT01098110|474649226|FG001|Overall Study|Lack of Efficacy|9|||
131827304|NCT01098110|474649227|FG002|Overall Study|Lack of Efficacy|27|||
131910226|NCT01773928|474958758|FG000|Overall Study|Randomized, had to leave, never returned|0|||
131910227|NCT01773928|474958759|FG001|Overall Study|Randomized, had to leave, never returned|0|||
131910228|NCT01773928|474958760|FG002|Overall Study|Randomized, had to leave, never returned|0|||
131910229|NCT01773928|474958761|FG003|Overall Study|Randomized, had to leave, never returned|1|||
131827305|NCT01098110|474649225|FG000|Overall Study|Other|4|||
131827306|NCT01098110|474649226|FG001|Overall Study|Other|7|||
131827307|NCT01098110|474649227|FG002|Overall Study|Other|5|||
131827308|NCT01098110|474649225|FG000|Overall Study|Untreated|1|||
131827309|NCT01098110|474649226|FG001|Overall Study|Untreated|1|||
131827310|NCT01098110|474649227|FG002|Overall Study|Untreated|0|||
131401318|NCT00837265|473091467|FG000|Main Phase|Decision of the investigator|0|||
131401319|NCT00837265|473091468|FG001|Main Phase|Decision of the investigator|0|||
131401320|NCT00837265|473091469|FG002|Main Phase|Decision of the investigator|0|||
131401321|NCT00837265|473091470|FG003|Main Phase|Decision of the investigator|0|||
131401322|NCT00837265|473091471|FG004|Main Phase|Decision of the investigator|0|||
131401323|NCT00837265|473091472|FG005|Main Phase|Decision of the investigator|2|||
131827311|NCT02147587|474649228|FG000|Overall Study|Adverse Event|9|||
131827312|NCT02147587|474649229|FG001|Overall Study|Adverse Event|4|||
131827313|NCT02147587|474649228|FG000|Overall Study|Lack of Efficacy|2|||
131827314|NCT02147587|474649229|FG001|Overall Study|Lack of Efficacy|1|||
131827315|NCT00263887|474649230|FG000|Overall Study|Withdrawal by Subject|1|||
131827316|NCT00263887|474649231|FG001|Overall Study|Withdrawal by Subject|1|||
131827317|NCT00263887|474649230|FG000|Overall Study|Lung transplantation|1|||
131827318|NCT00263887|474649231|FG001|Overall Study|Lung transplantation|2|||
131827319|NCT00263887|474649230|FG000|Overall Study|Too ill to attend visit|1|||
131827320|NCT00263887|474649231|FG001|Overall Study|Too ill to attend visit|0|||
131827321|NCT00263887|474649230|FG000|Overall Study|Adverse Event|0|||
131827322|NCT00263887|474649231|FG001|Overall Study|Adverse Event|2|||
131827323|NCT00263887|474649230|FG000|Overall Study|Disease progression|0|||
131827324|NCT00263887|474649231|FG001|Overall Study|Disease progression|1|||
131827325|NCT00263887|474649230|FG000|Overall Study|Lack of Efficacy|0|||
131827326|NCT00263887|474649231|FG001|Overall Study|Lack of Efficacy|1|||
131827327|NCT00530348|474649236|FG000|Overall Study|Adverse Event|5|||
131827328|NCT00530348|474649237|FG001|Overall Study|Adverse Event|1|||
131827329|NCT00530348|474649236|FG000|Overall Study|Death|0|||
131827330|NCT00530348|474649237|FG001|Overall Study|Death|1|||
131827331|NCT00530348|474649236|FG000|Overall Study|Lack of Efficacy|2|||
131827332|NCT00530348|474649237|FG001|Overall Study|Lack of Efficacy|0|||
131827333|NCT00530348|474649236|FG000|Overall Study|Lost to Follow-up|0|||
131827334|NCT00530348|474649237|FG001|Overall Study|Lost to Follow-up|2|||
131827335|NCT00530348|474649236|FG000|Overall Study|Physician Decision|1|||
131827336|NCT00530348|474649237|FG001|Overall Study|Physician Decision|2|||
131827337|NCT00530348|474649236|FG000|Overall Study|Pregnancy|1|||
131827338|NCT00530348|474649237|FG001|Overall Study|Pregnancy|0|||
131827339|NCT00530348|474649236|FG000|Overall Study|Withdrawal by Subject|12|||
131827340|NCT00530348|474649237|FG001|Overall Study|Withdrawal by Subject|12|||
131827341|NCT00530348|474649236|FG000|Overall Study|Randomised in error|1|||
131827342|NCT00530348|474649237|FG001|Overall Study|Randomised in error|0|||
131827343|NCT00530348|474649236|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
131827344|NCT00530348|474649237|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
131827345|NCT04364763|474649238|FG000|Overall Study|Death|1|||
131827346|NCT04364763|474649239|FG001|Overall Study|Death|2|||
131827347|NCT04364763|474649238|FG000|Overall Study|Lost to Follow-up|1|||
131827348|NCT04364763|474649239|FG001|Overall Study|Lost to Follow-up|0|||
131910230|NCT01773928|474958762|FG004|Overall Study|Randomized, had to leave, never returned|0|||
131910231|NCT01773928|474958763|FG005|Overall Study|Randomized, had to leave, never returned|0|||
131910232|NCT01773928|474958764|FG006|Overall Study|Randomized, had to leave, never returned|0|||
131910233|NCT01773928|474958765|FG007|Overall Study|Randomized, had to leave, never returned|0|||
131910234|NCT01773928|474958766|FG008|Overall Study|Randomized, had to leave, never returned|0|||
131910235|NCT01773928|474958758|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
131910236|NCT01773928|474958759|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
131910237|NCT01773928|474958760|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
131910238|NCT01773928|474958761|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
131910239|NCT01773928|474958762|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
131910240|NCT01773928|474958763|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
131910241|NCT01773928|474958764|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
131910242|NCT01773928|474958765|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
131910243|NCT01773928|474958766|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
131910244|NCT03092752|474958767|FG000|Overall Study|Aged <40 years|14209|||
131910245|NCT03092752|474958767|FG000|Overall Study|At least one claim with T2DM|61299|||
131910246|NCT03092752|474958767|FG000|Overall Study|Having no claim of study drugs|29282|||
131910247|NCT03092752|474958767|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
131910248|NCT03092752|474958767|FG000|Overall Study|<6 month history|245900|||
131910249|NCT01499810|474958775|FG000|Overall Study|Lost to Follow-up|10|||
131401324|NCT00837265|473091473|FG006|Main Phase|Decision of the investigator|1|||
131401325|NCT00837265|473091467|FG000|Main Phase|Adverse Event|0|||
131827349|NCT00983476|474649244|FG000|Overall Study|Did not receive intervention|17|||
131827350|NCT00983476|474649245|FG001|Overall Study|Did not receive intervention|22|||
131827351|NCT00983476|474649246|FG002|Overall Study|Did not receive intervention|0|||
131827352|NCT01175473|474649248|FG000|Overall Study|Adverse Event|2|||
131827353|NCT01175473|474649249|FG001|Overall Study|Adverse Event|2|||
131827354|NCT01857206|474649250|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
131827355|NCT01857206|474649251|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
131827356|NCT01857206|474649250|FG000|Overall Study|Lost to Follow-up|9|||
131827357|NCT01857206|474649251|FG001|Overall Study|Lost to Follow-up|6|||
131827358|NCT01857206|474649250|FG000|Overall Study|Unclassified|3|||
131827359|NCT01857206|474649251|FG001|Overall Study|Unclassified|3|||
131827360|NCT01857206|474649250|FG000|Overall Study|Withdrawal by Subject|1|||
131827361|NCT01857206|474649251|FG001|Overall Study|Withdrawal by Subject|0|||
131827362|NCT01857973|474649252|FG000|Overall Study|Subject did not meet required BG range|3|||
131827363|NCT01857973|474649252|FG000|Overall Study|drop out after 3 failed attempts|1|||
131827364|NCT01857973|474649252|FG000|Overall Study|Physician Decision|1|||
131827365|NCT00129116|474649255|FG000|Primary Phase|Lost to Follow-up|1|||
131827366|NCT00129116|474649256|FG001|Primary Phase|Lost to Follow-up|1|||
131827367|NCT00129116|474649257|FG002|Primary Phase|Lost to Follow-up|0|||
131827368|NCT00129116|474649258|FG003|Primary Phase|Lost to Follow-up|1|||
131827369|NCT00129116|474649259|FG004|Primary Phase|Lost to Follow-up|1|||
131827370|NCT00129116|474649255|FG000|Primary Phase|Protocol Violation|0|||
131827371|NCT00129116|474649256|FG001|Primary Phase|Protocol Violation|1|||
131827372|NCT00129116|474649257|FG002|Primary Phase|Protocol Violation|0|||
131827373|NCT00129116|474649258|FG003|Primary Phase|Protocol Violation|0|||
131827374|NCT00129116|474649259|FG004|Primary Phase|Protocol Violation|0|||
131827375|NCT00129116|474649255|FG000|Primary Phase|Adverse Event|1|||
131827376|NCT00129116|474649256|FG001|Primary Phase|Adverse Event|1|||
131827377|NCT00129116|474649257|FG002|Primary Phase|Adverse Event|0|||
131827378|NCT00129116|474649258|FG003|Primary Phase|Adverse Event|0|||
131827379|NCT00129116|474649259|FG004|Primary Phase|Adverse Event|0|||
131827380|NCT00129116|474649255|FG000|Primary Phase|Withdrawal by Subject|0|||
131827381|NCT00129116|474649256|FG001|Primary Phase|Withdrawal by Subject|1|||
131827382|NCT00129116|474649257|FG002|Primary Phase|Withdrawal by Subject|0|||
131827383|NCT00129116|474649258|FG003|Primary Phase|Withdrawal by Subject|0|||
131827384|NCT00129116|474649259|FG004|Primary Phase|Withdrawal by Subject|0|||
131827385|NCT00129116|474649255|FG000|Primary Phase|Other|0|||
131827386|NCT00129116|474649256|FG001|Primary Phase|Other|0|||
131827387|NCT00129116|474649257|FG002|Primary Phase|Other|1|||
131827388|NCT00129116|474649258|FG003|Primary Phase|Other|0|||
131827389|NCT00129116|474649259|FG004|Primary Phase|Other|0|||
131827390|NCT00129116|474649255|FG000|Booster Phase|Lost to Follow-up|2|||
131827391|NCT00129116|474649256|FG001|Booster Phase|Lost to Follow-up|0|||
131827392|NCT00129116|474649257|FG002|Booster Phase|Lost to Follow-up|0|||
131827393|NCT00129116|474649258|FG003|Booster Phase|Lost to Follow-up|0|||
131827394|NCT00129116|474649259|FG004|Booster Phase|Lost to Follow-up|1|||
131827395|NCT00388037|474649260|FG000|Overall Study|Protocol Violation|1|||
131827396|NCT00602537|474649261|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
131827397|NCT00602537|474649262|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
131827398|NCT00602537|474649261|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
131827399|NCT00602537|474649262|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
131827400|NCT00602537|474649261|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
131827401|NCT00602537|474649262|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
131827402|NCT00602537|474649261|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
131827403|NCT00602537|474649262|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
131827404|NCT00602537|474649261|FG000|Follow Up Study Comparison|Adverse Event|1|||
131827405|NCT00602537|474649262|FG001|Follow Up Study Comparison|Adverse Event|0|||
131827406|NCT00602537|474649261|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
131827407|NCT00602537|474649262|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
131827408|NCT00602537|474649261|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
131827409|NCT00602537|474649262|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
131827410|NCT02539368|474649269|FG000|Overall Study|Death|4|||
131827411|NCT02539368|474649270|FG001|Overall Study|Death|2|||
131827412|NCT02539368|474649271|FG002|Overall Study|Death|1|||
131827413|NCT02539368|474649272|FG003|Overall Study|Death|0|||
131827414|NCT02539368|474649273|FG004|Overall Study|Death|0|||
131827415|NCT02539368|474649269|FG000|Overall Study|Withdrawal by Subject|44|||
131827416|NCT02539368|474649270|FG001|Overall Study|Withdrawal by Subject|35|||
131827417|NCT02539368|474649271|FG002|Overall Study|Withdrawal by Subject|9|||
131827418|NCT02539368|474649272|FG003|Overall Study|Withdrawal by Subject|1|||
131827419|NCT02539368|474649273|FG004|Overall Study|Withdrawal by Subject|3|||
131827420|NCT02539368|474649269|FG000|Overall Study|Physician Decision|49|||
131827421|NCT02539368|474649270|FG001|Overall Study|Physician Decision|15|||
131827422|NCT02539368|474649271|FG002|Overall Study|Physician Decision|7|||
131827423|NCT02539368|474649272|FG003|Overall Study|Physician Decision|0|||
131827424|NCT02539368|474649273|FG004|Overall Study|Physician Decision|2|||
131827425|NCT02539368|474649269|FG000|Overall Study|Lost to Follow-up|96|||
131827426|NCT02539368|474649270|FG001|Overall Study|Lost to Follow-up|21|||
131827427|NCT02539368|474649271|FG002|Overall Study|Lost to Follow-up|16|||
131827428|NCT02539368|474649272|FG003|Overall Study|Lost to Follow-up|4|||
131827429|NCT02539368|474649273|FG004|Overall Study|Lost to Follow-up|3|||
131827430|NCT02539368|474649269|FG000|Overall Study|Adverse Event|44|||
131827431|NCT02539368|474649270|FG001|Overall Study|Adverse Event|5|||
131401326|NCT00837265|473091468|FG001|Main Phase|Adverse Event|0|||
131827432|NCT02539368|474649271|FG002|Overall Study|Adverse Event|9|||
131827433|NCT02539368|474649272|FG003|Overall Study|Adverse Event|0|||
131827434|NCT02539368|474649273|FG004|Overall Study|Adverse Event|3|||
131827435|NCT02539368|474649269|FG000|Overall Study|Participant Non-compliant|13|||
131827436|NCT02539368|474649270|FG001|Overall Study|Participant Non-compliant|2|||
131827437|NCT02539368|474649271|FG002|Overall Study|Participant Non-compliant|1|||
131827438|NCT02539368|474649272|FG003|Overall Study|Participant Non-compliant|1|||
131827439|NCT02539368|474649273|FG004|Overall Study|Participant Non-compliant|0|||
131827440|NCT02539368|474649269|FG000|Overall Study|Other|145|||
131827441|NCT02539368|474649270|FG001|Overall Study|Other|18|||
131827442|NCT02539368|474649271|FG002|Overall Study|Other|24|||
131827443|NCT02539368|474649272|FG003|Overall Study|Other|1|||
131827444|NCT02539368|474649273|FG004|Overall Study|Other|3|||
131827445|NCT02539368|474649269|FG000|Overall Study|Missing|10|||
131827446|NCT02539368|474649270|FG001|Overall Study|Missing|3|||
131827447|NCT02539368|474649271|FG002|Overall Study|Missing|0|||
131827448|NCT02539368|474649272|FG003|Overall Study|Missing|0|||
131827449|NCT02539368|474649273|FG004|Overall Study|Missing|0|||
131827450|NCT00869440|474649274|FG000|Overall Study|Withdrawal by Subject|1|||
131827451|NCT00869440|474649275|FG001|Overall Study|Withdrawal by Subject|0|||
131827452|NCT00869440|474649276|FG002|Overall Study|Withdrawal by Subject|0|||
131827453|NCT00869440|474649277|FG003|Overall Study|Withdrawal by Subject|0|||
131827454|NCT00869440|474649274|FG000|Overall Study|Physician Decision|1|||
131827455|NCT00869440|474649275|FG001|Overall Study|Physician Decision|1|||
131827456|NCT00869440|474649276|FG002|Overall Study|Physician Decision|0|||
131827457|NCT00869440|474649277|FG003|Overall Study|Physician Decision|0|||
131827458|NCT03558139|474649279|FG000|Overall Study|Consent Withdrawn|1|||
131827459|NCT03558139|474649280|FG001|Overall Study|Consent Withdrawn|1|||
131827460|NCT03558139|474649281|FG002|Overall Study|Consent Withdrawn|4|||
131827461|NCT03558139|474649279|FG000|Overall Study|Death|5|||
131827462|NCT03558139|474649280|FG001|Overall Study|Death|3|||
131827463|NCT03558139|474649281|FG002|Overall Study|Death|8|||
131827464|NCT03558139|474649279|FG000|Overall Study|Lost to Follow-up|0|||
131827465|NCT03558139|474649280|FG001|Overall Study|Lost to Follow-up|0|||
131827466|NCT03558139|474649281|FG002|Overall Study|Lost to Follow-up|3|||
131827467|NCT03558139|474649279|FG000|Overall Study|Study Ended Per Protocol|0|||
131827468|NCT03558139|474649280|FG001|Overall Study|Study Ended Per Protocol|3|||
131827469|NCT03558139|474649281|FG002|Overall Study|Study Ended Per Protocol|6|||
131827470|NCT02752802|474649282|FG000|Overall Study|Contrast Volume Not Collected|1|||
131827471|NCT02752802|474649283|FG001|Overall Study|Contrast Volume Not Collected|0|||
131827472|NCT00613730|474649284|FG000|Overall Study|Disease progression|2|||
131827473|NCT00613730|474649284|FG000|Overall Study|Administrative decision|1|||
131827474|NCT00479388|474649285|FG000|Overall Study|Adverse Event|90|||
131827475|NCT00479388|474649286|FG001|Overall Study|Adverse Event|45|||
131827476|NCT00479388|474649285|FG000|Overall Study|Lost to Follow-up|0|||
131827477|NCT00479388|474649286|FG001|Overall Study|Lost to Follow-up|2|||
131827478|NCT00479388|474649285|FG000|Overall Study|Protocol Violation|10|||
131827479|NCT00479388|474649286|FG001|Overall Study|Protocol Violation|9|||
131827480|NCT00479388|474649285|FG000|Overall Study|Withdrawal by Subject|32|||
131827481|NCT00479388|474649286|FG001|Overall Study|Withdrawal by Subject|17|||
131827482|NCT01955044|474649289|FG000|Overall Study|Death|1|||
131827483|NCT01955044|474649290|FG001|Overall Study|Death|1|||
131827484|NCT01955044|474649291|FG002|Overall Study|Death|0|||
131827485|NCT01876368|474649292|FG000|Overall Study|Adverse Event|2|||
131827486|NCT01876368|474649293|FG001|Overall Study|Adverse Event|5|||
131827487|NCT01876368|474649292|FG000|Overall Study|Lack of Efficacy|1|||
131827488|NCT01876368|474649293|FG001|Overall Study|Lack of Efficacy|0|||
131827489|NCT01876368|474649292|FG000|Overall Study|Lost to Follow-up|0|||
131827490|NCT01876368|474649293|FG001|Overall Study|Lost to Follow-up|1|||
131827491|NCT01876368|474649292|FG000|Overall Study|Non-compliance with study treatment|0|||
131827492|NCT01876368|474649293|FG001|Overall Study|Non-compliance with study treatment|1|||
131827493|NCT01876368|474649292|FG000|Overall Study|Physician Decision|0|||
131827494|NCT01876368|474649293|FG001|Overall Study|Physician Decision|2|||
131827495|NCT01876368|474649292|FG000|Overall Study|Protocol deviation|3|||
131827496|NCT01876368|474649293|FG001|Overall Study|Protocol deviation|3|||
131910250|NCT01499810|474958775|FG000|Overall Study|Protocol Violation|1|||
131401327|NCT00837265|473091469|FG002|Main Phase|Adverse Event|0|||
131827497|NCT01876368|474649292|FG000|Overall Study|Subject/guardian decision|3|||
131827498|NCT01876368|474649293|FG001|Overall Study|Subject/guardian decision|1|||
131827499|NCT01644149|474649294|FG000|Overall Study|Withdrawal by Subject|1|||
131827500|NCT01644149|474649295|FG001|Overall Study|Withdrawal by Subject|0|||
131827501|NCT01644149|474649294|FG000|Overall Study|Lost to Follow-up|3|||
131827502|NCT01644149|474649295|FG001|Overall Study|Lost to Follow-up|1|||
131827503|NCT05766787|474649296|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
131827504|NCT05766787|474649297|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
131827505|NCT05766787|474649296|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
131827506|NCT05766787|474649297|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
131827507|NCT05766787|474649296|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
131827508|NCT05766787|474649297|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
131827509|NCT01867606|474649298|FG000|Overall Study|Withdrawal by Subject|10|||
131827510|NCT01867606|474649299|FG001|Overall Study|Withdrawal by Subject|14|||
131827511|NCT01867606|474649298|FG000|Overall Study|Protocol Violation|0|||
131827512|NCT01867606|474649299|FG001|Overall Study|Protocol Violation|1|||
131827513|NCT01378962|474649300|FG000|Overall Study|Death|14|||
131827514|NCT01378962|474649300|FG000|Overall Study|Lost to Follow-up|1|||
131827515|NCT01378962|474649300|FG000|Overall Study|Other|2|||
131827516|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
131827517|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
131827518|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
131827519|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
131827520|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
131827521|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
131827522|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
131827523|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
131827524|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
131827525|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
131827526|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
131827527|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
131827528|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
131827529|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
131827530|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
131827531|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
131827532|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
131827533|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
131827534|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
131827535|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
131827536|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
131827537|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
131827538|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
131827539|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
131827540|NCT01435928|474649302|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
131827541|NCT01435928|474649303|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
131827542|NCT01435928|474649304|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
131827543|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
131827544|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
131827545|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
131827546|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
131827547|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
131827548|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
131827549|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
131827550|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
131827551|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
131827552|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
131827553|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
131827554|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
131827555|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
131827556|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
131827557|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
131827558|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
131827559|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
131827560|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
131827561|NCT01435928|474649302|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
131827562|NCT01435928|474649303|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
131827563|NCT01435928|474649304|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
131827564|NCT00292227|474649306|FG000|Patch Period|Adverse Event|1|||
131827565|NCT00292227|474649307|FG001|Patch Period|Adverse Event|0|||
131827566|NCT00292227|474649308|FG002|Patch Period|Adverse Event|2|||
131827567|NCT00292227|474649306|FG000|Patch Period|Withdrawal by Subject|0|||
131827568|NCT00292227|474649307|FG001|Patch Period|Withdrawal by Subject|0|||
131827569|NCT00292227|474649308|FG002|Patch Period|Withdrawal by Subject|1|||
131827570|NCT02093923|474649310|FG000|Overall Study|Lost to Follow-up|0|||
131827571|NCT02093923|474649311|FG001|Overall Study|Lost to Follow-up|0|||
131827572|NCT02093923|474649312|FG002|Overall Study|Lost to Follow-up|0|||
131827573|NCT02093923|474649313|FG003|Overall Study|Lost to Follow-up|1|||
131827574|NCT02093923|474649314|FG004|Overall Study|Lost to Follow-up|0|||
131827575|NCT02093923|474649310|FG000|Overall Study|Screen failure after randomization|0|||
131827576|NCT02093923|474649311|FG001|Overall Study|Screen failure after randomization|0|||
131827577|NCT02093923|474649312|FG002|Overall Study|Screen failure after randomization|0|||
131827578|NCT02093923|474649313|FG003|Overall Study|Screen failure after randomization|1|||
131827579|NCT02093923|474649314|FG004|Overall Study|Screen failure after randomization|0|||
131827580|NCT01662362|474649321|FG000|Overall Study|Lost to Follow-up|38|||
131827581|NCT01181531|474649326|FG000|Overall Study|Other|17|||
131827582|NCT01181531|474649327|FG001|Overall Study|Other|12|||
131827583|NCT01181531|474649326|FG000|Overall Study|Partial consent by subject withdrawn|0|||
131827584|NCT01181531|474649327|FG001|Overall Study|Partial consent by subject withdrawn|1|||
131827585|NCT01181531|474649326|FG000|Overall Study|Physician Decision|3|||
131827586|NCT01181531|474649327|FG001|Overall Study|Physician Decision|1|||
131827587|NCT01181531|474649326|FG000|Overall Study|Noncompliance|2|||
131827588|NCT01181531|474649327|FG001|Overall Study|Noncompliance|2|||
131827589|NCT01181531|474649326|FG000|Overall Study|Ineligibility determined|1|||
131827590|NCT01181531|474649327|FG001|Overall Study|Ineligibility determined|2|||
131827591|NCT01181531|474649326|FG000|Overall Study|Protocol Specified Criteria|15|||
131827592|NCT01181531|474649327|FG001|Overall Study|Protocol Specified Criteria|8|||
131827593|NCT01181531|474649326|FG000|Overall Study|Pregnancy|0|||
131827594|NCT01181531|474649327|FG001|Overall Study|Pregnancy|1|||
131827595|NCT01181531|474649326|FG000|Overall Study|Withdrawal by Subject|8|||
131827596|NCT01181531|474649327|FG001|Overall Study|Withdrawal by Subject|7|||
131827597|NCT01181531|474649326|FG000|Overall Study|Protocol Violation|6|||
131827598|NCT01181531|474649327|FG001|Overall Study|Protocol Violation|6|||
131827599|NCT01181531|474649326|FG000|Overall Study|Death|9|||
131827600|NCT01181531|474649327|FG001|Overall Study|Death|12|||
131827601|NCT01181531|474649326|FG000|Overall Study|Adverse Event|0|||
131827602|NCT01181531|474649327|FG001|Overall Study|Adverse Event|1|||
131827603|NCT00987831|474649328|FG000|Overall Study|Never flared in 12 months|1|||
131827604|NCT00987831|474649329|FG001|Overall Study|Never flared in 12 months|0|||
131827605|NCT00987831|474649330|FG002|Overall Study|Never flared in 12 months|0|||
131827606|NCT00987831|474649328|FG000|Overall Study|Lost to Follow-up|0|||
131827607|NCT00987831|474649329|FG001|Overall Study|Lost to Follow-up|3|||
131827608|NCT00987831|474649330|FG002|Overall Study|Lost to Follow-up|0|||
131827609|NCT00810602|474649332|FG000|Overall Study|Withdrawal by Subject|8|||
131827610|NCT00810602|474649333|FG001|Overall Study|Withdrawal by Subject|3|||
131827611|NCT02792218|474649334|FG000|Overall Study|Patient/guardian decision|15|||
131827612|NCT02792218|474649335|FG001|Overall Study|Patient/guardian decision|42|||
131827613|NCT02792218|474649334|FG000|Overall Study|Adverse Event|15|||
131827614|NCT02792218|474649335|FG001|Overall Study|Adverse Event|14|||
131827615|NCT02792218|474649334|FG000|Overall Study|Lost to Follow-up|10|||
131827616|NCT02792218|474649335|FG001|Overall Study|Lost to Follow-up|5|||
131827617|NCT02792218|474649334|FG000|Overall Study|Lack of Efficacy|1|||
131827618|NCT02792218|474649335|FG001|Overall Study|Lack of Efficacy|12|||
131827619|NCT02792218|474649334|FG000|Overall Study|Physician Decision|4|||
131827620|NCT02792218|474649335|FG001|Overall Study|Physician Decision|4|||
131827621|NCT02792218|474649334|FG000|Overall Study|Protocol deviation|3|||
131827622|NCT02792218|474649335|FG001|Overall Study|Protocol deviation|2|||
131827623|NCT02792218|474649334|FG000|Overall Study|New therapy for study indication|0|||
131827624|NCT02792218|474649335|FG001|Overall Study|New therapy for study indication|1|||
131401328|NCT00837265|473091470|FG003|Main Phase|Adverse Event|0|||
131401329|NCT00837265|473091471|FG004|Main Phase|Adverse Event|0|||
131401330|NCT00837265|473091472|FG005|Main Phase|Adverse Event|1|||
131401331|NCT00837265|473091473|FG006|Main Phase|Adverse Event|0|||
131827625|NCT02792218|474649334|FG000|Overall Study|Non-compliance with study treatment|0|||
131827626|NCT02792218|474649335|FG001|Overall Study|Non-compliance with study treatment|1|||
131827627|NCT02792218|474649334|FG000|Overall Study|Pregnancy|1|||
131827628|NCT02792218|474649335|FG001|Overall Study|Pregnancy|0|||
131827629|NCT00824369|474649336|FG000|Overall Study|Nolonger willing to participate in study|1|||
131827630|NCT00824369|474649337|FG001|Overall Study|Nolonger willing to participate in study|0|||
131827631|NCT00824369|474649338|FG002|Overall Study|Nolonger willing to participate in study|1|||
131827632|NCT00824369|474649339|FG003|Overall Study|Nolonger willing to participate in study|2|||
131827633|NCT00824369|474649340|FG004|Overall Study|Nolonger willing to participate in study|0|||
131827634|NCT00824369|474649341|FG005|Overall Study|Nolonger willing to participate in study|1|||
131827635|NCT00824369|474649336|FG000|Overall Study|Lost to Follow-up|0|||
131827636|NCT00824369|474649337|FG001|Overall Study|Lost to Follow-up|0|||
131827637|NCT00824369|474649338|FG002|Overall Study|Lost to Follow-up|0|||
131827638|NCT00824369|474649339|FG003|Overall Study|Lost to Follow-up|0|||
131827639|NCT00824369|474649340|FG004|Overall Study|Lost to Follow-up|1|||
131401332|NCT00837265|473091467|FG000|Main Phase|Death|0|||
131827640|NCT00824369|474649341|FG005|Overall Study|Lost to Follow-up|0|||
131827641|NCT00442546|474649345|FG000|Overall Study|Adverse Event|11|||
131827642|NCT00442546|474649346|FG001|Overall Study|Adverse Event|17|||
131827643|NCT00442546|474649347|FG002|Overall Study|Adverse Event|13|||
131827644|NCT00442546|474649345|FG000|Overall Study|Lost to Follow-up|1|||
131827645|NCT00442546|474649346|FG001|Overall Study|Lost to Follow-up|2|||
131827646|NCT00442546|474649347|FG002|Overall Study|Lost to Follow-up|1|||
131827647|NCT00442546|474649345|FG000|Overall Study|Other|4|||
131827648|NCT00442546|474649346|FG001|Overall Study|Other|9|||
131401333|NCT00837265|473091468|FG001|Main Phase|Death|0|||
131401334|NCT00837265|473091469|FG002|Main Phase|Death|0|||
131827649|NCT00442546|474649347|FG002|Overall Study|Other|6|||
131827650|NCT00442546|474649345|FG000|Overall Study|Withdrawal by Subject|5|||
131827651|NCT00442546|474649346|FG001|Overall Study|Withdrawal by Subject|5|||
131827652|NCT00442546|474649347|FG002|Overall Study|Withdrawal by Subject|7|||
131827653|NCT00442546|474649345|FG000|Overall Study|Randomized But Not Treated|5|||
131827654|NCT00442546|474649346|FG001|Overall Study|Randomized But Not Treated|4|||
131827655|NCT00442546|474649347|FG002|Overall Study|Randomized But Not Treated|6|||
131827656|NCT04100096|474651812|FG000|Overall Study|Adverse Event|19|||
131827657|NCT04100096|474651813|FG001|Overall Study|Adverse Event|7|||
131827658|NCT04100096|474651812|FG000|Overall Study|Lack of Efficacy|0|||
131827659|NCT04100096|474651813|FG001|Overall Study|Lack of Efficacy|1|||
131827660|NCT04100096|474651812|FG000|Overall Study|Lost to Follow-up|13|||
131827661|NCT04100096|474651813|FG001|Overall Study|Lost to Follow-up|11|||
131827662|NCT04100096|474651812|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131827663|NCT04100096|474651813|FG001|Overall Study|Non-Compliance With Study Drug|3|||
131827664|NCT04100096|474651812|FG000|Overall Study|Protocol Deviation|1|||
131827665|NCT04100096|474651813|FG001|Overall Study|Protocol Deviation|1|||
131827666|NCT04100096|474651812|FG000|Overall Study|Withdrawal by Participant|13|||
131827667|NCT04100096|474651813|FG001|Overall Study|Withdrawal by Participant|15|||
131827668|NCT02211014|474651816|FG000|Overall Study|Adverse Event|0|||
131827669|NCT02211014|474651817|FG001|Overall Study|Adverse Event|2|||
131827670|NCT02211014|474651816|FG000|Overall Study|Physician Decision|1|||
131827671|NCT02211014|474651817|FG001|Overall Study|Physician Decision|2|||
131827672|NCT02211014|474651816|FG000|Overall Study|Started another cancer therapy|1|||
131827673|NCT02211014|474651817|FG001|Overall Study|Started another cancer therapy|0|||
131827674|NCT02211014|474651816|FG000|Overall Study|Withdrawal by Subject|0|||
131827675|NCT02211014|474651817|FG001|Overall Study|Withdrawal by Subject|1|||
131827676|NCT02211014|474651816|FG000|Overall Study|In agreement with patient, no benefit|0|||
131827677|NCT02211014|474651817|FG001|Overall Study|In agreement with patient, no benefit|1|||
131827678|NCT02960438|474651818|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
131827679|NCT02960438|474651819|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
131827680|NCT02960438|474651820|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
131827681|NCT02960438|474651821|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
131827682|NCT02960438|474651818|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
131827683|NCT02960438|474651819|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
131827684|NCT02960438|474651820|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
131827685|NCT02960438|474651821|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
131827686|NCT02960438|474651818|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
131827687|NCT02960438|474651819|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
131827688|NCT02960438|474651820|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
131827689|NCT02960438|474651821|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
131827690|NCT02960438|474651818|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
131827691|NCT02960438|474651819|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
131827692|NCT02960438|474651820|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
131827693|NCT02960438|474651821|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
131827694|NCT02960438|474651818|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
131827695|NCT02960438|474651819|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
131827696|NCT02960438|474651820|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
131827697|NCT02960438|474651821|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
131827698|NCT02960438|474651818|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
131827699|NCT02960438|474651819|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
131827700|NCT02960438|474651820|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
131827701|NCT02960438|474651821|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
131827702|NCT02960438|474651818|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
131827703|NCT02960438|474651819|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
131827704|NCT02960438|474651820|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
131827705|NCT02960438|474651821|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
131827706|NCT02960438|474651818|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
131827707|NCT02960438|474651819|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
131827708|NCT02960438|474651820|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
131827709|NCT02960438|474651821|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
131827710|NCT02960438|474651818|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
131827711|NCT02960438|474651819|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
131827712|NCT02960438|474651820|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
131827713|NCT02960438|474651821|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
131827714|NCT02960438|474651818|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
131827715|NCT02960438|474651819|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
131827716|NCT02960438|474651820|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
131827717|NCT02960438|474651821|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
131827718|NCT02960438|474651818|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
131827719|NCT02960438|474651819|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
131827720|NCT02960438|474651820|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
131827721|NCT02960438|474651821|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
131827722|NCT02960438|474651818|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
131827723|NCT02960438|474651819|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
131827724|NCT02960438|474651820|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
131827725|NCT02960438|474651821|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
131827726|NCT01796964|474651829|FG000|Overall Study|Adverse Event|1|||
131827727|NCT01796964|474651830|FG001|Overall Study|Adverse Event|1|||
131827728|NCT01796964|474651829|FG000|Overall Study|Death|1|||
131827729|NCT01796964|474651830|FG001|Overall Study|Death|0|||
131827730|NCT01796964|474651829|FG000|Overall Study|Protocol Violation|0|||
131827731|NCT01796964|474651830|FG001|Overall Study|Protocol Violation|1|||
131827732|NCT01796964|474651829|FG000|Overall Study|Withdrawal by Subject|1|||
131827733|NCT01796964|474651830|FG001|Overall Study|Withdrawal by Subject|1|||
131827734|NCT04025684|474651831|FG000|Overall Study|Withdrawal by Subject|1|||
131827735|NCT04025684|474651832|FG001|Overall Study|Withdrawal by Subject|1|||
131827736|NCT04025684|474651833|FG002|Overall Study|Withdrawal by Subject|0|||
131827737|NCT04025684|474651834|FG003|Overall Study|Withdrawal by Subject|0|||
131827738|NCT04025684|474651831|FG000|Overall Study|Multiple reasons|1|||
131827739|NCT04025684|474651832|FG001|Overall Study|Multiple reasons|3|||
131827740|NCT04025684|474651833|FG002|Overall Study|Multiple reasons|0|||
131827741|NCT04025684|474651834|FG003|Overall Study|Multiple reasons|1|||
131827742|NCT02070757|474651835|FG000|Overall Study|Adverse Event|107|||
131827743|NCT02070757|474651836|FG001|Overall Study|Adverse Event|99|||
131827744|NCT02070757|474651835|FG000|Overall Study|Lost to Follow-up|7|||
131827745|NCT02070757|474651836|FG001|Overall Study|Lost to Follow-up|4|||
131827746|NCT02070757|474651835|FG000|Overall Study|Protocol Violation|0|||
131827747|NCT02070757|474651836|FG001|Overall Study|Protocol Violation|4|||
131827748|NCT02070757|474651835|FG000|Overall Study|Withdrawal by Subject|1|||
131827749|NCT02070757|474651836|FG001|Overall Study|Withdrawal by Subject|3|||
131827750|NCT02070757|474651835|FG000|Overall Study|Investigator Decision|0|||
131827751|NCT02070757|474651836|FG001|Overall Study|Investigator Decision|2|||
131827752|NCT02070757|474651835|FG000|Overall Study|Discharged from Study Hospital|2|||
131827753|NCT02070757|474651836|FG001|Overall Study|Discharged from Study Hospital|2|||
131827754|NCT01546922|474651837|FG000|First Period of 10 Weeks|Protocol Violation|3|||
131827755|NCT01546922|474651838|FG001|First Period of 10 Weeks|Protocol Violation|1|||
131827756|NCT01546922|474651837|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
131827757|NCT01546922|474651838|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
131827758|NCT01546922|474651837|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
131827759|NCT01546922|474651838|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
131827760|NCT01546922|474651837|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
131827761|NCT01546922|474651838|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
131827762|NCT01546922|474651837|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
131827763|NCT01546922|474651838|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
131827764|NCT01613378|474651844|FG000|Overall Study|Lack of Efficacy|13|||
131827765|NCT01613378|474651844|FG000|Overall Study|Adverse Event|11|||
131827766|NCT01613378|474651844|FG000|Overall Study|Withdrawal by Subject|8|||
131827767|NCT01613378|474651844|FG000|Overall Study|Death|2|||
131827768|NCT01613378|474651844|FG000|Overall Study|Lost to Follow-up|1|||
131827769|NCT01613378|474651844|FG000|Overall Study|Other Reason|4|||
131827770|NCT00794417|474651854|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
131827771|NCT00794417|474651855|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
131827772|NCT00794417|474651856|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
131827773|NCT00794417|474651857|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
131827774|NCT00794417|474651854|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
131827775|NCT00794417|474651855|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
131827776|NCT00794417|474651856|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
131827777|NCT00794417|474651857|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
131827778|NCT00794417|474651854|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
131827779|NCT00794417|474651855|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
131827780|NCT00794417|474651856|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
131827781|NCT00794417|474651857|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
131827782|NCT00794417|474651854|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
131827783|NCT00794417|474651855|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
131827784|NCT00794417|474651856|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
131827785|NCT00794417|474651857|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
131827786|NCT00794417|474651854|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
131827787|NCT00794417|474651855|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
131827788|NCT00794417|474651856|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
131401335|NCT00837265|473091470|FG003|Main Phase|Death|0|||
131827789|NCT00794417|474651857|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
131827790|NCT00794417|474651854|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
131827791|NCT00794417|474651855|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
131827792|NCT00794417|474651856|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
131827793|NCT00794417|474651857|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
131827794|NCT02744755|474651858|FG000|Study Period 1|Protocol Violation|2|||
131827795|NCT02744755|474651859|FG001|Study Period 1|Protocol Violation|1|||
131827796|NCT02744755|474651858|FG000|Study Period 1|not defined|0|||
131827797|NCT02744755|474651859|FG001|Study Period 1|not defined|1|||
131827798|NCT02744755|474651858|FG000|Study Period 1|Pregnancy|1|||
131827799|NCT02744755|474651859|FG001|Study Period 1|Pregnancy|0|||
131827800|NCT02744755|474651858|FG000|Study Period 1|Adverse Event|1|||
131827801|NCT02744755|474651859|FG001|Study Period 1|Adverse Event|1|||
131827802|NCT02744755|474651858|FG000|Study Period 1|Lost to Follow-up|1|||
131827803|NCT02744755|474651859|FG001|Study Period 1|Lost to Follow-up|1|||
131827804|NCT02744755|474651858|FG000|Study Period 1|Lack of Efficacy|1|||
131827805|NCT02744755|474651859|FG001|Study Period 1|Lack of Efficacy|0|||
131827806|NCT02744755|474651858|FG000|Study Period 1|Withdrawal by Subject|8|||
131827807|NCT02744755|474651859|FG001|Study Period 1|Withdrawal by Subject|4|||
131827808|NCT02744755|474651858|FG000|Study Period 2|Adverse Event|5|||
131827809|NCT02744755|474651859|FG001|Study Period 2|Adverse Event|0|||
131827810|NCT02744755|474651858|FG000|Study Period 2|Protocol Violation|1|||
131827811|NCT02744755|474651859|FG001|Study Period 2|Protocol Violation|0|||
131827812|NCT02744755|474651858|FG000|Study Period 2|not defined|3|||
131827813|NCT02744755|474651859|FG001|Study Period 2|not defined|2|||
131827814|NCT02744755|474651858|FG000|Study Period 2|Lost to Follow-up|0|||
131827815|NCT02744755|474651859|FG001|Study Period 2|Lost to Follow-up|2|||
131827816|NCT02744755|474651858|FG000|Study Period 2|Withdrawal by Subject|2|||
131827817|NCT02744755|474651859|FG001|Study Period 2|Withdrawal by Subject|2|||
131827818|NCT02744755|474651858|FG000|Study Period 2|Lack of Efficacy|3|||
131827819|NCT02744755|474651859|FG001|Study Period 2|Lack of Efficacy|2|||
131449874|NCT00885170|473276734|FG000|Overall Study|Lost to Follow-up|2|||
131449875|NCT00885170|473276735|FG001|Overall Study|Lost to Follow-up|1|||
131449876|NCT00885170|473276734|FG000|Overall Study|Physician Decision|2|||
131449877|NCT00885170|473276735|FG001|Overall Study|Physician Decision|1|||
131449878|NCT00885170|473276734|FG000|Overall Study|Protocol Violation|3|||
131449879|NCT00885170|473276735|FG001|Overall Study|Protocol Violation|1|||
131449880|NCT00885170|473276734|FG000|Overall Study|Withdrawal by Subject|13|||
131449881|NCT00885170|473276735|FG001|Overall Study|Withdrawal by Subject|13|||
131449882|NCT03771664|473276736|FG000|Overall Study|Adverse Event|1|||
131449883|NCT03771664|473276737|FG001|Overall Study|Adverse Event|0|||
131449884|NCT03771664|473276736|FG000|Overall Study|Lost to Follow-up|1|||
131449885|NCT03771664|473276737|FG001|Overall Study|Lost to Follow-up|0|||
131449886|NCT03771664|473276736|FG000|Overall Study|Withdrawal by Participant|1|||
131449887|NCT03771664|473276737|FG001|Overall Study|Withdrawal by Participant|4|||
131449888|NCT03771664|473276736|FG000|Overall Study|Randomized but not Treated|0|||
131449889|NCT03771664|473276737|FG001|Overall Study|Randomized but not Treated|1|||
131449890|NCT00561925|473276738|FG000|14 Day Lead-In Period|Adverse Event|38|||
131449891|NCT00561925|473276739|FG001|14 Day Lead-In Period|Adverse Event|0|||
131449892|NCT00561925|473276740|FG002|14 Day Lead-In Period|Adverse Event|0|||
131449893|NCT00561925|473276741|FG003|14 Day Lead-In Period|Adverse Event|0|||
131449894|NCT00561925|473276742|FG004|14 Day Lead-In Period|Adverse Event|0|||
131449895|NCT00561925|473276738|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
131449896|NCT00561925|473276739|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
131449897|NCT00561925|473276740|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
131449898|NCT00561925|473276741|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
131449899|NCT00561925|473276742|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
131449900|NCT00561925|473276738|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
131449901|NCT00561925|473276739|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
131449902|NCT00561925|473276740|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
131449903|NCT00561925|473276741|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
131449904|NCT00561925|473276742|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
131449905|NCT00561925|473276738|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
131827820|NCT00792623|474651860|FG000|Overall Study|Adverse Event|2|||
131827821|NCT00792623|474651860|FG000|Overall Study|Withdrawal by Subject|5|||
131827822|NCT00880087|474651861|FG000|Overall Study|Lost to Follow-up|0|||
131827823|NCT00880087|474651862|FG001|Overall Study|Lost to Follow-up|2|||
131910251|NCT01499810|474958775|FG000|Overall Study|Withdrawal by Subject|1|||
131827824|NCT00194792|474651863|FG000|Overall Study|Withdrawal by Subject|1|||
131449906|NCT00561925|473276739|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
131449907|NCT00561925|473276740|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
131827825|NCT01714739|474651864|FG000|Overall Study|Disease progression|3|||
131827826|NCT01714739|474651865|FG001|Overall Study|Disease progression|5|||
131827827|NCT01714739|474651866|FG002|Overall Study|Disease progression|5|||
131827828|NCT01714739|474651867|FG003|Overall Study|Disease progression|204|||
131827829|NCT01714739|474651868|FG004|Overall Study|Disease progression|1|||
131827830|NCT01714739|474651869|FG005|Overall Study|Disease progression|3|||
131827831|NCT01714739|474651870|FG006|Overall Study|Disease progression|5|||
131827832|NCT01714739|474651864|FG000|Overall Study|Study drug toxicity|1|||
131827833|NCT01714739|474651865|FG001|Overall Study|Study drug toxicity|1|||
131827834|NCT01714739|474651866|FG002|Overall Study|Study drug toxicity|1|||
131827835|NCT01714739|474651867|FG003|Overall Study|Study drug toxicity|15|||
131827836|NCT01714739|474651868|FG004|Overall Study|Study drug toxicity|0|||
131827837|NCT01714739|474651869|FG005|Overall Study|Study drug toxicity|0|||
131827838|NCT01714739|474651870|FG006|Overall Study|Study drug toxicity|5|||
131827839|NCT01714739|474651864|FG000|Overall Study|Death|0|||
131827840|NCT01714739|474651865|FG001|Overall Study|Death|0|||
131827841|NCT01714739|474651866|FG002|Overall Study|Death|0|||
131827842|NCT01714739|474651867|FG003|Overall Study|Death|1|||
131827843|NCT01714739|474651868|FG004|Overall Study|Death|0|||
131827844|NCT01714739|474651869|FG005|Overall Study|Death|0|||
131827845|NCT01714739|474651870|FG006|Overall Study|Death|0|||
131827846|NCT01714739|474651864|FG000|Overall Study|Adverse Event unrelated to drug|0|||
131827847|NCT01714739|474651865|FG001|Overall Study|Adverse Event unrelated to drug|0|||
131827848|NCT01714739|474651866|FG002|Overall Study|Adverse Event unrelated to drug|3|||
131827849|NCT01714739|474651867|FG003|Overall Study|Adverse Event unrelated to drug|21|||
131827850|NCT01714739|474651868|FG004|Overall Study|Adverse Event unrelated to drug|0|||
131827851|NCT01714739|474651869|FG005|Overall Study|Adverse Event unrelated to drug|0|||
131827852|NCT01714739|474651870|FG006|Overall Study|Adverse Event unrelated to drug|0|||
131827853|NCT01714739|474651864|FG000|Overall Study|Participant request to stop therapy|0|||
131827854|NCT01714739|474651865|FG001|Overall Study|Participant request to stop therapy|1|||
131401336|NCT00837265|473091471|FG004|Main Phase|Death|2|||
131401337|NCT00837265|473091472|FG005|Main Phase|Death|0|||
131401338|NCT00837265|473091473|FG006|Main Phase|Death|1|||
131401339|NCT00837265|473091467|FG000|Main Phase|Lost to Follow-up|0|||
131401340|NCT00837265|473091468|FG001|Main Phase|Lost to Follow-up|0|||
131401341|NCT00837265|473091469|FG002|Main Phase|Lost to Follow-up|0|||
131401342|NCT00837265|473091470|FG003|Main Phase|Lost to Follow-up|0|||
131827855|NCT01714739|474651866|FG002|Overall Study|Participant request to stop therapy|0|||
131827856|NCT01714739|474651867|FG003|Overall Study|Participant request to stop therapy|6|||
131827857|NCT01714739|474651868|FG004|Overall Study|Participant request to stop therapy|0|||
131827858|NCT01714739|474651869|FG005|Overall Study|Participant request to stop therapy|0|||
131827859|NCT01714739|474651870|FG006|Overall Study|Participant request to stop therapy|0|||
131827860|NCT01714739|474651864|FG000|Overall Study|Participant withdrew consent|0|||
131827861|NCT01714739|474651865|FG001|Overall Study|Participant withdrew consent|1|||
131827862|NCT01714739|474651866|FG002|Overall Study|Participant withdrew consent|0|||
131827863|NCT01714739|474651867|FG003|Overall Study|Participant withdrew consent|8|||
131827864|NCT01714739|474651868|FG004|Overall Study|Participant withdrew consent|0|||
131827865|NCT01714739|474651869|FG005|Overall Study|Participant withdrew consent|0|||
131827866|NCT01714739|474651870|FG006|Overall Study|Participant withdrew consent|0|||
131827867|NCT01714739|474651864|FG000|Overall Study|Lost to Follow-up|0|||
131827868|NCT01714739|474651865|FG001|Overall Study|Lost to Follow-up|0|||
131827869|NCT01714739|474651866|FG002|Overall Study|Lost to Follow-up|0|||
131827870|NCT01714739|474651867|FG003|Overall Study|Lost to Follow-up|1|||
131827871|NCT01714739|474651868|FG004|Overall Study|Lost to Follow-up|0|||
131827872|NCT01714739|474651869|FG005|Overall Study|Lost to Follow-up|0|||
131827873|NCT01714739|474651870|FG006|Overall Study|Lost to Follow-up|0|||
131827874|NCT01714739|474651864|FG000|Overall Study|Maximum clinical benefit|0|||
131827875|NCT01714739|474651865|FG001|Overall Study|Maximum clinical benefit|1|||
131827876|NCT01714739|474651866|FG002|Overall Study|Maximum clinical benefit|1|||
131827877|NCT01714739|474651867|FG003|Overall Study|Maximum clinical benefit|3|||
131827878|NCT01714739|474651868|FG004|Overall Study|Maximum clinical benefit|0|||
131827879|NCT01714739|474651869|FG005|Overall Study|Maximum clinical benefit|0|||
131827880|NCT01714739|474651870|FG006|Overall Study|Maximum clinical benefit|0|||
131827881|NCT01714739|474651864|FG000|Overall Study|Poor/non-comliance|0|||
131827882|NCT01714739|474651865|FG001|Overall Study|Poor/non-comliance|1|||
131827883|NCT01714739|474651866|FG002|Overall Study|Poor/non-comliance|0|||
131827884|NCT01714739|474651867|FG003|Overall Study|Poor/non-comliance|1|||
131827885|NCT01714739|474651868|FG004|Overall Study|Poor/non-comliance|0|||
131827886|NCT01714739|474651869|FG005|Overall Study|Poor/non-comliance|0|||
131827887|NCT01714739|474651870|FG006|Overall Study|Poor/non-comliance|0|||
131827888|NCT01714739|474651864|FG000|Overall Study|No longer meets study criteria|0|||
131827889|NCT01714739|474651865|FG001|Overall Study|No longer meets study criteria|0|||
131827890|NCT01714739|474651866|FG002|Overall Study|No longer meets study criteria|0|||
131827891|NCT01714739|474651867|FG003|Overall Study|No longer meets study criteria|1|||
131827892|NCT01714739|474651868|FG004|Overall Study|No longer meets study criteria|0|||
131827893|NCT01714739|474651869|FG005|Overall Study|No longer meets study criteria|0|||
131827894|NCT01714739|474651870|FG006|Overall Study|No longer meets study criteria|0|||
131827895|NCT01714739|474651864|FG000|Overall Study|Other reason|0|||
131827896|NCT01714739|474651865|FG001|Overall Study|Other reason|0|||
131827897|NCT01714739|474651866|FG002|Overall Study|Other reason|0|||
131827898|NCT01714739|474651867|FG003|Overall Study|Other reason|3|||
131827899|NCT01714739|474651868|FG004|Overall Study|Other reason|1|||
131827900|NCT01714739|474651869|FG005|Overall Study|Other reason|0|||
131827901|NCT01714739|474651870|FG006|Overall Study|Other reason|0|||
131827902|NCT03585959|474651871|FG000|Overall Study|Physician Decision|1|||
131827903|NCT03585959|474651871|FG000|Overall Study|Unsuccessful Procedure|2|||
131827904|NCT01740791|474651872|FG000|Overall Study|Randomized but never treated|5|||
131827905|NCT01740791|474651873|FG001|Overall Study|Randomized but never treated|3|||
131827906|NCT01740791|474651874|FG002|Overall Study|Randomized but never treated|2|||
131827907|NCT01740791|474651875|FG003|Overall Study|Randomized but never treated|2|||
131827908|NCT01740791|474651876|FG004|Overall Study|Randomized but never treated|1|||
131827909|NCT01740791|474651877|FG005|Overall Study|Randomized but never treated|3|||
131827910|NCT01740791|474651872|FG000|Overall Study|Lost to Follow-up|2|||
131401343|NCT00837265|473091471|FG004|Main Phase|Lost to Follow-up|1|||
131827911|NCT01740791|474651873|FG001|Overall Study|Lost to Follow-up|0|||
131827912|NCT01740791|474651874|FG002|Overall Study|Lost to Follow-up|2|||
131827913|NCT01740791|474651875|FG003|Overall Study|Lost to Follow-up|3|||
131827914|NCT01740791|474651876|FG004|Overall Study|Lost to Follow-up|2|||
131827915|NCT01740791|474651877|FG005|Overall Study|Lost to Follow-up|3|||
131827916|NCT01740791|474651872|FG000|Overall Study|Withdrew Consent|4|||
131827917|NCT01740791|474651873|FG001|Overall Study|Withdrew Consent|0|||
131827918|NCT01740791|474651874|FG002|Overall Study|Withdrew Consent|1|||
131827919|NCT01740791|474651875|FG003|Overall Study|Withdrew Consent|2|||
131827920|NCT01740791|474651876|FG004|Overall Study|Withdrew Consent|0|||
131827921|NCT01740791|474651877|FG005|Overall Study|Withdrew Consent|3|||
131827922|NCT01740791|474651872|FG000|Overall Study|Investigator's discretion|1|||
131827923|NCT01740791|474651873|FG001|Overall Study|Investigator's discretion|0|||
131827924|NCT01740791|474651874|FG002|Overall Study|Investigator's discretion|1|||
131827925|NCT01740791|474651875|FG003|Overall Study|Investigator's discretion|0|||
131827926|NCT01740791|474651876|FG004|Overall Study|Investigator's discretion|0|||
131827927|NCT01740791|474651877|FG005|Overall Study|Investigator's discretion|1|||
131827928|NCT01740791|474651872|FG000|Overall Study|Adverse Event|0|||
131827929|NCT01740791|474651873|FG001|Overall Study|Adverse Event|0|||
131827930|NCT01740791|474651874|FG002|Overall Study|Adverse Event|0|||
131827931|NCT01740791|474651875|FG003|Overall Study|Adverse Event|0|||
131827932|NCT01740791|474651876|FG004|Overall Study|Adverse Event|0|||
131827933|NCT01740791|474651877|FG005|Overall Study|Adverse Event|1|||
131827934|NCT04220775|474651880|FG000|Overall Study|Adverse Event|1|||
131827935|NCT04220775|474651881|FG001|Overall Study|Adverse Event|0|||
131827936|NCT04220775|474651880|FG000|Overall Study|Disease Progression|1|||
131827937|NCT04220775|474651881|FG001|Overall Study|Disease Progression|0|||
131827938|NCT00931463|474651882|FG000|Overall Study|Death|8|||
131827939|NCT00931463|474651883|FG001|Overall Study|Death|4|||
131827940|NCT00931463|474651882|FG000|Overall Study|Withdrawal by Subject|5|||
131827941|NCT00931463|474651883|FG001|Overall Study|Withdrawal by Subject|0|||
131827942|NCT00931463|474651882|FG000|Overall Study|Lost to Follow-up|4|||
131827943|NCT00931463|474651883|FG001|Overall Study|Lost to Follow-up|1|||
131827944|NCT03170869|474651884|FG000|Overall Study|Protocol Violation|5|||
131827945|NCT03170869|474651884|FG000|Overall Study|Early study termination|3|||
131827946|NCT01009515|474651885|FG000|Overall Study|Withdrawal by Subject|3|||
131827947|NCT02808819|474651887|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
131827948|NCT02808819|474651888|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
131827949|NCT02808819|474651887|FG000|Overall Study|Withdrawal by Subject|10|||
131827950|NCT02808819|474651888|FG001|Overall Study|Withdrawal by Subject|13|||
131827951|NCT02808819|474651887|FG000|Overall Study|Site terminated by sponsor|2|||
131827952|NCT02808819|474651888|FG001|Overall Study|Site terminated by sponsor|0|||
131827953|NCT02808819|474651887|FG000|Overall Study|Pregnancy|1|||
131827954|NCT02808819|474651888|FG001|Overall Study|Pregnancy|0|||
131827955|NCT02808819|474651887|FG000|Overall Study|Lost to Follow-up|1|||
131827956|NCT02808819|474651888|FG001|Overall Study|Lost to Follow-up|6|||
131827957|NCT02808819|474651887|FG000|Overall Study|Protocol Violation|0|||
131401344|NCT00837265|473091472|FG005|Main Phase|Lost to Follow-up|0|||
131401345|NCT00837265|473091473|FG006|Main Phase|Lost to Follow-up|0|||
131401346|NCT00837265|473091467|FG000|Main Phase|Principal investigator resignation|0|||
131401347|NCT00837265|473091468|FG001|Main Phase|Principal investigator resignation|0|||
131401348|NCT00837265|473091469|FG002|Main Phase|Principal investigator resignation|0|||
131401349|NCT00837265|473091470|FG003|Main Phase|Principal investigator resignation|0|||
131401350|NCT00837265|473091471|FG004|Main Phase|Principal investigator resignation|2|||
131827958|NCT02808819|474651888|FG001|Overall Study|Protocol Violation|1|||
131827959|NCT02808819|474651887|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
131827960|NCT02808819|474651888|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
131827961|NCT02808819|474651887|FG000|Overall Study|Death|1|||
131827962|NCT02808819|474651888|FG001|Overall Study|Death|0|||
131827963|NCT02808819|474651887|FG000|Overall Study|Adverse Event|3|||
131827964|NCT02808819|474651888|FG001|Overall Study|Adverse Event|4|||
131827965|NCT03573817|474651889|FG000|Overall Study|Adverse Event|0|||
131827966|NCT03573817|474651890|FG001|Overall Study|Adverse Event|2|||
131827967|NCT03573817|474651889|FG000|Overall Study|Protocol Violation|0|||
131827968|NCT03573817|474651890|FG001|Overall Study|Protocol Violation|1|||
131910252|NCT01884597|474958778|FG000|Overall Study|Adverse Event|0|||
131401351|NCT00837265|473091472|FG005|Main Phase|Principal investigator resignation|0|||
131401352|NCT00837265|473091473|FG006|Main Phase|Principal investigator resignation|0|||
131401353|NCT00837265|473091467|FG000|Main Phase|Participant's personal reason|0|||
131401354|NCT00837265|473091468|FG001|Main Phase|Participant's personal reason|0|||
131401355|NCT00837265|473091469|FG002|Main Phase|Participant's personal reason|0|||
131401356|NCT00837265|473091470|FG003|Main Phase|Participant's personal reason|0|||
131401357|NCT00837265|473091471|FG004|Main Phase|Participant's personal reason|1|||
131401358|NCT00837265|473091472|FG005|Main Phase|Participant's personal reason|0|||
131401359|NCT00837265|473091473|FG006|Main Phase|Participant's personal reason|0|||
131401360|NCT01474772|473091482|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
131401361|NCT01474772|473091483|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
131401362|NCT01474772|473091482|FG000|Period 1|AE not Related to Study Drug|1|||
131401363|NCT01474772|473091483|FG001|Period 1|AE not Related to Study Drug|0|||
131401364|NCT01474772|473091482|FG000|Period 1|Withdrawal by Subject|3|||
131401365|NCT01474772|473091483|FG001|Period 1|Withdrawal by Subject|1|||
131401366|NCT01474772|473091482|FG000|Period 1|Lost to Follow-up|1|||
131401367|NCT01474772|473091483|FG001|Period 1|Lost to Follow-up|0|||
131401368|NCT01474772|473091482|FG000|Period 1|Reason not Specified|1|||
131401369|NCT01474772|473091483|FG001|Period 1|Reason not Specified|1|||
131827969|NCT03573817|474651889|FG000|Overall Study|Withdrawal by Subject|1|||
131827970|NCT03573817|474651890|FG001|Overall Study|Withdrawal by Subject|1|||
131827971|NCT02013531|474651891|FG000|Overall Study|Lost to Follow-up|3|||
131827972|NCT02013531|474651891|FG000|Overall Study|Met Withdrawal Criteria|1|||
131827973|NCT02013531|474651891|FG000|Overall Study|Withdrawal by Subject|1|||
131827974|NCT03546647|474651892|FG000|Overall Study|Adverse Event|1|||
131827975|NCT03546647|474651893|FG001|Overall Study|Adverse Event|0|||
131827976|NCT02400476|474651894|FG000|Overall Study|Adverse Event|57|||
131827977|NCT02400476|474651895|FG001|Overall Study|Adverse Event|10|||
131827978|NCT02400476|474651896|FG002|Overall Study|Adverse Event|22|||
131827979|NCT02400476|474651897|FG003|Overall Study|Adverse Event|19|||
131827980|NCT02400476|474651898|FG004|Overall Study|Adverse Event|5|||
131827981|NCT02400476|474651899|FG005|Overall Study|Adverse Event|8|||
131827982|NCT02400476|474651894|FG000|Overall Study|Withdrawal by Subject|4|||
131827983|NCT02400476|474651895|FG001|Overall Study|Withdrawal by Subject|1|||
131827984|NCT02400476|474651896|FG002|Overall Study|Withdrawal by Subject|12|||
131827985|NCT02400476|474651897|FG003|Overall Study|Withdrawal by Subject|7|||
131827986|NCT02400476|474651898|FG004|Overall Study|Withdrawal by Subject|5|||
131827987|NCT02400476|474651899|FG005|Overall Study|Withdrawal by Subject|5|||
131827988|NCT02400476|474651894|FG000|Overall Study|Lost to Follow-up|0|||
131827989|NCT02400476|474651895|FG001|Overall Study|Lost to Follow-up|0|||
131827990|NCT02400476|474651896|FG002|Overall Study|Lost to Follow-up|0|||
131827991|NCT02400476|474651897|FG003|Overall Study|Lost to Follow-up|1|||
131827992|NCT02400476|474651898|FG004|Overall Study|Lost to Follow-up|3|||
131827993|NCT02400476|474651899|FG005|Overall Study|Lost to Follow-up|1|||
131827994|NCT02400476|474651894|FG000|Overall Study|Physician Decision|0|||
131827995|NCT02400476|474651895|FG001|Overall Study|Physician Decision|0|||
131827996|NCT02400476|474651896|FG002|Overall Study|Physician Decision|1|||
131827997|NCT02400476|474651897|FG003|Overall Study|Physician Decision|1|||
131827998|NCT02400476|474651898|FG004|Overall Study|Physician Decision|0|||
131827999|NCT02400476|474651899|FG005|Overall Study|Physician Decision|1|||
131828000|NCT02400476|474651894|FG000|Overall Study|Other, Disease Progression|0|||
131828001|NCT02400476|474651895|FG001|Overall Study|Other, Disease Progression|1|||
131828002|NCT02400476|474651896|FG002|Overall Study|Other, Disease Progression|2|||
131401370|NCT01474772|473091482|FG000|Washout|AE not Related to Study Drug|2|||
131401371|NCT01474772|473091483|FG001|Washout|AE not Related to Study Drug|0|||
131401372|NCT01474772|473091482|FG000|Washout|Withdrawal by Subject|1|||
131401373|NCT01474772|473091483|FG001|Washout|Withdrawal by Subject|0|||
131401374|NCT01474772|473091482|FG000|Washout|Lost to Follow-up|0|||
131401375|NCT01474772|473091483|FG001|Washout|Lost to Follow-up|1|||
131401376|NCT01474772|473091482|FG000|Washout|Reason not Specified|0|||
131401377|NCT01474772|473091483|FG001|Washout|Reason not Specified|1|||
131401378|NCT01474772|473091482|FG000|Period 2|Death|0|||
131401379|NCT01474772|473091483|FG001|Period 2|Death|1|||
131401380|NCT01474772|473091482|FG000|Period 2|AE Related to Study Drug|0|||
131401381|NCT01474772|473091483|FG001|Period 2|AE Related to Study Drug|1|||
131401382|NCT01474772|473091482|FG000|Period 2|AE not Related to Study Drug|4|||
131828003|NCT02400476|474651897|FG003|Overall Study|Other, Disease Progression|1|||
131828004|NCT02400476|474651898|FG004|Overall Study|Other, Disease Progression|2|||
131828005|NCT02400476|474651899|FG005|Overall Study|Other, Disease Progression|1|||
131828006|NCT02400476|474651894|FG000|Overall Study|Other, Decreased Quality of Life|0|||
131401383|NCT01474772|473091483|FG001|Period 2|AE not Related to Study Drug|1|||
131401384|NCT01474772|473091482|FG000|Period 2|Lack of Efficacy|1|||
131828007|NCT02400476|474651895|FG001|Overall Study|Other, Decreased Quality of Life|0|||
131828008|NCT02400476|474651896|FG002|Overall Study|Other, Decreased Quality of Life|2|||
131828009|NCT02400476|474651897|FG003|Overall Study|Other, Decreased Quality of Life|0|||
131401385|NCT01474772|473091483|FG001|Period 2|Lack of Efficacy|0|||
131401386|NCT01474772|473091482|FG000|Period 2|Withdrawal by Subject|3|||
131401387|NCT01474772|473091483|FG001|Period 2|Withdrawal by Subject|4|||
131401388|NCT01474772|473091482|FG000|Period 2|Lost to Follow-up|1|||
131401389|NCT01474772|473091483|FG001|Period 2|Lost to Follow-up|1|||
131401390|NCT01474772|473091482|FG000|Period 2|Reason not Specified|0|||
131401391|NCT01474772|473091483|FG001|Period 2|Reason not Specified|2|||
131828010|NCT02400476|474651898|FG004|Overall Study|Other, Decreased Quality of Life|0|||
131828011|NCT02400476|474651899|FG005|Overall Study|Other, Decreased Quality of Life|0|||
131828012|NCT02400476|474651894|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
131910253|NCT01884597|474958779|FG001|Overall Study|Adverse Event|0|||
131401392|NCT01474772|473091482|FG000|Follow-up|AE not Related to Study Drug|0|||
131401393|NCT01474772|473091483|FG001|Follow-up|AE not Related to Study Drug|1|||
131401394|NCT00223808|473091484|FG000|Overall Study|<5 hrs therapy before discharge|3|||
131401395|NCT00223808|473091485|FG001|Overall Study|<5 hrs therapy before discharge|5|||
131401396|NCT00223808|473091486|FG002|Overall Study|<5 hrs therapy before discharge|5|||
131401397|NCT03195660|473091487|FG000|Overall Study|The study was terminated|2|||
131401398|NCT05260073|473091489|FG000|Overall Study|Physician Decision|1|||
131401399|NCT05260073|473091489|FG000|Overall Study|Withdrawal by Subject|6|||
131401400|NCT05260073|473091489|FG000|Overall Study|Lost to Follow-up|14|||
131401401|NCT03458910|473091490|FG000|Overall Study|Withdrawal by Subject|7|||
131401402|NCT03458910|473091491|FG001|Overall Study|Withdrawal by Subject|8|||
131401403|NCT03458910|473091492|FG002|Overall Study|Withdrawal by Subject|6|||
131401404|NCT03458910|473091493|FG003|Overall Study|Withdrawal by Subject|4|||
131401405|NCT03458910|473091490|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
131401406|NCT03458910|473091491|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
131768687|NCT01632345|474429894|FG004|Treatment: Part II|Adverse Event|0|||
131401407|NCT03458910|473091492|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
131768688|NCT01632345|474429895|FG005|Treatment: Part II|Adverse Event|3|||
131768689|NCT01632345|474429896|FG006|Treatment: Part II|Adverse Event|8|||
131768690|NCT01632345|474429890|FG000|Treatment: Part II|Lost to Follow-up|0|||
131768691|NCT01632345|474429891|FG001|Treatment: Part II|Lost to Follow-up|0|||
131768692|NCT01632345|474429892|FG002|Treatment: Part II|Lost to Follow-up|0|||
131768693|NCT01632345|474429893|FG003|Treatment: Part II|Lost to Follow-up|0|||
131768694|NCT01632345|474429894|FG004|Treatment: Part II|Lost to Follow-up|0|||
131768695|NCT01632345|474429895|FG005|Treatment: Part II|Lost to Follow-up|3|||
131768696|NCT01632345|474429896|FG006|Treatment: Part II|Lost to Follow-up|1|||
131768697|NCT01632345|474429890|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
131768698|NCT01632345|474429891|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
131768699|NCT01632345|474429892|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
131768700|NCT01632345|474429893|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
131768701|NCT01632345|474429894|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
131768702|NCT01632345|474429895|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
131768703|NCT01632345|474429896|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
131768704|NCT01632345|474429890|FG000|Treatment: Part II|Withdrawal by Subject|0|||
131768705|NCT01632345|474429891|FG001|Treatment: Part II|Withdrawal by Subject|0|||
131768706|NCT01632345|474429892|FG002|Treatment: Part II|Withdrawal by Subject|0|||
131768707|NCT01632345|474429893|FG003|Treatment: Part II|Withdrawal by Subject|0|||
131768708|NCT01632345|474429894|FG004|Treatment: Part II|Withdrawal by Subject|0|||
131768709|NCT01632345|474429895|FG005|Treatment: Part II|Withdrawal by Subject|2|||
131768710|NCT01632345|474429896|FG006|Treatment: Part II|Withdrawal by Subject|2|||
131768711|NCT00529152|474429899|FG000|Overall Study|Adverse Event|2|||
131768712|NCT00529152|474429899|FG000|Overall Study|Withdrawal by Subject|2|||
131768713|NCT00529152|474429899|FG000|Overall Study|Lost to Follow-up|1|||
131768714|NCT01002573|474431827|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
131768715|NCT01002573|474431828|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
131768716|NCT01786707|474431829|FG000|Overall Study|Lost to Follow-up|1|||
131768717|NCT01786707|474431830|FG001|Overall Study|Lost to Follow-up|1|||
131768718|NCT02058940|474431831|FG000|Overall Study|Discharged from Critical Care Unit|1|||
131768719|NCT01519700|474431832|FG000|Overall Study|Death|1|||
131768720|NCT01519700|474431833|FG001|Overall Study|Death|0|||
131768721|NCT01519700|474431834|FG002|Overall Study|Death|0|||
131768722|NCT01519700|474431835|FG003|Overall Study|Death|0|||
131768723|NCT01519700|474431832|FG000|Overall Study|Lost to Follow-up|0|||
131768724|NCT01519700|474431833|FG001|Overall Study|Lost to Follow-up|0|||
131768725|NCT01519700|474431834|FG002|Overall Study|Lost to Follow-up|1|||
131768726|NCT01519700|474431835|FG003|Overall Study|Lost to Follow-up|1|||
131768727|NCT01519700|474431832|FG000|Overall Study|Physician Decision|1|||
131768728|NCT01519700|474431833|FG001|Overall Study|Physician Decision|1|||
131768729|NCT01519700|474431834|FG002|Overall Study|Physician Decision|3|||
131768730|NCT01519700|474431835|FG003|Overall Study|Physician Decision|0|||
131768731|NCT01519700|474431832|FG000|Overall Study|Withdrawal by Subject|5|||
131768732|NCT01519700|474431833|FG001|Overall Study|Withdrawal by Subject|3|||
131768733|NCT01519700|474431834|FG002|Overall Study|Withdrawal by Subject|3|||
131768734|NCT01519700|474431835|FG003|Overall Study|Withdrawal by Subject|2|||
131768735|NCT01519700|474431832|FG000|Overall Study|Other Reason|2|||
131768736|NCT01519700|474431833|FG001|Overall Study|Other Reason|2|||
131768737|NCT01519700|474431834|FG002|Overall Study|Other Reason|0|||
131828013|NCT02400476|474651895|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
131828014|NCT02400476|474651896|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
131828015|NCT02400476|474651897|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
131828016|NCT02400476|474651898|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
131828017|NCT02400476|474651899|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
131828018|NCT00003531|474651900|FG000|Overall Study|Not evaluable|10|||
131828019|NCT00588731|474651901|FG000|Overall Study|Withdrawal by Subject|3|||
131828020|NCT00588731|474651902|FG001|Overall Study|Withdrawal by Subject|2|||
131828021|NCT00251316|474651903|FG000|Overall Study|Physician Decision|2|||
131828022|NCT00251316|474651904|FG001|Overall Study|Physician Decision|3|||
131828023|NCT00346164|474651905|FG000|Overall Study|Adverse Event|0|||
131828024|NCT00346164|474651906|FG001|Overall Study|Adverse Event|0|||
131828025|NCT00346164|474651907|FG002|Overall Study|Adverse Event|0|||
131828026|NCT00346164|474651908|FG003|Overall Study|Adverse Event|1|||
131828027|NCT00346164|474651905|FG000|Overall Study|Lack of Efficacy|0|||
131828028|NCT00346164|474651906|FG001|Overall Study|Lack of Efficacy|1|||
131828029|NCT00346164|474651907|FG002|Overall Study|Lack of Efficacy|7|||
131828030|NCT00346164|474651908|FG003|Overall Study|Lack of Efficacy|25|||
131828031|NCT00346164|474651905|FG000|Overall Study|Physician Decision|0|||
131828032|NCT00346164|474651906|FG001|Overall Study|Physician Decision|1|||
131828033|NCT00346164|474651907|FG002|Overall Study|Physician Decision|2|||
131828034|NCT00346164|474651908|FG003|Overall Study|Physician Decision|27|||
131828035|NCT00346164|474651905|FG000|Overall Study|Protocol Violation|6|||
131828036|NCT00346164|474651906|FG001|Overall Study|Protocol Violation|2|||
131828037|NCT00346164|474651907|FG002|Overall Study|Protocol Violation|10|||
131828038|NCT00346164|474651908|FG003|Overall Study|Protocol Violation|4|||
131828039|NCT00346164|474651905|FG000|Overall Study|Withdrawal by Subject|0|||
131828040|NCT00346164|474651906|FG001|Overall Study|Withdrawal by Subject|0|||
131828041|NCT00346164|474651907|FG002|Overall Study|Withdrawal by Subject|2|||
131828042|NCT00346164|474651908|FG003|Overall Study|Withdrawal by Subject|0|||
131828043|NCT00346164|474651905|FG000|Overall Study|Ineligible|11|||
131828044|NCT00346164|474651906|FG001|Overall Study|Ineligible|2|||
131828045|NCT00346164|474651907|FG002|Overall Study|Ineligible|2|||
131828046|NCT00346164|474651908|FG003|Overall Study|Ineligible|23|||
131828047|NCT00346164|474651905|FG000|Overall Study|Refusal of further protocol therapy|0|||
131828048|NCT00346164|474651906|FG001|Overall Study|Refusal of further protocol therapy|1|||
131828049|NCT00346164|474651907|FG002|Overall Study|Refusal of further protocol therapy|3|||
131828050|NCT00346164|474651908|FG003|Overall Study|Refusal of further protocol therapy|15|||
131828051|NCT00346164|474651905|FG000|Overall Study|Inability to start week 16 tx on time|0|||
131828052|NCT00346164|474651906|FG001|Overall Study|Inability to start week 16 tx on time|0|||
131828053|NCT00346164|474651907|FG002|Overall Study|Inability to start week 16 tx on time|0|||
131828054|NCT00346164|474651908|FG003|Overall Study|Inability to start week 16 tx on time|11|||
131828055|NCT02692482|474651915|FG000|Overall Study|Death|2|||
131828056|NCT02692482|474651916|FG001|Overall Study|Death|2|||
131828057|NCT02692482|474651915|FG000|Overall Study|Withdrawal by Subject|1|||
131828058|NCT02692482|474651916|FG001|Overall Study|Withdrawal by Subject|2|||
131828059|NCT04232540|474651927|FG000|Overall Study|Lost to Follow-up|1|||
131828060|NCT04232540|474651928|FG001|Overall Study|Lost to Follow-up|0|||
131828061|NCT02105701|474651929|FG000|Overall Study|Lost to Follow-up|1|||
131828062|NCT02105701|474651930|FG001|Overall Study|Lost to Follow-up|0|||
131828063|NCT02105701|474651931|FG002|Overall Study|Lost to Follow-up|2|||
131828064|NCT02105701|474651932|FG003|Overall Study|Lost to Follow-up|1|||
131828065|NCT02105701|474651929|FG000|Overall Study|Protocol Violation|0|||
131828066|NCT02105701|474651930|FG001|Overall Study|Protocol Violation|0|||
131828067|NCT02105701|474651931|FG002|Overall Study|Protocol Violation|1|||
131828068|NCT02105701|474651932|FG003|Overall Study|Protocol Violation|0|||
131828069|NCT02105701|474651929|FG000|Overall Study|Withdrawal by Subject|2|||
131828070|NCT02105701|474651930|FG001|Overall Study|Withdrawal by Subject|1|||
131828071|NCT02105701|474651931|FG002|Overall Study|Withdrawal by Subject|0|||
131828072|NCT02105701|474651932|FG003|Overall Study|Withdrawal by Subject|1|||
131828073|NCT02105701|474651929|FG000|Overall Study|Death|1|||
131828074|NCT02105701|474651930|FG001|Overall Study|Death|0|||
131910254|NCT01884597|474958780|FG002|Overall Study|Adverse Event|1|||
131910255|NCT01884597|474958778|FG000|Overall Study|Lack of Efficacy|1|||
131828075|NCT02105701|474651931|FG002|Overall Study|Death|0|||
131828076|NCT02105701|474651932|FG003|Overall Study|Death|0|||
131828077|NCT03234608|474651933|FG000|Overall Study|Lost to Follow-up|23|||
131828078|NCT03234608|474651934|FG001|Overall Study|Lost to Follow-up|21|||
131828079|NCT03450629|474651935|FG000|Overall Study|Adverse Event|15|||
131828080|NCT03450629|474651936|FG001|Overall Study|Adverse Event|14|||
131828081|NCT03450629|474651935|FG000|Overall Study|Physician Decision|2|||
131828082|NCT03450629|474651936|FG001|Overall Study|Physician Decision|2|||
131828083|NCT03450629|474651935|FG000|Overall Study|Lack of Efficacy|2|||
131828084|NCT03450629|474651936|FG001|Overall Study|Lack of Efficacy|0|||
131828085|NCT03450629|474651935|FG000|Overall Study|Lost to Follow-up|4|||
131828086|NCT03450629|474651936|FG001|Overall Study|Lost to Follow-up|2|||
131828087|NCT03450629|474651935|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131910256|NCT01884597|474958779|FG001|Overall Study|Lack of Efficacy|0|||
131401408|NCT03458910|473091493|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
131401409|NCT04484649|473091494|FG000|Overall Study|Lost to Follow-up|2|||
131401410|NCT04484649|473091495|FG001|Overall Study|Lost to Follow-up|1|||
131401411|NCT04484649|473091494|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
131401412|NCT04484649|473091495|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
131401413|NCT01681069|473091500|FG000|Overall Study|Withdrawal by Subject|4|||
131401414|NCT01681069|473091501|FG001|Overall Study|Withdrawal by Subject|5|||
131401415|NCT01681069|473091500|FG000|Overall Study|Protocol Violation|1|||
131401416|NCT01681069|473091501|FG001|Overall Study|Protocol Violation|1|||
131401417|NCT01681069|473091500|FG000|Overall Study|Adverse Event|0|||
131401418|NCT01681069|473091501|FG001|Overall Study|Adverse Event|1|||
131401419|NCT01463696|473091502|FG000|Overall Study|Adverse Event|0|||
131401420|NCT01463696|473091503|FG001|Overall Study|Adverse Event|1|||
131401421|NCT01463696|473091504|FG002|Overall Study|Adverse Event|0|||
131401422|NCT01463696|473091505|FG003|Overall Study|Adverse Event|2|||
131401423|NCT01463696|473091506|FG004|Overall Study|Adverse Event|0|||
131401424|NCT01463696|473091507|FG005|Overall Study|Adverse Event|1|||
131401425|NCT01463696|473091508|FG006|Overall Study|Adverse Event|3|||
131828088|NCT03450629|474651936|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
131828089|NCT03450629|474651935|FG000|Overall Study|Non-Compliance With Study Drug|2|||
131828090|NCT03450629|474651936|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131828091|NCT03450629|474651935|FG000|Overall Study|Protocol Violation|11|||
131828092|NCT03450629|474651936|FG001|Overall Study|Protocol Violation|8|||
131828093|NCT03450629|474651935|FG000|Overall Study|Withdrawal by Subject|12|||
131828094|NCT03450629|474651936|FG001|Overall Study|Withdrawal by Subject|6|||
131828095|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
131828096|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828097|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828098|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828099|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828100|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828101|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828102|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828103|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
131828104|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
131828105|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828106|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828107|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828108|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828109|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828110|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828111|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828112|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
131828113|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
131828114|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828115|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828116|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828117|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828118|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828119|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828120|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828121|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
131828122|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
131828123|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828124|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828125|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828126|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131910257|NCT01884597|474958780|FG002|Overall Study|Lack of Efficacy|0|||
131910258|NCT01884597|474958778|FG000|Overall Study|Death|0|||
131401426|NCT01463696|473091509|FG007|Overall Study|Adverse Event|2|||
131401427|NCT01463696|473091502|FG000|Overall Study|Lost to Follow-up|0|||
131401428|NCT01463696|473091503|FG001|Overall Study|Lost to Follow-up|0|||
131401429|NCT01463696|473091504|FG002|Overall Study|Lost to Follow-up|1|||
131401430|NCT01463696|473091505|FG003|Overall Study|Lost to Follow-up|0|||
131401431|NCT01463696|473091506|FG004|Overall Study|Lost to Follow-up|0|||
131401432|NCT01463696|473091507|FG005|Overall Study|Lost to Follow-up|0|||
131401433|NCT01463696|473091508|FG006|Overall Study|Lost to Follow-up|0|||
131401434|NCT01463696|473091509|FG007|Overall Study|Lost to Follow-up|0|||
131401435|NCT01463696|473091502|FG000|Overall Study|Progressive Disease|0|||
131401436|NCT01463696|473091503|FG001|Overall Study|Progressive Disease|1|||
131828127|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828128|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828129|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828130|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
131828131|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
131828132|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828133|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828134|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828135|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828136|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828137|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828138|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828139|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
131828140|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
131828141|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828142|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828143|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828144|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828145|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828146|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828147|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828148|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131828149|NCT00739973|474651950|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
131828150|NCT00739973|474651951|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828151|NCT00739973|474651952|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828152|NCT00739973|474651953|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828153|NCT00739973|474651954|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828154|NCT00739973|474651955|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828155|NCT00739973|474651956|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828156|NCT00739973|474651957|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828157|NCT00739973|474651958|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
131828158|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
131401437|NCT01463696|473091504|FG002|Overall Study|Progressive Disease|0|||
131401438|NCT01463696|473091505|FG003|Overall Study|Progressive Disease|1|||
131401439|NCT01463696|473091506|FG004|Overall Study|Progressive Disease|0|||
131401440|NCT01463696|473091507|FG005|Overall Study|Progressive Disease|1|||
131401441|NCT01463696|473091508|FG006|Overall Study|Progressive Disease|4|||
131401442|NCT01463696|473091509|FG007|Overall Study|Progressive Disease|2|||
131401443|NCT01463696|473091502|FG000|Overall Study|Withdrawal by Subject|0|||
131401444|NCT01463696|473091503|FG001|Overall Study|Withdrawal by Subject|0|||
131401445|NCT01463696|473091504|FG002|Overall Study|Withdrawal by Subject|0|||
131401446|NCT01463696|473091505|FG003|Overall Study|Withdrawal by Subject|1|||
131401447|NCT01463696|473091506|FG004|Overall Study|Withdrawal by Subject|1|||
131401448|NCT01463696|473091507|FG005|Overall Study|Withdrawal by Subject|1|||
131401449|NCT01463696|473091508|FG006|Overall Study|Withdrawal by Subject|2|||
131401450|NCT01463696|473091509|FG007|Overall Study|Withdrawal by Subject|0|||
131401451|NCT01463696|473091502|FG000|Overall Study|Not Treated|0|||
131401452|NCT01463696|473091503|FG001|Overall Study|Not Treated|0|||
131401453|NCT01463696|473091504|FG002|Overall Study|Not Treated|0|||
131401454|NCT01463696|473091505|FG003|Overall Study|Not Treated|0|||
131401455|NCT01463696|473091506|FG004|Overall Study|Not Treated|0|||
131401456|NCT01463696|473091507|FG005|Overall Study|Not Treated|0|||
131401457|NCT01463696|473091508|FG006|Overall Study|Not Treated|1|||
131401458|NCT01463696|473091509|FG007|Overall Study|Not Treated|0|||
131401459|NCT03883165|473091512|FG000|Overall Study|Withdrawal by Subject|4|||
131401460|NCT03883165|473091513|FG001|Overall Study|Withdrawal by Subject|3|||
131401461|NCT00152477|473091519|FG000|Chemotherapy Period|Adverse Event|9|||
131401462|NCT00152477|473091520|FG001|Chemotherapy Period|Adverse Event|4|||
131401463|NCT00152477|473091521|FG002|Chemotherapy Period|Adverse Event|5|||
131401464|NCT00152477|473091519|FG000|Chemotherapy Period|Death|1|||
131401465|NCT00152477|473091520|FG001|Chemotherapy Period|Death|3|||
131401466|NCT00152477|473091521|FG002|Chemotherapy Period|Death|3|||
131401467|NCT00152477|473091519|FG000|Chemotherapy Period|Lack of Efficacy|4|||
131401468|NCT00152477|473091520|FG001|Chemotherapy Period|Lack of Efficacy|5|||
131401469|NCT00152477|473091521|FG002|Chemotherapy Period|Lack of Efficacy|6|||
131828159|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
131828160|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
131828161|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
131828162|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
131401470|NCT00152477|473091519|FG000|Chemotherapy Period|Lost to Follow-up|1|||
131401471|NCT00152477|473091520|FG001|Chemotherapy Period|Lost to Follow-up|0|||
131401472|NCT00152477|473091521|FG002|Chemotherapy Period|Lost to Follow-up|1|||
131401473|NCT00152477|473091519|FG000|Chemotherapy Period|Protocol Violation|1|||
131401474|NCT00152477|473091520|FG001|Chemotherapy Period|Protocol Violation|1|||
131401475|NCT00152477|473091521|FG002|Chemotherapy Period|Protocol Violation|0|||
131401476|NCT00152477|473091519|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
131401477|NCT00152477|473091520|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
131828163|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
131828164|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
131828165|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
131828166|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
131828167|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828168|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828169|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828170|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828171|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
131828172|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828173|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828174|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
131828175|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
131828176|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
131828177|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
131828178|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828179|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828180|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828181|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828182|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828183|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828184|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
131828185|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
131828186|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
131828187|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
131828188|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
131828189|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
131828190|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
131828191|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
131828192|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
131828193|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
131828194|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828195|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828196|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
131828197|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828198|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131401478|NCT00152477|473091521|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
131401479|NCT00152477|473091519|FG000|Chemotherapy Period|Progression of Disease|6|||
131401480|NCT00152477|473091520|FG001|Chemotherapy Period|Progression of Disease|8|||
131768738|NCT01519700|474431835|FG003|Overall Study|Other Reason|4|||
131768739|NCT02079077|474431836|FG000|Overall Study|Lost to Follow-up|5|||
131768740|NCT02079077|474431837|FG001|Overall Study|Lost to Follow-up|7|||
131768741|NCT02079077|474431836|FG000|Overall Study|Became STIs Positive|1|||
131768742|NCT02079077|474431837|FG001|Overall Study|Became STIs Positive|2|||
131768743|NCT00772031|474431838|FG000|Overall Study|Early termination of trial|12|||
131768744|NCT00772031|474431839|FG001|Overall Study|Early termination of trial|10|||
131768745|NCT00772031|474431838|FG000|Overall Study|Lost to Follow-up|20|||
131768746|NCT00772031|474431839|FG001|Overall Study|Lost to Follow-up|33|||
131768747|NCT00656136|474431840|FG000|Overall Study|Progressive disease|177|||
131768748|NCT00656136|474431841|FG001|Overall Study|Progressive disease|322|||
131768749|NCT00656136|474431840|FG000|Overall Study|Other Adverse Event|5|||
131768750|NCT00656136|474431841|FG001|Overall Study|Other Adverse Event|51|||
131768751|NCT00656136|474431840|FG000|Overall Study|Protocol Violation|2|||
131768752|NCT00656136|474431841|FG001|Overall Study|Protocol Violation|3|||
131768753|NCT00656136|474431840|FG000|Overall Study|Patient refused to take study medication|7|||
131768754|NCT00656136|474431841|FG001|Overall Study|Patient refused to take study medication|10|||
131768755|NCT00656136|474431840|FG000|Overall Study|Unknown and others|4|||
131828199|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828200|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828201|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828202|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
131828203|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
131828204|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
131828205|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
131828206|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
131828207|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
131828208|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
131828209|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
131828210|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
131828211|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
131828212|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
131828213|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
131828214|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
131828215|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
131828216|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
131828217|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
131828218|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
131828219|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
131910259|NCT01884597|474958779|FG001|Overall Study|Death|1|||
131828220|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
131828221|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828222|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828223|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828224|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828225|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828226|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828227|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
131828228|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828229|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
131828230|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
131828231|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
131828232|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
131828233|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
131828234|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
131828235|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
131828236|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
131828237|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
131828238|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
131828239|NCT00739973|474651950|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828240|NCT00739973|474651951|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
131828241|NCT00739973|474651952|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828242|NCT00739973|474651953|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828243|NCT00739973|474651954|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828244|NCT00739973|474651955|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828245|NCT00739973|474651956|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
131828246|NCT00739973|474651957|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828247|NCT00739973|474651958|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
131828248|NCT03078478|474651959|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
131828249|NCT03078478|474651960|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
131828250|NCT03078478|474651959|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
131828251|NCT03078478|474651960|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
131828252|NCT03078478|474651959|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
131828253|NCT03078478|474651960|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
131828254|NCT03078478|474651959|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
131828255|NCT03078478|474651960|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
131910260|NCT01884597|474958780|FG002|Overall Study|Death|0|||
131910261|NCT02097823|474958781|FG000|Overall Study|Withdrawal by Subject|1|||
131910262|NCT02097823|474958782|FG001|Overall Study|Withdrawal by Subject|1|||
131910263|NCT02273167|474958784|FG000|Overall Study|Adverse Event|1|||
131828256|NCT03078478|474651959|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
131828257|NCT03078478|474651960|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
131828258|NCT03078478|474651959|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
131828259|NCT03078478|474651960|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
131828260|NCT03078478|474651959|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
131828261|NCT03078478|474651960|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
131828262|NCT03078478|474651959|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
131828263|NCT03078478|474651960|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
131828264|NCT02339090|474651962|FG000|Overall Study|Adverse Event|1|||
131828265|NCT02339090|474651963|FG001|Overall Study|Adverse Event|0|||
131828266|NCT02339090|474651962|FG000|Overall Study|Lost to Follow-up|0|||
131828267|NCT02339090|474651963|FG001|Overall Study|Lost to Follow-up|1|||
131828268|NCT02339090|474651962|FG000|Overall Study|Non-compliance With Study Drug|0|||
131828269|NCT02339090|474651963|FG001|Overall Study|Non-compliance With Study Drug|1|||
131828270|NCT02339090|474651962|FG000|Overall Study|Withdrawal by Subject|2|||
131828271|NCT02339090|474651963|FG001|Overall Study|Withdrawal by Subject|1|||
131828272|NCT02339090|474651962|FG000|Overall Study|Poor Growth|3|||
131828273|NCT02339090|474651963|FG001|Overall Study|Poor Growth|0|||
131828274|NCT02339090|474651962|FG000|Overall Study|Randomized but not treated|0|||
131828275|NCT02339090|474651963|FG001|Overall Study|Randomized but not treated|2|||
131828276|NCT02737592|474651966|FG000|Overall Study|Withdrawal by Subject|1|||
131828277|NCT00248170|474651967|FG000|Overall Study|Withdrawal by Subject|71|||
131828278|NCT00248170|474651968|FG001|Overall Study|Withdrawal by Subject|79|||
131828279|NCT00248170|474651967|FG000|Overall Study|Protocol Violation|35|||
131828280|NCT00248170|474651968|FG001|Overall Study|Protocol Violation|30|||
131828281|NCT00248170|474651967|FG000|Overall Study|Lost to Follow-up|28|||
131828282|NCT00248170|474651968|FG001|Overall Study|Lost to Follow-up|35|||
131828283|NCT00248170|474651967|FG000|Overall Study|Disease progression|196|||
131401481|NCT00152477|473091521|FG002|Chemotherapy Period|Progression of Disease|4|||
131401482|NCT00152477|473091519|FG000|Chemotherapy Period|Investigator decision|0|||
131401483|NCT00152477|473091520|FG001|Chemotherapy Period|Investigator decision|0|||
131828284|NCT00248170|474651968|FG001|Overall Study|Disease progression|216|||
131828285|NCT00248170|474651967|FG000|Overall Study|Death|28|||
131828286|NCT00248170|474651968|FG001|Overall Study|Death|47|||
131828287|NCT00248170|474651967|FG000|Overall Study|Adverse Event|311|||
131828288|NCT00248170|474651968|FG001|Overall Study|Adverse Event|296|||
131828289|NCT00248170|474651967|FG000|Overall Study|Administrative problems|22|||
131828290|NCT00248170|474651968|FG001|Overall Study|Administrative problems|25|||
131828291|NCT00248170|474651967|FG000|Overall Study|Abnormal test procedure(s) result|49|||
131828292|NCT00248170|474651968|FG001|Overall Study|Abnormal test procedure(s) result|61|||
131828293|NCT00248170|474651967|FG000|Overall Study|Abnormal laboratory values|4|||
131828294|NCT00248170|474651968|FG001|Overall Study|Abnormal laboratory values|0|||
131828295|NCT00248170|474651967|FG000|Overall Study|Protocol deviation|17|||
131828296|NCT00248170|474651968|FG001|Overall Study|Protocol deviation|19|||
131828297|NCT01253317|474651982|FG000|Overall Study|Adverse Event|2|||
131828298|NCT01619579|474654007|FG000|Overall Study|Withdrawal by Subject|0|||
131828299|NCT01619579|474654008|FG001|Overall Study|Withdrawal by Subject|3|||
131828300|NCT02012452|474654012|FG000|Overall Study|Lost to Follow-up|2|||
131828301|NCT02012452|474654013|FG001|Overall Study|Lost to Follow-up|1|||
131828302|NCT02012452|474654012|FG000|Overall Study|Withdrawal by Subject|4|||
131828303|NCT02012452|474654013|FG001|Overall Study|Withdrawal by Subject|0|||
131828304|NCT02688387|474654014|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828305|NCT02688387|474654015|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828306|NCT02688387|474654016|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
131828307|NCT02688387|474654017|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828308|NCT02688387|474654018|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828309|NCT02688387|474654019|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828310|NCT02688387|474654020|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828311|NCT02688387|474654021|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828312|NCT02688387|474654022|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828313|NCT02688387|474654023|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828314|NCT02688387|474654024|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828315|NCT02688387|474654025|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828316|NCT02688387|474654026|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131401484|NCT00152477|473091521|FG002|Chemotherapy Period|Investigator decision|1|||
131401485|NCT00152477|473091519|FG000|Chemotherapy Period|Patient condition worsened|1|||
131828317|NCT02688387|474654027|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828318|NCT02688387|474654028|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828319|NCT02688387|474654029|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828320|NCT02688387|474654030|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828321|NCT02688387|474654031|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828322|NCT02688387|474654032|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828323|NCT02688387|474654033|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828324|NCT02688387|474654034|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828325|NCT02688387|474654035|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131828326|NCT02688387|474654014|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828327|NCT02688387|474654015|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828328|NCT02688387|474654016|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828329|NCT02688387|474654017|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
131828330|NCT02688387|474654018|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828331|NCT02688387|474654019|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828332|NCT02688387|474654020|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828333|NCT02688387|474654021|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828334|NCT02688387|474654022|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828335|NCT02688387|474654023|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828336|NCT02688387|474654024|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828337|NCT02688387|474654025|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828338|NCT02688387|474654026|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828339|NCT02688387|474654027|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828340|NCT02688387|474654028|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828341|NCT02688387|474654029|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828342|NCT02688387|474654030|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828343|NCT02688387|474654031|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828344|NCT02688387|474654032|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828345|NCT02688387|474654033|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828346|NCT02688387|474654034|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828347|NCT02688387|474654035|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828348|NCT02688387|474654014|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828349|NCT02688387|474654015|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
131828350|NCT02688387|474654016|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828351|NCT02688387|474654017|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828352|NCT02688387|474654018|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828353|NCT02688387|474654019|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828354|NCT02688387|474654020|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828355|NCT02688387|474654021|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828356|NCT02688387|474654022|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828357|NCT02688387|474654023|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828358|NCT02688387|474654024|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828359|NCT02688387|474654025|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828360|NCT02688387|474654026|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828361|NCT02688387|474654027|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828362|NCT02688387|474654028|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828363|NCT02688387|474654029|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828364|NCT02688387|474654030|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828365|NCT02688387|474654031|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828366|NCT02688387|474654032|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828367|NCT02688387|474654033|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828368|NCT02688387|474654034|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828369|NCT02688387|474654035|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
131828370|NCT02688387|474654014|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828371|NCT02688387|474654015|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828372|NCT02688387|474654016|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
131828373|NCT02688387|474654017|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828374|NCT02688387|474654018|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
131828375|NCT02688387|474654019|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828376|NCT02688387|474654020|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828377|NCT02688387|474654021|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828378|NCT02688387|474654022|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828379|NCT02688387|474654023|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828380|NCT02688387|474654024|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828381|NCT02688387|474654025|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828382|NCT02688387|474654026|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828383|NCT02688387|474654027|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828384|NCT02688387|474654028|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131910264|NCT02273167|474958785|FG001|Overall Study|Adverse Event|0|||
131401486|NCT00152477|473091520|FG001|Chemotherapy Period|Patient condition worsened|0|||
131401487|NCT00152477|473091521|FG002|Chemotherapy Period|Patient condition worsened|0|||
131401488|NCT00152477|473091519|FG000|Monotherapy Period|Adverse Event|1|||
131401489|NCT00152477|473091520|FG001|Monotherapy Period|Adverse Event|0|||
131401490|NCT00152477|473091521|FG002|Monotherapy Period|Adverse Event|5|||
131401491|NCT00152477|473091519|FG000|Monotherapy Period|Death|2|||
131401492|NCT00152477|473091520|FG001|Monotherapy Period|Death|0|||
131401493|NCT00152477|473091521|FG002|Monotherapy Period|Death|1|||
131401494|NCT00152477|473091519|FG000|Monotherapy Period|Lack of Efficacy|7|||
131401495|NCT00152477|473091520|FG001|Monotherapy Period|Lack of Efficacy|16|||
131401496|NCT00152477|473091521|FG002|Monotherapy Period|Lack of Efficacy|10|||
131828385|NCT02688387|474654029|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828386|NCT02688387|474654030|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828387|NCT02688387|474654031|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828388|NCT02688387|474654032|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828389|NCT02688387|474654033|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828390|NCT02688387|474654034|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828391|NCT02688387|474654035|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
131828392|NCT02688387|474654014|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
131828393|NCT02688387|474654015|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828394|NCT02688387|474654016|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828395|NCT02688387|474654017|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828396|NCT02688387|474654018|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131910265|NCT02273167|474958786|FG002|Overall Study|Adverse Event|0|||
131401497|NCT00152477|473091519|FG000|Monotherapy Period|Protocol Violation|0|||
131401498|NCT00152477|473091520|FG001|Monotherapy Period|Protocol Violation|1|||
131401499|NCT00152477|473091521|FG002|Monotherapy Period|Protocol Violation|0|||
131401500|NCT00152477|473091519|FG000|Monotherapy Period|Withdrawal by Subject|0|||
131401501|NCT00152477|473091520|FG001|Monotherapy Period|Withdrawal by Subject|0|||
131768756|NCT00656136|474431841|FG001|Overall Study|Unknown and others|4|||
131768757|NCT02406586|474431842|FG000|Overall Study|Lost to Follow-up|0|||
131768758|NCT02406586|474431843|FG001|Overall Study|Lost to Follow-up|4|||
131768759|NCT02406586|474431844|FG002|Overall Study|Lost to Follow-up|2|||
131768760|NCT02406586|474431842|FG000|Overall Study|Withdrawal by Subject|1|||
131768761|NCT02406586|474431843|FG001|Overall Study|Withdrawal by Subject|0|||
131768762|NCT02406586|474431844|FG002|Overall Study|Withdrawal by Subject|0|||
131768763|NCT00682539|474431845|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
131768764|NCT00682539|474431846|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
131768765|NCT00682539|474431847|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
131768766|NCT00682539|474431845|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
131768767|NCT00682539|474431846|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
131768768|NCT00682539|474431847|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
131768769|NCT03339999|474431850|FG000|Overall Study|Adverse Event|1|||
131768770|NCT03339999|474431851|FG001|Overall Study|Adverse Event|2|||
131768771|NCT03339999|474431852|FG002|Overall Study|Adverse Event|2|||
131768772|NCT03339999|474431853|FG003|Overall Study|Adverse Event|1|||
131768773|NCT03339999|474431850|FG000|Overall Study|Lack of Efficacy|0|||
131768774|NCT03339999|474431851|FG001|Overall Study|Lack of Efficacy|1|||
131768775|NCT03339999|474431852|FG002|Overall Study|Lack of Efficacy|0|||
131768776|NCT03339999|474431853|FG003|Overall Study|Lack of Efficacy|0|||
131768777|NCT03339999|474431850|FG000|Overall Study|Lost to Follow-up|0|||
131768778|NCT03339999|474431851|FG001|Overall Study|Lost to Follow-up|0|||
131768779|NCT03339999|474431852|FG002|Overall Study|Lost to Follow-up|0|||
131768780|NCT03339999|474431853|FG003|Overall Study|Lost to Follow-up|1|||
131768781|NCT03339999|474431850|FG000|Overall Study|Study Terminated by Sponsor|6|||
131768782|NCT03339999|474431851|FG001|Overall Study|Study Terminated by Sponsor|3|||
131768783|NCT03339999|474431852|FG002|Overall Study|Study Terminated by Sponsor|4|||
131768784|NCT03339999|474431853|FG003|Overall Study|Study Terminated by Sponsor|3|||
131768785|NCT00779142|474431866|FG000|Overall Study|Screen Failures|3|||
131768786|NCT04738123|474431868|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
131768787|NCT04738123|474431869|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
131768788|NCT04738123|474431868|FG000|Overall Study|Progressive Disease|0|||
131768789|NCT04738123|474431869|FG001|Overall Study|Progressive Disease|4|||
131768790|NCT04738123|474431868|FG000|Overall Study|Adverse Event|8|||
131768791|NCT04738123|474431869|FG001|Overall Study|Adverse Event|7|||
131768792|NCT04738123|474431868|FG000|Overall Study|Other Reasons|0|||
131768793|NCT04738123|474431869|FG001|Overall Study|Other Reasons|1|||
131768794|NCT04738123|474431868|FG000|Overall Study|Suicidal or assaultive behavior|0|||
131768795|NCT04738123|474431869|FG001|Overall Study|Suicidal or assaultive behavior|2|||
131768796|NCT04738123|474431868|FG000|Overall Study|Protocol Violation|2|||
131768797|NCT04738123|474431869|FG001|Overall Study|Protocol Violation|2|||
131768798|NCT04738123|474431868|FG000|Overall Study|Consent Withdrawn|35|||
131401502|NCT00152477|473091521|FG002|Monotherapy Period|Withdrawal by Subject|4|||
131401503|NCT00152477|473091519|FG000|Monotherapy Period|Progression of Disease|5|||
131828397|NCT02688387|474654019|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828398|NCT02688387|474654020|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828399|NCT02688387|474654021|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828400|NCT02688387|474654022|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828401|NCT02688387|474654023|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828402|NCT02688387|474654024|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828403|NCT02688387|474654025|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828404|NCT02688387|474654026|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828405|NCT02688387|474654027|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828406|NCT02688387|474654028|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828407|NCT02688387|474654029|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828408|NCT02688387|474654030|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828409|NCT02688387|474654031|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828410|NCT02688387|474654032|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828411|NCT02688387|474654033|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828412|NCT02688387|474654034|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828413|NCT02688387|474654035|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
131828414|NCT02688387|474654014|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828415|NCT02688387|474654015|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828416|NCT02688387|474654016|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828417|NCT02688387|474654017|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828418|NCT02688387|474654018|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828419|NCT02688387|474654019|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828420|NCT02688387|474654020|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828421|NCT02688387|474654021|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828422|NCT02688387|474654022|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828423|NCT02688387|474654023|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828424|NCT02688387|474654024|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
131828425|NCT02688387|474654025|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828426|NCT02688387|474654026|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828427|NCT02688387|474654027|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828428|NCT02688387|474654028|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828429|NCT02688387|474654029|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828430|NCT02688387|474654030|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828431|NCT02688387|474654031|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828432|NCT02688387|474654032|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828433|NCT02688387|474654033|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828434|NCT02688387|474654034|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828435|NCT02688387|474654035|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
131828436|NCT02688387|474654014|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828437|NCT02688387|474654015|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828438|NCT02688387|474654016|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828439|NCT02688387|474654017|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828440|NCT02688387|474654018|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828441|NCT02688387|474654019|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828442|NCT02688387|474654020|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828443|NCT02688387|474654021|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828444|NCT02688387|474654022|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828445|NCT02688387|474654023|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828446|NCT02688387|474654024|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828447|NCT02688387|474654025|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828448|NCT02688387|474654026|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828449|NCT02688387|474654027|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828450|NCT02688387|474654028|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
131828451|NCT02688387|474654029|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828452|NCT02688387|474654030|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828453|NCT02688387|474654031|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131401504|NCT00152477|473091520|FG001|Monotherapy Period|Progression of Disease|11|||
131828454|NCT02688387|474654032|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828455|NCT02688387|474654033|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131401505|NCT00152477|473091521|FG002|Monotherapy Period|Progression of Disease|12|||
131828456|NCT02688387|474654034|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828457|NCT02688387|474654035|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
131828458|NCT02688387|474654014|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828459|NCT02688387|474654015|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131910266|NCT02273167|474958784|FG000|Overall Study|Protocol Violation|3|||
131828460|NCT02688387|474654016|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828461|NCT02688387|474654017|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828462|NCT02688387|474654018|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828463|NCT02688387|474654019|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828464|NCT02688387|474654020|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828465|NCT02688387|474654021|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828466|NCT02688387|474654022|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828467|NCT02688387|474654023|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828468|NCT02688387|474654024|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828469|NCT02688387|474654025|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828470|NCT02688387|474654026|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828471|NCT02688387|474654027|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828472|NCT02688387|474654028|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828473|NCT02688387|474654029|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828474|NCT02688387|474654030|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828475|NCT02688387|474654031|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828476|NCT02688387|474654032|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828477|NCT02688387|474654033|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828478|NCT02688387|474654034|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
131828479|NCT02688387|474654035|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
131828480|NCT02688387|474654014|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828481|NCT02688387|474654015|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828482|NCT02688387|474654016|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828483|NCT02688387|474654017|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828484|NCT02688387|474654018|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828485|NCT02688387|474654019|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828486|NCT02688387|474654020|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828487|NCT02688387|474654021|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828488|NCT02688387|474654022|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828489|NCT02688387|474654023|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828490|NCT02688387|474654024|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828491|NCT02688387|474654025|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828492|NCT02688387|474654026|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828493|NCT02688387|474654027|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828494|NCT02688387|474654028|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828495|NCT02688387|474654029|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828496|NCT02688387|474654030|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828497|NCT02688387|474654031|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828498|NCT02688387|474654032|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
131828499|NCT02688387|474654033|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828500|NCT02688387|474654034|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
131828501|NCT02688387|474654035|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
131828502|NCT02688387|474654014|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828503|NCT02688387|474654015|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828504|NCT02688387|474654016|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828505|NCT02688387|474654017|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828506|NCT02688387|474654018|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828507|NCT02688387|474654019|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828508|NCT02688387|474654020|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828509|NCT02688387|474654021|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828510|NCT02688387|474654022|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828511|NCT02688387|474654023|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828512|NCT02688387|474654024|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828513|NCT02688387|474654025|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828514|NCT02688387|474654026|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828515|NCT02688387|474654027|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828516|NCT02688387|474654028|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828517|NCT02688387|474654029|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828518|NCT02688387|474654030|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828519|NCT02688387|474654031|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828520|NCT02688387|474654032|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828521|NCT02688387|474654033|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
131828522|NCT02688387|474654034|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828523|NCT02688387|474654035|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
131828524|NCT00802178|474654038|FG000|Overall Study|Lack of Efficacy|36|||
131828525|NCT00802178|474654038|FG000|Overall Study|Insufficient tolerability (IT)|17|||
131910267|NCT02273167|474958785|FG001|Overall Study|Protocol Violation|1|||
131828526|NCT00802178|474654038|FG000|Overall Study|Withdrawal by Subject|18|||
131828527|NCT00802178|474654038|FG000|Overall Study|Other|32|||
131828528|NCT00802178|474654038|FG000|Overall Study|Lack of efficacy and patient wish|1|||
131828529|NCT00802178|474654038|FG000|Overall Study|IT and patient wish|8|||
131828530|NCT00802178|474654038|FG000|Overall Study|Patients wish and other reason|1|||
131828531|NCT00804141|474654039|FG000|Overall Study|Adverse Event|157|||
131828532|NCT00804141|474654039|FG000|Overall Study|Death|4|||
131910268|NCT02273167|474958786|FG002|Overall Study|Protocol Violation|1|||
131910269|NCT02273167|474958784|FG000|Overall Study|Lost to Follow-up|0|||
131910270|NCT02273167|474958785|FG001|Overall Study|Lost to Follow-up|1|||
131910271|NCT02273167|474958786|FG002|Overall Study|Lost to Follow-up|1|||
131910272|NCT02273167|474958784|FG000|Overall Study|Withdrawal by Subject|10|||
131910273|NCT02273167|474958785|FG001|Overall Study|Withdrawal by Subject|12|||
131910274|NCT02273167|474958786|FG002|Overall Study|Withdrawal by Subject|11|||
131910275|NCT02273167|474958784|FG000|Overall Study|Various|10|||
131910276|NCT02273167|474958785|FG001|Overall Study|Various|9|||
131910277|NCT02273167|474958786|FG002|Overall Study|Various|8|||
131910278|NCT03082729|474958787|FG000|Overall Study|Lost to Follow-up|7|||
131401506|NCT00152477|473091519|FG000|Monotherapy Period|Patient decision|0|||
131401507|NCT00152477|473091520|FG001|Monotherapy Period|Patient decision|1|||
131401508|NCT00152477|473091521|FG002|Monotherapy Period|Patient decision|1|||
131910279|NCT03082729|474958787|FG000|Overall Study|Physician Decision|2|||
131910280|NCT03082729|474958787|FG000|Overall Study|Withdrawal by Subject|1|||
131910281|NCT03082729|474958787|FG000|Overall Study|Lack of Efficacy|9|||
131910282|NCT03082729|474958787|FG000|Overall Study|Adverse Event|4|||
131910283|NCT03082729|474958787|FG000|Overall Study|Protocol Violation|6|||
131910284|NCT03082729|474958787|FG000|Overall Study|Fear of study procedure|1|||
131910285|NCT03082729|474958787|FG000|Overall Study|Scheduling conflict|1|||
131910286|NCT03321721|474958788|FG000|Overall Study|Lost to Follow-up|4|||
131910287|NCT03321721|474958789|FG001|Overall Study|Lost to Follow-up|8|||
131910288|NCT03321721|474958790|FG002|Overall Study|Lost to Follow-up|11|||
131910289|NCT01416571|474958791|FG000|Overall Study|Lost to Follow-up|2|||
131910290|NCT03353220|474958792|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
131910291|NCT03353220|474958793|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
131910292|NCT01648764|474960721|FG000|Overall Study|Progressive Disease|0|||
131910293|NCT01648764|474960722|FG001|Overall Study|Progressive Disease|1|||
131910294|NCT01648764|474960723|FG002|Overall Study|Progressive Disease|0|||
131910295|NCT01648764|474960724|FG003|Overall Study|Progressive Disease|0|||
131401509|NCT00152477|473091519|FG000|Monotherapy Period|Study personel decision|0|||
131401510|NCT00152477|473091520|FG001|Monotherapy Period|Study personel decision|0|||
131828533|NCT00804141|474654039|FG000|Overall Study|Failed to return|96|||
131828534|NCT00804141|474654039|FG000|Overall Study|Investigator request|8|||
131828535|NCT00804141|474654039|FG000|Overall Study|Protocol Violation|85|||
131828536|NCT00804141|474654039|FG000|Overall Study|Withdrawal by Subject|131|||
131828537|NCT00804141|474654039|FG000|Overall Study|Lack of Efficacy|46|||
131828538|NCT00804141|474654039|FG000|Overall Study|Other than specified|30|||
131828539|NCT00804141|474654039|FG000|Overall Study|Enrolled but not treated|6|||
131828540|NCT00572039|474654040|FG000|Overall Study|Withdrawal by Subject|9|||
131828541|NCT00572039|474654041|FG001|Overall Study|Withdrawal by Subject|6|||
131828542|NCT00572039|474654040|FG000|Overall Study|Death|2|||
131828543|NCT00572039|474654041|FG001|Overall Study|Death|3|||
131828544|NCT00572039|474654040|FG000|Overall Study|Ill|5|||
131828545|NCT00572039|474654041|FG001|Overall Study|Ill|1|||
131828546|NCT02973321|474654044|FG000|Overall Study|Other than specified|0|||
131828547|NCT02973321|474654045|FG001|Overall Study|Other than specified|5|||
131828548|NCT02973321|474654046|FG002|Overall Study|Other than specified|3|||
131828549|NCT02973321|474654047|FG003|Overall Study|Other than specified|3|||
131828550|NCT02973321|474654048|FG004|Overall Study|Other than specified|1|||
131828551|NCT02973321|474654044|FG000|Overall Study|Lack of Efficacy|0|||
131828552|NCT02973321|474654045|FG001|Overall Study|Lack of Efficacy|0|||
131828553|NCT02973321|474654046|FG002|Overall Study|Lack of Efficacy|0|||
131828554|NCT02973321|474654047|FG003|Overall Study|Lack of Efficacy|0|||
131828555|NCT02973321|474654048|FG004|Overall Study|Lack of Efficacy|1|||
131828556|NCT02973321|474654044|FG000|Overall Study|Adverse Event|1|||
131828557|NCT02973321|474654045|FG001|Overall Study|Adverse Event|10|||
131828558|NCT02973321|474654046|FG002|Overall Study|Adverse Event|11|||
131828559|NCT02973321|474654047|FG003|Overall Study|Adverse Event|13|||
131828560|NCT02973321|474654048|FG004|Overall Study|Adverse Event|3|||
131828561|NCT01011556|474654055|FG000|Overall Study|Adverse Event|1|||
131828562|NCT01011556|474654056|FG001|Overall Study|Adverse Event|3|||
131828563|NCT01011556|474654057|FG002|Overall Study|Adverse Event|2|||
131828564|NCT01011556|474654058|FG003|Overall Study|Adverse Event|1|||
131828565|NCT01011556|474654055|FG000|Overall Study|Lost to Follow-up|1|||
131828566|NCT01011556|474654056|FG001|Overall Study|Lost to Follow-up|0|||
131828567|NCT01011556|474654057|FG002|Overall Study|Lost to Follow-up|0|||
131828568|NCT01011556|474654058|FG003|Overall Study|Lost to Follow-up|0|||
131828569|NCT01011556|474654055|FG000|Overall Study|Physician Decision|1|||
131828570|NCT01011556|474654056|FG001|Overall Study|Physician Decision|0|||
131828571|NCT01011556|474654057|FG002|Overall Study|Physician Decision|0|||
131828572|NCT01011556|474654058|FG003|Overall Study|Physician Decision|1|||
131828573|NCT01011556|474654055|FG000|Overall Study|Protocol Violation|0|||
131828574|NCT01011556|474654056|FG001|Overall Study|Protocol Violation|1|||
131828575|NCT01011556|474654057|FG002|Overall Study|Protocol Violation|0|||
131828576|NCT01011556|474654058|FG003|Overall Study|Protocol Violation|0|||
131828577|NCT01011556|474654055|FG000|Overall Study|Withdrawal by Subject|1|||
131828578|NCT01011556|474654056|FG001|Overall Study|Withdrawal by Subject|2|||
131828579|NCT01011556|474654057|FG002|Overall Study|Withdrawal by Subject|4|||
131828580|NCT01011556|474654058|FG003|Overall Study|Withdrawal by Subject|4|||
131828581|NCT01011556|474654055|FG000|Overall Study|Sponsor decision|0|||
131828582|NCT01011556|474654056|FG001|Overall Study|Sponsor decision|1|||
131828583|NCT01011556|474654057|FG002|Overall Study|Sponsor decision|1|||
131828584|NCT01011556|474654058|FG003|Overall Study|Sponsor decision|2|||
131828585|NCT01011556|474654055|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
131828586|NCT01011556|474654056|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
131828587|NCT01011556|474654057|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
131828588|NCT01011556|474654058|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
131828589|NCT01790113|474654060|FG000|Overall Study|Adverse Event|2|||
131828590|NCT01790113|474654061|FG001|Overall Study|Adverse Event|7|||
131828591|NCT01790113|474654060|FG000|Overall Study|Study ended due to FDA clearance|1|||
131828592|NCT01790113|474654061|FG001|Overall Study|Study ended due to FDA clearance|68|||
131828593|NCT00614822|474654063|FG000|Overall Study|Adverse Event|3|||
131828594|NCT00865514|474654064|FG000|Overall Study|Infusion cost exceeded funding|2|||
131828595|NCT03920280|474654065|FG000|Overall Study|Adverse Event|2|||
131828596|NCT03920280|474654066|FG001|Overall Study|Adverse Event|3|||
131828597|NCT03920280|474654065|FG000|Overall Study|Lost to Follow-up|0|||
131828598|NCT03920280|474654066|FG001|Overall Study|Lost to Follow-up|1|||
131828599|NCT03920280|474654065|FG000|Overall Study|Withdrawal by Subject|1|||
131828600|NCT03920280|474654066|FG001|Overall Study|Withdrawal by Subject|1|||
131828601|NCT03920280|474654065|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
131828602|NCT03920280|474654066|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
131828603|NCT01557920|474654067|FG000|Overall Study|Withdrawal by Subject|2|||
131828604|NCT01557920|474654068|FG001|Overall Study|Withdrawal by Subject|3|||
131828605|NCT01557920|474654067|FG000|Overall Study|Lack of Efficacy|1|||
131828606|NCT01557920|474654068|FG001|Overall Study|Lack of Efficacy|0|||
131828607|NCT01463982|474654069|FG000|Overall Study|Withdrawal by Subject|0|||
131828608|NCT01463982|474654070|FG001|Overall Study|Withdrawal by Subject|1|||
131828609|NCT01463982|474654071|FG002|Overall Study|Withdrawal by Subject|1|||
131828610|NCT01463982|474654072|FG003|Overall Study|Withdrawal by Subject|0|||
131828611|NCT01463982|474654069|FG000|Overall Study|Treatment delay over 5 week|0|||
131828612|NCT01463982|474654070|FG001|Overall Study|Treatment delay over 5 week|0|||
131828613|NCT01463982|474654071|FG002|Overall Study|Treatment delay over 5 week|1|||
131828614|NCT01463982|474654072|FG003|Overall Study|Treatment delay over 5 week|0|||
131828615|NCT00089076|474654073|FG000|Overall Study|Alternate Therapy|1|||
131828616|NCT00089076|474654073|FG000|Overall Study|Withdrawal by Subject|2|||
131828617|NCT00089076|474654073|FG000|Overall Study|Progression|7|||
131828618|NCT02075606|474654076|FG000|Overall Study|Adverse Event|5|||
131828619|NCT02075606|474654076|FG000|Overall Study|Withdrawal by Subject|1|||
131828620|NCT02075606|474654076|FG000|Overall Study|Death|1|||
131828621|NCT02075606|474654076|FG000|Overall Study|Investigator's decision|1|||
131828622|NCT02075606|474654076|FG000|Overall Study|Symptom management|1|||
131828623|NCT02075606|474654076|FG000|Overall Study|Increasing Symptoms|1|||
131828624|NCT02310763|474654081|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
131828625|NCT02310763|474654082|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
131828626|NCT02310763|474654083|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
131828627|NCT02310763|474654081|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
131828628|NCT02310763|474654082|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
131828629|NCT02310763|474654083|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
131828630|NCT02310763|474654081|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
131828631|NCT02310763|474654082|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
131828632|NCT02310763|474654083|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
131828633|NCT02310763|474654081|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
131828634|NCT02310763|474654082|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
131828635|NCT02310763|474654083|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
131828636|NCT02310763|474654081|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
131828637|NCT02310763|474654082|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
131828638|NCT02310763|474654083|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
131828639|NCT00271024|474654089|FG000|Overall Study|Lost Interest|3|||
131828640|NCT00271024|474654090|FG001|Overall Study|Lost Interest|4|||
131828641|NCT00271024|474654091|FG002|Overall Study|Lost Interest|2|||
131828642|NCT00271024|474654092|FG003|Overall Study|Lost Interest|3|||
131828643|NCT00271024|474654089|FG000|Overall Study|Unknown/Unspecified|11|||
131828644|NCT00271024|474654090|FG001|Overall Study|Unknown/Unspecified|11|||
131828645|NCT00271024|474654091|FG002|Overall Study|Unknown/Unspecified|8|||
131828646|NCT00271024|474654092|FG003|Overall Study|Unknown/Unspecified|4|||
131828647|NCT00271024|474654089|FG000|Overall Study|Protocol Violation|1|||
131828648|NCT00271024|474654090|FG001|Overall Study|Protocol Violation|6|||
131828649|NCT00271024|474654091|FG002|Overall Study|Protocol Violation|5|||
131828650|NCT00271024|474654092|FG003|Overall Study|Protocol Violation|11|||
131828651|NCT00271024|474654089|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
131401511|NCT00152477|473091521|FG002|Monotherapy Period|Study personel decision|1|||
131401512|NCT00425698|473091522|FG000|Overall Study|Adverse Event|3|||
131401513|NCT00425698|473091523|FG001|Overall Study|Adverse Event|1|||
131401514|NCT00425698|473091522|FG000|Overall Study|Withdrawal by Subject|0|||
131401515|NCT00425698|473091523|FG001|Overall Study|Withdrawal by Subject|1|||
131401516|NCT03275246|473091530|FG000|Overall Study|Protocol Violation|5|||
131401517|NCT03275246|473091530|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
131768799|NCT04738123|474431869|FG001|Overall Study|Consent Withdrawn|22|||
131401518|NCT02570152|473091533|FG000|Overall Study|Protocol Violation|2|||
131401519|NCT02570152|473091533|FG000|Overall Study|Migrated/moved from study area|13|||
131768800|NCT03982069|474431870|FG000|Overall Study|Lost to Follow-up|5|||
131768801|NCT03982069|474431871|FG001|Overall Study|Lost to Follow-up|5|||
131768802|NCT03982069|474431872|FG002|Overall Study|Lost to Follow-up|3|||
131768803|NCT03982069|474431873|FG003|Overall Study|Lost to Follow-up|5|||
131768804|NCT03982069|474431870|FG000|Overall Study|Physician Decision|0|||
131768805|NCT03982069|474431871|FG001|Overall Study|Physician Decision|1|||
131768806|NCT03982069|474431872|FG002|Overall Study|Physician Decision|0|||
131768807|NCT03982069|474431873|FG003|Overall Study|Physician Decision|0|||
131768808|NCT03982069|474431870|FG000|Overall Study|Withdrawal by Subject|2|||
131768809|NCT03982069|474431871|FG001|Overall Study|Withdrawal by Subject|1|||
131768810|NCT03982069|474431872|FG002|Overall Study|Withdrawal by Subject|5|||
131768811|NCT03982069|474431873|FG003|Overall Study|Withdrawal by Subject|2|||
131768812|NCT03982069|474431870|FG000|Overall Study|Specimen loss|3|||
131768813|NCT03982069|474431871|FG001|Overall Study|Specimen loss|3|||
131768814|NCT03982069|474431872|FG002|Overall Study|Specimen loss|1|||
131768815|NCT03982069|474431873|FG003|Overall Study|Specimen loss|1|||
131768816|NCT00787527|474431874|FG000|Overall Study|Toxicity|3|||
131768817|NCT00265382|474431878|FG000|Overall Study|Adverse Event|21|||
131768818|NCT00265382|474431878|FG000|Overall Study|Laboratory Abnormality|1|||
131768819|NCT00265382|474431878|FG000|Overall Study|Lost to Follow-up|3|||
131768820|NCT00265382|474431878|FG000|Overall Study|Lack of Efficacy|6|||
131768821|NCT00265382|474431878|FG000|Overall Study|Miscellaneous|6|||
131768822|NCT00265382|474431878|FG000|Overall Study|Withdrawal by Subject|13|||
131768823|NCT00265382|474431878|FG000|Overall Study|Study terminated by sponsor|94|||
131768824|NCT00265382|474431878|FG000|Overall Study|Death|1|||
131768825|NCT01474993|474431879|FG000|Overall Study|Lost to Follow-up|1|||
131768826|NCT01474993|474431880|FG001|Overall Study|Lost to Follow-up|2|||
131768827|NCT01474993|474431879|FG000|Overall Study|Adverse Event|0|||
131768828|NCT01474993|474431880|FG001|Overall Study|Adverse Event|1|||
131768829|NCT02242305|474431881|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
131768830|NCT02242305|474431882|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
131768831|NCT02242305|474431881|FG000|Overall Study|Adverse Event|1|||
131768832|NCT02242305|474431882|FG001|Overall Study|Adverse Event|0|||
131768833|NCT02242305|474431881|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
131768834|NCT02242305|474431882|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
131768835|NCT02242305|474431881|FG000|Overall Study|Subject withdraws inform consent|0|||
131768836|NCT02242305|474431882|FG001|Overall Study|Subject withdraws inform consent|4|||
131768837|NCT02242305|474431881|FG000|Overall Study|Lost to Follow-up|2|||
131768838|NCT02242305|474431882|FG001|Overall Study|Lost to Follow-up|0|||
131768839|NCT03451630|474431883|FG000|Overall Study|Death|15|||
131768840|NCT03451630|474431884|FG001|Overall Study|Death|16|||
131768841|NCT03451630|474431885|FG002|Overall Study|Death|11|||
131768842|NCT03451630|474431883|FG000|Overall Study|Lost to Follow-up|9|||
131768843|NCT03451630|474431884|FG001|Overall Study|Lost to Follow-up|0|||
131768844|NCT03451630|474431885|FG002|Overall Study|Lost to Follow-up|4|||
131768845|NCT03451630|474431883|FG000|Overall Study|Withdrawal by Subject|0|||
131768846|NCT03451630|474431884|FG001|Overall Study|Withdrawal by Subject|3|||
131768847|NCT03451630|474431885|FG002|Overall Study|Withdrawal by Subject|0|||
131768848|NCT03451630|474431883|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
131768849|NCT03451630|474431884|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
131768850|NCT03451630|474431885|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
131768851|NCT01724021|474431886|FG000|Overall Study|Adverse Event|11|||
131768852|NCT01724021|474431887|FG001|Overall Study|Adverse Event|6|||
131768853|NCT01724021|474431886|FG000|Overall Study|Death|46|||
131768854|NCT01724021|474431887|FG001|Overall Study|Death|58|||
131768855|NCT01724021|474431886|FG000|Overall Study|Participant request/ Withdrew consent|18|||
131401520|NCT00923975|473091537|FG000|Overall Study|Did not meet inclusion criteria|1|||
131401521|NCT01328535|473091538|FG000|Overall Study|Ineligible|1|||
131401522|NCT01005316|473091541|FG000|Overall Study|Adverse Event|0|||
131401523|NCT01005316|473091542|FG001|Overall Study|Adverse Event|0|||
131401524|NCT01005316|473091543|FG002|Overall Study|Adverse Event|0|||
131401525|NCT01005316|473091544|FG003|Overall Study|Adverse Event|1|||
131401526|NCT01005316|473091541|FG000|Overall Study|Death|20|||
131401527|NCT01005316|473091542|FG001|Overall Study|Death|5|||
131401528|NCT01005316|473091543|FG002|Overall Study|Death|1|||
131401529|NCT01005316|473091544|FG003|Overall Study|Death|15|||
131401530|NCT01005316|473091541|FG000|Overall Study|Study Termination|5|||
131401531|NCT01005316|473091542|FG001|Overall Study|Study Termination|63|||
131401532|NCT01005316|473091543|FG002|Overall Study|Study Termination|9|||
131401533|NCT01005316|473091544|FG003|Overall Study|Study Termination|85|||
131401534|NCT01005316|473091541|FG000|Overall Study|Lost to Follow-up|1|||
131401535|NCT01005316|473091542|FG001|Overall Study|Lost to Follow-up|3|||
131401536|NCT01005316|473091543|FG002|Overall Study|Lost to Follow-up|0|||
131401537|NCT01005316|473091544|FG003|Overall Study|Lost to Follow-up|2|||
131401538|NCT01005316|473091541|FG000|Overall Study|Physician Decision|6|||
131401539|NCT01005316|473091542|FG001|Overall Study|Physician Decision|0|||
131401540|NCT01005316|473091543|FG002|Overall Study|Physician Decision|0|||
131401541|NCT01005316|473091544|FG003|Overall Study|Physician Decision|0|||
131401542|NCT01005316|473091541|FG000|Overall Study|Sponsor Decision|6|||
131401543|NCT01005316|473091542|FG001|Overall Study|Sponsor Decision|3|||
131401544|NCT01005316|473091543|FG002|Overall Study|Sponsor Decision|0|||
131401545|NCT01005316|473091544|FG003|Overall Study|Sponsor Decision|0|||
131401546|NCT01005316|473091541|FG000|Overall Study|Withdrawal by Subject|1|||
131401547|NCT01005316|473091542|FG001|Overall Study|Withdrawal by Subject|1|||
131401548|NCT01005316|473091543|FG002|Overall Study|Withdrawal by Subject|0|||
131401549|NCT01005316|473091544|FG003|Overall Study|Withdrawal by Subject|2|||
131401550|NCT01005316|473091541|FG000|Overall Study|Consented to Another Study|2|||
131401551|NCT01005316|473091542|FG001|Overall Study|Consented to Another Study|0|||
131401552|NCT01005316|473091543|FG002|Overall Study|Consented to Another Study|0|||
131401553|NCT01005316|473091544|FG003|Overall Study|Consented to Another Study|0|||
131401554|NCT01005316|473091541|FG000|Overall Study|Delisted|8|||
131401555|NCT01005316|473091542|FG001|Overall Study|Delisted|0|||
131401556|NCT01005316|473091543|FG002|Overall Study|Delisted|0|||
131401557|NCT01005316|473091544|FG003|Overall Study|Delisted|0|||
131401558|NCT01005316|473091541|FG000|Overall Study|Transferred Care|1|||
131828652|NCT00271024|474654090|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
131828653|NCT00271024|474654091|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
131828654|NCT00271024|474654092|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
131828655|NCT00271024|474654089|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
131828656|NCT00271024|474654090|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
131828657|NCT00271024|474654091|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
131828658|NCT00271024|474654092|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
131828659|NCT00612677|474654097|FG000|Overall Study|study closed before treatment started|1|||
131828660|NCT03139240|474654098|FG000|Overall Study|Lost to Follow-up|0|||
131828661|NCT03139240|474654099|FG001|Overall Study|Lost to Follow-up|1|||
131828662|NCT03139240|474654100|FG002|Overall Study|Lost to Follow-up|1|||
131828663|NCT03139240|474654101|FG003|Overall Study|Lost to Follow-up|0|||
131828664|NCT03417830|474654102|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
131828665|NCT03417830|474654103|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
131828666|NCT00823199|474654104|FG000|Overall Study|Withdrawal by Subject|2|||
131828667|NCT01998243|474654105|FG000|Overall Study|Pregnancy|0|||
131828668|NCT01998243|474654106|FG001|Overall Study|Pregnancy|1|||
131828669|NCT01998243|474654105|FG000|Overall Study|Protocol Violation|5|||
131828670|NCT01998243|474654106|FG001|Overall Study|Protocol Violation|2|||
131828671|NCT01998243|474654105|FG000|Overall Study|Withdrawal by Subject|3|||
131828672|NCT01998243|474654106|FG001|Overall Study|Withdrawal by Subject|4|||
131828673|NCT00268892|474654109|FG000|Overall Study|Adverse Event|14|||
131828674|NCT00268892|474654110|FG001|Overall Study|Adverse Event|17|||
131828675|NCT00268892|474654111|FG002|Overall Study|Adverse Event|20|||
131828676|NCT00268892|474654109|FG000|Overall Study|Lack of Efficacy|1|||
131828677|NCT00268892|474654110|FG001|Overall Study|Lack of Efficacy|3|||
131401559|NCT01005316|473091542|FG001|Overall Study|Transferred Care|0|||
131828678|NCT00268892|474654111|FG002|Overall Study|Lack of Efficacy|0|||
131828679|NCT00268892|474654109|FG000|Overall Study|Withdrawal by Subject|14|||
131828680|NCT00268892|474654110|FG001|Overall Study|Withdrawal by Subject|15|||
131828681|NCT00268892|474654111|FG002|Overall Study|Withdrawal by Subject|13|||
131828682|NCT00268892|474654109|FG000|Overall Study|Physician Decision|0|||
131401560|NCT01005316|473091543|FG002|Overall Study|Transferred Care|1|||
131401561|NCT01005316|473091544|FG003|Overall Study|Transferred Care|3|||
131401562|NCT01005316|473091541|FG000|Overall Study|Retransplanted|0|||
131401563|NCT01005316|473091542|FG001|Overall Study|Retransplanted|1|||
131401564|NCT01005316|473091543|FG002|Overall Study|Retransplanted|0|||
131401565|NCT01005316|473091544|FG003|Overall Study|Retransplanted|0|||
131401566|NCT00960011|473091545|FG000|Overall Study|Death|5|||
131401567|NCT00960011|473091546|FG001|Overall Study|Death|0|||
131828683|NCT00268892|474654110|FG001|Overall Study|Physician Decision|1|||
131828684|NCT00268892|474654111|FG002|Overall Study|Physician Decision|0|||
131828685|NCT00268892|474654109|FG000|Overall Study|Lost to Follow-up|5|||
131828686|NCT00268892|474654110|FG001|Overall Study|Lost to Follow-up|2|||
131828687|NCT00268892|474654111|FG002|Overall Study|Lost to Follow-up|4|||
131828688|NCT00268892|474654109|FG000|Overall Study|Protocol Violation|0|||
131828689|NCT00268892|474654110|FG001|Overall Study|Protocol Violation|1|||
131828690|NCT00268892|474654111|FG002|Overall Study|Protocol Violation|0|||
131828691|NCT00268892|474654109|FG000|Overall Study|Disease Progression|1|||
131828692|NCT00268892|474654110|FG001|Overall Study|Disease Progression|1|||
131828693|NCT00268892|474654111|FG002|Overall Study|Disease Progression|0|||
131828694|NCT00268892|474654109|FG000|Overall Study|Trial Site Closed|4|||
131828695|NCT00268892|474654110|FG001|Overall Study|Trial Site Closed|2|||
131828696|NCT00268892|474654111|FG002|Overall Study|Trial Site Closed|2|||
131828697|NCT04569786|474654112|FG000|Overall Study|Lost to Follow-up|1|||
131828698|NCT04569786|474654113|FG001|Overall Study|Lost to Follow-up|0|||
131828699|NCT04569786|474654114|FG002|Overall Study|Lost to Follow-up|4|||
131828700|NCT04569786|474654115|FG003|Overall Study|Lost to Follow-up|1|||
131828701|NCT04569786|474654116|FG004|Overall Study|Lost to Follow-up|0|||
131828702|NCT04569786|474654112|FG000|Overall Study|Withdrawal by Subject|0|||
131828703|NCT04569786|474654113|FG001|Overall Study|Withdrawal by Subject|0|||
131828704|NCT04569786|474654114|FG002|Overall Study|Withdrawal by Subject|0|||
131828705|NCT04569786|474654115|FG003|Overall Study|Withdrawal by Subject|5|||
131828706|NCT04569786|474654116|FG004|Overall Study|Withdrawal by Subject|1|||
131828707|NCT04569786|474654112|FG000|Overall Study|Physician Decision|0|||
131828708|NCT04569786|474654113|FG001|Overall Study|Physician Decision|0|||
131828709|NCT04569786|474654114|FG002|Overall Study|Physician Decision|0|||
131828710|NCT04569786|474654115|FG003|Overall Study|Physician Decision|1|||
131828711|NCT04569786|474654116|FG004|Overall Study|Physician Decision|0|||
131828712|NCT01640184|474654117|FG000|Overall Study|Death|1|||
131828713|NCT01640184|474654118|FG001|Overall Study|Death|0|||
131828714|NCT01640184|474654119|FG002|Overall Study|Death|0|||
131828715|NCT01640184|474654117|FG000|Overall Study|Lost to Follow-up|4|||
131828716|NCT01640184|474654118|FG001|Overall Study|Lost to Follow-up|1|||
131828717|NCT01640184|474654119|FG002|Overall Study|Lost to Follow-up|0|||
131828718|NCT01640184|474654117|FG000|Overall Study|Physician Decision|3|||
131828719|NCT01640184|474654118|FG001|Overall Study|Physician Decision|0|||
131828720|NCT01640184|474654119|FG002|Overall Study|Physician Decision|0|||
131828721|NCT01640184|474654117|FG000|Overall Study|Withdrawal by Subject|0|||
131828722|NCT01640184|474654118|FG001|Overall Study|Withdrawal by Subject|1|||
131828723|NCT01640184|474654119|FG002|Overall Study|Withdrawal by Subject|1|||
131828724|NCT01640184|474654117|FG000|Overall Study|Protocol Violation|0|||
131828725|NCT01640184|474654118|FG001|Overall Study|Protocol Violation|0|||
131828726|NCT01640184|474654119|FG002|Overall Study|Protocol Violation|1|||
131828727|NCT01684878|474654120|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
131828728|NCT01684878|474654121|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
131828729|NCT01684878|474654122|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
131828730|NCT01684878|474654123|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
131828731|NCT01684878|474654120|FG000|Part 1: Safety Run in Phase|Death|15|||
131828732|NCT01684878|474654121|FG001|Part 1: Safety Run in Phase|Death|20|||
131828733|NCT01684878|474654122|FG002|Part 1: Safety Run in Phase|Death|0|||
131828734|NCT01684878|474654123|FG003|Part 1: Safety Run in Phase|Death|0|||
131828735|NCT01684878|474654120|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
131828736|NCT01684878|474654121|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
131828737|NCT01684878|474654122|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
131828738|NCT01684878|474654123|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
131828739|NCT01684878|474654120|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
131828740|NCT01684878|474654121|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
131828741|NCT01684878|474654122|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
131828742|NCT01684878|474654123|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
131828743|NCT01684878|474654120|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
131828744|NCT01684878|474654121|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
131828745|NCT01684878|474654122|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
131828746|NCT01684878|474654123|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
131828747|NCT01684878|474654120|FG000|Part 2: Randomized Phase|Death|0|||
131828748|NCT01684878|474654121|FG001|Part 2: Randomized Phase|Death|0|||
131828749|NCT01684878|474654122|FG002|Part 2: Randomized Phase|Death|62|||
131828750|NCT01684878|474654123|FG003|Part 2: Randomized Phase|Death|68|||
131828751|NCT01684878|474654120|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
131828752|NCT01684878|474654121|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
131828753|NCT01684878|474654122|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
131828754|NCT01684878|474654123|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
131828755|NCT01684878|474654120|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
131828756|NCT01684878|474654121|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
131828757|NCT01684878|474654122|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
131828758|NCT01684878|474654123|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
131828759|NCT01435031|474654127|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
131828760|NCT01435031|474654127|FG000|ITT at 1 Month|Death|1|||
131828761|NCT01435031|474654127|FG000|ITT at 1 Month|Lost to Follow-up|4|||
131828762|NCT01435031|474654127|FG000|ITT at 6 Months|Death|2|||
131828763|NCT01435031|474654127|FG000|ITT at 6 Months|Lost to Follow-up|3|||
131828764|NCT01435031|474654127|FG000|ITT at 1 Year|Death|1|||
131828765|NCT01435031|474654127|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
131828766|NCT01435031|474654127|FG000|ITT at 1 Year|Lost to Follow-up|6|||
131828767|NCT01435031|474654127|FG000|ITT at 2 Years|Death|7|||
131828768|NCT01435031|474654127|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
131828769|NCT01435031|474654127|FG000|ITT at 2 Years|Lost to Follow-up|4|||
131828770|NCT01435031|474654127|FG000|ITT at 3 Years|Death|5|||
131828771|NCT01435031|474654127|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
131828772|NCT01435031|474654127|FG000|ITT at 3 Years|Lost to Follow-up|4|||
131828773|NCT01435031|474654127|FG000|ITT at 4 Years|Death|4|||
131828774|NCT01435031|474654127|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
131828775|NCT01435031|474654127|FG000|ITT at 4 Years|Lost to Follow-up|1|||
131828776|NCT02927834|474654128|FG000|Overall Study|Lost to Follow-up|1|||
131828777|NCT02927834|474654129|FG001|Overall Study|Lost to Follow-up|2|||
131828778|NCT02927834|474654130|FG002|Overall Study|Lost to Follow-up|2|||
131828779|NCT02492841|474654131|FG000|Overall Study|Lost to Follow-up|34|||
131828780|NCT02492841|474654132|FG001|Overall Study|Lost to Follow-up|31|||
131828781|NCT02492841|474654133|FG002|Overall Study|Lost to Follow-up|35|||
131828782|NCT02260258|474654141|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
131828783|NCT02260258|474654142|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
131828784|NCT02563769|474654143|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
131828785|NCT02563769|474654144|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
131828786|NCT02563769|474654145|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
131828787|NCT00690482|474654148|FG000|Overall Study|Adverse Event|2|||
131828788|NCT00690482|474654149|FG001|Overall Study|Adverse Event|1|||
131828789|NCT00690482|474654148|FG000|Overall Study|Incorrect enrolment|0|||
131828790|NCT00690482|474654149|FG001|Overall Study|Incorrect enrolment|1|||
131828791|NCT00690482|474654148|FG000|Overall Study|Study-specific discontinuation criteria|1|||
131828792|NCT00690482|474654149|FG001|Overall Study|Study-specific discontinuation criteria|0|||
131828793|NCT00690482|474654148|FG000|Overall Study|Intake of prohibited medicine|1|||
131828794|NCT00690482|474654149|FG001|Overall Study|Intake of prohibited medicine|0|||
131828795|NCT00690482|474654148|FG000|Overall Study|withdrew consent at rand.day|0|||
131828796|NCT00690482|474654149|FG001|Overall Study|withdrew consent at rand.day|1|||
131828797|NCT01610063|474654150|FG000|Overall Study|Lost to Follow-up|42|||
131828798|NCT01610063|474654151|FG001|Overall Study|Lost to Follow-up|20|||
131828799|NCT04405739|474654152|FG000|Overall Study|Adverse Event|0|||
131828800|NCT04405739|474654153|FG001|Overall Study|Adverse Event|1|||
131828801|NCT04405739|474654154|FG002|Overall Study|Adverse Event|0|||
131828802|NCT04405739|474654155|FG003|Overall Study|Adverse Event|0|||
131828803|NCT04405739|474654152|FG000|Overall Study|Lost to Follow-up|0|||
131828804|NCT04405739|474654153|FG001|Overall Study|Lost to Follow-up|2|||
131828805|NCT04405739|474654154|FG002|Overall Study|Lost to Follow-up|1|||
131828806|NCT04405739|474654155|FG003|Overall Study|Lost to Follow-up|3|||
131828807|NCT04405739|474654152|FG000|Overall Study|Withdrawal by Subject|0|||
131828808|NCT04405739|474654153|FG001|Overall Study|Withdrawal by Subject|2|||
131828809|NCT04405739|474654154|FG002|Overall Study|Withdrawal by Subject|1|||
131828810|NCT04405739|474654155|FG003|Overall Study|Withdrawal by Subject|1|||
131828811|NCT04405739|474654152|FG000|Overall Study|Death|0|||
131828812|NCT04405739|474654153|FG001|Overall Study|Death|0|||
131828813|NCT04405739|474654154|FG002|Overall Study|Death|1|||
131828814|NCT04405739|474654155|FG003|Overall Study|Death|0|||
131828815|NCT04405739|474654152|FG000|Overall Study|Transferred to rehab|0|||
131828816|NCT04405739|474654153|FG001|Overall Study|Transferred to rehab|0|||
131828817|NCT04405739|474654154|FG002|Overall Study|Transferred to rehab|0|||
131828818|NCT04405739|474654155|FG003|Overall Study|Transferred to rehab|1|||
131828819|NCT04405739|474654152|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
131828820|NCT04405739|474654153|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
131828821|NCT04405739|474654154|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
131828822|NCT04405739|474654155|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
131828823|NCT01436643|474654156|FG000|2-week Pre-treatment|Abnormal test result|0|||
131828824|NCT01436643|474654157|FG001|2-week Pre-treatment|Abnormal test result|0|||
131828825|NCT01436643|474654158|FG002|2-week Pre-treatment|Abnormal test result|0|||
131828826|NCT01436643|474654159|FG003|2-week Pre-treatment|Abnormal test result|1|||
131828827|NCT01436643|474654156|FG000|2-week Pre-treatment|Adverse Event|0|||
131828828|NCT01436643|474654157|FG001|2-week Pre-treatment|Adverse Event|0|||
131828829|NCT01436643|474654158|FG002|2-week Pre-treatment|Adverse Event|0|||
131828830|NCT01436643|474654159|FG003|2-week Pre-treatment|Adverse Event|5|||
131828831|NCT01436643|474654156|FG000|2-week Pre-treatment|Protocol Violation|0|||
131828832|NCT01436643|474654157|FG001|2-week Pre-treatment|Protocol Violation|0|||
131828833|NCT01436643|474654158|FG002|2-week Pre-treatment|Protocol Violation|0|||
131828834|NCT01436643|474654159|FG003|2-week Pre-treatment|Protocol Violation|4|||
131401568|NCT00960011|473091545|FG000|Overall Study|Lost to Follow-up|6|||
131401569|NCT00960011|473091546|FG001|Overall Study|Lost to Follow-up|2|||
131401570|NCT04417218|473091547|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
131401571|NCT04417218|473091548|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
131401572|NCT00873041|473091551|FG000|Core Study|Adverse Event|2|||
131401573|NCT00873041|473091552|FG001|Core Study|Adverse Event|3|||
131401574|NCT00873041|473091553|FG002|Core Study|Adverse Event|1|||
131401575|NCT00873041|473091551|FG000|Core Study|Withdrawal by Subject|1|||
131401576|NCT00873041|473091552|FG001|Core Study|Withdrawal by Subject|2|||
131401577|NCT00873041|473091553|FG002|Core Study|Withdrawal by Subject|2|||
131401578|NCT00873041|473091551|FG000|Core Study|Lost to Follow-up|3|||
131401579|NCT00873041|473091552|FG001|Core Study|Lost to Follow-up|1|||
131401580|NCT00873041|473091553|FG002|Core Study|Lost to Follow-up|0|||
131401581|NCT00873041|473091551|FG000|Core Study|Abnormal laboratory value|0|||
131828835|NCT01436643|474654156|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
131828836|NCT01436643|474654157|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
131828837|NCT01436643|474654158|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
131828838|NCT01436643|474654159|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
131828839|NCT01436643|474654156|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
131828840|NCT01436643|474654157|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
131828841|NCT01436643|474654158|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
131828842|NCT01436643|474654159|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
131828843|NCT01436643|474654156|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
131828844|NCT01436643|474654157|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
131828845|NCT01436643|474654158|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
131828846|NCT01436643|474654159|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
131828847|NCT02148445|474654162|FG000|Overall Study|Death|1|||
131828848|NCT02148445|474654163|FG001|Overall Study|Death|3|||
131828849|NCT04230876|474654164|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
131828850|NCT04230876|474654165|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
131828851|NCT03438006|474654166|FG000|Overall Study|Adverse Event|1|||
131828852|NCT03438006|474654166|FG000|Overall Study|Lost to Follow-up|67|||
131828853|NCT03438006|474654166|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
131828854|NCT03438006|474654166|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
131828855|NCT03253094|474654167|FG000|Overall Study|Adverse Event|2|||
131828856|NCT03253094|474654168|FG001|Overall Study|Adverse Event|0|||
131828857|NCT03253094|474654169|FG002|Overall Study|Adverse Event|0|||
131828858|NCT03253094|474654170|FG003|Overall Study|Adverse Event|0|||
131828859|NCT03253094|474654171|FG004|Overall Study|Adverse Event|0|||
131828860|NCT03253094|474654172|FG005|Overall Study|Adverse Event|0|||
131828861|NCT03253094|474654167|FG000|Overall Study|Lack of Efficacy|0|||
131828862|NCT03253094|474654168|FG001|Overall Study|Lack of Efficacy|0|||
131828863|NCT03253094|474654169|FG002|Overall Study|Lack of Efficacy|2|||
131828864|NCT03253094|474654170|FG003|Overall Study|Lack of Efficacy|1|||
131828865|NCT03253094|474654171|FG004|Overall Study|Lack of Efficacy|2|||
131828866|NCT03253094|474654172|FG005|Overall Study|Lack of Efficacy|1|||
131828867|NCT03253094|474654167|FG000|Overall Study|Lost to Follow-up|0|||
131828868|NCT03253094|474654168|FG001|Overall Study|Lost to Follow-up|0|||
131828869|NCT03253094|474654169|FG002|Overall Study|Lost to Follow-up|1|||
131828870|NCT03253094|474654170|FG003|Overall Study|Lost to Follow-up|1|||
131828871|NCT03253094|474654171|FG004|Overall Study|Lost to Follow-up|0|||
131828872|NCT03253094|474654172|FG005|Overall Study|Lost to Follow-up|1|||
131828873|NCT03253094|474654167|FG000|Overall Study|Physician Decision|1|||
131828874|NCT03253094|474654168|FG001|Overall Study|Physician Decision|0|||
131828875|NCT03253094|474654169|FG002|Overall Study|Physician Decision|0|||
131828876|NCT03253094|474654170|FG003|Overall Study|Physician Decision|1|||
131828877|NCT03253094|474654171|FG004|Overall Study|Physician Decision|0|||
131828878|NCT03253094|474654172|FG005|Overall Study|Physician Decision|2|||
131828879|NCT03253094|474654167|FG000|Overall Study|Withdrawal by Subject|1|||
131828880|NCT03253094|474654168|FG001|Overall Study|Withdrawal by Subject|2|||
131828881|NCT03253094|474654169|FG002|Overall Study|Withdrawal by Subject|1|||
131828882|NCT03253094|474654170|FG003|Overall Study|Withdrawal by Subject|0|||
131828883|NCT03253094|474654171|FG004|Overall Study|Withdrawal by Subject|3|||
131401582|NCT00873041|473091552|FG001|Core Study|Abnormal laboratory value|0|||
131828884|NCT03253094|474654172|FG005|Overall Study|Withdrawal by Subject|0|||
131828885|NCT03253094|474654167|FG000|Overall Study|Other|0|||
131828886|NCT03253094|474654168|FG001|Overall Study|Other|1|||
131828887|NCT03253094|474654169|FG002|Overall Study|Other|2|||
131828888|NCT03253094|474654170|FG003|Overall Study|Other|1|||
131828889|NCT03253094|474654171|FG004|Overall Study|Other|0|||
131828890|NCT03253094|474654172|FG005|Overall Study|Other|0|||
131828891|NCT00576303|474654173|FG000|Dose Titration Period|Early withdrawal|17|||
131828892|NCT00576303|474654173|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
131401583|NCT00873041|473091553|FG002|Core Study|Abnormal laboratory value|1|||
131401584|NCT00873041|473091551|FG000|Core Study|Protocol deviation|1|||
131401585|NCT00873041|473091552|FG001|Core Study|Protocol deviation|0|||
131449908|NCT00561925|473276741|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
131828893|NCT00576303|474654173|FG000|Long Term Safety Period|Early withdrawal|16|||
131401586|NCT00873041|473091553|FG002|Core Study|Protocol deviation|1|||
131401587|NCT00873041|473091551|FG000|Extension Study|Adverse Event|1|||
131401588|NCT00873041|473091552|FG001|Extension Study|Adverse Event|0|||
131401589|NCT00873041|473091553|FG002|Extension Study|Adverse Event|1|||
131828894|NCT00955721|474654174|FG000|Overall Study|Physician Decision|1|||
131828895|NCT00955721|474654175|FG001|Overall Study|Physician Decision|0|||
131828896|NCT00955721|474654174|FG000|Overall Study|Death|1|||
131828897|NCT00955721|474654175|FG001|Overall Study|Death|0|||
131828898|NCT00955721|474654174|FG000|Overall Study|Withdrawal by Subject|1|||
131828899|NCT00955721|474654175|FG001|Overall Study|Withdrawal by Subject|0|||
131828900|NCT00749411|474654180|FG000|Overall Study|Adverse Event|0|||
131828901|NCT00749411|474654181|FG001|Overall Study|Adverse Event|2|||
131828902|NCT00749411|474654180|FG000|Overall Study|Lack of Efficacy|0|||
131828903|NCT00749411|474654181|FG001|Overall Study|Lack of Efficacy|1|||
131828904|NCT00749411|474654180|FG000|Overall Study|Protocol Violation|1|||
131828905|NCT00749411|474654181|FG001|Overall Study|Protocol Violation|1|||
131828906|NCT00749411|474654180|FG000|Overall Study|Protocol-defined stopping criteria|0|||
131828907|NCT00749411|474654181|FG001|Overall Study|Protocol-defined stopping criteria|1|||
131828908|NCT03183141|474654182|FG000|Overall Study|Withdrawal by Subject|2|||
131828909|NCT03183141|474654183|FG001|Overall Study|Withdrawal by Subject|4|||
131828910|NCT03183141|474654182|FG000|Overall Study|Death|0|||
131828911|NCT03183141|474654183|FG001|Overall Study|Death|8|||
131828912|NCT02756637|474654185|FG000|Overall Study|Not eligible for initial SWOG study|10|||
131828913|NCT02756637|474654186|FG001|Overall Study|Not eligible for initial SWOG study|10|||
131828914|NCT02756637|474654185|FG000|Overall Study|No available NLR value|44|||
131828915|NCT02756637|474654186|FG001|Overall Study|No available NLR value|44|||
131828916|NCT02756637|474654185|FG000|Overall Study|Did not complete curative therapy|33|||
131828917|NCT02756637|474654186|FG001|Overall Study|Did not complete curative therapy|0|||
131828918|NCT01507090|474654187|FG000|Overall Study|incomplete dataset|18|||
131828919|NCT03581188|474656091|FG000|Overall Study|Inclusion criteria not met|3|||
131828920|NCT03581188|474656092|FG001|Overall Study|Inclusion criteria not met|2|||
131828921|NCT03581188|474656091|FG000|Overall Study|Lost to Follow-up|5|||
131828922|NCT03581188|474656092|FG001|Overall Study|Lost to Follow-up|5|||
131828923|NCT03581188|474656091|FG000|Overall Study|Discontinued intervention|11|||
131828924|NCT03581188|474656092|FG001|Overall Study|Discontinued intervention|8|||
131828925|NCT02124902|474656095|FG000|Overall Study|Adverse Event|7|||
131828926|NCT02124902|474656096|FG001|Overall Study|Adverse Event|2|||
131828927|NCT02124902|474656095|FG000|Overall Study|Went to alternative treatment|4|||
131828928|NCT02124902|474656096|FG001|Overall Study|Went to alternative treatment|0|||
131828929|NCT02124902|474656095|FG000|Overall Study|Withdrawal by Subject|2|||
131828930|NCT02124902|474656096|FG001|Overall Study|Withdrawal by Subject|1|||
131828931|NCT02124902|474656095|FG000|Overall Study|Physician Decision|2|||
131828932|NCT02124902|474656096|FG001|Overall Study|Physician Decision|0|||
131828933|NCT02124902|474656095|FG000|Overall Study|Not eligible|1|||
131828934|NCT02124902|474656096|FG001|Overall Study|Not eligible|0|||
131828935|NCT02124902|474656095|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
131828936|NCT02124902|474656096|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
131828937|NCT02190279|474656097|FG000|Overall Study|Withdrawal consent|1|||
131828938|NCT02190279|474656098|FG001|Overall Study|Withdrawal consent|0|||
131828939|NCT02190279|474656099|FG002|Overall Study|Withdrawal consent|1|||
131828940|NCT02190279|474656097|FG000|Overall Study|Lost to Follow-up|2|||
131828941|NCT02190279|474656098|FG001|Overall Study|Lost to Follow-up|0|||
131828942|NCT02190279|474656099|FG002|Overall Study|Lost to Follow-up|0|||
131828943|NCT02190279|474656097|FG000|Overall Study|Refused further treatment|0|||
131828944|NCT02190279|474656098|FG001|Overall Study|Refused further treatment|0|||
131828945|NCT02190279|474656099|FG002|Overall Study|Refused further treatment|1|||
131828946|NCT02190279|474656097|FG000|Overall Study|Screening failure|0|||
131828947|NCT02190279|474656098|FG001|Overall Study|Screening failure|0|||
131828948|NCT02190279|474656099|FG002|Overall Study|Screening failure|1|||
131828949|NCT02938442|474656100|FG000|Overall Study|Death|0|||
131828950|NCT02938442|474656101|FG001|Overall Study|Death|1|||
131401590|NCT00873041|473091551|FG000|Extension Study|Administrative reasons|0|||
131401591|NCT00873041|473091552|FG001|Extension Study|Administrative reasons|0|||
131828951|NCT02938442|474656100|FG000|Overall Study|Lost to Follow-up|0|||
131828952|NCT02938442|474656101|FG001|Overall Study|Lost to Follow-up|1|||
131828953|NCT02938442|474656100|FG000|Overall Study|Physician Decision|0|||
131828954|NCT02938442|474656101|FG001|Overall Study|Physician Decision|1|||
131828955|NCT02938442|474656100|FG000|Overall Study|Withdrawal by Subject|2|||
131828956|NCT02938442|474656101|FG001|Overall Study|Withdrawal by Subject|0|||
131828957|NCT04403399|474656103|FG000|Period 2|Physician Decision|0|||
131828958|NCT04403399|474656104|FG001|Period 2|Physician Decision|1|||
131910296|NCT01648764|474960725|FG004|Overall Study|Progressive Disease|0|||
131401592|NCT00873041|473091553|FG002|Extension Study|Administrative reasons|1|||
131401593|NCT02516098|473091554|FG000|Period 1|Protocol Violation|1|||
131401594|NCT02516098|473091555|FG001|Period 1|Protocol Violation|0|||
131828959|NCT01606228|474656105|FG000|Overall Study|Lost to Follow-up|20|||
131828960|NCT01606228|474656105|FG000|Overall Study|Withdrawal by Subject|3|||
131828961|NCT01606228|474656105|FG000|Overall Study|Non-compliant|3|||
131828962|NCT01606228|474656105|FG000|Overall Study|Lack of Efficacy|2|||
131828963|NCT01606228|474656105|FG000|Overall Study|Adverse Event|1|||
131828964|NCT00546910|474656106|FG000|Overall Study|Adverse Event|2|||
131828965|NCT00546910|474656107|FG001|Overall Study|Adverse Event|3|||
131828966|NCT00546910|474656106|FG000|Overall Study|Lack of Efficacy|5|||
131828967|NCT00546910|474656107|FG001|Overall Study|Lack of Efficacy|7|||
131828968|NCT00546910|474656106|FG000|Overall Study|Physician Decision|0|||
131828969|NCT00546910|474656107|FG001|Overall Study|Physician Decision|1|||
131828970|NCT00546910|474656106|FG000|Overall Study|Withdrawal by Subject|2|||
131828971|NCT00546910|474656107|FG001|Overall Study|Withdrawal by Subject|0|||
131828972|NCT01115855|474656108|FG000|Overall Study|Adverse Event|16|||
131828973|NCT01115855|474656109|FG001|Overall Study|Adverse Event|18|||
131828974|NCT01115855|474656108|FG000|Overall Study|Death|6|||
131828975|NCT01115855|474656109|FG001|Overall Study|Death|5|||
131828976|NCT01115855|474656108|FG000|Overall Study|Lab Abnormality|1|||
131828977|NCT01115855|474656109|FG001|Overall Study|Lab Abnormality|1|||
131828978|NCT01115855|474656108|FG000|Overall Study|Protocol Violation|0|||
131828979|NCT01115855|474656109|FG001|Overall Study|Protocol Violation|1|||
131828980|NCT01115855|474656108|FG000|Overall Study|Withdrawal by Subject|5|||
131828981|NCT01115855|474656109|FG001|Overall Study|Withdrawal by Subject|5|||
131828982|NCT01115855|474656108|FG000|Overall Study|Other|8|||
131828983|NCT01115855|474656109|FG001|Overall Study|Other|6|||
131828984|NCT02284347|474656110|FG000|Overall Study|Lost to Follow-up|2|||
131828985|NCT02284347|474656110|FG000|Overall Study|Withdrawn prior to treatment|1|||
131828986|NCT01647711|474656114|FG000|Overall Study|Progressive disease|6|||
131828987|NCT01647711|474656115|FG001|Overall Study|Progressive disease|2|||
131828988|NCT01647711|474656116|FG002|Overall Study|Progressive disease|6|||
131828989|NCT01647711|474656117|FG003|Overall Study|Progressive disease|8|||
131828990|NCT01647711|474656118|FG004|Overall Study|Progressive disease|2|||
131828991|NCT01647711|474656114|FG000|Overall Study|Other adverse event|0|||
131828992|NCT01647711|474656115|FG001|Overall Study|Other adverse event|0|||
131828993|NCT01647711|474656116|FG002|Overall Study|Other adverse event|2|||
131828994|NCT01647711|474656117|FG003|Overall Study|Other adverse event|0|||
131828995|NCT01647711|474656118|FG004|Overall Study|Other adverse event|2|||
131828996|NCT01647711|474656114|FG000|Overall Study|Protocol Violation|0|||
131828997|NCT01647711|474656115|FG001|Overall Study|Protocol Violation|0|||
131828998|NCT01647711|474656116|FG002|Overall Study|Protocol Violation|0|||
131828999|NCT01647711|474656117|FG003|Overall Study|Protocol Violation|0|||
131829000|NCT01647711|474656118|FG004|Overall Study|Protocol Violation|1|||
131829001|NCT01647711|474656114|FG000|Overall Study|Refused to continue taking medication|0|||
131829002|NCT01647711|474656115|FG001|Overall Study|Refused to continue taking medication|0|||
131829003|NCT01647711|474656116|FG002|Overall Study|Refused to continue taking medication|0|||
131829004|NCT01647711|474656117|FG003|Overall Study|Refused to continue taking medication|2|||
131829005|NCT01647711|474656118|FG004|Overall Study|Refused to continue taking medication|1|||
131829006|NCT01647711|474656114|FG000|Overall Study|Other reason not defined|0|||
131829007|NCT01647711|474656115|FG001|Overall Study|Other reason not defined|1|||
131829008|NCT01647711|474656116|FG002|Overall Study|Other reason not defined|1|||
131829009|NCT01647711|474656117|FG003|Overall Study|Other reason not defined|1|||
131829010|NCT01647711|474656118|FG004|Overall Study|Other reason not defined|0|||
131829011|NCT04039919|474656123|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131829012|NCT04039919|474656124|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131829013|NCT04039919|474656125|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131829014|NCT04039919|474656126|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131829015|NCT04039919|474656127|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131829016|NCT04039919|474656123|FG000|Treatment Period 1|Sponsor's decision|0|||
131829017|NCT04039919|474656124|FG001|Treatment Period 1|Sponsor's decision|0|||
131829018|NCT04039919|474656125|FG002|Treatment Period 1|Sponsor's decision|0|||
131829019|NCT04039919|474656126|FG003|Treatment Period 1|Sponsor's decision|0|||
131829020|NCT04039919|474656127|FG004|Treatment Period 1|Sponsor's decision|16|||
131829021|NCT04039919|474656123|FG000|Treatment Period 5|Withdrawal by Subject|1|||
131829022|NCT04039919|474656124|FG001|Treatment Period 5|Withdrawal by Subject|0|||
131829023|NCT04039919|474656125|FG002|Treatment Period 5|Withdrawal by Subject|0|||
131829024|NCT04039919|474656126|FG003|Treatment Period 5|Withdrawal by Subject|0|||
131829025|NCT04039919|474656127|FG004|Treatment Period 5|Withdrawal by Subject|0|||
131829026|NCT00754013|474656128|FG000|Overall Study|Lost to Follow-up|1|||
131829027|NCT00754013|474656129|FG001|Overall Study|Lost to Follow-up|1|||
131829028|NCT00754013|474656128|FG000|Overall Study|didn't return after study termed|3|||
131829029|NCT00754013|474656129|FG001|Overall Study|didn't return after study termed|4|||
131829030|NCT00983918|474656130|FG000|Overall Study|conversion to open cholecystectomy|0|||
131829031|NCT00983918|474656131|FG001|Overall Study|conversion to open cholecystectomy|2|||
131829032|NCT00983918|474656132|FG002|Overall Study|conversion to open cholecystectomy|2|||
131829033|NCT00983918|474656133|FG003|Overall Study|conversion to open cholecystectomy|2|||
131829034|NCT01197417|474656141|FG000|Overall Study|Physician Decision|3|||
131829035|NCT01197417|474656142|FG001|Overall Study|Physician Decision|2|||
131829036|NCT01197417|474656141|FG000|Overall Study|Withdrawal by Subject|2|||
131829037|NCT01197417|474656142|FG001|Overall Study|Withdrawal by Subject|4|||
131829038|NCT01197417|474656141|FG000|Overall Study|Site miscommunication|0|||
131829039|NCT01197417|474656142|FG001|Overall Study|Site miscommunication|1|||
131829040|NCT01197417|474656141|FG000|Overall Study|Subject transferred to intensive care|0|||
131829041|NCT01197417|474656142|FG001|Overall Study|Subject transferred to intensive care|1|||
131829042|NCT01197417|474656141|FG000|Overall Study|Not consented in time to receive drug|0|||
131829043|NCT01197417|474656142|FG001|Overall Study|Not consented in time to receive drug|1|||
131829044|NCT01197417|474656141|FG000|Overall Study|Hypotension|1|||
131829045|NCT01197417|474656142|FG001|Overall Study|Hypotension|2|||
131829046|NCT01197417|474656141|FG000|Overall Study|Found to be ineligible|2|||
131829047|NCT01197417|474656142|FG001|Overall Study|Found to be ineligible|5|||
131829048|NCT01197417|474656141|FG000|Overall Study|No 25-hour magnesium level|0|||
131829049|NCT01197417|474656142|FG001|Overall Study|No 25-hour magnesium level|2|||
131829050|NCT03919448|474656143|FG000|Overall Study|Withdrawal by Subject|1|||
131829051|NCT03919448|474656144|FG001|Overall Study|Withdrawal by Subject|0|||
131829052|NCT03919448|474656145|FG002|Overall Study|Withdrawal by Subject|0|||
131829053|NCT00418522|474656148|FG000|Overall Study|Adverse Event|7|||
131829054|NCT00418522|474656149|FG001|Overall Study|Adverse Event|1|||
131829055|NCT00418522|474656148|FG000|Overall Study|Lack of Efficacy|1|||
131829056|NCT00418522|474656149|FG001|Overall Study|Lack of Efficacy|3|||
131829057|NCT00418522|474656148|FG000|Overall Study|Lost to Follow-up|10|||
131829058|NCT00418522|474656149|FG001|Overall Study|Lost to Follow-up|4|||
131829059|NCT00418522|474656148|FG000|Overall Study|Withdrawal by Subject|31|||
131829060|NCT00418522|474656149|FG001|Overall Study|Withdrawal by Subject|7|||
131829061|NCT00418522|474656148|FG000|Overall Study|Other|27|||
131829062|NCT00418522|474656149|FG001|Overall Study|Other|23|||
131829063|NCT00418522|474656148|FG000|Overall Study|Randomized but did not receive treatment|7|||
131829064|NCT00418522|474656149|FG001|Overall Study|Randomized but did not receive treatment|4|||
131829065|NCT02695719|474656150|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
131829066|NCT02695719|474656151|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
131829067|NCT02695719|474656150|FG000|Overall Study|Significant Protocol Deviation|0|||
131829068|NCT02695719|474656151|FG001|Overall Study|Significant Protocol Deviation|1|||
131829069|NCT02695719|474656150|FG000|Overall Study|Voluntary Withdrawal|1|||
131829070|NCT02695719|474656151|FG001|Overall Study|Voluntary Withdrawal|0|||
131829071|NCT01652729|474656152|FG000|Overall Study|Withdrawal by Subject|14|||
131829072|NCT01652729|474656153|FG001|Overall Study|Withdrawal by Subject|7|||
131829073|NCT01652729|474656154|FG002|Overall Study|Withdrawal by Subject|7|||
131829074|NCT01652729|474656152|FG000|Overall Study|Adverse Event|4|||
131829075|NCT01652729|474656153|FG001|Overall Study|Adverse Event|0|||
131829076|NCT01652729|474656154|FG002|Overall Study|Adverse Event|3|||
131829077|NCT01652729|474656152|FG000|Overall Study|Physician Decision|1|||
131829078|NCT01652729|474656153|FG001|Overall Study|Physician Decision|0|||
131829079|NCT01652729|474656154|FG002|Overall Study|Physician Decision|1|||
131829080|NCT01652729|474656152|FG000|Overall Study|Protocol Violation|1|||
131829081|NCT01652729|474656153|FG001|Overall Study|Protocol Violation|0|||
131829082|NCT01652729|474656154|FG002|Overall Study|Protocol Violation|0|||
131829083|NCT01652729|474656152|FG000|Overall Study|Lost to Follow-up|6|||
131829084|NCT01652729|474656153|FG001|Overall Study|Lost to Follow-up|6|||
131829085|NCT01652729|474656154|FG002|Overall Study|Lost to Follow-up|3|||
131829086|NCT01652729|474656152|FG000|Overall Study|Administrative|1|||
131829087|NCT01652729|474656153|FG001|Overall Study|Administrative|0|||
131829088|NCT01652729|474656154|FG002|Overall Study|Administrative|0|||
131829089|NCT00483548|474656155|FG000|Overall Study|Randomized; not treated with study drug|1|||
131829090|NCT00483548|474656156|FG001|Overall Study|Randomized; not treated with study drug|3|||
131829091|NCT00483548|474656155|FG000|Overall Study|Adverse Event|25|||
131829092|NCT00483548|474656156|FG001|Overall Study|Adverse Event|14|||
131829093|NCT00483548|474656155|FG000|Overall Study|Laboratory abnormality|1|||
131829094|NCT00483548|474656156|FG001|Overall Study|Laboratory abnormality|2|||
131829095|NCT00483548|474656155|FG000|Overall Study|Lack of Efficacy|4|||
131829096|NCT00483548|474656156|FG001|Overall Study|Lack of Efficacy|8|||
131829097|NCT00483548|474656155|FG000|Overall Study|Protocol Violation|11|||
131829098|NCT00483548|474656156|FG001|Overall Study|Protocol Violation|7|||
131829099|NCT00483548|474656155|FG000|Overall Study|Pregnancy|1|||
131829100|NCT00483548|474656156|FG001|Overall Study|Pregnancy|0|||
131829101|NCT00483548|474656155|FG000|Overall Study|Protocol required discontinuation|6|||
131829102|NCT00483548|474656156|FG001|Overall Study|Protocol required discontinuation|6|||
131829103|NCT00483548|474656155|FG000|Overall Study|Unable to comply with protocol schedule|1|||
131829104|NCT00483548|474656156|FG001|Overall Study|Unable to comply with protocol schedule|0|||
131829105|NCT00483548|474656155|FG000|Overall Study|Non-compliance with medication|2|||
131829106|NCT00483548|474656156|FG001|Overall Study|Non-compliance with medication|0|||
131829107|NCT00483548|474656155|FG000|Overall Study|Lost to Follow-up|3|||
131829108|NCT00483548|474656156|FG001|Overall Study|Lost to Follow-up|4|||
131829109|NCT00483548|474656155|FG000|Overall Study|Withdrawal by Subject|5|||
131829110|NCT00483548|474656156|FG001|Overall Study|Withdrawal by Subject|2|||
131829111|NCT00126126|474656159|FG000|Overall Study|Lost to Follow-up|0|||
131829112|NCT00126126|474656160|FG001|Overall Study|Lost to Follow-up|2|||
131829113|NCT04364737|474656161|FG000|Overall Study|Withdrawal by Subject|4|||
131829114|NCT04364737|474656162|FG001|Overall Study|Withdrawal by Subject|9|||
131829115|NCT04364737|474656161|FG000|Overall Study|Lost to Follow-up|1|||
131829116|NCT04364737|474656162|FG001|Overall Study|Lost to Follow-up|1|||
131829117|NCT01220609|474656163|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
131829118|NCT01220609|474656163|FG000|Overall Study|Ineligible- Wrong cell type|1|||
131829119|NCT01220609|474656163|FG000|Overall Study|Ineligible-Never treated|1|||
131829120|NCT00868296|474656164|FG000|Overall Study|Adverse Event|0|||
131829121|NCT00868296|474656165|FG001|Overall Study|Adverse Event|2|||
131829122|NCT00868296|474656164|FG000|Overall Study|Withdrawal by Subject|0|||
131829123|NCT00868296|474656165|FG001|Overall Study|Withdrawal by Subject|1|||
131829124|NCT00573170|474656166|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
131829125|NCT00573170|474656167|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
131829126|NCT00573170|474656168|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
131829127|NCT00573170|474656169|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
131829128|NCT00573170|474656170|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
131829129|NCT00573170|474656171|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
131829130|NCT00573170|474656166|FG000|First Washout Period|Adverse Event|1|||
131829131|NCT00573170|474656167|FG001|First Washout Period|Adverse Event|1|||
131829132|NCT00573170|474656168|FG002|First Washout Period|Adverse Event|0|||
131829133|NCT00573170|474656169|FG003|First Washout Period|Adverse Event|0|||
131829134|NCT00573170|474656170|FG004|First Washout Period|Adverse Event|0|||
131829135|NCT00573170|474656171|FG005|First Washout Period|Adverse Event|1|||
131829136|NCT00573170|474656166|FG000|First Washout Period|Lack of Efficacy|0|||
131829137|NCT00573170|474656167|FG001|First Washout Period|Lack of Efficacy|0|||
131829138|NCT00573170|474656168|FG002|First Washout Period|Lack of Efficacy|0|||
131829139|NCT00573170|474656169|FG003|First Washout Period|Lack of Efficacy|0|||
131829140|NCT00573170|474656170|FG004|First Washout Period|Lack of Efficacy|0|||
131829141|NCT00573170|474656171|FG005|First Washout Period|Lack of Efficacy|1|||
131829142|NCT00573170|474656166|FG000|First Washout Period|Lost to Follow-up|1|||
131829143|NCT00573170|474656167|FG001|First Washout Period|Lost to Follow-up|1|||
131829144|NCT00573170|474656168|FG002|First Washout Period|Lost to Follow-up|0|||
131829145|NCT00573170|474656169|FG003|First Washout Period|Lost to Follow-up|2|||
131829146|NCT00573170|474656170|FG004|First Washout Period|Lost to Follow-up|0|||
131829147|NCT00573170|474656171|FG005|First Washout Period|Lost to Follow-up|2|||
131829148|NCT00573170|474656166|FG000|First Washout Period|Withdrawal by Subject|2|||
131829149|NCT00573170|474656167|FG001|First Washout Period|Withdrawal by Subject|0|||
131829150|NCT00573170|474656168|FG002|First Washout Period|Withdrawal by Subject|0|||
131829151|NCT00573170|474656169|FG003|First Washout Period|Withdrawal by Subject|2|||
131829152|NCT00573170|474656170|FG004|First Washout Period|Withdrawal by Subject|3|||
131829153|NCT00573170|474656171|FG005|First Washout Period|Withdrawal by Subject|3|||
131829154|NCT00573170|474656166|FG000|First Washout Period|Other|4|||
131829155|NCT00573170|474656167|FG001|First Washout Period|Other|0|||
131829156|NCT00573170|474656168|FG002|First Washout Period|Other|1|||
131829157|NCT00573170|474656169|FG003|First Washout Period|Other|1|||
131829158|NCT00573170|474656170|FG004|First Washout Period|Other|0|||
131829159|NCT00573170|474656171|FG005|First Washout Period|Other|0|||
131829160|NCT00573170|474656166|FG000|Second Washout Period|Adverse Event|1|||
131829161|NCT00573170|474656167|FG001|Second Washout Period|Adverse Event|0|||
131829162|NCT00573170|474656168|FG002|Second Washout Period|Adverse Event|0|||
131829163|NCT00573170|474656169|FG003|Second Washout Period|Adverse Event|0|||
131829164|NCT00573170|474656170|FG004|Second Washout Period|Adverse Event|1|||
131829165|NCT00573170|474656171|FG005|Second Washout Period|Adverse Event|0|||
131829166|NCT00573170|474656166|FG000|Second Washout Period|Protocol Violation|2|||
131829167|NCT00573170|474656167|FG001|Second Washout Period|Protocol Violation|1|||
131829168|NCT00573170|474656168|FG002|Second Washout Period|Protocol Violation|1|||
131829169|NCT00573170|474656169|FG003|Second Washout Period|Protocol Violation|0|||
131829170|NCT00573170|474656170|FG004|Second Washout Period|Protocol Violation|0|||
131829171|NCT00573170|474656171|FG005|Second Washout Period|Protocol Violation|0|||
131829172|NCT00573170|474656166|FG000|Second Washout Period|Withdrawal by Subject|1|||
131829173|NCT00573170|474656167|FG001|Second Washout Period|Withdrawal by Subject|1|||
131829174|NCT00573170|474656168|FG002|Second Washout Period|Withdrawal by Subject|2|||
131829175|NCT00573170|474656169|FG003|Second Washout Period|Withdrawal by Subject|0|||
131829176|NCT00573170|474656170|FG004|Second Washout Period|Withdrawal by Subject|1|||
131829177|NCT00573170|474656171|FG005|Second Washout Period|Withdrawal by Subject|0|||
131829178|NCT00573170|474656166|FG000|Second Washout Period|Lost to Follow-up|0|||
131829179|NCT00573170|474656167|FG001|Second Washout Period|Lost to Follow-up|0|||
131829180|NCT00573170|474656168|FG002|Second Washout Period|Lost to Follow-up|0|||
131829181|NCT00573170|474656169|FG003|Second Washout Period|Lost to Follow-up|1|||
131829182|NCT00573170|474656170|FG004|Second Washout Period|Lost to Follow-up|0|||
131829183|NCT00573170|474656171|FG005|Second Washout Period|Lost to Follow-up|0|||
131829184|NCT00573170|474656166|FG000|Second Washout Period|Other|1|||
131829185|NCT00573170|474656167|FG001|Second Washout Period|Other|2|||
131829186|NCT00573170|474656168|FG002|Second Washout Period|Other|1|||
131829187|NCT00573170|474656169|FG003|Second Washout Period|Other|4|||
131829188|NCT00573170|474656170|FG004|Second Washout Period|Other|6|||
131829189|NCT00573170|474656171|FG005|Second Washout Period|Other|2|||
131829190|NCT00573170|474656166|FG000|Third Treatment Period|Withdrawal by Subject|1|||
131829191|NCT00573170|474656167|FG001|Third Treatment Period|Withdrawal by Subject|0|||
131829192|NCT00573170|474656168|FG002|Third Treatment Period|Withdrawal by Subject|0|||
131829193|NCT00573170|474656169|FG003|Third Treatment Period|Withdrawal by Subject|0|||
131829194|NCT00573170|474656170|FG004|Third Treatment Period|Withdrawal by Subject|0|||
131829195|NCT00573170|474656171|FG005|Third Treatment Period|Withdrawal by Subject|0|||
131829196|NCT00573170|474656166|FG000|Third Treatment Period|Lost to Follow-up|0|||
131829197|NCT00573170|474656167|FG001|Third Treatment Period|Lost to Follow-up|0|||
131829198|NCT00573170|474656168|FG002|Third Treatment Period|Lost to Follow-up|0|||
131829199|NCT00573170|474656169|FG003|Third Treatment Period|Lost to Follow-up|0|||
131829200|NCT00573170|474656170|FG004|Third Treatment Period|Lost to Follow-up|0|||
131829201|NCT00573170|474656171|FG005|Third Treatment Period|Lost to Follow-up|2|||
131829202|NCT03649412|474656172|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
131829203|NCT03649412|474656173|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
131829204|NCT03649412|474656172|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
131829205|NCT03649412|474656173|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
131829206|NCT03649412|474656172|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
131829207|NCT03649412|474656173|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131829208|NCT03649412|474656172|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
131829209|NCT03649412|474656173|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
131829210|NCT03649412|474656172|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
131829211|NCT03649412|474656173|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
131829212|NCT03649412|474656172|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
131829213|NCT03649412|474656173|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
131829214|NCT02865395|474656174|FG000|Overall Study|Physician Decision|6|||
131829215|NCT02865395|474656175|FG001|Overall Study|Physician Decision|10|||
131829216|NCT02865395|474656176|FG002|Overall Study|Physician Decision|7|||
131829217|NCT01439724|474656177|FG000|Overall Study|missing consultation|9|||
131829218|NCT01439724|474656178|FG001|Overall Study|missing consultation|8|||
131829219|NCT01040793|474656179|FG000|Overall Study|Adverse Event|5|||
131829220|NCT01040793|474656180|FG001|Overall Study|Adverse Event|3|||
131829221|NCT01040793|474656181|FG002|Overall Study|Adverse Event|0|||
131829222|NCT01040793|474656182|FG003|Overall Study|Adverse Event|2|||
131829223|NCT01040793|474656183|FG004|Overall Study|Adverse Event|2|||
131829224|NCT01040793|474656184|FG005|Overall Study|Adverse Event|1|||
131829225|NCT01040793|474656179|FG000|Overall Study|Protocol Violation|1|||
131829226|NCT01040793|474656180|FG001|Overall Study|Protocol Violation|1|||
131829227|NCT01040793|474656181|FG002|Overall Study|Protocol Violation|1|||
131829228|NCT01040793|474656182|FG003|Overall Study|Protocol Violation|0|||
131829229|NCT01040793|474656183|FG004|Overall Study|Protocol Violation|1|||
131829230|NCT01040793|474656184|FG005|Overall Study|Protocol Violation|0|||
131829231|NCT01040793|474656179|FG000|Overall Study|Lost to Follow-up|0|||
131829232|NCT01040793|474656180|FG001|Overall Study|Lost to Follow-up|1|||
131829233|NCT01040793|474656181|FG002|Overall Study|Lost to Follow-up|1|||
131829234|NCT01040793|474656182|FG003|Overall Study|Lost to Follow-up|0|||
131829235|NCT01040793|474656183|FG004|Overall Study|Lost to Follow-up|0|||
131829236|NCT01040793|474656184|FG005|Overall Study|Lost to Follow-up|0|||
131829237|NCT01040793|474656179|FG000|Overall Study|Withdrawal by Subject|0|||
131829238|NCT01040793|474656180|FG001|Overall Study|Withdrawal by Subject|0|||
131829239|NCT01040793|474656181|FG002|Overall Study|Withdrawal by Subject|0|||
131829240|NCT01040793|474656182|FG003|Overall Study|Withdrawal by Subject|2|||
131829241|NCT01040793|474656183|FG004|Overall Study|Withdrawal by Subject|0|||
131829242|NCT01040793|474656184|FG005|Overall Study|Withdrawal by Subject|0|||
131829243|NCT01040793|474656179|FG000|Overall Study|Other reasons not listed above|0|||
131829244|NCT01040793|474656180|FG001|Overall Study|Other reasons not listed above|0|||
131829245|NCT01040793|474656181|FG002|Overall Study|Other reasons not listed above|1|||
131829246|NCT01040793|474656182|FG003|Overall Study|Other reasons not listed above|0|||
131829247|NCT01040793|474656183|FG004|Overall Study|Other reasons not listed above|1|||
131401595|NCT02516098|473091554|FG000|Washout After Period 1|Adverse Event|0|||
131401596|NCT02516098|473091555|FG001|Washout After Period 1|Adverse Event|1|||
131401597|NCT02516098|473091554|FG000|Period 2|Withdrawal by Subject|0|||
131401598|NCT02516098|473091555|FG001|Period 2|Withdrawal by Subject|1|||
131401599|NCT01734395|473091558|FG000|Overall Study|Other|65|||
131829248|NCT01040793|474656184|FG005|Overall Study|Other reasons not listed above|0|||
131829249|NCT02487082|474656190|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
131829250|NCT02487082|474656191|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
131829251|NCT02487082|474656190|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
131829252|NCT02487082|474656191|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
131829253|NCT03297294|474656192|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
131829254|NCT03297294|474656193|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
131829255|NCT03297294|474656194|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131829256|NCT03297294|474656195|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131401600|NCT01734395|473091558|FG000|Overall Study|Lost to Follow-up|287|||
131829257|NCT03297294|474656196|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131829258|NCT03297294|474656192|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
131829259|NCT03297294|474656193|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
131829260|NCT03297294|474656194|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131829261|NCT03297294|474656195|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131829262|NCT03297294|474656196|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131829263|NCT03297294|474656192|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
131829264|NCT03297294|474656193|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
131829265|NCT03297294|474656194|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131829266|NCT03297294|474656195|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131829267|NCT03297294|474656196|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131829268|NCT03297294|474656192|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
131829269|NCT03297294|474656193|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
131829270|NCT03297294|474656194|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131829271|NCT03297294|474656195|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131829272|NCT03297294|474656196|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131829273|NCT03297294|474656192|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
131829274|NCT03297294|474656193|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
131829275|NCT03297294|474656194|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
131829276|NCT03297294|474656195|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
131829277|NCT03297294|474656196|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
131829278|NCT02039063|474656199|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
131829279|NCT02039063|474656200|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
131829280|NCT02039063|474656201|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
131829281|NCT02039063|474656202|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
131829282|NCT02039063|474656199|FG000|Treatment Phase|Progression of disease|0|||
131829283|NCT02039063|474656200|FG001|Treatment Phase|Progression of disease|0|||
131829284|NCT02039063|474656201|FG002|Treatment Phase|Progression of disease|1|||
131829285|NCT02039063|474656202|FG003|Treatment Phase|Progression of disease|1|||
131829286|NCT02039063|474656199|FG000|Extension Phase|Inadequate therapeutic effect|0|||
131829287|NCT02039063|474656200|FG001|Extension Phase|Inadequate therapeutic effect|1|||
131829288|NCT02039063|474656201|FG002|Extension Phase|Inadequate therapeutic effect|2|||
131829289|NCT02039063|474656202|FG003|Extension Phase|Inadequate therapeutic effect|0|||
131829290|NCT02039063|474656199|FG000|Extension Phase|Progression of disease|0|||
131829291|NCT02039063|474656200|FG001|Extension Phase|Progression of disease|0|||
131829292|NCT02039063|474656201|FG002|Extension Phase|Progression of disease|0|||
131829293|NCT02039063|474656202|FG003|Extension Phase|Progression of disease|1|||
131829294|NCT02039063|474656199|FG000|Extension Phase|Adverse Event|0|||
131829295|NCT02039063|474656200|FG001|Extension Phase|Adverse Event|0|||
131829296|NCT02039063|474656201|FG002|Extension Phase|Adverse Event|1|||
131829297|NCT02039063|474656202|FG003|Extension Phase|Adverse Event|0|||
131829298|NCT01198873|474656203|FG000|Overall Study|Adverse Event|4|||
131829299|NCT01198873|474656204|FG001|Overall Study|Adverse Event|7|||
131829300|NCT01198873|474656203|FG000|Overall Study|Study closure|29|||
131829301|NCT01198873|474656204|FG001|Overall Study|Study closure|23|||
131829302|NCT01198873|474656203|FG000|Overall Study|Other than above|4|||
131829303|NCT01198873|474656204|FG001|Overall Study|Other than above|2|||
131829304|NCT00895037|474656208|FG000|Overall Study|Death|0|||
131829305|NCT00895037|474656209|FG001|Overall Study|Death|2|||
131829306|NCT00895037|474656210|FG002|Overall Study|Death|1|||
131829307|NCT00104247|474656227|FG000|Overall Study|Withdrawal by Subject|1|||
131829308|NCT00104247|474656228|FG001|Overall Study|Withdrawal by Subject|0|||
131829309|NCT00104247|474656227|FG000|Overall Study|Noncompliant with dosing|0|||
131829310|NCT00104247|474656228|FG001|Overall Study|Noncompliant with dosing|1|||
131829311|NCT04798482|474656232|FG000|Overall Study|Physician Decision|1|||
131829312|NCT04798482|474656232|FG000|Overall Study|Lost eligibility|1|||
131829313|NCT03314662|474656238|FG000|Overall Study|Withdrawal by Subject|1|||
131829314|NCT03314662|474656239|FG001|Overall Study|Withdrawal by Subject|1|||
131829315|NCT03314662|474656240|FG002|Overall Study|Withdrawal by Subject|1|||
131829316|NCT03314662|474656238|FG000|Overall Study|Lost to Follow-up|5|||
131829317|NCT03314662|474656239|FG001|Overall Study|Lost to Follow-up|4|||
131829318|NCT03314662|474656240|FG002|Overall Study|Lost to Follow-up|4|||
131829319|NCT03314662|474656238|FG000|Overall Study|Death|2|||
131829320|NCT03314662|474656239|FG001|Overall Study|Death|0|||
131829321|NCT03314662|474656240|FG002|Overall Study|Death|0|||
131829322|NCT00438659|474656248|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
131829323|NCT00438659|474656249|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
131401601|NCT01734395|473091558|FG000|Overall Study|Lack of Efficacy|5|||
131401602|NCT01734395|473091558|FG000|Overall Study|Adverse Event|40|||
131829324|NCT00438659|474656248|FG000|Overall Study|Cancel|5|||
131829325|NCT00438659|474656249|FG001|Overall Study|Cancel|2|||
131829326|NCT03718117|474656250|FG000|Overall Study|Death|12|||
131829327|NCT03718117|474656251|FG001|Overall Study|Death|11|||
131829328|NCT03718117|474656252|FG002|Overall Study|Death|0|||
131829329|NCT03718117|474656250|FG000|Overall Study|Other|0|||
131829330|NCT03718117|474656251|FG001|Overall Study|Other|1|||
131829331|NCT03718117|474656252|FG002|Overall Study|Other|0|||
131829332|NCT03718117|474656250|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
131829333|NCT03718117|474656251|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
131829334|NCT03718117|474656252|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
131829335|NCT03718117|474656250|FG000|Overall Study|Participant not met eligibility criteria|0|||
131829336|NCT03718117|474656251|FG001|Overall Study|Participant not met eligibility criteria|0|||
131829337|NCT03718117|474656252|FG002|Overall Study|Participant not met eligibility criteria|2|||
131829338|NCT00206102|474656256|FG000|Overall Study|Adverse Event|119|||
131829339|NCT00206102|474656257|FG001|Overall Study|Adverse Event|82|||
131829340|NCT00206102|474656256|FG000|Overall Study|Protocol Violation|0|||
131829341|NCT00206102|474656257|FG001|Overall Study|Protocol Violation|2|||
131829342|NCT00206102|474656256|FG000|Overall Study|Lack of therapeutic response|16|||
131829343|NCT00206102|474656257|FG001|Overall Study|Lack of therapeutic response|11|||
131829344|NCT00206102|474656256|FG000|Overall Study|Lost to Follow-up|95|||
131829345|NCT00206102|474656257|FG001|Overall Study|Lost to Follow-up|66|||
131910297|NCT01648764|474960726|FG005|Overall Study|Progressive Disease|1|||
131910298|NCT01648764|474960727|FG006|Overall Study|Progressive Disease|1|||
131910299|NCT01648764|474960728|FG007|Overall Study|Progressive Disease|0|||
131910300|NCT01648764|474960729|FG008|Overall Study|Progressive Disease|0|||
131910301|NCT01648764|474960730|FG009|Overall Study|Progressive Disease|2|||
131910302|NCT01648764|474960731|FG010|Overall Study|Progressive Disease|0|||
131910303|NCT01648764|474960732|FG011|Overall Study|Progressive Disease|1|||
131910304|NCT01648764|474960733|FG012|Overall Study|Progressive Disease|2|||
131910305|NCT01648764|474960734|FG013|Overall Study|Progressive Disease|1|||
131910306|NCT01648764|474960721|FG000|Overall Study|Adverse Event|0|||
131910307|NCT01648764|474960722|FG001|Overall Study|Adverse Event|0|||
131910308|NCT01648764|474960723|FG002|Overall Study|Adverse Event|0|||
131910309|NCT01648764|474960724|FG003|Overall Study|Adverse Event|0|||
131910310|NCT01648764|474960725|FG004|Overall Study|Adverse Event|0|||
131910311|NCT01648764|474960726|FG005|Overall Study|Adverse Event|1|||
131910312|NCT01648764|474960727|FG006|Overall Study|Adverse Event|0|||
131910313|NCT01648764|474960728|FG007|Overall Study|Adverse Event|0|||
131910314|NCT01648764|474960729|FG008|Overall Study|Adverse Event|0|||
131910315|NCT01648764|474960730|FG009|Overall Study|Adverse Event|1|||
131910316|NCT01648764|474960731|FG010|Overall Study|Adverse Event|0|||
131910317|NCT01648764|474960732|FG011|Overall Study|Adverse Event|3|||
131910318|NCT01648764|474960733|FG012|Overall Study|Adverse Event|1|||
131910319|NCT01648764|474960734|FG013|Overall Study|Adverse Event|1|||
131910320|NCT01648764|474960721|FG000|Overall Study|Death|0|||
131910321|NCT01648764|474960722|FG001|Overall Study|Death|0|||
131910322|NCT01648764|474960723|FG002|Overall Study|Death|0|||
131910323|NCT01648764|474960724|FG003|Overall Study|Death|0|||
131910324|NCT01648764|474960725|FG004|Overall Study|Death|0|||
131910325|NCT01648764|474960726|FG005|Overall Study|Death|0|||
131910326|NCT01648764|474960727|FG006|Overall Study|Death|1|||
131910327|NCT01648764|474960728|FG007|Overall Study|Death|0|||
131910328|NCT01648764|474960729|FG008|Overall Study|Death|0|||
131910329|NCT01648764|474960730|FG009|Overall Study|Death|0|||
131910330|NCT01648764|474960731|FG010|Overall Study|Death|0|||
131910331|NCT01648764|474960732|FG011|Overall Study|Death|0|||
131910332|NCT01648764|474960733|FG012|Overall Study|Death|0|||
131910333|NCT01648764|474960734|FG013|Overall Study|Death|1|||
131910334|NCT01648764|474960721|FG000|Overall Study|Withdrawal by Subject|0|||
131910335|NCT01648764|474960722|FG001|Overall Study|Withdrawal by Subject|0|||
131910336|NCT01648764|474960723|FG002|Overall Study|Withdrawal by Subject|0|||
131910337|NCT01648764|474960724|FG003|Overall Study|Withdrawal by Subject|0|||
131910338|NCT01648764|474960725|FG004|Overall Study|Withdrawal by Subject|0|||
131910339|NCT01648764|474960726|FG005|Overall Study|Withdrawal by Subject|0|||
131910340|NCT01648764|474960727|FG006|Overall Study|Withdrawal by Subject|2|||
131910341|NCT01648764|474960728|FG007|Overall Study|Withdrawal by Subject|0|||
131910342|NCT01648764|474960729|FG008|Overall Study|Withdrawal by Subject|0|||
131910343|NCT01648764|474960730|FG009|Overall Study|Withdrawal by Subject|0|||
131910344|NCT01648764|474960731|FG010|Overall Study|Withdrawal by Subject|0|||
131910345|NCT01648764|474960732|FG011|Overall Study|Withdrawal by Subject|0|||
131910346|NCT01648764|474960733|FG012|Overall Study|Withdrawal by Subject|1|||
131910347|NCT01648764|474960734|FG013|Overall Study|Withdrawal by Subject|0|||
131910348|NCT01648764|474960721|FG000|Overall Study|Investigator Decision|0|||
131910349|NCT01648764|474960722|FG001|Overall Study|Investigator Decision|0|||
131910350|NCT01648764|474960723|FG002|Overall Study|Investigator Decision|0|||
131910351|NCT01648764|474960724|FG003|Overall Study|Investigator Decision|0|||
131910352|NCT01648764|474960725|FG004|Overall Study|Investigator Decision|0|||
131910353|NCT01648764|474960726|FG005|Overall Study|Investigator Decision|0|||
131910354|NCT01648764|474960727|FG006|Overall Study|Investigator Decision|1|||
131910355|NCT01648764|474960728|FG007|Overall Study|Investigator Decision|0|||
131910356|NCT01648764|474960729|FG008|Overall Study|Investigator Decision|0|||
131910357|NCT01648764|474960730|FG009|Overall Study|Investigator Decision|0|||
131910358|NCT01648764|474960731|FG010|Overall Study|Investigator Decision|0|||
131910359|NCT01648764|474960732|FG011|Overall Study|Investigator Decision|1|||
131910360|NCT01648764|474960733|FG012|Overall Study|Investigator Decision|0|||
131829346|NCT00206102|474656256|FG000|Overall Study|Withdrawal by Subject|118|||
131829347|NCT00206102|474656257|FG001|Overall Study|Withdrawal by Subject|101|||
131829348|NCT00206102|474656256|FG000|Overall Study|Study-specific discontinuation criteria|18|||
131829349|NCT00206102|474656257|FG001|Overall Study|Study-specific discontinuation criteria|17|||
131829350|NCT00206102|474656256|FG000|Overall Study|None of those categories|42|||
131829351|NCT00206102|474656257|FG001|Overall Study|None of those categories|36|||
131829352|NCT04117945|474656258|FG000|Overall Study|Death|1|||
131829353|NCT04117945|474656259|FG001|Overall Study|Death|0|||
131829354|NCT04117945|474656258|FG000|Overall Study|Withdrawal by Subject|3|||
131829355|NCT04117945|474656259|FG001|Overall Study|Withdrawal by Subject|1|||
131829356|NCT04117945|474656258|FG000|Overall Study|Disease Progression|0|||
131829357|NCT04117945|474656259|FG001|Overall Study|Disease Progression|2|||
131829358|NCT04117945|474656258|FG000|Overall Study|Ineligible|8|||
131829359|NCT04117945|474656259|FG001|Overall Study|Ineligible|7|||
131829360|NCT02056652|474656260|FG000|Overall Study|Withdrawal by Subject|1|||
131829361|NCT02056652|474656261|FG001|Overall Study|Withdrawal by Subject|0|||
131829362|NCT02056652|474656260|FG000|Overall Study|Lost to Follow-up|0|||
131829363|NCT02056652|474656261|FG001|Overall Study|Lost to Follow-up|3|||
131829364|NCT01917968|474656263|FG000|Overall Study|Death|3|||
131829365|NCT01917968|474656264|FG001|Overall Study|Death|2|||
131829366|NCT01917968|474656263|FG000|Overall Study|Lost to Follow-up|21|||
131829367|NCT01917968|474656264|FG001|Overall Study|Lost to Follow-up|39|||
131829368|NCT01917968|474656263|FG000|Overall Study|Physician Decision|1|||
131829369|NCT01917968|474656264|FG001|Overall Study|Physician Decision|2|||
131829370|NCT01917968|474656263|FG000|Overall Study|Withdrawal by Subject|20|||
131829371|NCT01917968|474656264|FG001|Overall Study|Withdrawal by Subject|35|||
131829372|NCT01917968|474656263|FG000|Overall Study|Subject Relocation|5|||
131829373|NCT01917968|474656264|FG001|Overall Study|Subject Relocation|1|||
131829374|NCT01917968|474656263|FG000|Overall Study|36M Missed Visit|3|||
131829375|NCT01917968|474656264|FG001|Overall Study|36M Missed Visit|2|||
131829376|NCT01917968|474656263|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
131829377|NCT01917968|474656264|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
131829378|NCT01917968|474656263|FG000|Overall Study|Change in Family Circumstances|0|||
131829379|NCT01917968|474656264|FG001|Overall Study|Change in Family Circumstances|1|||
131829380|NCT01917968|474656263|FG000|Overall Study|No Data Available|0|||
131829381|NCT01917968|474656264|FG001|Overall Study|No Data Available|2|||
131829382|NCT04034355|474656267|FG000|Overall Study|Study terminated by Sponsor|10|||
131829383|NCT04034355|474656268|FG001|Overall Study|Study terminated by Sponsor|17|||
131829384|NCT04034355|474656267|FG000|Overall Study|Withdrawal by Subject|12|||
131829385|NCT04034355|474656268|FG001|Overall Study|Withdrawal by Subject|11|||
131829386|NCT04034355|474656267|FG000|Overall Study|Site terminated by Sponsor|4|||
131829387|NCT04034355|474656268|FG001|Overall Study|Site terminated by Sponsor|5|||
131829388|NCT04034355|474656267|FG000|Overall Study|Adverse Event|2|||
131829389|NCT04034355|474656268|FG001|Overall Study|Adverse Event|0|||
131829390|NCT04034355|474656267|FG000|Overall Study|Death|1|||
131829391|NCT04034355|474656268|FG001|Overall Study|Death|1|||
131829392|NCT04034355|474656267|FG000|Overall Study|Not reported|2|||
131829393|NCT04034355|474656268|FG001|Overall Study|Not reported|0|||
131829394|NCT04034355|474656267|FG000|Overall Study|Lost to Follow-up|1|||
131829395|NCT04034355|474656268|FG001|Overall Study|Lost to Follow-up|0|||
131829396|NCT04034355|474656267|FG000|Overall Study|Physician Decision|1|||
131829397|NCT04034355|474656268|FG001|Overall Study|Physician Decision|0|||
131829398|NCT04034355|474656267|FG000|Overall Study|Protocol Violation|0|||
131829399|NCT04034355|474656268|FG001|Overall Study|Protocol Violation|1|||
131829400|NCT04034355|474656267|FG000|Overall Study|Progressive disease|1|||
131829401|NCT04034355|474656268|FG001|Overall Study|Progressive disease|0|||
131829402|NCT04678817|474657947|FG000|Overall Study|Lost to Follow-up|28|||
131829403|NCT04678817|474657948|FG001|Overall Study|Lost to Follow-up|0|||
131829404|NCT04678817|474657949|FG002|Overall Study|Lost to Follow-up|0|||
131829405|NCT03064438|474657952|FG000|Overall Study|Lost to Follow-up|1|||
131829406|NCT03064438|474657953|FG001|Overall Study|Lost to Follow-up|0|||
131829407|NCT03064438|474657952|FG000|Overall Study|Withdrawal by Subject|0|||
131829408|NCT03064438|474657953|FG001|Overall Study|Withdrawal by Subject|1|||
131829409|NCT01937351|474657954|FG000|Overall Study|Withdrawal by Subject|4|||
131829410|NCT01937351|474657955|FG001|Overall Study|Withdrawal by Subject|2|||
131829411|NCT01937351|474657954|FG000|Overall Study|Death|1|||
131829412|NCT01937351|474657955|FG001|Overall Study|Death|0|||
131829413|NCT01937351|474657954|FG000|Overall Study|Not treated w device, per protocol fail|4|||
131829414|NCT01937351|474657955|FG001|Overall Study|Not treated w device, per protocol fail|0|||
131829415|NCT01961687|474657956|FG000|Overall Study|Lost to Follow-up|19|||
131829416|NCT01961687|474657956|FG000|Overall Study|Re-operation|17|||
131829417|NCT01961687|474657956|FG000|Overall Study|Death|7|||
131829418|NCT01961687|474657956|FG000|Overall Study|Withdrawal by Subject|6|||
131829419|NCT01961687|474657956|FG000|Overall Study|Adverse Event|6|||
131829420|NCT01961687|474657956|FG000|Overall Study|Moved to area without study site|2|||
131829421|NCT01961687|474657956|FG000|Overall Study|Sponsor decision|2|||
131829422|NCT01961687|474657956|FG000|Overall Study|Physician Decision|1|||
131829423|NCT01961687|474657956|FG000|Overall Study|Unable to meet follow-up requirements|1|||
131829424|NCT01467479|474657957|FG000|Overall Study|No Study Medication|1|||
131829425|NCT01467479|474657958|FG001|Overall Study|No Study Medication|0|||
131829426|NCT01467479|474657959|FG002|Overall Study|No Study Medication|2|||
131829427|NCT01467479|474657957|FG000|Overall Study|Adverse Event|1|||
131829428|NCT01467479|474657958|FG001|Overall Study|Adverse Event|2|||
131829429|NCT01467479|474657959|FG002|Overall Study|Adverse Event|0|||
131829430|NCT01467479|474657957|FG000|Overall Study|Death|0|||
131829431|NCT01467479|474657958|FG001|Overall Study|Death|0|||
131829432|NCT01467479|474657959|FG002|Overall Study|Death|1|||
131829433|NCT01467479|474657957|FG000|Overall Study|Lost to Follow-up|2|||
131829434|NCT01467479|474657958|FG001|Overall Study|Lost to Follow-up|5|||
131829435|NCT01467479|474657959|FG002|Overall Study|Lost to Follow-up|3|||
131829436|NCT01467479|474657957|FG000|Overall Study|Withdrawal of Consent|3|||
131829437|NCT01467479|474657958|FG001|Overall Study|Withdrawal of Consent|7|||
131829438|NCT01467479|474657959|FG002|Overall Study|Withdrawal of Consent|7|||
131829439|NCT01467479|474657957|FG000|Overall Study|Study Terminated by Sponsor|1|||
131829440|NCT01467479|474657958|FG001|Overall Study|Study Terminated by Sponsor|3|||
131829441|NCT01467479|474657959|FG002|Overall Study|Study Terminated by Sponsor|3|||
131829442|NCT01467479|474657957|FG000|Overall Study|Other|1|||
131829443|NCT01467479|474657958|FG001|Overall Study|Other|0|||
131829444|NCT01467479|474657959|FG002|Overall Study|Other|0|||
131829445|NCT01684215|474657969|FG000|Phase 1, Part 1|Adverse Event|1|||
131829446|NCT01684215|474657970|FG001|Phase 1, Part 1|Adverse Event|0|||
131829447|NCT01684215|474657971|FG002|Phase 1, Part 1|Adverse Event|0|||
131829448|NCT01684215|474657972|FG003|Phase 1, Part 1|Adverse Event|0|||
131829449|NCT01684215|474657969|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
131829450|NCT01684215|474657970|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
131829451|NCT01684215|474657971|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
131829452|NCT01684215|474657972|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
131829453|NCT01684215|474657969|FG000|Phase 1, Part 2|Adverse Event|0|||
131829454|NCT01684215|474657970|FG001|Phase 1, Part 2|Adverse Event|0|||
131829455|NCT01684215|474657971|FG002|Phase 1, Part 2|Adverse Event|1|||
131829456|NCT01684215|474657972|FG003|Phase 1, Part 2|Adverse Event|0|||
131829457|NCT01684215|474657969|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
131829458|NCT01684215|474657970|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
131829459|NCT01684215|474657971|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
131829460|NCT01684215|474657972|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
131829461|NCT01684215|474657969|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
131829462|NCT01684215|474657970|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
131829463|NCT01684215|474657971|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
131829464|NCT01684215|474657972|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
131829465|NCT01684215|474657969|FG000|Phase 2|Death|0|||
131829466|NCT01684215|474657970|FG001|Phase 2|Death|0|||
131829467|NCT01684215|474657971|FG002|Phase 2|Death|0|||
131829468|NCT01684215|474657972|FG003|Phase 2|Death|8|||
131829469|NCT01684215|474657969|FG000|Phase 2|Study terminated by sponsor|0|||
131829470|NCT01684215|474657970|FG001|Phase 2|Study terminated by sponsor|0|||
131829471|NCT01684215|474657971|FG002|Phase 2|Study terminated by sponsor|0|||
131829472|NCT01684215|474657972|FG003|Phase 2|Study terminated by sponsor|30|||
131829473|NCT01684215|474657969|FG000|Phase 2|Enrolled but not treated|0|||
131829474|NCT01684215|474657970|FG001|Phase 2|Enrolled but not treated|0|||
131829475|NCT01684215|474657971|FG002|Phase 2|Enrolled but not treated|0|||
131829476|NCT01684215|474657972|FG003|Phase 2|Enrolled but not treated|1|||
131829477|NCT01684215|474657969|FG000|Phase 2|Lost to Follow-up|0|||
131829478|NCT01684215|474657970|FG001|Phase 2|Lost to Follow-up|0|||
131910361|NCT01648764|474960734|FG013|Overall Study|Investigator Decision|0|||
131910362|NCT01715831|474960735|FG000|Overall Study|Adverse Event|1|||
131910363|NCT00316004|474960736|FG000|Overall Study|Subject was not given study fluid.|14|||
131829479|NCT01684215|474657971|FG002|Phase 2|Lost to Follow-up|0|||
131829480|NCT01684215|474657972|FG003|Phase 2|Lost to Follow-up|4|||
131829481|NCT01301482|474657973|FG000|Overall Study|Withdrawal by Subject|1|||
131829482|NCT00480324|474657976|FG000|Overall Study|Adverse Event|1|||
131829483|NCT00480324|474657977|FG001|Overall Study|Adverse Event|1|||
131829484|NCT00480324|474657976|FG000|Overall Study|Protocol Violation|0|||
131829485|NCT00480324|474657977|FG001|Overall Study|Protocol Violation|1|||
131829486|NCT00480324|474657976|FG000|Overall Study|Withdrawal by Subject|14|||
131829487|NCT00480324|474657977|FG001|Overall Study|Withdrawal by Subject|5|||
131829488|NCT00480324|474657976|FG000|Overall Study|Lost to Follow-up|17|||
131829489|NCT00480324|474657977|FG001|Overall Study|Lost to Follow-up|8|||
131829490|NCT00480324|474657976|FG000|Overall Study|Subject's mother pregnant|0|||
131829491|NCT00480324|474657977|FG001|Overall Study|Subject's mother pregnant|1|||
131829492|NCT01915940|474657978|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
131829493|NCT01915940|474657979|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
131829494|NCT01915940|474657980|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
131829495|NCT01915940|474657978|FG000|Treatment Period|Decision of Participant|0|||
131829496|NCT01915940|474657979|FG001|Treatment Period|Decision of Participant|1|||
131829497|NCT01915940|474657980|FG002|Treatment Period|Decision of Participant|3|||
131910364|NCT00316004|474960737|FG001|Overall Study|Subject was not given study fluid.|14|||
131829498|NCT01915940|474657978|FG000|Treatment Period|Adverse Event|0|||
131829499|NCT01915940|474657979|FG001|Treatment Period|Adverse Event|9|||
131829500|NCT01915940|474657980|FG002|Treatment Period|Adverse Event|1|||
131829501|NCT01915940|474657978|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
131829502|NCT01915940|474657979|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
131829503|NCT01915940|474657980|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
131829504|NCT01316419|474657984|FG000|Overall Study|Not treated|103|||
131829505|NCT01316419|474657984|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
131829506|NCT01316419|474657984|FG000|Overall Study|Lost to Follow-up|19|||
131829507|NCT02310789|474657987|FG000|Overall Study|Adverse Event|1|||
131829508|NCT00440466|474657988|FG000|Overall Study|Death|3|||
131829509|NCT00440466|474657989|FG001|Overall Study|Death|2|||
131829510|NCT00440466|474657990|FG002|Overall Study|Death|9|||
131829511|NCT00440466|474657988|FG000|Overall Study|Adverse Event|3|||
131829512|NCT00440466|474657989|FG001|Overall Study|Adverse Event|4|||
131829513|NCT00440466|474657990|FG002|Overall Study|Adverse Event|11|||
131829514|NCT00440466|474657988|FG000|Overall Study|Lost to Follow-up|1|||
131829515|NCT00440466|474657989|FG001|Overall Study|Lost to Follow-up|0|||
131829516|NCT00440466|474657990|FG002|Overall Study|Lost to Follow-up|2|||
131829517|NCT00440466|474657988|FG000|Overall Study|Physician Decision|2|||
131829518|NCT00440466|474657989|FG001|Overall Study|Physician Decision|0|||
131829519|NCT00440466|474657990|FG002|Overall Study|Physician Decision|1|||
131829520|NCT00440466|474657988|FG000|Overall Study|Protocol Violation|2|||
131829521|NCT00440466|474657989|FG001|Overall Study|Protocol Violation|0|||
131829522|NCT00440466|474657990|FG002|Overall Study|Protocol Violation|4|||
131829523|NCT00440466|474657988|FG000|Overall Study|Withdrawal by Subject|2|||
131829524|NCT00440466|474657989|FG001|Overall Study|Withdrawal by Subject|5|||
131829525|NCT00440466|474657990|FG002|Overall Study|Withdrawal by Subject|9|||
131829526|NCT00440466|474657988|FG000|Overall Study|Began Dialysis|0|||
131829527|NCT00440466|474657989|FG001|Overall Study|Began Dialysis|0|||
131829528|NCT00440466|474657990|FG002|Overall Study|Began Dialysis|1|||
131829529|NCT00440466|474657988|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
131829530|NCT00440466|474657989|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
131829531|NCT00440466|474657990|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
131829532|NCT00743509|474657991|FG000|Overall Study|Withdrawal by Subject|2|||
131829533|NCT02065713|474657997|FG000|Overall Study|Adverse Event|0|||
131829534|NCT02065713|474657998|FG001|Overall Study|Adverse Event|1|||
131829535|NCT02065713|474657997|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131829536|NCT02065713|474657998|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131829537|NCT02694549|474657999|FG000|Overall Study|screen failures|2|||
131829538|NCT01534078|474658000|FG000|Overall Study|Death|1|||
131829539|NCT01534078|474658000|FG000|Overall Study|Withdrawal by Subject|1|||
131829540|NCT02459665|474658001|FG000|Overall Study|Withdrawal by Subject|0|||
131829541|NCT02459665|474658002|FG001|Overall Study|Withdrawal by Subject|1|||
131829542|NCT02459665|474658003|FG002|Overall Study|Withdrawal by Subject|1|||
131829543|NCT02459665|474658004|FG003|Overall Study|Withdrawal by Subject|2|||
131829544|NCT00986570|474658005|FG000|Overall Study|Lost to Follow-up|6|||
131829545|NCT00986570|474658005|FG000|Overall Study|Potential bias for objective assessment|1|||
131829546|NCT02225665|474658006|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
131829547|NCT02225665|474658007|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
131829548|NCT02225665|474658006|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
131829549|NCT02225665|474658007|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
131829550|NCT01311557|474658008|FG000|Overall Study|Serious adverse event|0|||
131829551|NCT01311557|474658009|FG001|Overall Study|Serious adverse event|1|||
131829552|NCT01311557|474658008|FG000|Overall Study|Protocol Violation|4|||
131829553|NCT01311557|474658009|FG001|Overall Study|Protocol Violation|2|||
131829554|NCT01311557|474658008|FG000|Overall Study|Lost to Follow-up|0|||
131829555|NCT01311557|474658009|FG001|Overall Study|Lost to Follow-up|1|||
131829556|NCT01311557|474658008|FG000|Overall Study|Withdrawal by Subject|1|||
131829557|NCT01311557|474658009|FG001|Overall Study|Withdrawal by Subject|2|||
131829558|NCT01470417|474658013|FG000|Overall Study|Disease progression|0|||
131829559|NCT01470417|474658014|FG001|Overall Study|Disease progression|2|||
131910365|NCT00316004|474960738|FG002|Overall Study|Subject was not given study fluid.|21|||
131910366|NCT01118299|474960741|FG000|Overall Study|Death|7|||
131401603|NCT01734395|473091558|FG000|Overall Study|Withdrawal by Subject|10|||
131910367|NCT01118299|474960742|FG001|Overall Study|Death|5|||
131401604|NCT01734395|473091558|FG000|Overall Study|Missing the reasons for not completed|3|||
131829560|NCT02418455|474658015|FG000|48-Week Treatment Period|Other- Not Specified|1|||
131829561|NCT02418455|474658015|FG000|Continuation Period|Sponsor Decision|7|||
131829562|NCT00493454|474658018|FG000|Overall Study|Withdrawal by Subject|1|||
131829563|NCT00103038|474658019|FG000|Overall Study|Withdrawal by Subject|8|||
131829564|NCT00103038|474658019|FG000|Overall Study|Screen failure|3|||
131829565|NCT00103038|474658019|FG000|Overall Study|Death|1|||
131829566|NCT00103038|474658019|FG000|Overall Study|Physician Decision|1|||
131829567|NCT04019054|474658021|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
131910368|NCT01118299|474960741|FG000|Overall Study|Withdrawal by Subject|8|||
131829568|NCT04019054|474658022|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
131829569|NCT04019054|474658021|FG000|Overall Study|Withdrawal by Subject|3|||
131829570|NCT04019054|474658022|FG001|Overall Study|Withdrawal by Subject|1|||
131829571|NCT00508027|474658028|FG000|Dose Level 1|Lost to Follow-up|4|||
131829572|NCT00508027|474658028|FG000|Dose Level 1|Withdrawal by Subject|2|||
131829573|NCT00508027|474658028|FG000|Dose Level 1|Physician Decision|2|||
131829574|NCT00508027|474658028|FG000|Dose Level 2|Lost to Follow-up|2|||
131829575|NCT00508027|474658028|FG000|Dose Level 2|Withdrawal by Subject|2|||
131829576|NCT01719562|474658029|FG000|Overall Study|Lost to Follow-up|1|||
131829577|NCT01719562|474658030|FG001|Overall Study|Lost to Follow-up|0|||
131829578|NCT01719562|474658029|FG000|Overall Study|Death|1|||
131829579|NCT01719562|474658030|FG001|Overall Study|Death|0|||
131829580|NCT01719562|474658029|FG000|Overall Study|New cancer diagnosis|1|||
131829581|NCT01719562|474658030|FG001|Overall Study|New cancer diagnosis|0|||
131829582|NCT03877926|474658033|FG000|Overall Study|Adverse Event|1|||
131829583|NCT03877926|474658034|FG001|Overall Study|Adverse Event|0|||
131829584|NCT03877926|474658035|FG002|Overall Study|Adverse Event|0|||
131829585|NCT03877926|474658036|FG003|Overall Study|Adverse Event|0|||
131829586|NCT03877926|474658033|FG000|Overall Study|Death|2|||
131829587|NCT03877926|474658034|FG001|Overall Study|Death|2|||
131829588|NCT03877926|474658035|FG002|Overall Study|Death|2|||
131829589|NCT03877926|474658036|FG003|Overall Study|Death|0|||
131829590|NCT03877926|474658033|FG000|Overall Study|Lost to Follow-up|41|||
131829591|NCT03877926|474658034|FG001|Overall Study|Lost to Follow-up|52|||
131829592|NCT03877926|474658035|FG002|Overall Study|Lost to Follow-up|45|||
131829593|NCT03877926|474658036|FG003|Overall Study|Lost to Follow-up|17|||
131829594|NCT03877926|474658033|FG000|Overall Study|Physician Decision|2|||
131829595|NCT03877926|474658034|FG001|Overall Study|Physician Decision|0|||
131829596|NCT03877926|474658035|FG002|Overall Study|Physician Decision|2|||
131829597|NCT03877926|474658036|FG003|Overall Study|Physician Decision|0|||
131829598|NCT03877926|474658033|FG000|Overall Study|Withdrawal by Subject|18|||
131829599|NCT03877926|474658034|FG001|Overall Study|Withdrawal by Subject|21|||
131829600|NCT03877926|474658035|FG002|Overall Study|Withdrawal by Subject|12|||
131829601|NCT03877926|474658036|FG003|Overall Study|Withdrawal by Subject|4|||
131829602|NCT03877926|474658033|FG000|Overall Study|Other - Various|4|||
131829603|NCT03877926|474658034|FG001|Overall Study|Other - Various|1|||
131829604|NCT03877926|474658035|FG002|Overall Study|Other - Various|1|||
131829605|NCT03877926|474658036|FG003|Overall Study|Other - Various|0|||
131829606|NCT03877926|474658033|FG000|Overall Study|Not Treated|3|||
131829607|NCT03877926|474658034|FG001|Overall Study|Not Treated|1|||
131829608|NCT03877926|474658035|FG002|Overall Study|Not Treated|1|||
131829609|NCT03877926|474658036|FG003|Overall Study|Not Treated|0|||
131829610|NCT03554317|474658038|FG000|Overall Study|Withdrawal by Subject|1|||
131829611|NCT03554317|474658038|FG000|Overall Study|PSA Progression|3|||
131829612|NCT03554317|474658038|FG000|Overall Study|Radiographic Progression|4|||
131829613|NCT00939627|474658039|FG000|Overall Study|Disease Progression|16|||
131829614|NCT00939627|474658040|FG001|Overall Study|Disease Progression|12|||
131829615|NCT00939627|474658041|FG002|Overall Study|Disease Progression|0|||
131829616|NCT00939627|474658039|FG000|Overall Study|Adverse Event|6|||
131829617|NCT00939627|474658040|FG001|Overall Study|Adverse Event|7|||
131829618|NCT00939627|474658041|FG002|Overall Study|Adverse Event|0|||
131829619|NCT00939627|474658039|FG000|Overall Study|Death|0|||
131829620|NCT00939627|474658040|FG001|Overall Study|Death|2|||
131829621|NCT00939627|474658041|FG002|Overall Study|Death|0|||
131829622|NCT00939627|474658039|FG000|Overall Study|Withdrawal by Subject|2|||
131829623|NCT00939627|474658040|FG001|Overall Study|Withdrawal by Subject|4|||
131829624|NCT00939627|474658041|FG002|Overall Study|Withdrawal by Subject|0|||
131829625|NCT00939627|474658039|FG000|Overall Study|Other complicating disease|1|||
131829626|NCT00939627|474658040|FG001|Overall Study|Other complicating disease|1|||
131829627|NCT00939627|474658041|FG002|Overall Study|Other complicating disease|0|||
131829628|NCT00939627|474658039|FG000|Overall Study|Not compliant|2|||
131829629|NCT00939627|474658040|FG001|Overall Study|Not compliant|0|||
131829630|NCT00939627|474658041|FG002|Overall Study|Not compliant|0|||
131829631|NCT00939627|474658039|FG000|Overall Study|No off-tx reason given|0|||
131829632|NCT00939627|474658040|FG001|Overall Study|No off-tx reason given|2|||
131829633|NCT00939627|474658041|FG002|Overall Study|No off-tx reason given|0|||
131829634|NCT00124462|474658042|FG000|Overall Study|Lost to Follow-up|3|||
131829635|NCT00124462|474658043|FG001|Overall Study|Lost to Follow-up|3|||
131829636|NCT00124462|474658042|FG000|Overall Study|Physician Decision|3|||
131829637|NCT00124462|474658043|FG001|Overall Study|Physician Decision|4|||
131829638|NCT00124462|474658042|FG000|Overall Study|Withdrawal by Subject|4|||
131829639|NCT00124462|474658043|FG001|Overall Study|Withdrawal by Subject|5|||
131829640|NCT00124462|474658042|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
131829641|NCT00124462|474658043|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
131829642|NCT00537199|474658044|FG000|Overall Study|Study Terminated|1|||
131829643|NCT00467831|474658047|FG000|Overall Study|Death|2|||
131829644|NCT00467831|474658047|FG000|Overall Study|Withdrawal by Subject|1|||
131829645|NCT00860743|474658052|FG000|Overall Study|Withdrawal by Subject|3|||
131829646|NCT00860743|474658053|FG001|Overall Study|Withdrawal by Subject|0|||
131829647|NCT02776553|474658057|FG000|Overall Study|Lost to Follow-up|1|||
131829648|NCT02776553|474658058|FG001|Overall Study|Lost to Follow-up|0|||
131829649|NCT02776553|474658057|FG000|Overall Study|got liver transplant|1|||
131829650|NCT02776553|474658058|FG001|Overall Study|got liver transplant|2|||
131829651|NCT02776553|474658057|FG000|Overall Study|had other surgery|1|||
131829652|NCT02776553|474658058|FG001|Overall Study|had other surgery|0|||
131829653|NCT02776553|474658057|FG000|Overall Study|Protocol Violation|0|||
131829654|NCT02776553|474658058|FG001|Overall Study|Protocol Violation|1|||
131829655|NCT00171340|474658060|FG000|Overall Study|Adverse Event|46|||
131829656|NCT00171340|474658061|FG001|Overall Study|Adverse Event|42|||
131829657|NCT00171340|474658060|FG000|Overall Study|Lack of Efficacy|29|||
131829658|NCT00171340|474658061|FG001|Overall Study|Lack of Efficacy|41|||
131829659|NCT00171340|474658060|FG000|Overall Study|Protocol Violation|7|||
131829660|NCT00171340|474658061|FG001|Overall Study|Protocol Violation|8|||
131829661|NCT00171340|474658060|FG000|Overall Study|Withdrawal by Subject|22|||
131829662|NCT00171340|474658061|FG001|Overall Study|Withdrawal by Subject|19|||
131829663|NCT00171340|474658060|FG000|Overall Study|Lost to Follow-up|0|||
131829664|NCT00171340|474658061|FG001|Overall Study|Lost to Follow-up|5|||
131829665|NCT00171340|474658060|FG000|Overall Study|Abnormal Laboratory Results|2|||
131829666|NCT00171340|474658061|FG001|Overall Study|Abnormal Laboratory Results|0|||
131829667|NCT00171340|474658060|FG000|Overall Study|Abnormal Test Procedure Results|6|||
131829668|NCT00171340|474658061|FG001|Overall Study|Abnormal Test Procedure Results|11|||
131829669|NCT00171340|474658060|FG000|Overall Study|No Longer Required Study Drug|1|||
131829670|NCT00171340|474658061|FG001|Overall Study|No Longer Required Study Drug|1|||
131829671|NCT00171340|474658060|FG000|Overall Study|Administrative Problems|5|||
131829672|NCT00171340|474658061|FG001|Overall Study|Administrative Problems|2|||
131829673|NCT00171340|474658060|FG000|Overall Study|Death|6|||
131829674|NCT00171340|474658061|FG001|Overall Study|Death|6|||
131829675|NCT01056640|474658064|FG000|Overall Study|Withdrawal by Subject|11|||
131829676|NCT01056640|474658065|FG001|Overall Study|Withdrawal by Subject|8|||
131829677|NCT01056640|474658064|FG000|Overall Study|Death|15|||
131829678|NCT01056640|474658065|FG001|Overall Study|Death|4|||
131829679|NCT00775528|474658067|FG000|Overall Study|Protocol Violation|1|||
131829680|NCT01930175|474658068|FG000|Core Study|Lost to Follow-up|0|||
131829681|NCT01930175|474658069|FG001|Core Study|Lost to Follow-up|1|||
131829682|NCT01930175|474658070|FG002|Core Study|Lost to Follow-up|0|||
131829683|NCT01930175|474658068|FG000|Core Study|Adverse Event|0|||
131829684|NCT01930175|474658069|FG001|Core Study|Adverse Event|0|||
131829685|NCT01930175|474658070|FG002|Core Study|Adverse Event|1|||
131829686|NCT02820740|474658071|FG000|Overall Study|Did not have procedure|2|||
131829687|NCT00834899|474658072|FG000|Overall Study|Withdrawal by Subject|1|||
131829688|NCT00834899|474658073|FG001|Overall Study|Withdrawal by Subject|1|||
131829689|NCT01534637|474658074|FG000|Overall Study|Physician Decision|3|||
131829690|NCT01534637|474658074|FG000|Overall Study|Lack of Efficacy|3|||
131829691|NCT01534637|474658074|FG000|Overall Study|Withdrawal by Subject|1|||
131829692|NCT01534637|474658074|FG000|Overall Study|Adverse Event|1|||
131829693|NCT01534637|474658074|FG000|Overall Study|Liver Mets before treatment|1|||
131829694|NCT00605917|474658075|FG000|Overall Study|Protocol Violation|79|||
131829695|NCT00890552|474658076|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
131829696|NCT00890552|474658076|FG000|On-treatment|Early prog disease/ death|10|||
131829697|NCT04965389|474658078|FG000|Overall Study|Other reasons|1|||
131829698|NCT04965389|474658079|FG001|Overall Study|Other reasons|0|||
131829699|NCT04965389|474658080|FG002|Overall Study|Other reasons|0|||
131829700|NCT04965389|474658081|FG003|Overall Study|Other reasons|0|||
131829701|NCT04965389|474658078|FG000|Overall Study|Participant withdrew consent|0|||
131829702|NCT04965389|474658079|FG001|Overall Study|Participant withdrew consent|1|||
131829703|NCT04965389|474658080|FG002|Overall Study|Participant withdrew consent|0|||
131829704|NCT04965389|474658081|FG003|Overall Study|Participant withdrew consent|0|||
131829705|NCT04965389|474658078|FG000|Overall Study|Poor/Non-compliance|0|||
131829706|NCT04965389|474658079|FG001|Overall Study|Poor/Non-compliance|1|||
131829707|NCT04965389|474658080|FG002|Overall Study|Poor/Non-compliance|0|||
131910369|NCT01118299|474960742|FG001|Overall Study|Withdrawal by Subject|8|||
131910370|NCT01118299|474960741|FG000|Overall Study|Lost to Follow-up|2|||
131910371|NCT01118299|474960742|FG001|Overall Study|Lost to Follow-up|1|||
131910372|NCT01118299|474960741|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
131910373|NCT01118299|474960742|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
131910374|NCT01454284|474960743|FG000|Overall Study|Adverse Event|20|||
131829708|NCT04965389|474658081|FG003|Overall Study|Poor/Non-compliance|0|||
131829709|NCT03903159|474658084|FG000|Overall Study|Discharged with Staff Approval|2|||
131829710|NCT03903159|474658084|FG000|Overall Study|Discharged at Staff Request|2|||
131829711|NCT03903159|474658084|FG000|Overall Study|Discharged Against Staff Advice|1|||
131829712|NCT01506908|474658085|FG000|Overall Study|Adverse Event|1|||
131829713|NCT01506908|474658086|FG001|Overall Study|Adverse Event|0|||
131829714|NCT00925301|474658087|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
131829715|NCT00925301|474658088|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
131829716|NCT00925301|474658089|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
131829717|NCT00925301|474658090|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
131829718|NCT00925301|474658087|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
131829719|NCT00925301|474658088|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
131829720|NCT00925301|474658089|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
131829721|NCT00925301|474658090|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
131401605|NCT01032291|473091559|FG000|Safety Lead-in|Adverse Event|1|||
131401606|NCT01032291|473091560|FG001|Safety Lead-in|Adverse Event|0|||
131401607|NCT01032291|473091561|FG002|Safety Lead-in|Adverse Event|0|||
131401608|NCT01032291|473091559|FG000|Safety Lead-in|Death|1|||
131401609|NCT01032291|473091560|FG001|Safety Lead-in|Death|0|||
131401610|NCT01032291|473091561|FG002|Safety Lead-in|Death|0|||
131401611|NCT01032291|473091559|FG000|Proof of Concept|Adverse Event|0|||
131401612|NCT01032291|473091560|FG001|Proof of Concept|Adverse Event|5|||
131401613|NCT01032291|473091561|FG002|Proof of Concept|Adverse Event|1|||
131401614|NCT01032291|473091559|FG000|Proof of Concept|Death|0|||
131401615|NCT01032291|473091560|FG001|Proof of Concept|Death|1|||
131401616|NCT01032291|473091561|FG002|Proof of Concept|Death|2|||
131401617|NCT01032291|473091559|FG000|Proof of Concept|Lack of Efficacy|0|||
131401618|NCT01032291|473091560|FG001|Proof of Concept|Lack of Efficacy|1|||
131401619|NCT01032291|473091561|FG002|Proof of Concept|Lack of Efficacy|0|||
131401620|NCT01032291|473091559|FG000|Proof of Concept|Never Received Study Drug|0|||
131401621|NCT01032291|473091560|FG001|Proof of Concept|Never Received Study Drug|1|||
131401622|NCT01032291|473091561|FG002|Proof of Concept|Never Received Study Drug|0|||
131401623|NCT00313313|473091562|FG000|Overall Study|Lack of Efficacy|14|||
131401624|NCT00313313|473091563|FG001|Overall Study|Lack of Efficacy|9|||
131401625|NCT00313313|473091564|FG002|Overall Study|Lack of Efficacy|20|||
131401626|NCT00313313|473091562|FG000|Overall Study|Withdrawal of consent by subject|18|||
131401627|NCT00313313|473091563|FG001|Overall Study|Withdrawal of consent by subject|17|||
131401628|NCT00313313|473091564|FG002|Overall Study|Withdrawal of consent by subject|31|||
131401629|NCT00313313|473091562|FG000|Overall Study|Lost to Follow-up|10|||
131401630|NCT00313313|473091563|FG001|Overall Study|Lost to Follow-up|7|||
131401631|NCT00313313|473091564|FG002|Overall Study|Lost to Follow-up|9|||
131829722|NCT00925301|474658087|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
131829723|NCT00925301|474658088|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
131829724|NCT00925301|474658089|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
131829725|NCT00925301|474658090|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
131829726|NCT00925301|474658087|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
131829727|NCT00925301|474658088|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
131829728|NCT00925301|474658089|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
131829729|NCT00925301|474658090|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
131829730|NCT00925301|474658087|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
131829731|NCT00925301|474658088|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
131829732|NCT00925301|474658089|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
131829733|NCT00925301|474658090|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
131829734|NCT00925301|474658087|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
131829735|NCT00925301|474658088|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
131829736|NCT00925301|474658089|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
131829737|NCT00925301|474658090|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
131829738|NCT00925301|474658087|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
131829739|NCT00925301|474658088|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
131829740|NCT00925301|474658089|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
131829741|NCT00925301|474658090|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
131829742|NCT01117766|474658091|FG000|First Intervention|Adverse Event|0|||
131829743|NCT01117766|474658092|FG001|First Intervention|Adverse Event|1|||
131829744|NCT01117766|474658091|FG000|First Intervention|Protocol Violation|1|||
131829745|NCT01117766|474658092|FG001|First Intervention|Protocol Violation|0|||
131829746|NCT01117766|474658091|FG000|Washout Period|Protocol Violation|0|||
131829747|NCT01117766|474658092|FG001|Washout Period|Protocol Violation|2|||
131829748|NCT01117766|474658091|FG000|Second Intervention|Lost to Follow-up|1|||
131829749|NCT01117766|474658092|FG001|Second Intervention|Lost to Follow-up|0|||
131401632|NCT00313313|473091562|FG000|Overall Study|Adverse Event|15|||
131401633|NCT00313313|473091563|FG001|Overall Study|Adverse Event|16|||
131401634|NCT00313313|473091564|FG002|Overall Study|Adverse Event|12|||
131401635|NCT00313313|473091562|FG000|Overall Study|Physician Decision|2|||
131401636|NCT00313313|473091563|FG001|Overall Study|Physician Decision|6|||
131829750|NCT01117766|474658091|FG000|Second Intervention|Other|1|||
131829751|NCT01117766|474658092|FG001|Second Intervention|Other|2|||
131829752|NCT01117766|474658091|FG000|Second Intervention|Adverse Event|0|||
131401637|NCT00313313|473091564|FG002|Overall Study|Physician Decision|4|||
131401638|NCT00313313|473091562|FG000|Overall Study|Poor/Noncompliance|3|||
131401639|NCT00313313|473091563|FG001|Overall Study|Poor/Noncompliance|6|||
131401640|NCT00313313|473091564|FG002|Overall Study|Poor/Noncompliance|2|||
131401641|NCT00313313|473091562|FG000|Overall Study|Pregnancy|1|||
131401642|NCT00313313|473091563|FG001|Overall Study|Pregnancy|2|||
131401643|NCT00313313|473091564|FG002|Overall Study|Pregnancy|0|||
131401644|NCT00313313|473091562|FG000|Overall Study|Death|0|||
131829753|NCT01117766|474658092|FG001|Second Intervention|Adverse Event|2|||
131829754|NCT01117766|474658091|FG000|Second Intervention|Withdrawal by Subject|0|||
131829755|NCT01117766|474658092|FG001|Second Intervention|Withdrawal by Subject|1|||
131829756|NCT01117987|474658093|FG000|Overall Study|Protocol deviation|0|||
131829757|NCT01117987|474658094|FG001|Overall Study|Protocol deviation|1|||
131829758|NCT01117987|474658093|FG000|Overall Study|Subject no longer requires study drug|1|||
131829759|NCT01117987|474658094|FG001|Overall Study|Subject no longer requires study drug|0|||
131829760|NCT01117987|474658093|FG000|Overall Study|Lost to Follow-up|1|||
131829761|NCT01117987|474658094|FG001|Overall Study|Lost to Follow-up|1|||
131829762|NCT01117987|474658093|FG000|Overall Study|Abnormal test procedure result|2|||
131829763|NCT01117987|474658094|FG001|Overall Study|Abnormal test procedure result|0|||
131829764|NCT01117987|474658093|FG000|Overall Study|Lack of Efficacy|3|||
131829765|NCT01117987|474658094|FG001|Overall Study|Lack of Efficacy|4|||
131829766|NCT01117987|474658093|FG000|Overall Study|Death|5|||
131829767|NCT01117987|474658094|FG001|Overall Study|Death|10|||
131829768|NCT01117987|474658093|FG000|Overall Study|Withdrawal by Subject|5|||
131829769|NCT01117987|474658094|FG001|Overall Study|Withdrawal by Subject|10|||
131829770|NCT01117987|474658093|FG000|Overall Study|Adverse Event|19|||
131829771|NCT01117987|474658094|FG001|Overall Study|Adverse Event|26|||
131829772|NCT01117987|474658093|FG000|Overall Study|Administrative problems|25|||
131829773|NCT01117987|474658094|FG001|Overall Study|Administrative problems|22|||
131829774|NCT00440115|474658095|FG000|Overall Study|Death|7|||
131829775|NCT00440115|474658096|FG001|Overall Study|Death|9|||
131829776|NCT00440115|474658097|FG002|Overall Study|Death|5|||
131829777|NCT00440115|474658095|FG000|Overall Study|Incarceration|0|||
131829778|NCT00440115|474658096|FG001|Overall Study|Incarceration|2|||
131829779|NCT00440115|474658097|FG002|Overall Study|Incarceration|1|||
131829780|NCT03069417|474658098|FG000|Overall Study|Lost to Follow-up|2|||
131829781|NCT03069417|474658099|FG001|Overall Study|Lost to Follow-up|0|||
131829782|NCT03069417|474658098|FG000|Overall Study|Reason Unknown|4|||
131829783|NCT03069417|474658099|FG001|Overall Study|Reason Unknown|7|||
131829784|NCT02244424|474658100|FG000|Overall Study|Lost to Follow-up|20|||
131829785|NCT02244424|474658101|FG001|Overall Study|Lost to Follow-up|10|||
131829786|NCT00402025|474658102|FG000|Overall Study|Adverse Event|0|||
131829787|NCT00402025|474658103|FG001|Overall Study|Adverse Event|0|||
131829788|NCT00402025|474658104|FG002|Overall Study|Adverse Event|2|||
131829789|NCT00402025|474658102|FG000|Overall Study|Death|0|||
131829790|NCT00402025|474658103|FG001|Overall Study|Death|1|||
131829791|NCT00402025|474658104|FG002|Overall Study|Death|5|||
131829792|NCT00402025|474658102|FG000|Overall Study|Disease Progression|1|||
131829793|NCT00402025|474658103|FG001|Overall Study|Disease Progression|1|||
131829794|NCT00402025|474658104|FG002|Overall Study|Disease Progression|2|||
131829795|NCT00402025|474658102|FG000|Overall Study|Physician Decision|1|||
131829796|NCT00402025|474658103|FG001|Overall Study|Physician Decision|1|||
131829797|NCT00402025|474658104|FG002|Overall Study|Physician Decision|0|||
131829798|NCT00402025|474658102|FG000|Overall Study|Participant Decision|0|||
131829799|NCT00402025|474658103|FG001|Overall Study|Participant Decision|0|||
131829800|NCT00402025|474658104|FG002|Overall Study|Participant Decision|1|||
131829801|NCT00784134|474659573|FG000|Overall Study|Lost to Follow-up|3|||
131829802|NCT00784134|474659574|FG001|Overall Study|Lost to Follow-up|6|||
131829803|NCT03785145|474659575|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
131829804|NCT03785145|474659576|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
131829805|NCT03785145|474659575|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
131829806|NCT03785145|474659576|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
131829807|NCT03785145|474659575|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
131829808|NCT03785145|474659576|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
131829809|NCT03785145|474659575|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
131829810|NCT03785145|474659576|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
131829811|NCT03785145|474659575|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
131829812|NCT03785145|474659576|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
131829813|NCT03785145|474659575|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
131829814|NCT03785145|474659576|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
131829815|NCT03785145|474659575|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
131829816|NCT03785145|474659576|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
131829817|NCT03785145|474659575|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
131829818|NCT03785145|474659576|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
131829819|NCT03785145|474659575|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
131829820|NCT03785145|474659576|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
131829821|NCT03785145|474659575|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
131829822|NCT03785145|474659576|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
131829823|NCT03785145|474659575|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
131829824|NCT03785145|474659576|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
131829825|NCT02999984|474659577|FG000|Overall Study|Treatment Failure|1|||
131829826|NCT03250299|474659578|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
131829827|NCT03250299|474659579|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
131829828|NCT03250299|474659580|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
131829829|NCT03250299|474659581|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
131829830|NCT03250299|474659582|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
131829831|NCT03250299|474659578|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
131829832|NCT03250299|474659579|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
131829833|NCT03250299|474659580|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
131829834|NCT03250299|474659581|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
131829835|NCT03250299|474659582|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
131829836|NCT03250299|474659578|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
131829837|NCT03250299|474659579|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
131829838|NCT03250299|474659580|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
131829839|NCT03250299|474659581|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
131829840|NCT03250299|474659582|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
131829841|NCT03250299|474659578|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
131829842|NCT03250299|474659579|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
131829843|NCT03250299|474659580|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
131829844|NCT03250299|474659581|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
131829845|NCT03250299|474659582|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
131829846|NCT03346070|474659587|FG000|Overall Study|Death|0|||
131829847|NCT03346070|474659588|FG001|Overall Study|Death|0|||
131829848|NCT03346070|474659589|FG002|Overall Study|Death|0|||
131829849|NCT03346070|474659590|FG003|Overall Study|Death|0|||
131829850|NCT03346070|474659591|FG004|Overall Study|Death|1|||
131829851|NCT03346070|474659587|FG000|Overall Study|Lost to Follow-up|0|||
131829852|NCT03346070|474659588|FG001|Overall Study|Lost to Follow-up|1|||
131829853|NCT03346070|474659589|FG002|Overall Study|Lost to Follow-up|2|||
131829854|NCT03346070|474659590|FG003|Overall Study|Lost to Follow-up|0|||
131829855|NCT03346070|474659591|FG004|Overall Study|Lost to Follow-up|0|||
131829856|NCT03346070|474659587|FG000|Overall Study|Physician Decision|0|||
131829857|NCT03346070|474659588|FG001|Overall Study|Physician Decision|0|||
131829858|NCT03346070|474659589|FG002|Overall Study|Physician Decision|0|||
131829859|NCT03346070|474659590|FG003|Overall Study|Physician Decision|1|||
131829860|NCT03346070|474659591|FG004|Overall Study|Physician Decision|1|||
131829861|NCT03346070|474659587|FG000|Overall Study|Withdrawal by Subject|1|||
131829862|NCT03346070|474659588|FG001|Overall Study|Withdrawal by Subject|0|||
131829863|NCT03346070|474659589|FG002|Overall Study|Withdrawal by Subject|0|||
131829864|NCT03346070|474659590|FG003|Overall Study|Withdrawal by Subject|1|||
131829865|NCT03346070|474659591|FG004|Overall Study|Withdrawal by Subject|0|||
131829866|NCT03346070|474659587|FG000|Overall Study|Study medication not received as planned|2|||
131829867|NCT03346070|474659588|FG001|Overall Study|Study medication not received as planned|3|||
131829868|NCT03346070|474659589|FG002|Overall Study|Study medication not received as planned|2|||
131829869|NCT03346070|474659590|FG003|Overall Study|Study medication not received as planned|3|||
131829870|NCT03346070|474659591|FG004|Overall Study|Study medication not received as planned|2|||
131829871|NCT03346070|474659587|FG000|Overall Study|Screen Failure|0|||
131829872|NCT03346070|474659588|FG001|Overall Study|Screen Failure|0|||
131829873|NCT03346070|474659589|FG002|Overall Study|Screen Failure|0|||
131829874|NCT03346070|474659590|FG003|Overall Study|Screen Failure|1|||
131829875|NCT03346070|474659591|FG004|Overall Study|Screen Failure|1|||
131829876|NCT00977548|474659593|FG000|Overall Study|Ineligible|4|||
131829877|NCT00977548|474659593|FG000|Overall Study|Adverse Event|8|||
131829878|NCT00977548|474659593|FG000|Overall Study|Withdrawal by Subject|1|||
131829879|NCT04086641|474659594|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
131829880|NCT04086641|474659595|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
131829881|NCT01042535|474659598|FG000|Overall Study|disease progression prior to treatment|3|||
131829882|NCT01042535|474659598|FG000|Overall Study|disease progression during treatment|3|||
131829883|NCT01042535|474659598|FG000|Overall Study|complications from other disease|2|||
131829884|NCT01546142|474659599|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
131829885|NCT01546142|474659600|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
131829886|NCT01546142|474659599|FG000|Overall Study|Subject Noncompliance|1|||
131829887|NCT01546142|474659600|FG001|Overall Study|Subject Noncompliance|1|||
131829888|NCT01546142|474659599|FG000|Overall Study|Adverse Event|6|||
131829889|NCT01546142|474659600|FG001|Overall Study|Adverse Event|3|||
131829890|NCT01546142|474659599|FG000|Overall Study|Lost to Follow-up|20|||
131829891|NCT01546142|474659600|FG001|Overall Study|Lost to Follow-up|15|||
131829892|NCT01546142|474659599|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
131829893|NCT01546142|474659600|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
131829894|NCT01546142|474659599|FG000|Overall Study|Subject Randomized but Not Treated|1|||
131829895|NCT01546142|474659600|FG001|Overall Study|Subject Randomized but Not Treated|0|||
131829896|NCT03438539|474659609|FG000|Overall Study|Lost to Follow-up|8|||
131829897|NCT03438539|474659610|FG001|Overall Study|Lost to Follow-up|4|||
131829898|NCT03438539|474659611|FG002|Overall Study|Lost to Follow-up|10|||
131829899|NCT03438539|474659612|FG003|Overall Study|Lost to Follow-up|9|||
131829900|NCT03438539|474659613|FG004|Overall Study|Lost to Follow-up|3|||
131829901|NCT03438539|474659614|FG005|Overall Study|Lost to Follow-up|8|||
131829902|NCT04213209|474659615|FG000|Overall Study|Protocol Violation|1|||
131829903|NCT04213209|474659616|FG001|Overall Study|Protocol Violation|0|||
131829904|NCT04213209|474659617|FG002|Overall Study|Protocol Violation|0|||
131829905|NCT04213209|474659618|FG003|Overall Study|Protocol Violation|0|||
131829906|NCT04213209|474659619|FG004|Overall Study|Protocol Violation|0|||
131829907|NCT04213209|474659620|FG005|Overall Study|Protocol Violation|0|||
131829908|NCT04776746|474659626|FG000|Overall Study|Study terminated by sponsor|61|||
131829909|NCT04776746|474659626|FG000|Overall Study|Adverse Event|5|||
131829910|NCT04776746|474659626|FG000|Overall Study|Death|4|||
131829911|NCT04776746|474659626|FG000|Overall Study|Lack of Efficacy|3|||
131829912|NCT04776746|474659626|FG000|Overall Study|Noncompliance with study drug|2|||
131829913|NCT04776746|474659626|FG000|Overall Study|Not related to COVID-19|2|||
131829914|NCT01005329|474659629|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
131449909|NCT00561925|473276742|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
131829915|NCT01223235|474659630|FG000|Overall Study|Withdrawal by Subject|1|||
131829916|NCT01360866|474659635|FG000|Overall Study|Lost to Follow-up|11|||
131829917|NCT01360866|474659636|FG001|Overall Study|Lost to Follow-up|28|||
131829918|NCT01360866|474659637|FG002|Overall Study|Lost to Follow-up|41|||
131829919|NCT01360866|474659638|FG003|Overall Study|Lost to Follow-up|0|||
131829920|NCT01360866|474659635|FG000|Overall Study|Adverse Event|56|||
131829921|NCT01360866|474659636|FG001|Overall Study|Adverse Event|61|||
131829922|NCT01360866|474659637|FG002|Overall Study|Adverse Event|134|||
131829923|NCT01360866|474659638|FG003|Overall Study|Adverse Event|6|||
131829924|NCT01360866|474659635|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
131829925|NCT01360866|474659636|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
131829926|NCT01360866|474659637|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
131829927|NCT01360866|474659638|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
131829928|NCT01360866|474659635|FG000|Overall Study|Withdrawn by Investigator|9|||
131829929|NCT01360866|474659636|FG001|Overall Study|Withdrawn by Investigator|8|||
131829930|NCT01360866|474659637|FG002|Overall Study|Withdrawn by Investigator|31|||
131829931|NCT01360866|474659638|FG003|Overall Study|Withdrawn by Investigator|2|||
131829932|NCT01360866|474659635|FG000|Overall Study|Withdrawal by participant|79|||
131829933|NCT01360866|474659636|FG001|Overall Study|Withdrawal by participant|89|||
131829934|NCT01360866|474659637|FG002|Overall Study|Withdrawal by participant|168|||
131829935|NCT01360866|474659638|FG003|Overall Study|Withdrawal by participant|8|||
131829936|NCT01360866|474659635|FG000|Overall Study|Protocol Deviation|25|||
131829937|NCT01360866|474659636|FG001|Overall Study|Protocol Deviation|33|||
131829938|NCT01360866|474659637|FG002|Overall Study|Protocol Deviation|61|||
131829939|NCT01360866|474659638|FG003|Overall Study|Protocol Deviation|2|||
131829940|NCT01360866|474659635|FG000|Overall Study|Lack of Efficacy|30|||
131829941|NCT01360866|474659636|FG001|Overall Study|Lack of Efficacy|40|||
131829942|NCT01360866|474659637|FG002|Overall Study|Lack of Efficacy|30|||
131829943|NCT01360866|474659638|FG003|Overall Study|Lack of Efficacy|4|||
131829944|NCT03702049|474659642|FG000|Overall Study|Lost to Follow-up|4|||
131829945|NCT03702049|474659642|FG000|Overall Study|Physician Decision|1|||
131829946|NCT00608517|474659647|FG000|Overall Study|Death|1|||
131829947|NCT00608517|474659648|FG001|Overall Study|Death|0|||
131829948|NCT00608517|474659649|FG002|Overall Study|Death|0|||
131829949|NCT01501110|474659656|FG000|Overall Study|Death|0|||
131829950|NCT01501110|474659657|FG001|Overall Study|Death|1|||
131829951|NCT01731886|474659658|FG000|Overall Study|Death|1|||
131829952|NCT01731886|474659659|FG001|Overall Study|Death|0|||
131829953|NCT01731886|474659658|FG000|Overall Study|Never started treatment|0|||
131829954|NCT01731886|474659659|FG001|Overall Study|Never started treatment|1|||
131829955|NCT01731886|474659658|FG000|Overall Study|Non-compliant|1|||
131829956|NCT01731886|474659659|FG001|Overall Study|Non-compliant|0|||
131829957|NCT01261624|474659660|FG000|Week 0 to Week 12|Disease Progression|1|||
131829958|NCT01261624|474659661|FG001|Week 0 to Week 12|Disease Progression|1|||
131829959|NCT01261624|474659660|FG000|Week 0 to Week 12|Insufficient Response|0|||
131829960|NCT01261624|474659661|FG001|Week 0 to Week 12|Insufficient Response|2|||
131829961|NCT01261624|474659660|FG000|Week 13 to Week 24|Insufficient Response|0|||
131829962|NCT01261624|474659661|FG001|Week 13 to Week 24|Insufficient Response|1|||
131829963|NCT02094261|474659664|FG000|Overall Study|Death|24|||
131829964|NCT02094261|474659664|FG000|Overall Study|Lost to Follow-up|1|||
131829965|NCT02094261|474659664|FG000|Overall Study|Withdrawal by Subject|4|||
131829966|NCT02094261|474659664|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
131829967|NCT02363439|474659667|FG000|Overall Study|Lack of Efficacy|4|||
131829968|NCT01832402|474659668|FG000|Overall Study|Lost to Follow-up|2|||
131829969|NCT01832402|474659669|FG001|Overall Study|Lost to Follow-up|0|||
131829970|NCT01832402|474659668|FG000|Overall Study|Withdrawal by Subject|3|||
131829971|NCT01832402|474659669|FG001|Overall Study|Withdrawal by Subject|3|||
131829972|NCT01832402|474659668|FG000|Overall Study|Declining Performance status|2|||
131829973|NCT01832402|474659669|FG001|Overall Study|Declining Performance status|1|||
131829974|NCT00941720|474659670|FG000|Overall Study|Withdrawal by Subject|1|||
131829975|NCT00941720|474659670|FG000|Overall Study|Insurance denied participation|11|||
131829976|NCT00941720|474659670|FG000|Overall Study|ineligible|2|||
131829977|NCT01682148|474659671|FG000|Overall Study|Withdrawal by Subject|2|||
131829978|NCT01682148|474659672|FG001|Overall Study|Withdrawal by Subject|0|||
131449910|NCT00561925|473276738|FG000|14 Day Lead-In Period|Other|5|||
131449911|NCT00561925|473276739|FG001|14 Day Lead-In Period|Other|0|||
131449912|NCT00561925|473276740|FG002|14 Day Lead-In Period|Other|0|||
131449913|NCT00561925|473276741|FG003|14 Day Lead-In Period|Other|0|||
131449914|NCT00561925|473276742|FG004|14 Day Lead-In Period|Other|0|||
131449915|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
131449916|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
131449917|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
131449918|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
131449919|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
131449920|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
131449921|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
131449922|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
131449923|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
131449924|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
131449925|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
131449926|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
131449927|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
131449928|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
131449929|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
131449930|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
131449931|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
131449932|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
131449933|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
131449934|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
131449935|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
131449936|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
131449937|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
131449938|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
131449939|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
131449940|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
131449941|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
131449942|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
131449943|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
131449944|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
131449945|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Death|0|||
131449946|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Death|6|||
131449947|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Death|3|||
131449948|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Death|0|||
131449949|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Death|0|||
131449950|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
131449951|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
131449952|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
131449953|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
131449954|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
131449955|NCT00561925|473276738|FG000|144-week Double-blind, Double-dummy|Other|0|||
131449956|NCT00561925|473276739|FG001|144-week Double-blind, Double-dummy|Other|8|||
131449957|NCT00561925|473276740|FG002|144-week Double-blind, Double-dummy|Other|11|||
131449958|NCT00561925|473276741|FG003|144-week Double-blind, Double-dummy|Other|0|||
131829979|NCT01682148|474659671|FG000|Overall Study|Lost to Follow-up|1|||
131829980|NCT01682148|474659672|FG001|Overall Study|Lost to Follow-up|2|||
131829981|NCT01682148|474659671|FG000|Overall Study|Protocol Violation|1|||
131829982|NCT01682148|474659672|FG001|Overall Study|Protocol Violation|1|||
131829983|NCT03827018|474659673|FG000|Overall Study|Adverse Event|1|||
131829984|NCT03827018|474659674|FG001|Overall Study|Adverse Event|0|||
131829985|NCT03827018|474659673|FG000|Overall Study|Withdrawal by Subject|2|||
131829986|NCT03827018|474659674|FG001|Overall Study|Withdrawal by Subject|2|||
131829987|NCT03827018|474659673|FG000|Overall Study|Lack of Efficacy|0|||
131829988|NCT03827018|474659674|FG001|Overall Study|Lack of Efficacy|1|||
131829989|NCT01803269|474659677|FG000|Overall Study|Withdrawal by Subject|3|||
131829990|NCT01803269|474659678|FG001|Overall Study|Withdrawal by Subject|0|||
131829991|NCT01803269|474659679|FG002|Overall Study|Withdrawal by Subject|0|||
131829992|NCT02087176|474659680|FG000|Overall Study|Withdrawal by Subject|1|||
131829993|NCT02087176|474659680|FG000|Overall Study|Death|10|||
131829994|NCT02087176|474659680|FG000|Overall Study|Censored|19|||
131829995|NCT02087176|474659680|FG000|Overall Study|Study Terminated by Sponsor|2|||
131829996|NCT03648879|474659681|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
131829997|NCT03812991|474659684|FG000|Overall Study|Lost to Follow-up|3|||
131829998|NCT03812991|474659685|FG001|Overall Study|Lost to Follow-up|1|||
131829999|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
131830000|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
131830001|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
131830002|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
131830003|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
131830004|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
131830005|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
131830006|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
131830007|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
131830008|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
131830009|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
131830010|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
131830011|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
131830012|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
131830013|NCT04740931|474659686|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
131830014|NCT04740931|474659687|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
131830015|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
131830016|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
131830017|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
131830018|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
131830019|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
131830020|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
131830021|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
131830022|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
131830023|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
131830024|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
131830025|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
131830026|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
131830027|NCT04740931|474659686|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
131830028|NCT04740931|474659687|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
131830029|NCT04099641|474659693|FG000|Overall Study|Death|46|||
131830030|NCT04099641|474659694|FG001|Overall Study|Death|12|||
131830031|NCT04099641|474659693|FG000|Overall Study|Lost to Follow-up|1|||
131830032|NCT04099641|474659694|FG001|Overall Study|Lost to Follow-up|0|||
131830033|NCT04099641|474659693|FG000|Overall Study|Withdrawal by Subject|2|||
131830034|NCT04099641|474659694|FG001|Overall Study|Withdrawal by Subject|0|||
131830035|NCT01192399|474659701|FG000|Overall Study|Lack of Efficacy|2|||
131830036|NCT01029392|474659702|FG000|Overall Study|Withdrawal by Subject|18|||
131830037|NCT01029392|474659703|FG001|Overall Study|Withdrawal by Subject|11|||
131830038|NCT01029392|474659702|FG000|Overall Study|Physician Decision|2|||
131830039|NCT01029392|474659703|FG001|Overall Study|Physician Decision|0|||
131830040|NCT00063882|474659704|FG000|Overall Study|Protocol Violation|3|||
131830041|NCT00063882|474659705|FG001|Overall Study|Protocol Violation|3|||
131830042|NCT00063882|474659704|FG000|Overall Study|Withdrawal by Subject|2|||
131830043|NCT00063882|474659705|FG001|Overall Study|Withdrawal by Subject|1|||
131830044|NCT02443545|474659706|FG000|Overall Study|Adverse Event|1|||
131830045|NCT02443545|474659707|FG001|Overall Study|Adverse Event|1|||
131830046|NCT02443545|474659706|FG000|Overall Study|Lost to Follow-up|0|||
131830047|NCT02443545|474659707|FG001|Overall Study|Lost to Follow-up|2|||
131830048|NCT02443545|474659706|FG000|Overall Study|Physician Decision|3|||
131830049|NCT02443545|474659707|FG001|Overall Study|Physician Decision|0|||
131830050|NCT02443545|474659706|FG000|Overall Study|Protocol Violation|8|||
131830051|NCT02443545|474659707|FG001|Overall Study|Protocol Violation|1|||
131830052|NCT02443545|474659706|FG000|Overall Study|Pregnancy|1|||
131830053|NCT02443545|474659707|FG001|Overall Study|Pregnancy|1|||
131830054|NCT02443545|474659706|FG000|Overall Study|Withdrawal by Subject|6|||
131830055|NCT02443545|474659707|FG001|Overall Study|Withdrawal by Subject|3|||
131830056|NCT02443545|474659706|FG000|Overall Study|Termination of study|20|||
131830057|NCT02443545|474659707|FG001|Overall Study|Termination of study|11|||
131830058|NCT00724373|474659708|FG000|Overall Study|Adverse Event|41|||
131830059|NCT00724373|474659708|FG000|Overall Study|Lack of Efficacy|82|||
131830060|NCT00724373|474659708|FG000|Overall Study|Lost to Follow-up|7|||
131830061|NCT00724373|474659708|FG000|Overall Study|Non-compliance|2|||
131830062|NCT00724373|474659708|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
131830063|NCT00724373|474659708|FG000|Overall Study|Participant moved away|1|||
131830064|NCT00724373|474659708|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
131830065|NCT00724373|474659708|FG000|Overall Study|Only to have 24 week regimen|1|||
131830066|NCT00724373|474659708|FG000|Overall Study|Viral Relapse|1|||
131830067|NCT00724373|474659708|FG000|Overall Study|Acute HCV infection|1|||
131830068|NCT00724373|474659708|FG000|Overall Study|Drug Relapse|1|||
131830069|NCT00724373|474659708|FG000|Overall Study|Tolerability|23|||
131830070|NCT00536484|474659709|FG000|Overall Study|Adverse Event|21|||
131830071|NCT00536484|474659710|FG001|Overall Study|Adverse Event|34|||
131910375|NCT01454284|474960744|FG001|Overall Study|Adverse Event|7|||
131830072|NCT00536484|474659709|FG000|Overall Study|Withdrawal by Subject|11|||
131830073|NCT00536484|474659710|FG001|Overall Study|Withdrawal by Subject|11|||
131830074|NCT00536484|474659709|FG000|Overall Study|Lost to Follow-up|8|||
131830075|NCT00536484|474659710|FG001|Overall Study|Lost to Follow-up|6|||
131830076|NCT00536484|474659709|FG000|Overall Study|Lack of Efficacy|16|||
131830077|NCT00536484|474659710|FG001|Overall Study|Lack of Efficacy|5|||
131830078|NCT00536484|474659709|FG000|Overall Study|Other|4|||
131830079|NCT00536484|474659710|FG001|Overall Study|Other|0|||
131830080|NCT00562120|474659712|FG000|First Intervention Period|Adverse Event|1|||
131830081|NCT00562120|474659713|FG001|First Intervention Period|Adverse Event|0|||
131830082|NCT00562120|474659714|FG002|First Intervention Period|Adverse Event|0|||
131830083|NCT00562120|474659715|FG003|First Intervention Period|Adverse Event|0|||
131830084|NCT00562120|474659712|FG000|First Intervention Period|Randomized but not Treated|1|||
131830085|NCT00562120|474659713|FG001|First Intervention Period|Randomized but not Treated|0|||
131830086|NCT00562120|474659714|FG002|First Intervention Period|Randomized but not Treated|0|||
131830087|NCT00562120|474659715|FG003|First Intervention Period|Randomized but not Treated|0|||
131830088|NCT03366194|474659716|FG000|Overall Study|Lost to Follow-up|2|||
131830089|NCT02953678|474659720|FG000|Overall Study|Adverse Event|20|||
131830090|NCT02953678|474659720|FG000|Overall Study|Death|7|||
131830091|NCT02953678|474659720|FG000|Overall Study|Physician Decision|23|||
131830092|NCT02953678|474659720|FG000|Overall Study|Progressive Disease of GVHD|7|||
131830093|NCT02953678|474659720|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
131830094|NCT02953678|474659720|FG000|Overall Study|Withdrawal by participant|3|||
131830095|NCT02953678|474659720|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
131830096|NCT02953678|474659720|FG000|Overall Study|Participants were transferred to commercial product.|3|||
131830097|NCT00952276|474659723|FG000|Overall Study|Withdrawal by Subject|1|||
131830098|NCT00952276|474659724|FG001|Overall Study|Withdrawal by Subject|0|||
131830099|NCT00952276|474659725|FG002|Overall Study|Withdrawal by Subject|0|||
131830100|NCT00952276|474659726|FG003|Overall Study|Withdrawal by Subject|1|||
131830101|NCT00952276|474659727|FG004|Overall Study|Withdrawal by Subject|0|||
131830102|NCT01730040|474660936|FG000|Overall Study|Randomized but not treated|0|||
131830103|NCT01730040|474660937|FG001|Overall Study|Randomized but not treated|0|||
131830104|NCT01730040|474660938|FG002|Overall Study|Randomized but not treated|0|||
131830105|NCT01730040|474660939|FG003|Overall Study|Randomized but not treated|0|||
131830106|NCT01730040|474660940|FG004|Overall Study|Randomized but not treated|0|||
131830107|NCT01730040|474660941|FG005|Overall Study|Randomized but not treated|1|||
131830108|NCT01730040|474660942|FG006|Overall Study|Randomized but not treated|0|||
131830109|NCT01730040|474660936|FG000|Overall Study|Subject moved|0|||
131830110|NCT01730040|474660937|FG001|Overall Study|Subject moved|0|||
131830111|NCT01730040|474660938|FG002|Overall Study|Subject moved|1|||
131830112|NCT01730040|474660939|FG003|Overall Study|Subject moved|0|||
131830113|NCT01730040|474660940|FG004|Overall Study|Subject moved|0|||
131830114|NCT01730040|474660941|FG005|Overall Study|Subject moved|0|||
131830115|NCT01730040|474660942|FG006|Overall Study|Subject moved|1|||
131830116|NCT01730040|474660936|FG000|Overall Study|Physician Decision|0|||
131830117|NCT01730040|474660937|FG001|Overall Study|Physician Decision|0|||
131830118|NCT01730040|474660938|FG002|Overall Study|Physician Decision|0|||
131830119|NCT01730040|474660939|FG003|Overall Study|Physician Decision|0|||
131830120|NCT01730040|474660940|FG004|Overall Study|Physician Decision|0|||
131830121|NCT01730040|474660941|FG005|Overall Study|Physician Decision|1|||
131830122|NCT01730040|474660942|FG006|Overall Study|Physician Decision|1|||
131830123|NCT01730040|474660936|FG000|Overall Study|Other than specified|7|||
131830124|NCT01730040|474660937|FG001|Overall Study|Other than specified|8|||
131830125|NCT01730040|474660938|FG002|Overall Study|Other than specified|5|||
131830126|NCT01730040|474660939|FG003|Overall Study|Other than specified|5|||
131830127|NCT01730040|474660940|FG004|Overall Study|Other than specified|5|||
131830128|NCT01730040|474660941|FG005|Overall Study|Other than specified|4|||
131830129|NCT01730040|474660942|FG006|Overall Study|Other than specified|4|||
131830130|NCT01730040|474660936|FG000|Overall Study|Adverse Event|4|||
131830131|NCT01730040|474660937|FG001|Overall Study|Adverse Event|3|||
131830132|NCT01730040|474660938|FG002|Overall Study|Adverse Event|5|||
131830133|NCT01730040|474660939|FG003|Overall Study|Adverse Event|3|||
131830134|NCT01730040|474660940|FG004|Overall Study|Adverse Event|1|||
131830135|NCT01730040|474660941|FG005|Overall Study|Adverse Event|1|||
131830136|NCT01730040|474660942|FG006|Overall Study|Adverse Event|2|||
131830137|NCT01730040|474660936|FG000|Overall Study|Poor compliance to protocol|2|||
131830138|NCT01730040|474660937|FG001|Overall Study|Poor compliance to protocol|4|||
131830139|NCT01730040|474660938|FG002|Overall Study|Poor compliance to protocol|0|||
131830140|NCT01730040|474660939|FG003|Overall Study|Poor compliance to protocol|0|||
131830141|NCT01730040|474660940|FG004|Overall Study|Poor compliance to protocol|0|||
131830142|NCT01730040|474660941|FG005|Overall Study|Poor compliance to protocol|0|||
131830143|NCT01730040|474660942|FG006|Overall Study|Poor compliance to protocol|1|||
131830144|NCT01552369|474660943|FG000|Overall Study|Did not consent to extended follow up|8|||
131830145|NCT01552369|474660944|FG001|Overall Study|Did not consent to extended follow up|9|||
131830146|NCT01213836|474660948|FG000|Period 1, First Intervention|Adverse Event|2|||
131910376|NCT01454284|474960743|FG000|Overall Study|Death|0|||
131910377|NCT01454284|474960744|FG001|Overall Study|Death|3|||
131830147|NCT01213836|474660949|FG001|Period 1, First Intervention|Adverse Event|1|||
131830148|NCT01213836|474660948|FG000|Period 1, First Intervention|Protocol Violation|0|||
131830149|NCT01213836|474660949|FG001|Period 1, First Intervention|Protocol Violation|1|||
131830150|NCT01213836|474660948|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
131830151|NCT01213836|474660949|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
131830152|NCT03768726|474660954|FG000|Treatment Phase|Adverse Event|2|||
131830153|NCT03768726|474660955|FG001|Treatment Phase|Adverse Event|2|||
131830154|NCT03768726|474660954|FG000|Treatment Phase|Lost to Follow-up|1|||
131830155|NCT03768726|474660955|FG001|Treatment Phase|Lost to Follow-up|0|||
131830156|NCT03768726|474660954|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
131830157|NCT03768726|474660955|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
131830158|NCT03768726|474660954|FG000|Treatment Phase|Withdrawal by Subject|3|||
131830159|NCT03768726|474660955|FG001|Treatment Phase|Withdrawal by Subject|1|||
131830160|NCT03768726|474660954|FG000|Follow-Up|Adverse Event|2|||
131830161|NCT03768726|474660955|FG001|Follow-Up|Adverse Event|2|||
131830162|NCT03768726|474660954|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
131830163|NCT03768726|474660955|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
131830164|NCT03768726|474660954|FG000|Follow-Up|Withdrawal by Subject|2|||
131830165|NCT03768726|474660955|FG001|Follow-Up|Withdrawal by Subject|0|||
131830166|NCT03768726|474660954|FG000|Follow-Up|Other|1|||
131830167|NCT03768726|474660955|FG001|Follow-Up|Other|0|||
131830168|NCT01286558|474660956|FG000|Overall Study|Adverse Event|1|||
131830169|NCT01286558|474660957|FG001|Overall Study|Adverse Event|1|||
131830170|NCT01286558|474660956|FG000|Overall Study|Withdrawal by Subject|0|||
131830171|NCT01286558|474660957|FG001|Overall Study|Withdrawal by Subject|1|||
131830172|NCT01787279|474660959|FG000|Overall Study|Lost to Follow-up|2|||
131830173|NCT01787279|474660959|FG000|Overall Study|Lack of Efficacy|1|||
131830174|NCT04109313|474660965|FG000|Overall Study|Pregnancy|1|||
131830175|NCT04109313|474660965|FG000|Overall Study|Adverse Event|11|||
131830176|NCT04109313|474660965|FG000|Overall Study|Lack of Efficacy|11|||
131830177|NCT04109313|474660965|FG000|Overall Study|Lost to Follow-up|1|||
131830178|NCT04109313|474660965|FG000|Overall Study|Physician Decision|2|||
131830179|NCT04109313|474660965|FG000|Overall Study|Subject Decision|13|||
131830180|NCT04109313|474660965|FG000|Overall Study|Covid-19 situation|2|||
131830181|NCT01272921|474660966|FG000|Overall Study|Protocol Violation|2|||
131830182|NCT01272921|474660967|FG001|Overall Study|Protocol Violation|1|||
131830183|NCT01132664|474660968|FG000|Phase lb|Adverse Event|0|||
131830184|NCT01132664|474660969|FG001|Phase lb|Adverse Event|1|||
131830185|NCT01132664|474660970|FG002|Phase lb|Adverse Event|0|||
131830186|NCT01132664|474660971|FG003|Phase lb|Adverse Event|0|||
131830187|NCT01132664|474660972|FG004|Phase lb|Adverse Event|0|||
131830188|NCT01132664|474660968|FG000|Phase lb|Withdrawal by Subject|1|||
131830189|NCT01132664|474660969|FG001|Phase lb|Withdrawal by Subject|2|||
131830190|NCT01132664|474660970|FG002|Phase lb|Withdrawal by Subject|0|||
131830191|NCT01132664|474660971|FG003|Phase lb|Withdrawal by Subject|0|||
131830192|NCT01132664|474660972|FG004|Phase lb|Withdrawal by Subject|0|||
131830193|NCT01132664|474660968|FG000|Phase lb|Disease Progression|4|||
131830194|NCT01132664|474660969|FG001|Phase lb|Disease Progression|9|||
131830195|NCT01132664|474660970|FG002|Phase lb|Disease Progression|0|||
131830196|NCT01132664|474660971|FG003|Phase lb|Disease Progression|0|||
131830197|NCT01132664|474660972|FG004|Phase lb|Disease Progression|0|||
131830198|NCT01132664|474660968|FG000|Phase ll|Death|0|||
131830199|NCT01132664|474660969|FG001|Phase ll|Death|0|||
131830200|NCT01132664|474660970|FG002|Phase ll|Death|2|||
131830201|NCT01132664|474660971|FG003|Phase ll|Death|0|||
131830202|NCT01132664|474660972|FG004|Phase ll|Death|0|||
131830203|NCT01132664|474660968|FG000|Phase ll|Adverse Event|0|||
131830204|NCT01132664|474660969|FG001|Phase ll|Adverse Event|0|||
131830205|NCT01132664|474660970|FG002|Phase ll|Adverse Event|10|||
131830206|NCT01132664|474660971|FG003|Phase ll|Adverse Event|0|||
131830207|NCT01132664|474660972|FG004|Phase ll|Adverse Event|0|||
131830208|NCT01132664|474660968|FG000|Phase ll|Withdrawal by Subject|0|||
131830209|NCT01132664|474660969|FG001|Phase ll|Withdrawal by Subject|0|||
131830210|NCT01132664|474660970|FG002|Phase ll|Withdrawal by Subject|3|||
131830211|NCT01132664|474660971|FG003|Phase ll|Withdrawal by Subject|0|||
131830212|NCT01132664|474660972|FG004|Phase ll|Withdrawal by Subject|0|||
131830213|NCT01132664|474660968|FG000|Phase ll|Disease progression|0|||
131830214|NCT01132664|474660969|FG001|Phase ll|Disease progression|0|||
131830215|NCT01132664|474660970|FG002|Phase ll|Disease progression|35|||
131830216|NCT01132664|474660971|FG003|Phase ll|Disease progression|0|||
131910378|NCT01454284|474960743|FG000|Overall Study|Lost to Follow-up|13|||
131830217|NCT01132664|474660972|FG004|Phase ll|Disease progression|0|||
131830218|NCT01132664|474660968|FG000|BM Cohort|Disease progression|0|||
131830219|NCT01132664|474660969|FG001|BM Cohort|Disease progression|0|||
131830220|NCT01132664|474660970|FG002|BM Cohort|Disease progression|0|||
131830221|NCT01132664|474660971|FG003|BM Cohort|Disease progression|3|||
131830222|NCT01132664|474660972|FG004|BM Cohort|Disease progression|4|||
131830223|NCT01132664|474660968|FG000|BM Cohort|Adverse Event|0|||
131830224|NCT01132664|474660969|FG001|BM Cohort|Adverse Event|0|||
131830225|NCT01132664|474660970|FG002|BM Cohort|Adverse Event|0|||
131830226|NCT01132664|474660971|FG003|BM Cohort|Adverse Event|0|||
131830227|NCT01132664|474660972|FG004|BM Cohort|Adverse Event|1|||
131830228|NCT01132664|474660968|FG000|BM Cohort|Withdrawal by Subject|0|||
131830229|NCT01132664|474660969|FG001|BM Cohort|Withdrawal by Subject|0|||
131830230|NCT01132664|474660970|FG002|BM Cohort|Withdrawal by Subject|0|||
131830231|NCT01132664|474660971|FG003|BM Cohort|Withdrawal by Subject|0|||
131830232|NCT01132664|474660972|FG004|BM Cohort|Withdrawal by Subject|1|||
131830233|NCT00892281|474660976|FG000|Overall Study|Adverse Event|65|||
131830234|NCT00892281|474660977|FG001|Overall Study|Adverse Event|8|||
131830235|NCT00892281|474660976|FG000|Overall Study|Lost to Follow-up|81|||
131830236|NCT00892281|474660977|FG001|Overall Study|Lost to Follow-up|8|||
131830237|NCT00892281|474660976|FG000|Overall Study|Pregnancy|1|||
131830238|NCT00892281|474660977|FG001|Overall Study|Pregnancy|0|||
131830239|NCT00892281|474660976|FG000|Overall Study|Protocol Violation|7|||
131830240|NCT00892281|474660977|FG001|Overall Study|Protocol Violation|2|||
131830241|NCT00892281|474660976|FG000|Overall Study|Withdrawal by Subject|86|||
131830242|NCT00892281|474660977|FG001|Overall Study|Withdrawal by Subject|14|||
131830243|NCT00892281|474660976|FG000|Overall Study|Subject failed to return for final visit|2|||
131830244|NCT00892281|474660977|FG001|Overall Study|Subject failed to return for final visit|0|||
131830245|NCT00892281|474660976|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
131830246|NCT00892281|474660977|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
131830247|NCT00892281|474660976|FG000|Overall Study|Final visit completed 4 weeks late|0|||
131830248|NCT00892281|474660977|FG001|Overall Study|Final visit completed 4 weeks late|1|||
131830249|NCT00892281|474660976|FG000|Overall Study|Subject completed day after study closed|1|||
131830250|NCT00892281|474660977|FG001|Overall Study|Subject completed day after study closed|0|||
131830251|NCT00892281|474660976|FG000|Overall Study|Family emergency|1|||
131830252|NCT00892281|474660977|FG001|Overall Study|Family emergency|0|||
131830253|NCT00892281|474660976|FG000|Overall Study|Last visit not done - death in family|1|||
131830254|NCT00892281|474660977|FG001|Overall Study|Last visit not done - death in family|0|||
131830255|NCT00892281|474660976|FG000|Overall Study|Did not meet incl/excl criteria|1|||
131830256|NCT00892281|474660977|FG001|Overall Study|Did not meet incl/excl criteria|0|||
131830257|NCT00892281|474660976|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
131830258|NCT00892281|474660977|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
131830259|NCT00892281|474660976|FG000|Overall Study|Unable to redeem the drug voucher|1|||
131830260|NCT00892281|474660977|FG001|Overall Study|Unable to redeem the drug voucher|0|||
131830261|NCT00892281|474660976|FG000|Overall Study|Subject not good candidate for study|1|||
131830262|NCT00892281|474660977|FG001|Overall Study|Subject not good candidate for study|0|||
131830263|NCT00892281|474660976|FG000|Overall Study|Subject did not return for any visits|1|||
131830264|NCT00892281|474660977|FG001|Overall Study|Subject did not return for any visits|0|||
131830265|NCT00892281|474660976|FG000|Overall Study|Subject missed several visits/lost meds|1|||
131830266|NCT00892281|474660977|FG001|Overall Study|Subject missed several visits/lost meds|0|||
131830267|NCT00892281|474660976|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
131830268|NCT00892281|474660977|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
131830269|NCT00892281|474660976|FG000|Overall Study|Scheduled for knee replacement|0|||
131830270|NCT00892281|474660977|FG001|Overall Study|Scheduled for knee replacement|1|||
131830271|NCT00892281|474660976|FG000|Overall Study|PI complained of inadequate compensation|3|||
131830272|NCT00892281|474660977|FG001|Overall Study|PI complained of inadequate compensation|0|||
131830273|NCT00892281|474660976|FG000|Overall Study|Subject lost interest in program|0|||
131830274|NCT00892281|474660977|FG001|Overall Study|Subject lost interest in program|1|||
131830275|NCT00892281|474660976|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
131830276|NCT00892281|474660977|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
131830277|NCT00892281|474660976|FG000|Overall Study|Death in family|1|||
131830278|NCT00892281|474660977|FG001|Overall Study|Death in family|0|||
131830279|NCT00892281|474660976|FG000|Overall Study|Lack of efficacy of study product|2|||
131830280|NCT00892281|474660977|FG001|Overall Study|Lack of efficacy of study product|0|||
131830281|NCT00892281|474660976|FG000|Overall Study|Subject not seen by PI at final visit|1|||
131830282|NCT00892281|474660977|FG001|Overall Study|Subject not seen by PI at final visit|0|||
131830283|NCT00892281|474660976|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
131830284|NCT00892281|474660977|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
131830285|NCT00892281|474660976|FG000|Overall Study|Missed multiple visits|1|||
131830286|NCT00892281|474660977|FG001|Overall Study|Missed multiple visits|0|||
131830287|NCT00892281|474660976|FG000|Overall Study|Missed visits rescheduled out of window|1|||
131830288|NCT00892281|474660977|FG001|Overall Study|Missed visits rescheduled out of window|0|||
131830289|NCT00892281|474660976|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
131830290|NCT00892281|474660977|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
131910379|NCT01454284|474960744|FG001|Overall Study|Lost to Follow-up|8|||
131910380|NCT01454284|474960743|FG000|Overall Study|Protocol Violation|9|||
131830291|NCT00892281|474660976|FG000|Overall Study|Subject had history of drug abuse|1|||
131830292|NCT00892281|474660977|FG001|Overall Study|Subject had history of drug abuse|0|||
131830293|NCT00892281|474660976|FG000|Overall Study|Rash on hand|1|||
131830294|NCT00892281|474660977|FG001|Overall Study|Rash on hand|0|||
131830295|NCT00892281|474660976|FG000|Overall Study|Visit 4 date out of window|1|||
131830296|NCT00892281|474660977|FG001|Overall Study|Visit 4 date out of window|0|||
131830297|NCT00655850|474660978|FG000|Overall Study|Death|2|||
131830298|NCT00655850|474660978|FG000|Overall Study|Withdrawal by Subject|1|||
131830299|NCT01567826|474660981|FG000|Overall Study|Lost to Follow-up|3|||
131830300|NCT01567826|474660982|FG001|Overall Study|Lost to Follow-up|2|||
131830301|NCT01048502|474660998|FG000|Overall Study|Lost to Follow-up|2|||
131830302|NCT01048502|474660999|FG001|Overall Study|Lost to Follow-up|0|||
131830303|NCT01048502|474661000|FG002|Overall Study|Lost to Follow-up|0|||
131830304|NCT01048502|474661001|FG003|Overall Study|Lost to Follow-up|0|||
131830305|NCT01048502|474660998|FG000|Overall Study|Adverse Event|1|||
131830306|NCT01048502|474660999|FG001|Overall Study|Adverse Event|0|||
131830307|NCT01048502|474661000|FG002|Overall Study|Adverse Event|0|||
131830308|NCT01048502|474661001|FG003|Overall Study|Adverse Event|0|||
131830309|NCT01048502|474660998|FG000|Overall Study|Withdrawal by Subject|1|||
131830310|NCT01048502|474660999|FG001|Overall Study|Withdrawal by Subject|4|||
131830311|NCT01048502|474661000|FG002|Overall Study|Withdrawal by Subject|5|||
131830312|NCT01048502|474661001|FG003|Overall Study|Withdrawal by Subject|3|||
131830313|NCT01048502|474660998|FG000|Overall Study|Physician Decision|0|||
131830314|NCT01048502|474660999|FG001|Overall Study|Physician Decision|3|||
131830315|NCT01048502|474661000|FG002|Overall Study|Physician Decision|0|||
131830316|NCT01048502|474661001|FG003|Overall Study|Physician Decision|1|||
131830317|NCT01138826|474661003|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
131830318|NCT01138826|474661004|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
131830319|NCT01138826|474661005|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
131830320|NCT01138826|474661006|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
131830321|NCT01138826|474661007|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
131830322|NCT01138826|474661008|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
131830323|NCT01333072|474661012|FG000|Overall Study|Lost to Follow-up|3|||
131830324|NCT01333072|474661013|FG001|Overall Study|Lost to Follow-up|0|||
131830325|NCT01333072|474661012|FG000|Overall Study|Adverse Event|2|||
131830326|NCT01333072|474661013|FG001|Overall Study|Adverse Event|4|||
131830327|NCT01333072|474661012|FG000|Overall Study|Physician Decision|1|||
131830328|NCT01333072|474661013|FG001|Overall Study|Physician Decision|0|||
131830329|NCT01557842|474661014|FG000|Overall Study|Lost to Follow-up|0|||
131830330|NCT01557842|474661015|FG001|Overall Study|Lost to Follow-up|1|||
131830331|NCT01557842|474661014|FG000|Overall Study|Death|1|||
131830332|NCT01557842|474661015|FG001|Overall Study|Death|0|||
131830333|NCT01557842|474661014|FG000|Overall Study|Lack of Efficacy|0|||
131830334|NCT01557842|474661015|FG001|Overall Study|Lack of Efficacy|1|||
131830335|NCT01557842|474661014|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
131830336|NCT01557842|474661015|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
131830337|NCT01557842|474661014|FG000|Overall Study|Study Terminated by Sponsor|3|||
131830338|NCT01557842|474661015|FG001|Overall Study|Study Terminated by Sponsor|4|||
131830339|NCT01557842|474661014|FG000|Overall Study|Not Ablated|2|||
131830340|NCT01557842|474661015|FG001|Overall Study|Not Ablated|0|||
131830341|NCT02457611|474661019|FG000|Overall Study|Lost to Follow-up|3|||
131830342|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
131830343|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
131830344|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
131830345|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
131830346|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
131830347|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
131830348|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
131830349|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
131830350|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
131830351|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
131830352|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
131830353|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
131830354|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
131830355|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
131830356|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
131830357|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
131830358|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
131830359|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
131830360|NCT00384293|474661020|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
131830361|NCT00384293|474661021|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
131830362|NCT00384293|474661022|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
131830363|NCT00384293|474661020|FG000|Post-randomization Period|Adverse Event|0|||
131830364|NCT00384293|474661021|FG001|Post-randomization Period|Adverse Event|23|||
131830365|NCT00384293|474661022|FG002|Post-randomization Period|Adverse Event|7|||
131830366|NCT00384293|474661020|FG000|Post-randomization Period|Lost to Follow-up|0|||
131830367|NCT00384293|474661021|FG001|Post-randomization Period|Lost to Follow-up|2|||
131830368|NCT00384293|474661022|FG002|Post-randomization Period|Lost to Follow-up|1|||
131830369|NCT00384293|474661020|FG000|Post-randomization Period|Protocol Violation|0|||
131830370|NCT00384293|474661021|FG001|Post-randomization Period|Protocol Violation|1|||
131449959|NCT00561925|473276742|FG004|144-week Double-blind, Double-dummy|Other|0|||
131830371|NCT00384293|474661022|FG002|Post-randomization Period|Protocol Violation|0|||
131830372|NCT00384293|474661020|FG000|Post-randomization Period|Withdrawal by Subject|0|||
131830373|NCT00384293|474661021|FG001|Post-randomization Period|Withdrawal by Subject|8|||
131830374|NCT00384293|474661022|FG002|Post-randomization Period|Withdrawal by Subject|6|||
131830375|NCT00384293|474661020|FG000|Post-randomization Period|Trial Termination|0|||
131830376|NCT00384293|474661021|FG001|Post-randomization Period|Trial Termination|180|||
131830377|NCT00384293|474661022|FG002|Post-randomization Period|Trial Termination|204|||
131830378|NCT00384293|474661020|FG000|Post-randomization Period|Patient Randomized in Error|0|||
131830379|NCT00384293|474661021|FG001|Post-randomization Period|Patient Randomized in Error|0|||
131830380|NCT00384293|474661022|FG002|Post-randomization Period|Patient Randomized in Error|1|||
131830381|NCT05212883|474661023|FG000|Overall Study|Invalid test result|125|||
131830382|NCT02502734|474661024|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
131830383|NCT02502734|474661025|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
131830384|NCT02502734|474661024|FG000|Washout Period|Adverse Event|1|||
131830385|NCT02502734|474661025|FG001|Washout Period|Adverse Event|0|||
131830386|NCT02674386|474661030|FG000|Overall Study|Lost to Follow-up|0|||
131830387|NCT02674386|474661031|FG001|Overall Study|Lost to Follow-up|1|||
131830388|NCT02674386|474661032|FG002|Overall Study|Lost to Follow-up|1|||
131830389|NCT02674386|474661030|FG000|Overall Study|Withdrawal by Subject|0|||
131830390|NCT02674386|474661031|FG001|Overall Study|Withdrawal by Subject|4|||
131910381|NCT01454284|474960744|FG001|Overall Study|Protocol Violation|6|||
131910382|NCT01454284|474960743|FG000|Overall Study|Withdrawal by Subject|58|||
131449960|NCT00561925|473276738|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
131449961|NCT00561925|473276739|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
131449962|NCT00561925|473276740|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
131449963|NCT00561925|473276741|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
131449964|NCT00561925|473276742|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
131449965|NCT00891904|473276743|FG000|Overall Study|Death|1|||
131449966|NCT00891904|473276743|FG000|Overall Study|Adverse Event|1|||
131449967|NCT05021978|473276744|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
131449968|NCT05021978|473276745|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
131449969|NCT05021978|473276746|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
131449970|NCT05021978|473276747|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
131449971|NCT05021978|473276744|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
131449972|NCT05021978|473276745|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
131449973|NCT05021978|473276746|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
131449974|NCT05021978|473276747|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
131449975|NCT00043979|473276748|FG000|Period 1|recipient with progressive disease|7|||
131449976|NCT00043979|473276749|FG001|Period 1|recipient with progressive disease|4|||
131449977|NCT00043979|473276750|FG002|Period 1|recipient with progressive disease|3|||
131449978|NCT03096288|473276752|FG000|Overall Study|Withdrawal by Subject|0|||
131449979|NCT03096288|473276753|FG001|Overall Study|Withdrawal by Subject|1|||
131449980|NCT03096288|473276754|FG002|Overall Study|Withdrawal by Subject|0|||
131449981|NCT03096288|473276755|FG003|Overall Study|Withdrawal by Subject|1|||
131449982|NCT02004093|473276761|FG000|Overall Study|Death|2|||
131449983|NCT02004093|473276762|FG001|Overall Study|Death|1|||
131449984|NCT02004093|473276761|FG000|Overall Study|Lack of Efficacy|66|||
131449985|NCT02004093|473276762|FG001|Overall Study|Lack of Efficacy|62|||
131449986|NCT02004093|473276761|FG000|Overall Study|Protocol Violation|0|||
131449987|NCT02004093|473276762|FG001|Overall Study|Protocol Violation|1|||
131449988|NCT02004093|473276761|FG000|Overall Study|Lost to Follow-up|0|||
131449989|NCT02004093|473276762|FG001|Overall Study|Lost to Follow-up|1|||
131449990|NCT02004093|473276761|FG000|Overall Study|Withdrawal by Subject|3|||
131449991|NCT02004093|473276762|FG001|Overall Study|Withdrawal by Subject|7|||
131449992|NCT02004093|473276761|FG000|Overall Study|Other|3|||
131449993|NCT02004093|473276762|FG001|Overall Study|Other|1|||
131449994|NCT01411891|473276763|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
131449995|NCT01411891|473276764|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
131449996|NCT00414596|473276766|FG000|Overall Study|Protocol Violation|2|||
131449997|NCT04639258|473276767|FG000|Overall Study|Screen failure|5|||
131449998|NCT04639258|473276767|FG000|Overall Study|Physician Decision|2|||
131449999|NCT04639258|473276767|FG000|Overall Study|Early study termination|3|||
131450000|NCT04639258|473276767|FG000|Overall Study|Withdrawal by Subject|1|||
131450001|NCT00658359|473276769|FG000|Overall Study|Death|3|||
131450002|NCT00658359|473276770|FG001|Overall Study|Death|1|||
131450003|NCT00658359|473276771|FG002|Overall Study|Death|2|||
131450004|NCT00658359|473276769|FG000|Overall Study|Adverse Event|13|||
131450005|NCT00658359|473276770|FG001|Overall Study|Adverse Event|6|||
131830391|NCT02674386|474661032|FG002|Overall Study|Withdrawal by Subject|0|||
131830392|NCT02674386|474661030|FG000|Overall Study|Other|0|||
131910383|NCT01454284|474960744|FG001|Overall Study|Withdrawal by Subject|36|||
131910384|NCT01454284|474960743|FG000|Overall Study|Physician Decision|16|||
131910385|NCT01454284|474960744|FG001|Overall Study|Physician Decision|11|||
131830393|NCT02674386|474661031|FG001|Overall Study|Other|1|||
131830394|NCT02674386|474661032|FG002|Overall Study|Other|0|||
131830395|NCT02674386|474661030|FG000|Overall Study|Enrolled but not evaluated|0|||
131830396|NCT02674386|474661031|FG001|Overall Study|Enrolled but not evaluated|4|||
131830397|NCT02674386|474661032|FG002|Overall Study|Enrolled but not evaluated|0|||
131830398|NCT02462486|474661037|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
131830399|NCT02462486|474661038|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
131830400|NCT02462486|474661039|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
131830401|NCT02462486|474661037|FG000|Overall Study|Adverse Event|53|||
131830402|NCT02462486|474661038|FG001|Overall Study|Adverse Event|48|||
131830403|NCT02462486|474661039|FG002|Overall Study|Adverse Event|21|||
131830404|NCT02462486|474661037|FG000|Overall Study|Lack of Efficacy|6|||
131830405|NCT02462486|474661038|FG001|Overall Study|Lack of Efficacy|12|||
131830406|NCT02462486|474661039|FG002|Overall Study|Lack of Efficacy|3|||
131830407|NCT02462486|474661037|FG000|Overall Study|Lost to Follow-up|3|||
131830408|NCT02462486|474661038|FG001|Overall Study|Lost to Follow-up|4|||
131830409|NCT02462486|474661039|FG002|Overall Study|Lost to Follow-up|2|||
131830410|NCT02462486|474661037|FG000|Overall Study|Withdrawal by Subject|25|||
131830411|NCT02462486|474661038|FG001|Overall Study|Withdrawal by Subject|22|||
131830412|NCT02462486|474661039|FG002|Overall Study|Withdrawal by Subject|19|||
131830413|NCT02462486|474661037|FG000|Overall Study|Protocol Violation|3|||
131830414|NCT02462486|474661038|FG001|Overall Study|Protocol Violation|1|||
131830415|NCT02462486|474661039|FG002|Overall Study|Protocol Violation|1|||
131830416|NCT02462486|474661037|FG000|Overall Study|Reason not Specified|3|||
131830417|NCT02462486|474661038|FG001|Overall Study|Reason not Specified|4|||
131830418|NCT02462486|474661039|FG002|Overall Study|Reason not Specified|3|||
131830419|NCT05444543|474661040|FG000|Overall Study|Withdrawal by Subject|1|||
131830420|NCT05444543|474661041|FG001|Overall Study|Withdrawal by Subject|0|||
131830421|NCT05444543|474661040|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
131830422|NCT05444543|474661041|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
131830423|NCT05444543|474661040|FG000|Overall Study|Adverse Event|0|||
131830424|NCT05444543|474661041|FG001|Overall Study|Adverse Event|1|||
131830425|NCT05444543|474661040|FG000|Overall Study|Family relocating at a distance from study site|0|||
131830426|NCT05444543|474661041|FG001|Overall Study|Family relocating at a distance from study site|1|||
131830427|NCT04668274|474661042|FG000|Part 1 Study Period 1|Adverse Event|3|||
131830428|NCT04668274|474661043|FG001|Part 1 Study Period 1|Adverse Event|0|||
131830429|NCT04668274|474661044|FG002|Part 1 Study Period 1|Adverse Event|0|||
131830430|NCT04668274|474661045|FG003|Part 1 Study Period 1|Adverse Event|0|||
131830431|NCT04668274|474661042|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
131830432|NCT04668274|474661043|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
131830433|NCT04668274|474661044|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
131830434|NCT04668274|474661045|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
131830435|NCT04668274|474661042|FG000|Part 1 Study Period 2|Other|0|||
131830436|NCT04668274|474661043|FG001|Part 1 Study Period 2|Other|1|||
131830437|NCT04668274|474661044|FG002|Part 1 Study Period 2|Other|0|||
131830438|NCT04668274|474661045|FG003|Part 1 Study Period 2|Other|0|||
131830439|NCT04668274|474661042|FG000|Part 1 Study Period 3|Adverse Event|0|||
131830440|NCT04668274|474661043|FG001|Part 1 Study Period 3|Adverse Event|0|||
131830441|NCT04668274|474661044|FG002|Part 1 Study Period 3|Adverse Event|1|||
131830442|NCT04668274|474661045|FG003|Part 1 Study Period 3|Adverse Event|0|||
131830443|NCT04668274|474661042|FG000|Part 1 Study Period 3|Other|0|||
131830444|NCT04668274|474661043|FG001|Part 1 Study Period 3|Other|0|||
131830445|NCT04668274|474661044|FG002|Part 1 Study Period 3|Other|2|||
131830446|NCT04668274|474661045|FG003|Part 1 Study Period 3|Other|0|||
131830447|NCT04668274|474661042|FG000|Part 2 Study Period 4|Other|0|||
131830448|NCT04668274|474661043|FG001|Part 2 Study Period 4|Other|0|||
131830449|NCT04668274|474661044|FG002|Part 2 Study Period 4|Other|0|||
131830450|NCT04668274|474661045|FG003|Part 2 Study Period 4|Other|1|||
131830451|NCT01202877|474661046|FG000|Overall Study|Disease Progression|0|||
131830452|NCT01202877|474661047|FG001|Overall Study|Disease Progression|1|||
131830453|NCT01202877|474661048|FG002|Overall Study|Disease Progression|2|||
131830454|NCT01202877|474661046|FG000|Overall Study|Adverse Event|0|||
131830455|NCT01202877|474661047|FG001|Overall Study|Adverse Event|0|||
131830456|NCT01202877|474661048|FG002|Overall Study|Adverse Event|2|||
131910386|NCT01454284|474960743|FG000|Overall Study|Sponsor Decision|0|||
131830457|NCT01202877|474661046|FG000|Overall Study|Withdrawal by Subject|0|||
131830458|NCT01202877|474661047|FG001|Overall Study|Withdrawal by Subject|0|||
131830459|NCT01202877|474661048|FG002|Overall Study|Withdrawal by Subject|1|||
131830460|NCT01202877|474661046|FG000|Overall Study|Death|0|||
131830461|NCT01202877|474661047|FG001|Overall Study|Death|0|||
131830462|NCT01202877|474661048|FG002|Overall Study|Death|1|||
131830463|NCT03043560|474661051|FG000|Overall Study|Discontinued Intervention|1|||
131830464|NCT03043560|474661052|FG001|Overall Study|Discontinued Intervention|2|||
131830465|NCT03043560|474661051|FG000|Overall Study|Lost to Follow-up|0|||
131830466|NCT03043560|474661052|FG001|Overall Study|Lost to Follow-up|1|||
131830467|NCT01382251|474661053|FG000|Overall Study|Surgeries cancelled or delayed|16|||
131830468|NCT01382251|474661054|FG001|Overall Study|Surgeries cancelled or delayed|16|||
131830469|NCT01382251|474661053|FG000|Overall Study|Lost to Follow-up|4|||
131401645|NCT00313313|473091563|FG001|Overall Study|Death|0|||
131401646|NCT00313313|473091564|FG002|Overall Study|Death|2|||
131401647|NCT00313313|473091562|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
131401648|NCT00313313|473091563|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
131401649|NCT00313313|473091564|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
131401650|NCT00758264|473091565|FG000|Active Phase|Withdrawal by Subject|0|||
131401651|NCT00758264|473091566|FG001|Active Phase|Withdrawal by Subject|0|||
131401652|NCT00758264|473091567|FG002|Active Phase|Withdrawal by Subject|1|||
131401653|NCT00758264|473091565|FG000|Active Phase|Lost to Follow-up|1|||
131401654|NCT00758264|473091566|FG001|Active Phase|Lost to Follow-up|0|||
131401655|NCT00758264|473091567|FG002|Active Phase|Lost to Follow-up|0|||
131401656|NCT00758264|473091565|FG000|Active Phase|Other|0|||
131401657|NCT00758264|473091566|FG001|Active Phase|Other|0|||
131401658|NCT00758264|473091567|FG002|Active Phase|Other|4|||
131401659|NCT01177553|473091568|FG000|Overall Study|babies not yet 6 months of age|1|||
131401660|NCT01177553|473091569|FG001|Overall Study|babies not yet 6 months of age|0|||
131401661|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
131401662|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
131401663|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
131401664|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
131401665|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
131401666|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
131910387|NCT01454284|474960744|FG001|Overall Study|Sponsor Decision|2|||
131910388|NCT02665117|474960745|FG000|Overall Study|Physician Decision|1|||
131910389|NCT02665117|474960746|FG001|Overall Study|Physician Decision|0|||
131910390|NCT00784875|474960747|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
131910391|NCT00784875|474960748|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
131910392|NCT00784875|474960749|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
131910393|NCT00784875|474960750|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
131910394|NCT00784875|474960747|FG000|Period A - Baseline|Adverse Event|0|||
131910395|NCT00784875|474960748|FG001|Period A - Baseline|Adverse Event|0|||
131910396|NCT00784875|474960749|FG002|Period A - Baseline|Adverse Event|0|||
131910397|NCT00784875|474960750|FG003|Period A - Baseline|Adverse Event|8|||
131910398|NCT00784875|474960747|FG000|Period A - Baseline|Protocol Violation|0|||
131910399|NCT00784875|474960748|FG001|Period A - Baseline|Protocol Violation|0|||
131910400|NCT00784875|474960749|FG002|Period A - Baseline|Protocol Violation|0|||
131910401|NCT00784875|474960750|FG003|Period A - Baseline|Protocol Violation|25|||
131910402|NCT00784875|474960747|FG000|Period A - Baseline|Withdrawal by Subject|0|||
131910403|NCT00784875|474960748|FG001|Period A - Baseline|Withdrawal by Subject|0|||
131910404|NCT00784875|474960749|FG002|Period A - Baseline|Withdrawal by Subject|0|||
131910405|NCT00784875|474960750|FG003|Period A - Baseline|Withdrawal by Subject|27|||
131910406|NCT00784875|474960747|FG000|Period A - Baseline|Physician Decision|0|||
131910407|NCT00784875|474960748|FG001|Period A - Baseline|Physician Decision|0|||
131910408|NCT00784875|474960749|FG002|Period A - Baseline|Physician Decision|0|||
131910409|NCT00784875|474960750|FG003|Period A - Baseline|Physician Decision|2|||
131910410|NCT00784875|474960747|FG000|Period A - Baseline|Sponsor Decision|0|||
131910411|NCT00784875|474960748|FG001|Period A - Baseline|Sponsor Decision|0|||
131910412|NCT00784875|474960749|FG002|Period A - Baseline|Sponsor Decision|0|||
131910413|NCT00784875|474960750|FG003|Period A - Baseline|Sponsor Decision|113|||
131910414|NCT00784875|474960747|FG000|Period A - Baseline|Lost to Follow-up|0|||
131910415|NCT00784875|474960748|FG001|Period A - Baseline|Lost to Follow-up|0|||
131910416|NCT00784875|474960749|FG002|Period A - Baseline|Lost to Follow-up|0|||
131910417|NCT00784875|474960750|FG003|Period A - Baseline|Lost to Follow-up|2|||
131910418|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
131910419|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
131910420|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
131910421|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
131910422|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
131910423|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
131910424|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
131910425|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
131910426|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
131910427|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
131910428|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
131910429|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
131910430|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
131910431|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
131910432|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
131910433|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
131401667|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
131401668|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
131910434|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
131910435|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
131910436|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
131830470|NCT01382251|474661054|FG001|Overall Study|Lost to Follow-up|4|||
131830471|NCT01382251|474661053|FG000|Overall Study|Contacted after study closed|1|||
131830472|NCT01382251|474661054|FG001|Overall Study|Contacted after study closed|1|||
131830473|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
131830474|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
131830475|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
131830476|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
131830477|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
131830478|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
131830479|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
131830480|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
131830481|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
131830482|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
131830483|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
131830484|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
131830485|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Death|0|||
131830486|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Death|1|||
131830487|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Death|0|||
131830488|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Death|0|||
131830489|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
131830490|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
131830491|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
131830492|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
131830493|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
131830494|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
131830495|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
131830496|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
131830497|NCT00545688|474661058|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
131830498|NCT00545688|474661059|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
131830499|NCT00545688|474661060|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
131830500|NCT00545688|474661061|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
131830501|NCT00545688|474661058|FG000|Adjuvant Treatment Period|Disease Progression|3|||
131830502|NCT00545688|474661059|FG001|Adjuvant Treatment Period|Disease Progression|3|||
131830503|NCT00545688|474661060|FG002|Adjuvant Treatment Period|Disease Progression|0|||
131830504|NCT00545688|474661061|FG003|Adjuvant Treatment Period|Disease Progression|7|||
131830505|NCT00545688|474661058|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
131830506|NCT00545688|474661059|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
131830507|NCT00545688|474661060|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
131830508|NCT00545688|474661061|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
131830509|NCT00545688|474661058|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
131830510|NCT00545688|474661059|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
131830511|NCT00545688|474661060|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
131830512|NCT00545688|474661061|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
131830513|NCT00545688|474661058|FG000|Adjuvant Treatment Period|Adverse Event|0|||
131830514|NCT00545688|474661059|FG001|Adjuvant Treatment Period|Adverse Event|3|||
131830515|NCT00545688|474661060|FG002|Adjuvant Treatment Period|Adverse Event|2|||
131830516|NCT00545688|474661061|FG003|Adjuvant Treatment Period|Adverse Event|2|||
131830517|NCT00545688|474661058|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
131830518|NCT00545688|474661059|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
131830519|NCT00545688|474661060|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
131830520|NCT00545688|474661061|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
131830521|NCT00545688|474661058|FG000|Follow-Up Period|Death|4|||
131830522|NCT00545688|474661059|FG001|Follow-Up Period|Death|2|||
131830523|NCT00545688|474661060|FG002|Follow-Up Period|Death|2|||
131830524|NCT00545688|474661061|FG003|Follow-Up Period|Death|6|||
131830525|NCT00545688|474661058|FG000|Follow-Up Period|Disease Progression|6|||
131830526|NCT00545688|474661059|FG001|Follow-Up Period|Disease Progression|5|||
131830527|NCT00545688|474661060|FG002|Follow-Up Period|Disease Progression|9|||
131830528|NCT00545688|474661061|FG003|Follow-Up Period|Disease Progression|9|||
131830529|NCT00545688|474661058|FG000|Follow-Up Period|Refused Treatment|6|||
131830530|NCT00545688|474661059|FG001|Follow-Up Period|Refused Treatment|2|||
131830531|NCT00545688|474661060|FG002|Follow-Up Period|Refused Treatment|0|||
131830532|NCT00545688|474661061|FG003|Follow-Up Period|Refused Treatment|2|||
131830533|NCT00545688|474661058|FG000|Follow-Up Period|Lost to Follow-up|3|||
131830534|NCT00545688|474661059|FG001|Follow-Up Period|Lost to Follow-up|3|||
131830535|NCT00545688|474661060|FG002|Follow-Up Period|Lost to Follow-up|3|||
131830536|NCT00545688|474661061|FG003|Follow-Up Period|Lost to Follow-up|1|||
131830537|NCT00545688|474661058|FG000|Follow-Up Period|Unspecified Reason|2|||
131830538|NCT00545688|474661059|FG001|Follow-Up Period|Unspecified Reason|5|||
131830539|NCT00545688|474661060|FG002|Follow-Up Period|Unspecified Reason|6|||
131830540|NCT00545688|474661061|FG003|Follow-Up Period|Unspecified Reason|8|||
131830541|NCT00545688|474661058|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
131830542|NCT00545688|474661059|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
131830543|NCT00545688|474661060|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
131830544|NCT00545688|474661061|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
131830545|NCT03123783|474661062|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
131830546|NCT03123783|474661063|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
131830547|NCT03123783|474661064|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
131830548|NCT03123783|474661065|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
131830549|NCT03123783|474661066|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
131830550|NCT03123783|474661067|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
131830551|NCT03123783|474661068|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
131830552|NCT03123783|474661062|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
131830553|NCT03123783|474661063|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
131830554|NCT03123783|474661064|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
131830555|NCT03123783|474661065|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
131830556|NCT03123783|474661066|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
131830557|NCT03123783|474661067|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
131830558|NCT03123783|474661068|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
131830559|NCT03123783|474661062|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
131830560|NCT03123783|474661063|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
131830561|NCT03123783|474661064|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
131830562|NCT03123783|474661065|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
131830563|NCT03123783|474661066|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
131830564|NCT03123783|474661067|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
131830565|NCT03123783|474661068|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
131830566|NCT03123783|474661062|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
131830567|NCT03123783|474661063|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
131830568|NCT03123783|474661064|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
131830569|NCT03123783|474661065|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
131830570|NCT03123783|474661066|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
131830571|NCT03123783|474661067|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
131830572|NCT03123783|474661068|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
131830573|NCT01010126|474662869|FG000|Overall Study|Withdrawal by Subject|1|||
131830574|NCT01010126|474662870|FG001|Overall Study|Withdrawal by Subject|0|||
131830575|NCT01010126|474662871|FG002|Overall Study|Withdrawal by Subject|1|||
131830576|NCT01010126|474662872|FG003|Overall Study|Withdrawal by Subject|0|||
131830577|NCT01010126|474662873|FG004|Overall Study|Withdrawal by Subject|3|||
131830578|NCT01010126|474662874|FG005|Overall Study|Withdrawal by Subject|0|||
131830579|NCT00595335|474662877|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
131830580|NCT00595335|474662878|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
131830581|NCT00595335|474662877|FG000|Baseline to Six Months|Disease Progression|1|||
131830582|NCT00595335|474662878|FG001|Baseline to Six Months|Disease Progression|1|||
131830583|NCT00595335|474662877|FG000|Baseline to Six Months|Adverse Event|1|||
131830584|NCT00595335|474662878|FG001|Baseline to Six Months|Adverse Event|0|||
131830585|NCT00595335|474662877|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
131830586|NCT00595335|474662878|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
131830587|NCT00595335|474662877|FG000|Six Months to Twelve Months|Disease Progression|1|||
131830588|NCT00595335|474662878|FG001|Six Months to Twelve Months|Disease Progression|0|||
131830589|NCT01647958|474662882|FG000|Initial Study|Lost to Follow-up|2|||
131830590|NCT01647958|474662883|FG001|Initial Study|Lost to Follow-up|3|||
131830591|NCT01647958|474662882|FG000|Continuation Phase|treatment received during Overall Study|39|||
131830592|NCT01647958|474662883|FG001|Continuation Phase|treatment received during Overall Study|0|||
131830593|NCT01647958|474662882|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
131830594|NCT01647958|474662883|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
131830595|NCT00544817|474662884|FG000|Combined Modality|Lack of Efficacy|2|||
131830596|NCT00544817|474662884|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
131830597|NCT00544817|474662884|FG000|Combined Modality|Adverse Event|2|||
131830598|NCT00544817|474662884|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
131830599|NCT00544817|474662884|FG000|No Treatment Interval|Lack of Efficacy|8|||
131830600|NCT00544817|474662884|FG000|No Treatment Interval|Physician Decision|3|||
131830601|NCT00544817|474662884|FG000|No Treatment Interval|Adverse Event|1|||
131830602|NCT00544817|474662884|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
131830603|NCT00544817|474662884|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
131830604|NCT00544817|474662884|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
131830605|NCT01131299|474662885|FG000|Overall Study|Withdrawal by Subject|4|||
131830606|NCT01131299|474662886|FG001|Overall Study|Withdrawal by Subject|7|||
131450006|NCT00658359|473276771|FG002|Overall Study|Adverse Event|9|||
131830607|NCT03686150|474662893|FG000|Overall Study|Withdrawal by Subject|1|||
131830608|NCT03686150|474662894|FG001|Overall Study|Withdrawal by Subject|1|||
131830609|NCT03686150|474662895|FG002|Overall Study|Withdrawal by Subject|1|||
131830610|NCT03686150|474662896|FG003|Overall Study|Withdrawal by Subject|0|||
131830611|NCT03686150|474662897|FG004|Overall Study|Withdrawal by Subject|1|||
131830612|NCT03686150|474662898|FG005|Overall Study|Withdrawal by Subject|2|||
131830613|NCT03686150|474662893|FG000|Overall Study|Physician Decision|1|||
131830614|NCT03686150|474662894|FG001|Overall Study|Physician Decision|0|||
131830615|NCT03686150|474662895|FG002|Overall Study|Physician Decision|0|||
131830616|NCT03686150|474662896|FG003|Overall Study|Physician Decision|0|||
131830617|NCT03686150|474662897|FG004|Overall Study|Physician Decision|0|||
131830618|NCT03686150|474662898|FG005|Overall Study|Physician Decision|1|||
131830619|NCT03686150|474662893|FG000|Overall Study|Lost to Follow-up|0|||
131830620|NCT03686150|474662894|FG001|Overall Study|Lost to Follow-up|1|||
131830621|NCT03686150|474662895|FG002|Overall Study|Lost to Follow-up|0|||
131830622|NCT03686150|474662896|FG003|Overall Study|Lost to Follow-up|0|||
131830623|NCT03686150|474662897|FG004|Overall Study|Lost to Follow-up|0|||
131830624|NCT03686150|474662898|FG005|Overall Study|Lost to Follow-up|0|||
131830625|NCT00614926|474662899|FG000|Overall Study|Burden of travel|1|||
131830626|NCT00614926|474662900|FG001|Overall Study|Burden of travel|0|||
131830627|NCT00614926|474662899|FG000|Overall Study|Adverse Event|3|||
131830628|NCT00614926|474662900|FG001|Overall Study|Adverse Event|0|||
131830629|NCT03341000|474662903|FG000|Overall Study|Adverse Event|1|||
131830630|NCT02676284|474662918|FG000|Overall Study|Withdrawal by Subject|1|||
131830631|NCT00107042|474662919|FG000|Overall Study|Lost to Follow-up|9|||
131830632|NCT00107042|474662920|FG001|Overall Study|Lost to Follow-up|7|||
131830633|NCT00107042|474662919|FG000|Overall Study|Withdrawal by Subject|6|||
131830634|NCT00107042|474662920|FG001|Overall Study|Withdrawal by Subject|1|||
131830635|NCT00107042|474662919|FG000|Overall Study|Moved out of area|5|||
131830636|NCT00107042|474662920|FG001|Overall Study|Moved out of area|3|||
131830637|NCT00107042|474662919|FG000|Overall Study|Pregnancy|1|||
131830638|NCT00107042|474662920|FG001|Overall Study|Pregnancy|1|||
131830639|NCT00107042|474662919|FG000|Overall Study|Inadvertent enrollment|0|||
131830640|NCT00107042|474662920|FG001|Overall Study|Inadvertent enrollment|1|||
131830641|NCT00107042|474662919|FG000|Overall Study|vaccinated outside window|1|||
131830642|NCT00107042|474662920|FG001|Overall Study|vaccinated outside window|1|||
131830643|NCT00107042|474662919|FG000|Overall Study|Disallowed medications|0|||
131830644|NCT00107042|474662920|FG001|Overall Study|Disallowed medications|2|||
131830645|NCT00140413|474662924|FG000|Overall Study|Lost to Follow-up|1|||
131830646|NCT00140413|474662925|FG001|Overall Study|Lost to Follow-up|0|||
131830647|NCT00140413|474662924|FG000|Overall Study|Withdrawal by Subject|2|||
131830648|NCT00140413|474662925|FG001|Overall Study|Withdrawal by Subject|0|||
131830649|NCT00865098|474662926|FG000|Overall Study|Progressive disease|1|||
131830650|NCT01304693|474662927|FG000|Overall Study|Adverse Event|0|||
131830651|NCT01304693|474662928|FG001|Overall Study|Adverse Event|0|||
131830652|NCT01304693|474662929|FG002|Overall Study|Adverse Event|0|||
131830653|NCT01304693|474662930|FG003|Overall Study|Adverse Event|0|||
131830654|NCT01304693|474662931|FG004|Overall Study|Adverse Event|1|||
131830655|NCT01304693|474662927|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
131830656|NCT01304693|474662928|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
131830657|NCT01304693|474662929|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
131830658|NCT01304693|474662930|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
131830659|NCT01304693|474662931|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
131830660|NCT02129647|474662932|FG000|Overall Study|Adverse Event|2|||
131830661|NCT02129647|474662932|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
131830662|NCT01715896|474662935|FG000|Overall Study|Lost to Follow-up|0|||
131830663|NCT01715896|474662936|FG001|Overall Study|Lost to Follow-up|2|||
131830664|NCT01715896|474662935|FG000|Overall Study|Withdrawal by Subject|1|||
131830665|NCT01715896|474662936|FG001|Overall Study|Withdrawal by Subject|4|||
131830666|NCT01715896|474662935|FG000|Overall Study|Other|2|||
131830667|NCT01715896|474662936|FG001|Overall Study|Other|5|||
131830668|NCT01570283|474662942|FG000|Cohort 1: Dose Level 1|Death|0|||
131830669|NCT01570283|474662943|FG001|Cohort 1: Dose Level 1|Death|1|||
131830670|NCT01570283|474662944|FG002|Cohort 1: Dose Level 1|Death|0|||
131830671|NCT01570283|474662945|FG003|Cohort 1: Dose Level 1|Death|0|||
131830672|NCT01570283|474662946|FG004|Cohort 1: Dose Level 1|Death|0|||
131830673|NCT01570283|474662947|FG005|Cohort 1: Dose Level 1|Death|0|||
131830674|NCT01570283|474662942|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
131830675|NCT01570283|474662943|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
131830676|NCT01570283|474662944|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
131830677|NCT01570283|474662945|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
131830678|NCT01570283|474662946|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
131830679|NCT01570283|474662947|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
131830680|NCT01570283|474662942|FG000|Cohort 2: Dose Level 2|Death|0|||
131830681|NCT01570283|474662943|FG001|Cohort 2: Dose Level 2|Death|0|||
131830682|NCT01570283|474662944|FG002|Cohort 2: Dose Level 2|Death|1|||
131830683|NCT01570283|474662945|FG003|Cohort 2: Dose Level 2|Death|0|||
131830684|NCT01570283|474662946|FG004|Cohort 2: Dose Level 2|Death|0|||
131830685|NCT01570283|474662947|FG005|Cohort 2: Dose Level 2|Death|0|||
131830686|NCT01570283|474662942|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
131830687|NCT01570283|474662943|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
131830688|NCT01570283|474662944|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
131830689|NCT01570283|474662945|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
131830690|NCT01570283|474662946|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
131830691|NCT01570283|474662947|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
131830692|NCT01570283|474662942|FG000|Cohort 3: Dose Level 3|Death|0|||
131830693|NCT01570283|474662943|FG001|Cohort 3: Dose Level 3|Death|0|||
131830694|NCT01570283|474662944|FG002|Cohort 3: Dose Level 3|Death|0|||
131830695|NCT01570283|474662945|FG003|Cohort 3: Dose Level 3|Death|0|||
131830696|NCT01570283|474662946|FG004|Cohort 3: Dose Level 3|Death|0|||
131830697|NCT01570283|474662947|FG005|Cohort 3: Dose Level 3|Death|1|||
131830698|NCT01570283|474662942|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
131830699|NCT01570283|474662943|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
131830700|NCT01570283|474662944|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
131830701|NCT01570283|474662945|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
131830702|NCT01570283|474662946|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
131830703|NCT01570283|474662947|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
131830704|NCT01833533|474662950|FG000|Overall Study|Adverse Event|0|||
131830705|NCT01833533|474662951|FG001|Overall Study|Adverse Event|1|||
131830706|NCT01833533|474662950|FG000|Overall Study|Lost to Follow-up|4|||
131830707|NCT01833533|474662951|FG001|Overall Study|Lost to Follow-up|9|||
131830708|NCT01833533|474662950|FG000|Overall Study|To Enter an Extension Study|0|||
131830709|NCT01833533|474662951|FG001|Overall Study|To Enter an Extension Study|4|||
131830710|NCT01833533|474662950|FG000|Overall Study|Other|2|||
131830711|NCT01833533|474662951|FG001|Overall Study|Other|7|||
131830712|NCT03005067|474662952|FG000|Overall Study|Withdrawal by Subject|3|||
131830713|NCT03005067|474662953|FG001|Overall Study|Withdrawal by Subject|2|||
131830714|NCT03005067|474662952|FG000|Overall Study|Adverse Event|4|||
131830715|NCT03005067|474662953|FG001|Overall Study|Adverse Event|3|||
131830716|NCT03005067|474662952|FG000|Overall Study|Other (reason not specified)|3|||
131830717|NCT03005067|474662953|FG001|Overall Study|Other (reason not specified)|1|||
131830718|NCT03005067|474662952|FG000|Overall Study|Protocol Violation|0|||
131830719|NCT03005067|474662953|FG001|Overall Study|Protocol Violation|1|||
131830720|NCT01483625|474662959|FG000|Overall Study|Adverse Event|1|||
131830721|NCT01483625|474662960|FG001|Overall Study|Adverse Event|1|||
131830722|NCT01483625|474662959|FG000|Overall Study|Refused to continue medication|2|||
131830723|NCT01483625|474662960|FG001|Overall Study|Refused to continue medication|1|||
131830724|NCT01483625|474662959|FG000|Overall Study|Due to other reason|1|||
131830725|NCT01483625|474662960|FG001|Overall Study|Due to other reason|0|||
131830726|NCT02280187|474662964|FG000|Overall Study|Lost to Follow-up|218|||
131830727|NCT03176784|474662976|FG000|Overall Study|Lost to Follow-up|77|||
131830728|NCT03176784|474662977|FG001|Overall Study|Lost to Follow-up|79|||
131830729|NCT03176784|474662978|FG002|Overall Study|Lost to Follow-up|79|||
131830730|NCT03176784|474662979|FG003|Overall Study|Lost to Follow-up|49|||
131830731|NCT03176784|474662976|FG000|Overall Study|Withdrawal by Subject|28|||
131830732|NCT03176784|474662977|FG001|Overall Study|Withdrawal by Subject|34|||
131830733|NCT03176784|474662978|FG002|Overall Study|Withdrawal by Subject|34|||
131830734|NCT03176784|474662979|FG003|Overall Study|Withdrawal by Subject|21|||
131830735|NCT00396331|474662980|FG000|Overall Study|Failed to mobilize - no transplant|8|||
131830736|NCT00396331|474662980|FG000|Overall Study|Did not go on to transplant|5|||
131830737|NCT00396331|474662980|FG000|Overall Study|Lost to Follow-up|3|||
131830738|NCT00396331|474662980|FG000|Overall Study|Death|16|||
131830739|NCT01351350|474662981|FG000|Overall Study|Disease Progression|5|||
131830740|NCT01351350|474662982|FG001|Overall Study|Disease Progression|13|||
131830741|NCT01351350|474662983|FG002|Overall Study|Disease Progression|6|||
131830742|NCT01351350|474662984|FG003|Overall Study|Disease Progression|8|||
131830743|NCT01351350|474662985|FG004|Overall Study|Disease Progression|5|||
131830744|NCT01351350|474662981|FG000|Overall Study|Adverse Event|1|||
131830745|NCT01351350|474662982|FG001|Overall Study|Adverse Event|10|||
131830746|NCT01351350|474662983|FG002|Overall Study|Adverse Event|1|||
131830747|NCT01351350|474662984|FG003|Overall Study|Adverse Event|2|||
131910437|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
131830748|NCT01351350|474662985|FG004|Overall Study|Adverse Event|0|||
131830749|NCT01351350|474662981|FG000|Overall Study|Participant Decision|2|||
131830750|NCT01351350|474662982|FG001|Overall Study|Participant Decision|6|||
131830751|NCT01351350|474662983|FG002|Overall Study|Participant Decision|3|||
131830752|NCT01351350|474662984|FG003|Overall Study|Participant Decision|3|||
131830753|NCT01351350|474662985|FG004|Overall Study|Participant Decision|2|||
131830754|NCT01351350|474662981|FG000|Overall Study|Enrolled but not Treated|0|||
131830755|NCT01351350|474662982|FG001|Overall Study|Enrolled but not Treated|0|||
131830756|NCT01351350|474662983|FG002|Overall Study|Enrolled but not Treated|1|||
131910438|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
131910439|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
131450007|NCT00658359|473276769|FG000|Overall Study|Protocol Violation|1|||
131450008|NCT00658359|473276770|FG001|Overall Study|Protocol Violation|0|||
131450009|NCT00658359|473276771|FG002|Overall Study|Protocol Violation|0|||
131450010|NCT00658359|473276769|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
131450011|NCT00658359|473276770|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
131450012|NCT00658359|473276771|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
131450013|NCT00658359|473276769|FG000|Overall Study|Withdrawal by Subject|7|||
131450014|NCT00658359|473276770|FG001|Overall Study|Withdrawal by Subject|4|||
131450015|NCT00658359|473276771|FG002|Overall Study|Withdrawal by Subject|2|||
131450016|NCT00658359|473276769|FG000|Overall Study|Lost to Follow-up|2|||
131450017|NCT00658359|473276770|FG001|Overall Study|Lost to Follow-up|2|||
131450018|NCT00658359|473276771|FG002|Overall Study|Lost to Follow-up|4|||
131450019|NCT00658359|473276769|FG000|Overall Study|Lack of Efficacy|0|||
131450020|NCT00658359|473276770|FG001|Overall Study|Lack of Efficacy|1|||
131450021|NCT00658359|473276771|FG002|Overall Study|Lack of Efficacy|0|||
131450022|NCT02754440|473276772|FG000|Overall Study|Protocol Violation|3|||
131450023|NCT02754440|473276773|FG001|Overall Study|Protocol Violation|2|||
131450024|NCT02754440|473276774|FG002|Overall Study|Protocol Violation|2|||
131450025|NCT02754440|473276775|FG003|Overall Study|Protocol Violation|6|||
131450026|NCT02754440|473276772|FG000|Overall Study|Adverse Event|3|||
131450027|NCT02754440|473276773|FG001|Overall Study|Adverse Event|1|||
131450028|NCT02754440|473276774|FG002|Overall Study|Adverse Event|0|||
131450029|NCT02754440|473276775|FG003|Overall Study|Adverse Event|9|||
131450030|NCT02754440|473276772|FG000|Overall Study|Withdrawal by Subject|0|||
131450031|NCT02754440|473276773|FG001|Overall Study|Withdrawal by Subject|0|||
131450032|NCT02754440|473276774|FG002|Overall Study|Withdrawal by Subject|0|||
131450033|NCT02754440|473276775|FG003|Overall Study|Withdrawal by Subject|1|||
131450034|NCT02754440|473276772|FG000|Overall Study|Equipment failure|0|||
131450035|NCT02754440|473276773|FG001|Overall Study|Equipment failure|5|||
131450036|NCT02754440|473276774|FG002|Overall Study|Equipment failure|5|||
131450037|NCT02754440|473276775|FG003|Overall Study|Equipment failure|7|||
131450038|NCT02754440|473276772|FG000|Overall Study|Subject issues not resulting in AE|0|||
131450039|NCT02754440|473276773|FG001|Overall Study|Subject issues not resulting in AE|0|||
131450040|NCT02754440|473276774|FG002|Overall Study|Subject issues not resulting in AE|0|||
131450041|NCT02754440|473276775|FG003|Overall Study|Subject issues not resulting in AE|12|||
131450042|NCT02558296|473276776|FG000|Completed the Study Through Week 24|Adverse Event|9|||
131450043|NCT02558296|473276777|FG001|Completed the Study Through Week 24|Adverse Event|3|||
131450044|NCT02558296|473276776|FG000|Completed the Study Through Week 24|Death|7|||
131450045|NCT02558296|473276777|FG001|Completed the Study Through Week 24|Death|7|||
131450046|NCT02558296|473276776|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
131450047|NCT02558296|473276777|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
131450048|NCT02558296|473276776|FG000|Completed the Study Through Week 24|Physician Decision|1|||
131450049|NCT02558296|473276777|FG001|Completed the Study Through Week 24|Physician Decision|0|||
131450050|NCT02558296|473276776|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
131450051|NCT02558296|473276777|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
131450052|NCT02558296|473276776|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
131450053|NCT02558296|473276777|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
131450054|NCT02558296|473276776|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
131450055|NCT02558296|473276777|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
131450056|NCT02558296|473276776|FG000|Completed the Study|Adverse Event|14|||
131450057|NCT02558296|473276777|FG001|Completed the Study|Adverse Event|5|||
131450058|NCT02558296|473276776|FG000|Completed the Study|Death|39|||
131450059|NCT02558296|473276777|FG001|Completed the Study|Death|25|||
131450060|NCT02558296|473276776|FG000|Completed the Study|Lost to Follow-up|31|||
131450061|NCT02558296|473276777|FG001|Completed the Study|Lost to Follow-up|23|||
131450062|NCT02558296|473276776|FG000|Completed the Study|Physician Decision|6|||
131450063|NCT02558296|473276777|FG001|Completed the Study|Physician Decision|0|||
131450064|NCT02558296|473276776|FG000|Completed the Study|Protocol Violation|2|||
131450065|NCT02558296|473276777|FG001|Completed the Study|Protocol Violation|1|||
131450066|NCT02558296|473276776|FG000|Completed the Study|Withdrawal by Subject|53|||
131450067|NCT02558296|473276777|FG001|Completed the Study|Withdrawal by Subject|31|||
131450068|NCT02558296|473276776|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
131450069|NCT02558296|473276777|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
131450070|NCT00297258|473276780|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
131450071|NCT00297258|473276780|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
131450072|NCT00297258|473276780|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
131450073|NCT00297258|473276780|FG000|Overall Study|Intercurrent Illness|3|||
131830757|NCT01351350|474662984|FG003|Overall Study|Enrolled but not Treated|0|||
131450074|NCT00297258|473276780|FG000|Overall Study|Intercurrent Death|2|||
131450075|NCT00297258|473276780|FG000|Overall Study|Deteriorization of General Condition|1|||
131450076|NCT00297258|473276780|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
131450077|NCT00297258|473276780|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
131830758|NCT01351350|474662985|FG004|Overall Study|Enrolled but not Treated|0|||
131830759|NCT04647383|474662990|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
131830760|NCT04647383|474662991|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
131830761|NCT04647383|474662992|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
131830762|NCT04647383|474662993|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
131830763|NCT00873119|474663001|FG000|Overall Study|Patient request|4|||
131830764|NCT00873119|474663002|FG001|Overall Study|Patient request|2|||
131830765|NCT00873119|474663001|FG000|Overall Study|Adverse Event|8|||
131830766|NCT00873119|474663002|FG001|Overall Study|Adverse Event|0|||
131830767|NCT00873119|474663001|FG000|Overall Study|Progressive disease|26|||
131830768|NCT00873119|474663002|FG001|Overall Study|Progressive disease|18|||
131830769|NCT00873119|474663001|FG000|Overall Study|Death|2|||
131830770|NCT00873119|474663002|FG001|Overall Study|Death|1|||
131830771|NCT00873119|474663001|FG000|Overall Study|Other|2|||
131830772|NCT00873119|474663002|FG001|Overall Study|Other|5|||
131830773|NCT00873119|474663001|FG000|Overall Study|Not treated|2|||
131830774|NCT00873119|474663002|FG001|Overall Study|Not treated|0|||
131830775|NCT00285584|474663003|FG000|Month 3|Lost to Follow-up|3|||
131830776|NCT00285584|474663004|FG001|Month 3|Lost to Follow-up|3|||
131830777|NCT00285584|474663003|FG000|Month 3|Withdrawal by Subject|1|||
131830778|NCT00285584|474663004|FG001|Month 3|Withdrawal by Subject|0|||
131830779|NCT00285584|474663003|FG000|Month 6|Lost to Follow-up|0|||
131830780|NCT00285584|474663004|FG001|Month 6|Lost to Follow-up|1|||
131830781|NCT00350402|474663005|FG000|Overall Study|Lost to Follow-up|1|||
131830782|NCT00350402|474663006|FG001|Overall Study|Lost to Follow-up|1|||
131830783|NCT01884688|474663007|FG000|Overall Study|Screen Failure|2|||
131830784|NCT00645944|474663008|FG000|Randomized|Withdrawal by Subject|1|||
131830785|NCT00645944|474663009|FG001|Randomized|Withdrawal by Subject|2|||
131830786|NCT00645944|474663008|FG000|Received Medication|Adverse Event|2|||
131830787|NCT00645944|474663009|FG001|Received Medication|Adverse Event|1|||
131830788|NCT00645944|474663008|FG000|Received Medication|Withdrawal by Subject|1|||
131830789|NCT00645944|474663009|FG001|Received Medication|Withdrawal by Subject|1|||
131830790|NCT00645944|474663008|FG000|Received Medication|Lost to Follow-up|1|||
131830791|NCT00645944|474663009|FG001|Received Medication|Lost to Follow-up|0|||
131830792|NCT00645944|474663008|FG000|Received Medication|Protocol Violation|2|||
131830793|NCT00645944|474663009|FG001|Received Medication|Protocol Violation|1|||
131830794|NCT02470091|474663010|FG000|Overall Study|Withdrawal by Subject|1|||
131830795|NCT02470091|474663011|FG001|Overall Study|Withdrawal by Subject|0|||
131830796|NCT02470091|474663010|FG000|Overall Study|Ineligible|0|||
131830797|NCT02470091|474663011|FG001|Overall Study|Ineligible|2|||
131830798|NCT00303667|474663012|FG000|Overall Study|Death|0|||
131830799|NCT00303667|474663013|FG001|Overall Study|Death|4|||
131830800|NCT01258101|474663014|FG000|Overall Study|Adverse Event|5|||
131830801|NCT01258101|474663015|FG001|Overall Study|Adverse Event|6|||
131830802|NCT01258101|474663016|FG002|Overall Study|Adverse Event|0|||
131830803|NCT01258101|474663017|FG003|Overall Study|Adverse Event|0|||
131830804|NCT01258101|474663014|FG000|Overall Study|Extra exclusion criterion amended|2|||
131830805|NCT01258101|474663015|FG001|Overall Study|Extra exclusion criterion amended|1|||
131830806|NCT01258101|474663016|FG002|Overall Study|Extra exclusion criterion amended|1|||
131830807|NCT01258101|474663017|FG003|Overall Study|Extra exclusion criterion amended|1|||
131830808|NCT01258101|474663014|FG000|Overall Study|Informed consent has been withdrawn|2|||
131830809|NCT01258101|474663015|FG001|Overall Study|Informed consent has been withdrawn|2|||
131830810|NCT01258101|474663016|FG002|Overall Study|Informed consent has been withdrawn|1|||
131830811|NCT01258101|474663017|FG003|Overall Study|Informed consent has been withdrawn|1|||
131830812|NCT01258101|474663014|FG000|Overall Study|Patient is not able to attend visits|8|||
131830813|NCT01258101|474663015|FG001|Overall Study|Patient is not able to attend visits|9|||
131830814|NCT01258101|474663016|FG002|Overall Study|Patient is not able to attend visits|7|||
131830815|NCT01258101|474663017|FG003|Overall Study|Patient is not able to attend visits|6|||
131830816|NCT01258101|474663014|FG000|Overall Study|Patient´s compliance|4|||
131830817|NCT01258101|474663015|FG001|Overall Study|Patient´s compliance|3|||
131830818|NCT01258101|474663016|FG002|Overall Study|Patient´s compliance|1|||
131830819|NCT01258101|474663017|FG003|Overall Study|Patient´s compliance|2|||
131830820|NCT01258101|474663014|FG000|Overall Study|Lost to Follow-up|5|||
131830821|NCT01258101|474663015|FG001|Overall Study|Lost to Follow-up|5|||
131830822|NCT01258101|474663016|FG002|Overall Study|Lost to Follow-up|0|||
131910440|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
131910441|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
131910442|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
131830823|NCT01258101|474663017|FG003|Overall Study|Lost to Follow-up|6|||
131830824|NCT01258101|474663014|FG000|Overall Study|PCR positive at week 24|0|||
131830825|NCT01258101|474663015|FG001|Overall Study|PCR positive at week 24|0|||
131830826|NCT01258101|474663016|FG002|Overall Study|PCR positive at week 24|0|||
131830827|NCT01258101|474663017|FG003|Overall Study|PCR positive at week 24|1|||
131830828|NCT01258101|474663014|FG000|Overall Study|Other reason|7|||
131830829|NCT01258101|474663015|FG001|Overall Study|Other reason|8|||
131830830|NCT01258101|474663016|FG002|Overall Study|Other reason|1|||
131830831|NCT01258101|474663017|FG003|Overall Study|Other reason|8|||
131830832|NCT01807117|474663019|FG000|Overall Study|Physician Decision|2|||
131830833|NCT01807117|474663019|FG000|Overall Study|Disease diagnosis not a study disease|1|||
131830834|NCT01103479|474663020|FG000|Overall Study|Up to date with CRC screening|1|||
131830835|NCT01103479|474663021|FG001|Overall Study|Up to date with CRC screening|9|||
131830836|NCT01103479|474663022|FG002|Overall Study|Up to date with CRC screening|12|||
131830837|NCT01103479|474663020|FG000|Overall Study|Family history of CRC|1|||
131830838|NCT01103479|474663021|FG001|Overall Study|Family history of CRC|0|||
131830839|NCT01103479|474663022|FG002|Overall Study|Family history of CRC|2|||
131830840|NCT01103479|474663020|FG000|Overall Study|Active cancer|1|||
131830841|NCT01103479|474663021|FG001|Overall Study|Active cancer|0|||
131830842|NCT01103479|474663022|FG002|Overall Study|Active cancer|0|||
131830843|NCT01103479|474663020|FG000|Overall Study|Saw non-study physician|2|||
131830844|NCT01103479|474663021|FG001|Overall Study|Saw non-study physician|0|||
131830845|NCT01103479|474663022|FG002|Overall Study|Saw non-study physician|0|||
131830846|NCT01523587|474663023|FG000|Overall Study|Other than listed|5|||
131830847|NCT01523587|474663024|FG001|Overall Study|Other than listed|5|||
131830848|NCT01523587|474663023|FG000|Overall Study|Worsening of underlying cancer disease|19|||
131830849|NCT01523587|474663024|FG001|Overall Study|Worsening of underlying cancer disease|34|||
131830850|NCT01523587|474663023|FG000|Overall Study|Adverse Event|68|||
131830851|NCT01523587|474663024|FG001|Overall Study|Adverse Event|52|||
131830852|NCT01523587|474663023|FG000|Overall Study|Protocol Violation|5|||
131830853|NCT01523587|474663024|FG001|Overall Study|Protocol Violation|3|||
131830854|NCT01523587|474663023|FG000|Overall Study|Lost to Follow-up|2|||
131830855|NCT01523587|474663024|FG001|Overall Study|Lost to Follow-up|2|||
131830856|NCT01523587|474663023|FG000|Overall Study|Withdrawal by Subject|28|||
131830857|NCT01523587|474663024|FG001|Overall Study|Withdrawal by Subject|20|||
131830858|NCT01523587|474663023|FG000|Overall Study|Withdrew due to Progressive disease|265|||
131830859|NCT01523587|474663024|FG001|Overall Study|Withdrew due to Progressive disease|279|||
131830860|NCT01523587|474663023|FG000|Overall Study|Randomised but bot treated|6|||
131830861|NCT01523587|474663024|FG001|Overall Study|Randomised but bot treated|2|||
131830862|NCT01298778|474663025|FG000|Overall Study|Lost to Follow-up|2|||
131830863|NCT01298778|474663026|FG001|Overall Study|Lost to Follow-up|3|||
131830864|NCT01298778|474663025|FG000|Overall Study|Incorrect use of VAS|1|||
131830865|NCT01298778|474663026|FG001|Overall Study|Incorrect use of VAS|0|||
131830866|NCT01298778|474663025|FG000|Overall Study|Withdrawal by Subject|0|||
131830867|NCT01298778|474663026|FG001|Overall Study|Withdrawal by Subject|1|||
131830868|NCT01298778|474663025|FG000|Overall Study|Protocol Violation|0|||
131830869|NCT01298778|474663026|FG001|Overall Study|Protocol Violation|1|||
131830870|NCT01298778|474663025|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
131830871|NCT01298778|474663026|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
131830872|NCT02709486|474663034|FG000|Overall Study|Adverse Event|2|||
131830873|NCT02709486|474663035|FG001|Overall Study|Adverse Event|5|||
131830874|NCT02709486|474663036|FG002|Overall Study|Adverse Event|3|||
131830875|NCT02709486|474663034|FG000|Overall Study|Death|0|||
131830876|NCT02709486|474663035|FG001|Overall Study|Death|0|||
131830877|NCT02709486|474663036|FG002|Overall Study|Death|2|||
131830878|NCT02709486|474663034|FG000|Overall Study|Insufficient clinical response|7|||
131830879|NCT02709486|474663035|FG001|Overall Study|Insufficient clinical response|3|||
131830880|NCT02709486|474663036|FG002|Overall Study|Insufficient clinical response|3|||
131830881|NCT02709486|474663034|FG000|Overall Study|Lost to Follow-up|3|||
131830882|NCT02709486|474663035|FG001|Overall Study|Lost to Follow-up|2|||
131830883|NCT02709486|474663036|FG002|Overall Study|Lost to Follow-up|2|||
131830884|NCT02709486|474663034|FG000|Overall Study|Other|0|||
131830885|NCT02709486|474663035|FG001|Overall Study|Other|2|||
131830886|NCT02709486|474663036|FG002|Overall Study|Other|3|||
131830887|NCT02709486|474663034|FG000|Overall Study|Withdrawal by Subject|32|||
131830888|NCT02709486|474663035|FG001|Overall Study|Withdrawal by Subject|22|||
131401669|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
131401670|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
131401671|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
131830889|NCT02709486|474663036|FG002|Overall Study|Withdrawal by Subject|32|||
131830890|NCT02377921|474663042|FG000|Overall Study|Subject non-compliance|1|||
131830891|NCT02377921|474663043|FG001|Overall Study|Subject non-compliance|1|||
131830892|NCT00706355|474663049|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
131830893|NCT00706355|474663050|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
131830894|NCT00706355|474663051|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
131830895|NCT00706355|474663052|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
131830896|NCT00706355|474663049|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
131830897|NCT00706355|474663050|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
131830898|NCT00706355|474663051|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
131830899|NCT00706355|474663052|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
131830900|NCT00706355|474663049|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
131830901|NCT00706355|474663050|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
131830902|NCT00706355|474663051|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
131401672|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
131830903|NCT00706355|474663052|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
131830904|NCT00706355|474663049|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
131830905|NCT00706355|474663050|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
131830906|NCT00706355|474663051|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
131830907|NCT00706355|474663052|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
131830908|NCT00706355|474663049|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
131830909|NCT00706355|474663050|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
131830910|NCT00706355|474663051|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
131830911|NCT00706355|474663052|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
131830912|NCT00706355|474663049|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
131830913|NCT00706355|474663050|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
131830914|NCT00706355|474663051|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
131830915|NCT00706355|474663052|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
131830916|NCT00706355|474663049|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
131830917|NCT00706355|474663050|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
131830918|NCT00706355|474663051|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
131830919|NCT00706355|474663052|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
131830920|NCT00706355|474663049|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
131830921|NCT00706355|474663050|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
131830922|NCT00706355|474663051|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
131830923|NCT00706355|474663052|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
131830924|NCT00706355|474663049|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
131830925|NCT00706355|474663050|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
131830926|NCT00706355|474663051|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
131830927|NCT00706355|474663052|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
131830928|NCT01020799|474663061|FG000|Overall Study|Adverse Event|4|||
131830929|NCT01020799|474663062|FG001|Overall Study|Adverse Event|3|||
131830930|NCT01020799|474663063|FG002|Overall Study|Adverse Event|2|||
131830931|NCT01020799|474663061|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
131830932|NCT01020799|474663062|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
131830933|NCT01020799|474663063|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
131830934|NCT01020799|474663061|FG000|Overall Study|Protocol Violation|3|||
131830935|NCT01020799|474663062|FG001|Overall Study|Protocol Violation|2|||
131830936|NCT01020799|474663063|FG002|Overall Study|Protocol Violation|0|||
131830937|NCT01020799|474663061|FG000|Overall Study|Withdrawal by Subject|2|||
131830938|NCT01020799|474663062|FG001|Overall Study|Withdrawal by Subject|2|||
131830939|NCT01020799|474663063|FG002|Overall Study|Withdrawal by Subject|3|||
131830940|NCT01020799|474663061|FG000|Overall Study|Lost to Follow-up|6|||
131830941|NCT01020799|474663062|FG001|Overall Study|Lost to Follow-up|4|||
131830942|NCT01020799|474663063|FG002|Overall Study|Lost to Follow-up|2|||
131830943|NCT04179019|474663064|FG000|Overall Study|Lost to Follow-up|2|||
131830944|NCT04179019|474663064|FG000|Overall Study|Physician Decision|2|||
131830945|NCT04179019|474663064|FG000|Overall Study|Withdrawal by Subject|5|||
131830946|NCT04179019|474663064|FG000|Overall Study|Adverse Event|4|||
131830947|NCT02549573|474663065|FG000|Overall Study|Withdrawal by Subject|0|||
131830948|NCT02549573|474663066|FG001|Overall Study|Withdrawal by Subject|2|||
131830949|NCT02549573|474663065|FG000|Overall Study|Protocol Violation|0|||
131830950|NCT02549573|474663066|FG001|Overall Study|Protocol Violation|1|||
131830951|NCT02658487|474665264|FG000|Overall Study|Death|2|||
131830952|NCT02658487|474665264|FG000|Overall Study|Disease progression|10|||
131830953|NCT02658487|474665264|FG000|Overall Study|Alternative therapy|1|||
131830954|NCT02658487|474665264|FG000|Overall Study|Adverse Event|1|||
131830955|NCT02658487|474665264|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
131830956|NCT02658487|474665264|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
131830957|NCT01432574|474665267|FG000|Overall Study|Moved|2|||
131830958|NCT01432574|474665267|FG000|Overall Study|Not interested|1|||
131830959|NCT02813421|474665268|FG000|Overall Study|Withdrawal by Subject|1|||
131830960|NCT02813421|474665269|FG001|Overall Study|Withdrawal by Subject|2|||
131830961|NCT02813421|474665268|FG000|Overall Study|Lost to Follow-up|1|||
131830962|NCT02813421|474665269|FG001|Overall Study|Lost to Follow-up|1|||
131830963|NCT00255151|474665270|FG000|Overall Study|Adverse Event|10|||
131830964|NCT00255151|474665271|FG001|Overall Study|Adverse Event|6|||
131830965|NCT00255151|474665272|FG002|Overall Study|Adverse Event|9|||
131830966|NCT00255151|474665270|FG000|Overall Study|Lost to Follow-up|4|||
131830967|NCT00255151|474665271|FG001|Overall Study|Lost to Follow-up|3|||
131830968|NCT00255151|474665272|FG002|Overall Study|Lost to Follow-up|4|||
131830969|NCT00255151|474665270|FG000|Overall Study|Withdrawal by Subject|18|||
131830970|NCT00255151|474665271|FG001|Overall Study|Withdrawal by Subject|17|||
131830971|NCT00255151|474665272|FG002|Overall Study|Withdrawal by Subject|8|||
131830972|NCT00255151|474665270|FG000|Overall Study|Noncompliance|0|||
131830973|NCT00255151|474665271|FG001|Overall Study|Noncompliance|1|||
131830974|NCT00255151|474665272|FG002|Overall Study|Noncompliance|2|||
131450078|NCT00297258|473276780|FG000|Overall Study|Switch to Commercial Treatment|1|||
131450079|NCT00297258|473276780|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
131830975|NCT00255151|474665270|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
131830976|NCT00255151|474665271|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
131830977|NCT00255151|474665272|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
131830978|NCT00255151|474665270|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
131830979|NCT00255151|474665271|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
131830980|NCT00255151|474665272|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
131830981|NCT00255151|474665270|FG000|Overall Study|Possible Barrett's Esophagus|1|||
131830982|NCT00255151|474665271|FG001|Overall Study|Possible Barrett's Esophagus|3|||
131830983|NCT00255151|474665272|FG002|Overall Study|Possible Barrett's Esophagus|8|||
131830984|NCT00255151|474665270|FG000|Overall Study|Esophageal Stricture|0|||
131830985|NCT00255151|474665271|FG001|Overall Study|Esophageal Stricture|0|||
131830986|NCT00255151|474665272|FG002|Overall Study|Esophageal Stricture|1|||
131830987|NCT00255151|474665270|FG000|Overall Study|Therapeutic Failure|11|||
131830988|NCT00255151|474665271|FG001|Overall Study|Therapeutic Failure|2|||
131830989|NCT00255151|474665272|FG002|Overall Study|Therapeutic Failure|3|||
131830990|NCT00706095|474665273|FG000|Overall Study|Progressive Disease|4|||
131830991|NCT00706095|474665274|FG001|Overall Study|Progressive Disease|5|||
131830992|NCT00706095|474665275|FG002|Overall Study|Progressive Disease|3|||
131830993|NCT00706095|474665273|FG000|Overall Study|Clinical Progression|1|||
131830994|NCT00706095|474665274|FG001|Overall Study|Clinical Progression|2|||
131830995|NCT00706095|474665275|FG002|Overall Study|Clinical Progression|2|||
131830996|NCT00706095|474665273|FG000|Overall Study|Withdrawal by Subject|1|||
131830997|NCT00706095|474665274|FG001|Overall Study|Withdrawal by Subject|0|||
131830998|NCT00706095|474665275|FG002|Overall Study|Withdrawal by Subject|0|||
131830999|NCT01685073|474665276|FG000|Overall Study|Lost to Follow-up|6|||
131450080|NCT01189032|473276781|FG000|Overall Study|Adverse Event|1|||
131450081|NCT01189032|473276782|FG001|Overall Study|Adverse Event|3|||
131450082|NCT01189032|473276783|FG002|Overall Study|Adverse Event|4|||
131450083|NCT01189032|473276781|FG000|Overall Study|Lack of Efficacy|2|||
131450084|NCT01189032|473276782|FG001|Overall Study|Lack of Efficacy|3|||
131450085|NCT01189032|473276783|FG002|Overall Study|Lack of Efficacy|0|||
131450086|NCT01189032|473276781|FG000|Overall Study|Withdrawal by Subject|1|||
131450087|NCT01189032|473276782|FG001|Overall Study|Withdrawal by Subject|0|||
131450088|NCT01189032|473276783|FG002|Overall Study|Withdrawal by Subject|1|||
131450089|NCT01189032|473276781|FG000|Overall Study|Protocol Violation|1|||
131450090|NCT01189032|473276782|FG001|Overall Study|Protocol Violation|1|||
131450091|NCT01189032|473276783|FG002|Overall Study|Protocol Violation|1|||
131450092|NCT02819804|473276784|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
131450093|NCT03388164|473276789|FG000|Overall Study|Withdrawal by Subject|3|||
131450094|NCT03388164|473276790|FG001|Overall Study|Withdrawal by Subject|1|||
131450095|NCT00346697|473276793|FG000|Overall Study|Lost to Follow-up|0|||
131450096|NCT00346697|473276794|FG001|Overall Study|Lost to Follow-up|1|||
131450097|NCT05375760|473276797|FG000|Overall Study|Adverse Event|1|||
131450098|NCT05375760|473276798|FG001|Overall Study|Adverse Event|0|||
131450099|NCT05375760|473276797|FG000|Overall Study|Death|0|||
131450100|NCT05375760|473276798|FG001|Overall Study|Death|1|||
131450101|NCT05375760|473276797|FG000|Overall Study|Lost to Follow-up|6|||
131450102|NCT05375760|473276798|FG001|Overall Study|Lost to Follow-up|6|||
131450103|NCT05375760|473276797|FG000|Overall Study|Withdrawal by Subject|17|||
131450104|NCT05375760|473276798|FG001|Overall Study|Withdrawal by Subject|19|||
131450105|NCT05375760|473276797|FG000|Overall Study|Dosing halted by FDA|96|||
131450106|NCT05375760|473276798|FG001|Overall Study|Dosing halted by FDA|100|||
131450107|NCT05375760|473276797|FG000|Overall Study|Not compliant with study visit|2|||
131450108|NCT05375760|473276798|FG001|Overall Study|Not compliant with study visit|0|||
131450109|NCT05375760|473276797|FG000|Overall Study|Physician Decision|1|||
131450110|NCT05375760|473276798|FG001|Overall Study|Physician Decision|0|||
131450111|NCT05375760|473276797|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
131450112|NCT05375760|473276798|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
131450113|NCT05375760|473276797|FG000|Overall Study|Participant moved|1|||
131450114|NCT05375760|473276798|FG001|Overall Study|Participant moved|0|||
131450115|NCT00363480|473276799|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
131450116|NCT00363480|473276799|FG000|Overall Study|Adverse Event|4|||
131831000|NCT01685073|474665277|FG001|Overall Study|Lost to Follow-up|8|||
131831001|NCT01685073|474665276|FG000|Overall Study|Withdrawal by Subject|24|||
131831002|NCT01685073|474665277|FG001|Overall Study|Withdrawal by Subject|24|||
131450117|NCT00363480|473276799|FG000|Overall Study|Lost to Follow-up|5|||
131450118|NCT00363480|473276799|FG000|Overall Study|Withdrawal by Subject|5|||
131450119|NCT00363480|473276799|FG000|Overall Study|Non-compliance of subject|1|||
131450120|NCT00363480|473276799|FG000|Overall Study|Participant discontinued on its own|1|||
131450121|NCT01721044|473276800|FG000|Treatment Period|Adverse Event|7|||
131450122|NCT01721044|473276801|FG001|Treatment Period|Adverse Event|7|||
131450123|NCT01721044|473276802|FG002|Treatment Period|Adverse Event|10|||
131831003|NCT01221090|474665283|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
131831004|NCT01221090|474665284|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
131831005|NCT01221090|474665285|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
131831006|NCT01221090|474665286|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
131831007|NCT01221090|474665283|FG000|Overall Study|Withdrawal by Subject|0|||
131831008|NCT01221090|474665284|FG001|Overall Study|Withdrawal by Subject|22|||
131831009|NCT01221090|474665285|FG002|Overall Study|Withdrawal by Subject|27|||
131831010|NCT01221090|474665286|FG003|Overall Study|Withdrawal by Subject|2|||
131831011|NCT00708708|474665287|FG000|Overall Study|Another therapy instead of Enbrel|141|||
131831012|NCT00708708|474665287|FG000|Overall Study|Lost to Follow-up|52|||
131831013|NCT00708708|474665287|FG000|Overall Study|Withdrawal by Subject|51|||
131831014|NCT00708708|474665287|FG000|Overall Study|Intolerance|42|||
131831015|NCT00708708|474665287|FG000|Overall Study|Another therapy along with Enbrel|15|||
131831016|NCT00708708|474665287|FG000|Overall Study|Other unspecified|11|||
131831017|NCT00708708|474665287|FG000|Overall Study|Good effectiveness|9|||
131831018|NCT00708708|474665287|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
131831019|NCT00708708|474665287|FG000|Overall Study|Administrative reasons|7|||
131831020|NCT00708708|474665287|FG000|Overall Study|Lack of effectiveness|4|||
131831021|NCT00708708|474665287|FG000|Overall Study|Lack of compliance|3|||
131831022|NCT00708708|474665287|FG000|Overall Study|Pregnancy|3|||
131831023|NCT00708708|474665287|FG000|Overall Study|Adverse Event|3|||
131831024|NCT00708708|474665287|FG000|Overall Study|Missing values|392|||
131831025|NCT00856830|474665288|FG000|Irinotecan & Bendamustine|Death|0|||
131831026|NCT00856830|474665289|FG001|Irinotecan & Bendamustine|Death|0|||
131831027|NCT00856830|474665290|FG002|Irinotecan & Bendamustine|Death|0|||
131831028|NCT00856830|474665291|FG003|Irinotecan & Bendamustine|Death|2|||
131831029|NCT00856830|474665288|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
131831030|NCT00856830|474665289|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
131831031|NCT00856830|474665290|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
131831032|NCT00856830|474665291|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
131831033|NCT01117337|474665294|FG000|Overall Study|Lost to Follow-up|4|||
131831034|NCT01117337|474665295|FG001|Overall Study|Lost to Follow-up|0|||
131831035|NCT05506358|474665296|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
131831036|NCT05506358|474665297|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
131831037|NCT05506358|474665298|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
131831038|NCT05506358|474665299|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
131831039|NCT05506358|474665300|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
131831040|NCT05506358|474665296|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
131831041|NCT05506358|474665297|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
131831042|NCT05506358|474665298|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
131831043|NCT05506358|474665299|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
131831044|NCT05506358|474665300|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
131831045|NCT05506358|474665296|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
131831046|NCT05506358|474665297|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
131831047|NCT05506358|474665298|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
131831048|NCT05506358|474665299|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
131831049|NCT05506358|474665300|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
131831050|NCT05506358|474665296|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
131831051|NCT05506358|474665297|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
131831052|NCT05506358|474665298|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
131831053|NCT05506358|474665299|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
131831054|NCT05506358|474665300|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
131831055|NCT05506358|474665296|FG000|Overall Study|HbE trait|0|||
131831056|NCT05506358|474665297|FG001|Overall Study|HbE trait|0|||
131831057|NCT05506358|474665298|FG002|Overall Study|HbE trait|0|||
131831058|NCT05506358|474665299|FG003|Overall Study|HbE trait|1|||
131831059|NCT05506358|474665300|FG004|Overall Study|HbE trait|0|||
131831060|NCT01659736|474665301|FG000|Treatment Period|Adverse Event|1|||
131831061|NCT01659736|474665302|FG001|Treatment Period|Adverse Event|1|||
131831062|NCT01659736|474665301|FG000|Treatment Period|Protocol Violation|3|||
131831063|NCT01659736|474665302|FG001|Treatment Period|Protocol Violation|1|||
131831064|NCT01659736|474665301|FG000|Treatment Period|Withdrawal by Subject|1|||
131831065|NCT01659736|474665302|FG001|Treatment Period|Withdrawal by Subject|0|||
131831066|NCT01659736|474665301|FG000|3-month Follow-up|Lost to Follow-up|0|||
131831067|NCT01659736|474665302|FG001|3-month Follow-up|Lost to Follow-up|1|||
131831068|NCT01744093|474665306|FG000|Overall Study|Withdrawal by Subject|6|||
131831069|NCT01744093|474665307|FG001|Overall Study|Withdrawal by Subject|1|||
131831070|NCT01173471|474665308|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131831071|NCT01173471|474665309|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131831072|NCT01173471|474665310|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
131831073|NCT01173471|474665311|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
131831074|NCT01173471|474665308|FG000|Overall Study|Condition under investigation worsened|2|||
131831075|NCT01173471|474665309|FG001|Overall Study|Condition under investigation worsened|0|||
131831076|NCT01173471|474665310|FG002|Overall Study|Condition under investigation worsened|0|||
131831077|NCT01173471|474665311|FG003|Overall Study|Condition under investigation worsened|0|||
131831078|NCT01173471|474665308|FG000|Overall Study|Lost to Follow-up|0|||
131831079|NCT01173471|474665309|FG001|Overall Study|Lost to Follow-up|0|||
131831080|NCT01173471|474665310|FG002|Overall Study|Lost to Follow-up|1|||
131831081|NCT01173471|474665311|FG003|Overall Study|Lost to Follow-up|0|||
131831082|NCT01173471|474665308|FG000|Overall Study|Reason given as Other|0|||
131831083|NCT01173471|474665309|FG001|Overall Study|Reason given as Other|0|||
131831084|NCT01173471|474665310|FG002|Overall Study|Reason given as Other|1|||
131831085|NCT01173471|474665311|FG003|Overall Study|Reason given as Other|0|||
131831086|NCT03028740|474665312|FG000|Overall Study|Did not Receive Study Drug|4|||
131831087|NCT03028740|474665313|FG001|Overall Study|Did not Receive Study Drug|5|||
131831088|NCT03028740|474665312|FG000|Overall Study|Adverse Event|8|||
131831089|NCT03028740|474665313|FG001|Overall Study|Adverse Event|26|||
131831090|NCT03028740|474665312|FG000|Overall Study|Lack of Efficacy|0|||
131831091|NCT03028740|474665313|FG001|Overall Study|Lack of Efficacy|1|||
131831092|NCT03028740|474665312|FG000|Overall Study|Withdrawal by Subject|48|||
131831093|NCT03028740|474665313|FG001|Overall Study|Withdrawal by Subject|101|||
131831094|NCT03028740|474665312|FG000|Overall Study|Lost to Follow-up|30|||
131831095|NCT03028740|474665313|FG001|Overall Study|Lost to Follow-up|54|||
131831096|NCT03028740|474665312|FG000|Overall Study|Physician Decision|4|||
131831097|NCT03028740|474665313|FG001|Overall Study|Physician Decision|11|||
131831098|NCT03028740|474665312|FG000|Overall Study|Protocol Violation|4|||
131831099|NCT03028740|474665313|FG001|Overall Study|Protocol Violation|8|||
131831100|NCT03028740|474665312|FG000|Overall Study|Non-compliance with Study Drug|0|||
131831101|NCT03028740|474665313|FG001|Overall Study|Non-compliance with Study Drug|2|||
131831102|NCT03028740|474665312|FG000|Overall Study|Study Terminated by Sponsor|467|||
131831103|NCT03028740|474665313|FG001|Overall Study|Study Terminated by Sponsor|917|||
131831104|NCT03028740|474665312|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
131831105|NCT03028740|474665313|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
131831106|NCT03028740|474665312|FG000|Overall Study|Reason not Specified|1|||
131831107|NCT03028740|474665313|FG001|Overall Study|Reason not Specified|5|||
131831108|NCT00685802|474665319|FG000|Washout Period of 7 Days|Protocol Violation|2|||
131831109|NCT00685802|474665320|FG001|Washout Period of 7 Days|Protocol Violation|0|||
131831110|NCT00685802|474665319|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131831111|NCT00685802|474665320|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131831112|NCT03336242|474665324|FG000|Overall Study|Adverse Event|0|||
131831113|NCT03336242|474665325|FG001|Overall Study|Adverse Event|1|||
131831114|NCT02224573|474665328|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
131831115|NCT02224573|474665329|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
131831116|NCT02224573|474665328|FG000|Treatment Phase|Started on Other IMP|1|||
131831117|NCT02224573|474665329|FG001|Treatment Phase|Started on Other IMP|0|||
131831118|NCT02224573|474665328|FG000|Treatment Phase|Participant Discontinued IMP|0|||
131831119|NCT02224573|474665329|FG001|Treatment Phase|Participant Discontinued IMP|1|||
131831120|NCT02224573|474665328|FG000|Treatment Phase|Lack of Efficacy|15|||
131831121|NCT02224573|474665329|FG001|Treatment Phase|Lack of Efficacy|8|||
131831122|NCT02224573|474665328|FG000|Treatment Phase|Began Commercial Product|1|||
131831123|NCT02224573|474665329|FG001|Treatment Phase|Began Commercial Product|0|||
131831124|NCT02224573|474665328|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
131831125|NCT02224573|474665329|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
131831126|NCT02224573|474665328|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
131831127|NCT02224573|474665329|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
131831128|NCT02224573|474665328|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
131831129|NCT02224573|474665329|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
131831130|NCT02224573|474665328|FG000|Treatment Phase|Continued Compassionate Use|1|||
131831131|NCT02224573|474665329|FG001|Treatment Phase|Continued Compassionate Use|0|||
131831132|NCT02224573|474665328|FG000|Treatment Phase|Lack of Efficiency|2|||
131831133|NCT02224573|474665329|FG001|Treatment Phase|Lack of Efficiency|1|||
131831134|NCT02224573|474665328|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
131831135|NCT02224573|474665329|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
131831136|NCT02224573|474665328|FG000|Treatment Phase|Participant Moved|2|||
131831137|NCT02224573|474665329|FG001|Treatment Phase|Participant Moved|0|||
131831138|NCT02224573|474665328|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
131831139|NCT02224573|474665329|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
131831140|NCT02224573|474665328|FG000|Treatment Phase|Refused Medication|1|||
131831141|NCT02224573|474665329|FG001|Treatment Phase|Refused Medication|1|||
131831142|NCT02224573|474665328|FG000|Treatment Phase|Adverse Event|26|||
131831143|NCT02224573|474665329|FG001|Treatment Phase|Adverse Event|38|||
131831144|NCT02224573|474665328|FG000|Treatment Phase|Placed in Group Home|0|||
131831145|NCT02224573|474665329|FG001|Treatment Phase|Placed in Group Home|1|||
131831146|NCT02224573|474665328|FG000|Treatment Phase|Pursued Other Trials|1|||
131831147|NCT02224573|474665329|FG001|Treatment Phase|Pursued Other Trials|0|||
131831148|NCT02224573|474665328|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
131831149|NCT02224573|474665329|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
131831150|NCT02224573|474665328|FG000|Treatment Phase|Lost to Follow-up|2|||
131831151|NCT02224573|474665329|FG001|Treatment Phase|Lost to Follow-up|1|||
131831152|NCT02224573|474665328|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
131831153|NCT02224573|474665329|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
131831154|NCT02224573|474665328|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
131831155|NCT02224573|474665329|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
131831156|NCT02224573|474665328|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
131831157|NCT02224573|474665329|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
131831158|NCT02224573|474665328|FG000|Taper Phase|Adverse Event|1|||
131831159|NCT02224573|474665329|FG001|Taper Phase|Adverse Event|1|||
131831160|NCT00252174|474665330|FG000|Overall Study|Withdrawal by Subject|0|||
131831161|NCT00252174|474665331|FG001|Overall Study|Withdrawal by Subject|1|||
131831162|NCT00252174|474665332|FG002|Overall Study|Withdrawal by Subject|0|||
131831163|NCT02546362|474665333|FG000|4-week Treatment Period|Lost to Follow-up|1|||
131831164|NCT02546362|474665333|FG000|4-week Treatment Period|Change in medication|2|||
131831165|NCT02546362|474665333|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
131831166|NCT02546362|474665333|FG000|12-week Treatment Period|Lost to Follow-up|2|||
131831167|NCT02546362|474665333|FG000|12-week Treatment Period|Change in medication|1|||
131831168|NCT00619359|474665334|FG000|Overall Study|Adverse Event|32|||
131831169|NCT00619359|474665335|FG001|Overall Study|Adverse Event|36|||
131831170|NCT00619359|474665334|FG000|Overall Study|Lost to Follow-up|12|||
131831171|NCT00619359|474665335|FG001|Overall Study|Lost to Follow-up|16|||
131831172|NCT00619359|474665334|FG000|Overall Study|Physician Decision|0|||
131831173|NCT00619359|474665335|FG001|Overall Study|Physician Decision|7|||
131831174|NCT00619359|474665334|FG000|Overall Study|Protocol Violation|1|||
131831175|NCT00619359|474665335|FG001|Overall Study|Protocol Violation|1|||
131831176|NCT00619359|474665334|FG000|Overall Study|Withdrawal by Subject|19|||
131831177|NCT00619359|474665335|FG001|Overall Study|Withdrawal by Subject|20|||
131831178|NCT00619359|474665334|FG000|Overall Study|Progressive Disease|3|||
131831179|NCT00619359|474665335|FG001|Overall Study|Progressive Disease|1|||
131831180|NCT00949988|474665338|FG000|Overall Study|Withdrawal by Subject|3|||
131831181|NCT00484419|474665345|FG000|Overall Study|Adverse Event|3|||
131831182|NCT00484419|474665346|FG001|Overall Study|Adverse Event|0|||
131831183|NCT00484419|474665347|FG002|Overall Study|Adverse Event|0|||
131831184|NCT00484419|474665345|FG000|Overall Study|Lost to Follow-up|1|||
131831185|NCT00484419|474665346|FG001|Overall Study|Lost to Follow-up|0|||
131831186|NCT00484419|474665347|FG002|Overall Study|Lost to Follow-up|2|||
131831187|NCT00484419|474665345|FG000|Overall Study|Withdrawal by Subject|3|||
131831188|NCT00484419|474665346|FG001|Overall Study|Withdrawal by Subject|1|||
131831189|NCT00484419|474665347|FG002|Overall Study|Withdrawal by Subject|1|||
131831190|NCT00484419|474665345|FG000|Overall Study|subject met discontinuation criteria|2|||
131831191|NCT00484419|474665346|FG001|Overall Study|subject met discontinuation criteria|2|||
131831192|NCT00484419|474665347|FG002|Overall Study|subject met discontinuation criteria|4|||
131831193|NCT00484419|474665345|FG000|Overall Study|required restricted medication|1|||
131831194|NCT00484419|474665346|FG001|Overall Study|required restricted medication|0|||
131831195|NCT00484419|474665347|FG002|Overall Study|required restricted medication|1|||
131831196|NCT00484419|474665345|FG000|Overall Study|Physician Decision|1|||
131831197|NCT00484419|474665346|FG001|Overall Study|Physician Decision|1|||
131831198|NCT00484419|474665347|FG002|Overall Study|Physician Decision|1|||
131831199|NCT00484419|474665345|FG000|Overall Study|subject unable to receive medication|1|||
131831200|NCT00484419|474665346|FG001|Overall Study|subject unable to receive medication|0|||
131831201|NCT00484419|474665347|FG002|Overall Study|subject unable to receive medication|0|||
131831202|NCT00484419|474665345|FG000|Overall Study|subject relocated|0|||
131831203|NCT00484419|474665346|FG001|Overall Study|subject relocated|1|||
131831204|NCT00484419|474665347|FG002|Overall Study|subject relocated|0|||
131831205|NCT00484419|474665345|FG000|Overall Study|sponsor decision, randomized in error|0|||
131831206|NCT00484419|474665346|FG001|Overall Study|sponsor decision, randomized in error|0|||
131831207|NCT00484419|474665347|FG002|Overall Study|sponsor decision, randomized in error|2|||
131831208|NCT01144403|474665349|FG000|Overall Study|Lost to Follow-up|3|||
131831209|NCT01144403|474665349|FG000|Overall Study|Death|1|||
131831210|NCT01144403|474665349|FG000|Overall Study|Adverse Event|1|||
131831211|NCT03891329|474665350|FG000|Overall Study|Death|5|||
131831212|NCT03891329|474665350|FG000|Overall Study|Lost to Follow-up|4|||
131831213|NCT03891329|474665350|FG000|Overall Study|Physician Decision|4|||
131831214|NCT03891329|474665350|FG000|Overall Study|Device explanted|3|||
131831215|NCT03891329|474665350|FG000|Overall Study|No study device implanted|3|||
131831216|NCT00680186|474665351|FG000|Overall Study|Adverse Event|47|||
131831217|NCT00680186|474665352|FG001|Overall Study|Adverse Event|44|||
131831218|NCT00680186|474665351|FG000|Overall Study|Protocol Violation|31|||
131831219|NCT00680186|474665352|FG001|Overall Study|Protocol Violation|26|||
131831220|NCT00680186|474665351|FG000|Overall Study|Lost to Follow-up|11|||
131831221|NCT00680186|474665352|FG001|Overall Study|Lost to Follow-up|6|||
131831222|NCT00680186|474665351|FG000|Overall Study|Withdrawal by Subject|32|||
131831223|NCT00680186|474665352|FG001|Overall Study|Withdrawal by Subject|39|||
131831224|NCT00680186|474665351|FG000|Overall Study|Other|4|||
131831225|NCT00680186|474665352|FG001|Overall Study|Other|1|||
131831226|NCT00466726|474665353|FG000|Overall Study|Not evaluable for response|14|||
131831227|NCT04403763|474665354|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
131831228|NCT04403763|474665355|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
131831229|NCT04403763|474665356|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
131831230|NCT04403763|474665357|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
131831231|NCT04403763|474665358|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
131831232|NCT04403763|474665359|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
131831233|NCT04403763|474665360|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
131831234|NCT04403763|474665354|FG000|Stage 1|Early termination due to PK tube failure|0|||
131831235|NCT04403763|474665355|FG001|Stage 1|Early termination due to PK tube failure|0|||
131831236|NCT04403763|474665356|FG002|Stage 1|Early termination due to PK tube failure|1|||
131831237|NCT04403763|474665357|FG003|Stage 1|Early termination due to PK tube failure|0|||
131831238|NCT04403763|474665358|FG004|Stage 1|Early termination due to PK tube failure|0|||
131831239|NCT04403763|474665359|FG005|Stage 1|Early termination due to PK tube failure|0|||
131831240|NCT04403763|474665360|FG006|Stage 1|Early termination due to PK tube failure|0|||
131831241|NCT04403763|474665354|FG000|Stage 2A|Adverse Event|0|||
131831242|NCT04403763|474665355|FG001|Stage 2A|Adverse Event|0|||
131831243|NCT04403763|474665356|FG002|Stage 2A|Adverse Event|0|||
131831244|NCT04403763|474665357|FG003|Stage 2A|Adverse Event|0|||
131831245|NCT04403763|474665358|FG004|Stage 2A|Adverse Event|0|||
131831246|NCT04403763|474665359|FG005|Stage 2A|Adverse Event|0|||
131831247|NCT04403763|474665360|FG006|Stage 2A|Adverse Event|1|||
131831248|NCT01376310|474665361|FG000|Overall Study|Study closed/terminated|1|||
131831249|NCT01376310|474665362|FG001|Overall Study|Study closed/terminated|2|||
131831250|NCT01376310|474665361|FG000|Overall Study|Withdrawal by Subject|8|||
131831251|NCT01376310|474665362|FG001|Overall Study|Withdrawal by Subject|2|||
131831252|NCT01376310|474665361|FG000|Overall Study|Physician Decision|26|||
131831253|NCT01376310|474665362|FG001|Overall Study|Physician Decision|7|||
131831254|NCT01376310|474665361|FG000|Overall Study|Lost to Follow-up|1|||
131831255|NCT01376310|474665362|FG001|Overall Study|Lost to Follow-up|0|||
131831256|NCT02096588|474665365|FG000|Overall Study|Lack of Efficacy|2|||
131831257|NCT02096588|474665366|FG001|Overall Study|Lack of Efficacy|0|||
131831258|NCT02096588|474665365|FG000|Overall Study|Withdrawal by Subject|0|||
131831259|NCT02096588|474665366|FG001|Overall Study|Withdrawal by Subject|1|||
131831260|NCT00606502|474665368|FG000|Randomization|Randomized but not treated|3|||
131831261|NCT00606502|474665369|FG001|Randomization|Randomized but not treated|0|||
131831262|NCT00606502|474665368|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
131831263|NCT00606502|474665369|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
131831264|NCT02610816|474665372|FG000|Phase 1|Withdrawal by Subject|2|||
131831265|NCT02610816|474665373|FG001|Phase 1|Withdrawal by Subject|6|||
131831266|NCT02610816|474665374|FG002|Phase 1|Withdrawal by Subject|0|||
131831267|NCT02610816|474665375|FG003|Phase 1|Withdrawal by Subject|0|||
131831268|NCT02610816|474665372|FG000|Phase 1|Lost to Follow-up|2|||
131831269|NCT02610816|474665373|FG001|Phase 1|Lost to Follow-up|1|||
131831270|NCT02610816|474665374|FG002|Phase 1|Lost to Follow-up|0|||
131831271|NCT02610816|474665375|FG003|Phase 1|Lost to Follow-up|0|||
131831272|NCT02610816|474665372|FG000|Phase 1|Physician Decision|0|||
131831273|NCT02610816|474665373|FG001|Phase 1|Physician Decision|1|||
131831274|NCT02610816|474665374|FG002|Phase 1|Physician Decision|0|||
131831275|NCT02610816|474665375|FG003|Phase 1|Physician Decision|0|||
131831276|NCT02610816|474665372|FG000|Phase 2|Withdrawal by Subject|0|||
131401673|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
131401674|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
131401675|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
131401676|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
131401677|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
131401678|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401679|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401680|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401681|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401682|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401683|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131450124|NCT01721044|473276800|FG000|Treatment Period|Death|0|||
131831277|NCT02610816|474665373|FG001|Phase 2|Withdrawal by Subject|0|||
131831278|NCT02610816|474665374|FG002|Phase 2|Withdrawal by Subject|9|||
131831279|NCT02610816|474665375|FG003|Phase 2|Withdrawal by Subject|3|||
131831280|NCT02610816|474665372|FG000|Phase 2|Lost to Follow-up|0|||
131831281|NCT02610816|474665373|FG001|Phase 2|Lost to Follow-up|0|||
131831282|NCT02610816|474665374|FG002|Phase 2|Lost to Follow-up|2|||
131831283|NCT02610816|474665375|FG003|Phase 2|Lost to Follow-up|0|||
131831284|NCT02610816|474665372|FG000|Phase 2|Physician Decision|0|||
131831285|NCT02610816|474665373|FG001|Phase 2|Physician Decision|0|||
131831286|NCT02610816|474665374|FG002|Phase 2|Physician Decision|0|||
131401684|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131450125|NCT01721044|473276801|FG001|Treatment Period|Death|0|||
131831287|NCT02610816|474665375|FG003|Phase 2|Physician Decision|2|||
131831288|NCT02610816|474665372|FG000|Phase 2|Pregnancy|0|||
131831289|NCT02610816|474665373|FG001|Phase 2|Pregnancy|0|||
131831290|NCT02610816|474665374|FG002|Phase 2|Pregnancy|0|||
131831291|NCT02610816|474665375|FG003|Phase 2|Pregnancy|1|||
131831292|NCT03438227|474665378|FG000|Overall Study|Withdrawal by Subject|10|||
131831293|NCT03438227|474665379|FG001|Overall Study|Withdrawal by Subject|5|||
131831294|NCT00384176|474665380|FG000|Overall Study|Death|239|||
131831295|NCT00384176|474665381|FG001|Overall Study|Death|247|||
131831296|NCT00384176|474665382|FG002|Overall Study|Death|105|||
131831297|NCT00384176|474665380|FG000|Overall Study|Withdrawal by Subject|52|||
131831298|NCT00384176|474665381|FG001|Overall Study|Withdrawal by Subject|48|||
131831299|NCT00384176|474665382|FG002|Overall Study|Withdrawal by Subject|22|||
131831300|NCT00384176|474665380|FG000|Overall Study|Lost to Follow-up|16|||
131831301|NCT00384176|474665381|FG001|Overall Study|Lost to Follow-up|18|||
131831302|NCT00384176|474665382|FG002|Overall Study|Lost to Follow-up|4|||
131831303|NCT00384176|474665380|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
131831304|NCT00384176|474665381|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
131831305|NCT00384176|474665382|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
131831306|NCT00384176|474665380|FG000|Overall Study|Longer QTC as Visit 1|1|||
131831307|NCT00384176|474665381|FG001|Overall Study|Longer QTC as Visit 1|0|||
131831308|NCT00384176|474665382|FG002|Overall Study|Longer QTC as Visit 1|0|||
131831309|NCT00384176|474665380|FG000|Overall Study|Toxicity of treatment|1|||
131831310|NCT00384176|474665381|FG001|Overall Study|Toxicity of treatment|0|||
131831311|NCT00384176|474665382|FG002|Overall Study|Toxicity of treatment|0|||
131831312|NCT00384176|474665380|FG000|Overall Study|Did not receive study treatment|0|||
131831313|NCT00384176|474665381|FG001|Overall Study|Did not receive study treatment|1|||
131831314|NCT00384176|474665382|FG002|Overall Study|Did not receive study treatment|1|||
131831315|NCT00384176|474665380|FG000|Overall Study|Physician Decision|0|||
131831316|NCT00384176|474665381|FG001|Overall Study|Physician Decision|2|||
131831317|NCT00384176|474665382|FG002|Overall Study|Physician Decision|0|||
131831318|NCT00384176|474665380|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
131831319|NCT00384176|474665381|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
131831320|NCT00384176|474665382|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
131831321|NCT01855048|474665383|FG000|Overall Study|Withdrawal by Subject|0|||
131831322|NCT01855048|474665384|FG001|Overall Study|Withdrawal by Subject|1|||
131831323|NCT01855048|474665385|FG002|Overall Study|Withdrawal by Subject|0|||
131831324|NCT01855048|474665386|FG003|Overall Study|Withdrawal by Subject|0|||
131831325|NCT01855048|474665387|FG004|Overall Study|Withdrawal by Subject|1|||
131831326|NCT01855048|474665388|FG005|Overall Study|Withdrawal by Subject|0|||
131831327|NCT02691741|474665389|FG000|Overall Study|Adverse Event|0|||
131831328|NCT02691741|474665390|FG001|Overall Study|Adverse Event|2|||
131831329|NCT02691741|474665389|FG000|Overall Study|Lost to Follow-up|1|||
131831330|NCT02691741|474665390|FG001|Overall Study|Lost to Follow-up|0|||
131831331|NCT02691741|474665389|FG000|Overall Study|Physician Decision|0|||
131831332|NCT02691741|474665390|FG001|Overall Study|Physician Decision|1|||
131831333|NCT02691741|474665389|FG000|Overall Study|Withdrawal by Subject|0|||
131831334|NCT02691741|474665390|FG001|Overall Study|Withdrawal by Subject|4|||
131831335|NCT02139124|474665391|FG000|Overall Study|Adverse Event|2|||
131831336|NCT02139124|474665392|FG001|Overall Study|Adverse Event|0|||
131831337|NCT02139124|474665393|FG002|Overall Study|Adverse Event|1|||
131831338|NCT02139124|474665394|FG003|Overall Study|Adverse Event|2|||
131831339|NCT02139124|474665395|FG004|Overall Study|Adverse Event|5|||
131831340|NCT02139124|474665391|FG000|Overall Study|Withdrawal by Subject|2|||
131831341|NCT02139124|474665392|FG001|Overall Study|Withdrawal by Subject|2|||
131831342|NCT02139124|474665393|FG002|Overall Study|Withdrawal by Subject|2|||
131831343|NCT02139124|474665394|FG003|Overall Study|Withdrawal by Subject|2|||
131831344|NCT02139124|474665395|FG004|Overall Study|Withdrawal by Subject|3|||
131831345|NCT02139124|474665391|FG000|Overall Study|Protocol Violation|0|||
131831346|NCT02139124|474665392|FG001|Overall Study|Protocol Violation|0|||
131831347|NCT02139124|474665393|FG002|Overall Study|Protocol Violation|0|||
131831348|NCT02139124|474665394|FG003|Overall Study|Protocol Violation|1|||
131831349|NCT02139124|474665395|FG004|Overall Study|Protocol Violation|1|||
131831350|NCT02139124|474665391|FG000|Overall Study|non-compliant|1|||
131831351|NCT02139124|474665392|FG001|Overall Study|non-compliant|0|||
131831352|NCT02139124|474665393|FG002|Overall Study|non-compliant|0|||
131910443|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
131910444|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
131910445|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
131910446|NCT00784875|474960747|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
131910447|NCT00784875|474960748|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
131910448|NCT00784875|474960749|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
131831353|NCT02139124|474665394|FG003|Overall Study|non-compliant|2|||
131831354|NCT02139124|474665395|FG004|Overall Study|non-compliant|0|||
131831355|NCT02139124|474665391|FG000|Overall Study|incarceration|0|||
131831356|NCT02139124|474665392|FG001|Overall Study|incarceration|0|||
131831357|NCT02139124|474665393|FG002|Overall Study|incarceration|1|||
131831358|NCT02139124|474665394|FG003|Overall Study|incarceration|0|||
131831359|NCT02139124|474665395|FG004|Overall Study|incarceration|0|||
131831360|NCT02139124|474665391|FG000|Overall Study|subject moved|1|||
131831361|NCT02139124|474665392|FG001|Overall Study|subject moved|0|||
131831362|NCT02139124|474665393|FG002|Overall Study|subject moved|0|||
131831363|NCT02139124|474665394|FG003|Overall Study|subject moved|0|||
131831364|NCT02139124|474665395|FG004|Overall Study|subject moved|0|||
131831365|NCT02139124|474665391|FG000|Overall Study|Lost to Follow-up|3|||
131831366|NCT02139124|474665392|FG001|Overall Study|Lost to Follow-up|2|||
131831367|NCT02139124|474665393|FG002|Overall Study|Lost to Follow-up|0|||
131831368|NCT02139124|474665394|FG003|Overall Study|Lost to Follow-up|5|||
131831369|NCT02139124|474665395|FG004|Overall Study|Lost to Follow-up|4|||
131831370|NCT03465436|474665396|FG000|Period 1|Protocol Violation|0|||
131831371|NCT03465436|474665397|FG001|Period 1|Protocol Violation|0|||
131831372|NCT03465436|474665398|FG002|Period 1|Protocol Violation|1|||
131831373|NCT03465436|474665399|FG003|Period 1|Protocol Violation|0|||
131831374|NCT03465436|474665396|FG000|Period 2|Protocol Violation|0|||
131831375|NCT03465436|474665397|FG001|Period 2|Protocol Violation|1|||
131831376|NCT03465436|474665398|FG002|Period 2|Protocol Violation|0|||
131831377|NCT03465436|474665399|FG003|Period 2|Protocol Violation|0|||
131831378|NCT03465436|474665396|FG000|Period 3|Protocol Violation|1|||
131831379|NCT03465436|474665397|FG001|Period 3|Protocol Violation|1|||
131831380|NCT03465436|474665398|FG002|Period 3|Protocol Violation|0|||
131831381|NCT03465436|474665399|FG003|Period 3|Protocol Violation|0|||
131831382|NCT03465436|474665396|FG000|Period 4|Protocol Violation|0|||
131831383|NCT03465436|474665397|FG001|Period 4|Protocol Violation|0|||
131831384|NCT03465436|474665398|FG002|Period 4|Protocol Violation|1|||
131831385|NCT03465436|474665399|FG003|Period 4|Protocol Violation|0|||
131831386|NCT01813071|474665400|FG000|Overall Study|Protocol Violation|0|||
131831387|NCT01813071|474665401|FG001|Overall Study|Protocol Violation|0|||
131831388|NCT01813071|474665402|FG002|Overall Study|Protocol Violation|0|||
131831389|NCT01813071|474665403|FG003|Overall Study|Protocol Violation|0|||
131831390|NCT01813071|474665404|FG004|Overall Study|Protocol Violation|1|||
131831391|NCT01813071|474665405|FG005|Overall Study|Protocol Violation|4|||
131831392|NCT01813071|474665406|FG006|Overall Study|Protocol Violation|2|||
131831393|NCT01813071|474665407|FG007|Overall Study|Protocol Violation|4|||
131831394|NCT01813071|474665408|FG008|Overall Study|Protocol Violation|2|||
131831395|NCT01813071|474665400|FG000|Overall Study|Withdrawal by Subject|0|||
131831396|NCT01813071|474665401|FG001|Overall Study|Withdrawal by Subject|0|||
131831397|NCT01813071|474665402|FG002|Overall Study|Withdrawal by Subject|0|||
131831398|NCT01813071|474665403|FG003|Overall Study|Withdrawal by Subject|0|||
131831399|NCT01813071|474665404|FG004|Overall Study|Withdrawal by Subject|0|||
131831400|NCT01813071|474665405|FG005|Overall Study|Withdrawal by Subject|1|||
131831401|NCT01813071|474665406|FG006|Overall Study|Withdrawal by Subject|0|||
131831402|NCT01813071|474665407|FG007|Overall Study|Withdrawal by Subject|0|||
131831403|NCT01813071|474665408|FG008|Overall Study|Withdrawal by Subject|0|||
131831404|NCT01813071|474665400|FG000|Overall Study|Adverse Event|0|||
131831405|NCT01813071|474665401|FG001|Overall Study|Adverse Event|0|||
131831406|NCT01813071|474665402|FG002|Overall Study|Adverse Event|0|||
131831407|NCT01813071|474665403|FG003|Overall Study|Adverse Event|0|||
131831408|NCT01813071|474665404|FG004|Overall Study|Adverse Event|0|||
131831409|NCT01813071|474665405|FG005|Overall Study|Adverse Event|1|||
131831410|NCT01813071|474665406|FG006|Overall Study|Adverse Event|0|||
131831411|NCT01813071|474665407|FG007|Overall Study|Adverse Event|0|||
131831412|NCT01813071|474665408|FG008|Overall Study|Adverse Event|0|||
131831413|NCT01813071|474665400|FG000|Overall Study|Physician Decision|0|||
131831414|NCT01813071|474665401|FG001|Overall Study|Physician Decision|0|||
131831415|NCT01813071|474665402|FG002|Overall Study|Physician Decision|0|||
131831416|NCT01813071|474665403|FG003|Overall Study|Physician Decision|0|||
131831417|NCT01813071|474665404|FG004|Overall Study|Physician Decision|0|||
131831418|NCT01813071|474665405|FG005|Overall Study|Physician Decision|0|||
131831419|NCT01813071|474665406|FG006|Overall Study|Physician Decision|1|||
131831420|NCT01813071|474665407|FG007|Overall Study|Physician Decision|0|||
131450126|NCT01721044|473276802|FG002|Treatment Period|Death|1|||
131831421|NCT01813071|474665408|FG008|Overall Study|Physician Decision|0|||
131831422|NCT01813071|474665400|FG000|Overall Study|Met inc/exc criteria|0|||
131831423|NCT01813071|474665401|FG001|Overall Study|Met inc/exc criteria|0|||
131831424|NCT01813071|474665402|FG002|Overall Study|Met inc/exc criteria|0|||
131831425|NCT01813071|474665403|FG003|Overall Study|Met inc/exc criteria|0|||
131831426|NCT01813071|474665404|FG004|Overall Study|Met inc/exc criteria|0|||
131831427|NCT01813071|474665405|FG005|Overall Study|Met inc/exc criteria|1|||
131831428|NCT01813071|474665406|FG006|Overall Study|Met inc/exc criteria|0|||
131831429|NCT01813071|474665407|FG007|Overall Study|Met inc/exc criteria|1|||
131831430|NCT01813071|474665408|FG008|Overall Study|Met inc/exc criteria|1|||
131831431|NCT01425528|474665409|FG000|Overall Study|Withdrawal by Subject|1|||
131831432|NCT01425528|474665410|FG001|Overall Study|Withdrawal by Subject|1|||
131831433|NCT02697773|474665411|FG000|Overall Study|Adverse Event|2|||
131831434|NCT02697773|474665412|FG001|Overall Study|Adverse Event|1|||
131831435|NCT02697773|474665413|FG002|Overall Study|Adverse Event|2|||
131831436|NCT02697773|474665411|FG000|Overall Study|Death|0|||
131831437|NCT02697773|474665412|FG001|Overall Study|Death|0|||
131831438|NCT02697773|474665413|FG002|Overall Study|Death|2|||
131831439|NCT02697773|474665411|FG000|Overall Study|Lack of Efficacy|4|||
131831440|NCT02697773|474665412|FG001|Overall Study|Lack of Efficacy|6|||
131831441|NCT02697773|474665413|FG002|Overall Study|Lack of Efficacy|6|||
131831442|NCT02697773|474665411|FG000|Overall Study|Lost to Follow-up|5|||
131831443|NCT02697773|474665412|FG001|Overall Study|Lost to Follow-up|5|||
131831444|NCT02697773|474665413|FG002|Overall Study|Lost to Follow-up|7|||
131831445|NCT02697773|474665411|FG000|Overall Study|Other|15|||
131831446|NCT02697773|474665412|FG001|Overall Study|Other|11|||
131831447|NCT02697773|474665413|FG002|Overall Study|Other|10|||
131831448|NCT02697773|474665411|FG000|Overall Study|Protocol Violation|1|||
131831449|NCT02697773|474665412|FG001|Overall Study|Protocol Violation|1|||
131831450|NCT02697773|474665413|FG002|Overall Study|Protocol Violation|0|||
131831451|NCT02697773|474665411|FG000|Overall Study|Withdrawal by Subject|10|||
131831452|NCT02697773|474665412|FG001|Overall Study|Withdrawal by Subject|13|||
131401685|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401686|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401687|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401688|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401689|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401690|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131401691|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
131401692|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
131401693|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
131401694|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
131401695|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
131401696|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
131401697|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
131401698|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
131401699|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
131401700|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
131401701|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
131401702|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
131401703|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
131401704|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
131401705|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
131401706|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
131401707|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
131831453|NCT02697773|474665413|FG002|Overall Study|Withdrawal by Subject|13|||
131831454|NCT02697773|474665411|FG000|Overall Study|Randomized but not treated|1|||
131831455|NCT02697773|474665412|FG001|Overall Study|Randomized but not treated|1|||
131831456|NCT02697773|474665413|FG002|Overall Study|Randomized but not treated|0|||
131831457|NCT00613834|474665414|FG000|Overall Study|Withdrawal by Subject|0|||
131831458|NCT00613834|474665415|FG001|Overall Study|Withdrawal by Subject|3|||
131831459|NCT00842530|474665416|FG000|Overall Study|Serious adverse event|0|||
131831460|NCT00842530|474665417|FG001|Overall Study|Serious adverse event|6|||
131831461|NCT00842530|474665416|FG000|Overall Study|Other adverse event|6|||
131831462|NCT00842530|474665417|FG001|Overall Study|Other adverse event|1|||
131831463|NCT00842530|474665416|FG000|Overall Study|Protocol Violation|32|||
131831464|NCT00842530|474665417|FG001|Overall Study|Protocol Violation|14|||
131831465|NCT00842530|474665416|FG000|Overall Study|Lost to Follow-up|6|||
131831466|NCT00842530|474665417|FG001|Overall Study|Lost to Follow-up|8|||
131831467|NCT00842530|474665416|FG000|Overall Study|Withdrawal by Subject|73|||
131831468|NCT00842530|474665417|FG001|Overall Study|Withdrawal by Subject|28|||
131831469|NCT02939950|474665418|FG000|Overall Study|Lost to Follow-up|13|||
131831470|NCT02939950|474665419|FG001|Overall Study|Lost to Follow-up|16|||
131831471|NCT02939950|474665418|FG000|Overall Study|Positive slit lamp findings|0|||
131831472|NCT02939950|474665419|FG001|Overall Study|Positive slit lamp findings|1|||
131401708|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
131401709|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
131401710|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
131831473|NCT02939950|474665418|FG000|Overall Study|Chalazion upper lid|0|||
131831474|NCT02939950|474665419|FG001|Overall Study|Chalazion upper lid|1|||
131401711|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
131401712|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
131831475|NCT02939950|474665418|FG000|Overall Study|Lack of motivation|0|||
131831476|NCT02939950|474665419|FG001|Overall Study|Lack of motivation|2|||
131831477|NCT02939950|474665418|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
131831478|NCT02939950|474665419|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
131831479|NCT02939950|474665418|FG000|Overall Study|Military orders|1|||
131831480|NCT02939950|474665419|FG001|Overall Study|Military orders|0|||
131831481|NCT02939950|474665418|FG000|Overall Study|Participant Relocated|5|||
131831482|NCT02939950|474665419|FG001|Overall Study|Participant Relocated|3|||
131831483|NCT02939950|474665418|FG000|Overall Study|Study related symptoms|8|||
131831484|NCT02939950|474665419|FG001|Overall Study|Study related symptoms|8|||
131831485|NCT02939950|474665418|FG000|Overall Study|Unacceptable lens movement|2|||
131831486|NCT02939950|474665419|FG001|Overall Study|Unacceptable lens movement|0|||
131831487|NCT02939950|474665418|FG000|Overall Study|Protocol Violation|6|||
131831488|NCT02939950|474665419|FG001|Overall Study|Protocol Violation|3|||
131831489|NCT02939950|474665418|FG000|Overall Study|Physician Decision|2|||
131831490|NCT02939950|474665419|FG001|Overall Study|Physician Decision|0|||
131831491|NCT02939950|474665418|FG000|Overall Study|Pregnancy|6|||
131831492|NCT02939950|474665419|FG001|Overall Study|Pregnancy|7|||
131831493|NCT02939950|474665418|FG000|Overall Study|Withdrawal by Subject|12|||
131831494|NCT02939950|474665419|FG001|Overall Study|Withdrawal by Subject|28|||
131831495|NCT02939950|474665418|FG000|Overall Study|Adverse Event|7|||
131831496|NCT02939950|474665419|FG001|Overall Study|Adverse Event|3|||
131831497|NCT02939950|474665418|FG000|Overall Study|Randomized, not dispensed|1|||
131831498|NCT02939950|474665419|FG001|Overall Study|Randomized, not dispensed|0|||
131831499|NCT02939950|474665418|FG000|Overall Study|Ineligible at Baseline|2|||
131831500|NCT02939950|474665419|FG001|Overall Study|Ineligible at Baseline|8|||
131831501|NCT02243293|474665423|FG000|Overall Study|Adverse Event|1|||
131831502|NCT02243293|474665424|FG001|Overall Study|Adverse Event|0|||
131831503|NCT02243293|474665425|FG002|Overall Study|Adverse Event|0|||
131831504|NCT02243293|474665426|FG003|Overall Study|Adverse Event|0|||
131831505|NCT02243293|474665427|FG004|Overall Study|Adverse Event|0|||
131831506|NCT02243293|474665428|FG005|Overall Study|Adverse Event|0|||
131831507|NCT02243293|474665429|FG006|Overall Study|Adverse Event|0|||
131831508|NCT02243293|474665430|FG007|Overall Study|Adverse Event|0|||
131831509|NCT02243293|474665431|FG008|Overall Study|Adverse Event|0|||
131831510|NCT02243293|474665432|FG009|Overall Study|Adverse Event|0|||
131831511|NCT02243293|474665433|FG010|Overall Study|Adverse Event|0|||
131831512|NCT02243293|474665434|FG011|Overall Study|Adverse Event|0|||
131831513|NCT02243293|474665435|FG012|Overall Study|Adverse Event|0|||
131831514|NCT02243293|474665436|FG013|Overall Study|Adverse Event|0|||
131831515|NCT02243293|474665437|FG014|Overall Study|Adverse Event|0|||
131831516|NCT02243293|474665438|FG015|Overall Study|Adverse Event|1|||
131831517|NCT02243293|474665439|FG016|Overall Study|Adverse Event|0|||
131831518|NCT02243293|474665440|FG017|Overall Study|Adverse Event|0|||
131831519|NCT02243293|474665441|FG018|Overall Study|Adverse Event|0|||
131831520|NCT02243293|474665442|FG019|Overall Study|Adverse Event|0|||
131831521|NCT02243293|474665443|FG020|Overall Study|Adverse Event|1|||
131831522|NCT02243293|474665444|FG021|Overall Study|Adverse Event|0|||
131831523|NCT02243293|474665423|FG000|Overall Study|Withdrawal by Subject|1|||
131831524|NCT02243293|474665424|FG001|Overall Study|Withdrawal by Subject|0|||
131831525|NCT02243293|474665425|FG002|Overall Study|Withdrawal by Subject|0|||
131831526|NCT02243293|474665426|FG003|Overall Study|Withdrawal by Subject|0|||
131831527|NCT02243293|474665427|FG004|Overall Study|Withdrawal by Subject|0|||
131831528|NCT02243293|474665428|FG005|Overall Study|Withdrawal by Subject|0|||
131831529|NCT02243293|474665429|FG006|Overall Study|Withdrawal by Subject|0|||
131831530|NCT02243293|474665430|FG007|Overall Study|Withdrawal by Subject|0|||
131831531|NCT02243293|474665431|FG008|Overall Study|Withdrawal by Subject|0|||
131831532|NCT02243293|474665432|FG009|Overall Study|Withdrawal by Subject|1|||
131831533|NCT02243293|474665433|FG010|Overall Study|Withdrawal by Subject|0|||
131831534|NCT02243293|474665434|FG011|Overall Study|Withdrawal by Subject|1|||
131831535|NCT02243293|474665435|FG012|Overall Study|Withdrawal by Subject|0|||
131831536|NCT02243293|474665436|FG013|Overall Study|Withdrawal by Subject|0|||
131831537|NCT02243293|474665437|FG014|Overall Study|Withdrawal by Subject|0|||
131831538|NCT02243293|474665438|FG015|Overall Study|Withdrawal by Subject|0|||
131831539|NCT02243293|474665439|FG016|Overall Study|Withdrawal by Subject|0|||
131831540|NCT02243293|474665440|FG017|Overall Study|Withdrawal by Subject|0|||
131831541|NCT02243293|474665441|FG018|Overall Study|Withdrawal by Subject|0|||
131831542|NCT02243293|474665442|FG019|Overall Study|Withdrawal by Subject|0|||
131831543|NCT02243293|474665443|FG020|Overall Study|Withdrawal by Subject|0|||
131831544|NCT02243293|474665444|FG021|Overall Study|Withdrawal by Subject|1|||
131831545|NCT02243293|474665423|FG000|Overall Study|Lost to Follow-up|0|||
131831546|NCT02243293|474665424|FG001|Overall Study|Lost to Follow-up|1|||
131831547|NCT02243293|474665425|FG002|Overall Study|Lost to Follow-up|1|||
131831548|NCT02243293|474665426|FG003|Overall Study|Lost to Follow-up|1|||
131831549|NCT02243293|474665427|FG004|Overall Study|Lost to Follow-up|0|||
131831550|NCT02243293|474665428|FG005|Overall Study|Lost to Follow-up|0|||
131831551|NCT02243293|474665429|FG006|Overall Study|Lost to Follow-up|3|||
131831552|NCT02243293|474665430|FG007|Overall Study|Lost to Follow-up|0|||
131831553|NCT02243293|474665431|FG008|Overall Study|Lost to Follow-up|0|||
131831554|NCT02243293|474665432|FG009|Overall Study|Lost to Follow-up|0|||
131831555|NCT02243293|474665433|FG010|Overall Study|Lost to Follow-up|0|||
131831556|NCT02243293|474665434|FG011|Overall Study|Lost to Follow-up|2|||
131910449|NCT00784875|474960750|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
131831557|NCT02243293|474665435|FG012|Overall Study|Lost to Follow-up|0|||
131831558|NCT02243293|474665436|FG013|Overall Study|Lost to Follow-up|0|||
131831559|NCT02243293|474665437|FG014|Overall Study|Lost to Follow-up|0|||
131831560|NCT02243293|474665438|FG015|Overall Study|Lost to Follow-up|0|||
131831561|NCT02243293|474665439|FG016|Overall Study|Lost to Follow-up|3|||
131831562|NCT02243293|474665440|FG017|Overall Study|Lost to Follow-up|1|||
131401713|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
131401714|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
131401715|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
131401716|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
131401717|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
131401718|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
131401719|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
131401720|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
131401721|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
131401722|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
131401723|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
131401724|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
131401725|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401726|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401727|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401728|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401729|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401730|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401731|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401732|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401733|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401734|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401735|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131401736|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
131831563|NCT02243293|474665441|FG018|Overall Study|Lost to Follow-up|0|||
131831564|NCT02243293|474665442|FG019|Overall Study|Lost to Follow-up|0|||
131831565|NCT02243293|474665443|FG020|Overall Study|Lost to Follow-up|1|||
131831566|NCT02243293|474665444|FG021|Overall Study|Lost to Follow-up|2|||
131831567|NCT02243293|474665423|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
131831568|NCT02243293|474665424|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
131831569|NCT02243293|474665425|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
131831570|NCT02243293|474665426|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
131831571|NCT02243293|474665427|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
131831572|NCT02243293|474665428|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
131831573|NCT02243293|474665429|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
131831574|NCT02243293|474665430|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
131831575|NCT02243293|474665431|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
131831576|NCT02243293|474665432|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
131831577|NCT02243293|474665433|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
131831578|NCT02243293|474665434|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
131831579|NCT02243293|474665435|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
131831580|NCT02243293|474665436|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
131831581|NCT02243293|474665437|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
131831582|NCT02243293|474665438|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
131831583|NCT02243293|474665439|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
131831584|NCT02243293|474665440|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
131831585|NCT02243293|474665441|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
131831586|NCT02243293|474665442|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
131831587|NCT02243293|474665443|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
131910450|NCT00784875|474960747|FG000|Period C|Adverse Event|1|||
131910451|NCT00784875|474960748|FG001|Period C|Adverse Event|0|||
131910452|NCT00784875|474960749|FG002|Period C|Adverse Event|4|||
131910453|NCT00784875|474960750|FG003|Period C|Adverse Event|2|||
131910454|NCT00784875|474960747|FG000|Period C|Protocol Violation|0|||
131910455|NCT00784875|474960748|FG001|Period C|Protocol Violation|0|||
131910456|NCT00784875|474960749|FG002|Period C|Protocol Violation|1|||
131910457|NCT00784875|474960750|FG003|Period C|Protocol Violation|2|||
131910458|NCT00784875|474960747|FG000|Period C|Lack of Efficacy|0|||
131910459|NCT00784875|474960748|FG001|Period C|Lack of Efficacy|0|||
131910460|NCT00784875|474960749|FG002|Period C|Lack of Efficacy|1|||
131910461|NCT00784875|474960750|FG003|Period C|Lack of Efficacy|0|||
131910462|NCT00784875|474960747|FG000|Period C|Withdrawal by Subject|1|||
131910463|NCT00784875|474960748|FG001|Period C|Withdrawal by Subject|1|||
131910464|NCT00784875|474960749|FG002|Period C|Withdrawal by Subject|2|||
131910465|NCT00784875|474960750|FG003|Period C|Withdrawal by Subject|0|||
131401737|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
131910466|NCT00784875|474960747|FG000|Period C|Physician Decision|0|||
131910467|NCT00784875|474960748|FG001|Period C|Physician Decision|0|||
131910468|NCT00784875|474960749|FG002|Period C|Physician Decision|1|||
131831588|NCT02243293|474665444|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
131910469|NCT00784875|474960750|FG003|Period C|Physician Decision|1|||
131910470|NCT00784875|474960747|FG000|Period C|Sponsor Decision|5|||
131910471|NCT00784875|474960748|FG001|Period C|Sponsor Decision|5|||
131910472|NCT00784875|474960749|FG002|Period C|Sponsor Decision|4|||
131831589|NCT02243293|474665423|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
131831590|NCT02243293|474665424|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
131831591|NCT02243293|474665425|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
131831592|NCT02243293|474665426|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
131831593|NCT02243293|474665427|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
131831594|NCT02243293|474665428|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
131831595|NCT02243293|474665429|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
131831596|NCT02243293|474665430|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
131831597|NCT02243293|474665431|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
131831598|NCT02243293|474665432|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
131831599|NCT02243293|474665433|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
131831600|NCT02243293|474665434|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
131831601|NCT02243293|474665435|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
131831602|NCT02243293|474665436|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
131831603|NCT02243293|474665437|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
131831604|NCT02243293|474665438|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
131831605|NCT02243293|474665439|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
131831606|NCT02243293|474665440|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
131831607|NCT02243293|474665441|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
131831608|NCT02243293|474665442|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
131831609|NCT02243293|474665443|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
131831610|NCT02243293|474665444|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
131831611|NCT01660022|474665445|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
131831612|NCT01660022|474665446|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
131831613|NCT01660022|474665447|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
131831614|NCT01660022|474665448|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
131831615|NCT01660022|474665449|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
131831616|NCT01660022|474665450|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
131831617|NCT01660022|474665445|FG000|First Sequence (7 Days)|Adverse Event|0|||
131831618|NCT01660022|474665446|FG001|First Sequence (7 Days)|Adverse Event|0|||
131831619|NCT01660022|474665447|FG002|First Sequence (7 Days)|Adverse Event|0|||
131831620|NCT01660022|474665448|FG003|First Sequence (7 Days)|Adverse Event|0|||
131831621|NCT01660022|474665449|FG004|First Sequence (7 Days)|Adverse Event|1|||
131831622|NCT01660022|474665450|FG005|First Sequence (7 Days)|Adverse Event|3|||
131831623|NCT01660022|474665445|FG000|First Sequence (7 Days)|Protocol Violation|0|||
131831624|NCT01660022|474665446|FG001|First Sequence (7 Days)|Protocol Violation|0|||
131831625|NCT01660022|474665447|FG002|First Sequence (7 Days)|Protocol Violation|0|||
131831626|NCT01660022|474665448|FG003|First Sequence (7 Days)|Protocol Violation|0|||
131831627|NCT01660022|474665449|FG004|First Sequence (7 Days)|Protocol Violation|0|||
131831628|NCT01660022|474665450|FG005|First Sequence (7 Days)|Protocol Violation|1|||
131831629|NCT00710749|474665459|FG000|First Intervention|Withdrawal by Subject|1|||
131831630|NCT00710749|474665460|FG001|First Intervention|Withdrawal by Subject|0|||
131831631|NCT04974619|474667474|FG000|Overall Study|Lost to Follow-up|0|||
131831632|NCT04974619|474667475|FG001|Overall Study|Lost to Follow-up|0|||
131831633|NCT04974619|474667476|FG002|Overall Study|Lost to Follow-up|1|||
131831634|NCT04974619|474667474|FG000|Overall Study|Withdrawal by Subject|0|||
131831635|NCT04974619|474667475|FG001|Overall Study|Withdrawal by Subject|0|||
131831636|NCT04974619|474667476|FG002|Overall Study|Withdrawal by Subject|1|||
131831637|NCT04974619|474667474|FG000|Overall Study|Protocol Violation|0|||
131831638|NCT04974619|474667475|FG001|Overall Study|Protocol Violation|1|||
131831639|NCT04974619|474667476|FG002|Overall Study|Protocol Violation|0|||
131831640|NCT02516410|474667477|FG000|Overall Study|Adverse Event|0|||
131831641|NCT02516410|474667478|FG001|Overall Study|Adverse Event|1|||
131831642|NCT02516410|474667477|FG000|Overall Study|Withdrawal by Subject|0|||
131831643|NCT02516410|474667478|FG001|Overall Study|Withdrawal by Subject|1|||
131401738|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
131831644|NCT01475253|474667481|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
131831645|NCT01475253|474667482|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
131831646|NCT01475253|474667483|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
131401739|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
131831647|NCT01475253|474667484|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
131831648|NCT01475253|474667481|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
131831649|NCT01475253|474667482|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
131831650|NCT01475253|474667483|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
131831651|NCT01475253|474667484|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
131831652|NCT03135899|474667485|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831653|NCT03135899|474667486|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831654|NCT03135899|474667487|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831655|NCT03135899|474667488|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831656|NCT03135899|474667489|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831657|NCT03135899|474667490|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831658|NCT03135899|474667491|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
131831659|NCT03135899|474667492|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
131831660|NCT03135899|474667485|FG000|Overall Study|Withdrawal by Subject|0|||
131831661|NCT03135899|474667486|FG001|Overall Study|Withdrawal by Subject|0|||
131831662|NCT03135899|474667487|FG002|Overall Study|Withdrawal by Subject|0|||
131831663|NCT03135899|474667488|FG003|Overall Study|Withdrawal by Subject|0|||
131831664|NCT03135899|474667489|FG004|Overall Study|Withdrawal by Subject|0|||
131831665|NCT03135899|474667490|FG005|Overall Study|Withdrawal by Subject|2|||
131831666|NCT03135899|474667491|FG006|Overall Study|Withdrawal by Subject|0|||
131831667|NCT03135899|474667492|FG007|Overall Study|Withdrawal by Subject|0|||
131831668|NCT04146363|474667493|FG000|Induction Period|Adverse Event|1|||
131831669|NCT04146363|474667494|FG001|Induction Period|Adverse Event|2|||
131831670|NCT04146363|474667495|FG002|Induction Period|Adverse Event|0|||
131831671|NCT04146363|474667496|FG003|Induction Period|Adverse Event|0|||
131831672|NCT04146363|474667497|FG004|Induction Period|Adverse Event|0|||
131831673|NCT04146363|474667498|FG005|Induction Period|Adverse Event|0|||
131831674|NCT04146363|474667499|FG006|Induction Period|Adverse Event|0|||
131831675|NCT04146363|474667500|FG007|Induction Period|Adverse Event|0|||
131831676|NCT04146363|474667501|FG008|Induction Period|Adverse Event|0|||
131831677|NCT04146363|474667502|FG009|Induction Period|Adverse Event|0|||
131831678|NCT04146363|474667503|FG010|Induction Period|Adverse Event|0|||
131831679|NCT04146363|474667493|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
131831680|NCT04146363|474667494|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
131831681|NCT04146363|474667495|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
131831682|NCT04146363|474667496|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
131831683|NCT04146363|474667497|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
131831684|NCT04146363|474667498|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
131831685|NCT04146363|474667499|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
131831686|NCT04146363|474667500|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
131831687|NCT04146363|474667501|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
131831688|NCT04146363|474667502|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
131831689|NCT04146363|474667503|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
131831690|NCT04146363|474667493|FG000|Induction Period|Lack of Efficacy|7|||
131831691|NCT04146363|474667494|FG001|Induction Period|Lack of Efficacy|2|||
131831692|NCT04146363|474667495|FG002|Induction Period|Lack of Efficacy|0|||
131831693|NCT04146363|474667496|FG003|Induction Period|Lack of Efficacy|0|||
131831694|NCT04146363|474667497|FG004|Induction Period|Lack of Efficacy|0|||
131831695|NCT04146363|474667498|FG005|Induction Period|Lack of Efficacy|0|||
131831696|NCT04146363|474667499|FG006|Induction Period|Lack of Efficacy|0|||
131831697|NCT04146363|474667500|FG007|Induction Period|Lack of Efficacy|0|||
131831698|NCT04146363|474667501|FG008|Induction Period|Lack of Efficacy|0|||
131831699|NCT04146363|474667502|FG009|Induction Period|Lack of Efficacy|0|||
131831700|NCT04146363|474667503|FG010|Induction Period|Lack of Efficacy|0|||
131831701|NCT04146363|474667493|FG000|Induction Period|Lost to Follow-up|1|||
131831702|NCT04146363|474667494|FG001|Induction Period|Lost to Follow-up|4|||
131831703|NCT04146363|474667495|FG002|Induction Period|Lost to Follow-up|0|||
131831704|NCT04146363|474667496|FG003|Induction Period|Lost to Follow-up|0|||
131831705|NCT04146363|474667497|FG004|Induction Period|Lost to Follow-up|0|||
131831706|NCT04146363|474667498|FG005|Induction Period|Lost to Follow-up|0|||
131831707|NCT04146363|474667499|FG006|Induction Period|Lost to Follow-up|0|||
131831708|NCT04146363|474667500|FG007|Induction Period|Lost to Follow-up|0|||
131831709|NCT04146363|474667501|FG008|Induction Period|Lost to Follow-up|0|||
131831710|NCT04146363|474667502|FG009|Induction Period|Lost to Follow-up|0|||
131831711|NCT04146363|474667503|FG010|Induction Period|Lost to Follow-up|0|||
131831712|NCT04146363|474667493|FG000|Induction Period|Positive quantiferon test|0|||
131831713|NCT04146363|474667494|FG001|Induction Period|Positive quantiferon test|1|||
131831714|NCT04146363|474667495|FG002|Induction Period|Positive quantiferon test|0|||
131831715|NCT04146363|474667496|FG003|Induction Period|Positive quantiferon test|0|||
131831716|NCT04146363|474667497|FG004|Induction Period|Positive quantiferon test|0|||
131831717|NCT04146363|474667498|FG005|Induction Period|Positive quantiferon test|0|||
131831718|NCT04146363|474667499|FG006|Induction Period|Positive quantiferon test|0|||
131831719|NCT04146363|474667500|FG007|Induction Period|Positive quantiferon test|0|||
131831720|NCT04146363|474667501|FG008|Induction Period|Positive quantiferon test|0|||
131831721|NCT04146363|474667502|FG009|Induction Period|Positive quantiferon test|0|||
131831722|NCT04146363|474667503|FG010|Induction Period|Positive quantiferon test|0|||
131831723|NCT04146363|474667493|FG000|Induction Period|Protocol Deviation|5|||
131910473|NCT00784875|474960750|FG003|Period C|Sponsor Decision|2|||
131910474|NCT00784875|474960747|FG000|Period D|Adverse Event|0|||
131450127|NCT01721044|473276800|FG000|Treatment Period|Lack of Efficacy|16|||
131831724|NCT04146363|474667494|FG001|Induction Period|Protocol Deviation|6|||
131831725|NCT04146363|474667495|FG002|Induction Period|Protocol Deviation|0|||
131831726|NCT04146363|474667496|FG003|Induction Period|Protocol Deviation|0|||
131831727|NCT04146363|474667497|FG004|Induction Period|Protocol Deviation|0|||
131831728|NCT04146363|474667498|FG005|Induction Period|Protocol Deviation|0|||
131831729|NCT04146363|474667499|FG006|Induction Period|Protocol Deviation|0|||
131831730|NCT04146363|474667500|FG007|Induction Period|Protocol Deviation|0|||
131831731|NCT04146363|474667501|FG008|Induction Period|Protocol Deviation|0|||
131831732|NCT04146363|474667502|FG009|Induction Period|Protocol Deviation|0|||
131831733|NCT04146363|474667503|FG010|Induction Period|Protocol Deviation|0|||
131831734|NCT04146363|474667493|FG000|Induction Period|Withdrawal by Subject|6|||
131831735|NCT04146363|474667494|FG001|Induction Period|Withdrawal by Subject|3|||
131831736|NCT04146363|474667495|FG002|Induction Period|Withdrawal by Subject|0|||
131831737|NCT04146363|474667496|FG003|Induction Period|Withdrawal by Subject|0|||
131831738|NCT04146363|474667497|FG004|Induction Period|Withdrawal by Subject|0|||
131831739|NCT04146363|474667498|FG005|Induction Period|Withdrawal by Subject|0|||
131831740|NCT04146363|474667499|FG006|Induction Period|Withdrawal by Subject|0|||
131831741|NCT04146363|474667500|FG007|Induction Period|Withdrawal by Subject|0|||
131831742|NCT04146363|474667501|FG008|Induction Period|Withdrawal by Subject|0|||
131831743|NCT04146363|474667502|FG009|Induction Period|Withdrawal by Subject|0|||
131831744|NCT04146363|474667503|FG010|Induction Period|Withdrawal by Subject|0|||
131831745|NCT04146363|474667493|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831746|NCT04146363|474667494|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831747|NCT04146363|474667495|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831748|NCT04146363|474667496|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831749|NCT04146363|474667497|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831750|NCT04146363|474667498|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831751|NCT04146363|474667499|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
131831752|NCT04146363|474667500|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
131831753|NCT04146363|474667501|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831754|NCT04146363|474667502|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831755|NCT04146363|474667503|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
131831756|NCT04146363|474667493|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831757|NCT04146363|474667494|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831758|NCT04146363|474667495|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831759|NCT04146363|474667496|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831760|NCT04146363|474667497|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831761|NCT04146363|474667498|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831762|NCT04146363|474667499|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831763|NCT04146363|474667500|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
131831764|NCT04146363|474667501|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831765|NCT04146363|474667502|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831766|NCT04146363|474667503|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131831767|NCT04146363|474667493|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831768|NCT04146363|474667494|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831769|NCT04146363|474667495|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831770|NCT04146363|474667496|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831771|NCT04146363|474667497|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831772|NCT04146363|474667498|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831773|NCT04146363|474667499|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
131831774|NCT04146363|474667500|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
131831775|NCT04146363|474667501|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831776|NCT04146363|474667502|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831777|NCT04146363|474667503|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131831778|NCT04146363|474667493|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831779|NCT04146363|474667494|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831780|NCT04146363|474667495|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
131831781|NCT04146363|474667496|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831782|NCT04146363|474667497|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831783|NCT04146363|474667498|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
131831784|NCT04146363|474667499|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831785|NCT04146363|474667500|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831786|NCT04146363|474667501|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831787|NCT04146363|474667502|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831788|NCT04146363|474667503|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
131831789|NCT04146363|474667493|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131831790|NCT04146363|474667494|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131831791|NCT04146363|474667495|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131910475|NCT00784875|474960748|FG001|Period D|Adverse Event|2|||
131910476|NCT00784875|474960749|FG002|Period D|Adverse Event|2|||
131910477|NCT00784875|474960750|FG003|Period D|Adverse Event|0|||
131910478|NCT00784875|474960747|FG000|Period D|Protocol Violation|1|||
131910479|NCT00784875|474960748|FG001|Period D|Protocol Violation|0|||
131910480|NCT00784875|474960749|FG002|Period D|Protocol Violation|0|||
131910481|NCT00784875|474960750|FG003|Period D|Protocol Violation|0|||
131831792|NCT04146363|474667496|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131831793|NCT04146363|474667497|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
131831794|NCT04146363|474667498|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
131831795|NCT04146363|474667499|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
131831796|NCT04146363|474667500|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
131831797|NCT04146363|474667501|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131831798|NCT04146363|474667502|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131831799|NCT04146363|474667503|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131831800|NCT04146363|474667493|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831801|NCT04146363|474667494|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831802|NCT04146363|474667495|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
131831803|NCT04146363|474667496|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831804|NCT04146363|474667497|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831805|NCT04146363|474667498|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
131831806|NCT04146363|474667499|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
131831807|NCT04146363|474667500|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
131831808|NCT04146363|474667501|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831809|NCT04146363|474667502|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831810|NCT04146363|474667503|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131831811|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831812|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831813|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831814|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831815|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831816|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831817|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831818|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831819|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
131831820|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
131831821|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
131831822|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831823|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831824|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831825|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831826|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831827|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831828|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831829|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131831830|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
131831831|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
131831832|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
131831833|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831834|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831835|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831836|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831837|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831838|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831839|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831840|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831841|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
131831842|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
131831843|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131831844|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831845|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831846|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831847|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831848|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831849|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831850|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831851|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831852|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
131831853|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
131831854|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
131831855|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131910482|NCT00784875|474960747|FG000|Period D|Withdrawal by Subject|2|||
131910483|NCT00784875|474960748|FG001|Period D|Withdrawal by Subject|0|||
131831856|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831857|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831858|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831859|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831860|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831861|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831862|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131831863|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
131831864|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
131831865|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
131831866|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831867|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831868|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831869|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831870|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831871|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831872|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831873|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831874|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831875|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
131831876|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
131831877|NCT04146363|474667493|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831878|NCT04146363|474667494|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831879|NCT04146363|474667495|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831880|NCT04146363|474667496|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831881|NCT04146363|474667497|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831882|NCT04146363|474667498|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831883|NCT04146363|474667499|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831884|NCT04146363|474667500|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831885|NCT04146363|474667501|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831886|NCT04146363|474667502|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
131831887|NCT04146363|474667503|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
131831888|NCT02914236|474667508|FG000|Overall Study|Lost to Follow-up|1|||
131831889|NCT02698865|474667509|FG000|Overall Study|Other|11|||
131831890|NCT02698865|474667510|FG001|Overall Study|Other|11|||
131831891|NCT02698865|474667509|FG000|Overall Study|Withdrawal by Subject|20|||
131831892|NCT02698865|474667510|FG001|Overall Study|Withdrawal by Subject|16|||
131831893|NCT02698865|474667509|FG000|Overall Study|Physician Decision|0|||
131831894|NCT02698865|474667510|FG001|Overall Study|Physician Decision|4|||
131831895|NCT02698865|474667509|FG000|Overall Study|Lost to Follow-up|4|||
131831896|NCT02698865|474667510|FG001|Overall Study|Lost to Follow-up|2|||
131831897|NCT03861481|474667511|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
131831898|NCT03861481|474667512|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
131831899|NCT03861481|474667511|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
131831900|NCT03861481|474667512|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
131831901|NCT03861481|474667511|FG000|Overall Study|Relapse|1|||
131831902|NCT03861481|474667512|FG001|Overall Study|Relapse|0|||
131831903|NCT03861481|474667511|FG000|Overall Study|Withdrawal by Subject|0|||
131831904|NCT03861481|474667512|FG001|Overall Study|Withdrawal by Subject|1|||
131831905|NCT03861481|474667511|FG000|Overall Study|Lack of Efficacy|4|||
131831906|NCT03861481|474667512|FG001|Overall Study|Lack of Efficacy|5|||
131831907|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
131831908|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
131831909|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
131831910|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
131831911|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
131831912|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
131831913|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
131831914|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
131831915|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
131831916|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
131831917|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
131831918|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
131831919|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
131831920|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
131831921|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
131831922|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
131831923|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
131910484|NCT00784875|474960749|FG002|Period D|Withdrawal by Subject|2|||
131401740|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401741|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401742|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401743|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401744|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131831924|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
131831925|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
131831926|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
131831927|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
131831928|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
131831929|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
131831930|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
131831931|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
131831932|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
131831933|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
131831934|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
131831935|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
131831936|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
131831937|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
131831938|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
131831939|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
131831940|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
131831941|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
131831942|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
131831943|NCT00773734|474667513|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
131831944|NCT00773734|474667514|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
131831945|NCT00773734|474667515|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
131831946|NCT00773734|474667516|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
131831947|NCT00773734|474667517|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
131831948|NCT00773734|474667518|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
131831949|NCT00773734|474667513|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
131831950|NCT00773734|474667514|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
131831951|NCT00773734|474667515|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
131831952|NCT00773734|474667516|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
131831953|NCT00773734|474667517|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
131831954|NCT00773734|474667518|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
131831955|NCT00773734|474667513|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
131831956|NCT00773734|474667514|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
131831957|NCT00773734|474667515|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
131831958|NCT00773734|474667516|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
131831959|NCT00773734|474667517|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
131831960|NCT00773734|474667518|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
131831961|NCT00773734|474667513|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
131831962|NCT00773734|474667514|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
131831963|NCT00773734|474667515|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
131831964|NCT00773734|474667516|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
131831965|NCT00773734|474667517|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
131831966|NCT00773734|474667518|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
131831967|NCT00773734|474667513|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
131831968|NCT00773734|474667514|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
131831969|NCT00773734|474667515|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
131831970|NCT00773734|474667516|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
131831971|NCT00773734|474667517|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
131831972|NCT00773734|474667518|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
131831973|NCT00773734|474667513|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
131831974|NCT00773734|474667514|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
131831975|NCT00773734|474667515|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
131831976|NCT00773734|474667516|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
131831977|NCT00773734|474667517|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
131831978|NCT00773734|474667518|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
131831979|NCT00773734|474667513|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
131401745|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131831980|NCT00773734|474667514|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
131831981|NCT00773734|474667515|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
131401746|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131831982|NCT00773734|474667516|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
131831983|NCT00773734|474667517|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
131831984|NCT00773734|474667518|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
131831985|NCT00773734|474667513|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
131831986|NCT00773734|474667514|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
131831987|NCT00773734|474667515|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
131831988|NCT00773734|474667516|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
131831989|NCT00773734|474667517|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
131831990|NCT00773734|474667518|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
131831991|NCT00773734|474667513|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
131831992|NCT00773734|474667514|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
131831993|NCT00773734|474667515|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
131831994|NCT00773734|474667516|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
131831995|NCT00773734|474667517|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
131831996|NCT00773734|474667518|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
131831997|NCT00773734|474667513|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
131831998|NCT00773734|474667514|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
131831999|NCT00773734|474667515|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
131832000|NCT00773734|474667516|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
131832001|NCT00773734|474667517|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
131832002|NCT00773734|474667518|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
131832003|NCT00773734|474667513|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
131832004|NCT00773734|474667514|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
131832005|NCT00773734|474667515|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
131832006|NCT00773734|474667516|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
131832007|NCT00773734|474667517|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
131832008|NCT00773734|474667518|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
131832009|NCT00773734|474667513|FG000|Extension: Active Treatment Week 24-52|Other|0|||
131832010|NCT00773734|474667514|FG001|Extension: Active Treatment Week 24-52|Other|0|||
131832011|NCT00773734|474667515|FG002|Extension: Active Treatment Week 24-52|Other|1|||
131832012|NCT00773734|474667516|FG003|Extension: Active Treatment Week 24-52|Other|2|||
131832013|NCT00773734|474667517|FG004|Extension: Active Treatment Week 24-52|Other|0|||
131832014|NCT00773734|474667518|FG005|Extension: Active Treatment Week 24-52|Other|1|||
131832015|NCT00773734|474667513|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
131832016|NCT00773734|474667514|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
131832017|NCT00773734|474667515|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
131832018|NCT00773734|474667516|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
131832019|NCT00773734|474667517|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
131401747|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401748|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401749|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401750|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
131401751|NCT03831191|473091571|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401752|NCT03831191|473091572|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401753|NCT03831191|473091573|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401754|NCT03831191|473091574|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
131401755|NCT03831191|473091575|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401756|NCT03831191|473091576|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
131832020|NCT00773734|474667518|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
131832021|NCT00773734|474667513|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
131832022|NCT00773734|474667514|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
131832023|NCT00773734|474667515|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
131832024|NCT00773734|474667516|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
131832025|NCT00773734|474667517|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
131832026|NCT00773734|474667518|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
131832027|NCT00773734|474667513|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
131401757|NCT03831191|473091577|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
131832028|NCT00773734|474667514|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
131832029|NCT00773734|474667515|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
131832030|NCT00773734|474667516|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
131832031|NCT00773734|474667517|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
131832032|NCT00773734|474667518|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
131832033|NCT00773734|474667513|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
131832034|NCT00773734|474667514|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
131832035|NCT00773734|474667515|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
131832036|NCT00773734|474667516|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
131910485|NCT00784875|474960750|FG003|Period D|Withdrawal by Subject|0|||
131832037|NCT00773734|474667517|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
131832038|NCT00773734|474667518|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
131832039|NCT01220297|474667521|FG000|Overall Study|Death|2|||
131832040|NCT01220297|474667521|FG000|Overall Study|Lost to Follow-up|1|||
131832041|NCT02148913|474667523|FG000|Overall Study|Death|0|||
131832042|NCT02148913|474667524|FG001|Overall Study|Death|1|||
131832043|NCT02148913|474667525|FG002|Overall Study|Death|0|||
131832044|NCT02148913|474667526|FG003|Overall Study|Death|0|||
131832045|NCT01287039|474667527|FG000|Overall Study|Noncompliance with study procedures|0|||
131832046|NCT01287039|474667528|FG001|Overall Study|Noncompliance with study procedures|1|||
131832047|NCT01287039|474667527|FG000|Overall Study|Change of location/residence|0|||
131832048|NCT01287039|474667528|FG001|Overall Study|Change of location/residence|3|||
131832049|NCT01287039|474667527|FG000|Overall Study|Elective surgery|0|||
131832050|NCT01287039|474667528|FG001|Overall Study|Elective surgery|1|||
131832051|NCT01287039|474667527|FG000|Overall Study|Protocol Violation|2|||
131832052|NCT01287039|474667528|FG001|Overall Study|Protocol Violation|3|||
131832053|NCT01287039|474667527|FG000|Overall Study|Excluded medication taken|1|||
131832054|NCT01287039|474667528|FG001|Overall Study|Excluded medication taken|0|||
131832055|NCT01287039|474667527|FG000|Overall Study|Noncompliance with study medication|0|||
131832056|NCT01287039|474667528|FG001|Overall Study|Noncompliance with study medication|1|||
131832057|NCT01287039|474667527|FG000|Overall Study|Problem with travel|0|||
131832058|NCT01287039|474667528|FG001|Overall Study|Problem with travel|1|||
131832059|NCT01287039|474667527|FG000|Overall Study|Death|1|||
131832060|NCT01287039|474667528|FG001|Overall Study|Death|0|||
131832061|NCT01287039|474667527|FG000|Overall Study|Change of residence|1|||
131832062|NCT01287039|474667528|FG001|Overall Study|Change of residence|0|||
131832063|NCT01287039|474667527|FG000|Overall Study|Adverse Event|7|||
131832064|NCT01287039|474667528|FG001|Overall Study|Adverse Event|4|||
131832065|NCT01287039|474667527|FG000|Overall Study|Withdrawal by Subject|14|||
131832066|NCT01287039|474667528|FG001|Overall Study|Withdrawal by Subject|11|||
131832067|NCT01287039|474667527|FG000|Overall Study|Lost to Follow-up|3|||
131832068|NCT01287039|474667528|FG001|Overall Study|Lost to Follow-up|2|||
131832069|NCT05016622|474667529|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
131832070|NCT05016622|474667529|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
131832071|NCT00918463|474667533|FG000|Overall Study|Death|1|||
131832072|NCT00918463|474667533|FG000|Overall Study|Lack of Efficacy|1|||
131832073|NCT01014624|474667537|FG000|Overall Study|Adverse Event|0|||
131832074|NCT01014624|474667538|FG001|Overall Study|Adverse Event|1|||
131832075|NCT01014624|474667537|FG000|Overall Study|Protocol Violation|1|||
131832076|NCT01014624|474667538|FG001|Overall Study|Protocol Violation|0|||
131832077|NCT01014624|474667537|FG000|Overall Study|Withdrawal by Subject|1|||
131832078|NCT01014624|474667538|FG001|Overall Study|Withdrawal by Subject|0|||
131832079|NCT02954159|474667540|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
131832080|NCT02954159|474667541|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
131832081|NCT02954159|474667540|FG000|Overall Study|Withdrawal by Subject|0|||
131832082|NCT02954159|474667541|FG001|Overall Study|Withdrawal by Subject|1|||
131832083|NCT03575871|474667545|FG000|Overall Study|Adverse Event|5|||
131832084|NCT03575871|474667546|FG001|Overall Study|Adverse Event|5|||
131832085|NCT03575871|474667547|FG002|Overall Study|Adverse Event|8|||
131832086|NCT03575871|474667545|FG000|Overall Study|Death|1|||
131832087|NCT03575871|474667546|FG001|Overall Study|Death|0|||
131832088|NCT03575871|474667547|FG002|Overall Study|Death|0|||
131832089|NCT03575871|474667545|FG000|Overall Study|Lack of Efficacy|5|||
131832090|NCT03575871|474667546|FG001|Overall Study|Lack of Efficacy|4|||
131832091|NCT03575871|474667547|FG002|Overall Study|Lack of Efficacy|7|||
131832092|NCT03575871|474667545|FG000|Overall Study|Lost to Follow-up|1|||
131832093|NCT03575871|474667546|FG001|Overall Study|Lost to Follow-up|1|||
131832094|NCT03575871|474667547|FG002|Overall Study|Lost to Follow-up|1|||
131832095|NCT03575871|474667545|FG000|Overall Study|Protocol Deviation|1|||
131832096|NCT03575871|474667546|FG001|Overall Study|Protocol Deviation|1|||
131832097|NCT03575871|474667547|FG002|Overall Study|Protocol Deviation|1|||
131832098|NCT03575871|474667545|FG000|Overall Study|Withdrawal by Subject|6|||
131832099|NCT03575871|474667546|FG001|Overall Study|Withdrawal by Subject|1|||
131832100|NCT03575871|474667547|FG002|Overall Study|Withdrawal by Subject|9|||
131832101|NCT03575871|474667545|FG000|Overall Study|Other than specified|2|||
131832102|NCT03575871|474667546|FG001|Overall Study|Other than specified|2|||
131832103|NCT03575871|474667547|FG002|Overall Study|Other than specified|0|||
131832104|NCT01045993|474667548|FG000|Overall Study|Treated-later found eligibility not met|0|||
131832105|NCT01045993|474667549|FG001|Overall Study|Treated-later found eligibility not met|1|||
131832106|NCT01045993|474667550|FG002|Overall Study|Treated-later found eligibility not met|0|||
131450128|NCT01721044|473276801|FG001|Treatment Period|Lack of Efficacy|4|||
131832107|NCT01045993|474667551|FG003|Overall Study|Treated-later found eligibility not met|0|||
131832108|NCT02581163|474667557|FG000|Overall Study|Failure to return|15|||
131832109|NCT02581163|474667557|FG000|Overall Study|Insufficient virological response|3|||
131832110|NCT02581163|474667557|FG000|Overall Study|Withdrew consent|1|||
131832111|NCT02581163|474667557|FG000|Overall Study|Death|1|||
131832112|NCT02581163|474667557|FG000|Overall Study|Other, not specified|9|||
131832113|NCT02791893|474667558|FG000|Blinded Phase|Lost to Follow-up|2|||
131832114|NCT02791893|474667559|FG001|Blinded Phase|Lost to Follow-up|2|||
131832115|NCT02791893|474667558|FG000|Blinded Phase|Withdrawal by Subject|1|||
131832116|NCT02791893|474667559|FG001|Blinded Phase|Withdrawal by Subject|2|||
131832117|NCT02791893|474667558|FG000|Open Label Phase|Lost to Follow-up|3|||
131832118|NCT02791893|474667559|FG001|Open Label Phase|Lost to Follow-up|0|||
131832119|NCT02791893|474667558|FG000|Open Label Phase|Withdrawal by Subject|0|||
131832120|NCT02791893|474667559|FG001|Open Label Phase|Withdrawal by Subject|2|||
131832121|NCT01206816|474667566|FG000|Overall Study|Protocol Violation|0|||
131832122|NCT01206816|474667567|FG001|Overall Study|Protocol Violation|0|||
131832123|NCT01206816|474667568|FG002|Overall Study|Protocol Violation|1|||
131832124|NCT01206816|474667569|FG003|Overall Study|Protocol Violation|0|||
131832125|NCT01206816|474667570|FG004|Overall Study|Protocol Violation|0|||
131832126|NCT01206816|474667571|FG005|Overall Study|Protocol Violation|0|||
131832127|NCT01206816|474667572|FG006|Overall Study|Protocol Violation|0|||
131832128|NCT01206816|474667566|FG000|Overall Study|Withdrawal by Subject|0|||
131832129|NCT01206816|474667567|FG001|Overall Study|Withdrawal by Subject|0|||
131832130|NCT01206816|474667568|FG002|Overall Study|Withdrawal by Subject|1|||
131832131|NCT01206816|474667569|FG003|Overall Study|Withdrawal by Subject|0|||
131401758|NCT03831191|473091578|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401759|NCT03831191|473091579|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401760|NCT03831191|473091580|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401761|NCT03831191|473091581|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401762|NCT03831191|473091582|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401763|NCT03831191|473091583|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401764|NCT03831191|473091584|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401765|NCT03831191|473091585|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
131401766|NCT03831191|473091571|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
131401767|NCT03831191|473091572|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
131401768|NCT03831191|473091573|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
131401769|NCT03831191|473091574|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
131401770|NCT03831191|473091575|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
131401771|NCT03831191|473091576|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
131401772|NCT03831191|473091577|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
131832132|NCT01206816|474667570|FG004|Overall Study|Withdrawal by Subject|0|||
131832133|NCT01206816|474667571|FG005|Overall Study|Withdrawal by Subject|0|||
131832134|NCT01206816|474667572|FG006|Overall Study|Withdrawal by Subject|0|||
131832135|NCT01206816|474667566|FG000|Overall Study|Progressive disease|3|||
131832136|NCT01206816|474667567|FG001|Overall Study|Progressive disease|3|||
131832137|NCT01206816|474667568|FG002|Overall Study|Progressive disease|13|||
131832138|NCT01206816|474667569|FG003|Overall Study|Progressive disease|3|||
131832139|NCT01206816|474667570|FG004|Overall Study|Progressive disease|3|||
131832140|NCT01206816|474667571|FG005|Overall Study|Progressive disease|16|||
131832141|NCT01206816|474667572|FG006|Overall Study|Progressive disease|3|||
131832142|NCT01206816|474667566|FG000|Overall Study|Other AE|0|||
131832143|NCT01206816|474667567|FG001|Overall Study|Other AE|0|||
131832144|NCT01206816|474667568|FG002|Overall Study|Other AE|4|||
131832145|NCT01206816|474667569|FG003|Overall Study|Other AE|0|||
131832146|NCT01206816|474667570|FG004|Overall Study|Other AE|0|||
131832147|NCT01206816|474667571|FG005|Overall Study|Other AE|3|||
131832148|NCT01206816|474667572|FG006|Overall Study|Other AE|2|||
131832149|NCT01206816|474667566|FG000|Overall Study|other than stated above|0|||
131832150|NCT01206816|474667567|FG001|Overall Study|other than stated above|0|||
131832151|NCT01206816|474667568|FG002|Overall Study|other than stated above|1|||
131832152|NCT01206816|474667569|FG003|Overall Study|other than stated above|0|||
131832153|NCT01206816|474667570|FG004|Overall Study|other than stated above|0|||
131832154|NCT01206816|474667571|FG005|Overall Study|other than stated above|0|||
131832155|NCT01206816|474667572|FG006|Overall Study|other than stated above|1|||
131832156|NCT05206448|474667573|FG000|Overall Study|Lost to Follow-up|2|||
131832157|NCT05206448|474667574|FG001|Overall Study|Lost to Follow-up|2|||
131832158|NCT05206448|474667573|FG000|Overall Study|Withdrawal by Subject|2|||
131832159|NCT05206448|474667574|FG001|Overall Study|Withdrawal by Subject|0|||
131832160|NCT05206448|474667573|FG000|Overall Study|found ineligible after randomization|1|||
131832161|NCT05206448|474667574|FG001|Overall Study|found ineligible after randomization|1|||
131832162|NCT05206448|474667573|FG000|Overall Study|unable to complete study due to personal constraints|1|||
131832163|NCT05206448|474667574|FG001|Overall Study|unable to complete study due to personal constraints|0|||
131832164|NCT05206448|474667573|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
131832165|NCT05206448|474667574|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
131832166|NCT02025010|474667575|FG000|Overall Study|Symptomatic or radiographic progression|36|||
131832167|NCT02025010|474667575|FG000|Overall Study|Adverse Event|6|||
131832168|NCT02025010|474667575|FG000|Overall Study|Physician Decision|7|||
131910486|NCT00784875|474960747|FG000|Period D|Physician Decision|0|||
131401773|NCT03831191|473091578|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
131401774|NCT03831191|473091579|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
131832169|NCT02025010|474667575|FG000|Overall Study|Withdrawal by Subject|3|||
131832170|NCT02025010|474667575|FG000|Overall Study|Intercurrent illness|3|||
131832171|NCT02025010|474667575|FG000|Overall Study|Patients still on treatment|3|||
131832172|NCT02025010|474667575|FG000|Overall Study|Never initiate the treatment|2|||
131832173|NCT01661881|474667577|FG000|Overall Study|Disease Progression|1|||
131832174|NCT00102687|474667585|FG000|Initial Period|Withdrawal by Subject|6|||
131832175|NCT00102687|474667586|FG001|Initial Period|Withdrawal by Subject|3|||
131832176|NCT00102687|474667587|FG002|Initial Period|Withdrawal by Subject|5|||
131832177|NCT00102687|474667588|FG003|Initial Period|Withdrawal by Subject|0|||
131832178|NCT00102687|474667589|FG004|Initial Period|Withdrawal by Subject|0|||
131832179|NCT00102687|474667585|FG000|Initial Period|Adverse Event|4|||
131832180|NCT00102687|474667586|FG001|Initial Period|Adverse Event|7|||
131832181|NCT00102687|474667587|FG002|Initial Period|Adverse Event|9|||
131832182|NCT00102687|474667588|FG003|Initial Period|Adverse Event|0|||
131832183|NCT00102687|474667589|FG004|Initial Period|Adverse Event|0|||
131832184|NCT00102687|474667585|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
131832185|NCT00102687|474667586|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
131832186|NCT00102687|474667587|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
131832187|NCT00102687|474667588|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
131832188|NCT00102687|474667589|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
131832189|NCT00102687|474667585|FG000|Initial Period|Protocol Violation|0|||
131832190|NCT00102687|474667586|FG001|Initial Period|Protocol Violation|0|||
131832191|NCT00102687|474667587|FG002|Initial Period|Protocol Violation|2|||
131832192|NCT00102687|474667588|FG003|Initial Period|Protocol Violation|0|||
131832193|NCT00102687|474667589|FG004|Initial Period|Protocol Violation|0|||
131832194|NCT00102687|474667585|FG000|Initial Period|Physician Decision|2|||
131832195|NCT00102687|474667586|FG001|Initial Period|Physician Decision|9|||
131832196|NCT00102687|474667587|FG002|Initial Period|Physician Decision|6|||
131832197|NCT00102687|474667588|FG003|Initial Period|Physician Decision|0|||
131832198|NCT00102687|474667589|FG004|Initial Period|Physician Decision|0|||
131832199|NCT00102687|474667585|FG000|Initial Period|Sponsor's decision|0|||
131832200|NCT00102687|474667586|FG001|Initial Period|Sponsor's decision|1|||
131832201|NCT00102687|474667587|FG002|Initial Period|Sponsor's decision|1|||
131832202|NCT00102687|474667588|FG003|Initial Period|Sponsor's decision|0|||
131832203|NCT00102687|474667589|FG004|Initial Period|Sponsor's decision|0|||
131832204|NCT00102687|474667585|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
131832205|NCT00102687|474667586|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
131832206|NCT00102687|474667587|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
131832207|NCT00102687|474667588|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
131832208|NCT00102687|474667589|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
131832209|NCT00102687|474667585|FG000|Initial Period|Death|1|||
131832210|NCT00102687|474667586|FG001|Initial Period|Death|1|||
131832211|NCT00102687|474667587|FG002|Initial Period|Death|1|||
131832212|NCT00102687|474667588|FG003|Initial Period|Death|0|||
131832213|NCT00102687|474667589|FG004|Initial Period|Death|0|||
131832214|NCT00102687|474667585|FG000|Maintenance Period|Withdrawal by Subject|4|||
131832215|NCT00102687|474667586|FG001|Maintenance Period|Withdrawal by Subject|0|||
131832216|NCT00102687|474667587|FG002|Maintenance Period|Withdrawal by Subject|2|||
131832217|NCT00102687|474667588|FG003|Maintenance Period|Withdrawal by Subject|3|||
131832218|NCT00102687|474667589|FG004|Maintenance Period|Withdrawal by Subject|1|||
131832219|NCT00102687|474667585|FG000|Maintenance Period|Adverse Event|1|||
131832220|NCT00102687|474667586|FG001|Maintenance Period|Adverse Event|0|||
131832221|NCT00102687|474667587|FG002|Maintenance Period|Adverse Event|0|||
131832222|NCT00102687|474667588|FG003|Maintenance Period|Adverse Event|1|||
131832223|NCT00102687|474667589|FG004|Maintenance Period|Adverse Event|3|||
131832224|NCT00102687|474667585|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
131832225|NCT00102687|474667586|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
131832226|NCT00102687|474667587|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
131832227|NCT00102687|474667588|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
131832228|NCT00102687|474667589|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
131832229|NCT00102687|474667585|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
131832230|NCT00102687|474667586|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
131832231|NCT00102687|474667587|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
131832232|NCT00102687|474667588|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
131832233|NCT00102687|474667589|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
131832234|NCT00102687|474667585|FG000|Maintenance Period|Death|0|||
131832235|NCT00102687|474667586|FG001|Maintenance Period|Death|0|||
131832236|NCT00102687|474667587|FG002|Maintenance Period|Death|0|||
131450129|NCT01721044|473276802|FG002|Treatment Period|Lack of Efficacy|4|||
131832237|NCT00102687|474667588|FG003|Maintenance Period|Death|1|||
131832238|NCT00102687|474667589|FG004|Maintenance Period|Death|1|||
131832239|NCT00102687|474667585|FG000|Maintenance Period|Physician Decision|1|||
131832240|NCT00102687|474667586|FG001|Maintenance Period|Physician Decision|2|||
131832241|NCT00102687|474667587|FG002|Maintenance Period|Physician Decision|3|||
131832242|NCT00102687|474667588|FG003|Maintenance Period|Physician Decision|0|||
131832243|NCT00102687|474667589|FG004|Maintenance Period|Physician Decision|4|||
131832244|NCT00355472|474667590|FG000|Overall Study|Physician Decision|1|||
131832245|NCT03095118|474667591|FG000|Overall Study|Adverse Event|1|||
131832246|NCT03095118|474667591|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
131832247|NCT03847194|474667594|FG000|Overall Study|Lost to Follow-up|2|||
131832248|NCT03847194|474667595|FG001|Overall Study|Lost to Follow-up|5|||
131832249|NCT03847194|474667594|FG000|Overall Study|Withdrawal by Subject|1|||
131832250|NCT03847194|474667595|FG001|Overall Study|Withdrawal by Subject|2|||
131832251|NCT03847194|474667594|FG000|Overall Study|Death|0|||
131832252|NCT03847194|474667595|FG001|Overall Study|Death|1|||
131832253|NCT02408120|474667596|FG000|Overall Study|Withdrawal by Subject|0|||
131832254|NCT02408120|474667597|FG001|Overall Study|Withdrawal by Subject|1|||
131832255|NCT02408120|474667596|FG000|Overall Study|Treatment Refusal|1|||
131832256|NCT02408120|474667597|FG001|Overall Study|Treatment Refusal|0|||
131832257|NCT02408120|474667596|FG000|Overall Study|Received Steroids|1|||
131832258|NCT02408120|474667597|FG001|Overall Study|Received Steroids|1|||
131832259|NCT02408120|474667596|FG000|Overall Study|Discharged same day|1|||
131832260|NCT02408120|474667597|FG001|Overall Study|Discharged same day|1|||
131832261|NCT02408120|474667596|FG000|Overall Study|Did not receive insulin|1|||
131832262|NCT02408120|474667597|FG001|Overall Study|Did not receive insulin|2|||
131832263|NCT00351351|474667598|FG000|Overall Study|surgical access pbs; device issues|9|||
131832264|NCT00351351|474667599|FG001|Overall Study|surgical access pbs; device issues|4|||
131832265|NCT02083926|474667612|FG000|Overall Study|Withdrawal by Subject|1|||
131832266|NCT02083926|474667613|FG001|Overall Study|Withdrawal by Subject|0|||
131832267|NCT00854373|474667615|FG000|Overall Study|Withdrawal by Subject|1|||
131832268|NCT00854373|474667616|FG001|Overall Study|Withdrawal by Subject|3|||
131832269|NCT00854373|474667615|FG000|Overall Study|Forgot to take study drug|1|||
131832270|NCT00854373|474667616|FG001|Overall Study|Forgot to take study drug|1|||
131832271|NCT00307931|474667617|FG000|Overall Study|Adverse Event|1|||
131832272|NCT02442271|474667618|FG000|Overall Study|Adverse Event|1|||
131832273|NCT02442271|474667618|FG000|Overall Study|Withdrew Consent|1|||
131832274|NCT02442271|474667618|FG000|Overall Study|Lost to Follow-up|1|||
131832275|NCT02442271|474667618|FG000|Overall Study|Other|1|||
131832276|NCT02149121|474667620|FG000|Main Study Period|Lack of Efficacy|2|||
131832277|NCT02149121|474667621|FG001|Main Study Period|Lack of Efficacy|2|||
131832278|NCT02149121|474667622|FG002|Main Study Period|Lack of Efficacy|1|||
131832279|NCT02149121|474667623|FG003|Main Study Period|Lack of Efficacy|0|||
131832280|NCT02149121|474667624|FG004|Main Study Period|Lack of Efficacy|0|||
131832281|NCT02149121|474667625|FG005|Main Study Period|Lack of Efficacy|0|||
131832282|NCT02149121|474667626|FG006|Main Study Period|Lack of Efficacy|0|||
131832283|NCT02149121|474667620|FG000|Main Study Period|Withdrawal by Subject|9|||
131832284|NCT02149121|474667621|FG001|Main Study Period|Withdrawal by Subject|5|||
131832285|NCT02149121|474667622|FG002|Main Study Period|Withdrawal by Subject|1|||
131832286|NCT02149121|474667623|FG003|Main Study Period|Withdrawal by Subject|0|||
131832287|NCT02149121|474667624|FG004|Main Study Period|Withdrawal by Subject|0|||
131832288|NCT02149121|474667625|FG005|Main Study Period|Withdrawal by Subject|0|||
131832289|NCT02149121|474667626|FG006|Main Study Period|Withdrawal by Subject|0|||
131832290|NCT02149121|474667620|FG000|Main Study Period|Adverse Event|2|||
131832291|NCT02149121|474667621|FG001|Main Study Period|Adverse Event|5|||
131832292|NCT02149121|474667622|FG002|Main Study Period|Adverse Event|1|||
131832293|NCT02149121|474667623|FG003|Main Study Period|Adverse Event|0|||
131832294|NCT02149121|474667624|FG004|Main Study Period|Adverse Event|0|||
131832295|NCT02149121|474667625|FG005|Main Study Period|Adverse Event|0|||
131832296|NCT02149121|474667626|FG006|Main Study Period|Adverse Event|0|||
131832297|NCT02149121|474667620|FG000|Main Study Period|Protocol Violation|2|||
131832298|NCT02149121|474667621|FG001|Main Study Period|Protocol Violation|0|||
131832299|NCT02149121|474667622|FG002|Main Study Period|Protocol Violation|0|||
131832300|NCT02149121|474667623|FG003|Main Study Period|Protocol Violation|0|||
131832301|NCT02149121|474667624|FG004|Main Study Period|Protocol Violation|0|||
131832302|NCT02149121|474667625|FG005|Main Study Period|Protocol Violation|0|||
131832303|NCT02149121|474667626|FG006|Main Study Period|Protocol Violation|0|||
131832304|NCT02149121|474667620|FG000|Main Study Period|Lost to Follow-up|2|||
131832305|NCT02149121|474667621|FG001|Main Study Period|Lost to Follow-up|1|||
131832306|NCT02149121|474667622|FG002|Main Study Period|Lost to Follow-up|0|||
131910487|NCT00784875|474960748|FG001|Period D|Physician Decision|1|||
131910488|NCT00784875|474960749|FG002|Period D|Physician Decision|0|||
131910489|NCT00784875|474960750|FG003|Period D|Physician Decision|0|||
131910490|NCT00784875|474960747|FG000|Period D|Sponsor Decision|1|||
131910491|NCT00784875|474960748|FG001|Period D|Sponsor Decision|1|||
131910492|NCT00784875|474960749|FG002|Period D|Sponsor Decision|1|||
131910493|NCT00784875|474960750|FG003|Period D|Sponsor Decision|0|||
131910494|NCT00784875|474960747|FG000|Period D|Lost to Follow-up|1|||
131910495|NCT00784875|474960748|FG001|Period D|Lost to Follow-up|0|||
131910496|NCT00784875|474960749|FG002|Period D|Lost to Follow-up|1|||
131910497|NCT00784875|474960750|FG003|Period D|Lost to Follow-up|1|||
131832307|NCT02149121|474667623|FG003|Main Study Period|Lost to Follow-up|0|||
131832308|NCT02149121|474667624|FG004|Main Study Period|Lost to Follow-up|0|||
131910498|NCT01829347|474960758|FG000|VTI-210|Death|5|||
131910499|NCT01829347|474960759|FG001|VTI-210|Death|3|||
131832309|NCT02149121|474667625|FG005|Main Study Period|Lost to Follow-up|0|||
131832310|NCT02149121|474667626|FG006|Main Study Period|Lost to Follow-up|0|||
131832311|NCT02149121|474667620|FG000|Main Study Period|Death|1|||
131832312|NCT02149121|474667621|FG001|Main Study Period|Death|0|||
131832313|NCT02149121|474667622|FG002|Main Study Period|Death|0|||
131832314|NCT02149121|474667623|FG003|Main Study Period|Death|0|||
131832315|NCT02149121|474667624|FG004|Main Study Period|Death|0|||
131832316|NCT02149121|474667625|FG005|Main Study Period|Death|0|||
131832317|NCT02149121|474667626|FG006|Main Study Period|Death|0|||
131832318|NCT02149121|474667620|FG000|Main Study Period|Physician Decision|1|||
131832319|NCT02149121|474667621|FG001|Main Study Period|Physician Decision|0|||
131832320|NCT02149121|474667622|FG002|Main Study Period|Physician Decision|0|||
131832321|NCT02149121|474667623|FG003|Main Study Period|Physician Decision|0|||
131832322|NCT02149121|474667624|FG004|Main Study Period|Physician Decision|0|||
131832323|NCT02149121|474667625|FG005|Main Study Period|Physician Decision|0|||
131832324|NCT02149121|474667626|FG006|Main Study Period|Physician Decision|0|||
131832325|NCT02149121|474667620|FG000|Main Study Period|Developed any malignancy|0|||
131832326|NCT02149121|474667621|FG001|Main Study Period|Developed any malignancy|1|||
131832327|NCT02149121|474667622|FG002|Main Study Period|Developed any malignancy|1|||
131832328|NCT02149121|474667623|FG003|Main Study Period|Developed any malignancy|0|||
131832329|NCT02149121|474667624|FG004|Main Study Period|Developed any malignancy|0|||
131832330|NCT02149121|474667625|FG005|Main Study Period|Developed any malignancy|0|||
131832331|NCT02149121|474667626|FG006|Main Study Period|Developed any malignancy|0|||
131832332|NCT02149121|474667620|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
131832333|NCT02149121|474667621|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
131832334|NCT02149121|474667622|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
131832335|NCT02149121|474667623|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
131832336|NCT02149121|474667624|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
131832337|NCT02149121|474667625|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
131832338|NCT02149121|474667626|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
131832339|NCT02149121|474667620|FG000|Main Study Period|Disease progression|0|||
131832340|NCT02149121|474667621|FG001|Main Study Period|Disease progression|1|||
131832341|NCT02149121|474667622|FG002|Main Study Period|Disease progression|0|||
131832342|NCT02149121|474667623|FG003|Main Study Period|Disease progression|0|||
131832343|NCT02149121|474667624|FG004|Main Study Period|Disease progression|0|||
131832344|NCT02149121|474667625|FG005|Main Study Period|Disease progression|0|||
131832345|NCT02149121|474667626|FG006|Main Study Period|Disease progression|0|||
131832346|NCT02149121|474667620|FG000|Extension Study Period|Withdrawal by Subject|0|||
131832347|NCT02149121|474667621|FG001|Extension Study Period|Withdrawal by Subject|0|||
131832348|NCT02149121|474667622|FG002|Extension Study Period|Withdrawal by Subject|0|||
131832349|NCT02149121|474667623|FG003|Extension Study Period|Withdrawal by Subject|1|||
131832350|NCT02149121|474667624|FG004|Extension Study Period|Withdrawal by Subject|0|||
131832351|NCT02149121|474667625|FG005|Extension Study Period|Withdrawal by Subject|2|||
131832352|NCT02149121|474667626|FG006|Extension Study Period|Withdrawal by Subject|0|||
131832353|NCT01172821|474667629|FG000|Overall Study|Adverse Event|5|||
131832354|NCT01172821|474667630|FG001|Overall Study|Adverse Event|2|||
131832355|NCT01172821|474667631|FG002|Overall Study|Adverse Event|2|||
131832356|NCT01172821|474667632|FG003|Overall Study|Adverse Event|7|||
131832357|NCT01172821|474667629|FG000|Overall Study|Protocol Violation|0|||
131832358|NCT01172821|474667630|FG001|Overall Study|Protocol Violation|2|||
131401775|NCT03831191|473091580|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
131832359|NCT01172821|474667631|FG002|Overall Study|Protocol Violation|1|||
131832360|NCT01172821|474667632|FG003|Overall Study|Protocol Violation|2|||
131832361|NCT01172821|474667629|FG000|Overall Study|Lost to Follow-up|4|||
131832362|NCT01172821|474667630|FG001|Overall Study|Lost to Follow-up|1|||
131832363|NCT01172821|474667631|FG002|Overall Study|Lost to Follow-up|2|||
131832364|NCT01172821|474667632|FG003|Overall Study|Lost to Follow-up|2|||
131832365|NCT01172821|474667629|FG000|Overall Study|Withdrawal by Subject|2|||
131832366|NCT01172821|474667630|FG001|Overall Study|Withdrawal by Subject|3|||
131832367|NCT01172821|474667631|FG002|Overall Study|Withdrawal by Subject|3|||
131832368|NCT01172821|474667632|FG003|Overall Study|Withdrawal by Subject|3|||
131832369|NCT01172821|474667629|FG000|Overall Study|Other|3|||
131832370|NCT01172821|474667630|FG001|Overall Study|Other|4|||
131832371|NCT01172821|474667631|FG002|Overall Study|Other|5|||
131832372|NCT01172821|474667632|FG003|Overall Study|Other|3|||
131832373|NCT00094094|474667633|FG000|Overall Study|Death|2|||
131832374|NCT00094094|474667633|FG000|Overall Study|Lack of Efficacy|23|||
131832375|NCT00094094|474667633|FG000|Overall Study|Adverse Event|7|||
131832376|NCT02985879|474667635|FG000|Overall Study|Adverse Event|7|||
131832377|NCT02985879|474667636|FG001|Overall Study|Adverse Event|9|||
131832378|NCT02985879|474667637|FG002|Overall Study|Adverse Event|7|||
131832379|NCT02985879|474667635|FG000|Overall Study|Withdrew consent|6|||
131832380|NCT02985879|474667636|FG001|Overall Study|Withdrew consent|8|||
131832381|NCT02985879|474667637|FG002|Overall Study|Withdrew consent|10|||
131832382|NCT02985879|474667635|FG000|Overall Study|Lost to Follow-up|1|||
131832383|NCT02985879|474667636|FG001|Overall Study|Lost to Follow-up|0|||
131832384|NCT02985879|474667637|FG002|Overall Study|Lost to Follow-up|2|||
131832385|NCT02985879|474667635|FG000|Overall Study|Other, not specified|62|||
131832386|NCT02985879|474667636|FG001|Overall Study|Other, not specified|58|||
131832387|NCT02985879|474667637|FG002|Overall Study|Other, not specified|58|||
131832388|NCT01000610|474669311|FG000|Overall Study|Adverse Event|1|||
131832389|NCT01000610|474669311|FG000|Overall Study|Lost to Follow-up|4|||
131832390|NCT01000610|474669311|FG000|Overall Study|Treatment failure|1|||
131832391|NCT00493246|474669312|FG000|Overall Study|Withdrawal by Subject|0|||
131832392|NCT00493246|474669313|FG001|Overall Study|Withdrawal by Subject|0|||
131832393|NCT00493246|474669314|FG002|Overall Study|Withdrawal by Subject|0|||
131832394|NCT00493246|474669315|FG003|Overall Study|Withdrawal by Subject|0|||
131832395|NCT00493246|474669316|FG004|Overall Study|Withdrawal by Subject|1|||
131832396|NCT00493246|474669317|FG005|Overall Study|Withdrawal by Subject|0|||
131832397|NCT00493246|474669318|FG006|Overall Study|Withdrawal by Subject|0|||
131832398|NCT00493246|474669319|FG007|Overall Study|Withdrawal by Subject|0|||
131832399|NCT00493246|474669312|FG000|Overall Study|No access to draw blood|0|||
131832400|NCT00493246|474669313|FG001|Overall Study|No access to draw blood|0|||
131832401|NCT00493246|474669314|FG002|Overall Study|No access to draw blood|0|||
131832402|NCT00493246|474669315|FG003|Overall Study|No access to draw blood|0|||
131832403|NCT00493246|474669316|FG004|Overall Study|No access to draw blood|0|||
131832404|NCT00493246|474669317|FG005|Overall Study|No access to draw blood|1|||
131832405|NCT00493246|474669318|FG006|Overall Study|No access to draw blood|0|||
131832406|NCT00493246|474669319|FG007|Overall Study|No access to draw blood|0|||
131832407|NCT00493246|474669312|FG000|Overall Study|Lost to Follow-up|0|||
131832408|NCT00493246|474669313|FG001|Overall Study|Lost to Follow-up|0|||
131832409|NCT00493246|474669314|FG002|Overall Study|Lost to Follow-up|0|||
131832410|NCT00493246|474669315|FG003|Overall Study|Lost to Follow-up|0|||
131832411|NCT00493246|474669316|FG004|Overall Study|Lost to Follow-up|0|||
131832412|NCT00493246|474669317|FG005|Overall Study|Lost to Follow-up|0|||
131832413|NCT00493246|474669318|FG006|Overall Study|Lost to Follow-up|1|||
131832414|NCT00493246|474669319|FG007|Overall Study|Lost to Follow-up|0|||
131832415|NCT00493779|474669326|FG000|Overall Study|Logistical issue at site|1|||
131832416|NCT01885182|474669328|FG000|Overall Study|Adverse Event|11|||
131832417|NCT01885182|474669329|FG001|Overall Study|Adverse Event|13|||
131832418|NCT01885182|474669328|FG000|Overall Study|Withdrawal by Subject|13|||
131832419|NCT01885182|474669329|FG001|Overall Study|Withdrawal by Subject|6|||
131832420|NCT01885182|474669328|FG000|Overall Study|Lost to Follow-up|2|||
131832421|NCT01885182|474669329|FG001|Overall Study|Lost to Follow-up|2|||
131832422|NCT01885182|474669328|FG000|Overall Study|Lack of Efficacy|8|||
131832423|NCT01885182|474669329|FG001|Overall Study|Lack of Efficacy|1|||
131832424|NCT01207440|474669336|FG000|Overall Study|Adverse Event|46|||
131832425|NCT01207440|474669337|FG001|Overall Study|Adverse Event|11|||
131832426|NCT01207440|474669338|FG002|Overall Study|Adverse Event|7|||
131832427|NCT01207440|474669339|FG003|Overall Study|Adverse Event|2|||
131832428|NCT01207440|474669340|FG004|Overall Study|Adverse Event|6|||
131832429|NCT01207440|474669341|FG005|Overall Study|Adverse Event|6|||
131832430|NCT01207440|474669342|FG006|Overall Study|Adverse Event|2|||
131832431|NCT01207440|474669336|FG000|Overall Study|Death|6|||
131832432|NCT01207440|474669337|FG001|Overall Study|Death|3|||
131832433|NCT01207440|474669338|FG002|Overall Study|Death|2|||
131832434|NCT01207440|474669339|FG003|Overall Study|Death|2|||
131832435|NCT01207440|474669340|FG004|Overall Study|Death|7|||
131832436|NCT01207440|474669341|FG005|Overall Study|Death|5|||
131832437|NCT01207440|474669342|FG006|Overall Study|Death|1|||
131832438|NCT01207440|474669336|FG000|Overall Study|Lack of Efficacy|13|||
131832439|NCT01207440|474669337|FG001|Overall Study|Lack of Efficacy|2|||
131832440|NCT01207440|474669338|FG002|Overall Study|Lack of Efficacy|5|||
131832441|NCT01207440|474669339|FG003|Overall Study|Lack of Efficacy|1|||
131832442|NCT01207440|474669340|FG004|Overall Study|Lack of Efficacy|2|||
131832443|NCT01207440|474669341|FG005|Overall Study|Lack of Efficacy|3|||
131832444|NCT01207440|474669342|FG006|Overall Study|Lack of Efficacy|0|||
131832445|NCT01207440|474669336|FG000|Overall Study|Lost to Follow-up|0|||
131832446|NCT01207440|474669337|FG001|Overall Study|Lost to Follow-up|0|||
131832447|NCT01207440|474669338|FG002|Overall Study|Lost to Follow-up|2|||
131832448|NCT01207440|474669339|FG003|Overall Study|Lost to Follow-up|1|||
131832449|NCT01207440|474669340|FG004|Overall Study|Lost to Follow-up|0|||
131832450|NCT01207440|474669341|FG005|Overall Study|Lost to Follow-up|0|||
131832451|NCT01207440|474669342|FG006|Overall Study|Lost to Follow-up|0|||
131832452|NCT01207440|474669336|FG000|Overall Study|Non-compliance with Study Drug|3|||
131832453|NCT01207440|474669337|FG001|Overall Study|Non-compliance with Study Drug|0|||
131832454|NCT01207440|474669338|FG002|Overall Study|Non-compliance with Study Drug|1|||
131832455|NCT01207440|474669339|FG003|Overall Study|Non-compliance with Study Drug|0|||
131832456|NCT01207440|474669340|FG004|Overall Study|Non-compliance with Study Drug|0|||
131832457|NCT01207440|474669341|FG005|Overall Study|Non-compliance with Study Drug|0|||
131832458|NCT01207440|474669342|FG006|Overall Study|Non-compliance with Study Drug|0|||
131832459|NCT01207440|474669336|FG000|Overall Study|Physician Decision|6|||
131832460|NCT01207440|474669337|FG001|Overall Study|Physician Decision|5|||
131832461|NCT01207440|474669338|FG002|Overall Study|Physician Decision|5|||
131832462|NCT01207440|474669339|FG003|Overall Study|Physician Decision|0|||
131832463|NCT01207440|474669340|FG004|Overall Study|Physician Decision|1|||
131832464|NCT01207440|474669341|FG005|Overall Study|Physician Decision|0|||
131832465|NCT01207440|474669342|FG006|Overall Study|Physician Decision|0|||
131832466|NCT01207440|474669336|FG000|Overall Study|Progressive Disease|19|||
131832467|NCT01207440|474669337|FG001|Overall Study|Progressive Disease|10|||
131832468|NCT01207440|474669338|FG002|Overall Study|Progressive Disease|19|||
131832469|NCT01207440|474669339|FG003|Overall Study|Progressive Disease|7|||
131832470|NCT01207440|474669340|FG004|Overall Study|Progressive Disease|23|||
131832471|NCT01207440|474669341|FG005|Overall Study|Progressive Disease|27|||
131832472|NCT01207440|474669342|FG006|Overall Study|Progressive Disease|0|||
131832473|NCT01207440|474669336|FG000|Overall Study|Protocol Violation|2|||
131832474|NCT01207440|474669337|FG001|Overall Study|Protocol Violation|0|||
131832475|NCT01207440|474669338|FG002|Overall Study|Protocol Violation|0|||
131832476|NCT01207440|474669339|FG003|Overall Study|Protocol Violation|0|||
131832477|NCT01207440|474669340|FG004|Overall Study|Protocol Violation|0|||
131832478|NCT01207440|474669341|FG005|Overall Study|Protocol Violation|0|||
131832479|NCT01207440|474669342|FG006|Overall Study|Protocol Violation|0|||
131832480|NCT01207440|474669336|FG000|Overall Study|Site Terminated by Sponsor|69|||
131832481|NCT01207440|474669337|FG001|Overall Study|Site Terminated by Sponsor|19|||
131832482|NCT01207440|474669338|FG002|Overall Study|Site Terminated by Sponsor|12|||
131832483|NCT01207440|474669339|FG003|Overall Study|Site Terminated by Sponsor|2|||
131832484|NCT01207440|474669340|FG004|Overall Study|Site Terminated by Sponsor|3|||
131832485|NCT01207440|474669341|FG005|Overall Study|Site Terminated by Sponsor|0|||
131832486|NCT01207440|474669342|FG006|Overall Study|Site Terminated by Sponsor|2|||
131832487|NCT01207440|474669336|FG000|Overall Study|Withdrawal by Subject|29|||
131832488|NCT01207440|474669337|FG001|Overall Study|Withdrawal by Subject|4|||
131832489|NCT01207440|474669338|FG002|Overall Study|Withdrawal by Subject|5|||
131401776|NCT03831191|473091581|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
131401777|NCT03831191|473091582|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
131401778|NCT03831191|473091583|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
131401779|NCT03831191|473091584|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
131401780|NCT03831191|473091585|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
131401781|NCT03831191|473091571|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401782|NCT03831191|473091572|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401783|NCT03831191|473091573|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401784|NCT03831191|473091574|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401785|NCT03831191|473091575|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401786|NCT03831191|473091576|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401787|NCT03831191|473091577|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401788|NCT03831191|473091578|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401789|NCT03831191|473091579|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401790|NCT03831191|473091580|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401791|NCT03831191|473091581|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401792|NCT03831191|473091582|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401793|NCT03831191|473091583|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401794|NCT03831191|473091584|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131401795|NCT03831191|473091585|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131401796|NCT03831191|473091571|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131401797|NCT03831191|473091572|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832490|NCT01207440|474669339|FG003|Overall Study|Withdrawal by Subject|3|||
131832491|NCT01207440|474669340|FG004|Overall Study|Withdrawal by Subject|2|||
131832492|NCT01207440|474669341|FG005|Overall Study|Withdrawal by Subject|2|||
131832493|NCT01207440|474669342|FG006|Overall Study|Withdrawal by Subject|0|||
131832494|NCT01207440|474669336|FG000|Overall Study|Reason Not Specified|10|||
131832495|NCT01207440|474669337|FG001|Overall Study|Reason Not Specified|10|||
131832496|NCT01207440|474669338|FG002|Overall Study|Reason Not Specified|7|||
131832497|NCT01207440|474669339|FG003|Overall Study|Reason Not Specified|0|||
131832498|NCT01207440|474669340|FG004|Overall Study|Reason Not Specified|4|||
131832499|NCT01207440|474669341|FG005|Overall Study|Reason Not Specified|3|||
131832500|NCT01207440|474669342|FG006|Overall Study|Reason Not Specified|0|||
131832501|NCT01592721|474669343|FG000|Long-term Follow-up|Death|1|||
131910500|NCT01829347|474960758|FG000|VTI-210|Withdrawal by Subject|1|||
131910501|NCT01829347|474960759|FG001|VTI-210|Withdrawal by Subject|0|||
131401798|NCT03831191|473091573|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832502|NCT00099268|474669351|FG000|Overall Study|Withdrawal by Subject|46|||
131832503|NCT00099268|474669352|FG001|Overall Study|Withdrawal by Subject|28|||
131832504|NCT00099268|474669351|FG000|Overall Study|Adverse Event|19|||
131832505|NCT00099268|474669352|FG001|Overall Study|Adverse Event|19|||
131832506|NCT00099268|474669351|FG000|Overall Study|Protocol Violation|9|||
131832507|NCT00099268|474669352|FG001|Overall Study|Protocol Violation|8|||
131910502|NCT01829347|474960758|FG000|VTI-210E|Death|2|||
131910503|NCT01829347|474960759|FG001|VTI-210E|Death|1|||
131832508|NCT00099268|474669351|FG000|Overall Study|Lost to Follow-up|6|||
131832509|NCT00099268|474669352|FG001|Overall Study|Lost to Follow-up|4|||
131832510|NCT00099268|474669351|FG000|Overall Study|Lack of Efficacy|5|||
131832511|NCT00099268|474669352|FG001|Overall Study|Lack of Efficacy|18|||
131832512|NCT00099268|474669351|FG000|Overall Study|Administrative problems|4|||
131832513|NCT00099268|474669352|FG001|Overall Study|Administrative problems|4|||
131832514|NCT00099268|474669351|FG000|Overall Study|Death|3|||
131832515|NCT00099268|474669352|FG001|Overall Study|Death|1|||
131832516|NCT03438396|474669354|FG000|Overall Study|Reason Not Specified|9|||
131832517|NCT03438396|474669354|FG000|Overall Study|Withdrawal by Subject|5|||
131832518|NCT03438396|474669354|FG000|Overall Study|Lost to Follow-up|2|||
131832519|NCT03438396|474669354|FG000|Overall Study|Death|85|||
131832520|NCT03438396|474669354|FG000|Overall Study|Not treated|1|||
131832521|NCT02006628|474669355|FG000|Overall Study|Adverse Event|1|||
131832522|NCT02006628|474669356|FG001|Overall Study|Adverse Event|1|||
131832523|NCT02006628|474669355|FG000|Overall Study|Withdrawal by Subject|2|||
131832524|NCT02006628|474669356|FG001|Overall Study|Withdrawal by Subject|1|||
131832525|NCT02017860|474669359|FG000|Overall Study|Adverse Event|1|||
131832526|NCT02017860|474669359|FG000|Overall Study|Withdrawal by Subject|1|||
131832527|NCT02488330|474669360|FG000|Overall Study|Adverse Event|1|||
131832528|NCT02488330|474669360|FG000|Overall Study|Physician Decision|2|||
131832529|NCT02488330|474669360|FG000|Overall Study|Death|2|||
131832530|NCT02488330|474669360|FG000|Overall Study|Disease Progression|3|||
131832531|NCT02488330|474669360|FG000|Overall Study|Study Termination by Sponsor|4|||
131832532|NCT01705236|474669363|FG000|Overall Study|Lost to Follow-up|1|||
131832533|NCT01705236|474669363|FG000|Overall Study|Administrative problems|2|||
131832534|NCT01705236|474669363|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
131832535|NCT01705236|474669363|FG000|Overall Study|Protocol Violation|3|||
131832536|NCT01705236|474669363|FG000|Overall Study|Abnormal test procedure result(s)|4|||
131832537|NCT01705236|474669363|FG000|Overall Study|Abnormal laboratory value(s)|4|||
131832538|NCT01705236|474669363|FG000|Overall Study|Withdrawal by Subject|5|||
131832539|NCT01705236|474669363|FG000|Overall Study|Adverse Event|5|||
131832540|NCT06972251|474669364|FG000|Overall Study|Withdrawal by Subject|1|||
131832541|NCT06972251|474669365|FG001|Overall Study|Withdrawal by Subject|0|||
131832542|NCT06972251|474669364|FG000|Overall Study|Lost to Follow-up|10|||
131832543|NCT06972251|474669365|FG001|Overall Study|Lost to Follow-up|2|||
131832544|NCT01829113|474669366|FG000|Overall Study|Disease Progression|37|||
131832545|NCT01829113|474669367|FG001|Overall Study|Disease Progression|48|||
131832546|NCT01829113|474669366|FG000|Overall Study|Adverse Event|14|||
131832547|NCT01829113|474669367|FG001|Overall Study|Adverse Event|10|||
131832548|NCT01829113|474669366|FG000|Overall Study|Withdrawal by Subject|17|||
131832549|NCT01829113|474669367|FG001|Overall Study|Withdrawal by Subject|10|||
131832550|NCT01829113|474669366|FG000|Overall Study|Death|4|||
131832551|NCT01829113|474669367|FG001|Overall Study|Death|6|||
131832552|NCT01829113|474669366|FG000|Overall Study|Sponsor Decision|1|||
131832553|NCT01829113|474669367|FG001|Overall Study|Sponsor Decision|1|||
131832554|NCT01829113|474669366|FG000|Overall Study|No Study Treatment Received|3|||
131832555|NCT01829113|474669367|FG001|Overall Study|No Study Treatment Received|2|||
131832556|NCT01829113|474669366|FG000|Overall Study|Physician Decision|1|||
131832557|NCT01829113|474669367|FG001|Overall Study|Physician Decision|1|||
131832558|NCT04134845|474669372|FG000|Overall Study|withdrawl by PI|5|||
131832559|NCT04134845|474669373|FG001|Overall Study|withdrawl by PI|12|||
131832560|NCT01341587|474669374|FG000|Overall Study|Lost to Follow-up|2|||
131832561|NCT01341587|474669375|FG001|Overall Study|Lost to Follow-up|0|||
131832562|NCT01341587|474669374|FG000|Overall Study|stopped using the meters|2|||
131832563|NCT01341587|474669375|FG001|Overall Study|stopped using the meters|10|||
131832564|NCT03739138|474669379|FG000|Overall Study|Death|0|||
131832565|NCT03739138|474669380|FG001|Overall Study|Death|7|||
131832566|NCT03739138|474669381|FG002|Overall Study|Death|4|||
131832567|NCT03739138|474669382|FG003|Overall Study|Death|13|||
131832568|NCT03739138|474669383|FG004|Overall Study|Death|0|||
131832569|NCT03739138|474669379|FG000|Overall Study|Lost to Follow-up|0|||
131832570|NCT03739138|474669380|FG001|Overall Study|Lost to Follow-up|0|||
131832571|NCT03739138|474669381|FG002|Overall Study|Lost to Follow-up|1|||
131832572|NCT03739138|474669382|FG003|Overall Study|Lost to Follow-up|0|||
131832573|NCT03739138|474669383|FG004|Overall Study|Lost to Follow-up|0|||
131832574|NCT03739138|474669379|FG000|Overall Study|Study Terminated By Sponsor|0|||
131832575|NCT03739138|474669380|FG001|Overall Study|Study Terminated By Sponsor|0|||
131832576|NCT03739138|474669381|FG002|Overall Study|Study Terminated By Sponsor|0|||
131832577|NCT03739138|474669382|FG003|Overall Study|Study Terminated By Sponsor|4|||
131832578|NCT03739138|474669383|FG004|Overall Study|Study Terminated By Sponsor|0|||
131832579|NCT03739138|474669379|FG000|Overall Study|Withdrawal by Subject|0|||
131832580|NCT03739138|474669380|FG001|Overall Study|Withdrawal by Subject|0|||
131832581|NCT03739138|474669381|FG002|Overall Study|Withdrawal by Subject|0|||
131832582|NCT03739138|474669382|FG003|Overall Study|Withdrawal by Subject|1|||
131832583|NCT03739138|474669383|FG004|Overall Study|Withdrawal by Subject|0|||
131832584|NCT02654587|474669384|FG000|Overall Study|patient alive at end of study|22|||
131832585|NCT02654587|474669385|FG001|Overall Study|patient alive at end of study|8|||
131832586|NCT02654587|474669384|FG000|Overall Study|Withdrawal by Subject|1|||
131832587|NCT02654587|474669385|FG001|Overall Study|Withdrawal by Subject|7|||
131832588|NCT01825837|474669386|FG000|PART I|Withdrawal by Subject|0|||
131832589|NCT01825837|474669387|FG001|PART I|Withdrawal by Subject|0|||
131832590|NCT01825837|474669388|FG002|PART I|Withdrawal by Subject|0|||
131832591|NCT01825837|474669389|FG003|PART I|Withdrawal by Subject|6|||
131832592|NCT01825837|474669386|FG000|PART I|Patient non-compliance|0|||
131832593|NCT01825837|474669387|FG001|PART I|Patient non-compliance|0|||
131832594|NCT01825837|474669388|FG002|PART I|Patient non-compliance|0|||
131832595|NCT01825837|474669389|FG003|PART I|Patient non-compliance|1|||
131832596|NCT01825837|474669386|FG000|PART I|Treatment failure|0|||
131832597|NCT01825837|474669387|FG001|PART I|Treatment failure|0|||
131832598|NCT01825837|474669388|FG002|PART I|Treatment failure|0|||
131832599|NCT01825837|474669389|FG003|PART I|Treatment failure|7|||
131832600|NCT01825837|474669386|FG000|PART I|reason unspecified|0|||
131832601|NCT01825837|474669387|FG001|PART I|reason unspecified|0|||
131832602|NCT01825837|474669388|FG002|PART I|reason unspecified|0|||
131832603|NCT01825837|474669389|FG003|PART I|reason unspecified|3|||
131832604|NCT01825837|474669386|FG000|PART II|Withdrawal by Subject|3|||
131832605|NCT01825837|474669387|FG001|PART II|Withdrawal by Subject|3|||
131832606|NCT01825837|474669388|FG002|PART II|Withdrawal by Subject|7|||
131832607|NCT01825837|474669389|FG003|PART II|Withdrawal by Subject|0|||
131832608|NCT01825837|474669386|FG000|PART II|Patient non-compliance|5|||
131832609|NCT01825837|474669387|FG001|PART II|Patient non-compliance|2|||
131832610|NCT01825837|474669388|FG002|PART II|Patient non-compliance|4|||
131832611|NCT01825837|474669389|FG003|PART II|Patient non-compliance|0|||
131832612|NCT01825837|474669386|FG000|PART II|Adverse Event|3|||
131832613|NCT01825837|474669387|FG001|PART II|Adverse Event|3|||
131832614|NCT01825837|474669388|FG002|PART II|Adverse Event|1|||
131832615|NCT01825837|474669389|FG003|PART II|Adverse Event|0|||
131832616|NCT01825837|474669386|FG000|PART II|Treatment failure|6|||
131832617|NCT01825837|474669387|FG001|PART II|Treatment failure|4|||
131832618|NCT01825837|474669388|FG002|PART II|Treatment failure|5|||
131832619|NCT01825837|474669389|FG003|PART II|Treatment failure|0|||
131832620|NCT01825837|474669386|FG000|PART II|reason unspecified|2|||
131832621|NCT01825837|474669387|FG001|PART II|reason unspecified|2|||
131832622|NCT01825837|474669388|FG002|PART II|reason unspecified|2|||
131832623|NCT01825837|474669389|FG003|PART II|reason unspecified|0|||
131832624|NCT00904748|474669390|FG000|Overall Study|Withdrawal by Subject|1|||
131832625|NCT00904748|474669391|FG001|Overall Study|Withdrawal by Subject|1|||
131832626|NCT00904748|474669392|FG002|Overall Study|Withdrawal by Subject|1|||
131832627|NCT00904748|474669393|FG003|Overall Study|Withdrawal by Subject|2|||
131832628|NCT00904748|474669394|FG004|Overall Study|Withdrawal by Subject|0|||
131832629|NCT00904748|474669395|FG005|Overall Study|Withdrawal by Subject|0|||
131832630|NCT00904748|474669390|FG000|Overall Study|Adverse Event|0|||
131832631|NCT00904748|474669391|FG001|Overall Study|Adverse Event|0|||
131832632|NCT00904748|474669392|FG002|Overall Study|Adverse Event|0|||
131832633|NCT00904748|474669393|FG003|Overall Study|Adverse Event|0|||
131832634|NCT00904748|474669394|FG004|Overall Study|Adverse Event|1|||
131832635|NCT00904748|474669395|FG005|Overall Study|Adverse Event|0|||
131832636|NCT02339740|474669396|FG000|Overall Study|Death|1|||
131832637|NCT02339740|474669397|FG001|Overall Study|Death|0|||
131832638|NCT02339740|474669396|FG000|Overall Study|Physician Decision|0|||
131832639|NCT02339740|474669397|FG001|Overall Study|Physician Decision|2|||
131832640|NCT02339740|474669396|FG000|Overall Study|Withdrawal by Subject|5|||
131832641|NCT02339740|474669397|FG001|Overall Study|Withdrawal by Subject|1|||
131832642|NCT02339740|474669396|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
131832643|NCT02339740|474669397|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
131832644|NCT02903238|474669399|FG000|Overall Study|Lost to Follow-up|4|||
131832645|NCT00700817|474669403|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
131832646|NCT00700817|474669404|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
131832647|NCT00700817|474669405|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
131832648|NCT00700817|474669406|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
131832649|NCT00700817|474669407|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
131832650|NCT00700817|474669403|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
131910504|NCT01829347|474960758|FG000|VTI-210E|Study terminated prematurely|1|||
131910505|NCT01829347|474960759|FG001|VTI-210E|Study terminated prematurely|5|||
131910506|NCT04018066|474960760|FG000|Overall Study|participants started taking medications during the study period|3|||
131910507|NCT04018066|474960760|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
131832651|NCT00700817|474669404|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
131832652|NCT00700817|474669405|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
131910508|NCT03817528|474960761|FG000|Overall Study|Withdrawal by Subject|1|||
131910509|NCT03817528|474960761|FG000|Overall Study|Adverse Event|2|||
131832653|NCT00700817|474669406|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
131832654|NCT00700817|474669407|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
131832655|NCT00700817|474669403|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
131832656|NCT00700817|474669404|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
131832657|NCT00700817|474669405|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
131832658|NCT00700817|474669406|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
131832659|NCT00700817|474669407|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
131832660|NCT00700817|474669403|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
131832661|NCT00700817|474669404|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
131832662|NCT00700817|474669405|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
131832663|NCT00700817|474669406|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
131832664|NCT00700817|474669407|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
131832665|NCT00700817|474669403|FG000|Week 0-26 (Main Period)|Unclassified|14|||
131832666|NCT00700817|474669404|FG001|Week 0-26 (Main Period)|Unclassified|4|||
131832667|NCT00700817|474669405|FG002|Week 0-26 (Main Period)|Unclassified|8|||
131832668|NCT00700817|474669406|FG003|Week 0-26 (Main Period)|Unclassified|0|||
131832669|NCT00700817|474669407|FG004|Week 0-26 (Main Period)|Unclassified|0|||
131832670|NCT00700817|474669403|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
131832671|NCT00700817|474669404|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
131832672|NCT00700817|474669405|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
131832673|NCT00700817|474669406|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
131832674|NCT00700817|474669407|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
131832675|NCT00700817|474669403|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
131832676|NCT00700817|474669404|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
131832677|NCT00700817|474669405|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
131832678|NCT00700817|474669406|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
131832679|NCT00700817|474669407|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
131832680|NCT00700817|474669403|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
131832681|NCT00700817|474669404|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
131832682|NCT00700817|474669405|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
131401799|NCT03831191|473091574|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832683|NCT00700817|474669406|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
131832684|NCT00700817|474669407|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
131832685|NCT00700817|474669403|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
131832686|NCT00700817|474669404|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
131832687|NCT00700817|474669405|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
131832688|NCT00700817|474669406|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
131832689|NCT00700817|474669407|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
131832690|NCT00700817|474669403|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
131832691|NCT00700817|474669404|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
131832692|NCT00700817|474669405|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
131832693|NCT00700817|474669406|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
131832694|NCT00700817|474669407|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
131832695|NCT00700817|474669403|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
131832696|NCT00700817|474669404|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
131832697|NCT00700817|474669405|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
131832698|NCT00700817|474669406|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
131832699|NCT00700817|474669407|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
131832700|NCT00700817|474669403|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
131832701|NCT00700817|474669404|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
131832702|NCT00700817|474669405|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
131832703|NCT00700817|474669406|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
131832704|NCT00700817|474669407|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
131832705|NCT00700817|474669403|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
131832706|NCT00700817|474669404|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
131832707|NCT00700817|474669405|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
131832708|NCT00700817|474669406|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
131832709|NCT00700817|474669407|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
131832710|NCT00700817|474669403|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
131832711|NCT00700817|474669404|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
131832712|NCT00700817|474669405|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
131832713|NCT00700817|474669406|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
131832714|NCT00700817|474669407|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
131832715|NCT00700817|474669403|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
131832716|NCT00700817|474669404|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
131832717|NCT00700817|474669405|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
131832718|NCT00700817|474669406|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
131832719|NCT00700817|474669407|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
131832720|NCT00767520|474669408|FG000|Overall Study|Participants still on treatment|11|||
131832721|NCT00767520|474669409|FG001|Overall Study|Participants still on treatment|15|||
131832722|NCT00767520|474669408|FG000|Overall Study|Randomized in error and Never treated|0|||
131832723|NCT00767520|474669409|FG001|Overall Study|Randomized in error and Never treated|2|||
131401800|NCT03831191|473091575|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832724|NCT02777918|474669412|FG000|Overall Study|Medical reasons|1|||
131832725|NCT02777918|474669413|FG001|Overall Study|Medical reasons|2|||
131832726|NCT02777918|474669412|FG000|Overall Study|Too busy / stressed|1|||
131401801|NCT03831191|473091576|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131401802|NCT03831191|473091577|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832727|NCT02777918|474669413|FG001|Overall Study|Too busy / stressed|1|||
131832728|NCT02777918|474669412|FG000|Overall Study|Withdrawal by Subject|1|||
131832729|NCT02777918|474669413|FG001|Overall Study|Withdrawal by Subject|1|||
131832730|NCT01338987|474669414|FG000|Overall Study|enrolled on new protocol|0|||
131832731|NCT01338987|474669415|FG001|Overall Study|enrolled on new protocol|0|||
131832732|NCT01338987|474669416|FG002|Overall Study|enrolled on new protocol|1|||
131832733|NCT01338987|474669417|FG003|Overall Study|enrolled on new protocol|0|||
131832734|NCT01338987|474669418|FG004|Overall Study|enrolled on new protocol|0|||
131832735|NCT01338987|474669414|FG000|Overall Study|Disease progression on study|2|||
131832736|NCT01338987|474669415|FG001|Overall Study|Disease progression on study|1|||
131832737|NCT01338987|474669416|FG002|Overall Study|Disease progression on study|1|||
131832738|NCT01338987|474669417|FG003|Overall Study|Disease progression on study|0|||
131832739|NCT01338987|474669418|FG004|Overall Study|Disease progression on study|0|||
131832740|NCT00757848|474669419|FG000|Overall Study|Voluntary discontinuation|1|||
131832741|NCT00757848|474669420|FG001|Overall Study|Voluntary discontinuation|0|||
131832742|NCT00757848|474669419|FG000|Overall Study|Adverse Event|1|||
131832743|NCT00757848|474669420|FG001|Overall Study|Adverse Event|2|||
131832744|NCT00757848|474669419|FG000|Overall Study|Incorrect enrolment|1|||
131832745|NCT00757848|474669420|FG001|Overall Study|Incorrect enrolment|0|||
131832746|NCT00058214|474669423|FG000|Overall Study|Adverse Event|1|||
131832747|NCT01118117|474669427|FG000|Overall Study|Death|8|||
131832748|NCT01118117|474669428|FG001|Overall Study|Death|0|||
131832749|NCT01118117|474669427|FG000|Overall Study|Lost to Follow-up|6|||
131832750|NCT01118117|474669428|FG001|Overall Study|Lost to Follow-up|0|||
131832751|NCT01118117|474669427|FG000|Overall Study|Missed 12 Month Visit|7|||
131832752|NCT01118117|474669428|FG001|Overall Study|Missed 12 Month Visit|0|||
131832753|NCT01277718|474669430|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
131832754|NCT01277718|474669431|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
131832755|NCT01277718|474669430|FG000|Period 2 - Second Intervention|Physician Decision|0|||
131832756|NCT01277718|474669431|FG001|Period 2 - Second Intervention|Physician Decision|2|||
131832757|NCT01524913|474669432|FG000|Overall Study|Lost to Follow-up|4|||
131832758|NCT01524913|474669433|FG001|Overall Study|Lost to Follow-up|0|||
131832759|NCT01524913|474669434|FG002|Overall Study|Lost to Follow-up|0|||
131832760|NCT03166124|474669437|FG000|Treatment Period 1|Adverse Event|0|||
131832761|NCT03166124|474669438|FG001|Treatment Period 1|Adverse Event|0|||
131832762|NCT03166124|474669439|FG002|Treatment Period 1|Adverse Event|1|||
131832763|NCT03166124|474669440|FG003|Treatment Period 1|Adverse Event|0|||
131832764|NCT03166124|474669437|FG000|Wash-out Period|Withdrawal by Subject|0|||
131832765|NCT03166124|474669438|FG001|Wash-out Period|Withdrawal by Subject|1|||
131832766|NCT03166124|474669439|FG002|Wash-out Period|Withdrawal by Subject|0|||
131401803|NCT03831191|473091578|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832767|NCT03166124|474669440|FG003|Wash-out Period|Withdrawal by Subject|1|||
131832768|NCT03166124|474669437|FG000|Wash-out Period|Adverse Event|0|||
131832769|NCT03166124|474669438|FG001|Wash-out Period|Adverse Event|1|||
131832770|NCT03166124|474669439|FG002|Wash-out Period|Adverse Event|1|||
131832771|NCT03166124|474669440|FG003|Wash-out Period|Adverse Event|0|||
131832772|NCT00766831|474669441|FG000|Overall Study|Withdrawal by Subject|4|||
131832773|NCT00766831|474669441|FG000|Overall Study|Lost to Follow-up|3|||
131832774|NCT00766831|474669441|FG000|Overall Study|Adverse Event|20|||
131832775|NCT00766831|474669441|FG000|Overall Study|Protocol Violation|15|||
131832776|NCT00766831|474669441|FG000|Overall Study|Physician Decision|5|||
131832777|NCT00766831|474669441|FG000|Overall Study|Withdrawal of consent|26|||
131832778|NCT00766831|474669441|FG000|Overall Study|Non cooperation by participants|14|||
131832779|NCT00766831|474669441|FG000|Overall Study|Other|28|||
131832780|NCT00788593|474669442|FG000|Placebo Run-in Phase|Adverse Event|2|||
131832781|NCT00788593|474669443|FG001|Placebo Run-in Phase|Adverse Event|0|||
131832782|NCT00788593|474669444|FG002|Placebo Run-in Phase|Adverse Event|0|||
131832783|NCT00788593|474669442|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
131832784|NCT00788593|474669443|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
131832785|NCT00788593|474669444|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
131832786|NCT00788593|474669442|FG000|Placebo Run-in Phase|Protocol Violation|2|||
131832787|NCT00788593|474669443|FG001|Placebo Run-in Phase|Protocol Violation|0|||
131832788|NCT00788593|474669444|FG002|Placebo Run-in Phase|Protocol Violation|0|||
131401804|NCT03831191|473091579|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131401805|NCT03831191|473091580|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131832789|NCT00788593|474669442|FG000|First Intervention Period|Adverse Event|0|||
131832790|NCT00788593|474669443|FG001|First Intervention Period|Adverse Event|1|||
131832791|NCT00788593|474669444|FG002|First Intervention Period|Adverse Event|0|||
131832792|NCT00788593|474669442|FG000|Second Intervention Period|Lost to Follow-up|0|||
131832793|NCT00788593|474669443|FG001|Second Intervention Period|Lost to Follow-up|1|||
131832794|NCT00788593|474669444|FG002|Second Intervention Period|Lost to Follow-up|0|||
131832795|NCT00788593|474669442|FG000|Second Intervention Period|Other|0|||
131832796|NCT00788593|474669443|FG001|Second Intervention Period|Other|0|||
131832797|NCT00788593|474669444|FG002|Second Intervention Period|Other|1|||
131832798|NCT00515034|474669445|FG000|Overall Study|Adverse Event|2|||
131832799|NCT00515034|474669446|FG001|Overall Study|Adverse Event|0|||
131832800|NCT00515034|474669447|FG002|Overall Study|Adverse Event|1|||
131832801|NCT00515034|474669448|FG003|Overall Study|Adverse Event|0|||
131832802|NCT00515034|474669445|FG000|Overall Study|Death|4|||
131832803|NCT00515034|474669446|FG001|Overall Study|Death|2|||
131832804|NCT00515034|474669447|FG002|Overall Study|Death|1|||
131832805|NCT00515034|474669448|FG003|Overall Study|Death|3|||
131832806|NCT00515034|474669445|FG000|Overall Study|Withdrawal by Subject|1|||
131832807|NCT00515034|474669446|FG001|Overall Study|Withdrawal by Subject|0|||
131832808|NCT00515034|474669447|FG002|Overall Study|Withdrawal by Subject|3|||
131832809|NCT00515034|474669448|FG003|Overall Study|Withdrawal by Subject|0|||
131832810|NCT00515034|474669445|FG000|Overall Study|Physician Decision|0|||
131832811|NCT00515034|474669446|FG001|Overall Study|Physician Decision|0|||
131832812|NCT00515034|474669447|FG002|Overall Study|Physician Decision|1|||
131832813|NCT00515034|474669448|FG003|Overall Study|Physician Decision|1|||
131832814|NCT00515034|474669445|FG000|Overall Study|Other|1|||
131832815|NCT00515034|474669446|FG001|Overall Study|Other|0|||
131832816|NCT00515034|474669447|FG002|Overall Study|Other|2|||
131832817|NCT00515034|474669448|FG003|Overall Study|Other|1|||
131832818|NCT01392326|474669451|FG000|Overall Study|Death|2|||
131832819|NCT01392326|474669452|FG001|Overall Study|Death|0|||
131832820|NCT01392326|474669453|FG002|Overall Study|Death|0|||
131832821|NCT01392326|474669451|FG000|Overall Study|Withdrawal by Subject|12|||
131832822|NCT01392326|474669452|FG001|Overall Study|Withdrawal by Subject|11|||
131832823|NCT01392326|474669453|FG002|Overall Study|Withdrawal by Subject|15|||
131832824|NCT01392326|474669451|FG000|Overall Study|Protocol Violation|2|||
131832825|NCT01392326|474669452|FG001|Overall Study|Protocol Violation|0|||
131832826|NCT01392326|474669453|FG002|Overall Study|Protocol Violation|0|||
131832827|NCT01392326|474669451|FG000|Overall Study|Pregnancy|0|||
131832828|NCT01392326|474669452|FG001|Overall Study|Pregnancy|0|||
131832829|NCT01392326|474669453|FG002|Overall Study|Pregnancy|1|||
131832830|NCT01392326|474669451|FG000|Overall Study|Physician Decision|7|||
131832831|NCT01392326|474669452|FG001|Overall Study|Physician Decision|5|||
131832832|NCT01392326|474669453|FG002|Overall Study|Physician Decision|2|||
131832833|NCT01392326|474669451|FG000|Overall Study|Lost to Follow-up|1|||
131832834|NCT01392326|474669452|FG001|Overall Study|Lost to Follow-up|3|||
131832835|NCT01392326|474669453|FG002|Overall Study|Lost to Follow-up|4|||
131832836|NCT01392326|474669451|FG000|Overall Study|Lack of Efficacy|14|||
131832837|NCT01392326|474669452|FG001|Overall Study|Lack of Efficacy|10|||
131832838|NCT01392326|474669453|FG002|Overall Study|Lack of Efficacy|15|||
131832839|NCT01392326|474669451|FG000|Overall Study|Adverse Event|9|||
131832840|NCT01392326|474669452|FG001|Overall Study|Adverse Event|6|||
131832841|NCT01392326|474669453|FG002|Overall Study|Adverse Event|11|||
131832842|NCT00233987|474669456|FG000|Overall Study|Withdrawal by Subject|1|||
131832843|NCT00233987|474669456|FG000|Overall Study|Lack of Efficacy|2|||
131832844|NCT00233987|474669456|FG000|Overall Study|Reason Under Review|1|||
131832845|NCT00233987|474669456|FG000|Overall Study|Other - Not Protocol Specified|5|||
131832846|NCT00233987|474669456|FG000|Overall Study|Eligible but No Treatment Received|2|||
131832847|NCT00233987|474669456|FG000|Overall Study|Ineligible|4|||
131832848|NCT00518622|474669461|FG000|Overall Study|Lost to Follow-up|0|||
131832849|NCT00518622|474669462|FG001|Overall Study|Lost to Follow-up|0|||
131832850|NCT00518622|474669463|FG002|Overall Study|Lost to Follow-up|1|||
131832851|NCT00518622|474669464|FG003|Overall Study|Lost to Follow-up|0|||
131832852|NCT00518622|474669465|FG004|Overall Study|Lost to Follow-up|0|||
131832853|NCT00518622|474669466|FG005|Overall Study|Lost to Follow-up|0|||
131832854|NCT00518622|474669467|FG006|Overall Study|Lost to Follow-up|0|||
131832855|NCT00518622|474669468|FG007|Overall Study|Lost to Follow-up|0|||
131832856|NCT00518622|474669461|FG000|Overall Study|Study medication taken incorrectly|0|||
131832857|NCT00518622|474669462|FG001|Overall Study|Study medication taken incorrectly|1|||
131832858|NCT00518622|474669463|FG002|Overall Study|Study medication taken incorrectly|0|||
131832859|NCT00518622|474669464|FG003|Overall Study|Study medication taken incorrectly|0|||
131832860|NCT00518622|474669465|FG004|Overall Study|Study medication taken incorrectly|0|||
131832861|NCT00518622|474669466|FG005|Overall Study|Study medication taken incorrectly|0|||
131832862|NCT00518622|474669467|FG006|Overall Study|Study medication taken incorrectly|0|||
131832863|NCT00518622|474669468|FG007|Overall Study|Study medication taken incorrectly|0|||
131832864|NCT01688726|474669469|FG000|Overall Study|Adverse Event|1|||
131832865|NCT01688726|474669470|FG001|Overall Study|Adverse Event|0|||
131832866|NCT01688726|474669469|FG000|Overall Study|Relocated abroad|0|||
131832867|NCT01688726|474669470|FG001|Overall Study|Relocated abroad|1|||
131832868|NCT03499119|474669471|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
131832869|NCT03499119|474669472|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
131832870|NCT03499119|474669473|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
131832871|NCT03499119|474669474|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
131832872|NCT03499119|474669471|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
131832873|NCT03499119|474669472|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
131832874|NCT03499119|474669473|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
131832875|NCT03499119|474669474|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
131832876|NCT03499119|474669471|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
131832877|NCT03499119|474669472|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
131832878|NCT03499119|474669473|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
131832879|NCT03499119|474669474|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
131832880|NCT03499119|474669471|FG000|Optional Extension Phase|Lost to Follow-up|0|||
131832881|NCT03499119|474669472|FG001|Optional Extension Phase|Lost to Follow-up|0|||
131832882|NCT03499119|474669473|FG002|Optional Extension Phase|Lost to Follow-up|0|||
131832883|NCT03499119|474669474|FG003|Optional Extension Phase|Lost to Follow-up|1|||
131832884|NCT03499119|474669471|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
131832885|NCT03499119|474669472|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
131832886|NCT03499119|474669473|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
131832887|NCT03499119|474669474|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
131832888|NCT03499119|474669471|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
131832889|NCT03499119|474669472|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
131832890|NCT03499119|474669473|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
131832891|NCT03499119|474669474|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
131832892|NCT04553913|474669475|FG000|Overall Study|patient's block resolved prior to PACU|1|||
131832893|NCT04553913|474669475|FG000|Overall Study|did not use the device properly|5|||
131832894|NCT03821272|474671485|FG000|Overall Study|Death|1|||
131832895|NCT03821272|474671486|FG001|Overall Study|Death|0|||
131832896|NCT03821272|474671485|FG000|Overall Study|Physician Decision|1|||
131832897|NCT03821272|474671486|FG001|Overall Study|Physician Decision|0|||
131832898|NCT03821272|474671485|FG000|Overall Study|Withdrawal by Subject|1|||
131832899|NCT03821272|474671486|FG001|Overall Study|Withdrawal by Subject|0|||
131832900|NCT05904769|474671487|FG000|Overall Study|Physician Decision|0|||
131832901|NCT05904769|474671488|FG001|Overall Study|Physician Decision|6|||
131832902|NCT05626803|474671491|FG000|Overall Study|Lost to Follow-up|0|||
131832903|NCT05626803|474671492|FG001|Overall Study|Lost to Follow-up|1|||
131832904|NCT05626803|474671493|FG002|Overall Study|Lost to Follow-up|0|||
131832905|NCT05626803|474671494|FG003|Overall Study|Lost to Follow-up|0|||
131832906|NCT00262041|474671497|FG000|Overall Study|Withdrawal by Subject|0|||
131832907|NCT00262041|474671498|FG001|Overall Study|Withdrawal by Subject|3|||
131832908|NCT00262041|474671499|FG002|Overall Study|Withdrawal by Subject|1|||
131832909|NCT00262041|474671497|FG000|Overall Study|Lost to Follow-up|1|||
131832910|NCT00262041|474671498|FG001|Overall Study|Lost to Follow-up|1|||
131832911|NCT00262041|474671499|FG002|Overall Study|Lost to Follow-up|5|||
131832912|NCT00262041|474671497|FG000|Overall Study|Unable to classify|1|||
131832913|NCT00262041|474671498|FG001|Overall Study|Unable to classify|0|||
131832914|NCT00262041|474671499|FG002|Overall Study|Unable to classify|0|||
131832915|NCT03578237|474671502|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
131832916|NCT03578237|474671503|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
131832917|NCT00973765|474671506|FG000|Overall Study|Lost to Follow-up|8|||
131832918|NCT00973765|474671507|FG001|Overall Study|Lost to Follow-up|14|||
131832919|NCT02384941|474671508|FG000|Overall Study|Adverse Event|11|||
131832920|NCT02384941|474671509|FG001|Overall Study|Adverse Event|13|||
131832921|NCT02384941|474671510|FG002|Overall Study|Adverse Event|17|||
131832922|NCT02384941|474671508|FG000|Overall Study|Lost to Follow-up|3|||
131832923|NCT02384941|474671509|FG001|Overall Study|Lost to Follow-up|2|||
131832924|NCT02384941|474671510|FG002|Overall Study|Lost to Follow-up|1|||
131832925|NCT02384941|474671508|FG000|Overall Study|Non-Compliance With Study Drug|2|||
131832926|NCT02384941|474671509|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131832927|NCT02384941|474671510|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131832928|NCT02384941|474671508|FG000|Overall Study|Physician Decision|1|||
131832929|NCT02384941|474671509|FG001|Overall Study|Physician Decision|1|||
131832930|NCT02384941|474671510|FG002|Overall Study|Physician Decision|0|||
131832931|NCT02384941|474671508|FG000|Overall Study|Protocol Violation|3|||
131832932|NCT02384941|474671509|FG001|Overall Study|Protocol Violation|0|||
131832933|NCT02384941|474671510|FG002|Overall Study|Protocol Violation|0|||
131832934|NCT02384941|474671508|FG000|Overall Study|Withdrawal by Subject|26|||
131832935|NCT02384941|474671509|FG001|Overall Study|Withdrawal by Subject|19|||
131832936|NCT02384941|474671510|FG002|Overall Study|Withdrawal by Subject|20|||
131832937|NCT02384941|474671508|FG000|Overall Study|Pregnancy|0|||
131832938|NCT02384941|474671509|FG001|Overall Study|Pregnancy|0|||
131832939|NCT02384941|474671510|FG002|Overall Study|Pregnancy|1|||
131832940|NCT02384941|474671508|FG000|Overall Study|Other than specified above|4|||
131832941|NCT02384941|474671509|FG001|Overall Study|Other than specified above|0|||
131832942|NCT02384941|474671510|FG002|Overall Study|Other than specified above|1|||
131832943|NCT02011113|474671511|FG000|Overall Study|Adverse Event|4|||
131832944|NCT02011113|474671511|FG000|Overall Study|Disease Progression (DP)|16|||
131450130|NCT01721044|473276800|FG000|Treatment Period|Lost to Follow-up|0|||
131450131|NCT01721044|473276801|FG001|Treatment Period|Lost to Follow-up|0|||
131832945|NCT02011113|474671511|FG000|Overall Study|Death|1|||
131832946|NCT02011113|474671511|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
131832947|NCT02011113|474671511|FG000|Overall Study|Investigator's judgement- DP|3|||
131832948|NCT02011113|474671511|FG000|Overall Study|Study terminated by sponsor|11|||
131832949|NCT02493777|474671512|FG000|Overall Study|Lost to Follow-up|0|||
131832950|NCT02493777|474671513|FG001|Overall Study|Lost to Follow-up|1|||
131832951|NCT01642914|474671514|FG000|Overall Study|Adverse Event|11|||
131832952|NCT01642914|474671515|FG001|Overall Study|Adverse Event|7|||
131832953|NCT01642914|474671516|FG002|Overall Study|Adverse Event|15|||
131832954|NCT01642914|474671514|FG000|Overall Study|Lack of Efficacy|9|||
131832955|NCT01642914|474671515|FG001|Overall Study|Lack of Efficacy|4|||
131832956|NCT01642914|474671516|FG002|Overall Study|Lack of Efficacy|2|||
131832957|NCT01642914|474671514|FG000|Overall Study|Protocol Violation|15|||
131832958|NCT01642914|474671515|FG001|Overall Study|Protocol Violation|13|||
131832959|NCT01642914|474671516|FG002|Overall Study|Protocol Violation|6|||
131832960|NCT01642914|474671514|FG000|Overall Study|Withdrawal by Subject|5|||
131832961|NCT01642914|474671515|FG001|Overall Study|Withdrawal by Subject|5|||
131832962|NCT01642914|474671516|FG002|Overall Study|Withdrawal by Subject|10|||
131832963|NCT01642914|474671514|FG000|Overall Study|Lost to Follow-up|5|||
131832964|NCT01642914|474671515|FG001|Overall Study|Lost to Follow-up|3|||
131832965|NCT01642914|474671516|FG002|Overall Study|Lost to Follow-up|7|||
131832966|NCT01642914|474671514|FG000|Overall Study|Other Reason|1|||
131832967|NCT01642914|474671515|FG001|Overall Study|Other Reason|0|||
131832968|NCT01642914|474671516|FG002|Overall Study|Other Reason|0|||
131832969|NCT00171301|474671517|FG000|Overall Study|Death|1|||
131832970|NCT00171301|474671518|FG001|Overall Study|Death|2|||
131832971|NCT00171301|474671517|FG000|Overall Study|Adverse Event|1|||
131832972|NCT00171301|474671518|FG001|Overall Study|Adverse Event|2|||
131832973|NCT00171301|474671517|FG000|Overall Study|Lost to Follow-up|6|||
131832974|NCT00171301|474671518|FG001|Overall Study|Lost to Follow-up|2|||
131832975|NCT00171301|474671517|FG000|Overall Study|Protocol Violation|0|||
131832976|NCT00171301|474671518|FG001|Overall Study|Protocol Violation|2|||
131832977|NCT00171301|474671517|FG000|Overall Study|Withdrawal by Subject|0|||
131832978|NCT00171301|474671518|FG001|Overall Study|Withdrawal by Subject|1|||
131832979|NCT04319159|474671519|FG000|Overall Study|Screening failure|13|||
131832980|NCT04319159|474671519|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
131832981|NCT04319159|474671519|FG000|Overall Study|Withdrawal by Subject|1|||
131832982|NCT06005597|474671520|FG000|Overall Study|Lost to Follow-up|1|||
131832983|NCT06005597|474671521|FG001|Overall Study|Lost to Follow-up|2|||
131832984|NCT06005597|474671522|FG002|Overall Study|Lost to Follow-up|1|||
131832985|NCT06005597|474671523|FG003|Overall Study|Lost to Follow-up|2|||
131832986|NCT06005597|474671520|FG000|Overall Study|Death|1|||
131832987|NCT06005597|474671521|FG001|Overall Study|Death|1|||
131832988|NCT06005597|474671522|FG002|Overall Study|Death|1|||
131832989|NCT06005597|474671523|FG003|Overall Study|Death|0|||
131832990|NCT02100319|474671524|FG000|Overall Study|Case Report Forms Uncollected|11|||
131832991|NCT02100319|474671524|FG000|Overall Study|Protocol Deviation|5|||
131832992|NCT02370914|474671525|FG000|Overall Study|Protocol Violation|2|||
131832993|NCT03375320|474671526|FG000|Overall Study|Adverse Event|34|||
131832994|NCT03375320|474671527|FG001|Overall Study|Adverse Event|9|||
131832995|NCT03375320|474671528|FG002|Overall Study|Adverse Event|10|||
131832996|NCT03375320|474671529|FG003|Overall Study|Adverse Event|0|||
131832997|NCT03375320|474671526|FG000|Overall Study|Death|6|||
131832998|NCT03375320|474671527|FG001|Overall Study|Death|3|||
131832999|NCT03375320|474671528|FG002|Overall Study|Death|0|||
131833000|NCT03375320|474671529|FG003|Overall Study|Death|0|||
131833001|NCT03375320|474671526|FG000|Overall Study|Withdrawal by Subject|7|||
131833002|NCT03375320|474671527|FG001|Overall Study|Withdrawal by Subject|4|||
131833003|NCT03375320|474671528|FG002|Overall Study|Withdrawal by Subject|5|||
131833004|NCT03375320|474671529|FG003|Overall Study|Withdrawal by Subject|4|||
131833005|NCT03375320|474671526|FG000|Overall Study|Progressive disease|55|||
131833006|NCT03375320|474671527|FG001|Overall Study|Progressive disease|41|||
131833007|NCT03375320|474671528|FG002|Overall Study|Progressive disease|29|||
131833008|NCT03375320|474671529|FG003|Overall Study|Progressive disease|24|||
131833009|NCT03375320|474671526|FG000|Overall Study|Alternative treatment|6|||
131833010|NCT03375320|474671527|FG001|Overall Study|Alternative treatment|1|||
131910510|NCT01027949|474960767|FG000|Overall Study|Death|174|||
131910511|NCT01027949|474960767|FG000|Overall Study|Progressive Disease|163|||
131910512|NCT01027949|474960767|FG000|Overall Study|Adverse Event|172|||
131833011|NCT03375320|474671528|FG002|Overall Study|Alternative treatment|1|||
131833012|NCT03375320|474671529|FG003|Overall Study|Alternative treatment|0|||
131833013|NCT03375320|474671526|FG000|Overall Study|Other disease|1|||
131833014|NCT03375320|474671527|FG001|Overall Study|Other disease|1|||
131833015|NCT03375320|474671528|FG002|Overall Study|Other disease|3|||
131833016|NCT03375320|474671529|FG003|Overall Study|Other disease|0|||
131833017|NCT03375320|474671526|FG000|Overall Study|Withdrawal prior to initiation|2|||
131833018|NCT03375320|474671527|FG001|Overall Study|Withdrawal prior to initiation|2|||
131833019|NCT03375320|474671528|FG002|Overall Study|Withdrawal prior to initiation|1|||
131833020|NCT03375320|474671529|FG003|Overall Study|Withdrawal prior to initiation|0|||
131833021|NCT03375320|474671526|FG000|Overall Study|Physician Decision|1|||
131833022|NCT03375320|474671527|FG001|Overall Study|Physician Decision|1|||
131833023|NCT03375320|474671528|FG002|Overall Study|Physician Decision|1|||
131833024|NCT03375320|474671529|FG003|Overall Study|Physician Decision|1|||
131833025|NCT03375320|474671526|FG000|Overall Study|Non-compliance|1|||
131833026|NCT03375320|474671527|FG001|Overall Study|Non-compliance|0|||
131910513|NCT01027949|474960767|FG000|Overall Study|Withdrawal by Subject|113|||
131833027|NCT03375320|474671528|FG002|Overall Study|Non-compliance|0|||
131833028|NCT03375320|474671529|FG003|Overall Study|Non-compliance|0|||
131833029|NCT02589522|474671531|FG000|Overall Study|Physician Decision|1|||
131833030|NCT02589522|474671532|FG001|Overall Study|Physician Decision|2|||
131833031|NCT02589522|474671533|FG002|Overall Study|Physician Decision|0|||
131833032|NCT02589522|474671531|FG000|Overall Study|Did not start treatment|1|||
131833033|NCT02589522|474671532|FG001|Overall Study|Did not start treatment|0|||
131833034|NCT02589522|474671533|FG002|Overall Study|Did not start treatment|0|||
131833035|NCT00754442|474671534|FG000|Overall Study|Withdrawal by Subject|5|||
131833036|NCT00754442|474671535|FG001|Overall Study|Withdrawal by Subject|3|||
131833037|NCT04479475|474671536|FG000|Overall Study|Withdrawal by Subject|7|||
131833038|NCT00296491|474671537|FG000|Overall Study|Low Pollen Counts|18|||
131833039|NCT00296491|474671538|FG001|Overall Study|Low Pollen Counts|26|||
131833040|NCT00296491|474671539|FG002|Overall Study|Low Pollen Counts|25|||
131833041|NCT00296491|474671540|FG003|Overall Study|Low Pollen Counts|16|||
131833042|NCT00296491|474671537|FG000|Overall Study|Protocol Violation|4|||
131833043|NCT00296491|474671538|FG001|Overall Study|Protocol Violation|6|||
131833044|NCT00296491|474671539|FG002|Overall Study|Protocol Violation|2|||
131833045|NCT00296491|474671540|FG003|Overall Study|Protocol Violation|3|||
131833046|NCT00296491|474671537|FG000|Overall Study|Adverse Event|1|||
131833047|NCT00296491|474671538|FG001|Overall Study|Adverse Event|3|||
131833048|NCT00296491|474671539|FG002|Overall Study|Adverse Event|1|||
131833049|NCT00296491|474671540|FG003|Overall Study|Adverse Event|4|||
131833050|NCT00296491|474671537|FG000|Overall Study|Withdrawn due to Asthma|0|||
131833051|NCT00296491|474671538|FG001|Overall Study|Withdrawn due to Asthma|0|||
131833052|NCT00296491|474671539|FG002|Overall Study|Withdrawn due to Asthma|0|||
131833053|NCT00296491|474671540|FG003|Overall Study|Withdrawn due to Asthma|4|||
131833054|NCT00296491|474671537|FG000|Overall Study|Withdrawal by Subject|7|||
131833055|NCT00296491|474671538|FG001|Overall Study|Withdrawal by Subject|3|||
131833056|NCT00296491|474671539|FG002|Overall Study|Withdrawal by Subject|3|||
131833057|NCT00296491|474671540|FG003|Overall Study|Withdrawal by Subject|2|||
131833058|NCT00296491|474671537|FG000|Overall Study|Non-Compliance|12|||
131833059|NCT00296491|474671538|FG001|Overall Study|Non-Compliance|13|||
131833060|NCT00296491|474671539|FG002|Overall Study|Non-Compliance|10|||
131833061|NCT00296491|474671540|FG003|Overall Study|Non-Compliance|14|||
131833062|NCT00296491|474671537|FG000|Overall Study|Lost to Follow-up|0|||
131833063|NCT00296491|474671538|FG001|Overall Study|Lost to Follow-up|2|||
131833064|NCT00296491|474671539|FG002|Overall Study|Lost to Follow-up|2|||
131833065|NCT00296491|474671540|FG003|Overall Study|Lost to Follow-up|0|||
131833066|NCT01300052|474671541|FG000|Overall Study|Adverse Event|3|||
131833067|NCT01300052|474671542|FG001|Overall Study|Adverse Event|0|||
131833068|NCT01300052|474671541|FG000|Overall Study|Withdrawal by Subject|2|||
131833069|NCT01300052|474671542|FG001|Overall Study|Withdrawal by Subject|2|||
131833070|NCT01300052|474671541|FG000|Overall Study|Protocol Violation|1|||
131833071|NCT01300052|474671542|FG001|Overall Study|Protocol Violation|1|||
131833072|NCT01231373|474671543|FG000|Overall Study|Withdrew consent prior to randomization|2|||
131833073|NCT01231373|474671544|FG001|Overall Study|Withdrew consent prior to randomization|1|||
131833074|NCT01231373|474671545|FG002|Overall Study|Withdrew consent prior to randomization|0|||
131833075|NCT01231373|474671546|FG003|Overall Study|Withdrew consent prior to randomization|0|||
131833076|NCT01231373|474671543|FG000|Overall Study|Lost to Follow-up|0|||
131833077|NCT01231373|474671544|FG001|Overall Study|Lost to Follow-up|0|||
131833078|NCT01231373|474671545|FG002|Overall Study|Lost to Follow-up|0|||
131833079|NCT01231373|474671546|FG003|Overall Study|Lost to Follow-up|1|||
131833080|NCT01231373|474671543|FG000|Overall Study|Withdrew Consent|1|||
131833081|NCT01231373|474671544|FG001|Overall Study|Withdrew Consent|0|||
131833082|NCT01231373|474671545|FG002|Overall Study|Withdrew Consent|0|||
131833083|NCT01231373|474671546|FG003|Overall Study|Withdrew Consent|0|||
131833084|NCT03451006|474671547|FG000|Overall Study|Withdrawal by Subject|2|||
131833085|NCT03451006|474671548|FG001|Overall Study|Withdrawal by Subject|2|||
131833086|NCT02547766|474671549|FG000|Overall Study|Withdrawal by Subject|1|||
131833087|NCT01929395|474671550|FG000|Overall Study|Did not complete - non-related toxicity|1|||
131833088|NCT01929395|474671551|FG001|Overall Study|Did not complete - non-related toxicity|0|||
131833089|NCT01929395|474671552|FG002|Overall Study|Did not complete - non-related toxicity|0|||
131401806|NCT03831191|473091581|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131833090|NCT01929395|474671550|FG000|Overall Study|Withdrawal by Subject|0|||
131833091|NCT01929395|474671551|FG001|Overall Study|Withdrawal by Subject|1|||
131833092|NCT01929395|474671552|FG002|Overall Study|Withdrawal by Subject|0|||
131833093|NCT01929395|474671550|FG000|Overall Study|Screen Fail|0|||
131833094|NCT01929395|474671551|FG001|Overall Study|Screen Fail|0|||
131833095|NCT01929395|474671552|FG002|Overall Study|Screen Fail|1|||
131833096|NCT02010255|474671553|FG000|Overall Study|Death|0|||
131833097|NCT02010255|474671554|FG001|Overall Study|Death|1|||
131833098|NCT02010255|474671555|FG002|Overall Study|Death|4|||
131833099|NCT02010255|474671556|FG003|Overall Study|Death|4|||
131833100|NCT02010255|474671557|FG004|Overall Study|Death|2|||
131833101|NCT02010255|474671558|FG005|Overall Study|Death|0|||
131833102|NCT02010255|474671559|FG006|Overall Study|Death|1|||
131833103|NCT02010255|474671560|FG007|Overall Study|Death|1|||
131833104|NCT02010255|474671561|FG008|Overall Study|Death|1|||
131833105|NCT02010255|474671562|FG009|Overall Study|Death|0|||
131833106|NCT02010255|474671563|FG010|Overall Study|Death|1|||
131833107|NCT02010255|474671564|FG011|Overall Study|Death|1|||
131833108|NCT02010255|474671565|FG012|Overall Study|Death|0|||
131833109|NCT02010255|474671566|FG013|Overall Study|Death|0|||
131833110|NCT02010255|474671553|FG000|Overall Study|Lack of Efficacy|4|||
131833111|NCT02010255|474671554|FG001|Overall Study|Lack of Efficacy|1|||
131833112|NCT02010255|474671555|FG002|Overall Study|Lack of Efficacy|2|||
131833113|NCT02010255|474671556|FG003|Overall Study|Lack of Efficacy|1|||
131833114|NCT02010255|474671557|FG004|Overall Study|Lack of Efficacy|1|||
131833115|NCT02010255|474671558|FG005|Overall Study|Lack of Efficacy|0|||
131833116|NCT02010255|474671559|FG006|Overall Study|Lack of Efficacy|0|||
131833117|NCT02010255|474671560|FG007|Overall Study|Lack of Efficacy|0|||
131833118|NCT02010255|474671561|FG008|Overall Study|Lack of Efficacy|0|||
131833119|NCT02010255|474671562|FG009|Overall Study|Lack of Efficacy|0|||
131833120|NCT02010255|474671563|FG010|Overall Study|Lack of Efficacy|1|||
131833121|NCT02010255|474671564|FG011|Overall Study|Lack of Efficacy|0|||
131833122|NCT02010255|474671565|FG012|Overall Study|Lack of Efficacy|0|||
131833123|NCT02010255|474671566|FG013|Overall Study|Lack of Efficacy|0|||
131833124|NCT02010255|474671553|FG000|Overall Study|Withdrew Consent|1|||
131833125|NCT02010255|474671554|FG001|Overall Study|Withdrew Consent|0|||
131833126|NCT02010255|474671555|FG002|Overall Study|Withdrew Consent|0|||
131833127|NCT02010255|474671556|FG003|Overall Study|Withdrew Consent|1|||
131833128|NCT02010255|474671557|FG004|Overall Study|Withdrew Consent|0|||
131833129|NCT02010255|474671558|FG005|Overall Study|Withdrew Consent|0|||
131833130|NCT02010255|474671559|FG006|Overall Study|Withdrew Consent|0|||
131833131|NCT02010255|474671560|FG007|Overall Study|Withdrew Consent|0|||
131833132|NCT02010255|474671561|FG008|Overall Study|Withdrew Consent|0|||
131833133|NCT02010255|474671562|FG009|Overall Study|Withdrew Consent|0|||
131833134|NCT02010255|474671563|FG010|Overall Study|Withdrew Consent|0|||
131833135|NCT02010255|474671564|FG011|Overall Study|Withdrew Consent|0|||
131833136|NCT02010255|474671565|FG012|Overall Study|Withdrew Consent|0|||
131833137|NCT02010255|474671566|FG013|Overall Study|Withdrew Consent|0|||
131833138|NCT02010255|474671553|FG000|Overall Study|Adverse Event|1|||
131833139|NCT02010255|474671554|FG001|Overall Study|Adverse Event|0|||
131833140|NCT02010255|474671555|FG002|Overall Study|Adverse Event|0|||
131833141|NCT02010255|474671556|FG003|Overall Study|Adverse Event|0|||
131833142|NCT02010255|474671557|FG004|Overall Study|Adverse Event|0|||
131833143|NCT02010255|474671558|FG005|Overall Study|Adverse Event|0|||
131833144|NCT02010255|474671559|FG006|Overall Study|Adverse Event|0|||
131833145|NCT02010255|474671560|FG007|Overall Study|Adverse Event|0|||
131833146|NCT02010255|474671561|FG008|Overall Study|Adverse Event|0|||
131833147|NCT02010255|474671562|FG009|Overall Study|Adverse Event|0|||
131833148|NCT02010255|474671563|FG010|Overall Study|Adverse Event|0|||
131833149|NCT02010255|474671564|FG011|Overall Study|Adverse Event|0|||
131833150|NCT02010255|474671565|FG012|Overall Study|Adverse Event|0|||
131833151|NCT02010255|474671566|FG013|Overall Study|Adverse Event|0|||
131833152|NCT02010255|474671553|FG000|Overall Study|Lost to Follow-up|0|||
131833153|NCT02010255|474671554|FG001|Overall Study|Lost to Follow-up|0|||
131833154|NCT02010255|474671555|FG002|Overall Study|Lost to Follow-up|1|||
131833155|NCT02010255|474671556|FG003|Overall Study|Lost to Follow-up|0|||
131833156|NCT02010255|474671557|FG004|Overall Study|Lost to Follow-up|1|||
131833157|NCT02010255|474671558|FG005|Overall Study|Lost to Follow-up|0|||
131833158|NCT02010255|474671559|FG006|Overall Study|Lost to Follow-up|0|||
131833159|NCT02010255|474671560|FG007|Overall Study|Lost to Follow-up|0|||
131833160|NCT02010255|474671561|FG008|Overall Study|Lost to Follow-up|0|||
131833161|NCT02010255|474671562|FG009|Overall Study|Lost to Follow-up|0|||
131833162|NCT02010255|474671563|FG010|Overall Study|Lost to Follow-up|0|||
131833163|NCT02010255|474671564|FG011|Overall Study|Lost to Follow-up|0|||
131833164|NCT02010255|474671565|FG012|Overall Study|Lost to Follow-up|0|||
131833165|NCT02010255|474671566|FG013|Overall Study|Lost to Follow-up|0|||
131833166|NCT02010255|474671553|FG000|Overall Study|Randomized but Not Treated|0|||
131833167|NCT02010255|474671554|FG001|Overall Study|Randomized but Not Treated|0|||
131833168|NCT02010255|474671555|FG002|Overall Study|Randomized but Not Treated|0|||
131833169|NCT02010255|474671556|FG003|Overall Study|Randomized but Not Treated|0|||
131833170|NCT02010255|474671557|FG004|Overall Study|Randomized but Not Treated|0|||
131833171|NCT02010255|474671558|FG005|Overall Study|Randomized but Not Treated|0|||
131833172|NCT02010255|474671559|FG006|Overall Study|Randomized but Not Treated|0|||
131833173|NCT02010255|474671560|FG007|Overall Study|Randomized but Not Treated|0|||
131833174|NCT02010255|474671561|FG008|Overall Study|Randomized but Not Treated|0|||
131833175|NCT02010255|474671562|FG009|Overall Study|Randomized but Not Treated|0|||
131833176|NCT02010255|474671563|FG010|Overall Study|Randomized but Not Treated|0|||
131833177|NCT02010255|474671564|FG011|Overall Study|Randomized but Not Treated|0|||
131833178|NCT02010255|474671565|FG012|Overall Study|Randomized but Not Treated|0|||
131833179|NCT02010255|474671566|FG013|Overall Study|Randomized but Not Treated|1|||
131833180|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
131833181|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
131833182|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
131833183|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
131833184|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
131833185|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
131833186|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
131833187|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
131833188|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
131833189|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
131833190|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
131833191|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
131833192|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
131833193|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
131833194|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
131833195|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
131833196|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
131833197|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
131833198|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
131833199|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
131833200|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
131833201|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
131833202|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
131833203|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
131833204|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
131833205|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
131833206|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
131833207|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
131833208|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Death|0|||
131833209|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Death|1|||
131833210|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Death|0|||
131833211|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Death|0|||
131833212|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
131833213|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
131910514|NCT01027949|474960767|FG000|Overall Study|Lost to Follow-up|17|||
131910515|NCT01027949|474960767|FG000|Overall Study|Protocol Violation|13|||
131910516|NCT01027949|474960767|FG000|Overall Study|PI Decision|8|||
131910517|NCT01027949|474960767|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
131910518|NCT01027949|474960767|FG000|Overall Study|Non-compliance with Study Procedures|7|||
131910519|NCT01027949|474960767|FG000|Overall Study|Lung Transplant|5|||
131910520|NCT01027949|474960767|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
131910521|NCT01027949|474960767|FG000|Overall Study|Use of Excluded Medication|2|||
131910522|NCT01027949|474960767|FG000|Overall Study|Patient Self-discontinuation|1|||
131910523|NCT01027949|474960767|FG000|Overall Study|Pregnancy|1|||
131910524|NCT01027949|474960767|FG000|Overall Study|Surgery|1|||
131910525|NCT02152007|474960780|FG000|Overall Study|Withdrawal by Subject|1|||
131910526|NCT00706797|474960783|FG000|Overall Study|Lack of Efficacy|3|||
131910527|NCT00706797|474960784|FG001|Overall Study|Lack of Efficacy|0|||
131910528|NCT00706797|474960783|FG000|Overall Study|Adverse Event|0|||
131910529|NCT00706797|474960784|FG001|Overall Study|Adverse Event|3|||
131910530|NCT00706797|474960783|FG000|Overall Study|Withdrawal by Subject|8|||
131910531|NCT00706797|474960784|FG001|Overall Study|Withdrawal by Subject|1|||
131910532|NCT00706797|474960783|FG000|Overall Study|Death|1|||
131910533|NCT00706797|474960784|FG001|Overall Study|Death|0|||
131833214|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
131833215|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
131833216|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
131833217|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
131833218|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
131833219|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
131833220|NCT02990806|474671569|FG000|Stage 1 (22 Weeks)|Other|1|||
131833221|NCT02990806|474671570|FG001|Stage 1 (22 Weeks)|Other|3|||
131833222|NCT02990806|474671571|FG002|Stage 1 (22 Weeks)|Other|0|||
131833223|NCT02990806|474671572|FG003|Stage 1 (22 Weeks)|Other|0|||
131833224|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
131833225|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
131833226|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
131833227|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
131833228|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Death|1|||
131833229|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Death|0|||
131833230|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Death|0|||
131833231|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Death|0|||
131833232|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
131833233|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
131910534|NCT00706797|474960783|FG000|Overall Study|Discontinuation of study by sponsor|52|||
131910535|NCT00706797|474960784|FG001|Overall Study|Discontinuation of study by sponsor|63|||
131910536|NCT00706797|474960783|FG000|Overall Study|Protocol Violation|3|||
131910537|NCT00706797|474960784|FG001|Overall Study|Protocol Violation|2|||
131910538|NCT00706797|474960783|FG000|Overall Study|Lost to Follow-up|1|||
131910539|NCT00706797|474960784|FG001|Overall Study|Lost to Follow-up|2|||
131833234|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
131833235|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
131833236|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
131833237|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
131833238|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
131833239|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
131833240|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
131833241|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
131833242|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
131833243|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
131833244|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
131833245|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
131833246|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
131833247|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
131833248|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
131833249|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
131833250|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
131833251|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
131833252|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
131833253|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
131833254|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
131833255|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
131833256|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
131833257|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
131833258|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
131833259|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
131833260|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
131833261|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
131833262|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
131833263|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
131833264|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
131833265|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
131833266|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
131833267|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
131833268|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Other|3|||
131833269|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Other|0|||
131833270|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Other|4|||
131833271|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Other|1|||
131833272|NCT02990806|474671569|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
131833273|NCT02990806|474671570|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
131833274|NCT02990806|474671571|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
131833275|NCT02990806|474671572|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
131833276|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
131833277|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
131833278|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
131833279|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
131833280|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
131833281|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
131833282|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
131910540|NCT00706797|474960783|FG000|Overall Study|Other|1|||
131910541|NCT00706797|474960784|FG001|Overall Study|Other|0|||
131910542|NCT00296335|474960786|FG000|Overall Study|Recurrence|3|||
131910543|NCT00296335|474960787|FG001|Overall Study|Recurrence|51|||
131910544|NCT00296335|474960786|FG000|Overall Study|Adverse Event|17|||
131910545|NCT00296335|474960787|FG001|Overall Study|Adverse Event|27|||
131910546|NCT00296335|474960786|FG000|Overall Study|Lost to Follow-up|7|||
131910547|NCT00296335|474960787|FG001|Overall Study|Lost to Follow-up|33|||
131910548|NCT00296335|474960786|FG000|Overall Study|Physician Decision|3|||
131910549|NCT00296335|474960787|FG001|Overall Study|Physician Decision|11|||
131910550|NCT02737722|474960788|FG000|Overall Study|Physician Decision|0|||
131910551|NCT02737722|474960789|FG001|Overall Study|Physician Decision|0|||
131910552|NCT02737722|474960790|FG002|Overall Study|Physician Decision|1|||
131910553|NCT02737722|474960791|FG003|Overall Study|Physician Decision|0|||
131910554|NCT00112957|474960792|FG000|Overall Study|Progressive disease|18|||
131910555|NCT00112957|474960792|FG000|Overall Study|Physician Decision|1|||
131910556|NCT02309359|474960797|FG000|Overall Study|Adverse Event|4|||
131910557|NCT02309359|474960798|FG001|Overall Study|Adverse Event|5|||
131910558|NCT02309359|474960799|FG002|Overall Study|Adverse Event|5|||
131910559|NCT02309359|474960800|FG003|Overall Study|Adverse Event|4|||
131910560|NCT02309359|474960801|FG004|Overall Study|Adverse Event|4|||
131910561|NCT02309359|474960797|FG000|Overall Study|Death|1|||
131910562|NCT02309359|474960798|FG001|Overall Study|Death|0|||
131833283|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
131833284|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
131833285|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
131833286|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
131833287|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
131833288|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
131833289|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
131833290|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
131833291|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
131833292|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
131833293|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
131833294|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
131833295|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
131833296|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
131833297|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
131833298|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
131833299|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
131833300|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
131833301|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
131833302|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
131833303|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
131833304|NCT02990806|474671569|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
131833305|NCT02990806|474671570|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
131833306|NCT02990806|474671571|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
131833307|NCT02990806|474671572|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
131833308|NCT00977431|474671573|FG000|Overall Study|Other than listed|1|||
131833309|NCT00977431|474671574|FG001|Overall Study|Other than listed|0|||
131833310|NCT00977431|474671575|FG002|Overall Study|Other than listed|0|||
131833311|NCT00977431|474671576|FG003|Overall Study|Other than listed|0|||
131833312|NCT00977431|474671577|FG004|Overall Study|Other than listed|2|||
131833313|NCT00977431|474671573|FG000|Overall Study|Protocol Violation|0|||
131833314|NCT00977431|474671574|FG001|Overall Study|Protocol Violation|0|||
131833315|NCT00977431|474671575|FG002|Overall Study|Protocol Violation|1|||
131833316|NCT00977431|474671576|FG003|Overall Study|Protocol Violation|0|||
131833317|NCT00977431|474671577|FG004|Overall Study|Protocol Violation|0|||
131833318|NCT00977431|474671573|FG000|Overall Study|Adverse Event|3|||
131833319|NCT00977431|474671574|FG001|Overall Study|Adverse Event|0|||
131833320|NCT00977431|474671575|FG002|Overall Study|Adverse Event|4|||
131833321|NCT00977431|474671576|FG003|Overall Study|Adverse Event|0|||
131833322|NCT00977431|474671577|FG004|Overall Study|Adverse Event|6|||
131833323|NCT00977431|474671573|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
131833324|NCT00977431|474671574|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
131833325|NCT00977431|474671575|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
131833326|NCT00977431|474671576|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
131833327|NCT00977431|474671577|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
131833328|NCT00977431|474671573|FG000|Overall Study|Progressive disease|2|||
131833329|NCT00977431|474671574|FG001|Overall Study|Progressive disease|6|||
131833330|NCT00977431|474671575|FG002|Overall Study|Progressive disease|1|||
131833331|NCT00977431|474671576|FG003|Overall Study|Progressive disease|3|||
131833332|NCT00977431|474671577|FG004|Overall Study|Progressive disease|5|||
131833333|NCT01010750|474671578|FG000|Second Intervention|Adverse Event|0|||
131833334|NCT01010750|474671579|FG001|Second Intervention|Adverse Event|1|||
131833335|NCT01010750|474671580|FG002|Second Intervention|Adverse Event|0|||
131833336|NCT01010750|474671581|FG003|Second Intervention|Adverse Event|0|||
131833337|NCT01010750|474671582|FG004|Second Intervention|Adverse Event|0|||
131910563|NCT02309359|474960799|FG002|Overall Study|Death|0|||
131910564|NCT02309359|474960800|FG003|Overall Study|Death|0|||
131910565|NCT02309359|474960801|FG004|Overall Study|Death|0|||
131910566|NCT02309359|474960797|FG000|Overall Study|Withdrawal by Subject|2|||
131833338|NCT01010750|474671583|FG005|Second Intervention|Adverse Event|0|||
131833339|NCT00720226|474671597|FG000|Overall Study|Withdrawal by Subject|7|||
131833340|NCT00720226|474671598|FG001|Overall Study|Withdrawal by Subject|4|||
131833341|NCT00958126|474671599|FG000|Overall Study|Serious Adverse Event|0|||
131833342|NCT00958126|474671600|FG001|Overall Study|Serious Adverse Event|2|||
131833343|NCT00958126|474671601|FG002|Overall Study|Serious Adverse Event|0|||
131833344|NCT00958126|474671602|FG003|Overall Study|Serious Adverse Event|0|||
131833345|NCT00958126|474671603|FG004|Overall Study|Serious Adverse Event|0|||
131833346|NCT00958126|474671604|FG005|Overall Study|Serious Adverse Event|0|||
131833347|NCT00958126|474671605|FG006|Overall Study|Serious Adverse Event|1|||
131833348|NCT00958126|474671606|FG007|Overall Study|Serious Adverse Event|0|||
131910567|NCT02309359|474960798|FG001|Overall Study|Withdrawal by Subject|2|||
131833349|NCT00958126|474671599|FG000|Overall Study|Withdrawal by Subject|0|||
131833350|NCT00958126|474671600|FG001|Overall Study|Withdrawal by Subject|2|||
131833351|NCT00958126|474671601|FG002|Overall Study|Withdrawal by Subject|0|||
131833352|NCT00958126|474671602|FG003|Overall Study|Withdrawal by Subject|0|||
131833353|NCT00958126|474671603|FG004|Overall Study|Withdrawal by Subject|0|||
131833354|NCT00958126|474671604|FG005|Overall Study|Withdrawal by Subject|0|||
131833355|NCT00958126|474671605|FG006|Overall Study|Withdrawal by Subject|0|||
131833356|NCT00958126|474671606|FG007|Overall Study|Withdrawal by Subject|0|||
131833357|NCT00958126|474671599|FG000|Overall Study|Moved away from study area|0|||
131833358|NCT00958126|474671600|FG001|Overall Study|Moved away from study area|0|||
131833359|NCT00958126|474671601|FG002|Overall Study|Moved away from study area|1|||
131833360|NCT00958126|474671602|FG003|Overall Study|Moved away from study area|1|||
131833361|NCT00958126|474671603|FG004|Overall Study|Moved away from study area|0|||
131833362|NCT00958126|474671604|FG005|Overall Study|Moved away from study area|0|||
131833363|NCT00958126|474671605|FG006|Overall Study|Moved away from study area|0|||
131833364|NCT00958126|474671606|FG007|Overall Study|Moved away from study area|0|||
131833365|NCT00958126|474671599|FG000|Overall Study|Lost to Follow-up|1|||
131833366|NCT00958126|474671600|FG001|Overall Study|Lost to Follow-up|5|||
131833367|NCT00958126|474671601|FG002|Overall Study|Lost to Follow-up|9|||
131833368|NCT00958126|474671602|FG003|Overall Study|Lost to Follow-up|8|||
131833369|NCT00958126|474671603|FG004|Overall Study|Lost to Follow-up|0|||
131833370|NCT00958126|474671604|FG005|Overall Study|Lost to Follow-up|0|||
131833371|NCT00958126|474671605|FG006|Overall Study|Lost to Follow-up|0|||
131833372|NCT00958126|474671606|FG007|Overall Study|Lost to Follow-up|0|||
131833373|NCT00958126|474671599|FG000|Overall Study|Sponsor/Investigator decision|0|||
131833374|NCT00958126|474671600|FG001|Overall Study|Sponsor/Investigator decision|0|||
131833375|NCT00958126|474671601|FG002|Overall Study|Sponsor/Investigator decision|0|||
131833376|NCT00958126|474671602|FG003|Overall Study|Sponsor/Investigator decision|1|||
131833377|NCT00958126|474671603|FG004|Overall Study|Sponsor/Investigator decision|0|||
131833378|NCT00958126|474671604|FG005|Overall Study|Sponsor/Investigator decision|0|||
131833379|NCT00958126|474671605|FG006|Overall Study|Sponsor/Investigator decision|0|||
131833380|NCT00958126|474671606|FG007|Overall Study|Sponsor/Investigator decision|0|||
131833381|NCT00958126|474671599|FG000|Overall Study|Other Reason|0|||
131833382|NCT00958126|474671600|FG001|Overall Study|Other Reason|0|||
131833383|NCT00958126|474671601|FG002|Overall Study|Other Reason|0|||
131833384|NCT00958126|474671602|FG003|Overall Study|Other Reason|1|||
131833385|NCT00958126|474671603|FG004|Overall Study|Other Reason|0|||
131833386|NCT00958126|474671604|FG005|Overall Study|Other Reason|1|||
131833387|NCT00958126|474671605|FG006|Overall Study|Other Reason|0|||
131833388|NCT00958126|474671606|FG007|Overall Study|Other Reason|0|||
131833389|NCT03401073|474671607|FG000|Overall Study|Lost to Follow-up|1|||
131833390|NCT03401073|474671608|FG001|Overall Study|Lost to Follow-up|2|||
131833391|NCT00733369|474671609|FG000|Overall Study|Lost to Follow-up|2|||
131833392|NCT00733369|474671610|FG001|Overall Study|Lost to Follow-up|1|||
131833393|NCT00733369|474671609|FG000|Overall Study|Adverse Event|4|||
131833394|NCT00733369|474671610|FG001|Overall Study|Adverse Event|4|||
131833395|NCT00733369|474671609|FG000|Overall Study|Protocol Violation|4|||
131833396|NCT00733369|474671610|FG001|Overall Study|Protocol Violation|4|||
131833397|NCT01470612|474671611|FG000|Overall Study|Adverse Event|20|||
131833398|NCT01470612|474671612|FG001|Overall Study|Adverse Event|80|||
131833399|NCT01470612|474671611|FG000|Overall Study|Death|0|||
131833400|NCT01470612|474671612|FG001|Overall Study|Death|1|||
131833401|NCT01470612|474671611|FG000|Overall Study|Lack of Efficacy|20|||
131833402|NCT01470612|474671612|FG001|Overall Study|Lack of Efficacy|326|||
131833403|NCT01470612|474671611|FG000|Overall Study|Lost to Follow-up|2|||
131833404|NCT01470612|474671612|FG001|Overall Study|Lost to Follow-up|5|||
131833405|NCT01470612|474671611|FG000|Overall Study|Did not meet entrance criteria|0|||
131910568|NCT02309359|474960799|FG002|Overall Study|Withdrawal by Subject|4|||
131910569|NCT02309359|474960800|FG003|Overall Study|Withdrawal by Subject|4|||
131910570|NCT02309359|474960801|FG004|Overall Study|Withdrawal by Subject|0|||
131910571|NCT02309359|474960797|FG000|Overall Study|Lack of Efficacy|3|||
131910572|NCT02309359|474960798|FG001|Overall Study|Lack of Efficacy|1|||
131910573|NCT02309359|474960799|FG002|Overall Study|Lack of Efficacy|0|||
131833406|NCT01470612|474671612|FG001|Overall Study|Did not meet entrance criteria|1|||
131833407|NCT01470612|474671611|FG000|Overall Study|Pregnancy|2|||
131833408|NCT01470612|474671612|FG001|Overall Study|Pregnancy|10|||
131833409|NCT01470612|474671611|FG000|Overall Study|Protocol Violation|2|||
131833410|NCT01470612|474671612|FG001|Overall Study|Protocol Violation|7|||
131833411|NCT01470612|474671611|FG000|Overall Study|Withdrawal by Subject|24|||
131833412|NCT01470612|474671612|FG001|Overall Study|Withdrawal by Subject|79|||
131833413|NCT01470612|474671611|FG000|Overall Study|Other|14|||
131833414|NCT01470612|474671612|FG001|Overall Study|Other|156|||
131833415|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
131833416|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
131833417|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
131833418|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
131910574|NCT02309359|474960800|FG003|Overall Study|Lack of Efficacy|0|||
131910575|NCT02309359|474960801|FG004|Overall Study|Lack of Efficacy|3|||
131833419|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
131833420|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
131833421|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
131833422|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
131833423|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
131833424|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
131833425|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
131833426|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
131833427|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
131833428|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
131833429|NCT02510014|474671613|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
131833430|NCT02510014|474671614|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
131833431|NCT02510014|474671613|FG000|Treatment Period|Adverse Event|11|||
131833432|NCT02510014|474671614|FG001|Treatment Period|Adverse Event|4|||
131833433|NCT02510014|474671613|FG000|Treatment Period|Withdrawal symptoms|3|||
131833434|NCT02510014|474671614|FG001|Treatment Period|Withdrawal symptoms|0|||
131833435|NCT02510014|474671613|FG000|Treatment Period|Lost to Follow-up|80|||
131833436|NCT02510014|474671614|FG001|Treatment Period|Lost to Follow-up|19|||
131833437|NCT02510014|474671613|FG000|Treatment Period|Physician Decision|5|||
131833438|NCT02510014|474671614|FG001|Treatment Period|Physician Decision|0|||
131833439|NCT02510014|474671613|FG000|Treatment Period|Withdrawal by Subject|67|||
131833440|NCT02510014|474671614|FG001|Treatment Period|Withdrawal by Subject|24|||
131833441|NCT02510014|474671613|FG000|Treatment Period|Withdrawn by the investigator|7|||
131833442|NCT02510014|474671614|FG001|Treatment Period|Withdrawn by the investigator|1|||
131833443|NCT02510014|474671613|FG000|Treatment Period|Protocol Violation|4|||
131833444|NCT02510014|474671614|FG001|Treatment Period|Protocol Violation|4|||
131833445|NCT02510014|474671613|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
131833446|NCT02510014|474671614|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
131833447|NCT00049842|474671618|FG000|Treatment Phase|Adverse Event|47|||
131833448|NCT00049842|474671619|FG001|Treatment Phase|Adverse Event|12|||
131833449|NCT00049842|474671618|FG000|Treatment Phase|Withdrawal by Subject|35|||
131833450|NCT00049842|474671619|FG001|Treatment Phase|Withdrawal by Subject|46|||
131833451|NCT00049842|474671618|FG000|Treatment Phase|Non-compliance with protocol|7|||
131833452|NCT00049842|474671619|FG001|Treatment Phase|Non-compliance with protocol|8|||
131833453|NCT00049842|474671618|FG000|Treatment Phase|Lost to Follow-up|4|||
131833454|NCT00049842|474671619|FG001|Treatment Phase|Lost to Follow-up|8|||
131833455|NCT00049842|474671618|FG000|Treatment Phase|Administrative|0|||
131833456|NCT00049842|474671619|FG001|Treatment Phase|Administrative|3|||
131833457|NCT00049842|474671618|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
131833458|NCT00049842|474671619|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
131833459|NCT00049842|474671618|FG000|Follow-up Phase|Adverse Event|6|||
131833460|NCT00049842|474671619|FG001|Follow-up Phase|Adverse Event|1|||
131833461|NCT00049842|474671618|FG000|Follow-up Phase|Other|1|||
131833462|NCT00049842|474671619|FG001|Follow-up Phase|Other|4|||
131833463|NCT00293202|474671620|FG000|Overall Study|Withdrawal by Subject|1|||
131833464|NCT00293202|474671621|FG001|Overall Study|Withdrawal by Subject|2|||
131833465|NCT00293202|474671620|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
131833466|NCT00293202|474671621|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
131833467|NCT00293202|474671620|FG000|Overall Study|on-hold due to fistula maturation time|1|||
131833468|NCT00293202|474671621|FG001|Overall Study|on-hold due to fistula maturation time|0|||
131833469|NCT01560507|474671622|FG000|Overall Study|Lost to Follow-up|3|||
131833470|NCT01560507|474671623|FG001|Overall Study|Lost to Follow-up|1|||
131833471|NCT01560507|474671624|FG002|Overall Study|Lost to Follow-up|2|||
131833472|NCT01560507|474671622|FG000|Overall Study|Withdrawal by Subject|1|||
131833473|NCT01560507|474671623|FG001|Overall Study|Withdrawal by Subject|1|||
131833474|NCT01560507|474671624|FG002|Overall Study|Withdrawal by Subject|0|||
131833475|NCT02080832|474671625|FG000|Overall Study|Excluded from analysis by MRI|9|||
131833476|NCT02080832|474671626|FG001|Overall Study|Excluded from analysis by MRI|10|||
131833477|NCT02080832|474671627|FG002|Overall Study|Excluded from analysis by MRI|14|||
131833478|NCT02080832|474671625|FG000|Overall Study|Lost to Follow-up|0|||
131833479|NCT02080832|474671626|FG001|Overall Study|Lost to Follow-up|2|||
131833480|NCT02080832|474671627|FG002|Overall Study|Lost to Follow-up|2|||
131833481|NCT03545191|474671628|FG000|Overall Study|Death|1|||
131833482|NCT03545191|474671629|FG001|Overall Study|Death|0|||
131833483|NCT03545191|474671630|FG002|Overall Study|Death|0|||
131833484|NCT03545191|474671628|FG000|Overall Study|Adverse Event|4|||
131833485|NCT03545191|474671629|FG001|Overall Study|Adverse Event|2|||
131833486|NCT03545191|474671630|FG002|Overall Study|Adverse Event|7|||
131833487|NCT03545191|474671628|FG000|Overall Study|Other reasons|3|||
131833488|NCT03545191|474671629|FG001|Overall Study|Other reasons|11|||
131833489|NCT03545191|474671630|FG002|Overall Study|Other reasons|8|||
131833490|NCT03545191|474671628|FG000|Overall Study|Withdrawal by Subject|13|||
131833491|NCT03545191|474671629|FG001|Overall Study|Withdrawal by Subject|10|||
131833492|NCT03545191|474671630|FG002|Overall Study|Withdrawal by Subject|12|||
131833493|NCT03545191|474671628|FG000|Overall Study|Lost to Follow-up|1|||
131833494|NCT03545191|474671629|FG001|Overall Study|Lost to Follow-up|2|||
131833495|NCT03545191|474671630|FG002|Overall Study|Lost to Follow-up|3|||
131833496|NCT02377063|474671634|FG000|Overall Study|Non-compliance|5|||
131833497|NCT00702208|474671635|FG000|Overall Study|Lost to Follow-up|28|||
131833498|NCT00702208|474671635|FG000|Overall Study|Did not self-lavage|1|||
131833499|NCT00702208|474671635|FG000|Overall Study|Unsatisfactory colposcopy|2|||
131833500|NCT02746627|474671636|FG000|Overall Study|Withdrawal by Subject|1|||
131833501|NCT02746627|474671637|FG001|Overall Study|Withdrawal by Subject|1|||
131833502|NCT02746627|474671638|FG002|Overall Study|Withdrawal by Subject|1|||
131833503|NCT02181296|474671639|FG000|Overall Study|Lost to Follow-up|7|||
131833504|NCT02181296|474671640|FG001|Overall Study|Lost to Follow-up|6|||
131833505|NCT02858726|474671643|FG000|Overall Study|Adverse Event|4|||
131833506|NCT02858726|474671644|FG001|Overall Study|Adverse Event|4|||
131833507|NCT02858726|474671645|FG002|Overall Study|Adverse Event|9|||
131833508|NCT02858726|474671646|FG003|Overall Study|Adverse Event|1|||
131833509|NCT02858726|474671643|FG000|Overall Study|Physician Decision|0|||
131833510|NCT02858726|474671644|FG001|Overall Study|Physician Decision|0|||
131833511|NCT02858726|474671645|FG002|Overall Study|Physician Decision|1|||
131833512|NCT02858726|474671646|FG003|Overall Study|Physician Decision|0|||
131833513|NCT02858726|474671643|FG000|Overall Study|Protocol Violation|0|||
131833514|NCT02858726|474671644|FG001|Overall Study|Protocol Violation|0|||
131833515|NCT02858726|474671645|FG002|Overall Study|Protocol Violation|0|||
131833516|NCT02858726|474671646|FG003|Overall Study|Protocol Violation|1|||
131833517|NCT02858726|474671643|FG000|Overall Study|Study Terminated by Sponsor|0|||
131833518|NCT02858726|474671644|FG001|Overall Study|Study Terminated by Sponsor|0|||
131833519|NCT02858726|474671645|FG002|Overall Study|Study Terminated by Sponsor|0|||
131833520|NCT02858726|474671646|FG003|Overall Study|Study Terminated by Sponsor|1|||
131833521|NCT02858726|474671643|FG000|Overall Study|Withdrawal by Subject|1|||
131833522|NCT02858726|474671644|FG001|Overall Study|Withdrawal by Subject|2|||
131833523|NCT02858726|474671645|FG002|Overall Study|Withdrawal by Subject|1|||
131833524|NCT02858726|474671646|FG003|Overall Study|Withdrawal by Subject|0|||
131833525|NCT02858726|474671643|FG000|Overall Study|Noncompliance|0|||
131833526|NCT02858726|474671644|FG001|Overall Study|Noncompliance|1|||
131833527|NCT02858726|474671645|FG002|Overall Study|Noncompliance|0|||
131833528|NCT02858726|474671646|FG003|Overall Study|Noncompliance|0|||
131833529|NCT01481324|474671650|FG000|Overall Study|Missing Data|0|||
131833530|NCT01481324|474671651|FG001|Overall Study|Missing Data|2|||
131833531|NCT01481324|474671652|FG002|Overall Study|Missing Data|2|||
131833532|NCT04459715|474671653|FG000|Overall Study|Adverse Event|3|||
131833533|NCT04459715|474671654|FG001|Overall Study|Adverse Event|3|||
131833534|NCT04459715|474671653|FG000|Overall Study|Death|111|||
131833535|NCT04459715|474671654|FG001|Overall Study|Death|93|||
131833536|NCT04459715|474671653|FG000|Overall Study|Lost to Follow-up|10|||
131833537|NCT04459715|474671654|FG001|Overall Study|Lost to Follow-up|9|||
131833538|NCT04459715|474671653|FG000|Overall Study|Other Reasons|4|||
131833539|NCT04459715|474671654|FG001|Overall Study|Other Reasons|5|||
131833540|NCT04459715|474671653|FG000|Overall Study|PROTOCOL DEVIATION|0|||
131833541|NCT04459715|474671654|FG001|Overall Study|PROTOCOL DEVIATION|1|||
131833542|NCT04459715|474671653|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
131833543|NCT04459715|474671654|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
131833544|NCT04459715|474671653|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
131833545|NCT04459715|474671654|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
131833546|NCT04459715|474671653|FG000|Overall Study|Withdrawal by Subject|22|||
131833547|NCT04459715|474671654|FG001|Overall Study|Withdrawal by Subject|22|||
131833548|NCT02427984|474671655|FG000|Overall Study|Lost to Follow-up|13|||
131833549|NCT02427984|474671656|FG001|Overall Study|Lost to Follow-up|5|||
131833550|NCT02427984|474671657|FG002|Overall Study|Lost to Follow-up|18|||
131833551|NCT04189445|474672787|FG000|Overall Study|Withdrawal of consent|8|||
131401807|NCT03831191|473091582|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131833552|NCT04189445|474672788|FG001|Overall Study|Withdrawal of consent|1|||
131833553|NCT04189445|474672789|FG002|Overall Study|Withdrawal of consent|0|||
131401808|NCT03831191|473091583|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131833554|NCT04189445|474672787|FG000|Overall Study|Study Terminated by Sponsor|25|||
131401809|NCT03831191|473091584|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131833555|NCT04189445|474672788|FG001|Overall Study|Study Terminated by Sponsor|3|||
131833556|NCT04189445|474672789|FG002|Overall Study|Study Terminated by Sponsor|0|||
131833557|NCT04189445|474672787|FG000|Overall Study|Death|54|||
131833558|NCT04189445|474672788|FG001|Overall Study|Death|24|||
131833559|NCT04189445|474672789|FG002|Overall Study|Death|0|||
131833560|NCT03959527|474672790|FG000|Overall Study|Withdrawal by Subject|8|||
131833561|NCT03959527|474672791|FG001|Overall Study|Withdrawal by Subject|3|||
131833562|NCT03959527|474672790|FG000|Overall Study|Lost to Follow-up|31|||
131833563|NCT03959527|474672791|FG001|Overall Study|Lost to Follow-up|15|||
131401810|NCT03831191|473091585|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
131833564|NCT03959527|474672790|FG000|Overall Study|Did not meet eligibility criteria|1|||
131833565|NCT03959527|474672791|FG001|Overall Study|Did not meet eligibility criteria|1|||
131833566|NCT03959527|474672790|FG000|Overall Study|Protocol Violation|10|||
131833567|NCT03959527|474672791|FG001|Overall Study|Protocol Violation|5|||
131910576|NCT02309359|474960797|FG000|Overall Study|Lost to Follow-up|0|||
131401811|NCT02300558|473091586|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
131401812|NCT02300558|473091586|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
131401813|NCT02300558|473091586|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
131401814|NCT02300558|473091586|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
131401815|NCT01054560|473091589|FG000|Overall Study|Death|10|||
131401816|NCT01054560|473091590|FG001|Overall Study|Death|21|||
131833568|NCT01688466|474672792|FG000|Overall Study|Withdrawal by Subject|2|||
131401817|NCT01054560|473091589|FG000|Overall Study|Lost to Follow-up|2|||
131401818|NCT01054560|473091590|FG001|Overall Study|Lost to Follow-up|5|||
131401819|NCT01054560|473091589|FG000|Overall Study|Withdrawal by Subject|0|||
131401820|NCT01054560|473091590|FG001|Overall Study|Withdrawal by Subject|2|||
131401821|NCT01054560|473091589|FG000|Overall Study|Physician Decision|1|||
131401822|NCT01054560|473091590|FG001|Overall Study|Physician Decision|0|||
131401823|NCT01106651|473091591|FG000|Overall Study|Adverse Event|17|||
131401824|NCT01106651|473091592|FG001|Overall Study|Adverse Event|9|||
131401825|NCT01106651|473091593|FG002|Overall Study|Adverse Event|23|||
131401826|NCT01106651|473091591|FG000|Overall Study|Lost to Follow-up|8|||
131401827|NCT01106651|473091592|FG001|Overall Study|Lost to Follow-up|2|||
131401828|NCT01106651|473091593|FG002|Overall Study|Lost to Follow-up|6|||
131401829|NCT01106651|473091591|FG000|Overall Study|Physician Decision|4|||
131401830|NCT01106651|473091592|FG001|Overall Study|Physician Decision|3|||
131401831|NCT01106651|473091593|FG002|Overall Study|Physician Decision|1|||
131401832|NCT01106651|473091591|FG000|Overall Study|Protocol Violation|1|||
131401833|NCT01106651|473091592|FG001|Overall Study|Protocol Violation|2|||
131401834|NCT01106651|473091593|FG002|Overall Study|Protocol Violation|1|||
131401835|NCT01106651|473091591|FG000|Overall Study|Withdrawal by Subject|14|||
131401836|NCT01106651|473091592|FG001|Overall Study|Withdrawal by Subject|7|||
131401837|NCT01106651|473091593|FG002|Overall Study|Withdrawal by Subject|4|||
131401838|NCT01106651|473091591|FG000|Overall Study|Noncompliance with study drug|1|||
131401839|NCT01106651|473091592|FG001|Overall Study|Noncompliance with study drug|0|||
131401840|NCT01106651|473091593|FG002|Overall Study|Noncompliance with study drug|2|||
131401841|NCT01106651|473091591|FG000|Overall Study|Other|34|||
131833569|NCT01688466|474672793|FG001|Overall Study|Withdrawal by Subject|1|||
131833570|NCT01688466|474672792|FG000|Overall Study|Death|0|||
131833571|NCT01688466|474672793|FG001|Overall Study|Death|1|||
131833572|NCT01688466|474672792|FG000|Overall Study|Adverse Event|0|||
131833573|NCT01688466|474672793|FG001|Overall Study|Adverse Event|4|||
131833574|NCT01688466|474672792|FG000|Overall Study|Not evaluable|0|||
131833575|NCT01688466|474672793|FG001|Overall Study|Not evaluable|1|||
131833576|NCT06029959|474672794|FG000|Overall Study|Physician Decision|6|||
131833577|NCT02631876|474672799|FG000|Overall Study|Death|96|||
131833578|NCT02631876|474672800|FG001|Overall Study|Death|50|||
131833579|NCT02631876|474672799|FG000|Overall Study|Investigator's discretion|1|||
131833580|NCT02631876|474672800|FG001|Overall Study|Investigator's discretion|0|||
131833581|NCT02631876|474672799|FG000|Overall Study|Lost to Follow-up|2|||
131833582|NCT02631876|474672800|FG001|Overall Study|Lost to Follow-up|0|||
131833583|NCT02631876|474672799|FG000|Overall Study|Withdrawal by Subject|16|||
131833584|NCT02631876|474672800|FG001|Overall Study|Withdrawal by Subject|9|||
131833585|NCT02631876|474672799|FG000|Overall Study|Other than specified|4|||
131833586|NCT02631876|474672800|FG001|Overall Study|Other than specified|4|||
131833587|NCT01013649|474672803|FG000|First Step|Withdrawal by Subject|36|||
131833588|NCT01013649|474672804|FG001|First Step|Withdrawal by Subject|19|||
131833589|NCT01013649|474672805|FG002|First Step|Withdrawal by Subject|0|||
131833590|NCT01013649|474672806|FG003|First Step|Withdrawal by Subject|0|||
131833591|NCT01013649|474672803|FG000|First Step|Progression|58|||
131833592|NCT01013649|474672804|FG001|First Step|Progression|23|||
131833593|NCT01013649|474672805|FG002|First Step|Progression|0|||
131833594|NCT01013649|474672806|FG003|First Step|Progression|0|||
131833595|NCT01013649|474672803|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
131833596|NCT01013649|474672804|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
131833597|NCT01013649|474672805|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
131833598|NCT01013649|474672806|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
131401842|NCT01106651|473091592|FG001|Overall Study|Other|31|||
131401843|NCT01106651|473091593|FG002|Overall Study|Other|21|||
131401844|NCT01106651|473091591|FG000|Overall Study|Death|0|||
131833599|NCT01013649|474672803|FG000|First Step|Death|3|||
131833600|NCT01013649|474672804|FG001|First Step|Death|4|||
131833601|NCT01013649|474672805|FG002|First Step|Death|0|||
131833602|NCT01013649|474672806|FG003|First Step|Death|0|||
131833603|NCT01013649|474672803|FG000|First Step|Adverse Event|9|||
131833604|NCT01013649|474672804|FG001|First Step|Adverse Event|5|||
131833605|NCT01013649|474672805|FG002|First Step|Adverse Event|0|||
131833606|NCT01013649|474672806|FG003|First Step|Adverse Event|0|||
131401845|NCT01106651|473091592|FG001|Overall Study|Death|3|||
131401846|NCT01106651|473091593|FG002|Overall Study|Death|0|||
131401847|NCT02135029|473091597|FG000|Overall Study|Adverse Event|2|||
131401848|NCT02135029|473091598|FG001|Overall Study|Adverse Event|2|||
131833607|NCT01013649|474672803|FG000|First Step|Other|4|||
131833608|NCT01013649|474672804|FG001|First Step|Other|6|||
131833609|NCT01013649|474672805|FG002|First Step|Other|0|||
131833610|NCT01013649|474672806|FG003|First Step|Other|0|||
131833611|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
131833612|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
131833613|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
131833614|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
131833615|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
131833616|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
131833617|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
131833618|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
131833619|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
131833620|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
131833621|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
131833622|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
131833623|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
131833624|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
131833625|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
131833626|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
131833627|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
131833628|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
131833629|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
131833630|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
131833631|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
131833632|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
131833633|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
131833634|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
131833635|NCT01421342|474672813|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
131833636|NCT01421342|474672814|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
131833637|NCT01421342|474672815|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
131833638|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
131833639|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
131833640|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
131833641|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
131833642|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
131833643|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
131833644|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
131833645|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
131833646|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
131833647|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
131833648|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
131833649|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
131833650|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
131833651|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
131833652|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
131833653|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
131833654|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
131833655|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
131833656|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
131833657|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
131833658|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
131833659|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
131833660|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
131833661|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
131833662|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
131833663|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
131833664|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
131833665|NCT01421342|474672813|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
131833666|NCT01421342|474672814|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
131833667|NCT01421342|474672815|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
131833668|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
131833669|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
131833670|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
131833671|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
131833672|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
131833673|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
131833674|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
131910577|NCT02309359|474960798|FG001|Overall Study|Lost to Follow-up|0|||
131833675|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
131833676|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
131833677|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
131833678|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
131833679|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
131833680|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
131833681|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
131833682|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
131833683|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
131833684|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
131833685|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
131833686|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
131833687|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
131833688|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
131833689|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
131833690|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
131833691|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
131833692|NCT01421342|474672813|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
131833693|NCT01421342|474672814|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
131833694|NCT01421342|474672815|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
131833695|NCT00468728|474672818|FG000|Treatment|criteria for mITT population|4|||
131833696|NCT00468728|474672819|FG001|Treatment|criteria for mITT population|11|||
131833697|NCT00468728|474672818|FG000|Follow-up|mITT failure|34|||
131833698|NCT00468728|474672819|FG001|Follow-up|mITT failure|31|||
131833699|NCT03463993|474672821|FG000|Overall Study|Lost to Follow-up|7|||
131833700|NCT03463993|474672822|FG001|Overall Study|Lost to Follow-up|8|||
131833701|NCT03463993|474672821|FG000|Overall Study|Withdrawal by Subject|2|||
131833702|NCT03463993|474672822|FG001|Overall Study|Withdrawal by Subject|0|||
131833703|NCT03463993|474672821|FG000|Overall Study|Protocol Violation|4|||
131833704|NCT03463993|474672822|FG001|Overall Study|Protocol Violation|1|||
131401849|NCT02135029|473091599|FG002|Overall Study|Adverse Event|2|||
131833705|NCT03463993|474672821|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
131833706|NCT03463993|474672822|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
131833707|NCT03463993|474672821|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
131833708|NCT03463993|474672822|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
131833709|NCT01478828|474672824|FG000|Overall Study|Adverse Event|1|||
131833710|NCT05611996|474672825|FG000|Overall Study|Ineligible|1|||
131833711|NCT05611996|474672825|FG000|Overall Study|Withdrawal by Subject|9|||
131833712|NCT05560763|474672826|FG000|Overall Study|Withdrawal by Subject|4|||
131833713|NCT03604341|474672827|FG000|Overall Study|Withdrawal by Subject|1|||
131833714|NCT03604341|474672828|FG001|Overall Study|Withdrawal by Subject|1|||
131833715|NCT03604341|474672827|FG000|Overall Study|Adverse Event|1|||
131833716|NCT03604341|474672828|FG001|Overall Study|Adverse Event|0|||
131833717|NCT03604341|474672827|FG000|Overall Study|Protocol Violation|0|||
131833718|NCT03604341|474672828|FG001|Overall Study|Protocol Violation|1|||
131833719|NCT03856593|474672834|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
131833720|NCT03856593|474672835|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
131833721|NCT01949116|474672837|FG000|Overall Study|Death|2|||
131833722|NCT01949116|474672838|FG001|Overall Study|Death|0|||
131833723|NCT01949116|474672837|FG000|Overall Study|Lost to Follow-up|1|||
131833724|NCT01949116|474672838|FG001|Overall Study|Lost to Follow-up|3|||
131833725|NCT01949116|474672837|FG000|Overall Study|Withdrawal by Subject|5|||
131833726|NCT01949116|474672838|FG001|Overall Study|Withdrawal by Subject|3|||
131833727|NCT02556307|474672839|FG000|Overall Study|Premature treatment interruption|11|||
131833728|NCT02556307|474672839|FG000|Overall Study|Lost to Follow-up|36|||
131833729|NCT02556307|474672839|FG000|Overall Study|Change to triple therapy|4|||
131833730|NCT02556307|474672839|FG000|Overall Study|Enrolled but not treated|2|||
131833731|NCT01564459|474672845|FG000|Run-In|Adverse Event|7|||
131833732|NCT01564459|474672846|FG001|Run-In|Adverse Event|0|||
131833733|NCT01564459|474672847|FG002|Run-In|Adverse Event|0|||
131833734|NCT01564459|474672845|FG000|Run-In|Lost to Follow-up|1|||
131401850|NCT02135029|473091597|FG000|Overall Study|Lost to Follow-up|0|||
131401851|NCT02135029|473091598|FG001|Overall Study|Lost to Follow-up|1|||
131833735|NCT01564459|474672846|FG001|Run-In|Lost to Follow-up|0|||
131833736|NCT01564459|474672847|FG002|Run-In|Lost to Follow-up|0|||
131833737|NCT01564459|474672845|FG000|Run-In|Non-compliance with study drug|2|||
131833738|NCT01564459|474672846|FG001|Run-In|Non-compliance with study drug|0|||
131833739|NCT01564459|474672847|FG002|Run-In|Non-compliance with study drug|0|||
131833740|NCT01564459|474672845|FG000|Run-In|Protocol Violation|1|||
131833741|NCT01564459|474672846|FG001|Run-In|Protocol Violation|0|||
131401852|NCT02135029|473091599|FG002|Overall Study|Lost to Follow-up|0|||
131833742|NCT01564459|474672847|FG002|Run-In|Protocol Violation|0|||
131833743|NCT01564459|474672845|FG000|Run-In|Withdrawal by Subject|1|||
131833744|NCT01564459|474672846|FG001|Run-In|Withdrawal by Subject|0|||
131833745|NCT01564459|474672847|FG002|Run-In|Withdrawal by Subject|0|||
131833746|NCT01564459|474672845|FG000|Double-blind Treatment|Adverse Event|0|||
131833747|NCT01564459|474672846|FG001|Double-blind Treatment|Adverse Event|0|||
131833748|NCT01564459|474672847|FG002|Double-blind Treatment|Adverse Event|1|||
131833749|NCT01138111|474672851|FG000|Overall Study|Withdrawal by Subject|5|||
131833750|NCT01138111|474672851|FG000|Overall Study|Adverse Event|1|||
131833751|NCT01138111|474672851|FG000|Overall Study|Death|1|||
131833752|NCT01138111|474672851|FG000|Overall Study|Lost to Follow-up|2|||
131833753|NCT00706992|474672852|FG000|Overall Study|Study termination|5|||
131833754|NCT00706992|474672853|FG001|Overall Study|Study termination|5|||
131833755|NCT00706992|474672854|FG002|Overall Study|Study termination|6|||
131833756|NCT00706992|474672855|FG003|Overall Study|Study termination|2|||
131833757|NCT00706992|474672856|FG004|Overall Study|Study termination|3|||
131833758|NCT00706992|474672857|FG005|Overall Study|Study termination|2|||
131833759|NCT00706992|474672858|FG006|Overall Study|Study termination|3|||
131833760|NCT00706992|474672852|FG000|Overall Study|Disease progression before treatment|0|||
131833761|NCT00706992|474672853|FG001|Overall Study|Disease progression before treatment|0|||
131833762|NCT00706992|474672854|FG002|Overall Study|Disease progression before treatment|0|||
131833763|NCT00706992|474672855|FG003|Overall Study|Disease progression before treatment|0|||
131833764|NCT00706992|474672856|FG004|Overall Study|Disease progression before treatment|1|||
131833765|NCT00706992|474672857|FG005|Overall Study|Disease progression before treatment|0|||
131833766|NCT00706992|474672858|FG006|Overall Study|Disease progression before treatment|0|||
131833767|NCT01491035|474672859|FG000|Overall Study|Lost to Follow-up|0|||
131833768|NCT01491035|474672860|FG001|Overall Study|Lost to Follow-up|0|||
131833769|NCT01491035|474672861|FG002|Overall Study|Lost to Follow-up|0|||
131833770|NCT01491035|474672862|FG003|Overall Study|Lost to Follow-up|0|||
131833771|NCT01491035|474672863|FG004|Overall Study|Lost to Follow-up|1|||
131833772|NCT01491035|474672864|FG005|Overall Study|Lost to Follow-up|0|||
131833773|NCT01491035|474672865|FG006|Overall Study|Lost to Follow-up|0|||
131833774|NCT01491035|474672866|FG007|Overall Study|Lost to Follow-up|0|||
131833775|NCT02999477|474672874|FG000|Overall Study|found ineligible after first dose|0|||
131833776|NCT02999477|474672875|FG001|Overall Study|found ineligible after first dose|1|||
131833777|NCT02999477|474672874|FG000|Overall Study|Withdrawal by Subject|1|||
131833778|NCT02999477|474672875|FG001|Overall Study|Withdrawal by Subject|1|||
131833779|NCT02960893|474674591|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
131833780|NCT02960893|474674592|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
131833781|NCT02960893|474674593|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
131833782|NCT02960893|474674594|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
131833783|NCT02960893|474674591|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
131833784|NCT02960893|474674592|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
131833785|NCT02960893|474674593|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
131833786|NCT02960893|474674594|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
131833787|NCT02960893|474674591|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
131833788|NCT02960893|474674592|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
131833789|NCT02960893|474674593|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
131833790|NCT02960893|474674594|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
131833791|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
131833792|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
131833793|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
131833794|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
131833795|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
131833796|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
131833797|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
131833798|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
131833799|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
131833800|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
131833801|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
131833802|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
131833803|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
131833804|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
131833805|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
131833806|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
131833807|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
131833808|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
131833809|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
131833810|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
131833811|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
131833812|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
131833813|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
131833814|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
131833815|NCT02960893|474674591|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
131833816|NCT02960893|474674592|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
131833817|NCT02960893|474674593|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
131833818|NCT02960893|474674594|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
131833819|NCT04285567|474674595|FG000|Overall Study|Death|3|||
131833820|NCT04285567|474674596|FG001|Overall Study|Death|3|||
131833821|NCT04285567|474674595|FG000|Overall Study|Lost to Follow-up|1|||
131833822|NCT04285567|474674596|FG001|Overall Study|Lost to Follow-up|1|||
131833823|NCT04285567|474674595|FG000|Overall Study|Reason Not Specified|1|||
131833824|NCT04285567|474674596|FG001|Overall Study|Reason Not Specified|1|||
131833825|NCT04285567|474674595|FG000|Overall Study|Physician Decision|2|||
131833826|NCT04285567|474674596|FG001|Overall Study|Physician Decision|1|||
131833827|NCT04285567|474674595|FG000|Overall Study|Withdrawal by Subject|2|||
131833828|NCT04285567|474674596|FG001|Overall Study|Withdrawal by Subject|6|||
131833829|NCT04285567|474674595|FG000|Overall Study|Adverse Event|1|||
131833830|NCT04285567|474674596|FG001|Overall Study|Adverse Event|0|||
131833831|NCT04285567|474674595|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
131833832|NCT04285567|474674596|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
131833833|NCT01408563|474674601|FG000|Overall Study|Ineligible after consent/ registration|2|||
131833834|NCT00380692|474674602|FG000|Study Period II - Double Blind|Adverse Event|1|||
131833835|NCT00380692|474674603|FG001|Study Period II - Double Blind|Adverse Event|0|||
131833836|NCT00380692|474674602|FG000|Study Period II - Double Blind|Protocol Violation|2|||
131833837|NCT00380692|474674603|FG001|Study Period II - Double Blind|Protocol Violation|2|||
131833838|NCT00380692|474674602|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
131833839|NCT00380692|474674603|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
131833840|NCT00380692|474674602|FG000|Study Period II - Double Blind|Physician Decision|0|||
131833841|NCT00380692|474674603|FG001|Study Period II - Double Blind|Physician Decision|1|||
131833842|NCT00380692|474674602|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
131833843|NCT00380692|474674603|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
131833844|NCT00380692|474674602|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
131833845|NCT00380692|474674603|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
131833846|NCT00380692|474674602|FG000|Study Period III - Open Label|Adverse Event|5|||
131833847|NCT00380692|474674603|FG001|Study Period III - Open Label|Adverse Event|3|||
131833848|NCT00380692|474674602|FG000|Study Period III - Open Label|Protocol Violation|0|||
131833849|NCT00380692|474674603|FG001|Study Period III - Open Label|Protocol Violation|0|||
131833850|NCT00380692|474674602|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
131833851|NCT00380692|474674603|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
131833852|NCT00380692|474674602|FG000|Study Period III - Open Label|Physician Decision|0|||
131833853|NCT00380692|474674603|FG001|Study Period III - Open Label|Physician Decision|3|||
131833854|NCT00380692|474674602|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
131833855|NCT00380692|474674603|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
131833856|NCT00380692|474674602|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
131833857|NCT00380692|474674603|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
131833858|NCT03197558|474674606|FG000|Overall Study|Tubes not placed|1|||
131833859|NCT04132336|474674607|FG000|Overall Study|Investigator Decision|0|||
131833860|NCT04132336|474674608|FG001|Overall Study|Investigator Decision|1|||
131833861|NCT04132336|474674609|FG002|Overall Study|Investigator Decision|0|||
131833862|NCT04132336|474674610|FG003|Overall Study|Investigator Decision|0|||
131833863|NCT04132336|474674611|FG004|Overall Study|Investigator Decision|0|||
131833864|NCT04132336|474674612|FG005|Overall Study|Investigator Decision|0|||
131833865|NCT04132336|474674613|FG006|Overall Study|Investigator Decision|0|||
131833866|NCT00584844|474674614|FG000|Overall Study|Withdrawal by Subject|59|||
131833867|NCT00584844|474674614|FG000|Overall Study|Screen Failure|20|||
131833868|NCT01939496|474674615|FG000|Overall Study|Adverse Event|2|||
131833869|NCT01939496|474674616|FG001|Overall Study|Adverse Event|0|||
131833870|NCT01939496|474674617|FG002|Overall Study|Adverse Event|0|||
131833871|NCT01939496|474674615|FG000|Overall Study|Lost to Follow-up|1|||
131833872|NCT01939496|474674616|FG001|Overall Study|Lost to Follow-up|1|||
131833873|NCT01939496|474674617|FG002|Overall Study|Lost to Follow-up|0|||
131833874|NCT01939496|474674615|FG000|Overall Study|Physician Decision|1|||
131833875|NCT01939496|474674616|FG001|Overall Study|Physician Decision|0|||
131833876|NCT01939496|474674617|FG002|Overall Study|Physician Decision|0|||
131833877|NCT01939496|474674615|FG000|Overall Study|Protocol Violation|3|||
131833878|NCT01939496|474674616|FG001|Overall Study|Protocol Violation|0|||
131833879|NCT01939496|474674617|FG002|Overall Study|Protocol Violation|0|||
131833880|NCT01939496|474674615|FG000|Overall Study|Withdrawal by Subject|0|||
131833881|NCT01939496|474674616|FG001|Overall Study|Withdrawal by Subject|1|||
131833882|NCT01939496|474674617|FG002|Overall Study|Withdrawal by Subject|1|||
131833883|NCT01939496|474674615|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
131833884|NCT01939496|474674616|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
131833885|NCT01939496|474674617|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
131401853|NCT02135029|473091597|FG000|Overall Study|Withdrawal by Subject|2|||
131401854|NCT02135029|473091598|FG001|Overall Study|Withdrawal by Subject|0|||
131401855|NCT02135029|473091599|FG002|Overall Study|Withdrawal by Subject|1|||
131833886|NCT01939496|474674615|FG000|Overall Study|Other|2|||
131833887|NCT01939496|474674616|FG001|Overall Study|Other|0|||
131833888|NCT01939496|474674617|FG002|Overall Study|Other|1|||
131833889|NCT03052322|474674618|FG000|Overall Study|Other un-specified|1|||
131833890|NCT03052322|474674619|FG001|Overall Study|Other un-specified|2|||
131833891|NCT03052322|474674618|FG000|Overall Study|Withdrawal by Subject|10|||
131833892|NCT03052322|474674619|FG001|Overall Study|Withdrawal by Subject|9|||
131833893|NCT03052322|474674618|FG000|Overall Study|Death|0|||
131833894|NCT03052322|474674619|FG001|Overall Study|Death|2|||
131833895|NCT03052322|474674618|FG000|Overall Study|Lack of Efficacy|1|||
131833896|NCT03052322|474674619|FG001|Overall Study|Lack of Efficacy|2|||
131833897|NCT03052322|474674618|FG000|Overall Study|Protocol Violation|1|||
131833898|NCT03052322|474674619|FG001|Overall Study|Protocol Violation|0|||
131833899|NCT03052322|474674618|FG000|Overall Study|Lost to Follow-up|2|||
131833900|NCT03052322|474674619|FG001|Overall Study|Lost to Follow-up|4|||
131833901|NCT03052322|474674618|FG000|Overall Study|Adverse Event|6|||
131833902|NCT03052322|474674619|FG001|Overall Study|Adverse Event|13|||
131833903|NCT04920916|474674620|FG000|Phase IIa 60 Day Study|Death|2|||
131833904|NCT04920916|474674621|FG001|Phase IIa 60 Day Study|Death|5|||
131833905|NCT04920916|474674620|FG000|1 Year Follow up (Phone Call)|Death|1|||
131833906|NCT04920916|474674621|FG001|1 Year Follow up (Phone Call)|Death|3|||
131833907|NCT04920916|474674620|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
131833908|NCT04920916|474674621|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
131833909|NCT01892657|474674624|FG000|Overall Study|Withdrawal by Subject|6|||
131833910|NCT01892657|474674624|FG000|Overall Study|Protocol Violation|12|||
131833911|NCT02712333|474674625|FG000|First Period|Withdrawal by Subject|3|||
131833912|NCT02712333|474674626|FG001|First Period|Withdrawal by Subject|2|||
131833913|NCT03228537|474674627|FG000|Neoadjuvant|Adverse Event|2|||
131833914|NCT03228537|474674627|FG000|Neoadjuvant|Progression/Relapse|4|||
131833915|NCT03228537|474674627|FG000|Neoadjuvant|Death|1|||
131833916|NCT03228537|474674627|FG000|Surgery|Death|1|||
131833917|NCT03228537|474674627|FG000|Surgery|Other - Not Protocol Specified|2|||
131833918|NCT03228537|474674627|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
131833919|NCT03228537|474674627|FG000|Maintenance|Progression/Relapse|10|||
131833920|NCT00136318|474674628|FG000|Overall Study|Adverse Event|5|||
131833921|NCT00136318|474674629|FG001|Overall Study|Adverse Event|5|||
131833922|NCT00136318|474674628|FG000|Overall Study|Withdrawal by Subject|2|||
131833923|NCT00136318|474674629|FG001|Overall Study|Withdrawal by Subject|2|||
131833924|NCT04572243|474674632|FG000|Core Study: 14 Weeks|Adverse Event|1|||
131833925|NCT04572243|474674633|FG001|Core Study: 14 Weeks|Adverse Event|2|||
131833926|NCT04572243|474674634|FG002|Core Study: 14 Weeks|Adverse Event|0|||
131833927|NCT04572243|474674635|FG003|Core Study: 14 Weeks|Adverse Event|0|||
131833928|NCT04572243|474674632|FG000|Core Study: 14 Weeks|Subject choice|0|||
131833929|NCT04572243|474674633|FG001|Core Study: 14 Weeks|Subject choice|2|||
131833930|NCT04572243|474674634|FG002|Core Study: 14 Weeks|Subject choice|0|||
131833931|NCT04572243|474674635|FG003|Core Study: 14 Weeks|Subject choice|0|||
131833932|NCT04572243|474674632|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
131833933|NCT04572243|474674633|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
131833934|NCT04572243|474674634|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
131833935|NCT04572243|474674635|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
131833936|NCT04572243|474674632|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
131833937|NCT04572243|474674633|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
131833938|NCT04572243|474674634|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
131833939|NCT04572243|474674635|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
131833940|NCT02278718|474674636|FG000|Overall Study|Adverse Event|1|||
131833941|NCT02278718|474674637|FG001|Overall Study|Adverse Event|0|||
131833942|NCT02278718|474674636|FG000|Overall Study|Lost to Follow-up|2|||
131833943|NCT02278718|474674637|FG001|Overall Study|Lost to Follow-up|4|||
131833944|NCT02278718|474674636|FG000|Overall Study|Withdrawal by Subject|1|||
131833945|NCT02278718|474674637|FG001|Overall Study|Withdrawal by Subject|4|||
131401856|NCT02135029|473091597|FG000|Overall Study|Other|0|||
131833946|NCT02278718|474674636|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
131401857|NCT02135029|473091598|FG001|Overall Study|Other|1|||
131833947|NCT02278718|474674637|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
131833948|NCT02278718|474674636|FG000|Overall Study|Missing|0|||
131833949|NCT02278718|474674637|FG001|Overall Study|Missing|1|||
131833950|NCT04440449|474674638|FG000|Overall Study|Lost to Follow-up|2|||
131833951|NCT04440449|474674639|FG001|Overall Study|Lost to Follow-up|0|||
131833952|NCT01763918|474674640|FG000|Overall Study|Withdrawal by Subject|2|||
131833953|NCT01763918|474674641|FG001|Overall Study|Withdrawal by Subject|1|||
131833954|NCT01763918|474674642|FG002|Overall Study|Withdrawal by Subject|1|||
131401858|NCT02135029|473091599|FG002|Overall Study|Other|0|||
131401859|NCT02135029|473091597|FG000|Overall Study|Death|0|||
131833955|NCT01763918|474674643|FG003|Overall Study|Withdrawal by Subject|2|||
131401860|NCT02135029|473091598|FG001|Overall Study|Death|1|||
131833956|NCT01763918|474674640|FG000|Overall Study|Sponsor Decision|4|||
131833957|NCT01763918|474674641|FG001|Overall Study|Sponsor Decision|0|||
131833958|NCT01763918|474674642|FG002|Overall Study|Sponsor Decision|9|||
131833959|NCT01763918|474674643|FG003|Overall Study|Sponsor Decision|0|||
131833960|NCT00897949|474674644|FG000|Overall Study|Adverse Event|1|||
131833961|NCT00897949|474674645|FG001|Overall Study|Adverse Event|1|||
131833962|NCT00897949|474674646|FG002|Overall Study|Adverse Event|0|||
131833963|NCT00897949|474674644|FG000|Overall Study|Lost to Follow-up|0|||
131833964|NCT00897949|474674645|FG001|Overall Study|Lost to Follow-up|2|||
131833965|NCT00897949|474674646|FG002|Overall Study|Lost to Follow-up|1|||
131833966|NCT00897949|474674644|FG000|Overall Study|Protocol Violation|6|||
131833967|NCT00897949|474674645|FG001|Overall Study|Protocol Violation|3|||
131833968|NCT00897949|474674646|FG002|Overall Study|Protocol Violation|1|||
131833969|NCT00897949|474674644|FG000|Overall Study|Withdrawal by Subject|1|||
131833970|NCT00897949|474674645|FG001|Overall Study|Withdrawal by Subject|2|||
131833971|NCT00897949|474674646|FG002|Overall Study|Withdrawal by Subject|0|||
131833972|NCT00897949|474674644|FG000|Overall Study|Patient Uncoorperative|0|||
131833973|NCT00897949|474674645|FG001|Overall Study|Patient Uncoorperative|2|||
131833974|NCT00897949|474674646|FG002|Overall Study|Patient Uncoorperative|1|||
131833975|NCT00897949|474674644|FG000|Overall Study|Lost to Follow-up|30|||
131833976|NCT00897949|474674645|FG001|Overall Study|Lost to Follow-up|23|||
131833977|NCT00897949|474674646|FG002|Overall Study|Lost to Follow-up|17|||
131833978|NCT00897949|474674644|FG000|Overall Study|Withdrawal by Subject|24|||
131833979|NCT00897949|474674645|FG001|Overall Study|Withdrawal by Subject|31|||
131833980|NCT00897949|474674646|FG002|Overall Study|Withdrawal by Subject|17|||
131833981|NCT00897949|474674644|FG000|Overall Study|Abnormal Prestudy Labs|2|||
131833982|NCT00897949|474674645|FG001|Overall Study|Abnormal Prestudy Labs|3|||
131833983|NCT00897949|474674646|FG002|Overall Study|Abnormal Prestudy Labs|4|||
131833984|NCT00897949|474674644|FG000|Overall Study|Abnormal Baseline ECG|2|||
131833985|NCT00897949|474674645|FG001|Overall Study|Abnormal Baseline ECG|2|||
131833986|NCT00897949|474674646|FG002|Overall Study|Abnormal Baseline ECG|4|||
131833987|NCT00897949|474674644|FG000|Overall Study|Need for Concom. Med.|0|||
131833988|NCT00897949|474674645|FG001|Overall Study|Need for Concom. Med.|1|||
131833989|NCT00897949|474674646|FG002|Overall Study|Need for Concom. Med.|1|||
131833990|NCT00897949|474674644|FG000|Overall Study|Lack of Migraine Attack|29|||
131833991|NCT00897949|474674645|FG001|Overall Study|Lack of Migraine Attack|30|||
131833992|NCT00897949|474674646|FG002|Overall Study|Lack of Migraine Attack|19|||
131833993|NCT00897949|474674644|FG000|Overall Study|Did not take study drug|9|||
131833994|NCT00897949|474674645|FG001|Overall Study|Did not take study drug|3|||
131833995|NCT00897949|474674646|FG002|Overall Study|Did not take study drug|4|||
131833996|NCT01553747|474674647|FG000|Overall Study|Protocol Violation|0|||
131833997|NCT01553747|474674648|FG001|Overall Study|Protocol Violation|2|||
131833998|NCT01553747|474674649|FG002|Overall Study|Protocol Violation|0|||
131833999|NCT01553747|474674647|FG000|Overall Study|Voluntarily withdrew|70|||
131834000|NCT01553747|474674648|FG001|Overall Study|Voluntarily withdrew|66|||
131834001|NCT01553747|474674649|FG002|Overall Study|Voluntarily withdrew|74|||
131834002|NCT01553747|474674647|FG000|Overall Study|Adverse event or SAE|32|||
131834003|NCT01553747|474674648|FG001|Overall Study|Adverse event or SAE|28|||
131834004|NCT01553747|474674649|FG002|Overall Study|Adverse event or SAE|19|||
131834005|NCT01553747|474674647|FG000|Overall Study|Physician decision: other|10|||
131834006|NCT01553747|474674648|FG001|Overall Study|Physician decision: other|8|||
131834007|NCT01553747|474674649|FG002|Overall Study|Physician decision: other|7|||
131834008|NCT01553747|474674647|FG000|Overall Study|Lost to Follow-up|11|||
131834009|NCT01553747|474674648|FG001|Overall Study|Lost to Follow-up|5|||
131834010|NCT01553747|474674649|FG002|Overall Study|Lost to Follow-up|6|||
131834011|NCT01553747|474674647|FG000|Overall Study|Sponsor decision, specify|7|||
131834012|NCT01553747|474674648|FG001|Overall Study|Sponsor decision, specify|5|||
131834013|NCT01553747|474674649|FG002|Overall Study|Sponsor decision, specify|0|||
131834014|NCT01553747|474674647|FG000|Overall Study|Physician decision: lack of efficacy|1|||
131834015|NCT01553747|474674648|FG001|Overall Study|Physician decision: lack of efficacy|5|||
131834016|NCT01553747|474674649|FG002|Overall Study|Physician decision: lack of efficacy|3|||
131834017|NCT05420012|474674654|FG000|Overall Study|Lost to Follow-up|0|||
131834018|NCT05420012|474674655|FG001|Overall Study|Lost to Follow-up|1|||
131401861|NCT02135029|473091599|FG002|Overall Study|Death|0|||
131401862|NCT00712725|473091600|FG000|Overall Study|Adverse Event|1|||
131401863|NCT00712725|473091601|FG001|Overall Study|Adverse Event|0|||
131834019|NCT03253744|474674657|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
131834020|NCT03253744|474674658|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
131834021|NCT03253744|474674659|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
131834022|NCT03253744|474674660|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
131834023|NCT02972502|474674663|FG000|Overall Study|Lost to Follow-up|3|||
131834024|NCT02972502|474674664|FG001|Overall Study|Lost to Follow-up|1|||
131834025|NCT02972502|474674663|FG000|Overall Study|Withdrawal by Subject|1|||
131834026|NCT02972502|474674664|FG001|Overall Study|Withdrawal by Subject|1|||
131834027|NCT03832738|474674665|FG000|Overall Study|Withdrawal by Subject|6|||
131834028|NCT03832738|474674666|FG001|Overall Study|Withdrawal by Subject|7|||
131834029|NCT03832738|474674667|FG002|Overall Study|Withdrawal by Subject|16|||
131834030|NCT03832738|474674665|FG000|Overall Study|Physician Decision|0|||
131834031|NCT03832738|474674666|FG001|Overall Study|Physician Decision|1|||
131834032|NCT03832738|474674667|FG002|Overall Study|Physician Decision|2|||
131834033|NCT03832738|474674665|FG000|Overall Study|Adverse Event|2|||
131834034|NCT03832738|474674666|FG001|Overall Study|Adverse Event|3|||
131834035|NCT03832738|474674667|FG002|Overall Study|Adverse Event|1|||
131834036|NCT03832738|474674665|FG000|Overall Study|Pregnancy|0|||
131834037|NCT03832738|474674666|FG001|Overall Study|Pregnancy|1|||
131834038|NCT03832738|474674667|FG002|Overall Study|Pregnancy|0|||
131834039|NCT03977701|474674670|FG000|Overall Study|COVID-19 pandemic|0|||
131834040|NCT03977701|474674671|FG001|Overall Study|COVID-19 pandemic|0|||
131834041|NCT03977701|474674672|FG002|Overall Study|COVID-19 pandemic|0|||
131834042|NCT03977701|474674673|FG003|Overall Study|COVID-19 pandemic|0|||
131834043|NCT03977701|474674674|FG004|Overall Study|COVID-19 pandemic|0|||
131834044|NCT03977701|474674675|FG005|Overall Study|COVID-19 pandemic|1|||
131834045|NCT03977701|474674676|FG006|Overall Study|COVID-19 pandemic|0|||
131834046|NCT03977701|474674677|FG007|Overall Study|COVID-19 pandemic|1|||
131834047|NCT03977701|474674678|FG008|Overall Study|COVID-19 pandemic|0|||
131834048|NCT03977701|474674679|FG009|Overall Study|COVID-19 pandemic|0|||
131834049|NCT01347866|474674680|FG000|Overall Study|Death|0|||
131834050|NCT01347866|474674681|FG001|Overall Study|Death|0|||
131834051|NCT01347866|474674682|FG002|Overall Study|Death|0|||
131834052|NCT01347866|474674683|FG003|Overall Study|Death|1|||
131834053|NCT01347866|474674684|FG004|Overall Study|Death|2|||
131834054|NCT01347866|474674685|FG005|Overall Study|Death|2|||
131834055|NCT01347866|474674686|FG006|Overall Study|Death|1|||
131834056|NCT01347866|474674687|FG007|Overall Study|Death|0|||
131834057|NCT01347866|474674688|FG008|Overall Study|Death|4|||
131834058|NCT01347866|474674689|FG009|Overall Study|Death|1|||
131834059|NCT01347866|474674690|FG010|Overall Study|Death|3|||
131834060|NCT01347866|474674691|FG011|Overall Study|Death|1|||
131834061|NCT01347866|474674692|FG012|Overall Study|Death|2|||
131401864|NCT00712725|473091602|FG002|Overall Study|Adverse Event|0|||
131401865|NCT00712725|473091603|FG003|Overall Study|Adverse Event|1|||
131401866|NCT00712725|473091604|FG004|Overall Study|Adverse Event|0|||
131834062|NCT01347866|474674693|FG013|Overall Study|Death|0|||
131834063|NCT01347866|474674694|FG014|Overall Study|Death|0|||
131834064|NCT01347866|474674695|FG015|Overall Study|Death|1|||
131834065|NCT01347866|474674696|FG016|Overall Study|Death|0|||
131834066|NCT01347866|474674680|FG000|Overall Study|Lost to Follow-up|0|||
131834067|NCT01347866|474674681|FG001|Overall Study|Lost to Follow-up|0|||
131834068|NCT01347866|474674682|FG002|Overall Study|Lost to Follow-up|0|||
131834069|NCT01347866|474674683|FG003|Overall Study|Lost to Follow-up|0|||
131834070|NCT01347866|474674684|FG004|Overall Study|Lost to Follow-up|0|||
131834071|NCT01347866|474674685|FG005|Overall Study|Lost to Follow-up|0|||
131834072|NCT01347866|474674686|FG006|Overall Study|Lost to Follow-up|0|||
131834073|NCT01347866|474674687|FG007|Overall Study|Lost to Follow-up|1|||
131834074|NCT01347866|474674688|FG008|Overall Study|Lost to Follow-up|1|||
131834075|NCT01347866|474674689|FG009|Overall Study|Lost to Follow-up|0|||
131834076|NCT01347866|474674690|FG010|Overall Study|Lost to Follow-up|0|||
131834077|NCT01347866|474674691|FG011|Overall Study|Lost to Follow-up|0|||
131834078|NCT01347866|474674692|FG012|Overall Study|Lost to Follow-up|0|||
131834079|NCT01347866|474674693|FG013|Overall Study|Lost to Follow-up|0|||
131834080|NCT01347866|474674694|FG014|Overall Study|Lost to Follow-up|0|||
131834081|NCT01347866|474674695|FG015|Overall Study|Lost to Follow-up|0|||
131834082|NCT01347866|474674696|FG016|Overall Study|Lost to Follow-up|0|||
131834083|NCT01347866|474674680|FG000|Overall Study|Other|3|||
131834084|NCT01347866|474674681|FG001|Overall Study|Other|1|||
131834085|NCT01347866|474674682|FG002|Overall Study|Other|1|||
131834086|NCT01347866|474674683|FG003|Overall Study|Other|4|||
131834087|NCT01347866|474674684|FG004|Overall Study|Other|5|||
131834088|NCT01347866|474674685|FG005|Overall Study|Other|0|||
131834089|NCT01347866|474674686|FG006|Overall Study|Other|5|||
131834090|NCT01347866|474674687|FG007|Overall Study|Other|3|||
131834091|NCT01347866|474674688|FG008|Overall Study|Other|22|||
131834092|NCT01347866|474674689|FG009|Overall Study|Other|5|||
131834093|NCT01347866|474674690|FG010|Overall Study|Other|0|||
131834094|NCT01347866|474674691|FG011|Overall Study|Other|3|||
131834095|NCT01347866|474674692|FG012|Overall Study|Other|4|||
131834096|NCT01347866|474674693|FG013|Overall Study|Other|4|||
131834097|NCT01347866|474674694|FG014|Overall Study|Other|2|||
131834098|NCT01347866|474674695|FG015|Overall Study|Other|3|||
131834099|NCT01347866|474674696|FG016|Overall Study|Other|0|||
131401867|NCT00712725|473091605|FG005|Overall Study|Adverse Event|0|||
131834100|NCT01347866|474674680|FG000|Overall Study|Subject refused further follow-up|2|||
131834101|NCT01347866|474674681|FG001|Overall Study|Subject refused further follow-up|0|||
131834102|NCT01347866|474674682|FG002|Overall Study|Subject refused further follow-up|0|||
131834103|NCT01347866|474674683|FG003|Overall Study|Subject refused further follow-up|2|||
131834104|NCT01347866|474674684|FG004|Overall Study|Subject refused further follow-up|0|||
131834105|NCT01347866|474674685|FG005|Overall Study|Subject refused further follow-up|1|||
131834106|NCT01347866|474674686|FG006|Overall Study|Subject refused further follow-up|0|||
131834107|NCT01347866|474674687|FG007|Overall Study|Subject refused further follow-up|0|||
131834108|NCT01347866|474674688|FG008|Overall Study|Subject refused further follow-up|4|||
131834109|NCT01347866|474674689|FG009|Overall Study|Subject refused further follow-up|1|||
131834110|NCT01347866|474674690|FG010|Overall Study|Subject refused further follow-up|0|||
131834111|NCT01347866|474674691|FG011|Overall Study|Subject refused further follow-up|0|||
131834112|NCT01347866|474674692|FG012|Overall Study|Subject refused further follow-up|1|||
131834113|NCT01347866|474674693|FG013|Overall Study|Subject refused further follow-up|3|||
131834114|NCT01347866|474674694|FG014|Overall Study|Subject refused further follow-up|1|||
131834115|NCT01347866|474674695|FG015|Overall Study|Subject refused further follow-up|0|||
131834116|NCT01347866|474674696|FG016|Overall Study|Subject refused further follow-up|2|||
131834117|NCT00430950|474674697|FG000|Overall Study|Adverse Event|7|||
131834118|NCT00430950|474674698|FG001|Overall Study|Adverse Event|6|||
131834119|NCT00430950|474674697|FG000|Overall Study|Withdrawal by Subject|1|||
131834120|NCT00430950|474674698|FG001|Overall Study|Withdrawal by Subject|0|||
131834121|NCT00430950|474674697|FG000|Overall Study|concomitant medication,etc.|5|||
131834122|NCT00430950|474674698|FG001|Overall Study|concomitant medication,etc.|7|||
131834123|NCT02429934|474674699|FG000|Overall Study|Withdrawal by Subject|0|||
131834124|NCT02429934|474674700|FG001|Overall Study|Withdrawal by Subject|2|||
131834125|NCT02429934|474674699|FG000|Overall Study|Adverse Event|2|||
131834126|NCT02429934|474674700|FG001|Overall Study|Adverse Event|0|||
131834127|NCT02429934|474674699|FG000|Overall Study|Lost to Follow-up|1|||
131834128|NCT02429934|474674700|FG001|Overall Study|Lost to Follow-up|1|||
131834129|NCT02429934|474674699|FG000|Overall Study|Physician Decision|1|||
131834130|NCT02429934|474674700|FG001|Overall Study|Physician Decision|0|||
131834131|NCT00869024|474674701|FG000|Overall Study|Death|2|||
131834132|NCT00869024|474674702|FG001|Overall Study|Death|3|||
131834133|NCT00869024|474674701|FG000|Overall Study|Lost to Follow-up|0|||
131834134|NCT00869024|474674702|FG001|Overall Study|Lost to Follow-up|1|||
131834135|NCT00869024|474674701|FG000|Overall Study|Protocol Violation|0|||
131834136|NCT00869024|474674702|FG001|Overall Study|Protocol Violation|1|||
131834137|NCT00831623|474674706|FG000|Overall Study|Withdrawal by Subject|9|||
131834138|NCT00831623|474674706|FG000|Overall Study|Lost to Follow-up|1|||
131834139|NCT00831623|474674706|FG000|Overall Study|Not 2 years post-treatment|12|||
131834140|NCT03351231|474674710|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
131834141|NCT03351231|474674710|FG000|Combination Therapy Period|Disease progression|2|||
131834142|NCT03351231|474674710|FG000|Combination Therapy Period|Study drug toxicity|1|||
131834143|NCT03351231|474674710|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
131834144|NCT03351231|474674710|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
131834145|NCT03351231|474674710|FG000|Safety Follow-Up Period|Other reason|2|||
131834146|NCT03487848|474674711|FG000|Overall Study|Lost to Follow-up|1|||
131834147|NCT00731549|474674712|FG000|Overall Study|Lost to Follow-up|19|||
131834148|NCT00731549|474674712|FG000|Overall Study|Met withdrawal criteria|24|||
131834149|NCT00731549|474674712|FG000|Overall Study|Physician Decision|16|||
131834150|NCT00731549|474674712|FG000|Overall Study|Withdrawal by Subject|89|||
131834151|NCT00731549|474674712|FG000|Overall Study|Protocol deviation|1|||
131834152|NCT00731549|474674712|FG000|Overall Study|Adverse Event|31|||
131834153|NCT00731549|474674712|FG000|Overall Study|Lack of efficacy with AE|37|||
131834154|NCT00731549|474674712|FG000|Overall Study|Lack of efficacy without AE|6|||
131834155|NCT00588640|474674713|FG000|Overall Study|Physician Decision|1|||
131834156|NCT00588640|474674713|FG000|Overall Study|Ineligible Patient|1|||
131834157|NCT02333487|474674714|FG000|Overall Study|Adverse Event|0|||
131834158|NCT02333487|474674715|FG001|Overall Study|Adverse Event|2|||
131834159|NCT02333487|474674716|FG002|Overall Study|Adverse Event|0|||
131834160|NCT02655016|474674717|FG000|Overall Study|Disease progression|6|||
131834161|NCT02655016|474674718|FG001|Overall Study|Disease progression|4|||
131834162|NCT02655016|474674717|FG000|Overall Study|Site closed|0|||
131834163|NCT02655016|474674718|FG001|Overall Study|Site closed|1|||
131834164|NCT02655016|474674717|FG000|Overall Study|Death|30|||
131834165|NCT02655016|474674718|FG001|Overall Study|Death|48|||
131834166|NCT02655016|474674717|FG000|Overall Study|Lost to Follow-up|1|||
131834167|NCT02655016|474674718|FG001|Overall Study|Lost to Follow-up|1|||
131834168|NCT02655016|474674717|FG000|Overall Study|Withdrawal by Subject|18|||
131834169|NCT02655016|474674718|FG001|Overall Study|Withdrawal by Subject|36|||
131834170|NCT00003138|474676350|FG000|Step 1|Reasons off treatment not documented|60|||
131834171|NCT00003138|474676351|FG001|Step 1|Reasons off treatment not documented|57|||
131834172|NCT00003138|474676350|FG000|Step 1|Never started treatment|1|||
131834173|NCT00003138|474676351|FG001|Step 1|Never started treatment|0|||
131834174|NCT00003138|474676350|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
131834175|NCT00003138|474676351|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
131834176|NCT00003138|474676350|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
131834177|NCT00003138|474676351|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
131834178|NCT00003138|474676350|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
131834179|NCT00003138|474676351|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
131834180|NCT00003138|474676350|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
131834181|NCT00003138|474676351|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
131834182|NCT04495283|474676353|FG000|Overall Study|Physician Decision|0|||
131834183|NCT04495283|474676354|FG001|Overall Study|Physician Decision|0|||
131834184|NCT04495283|474676355|FG002|Overall Study|Physician Decision|1|||
131834185|NCT04495283|474676353|FG000|Overall Study|Withdrawal by Subject|0|||
131834186|NCT04495283|474676354|FG001|Overall Study|Withdrawal by Subject|1|||
131834187|NCT04495283|474676355|FG002|Overall Study|Withdrawal by Subject|1|||
131834188|NCT04495283|474676353|FG000|Overall Study|Other|1|||
131834189|NCT04495283|474676354|FG001|Overall Study|Other|0|||
131834190|NCT04495283|474676355|FG002|Overall Study|Other|1|||
131834191|NCT05142566|474676358|FG000|Overall Study|Protocol Violation|1|||
131834192|NCT02091141|474676363|FG000|Overall Study|Death|280|||
131834193|NCT02091141|474676364|FG001|Overall Study|Death|118|||
131834194|NCT02091141|474676365|FG002|Overall Study|Death|46|||
131834195|NCT02091141|474676366|FG003|Overall Study|Death|13|||
131834196|NCT02091141|474676367|FG004|Overall Study|Death|31|||
131834197|NCT02091141|474676368|FG005|Overall Study|Death|16|||
131834198|NCT02091141|474676369|FG006|Overall Study|Death|12|||
131834199|NCT02091141|474676363|FG000|Overall Study|Withdrawal by Subject|21|||
131834200|NCT02091141|474676364|FG001|Overall Study|Withdrawal by Subject|13|||
131834201|NCT02091141|474676365|FG002|Overall Study|Withdrawal by Subject|3|||
131834202|NCT02091141|474676366|FG003|Overall Study|Withdrawal by Subject|2|||
131834203|NCT02091141|474676367|FG004|Overall Study|Withdrawal by Subject|2|||
131834204|NCT02091141|474676368|FG005|Overall Study|Withdrawal by Subject|3|||
131834205|NCT02091141|474676369|FG006|Overall Study|Withdrawal by Subject|0|||
131834206|NCT02091141|474676363|FG000|Overall Study|Lost to Follow-up|21|||
131834207|NCT02091141|474676364|FG001|Overall Study|Lost to Follow-up|5|||
131834208|NCT02091141|474676365|FG002|Overall Study|Lost to Follow-up|1|||
131834209|NCT02091141|474676366|FG003|Overall Study|Lost to Follow-up|0|||
131834210|NCT02091141|474676367|FG004|Overall Study|Lost to Follow-up|1|||
131834211|NCT02091141|474676368|FG005|Overall Study|Lost to Follow-up|2|||
131834212|NCT02091141|474676369|FG006|Overall Study|Lost to Follow-up|0|||
131834213|NCT02091141|474676363|FG000|Overall Study|Reason Not Specified|6|||
131834214|NCT02091141|474676364|FG001|Overall Study|Reason Not Specified|5|||
131834215|NCT02091141|474676365|FG002|Overall Study|Reason Not Specified|2|||
131834216|NCT02091141|474676366|FG003|Overall Study|Reason Not Specified|0|||
131834217|NCT02091141|474676367|FG004|Overall Study|Reason Not Specified|0|||
131834218|NCT02091141|474676368|FG005|Overall Study|Reason Not Specified|0|||
131834219|NCT02091141|474676369|FG006|Overall Study|Reason Not Specified|1|||
131834220|NCT02091141|474676363|FG000|Overall Study|Study Ended by Sponsor|1|||
131834221|NCT02091141|474676364|FG001|Overall Study|Study Ended by Sponsor|9|||
131834222|NCT02091141|474676365|FG002|Overall Study|Study Ended by Sponsor|0|||
131834223|NCT02091141|474676366|FG003|Overall Study|Study Ended by Sponsor|0|||
131834224|NCT02091141|474676367|FG004|Overall Study|Study Ended by Sponsor|0|||
131834225|NCT02091141|474676368|FG005|Overall Study|Study Ended by Sponsor|0|||
131834226|NCT02091141|474676369|FG006|Overall Study|Study Ended by Sponsor|0|||
131834227|NCT02091141|474676363|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
131834228|NCT02091141|474676364|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
131834229|NCT02091141|474676365|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
131834230|NCT02091141|474676366|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
131834231|NCT02091141|474676367|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
131834232|NCT02091141|474676368|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
131834233|NCT02091141|474676369|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
131834234|NCT02246439|474676370|FG000|Overall Study|Adverse Event|3|||
131834235|NCT02246439|474676371|FG001|Overall Study|Adverse Event|0|||
131834236|NCT02246439|474676370|FG000|Overall Study|Lost to Follow-up|7|||
131834237|NCT02246439|474676371|FG001|Overall Study|Lost to Follow-up|5|||
131834238|NCT02246439|474676370|FG000|Overall Study|Protocol Violation|0|||
131834239|NCT02246439|474676371|FG001|Overall Study|Protocol Violation|2|||
131834240|NCT02246439|474676370|FG000|Overall Study|Physician Decision|0|||
131834241|NCT02246439|474676371|FG001|Overall Study|Physician Decision|1|||
131834242|NCT02246439|474676370|FG000|Overall Study|Unkonwn|1|||
131834243|NCT02246439|474676371|FG001|Overall Study|Unkonwn|3|||
131834244|NCT02246439|474676370|FG000|Overall Study|Withdrawal by Subject|1|||
131834245|NCT02246439|474676371|FG001|Overall Study|Withdrawal by Subject|0|||
131834246|NCT03439852|474676372|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
131401868|NCT00712725|473091606|FG006|Overall Study|Adverse Event|0|||
131401869|NCT00712725|473091607|FG007|Overall Study|Adverse Event|0|||
131401870|NCT00712725|473091600|FG000|Overall Study|Lost to Follow-up|3|||
131834247|NCT03439852|474676373|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
131834248|NCT03439852|474676372|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
131834249|NCT03439852|474676373|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
131834250|NCT03439852|474676372|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
131834251|NCT03439852|474676373|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
131401871|NCT00712725|473091601|FG001|Overall Study|Lost to Follow-up|2|||
131834252|NCT02177136|474676382|FG000|DB Phase|Withdrawal by Subject|2|||
131834253|NCT02177136|474676383|FG001|DB Phase|Withdrawal by Subject|0|||
131834254|NCT02177136|474676384|FG002|DB Phase|Withdrawal by Subject|0|||
131834255|NCT02177136|474676385|FG003|DB Phase|Withdrawal by Subject|0|||
131834256|NCT02177136|474676382|FG000|DB Phase|Discontinued Due to Pruritus|1|||
131834257|NCT02177136|474676383|FG001|DB Phase|Discontinued Due to Pruritus|3|||
131834258|NCT02177136|474676384|FG002|DB Phase|Discontinued Due to Pruritus|0|||
131834259|NCT02177136|474676385|FG003|DB Phase|Discontinued Due to Pruritus|0|||
131834260|NCT02177136|474676382|FG000|DB Phase|Adverse Event|3|||
131834261|NCT02177136|474676383|FG001|DB Phase|Adverse Event|2|||
131834262|NCT02177136|474676384|FG002|DB Phase|Adverse Event|3|||
131834263|NCT02177136|474676385|FG003|DB Phase|Adverse Event|0|||
131834264|NCT02177136|474676382|FG000|DB Phase|Protocol Violation|0|||
131834265|NCT02177136|474676383|FG001|DB Phase|Protocol Violation|0|||
131834266|NCT02177136|474676384|FG002|DB Phase|Protocol Violation|1|||
131834267|NCT02177136|474676385|FG003|DB Phase|Protocol Violation|0|||
131834268|NCT02177136|474676382|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
131834269|NCT02177136|474676383|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
131834270|NCT02177136|474676384|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
131834271|NCT02177136|474676385|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
131834272|NCT02177136|474676382|FG000|LTSE Phase|Withdrawal by Subject|0|||
131834273|NCT02177136|474676383|FG001|LTSE Phase|Withdrawal by Subject|0|||
131834274|NCT02177136|474676384|FG002|LTSE Phase|Withdrawal by Subject|0|||
131834275|NCT02177136|474676385|FG003|LTSE Phase|Withdrawal by Subject|6|||
131834276|NCT02177136|474676382|FG000|LTSE Phase|Adverse Event|0|||
131834277|NCT02177136|474676383|FG001|LTSE Phase|Adverse Event|0|||
131834278|NCT02177136|474676384|FG002|LTSE Phase|Adverse Event|0|||
131834279|NCT02177136|474676385|FG003|LTSE Phase|Adverse Event|10|||
131834280|NCT02177136|474676382|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
131834281|NCT02177136|474676383|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
131834282|NCT02177136|474676384|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
131834283|NCT02177136|474676385|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
131834284|NCT02177136|474676382|FG000|LTSE Phase|Physician Decision|0|||
131834285|NCT02177136|474676383|FG001|LTSE Phase|Physician Decision|0|||
131834286|NCT02177136|474676384|FG002|LTSE Phase|Physician Decision|0|||
131834287|NCT02177136|474676385|FG003|LTSE Phase|Physician Decision|2|||
131834288|NCT02177136|474676382|FG000|LTSE Phase|Lost to Follow-up|0|||
131834289|NCT02177136|474676383|FG001|LTSE Phase|Lost to Follow-up|0|||
131834290|NCT02177136|474676384|FG002|LTSE Phase|Lost to Follow-up|0|||
131834291|NCT02177136|474676385|FG003|LTSE Phase|Lost to Follow-up|1|||
131834292|NCT02177136|474676382|FG000|LTSE Phase|Participant Moved|0|||
131834293|NCT02177136|474676383|FG001|LTSE Phase|Participant Moved|0|||
131834294|NCT02177136|474676384|FG002|LTSE Phase|Participant Moved|0|||
131834295|NCT02177136|474676385|FG003|LTSE Phase|Participant Moved|1|||
131834296|NCT02054130|474676386|FG000|Overall Study|Withdrawal by Subject|4|||
131834297|NCT02054130|474676387|FG001|Overall Study|Withdrawal by Subject|4|||
131834298|NCT02054130|474676388|FG002|Overall Study|Withdrawal by Subject|7|||
131834299|NCT02054130|474676389|FG003|Overall Study|Withdrawal by Subject|10|||
131834300|NCT02054130|474676386|FG000|Overall Study|Death|0|||
131834301|NCT02054130|474676387|FG001|Overall Study|Death|1|||
131834302|NCT02054130|474676388|FG002|Overall Study|Death|0|||
131834303|NCT02054130|474676389|FG003|Overall Study|Death|0|||
131834304|NCT02054130|474676386|FG000|Overall Study|Lost to Follow-up|0|||
131834305|NCT02054130|474676387|FG001|Overall Study|Lost to Follow-up|0|||
131834306|NCT02054130|474676388|FG002|Overall Study|Lost to Follow-up|1|||
131834307|NCT02054130|474676389|FG003|Overall Study|Lost to Follow-up|2|||
131834308|NCT02054130|474676386|FG000|Overall Study|Missed dose|4|||
131834309|NCT02054130|474676387|FG001|Overall Study|Missed dose|6|||
131834310|NCT02054130|474676388|FG002|Overall Study|Missed dose|7|||
131834311|NCT02054130|474676389|FG003|Overall Study|Missed dose|10|||
131834312|NCT01386684|474676390|FG000|Overall Study|Lost to Follow-up|51|||
131834313|NCT01386684|474676390|FG000|Overall Study|Other|51|||
131834314|NCT01386684|474676390|FG000|Overall Study|Death|47|||
131834315|NCT01386684|474676390|FG000|Overall Study|Withdrawal of Consent|44|||
131834316|NCT01386684|474676390|FG000|Overall Study|Alternative Therapy Required|37|||
131834317|NCT01386684|474676390|FG000|Overall Study|Disease Progression|28|||
131834318|NCT01386684|474676390|FG000|Overall Study|Adverse Event|20|||
131834319|NCT01386684|474676390|FG000|Overall Study|Noncompliance|8|||
131834320|NCT01386684|474676390|FG000|Overall Study|Protocol Violation|4|||
131834321|NCT01386684|474676390|FG000|Overall Study|Missing|3|||
131834322|NCT01032018|474676391|FG000|Overall Study|Lost to Follow-up|6|||
131834323|NCT01032018|474676392|FG001|Overall Study|Lost to Follow-up|5|||
131910578|NCT02309359|474960799|FG002|Overall Study|Lost to Follow-up|0|||
131910579|NCT02309359|474960800|FG003|Overall Study|Lost to Follow-up|1|||
131910580|NCT02309359|474960801|FG004|Overall Study|Lost to Follow-up|0|||
131401872|NCT00712725|473091602|FG002|Overall Study|Lost to Follow-up|1|||
131834324|NCT01032018|474676391|FG000|Overall Study|Death|0|||
131834325|NCT01032018|474676392|FG001|Overall Study|Death|1|||
131834326|NCT00094458|474676393|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
131834327|NCT00094458|474676394|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
131910581|NCT02309359|474960797|FG000|Overall Study|Other|2|||
131834328|NCT00094458|474676395|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
131834329|NCT00094458|474676396|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
131910582|NCT02309359|474960798|FG001|Overall Study|Other|0|||
131910583|NCT02309359|474960799|FG002|Overall Study|Other|2|||
131834330|NCT00094458|474676397|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
131834331|NCT00094458|474676398|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
131834332|NCT00094458|474676393|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
131834333|NCT00094458|474676394|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
131834334|NCT00094458|474676395|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
131834335|NCT00094458|474676396|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
131834336|NCT00094458|474676397|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
131834337|NCT00094458|474676398|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
131834338|NCT00094458|474676393|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
131834339|NCT00094458|474676394|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
131834340|NCT00094458|474676395|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
131834341|NCT00094458|474676396|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
131834342|NCT00094458|474676397|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
131834343|NCT00094458|474676398|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
131834344|NCT00094458|474676393|FG000|Main Study: Through Week 30|Adverse Event|38|||
131834345|NCT00094458|474676394|FG001|Main Study: Through Week 30|Adverse Event|20|||
131834346|NCT00094458|474676395|FG002|Main Study: Through Week 30|Adverse Event|28|||
131834347|NCT00094458|474676396|FG003|Main Study: Through Week 30|Adverse Event|0|||
131834348|NCT00094458|474676397|FG004|Main Study: Through Week 30|Adverse Event|0|||
131834349|NCT00094458|474676398|FG005|Main Study: Through Week 30|Adverse Event|0|||
131834350|NCT00094458|474676393|FG000|Main Study: Through Week 30|Death|1|||
131834351|NCT00094458|474676394|FG001|Main Study: Through Week 30|Death|0|||
131834352|NCT00094458|474676395|FG002|Main Study: Through Week 30|Death|0|||
131834353|NCT00094458|474676396|FG003|Main Study: Through Week 30|Death|0|||
131834354|NCT00094458|474676397|FG004|Main Study: Through Week 30|Death|0|||
131834355|NCT00094458|474676398|FG005|Main Study: Through Week 30|Death|0|||
131834356|NCT00094458|474676393|FG000|Main Study: Through Week 30|Other|19|||
131834357|NCT00094458|474676394|FG001|Main Study: Through Week 30|Other|16|||
131834358|NCT00094458|474676395|FG002|Main Study: Through Week 30|Other|9|||
131401873|NCT00712725|473091603|FG003|Overall Study|Lost to Follow-up|1|||
131401874|NCT00712725|473091604|FG004|Overall Study|Lost to Follow-up|2|||
131401875|NCT00712725|473091605|FG005|Overall Study|Lost to Follow-up|2|||
131401876|NCT00712725|473091606|FG006|Overall Study|Lost to Follow-up|3|||
131401877|NCT00712725|473091607|FG007|Overall Study|Lost to Follow-up|1|||
131401878|NCT00712725|473091600|FG000|Overall Study|Physician Decision|2|||
131401879|NCT00712725|473091601|FG001|Overall Study|Physician Decision|0|||
131401880|NCT00712725|473091602|FG002|Overall Study|Physician Decision|0|||
131401881|NCT00712725|473091603|FG003|Overall Study|Physician Decision|0|||
131401882|NCT00712725|473091604|FG004|Overall Study|Physician Decision|1|||
131401883|NCT00712725|473091605|FG005|Overall Study|Physician Decision|0|||
131401884|NCT00712725|473091606|FG006|Overall Study|Physician Decision|2|||
131401885|NCT00712725|473091607|FG007|Overall Study|Physician Decision|0|||
131401886|NCT00712725|473091600|FG000|Overall Study|Pregnancy|0|||
131401887|NCT00712725|473091601|FG001|Overall Study|Pregnancy|1|||
131401888|NCT00712725|473091602|FG002|Overall Study|Pregnancy|0|||
131401889|NCT00712725|473091603|FG003|Overall Study|Pregnancy|0|||
131401890|NCT00712725|473091604|FG004|Overall Study|Pregnancy|1|||
131401891|NCT00712725|473091605|FG005|Overall Study|Pregnancy|0|||
131401892|NCT00712725|473091606|FG006|Overall Study|Pregnancy|2|||
131401893|NCT00712725|473091607|FG007|Overall Study|Pregnancy|0|||
131401894|NCT00712725|473091600|FG000|Overall Study|Protocol Violation|2|||
131834359|NCT00094458|474676396|FG003|Main Study: Through Week 30|Other|0|||
131401895|NCT00712725|473091601|FG001|Overall Study|Protocol Violation|0|||
131834360|NCT00094458|474676397|FG004|Main Study: Through Week 30|Other|0|||
131834361|NCT00094458|474676398|FG005|Main Study: Through Week 30|Other|0|||
131834362|NCT00094458|474676393|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
131834363|NCT00094458|474676394|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
131834364|NCT00094458|474676395|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
131834365|NCT00094458|474676396|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
131401896|NCT00712725|473091602|FG002|Overall Study|Protocol Violation|1|||
131834366|NCT00094458|474676397|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
131834367|NCT00094458|474676398|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
131401897|NCT00712725|473091603|FG003|Overall Study|Protocol Violation|3|||
131401898|NCT00712725|473091604|FG004|Overall Study|Protocol Violation|2|||
131401899|NCT00712725|473091605|FG005|Overall Study|Protocol Violation|0|||
131401900|NCT00712725|473091606|FG006|Overall Study|Protocol Violation|1|||
131401901|NCT00712725|473091607|FG007|Overall Study|Protocol Violation|1|||
131401902|NCT00712725|473091600|FG000|Overall Study|Withdrawal by Subject|2|||
131401903|NCT00712725|473091601|FG001|Overall Study|Withdrawal by Subject|1|||
131401904|NCT00712725|473091602|FG002|Overall Study|Withdrawal by Subject|1|||
131401905|NCT00712725|473091603|FG003|Overall Study|Withdrawal by Subject|2|||
131834368|NCT00094458|474676393|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
131834369|NCT00094458|474676394|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
131834370|NCT00094458|474676395|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
131834371|NCT00094458|474676396|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
131401906|NCT00712725|473091604|FG004|Overall Study|Withdrawal by Subject|1|||
131401907|NCT00712725|473091605|FG005|Overall Study|Withdrawal by Subject|1|||
131401908|NCT00712725|473091606|FG006|Overall Study|Withdrawal by Subject|1|||
131401909|NCT00712725|473091607|FG007|Overall Study|Withdrawal by Subject|2|||
131401910|NCT00712725|473091600|FG000|Overall Study|Lack of Qualifying Event|16|||
131401911|NCT00712725|473091601|FG001|Overall Study|Lack of Qualifying Event|2|||
131401912|NCT00712725|473091602|FG002|Overall Study|Lack of Qualifying Event|6|||
131401913|NCT00712725|473091603|FG003|Overall Study|Lack of Qualifying Event|8|||
131401914|NCT00712725|473091604|FG004|Overall Study|Lack of Qualifying Event|11|||
131401915|NCT00712725|473091605|FG005|Overall Study|Lack of Qualifying Event|13|||
131401916|NCT00712725|473091606|FG006|Overall Study|Lack of Qualifying Event|11|||
131401917|NCT00712725|473091607|FG007|Overall Study|Lack of Qualifying Event|6|||
131401918|NCT00712725|473091600|FG000|Overall Study|Protocol Specified Criteria|3|||
131401919|NCT00712725|473091601|FG001|Overall Study|Protocol Specified Criteria|0|||
131401920|NCT00712725|473091602|FG002|Overall Study|Protocol Specified Criteria|1|||
131401921|NCT00712725|473091603|FG003|Overall Study|Protocol Specified Criteria|2|||
131401922|NCT00712725|473091604|FG004|Overall Study|Protocol Specified Criteria|1|||
131834372|NCT00094458|474676397|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
131834373|NCT00094458|474676398|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
131834374|NCT00094458|474676393|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
131834375|NCT00094458|474676394|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
131834376|NCT00094458|474676395|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
131834377|NCT00094458|474676396|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
131834378|NCT00094458|474676397|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
131401923|NCT00712725|473091605|FG005|Overall Study|Protocol Specified Criteria|0|||
131401924|NCT00712725|473091606|FG006|Overall Study|Protocol Specified Criteria|2|||
131401925|NCT00712725|473091607|FG007|Overall Study|Protocol Specified Criteria|1|||
131401926|NCT03466099|473091608|FG000|Overall Study|Adverse Event|1|||
131401927|NCT03466099|473091609|FG001|Overall Study|Adverse Event|1|||
131401928|NCT03466099|473091610|FG002|Overall Study|Adverse Event|1|||
131401929|NCT03466099|473091608|FG000|Overall Study|Withdrawal by Subject|2|||
131401930|NCT03466099|473091609|FG001|Overall Study|Withdrawal by Subject|3|||
131401931|NCT03466099|473091610|FG002|Overall Study|Withdrawal by Subject|1|||
131401932|NCT03466099|473091608|FG000|Overall Study|Use of rescue medication|8|||
131401933|NCT03466099|473091609|FG001|Overall Study|Use of rescue medication|9|||
131834379|NCT00094458|474676398|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
131834380|NCT00094458|474676393|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
131834381|NCT00094458|474676394|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
131834382|NCT00094458|474676395|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
131401934|NCT03466099|473091610|FG002|Overall Study|Use of rescue medication|13|||
131401935|NCT03466099|473091608|FG000|Overall Study|Rescued without meeting criteria|4|||
131401936|NCT03466099|473091609|FG001|Overall Study|Rescued without meeting criteria|1|||
131401937|NCT03466099|473091610|FG002|Overall Study|Rescued without meeting criteria|1|||
131401938|NCT03466099|473091608|FG000|Overall Study|Subject compliance|2|||
131401939|NCT03466099|473091609|FG001|Overall Study|Subject compliance|0|||
131401940|NCT03466099|473091610|FG002|Overall Study|Subject compliance|0|||
131401941|NCT03466099|473091608|FG000|Overall Study|Worsening disease|0|||
131401942|NCT03466099|473091609|FG001|Overall Study|Worsening disease|0|||
131401943|NCT03466099|473091610|FG002|Overall Study|Worsening disease|1|||
131401944|NCT04590404|473091611|FG000|Overall Study|Death|16|||
131401945|NCT04590404|473091612|FG001|Overall Study|Death|17|||
131401946|NCT04590404|473091611|FG000|Overall Study|Withdrawal by Subject|7|||
131450132|NCT01721044|473276802|FG002|Treatment Period|Lost to Follow-up|1|||
131450133|NCT01721044|473276800|FG000|Treatment Period|Physician Decision|1|||
131450134|NCT01721044|473276801|FG001|Treatment Period|Physician Decision|0|||
131450135|NCT01721044|473276802|FG002|Treatment Period|Physician Decision|2|||
131450136|NCT01721044|473276800|FG000|Treatment Period|Protocol Violation|1|||
131450137|NCT01721044|473276801|FG001|Treatment Period|Protocol Violation|0|||
131834383|NCT00094458|474676396|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
131834384|NCT00094458|474676397|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
131834385|NCT00094458|474676398|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
131910584|NCT02309359|474960800|FG003|Overall Study|Other|3|||
131401947|NCT04590404|473091612|FG001|Overall Study|Withdrawal by Subject|2|||
131401948|NCT00613327|473091615|FG000|Overall Study|Adverse Event|38|||
131401949|NCT00613327|473091615|FG000|Overall Study|Lost to Follow-up|8|||
131401950|NCT00613327|473091615|FG000|Overall Study|Withdrawal by Subject|6|||
131401951|NCT00613327|473091615|FG000|Overall Study|Protocol Violation|2|||
131401952|NCT00613327|473091615|FG000|Overall Study|Other|47|||
131401953|NCT02247011|473091616|FG000|Overall Study|Poor quality of radiological results|125|||
131401954|NCT03194568|473091617|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
131401955|NCT00780143|473091620|FG000|Overall Study|Progressive disease|1|||
131401956|NCT00780143|473091620|FG000|Overall Study|Toxicity|1|||
131450138|NCT01721044|473276802|FG002|Treatment Period|Protocol Violation|0|||
131834386|NCT00094458|474676393|FG000|OLE: Open-Label Extension|Adverse Event|0|||
131401957|NCT00780143|473091620|FG000|Overall Study|Adverse Event|1|||
131834387|NCT00094458|474676394|FG001|OLE: Open-Label Extension|Adverse Event|0|||
131834388|NCT00094458|474676395|FG002|OLE: Open-Label Extension|Adverse Event|0|||
131834389|NCT00094458|474676396|FG003|OLE: Open-Label Extension|Adverse Event|0|||
131834390|NCT00094458|474676397|FG004|OLE: Open-Label Extension|Adverse Event|3|||
131834391|NCT00094458|474676398|FG005|OLE: Open-Label Extension|Adverse Event|4|||
131834392|NCT00094458|474676393|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
131834393|NCT00094458|474676394|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
131834394|NCT00094458|474676395|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
131834395|NCT00094458|474676396|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
131834396|NCT00094458|474676397|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
131834397|NCT00094458|474676398|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
131834398|NCT00094458|474676393|FG000|OLE: Open-Label Extension|Patient decision|0|||
131834399|NCT00094458|474676394|FG001|OLE: Open-Label Extension|Patient decision|0|||
131834400|NCT00094458|474676395|FG002|OLE: Open-Label Extension|Patient decision|0|||
131834401|NCT00094458|474676396|FG003|OLE: Open-Label Extension|Patient decision|0|||
131834402|NCT00094458|474676397|FG004|OLE: Open-Label Extension|Patient decision|1|||
131834403|NCT00094458|474676398|FG005|OLE: Open-Label Extension|Patient decision|0|||
131834404|NCT03247517|474676399|FG000|Overall Study|Adverse Event|0|||
131834405|NCT03247517|474676400|FG001|Overall Study|Adverse Event|4|||
131834406|NCT03247517|474676401|FG002|Overall Study|Adverse Event|2|||
131834407|NCT03247517|474676399|FG000|Overall Study|Lost to Follow-up|2|||
131834408|NCT03247517|474676400|FG001|Overall Study|Lost to Follow-up|6|||
131834409|NCT03247517|474676401|FG002|Overall Study|Lost to Follow-up|4|||
131834410|NCT03247517|474676399|FG000|Overall Study|Consent withdrawn by caregiver|1|||
131834411|NCT03247517|474676400|FG001|Overall Study|Consent withdrawn by caregiver|4|||
131834412|NCT03247517|474676401|FG002|Overall Study|Consent withdrawn by caregiver|7|||
131834413|NCT03247517|474676399|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
131834414|NCT03247517|474676400|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
131834415|NCT03247517|474676401|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
131834416|NCT03247517|474676399|FG000|Overall Study|Protocol Violation|0|||
131834417|NCT03247517|474676400|FG001|Overall Study|Protocol Violation|2|||
131834418|NCT03247517|474676401|FG002|Overall Study|Protocol Violation|0|||
131834419|NCT03247517|474676399|FG000|Overall Study|Multiple reasons|3|||
131834420|NCT03247517|474676400|FG001|Overall Study|Multiple reasons|1|||
131834421|NCT03247517|474676401|FG002|Overall Study|Multiple reasons|0|||
131834422|NCT01996332|474676402|FG000|Overall Study|Adverse Event|117|||
131834423|NCT01996332|474676402|FG000|Overall Study|Lack of Efficacy|1245|||
131834424|NCT01996332|474676402|FG000|Overall Study|Death|264|||
131834425|NCT01996332|474676402|FG000|Overall Study|Protocol Violation|9|||
131834426|NCT01996332|474676402|FG000|Overall Study|Withdrawal by Subject|71|||
131834427|NCT01996332|474676402|FG000|Overall Study|Other|20|||
131834428|NCT01996332|474676402|FG000|Overall Study|Clinical Deterioration|28|||
131834429|NCT01996332|474676402|FG000|Overall Study|Physician Decision|17|||
131834430|NCT01996332|474676402|FG000|Overall Study|Lost to Follow-up|34|||
131834431|NCT02113189|474676403|FG000|Overall Study|Lost to follow up|2|||
131834432|NCT02113189|474676404|FG001|Overall Study|Lost to follow up|1|||
131834433|NCT02113189|474676405|FG002|Overall Study|Lost to follow up|3|||
131834434|NCT03265288|474676406|FG000|Overall Study|Adverse Event|0|||
131834435|NCT03265288|474676407|FG001|Overall Study|Adverse Event|1|||
131834436|NCT03265288|474676406|FG000|Overall Study|Withdrawal by Subject|13|||
131834437|NCT03265288|474676407|FG001|Overall Study|Withdrawal by Subject|5|||
131834438|NCT03265288|474676406|FG000|Overall Study|Drug Withdrawn|3|||
131834439|NCT03265288|474676407|FG001|Overall Study|Drug Withdrawn|3|||
131834440|NCT03265288|474676406|FG000|Overall Study|Any Other Reason|7|||
131834441|NCT03265288|474676407|FG001|Overall Study|Any Other Reason|3|||
131834442|NCT00931268|474676416|FG000|Overall Study|Lost to Follow-up|6|||
131834443|NCT01388166|474676417|FG000|Overall Study|Adverse Event|16|||
131834444|NCT01388166|474676417|FG000|Overall Study|Lost to Follow-up|30|||
131834445|NCT01388166|474676417|FG000|Overall Study|Others than specified above|13|||
131834446|NCT02072148|474676420|FG000|Overall Study|withdrew prior to surgery|23|||
131401958|NCT00082368|473091621|FG000|Overall Study|Not treated-pt had poor IV access|1|||
131401959|NCT03319953|473091624|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
131401960|NCT03319953|473091625|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
131401961|NCT03319953|473091626|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
131834447|NCT02072148|474676421|FG001|Overall Study|withdrew prior to surgery|0|||
131834448|NCT02072148|474676422|FG002|Overall Study|withdrew prior to surgery|0|||
131834449|NCT02072148|474676420|FG000|Overall Study|Death|0|||
131834450|NCT02072148|474676421|FG001|Overall Study|Death|0|||
131834451|NCT02072148|474676422|FG002|Overall Study|Death|1|||
131834452|NCT02072148|474676420|FG000|Overall Study|Withdrawal by Subject|0|||
131834453|NCT02072148|474676421|FG001|Overall Study|Withdrawal by Subject|13|||
131834454|NCT02072148|474676422|FG002|Overall Study|Withdrawal by Subject|12|||
131834455|NCT00430495|474676424|FG000|Overall Study|Adverse Event|2|||
131834456|NCT00430495|474676425|FG001|Overall Study|Adverse Event|3|||
131834457|NCT00430495|474676426|FG002|Overall Study|Adverse Event|2|||
131834458|NCT00430495|474676427|FG003|Overall Study|Adverse Event|0|||
131834459|NCT00430495|474676424|FG000|Overall Study|Death|0|||
131834460|NCT00430495|474676425|FG001|Overall Study|Death|0|||
131834461|NCT00430495|474676426|FG002|Overall Study|Death|1|||
131834462|NCT00430495|474676427|FG003|Overall Study|Death|0|||
131834463|NCT00430495|474676424|FG000|Overall Study|Lost to Follow-up|0|||
131834464|NCT00430495|474676425|FG001|Overall Study|Lost to Follow-up|1|||
131834465|NCT00430495|474676426|FG002|Overall Study|Lost to Follow-up|4|||
131834466|NCT00430495|474676427|FG003|Overall Study|Lost to Follow-up|0|||
131834467|NCT00430495|474676424|FG000|Overall Study|Protocol Violation|1|||
131834468|NCT00430495|474676425|FG001|Overall Study|Protocol Violation|0|||
131834469|NCT00430495|474676426|FG002|Overall Study|Protocol Violation|1|||
131834470|NCT00430495|474676427|FG003|Overall Study|Protocol Violation|0|||
131834471|NCT00430495|474676424|FG000|Overall Study|Disease Progression|1|||
131834472|NCT00430495|474676425|FG001|Overall Study|Disease Progression|1|||
131834473|NCT00430495|474676426|FG002|Overall Study|Disease Progression|0|||
131834474|NCT00430495|474676427|FG003|Overall Study|Disease Progression|0|||
131834475|NCT00430495|474676424|FG000|Overall Study|Other|8|||
131834476|NCT00430495|474676425|FG001|Overall Study|Other|2|||
131834477|NCT00430495|474676426|FG002|Overall Study|Other|5|||
131834478|NCT00430495|474676427|FG003|Overall Study|Other|4|||
131834479|NCT00430495|474676424|FG000|Overall Study|Randomized but not Treated|2|||
131834480|NCT00430495|474676425|FG001|Overall Study|Randomized but not Treated|0|||
131834481|NCT00430495|474676426|FG002|Overall Study|Randomized but not Treated|0|||
131834482|NCT00430495|474676427|FG003|Overall Study|Randomized but not Treated|0|||
131834483|NCT00158756|474676432|FG000|Overall Study|Withdrawal by Subject|5|||
131834484|NCT00158756|474676433|FG001|Overall Study|Withdrawal by Subject|0|||
131834485|NCT00158756|474676434|FG002|Overall Study|Withdrawal by Subject|6|||
131834486|NCT00158756|474676435|FG003|Overall Study|Withdrawal by Subject|1|||
131834487|NCT00158756|474676436|FG004|Overall Study|Withdrawal by Subject|3|||
131834488|NCT00158756|474676432|FG000|Overall Study|Adverse Event|0|||
131834489|NCT00158756|474676433|FG001|Overall Study|Adverse Event|0|||
131834490|NCT00158756|474676434|FG002|Overall Study|Adverse Event|1|||
131834491|NCT00158756|474676435|FG003|Overall Study|Adverse Event|0|||
131834492|NCT00158756|474676436|FG004|Overall Study|Adverse Event|0|||
131834493|NCT00158756|474676432|FG000|Overall Study|Serious adverse event|0|||
131834494|NCT00158756|474676433|FG001|Overall Study|Serious adverse event|0|||
131834495|NCT00158756|474676434|FG002|Overall Study|Serious adverse event|1|||
131834496|NCT00158756|474676435|FG003|Overall Study|Serious adverse event|0|||
131834497|NCT00158756|474676436|FG004|Overall Study|Serious adverse event|0|||
131834498|NCT02145026|474676437|FG000|Overall Study|Adverse Event|2|||
131834499|NCT02145026|474676437|FG000|Overall Study|Death|4|||
131834500|NCT02145026|474676437|FG000|Overall Study|Withdrawal by Subject|2|||
131834501|NCT02145026|474676437|FG000|Overall Study|Physician Decision|4|||
131834502|NCT00289874|474676438|FG000|Overall Study|Adverse Event|1|||
131834503|NCT00289874|474676439|FG001|Overall Study|Adverse Event|5|||
131834504|NCT00289874|474676438|FG000|Overall Study|Lost to Follow-up|1|||
131834505|NCT00289874|474676439|FG001|Overall Study|Lost to Follow-up|1|||
131834506|NCT00289874|474676438|FG000|Overall Study|Protocol Violation|3|||
131834507|NCT00289874|474676439|FG001|Overall Study|Protocol Violation|2|||
131834508|NCT00289874|474676438|FG000|Overall Study|Did not meet eligibility|1|||
131834509|NCT00289874|474676439|FG001|Overall Study|Did not meet eligibility|0|||
131834510|NCT03835325|474676440|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
131834511|NCT03835325|474676440|FG000|Overall Study|Selection failure|1|||
131834512|NCT00775606|474676443|FG000|Overall Study|Study sponsor terminated funding|3|||
131834513|NCT00775606|474676444|FG001|Overall Study|Study sponsor terminated funding|0|||
131834514|NCT01546649|474676445|FG000|Overall Study|Adverse Event|4|||
131834515|NCT01546649|474676446|FG001|Overall Study|Adverse Event|5|||
131834516|NCT01546649|474676445|FG000|Overall Study|Protocol Violation|1|||
131834517|NCT01546649|474676446|FG001|Overall Study|Protocol Violation|0|||
131834518|NCT01546649|474676445|FG000|Overall Study|Lack of Efficacy|1|||
131834519|NCT01546649|474676446|FG001|Overall Study|Lack of Efficacy|0|||
131834520|NCT01546649|474676445|FG000|Overall Study|Recurrence|1|||
131401962|NCT03319953|473091627|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
131834521|NCT01546649|474676446|FG001|Overall Study|Recurrence|1|||
131834522|NCT01546649|474676445|FG000|Overall Study|Discovery of secondary cancer|0|||
131834523|NCT01546649|474676446|FG001|Overall Study|Discovery of secondary cancer|1|||
131834524|NCT01546649|474676445|FG000|Overall Study|Withdrawal by Subject|1|||
131834525|NCT01546649|474676446|FG001|Overall Study|Withdrawal by Subject|2|||
131834526|NCT03212794|474676447|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
131834527|NCT03212794|474676448|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
131834528|NCT03212794|474676447|FG000|Overall Study|Lost to Follow-up|5|||
131834529|NCT03212794|474676448|FG001|Overall Study|Lost to Follow-up|6|||
131834530|NCT03212794|474676447|FG000|Overall Study|Incarcerated; unable to participate|2|||
131834531|NCT03212794|474676448|FG001|Overall Study|Incarcerated; unable to participate|0|||
131834532|NCT03212794|474676447|FG000|Overall Study|Withdrawal by Subject|1|||
131834533|NCT03212794|474676448|FG001|Overall Study|Withdrawal by Subject|0|||
131834534|NCT03212794|474676447|FG000|Overall Study|Death|0|||
131834535|NCT03212794|474676448|FG001|Overall Study|Death|1|||
131834536|NCT03212794|474676447|FG000|Overall Study|Found to be ineligible after allocation|0|||
131834537|NCT03212794|474676448|FG001|Overall Study|Found to be ineligible after allocation|1|||
131834538|NCT03212794|474676447|FG000|Overall Study|Relocated out of area|2|||
131834539|NCT03212794|474676448|FG001|Overall Study|Relocated out of area|0|||
131834540|NCT01134627|474676455|FG000|Overall Study|Adverse Event|47|||
131834541|NCT01134627|474676456|FG001|Overall Study|Adverse Event|31|||
131834542|NCT01134627|474676455|FG000|Overall Study|Lost to Follow-up|1|||
131834543|NCT01134627|474676456|FG001|Overall Study|Lost to Follow-up|2|||
131834544|NCT01134627|474676455|FG000|Overall Study|Protocol Violation|3|||
131834545|NCT01134627|474676456|FG001|Overall Study|Protocol Violation|5|||
131834546|NCT01134627|474676455|FG000|Overall Study|Lack of Efficacy|2|||
131834547|NCT01134627|474676456|FG001|Overall Study|Lack of Efficacy|12|||
131834548|NCT01134627|474676455|FG000|Overall Study|Withdrawal by Subject|4|||
131834549|NCT01134627|474676456|FG001|Overall Study|Withdrawal by Subject|3|||
131834550|NCT01134627|474676455|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
131834551|NCT01134627|474676456|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
131834552|NCT01134627|474676455|FG000|Overall Study|Other|11|||
131834553|NCT01134627|474676456|FG001|Overall Study|Other|14|||
131834554|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
131834555|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
131834556|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
131834557|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
131834558|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
131834559|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
131834560|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
131834561|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
131834562|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
131834563|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
131834564|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Subject decision|1|||
131834565|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Subject decision|1|||
131834566|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
131834567|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
131834568|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
131834569|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
131834570|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
131834571|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
131834572|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
131834573|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
131834574|NCT00518882|474676462|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
131834575|NCT00518882|474676463|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
131834576|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
131834577|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
131834578|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
131834579|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
131834580|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
131834581|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
131834582|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
131834583|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
131834584|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
131834585|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
131834586|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
131834587|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
131834588|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
131834589|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
131834590|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
131834591|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
131834592|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
131834593|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
131834594|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
131834595|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
131834596|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
131834597|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
131834598|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
131834599|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
131834600|NCT00518882|474676462|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
131834601|NCT00518882|474676463|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
131834602|NCT03395639|474676464|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
131834603|NCT03395639|474676465|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
131910585|NCT02309359|474960801|FG004|Overall Study|Other|2|||
131401963|NCT03319953|473091624|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
131834604|NCT03395639|474676466|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
131834605|NCT03395639|474676464|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
131834606|NCT03395639|474676465|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
131834607|NCT03395639|474676466|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
131834608|NCT03395639|474676464|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
131834609|NCT03395639|474676465|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
131834610|NCT03395639|474676466|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
131834611|NCT03395639|474676464|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
131834612|NCT03395639|474676465|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
131834613|NCT03395639|474676466|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
131834614|NCT03395639|474676464|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
131834615|NCT03395639|474676465|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
131450139|NCT01721044|473276800|FG000|Treatment Period|Withdrawal by Subject|7|||
131450140|NCT01721044|473276801|FG001|Treatment Period|Withdrawal by Subject|6|||
131450141|NCT01721044|473276802|FG002|Treatment Period|Withdrawal by Subject|1|||
131834616|NCT03395639|474676466|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
131834617|NCT00942331|474676467|FG000|Overall Study|Did not start treatment|15|||
131834618|NCT00942331|474676468|FG001|Overall Study|Did not start treatment|22|||
131834619|NCT00567476|474676473|FG000|Overall Study|Adverse Event|2|||
131834620|NCT00567476|474676474|FG001|Overall Study|Adverse Event|0|||
131834621|NCT00567476|474676473|FG000|Overall Study|Pregnancy|1|||
131834622|NCT00567476|474676474|FG001|Overall Study|Pregnancy|0|||
131834623|NCT00567476|474676473|FG000|Overall Study|Protocol Violation|4|||
131834624|NCT00567476|474676474|FG001|Overall Study|Protocol Violation|1|||
131834625|NCT00567476|474676473|FG000|Overall Study|Lost to Follow-up|0|||
131834626|NCT00567476|474676474|FG001|Overall Study|Lost to Follow-up|1|||
131834627|NCT00567476|474676473|FG000|Overall Study|Administrative issues|1|||
131834628|NCT00567476|474676474|FG001|Overall Study|Administrative issues|0|||
131834629|NCT00567476|474676473|FG000|Overall Study|Medical Decision|0|||
131834630|NCT00567476|474676474|FG001|Overall Study|Medical Decision|1|||
131834631|NCT00567476|474676473|FG000|Overall Study|Non-adherence to protocol|0|||
131834632|NCT00567476|474676474|FG001|Overall Study|Non-adherence to protocol|1|||
131834633|NCT02696031|474676476|FG000|Up to Week 24|Adverse Event|2|||
131834634|NCT02696031|474676477|FG001|Up to Week 24|Adverse Event|4|||
131834635|NCT02696031|474676478|FG002|Up to Week 24|Adverse Event|2|||
131910586|NCT00701363|474960803|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
131401964|NCT03319953|473091625|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
131401965|NCT03319953|473091626|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
131401966|NCT03319953|473091627|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
131401967|NCT03724981|473093522|FG000|First Device|Protocol Violation|1|||
131401968|NCT03724981|473093523|FG001|First Device|Protocol Violation|1|||
131401969|NCT00197145|473093524|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
131401970|NCT00197145|473093525|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
131401971|NCT00197145|473093524|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
131401972|NCT00197145|473093525|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
131401973|NCT00197145|473093524|FG000|Period 1: Randomized Treatment Phase|Other|2|||
131401974|NCT00197145|473093525|FG001|Period 1: Randomized Treatment Phase|Other|2|||
131401975|NCT00197145|473093524|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
131401976|NCT00197145|473093525|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
131401977|NCT00197145|473093524|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
131401978|NCT00197145|473093525|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
131401979|NCT00197145|473093524|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
131401980|NCT00197145|473093525|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
131401981|NCT00197145|473093524|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
131401982|NCT00197145|473093525|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
131401983|NCT00197145|473093524|FG000|Period 2 : Open Label Phase|Other|1|||
131401984|NCT00197145|473093525|FG001|Period 2 : Open Label Phase|Other|0|||
131401985|NCT03596047|473093528|FG000|Overall Study|Withdrawal by Subject|7|||
131401986|NCT03596047|473093529|FG001|Overall Study|Withdrawal by Subject|4|||
131401987|NCT03596047|473093528|FG000|Overall Study|Lost to Follow-up|0|||
131401988|NCT03596047|473093529|FG001|Overall Study|Lost to Follow-up|2|||
131401989|NCT02290691|473093530|FG000|Overall Study|Noncompliance|0|||
131401990|NCT02290691|473093531|FG001|Overall Study|Noncompliance|1|||
131401991|NCT02290691|473093530|FG000|Overall Study|Withdrawal by Subject|1|||
131450142|NCT04032093|473276805|FG000|Overall Study|Lost to Follow-up|7|||
131834636|NCT02696031|474676479|FG003|Up to Week 24|Adverse Event|0|||
131834637|NCT02696031|474676480|FG004|Up to Week 24|Adverse Event|0|||
131834638|NCT02696031|474676481|FG005|Up to Week 24|Adverse Event|0|||
131834639|NCT02696031|474676476|FG000|Up to Week 24|Lack of Efficacy|2|||
131834640|NCT02696031|474676477|FG001|Up to Week 24|Lack of Efficacy|1|||
131834641|NCT02696031|474676478|FG002|Up to Week 24|Lack of Efficacy|2|||
131401992|NCT02290691|473093531|FG001|Overall Study|Withdrawal by Subject|1|||
131401993|NCT02290691|473093530|FG000|Overall Study|Lost to Follow-up|7|||
131401994|NCT02290691|473093531|FG001|Overall Study|Lost to Follow-up|7|||
131834642|NCT02696031|474676479|FG003|Up to Week 24|Lack of Efficacy|0|||
131834643|NCT02696031|474676480|FG004|Up to Week 24|Lack of Efficacy|0|||
131834644|NCT02696031|474676481|FG005|Up to Week 24|Lack of Efficacy|0|||
131834645|NCT02696031|474676476|FG000|Up to Week 24|Lost to Follow-up|0|||
131834646|NCT02696031|474676477|FG001|Up to Week 24|Lost to Follow-up|1|||
131834647|NCT02696031|474676478|FG002|Up to Week 24|Lost to Follow-up|1|||
131834648|NCT02696031|474676479|FG003|Up to Week 24|Lost to Follow-up|0|||
131834649|NCT02696031|474676480|FG004|Up to Week 24|Lost to Follow-up|0|||
131834650|NCT02696031|474676481|FG005|Up to Week 24|Lost to Follow-up|0|||
131834651|NCT02696031|474676476|FG000|Up to Week 24|Physician Decision|1|||
131834652|NCT02696031|474676477|FG001|Up to Week 24|Physician Decision|0|||
131834653|NCT02696031|474676478|FG002|Up to Week 24|Physician Decision|1|||
131834654|NCT02696031|474676479|FG003|Up to Week 24|Physician Decision|0|||
131834655|NCT02696031|474676480|FG004|Up to Week 24|Physician Decision|0|||
131834656|NCT02696031|474676481|FG005|Up to Week 24|Physician Decision|0|||
131834657|NCT02696031|474676476|FG000|Up to Week 24|Protocol Violation|1|||
131834658|NCT02696031|474676477|FG001|Up to Week 24|Protocol Violation|0|||
131834659|NCT02696031|474676478|FG002|Up to Week 24|Protocol Violation|0|||
131834660|NCT02696031|474676479|FG003|Up to Week 24|Protocol Violation|0|||
131834661|NCT02696031|474676480|FG004|Up to Week 24|Protocol Violation|0|||
131834662|NCT02696031|474676481|FG005|Up to Week 24|Protocol Violation|0|||
131834663|NCT02696031|474676476|FG000|Up to Week 24|Withdrawal by Subject|4|||
131834664|NCT02696031|474676477|FG001|Up to Week 24|Withdrawal by Subject|1|||
131834665|NCT02696031|474676478|FG002|Up to Week 24|Withdrawal by Subject|5|||
131834666|NCT02696031|474676479|FG003|Up to Week 24|Withdrawal by Subject|0|||
131834667|NCT02696031|474676480|FG004|Up to Week 24|Withdrawal by Subject|0|||
131834668|NCT02696031|474676481|FG005|Up to Week 24|Withdrawal by Subject|0|||
131834669|NCT02696031|474676476|FG000|Up to Week 52|Adverse Event|4|||
131834670|NCT02696031|474676477|FG001|Up to Week 52|Adverse Event|5|||
131834671|NCT02696031|474676478|FG002|Up to Week 52|Adverse Event|3|||
131834672|NCT02696031|474676479|FG003|Up to Week 52|Adverse Event|0|||
131834673|NCT02696031|474676480|FG004|Up to Week 52|Adverse Event|0|||
131834674|NCT02696031|474676481|FG005|Up to Week 52|Adverse Event|0|||
131834675|NCT02696031|474676476|FG000|Up to Week 52|Lack of Efficacy|10|||
131834676|NCT02696031|474676477|FG001|Up to Week 52|Lack of Efficacy|7|||
131834677|NCT02696031|474676478|FG002|Up to Week 52|Lack of Efficacy|11|||
131834678|NCT02696031|474676479|FG003|Up to Week 52|Lack of Efficacy|0|||
131834679|NCT02696031|474676480|FG004|Up to Week 52|Lack of Efficacy|0|||
131834680|NCT02696031|474676481|FG005|Up to Week 52|Lack of Efficacy|0|||
131834681|NCT02696031|474676476|FG000|Up to Week 52|Lost to Follow-up|1|||
131834682|NCT02696031|474676477|FG001|Up to Week 52|Lost to Follow-up|1|||
131834683|NCT02696031|474676478|FG002|Up to Week 52|Lost to Follow-up|1|||
131834684|NCT02696031|474676479|FG003|Up to Week 52|Lost to Follow-up|0|||
131834685|NCT02696031|474676480|FG004|Up to Week 52|Lost to Follow-up|0|||
131834686|NCT02696031|474676481|FG005|Up to Week 52|Lost to Follow-up|0|||
131834687|NCT02696031|474676476|FG000|Up to Week 52|Physician Decision|1|||
131834688|NCT02696031|474676477|FG001|Up to Week 52|Physician Decision|1|||
131834689|NCT02696031|474676478|FG002|Up to Week 52|Physician Decision|2|||
131834690|NCT02696031|474676479|FG003|Up to Week 52|Physician Decision|0|||
131834691|NCT02696031|474676480|FG004|Up to Week 52|Physician Decision|0|||
131834692|NCT02696031|474676481|FG005|Up to Week 52|Physician Decision|0|||
131834693|NCT02696031|474676476|FG000|Up to Week 52|Pregnancy|0|||
131834694|NCT02696031|474676477|FG001|Up to Week 52|Pregnancy|2|||
131834695|NCT02696031|474676478|FG002|Up to Week 52|Pregnancy|0|||
131834696|NCT02696031|474676479|FG003|Up to Week 52|Pregnancy|0|||
131834697|NCT02696031|474676480|FG004|Up to Week 52|Pregnancy|0|||
131401995|NCT03895086|473093535|FG000|Overall Study|Early termination study|1|||
131401996|NCT03895086|473093536|FG001|Overall Study|Early termination study|0|||
131401997|NCT01089413|473093544|FG000|Overall Study|Lost to Follow-up|1|||
131834698|NCT02696031|474676481|FG005|Up to Week 52|Pregnancy|0|||
131834699|NCT02696031|474676476|FG000|Up to Week 52|Protocol Violation|1|||
131834700|NCT02696031|474676477|FG001|Up to Week 52|Protocol Violation|0|||
131834701|NCT02696031|474676478|FG002|Up to Week 52|Protocol Violation|0|||
131834702|NCT02696031|474676479|FG003|Up to Week 52|Protocol Violation|0|||
131834703|NCT02696031|474676480|FG004|Up to Week 52|Protocol Violation|0|||
131401998|NCT01089413|473093544|FG000|Overall Study|Progressive Disease|93|||
131401999|NCT01089413|473093544|FG000|Overall Study|Participant Withdrew Consent|1|||
131834704|NCT02696031|474676481|FG005|Up to Week 52|Protocol Violation|0|||
131834705|NCT02696031|474676476|FG000|Up to Week 52|Withdrawal by Subject|12|||
131834706|NCT02696031|474676477|FG001|Up to Week 52|Withdrawal by Subject|3|||
131834707|NCT02696031|474676478|FG002|Up to Week 52|Withdrawal by Subject|9|||
131834708|NCT02696031|474676479|FG003|Up to Week 52|Withdrawal by Subject|0|||
131834709|NCT02696031|474676480|FG004|Up to Week 52|Withdrawal by Subject|0|||
131834710|NCT02696031|474676481|FG005|Up to Week 52|Withdrawal by Subject|0|||
131834711|NCT02696031|474676476|FG000|Up to Week 104|Pregnancy|0|||
131834712|NCT02696031|474676477|FG001|Up to Week 104|Pregnancy|2|||
131834713|NCT02696031|474676478|FG002|Up to Week 104|Pregnancy|1|||
131834714|NCT02696031|474676479|FG003|Up to Week 104|Pregnancy|0|||
131834715|NCT02696031|474676480|FG004|Up to Week 104|Pregnancy|0|||
131834716|NCT02696031|474676481|FG005|Up to Week 104|Pregnancy|0|||
131834717|NCT02696031|474676476|FG000|Up to Week 104|Withdrawal by Subject|15|||
131834718|NCT02696031|474676477|FG001|Up to Week 104|Withdrawal by Subject|10|||
131834719|NCT02696031|474676478|FG002|Up to Week 104|Withdrawal by Subject|16|||
131834720|NCT02696031|474676479|FG003|Up to Week 104|Withdrawal by Subject|0|||
131834721|NCT02696031|474676480|FG004|Up to Week 104|Withdrawal by Subject|0|||
131834722|NCT02696031|474676481|FG005|Up to Week 104|Withdrawal by Subject|0|||
131834723|NCT02696031|474676476|FG000|Up to Week 104|Protocol Violation|1|||
131834724|NCT02696031|474676477|FG001|Up to Week 104|Protocol Violation|0|||
131834725|NCT02696031|474676478|FG002|Up to Week 104|Protocol Violation|0|||
131834726|NCT02696031|474676479|FG003|Up to Week 104|Protocol Violation|0|||
131834727|NCT02696031|474676480|FG004|Up to Week 104|Protocol Violation|0|||
131834728|NCT02696031|474676481|FG005|Up to Week 104|Protocol Violation|0|||
131834729|NCT02696031|474676476|FG000|Up to Week 104|Physician Decision|1|||
131834730|NCT02696031|474676477|FG001|Up to Week 104|Physician Decision|2|||
131834731|NCT02696031|474676478|FG002|Up to Week 104|Physician Decision|3|||
131834732|NCT02696031|474676479|FG003|Up to Week 104|Physician Decision|0|||
131834733|NCT02696031|474676480|FG004|Up to Week 104|Physician Decision|0|||
131834734|NCT02696031|474676481|FG005|Up to Week 104|Physician Decision|0|||
131834735|NCT02696031|474676476|FG000|Up to Week 104|Lost to Follow-up|2|||
131834736|NCT02696031|474676477|FG001|Up to Week 104|Lost to Follow-up|3|||
131834737|NCT02696031|474676478|FG002|Up to Week 104|Lost to Follow-up|1|||
131834738|NCT02696031|474676479|FG003|Up to Week 104|Lost to Follow-up|0|||
131834739|NCT02696031|474676480|FG004|Up to Week 104|Lost to Follow-up|0|||
131834740|NCT02696031|474676481|FG005|Up to Week 104|Lost to Follow-up|0|||
131834741|NCT02696031|474676476|FG000|Up to Week 104|Lack of Efficacy|13|||
131834742|NCT02696031|474676477|FG001|Up to Week 104|Lack of Efficacy|12|||
131834743|NCT02696031|474676478|FG002|Up to Week 104|Lack of Efficacy|11|||
131834744|NCT02696031|474676479|FG003|Up to Week 104|Lack of Efficacy|0|||
131834745|NCT02696031|474676480|FG004|Up to Week 104|Lack of Efficacy|0|||
131834746|NCT02696031|474676481|FG005|Up to Week 104|Lack of Efficacy|0|||
131834747|NCT02696031|474676476|FG000|Up to Week 104|Adverse Event|7|||
131834748|NCT02696031|474676477|FG001|Up to Week 104|Adverse Event|11|||
131834749|NCT02696031|474676478|FG002|Up to Week 104|Adverse Event|5|||
131834750|NCT02696031|474676479|FG003|Up to Week 104|Adverse Event|0|||
131834751|NCT02696031|474676480|FG004|Up to Week 104|Adverse Event|0|||
131834752|NCT02696031|474676481|FG005|Up to Week 104|Adverse Event|0|||
131834753|NCT02696031|474676476|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
131834754|NCT02696031|474676477|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
131834755|NCT02696031|474676478|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
131834756|NCT02696031|474676479|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
131834757|NCT02696031|474676480|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
131834758|NCT02696031|474676481|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
131834759|NCT02696031|474676476|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
131834760|NCT02696031|474676477|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
131834761|NCT02696031|474676478|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
131834762|NCT02696031|474676479|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
131834763|NCT02696031|474676480|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
131834764|NCT02696031|474676481|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
131834765|NCT02696031|474676476|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
131834766|NCT02696031|474676477|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
131834767|NCT02696031|474676478|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
131834768|NCT02696031|474676479|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
131834769|NCT02696031|474676480|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
131834770|NCT02696031|474676481|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
131834771|NCT02696031|474676476|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
131834772|NCT02696031|474676477|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
131834773|NCT02696031|474676478|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
131834774|NCT02696031|474676479|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
131834775|NCT02696031|474676480|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
131834776|NCT02696031|474676481|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
131834777|NCT02696031|474676476|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
131834778|NCT02696031|474676477|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
131834779|NCT02696031|474676478|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
131834780|NCT02696031|474676479|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
131834781|NCT02696031|474676480|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
131834782|NCT02696031|474676481|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
131834783|NCT02696031|474676476|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
131834784|NCT02696031|474676477|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
131834785|NCT02696031|474676478|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
131834786|NCT02696031|474676479|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
131834787|NCT02696031|474676480|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
131834788|NCT02696031|474676481|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
131834789|NCT02696031|474676476|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
131834790|NCT02696031|474676477|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
131834791|NCT02696031|474676478|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
131834792|NCT02696031|474676479|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
131834793|NCT02696031|474676480|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
131834794|NCT02696031|474676481|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
131834795|NCT00597116|474676482|FG000|Overall Study|Adverse Event|2|||
131834796|NCT00597116|474676483|FG001|Overall Study|Adverse Event|1|||
131834797|NCT00597116|474676482|FG000|Overall Study|Withdrawal by Subject|0|||
131834798|NCT00597116|474676483|FG001|Overall Study|Withdrawal by Subject|2|||
131834799|NCT00597116|474676482|FG000|Overall Study|Physician Decision|0|||
131834800|NCT00597116|474676483|FG001|Overall Study|Physician Decision|1|||
131834801|NCT00597116|474676482|FG000|Overall Study|Death|0|||
131834802|NCT00597116|474676483|FG001|Overall Study|Death|1|||
131834803|NCT00597116|474676482|FG000|Overall Study|Lost to Follow-up|1|||
131834804|NCT00597116|474676483|FG001|Overall Study|Lost to Follow-up|0|||
131834805|NCT00597116|474676482|FG000|Overall Study|Progressive disease|11|||
131834806|NCT00597116|474676483|FG001|Overall Study|Progressive disease|6|||
131834807|NCT01875471|474676487|FG000|Overall Study|Adverse Event|0|||
131834808|NCT01875471|474676488|FG001|Overall Study|Adverse Event|1|||
131834809|NCT01875471|474676487|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
131834810|NCT01875471|474676488|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
131834811|NCT03407118|474676489|FG000|Period 2|Withdrawal by Subject|1|||
131834812|NCT03407118|474676490|FG001|Period 2|Withdrawal by Subject|0|||
131834813|NCT01843348|474676496|FG000|Overall Study|Withdrawal by Subject|4|||
131834814|NCT01843348|474676497|FG001|Overall Study|Withdrawal by Subject|16|||
131834815|NCT01843348|474676498|FG002|Overall Study|Withdrawal by Subject|18|||
131834816|NCT01843348|474676496|FG000|Overall Study|Lost to Follow-up|5|||
131834817|NCT01843348|474676497|FG001|Overall Study|Lost to Follow-up|4|||
131834818|NCT01843348|474676498|FG002|Overall Study|Lost to Follow-up|2|||
131834819|NCT01843348|474676496|FG000|Overall Study|Death|5|||
131834820|NCT01843348|474676497|FG001|Overall Study|Death|3|||
131834821|NCT01843348|474676498|FG002|Overall Study|Death|4|||
131834822|NCT01843348|474676496|FG000|Overall Study|Graft loss/retransplantation|5|||
131834823|NCT01843348|474676497|FG001|Overall Study|Graft loss/retransplantation|8|||
131834824|NCT01843348|474676498|FG002|Overall Study|Graft loss/retransplantation|11|||
131834825|NCT01843348|474676496|FG000|Overall Study|Various reasons|4|||
131834826|NCT01843348|474676497|FG001|Overall Study|Various reasons|9|||
131834827|NCT01843348|474676498|FG002|Overall Study|Various reasons|6|||
131834828|NCT02039414|474676507|FG000|Overall Study|Delivered|1|||
131834829|NCT02039414|474676508|FG001|Overall Study|Delivered|1|||
131834830|NCT02039414|474676507|FG000|Overall Study|Lost to Follow-up|2|||
131834831|NCT02039414|474676508|FG001|Overall Study|Lost to Follow-up|0|||
131834832|NCT02039414|474676507|FG000|Overall Study|Protocol Violation|3|||
131834833|NCT02039414|474676508|FG001|Overall Study|Protocol Violation|1|||
131834834|NCT00653991|474676509|FG000|3 Month Follow-up|Participant would not respond|150|||
131834835|NCT00653991|474676510|FG001|3 Month Follow-up|Participant would not respond|157|||
131834836|NCT00653991|474676509|FG000|6 Month Follow-up|Participant would not respond|133|||
131834837|NCT00653991|474676510|FG001|6 Month Follow-up|Participant would not respond|141|||
131834838|NCT01297322|474676511|FG000|Overall Study|Lost to Follow-up|1|||
131834839|NCT01297322|474676512|FG001|Overall Study|Lost to Follow-up|0|||
131834840|NCT01297322|474676511|FG000|Overall Study|Withdrawal by Subject|0|||
131834841|NCT01297322|474676512|FG001|Overall Study|Withdrawal by Subject|1|||
131834842|NCT01297322|474676511|FG000|Overall Study|Protocol Violation|0|||
131834843|NCT01297322|474676512|FG001|Overall Study|Protocol Violation|3|||
131834844|NCT01111019|474676513|FG000|Overall Study|Withdrew Prematurely|2|||
131834845|NCT01111019|474676513|FG000|Overall Study|Other|1|||
131834846|NCT01583218|474676516|FG000|Overall Study|Withdrawal by Subject|43|||
131834847|NCT01583218|474676517|FG001|Overall Study|Withdrawal by Subject|29|||
131450143|NCT04032093|473276806|FG001|Overall Study|Lost to Follow-up|7|||
131450144|NCT04032093|473276807|FG002|Overall Study|Lost to Follow-up|6|||
131450145|NCT04032093|473276808|FG003|Overall Study|Lost to Follow-up|10|||
131450146|NCT04032093|473276809|FG004|Overall Study|Lost to Follow-up|13|||
131450147|NCT04032093|473276810|FG005|Overall Study|Lost to Follow-up|7|||
131450148|NCT04032093|473276811|FG006|Overall Study|Lost to Follow-up|7|||
131834848|NCT01583218|474676516|FG000|Overall Study|Death|206|||
131834849|NCT01583218|474676517|FG001|Overall Study|Death|211|||
131834850|NCT01583218|474676516|FG000|Overall Study|Lost to Follow-up|11|||
131834851|NCT01583218|474676517|FG001|Overall Study|Lost to Follow-up|17|||
131834852|NCT01583218|474676516|FG000|Overall Study|Adverse event or serious adverse event|3|||
131834853|NCT01583218|474676517|FG001|Overall Study|Adverse event or serious adverse event|3|||
131834854|NCT01583218|474676516|FG000|Overall Study|Patient /Family decision|3|||
131450149|NCT04032093|473276812|FG007|Overall Study|Lost to Follow-up|5|||
131834855|NCT01583218|474676517|FG001|Overall Study|Patient /Family decision|0|||
131402000|NCT01089413|473093544|FG000|Overall Study|Unacceptable Toxicity|12|||
131402001|NCT01089413|473093544|FG000|Overall Study|Death|10|||
131402002|NCT01089413|473093544|FG000|Overall Study|Metastasectomy|13|||
131402003|NCT01089413|473093544|FG000|Overall Study|Other|71|||
131402004|NCT02513485|473093545|FG000|Overall Study|Adverse Event|1|||
131402005|NCT02513485|473093546|FG001|Overall Study|Adverse Event|0|||
131402006|NCT02526524|473093547|FG000|Overall Study|Withdrawal by Subject|3|||
131402007|NCT02526524|473093548|FG001|Overall Study|Withdrawal by Subject|3|||
131402008|NCT02526524|473093549|FG002|Overall Study|Withdrawal by Subject|6|||
131402009|NCT02526524|473093550|FG003|Overall Study|Withdrawal by Subject|1|||
131402010|NCT02526524|473093551|FG004|Overall Study|Withdrawal by Subject|9|||
131402011|NCT02526524|473093552|FG005|Overall Study|Withdrawal by Subject|5|||
131402012|NCT02526524|473093547|FG000|Overall Study|Adverse Event|3|||
131402013|NCT02526524|473093548|FG001|Overall Study|Adverse Event|2|||
131402014|NCT02526524|473093549|FG002|Overall Study|Adverse Event|4|||
131402015|NCT02526524|473093550|FG003|Overall Study|Adverse Event|2|||
131402016|NCT02526524|473093551|FG004|Overall Study|Adverse Event|6|||
131402017|NCT02526524|473093552|FG005|Overall Study|Adverse Event|8|||
131402018|NCT02526524|473093547|FG000|Overall Study|Lost to Follow-up|2|||
131834856|NCT01583218|474676516|FG000|Overall Study|Cannot contact patient directly|1|||
131834857|NCT01583218|474676517|FG001|Overall Study|Cannot contact patient directly|2|||
131834858|NCT01583218|474676516|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
131834859|NCT01583218|474676517|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
131834860|NCT01583218|474676516|FG000|Overall Study|Patient did not wish to attend visits|0|||
131834861|NCT01583218|474676517|FG001|Overall Study|Patient did not wish to attend visits|1|||
131834862|NCT01583218|474676516|FG000|Overall Study|Patient randomized but not dosed|17|||
131834863|NCT01583218|474676517|FG001|Overall Study|Patient randomized but not dosed|16|||
131834864|NCT01583218|474676516|FG000|Overall Study|Patient was assessed via phone in person|1|||
131834865|NCT01583218|474676517|FG001|Overall Study|Patient was assessed via phone in person|0|||
131834866|NCT01583218|474676516|FG000|Overall Study|Patient deemed ineligible after random|2|||
131834867|NCT01583218|474676517|FG001|Overall Study|Patient deemed ineligible after random|0|||
131834868|NCT01583218|474676516|FG000|Overall Study|Patient was early terminated from study|0|||
131834869|NCT01583218|474676517|FG001|Overall Study|Patient was early terminated from study|1|||
131834870|NCT01583218|474676516|FG000|Overall Study|Patient was randomized due to mistake|1|||
131834871|NCT01583218|474676517|FG001|Overall Study|Patient was randomized due to mistake|0|||
131834872|NCT01583218|474676516|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
131834873|NCT01583218|474676517|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
131834874|NCT01583218|474676516|FG000|Overall Study|Withdraw of consent on day of random|1|||
131834875|NCT01583218|474676517|FG001|Overall Study|Withdraw of consent on day of random|0|||
131834876|NCT03334721|474676518|FG000|Overall Study|Withdrawal by Subject|1|||
131834877|NCT03334721|474676519|FG001|Overall Study|Withdrawal by Subject|0|||
131834878|NCT03334721|474676518|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
131834879|NCT03334721|474676519|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
131834880|NCT03623386|474677945|FG000|Overall Study|Protocol Violation|3|||
131834881|NCT03623386|474677946|FG001|Overall Study|Protocol Violation|2|||
131834882|NCT03623386|474677947|FG002|Overall Study|Protocol Violation|0|||
131834883|NCT03623386|474677945|FG000|Overall Study|Physician Decision|1|||
131834884|NCT03623386|474677946|FG001|Overall Study|Physician Decision|1|||
131834885|NCT03623386|474677947|FG002|Overall Study|Physician Decision|0|||
131834886|NCT03623386|474677945|FG000|Overall Study|Lost to Follow-up|0|||
131834887|NCT03623386|474677946|FG001|Overall Study|Lost to Follow-up|2|||
131834888|NCT03623386|474677947|FG002|Overall Study|Lost to Follow-up|0|||
131834889|NCT03623386|474677945|FG000|Overall Study|COVID-19|0|||
131834890|NCT03623386|474677946|FG001|Overall Study|COVID-19|1|||
131834891|NCT03623386|474677947|FG002|Overall Study|COVID-19|0|||
131834892|NCT04271735|474677948|FG000|Overall Study|Physician Decision|2|||
131834893|NCT04271735|474677949|FG001|Overall Study|Physician Decision|0|||
131834894|NCT00515541|474677950|FG000|Overall Study|Physician Decision|0|||
131834895|NCT00515541|474677951|FG001|Overall Study|Physician Decision|2|||
131834896|NCT00515541|474677952|FG002|Overall Study|Physician Decision|0|||
131834897|NCT00515541|474677953|FG003|Overall Study|Physician Decision|1|||
131834898|NCT00515541|474677950|FG000|Overall Study|No show for appointments|0|||
131834899|NCT00515541|474677951|FG001|Overall Study|No show for appointments|1|||
131834900|NCT00515541|474677952|FG002|Overall Study|No show for appointments|0|||
131910587|NCT00701363|474960804|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
131910588|NCT00701363|474960805|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
131834901|NCT00515541|474677953|FG003|Overall Study|No show for appointments|2|||
131834902|NCT00515541|474677950|FG000|Overall Study|Withdrawal by Subject|0|||
131402019|NCT02526524|473093548|FG001|Overall Study|Lost to Follow-up|3|||
131402020|NCT02526524|473093549|FG002|Overall Study|Lost to Follow-up|8|||
131402021|NCT02526524|473093550|FG003|Overall Study|Lost to Follow-up|1|||
131402022|NCT02526524|473093551|FG004|Overall Study|Lost to Follow-up|2|||
131402023|NCT02526524|473093552|FG005|Overall Study|Lost to Follow-up|5|||
131402024|NCT02526524|473093547|FG000|Overall Study|Protocol Violation|3|||
131834903|NCT00515541|474677951|FG001|Overall Study|Withdrawal by Subject|2|||
131834904|NCT00515541|474677952|FG002|Overall Study|Withdrawal by Subject|0|||
131834905|NCT00515541|474677953|FG003|Overall Study|Withdrawal by Subject|2|||
131834906|NCT02588950|474677954|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
131834907|NCT02588950|474677955|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
131834908|NCT02588950|474677956|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
131834909|NCT02588950|474677957|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
131834910|NCT02588950|474677954|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
131834911|NCT02588950|474677955|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
131834912|NCT02588950|474677956|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
131402025|NCT02526524|473093548|FG001|Overall Study|Protocol Violation|1|||
131834913|NCT02588950|474677957|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
131834914|NCT02669940|474677961|FG000|Overall Study|Failure to return|0|||
131834915|NCT02669940|474677962|FG001|Overall Study|Failure to return|3|||
131834916|NCT02669940|474677961|FG000|Overall Study|Insufficient follow-up data|1|||
131834917|NCT02669940|474677962|FG001|Overall Study|Insufficient follow-up data|0|||
131834918|NCT00986180|474677971|FG000|Overall Study|Adverse Event|21|||
131834919|NCT00986180|474677972|FG001|Overall Study|Adverse Event|23|||
131834920|NCT00986180|474677971|FG000|Overall Study|Lack of Efficacy|4|||
131834921|NCT00986180|474677972|FG001|Overall Study|Lack of Efficacy|3|||
131834922|NCT00986180|474677971|FG000|Overall Study|Lost to Follow-up|5|||
131834923|NCT00986180|474677972|FG001|Overall Study|Lost to Follow-up|7|||
131834924|NCT00986180|474677971|FG000|Overall Study|Physician Decision|1|||
131834925|NCT00986180|474677972|FG001|Overall Study|Physician Decision|3|||
131834926|NCT00986180|474677971|FG000|Overall Study|Protocol Violation|2|||
131834927|NCT00986180|474677972|FG001|Overall Study|Protocol Violation|0|||
131834928|NCT00986180|474677971|FG000|Overall Study|Withdrawal by Subject|1|||
131834929|NCT00986180|474677972|FG001|Overall Study|Withdrawal by Subject|9|||
131834930|NCT00986180|474677971|FG000|Overall Study|Miscellanies|10|||
131834931|NCT00986180|474677972|FG001|Overall Study|Miscellanies|11|||
131834932|NCT03251963|474677973|FG000|Overall Study|inappropriate Xa level timing|6|||
131834933|NCT03251963|474677974|FG001|Overall Study|inappropriate Xa level timing|3|||
131834934|NCT03251963|474677973|FG000|Overall Study|no peak Xa level drawn|2|||
131834935|NCT03251963|474677974|FG001|Overall Study|no peak Xa level drawn|0|||
131834936|NCT03251963|474677973|FG000|Overall Study|bled prior to Xa level|1|||
131834937|NCT03251963|474677974|FG001|Overall Study|bled prior to Xa level|2|||
131834938|NCT04295135|474677975|FG000|Overall Study|Withdrawal by Subject|2|||
131834939|NCT04295135|474677976|FG001|Overall Study|Withdrawal by Subject|1|||
131834940|NCT04295135|474677975|FG000|Overall Study|Subject left organization|8|||
131834941|NCT04295135|474677976|FG001|Overall Study|Subject left organization|4|||
131834942|NCT03484117|474677978|FG000|Overall Study|Lost to Follow-up|1|||
131834943|NCT03484117|474677979|FG001|Overall Study|Lost to Follow-up|3|||
131834944|NCT03484117|474677978|FG000|Overall Study|Declined participation in exit assess|1|||
131834945|NCT03484117|474677979|FG001|Overall Study|Declined participation in exit assess|1|||
131834946|NCT02303041|474677980|FG000|Overall Study|Adverse Event|1|||
131834947|NCT02303041|474677981|FG001|Overall Study|Adverse Event|2|||
131834948|NCT01901874|474677987|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
131834949|NCT01901874|474677987|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
131834950|NCT01901874|474677987|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
131834951|NCT01901874|474677987|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
131834952|NCT01901874|474677987|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
131834953|NCT01901874|474677987|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
131834954|NCT03978091|474677988|FG000|Overall Study|Lost to Follow-up|0|||
131402026|NCT02526524|473093549|FG002|Overall Study|Protocol Violation|5|||
131402027|NCT02526524|473093550|FG003|Overall Study|Protocol Violation|3|||
131834955|NCT03978091|474677989|FG001|Overall Study|Lost to Follow-up|0|||
131834956|NCT03978091|474677990|FG002|Overall Study|Lost to Follow-up|1|||
131834957|NCT03978091|474677991|FG003|Overall Study|Lost to Follow-up|0|||
131834958|NCT03978091|474677992|FG004|Overall Study|Lost to Follow-up|0|||
131834959|NCT03978091|474677993|FG005|Overall Study|Lost to Follow-up|0|||
131834960|NCT03978091|474677988|FG000|Overall Study|Withdrawal by Subject|0|||
131402028|NCT02526524|473093551|FG004|Overall Study|Protocol Violation|4|||
131834961|NCT03978091|474677989|FG001|Overall Study|Withdrawal by Subject|0|||
131450150|NCT04032093|473276813|FG008|Overall Study|Lost to Follow-up|9|||
131834962|NCT03978091|474677990|FG002|Overall Study|Withdrawal by Subject|0|||
131834963|NCT03978091|474677991|FG003|Overall Study|Withdrawal by Subject|1|||
131834964|NCT03978091|474677992|FG004|Overall Study|Withdrawal by Subject|1|||
131834965|NCT03978091|474677993|FG005|Overall Study|Withdrawal by Subject|0|||
131834966|NCT02595008|474677998|FG000|Overall Study|Enrolled In Error|1|||
131834967|NCT02595008|474677999|FG001|Overall Study|Enrolled In Error|0|||
131834968|NCT03078582|474678006|FG000|Overall Study|Adverse Event|0|||
131834969|NCT03078582|474678007|FG001|Overall Study|Adverse Event|8|||
131910589|NCT00701363|474960806|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
131402029|NCT02526524|473093552|FG005|Overall Study|Protocol Violation|3|||
131402030|NCT02526524|473093547|FG000|Overall Study|Loss of Glucose Control|0|||
131834970|NCT00257920|474678009|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
131402031|NCT02526524|473093548|FG001|Overall Study|Loss of Glucose Control|0|||
131402032|NCT02526524|473093549|FG002|Overall Study|Loss of Glucose Control|3|||
131402033|NCT02526524|473093550|FG003|Overall Study|Loss of Glucose Control|0|||
131402034|NCT02526524|473093551|FG004|Overall Study|Loss of Glucose Control|2|||
131402035|NCT02526524|473093552|FG005|Overall Study|Loss of Glucose Control|0|||
131402036|NCT02526524|473093547|FG000|Overall Study|Physician Decision|0|||
131402037|NCT02526524|473093548|FG001|Overall Study|Physician Decision|0|||
131402038|NCT02526524|473093549|FG002|Overall Study|Physician Decision|0|||
131402039|NCT02526524|473093550|FG003|Overall Study|Physician Decision|0|||
131402040|NCT02526524|473093551|FG004|Overall Study|Physician Decision|1|||
131402041|NCT02526524|473093552|FG005|Overall Study|Physician Decision|0|||
131402042|NCT02526524|473093547|FG000|Overall Study|Sponsor Decision|1|||
131402043|NCT02526524|473093548|FG001|Overall Study|Sponsor Decision|0|||
131402044|NCT02526524|473093549|FG002|Overall Study|Sponsor Decision|0|||
131402045|NCT02526524|473093550|FG003|Overall Study|Sponsor Decision|0|||
131402046|NCT02526524|473093551|FG004|Overall Study|Sponsor Decision|0|||
131402047|NCT02526524|473093552|FG005|Overall Study|Sponsor Decision|0|||
131402048|NCT00470093|473093559|FG000|Overall Study|Adverse Event|2|||
131402049|NCT00664560|473093560|FG000|Overall Study|Adverse Event|19|||
131402050|NCT00664560|473093561|FG001|Overall Study|Adverse Event|16|||
131402051|NCT00664560|473093562|FG002|Overall Study|Adverse Event|7|||
131402052|NCT00664560|473093560|FG000|Overall Study|Withdrawal by Subject|9|||
131402053|NCT00664560|473093561|FG001|Overall Study|Withdrawal by Subject|13|||
131402054|NCT00664560|473093562|FG002|Overall Study|Withdrawal by Subject|7|||
131402055|NCT00664560|473093560|FG000|Overall Study|Lost to Follow-up|0|||
131402056|NCT00664560|473093561|FG001|Overall Study|Lost to Follow-up|2|||
131834971|NCT00257920|474678010|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
131834972|NCT00257920|474678009|FG000|Period: Second Intervention|Other|2|||
131834973|NCT00257920|474678010|FG001|Period: Second Intervention|Other|1|||
131834974|NCT00560937|474678017|FG000|Overall Study|Withdrawal by Subject|0|||
131834975|NCT00560937|474678018|FG001|Overall Study|Withdrawal by Subject|1|||
131834976|NCT00560937|474678017|FG000|Overall Study|Physician Decision|1|||
131834977|NCT00560937|474678018|FG001|Overall Study|Physician Decision|1|||
131834978|NCT02025751|474678021|FG000|Overall Study|Lost to Follow-up|1|||
131834979|NCT02025751|474678022|FG001|Overall Study|Lost to Follow-up|0|||
131834980|NCT02025751|474678021|FG000|Overall Study|Adverse Event|0|||
131834981|NCT02025751|474678022|FG001|Overall Study|Adverse Event|1|||
131834982|NCT02025751|474678021|FG000|Overall Study|Physician Decision|0|||
131834983|NCT02025751|474678022|FG001|Overall Study|Physician Decision|1|||
131834984|NCT02025751|474678021|FG000|Overall Study|Withdrawal by Subject|0|||
131834985|NCT02025751|474678022|FG001|Overall Study|Withdrawal by Subject|1|||
131834986|NCT00891839|474678023|FG000|Overall Study|Adverse Event|2|||
131834987|NCT00891839|474678023|FG000|Overall Study|Withdrawal by Subject|2|||
131834988|NCT00891839|474678023|FG000|Overall Study|Disease progression|3|||
131834989|NCT02939014|474678026|FG000|Overall Study|Lost to Follow-up|1|||
131834990|NCT02939014|474678027|FG001|Overall Study|Lost to Follow-up|0|||
131834991|NCT02939014|474678026|FG000|Overall Study|Death|4|||
131834992|NCT02939014|474678027|FG001|Overall Study|Death|3|||
131834993|NCT03864042|474678028|FG000|DDI Phase|Adverse Event|2|||
131834994|NCT03864042|474678029|FG001|DDI Phase|Adverse Event|0|||
131834995|NCT03864042|474678030|FG002|DDI Phase|Adverse Event|0|||
131834996|NCT03864042|474678028|FG000|DDI Phase|Physician Decision|1|||
131834997|NCT03864042|474678029|FG001|DDI Phase|Physician Decision|0|||
131834998|NCT03864042|474678030|FG002|DDI Phase|Physician Decision|0|||
131834999|NCT03864042|474678028|FG000|DDI Phase|Progressive Disease|1|||
131835000|NCT03864042|474678029|FG001|DDI Phase|Progressive Disease|0|||
131835001|NCT03864042|474678030|FG002|DDI Phase|Progressive Disease|0|||
131910590|NCT00701363|474960803|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
131402057|NCT00664560|473093562|FG002|Overall Study|Lost to Follow-up|0|||
131450151|NCT04032093|473276814|FG009|Overall Study|Lost to Follow-up|12|||
131402058|NCT00664560|473093560|FG000|Overall Study|Other|11|||
131402059|NCT00664560|473093561|FG001|Overall Study|Other|4|||
131402060|NCT00664560|473093562|FG002|Overall Study|Other|5|||
131402061|NCT02456636|473093563|FG000|Overall Study|Death|0|||
131402062|NCT02456636|473093564|FG001|Overall Study|Death|3|||
131402063|NCT02456636|473093565|FG002|Overall Study|Death|0|||
131450152|NCT04032093|473276805|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131402064|NCT02456636|473093563|FG000|Overall Study|Pregnancy|1|||
131835002|NCT03864042|474678028|FG000|Post-DDI Phase|Adverse Event|5|||
131835003|NCT03864042|474678029|FG001|Post-DDI Phase|Adverse Event|3|||
131835004|NCT03864042|474678030|FG002|Post-DDI Phase|Adverse Event|2|||
131835005|NCT03864042|474678028|FG000|Post-DDI Phase|Progressive Disease|11|||
131835006|NCT03864042|474678029|FG001|Post-DDI Phase|Progressive Disease|6|||
131835007|NCT03864042|474678030|FG002|Post-DDI Phase|Progressive Disease|13|||
131835008|NCT03864042|474678028|FG000|Post-DDI Phase|Discretion of investigator|1|||
131835009|NCT03864042|474678029|FG001|Post-DDI Phase|Discretion of investigator|1|||
131835010|NCT03864042|474678030|FG002|Post-DDI Phase|Discretion of investigator|0|||
131835011|NCT03864042|474678028|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
131835012|NCT03864042|474678029|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
131835013|NCT03864042|474678030|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
131835014|NCT03864042|474678028|FG000|Post-DDI Phase|Withdrawal of consent|1|||
131835015|NCT03864042|474678029|FG001|Post-DDI Phase|Withdrawal of consent|2|||
131835016|NCT03864042|474678030|FG002|Post-DDI Phase|Withdrawal of consent|0|||
131835017|NCT02220725|474678031|FG000|Overall Study|Lost to Follow-up|0|||
131835018|NCT02220725|474678032|FG001|Overall Study|Lost to Follow-up|0|||
131835019|NCT02220725|474678033|FG002|Overall Study|Lost to Follow-up|0|||
131835020|NCT02220725|474678034|FG003|Overall Study|Lost to Follow-up|1|||
131835021|NCT02220725|474678031|FG000|Overall Study|Withdrawal by Subject|0|||
131835022|NCT02220725|474678032|FG001|Overall Study|Withdrawal by Subject|0|||
131835023|NCT02220725|474678033|FG002|Overall Study|Withdrawal by Subject|0|||
131835024|NCT02220725|474678034|FG003|Overall Study|Withdrawal by Subject|1|||
131835025|NCT05069155|474678037|FG000|Overall Study|Withdrawal by Subject|1|||
131835026|NCT05069155|474678038|FG001|Overall Study|Withdrawal by Subject|3|||
131835027|NCT02340221|474678039|FG000|Overall Study|Death|100|||
131835028|NCT02340221|474678040|FG001|Overall Study|Death|197|||
131835029|NCT02340221|474678039|FG000|Overall Study|Withdrawal by Participant|24|||
131835030|NCT02340221|474678040|FG001|Overall Study|Withdrawal by Participant|37|||
131835031|NCT02340221|474678039|FG000|Overall Study|Lost to Follow-up|4|||
131835032|NCT02340221|474678040|FG001|Overall Study|Lost to Follow-up|15|||
131835033|NCT02340221|474678039|FG000|Overall Study|Reason Not Specified|85|||
131835034|NCT02340221|474678040|FG001|Overall Study|Reason Not Specified|165|||
131835035|NCT02340221|474678039|FG000|Overall Study|Study Terminated by Sponsor|1|||
131835036|NCT02340221|474678040|FG001|Overall Study|Study Terminated by Sponsor|3|||
131835037|NCT00103402|474678041|FG000|Overall Study|Adverse Event|3|||
131835038|NCT00103402|474678042|FG001|Overall Study|Adverse Event|4|||
131835039|NCT00103402|474678041|FG000|Overall Study|Lost to Follow-up|8|||
131835040|NCT00103402|474678042|FG001|Overall Study|Lost to Follow-up|7|||
131835041|NCT00103402|474678041|FG000|Overall Study|Dissatisfied/No longer interested|6|||
131835042|NCT00103402|474678042|FG001|Overall Study|Dissatisfied/No longer interested|6|||
131835043|NCT00103402|474678041|FG000|Overall Study|Personal constraints/Other|5|||
131835044|NCT00103402|474678042|FG001|Overall Study|Personal constraints/Other|0|||
131835045|NCT01393730|474678043|FG000|Overall Study|Withdrawal by Subject|3|||
131835046|NCT01393730|474678043|FG000|Overall Study|Other|2|||
131835047|NCT01393730|474678043|FG000|Overall Study|Adverse Event|1|||
131835048|NCT00712985|474678047|FG000|Overall Study|1 withdrew prior to start of drug|1|||
131835049|NCT00712985|474678047|FG000|Overall Study|1 patient moved out of state|1|||
131835050|NCT00712985|474678047|FG000|Overall Study|Lack of Efficacy|3|||
131835051|NCT00123955|474678053|FG000|Overall Study|Adverse Event|1|||
131835052|NCT00123955|474678054|FG001|Overall Study|Adverse Event|0|||
131835053|NCT00123955|474678053|FG000|Overall Study|Withdrawal by Subject|4|||
131835054|NCT00123955|474678054|FG001|Overall Study|Withdrawal by Subject|3|||
131835055|NCT00123955|474678053|FG000|Overall Study|Death|0|||
131835056|NCT00123955|474678054|FG001|Overall Study|Death|1|||
131835057|NCT04556552|474679740|FG000|Overall Study|Lost to Follow-up|1|||
131835058|NCT04556552|474679741|FG001|Overall Study|Lost to Follow-up|0|||
131835059|NCT04556552|474679740|FG000|Overall Study|Claustrophobia|0|||
131835060|NCT04556552|474679741|FG001|Overall Study|Claustrophobia|1|||
131835061|NCT04556552|474679740|FG000|Overall Study|Inability to continue|0|||
131835062|NCT04556552|474679741|FG001|Overall Study|Inability to continue|1|||
131835063|NCT00605865|474679742|FG000|Overall Study|Protocol Violation|115|||
131835064|NCT02119286|474679749|FG000|Overall Study|Adverse Event|9|||
131835065|NCT02119286|474679750|FG001|Overall Study|Adverse Event|7|||
131835066|NCT02119286|474679751|FG002|Overall Study|Adverse Event|2|||
131835067|NCT02119286|474679749|FG000|Overall Study|Lack of Efficacy|11|||
131835068|NCT02119286|474679750|FG001|Overall Study|Lack of Efficacy|3|||
131835069|NCT02119286|474679751|FG002|Overall Study|Lack of Efficacy|4|||
131835070|NCT02119286|474679749|FG000|Overall Study|Lost to Follow-up|2|||
131835071|NCT02119286|474679750|FG001|Overall Study|Lost to Follow-up|0|||
131835072|NCT02119286|474679751|FG002|Overall Study|Lost to Follow-up|1|||
131835073|NCT02119286|474679749|FG000|Overall Study|Withdrawal by Subject|4|||
131835074|NCT02119286|474679750|FG001|Overall Study|Withdrawal by Subject|1|||
131835075|NCT02119286|474679751|FG002|Overall Study|Withdrawal by Subject|0|||
131910591|NCT00701363|474960804|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
131450153|NCT04032093|473276806|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131835076|NCT03310411|474679752|FG000|Period 1|Adverse Event|0|||
131835077|NCT03310411|474679753|FG001|Period 1|Adverse Event|0|||
131835078|NCT03310411|474679754|FG002|Period 1|Adverse Event|0|||
131835079|NCT03310411|474679755|FG003|Period 1|Adverse Event|1|||
131835080|NCT00619112|474679756|FG000|Overall Study|Adverse Event|1|||
131835081|NCT00619112|474679757|FG001|Overall Study|Adverse Event|2|||
131835082|NCT02040779|474679765|FG000|Overall Study|Adverse Event|1|||
131835083|NCT02040779|474679766|FG001|Overall Study|Adverse Event|0|||
131835084|NCT02040779|474679767|FG002|Overall Study|Adverse Event|0|||
131835085|NCT02040779|474679765|FG000|Overall Study|Withdrawal by Subject|4|||
131835086|NCT02040779|474679766|FG001|Overall Study|Withdrawal by Subject|1|||
131835087|NCT02040779|474679767|FG002|Overall Study|Withdrawal by Subject|3|||
131835088|NCT02040779|474679765|FG000|Overall Study|Non-compliance|0|||
131835089|NCT02040779|474679766|FG001|Overall Study|Non-compliance|1|||
131835090|NCT02040779|474679767|FG002|Overall Study|Non-compliance|0|||
131835091|NCT02040779|474679765|FG000|Overall Study|Protocol Violation|2|||
131835092|NCT02040779|474679766|FG001|Overall Study|Protocol Violation|1|||
131835093|NCT02040779|474679767|FG002|Overall Study|Protocol Violation|0|||
131835094|NCT02040779|474679765|FG000|Overall Study|Lost to Follow-up|1|||
131835095|NCT02040779|474679766|FG001|Overall Study|Lost to Follow-up|2|||
131835096|NCT02040779|474679767|FG002|Overall Study|Lost to Follow-up|1|||
131835097|NCT02040779|474679765|FG000|Overall Study|Lack of Efficacy|4|||
131835098|NCT02040779|474679766|FG001|Overall Study|Lack of Efficacy|2|||
131835099|NCT02040779|474679767|FG002|Overall Study|Lack of Efficacy|0|||
131835100|NCT02132637|474679768|FG000|Study Period 1|Withdrawal by Subject|0|||
131835101|NCT02132637|474679769|FG001|Study Period 1|Withdrawal by Subject|4|||
131835102|NCT02132637|474679768|FG000|Study Period 1|Physician Decision|1|||
131835103|NCT02132637|474679769|FG001|Study Period 1|Physician Decision|0|||
131835104|NCT02132637|474679768|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
131835105|NCT02132637|474679769|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
131835106|NCT02132637|474679768|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
131835107|NCT02132637|474679769|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
131835108|NCT00652028|474679774|FG000|Overall Study|Adverse Event|1|||
131835109|NCT00652028|474679775|FG001|Overall Study|Adverse Event|0|||
131835110|NCT00652028|474679776|FG002|Overall Study|Adverse Event|0|||
131835111|NCT00652028|474679777|FG003|Overall Study|Adverse Event|0|||
131835112|NCT00652028|474679774|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
131835113|NCT00652028|474679775|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
131835114|NCT00652028|474679776|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
131835115|NCT00652028|474679777|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
131835116|NCT00652028|474679774|FG000|Overall Study|Physician Decision|0|||
131835117|NCT00652028|474679775|FG001|Overall Study|Physician Decision|0|||
131835118|NCT00652028|474679776|FG002|Overall Study|Physician Decision|1|||
131835119|NCT00652028|474679777|FG003|Overall Study|Physician Decision|0|||
131835120|NCT02400671|474679780|FG000|Overall Study|Death|5|||
131835121|NCT02400671|474679781|FG001|Overall Study|Death|3|||
131835122|NCT02400671|474679782|FG002|Overall Study|Death|4|||
131835123|NCT02400671|474679780|FG000|Overall Study|Lost to Follow-up|20|||
131835124|NCT02400671|474679781|FG001|Overall Study|Lost to Follow-up|27|||
131835125|NCT02400671|474679782|FG002|Overall Study|Lost to Follow-up|24|||
131835126|NCT02400671|474679780|FG000|Overall Study|Withdrawal by Subject|2|||
131835127|NCT02400671|474679781|FG001|Overall Study|Withdrawal by Subject|2|||
131835128|NCT02400671|474679782|FG002|Overall Study|Withdrawal by Subject|0|||
131835129|NCT04397445|474679790|FG000|Overall Study|Withdrawal by Subject|1|||
131835130|NCT04397445|474679791|FG001|Overall Study|Withdrawal by Subject|0|||
131835131|NCT04397445|474679792|FG002|Overall Study|Withdrawal by Subject|0|||
131835132|NCT04397445|474679793|FG003|Overall Study|Withdrawal by Subject|0|||
131835133|NCT01429051|474679794|FG000|Titration Phase|Death|1|||
131835134|NCT01429051|474679794|FG000|Titration Phase|Withdrawal by Subject|7|||
131835135|NCT01429051|474679794|FG000|Titration Phase|Physician Decision|1|||
131835136|NCT01429051|474679794|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
131835137|NCT01429051|474679794|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
131835138|NCT01429051|474679794|FG000|Efficacy Phase|Adverse Event|1|||
131835139|NCT01429051|474679794|FG000|Efficacy Phase|Death|1|||
131835140|NCT01429051|474679794|FG000|Tolerability Phase|Death|5|||
131835141|NCT01429051|474679794|FG000|Tolerability Phase|Adverse Event|2|||
131835142|NCT01429051|474679794|FG000|Tolerability Phase|Withdrawal by Subject|5|||
131835143|NCT01429051|474679794|FG000|Tolerability Phase|Physician Decision|1|||
131835144|NCT01429051|474679794|FG000|Tolerability Phase|Other|2|||
131835145|NCT03921151|474679795|FG000|Overall Study|Withdrawal by Subject|11|||
131835146|NCT03921151|474679796|FG001|Overall Study|Withdrawal by Subject|16|||
131835147|NCT03656874|474679798|FG000|Overall Study|Lost to Follow-up|3|||
131835148|NCT03656874|474679799|FG001|Overall Study|Lost to Follow-up|17|||
131835149|NCT00857792|474679800|FG000|Overall Study|inadequate image quality for analysis|12|||
131835150|NCT01797835|474679805|FG000|Overall Study|Lost to Follow-up|31|||
131835151|NCT01797835|474679806|FG001|Overall Study|Lost to Follow-up|27|||
131835152|NCT03001219|474679807|FG000|Proof of Concept|Study Termination by Sponsor|0|||
131835153|NCT03001219|474679808|FG001|Proof of Concept|Study Termination by Sponsor|1|||
131835154|NCT03001219|474679807|FG000|Proof of Concept|Withdrawal by Subject|0|||
131835155|NCT03001219|474679808|FG001|Proof of Concept|Withdrawal by Subject|4|||
131835156|NCT03001219|474679807|FG000|Proof of Concept|Protocol Deviation|0|||
131835157|NCT03001219|474679808|FG001|Proof of Concept|Protocol Deviation|1|||
131835158|NCT03001219|474679807|FG000|Proof of Concept|Adverse Event|1|||
131835159|NCT03001219|474679808|FG001|Proof of Concept|Adverse Event|1|||
131835160|NCT03001219|474679807|FG000|Proof of Concept|Physician Decision|1|||
131835161|NCT03001219|474679808|FG001|Proof of Concept|Physician Decision|0|||
131835162|NCT03001219|474679807|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
131835163|NCT03001219|474679808|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
131835164|NCT03001219|474679807|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
131835165|NCT03001219|474679808|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
131835166|NCT03001219|474679807|FG000|Extension Period Analysis|Physician Decision|0|||
131835167|NCT03001219|474679808|FG001|Extension Period Analysis|Physician Decision|1|||
131835168|NCT03001219|474679807|FG000|Extension Period Analysis|Adverse Event|1|||
131835169|NCT03001219|474679808|FG001|Extension Period Analysis|Adverse Event|1|||
131835170|NCT03001219|474679807|FG000|Extension Period Analysis|Protocol Deviation|0|||
131835171|NCT03001219|474679808|FG001|Extension Period Analysis|Protocol Deviation|1|||
131835172|NCT03001219|474679807|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
131835173|NCT03001219|474679808|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
131835174|NCT01195103|474679810|FG000|Overall Study|Withdrawal by Subject|1|||
131835175|NCT01195103|474679811|FG001|Overall Study|Withdrawal by Subject|0|||
131835176|NCT01195103|474679812|FG002|Overall Study|Withdrawal by Subject|0|||
131835177|NCT02528123|474679813|FG000|Overall Study|Lost to Follow-up|1|||
131835178|NCT03733210|474679814|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
131835179|NCT03733210|474679815|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
131835180|NCT03760250|474679817|FG000|Overall Study|Withdrawal by Subject|1|||
131835181|NCT03760250|474679817|FG000|Overall Study|Physician Decision|1|||
131835182|NCT04421586|474679824|FG000|Overall Study|Death|0|||
131835183|NCT04421586|474679825|FG001|Overall Study|Death|1|||
131835184|NCT04421586|474679824|FG000|Overall Study|Lost to Follow-up|2|||
131835185|NCT04421586|474679825|FG001|Overall Study|Lost to Follow-up|2|||
131835186|NCT04421586|474679824|FG000|Overall Study|Withdrawn by PI|1|||
131835187|NCT04421586|474679825|FG001|Overall Study|Withdrawn by PI|0|||
131835188|NCT04421586|474679824|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
131835189|NCT04421586|474679825|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
131835190|NCT02963441|474679826|FG000|Overall Study|Protocol violation or withdrawn|8|||
131835191|NCT02963441|474679826|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
131835192|NCT02963441|474679826|FG000|Overall Study|IDx-DR insufficient quality|33|||
131835193|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Adverse Event|9|||
131835194|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Adverse Event|4|||
131835195|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Adverse Event|5|||
131835196|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Adverse Event|9|||
131835197|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Adverse Event|8|||
131835198|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Adverse Event|0|||
131835199|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Adverse Event|0|||
131835200|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
131835201|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
131835202|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
131835203|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
131835204|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
131835205|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
131835206|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
131835207|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Death|1|||
131835208|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Death|1|||
131835209|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Death|1|||
131835210|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Death|1|||
131835211|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Death|0|||
131835212|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Death|0|||
131835213|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Death|0|||
131835214|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
131835215|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
131835216|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
131835217|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
131835218|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
131835219|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
131835220|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
131835221|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
131835222|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
131835223|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
131835224|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
131402065|NCT02456636|473093564|FG001|Overall Study|Pregnancy|3|||
131402066|NCT02456636|473093565|FG002|Overall Study|Pregnancy|5|||
131402067|NCT02456636|473093563|FG000|Overall Study|Physician Decision|4|||
131835225|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
131835226|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
131835227|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
131835228|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
131835229|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
131835230|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
131835231|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
131835232|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
131835233|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
131402068|NCT02456636|473093564|FG001|Overall Study|Physician Decision|5|||
131402069|NCT02456636|473093565|FG002|Overall Study|Physician Decision|4|||
131835234|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
131835235|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Other|2|||
131835236|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Other|9|||
131835237|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Other|9|||
131835238|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Other|3|||
131835239|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Other|2|||
131835240|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Other|0|||
131835241|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Other|0|||
131835242|NCT00361335|474679828|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
131835243|NCT00361335|474679829|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
131835244|NCT00361335|474679830|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
131835245|NCT00361335|474679831|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
131835246|NCT00361335|474679832|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
131835247|NCT00361335|474679833|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
131835248|NCT00361335|474679834|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
131835249|NCT00361335|474679828|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
131835250|NCT00361335|474679829|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
131835251|NCT00361335|474679830|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
131835252|NCT00361335|474679831|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
131835253|NCT00361335|474679832|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
131835254|NCT00361335|474679833|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
131835255|NCT00361335|474679834|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
131835256|NCT00361335|474679828|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
131835257|NCT00361335|474679829|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
131835258|NCT00361335|474679830|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
131835259|NCT00361335|474679831|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
131835260|NCT00361335|474679832|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
131835261|NCT00361335|474679833|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
131835262|NCT00361335|474679834|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
131835263|NCT00361335|474679828|FG000|SC Period: Week E0 to Week E24|Death|0|||
131835264|NCT00361335|474679829|FG001|SC Period: Week E0 to Week E24|Death|0|||
131835265|NCT00361335|474679830|FG002|SC Period: Week E0 to Week E24|Death|0|||
131835266|NCT00361335|474679831|FG003|SC Period: Week E0 to Week E24|Death|0|||
131835267|NCT00361335|474679832|FG004|SC Period: Week E0 to Week E24|Death|0|||
131835268|NCT00361335|474679833|FG005|SC Period: Week E0 to Week E24|Death|0|||
131835269|NCT00361335|474679834|FG006|SC Period: Week E0 to Week E24|Death|1|||
131835270|NCT00361335|474679828|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
131835271|NCT00361335|474679829|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
131835272|NCT00361335|474679830|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
131835273|NCT00361335|474679831|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
131835274|NCT00361335|474679832|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
131835275|NCT00361335|474679833|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
131835276|NCT00361335|474679834|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
131835277|NCT00361335|474679828|FG000|SC Period: Week E0 to Week E24|Other|1|||
131835278|NCT00361335|474679829|FG001|SC Period: Week E0 to Week E24|Other|0|||
131835279|NCT00361335|474679830|FG002|SC Period: Week E0 to Week E24|Other|0|||
131835280|NCT00361335|474679831|FG003|SC Period: Week E0 to Week E24|Other|1|||
131835281|NCT00361335|474679832|FG004|SC Period: Week E0 to Week E24|Other|0|||
131835282|NCT00361335|474679833|FG005|SC Period: Week E0 to Week E24|Other|1|||
131835283|NCT00361335|474679834|FG006|SC Period: Week E0 to Week E24|Other|2|||
131835284|NCT00361335|474679828|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
131835285|NCT00361335|474679829|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
131835286|NCT00361335|474679830|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
131835287|NCT00361335|474679831|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
131835288|NCT00361335|474679832|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
131835289|NCT00361335|474679833|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
131835290|NCT00361335|474679834|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
131835291|NCT05065983|474679835|FG000|Overall Study|Lost to Follow-up|2|||
131835292|NCT01765582|474679836|FG000|Overall Study|Other|3|||
131835293|NCT01765582|474679837|FG001|Overall Study|Other|6|||
131835294|NCT01765582|474679838|FG002|Overall Study|Other|9|||
131835295|NCT01765582|474679836|FG000|Overall Study|Lost to Follow-up|2|||
131835296|NCT01765582|474679837|FG001|Overall Study|Lost to Follow-up|2|||
131835297|NCT01765582|474679838|FG002|Overall Study|Lost to Follow-up|1|||
131835298|NCT01765582|474679836|FG000|Overall Study|Death|31|||
131835299|NCT01765582|474679837|FG001|Overall Study|Death|36|||
131835300|NCT01765582|474679838|FG002|Overall Study|Death|33|||
131835301|NCT01765582|474679836|FG000|Overall Study|Sponsor Decision|46|||
131835302|NCT01765582|474679837|FG001|Overall Study|Sponsor Decision|42|||
131835303|NCT01765582|474679838|FG002|Overall Study|Sponsor Decision|42|||
131835304|NCT01765582|474679836|FG000|Overall Study|Withdrawal of Consent|11|||
131835305|NCT01765582|474679837|FG001|Overall Study|Withdrawal of Consent|6|||
131835306|NCT01765582|474679838|FG002|Overall Study|Withdrawal of Consent|10|||
131835307|NCT01691820|474679839|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
131835308|NCT01691820|474679840|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
131835309|NCT01691820|474679839|FG000|Overall Study|Migrated/moved from study area|7|||
131835310|NCT01691820|474679840|FG001|Overall Study|Migrated/moved from study area|4|||
131835311|NCT01691820|474679839|FG000|Overall Study|Lost to Follow-up|6|||
131835312|NCT01691820|474679840|FG001|Overall Study|Lost to Follow-up|17|||
131835313|NCT01691820|474679839|FG000|Overall Study|Other (unspecified)|4|||
131835314|NCT01691820|474679840|FG001|Overall Study|Other (unspecified)|1|||
131835315|NCT00616941|474679845|FG000|Overall Study|Progressive Disease|1|||
131835316|NCT00616941|474679846|FG001|Overall Study|Progressive Disease|2|||
131835317|NCT00616941|474679847|FG002|Overall Study|Progressive Disease|1|||
131835318|NCT00616941|474679845|FG000|Overall Study|Adverse Event|0|||
131835319|NCT00616941|474679846|FG001|Overall Study|Adverse Event|1|||
131835320|NCT00616941|474679847|FG002|Overall Study|Adverse Event|1|||
131835321|NCT00616941|474679845|FG000|Overall Study|Subject Non-compliance|0|||
131835322|NCT00616941|474679846|FG001|Overall Study|Subject Non-compliance|0|||
131835323|NCT00616941|474679847|FG002|Overall Study|Subject Non-compliance|1|||
131835324|NCT00616941|474679845|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
131835325|NCT00616941|474679846|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
131835326|NCT00616941|474679847|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
131835327|NCT00616941|474679845|FG000|Overall Study|Vaccination Suspended|0|||
131835328|NCT00616941|474679846|FG001|Overall Study|Vaccination Suspended|0|||
131835329|NCT00616941|474679847|FG002|Overall Study|Vaccination Suspended|3|||
131835330|NCT04505293|474679855|FG000|Overall Study|Lost to Follow-up|2|||
131835331|NCT04505293|474679855|FG000|Overall Study|Withdrawal by Subject|6|||
131835332|NCT04505293|474679855|FG000|Overall Study|CT scan unreadable|277|||
131835333|NCT00076804|474679856|FG000|Overall Study|Death|9|||
131835334|NCT00076804|474679857|FG001|Overall Study|Death|20|||
131835335|NCT00076804|474679856|FG000|Overall Study|Lost to Follow-up|9|||
131835336|NCT00076804|474679857|FG001|Overall Study|Lost to Follow-up|9|||
131835337|NCT00076804|474679856|FG000|Overall Study|Withdrawal by Subject|10|||
131835338|NCT00076804|474679857|FG001|Overall Study|Withdrawal by Subject|8|||
131835339|NCT00076804|474679856|FG000|Overall Study|Early study Closure|32|||
131835340|NCT00076804|474679857|FG001|Overall Study|Early study Closure|32|||
131835341|NCT01732874|474679859|FG000|Overall Study|Withdrawal by Subject|5|||
131835342|NCT01732874|474679860|FG001|Overall Study|Withdrawal by Subject|1|||
131835343|NCT01732874|474679859|FG000|Overall Study|Death of Infant|3|||
131835344|NCT01732874|474679860|FG001|Overall Study|Death of Infant|2|||
131835345|NCT02408068|474679861|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
131835346|NCT02408068|474679862|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
131835347|NCT02408068|474679863|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
131835348|NCT02408068|474679864|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
131835349|NCT02408068|474679865|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
131835350|NCT02408068|474679866|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
131835351|NCT02458092|474679867|FG000|Overall Study|Withdrawal by Subject|1|||
131835352|NCT02458092|474679868|FG001|Overall Study|Withdrawal by Subject|0|||
131835353|NCT03852459|474679871|FG000|Overall Study|Adverse Event|2|||
131835354|NCT03852459|474679872|FG001|Overall Study|Adverse Event|2|||
131835355|NCT03852459|474679871|FG000|Overall Study|Withdrawal by Subject|1|||
131835356|NCT03852459|474679872|FG001|Overall Study|Withdrawal by Subject|1|||
131835357|NCT00770692|474679875|FG000|Overall Study|Withdrawal by Subject|7|||
131835358|NCT00770692|474679876|FG001|Overall Study|Withdrawal by Subject|9|||
131835359|NCT00770692|474679877|FG002|Overall Study|Withdrawal by Subject|9|||
131835360|NCT00770692|474679878|FG003|Overall Study|Withdrawal by Subject|6|||
131835361|NCT00770692|474679875|FG000|Overall Study|Adverse Event|3|||
131835362|NCT00770692|474679876|FG001|Overall Study|Adverse Event|0|||
131835363|NCT00770692|474679877|FG002|Overall Study|Adverse Event|4|||
131835364|NCT00770692|474679878|FG003|Overall Study|Adverse Event|4|||
131835365|NCT00770692|474679875|FG000|Overall Study|Investigator judgment|2|||
131835366|NCT00770692|474679876|FG001|Overall Study|Investigator judgment|0|||
131835367|NCT00770692|474679877|FG002|Overall Study|Investigator judgment|1|||
131835368|NCT00770692|474679878|FG003|Overall Study|Investigator judgment|1|||
131835369|NCT01846273|474679884|FG000|Overall Study|Adverse Event|9|||
131835370|NCT01846273|474679885|FG001|Overall Study|Adverse Event|7|||
131835371|NCT01846273|474679886|FG002|Overall Study|Adverse Event|0|||
131835372|NCT01846273|474679884|FG000|Overall Study|Subject withdrew consent|5|||
131835373|NCT01846273|474679885|FG001|Overall Study|Subject withdrew consent|8|||
131910592|NCT00701363|474960805|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
131835374|NCT01846273|474679886|FG002|Overall Study|Subject withdrew consent|0|||
131835375|NCT01846273|474679884|FG000|Overall Study|Lost to Follow-up|2|||
131835376|NCT01846273|474679885|FG001|Overall Study|Lost to Follow-up|1|||
131835377|NCT01846273|474679886|FG002|Overall Study|Lost to Follow-up|0|||
131835378|NCT01846273|474679884|FG000|Overall Study|Administrative problems|1|||
131835379|NCT01846273|474679885|FG001|Overall Study|Administrative problems|0|||
131835380|NCT01846273|474679886|FG002|Overall Study|Administrative problems|0|||
131835381|NCT01846273|474679884|FG000|Overall Study|Death|2|||
131835382|NCT01846273|474679885|FG001|Overall Study|Death|1|||
131835383|NCT01846273|474679886|FG002|Overall Study|Death|0|||
131835384|NCT01846273|474679884|FG000|Overall Study|Disease Progression|0|||
131835385|NCT01846273|474679885|FG001|Overall Study|Disease Progression|4|||
131835386|NCT01846273|474679886|FG002|Overall Study|Disease Progression|0|||
131835387|NCT01846273|474679884|FG000|Overall Study|Protocol Deviation|2|||
131835388|NCT01846273|474679885|FG001|Overall Study|Protocol Deviation|3|||
131835389|NCT01846273|474679886|FG002|Overall Study|Protocol Deviation|0|||
131835390|NCT01846273|474679884|FG000|Overall Study|Physician Decision|1|||
131835391|NCT01846273|474679885|FG001|Overall Study|Physician Decision|2|||
131835392|NCT01846273|474679886|FG002|Overall Study|Physician Decision|0|||
131835393|NCT01673698|474679887|FG000|Overall Study|Lost to Follow-up|51|||
131835394|NCT01673698|474679888|FG001|Overall Study|Lost to Follow-up|13|||
131835395|NCT02384850|474679889|FG000|Overall Study|Withdrawal by Subject|2|||
131835396|NCT02384850|474679890|FG001|Overall Study|Withdrawal by Subject|2|||
131835397|NCT02013375|474679891|FG000|Overall Study|Did not engraft|1|||
131835398|NCT02013375|474679891|FG000|Overall Study|Did not engraft|1|||
131835399|NCT02674061|474679892|FG000|Overall Study|Death|229|||
131835400|NCT02674061|474679893|FG001|Overall Study|Death|77|||
131835401|NCT02674061|474679892|FG000|Overall Study|Lost to Follow-up|3|||
131835402|NCT02674061|474679893|FG001|Overall Study|Lost to Follow-up|3|||
131835403|NCT02674061|474679892|FG000|Overall Study|Withdrawal by Subject|9|||
131835404|NCT02674061|474679893|FG001|Overall Study|Withdrawal by Subject|1|||
131835405|NCT02674061|474679892|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
131835406|NCT02674061|474679893|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
131835407|NCT01299805|474679894|FG000|Overall Study|Adverse Event|2|||
131835408|NCT01299805|474679895|FG001|Overall Study|Adverse Event|0|||
131835409|NCT01558297|474679902|FG000|Overall Study|Withdrawal by Subject|2|||
131835410|NCT01558297|474679903|FG001|Overall Study|Withdrawal by Subject|2|||
131835411|NCT01558297|474679904|FG002|Overall Study|Withdrawal by Subject|1|||
131835412|NCT04969861|474679905|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
131835413|NCT04969861|474679906|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
131835414|NCT02932228|474679912|FG000|Overall Study|Death|8|||
131835415|NCT02932228|474679913|FG001|Overall Study|Death|23|||
131835416|NCT02932228|474679912|FG000|Overall Study|not eligible upon chart review|2|||
131835417|NCT02932228|474679913|FG001|Overall Study|not eligible upon chart review|5|||
131835418|NCT02522403|474681703|FG000|Overall Study|Lost to Follow-up|2|||
131835419|NCT02522403|474681704|FG001|Overall Study|Lost to Follow-up|2|||
131835420|NCT02522403|474681703|FG000|Overall Study|Withdrawal by Subject|2|||
131835421|NCT02522403|474681704|FG001|Overall Study|Withdrawal by Subject|4|||
131835422|NCT04718194|474681705|FG000|Overall Study|Withdrawal by Subject|3|||
131835423|NCT04718194|474681706|FG001|Overall Study|Withdrawal by Subject|0|||
131835424|NCT04718194|474681705|FG000|Overall Study|Lost to Follow-up|3|||
131835425|NCT04718194|474681706|FG001|Overall Study|Lost to Follow-up|0|||
131835426|NCT01215513|474681707|FG000|Overall Study|Not completed CS42|9|||
131835427|NCT01215513|474681707|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
131835428|NCT01215513|474681707|FG000|Overall Study|Adverse event (CS42A)|2|||
131835429|NCT01215513|474681707|FG000|Overall Study|Physician decision (CS42A)|6|||
131835430|NCT01215513|474681707|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
131835431|NCT01215513|474681707|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
131835432|NCT01553279|474681708|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
131835433|NCT01553279|474681709|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
131835434|NCT01553279|474681708|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
131835435|NCT01553279|474681709|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
131835436|NCT01553279|474681708|FG000|Interim Period|Withdrawal by Subject|2|||
131835437|NCT01553279|474681709|FG001|Interim Period|Withdrawal by Subject|2|||
131835438|NCT01553279|474681708|FG000|Interim Period|Lost to Follow-up|1|||
131835439|NCT01553279|474681709|FG001|Interim Period|Lost to Follow-up|0|||
131835440|NCT01553279|474681708|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
131835441|NCT01553279|474681709|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
131835442|NCT01553279|474681708|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
131835443|NCT01553279|474681709|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
131835444|NCT03955471|474681710|FG000|Overall Study|Death|22|||
131835445|NCT03955471|474681710|FG000|Overall Study|Lost to Follow-up|1|||
131835446|NCT03955471|474681710|FG000|Overall Study|Withdrawal by Subject|6|||
131835447|NCT03955471|474681710|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
131835448|NCT00793780|474681716|FG000|Overall Study|Withdrawal by Subject|2|||
131910593|NCT00701363|474960806|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
131450154|NCT04032093|473276807|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
131835449|NCT00793780|474681717|FG001|Overall Study|Withdrawal by Subject|1|||
131835450|NCT02858492|474681718|FG000|Overall Study|Withdrawal by Subject|0|||
131835451|NCT02858492|474681719|FG001|Overall Study|Withdrawal by Subject|1|||
131835452|NCT02858492|474681720|FG002|Overall Study|Withdrawal by Subject|0|||
131835453|NCT02858492|474681721|FG003|Overall Study|Withdrawal by Subject|1|||
131835454|NCT02858492|474681718|FG000|Overall Study|Adverse Event|0|||
131835455|NCT02858492|474681719|FG001|Overall Study|Adverse Event|0|||
131835456|NCT02858492|474681720|FG002|Overall Study|Adverse Event|0|||
131402070|NCT02456636|473093563|FG000|Overall Study|Withdrawal by Subject|13|||
131402071|NCT02456636|473093564|FG001|Overall Study|Withdrawal by Subject|14|||
131402072|NCT02456636|473093565|FG002|Overall Study|Withdrawal by Subject|16|||
131402073|NCT02456636|473093563|FG000|Overall Study|Lost to Follow-up|50|||
131835457|NCT02858492|474681721|FG003|Overall Study|Adverse Event|3|||
131835458|NCT02858492|474681718|FG000|Overall Study|Lack of Efficacy|0|||
131835459|NCT02858492|474681719|FG001|Overall Study|Lack of Efficacy|0|||
131835460|NCT02858492|474681720|FG002|Overall Study|Lack of Efficacy|0|||
131835461|NCT02858492|474681721|FG003|Overall Study|Lack of Efficacy|1|||
131835462|NCT02858492|474681718|FG000|Overall Study|Protocol defined stopping criteria|0|||
131835463|NCT02858492|474681719|FG001|Overall Study|Protocol defined stopping criteria|0|||
131835464|NCT02858492|474681720|FG002|Overall Study|Protocol defined stopping criteria|0|||
131835465|NCT02858492|474681721|FG003|Overall Study|Protocol defined stopping criteria|1|||
131835466|NCT01995266|474681722|FG000|Overall Study|Death|1|||
131835467|NCT01995266|474681722|FG000|Overall Study|Lack of Efficacy|6|||
131835468|NCT01995266|474681722|FG000|Overall Study|Adverse Event|2|||
131835469|NCT00922272|474681723|FG000|Open-label Phase|Adverse Event|5|||
131835470|NCT00922272|474681724|FG001|Open-label Phase|Adverse Event|0|||
131835471|NCT00922272|474681723|FG000|Open-label Phase|Protocol Violation|1|||
131835472|NCT00922272|474681724|FG001|Open-label Phase|Protocol Violation|0|||
131835473|NCT00922272|474681723|FG000|Open-label Phase|Withdrawal by Subject|11|||
131835474|NCT00922272|474681724|FG001|Open-label Phase|Withdrawal by Subject|0|||
131835475|NCT00922272|474681723|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
131835476|NCT00922272|474681724|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
131835477|NCT00922272|474681723|FG000|Open-label Phase|Withdrawal criteria met|5|||
131402074|NCT02456636|473093564|FG001|Overall Study|Lost to Follow-up|44|||
131402075|NCT02456636|473093565|FG002|Overall Study|Lost to Follow-up|50|||
131402076|NCT03350035|473093568|FG000|Overall Study|Lack of Efficacy|2|||
131402077|NCT03350035|473093569|FG001|Overall Study|Lack of Efficacy|0|||
131402078|NCT03350035|473093570|FG002|Overall Study|Lack of Efficacy|0|||
131402079|NCT03350035|473093568|FG000|Overall Study|Subject discharged to hospice|0|||
131402080|NCT03350035|473093569|FG001|Overall Study|Subject discharged to hospice|0|||
131402081|NCT03350035|473093570|FG002|Overall Study|Subject discharged to hospice|1|||
131402082|NCT02379221|473093571|FG000|Overall Study|Lost to Follow-up|1|||
131402083|NCT01610557|473093572|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
131402084|NCT01610557|473093573|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
131402085|NCT01610557|473093574|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
131402086|NCT01610557|473093575|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
131402087|NCT01610557|473093576|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
131402088|NCT01610557|473093572|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
131402089|NCT01610557|473093573|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
131402090|NCT01610557|473093574|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
131402091|NCT01610557|473093575|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
131402092|NCT01610557|473093576|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
131402093|NCT02039219|473093577|FG000|Treatment|Withdrawal by Subject|1|||
131402094|NCT02039219|473093578|FG001|Treatment|Withdrawal by Subject|0|||
131402095|NCT02039219|473093577|FG000|Treatment|Adverse Event|0|||
131402096|NCT02039219|473093578|FG001|Treatment|Adverse Event|1|||
131402097|NCT02039219|473093577|FG000|Treatment|Physician Decision|1|||
131402098|NCT02039219|473093578|FG001|Treatment|Physician Decision|0|||
131402099|NCT02039219|473093577|FG000|Treatment|Lost to Follow-up|0|||
131402100|NCT02039219|473093578|FG001|Treatment|Lost to Follow-up|1|||
131402101|NCT02039219|473093577|FG000|Treatment|Protocol Violation|1|||
131402102|NCT02039219|473093578|FG001|Treatment|Protocol Violation|0|||
131402103|NCT02039219|473093577|FG000|Treatment|Death|1|||
131402104|NCT02039219|473093578|FG001|Treatment|Death|0|||
131402105|NCT02039219|473093577|FG000|Follow up|Adverse Event|0|||
131402106|NCT02039219|473093578|FG001|Follow up|Adverse Event|1|||
131402107|NCT02974855|473093579|FG000|Overall Study|Adverse Event|0|||
131402108|NCT02974855|473093580|FG001|Overall Study|Adverse Event|1|||
131402109|NCT02974855|473093581|FG002|Overall Study|Adverse Event|0|||
131402110|NCT02974855|473093582|FG003|Overall Study|Adverse Event|1|||
131402111|NCT03576066|473093583|FG000|Overall Study|Noncompliance with study drug|0|||
131402112|NCT03576066|473093584|FG001|Overall Study|Noncompliance with study drug|1|||
131402113|NCT00129701|473093585|FG000|Overall Study|Withdrawal by Subject|33|||
131450155|NCT04032093|473276808|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
131835478|NCT00922272|474681724|FG001|Open-label Phase|Withdrawal criteria met|0|||
131835479|NCT00922272|474681723|FG000|Double-blind Phase|Adverse Event|1|||
131402114|NCT02750345|473093586|FG000|Intervention 1|Adverse Event|0|||
131402115|NCT02750345|473093587|FG001|Intervention 1|Adverse Event|0|||
131402116|NCT02750345|473093588|FG002|Intervention 1|Adverse Event|0|||
131402117|NCT02750345|473093589|FG003|Intervention 1|Adverse Event|0|||
131402118|NCT02750345|473093590|FG004|Intervention 1|Adverse Event|1|||
131402119|NCT02750345|473093591|FG005|Intervention 1|Adverse Event|0|||
131402120|NCT00006164|473093592|FG000|Overall Study|Withdrew or lost to follow-up|70|||
131835480|NCT00922272|474681724|FG001|Double-blind Phase|Adverse Event|1|||
131402121|NCT00006164|473093593|FG001|Overall Study|Withdrew or lost to follow-up|81|||
131402122|NCT00633074|473093596|FG000|Overall Study|Adverse Event|1|||
131402123|NCT00633074|473093597|FG001|Overall Study|Adverse Event|0|||
131835481|NCT00922272|474681723|FG000|Double-blind Phase|Withdrawal by Subject|1|||
131835482|NCT00922272|474681724|FG001|Double-blind Phase|Withdrawal by Subject|1|||
131835483|NCT00922272|474681723|FG000|Double-blind Phase|Lost to Follow-up|2|||
131835484|NCT00922272|474681724|FG001|Double-blind Phase|Lost to Follow-up|1|||
131835485|NCT00922272|474681723|FG000|Double-blind Phase|Withdrawal criteria met|1|||
131835486|NCT00922272|474681724|FG001|Double-blind Phase|Withdrawal criteria met|1|||
131835487|NCT00922272|474681723|FG000|Double-blind Phase|Noncompliance|1|||
131835488|NCT00922272|474681724|FG001|Double-blind Phase|Noncompliance|1|||
131835489|NCT00922272|474681723|FG000|Double-blind Phase|Positive urine drug screen|1|||
131835490|NCT00922272|474681724|FG001|Double-blind Phase|Positive urine drug screen|1|||
131835491|NCT02072824|474681725|FG000|Overall Study|Insufficient clinical response|1|||
131835492|NCT02072824|474681726|FG001|Overall Study|Insufficient clinical response|0|||
131835493|NCT02072824|474681727|FG002|Overall Study|Insufficient clinical response|1|||
131835494|NCT02072824|474681725|FG000|Overall Study|No longer willing to participate|1|||
131835495|NCT02072824|474681726|FG001|Overall Study|No longer willing to participate|0|||
131835496|NCT02072824|474681727|FG002|Overall Study|No longer willing to participate|1|||
131835497|NCT02072824|474681725|FG000|Overall Study|Medication error|0|||
131835498|NCT02072824|474681726|FG001|Overall Study|Medication error|1|||
131835499|NCT02072824|474681727|FG002|Overall Study|Medication error|0|||
131835500|NCT02072824|474681725|FG000|Overall Study|Adverse Event|0|||
131835501|NCT02072824|474681726|FG001|Overall Study|Adverse Event|0|||
131835502|NCT02072824|474681727|FG002|Overall Study|Adverse Event|1|||
131835503|NCT03084367|474681728|FG000|Overall Study|Lost to Follow-up|32|||
131835504|NCT03084367|474681728|FG000|Overall Study|Withdrawal by Subject|4|||
131835505|NCT03084367|474681728|FG000|Overall Study|Other|1|||
131835506|NCT00841906|474681729|FG000|Overall Study|Withdrawal by Subject|2|||
131835507|NCT00841906|474681730|FG001|Overall Study|Withdrawal by Subject|0|||
131835508|NCT02667288|474681731|FG000|Overall Study|Protocol Violation|5|||
131835509|NCT02667288|474681731|FG000|Overall Study|Lost to Follow-up|3|||
131835510|NCT02667288|474681731|FG000|Overall Study|Withdrawal by Subject|5|||
131835511|NCT01196078|474681732|FG000|Overall Study|Withdrawal by Subject|3|||
131835512|NCT01196078|474681733|FG001|Overall Study|Withdrawal by Subject|5|||
131835513|NCT01196078|474681732|FG000|Overall Study|Adverse Event|4|||
131835514|NCT01196078|474681733|FG001|Overall Study|Adverse Event|4|||
131835515|NCT01196078|474681732|FG000|Overall Study|Protocol Violation|2|||
131835516|NCT01196078|474681733|FG001|Overall Study|Protocol Violation|1|||
131835517|NCT01196078|474681732|FG000|Overall Study|Lack of Efficacy|17|||
131835518|NCT01196078|474681733|FG001|Overall Study|Lack of Efficacy|23|||
131835519|NCT01196078|474681732|FG000|Overall Study|Lost to Follow-up|1|||
131835520|NCT01196078|474681733|FG001|Overall Study|Lost to Follow-up|0|||
131835521|NCT01196078|474681732|FG000|Overall Study|Death|6|||
131835522|NCT01196078|474681733|FG001|Overall Study|Death|4|||
131835523|NCT00912093|474681734|FG000|The Controlled Phase|Death|0|||
131835524|NCT00912093|474681735|FG001|The Controlled Phase|Death|1|||
131835525|NCT00912093|474681736|FG002|The Controlled Phase|Death|0|||
131835526|NCT00912093|474681737|FG003|The Controlled Phase|Death|0|||
131835527|NCT00912093|474681738|FG004|The Controlled Phase|Death|0|||
131835528|NCT00912093|474681734|FG000|The Controlled Phase|Medical Condition|0|||
131835529|NCT00912093|474681735|FG001|The Controlled Phase|Medical Condition|1|||
131835530|NCT00912093|474681736|FG002|The Controlled Phase|Medical Condition|0|||
131402124|NCT00365105|473093598|FG000|Overall Study|Protocol Violation|5|||
131402125|NCT00365105|473093599|FG001|Overall Study|Protocol Violation|8|||
131835531|NCT00912093|474681737|FG003|The Controlled Phase|Medical Condition|0|||
131835532|NCT00912093|474681738|FG004|The Controlled Phase|Medical Condition|0|||
131835533|NCT00912093|474681734|FG000|The Controlled Phase|Lost to Follow-up|0|||
131835534|NCT00912093|474681735|FG001|The Controlled Phase|Lost to Follow-up|0|||
131835535|NCT00912093|474681736|FG002|The Controlled Phase|Lost to Follow-up|0|||
131835536|NCT00912093|474681737|FG003|The Controlled Phase|Lost to Follow-up|0|||
131835537|NCT00912093|474681738|FG004|The Controlled Phase|Lost to Follow-up|1|||
131835538|NCT01403064|474681743|FG000|Overall Study|Death|0|||
131835539|NCT01403064|474681744|FG001|Overall Study|Death|0|||
131835540|NCT01403064|474681745|FG002|Overall Study|Death|1|||
131402126|NCT00608023|473093600|FG000|Overall Study|Withdrawal by Subject|8|||
131835541|NCT01403064|474681746|FG003|Overall Study|Death|1|||
131835542|NCT01403064|474681743|FG000|Overall Study|Withdrawal by Subject|0|||
131835543|NCT01403064|474681744|FG001|Overall Study|Withdrawal by Subject|0|||
131835544|NCT01403064|474681745|FG002|Overall Study|Withdrawal by Subject|1|||
131835545|NCT01403064|474681746|FG003|Overall Study|Withdrawal by Subject|1|||
131835546|NCT01403064|474681743|FG000|Overall Study|Other|1|||
131835547|NCT01403064|474681744|FG001|Overall Study|Other|0|||
131835548|NCT01403064|474681745|FG002|Overall Study|Other|2|||
131835549|NCT01403064|474681746|FG003|Overall Study|Other|1|||
131402127|NCT00608023|473093601|FG001|Overall Study|Withdrawal by Subject|10|||
131835550|NCT02621034|474681747|FG000|Overall Study|Lost to Follow-up|3|||
131835551|NCT02621034|474681748|FG001|Overall Study|Lost to Follow-up|2|||
131835552|NCT02621034|474681749|FG002|Overall Study|Lost to Follow-up|5|||
131835553|NCT04688931|474681750|FG000|Overall Study|Adverse Event|4|||
131835554|NCT04688931|474681751|FG001|Overall Study|Adverse Event|1|||
131835555|NCT04688931|474681750|FG000|Overall Study|Withdrawal by Subject|5|||
131835556|NCT04688931|474681751|FG001|Overall Study|Withdrawal by Subject|16|||
131835557|NCT04688931|474681750|FG000|Overall Study|Physician Decision|3|||
131835558|NCT04688931|474681751|FG001|Overall Study|Physician Decision|5|||
131835559|NCT04688931|474681750|FG000|Overall Study|Noncompliance|0|||
131835560|NCT04688931|474681751|FG001|Overall Study|Noncompliance|1|||
131835561|NCT04688931|474681750|FG000|Overall Study|Lost to Follow-up|1|||
131835562|NCT04688931|474681751|FG001|Overall Study|Lost to Follow-up|3|||
131835563|NCT04688931|474681750|FG000|Overall Study|Randomization Error|3|||
131835564|NCT04688931|474681751|FG001|Overall Study|Randomization Error|0|||
131835565|NCT04688931|474681750|FG000|Overall Study|Not Eligible|1|||
131835566|NCT04688931|474681751|FG001|Overall Study|Not Eligible|3|||
131835567|NCT04688931|474681750|FG000|Overall Study|Disease Progression|0|||
131835568|NCT04688931|474681751|FG001|Overall Study|Disease Progression|2|||
131835569|NCT04688931|474681750|FG000|Overall Study|Sponsor Requirement|1|||
131835570|NCT04688931|474681751|FG001|Overall Study|Sponsor Requirement|1|||
131835571|NCT04688931|474681750|FG000|Overall Study|Other Reason|1|||
131835572|NCT04688931|474681751|FG001|Overall Study|Other Reason|2|||
131835573|NCT01968694|474681752|FG000|Washout (1 Month)|Lost to Follow-up|0|||
131835574|NCT01968694|474681753|FG001|Washout (1 Month)|Lost to Follow-up|1|||
131835575|NCT00354341|474681754|FG000|Overall Study|Adverse Event|1|||
131835576|NCT00354341|474681755|FG001|Overall Study|Adverse Event|0|||
131835577|NCT00354341|474681754|FG000|Overall Study|Death|0|||
131835578|NCT00354341|474681755|FG001|Overall Study|Death|2|||
131835579|NCT00354341|474681754|FG000|Overall Study|Refused treatment|1|||
131910594|NCT00701363|474960803|FG000|Treatment Phase 1|Adverse Event|7|||
131910595|NCT00701363|474960804|FG001|Treatment Phase 1|Adverse Event|0|||
131910596|NCT00701363|474960805|FG002|Treatment Phase 1|Adverse Event|0|||
131910597|NCT00701363|474960806|FG003|Treatment Phase 1|Adverse Event|0|||
131910598|NCT00701363|474960803|FG000|Treatment Phase 1|Protocol Violation|1|||
131910599|NCT00701363|474960804|FG001|Treatment Phase 1|Protocol Violation|0|||
131910600|NCT00701363|474960805|FG002|Treatment Phase 1|Protocol Violation|0|||
131910601|NCT00701363|474960806|FG003|Treatment Phase 1|Protocol Violation|0|||
131910602|NCT00701363|474960803|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
131910603|NCT00701363|474960804|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
131910604|NCT00701363|474960805|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
131910605|NCT00701363|474960806|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
131910606|NCT00701363|474960803|FG000|Treatment Phase 1|Lack of Efficacy|1|||
131910607|NCT00701363|474960804|FG001|Treatment Phase 1|Lack of Efficacy|0|||
131910608|NCT00701363|474960805|FG002|Treatment Phase 1|Lack of Efficacy|0|||
131910609|NCT00701363|474960806|FG003|Treatment Phase 1|Lack of Efficacy|0|||
131910610|NCT00701363|474960803|FG000|Treatment Phase 2|Adverse Event|0|||
131910611|NCT00701363|474960804|FG001|Treatment Phase 2|Adverse Event|0|||
131910612|NCT00701363|474960805|FG002|Treatment Phase 2|Adverse Event|1|||
131910613|NCT00701363|474960806|FG003|Treatment Phase 2|Adverse Event|0|||
131910614|NCT00701363|474960803|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
131910615|NCT00701363|474960804|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
131910616|NCT00701363|474960805|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
131910617|NCT00701363|474960806|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
131910618|NCT05144945|474960807|FG000|Overall Study|Withdrawal by Subject|1|||
131910619|NCT05144945|474960808|FG001|Overall Study|Withdrawal by Subject|0|||
131910620|NCT00284856|474960809|FG000|Overall Study|Adverse Event|3|||
131910621|NCT00284856|474960810|FG001|Overall Study|Adverse Event|3|||
131910622|NCT00284856|474960811|FG002|Overall Study|Adverse Event|3|||
131910623|NCT00284856|474960809|FG000|Overall Study|Lack of Efficacy|2|||
131402128|NCT00608023|473093602|FG002|Overall Study|Withdrawal by Subject|7|||
131402129|NCT00608023|473093600|FG000|Overall Study|Adverse Event|1|||
131402130|NCT00608023|473093601|FG001|Overall Study|Adverse Event|4|||
131835580|NCT00354341|474681755|FG001|Overall Study|Refused treatment|2|||
131835581|NCT00354341|474681754|FG000|Overall Study|Failure to return|0|||
131835582|NCT00354341|474681755|FG001|Overall Study|Failure to return|1|||
131835583|NCT00354341|474681754|FG000|Overall Study|Other|1|||
131835584|NCT00354341|474681755|FG001|Overall Study|Other|2|||
131835585|NCT00251719|474681756|FG000|Overall Study|Adverse Event|14|||
131835586|NCT00251719|474681757|FG001|Overall Study|Adverse Event|8|||
131835587|NCT00251719|474681758|FG002|Overall Study|Adverse Event|7|||
131910624|NCT00284856|474960810|FG001|Overall Study|Lack of Efficacy|1|||
131910625|NCT00284856|474960811|FG002|Overall Study|Lack of Efficacy|8|||
131910626|NCT00284856|474960809|FG000|Overall Study|Lost to Follow-up|25|||
131910627|NCT00284856|474960810|FG001|Overall Study|Lost to Follow-up|21|||
131910628|NCT00284856|474960811|FG002|Overall Study|Lost to Follow-up|22|||
131910629|NCT00284856|474960809|FG000|Overall Study|Protocol Violation|5|||
131910630|NCT00284856|474960810|FG001|Overall Study|Protocol Violation|4|||
131402131|NCT00608023|473093602|FG002|Overall Study|Adverse Event|5|||
131835588|NCT00251719|474681756|FG000|Overall Study|Protocol Violation|1|||
131910631|NCT00284856|474960811|FG002|Overall Study|Protocol Violation|5|||
131910632|NCT00284856|474960809|FG000|Overall Study|Withdrawal by Subject|12|||
131402132|NCT00608023|473093600|FG000|Overall Study|Lost to Follow-up|2|||
131402133|NCT00608023|473093601|FG001|Overall Study|Lost to Follow-up|2|||
131402134|NCT00608023|473093602|FG002|Overall Study|Lost to Follow-up|1|||
131402135|NCT00608023|473093600|FG000|Overall Study|Protocol Violation|1|||
131402136|NCT00608023|473093601|FG001|Overall Study|Protocol Violation|3|||
131402137|NCT00608023|473093602|FG002|Overall Study|Protocol Violation|1|||
131402138|NCT00608023|473093600|FG000|Overall Study|Unknown reason|0|||
131835589|NCT00251719|474681757|FG001|Overall Study|Protocol Violation|1|||
131402139|NCT00608023|473093601|FG001|Overall Study|Unknown reason|3|||
131402140|NCT00608023|473093602|FG002|Overall Study|Unknown reason|0|||
131402141|NCT06422364|473093603|FG000|Overall Study|Withdrawn due to study closure|0|||
131402142|NCT06422364|473093604|FG001|Overall Study|Withdrawn due to study closure|2|||
131402143|NCT00245050|473093605|FG000|Overall Study|Adverse Event|3|||
131402144|NCT00245050|473093606|FG001|Overall Study|Adverse Event|2|||
131402145|NCT03905265|473093608|FG000|Overall Study|Withdrawal by Subject|1|||
131402146|NCT03905265|473093609|FG001|Overall Study|Withdrawal by Subject|1|||
131835590|NCT00251719|474681758|FG002|Overall Study|Protocol Violation|1|||
131835591|NCT00251719|474681756|FG000|Overall Study|Lost to Follow-up|5|||
131835592|NCT00251719|474681757|FG001|Overall Study|Lost to Follow-up|11|||
131835593|NCT00251719|474681758|FG002|Overall Study|Lost to Follow-up|8|||
131835594|NCT00251719|474681756|FG000|Overall Study|Withdrawal by Subject|14|||
131835595|NCT00251719|474681757|FG001|Overall Study|Withdrawal by Subject|12|||
131835596|NCT00251719|474681758|FG002|Overall Study|Withdrawal by Subject|11|||
131835597|NCT00251719|474681756|FG000|Overall Study|Lack of Efficacy|2|||
131835598|NCT00251719|474681757|FG001|Overall Study|Lack of Efficacy|1|||
131835599|NCT00251719|474681758|FG002|Overall Study|Lack of Efficacy|0|||
131835600|NCT00251719|474681756|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
131835601|NCT00251719|474681757|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
131835602|NCT00251719|474681758|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
131835603|NCT00251719|474681756|FG000|Overall Study|Investigator decision|1|||
131835604|NCT00251719|474681757|FG001|Overall Study|Investigator decision|1|||
131835605|NCT00251719|474681758|FG002|Overall Study|Investigator decision|0|||
131835606|NCT00251719|474681756|FG000|Overall Study|Noncompliance|2|||
131835607|NCT00251719|474681757|FG001|Overall Study|Noncompliance|3|||
131835608|NCT00251719|474681758|FG002|Overall Study|Noncompliance|1|||
131835609|NCT00251719|474681756|FG000|Overall Study|Barrett's esophagus|2|||
131835610|NCT00251719|474681757|FG001|Overall Study|Barrett's esophagus|2|||
131835611|NCT00251719|474681758|FG002|Overall Study|Barrett's esophagus|0|||
131835612|NCT00557076|474681761|FG000|Overall Study|Unblinding|0|||
131835613|NCT00557076|474681762|FG001|Overall Study|Unblinding|1|||
131835614|NCT00688376|474681763|FG000|Double-Blind Phase|Adverse Event|4|||
131835615|NCT00688376|474681764|FG001|Double-Blind Phase|Adverse Event|4|||
131835616|NCT00688376|474681763|FG000|Double-Blind Phase|Protocol Violation|1|||
131835617|NCT00688376|474681764|FG001|Double-Blind Phase|Protocol Violation|2|||
131835618|NCT00688376|474681763|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
131835619|NCT00688376|474681764|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
131835620|NCT00688376|474681763|FG000|Double-Blind Phase|Not treated|0|||
131835621|NCT00688376|474681764|FG001|Double-Blind Phase|Not treated|1|||
131835622|NCT00688376|474681763|FG000|Blinded Extension Phase|Adverse Event|3|||
131835623|NCT00688376|474681764|FG001|Blinded Extension Phase|Adverse Event|4|||
131835624|NCT00688376|474681763|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
131835625|NCT00688376|474681764|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
131835626|NCT00688376|474681763|FG000|Blinded Extension Phase|Physician Decision|1|||
131835627|NCT00688376|474681764|FG001|Blinded Extension Phase|Physician Decision|0|||
131835628|NCT00688376|474681763|FG000|Blinded Extension Phase|Other|1|||
131835629|NCT00688376|474681764|FG001|Blinded Extension Phase|Other|0|||
131835630|NCT04392583|474681765|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
131835631|NCT01070771|474681769|FG000|Overall Study|Adverse Event|2|||
131835632|NCT01070771|474681769|FG000|Overall Study|Protocol Violation|1|||
131835633|NCT01370213|474681770|FG000|Overall Study|Early Death|1|||
131835634|NCT01370213|474681771|FG001|Overall Study|Early Death|0|||
131835635|NCT01370213|474681772|FG002|Overall Study|Early Death|0|||
131835636|NCT01370213|474681770|FG000|Overall Study|Not evaluable|0|||
131835637|NCT01370213|474681771|FG001|Overall Study|Not evaluable|2|||
131835638|NCT01370213|474681772|FG002|Overall Study|Not evaluable|0|||
131835639|NCT00038649|474681773|FG000|Overall Study|Adverse Event|9|||
131835640|NCT03629028|474681774|FG000|Overall Study|Lost to Follow-up|26|||
131402147|NCT03905265|473093610|FG002|Overall Study|Withdrawal by Subject|0|||
131402148|NCT03905265|473093611|FG003|Overall Study|Withdrawal by Subject|0|||
131402149|NCT03888235|473093613|FG000|Overall Study|Lost to Follow-up|1|||
131402150|NCT03888235|473093614|FG001|Overall Study|Lost to Follow-up|1|||
131835641|NCT03629028|474681775|FG001|Overall Study|Lost to Follow-up|23|||
131835642|NCT03629028|474681774|FG000|Overall Study|Pregnancy|4|||
131835643|NCT03629028|474681775|FG001|Overall Study|Pregnancy|2|||
131835644|NCT03629028|474681774|FG000|Overall Study|intolerance to examination|2|||
131835645|NCT03629028|474681775|FG001|Overall Study|intolerance to examination|0|||
131402151|NCT03888235|473093615|FG002|Overall Study|Lost to Follow-up|0|||
131402152|NCT03832322|473093622|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
131402153|NCT03832322|473093623|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
131402154|NCT00404755|473093624|FG000|Phase I (Bupropion)|Adverse Event|3|||
131402155|NCT00404755|473093624|FG000|Phase I (Bupropion)|Other|1|||
131402156|NCT00404755|473093624|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
131402157|NCT00350870|473093625|FG000|Overall Study|Withdrawal by Subject|21|||
131402158|NCT00350870|473093626|FG001|Overall Study|Withdrawal by Subject|17|||
131402159|NCT00350870|473093627|FG002|Overall Study|Withdrawal by Subject|15|||
131835646|NCT03097588|474681784|FG000|Overall Study|Adverse Event|1|||
131835647|NCT02687360|474681785|FG000|Overall Study|Withdrawal by Subject|3|||
131835648|NCT02687360|474681786|FG001|Overall Study|Withdrawal by Subject|0|||
131835649|NCT02989168|474681787|FG000|Overall Study|Withdrawal by Subject|2|||
131402160|NCT00350870|473093628|FG003|Overall Study|Withdrawal by Subject|14|||
131835650|NCT02989168|474681788|FG001|Overall Study|Withdrawal by Subject|0|||
131835651|NCT02989168|474681787|FG000|Overall Study|Physician Decision|0|||
131835652|NCT02989168|474681788|FG001|Overall Study|Physician Decision|1|||
131835653|NCT02989168|474681787|FG000|Overall Study|Adverse Event|1|||
131835654|NCT02989168|474681788|FG001|Overall Study|Adverse Event|2|||
131835655|NCT02989168|474681787|FG000|Overall Study|Sponsor stopped study.|1|||
131835656|NCT02989168|474681788|FG001|Overall Study|Sponsor stopped study.|0|||
131835657|NCT03456960|474681789|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131835658|NCT03456960|474681790|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131835659|NCT03456960|474681791|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
131835660|NCT03456960|474681792|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
131835661|NCT03456960|474681793|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131835662|NCT03456960|474681794|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131835663|NCT03456960|474681789|FG000|Period 2 (1 Day)|Adverse Event|1|||
131835664|NCT03456960|474681790|FG001|Period 2 (1 Day)|Adverse Event|0|||
131835665|NCT03456960|474681791|FG002|Period 2 (1 Day)|Adverse Event|0|||
131835666|NCT03456960|474681792|FG003|Period 2 (1 Day)|Adverse Event|1|||
131835667|NCT03456960|474681793|FG004|Period 2 (1 Day)|Adverse Event|0|||
131835668|NCT03456960|474681794|FG005|Period 2 (1 Day)|Adverse Event|0|||
131835669|NCT03828448|474681795|FG000|Overall Study|Sponsor's Discretion|34|||
131835670|NCT02037165|474681796|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
131835671|NCT02037165|474681797|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
131835672|NCT02037165|474681798|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
131835673|NCT02037165|474681799|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
131835674|NCT02037165|474681800|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
131835675|NCT00532935|474681801|FG000|Overall Study|Adverse Event|11|||
131835676|NCT00532935|474681802|FG001|Overall Study|Adverse Event|12|||
131835677|NCT00532935|474681801|FG000|Overall Study|Lack of Efficacy|0|||
131835678|NCT00532935|474681802|FG001|Overall Study|Lack of Efficacy|3|||
131835679|NCT00532935|474681801|FG000|Overall Study|Lost to Follow-up|10|||
131835680|NCT00532935|474681802|FG001|Overall Study|Lost to Follow-up|6|||
131835681|NCT00532935|474681801|FG000|Overall Study|Physician Decision|4|||
131835682|NCT00532935|474681802|FG001|Overall Study|Physician Decision|5|||
131835683|NCT00532935|474681801|FG000|Overall Study|Pregnancy|1|||
131835684|NCT00532935|474681802|FG001|Overall Study|Pregnancy|0|||
131835685|NCT00532935|474681801|FG000|Overall Study|Protocol Violation|4|||
131835686|NCT00532935|474681802|FG001|Overall Study|Protocol Violation|2|||
131835687|NCT00532935|474681801|FG000|Overall Study|Withdrawal by Subject|10|||
131835688|NCT00532935|474681802|FG001|Overall Study|Withdrawal by Subject|9|||
131835689|NCT00532935|474681801|FG000|Overall Study|Protocol Specific Criteria|11|||
131835690|NCT00532935|474681802|FG001|Overall Study|Protocol Specific Criteria|15|||
131835691|NCT00456495|474681803|FG000|Overall Study|Physician Decision|2|||
131835692|NCT02192164|474681804|FG000|Overall Study|Other|8|||
131835693|NCT02192164|474681804|FG000|Overall Study|Withdrawal by Subject|1|||
131835694|NCT02192164|474681804|FG000|Overall Study|Physician Decision|4|||
131835695|NCT02192164|474681804|FG000|Overall Study|Did not meet the exclusion criteria|1|||
131835696|NCT01300923|474681805|FG000|Overall Study|Physician Decision|0|||
131835697|NCT01300923|474681806|FG001|Overall Study|Physician Decision|2|||
131835698|NCT01568866|474681807|FG000|Overall Study|Disease Progression|208|||
131835699|NCT01568866|474681808|FG001|Overall Study|Disease Progression|183|||
131835700|NCT01568866|474681807|FG000|Overall Study|Adverse Event|94|||
131402161|NCT00350870|473093625|FG000|Overall Study|Physician Decision|1|||
131835701|NCT01568866|474681808|FG001|Overall Study|Adverse Event|96|||
131835702|NCT01568866|474681807|FG000|Overall Study|Patient Request|55|||
131835703|NCT01568866|474681808|FG001|Overall Study|Patient Request|71|||
131835704|NCT01568866|474681807|FG000|Overall Study|Physician Decision|40|||
131835705|NCT01568866|474681808|FG001|Overall Study|Physician Decision|32|||
131835706|NCT01568866|474681807|FG000|Overall Study|Withdrawal by Subject|19|||
131402162|NCT00350870|473093626|FG001|Overall Study|Physician Decision|0|||
131402163|NCT00350870|473093627|FG002|Overall Study|Physician Decision|1|||
131402164|NCT00350870|473093628|FG003|Overall Study|Physician Decision|1|||
131835707|NCT01568866|474681808|FG001|Overall Study|Withdrawal by Subject|11|||
131835708|NCT01568866|474681807|FG000|Overall Study|Death|10|||
131835709|NCT01568866|474681808|FG001|Overall Study|Death|18|||
131835710|NCT01568866|474681807|FG000|Overall Study|Protocol Non-compliance|2|||
131835711|NCT01568866|474681808|FG001|Overall Study|Protocol Non-compliance|4|||
131835712|NCT01568866|474681807|FG000|Overall Study|Lost to Follow-up|1|||
131835713|NCT01568866|474681808|FG001|Overall Study|Lost to Follow-up|0|||
131835714|NCT01568866|474681807|FG000|Overall Study|Randomized but Not Dosed|9|||
131835715|NCT01568866|474681808|FG001|Overall Study|Randomized but Not Dosed|1|||
131835716|NCT00851643|474681809|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
131835717|NCT00851643|474681810|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
131835718|NCT00851643|474681811|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
131835719|NCT00851643|474681812|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
131835720|NCT00851643|474681813|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
131835721|NCT00851643|474681814|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
131835722|NCT00851643|474681809|FG000|Base Study (Up to 12 Months)|Other|0|||
131835723|NCT00851643|474681810|FG001|Base Study (Up to 12 Months)|Other|0|||
131835724|NCT00851643|474681811|FG002|Base Study (Up to 12 Months)|Other|0|||
131835725|NCT00851643|474681812|FG003|Base Study (Up to 12 Months)|Other|0|||
131835726|NCT00851643|474681813|FG004|Base Study (Up to 12 Months)|Other|0|||
131835727|NCT00851643|474681814|FG005|Base Study (Up to 12 Months)|Other|1|||
131835728|NCT00851643|474681809|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
131835729|NCT00851643|474681810|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
131835730|NCT00851643|474681811|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
131835731|NCT00851643|474681812|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
131835732|NCT00851643|474681813|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
131835733|NCT00851643|474681814|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
131835734|NCT00851643|474681809|FG000|Extension Study (Up to 36 Months)|Moved|0|||
131835735|NCT00851643|474681810|FG001|Extension Study (Up to 36 Months)|Moved|2|||
131835736|NCT00851643|474681811|FG002|Extension Study (Up to 36 Months)|Moved|1|||
131835737|NCT00851643|474681812|FG003|Extension Study (Up to 36 Months)|Moved|1|||
131835738|NCT00851643|474681813|FG004|Extension Study (Up to 36 Months)|Moved|0|||
131835739|NCT00851643|474681814|FG005|Extension Study (Up to 36 Months)|Moved|1|||
131835740|NCT01698775|474681817|FG000|Phase A|Adverse Event|2|||
131835741|NCT01698775|474681818|FG001|Phase A|Adverse Event|1|||
131835742|NCT01698775|474681817|FG000|Phase A|Death|1|||
131835743|NCT01698775|474681818|FG001|Phase A|Death|1|||
131835744|NCT01698775|474681817|FG000|Phase A|Lack of Efficacy|1|||
131835745|NCT01698775|474681818|FG001|Phase A|Lack of Efficacy|0|||
131835746|NCT01698775|474681817|FG000|Phase A|Lost to Follow-up|1|||
131835747|NCT01698775|474681818|FG001|Phase A|Lost to Follow-up|2|||
131835748|NCT01698775|474681817|FG000|Phase A|Protocol Violation|1|||
131835749|NCT01698775|474681818|FG001|Phase A|Protocol Violation|0|||
131835750|NCT01698775|474681817|FG000|Phase A|Withdrawal by Subject|3|||
131835751|NCT01698775|474681818|FG001|Phase A|Withdrawal by Subject|4|||
131835752|NCT01698775|474681817|FG000|Phase A|Kidney [transplant]|0|||
131835753|NCT01698775|474681818|FG001|Phase A|Kidney [transplant]|1|||
131835754|NCT01698775|474681817|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
131835755|NCT01698775|474681818|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
131835756|NCT01698775|474681817|FG000|Phase B|Adverse Event|6|||
131835757|NCT01698775|474681818|FG001|Phase B|Adverse Event|3|||
131835758|NCT01698775|474681817|FG000|Phase B|Death|0|||
131835759|NCT01698775|474681818|FG001|Phase B|Death|1|||
131835760|NCT01698775|474681817|FG000|Phase B|Lack of Efficacy|0|||
131835761|NCT01698775|474681818|FG001|Phase B|Lack of Efficacy|1|||
131835762|NCT01698775|474681817|FG000|Phase B|Lost to Follow-up|0|||
131835763|NCT01698775|474681818|FG001|Phase B|Lost to Follow-up|1|||
131835764|NCT01698775|474681817|FG000|Phase B|Physician Decision|1|||
131835765|NCT01698775|474681818|FG001|Phase B|Physician Decision|1|||
131835766|NCT01698775|474681817|FG000|Phase B|Protocol Violation|1|||
131835767|NCT01698775|474681818|FG001|Phase B|Protocol Violation|1|||
131835768|NCT01698775|474681817|FG000|Phase B|Withdrawal by Subject|6|||
131835769|NCT01698775|474681818|FG001|Phase B|Withdrawal by Subject|2|||
131835770|NCT00359788|474681819|FG000|Overall Study|Adverse Event|11|||
131835771|NCT00359788|474681820|FG001|Overall Study|Adverse Event|10|||
131835772|NCT00359788|474681819|FG000|Overall Study|Lack of Efficacy|1|||
131835773|NCT00359788|474681820|FG001|Overall Study|Lack of Efficacy|2|||
131835774|NCT00359788|474681819|FG000|Overall Study|Lost to Follow-up|3|||
131835775|NCT00359788|474681820|FG001|Overall Study|Lost to Follow-up|2|||
131835776|NCT00359788|474681819|FG000|Overall Study|Withdrawal by Subject|4|||
131835777|NCT00359788|474681820|FG001|Overall Study|Withdrawal by Subject|1|||
131835778|NCT00359788|474681819|FG000|Overall Study|Protocol Violation|4|||
131835779|NCT00359788|474681820|FG001|Overall Study|Protocol Violation|2|||
131835780|NCT01244061|474681825|FG000|Overall Study|Death|1|||
131835781|NCT01244061|474681826|FG001|Overall Study|Death|0|||
131835782|NCT01244061|474681825|FG000|Overall Study|Did not meet entrance criteria|1|||
131910633|NCT00284856|474960810|FG001|Overall Study|Withdrawal by Subject|16|||
131910634|NCT00284856|474960811|FG002|Overall Study|Withdrawal by Subject|18|||
131910635|NCT00284856|474960809|FG000|Overall Study|Other|4|||
131835783|NCT01244061|474681826|FG001|Overall Study|Did not meet entrance criteria|0|||
131835784|NCT01244061|474681825|FG000|Overall Study|Lack of Efficacy|1|||
131835785|NCT01244061|474681826|FG001|Overall Study|Lack of Efficacy|3|||
131835786|NCT01244061|474681825|FG000|Overall Study|Lost to Follow-up|34|||
131835787|NCT01244061|474681826|FG001|Overall Study|Lost to Follow-up|30|||
131835788|NCT01244061|474681825|FG000|Overall Study|Withdrawal by Subject|29|||
131835789|NCT01244061|474681826|FG001|Overall Study|Withdrawal by Subject|46|||
131835790|NCT01244061|474681825|FG000|Overall Study|Other|8|||
131835791|NCT01244061|474681826|FG001|Overall Study|Other|19|||
131835792|NCT01244061|474681825|FG000|Overall Study|Protocol Violation|1|||
131835793|NCT01244061|474681826|FG001|Overall Study|Protocol Violation|1|||
131835794|NCT01244061|474681825|FG000|Overall Study|Adverse Event|5|||
131835795|NCT01244061|474681826|FG001|Overall Study|Adverse Event|2|||
131835796|NCT01244061|474681825|FG000|Overall Study|Randomized but not treated|2|||
131835797|NCT01244061|474681826|FG001|Overall Study|Randomized but not treated|2|||
131835798|NCT02143583|474681827|FG000|Overall Study|Withdrawal by Subject|1|||
131835799|NCT02143583|474681828|FG001|Overall Study|Withdrawal by Subject|0|||
131835800|NCT02143583|474681829|FG002|Overall Study|Withdrawal by Subject|1|||
131835801|NCT02143583|474681827|FG000|Overall Study|husband illness|0|||
131835802|NCT02143583|474681828|FG001|Overall Study|husband illness|0|||
131835803|NCT02143583|474681829|FG002|Overall Study|husband illness|1|||
131835804|NCT01641133|474681830|FG000|Overall Study|Protocol Violation|0|||
131835805|NCT01641133|474681831|FG001|Overall Study|Protocol Violation|1|||
131835806|NCT01641133|474681832|FG002|Overall Study|Protocol Violation|1|||
131835807|NCT01641133|474681830|FG000|Overall Study|Migrated/moved from study area|5|||
131835808|NCT01641133|474681831|FG001|Overall Study|Migrated/moved from study area|3|||
131835809|NCT01641133|474681832|FG002|Overall Study|Migrated/moved from study area|1|||
131835810|NCT01641133|474681830|FG000|Overall Study|Adverse Event|0|||
131835811|NCT01641133|474681831|FG001|Overall Study|Adverse Event|0|||
131835812|NCT01641133|474681832|FG002|Overall Study|Adverse Event|1|||
131835813|NCT01641133|474681830|FG000|Overall Study|Withdrawal by Subject|5|||
131835814|NCT01641133|474681831|FG001|Overall Study|Withdrawal by Subject|3|||
131835815|NCT01641133|474681832|FG002|Overall Study|Withdrawal by Subject|3|||
131835816|NCT01641133|474681830|FG000|Overall Study|Lost to Follow-up|0|||
131835817|NCT01641133|474681831|FG001|Overall Study|Lost to Follow-up|2|||
131835818|NCT01641133|474681832|FG002|Overall Study|Lost to Follow-up|2|||
131835819|NCT00673933|474681833|FG000|Overall Study|Withdrawal by Subject|2|||
131835820|NCT00673933|474681833|FG000|Overall Study|Lost to Follow-up|1|||
131835821|NCT04932941|474681836|FG000|Overall Study|Lost to Follow-up|3|||
131835822|NCT04932941|474681837|FG001|Overall Study|Lost to Follow-up|1|||
131835823|NCT04932941|474681836|FG000|Overall Study|Withdrawal by Subject|7|||
131835824|NCT04932941|474681837|FG001|Overall Study|Withdrawal by Subject|4|||
131835825|NCT04932941|474681836|FG000|Overall Study|Other|4|||
131402165|NCT01453205|473093629|FG000|Overall Study|Lost to Follow-up|3|||
131835826|NCT04932941|474681837|FG001|Overall Study|Other|2|||
131835827|NCT01366443|474681838|FG000|Overall Study|Lost to Follow-up|2|||
131835828|NCT01366443|474681838|FG000|Overall Study|Under 18 yo|1|||
131835829|NCT02394730|474681844|FG000|Overall Study|Lost to Follow-up|1|||
131835830|NCT02394730|474681845|FG001|Overall Study|Lost to Follow-up|0|||
131402166|NCT01453205|473093630|FG001|Overall Study|Lost to Follow-up|0|||
131402167|NCT01453205|473093631|FG002|Overall Study|Lost to Follow-up|1|||
131835831|NCT02394730|474681844|FG000|Overall Study|Withdrawal by Subject|0|||
131835832|NCT02394730|474681845|FG001|Overall Study|Withdrawal by Subject|1|||
131835833|NCT00507546|474681846|FG000|Overall Study|Withdrawal by Subject|1|||
131835834|NCT00507546|474681847|FG001|Overall Study|Withdrawal by Subject|0|||
131835835|NCT00507546|474681846|FG000|Overall Study|Protocol Violation|1|||
131835836|NCT00507546|474681847|FG001|Overall Study|Protocol Violation|0|||
131835837|NCT00507546|474681846|FG000|Overall Study|Physician Decision|0|||
131835838|NCT00507546|474681847|FG001|Overall Study|Physician Decision|1|||
131835839|NCT03510182|474681850|FG000|Overall Study|Withdrawal by Subject|2|||
131402168|NCT01453205|473093629|FG000|Overall Study|Withdrawal by Subject|8|||
131402169|NCT01453205|473093630|FG001|Overall Study|Withdrawal by Subject|3|||
131835840|NCT01334710|474681851|FG000|Overall Study|Trial was terminated|3|||
131835841|NCT01902628|474681852|FG000|Overall Study|Withdrawal of participant's consent|7|||
131835842|NCT01902628|474681852|FG000|Overall Study|Adverse Event|41|||
131835843|NCT01902628|474681852|FG000|Overall Study|Lost to Follow-up|35|||
131835844|NCT01232491|474681853|FG000|Overall Study|Adverse Event|13|||
131835845|NCT01232491|474681854|FG001|Overall Study|Adverse Event|8|||
131835846|NCT01232491|474681853|FG000|Overall Study|Lack of Efficacy|1|||
131835847|NCT01232491|474681854|FG001|Overall Study|Lack of Efficacy|5|||
131835848|NCT01232491|474681853|FG000|Overall Study|Protocol Violation|13|||
131835849|NCT01232491|474681854|FG001|Overall Study|Protocol Violation|11|||
131835850|NCT01232491|474681853|FG000|Overall Study|Withdrawal Criteria|12|||
131835851|NCT01232491|474681854|FG001|Overall Study|Withdrawal Criteria|21|||
131835852|NCT01232491|474681853|FG000|Overall Study|Other|21|||
131402170|NCT01453205|473093631|FG002|Overall Study|Withdrawal by Subject|0|||
131835853|NCT01232491|474681854|FG001|Overall Study|Other|18|||
131835854|NCT04905290|474683096|FG000|Overall Study|Adverse Event|4|||
131835855|NCT04905290|474683096|FG000|Overall Study|Death|2|||
131835856|NCT04905290|474683096|FG000|Overall Study|Withdrawal by Subject|4|||
131835857|NCT04905290|474683096|FG000|Overall Study|Physician Decision|2|||
131835858|NCT04905290|474683096|FG000|Overall Study|Lost to Follow-up|2|||
131835859|NCT04905290|474683096|FG000|Overall Study|Screen Failure|2|||
131835860|NCT04905290|474683096|FG000|Overall Study|Unsuccessful Procedure|2|||
131835861|NCT04319718|474683097|FG000|Overall Study|Adverse Event|0|||
131835862|NCT04319718|474683098|FG001|Overall Study|Adverse Event|2|||
131835863|NCT04319718|474683097|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
131835864|NCT04319718|474683098|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
131835865|NCT01288053|474683099|FG000|Overall Study|Death|1|||
131835866|NCT00144781|474683100|FG000|Overall Study|Adverse Event|0|||
131835867|NCT00144781|474683101|FG001|Overall Study|Adverse Event|1|||
131835868|NCT00144781|474683102|FG002|Overall Study|Adverse Event|0|||
131835869|NCT00144781|474683103|FG003|Overall Study|Adverse Event|0|||
131835870|NCT00144781|474683100|FG000|Overall Study|Non-compliant|0|||
131835871|NCT00144781|474683101|FG001|Overall Study|Non-compliant|1|||
131835872|NCT00144781|474683102|FG002|Overall Study|Non-compliant|0|||
131835873|NCT00144781|474683103|FG003|Overall Study|Non-compliant|0|||
131835874|NCT02068092|474683104|FG000|Overall Study|Physician Decision|2|||
131835875|NCT02068092|474683104|FG000|Overall Study|Adverse Event|2|||
131835876|NCT02068092|474683104|FG000|Overall Study|Lost to Follow-up|4|||
131835877|NCT02068092|474683104|FG000|Overall Study|Withdrawal by Subject|2|||
131835878|NCT06204887|474683105|FG000|Overall Study|Lost to Follow-up|3|||
131835879|NCT06204887|474683106|FG001|Overall Study|Lost to Follow-up|4|||
131835880|NCT06204887|474683107|FG002|Overall Study|Lost to Follow-up|1|||
131835881|NCT06204887|474683108|FG003|Overall Study|Lost to Follow-up|6|||
131835882|NCT01045421|474683109|FG000|Phase 1|Progressive Disease|0|||
131835883|NCT01045421|474683110|FG001|Phase 1|Progressive Disease|0|||
131835884|NCT01045421|474683111|FG002|Phase 1|Progressive Disease|0|||
131835885|NCT01045421|474683112|FG003|Phase 1|Progressive Disease|0|||
131835886|NCT01045421|474683113|FG004|Phase 1|Progressive Disease|1|||
131835887|NCT01045421|474683114|FG005|Phase 1|Progressive Disease|0|||
131835888|NCT01045421|474683115|FG006|Phase 1|Progressive Disease|0|||
131835889|NCT01045421|474683116|FG007|Phase 1|Progressive Disease|0|||
131835890|NCT01045421|474683117|FG008|Phase 1|Progressive Disease|0|||
131835891|NCT01045421|474683118|FG009|Phase 1|Progressive Disease|0|||
131835892|NCT01045421|474683119|FG010|Phase 1|Progressive Disease|0|||
131835893|NCT01045421|474683109|FG000|Phase 1|Withdrawal by Subject|0|||
131835894|NCT01045421|474683110|FG001|Phase 1|Withdrawal by Subject|0|||
131835895|NCT01045421|474683111|FG002|Phase 1|Withdrawal by Subject|0|||
131835896|NCT01045421|474683112|FG003|Phase 1|Withdrawal by Subject|1|||
131835897|NCT01045421|474683113|FG004|Phase 1|Withdrawal by Subject|0|||
131835898|NCT01045421|474683114|FG005|Phase 1|Withdrawal by Subject|0|||
131835899|NCT01045421|474683115|FG006|Phase 1|Withdrawal by Subject|0|||
131835900|NCT01045421|474683116|FG007|Phase 1|Withdrawal by Subject|0|||
131835901|NCT01045421|474683117|FG008|Phase 1|Withdrawal by Subject|0|||
131835902|NCT01045421|474683118|FG009|Phase 1|Withdrawal by Subject|0|||
131835903|NCT01045421|474683119|FG010|Phase 1|Withdrawal by Subject|0|||
131835904|NCT01045421|474683109|FG000|Phase 2|Progressive Disease|0|||
131835905|NCT01045421|474683110|FG001|Phase 2|Progressive Disease|0|||
131835906|NCT01045421|474683111|FG002|Phase 2|Progressive Disease|0|||
131835907|NCT01045421|474683112|FG003|Phase 2|Progressive Disease|0|||
131835908|NCT01045421|474683113|FG004|Phase 2|Progressive Disease|0|||
131835909|NCT01045421|474683114|FG005|Phase 2|Progressive Disease|0|||
131835910|NCT01045421|474683115|FG006|Phase 2|Progressive Disease|0|||
131835911|NCT01045421|474683116|FG007|Phase 2|Progressive Disease|1|||
131835912|NCT01045421|474683117|FG008|Phase 2|Progressive Disease|1|||
131835913|NCT01045421|474683118|FG009|Phase 2|Progressive Disease|1|||
131835914|NCT01045421|474683119|FG010|Phase 2|Progressive Disease|1|||
131835915|NCT01045421|474683109|FG000|Phase 2|Death|0|||
131835916|NCT01045421|474683110|FG001|Phase 2|Death|0|||
131835917|NCT01045421|474683111|FG002|Phase 2|Death|0|||
131835918|NCT01045421|474683112|FG003|Phase 2|Death|0|||
131835919|NCT01045421|474683113|FG004|Phase 2|Death|0|||
131835920|NCT01045421|474683114|FG005|Phase 2|Death|0|||
131835921|NCT01045421|474683115|FG006|Phase 2|Death|0|||
131835922|NCT01045421|474683116|FG007|Phase 2|Death|1|||
131835923|NCT01045421|474683117|FG008|Phase 2|Death|1|||
131835924|NCT01045421|474683118|FG009|Phase 2|Death|2|||
131835925|NCT01045421|474683119|FG010|Phase 2|Death|0|||
131835926|NCT01045421|474683109|FG000|Phase 2|Other|0|||
131835927|NCT01045421|474683110|FG001|Phase 2|Other|0|||
131835928|NCT01045421|474683111|FG002|Phase 2|Other|0|||
131835929|NCT01045421|474683112|FG003|Phase 2|Other|0|||
131835930|NCT01045421|474683113|FG004|Phase 2|Other|0|||
131835931|NCT01045421|474683114|FG005|Phase 2|Other|0|||
131835932|NCT01045421|474683115|FG006|Phase 2|Other|0|||
131835933|NCT01045421|474683116|FG007|Phase 2|Other|3|||
131835934|NCT01045421|474683117|FG008|Phase 2|Other|0|||
131835935|NCT01045421|474683118|FG009|Phase 2|Other|0|||
131835936|NCT01045421|474683119|FG010|Phase 2|Other|1|||
131835937|NCT03340064|474683120|FG000|First Period|Adverse Event, non-fatal|2|||
131835938|NCT03340064|474683121|FG001|First Period|Adverse Event, non-fatal|0|||
131835939|NCT03340064|474683120|FG000|First Period|Lack of Efficacy|3|||
131835940|NCT03340064|474683121|FG001|First Period|Lack of Efficacy|0|||
131835941|NCT03340064|474683120|FG000|Second Period|Adverse Event, non-fatal|1|||
131835942|NCT03340064|474683121|FG001|Second Period|Adverse Event, non-fatal|1|||
131835943|NCT03340064|474683120|FG000|Second Period|Lack of Efficacy|11|||
131835944|NCT03340064|474683121|FG001|Second Period|Lack of Efficacy|0|||
131835945|NCT03340064|474683120|FG000|Second Period|Physician Decision|3|||
131835946|NCT03340064|474683121|FG001|Second Period|Physician Decision|0|||
131835947|NCT03340064|474683120|FG000|Second Period|Withdrawal by Subject|2|||
131835948|NCT03340064|474683121|FG001|Second Period|Withdrawal by Subject|1|||
131835949|NCT03340064|474683120|FG000|Second Period|Approved Drug Available For Indication|1|||
131835950|NCT03340064|474683121|FG001|Second Period|Approved Drug Available For Indication|0|||
131835951|NCT03340064|474683120|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
131835952|NCT03340064|474683121|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
131835953|NCT00856973|474683124|FG000|Overall Study|Adverse Event|5|||
131835954|NCT00856973|474683125|FG001|Overall Study|Adverse Event|5|||
131835955|NCT00856973|474683126|FG002|Overall Study|Adverse Event|3|||
131835956|NCT00856973|474683124|FG000|Overall Study|Lost to Follow-up|6|||
131835957|NCT00856973|474683125|FG001|Overall Study|Lost to Follow-up|3|||
131835958|NCT00856973|474683126|FG002|Overall Study|Lost to Follow-up|5|||
131835959|NCT00856973|474683124|FG000|Overall Study|Physician Decision|0|||
131835960|NCT00856973|474683125|FG001|Overall Study|Physician Decision|3|||
131835961|NCT00856973|474683126|FG002|Overall Study|Physician Decision|1|||
131835962|NCT00856973|474683124|FG000|Overall Study|Protocol Violation|1|||
131835963|NCT00856973|474683125|FG001|Overall Study|Protocol Violation|2|||
131835964|NCT00856973|474683126|FG002|Overall Study|Protocol Violation|1|||
131835965|NCT00856973|474683124|FG000|Overall Study|Withdrawal by Subject|13|||
131835966|NCT00856973|474683125|FG001|Overall Study|Withdrawal by Subject|16|||
131835967|NCT00856973|474683126|FG002|Overall Study|Withdrawal by Subject|15|||
131835968|NCT00856973|474683124|FG000|Overall Study|Other|11|||
131835969|NCT00856973|474683125|FG001|Overall Study|Other|12|||
131835970|NCT00856973|474683126|FG002|Overall Study|Other|13|||
131835971|NCT04551911|474683130|FG000|Overall Study|Lost to Follow-up|2|||
131835972|NCT04551911|474683131|FG001|Overall Study|Lost to Follow-up|1|||
131835973|NCT04551911|474683130|FG000|Overall Study|Withdrawal by Subject|10|||
131835974|NCT04551911|474683131|FG001|Overall Study|Withdrawal by Subject|10|||
131835975|NCT04551911|474683130|FG000|Overall Study|Did not receive the study drug|3|||
131835976|NCT04551911|474683131|FG001|Overall Study|Did not receive the study drug|4|||
131835977|NCT01030341|474683132|FG000|Overall Study|Withdrawal by Subject|1|||
131835978|NCT01030341|474683132|FG000|Overall Study|Lost to Follow-up|2|||
131835979|NCT00821873|474683133|FG000|Overall Study|Lost to Follow-up|4|||
131835980|NCT02751359|474683143|FG000|Overall Study|Lost to Follow-up|1|||
131835981|NCT00127036|474683144|FG000|Overall Study|Insufficient Data for Analysis|6|||
131835982|NCT00127036|474683145|FG001|Overall Study|Insufficient Data for Analysis|11|||
131835983|NCT00127036|474683144|FG000|Overall Study|Screen Failure|2|||
131835984|NCT00127036|474683145|FG001|Overall Study|Screen Failure|0|||
131835985|NCT00270257|474683148|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
131835986|NCT00270257|474683149|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
131835987|NCT00450619|474683152|FG000|Overall Study|refused treatment after randomization|2|||
131835988|NCT00450619|474683153|FG001|Overall Study|refused treatment after randomization|0|||
131835989|NCT00450619|474683152|FG000|Overall Study|did not progress; refused further trmt|1|||
131835990|NCT00450619|474683153|FG001|Overall Study|did not progress; refused further trmt|1|||
131835991|NCT00450619|474683152|FG000|Overall Study|Adverse Event|1|||
131835992|NCT00450619|474683153|FG001|Overall Study|Adverse Event|0|||
131835993|NCT02372071|474683165|FG000|Overall Study|Protocol Violation|18|||
131835994|NCT02923674|474683168|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
131835995|NCT02923674|474683169|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
131835996|NCT02923674|474683170|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
131835997|NCT02923674|474683168|FG000|Overall Study|Lost to Follow-up|7|||
131835998|NCT02923674|474683169|FG001|Overall Study|Lost to Follow-up|12|||
131835999|NCT02923674|474683170|FG002|Overall Study|Lost to Follow-up|7|||
131836000|NCT02923674|474683168|FG000|Overall Study|Problem with intervention|2|||
131836001|NCT02923674|474683169|FG001|Overall Study|Problem with intervention|2|||
131836002|NCT02923674|474683170|FG002|Overall Study|Problem with intervention|1|||
131836003|NCT02923674|474683168|FG000|Overall Study|Adverse Event|3|||
131836004|NCT02923674|474683169|FG001|Overall Study|Adverse Event|1|||
131836005|NCT02923674|474683170|FG002|Overall Study|Adverse Event|1|||
131836006|NCT02923674|474683168|FG000|Overall Study|Withdrawal by Subject|2|||
131836007|NCT02923674|474683169|FG001|Overall Study|Withdrawal by Subject|2|||
131836008|NCT02923674|474683170|FG002|Overall Study|Withdrawal by Subject|2|||
131836009|NCT01621191|474683171|FG000|Overall Study|Adverse Event|9|||
131836010|NCT01621191|474683171|FG000|Overall Study|Withdrawal by Subject|8|||
131836011|NCT01621191|474683171|FG000|Overall Study|Lack of Efficacy|6|||
131836012|NCT01621191|474683171|FG000|Overall Study|Lost to Follow-up|1|||
131836013|NCT01621191|474683171|FG000|Overall Study|Site Removed From Study|1|||
131836014|NCT00706381|474683172|FG000|Overall Study|Lost to Follow-up|0|||
131836015|NCT00706381|474683173|FG001|Overall Study|Lost to Follow-up|1|||
131836016|NCT00706381|474683174|FG002|Overall Study|Lost to Follow-up|1|||
131836017|NCT00706381|474683175|FG003|Overall Study|Lost to Follow-up|0|||
131836018|NCT04355663|474683176|FG000|Overall Study|Physician Decision|2|||
131836019|NCT04355663|474683177|FG001|Overall Study|Physician Decision|7|||
131836020|NCT04355663|474683178|FG002|Overall Study|Physician Decision|0|||
131836021|NCT04355663|474683176|FG000|Overall Study|Adverse Event|0|||
131836022|NCT04355663|474683177|FG001|Overall Study|Adverse Event|0|||
131836023|NCT04355663|474683178|FG002|Overall Study|Adverse Event|1|||
131836024|NCT04355663|474683176|FG000|Overall Study|Withdrawal by Subject|0|||
131836025|NCT04355663|474683177|FG001|Overall Study|Withdrawal by Subject|8|||
131836026|NCT04355663|474683178|FG002|Overall Study|Withdrawal by Subject|3|||
131836027|NCT00160641|474683182|FG000|Overall Study|Adverse Event|102|||
131836028|NCT00160641|474683182|FG000|Overall Study|Withdrawal by Subject|87|||
131836029|NCT00160641|474683182|FG000|Overall Study|Lost to Follow-up|8|||
131836030|NCT00160641|474683182|FG000|Overall Study|Lack of Efficacy|12|||
131836031|NCT00160641|474683182|FG000|Overall Study|Protocol Violation|3|||
131836032|NCT00160641|474683182|FG000|Overall Study|Other|9|||
131836033|NCT00995085|474683187|FG000|Overall Study|Withdrawal by Subject|5|||
131836034|NCT01640873|474683193|FG000|Overall Study|Protocol Violation|2|||
131836035|NCT01640873|474683194|FG001|Overall Study|Protocol Violation|1|||
131836036|NCT01321008|474683195|FG000|Overall Study|Early Study Termination|1|||
131836037|NCT02749292|474683198|FG000|Overall Study|Physician Decision|1|||
131836038|NCT02749292|474683199|FG001|Overall Study|Physician Decision|0|||
131836039|NCT02749292|474683198|FG000|Overall Study|Withdrawal by Subject|5|||
131836040|NCT02749292|474683199|FG001|Overall Study|Withdrawal by Subject|7|||
131836041|NCT02749292|474683198|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
131836042|NCT02749292|474683199|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
131836043|NCT02749292|474683198|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
131836044|NCT02749292|474683199|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
131836045|NCT02749292|474683198|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
131836046|NCT02749292|474683199|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
131836047|NCT02749292|474683198|FG000|Overall Study|Adverse Event|4|||
131836048|NCT02749292|474683199|FG001|Overall Study|Adverse Event|1|||
131836049|NCT02749292|474683198|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
131836050|NCT02749292|474683199|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
131836051|NCT02749292|474683198|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
131836052|NCT02749292|474683199|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
131836053|NCT02749292|474683198|FG000|Overall Study|Requiring glucocorticoids|0|||
131836054|NCT02749292|474683199|FG001|Overall Study|Requiring glucocorticoids|3|||
131836055|NCT02749292|474683198|FG000|Overall Study|Cancer|1|||
131836056|NCT02749292|474683199|FG001|Overall Study|Cancer|0|||
131836057|NCT00251641|474683200|FG000|Overall Study|Adverse Event|80|||
131836058|NCT00251641|474683201|FG001|Overall Study|Adverse Event|8|||
131836059|NCT00251641|474683200|FG000|Overall Study|Lack of Efficacy|2|||
131836060|NCT00251641|474683201|FG001|Overall Study|Lack of Efficacy|1|||
131836061|NCT00251641|474683200|FG000|Overall Study|Progression of Disease|0|||
131836062|NCT00251641|474683201|FG001|Overall Study|Progression of Disease|2|||
131836063|NCT00251641|474683200|FG000|Overall Study|Lost to Follow-up|3|||
131836064|NCT00251641|474683201|FG001|Overall Study|Lost to Follow-up|3|||
131836065|NCT00251641|474683200|FG000|Overall Study|Withdrawal by Subject|6|||
131836066|NCT00251641|474683201|FG001|Overall Study|Withdrawal by Subject|8|||
131836067|NCT00251641|474683200|FG000|Overall Study|Protocol Violation|10|||
131836068|NCT00251641|474683201|FG001|Overall Study|Protocol Violation|2|||
131836069|NCT00251641|474683200|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
131836070|NCT00251641|474683201|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
131836071|NCT00251641|474683200|FG000|Overall Study|Switched Treatment|9|||
131836072|NCT00251641|474683201|FG001|Overall Study|Switched Treatment|63|||
131836073|NCT02093221|474683204|FG000|Overall Study|Adverse Event|1|||
131836074|NCT02093221|474683205|FG001|Overall Study|Adverse Event|0|||
131836075|NCT02093221|474683206|FG002|Overall Study|Adverse Event|0|||
131836076|NCT02093221|474683207|FG003|Overall Study|Adverse Event|0|||
131836077|NCT02093221|474683208|FG004|Overall Study|Adverse Event|0|||
131836078|NCT02093221|474683204|FG000|Overall Study|Withdrawal by Subject|1|||
131836079|NCT02093221|474683205|FG001|Overall Study|Withdrawal by Subject|1|||
131836080|NCT02093221|474683206|FG002|Overall Study|Withdrawal by Subject|4|||
131836081|NCT02093221|474683207|FG003|Overall Study|Withdrawal by Subject|1|||
131836082|NCT02093221|474683208|FG004|Overall Study|Withdrawal by Subject|1|||
131836083|NCT02093221|474683204|FG000|Overall Study|Lost to Follow-up|2|||
131836084|NCT02093221|474683205|FG001|Overall Study|Lost to Follow-up|0|||
131836085|NCT02093221|474683206|FG002|Overall Study|Lost to Follow-up|1|||
131836086|NCT02093221|474683207|FG003|Overall Study|Lost to Follow-up|1|||
131836087|NCT02093221|474683208|FG004|Overall Study|Lost to Follow-up|0|||
131836088|NCT02093221|474683204|FG000|Overall Study|Death|0|||
131836089|NCT02093221|474683205|FG001|Overall Study|Death|1|||
131836090|NCT02093221|474683206|FG002|Overall Study|Death|0|||
131836091|NCT02093221|474683207|FG003|Overall Study|Death|0|||
131836092|NCT02093221|474683208|FG004|Overall Study|Death|0|||
131836093|NCT02093221|474683204|FG000|Overall Study|Protocol Violation|0|||
131836094|NCT02093221|474683205|FG001|Overall Study|Protocol Violation|1|||
131836095|NCT02093221|474683206|FG002|Overall Study|Protocol Violation|0|||
131836096|NCT02093221|474683207|FG003|Overall Study|Protocol Violation|0|||
131836097|NCT02093221|474683208|FG004|Overall Study|Protocol Violation|0|||
131836098|NCT02093221|474683204|FG000|Overall Study|Study termination|6|||
131836099|NCT02093221|474683205|FG001|Overall Study|Study termination|5|||
131836100|NCT02093221|474683206|FG002|Overall Study|Study termination|4|||
131836101|NCT02093221|474683207|FG003|Overall Study|Study termination|6|||
131836102|NCT02093221|474683208|FG004|Overall Study|Study termination|7|||
131836103|NCT00876018|474683209|FG000|Overall Study|Lost to Follow-up|0|||
131836104|NCT00876018|474683210|FG001|Overall Study|Lost to Follow-up|1|||
131836105|NCT00876018|474683211|FG002|Overall Study|Lost to Follow-up|1|||
131836106|NCT00876018|474683209|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
131836107|NCT00876018|474683210|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
131836108|NCT00876018|474683211|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
131836109|NCT00062751|474683212|FG000|Overall Study|Disease progression|24|||
131836110|NCT00062751|474683213|FG001|Overall Study|Disease progression|17|||
131836111|NCT00062751|474683214|FG002|Overall Study|Disease progression|24|||
131836112|NCT00062751|474683215|FG003|Overall Study|Disease progression|2|||
131836113|NCT00062751|474683216|FG004|Overall Study|Disease progression|2|||
131836114|NCT00062751|474683212|FG000|Overall Study|Adverse Event|4|||
131836115|NCT00062751|474683213|FG001|Overall Study|Adverse Event|7|||
131836116|NCT00062751|474683214|FG002|Overall Study|Adverse Event|2|||
131836117|NCT00062751|474683215|FG003|Overall Study|Adverse Event|2|||
131836118|NCT00062751|474683216|FG004|Overall Study|Adverse Event|2|||
131836119|NCT00062751|474683212|FG000|Overall Study|Other|2|||
131836120|NCT00062751|474683213|FG001|Overall Study|Other|3|||
131836121|NCT00062751|474683214|FG002|Overall Study|Other|1|||
131836122|NCT00062751|474683215|FG003|Overall Study|Other|0|||
131836123|NCT00062751|474683216|FG004|Overall Study|Other|1|||
131836124|NCT00062751|474683212|FG000|Overall Study|Withdrawal by Subject|1|||
131836125|NCT00062751|474683213|FG001|Overall Study|Withdrawal by Subject|2|||
131836126|NCT00062751|474683214|FG002|Overall Study|Withdrawal by Subject|2|||
131836127|NCT00062751|474683215|FG003|Overall Study|Withdrawal by Subject|1|||
131836128|NCT00062751|474683216|FG004|Overall Study|Withdrawal by Subject|0|||
131836129|NCT00062751|474683212|FG000|Overall Study|Symptomatic deterioration|1|||
131836130|NCT00062751|474683213|FG001|Overall Study|Symptomatic deterioration|1|||
131836131|NCT00062751|474683214|FG002|Overall Study|Symptomatic deterioration|0|||
131836132|NCT00062751|474683215|FG003|Overall Study|Symptomatic deterioration|0|||
131836133|NCT00062751|474683216|FG004|Overall Study|Symptomatic deterioration|1|||
131836134|NCT00062751|474683212|FG000|Overall Study|Death|1|||
131836135|NCT00062751|474683213|FG001|Overall Study|Death|0|||
131836136|NCT00062751|474683214|FG002|Overall Study|Death|1|||
131836137|NCT00062751|474683215|FG003|Overall Study|Death|0|||
131836138|NCT00062751|474683216|FG004|Overall Study|Death|0|||
131836139|NCT01301508|474683228|FG000|Overall Study|Withdrawal by Subject|1|||
131836140|NCT01301508|474683229|FG001|Overall Study|Withdrawal by Subject|2|||
131836141|NCT01301508|474683228|FG000|Overall Study|Lost to Follow-up|0|||
131836142|NCT01301508|474683229|FG001|Overall Study|Lost to Follow-up|1|||
131836143|NCT02707861|474683230|FG000|Overall Study|Went onto commercial drug|30|||
131836144|NCT02707861|474683231|FG001|Overall Study|Went onto commercial drug|23|||
131836145|NCT02707861|474683230|FG000|Overall Study|Adverse Event|2|||
131836146|NCT02707861|474683231|FG001|Overall Study|Adverse Event|3|||
131836147|NCT02707861|474683230|FG000|Overall Study|Death|5|||
131836148|NCT02707861|474683231|FG001|Overall Study|Death|2|||
131836149|NCT02707861|474683230|FG000|Overall Study|Lack of Efficacy|0|||
131836150|NCT02707861|474683231|FG001|Overall Study|Lack of Efficacy|2|||
131836151|NCT02707861|474683230|FG000|Overall Study|Physician Decision|1|||
131836152|NCT02707861|474683231|FG001|Overall Study|Physician Decision|4|||
131836153|NCT02707861|474683230|FG000|Overall Study|Withdrawal by Subject|2|||
131402171|NCT01453205|473093629|FG000|Overall Study|Death|24|||
131836154|NCT02707861|474683231|FG001|Overall Study|Withdrawal by Subject|1|||
131836155|NCT02707861|474683230|FG000|Overall Study|Lost to Follow-up|1|||
131836156|NCT02707861|474683231|FG001|Overall Study|Lost to Follow-up|3|||
131836157|NCT01940497|474683232|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
131836158|NCT01940497|474683233|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
131836159|NCT01940497|474683232|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
131402172|NCT01453205|473093630|FG001|Overall Study|Death|22|||
131836160|NCT01940497|474683233|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
131836161|NCT01940497|474683232|FG000|Overall Study|Violation of Entry Criteria|1|||
131836162|NCT01940497|474683233|FG001|Overall Study|Violation of Entry Criteria|1|||
131836163|NCT01940497|474683232|FG000|Overall Study|Refused Treatment|1|||
131836164|NCT01940497|474683233|FG001|Overall Study|Refused Treatment|3|||
131836165|NCT01940497|474683232|FG000|Overall Study|Withdrew Consent|6|||
131836166|NCT01940497|474683233|FG001|Overall Study|Withdrew Consent|2|||
131836167|NCT01940497|474683232|FG000|Overall Study|Administrative/Other|1|||
131910636|NCT00284856|474960810|FG001|Overall Study|Other|5|||
131836168|NCT01940497|474683233|FG001|Overall Study|Administrative/Other|1|||
131836169|NCT03123861|474683234|FG000|Overall Study|Protocol Violation|1|||
131836170|NCT03123861|474683235|FG001|Overall Study|Protocol Violation|1|||
131836171|NCT03123861|474683234|FG000|Overall Study|Withdrawal by Subject|2|||
131910637|NCT00284856|474960811|FG002|Overall Study|Other|4|||
131836172|NCT03123861|474683235|FG001|Overall Study|Withdrawal by Subject|2|||
131836173|NCT00369382|474683238|FG000|Overall Study|Death|0|||
131836174|NCT00369382|474683239|FG001|Overall Study|Death|2|||
131836175|NCT00369382|474683238|FG000|Overall Study|Physician Decision|2|||
131836176|NCT00369382|474683239|FG001|Overall Study|Physician Decision|1|||
131836177|NCT00369382|474683238|FG000|Overall Study|Withdrawal by Subject|5|||
131836178|NCT00369382|474683239|FG001|Overall Study|Withdrawal by Subject|0|||
131836179|NCT00369382|474683238|FG000|Overall Study|Randomized, not treated|2|||
131836180|NCT00369382|474683239|FG001|Overall Study|Randomized, not treated|0|||
131836181|NCT00369382|474683238|FG000|Overall Study|Other|1|||
131836182|NCT00369382|474683239|FG001|Overall Study|Other|0|||
131836183|NCT00448136|474683240|FG000|Overall Study|Death|3|||
131836184|NCT00448136|474683241|FG001|Overall Study|Death|8|||
131836185|NCT00448136|474683240|FG000|Overall Study|Investigator's decision (progression)|1|||
131836186|NCT00448136|474683241|FG001|Overall Study|Investigator's decision (progression)|0|||
131836187|NCT01663727|474683242|FG000|Overall Study|Death|161|||
131836188|NCT01663727|474683243|FG001|Overall Study|Death|155|||
131836189|NCT01663727|474683242|FG000|Overall Study|Lost to Follow-up|10|||
131836190|NCT01663727|474683243|FG001|Overall Study|Lost to Follow-up|8|||
131836191|NCT01663727|474683242|FG000|Overall Study|Withdrawal by Subject|18|||
131836192|NCT01663727|474683243|FG001|Overall Study|Withdrawal by Subject|25|||
131836193|NCT01663727|474683242|FG000|Overall Study|Study Terminated|51|||
131836194|NCT01663727|474683243|FG001|Overall Study|Study Terminated|50|||
131836195|NCT01663727|474683242|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
131836196|NCT01663727|474683243|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
131836197|NCT01663727|474683242|FG000|Overall Study|Withdrawal prior to dosing.|1|||
131836198|NCT01663727|474683243|FG001|Overall Study|Withdrawal prior to dosing.|0|||
131836199|NCT00375492|474683244|FG000|Overall Study|Adverse Event|4|||
131836200|NCT00375492|474683245|FG001|Overall Study|Adverse Event|5|||
131836201|NCT00375492|474683244|FG000|Overall Study|Entry Criteria Not Met|0|||
131836202|NCT00375492|474683245|FG001|Overall Study|Entry Criteria Not Met|1|||
131836203|NCT00375492|474683244|FG000|Overall Study|Loss of Glucose Control|0|||
131836204|NCT00375492|474683245|FG001|Overall Study|Loss of Glucose Control|1|||
131836205|NCT00375492|474683244|FG000|Overall Study|Lost to Follow-up|10|||
131836206|NCT00375492|474683245|FG001|Overall Study|Lost to Follow-up|5|||
131836207|NCT00375492|474683244|FG000|Overall Study|Physician Decision|0|||
131836208|NCT00375492|474683245|FG001|Overall Study|Physician Decision|4|||
131836209|NCT00375492|474683244|FG000|Overall Study|Protocol Violation|6|||
131836210|NCT00375492|474683245|FG001|Overall Study|Protocol Violation|3|||
131836211|NCT00375492|474683244|FG000|Overall Study|Sponsor Decision|0|||
131836212|NCT00375492|474683245|FG001|Overall Study|Sponsor Decision|1|||
131836213|NCT00375492|474683244|FG000|Overall Study|Withdrawal by Subject|6|||
131836214|NCT00375492|474683245|FG001|Overall Study|Withdrawal by Subject|6|||
131836215|NCT03295318|474684587|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
131836216|NCT03295318|474684588|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
131836217|NCT03295318|474684589|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
131836218|NCT03295318|474684587|FG000|Overall Study|Death|1|||
131836219|NCT03295318|474684588|FG001|Overall Study|Death|1|||
131836220|NCT03295318|474684589|FG002|Overall Study|Death|1|||
131836221|NCT03295318|474684587|FG000|Overall Study|Protocol Violation|4|||
131836222|NCT03295318|474684588|FG001|Overall Study|Protocol Violation|3|||
131836223|NCT03295318|474684589|FG002|Overall Study|Protocol Violation|3|||
131836224|NCT03295318|474684587|FG000|Overall Study|Withdrawal by Subject|0|||
131836225|NCT03295318|474684588|FG001|Overall Study|Withdrawal by Subject|0|||
131836226|NCT03295318|474684589|FG002|Overall Study|Withdrawal by Subject|1|||
131836227|NCT03295318|474684587|FG000|Overall Study|Subject discontinued due to travel|0|||
131836228|NCT03295318|474684588|FG001|Overall Study|Subject discontinued due to travel|1|||
131836229|NCT03295318|474684589|FG002|Overall Study|Subject discontinued due to travel|0|||
131836230|NCT03596151|474684596|FG000|Overall Study|Withdrawal by Subject|1|||
131836231|NCT00729248|474684598|FG000|Overall Study|Physician Decision|2|||
131836232|NCT03222583|474684603|FG000|Overall Study|Withdrawal by Subject|3|||
131836233|NCT03222583|474684604|FG001|Overall Study|Withdrawal by Subject|3|||
131836234|NCT03222583|474684603|FG000|Overall Study|Lost to Follow-up|1|||
131836235|NCT03222583|474684604|FG001|Overall Study|Lost to Follow-up|0|||
131402173|NCT01453205|473093631|FG002|Overall Study|Death|18|||
131836236|NCT03222583|474684603|FG000|Overall Study|Other|1|||
131836237|NCT03222583|474684604|FG001|Overall Study|Other|3|||
131836238|NCT03573505|474684605|FG000|Overall Study|Adverse Event|1|||
131836239|NCT03573505|474684606|FG001|Overall Study|Adverse Event|1|||
131836240|NCT03573505|474684605|FG000|Overall Study|Consent withdrawn|0|||
131836241|NCT03573505|474684606|FG001|Overall Study|Consent withdrawn|1|||
131910638|NCT01192815|474960812|FG000|Overall Study|Withdrawal by Subject|1|||
131836242|NCT03573505|474684605|FG000|Overall Study|Disease progression|0|||
131836243|NCT03573505|474684606|FG001|Overall Study|Disease progression|1|||
131836244|NCT03573505|474684605|FG000|Overall Study|Site Terminated by Sponsor|1|||
131836245|NCT03573505|474684606|FG001|Overall Study|Site Terminated by Sponsor|1|||
131836246|NCT03573505|474684605|FG000|Overall Study|Study terminated by sponsor|50|||
131836247|NCT03573505|474684606|FG001|Overall Study|Study terminated by sponsor|45|||
131836248|NCT03573505|474684605|FG000|Overall Study|Reason not specified|0|||
131836249|NCT03573505|474684606|FG001|Overall Study|Reason not specified|1|||
131836250|NCT03573505|474684605|FG000|Overall Study|Death|0|||
131836251|NCT03573505|474684606|FG001|Overall Study|Death|4|||
131836252|NCT04280705|474684607|FG000|Overall Study|Enrolled but not treated|4|||
131836253|NCT04280705|474684608|FG001|Overall Study|Enrolled but not treated|10|||
131836254|NCT04280705|474684607|FG000|Overall Study|Physician Decision|1|||
131836255|NCT04280705|474684608|FG001|Overall Study|Physician Decision|0|||
131836256|NCT04280705|474684607|FG000|Overall Study|Withdrawal by Subject|7|||
131836257|NCT04280705|474684608|FG001|Overall Study|Withdrawal by Subject|9|||
131836258|NCT04280705|474684607|FG000|Overall Study|Adverse Event|0|||
131836259|NCT04280705|474684608|FG001|Overall Study|Adverse Event|4|||
131836260|NCT04280705|474684607|FG000|Overall Study|Transferred to another hospital|1|||
131836261|NCT04280705|474684608|FG001|Overall Study|Transferred to another hospital|1|||
131836262|NCT04268316|474684611|FG000|Overall Study|Withdrawal by Subject|2|||
131836263|NCT04268316|474684612|FG001|Overall Study|Withdrawal by Subject|1|||
131910639|NCT01192815|474960812|FG000|Overall Study|Lack of Efficacy|1|||
131910640|NCT03426878|474960813|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
131910641|NCT03426878|474960813|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
131910642|NCT03426878|474960813|FG000|Overall Study|Declined to receive results|3|||
131910643|NCT03426878|474960813|FG000|Overall Study|Received negative results by mailed letter|65|||
131910644|NCT03426878|474960813|FG000|Overall Study|Lost to Follow-up|177|||
131910645|NCT01286129|474960814|FG000|Overall Study|Withdrawal by Subject|4|||
131910646|NCT01286129|474960815|FG001|Overall Study|Withdrawal by Subject|1|||
131910647|NCT01286129|474960814|FG000|Overall Study|Could not comply with study requirements|4|||
131910648|NCT01286129|474960815|FG001|Overall Study|Could not comply with study requirements|4|||
131910649|NCT00071981|474960820|FG000|Overall Study|Lack of Efficacy|37|||
131910650|NCT00071981|474960821|FG001|Overall Study|Lack of Efficacy|29|||
131910651|NCT00071981|474960822|FG002|Overall Study|Lack of Efficacy|30|||
131910652|NCT00071981|474960823|FG003|Overall Study|Lack of Efficacy|43|||
131910653|NCT00071981|474960820|FG000|Overall Study|Adverse Event|4|||
131910654|NCT00071981|474960821|FG001|Overall Study|Adverse Event|4|||
131910655|NCT00071981|474960822|FG002|Overall Study|Adverse Event|3|||
131910656|NCT00071981|474960823|FG003|Overall Study|Adverse Event|1|||
131910657|NCT00071981|474960820|FG000|Overall Study|Death|0|||
131910658|NCT00071981|474960821|FG001|Overall Study|Death|0|||
131910659|NCT00071981|474960822|FG002|Overall Study|Death|1|||
131910660|NCT00071981|474960823|FG003|Overall Study|Death|1|||
131910661|NCT00071981|474960820|FG000|Overall Study|Withdrawal by Subject|3|||
131910662|NCT00071981|474960821|FG001|Overall Study|Withdrawal by Subject|1|||
131910663|NCT00071981|474960822|FG002|Overall Study|Withdrawal by Subject|0|||
131910664|NCT00071981|474960823|FG003|Overall Study|Withdrawal by Subject|0|||
131910665|NCT00071981|474960820|FG000|Overall Study|No protocol therapy|2|||
131910666|NCT00071981|474960821|FG001|Overall Study|No protocol therapy|5|||
131910667|NCT00071981|474960822|FG002|Overall Study|No protocol therapy|1|||
131910668|NCT00071981|474960823|FG003|Overall Study|No protocol therapy|0|||
131910669|NCT00071981|474960820|FG000|Overall Study|others (not specified in the study)|0|||
131910670|NCT00071981|474960821|FG001|Overall Study|others (not specified in the study)|2|||
131910671|NCT00071981|474960822|FG002|Overall Study|others (not specified in the study)|2|||
131910672|NCT00071981|474960823|FG003|Overall Study|others (not specified in the study)|0|||
131910673|NCT01394276|474960824|FG000|Overall Study|Related Adverse event (AEs)|15|||
131910674|NCT01394276|474960824|FG000|Overall Study|Not related AEs|9|||
131910675|NCT01394276|474960824|FG000|Overall Study|Remission of disease|2|||
131910676|NCT01394276|474960824|FG000|Overall Study|Insufficient therapeutic effect|17|||
131910677|NCT01394276|474960824|FG000|Overall Study|Insufficient compliance|9|||
131910678|NCT01394276|474960824|FG000|Overall Study|Lost to Follow-up|5|||
131910679|NCT01394276|474960824|FG000|Overall Study|Participant moved to another site|1|||
131910680|NCT01394276|474960824|FG000|Overall Study|Pregnancy|1|||
131910681|NCT01394276|474960824|FG000|Overall Study|unavailability of drug at the Hospital|2|||
131836264|NCT04268316|474684613|FG002|Overall Study|Withdrawal by Subject|0|||
131836265|NCT03188718|474684614|FG000|Overall Study|Participant noncompliance|4|||
131836266|NCT03188718|474684614|FG000|Overall Study|Withdrawal by Subject|1|||
131836267|NCT03188718|474684614|FG000|Overall Study|Device failure|3|||
131836268|NCT04032158|474684615|FG000|Overall Study|Study Termination|2|||
131910682|NCT01394276|474960824|FG000|Overall Study|Symptoms of concurrent diseases|1|||
131910683|NCT00465179|474960827|FG000|Overall Study|Adverse Event|4|||
131910684|NCT00465179|474960827|FG000|Overall Study|Withdrawal by Subject|2|||
131910685|NCT00465179|474960827|FG000|Overall Study|Progression of Disease|47|||
131910686|NCT00262925|474960830|FG000|Overall Study|Lack of Efficacy|3|||
131910687|NCT00262925|474960830|FG000|Overall Study|Adverse Event|4|||
131836269|NCT04032158|474684616|FG001|Overall Study|Study Termination|1|||
131836270|NCT02034058|474684626|FG000|Overall Study|Death|3|||
131836271|NCT00714493|474684630|FG000|Overall Study|Adverse Event|11|||
131910688|NCT00262925|474960830|FG000|Overall Study|Death|2|||
131910689|NCT00262925|474960830|FG000|Overall Study|alternative therapy|1|||
131910690|NCT00262925|474960830|FG000|Overall Study|Other|1|||
131910691|NCT04682301|474960831|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
131910692|NCT04682301|474960831|FG000|Overall Study|Death|2|||
131910693|NCT00560404|474960832|FG000|Overall Study|Adverse Event|2|||
131910694|NCT00560404|474960833|FG001|Overall Study|Adverse Event|3|||
131910695|NCT00560404|474960832|FG000|Overall Study|Death|3|||
131910696|NCT00560404|474960833|FG001|Overall Study|Death|3|||
131910697|NCT00560404|474960832|FG000|Overall Study|Protocol Violation|12|||
131910698|NCT00560404|474960833|FG001|Overall Study|Protocol Violation|7|||
131910699|NCT00560404|474960832|FG000|Overall Study|Administrative Reasons|1|||
131910700|NCT00560404|474960833|FG001|Overall Study|Administrative Reasons|1|||
131910701|NCT00560404|474960832|FG000|Overall Study|Withdrew Consent|4|||
131910702|NCT00560404|474960833|FG001|Overall Study|Withdrew Consent|0|||
131910703|NCT00560404|474960832|FG000|Overall Study|Failure to return|1|||
131910704|NCT00560404|474960833|FG001|Overall Study|Failure to return|2|||
131910705|NCT00560404|474960832|FG000|Overall Study|Other withdrawal reason|13|||
131910706|NCT00560404|474960833|FG001|Overall Study|Other withdrawal reason|5|||
131910707|NCT02187783|474960834|FG000|Overall Study|Adverse Event|8|||
131910708|NCT02187783|474960834|FG000|Overall Study|Death|3|||
131910709|NCT02187783|474960834|FG000|Overall Study|Progressive disease|80|||
131910710|NCT02187783|474960834|FG000|Overall Study|Protocol Violation|3|||
131910711|NCT02187783|474960834|FG000|Overall Study|Physician Decision|2|||
131910712|NCT02187783|474960834|FG000|Overall Study|Withdrawal by Subject|9|||
131910713|NCT02187783|474960834|FG000|Overall Study|Study terminated by sponsor|1|||
131910714|NCT00471497|474960835|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
131910715|NCT00471497|474960836|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
131910716|NCT00471497|474960837|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
131910717|NCT00471497|474960835|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
131910718|NCT00471497|474960836|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
131910719|NCT00471497|474960837|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
131910720|NCT00471497|474960835|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
131910721|NCT00471497|474960836|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
131910722|NCT00471497|474960837|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
131910723|NCT00471497|474960835|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
131910724|NCT00471497|474960836|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
131910725|NCT00471497|474960837|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
131910726|NCT00471497|474960835|FG000|Core Treatment Phase|Lost to Follow-up|6|||
131910727|NCT00471497|474960836|FG001|Core Treatment Phase|Lost to Follow-up|6|||
131910728|NCT00471497|474960837|FG002|Core Treatment Phase|Lost to Follow-up|3|||
131910729|NCT00471497|474960835|FG000|Core Treatment Phase|Death|3|||
131910730|NCT00471497|474960836|FG001|Core Treatment Phase|Death|9|||
131910731|NCT00471497|474960837|FG002|Core Treatment Phase|Death|3|||
131836272|NCT00714493|474684630|FG000|Overall Study|Death|3|||
131836273|NCT00714493|474684630|FG000|Overall Study|Lack of Efficacy|10|||
131836274|NCT00714493|474684630|FG000|Overall Study|Lost to Follow-up|3|||
131836275|NCT00714493|474684630|FG000|Overall Study|Protocol Violation|12|||
131836276|NCT00714493|474684630|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
131836277|NCT00714493|474684630|FG000|Overall Study|OTHER|2|||
131836278|NCT00506129|474684631|FG000|Overall Study|Disease Progression/Relapse|15|||
131836279|NCT00506129|474684631|FG000|Overall Study|Death|7|||
131836280|NCT01400919|474684632|FG000|Overall Study|Withdrawal by Subject|4|||
131836281|NCT01400919|474684632|FG000|Overall Study|Lost to Follow-up|2|||
131836282|NCT01400919|474684632|FG000|Overall Study|Missed visit|2|||
131836283|NCT00158600|474684633|FG000|Overall Study|unable to commit time to study|0|||
131836284|NCT00158600|474684634|FG001|Overall Study|unable to commit time to study|1|||
131836285|NCT00158600|474684633|FG000|Overall Study|Adverse Event|2|||
131836286|NCT00158600|474684634|FG001|Overall Study|Adverse Event|1|||
131836287|NCT00158600|474684633|FG000|Overall Study|Death|1|||
131836288|NCT00158600|474684634|FG001|Overall Study|Death|0|||
131836289|NCT00158600|474684633|FG000|Overall Study|Withdrawal by Subject|2|||
131836290|NCT00158600|474684634|FG001|Overall Study|Withdrawal by Subject|2|||
131836291|NCT00003875|474684635|FG000|Overall Study|Screen Failed|1|||
131836292|NCT01780987|474684636|FG000|Overall Study|Adverse Event|0|||
131836293|NCT01780987|474684637|FG001|Overall Study|Adverse Event|4|||
131836294|NCT01780987|474684636|FG000|Overall Study|Withdrawal by Subject|2|||
131836295|NCT01780987|474684637|FG001|Overall Study|Withdrawal by Subject|0|||
131836296|NCT01780987|474684636|FG000|Overall Study|Request of Changing Hospital|0|||
131836297|NCT01780987|474684637|FG001|Overall Study|Request of Changing Hospital|1|||
131910732|NCT00471497|474960835|FG000|Core Treatment Phase|Disease Progression|10|||
131910733|NCT00471497|474960836|FG001|Core Treatment Phase|Disease Progression|2|||
131836298|NCT01780987|474684636|FG000|Overall Study|Changing Residence|1|||
131402174|NCT01453205|473093629|FG000|Overall Study|Other|45|||
131836299|NCT01780987|474684637|FG001|Overall Study|Changing Residence|0|||
131910734|NCT00471497|474960837|FG002|Core Treatment Phase|Disease Progression|4|||
131836300|NCT01780987|474684636|FG000|Overall Study|Not Receiving any Study Medication|0|||
131836301|NCT01780987|474684637|FG001|Overall Study|Not Receiving any Study Medication|1|||
131910735|NCT00471497|474960835|FG000|Core Treatment Phase|Protocol Violation|6|||
131910736|NCT00471497|474960836|FG001|Core Treatment Phase|Protocol Violation|15|||
131836302|NCT04168190|474684638|FG000|Overall Study|Lost to Follow-up|0|||
131836303|NCT04168190|474684639|FG001|Overall Study|Lost to Follow-up|1|||
131836304|NCT04168190|474684640|FG002|Overall Study|Lost to Follow-up|0|||
131836305|NCT04168190|474684641|FG003|Overall Study|Lost to Follow-up|7|||
131836306|NCT04168190|474684642|FG004|Overall Study|Lost to Follow-up|5|||
131836307|NCT04168190|474684638|FG000|Overall Study|Withdrawal by Subject|1|||
131836308|NCT04168190|474684639|FG001|Overall Study|Withdrawal by Subject|0|||
131836309|NCT04168190|474684640|FG002|Overall Study|Withdrawal by Subject|0|||
131836310|NCT04168190|474684641|FG003|Overall Study|Withdrawal by Subject|2|||
131836311|NCT04168190|474684642|FG004|Overall Study|Withdrawal by Subject|4|||
131836312|NCT04168190|474684638|FG000|Overall Study|Death|0|||
131836313|NCT04168190|474684639|FG001|Overall Study|Death|0|||
131836314|NCT04168190|474684640|FG002|Overall Study|Death|0|||
131836315|NCT04168190|474684641|FG003|Overall Study|Death|1|||
131836316|NCT04168190|474684642|FG004|Overall Study|Death|0|||
131836317|NCT00629265|474684643|FG000|Overall Study|Lost to Follow-up|4|||
131836318|NCT00629265|474684644|FG001|Overall Study|Lost to Follow-up|5|||
131836319|NCT00629265|474684643|FG000|Overall Study|Withdrawal by Subject|11|||
131836320|NCT00629265|474684644|FG001|Overall Study|Withdrawal by Subject|8|||
131836321|NCT00629265|474684643|FG000|Overall Study|Death|1|||
131836322|NCT00629265|474684644|FG001|Overall Study|Death|0|||
131836323|NCT00629265|474684643|FG000|Overall Study|Adverse Event|2|||
131836324|NCT00629265|474684644|FG001|Overall Study|Adverse Event|0|||
131836325|NCT00629265|474684643|FG000|Overall Study|HNC Recurrence|4|||
131836326|NCT00629265|474684644|FG001|Overall Study|HNC Recurrence|0|||
131836327|NCT00629265|474684643|FG000|Overall Study|Other CA Requiring Treatment|1|||
131836328|NCT00629265|474684644|FG001|Overall Study|Other CA Requiring Treatment|3|||
131836329|NCT00629265|474684643|FG000|Overall Study|Needed Esophageal Dilation|4|||
131836330|NCT00629265|474684644|FG001|Overall Study|Needed Esophageal Dilation|1|||
131836331|NCT00629265|474684643|FG000|Overall Study|Unrelated Medical Complications|3|||
131836332|NCT00629265|474684644|FG001|Overall Study|Unrelated Medical Complications|1|||
131836333|NCT00629265|474684643|FG000|Overall Study|Unknown Reason|2|||
131836334|NCT00629265|474684644|FG001|Overall Study|Unknown Reason|2|||
131836335|NCT04465630|474684645|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
131836336|NCT04465630|474684645|FG000|Overall Study|Screen failure|8|||
131836337|NCT04465630|474684645|FG000|Overall Study|Baseline failure|16|||
131836338|NCT02005887|474684648|FG000|Overall Study|Protocol Violation|0|||
131910737|NCT00471497|474960837|FG002|Core Treatment Phase|Protocol Violation|11|||
131910738|NCT00471497|474960835|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
131910739|NCT00471497|474960836|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
131910740|NCT00471497|474960837|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
131910741|NCT00471497|474960835|FG000|Core Treatment Phase|Administrative problems|14|||
131910742|NCT00471497|474960836|FG001|Core Treatment Phase|Administrative problems|14|||
131910743|NCT00471497|474960837|FG002|Core Treatment Phase|Administrative problems|12|||
131910744|NCT00471497|474960835|FG000|Core Treatment Phase|Adverse Event|43|||
131910745|NCT00471497|474960836|FG001|Core Treatment Phase|Adverse Event|53|||
131910746|NCT00471497|474960837|FG002|Core Treatment Phase|Adverse Event|89|||
131910747|NCT00471497|474960835|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
131910748|NCT00471497|474960836|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
131910749|NCT00471497|474960837|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
131910750|NCT00471497|474960835|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
131910751|NCT00471497|474960836|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
131910752|NCT00471497|474960837|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
131910753|NCT00471497|474960835|FG000|Extension Phase|Adverse Event|9|||
131836339|NCT02005887|474684649|FG001|Overall Study|Protocol Violation|2|||
131836340|NCT01615263|474684650|FG000|Overall Study|Post-randomization exclusion|0|||
131836341|NCT01615263|474684651|FG001|Overall Study|Post-randomization exclusion|2|||
131836342|NCT00857259|474684652|FG000|Overall Study|Protocol Violation|1|||
131836343|NCT00857259|474684653|FG001|Overall Study|Protocol Violation|0|||
131836344|NCT00857259|474684654|FG002|Overall Study|Protocol Violation|1|||
131836345|NCT02701413|474684655|FG000|Overall Study|Withdrawal by Subject|7|||
131836346|NCT02701413|474684656|FG001|Overall Study|Withdrawal by Subject|11|||
131836347|NCT02138136|474684659|FG000|Overall Study|Protocol Violation|4|||
131836348|NCT02138136|474684659|FG000|Overall Study|Physician Decision|7|||
131836349|NCT02138136|474684659|FG000|Overall Study|Lack of Efficacy|35|||
131836350|NCT02138136|474684659|FG000|Overall Study|Pregnancy|2|||
131836351|NCT02138136|474684659|FG000|Overall Study|Adverse Event|18|||
131836352|NCT02138136|474684659|FG000|Overall Study|Withdrawal by Subject|36|||
131836353|NCT02138136|474684659|FG000|Overall Study|Lost to Follow-up|32|||
131836354|NCT02138136|474684659|FG000|Overall Study|Withdrawn by Sponsor|5|||
131836355|NCT01660334|474684662|FG000|Overall Study|Lost to Follow-up|1|||
131836356|NCT00311311|474684664|FG000|Overall Study|Adverse Event|3|||
131836357|NCT00311311|474684665|FG001|Overall Study|Adverse Event|2|||
131910754|NCT00471497|474960836|FG001|Extension Phase|Adverse Event|5|||
131910755|NCT00471497|474960837|FG002|Extension Phase|Adverse Event|1|||
131836358|NCT00311311|474684664|FG000|Overall Study|Withdrawal by Subject|1|||
131836359|NCT00311311|474684665|FG001|Overall Study|Withdrawal by Subject|1|||
131836360|NCT00311311|474684664|FG000|Overall Study|Noncompliance|0|||
131836361|NCT00311311|474684665|FG001|Overall Study|Noncompliance|1|||
131836362|NCT00311311|474684664|FG000|Overall Study|Study Termination by Sponsor|3|||
131836363|NCT00311311|474684665|FG001|Overall Study|Study Termination by Sponsor|4|||
131836364|NCT00311311|474684664|FG000|Overall Study|Death|1|||
131836365|NCT00311311|474684665|FG001|Overall Study|Death|0|||
131836366|NCT00311311|474684664|FG000|Overall Study|Lack of ancillary assistance|0|||
131836367|NCT00311311|474684665|FG001|Overall Study|Lack of ancillary assistance|1|||
131836368|NCT03979820|474684667|FG000|Overall Study|Protocol Violation|1|||
131836369|NCT03979820|474684668|FG001|Overall Study|Protocol Violation|0|||
131836370|NCT03979820|474684669|FG002|Overall Study|Protocol Violation|0|||
131836371|NCT03979820|474684670|FG003|Overall Study|Protocol Violation|0|||
131836372|NCT03979820|474684667|FG000|Overall Study|Withdrawal by Subject|0|||
131836373|NCT03979820|474684668|FG001|Overall Study|Withdrawal by Subject|0|||
131836374|NCT03979820|474684669|FG002|Overall Study|Withdrawal by Subject|1|||
131836375|NCT03979820|474684670|FG003|Overall Study|Withdrawal by Subject|0|||
131836376|NCT03979820|474684667|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
131836377|NCT03979820|474684668|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
131836378|NCT03979820|474684669|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
131836379|NCT03979820|474684670|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
131836380|NCT00988065|474684671|FG000|Overall Study|Adverse Event|4|||
131836381|NCT00988065|474684672|FG001|Overall Study|Adverse Event|10|||
131836382|NCT00988065|474684673|FG002|Overall Study|Adverse Event|2|||
131836383|NCT00988065|474684671|FG000|Overall Study|Lost to Follow-up|1|||
131836384|NCT00988065|474684672|FG001|Overall Study|Lost to Follow-up|2|||
131836385|NCT00988065|474684673|FG002|Overall Study|Lost to Follow-up|2|||
131836386|NCT00988065|474684671|FG000|Overall Study|Subject withdrew consent|3|||
131836387|NCT00988065|474684672|FG001|Overall Study|Subject withdrew consent|5|||
131836388|NCT00988065|474684673|FG002|Overall Study|Subject withdrew consent|2|||
131836389|NCT00988065|474684671|FG000|Overall Study|Noncompliance with protocol|5|||
131836390|NCT00988065|474684672|FG001|Overall Study|Noncompliance with protocol|6|||
131836391|NCT00988065|474684673|FG002|Overall Study|Noncompliance with protocol|9|||
131836392|NCT01229735|474684674|FG000|Overall Study|Lack of Efficacy|8|||
131836393|NCT01229735|474684675|FG001|Overall Study|Lack of Efficacy|8|||
131836394|NCT01229735|474684674|FG000|Overall Study|Protocol Violation|13|||
131836395|NCT01229735|474684675|FG001|Overall Study|Protocol Violation|8|||
131836396|NCT01229735|474684674|FG000|Overall Study|Lost to Follow-up|0|||
131836397|NCT01229735|474684675|FG001|Overall Study|Lost to Follow-up|2|||
131836398|NCT01229735|474684674|FG000|Overall Study|Withdrawal by Subject|18|||
131836399|NCT01229735|474684675|FG001|Overall Study|Withdrawal by Subject|17|||
131836400|NCT01229735|474684674|FG000|Overall Study|Other Reason|13|||
131836401|NCT01229735|474684675|FG001|Overall Study|Other Reason|10|||
131836402|NCT01229735|474684674|FG000|Overall Study|SAE, non-fatal|0|||
131836403|NCT01229735|474684675|FG001|Overall Study|SAE, non-fatal|4|||
131836404|NCT01229735|474684674|FG000|Overall Study|AE, non-serious non-fatal|13|||
131836405|NCT01229735|474684675|FG001|Overall Study|AE, non-serious non-fatal|17|||
131836406|NCT01229735|474684674|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131836407|NCT01229735|474684675|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131836408|NCT02685202|474684676|FG000|Overall Study|Lost to Follow-up|9|||
131836409|NCT02787408|474684677|FG000|Overall Study|Death|16|||
131836410|NCT02787408|474684677|FG000|Overall Study|Withdrawal by Subject|1|||
131836411|NCT02787408|474684677|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
131836412|NCT01782482|474684678|FG000|Overall Study|Adverse Event|2|||
131836413|NCT01782482|474684679|FG001|Overall Study|Adverse Event|1|||
131836414|NCT01782482|474684678|FG000|Overall Study|Lost to Follow-up|2|||
131836415|NCT01782482|474684679|FG001|Overall Study|Lost to Follow-up|3|||
131836416|NCT01782482|474684678|FG000|Overall Study|Physician Decision|1|||
131836417|NCT01782482|474684679|FG001|Overall Study|Physician Decision|0|||
131836418|NCT01782482|474684678|FG000|Overall Study|Protocol Violation|1|||
131836419|NCT01782482|474684679|FG001|Overall Study|Protocol Violation|0|||
131836420|NCT01782482|474684678|FG000|Overall Study|Withdrawal by Subject|2|||
131836421|NCT01782482|474684679|FG001|Overall Study|Withdrawal by Subject|3|||
131836422|NCT01782482|474684678|FG000|Overall Study|Randomized in Error|2|||
131836423|NCT01782482|474684679|FG001|Overall Study|Randomized in Error|2|||
131836424|NCT01782482|474684678|FG000|Overall Study|Habitually wearing toric lens OS|0|||
131836425|NCT01782482|474684679|FG001|Overall Study|Habitually wearing toric lens OS|1|||
131836426|NCT00985712|474684681|FG000|Overall Study|Adverse Event|0|||
131836427|NCT00985712|474684682|FG001|Overall Study|Adverse Event|1|||
131836428|NCT00985712|474684681|FG000|Overall Study|Lost to Follow-up|2|||
131836429|NCT00985712|474684682|FG001|Overall Study|Lost to Follow-up|2|||
131836430|NCT00985712|474684681|FG000|Overall Study|Protocol Violation|0|||
131836431|NCT00985712|474684682|FG001|Overall Study|Protocol Violation|1|||
131836432|NCT00985712|474684681|FG000|Overall Study|Withdrawal by Subject|4|||
131836433|NCT00985712|474684682|FG001|Overall Study|Withdrawal by Subject|1|||
131836434|NCT00985712|474684681|FG000|Overall Study|Sponsor decision|0|||
131402175|NCT01453205|473093630|FG001|Overall Study|Other|27|||
131402176|NCT01453205|473093631|FG002|Overall Study|Other|35|||
131402177|NCT03268954|473093632|FG000|Overall Study|Ongoing|23|||
131402178|NCT03268954|473093633|FG001|Overall Study|Ongoing|31|||
131402179|NCT03268954|473093632|FG000|Overall Study|Adverse Event|53|||
131402180|NCT03268954|473093633|FG001|Overall Study|Adverse Event|62|||
131402181|NCT03268954|473093632|FG000|Overall Study|Withdrawal by Subject|25|||
131402182|NCT03268954|473093633|FG001|Overall Study|Withdrawal by Subject|16|||
131402183|NCT03268954|473093632|FG000|Overall Study|Progressive Disease|61|||
131402184|NCT03268954|473093633|FG001|Overall Study|Progressive Disease|48|||
131836435|NCT00985712|474684682|FG001|Overall Study|Sponsor decision|2|||
131402185|NCT03268954|473093632|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
131402186|NCT03268954|473093633|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
131402187|NCT03268954|473093632|FG000|Overall Study|Reason not Specified|40|||
131402188|NCT03268954|473093633|FG001|Overall Study|Reason not Specified|40|||
131402189|NCT03255967|473093634|FG000|Overall Study|Adverse Event|26|||
131402190|NCT03255967|473093635|FG001|Overall Study|Adverse Event|30|||
131402191|NCT03255967|473093634|FG000|Overall Study|Withdrawal by Subject|6|||
131402192|NCT03255967|473093635|FG001|Overall Study|Withdrawal by Subject|6|||
131402193|NCT03255967|473093634|FG000|Overall Study|Schedule conflict|6|||
131402194|NCT03255967|473093635|FG001|Overall Study|Schedule conflict|4|||
131402195|NCT03255967|473093634|FG000|Overall Study|POA did not sign consent form|2|||
131402196|NCT03255967|473093635|FG001|Overall Study|POA did not sign consent form|0|||
131402197|NCT00778258|473093636|FG000|Overall Study|Adverse Event|1|||
131402198|NCT00778258|473093637|FG001|Overall Study|Adverse Event|0|||
131402199|NCT00778258|473093638|FG002|Overall Study|Adverse Event|0|||
131402200|NCT00778258|473093639|FG003|Overall Study|Adverse Event|0|||
131402201|NCT00778258|473093640|FG004|Overall Study|Adverse Event|0|||
131402202|NCT00778258|473093641|FG005|Overall Study|Adverse Event|1|||
131402203|NCT00778258|473093642|FG006|Overall Study|Adverse Event|0|||
131402204|NCT00778258|473093643|FG007|Overall Study|Adverse Event|0|||
131402205|NCT00778258|473093644|FG008|Overall Study|Adverse Event|0|||
131402206|NCT00778258|473093636|FG000|Overall Study|Lost to Follow-up|0|||
131402207|NCT00778258|473093637|FG001|Overall Study|Lost to Follow-up|0|||
131402208|NCT00778258|473093638|FG002|Overall Study|Lost to Follow-up|2|||
131402209|NCT00778258|473093639|FG003|Overall Study|Lost to Follow-up|0|||
131402210|NCT00778258|473093640|FG004|Overall Study|Lost to Follow-up|0|||
131402211|NCT00778258|473093641|FG005|Overall Study|Lost to Follow-up|3|||
131402212|NCT00778258|473093642|FG006|Overall Study|Lost to Follow-up|2|||
131402213|NCT00778258|473093643|FG007|Overall Study|Lost to Follow-up|2|||
131402214|NCT00778258|473093644|FG008|Overall Study|Lost to Follow-up|0|||
131402215|NCT00778258|473093636|FG000|Overall Study|Withdrawal by Subject|6|||
131402216|NCT00778258|473093637|FG001|Overall Study|Withdrawal by Subject|2|||
131402217|NCT00778258|473093638|FG002|Overall Study|Withdrawal by Subject|8|||
131402218|NCT00778258|473093639|FG003|Overall Study|Withdrawal by Subject|2|||
131402219|NCT00778258|473093640|FG004|Overall Study|Withdrawal by Subject|0|||
131402220|NCT00778258|473093641|FG005|Overall Study|Withdrawal by Subject|6|||
131402221|NCT00778258|473093642|FG006|Overall Study|Withdrawal by Subject|12|||
131402222|NCT00778258|473093643|FG007|Overall Study|Withdrawal by Subject|12|||
131402223|NCT00778258|473093644|FG008|Overall Study|Withdrawal by Subject|4|||
131402224|NCT00778258|473093636|FG000|Overall Study|New Contraindication|0|||
131402225|NCT00778258|473093637|FG001|Overall Study|New Contraindication|0|||
131402226|NCT00778258|473093638|FG002|Overall Study|New Contraindication|0|||
131402227|NCT00778258|473093639|FG003|Overall Study|New Contraindication|0|||
131402228|NCT00778258|473093640|FG004|Overall Study|New Contraindication|0|||
131402229|NCT00778258|473093641|FG005|Overall Study|New Contraindication|0|||
131402230|NCT00778258|473093642|FG006|Overall Study|New Contraindication|0|||
131402231|NCT00778258|473093643|FG007|Overall Study|New Contraindication|1|||
131402232|NCT00778258|473093644|FG008|Overall Study|New Contraindication|0|||
131402233|NCT00778258|473093636|FG000|Overall Study|Non-compliance|0|||
131836436|NCT03096847|474684683|FG000|Overall Study|Other|2|||
131836437|NCT03096847|474684684|FG001|Overall Study|Other|1|||
131836438|NCT03096847|474684685|FG002|Overall Study|Other|2|||
131836439|NCT03096847|474684683|FG000|Overall Study|Lost to Follow-up|1|||
131402234|NCT00778258|473093637|FG001|Overall Study|Non-compliance|0|||
131402235|NCT00778258|473093638|FG002|Overall Study|Non-compliance|0|||
131402236|NCT00778258|473093639|FG003|Overall Study|Non-compliance|1|||
131402237|NCT00778258|473093640|FG004|Overall Study|Non-compliance|0|||
131402238|NCT00778258|473093641|FG005|Overall Study|Non-compliance|0|||
131402239|NCT00778258|473093642|FG006|Overall Study|Non-compliance|0|||
131402240|NCT00778258|473093643|FG007|Overall Study|Non-compliance|0|||
131402241|NCT00778258|473093644|FG008|Overall Study|Non-compliance|0|||
131402242|NCT00778258|473093636|FG000|Overall Study|Other|0|||
131402243|NCT00778258|473093637|FG001|Overall Study|Other|0|||
131402244|NCT00778258|473093638|FG002|Overall Study|Other|0|||
131402245|NCT00778258|473093639|FG003|Overall Study|Other|0|||
131402246|NCT00778258|473093640|FG004|Overall Study|Other|0|||
131402247|NCT00778258|473093641|FG005|Overall Study|Other|0|||
131836440|NCT03096847|474684684|FG001|Overall Study|Lost to Follow-up|0|||
131836441|NCT03096847|474684685|FG002|Overall Study|Lost to Follow-up|1|||
131836442|NCT03096847|474684683|FG000|Overall Study|Death|6|||
131836443|NCT03096847|474684684|FG001|Overall Study|Death|0|||
131836444|NCT03096847|474684685|FG002|Overall Study|Death|2|||
131836445|NCT03096847|474684683|FG000|Overall Study|Protocol Violation|3|||
131836446|NCT03096847|474684684|FG001|Overall Study|Protocol Violation|0|||
131836447|NCT03096847|474684685|FG002|Overall Study|Protocol Violation|6|||
131836448|NCT03096847|474684683|FG000|Overall Study|Physician Decision|12|||
131836449|NCT03096847|474684684|FG001|Overall Study|Physician Decision|2|||
131836450|NCT03096847|474684685|FG002|Overall Study|Physician Decision|8|||
131836451|NCT03096847|474684683|FG000|Overall Study|Withdrawal by Subject|24|||
131836452|NCT03096847|474684684|FG001|Overall Study|Withdrawal by Subject|1|||
131836453|NCT03096847|474684685|FG002|Overall Study|Withdrawal by Subject|12|||
131836454|NCT03096847|474684683|FG000|Overall Study|Adverse Event|72|||
131836455|NCT03096847|474684684|FG001|Overall Study|Adverse Event|6|||
131836456|NCT03096847|474684685|FG002|Overall Study|Adverse Event|28|||
131836457|NCT03096847|474684683|FG000|Overall Study|Progressive disease|97|||
131836458|NCT03096847|474684684|FG001|Overall Study|Progressive disease|10|||
131836459|NCT03096847|474684685|FG002|Overall Study|Progressive disease|78|||
131836460|NCT03096847|474684683|FG000|Overall Study|Non-compliance with study medication|1|||
131836461|NCT03096847|474684684|FG001|Overall Study|Non-compliance with study medication|0|||
131836462|NCT03096847|474684685|FG002|Overall Study|Non-compliance with study medication|0|||
131836463|NCT03096847|474684683|FG000|Overall Study|New therapy for study indication|1|||
131836464|NCT03096847|474684684|FG001|Overall Study|New therapy for study indication|0|||
131836465|NCT03096847|474684685|FG002|Overall Study|New therapy for study indication|1|||
131836466|NCT01230892|474684688|FG000|Overall Study|Withdrawal by Subject|1|||
131836467|NCT01230892|474684689|FG001|Overall Study|Withdrawal by Subject|1|||
131836468|NCT01230892|474684688|FG000|Overall Study|Lost to Follow-up|2|||
131836469|NCT01230892|474684689|FG001|Overall Study|Lost to Follow-up|0|||
131836470|NCT00679913|474684690|FG000|Overall Study|Protocol Violation|18|||
131836471|NCT00679913|474684691|FG001|Overall Study|Protocol Violation|13|||
131836472|NCT00725621|474684692|FG000|Overall Study|Adverse Event|25|||
131836473|NCT00725621|474684692|FG000|Overall Study|Lack of Efficacy|46|||
131836474|NCT00725621|474684692|FG000|Overall Study|Withdrawal by Subject|57|||
131836475|NCT00725621|474684692|FG000|Overall Study|Physician Decision|19|||
131836476|NCT00725621|474684692|FG000|Overall Study|Lost to Follow-up|52|||
131836477|NCT00725621|474684692|FG000|Overall Study|Non-compliance|8|||
131836478|NCT00725621|474684692|FG000|Overall Study|Continued treatment by other physician|6|||
131836479|NCT00725621|474684692|FG000|Overall Study|Switched to other study|1|||
131836480|NCT00725621|474684692|FG000|Overall Study|Switched to other drug|1|||
131836481|NCT00725621|474684692|FG000|Overall Study|Prepared for elective surgery|1|||
131836482|NCT00725621|474684692|FG000|Overall Study|Reason not specified|55|||
131836483|NCT01189500|474684693|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
131836484|NCT01189500|474684693|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
131836485|NCT01000493|474684694|FG000|Overall Study|Adverse Event|3|||
131836486|NCT01000493|474684695|FG001|Overall Study|Adverse Event|6|||
131836487|NCT01000493|474684694|FG000|Overall Study|Lack of Efficacy|1|||
131836488|NCT01000493|474684695|FG001|Overall Study|Lack of Efficacy|1|||
131836489|NCT01000493|474684694|FG000|Overall Study|Protocol Violation|1|||
131836490|NCT01000493|474684695|FG001|Overall Study|Protocol Violation|8|||
131836491|NCT01000493|474684694|FG000|Overall Study|Study closed/terminated|25|||
131836492|NCT01000493|474684695|FG001|Overall Study|Study closed/terminated|23|||
131836493|NCT01000493|474684694|FG000|Overall Study|Lost to Follow-up|5|||
131836494|NCT01000493|474684695|FG001|Overall Study|Lost to Follow-up|9|||
131836495|NCT01000493|474684694|FG000|Overall Study|Physician Decision|1|||
131836496|NCT01000493|474684695|FG001|Overall Study|Physician Decision|1|||
131836497|NCT01000493|474684694|FG000|Overall Study|Withdrawal by Subject|3|||
131836498|NCT01000493|474684695|FG001|Overall Study|Withdrawal by Subject|7|||
131836499|NCT01144364|474684696|FG000|Induction Phase|Disease progression|14|||
131836500|NCT01144364|474684697|FG001|Induction Phase|Disease progression|0|||
131836501|NCT01144364|474684698|FG002|Induction Phase|Disease progression|0|||
131836502|NCT01144364|474684696|FG000|Induction Phase|Adverse Event|9|||
131836503|NCT01144364|474684697|FG001|Induction Phase|Adverse Event|0|||
131402248|NCT00778258|473093642|FG006|Overall Study|Other|1|||
131836504|NCT01144364|474684698|FG002|Induction Phase|Adverse Event|0|||
131836505|NCT01144364|474684696|FG000|Induction Phase|Death|1|||
131836506|NCT01144364|474684697|FG001|Induction Phase|Death|0|||
131836507|NCT01144364|474684698|FG002|Induction Phase|Death|0|||
131836508|NCT01144364|474684696|FG000|Induction Phase|Withdrawal by Subject|1|||
131836509|NCT01144364|474684697|FG001|Induction Phase|Withdrawal by Subject|0|||
131836510|NCT01144364|474684698|FG002|Induction Phase|Withdrawal by Subject|0|||
131836511|NCT01144364|474684696|FG000|Induction Phase|Lost to Follow-up|2|||
131836512|NCT01144364|474684697|FG001|Induction Phase|Lost to Follow-up|0|||
131836513|NCT01144364|474684698|FG002|Induction Phase|Lost to Follow-up|0|||
131402249|NCT00778258|473093643|FG007|Overall Study|Other|0|||
131836514|NCT01144364|474684696|FG000|Induction Phase|Physician Decision|1|||
131836515|NCT01144364|474684697|FG001|Induction Phase|Physician Decision|0|||
131836516|NCT01144364|474684698|FG002|Induction Phase|Physician Decision|0|||
131836517|NCT01144364|474684696|FG000|Induction Phase|Stable disease|2|||
131836518|NCT01144364|474684697|FG001|Induction Phase|Stable disease|0|||
131836519|NCT01144364|474684698|FG002|Induction Phase|Stable disease|0|||
131836520|NCT01144364|474684696|FG000|Induction Phase|Secondary neoplasia|1|||
131836521|NCT01144364|474684697|FG001|Induction Phase|Secondary neoplasia|0|||
131836522|NCT01144364|474684698|FG002|Induction Phase|Secondary neoplasia|0|||
131836523|NCT01144364|474684696|FG000|Induction Phase|Protocol Violation|1|||
131836524|NCT01144364|474684697|FG001|Induction Phase|Protocol Violation|0|||
131836525|NCT01144364|474684698|FG002|Induction Phase|Protocol Violation|0|||
131836526|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
131836527|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
131836528|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
131836529|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
131836530|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
131836531|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
131836532|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Death|0|||
131836533|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Death|2|||
131836534|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Death|0|||
131836535|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
131836536|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
131836537|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
131836538|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
131836539|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
131836540|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
131836541|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
131836542|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
131836543|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
131836544|NCT01144364|474684696|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
131836545|NCT01144364|474684697|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
131836546|NCT01144364|474684698|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
131836547|NCT02206620|474684701|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131836548|NCT02206620|474684702|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131836549|NCT02206620|474684701|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
131836550|NCT02206620|474684702|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
131836551|NCT01346774|474684703|FG000|Overall Study|Did not take a single dose|6|||
131836552|NCT01346774|474684704|FG001|Overall Study|Did not take a single dose|4|||
131836553|NCT01346774|474684703|FG000|Overall Study|Lost to Follow-up|3|||
131836554|NCT01346774|474684704|FG001|Overall Study|Lost to Follow-up|4|||
131836555|NCT01346774|474684703|FG000|Overall Study|Withdrawal by Subject|1|||
131836556|NCT01346774|474684704|FG001|Overall Study|Withdrawal by Subject|4|||
131836557|NCT01346774|474684703|FG000|Overall Study|Protocol Violation|2|||
131836558|NCT01346774|474684704|FG001|Overall Study|Protocol Violation|3|||
131836559|NCT01346774|474684703|FG000|Overall Study|Adverse Event|1|||
131836560|NCT01346774|474684704|FG001|Overall Study|Adverse Event|2|||
131836561|NCT01929031|474684705|FG000|Overall Study|Adverse Event|3|||
131836562|NCT01929031|474684706|FG001|Overall Study|Adverse Event|1|||
131836563|NCT01929031|474684707|FG002|Overall Study|Adverse Event|1|||
131836564|NCT01929031|474684708|FG003|Overall Study|Adverse Event|0|||
131836565|NCT01929031|474684709|FG004|Overall Study|Adverse Event|0|||
131836566|NCT01929031|474684710|FG005|Overall Study|Adverse Event|0|||
131836567|NCT01929031|474684705|FG000|Overall Study|Protocol Violation|1|||
131836568|NCT01929031|474684706|FG001|Overall Study|Protocol Violation|0|||
131836569|NCT01929031|474684707|FG002|Overall Study|Protocol Violation|0|||
131836570|NCT01929031|474684708|FG003|Overall Study|Protocol Violation|0|||
131836571|NCT01929031|474684709|FG004|Overall Study|Protocol Violation|0|||
131836572|NCT01929031|474684710|FG005|Overall Study|Protocol Violation|1|||
131836573|NCT01929031|474684705|FG000|Overall Study|Reason other than specified above|0|||
131836574|NCT01929031|474684706|FG001|Overall Study|Reason other than specified above|1|||
131836575|NCT01929031|474684707|FG002|Overall Study|Reason other than specified above|0|||
131836576|NCT01929031|474684708|FG003|Overall Study|Reason other than specified above|0|||
131836577|NCT01929031|474684709|FG004|Overall Study|Reason other than specified above|1|||
131836578|NCT01929031|474684710|FG005|Overall Study|Reason other than specified above|0|||
131836579|NCT05816200|474684711|FG000|Overall Study|Lost to Follow-up|2|||
131836580|NCT05816200|474684712|FG001|Overall Study|Lost to Follow-up|1|||
131836581|NCT00609466|474684718|FG000|Overall Study|Withdrawal by Subject|0|||
131836582|NCT00609466|474684719|FG001|Overall Study|Withdrawal by Subject|1|||
131836583|NCT00609466|474684720|FG002|Overall Study|Withdrawal by Subject|1|||
131836584|NCT00609466|474684718|FG000|Overall Study|Adverse Event|2|||
131836585|NCT00609466|474684719|FG001|Overall Study|Adverse Event|3|||
131836586|NCT00609466|474684720|FG002|Overall Study|Adverse Event|1|||
131836587|NCT00609466|474684718|FG000|Overall Study|Lack of Efficacy|0|||
131836588|NCT00609466|474684719|FG001|Overall Study|Lack of Efficacy|2|||
131836589|NCT00609466|474684720|FG002|Overall Study|Lack of Efficacy|2|||
131836590|NCT03512262|474684721|FG000|Overall Study|Adverse Event|8|||
131836591|NCT03512262|474684722|FG001|Overall Study|Adverse Event|3|||
131402250|NCT00778258|473093644|FG008|Overall Study|Other|0|||
131836592|NCT03512262|474684721|FG000|Overall Study|Death (non-treatment emergent)|1|||
131836593|NCT03512262|474684722|FG001|Overall Study|Death (non-treatment emergent)|0|||
131836594|NCT03512262|474684721|FG000|Overall Study|Withdrawal by Subject|17|||
131836595|NCT03512262|474684722|FG001|Overall Study|Withdrawal by Subject|9|||
131836596|NCT03512262|474684721|FG000|Overall Study|Lost to Follow-up|7|||
131836597|NCT03512262|474684722|FG001|Overall Study|Lost to Follow-up|1|||
131836598|NCT03512262|474684721|FG000|Overall Study|Other than Specified|2|||
131836599|NCT03512262|474684722|FG001|Overall Study|Other than Specified|2|||
131836600|NCT03407430|474684723|FG000|Washout|Protocol Violation|1|||
131836601|NCT03407430|474684724|FG001|Washout|Protocol Violation|0|||
131836602|NCT00321737|474684725|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
131836603|NCT00321737|474684726|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
131836604|NCT00321737|474684727|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
131836605|NCT00321737|474684725|FG000|Overall Study|Adverse Event|11|||
131836606|NCT00321737|474684726|FG001|Overall Study|Adverse Event|3|||
131836607|NCT00321737|474684727|FG002|Overall Study|Adverse Event|6|||
131836608|NCT00321737|474684725|FG000|Overall Study|Lost to Follow-up|5|||
131836609|NCT00321737|474684726|FG001|Overall Study|Lost to Follow-up|5|||
131836610|NCT00321737|474684727|FG002|Overall Study|Lost to Follow-up|6|||
131836611|NCT00321737|474684725|FG000|Overall Study|Withdrawal by Subject|19|||
131836612|NCT00321737|474684726|FG001|Overall Study|Withdrawal by Subject|12|||
131836613|NCT00321737|474684727|FG002|Overall Study|Withdrawal by Subject|17|||
131836614|NCT00321737|474684725|FG000|Overall Study|Protocol Violation|0|||
131836615|NCT00321737|474684726|FG001|Overall Study|Protocol Violation|0|||
131836616|NCT00321737|474684727|FG002|Overall Study|Protocol Violation|1|||
131836617|NCT00321737|474684725|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
131836618|NCT00321737|474684726|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
131836619|NCT00321737|474684727|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
131836620|NCT00321737|474684725|FG000|Overall Study|Possible Barrett's Esophagus|2|||
131836621|NCT00321737|474684726|FG001|Overall Study|Possible Barrett's Esophagus|1|||
131836622|NCT00321737|474684727|FG002|Overall Study|Possible Barrett's Esophagus|1|||
131836623|NCT00321737|474684725|FG000|Overall Study|Therapeutic Failure|6|||
131836624|NCT00321737|474684726|FG001|Overall Study|Therapeutic Failure|0|||
131836625|NCT00321737|474684727|FG002|Overall Study|Therapeutic Failure|2|||
131836626|NCT00321737|474684725|FG000|Overall Study|Pregnancy|0|||
131836627|NCT00321737|474684726|FG001|Overall Study|Pregnancy|2|||
131836628|NCT00321737|474684727|FG002|Overall Study|Pregnancy|0|||
131836629|NCT00321737|474684725|FG000|Overall Study|Noncompliance|2|||
131836630|NCT00321737|474684726|FG001|Overall Study|Noncompliance|0|||
131836631|NCT00321737|474684727|FG002|Overall Study|Noncompliance|0|||
131836632|NCT00321737|474684725|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
131836633|NCT00321737|474684726|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
131836634|NCT00321737|474684727|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
131836635|NCT01195272|474684728|FG000|Overall Study|Adverse Event|1|||
131836636|NCT01195272|474684728|FG000|Overall Study|Lack of Efficacy|3|||
131836637|NCT03188666|474686287|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
131836638|NCT03188666|474686288|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
131836639|NCT03188666|474686289|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
131836640|NCT03188666|474686290|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
131836641|NCT03188666|474686287|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
131836642|NCT03188666|474686288|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
131836643|NCT03188666|474686289|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
131836644|NCT03188666|474686290|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
131836645|NCT03188666|474686287|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
131836646|NCT03188666|474686288|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
131836647|NCT03188666|474686289|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
131836648|NCT03188666|474686290|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
131836649|NCT03188666|474686287|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
131836650|NCT03188666|474686288|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
131836651|NCT03188666|474686289|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
131836652|NCT03188666|474686290|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
131402251|NCT01202188|473093648|FG000|Overall Study|Protocol deviation|14|||
131402252|NCT01202188|473093649|FG001|Overall Study|Protocol deviation|8|||
131402253|NCT01202188|473093650|FG002|Overall Study|Protocol deviation|12|||
131836653|NCT03696953|474686291|FG000|Overall Study|Withdrawal by Subject|6|||
131836654|NCT03696953|474686292|FG001|Overall Study|Withdrawal by Subject|1|||
131836655|NCT03696953|474686291|FG000|Overall Study|missed GBS swabs|2|||
131836656|NCT03696953|474686292|FG001|Overall Study|missed GBS swabs|2|||
131836657|NCT03696953|474686291|FG000|Overall Study|lost study bottle containing capsules|2|||
131836658|NCT03696953|474686292|FG001|Overall Study|lost study bottle containing capsules|0|||
131836659|NCT03696953|474686291|FG000|Overall Study|Premature birth|1|||
131836660|NCT03696953|474686292|FG001|Overall Study|Premature birth|4|||
131402254|NCT01202188|473093651|FG003|Overall Study|Protocol deviation|10|||
131402255|NCT01202188|473093652|FG004|Overall Study|Protocol deviation|11|||
131836661|NCT03696953|474686291|FG000|Overall Study|Gestational hypertension|1|||
131836662|NCT03696953|474686292|FG001|Overall Study|Gestational hypertension|1|||
131836663|NCT03696953|474686291|FG000|Overall Study|Gestational diabetes|2|||
131836664|NCT03696953|474686292|FG001|Overall Study|Gestational diabetes|1|||
131836665|NCT03696953|474686291|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
131836666|NCT03696953|474686292|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
131836667|NCT03696953|474686291|FG000|Overall Study|Changed prenatal provider|1|||
131836668|NCT03696953|474686292|FG001|Overall Study|Changed prenatal provider|1|||
131836669|NCT03502707|474686293|FG000|Overall Study|Adverse Event|0|||
131836670|NCT03502707|474686294|FG001|Overall Study|Adverse Event|0|||
131836671|NCT03502707|474686295|FG002|Overall Study|Adverse Event|0|||
131836672|NCT03502707|474686296|FG003|Overall Study|Adverse Event|0|||
131836673|NCT03502707|474686297|FG004|Overall Study|Adverse Event|0|||
131836674|NCT03502707|474686298|FG005|Overall Study|Adverse Event|0|||
131836675|NCT03502707|474686299|FG006|Overall Study|Adverse Event|0|||
131836676|NCT03502707|474686300|FG007|Overall Study|Adverse Event|0|||
131836677|NCT03502707|474686301|FG008|Overall Study|Adverse Event|0|||
131836678|NCT03502707|474686302|FG009|Overall Study|Adverse Event|0|||
131836679|NCT03502707|474686303|FG010|Overall Study|Adverse Event|0|||
131836680|NCT03502707|474686304|FG011|Overall Study|Adverse Event|0|||
131836681|NCT03502707|474686305|FG012|Overall Study|Adverse Event|0|||
131836682|NCT03502707|474686306|FG013|Overall Study|Adverse Event|0|||
131836683|NCT03502707|474686307|FG014|Overall Study|Adverse Event|0|||
131836684|NCT03502707|474686308|FG015|Overall Study|Adverse Event|1|||
131836685|NCT03502707|474686309|FG016|Overall Study|Adverse Event|5|||
131836686|NCT03502707|474686310|FG017|Overall Study|Adverse Event|0|||
131836687|NCT03502707|474686293|FG000|Overall Study|Death|0|||
131836688|NCT03502707|474686294|FG001|Overall Study|Death|0|||
131836689|NCT03502707|474686295|FG002|Overall Study|Death|0|||
131836690|NCT03502707|474686296|FG003|Overall Study|Death|1|||
131836691|NCT03502707|474686297|FG004|Overall Study|Death|0|||
131836692|NCT03502707|474686298|FG005|Overall Study|Death|0|||
131836693|NCT03502707|474686299|FG006|Overall Study|Death|0|||
131836694|NCT03502707|474686300|FG007|Overall Study|Death|0|||
131836695|NCT03502707|474686301|FG008|Overall Study|Death|1|||
131836696|NCT03502707|474686302|FG009|Overall Study|Death|1|||
131836697|NCT03502707|474686303|FG010|Overall Study|Death|0|||
131836698|NCT03502707|474686304|FG011|Overall Study|Death|0|||
131836699|NCT03502707|474686305|FG012|Overall Study|Death|1|||
131836700|NCT03502707|474686306|FG013|Overall Study|Death|0|||
131836701|NCT03502707|474686307|FG014|Overall Study|Death|0|||
131836702|NCT03502707|474686308|FG015|Overall Study|Death|1|||
131836703|NCT03502707|474686309|FG016|Overall Study|Death|0|||
131836704|NCT03502707|474686310|FG017|Overall Study|Death|0|||
131836705|NCT03502707|474686293|FG000|Overall Study|Lost to Follow-up|0|||
131836706|NCT03502707|474686294|FG001|Overall Study|Lost to Follow-up|0|||
131836707|NCT03502707|474686295|FG002|Overall Study|Lost to Follow-up|0|||
131836708|NCT03502707|474686296|FG003|Overall Study|Lost to Follow-up|0|||
131836709|NCT03502707|474686297|FG004|Overall Study|Lost to Follow-up|0|||
131836710|NCT03502707|474686298|FG005|Overall Study|Lost to Follow-up|0|||
131836711|NCT03502707|474686299|FG006|Overall Study|Lost to Follow-up|0|||
131836712|NCT03502707|474686300|FG007|Overall Study|Lost to Follow-up|5|||
131836713|NCT03502707|474686301|FG008|Overall Study|Lost to Follow-up|0|||
131836714|NCT03502707|474686302|FG009|Overall Study|Lost to Follow-up|2|||
131836715|NCT03502707|474686303|FG010|Overall Study|Lost to Follow-up|1|||
131836716|NCT03502707|474686304|FG011|Overall Study|Lost to Follow-up|2|||
131836717|NCT03502707|474686305|FG012|Overall Study|Lost to Follow-up|1|||
131836718|NCT03502707|474686306|FG013|Overall Study|Lost to Follow-up|1|||
131836719|NCT03502707|474686307|FG014|Overall Study|Lost to Follow-up|0|||
131836720|NCT03502707|474686308|FG015|Overall Study|Lost to Follow-up|4|||
131836721|NCT03502707|474686309|FG016|Overall Study|Lost to Follow-up|9|||
131836722|NCT03502707|474686310|FG017|Overall Study|Lost to Follow-up|2|||
131836723|NCT03502707|474686293|FG000|Overall Study|Physician Decision|0|||
131836724|NCT03502707|474686294|FG001|Overall Study|Physician Decision|0|||
131836725|NCT03502707|474686295|FG002|Overall Study|Physician Decision|0|||
131836726|NCT03502707|474686296|FG003|Overall Study|Physician Decision|0|||
131836727|NCT03502707|474686297|FG004|Overall Study|Physician Decision|0|||
131836728|NCT03502707|474686298|FG005|Overall Study|Physician Decision|0|||
131836729|NCT03502707|474686299|FG006|Overall Study|Physician Decision|0|||
131836730|NCT03502707|474686300|FG007|Overall Study|Physician Decision|0|||
131836731|NCT03502707|474686301|FG008|Overall Study|Physician Decision|2|||
131836732|NCT03502707|474686302|FG009|Overall Study|Physician Decision|1|||
131836733|NCT03502707|474686303|FG010|Overall Study|Physician Decision|0|||
131836734|NCT03502707|474686304|FG011|Overall Study|Physician Decision|0|||
131836735|NCT03502707|474686305|FG012|Overall Study|Physician Decision|0|||
131836736|NCT03502707|474686306|FG013|Overall Study|Physician Decision|0|||
131836737|NCT03502707|474686307|FG014|Overall Study|Physician Decision|1|||
131836738|NCT03502707|474686308|FG015|Overall Study|Physician Decision|3|||
131836739|NCT03502707|474686309|FG016|Overall Study|Physician Decision|0|||
131836740|NCT03502707|474686310|FG017|Overall Study|Physician Decision|0|||
131836741|NCT03502707|474686293|FG000|Overall Study|Protocol Violation|0|||
131836742|NCT03502707|474686294|FG001|Overall Study|Protocol Violation|0|||
131836743|NCT03502707|474686295|FG002|Overall Study|Protocol Violation|0|||
131836744|NCT03502707|474686296|FG003|Overall Study|Protocol Violation|0|||
131836745|NCT03502707|474686297|FG004|Overall Study|Protocol Violation|0|||
131836746|NCT03502707|474686298|FG005|Overall Study|Protocol Violation|0|||
131836747|NCT03502707|474686299|FG006|Overall Study|Protocol Violation|0|||
131836748|NCT03502707|474686300|FG007|Overall Study|Protocol Violation|0|||
131836749|NCT03502707|474686301|FG008|Overall Study|Protocol Violation|0|||
131836750|NCT03502707|474686302|FG009|Overall Study|Protocol Violation|0|||
131836751|NCT03502707|474686303|FG010|Overall Study|Protocol Violation|0|||
131836752|NCT03502707|474686304|FG011|Overall Study|Protocol Violation|0|||
131836753|NCT03502707|474686305|FG012|Overall Study|Protocol Violation|0|||
131836754|NCT03502707|474686306|FG013|Overall Study|Protocol Violation|0|||
131836755|NCT03502707|474686307|FG014|Overall Study|Protocol Violation|0|||
131836756|NCT03502707|474686308|FG015|Overall Study|Protocol Violation|1|||
131836757|NCT03502707|474686309|FG016|Overall Study|Protocol Violation|0|||
131836758|NCT03502707|474686310|FG017|Overall Study|Protocol Violation|0|||
131836759|NCT03502707|474686293|FG000|Overall Study|Withdrawal by Subject|1|||
131836760|NCT03502707|474686294|FG001|Overall Study|Withdrawal by Subject|1|||
131836761|NCT03502707|474686295|FG002|Overall Study|Withdrawal by Subject|0|||
131836762|NCT03502707|474686296|FG003|Overall Study|Withdrawal by Subject|0|||
131836763|NCT03502707|474686297|FG004|Overall Study|Withdrawal by Subject|0|||
131836764|NCT03502707|474686298|FG005|Overall Study|Withdrawal by Subject|2|||
131836765|NCT03502707|474686299|FG006|Overall Study|Withdrawal by Subject|0|||
131836766|NCT03502707|474686300|FG007|Overall Study|Withdrawal by Subject|3|||
131836767|NCT03502707|474686301|FG008|Overall Study|Withdrawal by Subject|1|||
131836768|NCT03502707|474686302|FG009|Overall Study|Withdrawal by Subject|2|||
131836769|NCT03502707|474686303|FG010|Overall Study|Withdrawal by Subject|12|||
131836770|NCT03502707|474686304|FG011|Overall Study|Withdrawal by Subject|23|||
131836771|NCT03502707|474686305|FG012|Overall Study|Withdrawal by Subject|5|||
131836772|NCT03502707|474686306|FG013|Overall Study|Withdrawal by Subject|3|||
131836773|NCT03502707|474686307|FG014|Overall Study|Withdrawal by Subject|3|||
131836774|NCT03502707|474686308|FG015|Overall Study|Withdrawal by Subject|43|||
131836775|NCT03502707|474686309|FG016|Overall Study|Withdrawal by Subject|44|||
131836776|NCT03502707|474686310|FG017|Overall Study|Withdrawal by Subject|18|||
131836777|NCT03502707|474686293|FG000|Overall Study|Sponsor's Decision|1|||
131836778|NCT03502707|474686294|FG001|Overall Study|Sponsor's Decision|0|||
131836779|NCT03502707|474686295|FG002|Overall Study|Sponsor's Decision|0|||
131836780|NCT03502707|474686296|FG003|Overall Study|Sponsor's Decision|0|||
131836781|NCT03502707|474686297|FG004|Overall Study|Sponsor's Decision|0|||
131836782|NCT03502707|474686298|FG005|Overall Study|Sponsor's Decision|0|||
131836783|NCT03502707|474686299|FG006|Overall Study|Sponsor's Decision|0|||
131836784|NCT03502707|474686300|FG007|Overall Study|Sponsor's Decision|0|||
131836785|NCT03502707|474686301|FG008|Overall Study|Sponsor's Decision|0|||
131836786|NCT03502707|474686302|FG009|Overall Study|Sponsor's Decision|1|||
131836787|NCT03502707|474686303|FG010|Overall Study|Sponsor's Decision|0|||
131836788|NCT03502707|474686304|FG011|Overall Study|Sponsor's Decision|0|||
131836789|NCT03502707|474686305|FG012|Overall Study|Sponsor's Decision|0|||
131836790|NCT03502707|474686306|FG013|Overall Study|Sponsor's Decision|0|||
131836791|NCT03502707|474686307|FG014|Overall Study|Sponsor's Decision|0|||
131836792|NCT03502707|474686308|FG015|Overall Study|Sponsor's Decision|2|||
131836793|NCT03502707|474686309|FG016|Overall Study|Sponsor's Decision|1|||
131836794|NCT03502707|474686310|FG017|Overall Study|Sponsor's Decision|0|||
131836795|NCT03502707|474686293|FG000|Overall Study|Initiated Prohibited Medication|0|||
131836796|NCT03502707|474686294|FG001|Overall Study|Initiated Prohibited Medication|0|||
131836797|NCT03502707|474686295|FG002|Overall Study|Initiated Prohibited Medication|0|||
131836798|NCT03502707|474686296|FG003|Overall Study|Initiated Prohibited Medication|0|||
131836799|NCT03502707|474686297|FG004|Overall Study|Initiated Prohibited Medication|0|||
131836800|NCT03502707|474686298|FG005|Overall Study|Initiated Prohibited Medication|0|||
131836801|NCT03502707|474686299|FG006|Overall Study|Initiated Prohibited Medication|0|||
131836802|NCT03502707|474686300|FG007|Overall Study|Initiated Prohibited Medication|0|||
131836803|NCT03502707|474686301|FG008|Overall Study|Initiated Prohibited Medication|0|||
131836804|NCT03502707|474686302|FG009|Overall Study|Initiated Prohibited Medication|0|||
131836805|NCT03502707|474686303|FG010|Overall Study|Initiated Prohibited Medication|0|||
131836806|NCT03502707|474686304|FG011|Overall Study|Initiated Prohibited Medication|0|||
131836807|NCT03502707|474686305|FG012|Overall Study|Initiated Prohibited Medication|0|||
131836808|NCT03502707|474686306|FG013|Overall Study|Initiated Prohibited Medication|0|||
131836809|NCT03502707|474686307|FG014|Overall Study|Initiated Prohibited Medication|0|||
131836810|NCT03502707|474686308|FG015|Overall Study|Initiated Prohibited Medication|0|||
131836811|NCT03502707|474686309|FG016|Overall Study|Initiated Prohibited Medication|1|||
131836812|NCT03502707|474686310|FG017|Overall Study|Initiated Prohibited Medication|0|||
131836813|NCT03502707|474686293|FG000|Overall Study|Other|0|||
131836814|NCT03502707|474686294|FG001|Overall Study|Other|0|||
131836815|NCT03502707|474686295|FG002|Overall Study|Other|0|||
131836816|NCT03502707|474686296|FG003|Overall Study|Other|0|||
131836817|NCT03502707|474686297|FG004|Overall Study|Other|0|||
131836818|NCT03502707|474686298|FG005|Overall Study|Other|0|||
131836819|NCT03502707|474686299|FG006|Overall Study|Other|0|||
131836820|NCT03502707|474686300|FG007|Overall Study|Other|0|||
131836821|NCT03502707|474686301|FG008|Overall Study|Other|1|||
131836822|NCT03502707|474686302|FG009|Overall Study|Other|1|||
131836823|NCT03502707|474686303|FG010|Overall Study|Other|2|||
131836824|NCT03502707|474686304|FG011|Overall Study|Other|0|||
131836825|NCT03502707|474686305|FG012|Overall Study|Other|0|||
131836826|NCT03502707|474686306|FG013|Overall Study|Other|0|||
131836827|NCT03502707|474686307|FG014|Overall Study|Other|0|||
131836828|NCT03502707|474686308|FG015|Overall Study|Other|4|||
131836829|NCT03502707|474686309|FG016|Overall Study|Other|1|||
131836830|NCT03502707|474686310|FG017|Overall Study|Other|0|||
131836831|NCT03502707|474686293|FG000|Overall Study|Randomized but not vaccinated|0|||
131836832|NCT03502707|474686294|FG001|Overall Study|Randomized but not vaccinated|0|||
131836833|NCT03502707|474686295|FG002|Overall Study|Randomized but not vaccinated|0|||
131836834|NCT03502707|474686296|FG003|Overall Study|Randomized but not vaccinated|0|||
131836835|NCT03502707|474686297|FG004|Overall Study|Randomized but not vaccinated|0|||
131836836|NCT03502707|474686298|FG005|Overall Study|Randomized but not vaccinated|0|||
131836837|NCT03502707|474686299|FG006|Overall Study|Randomized but not vaccinated|0|||
131836838|NCT03502707|474686300|FG007|Overall Study|Randomized but not vaccinated|0|||
131836839|NCT03502707|474686301|FG008|Overall Study|Randomized but not vaccinated|0|||
131836840|NCT03502707|474686302|FG009|Overall Study|Randomized but not vaccinated|0|||
131836841|NCT03502707|474686303|FG010|Overall Study|Randomized but not vaccinated|0|||
131836842|NCT03502707|474686304|FG011|Overall Study|Randomized but not vaccinated|1|||
131836843|NCT03502707|474686305|FG012|Overall Study|Randomized but not vaccinated|0|||
131836844|NCT03502707|474686306|FG013|Overall Study|Randomized but not vaccinated|0|||
131836845|NCT03502707|474686307|FG014|Overall Study|Randomized but not vaccinated|0|||
131836846|NCT03502707|474686308|FG015|Overall Study|Randomized but not vaccinated|0|||
131836847|NCT03502707|474686309|FG016|Overall Study|Randomized but not vaccinated|0|||
131836848|NCT03502707|474686310|FG017|Overall Study|Randomized but not vaccinated|1|||
131836849|NCT04908683|474686311|FG000|Overall Study|Failure to meet continuation criteria|34|||
131836850|NCT04908683|474686312|FG001|Overall Study|Failure to meet continuation criteria|22|||
131836851|NCT04908683|474686311|FG000|Overall Study|Initiated prohibited medication|3|||
131836852|NCT04908683|474686312|FG001|Overall Study|Initiated prohibited medication|0|||
131836853|NCT04908683|474686311|FG000|Overall Study|Randomized by mistake|1|||
131836854|NCT04908683|474686312|FG001|Overall Study|Randomized by mistake|0|||
131836855|NCT04908683|474686311|FG000|Overall Study|Lost to Follow-up|679|||
131836856|NCT04908683|474686312|FG001|Overall Study|Lost to Follow-up|341|||
131836857|NCT04908683|474686311|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
131836858|NCT04908683|474686312|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
131836859|NCT04908683|474686311|FG000|Overall Study|Physician Decision|44|||
131836860|NCT04908683|474686312|FG001|Overall Study|Physician Decision|35|||
131836861|NCT04908683|474686311|FG000|Overall Study|Technical problems|12|||
131836862|NCT04908683|474686312|FG001|Overall Study|Technical problems|9|||
131836863|NCT04908683|474686311|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
131836864|NCT04908683|474686312|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
131836865|NCT04908683|474686311|FG000|Overall Study|Protocol Violation|2|||
131836866|NCT04908683|474686312|FG001|Overall Study|Protocol Violation|0|||
131836867|NCT04908683|474686311|FG000|Overall Study|Withdrawal by Subject|1188|||
131836868|NCT04908683|474686312|FG001|Overall Study|Withdrawal by Subject|570|||
131836869|NCT04908683|474686311|FG000|Overall Study|Site Closure by Sponsor|6|||
131836870|NCT04908683|474686312|FG001|Overall Study|Site Closure by Sponsor|3|||
131836871|NCT04908683|474686311|FG000|Overall Study|Adverse Event|21|||
131836872|NCT04908683|474686312|FG001|Overall Study|Adverse Event|11|||
131836873|NCT04908683|474686311|FG000|Overall Study|Death|101|||
131836874|NCT04908683|474686312|FG001|Overall Study|Death|61|||
131836875|NCT04908683|474686311|FG000|Overall Study|Sponsor's decision|14398|||
131836876|NCT04908683|474686312|FG001|Overall Study|Sponsor's decision|7205|||
131836877|NCT04908683|474686311|FG000|Overall Study|Other|92|||
131836878|NCT04908683|474686312|FG001|Overall Study|Other|50|||
131836879|NCT04908683|474686311|FG000|Overall Study|Randomized not vaccinated|108|||
131836880|NCT04908683|474686312|FG001|Overall Study|Randomized not vaccinated|52|||
131836881|NCT02221037|474686314|FG000|Overall Study|Physician Decision|0|||
131836882|NCT02221037|474686315|FG001|Overall Study|Physician Decision|0|||
131836883|NCT02221037|474686316|FG002|Overall Study|Physician Decision|1|||
131836884|NCT02221037|474686317|FG003|Overall Study|Physician Decision|0|||
131836885|NCT01293539|474686318|FG000|Overall Study|Physician Decision|1|||
131836886|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Death|89|||
131836887|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Death|193|||
131836888|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Death|198|||
131836889|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
131836890|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
131836891|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
131836892|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
131836893|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
131836894|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
131836895|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
131836896|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
131836897|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
131836898|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
131402256|NCT01202188|473093648|FG000|Overall Study|Subject withdrew consent|12|||
131402257|NCT01202188|473093649|FG001|Overall Study|Subject withdrew consent|13|||
131836899|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
131836900|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
131836901|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
131836902|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
131836903|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
131836904|NCT02031458|474686319|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
131836905|NCT02031458|474686320|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
131836906|NCT02031458|474686321|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
131836907|NCT02031458|474686319|FG000|Baseline to May 8, 2015|Death|36|||
131836908|NCT02031458|474686320|FG001|Baseline to May 8, 2015|Death|87|||
131836909|NCT02031458|474686321|FG002|Baseline to May 8, 2015|Death|100|||
131836910|NCT02031458|474686319|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
131836911|NCT02031458|474686320|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
131836912|NCT02031458|474686321|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
131836913|NCT02031458|474686319|FG000|Baseline to May 8, 2015|Physician Decision|0|||
131836914|NCT02031458|474686320|FG001|Baseline to May 8, 2015|Physician Decision|1|||
131836915|NCT02031458|474686321|FG002|Baseline to May 8, 2015|Physician Decision|0|||
131836916|NCT02031458|474686319|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
131836917|NCT02031458|474686320|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
131836918|NCT02031458|474686321|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
131836919|NCT02031458|474686319|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
131836920|NCT02031458|474686320|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
131836921|NCT02031458|474686321|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
131836922|NCT02031458|474686319|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
131836923|NCT02031458|474686320|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
131836924|NCT02031458|474686321|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
131836925|NCT02031458|474686319|FG000|Baseline to May 8, 2015|On Treatment|43|||
131836926|NCT02031458|474686320|FG001|Baseline to May 8, 2015|On Treatment|81|||
131836927|NCT02031458|474686321|FG002|Baseline to May 8, 2015|On Treatment|73|||
131836928|NCT02031458|474686319|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
131836929|NCT02031458|474686320|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
131836930|NCT02031458|474686321|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
131836931|NCT00059787|474686325|FG000|Overall Study|Adverse Event|13|||
131836932|NCT00059787|474686325|FG000|Overall Study|disease progression|2|||
131836933|NCT00059787|474686325|FG000|Overall Study|ineligible|1|||
131836934|NCT00059787|474686325|FG000|Overall Study|Other|4|||
131836935|NCT00292188|474686326|FG000|Single-Blind|Adverse Event|14|||
131836936|NCT00292188|474686327|FG001|Single-Blind|Adverse Event|0|||
131836937|NCT00292188|474686328|FG002|Single-Blind|Adverse Event|0|||
131836938|NCT00292188|474686326|FG000|Single-Blind|Lack of Efficacy|2|||
131836939|NCT00292188|474686327|FG001|Single-Blind|Lack of Efficacy|0|||
131836940|NCT00292188|474686328|FG002|Single-Blind|Lack of Efficacy|0|||
131836941|NCT00292188|474686326|FG000|Single-Blind|Laboratory Abnormality|5|||
131836942|NCT00292188|474686327|FG001|Single-Blind|Laboratory Abnormality|0|||
131836943|NCT00292188|474686328|FG002|Single-Blind|Laboratory Abnormality|0|||
131836944|NCT00292188|474686326|FG000|Single-Blind|Lost to Follow-up|3|||
131836945|NCT00292188|474686327|FG001|Single-Blind|Lost to Follow-up|0|||
131402258|NCT01202188|473093650|FG002|Overall Study|Subject withdrew consent|22|||
131402259|NCT01202188|473093651|FG003|Overall Study|Subject withdrew consent|11|||
131402260|NCT01202188|473093652|FG004|Overall Study|Subject withdrew consent|13|||
131402261|NCT01202188|473093648|FG000|Overall Study|Adverse Event|5|||
131402262|NCT01202188|473093649|FG001|Overall Study|Adverse Event|23|||
131402263|NCT01202188|473093650|FG002|Overall Study|Adverse Event|13|||
131402264|NCT01202188|473093651|FG003|Overall Study|Adverse Event|10|||
131402265|NCT01202188|473093652|FG004|Overall Study|Adverse Event|10|||
131402266|NCT01202188|473093648|FG000|Overall Study|Administrative problems|3|||
131402267|NCT01202188|473093649|FG001|Overall Study|Administrative problems|2|||
131450156|NCT04032093|473276809|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
131836946|NCT00292188|474686328|FG002|Single-Blind|Lost to Follow-up|0|||
131836947|NCT00292188|474686326|FG000|Single-Blind|Other|77|||
131836948|NCT00292188|474686327|FG001|Single-Blind|Other|0|||
131836949|NCT00292188|474686328|FG002|Single-Blind|Other|0|||
131836950|NCT00292188|474686326|FG000|Single-Blind|Withdrawal by Subject|12|||
131910756|NCT00471497|474960835|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
131402268|NCT01202188|473093650|FG002|Overall Study|Administrative problems|1|||
131836951|NCT00292188|474686327|FG001|Single-Blind|Withdrawal by Subject|0|||
131836952|NCT00292188|474686328|FG002|Single-Blind|Withdrawal by Subject|0|||
131836953|NCT00292188|474686326|FG000|Single-Blind|Did not receive treatment|1|||
131836954|NCT00292188|474686327|FG001|Single-Blind|Did not receive treatment|0|||
131836955|NCT00292188|474686328|FG002|Single-Blind|Did not receive treatment|0|||
131836956|NCT00292188|474686326|FG000|Double-Blind|Adverse Event|0|||
131836957|NCT00292188|474686327|FG001|Double-Blind|Adverse Event|25|||
131836958|NCT00292188|474686328|FG002|Double-Blind|Adverse Event|9|||
131836959|NCT00292188|474686326|FG000|Double-Blind|Lack of Efficacy|0|||
131836960|NCT00292188|474686327|FG001|Double-Blind|Lack of Efficacy|2|||
131836961|NCT00292188|474686328|FG002|Double-Blind|Lack of Efficacy|12|||
131836962|NCT00292188|474686326|FG000|Double-Blind|Lost to Follow-up|0|||
131836963|NCT00292188|474686327|FG001|Double-Blind|Lost to Follow-up|1|||
131836964|NCT00292188|474686328|FG002|Double-Blind|Lost to Follow-up|0|||
131836965|NCT00292188|474686326|FG000|Double-Blind|Other|0|||
131836966|NCT00292188|474686327|FG001|Double-Blind|Other|3|||
131836967|NCT00292188|474686328|FG002|Double-Blind|Other|4|||
131836968|NCT00292188|474686326|FG000|Double-Blind|Withdrawal by Subject|0|||
131836969|NCT00292188|474686327|FG001|Double-Blind|Withdrawal by Subject|0|||
131836970|NCT00292188|474686328|FG002|Double-Blind|Withdrawal by Subject|3|||
131836971|NCT00292188|474686326|FG000|Double-Blind|Laboratory Abnormality|0|||
131836972|NCT00292188|474686327|FG001|Double-Blind|Laboratory Abnormality|0|||
131836973|NCT00292188|474686328|FG002|Double-Blind|Laboratory Abnormality|1|||
131836974|NCT00824616|474686329|FG000|Overall Study|Adverse Event|2|||
131836975|NCT00824616|474686330|FG001|Overall Study|Adverse Event|1|||
131836976|NCT00824616|474686329|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
131836977|NCT00824616|474686330|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
131836978|NCT00824616|474686329|FG000|Overall Study|Hyperglycemia|1|||
131836979|NCT00824616|474686330|FG001|Overall Study|Hyperglycemia|1|||
131836980|NCT00824616|474686329|FG000|Overall Study|Lack of Efficacy|2|||
131836981|NCT00824616|474686330|FG001|Overall Study|Lack of Efficacy|1|||
131836982|NCT00824616|474686329|FG000|Overall Study|Lost to Follow-up|0|||
131836983|NCT00824616|474686330|FG001|Overall Study|Lost to Follow-up|1|||
131836984|NCT00824616|474686329|FG000|Overall Study|Withdrawal by Subject|1|||
131836985|NCT00824616|474686330|FG001|Overall Study|Withdrawal by Subject|1|||
131836986|NCT04322149|474686331|FG000|Overall Study|Adverse Event|1|||
131836987|NCT04322149|474686332|FG001|Overall Study|Adverse Event|1|||
131836988|NCT04322149|474686333|FG002|Overall Study|Adverse Event|0|||
131836989|NCT04322149|474686334|FG003|Overall Study|Adverse Event|0|||
131836990|NCT04322149|474686331|FG000|Overall Study|Withdrawal by Subject|0|||
131836991|NCT04322149|474686332|FG001|Overall Study|Withdrawal by Subject|0|||
131836992|NCT04322149|474686333|FG002|Overall Study|Withdrawal by Subject|0|||
131836993|NCT04322149|474686334|FG003|Overall Study|Withdrawal by Subject|2|||
131836994|NCT04322149|474686331|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
131836995|NCT04322149|474686332|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
131836996|NCT04322149|474686333|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
131836997|NCT04322149|474686334|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
131836998|NCT00103311|474686343|FG000|Overall Study|Lost to Follow-up|1|||
131836999|NCT00103311|474686344|FG001|Overall Study|Lost to Follow-up|0|||
131837000|NCT00103311|474686343|FG000|Overall Study|Withdrawal by Subject|2|||
131837001|NCT00103311|474686344|FG001|Overall Study|Withdrawal by Subject|1|||
131837002|NCT00103311|474686343|FG000|Overall Study|Adverse Event|1|||
131837003|NCT00103311|474686344|FG001|Overall Study|Adverse Event|0|||
131837004|NCT00974974|474686346|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
131837005|NCT00974974|474686347|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
131837006|NCT00974974|474686346|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
131837007|NCT00974974|474686347|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
131837008|NCT00974974|474686346|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
131837009|NCT00974974|474686347|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
131837010|NCT00974974|474686346|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
131837011|NCT00974974|474686347|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
131837012|NCT00974974|474686346|FG000|IR CD-LD Dose Adjustment|Various|0|||
131910757|NCT00471497|474960836|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
131910758|NCT00471497|474960837|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
131910759|NCT00471497|474960835|FG000|Extension Phase|Withdrawal by Subject|3|||
131450157|NCT04032093|473276810|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
131910760|NCT00471497|474960836|FG001|Extension Phase|Withdrawal by Subject|1|||
131450158|NCT04032093|473276811|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
131450159|NCT04032093|473276812|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
131837013|NCT00974974|474686347|FG001|IR CD-LD Dose Adjustment|Various|9|||
131837014|NCT00974974|474686346|FG000|IPX066 Dose Conversion|Adverse Event|23|||
131910761|NCT00471497|474960837|FG002|Extension Phase|Withdrawal by Subject|0|||
131837015|NCT00974974|474686347|FG001|IPX066 Dose Conversion|Adverse Event|0|||
131837016|NCT00974974|474686346|FG000|IPX066 Dose Conversion|Death|2|||
131837017|NCT00974974|474686347|FG001|IPX066 Dose Conversion|Death|0|||
131837018|NCT00974974|474686346|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
131837019|NCT00974974|474686347|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
131910762|NCT00471497|474960835|FG000|Extension Phase|Lost to Follow-up|2|||
131910763|NCT00471497|474960836|FG001|Extension Phase|Lost to Follow-up|0|||
131402269|NCT01202188|473093651|FG003|Overall Study|Administrative problems|1|||
131837020|NCT00974974|474686346|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
131837021|NCT00974974|474686347|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
131837022|NCT00974974|474686346|FG000|IPX066 Dose Conversion|Various|3|||
131837023|NCT00974974|474686347|FG001|IPX066 Dose Conversion|Various|0|||
131837024|NCT00974974|474686346|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
131837025|NCT00974974|474686347|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
131837026|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
131837027|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
131837028|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
131837029|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
131837030|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
131837031|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
131837032|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
131837033|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
131837034|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
131837035|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
131837036|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
131837037|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
131837038|NCT00974974|474686346|FG000|Maintenance - Double Blind Treatment|Various|4|||
131837039|NCT00974974|474686347|FG001|Maintenance - Double Blind Treatment|Various|0|||
131837040|NCT01959035|474686348|FG000|Overall Study|Adverse Event|5|||
131837041|NCT01959035|474686348|FG000|Overall Study|Withdrawal by Subject|4|||
131837042|NCT01959035|474686348|FG000|Overall Study|Lost to Follow-up|1|||
131837043|NCT01959035|474686348|FG000|Overall Study|Other (no primary reason given)|1|||
131837044|NCT03254602|474686349|FG000|Overall Study|Lost to Follow-up|4|||
131837045|NCT02963311|474686352|FG000|Overall Study|Withdrawal by Subject|1|||
131837046|NCT02963311|474686352|FG000|Overall Study|Screen Failure|4|||
131837047|NCT02836496|474686353|FG000|Overall Study|Adverse Event|2|||
131837048|NCT02836496|474686354|FG001|Overall Study|Adverse Event|1|||
131837049|NCT02836496|474686353|FG000|Overall Study|Withdrawal by Subject|0|||
131837050|NCT02836496|474686354|FG001|Overall Study|Withdrawal by Subject|1|||
131837051|NCT00846521|474686366|FG000|Overall Study|Withdrawal by Subject|5|||
131837052|NCT00846521|474686366|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
131837053|NCT00846521|474686366|FG000|Overall Study|Protocol Violation|1|||
131837054|NCT02618408|474686367|FG000|Overall Study|Withdrawal by Subject|1|||
131837055|NCT02618408|474686368|FG001|Overall Study|Withdrawal by Subject|0|||
131837056|NCT02618408|474686369|FG002|Overall Study|Withdrawal by Subject|4|||
131837057|NCT02618408|474686367|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
131837058|NCT02618408|474686368|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
131837059|NCT02618408|474686369|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
131837060|NCT02618408|474686367|FG000|Overall Study|Lost to Follow-up|4|||
131837061|NCT02618408|474686368|FG001|Overall Study|Lost to Follow-up|2|||
131837062|NCT02618408|474686369|FG002|Overall Study|Lost to Follow-up|6|||
131837063|NCT02618408|474686367|FG000|Overall Study|Adverse Event|4|||
131837064|NCT02618408|474686368|FG001|Overall Study|Adverse Event|0|||
131837065|NCT02618408|474686369|FG002|Overall Study|Adverse Event|10|||
131837066|NCT02618408|474686367|FG000|Overall Study|Physician Decision|1|||
131837067|NCT02618408|474686368|FG001|Overall Study|Physician Decision|1|||
131837068|NCT02618408|474686369|FG002|Overall Study|Physician Decision|2|||
131837069|NCT02618408|474686367|FG000|Overall Study|Protocol Violation|1|||
131837070|NCT02618408|474686368|FG001|Overall Study|Protocol Violation|1|||
131837071|NCT02618408|474686369|FG002|Overall Study|Protocol Violation|2|||
131837072|NCT02618408|474686367|FG000|Overall Study|Other, Multiple Categories|0|||
131837073|NCT02618408|474686368|FG001|Overall Study|Other, Multiple Categories|0|||
131837074|NCT02618408|474686369|FG002|Overall Study|Other, Multiple Categories|4|||
131837075|NCT01460901|474686379|FG000|Overall Study|Withdrawal by Subject|2|||
131837076|NCT02566993|474686380|FG000|Overall Study|Randomized but not treated|5|||
131837077|NCT02566993|474686381|FG001|Overall Study|Randomized but not treated|16|||
131837078|NCT02566993|474686380|FG000|Overall Study|Progressive disease|213|||
131837079|NCT02566993|474686381|FG001|Overall Study|Progressive disease|152|||
131837080|NCT02566993|474686380|FG000|Overall Study|Withdrawal by Subject|12|||
131837081|NCT02566993|474686381|FG001|Overall Study|Withdrawal by Subject|28|||
131837082|NCT02566993|474686380|FG000|Overall Study|Death|17|||
131837083|NCT02566993|474686381|FG001|Overall Study|Death|23|||
131837084|NCT02566993|474686380|FG000|Overall Study|Physician Decision|10|||
131837085|NCT02566993|474686381|FG001|Overall Study|Physician Decision|17|||
131837086|NCT02566993|474686380|FG000|Overall Study|Study drug-related adverse event|20|||
131837087|NCT02566993|474686381|FG001|Overall Study|Study drug-related adverse event|41|||
131837088|NCT02566993|474686380|FG000|Overall Study|Non study drug-related adverse event|9|||
131837089|NCT02566993|474686381|FG001|Overall Study|Non study drug-related adverse event|9|||
131837090|NCT02566993|474686380|FG000|Overall Study|Symptomatic deterioration|9|||
131402270|NCT01202188|473093652|FG004|Overall Study|Administrative problems|2|||
131402271|NCT01202188|473093648|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131402272|NCT01202188|473093649|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131402273|NCT01202188|473093650|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131402274|NCT01202188|473093651|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
131402275|NCT01202188|473093652|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
131402276|NCT01202188|473093648|FG000|Overall Study|Lost to Follow-up|1|||
131402277|NCT01202188|473093649|FG001|Overall Study|Lost to Follow-up|1|||
131837091|NCT02566993|474686381|FG001|Overall Study|Symptomatic deterioration|16|||
131837092|NCT02566993|474686380|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
131837093|NCT02566993|474686381|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
131837094|NCT02566993|474686380|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
131837095|NCT02566993|474686381|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
131837096|NCT02566993|474686380|FG000|Overall Study|Screening failure|2|||
131837097|NCT02566993|474686381|FG001|Overall Study|Screening failure|0|||
131837098|NCT02566993|474686380|FG000|Overall Study|Lost to Follow-up|0|||
131837099|NCT02566993|474686381|FG001|Overall Study|Lost to Follow-up|1|||
131837100|NCT02566993|474686380|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
131837101|NCT02566993|474686381|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
131837102|NCT01169532|474686383|FG000|Overall Study|Withdrawal by Subject|1|||
131837103|NCT03127644|474686394|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131837104|NCT03127644|474686395|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131837105|NCT03127644|474686396|FG002|Overall Study|Study-specific withdrawal criteria|2|||
131837106|NCT02032706|474686399|FG000|Overall Study|Did not qualify|5|||
131837107|NCT02032706|474686399|FG000|Overall Study|Protocol Violation|1|||
131837108|NCT00895947|474686400|FG000|Overall Study|Adverse Event|3|||
131837109|NCT00895947|474686401|FG001|Overall Study|Adverse Event|4|||
131837110|NCT00895947|474686400|FG000|Overall Study|Lost to Follow-up|3|||
131837111|NCT00895947|474686401|FG001|Overall Study|Lost to Follow-up|4|||
131837112|NCT00895947|474686400|FG000|Overall Study|Protocol Violation|4|||
131837113|NCT00895947|474686401|FG001|Overall Study|Protocol Violation|2|||
131837114|NCT00895947|474686400|FG000|Overall Study|Withdrawal by Subject|2|||
131837115|NCT00895947|474686401|FG001|Overall Study|Withdrawal by Subject|0|||
131837116|NCT04620135|474686404|FG000|Study Completion|Adverse Event|2|||
131837117|NCT04620135|474686405|FG001|Study Completion|Adverse Event|3|||
131837118|NCT04620135|474686404|FG000|Study Completion|Withdrawal by Subject|2|||
131837119|NCT04620135|474686405|FG001|Study Completion|Withdrawal by Subject|0|||
131837120|NCT01550744|474686409|FG000|Open-Label|Lost to Follow-up|7|||
131837121|NCT01550744|474686410|FG001|Open-Label|Lost to Follow-up|0|||
131837122|NCT01550744|474686411|FG002|Open-Label|Lost to Follow-up|0|||
131837123|NCT01550744|474686409|FG000|Open-Label|Withdrawal by Subject|13|||
131837124|NCT01550744|474686410|FG001|Open-Label|Withdrawal by Subject|0|||
131837125|NCT01550744|474686411|FG002|Open-Label|Withdrawal by Subject|0|||
131402278|NCT01202188|473093650|FG002|Overall Study|Lost to Follow-up|0|||
131402279|NCT01202188|473093651|FG003|Overall Study|Lost to Follow-up|4|||
131402280|NCT01202188|473093652|FG004|Overall Study|Lost to Follow-up|1|||
131837126|NCT01550744|474686409|FG000|Open-Label|Adverse Event|11|||
131837127|NCT01550744|474686410|FG001|Open-Label|Adverse Event|0|||
131837128|NCT01550744|474686411|FG002|Open-Label|Adverse Event|0|||
131837129|NCT01550744|474686409|FG000|Open-Label|Lack of Efficacy|4|||
131837130|NCT01550744|474686410|FG001|Open-Label|Lack of Efficacy|0|||
131837131|NCT01550744|474686411|FG002|Open-Label|Lack of Efficacy|0|||
131837132|NCT01550744|474686409|FG000|Open-Label|Protocol Violation|4|||
131837133|NCT01550744|474686410|FG001|Open-Label|Protocol Violation|0|||
131837134|NCT01550744|474686411|FG002|Open-Label|Protocol Violation|0|||
131402281|NCT01202188|473093648|FG000|Overall Study|Death|1|||
131402282|NCT01202188|473093649|FG001|Overall Study|Death|1|||
131402283|NCT01202188|473093650|FG002|Overall Study|Death|1|||
131402284|NCT01202188|473093651|FG003|Overall Study|Death|1|||
131450160|NCT04032093|473276813|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
131450161|NCT04032093|473276814|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
131837135|NCT01550744|474686409|FG000|Open-Label|Not all 3 study drug injections received|2|||
131837136|NCT01550744|474686410|FG001|Open-Label|Not all 3 study drug injections received|0|||
131837137|NCT01550744|474686411|FG002|Open-Label|Not all 3 study drug injections received|0|||
131837138|NCT01550744|474686409|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
131837139|NCT01550744|474686410|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
131837140|NCT01550744|474686411|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
131837141|NCT01550744|474686409|FG000|Open-Label|Other|1|||
131837142|NCT01550744|474686410|FG001|Open-Label|Other|0|||
131837143|NCT01550744|474686411|FG002|Open-Label|Other|0|||
131837144|NCT01550744|474686409|FG000|Double-Blind|Lost to Follow-up|0|||
131837145|NCT01550744|474686410|FG001|Double-Blind|Lost to Follow-up|6|||
131402285|NCT01202188|473093652|FG004|Overall Study|Death|0|||
131402286|NCT01202188|473093648|FG000|Overall Study|Abnormal test procedure result (s)|0|||
131402287|NCT01202188|473093649|FG001|Overall Study|Abnormal test procedure result (s)|0|||
131402288|NCT01202188|473093650|FG002|Overall Study|Abnormal test procedure result (s)|2|||
131837146|NCT01550744|474686411|FG002|Double-Blind|Lost to Follow-up|12|||
131837147|NCT01550744|474686409|FG000|Double-Blind|Withdrawal by Subject|0|||
131837148|NCT01550744|474686410|FG001|Double-Blind|Withdrawal by Subject|2|||
131837149|NCT01550744|474686411|FG002|Double-Blind|Withdrawal by Subject|15|||
131837150|NCT01550744|474686409|FG000|Double-Blind|Adverse Event|0|||
131837151|NCT01550744|474686410|FG001|Double-Blind|Adverse Event|4|||
131837152|NCT01550744|474686411|FG002|Double-Blind|Adverse Event|15|||
131837153|NCT01550744|474686409|FG000|Double-Blind|Death|0|||
131837154|NCT01550744|474686410|FG001|Double-Blind|Death|1|||
131837155|NCT01550744|474686411|FG002|Double-Blind|Death|0|||
131837156|NCT01550744|474686409|FG000|Double-Blind|Lack of Efficacy|0|||
131837157|NCT01550744|474686410|FG001|Double-Blind|Lack of Efficacy|2|||
131837158|NCT01550744|474686411|FG002|Double-Blind|Lack of Efficacy|8|||
131837159|NCT01550744|474686409|FG000|Double-Blind|Protocol Violation|0|||
131837160|NCT01550744|474686410|FG001|Double-Blind|Protocol Violation|0|||
131837161|NCT01550744|474686411|FG002|Double-Blind|Protocol Violation|4|||
131837162|NCT01550744|474686409|FG000|Double-Blind|Pregnancy|0|||
131837163|NCT01550744|474686410|FG001|Double-Blind|Pregnancy|0|||
131837164|NCT01550744|474686411|FG002|Double-Blind|Pregnancy|3|||
131837165|NCT01550744|474686409|FG000|Double-Blind|Other|0|||
131837166|NCT01550744|474686410|FG001|Double-Blind|Other|2|||
131837167|NCT01550744|474686411|FG002|Double-Blind|Other|10|||
131837168|NCT02130882|474686413|FG000|Overall Study|Withdrawal by Subject|0|||
131837169|NCT02130882|474686414|FG001|Overall Study|Withdrawal by Subject|1|||
131837170|NCT00444457|474686417|FG000|Infant Series|Other|0|||
131837171|NCT00444457|474686418|FG001|Infant Series|Other|1|||
131837172|NCT00444457|474686419|FG002|Infant Series|Other|0|||
131402289|NCT01202188|473093651|FG003|Overall Study|Abnormal test procedure result (s)|0|||
131402290|NCT01202188|473093652|FG004|Overall Study|Abnormal test procedure result (s)|0|||
131402291|NCT00487942|473093660|FG000|Overall Study|Adverse Event|1|||
131402292|NCT00487942|473093661|FG001|Overall Study|Adverse Event|1|||
131402293|NCT00487942|473093662|FG002|Overall Study|Adverse Event|1|||
131402294|NCT00487942|473093663|FG003|Overall Study|Adverse Event|1|||
131402295|NCT00487942|473093660|FG000|Overall Study|Lost to Follow-up|1|||
131402296|NCT00487942|473093661|FG001|Overall Study|Lost to Follow-up|0|||
131402297|NCT00487942|473093662|FG002|Overall Study|Lost to Follow-up|0|||
131402298|NCT00487942|473093663|FG003|Overall Study|Lost to Follow-up|1|||
131402299|NCT00487942|473093660|FG000|Overall Study|Protocol Violation|1|||
131402300|NCT00487942|473093661|FG001|Overall Study|Protocol Violation|1|||
131402301|NCT00487942|473093662|FG002|Overall Study|Protocol Violation|0|||
131402302|NCT00487942|473093663|FG003|Overall Study|Protocol Violation|0|||
131402303|NCT00487942|473093660|FG000|Overall Study|Withdrawal by Subject|0|||
131402304|NCT00487942|473093661|FG001|Overall Study|Withdrawal by Subject|1|||
131402305|NCT00487942|473093662|FG002|Overall Study|Withdrawal by Subject|2|||
131402306|NCT00487942|473093663|FG003|Overall Study|Withdrawal by Subject|0|||
131402307|NCT02640625|473095409|FG000|Overall Study|Adverse Event|1|||
131402308|NCT00790868|473095410|FG000|Overall Study|Withdrawal by Subject|4|||
131402309|NCT00790868|473095411|FG001|Overall Study|Withdrawal by Subject|5|||
131402310|NCT00790868|473095410|FG000|Overall Study|Lost to Follow-up|2|||
131402311|NCT00790868|473095411|FG001|Overall Study|Lost to Follow-up|12|||
131402312|NCT01380535|473095412|FG000|Overall Study|Adverse Event|3|||
131402313|NCT01380535|473095413|FG001|Overall Study|Adverse Event|3|||
131402314|NCT01380535|473095412|FG000|Overall Study|Death|3|||
131402315|NCT01380535|473095413|FG001|Overall Study|Death|0|||
131837173|NCT00444457|474686420|FG003|Infant Series|Other|0|||
131837174|NCT00444457|474686417|FG000|Infant Series|Parent or legal guardian request|18|||
131837175|NCT00444457|474686418|FG001|Infant Series|Parent or legal guardian request|29|||
131837176|NCT00444457|474686419|FG002|Infant Series|Parent or legal guardian request|34|||
131837177|NCT00444457|474686420|FG003|Infant Series|Parent or legal guardian request|14|||
131837178|NCT00444457|474686417|FG000|Infant Series|Lost to Follow-up|10|||
131837179|NCT00444457|474686418|FG001|Infant Series|Lost to Follow-up|11|||
131837180|NCT00444457|474686419|FG002|Infant Series|Lost to Follow-up|7|||
131837181|NCT00444457|474686420|FG003|Infant Series|Lost to Follow-up|6|||
131837182|NCT00444457|474686417|FG000|Infant Series|Protocol Violation|16|||
131837183|NCT00444457|474686418|FG001|Infant Series|Protocol Violation|8|||
131837184|NCT00444457|474686419|FG002|Infant Series|Protocol Violation|6|||
131402316|NCT01380535|473095412|FG000|Overall Study|Study site closed|0|||
131402317|NCT01380535|473095413|FG001|Overall Study|Study site closed|5|||
131402318|NCT01380535|473095412|FG000|Overall Study|Withdrawal by Subject|1|||
131402319|NCT01380535|473095413|FG001|Overall Study|Withdrawal by Subject|2|||
131402320|NCT01380535|473095412|FG000|Overall Study|Protocol Violation|0|||
131402321|NCT01380535|473095413|FG001|Overall Study|Protocol Violation|2|||
131402322|NCT01380535|473095412|FG000|Overall Study|Lack of Efficacy|0|||
131402323|NCT01380535|473095413|FG001|Overall Study|Lack of Efficacy|3|||
131837185|NCT00444457|474686420|FG003|Infant Series|Protocol Violation|3|||
131837186|NCT00444457|474686417|FG000|Infant Series|Failed to return|5|||
131837187|NCT00444457|474686418|FG001|Infant Series|Failed to return|4|||
131402324|NCT02596958|473095418|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
131837188|NCT00444457|474686419|FG002|Infant Series|Failed to return|4|||
131837189|NCT00444457|474686420|FG003|Infant Series|Failed to return|2|||
131837190|NCT00444457|474686417|FG000|Infant Series|Investigator request|4|||
131837191|NCT00444457|474686418|FG001|Infant Series|Investigator request|3|||
131837192|NCT00444457|474686419|FG002|Infant Series|Investigator request|3|||
131837193|NCT00444457|474686420|FG003|Infant Series|Investigator request|2|||
131837194|NCT00444457|474686417|FG000|Infant Series|Other|0|||
131837195|NCT00444457|474686418|FG001|Infant Series|Other|2|||
131837196|NCT00444457|474686419|FG002|Infant Series|Other|4|||
131837197|NCT00444457|474686420|FG003|Infant Series|Other|0|||
131402325|NCT02596958|473095418|FG000|Overall Study|Cancer Progression|441|||
131402326|NCT02596958|473095418|FG000|Overall Study|Death From Cancer|112|||
131402327|NCT02596958|473095418|FG000|Overall Study|Death From Other Cause|33|||
131402328|NCT02596958|473095418|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
131402329|NCT02596958|473095418|FG000|Overall Study|Administrative Reasons/Other|231|||
131402330|NCT02596958|473095418|FG000|Overall Study|Lost to Follow-up|33|||
131402331|NCT02596958|473095418|FG000|Overall Study|Missing|32|||
131402332|NCT02596958|473095418|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
131402333|NCT01559259|473095419|FG000|Overall Study|Withdrawal by Subject|0|||
131402334|NCT01559259|473095420|FG001|Overall Study|Withdrawal by Subject|0|||
131402335|NCT01559259|473095421|FG002|Overall Study|Withdrawal by Subject|0|||
131402336|NCT01559259|473095422|FG003|Overall Study|Withdrawal by Subject|1|||
131402337|NCT01559259|473095423|FG004|Overall Study|Withdrawal by Subject|0|||
131402338|NCT01559259|473095419|FG000|Overall Study|Adverse Event|0|||
131402339|NCT01559259|473095420|FG001|Overall Study|Adverse Event|1|||
131402340|NCT01559259|473095421|FG002|Overall Study|Adverse Event|1|||
131837198|NCT00444457|474686417|FG000|Infant Series|Adverse Event|1|||
131837199|NCT00444457|474686418|FG001|Infant Series|Adverse Event|2|||
131837200|NCT00444457|474686419|FG002|Infant Series|Adverse Event|2|||
131837201|NCT00444457|474686420|FG003|Infant Series|Adverse Event|0|||
131837202|NCT00444457|474686417|FG000|Infant Series|Death|0|||
131837203|NCT00444457|474686418|FG001|Infant Series|Death|1|||
131837204|NCT00444457|474686419|FG002|Infant Series|Death|1|||
131837205|NCT00444457|474686420|FG003|Infant Series|Death|1|||
131837206|NCT00444457|474686417|FG000|After Infant Series|Other|0|||
131837207|NCT00444457|474686418|FG001|After Infant Series|Other|1|||
131837208|NCT00444457|474686419|FG002|After Infant Series|Other|1|||
131837209|NCT00444457|474686420|FG003|After Infant Series|Other|1|||
131837210|NCT00444457|474686417|FG000|After Infant Series|Parent or legal guardian request|4|||
131837211|NCT00444457|474686418|FG001|After Infant Series|Parent or legal guardian request|11|||
131837212|NCT00444457|474686419|FG002|After Infant Series|Parent or legal guardian request|6|||
131837213|NCT00444457|474686420|FG003|After Infant Series|Parent or legal guardian request|3|||
131837214|NCT00444457|474686417|FG000|After Infant Series|Failed to return|7|||
131837215|NCT00444457|474686418|FG001|After Infant Series|Failed to return|6|||
131837216|NCT00444457|474686419|FG002|After Infant Series|Failed to return|5|||
131837217|NCT00444457|474686420|FG003|After Infant Series|Failed to return|1|||
131837218|NCT00444457|474686417|FG000|After Infant Series|Lost to Follow-up|5|||
131837219|NCT00444457|474686418|FG001|After Infant Series|Lost to Follow-up|5|||
131837220|NCT00444457|474686419|FG002|After Infant Series|Lost to Follow-up|5|||
131837221|NCT00444457|474686420|FG003|After Infant Series|Lost to Follow-up|2|||
131837222|NCT00444457|474686417|FG000|After Infant Series|Protocol Violation|2|||
131837223|NCT00444457|474686418|FG001|After Infant Series|Protocol Violation|4|||
131837224|NCT00444457|474686419|FG002|After Infant Series|Protocol Violation|2|||
131837225|NCT00444457|474686420|FG003|After Infant Series|Protocol Violation|2|||
131837226|NCT00444457|474686417|FG000|After Infant Series|Adverse Event|2|||
131837227|NCT00444457|474686418|FG001|After Infant Series|Adverse Event|2|||
131837228|NCT00444457|474686419|FG002|After Infant Series|Adverse Event|0|||
131837229|NCT00444457|474686420|FG003|After Infant Series|Adverse Event|0|||
131837230|NCT00444457|474686417|FG000|After Infant Series|Investigator request|0|||
131837231|NCT00444457|474686418|FG001|After Infant Series|Investigator request|0|||
131837232|NCT00444457|474686419|FG002|After Infant Series|Investigator request|0|||
131837233|NCT00444457|474686420|FG003|After Infant Series|Investigator request|1|||
131837234|NCT00444457|474686417|FG000|After Infant Series|Other|0|||
131837235|NCT00444457|474686418|FG001|After Infant Series|Other|1|||
131837236|NCT00444457|474686419|FG002|After Infant Series|Other|0|||
131837237|NCT00444457|474686420|FG003|After Infant Series|Other|0|||
131837238|NCT00444457|474686417|FG000|Toddler Dose|Lost to Follow-up|4|||
131837239|NCT00444457|474686418|FG001|Toddler Dose|Lost to Follow-up|1|||
131910764|NCT00471497|474960837|FG002|Extension Phase|Lost to Follow-up|0|||
131402341|NCT01559259|473095422|FG003|Overall Study|Adverse Event|0|||
131837240|NCT00444457|474686419|FG002|Toddler Dose|Lost to Follow-up|1|||
131837241|NCT00444457|474686420|FG003|Toddler Dose|Lost to Follow-up|3|||
131837242|NCT00444457|474686417|FG000|Toddler Dose|Failed to return|2|||
131402342|NCT01559259|473095423|FG004|Overall Study|Adverse Event|0|||
131402343|NCT04753658|473095425|FG000|Overall Study|Progressive disease|7|||
131837243|NCT00444457|474686418|FG001|Toddler Dose|Failed to return|2|||
131837244|NCT00444457|474686419|FG002|Toddler Dose|Failed to return|1|||
131837245|NCT00444457|474686420|FG003|Toddler Dose|Failed to return|3|||
131837246|NCT00444457|474686417|FG000|Toddler Dose|Parent or legal guardian request|0|||
131910765|NCT00471497|474960835|FG000|Extension Phase|Death|1|||
131402344|NCT04753658|473095425|FG000|Overall Study|Other|7|||
131402345|NCT04753658|473095425|FG000|Overall Study|Adverse Event|1|||
131402346|NCT00306293|473095426|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
131837247|NCT00444457|474686418|FG001|Toddler Dose|Parent or legal guardian request|3|||
131837248|NCT00444457|474686419|FG002|Toddler Dose|Parent or legal guardian request|2|||
131837249|NCT00444457|474686420|FG003|Toddler Dose|Parent or legal guardian request|1|||
131837250|NCT00444457|474686417|FG000|Toddler Dose|Protocol Violation|1|||
131837251|NCT00444457|474686418|FG001|Toddler Dose|Protocol Violation|0|||
131837252|NCT00444457|474686419|FG002|Toddler Dose|Protocol Violation|0|||
131837253|NCT00444457|474686420|FG003|Toddler Dose|Protocol Violation|1|||
131837254|NCT01121666|474686423|FG000|Overall Study|Protocol Violation|29|||
131402347|NCT00306293|473095427|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
131402348|NCT00306293|473095426|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
131402349|NCT00306293|473095427|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
131402350|NCT00306293|473095426|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
131402351|NCT00306293|473095427|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
131402352|NCT00306293|473095426|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
131402353|NCT00306293|473095427|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
131402354|NCT00306293|473095426|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
131402355|NCT00306293|473095427|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
131402356|NCT00306293|473095426|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
131402357|NCT00306293|473095427|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
131837255|NCT01121666|474686424|FG001|Overall Study|Protocol Violation|10|||
131837256|NCT03176459|474686427|FG000|Overall Study|Lost to Follow-up|5|||
131837257|NCT03176459|474686428|FG001|Overall Study|Lost to Follow-up|7|||
131837258|NCT01769339|474686429|FG000|Overall Study|Lost to Follow-up|42|||
131837259|NCT01769339|474686429|FG000|Overall Study|Adverse Event|1|||
131837260|NCT00290251|474686430|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
131837261|NCT00290251|474686431|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
131837262|NCT00290251|474686432|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
131402358|NCT00306293|473095426|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
131402359|NCT00306293|473095427|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
131402360|NCT00306293|473095426|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
131402361|NCT00306293|473095427|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
131402362|NCT00218634|473095428|FG000|Overall Study|Lost to Follow-up|8|||
131402363|NCT00218634|473095429|FG001|Overall Study|Lost to Follow-up|15|||
131402364|NCT05243745|473095430|FG000|Overall Study|Withdrawal by Subject|0|||
131402365|NCT05243745|473095431|FG001|Overall Study|Withdrawal by Subject|0|||
131402366|NCT05243745|473095432|FG002|Overall Study|Withdrawal by Subject|0|||
131402367|NCT05243745|473095433|FG003|Overall Study|Withdrawal by Subject|1|||
131402368|NCT05243745|473095430|FG000|Overall Study|Unable to Attend Visit 6|0|||
131402369|NCT05243745|473095431|FG001|Overall Study|Unable to Attend Visit 6|0|||
131402370|NCT05243745|473095432|FG002|Overall Study|Unable to Attend Visit 6|1|||
131402371|NCT05243745|473095433|FG003|Overall Study|Unable to Attend Visit 6|0|||
131402372|NCT02199314|473095436|FG000|Overall Study|Withdrawal by Subject|6|||
131402373|NCT02199314|473095436|FG000|Overall Study|Physician Decision|10|||
131402374|NCT00176488|473095437|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
131402375|NCT01044745|473095438|FG000|Overall Study|Ineiligible|2|||
131402376|NCT01159171|473095443|FG000|Overall Study|Adverse Event|11|||
131402377|NCT01159171|473095443|FG000|Overall Study|Progression of Disease|28|||
131402378|NCT01159171|473095443|FG000|Overall Study|Protocol Violation|1|||
131402379|NCT01159171|473095443|FG000|Overall Study|Need for Surgery|5|||
131402380|NCT01159171|473095443|FG000|Overall Study|Medical Decision|4|||
131402381|NCT01159171|473095443|FG000|Overall Study|Death|1|||
131402382|NCT01892436|473095444|FG000|Overall Study|Withdrawal by Subject|8|||
131402383|NCT01892436|473095445|FG001|Overall Study|Withdrawal by Subject|15|||
131837263|NCT00290251|474686433|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
131837264|NCT00290251|474686434|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
131837265|NCT00290251|474686435|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
131837266|NCT00290251|474686430|FG000|Treatment 1 (Months 2-4)|headache|0|||
131837267|NCT00290251|474686431|FG001|Treatment 1 (Months 2-4)|headache|0|||
131837268|NCT00290251|474686432|FG002|Treatment 1 (Months 2-4)|headache|0|||
131837269|NCT00290251|474686433|FG003|Treatment 1 (Months 2-4)|headache|0|||
131402384|NCT01892436|473095446|FG002|Overall Study|Withdrawal by Subject|4|||
131402385|NCT01892436|473095447|FG003|Overall Study|Withdrawal by Subject|4|||
131402386|NCT01892436|473095444|FG000|Overall Study|Death|1|||
131402387|NCT01892436|473095445|FG001|Overall Study|Death|1|||
131402388|NCT01892436|473095446|FG002|Overall Study|Death|0|||
131402389|NCT01892436|473095447|FG003|Overall Study|Death|0|||
131402390|NCT01892436|473095444|FG000|Overall Study|Physician Decision|2|||
131402391|NCT01892436|473095445|FG001|Overall Study|Physician Decision|1|||
131402392|NCT01892436|473095446|FG002|Overall Study|Physician Decision|0|||
131402393|NCT01892436|473095447|FG003|Overall Study|Physician Decision|1|||
131837270|NCT00290251|474686434|FG004|Treatment 1 (Months 2-4)|headache|1|||
131402394|NCT01892436|473095444|FG000|Overall Study|Pregnancy|0|||
131837271|NCT00290251|474686435|FG005|Treatment 1 (Months 2-4)|headache|0|||
131837272|NCT00290251|474686430|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
131837273|NCT00290251|474686431|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
131837274|NCT00290251|474686432|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
131837275|NCT00290251|474686433|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
131837276|NCT00290251|474686434|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
131837277|NCT00290251|474686435|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
131837278|NCT02788045|474687785|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
131837279|NCT02788045|474687786|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
131837280|NCT02788045|474687787|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
131837281|NCT02788045|474687785|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
131837282|NCT02788045|474687786|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
131837283|NCT02788045|474687787|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
131837284|NCT02788045|474687785|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
131837285|NCT02788045|474687786|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
131837286|NCT02788045|474687787|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
131837287|NCT02788045|474687785|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
131837288|NCT02788045|474687786|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
131837289|NCT02788045|474687787|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
131837290|NCT02788045|474687785|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
131837291|NCT02788045|474687786|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
131837292|NCT02788045|474687787|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
131837293|NCT02788045|474687785|FG000|Main Study (Up to Week 72)|Other|3|||
131837294|NCT02788045|474687786|FG001|Main Study (Up to Week 72)|Other|0|||
131837295|NCT02788045|474687787|FG002|Main Study (Up to Week 72)|Other|0|||
131837296|NCT02788045|474687785|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
131837297|NCT02788045|474687786|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
131837298|NCT02788045|474687787|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
131837299|NCT02788045|474687785|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
131837300|NCT02788045|474687786|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
131837301|NCT02788045|474687787|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
131837302|NCT02788045|474687785|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
131837303|NCT02788045|474687786|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
131837304|NCT02788045|474687787|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
131837305|NCT00866658|474687791|FG000|Overall Study|Adverse Event|5|||
131837306|NCT00866658|474687792|FG001|Overall Study|Adverse Event|14|||
131837307|NCT00866658|474687791|FG000|Overall Study|Lack of Efficacy|2|||
131837308|NCT00866658|474687792|FG001|Overall Study|Lack of Efficacy|1|||
131837309|NCT00866658|474687791|FG000|Overall Study|Withdrawal by Subject|1|||
131837310|NCT00866658|474687792|FG001|Overall Study|Withdrawal by Subject|0|||
131837311|NCT00866658|474687791|FG000|Overall Study|Protocol Violation|1|||
131837312|NCT00866658|474687792|FG001|Overall Study|Protocol Violation|1|||
131837313|NCT00866658|474687791|FG000|Overall Study|Familial and Personal Reasons|4|||
131837314|NCT00866658|474687792|FG001|Overall Study|Familial and Personal Reasons|5|||
131837315|NCT00609518|474687794|FG000|Overall Study|Death from Study Disease|32|||
131837316|NCT00609518|474687795|FG001|Overall Study|Death from Study Disease|32|||
131837317|NCT00609518|474687794|FG000|Overall Study|Withdrawal by Subject|5|||
131837318|NCT00609518|474687795|FG001|Overall Study|Withdrawal by Subject|3|||
131837319|NCT00609518|474687794|FG000|Overall Study|Lost to Follow-up|3|||
131837320|NCT00609518|474687795|FG001|Overall Study|Lost to Follow-up|0|||
131837321|NCT00609518|474687794|FG000|Overall Study|Physician Decision|1|||
131837322|NCT00609518|474687795|FG001|Overall Study|Physician Decision|3|||
131837323|NCT00609518|474687794|FG000|Overall Study|Death from Adverse Event|2|||
131837324|NCT00609518|474687795|FG001|Overall Study|Death from Adverse Event|2|||
131837325|NCT01687478|474687796|FG000|Overall Study|Adverse Event|3|||
131837326|NCT01687478|474687797|FG001|Overall Study|Adverse Event|10|||
131837327|NCT01687478|474687796|FG000|Overall Study|Lost to Follow-up|1|||
131837328|NCT01687478|474687797|FG001|Overall Study|Lost to Follow-up|3|||
131837329|NCT01687478|474687796|FG000|Overall Study|Protocol Violation|0|||
131837330|NCT01687478|474687797|FG001|Overall Study|Protocol Violation|2|||
131837331|NCT01687478|474687796|FG000|Overall Study|Withdrawal by Subject|21|||
131837332|NCT01687478|474687797|FG001|Overall Study|Withdrawal by Subject|19|||
131837333|NCT01687478|474687796|FG000|Overall Study|Physician Decision|1|||
131837334|NCT01687478|474687797|FG001|Overall Study|Physician Decision|3|||
131837335|NCT01687478|474687796|FG000|Overall Study|Entry Criteria Not Met|6|||
131837336|NCT01687478|474687797|FG001|Overall Study|Entry Criteria Not Met|2|||
131837337|NCT05855616|474687798|FG000|Overall Study|Lost to Follow-up|1|||
131837338|NCT05855616|474687799|FG001|Overall Study|Lost to Follow-up|2|||
131837339|NCT01700049|474687802|FG000|Overall Study|Withdrawal by Subject|1|||
131837340|NCT01248013|474687803|FG000|Overall Study|Withdrawal by Subject|14|||
131837341|NCT01859130|474687804|FG000|Overall Study|Death|4|||
131837342|NCT01859130|474687804|FG000|Overall Study|Lost to Follow-up|16|||
131402395|NCT01892436|473095445|FG001|Overall Study|Pregnancy|2|||
131837343|NCT01859130|474687804|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
131837344|NCT01859130|474687804|FG000|Overall Study|Physician Decision|6|||
131837345|NCT01859130|474687804|FG000|Overall Study|Withdrawal by Subject|17|||
131837346|NCT01859130|474687804|FG000|Overall Study|Adverse Event|11|||
131837347|NCT00307034|474687805|FG000|Overall Study|Adverse Event|1|||
131837348|NCT00307034|474687806|FG001|Overall Study|Adverse Event|2|||
131837349|NCT00307034|474687805|FG000|Overall Study|Withdrawal by Subject|1|||
131837350|NCT00307034|474687806|FG001|Overall Study|Withdrawal by Subject|2|||
131837351|NCT00307034|474687805|FG000|Overall Study|Lost to Follow-up|0|||
131837352|NCT00307034|474687806|FG001|Overall Study|Lost to Follow-up|3|||
131837353|NCT01246011|474687809|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
131837354|NCT01246011|474687810|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
131837355|NCT01246011|474687811|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
131837356|NCT01246011|474687809|FG000|Overall Study|Withdrawal by Subject|0|||
131837357|NCT01246011|474687810|FG001|Overall Study|Withdrawal by Subject|0|||
131837358|NCT01246011|474687811|FG002|Overall Study|Withdrawal by Subject|1|||
131837359|NCT04492020|474687812|FG000|Overall Study|Adverse Event|1|||
131837360|NCT04492020|474687813|FG001|Overall Study|Adverse Event|3|||
131837361|NCT04492020|474687812|FG000|Overall Study|Withdrawal by Subject|4|||
131837362|NCT04492020|474687813|FG001|Overall Study|Withdrawal by Subject|3|||
131837363|NCT04492020|474687812|FG000|Overall Study|Lost to Follow-up|4|||
131837364|NCT04492020|474687813|FG001|Overall Study|Lost to Follow-up|3|||
131837365|NCT04492020|474687812|FG000|Overall Study|Protocol Violation|5|||
131837366|NCT04492020|474687813|FG001|Overall Study|Protocol Violation|2|||
131837367|NCT04492020|474687812|FG000|Overall Study|Lack of Qualifying Event|25|||
131837368|NCT04492020|474687813|FG001|Overall Study|Lack of Qualifying Event|27|||
131837369|NCT04492020|474687812|FG000|Overall Study|Non-compliance with Study Drug|2|||
131837370|NCT04492020|474687813|FG001|Overall Study|Non-compliance with Study Drug|1|||
131837371|NCT02792959|474687818|FG000|Overall Study|Protocol Violation|1|||
131837372|NCT03914950|474687822|FG000|Overall Study|Physician Decision|54|||
131837373|NCT02575911|474687823|FG000|Overall Study|Lost to Follow-up|1|||
131837374|NCT01249365|474687824|FG000|Overall Study|Lost to Follow-up|1|||
131837375|NCT00950963|474687825|FG000|Overall Study|Lost to Follow-up|29|||
131837376|NCT00950963|474687826|FG001|Overall Study|Lost to Follow-up|24|||
131837377|NCT01732484|474687828|FG000|Overall Study|Death|7|||
131837378|NCT01732484|474687828|FG000|Overall Study|Lost to Follow-up|14|||
131837379|NCT01732484|474687828|FG000|Overall Study|chronical illness|5|||
131837380|NCT01087489|474687829|FG000|Overall Study|enrolled in another VA study|0|||
131837381|NCT01087489|474687830|FG001|Overall Study|enrolled in another VA study|1|||
131837382|NCT01087489|474687829|FG000|Overall Study|Death|0|||
131837383|NCT01087489|474687830|FG001|Overall Study|Death|1|||
131837384|NCT01087489|474687829|FG000|Overall Study|unable to survey by telephone|0|||
131837385|NCT01087489|474687830|FG001|Overall Study|unable to survey by telephone|1|||
131837386|NCT00893737|474687831|FG000|Overall Study|Adverse Event|4|||
131837387|NCT00893737|474687831|FG000|Overall Study|Withdrawal by Subject|2|||
131837388|NCT00893737|474687831|FG000|Overall Study|Lost to Follow-up|6|||
131837389|NCT01156142|474687832|FG000|Overall Study|Withdrawal by Subject|8|||
131837390|NCT01156142|474687833|FG001|Overall Study|Withdrawal by Subject|6|||
131837391|NCT01156142|474687832|FG000|Overall Study|Ineligible|0|||
131837392|NCT01156142|474687833|FG001|Overall Study|Ineligible|1|||
131837393|NCT00928707|474687834|FG000|Overall Study|Protocol Violation|1|||
131837394|NCT00928707|474687835|FG001|Overall Study|Protocol Violation|0|||
131837395|NCT00132028|474687836|FG000|Overall Study|Adverse Event|7|||
131837396|NCT00132028|474687836|FG000|Overall Study|Death|2|||
131837397|NCT00132028|474687836|FG000|Overall Study|Lack of Efficacy|11|||
131837398|NCT00132028|474687836|FG000|Overall Study|Withdrawal by Subject|2|||
131837399|NCT00132028|474687836|FG000|Overall Study|not eligible|2|||
131837400|NCT00132028|474687836|FG000|Overall Study|Physician Decision|3|||
131837401|NCT02140411|474687837|FG000|Overall Study|Adverse Event|1|||
131837402|NCT03981419|474687840|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
131837403|NCT03981419|474687841|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
131837404|NCT01330459|474687846|FG000|Overall Study|Physician Decision|0|||
131837405|NCT01330459|474687847|FG001|Overall Study|Physician Decision|2|||
131837406|NCT01359644|474687849|FG000|Treatment Period|Lack of Efficacy|0|||
131837407|NCT01359644|474687850|FG001|Treatment Period|Lack of Efficacy|1|||
131837408|NCT01359644|474687851|FG002|Treatment Period|Lack of Efficacy|0|||
131837409|NCT01359644|474687852|FG003|Treatment Period|Lack of Efficacy|0|||
131837410|NCT01359644|474687853|FG004|Treatment Period|Lack of Efficacy|0|||
131837411|NCT01359644|474687854|FG005|Treatment Period|Lack of Efficacy|0|||
131837412|NCT01359644|474687855|FG006|Treatment Period|Lack of Efficacy|0|||
131837413|NCT01359644|474687856|FG007|Treatment Period|Lack of Efficacy|0|||
131837414|NCT01359644|474687857|FG008|Treatment Period|Lack of Efficacy|0|||
131837415|NCT01359644|474687858|FG009|Treatment Period|Lack of Efficacy|0|||
131837416|NCT01359644|474687849|FG000|Treatment Period|Adverse Event|0|||
131837417|NCT01359644|474687850|FG001|Treatment Period|Adverse Event|0|||
131837418|NCT01359644|474687851|FG002|Treatment Period|Adverse Event|1|||
131837419|NCT01359644|474687852|FG003|Treatment Period|Adverse Event|0|||
131837420|NCT01359644|474687853|FG004|Treatment Period|Adverse Event|0|||
131837421|NCT01359644|474687854|FG005|Treatment Period|Adverse Event|1|||
131837422|NCT01359644|474687855|FG006|Treatment Period|Adverse Event|0|||
131837423|NCT01359644|474687856|FG007|Treatment Period|Adverse Event|0|||
131837424|NCT01359644|474687857|FG008|Treatment Period|Adverse Event|0|||
131837425|NCT01359644|474687858|FG009|Treatment Period|Adverse Event|0|||
131837426|NCT01359644|474687849|FG000|Treatment Period|Lost to Follow-up|0|||
131837427|NCT01359644|474687850|FG001|Treatment Period|Lost to Follow-up|0|||
131837428|NCT01359644|474687851|FG002|Treatment Period|Lost to Follow-up|0|||
131837429|NCT01359644|474687852|FG003|Treatment Period|Lost to Follow-up|0|||
131837430|NCT01359644|474687853|FG004|Treatment Period|Lost to Follow-up|0|||
131837431|NCT01359644|474687854|FG005|Treatment Period|Lost to Follow-up|1|||
131837432|NCT01359644|474687855|FG006|Treatment Period|Lost to Follow-up|0|||
131837433|NCT01359644|474687856|FG007|Treatment Period|Lost to Follow-up|0|||
131837434|NCT01359644|474687857|FG008|Treatment Period|Lost to Follow-up|0|||
131837435|NCT01359644|474687858|FG009|Treatment Period|Lost to Follow-up|0|||
131837436|NCT01359644|474687849|FG000|Follow-up Period|Withdrawal by Subject|0|||
131837437|NCT01359644|474687850|FG001|Follow-up Period|Withdrawal by Subject|0|||
131837438|NCT01359644|474687851|FG002|Follow-up Period|Withdrawal by Subject|0|||
131837439|NCT01359644|474687852|FG003|Follow-up Period|Withdrawal by Subject|0|||
131837440|NCT01359644|474687853|FG004|Follow-up Period|Withdrawal by Subject|0|||
131837441|NCT01359644|474687854|FG005|Follow-up Period|Withdrawal by Subject|1|||
131837442|NCT01359644|474687855|FG006|Follow-up Period|Withdrawal by Subject|0|||
131837443|NCT01359644|474687856|FG007|Follow-up Period|Withdrawal by Subject|0|||
131837444|NCT01359644|474687857|FG008|Follow-up Period|Withdrawal by Subject|0|||
131837445|NCT01359644|474687858|FG009|Follow-up Period|Withdrawal by Subject|0|||
131837446|NCT01359644|474687849|FG000|Follow-up Period|Lost to Follow-up|0|||
131837447|NCT01359644|474687850|FG001|Follow-up Period|Lost to Follow-up|0|||
131837448|NCT01359644|474687851|FG002|Follow-up Period|Lost to Follow-up|0|||
131837449|NCT01359644|474687852|FG003|Follow-up Period|Lost to Follow-up|0|||
131837450|NCT01359644|474687853|FG004|Follow-up Period|Lost to Follow-up|0|||
131837451|NCT01359644|474687854|FG005|Follow-up Period|Lost to Follow-up|0|||
131837452|NCT01359644|474687855|FG006|Follow-up Period|Lost to Follow-up|1|||
131837453|NCT01359644|474687856|FG007|Follow-up Period|Lost to Follow-up|2|||
131837454|NCT01359644|474687857|FG008|Follow-up Period|Lost to Follow-up|0|||
131837455|NCT01359644|474687858|FG009|Follow-up Period|Lost to Follow-up|0|||
131837456|NCT01355159|474687869|FG000|Overall Study|Withdrew consent|39|||
131837457|NCT01355159|474687870|FG001|Overall Study|Withdrew consent|47|||
131837458|NCT01355159|474687869|FG000|Overall Study|No primary outcome data|17|||
131837459|NCT01355159|474687870|FG001|Overall Study|No primary outcome data|11|||
131837460|NCT01355159|474687869|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
131837461|NCT01355159|474687870|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
131837462|NCT01355159|474687869|FG000|Overall Study|Early intrauterine fetal death|6|||
131837463|NCT01355159|474687870|FG001|Overall Study|Early intrauterine fetal death|6|||
131837464|NCT01194973|474687871|FG000|Screening Period|Screen Failure|3|||
131837465|NCT01194973|474687871|FG000|26 Week Treatment Period|Adverse Event|1|||
131837466|NCT01194973|474687871|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
131837467|NCT01194973|474687871|FG000|26 Week Treatment Period|Pregnancy|1|||
131837468|NCT00359632|474687874|FG000|Overall Study|Death|2|||
131837469|NCT00359632|474687875|FG001|Overall Study|Death|0|||
131837470|NCT00359632|474687874|FG000|Overall Study|Adverse Event|1|||
131837471|NCT00359632|474687875|FG001|Overall Study|Adverse Event|0|||
131837472|NCT00359632|474687874|FG000|Overall Study|Non-compliance with visit schedule|1|||
131837473|NCT00359632|474687875|FG001|Overall Study|Non-compliance with visit schedule|0|||
131837474|NCT04700280|474687876|FG000|Overall Study|Adverse Event|4|||
131837475|NCT04700280|474687877|FG001|Overall Study|Adverse Event|0|||
131837476|NCT04700280|474687876|FG000|Overall Study|Lack of Efficacy|1|||
131837477|NCT04700280|474687877|FG001|Overall Study|Lack of Efficacy|0|||
131837478|NCT04700280|474687876|FG000|Overall Study|Study terminated by sponsor|5|||
131837479|NCT04700280|474687877|FG001|Overall Study|Study terminated by sponsor|3|||
131837480|NCT04700280|474687876|FG000|Overall Study|Other than specified|1|||
131837481|NCT04700280|474687877|FG001|Overall Study|Other than specified|0|||
131837482|NCT02615171|474687878|FG000|Overall Study|Lost to Follow-up|2|||
131837483|NCT02615171|474687879|FG001|Overall Study|Lost to Follow-up|1|||
131837484|NCT00741936|474687891|FG000|Overall Study|Lost to Follow-up|1|||
131837485|NCT00741936|474687892|FG001|Overall Study|Lost to Follow-up|1|||
131910766|NCT00471497|474960836|FG001|Extension Phase|Death|0|||
131910767|NCT00471497|474960837|FG002|Extension Phase|Death|0|||
131837486|NCT00741936|474687891|FG000|Overall Study|Adverse Event|3|||
131837487|NCT00741936|474687892|FG001|Overall Study|Adverse Event|4|||
131837488|NCT00741936|474687891|FG000|Overall Study|Pregnancy|0|||
131837489|NCT00741936|474687892|FG001|Overall Study|Pregnancy|1|||
131837490|NCT00741936|474687891|FG000|Overall Study|Protocol Violation|2|||
131837491|NCT00741936|474687892|FG001|Overall Study|Protocol Violation|0|||
131837492|NCT00741936|474687891|FG000|Overall Study|Lack of Efficacy|0|||
131837493|NCT00741936|474687892|FG001|Overall Study|Lack of Efficacy|2|||
131837494|NCT00741936|474687891|FG000|Overall Study|Low compliance|3|||
131837495|NCT00741936|474687892|FG001|Overall Study|Low compliance|0|||
131837496|NCT00513682|474687893|FG000|Washout Phase|Adverse Event|2|||
131837497|NCT00502801|474687894|FG000|Treatment Period|Withdrawal by Subject|3|||
131837498|NCT00502801|474687894|FG000|Treatment Period|Adverse Event|7|||
131837499|NCT00502801|474687894|FG000|Treatment Period|Death|14|||
131837500|NCT00502801|474687894|FG000|Treatment Period|OTHER|30|||
131837501|NCT00502801|474687894|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
131837502|NCT00502801|474687894|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
131837503|NCT00502801|474687894|FG000|End of Therapy to Test of Cure|Death|3|||
131837504|NCT00502801|474687894|FG000|End of Therapy to Test of Cure|OTHER|2|||
131837505|NCT03212521|474687898|FG000|Overall Study|Adverse Event|1|||
131837506|NCT03212521|474687898|FG000|Overall Study|Lost to Follow-up|4|||
131837507|NCT03212521|474687898|FG000|Overall Study|Withdrawal by Subject|1|||
131837508|NCT03212521|474687898|FG000|Overall Study|Other|1|||
131837509|NCT02041091|474687899|FG000|Treatment|Adverse Event|3|||
131837510|NCT02041091|474687900|FG001|Treatment|Adverse Event|3|||
131837511|NCT02041091|474687899|FG000|Treatment|Withdrawal by Subject|2|||
131837512|NCT02041091|474687900|FG001|Treatment|Withdrawal by Subject|4|||
131837513|NCT02041091|474687899|FG000|Treatment|Physician Decision|1|||
131837514|NCT02041091|474687900|FG001|Treatment|Physician Decision|0|||
131837515|NCT02041091|474687899|FG000|Treatment|Sponsor Decision|15|||
131837516|NCT02041091|474687900|FG001|Treatment|Sponsor Decision|16|||
131837517|NCT02041091|474687899|FG000|Treatment|Lost to Follow-up|1|||
131837518|NCT02041091|474687900|FG001|Treatment|Lost to Follow-up|0|||
131837519|NCT02041091|474687899|FG000|Optional Safety Extension Period|Adverse Event|4|||
131837520|NCT02041091|474687900|FG001|Optional Safety Extension Period|Adverse Event|2|||
131837521|NCT02041091|474687899|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
131837522|NCT02041091|474687900|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
131837523|NCT02041091|474687899|FG000|Optional Safety Extension Period|Protocol Violation|2|||
131837524|NCT02041091|474687900|FG001|Optional Safety Extension Period|Protocol Violation|0|||
131837525|NCT02041091|474687899|FG000|Optional Safety Extension Period|Physician Decision|2|||
131837526|NCT02041091|474687900|FG001|Optional Safety Extension Period|Physician Decision|1|||
131837527|NCT02041091|474687899|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
131837528|NCT02041091|474687900|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
131837529|NCT02041091|474687899|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
131837530|NCT02041091|474687900|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
131837531|NCT01602965|474687901|FG000|Overall Study|Lost to Follow-up|4|||
131837532|NCT01602965|474687902|FG001|Overall Study|Lost to Follow-up|2|||
131837533|NCT01150890|474687903|FG000|Overall Study|Other|0|||
131837534|NCT01150890|474687904|FG001|Overall Study|Other|1|||
131837535|NCT01150890|474687905|FG002|Overall Study|Other|0|||
131837536|NCT01150890|474687906|FG003|Overall Study|Other|2|||
131837537|NCT01150890|474687903|FG000|Overall Study|Pregnancy|0|||
131837538|NCT01150890|474687904|FG001|Overall Study|Pregnancy|0|||
131837539|NCT01150890|474687905|FG002|Overall Study|Pregnancy|0|||
131837540|NCT01150890|474687906|FG003|Overall Study|Pregnancy|1|||
131837541|NCT01150890|474687903|FG000|Overall Study|Administrative Decision|4|||
131837542|NCT01150890|474687904|FG001|Overall Study|Administrative Decision|4|||
131837543|NCT01150890|474687905|FG002|Overall Study|Administrative Decision|5|||
131837544|NCT01150890|474687906|FG003|Overall Study|Administrative Decision|6|||
131837545|NCT01150890|474687903|FG000|Overall Study|Ineligibility determined|0|||
131837546|NCT01150890|474687904|FG001|Overall Study|Ineligibility determined|1|||
131837547|NCT01150890|474687905|FG002|Overall Study|Ineligibility determined|0|||
131837548|NCT01150890|474687906|FG003|Overall Study|Ineligibility determined|0|||
131837549|NCT01150890|474687903|FG000|Overall Study|Adverse Event|0|||
131837550|NCT01150890|474687904|FG001|Overall Study|Adverse Event|0|||
131837551|NCT01150890|474687905|FG002|Overall Study|Adverse Event|2|||
131837552|NCT01150890|474687906|FG003|Overall Study|Adverse Event|0|||
131837553|NCT01150890|474687903|FG000|Overall Study|Withdrawal by Subject|0|||
131837554|NCT01150890|474687904|FG001|Overall Study|Withdrawal by Subject|0|||
131837555|NCT01150890|474687905|FG002|Overall Study|Withdrawal by Subject|2|||
131837556|NCT01150890|474687906|FG003|Overall Study|Withdrawal by Subject|1|||
131837557|NCT01150890|474687903|FG000|Overall Study|Disease progression|0|||
131837558|NCT01150890|474687904|FG001|Overall Study|Disease progression|7|||
131837559|NCT01150890|474687905|FG002|Overall Study|Disease progression|3|||
131837560|NCT01150890|474687906|FG003|Overall Study|Disease progression|7|||
131837561|NCT00922987|474687907|FG000|Overall Study|Insufficient clinical response|1|||
131837562|NCT00922987|474687907|FG000|Overall Study|Protocol Violation|2|||
131837563|NCT00922987|474687907|FG000|Overall Study|Adverse Event|1|||
131837564|NCT00446199|474687908|FG000|Overall Study|Adverse Event|7|||
131837565|NCT00446199|474687909|FG001|Overall Study|Adverse Event|4|||
131837566|NCT00446199|474687910|FG002|Overall Study|Adverse Event|6|||
131837567|NCT00446199|474687911|FG003|Overall Study|Adverse Event|4|||
131837568|NCT00446199|474687908|FG000|Overall Study|Lost to Follow-up|4|||
131837569|NCT00446199|474687909|FG001|Overall Study|Lost to Follow-up|5|||
131837570|NCT00446199|474687910|FG002|Overall Study|Lost to Follow-up|2|||
131837571|NCT00446199|474687911|FG003|Overall Study|Lost to Follow-up|6|||
131837572|NCT00446199|474687908|FG000|Overall Study|Protocol Violation|1|||
131837573|NCT00446199|474687909|FG001|Overall Study|Protocol Violation|2|||
131837574|NCT00446199|474687910|FG002|Overall Study|Protocol Violation|1|||
131837575|NCT00446199|474687911|FG003|Overall Study|Protocol Violation|3|||
131837576|NCT00446199|474687908|FG000|Overall Study|Withdrawal by Subject|2|||
131837577|NCT00446199|474687909|FG001|Overall Study|Withdrawal by Subject|5|||
131837578|NCT00446199|474687910|FG002|Overall Study|Withdrawal by Subject|9|||
131837579|NCT00446199|474687911|FG003|Overall Study|Withdrawal by Subject|10|||
131837580|NCT00446199|474687908|FG000|Overall Study|Site termination|2|||
131837581|NCT00446199|474687909|FG001|Overall Study|Site termination|0|||
131837582|NCT00446199|474687910|FG002|Overall Study|Site termination|0|||
131837583|NCT00446199|474687911|FG003|Overall Study|Site termination|1|||
131837584|NCT00446199|474687908|FG000|Overall Study|Randomization in Error|2|||
131837585|NCT00446199|474687909|FG001|Overall Study|Randomization in Error|0|||
131837586|NCT00446199|474687910|FG002|Overall Study|Randomization in Error|1|||
131837587|NCT00446199|474687911|FG003|Overall Study|Randomization in Error|1|||
131837588|NCT00446199|474687908|FG000|Overall Study|Lack of Efficacy|1|||
131837589|NCT00446199|474687909|FG001|Overall Study|Lack of Efficacy|0|||
131837590|NCT00446199|474687910|FG002|Overall Study|Lack of Efficacy|0|||
131837591|NCT00446199|474687911|FG003|Overall Study|Lack of Efficacy|1|||
131837592|NCT00446199|474687908|FG000|Overall Study|Non-compliant with study drug|1|||
131837593|NCT00446199|474687909|FG001|Overall Study|Non-compliant with study drug|0|||
131837594|NCT00446199|474687910|FG002|Overall Study|Non-compliant with study drug|5|||
131837595|NCT00446199|474687911|FG003|Overall Study|Non-compliant with study drug|0|||
131837596|NCT00446199|474687908|FG000|Overall Study|Non-compliant with visit schedule|1|||
131837597|NCT00446199|474687909|FG001|Overall Study|Non-compliant with visit schedule|1|||
131837598|NCT00446199|474687910|FG002|Overall Study|Non-compliant with visit schedule|1|||
131837599|NCT00446199|474687911|FG003|Overall Study|Non-compliant with visit schedule|2|||
131837600|NCT00446199|474687908|FG000|Overall Study|Hormone fear|0|||
131837601|NCT00446199|474687909|FG001|Overall Study|Hormone fear|0|||
131837602|NCT00446199|474687910|FG002|Overall Study|Hormone fear|0|||
131837603|NCT00446199|474687911|FG003|Overall Study|Hormone fear|1|||
131837604|NCT00446199|474687908|FG000|Overall Study|Lost interest in study participation|0|||
131837605|NCT00446199|474687909|FG001|Overall Study|Lost interest in study participation|1|||
131837606|NCT00446199|474687910|FG002|Overall Study|Lost interest in study participation|0|||
131837607|NCT00446199|474687911|FG003|Overall Study|Lost interest in study participation|0|||
131837608|NCT00446199|474687908|FG000|Overall Study|In-/Exclusion criterion violated|2|||
131837609|NCT00446199|474687909|FG001|Overall Study|In-/Exclusion criterion violated|1|||
131837610|NCT00446199|474687910|FG002|Overall Study|In-/Exclusion criterion violated|2|||
131837611|NCT00446199|474687911|FG003|Overall Study|In-/Exclusion criterion violated|1|||
131837612|NCT00446199|474687908|FG000|Overall Study|Move|0|||
131837613|NCT00446199|474687909|FG001|Overall Study|Move|1|||
131837614|NCT00446199|474687910|FG002|Overall Study|Move|0|||
131837615|NCT00446199|474687911|FG003|Overall Study|Move|0|||
131837616|NCT03071094|474687915|FG000|Overall Study|Death|1|||
131837617|NCT03071094|474687916|FG001|Overall Study|Death|1|||
131837618|NCT03071094|474687915|FG000|Overall Study|Adverse Event|1|||
131837619|NCT03071094|474687916|FG001|Overall Study|Adverse Event|0|||
131837620|NCT02312063|474687917|FG000|Overall Study|Withdrawal by Subject|0|||
131837621|NCT02312063|474687918|FG001|Overall Study|Withdrawal by Subject|1|||
131837622|NCT01079832|474687919|FG000|Overall Study|Withdrawal by Subject|1|||
131837623|NCT02283294|474687920|FG000|Overall Study|Lost to Follow-up|1|||
131837624|NCT02283294|474687921|FG001|Overall Study|Lost to Follow-up|1|||
131837625|NCT02283294|474687920|FG000|Overall Study|Withdrawal by Subject|1|||
131837626|NCT02283294|474687921|FG001|Overall Study|Withdrawal by Subject|6|||
131837627|NCT02283294|474687920|FG000|Overall Study|Protocol Violation|1|||
131837628|NCT02283294|474687921|FG001|Overall Study|Protocol Violation|0|||
131837629|NCT02283294|474687920|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
131837630|NCT02283294|474687921|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
131837631|NCT04062448|474691090|FG000|Overall Study|Lost to Follow-up|1|||
131837632|NCT04062448|474691090|FG000|Overall Study|Withdrawal by Subject|2|||
131837633|NCT05101486|474691091|FG000|Overall Study|Death|1|||
131837634|NCT05101486|474691092|FG001|Overall Study|Death|0|||
131837635|NCT05101486|474691093|FG002|Overall Study|Death|1|||
131837636|NCT05101486|474691091|FG000|Overall Study|Lost to Follow-up|12|||
131837637|NCT05101486|474691092|FG001|Overall Study|Lost to Follow-up|8|||
131402396|NCT01892436|473095446|FG002|Overall Study|Pregnancy|1|||
131837638|NCT05101486|474691093|FG002|Overall Study|Lost to Follow-up|17|||
131402397|NCT01892436|473095447|FG003|Overall Study|Pregnancy|0|||
131402398|NCT01892436|473095444|FG000|Overall Study|Technical problems|2|||
131402399|NCT01892436|473095445|FG001|Overall Study|Technical problems|1|||
131402400|NCT01892436|473095446|FG002|Overall Study|Technical problems|1|||
131837639|NCT05101486|474691091|FG000|Overall Study|Physician Decision|1|||
131837640|NCT05101486|474691092|FG001|Overall Study|Physician Decision|0|||
131837641|NCT05101486|474691093|FG002|Overall Study|Physician Decision|0|||
131837642|NCT05101486|474691091|FG000|Overall Study|Protocol Violation|0|||
131837643|NCT05101486|474691092|FG001|Overall Study|Protocol Violation|0|||
131837644|NCT05101486|474691093|FG002|Overall Study|Protocol Violation|1|||
131837645|NCT05101486|474691091|FG000|Overall Study|Withdrawal by Subject|5|||
131837646|NCT05101486|474691092|FG001|Overall Study|Withdrawal by Subject|2|||
131837647|NCT05101486|474691093|FG002|Overall Study|Withdrawal by Subject|4|||
131837648|NCT05101486|474691091|FG000|Overall Study|Randomized but not vaccinated|1|||
131837649|NCT05101486|474691092|FG001|Overall Study|Randomized but not vaccinated|1|||
131837650|NCT05101486|474691093|FG002|Overall Study|Randomized but not vaccinated|1|||
131837651|NCT03047473|474691094|FG000|Overall Study|Lost to Follow-up|2|||
131837652|NCT02935686|474691095|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
131837653|NCT02935686|474691096|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
131837654|NCT02935686|474691097|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
131837655|NCT02935686|474691098|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
131837656|NCT02935686|474691099|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
131837657|NCT02935686|474691095|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
131837658|NCT02935686|474691096|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
131837659|NCT02935686|474691097|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
131837660|NCT02935686|474691098|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
131837661|NCT02935686|474691099|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
131837662|NCT02935686|474691095|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
131837663|NCT02935686|474691096|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
131837664|NCT02935686|474691097|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
131837665|NCT02935686|474691098|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
131837666|NCT02935686|474691099|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
131837667|NCT02935686|474691095|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
131837668|NCT02935686|474691096|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
131837669|NCT02935686|474691097|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
131837670|NCT02935686|474691098|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
131837671|NCT02935686|474691099|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
131837672|NCT02935686|474691095|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
131837673|NCT02935686|474691096|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
131837674|NCT02935686|474691097|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
131837675|NCT02935686|474691098|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
131837676|NCT02935686|474691099|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
131837677|NCT02935686|474691095|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
131837678|NCT02935686|474691096|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
131837679|NCT02935686|474691097|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
131837680|NCT02935686|474691098|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
131837681|NCT02935686|474691099|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
131837682|NCT02935686|474691095|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
131837683|NCT02935686|474691096|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
131837684|NCT02935686|474691097|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
131837685|NCT02935686|474691098|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
131837686|NCT02935686|474691099|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
131837687|NCT02935686|474691095|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
131837688|NCT02935686|474691096|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
131837689|NCT02935686|474691097|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
131837690|NCT02935686|474691098|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
131837691|NCT02935686|474691099|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
131837692|NCT02935686|474691095|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
131837693|NCT02935686|474691096|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
131837694|NCT02935686|474691097|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
131837695|NCT02935686|474691098|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
131837696|NCT02935686|474691099|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
131837697|NCT02935686|474691095|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
131837698|NCT02935686|474691096|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
131837699|NCT02935686|474691097|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
131837700|NCT02935686|474691098|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
131837701|NCT02935686|474691099|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
131837702|NCT02935686|474691095|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
131837703|NCT02935686|474691096|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
131837704|NCT02935686|474691097|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
131837705|NCT02935686|474691098|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
131837706|NCT02935686|474691099|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
131837707|NCT00541970|474691105|FG000|Month 7|Protocol Violation|9|||
131837708|NCT00541970|474691106|FG001|Month 7|Protocol Violation|13|||
131837709|NCT00541970|474691107|FG002|Month 7|Protocol Violation|11|||
131837710|NCT00541970|474691108|FG003|Month 7|Protocol Violation|5|||
131910768|NCT00471497|474960835|FG000|Extension Phase|Disease progression|2|||
131837711|NCT00541970|474691105|FG000|Month 12|Adverse Event|0|||
131837712|NCT00541970|474691106|FG001|Month 12|Adverse Event|1|||
131837713|NCT00541970|474691107|FG002|Month 12|Adverse Event|1|||
131837714|NCT00541970|474691108|FG003|Month 12|Adverse Event|1|||
131837715|NCT00541970|474691105|FG000|Month 12|Protocol Violation|12|||
131837716|NCT00541970|474691106|FG001|Month 12|Protocol Violation|21|||
131837717|NCT00541970|474691107|FG002|Month 12|Protocol Violation|20|||
131837718|NCT00541970|474691108|FG003|Month 12|Protocol Violation|15|||
131837719|NCT00541970|474691105|FG000|Month 18|Adverse Event|0|||
131837720|NCT00541970|474691106|FG001|Month 18|Adverse Event|1|||
131837721|NCT00541970|474691107|FG002|Month 18|Adverse Event|1|||
131837722|NCT00541970|474691108|FG003|Month 18|Adverse Event|1|||
131837723|NCT00541970|474691105|FG000|Month 18|Protocol Violation|14|||
131837724|NCT00541970|474691106|FG001|Month 18|Protocol Violation|23|||
131837725|NCT00541970|474691107|FG002|Month 18|Protocol Violation|24|||
131837726|NCT00541970|474691108|FG003|Month 18|Protocol Violation|16|||
131837727|NCT00541970|474691105|FG000|Month 24|Adverse Event|0|||
131837728|NCT00541970|474691106|FG001|Month 24|Adverse Event|1|||
131837729|NCT00541970|474691107|FG002|Month 24|Adverse Event|1|||
131837730|NCT00541970|474691108|FG003|Month 24|Adverse Event|1|||
131837731|NCT00541970|474691105|FG000|Month 24|Protocol Violation|29|||
131837732|NCT00541970|474691106|FG001|Month 24|Protocol Violation|31|||
131837733|NCT00541970|474691107|FG002|Month 24|Protocol Violation|31|||
131837734|NCT00541970|474691108|FG003|Month 24|Protocol Violation|21|||
131837735|NCT00541970|474691105|FG000|Month 36|Protocol Violation|61|||
131837736|NCT00541970|474691106|FG001|Month 36|Protocol Violation|66|||
131837737|NCT00541970|474691107|FG002|Month 36|Protocol Violation|66|||
131837738|NCT00541970|474691108|FG003|Month 36|Protocol Violation|60|||
131837739|NCT00541970|474691105|FG000|Month 48|Withdrawal by Subject|2|||
131837740|NCT00541970|474691106|FG001|Month 48|Withdrawal by Subject|4|||
131837741|NCT00541970|474691107|FG002|Month 48|Withdrawal by Subject|4|||
131837742|NCT00541970|474691108|FG003|Month 48|Withdrawal by Subject|2|||
131837743|NCT00541970|474691105|FG000|Month 48|Other|3|||
131837744|NCT00541970|474691106|FG001|Month 48|Other|1|||
131837745|NCT00541970|474691107|FG002|Month 48|Other|1|||
131837746|NCT00541970|474691108|FG003|Month 48|Other|0|||
131837747|NCT00541970|474691105|FG000|Month 48|Lost to Follow-up|66|||
131837748|NCT00541970|474691106|FG001|Month 48|Lost to Follow-up|68|||
131837749|NCT00541970|474691107|FG002|Month 48|Lost to Follow-up|68|||
131837750|NCT00541970|474691108|FG003|Month 48|Lost to Follow-up|73|||
131837751|NCT00541970|474691105|FG000|Month 60|Protocol Violation|78|||
131837752|NCT00541970|474691106|FG001|Month 60|Protocol Violation|77|||
131837753|NCT00541970|474691107|FG002|Month 60|Protocol Violation|82|||
131837754|NCT00541970|474691108|FG003|Month 60|Protocol Violation|72|||
131837755|NCT01884311|474691109|FG000|Overall Study|Withdrawal by Subject|3|||
131837756|NCT01884311|474691109|FG000|Overall Study|withdrew consent due to AEs|1|||
131837757|NCT01884311|474691109|FG000|Overall Study|Precautionary measure|1|||
131837758|NCT00321828|474691110|FG000|Overall Study|Ineligible|3|||
131837759|NCT00321828|474691110|FG000|Overall Study|No follow up data|1|||
131837760|NCT02307266|474691113|FG000|Overall Study|Adverse Event|3|||
131837761|NCT02307266|474691114|FG001|Overall Study|Adverse Event|1|||
131837762|NCT02307266|474691115|FG002|Overall Study|Adverse Event|5|||
131837763|NCT02307266|474691113|FG000|Overall Study|Withdrawal by Subject|2|||
131837764|NCT02307266|474691114|FG001|Overall Study|Withdrawal by Subject|0|||
131837765|NCT02307266|474691115|FG002|Overall Study|Withdrawal by Subject|1|||
131837766|NCT02307266|474691113|FG000|Overall Study|Lost to Follow-up|3|||
131837767|NCT02307266|474691114|FG001|Overall Study|Lost to Follow-up|0|||
131837768|NCT02307266|474691115|FG002|Overall Study|Lost to Follow-up|0|||
131837769|NCT00062010|474691116|FG000|Overall Study|Ineligible|3|||
131837770|NCT02856880|474691117|FG000|Overall Study|Withdrawal of consent|1|||
131837771|NCT00573157|474691118|FG000|Overall Study|Adverse Event|3|||
131837772|NCT00573157|474691119|FG001|Overall Study|Adverse Event|1|||
131837773|NCT00573157|474691118|FG000|Overall Study|Other|1|||
131837774|NCT00573157|474691119|FG001|Overall Study|Other|1|||
131837775|NCT02944383|474691120|FG000|Overall Study|Lost to Follow-up|0|||
131837776|NCT02944383|474691121|FG001|Overall Study|Lost to Follow-up|0|||
131837777|NCT02944383|474691122|FG002|Overall Study|Lost to Follow-up|1|||
131837778|NCT02944383|474691120|FG000|Overall Study|Withdrawal by Subject|1|||
131837779|NCT02944383|474691121|FG001|Overall Study|Withdrawal by Subject|0|||
131837780|NCT02944383|474691122|FG002|Overall Study|Withdrawal by Subject|0|||
131837781|NCT01183221|474691127|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
131837782|NCT01183221|474691128|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
131837783|NCT00858143|474691134|FG000|Overall Study|Adverse Event|16|||
131837784|NCT00858143|474691134|FG000|Overall Study|Lack of Efficacy|4|||
131837785|NCT00858143|474691134|FG000|Overall Study|Death|7|||
131837786|NCT00858143|474691134|FG000|Overall Study|Other|23|||
131837787|NCT00852969|474691137|FG000|Overall Study|Adverse Event|0|||
131837788|NCT00852969|474691138|FG001|Overall Study|Adverse Event|1|||
131837789|NCT00852969|474691137|FG000|Overall Study|Lost to Follow-up|0|||
131837790|NCT00852969|474691138|FG001|Overall Study|Lost to Follow-up|1|||
131837791|NCT03853148|474691139|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
131837792|NCT03853148|474691140|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
131837793|NCT03853148|474691141|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
131837794|NCT03853148|474691142|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
131837795|NCT00658658|474691143|FG000|Overall Study|Withdrawal by Subject|0|||
131837796|NCT00658658|474691144|FG001|Overall Study|Withdrawal by Subject|1|||
131837797|NCT00658658|474691145|FG002|Overall Study|Withdrawal by Subject|0|||
131837798|NCT00658658|474691146|FG003|Overall Study|Withdrawal by Subject|0|||
131837799|NCT00658658|474691147|FG004|Overall Study|Withdrawal by Subject|0|||
131837800|NCT00658658|474691143|FG000|Overall Study|Death|4|||
131837801|NCT00658658|474691144|FG001|Overall Study|Death|0|||
131837802|NCT00658658|474691145|FG002|Overall Study|Death|0|||
131837803|NCT00658658|474691146|FG003|Overall Study|Death|1|||
131837804|NCT00658658|474691147|FG004|Overall Study|Death|1|||
131837805|NCT00658658|474691143|FG000|Overall Study|Disease Progression|0|||
131837806|NCT00658658|474691144|FG001|Overall Study|Disease Progression|1|||
131837807|NCT00658658|474691145|FG002|Overall Study|Disease Progression|0|||
131837808|NCT00658658|474691146|FG003|Overall Study|Disease Progression|1|||
131837809|NCT00658658|474691147|FG004|Overall Study|Disease Progression|3|||
131837810|NCT00658658|474691143|FG000|Overall Study|Protocol-specified Criteria|1|||
131837811|NCT00658658|474691144|FG001|Overall Study|Protocol-specified Criteria|0|||
131837812|NCT00658658|474691145|FG002|Overall Study|Protocol-specified Criteria|0|||
131837813|NCT00658658|474691146|FG003|Overall Study|Protocol-specified Criteria|0|||
131837814|NCT00658658|474691147|FG004|Overall Study|Protocol-specified Criteria|0|||
131837815|NCT00658658|474691143|FG000|Overall Study|Other|0|||
131837816|NCT00658658|474691144|FG001|Overall Study|Other|0|||
131837817|NCT00658658|474691145|FG002|Overall Study|Other|0|||
131837818|NCT00658658|474691146|FG003|Overall Study|Other|0|||
131837819|NCT00658658|474691147|FG004|Overall Study|Other|1|||
131837820|NCT00678041|474691150|FG000|Overall Study|Physician Decision|5|||
131837821|NCT00678041|474691151|FG001|Overall Study|Physician Decision|5|||
131837822|NCT02358343|474691152|FG000|Screening Intervention|Death|0|||
131837823|NCT02358343|474691153|FG001|Screening Intervention|Death|2|||
131837824|NCT02358343|474691154|FG002|Screening Intervention|Death|0|||
131837825|NCT02358343|474691155|FG003|Screening Intervention|Death|0|||
131837826|NCT02358343|474691156|FG004|Screening Intervention|Death|0|||
131837827|NCT02358343|474691152|FG000|Screening Intervention|Withdrawal by Subject|1|||
131837828|NCT02358343|474691153|FG001|Screening Intervention|Withdrawal by Subject|0|||
131837829|NCT02358343|474691154|FG002|Screening Intervention|Withdrawal by Subject|0|||
131837830|NCT02358343|474691155|FG003|Screening Intervention|Withdrawal by Subject|0|||
131837831|NCT02358343|474691156|FG004|Screening Intervention|Withdrawal by Subject|0|||
131837832|NCT02358343|474691152|FG000|Screening Intervention|Determined Ineligible|5|||
131837833|NCT02358343|474691153|FG001|Screening Intervention|Determined Ineligible|6|||
131837834|NCT02358343|474691154|FG002|Screening Intervention|Determined Ineligible|0|||
131837835|NCT02358343|474691155|FG003|Screening Intervention|Determined Ineligible|0|||
131837836|NCT02358343|474691156|FG004|Screening Intervention|Determined Ineligible|0|||
131837837|NCT02358343|474691152|FG000|Comparative Efficacy Trial / Observation|Death|0|||
131837838|NCT02358343|474691153|FG001|Comparative Efficacy Trial / Observation|Death|0|||
131837839|NCT02358343|474691154|FG002|Comparative Efficacy Trial / Observation|Death|2|||
131402401|NCT01892436|473095447|FG003|Overall Study|Technical problems|1|||
131402402|NCT01892436|473095444|FG000|Overall Study|Lack of Efficacy|1|||
131402403|NCT01892436|473095445|FG001|Overall Study|Lack of Efficacy|2|||
131402404|NCT01892436|473095446|FG002|Overall Study|Lack of Efficacy|2|||
131402405|NCT01892436|473095447|FG003|Overall Study|Lack of Efficacy|2|||
131402406|NCT01892436|473095444|FG000|Overall Study|Lost to Follow-up|1|||
131837840|NCT02358343|474691155|FG003|Comparative Efficacy Trial / Observation|Death|0|||
131837841|NCT02358343|474691156|FG004|Comparative Efficacy Trial / Observation|Death|0|||
131402407|NCT01892436|473095445|FG001|Overall Study|Lost to Follow-up|1|||
131402408|NCT01892436|473095446|FG002|Overall Study|Lost to Follow-up|1|||
131402409|NCT01892436|473095447|FG003|Overall Study|Lost to Follow-up|3|||
131402410|NCT01892436|473095444|FG000|Overall Study|non-compliance with treatment|1|||
131837842|NCT02358343|474691152|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
131837843|NCT02358343|474691153|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
131837844|NCT02358343|474691154|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
131837845|NCT02358343|474691155|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
131837846|NCT02358343|474691156|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
131837847|NCT02358343|474691152|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
131402411|NCT01892436|473095445|FG001|Overall Study|non-compliance with treatment|0|||
131837848|NCT02358343|474691153|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
131837849|NCT02358343|474691154|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
131837850|NCT02358343|474691155|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
131837851|NCT02358343|474691156|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
131910769|NCT00471497|474960836|FG001|Extension Phase|Disease progression|0|||
131837852|NCT00090610|474691159|FG000|Overall Study|Withdrawal by Subject|1|||
131837853|NCT00090610|474691160|FG001|Overall Study|Withdrawal by Subject|1|||
131837854|NCT00807248|474691161|FG000|Overall Study|Adverse Event|1|||
131837855|NCT00807248|474691162|FG001|Overall Study|Adverse Event|2|||
131402412|NCT01892436|473095446|FG002|Overall Study|non-compliance with treatment|0|||
131402413|NCT01892436|473095447|FG003|Overall Study|non-compliance with treatment|0|||
131837856|NCT00807248|474691163|FG002|Overall Study|Adverse Event|2|||
131837857|NCT00807248|474691164|FG003|Overall Study|Adverse Event|6|||
131837858|NCT00807248|474691161|FG000|Overall Study|Lack of Efficacy|14|||
131837859|NCT00807248|474691162|FG001|Overall Study|Lack of Efficacy|4|||
131837860|NCT00807248|474691163|FG002|Overall Study|Lack of Efficacy|8|||
131837861|NCT00807248|474691164|FG003|Overall Study|Lack of Efficacy|3|||
131837862|NCT00807248|474691161|FG000|Overall Study|Protocol Violation|0|||
131837863|NCT00807248|474691162|FG001|Overall Study|Protocol Violation|1|||
131837864|NCT00807248|474691163|FG002|Overall Study|Protocol Violation|1|||
131837865|NCT00807248|474691164|FG003|Overall Study|Protocol Violation|0|||
131837866|NCT00807248|474691161|FG000|Overall Study|Withdrawal of Consent|5|||
131837867|NCT00807248|474691162|FG001|Overall Study|Withdrawal of Consent|5|||
131837868|NCT00807248|474691163|FG002|Overall Study|Withdrawal of Consent|5|||
131837869|NCT00807248|474691164|FG003|Overall Study|Withdrawal of Consent|5|||
131837870|NCT00807248|474691161|FG000|Overall Study|Lost to Follow-up|1|||
131837871|NCT00807248|474691162|FG001|Overall Study|Lost to Follow-up|0|||
131837872|NCT00807248|474691163|FG002|Overall Study|Lost to Follow-up|0|||
131837873|NCT00807248|474691164|FG003|Overall Study|Lost to Follow-up|0|||
131837874|NCT00807248|474691161|FG000|Overall Study|Other Reason|0|||
131837875|NCT00807248|474691162|FG001|Overall Study|Other Reason|0|||
131837876|NCT00807248|474691163|FG002|Overall Study|Other Reason|2|||
131837877|NCT00807248|474691164|FG003|Overall Study|Other Reason|0|||
131837878|NCT02444793|474691165|FG000|Overall Study|Lost to Follow-up|2|||
131837879|NCT02444793|474691166|FG001|Overall Study|Lost to Follow-up|2|||
131837880|NCT02444793|474691167|FG002|Overall Study|Lost to Follow-up|0|||
131837881|NCT02444793|474691168|FG003|Overall Study|Lost to Follow-up|0|||
131837882|NCT02444793|474691165|FG000|Overall Study|Death|0|||
131837883|NCT02444793|474691166|FG001|Overall Study|Death|3|||
131837884|NCT02444793|474691167|FG002|Overall Study|Death|0|||
131837885|NCT02444793|474691168|FG003|Overall Study|Death|0|||
131837886|NCT02444793|474691165|FG000|Overall Study|Other|0|||
131837887|NCT02444793|474691166|FG001|Overall Study|Other|0|||
131837888|NCT02444793|474691167|FG002|Overall Study|Other|2|||
131837889|NCT02444793|474691168|FG003|Overall Study|Other|0|||
131837890|NCT02444793|474691165|FG000|Overall Study|Objective progression or relapse|9|||
131837891|NCT02444793|474691166|FG001|Overall Study|Objective progression or relapse|1|||
131837892|NCT02444793|474691167|FG002|Overall Study|Objective progression or relapse|2|||
131837893|NCT02444793|474691168|FG003|Overall Study|Objective progression or relapse|3|||
131837894|NCT02504671|474691170|FG000|Overall Study|Withdrawal by Subject|1|||
131837895|NCT02504671|474691171|FG001|Overall Study|Withdrawal by Subject|5|||
131837896|NCT02504671|474691172|FG002|Overall Study|Withdrawal by Subject|4|||
131837897|NCT02504671|474691173|FG003|Overall Study|Withdrawal by Subject|4|||
131837898|NCT02504671|474691174|FG004|Overall Study|Withdrawal by Subject|5|||
131837899|NCT02504671|474691175|FG005|Overall Study|Withdrawal by Subject|3|||
131837900|NCT02504671|474691170|FG000|Overall Study|Lack of Efficacy|1|||
131837901|NCT02504671|474691171|FG001|Overall Study|Lack of Efficacy|3|||
131837902|NCT02504671|474691172|FG002|Overall Study|Lack of Efficacy|1|||
131837903|NCT02504671|474691173|FG003|Overall Study|Lack of Efficacy|0|||
131837904|NCT02504671|474691174|FG004|Overall Study|Lack of Efficacy|4|||
131837905|NCT02504671|474691175|FG005|Overall Study|Lack of Efficacy|4|||
131837906|NCT02504671|474691170|FG000|Overall Study|Adverse Event|1|||
131837907|NCT02504671|474691171|FG001|Overall Study|Adverse Event|1|||
131837908|NCT02504671|474691172|FG002|Overall Study|Adverse Event|0|||
131837909|NCT02504671|474691173|FG003|Overall Study|Adverse Event|1|||
131837910|NCT02504671|474691174|FG004|Overall Study|Adverse Event|0|||
131837911|NCT02504671|474691175|FG005|Overall Study|Adverse Event|2|||
131837912|NCT02504671|474691170|FG000|Overall Study|Protocol Violation|2|||
131837913|NCT02504671|474691171|FG001|Overall Study|Protocol Violation|1|||
131837914|NCT02504671|474691172|FG002|Overall Study|Protocol Violation|0|||
131837915|NCT02504671|474691173|FG003|Overall Study|Protocol Violation|0|||
131837916|NCT02504671|474691174|FG004|Overall Study|Protocol Violation|0|||
131837917|NCT02504671|474691175|FG005|Overall Study|Protocol Violation|1|||
131837918|NCT02504671|474691170|FG000|Overall Study|Lost to Follow-up|0|||
131837919|NCT02504671|474691171|FG001|Overall Study|Lost to Follow-up|0|||
131837920|NCT02504671|474691172|FG002|Overall Study|Lost to Follow-up|2|||
131837921|NCT02504671|474691173|FG003|Overall Study|Lost to Follow-up|0|||
131837922|NCT02504671|474691174|FG004|Overall Study|Lost to Follow-up|0|||
131837923|NCT02504671|474691175|FG005|Overall Study|Lost to Follow-up|1|||
131450162|NCT04032093|473276805|FG000|Overall Study|Other|1|||
131837924|NCT02504671|474691170|FG000|Overall Study|Protocol defined stopping criteria|7|||
131837925|NCT02504671|474691171|FG001|Overall Study|Protocol defined stopping criteria|4|||
131837926|NCT02504671|474691172|FG002|Overall Study|Protocol defined stopping criteria|3|||
131837927|NCT02504671|474691173|FG003|Overall Study|Protocol defined stopping criteria|5|||
131837928|NCT02504671|474691174|FG004|Overall Study|Protocol defined stopping criteria|3|||
131837929|NCT02504671|474691175|FG005|Overall Study|Protocol defined stopping criteria|3|||
131837930|NCT00210249|474691176|FG000|Overall Study|Lost to Follow-up|5|||
131837931|NCT00210249|474691176|FG000|Overall Study|Protocol Violation|11|||
131837932|NCT02518919|474691177|FG000|Overall Study|Protocol Violation|1|||
131837933|NCT02518919|474691178|FG001|Overall Study|Protocol Violation|1|||
131837934|NCT02518919|474691179|FG002|Overall Study|Protocol Violation|2|||
131837935|NCT00599521|474691180|FG000|Overall Study|Lack of Efficacy|4|||
131837936|NCT00599521|474691181|FG001|Overall Study|Lack of Efficacy|8|||
131837937|NCT00599521|474691180|FG000|Overall Study|Adverse Event|4|||
131837938|NCT00599521|474691181|FG001|Overall Study|Adverse Event|1|||
131837939|NCT00599521|474691180|FG000|Overall Study|Withdrawal by Subject|28|||
131837940|NCT00599521|474691181|FG001|Overall Study|Withdrawal by Subject|34|||
131837941|NCT00599521|474691180|FG000|Overall Study|Protocol Violation|1|||
131837942|NCT00599521|474691181|FG001|Overall Study|Protocol Violation|1|||
131837943|NCT00599521|474691180|FG000|Overall Study|Lost to Follow-up|23|||
131837944|NCT00599521|474691181|FG001|Overall Study|Lost to Follow-up|23|||
131837945|NCT00599521|474691180|FG000|Overall Study|Pregnancy|0|||
131837946|NCT00599521|474691181|FG001|Overall Study|Pregnancy|2|||
131837947|NCT04498403|474691182|FG000|Overall Study|Adverse Event|1|||
131837948|NCT04498403|474691183|FG001|Overall Study|Adverse Event|0|||
131837949|NCT04498403|474691182|FG000|Overall Study|Study Terminated By Sponsor|29|||
131837950|NCT04498403|474691183|FG001|Overall Study|Study Terminated By Sponsor|10|||
131837951|NCT00577395|474691184|FG000|Overall Study|Study was terminated early by Sponsor|7|||
131837952|NCT00577395|474691185|FG001|Overall Study|Study was terminated early by Sponsor|6|||
131837953|NCT01206101|474691188|FG000|Overall Study|Adverse Event|1|||
131837954|NCT01206101|474691189|FG001|Overall Study|Adverse Event|0|||
131837955|NCT01206101|474691188|FG000|Overall Study|Physician Decision|0|||
131837956|NCT01206101|474691189|FG001|Overall Study|Physician Decision|1|||
131837957|NCT01206101|474691188|FG000|Overall Study|Unclassified|1|||
131837958|NCT01206101|474691189|FG001|Overall Study|Unclassified|0|||
131837959|NCT04709835|474691192|FG000|Overall Study|Withdrawal by Subject|0|||
131837960|NCT04709835|474691193|FG001|Overall Study|Withdrawal by Subject|1|||
131837961|NCT04709835|474691194|FG002|Overall Study|Withdrawal by Subject|0|||
131837962|NCT04325204|474691195|FG000|Overall Study|Death|0|||
131837963|NCT04325204|474691196|FG001|Overall Study|Death|1|||
131837964|NCT04325204|474691195|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
131837965|NCT04325204|474691196|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
131837966|NCT04325204|474691195|FG000|Overall Study|Lost to Follow-up|8|||
131837967|NCT04325204|474691196|FG001|Overall Study|Lost to Follow-up|8|||
131837968|NCT04325204|474691195|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
131837969|NCT04325204|474691196|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
131837970|NCT04710979|474691198|FG000|Overall Study|Lost to Follow-up|2|||
131837971|NCT04710979|474691199|FG001|Overall Study|Lost to Follow-up|4|||
131837972|NCT04710979|474691198|FG000|Overall Study|Withdrawal by Subject|1|||
131837973|NCT04710979|474691199|FG001|Overall Study|Withdrawal by Subject|0|||
131837974|NCT01462318|474691205|FG000|Main Study / TP-DI Study|Other|2|||
131837975|NCT01462318|474691206|FG001|Main Study / TP-DI Study|Other|0|||
131837976|NCT01462318|474691207|FG002|Main Study / TP-DI Study|Other|0|||
131837977|NCT01462318|474691205|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
131837978|NCT01462318|474691206|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
131837979|NCT01462318|474691207|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
131837980|NCT01462318|474691205|FG000|Main Study / TP-DI Study|Adverse Event|4|||
131837981|NCT01462318|474691206|FG001|Main Study / TP-DI Study|Adverse Event|0|||
131837982|NCT01462318|474691207|FG002|Main Study / TP-DI Study|Adverse Event|0|||
131837983|NCT01462318|474691205|FG000|Extension Phase|Lost to Follow-up|0|||
131837984|NCT01462318|474691206|FG001|Extension Phase|Lost to Follow-up|0|||
131837985|NCT01462318|474691207|FG002|Extension Phase|Lost to Follow-up|1|||
131837986|NCT01462318|474691205|FG000|Extension Phase|Other|0|||
131837987|NCT01462318|474691206|FG001|Extension Phase|Other|0|||
131837988|NCT01462318|474691207|FG002|Extension Phase|Other|1|||
131837989|NCT01462318|474691205|FG000|Extension Phase|Disease Progression|0|||
131837990|NCT01462318|474691206|FG001|Extension Phase|Disease Progression|0|||
131837991|NCT01462318|474691207|FG002|Extension Phase|Disease Progression|1|||
131837992|NCT01462318|474691205|FG000|Extension Phase|Withdrawal by Subject|0|||
131837993|NCT01462318|474691206|FG001|Extension Phase|Withdrawal by Subject|0|||
131837994|NCT01462318|474691207|FG002|Extension Phase|Withdrawal by Subject|15|||
131837995|NCT01462318|474691205|FG000|Extension Phase|Investigator Decision|0|||
131837996|NCT01462318|474691206|FG001|Extension Phase|Investigator Decision|0|||
131837997|NCT01462318|474691207|FG002|Extension Phase|Investigator Decision|5|||
131837998|NCT01462318|474691205|FG000|Extension Phase|Adverse Event|0|||
131837999|NCT01462318|474691206|FG001|Extension Phase|Adverse Event|0|||
131838000|NCT01462318|474691207|FG002|Extension Phase|Adverse Event|22|||
131838001|NCT00667810|474691208|FG000|Overall Study|Adverse Event|13|||
131838002|NCT00667810|474691209|FG001|Overall Study|Adverse Event|14|||
131838003|NCT00667810|474691210|FG002|Overall Study|Adverse Event|19|||
131838004|NCT00667810|474691211|FG003|Overall Study|Adverse Event|1|||
131838005|NCT00667810|474691208|FG000|Overall Study|Death|1|||
131838006|NCT00667810|474691209|FG001|Overall Study|Death|1|||
131838007|NCT00667810|474691210|FG002|Overall Study|Death|3|||
131838008|NCT00667810|474691211|FG003|Overall Study|Death|0|||
131838009|NCT00667810|474691208|FG000|Overall Study|Lack of Efficacy|1|||
131838010|NCT00667810|474691209|FG001|Overall Study|Lack of Efficacy|0|||
131838011|NCT00667810|474691210|FG002|Overall Study|Lack of Efficacy|2|||
131838012|NCT00667810|474691211|FG003|Overall Study|Lack of Efficacy|0|||
131838013|NCT00667810|474691208|FG000|Overall Study|Lost to Follow-up|1|||
131838014|NCT00667810|474691209|FG001|Overall Study|Lost to Follow-up|4|||
131838015|NCT00667810|474691210|FG002|Overall Study|Lost to Follow-up|2|||
131838016|NCT00667810|474691211|FG003|Overall Study|Lost to Follow-up|0|||
131838017|NCT00667810|474691208|FG000|Overall Study|Physician Decision|1|||
131838018|NCT00667810|474691209|FG001|Overall Study|Physician Decision|1|||
131838019|NCT00667810|474691210|FG002|Overall Study|Physician Decision|2|||
131838020|NCT00667810|474691211|FG003|Overall Study|Physician Decision|0|||
131838021|NCT00667810|474691208|FG000|Overall Study|Protocol Violation|0|||
131838022|NCT00667810|474691209|FG001|Overall Study|Protocol Violation|2|||
131838023|NCT00667810|474691210|FG002|Overall Study|Protocol Violation|0|||
131838024|NCT00667810|474691211|FG003|Overall Study|Protocol Violation|0|||
131838025|NCT00667810|474691208|FG000|Overall Study|Withdrawal by Subject|14|||
131838026|NCT00667810|474691209|FG001|Overall Study|Withdrawal by Subject|20|||
131838027|NCT00667810|474691210|FG002|Overall Study|Withdrawal by Subject|29|||
131838028|NCT00667810|474691211|FG003|Overall Study|Withdrawal by Subject|1|||
131838029|NCT00667810|474691208|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
131838030|NCT00667810|474691209|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
131838031|NCT00667810|474691210|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
131838032|NCT00667810|474691211|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
131838033|NCT00667810|474691208|FG000|Overall Study|Failed to Return|0|||
131838034|NCT00667810|474691209|FG001|Overall Study|Failed to Return|0|||
131838035|NCT00667810|474691210|FG002|Overall Study|Failed to Return|2|||
131838036|NCT00667810|474691211|FG003|Overall Study|Failed to Return|0|||
131838037|NCT00667810|474691208|FG000|Overall Study|Loss of Caregiver|0|||
131838038|NCT00667810|474691209|FG001|Overall Study|Loss of Caregiver|1|||
131838039|NCT00667810|474691210|FG002|Overall Study|Loss of Caregiver|3|||
131838040|NCT00667810|474691211|FG003|Overall Study|Loss of Caregiver|0|||
131838041|NCT00667810|474691208|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
131838042|NCT00667810|474691209|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
131838043|NCT00667810|474691210|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
131838044|NCT00667810|474691211|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
131838045|NCT00667810|474691208|FG000|Overall Study|Other|6|||
131838046|NCT00667810|474691209|FG001|Overall Study|Other|6|||
131838047|NCT00667810|474691210|FG002|Overall Study|Other|5|||
131838048|NCT00667810|474691211|FG003|Overall Study|Other|0|||
131838049|NCT04442490|474691218|FG000|Overall Study|Withdrawal by Subject|18|||
131838050|NCT04442490|474691219|FG001|Overall Study|Withdrawal by Subject|10|||
131838051|NCT04442490|474691218|FG000|Overall Study|Lost to Follow-up|7|||
131838052|NCT04442490|474691219|FG001|Overall Study|Lost to Follow-up|7|||
131838053|NCT04442490|474691218|FG000|Overall Study|Adverse Event|2|||
131838054|NCT04442490|474691219|FG001|Overall Study|Adverse Event|6|||
131838055|NCT04442490|474691218|FG000|Overall Study|Noncompliance|3|||
131838056|NCT04442490|474691219|FG001|Overall Study|Noncompliance|1|||
131838057|NCT04442490|474691218|FG000|Overall Study|Physician Decision|2|||
131838058|NCT04442490|474691219|FG001|Overall Study|Physician Decision|1|||
131838059|NCT04442490|474691218|FG000|Overall Study|Reason not Specified|2|||
131838060|NCT04442490|474691219|FG001|Overall Study|Reason not Specified|1|||
131838061|NCT04442490|474691218|FG000|Overall Study|Randomized but not Treated|3|||
131838062|NCT04442490|474691219|FG001|Overall Study|Randomized but not Treated|3|||
131838063|NCT02227147|474691220|FG000|Controlled Treatment Period|Adverse Event|4|||
131838064|NCT02227147|474691221|FG001|Controlled Treatment Period|Adverse Event|3|||
131838065|NCT02227147|474691220|FG000|Controlled Treatment Period|Other|2|||
131838066|NCT02227147|474691221|FG001|Controlled Treatment Period|Other|0|||
131838067|NCT02227147|474691220|FG000|Follow-up Period|Other|3|||
131838068|NCT02227147|474691221|FG001|Follow-up Period|Other|5|||
131838069|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
131838070|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
131838071|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
131838072|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
131838073|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
131838074|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
131838075|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
131838076|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
131838077|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
131838078|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
131838079|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
131838080|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
131838081|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
131838082|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
131838083|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
131838084|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
131838085|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
131838086|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
131402414|NCT01892436|473095444|FG000|Overall Study|Adverse Event|7|||
131402415|NCT01892436|473095445|FG001|Overall Study|Adverse Event|6|||
131838087|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
131838088|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
131838089|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
131838090|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
131838091|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
131838092|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
131838093|NCT03514641|474691222|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
131838094|NCT03514641|474691223|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
131838095|NCT03514641|474691224|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
131838096|NCT03514641|474691225|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
131838097|NCT03514641|474691222|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
131838098|NCT03514641|474691223|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
131838099|NCT03514641|474691224|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
131838100|NCT03514641|474691225|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
131838101|NCT03514641|474691222|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
131838102|NCT03514641|474691223|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
131838103|NCT03514641|474691224|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
131838104|NCT03514641|474691225|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
131838105|NCT03514641|474691222|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
131838106|NCT03514641|474691223|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
131838107|NCT03514641|474691224|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
131838108|NCT03514641|474691225|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
131838109|NCT03514641|474691222|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
131838110|NCT03514641|474691223|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
131838111|NCT03514641|474691224|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
131838112|NCT03514641|474691225|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
131838113|NCT03514641|474691222|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
131838114|NCT03514641|474691223|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
131838115|NCT03514641|474691224|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
131838116|NCT03514641|474691225|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
131838117|NCT01449279|474691226|FG000|Overall Study|Lack of Efficacy|5|||
131838118|NCT01449279|474691226|FG000|Overall Study|Toxicity|2|||
131838119|NCT00505375|474691227|FG000|Overall Study|Death|1|||
131838120|NCT00505375|474691228|FG001|Overall Study|Death|0|||
131838121|NCT00505375|474691227|FG000|Overall Study|Withdrawal by Subject|2|||
131838122|NCT00505375|474691228|FG001|Overall Study|Withdrawal by Subject|2|||
131838123|NCT00505375|474691227|FG000|Overall Study|Lost to Follow-up|0|||
131838124|NCT00505375|474691228|FG001|Overall Study|Lost to Follow-up|2|||
131838125|NCT00505375|474691227|FG000|Overall Study|Pregnancy|1|||
131838126|NCT00505375|474691228|FG001|Overall Study|Pregnancy|0|||
131838127|NCT00505375|474691227|FG000|Overall Study|Travel issues|0|||
131838128|NCT00505375|474691228|FG001|Overall Study|Travel issues|1|||
131838129|NCT01561430|474691231|FG000|Overall Study|Adverse Event|0|||
131838130|NCT01561430|474691232|FG001|Overall Study|Adverse Event|0|||
131838131|NCT01561430|474691233|FG002|Overall Study|Adverse Event|3|||
131838132|NCT01561430|474691234|FG003|Overall Study|Adverse Event|1|||
131838133|NCT01561430|474691231|FG000|Overall Study|Withdrawal by Subject|0|||
131838134|NCT01561430|474691232|FG001|Overall Study|Withdrawal by Subject|0|||
131838135|NCT01561430|474691233|FG002|Overall Study|Withdrawal by Subject|1|||
131838136|NCT01561430|474691234|FG003|Overall Study|Withdrawal by Subject|0|||
131838137|NCT01561430|474691231|FG000|Overall Study|Physician Decision|0|||
131838138|NCT01561430|474691232|FG001|Overall Study|Physician Decision|1|||
131838139|NCT01561430|474691233|FG002|Overall Study|Physician Decision|0|||
131838140|NCT01561430|474691234|FG003|Overall Study|Physician Decision|0|||
131838141|NCT01561430|474691231|FG000|Overall Study|Sponsor Decision|1|||
131838142|NCT01561430|474691232|FG001|Overall Study|Sponsor Decision|14|||
131838143|NCT01561430|474691233|FG002|Overall Study|Sponsor Decision|13|||
131838144|NCT01561430|474691234|FG003|Overall Study|Sponsor Decision|12|||
131838145|NCT03709823|474691235|FG000|Overall Study|Adverse Event|0|||
131838146|NCT03709823|474691236|FG001|Overall Study|Adverse Event|0|||
131838147|NCT03709823|474691237|FG002|Overall Study|Adverse Event|1|||
131838148|NCT03709823|474691238|FG003|Overall Study|Adverse Event|0|||
131838149|NCT03709823|474691239|FG004|Overall Study|Adverse Event|0|||
131838150|NCT03709823|474691240|FG005|Overall Study|Adverse Event|0|||
131838151|NCT03709823|474691235|FG000|Overall Study|Lost to Follow-up|2|||
131838152|NCT03709823|474691236|FG001|Overall Study|Lost to Follow-up|2|||
131838153|NCT03709823|474691237|FG002|Overall Study|Lost to Follow-up|2|||
131838154|NCT03709823|474691238|FG003|Overall Study|Lost to Follow-up|1|||
131838155|NCT03709823|474691239|FG004|Overall Study|Lost to Follow-up|1|||
131838156|NCT03709823|474691240|FG005|Overall Study|Lost to Follow-up|0|||
131838157|NCT03709823|474691235|FG000|Overall Study|Withdrawal by Subject|1|||
131838158|NCT03709823|474691236|FG001|Overall Study|Withdrawal by Subject|3|||
131838159|NCT03709823|474691237|FG002|Overall Study|Withdrawal by Subject|0|||
131910770|NCT00471497|474960837|FG002|Extension Phase|Disease progression|0|||
131910771|NCT00471497|474960835|FG000|Extension Phase|Protocol Violation|2|||
131838160|NCT03709823|474691238|FG003|Overall Study|Withdrawal by Subject|0|||
131838161|NCT03709823|474691239|FG004|Overall Study|Withdrawal by Subject|0|||
131838162|NCT03709823|474691240|FG005|Overall Study|Withdrawal by Subject|0|||
131838163|NCT03709823|474691235|FG000|Overall Study|Other, Not Specified|0|||
131838164|NCT03709823|474691236|FG001|Overall Study|Other, Not Specified|0|||
131838165|NCT03709823|474691237|FG002|Overall Study|Other, Not Specified|0|||
131838166|NCT03709823|474691238|FG003|Overall Study|Other, Not Specified|1|||
131838167|NCT03709823|474691239|FG004|Overall Study|Other, Not Specified|0|||
131838168|NCT03709823|474691240|FG005|Overall Study|Other, Not Specified|0|||
131838169|NCT04234984|474691241|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
131838170|NCT04234984|474691241|FG000|Follow-up at the Second Time Point|Death|1|||
131838171|NCT04234984|474691241|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
131838172|NCT01055132|474691242|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
131838173|NCT01055132|474691243|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
131838174|NCT01055132|474691242|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
131838175|NCT01055132|474691243|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
131838176|NCT02038907|474691244|FG000|Overall Study|Protocol Violation|0|||
131838177|NCT02038907|474691245|FG001|Overall Study|Protocol Violation|0|||
131838178|NCT02038907|474691246|FG002|Overall Study|Protocol Violation|0|||
131838179|NCT02038907|474691247|FG003|Overall Study|Protocol Violation|0|||
131838180|NCT02038907|474691248|FG004|Overall Study|Protocol Violation|0|||
131838181|NCT02038907|474691249|FG005|Overall Study|Protocol Violation|0|||
131838182|NCT02038907|474691250|FG006|Overall Study|Protocol Violation|0|||
131838183|NCT02038907|474691251|FG007|Overall Study|Protocol Violation|0|||
131838184|NCT02038907|474691252|FG008|Overall Study|Protocol Violation|0|||
131838185|NCT02038907|474691253|FG009|Overall Study|Protocol Violation|0|||
131838186|NCT02038907|474691254|FG010|Overall Study|Protocol Violation|1|||
131838187|NCT02038907|474691255|FG011|Overall Study|Protocol Violation|0|||
131838188|NCT02038907|474691256|FG012|Overall Study|Protocol Violation|0|||
131838189|NCT02038907|474691257|FG013|Overall Study|Protocol Violation|0|||
131838190|NCT02038907|474691244|FG000|Overall Study|Withdrawal by Subject|0|||
131838191|NCT02038907|474691245|FG001|Overall Study|Withdrawal by Subject|0|||
131838192|NCT02038907|474691246|FG002|Overall Study|Withdrawal by Subject|0|||
131838193|NCT02038907|474691247|FG003|Overall Study|Withdrawal by Subject|0|||
131838194|NCT02038907|474691248|FG004|Overall Study|Withdrawal by Subject|0|||
131838195|NCT02038907|474691249|FG005|Overall Study|Withdrawal by Subject|0|||
131838196|NCT02038907|474691250|FG006|Overall Study|Withdrawal by Subject|0|||
131838197|NCT02038907|474691251|FG007|Overall Study|Withdrawal by Subject|0|||
131838198|NCT02038907|474691252|FG008|Overall Study|Withdrawal by Subject|0|||
131838199|NCT02038907|474691253|FG009|Overall Study|Withdrawal by Subject|0|||
131838200|NCT02038907|474691254|FG010|Overall Study|Withdrawal by Subject|1|||
131838201|NCT02038907|474691255|FG011|Overall Study|Withdrawal by Subject|0|||
131838202|NCT02038907|474691256|FG012|Overall Study|Withdrawal by Subject|0|||
131838203|NCT02038907|474691257|FG013|Overall Study|Withdrawal by Subject|0|||
131838204|NCT02746471|474691258|FG000|Overall Study|Death|43|||
131838205|NCT02746471|474691258|FG000|Overall Study|Exited before 36 months|1119|||
131838206|NCT04594707|474691259|FG000|Overall Study|Adverse Event|0|||
131838207|NCT04594707|474691260|FG001|Overall Study|Adverse Event|0|||
131838208|NCT04594707|474691261|FG002|Overall Study|Adverse Event|1|||
131838209|NCT04594707|474691259|FG000|Overall Study|Death|0|||
131838210|NCT04594707|474691260|FG001|Overall Study|Death|2|||
131838211|NCT04594707|474691261|FG002|Overall Study|Death|2|||
131838212|NCT04594707|474691259|FG000|Overall Study|Lung Transplant|0|||
131838213|NCT04594707|474691260|FG001|Overall Study|Lung Transplant|0|||
131838214|NCT04594707|474691261|FG002|Overall Study|Lung Transplant|1|||
131838215|NCT04594707|474691259|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
131838216|NCT04594707|474691260|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
131838217|NCT04594707|474691261|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
131838218|NCT04594707|474691259|FG000|Overall Study|Study Terminated By Sponsor|19|||
131838219|NCT04594707|474691260|FG001|Overall Study|Study Terminated By Sponsor|47|||
131838220|NCT04594707|474691261|FG002|Overall Study|Study Terminated By Sponsor|41|||
131838221|NCT04594707|474691259|FG000|Overall Study|Withdrawal by Subject|1|||
131838222|NCT04594707|474691260|FG001|Overall Study|Withdrawal by Subject|0|||
131838223|NCT04594707|474691261|FG002|Overall Study|Withdrawal by Subject|2|||
131838224|NCT01593696|474691265|FG000|Dose Escalation|Progressive Disease|2|||
131838225|NCT01593696|474691266|FG001|Dose Escalation|Progressive Disease|0|||
131838226|NCT01593696|474691267|FG002|Dose Escalation|Progressive Disease|0|||
131838227|NCT01593696|474691268|FG003|Dose Escalation|Progressive Disease|0|||
131838228|NCT01593696|474691265|FG000|Dose Expansion|Fungal infection|0|||
131838229|NCT01593696|474691266|FG001|Dose Expansion|Fungal infection|0|||
131838230|NCT01593696|474691267|FG002|Dose Expansion|Fungal infection|1|||
131838231|NCT01593696|474691268|FG003|Dose Expansion|Fungal infection|0|||
131910772|NCT00471497|474960836|FG001|Extension Phase|Protocol Violation|2|||
131402416|NCT01892436|473095446|FG002|Overall Study|Adverse Event|2|||
131402417|NCT01892436|473095447|FG003|Overall Study|Adverse Event|3|||
131402418|NCT00733291|473095458|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
131402419|NCT00733291|473095459|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
131402420|NCT00733291|473095460|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
131402421|NCT00733291|473095461|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
131402422|NCT02242435|473095462|FG000|Overall Study|Lost to Follow-up|3|||
131402423|NCT02242435|473095463|FG001|Overall Study|Lost to Follow-up|4|||
131402424|NCT02242435|473095462|FG000|Overall Study|Adverse Event|3|||
131838232|NCT01936623|474691271|FG000|Overall Study|Lost to Follow-up|0|||
131838233|NCT01936623|474691272|FG001|Overall Study|Lost to Follow-up|5|||
131838234|NCT03579966|474691273|FG000|Overall Study|Adverse Event|6|||
131838235|NCT03579966|474691273|FG000|Overall Study|Lost to Follow-up|4|||
131838236|NCT03579966|474691273|FG000|Overall Study|Physician Decision|10|||
131838237|NCT03579966|474691273|FG000|Overall Study|Pregnancy|1|||
131838238|NCT03579966|474691273|FG000|Overall Study|Withdrawal by Subject|16|||
131838239|NCT03579966|474691273|FG000|Overall Study|Study terminated by Sponsor|22|||
131838240|NCT03579966|474691273|FG000|Overall Study|Protocol Violation|1|||
131838241|NCT01340768|474691276|FG000|Overall Study|Lost to Follow-up|10|||
131838242|NCT01340768|474691277|FG001|Overall Study|Lost to Follow-up|4|||
131838243|NCT01340768|474691276|FG000|Overall Study|Withdrawal by Subject|5|||
131838244|NCT01340768|474691277|FG001|Overall Study|Withdrawal by Subject|1|||
131838245|NCT01340768|474691276|FG000|Overall Study|Other|2|||
131838246|NCT01340768|474691277|FG001|Overall Study|Other|0|||
131838247|NCT03052959|474691280|FG000|Overall Study|Lost to Follow-up|4|||
131838248|NCT03052959|474691281|FG001|Overall Study|Lost to Follow-up|5|||
131838249|NCT00415194|474691282|FG000|Overall Study|Adverse Event|37|||
131838250|NCT00415194|474691283|FG001|Overall Study|Adverse Event|32|||
131838251|NCT00415194|474691282|FG000|Overall Study|Entry Criteria Not Met|4|||
131838252|NCT00415194|474691283|FG001|Overall Study|Entry Criteria Not Met|8|||
131838253|NCT00415194|474691282|FG000|Overall Study|Lost to Follow-up|1|||
131838254|NCT00415194|474691283|FG001|Overall Study|Lost to Follow-up|0|||
131838255|NCT00415194|474691282|FG000|Overall Study|Physician Decision|10|||
131838256|NCT00415194|474691283|FG001|Overall Study|Physician Decision|16|||
131838257|NCT00415194|474691282|FG000|Overall Study|Progressive Disease|180|||
131838258|NCT00415194|474691283|FG001|Overall Study|Progressive Disease|217|||
131838259|NCT00415194|474691282|FG000|Overall Study|Protocol Violation|4|||
131838260|NCT00415194|474691283|FG001|Overall Study|Protocol Violation|2|||
131838261|NCT00415194|474691282|FG000|Overall Study|Withdrawal by Subject|28|||
131838262|NCT00415194|474691283|FG001|Overall Study|Withdrawal by Subject|21|||
131838263|NCT00415194|474691282|FG000|Overall Study|Death Due to Study Disease|26|||
131838264|NCT00415194|474691283|FG001|Overall Study|Death Due to Study Disease|29|||
131838265|NCT00415194|474691282|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
131838266|NCT00415194|474691283|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
131838267|NCT00415194|474691282|FG000|Overall Study|Death Due to Procedural Related AE|0|||
131838268|NCT00415194|474691283|FG001|Overall Study|Death Due to Procedural Related AE|1|||
131838269|NCT00415194|474691282|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
131838270|NCT00415194|474691283|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
131838271|NCT01297465|474691284|FG000|Overall Study|Lack of Ovarian Response|1|||
131838272|NCT01297465|474691285|FG001|Overall Study|Lack of Ovarian Response|1|||
131838273|NCT01297465|474691284|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
131838274|NCT01297465|474691285|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131838275|NCT01297465|474691284|FG000|Overall Study|No Oocytes Retrieved|1|||
131838276|NCT01297465|474691285|FG001|Overall Study|No Oocytes Retrieved|1|||
131838277|NCT01297465|474691284|FG000|Overall Study|Poor oocyte quality|0|||
131838278|NCT01297465|474691285|FG001|Overall Study|Poor oocyte quality|1|||
131838279|NCT01297465|474691284|FG000|Overall Study|No Fertilization|6|||
131838280|NCT01297465|474691285|FG001|Overall Study|No Fertilization|4|||
131838281|NCT01297465|474691284|FG000|Overall Study|All Embryos Discarded|0|||
131838282|NCT01297465|474691285|FG001|Overall Study|All Embryos Discarded|1|||
131838283|NCT01297465|474691284|FG000|Overall Study|Intention to Freeze all Embryos|0|||
131838284|NCT01297465|474691285|FG001|Overall Study|Intention to Freeze all Embryos|1|||
131838285|NCT00369655|474691286|FG000|Overall Study|Refusal of further treatment|2|||
131838286|NCT04049617|474691287|FG000|Overall Study|Adverse Event|0|||
131838287|NCT04049617|474691288|FG001|Overall Study|Adverse Event|0|||
131838288|NCT04049617|474691289|FG002|Overall Study|Adverse Event|0|||
131838289|NCT04049617|474691290|FG003|Overall Study|Adverse Event|1|||
131838290|NCT04049617|474691291|FG004|Overall Study|Adverse Event|0|||
131910773|NCT00471497|474960837|FG002|Extension Phase|Protocol Violation|0|||
131910774|NCT00392223|474960838|FG000|Overall Study|Adverse Event|5|||
131838291|NCT04049617|474691292|FG005|Overall Study|Adverse Event|0|||
131838292|NCT04049617|474691287|FG000|Overall Study|Death|0|||
131838293|NCT04049617|474691288|FG001|Overall Study|Death|0|||
131402425|NCT02242435|473095463|FG001|Overall Study|Adverse Event|2|||
131838294|NCT04049617|474691289|FG002|Overall Study|Death|0|||
131838295|NCT04049617|474691290|FG003|Overall Study|Death|0|||
131910775|NCT00392223|474960839|FG001|Overall Study|Adverse Event|4|||
131838296|NCT04049617|474691291|FG004|Overall Study|Death|0|||
131838297|NCT04049617|474691292|FG005|Overall Study|Death|1|||
131838298|NCT04049617|474691287|FG000|Overall Study|Lost to Follow-up|0|||
131838299|NCT04049617|474691288|FG001|Overall Study|Lost to Follow-up|0|||
131838300|NCT04049617|474691289|FG002|Overall Study|Lost to Follow-up|0|||
131838301|NCT04049617|474691290|FG003|Overall Study|Lost to Follow-up|1|||
131838302|NCT04049617|474691291|FG004|Overall Study|Lost to Follow-up|0|||
131838303|NCT04049617|474691292|FG005|Overall Study|Lost to Follow-up|0|||
131838304|NCT04049617|474691287|FG000|Overall Study|Withdrew consent|0|||
131838305|NCT04049617|474691288|FG001|Overall Study|Withdrew consent|0|||
131838306|NCT04049617|474691289|FG002|Overall Study|Withdrew consent|1|||
131838307|NCT04049617|474691290|FG003|Overall Study|Withdrew consent|0|||
131838308|NCT04049617|474691291|FG004|Overall Study|Withdrew consent|0|||
131838309|NCT04049617|474691292|FG005|Overall Study|Withdrew consent|0|||
131838310|NCT03551496|474691293|FG000|Overall Study|Death|11|||
131838311|NCT03551496|474691294|FG001|Overall Study|Death|7|||
131838312|NCT03551496|474691293|FG000|Overall Study|Withdrawal by Subject|4|||
131838313|NCT03551496|474691294|FG001|Overall Study|Withdrawal by Subject|3|||
131838314|NCT03551496|474691293|FG000|Overall Study|Other Reasons|1|||
131838315|NCT03551496|474691294|FG001|Overall Study|Other Reasons|0|||
131838316|NCT00140426|474691295|FG000|Overall Study|Withdrawal by Subject|0|||
131838317|NCT00140426|474691296|FG001|Overall Study|Withdrawal by Subject|3|||
131838318|NCT02149108|474691297|FG000|Overall Study|Not treated|1|||
131838319|NCT02149108|474691298|FG001|Overall Study|Not treated|2|||
131838320|NCT02149108|474691297|FG000|Overall Study|Progressive Disease (PD)|324|||
131838321|NCT02149108|474691298|FG001|Overall Study|Progressive Disease (PD)|318|||
131838322|NCT02149108|474691297|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
131838323|NCT02149108|474691298|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
131838324|NCT02149108|474691297|FG000|Overall Study|Other Adverse Event (AE)|8|||
131838325|NCT02149108|474691298|FG001|Overall Study|Other Adverse Event (AE)|18|||
131838326|NCT02149108|474691297|FG000|Overall Study|Other not defined above|0|||
131838327|NCT02149108|474691298|FG001|Overall Study|Other not defined above|2|||
131838328|NCT02149108|474691297|FG000|Overall Study|Refusal to continue trial medication|15|||
131838329|NCT02149108|474691298|FG001|Overall Study|Refusal to continue trial medication|11|||
131838330|NCT02149108|474691297|FG000|Overall Study|Lost to Follow-up|1|||
131838331|NCT02149108|474691298|FG001|Overall Study|Lost to Follow-up|0|||
131838332|NCT02731326|474691299|FG000|Overall Study|Withdrawal by Subject|4|||
131838333|NCT02731326|474691300|FG001|Overall Study|Withdrawal by Subject|1|||
131838334|NCT02731326|474691299|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
131838335|NCT02731326|474691300|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
131838336|NCT02731326|474691299|FG000|Overall Study|Discharged without AliveCor|10|||
131838337|NCT02731326|474691300|FG001|Overall Study|Discharged without AliveCor|0|||
131838338|NCT02731326|474691299|FG000|Overall Study|Duplicate Participant|1|||
131838339|NCT02731326|474691300|FG001|Overall Study|Duplicate Participant|1|||
131838340|NCT05070546|474691301|FG000|Overall Study|Death|0|||
131838341|NCT05070546|474691302|FG001|Overall Study|Death|0|||
131838342|NCT05070546|474691303|FG002|Overall Study|Death|0|||
131838343|NCT05070546|474691304|FG003|Overall Study|Death|0|||
131838344|NCT05070546|474691305|FG004|Overall Study|Death|0|||
131838345|NCT05070546|474691306|FG005|Overall Study|Death|1|||
131838346|NCT05070546|474691301|FG000|Overall Study|Lost to Follow-up|8|||
131838347|NCT05070546|474691302|FG001|Overall Study|Lost to Follow-up|2|||
131838348|NCT05070546|474691303|FG002|Overall Study|Lost to Follow-up|7|||
131838349|NCT05070546|474691304|FG003|Overall Study|Lost to Follow-up|1|||
131838350|NCT05070546|474691305|FG004|Overall Study|Lost to Follow-up|2|||
131838351|NCT05070546|474691306|FG005|Overall Study|Lost to Follow-up|0|||
131838352|NCT05070546|474691301|FG000|Overall Study|Withdrawal by Subject|1|||
131838353|NCT05070546|474691302|FG001|Overall Study|Withdrawal by Subject|1|||
131838354|NCT05070546|474691303|FG002|Overall Study|Withdrawal by Subject|3|||
131838355|NCT05070546|474691304|FG003|Overall Study|Withdrawal by Subject|0|||
131838356|NCT05070546|474691305|FG004|Overall Study|Withdrawal by Subject|0|||
131838357|NCT05070546|474691306|FG005|Overall Study|Withdrawal by Subject|0|||
131838358|NCT05070546|474691301|FG000|Overall Study|Other|0|||
131838359|NCT05070546|474691302|FG001|Overall Study|Other|0|||
131838360|NCT05070546|474691303|FG002|Overall Study|Other|0|||
131838361|NCT05070546|474691304|FG003|Overall Study|Other|0|||
131838362|NCT05070546|474691305|FG004|Overall Study|Other|3|||
131838363|NCT05070546|474691306|FG005|Overall Study|Other|0|||
131838364|NCT05070546|474691301|FG000|Overall Study|Randomized but not vaccinated|1|||
131838365|NCT05070546|474691302|FG001|Overall Study|Randomized but not vaccinated|0|||
131838366|NCT05070546|474691303|FG002|Overall Study|Randomized but not vaccinated|1|||
131838367|NCT05070546|474691304|FG003|Overall Study|Randomized but not vaccinated|1|||
131838368|NCT05070546|474691305|FG004|Overall Study|Randomized but not vaccinated|3|||
131838369|NCT05070546|474691306|FG005|Overall Study|Randomized but not vaccinated|0|||
131838370|NCT00302081|474691315|FG000|Overall Study|Adverse Event|6|||
131838371|NCT00302081|474691316|FG001|Overall Study|Adverse Event|5|||
131838372|NCT00302081|474691317|FG002|Overall Study|Adverse Event|4|||
131838373|NCT00302081|474691315|FG000|Overall Study|Lost to Follow-up|21|||
131402426|NCT02242435|473095462|FG000|Overall Study|Withdrawal by Subject|13|||
131402427|NCT02242435|473095463|FG001|Overall Study|Withdrawal by Subject|8|||
131402428|NCT02242435|473095462|FG000|Overall Study|Death|0|||
131402429|NCT02242435|473095463|FG001|Overall Study|Death|1|||
131402430|NCT02242435|473095462|FG000|Overall Study|Protocol Violation|1|||
131402431|NCT02242435|473095463|FG001|Overall Study|Protocol Violation|0|||
131838374|NCT00302081|474691316|FG001|Overall Study|Lost to Follow-up|18|||
131838375|NCT00302081|474691317|FG002|Overall Study|Lost to Follow-up|28|||
131838376|NCT00302081|474691315|FG000|Overall Study|Withdrawal by Subject|8|||
131838377|NCT00302081|474691316|FG001|Overall Study|Withdrawal by Subject|12|||
131838378|NCT00302081|474691317|FG002|Overall Study|Withdrawal by Subject|8|||
131838379|NCT00302081|474691315|FG000|Overall Study|Protocol Violation|5|||
131838380|NCT00302081|474691316|FG001|Overall Study|Protocol Violation|1|||
131838381|NCT00302081|474691317|FG002|Overall Study|Protocol Violation|2|||
131838382|NCT00302081|474691315|FG000|Overall Study|Lack of Efficacy|1|||
131838383|NCT00302081|474691316|FG001|Overall Study|Lack of Efficacy|0|||
131838384|NCT00302081|474691317|FG002|Overall Study|Lack of Efficacy|5|||
131838385|NCT00302081|474691315|FG000|Overall Study|Death|2|||
131838386|NCT00302081|474691316|FG001|Overall Study|Death|1|||
131838387|NCT00302081|474691317|FG002|Overall Study|Death|0|||
131838388|NCT00302081|474691315|FG000|Overall Study|Other|13|||
131838389|NCT00302081|474691316|FG001|Overall Study|Other|6|||
131838390|NCT00302081|474691317|FG002|Overall Study|Other|5|||
131838391|NCT04771403|474691318|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
131838392|NCT04771403|474691319|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
131838393|NCT04771403|474691318|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
131838394|NCT04771403|474691319|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
131838395|NCT04771403|474691318|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
131838396|NCT04771403|474691319|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
131838397|NCT04771403|474691318|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
131838398|NCT04771403|474691319|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
131838399|NCT04771403|474691318|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
131838400|NCT04771403|474691319|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
131838401|NCT04771403|474691318|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
131838402|NCT04771403|474691319|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
131838403|NCT04771403|474691318|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
131838404|NCT04771403|474691319|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
131838405|NCT04771403|474691318|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
131838406|NCT04771403|474691319|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
131838407|NCT00816361|474691324|FG000|Overall Study|Withdrawal by Subject|0|||
131838408|NCT00816361|474691325|FG001|Overall Study|Withdrawal by Subject|0|||
131838409|NCT00816361|474691326|FG002|Overall Study|Withdrawal by Subject|0|||
131838410|NCT00816361|474691327|FG003|Overall Study|Withdrawal by Subject|0|||
131838411|NCT00816361|474691328|FG004|Overall Study|Withdrawal by Subject|1|||
131838412|NCT00816361|474691329|FG005|Overall Study|Withdrawal by Subject|2|||
131838413|NCT00816361|474691330|FG006|Overall Study|Withdrawal by Subject|0|||
131838414|NCT00816361|474691331|FG007|Overall Study|Withdrawal by Subject|2|||
131838415|NCT00816361|474691332|FG008|Overall Study|Withdrawal by Subject|1|||
131838416|NCT00816361|474691324|FG000|Overall Study|Death|4|||
131838417|NCT00816361|474691325|FG001|Overall Study|Death|3|||
131838418|NCT00816361|474691326|FG002|Overall Study|Death|3|||
131838419|NCT00816361|474691327|FG003|Overall Study|Death|3|||
131838420|NCT00816361|474691328|FG004|Overall Study|Death|1|||
131838421|NCT00816361|474691329|FG005|Overall Study|Death|1|||
131838422|NCT00816361|474691330|FG006|Overall Study|Death|3|||
131838423|NCT00816361|474691331|FG007|Overall Study|Death|7|||
131838424|NCT00816361|474691332|FG008|Overall Study|Death|8|||
131838425|NCT00816361|474691324|FG000|Overall Study|Other|0|||
131838426|NCT00816361|474691325|FG001|Overall Study|Other|0|||
131838427|NCT00816361|474691326|FG002|Overall Study|Other|0|||
131838428|NCT00816361|474691327|FG003|Overall Study|Other|0|||
131838429|NCT00816361|474691328|FG004|Overall Study|Other|0|||
131838430|NCT00816361|474691329|FG005|Overall Study|Other|0|||
131838431|NCT00816361|474691330|FG006|Overall Study|Other|0|||
131838432|NCT00816361|474691331|FG007|Overall Study|Other|0|||
131402432|NCT02242435|473095462|FG000|Overall Study|Physician Decision|0|||
131838433|NCT00816361|474691332|FG008|Overall Study|Other|1|||
131838434|NCT00546572|474691333|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
131838435|NCT00546572|474691334|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
131838436|NCT00546572|474691333|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
131838437|NCT00546572|474691334|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
131838438|NCT00546572|474691333|FG000|Vax 1 / Year 0|Protocol Violation|3|||
131838439|NCT00546572|474691334|FG001|Vax 1 / Year 0|Protocol Violation|4|||
131838440|NCT00546572|474691333|FG000|Vax 1 / Year 0|Death|2|||
131838441|NCT00546572|474691334|FG001|Vax 1 / Year 0|Death|2|||
131838442|NCT00546572|474691333|FG000|Vax 1 / Year 0|Adverse Event|0|||
131838443|NCT00546572|474691334|FG001|Vax 1 / Year 0|Adverse Event|1|||
131838444|NCT00546572|474691333|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
131838445|NCT00546572|474691334|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
131838446|NCT00546572|474691333|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
131838447|NCT00546572|474691334|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
131838448|NCT00546572|474691333|FG000|Vax 2 / Year 1|Other|1|||
131838449|NCT00546572|474691334|FG001|Vax 2 / Year 1|Other|1|||
131838450|NCT00546572|474691333|FG000|Vax 2 / Year 1|Adverse Event|1|||
131838451|NCT00546572|474691334|FG001|Vax 2 / Year 1|Adverse Event|0|||
131838452|NCT00546572|474691333|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
131838453|NCT00546572|474691334|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
131838454|NCT02049450|474693466|FG000|Overall Study|Adverse Event|2|||
131838455|NCT02049450|474693466|FG000|Overall Study|Withdrawal by Subject|1|||
131838456|NCT02049450|474693466|FG000|Overall Study|Patients/guardian decision|1|||
131838457|NCT04711902|474693467|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
131838458|NCT04711902|474693468|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
131838459|NCT04711902|474693469|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
131838460|NCT04711902|474693470|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
131838461|NCT04711902|474693471|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
131838462|NCT04711902|474693472|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
131838463|NCT03827564|474693473|FG000|Overall Study|Discontinued due to Study Termination|1|||
131838464|NCT03827564|474693474|FG001|Overall Study|Discontinued due to Study Termination|0|||
131838465|NCT00891371|474693475|FG000|Pre-assignment|Inclusion/exclusion|5|||
131838466|NCT00891371|474693475|FG000|Pre-assignment|Consent withdrawal|1|||
131838467|NCT00891371|474693475|FG000|Treatment|Lack of Efficacy|5|||
131838468|NCT00891371|474693475|FG000|Treatment|Adverse Event|2|||
131838469|NCT00891371|474693475|FG000|Treatment|Death|1|||
131838470|NCT00891371|474693475|FG000|Treatment|Lost to Follow-up|1|||
131838471|NCT02238626|474693476|FG000|Overall Study|Adverse Event|3|||
131838472|NCT02238626|474693477|FG001|Overall Study|Adverse Event|5|||
131838473|NCT02238626|474693478|FG002|Overall Study|Adverse Event|0|||
131838474|NCT02238626|474693479|FG003|Overall Study|Adverse Event|3|||
131838475|NCT02238626|474693476|FG000|Overall Study|Lost to Follow-up|2|||
131838476|NCT02238626|474693477|FG001|Overall Study|Lost to Follow-up|4|||
131450163|NCT04032093|473276806|FG001|Overall Study|Other|0|||
131838477|NCT02238626|474693478|FG002|Overall Study|Lost to Follow-up|2|||
131838478|NCT02238626|474693479|FG003|Overall Study|Lost to Follow-up|2|||
131838479|NCT02238626|474693476|FG000|Overall Study|Withdrawal by Subject|0|||
131838480|NCT02238626|474693477|FG001|Overall Study|Withdrawal by Subject|3|||
131838481|NCT02238626|474693478|FG002|Overall Study|Withdrawal by Subject|0|||
131838482|NCT02238626|474693479|FG003|Overall Study|Withdrawal by Subject|1|||
131838483|NCT02238626|474693476|FG000|Overall Study|Death|0|||
131838484|NCT02238626|474693477|FG001|Overall Study|Death|0|||
131838485|NCT02238626|474693478|FG002|Overall Study|Death|1|||
131838486|NCT02238626|474693479|FG003|Overall Study|Death|1|||
131838487|NCT02238626|474693476|FG000|Overall Study|Other|0|||
131838488|NCT02238626|474693477|FG001|Overall Study|Other|2|||
131838489|NCT02238626|474693478|FG002|Overall Study|Other|0|||
131838490|NCT02238626|474693479|FG003|Overall Study|Other|0|||
131838491|NCT02622113|474693482|FG000|Overall Study|Adverse Event|4|||
131838492|NCT02622113|474693483|FG001|Overall Study|Adverse Event|4|||
131838493|NCT02622113|474693482|FG000|Overall Study|Physician Decision|0|||
131838494|NCT02622113|474693483|FG001|Overall Study|Physician Decision|1|||
131838495|NCT02622113|474693482|FG000|Overall Study|Withdrawal by Subject|0|||
131838496|NCT02622113|474693483|FG001|Overall Study|Withdrawal by Subject|2|||
131838497|NCT02622113|474693482|FG000|Overall Study|Stopping Criteria|1|||
131838498|NCT02622113|474693483|FG001|Overall Study|Stopping Criteria|3|||
131838499|NCT03201250|474693487|FG000|Overall Study|screen failures|3|||
131450164|NCT04032093|473276807|FG002|Overall Study|Other|0|||
131838500|NCT03201250|474693488|FG001|Overall Study|screen failures|0|||
131838501|NCT03201250|474693489|FG002|Overall Study|screen failures|0|||
131838502|NCT03167723|474693490|FG000|Overall Study|Protocol Violation|4|||
131838503|NCT03167723|474693491|FG001|Overall Study|Protocol Violation|6|||
131450165|NCT04032093|473276808|FG003|Overall Study|Other|1|||
131838504|NCT01175811|474693493|FG000|Overall Study|Adverse Event|1|||
131838505|NCT01175811|474693494|FG001|Overall Study|Adverse Event|1|||
131838506|NCT01175811|474693493|FG000|Overall Study|Entry criteria not met|3|||
131838507|NCT01175811|474693494|FG001|Overall Study|Entry criteria not met|1|||
131838508|NCT01175811|474693493|FG000|Overall Study|Lack of Efficacy|1|||
131838509|NCT01175811|474693494|FG001|Overall Study|Lack of Efficacy|0|||
131838510|NCT01175811|474693493|FG000|Overall Study|Lost to Follow-up|3|||
131838511|NCT01175811|474693494|FG001|Overall Study|Lost to Follow-up|2|||
131838512|NCT01175811|474693493|FG000|Overall Study|Physician Decision|1|||
131838513|NCT01175811|474693494|FG001|Overall Study|Physician Decision|1|||
131838514|NCT01175811|474693493|FG000|Overall Study|Protocol Violation|1|||
131838515|NCT01175811|474693494|FG001|Overall Study|Protocol Violation|2|||
131838516|NCT01175811|474693493|FG000|Overall Study|Withdrawal by Subject|6|||
131838517|NCT01175811|474693494|FG001|Overall Study|Withdrawal by Subject|7|||
131838518|NCT00969540|474693495|FG000|Overall Study|Lost to Follow-up|1|||
131838519|NCT00969540|474693496|FG001|Overall Study|Lost to Follow-up|1|||
131838520|NCT02397408|474693497|FG000|Overall Study|Physician Decision|4|||
131838521|NCT02397408|474693497|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
131838522|NCT01683838|474693498|FG000|Overall Study|Adverse Event|12|||
131838523|NCT01683838|474693499|FG001|Overall Study|Adverse Event|2|||
131838524|NCT01683838|474693498|FG000|Overall Study|Protocol Violation|3|||
131838525|NCT01683838|474693499|FG001|Overall Study|Protocol Violation|1|||
131838526|NCT01683838|474693498|FG000|Overall Study|Withdrawal by Subject|6|||
131838527|NCT01683838|474693499|FG001|Overall Study|Withdrawal by Subject|5|||
131838528|NCT01683838|474693498|FG000|Overall Study|Lost to Follow-up|1|||
131838529|NCT01683838|474693499|FG001|Overall Study|Lost to Follow-up|1|||
131838530|NCT01683838|474693498|FG000|Overall Study|Other|4|||
131838531|NCT01683838|474693499|FG001|Overall Study|Other|3|||
131838532|NCT01646138|474693500|FG000|Overall Study|Lost to Follow-up|0|||
131838533|NCT01646138|474693501|FG001|Overall Study|Lost to Follow-up|0|||
131838534|NCT01646138|474693502|FG002|Overall Study|Lost to Follow-up|0|||
131838535|NCT01646138|474693503|FG003|Overall Study|Lost to Follow-up|0|||
131838536|NCT01646138|474693504|FG004|Overall Study|Lost to Follow-up|2|||
131838537|NCT01524679|474693505|FG000|Overall Study|Lost to Follow-up|1|||
131838538|NCT01524679|474693506|FG001|Overall Study|Lost to Follow-up|4|||
131838539|NCT01524679|474693505|FG000|Overall Study|Withdrawal by Subject|4|||
131838540|NCT01524679|474693506|FG001|Overall Study|Withdrawal by Subject|4|||
131838541|NCT01524679|474693505|FG000|Overall Study|Adverse Event|9|||
131838542|NCT01524679|474693506|FG001|Overall Study|Adverse Event|0|||
131838543|NCT01524679|474693505|FG000|Overall Study|Protocol Violation|1|||
131838544|NCT01524679|474693506|FG001|Overall Study|Protocol Violation|0|||
131838545|NCT01524679|474693505|FG000|Overall Study|Lack of Efficacy|2|||
131838546|NCT01524679|474693506|FG001|Overall Study|Lack of Efficacy|0|||
131838547|NCT01524679|474693505|FG000|Overall Study|e.g.wish for children, relocation|6|||
131838548|NCT01524679|474693506|FG001|Overall Study|e.g.wish for children, relocation|1|||
131838549|NCT04765384|474693507|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
131838550|NCT04765384|474693508|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
131838551|NCT04765384|474693509|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
131838552|NCT04765384|474693510|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
131838553|NCT04765384|474693511|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
131838554|NCT04765384|474693512|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
131838555|NCT04765384|474693507|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
131838556|NCT04765384|474693508|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
131838557|NCT04765384|474693509|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
131838558|NCT04765384|474693510|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
131838559|NCT04765384|474693511|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
131838560|NCT04765384|474693512|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
131838561|NCT04765384|474693507|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
131838562|NCT04765384|474693508|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
131838563|NCT04765384|474693509|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
131838564|NCT04765384|474693510|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
131838565|NCT04765384|474693511|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
131838566|NCT04765384|474693512|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
131838567|NCT04765384|474693507|FG000|Post-natal: Neonates and Infants|Death|0|||
131838568|NCT04765384|474693508|FG001|Post-natal: Neonates and Infants|Death|0|||
131838569|NCT04765384|474693509|FG002|Post-natal: Neonates and Infants|Death|0|||
131838570|NCT04765384|474693510|FG003|Post-natal: Neonates and Infants|Death|1|||
131838571|NCT04765384|474693511|FG004|Post-natal: Neonates and Infants|Death|0|||
131838572|NCT04765384|474693512|FG005|Post-natal: Neonates and Infants|Death|0|||
131838573|NCT04765384|474693507|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
131838574|NCT04765384|474693508|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
131910776|NCT00392223|474960838|FG000|Overall Study|Lost to Follow-up|1|||
131838575|NCT04765384|474693509|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
131838576|NCT04765384|474693510|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
131838577|NCT04765384|474693511|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
131838578|NCT04765384|474693512|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
131838579|NCT01971970|474693513|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
131838580|NCT01971970|474693514|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
131838581|NCT01971970|474693513|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
131910777|NCT00392223|474960839|FG001|Overall Study|Lost to Follow-up|4|||
131838582|NCT01971970|474693514|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
131838583|NCT01971970|474693513|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
131838584|NCT01971970|474693514|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
131838585|NCT01971970|474693513|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
131838586|NCT01971970|474693514|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
131838587|NCT01971970|474693513|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
131838588|NCT01971970|474693514|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
131838589|NCT01971970|474693513|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
131838590|NCT01971970|474693514|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
131838591|NCT01971970|474693513|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
131838592|NCT01971970|474693514|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
131838593|NCT00848107|474693515|FG000|Overall Study|Lost to Follow-up|2|||
131838594|NCT00848107|474693515|FG000|Overall Study|Withdrawal by Subject|8|||
131838595|NCT00848107|474693515|FG000|Overall Study|Adverse Event|9|||
131838596|NCT00848107|474693515|FG000|Overall Study|Death|1|||
131838597|NCT00848107|474693515|FG000|Overall Study|Pregnancy|1|||
131838598|NCT02335983|474693516|FG000|Overall Study|Sponsor Decision|0|||
131838599|NCT02335983|474693517|FG001|Overall Study|Sponsor Decision|0|||
131838600|NCT02335983|474693518|FG002|Overall Study|Sponsor Decision|1|||
131838601|NCT02335983|474693519|FG003|Overall Study|Sponsor Decision|1|||
131838602|NCT02335983|474693520|FG004|Overall Study|Sponsor Decision|0|||
131838603|NCT02335983|474693521|FG005|Overall Study|Sponsor Decision|1|||
131838604|NCT02335983|474693516|FG000|Overall Study|Withdrawal by Subject|3|||
131838605|NCT02335983|474693517|FG001|Overall Study|Withdrawal by Subject|2|||
131838606|NCT02335983|474693518|FG002|Overall Study|Withdrawal by Subject|2|||
131838607|NCT02335983|474693519|FG003|Overall Study|Withdrawal by Subject|1|||
131838608|NCT02335983|474693520|FG004|Overall Study|Withdrawal by Subject|3|||
131838609|NCT02335983|474693521|FG005|Overall Study|Withdrawal by Subject|9|||
131838610|NCT02335983|474693516|FG000|Overall Study|Death|0|||
131838611|NCT02335983|474693517|FG001|Overall Study|Death|0|||
131838612|NCT02335983|474693518|FG002|Overall Study|Death|2|||
131838613|NCT02335983|474693519|FG003|Overall Study|Death|0|||
131838614|NCT02335983|474693520|FG004|Overall Study|Death|0|||
131838615|NCT02335983|474693521|FG005|Overall Study|Death|0|||
131838616|NCT02335983|474693516|FG000|Overall Study|Lost to Follow-up|0|||
131838617|NCT02335983|474693517|FG001|Overall Study|Lost to Follow-up|0|||
131838618|NCT02335983|474693518|FG002|Overall Study|Lost to Follow-up|0|||
131838619|NCT02335983|474693519|FG003|Overall Study|Lost to Follow-up|0|||
131838620|NCT02335983|474693520|FG004|Overall Study|Lost to Follow-up|0|||
131838621|NCT02335983|474693521|FG005|Overall Study|Lost to Follow-up|1|||
131838622|NCT02335983|474693516|FG000|Overall Study|Protocol Specified Criteria|5|||
131838623|NCT02335983|474693517|FG001|Overall Study|Protocol Specified Criteria|7|||
131838624|NCT02335983|474693518|FG002|Overall Study|Protocol Specified Criteria|27|||
131838625|NCT02335983|474693519|FG003|Overall Study|Protocol Specified Criteria|7|||
131838626|NCT02335983|474693520|FG004|Overall Study|Protocol Specified Criteria|5|||
131838627|NCT02335983|474693521|FG005|Overall Study|Protocol Specified Criteria|21|||
131838628|NCT00987389|474693522|FG000|Overall Study|Ineligible|0|||
131838629|NCT00987389|474693523|FG001|Overall Study|Ineligible|3|||
131838630|NCT00987389|474693524|FG002|Overall Study|Ineligible|0|||
131838631|NCT00987389|474693525|FG003|Overall Study|Ineligible|0|||
131838632|NCT00987389|474693522|FG000|Overall Study|Lost to Follow-up|4|||
131838633|NCT00987389|474693523|FG001|Overall Study|Lost to Follow-up|1|||
131838634|NCT00987389|474693524|FG002|Overall Study|Lost to Follow-up|3|||
131838635|NCT00987389|474693525|FG003|Overall Study|Lost to Follow-up|1|||
131838636|NCT00987389|474693522|FG000|Overall Study|Withdrawal by Subject|4|||
131838637|NCT00987389|474693523|FG001|Overall Study|Withdrawal by Subject|3|||
131838638|NCT00987389|474693524|FG002|Overall Study|Withdrawal by Subject|2|||
131838639|NCT00987389|474693525|FG003|Overall Study|Withdrawal by Subject|1|||
131838640|NCT00987389|474693522|FG000|Overall Study|Withdrawn from Treatment|0|||
131838641|NCT00987389|474693523|FG001|Overall Study|Withdrawn from Treatment|1|||
131838642|NCT00987389|474693524|FG002|Overall Study|Withdrawn from Treatment|0|||
131838643|NCT00987389|474693525|FG003|Overall Study|Withdrawn from Treatment|0|||
131838644|NCT00987389|474693522|FG000|Overall Study|Multiple different reasons|1|||
131838645|NCT00987389|474693523|FG001|Overall Study|Multiple different reasons|0|||
131838646|NCT00987389|474693524|FG002|Overall Study|Multiple different reasons|3|||
131838647|NCT00987389|474693525|FG003|Overall Study|Multiple different reasons|1|||
131838648|NCT00655876|474693526|FG000|Overall Study|Protocol Violation|9|||
131838649|NCT00655876|474693527|FG001|Overall Study|Protocol Violation|7|||
131838650|NCT01831765|474693528|FG000|Overall Study|Lack of Efficacy|1|||
131838651|NCT01831765|474693529|FG001|Overall Study|Lack of Efficacy|0|||
131838652|NCT01831765|474693530|FG002|Overall Study|Lack of Efficacy|0|||
131838653|NCT01831765|474693528|FG000|Overall Study|Other, sponsor withdrew subject|0|||
131838654|NCT01831765|474693529|FG001|Overall Study|Other, sponsor withdrew subject|1|||
131838655|NCT01831765|474693530|FG002|Overall Study|Other, sponsor withdrew subject|0|||
131838656|NCT01831765|474693528|FG000|Overall Study|Pregnancy|1|||
131838657|NCT01831765|474693529|FG001|Overall Study|Pregnancy|1|||
131838658|NCT01831765|474693530|FG002|Overall Study|Pregnancy|2|||
131838659|NCT01831765|474693528|FG000|Overall Study|Death|0|||
131838660|NCT01831765|474693529|FG001|Overall Study|Death|1|||
131838661|NCT01831765|474693530|FG002|Overall Study|Death|1|||
131838662|NCT01831765|474693528|FG000|Overall Study|Other, site closed|1|||
131838663|NCT01831765|474693529|FG001|Overall Study|Other, site closed|1|||
131838664|NCT01831765|474693530|FG002|Overall Study|Other, site closed|0|||
131838665|NCT01831765|474693528|FG000|Overall Study|Adverse Event|5|||
131838666|NCT01831765|474693529|FG001|Overall Study|Adverse Event|3|||
131838667|NCT01831765|474693530|FG002|Overall Study|Adverse Event|3|||
131838668|NCT01831765|474693528|FG000|Overall Study|Withdrawal by Subject|22|||
131838669|NCT01831765|474693529|FG001|Overall Study|Withdrawal by Subject|7|||
131838670|NCT01831765|474693530|FG002|Overall Study|Withdrawal by Subject|17|||
131838671|NCT01831765|474693528|FG000|Overall Study|Withdrawal criteria|12|||
131838672|NCT01831765|474693529|FG001|Overall Study|Withdrawal criteria|10|||
131838673|NCT01831765|474693530|FG002|Overall Study|Withdrawal criteria|16|||
131838674|NCT01831765|474693528|FG000|Overall Study|Lost to Follow-up|2|||
131838675|NCT01831765|474693529|FG001|Overall Study|Lost to Follow-up|3|||
131838676|NCT01831765|474693530|FG002|Overall Study|Lost to Follow-up|3|||
131838677|NCT00326963|474693531|FG000|Overall Study|Adverse Event|2|||
131838678|NCT00326963|474693531|FG000|Overall Study|Injection site reaction|1|||
131838679|NCT00326963|474693531|FG000|Overall Study|Death|1|||
131838680|NCT00326963|474693531|FG000|Overall Study|Failure to return|10|||
131838681|NCT00326963|474693531|FG000|Overall Study|Withdrawal by Subject|10|||
131838682|NCT00326963|474693531|FG000|Overall Study|Refused treatment / did not cooperate|5|||
131838683|NCT00326963|474693531|FG000|Overall Study|Violation of selection criteria at entry|2|||
131838684|NCT00326963|474693531|FG000|Overall Study|Other protocol violation|1|||
131838685|NCT00326963|474693531|FG000|Overall Study|Administrative / other|1|||
131838686|NCT00859586|474693532|FG000|Overall Study|Donors|4|||
131838687|NCT02524730|474693533|FG000|Overall Study|Lost to Follow-up|5|||
131838688|NCT02524730|474693533|FG000|Overall Study|Withdrawal by Subject|18|||
131838689|NCT02524730|474693533|FG000|Overall Study|Death|10|||
131838690|NCT02524730|474693533|FG000|Overall Study|Adverse Event|8|||
131838691|NCT02524730|474693533|FG000|Overall Study|Protocol Violation|1|||
131838692|NCT02524730|474693533|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
131838693|NCT00507130|474693534|FG000|Overall Study|Lost to Follow-up|0|||
131838694|NCT00507130|474693535|FG001|Overall Study|Lost to Follow-up|0|||
131838695|NCT00507130|474693536|FG002|Overall Study|Lost to Follow-up|1|||
131838696|NCT00507130|474693537|FG003|Overall Study|Lost to Follow-up|1|||
131838697|NCT00507130|474693534|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
131838698|NCT00507130|474693535|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
131838699|NCT00507130|474693536|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
131838700|NCT00507130|474693537|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
131838701|NCT00080938|474693542|FG000|Overall Study|Adverse Event|3|||
131838702|NCT00080938|474693542|FG000|Overall Study|Withdrawal by Subject|6|||
131838703|NCT00080938|474693542|FG000|Overall Study|Death|2|||
131838704|NCT00080938|474693542|FG000|Overall Study|Lack of Efficacy|7|||
131838705|NCT00080938|474693542|FG000|Overall Study|other disease|1|||
131838706|NCT00080938|474693542|FG000|Overall Study|Not started protocol therapy|1|||
131838707|NCT00080938|474693542|FG000|Overall Study|Ineligible|4|||
131838708|NCT00706511|474693543|FG000|Overall Study|Withdrawal by Subject|1|||
131838709|NCT00706511|474693544|FG001|Overall Study|Withdrawal by Subject|0|||
131838710|NCT00706511|474693545|FG002|Overall Study|Withdrawal by Subject|0|||
131838711|NCT00706511|474693546|FG003|Overall Study|Withdrawal by Subject|0|||
131838712|NCT01006135|474693557|FG000|Overall Study|Adverse Event|22|||
131838713|NCT01006135|474693557|FG000|Overall Study|Protocol Violation|14|||
131838714|NCT01006135|474693557|FG000|Overall Study|Lost to Follow-up|32|||
131838715|NCT01006135|474693557|FG000|Overall Study|Other|72|||
131838716|NCT05297578|474693559|FG000|Overall Study|Lost to Follow-up|1|||
131838717|NCT05297578|474693560|FG001|Overall Study|Lost to Follow-up|1|||
131838718|NCT05297578|474693561|FG002|Overall Study|Lost to Follow-up|2|||
131838719|NCT05297578|474693562|FG003|Overall Study|Lost to Follow-up|1|||
131838720|NCT05297578|474693559|FG000|Overall Study|Death|0|||
131838721|NCT05297578|474693560|FG001|Overall Study|Death|1|||
131838722|NCT05297578|474693561|FG002|Overall Study|Death|0|||
131838723|NCT05297578|474693562|FG003|Overall Study|Death|0|||
131838724|NCT05297578|474693559|FG000|Overall Study|Withdrawal by Subject|0|||
131838725|NCT05297578|474693560|FG001|Overall Study|Withdrawal by Subject|0|||
131838726|NCT05297578|474693561|FG002|Overall Study|Withdrawal by Subject|1|||
131838727|NCT05297578|474693562|FG003|Overall Study|Withdrawal by Subject|0|||
131838728|NCT00117325|474693563|FG000|Overall Study|Adverse Event|3|||
131838729|NCT00117325|474693564|FG001|Overall Study|Adverse Event|3|||
131838730|NCT00117325|474693563|FG000|Overall Study|Lost to Follow-up|1|||
131838731|NCT00117325|474693564|FG001|Overall Study|Lost to Follow-up|1|||
131838732|NCT00117325|474693563|FG000|Overall Study|Protocol Violation|2|||
131838733|NCT00117325|474693564|FG001|Overall Study|Protocol Violation|3|||
131838734|NCT00117325|474693563|FG000|Overall Study|Withdrawal by Subject|3|||
131838735|NCT00117325|474693564|FG001|Overall Study|Withdrawal by Subject|2|||
131838736|NCT00117325|474693563|FG000|Overall Study|Lack of Efficacy|1|||
131838737|NCT00117325|474693564|FG001|Overall Study|Lack of Efficacy|0|||
131402433|NCT02242435|473095463|FG001|Overall Study|Physician Decision|1|||
131402434|NCT02759107|473095467|FG000|Overall Study|Adverse Event|0|||
131402435|NCT02759107|473095468|FG001|Overall Study|Adverse Event|0|||
131402436|NCT02759107|473095469|FG002|Overall Study|Adverse Event|0|||
131402437|NCT02759107|473095470|FG003|Overall Study|Adverse Event|0|||
131402438|NCT02759107|473095471|FG004|Overall Study|Adverse Event|0|||
131402439|NCT02759107|473095472|FG005|Overall Study|Adverse Event|0|||
131402440|NCT02759107|473095473|FG006|Overall Study|Adverse Event|0|||
131402441|NCT02759107|473095474|FG007|Overall Study|Adverse Event|0|||
131402442|NCT02759107|473095475|FG008|Overall Study|Adverse Event|0|||
131402443|NCT02759107|473095476|FG009|Overall Study|Adverse Event|0|||
131402444|NCT02759107|473095477|FG010|Overall Study|Adverse Event|0|||
131402445|NCT02759107|473095478|FG011|Overall Study|Adverse Event|0|||
131402446|NCT02759107|473095479|FG012|Overall Study|Adverse Event|2|||
131402447|NCT02759107|473095480|FG013|Overall Study|Adverse Event|0|||
131402448|NCT02759107|473095481|FG014|Overall Study|Adverse Event|0|||
131402449|NCT02759107|473095482|FG015|Overall Study|Adverse Event|1|||
131402450|NCT02759107|473095483|FG016|Overall Study|Adverse Event|0|||
131402451|NCT02759107|473095484|FG017|Overall Study|Adverse Event|2|||
131402452|NCT02759107|473095467|FG000|Overall Study|Scheduling Conflict|0|||
131402453|NCT02759107|473095468|FG001|Overall Study|Scheduling Conflict|0|||
131402454|NCT02759107|473095469|FG002|Overall Study|Scheduling Conflict|0|||
131402455|NCT02759107|473095470|FG003|Overall Study|Scheduling Conflict|0|||
131402456|NCT02759107|473095471|FG004|Overall Study|Scheduling Conflict|0|||
131402457|NCT02759107|473095472|FG005|Overall Study|Scheduling Conflict|0|||
131402458|NCT02759107|473095473|FG006|Overall Study|Scheduling Conflict|0|||
131402459|NCT02759107|473095474|FG007|Overall Study|Scheduling Conflict|0|||
131402460|NCT02759107|473095475|FG008|Overall Study|Scheduling Conflict|0|||
131402461|NCT02759107|473095476|FG009|Overall Study|Scheduling Conflict|1|||
131402462|NCT02759107|473095477|FG010|Overall Study|Scheduling Conflict|0|||
131402463|NCT02759107|473095478|FG011|Overall Study|Scheduling Conflict|0|||
131402464|NCT02759107|473095479|FG012|Overall Study|Scheduling Conflict|0|||
131402465|NCT02759107|473095480|FG013|Overall Study|Scheduling Conflict|0|||
131402466|NCT02759107|473095481|FG014|Overall Study|Scheduling Conflict|0|||
131402467|NCT02759107|473095482|FG015|Overall Study|Scheduling Conflict|0|||
131402468|NCT02759107|473095483|FG016|Overall Study|Scheduling Conflict|0|||
131402469|NCT02759107|473095484|FG017|Overall Study|Scheduling Conflict|0|||
131402470|NCT00420004|473095492|FG000|Overall Study|Adverse Event|4|||
131402471|NCT00420004|473095493|FG001|Overall Study|Adverse Event|1|||
131402472|NCT00420004|473095494|FG002|Overall Study|Adverse Event|1|||
131402473|NCT00420004|473095492|FG000|Overall Study|Lack of Efficacy|5|||
131838738|NCT00117325|474693563|FG000|Overall Study|Use of prohibited medicine|1|||
131838739|NCT00117325|474693564|FG001|Overall Study|Use of prohibited medicine|2|||
131838740|NCT00117325|474693563|FG000|Overall Study|Early termination|1|||
131838741|NCT00117325|474693564|FG001|Overall Study|Early termination|1|||
131838742|NCT00117325|474693563|FG000|Overall Study|Admisnitrative|1|||
131838743|NCT00117325|474693564|FG001|Overall Study|Admisnitrative|0|||
131838744|NCT00338455|474693565|FG000|Overall Study|Death|2|||
131838745|NCT00338455|474693566|FG001|Overall Study|Death|1|||
131838746|NCT00338455|474693565|FG000|Overall Study|Physician Decision|1|||
131838747|NCT00338455|474693566|FG001|Overall Study|Physician Decision|0|||
131838748|NCT02266134|474693567|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
131838749|NCT02266134|474693568|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
131838750|NCT02266134|474693569|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
131838751|NCT02266134|474693570|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
131838752|NCT02266134|474693567|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
131838753|NCT02266134|474693568|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
131838754|NCT02266134|474693569|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
131838755|NCT02266134|474693570|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
131838756|NCT02266134|474693567|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
131838757|NCT02266134|474693568|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
131838758|NCT02266134|474693569|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
131838759|NCT02266134|474693570|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
131838760|NCT02266134|474693567|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
131402474|NCT00420004|473095493|FG001|Overall Study|Lack of Efficacy|4|||
131402475|NCT00420004|473095494|FG002|Overall Study|Lack of Efficacy|1|||
131402476|NCT00420004|473095492|FG000|Overall Study|Lost to Follow-up|31|||
131838761|NCT02266134|474693568|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
131402477|NCT00420004|473095493|FG001|Overall Study|Lost to Follow-up|12|||
131402478|NCT00420004|473095494|FG002|Overall Study|Lost to Follow-up|10|||
131402479|NCT00420004|473095492|FG000|Overall Study|Entry Criteria Not Met|0|||
131402480|NCT00420004|473095493|FG001|Overall Study|Entry Criteria Not Met|1|||
131402481|NCT00420004|473095494|FG002|Overall Study|Entry Criteria Not Met|0|||
131402482|NCT00420004|473095492|FG000|Overall Study|Physician Decision|14|||
131402483|NCT00420004|473095493|FG001|Overall Study|Physician Decision|4|||
131402484|NCT00420004|473095494|FG002|Overall Study|Physician Decision|2|||
131838762|NCT02266134|474693569|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
131402485|NCT00420004|473095492|FG000|Overall Study|Protocol Violation|5|||
131402486|NCT00420004|473095493|FG001|Overall Study|Protocol Violation|4|||
131402487|NCT00420004|473095494|FG002|Overall Study|Protocol Violation|3|||
131402488|NCT00420004|473095492|FG000|Overall Study|Withdrawal by Subject|67|||
131402489|NCT00420004|473095493|FG001|Overall Study|Withdrawal by Subject|42|||
131402490|NCT00420004|473095494|FG002|Overall Study|Withdrawal by Subject|14|||
131402491|NCT00420004|473095492|FG000|Overall Study|Sponsor Decision|3|||
131402492|NCT00420004|473095493|FG001|Overall Study|Sponsor Decision|3|||
131402493|NCT00420004|473095494|FG002|Overall Study|Sponsor Decision|1|||
131402494|NCT00591149|473095495|FG000|Overall Study|Adverse Event|4|||
131402495|NCT00591149|473095495|FG000|Overall Study|Withdrawal by Subject|1|||
131402496|NCT05312632|473095496|FG000|Overall Study|Adverse Event|12|||
131402497|NCT05312632|473095496|FG000|Overall Study|Withdrawal by Subject|10|||
131402498|NCT05312632|473095496|FG000|Overall Study|Lack of Efficacy|4|||
131402499|NCT05312632|473095496|FG000|Overall Study|Non-compliance with study procedures|9|||
131402500|NCT05312632|473095496|FG000|Overall Study|Other|4|||
131402501|NCT02019108|473095497|FG000|Overall Study|Lost to Follow-up|5|||
131402502|NCT02019108|473095498|FG001|Overall Study|Lost to Follow-up|7|||
131402503|NCT00519376|473095501|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402504|NCT00519376|473095502|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402505|NCT00519376|473095503|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402506|NCT00519376|473095504|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402507|NCT00519376|473095505|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402508|NCT00519376|473095506|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402509|NCT00519376|473095507|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402510|NCT00519376|473095508|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402511|NCT00519376|473095509|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402512|NCT00519376|473095510|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402513|NCT00519376|473095511|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402514|NCT00519376|473095512|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402515|NCT00519376|473095513|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
131402516|NCT00519376|473095514|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402517|NCT00519376|473095515|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402518|NCT00519376|473095516|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
131402519|NCT00519376|473095501|FG000|Treatment Period 4|Lost to Follow-up|0|||
131402520|NCT00519376|473095502|FG001|Treatment Period 4|Lost to Follow-up|0|||
131838763|NCT02266134|474693570|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
131838764|NCT02266134|474693567|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
131838765|NCT02266134|474693568|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
131838766|NCT02266134|474693569|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
131838767|NCT02266134|474693570|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
131838768|NCT02266134|474693567|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
131838769|NCT02266134|474693568|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
131838770|NCT02266134|474693569|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
131838771|NCT02266134|474693570|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
131838772|NCT02272634|474693575|FG000|Overall Study|Adverse Event|1|||
131838773|NCT02272634|474693576|FG001|Overall Study|Adverse Event|0|||
131838774|NCT02272634|474693577|FG002|Overall Study|Adverse Event|0|||
131838775|NCT02272634|474693575|FG000|Overall Study|Protocol Violation|0|||
131838776|NCT02272634|474693576|FG001|Overall Study|Protocol Violation|0|||
131838777|NCT02272634|474693577|FG002|Overall Study|Protocol Violation|1|||
131838778|NCT02272634|474693575|FG000|Overall Study|Withdrawal by Subject|0|||
131838779|NCT02272634|474693576|FG001|Overall Study|Withdrawal by Subject|1|||
131838780|NCT02272634|474693577|FG002|Overall Study|Withdrawal by Subject|0|||
131838781|NCT01437943|474693579|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
131838782|NCT01437943|474693580|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
131838783|NCT01437943|474693579|FG000|Overall Study|Subject expressed pregnancy plans|1|||
131838784|NCT01437943|474693580|FG001|Overall Study|Subject expressed pregnancy plans|0|||
131838785|NCT01437943|474693579|FG000|Overall Study|Adverse Event|2|||
131838786|NCT01437943|474693580|FG001|Overall Study|Adverse Event|0|||
131838787|NCT04647721|474693581|FG000|Overall Study|Withdrawal by Subject|0|||
131838788|NCT04647721|474693582|FG001|Overall Study|Withdrawal by Subject|2|||
131838789|NCT04647721|474693581|FG000|Overall Study|Lost to Follow-up|2|||
131838790|NCT04647721|474693582|FG001|Overall Study|Lost to Follow-up|0|||
131838791|NCT01986010|474693583|FG000|Overall Study|Adverse Event|0|||
131838792|NCT01986010|474693584|FG001|Overall Study|Adverse Event|1|||
131838793|NCT01986010|474693585|FG002|Overall Study|Adverse Event|0|||
131838794|NCT01986010|474693586|FG003|Overall Study|Adverse Event|0|||
131838795|NCT01986010|474693587|FG004|Overall Study|Adverse Event|0|||
131402521|NCT00519376|473095503|FG002|Treatment Period 4|Lost to Follow-up|1|||
131402522|NCT00519376|473095504|FG003|Treatment Period 4|Lost to Follow-up|0|||
131402523|NCT00519376|473095505|FG004|Treatment Period 4|Lost to Follow-up|0|||
131838796|NCT01986010|474693588|FG005|Overall Study|Adverse Event|0|||
131838797|NCT01986010|474693589|FG006|Overall Study|Adverse Event|0|||
131838798|NCT01986010|474693590|FG007|Overall Study|Adverse Event|0|||
131838799|NCT01986010|474693591|FG008|Overall Study|Adverse Event|0|||
131838800|NCT01986010|474693592|FG009|Overall Study|Adverse Event|0|||
131838801|NCT01986010|474693593|FG010|Overall Study|Adverse Event|0|||
131838802|NCT01986010|474693594|FG011|Overall Study|Adverse Event|0|||
131838803|NCT01986010|474693595|FG012|Overall Study|Adverse Event|0|||
131838804|NCT01986010|474693596|FG013|Overall Study|Adverse Event|0|||
131838805|NCT01986010|474693597|FG014|Overall Study|Adverse Event|0|||
131838806|NCT01986010|474693598|FG015|Overall Study|Adverse Event|1|||
131838807|NCT01986010|474693599|FG016|Overall Study|Adverse Event|0|||
131838808|NCT01986010|474693583|FG000|Overall Study|Lost to Follow-up|2|||
131838809|NCT01986010|474693584|FG001|Overall Study|Lost to Follow-up|1|||
131838810|NCT01986010|474693585|FG002|Overall Study|Lost to Follow-up|2|||
131838811|NCT01986010|474693586|FG003|Overall Study|Lost to Follow-up|2|||
131838812|NCT01986010|474693587|FG004|Overall Study|Lost to Follow-up|2|||
131838813|NCT01986010|474693588|FG005|Overall Study|Lost to Follow-up|2|||
131838814|NCT01986010|474693589|FG006|Overall Study|Lost to Follow-up|0|||
131838815|NCT01986010|474693590|FG007|Overall Study|Lost to Follow-up|0|||
131838816|NCT01986010|474693591|FG008|Overall Study|Lost to Follow-up|4|||
131838817|NCT01986010|474693592|FG009|Overall Study|Lost to Follow-up|2|||
131838818|NCT01986010|474693593|FG010|Overall Study|Lost to Follow-up|0|||
131838819|NCT01986010|474693594|FG011|Overall Study|Lost to Follow-up|1|||
131838820|NCT01986010|474693595|FG012|Overall Study|Lost to Follow-up|1|||
131838821|NCT01986010|474693596|FG013|Overall Study|Lost to Follow-up|1|||
131838822|NCT01986010|474693597|FG014|Overall Study|Lost to Follow-up|2|||
131838823|NCT01986010|474693598|FG015|Overall Study|Lost to Follow-up|0|||
131838824|NCT01986010|474693599|FG016|Overall Study|Lost to Follow-up|0|||
131838825|NCT01986010|474693583|FG000|Overall Study|Physician Decision|0|||
131838826|NCT01986010|474693584|FG001|Overall Study|Physician Decision|0|||
131838827|NCT01986010|474693585|FG002|Overall Study|Physician Decision|0|||
131838828|NCT01986010|474693586|FG003|Overall Study|Physician Decision|0|||
131838829|NCT01986010|474693587|FG004|Overall Study|Physician Decision|0|||
131838830|NCT01986010|474693588|FG005|Overall Study|Physician Decision|0|||
131838831|NCT01986010|474693589|FG006|Overall Study|Physician Decision|0|||
131838832|NCT01986010|474693590|FG007|Overall Study|Physician Decision|0|||
131838833|NCT01986010|474693591|FG008|Overall Study|Physician Decision|0|||
131838834|NCT01986010|474693592|FG009|Overall Study|Physician Decision|0|||
131838835|NCT01986010|474693593|FG010|Overall Study|Physician Decision|0|||
131838836|NCT01986010|474693594|FG011|Overall Study|Physician Decision|0|||
131838837|NCT01986010|474693595|FG012|Overall Study|Physician Decision|0|||
131838838|NCT01986010|474693596|FG013|Overall Study|Physician Decision|0|||
131838839|NCT01986010|474693597|FG014|Overall Study|Physician Decision|1|||
131838840|NCT01986010|474693598|FG015|Overall Study|Physician Decision|0|||
131838841|NCT01986010|474693599|FG016|Overall Study|Physician Decision|0|||
131838842|NCT01986010|474693583|FG000|Overall Study|Withdrawal by Subject|2|||
131838843|NCT01986010|474693584|FG001|Overall Study|Withdrawal by Subject|2|||
131910778|NCT00392223|474960838|FG000|Overall Study|Protocol Violation|0|||
131838844|NCT01986010|474693585|FG002|Overall Study|Withdrawal by Subject|3|||
131838845|NCT01986010|474693586|FG003|Overall Study|Withdrawal by Subject|0|||
131838846|NCT01986010|474693587|FG004|Overall Study|Withdrawal by Subject|2|||
131838847|NCT01986010|474693588|FG005|Overall Study|Withdrawal by Subject|4|||
131838848|NCT01986010|474693589|FG006|Overall Study|Withdrawal by Subject|0|||
131838849|NCT01986010|474693590|FG007|Overall Study|Withdrawal by Subject|0|||
131838850|NCT01986010|474693591|FG008|Overall Study|Withdrawal by Subject|0|||
131838851|NCT01986010|474693592|FG009|Overall Study|Withdrawal by Subject|0|||
131838852|NCT01986010|474693593|FG010|Overall Study|Withdrawal by Subject|0|||
131838853|NCT01986010|474693594|FG011|Overall Study|Withdrawal by Subject|2|||
131838854|NCT01986010|474693595|FG012|Overall Study|Withdrawal by Subject|0|||
131838855|NCT01986010|474693596|FG013|Overall Study|Withdrawal by Subject|1|||
131838856|NCT01986010|474693597|FG014|Overall Study|Withdrawal by Subject|2|||
131838857|NCT01986010|474693598|FG015|Overall Study|Withdrawal by Subject|0|||
131838858|NCT01986010|474693599|FG016|Overall Study|Withdrawal by Subject|0|||
131838859|NCT01986010|474693583|FG000|Overall Study|Status Not Recorded|2|||
131838860|NCT01986010|474693584|FG001|Overall Study|Status Not Recorded|4|||
131838861|NCT01986010|474693585|FG002|Overall Study|Status Not Recorded|2|||
131838862|NCT01986010|474693586|FG003|Overall Study|Status Not Recorded|0|||
131838863|NCT01986010|474693587|FG004|Overall Study|Status Not Recorded|1|||
131838864|NCT01986010|474693588|FG005|Overall Study|Status Not Recorded|2|||
131838865|NCT01986010|474693589|FG006|Overall Study|Status Not Recorded|0|||
131838866|NCT01986010|474693590|FG007|Overall Study|Status Not Recorded|0|||
131838867|NCT01986010|474693591|FG008|Overall Study|Status Not Recorded|2|||
131838868|NCT01986010|474693592|FG009|Overall Study|Status Not Recorded|1|||
131838869|NCT01986010|474693593|FG010|Overall Study|Status Not Recorded|7|||
131838870|NCT01986010|474693594|FG011|Overall Study|Status Not Recorded|7|||
131838871|NCT01986010|474693595|FG012|Overall Study|Status Not Recorded|9|||
131838872|NCT01986010|474693596|FG013|Overall Study|Status Not Recorded|9|||
131838873|NCT01986010|474693597|FG014|Overall Study|Status Not Recorded|5|||
131910779|NCT00392223|474960839|FG001|Overall Study|Protocol Violation|3|||
131838874|NCT01986010|474693598|FG015|Overall Study|Status Not Recorded|10|||
131838875|NCT01986010|474693599|FG016|Overall Study|Status Not Recorded|4|||
131838876|NCT01335997|474693600|FG000|Period I and II|Adverse Event|63|||
131838877|NCT01335997|474693601|FG001|Period I and II|Adverse Event|43|||
131838878|NCT01335997|474693600|FG000|Period I and II|Noncompliance with Study Drug|1|||
131838879|NCT01335997|474693601|FG001|Period I and II|Noncompliance with Study Drug|1|||
131402524|NCT00519376|473095506|FG005|Treatment Period 4|Lost to Follow-up|0|||
131402525|NCT00519376|473095507|FG006|Treatment Period 4|Lost to Follow-up|0|||
131402526|NCT00519376|473095508|FG007|Treatment Period 4|Lost to Follow-up|0|||
131402527|NCT00519376|473095509|FG008|Treatment Period 4|Lost to Follow-up|0|||
131402528|NCT00519376|473095510|FG009|Treatment Period 4|Lost to Follow-up|0|||
131402529|NCT00519376|473095511|FG010|Treatment Period 4|Lost to Follow-up|0|||
131402530|NCT00519376|473095512|FG011|Treatment Period 4|Lost to Follow-up|0|||
131402531|NCT00519376|473095513|FG012|Treatment Period 4|Lost to Follow-up|0|||
131402532|NCT00519376|473095514|FG013|Treatment Period 4|Lost to Follow-up|0|||
131402533|NCT00519376|473095515|FG014|Treatment Period 4|Lost to Follow-up|0|||
131402534|NCT00519376|473095516|FG015|Treatment Period 4|Lost to Follow-up|0|||
131402535|NCT04569136|473095522|FG000|Overall Study|Lost to Follow-up|2|||
131402536|NCT04569136|473095523|FG001|Overall Study|Lost to Follow-up|0|||
131402537|NCT04569136|473095524|FG002|Overall Study|Lost to Follow-up|1|||
131402538|NCT01466660|473095529|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
131402539|NCT01466660|473095530|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
131838880|NCT01335997|474693600|FG000|Period I and II|Lost to Follow-up|3|||
131838881|NCT01335997|474693601|FG001|Period I and II|Lost to Follow-up|5|||
131838882|NCT01335997|474693600|FG000|Period I and II|Withdrawal by Subject|9|||
131838883|NCT01335997|474693601|FG001|Period I and II|Withdrawal by Subject|4|||
131838884|NCT01335997|474693600|FG000|Period I and II|Study Terminated by Sponsor|406|||
131838885|NCT01335997|474693601|FG001|Period I and II|Study Terminated by Sponsor|415|||
131838886|NCT01335997|474693600|FG000|Period I and II|Protocol Violation|9|||
131838887|NCT01335997|474693601|FG001|Period I and II|Protocol Violation|10|||
131838888|NCT01335997|474693600|FG000|Period I and II|Physician Decision|2|||
131838889|NCT01335997|474693601|FG001|Period I and II|Physician Decision|1|||
131838890|NCT01335997|474693600|FG000|Period III|Adverse Event|0|||
131838891|NCT01335997|474693601|FG001|Period III|Adverse Event|2|||
131838892|NCT01335997|474693600|FG000|Period III|Study Terminated by Sponsor|77|||
131838893|NCT01335997|474693601|FG001|Period III|Study Terminated by Sponsor|76|||
131838894|NCT01335997|474693600|FG000|Period III|Protocol Violation|0|||
131838895|NCT01335997|474693601|FG001|Period III|Protocol Violation|1|||
131838896|NCT01335997|474693600|FG000|Period III|Lost to Follow-up|1|||
131838897|NCT01335997|474693601|FG001|Period III|Lost to Follow-up|0|||
131838898|NCT04740814|474693602|FG000|Overall Study|Adverse Event|3|||
131838899|NCT04740814|474693602|FG000|Overall Study|Protocol Violation|2|||
131838900|NCT04740814|474693602|FG000|Overall Study|Lost to Follow-up|2|||
131838901|NCT04740814|474693602|FG000|Overall Study|Withdrawal by Subject|3|||
131838902|NCT02500641|474693605|FG000|Overall Study|Adverse Event|0|||
131838903|NCT02500641|474693606|FG001|Overall Study|Adverse Event|2|||
131838904|NCT02500641|474693605|FG000|Overall Study|Withdrawal by Subject|4|||
131838905|NCT02500641|474693606|FG001|Overall Study|Withdrawal by Subject|5|||
131838906|NCT02500641|474693605|FG000|Overall Study|Unable to follow study procedures|3|||
131838907|NCT02500641|474693606|FG001|Overall Study|Unable to follow study procedures|2|||
131838908|NCT02500641|474693605|FG000|Overall Study|Protocol Violation|1|||
131838909|NCT02500641|474693606|FG001|Overall Study|Protocol Violation|2|||
131838910|NCT02500641|474693605|FG000|Overall Study|Lost to Follow-up|1|||
131838911|NCT02500641|474693606|FG001|Overall Study|Lost to Follow-up|0|||
131838912|NCT02500641|474693605|FG000|Overall Study|Sponsor decision|1|||
131838913|NCT02500641|474693606|FG001|Overall Study|Sponsor decision|0|||
131838914|NCT02500641|474693605|FG000|Overall Study|Non compliance to study drug|0|||
131838915|NCT02500641|474693606|FG001|Overall Study|Non compliance to study drug|1|||
131838916|NCT01408628|474693611|FG000|Consented|Withdrawal by Subject|12|||
131838917|NCT01408628|474693611|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
131838918|NCT01408628|474693611|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
131838919|NCT01408628|474693611|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
131838920|NCT01941940|474693612|FG000|Overall Study|Adverse Event|11|||
131838921|NCT01941940|474693612|FG000|Overall Study|Lost to Follow-up|2|||
131838922|NCT01941940|474693612|FG000|Overall Study|Physician Decision|2|||
131838923|NCT01941940|474693612|FG000|Overall Study|Withdrawal by Subject|15|||
131838924|NCT01941940|474693612|FG000|Overall Study|Death|1|||
131838925|NCT01941940|474693612|FG000|Overall Study|Other|1|||
131838926|NCT01941940|474693612|FG000|Overall Study|Other|1|||
131838927|NCT00750308|474693613|FG000|First Treatment|Adverse Event|0|||
131838928|NCT00750308|474693614|FG001|First Treatment|Adverse Event|1|||
131838929|NCT00750308|474693615|FG002|First Treatment|Adverse Event|0|||
131838930|NCT00750308|474693616|FG003|First Treatment|Adverse Event|0|||
131838931|NCT00750308|474693617|FG004|First Treatment|Adverse Event|0|||
131402540|NCT01466660|473095529|FG000|Overall Study|Worsening of underlying cancer disease|5|||
131838932|NCT00750308|474693618|FG005|First Treatment|Adverse Event|0|||
131450166|NCT04032093|473276809|FG004|Overall Study|Other|1|||
131838933|NCT00750308|474693619|FG006|First Treatment|Adverse Event|0|||
131838934|NCT00750308|474693620|FG007|First Treatment|Adverse Event|0|||
131838935|NCT00750308|474693621|FG008|First Treatment|Adverse Event|0|||
131838936|NCT00750308|474693622|FG009|First Treatment|Adverse Event|0|||
131838937|NCT00750308|474693623|FG010|First Treatment|Adverse Event|1|||
131838938|NCT00750308|474693624|FG011|First Treatment|Adverse Event|1|||
131838939|NCT00750308|474693613|FG000|First Treatment|Withdrawal by Subject|0|||
131838940|NCT00750308|474693614|FG001|First Treatment|Withdrawal by Subject|0|||
131838941|NCT00750308|474693615|FG002|First Treatment|Withdrawal by Subject|0|||
131838942|NCT00750308|474693616|FG003|First Treatment|Withdrawal by Subject|1|||
131838943|NCT00750308|474693617|FG004|First Treatment|Withdrawal by Subject|0|||
131838944|NCT00750308|474693618|FG005|First Treatment|Withdrawal by Subject|0|||
131838945|NCT00750308|474693619|FG006|First Treatment|Withdrawal by Subject|0|||
131838946|NCT00750308|474693620|FG007|First Treatment|Withdrawal by Subject|1|||
131838947|NCT00750308|474693621|FG008|First Treatment|Withdrawal by Subject|0|||
131838948|NCT00750308|474693622|FG009|First Treatment|Withdrawal by Subject|0|||
131838949|NCT00750308|474693623|FG010|First Treatment|Withdrawal by Subject|0|||
131838950|NCT00750308|474693624|FG011|First Treatment|Withdrawal by Subject|0|||
131838951|NCT00750308|474693613|FG000|Second Treatment|Adverse Event|0|||
131838952|NCT00750308|474693614|FG001|Second Treatment|Adverse Event|0|||
131838953|NCT00750308|474693615|FG002|Second Treatment|Adverse Event|0|||
131838954|NCT00750308|474693616|FG003|Second Treatment|Adverse Event|0|||
131838955|NCT00750308|474693617|FG004|Second Treatment|Adverse Event|0|||
131838956|NCT00750308|474693618|FG005|Second Treatment|Adverse Event|1|||
131838957|NCT00750308|474693619|FG006|Second Treatment|Adverse Event|0|||
131838958|NCT00750308|474693620|FG007|Second Treatment|Adverse Event|0|||
131838959|NCT00750308|474693621|FG008|Second Treatment|Adverse Event|1|||
131838960|NCT00750308|474693622|FG009|Second Treatment|Adverse Event|0|||
131838961|NCT00750308|474693623|FG010|Second Treatment|Adverse Event|0|||
131838962|NCT00750308|474693624|FG011|Second Treatment|Adverse Event|0|||
131838963|NCT00750308|474693613|FG000|Second Treatment|Withdrawal by Subject|0|||
131838964|NCT00750308|474693614|FG001|Second Treatment|Withdrawal by Subject|0|||
131838965|NCT00750308|474693615|FG002|Second Treatment|Withdrawal by Subject|0|||
131838966|NCT00750308|474693616|FG003|Second Treatment|Withdrawal by Subject|0|||
131838967|NCT00750308|474693617|FG004|Second Treatment|Withdrawal by Subject|1|||
131838968|NCT00750308|474693618|FG005|Second Treatment|Withdrawal by Subject|0|||
131838969|NCT00750308|474693619|FG006|Second Treatment|Withdrawal by Subject|0|||
131838970|NCT00750308|474693620|FG007|Second Treatment|Withdrawal by Subject|0|||
131838971|NCT00750308|474693621|FG008|Second Treatment|Withdrawal by Subject|0|||
131838972|NCT00750308|474693622|FG009|Second Treatment|Withdrawal by Subject|0|||
131838973|NCT00750308|474693623|FG010|Second Treatment|Withdrawal by Subject|0|||
131838974|NCT00750308|474693624|FG011|Second Treatment|Withdrawal by Subject|0|||
131838975|NCT00750308|474693613|FG000|Third Treatment|Withdrawal by Subject|0|||
131838976|NCT00750308|474693614|FG001|Third Treatment|Withdrawal by Subject|1|||
131838977|NCT00750308|474693615|FG002|Third Treatment|Withdrawal by Subject|0|||
131838978|NCT00750308|474693616|FG003|Third Treatment|Withdrawal by Subject|0|||
131838979|NCT00750308|474693617|FG004|Third Treatment|Withdrawal by Subject|0|||
131838980|NCT00750308|474693618|FG005|Third Treatment|Withdrawal by Subject|0|||
131838981|NCT00750308|474693619|FG006|Third Treatment|Withdrawal by Subject|0|||
131450167|NCT04032093|473276810|FG005|Overall Study|Other|0|||
131450168|NCT04032093|473276811|FG006|Overall Study|Other|0|||
131450169|NCT04032093|473276812|FG007|Overall Study|Other|0|||
131450170|NCT04032093|473276813|FG008|Overall Study|Other|0|||
131450171|NCT04032093|473276814|FG009|Overall Study|Other|1|||
131450172|NCT04032093|473276805|FG000|Overall Study|Withdrawal by Subject|1|||
131450173|NCT04032093|473276806|FG001|Overall Study|Withdrawal by Subject|3|||
131450174|NCT04032093|473276807|FG002|Overall Study|Withdrawal by Subject|2|||
131450175|NCT04032093|473276808|FG003|Overall Study|Withdrawal by Subject|2|||
131450176|NCT04032093|473276809|FG004|Overall Study|Withdrawal by Subject|3|||
131450177|NCT04032093|473276810|FG005|Overall Study|Withdrawal by Subject|0|||
131838982|NCT00750308|474693620|FG007|Third Treatment|Withdrawal by Subject|0|||
131838983|NCT00750308|474693621|FG008|Third Treatment|Withdrawal by Subject|0|||
131838984|NCT00750308|474693622|FG009|Third Treatment|Withdrawal by Subject|0|||
131838985|NCT00750308|474693623|FG010|Third Treatment|Withdrawal by Subject|0|||
131450178|NCT04032093|473276811|FG006|Overall Study|Withdrawal by Subject|0|||
131838986|NCT00750308|474693624|FG011|Third Treatment|Withdrawal by Subject|0|||
131838987|NCT02450526|474693625|FG000|DB Period (Cycle 1)|Adverse Event|0|||
131838988|NCT02450526|474693626|FG001|DB Period (Cycle 1)|Adverse Event|0|||
131838989|NCT02450526|474693627|FG002|DB Period (Cycle 1)|Adverse Event|2|||
131838990|NCT02450526|474693628|FG003|DB Period (Cycle 1)|Adverse Event|0|||
131838991|NCT02450526|474693629|FG004|DB Period (Cycle 1)|Adverse Event|0|||
131838992|NCT02450526|474693625|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
131838993|NCT02450526|474693626|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
131450179|NCT04032093|473276812|FG007|Overall Study|Withdrawal by Subject|0|||
131838994|NCT02450526|474693627|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
131450180|NCT04032093|473276813|FG008|Overall Study|Withdrawal by Subject|0|||
131838995|NCT02450526|474693628|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
131838996|NCT02450526|474693629|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
131838997|NCT02450526|474693625|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
131838998|NCT02450526|474693626|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
131838999|NCT02450526|474693627|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
131839000|NCT02450526|474693628|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
131839001|NCT02450526|474693629|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
131839002|NCT02450526|474693625|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
131839003|NCT02450526|474693626|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
131839004|NCT02450526|474693627|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
131839005|NCT02450526|474693628|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
131839006|NCT02450526|474693629|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
131839007|NCT02450526|474693625|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
131839008|NCT02450526|474693626|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
131839009|NCT02450526|474693627|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
131839010|NCT02450526|474693628|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
131839011|NCT02450526|474693629|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
131839012|NCT02450526|474693625|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
131839013|NCT02450526|474693626|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
131839014|NCT02450526|474693627|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
131839015|NCT02450526|474693628|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
131839016|NCT02450526|474693629|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
131839017|NCT02450526|474693625|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
131839018|NCT02450526|474693626|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
131839019|NCT02450526|474693627|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
131839020|NCT02450526|474693628|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
131839021|NCT02450526|474693629|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
131839022|NCT02450526|474693625|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
131839023|NCT02450526|474693626|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
131839024|NCT02450526|474693627|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
131839025|NCT02450526|474693628|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
131839026|NCT02450526|474693629|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
131839027|NCT02435836|474693630|FG000|Overall Study|Lost to Follow-up|21|||
131839028|NCT02435836|474693630|FG000|Overall Study|Lack of Efficacy|1|||
131839029|NCT02435836|474693630|FG000|Overall Study|Withdrawal by Subject|236|||
131839030|NCT02435836|474693630|FG000|Overall Study|Insufficient Clinical Response|26|||
131839031|NCT02435836|474693630|FG000|Overall Study|Adverse Event|44|||
131839032|NCT02435836|474693630|FG000|Overall Study|Sponsor discontinued trial|167|||
131839033|NCT02435836|474693630|FG000|Overall Study|Noncompliance|27|||
131839034|NCT02435836|474693630|FG000|Overall Study|Protocol Violation|6|||
131839035|NCT02435836|474693630|FG000|Overall Study|Met Withdrawal Criteria|7|||
131839036|NCT02435836|474693630|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
131839037|NCT01970865|474693631|FG000|Overall Study|Death|3|||
131839038|NCT01970865|474693632|FG001|Overall Study|Death|2|||
131839039|NCT01970865|474693633|FG002|Overall Study|Death|3|||
131839040|NCT01970865|474693634|FG003|Overall Study|Death|6|||
131839041|NCT01970865|474693635|FG004|Overall Study|Death|9|||
131839042|NCT01970865|474693636|FG005|Overall Study|Death|3|||
131839043|NCT01970865|474693637|FG006|Overall Study|Death|2|||
131839044|NCT01970865|474693638|FG007|Overall Study|Death|3|||
131839045|NCT01970865|474693639|FG008|Overall Study|Death|2|||
131839046|NCT01970865|474693640|FG009|Overall Study|Death|2|||
131839047|NCT01970865|474693641|FG010|Overall Study|Death|8|||
131839048|NCT01970865|474693642|FG011|Overall Study|Death|13|||
131839049|NCT01970865|474693643|FG012|Overall Study|Death|25|||
131839050|NCT01970865|474693644|FG013|Overall Study|Death|46|||
131839051|NCT01970865|474693645|FG014|Overall Study|Death|37|||
131839052|NCT01970865|474693646|FG015|Overall Study|Death|22|||
131839053|NCT01970865|474693647|FG016|Overall Study|Death|1|||
131839054|NCT01970865|474693648|FG017|Overall Study|Death|17|||
131839055|NCT01970865|474693631|FG000|Overall Study|Lost to Follow-up|0|||
131839056|NCT01970865|474693632|FG001|Overall Study|Lost to Follow-up|0|||
131839057|NCT01970865|474693633|FG002|Overall Study|Lost to Follow-up|0|||
131839058|NCT01970865|474693634|FG003|Overall Study|Lost to Follow-up|1|||
131839059|NCT01970865|474693635|FG004|Overall Study|Lost to Follow-up|1|||
131839060|NCT01970865|474693636|FG005|Overall Study|Lost to Follow-up|0|||
131839061|NCT01970865|474693637|FG006|Overall Study|Lost to Follow-up|0|||
131839062|NCT01970865|474693638|FG007|Overall Study|Lost to Follow-up|0|||
131839063|NCT01970865|474693639|FG008|Overall Study|Lost to Follow-up|0|||
131839064|NCT01970865|474693640|FG009|Overall Study|Lost to Follow-up|0|||
131839065|NCT01970865|474693641|FG010|Overall Study|Lost to Follow-up|1|||
131839066|NCT01970865|474693642|FG011|Overall Study|Lost to Follow-up|0|||
131839067|NCT01970865|474693643|FG012|Overall Study|Lost to Follow-up|2|||
131839068|NCT01970865|474693644|FG013|Overall Study|Lost to Follow-up|0|||
131839069|NCT01970865|474693645|FG014|Overall Study|Lost to Follow-up|1|||
131839070|NCT01970865|474693646|FG015|Overall Study|Lost to Follow-up|4|||
131839071|NCT01970865|474693647|FG016|Overall Study|Lost to Follow-up|0|||
131839072|NCT01970865|474693648|FG017|Overall Study|Lost to Follow-up|1|||
131839073|NCT01970865|474693631|FG000|Overall Study|Other|0|||
131839074|NCT01970865|474693632|FG001|Overall Study|Other|1|||
131839075|NCT01970865|474693633|FG002|Overall Study|Other|0|||
131839076|NCT01970865|474693634|FG003|Overall Study|Other|1|||
131839077|NCT01970865|474693635|FG004|Overall Study|Other|1|||
131839078|NCT01970865|474693636|FG005|Overall Study|Other|0|||
131839079|NCT01970865|474693637|FG006|Overall Study|Other|1|||
131839080|NCT01970865|474693638|FG007|Overall Study|Other|0|||
131839081|NCT01970865|474693639|FG008|Overall Study|Other|0|||
131839082|NCT01970865|474693640|FG009|Overall Study|Other|0|||
131839083|NCT01970865|474693641|FG010|Overall Study|Other|2|||
131839084|NCT01970865|474693642|FG011|Overall Study|Other|3|||
131839085|NCT01970865|474693643|FG012|Overall Study|Other|8|||
131839086|NCT01970865|474693644|FG013|Overall Study|Other|3|||
131839087|NCT01970865|474693645|FG014|Overall Study|Other|2|||
131839088|NCT01970865|474693646|FG015|Overall Study|Other|3|||
131839089|NCT01970865|474693647|FG016|Overall Study|Other|0|||
131839090|NCT01970865|474693648|FG017|Overall Study|Other|2|||
131839091|NCT01970865|474693631|FG000|Overall Study|Participant refused further follow-up|0|||
131839092|NCT01970865|474693632|FG001|Overall Study|Participant refused further follow-up|0|||
131839093|NCT01970865|474693633|FG002|Overall Study|Participant refused further follow-up|0|||
131839094|NCT01970865|474693634|FG003|Overall Study|Participant refused further follow-up|2|||
131839095|NCT01970865|474693635|FG004|Overall Study|Participant refused further follow-up|3|||
131839096|NCT01970865|474693636|FG005|Overall Study|Participant refused further follow-up|0|||
131839097|NCT01970865|474693637|FG006|Overall Study|Participant refused further follow-up|0|||
131839098|NCT01970865|474693638|FG007|Overall Study|Participant refused further follow-up|0|||
131839099|NCT01970865|474693639|FG008|Overall Study|Participant refused further follow-up|0|||
131839100|NCT01970865|474693640|FG009|Overall Study|Participant refused further follow-up|0|||
131839101|NCT01970865|474693641|FG010|Overall Study|Participant refused further follow-up|1|||
131839102|NCT01970865|474693642|FG011|Overall Study|Participant refused further follow-up|4|||
131839103|NCT01970865|474693643|FG012|Overall Study|Participant refused further follow-up|7|||
131839104|NCT01970865|474693644|FG013|Overall Study|Participant refused further follow-up|8|||
131839105|NCT01970865|474693645|FG014|Overall Study|Participant refused further follow-up|3|||
131839106|NCT01970865|474693646|FG015|Overall Study|Participant refused further follow-up|11|||
131839107|NCT01970865|474693647|FG016|Overall Study|Participant refused further follow-up|0|||
131839108|NCT01970865|474693648|FG017|Overall Study|Participant refused further follow-up|6|||
131839109|NCT01855074|474693651|FG000|Overall Study|Adverse Event|1|||
131839110|NCT01855074|474693651|FG000|Overall Study|Lost to Follow-up|4|||
131839111|NCT01855074|474693651|FG000|Overall Study|Withdrawal by Subject|8|||
131839112|NCT01855074|474693651|FG000|Overall Study|Started but not treated|1|||
131839113|NCT04221789|474695498|FG000|Overall Study|deviation from protoco|22|||
131839114|NCT04221789|474695499|FG001|Overall Study|deviation from protoco|8|||
131839115|NCT06077487|474695500|FG000|Overall Study|Withdrawal by Subject|0|||
131839116|NCT06077487|474695501|FG001|Overall Study|Withdrawal by Subject|1|||
131839117|NCT03747601|474695502|FG000|Overall Study|COVID halt to visits|4|||
131839118|NCT03303625|474695503|FG000|Overall Study|Withdrawal by Subject|2|||
131839119|NCT03303625|474695504|FG001|Overall Study|Withdrawal by Subject|0|||
131839120|NCT03303625|474695505|FG002|Overall Study|Withdrawal by Subject|0|||
131839121|NCT03303625|474695506|FG003|Overall Study|Withdrawal by Subject|0|||
131839122|NCT00759902|474695508|FG000|Overall Study|Adverse Event|0|||
131839123|NCT00759902|474695509|FG001|Overall Study|Adverse Event|1|||
131839124|NCT02128217|474695512|FG000|Overall Study|Lost to Follow-up|0|||
131839125|NCT02128217|474695513|FG001|Overall Study|Lost to Follow-up|1|||
131839126|NCT05071313|474695514|FG000|Overall Study|Lost to Follow-up|17|||
131839127|NCT05071313|474695515|FG001|Overall Study|Lost to Follow-up|10|||
131839128|NCT05071313|474695514|FG000|Overall Study|Physician Decision|1|||
131839129|NCT05071313|474695515|FG001|Overall Study|Physician Decision|6|||
131839130|NCT05071313|474695514|FG000|Overall Study|Death|1|||
131839131|NCT05071313|474695515|FG001|Overall Study|Death|0|||
131839132|NCT05071313|474695514|FG000|Overall Study|Withdrawal by Subject|10|||
131839133|NCT05071313|474695515|FG001|Overall Study|Withdrawal by Subject|15|||
131839134|NCT05071313|474695514|FG000|Overall Study|Other|1|||
131839135|NCT05071313|474695515|FG001|Overall Study|Other|0|||
131839136|NCT05071313|474695514|FG000|Overall Study|Randomized but not vaccinated|4|||
131839137|NCT05071313|474695515|FG001|Overall Study|Randomized but not vaccinated|2|||
131839138|NCT03107026|474695516|FG000|Overall Study|Adverse Event|2|||
131839139|NCT03107026|474695517|FG001|Overall Study|Adverse Event|14|||
131839140|NCT03107026|474695518|FG002|Overall Study|Adverse Event|23|||
131839141|NCT03107026|474695516|FG000|Overall Study|Lost to Follow-up|12|||
131839142|NCT03107026|474695517|FG001|Overall Study|Lost to Follow-up|12|||
131839143|NCT03107026|474695518|FG002|Overall Study|Lost to Follow-up|13|||
131839144|NCT03107026|474695516|FG000|Overall Study|Protocol Violation|1|||
131839145|NCT03107026|474695517|FG001|Overall Study|Protocol Violation|2|||
131839146|NCT03107026|474695518|FG002|Overall Study|Protocol Violation|0|||
131402541|NCT01466660|473095530|FG001|Overall Study|Worsening of underlying cancer disease|2|||
131839147|NCT03107026|474695516|FG000|Overall Study|Pregnancy|1|||
131839148|NCT03107026|474695517|FG001|Overall Study|Pregnancy|0|||
131839149|NCT03107026|474695518|FG002|Overall Study|Pregnancy|0|||
131839150|NCT03107026|474695516|FG000|Overall Study|Withdrawal by Subject|13|||
131839151|NCT03107026|474695517|FG001|Overall Study|Withdrawal by Subject|5|||
131839152|NCT03107026|474695518|FG002|Overall Study|Withdrawal by Subject|17|||
131839153|NCT03107026|474695516|FG000|Overall Study|non compliance with study visits|1|||
131839154|NCT03107026|474695517|FG001|Overall Study|non compliance with study visits|2|||
131839155|NCT03107026|474695518|FG002|Overall Study|non compliance with study visits|0|||
131839156|NCT03107026|474695516|FG000|Overall Study|non-compliance with study drug|2|||
131839157|NCT03107026|474695517|FG001|Overall Study|non-compliance with study drug|2|||
131839158|NCT03107026|474695518|FG002|Overall Study|non-compliance with study drug|3|||
131839159|NCT03107026|474695516|FG000|Overall Study|Physician Decision|0|||
131839160|NCT03107026|474695517|FG001|Overall Study|Physician Decision|1|||
131839161|NCT03107026|474695518|FG002|Overall Study|Physician Decision|0|||
131839162|NCT01951885|474695521|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
131839163|NCT01951885|474695522|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
131839164|NCT01951885|474695521|FG000|Overall Study|Adverse Event|1|||
131839165|NCT01951885|474695522|FG001|Overall Study|Adverse Event|0|||
131839166|NCT01951885|474695521|FG000|Overall Study|Withdrawal by Subject|0|||
131839167|NCT01951885|474695522|FG001|Overall Study|Withdrawal by Subject|1|||
131839168|NCT01951885|474695521|FG000|Overall Study|ineligible due to a change in donor|0|||
131839169|NCT01951885|474695522|FG001|Overall Study|ineligible due to a change in donor|1|||
131839170|NCT01951885|474695521|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
131839171|NCT01951885|474695522|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
131839172|NCT03347422|474695526|FG000|Part A (26 Weeks)|Adverse Event|3|||
131839173|NCT03347422|474695527|FG001|Part A (26 Weeks)|Adverse Event|0|||
131839174|NCT03347422|474695526|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
131839175|NCT03347422|474695527|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
131839176|NCT03347422|474695526|FG000|Part B (149 Weeks)|Adverse Event|0|||
131839177|NCT03347422|474695527|FG001|Part B (149 Weeks)|Adverse Event|1|||
131839178|NCT03347422|474695526|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
131839179|NCT03347422|474695527|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
131839180|NCT03347422|474695526|FG000|Part B (149 Weeks)|Other|1|||
131839181|NCT03347422|474695527|FG001|Part B (149 Weeks)|Other|0|||
131839182|NCT05183217|474695528|FG000|Overall Study|Withdrawal by Subject|1|||
131839183|NCT05183217|474695529|FG001|Overall Study|Withdrawal by Subject|1|||
131839184|NCT01155024|474695531|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
131839185|NCT01155024|474695532|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
131839186|NCT01155024|474695531|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
131839187|NCT01155024|474695532|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
131839188|NCT01155024|474695531|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
131839189|NCT01155024|474695532|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
131839190|NCT04585789|474695533|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
131839191|NCT04585789|474695534|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
131839192|NCT04585789|474695535|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
131839193|NCT04585789|474695533|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
131839194|NCT04585789|474695534|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
131839195|NCT04585789|474695535|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
131839196|NCT01383135|474695542|FG000|Overall Study|Not Scanned / Imaged|1|||
131839197|NCT01383135|474695543|FG001|Overall Study|Not Scanned / Imaged|0|||
131839198|NCT01383135|474695544|FG002|Overall Study|Not Scanned / Imaged|1|||
131839199|NCT01383135|474695545|FG003|Overall Study|Not Scanned / Imaged|0|||
131839200|NCT00801099|474695547|FG000|Overall Study|Lost to Follow-up|101|||
131839201|NCT03397771|474695550|FG000|Overall Study|2 erroneously randomized, never treated|3|||
131839202|NCT03397771|474695551|FG001|Overall Study|2 erroneously randomized, never treated|1|||
131839203|NCT03397771|474695550|FG000|Overall Study|Withdrawal by Subject|1|||
131839204|NCT03397771|474695551|FG001|Overall Study|Withdrawal by Subject|3|||
131839205|NCT03397771|474695550|FG000|Overall Study|Protocol Violation|2|||
131839206|NCT03397771|474695551|FG001|Overall Study|Protocol Violation|2|||
131839207|NCT03397771|474695550|FG000|Overall Study|Adverse Event|2|||
131839208|NCT03397771|474695551|FG001|Overall Study|Adverse Event|1|||
131839209|NCT04078126|474695557|FG000|Washout|Study put on hold due to COVID-19|0|||
131839210|NCT04078126|474695558|FG001|Washout|Study put on hold due to COVID-19|2|||
131839211|NCT04078126|474695557|FG000|Period 2|Study put on hold due to COVID-19|1|||
131839212|NCT04078126|474695558|FG001|Period 2|Study put on hold due to COVID-19|1|||
131839213|NCT03321630|474695561|FG000|Overall Study|Adverse Event|1|||
131839214|NCT03321630|474695561|FG000|Overall Study|Investigator Discretion|2|||
131839215|NCT03321630|474695561|FG000|Overall Study|Withdrawal by Subject|1|||
131839216|NCT02981303|474695562|FG000|Overall Study|Progressive Disease|17|||
131839217|NCT02981303|474695563|FG001|Overall Study|Progressive Disease|37|||
131839218|NCT02981303|474695562|FG000|Overall Study|Adverse Event|1|||
131839219|NCT02981303|474695563|FG001|Overall Study|Adverse Event|4|||
131839220|NCT02981303|474695562|FG000|Overall Study|Withdrawal by Subject|0|||
131839221|NCT02981303|474695563|FG001|Overall Study|Withdrawal by Subject|1|||
131402542|NCT01466660|473095529|FG000|Overall Study|Other adverse event|19|||
131402543|NCT01466660|473095530|FG001|Overall Study|Other adverse event|18|||
131402544|NCT01466660|473095529|FG000|Overall Study|Protocol Violation|2|||
131402545|NCT01466660|473095530|FG001|Overall Study|Protocol Violation|1|||
131450181|NCT04032093|473276814|FG009|Overall Study|Withdrawal by Subject|0|||
131450182|NCT04032093|473276805|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131839222|NCT02325518|474695564|FG000|Overall Study|Adverse Event|4|||
131839223|NCT02325518|474695565|FG001|Overall Study|Adverse Event|1|||
131839224|NCT02325518|474695564|FG000|Overall Study|Physician Decision|0|||
131839225|NCT02325518|474695565|FG001|Overall Study|Physician Decision|1|||
131839226|NCT02325518|474695564|FG000|Overall Study|Withdrawal by Subject|0|||
131839227|NCT02325518|474695565|FG001|Overall Study|Withdrawal by Subject|1|||
131839228|NCT03393806|474695568|FG000|Overall Study|Physician Decision|1|||
131839229|NCT03393806|474695569|FG001|Overall Study|Physician Decision|0|||
131839230|NCT00886288|474695570|FG000|Overall Study|no respect of the 12 weeks period|657|||
131839231|NCT00886288|474695571|FG001|Overall Study|no respect of the 12 weeks period|227|||
131839232|NCT00886288|474695570|FG000|Overall Study|Lost to Follow-up|86|||
131839233|NCT00886288|474695571|FG001|Overall Study|Lost to Follow-up|0|||
131839234|NCT01259115|474695572|FG000|Period 1|Adverse Event|1|||
131839235|NCT01259115|474695573|FG001|Period 1|Adverse Event|0|||
131839236|NCT01259115|474695572|FG000|Period 1|Protocol Violation|2|||
131839237|NCT01259115|474695573|FG001|Period 1|Protocol Violation|0|||
131839238|NCT01259115|474695572|FG000|Period 1|Lost to Follow-up|0|||
131839239|NCT01259115|474695573|FG001|Period 1|Lost to Follow-up|1|||
131839240|NCT01259115|474695572|FG000|Period 2|Adverse Event|1|||
131839241|NCT01259115|474695573|FG001|Period 2|Adverse Event|0|||
131839242|NCT01675661|474695574|FG000|Overall Study|Lost to Follow-up|22|||
131839243|NCT01675661|474695575|FG001|Overall Study|Lost to Follow-up|23|||
131839244|NCT01675661|474695574|FG000|Overall Study|Practical problems|9|||
131839245|NCT01675661|474695575|FG001|Overall Study|Practical problems|5|||
131839246|NCT01675661|474695574|FG000|Overall Study|Moved away|5|||
131839247|NCT01675661|474695575|FG001|Overall Study|Moved away|6|||
131839248|NCT01675661|474695574|FG000|Overall Study|Withdrawal by Subject|3|||
131839249|NCT01675661|474695575|FG001|Overall Study|Withdrawal by Subject|7|||
131839250|NCT01675661|474695574|FG000|Overall Study|Physician Decision|0|||
131839251|NCT01675661|474695575|FG001|Overall Study|Physician Decision|2|||
131839252|NCT01675661|474695574|FG000|Overall Study|Death|0|||
131839253|NCT01675661|474695575|FG001|Overall Study|Death|1|||
131839254|NCT01675661|474695574|FG000|Overall Study|Other reason|1|||
131839255|NCT01675661|474695575|FG001|Overall Study|Other reason|2|||
131839256|NCT00977379|474695576|FG000|Overall Study|Withdrawal by Subject|1|||
131839257|NCT00977379|474695577|FG001|Overall Study|Withdrawal by Subject|1|||
131839258|NCT00977379|474695576|FG000|Overall Study|Death|7|||
131839259|NCT00977379|474695577|FG001|Overall Study|Death|9|||
131839260|NCT00977379|474695576|FG000|Overall Study|Premature Study Termination|4|||
131839261|NCT00977379|474695577|FG001|Overall Study|Premature Study Termination|0|||
131839262|NCT00977379|474695576|FG000|Overall Study|Participant Moving House|0|||
131839263|NCT00977379|474695577|FG001|Overall Study|Participant Moving House|1|||
131839264|NCT00977379|474695576|FG000|Overall Study|Randomization Error|0|||
131839265|NCT00977379|474695577|FG001|Overall Study|Randomization Error|1|||
131839266|NCT02992418|474695584|FG000|Overall Study|Withdrawal by Subject|11|||
131839267|NCT02992418|474695585|FG001|Overall Study|Withdrawal by Subject|12|||
131839268|NCT02992418|474695584|FG000|Overall Study|Non-compliance with the protocol|308|||
131839269|NCT02992418|474695585|FG001|Overall Study|Non-compliance with the protocol|308|||
131839270|NCT02992418|474695584|FG000|Overall Study|Lost to Follow-up|27|||
131839271|NCT02992418|474695585|FG001|Overall Study|Lost to Follow-up|22|||
131839272|NCT03246126|474695590|FG000|Overall Study|Withdrawal by Subject|0|||
131839273|NCT03246126|474695591|FG001|Overall Study|Withdrawal by Subject|1|||
131839274|NCT05084963|474695595|FG000|Overall Study|Withdrawal by Subject|0|||
131839275|NCT05084963|474695596|FG001|Overall Study|Withdrawal by Subject|0|||
131839276|NCT05084963|474695597|FG002|Overall Study|Withdrawal by Subject|1|||
131839277|NCT05442866|474695598|FG000|Overall Study|Death|1|||
131839278|NCT05442866|474695598|FG000|Overall Study|Lost to Follow-up|9|||
131839279|NCT05442866|474695598|FG000|Overall Study|Protocol Violation|1|||
131839280|NCT03819049|474695599|FG000|Overall Study|Lost to Follow-up|1|||
131839281|NCT03819049|474695600|FG001|Overall Study|Lost to Follow-up|2|||
131839282|NCT03819049|474695601|FG002|Overall Study|Lost to Follow-up|9|||
131450183|NCT04032093|473276806|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131839283|NCT03819049|474695602|FG003|Overall Study|Lost to Follow-up|0|||
131839284|NCT03819049|474695603|FG004|Overall Study|Lost to Follow-up|3|||
131839285|NCT03819049|474695604|FG005|Overall Study|Lost to Follow-up|1|||
131839286|NCT03819049|474695605|FG006|Overall Study|Lost to Follow-up|0|||
131839287|NCT03819049|474695599|FG000|Overall Study|Withdrawal by Subject|0|||
131450184|NCT04032093|473276807|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131910780|NCT00392223|474960838|FG000|Overall Study|Withdrawal by Subject|3|||
131910781|NCT00392223|474960839|FG001|Overall Study|Withdrawal by Subject|2|||
131839288|NCT03819049|474695600|FG001|Overall Study|Withdrawal by Subject|0|||
131839289|NCT03819049|474695601|FG002|Overall Study|Withdrawal by Subject|18|||
131839290|NCT03819049|474695602|FG003|Overall Study|Withdrawal by Subject|0|||
131839291|NCT03819049|474695603|FG004|Overall Study|Withdrawal by Subject|10|||
131839292|NCT03819049|474695604|FG005|Overall Study|Withdrawal by Subject|9|||
131839293|NCT03819049|474695605|FG006|Overall Study|Withdrawal by Subject|1|||
131839294|NCT03819049|474695599|FG000|Overall Study|Ongoing|0|||
131839295|NCT03819049|474695600|FG001|Overall Study|Ongoing|0|||
131839296|NCT03819049|474695601|FG002|Overall Study|Ongoing|75|||
131839297|NCT03819049|474695602|FG003|Overall Study|Ongoing|0|||
131839298|NCT03819049|474695603|FG004|Overall Study|Ongoing|41|||
131839299|NCT03819049|474695604|FG005|Overall Study|Ongoing|0|||
131839300|NCT03819049|474695605|FG006|Overall Study|Ongoing|0|||
131839301|NCT03819049|474695599|FG000|Overall Study|Other|0|||
131839302|NCT03819049|474695600|FG001|Overall Study|Other|0|||
131839303|NCT03819049|474695601|FG002|Overall Study|Other|2|||
131839304|NCT03819049|474695602|FG003|Overall Study|Other|0|||
131839305|NCT03819049|474695603|FG004|Overall Study|Other|0|||
131839306|NCT03819049|474695604|FG005|Overall Study|Other|0|||
131839307|NCT03819049|474695605|FG006|Overall Study|Other|0|||
131839308|NCT03819049|474695599|FG000|Overall Study|Randomized but not vaccinated|0|||
131839309|NCT03819049|474695600|FG001|Overall Study|Randomized but not vaccinated|0|||
131839310|NCT03819049|474695601|FG002|Overall Study|Randomized but not vaccinated|0|||
131839311|NCT03819049|474695602|FG003|Overall Study|Randomized but not vaccinated|1|||
131839312|NCT03819049|474695603|FG004|Overall Study|Randomized but not vaccinated|0|||
131839313|NCT03819049|474695604|FG005|Overall Study|Randomized but not vaccinated|2|||
131839314|NCT03819049|474695605|FG006|Overall Study|Randomized but not vaccinated|1|||
131839315|NCT03819049|474695599|FG000|Overall Study|Physician Decision|0|||
131839316|NCT03819049|474695600|FG001|Overall Study|Physician Decision|0|||
131839317|NCT03819049|474695601|FG002|Overall Study|Physician Decision|0|||
131839318|NCT03819049|474695602|FG003|Overall Study|Physician Decision|0|||
131839319|NCT03819049|474695603|FG004|Overall Study|Physician Decision|0|||
131839320|NCT03819049|474695604|FG005|Overall Study|Physician Decision|0|||
131839321|NCT03819049|474695605|FG006|Overall Study|Physician Decision|1|||
131839322|NCT01568320|474695606|FG000|Overall Study|Death|20|||
131839323|NCT01568320|474695606|FG000|Overall Study|Lost to Follow-up|9|||
131839324|NCT01568320|474695606|FG000|Overall Study|Withdrawal by Subject|10|||
131839325|NCT01568320|474695606|FG000|Overall Study|Conversion to open repair|1|||
131839326|NCT01568320|474695606|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
131839327|NCT01616953|474695607|FG000|Overall Study|Lost to Follow-up|1|||
131839328|NCT01616953|474695608|FG001|Overall Study|Lost to Follow-up|0|||
131839329|NCT01616953|474695607|FG000|Overall Study|lack of bone and soft tissue|1|||
131839330|NCT01616953|474695608|FG001|Overall Study|lack of bone and soft tissue|0|||
131839331|NCT01394952|474695609|FG000|Overall Study|Lost to Follow-up|0|||
131839332|NCT01394952|474695610|FG001|Overall Study|Lost to Follow-up|5|||
131839333|NCT01394952|474695609|FG000|Overall Study|Withdrawal by Subject|10|||
131839334|NCT01394952|474695610|FG001|Overall Study|Withdrawal by Subject|5|||
131839335|NCT01394952|474695609|FG000|Overall Study|Physician Decision|2|||
131839336|NCT01394952|474695610|FG001|Overall Study|Physician Decision|0|||
131839337|NCT01394952|474695609|FG000|Overall Study|Sponsor Decision|5|||
131839338|NCT01394952|474695610|FG001|Overall Study|Sponsor Decision|7|||
131839339|NCT01103466|474695613|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
131839340|NCT01103466|474695614|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
131839341|NCT01103466|474695615|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
131839342|NCT01103466|474695613|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
131839343|NCT01103466|474695614|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
131839344|NCT01103466|474695615|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
131839345|NCT01103466|474695613|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
131839346|NCT01103466|474695614|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
131839347|NCT01103466|474695615|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
131839348|NCT01103466|474695613|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
131839349|NCT01103466|474695614|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
131839350|NCT01103466|474695615|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
131839351|NCT01103466|474695613|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
131839352|NCT01103466|474695614|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
131839353|NCT01103466|474695615|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
131839354|NCT01103466|474695613|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
131839355|NCT01103466|474695614|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
131839356|NCT01103466|474695615|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
131839357|NCT02331368|474695620|FG000|Overall Study|Withdrawal by Subject|3|||
131839358|NCT01763684|474695623|FG000|Overall Study|Study terminated early due to low enrollment|126|||
131839359|NCT01763684|474695624|FG001|Overall Study|Study terminated early due to low enrollment|127|||
131839360|NCT01763684|474695623|FG000|Overall Study|Study surgery not performed|7|||
131839361|NCT01763684|474695624|FG001|Overall Study|Study surgery not performed|6|||
131839362|NCT00643565|474695631|FG000|Overall Study|Death|12|||
131839363|NCT00643565|474695632|FG001|Overall Study|Death|11|||
131839364|NCT00643565|474695631|FG000|Overall Study|Withdrawal by Subject|4|||
131910782|NCT00402831|474960840|FG000|Overall Study|Lost to Follow-up|1|||
131839365|NCT00643565|474695632|FG001|Overall Study|Withdrawal by Subject|1|||
131839366|NCT00643565|474695631|FG000|Overall Study|Lost to Follow-up|0|||
131839367|NCT00643565|474695632|FG001|Overall Study|Lost to Follow-up|6|||
131839368|NCT00643565|474695631|FG000|Overall Study|Other|7|||
131839369|NCT00643565|474695632|FG001|Overall Study|Other|8|||
131839370|NCT00643565|474695631|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
131839371|NCT00643565|474695632|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
131839372|NCT00643565|474695631|FG000|Overall Study|Recurrence of Disease|2|||
131839373|NCT00643565|474695632|FG001|Overall Study|Recurrence of Disease|1|||
131839374|NCT00643565|474695631|FG000|Overall Study|Progression of Disease|18|||
131839375|NCT00643565|474695632|FG001|Overall Study|Progression of Disease|14|||
131839376|NCT00643565|474695631|FG000|Overall Study|Protocol Violation|3|||
131839377|NCT00643565|474695632|FG001|Overall Study|Protocol Violation|0|||
131839378|NCT00643565|474695631|FG000|Overall Study|Did Not Cooperate|0|||
131839379|NCT00643565|474695632|FG001|Overall Study|Did Not Cooperate|1|||
131839380|NCT00643565|474695631|FG000|Overall Study|Administrative|22|||
131839381|NCT00643565|474695632|FG001|Overall Study|Administrative|16|||
131839382|NCT00643565|474695631|FG000|Overall Study|Adverse Event|5|||
131839383|NCT00643565|474695632|FG001|Overall Study|Adverse Event|8|||
131839384|NCT02317614|474695633|FG000|Overall Study|Lost to Follow-up|1|||
131839385|NCT02317614|474695634|FG001|Overall Study|Lost to Follow-up|1|||
131839386|NCT02317614|474695633|FG000|Overall Study|Withdrawal by Subject|1|||
131839387|NCT02317614|474695634|FG001|Overall Study|Withdrawal by Subject|0|||
131839388|NCT02317614|474695633|FG000|Overall Study|Death|1|||
131839389|NCT02317614|474695634|FG001|Overall Study|Death|1|||
131839390|NCT04453202|474695639|FG000|Overall Study|Adverse Event|0|||
131839391|NCT04453202|474695640|FG001|Overall Study|Adverse Event|0|||
131839392|NCT04453202|474695641|FG002|Overall Study|Adverse Event|0|||
131839393|NCT04453202|474695642|FG003|Overall Study|Adverse Event|0|||
131839394|NCT04453202|474695643|FG004|Overall Study|Adverse Event|0|||
131839395|NCT04453202|474695644|FG005|Overall Study|Adverse Event|0|||
131839396|NCT04453202|474695645|FG006|Overall Study|Adverse Event|1|||
131839397|NCT04453202|474695646|FG007|Overall Study|Adverse Event|0|||
131839398|NCT04453202|474695647|FG008|Overall Study|Adverse Event|0|||
131839399|NCT04453202|474695648|FG009|Overall Study|Adverse Event|0|||
131839400|NCT04453202|474695649|FG010|Overall Study|Adverse Event|0|||
131839401|NCT04453202|474695639|FG000|Overall Study|Death|0|||
131839402|NCT04453202|474695640|FG001|Overall Study|Death|0|||
131839403|NCT04453202|474695641|FG002|Overall Study|Death|0|||
131839404|NCT04453202|474695642|FG003|Overall Study|Death|0|||
131839405|NCT04453202|474695643|FG004|Overall Study|Death|0|||
131839406|NCT04453202|474695644|FG005|Overall Study|Death|0|||
131839407|NCT04453202|474695645|FG006|Overall Study|Death|0|||
131839408|NCT04453202|474695646|FG007|Overall Study|Death|0|||
131839409|NCT04453202|474695647|FG008|Overall Study|Death|0|||
131839410|NCT04453202|474695648|FG009|Overall Study|Death|1|||
131839411|NCT04453202|474695649|FG010|Overall Study|Death|0|||
131839412|NCT04453202|474695639|FG000|Overall Study|Lost to Follow-up|0|||
131839413|NCT04453202|474695640|FG001|Overall Study|Lost to Follow-up|1|||
131839414|NCT04453202|474695641|FG002|Overall Study|Lost to Follow-up|0|||
131839415|NCT04453202|474695642|FG003|Overall Study|Lost to Follow-up|1|||
131839416|NCT04453202|474695643|FG004|Overall Study|Lost to Follow-up|0|||
131839417|NCT04453202|474695644|FG005|Overall Study|Lost to Follow-up|0|||
131839418|NCT04453202|474695645|FG006|Overall Study|Lost to Follow-up|0|||
131839419|NCT04453202|474695646|FG007|Overall Study|Lost to Follow-up|0|||
131839420|NCT04453202|474695647|FG008|Overall Study|Lost to Follow-up|0|||
131839421|NCT04453202|474695648|FG009|Overall Study|Lost to Follow-up|1|||
131839422|NCT04453202|474695649|FG010|Overall Study|Lost to Follow-up|1|||
131839423|NCT04453202|474695639|FG000|Overall Study|Withdrawal by Subject|1|||
131839424|NCT04453202|474695640|FG001|Overall Study|Withdrawal by Subject|2|||
131839425|NCT04453202|474695641|FG002|Overall Study|Withdrawal by Subject|1|||
131839426|NCT04453202|474695642|FG003|Overall Study|Withdrawal by Subject|2|||
131839427|NCT04453202|474695643|FG004|Overall Study|Withdrawal by Subject|1|||
131839428|NCT04453202|474695644|FG005|Overall Study|Withdrawal by Subject|1|||
131839429|NCT04453202|474695645|FG006|Overall Study|Withdrawal by Subject|0|||
131839430|NCT04453202|474695646|FG007|Overall Study|Withdrawal by Subject|0|||
131839431|NCT04453202|474695647|FG008|Overall Study|Withdrawal by Subject|0|||
131839432|NCT04453202|474695648|FG009|Overall Study|Withdrawal by Subject|1|||
131839433|NCT04453202|474695649|FG010|Overall Study|Withdrawal by Subject|0|||
131839434|NCT04453202|474695639|FG000|Overall Study|Adverse Event|0|||
131839435|NCT04453202|474695640|FG001|Overall Study|Adverse Event|0|||
131839436|NCT04453202|474695641|FG002|Overall Study|Adverse Event|0|||
131839437|NCT04453202|474695642|FG003|Overall Study|Adverse Event|0|||
131839438|NCT04453202|474695643|FG004|Overall Study|Adverse Event|0|||
131839439|NCT04453202|474695644|FG005|Overall Study|Adverse Event|1|||
131839440|NCT04453202|474695645|FG006|Overall Study|Adverse Event|0|||
131402546|NCT01466660|473095529|FG000|Overall Study|Refused continuation of trial medication|4|||
131402547|NCT01466660|473095530|FG001|Overall Study|Refused continuation of trial medication|3|||
131839441|NCT04453202|474695646|FG007|Overall Study|Adverse Event|0|||
131402548|NCT01466660|473095529|FG000|Overall Study|Other reason not defined above|10|||
131839442|NCT04453202|474695647|FG008|Overall Study|Adverse Event|0|||
131839443|NCT04453202|474695648|FG009|Overall Study|Adverse Event|0|||
131839444|NCT04453202|474695649|FG010|Overall Study|Adverse Event|0|||
131839445|NCT00669071|474695650|FG000|Overall Study|Lost to Follow-up|3|||
131839446|NCT00669071|474695650|FG000|Overall Study|Final visit 40 days out of window|1|||
131402549|NCT01466660|473095530|FG001|Overall Study|Other reason not defined above|8|||
131839447|NCT02357342|474695658|FG000|First 6 Months|Death|2|||
131839448|NCT02357342|474695659|FG001|First 6 Months|Death|0|||
131839449|NCT01674647|474695660|FG000|Treatment Period|Death|4|||
131839450|NCT01674647|474695661|FG001|Treatment Period|Death|1|||
131839451|NCT01674647|474695660|FG000|Treatment Period|Efficacy outcome reached|0|||
131839452|NCT01674647|474695661|FG001|Treatment Period|Efficacy outcome reached|1|||
131839453|NCT01674647|474695660|FG000|Treatment Period|Physician Decision|3|||
131839454|NCT01674647|474695661|FG001|Treatment Period|Physician Decision|1|||
131839455|NCT01674647|474695660|FG000|Treatment Period|Adverse Event|60|||
131839456|NCT01674647|474695661|FG001|Treatment Period|Adverse Event|22|||
131839457|NCT01674647|474695660|FG000|Treatment Period|Non-compliance with study drug|3|||
131839458|NCT01674647|474695661|FG001|Treatment Period|Non-compliance with study drug|0|||
131839459|NCT01674647|474695660|FG000|Treatment Period|Lost to Follow-up|1|||
131839460|NCT01674647|474695661|FG001|Treatment Period|Lost to Follow-up|1|||
131839461|NCT01674647|474695660|FG000|Treatment Period|Withdrawal by Subject|19|||
131839462|NCT01674647|474695661|FG001|Treatment Period|Withdrawal by Subject|16|||
131839463|NCT01674647|474695660|FG000|Treatment Period|Switching to other therapy|5|||
131839464|NCT01674647|474695661|FG001|Treatment Period|Switching to other therapy|2|||
131839465|NCT01674647|474695660|FG000|Treatment Period|Logistical difficulties|5|||
131839466|NCT01674647|474695661|FG001|Treatment Period|Logistical difficulties|8|||
131839467|NCT01674647|474695660|FG000|Treatment Period|Treatment failure|0|||
131839468|NCT01674647|474695661|FG001|Treatment Period|Treatment failure|14|||
131839469|NCT01674647|474695660|FG000|Treatment Period|Protocol Violation|56|||
131839470|NCT01674647|474695661|FG001|Treatment Period|Protocol Violation|36|||
131839471|NCT01674647|474695660|FG000|30-day Safety Follow-up Period|Death|3|||
131839472|NCT01674647|474695661|FG001|30-day Safety Follow-up Period|Death|2|||
131839473|NCT01674647|474695660|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
131839474|NCT01674647|474695661|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
131839475|NCT01674647|474695660|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
131839476|NCT01674647|474695661|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
131839477|NCT01674647|474695660|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
131839478|NCT01674647|474695661|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
131839479|NCT01674647|474695660|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
131839480|NCT01674647|474695661|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
131839481|NCT01674647|474695660|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
131839482|NCT01674647|474695661|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
131839483|NCT01490866|474695663|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
131839484|NCT01490866|474695663|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
131839485|NCT01490866|474695663|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
131839486|NCT01490866|474695663|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
131839487|NCT01490866|474695663|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
131839488|NCT01490866|474695663|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
131839489|NCT01490866|474695663|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
131839490|NCT01490866|474695663|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
131839491|NCT01490866|474695663|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
131839492|NCT01490866|474695663|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
131839493|NCT01490866|474695663|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
131839494|NCT02980874|474695664|FG000|Overall Study|Adverse Event|2|||
131839495|NCT02980874|474695665|FG001|Overall Study|Adverse Event|7|||
131839496|NCT02980874|474695664|FG000|Overall Study|Withdrawal by Subject|7|||
131839497|NCT02980874|474695665|FG001|Overall Study|Withdrawal by Subject|2|||
131839498|NCT02980874|474695664|FG000|Overall Study|Lost to Follow-up|5|||
131839499|NCT02980874|474695665|FG001|Overall Study|Lost to Follow-up|5|||
131839500|NCT02980874|474695664|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
131839501|NCT02980874|474695665|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
131839502|NCT02980874|474695664|FG000|Overall Study|Unknown study completion status|1|||
131839503|NCT02980874|474695665|FG001|Overall Study|Unknown study completion status|0|||
131839504|NCT00914459|474695666|FG000|Overall Study|Protocol Violation|0|||
131839505|NCT00914459|474695667|FG001|Overall Study|Protocol Violation|1|||
131839506|NCT00914459|474695666|FG000|Overall Study|Parent/Legal guardian request|1|||
131839507|NCT00914459|474695667|FG001|Overall Study|Parent/Legal guardian request|0|||
131839508|NCT01661179|474695668|FG000|Overall Study|Death|1|||
131839509|NCT01661179|474695668|FG000|Overall Study|Withdrawal by Subject|1|||
131839510|NCT01661179|474695668|FG000|Overall Study|Other Eligibility criteria|4|||
131839511|NCT01946191|474695669|FG000|Allocation|Did not complete orientation|1|||
131402550|NCT02650128|473095531|FG000|Overall Study|Death|2|||
131839512|NCT01946191|474695670|FG001|Allocation|Did not complete orientation|1|||
131839513|NCT01946191|474695669|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
131839514|NCT01946191|474695670|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
131839515|NCT01946191|474695669|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
131839516|NCT01946191|474695670|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
131910783|NCT00402831|474960841|FG001|Overall Study|Lost to Follow-up|2|||
131839517|NCT01946191|474695669|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
131839518|NCT01946191|474695670|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
131839519|NCT01629966|474695671|FG000|Overall Study|Pregnancy|0|||
131839520|NCT01629966|474695672|FG001|Overall Study|Pregnancy|1|||
131839521|NCT01629966|474695673|FG002|Overall Study|Pregnancy|0|||
131839522|NCT01629966|474695671|FG000|Overall Study|Lost to Follow-up|10|||
131839523|NCT01629966|474695672|FG001|Overall Study|Lost to Follow-up|13|||
131839524|NCT01629966|474695673|FG002|Overall Study|Lost to Follow-up|9|||
131839525|NCT01629966|474695671|FG000|Overall Study|Withdrawal by Subject|8|||
131839526|NCT01629966|474695672|FG001|Overall Study|Withdrawal by Subject|9|||
131839527|NCT01629966|474695673|FG002|Overall Study|Withdrawal by Subject|16|||
131839528|NCT01629966|474695671|FG000|Overall Study|Protocol Violation|7|||
131839529|NCT01629966|474695672|FG001|Overall Study|Protocol Violation|9|||
131839530|NCT01629966|474695673|FG002|Overall Study|Protocol Violation|7|||
131839531|NCT01629966|474695671|FG000|Overall Study|Lack of Efficacy|5|||
131839532|NCT01629966|474695672|FG001|Overall Study|Lack of Efficacy|2|||
131839533|NCT01629966|474695673|FG002|Overall Study|Lack of Efficacy|4|||
131839534|NCT01629966|474695671|FG000|Overall Study|Adverse Event|11|||
131839535|NCT01629966|474695672|FG001|Overall Study|Adverse Event|18|||
131839536|NCT01629966|474695673|FG002|Overall Study|Adverse Event|30|||
131839537|NCT04568031|474695674|FG000|Overall Study|Lost to Follow-up|1|||
131839538|NCT04568031|474695675|FG001|Overall Study|Lost to Follow-up|0|||
131839539|NCT04568031|474695676|FG002|Overall Study|Lost to Follow-up|0|||
131839540|NCT04568031|474695677|FG003|Overall Study|Lost to Follow-up|0|||
131839541|NCT04568031|474695674|FG000|Overall Study|Physician Decision|1|||
131839542|NCT04568031|474695675|FG001|Overall Study|Physician Decision|0|||
131839543|NCT04568031|474695676|FG002|Overall Study|Physician Decision|1|||
131839544|NCT04568031|474695677|FG003|Overall Study|Physician Decision|0|||
131839545|NCT04568031|474695674|FG000|Overall Study|Withdrawal by Subject|1|||
131839546|NCT04568031|474695675|FG001|Overall Study|Withdrawal by Subject|0|||
131839547|NCT04568031|474695676|FG002|Overall Study|Withdrawal by Subject|4|||
131839548|NCT04568031|474695677|FG003|Overall Study|Withdrawal by Subject|1|||
131839549|NCT04188301|474695678|FG000|Month 3|Lost to Follow-up|0|||
131839550|NCT04188301|474695679|FG001|Month 3|Lost to Follow-up|0|||
131839551|NCT04188301|474695680|FG002|Month 3|Lost to Follow-up|1|||
131839552|NCT04188301|474695678|FG000|Month 12|Lost to Follow-up|0|||
131839553|NCT04188301|474695679|FG001|Month 12|Lost to Follow-up|0|||
131839554|NCT04188301|474695680|FG002|Month 12|Lost to Follow-up|2|||
131839555|NCT04188301|474695678|FG000|Month 12|Death|1|||
131839556|NCT04188301|474695679|FG001|Month 12|Death|1|||
131839557|NCT04188301|474695680|FG002|Month 12|Death|0|||
131839558|NCT04188301|474695678|FG000|Month 18|Lost to Follow-up|6|||
131839559|NCT04188301|474695679|FG001|Month 18|Lost to Follow-up|0|||
131839560|NCT04188301|474695680|FG002|Month 18|Lost to Follow-up|0|||
131839561|NCT03548064|474698005|FG000|Overall Study|Withdrawal by Subject|0|||
131839562|NCT03548064|474698006|FG001|Overall Study|Withdrawal by Subject|0|||
131839563|NCT03548064|474698007|FG002|Overall Study|Withdrawal by Subject|0|||
131839564|NCT03548064|474698008|FG003|Overall Study|Withdrawal by Subject|1|||
131839565|NCT03548064|474698009|FG004|Overall Study|Withdrawal by Subject|0|||
131839566|NCT03548064|474698010|FG005|Overall Study|Withdrawal by Subject|0|||
131839567|NCT03548064|474698011|FG006|Overall Study|Withdrawal by Subject|0|||
131839568|NCT03548064|474698012|FG007|Overall Study|Withdrawal by Subject|0|||
131839569|NCT03548064|474698005|FG000|Overall Study|Lost to Follow-up|0|||
131839570|NCT03548064|474698006|FG001|Overall Study|Lost to Follow-up|0|||
131839571|NCT03548064|474698007|FG002|Overall Study|Lost to Follow-up|0|||
131839572|NCT03548064|474698008|FG003|Overall Study|Lost to Follow-up|0|||
131839573|NCT03548064|474698009|FG004|Overall Study|Lost to Follow-up|2|||
131839574|NCT03548064|474698010|FG005|Overall Study|Lost to Follow-up|0|||
131839575|NCT03548064|474698011|FG006|Overall Study|Lost to Follow-up|0|||
131839576|NCT03548064|474698012|FG007|Overall Study|Lost to Follow-up|0|||
131839577|NCT03548064|474698005|FG000|Overall Study|Covid-19 Pandemic|0|||
131910784|NCT00402831|474960840|FG000|Overall Study|Non-compliance with protocol|0|||
131402551|NCT01801436|473095547|FG000|Overall Study|Withdrawal by Subject|3|||
131402552|NCT01801436|473095547|FG000|Overall Study|Adverse Event|2|||
131402553|NCT01801436|473095547|FG000|Overall Study|Progressive disease|4|||
131402554|NCT01885208|473095548|FG000|Overall Study|Unclassified|32|||
131402555|NCT01885208|473095549|FG001|Overall Study|Unclassified|38|||
131402556|NCT01973387|473095553|FG000|Overall Study|Adverse Event|14|||
131402557|NCT01973387|473095554|FG001|Overall Study|Adverse Event|4|||
131402558|NCT01973387|473095553|FG000|Overall Study|Withdrawal by Subject|7|||
131402559|NCT01973387|473095554|FG001|Overall Study|Withdrawal by Subject|4|||
131402560|NCT01973387|473095553|FG000|Overall Study|Study terminated by sponsor|63|||
131402561|NCT01973387|473095554|FG001|Overall Study|Study terminated by sponsor|0|||
131402562|NCT01973387|473095553|FG000|Overall Study|Progressive disease or relapse|16|||
131839578|NCT03548064|474698006|FG001|Overall Study|Covid-19 Pandemic|0|||
131839579|NCT03548064|474698007|FG002|Overall Study|Covid-19 Pandemic|0|||
131839580|NCT03548064|474698008|FG003|Overall Study|Covid-19 Pandemic|0|||
131839581|NCT03548064|474698009|FG004|Overall Study|Covid-19 Pandemic|10|||
131839582|NCT03548064|474698010|FG005|Overall Study|Covid-19 Pandemic|3|||
131839583|NCT03548064|474698011|FG006|Overall Study|Covid-19 Pandemic|0|||
131839584|NCT03548064|474698012|FG007|Overall Study|Covid-19 Pandemic|0|||
131839585|NCT04732221|474698013|FG000|Base Period|Death|2|||
131839586|NCT04732221|474698014|FG001|Base Period|Death|0|||
131839587|NCT04732221|474698015|FG002|Base Period|Death|0|||
131839588|NCT04732221|474698016|FG003|Base Period|Death|0|||
131839589|NCT04732221|474698017|FG004|Base Period|Death|0|||
131839590|NCT04732221|474698018|FG005|Base Period|Death|0|||
131839591|NCT04732221|474698019|FG006|Base Period|Death|0|||
131839592|NCT04732221|474698013|FG000|Base Period|Withdrawal by Subject|0|||
131839593|NCT04732221|474698014|FG001|Base Period|Withdrawal by Subject|1|||
131839594|NCT04732221|474698015|FG002|Base Period|Withdrawal by Subject|1|||
131839595|NCT04732221|474698016|FG003|Base Period|Withdrawal by Subject|0|||
131839596|NCT04732221|474698017|FG004|Base Period|Withdrawal by Subject|0|||
131839597|NCT04732221|474698018|FG005|Base Period|Withdrawal by Subject|0|||
131839598|NCT04732221|474698019|FG006|Base Period|Withdrawal by Subject|0|||
131839599|NCT04732221|474698013|FG000|Extension Period|Adverse Event|0|||
131839600|NCT04732221|474698014|FG001|Extension Period|Adverse Event|0|||
131839601|NCT04732221|474698015|FG002|Extension Period|Adverse Event|0|||
131839602|NCT04732221|474698016|FG003|Extension Period|Adverse Event|0|||
131839603|NCT04732221|474698017|FG004|Extension Period|Adverse Event|0|||
131839604|NCT04732221|474698018|FG005|Extension Period|Adverse Event|1|||
131839605|NCT04732221|474698019|FG006|Extension Period|Adverse Event|0|||
131839606|NCT04732221|474698013|FG000|Extension Period|Death|0|||
131839607|NCT04732221|474698014|FG001|Extension Period|Death|0|||
131839608|NCT04732221|474698015|FG002|Extension Period|Death|0|||
131839609|NCT04732221|474698016|FG003|Extension Period|Death|0|||
131839610|NCT04732221|474698017|FG004|Extension Period|Death|1|||
131839611|NCT04732221|474698018|FG005|Extension Period|Death|0|||
131839612|NCT04732221|474698019|FG006|Extension Period|Death|2|||
131839613|NCT04732221|474698013|FG000|Extension Period|Pregnancy|0|||
131839614|NCT04732221|474698014|FG001|Extension Period|Pregnancy|0|||
131839615|NCT04732221|474698015|FG002|Extension Period|Pregnancy|0|||
131839616|NCT04732221|474698016|FG003|Extension Period|Pregnancy|0|||
131839617|NCT04732221|474698017|FG004|Extension Period|Pregnancy|1|||
131839618|NCT04732221|474698018|FG005|Extension Period|Pregnancy|0|||
131839619|NCT04732221|474698019|FG006|Extension Period|Pregnancy|0|||
131839620|NCT04732221|474698013|FG000|Extension Period|Sponsors Decision|0|||
131839621|NCT04732221|474698014|FG001|Extension Period|Sponsors Decision|0|||
131839622|NCT04732221|474698015|FG002|Extension Period|Sponsors Decision|0|||
131839623|NCT04732221|474698016|FG003|Extension Period|Sponsors Decision|0|||
131839624|NCT04732221|474698017|FG004|Extension Period|Sponsors Decision|41|||
131839625|NCT04732221|474698018|FG005|Extension Period|Sponsors Decision|40|||
131839626|NCT04732221|474698019|FG006|Extension Period|Sponsors Decision|40|||
131839627|NCT04732221|474698013|FG000|Extension Period|Withdrawal by Subject|0|||
131839628|NCT04732221|474698014|FG001|Extension Period|Withdrawal by Subject|0|||
131839629|NCT04732221|474698015|FG002|Extension Period|Withdrawal by Subject|0|||
131839630|NCT04732221|474698016|FG003|Extension Period|Withdrawal by Subject|0|||
131839631|NCT04732221|474698017|FG004|Extension Period|Withdrawal by Subject|1|||
131839632|NCT04732221|474698018|FG005|Extension Period|Withdrawal by Subject|5|||
131839633|NCT04732221|474698019|FG006|Extension Period|Withdrawal by Subject|2|||
131839634|NCT01367665|474698020|FG000|Overall Study|Death|102|||
131839635|NCT01367665|474698021|FG001|Overall Study|Death|19|||
131839636|NCT01367665|474698020|FG000|Overall Study|Lost to Follow-up|222|||
131839637|NCT01367665|474698021|FG001|Overall Study|Lost to Follow-up|22|||
131839638|NCT01367665|474698020|FG000|Overall Study|Not Done|118|||
131839639|NCT01367665|474698021|FG001|Overall Study|Not Done|14|||
131839640|NCT00394524|474698022|FG000|Overall Study|Protocol Violation|2|||
131839641|NCT00394524|474698023|FG001|Overall Study|Protocol Violation|3|||
131839642|NCT00394524|474698022|FG000|Overall Study|Death|1|||
131839643|NCT00394524|474698023|FG001|Overall Study|Death|0|||
131839644|NCT00394524|474698022|FG000|Overall Study|Withdrawal by Subject|0|||
131839645|NCT00394524|474698023|FG001|Overall Study|Withdrawal by Subject|1|||
131839646|NCT02669758|474698025|FG000|Overall Study|Withdrawal by Subject|43|||
131839647|NCT02669758|474698025|FG000|Overall Study|Lost to Follow-up|19|||
131839648|NCT02669758|474698025|FG000|Overall Study|Adverse Event|16|||
131839649|NCT02669758|474698025|FG000|Overall Study|Non-Compliance with Study Drug|8|||
131839650|NCT02669758|474698025|FG000|Overall Study|Lack of Efficacy|5|||
131839651|NCT02669758|474698025|FG000|Overall Study|Pregnancy|1|||
131839652|NCT02669758|474698025|FG000|Overall Study|Study noncompliance|1|||
131910785|NCT00402831|474960841|FG001|Overall Study|Non-compliance with protocol|1|||
131910786|NCT01114724|474960844|FG000|Overall Study|Death|8|||
131910787|NCT01114724|474960844|FG000|Overall Study|Lost to Follow-up|1|||
131839653|NCT02669758|474698025|FG000|Overall Study|Protocol Violation|1|||
131839654|NCT02455050|474698026|FG000|Treatment Period 1|Lost to Follow-up|1|||
131839655|NCT02455050|474698027|FG001|Treatment Period 1|Lost to Follow-up|1|||
131839656|NCT02455050|474698028|FG002|Treatment Period 1|Lost to Follow-up|1|||
131839657|NCT02455050|474698029|FG003|Treatment Period 1|Lost to Follow-up|2|||
131839658|NCT02455050|474698026|FG000|Treatment Period 2|Lost to Follow-up|1|||
131839659|NCT02455050|474698027|FG001|Treatment Period 2|Lost to Follow-up|0|||
131839660|NCT02455050|474698028|FG002|Treatment Period 2|Lost to Follow-up|2|||
131839661|NCT02455050|474698029|FG003|Treatment Period 2|Lost to Follow-up|1|||
131839662|NCT02393248|474698030|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839663|NCT02393248|474698031|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
131839664|NCT02393248|474698032|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839665|NCT02393248|474698033|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839666|NCT02393248|474698034|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839667|NCT02393248|474698035|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
131839668|NCT02393248|474698036|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
131839669|NCT02393248|474698037|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839670|NCT02393248|474698038|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839671|NCT02393248|474698039|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839672|NCT02393248|474698040|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839673|NCT02393248|474698041|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839674|NCT02393248|474698042|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839675|NCT02393248|474698043|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839676|NCT02393248|474698044|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839677|NCT02393248|474698045|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839678|NCT02393248|474698046|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839679|NCT02393248|474698047|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839680|NCT02393248|474698048|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839681|NCT02393248|474698049|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839682|NCT02393248|474698050|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839683|NCT02393248|474698051|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839684|NCT02393248|474698052|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839685|NCT02393248|474698053|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839686|NCT02393248|474698054|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131839687|NCT02393248|474698030|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839688|NCT02393248|474698031|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
131839689|NCT02393248|474698032|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839690|NCT02393248|474698033|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839691|NCT02393248|474698034|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839692|NCT02393248|474698035|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839693|NCT02393248|474698036|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839694|NCT02393248|474698037|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839695|NCT02393248|474698038|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839696|NCT02393248|474698039|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839697|NCT02393248|474698040|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839698|NCT02393248|474698041|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839699|NCT02393248|474698042|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131450185|NCT04032093|473276808|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131450186|NCT04032093|473276809|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131450187|NCT04032093|473276810|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131450188|NCT04032093|473276811|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
131450189|NCT04032093|473276812|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
131450190|NCT04032093|473276813|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
131450191|NCT04032093|473276814|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
131450192|NCT04032093|473276805|FG000|Overall Study|Adverse Event|0|||
131450193|NCT04032093|473276806|FG001|Overall Study|Adverse Event|0|||
131450194|NCT04032093|473276807|FG002|Overall Study|Adverse Event|0|||
131839700|NCT02393248|474698043|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839701|NCT02393248|474698044|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839702|NCT02393248|474698045|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839703|NCT02393248|474698046|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839704|NCT02393248|474698047|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839705|NCT02393248|474698048|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839706|NCT02393248|474698049|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839707|NCT02393248|474698050|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839708|NCT02393248|474698051|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839709|NCT02393248|474698052|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839710|NCT02393248|474698053|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839711|NCT02393248|474698054|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131839712|NCT02393248|474698030|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
131839713|NCT02393248|474698031|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
131839714|NCT02393248|474698032|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
131839715|NCT02393248|474698033|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
131839716|NCT02393248|474698034|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
131839717|NCT02393248|474698035|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
131839718|NCT02393248|474698036|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
131839719|NCT02393248|474698037|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
131839720|NCT02393248|474698038|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
131839721|NCT02393248|474698039|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
131839722|NCT02393248|474698040|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
131839723|NCT02393248|474698041|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
131839724|NCT02393248|474698042|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
131839725|NCT02393248|474698043|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
131839726|NCT02393248|474698044|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
131402563|NCT01973387|473095554|FG001|Overall Study|Progressive disease or relapse|5|||
131402564|NCT01973387|473095553|FG000|Overall Study|Death|4|||
131402565|NCT01973387|473095554|FG001|Overall Study|Death|3|||
131402566|NCT01973387|473095553|FG000|Overall Study|Randomized, not treated|2|||
131402567|NCT01973387|473095554|FG001|Overall Study|Randomized, not treated|2|||
131839727|NCT02393248|474698045|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
131839728|NCT02393248|474698046|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
131839729|NCT02393248|474698047|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
131839730|NCT02393248|474698048|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
131839731|NCT02393248|474698049|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
131839732|NCT02393248|474698050|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
131839733|NCT02393248|474698051|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
131839734|NCT02393248|474698052|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
131839735|NCT02393248|474698053|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
131839736|NCT02393248|474698054|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
131839737|NCT02393248|474698030|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
131839738|NCT02393248|474698031|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839739|NCT02393248|474698032|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839740|NCT02393248|474698033|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839741|NCT02393248|474698034|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839742|NCT02393248|474698035|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839743|NCT02393248|474698036|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839744|NCT02393248|474698037|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839745|NCT02393248|474698038|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839746|NCT02393248|474698039|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839747|NCT02393248|474698040|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839748|NCT02393248|474698041|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839749|NCT02393248|474698042|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839750|NCT02393248|474698043|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839751|NCT02393248|474698044|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839752|NCT02393248|474698045|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839753|NCT02393248|474698046|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839754|NCT02393248|474698047|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839755|NCT02393248|474698048|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839756|NCT02393248|474698049|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839757|NCT02393248|474698050|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839758|NCT02393248|474698051|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839759|NCT02393248|474698052|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839760|NCT02393248|474698053|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839761|NCT02393248|474698054|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
131839762|NCT02393248|474698030|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839763|NCT02393248|474698031|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839764|NCT02393248|474698032|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839765|NCT02393248|474698033|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839766|NCT02393248|474698034|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839767|NCT02393248|474698035|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
131839768|NCT02393248|474698036|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
131839769|NCT02393248|474698037|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839770|NCT02393248|474698038|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839771|NCT02393248|474698039|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
131839772|NCT02393248|474698040|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839773|NCT02393248|474698041|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839774|NCT02393248|474698042|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839775|NCT02393248|474698043|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839776|NCT02393248|474698044|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839777|NCT02393248|474698045|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839778|NCT02393248|474698046|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839779|NCT02393248|474698047|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131402568|NCT01498575|473095555|FG000|Overall Sample|Withdrawal by Subject|60|||
131839780|NCT02393248|474698048|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839781|NCT02393248|474698049|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839782|NCT02393248|474698050|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839783|NCT02393248|474698051|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839784|NCT02393248|474698052|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839785|NCT02393248|474698053|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839786|NCT02393248|474698054|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
131839787|NCT02393248|474698030|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839788|NCT02393248|474698031|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839789|NCT02393248|474698032|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839790|NCT02393248|474698033|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839791|NCT02393248|474698034|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839792|NCT02393248|474698035|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839793|NCT02393248|474698036|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
131839794|NCT02393248|474698037|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839795|NCT02393248|474698038|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839796|NCT02393248|474698039|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839797|NCT02393248|474698040|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839798|NCT02393248|474698041|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839799|NCT02393248|474698042|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839800|NCT02393248|474698043|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839801|NCT02393248|474698044|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839802|NCT02393248|474698045|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839803|NCT02393248|474698046|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839804|NCT02393248|474698047|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839805|NCT02393248|474698048|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839806|NCT02393248|474698049|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839807|NCT02393248|474698050|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839808|NCT02393248|474698051|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839809|NCT02393248|474698052|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839810|NCT02393248|474698053|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839811|NCT02393248|474698054|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
131839812|NCT02393248|474698030|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839813|NCT02393248|474698031|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839814|NCT02393248|474698032|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839815|NCT02393248|474698033|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839816|NCT02393248|474698034|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839817|NCT02393248|474698035|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839818|NCT02393248|474698036|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839819|NCT02393248|474698037|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839820|NCT02393248|474698038|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839821|NCT02393248|474698039|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839822|NCT02393248|474698040|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839823|NCT02393248|474698041|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
131839824|NCT02393248|474698042|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
131839825|NCT02393248|474698043|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
131839826|NCT02393248|474698044|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
131839827|NCT02393248|474698045|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839828|NCT02393248|474698046|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839829|NCT02393248|474698047|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839830|NCT02393248|474698048|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839831|NCT02393248|474698049|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839832|NCT02393248|474698050|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839833|NCT02393248|474698051|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839834|NCT02393248|474698052|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839835|NCT02393248|474698053|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131839836|NCT02393248|474698054|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
131450195|NCT04032093|473276808|FG003|Overall Study|Adverse Event|0|||
131450196|NCT04032093|473276809|FG004|Overall Study|Adverse Event|0|||
131450197|NCT04032093|473276810|FG005|Overall Study|Adverse Event|0|||
131839837|NCT02393248|474698030|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839838|NCT02393248|474698031|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839839|NCT02393248|474698032|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839840|NCT02393248|474698033|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839841|NCT02393248|474698034|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839842|NCT02393248|474698035|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839843|NCT02393248|474698036|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839844|NCT02393248|474698037|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839845|NCT02393248|474698038|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839846|NCT02393248|474698039|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839847|NCT02393248|474698040|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
131839848|NCT02393248|474698041|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
131839849|NCT02393248|474698042|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839850|NCT02393248|474698043|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839851|NCT02393248|474698044|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839852|NCT02393248|474698045|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839853|NCT02393248|474698046|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839854|NCT02393248|474698047|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839855|NCT02393248|474698048|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839856|NCT02393248|474698049|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839857|NCT02393248|474698050|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839858|NCT02393248|474698051|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839859|NCT02393248|474698052|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839860|NCT02393248|474698053|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839861|NCT02393248|474698054|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
131839862|NCT02393248|474698030|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
131839863|NCT02393248|474698031|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
131839864|NCT02393248|474698032|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
131839865|NCT02393248|474698033|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
131839866|NCT02393248|474698034|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
131839867|NCT02393248|474698035|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
131839868|NCT02393248|474698036|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
131839869|NCT02393248|474698037|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
131839870|NCT02393248|474698038|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
131839871|NCT02393248|474698039|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
131839872|NCT02393248|474698040|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
131839873|NCT02393248|474698041|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
131839874|NCT02393248|474698042|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
131839875|NCT02393248|474698043|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
131839876|NCT02393248|474698044|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
131839877|NCT02393248|474698045|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
131839878|NCT02393248|474698046|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
131839879|NCT02393248|474698047|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
131839880|NCT02393248|474698048|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
131839881|NCT02393248|474698049|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
131839882|NCT02393248|474698050|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
131839883|NCT02393248|474698051|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
131839884|NCT02393248|474698052|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
131839885|NCT02393248|474698053|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
131839886|NCT02393248|474698054|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
131839887|NCT02393248|474698030|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839888|NCT02393248|474698031|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839889|NCT02393248|474698032|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839890|NCT02393248|474698033|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839891|NCT02393248|474698034|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839892|NCT02393248|474698035|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839893|NCT02393248|474698036|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839894|NCT02393248|474698037|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839895|NCT02393248|474698038|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839896|NCT02393248|474698039|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839897|NCT02393248|474698040|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839898|NCT02393248|474698041|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
131839899|NCT02393248|474698042|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839900|NCT02393248|474698043|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
131839901|NCT02393248|474698044|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839902|NCT02393248|474698045|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131450198|NCT04032093|473276811|FG006|Overall Study|Adverse Event|0|||
131402569|NCT01498575|473095556|FG001|Overall Sample|Withdrawal by Subject|14|||
131402570|NCT01498575|473095555|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
131839903|NCT02393248|474698046|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839904|NCT02393248|474698047|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839905|NCT02393248|474698048|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839906|NCT02393248|474698049|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839907|NCT02393248|474698050|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839908|NCT02393248|474698051|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839909|NCT02393248|474698052|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839910|NCT02393248|474698053|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839911|NCT02393248|474698054|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
131839912|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839913|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839914|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839915|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839916|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839917|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839918|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839919|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839920|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839921|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839922|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839923|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839924|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839925|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839926|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839927|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839928|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839929|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839930|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
131839931|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839932|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
131839933|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
131839934|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839935|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
131839936|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
131839937|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Death|0|||
131839938|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Death|0|||
131839939|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Death|0|||
131839940|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Death|0|||
131839941|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Death|0|||
131839942|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Death|0|||
131839943|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Death|0|||
131839944|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Death|0|||
131839945|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Death|0|||
131839946|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Death|0|||
131839947|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Death|0|||
131839948|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Death|0|||
131839949|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Death|0|||
131839950|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Death|0|||
131839951|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Death|0|||
131839952|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Death|1|||
131839953|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Death|7|||
131839954|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Death|5|||
131839955|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Death|5|||
131839956|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Death|3|||
131839957|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Death|7|||
131839958|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Death|5|||
131839959|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Death|6|||
131839960|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Death|3|||
131839961|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Death|0|||
131839962|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839963|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839964|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839965|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839966|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839967|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131402571|NCT01498575|473095556|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
131839968|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839969|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839970|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839971|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839972|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839973|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839974|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839975|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839976|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839977|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839978|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839979|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
131839980|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
131839981|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
131839982|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
131839983|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
131839984|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
131839985|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
131839986|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
131839987|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Disease Progression|0|||
131839988|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Disease Progression|0|||
131839989|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Disease Progression|0|||
131839990|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Disease Progression|0|||
131839991|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Disease Progression|0|||
131839992|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Disease Progression|0|||
131839993|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Disease Progression|0|||
131839994|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Disease Progression|0|||
131839995|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Disease Progression|0|||
131839996|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Disease Progression|0|||
131839997|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Disease Progression|0|||
131839998|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Disease Progression|0|||
131839999|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Disease Progression|0|||
131840000|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Disease Progression|0|||
131840001|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Disease Progression|0|||
131840002|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Disease Progression|0|||
131840003|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Disease Progression|0|||
131840004|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Disease Progression|0|||
131840005|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Disease Progression|0|||
131840006|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Disease Progression|0|||
131840007|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Disease Progression|2|||
131840008|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Disease Progression|1|||
131840009|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Disease Progression|0|||
131840010|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Disease Progression|0|||
131840011|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Disease Progression|0|||
131840012|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840013|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840014|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840015|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840016|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840017|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840018|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840019|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840020|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840021|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840022|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840023|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840024|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840025|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840026|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840027|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
131450199|NCT04032093|473276812|FG007|Overall Study|Adverse Event|0|||
131450200|NCT04032093|473276813|FG008|Overall Study|Adverse Event|0|||
131840028|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840029|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840030|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840031|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840032|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
131840033|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
131840034|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840035|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840036|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
131840037|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840038|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840039|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840040|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840041|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840042|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840043|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840044|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840045|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840046|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840047|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840048|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840049|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840050|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840051|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840052|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840053|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840054|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840055|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840056|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840057|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
131840058|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840059|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840060|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840061|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
131840062|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Adverse Event|0|||
131840063|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Adverse Event|0|||
131840064|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Adverse Event|0|||
131840065|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Adverse Event|0|||
131840066|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Adverse Event|0|||
131840067|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Adverse Event|0|||
131840068|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Adverse Event|0|||
131840069|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Adverse Event|0|||
131840070|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Adverse Event|0|||
131840071|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Adverse Event|0|||
131840072|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Adverse Event|0|||
131840073|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Adverse Event|0|||
131840074|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Adverse Event|0|||
131840075|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Adverse Event|0|||
131840076|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Adverse Event|0|||
131840077|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Adverse Event|0|||
131840078|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Adverse Event|0|||
131840079|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Adverse Event|0|||
131840080|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Adverse Event|0|||
131840081|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Adverse Event|0|||
131840082|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Adverse Event|0|||
131840083|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Adverse Event|0|||
131840084|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Adverse Event|0|||
131840085|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Adverse Event|1|||
131840086|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Adverse Event|0|||
131840087|NCT02393248|474698030|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840088|NCT02393248|474698031|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840089|NCT02393248|474698032|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840090|NCT02393248|474698033|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840091|NCT02393248|474698034|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840092|NCT02393248|474698035|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840093|NCT02393248|474698036|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840094|NCT02393248|474698037|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840095|NCT02393248|474698038|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131910788|NCT01114724|474960844|FG000|Overall Study|Withdrawal by Subject|1|||
131910789|NCT02814526|474960850|FG000|Overall Study|Adverse Event|4|||
131910790|NCT02814526|474960851|FG001|Overall Study|Adverse Event|3|||
131910791|NCT02814526|474960850|FG000|Overall Study|Death|1|||
131910792|NCT02814526|474960851|FG001|Overall Study|Death|1|||
131450201|NCT04032093|473276814|FG009|Overall Study|Adverse Event|1|||
131840096|NCT02393248|474698039|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840097|NCT02393248|474698040|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840098|NCT02393248|474698041|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840099|NCT02393248|474698042|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840100|NCT02393248|474698043|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840101|NCT02393248|474698044|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840102|NCT02393248|474698045|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840103|NCT02393248|474698046|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840104|NCT02393248|474698047|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840105|NCT02393248|474698048|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840106|NCT02393248|474698049|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840107|NCT02393248|474698050|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840108|NCT02393248|474698051|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840109|NCT02393248|474698052|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840110|NCT02393248|474698053|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
131840111|NCT02393248|474698054|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
131840112|NCT02605993|474698057|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
131840113|NCT02605993|474698058|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
131840114|NCT02605993|474698059|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
131840115|NCT02605993|474698060|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
131840116|NCT03493386|474698061|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131840117|NCT03493386|474698062|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
131840118|NCT03493386|474698063|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131840119|NCT03493386|474698064|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131840120|NCT04645966|474698065|FG000|Vaccination Phase|Adverse Event|1|||
131840121|NCT04645966|474698066|FG001|Vaccination Phase|Adverse Event|0|||
131840122|NCT04645966|474698067|FG002|Vaccination Phase|Adverse Event|0|||
131840123|NCT04645966|474698068|FG003|Vaccination Phase|Adverse Event|0|||
131840124|NCT04645966|474698069|FG004|Vaccination Phase|Adverse Event|0|||
131840125|NCT04645966|474698070|FG005|Vaccination Phase|Adverse Event|0|||
131840126|NCT04645966|474698071|FG006|Vaccination Phase|Adverse Event|1|||
131840127|NCT04645966|474698072|FG007|Vaccination Phase|Adverse Event|0|||
131840128|NCT04645966|474698073|FG008|Vaccination Phase|Adverse Event|0|||
131840129|NCT04645966|474698065|FG000|Vaccination Phase|Death|0|||
131840130|NCT04645966|474698066|FG001|Vaccination Phase|Death|0|||
131840131|NCT04645966|474698067|FG002|Vaccination Phase|Death|0|||
131840132|NCT04645966|474698068|FG003|Vaccination Phase|Death|0|||
131840133|NCT04645966|474698069|FG004|Vaccination Phase|Death|0|||
131840134|NCT04645966|474698070|FG005|Vaccination Phase|Death|1|||
131840135|NCT04645966|474698071|FG006|Vaccination Phase|Death|0|||
131840136|NCT04645966|474698072|FG007|Vaccination Phase|Death|0|||
131840137|NCT04645966|474698073|FG008|Vaccination Phase|Death|0|||
131840138|NCT04645966|474698065|FG000|Vaccination Phase|Protocol Violation|0|||
131840139|NCT04645966|474698066|FG001|Vaccination Phase|Protocol Violation|0|||
131840140|NCT04645966|474698067|FG002|Vaccination Phase|Protocol Violation|0|||
131840141|NCT04645966|474698068|FG003|Vaccination Phase|Protocol Violation|0|||
131840142|NCT04645966|474698069|FG004|Vaccination Phase|Protocol Violation|1|||
131840143|NCT04645966|474698070|FG005|Vaccination Phase|Protocol Violation|0|||
131840144|NCT04645966|474698071|FG006|Vaccination Phase|Protocol Violation|0|||
131840145|NCT04645966|474698072|FG007|Vaccination Phase|Protocol Violation|0|||
131840146|NCT04645966|474698073|FG008|Vaccination Phase|Protocol Violation|0|||
131840147|NCT04645966|474698065|FG000|Vaccination Phase|Study terminated by sponsor|0|||
131840148|NCT04645966|474698066|FG001|Vaccination Phase|Study terminated by sponsor|0|||
131840149|NCT04645966|474698067|FG002|Vaccination Phase|Study terminated by sponsor|14|||
131840150|NCT04645966|474698068|FG003|Vaccination Phase|Study terminated by sponsor|15|||
131840151|NCT04645966|474698069|FG004|Vaccination Phase|Study terminated by sponsor|47|||
131840152|NCT04645966|474698070|FG005|Vaccination Phase|Study terminated by sponsor|43|||
131840153|NCT04645966|474698071|FG006|Vaccination Phase|Study terminated by sponsor|29|||
131840154|NCT04645966|474698072|FG007|Vaccination Phase|Study terminated by sponsor|29|||
131840155|NCT04645966|474698073|FG008|Vaccination Phase|Study terminated by sponsor|12|||
131840156|NCT04645966|474698065|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
131840157|NCT04645966|474698066|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
131450202|NCT04032093|473276805|FG000|Overall Study|Physician Decision|0|||
131450203|NCT04032093|473276806|FG001|Overall Study|Physician Decision|0|||
131450204|NCT04032093|473276807|FG002|Overall Study|Physician Decision|0|||
131450205|NCT04032093|473276808|FG003|Overall Study|Physician Decision|0|||
131450206|NCT04032093|473276809|FG004|Overall Study|Physician Decision|0|||
131450207|NCT04032093|473276810|FG005|Overall Study|Physician Decision|1|||
131450208|NCT04032093|473276811|FG006|Overall Study|Physician Decision|0|||
131450209|NCT04032093|473276812|FG007|Overall Study|Physician Decision|0|||
131450210|NCT04032093|473276813|FG008|Overall Study|Physician Decision|0|||
131450211|NCT04032093|473276814|FG009|Overall Study|Physician Decision|0|||
131450212|NCT01457703|473276821|FG000|Overall Study|Screen Failure|5|||
131840158|NCT04645966|474698067|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
131840159|NCT04645966|474698068|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
131840160|NCT04645966|474698069|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
131840161|NCT04645966|474698070|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
131840162|NCT04645966|474698071|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
131840163|NCT04645966|474698072|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
131840164|NCT04645966|474698073|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
131840165|NCT04645966|474698065|FG000|Vaccination Phase|Other|0|||
131840166|NCT04645966|474698066|FG001|Vaccination Phase|Other|0|||
131840167|NCT04645966|474698067|FG002|Vaccination Phase|Other|0|||
131840168|NCT04645966|474698068|FG003|Vaccination Phase|Other|0|||
131840169|NCT04645966|474698069|FG004|Vaccination Phase|Other|0|||
131840170|NCT04645966|474698070|FG005|Vaccination Phase|Other|2|||
131840171|NCT04645966|474698071|FG006|Vaccination Phase|Other|0|||
131840172|NCT04645966|474698072|FG007|Vaccination Phase|Other|0|||
131840173|NCT04645966|474698073|FG008|Vaccination Phase|Other|0|||
131840174|NCT04645966|474698065|FG000|Vaccination Phase|Lost to Follow-up|0|||
131840175|NCT04645966|474698066|FG001|Vaccination Phase|Lost to Follow-up|0|||
131840176|NCT04645966|474698067|FG002|Vaccination Phase|Lost to Follow-up|0|||
131840177|NCT04645966|474698068|FG003|Vaccination Phase|Lost to Follow-up|0|||
131840178|NCT04645966|474698069|FG004|Vaccination Phase|Lost to Follow-up|0|||
131840179|NCT04645966|474698070|FG005|Vaccination Phase|Lost to Follow-up|0|||
131840180|NCT04645966|474698071|FG006|Vaccination Phase|Lost to Follow-up|0|||
131840181|NCT04645966|474698072|FG007|Vaccination Phase|Lost to Follow-up|1|||
131840182|NCT04645966|474698073|FG008|Vaccination Phase|Lost to Follow-up|0|||
131840183|NCT04645966|474698065|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
131840184|NCT04645966|474698066|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
131840185|NCT04645966|474698067|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
131840186|NCT04645966|474698068|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
131840187|NCT04645966|474698069|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
131840188|NCT04645966|474698070|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
131840189|NCT04645966|474698071|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
131840190|NCT04645966|474698072|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
131840191|NCT04645966|474698073|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
131840192|NCT04645966|474698065|FG000|Follow-up Phase|Lost to Follow-up|0|||
131840193|NCT04645966|474698066|FG001|Follow-up Phase|Lost to Follow-up|0|||
131840194|NCT04645966|474698067|FG002|Follow-up Phase|Lost to Follow-up|0|||
131840195|NCT04645966|474698068|FG003|Follow-up Phase|Lost to Follow-up|0|||
131840196|NCT04645966|474698069|FG004|Follow-up Phase|Lost to Follow-up|0|||
131840197|NCT04645966|474698070|FG005|Follow-up Phase|Lost to Follow-up|0|||
131840198|NCT04645966|474698071|FG006|Follow-up Phase|Lost to Follow-up|0|||
131840199|NCT04645966|474698072|FG007|Follow-up Phase|Lost to Follow-up|1|||
131840200|NCT04645966|474698073|FG008|Follow-up Phase|Lost to Follow-up|0|||
131840201|NCT02116608|474698075|FG000|Overall Study|Lost to Follow-up|0|||
131840202|NCT02116608|474698076|FG001|Overall Study|Lost to Follow-up|0|||
131840203|NCT02116608|474698077|FG002|Overall Study|Lost to Follow-up|1|||
131840204|NCT02116608|474698075|FG000|Overall Study|Physician Decision|0|||
131840205|NCT02116608|474698076|FG001|Overall Study|Physician Decision|1|||
131840206|NCT02116608|474698077|FG002|Overall Study|Physician Decision|0|||
131840207|NCT02116608|474698075|FG000|Overall Study|Death|0|||
131840208|NCT02116608|474698076|FG001|Overall Study|Death|1|||
131840209|NCT02116608|474698077|FG002|Overall Study|Death|0|||
131840210|NCT00988442|474698079|FG000|Overall Study|Death|1|||
131840211|NCT00988442|474698080|FG001|Overall Study|Death|2|||
131840212|NCT00988442|474698079|FG000|Overall Study|Lost to Follow-up|0|||
131840213|NCT00988442|474698080|FG001|Overall Study|Lost to Follow-up|1|||
131840214|NCT00988442|474698079|FG000|Overall Study|Early Study Closure|29|||
131840215|NCT00988442|474698080|FG001|Overall Study|Early Study Closure|25|||
131450213|NCT01457703|473276822|FG001|Overall Study|Screen Failure|7|||
131840216|NCT01468818|474698086|FG000|Overall Study|Death during treatment|2|||
131840217|NCT01212588|474698087|FG000|Overall Study|Physician Decision|0|||
131840218|NCT01212588|474698088|FG001|Overall Study|Physician Decision|1|||
131840219|NCT01212588|474698087|FG000|Overall Study|Protocol Violation|1|||
131840220|NCT01212588|474698088|FG001|Overall Study|Protocol Violation|1|||
131840221|NCT01735955|474698093|FG000|Overall Study|Administrative problems|1|||
131840222|NCT01735955|474698093|FG000|Overall Study|Patient/guardian decision|1|||
131840223|NCT01735955|474698093|FG000|Overall Study|Patient withdrew consent|2|||
131840224|NCT01735955|474698093|FG000|Overall Study|Physician Decision|4|||
131840225|NCT01735955|474698093|FG000|Overall Study|Disease progression|24|||
131840226|NCT01735955|474698093|FG000|Overall Study|Adverse Event|5|||
131840227|NCT03317834|474698096|FG000|Overall Study|Death|2|||
131840228|NCT03317834|474698096|FG000|Overall Study|Device Revision|5|||
131840229|NCT03317834|474698096|FG000|Overall Study|Withdrawal by Subject|13|||
131840230|NCT03317834|474698096|FG000|Overall Study|Lost to Follow-up|13|||
131840231|NCT00123474|474698102|FG000|Randomized to Treatment|Randomized, never treated|1|||
131840232|NCT00123474|474698103|FG001|Randomized to Treatment|Randomized, never treated|4|||
131840233|NCT00123474|474698104|FG002|Randomized to Treatment|Randomized, never treated|2|||
131840234|NCT00123474|474698105|FG003|Randomized to Treatment|Randomized, never treated|1|||
131840235|NCT00123474|474698102|FG000|As Treated at Study Closure|not reported when site closed|1|||
131840236|NCT00123474|474698103|FG001|As Treated at Study Closure|not reported when site closed|0|||
131840237|NCT00123474|474698104|FG002|As Treated at Study Closure|not reported when site closed|1|||
131840238|NCT00123474|474698105|FG003|As Treated at Study Closure|not reported when site closed|0|||
131840239|NCT00123474|474698102|FG000|As Treated at Study Closure|Adverse Event|10|||
131840240|NCT00123474|474698103|FG001|As Treated at Study Closure|Adverse Event|4|||
131840241|NCT00123474|474698104|FG002|As Treated at Study Closure|Adverse Event|10|||
131840242|NCT00123474|474698105|FG003|As Treated at Study Closure|Adverse Event|8|||
131840243|NCT00123474|474698102|FG000|As Treated at Study Closure|Disease Progression|35|||
131840244|NCT00123474|474698103|FG001|As Treated at Study Closure|Disease Progression|42|||
131840245|NCT00123474|474698104|FG002|As Treated at Study Closure|Disease Progression|29|||
131840246|NCT00123474|474698105|FG003|As Treated at Study Closure|Disease Progression|27|||
131840247|NCT00123474|474698102|FG000|As Treated at Study Closure|Investigator Request|12|||
131840248|NCT00123474|474698103|FG001|As Treated at Study Closure|Investigator Request|6|||
131840249|NCT00123474|474698104|FG002|As Treated at Study Closure|Investigator Request|7|||
131840250|NCT00123474|474698105|FG003|As Treated at Study Closure|Investigator Request|5|||
131840251|NCT00123474|474698102|FG000|As Treated at Study Closure|non-specified|54|||
131840252|NCT00123474|474698103|FG001|As Treated at Study Closure|non-specified|47|||
131840253|NCT00123474|474698104|FG002|As Treated at Study Closure|non-specified|57|||
131840254|NCT00123474|474698105|FG003|As Treated at Study Closure|non-specified|60|||
131840255|NCT00123474|474698102|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
131840256|NCT00123474|474698103|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
131840257|NCT00123474|474698104|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
131840258|NCT00123474|474698105|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
131840259|NCT00123474|474698102|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
131840260|NCT00123474|474698103|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
131840261|NCT00123474|474698104|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
131840262|NCT00123474|474698105|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
131840263|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
131840264|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
131840265|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
131840266|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
131840267|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
131840268|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
131840269|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
131840270|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
131840271|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
131840272|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840273|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
131840274|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840275|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840276|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840277|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840278|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840279|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840280|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131840281|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840282|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
131840283|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840284|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
131840285|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840286|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840287|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840288|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840289|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840290|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840291|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
131840292|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840293|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
131840294|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840295|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840296|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840297|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840298|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
131840299|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
131840300|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
131840301|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
131840302|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840303|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
131840304|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840305|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840306|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840307|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840308|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840309|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
131840310|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840311|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840312|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840313|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840314|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840315|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840316|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
131840317|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840318|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840319|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840320|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
131840321|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840322|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840323|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840324|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840325|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840326|NCT03893565|474698110|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
131840327|NCT03893565|474698111|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
131840328|NCT03893565|474698112|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
131840329|NCT03893565|474698113|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
131840330|NCT03893565|474698114|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
131840331|NCT03893565|474698115|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
131840332|NCT03893565|474698116|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
131840333|NCT03893565|474698117|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
131840334|NCT03893565|474698118|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
131840335|NCT03893565|474698110|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
131840336|NCT03893565|474698111|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
131840337|NCT03893565|474698112|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
131840338|NCT03893565|474698113|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
131840339|NCT03893565|474698114|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
131840340|NCT03893565|474698115|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
131840341|NCT03893565|474698116|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
131840342|NCT03893565|474698117|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
131840343|NCT03893565|474698118|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
131840344|NCT03893565|474698110|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840345|NCT03893565|474698111|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840346|NCT03893565|474698112|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840347|NCT03893565|474698113|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840348|NCT03893565|474698114|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840349|NCT03893565|474698115|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840350|NCT03893565|474698116|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
131840351|NCT03893565|474698117|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840352|NCT03893565|474698118|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
131840353|NCT03893565|474698110|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131840354|NCT03893565|474698111|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131840355|NCT03893565|474698112|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131910793|NCT02814526|474960850|FG000|Overall Study|Lost to Follow-up|3|||
131840356|NCT03893565|474698113|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131840357|NCT03893565|474698114|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131840358|NCT03893565|474698115|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
131840359|NCT03893565|474698116|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
131840360|NCT03893565|474698117|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131840361|NCT03893565|474698118|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
131840362|NCT03893565|474698110|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
131840363|NCT03893565|474698111|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
131840364|NCT03893565|474698112|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
131840365|NCT03893565|474698113|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
131840366|NCT03893565|474698114|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
131840367|NCT03893565|474698115|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
131840368|NCT03893565|474698116|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
131840369|NCT03893565|474698117|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
131840370|NCT03893565|474698118|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
131840371|NCT03893565|474698110|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840372|NCT03893565|474698111|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840373|NCT03893565|474698112|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840374|NCT03893565|474698113|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840375|NCT03893565|474698114|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840376|NCT03893565|474698115|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840377|NCT03893565|474698116|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840378|NCT03893565|474698117|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
131840379|NCT03893565|474698118|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
131840380|NCT03893565|474698110|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840381|NCT03893565|474698111|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840382|NCT03893565|474698112|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840383|NCT03893565|474698113|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840384|NCT03893565|474698114|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840385|NCT03893565|474698115|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840386|NCT03893565|474698116|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840387|NCT03893565|474698117|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
131840388|NCT03893565|474698118|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
131840389|NCT03893565|474698110|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840390|NCT03893565|474698111|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840391|NCT03893565|474698112|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840392|NCT03893565|474698113|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840393|NCT03893565|474698114|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840394|NCT03893565|474698115|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840395|NCT03893565|474698116|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840396|NCT03893565|474698117|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
131840397|NCT03893565|474698118|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131840398|NCT03893565|474698110|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840399|NCT03893565|474698111|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840400|NCT03893565|474698112|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840401|NCT03893565|474698113|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840402|NCT03893565|474698114|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840403|NCT03893565|474698115|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840404|NCT03893565|474698116|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840405|NCT03893565|474698117|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
131840406|NCT03893565|474698118|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
131840407|NCT02387983|474698122|FG000|Overall Study|Adverse Event|4|||
131840408|NCT02387983|474698122|FG000|Overall Study|Protocol Violation|1|||
131840409|NCT02387983|474698122|FG000|Overall Study|Withdrawal by Subject|2|||
131840410|NCT03569228|474698123|FG000|Overall Study|Withdrawal by PI|0|||
131840411|NCT03569228|474698124|FG001|Overall Study|Withdrawal by PI|0|||
131840412|NCT03569228|474698125|FG002|Overall Study|Withdrawal by PI|2|||
131840413|NCT03569228|474698126|FG003|Overall Study|Withdrawal by PI|2|||
131840414|NCT03569228|474698127|FG004|Overall Study|Withdrawal by PI|1|||
131840415|NCT03569228|474698128|FG005|Overall Study|Withdrawal by PI|0|||
131840416|NCT03569228|474698129|FG006|Overall Study|Withdrawal by PI|0|||
131840417|NCT03569228|474698130|FG007|Overall Study|Withdrawal by PI|0|||
131840418|NCT03569228|474698131|FG008|Overall Study|Withdrawal by PI|0|||
131840419|NCT03569228|474698123|FG000|Overall Study|Lost to Follow-up|0|||
131910794|NCT02814526|474960851|FG001|Overall Study|Lost to Follow-up|4|||
131910795|NCT02814526|474960850|FG000|Overall Study|non site physician decision|1|||
131840420|NCT03569228|474698124|FG001|Overall Study|Lost to Follow-up|0|||
131840421|NCT03569228|474698125|FG002|Overall Study|Lost to Follow-up|0|||
131840422|NCT03569228|474698126|FG003|Overall Study|Lost to Follow-up|0|||
131840423|NCT03569228|474698127|FG004|Overall Study|Lost to Follow-up|0|||
131840424|NCT03569228|474698128|FG005|Overall Study|Lost to Follow-up|0|||
131840425|NCT03569228|474698129|FG006|Overall Study|Lost to Follow-up|0|||
131840426|NCT03569228|474698130|FG007|Overall Study|Lost to Follow-up|0|||
131840427|NCT03569228|474698131|FG008|Overall Study|Lost to Follow-up|1|||
131840428|NCT03569228|474698123|FG000|Overall Study|Screen Fail|2|||
131840429|NCT03569228|474698124|FG001|Overall Study|Screen Fail|2|||
131840430|NCT03569228|474698125|FG002|Overall Study|Screen Fail|1|||
131840431|NCT03569228|474698126|FG003|Overall Study|Screen Fail|1|||
131840432|NCT03569228|474698127|FG004|Overall Study|Screen Fail|1|||
131840433|NCT03569228|474698128|FG005|Overall Study|Screen Fail|3|||
131840434|NCT03569228|474698129|FG006|Overall Study|Screen Fail|1|||
131840435|NCT03569228|474698130|FG007|Overall Study|Screen Fail|5|||
131840436|NCT03569228|474698131|FG008|Overall Study|Screen Fail|2|||
131840437|NCT00085423|474698136|FG000|Overall Study|Withdrawal by Subject|1|||
131840438|NCT00085423|474698136|FG000|Overall Study|screen failure|1|||
131840439|NCT02440568|474698137|FG000|Overall Study|Death|1|||
131840440|NCT02440568|474698138|FG001|Overall Study|Death|3|||
131840441|NCT02440568|474698139|FG002|Overall Study|Death|4|||
131840442|NCT02440568|474698140|FG003|Overall Study|Death|2|||
131840443|NCT02440568|474698137|FG000|Overall Study|Lack of Efficacy|2|||
131840444|NCT02440568|474698138|FG001|Overall Study|Lack of Efficacy|0|||
131840445|NCT02440568|474698139|FG002|Overall Study|Lack of Efficacy|1|||
131840446|NCT02440568|474698140|FG003|Overall Study|Lack of Efficacy|0|||
131840447|NCT02440568|474698137|FG000|Overall Study|Lost to Follow-up|1|||
131840448|NCT02440568|474698138|FG001|Overall Study|Lost to Follow-up|0|||
131840449|NCT02440568|474698139|FG002|Overall Study|Lost to Follow-up|0|||
131840450|NCT02440568|474698140|FG003|Overall Study|Lost to Follow-up|0|||
131840451|NCT00536263|474698146|FG000|Overall Study|Adverse Event|5|||
131840452|NCT00536263|474698147|FG001|Overall Study|Adverse Event|5|||
131840453|NCT00536263|474698148|FG002|Overall Study|Adverse Event|7|||
131840454|NCT00536263|474698146|FG000|Overall Study|Lost to Follow-up|3|||
131840455|NCT00536263|474698147|FG001|Overall Study|Lost to Follow-up|4|||
131840456|NCT00536263|474698148|FG002|Overall Study|Lost to Follow-up|4|||
131840457|NCT00536263|474698146|FG000|Overall Study|Subject withdrew - not treatment related|2|||
131840458|NCT00536263|474698147|FG001|Overall Study|Subject withdrew - not treatment related|0|||
131840459|NCT00536263|474698148|FG002|Overall Study|Subject withdrew - not treatment related|5|||
131840460|NCT00536263|474698146|FG000|Overall Study|Subject withdrew - treatment related|0|||
131840461|NCT00536263|474698147|FG001|Overall Study|Subject withdrew - treatment related|3|||
131840462|NCT00536263|474698148|FG002|Overall Study|Subject withdrew - treatment related|2|||
131840463|NCT00536263|474698146|FG000|Overall Study|Noncompliance with protocol|0|||
131840464|NCT00536263|474698147|FG001|Overall Study|Noncompliance with protocol|0|||
131840465|NCT00536263|474698148|FG002|Overall Study|Noncompliance with protocol|1|||
131840466|NCT00536263|474698146|FG000|Overall Study|Did not meet protocol eligibility|1|||
131840467|NCT00536263|474698147|FG001|Overall Study|Did not meet protocol eligibility|2|||
131840468|NCT00536263|474698148|FG002|Overall Study|Did not meet protocol eligibility|2|||
131840469|NCT02302859|474698154|FG000|Overall Study|Lost Phone|1|||
131840470|NCT02302859|474698155|FG001|Overall Study|Lost Phone|1|||
131840471|NCT02302859|474698154|FG000|Overall Study|Withdrawal by Subject|0|||
131840472|NCT02302859|474698155|FG001|Overall Study|Withdrawal by Subject|1|||
131840473|NCT02283983|474698158|FG000|Overall Study|Inclusion criteria not met|0|||
131840474|NCT02283983|474698159|FG001|Overall Study|Inclusion criteria not met|1|||
131840475|NCT02283983|474698158|FG000|Overall Study|Withdrawal by Subject|4|||
131840476|NCT02283983|474698159|FG001|Overall Study|Withdrawal by Subject|2|||
131840477|NCT02283983|474698158|FG000|Overall Study|Protocol Violation|0|||
131840478|NCT02283983|474698159|FG001|Overall Study|Protocol Violation|4|||
131840479|NCT02283983|474698158|FG000|Overall Study|Physician Decision|2|||
131840480|NCT02283983|474698159|FG001|Overall Study|Physician Decision|4|||
131840481|NCT02283983|474698158|FG000|Overall Study|Death|1|||
131840482|NCT02283983|474698159|FG001|Overall Study|Death|0|||
131840483|NCT02283983|474698158|FG000|Overall Study|Adverse Event|1|||
131840484|NCT02283983|474698159|FG001|Overall Study|Adverse Event|0|||
131840485|NCT02283983|474698158|FG000|Overall Study|Lost to Follow-up|9|||
131840486|NCT02283983|474698159|FG001|Overall Study|Lost to Follow-up|8|||
131840487|NCT02283983|474698158|FG000|Overall Study|Relapse|1|||
131840488|NCT02283983|474698159|FG001|Overall Study|Relapse|0|||
131840489|NCT03276221|474698167|FG000|Overall Study|Lost to Follow-up|6|||
131840490|NCT03276221|474698168|FG001|Overall Study|Lost to Follow-up|2|||
131840491|NCT03276221|474698169|FG002|Overall Study|Lost to Follow-up|0|||
131840492|NCT03276221|474698167|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
131840493|NCT03276221|474698168|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
131840494|NCT03276221|474698169|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
131840495|NCT02912650|474698170|FG000|Overall Study|Withdrawal by Subject|1|||
131840496|NCT02912650|474698171|FG001|Overall Study|Withdrawal by Subject|0|||
131840497|NCT02912650|474698172|FG002|Overall Study|Withdrawal by Subject|1|||
131840498|NCT02912650|474698173|FG003|Overall Study|Withdrawal by Subject|5|||
131840499|NCT02912650|474698170|FG000|Overall Study|Adverse Event|0|||
131840500|NCT02912650|474698171|FG001|Overall Study|Adverse Event|0|||
131840501|NCT02912650|474698172|FG002|Overall Study|Adverse Event|1|||
131840502|NCT02912650|474698173|FG003|Overall Study|Adverse Event|0|||
131840503|NCT01791153|474698175|FG000|Part 1: Blinded Period|Adverse Event|7|||
131840504|NCT01791153|474698176|FG001|Part 1: Blinded Period|Adverse Event|3|||
131840505|NCT01791153|474698177|FG002|Part 1: Blinded Period|Adverse Event|2|||
131840506|NCT01791153|474698178|FG003|Part 1: Blinded Period|Adverse Event|0|||
131840507|NCT01791153|474698179|FG004|Part 1: Blinded Period|Adverse Event|0|||
131840508|NCT01791153|474698180|FG005|Part 1: Blinded Period|Adverse Event|0|||
131840509|NCT01791153|474698181|FG006|Part 1: Blinded Period|Adverse Event|0|||
131840510|NCT01791153|474698182|FG007|Part 1: Blinded Period|Adverse Event|0|||
131840511|NCT01791153|474698175|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
131840512|NCT01791153|474698176|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
131840513|NCT01791153|474698177|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
131840514|NCT01791153|474698178|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
131840515|NCT01791153|474698179|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
131840516|NCT01791153|474698180|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
131840517|NCT01791153|474698181|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
131840518|NCT01791153|474698182|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
131840519|NCT01791153|474698175|FG000|Part 1: Blinded Period|Non-Compliance|1|||
131840520|NCT01791153|474698176|FG001|Part 1: Blinded Period|Non-Compliance|0|||
131840521|NCT01791153|474698177|FG002|Part 1: Blinded Period|Non-Compliance|0|||
131840522|NCT01791153|474698178|FG003|Part 1: Blinded Period|Non-Compliance|0|||
131840523|NCT01791153|474698179|FG004|Part 1: Blinded Period|Non-Compliance|0|||
131840524|NCT01791153|474698180|FG005|Part 1: Blinded Period|Non-Compliance|0|||
131840525|NCT01791153|474698181|FG006|Part 1: Blinded Period|Non-Compliance|0|||
131840526|NCT01791153|474698182|FG007|Part 1: Blinded Period|Non-Compliance|0|||
131840527|NCT01791153|474698175|FG000|Part 1: Blinded Period|Physician Decision|0|||
131840528|NCT01791153|474698176|FG001|Part 1: Blinded Period|Physician Decision|0|||
131840529|NCT01791153|474698177|FG002|Part 1: Blinded Period|Physician Decision|0|||
131840530|NCT01791153|474698178|FG003|Part 1: Blinded Period|Physician Decision|1|||
131840531|NCT01791153|474698179|FG004|Part 1: Blinded Period|Physician Decision|0|||
131840532|NCT01791153|474698180|FG005|Part 1: Blinded Period|Physician Decision|0|||
131840533|NCT01791153|474698181|FG006|Part 1: Blinded Period|Physician Decision|0|||
131840534|NCT01791153|474698182|FG007|Part 1: Blinded Period|Physician Decision|0|||
131840535|NCT01791153|474698175|FG000|Part 1: Blinded Period|Protocol Violation|0|||
131840536|NCT01791153|474698176|FG001|Part 1: Blinded Period|Protocol Violation|0|||
131840537|NCT01791153|474698177|FG002|Part 1: Blinded Period|Protocol Violation|0|||
131840538|NCT01791153|474698178|FG003|Part 1: Blinded Period|Protocol Violation|1|||
131840539|NCT01791153|474698179|FG004|Part 1: Blinded Period|Protocol Violation|0|||
131840540|NCT01791153|474698180|FG005|Part 1: Blinded Period|Protocol Violation|0|||
131840541|NCT01791153|474698181|FG006|Part 1: Blinded Period|Protocol Violation|0|||
131840542|NCT01791153|474698182|FG007|Part 1: Blinded Period|Protocol Violation|0|||
131840543|NCT01791153|474698175|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
131840544|NCT01791153|474698176|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
131840545|NCT01791153|474698177|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
131840546|NCT01791153|474698178|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
131840547|NCT01791153|474698179|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
131840548|NCT01791153|474698180|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
131840549|NCT01791153|474698181|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
131840550|NCT01791153|474698182|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
131840551|NCT01791153|474698175|FG000|Part 2: Open-label Period|Adverse Event|0|||
131840552|NCT01791153|474698176|FG001|Part 2: Open-label Period|Adverse Event|0|||
131840553|NCT01791153|474698177|FG002|Part 2: Open-label Period|Adverse Event|0|||
131840554|NCT01791153|474698178|FG003|Part 2: Open-label Period|Adverse Event|0|||
131840555|NCT01791153|474698179|FG004|Part 2: Open-label Period|Adverse Event|0|||
131840556|NCT01791153|474698180|FG005|Part 2: Open-label Period|Adverse Event|1|||
131840557|NCT01791153|474698181|FG006|Part 2: Open-label Period|Adverse Event|1|||
131840558|NCT01791153|474698182|FG007|Part 2: Open-label Period|Adverse Event|2|||
131840559|NCT01791153|474698175|FG000|Part 2: Open-label Period|Death|0|||
131840560|NCT01791153|474698176|FG001|Part 2: Open-label Period|Death|0|||
131840561|NCT01791153|474698177|FG002|Part 2: Open-label Period|Death|0|||
131840562|NCT01791153|474698178|FG003|Part 2: Open-label Period|Death|0|||
131840563|NCT01791153|474698179|FG004|Part 2: Open-label Period|Death|0|||
131840564|NCT01791153|474698180|FG005|Part 2: Open-label Period|Death|1|||
131840565|NCT01791153|474698181|FG006|Part 2: Open-label Period|Death|1|||
131840566|NCT01791153|474698182|FG007|Part 2: Open-label Period|Death|1|||
131840567|NCT01791153|474698175|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
131840568|NCT01791153|474698176|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
131840569|NCT01791153|474698177|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
131840570|NCT01791153|474698178|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
131840571|NCT01791153|474698179|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
131840572|NCT01791153|474698180|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
131840573|NCT01791153|474698181|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
131840574|NCT01791153|474698182|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
131840575|NCT01791153|474698175|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
131840576|NCT01791153|474698176|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
131840577|NCT01791153|474698177|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
131840578|NCT01791153|474698178|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
131840579|NCT01791153|474698179|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
131840580|NCT01791153|474698180|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
131840581|NCT01791153|474698181|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
131840582|NCT01791153|474698182|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
131840583|NCT01791153|474698175|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
131840584|NCT01791153|474698176|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
131840585|NCT01791153|474698177|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
131840586|NCT01791153|474698178|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
131840587|NCT01791153|474698179|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
131840588|NCT01791153|474698180|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
131840589|NCT01791153|474698181|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
131840590|NCT01791153|474698182|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
131840591|NCT01791153|474698175|FG000|Part 2: Open-label Period|Physician Decision|0|||
131840592|NCT01791153|474698176|FG001|Part 2: Open-label Period|Physician Decision|0|||
131840593|NCT01791153|474698177|FG002|Part 2: Open-label Period|Physician Decision|0|||
131840594|NCT01791153|474698178|FG003|Part 2: Open-label Period|Physician Decision|0|||
131840595|NCT01791153|474698179|FG004|Part 2: Open-label Period|Physician Decision|1|||
131840596|NCT01791153|474698180|FG005|Part 2: Open-label Period|Physician Decision|1|||
131840597|NCT01791153|474698181|FG006|Part 2: Open-label Period|Physician Decision|0|||
131840598|NCT01791153|474698182|FG007|Part 2: Open-label Period|Physician Decision|0|||
131840599|NCT02562482|474698183|FG000|Overall Study|Enrolled, but did not receive product|4|||
131840600|NCT02562482|474698184|FG001|Overall Study|Enrolled, but did not receive product|0|||
131840601|NCT02562482|474698183|FG000|Overall Study|Lost to Follow-up|9|||
131840602|NCT02562482|474698184|FG001|Overall Study|Lost to Follow-up|6|||
131840603|NCT02562482|474698183|FG000|Overall Study|Moved from area|2|||
131840604|NCT02562482|474698184|FG001|Overall Study|Moved from area|3|||
131840605|NCT02562482|474698183|FG000|Overall Study|Withdrawal by Subject|5|||
131840606|NCT02562482|474698184|FG001|Overall Study|Withdrawal by Subject|3|||
131840607|NCT02562482|474698183|FG000|Overall Study|Physician Decision|1|||
131840608|NCT02562482|474698184|FG001|Overall Study|Physician Decision|3|||
131840609|NCT02562482|474698183|FG000|Overall Study|Illness/Injury unrelated to product|0|||
131840610|NCT02562482|474698184|FG001|Overall Study|Illness/Injury unrelated to product|1|||
131840611|NCT00975286|474698185|FG000|Overall Study|Adverse Event|9|||
131840612|NCT00975286|474698186|FG001|Overall Study|Adverse Event|19|||
131840613|NCT00975286|474698185|FG000|Overall Study|Protocol Violation|1|||
131840614|NCT00975286|474698186|FG001|Overall Study|Protocol Violation|2|||
131840615|NCT00975286|474698185|FG000|Overall Study|Withdrawal by Subject|0|||
131840616|NCT00975286|474698186|FG001|Overall Study|Withdrawal by Subject|2|||
131840617|NCT00975286|474698185|FG000|Overall Study|Familial and Personal Reasons|2|||
131840618|NCT00975286|474698186|FG001|Overall Study|Familial and Personal Reasons|2|||
131840619|NCT00975286|474698185|FG000|Overall Study|Poor Compliance to Protocol|0|||
131840620|NCT00975286|474698186|FG001|Overall Study|Poor Compliance to Protocol|2|||
131840621|NCT00975286|474698185|FG000|Overall Study|Sponsor Decision|0|||
131840622|NCT00975286|474698186|FG001|Overall Study|Sponsor Decision|2|||
131840623|NCT01181271|474698187|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
131840624|NCT01181271|474698187|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
131840625|NCT01181271|474698187|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
131840626|NCT01181271|474698187|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
131840627|NCT00228423|474698195|FG000|Overall Study|Adverse Event|2|||
131840628|NCT00228423|474698196|FG001|Overall Study|Adverse Event|5|||
131840629|NCT00228423|474698195|FG000|Overall Study|Withdrawal by Subject|7|||
131840630|NCT00228423|474698196|FG001|Overall Study|Withdrawal by Subject|3|||
131840631|NCT00228423|474698195|FG000|Overall Study|Protocol Violation|1|||
131840632|NCT00228423|474698196|FG001|Overall Study|Protocol Violation|3|||
131840633|NCT00228423|474698195|FG000|Overall Study|Physician Decision|0|||
131840634|NCT00228423|474698196|FG001|Overall Study|Physician Decision|1|||
131840635|NCT01709838|474698204|FG000|Overall Study|Withdrawal by Subject|21|||
131840636|NCT01709838|474698204|FG000|Overall Study|Lost to Follow-up|16|||
131840637|NCT01709838|474698204|FG000|Overall Study|Pregnancy|10|||
131840638|NCT01709838|474698204|FG000|Overall Study|Subject/guardian decision|8|||
131840639|NCT01709838|474698204|FG000|Overall Study|Adverse Event|4|||
131840640|NCT01709838|474698204|FG000|Overall Study|Physician Decision|4|||
131840641|NCT01709838|474698204|FG000|Overall Study|Death|3|||
131840642|NCT01709838|474698204|FG000|Overall Study|Protocol Violation|1|||
131840643|NCT00594646|474698210|FG000|Overall Study|Withdrawal by Subject|1|||
131840644|NCT00594646|474698210|FG000|Overall Study|Lost to Follow-up|15|||
131840645|NCT03907462|474698213|FG000|Overall Study|Physician Decision|1|||
131840646|NCT03907462|474698214|FG001|Overall Study|Physician Decision|3|||
131840647|NCT03907462|474698215|FG002|Overall Study|Physician Decision|1|||
131840648|NCT03907462|474698213|FG000|Overall Study|Withdrawal by Subject|6|||
131840649|NCT03907462|474698214|FG001|Overall Study|Withdrawal by Subject|3|||
131840650|NCT03907462|474698215|FG002|Overall Study|Withdrawal by Subject|3|||
131840651|NCT03907462|474698213|FG000|Overall Study|Pregnancy|4|||
131840652|NCT03907462|474698214|FG001|Overall Study|Pregnancy|2|||
131840653|NCT03907462|474698215|FG002|Overall Study|Pregnancy|6|||
131840654|NCT03907462|474698213|FG000|Overall Study|Lost to Follow-up|16|||
131840655|NCT03907462|474698214|FG001|Overall Study|Lost to Follow-up|18|||
131840656|NCT03907462|474698215|FG002|Overall Study|Lost to Follow-up|22|||
131840657|NCT05011123|474701114|FG000|Overall Study|Withdrawal by Subject|4|||
131840658|NCT05011123|474701115|FG001|Overall Study|Withdrawal by Subject|2|||
131402572|NCT01498575|473095555|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
131840659|NCT05011123|474701114|FG000|Overall Study|Lost to Follow-up|7|||
131840660|NCT05011123|474701115|FG001|Overall Study|Lost to Follow-up|6|||
131840661|NCT05011123|474701114|FG000|Overall Study|Ongoing at the time of DBL date|36|||
131840662|NCT05011123|474701115|FG001|Overall Study|Ongoing at the time of DBL date|10|||
131840663|NCT05011123|474701114|FG000|Overall Study|Randomized but did not receive vaccination|1|||
131840664|NCT05011123|474701115|FG001|Overall Study|Randomized but did not receive vaccination|0|||
131840665|NCT03845296|474701124|FG000|Overall Study|On Treatment|2|||
131840666|NCT03845296|474701125|FG001|Overall Study|On Treatment|1|||
131840667|NCT03845296|474701124|FG000|Overall Study|Adverse Event|4|||
131840668|NCT03845296|474701125|FG001|Overall Study|Adverse Event|11|||
131840669|NCT03845296|474701124|FG000|Overall Study|Refusal unrelated to adverse event|0|||
131840670|NCT03845296|474701125|FG001|Overall Study|Refusal unrelated to adverse event|1|||
131840671|NCT03845296|474701124|FG000|Overall Study|Progression/relapse|14|||
131840672|NCT03845296|474701125|FG001|Overall Study|Progression/relapse|18|||
131840673|NCT03845296|474701124|FG000|Overall Study|Death|4|||
131840674|NCT03845296|474701125|FG001|Overall Study|Death|0|||
131840675|NCT03845296|474701124|FG000|Overall Study|Other - not protocol specified|1|||
131840676|NCT03845296|474701125|FG001|Overall Study|Other - not protocol specified|3|||
131840677|NCT02081209|474701126|FG000|Overall Study|Withdrawal by Subject|1|||
131840678|NCT04305587|474701128|FG000|Overall Study|Withdrawal by Subject|0|||
131840679|NCT04305587|474701129|FG001|Overall Study|Withdrawal by Subject|0|||
131840680|NCT04305587|474701130|FG002|Overall Study|Withdrawal by Subject|0|||
131840681|NCT04305587|474701131|FG003|Overall Study|Withdrawal by Subject|1|||
131840682|NCT04305587|474701132|FG004|Overall Study|Withdrawal by Subject|0|||
131840683|NCT04305587|474701133|FG005|Overall Study|Withdrawal by Subject|0|||
131840684|NCT04305587|474701134|FG006|Overall Study|Withdrawal by Subject|0|||
131840685|NCT04305587|474701135|FG007|Overall Study|Withdrawal by Subject|0|||
131840686|NCT04305587|474701136|FG008|Overall Study|Withdrawal by Subject|0|||
131840687|NCT02752906|474701137|FG000|Overall Study|Protocol Violation|2|||
131840688|NCT02752906|474701138|FG001|Overall Study|Protocol Violation|1|||
131840689|NCT02752906|474701137|FG000|Overall Study|Withdrawal by Subject|2|||
131840690|NCT02752906|474701138|FG001|Overall Study|Withdrawal by Subject|2|||
131402573|NCT01498575|473095556|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
131402574|NCT01126437|473095560|FG000|Overall Study|Not treated|11|||
131402575|NCT01126437|473095561|FG001|Overall Study|Not treated|18|||
131402576|NCT01126437|473095562|FG002|Overall Study|Not treated|19|||
131402577|NCT01126437|473095560|FG000|Overall Study|Sites with data irregularities/fraud|6|||
131402578|NCT01126437|473095561|FG001|Overall Study|Sites with data irregularities/fraud|6|||
131402579|NCT01126437|473095562|FG002|Overall Study|Sites with data irregularities/fraud|7|||
131402580|NCT01126437|473095560|FG000|Overall Study|Adverse Event|602|||
131402581|NCT01126437|473095561|FG001|Overall Study|Adverse Event|606|||
131402582|NCT01126437|473095562|FG002|Overall Study|Adverse Event|635|||
131402583|NCT01126437|473095560|FG000|Overall Study|Lack of Efficacy|65|||
131402584|NCT01126437|473095561|FG001|Overall Study|Lack of Efficacy|60|||
131402585|NCT01126437|473095562|FG002|Overall Study|Lack of Efficacy|59|||
131402586|NCT01126437|473095560|FG000|Overall Study|Protocol Violation|64|||
131402587|NCT01126437|473095561|FG001|Overall Study|Protocol Violation|66|||
131402588|NCT01126437|473095562|FG002|Overall Study|Protocol Violation|41|||
131402589|NCT01126437|473095560|FG000|Overall Study|Lost to Follow-up|52|||
131402590|NCT01126437|473095561|FG001|Overall Study|Lost to Follow-up|63|||
131402591|NCT01126437|473095562|FG002|Overall Study|Lost to Follow-up|55|||
131450214|NCT01457703|473276821|FG000|Overall Study|Withdrawal by Subject|1|||
131450215|NCT01457703|473276822|FG001|Overall Study|Withdrawal by Subject|4|||
131450216|NCT00949702|473276823|FG000|Overall Study|Death|40|||
131840691|NCT02752906|474701137|FG000|Overall Study|Lost to Follow-up|3|||
131840692|NCT02752906|474701138|FG001|Overall Study|Lost to Follow-up|2|||
131840693|NCT02492880|474701140|FG000|Overall Study|Lost to Follow-up|1|||
131840694|NCT02492880|474701140|FG000|Overall Study|Protocol Violation|1|||
131840695|NCT00554190|474701141|FG000|Overall Study|Termination forms not completed|10|||
131840696|NCT01502410|474701143|FG000|Overall Study|Adverse Event|1|||
131840697|NCT01502410|474701144|FG001|Overall Study|Adverse Event|2|||
131402592|NCT01126437|473095560|FG000|Overall Study|Withdrawal by Subject|331|||
131402593|NCT01126437|473095561|FG001|Overall Study|Withdrawal by Subject|335|||
131402594|NCT01126437|473095562|FG002|Overall Study|Withdrawal by Subject|319|||
131402595|NCT01126437|473095560|FG000|Overall Study|Other reason not specified|210|||
131840698|NCT01502410|474701145|FG002|Overall Study|Adverse Event|0|||
131840699|NCT01502410|474701146|FG003|Overall Study|Adverse Event|0|||
131840700|NCT01502410|474701143|FG000|Overall Study|Lack of Efficacy|7|||
131840701|NCT01502410|474701144|FG001|Overall Study|Lack of Efficacy|7|||
131840702|NCT01502410|474701145|FG002|Overall Study|Lack of Efficacy|0|||
131840703|NCT01502410|474701146|FG003|Overall Study|Lack of Efficacy|0|||
131840704|NCT01502410|474701143|FG000|Overall Study|Physician Decision|0|||
131840705|NCT01502410|474701144|FG001|Overall Study|Physician Decision|1|||
131840706|NCT01502410|474701145|FG002|Overall Study|Physician Decision|0|||
131840707|NCT01502410|474701146|FG003|Overall Study|Physician Decision|0|||
131840708|NCT01502410|474701143|FG000|Overall Study|Withdrawal by Subject|2|||
131840709|NCT01502410|474701144|FG001|Overall Study|Withdrawal by Subject|0|||
131840710|NCT01502410|474701145|FG002|Overall Study|Withdrawal by Subject|0|||
131840711|NCT01502410|474701146|FG003|Overall Study|Withdrawal by Subject|0|||
131840712|NCT02903030|474701147|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
131840713|NCT02903030|474701148|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
131840714|NCT03786718|474701152|FG000|Overall Study|Lost to Follow-up|3|||
131840715|NCT03786718|474701152|FG000|Overall Study|Withdrawal by Subject|1|||
131840716|NCT03786718|474701152|FG000|Overall Study|Did not use the intervention|2|||
131840717|NCT03786718|474701152|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
131840718|NCT01345175|474701156|FG000|Overall Study|Physician Decision|0|||
131840719|NCT01345175|474701157|FG001|Overall Study|Physician Decision|1|||
131840720|NCT01345175|474701156|FG000|Overall Study|Withdrawal by Subject|1|||
131840721|NCT01345175|474701157|FG001|Overall Study|Withdrawal by Subject|1|||
131840722|NCT01345175|474701156|FG000|Overall Study|Failed to complete BFI|3|||
131840723|NCT01345175|474701157|FG001|Overall Study|Failed to complete BFI|2|||
131840724|NCT01345175|474701156|FG000|Overall Study|Stopped taking medication|2|||
131840725|NCT01345175|474701157|FG001|Overall Study|Stopped taking medication|2|||
131840726|NCT04112173|474701158|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
131840727|NCT02906930|474701159|FG000|Overall Study|Withdrawal by Subject|0|||
131840728|NCT02906930|474701160|FG001|Overall Study|Withdrawal by Subject|5|||
131840729|NCT02906930|474701161|FG002|Overall Study|Withdrawal by Subject|5|||
131840730|NCT02906930|474701162|FG003|Overall Study|Withdrawal by Subject|4|||
131840731|NCT02906930|474701159|FG000|Overall Study|Lost to Follow-up|5|||
131840732|NCT02906930|474701160|FG001|Overall Study|Lost to Follow-up|7|||
131840733|NCT02906930|474701161|FG002|Overall Study|Lost to Follow-up|5|||
131840734|NCT02906930|474701162|FG003|Overall Study|Lost to Follow-up|2|||
131840735|NCT02906930|474701159|FG000|Overall Study|Death|0|||
131840736|NCT02906930|474701160|FG001|Overall Study|Death|0|||
131840737|NCT02906930|474701161|FG002|Overall Study|Death|1|||
131840738|NCT02906930|474701162|FG003|Overall Study|Death|0|||
131840739|NCT02906930|474701159|FG000|Overall Study|Other|1|||
131840740|NCT02906930|474701160|FG001|Overall Study|Other|2|||
131840741|NCT02906930|474701161|FG002|Overall Study|Other|1|||
131840742|NCT02906930|474701162|FG003|Overall Study|Other|2|||
131840743|NCT02570113|474701172|FG000|Overall Study|Withdrawal by Subject|3|||
131840744|NCT02564211|474701173|FG000|Overall Study|Adverse Event|4|||
131840745|NCT00910091|474701174|FG000|Pre-assignment|Withdrawal by Subject|0|||
131840746|NCT00910091|474701175|FG001|Pre-assignment|Withdrawal by Subject|2|||
131840747|NCT00910091|474701174|FG000|Treatment and Survival|Withdrawal by Subject|3|||
131840748|NCT00910091|474701175|FG001|Treatment and Survival|Withdrawal by Subject|4|||
131840749|NCT00910091|474701174|FG000|Treatment and Survival|Adverse Event|1|||
131840750|NCT00910091|474701175|FG001|Treatment and Survival|Adverse Event|0|||
131840751|NCT00622466|474701178|FG000|Overall Study|Death|1|||
131840752|NCT00622466|474701178|FG000|Overall Study|Adverse Event|1|||
131840753|NCT00622466|474701178|FG000|Overall Study|Withdrawal by Subject|2|||
131840754|NCT01908816|474701179|FG000|Overall Study|Subject's no longer requires study drug|0|||
131840755|NCT01908816|474701180|FG001|Overall Study|Subject's no longer requires study drug|0|||
131840756|NCT01908816|474701181|FG002|Overall Study|Subject's no longer requires study drug|0|||
131402596|NCT01126437|473095561|FG001|Overall Study|Other reason not specified|176|||
131402597|NCT01126437|473095562|FG002|Overall Study|Other reason not specified|178|||
131402598|NCT01972308|473095565|FG000|Overall Study|Withdrawal by Subject|0|||
131402599|NCT01972308|473095566|FG001|Overall Study|Withdrawal by Subject|1|||
131402600|NCT01972308|473095565|FG000|Overall Study|Lost to Follow-up|4|||
131402601|NCT01972308|473095566|FG001|Overall Study|Lost to Follow-up|6|||
131840757|NCT01908816|474701182|FG003|Overall Study|Subject's no longer requires study drug|1|||
131840758|NCT01908816|474701179|FG000|Overall Study|Protocol deviation|1|||
131840759|NCT01908816|474701180|FG001|Overall Study|Protocol deviation|2|||
131840760|NCT01908816|474701181|FG002|Overall Study|Protocol deviation|1|||
131840761|NCT01908816|474701182|FG003|Overall Study|Protocol deviation|1|||
131840762|NCT01908816|474701179|FG000|Overall Study|Withdrawal by Subject|0|||
131840763|NCT01908816|474701180|FG001|Overall Study|Withdrawal by Subject|4|||
131402602|NCT01972308|473095565|FG000|Overall Study|Death|4|||
131402603|NCT01972308|473095566|FG001|Overall Study|Death|1|||
131840764|NCT01908816|474701181|FG002|Overall Study|Withdrawal by Subject|2|||
131840765|NCT01908816|474701182|FG003|Overall Study|Withdrawal by Subject|2|||
131840766|NCT01908816|474701179|FG000|Overall Study|Lost to Follow-up|3|||
131840767|NCT01908816|474701180|FG001|Overall Study|Lost to Follow-up|5|||
131840768|NCT01908816|474701181|FG002|Overall Study|Lost to Follow-up|4|||
131840769|NCT01908816|474701182|FG003|Overall Study|Lost to Follow-up|2|||
131840770|NCT01908816|474701179|FG000|Overall Study|Death|1|||
131840771|NCT01908816|474701180|FG001|Overall Study|Death|0|||
131840772|NCT01908816|474701181|FG002|Overall Study|Death|7|||
131840773|NCT01908816|474701182|FG003|Overall Study|Death|1|||
131840774|NCT01908816|474701179|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131840775|NCT01908816|474701180|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
131840776|NCT01908816|474701181|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131840777|NCT01908816|474701182|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131840778|NCT01908816|474701179|FG000|Overall Study|Early termination|87|||
131840779|NCT01908816|474701180|FG001|Overall Study|Early termination|60|||
131840780|NCT01908816|474701181|FG002|Overall Study|Early termination|43|||
131840781|NCT01908816|474701182|FG003|Overall Study|Early termination|28|||
131840782|NCT01154816|474701183|FG000|Overall Study|Withdrawal by Subject|1|||
131840783|NCT01154816|474701184|FG001|Overall Study|Withdrawal by Subject|0|||
131840784|NCT01154816|474701185|FG002|Overall Study|Withdrawal by Subject|0|||
131840785|NCT01154816|474701186|FG003|Overall Study|Withdrawal by Subject|1|||
131840786|NCT01154816|474701187|FG004|Overall Study|Withdrawal by Subject|0|||
131840787|NCT01154816|474701188|FG005|Overall Study|Withdrawal by Subject|0|||
131840788|NCT01154816|474701189|FG006|Overall Study|Withdrawal by Subject|0|||
131840789|NCT01154816|474701190|FG007|Overall Study|Withdrawal by Subject|0|||
131840790|NCT01154816|474701191|FG008|Overall Study|Withdrawal by Subject|1|||
131840791|NCT01154816|474701192|FG009|Overall Study|Withdrawal by Subject|3|||
131840792|NCT01154816|474701193|FG010|Overall Study|Withdrawal by Subject|0|||
131840793|NCT01154816|474701194|FG011|Overall Study|Withdrawal by Subject|0|||
131840794|NCT01154816|474701183|FG000|Overall Study|Progressive Disease|13|||
131840795|NCT01154816|474701184|FG001|Overall Study|Progressive Disease|8|||
131840796|NCT01154816|474701185|FG002|Overall Study|Progressive Disease|9|||
131840797|NCT01154816|474701186|FG003|Overall Study|Progressive Disease|9|||
131840798|NCT01154816|474701187|FG004|Overall Study|Progressive Disease|8|||
131840799|NCT01154816|474701188|FG005|Overall Study|Progressive Disease|8|||
131840800|NCT01154816|474701189|FG006|Overall Study|Progressive Disease|5|||
131840801|NCT01154816|474701190|FG007|Overall Study|Progressive Disease|6|||
131840802|NCT01154816|474701191|FG008|Overall Study|Progressive Disease|8|||
131840803|NCT01154816|474701192|FG009|Overall Study|Progressive Disease|6|||
131840804|NCT01154816|474701193|FG010|Overall Study|Progressive Disease|10|||
131840805|NCT01154816|474701194|FG011|Overall Study|Progressive Disease|3|||
131840806|NCT01154816|474701183|FG000|Overall Study|Physician Decision|1|||
131840807|NCT01154816|474701184|FG001|Overall Study|Physician Decision|0|||
131840808|NCT01154816|474701185|FG002|Overall Study|Physician Decision|1|||
131840809|NCT01154816|474701186|FG003|Overall Study|Physician Decision|0|||
131840810|NCT01154816|474701187|FG004|Overall Study|Physician Decision|2|||
131840811|NCT01154816|474701188|FG005|Overall Study|Physician Decision|0|||
131840812|NCT01154816|474701189|FG006|Overall Study|Physician Decision|0|||
131840813|NCT01154816|474701190|FG007|Overall Study|Physician Decision|0|||
131840814|NCT01154816|474701191|FG008|Overall Study|Physician Decision|0|||
131840815|NCT01154816|474701192|FG009|Overall Study|Physician Decision|1|||
131840816|NCT01154816|474701193|FG010|Overall Study|Physician Decision|1|||
131840817|NCT01154816|474701194|FG011|Overall Study|Physician Decision|1|||
131840818|NCT01154816|474701183|FG000|Overall Study|Adverse Event|5|||
131840819|NCT01154816|474701184|FG001|Overall Study|Adverse Event|2|||
131840820|NCT01154816|474701185|FG002|Overall Study|Adverse Event|0|||
131840821|NCT01154816|474701186|FG003|Overall Study|Adverse Event|0|||
131840822|NCT01154816|474701187|FG004|Overall Study|Adverse Event|0|||
131840823|NCT01154816|474701188|FG005|Overall Study|Adverse Event|0|||
131840824|NCT01154816|474701189|FG006|Overall Study|Adverse Event|1|||
131840825|NCT01154816|474701190|FG007|Overall Study|Adverse Event|1|||
131840826|NCT01154816|474701191|FG008|Overall Study|Adverse Event|0|||
131840827|NCT01154816|474701192|FG009|Overall Study|Adverse Event|0|||
131840828|NCT01154816|474701193|FG010|Overall Study|Adverse Event|0|||
131840829|NCT01154816|474701194|FG011|Overall Study|Adverse Event|0|||
131450217|NCT00949702|473276823|FG000|Overall Study|Disease progression|7|||
131840830|NCT02628743|474701196|FG000|Overall Study|Other|3|||
131840831|NCT02628743|474701196|FG000|Overall Study|Withdrawal by Subject|50|||
131840832|NCT02628743|474701196|FG000|Overall Study|Study Terminated by Sponsor|76|||
131840833|NCT02628743|474701196|FG000|Overall Study|Physician Decision|2|||
131840834|NCT02603393|474701197|FG000|Overall Study|Patient/guardian decision|32|||
131840835|NCT02603393|474701198|FG001|Overall Study|Patient/guardian decision|18|||
131840836|NCT02603393|474701197|FG000|Overall Study|Adverse Event|17|||
131840837|NCT02603393|474701198|FG001|Overall Study|Adverse Event|15|||
131840838|NCT02603393|474701197|FG000|Overall Study|Technical problems|4|||
131840839|NCT02603393|474701198|FG001|Overall Study|Technical problems|7|||
131840840|NCT02603393|474701197|FG000|Overall Study|Lack of Efficacy|7|||
131840841|NCT02603393|474701198|FG001|Overall Study|Lack of Efficacy|2|||
131840842|NCT02603393|474701197|FG000|Overall Study|Death|3|||
131840843|NCT02603393|474701198|FG001|Overall Study|Death|4|||
131840844|NCT02603393|474701197|FG000|Overall Study|Physician Decision|3|||
131840845|NCT02603393|474701198|FG001|Overall Study|Physician Decision|3|||
131840846|NCT02603393|474701197|FG000|Overall Study|Protocol deviation|2|||
131840847|NCT02603393|474701198|FG001|Overall Study|Protocol deviation|3|||
131840848|NCT02603393|474701197|FG000|Overall Study|Lost to Follow-up|1|||
131450218|NCT00949702|473276823|FG000|Overall Study|Withdrawal of consent|1|||
131450219|NCT01654302|473276824|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
131450220|NCT01654302|473276825|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
131450221|NCT03815929|473276826|FG000|Overall Study|Lost to Follow-up|2|||
131450222|NCT03815929|473276827|FG001|Overall Study|Lost to Follow-up|1|||
131840849|NCT02603393|474701198|FG001|Overall Study|Lost to Follow-up|2|||
131840850|NCT02603393|474701197|FG000|Overall Study|Non-compliance with study treatment|1|||
131840851|NCT02603393|474701198|FG001|Overall Study|Non-compliance with study treatment|0|||
131840852|NCT02603393|474701197|FG000|Overall Study|Sponsor decision|1|||
131840853|NCT02603393|474701198|FG001|Overall Study|Sponsor decision|0|||
131840854|NCT00593736|474701201|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
131840855|NCT00593736|474701202|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
131840856|NCT00593736|474701203|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
131840857|NCT00593736|474701204|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
131840858|NCT00593736|474701201|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
131840859|NCT00593736|474701202|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
131840860|NCT00593736|474701203|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
131840861|NCT00593736|474701204|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
131840862|NCT00593736|474701201|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
131840863|NCT00593736|474701202|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
131840864|NCT00593736|474701203|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
131840865|NCT00593736|474701204|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
131840866|NCT00593736|474701201|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
131840867|NCT00593736|474701202|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
131840868|NCT00593736|474701203|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
131840869|NCT00593736|474701204|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
131840870|NCT00593736|474701201|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
131840871|NCT00593736|474701202|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
131840872|NCT00593736|474701203|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
131840873|NCT00593736|474701204|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
131840874|NCT00593736|474701201|FG000|Screening Period and Placebo Run-in|Various|0|||
131840875|NCT00593736|474701202|FG001|Screening Period and Placebo Run-in|Various|0|||
131840876|NCT00593736|474701203|FG002|Screening Period and Placebo Run-in|Various|0|||
131840877|NCT00593736|474701204|FG003|Screening Period and Placebo Run-in|Various|25|||
131840878|NCT00593736|474701201|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
131840879|NCT00593736|474701202|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
131840880|NCT00593736|474701203|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
131840881|NCT00593736|474701204|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
131840882|NCT00593736|474701201|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
131840883|NCT00593736|474701202|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
131840884|NCT00593736|474701203|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
131840885|NCT00593736|474701204|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
131840886|NCT00593736|474701201|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
131840887|NCT00593736|474701202|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
131840888|NCT00593736|474701203|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
131840889|NCT00593736|474701204|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
131840890|NCT00593736|474701201|FG000|Treatment Period and Placebo Run-out|Various|1|||
131840891|NCT00593736|474701202|FG001|Treatment Period and Placebo Run-out|Various|1|||
131840892|NCT00593736|474701203|FG002|Treatment Period and Placebo Run-out|Various|1|||
131840893|NCT00593736|474701204|FG003|Treatment Period and Placebo Run-out|Various|0|||
131840894|NCT01868893|474701205|FG000|Overall Study|Adverse Event|2|||
131840895|NCT01868893|474701205|FG000|Overall Study|Commercial availability of study drug|17|||
131840896|NCT01868893|474701205|FG000|Overall Study|Neutropenia|1|||
131840897|NCT01857271|474701206|FG000|Overall Study|Lost to Follow-up|1|||
131840898|NCT01783548|474701207|FG000|Overall Study|Adverse Event|8|||
131840899|NCT01783548|474701208|FG001|Overall Study|Adverse Event|4|||
131840900|NCT01783548|474701207|FG000|Overall Study|Withdrawal by Subject|11|||
131840901|NCT01783548|474701208|FG001|Overall Study|Withdrawal by Subject|8|||
131450223|NCT03815929|473276828|FG002|Overall Study|Lost to Follow-up|0|||
131450224|NCT03815929|473276826|FG000|Overall Study|Physician Decision|2|||
131840902|NCT01783548|474701207|FG000|Overall Study|Non-compliance|4|||
131840903|NCT01783548|474701208|FG001|Overall Study|Non-compliance|0|||
131840904|NCT01783548|474701207|FG000|Overall Study|Protocol Violation|2|||
131840905|NCT01783548|474701208|FG001|Overall Study|Protocol Violation|2|||
131840906|NCT01783548|474701207|FG000|Overall Study|Lost to Follow-up|8|||
131910796|NCT02814526|474960851|FG001|Overall Study|non site physician decision|0|||
131450225|NCT03815929|473276827|FG001|Overall Study|Physician Decision|2|||
131840907|NCT01783548|474701208|FG001|Overall Study|Lost to Follow-up|3|||
131840908|NCT01783548|474701207|FG000|Overall Study|Lack of Efficacy|1|||
131840909|NCT01783548|474701208|FG001|Overall Study|Lack of Efficacy|1|||
131840910|NCT03825341|474701209|FG000|Overall Study|Withdrawal by Subject|0|||
131840911|NCT03825341|474701210|FG001|Overall Study|Withdrawal by Subject|1|||
131840912|NCT00289536|474701212|FG000|Period 3|Lost to Follow-up|0|||
131840913|NCT00289536|474701213|FG001|Period 3|Lost to Follow-up|0|||
131840914|NCT00289536|474701214|FG002|Period 3|Lost to Follow-up|1|||
131840915|NCT00552578|474701223|FG000|Overall Study|Lost to Follow-up|1|||
131840916|NCT00552578|474701224|FG001|Overall Study|Lost to Follow-up|1|||
131840917|NCT04053465|474701225|FG000|Overall Study|Withdrawal by Subject|4|||
131840918|NCT04053465|474701226|FG001|Overall Study|Withdrawal by Subject|4|||
131840919|NCT02338193|474701228|FG000|Overall Study|Withdrawal by Subject|0|||
131840920|NCT02338193|474701229|FG001|Overall Study|Withdrawal by Subject|0|||
131840921|NCT02338193|474701230|FG002|Overall Study|Withdrawal by Subject|2|||
131840922|NCT02338193|474701228|FG000|Overall Study|Pregnancy|0|||
131840923|NCT02338193|474701229|FG001|Overall Study|Pregnancy|1|||
131840924|NCT02338193|474701230|FG002|Overall Study|Pregnancy|1|||
131840925|NCT02338193|474701228|FG000|Overall Study|Noncompliant with visits|2|||
131840926|NCT02338193|474701229|FG001|Overall Study|Noncompliant with visits|2|||
131840927|NCT02338193|474701230|FG002|Overall Study|Noncompliant with visits|7|||
131840928|NCT02338193|474701228|FG000|Overall Study|moved out of state|0|||
131840929|NCT02338193|474701229|FG001|Overall Study|moved out of state|1|||
131840930|NCT02338193|474701230|FG002|Overall Study|moved out of state|0|||
131840931|NCT02338193|474701228|FG000|Overall Study|intolerant of side effects|1|||
131840932|NCT02338193|474701229|FG001|Overall Study|intolerant of side effects|0|||
131840933|NCT02338193|474701230|FG002|Overall Study|intolerant of side effects|0|||
131840934|NCT01447420|474701231|FG000|Overall Study|Adverse Event|2|||
131840935|NCT01447420|474701232|FG001|Overall Study|Adverse Event|4|||
131840936|NCT01447420|474701233|FG002|Overall Study|Adverse Event|2|||
131840937|NCT01447420|474701231|FG000|Overall Study|Protocol Violation|3|||
131840938|NCT01447420|474701232|FG001|Overall Study|Protocol Violation|3|||
131840939|NCT01447420|474701233|FG002|Overall Study|Protocol Violation|0|||
131840940|NCT01447420|474701231|FG000|Overall Study|Withdrawal by Subject|4|||
131840941|NCT01447420|474701232|FG001|Overall Study|Withdrawal by Subject|1|||
131840942|NCT01447420|474701233|FG002|Overall Study|Withdrawal by Subject|0|||
131840943|NCT01447420|474701231|FG000|Overall Study|Lack of Efficacy|1|||
131840944|NCT01447420|474701232|FG001|Overall Study|Lack of Efficacy|19|||
131840945|NCT01447420|474701233|FG002|Overall Study|Lack of Efficacy|8|||
131840946|NCT05788289|474701240|FG000|Overall Study|Death|3|||
131840947|NCT01974440|474701241|FG000|Overall Study|Lost to Follow-up|7|||
131840948|NCT01974440|474701242|FG001|Overall Study|Lost to Follow-up|7|||
131840949|NCT01974440|474701241|FG000|Overall Study|Withdrawal by Subject|24|||
131840950|NCT01974440|474701242|FG001|Overall Study|Withdrawal by Subject|20|||
131840951|NCT01974440|474701241|FG000|Overall Study|Sponsor decision|109|||
131840952|NCT01974440|474701242|FG001|Overall Study|Sponsor decision|110|||
131840953|NCT00762437|474701243|FG000|Overall Study|Lost to Follow-up|7|||
131840954|NCT00762437|474701243|FG000|Overall Study|Missed final study visit|11|||
131840955|NCT00762437|474701243|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
131840956|NCT06354998|474701244|FG000|Overall Study|Withdrawal by Subject|3|||
131840957|NCT06354998|474701245|FG001|Overall Study|Withdrawal by Subject|0|||
131840958|NCT00826449|474701248|FG000|Overall Study|Disease Progression|4|||
131840959|NCT00826449|474701248|FG000|Overall Study|Withdrawal by Subject|1|||
131840960|NCT02994940|474701249|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
131840961|NCT02994940|474701250|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
131840962|NCT02994940|474701249|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
131840963|NCT02994940|474701250|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
131840964|NCT02994940|474701249|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
131840965|NCT02994940|474701250|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
131840966|NCT03285308|474701255|FG000|Overall Study|Adverse Event|3|||
131840967|NCT03285308|474701256|FG001|Overall Study|Adverse Event|7|||
131840968|NCT03285308|474701255|FG000|Overall Study|Withdrawal by Subject|8|||
131840969|NCT03285308|474701256|FG001|Overall Study|Withdrawal by Subject|9|||
131840970|NCT03285308|474701255|FG000|Overall Study|Lost to Follow-up|3|||
131840971|NCT03285308|474701256|FG001|Overall Study|Lost to Follow-up|1|||
131840972|NCT03285308|474701255|FG000|Overall Study|Protocol Deviation|6|||
131840973|NCT03285308|474701256|FG001|Overall Study|Protocol Deviation|5|||
131840974|NCT03285308|474701255|FG000|Overall Study|Reason not Specified|0|||
131840975|NCT03285308|474701256|FG001|Overall Study|Reason not Specified|1|||
131910797|NCT02814526|474960850|FG000|Overall Study|participant noncompliance|1|||
131910798|NCT02814526|474960851|FG001|Overall Study|participant noncompliance|1|||
131840976|NCT01157897|474701258|FG000|Overall Study|Lost to Follow-up|2|||
131840977|NCT01157897|474701259|FG001|Overall Study|Lost to Follow-up|0|||
131840978|NCT01157897|474701260|FG002|Overall Study|Lost to Follow-up|0|||
131840979|NCT01157897|474701261|FG003|Overall Study|Lost to Follow-up|1|||
131840980|NCT01157897|474701258|FG000|Overall Study|Relocated|0|||
131840981|NCT01157897|474701259|FG001|Overall Study|Relocated|2|||
131840982|NCT01157897|474701260|FG002|Overall Study|Relocated|0|||
131840983|NCT01157897|474701261|FG003|Overall Study|Relocated|0|||
131840984|NCT03734666|474701262|FG000|Overall Study|Other|7|||
131840985|NCT03734666|474701263|FG001|Overall Study|Other|4|||
131840986|NCT03734666|474701262|FG000|Overall Study|Lost to Follow-up|12|||
131840987|NCT03734666|474701263|FG001|Overall Study|Lost to Follow-up|12|||
131840988|NCT00424775|474701264|FG000|Overall Study|Adverse Event|2|||
131840989|NCT00424775|474701265|FG001|Overall Study|Adverse Event|0|||
131840990|NCT00424775|474701264|FG000|Overall Study|Lack of Efficacy|1|||
131840991|NCT00424775|474701265|FG001|Overall Study|Lack of Efficacy|0|||
131840992|NCT00681590|474701266|FG000|Overall Study|Withdrawal by Subject|2|||
131840993|NCT00681590|474701267|FG001|Overall Study|Withdrawal by Subject|12|||
131840994|NCT01898650|474701269|FG000|Overall Study|the subject would not lie still for imaging|1|||
131840995|NCT04156620|474701270|FG000|Overall Study|Adverse event - TP 1|5|||
131840996|NCT04156620|474701271|FG001|Overall Study|Adverse event - TP 1|2|||
131840997|NCT04156620|474701270|FG000|Overall Study|Lost to follow-up TP 1|1|||
131840998|NCT04156620|474701271|FG001|Overall Study|Lost to follow-up TP 1|1|||
131840999|NCT04156620|474701270|FG000|Overall Study|Progressive disease - TP 1|0|||
131841000|NCT04156620|474701271|FG001|Overall Study|Progressive disease - TP 1|1|||
131841001|NCT04156620|474701270|FG000|Overall Study|Subject decision - TP 1|3|||
131841002|NCT04156620|474701271|FG001|Overall Study|Subject decision - TP 1|5|||
131841003|NCT04156620|474701270|FG000|Overall Study|Adverse event - TP 2|5|||
131841004|NCT04156620|474701271|FG001|Overall Study|Adverse event - TP 2|6|||
131841005|NCT04156620|474701270|FG000|Overall Study|Death - TP 2|1|||
131841006|NCT04156620|474701271|FG001|Overall Study|Death - TP 2|0|||
131841007|NCT04156620|474701270|FG000|Overall Study|Lost to follow-up - TP 2|5|||
131841008|NCT04156620|474701271|FG001|Overall Study|Lost to follow-up - TP 2|2|||
131841009|NCT04156620|474701270|FG000|Overall Study|Physician decision - TP 2|4|||
131841010|NCT04156620|474701271|FG001|Overall Study|Physician decision - TP 2|2|||
131841011|NCT04156620|474701270|FG000|Overall Study|Pregnancy - TP 2|1|||
131841012|NCT04156620|474701271|FG001|Overall Study|Pregnancy - TP 2|1|||
131841013|NCT04156620|474701270|FG000|Overall Study|Subject decision - TP 2|11|||
131841014|NCT04156620|474701271|FG001|Overall Study|Subject decision - TP 2|9|||
131841015|NCT04156620|474701270|FG000|Overall Study|New therapy for study indication - TP 2|1|||
131841016|NCT04156620|474701271|FG001|Overall Study|New therapy for study indication - TP 2|0|||
131841017|NCT02722148|474701272|FG000|Overall Study|Lost to Follow-up|2|||
131841018|NCT02722148|474701272|FG000|Overall Study|Non compliant with treatment regimen|3|||
131841019|NCT04135196|474701273|FG000|Overall Study|Lost to Follow-up|8|||
131841020|NCT04135196|474701274|FG001|Overall Study|Lost to Follow-up|7|||
131841021|NCT04135196|474701275|FG002|Overall Study|Lost to Follow-up|8|||
131841022|NCT04135196|474701276|FG003|Overall Study|Lost to Follow-up|9|||
131841023|NCT04135196|474701277|FG004|Overall Study|Lost to Follow-up|1|||
131841024|NCT04135196|474701273|FG000|Overall Study|Pregnancy|0|||
131841025|NCT04135196|474701274|FG001|Overall Study|Pregnancy|0|||
131841026|NCT04135196|474701275|FG002|Overall Study|Pregnancy|1|||
131841027|NCT04135196|474701276|FG003|Overall Study|Pregnancy|0|||
131841028|NCT04135196|474701277|FG004|Overall Study|Pregnancy|0|||
131841029|NCT04135196|474701273|FG000|Overall Study|Withdrawal by Subject|0|||
131841030|NCT04135196|474701274|FG001|Overall Study|Withdrawal by Subject|0|||
131841031|NCT04135196|474701275|FG002|Overall Study|Withdrawal by Subject|0|||
131841032|NCT04135196|474701276|FG003|Overall Study|Withdrawal by Subject|0|||
131841033|NCT04135196|474701277|FG004|Overall Study|Withdrawal by Subject|1|||
131841034|NCT01753336|474701279|FG000|Overall Study|Patient decision|12|||
131841035|NCT01753336|474701279|FG000|Overall Study|Lost to Follow-up|3|||
131841036|NCT01753336|474701279|FG000|Overall Study|Physician Decision|2|||
131841037|NCT01753336|474701279|FG000|Overall Study|Sponsor's decision|2|||
131841038|NCT01753336|474701279|FG000|Overall Study|Withdrawal by Subject|1|||
131841039|NCT00809159|474701280|FG000|Part 1|Adverse Event|1|||
131841040|NCT00809159|474701281|FG001|Part 1|Adverse Event|1|||
131841041|NCT00809159|474701282|FG002|Part 1|Adverse Event|0|||
131841042|NCT00809159|474701283|FG003|Part 1|Adverse Event|0|||
131841043|NCT00809159|474701284|FG004|Part 1|Adverse Event|0|||
131841044|NCT00809159|474701285|FG005|Part 1|Adverse Event|0|||
131841045|NCT00809159|474701280|FG000|Part 1|Lost to Follow-up|1|||
131841046|NCT00809159|474701281|FG001|Part 1|Lost to Follow-up|0|||
131841047|NCT00809159|474701282|FG002|Part 1|Lost to Follow-up|0|||
131841048|NCT00809159|474701283|FG003|Part 1|Lost to Follow-up|0|||
131841049|NCT00809159|474701284|FG004|Part 1|Lost to Follow-up|0|||
131841050|NCT00809159|474701285|FG005|Part 1|Lost to Follow-up|0|||
131841051|NCT00809159|474701280|FG000|Part 1|Withdrawal by Subject|3|||
131841052|NCT00809159|474701281|FG001|Part 1|Withdrawal by Subject|1|||
131841053|NCT00809159|474701282|FG002|Part 1|Withdrawal by Subject|0|||
131841054|NCT00809159|474701283|FG003|Part 1|Withdrawal by Subject|0|||
131841055|NCT00809159|474701284|FG004|Part 1|Withdrawal by Subject|0|||
131841056|NCT00809159|474701285|FG005|Part 1|Withdrawal by Subject|0|||
131841057|NCT00809159|474701280|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
131450226|NCT03815929|473276828|FG002|Overall Study|Physician Decision|0|||
131841058|NCT00809159|474701281|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
131841059|NCT00809159|474701282|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
131841060|NCT00809159|474701283|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
131841061|NCT00809159|474701284|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
131841062|NCT00809159|474701285|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
131841063|NCT00809159|474701280|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
131841064|NCT00809159|474701281|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
131841065|NCT00809159|474701282|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
131841066|NCT00809159|474701283|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
131841067|NCT00809159|474701284|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
131841068|NCT00809159|474701285|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
131841069|NCT00809159|474701280|FG000|Part 1 and 2|Administrative problems|0|||
131841070|NCT00809159|474701281|FG001|Part 1 and 2|Administrative problems|0|||
131841071|NCT00809159|474701282|FG002|Part 1 and 2|Administrative problems|0|||
131841072|NCT00809159|474701283|FG003|Part 1 and 2|Administrative problems|1|||
131841073|NCT00809159|474701284|FG004|Part 1 and 2|Administrative problems|0|||
131841074|NCT00809159|474701285|FG005|Part 1 and 2|Administrative problems|0|||
131841075|NCT00809159|474701280|FG000|Part 1 and 2|Adverse Event|0|||
131841076|NCT00809159|474701281|FG001|Part 1 and 2|Adverse Event|0|||
131841077|NCT00809159|474701282|FG002|Part 1 and 2|Adverse Event|1|||
131841078|NCT00809159|474701283|FG003|Part 1 and 2|Adverse Event|0|||
131841079|NCT00809159|474701284|FG004|Part 1 and 2|Adverse Event|1|||
131841080|NCT00809159|474701285|FG005|Part 1 and 2|Adverse Event|1|||
131841081|NCT00809159|474701280|FG000|Part 1 and 2|Lost to Follow-up|0|||
131841082|NCT00809159|474701281|FG001|Part 1 and 2|Lost to Follow-up|0|||
131841083|NCT00809159|474701282|FG002|Part 1 and 2|Lost to Follow-up|1|||
131841084|NCT00809159|474701283|FG003|Part 1 and 2|Lost to Follow-up|1|||
131841085|NCT00809159|474701284|FG004|Part 1 and 2|Lost to Follow-up|0|||
131841086|NCT00809159|474701285|FG005|Part 1 and 2|Lost to Follow-up|0|||
131841087|NCT00809159|474701280|FG000|Part 1 and 2|Withdrawal by Subject|0|||
131841088|NCT00809159|474701281|FG001|Part 1 and 2|Withdrawal by Subject|0|||
131841089|NCT00809159|474701282|FG002|Part 1 and 2|Withdrawal by Subject|4|||
131841090|NCT00809159|474701283|FG003|Part 1 and 2|Withdrawal by Subject|0|||
131841091|NCT00809159|474701284|FG004|Part 1 and 2|Withdrawal by Subject|0|||
131841092|NCT00809159|474701285|FG005|Part 1 and 2|Withdrawal by Subject|1|||
131841093|NCT03201211|474701289|FG000|Overall Study|Adverse Event|1|||
131841094|NCT03201211|474701290|FG001|Overall Study|Adverse Event|0|||
131841095|NCT03201211|474701291|FG002|Overall Study|Adverse Event|0|||
131841096|NCT03201211|474701289|FG000|Overall Study|Protocol Violation|1|||
131841097|NCT03201211|474701290|FG001|Overall Study|Protocol Violation|0|||
131841098|NCT03201211|474701291|FG002|Overall Study|Protocol Violation|0|||
131841099|NCT03201211|474701289|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131841100|NCT03201211|474701290|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131841101|NCT03201211|474701291|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
131841102|NCT03201211|474701289|FG000|Overall Study|OTHER unknown reasons|0|||
131841103|NCT03201211|474701290|FG001|Overall Study|OTHER unknown reasons|1|||
131841104|NCT03201211|474701291|FG002|Overall Study|OTHER unknown reasons|0|||
131841105|NCT01083810|474701292|FG000|Overall Study|Lost to Follow-up|23|||
131841106|NCT01083810|474701293|FG001|Overall Study|Lost to Follow-up|11|||
131841107|NCT01083810|474701294|FG002|Overall Study|Lost to Follow-up|4|||
131841108|NCT01083810|474701292|FG000|Overall Study|Adverse Event|15|||
131841109|NCT01083810|474701293|FG001|Overall Study|Adverse Event|11|||
131841110|NCT01083810|474701294|FG002|Overall Study|Adverse Event|4|||
131841111|NCT01083810|474701292|FG000|Overall Study|Withdrawal by Subject|7|||
131841112|NCT01083810|474701293|FG001|Overall Study|Withdrawal by Subject|2|||
131841113|NCT01083810|474701294|FG002|Overall Study|Withdrawal by Subject|4|||
131841114|NCT01083810|474701292|FG000|Overall Study|Reason not reported|6|||
131841115|NCT01083810|474701293|FG001|Overall Study|Reason not reported|1|||
131841116|NCT01083810|474701294|FG002|Overall Study|Reason not reported|1|||
131841117|NCT01083810|474701292|FG000|Overall Study|Non-compliance|4|||
131841118|NCT01083810|474701293|FG001|Overall Study|Non-compliance|7|||
131841119|NCT01083810|474701294|FG002|Overall Study|Non-compliance|2|||
131841120|NCT01083810|474701292|FG000|Overall Study|Simplification|4|||
131841121|NCT01083810|474701293|FG001|Overall Study|Simplification|1|||
131841122|NCT01083810|474701294|FG002|Overall Study|Simplification|0|||
131841123|NCT01083810|474701292|FG000|Overall Study|Death|2|||
131841124|NCT01083810|474701293|FG001|Overall Study|Death|2|||
131841125|NCT01083810|474701294|FG002|Overall Study|Death|3|||
131841126|NCT01083810|474701292|FG000|Overall Study|Co-morbidities|1|||
131841127|NCT01083810|474701293|FG001|Overall Study|Co-morbidities|0|||
131841128|NCT01083810|474701294|FG002|Overall Study|Co-morbidities|0|||
131841129|NCT01083810|474701292|FG000|Overall Study|Participation in study|1|||
131841130|NCT01083810|474701293|FG001|Overall Study|Participation in study|0|||
131841131|NCT01083810|474701294|FG002|Overall Study|Participation in study|0|||
131841132|NCT01083810|474701292|FG000|Overall Study|Therapy break|1|||
131841133|NCT01083810|474701293|FG001|Overall Study|Therapy break|2|||
131841134|NCT01083810|474701294|FG002|Overall Study|Therapy break|2|||
131841135|NCT01083810|474701292|FG000|Overall Study|Virologic failure|1|||
131841136|NCT01083810|474701293|FG001|Overall Study|Virologic failure|8|||
131841137|NCT01083810|474701294|FG002|Overall Study|Virologic failure|0|||
131841138|NCT02991430|474701297|FG000|Treatment Period 1|Adverse Event|1|||
131841139|NCT02991430|474701298|FG001|Treatment Period 1|Adverse Event|0|||
131841140|NCT02991430|474701299|FG002|Treatment Period 1|Adverse Event|2|||
131841141|NCT02991430|474701297|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131841142|NCT02991430|474701298|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131841143|NCT02991430|474701299|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131841144|NCT02991430|474701297|FG000|Treatment Period 2|Study Termination|6|||
131841145|NCT02991430|474701298|FG001|Treatment Period 2|Study Termination|3|||
131841146|NCT02991430|474701299|FG002|Treatment Period 2|Study Termination|3|||
131841147|NCT02991430|474701297|FG000|Treatment Period 2|Lost to Follow-up|0|||
131841148|NCT02991430|474701298|FG001|Treatment Period 2|Lost to Follow-up|0|||
131841149|NCT02991430|474701299|FG002|Treatment Period 2|Lost to Follow-up|1|||
131841150|NCT02991430|474701297|FG000|Post-treatment Observation Period|Study Termination|3|||
131841151|NCT02991430|474701298|FG001|Post-treatment Observation Period|Study Termination|6|||
131841152|NCT02991430|474701299|FG002|Post-treatment Observation Period|Study Termination|5|||
131841153|NCT03118570|474701300|FG000|Overall Study|Adverse Event|2|||
131841154|NCT03118570|474701301|FG001|Overall Study|Adverse Event|0|||
131841155|NCT03118570|474701302|FG002|Overall Study|Adverse Event|0|||
131841156|NCT03118570|474701303|FG003|Overall Study|Adverse Event|0|||
131841157|NCT03118570|474701304|FG004|Overall Study|Adverse Event|3|||
131841158|NCT03118570|474701300|FG000|Overall Study|Withdrawal by Subject|0|||
131841159|NCT03118570|474701301|FG001|Overall Study|Withdrawal by Subject|1|||
131841160|NCT03118570|474701302|FG002|Overall Study|Withdrawal by Subject|4|||
131841161|NCT03118570|474701303|FG003|Overall Study|Withdrawal by Subject|0|||
131841162|NCT03118570|474701304|FG004|Overall Study|Withdrawal by Subject|1|||
131841163|NCT03118570|474701300|FG000|Overall Study|Lost to Follow-up|2|||
131841164|NCT03118570|474701301|FG001|Overall Study|Lost to Follow-up|3|||
131841165|NCT03118570|474701302|FG002|Overall Study|Lost to Follow-up|1|||
131841166|NCT03118570|474701303|FG003|Overall Study|Lost to Follow-up|0|||
131841167|NCT03118570|474701304|FG004|Overall Study|Lost to Follow-up|1|||
131841168|NCT03118570|474701300|FG000|Overall Study|Other, Not Specified|1|||
131841169|NCT03118570|474701301|FG001|Overall Study|Other, Not Specified|3|||
131841170|NCT03118570|474701302|FG002|Overall Study|Other, Not Specified|0|||
131841171|NCT03118570|474701303|FG003|Overall Study|Other, Not Specified|0|||
131841172|NCT03118570|474701304|FG004|Overall Study|Other, Not Specified|0|||
131841173|NCT03970837|474701305|FG000|Overall Study|Adverse Event|23|||
131841174|NCT03970837|474701306|FG001|Overall Study|Adverse Event|20|||
131841175|NCT03970837|474701307|FG002|Overall Study|Adverse Event|16|||
131841176|NCT03970837|474701308|FG003|Overall Study|Adverse Event|6|||
131841177|NCT03970837|474701309|FG004|Overall Study|Adverse Event|4|||
131841178|NCT03970837|474701310|FG005|Overall Study|Adverse Event|5|||
131841179|NCT03970837|474701311|FG006|Overall Study|Adverse Event|1|||
131841180|NCT03970837|474701312|FG007|Overall Study|Adverse Event|5|||
131841181|NCT03970837|474701313|FG008|Overall Study|Adverse Event|0|||
131841182|NCT03970837|474701314|FG009|Overall Study|Adverse Event|0|||
131841183|NCT03970837|474701315|FG010|Overall Study|Adverse Event|1|||
131841184|NCT03970837|474701316|FG011|Overall Study|Adverse Event|1|||
131841185|NCT03970837|474701305|FG000|Overall Study|Lack of Efficacy|14|||
131841186|NCT03970837|474701306|FG001|Overall Study|Lack of Efficacy|12|||
131841187|NCT03970837|474701307|FG002|Overall Study|Lack of Efficacy|1|||
131841188|NCT03970837|474701308|FG003|Overall Study|Lack of Efficacy|2|||
131841189|NCT03970837|474701309|FG004|Overall Study|Lack of Efficacy|3|||
131841190|NCT03970837|474701310|FG005|Overall Study|Lack of Efficacy|4|||
131841191|NCT03970837|474701311|FG006|Overall Study|Lack of Efficacy|6|||
131841192|NCT03970837|474701312|FG007|Overall Study|Lack of Efficacy|1|||
131841193|NCT03970837|474701313|FG008|Overall Study|Lack of Efficacy|1|||
131841194|NCT03970837|474701314|FG009|Overall Study|Lack of Efficacy|0|||
131841195|NCT03970837|474701315|FG010|Overall Study|Lack of Efficacy|0|||
131841196|NCT03970837|474701316|FG011|Overall Study|Lack of Efficacy|0|||
131841197|NCT03970837|474701305|FG000|Overall Study|Lost to Follow-up|6|||
131841198|NCT03970837|474701306|FG001|Overall Study|Lost to Follow-up|5|||
131841199|NCT03970837|474701307|FG002|Overall Study|Lost to Follow-up|5|||
131841200|NCT03970837|474701308|FG003|Overall Study|Lost to Follow-up|1|||
131841201|NCT03970837|474701309|FG004|Overall Study|Lost to Follow-up|0|||
131841202|NCT03970837|474701310|FG005|Overall Study|Lost to Follow-up|2|||
131841203|NCT03970837|474701311|FG006|Overall Study|Lost to Follow-up|0|||
131841204|NCT03970837|474701312|FG007|Overall Study|Lost to Follow-up|0|||
131841205|NCT03970837|474701313|FG008|Overall Study|Lost to Follow-up|0|||
131841206|NCT03970837|474701314|FG009|Overall Study|Lost to Follow-up|0|||
131841207|NCT03970837|474701315|FG010|Overall Study|Lost to Follow-up|0|||
131841208|NCT03970837|474701316|FG011|Overall Study|Lost to Follow-up|0|||
131841209|NCT03970837|474701305|FG000|Overall Study|Protocol Violation|1|||
131841210|NCT03970837|474701306|FG001|Overall Study|Protocol Violation|0|||
131841211|NCT03970837|474701307|FG002|Overall Study|Protocol Violation|0|||
131841212|NCT03970837|474701308|FG003|Overall Study|Protocol Violation|0|||
131841213|NCT03970837|474701309|FG004|Overall Study|Protocol Violation|0|||
131841214|NCT03970837|474701310|FG005|Overall Study|Protocol Violation|0|||
131841215|NCT03970837|474701311|FG006|Overall Study|Protocol Violation|0|||
131841216|NCT03970837|474701312|FG007|Overall Study|Protocol Violation|0|||
131841217|NCT03970837|474701313|FG008|Overall Study|Protocol Violation|0|||
131841218|NCT03970837|474701314|FG009|Overall Study|Protocol Violation|0|||
131841219|NCT03970837|474701315|FG010|Overall Study|Protocol Violation|0|||
131402604|NCT01846663|473095571|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
131402605|NCT01846663|473095572|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
131402606|NCT01846663|473095571|FG000|Overall Study|Withdrawal by Subject|1|||
131402607|NCT01846663|473095572|FG001|Overall Study|Withdrawal by Subject|0|||
131402608|NCT01846663|473095571|FG000|Overall Study|Adverse Event|1|||
131402609|NCT01846663|473095572|FG001|Overall Study|Adverse Event|2|||
131402610|NCT03525600|473095578|FG000|Overall Study|Adverse Event|9|||
131402611|NCT03525600|473095579|FG001|Overall Study|Adverse Event|6|||
131402612|NCT03525600|473095580|FG002|Overall Study|Adverse Event|5|||
131402613|NCT03525600|473095581|FG003|Overall Study|Adverse Event|3|||
131402614|NCT03525600|473095578|FG000|Overall Study|Lost to Follow-up|2|||
131402615|NCT03525600|473095579|FG001|Overall Study|Lost to Follow-up|4|||
131402616|NCT03525600|473095580|FG002|Overall Study|Lost to Follow-up|4|||
131402617|NCT03525600|473095581|FG003|Overall Study|Lost to Follow-up|0|||
131402618|NCT03525600|473095578|FG000|Overall Study|Physician Decision|1|||
131402619|NCT03525600|473095579|FG001|Overall Study|Physician Decision|0|||
131402620|NCT03525600|473095580|FG002|Overall Study|Physician Decision|2|||
131402621|NCT03525600|473095581|FG003|Overall Study|Physician Decision|0|||
131402622|NCT03525600|473095578|FG000|Overall Study|Consent withdrawal|36|||
131402623|NCT03525600|473095579|FG001|Overall Study|Consent withdrawal|20|||
131402624|NCT03525600|473095580|FG002|Overall Study|Consent withdrawal|6|||
131402625|NCT03525600|473095581|FG003|Overall Study|Consent withdrawal|13|||
131402626|NCT03525600|473095578|FG000|Overall Study|Death|7|||
131402627|NCT03525600|473095579|FG001|Overall Study|Death|6|||
131402628|NCT03525600|473095580|FG002|Overall Study|Death|4|||
131402629|NCT03525600|473095581|FG003|Overall Study|Death|3|||
131402630|NCT03525600|473095578|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
131402631|NCT03525600|473095579|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
131402632|NCT03525600|473095580|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
131402633|NCT03525600|473095581|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
131402634|NCT03525600|473095578|FG000|Overall Study|Other|0|||
131402635|NCT03525600|473095579|FG001|Overall Study|Other|1|||
131841220|NCT03970837|474701316|FG011|Overall Study|Protocol Violation|0|||
131841221|NCT03970837|474701305|FG000|Overall Study|Physician Decision|5|||
131841222|NCT03970837|474701306|FG001|Overall Study|Physician Decision|8|||
131841223|NCT03970837|474701307|FG002|Overall Study|Physician Decision|4|||
131841224|NCT03970837|474701308|FG003|Overall Study|Physician Decision|1|||
131841225|NCT03970837|474701309|FG004|Overall Study|Physician Decision|5|||
131841226|NCT03970837|474701310|FG005|Overall Study|Physician Decision|2|||
131841227|NCT03970837|474701311|FG006|Overall Study|Physician Decision|4|||
131841228|NCT03970837|474701312|FG007|Overall Study|Physician Decision|5|||
131841229|NCT03970837|474701313|FG008|Overall Study|Physician Decision|0|||
131841230|NCT03970837|474701314|FG009|Overall Study|Physician Decision|1|||
131841231|NCT03970837|474701315|FG010|Overall Study|Physician Decision|0|||
131841232|NCT03970837|474701316|FG011|Overall Study|Physician Decision|0|||
131841233|NCT03970837|474701305|FG000|Overall Study|Withdrawal by Subject|32|||
131841234|NCT03970837|474701306|FG001|Overall Study|Withdrawal by Subject|35|||
131841235|NCT03970837|474701307|FG002|Overall Study|Withdrawal by Subject|12|||
131841236|NCT03970837|474701308|FG003|Overall Study|Withdrawal by Subject|8|||
131841237|NCT03970837|474701309|FG004|Overall Study|Withdrawal by Subject|6|||
131841238|NCT03970837|474701310|FG005|Overall Study|Withdrawal by Subject|8|||
131841239|NCT03970837|474701311|FG006|Overall Study|Withdrawal by Subject|2|||
131841240|NCT03970837|474701312|FG007|Overall Study|Withdrawal by Subject|3|||
131841241|NCT03970837|474701313|FG008|Overall Study|Withdrawal by Subject|0|||
131402636|NCT03525600|473095580|FG002|Overall Study|Other|0|||
131402637|NCT03525600|473095581|FG003|Overall Study|Other|0|||
131402638|NCT03703817|473095591|FG000|Overall Study|Not meeting eligibility criteria|7|||
131841242|NCT03970837|474701314|FG009|Overall Study|Withdrawal by Subject|0|||
131841243|NCT03970837|474701315|FG010|Overall Study|Withdrawal by Subject|0|||
131841244|NCT03970837|474701316|FG011|Overall Study|Withdrawal by Subject|1|||
131841245|NCT03970837|474701305|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
131402639|NCT03703817|473095592|FG001|Overall Study|Not meeting eligibility criteria|4|||
131402640|NCT05248997|473095596|FG000|Overall Study|Lost to Follow-up|1|||
131402641|NCT05248997|473095597|FG001|Overall Study|Lost to Follow-up|1|||
131402642|NCT05248997|473095596|FG000|Overall Study|Randomized but not treated|32|||
131402643|NCT05248997|473095597|FG001|Overall Study|Randomized but not treated|25|||
131402644|NCT04262882|473095599|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
131841246|NCT03970837|474701306|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
131841247|NCT03970837|474701307|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
131841248|NCT03970837|474701308|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
131841249|NCT03970837|474701309|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
131841250|NCT03970837|474701310|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131841251|NCT03970837|474701311|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131841252|NCT03970837|474701312|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131841253|NCT03970837|474701313|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
131841254|NCT03970837|474701314|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
131841255|NCT03970837|474701315|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
131841256|NCT03970837|474701316|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
131841257|NCT03970837|474701305|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131841258|NCT03970837|474701306|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131841259|NCT03970837|474701307|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131841260|NCT03970837|474701308|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131841261|NCT03970837|474701309|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131841262|NCT03970837|474701310|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131841263|NCT03970837|474701311|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
131841264|NCT03970837|474701312|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
131841265|NCT03970837|474701313|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
131841266|NCT03970837|474701314|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
131841267|NCT03970837|474701315|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
131841268|NCT03970837|474701316|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
131841269|NCT01770392|474701317|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
131841270|NCT04639713|474701318|FG000|Overall Study|Protocol Noncompliance|2|||
131841271|NCT04639713|474701318|FG000|Overall Study|Withdrawal by Subject|1|||
131841272|NCT01104779|474701327|FG000|Overall Study|Protocol Violation|1|||
131841273|NCT01104779|474701328|FG001|Overall Study|Protocol Violation|2|||
131841274|NCT01104779|474701329|FG002|Overall Study|Protocol Violation|2|||
131841275|NCT01104779|474701327|FG000|Overall Study|Lack of Efficacy|26|||
131841276|NCT01104779|474701328|FG001|Overall Study|Lack of Efficacy|12|||
131841277|NCT01104779|474701329|FG002|Overall Study|Lack of Efficacy|13|||
131841278|NCT01104779|474701327|FG000|Overall Study|Adverse Event|13|||
131841279|NCT01104779|474701328|FG001|Overall Study|Adverse Event|14|||
131841280|NCT01104779|474701329|FG002|Overall Study|Adverse Event|13|||
131841281|NCT01104779|474701327|FG000|Overall Study|Did not meet inc/exc criteria|1|||
131841282|NCT01104779|474701328|FG001|Overall Study|Did not meet inc/exc criteria|1|||
131841283|NCT01104779|474701329|FG002|Overall Study|Did not meet inc/exc criteria|1|||
131841284|NCT01104779|474701327|FG000|Overall Study|Other reasons|0|||
131841285|NCT01104779|474701328|FG001|Overall Study|Other reasons|1|||
131841286|NCT01104779|474701329|FG002|Overall Study|Other reasons|0|||
131841287|NCT01104779|474701327|FG000|Overall Study|Lost to Follow-up|2|||
131841288|NCT01104779|474701328|FG001|Overall Study|Lost to Follow-up|0|||
131841289|NCT01104779|474701329|FG002|Overall Study|Lost to Follow-up|1|||
131841290|NCT01104779|474701327|FG000|Overall Study|Withdrawal by Subject|16|||
131841291|NCT01104779|474701328|FG001|Overall Study|Withdrawal by Subject|25|||
131841292|NCT01104779|474701329|FG002|Overall Study|Withdrawal by Subject|32|||
131841293|NCT03753763|474701330|FG000|Overall Study|Adverse Event|2|||
131841294|NCT03753763|474701331|FG001|Overall Study|Adverse Event|0|||
131841295|NCT03753763|474701330|FG000|Overall Study|Withdrawal by Subject|3|||
131841296|NCT03753763|474701331|FG001|Overall Study|Withdrawal by Subject|1|||
131841297|NCT03753763|474701330|FG000|Overall Study|clinical deterioration|1|||
131841298|NCT03753763|474701331|FG001|Overall Study|clinical deterioration|0|||
131841299|NCT00389831|474701332|FG000|Overall Study|Lack of Efficacy|0|||
131841300|NCT00389831|474701333|FG001|Overall Study|Lack of Efficacy|2|||
131841301|NCT00389831|474701332|FG000|Overall Study|Did not receive treatment.|0|||
131841302|NCT00389831|474701333|FG001|Overall Study|Did not receive treatment.|2|||
131841303|NCT00389831|474701332|FG000|Overall Study|Other reasons|0|||
131841304|NCT00389831|474701333|FG001|Overall Study|Other reasons|2|||
131841305|NCT00389831|474701332|FG000|Overall Study|Lost to Follow-up|0|||
131841306|NCT00389831|474701333|FG001|Overall Study|Lost to Follow-up|1|||
131841307|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
131841308|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
131841309|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841310|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841311|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841312|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841313|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841314|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841315|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841316|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841317|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841318|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841319|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841320|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
131841321|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
131841322|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
131841323|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841324|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841325|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841326|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841327|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841328|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841329|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841330|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841331|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841332|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841333|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841334|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131841335|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
131841336|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
131841337|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841338|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841339|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841340|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841341|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841342|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841343|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841344|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841345|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841346|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841347|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841348|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
131841349|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
131841350|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
131841351|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841352|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841353|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841354|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841355|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841356|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841357|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841358|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841359|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841360|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841361|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841362|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
131841363|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
131841364|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
131841365|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841366|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841367|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841368|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841369|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841370|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841371|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841372|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841373|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841374|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841375|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841376|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
131841377|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
131841378|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
131841379|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841380|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841381|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841382|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841383|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841384|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841385|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841386|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841387|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841388|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841389|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131841390|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
131910799|NCT02814526|474960850|FG000|Overall Study|Withdrawal by Subject|20|||
131910800|NCT02814526|474960851|FG001|Overall Study|Withdrawal by Subject|14|||
131910801|NCT02814526|474960850|FG000|Overall Study|safety risk|2|||
131841391|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
131841392|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
131841393|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841394|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841395|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841396|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841397|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841398|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841399|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841400|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841401|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841402|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841403|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131402645|NCT04262882|473095600|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
131402646|NCT04262882|473095599|FG000|Overall Study|Lost to Follow-up|1|||
131402647|NCT04262882|473095600|FG001|Overall Study|Lost to Follow-up|0|||
131402648|NCT01301066|473095601|FG000|Overall Study|Lost to Follow-up|5|||
131402649|NCT01301066|473095602|FG001|Overall Study|Lost to Follow-up|11|||
131402650|NCT01301066|473095601|FG000|Overall Study|Protocol Violation|8|||
131402651|NCT01301066|473095602|FG001|Overall Study|Protocol Violation|7|||
131402652|NCT01301066|473095601|FG000|Overall Study|Withdrawal by Subject|4|||
131402653|NCT01301066|473095602|FG001|Overall Study|Withdrawal by Subject|9|||
131402654|NCT01301066|473095601|FG000|Overall Study|Adverse Event|6|||
131402655|NCT01301066|473095602|FG001|Overall Study|Adverse Event|6|||
131402656|NCT01301066|473095601|FG000|Overall Study|Sponsor Decision|2|||
131402657|NCT01301066|473095602|FG001|Overall Study|Sponsor Decision|1|||
131402658|NCT01301066|473095601|FG000|Overall Study|Physician Decision|0|||
131402659|NCT01301066|473095602|FG001|Overall Study|Physician Decision|1|||
131402660|NCT01301066|473095601|FG000|Overall Study|Other|2|||
131402661|NCT01301066|473095602|FG001|Overall Study|Other|0|||
131402662|NCT03219034|473095607|FG000|Overall Study|Lost to Follow-up|9|||
131402663|NCT03219034|473095608|FG001|Overall Study|Lost to Follow-up|13|||
131402664|NCT03219034|473095607|FG000|Overall Study|Additional dental work needed|1|||
131402665|NCT03219034|473095608|FG001|Overall Study|Additional dental work needed|0|||
131402666|NCT03219034|473095607|FG000|Overall Study|UPPP Surgery|1|||
131402667|NCT03219034|473095608|FG001|Overall Study|UPPP Surgery|0|||
131402668|NCT03219034|473095607|FG000|Overall Study|Dental sensitivity|0|||
131402669|NCT03219034|473095608|FG001|Overall Study|Dental sensitivity|1|||
131402670|NCT03219034|473095607|FG000|Overall Study|Death in family|0|||
131402671|NCT03219034|473095608|FG001|Overall Study|Death in family|1|||
131402672|NCT02438384|473095609|FG000|Overall Study|Lost to Follow-up|8|||
131402673|NCT02438384|473095610|FG001|Overall Study|Lost to Follow-up|6|||
131402674|NCT02438384|473095611|FG002|Overall Study|Lost to Follow-up|4|||
131402675|NCT03315793|473095612|FG000|Overall Study|Adverse Event|4|||
131402676|NCT03315793|473095613|FG001|Overall Study|Adverse Event|2|||
131402677|NCT03315793|473095612|FG000|Overall Study|Protocol Deviation|1|||
131402678|NCT03315793|473095613|FG001|Overall Study|Protocol Deviation|0|||
131402679|NCT03315793|473095612|FG000|Overall Study|Difficult for regular visit|0|||
131402680|NCT03315793|473095613|FG001|Overall Study|Difficult for regular visit|1|||
131841404|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
131841405|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
131841406|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
131841407|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841408|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841409|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841410|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841411|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131910802|NCT02814526|474960851|FG001|Overall Study|safety risk|1|||
131402681|NCT00511433|473097761|FG000|Overall Study|Adverse Event|5|||
131402682|NCT00511433|473097762|FG001|Overall Study|Adverse Event|0|||
131402683|NCT00511433|473097761|FG000|Overall Study|Other Reason|1|||
131402684|NCT00511433|473097762|FG001|Overall Study|Other Reason|1|||
131402685|NCT01740089|473097763|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
131402686|NCT01740089|473097764|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
131402687|NCT01740089|473097765|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
131402688|NCT01740089|473097763|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
131402689|NCT01740089|473097764|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
131402690|NCT01740089|473097765|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
131402691|NCT01740089|473097763|FG000|After 12 Weeks|Lack of Efficacy|3|||
131402692|NCT01740089|473097764|FG001|After 12 Weeks|Lack of Efficacy|1|||
131402693|NCT01740089|473097765|FG002|After 12 Weeks|Lack of Efficacy|4|||
131402694|NCT01740089|473097763|FG000|After 12 Weeks|Adverse Event|2|||
131841412|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841413|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841414|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841415|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841416|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841417|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841418|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
131841419|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
131841420|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
131841421|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841422|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841423|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841424|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841425|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841426|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841427|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841428|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841429|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841430|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841431|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841432|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
131841433|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
131841434|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
131841435|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841436|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841437|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841438|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841439|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841440|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841441|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841442|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841443|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841444|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841445|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841446|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
131841447|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
131841448|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
131841449|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841450|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841451|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841452|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841453|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841454|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841455|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841456|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841457|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841458|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841459|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841460|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131841461|NCT03982199|474701334|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
131841462|NCT03982199|474701335|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
131841463|NCT03982199|474701336|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841464|NCT03982199|474701337|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841465|NCT03982199|474701338|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841466|NCT03982199|474701339|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841467|NCT03982199|474701340|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841468|NCT03982199|474701341|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841469|NCT03982199|474701342|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841470|NCT03982199|474701343|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841471|NCT03982199|474701344|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841472|NCT03982199|474701345|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841473|NCT03982199|474701346|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841474|NCT03982199|474701347|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
131841475|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841476|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841477|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841478|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
131841479|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841480|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841481|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841482|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841483|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841484|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841485|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841486|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841487|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841488|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
131841489|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841490|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841491|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
131841492|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841493|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841494|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841495|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841496|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841497|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841498|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841499|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841500|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841501|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841502|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
131841503|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841504|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841505|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
131841506|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841507|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841508|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841509|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841510|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841511|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841512|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841513|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841514|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841515|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841516|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
131841517|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841518|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841519|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
131841520|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
131841521|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841522|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841523|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841524|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841525|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841526|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841527|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841528|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841529|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841530|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
131841531|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841532|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841533|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841534|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
131841535|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841536|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841537|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841538|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131910803|NCT02814526|474960850|FG000|Overall Study|early termination-study terminated|1|||
131841539|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841540|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841541|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841542|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841543|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841544|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
131841545|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841546|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841547|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
131841548|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
131841549|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841550|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841551|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841552|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841553|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841554|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841555|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841556|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841557|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841558|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
131841559|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841560|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841561|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841562|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841563|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841564|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841565|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841566|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841567|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
131841568|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131910804|NCT02814526|474960851|FG001|Overall Study|early termination-study terminated|2|||
131910805|NCT02814526|474960850|FG000|Overall Study|Other|0|||
131841569|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841570|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841571|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841572|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
131841573|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841574|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841575|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841576|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841577|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841578|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841579|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841580|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841581|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
131841582|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841583|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841584|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131402695|NCT01740089|473097764|FG001|After 12 Weeks|Adverse Event|0|||
131402696|NCT01740089|473097765|FG002|After 12 Weeks|Adverse Event|5|||
131402697|NCT01740089|473097763|FG000|After 12 Weeks|Protocol Violation|1|||
131402698|NCT01740089|473097764|FG001|After 12 Weeks|Protocol Violation|1|||
131402699|NCT01740089|473097765|FG002|After 12 Weeks|Protocol Violation|1|||
131402700|NCT01740089|473097763|FG000|After 12 Weeks|Withdrawal by Subject|1|||
131841585|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841586|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
131841587|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841588|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841589|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131910806|NCT02814526|474960851|FG001|Overall Study|Other|4|||
131910807|NCT01981616|474960857|FG000|Overall Study|Adverse Event|0|||
131402701|NCT01740089|473097764|FG001|After 12 Weeks|Withdrawal by Subject|1|||
131402702|NCT01740089|473097765|FG002|After 12 Weeks|Withdrawal by Subject|1|||
131402703|NCT01579565|473097768|FG000|Randomized|Adverse Event|1|||
131450227|NCT03815929|473276826|FG000|Overall Study|Withdrawal by Subject|0|||
131402704|NCT01579565|473097769|FG001|Randomized|Adverse Event|3|||
131841590|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841591|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841592|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841593|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841594|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841595|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
131841596|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841597|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841598|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841599|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131402705|NCT01579565|473097768|FG000|Randomized|Withdrawal by Subject|3|||
131402706|NCT01579565|473097769|FG001|Randomized|Withdrawal by Subject|0|||
131841600|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
131841601|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841602|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841603|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841604|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841605|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841606|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841607|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841608|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841609|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
131841610|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841611|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841612|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841613|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841614|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
131841615|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841616|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841617|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841618|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841619|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841620|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841621|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841622|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841623|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
131841624|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841625|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841626|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841627|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841628|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
131841629|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841630|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841631|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841632|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841633|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841634|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
131841635|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841636|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
131841637|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
131841638|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841639|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841640|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841641|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841642|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
131841643|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841644|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841645|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841646|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841647|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841648|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841649|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841650|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131402707|NCT01579565|473097768|FG000|Randomized|inadequate preoperative pupil dilation|0|||
131841651|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
131841652|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841653|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841654|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841655|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841656|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
131841657|NCT03982199|474701334|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841658|NCT03982199|474701335|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841659|NCT03982199|474701336|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841660|NCT03982199|474701337|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841661|NCT03982199|474701338|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841662|NCT03982199|474701339|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
131841663|NCT03982199|474701340|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841664|NCT03982199|474701341|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
131841665|NCT03982199|474701342|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
131841666|NCT03982199|474701343|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841667|NCT03982199|474701344|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841668|NCT03982199|474701345|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841669|NCT03982199|474701346|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841670|NCT03982199|474701347|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131841671|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841672|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841673|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841674|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841675|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841676|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841677|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841678|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841679|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
131841680|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
131841681|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
131841682|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
131841683|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
131841684|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
131841685|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841686|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841687|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841688|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841689|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841690|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841691|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841692|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841693|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841694|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
131841695|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841696|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841697|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841698|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
131841699|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841700|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131910808|NCT01981616|474960858|FG001|Overall Study|Adverse Event|1|||
131910809|NCT01981616|474960857|FG000|Overall Study|Protocol Violation|1|||
131910810|NCT01981616|474960858|FG001|Overall Study|Protocol Violation|0|||
131910811|NCT00094445|474960859|FG000|Overall Study|Withdrawal by Subject|3|||
131910812|NCT00094445|474960859|FG000|Overall Study|Lost to Follow-up|1|||
131910813|NCT00094445|474960859|FG000|Overall Study|Progressive Disease|2|||
131910814|NCT00769561|474960862|FG000|Overall Study|Withdrawal by Subject|2|||
131910815|NCT00769561|474960863|FG001|Overall Study|Withdrawal by Subject|2|||
131910816|NCT00769561|474960862|FG000|Overall Study|Lost to Follow-up|1|||
131910817|NCT00769561|474960863|FG001|Overall Study|Lost to Follow-up|3|||
131910818|NCT04711005|474960864|FG000|Overall Study|Withdrawal by Subject|0|||
131910819|NCT04711005|474960865|FG001|Overall Study|Withdrawal by Subject|0|||
131910820|NCT04711005|474960866|FG002|Overall Study|Withdrawal by Subject|0|||
131402708|NCT01579565|473097769|FG001|Randomized|inadequate preoperative pupil dilation|1|||
131402709|NCT01579565|473097768|FG000|Randomized|prohibited preoperative eating|1|||
131402710|NCT01579565|473097769|FG001|Randomized|prohibited preoperative eating|0|||
131402711|NCT01579565|473097768|FG000|Randomized|prohibited preoperative medication|0|||
131402712|NCT01579565|473097769|FG001|Randomized|prohibited preoperative medication|1|||
131402713|NCT01579565|473097768|FG000|Treated|Physician Decision|0|||
131402714|NCT01579565|473097769|FG001|Treated|Physician Decision|1|||
131402715|NCT01579565|473097768|FG000|Treated|Lost to Follow-up|2|||
131402716|NCT01579565|473097769|FG001|Treated|Lost to Follow-up|1|||
131402717|NCT01579565|473097768|FG000|Treated|declined to return for final visit|0|||
131402718|NCT01579565|473097769|FG001|Treated|declined to return for final visit|1|||
131402719|NCT02013206|473097770|FG000|Overall Study|Progressive disease (PD)|14|||
131402720|NCT02013206|473097771|FG001|Overall Study|Progressive disease (PD)|17|||
131402721|NCT02013206|473097770|FG000|Overall Study|Symptomatic deterioration|3|||
131402722|NCT02013206|473097771|FG001|Overall Study|Symptomatic deterioration|1|||
131402723|NCT02013206|473097770|FG000|Overall Study|Adverse Event|1|||
131402724|NCT02013206|473097771|FG001|Overall Study|Adverse Event|0|||
131402725|NCT02013206|473097770|FG000|Overall Study|Patient refusal|2|||
131402726|NCT02013206|473097771|FG001|Overall Study|Patient refusal|0|||
131402727|NCT02013206|473097770|FG000|Overall Study|Patient non-compliance|1|||
131402728|NCT02013206|473097771|FG001|Overall Study|Patient non-compliance|0|||
131402729|NCT02013206|473097770|FG000|Overall Study|Death|1|||
131402730|NCT02013206|473097771|FG001|Overall Study|Death|2|||
131402731|NCT02013206|473097770|FG000|Overall Study|Other reasons off treatment|5|||
131402732|NCT02013206|473097771|FG001|Overall Study|Other reasons off treatment|2|||
131402733|NCT02867813|473097772|FG000|Overall Study|Withdrawal by Subject|57|||
131402734|NCT02867813|473097773|FG001|Overall Study|Withdrawal by Subject|56|||
131402735|NCT02867813|473097772|FG000|Overall Study|Decision by Sponsor|7|||
131402736|NCT02867813|473097773|FG001|Overall Study|Decision by Sponsor|7|||
131402737|NCT02867813|473097772|FG000|Overall Study|Lost to Follow-up|91|||
131402738|NCT02867813|473097773|FG001|Overall Study|Lost to Follow-up|78|||
131402739|NCT02867813|473097772|FG000|Overall Study|Missing|2|||
131402740|NCT02867813|473097773|FG001|Overall Study|Missing|1|||
131402741|NCT02867813|473097772|FG000|Overall Study|Death|294|||
131402742|NCT02867813|473097773|FG001|Overall Study|Death|268|||
131402743|NCT02791191|473097779|FG000|Overall Study|Adverse Event|2|||
131402744|NCT02791191|473097780|FG001|Overall Study|Adverse Event|4|||
131402745|NCT02791191|473097781|FG002|Overall Study|Adverse Event|5|||
131402746|NCT02791191|473097779|FG000|Overall Study|Lack of Efficacy|0|||
131841701|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841702|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841703|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841704|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841705|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841706|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841707|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841708|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841709|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841710|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841711|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
131841712|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
131841713|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841714|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841715|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841716|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841717|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841718|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841719|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841720|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841721|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841722|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131841723|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
131841724|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
131841725|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
131841726|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131402747|NCT02791191|473097780|FG001|Overall Study|Lack of Efficacy|1|||
131402748|NCT02791191|473097781|FG002|Overall Study|Lack of Efficacy|0|||
131402749|NCT02791191|473097779|FG000|Overall Study|Study Drug Non-Compliance|0|||
131402750|NCT02791191|473097780|FG001|Overall Study|Study Drug Non-Compliance|2|||
131402751|NCT02791191|473097781|FG002|Overall Study|Study Drug Non-Compliance|0|||
131402752|NCT02791191|473097779|FG000|Overall Study|Site Closed by Sponsor|1|||
131402753|NCT02791191|473097780|FG001|Overall Study|Site Closed by Sponsor|1|||
131402754|NCT02791191|473097781|FG002|Overall Study|Site Closed by Sponsor|3|||
131402755|NCT02791191|473097779|FG000|Overall Study|Progressive Disease|1|||
131402756|NCT02791191|473097780|FG001|Overall Study|Progressive Disease|0|||
131402757|NCT02791191|473097781|FG002|Overall Study|Progressive Disease|0|||
131402758|NCT02791191|473097779|FG000|Overall Study|Study Terminated by Sponsor|29|||
131402759|NCT02791191|473097780|FG001|Overall Study|Study Terminated by Sponsor|101|||
131402760|NCT02791191|473097781|FG002|Overall Study|Study Terminated by Sponsor|109|||
131402761|NCT02791191|473097779|FG000|Overall Study|Withdrawal by Subject|3|||
131402762|NCT02791191|473097780|FG001|Overall Study|Withdrawal by Subject|1|||
131402763|NCT02791191|473097781|FG002|Overall Study|Withdrawal by Subject|3|||
131402764|NCT02791191|473097779|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
131402765|NCT02791191|473097780|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
131402766|NCT02791191|473097781|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
131402767|NCT01952665|473097782|FG000|Overall Study|Physician Decision|3|||
131402768|NCT01952665|473097783|FG001|Overall Study|Physician Decision|2|||
131402769|NCT01952665|473097782|FG000|Overall Study|Lost to Follow-up|1|||
131402770|NCT01952665|473097783|FG001|Overall Study|Lost to Follow-up|2|||
131402771|NCT01952665|473097782|FG000|Overall Study|Adverse Event|2|||
131402772|NCT01952665|473097783|FG001|Overall Study|Adverse Event|1|||
131402773|NCT01952665|473097782|FG000|Overall Study|Protocol Violation|0|||
131402774|NCT01952665|473097783|FG001|Overall Study|Protocol Violation|1|||
131402775|NCT01537081|473097785|FG000|Overall Study|Adverse Event|5|||
131402776|NCT01537081|473097786|FG001|Overall Study|Adverse Event|2|||
131841727|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841728|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841729|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841730|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841731|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841732|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841733|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841734|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841735|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841736|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841737|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841738|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841739|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
131841740|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
131841741|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841742|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841743|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841744|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841745|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841746|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841747|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841748|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841749|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841750|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841751|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841752|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131841753|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
131841754|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
131841755|NCT03982199|474701334|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841756|NCT03982199|474701335|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841757|NCT03982199|474701336|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841758|NCT03982199|474701337|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841759|NCT03982199|474701338|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841760|NCT03982199|474701339|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841761|NCT03982199|474701340|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841762|NCT03982199|474701341|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131402777|NCT01537081|473097787|FG002|Overall Study|Adverse Event|2|||
131402778|NCT01537081|473097785|FG000|Overall Study|Lack of Efficacy|2|||
131402779|NCT01537081|473097786|FG001|Overall Study|Lack of Efficacy|1|||
131402780|NCT01537081|473097787|FG002|Overall Study|Lack of Efficacy|0|||
131402781|NCT01537081|473097785|FG000|Overall Study|Lost to Follow-up|17|||
131402782|NCT01537081|473097786|FG001|Overall Study|Lost to Follow-up|15|||
131402783|NCT01537081|473097787|FG002|Overall Study|Lost to Follow-up|9|||
131841763|NCT03982199|474701342|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841764|NCT03982199|474701343|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131402784|NCT01537081|473097785|FG000|Overall Study|Protocol Violation|3|||
131402785|NCT01537081|473097786|FG001|Overall Study|Protocol Violation|2|||
131450228|NCT03815929|473276827|FG001|Overall Study|Withdrawal by Subject|0|||
131450229|NCT03815929|473276828|FG002|Overall Study|Withdrawal by Subject|1|||
131450230|NCT03313037|473276829|FG000|Overall Study|Protocol Violation|4|||
131450231|NCT03313037|473276830|FG001|Overall Study|Protocol Violation|1|||
131450232|NCT03313037|473276829|FG000|Overall Study|Other|1|||
131450233|NCT03313037|473276830|FG001|Overall Study|Other|1|||
131450234|NCT03313037|473276829|FG000|Overall Study|Withdrawal by Subject|4|||
131450235|NCT03313037|473276830|FG001|Overall Study|Withdrawal by Subject|3|||
131450236|NCT03313037|473276829|FG000|Overall Study|No longer meets eligibility criteria|1|||
131450237|NCT03313037|473276830|FG001|Overall Study|No longer meets eligibility criteria|7|||
131450238|NCT03313037|473276829|FG000|Overall Study|Lost to Follow-up|9|||
131450239|NCT03313037|473276830|FG001|Overall Study|Lost to Follow-up|8|||
131841765|NCT03982199|474701344|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841766|NCT03982199|474701345|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841767|NCT03982199|474701346|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
131841768|NCT03982199|474701347|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
131841769|NCT00006721|474704258|FG000|Overall Study|Adverse Event|0|||
131841770|NCT00006721|474704259|FG001|Overall Study|Adverse Event|4|||
131841771|NCT00006721|474704260|FG002|Overall Study|Adverse Event|4|||
131841772|NCT00006721|474704258|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131841773|NCT00006721|474704259|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
131841774|NCT00006721|474704260|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
131841775|NCT00006721|474704258|FG000|Overall Study|Progression/Relapse|0|||
131841776|NCT00006721|474704259|FG001|Overall Study|Progression/Relapse|1|||
131841777|NCT00006721|474704260|FG002|Overall Study|Progression/Relapse|2|||
131841778|NCT00006721|474704258|FG000|Overall Study|Death|0|||
131841779|NCT00006721|474704259|FG001|Overall Study|Death|1|||
131841780|NCT00006721|474704260|FG002|Overall Study|Death|2|||
131841781|NCT00006721|474704258|FG000|Overall Study|Other - Not Protocol Specified|0|||
131841782|NCT00006721|474704259|FG001|Overall Study|Other - Not Protocol Specified|7|||
131841783|NCT00006721|474704260|FG002|Overall Study|Other - Not Protocol Specified|7|||
131841784|NCT00006721|474704258|FG000|Overall Study|Ineligible|2|||
131841785|NCT00006721|474704259|FG001|Overall Study|Ineligible|12|||
131841786|NCT00006721|474704260|FG002|Overall Study|Ineligible|10|||
131841787|NCT00006721|474704258|FG000|Overall Study|Eligible but no Treatment Received|1|||
131841788|NCT00006721|474704259|FG001|Overall Study|Eligible but no Treatment Received|0|||
131841789|NCT00006721|474704260|FG002|Overall Study|Eligible but no Treatment Received|0|||
131841790|NCT05091307|474704261|FG000|Overall Study|Death|0|||
131841791|NCT05091307|474704262|FG001|Overall Study|Death|0|||
131841792|NCT05091307|474704263|FG002|Overall Study|Death|1|||
131841793|NCT05091307|474704264|FG003|Overall Study|Death|0|||
131841794|NCT05091307|474704261|FG000|Overall Study|Lost to Follow-up|33|||
131841795|NCT05091307|474704262|FG001|Overall Study|Lost to Follow-up|33|||
131841796|NCT05091307|474704263|FG002|Overall Study|Lost to Follow-up|2|||
131841797|NCT05091307|474704264|FG003|Overall Study|Lost to Follow-up|0|||
131841798|NCT05091307|474704261|FG000|Overall Study|Physician Decision|1|||
131841799|NCT05091307|474704262|FG001|Overall Study|Physician Decision|0|||
131841800|NCT05091307|474704263|FG002|Overall Study|Physician Decision|0|||
131841801|NCT05091307|474704264|FG003|Overall Study|Physician Decision|0|||
131841802|NCT05091307|474704261|FG000|Overall Study|Protocol Violation|1|||
131841803|NCT05091307|474704262|FG001|Overall Study|Protocol Violation|0|||
131841804|NCT05091307|474704263|FG002|Overall Study|Protocol Violation|0|||
131841805|NCT05091307|474704264|FG003|Overall Study|Protocol Violation|0|||
131841806|NCT05091307|474704261|FG000|Overall Study|Withdrawal by Subject|16|||
131841807|NCT05091307|474704262|FG001|Overall Study|Withdrawal by Subject|16|||
131841808|NCT05091307|474704263|FG002|Overall Study|Withdrawal by Subject|0|||
131841809|NCT05091307|474704264|FG003|Overall Study|Withdrawal by Subject|1|||
131841810|NCT05091307|474704261|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
131841811|NCT05091307|474704262|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
131450240|NCT03313037|473276829|FG000|Overall Study|Randomized but not treated|1|||
131450241|NCT03313037|473276830|FG001|Overall Study|Randomized but not treated|0|||
131841812|NCT05091307|474704263|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
131841813|NCT05091307|474704264|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
131841814|NCT05091307|474704261|FG000|Overall Study|Initiated Prohibited Medication|1|||
131841815|NCT05091307|474704262|FG001|Overall Study|Initiated Prohibited Medication|0|||
131841816|NCT05091307|474704263|FG002|Overall Study|Initiated Prohibited Medication|0|||
131841817|NCT05091307|474704264|FG003|Overall Study|Initiated Prohibited Medication|0|||
131841818|NCT05091307|474704261|FG000|Overall Study|Other|4|||
131841819|NCT05091307|474704262|FG001|Overall Study|Other|4|||
131841820|NCT05091307|474704263|FG002|Overall Study|Other|0|||
131841821|NCT05091307|474704264|FG003|Overall Study|Other|0|||
131841822|NCT05091307|474704261|FG000|Overall Study|Randomized but not vaccinated|0|||
131841823|NCT05091307|474704262|FG001|Overall Study|Randomized but not vaccinated|2|||
131450242|NCT02379091|473276831|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131450243|NCT02379091|473276832|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
131841824|NCT05091307|474704263|FG002|Overall Study|Randomized but not vaccinated|0|||
131841825|NCT05091307|474704264|FG003|Overall Study|Randomized but not vaccinated|0|||
131841826|NCT04347122|474704273|FG000|Overall Study|Physician Decision|0|||
131841827|NCT04347122|474704274|FG001|Overall Study|Physician Decision|3|||
131841828|NCT04347122|474704275|FG002|Overall Study|Physician Decision|3|||
131841829|NCT04347122|474704276|FG003|Overall Study|Physician Decision|6|||
131841830|NCT03589768|474704281|FG000|Overall Study|Death|1|||
131841831|NCT03589768|474704282|FG001|Overall Study|Death|0|||
131841832|NCT03589768|474704283|FG002|Overall Study|Death|8|||
131841833|NCT03589768|474704284|FG003|Overall Study|Death|3|||
131841834|NCT03589768|474704281|FG000|Overall Study|Withdrawal by Subject|2|||
131841835|NCT03589768|474704282|FG001|Overall Study|Withdrawal by Subject|0|||
131841836|NCT03589768|474704283|FG002|Overall Study|Withdrawal by Subject|0|||
131841837|NCT03589768|474704284|FG003|Overall Study|Withdrawal by Subject|0|||
131841838|NCT03589768|474704281|FG000|Overall Study|Protocol Violation|1|||
131841839|NCT03589768|474704282|FG001|Overall Study|Protocol Violation|0|||
131841840|NCT03589768|474704283|FG002|Overall Study|Protocol Violation|0|||
131841841|NCT03589768|474704284|FG003|Overall Study|Protocol Violation|0|||
131841842|NCT05327816|474704285|FG000|Overall Study|Lost to Follow-up|1|||
131841843|NCT05327816|474704286|FG001|Overall Study|Lost to Follow-up|0|||
131841844|NCT05327816|474704287|FG002|Overall Study|Lost to Follow-up|0|||
131841845|NCT05327816|474704288|FG003|Overall Study|Lost to Follow-up|0|||
131841846|NCT05327816|474704289|FG004|Overall Study|Lost to Follow-up|0|||
131841847|NCT05327816|474704290|FG005|Overall Study|Lost to Follow-up|0|||
131841848|NCT05327816|474704291|FG006|Overall Study|Lost to Follow-up|0|||
131841849|NCT05327816|474704292|FG007|Overall Study|Lost to Follow-up|0|||
131910821|NCT04711005|474960867|FG003|Overall Study|Withdrawal by Subject|0|||
131910822|NCT04711005|474960868|FG004|Overall Study|Withdrawal by Subject|0|||
131910823|NCT04711005|474960869|FG005|Overall Study|Withdrawal by Subject|0|||
131402786|NCT01537081|473097787|FG002|Overall Study|Protocol Violation|2|||
131841850|NCT05327816|474704293|FG008|Overall Study|Lost to Follow-up|0|||
131841851|NCT05327816|474704294|FG009|Overall Study|Lost to Follow-up|1|||
131841852|NCT05327816|474704295|FG010|Overall Study|Lost to Follow-up|0|||
131841853|NCT05327816|474704285|FG000|Overall Study|Withdrawal by Subject|0|||
131841854|NCT05327816|474704286|FG001|Overall Study|Withdrawal by Subject|0|||
131841855|NCT05327816|474704287|FG002|Overall Study|Withdrawal by Subject|0|||
131841856|NCT05327816|474704288|FG003|Overall Study|Withdrawal by Subject|0|||
131841857|NCT05327816|474704289|FG004|Overall Study|Withdrawal by Subject|1|||
131841858|NCT05327816|474704290|FG005|Overall Study|Withdrawal by Subject|1|||
131841859|NCT05327816|474704291|FG006|Overall Study|Withdrawal by Subject|0|||
131841860|NCT05327816|474704292|FG007|Overall Study|Withdrawal by Subject|0|||
131841861|NCT05327816|474704293|FG008|Overall Study|Withdrawal by Subject|0|||
131841862|NCT05327816|474704294|FG009|Overall Study|Withdrawal by Subject|0|||
131841863|NCT05327816|474704295|FG010|Overall Study|Withdrawal by Subject|0|||
131841864|NCT05327816|474704285|FG000|Overall Study|Study Terminated by Sponsor|11|||
131841865|NCT05327816|474704286|FG001|Overall Study|Study Terminated by Sponsor|12|||
131841866|NCT05327816|474704287|FG002|Overall Study|Study Terminated by Sponsor|12|||
131841867|NCT05327816|474704288|FG003|Overall Study|Study Terminated by Sponsor|12|||
131841868|NCT05327816|474704289|FG004|Overall Study|Study Terminated by Sponsor|11|||
131841869|NCT05327816|474704290|FG005|Overall Study|Study Terminated by Sponsor|11|||
131841870|NCT05327816|474704291|FG006|Overall Study|Study Terminated by Sponsor|11|||
131841871|NCT05327816|474704292|FG007|Overall Study|Study Terminated by Sponsor|11|||
131841872|NCT05327816|474704293|FG008|Overall Study|Study Terminated by Sponsor|11|||
131841873|NCT05327816|474704294|FG009|Overall Study|Study Terminated by Sponsor|11|||
131841874|NCT05327816|474704295|FG010|Overall Study|Study Terminated by Sponsor|12|||
131841875|NCT05327816|474704285|FG000|Overall Study|Randomized but not treated|0|||
131841876|NCT05327816|474704286|FG001|Overall Study|Randomized but not treated|0|||
131841877|NCT05327816|474704287|FG002|Overall Study|Randomized but not treated|0|||
131841878|NCT05327816|474704288|FG003|Overall Study|Randomized but not treated|0|||
131841879|NCT05327816|474704289|FG004|Overall Study|Randomized but not treated|0|||
131841880|NCT05327816|474704290|FG005|Overall Study|Randomized but not treated|0|||
131841881|NCT05327816|474704291|FG006|Overall Study|Randomized but not treated|1|||
131841882|NCT05327816|474704292|FG007|Overall Study|Randomized but not treated|1|||
131841883|NCT05327816|474704293|FG008|Overall Study|Randomized but not treated|1|||
131841884|NCT05327816|474704294|FG009|Overall Study|Randomized but not treated|0|||
131841885|NCT05327816|474704295|FG010|Overall Study|Randomized but not treated|0|||
131910824|NCT04711005|474960870|FG006|Overall Study|Withdrawal by Subject|0|||
131402787|NCT01537081|473097785|FG000|Overall Study|Withdrawal by Subject|6|||
131402788|NCT01537081|473097786|FG001|Overall Study|Withdrawal by Subject|11|||
131402789|NCT01537081|473097787|FG002|Overall Study|Withdrawal by Subject|3|||
131402790|NCT01537081|473097785|FG000|Overall Study|Physician Decision|5|||
131402791|NCT01537081|473097786|FG001|Overall Study|Physician Decision|6|||
131402792|NCT01537081|473097787|FG002|Overall Study|Physician Decision|0|||
131402793|NCT01537081|473097785|FG000|Overall Study|Sponsor decision|0|||
131402794|NCT01537081|473097786|FG001|Overall Study|Sponsor decision|1|||
131402795|NCT01537081|473097787|FG002|Overall Study|Sponsor decision|0|||
131841886|NCT00112866|474704296|FG000|Overall Study|Protocol Violation|1|||
131841887|NCT00112866|474704297|FG001|Overall Study|Protocol Violation|0|||
131841888|NCT00112866|474704296|FG000|Overall Study|did not start treatment post-op|1|||
131841889|NCT00112866|474704297|FG001|Overall Study|did not start treatment post-op|2|||
131841890|NCT01167257|474704299|FG000|Overall Study|Lost to Follow-up|2|||
131841891|NCT01167257|474704300|FG001|Overall Study|Lost to Follow-up|2|||
131841892|NCT01167257|474704299|FG000|Overall Study|Withdrew consent|1|||
131841893|NCT01167257|474704300|FG001|Overall Study|Withdrew consent|1|||
131841894|NCT01200992|474704303|FG000|Overall Study|Study terminated early|35|||
131841895|NCT01200992|474704304|FG001|Overall Study|Study terminated early|41|||
131841896|NCT01200992|474704303|FG000|Overall Study|Randomized but not treated|2|||
131841897|NCT01200992|474704304|FG001|Overall Study|Randomized but not treated|0|||
131841898|NCT02213510|474704313|FG000|Overall Study|Death|0|||
131841899|NCT02213510|474704314|FG001|Overall Study|Death|1|||
131841900|NCT02213510|474704313|FG000|Overall Study|Lost to Follow-up|1|||
131841901|NCT02213510|474704314|FG001|Overall Study|Lost to Follow-up|0|||
131841902|NCT00368979|474704317|FG000|Overall Study|Adverse Event|9|||
131841903|NCT00368979|474704318|FG001|Overall Study|Adverse Event|16|||
131841904|NCT00368979|474704317|FG000|Overall Study|Lack of Efficacy|5|||
131841905|NCT00368979|474704318|FG001|Overall Study|Lack of Efficacy|3|||
131841906|NCT00368979|474704317|FG000|Overall Study|Other|3|||
131841907|NCT00368979|474704318|FG001|Overall Study|Other|1|||
131841908|NCT00368979|474704317|FG000|Overall Study|Lost to Follow-up|1|||
131841909|NCT00368979|474704318|FG001|Overall Study|Lost to Follow-up|0|||
131841910|NCT00368979|474704317|FG000|Overall Study|Protocol Violation|2|||
131841911|NCT00368979|474704318|FG001|Overall Study|Protocol Violation|1|||
131841912|NCT00368979|474704317|FG000|Overall Study|Withdrawal by Subject|5|||
131841913|NCT00368979|474704318|FG001|Overall Study|Withdrawal by Subject|9|||
131841914|NCT04241315|474704331|FG000|Overall Study|Withdrawal by Subject|0|||
131841915|NCT04241315|474704332|FG001|Overall Study|Withdrawal by Subject|1|||
131841916|NCT00699283|474704333|FG000|Overall Study|Lack of Efficacy|15|||
131841917|NCT00699283|474704334|FG001|Overall Study|Lack of Efficacy|5|||
131841918|NCT00699283|474704333|FG000|Overall Study|Lost to Follow-up|2|||
131841919|NCT00699283|474704334|FG001|Overall Study|Lost to Follow-up|0|||
131841920|NCT00699283|474704333|FG000|Overall Study|Withdrawal by Subject|1|||
131841921|NCT00699283|474704334|FG001|Overall Study|Withdrawal by Subject|0|||
131841922|NCT00699283|474704333|FG000|Overall Study|Other Reason|5|||
131841923|NCT00699283|474704334|FG001|Overall Study|Other Reason|1|||
131841924|NCT00699283|474704333|FG000|Overall Study|SAE, non-fatal|1|||
131841925|NCT00699283|474704334|FG001|Overall Study|SAE, non-fatal|1|||
131841926|NCT00699283|474704333|FG000|Overall Study|AE, non-serious non-fatal|8|||
131841927|NCT00699283|474704334|FG001|Overall Study|AE, non-serious non-fatal|1|||
131841928|NCT00699283|474704333|FG000|Overall Study|AE of unknown type|1|||
131841929|NCT00699283|474704334|FG001|Overall Study|AE of unknown type|0|||
131841930|NCT01398514|474704339|FG000|Overall Study|Adverse Event|1|||
131841931|NCT01398514|474704340|FG001|Overall Study|Adverse Event|0|||
131841932|NCT01398514|474704339|FG000|Overall Study|Non-compliance with study procedures|2|||
131841933|NCT01398514|474704340|FG001|Overall Study|Non-compliance with study procedures|0|||
131841934|NCT01398514|474704339|FG000|Overall Study|Physiologic non-responsiveness|1|||
131841935|NCT01398514|474704340|FG001|Overall Study|Physiologic non-responsiveness|3|||
131841936|NCT01398514|474704339|FG000|Overall Study|Failure to show a conditioned response|4|||
131841937|NCT01398514|474704340|FG001|Overall Study|Failure to show a conditioned response|3|||
131841938|NCT00631657|474704341|FG000|6-Month Treatment Period|Adverse Event|47|||
131841939|NCT00631657|474704342|FG001|6-Month Treatment Period|Adverse Event|0|||
131841940|NCT00631657|474704343|FG002|6-Month Treatment Period|Adverse Event|7|||
131841941|NCT00631657|474704341|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
131841942|NCT00631657|474704342|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
131841943|NCT00631657|474704343|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
131841944|NCT00631657|474704341|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
131402796|NCT01537081|473097785|FG000|Overall Study|Assigned but never dosed|1|||
131402797|NCT01537081|473097786|FG001|Overall Study|Assigned but never dosed|0|||
131841945|NCT00631657|474704342|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
131841946|NCT00631657|474704343|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
131841947|NCT00631657|474704341|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
131841948|NCT00631657|474704342|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
131841949|NCT00631657|474704343|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
131841950|NCT00631657|474704341|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
131841951|NCT00631657|474704342|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
131402798|NCT01537081|473097787|FG002|Overall Study|Assigned but never dosed|0|||
131841952|NCT00631657|474704343|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
131402799|NCT01463111|473097790|FG000|Overall Study|Withdrawal by Subject|2|||
131841953|NCT00631657|474704341|FG000|6-Month Treatment Period|Other|16|||
131402800|NCT01463111|473097790|FG000|Overall Study|Lost to Follow-up|5|||
131841954|NCT00631657|474704342|FG001|6-Month Treatment Period|Other|0|||
131841955|NCT00631657|474704343|FG002|6-Month Treatment Period|Other|4|||
131841956|NCT00631657|474704341|FG000|6-Month Treatment Period|Not Treated|2|||
131841957|NCT00631657|474704342|FG001|6-Month Treatment Period|Not Treated|0|||
131841958|NCT00631657|474704343|FG002|6-Month Treatment Period|Not Treated|1|||
131841959|NCT00631657|474704341|FG000|7-Day Discontinuation Period|Not Treated|1|||
131841960|NCT00631657|474704342|FG001|7-Day Discontinuation Period|Not Treated|1|||
131841961|NCT00631657|474704343|FG002|7-Day Discontinuation Period|Not Treated|1|||
131841962|NCT00631657|474704341|FG000|7-Day Discontinuation Period|Other|1|||
131841963|NCT00631657|474704342|FG001|7-Day Discontinuation Period|Other|0|||
131841964|NCT00631657|474704343|FG002|7-Day Discontinuation Period|Other|0|||
131841965|NCT00754650|474704348|FG000|Overall Study|Disease Progression|2|||
131841966|NCT00805675|474704349|FG000|Overall Study|Adverse Event|0|||
131841967|NCT00805675|474704350|FG001|Overall Study|Adverse Event|0|||
131841968|NCT00805675|474704351|FG002|Overall Study|Adverse Event|1|||
131841969|NCT02771795|474704352|FG000|Overall Study|Withdrawal by Subject|47|||
131841970|NCT02771795|474704353|FG001|Overall Study|Withdrawal by Subject|37|||
131841971|NCT02771795|474704352|FG000|Overall Study|Termination by premature discontinuation of study|168|||
131841972|NCT02771795|474704353|FG001|Overall Study|Termination by premature discontinuation of study|185|||
131841973|NCT03537599|474704357|FG000|Overall Study|Disease Progression|2|||
131841974|NCT03537599|474704358|FG001|Overall Study|Disease Progression|1|||
131841975|NCT03537599|474704357|FG000|Overall Study|Death|0|||
131841976|NCT03537599|474704358|FG001|Overall Study|Death|1|||
131841977|NCT01007942|474704359|FG000|Overall Study|Adverse Event|29|||
131841978|NCT01007942|474704360|FG001|Overall Study|Adverse Event|14|||
131841979|NCT01007942|474704359|FG000|Overall Study|Abnormal test procedure|0|||
131841980|NCT01007942|474704360|FG001|Overall Study|Abnormal test procedure|1|||
131841981|NCT01007942|474704359|FG000|Overall Study|Disease progression|217|||
131841982|NCT01007942|474704360|FG001|Overall Study|Disease progression|242|||
131841983|NCT01007942|474704359|FG000|Overall Study|New cancer therapy|5|||
131841984|NCT01007942|474704360|FG001|Overall Study|New cancer therapy|1|||
131841985|NCT01007942|474704359|FG000|Overall Study|Protocol Violation|1|||
131841986|NCT01007942|474704360|FG001|Overall Study|Protocol Violation|1|||
131841987|NCT01007942|474704359|FG000|Overall Study|Withdrawal by Subject|19|||
131841988|NCT01007942|474704360|FG001|Overall Study|Withdrawal by Subject|14|||
131841989|NCT01007942|474704359|FG000|Overall Study|Lost to Follow-up|1|||
131841990|NCT01007942|474704360|FG001|Overall Study|Lost to Follow-up|0|||
131841991|NCT01007942|474704359|FG000|Overall Study|Administrative problems|2|||
131841992|NCT01007942|474704360|FG001|Overall Study|Administrative problems|0|||
131841993|NCT01007942|474704359|FG000|Overall Study|Death|3|||
131841994|NCT01007942|474704360|FG001|Overall Study|Death|2|||
131841995|NCT01007942|474704359|FG000|Overall Study|Patients untreated|4|||
131841996|NCT01007942|474704360|FG001|Overall Study|Patients untreated|3|||
131841997|NCT00325195|474704361|FG000|Randomized|Not dosed|5|||
131841998|NCT00325195|474704362|FG001|Randomized|Not dosed|5|||
131841999|NCT00325195|474704363|FG002|Randomized|Not dosed|3|||
131842000|NCT00325195|474704361|FG000|Received Intervention: ITT Population|Adverse Event|15|||
131842001|NCT00325195|474704362|FG001|Received Intervention: ITT Population|Adverse Event|17|||
131842002|NCT00325195|474704363|FG002|Received Intervention: ITT Population|Adverse Event|1|||
131842003|NCT00325195|474704361|FG000|Received Intervention: ITT Population|Death|3|||
131842004|NCT00325195|474704362|FG001|Received Intervention: ITT Population|Death|1|||
131842005|NCT00325195|474704363|FG002|Received Intervention: ITT Population|Death|0|||
131842006|NCT00325195|474704361|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
131842007|NCT00325195|474704362|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
131842008|NCT00325195|474704363|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
131842009|NCT00325195|474704361|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
131842010|NCT00325195|474704362|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
131842011|NCT00325195|474704363|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
131842012|NCT00325195|474704361|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
131842013|NCT00325195|474704362|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
131842014|NCT00325195|474704363|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
131842015|NCT05083585|474704364|FG000|Overall Study|Death|1|||
131842016|NCT05083585|474704365|FG001|Overall Study|Death|1|||
131842017|NCT05083585|474704364|FG000|Overall Study|Lost to Follow-up|1|||
131842018|NCT05083585|474704365|FG001|Overall Study|Lost to Follow-up|1|||
131842019|NCT05083585|474704364|FG000|Overall Study|Withdrawal by Subject|2|||
131842020|NCT05083585|474704365|FG001|Overall Study|Withdrawal by Subject|0|||
131842021|NCT05083585|474704364|FG000|Overall Study|Randomized but not vaccinated|2|||
131842022|NCT05083585|474704365|FG001|Overall Study|Randomized but not vaccinated|0|||
131402801|NCT01463111|473097790|FG000|Overall Study|Physician Decision|2|||
131842023|NCT03929757|474704366|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
131842024|NCT03929757|474704367|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
131842025|NCT03929757|474704368|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
131842026|NCT03929757|474704366|FG000|Main Study: Up to Day 365|Other|1|||
131842027|NCT03929757|474704367|FG001|Main Study: Up to Day 365|Other|0|||
131842028|NCT03929757|474704368|FG002|Main Study: Up to Day 365|Other|0|||
131842029|NCT03929757|474704366|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
131842030|NCT03929757|474704367|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
131842031|NCT03929757|474704368|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
131842032|NCT00114166|474704369|FG000|Overall Study|Wrong primary|0|||
131842033|NCT00114166|474704370|FG001|Overall Study|Wrong primary|1|||
131842034|NCT03402750|474704371|FG000|Overall Study|Lost to Follow-up|2|||
131842035|NCT03402750|474704372|FG001|Overall Study|Lost to Follow-up|1|||
131842036|NCT02534844|474704373|FG000|Part B|Withdrawal by Subject|0|||
131842037|NCT02534844|474704374|FG001|Part B|Withdrawal by Subject|0|||
131842038|NCT02534844|474704375|FG002|Part B|Withdrawal by Subject|0|||
131842039|NCT02534844|474704376|FG003|Part B|Withdrawal by Subject|0|||
131842040|NCT02534844|474704377|FG004|Part B|Withdrawal by Subject|2|||
131842041|NCT02534844|474704378|FG005|Part B|Withdrawal by Subject|1|||
131842042|NCT03560986|474704379|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
131842043|NCT03560986|474704380|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
131842044|NCT03560986|474704379|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
131842045|NCT03560986|474704380|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
131842046|NCT03560986|474704379|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
131842047|NCT03560986|474704380|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
131842048|NCT03560986|474704379|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
131842049|NCT03560986|474704380|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
131842050|NCT03560986|474704379|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
131842051|NCT03560986|474704380|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
131842052|NCT03560986|474704379|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
131842053|NCT03560986|474704380|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
131842054|NCT03560986|474704379|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
131402802|NCT03285958|473097791|FG000|Overall Study|Lost to Follow-up|1|||
131842055|NCT03560986|474704380|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
131402803|NCT03285958|473097792|FG001|Overall Study|Lost to Follow-up|1|||
131402804|NCT03285958|473097791|FG000|Overall Study|Withdrawal by Subject|1|||
131402805|NCT03285958|473097792|FG001|Overall Study|Withdrawal by Subject|0|||
131402806|NCT03285958|473097791|FG000|Overall Study|Not able to attend required orientation|3|||
131402807|NCT03285958|473097792|FG001|Overall Study|Not able to attend required orientation|0|||
131402808|NCT03116828|473097795|FG000|Overall Study|Adverse Event|1|||
131402809|NCT03116828|473097796|FG001|Overall Study|Adverse Event|10|||
131402810|NCT03116828|473097795|FG000|Overall Study|Withdrawal by Subject|4|||
131402811|NCT03116828|473097796|FG001|Overall Study|Withdrawal by Subject|8|||
131402812|NCT03116828|473097795|FG000|Overall Study|OTHER|3|||
131402813|NCT03116828|473097796|FG001|Overall Study|OTHER|3|||
131402814|NCT00882583|473097797|FG000|Overall Study|Physician Decision|1|||
131402815|NCT00882583|473097798|FG001|Overall Study|Physician Decision|0|||
131842056|NCT04283500|474704392|FG000|Overall Study|Lost to Follow-up|8|||
131842057|NCT04283500|474704392|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
131842058|NCT01059344|474704395|FG000|Overall Study|Adverse Event|12|||
131842059|NCT01059344|474704396|FG001|Overall Study|Adverse Event|30|||
131402816|NCT00882583|473097797|FG000|Overall Study|Adverse Event|0|||
131402817|NCT00882583|473097798|FG001|Overall Study|Adverse Event|1|||
131402818|NCT00185380|473097806|FG000|Overall Study|Adverse Event|41|||
131842060|NCT01059344|474704395|FG000|Overall Study|Withdrawal by Subject|6|||
131842061|NCT01059344|474704396|FG001|Overall Study|Withdrawal by Subject|9|||
131842062|NCT01059344|474704395|FG000|Overall Study|Lost to Follow-up|1|||
131842063|NCT01059344|474704396|FG001|Overall Study|Lost to Follow-up|1|||
131842064|NCT01059344|474704395|FG000|Overall Study|Other|3|||
131842065|NCT01059344|474704396|FG001|Overall Study|Other|6|||
131842066|NCT01739348|474704397|FG000|Part I (Base Study)|Adverse Event|41|||
131842067|NCT01739348|474704398|FG001|Part I (Base Study)|Adverse Event|52|||
131842068|NCT01739348|474704399|FG002|Part I (Base Study)|Adverse Event|8|||
131842069|NCT01739348|474704400|FG003|Part I (Base Study)|Adverse Event|33|||
131842070|NCT01739348|474704397|FG000|Part I (Base Study)|Death|10|||
131842071|NCT01739348|474704398|FG001|Part I (Base Study)|Death|7|||
131842072|NCT01739348|474704399|FG002|Part I (Base Study)|Death|2|||
131842073|NCT01739348|474704400|FG003|Part I (Base Study)|Death|8|||
131402819|NCT00185380|473097807|FG001|Overall Study|Adverse Event|43|||
131842074|NCT01739348|474704397|FG000|Part I (Base Study)|Lack of Efficacy|3|||
131842075|NCT01739348|474704398|FG001|Part I (Base Study)|Lack of Efficacy|8|||
131842076|NCT01739348|474704399|FG002|Part I (Base Study)|Lack of Efficacy|0|||
131842077|NCT01739348|474704400|FG003|Part I (Base Study)|Lack of Efficacy|7|||
131402820|NCT00185380|473097808|FG002|Overall Study|Adverse Event|48|||
131402821|NCT00185380|473097806|FG000|Overall Study|Lost to Follow-up|0|||
131402822|NCT00185380|473097807|FG001|Overall Study|Lost to Follow-up|4|||
131402823|NCT00185380|473097808|FG002|Overall Study|Lost to Follow-up|3|||
131842078|NCT01739348|474704397|FG000|Part I (Base Study)|Lost to Follow-up|4|||
131842079|NCT01739348|474704398|FG001|Part I (Base Study)|Lost to Follow-up|2|||
131842080|NCT01739348|474704399|FG002|Part I (Base Study)|Lost to Follow-up|4|||
131842081|NCT01739348|474704400|FG003|Part I (Base Study)|Lost to Follow-up|4|||
131402824|NCT00185380|473097806|FG000|Overall Study|Pregnancy|1|||
131402825|NCT00185380|473097807|FG001|Overall Study|Pregnancy|4|||
131402826|NCT00185380|473097808|FG002|Overall Study|Pregnancy|0|||
131402827|NCT00185380|473097806|FG000|Overall Study|Protocol Violation|2|||
131842082|NCT01739348|474704397|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
131842083|NCT01739348|474704398|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
131842084|NCT01739348|474704399|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
131842085|NCT01739348|474704400|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
131842086|NCT01739348|474704397|FG000|Part I (Base Study)|Physician Decision|10|||
131842087|NCT01739348|474704398|FG001|Part I (Base Study)|Physician Decision|7|||
131842088|NCT01739348|474704399|FG002|Part I (Base Study)|Physician Decision|1|||
131402828|NCT00185380|473097807|FG001|Overall Study|Protocol Violation|2|||
131402829|NCT00185380|473097808|FG002|Overall Study|Protocol Violation|1|||
131402830|NCT00185380|473097806|FG000|Overall Study|Withdrawal by Subject|1|||
131402831|NCT00185380|473097807|FG001|Overall Study|Withdrawal by Subject|2|||
131402832|NCT00185380|473097808|FG002|Overall Study|Withdrawal by Subject|0|||
131402833|NCT00185380|473097806|FG000|Overall Study|Failed insertion|1|||
131842089|NCT01739348|474704400|FG003|Part I (Base Study)|Physician Decision|4|||
131842090|NCT01739348|474704397|FG000|Part I (Base Study)|Protocol Violation|2|||
131842091|NCT01739348|474704398|FG001|Part I (Base Study)|Protocol Violation|0|||
131842092|NCT01739348|474704399|FG002|Part I (Base Study)|Protocol Violation|1|||
131842093|NCT01739348|474704400|FG003|Part I (Base Study)|Protocol Violation|2|||
131842094|NCT01739348|474704397|FG000|Part I (Base Study)|Screen Failure|2|||
131842095|NCT01739348|474704398|FG001|Part I (Base Study)|Screen Failure|0|||
131842096|NCT01739348|474704399|FG002|Part I (Base Study)|Screen Failure|0|||
131842097|NCT01739348|474704400|FG003|Part I (Base Study)|Screen Failure|0|||
131842098|NCT01739348|474704397|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
131842099|NCT01739348|474704398|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
131842100|NCT01739348|474704399|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
131842101|NCT01739348|474704400|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
131842102|NCT01739348|474704397|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
131842103|NCT01739348|474704398|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
131842104|NCT01739348|474704399|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
131842105|NCT01739348|474704400|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
131842106|NCT01739348|474704397|FG000|Part I (Base Study)|Participant Moved|4|||
131842107|NCT01739348|474704398|FG001|Part I (Base Study)|Participant Moved|3|||
131842108|NCT01739348|474704399|FG002|Part I (Base Study)|Participant Moved|1|||
131842109|NCT01739348|474704400|FG003|Part I (Base Study)|Participant Moved|7|||
131842110|NCT01739348|474704397|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
131842111|NCT01739348|474704398|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
131842112|NCT01739348|474704399|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
131842113|NCT01739348|474704400|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
131842114|NCT01739348|474704397|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
131842115|NCT01739348|474704398|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
131842116|NCT01739348|474704399|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
131842117|NCT01739348|474704400|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
131842118|NCT01739348|474704397|FG000|Part II (Extension Study)|Adverse Event|10|||
131842119|NCT01739348|474704398|FG001|Part II (Extension Study)|Adverse Event|11|||
131842120|NCT01739348|474704399|FG002|Part II (Extension Study)|Adverse Event|7|||
131842121|NCT01739348|474704400|FG003|Part II (Extension Study)|Adverse Event|26|||
131842122|NCT01739348|474704397|FG000|Part II (Extension Study)|Death|3|||
131842123|NCT01739348|474704398|FG001|Part II (Extension Study)|Death|3|||
131842124|NCT01739348|474704399|FG002|Part II (Extension Study)|Death|2|||
131842125|NCT01739348|474704400|FG003|Part II (Extension Study)|Death|6|||
131842126|NCT01739348|474704397|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
131842127|NCT01739348|474704398|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
131842128|NCT01739348|474704399|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
131842129|NCT01739348|474704400|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
131842130|NCT01739348|474704397|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
131842131|NCT01739348|474704398|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
131842132|NCT01739348|474704399|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
131842133|NCT01739348|474704400|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
131842134|NCT01739348|474704397|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
131842135|NCT01739348|474704398|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
131842136|NCT01739348|474704399|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
131842137|NCT01739348|474704400|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
131842138|NCT01739348|474704397|FG000|Part II (Extension Study)|Physician Decision|7|||
131842139|NCT01739348|474704398|FG001|Part II (Extension Study)|Physician Decision|11|||
131842140|NCT01739348|474704399|FG002|Part II (Extension Study)|Physician Decision|6|||
131842141|NCT01739348|474704400|FG003|Part II (Extension Study)|Physician Decision|12|||
131842142|NCT01739348|474704397|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
131842143|NCT01739348|474704398|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
131842144|NCT01739348|474704399|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
131842145|NCT01739348|474704400|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
131402834|NCT00185380|473097807|FG001|Overall Study|Failed insertion|1|||
131402835|NCT00185380|473097808|FG002|Overall Study|Failed insertion|2|||
131842146|NCT01739348|474704397|FG000|Part II (Extension Study)|Participant Moved|3|||
131842147|NCT01739348|474704398|FG001|Part II (Extension Study)|Participant Moved|3|||
131842148|NCT01739348|474704399|FG002|Part II (Extension Study)|Participant Moved|0|||
131842149|NCT01739348|474704400|FG003|Part II (Extension Study)|Participant Moved|3|||
131842150|NCT01739348|474704397|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
131842151|NCT01739348|474704398|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
131842152|NCT01739348|474704399|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
131842153|NCT01739348|474704400|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
131842154|NCT01739348|474704397|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
131842155|NCT01739348|474704398|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
131842156|NCT01739348|474704399|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
131842157|NCT01739348|474704400|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
131842158|NCT00742924|474704404|FG000|Overall Study|Adverse Event|0|||
131842159|NCT00742924|474704405|FG001|Overall Study|Adverse Event|0|||
131842160|NCT00742924|474704406|FG002|Overall Study|Adverse Event|1|||
131842161|NCT00742924|474704407|FG003|Overall Study|Adverse Event|1|||
131842162|NCT00742924|474704404|FG000|Overall Study|Lack of Efficacy|5|||
131842163|NCT00742924|474704405|FG001|Overall Study|Lack of Efficacy|1|||
131842164|NCT00742924|474704406|FG002|Overall Study|Lack of Efficacy|2|||
131842165|NCT00742924|474704407|FG003|Overall Study|Lack of Efficacy|4|||
131842166|NCT00742924|474704404|FG000|Overall Study|Physician Decision|0|||
131842167|NCT00742924|474704405|FG001|Overall Study|Physician Decision|0|||
131842168|NCT00742924|474704406|FG002|Overall Study|Physician Decision|0|||
131842169|NCT00742924|474704407|FG003|Overall Study|Physician Decision|1|||
131842170|NCT00742924|474704404|FG000|Overall Study|Withdrawal by Subject|0|||
131842171|NCT00742924|474704405|FG001|Overall Study|Withdrawal by Subject|1|||
131842172|NCT00742924|474704406|FG002|Overall Study|Withdrawal by Subject|1|||
131842173|NCT00742924|474704407|FG003|Overall Study|Withdrawal by Subject|0|||
131842174|NCT00660400|474704408|FG000|Overall Study|Lack of insurance approval|1|||
131842175|NCT00660400|474704408|FG000|Overall Study|Suboptimal organ function|1|||
131842176|NCT00660400|474704408|FG000|Overall Study|Intracranial hemorrhage|1|||
131842177|NCT00660400|474704408|FG000|Overall Study|Withdrawal by Subject|1|||
131842178|NCT02987959|474704409|FG000|Overall Study|Grantor stopped supply of drugs|6|||
131842179|NCT04126213|474704410|FG000|Overall Study|Lost to Follow-up|9|||
131842180|NCT04126213|474704411|FG001|Overall Study|Lost to Follow-up|1|||
131842181|NCT04126213|474704412|FG002|Overall Study|Lost to Follow-up|5|||
131842182|NCT04126213|474704413|FG003|Overall Study|Lost to Follow-up|10|||
131842183|NCT04126213|474704414|FG004|Overall Study|Lost to Follow-up|4|||
131842184|NCT04126213|474704415|FG005|Overall Study|Lost to Follow-up|7|||
131842185|NCT04126213|474704410|FG000|Overall Study|Withdrawal by Subject|3|||
131842186|NCT04126213|474704411|FG001|Overall Study|Withdrawal by Subject|2|||
131842187|NCT04126213|474704412|FG002|Overall Study|Withdrawal by Subject|1|||
131842188|NCT04126213|474704413|FG003|Overall Study|Withdrawal by Subject|1|||
131842189|NCT04126213|474704414|FG004|Overall Study|Withdrawal by Subject|1|||
131842190|NCT04126213|474704415|FG005|Overall Study|Withdrawal by Subject|1|||
131842191|NCT04126213|474704410|FG000|Overall Study|Other|0|||
131842192|NCT04126213|474704411|FG001|Overall Study|Other|0|||
131842193|NCT04126213|474704412|FG002|Overall Study|Other|2|||
131842194|NCT04126213|474704413|FG003|Overall Study|Other|2|||
131842195|NCT04126213|474704414|FG004|Overall Study|Other|0|||
131842196|NCT04126213|474704415|FG005|Overall Study|Other|1|||
131842197|NCT04126213|474704410|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131842198|NCT04126213|474704411|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131842199|NCT04126213|474704412|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131842200|NCT04126213|474704413|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131842201|NCT04126213|474704414|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131842202|NCT04126213|474704415|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131842203|NCT02853370|474704416|FG000|Overall Study|Physician Decision|1|||
131842204|NCT02853370|474704416|FG000|Overall Study|Lack of Efficacy|2|||
131842205|NCT02853370|474704416|FG000|Overall Study|Death|1|||
131842206|NCT02853370|474704416|FG000|Overall Study|Adverse Event|4|||
131842207|NCT02853370|474704416|FG000|Overall Study|Withdrawal by Subject|3|||
131842208|NCT00911807|474704417|FG000|Overall Study|Adverse Event|2|||
131842209|NCT00911807|474704418|FG001|Overall Study|Adverse Event|1|||
131842210|NCT00911807|474704419|FG002|Overall Study|Adverse Event|5|||
131842211|NCT00911807|474704417|FG000|Overall Study|Death|0|||
131842212|NCT00911807|474704418|FG001|Overall Study|Death|0|||
131842213|NCT00911807|474704419|FG002|Overall Study|Death|1|||
131842214|NCT00911807|474704417|FG000|Overall Study|Protocol Violation|6|||
131842215|NCT00911807|474704418|FG001|Overall Study|Protocol Violation|4|||
131842216|NCT00911807|474704419|FG002|Overall Study|Protocol Violation|9|||
131842217|NCT00911807|474704417|FG000|Overall Study|Withdrawal by Subject|8|||
131842218|NCT00911807|474704418|FG001|Overall Study|Withdrawal by Subject|10|||
131842219|NCT00911807|474704419|FG002|Overall Study|Withdrawal by Subject|7|||
131842220|NCT00911807|474704417|FG000|Overall Study|Organizational reasons|1|||
131842221|NCT00911807|474704418|FG001|Overall Study|Organizational reasons|3|||
131402836|NCT00185380|473097806|FG000|Overall Study|Planned pregnancy|9|||
131402837|NCT00185380|473097807|FG001|Overall Study|Planned pregnancy|12|||
131402838|NCT00185380|473097808|FG002|Overall Study|Planned pregnancy|12|||
131842222|NCT00911807|474704419|FG002|Overall Study|Organizational reasons|1|||
131842223|NCT02132754|474704420|FG000|Overall Study|Adverse Event|0|||
131842224|NCT02132754|474704421|FG001|Overall Study|Adverse Event|0|||
131842225|NCT02132754|474704422|FG002|Overall Study|Adverse Event|0|||
131842226|NCT02132754|474704423|FG003|Overall Study|Adverse Event|0|||
131842227|NCT02132754|474704424|FG004|Overall Study|Adverse Event|0|||
131842228|NCT02132754|474704425|FG005|Overall Study|Adverse Event|0|||
131842229|NCT02132754|474704426|FG006|Overall Study|Adverse Event|0|||
131842230|NCT02132754|474704427|FG007|Overall Study|Adverse Event|0|||
131842231|NCT02132754|474704428|FG008|Overall Study|Adverse Event|0|||
131842232|NCT02132754|474704429|FG009|Overall Study|Adverse Event|0|||
131842233|NCT02132754|474704430|FG010|Overall Study|Adverse Event|0|||
131842234|NCT02132754|474704431|FG011|Overall Study|Adverse Event|0|||
131842235|NCT02132754|474704432|FG012|Overall Study|Adverse Event|0|||
131842236|NCT02132754|474704433|FG013|Overall Study|Adverse Event|0|||
131842237|NCT02132754|474704434|FG014|Overall Study|Adverse Event|0|||
131842238|NCT02132754|474704435|FG015|Overall Study|Adverse Event|0|||
131842239|NCT02132754|474704436|FG016|Overall Study|Adverse Event|0|||
131842240|NCT02132754|474704437|FG017|Overall Study|Adverse Event|1|||
131842241|NCT02132754|474704438|FG018|Overall Study|Adverse Event|0|||
131842242|NCT02132754|474704439|FG019|Overall Study|Adverse Event|0|||
131842243|NCT02132754|474704440|FG020|Overall Study|Adverse Event|0|||
131842244|NCT02132754|474704441|FG021|Overall Study|Adverse Event|0|||
131842245|NCT02132754|474704442|FG022|Overall Study|Adverse Event|0|||
131842246|NCT02132754|474704443|FG023|Overall Study|Adverse Event|0|||
131842247|NCT02132754|474704444|FG024|Overall Study|Adverse Event|0|||
131842248|NCT02132754|474704445|FG025|Overall Study|Adverse Event|1|||
131842249|NCT02132754|474704446|FG026|Overall Study|Adverse Event|1|||
131842250|NCT02132754|474704447|FG027|Overall Study|Adverse Event|0|||
131842251|NCT02132754|474704448|FG028|Overall Study|Adverse Event|0|||
131842252|NCT02132754|474704449|FG029|Overall Study|Adverse Event|0|||
131842253|NCT02132754|474704450|FG030|Overall Study|Adverse Event|1|||
131842254|NCT02132754|474704451|FG031|Overall Study|Adverse Event|0|||
131842255|NCT02132754|474704452|FG032|Overall Study|Adverse Event|1|||
131842256|NCT02132754|474704453|FG033|Overall Study|Adverse Event|1|||
131842257|NCT02132754|474704420|FG000|Overall Study|Clinical Progression|0|||
131842258|NCT02132754|474704421|FG001|Overall Study|Clinical Progression|0|||
131842259|NCT02132754|474704422|FG002|Overall Study|Clinical Progression|0|||
131842260|NCT02132754|474704423|FG003|Overall Study|Clinical Progression|0|||
131842261|NCT02132754|474704424|FG004|Overall Study|Clinical Progression|0|||
131842262|NCT02132754|474704425|FG005|Overall Study|Clinical Progression|0|||
131842263|NCT02132754|474704426|FG006|Overall Study|Clinical Progression|0|||
131842264|NCT02132754|474704427|FG007|Overall Study|Clinical Progression|0|||
131842265|NCT02132754|474704428|FG008|Overall Study|Clinical Progression|0|||
131842266|NCT02132754|474704429|FG009|Overall Study|Clinical Progression|1|||
131842267|NCT02132754|474704430|FG010|Overall Study|Clinical Progression|0|||
131842268|NCT02132754|474704431|FG011|Overall Study|Clinical Progression|0|||
131842269|NCT02132754|474704432|FG012|Overall Study|Clinical Progression|0|||
131842270|NCT02132754|474704433|FG013|Overall Study|Clinical Progression|0|||
131842271|NCT02132754|474704434|FG014|Overall Study|Clinical Progression|0|||
131842272|NCT02132754|474704435|FG015|Overall Study|Clinical Progression|0|||
131842273|NCT02132754|474704436|FG016|Overall Study|Clinical Progression|1|||
131842274|NCT02132754|474704437|FG017|Overall Study|Clinical Progression|1|||
131842275|NCT02132754|474704438|FG018|Overall Study|Clinical Progression|0|||
131842276|NCT02132754|474704439|FG019|Overall Study|Clinical Progression|1|||
131842277|NCT02132754|474704440|FG020|Overall Study|Clinical Progression|0|||
131842278|NCT02132754|474704441|FG021|Overall Study|Clinical Progression|0|||
131842279|NCT02132754|474704442|FG022|Overall Study|Clinical Progression|1|||
131842280|NCT02132754|474704443|FG023|Overall Study|Clinical Progression|0|||
131842281|NCT02132754|474704444|FG024|Overall Study|Clinical Progression|1|||
131842282|NCT02132754|474704445|FG025|Overall Study|Clinical Progression|1|||
131842283|NCT02132754|474704446|FG026|Overall Study|Clinical Progression|0|||
131842284|NCT02132754|474704447|FG027|Overall Study|Clinical Progression|1|||
131842285|NCT02132754|474704448|FG028|Overall Study|Clinical Progression|1|||
131842286|NCT02132754|474704449|FG029|Overall Study|Clinical Progression|0|||
131842287|NCT02132754|474704450|FG030|Overall Study|Clinical Progression|1|||
131842288|NCT02132754|474704451|FG031|Overall Study|Clinical Progression|0|||
131842289|NCT02132754|474704452|FG032|Overall Study|Clinical Progression|0|||
131842290|NCT02132754|474704453|FG033|Overall Study|Clinical Progression|2|||
131842291|NCT02132754|474704420|FG000|Overall Study|Death|0|||
131842292|NCT02132754|474704421|FG001|Overall Study|Death|0|||
131402839|NCT00185380|473097806|FG000|Overall Study|No need for contraception|3|||
131842293|NCT02132754|474704422|FG002|Overall Study|Death|0|||
131842294|NCT02132754|474704423|FG003|Overall Study|Death|0|||
131842295|NCT02132754|474704424|FG004|Overall Study|Death|0|||
131842296|NCT02132754|474704425|FG005|Overall Study|Death|0|||
131842297|NCT02132754|474704426|FG006|Overall Study|Death|0|||
131842298|NCT02132754|474704427|FG007|Overall Study|Death|0|||
131842299|NCT02132754|474704428|FG008|Overall Study|Death|0|||
131842300|NCT02132754|474704429|FG009|Overall Study|Death|0|||
131842301|NCT02132754|474704430|FG010|Overall Study|Death|0|||
131842302|NCT02132754|474704431|FG011|Overall Study|Death|0|||
131842303|NCT02132754|474704432|FG012|Overall Study|Death|0|||
131842304|NCT02132754|474704433|FG013|Overall Study|Death|0|||
131842305|NCT02132754|474704434|FG014|Overall Study|Death|0|||
131842306|NCT02132754|474704435|FG015|Overall Study|Death|1|||
131842307|NCT02132754|474704436|FG016|Overall Study|Death|0|||
131842308|NCT02132754|474704437|FG017|Overall Study|Death|0|||
131842309|NCT02132754|474704438|FG018|Overall Study|Death|0|||
131842310|NCT02132754|474704439|FG019|Overall Study|Death|1|||
131842311|NCT02132754|474704440|FG020|Overall Study|Death|0|||
131842312|NCT02132754|474704441|FG021|Overall Study|Death|1|||
131842313|NCT02132754|474704442|FG022|Overall Study|Death|0|||
131842314|NCT02132754|474704443|FG023|Overall Study|Death|0|||
131842315|NCT02132754|474704444|FG024|Overall Study|Death|0|||
131842316|NCT02132754|474704445|FG025|Overall Study|Death|0|||
131842317|NCT02132754|474704446|FG026|Overall Study|Death|1|||
131842318|NCT02132754|474704447|FG027|Overall Study|Death|0|||
131842319|NCT02132754|474704448|FG028|Overall Study|Death|0|||
131842320|NCT02132754|474704449|FG029|Overall Study|Death|0|||
131842321|NCT02132754|474704450|FG030|Overall Study|Death|0|||
131842322|NCT02132754|474704451|FG031|Overall Study|Death|0|||
131842323|NCT02132754|474704452|FG032|Overall Study|Death|0|||
131842324|NCT02132754|474704453|FG033|Overall Study|Death|2|||
131842325|NCT02132754|474704420|FG000|Overall Study|Excluded Medication|0|||
131842326|NCT02132754|474704421|FG001|Overall Study|Excluded Medication|0|||
131842327|NCT02132754|474704422|FG002|Overall Study|Excluded Medication|0|||
131842328|NCT02132754|474704423|FG003|Overall Study|Excluded Medication|0|||
131842329|NCT02132754|474704424|FG004|Overall Study|Excluded Medication|0|||
131842330|NCT02132754|474704425|FG005|Overall Study|Excluded Medication|0|||
131842331|NCT02132754|474704426|FG006|Overall Study|Excluded Medication|0|||
131842332|NCT02132754|474704427|FG007|Overall Study|Excluded Medication|0|||
131842333|NCT02132754|474704428|FG008|Overall Study|Excluded Medication|0|||
131842334|NCT02132754|474704429|FG009|Overall Study|Excluded Medication|0|||
131842335|NCT02132754|474704430|FG010|Overall Study|Excluded Medication|0|||
131842336|NCT02132754|474704431|FG011|Overall Study|Excluded Medication|0|||
131842337|NCT02132754|474704432|FG012|Overall Study|Excluded Medication|0|||
131842338|NCT02132754|474704433|FG013|Overall Study|Excluded Medication|0|||
131842339|NCT02132754|474704434|FG014|Overall Study|Excluded Medication|0|||
131842340|NCT02132754|474704435|FG015|Overall Study|Excluded Medication|0|||
131842341|NCT02132754|474704436|FG016|Overall Study|Excluded Medication|0|||
131842342|NCT02132754|474704437|FG017|Overall Study|Excluded Medication|0|||
131842343|NCT02132754|474704438|FG018|Overall Study|Excluded Medication|0|||
131842344|NCT02132754|474704439|FG019|Overall Study|Excluded Medication|0|||
131842345|NCT02132754|474704440|FG020|Overall Study|Excluded Medication|1|||
131842346|NCT02132754|474704441|FG021|Overall Study|Excluded Medication|0|||
131842347|NCT02132754|474704442|FG022|Overall Study|Excluded Medication|0|||
131842348|NCT02132754|474704443|FG023|Overall Study|Excluded Medication|0|||
131842349|NCT02132754|474704444|FG024|Overall Study|Excluded Medication|0|||
131842350|NCT02132754|474704445|FG025|Overall Study|Excluded Medication|0|||
131842351|NCT02132754|474704446|FG026|Overall Study|Excluded Medication|0|||
131842352|NCT02132754|474704447|FG027|Overall Study|Excluded Medication|0|||
131842353|NCT02132754|474704448|FG028|Overall Study|Excluded Medication|0|||
131842354|NCT02132754|474704449|FG029|Overall Study|Excluded Medication|0|||
131842355|NCT02132754|474704450|FG030|Overall Study|Excluded Medication|0|||
131842356|NCT02132754|474704451|FG031|Overall Study|Excluded Medication|0|||
131842357|NCT02132754|474704452|FG032|Overall Study|Excluded Medication|0|||
131842358|NCT02132754|474704453|FG033|Overall Study|Excluded Medication|1|||
131842359|NCT02132754|474704420|FG000|Overall Study|Physician Decision|0|||
131842360|NCT02132754|474704421|FG001|Overall Study|Physician Decision|0|||
131842361|NCT02132754|474704422|FG002|Overall Study|Physician Decision|0|||
131842362|NCT02132754|474704423|FG003|Overall Study|Physician Decision|0|||
131842363|NCT02132754|474704424|FG004|Overall Study|Physician Decision|0|||
131842364|NCT02132754|474704425|FG005|Overall Study|Physician Decision|0|||
131842365|NCT02132754|474704426|FG006|Overall Study|Physician Decision|0|||
131842366|NCT02132754|474704427|FG007|Overall Study|Physician Decision|0|||
131842367|NCT02132754|474704428|FG008|Overall Study|Physician Decision|0|||
131842368|NCT02132754|474704429|FG009|Overall Study|Physician Decision|1|||
131842369|NCT02132754|474704430|FG010|Overall Study|Physician Decision|0|||
131842370|NCT02132754|474704431|FG011|Overall Study|Physician Decision|1|||
131842371|NCT02132754|474704432|FG012|Overall Study|Physician Decision|1|||
131842372|NCT02132754|474704433|FG013|Overall Study|Physician Decision|0|||
131842373|NCT02132754|474704434|FG014|Overall Study|Physician Decision|0|||
131842374|NCT02132754|474704435|FG015|Overall Study|Physician Decision|1|||
131842375|NCT02132754|474704436|FG016|Overall Study|Physician Decision|0|||
131842376|NCT02132754|474704437|FG017|Overall Study|Physician Decision|0|||
131842377|NCT02132754|474704438|FG018|Overall Study|Physician Decision|0|||
131842378|NCT02132754|474704439|FG019|Overall Study|Physician Decision|0|||
131842379|NCT02132754|474704440|FG020|Overall Study|Physician Decision|0|||
131842380|NCT02132754|474704441|FG021|Overall Study|Physician Decision|0|||
131842381|NCT02132754|474704442|FG022|Overall Study|Physician Decision|0|||
131842382|NCT02132754|474704443|FG023|Overall Study|Physician Decision|0|||
131842383|NCT02132754|474704444|FG024|Overall Study|Physician Decision|1|||
131842384|NCT02132754|474704445|FG025|Overall Study|Physician Decision|0|||
131842385|NCT02132754|474704446|FG026|Overall Study|Physician Decision|0|||
131842386|NCT02132754|474704447|FG027|Overall Study|Physician Decision|0|||
131842387|NCT02132754|474704448|FG028|Overall Study|Physician Decision|0|||
131842388|NCT02132754|474704449|FG029|Overall Study|Physician Decision|0|||
131842389|NCT02132754|474704450|FG030|Overall Study|Physician Decision|0|||
131842390|NCT02132754|474704451|FG031|Overall Study|Physician Decision|1|||
131842391|NCT02132754|474704452|FG032|Overall Study|Physician Decision|0|||
131842392|NCT02132754|474704453|FG033|Overall Study|Physician Decision|3|||
131842393|NCT02132754|474704420|FG000|Overall Study|Progressive Disease|1|||
131842394|NCT02132754|474704421|FG001|Overall Study|Progressive Disease|1|||
131842395|NCT02132754|474704422|FG002|Overall Study|Progressive Disease|1|||
131842396|NCT02132754|474704423|FG003|Overall Study|Progressive Disease|1|||
131842397|NCT02132754|474704424|FG004|Overall Study|Progressive Disease|1|||
131842398|NCT02132754|474704425|FG005|Overall Study|Progressive Disease|1|||
131842399|NCT02132754|474704426|FG006|Overall Study|Progressive Disease|1|||
131842400|NCT02132754|474704427|FG007|Overall Study|Progressive Disease|1|||
131842401|NCT02132754|474704428|FG008|Overall Study|Progressive Disease|1|||
131842402|NCT02132754|474704429|FG009|Overall Study|Progressive Disease|3|||
131842403|NCT02132754|474704430|FG010|Overall Study|Progressive Disease|3|||
131842404|NCT02132754|474704431|FG011|Overall Study|Progressive Disease|2|||
131842405|NCT02132754|474704432|FG012|Overall Study|Progressive Disease|2|||
131842406|NCT02132754|474704433|FG013|Overall Study|Progressive Disease|3|||
131842407|NCT02132754|474704434|FG014|Overall Study|Progressive Disease|2|||
131842408|NCT02132754|474704435|FG015|Overall Study|Progressive Disease|1|||
131842409|NCT02132754|474704436|FG016|Overall Study|Progressive Disease|2|||
131842410|NCT02132754|474704437|FG017|Overall Study|Progressive Disease|1|||
131842411|NCT02132754|474704438|FG018|Overall Study|Progressive Disease|3|||
131842412|NCT02132754|474704439|FG019|Overall Study|Progressive Disease|1|||
131842413|NCT02132754|474704440|FG020|Overall Study|Progressive Disease|1|||
131842414|NCT02132754|474704441|FG021|Overall Study|Progressive Disease|3|||
131842415|NCT02132754|474704442|FG022|Overall Study|Progressive Disease|2|||
131842416|NCT02132754|474704443|FG023|Overall Study|Progressive Disease|3|||
131842417|NCT02132754|474704444|FG024|Overall Study|Progressive Disease|0|||
131842418|NCT02132754|474704445|FG025|Overall Study|Progressive Disease|1|||
131842419|NCT02132754|474704446|FG026|Overall Study|Progressive Disease|2|||
131842420|NCT02132754|474704447|FG027|Overall Study|Progressive Disease|1|||
131842421|NCT02132754|474704448|FG028|Overall Study|Progressive Disease|2|||
131842422|NCT02132754|474704449|FG029|Overall Study|Progressive Disease|3|||
131842423|NCT02132754|474704450|FG030|Overall Study|Progressive Disease|1|||
131842424|NCT02132754|474704451|FG031|Overall Study|Progressive Disease|1|||
131842425|NCT02132754|474704452|FG032|Overall Study|Progressive Disease|3|||
131842426|NCT02132754|474704453|FG033|Overall Study|Progressive Disease|6|||
131842427|NCT02132754|474704420|FG000|Overall Study|Screen Failure|0|||
131842428|NCT02132754|474704421|FG001|Overall Study|Screen Failure|0|||
131842429|NCT02132754|474704422|FG002|Overall Study|Screen Failure|0|||
131842430|NCT02132754|474704423|FG003|Overall Study|Screen Failure|0|||
131842431|NCT02132754|474704424|FG004|Overall Study|Screen Failure|0|||
131842432|NCT02132754|474704425|FG005|Overall Study|Screen Failure|0|||
131842433|NCT02132754|474704426|FG006|Overall Study|Screen Failure|0|||
131842434|NCT02132754|474704427|FG007|Overall Study|Screen Failure|0|||
131842435|NCT02132754|474704428|FG008|Overall Study|Screen Failure|0|||
131842436|NCT02132754|474704429|FG009|Overall Study|Screen Failure|0|||
131842437|NCT02132754|474704430|FG010|Overall Study|Screen Failure|0|||
131842438|NCT02132754|474704431|FG011|Overall Study|Screen Failure|0|||
131842439|NCT02132754|474704432|FG012|Overall Study|Screen Failure|0|||
131842440|NCT02132754|474704433|FG013|Overall Study|Screen Failure|0|||
131842441|NCT02132754|474704434|FG014|Overall Study|Screen Failure|0|||
131842442|NCT02132754|474704435|FG015|Overall Study|Screen Failure|0|||
131842443|NCT02132754|474704436|FG016|Overall Study|Screen Failure|0|||
131842444|NCT02132754|474704437|FG017|Overall Study|Screen Failure|0|||
131842445|NCT02132754|474704438|FG018|Overall Study|Screen Failure|0|||
131842446|NCT02132754|474704439|FG019|Overall Study|Screen Failure|1|||
131842447|NCT02132754|474704440|FG020|Overall Study|Screen Failure|0|||
131842448|NCT02132754|474704441|FG021|Overall Study|Screen Failure|1|||
131842449|NCT02132754|474704442|FG022|Overall Study|Screen Failure|0|||
131842450|NCT02132754|474704443|FG023|Overall Study|Screen Failure|0|||
131842451|NCT02132754|474704444|FG024|Overall Study|Screen Failure|0|||
131842452|NCT02132754|474704445|FG025|Overall Study|Screen Failure|0|||
131842453|NCT02132754|474704446|FG026|Overall Study|Screen Failure|0|||
131842454|NCT02132754|474704447|FG027|Overall Study|Screen Failure|0|||
131842455|NCT02132754|474704448|FG028|Overall Study|Screen Failure|0|||
131842456|NCT02132754|474704449|FG029|Overall Study|Screen Failure|0|||
131842457|NCT02132754|474704450|FG030|Overall Study|Screen Failure|0|||
131842458|NCT02132754|474704451|FG031|Overall Study|Screen Failure|0|||
131842459|NCT02132754|474704452|FG032|Overall Study|Screen Failure|0|||
131842460|NCT02132754|474704453|FG033|Overall Study|Screen Failure|0|||
131842461|NCT02132754|474704420|FG000|Overall Study|Transferred to Extension Study|0|||
131842462|NCT02132754|474704421|FG001|Overall Study|Transferred to Extension Study|0|||
131842463|NCT02132754|474704422|FG002|Overall Study|Transferred to Extension Study|0|||
131842464|NCT02132754|474704423|FG003|Overall Study|Transferred to Extension Study|0|||
131842465|NCT02132754|474704424|FG004|Overall Study|Transferred to Extension Study|0|||
131842466|NCT02132754|474704425|FG005|Overall Study|Transferred to Extension Study|0|||
131842467|NCT02132754|474704426|FG006|Overall Study|Transferred to Extension Study|0|||
131842468|NCT02132754|474704427|FG007|Overall Study|Transferred to Extension Study|0|||
131842469|NCT02132754|474704428|FG008|Overall Study|Transferred to Extension Study|0|||
131842470|NCT02132754|474704429|FG009|Overall Study|Transferred to Extension Study|0|||
131842471|NCT02132754|474704430|FG010|Overall Study|Transferred to Extension Study|0|||
131842472|NCT02132754|474704431|FG011|Overall Study|Transferred to Extension Study|0|||
131842473|NCT02132754|474704432|FG012|Overall Study|Transferred to Extension Study|0|||
131842474|NCT02132754|474704433|FG013|Overall Study|Transferred to Extension Study|0|||
131842475|NCT02132754|474704434|FG014|Overall Study|Transferred to Extension Study|0|||
131842476|NCT02132754|474704435|FG015|Overall Study|Transferred to Extension Study|0|||
131842477|NCT02132754|474704436|FG016|Overall Study|Transferred to Extension Study|0|||
131842478|NCT02132754|474704437|FG017|Overall Study|Transferred to Extension Study|0|||
131842479|NCT02132754|474704438|FG018|Overall Study|Transferred to Extension Study|0|||
131842480|NCT02132754|474704439|FG019|Overall Study|Transferred to Extension Study|0|||
131842481|NCT02132754|474704440|FG020|Overall Study|Transferred to Extension Study|0|||
131842482|NCT02132754|474704441|FG021|Overall Study|Transferred to Extension Study|0|||
131842483|NCT02132754|474704442|FG022|Overall Study|Transferred to Extension Study|0|||
131842484|NCT02132754|474704443|FG023|Overall Study|Transferred to Extension Study|0|||
131842485|NCT02132754|474704444|FG024|Overall Study|Transferred to Extension Study|0|||
131842486|NCT02132754|474704445|FG025|Overall Study|Transferred to Extension Study|0|||
131842487|NCT02132754|474704446|FG026|Overall Study|Transferred to Extension Study|0|||
131842488|NCT02132754|474704447|FG027|Overall Study|Transferred to Extension Study|0|||
131842489|NCT02132754|474704448|FG028|Overall Study|Transferred to Extension Study|0|||
131842490|NCT02132754|474704449|FG029|Overall Study|Transferred to Extension Study|0|||
131842491|NCT02132754|474704450|FG030|Overall Study|Transferred to Extension Study|0|||
131842492|NCT02132754|474704451|FG031|Overall Study|Transferred to Extension Study|0|||
131842493|NCT02132754|474704452|FG032|Overall Study|Transferred to Extension Study|0|||
131842494|NCT02132754|474704453|FG033|Overall Study|Transferred to Extension Study|6|||
131842495|NCT02132754|474704420|FG000|Overall Study|Withdrawal by Subject|0|||
131842496|NCT02132754|474704421|FG001|Overall Study|Withdrawal by Subject|0|||
131842497|NCT02132754|474704422|FG002|Overall Study|Withdrawal by Subject|0|||
131842498|NCT02132754|474704423|FG003|Overall Study|Withdrawal by Subject|0|||
131842499|NCT02132754|474704424|FG004|Overall Study|Withdrawal by Subject|0|||
131842500|NCT02132754|474704425|FG005|Overall Study|Withdrawal by Subject|0|||
131842501|NCT02132754|474704426|FG006|Overall Study|Withdrawal by Subject|0|||
131842502|NCT02132754|474704427|FG007|Overall Study|Withdrawal by Subject|0|||
131842503|NCT02132754|474704428|FG008|Overall Study|Withdrawal by Subject|0|||
131842504|NCT02132754|474704429|FG009|Overall Study|Withdrawal by Subject|1|||
131842505|NCT02132754|474704430|FG010|Overall Study|Withdrawal by Subject|0|||
131842506|NCT02132754|474704431|FG011|Overall Study|Withdrawal by Subject|0|||
131842507|NCT02132754|474704432|FG012|Overall Study|Withdrawal by Subject|1|||
131842508|NCT02132754|474704433|FG013|Overall Study|Withdrawal by Subject|0|||
131842509|NCT02132754|474704434|FG014|Overall Study|Withdrawal by Subject|1|||
131842510|NCT02132754|474704435|FG015|Overall Study|Withdrawal by Subject|2|||
131842511|NCT02132754|474704436|FG016|Overall Study|Withdrawal by Subject|1|||
131842512|NCT02132754|474704437|FG017|Overall Study|Withdrawal by Subject|0|||
131842513|NCT02132754|474704438|FG018|Overall Study|Withdrawal by Subject|0|||
131450244|NCT02379091|473276833|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131450245|NCT02379091|473276834|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
131450246|NCT02379091|473276831|FG000|Overall Study|Principal Investigator Discretion|0|||
131450247|NCT02379091|473276832|FG001|Overall Study|Principal Investigator Discretion|1|||
131450248|NCT02379091|473276833|FG002|Overall Study|Principal Investigator Discretion|0|||
131450249|NCT02379091|473276834|FG003|Overall Study|Principal Investigator Discretion|0|||
131450250|NCT02379091|473276831|FG000|Overall Study|Lost to Follow-up|0|||
131450251|NCT02379091|473276832|FG001|Overall Study|Lost to Follow-up|0|||
131450252|NCT02379091|473276833|FG002|Overall Study|Lost to Follow-up|0|||
131450253|NCT02379091|473276834|FG003|Overall Study|Lost to Follow-up|1|||
131450254|NCT02379091|473276831|FG000|Overall Study|Voluntary Withdrawal|2|||
131450255|NCT02379091|473276832|FG001|Overall Study|Voluntary Withdrawal|5|||
131450256|NCT02379091|473276833|FG002|Overall Study|Voluntary Withdrawal|2|||
131450257|NCT02379091|473276834|FG003|Overall Study|Voluntary Withdrawal|4|||
131450258|NCT02379091|473276831|FG000|Overall Study|Study Termination|7|||
131450259|NCT02379091|473276832|FG001|Overall Study|Study Termination|2|||
131450260|NCT02379091|473276833|FG002|Overall Study|Study Termination|5|||
131450261|NCT02379091|473276834|FG003|Overall Study|Study Termination|8|||
131450262|NCT02379091|473276831|FG000|Overall Study|Lack of Efficacy|3|||
131450263|NCT02379091|473276832|FG001|Overall Study|Lack of Efficacy|0|||
131402840|NCT00185380|473097807|FG001|Overall Study|No need for contraception|3|||
131402841|NCT00185380|473097808|FG002|Overall Study|No need for contraception|3|||
131402842|NCT00185380|473097806|FG000|Overall Study|Could not attend visits|2|||
131842514|NCT02132754|474704439|FG019|Overall Study|Withdrawal by Subject|0|||
131842515|NCT02132754|474704440|FG020|Overall Study|Withdrawal by Subject|1|||
131842516|NCT02132754|474704441|FG021|Overall Study|Withdrawal by Subject|0|||
131842517|NCT02132754|474704442|FG022|Overall Study|Withdrawal by Subject|0|||
131842518|NCT02132754|474704443|FG023|Overall Study|Withdrawal by Subject|0|||
131842519|NCT02132754|474704444|FG024|Overall Study|Withdrawal by Subject|1|||
131842520|NCT02132754|474704445|FG025|Overall Study|Withdrawal by Subject|0|||
131842521|NCT02132754|474704446|FG026|Overall Study|Withdrawal by Subject|0|||
131842522|NCT02132754|474704447|FG027|Overall Study|Withdrawal by Subject|1|||
131842523|NCT02132754|474704448|FG028|Overall Study|Withdrawal by Subject|0|||
131842524|NCT02132754|474704449|FG029|Overall Study|Withdrawal by Subject|0|||
131842525|NCT02132754|474704450|FG030|Overall Study|Withdrawal by Subject|0|||
131842526|NCT02132754|474704451|FG031|Overall Study|Withdrawal by Subject|1|||
131842527|NCT02132754|474704452|FG032|Overall Study|Withdrawal by Subject|0|||
131842528|NCT02132754|474704453|FG033|Overall Study|Withdrawal by Subject|2|||
131842529|NCT00477295|474704458|FG000|Overall Study|Adverse Event|31|||
131842530|NCT00477295|474704459|FG001|Overall Study|Adverse Event|35|||
131842531|NCT00477295|474704458|FG000|Overall Study|Withdrawal by Subject|35|||
131842532|NCT00477295|474704459|FG001|Overall Study|Withdrawal by Subject|24|||
131842533|NCT00477295|474704458|FG000|Overall Study|Lack of Efficacy|23|||
131842534|NCT00477295|474704459|FG001|Overall Study|Lack of Efficacy|23|||
131842535|NCT00477295|474704458|FG000|Overall Study|Protocol Violation|3|||
131842536|NCT00477295|474704459|FG001|Overall Study|Protocol Violation|8|||
131842537|NCT00477295|474704458|FG000|Overall Study|Physician Decision|4|||
131842538|NCT00477295|474704459|FG001|Overall Study|Physician Decision|5|||
131842539|NCT00477295|474704458|FG000|Overall Study|Lost to Follow-up|21|||
131842540|NCT00477295|474704459|FG001|Overall Study|Lost to Follow-up|11|||
131842541|NCT00477295|474704458|FG000|Overall Study|Other|4|||
131842542|NCT00477295|474704459|FG001|Overall Study|Other|3|||
131842543|NCT01425723|474704462|FG000|Overall Study|Lack of Efficacy|0|||
131842544|NCT01425723|474704463|FG001|Overall Study|Lack of Efficacy|1|||
131842545|NCT01425723|474704462|FG000|Overall Study|Withdrawal by Subject|1|||
131842546|NCT01425723|474704463|FG001|Overall Study|Withdrawal by Subject|4|||
131842547|NCT01425723|474704462|FG000|Overall Study|Lost to Follow-up|0|||
131842548|NCT01425723|474704463|FG001|Overall Study|Lost to Follow-up|3|||
131842549|NCT01425723|474704462|FG000|Overall Study|Physician Decision|2|||
131842550|NCT01425723|474704463|FG001|Overall Study|Physician Decision|0|||
131842551|NCT01425723|474704462|FG000|Overall Study|Other|1|||
131842552|NCT01425723|474704463|FG001|Overall Study|Other|10|||
131842553|NCT00186043|474704464|FG000|Overall Study|Lack of Efficacy|1|||
131842554|NCT00186043|474704465|FG001|Overall Study|Lack of Efficacy|3|||
131842555|NCT00186043|474704464|FG000|Overall Study|Lost to Follow-up|4|||
131842556|NCT00186043|474704465|FG001|Overall Study|Lost to Follow-up|6|||
131842557|NCT00186043|474704464|FG000|Overall Study|Withdrawal by Subject|1|||
131842558|NCT00186043|474704465|FG001|Overall Study|Withdrawal by Subject|0|||
131842559|NCT00186043|474704464|FG000|Overall Study|Adverse Event|7|||
131842560|NCT00186043|474704465|FG001|Overall Study|Adverse Event|3|||
131842561|NCT00186043|474704464|FG000|Overall Study|Protocol Violation|2|||
131842562|NCT00186043|474704465|FG001|Overall Study|Protocol Violation|1|||
131842563|NCT03258853|474704478|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
131842564|NCT03258853|474704479|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
131842565|NCT03870477|474704480|FG000|Overall Study|Early Study Termination|1|||
131842566|NCT00620659|474704485|FG000|Treatment Period 1|Adverse Event|1|||
131842567|NCT00620659|474704486|FG001|Treatment Period 1|Adverse Event|0|||
131842568|NCT00620659|474704487|FG002|Treatment Period 1|Adverse Event|0|||
131842569|NCT00620659|474704488|FG003|Treatment Period 1|Adverse Event|3|||
131842570|NCT00620659|474704489|FG004|Treatment Period 1|Adverse Event|0|||
131842571|NCT00620659|474704490|FG005|Treatment Period 1|Adverse Event|0|||
131842572|NCT00620659|474704485|FG000|Treatment Period 1|Protocol Violation|1|||
131842573|NCT00620659|474704486|FG001|Treatment Period 1|Protocol Violation|0|||
131842574|NCT00620659|474704487|FG002|Treatment Period 1|Protocol Violation|0|||
131842575|NCT00620659|474704488|FG003|Treatment Period 1|Protocol Violation|0|||
131842576|NCT00620659|474704489|FG004|Treatment Period 1|Protocol Violation|0|||
131842577|NCT00620659|474704490|FG005|Treatment Period 1|Protocol Violation|0|||
131842578|NCT00620659|474704485|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131842579|NCT00620659|474704486|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131842580|NCT00620659|474704487|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131842581|NCT00620659|474704488|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131842582|NCT00620659|474704489|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131842583|NCT00620659|474704490|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131402843|NCT00185380|473097807|FG001|Overall Study|Could not attend visits|0|||
131842584|NCT00620659|474704485|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
131842585|NCT00620659|474704486|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
131842586|NCT00620659|474704487|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
131842587|NCT00620659|474704488|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
131842588|NCT00620659|474704489|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
131402844|NCT00185380|473097808|FG002|Overall Study|Could not attend visits|4|||
131402845|NCT00185380|473097806|FG000|Overall Study|personal reason|6|||
131402846|NCT00185380|473097807|FG001|Overall Study|personal reason|1|||
131842589|NCT00620659|474704490|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
131842590|NCT00620659|474704485|FG000|Treatment Period 2|Adverse Event|0|||
131842591|NCT00620659|474704486|FG001|Treatment Period 2|Adverse Event|3|||
131842592|NCT00620659|474704487|FG002|Treatment Period 2|Adverse Event|0|||
131842593|NCT00620659|474704488|FG003|Treatment Period 2|Adverse Event|0|||
131842594|NCT00620659|474704489|FG004|Treatment Period 2|Adverse Event|2|||
131842595|NCT00620659|474704490|FG005|Treatment Period 2|Adverse Event|0|||
131842596|NCT00620659|474704485|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131842597|NCT00620659|474704486|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131842598|NCT00620659|474704487|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131842599|NCT00620659|474704488|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131842600|NCT00620659|474704489|FG004|Treatment Period 2|Withdrawal by Subject|3|||
131842601|NCT00620659|474704490|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131842602|NCT00620659|474704485|FG000|Placebo Washout Period 2|Adverse Event|2|||
131842603|NCT00620659|474704486|FG001|Placebo Washout Period 2|Adverse Event|0|||
131842604|NCT00620659|474704487|FG002|Placebo Washout Period 2|Adverse Event|0|||
131842605|NCT00620659|474704488|FG003|Placebo Washout Period 2|Adverse Event|0|||
131842606|NCT00620659|474704489|FG004|Placebo Washout Period 2|Adverse Event|0|||
131842607|NCT00620659|474704490|FG005|Placebo Washout Period 2|Adverse Event|0|||
131842608|NCT00620659|474704485|FG000|Treatment Period 3|Adverse Event|0|||
131842609|NCT00620659|474704486|FG001|Treatment Period 3|Adverse Event|2|||
131842610|NCT00620659|474704487|FG002|Treatment Period 3|Adverse Event|0|||
131842611|NCT00620659|474704488|FG003|Treatment Period 3|Adverse Event|0|||
131842612|NCT00620659|474704489|FG004|Treatment Period 3|Adverse Event|0|||
131842613|NCT00620659|474704490|FG005|Treatment Period 3|Adverse Event|0|||
131842614|NCT00620659|474704485|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131842615|NCT00620659|474704486|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131842616|NCT00620659|474704487|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131842617|NCT00620659|474704488|FG003|Treatment Period 3|Withdrawal by Subject|1|||
131842618|NCT00620659|474704489|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131842619|NCT00620659|474704490|FG005|Treatment Period 3|Withdrawal by Subject|0|||
131842620|NCT01193127|474704491|FG000|Randomized|Surgery Cancelled|0|||
131842621|NCT01193127|474704492|FG001|Randomized|Surgery Cancelled|0|||
131842622|NCT01193127|474704493|FG002|Randomized|Surgery Cancelled|0|||
131842623|NCT01193127|474704494|FG003|Randomized|Surgery Cancelled|1|||
131842624|NCT01193127|474704491|FG000|Treated|Withdrawal by Subject|0|||
131842625|NCT01193127|474704492|FG001|Treated|Withdrawal by Subject|0|||
131842626|NCT01193127|474704493|FG002|Treated|Withdrawal by Subject|0|||
131842627|NCT01193127|474704494|FG003|Treated|Withdrawal by Subject|1|||
131842628|NCT03246646|474704495|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
131842629|NCT03246646|474704496|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
131842630|NCT03246646|474704495|FG000|Overall Study|Withdrawal by Subject|3|||
131842631|NCT03246646|474704496|FG001|Overall Study|Withdrawal by Subject|0|||
131842632|NCT03246646|474704495|FG000|Overall Study|Lost to Follow-up|7|||
131842633|NCT03246646|474704496|FG001|Overall Study|Lost to Follow-up|0|||
131842634|NCT02352779|474704499|FG000|Overall Study|Personal Issues|1|||
131842635|NCT02352779|474704500|FG001|Overall Study|Personal Issues|1|||
131842636|NCT02352779|474704501|FG002|Overall Study|Personal Issues|0|||
131842637|NCT02352779|474704499|FG000|Overall Study|Too Many Forms|2|||
131842638|NCT02352779|474704500|FG001|Overall Study|Too Many Forms|0|||
131842639|NCT02352779|474704501|FG002|Overall Study|Too Many Forms|0|||
131842640|NCT02352779|474704499|FG000|Overall Study|Feeling Overwhelmed|1|||
131842641|NCT02352779|474704500|FG001|Overall Study|Feeling Overwhelmed|0|||
131842642|NCT02352779|474704501|FG002|Overall Study|Feeling Overwhelmed|0|||
131842643|NCT02352779|474704499|FG000|Overall Study|Disliked Intervention|1|||
131842644|NCT02352779|474704500|FG001|Overall Study|Disliked Intervention|0|||
131842645|NCT02352779|474704501|FG002|Overall Study|Disliked Intervention|0|||
131842646|NCT02352779|474704499|FG000|Overall Study|Changed Mind|1|||
131842647|NCT02352779|474704500|FG001|Overall Study|Changed Mind|0|||
131842648|NCT02352779|474704501|FG002|Overall Study|Changed Mind|0|||
131402847|NCT00185380|473097808|FG002|Overall Study|personal reason|1|||
131842649|NCT02352779|474704499|FG000|Overall Study|Study Related Symptoms|1|||
131842650|NCT02352779|474704500|FG001|Overall Study|Study Related Symptoms|0|||
131842651|NCT02352779|474704501|FG002|Overall Study|Study Related Symptoms|0|||
131842652|NCT02352779|474704499|FG000|Overall Study|Absence of Symptoms|1|||
131842653|NCT02352779|474704500|FG001|Overall Study|Absence of Symptoms|0|||
131842654|NCT02352779|474704501|FG002|Overall Study|Absence of Symptoms|0|||
131450264|NCT02379091|473276833|FG002|Overall Study|Lack of Efficacy|0|||
131842655|NCT02352779|474704499|FG000|Overall Study|Other Medical Reason|0|||
131842656|NCT02352779|474704500|FG001|Overall Study|Other Medical Reason|0|||
131842657|NCT02352779|474704501|FG002|Overall Study|Other Medical Reason|1|||
131842658|NCT02352779|474704499|FG000|Overall Study|No Reason|0|||
131842659|NCT02352779|474704500|FG001|Overall Study|No Reason|0|||
131402848|NCT03842969|473097819|FG000|Overall Study|Participant declined follow-up visit|0|||
131402849|NCT03842969|473097820|FG001|Overall Study|Participant declined follow-up visit|1|||
131402850|NCT03842969|473097821|FG002|Overall Study|Participant declined follow-up visit|0|||
131402851|NCT03842969|473097819|FG000|Overall Study|Sponsor's decision|12|||
131402852|NCT03842969|473097820|FG001|Overall Study|Sponsor's decision|99|||
131402853|NCT03842969|473097821|FG002|Overall Study|Sponsor's decision|61|||
131402854|NCT03842969|473097819|FG000|Overall Study|Pregnancy|0|||
131402855|NCT03842969|473097820|FG001|Overall Study|Pregnancy|0|||
131402856|NCT03842969|473097821|FG002|Overall Study|Pregnancy|1|||
131842660|NCT02352779|474704501|FG002|Overall Study|No Reason|1|||
131842661|NCT04555720|474704504|FG000|Overall Study|Lost to Follow-up|2|||
131842662|NCT04555720|474704505|FG001|Overall Study|Lost to Follow-up|0|||
131842663|NCT04555720|474704506|FG002|Overall Study|Lost to Follow-up|0|||
131842664|NCT04555720|474704507|FG003|Overall Study|Lost to Follow-up|0|||
131842665|NCT04555720|474704504|FG000|Overall Study|Withdrawal by Subject|4|||
131842666|NCT04555720|474704505|FG001|Overall Study|Withdrawal by Subject|6|||
131842667|NCT04555720|474704506|FG002|Overall Study|Withdrawal by Subject|0|||
131842668|NCT04555720|474704507|FG003|Overall Study|Withdrawal by Subject|0|||
131842669|NCT00968799|474704508|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
131842670|NCT00719849|474704511|FG000|Overall Study|Death|0|||
131842671|NCT00719849|474704512|FG001|Overall Study|Death|1|||
131842672|NCT01372774|474704515|FG000|Overall Study|Withdrawal prior to treatment|4|||
131842673|NCT01372774|474704516|FG001|Overall Study|Withdrawal prior to treatment|5|||
131842674|NCT02201290|474704521|FG000|Overall Study|Withdrawal by Subject|2|||
131842675|NCT02201290|474704521|FG000|Overall Study|Lack of Efficacy|2|||
131842676|NCT02201290|474704521|FG000|Overall Study|Adverse Event|1|||
131842677|NCT00871741|474704522|FG000|Overall Study|Premature study termination|9|||
131842678|NCT00871741|474704523|FG001|Overall Study|Premature study termination|7|||
131842679|NCT03433755|474704524|FG000|Overall Study|Lost to Follow-up|1|||
131842680|NCT03433755|474704525|FG001|Overall Study|Lost to Follow-up|0|||
131842681|NCT03433755|474704526|FG002|Overall Study|Lost to Follow-up|0|||
131842682|NCT03433755|474704527|FG003|Overall Study|Lost to Follow-up|0|||
131842683|NCT03433755|474704524|FG000|Overall Study|Decision by Sponsor|1|||
131842684|NCT03433755|474704525|FG001|Overall Study|Decision by Sponsor|0|||
131842685|NCT03433755|474704526|FG002|Overall Study|Decision by Sponsor|0|||
131842686|NCT03433755|474704527|FG003|Overall Study|Decision by Sponsor|0|||
131842687|NCT01565850|474704528|FG000|Overall Study|Adverse Event|0|||
131842688|NCT01565850|474704529|FG001|Overall Study|Adverse Event|1|||
131842689|NCT01565850|474704528|FG000|Overall Study|Lost to Follow-up|12|||
131842690|NCT01565850|474704529|FG001|Overall Study|Lost to Follow-up|4|||
131842691|NCT01565850|474704528|FG000|Overall Study|Investigator's Discretion|2|||
131402857|NCT03842969|473097819|FG000|Overall Study|Death|1|||
131402858|NCT03842969|473097820|FG001|Overall Study|Death|0|||
131402859|NCT03842969|473097821|FG002|Overall Study|Death|1|||
131402860|NCT03842969|473097819|FG000|Overall Study|Withdrawal by Subject|3|||
131402861|NCT03842969|473097820|FG001|Overall Study|Withdrawal by Subject|30|||
131402862|NCT03842969|473097821|FG002|Overall Study|Withdrawal by Subject|18|||
131402863|NCT03842969|473097819|FG000|Overall Study|Protocol Violation|1|||
131402864|NCT03842969|473097820|FG001|Overall Study|Protocol Violation|1|||
131402865|NCT03842969|473097821|FG002|Overall Study|Protocol Violation|0|||
131402866|NCT03842969|473097819|FG000|Overall Study|Physician Decision|0|||
131402867|NCT03842969|473097820|FG001|Overall Study|Physician Decision|3|||
131402868|NCT03842969|473097821|FG002|Overall Study|Physician Decision|0|||
131402869|NCT03842969|473097819|FG000|Overall Study|Lost to Follow-up|0|||
131402870|NCT03842969|473097820|FG001|Overall Study|Lost to Follow-up|2|||
131842692|NCT01565850|474704529|FG001|Overall Study|Investigator's Discretion|1|||
131402871|NCT03842969|473097821|FG002|Overall Study|Lost to Follow-up|0|||
131450265|NCT02379091|473276834|FG003|Overall Study|Lack of Efficacy|0|||
131450266|NCT02205736|473276835|FG000|Overall Study|Lost to Follow-up|106|||
131842693|NCT01565850|474704528|FG000|Overall Study|Participant noncompliance|2|||
131842694|NCT01565850|474704529|FG001|Overall Study|Participant noncompliance|0|||
131402872|NCT03842969|473097819|FG000|Overall Study|Adverse Event|0|||
131402873|NCT03842969|473097820|FG001|Overall Study|Adverse Event|2|||
131402874|NCT03842969|473097821|FG002|Overall Study|Adverse Event|0|||
131402875|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Adverse Event|76|||
131402876|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Adverse Event|0|||
131402877|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Adverse Event|0|||
131450267|NCT04161157|473276839|FG000|Overall Study|Lost to Follow-up|4|||
131450268|NCT04161157|473276839|FG000|Overall Study|Death|3|||
131450269|NCT04161157|473276839|FG000|Overall Study|Ineligible|2|||
131402878|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Death|3|||
131402879|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Death|0|||
131450270|NCT04161157|473276839|FG000|Overall Study|Withdrawal by Subject|4|||
131402880|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Death|0|||
131402881|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
131450271|NCT03278249|473276849|FG000|Overall Study|Withdrawal by Subject|2|||
131842695|NCT01565850|474704528|FG000|Overall Study|Withdrew Consent|4|||
131842696|NCT01565850|474704529|FG001|Overall Study|Withdrew Consent|2|||
131450272|NCT03278249|473276849|FG000|Overall Study|Lost to Follow-up|1|||
131842697|NCT04941729|474706316|FG000|Overall Study|Death|0|||
131842698|NCT04941729|474706317|FG001|Overall Study|Death|1|||
131842699|NCT04941729|474706316|FG000|Overall Study|Study terminated by sponsor|11|||
131842700|NCT04941729|474706317|FG001|Overall Study|Study terminated by sponsor|10|||
131842701|NCT03190330|474706319|FG000|Overall Study|Adverse Event|2|||
131842702|NCT03190330|474706319|FG000|Overall Study|Death|10|||
131842703|NCT03190330|474706319|FG000|Overall Study|Lost to Follow-up|1|||
131842704|NCT03190330|474706319|FG000|Overall Study|Withdrawal by Subject|6|||
131842705|NCT03190330|474706319|FG000|Overall Study|Progressive Disease|1|||
131842706|NCT03611543|474706320|FG000|Overall Study|Withdrawal by Subject|4|||
131842707|NCT03611543|474706321|FG001|Overall Study|Withdrawal by Subject|4|||
131842708|NCT03611543|474706320|FG000|Overall Study|Physician Decision|1|||
131842709|NCT03611543|474706321|FG001|Overall Study|Physician Decision|1|||
131842710|NCT03611543|474706320|FG000|Overall Study|Protocol Violation|2|||
131842711|NCT03611543|474706321|FG001|Overall Study|Protocol Violation|2|||
131842712|NCT03611543|474706320|FG000|Overall Study|Device failure|2|||
131842713|NCT03611543|474706321|FG001|Overall Study|Device failure|2|||
131842714|NCT03611543|474706320|FG000|Overall Study|Missing information|5|||
131842715|NCT03611543|474706321|FG001|Overall Study|Missing information|5|||
131842716|NCT02799095|474706322|FG000|Part A|Adverse Event|1|||
131842717|NCT02799095|474706323|FG001|Part A|Adverse Event|0|||
131842718|NCT02799095|474706324|FG002|Part A|Adverse Event|1|||
131842719|NCT02799095|474706325|FG003|Part A|Adverse Event|4|||
131842720|NCT02799095|474706326|FG004|Part A|Adverse Event|1|||
131842721|NCT02799095|474706327|FG005|Part A|Adverse Event|0|||
131842722|NCT02799095|474706328|FG006|Part A|Adverse Event|0|||
131842723|NCT02799095|474706329|FG007|Part A|Adverse Event|0|||
131842724|NCT02799095|474706330|FG008|Part A|Adverse Event|0|||
131842725|NCT02799095|474706331|FG009|Part A|Adverse Event|0|||
131842726|NCT02799095|474706332|FG010|Part A|Adverse Event|0|||
131842727|NCT02799095|474706333|FG011|Part A|Adverse Event|0|||
131842728|NCT02799095|474706334|FG012|Part A|Adverse Event|0|||
131842729|NCT02799095|474706335|FG013|Part A|Adverse Event|0|||
131842730|NCT02799095|474706336|FG014|Part A|Adverse Event|0|||
131842731|NCT02799095|474706337|FG015|Part A|Adverse Event|0|||
131842732|NCT02799095|474706338|FG016|Part A|Adverse Event|0|||
131842733|NCT02799095|474706322|FG000|Part A|Death|0|||
131842734|NCT02799095|474706323|FG001|Part A|Death|0|||
131842735|NCT02799095|474706324|FG002|Part A|Death|0|||
131842736|NCT02799095|474706325|FG003|Part A|Death|0|||
131842737|NCT02799095|474706326|FG004|Part A|Death|0|||
131842738|NCT02799095|474706327|FG005|Part A|Death|0|||
131842739|NCT02799095|474706328|FG006|Part A|Death|3|||
131842740|NCT02799095|474706329|FG007|Part A|Death|0|||
131842741|NCT02799095|474706330|FG008|Part A|Death|0|||
131842742|NCT02799095|474706331|FG009|Part A|Death|0|||
131842743|NCT02799095|474706332|FG010|Part A|Death|0|||
131842744|NCT02799095|474706333|FG011|Part A|Death|0|||
131842745|NCT02799095|474706334|FG012|Part A|Death|0|||
131842746|NCT02799095|474706335|FG013|Part A|Death|0|||
131842747|NCT02799095|474706336|FG014|Part A|Death|0|||
131842748|NCT02799095|474706337|FG015|Part A|Death|0|||
131842749|NCT02799095|474706338|FG016|Part A|Death|0|||
131842750|NCT02799095|474706322|FG000|Part A|Lost to Follow-up|0|||
131842751|NCT02799095|474706323|FG001|Part A|Lost to Follow-up|1|||
131842752|NCT02799095|474706324|FG002|Part A|Lost to Follow-up|0|||
131842753|NCT02799095|474706325|FG003|Part A|Lost to Follow-up|0|||
131842754|NCT02799095|474706326|FG004|Part A|Lost to Follow-up|0|||
131842755|NCT02799095|474706327|FG005|Part A|Lost to Follow-up|0|||
131842756|NCT02799095|474706328|FG006|Part A|Lost to Follow-up|1|||
131842757|NCT02799095|474706329|FG007|Part A|Lost to Follow-up|0|||
131842758|NCT02799095|474706330|FG008|Part A|Lost to Follow-up|0|||
131842759|NCT02799095|474706331|FG009|Part A|Lost to Follow-up|0|||
131842760|NCT02799095|474706332|FG010|Part A|Lost to Follow-up|0|||
131842761|NCT02799095|474706333|FG011|Part A|Lost to Follow-up|0|||
131842762|NCT02799095|474706334|FG012|Part A|Lost to Follow-up|0|||
131842763|NCT02799095|474706335|FG013|Part A|Lost to Follow-up|0|||
131842764|NCT02799095|474706336|FG014|Part A|Lost to Follow-up|0|||
131842765|NCT02799095|474706337|FG015|Part A|Lost to Follow-up|0|||
131842766|NCT02799095|474706338|FG016|Part A|Lost to Follow-up|0|||
131842767|NCT02799095|474706322|FG000|Part A|Progressive Disease|3|||
131842768|NCT02799095|474706323|FG001|Part A|Progressive Disease|3|||
131842769|NCT02799095|474706324|FG002|Part A|Progressive Disease|3|||
131842770|NCT02799095|474706325|FG003|Part A|Progressive Disease|2|||
131842771|NCT02799095|474706326|FG004|Part A|Progressive Disease|2|||
131842772|NCT02799095|474706327|FG005|Part A|Progressive Disease|0|||
131842773|NCT02799095|474706328|FG006|Part A|Progressive Disease|0|||
131842774|NCT02799095|474706329|FG007|Part A|Progressive Disease|0|||
131842775|NCT02799095|474706330|FG008|Part A|Progressive Disease|0|||
131842776|NCT02799095|474706331|FG009|Part A|Progressive Disease|0|||
131842777|NCT02799095|474706332|FG010|Part A|Progressive Disease|0|||
131842778|NCT02799095|474706333|FG011|Part A|Progressive Disease|0|||
131842779|NCT02799095|474706334|FG012|Part A|Progressive Disease|0|||
131842780|NCT02799095|474706335|FG013|Part A|Progressive Disease|0|||
131842781|NCT02799095|474706336|FG014|Part A|Progressive Disease|0|||
131842782|NCT02799095|474706337|FG015|Part A|Progressive Disease|0|||
131842783|NCT02799095|474706338|FG016|Part A|Progressive Disease|0|||
131842784|NCT02799095|474706322|FG000|Part A|Clinical Progression|1|||
131842785|NCT02799095|474706323|FG001|Part A|Clinical Progression|0|||
131842786|NCT02799095|474706324|FG002|Part A|Clinical Progression|2|||
131842787|NCT02799095|474706325|FG003|Part A|Clinical Progression|1|||
131842788|NCT02799095|474706326|FG004|Part A|Clinical Progression|5|||
131842789|NCT02799095|474706327|FG005|Part A|Clinical Progression|0|||
131842790|NCT02799095|474706328|FG006|Part A|Clinical Progression|0|||
131842791|NCT02799095|474706329|FG007|Part A|Clinical Progression|0|||
131842792|NCT02799095|474706330|FG008|Part A|Clinical Progression|0|||
131842793|NCT02799095|474706331|FG009|Part A|Clinical Progression|0|||
131842794|NCT02799095|474706332|FG010|Part A|Clinical Progression|0|||
131842795|NCT02799095|474706333|FG011|Part A|Clinical Progression|0|||
131842796|NCT02799095|474706334|FG012|Part A|Clinical Progression|0|||
131842797|NCT02799095|474706335|FG013|Part A|Clinical Progression|0|||
131842798|NCT02799095|474706336|FG014|Part A|Clinical Progression|0|||
131842799|NCT02799095|474706337|FG015|Part A|Clinical Progression|0|||
131842800|NCT02799095|474706338|FG016|Part A|Clinical Progression|0|||
131842801|NCT02799095|474706322|FG000|Part A|Protocol Deviation|0|||
131842802|NCT02799095|474706323|FG001|Part A|Protocol Deviation|0|||
131842803|NCT02799095|474706324|FG002|Part A|Protocol Deviation|1|||
131842804|NCT02799095|474706325|FG003|Part A|Protocol Deviation|0|||
131842805|NCT02799095|474706326|FG004|Part A|Protocol Deviation|0|||
131842806|NCT02799095|474706327|FG005|Part A|Protocol Deviation|0|||
131842807|NCT02799095|474706328|FG006|Part A|Protocol Deviation|0|||
131842808|NCT02799095|474706329|FG007|Part A|Protocol Deviation|0|||
131842809|NCT02799095|474706330|FG008|Part A|Protocol Deviation|0|||
131842810|NCT02799095|474706331|FG009|Part A|Protocol Deviation|0|||
131842811|NCT02799095|474706332|FG010|Part A|Protocol Deviation|0|||
131842812|NCT02799095|474706333|FG011|Part A|Protocol Deviation|0|||
131842813|NCT02799095|474706334|FG012|Part A|Protocol Deviation|0|||
131842814|NCT02799095|474706335|FG013|Part A|Protocol Deviation|0|||
131842815|NCT02799095|474706336|FG014|Part A|Protocol Deviation|0|||
131842816|NCT02799095|474706337|FG015|Part A|Protocol Deviation|0|||
131842817|NCT02799095|474706338|FG016|Part A|Protocol Deviation|0|||
131842818|NCT02799095|474706322|FG000|Part A|Withdrawal by Subject|0|||
131842819|NCT02799095|474706323|FG001|Part A|Withdrawal by Subject|0|||
131842820|NCT02799095|474706324|FG002|Part A|Withdrawal by Subject|0|||
131842821|NCT02799095|474706325|FG003|Part A|Withdrawal by Subject|1|||
131842822|NCT02799095|474706326|FG004|Part A|Withdrawal by Subject|3|||
131842823|NCT02799095|474706327|FG005|Part A|Withdrawal by Subject|1|||
131842824|NCT02799095|474706328|FG006|Part A|Withdrawal by Subject|1|||
131842825|NCT02799095|474706329|FG007|Part A|Withdrawal by Subject|0|||
131842826|NCT02799095|474706330|FG008|Part A|Withdrawal by Subject|0|||
131842827|NCT02799095|474706331|FG009|Part A|Withdrawal by Subject|0|||
131842828|NCT02799095|474706332|FG010|Part A|Withdrawal by Subject|0|||
131842829|NCT02799095|474706333|FG011|Part A|Withdrawal by Subject|0|||
131842830|NCT02799095|474706334|FG012|Part A|Withdrawal by Subject|0|||
131842831|NCT02799095|474706335|FG013|Part A|Withdrawal by Subject|0|||
131842832|NCT02799095|474706336|FG014|Part A|Withdrawal by Subject|0|||
131842833|NCT02799095|474706337|FG015|Part A|Withdrawal by Subject|0|||
131842834|NCT02799095|474706338|FG016|Part A|Withdrawal by Subject|0|||
131842835|NCT02799095|474706322|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
131842836|NCT02799095|474706323|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
131842837|NCT02799095|474706324|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
131842838|NCT02799095|474706325|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
131842839|NCT02799095|474706326|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
131842840|NCT02799095|474706327|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
131842841|NCT02799095|474706328|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
131842842|NCT02799095|474706329|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
131842843|NCT02799095|474706330|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
131842844|NCT02799095|474706331|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
131842845|NCT02799095|474706332|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
131842846|NCT02799095|474706333|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
131842847|NCT02799095|474706334|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
131842848|NCT02799095|474706335|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
131842849|NCT02799095|474706336|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
131842850|NCT02799095|474706337|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
131842851|NCT02799095|474706338|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
131402882|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
131402883|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
131842852|NCT02799095|474706322|FG000|Part B|Death|0|||
131842853|NCT02799095|474706323|FG001|Part B|Death|0|||
131842854|NCT02799095|474706324|FG002|Part B|Death|0|||
131842855|NCT02799095|474706325|FG003|Part B|Death|0|||
131842856|NCT02799095|474706326|FG004|Part B|Death|0|||
131402884|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Physician Decision|9|||
131842857|NCT02799095|474706327|FG005|Part B|Death|0|||
131842858|NCT02799095|474706328|FG006|Part B|Death|0|||
131842859|NCT02799095|474706329|FG007|Part B|Death|7|||
131842860|NCT02799095|474706330|FG008|Part B|Death|7|||
131842861|NCT02799095|474706331|FG009|Part B|Death|0|||
131450273|NCT04988477|473276850|FG000|Overall Study|Death|1|||
131450274|NCT04988477|473276851|FG001|Overall Study|Death|0|||
131842862|NCT02799095|474706332|FG010|Part B|Death|0|||
131842863|NCT02799095|474706333|FG011|Part B|Death|0|||
131842864|NCT02799095|474706334|FG012|Part B|Death|0|||
131842865|NCT02799095|474706335|FG013|Part B|Death|0|||
131842866|NCT02799095|474706336|FG014|Part B|Death|0|||
131842867|NCT02799095|474706337|FG015|Part B|Death|0|||
131842868|NCT02799095|474706338|FG016|Part B|Death|0|||
131842869|NCT02799095|474706322|FG000|Part B|Progressive Disease|0|||
131842870|NCT02799095|474706323|FG001|Part B|Progressive Disease|0|||
131842871|NCT02799095|474706324|FG002|Part B|Progressive Disease|0|||
131842872|NCT02799095|474706325|FG003|Part B|Progressive Disease|0|||
131842873|NCT02799095|474706326|FG004|Part B|Progressive Disease|0|||
131842874|NCT02799095|474706327|FG005|Part B|Progressive Disease|0|||
131842875|NCT02799095|474706328|FG006|Part B|Progressive Disease|0|||
131842876|NCT02799095|474706329|FG007|Part B|Progressive Disease|1|||
131842877|NCT02799095|474706330|FG008|Part B|Progressive Disease|0|||
131842878|NCT02799095|474706331|FG009|Part B|Progressive Disease|0|||
131842879|NCT02799095|474706332|FG010|Part B|Progressive Disease|0|||
131842880|NCT02799095|474706333|FG011|Part B|Progressive Disease|0|||
131842881|NCT02799095|474706334|FG012|Part B|Progressive Disease|0|||
131842882|NCT02799095|474706335|FG013|Part B|Progressive Disease|0|||
131842883|NCT02799095|474706336|FG014|Part B|Progressive Disease|0|||
131842884|NCT02799095|474706337|FG015|Part B|Progressive Disease|0|||
131842885|NCT02799095|474706338|FG016|Part B|Progressive Disease|0|||
131842886|NCT02799095|474706322|FG000|Part B|Withdrawal by Subject|0|||
131842887|NCT02799095|474706323|FG001|Part B|Withdrawal by Subject|0|||
131842888|NCT02799095|474706324|FG002|Part B|Withdrawal by Subject|0|||
131842889|NCT02799095|474706325|FG003|Part B|Withdrawal by Subject|0|||
131842890|NCT02799095|474706326|FG004|Part B|Withdrawal by Subject|0|||
131842891|NCT02799095|474706327|FG005|Part B|Withdrawal by Subject|0|||
131842892|NCT02799095|474706328|FG006|Part B|Withdrawal by Subject|0|||
131842893|NCT02799095|474706329|FG007|Part B|Withdrawal by Subject|10|||
131842894|NCT02799095|474706330|FG008|Part B|Withdrawal by Subject|7|||
131842895|NCT02799095|474706331|FG009|Part B|Withdrawal by Subject|0|||
131842896|NCT02799095|474706332|FG010|Part B|Withdrawal by Subject|0|||
131842897|NCT02799095|474706333|FG011|Part B|Withdrawal by Subject|0|||
131842898|NCT02799095|474706334|FG012|Part B|Withdrawal by Subject|0|||
131842899|NCT02799095|474706335|FG013|Part B|Withdrawal by Subject|0|||
131842900|NCT02799095|474706336|FG014|Part B|Withdrawal by Subject|0|||
131842901|NCT02799095|474706337|FG015|Part B|Withdrawal by Subject|0|||
131842902|NCT02799095|474706338|FG016|Part B|Withdrawal by Subject|0|||
131842903|NCT02799095|474706322|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
131842904|NCT02799095|474706323|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
131842905|NCT02799095|474706324|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
131842906|NCT02799095|474706325|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
131842907|NCT02799095|474706326|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
131842908|NCT02799095|474706327|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
131842909|NCT02799095|474706328|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
131842910|NCT02799095|474706329|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
131842911|NCT02799095|474706330|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
131842912|NCT02799095|474706331|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
131842913|NCT02799095|474706332|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
131842914|NCT02799095|474706333|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
131842915|NCT02799095|474706334|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
131842916|NCT02799095|474706335|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
131842917|NCT02799095|474706336|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
131842918|NCT02799095|474706337|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
131842919|NCT02799095|474706338|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
131842920|NCT02799095|474706322|FG000|Part C|Adverse Event|0|||
131842921|NCT02799095|474706323|FG001|Part C|Adverse Event|0|||
131842922|NCT02799095|474706324|FG002|Part C|Adverse Event|0|||
131842923|NCT02799095|474706325|FG003|Part C|Adverse Event|0|||
131842924|NCT02799095|474706326|FG004|Part C|Adverse Event|0|||
131842925|NCT02799095|474706327|FG005|Part C|Adverse Event|0|||
131910825|NCT04711005|474960871|FG007|Overall Study|Withdrawal by Subject|1|||
131450275|NCT04988477|473276852|FG002|Overall Study|Death|0|||
131450276|NCT04988477|473276850|FG000|Overall Study|Lost to Follow-up|5|||
131842926|NCT02799095|474706328|FG006|Part C|Adverse Event|0|||
131842927|NCT02799095|474706329|FG007|Part C|Adverse Event|0|||
131842928|NCT02799095|474706330|FG008|Part C|Adverse Event|0|||
131842929|NCT02799095|474706331|FG009|Part C|Adverse Event|0|||
131842930|NCT02799095|474706332|FG010|Part C|Adverse Event|3|||
131842931|NCT02799095|474706333|FG011|Part C|Adverse Event|1|||
131842932|NCT02799095|474706334|FG012|Part C|Adverse Event|0|||
131842933|NCT02799095|474706335|FG013|Part C|Adverse Event|1|||
131842934|NCT02799095|474706336|FG014|Part C|Adverse Event|0|||
131842935|NCT02799095|474706337|FG015|Part C|Adverse Event|0|||
131842936|NCT02799095|474706338|FG016|Part C|Adverse Event|0|||
131842937|NCT02799095|474706322|FG000|Part C|Death|0|||
131842938|NCT02799095|474706323|FG001|Part C|Death|0|||
131842939|NCT02799095|474706324|FG002|Part C|Death|0|||
131402885|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Physician Decision|0|||
131402886|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Physician Decision|0|||
131402887|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
131402888|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
131402889|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
131842940|NCT02799095|474706325|FG003|Part C|Death|0|||
131842941|NCT02799095|474706326|FG004|Part C|Death|0|||
131842942|NCT02799095|474706327|FG005|Part C|Death|0|||
131842943|NCT02799095|474706328|FG006|Part C|Death|0|||
131842944|NCT02799095|474706329|FG007|Part C|Death|0|||
131842945|NCT02799095|474706330|FG008|Part C|Death|0|||
131842946|NCT02799095|474706331|FG009|Part C|Death|0|||
131842947|NCT02799095|474706332|FG010|Part C|Death|7|||
131842948|NCT02799095|474706333|FG011|Part C|Death|5|||
131842949|NCT02799095|474706334|FG012|Part C|Death|6|||
131842950|NCT02799095|474706335|FG013|Part C|Death|8|||
131842951|NCT02799095|474706336|FG014|Part C|Death|1|||
131842952|NCT02799095|474706337|FG015|Part C|Death|8|||
131842953|NCT02799095|474706338|FG016|Part C|Death|1|||
131842954|NCT02799095|474706322|FG000|Part C|Lost to Follow-up|0|||
131842955|NCT02799095|474706323|FG001|Part C|Lost to Follow-up|0|||
131842956|NCT02799095|474706324|FG002|Part C|Lost to Follow-up|0|||
131842957|NCT02799095|474706325|FG003|Part C|Lost to Follow-up|0|||
131842958|NCT02799095|474706326|FG004|Part C|Lost to Follow-up|0|||
131842959|NCT02799095|474706327|FG005|Part C|Lost to Follow-up|0|||
131842960|NCT02799095|474706328|FG006|Part C|Lost to Follow-up|0|||
131842961|NCT02799095|474706329|FG007|Part C|Lost to Follow-up|0|||
131842962|NCT02799095|474706330|FG008|Part C|Lost to Follow-up|0|||
131842963|NCT02799095|474706331|FG009|Part C|Lost to Follow-up|0|||
131842964|NCT02799095|474706332|FG010|Part C|Lost to Follow-up|1|||
131842965|NCT02799095|474706333|FG011|Part C|Lost to Follow-up|1|||
131842966|NCT02799095|474706334|FG012|Part C|Lost to Follow-up|1|||
131842967|NCT02799095|474706335|FG013|Part C|Lost to Follow-up|3|||
131842968|NCT02799095|474706336|FG014|Part C|Lost to Follow-up|0|||
131842969|NCT02799095|474706337|FG015|Part C|Lost to Follow-up|0|||
131842970|NCT02799095|474706338|FG016|Part C|Lost to Follow-up|0|||
131842971|NCT02799095|474706322|FG000|Part C|Progressive Disease|0|||
131842972|NCT02799095|474706323|FG001|Part C|Progressive Disease|0|||
131842973|NCT02799095|474706324|FG002|Part C|Progressive Disease|0|||
131842974|NCT02799095|474706325|FG003|Part C|Progressive Disease|0|||
131842975|NCT02799095|474706326|FG004|Part C|Progressive Disease|0|||
131842976|NCT02799095|474706327|FG005|Part C|Progressive Disease|0|||
131842977|NCT02799095|474706328|FG006|Part C|Progressive Disease|0|||
131842978|NCT02799095|474706329|FG007|Part C|Progressive Disease|0|||
131842979|NCT02799095|474706330|FG008|Part C|Progressive Disease|0|||
131842980|NCT02799095|474706331|FG009|Part C|Progressive Disease|2|||
131842981|NCT02799095|474706332|FG010|Part C|Progressive Disease|13|||
131842982|NCT02799095|474706333|FG011|Part C|Progressive Disease|2|||
131842983|NCT02799095|474706334|FG012|Part C|Progressive Disease|0|||
131842984|NCT02799095|474706335|FG013|Part C|Progressive Disease|1|||
131842985|NCT02799095|474706336|FG014|Part C|Progressive Disease|0|||
131842986|NCT02799095|474706337|FG015|Part C|Progressive Disease|0|||
131842987|NCT02799095|474706338|FG016|Part C|Progressive Disease|0|||
131842988|NCT02799095|474706322|FG000|Part C|Clinical Progression|0|||
131842989|NCT02799095|474706323|FG001|Part C|Clinical Progression|0|||
131842990|NCT02799095|474706324|FG002|Part C|Clinical Progression|0|||
131842991|NCT02799095|474706325|FG003|Part C|Clinical Progression|0|||
131842992|NCT02799095|474706326|FG004|Part C|Clinical Progression|0|||
131842993|NCT02799095|474706327|FG005|Part C|Clinical Progression|0|||
131842994|NCT02799095|474706328|FG006|Part C|Clinical Progression|0|||
131842995|NCT02799095|474706329|FG007|Part C|Clinical Progression|0|||
131402890|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Disease progression|45|||
131842996|NCT02799095|474706330|FG008|Part C|Clinical Progression|0|||
131842997|NCT02799095|474706331|FG009|Part C|Clinical Progression|1|||
131842998|NCT02799095|474706332|FG010|Part C|Clinical Progression|3|||
131842999|NCT02799095|474706333|FG011|Part C|Clinical Progression|0|||
131843000|NCT02799095|474706334|FG012|Part C|Clinical Progression|0|||
131843001|NCT02799095|474706335|FG013|Part C|Clinical Progression|1|||
131843002|NCT02799095|474706336|FG014|Part C|Clinical Progression|0|||
131843003|NCT02799095|474706337|FG015|Part C|Clinical Progression|0|||
131843004|NCT02799095|474706338|FG016|Part C|Clinical Progression|0|||
131843005|NCT02799095|474706322|FG000|Part C|Withdrawal by Subject|0|||
131402891|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Disease progression|0|||
131450277|NCT04988477|473276851|FG001|Overall Study|Lost to Follow-up|2|||
131843006|NCT02799095|474706323|FG001|Part C|Withdrawal by Subject|0|||
131843007|NCT02799095|474706324|FG002|Part C|Withdrawal by Subject|0|||
131843008|NCT02799095|474706325|FG003|Part C|Withdrawal by Subject|0|||
131843009|NCT02799095|474706326|FG004|Part C|Withdrawal by Subject|0|||
131843010|NCT02799095|474706327|FG005|Part C|Withdrawal by Subject|0|||
131843011|NCT02799095|474706328|FG006|Part C|Withdrawal by Subject|0|||
131843012|NCT02799095|474706329|FG007|Part C|Withdrawal by Subject|0|||
131843013|NCT02799095|474706330|FG008|Part C|Withdrawal by Subject|0|||
131843014|NCT02799095|474706331|FG009|Part C|Withdrawal by Subject|0|||
131843015|NCT02799095|474706332|FG010|Part C|Withdrawal by Subject|13|||
131450278|NCT04988477|473276852|FG002|Overall Study|Lost to Follow-up|0|||
131450279|NCT04988477|473276850|FG000|Overall Study|Withdrawal by Subject|2|||
131450280|NCT04988477|473276851|FG001|Overall Study|Withdrawal by Subject|0|||
131450281|NCT04988477|473276852|FG002|Overall Study|Withdrawal by Subject|0|||
131843016|NCT02799095|474706333|FG011|Part C|Withdrawal by Subject|15|||
131843017|NCT02799095|474706334|FG012|Part C|Withdrawal by Subject|13|||
131450282|NCT04040933|473278131|FG000|Overall Study|Protocol Violation|1|||
131843018|NCT02799095|474706335|FG013|Part C|Withdrawal by Subject|21|||
131843019|NCT02799095|474706336|FG014|Part C|Withdrawal by Subject|0|||
131843020|NCT02799095|474706337|FG015|Part C|Withdrawal by Subject|12|||
131843021|NCT02799095|474706338|FG016|Part C|Withdrawal by Subject|1|||
131843022|NCT02799095|474706322|FG000|Part C|Physician Decision|0|||
131843023|NCT02799095|474706323|FG001|Part C|Physician Decision|0|||
131843024|NCT02799095|474706324|FG002|Part C|Physician Decision|0|||
131843025|NCT02799095|474706325|FG003|Part C|Physician Decision|0|||
131843026|NCT02799095|474706326|FG004|Part C|Physician Decision|0|||
131843027|NCT02799095|474706327|FG005|Part C|Physician Decision|0|||
131843028|NCT02799095|474706328|FG006|Part C|Physician Decision|0|||
131843029|NCT02799095|474706329|FG007|Part C|Physician Decision|0|||
131843030|NCT02799095|474706330|FG008|Part C|Physician Decision|0|||
131843031|NCT02799095|474706331|FG009|Part C|Physician Decision|0|||
131843032|NCT02799095|474706332|FG010|Part C|Physician Decision|1|||
131843033|NCT02799095|474706333|FG011|Part C|Physician Decision|0|||
131843034|NCT02799095|474706334|FG012|Part C|Physician Decision|0|||
131843035|NCT02799095|474706335|FG013|Part C|Physician Decision|0|||
131843036|NCT02799095|474706336|FG014|Part C|Physician Decision|0|||
131843037|NCT02799095|474706337|FG015|Part C|Physician Decision|0|||
131843038|NCT02799095|474706338|FG016|Part C|Physician Decision|0|||
131843039|NCT02799095|474706322|FG000|Part C|Other|0|||
131843040|NCT02799095|474706323|FG001|Part C|Other|0|||
131843041|NCT02799095|474706324|FG002|Part C|Other|0|||
131843042|NCT02799095|474706325|FG003|Part C|Other|0|||
131843043|NCT02799095|474706326|FG004|Part C|Other|0|||
131843044|NCT02799095|474706327|FG005|Part C|Other|0|||
131843045|NCT02799095|474706328|FG006|Part C|Other|0|||
131843046|NCT02799095|474706329|FG007|Part C|Other|0|||
131843047|NCT02799095|474706330|FG008|Part C|Other|0|||
131843048|NCT02799095|474706331|FG009|Part C|Other|0|||
131843049|NCT02799095|474706332|FG010|Part C|Other|0|||
131843050|NCT02799095|474706333|FG011|Part C|Other|2|||
131843051|NCT02799095|474706334|FG012|Part C|Other|2|||
131843052|NCT02799095|474706335|FG013|Part C|Other|0|||
131843053|NCT02799095|474706336|FG014|Part C|Other|0|||
131843054|NCT02799095|474706337|FG015|Part C|Other|0|||
131843055|NCT02799095|474706338|FG016|Part C|Other|0|||
131843056|NCT04994483|474706342|FG000|Overall Study|Adverse Event|26|||
131843057|NCT04994483|474706343|FG001|Overall Study|Adverse Event|17|||
131843058|NCT04994483|474706342|FG000|Overall Study|Lost to Follow-up|6|||
131843059|NCT04994483|474706343|FG001|Overall Study|Lost to Follow-up|10|||
131843060|NCT04994483|474706342|FG000|Overall Study|Noncompliance with study drug|8|||
131843061|NCT04994483|474706343|FG001|Overall Study|Noncompliance with study drug|5|||
131843062|NCT04994483|474706342|FG000|Overall Study|Physician Decision|5|||
131843063|NCT04994483|474706343|FG001|Overall Study|Physician Decision|0|||
131843064|NCT04994483|474706342|FG000|Overall Study|Withdrawal by Subject|41|||
131843065|NCT04994483|474706343|FG001|Overall Study|Withdrawal by Subject|38|||
131843066|NCT04994483|474706342|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
131843067|NCT04994483|474706343|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
131843068|NCT04994483|474706342|FG000|Overall Study|Met stopping criteria|1|||
131450283|NCT04040933|473278131|FG000|Overall Study|Withdrawal by Subject|2|||
131450284|NCT01354899|473278132|FG000|Overall Study|discharge from the hospital|2|||
131843069|NCT04994483|474706343|FG001|Overall Study|Met stopping criteria|0|||
131843070|NCT04994483|474706342|FG000|Overall Study|Randomized in error, not treated|4|||
131843071|NCT04994483|474706343|FG001|Overall Study|Randomized in error, not treated|3|||
131843072|NCT04994483|474706342|FG000|Overall Study|Lack of a reliable study partner|0|||
131843073|NCT04994483|474706343|FG001|Overall Study|Lack of a reliable study partner|1|||
131843074|NCT04994483|474706342|FG000|Overall Study|Met MRI exclusion criteria|0|||
131843075|NCT04994483|474706343|FG001|Overall Study|Met MRI exclusion criteria|1|||
131843076|NCT00792935|474706344|FG000|Overall Study|Adverse Event|2|||
131843077|NCT00792935|474706345|FG001|Overall Study|Adverse Event|1|||
131843078|NCT00792935|474706344|FG000|Overall Study|Lost to Follow-up|0|||
131450285|NCT01354899|473278132|FG000|Overall Study|Protocol Violation|1|||
131843079|NCT00792935|474706345|FG001|Overall Study|Lost to Follow-up|1|||
131843080|NCT00792935|474706344|FG000|Overall Study|Protocol Violation|2|||
131843081|NCT00792935|474706345|FG001|Overall Study|Protocol Violation|0|||
131843082|NCT00792935|474706344|FG000|Overall Study|Withdrawal by Subject|0|||
131843083|NCT00792935|474706345|FG001|Overall Study|Withdrawal by Subject|1|||
131843084|NCT03186781|474706346|FG000|Overall Study|Lost to Follow-up|0|||
131843085|NCT03186781|474706347|FG001|Overall Study|Lost to Follow-up|0|||
131843086|NCT03186781|474706348|FG002|Overall Study|Lost to Follow-up|1|||
131843087|NCT03186781|474706349|FG003|Overall Study|Lost to Follow-up|0|||
131843088|NCT03186781|474706350|FG004|Overall Study|Lost to Follow-up|1|||
131843089|NCT03186781|474706351|FG005|Overall Study|Lost to Follow-up|0|||
131843090|NCT03186781|474706346|FG000|Overall Study|Moved from Area|0|||
131843091|NCT03186781|474706347|FG001|Overall Study|Moved from Area|0|||
131843092|NCT03186781|474706348|FG002|Overall Study|Moved from Area|0|||
131843093|NCT03186781|474706349|FG003|Overall Study|Moved from Area|0|||
131843094|NCT03186781|474706350|FG004|Overall Study|Moved from Area|1|||
131843095|NCT03186781|474706351|FG005|Overall Study|Moved from Area|0|||
131843096|NCT03186781|474706346|FG000|Overall Study|Withdrawal by Subject|0|||
131402892|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Disease progression|0|||
131402893|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
131402894|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
131843097|NCT03186781|474706347|FG001|Overall Study|Withdrawal by Subject|0|||
131843098|NCT03186781|474706348|FG002|Overall Study|Withdrawal by Subject|0|||
131843099|NCT03186781|474706349|FG003|Overall Study|Withdrawal by Subject|0|||
131843100|NCT03186781|474706350|FG004|Overall Study|Withdrawal by Subject|1|||
131843101|NCT03186781|474706351|FG005|Overall Study|Withdrawal by Subject|0|||
131843102|NCT04663295|474706352|FG000|Run-in Period|Withdrawal by Subject|3|||
131843103|NCT04663295|474706352|FG000|Overall Study Period|Pregnancy|1|||
131843104|NCT04663295|474706352|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
131843105|NCT03665441|474706353|FG000|Overall Study|survival follow up ongoing|23|||
131843106|NCT03665441|474706354|FG001|Overall Study|survival follow up ongoing|0|||
131843107|NCT03665441|474706353|FG000|Overall Study|Patients ongoing on treatment|9|||
131843108|NCT03665441|474706354|FG001|Overall Study|Patients ongoing on treatment|6|||
131843109|NCT03665441|474706353|FG000|Overall Study|Randomized but not treated|7|||
131843110|NCT03665441|474706354|FG001|Overall Study|Randomized but not treated|11|||
131843111|NCT00191113|474706355|FG000|Core Study|Withdrawal by Subject|25|||
131843112|NCT00191113|474706356|FG001|Core Study|Withdrawal by Subject|9|||
131843113|NCT00191113|474706355|FG000|Core Study|Protocol Violation|6|||
131843114|NCT00191113|474706356|FG001|Core Study|Protocol Violation|2|||
131843115|NCT00191113|474706355|FG000|Core Study|Lost to Follow-up|3|||
131843116|NCT00191113|474706356|FG001|Core Study|Lost to Follow-up|0|||
131843117|NCT00191113|474706355|FG000|Core Study|Adverse Event|0|||
131843118|NCT00191113|474706356|FG001|Core Study|Adverse Event|2|||
131843119|NCT00191113|474706355|FG000|Core Study|Lack of Efficacy|0|||
131843120|NCT00191113|474706356|FG001|Core Study|Lack of Efficacy|2|||
131843121|NCT00191113|474706355|FG000|Core Study|Death|1|||
131843122|NCT00191113|474706356|FG001|Core Study|Death|0|||
131843123|NCT03954834|474706357|FG000|Overall Study|Adverse Event|1|||
131843124|NCT03954834|474706358|FG001|Overall Study|Adverse Event|3|||
131843125|NCT03954834|474706359|FG002|Overall Study|Adverse Event|1|||
131843126|NCT03954834|474706360|FG003|Overall Study|Adverse Event|1|||
131843127|NCT03954834|474706357|FG000|Overall Study|Death|0|||
131843128|NCT03954834|474706358|FG001|Overall Study|Death|0|||
131843129|NCT03954834|474706359|FG002|Overall Study|Death|0|||
131843130|NCT03954834|474706360|FG003|Overall Study|Death|1|||
131843131|NCT03954834|474706357|FG000|Overall Study|Physician Decision|0|||
131843132|NCT03954834|474706358|FG001|Overall Study|Physician Decision|1|||
131843133|NCT03954834|474706359|FG002|Overall Study|Physician Decision|0|||
131843134|NCT03954834|474706360|FG003|Overall Study|Physician Decision|2|||
131843135|NCT03954834|474706357|FG000|Overall Study|Protocol Violation|1|||
131843136|NCT03954834|474706358|FG001|Overall Study|Protocol Violation|0|||
131843137|NCT03954834|474706359|FG002|Overall Study|Protocol Violation|0|||
131843138|NCT03954834|474706360|FG003|Overall Study|Protocol Violation|1|||
131843139|NCT03954834|474706357|FG000|Overall Study|Withdrawal by Subject|2|||
131843140|NCT03954834|474706358|FG001|Overall Study|Withdrawal by Subject|3|||
131843141|NCT03954834|474706359|FG002|Overall Study|Withdrawal by Subject|13|||
131843142|NCT03954834|474706360|FG003|Overall Study|Withdrawal by Subject|6|||
131843143|NCT03954834|474706357|FG000|Overall Study|Participant left the country|0|||
131843144|NCT03954834|474706358|FG001|Overall Study|Participant left the country|0|||
131843145|NCT03954834|474706359|FG002|Overall Study|Participant left the country|1|||
131843146|NCT03954834|474706360|FG003|Overall Study|Participant left the country|0|||
131843147|NCT03954834|474706357|FG000|Overall Study|Lost to Follow-up|3|||
131402895|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
131843148|NCT03954834|474706358|FG001|Overall Study|Lost to Follow-up|2|||
131843149|NCT03954834|474706359|FG002|Overall Study|Lost to Follow-up|3|||
131843150|NCT03954834|474706360|FG003|Overall Study|Lost to Follow-up|5|||
131843151|NCT03047330|474706366|FG000|Sleep Block 1|Withdrawal by Subject|3|||
131843152|NCT00663026|474706370|FG000|Overall Study|Lost to Follow-up|1|||
131843153|NCT00663026|474706371|FG001|Overall Study|Lost to Follow-up|0|||
131843154|NCT00663026|474706372|FG002|Overall Study|Lost to Follow-up|0|||
131843155|NCT00663026|474706370|FG000|Overall Study|Other|1|||
131843156|NCT00663026|474706371|FG001|Overall Study|Other|2|||
131843157|NCT00663026|474706372|FG002|Overall Study|Other|0|||
131843158|NCT00663026|474706370|FG000|Overall Study|Adverse Event|0|||
131843159|NCT00663026|474706371|FG001|Overall Study|Adverse Event|2|||
131843160|NCT00663026|474706372|FG002|Overall Study|Adverse Event|3|||
131843161|NCT00663026|474706370|FG000|Overall Study|Caregiver Request|0|||
131843162|NCT00663026|474706371|FG001|Overall Study|Caregiver Request|2|||
131843163|NCT00663026|474706372|FG002|Overall Study|Caregiver Request|0|||
131843164|NCT00663026|474706370|FG000|Overall Study|Withdrawal by Subject|0|||
131402896|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
131402897|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
131402898|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
131402899|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
131402900|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
131402901|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
131402902|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
131402903|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
131402904|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
131402905|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
131402906|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
131450286|NCT01376804|473278133|FG000|Treatment Period|Withdrawal by Subject|1|||
131450287|NCT01376804|473278133|FG000|Treatment Period|Adverse Event|6|||
131450288|NCT01376804|473278133|FG000|Treatment Period|Patient did not receive study drug|1|||
131450289|NCT01071798|473278134|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
131450290|NCT01071798|473278134|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
131450291|NCT01071798|473278134|FG000|Participants Who Received One Cycle|Patient requirement|20|||
131450292|NCT01071798|473278134|FG000|Participants Who Received One Cycle|Death|5|||
131450293|NCT01071798|473278134|FG000|Participants Who Received One Cycle|Change of therapy|6|||
131450294|NCT01071798|473278134|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
131450295|NCT01071798|473278134|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
131450296|NCT01071798|473278134|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
131450297|NCT01071798|473278134|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
131450298|NCT01071798|473278134|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
131450299|NCT00641667|473278135|FG000|Overall Study|Withdrawal by Subject|1|||
131450300|NCT00641667|473278135|FG000|Overall Study|Adverse Event|1|||
131450301|NCT00641667|473278135|FG000|Overall Study|Physician Decision|1|||
131450302|NCT00641667|473278135|FG000|Overall Study|Worsening of underlying disease|3|||
131450303|NCT00904033|473278140|FG000|Overall Study|Withdrawal by Subject|1|||
131450304|NCT00904033|473278141|FG001|Overall Study|Withdrawal by Subject|1|||
131450305|NCT00904033|473278142|FG002|Overall Study|Withdrawal by Subject|0|||
131450306|NCT00904033|473278143|FG003|Overall Study|Withdrawal by Subject|0|||
131450307|NCT00904033|473278140|FG000|Overall Study|Physician Decision|0|||
131450308|NCT00904033|473278141|FG001|Overall Study|Physician Decision|0|||
131450309|NCT00904033|473278142|FG002|Overall Study|Physician Decision|1|||
131843165|NCT00663026|474706371|FG001|Overall Study|Withdrawal by Subject|0|||
131843166|NCT00663026|474706372|FG002|Overall Study|Withdrawal by Subject|1|||
131843167|NCT01570686|474706373|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131843168|NCT01570686|474706374|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131843169|NCT01570686|474706373|FG000|Overall Study|Administrative problems|0|||
131843170|NCT01570686|474706374|FG001|Overall Study|Administrative problems|1|||
131843171|NCT01570686|474706373|FG000|Overall Study|Adverse Event|8|||
131450310|NCT00904033|473278143|FG003|Overall Study|Physician Decision|0|||
131843172|NCT01570686|474706374|FG001|Overall Study|Adverse Event|6|||
131843173|NCT01570686|474706373|FG000|Overall Study|Lost to Follow-up|4|||
131843174|NCT01570686|474706374|FG001|Overall Study|Lost to Follow-up|3|||
131843175|NCT01570686|474706373|FG000|Overall Study|Protocol Deviation|3|||
131843176|NCT01570686|474706374|FG001|Overall Study|Protocol Deviation|0|||
131843177|NCT01570686|474706373|FG000|Overall Study|Withdrawal by Subject|4|||
131843178|NCT01570686|474706374|FG001|Overall Study|Withdrawal by Subject|4|||
131843179|NCT01570686|474706373|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131843180|NCT01570686|474706374|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131843181|NCT00806286|474706375|FG000|Overall Study|Adverse Event|5|||
131843182|NCT00806286|474706376|FG001|Overall Study|Adverse Event|2|||
131843183|NCT00806286|474706377|FG002|Overall Study|Adverse Event|0|||
131843184|NCT00806286|474706375|FG000|Overall Study|Disease progression|31|||
131843185|NCT00806286|474706376|FG001|Overall Study|Disease progression|38|||
131843186|NCT00806286|474706377|FG002|Overall Study|Disease progression|1|||
131450311|NCT00904033|473278140|FG000|Overall Study|Unable to obtain final blood draw|0|||
131450312|NCT00904033|473278141|FG001|Overall Study|Unable to obtain final blood draw|0|||
131450313|NCT00904033|473278142|FG002|Overall Study|Unable to obtain final blood draw|0|||
131450314|NCT00904033|473278143|FG003|Overall Study|Unable to obtain final blood draw|2|||
131843187|NCT00806286|474706375|FG000|Overall Study|Death|1|||
131843188|NCT00806286|474706376|FG001|Overall Study|Death|6|||
131843189|NCT00806286|474706377|FG002|Overall Study|Death|0|||
131450315|NCT01357850|473278144|FG000|Overall Study|Lost to Follow-up|1|||
131450316|NCT01357850|473278145|FG001|Overall Study|Lost to Follow-up|0|||
131450317|NCT01357850|473278146|FG002|Overall Study|Lost to Follow-up|0|||
131843190|NCT00806286|474706375|FG000|Overall Study|Lost to Follow-up|0|||
131843191|NCT00806286|474706376|FG001|Overall Study|Lost to Follow-up|1|||
131843192|NCT00806286|474706377|FG002|Overall Study|Lost to Follow-up|0|||
131843193|NCT00806286|474706375|FG000|Overall Study|Withdrawal by Subject|8|||
131843194|NCT00806286|474706376|FG001|Overall Study|Withdrawal by Subject|3|||
131843195|NCT00806286|474706377|FG002|Overall Study|Withdrawal by Subject|1|||
131843196|NCT00806286|474706375|FG000|Overall Study|Physician Decision|2|||
131843197|NCT00806286|474706376|FG001|Overall Study|Physician Decision|2|||
131843198|NCT00806286|474706377|FG002|Overall Study|Physician Decision|0|||
131843199|NCT00806286|474706375|FG000|Overall Study|Due to a variety of reasons|7|||
131843200|NCT00806286|474706376|FG001|Overall Study|Due to a variety of reasons|2|||
131843201|NCT00806286|474706377|FG002|Overall Study|Due to a variety of reasons|1|||
131843202|NCT03469336|474706378|FG000|Overall Study|Adverse Event|1|||
131843203|NCT02006693|474706381|FG000|Overall Study|No Reason Specified|6|||
131843204|NCT02006693|474706382|FG001|Overall Study|No Reason Specified|8|||
131843205|NCT02006693|474706381|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
131843206|NCT02006693|474706382|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
131843207|NCT02006693|474706381|FG000|Overall Study|XEN Implant Explantation|0|||
131843208|NCT02006693|474706382|FG001|Overall Study|XEN Implant Explantation|1|||
131843209|NCT02006693|474706381|FG000|Overall Study|Death|2|||
131843210|NCT02006693|474706382|FG001|Overall Study|Death|2|||
131843211|NCT02006693|474706381|FG000|Overall Study|Lost to Follow-up|4|||
131843212|NCT02006693|474706382|FG001|Overall Study|Lost to Follow-up|1|||
131843213|NCT02006693|474706381|FG000|Overall Study|Patient Decision|4|||
131843214|NCT02006693|474706382|FG001|Overall Study|Patient Decision|0|||
131843215|NCT01119508|474706385|FG000|Overall Study|Adverse Event|56|||
131402907|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
131402908|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
131402909|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
131402910|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
131402911|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
131402912|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
131402913|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
131402914|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
131402915|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
131402916|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
131402917|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
131402918|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
131402919|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
131402920|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Promotor request|1|||
131402921|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Promotor request|0|||
131402922|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Promotor request|0|||
131402923|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
131402924|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
131402925|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
131402926|NCT01461928|473097822|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
131402927|NCT01461928|473097823|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
131402928|NCT01461928|473097824|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
131402929|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Death|3|||
131402930|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Death|0|||
131402931|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Death|0|||
131402932|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
131402933|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
131402934|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
131402935|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
131402936|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
131402937|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
131402938|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Diseases progression|91|||
131402939|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Diseases progression|0|||
131402940|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Diseases progression|0|||
131402941|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Adverse Event|70|||
131402942|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Adverse Event|0|||
131402943|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Adverse Event|0|||
131402944|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Physician Decision|9|||
131402945|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Physician Decision|0|||
131402946|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Physician Decision|0|||
131843216|NCT01119508|474706385|FG000|Overall Study|Withdrawal by Subject|2|||
131843217|NCT01119508|474706385|FG000|Overall Study|Died before tumor response evaluation|1|||
131843218|NCT00265395|474706386|FG000|Overall Study|Adverse Event|3|||
131402947|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
131402948|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
131402949|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
131843219|NCT00265395|474706387|FG001|Overall Study|Adverse Event|6|||
131843220|NCT00265395|474706386|FG000|Overall Study|Lost to Follow-up|2|||
131843221|NCT00265395|474706387|FG001|Overall Study|Lost to Follow-up|1|||
131843222|NCT00265395|474706386|FG000|Overall Study|Withdrawal by Subject|1|||
131843223|NCT00265395|474706387|FG001|Overall Study|Withdrawal by Subject|6|||
131843224|NCT00265395|474706386|FG000|Overall Study|Protocol Violation|2|||
131843225|NCT00265395|474706387|FG001|Overall Study|Protocol Violation|2|||
131843226|NCT00265395|474706386|FG000|Overall Study|Lack of Efficacy|0|||
131843227|NCT00265395|474706387|FG001|Overall Study|Lack of Efficacy|1|||
131843228|NCT00265395|474706386|FG000|Overall Study|Administrative|0|||
131843229|NCT00265395|474706387|FG001|Overall Study|Administrative|1|||
131843230|NCT01716715|474706388|FG000|Overall Study|Never Treated|2|||
131843231|NCT01716715|474706389|FG001|Overall Study|Never Treated|4|||
131843232|NCT00626392|474706390|FG000|Run-in Period|Adverse Event|0|||
131843233|NCT00626392|474706391|FG001|Run-in Period|Adverse Event|0|||
131843234|NCT00626392|474706392|FG002|Run-in Period|Adverse Event|1|||
131843235|NCT00626392|474706393|FG003|Run-in Period|Adverse Event|0|||
131843236|NCT00626392|474706394|FG004|Run-in Period|Adverse Event|1|||
131843237|NCT00626392|474706395|FG005|Run-in Period|Adverse Event|0|||
131843238|NCT00626392|474706390|FG000|Run-in Period|Withdrawal by Subject|0|||
131843239|NCT00626392|474706391|FG001|Run-in Period|Withdrawal by Subject|1|||
131843240|NCT00626392|474706392|FG002|Run-in Period|Withdrawal by Subject|1|||
131843241|NCT00626392|474706393|FG003|Run-in Period|Withdrawal by Subject|1|||
131843242|NCT00626392|474706394|FG004|Run-in Period|Withdrawal by Subject|3|||
131843243|NCT00626392|474706395|FG005|Run-in Period|Withdrawal by Subject|1|||
131843244|NCT00626392|474706390|FG000|Run-in Period|Noncompliance|1|||
131843245|NCT00626392|474706391|FG001|Run-in Period|Noncompliance|0|||
131843246|NCT00626392|474706392|FG002|Run-in Period|Noncompliance|1|||
131843247|NCT00626392|474706393|FG003|Run-in Period|Noncompliance|0|||
131843248|NCT00626392|474706394|FG004|Run-in Period|Noncompliance|0|||
131843249|NCT00626392|474706395|FG005|Run-in Period|Noncompliance|0|||
131843250|NCT00626392|474706390|FG000|Coadministration Period|Adverse Event|3|||
131843251|NCT00626392|474706391|FG001|Coadministration Period|Adverse Event|1|||
131843252|NCT00626392|474706392|FG002|Coadministration Period|Adverse Event|7|||
131843253|NCT00626392|474706393|FG003|Coadministration Period|Adverse Event|4|||
131843254|NCT00626392|474706394|FG004|Coadministration Period|Adverse Event|3|||
131843255|NCT00626392|474706395|FG005|Coadministration Period|Adverse Event|4|||
131843256|NCT00626392|474706390|FG000|Coadministration Period|Withdrawal by Subject|1|||
131843257|NCT00626392|474706391|FG001|Coadministration Period|Withdrawal by Subject|1|||
131843258|NCT00626392|474706392|FG002|Coadministration Period|Withdrawal by Subject|0|||
131843259|NCT00626392|474706393|FG003|Coadministration Period|Withdrawal by Subject|1|||
131843260|NCT00626392|474706394|FG004|Coadministration Period|Withdrawal by Subject|0|||
131843261|NCT00626392|474706395|FG005|Coadministration Period|Withdrawal by Subject|1|||
131843262|NCT00626392|474706390|FG000|Coadministration Period|Protocol Violation|0|||
131843263|NCT00626392|474706391|FG001|Coadministration Period|Protocol Violation|1|||
131843264|NCT00626392|474706392|FG002|Coadministration Period|Protocol Violation|0|||
131843265|NCT00626392|474706393|FG003|Coadministration Period|Protocol Violation|1|||
131843266|NCT00626392|474706394|FG004|Coadministration Period|Protocol Violation|1|||
131843267|NCT00626392|474706395|FG005|Coadministration Period|Protocol Violation|0|||
131843268|NCT00626392|474706390|FG000|Coadministration Period|Other|0|||
131843269|NCT00626392|474706391|FG001|Coadministration Period|Other|2|||
131843270|NCT00626392|474706392|FG002|Coadministration Period|Other|3|||
131843271|NCT00626392|474706393|FG003|Coadministration Period|Other|1|||
131843272|NCT00626392|474706394|FG004|Coadministration Period|Other|1|||
131843273|NCT00626392|474706395|FG005|Coadministration Period|Other|1|||
131843274|NCT03327792|474706396|FG000|Overall Study|Adverse Event|4|||
131843275|NCT03327792|474706397|FG001|Overall Study|Adverse Event|0|||
131843276|NCT03327792|474706396|FG000|Overall Study|Family/Personal issues|3|||
131843277|NCT03327792|474706397|FG001|Overall Study|Family/Personal issues|2|||
131843278|NCT03327792|474706396|FG000|Overall Study|Lost to Follow-up|0|||
131843279|NCT03327792|474706397|FG001|Overall Study|Lost to Follow-up|1|||
131843280|NCT01085734|474706405|FG000|Overall Study|Adverse Event|0|||
131843281|NCT01085734|474706406|FG001|Overall Study|Adverse Event|2|||
131843282|NCT01085734|474706405|FG000|Overall Study|Death|1|||
131843283|NCT01085734|474706406|FG001|Overall Study|Death|0|||
131843284|NCT01085734|474706405|FG000|Overall Study|Lost to Follow-up|0|||
131843285|NCT01085734|474706406|FG001|Overall Study|Lost to Follow-up|1|||
131843286|NCT01085734|474706405|FG000|Overall Study|Withdrawal by Subject|0|||
131843287|NCT01085734|474706406|FG001|Overall Study|Withdrawal by Subject|1|||
131843288|NCT04562155|474706407|FG000|Overall Study|COVID-19 pandemic|0|||
131843289|NCT04562155|474706408|FG001|Overall Study|COVID-19 pandemic|0|||
131843290|NCT04562155|474706409|FG002|Overall Study|COVID-19 pandemic|0|||
131450318|NCT01357850|473278147|FG003|Overall Study|Lost to Follow-up|0|||
131843291|NCT04562155|474706410|FG003|Overall Study|COVID-19 pandemic|1|||
131843292|NCT04562155|474706407|FG000|Overall Study|Adverse Event|7|||
131843293|NCT04562155|474706408|FG001|Overall Study|Adverse Event|3|||
131843294|NCT04562155|474706409|FG002|Overall Study|Adverse Event|8|||
131843295|NCT04562155|474706410|FG003|Overall Study|Adverse Event|1|||
131843296|NCT04562155|474706407|FG000|Overall Study|Withdrawal by Subject|3|||
131843297|NCT04562155|474706408|FG001|Overall Study|Withdrawal by Subject|6|||
131843298|NCT04562155|474706409|FG002|Overall Study|Withdrawal by Subject|3|||
131843299|NCT04562155|474706410|FG003|Overall Study|Withdrawal by Subject|3|||
131843300|NCT04562155|474706407|FG000|Overall Study|Participant personal reason|1|||
131843301|NCT04562155|474706408|FG001|Overall Study|Participant personal reason|0|||
131843302|NCT04562155|474706409|FG002|Overall Study|Participant personal reason|2|||
131843303|NCT04562155|474706410|FG003|Overall Study|Participant personal reason|1|||
131843304|NCT01085201|474706411|FG000|Overall Study|Scheduling conflict|1|||
131843305|NCT01085201|474706412|FG001|Overall Study|Scheduling conflict|0|||
131843306|NCT01085201|474706413|FG002|Overall Study|Scheduling conflict|1|||
131843307|NCT01085201|474706414|FG003|Overall Study|Scheduling conflict|0|||
131843308|NCT01085201|474706415|FG004|Overall Study|Scheduling conflict|0|||
131843309|NCT01085201|474706411|FG000|Overall Study|Unknown- no study drug|2|||
131843310|NCT01085201|474706412|FG001|Overall Study|Unknown- no study drug|0|||
131843311|NCT01085201|474706413|FG002|Overall Study|Unknown- no study drug|0|||
131843312|NCT01085201|474706414|FG003|Overall Study|Unknown- no study drug|0|||
131843313|NCT01085201|474706415|FG004|Overall Study|Unknown- no study drug|0|||
131843314|NCT01085201|474706411|FG000|Overall Study|Fond ineligible after consent|0|||
131843315|NCT01085201|474706412|FG001|Overall Study|Fond ineligible after consent|1|||
131843316|NCT01085201|474706413|FG002|Overall Study|Fond ineligible after consent|1|||
131843317|NCT01085201|474706414|FG003|Overall Study|Fond ineligible after consent|0|||
131843318|NCT01085201|474706415|FG004|Overall Study|Fond ineligible after consent|0|||
131843319|NCT02643355|474706418|FG000|Overall Study|Withdrawal by Subject|1|||
131843320|NCT02643355|474706419|FG001|Overall Study|Withdrawal by Subject|3|||
131843321|NCT02643355|474706418|FG000|Overall Study|Protocol Violation|0|||
131843322|NCT02643355|474706419|FG001|Overall Study|Protocol Violation|2|||
131843323|NCT02695537|474706420|FG000|Overall Study|Adverse Event|3|||
131843324|NCT02695537|474706420|FG000|Overall Study|Lack of Efficacy|28|||
131843325|NCT02695537|474706420|FG000|Overall Study|Withdrawal by Subject|4|||
131843326|NCT02695537|474706420|FG000|Overall Study|Protocol Violation|3|||
131843327|NCT01715571|474706421|FG000|Overall Study|Lost to Follow-up|8|||
131843328|NCT04524364|474706422|FG000|Overall Study|Physician Decision|3|||
131843329|NCT04524364|474706423|FG001|Overall Study|Physician Decision|6|||
131843330|NCT04524364|474706422|FG000|Overall Study|Adverse Event|0|||
131843331|NCT04524364|474706423|FG001|Overall Study|Adverse Event|1|||
131843332|NCT04524364|474706422|FG000|Overall Study|Investigational device deficiency|0|||
131843333|NCT04524364|474706423|FG001|Overall Study|Investigational device deficiency|1|||
131843334|NCT04524364|474706422|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
131843335|NCT04524364|474706423|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
131843336|NCT04524364|474706422|FG000|Overall Study|Device unavailability|0|||
131843337|NCT04524364|474706423|FG001|Overall Study|Device unavailability|2|||
131843338|NCT04524364|474706422|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
131843339|NCT04524364|474706423|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
131843340|NCT04524364|474706422|FG000|Overall Study|Low International normalized ratio (INR)|1|||
131843341|NCT04524364|474706423|FG001|Overall Study|Low International normalized ratio (INR)|0|||
131843342|NCT04480710|474706430|FG000|Overall Study|Adverse Event|0|||
131843343|NCT04480710|474706431|FG001|Overall Study|Adverse Event|2|||
131843344|NCT04480710|474706432|FG002|Overall Study|Adverse Event|0|||
131843345|NCT04480710|474706433|FG003|Overall Study|Adverse Event|0|||
131843346|NCT04480710|474706430|FG000|Overall Study|Withdrawal by Subject|0|||
131843347|NCT04480710|474706431|FG001|Overall Study|Withdrawal by Subject|1|||
131843348|NCT04480710|474706432|FG002|Overall Study|Withdrawal by Subject|0|||
131843349|NCT04480710|474706433|FG003|Overall Study|Withdrawal by Subject|0|||
131843350|NCT04480710|474706430|FG000|Overall Study|Physician Decision|0|||
131843351|NCT04480710|474706431|FG001|Overall Study|Physician Decision|0|||
131843352|NCT04480710|474706432|FG002|Overall Study|Physician Decision|1|||
131843353|NCT04480710|474706433|FG003|Overall Study|Physician Decision|0|||
131843354|NCT03233230|474706435|FG000|Overall Study|Adverse Event|6|||
131843355|NCT03233230|474706436|FG001|Overall Study|Adverse Event|3|||
131843356|NCT03233230|474706437|FG002|Overall Study|Adverse Event|6|||
131843357|NCT03233230|474706438|FG003|Overall Study|Adverse Event|3|||
131843358|NCT03233230|474706435|FG000|Overall Study|Protocol Violation|1|||
131843359|NCT03233230|474706436|FG001|Overall Study|Protocol Violation|2|||
131843360|NCT03233230|474706437|FG002|Overall Study|Protocol Violation|1|||
131843361|NCT03233230|474706438|FG003|Overall Study|Protocol Violation|1|||
131843362|NCT03233230|474706435|FG000|Overall Study|Lack of Efficacy|1|||
131402950|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
131402951|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
131843363|NCT03233230|474706436|FG001|Overall Study|Lack of Efficacy|0|||
131843364|NCT03233230|474706437|FG002|Overall Study|Lack of Efficacy|0|||
131843365|NCT03233230|474706438|FG003|Overall Study|Lack of Efficacy|0|||
131843366|NCT03233230|474706435|FG000|Overall Study|Other|5|||
131843367|NCT03233230|474706436|FG001|Overall Study|Other|5|||
131843368|NCT03233230|474706437|FG002|Overall Study|Other|5|||
131843369|NCT03233230|474706438|FG003|Overall Study|Other|3|||
131843370|NCT03233230|474706435|FG000|Overall Study|Withdrawal by Subject|2|||
131843371|NCT03233230|474706436|FG001|Overall Study|Withdrawal by Subject|2|||
131843372|NCT03233230|474706437|FG002|Overall Study|Withdrawal by Subject|0|||
131843373|NCT03233230|474706438|FG003|Overall Study|Withdrawal by Subject|1|||
131843374|NCT03233230|474706435|FG000|Overall Study|Lost to Follow-up|0|||
131843375|NCT03233230|474706436|FG001|Overall Study|Lost to Follow-up|3|||
131843376|NCT03233230|474706437|FG002|Overall Study|Lost to Follow-up|0|||
131843377|NCT03233230|474706438|FG003|Overall Study|Lost to Follow-up|0|||
131843378|NCT00311402|474706441|FG000|Overall Study|Adverse Event|118|||
131843379|NCT00311402|474706442|FG001|Overall Study|Adverse Event|105|||
131843380|NCT00311402|474706441|FG000|Overall Study|Lost to Follow-up|0|||
131843381|NCT00311402|474706442|FG001|Overall Study|Lost to Follow-up|3|||
131843382|NCT00311402|474706441|FG000|Overall Study|Withdrawal by Subject|17|||
131843383|NCT00311402|474706442|FG001|Overall Study|Withdrawal by Subject|18|||
131843384|NCT00311402|474706441|FG000|Overall Study|Lack of Efficacy|58|||
131843385|NCT00311402|474706442|FG001|Overall Study|Lack of Efficacy|42|||
131843386|NCT00311402|474706441|FG000|Overall Study|Protocol Violation|7|||
131843387|NCT00311402|474706442|FG001|Overall Study|Protocol Violation|6|||
131843388|NCT00311402|474706441|FG000|Overall Study|IRB's rejection etc.|10|||
131843389|NCT00311402|474706442|FG001|Overall Study|IRB's rejection etc.|3|||
131843390|NCT02640053|474706443|FG000|Overall Study|Withdrawal by Subject|2|||
131843391|NCT02640053|474706444|FG001|Overall Study|Withdrawal by Subject|1|||
131843392|NCT02640053|474706443|FG000|Overall Study|Adverse Event|1|||
131843393|NCT02640053|474706444|FG001|Overall Study|Adverse Event|1|||
131843394|NCT02640053|474706443|FG000|Overall Study|Alternative Therapy|1|||
131843395|NCT02640053|474706444|FG001|Overall Study|Alternative Therapy|1|||
131843396|NCT02640053|474706443|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
131843397|NCT02640053|474706444|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
131843398|NCT03283761|474706445|FG000|Study Treatment|Patient Non-Compliance|1|||
131843399|NCT03283761|474706445|FG000|Study Treatment|Alternative Cancer Therapy|7|||
131843400|NCT03283761|474706445|FG000|Study Treatment|Disease progression|21|||
131843401|NCT03283761|474706445|FG000|Study Treatment|Adverse Event|3|||
131843402|NCT03283761|474706445|FG000|Study Treatment|Withdrawal by Subject|4|||
131843403|NCT03283761|474706445|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
131843404|NCT03283761|474706445|FG000|Study Treatment|Symptomatic Deterioration|1|||
131843405|NCT03283761|474706445|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
131843406|NCT03283761|474706445|FG000|Follow up|Lost to Follow-up|1|||
131843407|NCT03283761|474706445|FG000|Follow up|Symptomatic Deterioration|1|||
131843408|NCT03283761|474706445|FG000|Follow up|Death|29|||
131843409|NCT03283761|474706445|FG000|Follow up|study terminated|4|||
131843410|NCT03283761|474706445|FG000|Follow up|Primary Investigator Withdrawal|1|||
131843411|NCT03283761|474706445|FG000|Follow up|Switched to alternative therapy|1|||
131843412|NCT03283761|474706445|FG000|Follow up|Subject is now in Hospice|1|||
131843413|NCT03275064|474706446|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
131843414|NCT03275064|474706447|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
131843415|NCT03275064|474706448|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
131843416|NCT03275064|474706449|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
131843417|NCT03275064|474706450|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
131843418|NCT03275064|474706446|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
131843419|NCT03275064|474706447|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
131843420|NCT03275064|474706448|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
131843421|NCT03275064|474706449|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
131843422|NCT03275064|474706450|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
131843423|NCT03275064|474706446|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
131843424|NCT03275064|474706447|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
131843425|NCT03275064|474706448|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
131843426|NCT03275064|474706449|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
131843427|NCT03275064|474706450|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
131843428|NCT03275064|474706446|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
131843429|NCT03275064|474706447|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
131843430|NCT03275064|474706448|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
131843431|NCT03275064|474706449|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
131402952|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
131402953|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
131402954|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
131402955|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
131843432|NCT03275064|474706450|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
131843433|NCT03275064|474706446|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
131843434|NCT03275064|474706447|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
131843435|NCT03275064|474706448|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
131910826|NCT04711005|474960872|FG008|Overall Study|Withdrawal by Subject|0|||
131910827|NCT04711005|474960873|FG009|Overall Study|Withdrawal by Subject|0|||
131910828|NCT04711005|474960864|FG000|Overall Study|Physician Decision|0|||
131843436|NCT03275064|474706449|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
131843437|NCT03275064|474706450|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
131843438|NCT04159935|474706451|FG000|Overall Study|Study terminated due to COVID-19|1|||
131843439|NCT04159935|474706452|FG001|Overall Study|Study terminated due to COVID-19|3|||
131843440|NCT01341782|474706453|FG000|Overall Study|Adverse Event|1|||
131843441|NCT01341782|474706454|FG001|Overall Study|Adverse Event|1|||
131843442|NCT01341782|474706453|FG000|Overall Study|Withdrawal by Subject|6|||
131843443|NCT01341782|474706454|FG001|Overall Study|Withdrawal by Subject|5|||
131843444|NCT01341782|474706453|FG000|Overall Study|Missed 3 consecutive doses|0|||
131843445|NCT01341782|474706454|FG001|Overall Study|Missed 3 consecutive doses|4|||
131450319|NCT03349034|473278150|FG000|Overall Study|catheters dislodged during transport|2|||
131450320|NCT03349034|473278151|FG001|Overall Study|catheters dislodged during transport|0|||
131450321|NCT03349034|473278150|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
131450322|NCT03349034|473278151|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
131450323|NCT03349034|473278150|FG000|Overall Study|soft tissue flap used|1|||
131450324|NCT03349034|473278151|FG001|Overall Study|soft tissue flap used|0|||
131450325|NCT03349034|473278150|FG000|Overall Study|Other|0|||
131450326|NCT03349034|473278151|FG001|Overall Study|Other|1|||
131450327|NCT00865566|473278152|FG000|Overall Study|Death|1|||
131450328|NCT00865566|473278153|FG001|Overall Study|Death|11|||
131450329|NCT00865566|473278152|FG000|Overall Study|Lost to Follow-up|314|||
131450330|NCT00865566|473278153|FG001|Overall Study|Lost to Follow-up|315|||
131450331|NCT00865566|473278152|FG000|Overall Study|Withdrawal by Subject|45|||
131450332|NCT00865566|473278153|FG001|Overall Study|Withdrawal by Subject|65|||
131450333|NCT00865566|473278152|FG000|Overall Study|Physician Decision|0|||
131450334|NCT00865566|473278153|FG001|Overall Study|Physician Decision|1|||
131450335|NCT00865566|473278152|FG000|Overall Study|Participant relocated|78|||
131450336|NCT00865566|473278153|FG001|Overall Study|Participant relocated|107|||
131450337|NCT00865566|473278152|FG000|Overall Study|Participant unable to adhere|27|||
131450338|NCT00865566|473278153|FG001|Overall Study|Participant unable to adhere|42|||
131450339|NCT00865566|473278152|FG000|Overall Study|Other; N=245 due to early study closure|154|||
131450340|NCT00865566|473278153|FG001|Overall Study|Other; N=245 due to early study closure|139|||
131450341|NCT00865566|473278152|FG000|Overall Study|HIV infection|5|||
131450342|NCT00865566|473278153|FG001|Overall Study|HIV infection|7|||
131450343|NCT00815659|473278154|FG000|Overall Study|Adverse Event|9|||
131450344|NCT00815659|473278154|FG000|Overall Study|Withdrawal by Subject|9|||
131450345|NCT00815659|473278154|FG000|Overall Study|Lost to Follow-up|4|||
131450346|NCT00815659|473278154|FG000|Overall Study|Protocol Violation|1|||
131450347|NCT02395471|473278155|FG000|Overall Study|Lost to Follow-up|2|||
131450348|NCT02395471|473278156|FG001|Overall Study|Lost to Follow-up|0|||
131450349|NCT02395471|473278155|FG000|Overall Study|Withdrawal by Subject|2|||
131450350|NCT02395471|473278156|FG001|Overall Study|Withdrawal by Subject|1|||
131450351|NCT02395471|473278155|FG000|Overall Study|Physician Decision|1|||
131450352|NCT02395471|473278156|FG001|Overall Study|Physician Decision|0|||
131450353|NCT02395471|473278155|FG000|Overall Study|Protocol Violation|0|||
131450354|NCT02395471|473278156|FG001|Overall Study|Protocol Violation|1|||
131450355|NCT02395471|473278155|FG000|Overall Study|Failure to swollow sponge twice|1|||
131843446|NCT01341782|474706453|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
131843447|NCT01341782|474706454|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
131843448|NCT01341782|474706453|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
131843449|NCT01341782|474706454|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
131843450|NCT01341782|474706453|FG000|Overall Study|Other|5|||
131843451|NCT01341782|474706454|FG001|Overall Study|Other|0|||
131843452|NCT00620555|474706455|FG000|Overall Study|Adverse Event|4|||
131843453|NCT00620555|474706455|FG000|Overall Study|Protocol Violation|2|||
131843454|NCT00620555|474706455|FG000|Overall Study|Lack of Efficacy|12|||
131843455|NCT00620555|474706455|FG000|Overall Study|Withdrawal by Subject|1|||
131843456|NCT00620555|474706455|FG000|Overall Study|Choice of other treatment|1|||
131843457|NCT00620555|474706455|FG000|Overall Study|Visit failure against planned|1|||
131843458|NCT02036775|474706456|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
131843459|NCT02036775|474706457|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
131843460|NCT02036775|474706458|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
131843461|NCT02036775|474706459|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
131450356|NCT02395471|473278156|FG001|Overall Study|Failure to swollow sponge twice|0|||
131450357|NCT02395471|473278155|FG000|Overall Study|Patient did not return for procedure|0|||
131450358|NCT02395471|473278156|FG001|Overall Study|Patient did not return for procedure|1|||
131450359|NCT02395471|473278155|FG000|Overall Study|Subject not eligible|1|||
131450360|NCT02395471|473278156|FG001|Overall Study|Subject not eligible|0|||
131450361|NCT03847896|473278157|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
131450362|NCT03847896|473278158|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
131843462|NCT02036775|474706460|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
131843463|NCT02036775|474706461|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
131843464|NCT01140503|474706462|FG000|Overall Study|Withdrawal by Subject|1|||
131843465|NCT00724048|474706463|FG000|Overall Study|Adverse Event|1|||
131843466|NCT00724048|474706464|FG001|Overall Study|Adverse Event|1|||
131843467|NCT00724048|474706465|FG002|Overall Study|Adverse Event|1|||
131843468|NCT00724048|474706466|FG003|Overall Study|Adverse Event|0|||
131843469|NCT00724048|474706463|FG000|Overall Study|Lost to Follow-up|0|||
131843470|NCT00724048|474706464|FG001|Overall Study|Lost to Follow-up|1|||
131843471|NCT00724048|474706465|FG002|Overall Study|Lost to Follow-up|0|||
131843472|NCT00724048|474706466|FG003|Overall Study|Lost to Follow-up|0|||
131843473|NCT00724048|474706463|FG000|Overall Study|Withdrawal by Subject|1|||
131843474|NCT00724048|474706464|FG001|Overall Study|Withdrawal by Subject|2|||
131843475|NCT00724048|474706465|FG002|Overall Study|Withdrawal by Subject|1|||
131843476|NCT00724048|474706466|FG003|Overall Study|Withdrawal by Subject|2|||
131843477|NCT00724048|474706463|FG000|Overall Study|Investigator decision|0|||
131843478|NCT00724048|474706464|FG001|Overall Study|Investigator decision|0|||
131843479|NCT00724048|474706465|FG002|Overall Study|Investigator decision|1|||
131843480|NCT00724048|474706466|FG003|Overall Study|Investigator decision|0|||
131843481|NCT00724048|474706463|FG000|Overall Study|Did not tolerate study drug|0|||
131843482|NCT00724048|474706464|FG001|Overall Study|Did not tolerate study drug|0|||
131843483|NCT00724048|474706465|FG002|Overall Study|Did not tolerate study drug|0|||
131843484|NCT00724048|474706466|FG003|Overall Study|Did not tolerate study drug|1|||
131843485|NCT00724048|474706463|FG000|Overall Study|Other than specified|1|||
131843486|NCT00724048|474706464|FG001|Overall Study|Other than specified|1|||
131843487|NCT00724048|474706465|FG002|Overall Study|Other than specified|0|||
131843488|NCT00724048|474706466|FG003|Overall Study|Other than specified|0|||
131843489|NCT03923530|474706467|FG000|Overall Study|Withdrawal by Subject|1|||
131843490|NCT03923530|474706467|FG000|Overall Study|screen failure|3|||
131843491|NCT04430855|474706480|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
131843492|NCT04430855|474706481|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
131843493|NCT04430855|474706480|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
131843494|NCT04430855|474706481|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
131843495|NCT04430855|474706480|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
131843496|NCT04430855|474706481|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
131843497|NCT04430855|474706480|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
131843498|NCT04430855|474706481|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
131843499|NCT04430855|474706480|FG000|Period 1 (Weeks 1-12)|Other|0|||
131843500|NCT04430855|474706481|FG001|Period 1 (Weeks 1-12)|Other|1|||
131843501|NCT04430855|474706480|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
131843502|NCT04430855|474706481|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
131843503|NCT04430855|474706480|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
131843504|NCT04430855|474706481|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
131843505|NCT04430855|474706480|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
131843506|NCT04430855|474706481|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
131843507|NCT04874636|474706482|FG000|Overall Study|Adverse Event|17|||
131843508|NCT04874636|474706483|FG001|Overall Study|Adverse Event|7|||
131843509|NCT04874636|474706482|FG000|Overall Study|Lost to Follow-up|1|||
131843510|NCT04874636|474706483|FG001|Overall Study|Lost to Follow-up|0|||
131843511|NCT04874636|474706482|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131843512|NCT04874636|474706483|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131843513|NCT04874636|474706482|FG000|Overall Study|Physician Decision|1|||
131843514|NCT04874636|474706483|FG001|Overall Study|Physician Decision|0|||
131843515|NCT04874636|474706482|FG000|Overall Study|Withdrawal by Subject|6|||
131843516|NCT04874636|474706483|FG001|Overall Study|Withdrawal by Subject|5|||
131843517|NCT02022748|474708753|FG000|Overall Study|Adverse Event|1|||
131843518|NCT02022748|474708754|FG001|Overall Study|Adverse Event|1|||
131843519|NCT02022748|474708755|FG002|Overall Study|Adverse Event|0|||
131843520|NCT02022748|474708753|FG000|Overall Study|Withdrawal by Subject|0|||
131843521|NCT02022748|474708754|FG001|Overall Study|Withdrawal by Subject|1|||
131843522|NCT02022748|474708755|FG002|Overall Study|Withdrawal by Subject|0|||
131843523|NCT00633243|474708756|FG000|Overall Study|Withdrawal by Subject|0|||
131402956|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Not compliant|1|||
131402957|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Not compliant|0|||
131402958|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Not compliant|0|||
131843524|NCT00633243|474708757|FG001|Overall Study|Withdrawal by Subject|1|||
131843525|NCT00633243|474708756|FG000|Overall Study|incarceration|0|||
131843526|NCT00633243|474708757|FG001|Overall Study|incarceration|2|||
131843527|NCT00633243|474708756|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
131843528|NCT00633243|474708757|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
131843529|NCT00633243|474708756|FG000|Overall Study|Not comfortable with self-injecting|0|||
131843530|NCT00633243|474708757|FG001|Overall Study|Not comfortable with self-injecting|1|||
131402959|NCT01461928|473097822|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
131843531|NCT00633243|474708756|FG000|Overall Study|Mental Health--Depression|0|||
131843532|NCT00633243|474708757|FG001|Overall Study|Mental Health--Depression|1|||
131843533|NCT00633243|474708756|FG000|Overall Study|Couldn't tolerate side-effects|1|||
131843534|NCT00633243|474708757|FG001|Overall Study|Couldn't tolerate side-effects|1|||
131843535|NCT00461253|474708758|FG000|Overall Study|Death|985|||
131843536|NCT00461253|474708759|FG001|Overall Study|Death|0|||
131843537|NCT00461253|474708758|FG000|Overall Study|Protocol Violation|613|||
131843538|NCT00461253|474708759|FG001|Overall Study|Protocol Violation|236|||
131843539|NCT00461253|474708758|FG000|Overall Study|no response|2609|||
131843540|NCT00461253|474708759|FG001|Overall Study|no response|11789|||
131843541|NCT00461253|474708758|FG000|Overall Study|administrative|773|||
131843542|NCT00461253|474708759|FG001|Overall Study|administrative|7773|||
131843543|NCT04240392|474708760|FG000|Overall Study|Withdrawal by Subject|13|||
131843544|NCT04240392|474708761|FG001|Overall Study|Withdrawal by Subject|4|||
131843545|NCT04240392|474708760|FG000|Overall Study|Lost to Follow-up|11|||
131843546|NCT04240392|474708761|FG001|Overall Study|Lost to Follow-up|12|||
131843547|NCT01523457|474708762|FG000|Overall Study|Withdrawal by Subject|7|||
131843548|NCT01523457|474708763|FG001|Overall Study|Withdrawal by Subject|2|||
131843549|NCT03283319|474708764|FG000|Overall Study|Lost to Follow-up|5|||
131843550|NCT03283319|474708765|FG001|Overall Study|Lost to Follow-up|4|||
131843551|NCT03283319|474708766|FG002|Overall Study|Lost to Follow-up|5|||
131843552|NCT03283319|474708767|FG003|Overall Study|Lost to Follow-up|5|||
131843553|NCT03283319|474708768|FG004|Overall Study|Lost to Follow-up|4|||
131843554|NCT03283319|474708769|FG005|Overall Study|Lost to Follow-up|3|||
131843555|NCT03283319|474708764|FG000|Overall Study|Withdrawal by Subject|2|||
131843556|NCT03283319|474708765|FG001|Overall Study|Withdrawal by Subject|2|||
131843557|NCT03283319|474708766|FG002|Overall Study|Withdrawal by Subject|2|||
131843558|NCT03283319|474708767|FG003|Overall Study|Withdrawal by Subject|1|||
131843559|NCT03283319|474708768|FG004|Overall Study|Withdrawal by Subject|0|||
131843560|NCT03283319|474708769|FG005|Overall Study|Withdrawal by Subject|1|||
131843561|NCT03283319|474708764|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
131843562|NCT03283319|474708765|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
131843563|NCT03283319|474708766|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
131843564|NCT03283319|474708767|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
131843565|NCT03283319|474708768|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
131843566|NCT03283319|474708769|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
131843567|NCT00721630|474708770|FG000|Overall Study|Participant found to be ineligible|1|||
131843568|NCT03700385|474708773|FG000|Overall Study|Lost to Follow-up|1|||
131843569|NCT01555671|474708777|FG000|Overall Study|Physician Decision|20|||
131843570|NCT01555671|474708778|FG001|Overall Study|Physician Decision|25|||
131843571|NCT00372411|474708779|FG000|Overall Study|Withdrawal by Subject|3|||
131843572|NCT00372411|474708780|FG001|Overall Study|Withdrawal by Subject|4|||
131843573|NCT00372411|474708781|FG002|Overall Study|Withdrawal by Subject|1|||
131843574|NCT00372411|474708779|FG000|Overall Study|Death|0|||
131843575|NCT00372411|474708780|FG001|Overall Study|Death|2|||
131843576|NCT00372411|474708781|FG002|Overall Study|Death|1|||
131843577|NCT00372411|474708779|FG000|Overall Study|Lost to Follow-up|1|||
131843578|NCT00372411|474708780|FG001|Overall Study|Lost to Follow-up|1|||
131843579|NCT00372411|474708781|FG002|Overall Study|Lost to Follow-up|1|||
131843580|NCT00372411|474708779|FG000|Overall Study|Adverse Event|1|||
131843581|NCT00372411|474708780|FG001|Overall Study|Adverse Event|1|||
131843582|NCT00372411|474708781|FG002|Overall Study|Adverse Event|0|||
131843583|NCT04590040|474708782|FG000|Treatment Period|Lost to Follow-up|2|||
131843584|NCT04590040|474708783|FG001|Treatment Period|Lost to Follow-up|5|||
131843585|NCT04590040|474708784|FG002|Treatment Period|Lost to Follow-up|0|||
131843586|NCT04590040|474708782|FG000|Treatment Period|Physician Decision|0|||
131402960|NCT01461928|473097823|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
131402961|NCT01461928|473097824|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
131402962|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Adverse Event|0|||
131402963|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Adverse Event|2|||
131402964|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Adverse Event|0|||
131843587|NCT04590040|474708783|FG001|Treatment Period|Physician Decision|0|||
131910829|NCT04711005|474960865|FG001|Overall Study|Physician Decision|0|||
131910830|NCT04711005|474960866|FG002|Overall Study|Physician Decision|0|||
131910831|NCT04711005|474960867|FG003|Overall Study|Physician Decision|0|||
131910832|NCT04711005|474960868|FG004|Overall Study|Physician Decision|0|||
131910833|NCT04711005|474960869|FG005|Overall Study|Physician Decision|0|||
131910834|NCT04711005|474960870|FG006|Overall Study|Physician Decision|0|||
131910835|NCT04711005|474960871|FG007|Overall Study|Physician Decision|2|||
131910836|NCT04711005|474960872|FG008|Overall Study|Physician Decision|1|||
131910837|NCT04711005|474960873|FG009|Overall Study|Physician Decision|0|||
131910838|NCT03054428|474960881|FG000|Overall Study|Physician Decision|0|||
131910839|NCT03054428|474960882|FG001|Overall Study|Physician Decision|1|||
131910840|NCT03054428|474960883|FG002|Overall Study|Physician Decision|1|||
131402965|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Death|0|||
131843588|NCT04590040|474708784|FG002|Treatment Period|Physician Decision|2|||
131843589|NCT01284361|474708787|FG000|Overall Study|Withdrawal by Subject|1|||
131843590|NCT01284361|474708787|FG000|Overall Study|Protocol Violation|5|||
131843591|NCT01284361|474708787|FG000|Overall Study|Adverse Event|1|||
131843592|NCT01284361|474708787|FG000|Overall Study|Lost to Follow-up|2|||
131843593|NCT00686075|474708788|FG000|Overall Study|Withdrawal by Subject|4|||
131402966|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Death|10|||
131843594|NCT00686075|474708789|FG001|Overall Study|Withdrawal by Subject|3|||
131843595|NCT00686075|474708790|FG002|Overall Study|Withdrawal by Subject|3|||
131910841|NCT03054428|474960881|FG000|Overall Study|Lack of Efficacy|3|||
131402967|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Death|8|||
131402968|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Physician Decision|0|||
131402969|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Physician Decision|0|||
131402970|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Physician Decision|4|||
131402971|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
131402972|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
131402973|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
131402974|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Moved to another town|0|||
131402975|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Moved to another town|1|||
131402976|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Moved to another town|0|||
131402977|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Disease progression|0|||
131402978|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Disease progression|0|||
131402979|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Disease progression|3|||
131843596|NCT00686075|474708791|FG003|Overall Study|Withdrawal by Subject|7|||
131843597|NCT00686075|474708792|FG004|Overall Study|Withdrawal by Subject|1|||
131843598|NCT00686075|474708793|FG005|Overall Study|Withdrawal by Subject|0|||
131910842|NCT03054428|474960882|FG001|Overall Study|Lack of Efficacy|1|||
131910843|NCT03054428|474960883|FG002|Overall Study|Lack of Efficacy|0|||
131910844|NCT03054428|474960881|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
131910845|NCT03054428|474960882|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
131910846|NCT03054428|474960883|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
131910847|NCT03054428|474960881|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
131910848|NCT03054428|474960882|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
131910849|NCT03054428|474960883|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
131910850|NCT03054428|474960881|FG000|Overall Study|Transitioned to OLE study|76|||
131910851|NCT03054428|474960882|FG001|Overall Study|Transitioned to OLE study|76|||
131910852|NCT03054428|474960883|FG002|Overall Study|Transitioned to OLE study|73|||
131910853|NCT03054428|474960881|FG000|Overall Study|Withdrawal by Subject|3|||
131910854|NCT03054428|474960882|FG001|Overall Study|Withdrawal by Subject|2|||
131910855|NCT03054428|474960883|FG002|Overall Study|Withdrawal by Subject|3|||
131910856|NCT03054428|474960881|FG000|Overall Study|Lost to Follow-up|0|||
131910857|NCT03054428|474960882|FG001|Overall Study|Lost to Follow-up|0|||
131910858|NCT03054428|474960883|FG002|Overall Study|Lost to Follow-up|1|||
131910859|NCT03573297|474960886|FG000|Open Label Treatment Period|Adverse Event|67|||
131910860|NCT03573297|474960887|FG001|Open Label Treatment Period|Adverse Event|0|||
131910861|NCT03573297|474960888|FG002|Open Label Treatment Period|Adverse Event|0|||
131910862|NCT03573297|474960889|FG003|Open Label Treatment Period|Adverse Event|0|||
131910863|NCT03573297|474960886|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
131910864|NCT03573297|474960887|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
131910865|NCT03573297|474960888|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
131910866|NCT03573297|474960889|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
131910867|NCT03573297|474960886|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
131910868|NCT03573297|474960887|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
131910869|NCT03573297|474960888|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
131402980|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
131450363|NCT03847896|473278159|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
131843599|NCT00686075|474708794|FG006|Overall Study|Withdrawal by Subject|0|||
131450364|NCT03847896|473278160|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
131843600|NCT00686075|474708795|FG007|Overall Study|Withdrawal by Subject|2|||
131843601|NCT00686075|474708796|FG008|Overall Study|Withdrawal by Subject|4|||
131843602|NCT00686075|474708797|FG009|Overall Study|Withdrawal by Subject|6|||
131843603|NCT00686075|474708788|FG000|Overall Study|Lost to Follow-up|3|||
131843604|NCT00686075|474708789|FG001|Overall Study|Lost to Follow-up|6|||
131843605|NCT00686075|474708790|FG002|Overall Study|Lost to Follow-up|3|||
131843606|NCT00686075|474708791|FG003|Overall Study|Lost to Follow-up|2|||
131843607|NCT00686075|474708792|FG004|Overall Study|Lost to Follow-up|3|||
131843608|NCT00686075|474708793|FG005|Overall Study|Lost to Follow-up|3|||
131843609|NCT00686075|474708794|FG006|Overall Study|Lost to Follow-up|0|||
131843610|NCT00686075|474708795|FG007|Overall Study|Lost to Follow-up|0|||
131843611|NCT00686075|474708796|FG008|Overall Study|Lost to Follow-up|2|||
131843612|NCT00686075|474708797|FG009|Overall Study|Lost to Follow-up|3|||
131843613|NCT00686075|474708788|FG000|Overall Study|Other|1|||
131843614|NCT00686075|474708789|FG001|Overall Study|Other|1|||
131910870|NCT03573297|474960889|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
131910871|NCT03573297|474960886|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
131910872|NCT03573297|474960887|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
131910873|NCT03573297|474960888|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
131843615|NCT00686075|474708790|FG002|Overall Study|Other|0|||
131402981|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
131402982|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
131843616|NCT00686075|474708791|FG003|Overall Study|Other|0|||
131843617|NCT00686075|474708792|FG004|Overall Study|Other|0|||
131843618|NCT00686075|474708793|FG005|Overall Study|Other|0|||
131843619|NCT00686075|474708794|FG006|Overall Study|Other|0|||
131843620|NCT00686075|474708795|FG007|Overall Study|Other|0|||
131843621|NCT00686075|474708796|FG008|Overall Study|Other|0|||
131843622|NCT00686075|474708797|FG009|Overall Study|Other|1|||
131843623|NCT04715932|474708798|FG000|Overall Study|Lost to Follow-up|1|||
131843624|NCT04715932|474708799|FG001|Overall Study|Lost to Follow-up|0|||
131843625|NCT03783039|474708812|FG000|Overall Study|Death|2|||
131843626|NCT03783039|474708813|FG001|Overall Study|Death|1|||
131843627|NCT01682863|474708814|FG000|Overall Study|Subject/guardian decision|19|||
131843628|NCT01682863|474708815|FG001|Overall Study|Subject/guardian decision|12|||
131843629|NCT01682863|474708816|FG002|Overall Study|Subject/guardian decision|10|||
131843630|NCT01682863|474708814|FG000|Overall Study|Lost to Follow-up|5|||
131843631|NCT01682863|474708815|FG001|Overall Study|Lost to Follow-up|1|||
131843632|NCT01682863|474708816|FG002|Overall Study|Lost to Follow-up|6|||
131843633|NCT01682863|474708814|FG000|Overall Study|Death|1|||
131843634|NCT01682863|474708815|FG001|Overall Study|Death|3|||
131843635|NCT01682863|474708816|FG002|Overall Study|Death|4|||
131843636|NCT01682863|474708814|FG000|Overall Study|Protocol deviation|1|||
131843637|NCT01682863|474708815|FG001|Overall Study|Protocol deviation|0|||
131843638|NCT01682863|474708816|FG002|Overall Study|Protocol deviation|1|||
131843639|NCT01682863|474708814|FG000|Overall Study|Technical problems|1|||
131843640|NCT01682863|474708815|FG001|Overall Study|Technical problems|0|||
131843641|NCT01682863|474708816|FG002|Overall Study|Technical problems|0|||
131843642|NCT01682863|474708814|FG000|Overall Study|Adverse Event|0|||
131843643|NCT01682863|474708815|FG001|Overall Study|Adverse Event|1|||
131843644|NCT01682863|474708816|FG002|Overall Study|Adverse Event|2|||
131843645|NCT01682863|474708814|FG000|Overall Study|Physician Decision|0|||
131843646|NCT01682863|474708815|FG001|Overall Study|Physician Decision|0|||
131843647|NCT01682863|474708816|FG002|Overall Study|Physician Decision|1|||
131843648|NCT00918138|474708818|FG000|Overall Study|Subject withdrew consent|1|||
131843649|NCT00918138|474708819|FG001|Overall Study|Subject withdrew consent|1|||
131843650|NCT00918138|474708818|FG000|Overall Study|Death|1|||
131843651|NCT00918138|474708819|FG001|Overall Study|Death|0|||
131843652|NCT00699374|474708820|FG000|Overall Study|Death|93|||
131843653|NCT00699374|474708821|FG001|Overall Study|Death|83|||
131843654|NCT00699374|474708820|FG000|Overall Study|Adverse Event|70|||
131843655|NCT00699374|474708821|FG001|Overall Study|Adverse Event|67|||
131843656|NCT00699374|474708820|FG000|Overall Study|Global deterioration of health status|7|||
131843657|NCT00699374|474708821|FG001|Overall Study|Global deterioration of health status|8|||
131843658|NCT00699374|474708820|FG000|Overall Study|Lost to Follow-up|3|||
131843659|NCT00699374|474708821|FG001|Overall Study|Lost to Follow-up|5|||
131843660|NCT00699374|474708820|FG000|Overall Study|Withdrawal by Subject|34|||
131843661|NCT00699374|474708821|FG001|Overall Study|Withdrawal by Subject|44|||
131843662|NCT00699374|474708820|FG000|Overall Study|Objective progression or relapse|281|||
131843663|NCT00699374|474708821|FG001|Overall Study|Objective progression or relapse|277|||
131843664|NCT00699374|474708820|FG000|Overall Study|Other|18|||
131843665|NCT00699374|474708821|FG001|Overall Study|Other|15|||
131843666|NCT00699374|474708820|FG000|Overall Study|Protocol Violation|2|||
131843667|NCT00699374|474708821|FG001|Overall Study|Protocol Violation|6|||
131843668|NCT00699374|474708820|FG000|Overall Study|Study terminated by sponsor|13|||
131843669|NCT00699374|474708821|FG001|Overall Study|Study terminated by sponsor|28|||
131843670|NCT00699374|474708820|FG000|Overall Study|Randomized but not treated|4|||
131843671|NCT00699374|474708821|FG001|Overall Study|Randomized but not treated|2|||
131843672|NCT00699374|474708820|FG000|Overall Study|Died 28 days after last dose|5|||
131843673|NCT00699374|474708821|FG001|Overall Study|Died 28 days after last dose|9|||
131843674|NCT02085135|474708824|FG000|Overall Study|Adverse Event|4|||
131843675|NCT02085135|474708825|FG001|Overall Study|Adverse Event|7|||
131843676|NCT02085135|474708824|FG000|Overall Study|Lost to Follow-up|2|||
131843677|NCT02085135|474708825|FG001|Overall Study|Lost to Follow-up|2|||
131843678|NCT02085135|474708824|FG000|Overall Study|Withdrawal by Subject|3|||
131843679|NCT02085135|474708825|FG001|Overall Study|Withdrawal by Subject|0|||
131843680|NCT02085135|474708824|FG000|Overall Study|Lack of Efficacy|2|||
131843681|NCT02085135|474708825|FG001|Overall Study|Lack of Efficacy|0|||
131843682|NCT01136967|474708827|FG000|Overall Study|Adverse Event|9|||
131843683|NCT01136967|474708828|FG001|Overall Study|Adverse Event|12|||
131402983|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
131402984|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
131402985|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
131402986|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
131843684|NCT01136967|474708827|FG000|Overall Study|Participant Choice|8|||
131843685|NCT01136967|474708828|FG001|Overall Study|Participant Choice|3|||
131843686|NCT01136967|474708827|FG000|Overall Study|Lost to Follow-up|0|||
131843687|NCT01136967|474708828|FG001|Overall Study|Lost to Follow-up|1|||
131843688|NCT01136967|474708827|FG000|Overall Study|Withdrawal by Subject|1|||
131843689|NCT01136967|474708828|FG001|Overall Study|Withdrawal by Subject|2|||
131843690|NCT01136967|474708827|FG000|Overall Study|Clinical Progression|3|||
131843691|NCT01136967|474708828|FG001|Overall Study|Clinical Progression|5|||
131843692|NCT01136967|474708827|FG000|Overall Study|Radiation|1|||
131843693|NCT01136967|474708828|FG001|Overall Study|Radiation|0|||
131843694|NCT01136967|474708827|FG000|Overall Study|Non-compliance|1|||
131843695|NCT01136967|474708828|FG001|Overall Study|Non-compliance|0|||
131843696|NCT01136967|474708827|FG000|Overall Study|Investigator's Choice|1|||
131843697|NCT01136967|474708828|FG001|Overall Study|Investigator's Choice|1|||
131843698|NCT01136967|474708827|FG000|Overall Study|Increase in Lesion Size|0|||
131843699|NCT01136967|474708828|FG001|Overall Study|Increase in Lesion Size|2|||
131843700|NCT01136967|474708827|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
131843701|NCT01136967|474708828|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
131843702|NCT02885181|474708830|FG000|Overall Study|Investigator's Discretion|0|||
131843703|NCT02885181|474708831|FG001|Overall Study|Investigator's Discretion|1|||
131843704|NCT02885181|474708832|FG002|Overall Study|Investigator's Discretion|0|||
131843705|NCT02885181|474708833|FG003|Overall Study|Investigator's Discretion|1|||
131843706|NCT02885181|474708830|FG000|Overall Study|Adverse Event|0|||
131843707|NCT02885181|474708831|FG001|Overall Study|Adverse Event|0|||
131843708|NCT02885181|474708832|FG002|Overall Study|Adverse Event|0|||
131843709|NCT02885181|474708833|FG003|Overall Study|Adverse Event|1|||
131843710|NCT02885181|474708830|FG000|Overall Study|Withdrawal by Subject|0|||
131843711|NCT02885181|474708831|FG001|Overall Study|Withdrawal by Subject|0|||
131843712|NCT02885181|474708832|FG002|Overall Study|Withdrawal by Subject|0|||
131843713|NCT02885181|474708833|FG003|Overall Study|Withdrawal by Subject|1|||
131843714|NCT03839823|474708834|FG000|Overall Study|Adverse Event|8|||
131843715|NCT03839823|474708835|FG001|Overall Study|Adverse Event|4|||
131843716|NCT03839823|474708834|FG000|Overall Study|Death|1|||
131843717|NCT03839823|474708835|FG001|Overall Study|Death|0|||
131843718|NCT03839823|474708834|FG000|Overall Study|Physician Decision|1|||
131843719|NCT03839823|474708835|FG001|Overall Study|Physician Decision|5|||
131843720|NCT03839823|474708834|FG000|Overall Study|Progressive Disease (PD)|65|||
131843721|NCT03839823|474708835|FG001|Overall Study|Progressive Disease (PD)|65|||
131843722|NCT03839823|474708834|FG000|Overall Study|Subject Decision|2|||
131843723|NCT03839823|474708835|FG001|Overall Study|Subject Decision|9|||
131843724|NCT03839823|474708834|FG000|Overall Study|Not Treated|0|||
131843725|NCT03839823|474708835|FG001|Overall Study|Not Treated|10|||
131843726|NCT04228783|474708836|FG000|Overall Study|Adverse Event|1|||
131843727|NCT04228783|474708837|FG001|Overall Study|Adverse Event|0|||
131843728|NCT04228783|474708838|FG002|Overall Study|Adverse Event|2|||
131843729|NCT04228783|474708839|FG003|Overall Study|Adverse Event|0|||
131843730|NCT04228783|474708840|FG004|Overall Study|Adverse Event|0|||
131843731|NCT04228783|474708841|FG005|Overall Study|Adverse Event|1|||
131843732|NCT04228783|474708836|FG000|Overall Study|Death|0|||
131843733|NCT04228783|474708837|FG001|Overall Study|Death|0|||
131843734|NCT04228783|474708838|FG002|Overall Study|Death|0|||
131843735|NCT04228783|474708839|FG003|Overall Study|Death|0|||
131843736|NCT04228783|474708840|FG004|Overall Study|Death|1|||
131843737|NCT04228783|474708841|FG005|Overall Study|Death|0|||
131843738|NCT04228783|474708836|FG000|Overall Study|Lost to Follow-up|36|||
131843739|NCT04228783|474708837|FG001|Overall Study|Lost to Follow-up|36|||
131843740|NCT04228783|474708838|FG002|Overall Study|Lost to Follow-up|28|||
131843741|NCT04228783|474708839|FG003|Overall Study|Lost to Follow-up|6|||
131843742|NCT04228783|474708840|FG004|Overall Study|Lost to Follow-up|14|||
131843743|NCT04228783|474708841|FG005|Overall Study|Lost to Follow-up|3|||
131843744|NCT04228783|474708836|FG000|Overall Study|Physician Decision|1|||
131843745|NCT04228783|474708837|FG001|Overall Study|Physician Decision|2|||
131843746|NCT04228783|474708838|FG002|Overall Study|Physician Decision|0|||
131843747|NCT04228783|474708839|FG003|Overall Study|Physician Decision|0|||
131843748|NCT04228783|474708840|FG004|Overall Study|Physician Decision|0|||
131843749|NCT04228783|474708841|FG005|Overall Study|Physician Decision|0|||
131843750|NCT04228783|474708836|FG000|Overall Study|Protocol Violation|0|||
131843751|NCT04228783|474708837|FG001|Overall Study|Protocol Violation|0|||
131843752|NCT04228783|474708838|FG002|Overall Study|Protocol Violation|0|||
131843753|NCT04228783|474708839|FG003|Overall Study|Protocol Violation|1|||
131843754|NCT04228783|474708840|FG004|Overall Study|Protocol Violation|0|||
131843755|NCT04228783|474708841|FG005|Overall Study|Protocol Violation|0|||
131843756|NCT04228783|474708836|FG000|Overall Study|Withdrawal by Subject|6|||
131843757|NCT04228783|474708837|FG001|Overall Study|Withdrawal by Subject|10|||
131843758|NCT04228783|474708838|FG002|Overall Study|Withdrawal by Subject|19|||
131843759|NCT04228783|474708839|FG003|Overall Study|Withdrawal by Subject|1|||
131843760|NCT04228783|474708840|FG004|Overall Study|Withdrawal by Subject|2|||
131843761|NCT04228783|474708841|FG005|Overall Study|Withdrawal by Subject|0|||
131402987|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
131402988|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
131843762|NCT04228783|474708836|FG000|Overall Study|Other|4|||
131843763|NCT04228783|474708837|FG001|Overall Study|Other|3|||
131843764|NCT04228783|474708838|FG002|Overall Study|Other|2|||
131843765|NCT04228783|474708839|FG003|Overall Study|Other|1|||
131843766|NCT04228783|474708840|FG004|Overall Study|Other|0|||
131843767|NCT04228783|474708841|FG005|Overall Study|Other|0|||
131843768|NCT03151811|474708847|FG000|Overall Study|Randomized But Not Treated|18|||
131843769|NCT03151811|474708848|FG001|Overall Study|Randomized But Not Treated|3|||
131843770|NCT03151811|474708847|FG000|Overall Study|Progressive Disease|130|||
131843771|NCT03151811|474708848|FG001|Overall Study|Progressive Disease|170|||
131843772|NCT03151811|474708847|FG000|Overall Study|Adverse Event|49|||
131843773|NCT03151811|474708848|FG001|Overall Study|Adverse Event|40|||
131843774|NCT03151811|474708847|FG000|Overall Study|Lack of Efficacy|6|||
131843775|NCT03151811|474708848|FG001|Overall Study|Lack of Efficacy|8|||
131843776|NCT03151811|474708847|FG000|Overall Study|Physician Decision|21|||
131843777|NCT03151811|474708848|FG001|Overall Study|Physician Decision|9|||
131843778|NCT03151811|474708847|FG000|Overall Study|Withdrawal by Subject|17|||
131843779|NCT03151811|474708848|FG001|Overall Study|Withdrawal by Subject|7|||
131843780|NCT03151811|474708847|FG000|Overall Study|Lost to Follow-up|0|||
131843781|NCT03151811|474708848|FG001|Overall Study|Lost to Follow-up|1|||
131843782|NCT03151811|474708847|FG000|Overall Study|Study Terminated by Sponsor|5|||
131843783|NCT03151811|474708848|FG001|Overall Study|Study Terminated by Sponsor|11|||
131843784|NCT01517373|474708851|FG000|Run-in Period|Death|1|||
131843785|NCT01517373|474708852|FG001|Run-in Period|Death|0|||
131843786|NCT01517373|474708853|FG002|Run-in Period|Death|0|||
131843787|NCT01517373|474708854|FG003|Run-in Period|Death|0|||
131843788|NCT01517373|474708855|FG004|Run-in Period|Death|0|||
131843789|NCT01517373|474708856|FG005|Run-in Period|Death|0|||
131843790|NCT01517373|474708851|FG000|Run-in Period|Adverse Event|5|||
131843791|NCT01517373|474708852|FG001|Run-in Period|Adverse Event|0|||
131843792|NCT01517373|474708853|FG002|Run-in Period|Adverse Event|0|||
131843793|NCT01517373|474708854|FG003|Run-in Period|Adverse Event|0|||
131843794|NCT01517373|474708855|FG004|Run-in Period|Adverse Event|0|||
131843795|NCT01517373|474708856|FG005|Run-in Period|Adverse Event|0|||
131843796|NCT01517373|474708851|FG000|Run-in Period|Did not meet eligibility criteria|34|||
131843797|NCT01517373|474708852|FG001|Run-in Period|Did not meet eligibility criteria|0|||
131843798|NCT01517373|474708853|FG002|Run-in Period|Did not meet eligibility criteria|0|||
131843799|NCT01517373|474708854|FG003|Run-in Period|Did not meet eligibility criteria|0|||
131843800|NCT01517373|474708855|FG004|Run-in Period|Did not meet eligibility criteria|0|||
131843801|NCT01517373|474708856|FG005|Run-in Period|Did not meet eligibility criteria|0|||
131843802|NCT01517373|474708851|FG000|Run-in Period|Lost to Follow-up|1|||
131843803|NCT01517373|474708852|FG001|Run-in Period|Lost to Follow-up|0|||
131843804|NCT01517373|474708853|FG002|Run-in Period|Lost to Follow-up|0|||
131843805|NCT01517373|474708854|FG003|Run-in Period|Lost to Follow-up|0|||
131843806|NCT01517373|474708855|FG004|Run-in Period|Lost to Follow-up|0|||
131843807|NCT01517373|474708856|FG005|Run-in Period|Lost to Follow-up|0|||
131843808|NCT01517373|474708851|FG000|Run-in Period|Withdrawal by Subject|12|||
131843809|NCT01517373|474708852|FG001|Run-in Period|Withdrawal by Subject|0|||
131843810|NCT01517373|474708853|FG002|Run-in Period|Withdrawal by Subject|0|||
131843811|NCT01517373|474708854|FG003|Run-in Period|Withdrawal by Subject|0|||
131843812|NCT01517373|474708855|FG004|Run-in Period|Withdrawal by Subject|0|||
131843813|NCT01517373|474708856|FG005|Run-in Period|Withdrawal by Subject|0|||
131843814|NCT01517373|474708851|FG000|Run-in Period|Sponsor Decision|3|||
131843815|NCT01517373|474708852|FG001|Run-in Period|Sponsor Decision|0|||
131843816|NCT01517373|474708853|FG002|Run-in Period|Sponsor Decision|0|||
131843817|NCT01517373|474708854|FG003|Run-in Period|Sponsor Decision|0|||
131843818|NCT01517373|474708855|FG004|Run-in Period|Sponsor Decision|0|||
131843819|NCT01517373|474708856|FG005|Run-in Period|Sponsor Decision|0|||
131843820|NCT01517373|474708851|FG000|Run-in Period|Other|1|||
131843821|NCT01517373|474708852|FG001|Run-in Period|Other|0|||
131843822|NCT01517373|474708853|FG002|Run-in Period|Other|0|||
131843823|NCT01517373|474708854|FG003|Run-in Period|Other|0|||
131843824|NCT01517373|474708855|FG004|Run-in Period|Other|0|||
131843825|NCT01517373|474708856|FG005|Run-in Period|Other|0|||
131843826|NCT01517373|474708851|FG000|Treatment Period|Adverse Event|0|||
131843827|NCT01517373|474708852|FG001|Treatment Period|Adverse Event|0|||
131843828|NCT01517373|474708853|FG002|Treatment Period|Adverse Event|0|||
131843829|NCT01517373|474708854|FG003|Treatment Period|Adverse Event|0|||
131910874|NCT03573297|474960889|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
131910875|NCT03573297|474960886|FG000|Open Label Treatment Period|Pregnancy|1|||
131843830|NCT01517373|474708855|FG004|Treatment Period|Adverse Event|0|||
131843831|NCT01517373|474708856|FG005|Treatment Period|Adverse Event|2|||
131843832|NCT01517373|474708851|FG000|Treatment Period|Lost to Follow-up|0|||
131843833|NCT01517373|474708852|FG001|Treatment Period|Lost to Follow-up|0|||
131843834|NCT01517373|474708853|FG002|Treatment Period|Lost to Follow-up|1|||
131843835|NCT01517373|474708854|FG003|Treatment Period|Lost to Follow-up|1|||
131843836|NCT01517373|474708855|FG004|Treatment Period|Lost to Follow-up|0|||
131843837|NCT01517373|474708856|FG005|Treatment Period|Lost to Follow-up|0|||
131843838|NCT01517373|474708851|FG000|Treatment Period|Withdrawal by Subject|0|||
131843839|NCT01517373|474708852|FG001|Treatment Period|Withdrawal by Subject|3|||
131843840|NCT01517373|474708853|FG002|Treatment Period|Withdrawal by Subject|2|||
131843841|NCT01517373|474708854|FG003|Treatment Period|Withdrawal by Subject|2|||
131450365|NCT03847896|473278161|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
131843842|NCT01517373|474708855|FG004|Treatment Period|Withdrawal by Subject|2|||
131843843|NCT01517373|474708856|FG005|Treatment Period|Withdrawal by Subject|3|||
131843844|NCT01517373|474708851|FG000|Treatment Period|Other|0|||
131843845|NCT01517373|474708852|FG001|Treatment Period|Other|0|||
131843846|NCT01517373|474708853|FG002|Treatment Period|Other|0|||
131843847|NCT01517373|474708854|FG003|Treatment Period|Other|0|||
131843848|NCT01517373|474708855|FG004|Treatment Period|Other|1|||
131910876|NCT03573297|474960887|FG001|Open Label Treatment Period|Pregnancy|0|||
131910877|NCT03573297|474960888|FG002|Open Label Treatment Period|Pregnancy|0|||
131910878|NCT03573297|474960889|FG003|Open Label Treatment Period|Pregnancy|0|||
131910879|NCT03573297|474960886|FG000|Open Label Treatment Period|Protocol Violation|17|||
131910880|NCT03573297|474960887|FG001|Open Label Treatment Period|Protocol Violation|0|||
131910881|NCT03573297|474960888|FG002|Open Label Treatment Period|Protocol Violation|0|||
131910882|NCT03573297|474960889|FG003|Open Label Treatment Period|Protocol Violation|0|||
131910883|NCT03573297|474960886|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
131910884|NCT03573297|474960887|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
131450366|NCT03847896|473278157|FG000|Overall Study|Withdrawal by Subject|2|||
131450367|NCT03847896|473278158|FG001|Overall Study|Withdrawal by Subject|10|||
131450368|NCT03847896|473278159|FG002|Overall Study|Withdrawal by Subject|5|||
131843849|NCT01517373|474708856|FG005|Treatment Period|Other|0|||
131843850|NCT01517373|474708851|FG000|Treatment Period|Protocol Violation|0|||
131843851|NCT01517373|474708852|FG001|Treatment Period|Protocol Violation|0|||
131843852|NCT01517373|474708853|FG002|Treatment Period|Protocol Violation|0|||
131843853|NCT01517373|474708854|FG003|Treatment Period|Protocol Violation|0|||
131843854|NCT01517373|474708855|FG004|Treatment Period|Protocol Violation|1|||
131843855|NCT01517373|474708856|FG005|Treatment Period|Protocol Violation|0|||
131843856|NCT01517373|474708851|FG000|Treatment Period|Lack of Efficacy|0|||
131843857|NCT01517373|474708852|FG001|Treatment Period|Lack of Efficacy|1|||
131843858|NCT01517373|474708853|FG002|Treatment Period|Lack of Efficacy|1|||
131843859|NCT01517373|474708854|FG003|Treatment Period|Lack of Efficacy|3|||
131843860|NCT01517373|474708855|FG004|Treatment Period|Lack of Efficacy|2|||
131843861|NCT01517373|474708856|FG005|Treatment Period|Lack of Efficacy|0|||
131843862|NCT01517373|474708851|FG000|Treatment Period|Medication error without AEs|0|||
131843863|NCT01517373|474708852|FG001|Treatment Period|Medication error without AEs|0|||
131843864|NCT01517373|474708853|FG002|Treatment Period|Medication error without AEs|2|||
131843865|NCT01517373|474708854|FG003|Treatment Period|Medication error without AEs|1|||
131843866|NCT01517373|474708855|FG004|Treatment Period|Medication error without AEs|0|||
131843867|NCT01517373|474708856|FG005|Treatment Period|Medication error without AEs|2|||
131843868|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
131843869|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
131843870|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
131843871|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
131843872|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
131843873|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
131843874|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
131843875|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
131843876|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
131843877|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
131843878|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Death|1|||
131843879|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Death|0|||
131843880|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Death|0|||
131843881|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Death|0|||
131843882|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Death|0|||
131843883|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
131843884|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
131843885|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
131843886|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
131843887|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
131843888|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
131843889|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
131843890|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
131843891|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
131843892|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
131843893|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
131843894|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
131843895|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
131843896|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
131843897|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
131843898|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
131843899|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
131843900|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
131843901|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
131843902|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131843903|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
131910885|NCT03573297|474960888|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
131910886|NCT03573297|474960889|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
131910887|NCT03573297|474960886|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
131843904|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131843905|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131843906|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131843907|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131843908|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Other|4|||
131843909|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Other|4|||
131843910|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Other|3|||
131843911|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Other|1|||
131843912|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Other|0|||
131843913|NCT01081834|474708858|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
131843914|NCT01081834|474708859|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
131843915|NCT01081834|474708860|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
131843916|NCT01081834|474708861|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
131843917|NCT01081834|474708862|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
131843918|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
131843919|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
131843920|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
131843921|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
131843922|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
131843923|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Death|1|||
131843924|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Death|0|||
131843925|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Death|0|||
131843926|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Death|0|||
131843927|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Death|0|||
131843928|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
131843929|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
131843930|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131843931|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131843932|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131843933|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131843934|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131843935|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131843936|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131843937|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131843938|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131843939|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
131843940|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131843941|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131843942|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131843943|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
131843944|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131843945|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
131843946|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131843947|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131843948|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
131843949|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
131843950|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
131843951|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
131843952|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
131843953|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Other|4|||
131843954|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Other|5|||
131843955|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Other|4|||
131843956|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Other|0|||
131843957|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Other|0|||
131843958|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
131843959|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
131843960|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
131843961|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
131843962|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
131910888|NCT03573297|474960887|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
131910889|NCT03573297|474960888|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
131402989|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
131402990|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
131450369|NCT03847896|473278160|FG003|Overall Study|Withdrawal by Subject|9|||
131450370|NCT03847896|473278161|FG004|Overall Study|Withdrawal by Subject|8|||
131450371|NCT03847896|473278157|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131450372|NCT03847896|473278158|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131450373|NCT03847896|473278159|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131450374|NCT03847896|473278160|FG003|Overall Study|Withdrawal by parent/guardian|0|||
131450375|NCT03847896|473278161|FG004|Overall Study|Withdrawal by parent/guardian|0|||
131450376|NCT03847896|473278157|FG000|Overall Study|Adverse Event|2|||
131450377|NCT03847896|473278158|FG001|Overall Study|Adverse Event|1|||
131450378|NCT03847896|473278159|FG002|Overall Study|Adverse Event|3|||
131450379|NCT03847896|473278160|FG003|Overall Study|Adverse Event|2|||
131450380|NCT03847896|473278161|FG004|Overall Study|Adverse Event|4|||
131450381|NCT03847896|473278157|FG000|Overall Study|A severe exacerbation event|0|||
131450382|NCT03847896|473278158|FG001|Overall Study|A severe exacerbation event|0|||
131450383|NCT03847896|473278159|FG002|Overall Study|A severe exacerbation event|0|||
131450384|NCT03847896|473278160|FG003|Overall Study|A severe exacerbation event|0|||
131450385|NCT03847896|473278161|FG004|Overall Study|A severe exacerbation event|3|||
131450386|NCT03847896|473278157|FG000|Overall Study|Protocol Violation|0|||
131450387|NCT03847896|473278158|FG001|Overall Study|Protocol Violation|2|||
131450388|NCT03847896|473278159|FG002|Overall Study|Protocol Violation|1|||
131450389|NCT03847896|473278160|FG003|Overall Study|Protocol Violation|0|||
131450390|NCT03847896|473278161|FG004|Overall Study|Protocol Violation|2|||
131450391|NCT03847896|473278157|FG000|Overall Study|Lost to Follow-up|0|||
131450392|NCT03847896|473278158|FG001|Overall Study|Lost to Follow-up|0|||
131450393|NCT03847896|473278159|FG002|Overall Study|Lost to Follow-up|0|||
131450394|NCT03847896|473278160|FG003|Overall Study|Lost to Follow-up|1|||
131450395|NCT03847896|473278161|FG004|Overall Study|Lost to Follow-up|0|||
131450396|NCT03847896|473278157|FG000|Overall Study|Condition under investigation worsened|0|||
131450397|NCT03847896|473278158|FG001|Overall Study|Condition under investigation worsened|0|||
131450398|NCT03847896|473278159|FG002|Overall Study|Condition under investigation worsened|0|||
131450399|NCT03847896|473278160|FG003|Overall Study|Condition under investigation worsened|1|||
131450400|NCT03847896|473278161|FG004|Overall Study|Condition under investigation worsened|1|||
131450401|NCT03847896|473278157|FG000|Overall Study|Lack of Efficacy|0|||
131450402|NCT03847896|473278158|FG001|Overall Study|Lack of Efficacy|0|||
131450403|NCT03847896|473278159|FG002|Overall Study|Lack of Efficacy|0|||
131450404|NCT03847896|473278160|FG003|Overall Study|Lack of Efficacy|2|||
131450405|NCT03847896|473278161|FG004|Overall Study|Lack of Efficacy|2|||
131450406|NCT03847896|473278157|FG000|Overall Study|Other reasons|3|||
131450407|NCT03847896|473278158|FG001|Overall Study|Other reasons|3|||
131450408|NCT03847896|473278159|FG002|Overall Study|Other reasons|1|||
131450409|NCT03847896|473278160|FG003|Overall Study|Other reasons|2|||
131450410|NCT03847896|473278161|FG004|Overall Study|Other reasons|1|||
131450411|NCT02978781|473278162|FG000|Part A|Adverse Event|1|||
131450412|NCT02978781|473278163|FG001|Part A|Adverse Event|1|||
131843963|NCT01081834|474708858|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131843964|NCT01081834|474708859|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
131843965|NCT01081834|474708860|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131843966|NCT01081834|474708861|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131843967|NCT01081834|474708862|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131843968|NCT04516759|474708871|FG000|Overall Study|Withdrawal by Subject|1|||
131843969|NCT04516759|474708872|FG001|Overall Study|Withdrawal by Subject|1|||
131843970|NCT04516759|474708871|FG000|Overall Study|Other|0|||
131843971|NCT04516759|474708872|FG001|Overall Study|Other|1|||
131843972|NCT00528411|474708873|FG000|Overall Study|Adverse Event|4|||
131843973|NCT00528411|474708874|FG001|Overall Study|Adverse Event|0|||
131843974|NCT00528411|474708875|FG002|Overall Study|Adverse Event|1|||
131843975|NCT00528411|474708873|FG000|Overall Study|Incorrect Enrolment|1|||
131843976|NCT00528411|474708874|FG001|Overall Study|Incorrect Enrolment|1|||
131843977|NCT00528411|474708875|FG002|Overall Study|Incorrect Enrolment|0|||
131843978|NCT00528411|474708873|FG000|Overall Study|Severe non-compliance to protocol|0|||
131843979|NCT00528411|474708874|FG001|Overall Study|Severe non-compliance to protocol|1|||
131843980|NCT00528411|474708875|FG002|Overall Study|Severe non-compliance to protocol|0|||
131843981|NCT00528411|474708873|FG000|Overall Study|Prior commitment medication|0|||
131910890|NCT03573297|474960889|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
131450413|NCT02978781|473278164|FG002|Part A|Adverse Event|0|||
131450414|NCT02978781|473278165|FG003|Part A|Adverse Event|0|||
131450415|NCT02978781|473278166|FG004|Part A|Adverse Event|0|||
131450416|NCT02978781|473278162|FG000|Part A|Withdrawal by Subject|0|||
131450417|NCT02978781|473278163|FG001|Part A|Withdrawal by Subject|1|||
131450418|NCT02978781|473278164|FG002|Part A|Withdrawal by Subject|0|||
131450419|NCT02978781|473278165|FG003|Part A|Withdrawal by Subject|0|||
131450420|NCT02978781|473278166|FG004|Part A|Withdrawal by Subject|0|||
131450421|NCT02978781|473278162|FG000|Part B|Withdrawal by Subject|0|||
131450422|NCT02978781|473278163|FG001|Part B|Withdrawal by Subject|0|||
131450423|NCT02978781|473278164|FG002|Part B|Withdrawal by Subject|0|||
131450424|NCT02978781|473278165|FG003|Part B|Withdrawal by Subject|1|||
131450425|NCT02978781|473278166|FG004|Part B|Withdrawal by Subject|0|||
131843982|NCT00528411|474708874|FG001|Overall Study|Prior commitment medication|1|||
131843983|NCT00528411|474708875|FG002|Overall Study|Prior commitment medication|0|||
131843984|NCT01221363|474708879|FG000|Overall Study|Pregnancy|1|||
131843985|NCT01221363|474708880|FG001|Overall Study|Pregnancy|0|||
131843986|NCT01221363|474708879|FG000|Overall Study|Withdrawal by Subject|11|||
131843987|NCT01221363|474708880|FG001|Overall Study|Withdrawal by Subject|5|||
131843988|NCT00407758|474708881|FG000|Overall Study|ineligible -improper prior treatment|1|||
131843989|NCT01822275|474708882|FG000|Overall Study|Withdrawal by Subject|3|||
131843990|NCT01822275|474708882|FG000|Overall Study|Adverse Event|3|||
131843991|NCT01822275|474708882|FG000|Overall Study|Progression|14|||
131843992|NCT01822275|474708882|FG000|Overall Study|Physician Decision|2|||
131843993|NCT01458106|474708883|FG000|Overall Study|Withdrawal by Subject|2|||
131843994|NCT01458106|474708884|FG001|Overall Study|Withdrawal by Subject|0|||
131843995|NCT01458106|474708883|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
131843996|NCT01458106|474708884|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
131843997|NCT01458106|474708883|FG000|Overall Study|Withdrawn Per Protocol|0|||
131843998|NCT01458106|474708884|FG001|Overall Study|Withdrawn Per Protocol|1|||
131843999|NCT00073021|474708885|FG000|Overall Study|Protocol Violation|2|||
131844000|NCT00073021|474708886|FG001|Overall Study|Protocol Violation|1|||
131844001|NCT00073021|474708885|FG000|Overall Study|Adverse Event|4|||
131844002|NCT00073021|474708886|FG001|Overall Study|Adverse Event|4|||
131844003|NCT00073021|474708885|FG000|Overall Study|Withdrawal by Subject|6|||
131844004|NCT00073021|474708886|FG001|Overall Study|Withdrawal by Subject|5|||
131844005|NCT00073021|474708885|FG000|Overall Study|Physician Decision|3|||
131844006|NCT00073021|474708886|FG001|Overall Study|Physician Decision|1|||
131844007|NCT00073021|474708885|FG000|Overall Study|Lack of Efficacy|11|||
131844008|NCT00073021|474708886|FG001|Overall Study|Lack of Efficacy|5|||
131844009|NCT00855803|474708887|FG000|Overall Study|Death|2|||
131844010|NCT00855803|474708887|FG000|Overall Study|Lost to Follow-up|2|||
131844011|NCT00855803|474708887|FG000|Overall Study|Technical inability to undergo procedure|2|||
131844012|NCT00855803|474708887|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
131844013|NCT00855803|474708887|FG000|Overall Study|Withdrawal by Subject|3|||
131844014|NCT00855803|474708887|FG000|Overall Study|Physician Decision|3|||
131844015|NCT01672970|474708889|FG000|Overall Study|Lack of Efficacy|12|||
131844016|NCT01672970|474708889|FG000|Overall Study|Adverse Event|18|||
131844017|NCT01672970|474708889|FG000|Overall Study|Withdrawal by Subject|2|||
131844018|NCT01672970|474708889|FG000|Overall Study|Lost to Follow-up|5|||
131844019|NCT01672970|474708889|FG000|Overall Study|Other|9|||
131844020|NCT01672970|474708889|FG000|Overall Study|Enrolled but not treated|1|||
131844021|NCT03276780|474708890|FG000|Overall Study|Withdrawal by Subject|5|||
131844022|NCT03276780|474708891|FG001|Overall Study|Withdrawal by Subject|3|||
131844023|NCT03276780|474708890|FG000|Overall Study|Lost to Follow-up|3|||
131844024|NCT03276780|474708891|FG001|Overall Study|Lost to Follow-up|5|||
131844025|NCT03276780|474708890|FG000|Overall Study|Moved out of state|1|||
131844026|NCT03276780|474708891|FG001|Overall Study|Moved out of state|1|||
131844027|NCT03276780|474708890|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
131844028|NCT03276780|474708891|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
131910891|NCT03573297|474960886|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
131910892|NCT03573297|474960887|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
131910893|NCT03573297|474960888|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
131910894|NCT03573297|474960889|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
131910895|NCT03573297|474960886|FG000|Open Label Treatment Period|Other, Not Specified|7|||
131910896|NCT03573297|474960887|FG001|Open Label Treatment Period|Other, Not Specified|0|||
131910897|NCT03573297|474960888|FG002|Open Label Treatment Period|Other, Not Specified|0|||
131844029|NCT03276780|474708890|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
131844030|NCT03276780|474708891|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
131844031|NCT03835221|474708892|FG000|Methafilcon A|Withdrawal by Subject|1|||
131844032|NCT00390221|474708894|FG000|Overall Study|Lost to Follow-up|0|||
131844033|NCT00390221|474708895|FG001|Overall Study|Lost to Follow-up|3|||
131844034|NCT00390221|474708896|FG002|Overall Study|Lost to Follow-up|0|||
131844035|NCT00390221|474708894|FG000|Overall Study|Adverse Event|1|||
131844036|NCT00390221|474708895|FG001|Overall Study|Adverse Event|4|||
131844037|NCT00390221|474708896|FG002|Overall Study|Adverse Event|3|||
131910898|NCT03573297|474960889|FG003|Open Label Treatment Period|Other, Not Specified|0|||
131844038|NCT00390221|474708894|FG000|Overall Study|Investigator Decision|0|||
131402991|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
131844039|NCT00390221|474708895|FG001|Overall Study|Investigator Decision|0|||
131844040|NCT00390221|474708896|FG002|Overall Study|Investigator Decision|1|||
131844041|NCT00390221|474708894|FG000|Overall Study|Withdrawal by Subject|13|||
131844042|NCT00390221|474708895|FG001|Overall Study|Withdrawal by Subject|9|||
131844043|NCT00390221|474708896|FG002|Overall Study|Withdrawal by Subject|7|||
131402992|NCT01461928|473097822|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
131844044|NCT00390221|474708894|FG000|Overall Study|Subject Non-compliance|1|||
131844045|NCT00390221|474708895|FG001|Overall Study|Subject Non-compliance|0|||
131450426|NCT02978781|473278162|FG000|Part C|Adverse Event|0|||
131450427|NCT02978781|473278163|FG001|Part C|Adverse Event|0|||
131450428|NCT02978781|473278164|FG002|Part C|Adverse Event|0|||
131450429|NCT02978781|473278165|FG003|Part C|Adverse Event|0|||
131450430|NCT02978781|473278166|FG004|Part C|Adverse Event|2|||
131450431|NCT02978781|473278162|FG000|Part C|Withdrawal by Subject|0|||
131450432|NCT02978781|473278163|FG001|Part C|Withdrawal by Subject|0|||
131450433|NCT02978781|473278164|FG002|Part C|Withdrawal by Subject|0|||
131450434|NCT02978781|473278165|FG003|Part C|Withdrawal by Subject|0|||
131450435|NCT02978781|473278166|FG004|Part C|Withdrawal by Subject|1|||
131450436|NCT02978781|473278162|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
131450437|NCT02978781|473278163|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
131450438|NCT02978781|473278164|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
131450439|NCT02978781|473278165|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
131450440|NCT02978781|473278166|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
131450441|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
131450442|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
131450443|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Adverse Event|31|||
131450444|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Adverse Event|21|||
131450445|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
131450446|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
131450447|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
131450448|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
131450449|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
131450450|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
131450451|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
131450452|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
131450453|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Administrative problems|3|||
131450454|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Administrative problems|3|||
131450455|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Death|5|||
131450456|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Death|8|||
131450457|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Disease progression|139|||
131450458|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Disease progression|119|||
131450459|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
131844046|NCT00390221|474708896|FG002|Overall Study|Subject Non-compliance|2|||
131844047|NCT00390221|474708894|FG000|Overall Study|Other|3|||
131844048|NCT00390221|474708895|FG001|Overall Study|Other|4|||
131844049|NCT00390221|474708896|FG002|Overall Study|Other|2|||
131844050|NCT02533375|474708897|FG000|Overall Study|Lack of Efficacy|3|||
131844051|NCT02533375|474708897|FG000|Overall Study|Adverse Event|2|||
131844052|NCT02823652|474708901|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
131844053|NCT02823652|474708902|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
131844054|NCT02823652|474708903|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
131844055|NCT02823652|474708901|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
131844056|NCT02823652|474708902|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
131844057|NCT02823652|474708903|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
131844058|NCT02823652|474708901|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
131844059|NCT02823652|474708902|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
131844060|NCT02823652|474708903|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
131844061|NCT02823652|474708901|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
131844062|NCT02823652|474708902|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
131844063|NCT02823652|474708903|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
131844064|NCT03567382|474708908|FG000|Overall Study|Lost to Follow-up|1|||
131844065|NCT03567382|474708909|FG001|Overall Study|Lost to Follow-up|21|||
131844066|NCT03567382|474708910|FG002|Overall Study|Lost to Follow-up|1|||
131844067|NCT03567382|474708911|FG003|Overall Study|Lost to Follow-up|21|||
131844068|NCT03567382|474708908|FG000|Overall Study|Withdrawal by Subject|2|||
131844069|NCT03567382|474708909|FG001|Overall Study|Withdrawal by Subject|14|||
131844070|NCT03567382|474708910|FG002|Overall Study|Withdrawal by Subject|1|||
131844071|NCT03567382|474708911|FG003|Overall Study|Withdrawal by Subject|12|||
131844072|NCT04345601|474710530|FG000|Overall Study|Death|0|||
131844073|NCT04345601|474710531|FG001|Overall Study|Death|3|||
131844074|NCT04345601|474710532|FG002|Overall Study|Death|2|||
131844075|NCT04345601|474710530|FG000|Overall Study|Lost to Follow-up|0|||
131844076|NCT04345601|474710531|FG001|Overall Study|Lost to Follow-up|0|||
131844077|NCT04345601|474710532|FG002|Overall Study|Lost to Follow-up|2|||
131844078|NCT00000378|474710533|FG000|Overall Study|Lack of Efficacy|16|||
131844079|NCT00000378|474710534|FG001|Overall Study|Lack of Efficacy|14|||
131844080|NCT04003896|474710537|FG000|Overall Study|Withdrawal by Subject|3|||
131450460|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
131450461|NCT00785785|473278167|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
131450462|NCT00785785|473278168|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
131450463|NCT00785785|473278167|FG000|Optional Extension Phase|Adverse Event|4|||
131450464|NCT00785785|473278168|FG001|Optional Extension Phase|Adverse Event|5|||
131844081|NCT04003896|474710537|FG000|Overall Study|Physician Decision|1|||
131844082|NCT02315196|474710541|FG000|Overall Study|Withdrew consent|9|||
131844083|NCT00470067|474710542|FG000|Overall Study|Death|1|||
131844084|NCT00470067|474710542|FG000|Overall Study|Disease Progression|6|||
131844085|NCT02563106|474710543|FG000|Overall Study|Withdrawal by Subject|7|||
131844086|NCT02563106|474710544|FG001|Overall Study|Withdrawal by Subject|8|||
131844087|NCT02563106|474710543|FG000|Overall Study|Adverse Event|17|||
131844088|NCT02563106|474710544|FG001|Overall Study|Adverse Event|15|||
131844089|NCT02563106|474710543|FG000|Overall Study|Protocol Violation|1|||
131844090|NCT02563106|474710544|FG001|Overall Study|Protocol Violation|0|||
131844091|NCT02563106|474710543|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
131844092|NCT02563106|474710544|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
131844093|NCT02563106|474710543|FG000|Overall Study|Lost to Follow-up|3|||
131844094|NCT02563106|474710544|FG001|Overall Study|Lost to Follow-up|2|||
131844095|NCT02563106|474710543|FG000|Overall Study|Physician Decision|3|||
131844096|NCT02563106|474710544|FG001|Overall Study|Physician Decision|1|||
131844097|NCT02563106|474710543|FG000|Overall Study|Other reason - not specified|2|||
131844098|NCT02563106|474710544|FG001|Overall Study|Other reason - not specified|1|||
131844099|NCT01059539|474710545|FG000|Overall Study|Adverse Event|66|||
131844100|NCT01059539|474710545|FG000|Overall Study|Insufficient Therapeutic Response|26|||
131844101|NCT01059539|474710545|FG000|Overall Study|Protocol Violation|55|||
131844102|NCT01059539|474710545|FG000|Overall Study|Withdrawal of Consent|80|||
131844103|NCT01059539|474710545|FG000|Overall Study|Lost to Follow-up|42|||
131844104|NCT01059539|474710545|FG000|Overall Study|Reason Not Specified|2|||
131844105|NCT00537303|474710546|FG000|Overall Study|Adverse Event|1|||
131844106|NCT00537303|474710547|FG001|Overall Study|Adverse Event|4|||
131844107|NCT00537303|474710546|FG000|Overall Study|Lack of Efficacy|6|||
131844108|NCT00537303|474710547|FG001|Overall Study|Lack of Efficacy|7|||
131844109|NCT00537303|474710546|FG000|Overall Study|Protocol Violation|8|||
131844110|NCT00537303|474710547|FG001|Overall Study|Protocol Violation|4|||
131844111|NCT00537303|474710546|FG000|Overall Study|Withdrawal criteria|3|||
131844112|NCT00537303|474710547|FG001|Overall Study|Withdrawal criteria|3|||
131844113|NCT00537303|474710546|FG000|Overall Study|Unclassified|8|||
131844114|NCT00537303|474710547|FG001|Overall Study|Unclassified|7|||
131844115|NCT04091659|474710548|FG000|Overall Study|Protocol Violation|3|||
131844116|NCT04091659|474710549|FG001|Overall Study|Protocol Violation|0|||
131844117|NCT04091659|474710548|FG000|Overall Study|Lost to Follow-up|0|||
131844118|NCT04091659|474710549|FG001|Overall Study|Lost to Follow-up|1|||
131844119|NCT03678285|474710552|FG000|Overall Study|Adverse Event|2|||
131844120|NCT03678285|474710552|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
131844121|NCT03678285|474710552|FG000|Overall Study|Dehydrated prior to start of workout|1|||
131844122|NCT01777620|474710553|FG000|Overall Study|Subject Withdrawal|1|||
131844123|NCT01777620|474710554|FG001|Overall Study|Subject Withdrawal|0|||
131844124|NCT01475097|474710555|FG000|Overall Study|Protocol Violation|1|||
131844125|NCT01475097|474710556|FG001|Overall Study|Protocol Violation|1|||
131844126|NCT00851318|474710567|FG000|Overall Study|Withdrawal by Subject|7|||
131844127|NCT00851318|474710568|FG001|Overall Study|Withdrawal by Subject|1|||
131844128|NCT00851318|474710569|FG002|Overall Study|Withdrawal by Subject|5|||
131844129|NCT00851318|474710570|FG003|Overall Study|Withdrawal by Subject|3|||
131844130|NCT00851318|474710567|FG000|Overall Study|Adverse Event|13|||
131844131|NCT00851318|474710568|FG001|Overall Study|Adverse Event|2|||
131844132|NCT00851318|474710569|FG002|Overall Study|Adverse Event|9|||
131844133|NCT00851318|474710570|FG003|Overall Study|Adverse Event|12|||
131844134|NCT00851318|474710567|FG000|Overall Study|Pregnancy|0|||
131844135|NCT00851318|474710568|FG001|Overall Study|Pregnancy|0|||
131844136|NCT00851318|474710569|FG002|Overall Study|Pregnancy|1|||
131844137|NCT00851318|474710570|FG003|Overall Study|Pregnancy|1|||
131844138|NCT00851318|474710567|FG000|Overall Study|Lack of Efficacy|8|||
131844139|NCT00851318|474710568|FG001|Overall Study|Lack of Efficacy|2|||
131844140|NCT00851318|474710569|FG002|Overall Study|Lack of Efficacy|4|||
131844141|NCT00851318|474710570|FG003|Overall Study|Lack of Efficacy|2|||
131844142|NCT00851318|474710567|FG000|Overall Study|Non-compliance with Study Procedures|2|||
131844143|NCT00851318|474710568|FG001|Overall Study|Non-compliance with Study Procedures|0|||
131844144|NCT00851318|474710569|FG002|Overall Study|Non-compliance with Study Procedures|1|||
131844145|NCT00851318|474710570|FG003|Overall Study|Non-compliance with Study Procedures|0|||
131844146|NCT00851318|474710567|FG000|Overall Study|Physician Decision|0|||
131844147|NCT00851318|474710568|FG001|Overall Study|Physician Decision|0|||
131844148|NCT00851318|474710569|FG002|Overall Study|Physician Decision|1|||
131844149|NCT00851318|474710570|FG003|Overall Study|Physician Decision|1|||
131844150|NCT01844856|474710577|FG000|Overall Study|Lost to Follow-up|15|||
131844151|NCT01844856|474710578|FG001|Overall Study|Lost to Follow-up|3|||
131844152|NCT01844856|474710577|FG000|Overall Study|Adverse Event|3|||
131844153|NCT01844856|474710578|FG001|Overall Study|Adverse Event|6|||
131434000|NCT00985465|473214593|FG000|Overall Study|Considered to be part of the other group|0|||
131844154|NCT01844856|474710577|FG000|Overall Study|Withdrawal by Subject|3|||
131844155|NCT01844856|474710578|FG001|Overall Study|Withdrawal by Subject|2|||
131844156|NCT01844856|474710577|FG000|Overall Study|Noncompliance|2|||
131844157|NCT01844856|474710578|FG001|Overall Study|Noncompliance|3|||
131844158|NCT01844856|474710577|FG000|Overall Study|Enterococcus Resistant|0|||
131844159|NCT01844856|474710578|FG001|Overall Study|Enterococcus Resistant|1|||
131844160|NCT01844856|474710577|FG000|Overall Study|Inadvertently Not Scheduled|1|||
131844161|NCT01844856|474710578|FG001|Overall Study|Inadvertently Not Scheduled|0|||
131844162|NCT01844856|474710577|FG000|Overall Study|Randomized but was a Screen Failure|0|||
131844163|NCT01844856|474710578|FG001|Overall Study|Randomized but was a Screen Failure|1|||
131844164|NCT01001988|474710579|FG000|Overall Study|Protocol Violation|84|||
131844165|NCT01001988|474710579|FG000|Overall Study|Withdrawal by Subject|18|||
131844166|NCT01001988|474710579|FG000|Overall Study|Lost to Follow-up|15|||
131844167|NCT01329549|474710581|FG000|Overall Study|Withdrawal by Subject|1|||
131844168|NCT01329549|474710581|FG000|Overall Study|Adverse Event|1|||
131844169|NCT03597529|474710591|FG000|Overall Study|Lost to Follow-up|10|||
131844170|NCT03597529|474710592|FG001|Overall Study|Lost to Follow-up|12|||
131844171|NCT03597529|474710591|FG000|Overall Study|Physician Decision|3|||
131844172|NCT03597529|474710592|FG001|Overall Study|Physician Decision|1|||
131844173|NCT03597529|474710591|FG000|Overall Study|Withdrawal by Subject|6|||
131844174|NCT03597529|474710592|FG001|Overall Study|Withdrawal by Subject|3|||
131844175|NCT03597529|474710591|FG000|Overall Study|Non-compliant with study activities|1|||
131844176|NCT03597529|474710592|FG001|Overall Study|Non-compliant with study activities|2|||
131844177|NCT03196635|474710597|FG000|Overall Study|Withdrawal by Subject|1|||
131844178|NCT00998309|474710601|FG000|Overall Study|Protocol Violation|4|||
131844179|NCT02865460|474710602|FG000|Overall Study|Adverse Event|1|||
131844180|NCT02865460|474710603|FG001|Overall Study|Adverse Event|0|||
131844181|NCT02865460|474710602|FG000|Overall Study|Withdrawal by Subject|1|||
131844182|NCT02865460|474710603|FG001|Overall Study|Withdrawal by Subject|1|||
131450465|NCT00785785|473278167|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
131450466|NCT00785785|473278168|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
131450467|NCT00785785|473278167|FG000|Optional Extension Phase|Lost to Follow-up|1|||
131450468|NCT00785785|473278168|FG001|Optional Extension Phase|Lost to Follow-up|0|||
131450469|NCT00785785|473278167|FG000|Optional Extension Phase|Administrative problems|2|||
131844183|NCT02865460|474710602|FG000|Overall Study|Lost to Follow-up|7|||
131844184|NCT02865460|474710603|FG001|Overall Study|Lost to Follow-up|4|||
131844185|NCT02865460|474710602|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
131844186|NCT02865460|474710603|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
131844187|NCT02238795|474710611|FG000|Overall Study|Patient without purpura fulminans|1|||
131844188|NCT01292226|474710615|FG000|Overall Study|Adverse Event|5|||
131844189|NCT01292226|474710615|FG000|Overall Study|Death|1|||
131844190|NCT01292226|474710615|FG000|Overall Study|Graft loss|1|||
131844191|NCT01292226|474710615|FG000|Overall Study|Protocol Violation|3|||
131844192|NCT01292226|474710615|FG000|Overall Study|Withdrawal by Subject|1|||
131844193|NCT01292226|474710615|FG000|Overall Study|Other|2|||
131844194|NCT01584843|474710616|FG000|First Treatment Period|Adverse Event|0|||
131844195|NCT01584843|474710617|FG001|First Treatment Period|Adverse Event|0|||
131844196|NCT01584843|474710618|FG002|First Treatment Period|Adverse Event|1|||
131844197|NCT01584843|474710619|FG003|First Treatment Period|Adverse Event|0|||
131844198|NCT01584843|474710620|FG004|First Treatment Period|Adverse Event|0|||
131844199|NCT01584843|474710621|FG005|First Treatment Period|Adverse Event|0|||
131910899|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
131910900|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
131910901|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
131910902|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
131910903|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131910904|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131910905|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Adverse Event|5|||
131910906|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Adverse Event|1|||
131910907|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
131910908|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
131910909|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
131910910|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
131910911|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131910912|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
131844200|NCT01584843|474710616|FG000|First Treatment Period|Protocol Violation|0|||
131844201|NCT01584843|474710617|FG001|First Treatment Period|Protocol Violation|0|||
131844202|NCT01584843|474710618|FG002|First Treatment Period|Protocol Violation|0|||
131844203|NCT01584843|474710619|FG003|First Treatment Period|Protocol Violation|0|||
131844204|NCT01584843|474710620|FG004|First Treatment Period|Protocol Violation|0|||
131844205|NCT01584843|474710621|FG005|First Treatment Period|Protocol Violation|1|||
131844206|NCT01584843|474710616|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
131844207|NCT01584843|474710617|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
131844208|NCT01584843|474710618|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
131844209|NCT01584843|474710619|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
131844210|NCT01584843|474710620|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
131844211|NCT01584843|474710621|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
131844212|NCT01584843|474710616|FG000|Second Treatment Period|Withdrawal by Subject|0|||
131844213|NCT01584843|474710617|FG001|Second Treatment Period|Withdrawal by Subject|0|||
131844214|NCT01584843|474710618|FG002|Second Treatment Period|Withdrawal by Subject|0|||
131844215|NCT01584843|474710619|FG003|Second Treatment Period|Withdrawal by Subject|0|||
131844216|NCT01584843|474710620|FG004|Second Treatment Period|Withdrawal by Subject|0|||
131844217|NCT01584843|474710621|FG005|Second Treatment Period|Withdrawal by Subject|1|||
131844218|NCT02196701|474710622|FG000|Overall Study|Adverse Event|1|||
131844219|NCT02196701|474710622|FG000|Overall Study|Lost to Follow-up|1|||
131844220|NCT02196701|474710622|FG000|Overall Study|Non-adherence to Protocol|1|||
131844221|NCT00827632|474710624|FG000|Overall Study|Lost to Follow-up|8|||
131844222|NCT00827632|474710625|FG001|Overall Study|Lost to Follow-up|12|||
131844223|NCT00827632|474710624|FG000|Overall Study|Early withdrawal|14|||
131844224|NCT00827632|474710625|FG001|Overall Study|Early withdrawal|11|||
131844225|NCT01910389|474710627|FG000|Overall Study|Withdrawal by Subject|2|||
131844226|NCT01910389|474710628|FG001|Overall Study|Withdrawal by Subject|0|||
131844227|NCT01910389|474710627|FG000|Overall Study|Study Closed|13|||
131844228|NCT01910389|474710628|FG001|Overall Study|Study Closed|8|||
131844229|NCT04669691|474710642|FG000|Overall Study|Death|0|||
131844230|NCT04669691|474710643|FG001|Overall Study|Death|1|||
131844231|NCT04669691|474710644|FG002|Overall Study|Death|0|||
131844232|NCT04669691|474710645|FG003|Overall Study|Death|0|||
131844233|NCT04669691|474710646|FG004|Overall Study|Death|0|||
131844234|NCT04669691|474710647|FG005|Overall Study|Death|0|||
131844235|NCT03050060|474710648|FG000|Overall Study|Adverse Event|7|||
131844236|NCT03050060|474710648|FG000|Overall Study|Withdrawal by Subject|1|||
131844237|NCT03050060|474710648|FG000|Overall Study|Progression|7|||
131844238|NCT02304458|474710649|FG000|Overall Study|Adverse Event|0|||
131844239|NCT02304458|474710650|FG001|Overall Study|Adverse Event|0|||
131844240|NCT02304458|474710651|FG002|Overall Study|Adverse Event|7|||
131844241|NCT02304458|474710652|FG003|Overall Study|Adverse Event|0|||
131844242|NCT02304458|474710653|FG004|Overall Study|Adverse Event|0|||
131844243|NCT02304458|474710654|FG005|Overall Study|Adverse Event|0|||
131844244|NCT02304458|474710655|FG006|Overall Study|Adverse Event|3|||
131844245|NCT02304458|474710656|FG007|Overall Study|Adverse Event|4|||
131844246|NCT02304458|474710649|FG000|Overall Study|Death|0|||
131844247|NCT02304458|474710650|FG001|Overall Study|Death|0|||
131844248|NCT02304458|474710651|FG002|Overall Study|Death|2|||
131844249|NCT02304458|474710652|FG003|Overall Study|Death|0|||
131844250|NCT02304458|474710653|FG004|Overall Study|Death|0|||
131844251|NCT02304458|474710654|FG005|Overall Study|Death|0|||
131844252|NCT02304458|474710655|FG006|Overall Study|Death|1|||
131844253|NCT02304458|474710656|FG007|Overall Study|Death|0|||
131844254|NCT02304458|474710649|FG000|Overall Study|Lack of Efficacy|4|||
131844255|NCT02304458|474710650|FG001|Overall Study|Lack of Efficacy|6|||
131844256|NCT02304458|474710651|FG002|Overall Study|Lack of Efficacy|38|||
131844257|NCT02304458|474710652|FG003|Overall Study|Lack of Efficacy|5|||
131844258|NCT02304458|474710653|FG004|Overall Study|Lack of Efficacy|6|||
131844259|NCT02304458|474710654|FG005|Overall Study|Lack of Efficacy|6|||
131844260|NCT02304458|474710655|FG006|Overall Study|Lack of Efficacy|21|||
131844261|NCT02304458|474710656|FG007|Overall Study|Lack of Efficacy|4|||
131844262|NCT02304458|474710649|FG000|Overall Study|Physician Decision|2|||
131844263|NCT02304458|474710650|FG001|Overall Study|Physician Decision|0|||
131844264|NCT02304458|474710651|FG002|Overall Study|Physician Decision|16|||
131844265|NCT02304458|474710652|FG003|Overall Study|Physician Decision|1|||
131844266|NCT02304458|474710653|FG004|Overall Study|Physician Decision|0|||
131844267|NCT02304458|474710654|FG005|Overall Study|Physician Decision|0|||
131844268|NCT02304458|474710655|FG006|Overall Study|Physician Decision|3|||
131844269|NCT02304458|474710656|FG007|Overall Study|Physician Decision|0|||
131844270|NCT02304458|474710649|FG000|Overall Study|Protocol Violation|0|||
131844271|NCT02304458|474710650|FG001|Overall Study|Protocol Violation|0|||
131844272|NCT02304458|474710651|FG002|Overall Study|Protocol Violation|1|||
131844273|NCT02304458|474710652|FG003|Overall Study|Protocol Violation|0|||
131844274|NCT02304458|474710653|FG004|Overall Study|Protocol Violation|0|||
131844275|NCT02304458|474710654|FG005|Overall Study|Protocol Violation|0|||
131844276|NCT02304458|474710655|FG006|Overall Study|Protocol Violation|0|||
131844277|NCT02304458|474710656|FG007|Overall Study|Protocol Violation|0|||
131844278|NCT02304458|474710649|FG000|Overall Study|Withdrawal by Subject|1|||
131844279|NCT02304458|474710650|FG001|Overall Study|Withdrawal by Subject|0|||
131844280|NCT02304458|474710651|FG002|Overall Study|Withdrawal by Subject|7|||
131844281|NCT02304458|474710652|FG003|Overall Study|Withdrawal by Subject|0|||
131844282|NCT02304458|474710653|FG004|Overall Study|Withdrawal by Subject|0|||
131844283|NCT02304458|474710654|FG005|Overall Study|Withdrawal by Subject|0|||
131844284|NCT02304458|474710655|FG006|Overall Study|Withdrawal by Subject|1|||
131844285|NCT02304458|474710656|FG007|Overall Study|Withdrawal by Subject|0|||
131844286|NCT03401450|474710657|FG000|Overall Study|Lost to Follow-up|4|||
131844287|NCT03401450|474710658|FG001|Overall Study|Lost to Follow-up|6|||
131844288|NCT03401450|474710657|FG000|Overall Study|Anesthesia plan changed|2|||
131844289|NCT03401450|474710658|FG001|Overall Study|Anesthesia plan changed|2|||
131844290|NCT03401450|474710657|FG000|Overall Study|Did not complete medication diary|4|||
131844291|NCT03401450|474710658|FG001|Overall Study|Did not complete medication diary|2|||
131844292|NCT03401450|474710657|FG000|Overall Study|post surgery medication change|2|||
131844293|NCT03401450|474710658|FG001|Overall Study|post surgery medication change|1|||
131844294|NCT03401450|474710657|FG000|Overall Study|Cancelled surgery|0|||
131844295|NCT03401450|474710658|FG001|Overall Study|Cancelled surgery|2|||
131844296|NCT02288182|474710659|FG000|Overall Study|Adverse Event|0|||
131844297|NCT02288182|474710660|FG001|Overall Study|Adverse Event|1|||
131844298|NCT02288182|474710659|FG000|Overall Study|Lost to Follow-up|0|||
131844299|NCT02288182|474710660|FG001|Overall Study|Lost to Follow-up|1|||
131844300|NCT02582866|474710661|FG000|Overall Study|Death|1|||
131844301|NCT02582866|474710661|FG000|Overall Study|Lack of Efficacy|2|||
131844302|NCT02582866|474710661|FG000|Overall Study|Lost to Follow-up|2|||
131844303|NCT02582866|474710661|FG000|Overall Study|Withdrawal by Subject|7|||
131844304|NCT02582866|474710661|FG000|Overall Study|Investigator decision|5|||
131844305|NCT02582866|474710661|FG000|Overall Study|Participant wants to get pregnant|1|||
131844306|NCT02582866|474710661|FG000|Overall Study|Pregnancy|2|||
131844307|NCT02582866|474710661|FG000|Overall Study|Sponsor decision|1|||
131844308|NCT02582866|474710661|FG000|Overall Study|Withdrawal due to personal reasons|1|||
131844309|NCT01214915|474710666|FG000|Overall Study|Adverse Event|8|||
131844310|NCT01214915|474710666|FG000|Overall Study|Lack of Efficacy|3|||
131844311|NCT02056392|474710667|FG000|Overall Study|Lost to Follow-up|0|||
131844312|NCT02056392|474710668|FG001|Overall Study|Lost to Follow-up|1|||
131844313|NCT02056392|474710669|FG002|Overall Study|Lost to Follow-up|2|||
131844314|NCT02056392|474710670|FG003|Overall Study|Lost to Follow-up|0|||
131844315|NCT02056392|474710671|FG004|Overall Study|Lost to Follow-up|0|||
131844316|NCT02056392|474710672|FG005|Overall Study|Lost to Follow-up|0|||
131844317|NCT02056392|474710667|FG000|Overall Study|Protocol Violation|1|||
131844318|NCT02056392|474710668|FG001|Overall Study|Protocol Violation|0|||
131844319|NCT02056392|474710669|FG002|Overall Study|Protocol Violation|1|||
131844320|NCT02056392|474710670|FG003|Overall Study|Protocol Violation|0|||
131844321|NCT02056392|474710671|FG004|Overall Study|Protocol Violation|0|||
131844322|NCT02056392|474710672|FG005|Overall Study|Protocol Violation|0|||
131844323|NCT02056392|474710667|FG000|Overall Study|Withdrawal by Subject|1|||
131844324|NCT02056392|474710668|FG001|Overall Study|Withdrawal by Subject|0|||
131844325|NCT02056392|474710669|FG002|Overall Study|Withdrawal by Subject|0|||
131844326|NCT02056392|474710670|FG003|Overall Study|Withdrawal by Subject|0|||
131844327|NCT02056392|474710671|FG004|Overall Study|Withdrawal by Subject|1|||
131844328|NCT02056392|474710672|FG005|Overall Study|Withdrawal by Subject|0|||
131844329|NCT03866902|474710673|FG000|Overall Study|Lost to Follow-up|98|||
131844330|NCT03866902|474710674|FG001|Overall Study|Lost to Follow-up|82|||
131844331|NCT03866902|474710673|FG000|Overall Study|Pregnancy|18|||
131844332|NCT03866902|474710674|FG001|Overall Study|Pregnancy|24|||
131844333|NCT04730349|474710677|FG000|Overall Study|Participant withdrew consent|1|||
131844334|NCT04730349|474710678|FG001|Overall Study|Participant withdrew consent|0|||
131844335|NCT04730349|474710677|FG000|Overall Study|Disease progression|6|||
131844336|NCT04730349|474710678|FG001|Overall Study|Disease progression|4|||
131844337|NCT04730349|474710677|FG000|Overall Study|Study drug toxicity|0|||
131844338|NCT04730349|474710678|FG001|Overall Study|Study drug toxicity|1|||
131844339|NCT03155945|474710679|FG000|Overall Study|Lost to Follow-up|0|||
131844340|NCT03155945|474710680|FG001|Overall Study|Lost to Follow-up|1|||
131844341|NCT03155945|474710679|FG000|Overall Study|Withdrawal by Subject|0|||
131844342|NCT03155945|474710680|FG001|Overall Study|Withdrawal by Subject|1|||
131844343|NCT03155945|474710679|FG000|Overall Study|Other Reason|0|||
131844344|NCT03155945|474710680|FG001|Overall Study|Other Reason|1|||
131844345|NCT03395405|474712547|FG000|Overall Study|Death|0|||
131844346|NCT03395405|474712548|FG001|Overall Study|Death|2|||
131844347|NCT03395405|474712547|FG000|Overall Study|Lost to Follow-up|0|||
131844348|NCT03395405|474712548|FG001|Overall Study|Lost to Follow-up|1|||
131844349|NCT03395405|474712547|FG000|Overall Study|Protocol Violation|0|||
131844350|NCT03395405|474712548|FG001|Overall Study|Protocol Violation|1|||
131844351|NCT03395405|474712547|FG000|Overall Study|Withdrawal by Subject|3|||
131844352|NCT03395405|474712548|FG001|Overall Study|Withdrawal by Subject|1|||
131844353|NCT03395405|474712547|FG000|Overall Study|COVID-19 Pandemic|1|||
131844354|NCT03395405|474712548|FG001|Overall Study|COVID-19 Pandemic|0|||
131844355|NCT01957397|474712551|FG000|Test Period 1|sudden leakage/small bag|1|||
131844356|NCT01957397|474712552|FG001|Test Period 1|sudden leakage/small bag|1|||
131844357|NCT01957397|474712551|FG000|Test Period 1|Withdrawal by Subject|1|||
131844358|NCT01957397|474712552|FG001|Test Period 1|Withdrawal by Subject|0|||
131844359|NCT01957397|474712551|FG000|Test Period 2|Adverse Event|0|||
131844360|NCT01957397|474712552|FG001|Test Period 2|Adverse Event|1|||
131844361|NCT01957397|474712551|FG000|Test Period 3|Adverse Event|1|||
131844362|NCT01957397|474712552|FG001|Test Period 3|Adverse Event|2|||
131844363|NCT01957397|474712551|FG000|Test Period 3|the adhesive did not work|1|||
131844364|NCT01957397|474712552|FG001|Test Period 3|the adhesive did not work|0|||
131844365|NCT00324649|474712553|FG000|Overall Study|Adverse Event|1|||
131844366|NCT00324649|474712554|FG001|Overall Study|Adverse Event|4|||
131844367|NCT00324649|474712553|FG000|Overall Study|Withdrawal by Subject|0|||
131844368|NCT00324649|474712554|FG001|Overall Study|Withdrawal by Subject|1|||
131844369|NCT00324649|474712553|FG000|Overall Study|Noncompliance|1|||
131844370|NCT00324649|474712554|FG001|Overall Study|Noncompliance|0|||
131844371|NCT00540293|474712555|FG000|Overall Study|Adverse event related to study drug|10|||
131844372|NCT00540293|474712555|FG000|Overall Study|Adverse event not related to study drug|7|||
131844373|NCT00540293|474712555|FG000|Overall Study|Withdrawal by Subject|6|||
131844374|NCT00540293|474712555|FG000|Overall Study|Protocol violation, & subject schedule|12|||
131844375|NCT02740699|474712560|FG000|Overall Study|Lost to Follow-up|5|||
131844376|NCT02740699|474712560|FG000|Overall Study|Withdrawal by Subject|14|||
131844377|NCT02740699|474712560|FG000|Overall Study|Physician Decision|5|||
131844378|NCT02585934|474712561|FG000|Overall Study|Lost to Follow-up|2|||
131844379|NCT02585934|474712562|FG001|Overall Study|Lost to Follow-up|2|||
131844380|NCT02585934|474712561|FG000|Overall Study|Protocol Violation|14|||
131844381|NCT02585934|474712562|FG001|Overall Study|Protocol Violation|11|||
131844382|NCT02585934|474712561|FG000|Overall Study|Adverse Event|21|||
131844383|NCT02585934|474712562|FG001|Overall Study|Adverse Event|22|||
131844384|NCT02585934|474712561|FG000|Overall Study|Physician Decision|3|||
131844385|NCT02585934|474712562|FG001|Overall Study|Physician Decision|2|||
131844386|NCT02585934|474712561|FG000|Overall Study|Withdrawal by Subject|7|||
131844387|NCT02585934|474712562|FG001|Overall Study|Withdrawal by Subject|21|||
131844388|NCT02585934|474712561|FG000|Overall Study|Lack of Efficacy|2|||
131844389|NCT02585934|474712562|FG001|Overall Study|Lack of Efficacy|1|||
131844390|NCT02585934|474712561|FG000|Overall Study|Death|2|||
131844391|NCT02585934|474712562|FG001|Overall Study|Death|0|||
131844392|NCT02585934|474712561|FG000|Overall Study|Caregiver Withdrew Consent|7|||
131844393|NCT02585934|474712562|FG001|Overall Study|Caregiver Withdrew Consent|7|||
131844394|NCT02585934|474712561|FG000|Overall Study|Sponsor Termination|1|||
131844395|NCT02585934|474712562|FG001|Overall Study|Sponsor Termination|2|||
131844396|NCT02585934|474712561|FG000|Overall Study|Another Reason|10|||
131844397|NCT02585934|474712562|FG001|Overall Study|Another Reason|5|||
131844398|NCT04713553|474712563|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
131844399|NCT04713553|474712564|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
131844400|NCT04713553|474712565|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
131844401|NCT04713553|474712566|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
131844402|NCT04713553|474712567|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
131844403|NCT04713553|474712568|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
131844404|NCT04713553|474712569|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
131844405|NCT04713553|474712563|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
131844406|NCT04713553|474712564|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
131844407|NCT04713553|474712565|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
131844408|NCT04713553|474712566|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
131844409|NCT04713553|474712567|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
131844410|NCT04713553|474712568|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
131844411|NCT04713553|474712569|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
131844412|NCT04713553|474712563|FG000|Primary Study (2 Months)|Other|1|||
131844413|NCT04713553|474712564|FG001|Primary Study (2 Months)|Other|2|||
131844414|NCT04713553|474712565|FG002|Primary Study (2 Months)|Other|0|||
131844415|NCT04713553|474712566|FG003|Primary Study (2 Months)|Other|0|||
131844416|NCT04713553|474712567|FG004|Primary Study (2 Months)|Other|1|||
131844417|NCT04713553|474712568|FG005|Primary Study (2 Months)|Other|0|||
131844418|NCT04713553|474712569|FG006|Primary Study (2 Months)|Other|0|||
131844419|NCT04713553|474712563|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
131450470|NCT00785785|473278168|FG001|Optional Extension Phase|Administrative problems|0|||
131450471|NCT00785785|473278167|FG000|Optional Extension Phase|Death|1|||
131450472|NCT00785785|473278168|FG001|Optional Extension Phase|Death|5|||
131450473|NCT00785785|473278167|FG000|Optional Extension Phase|Disease progression|22|||
131450474|NCT00785785|473278168|FG001|Optional Extension Phase|Disease progression|70|||
131844420|NCT04713553|474712564|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
131844421|NCT04713553|474712565|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
131844422|NCT04713553|474712566|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
131844423|NCT04713553|474712567|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
131844424|NCT04713553|474712568|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
131844425|NCT04713553|474712569|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
131844426|NCT04713553|474712563|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
131844427|NCT04713553|474712564|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
131844428|NCT04713553|474712565|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
131844429|NCT04713553|474712566|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
131844430|NCT04713553|474712567|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
131844431|NCT04713553|474712568|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
131844432|NCT04713553|474712569|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
131450475|NCT00785785|473278167|FG000|Optional Extension Phase|Protocol deviation|0|||
131450476|NCT00785785|473278168|FG001|Optional Extension Phase|Protocol deviation|2|||
131450477|NCT00785785|473278167|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
131910913|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
131402993|NCT01461928|473097823|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
131844433|NCT02448706|474712570|FG000|Overall Study|Withdrawal by Subject|4|||
131844434|NCT02448706|474712571|FG001|Overall Study|Withdrawal by Subject|3|||
131844435|NCT02448706|474712570|FG000|Overall Study|Protocol Violation|1|||
131844436|NCT02448706|474712571|FG001|Overall Study|Protocol Violation|1|||
131844437|NCT01359969|474712575|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
131844438|NCT03972163|474712579|FG000|Overall Study|Death|0|||
131844439|NCT03972163|474712580|FG001|Overall Study|Death|1|||
131844440|NCT03400943|474712585|FG000|Treatment Period 1|Adverse Event|0|||
131844441|NCT03400943|474712586|FG001|Treatment Period 1|Adverse Event|0|||
131844442|NCT03400943|474712587|FG002|Treatment Period 1|Adverse Event|0|||
131844443|NCT03400943|474712588|FG003|Treatment Period 1|Adverse Event|1|||
131844444|NCT03400943|474712585|FG000|Treatment Period 1|Lost to Follow-up|1|||
131844445|NCT03400943|474712586|FG001|Treatment Period 1|Lost to Follow-up|0|||
131844446|NCT03400943|474712587|FG002|Treatment Period 1|Lost to Follow-up|0|||
131844447|NCT03400943|474712588|FG003|Treatment Period 1|Lost to Follow-up|0|||
131844448|NCT03400943|474712585|FG000|Treatment Period 1|Protocol Violation|0|||
131844449|NCT03400943|474712586|FG001|Treatment Period 1|Protocol Violation|1|||
131844450|NCT03400943|474712587|FG002|Treatment Period 1|Protocol Violation|1|||
131844451|NCT03400943|474712588|FG003|Treatment Period 1|Protocol Violation|0|||
131844452|NCT03400943|474712585|FG000|Treatment Period 1|Study terminated by sponsor|2|||
131844453|NCT03400943|474712586|FG001|Treatment Period 1|Study terminated by sponsor|0|||
131844454|NCT03400943|474712587|FG002|Treatment Period 1|Study terminated by sponsor|0|||
131844455|NCT03400943|474712588|FG003|Treatment Period 1|Study terminated by sponsor|1|||
131844456|NCT03400943|474712585|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131844457|NCT03400943|474712586|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131844458|NCT03400943|474712587|FG002|Treatment Period 1|Withdrawal by Subject|3|||
131844459|NCT03400943|474712588|FG003|Treatment Period 1|Withdrawal by Subject|1|||
131844460|NCT03400943|474712585|FG000|Treatment Period 1|Other|2|||
131844461|NCT03400943|474712586|FG001|Treatment Period 1|Other|1|||
131844462|NCT03400943|474712587|FG002|Treatment Period 1|Other|2|||
131844463|NCT03400943|474712588|FG003|Treatment Period 1|Other|2|||
131844464|NCT03400943|474712585|FG000|Post-treatment Period 1|Adverse Event|2|||
131844465|NCT03400943|474712586|FG001|Post-treatment Period 1|Adverse Event|0|||
131844466|NCT03400943|474712587|FG002|Post-treatment Period 1|Adverse Event|0|||
131844467|NCT03400943|474712588|FG003|Post-treatment Period 1|Adverse Event|0|||
131844468|NCT03400943|474712585|FG000|Post-treatment Period 1|Protocol Violation|1|||
131844469|NCT03400943|474712586|FG001|Post-treatment Period 1|Protocol Violation|0|||
131844470|NCT03400943|474712587|FG002|Post-treatment Period 1|Protocol Violation|0|||
131844471|NCT03400943|474712588|FG003|Post-treatment Period 1|Protocol Violation|0|||
131844472|NCT03400943|474712585|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
131844473|NCT03400943|474712586|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
131844474|NCT03400943|474712587|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
131844475|NCT03400943|474712588|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
131844476|NCT03400943|474712585|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
131844477|NCT03400943|474712586|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
131844478|NCT03400943|474712587|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
131844479|NCT03400943|474712588|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
131844480|NCT03400943|474712585|FG000|Post-treatment Period 1|Other|2|||
131844481|NCT03400943|474712586|FG001|Post-treatment Period 1|Other|0|||
131844482|NCT03400943|474712587|FG002|Post-treatment Period 1|Other|4|||
131844483|NCT03400943|474712588|FG003|Post-treatment Period 1|Other|5|||
131844484|NCT03400943|474712585|FG000|Treatment Period 2|Study terminated by sponsor|0|||
131844485|NCT03400943|474712586|FG001|Treatment Period 2|Study terminated by sponsor|1|||
131844486|NCT03400943|474712587|FG002|Treatment Period 2|Study terminated by sponsor|0|||
131844487|NCT03400943|474712588|FG003|Treatment Period 2|Study terminated by sponsor|0|||
131844488|NCT03400943|474712585|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131844489|NCT03400943|474712586|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131844490|NCT03400943|474712587|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131844491|NCT03400943|474712588|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131844492|NCT03400943|474712585|FG000|Treatment Period 2|Other|1|||
131402994|NCT01461928|473097824|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
131402995|NCT00191724|473097828|FG000|Overall Study|Adverse Event|0|||
131402996|NCT00191724|473097829|FG001|Overall Study|Adverse Event|0|||
131402997|NCT00191724|473097830|FG002|Overall Study|Adverse Event|1|||
131402998|NCT00191724|473097831|FG003|Overall Study|Adverse Event|0|||
131402999|NCT00191724|473097832|FG004|Overall Study|Adverse Event|0|||
131403000|NCT00191724|473097828|FG000|Overall Study|Lost to Follow-up|1|||
131844493|NCT03400943|474712586|FG001|Treatment Period 2|Other|6|||
131910914|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
131910915|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131910916|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
131403001|NCT00191724|473097829|FG001|Overall Study|Lost to Follow-up|1|||
131844494|NCT03400943|474712587|FG002|Treatment Period 2|Other|0|||
131844495|NCT03400943|474712588|FG003|Treatment Period 2|Other|0|||
131844496|NCT03400943|474712585|FG000|Follow-up Period|Withdrawal by Subject|1|||
131844497|NCT03400943|474712586|FG001|Follow-up Period|Withdrawal by Subject|0|||
131844498|NCT03400943|474712587|FG002|Follow-up Period|Withdrawal by Subject|0|||
131844499|NCT03400943|474712588|FG003|Follow-up Period|Withdrawal by Subject|0|||
131844500|NCT04729309|474712589|FG000|Period 1|Subject unable to return for Period 2|3|||
131844501|NCT04729309|474712590|FG001|Period 1|Subject unable to return for Period 2|0|||
131844502|NCT04729309|474712589|FG000|Period 1|Lost to Follow-up|1|||
131844503|NCT04729309|474712590|FG001|Period 1|Lost to Follow-up|0|||
131844504|NCT00616629|474712593|FG000|Overall Study|Protocol Violation|1|||
131844505|NCT00616629|474712594|FG001|Overall Study|Protocol Violation|2|||
131844506|NCT00616629|474712595|FG002|Overall Study|Protocol Violation|1|||
131844507|NCT00616629|474712596|FG003|Overall Study|Protocol Violation|0|||
131844508|NCT00616629|474712597|FG004|Overall Study|Protocol Violation|0|||
131844509|NCT00616629|474712593|FG000|Overall Study|AV-block|1|||
131844510|NCT00616629|474712594|FG001|Overall Study|AV-block|0|||
131844511|NCT00616629|474712595|FG002|Overall Study|AV-block|0|||
131844512|NCT00616629|474712596|FG003|Overall Study|AV-block|0|||
131844513|NCT00616629|474712597|FG004|Overall Study|AV-block|0|||
131844514|NCT04005352|474712599|FG000|Overall Study|Adverse Event|4|||
131844515|NCT04005352|474712600|FG001|Overall Study|Adverse Event|5|||
131844516|NCT04005352|474712599|FG000|Overall Study|Death|4|||
131844517|NCT04005352|474712600|FG001|Overall Study|Death|2|||
131844518|NCT04005352|474712599|FG000|Overall Study|Lost to Follow-up|6|||
131844519|NCT04005352|474712600|FG001|Overall Study|Lost to Follow-up|2|||
131844520|NCT04005352|474712599|FG000|Overall Study|Physician Decision|7|||
131844521|NCT04005352|474712600|FG001|Overall Study|Physician Decision|13|||
131844522|NCT04005352|474712599|FG000|Overall Study|Protocol Violation|0|||
131844523|NCT04005352|474712600|FG001|Overall Study|Protocol Violation|1|||
131844524|NCT04005352|474712599|FG000|Overall Study|Withdrawal by Subject|28|||
131844525|NCT04005352|474712600|FG001|Overall Study|Withdrawal by Subject|38|||
131844526|NCT00936897|474712603|FG000|Overall Study|Withdrawal by Subject|9|||
131844527|NCT00936897|474712604|FG001|Overall Study|Withdrawal by Subject|19|||
131844528|NCT00936897|474712603|FG000|Overall Study|Adverse Event|4|||
131844529|NCT00936897|474712604|FG001|Overall Study|Adverse Event|13|||
131844530|NCT00936897|474712603|FG000|Overall Study|Other|3|||
131844531|NCT00936897|474712604|FG001|Overall Study|Other|9|||
131844532|NCT00936897|474712603|FG000|Overall Study|Lost to Follow-up|1|||
131844533|NCT00936897|474712604|FG001|Overall Study|Lost to Follow-up|10|||
131844534|NCT00936897|474712603|FG000|Overall Study|Administrative Decision|1|||
131844535|NCT00936897|474712604|FG001|Overall Study|Administrative Decision|2|||
131844536|NCT00936897|474712603|FG000|Overall Study|Protocol Violation|1|||
131844537|NCT00936897|474712604|FG001|Overall Study|Protocol Violation|1|||
131844538|NCT00936897|474712603|FG000|Overall Study|Ineligibility Determined|0|||
131910917|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
131910918|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
131910919|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131910920|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
131910921|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
131910922|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
131910923|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
131910924|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
131910925|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
131910926|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
131910927|NCT03573297|474960886|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
131910928|NCT03573297|474960887|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
131910929|NCT03573297|474960888|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
131844539|NCT00936897|474712604|FG001|Overall Study|Ineligibility Determined|3|||
131844540|NCT00936897|474712603|FG000|Overall Study|Noncompliance|0|||
131844541|NCT00936897|474712604|FG001|Overall Study|Noncompliance|2|||
131844542|NCT00936897|474712603|FG000|Overall Study|Death|0|||
131844543|NCT00936897|474712604|FG001|Overall Study|Death|1|||
131403002|NCT00191724|473097830|FG002|Overall Study|Lost to Follow-up|0|||
131844544|NCT00417170|474712605|FG000|Overall Study|Adverse Event|1|||
131403003|NCT00191724|473097831|FG003|Overall Study|Lost to Follow-up|2|||
131403004|NCT00191724|473097832|FG004|Overall Study|Lost to Follow-up|3|||
131844545|NCT00417170|474712606|FG001|Overall Study|Adverse Event|1|||
131844546|NCT00417170|474712605|FG000|Overall Study|Withdrawal by Subject|1|||
131844547|NCT00417170|474712606|FG001|Overall Study|Withdrawal by Subject|1|||
131844548|NCT00417170|474712605|FG000|Overall Study|Lost to Follow-up|0|||
131844549|NCT00417170|474712606|FG001|Overall Study|Lost to Follow-up|1|||
131844550|NCT04058067|474712607|FG000|Overall Study|Adverse Event|2|||
131844551|NCT04058067|474712608|FG001|Overall Study|Adverse Event|0|||
131844552|NCT04058067|474712607|FG000|Overall Study|Death|0|||
131844553|NCT04058067|474712608|FG001|Overall Study|Death|1|||
131844554|NCT04058067|474712607|FG000|Overall Study|Physician Decision|3|||
131910930|NCT03573297|474960889|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
131844555|NCT04058067|474712608|FG001|Overall Study|Physician Decision|1|||
131844556|NCT04058067|474712607|FG000|Overall Study|Protocol Violation|0|||
131844557|NCT04058067|474712608|FG001|Overall Study|Protocol Violation|1|||
131844558|NCT04058067|474712607|FG000|Overall Study|Withdrawal by Subject|7|||
131844559|NCT04058067|474712608|FG001|Overall Study|Withdrawal by Subject|8|||
131844560|NCT05005312|474712609|FG000|Overall Study|Enrolled, but not treated|0|||
131844561|NCT05005312|474712610|FG001|Overall Study|Enrolled, but not treated|1|||
131844562|NCT01283035|474712612|FG000|Overall Study|Subject later found ineligible|1|||
131844563|NCT00867503|474712613|FG000|Overall Study|Withdrawal by Subject|1|||
131844564|NCT02704403|474712614|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
131844565|NCT02704403|474712615|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
131844566|NCT02704403|474712614|FG000|Overall Study|Administrative reasons by sponsor|1251|||
131844567|NCT02704403|474712615|FG001|Overall Study|Administrative reasons by sponsor|616|||
131844568|NCT02704403|474712614|FG000|Overall Study|Death|4|||
131844569|NCT02704403|474712615|FG001|Overall Study|Death|3|||
131844570|NCT02704403|474712614|FG000|Overall Study|Endpoint event|52|||
131844571|NCT02704403|474712615|FG001|Overall Study|Endpoint event|24|||
131844572|NCT02704403|474712614|FG000|Overall Study|Lost to Follow-up|22|||
131844573|NCT02704403|474712615|FG001|Overall Study|Lost to Follow-up|11|||
131844574|NCT02704403|474712614|FG000|Overall Study|Protocol Violation|15|||
131844575|NCT02704403|474712615|FG001|Overall Study|Protocol Violation|15|||
131844576|NCT02704403|474712614|FG000|Overall Study|Adverse Event|2|||
131844577|NCT02704403|474712615|FG001|Overall Study|Adverse Event|0|||
131844578|NCT02704403|474712614|FG000|Overall Study|Withdrawal by Subject|85|||
131844579|NCT02704403|474712615|FG001|Overall Study|Withdrawal by Subject|45|||
131844580|NCT02704403|474712614|FG000|Overall Study|Investigator decision|1|||
131844581|NCT02704403|474712615|FG001|Overall Study|Investigator decision|1|||
131403005|NCT00191724|473097828|FG000|Overall Study|Withdrawal by Subject|0|||
131403006|NCT00191724|473097829|FG001|Overall Study|Withdrawal by Subject|0|||
131403007|NCT00191724|473097830|FG002|Overall Study|Withdrawal by Subject|0|||
131403008|NCT00191724|473097831|FG003|Overall Study|Withdrawal by Subject|1|||
131403009|NCT00191724|473097832|FG004|Overall Study|Withdrawal by Subject|0|||
131403010|NCT02301546|473097833|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
131403011|NCT02301546|473097834|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
131403012|NCT02301546|473097833|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
131403013|NCT02301546|473097834|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
131403014|NCT02301546|473097833|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
131403015|NCT02301546|473097834|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
131403016|NCT02301546|473097833|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
131403017|NCT02301546|473097834|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
131403018|NCT02301546|473097833|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
131403019|NCT02301546|473097834|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
131403020|NCT02301546|473097833|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
131403021|NCT02301546|473097834|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
131403022|NCT02301546|473097833|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
131403023|NCT02301546|473097834|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
131403024|NCT04085458|473097839|FG000|Overall Study|Other|1|||
131403025|NCT04085458|473097839|FG000|Overall Study|Withdrawal by Subject|2|||
131403026|NCT04085458|473097839|FG000|Overall Study|Adverse Event|2|||
131403027|NCT02447250|473097840|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
131403028|NCT02447250|473097840|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
131403029|NCT02447250|473097840|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
131403030|NCT03632993|473097841|FG000|Overall Study|Withdrawal by Subject|1|||
131403031|NCT03632993|473097842|FG001|Overall Study|Withdrawal by Subject|0|||
131403032|NCT03632993|473097843|FG002|Overall Study|Withdrawal by Subject|0|||
131403033|NCT03632993|473097844|FG003|Overall Study|Withdrawal by Subject|0|||
131403034|NCT03632993|473097845|FG004|Overall Study|Withdrawal by Subject|0|||
131403035|NCT03632993|473097846|FG005|Overall Study|Withdrawal by Subject|0|||
131403036|NCT03632993|473097847|FG006|Overall Study|Withdrawal by Subject|0|||
131403037|NCT03632993|473097848|FG007|Overall Study|Withdrawal by Subject|0|||
131403038|NCT03632993|473097849|FG008|Overall Study|Withdrawal by Subject|0|||
131403039|NCT03632993|473097850|FG009|Overall Study|Withdrawal by Subject|1|||
131403040|NCT03632993|473097841|FG000|Overall Study|Protocol Non-compliance|0|||
131403041|NCT03632993|473097842|FG001|Overall Study|Protocol Non-compliance|1|||
131844582|NCT02704403|474712614|FG000|Overall Study|Follow-up not possible|1|||
131844583|NCT02704403|474712615|FG001|Overall Study|Follow-up not possible|2|||
131844584|NCT01442688|474712616|FG000|First Intervention|Withdrawal by Subject|1|||
131844585|NCT01442688|474712617|FG001|First Intervention|Withdrawal by Subject|0|||
131844586|NCT01442688|474712616|FG000|First Intervention|subject incarcerated|1|||
131403042|NCT03632993|473097843|FG002|Overall Study|Protocol Non-compliance|0|||
131403043|NCT03632993|473097844|FG003|Overall Study|Protocol Non-compliance|0|||
131403044|NCT03632993|473097845|FG004|Overall Study|Protocol Non-compliance|0|||
131844587|NCT01442688|474712617|FG001|First Intervention|subject incarcerated|0|||
131910931|NCT01093846|474960892|FG000|Overall Study|Adverse Event|0|||
131910932|NCT01093846|474960893|FG001|Overall Study|Adverse Event|0|||
131910933|NCT01093846|474960894|FG002|Overall Study|Adverse Event|1|||
131910934|NCT01093846|474960892|FG000|Overall Study|Lack of Efficacy|0|||
131910935|NCT01093846|474960893|FG001|Overall Study|Lack of Efficacy|0|||
131910936|NCT01093846|474960894|FG002|Overall Study|Lack of Efficacy|4|||
131910937|NCT01093846|474960892|FG000|Overall Study|Condition no longer required study drug|1|||
131844588|NCT01442688|474712616|FG000|Second Intervention|Adverse Event|1|||
131844589|NCT01442688|474712617|FG001|Second Intervention|Adverse Event|0|||
131844590|NCT00927394|474712620|FG000|Overall Study|Adverse Event|14|||
131844591|NCT00927394|474712621|FG001|Overall Study|Adverse Event|9|||
131844592|NCT00927394|474712620|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
131844593|NCT00927394|474712621|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
131844594|NCT00927394|474712620|FG000|Overall Study|Withdrawal by Subject|20|||
131844595|NCT00927394|474712621|FG001|Overall Study|Withdrawal by Subject|24|||
131844596|NCT00927394|474712620|FG000|Overall Study|Lost to Follow-up|8|||
131844597|NCT00927394|474712621|FG001|Overall Study|Lost to Follow-up|14|||
131844598|NCT00927394|474712620|FG000|Overall Study|Administrative Problem|1|||
131844599|NCT00927394|474712621|FG001|Overall Study|Administrative Problem|0|||
131844600|NCT00927394|474712620|FG000|Overall Study|Death|1|||
131844601|NCT00927394|474712621|FG001|Overall Study|Death|1|||
131844602|NCT00927394|474712620|FG000|Overall Study|Protocol deviation|16|||
131844603|NCT00927394|474712621|FG001|Overall Study|Protocol deviation|13|||
131844604|NCT00927394|474712620|FG000|Overall Study|Randomized in error|0|||
131844605|NCT00927394|474712621|FG001|Overall Study|Randomized in error|1|||
131844606|NCT02792699|474712627|FG000|Overall Study|Adverse Event|1|||
131844607|NCT02792699|474712628|FG001|Overall Study|Adverse Event|2|||
131844608|NCT02792699|474712629|FG002|Overall Study|Adverse Event|4|||
131844609|NCT02792699|474712627|FG000|Overall Study|Withdrawal by Subject|4|||
131844610|NCT02792699|474712628|FG001|Overall Study|Withdrawal by Subject|4|||
131844611|NCT02792699|474712629|FG002|Overall Study|Withdrawal by Subject|3|||
131844612|NCT02792699|474712627|FG000|Overall Study|Lost to Follow-up|0|||
131844613|NCT02792699|474712628|FG001|Overall Study|Lost to Follow-up|1|||
131844614|NCT02792699|474712629|FG002|Overall Study|Lost to Follow-up|2|||
131844615|NCT02792699|474712627|FG000|Overall Study|Physician Decision|2|||
131844616|NCT02792699|474712628|FG001|Overall Study|Physician Decision|0|||
131844617|NCT02792699|474712629|FG002|Overall Study|Physician Decision|0|||
131844618|NCT02792699|474712627|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
131844619|NCT02792699|474712628|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
131844620|NCT02792699|474712629|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
131844621|NCT02792699|474712627|FG000|Overall Study|Other|1|||
131844622|NCT02792699|474712628|FG001|Overall Study|Other|0|||
131844623|NCT02792699|474712629|FG002|Overall Study|Other|0|||
131844624|NCT04623086|474712630|FG000|Overall Study|Withdrawal by Subject|0|||
131844625|NCT04623086|474712631|FG001|Overall Study|Withdrawal by Subject|0|||
131844626|NCT04623086|474712632|FG002|Overall Study|Withdrawal by Subject|10|||
131844627|NCT01755767|474712633|FG000|Overall Study|Progressive Disease|8|||
131844628|NCT01755767|474712634|FG001|Overall Study|Progressive Disease|7|||
131844629|NCT01755767|474712635|FG002|Overall Study|Progressive Disease|91|||
131844630|NCT01755767|474712636|FG003|Overall Study|Progressive Disease|43|||
131844631|NCT01755767|474712633|FG000|Overall Study|Clinical Disease Progression|4|||
131844632|NCT01755767|474712634|FG001|Overall Study|Clinical Disease Progression|2|||
131844633|NCT01755767|474712635|FG002|Overall Study|Clinical Disease Progression|29|||
131844634|NCT01755767|474712636|FG003|Overall Study|Clinical Disease Progression|20|||
131844635|NCT01755767|474712633|FG000|Overall Study|Radiographic Disease Progression|9|||
131844636|NCT01755767|474712634|FG001|Overall Study|Radiographic Disease Progression|4|||
131844637|NCT01755767|474712635|FG002|Overall Study|Radiographic Disease Progression|44|||
131844638|NCT01755767|474712636|FG003|Overall Study|Radiographic Disease Progression|27|||
131844639|NCT01755767|474712633|FG000|Overall Study|Adverse Event|6|||
131844640|NCT01755767|474712634|FG001|Overall Study|Adverse Event|0|||
131844641|NCT01755767|474712635|FG002|Overall Study|Adverse Event|28|||
131844642|NCT01755767|474712636|FG003|Overall Study|Adverse Event|11|||
131844643|NCT01755767|474712633|FG000|Overall Study|Death|1|||
131844644|NCT01755767|474712634|FG001|Overall Study|Death|2|||
131844645|NCT01755767|474712635|FG002|Overall Study|Death|15|||
131844646|NCT01755767|474712636|FG003|Overall Study|Death|4|||
131844647|NCT01755767|474712633|FG000|Overall Study|Subject Decision|0|||
131844648|NCT01755767|474712634|FG001|Overall Study|Subject Decision|0|||
131844649|NCT01755767|474712635|FG002|Overall Study|Subject Decision|10|||
131844650|NCT01755767|474712636|FG003|Overall Study|Subject Decision|3|||
131844651|NCT01755767|474712633|FG000|Overall Study|Withdrawal by Subject|0|||
131844652|NCT01755767|474712634|FG001|Overall Study|Withdrawal by Subject|0|||
131844653|NCT01755767|474712635|FG002|Overall Study|Withdrawal by Subject|2|||
131844654|NCT01755767|474712636|FG003|Overall Study|Withdrawal by Subject|1|||
131910938|NCT01093846|474960893|FG001|Overall Study|Condition no longer required study drug|1|||
131910939|NCT01093846|474960894|FG002|Overall Study|Condition no longer required study drug|1|||
131910940|NCT01093846|474960892|FG000|Overall Study|Administrative Problems|18|||
131910941|NCT01093846|474960893|FG001|Overall Study|Administrative Problems|17|||
131450478|NCT00785785|473278168|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
131450479|NCT02453321|473278169|FG000|Overall Study|Weakness|1|||
131450480|NCT02453321|473278170|FG001|Overall Study|Weakness|1|||
131450481|NCT02453321|473278171|FG002|Overall Study|Weakness|2|||
131450482|NCT02453321|473278169|FG000|Overall Study|Deep Venous Thrombosis|0|||
131450483|NCT02453321|473278170|FG001|Overall Study|Deep Venous Thrombosis|1|||
131450484|NCT02453321|473278171|FG002|Overall Study|Deep Venous Thrombosis|0|||
131450485|NCT00521404|473278172|FG000|Overall Study|Adverse Event|13|||
131450486|NCT00521404|473278172|FG000|Overall Study|Disease Progression|33|||
131450487|NCT00521404|473278172|FG000|Overall Study|Investigator decision|5|||
131450488|NCT00521404|473278172|FG000|Overall Study|Withdrawal of consent|3|||
131450489|NCT00521404|473278172|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
131450490|NCT00521404|473278172|FG000|Overall Study|Other|7|||
131450491|NCT02282605|473278175|FG000|Overall Study|negative SA result on Day -1|3|||
131450492|NCT02282605|473278176|FG001|Overall Study|negative SA result on Day -1|0|||
131450493|NCT02282605|473278177|FG002|Overall Study|negative SA result on Day -1|0|||
131450494|NCT01383356|473278180|FG000|Period 1|Adverse Event|5|||
131450495|NCT01383356|473278181|FG001|Period 1|Adverse Event|3|||
131450496|NCT01383356|473278180|FG000|Period 1|Non-compliance|3|||
131450497|NCT01383356|473278181|FG001|Period 1|Non-compliance|0|||
131450498|NCT01383356|473278180|FG000|Period 1|Out of Range Mid-study-Test|0|||
131450499|NCT01383356|473278181|FG001|Period 1|Out of Range Mid-study-Test|1|||
131450500|NCT01383356|473278180|FG000|Period 1|Personal|0|||
131450501|NCT01383356|473278181|FG001|Period 1|Personal|2|||
131450502|NCT00892099|473278182|FG000|Overall Study|Death|1|||
131450503|NCT00892099|473278183|FG001|Overall Study|Death|0|||
131450504|NCT00892099|473278184|FG002|Overall Study|Death|1|||
131450505|NCT00892099|473278182|FG000|Overall Study|Adverse Event|1|||
131450506|NCT00892099|473278183|FG001|Overall Study|Adverse Event|0|||
131450507|NCT00892099|473278184|FG002|Overall Study|Adverse Event|0|||
131450508|NCT00892099|473278182|FG000|Overall Study|replocated|1|||
131450509|NCT00892099|473278183|FG001|Overall Study|replocated|0|||
131450510|NCT00892099|473278184|FG002|Overall Study|replocated|2|||
131450511|NCT00892099|473278182|FG000|Overall Study|Prolonged hospitalization|1|||
131450512|NCT00892099|473278183|FG001|Overall Study|Prolonged hospitalization|0|||
131450513|NCT00892099|473278184|FG002|Overall Study|Prolonged hospitalization|1|||
131450514|NCT00892099|473278182|FG000|Overall Study|no further details|1|||
131450515|NCT00892099|473278183|FG001|Overall Study|no further details|0|||
131450516|NCT00892099|473278184|FG002|Overall Study|no further details|1|||
131450517|NCT00892099|473278182|FG000|Overall Study|kidney function recovered|0|||
131450518|NCT00892099|473278183|FG001|Overall Study|kidney function recovered|1|||
131450519|NCT00892099|473278184|FG002|Overall Study|kidney function recovered|0|||
131450520|NCT00892099|473278182|FG000|Overall Study|investigator decision|0|||
131844655|NCT01755767|474712633|FG000|Overall Study|Other|0|||
131844656|NCT01755767|474712634|FG001|Overall Study|Other|0|||
131844657|NCT01755767|474712635|FG002|Overall Study|Other|2|||
131844658|NCT01755767|474712636|FG003|Overall Study|Other|3|||
131844659|NCT01755767|474712633|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
131844660|NCT01755767|474712634|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
131844661|NCT01755767|474712635|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
131844662|NCT01755767|474712636|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
131844663|NCT03464630|474712637|FG000|Overall Study|Lost to Follow-up|62|||
131844664|NCT03464630|474712638|FG001|Overall Study|Lost to Follow-up|52|||
131844665|NCT03464630|474712637|FG000|Overall Study|Withdrawal by Subject|16|||
131844666|NCT03464630|474712638|FG001|Overall Study|Withdrawal by Subject|10|||
131844667|NCT03464630|474712637|FG000|Overall Study|Passive Disengagement|8|||
131844668|NCT03464630|474712638|FG001|Overall Study|Passive Disengagement|4|||
131844669|NCT00191165|474712639|FG000|Overall Study|Adverse Event|2|||
131844670|NCT00191165|474712640|FG001|Overall Study|Adverse Event|0|||
131844671|NCT00191165|474712639|FG000|Overall Study|Protocol Violation|0|||
131844672|NCT00191165|474712640|FG001|Overall Study|Protocol Violation|1|||
131844673|NCT00191165|474712639|FG000|Overall Study|Participant Moved Away|0|||
131844674|NCT00191165|474712640|FG001|Overall Study|Participant Moved Away|1|||
131844675|NCT00380744|474712644|FG000|Overall Study|Death|0|||
131450521|NCT00892099|473278183|FG001|Overall Study|investigator decision|0|||
131450522|NCT00892099|473278184|FG002|Overall Study|investigator decision|1|||
131450523|NCT00892099|473278182|FG000|Overall Study|Lost to Follow-up|0|||
131450524|NCT00892099|473278183|FG001|Overall Study|Lost to Follow-up|0|||
131450525|NCT00892099|473278184|FG002|Overall Study|Lost to Follow-up|1|||
131450526|NCT02919995|473278186|FG000|Overall Study|Adverse Event|0|||
131450527|NCT02919995|473278187|FG001|Overall Study|Adverse Event|0|||
131450528|NCT02919995|473278188|FG002|Overall Study|Adverse Event|0|||
131450529|NCT02919995|473278189|FG003|Overall Study|Adverse Event|0|||
131844676|NCT00380744|474712645|FG001|Overall Study|Death|0|||
131844677|NCT00380744|474712646|FG002|Overall Study|Death|0|||
131844678|NCT00380744|474712647|FG003|Overall Study|Death|0|||
131844679|NCT00380744|474712648|FG004|Overall Study|Death|0|||
131450530|NCT02919995|473278190|FG004|Overall Study|Adverse Event|0|||
131450531|NCT02919995|473278191|FG005|Overall Study|Adverse Event|1|||
131844680|NCT00380744|474712649|FG005|Overall Study|Death|0|||
131844681|NCT00380744|474712650|FG006|Overall Study|Death|1|||
131844682|NCT00380744|474712644|FG000|Overall Study|Withdrawal by Subject|1|||
131844683|NCT00380744|474712645|FG001|Overall Study|Withdrawal by Subject|0|||
131844684|NCT00380744|474712646|FG002|Overall Study|Withdrawal by Subject|0|||
131844685|NCT00380744|474712647|FG003|Overall Study|Withdrawal by Subject|0|||
131844686|NCT00380744|474712648|FG004|Overall Study|Withdrawal by Subject|0|||
131844687|NCT00380744|474712649|FG005|Overall Study|Withdrawal by Subject|0|||
131844688|NCT00380744|474712650|FG006|Overall Study|Withdrawal by Subject|0|||
131844689|NCT00077857|474712652|FG000|Overall Study|Adverse Event|30|||
131844690|NCT00077857|474712653|FG001|Overall Study|Adverse Event|32|||
131844691|NCT00077857|474712652|FG000|Overall Study|Death|7|||
131844692|NCT00077857|474712653|FG001|Overall Study|Death|3|||
131844693|NCT00077857|474712652|FG000|Overall Study|Insufficient therapeutic response|112|||
131844694|NCT00077857|474712653|FG001|Overall Study|Insufficient therapeutic response|128|||
131844695|NCT00077857|474712652|FG000|Overall Study|Violation of selection criteria at entry|3|||
131844696|NCT00077857|474712653|FG001|Overall Study|Violation of selection criteria at entry|1|||
131844697|NCT00077857|474712652|FG000|Overall Study|Other protocol violation|0|||
131844698|NCT00077857|474712653|FG001|Overall Study|Other protocol violation|1|||
131844699|NCT00077857|474712652|FG000|Overall Study|Refused treatment|29|||
131844700|NCT00077857|474712653|FG001|Overall Study|Refused treatment|21|||
131844701|NCT00077857|474712652|FG000|Overall Study|Failure to return|5|||
131844702|NCT00077857|474712653|FG001|Overall Study|Failure to return|5|||
131844703|NCT00077857|474712652|FG000|Overall Study|Other|15|||
131844704|NCT00077857|474712653|FG001|Overall Study|Other|13|||
131844705|NCT04480021|474712654|FG000|Overall Study|Lost to Follow-up|3|||
131844706|NCT04480021|474712655|FG001|Overall Study|Lost to Follow-up|4|||
131844707|NCT01844505|474712658|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
131844708|NCT01844505|474712659|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
131844709|NCT01844505|474712660|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
131844710|NCT01844505|474712658|FG000|Treatment Period|Other Reasons|120|||
131844711|NCT01844505|474712659|FG001|Treatment Period|Other Reasons|136|||
131844712|NCT01844505|474712660|FG002|Treatment Period|Other Reasons|58|||
131844713|NCT01844505|474712658|FG000|Treatment Period|Lost to Follow-up|9|||
131844714|NCT01844505|474712659|FG001|Treatment Period|Lost to Follow-up|11|||
131844715|NCT01844505|474712660|FG002|Treatment Period|Lost to Follow-up|6|||
131844716|NCT01844505|474712658|FG000|Treatment Period|Death|175|||
131844717|NCT01844505|474712659|FG001|Treatment Period|Death|154|||
131844718|NCT01844505|474712660|FG002|Treatment Period|Death|228|||
131844719|NCT03384654|474712661|FG000|Overall Study|Withdrawal by Subject|0|||
131844720|NCT03384654|474712662|FG001|Overall Study|Withdrawal by Subject|0|||
131844721|NCT03384654|474712663|FG002|Overall Study|Withdrawal by Subject|1|||
131844722|NCT03384654|474712664|FG003|Overall Study|Withdrawal by Subject|0|||
131844723|NCT02348723|474712665|FG000|Overall Study|No ablation|21|||
131844724|NCT02348723|474712666|FG001|Overall Study|No ablation|20|||
131844725|NCT02348723|474712665|FG000|Overall Study|Non-compliant with Protocol|1|||
131844726|NCT02348723|474712666|FG001|Overall Study|Non-compliant with Protocol|0|||
131844727|NCT02348723|474712665|FG000|Overall Study|Lost to Follow-up|1|||
131844728|NCT02348723|474712666|FG001|Overall Study|Lost to Follow-up|1|||
131844729|NCT02348723|474712665|FG000|Overall Study|Consent withdrawn|1|||
131844730|NCT02348723|474712666|FG001|Overall Study|Consent withdrawn|3|||
131844731|NCT02348723|474712665|FG000|Overall Study|Reason other than specified|1|||
131844732|NCT02348723|474712666|FG001|Overall Study|Reason other than specified|1|||
131844733|NCT02348723|474712665|FG000|Overall Study|Adverse Event|3|||
131844734|NCT02348723|474712666|FG001|Overall Study|Adverse Event|1|||
131844735|NCT01268501|474712667|FG000|Overall Study|Lost to Follow-up|1|||
131844736|NCT01268501|474712667|FG000|Overall Study|Withdrawal by Subject|3|||
131844737|NCT01268501|474712667|FG000|Overall Study|Unacceptable Subjective Vision|3|||
131844738|NCT01268501|474712667|FG000|Overall Study|Handling Difficulties|2|||
131844739|NCT00678886|474712669|FG000|Overall Study|Withdrawal by Subject|0|||
131844740|NCT00678886|474712670|FG001|Overall Study|Withdrawal by Subject|0|||
131844741|NCT00678886|474712671|FG002|Overall Study|Withdrawal by Subject|4|||
131844742|NCT00678886|474712672|FG003|Overall Study|Withdrawal by Subject|6|||
131844743|NCT00678886|474712669|FG000|Overall Study|Physician Decision|0|||
131844744|NCT00678886|474712670|FG001|Overall Study|Physician Decision|0|||
131844745|NCT00678886|474712671|FG002|Overall Study|Physician Decision|1|||
131844746|NCT00678886|474712672|FG003|Overall Study|Physician Decision|1|||
131844747|NCT00678886|474712669|FG000|Overall Study|Lost to Follow-up|0|||
131844748|NCT00678886|474712670|FG001|Overall Study|Lost to Follow-up|0|||
131844749|NCT00678886|474712671|FG002|Overall Study|Lost to Follow-up|3|||
131844750|NCT00678886|474712672|FG003|Overall Study|Lost to Follow-up|2|||
131844751|NCT00678886|474712669|FG000|Overall Study|Other|0|||
131844752|NCT00678886|474712670|FG001|Overall Study|Other|0|||
131844753|NCT00678886|474712671|FG002|Overall Study|Other|1|||
131844754|NCT00678886|474712672|FG003|Overall Study|Other|0|||
131844755|NCT00206323|474712673|FG000|Overall Study|Lack of Efficacy|4|||
131844756|NCT00206323|474712674|FG001|Overall Study|Lack of Efficacy|1|||
131844757|NCT00206323|474712673|FG000|Overall Study|Adverse Event|1|||
131844758|NCT00206323|474712674|FG001|Overall Study|Adverse Event|1|||
131844759|NCT00206323|474712673|FG000|Overall Study|Lost to Follow-up|1|||
131450532|NCT03133793|473278195|FG000|Overall Study|Withdrawal by Subject|0|||
131450533|NCT03133793|473278196|FG001|Overall Study|Withdrawal by Subject|4|||
131450534|NCT03133793|473278197|FG002|Overall Study|Withdrawal by Subject|2|||
131450535|NCT03133793|473278198|FG003|Overall Study|Withdrawal by Subject|4|||
131450536|NCT03133793|473278195|FG000|Overall Study|Lost to Follow-up|1|||
131450537|NCT03133793|473278196|FG001|Overall Study|Lost to Follow-up|0|||
131450538|NCT03133793|473278197|FG002|Overall Study|Lost to Follow-up|2|||
131450539|NCT03133793|473278198|FG003|Overall Study|Lost to Follow-up|0|||
131450540|NCT03133793|473278195|FG000|Overall Study|Death|0|||
131450541|NCT03133793|473278196|FG001|Overall Study|Death|0|||
131450542|NCT03133793|473278197|FG002|Overall Study|Death|0|||
131450543|NCT03133793|473278198|FG003|Overall Study|Death|1|||
131450544|NCT02839200|473278199|FG000|Overall Study|Withdrawal by Subject|2|||
131450545|NCT02839200|473278200|FG001|Overall Study|Withdrawal by Subject|0|||
131450546|NCT02839200|473278201|FG002|Overall Study|Withdrawal by Subject|1|||
131450547|NCT02839200|473278202|FG003|Overall Study|Withdrawal by Subject|0|||
131450548|NCT02839200|473278203|FG004|Overall Study|Withdrawal by Subject|0|||
131450549|NCT02839200|473278204|FG005|Overall Study|Withdrawal by Subject|1|||
131450550|NCT02839200|473278199|FG000|Overall Study|Lost to Follow-up|2|||
131450551|NCT02839200|473278200|FG001|Overall Study|Lost to Follow-up|0|||
131450552|NCT02839200|473278201|FG002|Overall Study|Lost to Follow-up|0|||
131450553|NCT02839200|473278202|FG003|Overall Study|Lost to Follow-up|0|||
131450554|NCT02839200|473278203|FG004|Overall Study|Lost to Follow-up|1|||
131450555|NCT02839200|473278204|FG005|Overall Study|Lost to Follow-up|0|||
131450556|NCT02839200|473278199|FG000|Overall Study|Adverse Event|0|||
131450557|NCT02839200|473278200|FG001|Overall Study|Adverse Event|0|||
131450558|NCT02839200|473278201|FG002|Overall Study|Adverse Event|0|||
131450559|NCT02839200|473278202|FG003|Overall Study|Adverse Event|0|||
131450560|NCT02839200|473278203|FG004|Overall Study|Adverse Event|1|||
131450561|NCT02839200|473278204|FG005|Overall Study|Adverse Event|0|||
131450562|NCT02839200|473278199|FG000|Overall Study|Randomized in error|0|||
131450563|NCT02839200|473278200|FG001|Overall Study|Randomized in error|1|||
131450564|NCT02839200|473278201|FG002|Overall Study|Randomized in error|0|||
131450565|NCT02839200|473278202|FG003|Overall Study|Randomized in error|0|||
131450566|NCT02839200|473278203|FG004|Overall Study|Randomized in error|0|||
131450567|NCT02839200|473278204|FG005|Overall Study|Randomized in error|0|||
131450568|NCT04139018|473278205|FG000|Overall Study|Screen fail|1|||
131450569|NCT04139018|473278206|FG001|Overall Study|Screen fail|0|||
131450570|NCT04139018|473278205|FG000|Overall Study|Withdrawal by Subject|2|||
131450571|NCT04139018|473278206|FG001|Overall Study|Withdrawal by Subject|0|||
131450572|NCT04139018|473278205|FG000|Overall Study|Lost to Follow-up|0|||
131450573|NCT04139018|473278206|FG001|Overall Study|Lost to Follow-up|1|||
131450574|NCT04476797|473278208|FG000|Overall Study|Withdrawal by Subject|1|||
131450575|NCT04476797|473278209|FG001|Overall Study|Withdrawal by Subject|0|||
131450576|NCT04476797|473278210|FG002|Overall Study|Withdrawal by Subject|0|||
131450577|NCT04476797|473278208|FG000|Overall Study|Death|0|||
131450578|NCT04476797|473278209|FG001|Overall Study|Death|1|||
131844760|NCT00206323|474712674|FG001|Overall Study|Lost to Follow-up|1|||
131844761|NCT01147107|474712675|FG000|Overall Study|Lack of Efficacy|5|||
131844762|NCT01147107|474712676|FG001|Overall Study|Lack of Efficacy|0|||
131844763|NCT01147107|474712675|FG000|Overall Study|Withdrawal by Subject|1|||
131844764|NCT01147107|474712676|FG001|Overall Study|Withdrawal by Subject|1|||
131844765|NCT03918109|474712684|FG000|Overall Study|Withdrawal by Subject|0|||
131844766|NCT03918109|474712685|FG001|Overall Study|Withdrawal by Subject|0|||
131844767|NCT03918109|474712686|FG002|Overall Study|Withdrawal by Subject|2|||
131844768|NCT03918109|474712687|FG003|Overall Study|Withdrawal by Subject|1|||
131844769|NCT03918109|474712684|FG000|Overall Study|Lost to Follow-up|0|||
131844770|NCT03918109|474712685|FG001|Overall Study|Lost to Follow-up|0|||
131844771|NCT03918109|474712686|FG002|Overall Study|Lost to Follow-up|0|||
131844772|NCT03918109|474712687|FG003|Overall Study|Lost to Follow-up|1|||
131844773|NCT00861198|474712688|FG000|Overall Study|SpyGlass Failed|5|||
131844774|NCT02011386|474712689|FG000|Overall Study|Non-compliance|2|||
131910942|NCT01093846|474960894|FG002|Overall Study|Administrative Problems|15|||
131450579|NCT04476797|473278210|FG002|Overall Study|Death|2|||
131450580|NCT04476797|473278208|FG000|Overall Study|Sponsor Terminated Study|0|||
131450581|NCT04476797|473278209|FG001|Overall Study|Sponsor Terminated Study|18|||
131450582|NCT04476797|473278210|FG002|Overall Study|Sponsor Terminated Study|17|||
131450583|NCT03614156|473278227|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
131450584|NCT03614156|473278228|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
131450585|NCT03614156|473278229|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
131450586|NCT03614156|473278230|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
131450587|NCT03614156|473278227|FG000|Open-Label Treatment Period|Adverse Event|7|||
131450588|NCT03614156|473278228|FG001|Open-Label Treatment Period|Adverse Event|0|||
131450589|NCT03614156|473278229|FG002|Open-Label Treatment Period|Adverse Event|0|||
131844775|NCT02011386|474712689|FG000|Overall Study|Lack of Efficacy|3|||
131844776|NCT01197755|474712690|FG000|Overall Study|Adverse Event|8|||
131844777|NCT01197755|474712691|FG001|Overall Study|Adverse Event|10|||
131844778|NCT01197755|474712692|FG002|Overall Study|Adverse Event|10|||
131844779|NCT01197755|474712690|FG000|Overall Study|Study-specific discontinuation criteria|2|||
131844780|NCT01197755|474712691|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131844781|NCT01197755|474712692|FG002|Overall Study|Study-specific discontinuation criteria|0|||
131844782|NCT01197755|474712690|FG000|Overall Study|Entered the long-term extension study|18|||
131844783|NCT01197755|474712691|FG001|Overall Study|Entered the long-term extension study|21|||
131844784|NCT01197755|474712692|FG002|Overall Study|Entered the long-term extension study|35|||
131844785|NCT01197755|474712690|FG000|Overall Study|Lack of therapeutic response|0|||
131844786|NCT01197755|474712691|FG001|Overall Study|Lack of therapeutic response|7|||
131844787|NCT01197755|474712692|FG002|Overall Study|Lack of therapeutic response|4|||
131844788|NCT01197755|474712690|FG000|Overall Study|Severe non-compliance to the protocol|2|||
131844789|NCT01197755|474712691|FG001|Overall Study|Severe non-compliance to the protocol|1|||
131844790|NCT01197755|474712692|FG002|Overall Study|Severe non-compliance to the protocol|2|||
131844791|NCT01197755|474712690|FG000|Overall Study|Withdrawal by Subject|1|||
131844792|NCT01197755|474712691|FG001|Overall Study|Withdrawal by Subject|0|||
131844793|NCT01197755|474712692|FG002|Overall Study|Withdrawal by Subject|0|||
131844794|NCT01197755|474712690|FG000|Overall Study|Lost to Follow-up|0|||
131844795|NCT01197755|474712691|FG001|Overall Study|Lost to Follow-up|0|||
131844796|NCT01197755|474712692|FG002|Overall Study|Lost to Follow-up|1|||
131844797|NCT01197755|474712690|FG000|Overall Study|eg, change in circumstances|7|||
131844798|NCT01197755|474712691|FG001|Overall Study|eg, change in circumstances|3|||
131844799|NCT01197755|474712692|FG002|Overall Study|eg, change in circumstances|2|||
131844800|NCT03365011|474712693|FG000|Overall Study|Withdrawal by Subject|1|||
131844801|NCT03365011|474712694|FG001|Overall Study|Withdrawal by Subject|2|||
131844802|NCT00499174|474712695|FG000|Overall Study|Physician Decision|78|||
131844803|NCT00499174|474712696|FG001|Overall Study|Physician Decision|9|||
131844804|NCT00319982|474712702|FG000|Overall Study|Withdrawal by Subject|1|||
131844805|NCT00319982|474712703|FG001|Overall Study|Withdrawal by Subject|0|||
131844806|NCT00761865|474712704|FG000|Overall Study|Lost to Follow-up|8|||
131844807|NCT00761865|474712705|FG001|Overall Study|Lost to Follow-up|7|||
131844808|NCT02351960|474712706|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
131844809|NCT02351960|474712707|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
131844810|NCT02351960|474712706|FG000|Overall Study|Voluntary Withdrawal|5|||
131844811|NCT02351960|474712707|FG001|Overall Study|Voluntary Withdrawal|4|||
131844812|NCT02351960|474712706|FG000|Overall Study|Significant Protocol Deviation|0|||
131844813|NCT02351960|474712707|FG001|Overall Study|Significant Protocol Deviation|5|||
131844814|NCT00758680|474712708|FG000|Overall Study|Adverse Event|0|||
131844815|NCT00758680|474712709|FG001|Overall Study|Adverse Event|0|||
131844816|NCT00758680|474712710|FG002|Overall Study|Adverse Event|0|||
131844817|NCT00758680|474712711|FG003|Overall Study|Adverse Event|0|||
131844818|NCT00758680|474712712|FG004|Overall Study|Adverse Event|0|||
131844819|NCT00758680|474712713|FG005|Overall Study|Adverse Event|0|||
131844820|NCT00758680|474712714|FG006|Overall Study|Adverse Event|0|||
131844821|NCT00758680|474712715|FG007|Overall Study|Adverse Event|1|||
131844822|NCT00758680|474712716|FG008|Overall Study|Adverse Event|0|||
131844823|NCT00758680|474712717|FG009|Overall Study|Adverse Event|1|||
131844824|NCT00758680|474712708|FG000|Overall Study|Laboratory Adverse Event|0|||
131844825|NCT00758680|474712709|FG001|Overall Study|Laboratory Adverse Event|0|||
131844826|NCT00758680|474712710|FG002|Overall Study|Laboratory Adverse Event|0|||
131844827|NCT00758680|474712711|FG003|Overall Study|Laboratory Adverse Event|0|||
131844828|NCT00758680|474712712|FG004|Overall Study|Laboratory Adverse Event|0|||
131844829|NCT00758680|474712713|FG005|Overall Study|Laboratory Adverse Event|0|||
131844830|NCT00758680|474712714|FG006|Overall Study|Laboratory Adverse Event|0|||
131844831|NCT00758680|474712715|FG007|Overall Study|Laboratory Adverse Event|0|||
131844832|NCT00758680|474712716|FG008|Overall Study|Laboratory Adverse Event|1|||
131844833|NCT00758680|474712717|FG009|Overall Study|Laboratory Adverse Event|0|||
131844834|NCT00758680|474712708|FG000|Overall Study|Withdrawal by Subject|0|||
131844835|NCT00758680|474712709|FG001|Overall Study|Withdrawal by Subject|0|||
131844836|NCT00758680|474712710|FG002|Overall Study|Withdrawal by Subject|0|||
131844837|NCT00758680|474712711|FG003|Overall Study|Withdrawal by Subject|0|||
131844838|NCT00758680|474712712|FG004|Overall Study|Withdrawal by Subject|0|||
131844839|NCT00758680|474712713|FG005|Overall Study|Withdrawal by Subject|0|||
131844840|NCT00758680|474712714|FG006|Overall Study|Withdrawal by Subject|1|||
131844841|NCT00758680|474712715|FG007|Overall Study|Withdrawal by Subject|0|||
131844842|NCT00758680|474712716|FG008|Overall Study|Withdrawal by Subject|1|||
131844843|NCT00758680|474712717|FG009|Overall Study|Withdrawal by Subject|0|||
131844844|NCT01094886|474712718|FG000|Overall Study|Adverse Event|2|||
131844845|NCT01094886|474712718|FG000|Overall Study|Withdrawal by Subject|5|||
131844846|NCT00638027|474712722|FG000|Overall Study|Adverse Event|0|||
131844847|NCT00638027|474712723|FG001|Overall Study|Adverse Event|2|||
131844848|NCT01177059|474712727|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
131844849|NCT01177059|474712727|FG000|Overall Study|Withdrew consent|2|||
131844850|NCT01177059|474712727|FG000|Overall Study|Lost to Follow-up|18|||
131844851|NCT01161407|474714493|FG000|Overall Study|Protocol Violation|3|||
131844852|NCT01161407|474714494|FG001|Overall Study|Protocol Violation|1|||
131844853|NCT00849186|474714500|FG000|Overall Study|Adverse Event|2|||
131910943|NCT02781324|474960895|FG000|Overall Study|Withdrawal by Subject|1|||
131910944|NCT02781324|474960896|FG001|Overall Study|Withdrawal by Subject|0|||
131910945|NCT02781324|474960895|FG000|Overall Study|Physician Decision|1|||
131910946|NCT02781324|474960896|FG001|Overall Study|Physician Decision|2|||
131910947|NCT00661388|474960898|FG000|Overall Study|Adverse Event|14|||
131910948|NCT00661388|474960898|FG000|Overall Study|Protocol Violation|7|||
131910949|NCT00661388|474960898|FG000|Overall Study|Renal transplantation|1|||
131910950|NCT00661388|474960898|FG000|Overall Study|Dialysis initiation|1|||
131910951|NCT00661388|474960898|FG000|Overall Study|Administrative reasons|1|||
131403045|NCT03632993|473097846|FG005|Overall Study|Protocol Non-compliance|0|||
131403046|NCT03632993|473097847|FG006|Overall Study|Protocol Non-compliance|0|||
131403047|NCT03632993|473097848|FG007|Overall Study|Protocol Non-compliance|0|||
131403048|NCT03632993|473097849|FG008|Overall Study|Protocol Non-compliance|0|||
131844854|NCT00849186|474714500|FG000|Overall Study|Withdrawal by Subject|1|||
131844855|NCT00849186|474714500|FG000|Overall Study|not treated|6|||
131844856|NCT00849186|474714500|FG000|Overall Study|Other|1|||
131844857|NCT00492024|474714503|FG000|Treatment|Adverse Event|3|||
131844858|NCT00492024|474714504|FG001|Treatment|Adverse Event|1|||
131844859|NCT00492024|474714503|FG000|Treatment|Lack of Efficacy|21|||
131844860|NCT00492024|474714504|FG001|Treatment|Lack of Efficacy|20|||
131844861|NCT00492024|474714503|FG000|Treatment|Lost to Follow-up|3|||
131844862|NCT00492024|474714504|FG001|Treatment|Lost to Follow-up|1|||
131844863|NCT00492024|474714503|FG000|Treatment|Withdrawal by Subject|2|||
131844864|NCT00492024|474714504|FG001|Treatment|Withdrawal by Subject|0|||
131844865|NCT00492024|474714503|FG000|Follow up|Lack of Efficacy|0|||
131844866|NCT00492024|474714504|FG001|Follow up|Lack of Efficacy|1|||
131844867|NCT00492024|474714503|FG000|Follow up|Lost to Follow-up|1|||
131844868|NCT00492024|474714504|FG001|Follow up|Lost to Follow-up|1|||
131403049|NCT03632993|473097850|FG009|Overall Study|Protocol Non-compliance|0|||
131403050|NCT03632993|473097841|FG000|Overall Study|Lost to Follow-up|0|||
131403051|NCT03632993|473097842|FG001|Overall Study|Lost to Follow-up|0|||
131403052|NCT03632993|473097843|FG002|Overall Study|Lost to Follow-up|0|||
131844869|NCT03247816|474714505|FG000|Overall Study|Adverse Event|12|||
131403053|NCT03632993|473097844|FG003|Overall Study|Lost to Follow-up|0|||
131403054|NCT03632993|473097845|FG004|Overall Study|Lost to Follow-up|0|||
131403055|NCT03632993|473097846|FG005|Overall Study|Lost to Follow-up|1|||
131403056|NCT03632993|473097847|FG006|Overall Study|Lost to Follow-up|0|||
131403057|NCT03632993|473097848|FG007|Overall Study|Lost to Follow-up|1|||
131403058|NCT03632993|473097849|FG008|Overall Study|Lost to Follow-up|0|||
131403059|NCT03632993|473097850|FG009|Overall Study|Lost to Follow-up|0|||
131844870|NCT03247816|474714505|FG000|Overall Study|Physician Decision|3|||
131844871|NCT03247816|474714505|FG000|Overall Study|Lack of Efficacy|1|||
131844872|NCT03247816|474714505|FG000|Overall Study|Lost to Follow-up|10|||
131844873|NCT03247816|474714505|FG000|Overall Study|Missing Feraccru stop date|3|||
131844874|NCT03200912|474714510|FG000|Overall Study|Adverse Event|3|||
131844875|NCT03200912|474714511|FG001|Overall Study|Adverse Event|0|||
131403060|NCT03632993|473097841|FG000|Overall Study|Adverse Event|0|||
131403061|NCT03632993|473097842|FG001|Overall Study|Adverse Event|0|||
131403062|NCT03632993|473097843|FG002|Overall Study|Adverse Event|0|||
131403063|NCT03632993|473097844|FG003|Overall Study|Adverse Event|0|||
131403064|NCT03632993|473097845|FG004|Overall Study|Adverse Event|0|||
131403065|NCT03632993|473097846|FG005|Overall Study|Adverse Event|1|||
131403066|NCT03632993|473097847|FG006|Overall Study|Adverse Event|0|||
131403067|NCT03632993|473097848|FG007|Overall Study|Adverse Event|1|||
131403068|NCT03632993|473097849|FG008|Overall Study|Adverse Event|0|||
131403069|NCT03632993|473097850|FG009|Overall Study|Adverse Event|0|||
131403070|NCT03224507|473097851|FG000|Overall Study|Death|3|||
131403071|NCT03224507|473097852|FG001|Overall Study|Death|0|||
131403072|NCT03224507|473097851|FG000|Overall Study|Lack of Efficacy|6|||
131403073|NCT03224507|473097852|FG001|Overall Study|Lack of Efficacy|0|||
131403074|NCT03224507|473097851|FG000|Overall Study|Withdrawal by Subject|6|||
131403075|NCT03224507|473097852|FG001|Overall Study|Withdrawal by Subject|0|||
131403076|NCT01562314|473097862|FG000|Overall Study|Adverse Event|10|||
131403077|NCT01562314|473097863|FG001|Overall Study|Adverse Event|5|||
131403078|NCT01562314|473097862|FG000|Overall Study|Met Withdrawal Criteria|3|||
131403079|NCT01562314|473097863|FG001|Overall Study|Met Withdrawal Criteria|2|||
131403080|NCT01562314|473097862|FG000|Overall Study|Withdrawal by Subject|0|||
131403081|NCT01562314|473097863|FG001|Overall Study|Withdrawal by Subject|1|||
131403082|NCT02851797|473097864|FG000|Overall Study|Withdrawal by Subject|4|||
131403083|NCT02851797|473097865|FG001|Overall Study|Withdrawal by Subject|2|||
131403084|NCT02851797|473097864|FG000|Overall Study|Adverse Event|3|||
131403085|NCT02851797|473097865|FG001|Overall Study|Adverse Event|0|||
131403086|NCT03655054|473097866|FG000|Overall Study|Lost to Follow-up|1|||
131403087|NCT03077438|473097867|FG000|Overall Study|Protocol Violation|3|||
131403088|NCT03077438|473097868|FG001|Overall Study|Protocol Violation|5|||
131403089|NCT03077438|473097867|FG000|Overall Study|Withdrawal by Subject|3|||
131403090|NCT03077438|473097868|FG001|Overall Study|Withdrawal by Subject|6|||
131403091|NCT03077438|473097867|FG000|Overall Study|Lost to Follow-up|6|||
131403092|NCT03077438|473097868|FG001|Overall Study|Lost to Follow-up|3|||
131403093|NCT00813865|473097872|FG000|Overall Study|Failure to Respond|3|||
131403094|NCT00813865|473097872|FG000|Overall Study|Lost to Follow-up|3|||
131403095|NCT00813865|473097872|FG000|Overall Study|Withdrawal by Subject|1|||
131403096|NCT01190475|473097875|FG000|Overall Study|Withdrawal by Subject|0|||
131403097|NCT01190475|473097876|FG001|Overall Study|Withdrawal by Subject|0|||
131403098|NCT01190475|473097877|FG002|Overall Study|Withdrawal by Subject|1|||
131403099|NCT02256384|473097878|FG000|Overall Study|Withdrawal by Subject|12|||
131403100|NCT02256384|473097878|FG000|Overall Study|Equipment not capturing data|2|||
131403101|NCT00624585|473097879|FG000|Overall Study|Death|3|||
131403102|NCT00624585|473097879|FG000|Overall Study|Disease Progression|6|||
131403103|NCT00624585|473097879|FG000|Overall Study|Adverse Event|3|||
131403104|NCT00543803|473097880|FG000|Overall Study|Adverse Event|14|||
131403105|NCT00543803|473097880|FG000|Overall Study|Lack of Efficacy|22|||
131403106|NCT00543803|473097880|FG000|Overall Study|Lost to Follow-up|20|||
131403107|NCT00543803|473097880|FG000|Overall Study|Other|86|||
131403108|NCT04295681|473097898|FG000|Overall Study|Eligibility error|1|||
131403109|NCT04295681|473097899|FG001|Overall Study|Eligibility error|3|||
131403110|NCT00676520|473097906|FG000|Overall Study|Withdrawal by Subject|163|||
131403111|NCT00676520|473097906|FG000|Overall Study|Lost to Follow-up|162|||
131403112|NCT00676520|473097906|FG000|Overall Study|Death|159|||
131403113|NCT00676520|473097906|FG000|Overall Study|Physician Decision|20|||
131403114|NCT00676520|473097906|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
131403115|NCT00676520|473097906|FG000|Overall Study|Other Reason|18|||
131403116|NCT01425359|473097907|FG000|Overall Study|Randomized but Not Treated|2|||
131403117|NCT01425359|473097908|FG001|Overall Study|Randomized but Not Treated|3|||
131403118|NCT01425359|473097907|FG000|Overall Study|Adverse Event|9|||
131403119|NCT01425359|473097908|FG001|Overall Study|Adverse Event|8|||
131403120|NCT01425359|473097907|FG000|Overall Study|Revascularization|0|||
131403121|NCT01425359|473097908|FG001|Overall Study|Revascularization|1|||
131403122|NCT01425359|473097907|FG000|Overall Study|Death|0|||
131403123|NCT01425359|473097908|FG001|Overall Study|Death|1|||
131403124|NCT01425359|473097907|FG000|Overall Study|Unsatisfactory Response|1|||
131403125|NCT01425359|473097908|FG001|Overall Study|Unsatisfactory Response|0|||
131403126|NCT01425359|473097907|FG000|Overall Study|Protocol Violation|1|||
131844876|NCT03200912|474714512|FG002|Overall Study|Adverse Event|0|||
131403127|NCT01425359|473097908|FG001|Overall Study|Protocol Violation|2|||
131403128|NCT01425359|473097907|FG000|Overall Study|Subject Withdrew Consent|1|||
131403129|NCT01425359|473097908|FG001|Overall Study|Subject Withdrew Consent|2|||
131403130|NCT01425359|473097907|FG000|Overall Study|Investigator's Discretion|2|||
131403131|NCT01425359|473097908|FG001|Overall Study|Investigator's Discretion|0|||
131403132|NCT01425359|473097907|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
131403133|NCT01425359|473097908|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
131403134|NCT03172325|473097919|FG000|Overall Study|Adverse Event|2|||
131403135|NCT03172325|473097920|FG001|Overall Study|Adverse Event|3|||
131403136|NCT03172325|473097919|FG000|Overall Study|Positive PPD|1|||
131403137|NCT03172325|473097920|FG001|Overall Study|Positive PPD|0|||
131844877|NCT03200912|474714510|FG000|Overall Study|Withdrawal by Subject|1|||
131844878|NCT03200912|474714511|FG001|Overall Study|Withdrawal by Subject|2|||
131844879|NCT03200912|474714512|FG002|Overall Study|Withdrawal by Subject|4|||
131450590|NCT03614156|473278230|FG003|Open-Label Treatment Period|Adverse Event|0|||
131450591|NCT03614156|473278227|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
131450592|NCT03614156|473278228|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
131450593|NCT03614156|473278229|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131450594|NCT03614156|473278230|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
131450595|NCT03614156|473278227|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
131450596|NCT03614156|473278228|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
131450597|NCT03614156|473278229|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
131450598|NCT03614156|473278230|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
131450599|NCT03614156|473278227|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
131450600|NCT03614156|473278228|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
131450601|NCT03614156|473278229|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
131450602|NCT03614156|473278230|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
131450603|NCT03614156|473278227|FG000|Open-Label Treatment Period|Protocol Violation|2|||
131450604|NCT03614156|473278228|FG001|Open-Label Treatment Period|Protocol Violation|0|||
131450605|NCT03614156|473278229|FG002|Open-Label Treatment Period|Protocol Violation|0|||
131450606|NCT03614156|473278230|FG003|Open-Label Treatment Period|Protocol Violation|0|||
131450607|NCT03614156|473278227|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
131450608|NCT03614156|473278228|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
131450609|NCT03614156|473278229|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
131450610|NCT03614156|473278230|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
131450611|NCT03614156|473278227|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
131450612|NCT03614156|473278228|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
131844880|NCT03200912|474714510|FG000|Overall Study|Non-compliance with study drug|0|||
131844881|NCT03200912|474714511|FG001|Overall Study|Non-compliance with study drug|1|||
131844882|NCT03200912|474714512|FG002|Overall Study|Non-compliance with study drug|0|||
131844883|NCT02309138|474714513|FG000|Overall Study|Withdrawal by Subject|44|||
131844884|NCT02309138|474714514|FG001|Overall Study|Withdrawal by Subject|15|||
131844885|NCT02309138|474714513|FG000|Overall Study|Protocol Violation|4|||
131844886|NCT02309138|474714514|FG001|Overall Study|Protocol Violation|2|||
131910952|NCT01113749|474963070|FG000|Overall Study|Lost to Follow-up|1|||
131403138|NCT03172325|473097919|FG000|Overall Study|Poor Compliance|1|||
131403139|NCT03172325|473097920|FG001|Overall Study|Poor Compliance|1|||
131403140|NCT03305419|473097927|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403141|NCT03305419|473097928|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
131403142|NCT03305419|473097929|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403143|NCT03305419|473097930|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403144|NCT03305419|473097931|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403145|NCT03305419|473097932|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403146|NCT03305419|473097933|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403147|NCT03305419|473097934|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
131403148|NCT03305419|473097927|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
131403149|NCT03305419|473097928|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403150|NCT03305419|473097929|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403151|NCT03305419|473097930|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403152|NCT03305419|473097931|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403153|NCT03305419|473097932|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403154|NCT03305419|473097933|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403155|NCT03305419|473097934|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
131403156|NCT03305419|473097927|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
131403157|NCT03305419|473097928|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403158|NCT03305419|473097929|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403159|NCT03305419|473097930|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403160|NCT03305419|473097931|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403161|NCT03305419|473097932|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403162|NCT03305419|473097933|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403163|NCT03305419|473097934|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
131403164|NCT03305419|473097927|FG000|Part B (14 Days)|Adverse Event|0|||
131403165|NCT03305419|473097928|FG001|Part B (14 Days)|Adverse Event|0|||
131403166|NCT03305419|473097929|FG002|Part B (14 Days)|Adverse Event|0|||
131403167|NCT03305419|473097930|FG003|Part B (14 Days)|Adverse Event|0|||
131844887|NCT02309138|474714513|FG000|Overall Study|delivered before visit 2|0|||
131844888|NCT02309138|474714514|FG001|Overall Study|delivered before visit 2|1|||
131403168|NCT03305419|473097931|FG004|Part B (14 Days)|Adverse Event|1|||
131403169|NCT03305419|473097932|FG005|Part B (14 Days)|Adverse Event|2|||
131403170|NCT03305419|473097933|FG006|Part B (14 Days)|Adverse Event|4|||
131450613|NCT03614156|473278229|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
131450614|NCT03614156|473278230|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
131450615|NCT03614156|473278227|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
131450616|NCT03614156|473278228|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
131450617|NCT03614156|473278229|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
131450618|NCT03614156|473278230|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
131450619|NCT03614156|473278227|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131450620|NCT03614156|473278228|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
131450621|NCT03614156|473278229|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131450622|NCT03614156|473278230|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131450623|NCT03614156|473278227|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131450624|NCT03614156|473278228|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131450625|NCT03614156|473278229|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
131844889|NCT03421730|474714522|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131450626|NCT03614156|473278230|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
131450627|NCT03614156|473278227|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
131450628|NCT03614156|473278228|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
131450629|NCT03614156|473278229|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
131450630|NCT03614156|473278230|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
131450631|NCT03614156|473278227|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
131450632|NCT03614156|473278228|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
131450633|NCT03614156|473278229|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
131450634|NCT03614156|473278230|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
131450635|NCT03614156|473278227|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
131450636|NCT03614156|473278228|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
131450637|NCT03614156|473278229|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
131450638|NCT03614156|473278230|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
131450639|NCT03614156|473278227|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
131450640|NCT03614156|473278228|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
131450641|NCT03614156|473278229|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
131450642|NCT03614156|473278230|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
131450643|NCT03614156|473278227|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
131450644|NCT03614156|473278228|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
131450645|NCT03614156|473278229|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
131450646|NCT03614156|473278230|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
131450647|NCT03614156|473278227|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
131450648|NCT03614156|473278228|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
131450649|NCT03614156|473278229|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
131450650|NCT03614156|473278230|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
131450651|NCT04287517|473278235|FG000|Overall Study|Withdrawal by Subject|1|||
131450652|NCT04287517|473278236|FG001|Overall Study|Withdrawal by Subject|1|||
131450653|NCT03070964|473278237|FG000|Overall Study|Progressive disease|8|||
131450654|NCT03070964|473278237|FG000|Overall Study|Treatment-unrelated adverse event|2|||
131450655|NCT03070964|473278237|FG000|Overall Study|Never treated|1|||
131450656|NCT03070964|473278237|FG000|Overall Study|Physician Decision|1|||
131450657|NCT03070964|473278237|FG000|Overall Study|Withdrawal by Subject|1|||
131450658|NCT03070964|473278237|FG000|Overall Study|Adverse Event|1|||
131450659|NCT00834093|473278240|FG000|Overall Study|Progressive Disease|3|||
131450660|NCT00834093|473278240|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
131450661|NCT02745119|473278241|FG000|Overall Study|Adverse Event|1|||
131450662|NCT02745119|473278242|FG001|Overall Study|Adverse Event|0|||
131450663|NCT02745119|473278243|FG002|Overall Study|Adverse Event|1|||
131450664|NCT02745119|473278244|FG003|Overall Study|Adverse Event|3|||
131450665|NCT02745119|473278241|FG000|Overall Study|Death|3|||
131450666|NCT02745119|473278242|FG001|Overall Study|Death|3|||
131450667|NCT02745119|473278243|FG002|Overall Study|Death|0|||
131450668|NCT02745119|473278244|FG003|Overall Study|Death|4|||
131450669|NCT02745119|473278241|FG000|Overall Study|Lost to Follow-up|0|||
131450670|NCT02745119|473278242|FG001|Overall Study|Lost to Follow-up|0|||
131450671|NCT02745119|473278243|FG002|Overall Study|Lost to Follow-up|0|||
131450672|NCT02745119|473278244|FG003|Overall Study|Lost to Follow-up|1|||
131844890|NCT03421730|474714523|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
131450673|NCT02745119|473278241|FG000|Overall Study|Protocol Deviation|0|||
131450674|NCT02745119|473278242|FG001|Overall Study|Protocol Deviation|0|||
131910953|NCT01113749|474963071|FG001|Overall Study|Lost to Follow-up|2|||
131450675|NCT02745119|473278243|FG002|Overall Study|Protocol Deviation|0|||
131450676|NCT02745119|473278244|FG003|Overall Study|Protocol Deviation|1|||
131450677|NCT02745119|473278241|FG000|Overall Study|Withdrawal by Subject|7|||
131450678|NCT02745119|473278242|FG001|Overall Study|Withdrawal by Subject|15|||
131450679|NCT02745119|473278243|FG002|Overall Study|Withdrawal by Subject|8|||
131450680|NCT02745119|473278244|FG003|Overall Study|Withdrawal by Subject|14|||
131910954|NCT03427892|474963072|FG000|Overall Study|Lost to Follow-up|2|||
131910955|NCT01673386|474963073|FG000|Overall Study|Study terminated by sponsor|16|||
131910956|NCT01673386|474963074|FG001|Overall Study|Study terminated by sponsor|22|||
131910957|NCT01673386|474963073|FG000|Overall Study|Adverse Event|5|||
131910958|NCT01673386|474963074|FG001|Overall Study|Adverse Event|2|||
131910959|NCT01673386|474963073|FG000|Overall Study|Progressive disease|4|||
131910960|NCT01673386|474963074|FG001|Overall Study|Progressive disease|1|||
131910961|NCT01673386|474963073|FG000|Overall Study|Withdrawal by Subject|0|||
131910962|NCT01673386|474963074|FG001|Overall Study|Withdrawal by Subject|2|||
131910963|NCT00274456|474963078|FG000|Overall Study|Still on treatment|2|||
131910964|NCT00274456|474963079|FG001|Overall Study|Still on treatment|3|||
131910965|NCT00274456|474963080|FG002|Overall Study|Still on treatment|5|||
131910966|NCT00274456|474963081|FG003|Overall Study|Still on treatment|1|||
131910967|NCT00274456|474963078|FG000|Overall Study|Unacceptable toxicity|10|||
131910968|NCT00274456|474963079|FG001|Overall Study|Unacceptable toxicity|5|||
131910969|NCT00274456|474963080|FG002|Overall Study|Unacceptable toxicity|12|||
131910970|NCT00274456|474963081|FG003|Overall Study|Unacceptable toxicity|16|||
131910971|NCT00274456|474963078|FG000|Overall Study|Adverse Event|0|||
131910972|NCT00274456|474963079|FG001|Overall Study|Adverse Event|1|||
131910973|NCT00274456|474963080|FG002|Overall Study|Adverse Event|2|||
131910974|NCT00274456|474963081|FG003|Overall Study|Adverse Event|2|||
131910975|NCT00274456|474963078|FG000|Overall Study|Physician Decision|7|||
131910976|NCT00274456|474963079|FG001|Overall Study|Physician Decision|5|||
131910977|NCT00274456|474963080|FG002|Overall Study|Physician Decision|6|||
131910978|NCT00274456|474963081|FG003|Overall Study|Physician Decision|13|||
131910979|NCT00274456|474963078|FG000|Overall Study|Lost to Follow-up|0|||
131910980|NCT00274456|474963079|FG001|Overall Study|Lost to Follow-up|0|||
131910981|NCT00274456|474963080|FG002|Overall Study|Lost to Follow-up|1|||
131910982|NCT00274456|474963081|FG003|Overall Study|Lost to Follow-up|0|||
131910983|NCT00274456|474963078|FG000|Overall Study|Withdrawal by Subject|18|||
131910984|NCT00274456|474963079|FG001|Overall Study|Withdrawal by Subject|13|||
131910985|NCT00274456|474963080|FG002|Overall Study|Withdrawal by Subject|9|||
131910986|NCT00274456|474963081|FG003|Overall Study|Withdrawal by Subject|13|||
131910987|NCT02034006|474963082|FG000|Overall Study|Withdrawal by Subject|7|||
131910988|NCT02034006|474963082|FG000|Overall Study|Lost to Follow-up|5|||
131910989|NCT02034006|474963082|FG000|Overall Study|Death|1|||
131910990|NCT02034006|474963082|FG000|Overall Study|Pregnancy|1|||
131910991|NCT00750269|474963083|FG000|Overall Study|Protocol Violation|0|||
131910992|NCT00750269|474963084|FG001|Overall Study|Protocol Violation|1|||
131910993|NCT00750269|474963085|FG002|Overall Study|Protocol Violation|1|||
131910994|NCT00750269|474963086|FG003|Overall Study|Protocol Violation|2|||
131910995|NCT00750269|474963087|FG004|Overall Study|Protocol Violation|4|||
131910996|NCT00750269|474963083|FG000|Overall Study|Withdrawal by Subject|0|||
131910997|NCT00750269|474963084|FG001|Overall Study|Withdrawal by Subject|0|||
131910998|NCT00750269|474963085|FG002|Overall Study|Withdrawal by Subject|2|||
131910999|NCT00750269|474963086|FG003|Overall Study|Withdrawal by Subject|2|||
131911000|NCT00750269|474963087|FG004|Overall Study|Withdrawal by Subject|2|||
131911001|NCT00750269|474963083|FG000|Overall Study|Physician Decision|0|||
131844891|NCT03421730|474714524|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844892|NCT03421730|474714525|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844893|NCT03421730|474714526|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844894|NCT03421730|474714527|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844895|NCT03421730|474714528|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844896|NCT03421730|474714529|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844897|NCT03421730|474714530|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844898|NCT03421730|474714531|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844899|NCT03421730|474714532|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844900|NCT03421730|474714533|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131844901|NCT03421730|474714522|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844902|NCT03421730|474714523|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844903|NCT03421730|474714524|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844904|NCT03421730|474714525|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844905|NCT03421730|474714526|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
131844906|NCT03421730|474714527|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844907|NCT03421730|474714528|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844908|NCT03421730|474714529|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131911002|NCT00750269|474963084|FG001|Overall Study|Physician Decision|0|||
131911003|NCT00750269|474963085|FG002|Overall Study|Physician Decision|0|||
131911004|NCT00750269|474963086|FG003|Overall Study|Physician Decision|0|||
131911005|NCT00750269|474963087|FG004|Overall Study|Physician Decision|2|||
131911006|NCT00750269|474963083|FG000|Overall Study|Patient too large for positioning|0|||
131911007|NCT00750269|474963084|FG001|Overall Study|Patient too large for positioning|0|||
131403171|NCT03305419|473097934|FG007|Part B (14 Days)|Adverse Event|0|||
131403172|NCT03305419|473097927|FG000|Part B (14 Days)|Physician Decision|0|||
131403173|NCT03305419|473097928|FG001|Part B (14 Days)|Physician Decision|0|||
131403174|NCT03305419|473097929|FG002|Part B (14 Days)|Physician Decision|0|||
131403175|NCT03305419|473097930|FG003|Part B (14 Days)|Physician Decision|0|||
131403176|NCT03305419|473097931|FG004|Part B (14 Days)|Physician Decision|2|||
131403177|NCT03305419|473097932|FG005|Part B (14 Days)|Physician Decision|8|||
131403178|NCT03305419|473097933|FG006|Part B (14 Days)|Physician Decision|1|||
131403179|NCT03305419|473097934|FG007|Part B (14 Days)|Physician Decision|0|||
131403180|NCT00075946|473097935|FG000|Overall Study|Path ineligible: undetermined histology|0|||
131844909|NCT03421730|474714530|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844910|NCT03421730|474714531|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844911|NCT03421730|474714532|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844912|NCT03421730|474714533|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
131844913|NCT02901548|474714536|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
131844914|NCT01338870|474714537|FG000|Overall Study|Lost to Follow-up|0|||
131844915|NCT01338870|474714538|FG001|Overall Study|Lost to Follow-up|0|||
131844916|NCT01338870|474714539|FG002|Overall Study|Lost to Follow-up|1|||
131844917|NCT01338870|474714540|FG003|Overall Study|Lost to Follow-up|0|||
131844918|NCT01338870|474714541|FG004|Overall Study|Lost to Follow-up|1|||
131844919|NCT01338870|474714542|FG005|Overall Study|Lost to Follow-up|0|||
131844920|NCT01338870|474714537|FG000|Overall Study|Withdrawal by Subject|2|||
131844921|NCT01338870|474714538|FG001|Overall Study|Withdrawal by Subject|3|||
131844922|NCT01338870|474714539|FG002|Overall Study|Withdrawal by Subject|4|||
131844923|NCT01338870|474714540|FG003|Overall Study|Withdrawal by Subject|0|||
131844924|NCT01338870|474714541|FG004|Overall Study|Withdrawal by Subject|0|||
131844925|NCT01338870|474714542|FG005|Overall Study|Withdrawal by Subject|2|||
131844926|NCT01338870|474714537|FG000|Overall Study|Other|3|||
131844927|NCT01338870|474714538|FG001|Overall Study|Other|3|||
131844928|NCT01338870|474714539|FG002|Overall Study|Other|3|||
131911008|NCT00750269|474963085|FG002|Overall Study|Patient too large for positioning|1|||
131911009|NCT00750269|474963086|FG003|Overall Study|Patient too large for positioning|0|||
131911010|NCT00750269|474963087|FG004|Overall Study|Patient too large for positioning|0|||
131911011|NCT00750269|474963083|FG000|Overall Study|Site error|0|||
131911012|NCT00750269|474963084|FG001|Overall Study|Site error|0|||
131911013|NCT00750269|474963085|FG002|Overall Study|Site error|0|||
131911014|NCT00750269|474963086|FG003|Overall Study|Site error|1|||
131911015|NCT00750269|474963087|FG004|Overall Study|Site error|0|||
131911016|NCT00750269|474963083|FG000|Overall Study|SBRT plan could not be drawn|0|||
131911017|NCT00750269|474963084|FG001|Overall Study|SBRT plan could not be drawn|0|||
131911018|NCT00750269|474963085|FG002|Overall Study|SBRT plan could not be drawn|0|||
131911019|NCT00750269|474963086|FG003|Overall Study|SBRT plan could not be drawn|0|||
131911020|NCT00750269|474963087|FG004|Overall Study|SBRT plan could not be drawn|1|||
131911021|NCT00750269|474963083|FG000|Overall Study|Fiducials could not be placed|0|||
131911022|NCT00750269|474963084|FG001|Overall Study|Fiducials could not be placed|0|||
131911023|NCT00750269|474963085|FG002|Overall Study|Fiducials could not be placed|0|||
131911024|NCT00750269|474963086|FG003|Overall Study|Fiducials could not be placed|0|||
131911025|NCT00750269|474963087|FG004|Overall Study|Fiducials could not be placed|1|||
131911026|NCT02934178|474963088|FG000|Received Vaccination 2|Death|0|||
131911027|NCT02934178|474963089|FG001|Received Vaccination 2|Death|1|||
131911028|NCT02934178|474963088|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
131911029|NCT02934178|474963089|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
131911030|NCT01898078|474963092|FG000|Overall Study|Progressive Disease|1|||
131911031|NCT01898078|474963093|FG001|Overall Study|Progressive Disease|5|||
131911032|NCT01898078|474963092|FG000|Overall Study|Adverse Event|2|||
131911033|NCT01898078|474963093|FG001|Overall Study|Adverse Event|1|||
131911034|NCT01898078|474963092|FG000|Overall Study|Withdrawal by Subject|1|||
131911035|NCT01898078|474963093|FG001|Overall Study|Withdrawal by Subject|1|||
131911036|NCT01898078|474963092|FG000|Overall Study|Symptomatic Deterioration|2|||
131911037|NCT01898078|474963093|FG001|Overall Study|Symptomatic Deterioration|0|||
131911038|NCT01898078|474963092|FG000|Overall Study|Reason not Specified|0|||
131403181|NCT00075946|473097936|FG001|Overall Study|Path ineligible: undetermined histology|0|||
131403182|NCT00075946|473097937|FG002|Overall Study|Path ineligible: undetermined histology|0|||
131911039|NCT01898078|474963093|FG001|Overall Study|Reason not Specified|1|||
131403183|NCT00075946|473097938|FG003|Overall Study|Path ineligible: undetermined histology|0|||
131844929|NCT01338870|474714540|FG003|Overall Study|Other|2|||
131844930|NCT01338870|474714541|FG004|Overall Study|Other|0|||
131844931|NCT01338870|474714542|FG005|Overall Study|Other|2|||
131844932|NCT01338870|474714537|FG000|Overall Study|Protocol Violation|0|||
131844933|NCT01338870|474714538|FG001|Overall Study|Protocol Violation|2|||
131911040|NCT02100631|474963098|FG000|Overall Study|Withdrawal by Subject|1|||
131911041|NCT02100631|474963099|FG001|Overall Study|Withdrawal by Subject|0|||
131911042|NCT02100631|474963100|FG002|Overall Study|Withdrawal by Subject|0|||
131911043|NCT02100631|474963098|FG000|Overall Study|Lost to Follow-up|3|||
131911044|NCT02100631|474963099|FG001|Overall Study|Lost to Follow-up|4|||
131450681|NCT02745119|473278241|FG000|Overall Study|Study Terminated by Sponsor|134|||
131450682|NCT02745119|473278242|FG001|Overall Study|Study Terminated by Sponsor|252|||
131450683|NCT02745119|473278243|FG002|Overall Study|Study Terminated by Sponsor|135|||
131450684|NCT02745119|473278244|FG003|Overall Study|Study Terminated by Sponsor|251|||
131450685|NCT02745119|473278241|FG000|Overall Study|Physician Decision|0|||
131450686|NCT02745119|473278242|FG001|Overall Study|Physician Decision|2|||
131450687|NCT02745119|473278243|FG002|Overall Study|Physician Decision|2|||
131450688|NCT02745119|473278244|FG003|Overall Study|Physician Decision|2|||
131450689|NCT02745119|473278241|FG000|Overall Study|Reason Not Specified|0|||
131450690|NCT02745119|473278242|FG001|Overall Study|Reason Not Specified|2|||
131450691|NCT02745119|473278243|FG002|Overall Study|Reason Not Specified|0|||
131450692|NCT02745119|473278244|FG003|Overall Study|Reason Not Specified|1|||
131450693|NCT01587924|473278245|FG000|Overall Study|Adverse Event|0|||
131450694|NCT01587924|473278246|FG001|Overall Study|Adverse Event|2|||
131450695|NCT01587924|473278247|FG002|Overall Study|Adverse Event|0|||
131450696|NCT01587924|473278248|FG003|Overall Study|Adverse Event|0|||
131450697|NCT01587924|473278245|FG000|Overall Study|Protocol Violation|2|||
131450698|NCT01587924|473278246|FG001|Overall Study|Protocol Violation|1|||
131450699|NCT01587924|473278247|FG002|Overall Study|Protocol Violation|2|||
131450700|NCT01587924|473278248|FG003|Overall Study|Protocol Violation|1|||
131450701|NCT01587924|473278245|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
131450702|NCT01587924|473278246|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
131450703|NCT01587924|473278247|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
131450704|NCT01587924|473278248|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
131450705|NCT01587924|473278245|FG000|Overall Study|Withdrawal by Subject|0|||
131450706|NCT01587924|473278246|FG001|Overall Study|Withdrawal by Subject|1|||
131450707|NCT01587924|473278247|FG002|Overall Study|Withdrawal by Subject|1|||
131450708|NCT01587924|473278248|FG003|Overall Study|Withdrawal by Subject|0|||
131450709|NCT00432172|473278249|FG000|Overall Study|Physician Decision|0|||
131450710|NCT00432172|473278250|FG001|Overall Study|Physician Decision|0|||
131450711|NCT00432172|473278251|FG002|Overall Study|Physician Decision|2|||
131450712|NCT00432172|473278252|FG003|Overall Study|Physician Decision|0|||
131450713|NCT00432172|473278249|FG000|Overall Study|Adverse Event|4|||
131450714|NCT00432172|473278250|FG001|Overall Study|Adverse Event|2|||
131450715|NCT00432172|473278251|FG002|Overall Study|Adverse Event|4|||
131450716|NCT00432172|473278252|FG003|Overall Study|Adverse Event|3|||
131450717|NCT00432172|473278249|FG000|Overall Study|Disease progression|0|||
131450718|NCT00432172|473278250|FG001|Overall Study|Disease progression|2|||
131450719|NCT00432172|473278251|FG002|Overall Study|Disease progression|5|||
131450720|NCT00432172|473278252|FG003|Overall Study|Disease progression|1|||
131450721|NCT00432172|473278249|FG000|Overall Study|Withdrawal by Subject|0|||
131450722|NCT00432172|473278250|FG001|Overall Study|Withdrawal by Subject|1|||
131450723|NCT00432172|473278251|FG002|Overall Study|Withdrawal by Subject|0|||
131450724|NCT00432172|473278252|FG003|Overall Study|Withdrawal by Subject|2|||
131450725|NCT00432172|473278249|FG000|Overall Study|No treatment received|2|||
131450726|NCT00432172|473278250|FG001|Overall Study|No treatment received|2|||
131450727|NCT00432172|473278251|FG002|Overall Study|No treatment received|0|||
131450728|NCT00432172|473278252|FG003|Overall Study|No treatment received|1|||
131450729|NCT02425943|473278253|FG000|Overall Study|Adverse Event|3|||
131450730|NCT02425943|473278254|FG001|Overall Study|Adverse Event|1|||
131450731|NCT02425943|473278253|FG000|Overall Study|Lost to Follow-up|59|||
131450732|NCT02425943|473278254|FG001|Overall Study|Lost to Follow-up|37|||
131450733|NCT02425943|473278253|FG000|Overall Study|Protocol Violation|4|||
131844934|NCT01338870|474714539|FG002|Overall Study|Protocol Violation|2|||
131844935|NCT01338870|474714540|FG003|Overall Study|Protocol Violation|2|||
131844936|NCT01338870|474714541|FG004|Overall Study|Protocol Violation|1|||
131844937|NCT01338870|474714542|FG005|Overall Study|Protocol Violation|1|||
131844938|NCT01338870|474714537|FG000|Overall Study|Adverse Event|4|||
131844939|NCT01338870|474714538|FG001|Overall Study|Adverse Event|4|||
131844940|NCT01338870|474714539|FG002|Overall Study|Adverse Event|1|||
131844941|NCT01338870|474714540|FG003|Overall Study|Adverse Event|5|||
131844942|NCT01338870|474714541|FG004|Overall Study|Adverse Event|4|||
131450734|NCT02425943|473278254|FG001|Overall Study|Protocol Violation|1|||
131450735|NCT02425943|473278253|FG000|Overall Study|Withdrawal by Subject|64|||
131450736|NCT02425943|473278254|FG001|Overall Study|Withdrawal by Subject|31|||
131450737|NCT02425943|473278253|FG000|Overall Study|Other|6|||
131450738|NCT02425943|473278254|FG001|Overall Study|Other|0|||
131450739|NCT06042855|473278257|FG000|Overall Study|No Receipt of Study Drug|48|||
131450740|NCT06042855|473278258|FG001|Overall Study|No Receipt of Study Drug|57|||
131450741|NCT06042855|473278257|FG000|Overall Study|Administratively Withdrawn|59|||
131450742|NCT06042855|473278258|FG001|Overall Study|Administratively Withdrawn|59|||
131450743|NCT02129699|473278263|FG000|Overall Study|Did not start treatment|3|||
131450744|NCT02129699|473278264|FG001|Overall Study|Did not start treatment|2|||
131450745|NCT01987453|473279587|FG000|Overall Study|Death|0|||
131450746|NCT01987453|473279588|FG001|Overall Study|Death|0|||
131450747|NCT01987453|473279589|FG002|Overall Study|Death|1|||
131844943|NCT01338870|474714542|FG005|Overall Study|Adverse Event|1|||
131844944|NCT00468650|474714546|FG000|Overall Study|Lost to Follow-up|4|||
131844945|NCT00468650|474714546|FG000|Overall Study|Withdrawal by Subject|2|||
131403184|NCT00075946|473097939|FG004|Overall Study|Path ineligible: undetermined histology|6|||
131403185|NCT00075946|473097935|FG000|Overall Study|Did not achieve response after induction|0|||
131403186|NCT00075946|473097936|FG001|Overall Study|Did not achieve response after induction|0|||
131844946|NCT00468650|474714546|FG000|Overall Study|Protocol Violation|1|||
131844947|NCT00423319|474714547|FG000|Overall Study|Death|2|||
131844948|NCT00423319|474714548|FG001|Overall Study|Death|0|||
131844949|NCT00423319|474714547|FG000|Overall Study|Adverse Event|93|||
131844950|NCT00423319|474714548|FG001|Overall Study|Adverse Event|112|||
131844951|NCT00423319|474714547|FG000|Overall Study|Withdrawal by Subject|86|||
131844952|NCT00423319|474714548|FG001|Overall Study|Withdrawal by Subject|99|||
131844953|NCT00423319|474714547|FG000|Overall Study|Lost to Follow-up|4|||
131844954|NCT00423319|474714548|FG001|Overall Study|Lost to Follow-up|3|||
131844955|NCT00423319|474714547|FG000|Overall Study|Poor compliance or noncompliance|1|||
131844956|NCT00423319|474714548|FG001|Overall Study|Poor compliance or noncompliance|1|||
131844957|NCT00423319|474714547|FG000|Overall Study|No longer meets study criteria|15|||
131844958|NCT00423319|474714548|FG001|Overall Study|No longer meets study criteria|15|||
131844959|NCT00423319|474714547|FG000|Overall Study|Other|23|||
131844960|NCT00423319|474714548|FG001|Overall Study|Other|22|||
131844961|NCT02639052|474714549|FG000|Overall Study|Lost to Follow-up|1|||
131844962|NCT00128830|474714552|FG000|Overall Study|Adverse Event|10|||
131844963|NCT00128830|474714552|FG000|Overall Study|Withdrawal by Subject|14|||
131844964|NCT00128830|474714552|FG000|Overall Study|Lost to Follow-up|4|||
131844965|NCT00128830|474714552|FG000|Overall Study|Reached a virologic endpoint|29|||
131844966|NCT00128830|474714552|FG000|Overall Study|Non-compliant|4|||
131844967|NCT00128830|474714552|FG000|Overall Study|Discontinued or ineligible for study|2|||
131844968|NCT00128830|474714552|FG000|Overall Study|Other|9|||
131844969|NCT02730351|474714553|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
131844970|NCT02730351|474714554|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
131844971|NCT02730351|474714553|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
131844972|NCT02730351|474714554|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
131844973|NCT02730351|474714553|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
131844974|NCT02730351|474714554|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
131844975|NCT02730351|474714553|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
131844976|NCT02730351|474714554|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
131844977|NCT02730351|474714553|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
131844978|NCT02730351|474714554|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
131844979|NCT00838435|474714555|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
131844980|NCT00838435|474714555|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
131844981|NCT00838435|474714555|FG000|Part 2 (7 Years)|Adverse Event|2|||
131844982|NCT00838435|474714555|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
131844983|NCT00838435|474714555|FG000|Part 2 (7 Years)|Physician Decision|1|||
131844984|NCT00838435|474714555|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
131844985|NCT00838435|474714555|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
131844986|NCT03796039|474714557|FG000|Overall Study|Death|2|||
131844987|NCT03796039|474714558|FG001|Overall Study|Death|1|||
131844988|NCT03796039|474714557|FG000|Overall Study|Withdrawal by Subject|7|||
131844989|NCT03796039|474714558|FG001|Overall Study|Withdrawal by Subject|4|||
131844990|NCT02927366|474714559|FG000|Overall Study|Adverse Event|1|||
131844991|NCT02927366|474714560|FG001|Overall Study|Adverse Event|0|||
131844992|NCT02927366|474714559|FG000|Overall Study|Patient schedule|1|||
131844993|NCT02927366|474714560|FG001|Overall Study|Patient schedule|0|||
131844994|NCT04874155|474714565|FG000|Overall Study|Lost to Follow-up|1|||
131844995|NCT04874155|474714566|FG001|Overall Study|Lost to Follow-up|1|||
131844996|NCT04874155|474714565|FG000|Overall Study|Withdrawal by Subject|2|||
131844997|NCT04874155|474714566|FG001|Overall Study|Withdrawal by Subject|2|||
131844998|NCT03201965|474714573|FG000|Overall Study|Death|5|||
131844999|NCT03201965|474714574|FG001|Overall Study|Death|27|||
131845000|NCT03201965|474714575|FG002|Overall Study|Death|27|||
131845001|NCT03201965|474714573|FG000|Overall Study|Lost to Follow-up|0|||
131845002|NCT03201965|474714574|FG001|Overall Study|Lost to Follow-up|1|||
131403187|NCT00075946|473097937|FG002|Overall Study|Did not achieve response after induction|0|||
131403188|NCT00075946|473097938|FG003|Overall Study|Did not achieve response after induction|0|||
131845003|NCT03201965|474714575|FG002|Overall Study|Lost to Follow-up|0|||
131845004|NCT03201965|474714573|FG000|Overall Study|Withdrawal by Subject|3|||
131845005|NCT03201965|474714574|FG001|Overall Study|Withdrawal by Subject|13|||
131845006|NCT03201965|474714575|FG002|Overall Study|Withdrawal by Subject|4|||
131845007|NCT03201965|474714573|FG000|Overall Study|Ongoing|20|||
131845008|NCT03201965|474714574|FG001|Overall Study|Ongoing|152|||
131845009|NCT03201965|474714575|FG002|Overall Study|Ongoing|164|||
131845010|NCT02365558|474714576|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
131845011|NCT02365558|474714577|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
131845012|NCT02365558|474714576|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
131845013|NCT02365558|474714577|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
131845014|NCT00369317|474714578|FG000|Overall Study|Adverse Event|3|||
131845015|NCT00369317|474714578|FG000|Overall Study|Death|1|||
131845016|NCT00369317|474714578|FG000|Overall Study|Lack of Efficacy|5|||
131845017|NCT00369317|474714578|FG000|Overall Study|Physician Decision|2|||
131845018|NCT00369317|474714578|FG000|Overall Study|Withdrawal by Subject|8|||
131845019|NCT00369317|474714578|FG000|Overall Study|Ineligible|1|||
131845020|NCT02828241|474714584|FG000|Overall Study|Adverse Event|7|||
131845021|NCT02828241|474714585|FG001|Overall Study|Adverse Event|2|||
131845022|NCT02828241|474714584|FG000|Overall Study|Protocol Violation|1|||
131845023|NCT02828241|474714585|FG001|Overall Study|Protocol Violation|0|||
131845024|NCT03185013|474714588|FG000|Overall Study|Withdrawal by Subject|5|||
131845025|NCT03185013|474714589|FG001|Overall Study|Withdrawal by Subject|3|||
131845026|NCT03185013|474714588|FG000|Overall Study|Adverse Event|1|||
131845027|NCT03185013|474714589|FG001|Overall Study|Adverse Event|0|||
131845028|NCT03185013|474714588|FG000|Overall Study|Progressive Disease|1|||
131845029|NCT03185013|474714589|FG001|Overall Study|Progressive Disease|0|||
131845030|NCT03185013|474714588|FG000|Overall Study|Lost to Follow-up|8|||
131845031|NCT03185013|474714589|FG001|Overall Study|Lost to Follow-up|2|||
131845032|NCT03185013|474714588|FG000|Overall Study|Physician Decision|1|||
131845033|NCT03185013|474714589|FG001|Overall Study|Physician Decision|0|||
131845034|NCT03185013|474714588|FG000|Overall Study|Protocol Deviation|2|||
131845035|NCT03185013|474714589|FG001|Overall Study|Protocol Deviation|0|||
131845036|NCT03185013|474714588|FG000|Overall Study|Reason not Specified|3|||
131845037|NCT03185013|474714589|FG001|Overall Study|Reason not Specified|2|||
131845038|NCT03185013|474714588|FG000|Overall Study|Death|1|||
131845039|NCT03185013|474714589|FG001|Overall Study|Death|0|||
131845040|NCT00510289|474714593|FG000|Overall Study|Withdrawal by Subject|7|||
131845041|NCT00510289|474714593|FG000|Overall Study|Refused bone marrow biopsy|2|||
131845042|NCT00510289|474714593|FG000|Overall Study|Lost to Follow-up|1|||
131845043|NCT00510289|474714593|FG000|Overall Study|Progressed prior to starting drug|2|||
131845044|NCT00673387|474714596|FG000|Overall Study|Withdrawal by Subject|15|||
131845045|NCT00673387|474714597|FG001|Overall Study|Withdrawal by Subject|16|||
131845046|NCT00673387|474714598|FG002|Overall Study|Withdrawal by Subject|20|||
131845047|NCT00673387|474714599|FG003|Overall Study|Withdrawal by Subject|16|||
131845048|NCT00673387|474714600|FG004|Overall Study|Withdrawal by Subject|18|||
131845049|NCT00673387|474714601|FG005|Overall Study|Withdrawal by Subject|21|||
131845050|NCT00673387|474714602|FG006|Overall Study|Withdrawal by Subject|15|||
131845051|NCT00673387|474714603|FG007|Overall Study|Withdrawal by Subject|21|||
131845052|NCT00673387|474714596|FG000|Overall Study|Adverse Event|3|||
131845053|NCT00673387|474714597|FG001|Overall Study|Adverse Event|1|||
131845054|NCT00673387|474714598|FG002|Overall Study|Adverse Event|5|||
131845055|NCT00673387|474714599|FG003|Overall Study|Adverse Event|2|||
131845056|NCT00673387|474714600|FG004|Overall Study|Adverse Event|6|||
131845057|NCT00673387|474714601|FG005|Overall Study|Adverse Event|2|||
131845058|NCT00673387|474714602|FG006|Overall Study|Adverse Event|5|||
131845059|NCT00673387|474714603|FG007|Overall Study|Adverse Event|5|||
131845060|NCT00673387|474714596|FG000|Overall Study|Physician Decision|0|||
131845061|NCT00673387|474714597|FG001|Overall Study|Physician Decision|0|||
131845062|NCT00673387|474714598|FG002|Overall Study|Physician Decision|0|||
131845063|NCT00673387|474714599|FG003|Overall Study|Physician Decision|0|||
131845064|NCT00673387|474714600|FG004|Overall Study|Physician Decision|0|||
131845065|NCT00673387|474714601|FG005|Overall Study|Physician Decision|5|||
131845066|NCT00673387|474714602|FG006|Overall Study|Physician Decision|1|||
131845067|NCT00673387|474714603|FG007|Overall Study|Physician Decision|1|||
131845068|NCT00673387|474714596|FG000|Overall Study|Protocol Violation|3|||
131845069|NCT00673387|474714597|FG001|Overall Study|Protocol Violation|0|||
131845070|NCT00673387|474714598|FG002|Overall Study|Protocol Violation|1|||
131845071|NCT00673387|474714599|FG003|Overall Study|Protocol Violation|2|||
131845072|NCT00673387|474714600|FG004|Overall Study|Protocol Violation|0|||
131845073|NCT00673387|474714601|FG005|Overall Study|Protocol Violation|1|||
131845074|NCT00673387|474714602|FG006|Overall Study|Protocol Violation|1|||
131845075|NCT00673387|474714603|FG007|Overall Study|Protocol Violation|3|||
131845076|NCT00673387|474714596|FG000|Overall Study|Lost to Follow-up|8|||
131845077|NCT00673387|474714597|FG001|Overall Study|Lost to Follow-up|6|||
131845078|NCT00673387|474714598|FG002|Overall Study|Lost to Follow-up|5|||
131845079|NCT00673387|474714599|FG003|Overall Study|Lost to Follow-up|6|||
131403189|NCT00075946|473097939|FG004|Overall Study|Did not achieve response after induction|182|||
131845080|NCT00673387|474714600|FG004|Overall Study|Lost to Follow-up|6|||
131845081|NCT00673387|474714601|FG005|Overall Study|Lost to Follow-up|5|||
131845082|NCT00673387|474714602|FG006|Overall Study|Lost to Follow-up|8|||
131845083|NCT00673387|474714603|FG007|Overall Study|Lost to Follow-up|5|||
131845084|NCT00960115|474714606|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
131845085|NCT00960115|474714607|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
131845086|NCT00371397|474714610|FG000|Session 1|Withdrawal by Subject|1|||
131845087|NCT00371397|474714611|FG001|Session 1|Withdrawal by Subject|0|||
131845088|NCT00371397|474714612|FG002|Session 1|Withdrawal by Subject|0|||
131845089|NCT00371397|474714613|FG003|Session 1|Withdrawal by Subject|0|||
131845090|NCT00371397|474714614|FG004|Session 1|Withdrawal by Subject|0|||
131845091|NCT00371397|474714615|FG005|Session 1|Withdrawal by Subject|0|||
131845092|NCT00371397|474714616|FG006|Session 1|Withdrawal by Subject|0|||
131845093|NCT00371397|474714617|FG007|Session 1|Withdrawal by Subject|1|||
131845094|NCT00371397|474714618|FG008|Session 1|Withdrawal by Subject|0|||
131403190|NCT00075946|473097935|FG000|Overall Study|Incorrectly randomized (no response)|5|||
131845095|NCT00371397|474714619|FG009|Session 1|Withdrawal by Subject|0|||
131845096|NCT00371397|474714620|FG010|Session 1|Withdrawal by Subject|0|||
131845097|NCT00371397|474714621|FG011|Session 1|Withdrawal by Subject|0|||
131845098|NCT03014180|474714622|FG000|Overall Study|Protocol Violation|2|||
131845099|NCT01284621|474714623|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
131845100|NCT01284621|474714624|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
131845101|NCT01284621|474714625|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
131845102|NCT01284621|474714626|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
131845103|NCT01284621|474714627|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
131845104|NCT01284621|474714628|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
131845105|NCT02802631|474714631|FG000|Overall Study|Withdrawal by Subject|1|||
131845106|NCT02802631|474714632|FG001|Overall Study|Withdrawal by Subject|0|||
131845107|NCT02802631|474714633|FG002|Overall Study|Withdrawal by Subject|0|||
131845108|NCT02802631|474714634|FG003|Overall Study|Withdrawal by Subject|0|||
131845109|NCT02802631|474714635|FG004|Overall Study|Withdrawal by Subject|0|||
131845110|NCT02802631|474714636|FG005|Overall Study|Withdrawal by Subject|0|||
131845111|NCT02802631|474714637|FG006|Overall Study|Withdrawal by Subject|0|||
131845112|NCT02802631|474714638|FG007|Overall Study|Withdrawal by Subject|0|||
131845113|NCT02802631|474714631|FG000|Overall Study|Physician Decision|1|||
131845114|NCT02802631|474714632|FG001|Overall Study|Physician Decision|0|||
131845115|NCT02802631|474714633|FG002|Overall Study|Physician Decision|0|||
131845116|NCT02802631|474714634|FG003|Overall Study|Physician Decision|0|||
131845117|NCT02802631|474714635|FG004|Overall Study|Physician Decision|0|||
131845118|NCT02802631|474714636|FG005|Overall Study|Physician Decision|0|||
131845119|NCT02802631|474714637|FG006|Overall Study|Physician Decision|1|||
131845120|NCT02802631|474714638|FG007|Overall Study|Physician Decision|0|||
131845121|NCT02802631|474714631|FG000|Overall Study|Adverse Event|0|||
131845122|NCT02802631|474714632|FG001|Overall Study|Adverse Event|2|||
131845123|NCT02802631|474714633|FG002|Overall Study|Adverse Event|0|||
131845124|NCT02802631|474714634|FG003|Overall Study|Adverse Event|1|||
131845125|NCT02802631|474714635|FG004|Overall Study|Adverse Event|6|||
131845126|NCT02802631|474714636|FG005|Overall Study|Adverse Event|1|||
131845127|NCT02802631|474714637|FG006|Overall Study|Adverse Event|4|||
131845128|NCT02802631|474714638|FG007|Overall Study|Adverse Event|0|||
131845129|NCT02802631|474714631|FG000|Overall Study|Sponsor Decision|0|||
131845130|NCT02802631|474714632|FG001|Overall Study|Sponsor Decision|0|||
131845131|NCT02802631|474714633|FG002|Overall Study|Sponsor Decision|6|||
131845132|NCT02802631|474714634|FG003|Overall Study|Sponsor Decision|0|||
131845133|NCT02802631|474714635|FG004|Overall Study|Sponsor Decision|2|||
131845134|NCT02802631|474714636|FG005|Overall Study|Sponsor Decision|0|||
131845135|NCT02802631|474714637|FG006|Overall Study|Sponsor Decision|0|||
131845136|NCT02802631|474714638|FG007|Overall Study|Sponsor Decision|4|||
131845137|NCT02377427|474714639|FG000|Part A (Up to Week 20)|Physician Decision|1|||
131845138|NCT02377427|474714640|FG001|Part A (Up to Week 20)|Physician Decision|0|||
131845139|NCT02377427|474714641|FG002|Part A (Up to Week 20)|Physician Decision|0|||
131845140|NCT02377427|474714642|FG003|Part A (Up to Week 20)|Physician Decision|0|||
131845141|NCT02377427|474714643|FG004|Part A (Up to Week 20)|Physician Decision|0|||
131845142|NCT02377427|474714639|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
131845143|NCT02377427|474714640|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
131845144|NCT02377427|474714641|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
131845145|NCT02377427|474714642|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
131845146|NCT02377427|474714643|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
131845147|NCT02377427|474714639|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
131845148|NCT02377427|474714640|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131845149|NCT02377427|474714641|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131845150|NCT02377427|474714642|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131845151|NCT02377427|474714643|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131845152|NCT02377427|474714639|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
131845153|NCT02377427|474714640|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
131845154|NCT02377427|474714641|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
131845155|NCT02377427|474714642|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
131845156|NCT02377427|474714643|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
131845157|NCT02342639|474714644|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
131911045|NCT02100631|474963100|FG002|Overall Study|Lost to Follow-up|0|||
131911046|NCT02100631|474963098|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
131403191|NCT00075946|473097936|FG001|Overall Study|Incorrectly randomized (no response)|5|||
131845158|NCT02342639|474714645|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
131845159|NCT02342639|474714644|FG000|Overall Study|Protocol Violation|0|||
131845160|NCT02342639|474714645|FG001|Overall Study|Protocol Violation|2|||
131845161|NCT02212379|474714646|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
131845162|NCT02212379|474714646|FG000|From Baseline to Week 48|Adverse Event|7|||
131845163|NCT02212379|474714646|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
131845164|NCT02212379|474714646|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
131845165|NCT02212379|474714646|FG000|From Week 48 to Week 96|Adverse Event|1|||
131845166|NCT02212379|474714646|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
131845167|NCT02105974|474714647|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
131845168|NCT02105974|474714648|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
131845169|NCT02105974|474714649|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
131403192|NCT00075946|473097937|FG002|Overall Study|Incorrectly randomized (no response)|5|||
131403193|NCT00075946|473097938|FG003|Overall Study|Incorrectly randomized (no response)|1|||
131403194|NCT00075946|473097939|FG004|Overall Study|Incorrectly randomized (no response)|0|||
131403195|NCT00075946|473097935|FG000|Overall Study|Adverse Event|2|||
131845170|NCT02105974|474714647|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
131845171|NCT02105974|474714648|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
131845172|NCT02105974|474714649|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
131845173|NCT02105974|474714647|FG000|2 Week Run-in Period|Adverse Event|6|||
131403196|NCT00075946|473097936|FG001|Overall Study|Adverse Event|10|||
131403197|NCT00075946|473097937|FG002|Overall Study|Adverse Event|0|||
131403198|NCT00075946|473097938|FG003|Overall Study|Adverse Event|2|||
131403199|NCT00075946|473097939|FG004|Overall Study|Adverse Event|0|||
131403200|NCT00075946|473097935|FG000|Overall Study|Death|0|||
131403201|NCT00075946|473097936|FG001|Overall Study|Death|1|||
131403202|NCT00075946|473097937|FG002|Overall Study|Death|0|||
131403203|NCT00075946|473097938|FG003|Overall Study|Death|0|||
131403204|NCT00075946|473097939|FG004|Overall Study|Death|0|||
131403205|NCT00075946|473097935|FG000|Overall Study|Withdrawal by Subject|23|||
131403206|NCT00075946|473097936|FG001|Overall Study|Withdrawal by Subject|58|||
131403207|NCT00075946|473097937|FG002|Overall Study|Withdrawal by Subject|4|||
131403208|NCT00075946|473097938|FG003|Overall Study|Withdrawal by Subject|9|||
131403209|NCT00075946|473097939|FG004|Overall Study|Withdrawal by Subject|0|||
131403210|NCT00075946|473097935|FG000|Overall Study|Alternative therapy|16|||
131403211|NCT00075946|473097936|FG001|Overall Study|Alternative therapy|2|||
131403212|NCT00075946|473097937|FG002|Overall Study|Alternative therapy|5|||
131403213|NCT00075946|473097938|FG003|Overall Study|Alternative therapy|0|||
131403214|NCT00075946|473097939|FG004|Overall Study|Alternative therapy|0|||
131403215|NCT00075946|473097935|FG000|Overall Study|Other complicating disease|7|||
131403216|NCT00075946|473097936|FG001|Overall Study|Other complicating disease|13|||
131403217|NCT00075946|473097937|FG002|Overall Study|Other complicating disease|1|||
131403218|NCT00075946|473097938|FG003|Overall Study|Other complicating disease|4|||
131403219|NCT00075946|473097939|FG004|Overall Study|Other complicating disease|0|||
131403220|NCT00075946|473097935|FG000|Overall Study|No response to retreatment|23|||
131403221|NCT00075946|473097936|FG001|Overall Study|No response to retreatment|0|||
131403222|NCT00075946|473097937|FG002|Overall Study|No response to retreatment|2|||
131845174|NCT02105974|474714648|FG001|2 Week Run-in Period|Adverse Event|0|||
131845175|NCT02105974|474714649|FG002|2 Week Run-in Period|Adverse Event|0|||
131845176|NCT02105974|474714647|FG000|2 Week Run-in Period|Study closed/terminated|1|||
131845177|NCT02105974|474714648|FG001|2 Week Run-in Period|Study closed/terminated|0|||
131845178|NCT02105974|474714649|FG002|2 Week Run-in Period|Study closed/terminated|0|||
131845179|NCT02105974|474714647|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
131845180|NCT02105974|474714648|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
131845181|NCT02105974|474714649|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
131845182|NCT02105974|474714647|FG000|2 Week Run-in Period|Withdrew consent|23|||
131845183|NCT02105974|474714648|FG001|2 Week Run-in Period|Withdrew consent|0|||
131845184|NCT02105974|474714649|FG002|2 Week Run-in Period|Withdrew consent|0|||
131845185|NCT02105974|474714647|FG000|2 Week Run-in Period|Investigator discretion|8|||
131845186|NCT02105974|474714648|FG001|2 Week Run-in Period|Investigator discretion|0|||
131845187|NCT02105974|474714649|FG002|2 Week Run-in Period|Investigator discretion|0|||
131845188|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
131845189|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
131845190|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
131845191|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
131845192|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
131845193|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
131403223|NCT00075946|473097938|FG003|Overall Study|No response to retreatment|0|||
131403224|NCT00075946|473097939|FG004|Overall Study|No response to retreatment|0|||
131403225|NCT00075946|473097935|FG000|Overall Study|Time to progression less than 6 months|15|||
131845194|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
131403226|NCT00075946|473097936|FG001|Overall Study|Time to progression less than 6 months|30|||
131403227|NCT00075946|473097937|FG002|Overall Study|Time to progression less than 6 months|8|||
131403228|NCT00075946|473097938|FG003|Overall Study|Time to progression less than 6 months|3|||
131403229|NCT00075946|473097939|FG004|Overall Study|Time to progression less than 6 months|0|||
131403230|NCT00075946|473097935|FG000|Overall Study|Other|57|||
131845195|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
131845196|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
131845197|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
131845198|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
131845199|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
131845200|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
131845201|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
131845202|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
131845203|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
131845204|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
131845205|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
131845206|NCT02105974|474714647|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
131845207|NCT02105974|474714648|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
131845208|NCT02105974|474714649|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
131845209|NCT02968849|474714650|FG000|Overall Study|Death|8|||
131845210|NCT02968849|474714651|FG001|Overall Study|Death|10|||
131845211|NCT02968849|474714650|FG000|Overall Study|Lost to Follow-up|31|||
131845212|NCT02968849|474714651|FG001|Overall Study|Lost to Follow-up|29|||
131845213|NCT02968849|474714650|FG000|Overall Study|Withdrawal by Subject|73|||
131845214|NCT02968849|474714651|FG001|Overall Study|Withdrawal by Subject|64|||
131845215|NCT02968849|474714650|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
131845216|NCT02968849|474714651|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
131845217|NCT02968849|474714650|FG000|Overall Study|Physician Decision|6|||
131845218|NCT02968849|474714651|FG001|Overall Study|Physician Decision|9|||
131845219|NCT02968849|474714650|FG000|Overall Study|Other|16|||
131845220|NCT02968849|474714651|FG001|Overall Study|Other|10|||
131845221|NCT02013674|474714654|FG000|Overall Study|Death|0|||
131845222|NCT02013674|474714655|FG001|Overall Study|Death|1|||
131845223|NCT02013674|474714654|FG000|Overall Study|Lost to Follow-up|1|||
131845224|NCT02013674|474714655|FG001|Overall Study|Lost to Follow-up|0|||
131845225|NCT00416884|474714657|FG000|Overall Study|Study terminated due to low accrual|1|||
131845226|NCT02203331|474714658|FG000|Overall Study|Pregnancy|1|||
131845227|NCT02203331|474714659|FG001|Overall Study|Pregnancy|0|||
131845228|NCT02203331|474714660|FG002|Overall Study|Pregnancy|0|||
131845229|NCT02203331|474714661|FG003|Overall Study|Pregnancy|0|||
131845230|NCT02203331|474714662|FG004|Overall Study|Pregnancy|2|||
131845231|NCT02203331|474714663|FG005|Overall Study|Pregnancy|0|||
131845232|NCT02203331|474714658|FG000|Overall Study|Withdrawal by Subject|1|||
131845233|NCT02203331|474714659|FG001|Overall Study|Withdrawal by Subject|0|||
131845234|NCT02203331|474714660|FG002|Overall Study|Withdrawal by Subject|1|||
131845235|NCT02203331|474714661|FG003|Overall Study|Withdrawal by Subject|0|||
131845236|NCT02203331|474714662|FG004|Overall Study|Withdrawal by Subject|0|||
131845237|NCT02203331|474714663|FG005|Overall Study|Withdrawal by Subject|3|||
131845238|NCT02203331|474714658|FG000|Overall Study|Adverse Event|4|||
131845239|NCT02203331|474714659|FG001|Overall Study|Adverse Event|8|||
131845240|NCT02203331|474714660|FG002|Overall Study|Adverse Event|3|||
131845241|NCT02203331|474714661|FG003|Overall Study|Adverse Event|4|||
131845242|NCT02203331|474714662|FG004|Overall Study|Adverse Event|3|||
131845243|NCT02203331|474714663|FG005|Overall Study|Adverse Event|3|||
131845244|NCT02203331|474714658|FG000|Overall Study|Other Reasons|1|||
131845245|NCT02203331|474714659|FG001|Overall Study|Other Reasons|2|||
131845246|NCT02203331|474714660|FG002|Overall Study|Other Reasons|0|||
131845247|NCT02203331|474714661|FG003|Overall Study|Other Reasons|2|||
131845248|NCT02203331|474714662|FG004|Overall Study|Other Reasons|0|||
131845249|NCT02203331|474714663|FG005|Overall Study|Other Reasons|0|||
131845250|NCT02203331|474714658|FG000|Overall Study|Lack of Efficacy|0|||
131845251|NCT02203331|474714659|FG001|Overall Study|Lack of Efficacy|2|||
131845252|NCT02203331|474714660|FG002|Overall Study|Lack of Efficacy|1|||
131845253|NCT02203331|474714661|FG003|Overall Study|Lack of Efficacy|0|||
131845254|NCT02203331|474714662|FG004|Overall Study|Lack of Efficacy|0|||
131845255|NCT02203331|474714663|FG005|Overall Study|Lack of Efficacy|1|||
131845256|NCT02203331|474714658|FG000|Overall Study|Protocol Violation|0|||
131845257|NCT02203331|474714659|FG001|Overall Study|Protocol Violation|2|||
131845258|NCT02203331|474714660|FG002|Overall Study|Protocol Violation|0|||
131845259|NCT02203331|474714661|FG003|Overall Study|Protocol Violation|1|||
131845260|NCT02203331|474714662|FG004|Overall Study|Protocol Violation|1|||
131845261|NCT02203331|474714663|FG005|Overall Study|Protocol Violation|0|||
131845262|NCT02203331|474714658|FG000|Overall Study|Lost to Follow-up|0|||
131845263|NCT02203331|474714659|FG001|Overall Study|Lost to Follow-up|0|||
131845264|NCT02203331|474714660|FG002|Overall Study|Lost to Follow-up|0|||
131845265|NCT02203331|474714661|FG003|Overall Study|Lost to Follow-up|0|||
131845266|NCT02203331|474714662|FG004|Overall Study|Lost to Follow-up|1|||
131845267|NCT02203331|474714663|FG005|Overall Study|Lost to Follow-up|0|||
131845268|NCT03510598|474715876|FG000|Overall Study|Withdrawal by Subject|1|||
131845269|NCT05307510|474715878|FG000|Overall Study|Lost to Follow-up|3|||
131845270|NCT05307510|474715879|FG001|Overall Study|Lost to Follow-up|6|||
131845271|NCT05307510|474715878|FG000|Overall Study|Withdrawal by Subject|0|||
131845272|NCT05307510|474715879|FG001|Overall Study|Withdrawal by Subject|1|||
131845273|NCT03610516|474715882|FG000|Treatment Epoch|Adverse Event|3|||
131845274|NCT03610516|474715883|FG001|Treatment Epoch|Adverse Event|1|||
131845275|NCT03610516|474715882|FG000|Treatment Epoch|Death|1|||
131450748|NCT01987453|473279587|FG000|Overall Study|Lack of Efficacy|1|||
131450749|NCT01987453|473279588|FG001|Overall Study|Lack of Efficacy|12|||
131450750|NCT01987453|473279589|FG002|Overall Study|Lack of Efficacy|0|||
131450751|NCT01590888|473279591|FG000|Overall Study|Adverse Event|3|||
131450752|NCT01590888|473279592|FG001|Overall Study|Adverse Event|0|||
131450753|NCT01590888|473279593|FG002|Overall Study|Adverse Event|1|||
131450754|NCT01590888|473279591|FG000|Overall Study|Lost to Follow-up|1|||
131450755|NCT01590888|473279592|FG001|Overall Study|Lost to Follow-up|0|||
131450756|NCT01590888|473279593|FG002|Overall Study|Lost to Follow-up|0|||
131450757|NCT02331277|473279594|FG000|Overall Study|Withdrawal by Subject|1|||
131450758|NCT02331277|473279595|FG001|Overall Study|Withdrawal by Subject|0|||
131450759|NCT03978117|473279596|FG000|Overall Study|Non-Compliance|26|||
131450760|NCT03978117|473279597|FG001|Overall Study|Non-Compliance|26|||
131450761|NCT03978117|473279596|FG000|Overall Study|Lost to Follow-up|4|||
131450762|NCT03978117|473279597|FG001|Overall Study|Lost to Follow-up|4|||
131450763|NCT05462756|473279598|FG000|Treatment Period|Adverse Event|3|||
131450764|NCT05462756|473279599|FG001|Treatment Period|Adverse Event|0|||
131450765|NCT05462756|473279598|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
131450766|NCT05462756|473279599|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
131450767|NCT05462756|473279598|FG000|Treatment Period|Death|0|||
131450768|NCT05462756|473279599|FG001|Treatment Period|Death|1|||
131450769|NCT05462756|473279598|FG000|Treatment Period|Lost to Follow-up|2|||
131450770|NCT05462756|473279599|FG001|Treatment Period|Lost to Follow-up|1|||
131450771|NCT05462756|473279598|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
131450772|NCT05462756|473279599|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
131450773|NCT05462756|473279598|FG000|Treatment Period|Physician Decision|2|||
131450774|NCT05462756|473279599|FG001|Treatment Period|Physician Decision|0|||
131450775|NCT05462756|473279598|FG000|Treatment Period|Protocol Violation|0|||
131450776|NCT05462756|473279599|FG001|Treatment Period|Protocol Violation|1|||
131450777|NCT05462756|473279598|FG000|Treatment Period|Withdrawal by Subject|5|||
131450778|NCT05462756|473279599|FG001|Treatment Period|Withdrawal by Subject|12|||
131450779|NCT05462756|473279598|FG000|Follow-Up Period|Adverse Event|1|||
131450780|NCT05462756|473279599|FG001|Follow-Up Period|Adverse Event|0|||
131450781|NCT05462756|473279598|FG000|Follow-Up Period|Death|1|||
131450782|NCT05462756|473279599|FG001|Follow-Up Period|Death|0|||
131450783|NCT05462756|473279598|FG000|Follow-Up Period|Lost to Follow-up|3|||
131450784|NCT05462756|473279599|FG001|Follow-Up Period|Lost to Follow-up|1|||
131450785|NCT05462756|473279598|FG000|Follow-Up Period|Withdrawal by Subject|0|||
131450786|NCT05462756|473279599|FG001|Follow-Up Period|Withdrawal by Subject|4|||
131450787|NCT00990704|473279600|FG000|Overall Study|Adverse Event|1|||
131450788|NCT00990704|473279601|FG001|Overall Study|Adverse Event|1|||
131450789|NCT00990704|473279600|FG000|Overall Study|Physician Decision|0|||
131450790|NCT00990704|473279601|FG001|Overall Study|Physician Decision|1|||
131450791|NCT01235741|473279605|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
131450792|NCT01235741|473279606|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
131450793|NCT01235741|473279607|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
131450794|NCT01235741|473279605|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
131450795|NCT01235741|473279606|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
131450796|NCT01235741|473279607|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
131450797|NCT01235741|473279605|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
131450798|NCT01235741|473279606|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
131450799|NCT01235741|473279607|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
131450800|NCT01235741|473279605|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
131450801|NCT01235741|473279606|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
131450802|NCT01235741|473279607|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
131450803|NCT01235741|473279605|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
131450804|NCT01235741|473279606|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
131450805|NCT01235741|473279607|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
131450806|NCT01235741|473279605|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
131450807|NCT01235741|473279606|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
131845276|NCT03610516|474715883|FG001|Treatment Epoch|Death|0|||
131845277|NCT03610516|474715882|FG000|Treatment Epoch|Lack of Efficacy|0|||
131845278|NCT03610516|474715883|FG001|Treatment Epoch|Lack of Efficacy|1|||
131845279|NCT03610516|474715882|FG000|Treatment Epoch|No longer requires treatment|1|||
131845280|NCT03610516|474715883|FG001|Treatment Epoch|No longer requires treatment|0|||
131450808|NCT01235741|473279607|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
131450809|NCT01235741|473279605|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
131450810|NCT01235741|473279606|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
131450811|NCT01235741|473279607|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
131450812|NCT01235741|473279605|FG000|Randomized to Treatment|Adverse Event|0|||
131450813|NCT01235741|473279606|FG001|Randomized to Treatment|Adverse Event|1|||
131450814|NCT01235741|473279607|FG002|Randomized to Treatment|Adverse Event|1|||
131845281|NCT03610516|474715882|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
131450815|NCT01235741|473279605|FG000|Randomized to Treatment|Sponsor terminated study|0|||
131450816|NCT01235741|473279606|FG001|Randomized to Treatment|Sponsor terminated study|35|||
131450817|NCT01235741|473279607|FG002|Randomized to Treatment|Sponsor terminated study|34|||
131450818|NCT01235741|473279605|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
131450819|NCT01235741|473279606|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
131450820|NCT01235741|473279607|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
131450821|NCT01235741|473279605|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
131450822|NCT01235741|473279606|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
131450823|NCT01235741|473279607|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
131450824|NCT01235741|473279605|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
131450825|NCT01235741|473279606|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
131450826|NCT01235741|473279607|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
131450827|NCT01177397|473279608|FG000|Overall Study|Protocol Violation|0|||
131450828|NCT01177397|473279609|FG001|Overall Study|Protocol Violation|0|||
131450829|NCT01177397|473279610|FG002|Overall Study|Protocol Violation|0|||
131450830|NCT01177397|473279611|FG003|Overall Study|Protocol Violation|0|||
131450831|NCT01177397|473279612|FG004|Overall Study|Protocol Violation|0|||
131450832|NCT01177397|473279613|FG005|Overall Study|Protocol Violation|1|||
131450833|NCT01177397|473279614|FG006|Overall Study|Protocol Violation|0|||
131450834|NCT01177397|473279615|FG007|Overall Study|Protocol Violation|0|||
131450835|NCT01177397|473279616|FG008|Overall Study|Protocol Violation|0|||
131450836|NCT01177397|473279617|FG009|Overall Study|Protocol Violation|0|||
131450837|NCT01177397|473279618|FG010|Overall Study|Protocol Violation|0|||
131450838|NCT01177397|473279619|FG011|Overall Study|Protocol Violation|0|||
131450839|NCT01177397|473279608|FG000|Overall Study|Lost to Follow-up|0|||
131450840|NCT01177397|473279609|FG001|Overall Study|Lost to Follow-up|0|||
131450841|NCT01177397|473279610|FG002|Overall Study|Lost to Follow-up|0|||
131450842|NCT01177397|473279611|FG003|Overall Study|Lost to Follow-up|0|||
131450843|NCT01177397|473279612|FG004|Overall Study|Lost to Follow-up|1|||
131450844|NCT01177397|473279613|FG005|Overall Study|Lost to Follow-up|0|||
131450845|NCT01177397|473279614|FG006|Overall Study|Lost to Follow-up|0|||
131450846|NCT01177397|473279615|FG007|Overall Study|Lost to Follow-up|2|||
131450847|NCT01177397|473279616|FG008|Overall Study|Lost to Follow-up|0|||
131450848|NCT01177397|473279617|FG009|Overall Study|Lost to Follow-up|0|||
131450849|NCT01177397|473279618|FG010|Overall Study|Lost to Follow-up|0|||
131450850|NCT01177397|473279619|FG011|Overall Study|Lost to Follow-up|0|||
131450851|NCT01177397|473279608|FG000|Overall Study|Death|0|||
131450852|NCT01177397|473279609|FG001|Overall Study|Death|0|||
131450853|NCT01177397|473279610|FG002|Overall Study|Death|1|||
131450854|NCT01177397|473279611|FG003|Overall Study|Death|1|||
131450855|NCT01177397|473279612|FG004|Overall Study|Death|0|||
131450856|NCT01177397|473279613|FG005|Overall Study|Death|0|||
131450857|NCT01177397|473279614|FG006|Overall Study|Death|0|||
131450858|NCT01177397|473279615|FG007|Overall Study|Death|5|||
131450859|NCT01177397|473279616|FG008|Overall Study|Death|2|||
131450860|NCT01177397|473279617|FG009|Overall Study|Death|1|||
131450861|NCT01177397|473279618|FG010|Overall Study|Death|0|||
131450862|NCT01177397|473279619|FG011|Overall Study|Death|0|||
131450863|NCT01177397|473279608|FG000|Overall Study|Withdrawal by Subject|0|||
131450864|NCT01177397|473279609|FG001|Overall Study|Withdrawal by Subject|0|||
131450865|NCT01177397|473279610|FG002|Overall Study|Withdrawal by Subject|1|||
131450866|NCT01177397|473279611|FG003|Overall Study|Withdrawal by Subject|1|||
131450867|NCT01177397|473279612|FG004|Overall Study|Withdrawal by Subject|1|||
131450868|NCT01177397|473279613|FG005|Overall Study|Withdrawal by Subject|2|||
131450869|NCT01177397|473279614|FG006|Overall Study|Withdrawal by Subject|0|||
131450870|NCT01177397|473279615|FG007|Overall Study|Withdrawal by Subject|5|||
131845282|NCT03610516|474715883|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
131845283|NCT03610516|474715882|FG000|Treatment Epoch|Physician Decision|8|||
131845284|NCT03610516|474715883|FG001|Treatment Epoch|Physician Decision|5|||
131450871|NCT01177397|473279616|FG008|Overall Study|Withdrawal by Subject|9|||
131450872|NCT01177397|473279617|FG009|Overall Study|Withdrawal by Subject|1|||
131450873|NCT01177397|473279618|FG010|Overall Study|Withdrawal by Subject|1|||
131450874|NCT01177397|473279619|FG011|Overall Study|Withdrawal by Subject|0|||
131450875|NCT01177397|473279608|FG000|Overall Study|Adverse Event|0|||
131450876|NCT01177397|473279609|FG001|Overall Study|Adverse Event|0|||
131450877|NCT01177397|473279610|FG002|Overall Study|Adverse Event|1|||
131450878|NCT01177397|473279611|FG003|Overall Study|Adverse Event|2|||
131450879|NCT01177397|473279612|FG004|Overall Study|Adverse Event|0|||
131450880|NCT01177397|473279613|FG005|Overall Study|Adverse Event|12|||
131450881|NCT01177397|473279614|FG006|Overall Study|Adverse Event|1|||
131450882|NCT01177397|473279615|FG007|Overall Study|Adverse Event|14|||
131450883|NCT01177397|473279616|FG008|Overall Study|Adverse Event|8|||
131450884|NCT01177397|473279617|FG009|Overall Study|Adverse Event|6|||
131450885|NCT01177397|473279618|FG010|Overall Study|Adverse Event|3|||
131450886|NCT01177397|473279619|FG011|Overall Study|Adverse Event|7|||
131450887|NCT01177397|473279608|FG000|Overall Study|Disease progression|1|||
131450888|NCT01177397|473279609|FG001|Overall Study|Disease progression|2|||
131450889|NCT01177397|473279610|FG002|Overall Study|Disease progression|5|||
131450890|NCT01177397|473279611|FG003|Overall Study|Disease progression|5|||
131450891|NCT01177397|473279612|FG004|Overall Study|Disease progression|4|||
131450892|NCT01177397|473279613|FG005|Overall Study|Disease progression|10|||
131450893|NCT01177397|473279614|FG006|Overall Study|Disease progression|10|||
131450894|NCT01177397|473279615|FG007|Overall Study|Disease progression|21|||
131450895|NCT01177397|473279616|FG008|Overall Study|Disease progression|18|||
131450896|NCT01177397|473279617|FG009|Overall Study|Disease progression|12|||
131450897|NCT01177397|473279618|FG010|Overall Study|Disease progression|10|||
131450898|NCT01177397|473279619|FG011|Overall Study|Disease progression|8|||
131450899|NCT01177397|473279608|FG000|Overall Study|Other reasons|0|||
131450900|NCT01177397|473279609|FG001|Overall Study|Other reasons|0|||
131450901|NCT01177397|473279610|FG002|Overall Study|Other reasons|1|||
131845285|NCT03610516|474715882|FG000|Treatment Epoch|Protocol Deviation|1|||
131845286|NCT03610516|474715883|FG001|Treatment Epoch|Protocol Deviation|0|||
131845287|NCT03610516|474715882|FG000|Treatment Epoch|Withdrawal by Subject|3|||
131845288|NCT03610516|474715883|FG001|Treatment Epoch|Withdrawal by Subject|1|||
131845289|NCT03610516|474715882|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
131845290|NCT03610516|474715883|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
131845291|NCT03610516|474715882|FG000|Post-Treatment Follow-up|Death|1|||
131845292|NCT03610516|474715883|FG001|Post-Treatment Follow-up|Death|0|||
131845293|NCT02886624|474715885|FG000|12-week Post Treatment Follow-up|Death|1|||
131845294|NCT02886624|474715885|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
131845295|NCT01056289|474715888|FG000|Open-label Phase|Adverse Event|29|||
131845296|NCT01056289|474715889|FG001|Open-label Phase|Adverse Event|0|||
131845297|NCT01056289|474715890|FG002|Open-label Phase|Adverse Event|0|||
131845298|NCT01056289|474715891|FG003|Open-label Phase|Adverse Event|0|||
131845299|NCT01056289|474715888|FG000|Open-label Phase|Lost to Follow-up|30|||
131845300|NCT01056289|474715889|FG001|Open-label Phase|Lost to Follow-up|0|||
131845301|NCT01056289|474715890|FG002|Open-label Phase|Lost to Follow-up|0|||
131845302|NCT01056289|474715891|FG003|Open-label Phase|Lost to Follow-up|0|||
131845303|NCT01056289|474715888|FG000|Open-label Phase|Other|9|||
131845304|NCT01056289|474715889|FG001|Open-label Phase|Other|0|||
131845305|NCT01056289|474715890|FG002|Open-label Phase|Other|0|||
131845306|NCT01056289|474715891|FG003|Open-label Phase|Other|0|||
131845307|NCT01056289|474715888|FG000|Open-label Phase|Protocol Violation|6|||
131845308|NCT01056289|474715889|FG001|Open-label Phase|Protocol Violation|0|||
131845309|NCT01056289|474715890|FG002|Open-label Phase|Protocol Violation|0|||
131845310|NCT01056289|474715891|FG003|Open-label Phase|Protocol Violation|0|||
131845311|NCT01056289|474715888|FG000|Open-label Phase|Withdrawal by Subject|26|||
131845312|NCT01056289|474715889|FG001|Open-label Phase|Withdrawal by Subject|0|||
131845313|NCT01056289|474715890|FG002|Open-label Phase|Withdrawal by Subject|0|||
131845314|NCT01056289|474715891|FG003|Open-label Phase|Withdrawal by Subject|0|||
131845315|NCT01056289|474715888|FG000|Open-label Phase|Lack of Efficacy|18|||
131845316|NCT01056289|474715889|FG001|Open-label Phase|Lack of Efficacy|0|||
131845317|NCT01056289|474715890|FG002|Open-label Phase|Lack of Efficacy|0|||
131845318|NCT01056289|474715891|FG003|Open-label Phase|Lack of Efficacy|0|||
131845319|NCT01056289|474715888|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
131845320|NCT01056289|474715889|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
131845321|NCT01056289|474715890|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
131911047|NCT02100631|474963099|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
131911048|NCT02100631|474963100|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
131911049|NCT01075048|474963101|FG000|Overall Study|Death|4|||
131911050|NCT01075048|474963102|FG001|Overall Study|Death|17|||
131911051|NCT01075048|474963103|FG002|Overall Study|Death|12|||
131911052|NCT01075048|474963101|FG000|Overall Study|Start of other or new therapy|4|||
131911053|NCT01075048|474963102|FG001|Overall Study|Start of other or new therapy|36|||
131911054|NCT01075048|474963103|FG002|Overall Study|Start of other or new therapy|46|||
131911055|NCT01075048|474963101|FG000|Overall Study|Withdrawal by Subject|1|||
131911056|NCT01075048|474963102|FG001|Overall Study|Withdrawal by Subject|6|||
131911057|NCT01075048|474963103|FG002|Overall Study|Withdrawal by Subject|3|||
131911058|NCT01075048|474963101|FG000|Overall Study|Lost to Follow-up|0|||
131911059|NCT01075048|474963102|FG001|Overall Study|Lost to Follow-up|1|||
131911060|NCT01075048|474963103|FG002|Overall Study|Lost to Follow-up|1|||
131845322|NCT01056289|474715891|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
131911061|NCT01287936|474963107|FG000|Overall Study|Lost to Follow-up|0|||
131911062|NCT01287936|474963108|FG001|Overall Study|Lost to Follow-up|1|||
131450902|NCT01177397|473279611|FG003|Overall Study|Other reasons|0|||
131450903|NCT01177397|473279612|FG004|Overall Study|Other reasons|1|||
131845323|NCT01056289|474715888|FG000|Double-blind Phase|Adverse Event|0|||
131845324|NCT01056289|474715889|FG001|Double-blind Phase|Adverse Event|1|||
131845325|NCT01056289|474715890|FG002|Double-blind Phase|Adverse Event|2|||
131845326|NCT01056289|474715891|FG003|Double-blind Phase|Adverse Event|1|||
131845327|NCT01056289|474715888|FG000|Double-blind Phase|Lost to Follow-up|0|||
131845328|NCT01056289|474715889|FG001|Double-blind Phase|Lost to Follow-up|2|||
131911063|NCT01287936|474963109|FG002|Overall Study|Lost to Follow-up|1|||
131911064|NCT01140906|474963110|FG000|Overall Study|Adverse Event|7|||
131845329|NCT01056289|474715890|FG002|Double-blind Phase|Lost to Follow-up|2|||
131845330|NCT01056289|474715891|FG003|Double-blind Phase|Lost to Follow-up|2|||
131845331|NCT01056289|474715888|FG000|Double-blind Phase|Other|0|||
131845332|NCT01056289|474715889|FG001|Double-blind Phase|Other|0|||
131845333|NCT01056289|474715890|FG002|Double-blind Phase|Other|1|||
131403231|NCT00075946|473097936|FG001|Overall Study|Other|32|||
131403232|NCT00075946|473097937|FG002|Overall Study|Other|3|||
131403233|NCT00075946|473097938|FG003|Overall Study|Other|11|||
131403234|NCT00075946|473097939|FG004|Overall Study|Other|0|||
131403235|NCT00889603|473097942|FG000|Overall Study|Adverse Event|7|||
131403236|NCT00889603|473097942|FG000|Overall Study|Death|3|||
131403237|NCT00889603|473097942|FG000|Overall Study|Lost to Follow-up|19|||
131403238|NCT00889603|473097942|FG000|Overall Study|No longer willing to participant in stud|4|||
131403239|NCT00889603|473097942|FG000|Overall Study|Other|4|||
131403240|NCT01229254|473097944|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
131403241|NCT01229254|473097945|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
131403242|NCT01229254|473097946|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
131403243|NCT01229254|473097944|FG000|Overall Study|Adverse Event|4|||
131403244|NCT01229254|473097945|FG001|Overall Study|Adverse Event|5|||
131403245|NCT01229254|473097946|FG002|Overall Study|Adverse Event|3|||
131403246|NCT01229254|473097944|FG000|Overall Study|Lost to Follow-up|3|||
131403247|NCT01229254|473097945|FG001|Overall Study|Lost to Follow-up|0|||
131403248|NCT01229254|473097946|FG002|Overall Study|Lost to Follow-up|1|||
131403249|NCT01229254|473097944|FG000|Overall Study|Physician Decision|0|||
131403250|NCT01229254|473097945|FG001|Overall Study|Physician Decision|3|||
131403251|NCT01229254|473097946|FG002|Overall Study|Physician Decision|0|||
131403252|NCT01229254|473097944|FG000|Overall Study|Protocol Violation|4|||
131403253|NCT01229254|473097945|FG001|Overall Study|Protocol Violation|6|||
131403254|NCT01229254|473097946|FG002|Overall Study|Protocol Violation|5|||
131403255|NCT01229254|473097944|FG000|Overall Study|Withdrawal by Subject|1|||
131403256|NCT01229254|473097945|FG001|Overall Study|Withdrawal by Subject|0|||
131403257|NCT01229254|473097946|FG002|Overall Study|Withdrawal by Subject|1|||
131403258|NCT01229254|473097944|FG000|Overall Study|Non-compliance with Study Drug|0|||
131403259|NCT01229254|473097945|FG001|Overall Study|Non-compliance with Study Drug|1|||
131403260|NCT01229254|473097946|FG002|Overall Study|Non-compliance with Study Drug|1|||
131403261|NCT03070223|473097952|FG000|Overall Study|Lost to Follow-up|34|||
131403262|NCT03070223|473097953|FG001|Overall Study|Lost to Follow-up|27|||
131403263|NCT03070223|473097952|FG000|Overall Study|Withdrawal by Subject|12|||
131403264|NCT03070223|473097953|FG001|Overall Study|Withdrawal by Subject|22|||
131403265|NCT03070223|473097952|FG000|Overall Study|Protocol Violation|0|||
131403266|NCT03070223|473097953|FG001|Overall Study|Protocol Violation|1|||
131403267|NCT02438683|473097954|FG000|Overall Study|Adverse Event|1|||
131403268|NCT02438683|473097955|FG001|Overall Study|Adverse Event|0|||
131403269|NCT02438683|473097956|FG002|Overall Study|Adverse Event|0|||
131403270|NCT02438683|473097957|FG003|Overall Study|Adverse Event|0|||
131403271|NCT02438683|473097958|FG004|Overall Study|Adverse Event|0|||
131403272|NCT02438683|473097959|FG005|Overall Study|Adverse Event|0|||
131403273|NCT05425732|473099747|FG000|Overall Study|Death|4|||
131403274|NCT05425732|473099748|FG001|Overall Study|Death|2|||
131403275|NCT05425732|473099749|FG002|Overall Study|Death|0|||
131403276|NCT05425732|473099750|FG003|Overall Study|Death|0|||
131403277|NCT05425732|473099747|FG000|Overall Study|Lost to Follow-up|10|||
131403278|NCT05425732|473099748|FG001|Overall Study|Lost to Follow-up|15|||
131403279|NCT05425732|473099749|FG002|Overall Study|Lost to Follow-up|5|||
131403280|NCT05425732|473099750|FG003|Overall Study|Lost to Follow-up|3|||
131403281|NCT05425732|473099747|FG000|Overall Study|Physician Decision|0|||
131403282|NCT05425732|473099748|FG001|Overall Study|Physician Decision|2|||
131403283|NCT05425732|473099749|FG002|Overall Study|Physician Decision|0|||
131403284|NCT05425732|473099750|FG003|Overall Study|Physician Decision|0|||
131403285|NCT05425732|473099747|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131403286|NCT05425732|473099748|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
131403287|NCT05425732|473099749|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131450904|NCT01177397|473279613|FG005|Overall Study|Other reasons|1|||
131450905|NCT01177397|473279614|FG006|Overall Study|Other reasons|2|||
131845334|NCT01056289|474715891|FG003|Double-blind Phase|Other|2|||
131845335|NCT01056289|474715888|FG000|Double-blind Phase|Protocol Violation|0|||
131845336|NCT01056289|474715889|FG001|Double-blind Phase|Protocol Violation|0|||
131845337|NCT01056289|474715890|FG002|Double-blind Phase|Protocol Violation|1|||
131403288|NCT05425732|473099750|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131403289|NCT05425732|473099747|FG000|Overall Study|Withdrawal by Subject|4|||
131403290|NCT05425732|473099748|FG001|Overall Study|Withdrawal by Subject|8|||
131403291|NCT05425732|473099749|FG002|Overall Study|Withdrawal by Subject|1|||
131403292|NCT05425732|473099750|FG003|Overall Study|Withdrawal by Subject|1|||
131403293|NCT05425732|473099747|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
131845338|NCT01056289|474715891|FG003|Double-blind Phase|Protocol Violation|1|||
131403294|NCT05425732|473099748|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
131403295|NCT05425732|473099749|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
131845339|NCT01056289|474715888|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131845340|NCT01056289|474715889|FG001|Double-blind Phase|Withdrawal by Subject|0|||
131845341|NCT01056289|474715890|FG002|Double-blind Phase|Withdrawal by Subject|4|||
131845342|NCT01056289|474715891|FG003|Double-blind Phase|Withdrawal by Subject|2|||
131845343|NCT01056289|474715888|FG000|Double-blind Phase|Discontinuation symptom|0|||
131845344|NCT01056289|474715889|FG001|Double-blind Phase|Discontinuation symptom|1|||
131845345|NCT01056289|474715890|FG002|Double-blind Phase|Discontinuation symptom|2|||
131845346|NCT01056289|474715891|FG003|Double-blind Phase|Discontinuation symptom|2|||
131845347|NCT01056289|474715888|FG000|Double-blind Phase|Physician Decision|0|||
131845348|NCT01056289|474715889|FG001|Double-blind Phase|Physician Decision|0|||
131845349|NCT01056289|474715890|FG002|Double-blind Phase|Physician Decision|1|||
131845350|NCT01056289|474715891|FG003|Double-blind Phase|Physician Decision|0|||
131845351|NCT01199471|474715894|FG000|Overall Study|Protocol Violation|4|||
131845352|NCT01199471|474715894|FG000|Overall Study|Withdrawal by Subject|1|||
131845353|NCT01199471|474715894|FG000|Overall Study|Physician Decision|1|||
131845354|NCT01664130|474715901|FG000|Overall Study|competing secondary disease|2|||
131845355|NCT00554606|474715902|FG000|Overall Study|Adverse Event|3|||
131845356|NCT00554606|474715902|FG000|Overall Study|Abnormal laboratory values|1|||
131845357|NCT00554606|474715902|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
131845358|NCT00554606|474715902|FG000|Overall Study|Subject withdrew consent|2|||
131845359|NCT00554606|474715902|FG000|Overall Study|Lost to Follow-up|2|||
131845360|NCT00554606|474715902|FG000|Overall Study|Administrative problems|60|||
131845361|NCT00554606|474715902|FG000|Overall Study|Death|1|||
131845362|NCT00554606|474715902|FG000|Overall Study|Protocol deviation|2|||
131845363|NCT03323437|474715904|FG000|Overall Study|Withdrawal by Subject|0|||
131845364|NCT03323437|474715905|FG001|Overall Study|Withdrawal by Subject|4|||
131845365|NCT01305044|474715908|FG000|Overall Study|Withdrawal by Subject|3|||
131845366|NCT01305044|474715909|FG001|Overall Study|Withdrawal by Subject|6|||
131845367|NCT03257865|474715914|FG000|Overall Study|Adverse Event|4|||
131845368|NCT03257865|474715915|FG001|Overall Study|Adverse Event|8|||
131845369|NCT03257865|474715914|FG000|Overall Study|Lack of Efficacy|1|||
131845370|NCT03257865|474715915|FG001|Overall Study|Lack of Efficacy|2|||
131845371|NCT03257865|474715914|FG000|Overall Study|Non-compliance with Study Drug|0|||
131845372|NCT03257865|474715915|FG001|Overall Study|Non-compliance with Study Drug|2|||
131845373|NCT03257865|474715914|FG000|Overall Study|Withdrawal by Subject|23|||
131845374|NCT03257865|474715915|FG001|Overall Study|Withdrawal by Subject|17|||
131845375|NCT03257865|474715914|FG000|Overall Study|Physician Decision|3|||
131845376|NCT03257865|474715915|FG001|Overall Study|Physician Decision|1|||
131845377|NCT03257865|474715914|FG000|Overall Study|Other|0|||
131845378|NCT03257865|474715915|FG001|Overall Study|Other|1|||
131845379|NCT03257865|474715914|FG000|Overall Study|Lost to Follow-up|4|||
131845380|NCT03257865|474715915|FG001|Overall Study|Lost to Follow-up|4|||
131845381|NCT02677714|474715916|FG000|Overall Study|Withdrawal by Subject|2|||
131845382|NCT02677714|474715917|FG001|Overall Study|Withdrawal by Subject|0|||
131845383|NCT04015908|474715921|FG000|Overall Study|Lost to Follow-up|0|||
131845384|NCT04015908|474715922|FG001|Overall Study|Lost to Follow-up|1|||
131845385|NCT02538965|474715923|FG000|Treatment Period|Other = Death due to disease progression|1|||
131845386|NCT02538965|474715923|FG000|Treatment Period|Adverse Event|2|||
131845387|NCT02538965|474715923|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
131845388|NCT02538965|474715923|FG000|Treatment Period|Treatment Failure|9|||
131845389|NCT02538965|474715923|FG000|Treatment Period|Disease Progression|1|||
131845390|NCT02538965|474715923|FG000|Treatment Period|Physician Decision|2|||
131845391|NCT02538965|474715923|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
131845392|NCT02538965|474715923|FG000|Follow-Up Period|Withdrawal by Parent|4|||
131845393|NCT00875797|474715924|FG000|Overall Study|Protocol Violation|6|||
131845394|NCT00875797|474715925|FG001|Overall Study|Protocol Violation|3|||
131845395|NCT00715624|474715926|FG000|Overall Study|Adverse Event|12|||
131845396|NCT00715624|474715927|FG001|Overall Study|Adverse Event|37|||
131845397|NCT00715624|474715926|FG000|Overall Study|Lack of Efficacy|11|||
131845398|NCT00715624|474715927|FG001|Overall Study|Lack of Efficacy|11|||
131845399|NCT00715624|474715926|FG000|Overall Study|Lost to Follow-up|1|||
131845400|NCT00715624|474715927|FG001|Overall Study|Lost to Follow-up|2|||
131845401|NCT00715624|474715926|FG000|Overall Study|Protocol Violation|1|||
131845402|NCT00715624|474715927|FG001|Overall Study|Protocol Violation|0|||
131845403|NCT00715624|474715926|FG000|Overall Study|Withdrawal by Subject|11|||
131845404|NCT00715624|474715927|FG001|Overall Study|Withdrawal by Subject|25|||
131845405|NCT00715624|474715926|FG000|Overall Study|Familial and personal reasons|10|||
131845406|NCT00715624|474715927|FG001|Overall Study|Familial and personal reasons|22|||
131845407|NCT00715624|474715926|FG000|Overall Study|Poor compliance|6|||
131845408|NCT00715624|474715927|FG001|Overall Study|Poor compliance|13|||
131845409|NCT00715624|474715926|FG000|Overall Study|Sponsor decision|0|||
131845410|NCT00715624|474715927|FG001|Overall Study|Sponsor decision|4|||
131845411|NCT00715624|474715926|FG000|Overall Study|Incorrect randomization (not treated)|0|||
131845412|NCT00715624|474715927|FG001|Overall Study|Incorrect randomization (not treated)|1|||
131845413|NCT00715624|474715926|FG000|Overall Study|Other|0|||
131845414|NCT00715624|474715927|FG001|Overall Study|Other|1|||
131845415|NCT01955083|474715931|FG000|Overall Study|Lost to Follow-up|1|||
131845416|NCT01955083|474715932|FG001|Overall Study|Lost to Follow-up|1|||
131845417|NCT00901576|474715943|FG000|Second Intervention|Withdrawal by Subject|0|||
131845418|NCT00901576|474715944|FG001|Second Intervention|Withdrawal by Subject|0|||
131845419|NCT00901576|474715945|FG002|Second Intervention|Withdrawal by Subject|0|||
131845420|NCT00901576|474715946|FG003|Second Intervention|Withdrawal by Subject|1|||
131845421|NCT00901576|474715947|FG004|Second Intervention|Withdrawal by Subject|0|||
131845422|NCT00901576|474715948|FG005|Second Intervention|Withdrawal by Subject|1|||
131845423|NCT00901576|474715943|FG000|Second Intervention|Physician Decision|1|||
131403296|NCT05425732|473099750|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
131403297|NCT04187144|473099751|FG000|Overall Study|Lost to Follow-up|12|||
131403298|NCT04187144|473099752|FG001|Overall Study|Lost to Follow-up|11|||
131403299|NCT04187144|473099751|FG000|Overall Study|Withdrawal by Subject|20|||
131403300|NCT04187144|473099752|FG001|Overall Study|Withdrawal by Subject|18|||
131403301|NCT04187144|473099751|FG000|Overall Study|Adverse Event|19|||
131403302|NCT04187144|473099752|FG001|Overall Study|Adverse Event|4|||
131403303|NCT04187144|473099751|FG000|Overall Study|Physician Decision|5|||
131403304|NCT04187144|473099752|FG001|Overall Study|Physician Decision|3|||
131403305|NCT04187144|473099751|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
131403306|NCT04187144|473099752|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
131403307|NCT04187144|473099751|FG000|Overall Study|Protocol Deviation|1|||
131403308|NCT04187144|473099752|FG001|Overall Study|Protocol Deviation|4|||
131403309|NCT02650804|473099753|FG000|Overall Study|Adverse Event|3|||
131403310|NCT02650804|473099754|FG001|Overall Study|Adverse Event|2|||
131403311|NCT02650804|473099753|FG000|Overall Study|Death|1|||
131403312|NCT02650804|473099754|FG001|Overall Study|Death|2|||
131403313|NCT02650804|473099753|FG000|Overall Study|Progressive Disease|7|||
131403314|NCT02650804|473099754|FG001|Overall Study|Progressive Disease|10|||
131403315|NCT02650804|473099753|FG000|Overall Study|Physician Decision|0|||
131403316|NCT02650804|473099754|FG001|Overall Study|Physician Decision|2|||
131403317|NCT02650804|473099753|FG000|Overall Study|Withdrawal by Subject|1|||
131403318|NCT02650804|473099754|FG001|Overall Study|Withdrawal by Subject|4|||
131403319|NCT02650804|473099753|FG000|Overall Study|Symptomatic deterioration|5|||
131403320|NCT02650804|473099754|FG001|Overall Study|Symptomatic deterioration|7|||
131403321|NCT02650804|473099753|FG000|Overall Study|Protocol Violation|0|||
131403322|NCT02650804|473099754|FG001|Overall Study|Protocol Violation|1|||
131403323|NCT02743949|473099755|FG000|Overall Study|Adverse Event|0|||
131403324|NCT02743949|473099756|FG001|Overall Study|Adverse Event|0|||
131403325|NCT02743949|473099757|FG002|Overall Study|Adverse Event|2|||
131403326|NCT02743949|473099755|FG000|Overall Study|Significant Protocol Deviation|2|||
131403327|NCT02743949|473099756|FG001|Overall Study|Significant Protocol Deviation|0|||
131403328|NCT02743949|473099757|FG002|Overall Study|Significant Protocol Deviation|1|||
131403329|NCT02743949|473099755|FG000|Overall Study|Voluntary Withdrawal|2|||
131403330|NCT02743949|473099756|FG001|Overall Study|Voluntary Withdrawal|1|||
131403331|NCT02743949|473099757|FG002|Overall Study|Voluntary Withdrawal|0|||
131403332|NCT03389555|473099758|FG000|Overall Study|Protocol Violation|1|||
131450906|NCT01177397|473279615|FG007|Overall Study|Other reasons|6|||
131450907|NCT01177397|473279616|FG008|Overall Study|Other reasons|10|||
131450908|NCT01177397|473279617|FG009|Overall Study|Other reasons|8|||
131450909|NCT01177397|473279618|FG010|Overall Study|Other reasons|0|||
131450910|NCT01177397|473279619|FG011|Overall Study|Other reasons|2|||
131450911|NCT00118417|473279620|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
131450912|NCT00118417|473279621|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
131450913|NCT00118417|473279620|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
131450914|NCT00118417|473279621|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
131450915|NCT00118417|473279620|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
131450916|NCT00118417|473279621|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
131450917|NCT00118417|473279620|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
131450918|NCT00118417|473279621|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
131450919|NCT00118417|473279620|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
131450920|NCT00118417|473279621|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
131450921|NCT01544335|473279622|FG000|Overall Study|Lost to Follow-up|27|||
131450922|NCT01544335|473279622|FG000|Overall Study|Death|4|||
131845424|NCT00901576|474715944|FG001|Second Intervention|Physician Decision|0|||
131845425|NCT00901576|474715945|FG002|Second Intervention|Physician Decision|0|||
131403333|NCT03389555|473099759|FG001|Overall Study|Protocol Violation|3|||
131450923|NCT01544335|473279622|FG000|Overall Study|Disease progression|3|||
131450924|NCT01544335|473279622|FG000|Overall Study|Baseline Measurements not Available|19|||
131450925|NCT02560558|473279623|FG000|Overall Study|Adverse Event|1|||
131450926|NCT02560558|473279624|FG001|Overall Study|Adverse Event|0|||
131845426|NCT00901576|474715946|FG003|Second Intervention|Physician Decision|0|||
131403334|NCT03389555|473099758|FG000|Overall Study|Death|1|||
131403335|NCT03389555|473099759|FG001|Overall Study|Death|0|||
131403336|NCT00920218|473099760|FG000|Overall Study|Serious Adverse Event|2|||
131403337|NCT00920218|473099761|FG001|Overall Study|Serious Adverse Event|0|||
131403338|NCT00920218|473099762|FG002|Overall Study|Serious Adverse Event|2|||
131403339|NCT00920218|473099763|FG003|Overall Study|Serious Adverse Event|1|||
131845427|NCT00901576|474715947|FG004|Second Intervention|Physician Decision|0|||
131845428|NCT00901576|474715948|FG005|Second Intervention|Physician Decision|0|||
131845429|NCT04546724|474715949|FG000|Overall Study|Withdrawal by Subject|145|||
131845430|NCT04546724|474715950|FG001|Overall Study|Withdrawal by Subject|41|||
131845431|NCT04546724|474715949|FG000|Overall Study|Adverse Event|1|||
131845432|NCT04546724|474715950|FG001|Overall Study|Adverse Event|1|||
131845433|NCT04546724|474715949|FG000|Overall Study|Lost to Follow-up|186|||
131845434|NCT04546724|474715950|FG001|Overall Study|Lost to Follow-up|63|||
131845435|NCT04546724|474715949|FG000|Overall Study|Physician Decision|8|||
131845436|NCT04546724|474715950|FG001|Overall Study|Physician Decision|2|||
131845437|NCT04546724|474715949|FG000|Overall Study|Death|2|||
131403340|NCT00920218|473099760|FG000|Overall Study|Withdrawal by Subject|0|||
131403341|NCT00920218|473099761|FG001|Overall Study|Withdrawal by Subject|3|||
131403342|NCT00920218|473099762|FG002|Overall Study|Withdrawal by Subject|2|||
131403343|NCT00920218|473099763|FG003|Overall Study|Withdrawal by Subject|0|||
131403344|NCT00920218|473099760|FG000|Overall Study|Migrated/moved from study area|0|||
131403345|NCT00920218|473099761|FG001|Overall Study|Migrated/moved from study area|0|||
131403346|NCT00920218|473099762|FG002|Overall Study|Migrated/moved from study area|1|||
131403347|NCT00920218|473099763|FG003|Overall Study|Migrated/moved from study area|0|||
131403348|NCT00920218|473099760|FG000|Overall Study|Lost to Follow-up|0|||
131403349|NCT00920218|473099761|FG001|Overall Study|Lost to Follow-up|1|||
131403350|NCT00920218|473099762|FG002|Overall Study|Lost to Follow-up|0|||
131403351|NCT00920218|473099763|FG003|Overall Study|Lost to Follow-up|3|||
131403352|NCT00920218|473099760|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
131403353|NCT00920218|473099761|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
131403354|NCT00920218|473099762|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
131403355|NCT00920218|473099763|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
131403356|NCT00920218|473099760|FG000|Overall Study|Other|0|||
131403357|NCT00920218|473099761|FG001|Overall Study|Other|0|||
131403358|NCT00920218|473099762|FG002|Overall Study|Other|1|||
131403359|NCT00920218|473099763|FG003|Overall Study|Other|0|||
131403360|NCT01007435|473099764|FG000|Overall Study|Adverse Event|16|||
131403361|NCT01007435|473099765|FG001|Overall Study|Adverse Event|25|||
131403362|NCT01007435|473099766|FG002|Overall Study|Adverse Event|47|||
131403363|NCT01007435|473099767|FG003|Overall Study|Adverse Event|31|||
131403364|NCT01007435|473099764|FG000|Overall Study|Death|2|||
131403365|NCT01007435|473099765|FG001|Overall Study|Death|4|||
131403366|NCT01007435|473099766|FG002|Overall Study|Death|2|||
131403367|NCT01007435|473099767|FG003|Overall Study|Death|1|||
131403368|NCT01007435|473099764|FG000|Overall Study|Insufficient Therapeutic Response|21|||
131403369|NCT01007435|473099765|FG001|Overall Study|Insufficient Therapeutic Response|7|||
131403370|NCT01007435|473099766|FG002|Overall Study|Insufficient Therapeutic Response|2|||
131403371|NCT01007435|473099767|FG003|Overall Study|Insufficient Therapeutic Response|9|||
131403372|NCT01007435|473099764|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
131403373|NCT01007435|473099765|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
131403374|NCT01007435|473099766|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
131403375|NCT01007435|473099767|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
131403376|NCT01007435|473099764|FG000|Overall Study|Other Protocol Violation|2|||
131403377|NCT01007435|473099765|FG001|Overall Study|Other Protocol Violation|0|||
131403378|NCT01007435|473099766|FG002|Overall Study|Other Protocol Violation|1|||
131403379|NCT01007435|473099767|FG003|Overall Study|Other Protocol Violation|0|||
131403380|NCT01007435|473099764|FG000|Overall Study|Refused Treatment|13|||
131403381|NCT01007435|473099765|FG001|Overall Study|Refused Treatment|13|||
131403382|NCT01007435|473099766|FG002|Overall Study|Refused Treatment|5|||
131403383|NCT01007435|473099767|FG003|Overall Study|Refused Treatment|8|||
131403384|NCT01007435|473099764|FG000|Overall Study|Failure to Return|5|||
131403385|NCT01007435|473099765|FG001|Overall Study|Failure to Return|4|||
131403386|NCT01007435|473099766|FG002|Overall Study|Failure to Return|3|||
131845438|NCT04546724|474715950|FG001|Overall Study|Death|1|||
131845439|NCT04546724|474715949|FG000|Overall Study|subject has been out of town|1|||
131845440|NCT04546724|474715950|FG001|Overall Study|subject has been out of town|0|||
131845441|NCT04546724|474715949|FG000|Overall Study|subject is incarcerated|2|||
131845442|NCT04546724|474715950|FG001|Overall Study|subject is incarcerated|0|||
131845443|NCT04546724|474715949|FG000|Overall Study|subject is relocating|12|||
131845444|NCT04546724|474715950|FG001|Overall Study|subject is relocating|4|||
131845445|NCT04546724|474715949|FG000|Overall Study|Subject in another study|1|||
131845446|NCT04546724|474715950|FG001|Overall Study|Subject in another study|1|||
131845447|NCT02256436|474715951|FG000|Overall Study|Adverse Event|9|||
131403387|NCT01007435|473099767|FG003|Overall Study|Failure to Return|6|||
131845448|NCT02256436|474715952|FG001|Overall Study|Adverse Event|14|||
131403388|NCT01007435|473099764|FG000|Overall Study|Reason not Specified|1|||
131403389|NCT01007435|473099765|FG001|Overall Study|Reason not Specified|1|||
131403390|NCT01007435|473099766|FG002|Overall Study|Reason not Specified|2|||
131403391|NCT01007435|473099767|FG003|Overall Study|Reason not Specified|1|||
131403392|NCT01345591|473099770|FG000|Overall Study|Lost to Follow-up|1|||
131845449|NCT02256436|474715951|FG000|Overall Study|Death|216|||
131845450|NCT02256436|474715952|FG001|Overall Study|Death|208|||
131450927|NCT02560558|473279623|FG000|Overall Study|Death|0|||
131450928|NCT02560558|473279624|FG001|Overall Study|Death|2|||
131450929|NCT02560558|473279623|FG000|Overall Study|Lost to Follow-up|0|||
131450930|NCT02560558|473279624|FG001|Overall Study|Lost to Follow-up|4|||
131450931|NCT02560558|473279623|FG000|Overall Study|Protocol Violation|3|||
131450932|NCT02560558|473279624|FG001|Overall Study|Protocol Violation|0|||
131450933|NCT02560558|473279623|FG000|Overall Study|Withdrawal by Subject|3|||
131845451|NCT02256436|474715951|FG000|Overall Study|Lost to Follow-up|1|||
131845452|NCT02256436|474715952|FG001|Overall Study|Lost to Follow-up|2|||
131845453|NCT02256436|474715951|FG000|Overall Study|Physician Decision|1|||
131845454|NCT02256436|474715952|FG001|Overall Study|Physician Decision|0|||
131845455|NCT02256436|474715951|FG000|Overall Study|Protocol Violation|0|||
131845456|NCT02256436|474715952|FG001|Overall Study|Protocol Violation|1|||
131845457|NCT02256436|474715951|FG000|Overall Study|Withdrawal by Subject|26|||
131845458|NCT02256436|474715952|FG001|Overall Study|Withdrawal by Subject|10|||
131845459|NCT02256436|474715951|FG000|Overall Study|Transferred to Extension Study|11|||
131845460|NCT02256436|474715952|FG001|Overall Study|Transferred to Extension Study|23|||
131845461|NCT02256436|474715951|FG000|Overall Study|Did Not Continue on Extension Study|8|||
131403393|NCT02231892|473099771|FG000|Overall Study|Lost to Follow-up|1|||
131403394|NCT02231892|473099772|FG001|Overall Study|Lost to Follow-up|0|||
131403395|NCT02231892|473099773|FG002|Overall Study|Lost to Follow-up|3|||
131403396|NCT02231892|473099771|FG000|Overall Study|Withdrawal by Subject|4|||
131403397|NCT02231892|473099772|FG001|Overall Study|Withdrawal by Subject|3|||
131403398|NCT02231892|473099773|FG002|Overall Study|Withdrawal by Subject|15|||
131403399|NCT02231892|473099771|FG000|Overall Study|Physician Decision|0|||
131403400|NCT02231892|473099772|FG001|Overall Study|Physician Decision|2|||
131403401|NCT02231892|473099773|FG002|Overall Study|Physician Decision|4|||
131403402|NCT02231892|473099771|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
131403403|NCT02231892|473099772|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
131403404|NCT02231892|473099773|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
131403405|NCT02231892|473099771|FG000|Overall Study|Participant motor threshold was >83%|0|||
131403406|NCT02231892|473099772|FG001|Overall Study|Participant motor threshold was >83%|0|||
131403407|NCT02231892|473099773|FG002|Overall Study|Participant motor threshold was >83%|9|||
131403408|NCT02231892|473099771|FG000|Overall Study|Could not find motor threshold|2|||
131845462|NCT02256436|474715952|FG001|Overall Study|Did Not Continue on Extension Study|12|||
131845463|NCT03583086|474715953|FG000|Overall Study|Death|2|||
131845464|NCT03583086|474715954|FG001|Overall Study|Death|6|||
131845465|NCT03583086|474715955|FG002|Overall Study|Death|12|||
131845466|NCT03583086|474715956|FG003|Overall Study|Death|10|||
131845467|NCT03583086|474715957|FG004|Overall Study|Death|14|||
131845468|NCT03583086|474715958|FG005|Overall Study|Death|14|||
131845469|NCT03583086|474715959|FG006|Overall Study|Death|4|||
131845470|NCT03583086|474715953|FG000|Overall Study|Withdrawal by Subject|0|||
131845471|NCT03583086|474715954|FG001|Overall Study|Withdrawal by Subject|0|||
131845472|NCT03583086|474715955|FG002|Overall Study|Withdrawal by Subject|1|||
131845473|NCT03583086|474715956|FG003|Overall Study|Withdrawal by Subject|0|||
131845474|NCT03583086|474715957|FG004|Overall Study|Withdrawal by Subject|0|||
131845475|NCT03583086|474715958|FG005|Overall Study|Withdrawal by Subject|0|||
131845476|NCT03583086|474715959|FG006|Overall Study|Withdrawal by Subject|1|||
131845477|NCT03583086|474715953|FG000|Overall Study|Refused follow-up|0|||
131845478|NCT03583086|474715954|FG001|Overall Study|Refused follow-up|0|||
131845479|NCT03583086|474715955|FG002|Overall Study|Refused follow-up|1|||
131845480|NCT03583086|474715956|FG003|Overall Study|Refused follow-up|0|||
131845481|NCT03583086|474715957|FG004|Overall Study|Refused follow-up|1|||
131845482|NCT03583086|474715958|FG005|Overall Study|Refused follow-up|0|||
131845483|NCT03583086|474715959|FG006|Overall Study|Refused follow-up|0|||
131845484|NCT03583086|474715953|FG000|Overall Study|Declining Performance Status|0|||
131845485|NCT03583086|474715954|FG001|Overall Study|Declining Performance Status|0|||
131845486|NCT03583086|474715955|FG002|Overall Study|Declining Performance Status|1|||
131845487|NCT03583086|474715956|FG003|Overall Study|Declining Performance Status|0|||
131845488|NCT03583086|474715957|FG004|Overall Study|Declining Performance Status|0|||
131845489|NCT03583086|474715958|FG005|Overall Study|Declining Performance Status|0|||
131845490|NCT03583086|474715959|FG006|Overall Study|Declining Performance Status|0|||
131845491|NCT03583086|474715953|FG000|Overall Study|Still on study|0|||
131845492|NCT03583086|474715954|FG001|Overall Study|Still on study|0|||
131403409|NCT02231892|473099772|FG001|Overall Study|Could not find motor threshold|0|||
131403410|NCT02231892|473099773|FG002|Overall Study|Could not find motor threshold|1|||
131450934|NCT02560558|473279624|FG001|Overall Study|Withdrawal by Subject|0|||
131450935|NCT00275509|473279625|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
131845493|NCT03583086|474715955|FG002|Overall Study|Still on study|0|||
131845494|NCT03583086|474715956|FG003|Overall Study|Still on study|1|||
131845495|NCT03583086|474715957|FG004|Overall Study|Still on study|0|||
131845496|NCT03583086|474715958|FG005|Overall Study|Still on study|0|||
131845497|NCT03583086|474715959|FG006|Overall Study|Still on study|1|||
131845498|NCT03583086|474715953|FG000|Overall Study|Disease progression|0|||
131845499|NCT03583086|474715954|FG001|Overall Study|Disease progression|0|||
131845500|NCT03583086|474715955|FG002|Overall Study|Disease progression|0|||
131450936|NCT00275509|473279626|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
131450937|NCT02892448|473279627|FG000|Overall Study|Screening failure|2|||
131450938|NCT02892448|473279628|FG001|Overall Study|Screening failure|2|||
131450939|NCT02892448|473279629|FG002|Overall Study|Screening failure|1|||
131450940|NCT00686686|473279630|FG000|Overall Study|Non-compliance|1|||
131450941|NCT00686686|473279630|FG000|Overall Study|Adverse Event|2|||
131450942|NCT00686686|473279630|FG000|Overall Study|Lost to Follow-up|3|||
131450943|NCT00131248|473279633|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
131450944|NCT00131248|473279634|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
131450945|NCT01254422|473279635|FG000|Overall Study|Protocol Violation|1|||
131450946|NCT01254422|473279636|FG001|Overall Study|Protocol Violation|0|||
131450947|NCT01254422|473279635|FG000|Overall Study|Adverse Event|1|||
131450948|NCT01254422|473279636|FG001|Overall Study|Adverse Event|0|||
131450949|NCT01254422|473279635|FG000|Overall Study|Serious adverse event|0|||
131450950|NCT01254422|473279636|FG001|Overall Study|Serious adverse event|1|||
131450951|NCT01254422|473279635|FG000|Overall Study|Lost to Follow-up|1|||
131450952|NCT01254422|473279636|FG001|Overall Study|Lost to Follow-up|0|||
131450953|NCT00643162|473279637|FG000|Overall Study|Withdrawal by Subject|1|||
131450954|NCT00643162|473279638|FG001|Overall Study|Withdrawal by Subject|1|||
131450955|NCT02691507|473279639|FG000|Overall Study|Missed Visit 3|0|||
131450956|NCT02691507|473279640|FG001|Overall Study|Missed Visit 3|1|||
131450957|NCT03023397|473279641|FG000|Run-In|Failed screening allergen challenge|1|||
131450958|NCT03023397|473279642|FG001|Run-In|Failed screening allergen challenge|0|||
131450959|NCT03023397|473279643|FG002|Run-In|Failed screening allergen challenge|0|||
131450960|NCT03023397|473279641|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
131450961|NCT03023397|473279642|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
131450962|NCT03023397|473279643|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
131450963|NCT01146795|473279644|FG000|Overall Study|Withdrawal by Subject|4|||
131450964|NCT01146795|473279644|FG000|Overall Study|Adverse Event|6|||
131450965|NCT01146795|473279644|FG000|Overall Study|Still in treatment at study closure|10|||
131450966|NCT00541385|473279645|FG000|Overall Study|Adverse Event|6|||
131450967|NCT00541385|473279646|FG001|Overall Study|Adverse Event|3|||
131450968|NCT00541385|473279645|FG000|Overall Study|Withdrawal by Subject|2|||
131450969|NCT00541385|473279646|FG001|Overall Study|Withdrawal by Subject|2|||
131450970|NCT00541385|473279645|FG000|Overall Study|Lost to Follow-up|6|||
131450971|NCT00541385|473279646|FG001|Overall Study|Lost to Follow-up|1|||
131450972|NCT00541385|473279645|FG000|Overall Study|Parasite reappearance/malaria|67|||
131450973|NCT00541385|473279646|FG001|Overall Study|Parasite reappearance/malaria|32|||
131450974|NCT04139798|473279648|FG000|Overall Study|Withdrawal by Subject|6|||
131450975|NCT04139798|473279649|FG001|Overall Study|Withdrawal by Subject|5|||
131450976|NCT04139798|473279648|FG000|Overall Study|Lost to Follow-up|2|||
131450977|NCT04139798|473279649|FG001|Overall Study|Lost to Follow-up|5|||
131845501|NCT03583086|474715956|FG003|Overall Study|Disease progression|0|||
131845502|NCT03583086|474715957|FG004|Overall Study|Disease progression|0|||
131845503|NCT03583086|474715958|FG005|Overall Study|Disease progression|0|||
131845504|NCT03583086|474715959|FG006|Overall Study|Disease progression|1|||
131845505|NCT03583086|474715953|FG000|Overall Study|Undergoing radiation therapy|0|||
131845506|NCT03583086|474715954|FG001|Overall Study|Undergoing radiation therapy|0|||
131845507|NCT03583086|474715955|FG002|Overall Study|Undergoing radiation therapy|0|||
131845508|NCT03583086|474715956|FG003|Overall Study|Undergoing radiation therapy|0|||
131845509|NCT03583086|474715957|FG004|Overall Study|Undergoing radiation therapy|0|||
131845510|NCT03583086|474715958|FG005|Overall Study|Undergoing radiation therapy|0|||
131845511|NCT03583086|474715959|FG006|Overall Study|Undergoing radiation therapy|1|||
131845512|NCT03583086|474715953|FG000|Overall Study|Lost to Follow-up|0|||
131845513|NCT03583086|474715954|FG001|Overall Study|Lost to Follow-up|0|||
131845514|NCT03583086|474715955|FG002|Overall Study|Lost to Follow-up|0|||
131845515|NCT03583086|474715956|FG003|Overall Study|Lost to Follow-up|0|||
131845516|NCT03583086|474715957|FG004|Overall Study|Lost to Follow-up|0|||
131845517|NCT03583086|474715958|FG005|Overall Study|Lost to Follow-up|1|||
131845518|NCT03583086|474715959|FG006|Overall Study|Lost to Follow-up|0|||
131845519|NCT03583086|474715953|FG000|Overall Study|Adverse Event|0|||
131845520|NCT03583086|474715954|FG001|Overall Study|Adverse Event|0|||
131845521|NCT03583086|474715955|FG002|Overall Study|Adverse Event|0|||
131845522|NCT03583086|474715956|FG003|Overall Study|Adverse Event|0|||
131845523|NCT03583086|474715957|FG004|Overall Study|Adverse Event|0|||
131845524|NCT03583086|474715958|FG005|Overall Study|Adverse Event|1|||
131845525|NCT03583086|474715959|FG006|Overall Study|Adverse Event|0|||
131450978|NCT04139798|473279648|FG000|Overall Study|Discontinued|4|||
131450979|NCT04139798|473279649|FG001|Overall Study|Discontinued|2|||
131450980|NCT04139798|473279648|FG000|Overall Study|Adverse Event|1|||
131450981|NCT04139798|473279649|FG001|Overall Study|Adverse Event|3|||
131450982|NCT04139798|473279648|FG000|Overall Study|Protocol Violation|1|||
131845526|NCT01696279|474715960|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
131845527|NCT01696279|474715961|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
131845528|NCT01696279|474715962|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
131911065|NCT01140906|474963111|FG001|Overall Study|Adverse Event|10|||
131403411|NCT02231892|473099771|FG000|Overall Study|Could not find reliable motor hotspot|0|||
131403412|NCT02231892|473099772|FG001|Overall Study|Could not find reliable motor hotspot|0|||
131403413|NCT02231892|473099773|FG002|Overall Study|Could not find reliable motor hotspot|1|||
131403414|NCT02680041|473099775|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
131403415|NCT02680041|473099775|FG000|Overall Study|Lost to Follow-up|2|||
131403416|NCT02186652|473099776|FG000|Overall Study|Lost to Follow-up|2|||
131403417|NCT02186652|473099777|FG001|Overall Study|Lost to Follow-up|0|||
131403418|NCT00744978|473099778|FG000|Period 1|Lost to Follow-up|1|||
131403419|NCT00744978|473099779|FG001|Period 1|Lost to Follow-up|0|||
131403420|NCT00744978|473099778|FG000|Period 1|Withdrawal by Subject|0|||
131403421|NCT00744978|473099779|FG001|Period 1|Withdrawal by Subject|2|||
131403422|NCT00744978|473099778|FG000|Period 1|Other|0|||
131403423|NCT00744978|473099779|FG001|Period 1|Other|2|||
131403424|NCT00744978|473099778|FG000|Period 1|Adverse Event|4|||
131403425|NCT00744978|473099779|FG001|Period 1|Adverse Event|0|||
131403426|NCT00744978|473099778|FG000|Period 1|Randomized but not Treated|1|||
131403427|NCT00744978|473099779|FG001|Period 1|Randomized but not Treated|1|||
131403428|NCT00744978|473099778|FG000|Period 2|Adverse Event|0|||
131403429|NCT00744978|473099779|FG001|Period 2|Adverse Event|1|||
131403430|NCT00515294|473099783|FG000|Overall Study|Lost to Follow-up|3|||
131403431|NCT00515294|473099784|FG001|Overall Study|Lost to Follow-up|2|||
131403432|NCT00515294|473099785|FG002|Overall Study|Lost to Follow-up|3|||
131403433|NCT00515294|473099786|FG003|Overall Study|Lost to Follow-up|1|||
131403434|NCT00515294|473099783|FG000|Overall Study|Driver simulator problems|1|||
131403435|NCT00515294|473099784|FG001|Overall Study|Driver simulator problems|1|||
131403436|NCT00515294|473099785|FG002|Overall Study|Driver simulator problems|1|||
131403437|NCT00515294|473099786|FG003|Overall Study|Driver simulator problems|3|||
131403438|NCT00515294|473099783|FG000|Overall Study|Caffeine amount inaccurate|5|||
131403439|NCT00515294|473099784|FG001|Overall Study|Caffeine amount inaccurate|0|||
131403440|NCT00515294|473099785|FG002|Overall Study|Caffeine amount inaccurate|7|||
131403441|NCT00515294|473099786|FG003|Overall Study|Caffeine amount inaccurate|0|||
131403442|NCT03943550|473099793|FG000|Overall Study|Adverse Event|0|||
131403443|NCT03943550|473099794|FG001|Overall Study|Adverse Event|0|||
131403444|NCT03943550|473099795|FG002|Overall Study|Adverse Event|1|||
131403445|NCT03943550|473099793|FG000|Overall Study|Lost to Follow-up|0|||
131403446|NCT03943550|473099794|FG001|Overall Study|Lost to Follow-up|0|||
131403447|NCT03943550|473099795|FG002|Overall Study|Lost to Follow-up|1|||
131403448|NCT03943550|473099793|FG000|Overall Study|Progressive Disease|0|||
131403449|NCT03943550|473099794|FG001|Overall Study|Progressive Disease|0|||
131403450|NCT03943550|473099795|FG002|Overall Study|Progressive Disease|2|||
131403451|NCT03943550|473099793|FG000|Overall Study|Participant Moved Out of the Country|0|||
131403452|NCT03943550|473099794|FG001|Overall Study|Participant Moved Out of the Country|1|||
131403453|NCT03943550|473099795|FG002|Overall Study|Participant Moved Out of the Country|0|||
131403454|NCT03359785|473099796|FG000|Overall Study|Protocol Violation|0|||
131403455|NCT03359785|473099797|FG001|Overall Study|Protocol Violation|1|||
131403456|NCT03359785|473099798|FG002|Overall Study|Protocol Violation|0|||
131403457|NCT03359785|473099799|FG003|Overall Study|Protocol Violation|0|||
131403458|NCT03359785|473099796|FG000|Overall Study|Early study termination due to study pause|0|||
131403459|NCT03359785|473099797|FG001|Overall Study|Early study termination due to study pause|0|||
131403460|NCT03359785|473099798|FG002|Overall Study|Early study termination due to study pause|2|||
131403461|NCT03359785|473099799|FG003|Overall Study|Early study termination due to study pause|0|||
131403462|NCT03359785|473099796|FG000|Overall Study|Withdrawal by Subject|2|||
131403463|NCT03359785|473099797|FG001|Overall Study|Withdrawal by Subject|2|||
131403464|NCT03359785|473099798|FG002|Overall Study|Withdrawal by Subject|0|||
131403465|NCT03359785|473099799|FG003|Overall Study|Withdrawal by Subject|0|||
131403466|NCT00223977|473099800|FG000|Overall Study|Adverse Event|7|||
131403467|NCT00223977|473099801|FG001|Overall Study|Adverse Event|10|||
131403468|NCT00223977|473099802|FG002|Overall Study|Adverse Event|0|||
131403469|NCT00223977|473099800|FG000|Overall Study|Protocol Violation|0|||
131403470|NCT00223977|473099801|FG001|Overall Study|Protocol Violation|0|||
131403471|NCT00223977|473099802|FG002|Overall Study|Protocol Violation|1|||
131403472|NCT00223977|473099800|FG000|Overall Study|Withdrawal by Subject|1|||
131403473|NCT00223977|473099801|FG001|Overall Study|Withdrawal by Subject|1|||
131403474|NCT00223977|473099802|FG002|Overall Study|Withdrawal by Subject|2|||
131403475|NCT00223977|473099800|FG000|Overall Study|Other|1|||
131403476|NCT00223977|473099801|FG001|Overall Study|Other|0|||
131403477|NCT00223977|473099802|FG002|Overall Study|Other|0|||
131403478|NCT01895543|473099803|FG000|Overall Study|Withdrawal by Subject|43|||
131403479|NCT01895543|473099803|FG000|Overall Study|Lost to Follow-up|25|||
131403480|NCT01895543|473099803|FG000|Overall Study|Adverse Event|28|||
131403481|NCT01895543|473099803|FG000|Overall Study|Subject's substantial non-compliance|6|||
131403482|NCT01895543|473099803|FG000|Overall Study|Protocol Violation|1|||
131403483|NCT01895543|473099803|FG000|Overall Study|Physician Decision|2|||
131403484|NCT01895543|473099803|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
131403485|NCT04659174|473099812|FG000|Overall Study|Sponsor decision to discontinue study|0|||
131450983|NCT04139798|473279649|FG001|Overall Study|Protocol Violation|0|||
131845529|NCT01696279|474715963|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
131845530|NCT01696279|474715960|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
131845531|NCT01696279|474715961|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
131845532|NCT01696279|474715962|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
131845533|NCT01696279|474715963|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
131845534|NCT01696279|474715960|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
131845535|NCT01696279|474715961|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
131845536|NCT01696279|474715962|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
131845537|NCT01696279|474715963|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
131845538|NCT01696279|474715960|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
131845539|NCT01696279|474715961|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
131845540|NCT01696279|474715962|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
131845541|NCT01696279|474715963|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
131845542|NCT01696279|474715960|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
131845543|NCT01696279|474715961|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
131845544|NCT01696279|474715962|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
131845545|NCT01696279|474715963|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
131845546|NCT01696279|474715960|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
131845547|NCT01696279|474715961|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
131845548|NCT01696279|474715962|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
131845549|NCT01696279|474715963|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
131845550|NCT01696279|474715960|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
131845551|NCT01696279|474715961|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
131845552|NCT01696279|474715962|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
131845553|NCT01696279|474715963|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
131845554|NCT01696279|474715960|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
131845555|NCT01696279|474715961|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
131845556|NCT01696279|474715962|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
131845557|NCT01696279|474715963|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
131845558|NCT01696279|474715960|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
131845559|NCT01696279|474715961|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
131845560|NCT01696279|474715962|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
131845561|NCT01696279|474715963|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
131845562|NCT01696279|474715960|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
131845563|NCT01696279|474715961|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
131845564|NCT01696279|474715962|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
131845565|NCT01696279|474715963|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
131845566|NCT01696279|474715960|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
131845567|NCT01696279|474715961|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
131845568|NCT01696279|474715962|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
131845569|NCT01696279|474715963|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
131845570|NCT03201445|474715965|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
131845571|NCT03201445|474715966|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
131845572|NCT03201445|474715965|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
131845573|NCT03201445|474715966|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
131845574|NCT03201445|474715965|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
131845575|NCT03201445|474715966|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
131845576|NCT03201445|474715965|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
131845577|NCT03201445|474715966|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
131845578|NCT03201445|474715965|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
131845579|NCT03201445|474715966|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
131845580|NCT03201445|474715965|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
131845581|NCT03201445|474715966|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
131845582|NCT03201445|474715965|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
131845583|NCT03201445|474715966|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
131845584|NCT03201445|474715965|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
131845585|NCT03201445|474715966|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
131845586|NCT03201445|474715965|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
131845587|NCT03201445|474715966|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
131845588|NCT03201445|474715965|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
131845589|NCT03201445|474715966|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
131845590|NCT03201445|474715965|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
131845591|NCT03201445|474715966|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
131845592|NCT03201445|474715965|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
131845593|NCT03201445|474715966|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
131450984|NCT01599637|473279655|FG000|Overall Study|administrative problems|0|||
131450985|NCT01599637|473279656|FG001|Overall Study|administrative problems|2|||
131450986|NCT01599637|473279657|FG002|Overall Study|administrative problems|0|||
131450987|NCT01599637|473279655|FG000|Overall Study|Adverse Event|1|||
131450988|NCT01599637|473279656|FG001|Overall Study|Adverse Event|0|||
131450989|NCT01599637|473279657|FG002|Overall Study|Adverse Event|0|||
131450990|NCT02721966|473279658|FG000|Overall Study|Protocol Violation|1|||
131450991|NCT02721966|473279659|FG001|Overall Study|Protocol Violation|0|||
131450992|NCT02721966|473279660|FG002|Overall Study|Protocol Violation|0|||
131450993|NCT02721966|473279661|FG003|Overall Study|Protocol Violation|0|||
131450994|NCT02721966|473279662|FG004|Overall Study|Protocol Violation|0|||
131450995|NCT02721966|473279658|FG000|Overall Study|Withdrawal by Subject|9|||
131450996|NCT02721966|473279659|FG001|Overall Study|Withdrawal by Subject|2|||
131450997|NCT02721966|473279660|FG002|Overall Study|Withdrawal by Subject|3|||
131450998|NCT02721966|473279661|FG003|Overall Study|Withdrawal by Subject|7|||
131450999|NCT02721966|473279662|FG004|Overall Study|Withdrawal by Subject|0|||
131451000|NCT02721966|473279658|FG000|Overall Study|Adverse Event|4|||
131451001|NCT02721966|473279659|FG001|Overall Study|Adverse Event|4|||
131451002|NCT02721966|473279660|FG002|Overall Study|Adverse Event|3|||
131451003|NCT02721966|473279661|FG003|Overall Study|Adverse Event|0|||
131451004|NCT02721966|473279662|FG004|Overall Study|Adverse Event|0|||
131451005|NCT02721966|473279658|FG000|Overall Study|Death|1|||
131451006|NCT02721966|473279659|FG001|Overall Study|Death|0|||
131451007|NCT02721966|473279660|FG002|Overall Study|Death|0|||
131451008|NCT02721966|473279661|FG003|Overall Study|Death|0|||
131451009|NCT02721966|473279662|FG004|Overall Study|Death|0|||
131451010|NCT02721966|473279658|FG000|Overall Study|Lack of Efficacy|7|||
131451011|NCT02721966|473279659|FG001|Overall Study|Lack of Efficacy|4|||
131845594|NCT03201445|474715965|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
131845595|NCT03201445|474715966|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
131845596|NCT03201445|474715965|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
131845597|NCT03201445|474715966|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
131845598|NCT03201445|474715965|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
131845599|NCT03201445|474715966|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
131845600|NCT03201445|474715965|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
131845601|NCT03201445|474715966|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
131845602|NCT03201445|474715965|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
131845603|NCT03201445|474715966|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
131845604|NCT03201445|474715965|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
131845605|NCT03201445|474715966|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
131845606|NCT03201445|474715965|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
131845607|NCT03201445|474715966|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
131845608|NCT03201445|474715965|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
131845609|NCT03201445|474715966|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
131845610|NCT03201445|474715965|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
131845611|NCT03201445|474715966|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
131845612|NCT01346293|474715969|FG000|Overall Study|Protocol Violation|30|||
131845613|NCT01346293|474715970|FG001|Overall Study|Protocol Violation|9|||
131845614|NCT01346293|474715969|FG000|Overall Study|Lost to Follow-up|21|||
131845615|NCT01346293|474715970|FG001|Overall Study|Lost to Follow-up|8|||
131845616|NCT01346293|474715969|FG000|Overall Study|Withdrawal by Subject|15|||
131845617|NCT01346293|474715970|FG001|Overall Study|Withdrawal by Subject|4|||
131845618|NCT01346293|474715969|FG000|Overall Study|Other|1|||
131845619|NCT01346293|474715970|FG001|Overall Study|Other|0|||
131451012|NCT02721966|473279660|FG002|Overall Study|Lack of Efficacy|0|||
131451013|NCT02721966|473279661|FG003|Overall Study|Lack of Efficacy|0|||
131451014|NCT02721966|473279662|FG004|Overall Study|Lack of Efficacy|0|||
131845620|NCT01441947|474715972|FG000|Overall Study|Withdrawal by Subject|3|||
131845621|NCT01441947|474715973|FG001|Overall Study|Withdrawal by Subject|0|||
131845622|NCT04106661|474715976|FG000|Overall Study|Protocol Violation|3|||
131845623|NCT04106661|474715977|FG001|Overall Study|Protocol Violation|0|||
131845624|NCT04106661|474715976|FG000|Overall Study|Scheduling difficulties|1|||
131845625|NCT04106661|474715977|FG001|Overall Study|Scheduling difficulties|1|||
131845626|NCT00587990|474715978|FG000|Overall Study|Death|0|||
131845627|NCT00587990|474715979|FG001|Overall Study|Death|0|||
131845628|NCT00587990|474715980|FG002|Overall Study|Death|1|||
131845629|NCT02754856|474715981|FG000|Overall Study|Withdrawal by Subject|1|||
131845630|NCT00530218|474715982|FG000|Overall Study|CMV Not Detected|13|||
131845631|NCT00530218|474715982|FG000|Overall Study|Death|12|||
131451015|NCT02721966|473279658|FG000|Overall Study|Lost to Follow-up|0|||
131845632|NCT03477903|474715985|FG000|Overall Study|Study Terminated by Sponsor|1|||
131451016|NCT02721966|473279659|FG001|Overall Study|Lost to Follow-up|0|||
131451017|NCT02721966|473279660|FG002|Overall Study|Lost to Follow-up|3|||
131451018|NCT02721966|473279661|FG003|Overall Study|Lost to Follow-up|0|||
131451019|NCT02721966|473279662|FG004|Overall Study|Lost to Follow-up|0|||
131845633|NCT02774642|474715986|FG000|Overall Study|Lost to Follow-up|9|||
131403486|NCT04659174|473099813|FG001|Overall Study|Sponsor decision to discontinue study|2|||
131403487|NCT04659174|473099812|FG000|Overall Study|Lost to Follow-up|9|||
131403488|NCT04659174|473099813|FG001|Overall Study|Lost to Follow-up|11|||
131403489|NCT04659174|473099812|FG000|Overall Study|Adverse Event|8|||
131403490|NCT04659174|473099813|FG001|Overall Study|Adverse Event|5|||
131403491|NCT04659174|473099812|FG000|Overall Study|Withdrawal by Subject|17|||
131403492|NCT04659174|473099813|FG001|Overall Study|Withdrawal by Subject|33|||
131403493|NCT04659174|473099812|FG000|Overall Study|Progressive disease|0|||
131403494|NCT04659174|473099813|FG001|Overall Study|Progressive disease|2|||
131403495|NCT04659174|473099812|FG000|Overall Study|Other reasons|0|||
131403496|NCT04659174|473099813|FG001|Overall Study|Other reasons|2|||
131403497|NCT04659174|473099812|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
131403498|NCT04659174|473099813|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
131845634|NCT02774642|474715987|FG001|Overall Study|Lost to Follow-up|7|||
131845635|NCT02329847|474715988|FG000|Overall Study|Death|4|||
131845636|NCT02329847|474715989|FG001|Overall Study|Death|4|||
131845637|NCT02329847|474715990|FG002|Overall Study|Death|22|||
131845638|NCT02329847|474715991|FG003|Overall Study|Death|12|||
131845639|NCT02329847|474715992|FG004|Overall Study|Death|20|||
131845640|NCT02329847|474715993|FG005|Overall Study|Death|13|||
131845641|NCT02329847|474715988|FG000|Overall Study|Lost to Follow-up|0|||
131845642|NCT02329847|474715989|FG001|Overall Study|Lost to Follow-up|0|||
131845643|NCT02329847|474715990|FG002|Overall Study|Lost to Follow-up|2|||
131845644|NCT02329847|474715991|FG003|Overall Study|Lost to Follow-up|3|||
131845645|NCT02329847|474715992|FG004|Overall Study|Lost to Follow-up|0|||
131845646|NCT02329847|474715993|FG005|Overall Study|Lost to Follow-up|1|||
131845647|NCT02329847|474715988|FG000|Overall Study|Physician Decision|0|||
131845648|NCT02329847|474715989|FG001|Overall Study|Physician Decision|0|||
131845649|NCT02329847|474715990|FG002|Overall Study|Physician Decision|0|||
131845650|NCT02329847|474715991|FG003|Overall Study|Physician Decision|0|||
131845651|NCT02329847|474715992|FG004|Overall Study|Physician Decision|1|||
131845652|NCT02329847|474715993|FG005|Overall Study|Physician Decision|0|||
131845653|NCT02329847|474715988|FG000|Overall Study|Withdrawal by Subject|2|||
131845654|NCT02329847|474715989|FG001|Overall Study|Withdrawal by Subject|1|||
131845655|NCT02329847|474715990|FG002|Overall Study|Withdrawal by Subject|5|||
131845656|NCT02329847|474715991|FG003|Overall Study|Withdrawal by Subject|7|||
131845657|NCT02329847|474715992|FG004|Overall Study|Withdrawal by Subject|8|||
131845658|NCT02329847|474715993|FG005|Overall Study|Withdrawal by Subject|3|||
131845659|NCT02329847|474715988|FG000|Overall Study|Other|1|||
131845660|NCT02329847|474715989|FG001|Overall Study|Other|2|||
131845661|NCT02329847|474715990|FG002|Overall Study|Other|6|||
131845662|NCT02329847|474715991|FG003|Overall Study|Other|13|||
131845663|NCT02329847|474715992|FG004|Overall Study|Other|10|||
131845664|NCT02329847|474715993|FG005|Overall Study|Other|3|||
131845665|NCT05293639|474715994|FG000|Overall Study|Withdrawal by Subject|1|||
131845666|NCT05293639|474715995|FG001|Overall Study|Withdrawal by Subject|1|||
131845667|NCT05293639|474715996|FG002|Overall Study|Withdrawal by Subject|2|||
131845668|NCT05293639|474715994|FG000|Overall Study|Death|0|||
131845669|NCT05293639|474715995|FG001|Overall Study|Death|1|||
131845670|NCT05293639|474715996|FG002|Overall Study|Death|0|||
131845671|NCT05293639|474715994|FG000|Overall Study|Lost to Follow-up|0|||
131845672|NCT05293639|474715995|FG001|Overall Study|Lost to Follow-up|0|||
131845673|NCT05293639|474715996|FG002|Overall Study|Lost to Follow-up|5|||
131845674|NCT05293639|474715994|FG000|Overall Study|Other|0|||
131845675|NCT05293639|474715995|FG001|Overall Study|Other|0|||
131845676|NCT05293639|474715996|FG002|Overall Study|Other|1|||
131845677|NCT00426361|474716000|FG000|Overall Study|Lost to Follow-up|3|||
131845678|NCT00426361|474716001|FG001|Overall Study|Lost to Follow-up|2|||
131845679|NCT00426361|474716002|FG002|Overall Study|Lost to Follow-up|5|||
131845680|NCT00426361|474716000|FG000|Overall Study|Withdrawal by Subject|1|||
131845681|NCT00426361|474716001|FG001|Overall Study|Withdrawal by Subject|3|||
131911066|NCT01140906|474963112|FG002|Overall Study|Adverse Event|17|||
131911067|NCT01140906|474963113|FG003|Overall Study|Adverse Event|7|||
131911068|NCT01140906|474963110|FG000|Overall Study|Lack of Efficacy|6|||
131403499|NCT04659174|473099812|FG000|Overall Study|Alcohol or illegal drug use|0|||
131403500|NCT04659174|473099813|FG001|Overall Study|Alcohol or illegal drug use|3|||
131403501|NCT04659174|473099812|FG000|Overall Study|Violation of entry criteria|1|||
131403502|NCT04659174|473099813|FG001|Overall Study|Violation of entry criteria|0|||
131403503|NCT04659174|473099812|FG000|Overall Study|Death|0|||
131911069|NCT01140906|474963111|FG001|Overall Study|Lack of Efficacy|8|||
131845682|NCT00426361|474716002|FG002|Overall Study|Withdrawal by Subject|0|||
131845683|NCT02099682|474716003|FG000|Overall Study|Data Not Available|51|||
131845684|NCT02099682|474716003|FG000|Overall Study|Lost to Follow-up|31|||
131845685|NCT02099682|474716003|FG000|Overall Study|Other|29|||
131845686|NCT00704730|474716004|FG000|Overall Study|Adverse Event|35|||
131845687|NCT00704730|474716005|FG001|Overall Study|Adverse Event|9|||
131845688|NCT00704730|474716004|FG000|Overall Study|Death|11|||
131845689|NCT00704730|474716005|FG001|Overall Study|Death|5|||
131845690|NCT00704730|474716004|FG000|Overall Study|Physician Decision|2|||
131451020|NCT02721966|473279658|FG000|Overall Study|Physician Decision|1|||
131451021|NCT02721966|473279659|FG001|Overall Study|Physician Decision|1|||
131451022|NCT02721966|473279660|FG002|Overall Study|Physician Decision|0|||
131451023|NCT02721966|473279661|FG003|Overall Study|Physician Decision|0|||
131451024|NCT02721966|473279662|FG004|Overall Study|Physician Decision|0|||
131451025|NCT02721966|473279658|FG000|Overall Study|Pregnancy|1|||
131451026|NCT02721966|473279659|FG001|Overall Study|Pregnancy|0|||
131451027|NCT02721966|473279660|FG002|Overall Study|Pregnancy|0|||
131451028|NCT02721966|473279661|FG003|Overall Study|Pregnancy|0|||
131451029|NCT02721966|473279662|FG004|Overall Study|Pregnancy|0|||
131451030|NCT02721966|473279658|FG000|Overall Study|Did not continue to period 2|5|||
131451031|NCT02721966|473279659|FG001|Overall Study|Did not continue to period 2|12|||
131451032|NCT02721966|473279660|FG002|Overall Study|Did not continue to period 2|0|||
131451033|NCT02721966|473279661|FG003|Overall Study|Did not continue to period 2|0|||
131451034|NCT02721966|473279662|FG004|Overall Study|Did not continue to period 2|5|||
131451035|NCT03857867|473279663|FG000|Overall Study|Physician Decision|1|||
131451036|NCT02157883|473279664|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
131451037|NCT02157883|473279664|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
131451038|NCT02157883|473279664|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
131451039|NCT02157883|473279664|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
131451040|NCT02157883|473279664|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
131451041|NCT01578486|473279665|FG000|Overall Study|Physician Decision|3|||
131451042|NCT01578486|473279665|FG000|Overall Study|Withdrawal by Subject|2|||
131451043|NCT02536963|473279666|FG000|Overall Study|Withdrawal by Subject|18|||
131451044|NCT01106248|473279668|FG000|Overall Study|Adverse Event|1|||
131451045|NCT01106248|473279668|FG000|Overall Study|Administrative|2|||
131451046|NCT00357903|473279669|FG000|Overall Study|Adverse Event|87|||
131451047|NCT00357903|473279670|FG001|Overall Study|Adverse Event|4|||
131451048|NCT00357903|473279669|FG000|Overall Study|Death|33|||
131451049|NCT00357903|473279670|FG001|Overall Study|Death|0|||
131451050|NCT00357903|473279669|FG000|Overall Study|Lost to Follow-up|23|||
131451051|NCT00357903|473279670|FG001|Overall Study|Lost to Follow-up|4|||
131451052|NCT00357903|473279669|FG000|Overall Study|Physician Decision|39|||
131451053|NCT00357903|473279670|FG001|Overall Study|Physician Decision|5|||
131451054|NCT00357903|473279669|FG000|Overall Study|Withdrawal by Subject|57|||
131451055|NCT00357903|473279670|FG001|Overall Study|Withdrawal by Subject|7|||
131451056|NCT00357903|473279669|FG000|Overall Study|Completed month 12 only|0|||
131451057|NCT00357903|473279670|FG001|Overall Study|Completed month 12 only|1|||
131451058|NCT00357903|473279669|FG000|Overall Study|Protocol issues|14|||
131451059|NCT00357903|473279670|FG001|Overall Study|Protocol issues|3|||
131451060|NCT00357903|473279669|FG000|Overall Study|Response status|61|||
131451061|NCT00357903|473279670|FG001|Overall Study|Response status|9|||
131451062|NCT00357903|473279669|FG000|Overall Study|Other|49|||
131451063|NCT00357903|473279670|FG001|Overall Study|Other|10|||
131451064|NCT00606593|473279671|FG000|Overall Study|Adverse Event|0|||
131451065|NCT00606593|473279672|FG001|Overall Study|Adverse Event|0|||
131451066|NCT00606593|473279673|FG002|Overall Study|Adverse Event|0|||
131451067|NCT00606593|473279674|FG003|Overall Study|Adverse Event|1|||
131451068|NCT00606593|473279675|FG004|Overall Study|Adverse Event|1|||
131451069|NCT00606593|473279676|FG005|Overall Study|Adverse Event|0|||
131451070|NCT00606593|473279677|FG006|Overall Study|Adverse Event|1|||
131451071|NCT00606593|473279678|FG007|Overall Study|Adverse Event|2|||
131451072|NCT00606593|473279679|FG008|Overall Study|Adverse Event|1|||
131451073|NCT00606593|473279680|FG009|Overall Study|Adverse Event|0|||
131451074|NCT00606593|473279671|FG000|Overall Study|Withdrawal of consent|1|||
131451075|NCT00606593|473279672|FG001|Overall Study|Withdrawal of consent|0|||
131451076|NCT00606593|473279673|FG002|Overall Study|Withdrawal of consent|1|||
131451077|NCT00606593|473279674|FG003|Overall Study|Withdrawal of consent|0|||
131451078|NCT00606593|473279675|FG004|Overall Study|Withdrawal of consent|0|||
131451079|NCT00606593|473279676|FG005|Overall Study|Withdrawal of consent|0|||
131451080|NCT00606593|473279677|FG006|Overall Study|Withdrawal of consent|0|||
131451081|NCT00606593|473279678|FG007|Overall Study|Withdrawal of consent|0|||
131845691|NCT00704730|474716005|FG001|Overall Study|Physician Decision|0|||
131845692|NCT00704730|474716004|FG000|Overall Study|Did not receive drug|5|||
131845693|NCT00704730|474716005|FG001|Overall Study|Did not receive drug|2|||
131845694|NCT00704730|474716004|FG000|Overall Study|Disease progression per PI|58|||
131845695|NCT00704730|474716005|FG001|Overall Study|Disease progression per PI|67|||
131845696|NCT00704730|474716004|FG000|Overall Study|data unavailable|1|||
131845697|NCT00704730|474716005|FG001|Overall Study|data unavailable|0|||
131845698|NCT00704730|474716004|FG000|Overall Study|Withdrawal by Subject|9|||
131451082|NCT00606593|473279679|FG008|Overall Study|Withdrawal of consent|0|||
131451083|NCT00606593|473279680|FG009|Overall Study|Withdrawal of consent|0|||
131845699|NCT00704730|474716005|FG001|Overall Study|Withdrawal by Subject|13|||
131911070|NCT01140906|474963112|FG002|Overall Study|Lack of Efficacy|2|||
131451084|NCT00606593|473279671|FG000|Overall Study|Administrative/Other|0|||
131451085|NCT00606593|473279672|FG001|Overall Study|Administrative/Other|0|||
131845700|NCT05065567|474716007|FG000|Overall Study|Lost to Follow-up|10|||
131845701|NCT05065567|474716008|FG001|Overall Study|Lost to Follow-up|9|||
131451086|NCT00606593|473279673|FG002|Overall Study|Administrative/Other|1|||
131451087|NCT00606593|473279674|FG003|Overall Study|Administrative/Other|0|||
131451088|NCT00606593|473279675|FG004|Overall Study|Administrative/Other|0|||
131845702|NCT05065567|474716009|FG002|Overall Study|Lost to Follow-up|6|||
131845703|NCT04051619|474716010|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
131451089|NCT00606593|473279676|FG005|Overall Study|Administrative/Other|0|||
131451090|NCT00606593|473279677|FG006|Overall Study|Administrative/Other|0|||
131451091|NCT00606593|473279678|FG007|Overall Study|Administrative/Other|0|||
131451092|NCT00606593|473279679|FG008|Overall Study|Administrative/Other|0|||
131451093|NCT00606593|473279680|FG009|Overall Study|Administrative/Other|0|||
131451094|NCT03181529|473279681|FG000|Overall Study|Withdrawal by Subject|1|||
131451095|NCT03181529|473279682|FG001|Overall Study|Withdrawal by Subject|1|||
131451096|NCT03181529|473279681|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
131451097|NCT03181529|473279682|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
131451098|NCT00525161|473279685|FG000|Overall Study|Adverse Event|1|||
131451099|NCT01076361|473279689|FG000|Overall Study|22 leads were excluded from analysis|21|||
131451100|NCT02447003|473279690|FG000|Overall Study|Other|0|||
131451101|NCT02447003|473279691|FG001|Overall Study|Other|4|||
131451102|NCT02447003|473279690|FG000|Overall Study|Site discontinued|0|||
131451103|NCT02447003|473279691|FG001|Overall Study|Site discontinued|2|||
131451104|NCT02447003|473279690|FG000|Overall Study|Physician Decision|0|||
131451105|NCT02447003|473279691|FG001|Overall Study|Physician Decision|1|||
131451106|NCT02447003|473279690|FG000|Overall Study|Withdrawal by Subject|4|||
131451107|NCT02447003|473279691|FG001|Overall Study|Withdrawal by Subject|3|||
131451108|NCT02447003|473279690|FG000|Overall Study|Sponsor Decision|6|||
131451109|NCT02447003|473279691|FG001|Overall Study|Sponsor Decision|11|||
131451110|NCT02447003|473279690|FG000|Overall Study|Progressive Disease|1|||
131451111|NCT02447003|473279691|FG001|Overall Study|Progressive Disease|0|||
131451112|NCT02447003|473279690|FG000|Overall Study|Lost to Follow-up|5|||
131451113|NCT02447003|473279691|FG001|Overall Study|Lost to Follow-up|0|||
131451114|NCT02447003|473279690|FG000|Overall Study|Death|154|||
131451115|NCT02447003|473279691|FG001|Overall Study|Death|63|||
131451116|NCT03848728|473279692|FG000|Overall Study|Death|16|||
131451117|NCT03848728|473279693|FG001|Overall Study|Death|13|||
131451118|NCT03848728|473279692|FG000|Overall Study|Outmigrated to non-study community|98|||
131451119|NCT03848728|473279693|FG001|Overall Study|Outmigrated to non-study community|106|||
131451120|NCT03848728|473279692|FG000|Overall Study|Transfered to non-study clinic|32|||
131451121|NCT03848728|473279693|FG001|Overall Study|Transfered to non-study clinic|48|||
131451122|NCT03848728|473279692|FG000|Overall Study|Withdrawal by Subject|1|||
131451123|NCT03848728|473279693|FG001|Overall Study|Withdrawal by Subject|0|||
131451124|NCT00630838|473279696|FG000|Overall Study|Death|0|||
131451125|NCT00630838|473279697|FG001|Overall Study|Death|1|||
131451126|NCT00630838|473279696|FG000|Overall Study|Lost to Follow-up|0|||
131451127|NCT00630838|473279697|FG001|Overall Study|Lost to Follow-up|1|||
131451128|NCT01108185|473279698|FG000|Overall Study|Non-compliance|15|||
131451129|NCT01108185|473279698|FG000|Overall Study|Lost to Follow-up|12|||
131451130|NCT02581410|473279699|FG000|Vaccination Phase|Adverse Event|2|||
131451131|NCT02581410|473279700|FG001|Vaccination Phase|Adverse Event|1|||
131451132|NCT02581410|473279699|FG000|Vaccination Phase|Withdrawal by Subject|0|||
131451133|NCT02581410|473279700|FG001|Vaccination Phase|Withdrawal by Subject|1|||
131451134|NCT02581410|473279699|FG000|Vaccination Phase|Migrated/moved from study area|0|||
131451135|NCT02581410|473279700|FG001|Vaccination Phase|Migrated/moved from study area|1|||
131845704|NCT04051619|474716011|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
131845705|NCT04051619|474716010|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
131845706|NCT04051619|474716011|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
131845707|NCT02065700|474718046|FG000|Overall Study|Adverse Event|165|||
131845708|NCT02065700|474718047|FG001|Overall Study|Adverse Event|101|||
131845709|NCT02065700|474718046|FG000|Overall Study|Withdrawal by Subject|90|||
131845710|NCT02065700|474718047|FG001|Overall Study|Withdrawal by Subject|29|||
131845711|NCT02065700|474718046|FG000|Overall Study|Lost to Follow-up|12|||
131451136|NCT02581410|473279699|FG000|End of Study Phase|Adverse Event|4|||
131845712|NCT02065700|474718047|FG001|Overall Study|Lost to Follow-up|9|||
131845713|NCT02065700|474718046|FG000|Overall Study|Physician Decision|2|||
131845714|NCT02065700|474718047|FG001|Overall Study|Physician Decision|0|||
131451137|NCT02581410|473279700|FG001|End of Study Phase|Adverse Event|3|||
131451138|NCT02581410|473279699|FG000|End of Study Phase|Withdrawal by Subject|1|||
131451139|NCT02581410|473279700|FG001|End of Study Phase|Withdrawal by Subject|2|||
131451140|NCT02581410|473279699|FG000|End of Study Phase|Migrated/moved from study area|0|||
131451141|NCT02581410|473279700|FG001|End of Study Phase|Migrated/moved from study area|3|||
131451142|NCT02581410|473279699|FG000|End of Study Phase|Lost to Follow-up|0|||
131451143|NCT02581410|473279700|FG001|End of Study Phase|Lost to Follow-up|2|||
131451144|NCT02581410|473279699|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
131451145|NCT02581410|473279700|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
131451146|NCT00670748|473279703|FG000|Overall Study|Death during treatment|1|||
131451147|NCT00670748|473279704|FG001|Overall Study|Death during treatment|1|||
131845715|NCT02065700|474718046|FG000|Overall Study|Sponsor Request|38|||
131845716|NCT02065700|474718047|FG001|Overall Study|Sponsor Request|15|||
131845717|NCT02065700|474718046|FG000|Overall Study|Treatment Failure|3|||
131845718|NCT02065700|474718047|FG001|Overall Study|Treatment Failure|2|||
131845719|NCT02065700|474718046|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
131845720|NCT02065700|474718047|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
131845721|NCT02065700|474718046|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
131845722|NCT02065700|474718047|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
131845723|NCT02065700|474718046|FG000|Overall Study|Non-compliance with Study Procedures|2|||
131845724|NCT02065700|474718047|FG001|Overall Study|Non-compliance with Study Procedures|0|||
131845725|NCT02065700|474718046|FG000|Overall Study|Not Defined|21|||
131845726|NCT02065700|474718047|FG001|Overall Study|Not Defined|3|||
131845727|NCT00605540|474718052|FG000|Overall Study|Death|15|||
131845728|NCT00605540|474718052|FG000|Overall Study|Lost to Follow-up|23|||
131845729|NCT01544179|474718055|FG000|Overall Study|Death|50|||
131845730|NCT01544179|474718056|FG001|Overall Study|Death|37|||
131845731|NCT01544179|474718055|FG000|Overall Study|Lost to Follow-up|0|||
131845732|NCT01544179|474718056|FG001|Overall Study|Lost to Follow-up|1|||
131845733|NCT01544179|474718055|FG000|Overall Study|Adverse Event|0|||
131845734|NCT01544179|474718056|FG001|Overall Study|Adverse Event|1|||
131845735|NCT01544179|474718055|FG000|Overall Study|Withdrawal by Subject|12|||
131845736|NCT01544179|474718056|FG001|Overall Study|Withdrawal by Subject|7|||
131845737|NCT01544179|474718055|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
131845738|NCT01544179|474718056|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131845739|NCT00049530|474718059|FG000|Overall Study|Lack of Efficacy|25|||
131845740|NCT00049530|474718059|FG000|Overall Study|Adverse Event|2|||
131845741|NCT00049530|474718059|FG000|Overall Study|Death|1|||
131845742|NCT00049530|474718059|FG000|Overall Study|symptomatic deterioration|1|||
131845743|NCT00049530|474718059|FG000|Overall Study|ineligible|3|||
131845744|NCT01635283|474718062|FG000|Overall Study|Tumor Progression|3|||
131845745|NCT01635283|474718062|FG000|Overall Study|Lost to Follow-up|1|||
131845746|NCT01438996|474718063|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
131845747|NCT01438996|474718064|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
131845748|NCT01438996|474718065|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
131845749|NCT01433549|474718066|FG000|Phase 2: Second Study Product|Adverse Event|0|||
131845750|NCT01433549|474718067|FG001|Phase 2: Second Study Product|Adverse Event|1|||
131845751|NCT03511326|474718070|FG000|Overall Study|Withdrawal by Subject|1|||
131845752|NCT04628793|474718071|FG000|Overall Study|Study terminated by sponsor|0|||
131845753|NCT04628793|474718072|FG001|Overall Study|Study terminated by sponsor|0|||
131403504|NCT04659174|473099813|FG001|Overall Study|Death|1|||
131403505|NCT05129449|473099816|FG000|Overall Study|Protocol Violation|1|||
131403506|NCT03650803|473099820|FG000|Overall Study|Lost to Follow-up|6|||
131403507|NCT02901054|473099821|FG000|Overall Study|Physician Decision|1|||
131403508|NCT02901054|473099821|FG000|Overall Study|Withdrawal by Subject|3|||
131403509|NCT01818258|473099823|FG000|Overall Study|Death|3|||
131403510|NCT01818258|473099824|FG001|Overall Study|Death|0|||
131403511|NCT01818258|473099823|FG000|Overall Study|Withdrawal by Subject|0|||
131403512|NCT01818258|473099824|FG001|Overall Study|Withdrawal by Subject|1|||
131403513|NCT01818258|473099823|FG000|Overall Study|Lost to Follow-up|0|||
131403514|NCT01818258|473099824|FG001|Overall Study|Lost to Follow-up|1|||
131403515|NCT01818258|473099823|FG000|Overall Study|Unable to Travel to Clinic|0|||
131403516|NCT01818258|473099824|FG001|Overall Study|Unable to Travel to Clinic|1|||
131403517|NCT02099344|473099825|FG000|Overall Study|Physician Decision|1|||
131403518|NCT02099344|473099826|FG001|Overall Study|Physician Decision|0|||
131403519|NCT02839720|473099831|FG000|Overall Study|Adverse Event|2|||
131403520|NCT02839720|473099831|FG000|Overall Study|Non-compliance|2|||
131403521|NCT02839720|473099831|FG000|Overall Study|Intercurrent Illness|1|||
131403522|NCT02839720|473099831|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
131403523|NCT02649218|473099832|FG000|Overall Study|Adverse Event|8|||
131403524|NCT02649218|473099832|FG000|Overall Study|Lack of Efficacy|8|||
131403525|NCT02649218|473099832|FG000|Overall Study|Pregnancy|3|||
131403526|NCT02649218|473099832|FG000|Overall Study|Protocol Violation|3|||
131403527|NCT02649218|473099832|FG000|Overall Study|Physician Decision|1|||
131403528|NCT02649218|473099832|FG000|Overall Study|Withdrawal by Subject|2|||
131403529|NCT05145322|473099835|FG000|Overall Study|Lost to Follow-up|4|||
131845754|NCT04628793|474718073|FG002|Overall Study|Study terminated by sponsor|8|||
131845755|NCT04628793|474718071|FG000|Overall Study|Withdrawal by Subject|2|||
131845756|NCT04628793|474718072|FG001|Overall Study|Withdrawal by Subject|3|||
131845757|NCT04628793|474718073|FG002|Overall Study|Withdrawal by Subject|0|||
131403530|NCT05145322|473099836|FG001|Overall Study|Lost to Follow-up|5|||
131845758|NCT04628793|474718071|FG000|Overall Study|Lost to Follow-up|0|||
131845759|NCT04628793|474718072|FG001|Overall Study|Lost to Follow-up|1|||
131845760|NCT04628793|474718073|FG002|Overall Study|Lost to Follow-up|0|||
131845761|NCT01934335|474718075|FG000|Overall Study|Withdrawal by Subject|1|||
131845762|NCT01934335|474718076|FG001|Overall Study|Withdrawal by Subject|1|||
131845763|NCT01756079|474718077|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
131845764|NCT01756079|474718077|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
131911071|NCT01140906|474963113|FG003|Overall Study|Lack of Efficacy|1|||
131911072|NCT01140906|474963110|FG000|Overall Study|Non-compliance|0|||
131911073|NCT01140906|474963111|FG001|Overall Study|Non-compliance|1|||
131403531|NCT01349322|473099837|FG000|Overall Study|Protocol Violation|45|||
131403532|NCT01349322|473099838|FG001|Overall Study|Protocol Violation|47|||
131403533|NCT00503581|473099839|FG000|Overall Study|Study closed|3|||
131403534|NCT00503581|473099840|FG001|Overall Study|Study closed|4|||
131403535|NCT00503581|473099841|FG002|Overall Study|Study closed|2|||
131403536|NCT06107803|473099843|FG000|Overall Study|Adverse Event|1|||
131403537|NCT06107803|473099843|FG000|Overall Study|Withdrawal by Subject|2|||
131403538|NCT06107803|473099843|FG000|Overall Study|Protocol Violation|1|||
131403539|NCT04730635|473099845|FG000|Overall Study|Lost to Follow-up|1|||
131403540|NCT04730635|473099846|FG001|Overall Study|Lost to Follow-up|0|||
131403541|NCT04730635|473099845|FG000|Overall Study|Withdrawal by Subject|0|||
131403542|NCT04730635|473099846|FG001|Overall Study|Withdrawal by Subject|1|||
131403543|NCT01096368|473099847|FG000|Overall Study|Death|0|||
131403544|NCT01096368|473099848|FG001|Overall Study|Death|1|||
131403545|NCT01096368|473099849|FG002|Overall Study|Death|0|||
131403546|NCT01096368|473099850|FG003|Overall Study|Death|0|||
131403547|NCT01096368|473099851|FG004|Overall Study|Death|0|||
131403548|NCT01096368|473099847|FG000|Overall Study|Physician Decision|0|||
131403549|NCT01096368|473099848|FG001|Overall Study|Physician Decision|13|||
131403550|NCT01096368|473099849|FG002|Overall Study|Physician Decision|2|||
131403551|NCT01096368|473099850|FG003|Overall Study|Physician Decision|4|||
131403552|NCT01096368|473099851|FG004|Overall Study|Physician Decision|6|||
131403553|NCT01096368|473099847|FG000|Overall Study|Withdrawal by Subject|0|||
131403554|NCT01096368|473099848|FG001|Overall Study|Withdrawal by Subject|52|||
131403555|NCT01096368|473099849|FG002|Overall Study|Withdrawal by Subject|0|||
131403556|NCT01096368|473099850|FG003|Overall Study|Withdrawal by Subject|10|||
131403557|NCT01096368|473099851|FG004|Overall Study|Withdrawal by Subject|14|||
131403558|NCT01096368|473099847|FG000|Overall Study|Ineligible|0|||
131403559|NCT01096368|473099848|FG001|Overall Study|Ineligible|3|||
131403560|NCT01096368|473099849|FG002|Overall Study|Ineligible|2|||
131403561|NCT01096368|473099850|FG003|Overall Study|Ineligible|0|||
131403562|NCT01096368|473099851|FG004|Overall Study|Ineligible|25|||
131403563|NCT01096368|473099847|FG000|Overall Study|Did not start treatment|0|||
131403564|NCT01096368|473099848|FG001|Overall Study|Did not start treatment|4|||
131403565|NCT01096368|473099849|FG002|Overall Study|Did not start treatment|4|||
131403566|NCT01096368|473099850|FG003|Overall Study|Did not start treatment|0|||
131403567|NCT01096368|473099851|FG004|Overall Study|Did not start treatment|0|||
131403568|NCT01096368|473099847|FG000|Overall Study|Progressive disease|0|||
131403569|NCT01096368|473099848|FG001|Overall Study|Progressive disease|6|||
131403570|NCT01096368|473099849|FG002|Overall Study|Progressive disease|0|||
131403571|NCT01096368|473099850|FG003|Overall Study|Progressive disease|10|||
131403572|NCT01096368|473099851|FG004|Overall Study|Progressive disease|3|||
131403573|NCT01096368|473099847|FG000|Overall Study|Other|0|||
131403574|NCT01096368|473099848|FG001|Overall Study|Other|0|||
131403575|NCT01096368|473099849|FG002|Overall Study|Other|1|||
131403576|NCT01096368|473099850|FG003|Overall Study|Other|0|||
131403577|NCT01096368|473099851|FG004|Overall Study|Other|0|||
131403578|NCT01096368|473099847|FG000|Overall Study|Treated with institutional review|0|||
131403579|NCT01096368|473099848|FG001|Overall Study|Treated with institutional review|0|||
131403580|NCT01096368|473099849|FG002|Overall Study|Treated with institutional review|0|||
131403581|NCT01096368|473099850|FG003|Overall Study|Treated with institutional review|0|||
131451148|NCT00670748|473279705|FG002|Overall Study|Death during treatment|1|||
131451149|NCT00670748|473279706|FG003|Overall Study|Death during treatment|0|||
131451150|NCT00670748|473279703|FG000|Overall Study|Not off study|2|||
131451151|NCT00670748|473279704|FG001|Overall Study|Not off study|1|||
131451152|NCT00670748|473279705|FG002|Overall Study|Not off study|1|||
131451153|NCT00670748|473279706|FG003|Overall Study|Not off study|1|||
131451154|NCT06083506|473279711|FG000|Overall Study|Physician Decision|2|||
131451155|NCT06083506|473279711|FG000|Overall Study|Lack of Efficacy|1|||
131451156|NCT03529422|473279712|FG000|Overall Study|Withdrawal by Subject|1|||
131451157|NCT03529422|473279712|FG000|Overall Study|Protocol Violation|1|||
131451158|NCT03529422|473279712|FG000|Overall Study|Disease progression|2|||
131451159|NCT02000115|473279713|FG000|Overall Study|Death|56|||
131451160|NCT02000115|473279714|FG001|Overall Study|Death|45|||
131451161|NCT02000115|473279715|FG002|Overall Study|Death|0|||
131451162|NCT02000115|473279716|FG003|Overall Study|Death|0|||
131451163|NCT02000115|473279713|FG000|Overall Study|Missed Visit|6|||
131451164|NCT02000115|473279714|FG001|Overall Study|Missed Visit|8|||
131451165|NCT02000115|473279715|FG002|Overall Study|Missed Visit|1|||
131403582|NCT01096368|473099851|FG004|Overall Study|Treated with institutional review|1|||
131403583|NCT04934800|473099852|FG000|Overall Study|Other|1|||
131403584|NCT04934800|473099852|FG000|Overall Study|Withdrawal by Subject|5|||
131403585|NCT04934800|473099852|FG000|Overall Study|Lack of Efficacy|1|||
131403586|NCT04934800|473099852|FG000|Overall Study|Adverse Event|9|||
131403587|NCT04934800|473099852|FG000|Overall Study|Lost to Follow-up|5|||
131451166|NCT02000115|473279716|FG003|Overall Study|Missed Visit|0|||
131451167|NCT02000115|473279713|FG000|Overall Study|Protocol Violation|2|||
131911074|NCT01140906|474963112|FG002|Overall Study|Non-compliance|0|||
131451168|NCT02000115|473279714|FG001|Overall Study|Protocol Violation|1|||
131451169|NCT02000115|473279715|FG002|Overall Study|Protocol Violation|0|||
131451170|NCT02000115|473279716|FG003|Overall Study|Protocol Violation|0|||
131451171|NCT02000115|473279713|FG000|Overall Study|Physician Decision|2|||
131451172|NCT02000115|473279714|FG001|Overall Study|Physician Decision|0|||
131451173|NCT02000115|473279715|FG002|Overall Study|Physician Decision|0|||
131451174|NCT02000115|473279716|FG003|Overall Study|Physician Decision|0|||
131451175|NCT02000115|473279713|FG000|Overall Study|Withdrawal by Subject|11|||
131451176|NCT02000115|473279714|FG001|Overall Study|Withdrawal by Subject|11|||
131451177|NCT02000115|473279715|FG002|Overall Study|Withdrawal by Subject|0|||
131451178|NCT02000115|473279716|FG003|Overall Study|Withdrawal by Subject|0|||
131451179|NCT02000115|473279713|FG000|Overall Study|Lost to Follow-up|0|||
131451180|NCT02000115|473279714|FG001|Overall Study|Lost to Follow-up|1|||
131451181|NCT02000115|473279715|FG002|Overall Study|Lost to Follow-up|0|||
131451182|NCT02000115|473279716|FG003|Overall Study|Lost to Follow-up|0|||
131451183|NCT02000115|473279713|FG000|Overall Study|Non-compliance|2|||
131451184|NCT02000115|473279714|FG001|Overall Study|Non-compliance|1|||
131451185|NCT02000115|473279715|FG002|Overall Study|Non-compliance|0|||
131451186|NCT02000115|473279716|FG003|Overall Study|Non-compliance|0|||
131451187|NCT02000115|473279713|FG000|Overall Study|Withdrawn on day of randomization|0|||
131451188|NCT02000115|473279714|FG001|Overall Study|Withdrawn on day of randomization|1|||
131451189|NCT02000115|473279715|FG002|Overall Study|Withdrawn on day of randomization|0|||
131451190|NCT02000115|473279716|FG003|Overall Study|Withdrawn on day of randomization|0|||
131451191|NCT02000115|473279713|FG000|Overall Study|Still on Study|0|||
131451192|NCT02000115|473279714|FG001|Overall Study|Still on Study|0|||
131451193|NCT02000115|473279715|FG002|Overall Study|Still on Study|0|||
131451194|NCT02000115|473279716|FG003|Overall Study|Still on Study|53|||
131451195|NCT05006573|473279717|FG000|Double-blind Treatment Period|Physician Decision|2|||
131451196|NCT05006573|473279718|FG001|Double-blind Treatment Period|Physician Decision|0|||
131451197|NCT05006573|473279717|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
131451198|NCT05006573|473279718|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
131451199|NCT05006573|473279717|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
131451200|NCT05006573|473279718|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131451201|NCT05006573|473279717|FG000|Double-blind Treatment Period|Protocol Violation|2|||
131451202|NCT05006573|473279718|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131451203|NCT05006573|473279717|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
131451204|NCT05006573|473279718|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
131451205|NCT05006573|473279717|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
131451206|NCT05006573|473279718|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
131451207|NCT03493464|473279723|FG000|Overall Study|Surgery not performed|1|||
131451208|NCT02374450|473279724|FG000|Overall Study|Protocol Violation|0|||
131451209|NCT02374450|473279725|FG001|Overall Study|Protocol Violation|1|||
131451210|NCT02374450|473279726|FG002|Overall Study|Protocol Violation|0|||
131451211|NCT02374450|473279724|FG000|Overall Study|Withdrawal by Subject|91|||
131451212|NCT02374450|473279725|FG001|Overall Study|Withdrawal by Subject|110|||
131451213|NCT02374450|473279726|FG002|Overall Study|Withdrawal by Subject|4|||
131451214|NCT02374450|473279724|FG000|Overall Study|Lost to Follow-up|168|||
131451215|NCT02374450|473279725|FG001|Overall Study|Lost to Follow-up|194|||
131451216|NCT02374450|473279726|FG002|Overall Study|Lost to Follow-up|138|||
131451217|NCT02374450|473279724|FG000|Overall Study|Death|173|||
131451218|NCT02374450|473279725|FG001|Overall Study|Death|185|||
131451219|NCT02374450|473279726|FG002|Overall Study|Death|81|||
131451220|NCT02374450|473279724|FG000|Overall Study|Migrated from the study area|538|||
131451221|NCT02374450|473279725|FG001|Overall Study|Migrated from the study area|648|||
131451222|NCT02374450|473279726|FG002|Overall Study|Migrated from the study area|181|||
131451223|NCT02374450|473279724|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
131451224|NCT02374450|473279725|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
131451225|NCT02374450|473279726|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
131451226|NCT02374450|473279724|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
131451227|NCT02374450|473279725|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
131451228|NCT02374450|473279726|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
131451229|NCT02374450|473279724|FG000|Overall Study|Other|0|||
131451230|NCT02374450|473279725|FG001|Overall Study|Other|21|||
131451231|NCT02374450|473279726|FG002|Overall Study|Other|79|||
131451232|NCT01442103|473281488|FG000|Overall Study|Lost to Follow-up|2|||
131451233|NCT02202759|473281489|FG000|Overall Study|Study Terminated by Sponsor|3|||
131451234|NCT02202759|473281490|FG001|Overall Study|Study Terminated by Sponsor|3|||
131451235|NCT02202759|473281491|FG002|Overall Study|Study Terminated by Sponsor|3|||
131451236|NCT02202759|473281489|FG000|Overall Study|Withdrawal by Subject|2|||
131451237|NCT02202759|473281490|FG001|Overall Study|Withdrawal by Subject|1|||
131451238|NCT02202759|473281491|FG002|Overall Study|Withdrawal by Subject|1|||
131451239|NCT02202759|473281489|FG000|Overall Study|Reason not Specified|4|||
131451240|NCT02202759|473281490|FG001|Overall Study|Reason not Specified|11|||
131451241|NCT02202759|473281491|FG002|Overall Study|Reason not Specified|10|||
131451242|NCT04953728|473281492|FG000|Overall Study|Withdrawal by Subject|3|||
131911075|NCT01140906|474963113|FG003|Overall Study|Non-compliance|1|||
131911076|NCT01140906|474963110|FG000|Overall Study|Protocol Violation|5|||
131911077|NCT01140906|474963111|FG001|Overall Study|Protocol Violation|3|||
131911078|NCT01140906|474963112|FG002|Overall Study|Protocol Violation|2|||
131911079|NCT01140906|474963113|FG003|Overall Study|Protocol Violation|1|||
131911080|NCT01140906|474963110|FG000|Overall Study|Withdrawal of consent|6|||
131911081|NCT01140906|474963111|FG001|Overall Study|Withdrawal of consent|6|||
131911082|NCT01140906|474963112|FG002|Overall Study|Withdrawal of consent|2|||
131911083|NCT01140906|474963113|FG003|Overall Study|Withdrawal of consent|2|||
131911084|NCT01140906|474963110|FG000|Overall Study|Lost to Follow-up|1|||
131911085|NCT01140906|474963111|FG001|Overall Study|Lost to Follow-up|1|||
131911086|NCT01140906|474963112|FG002|Overall Study|Lost to Follow-up|0|||
131911087|NCT01140906|474963113|FG003|Overall Study|Lost to Follow-up|2|||
131911088|NCT01140906|474963110|FG000|Overall Study|Administrative or other reason|0|||
131911089|NCT01140906|474963111|FG001|Overall Study|Administrative or other reason|5|||
131911090|NCT01140906|474963112|FG002|Overall Study|Administrative or other reason|3|||
131911091|NCT01140906|474963113|FG003|Overall Study|Administrative or other reason|2|||
131911092|NCT00703534|474963114|FG000|Overall Study|Adverse Event|14|||
131911093|NCT00703534|474963115|FG001|Overall Study|Adverse Event|3|||
131911094|NCT00703534|474963114|FG000|Overall Study|Withdrawal by Subject|8|||
131911095|NCT00703534|474963115|FG001|Overall Study|Withdrawal by Subject|7|||
131911096|NCT00703534|474963114|FG000|Overall Study|Incorrect Enrollment|6|||
131911097|NCT00703534|474963115|FG001|Overall Study|Incorrect Enrollment|6|||
131911098|NCT00703534|474963114|FG000|Overall Study|Lost to Follow-up|1|||
131911099|NCT00703534|474963115|FG001|Overall Study|Lost to Follow-up|4|||
131911100|NCT00703534|474963114|FG000|Overall Study|Severe Non Compliance|1|||
131911101|NCT00703534|474963115|FG001|Overall Study|Severe Non Compliance|5|||
131911102|NCT00336544|474963116|FG000|Overall Study|Lack of Efficacy|8|||
131911103|NCT00336544|474963117|FG001|Overall Study|Lack of Efficacy|5|||
131911104|NCT00336544|474963116|FG000|Overall Study|Adverse Event|4|||
131911105|NCT00336544|474963117|FG001|Overall Study|Adverse Event|9|||
131911106|NCT00336544|474963116|FG000|Overall Study|Withdrawal by Subject|4|||
131911107|NCT00336544|474963117|FG001|Overall Study|Withdrawal by Subject|3|||
131911108|NCT00336544|474963116|FG000|Overall Study|Other|3|||
131911109|NCT00336544|474963117|FG001|Overall Study|Other|5|||
131911110|NCT01649765|474963118|FG000|Overall Study|Adverse Event|5|||
131911111|NCT01649765|474963119|FG001|Overall Study|Adverse Event|3|||
131911112|NCT01649765|474963118|FG000|Overall Study|Lack of Efficacy|1|||
131911113|NCT01649765|474963119|FG001|Overall Study|Lack of Efficacy|1|||
131911114|NCT01649765|474963118|FG000|Overall Study|Physician Decision|0|||
131911115|NCT01649765|474963119|FG001|Overall Study|Physician Decision|3|||
131911116|NCT01649765|474963118|FG000|Overall Study|Protocol Violation|1|||
131911117|NCT01649765|474963119|FG001|Overall Study|Protocol Violation|0|||
131911118|NCT01649765|474963118|FG000|Overall Study|Withdrawal by Subject|2|||
131911119|NCT01649765|474963119|FG001|Overall Study|Withdrawal by Subject|1|||
131911120|NCT00715208|474963120|FG000|Overall Study|Withdrawal by Subject|1|||
131911121|NCT00715208|474963121|FG001|Overall Study|Withdrawal by Subject|1|||
131911122|NCT00715208|474963120|FG000|Overall Study|Adverse Event|0|||
131911123|NCT00715208|474963121|FG001|Overall Study|Adverse Event|6|||
131911124|NCT00715208|474963120|FG000|Overall Study|Lack of Efficacy|0|||
131911125|NCT00715208|474963121|FG001|Overall Study|Lack of Efficacy|2|||
131911126|NCT01316614|474963122|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
131911127|NCT01316614|474963122|FG000|Overall Study|Cytology slides not available for review|4|||
131403588|NCT04934800|473099852|FG000|Overall Study|Enrolled but not treated|1|||
131403589|NCT00516906|473099853|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
131403590|NCT00516906|473099854|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
131403591|NCT01974206|473099857|FG000|Overall Study|Did Not Take Study Drug|0|||
131403592|NCT01974206|473099858|FG001|Overall Study|Did Not Take Study Drug|1|||
131403593|NCT01974206|473099857|FG000|Overall Study|Physician Decision|1|||
131403594|NCT01974206|473099858|FG001|Overall Study|Physician Decision|0|||
131403595|NCT01974206|473099857|FG000|Overall Study|Withdrawal by Subject|3|||
131403596|NCT01974206|473099858|FG001|Overall Study|Withdrawal by Subject|0|||
131403597|NCT01974206|473099857|FG000|Overall Study|Lost to Follow-up|1|||
131403598|NCT01974206|473099858|FG001|Overall Study|Lost to Follow-up|0|||
131403599|NCT01974206|473099857|FG000|Overall Study|Death|1|||
131911128|NCT01316614|474963122|FG000|Overall Study|Cystic lesion|5|||
131911129|NCT01316614|474963122|FG000|Overall Study|Inadequate number of passes|2|||
131911130|NCT01316614|474963122|FG000|Overall Study|Medically unstable|1|||
131911131|NCT03427411|474963123|FG000|Overall Study|Screen failure - platelets too low|0|||
131911132|NCT03427411|474963124|FG001|Overall Study|Screen failure - platelets too low|1|||
131911133|NCT00076570|474963125|FG000|Overall Study|Drug intolerance|8|||
131403600|NCT01974206|473099858|FG001|Overall Study|Death|0|||
131403601|NCT02118766|473099863|FG000|Overall Study|Adverse Event|7|||
131403602|NCT02118766|473099864|FG001|Overall Study|Adverse Event|2|||
131911134|NCT00076570|474963126|FG001|Overall Study|Drug intolerance|8|||
131911135|NCT04889040|474963127|FG000|Overall Study|Withdrawal by Subject|3|||
131911136|NCT04889040|474963128|FG001|Overall Study|Withdrawal by Subject|3|||
131911137|NCT04889040|474963127|FG000|Overall Study|Lost to Follow-up|0|||
131845765|NCT01756079|474718077|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
131845766|NCT01756079|474718077|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
131845767|NCT01756079|474718077|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
131845768|NCT04746794|474718078|FG000|Overall Study|Did not complete any study assessment|50303|||
131845769|NCT04746794|474718079|FG001|Overall Study|Did not complete any study assessment|44997|||
131845770|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
131845771|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
131845772|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
131845773|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
131845774|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
131845775|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
131845776|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
131845777|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
131845778|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
131845779|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
131845780|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
131845781|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
131845782|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
131845783|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
131845784|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
131845785|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
131845786|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
131845787|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
131845788|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
131845789|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
131845790|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
131845791|NCT04040192|474718080|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
131845792|NCT04040192|474718081|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
131845793|NCT04040192|474718082|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
131845794|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
131845795|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
131845796|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
131845797|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
131845798|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
131845799|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
131845800|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
131845801|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
131845802|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
131845803|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
131845804|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
131845805|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
131845806|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
131845807|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
131845808|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
131845809|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
131845810|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
131845811|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
131845812|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
131845813|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
131845814|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
131845815|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
131845816|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
131845817|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
131403603|NCT02118766|473099863|FG000|Overall Study|Withdrawal by Subject|3|||
131403604|NCT02118766|473099864|FG001|Overall Study|Withdrawal by Subject|6|||
131403605|NCT02118766|473099863|FG000|Overall Study|Lost to Follow-up|5|||
131403606|NCT02118766|473099864|FG001|Overall Study|Lost to Follow-up|4|||
131403607|NCT02118766|473099863|FG000|Overall Study|Withdrawal by parent/guardian|12|||
131403608|NCT02118766|473099864|FG001|Overall Study|Withdrawal by parent/guardian|18|||
131403609|NCT02118766|473099863|FG000|Overall Study|Other|3|||
131403610|NCT02118766|473099864|FG001|Overall Study|Other|1|||
131403611|NCT02684058|473099870|FG000|Treatment Period|Progressive disease|4|||
131911138|NCT04889040|474963128|FG001|Overall Study|Lost to Follow-up|1|||
131403612|NCT02684058|473099871|FG001|Treatment Period|Progressive disease|10|||
131845818|NCT04040192|474718080|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
131845819|NCT04040192|474718081|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
131845820|NCT04040192|474718082|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
131403613|NCT02684058|473099872|FG002|Treatment Period|Progressive disease|19|||
131403614|NCT02684058|473099870|FG000|Treatment Period|Adverse Event|3|||
131403615|NCT02684058|473099871|FG001|Treatment Period|Adverse Event|8|||
131403616|NCT02684058|473099872|FG002|Treatment Period|Adverse Event|1|||
131403617|NCT02684058|473099870|FG000|Treatment Period|Physician Decision|5|||
131403618|NCT02684058|473099871|FG001|Treatment Period|Physician Decision|1|||
131403619|NCT02684058|473099872|FG002|Treatment Period|Physician Decision|2|||
131403620|NCT02684058|473099870|FG000|Treatment Period|New therapy for study indication|1|||
131403621|NCT02684058|473099871|FG001|Treatment Period|New therapy for study indication|0|||
131403622|NCT02684058|473099872|FG002|Treatment Period|New therapy for study indication|0|||
131403623|NCT02684058|473099870|FG000|Treatment Period|Protocol deviation|0|||
131403624|NCT02684058|473099871|FG001|Treatment Period|Protocol deviation|1|||
131403625|NCT02684058|473099872|FG002|Treatment Period|Protocol deviation|0|||
131403626|NCT02684058|473099870|FG000|Treatment Period|Subject/guardian decision|4|||
131403627|NCT02684058|473099871|FG001|Treatment Period|Subject/guardian decision|3|||
131403628|NCT02684058|473099872|FG002|Treatment Period|Subject/guardian decision|0|||
131403629|NCT02684058|473099870|FG000|Treatment Period|Death|0|||
131403630|NCT02684058|473099871|FG001|Treatment Period|Death|0|||
131403631|NCT02684058|473099872|FG002|Treatment Period|Death|2|||
131403632|NCT02684058|473099870|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131403633|NCT02684058|473099871|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131403634|NCT02684058|473099872|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
131403635|NCT02684058|473099870|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
131403636|NCT02684058|473099871|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
131403637|NCT02684058|473099872|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
131403638|NCT02684058|473099870|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
131403639|NCT02684058|473099871|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
131403640|NCT02684058|473099872|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
131403641|NCT02684058|473099870|FG000|Post-treatment Efficacy Follow-up|Death|0|||
131403642|NCT02684058|473099871|FG001|Post-treatment Efficacy Follow-up|Death|0|||
131403643|NCT02684058|473099872|FG002|Post-treatment Efficacy Follow-up|Death|3|||
131403644|NCT02684058|473099870|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
131403645|NCT02684058|473099871|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
131403646|NCT02684058|473099872|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
131403647|NCT02684058|473099870|FG000|Post-treatment Survival Follow-up|Death|0|||
131403648|NCT02684058|473099871|FG001|Post-treatment Survival Follow-up|Death|0|||
131403649|NCT02684058|473099872|FG002|Post-treatment Survival Follow-up|Death|7|||
131403650|NCT02684058|473099870|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
131403651|NCT02684058|473099871|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
131403652|NCT02684058|473099872|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
131403653|NCT02684058|473099870|FG000|Crossover Treatment Period|Progressive disease|0|||
131403654|NCT02684058|473099871|FG001|Crossover Treatment Period|Progressive disease|1|||
131403655|NCT02684058|473099872|FG002|Crossover Treatment Period|Progressive disease|0|||
131403656|NCT04669262|473099886|FG000|Overall Study|Withdrawal by Subject|0|||
131403657|NCT04669262|473099887|FG001|Overall Study|Withdrawal by Subject|0|||
131403658|NCT04669262|473099888|FG002|Overall Study|Withdrawal by Subject|0|||
131403659|NCT04669262|473099889|FG003|Overall Study|Withdrawal by Subject|1|||
131403660|NCT04669262|473099886|FG000|Overall Study|Randomized but Not Treated|0|||
131403661|NCT04669262|473099887|FG001|Overall Study|Randomized but Not Treated|1|||
131403662|NCT04669262|473099888|FG002|Overall Study|Randomized but Not Treated|0|||
131403663|NCT04669262|473099889|FG003|Overall Study|Randomized but Not Treated|0|||
131403664|NCT05151445|473099890|FG000|Overall Study|Withdrawal by Subject|3|||
131403665|NCT01638013|473099891|FG000|Overall Study|Adverse Event|36|||
131403666|NCT01638013|473099892|FG001|Overall Study|Adverse Event|29|||
131403667|NCT01638013|473099893|FG002|Overall Study|Adverse Event|48|||
131403668|NCT01638013|473099891|FG000|Overall Study|Lack of Efficacy|39|||
131403669|NCT01638013|473099892|FG001|Overall Study|Lack of Efficacy|11|||
131403670|NCT01638013|473099893|FG002|Overall Study|Lack of Efficacy|14|||
131403671|NCT01638013|473099891|FG000|Overall Study|Protocol Violation|10|||
131403672|NCT01638013|473099892|FG001|Overall Study|Protocol Violation|7|||
131403673|NCT01638013|473099893|FG002|Overall Study|Protocol Violation|11|||
131403674|NCT01638013|473099891|FG000|Overall Study|Met discontinuation criteria|4|||
131403675|NCT01638013|473099892|FG001|Overall Study|Met discontinuation criteria|0|||
131403676|NCT01638013|473099893|FG002|Overall Study|Met discontinuation criteria|7|||
131403677|NCT01638013|473099891|FG000|Overall Study|Subject Lost to Follow up|1|||
131403678|NCT01638013|473099892|FG001|Overall Study|Subject Lost to Follow up|0|||
131403679|NCT01638013|473099893|FG002|Overall Study|Subject Lost to Follow up|1|||
131403680|NCT01638013|473099891|FG000|Overall Study|Miscellaneous|25|||
131403681|NCT01638013|473099892|FG001|Overall Study|Miscellaneous|19|||
131403682|NCT01638013|473099893|FG002|Overall Study|Miscellaneous|23|||
131845821|NCT01422187|474718087|FG000|Overall Study|Personal reason|1|||
131845822|NCT01422187|474718088|FG001|Overall Study|Personal reason|0|||
131845823|NCT01422187|474718089|FG002|Overall Study|Personal reason|0|||
131845824|NCT01422187|474718087|FG000|Overall Study|Lost to Follow-up|0|||
131845825|NCT01422187|474718088|FG001|Overall Study|Lost to Follow-up|1|||
131845826|NCT01422187|474718089|FG002|Overall Study|Lost to Follow-up|0|||
131845827|NCT00469144|474718090|FG000|Overall Study|Death|0|||
131845828|NCT00469144|474718091|FG001|Overall Study|Death|1|||
131845829|NCT00469144|474718090|FG000|Overall Study|No Response|5|||
131845830|NCT00469144|474718091|FG001|Overall Study|No Response|5|||
131845831|NCT00469144|474718090|FG000|Overall Study|Progressive Disease|1|||
131845832|NCT00469144|474718091|FG001|Overall Study|Progressive Disease|0|||
131845833|NCT02227446|474718092|FG000|Overall Study|not eligible post randomization|18|||
131845834|NCT02227446|474718093|FG001|Overall Study|not eligible post randomization|29|||
131845835|NCT02227446|474718092|FG000|Overall Study|Withdrawal by Subject|4|||
131845836|NCT02227446|474718093|FG001|Overall Study|Withdrawal by Subject|5|||
131845837|NCT02121392|474718094|FG000|Prior to Intervention|Protocol Violation|40|||
131845838|NCT02121392|474718095|FG001|Prior to Intervention|Protocol Violation|35|||
131845839|NCT02121392|474718094|FG000|Prior to Intervention|Withdrawal by Subject|8|||
131845840|NCT02121392|474718095|FG001|Prior to Intervention|Withdrawal by Subject|6|||
131845841|NCT02121392|474718094|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
131845842|NCT02121392|474718095|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
131845843|NCT02121392|474718094|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
131845844|NCT02121392|474718095|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
131845845|NCT01352416|474718096|FG000|Overall Study|Physician Decision|1|||
131845846|NCT01352416|474718097|FG001|Overall Study|Physician Decision|2|||
131845847|NCT01352416|474718098|FG002|Overall Study|Physician Decision|2|||
131845848|NCT01352416|474718099|FG003|Overall Study|Physician Decision|1|||
131403683|NCT01638013|473099891|FG000|Overall Study|Withdrawal of Consent|16|||
131403684|NCT01638013|473099892|FG001|Overall Study|Withdrawal of Consent|12|||
131403685|NCT01638013|473099893|FG002|Overall Study|Withdrawal of Consent|16|||
131403686|NCT01638013|473099891|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
131403687|NCT01638013|473099892|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
131403688|NCT01638013|473099893|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
131403689|NCT01846299|473099896|FG000|Overall Study|Physician Decision|4|||
131403690|NCT01846299|473099897|FG001|Overall Study|Physician Decision|2|||
131403691|NCT01846299|473099896|FG000|Overall Study|Protocol deviation|1|||
131403692|NCT01846299|473099897|FG001|Overall Study|Protocol deviation|0|||
131403693|NCT01846299|473099896|FG000|Overall Study|Death|1|||
131403694|NCT01846299|473099897|FG001|Overall Study|Death|2|||
131403695|NCT01846299|473099896|FG000|Overall Study|Lost to Follow-up|3|||
131403696|NCT01846299|473099897|FG001|Overall Study|Lost to Follow-up|0|||
131403697|NCT01846299|473099896|FG000|Overall Study|Withdrawal by Subject|1|||
131403698|NCT01846299|473099897|FG001|Overall Study|Withdrawal by Subject|6|||
131403699|NCT01846299|473099896|FG000|Overall Study|Adverse Event|2|||
131403700|NCT01846299|473099897|FG001|Overall Study|Adverse Event|0|||
131403701|NCT03559517|473099898|FG000|Overall Study|Withdrawal by Subject|1|||
131403702|NCT03559517|473099899|FG001|Overall Study|Withdrawal by Subject|0|||
131403703|NCT03559517|473099900|FG002|Overall Study|Withdrawal by Subject|0|||
131403704|NCT01330628|473099902|FG000|Overall Study|Death|2|||
131403705|NCT01330628|473099903|FG001|Overall Study|Death|3|||
131403706|NCT01330628|473099902|FG000|Overall Study|Lost to Follow-up|5|||
131403707|NCT01330628|473099903|FG001|Overall Study|Lost to Follow-up|6|||
131403708|NCT01330628|473099902|FG000|Overall Study|Adverse Event|44|||
131403709|NCT01330628|473099903|FG001|Overall Study|Adverse Event|25|||
131403710|NCT01330628|473099902|FG000|Overall Study|Withdrawn|18|||
131403711|NCT01330628|473099903|FG001|Overall Study|Withdrawn|6|||
131403712|NCT01330628|473099902|FG000|Overall Study|Didn't receive study treatment|1|||
131403713|NCT01330628|473099903|FG001|Overall Study|Didn't receive study treatment|0|||
131403714|NCT01357161|473099904|FG000|Part 1 (Open Label Run-in)|Death|5|||
131403715|NCT01357161|473099905|FG001|Part 1 (Open Label Run-in)|Death|0|||
131403716|NCT01357161|473099906|FG002|Part 1 (Open Label Run-in)|Death|0|||
131403717|NCT01357161|473099904|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
131403718|NCT01357161|473099905|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
131403719|NCT01357161|473099906|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
131403720|NCT01357161|473099904|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
131403721|NCT01357161|473099905|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
131845849|NCT00229723|474718108|FG000|Concomitant Phase|Adverse Event|4|||
131403722|NCT01357161|473099906|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
131451243|NCT04953728|473281492|FG000|Overall Study|Physician Decision|1|||
131845850|NCT00229723|474718109|FG001|Concomitant Phase|Adverse Event|2|||
131845851|NCT00229723|474718110|FG002|Concomitant Phase|Adverse Event|5|||
131845852|NCT00229723|474718111|FG003|Concomitant Phase|Adverse Event|2|||
131845853|NCT00229723|474718112|FG004|Concomitant Phase|Adverse Event|0|||
131403723|NCT01357161|473099904|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
131403724|NCT01357161|473099905|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
131403725|NCT01357161|473099906|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
131451244|NCT02105662|473281493|FG000|Overall Study|Lost to Follow-up|5|||
131911139|NCT04889040|474963127|FG000|Overall Study|Adverse Event|2|||
131911140|NCT04889040|474963128|FG001|Overall Study|Adverse Event|1|||
131911141|NCT02058095|474963129|FG000|Overall Study|Adverse Event|1|||
131911142|NCT02058095|474963130|FG001|Overall Study|Adverse Event|0|||
131911143|NCT00998946|474963131|FG000|Overall Study|Lost to Follow-up|1|||
131911144|NCT00998946|474963131|FG000|Overall Study|Withdrawal by Subject|1|||
131911145|NCT00998946|474963131|FG000|Overall Study|Death|2|||
131911146|NCT00998946|474963131|FG000|Overall Study|Reason Unspecified|3|||
131911147|NCT00998946|474963131|FG000|Overall Study|Enrolled but not Dosed|2|||
131911148|NCT01432951|474963134|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
131911149|NCT00853385|474963135|FG000|Overall Study|Death|0|||
131911150|NCT00853385|474963136|FG001|Overall Study|Death|0|||
131911151|NCT00853385|474963137|FG002|Overall Study|Death|0|||
131911152|NCT00853385|474963138|FG003|Overall Study|Death|0|||
131911153|NCT00853385|474963139|FG004|Overall Study|Death|1|||
131911154|NCT00853385|474963135|FG000|Overall Study|Adverse Event|24|||
131911155|NCT00853385|474963136|FG001|Overall Study|Adverse Event|24|||
131911156|NCT00853385|474963137|FG002|Overall Study|Adverse Event|2|||
131911157|NCT00853385|474963138|FG003|Overall Study|Adverse Event|5|||
131911158|NCT00853385|474963139|FG004|Overall Study|Adverse Event|22|||
131911159|NCT00853385|474963135|FG000|Overall Study|Lack of Efficacy|6|||
131911160|NCT00853385|474963136|FG001|Overall Study|Lack of Efficacy|7|||
131911161|NCT00853385|474963137|FG002|Overall Study|Lack of Efficacy|3|||
131911162|NCT00853385|474963138|FG003|Overall Study|Lack of Efficacy|3|||
131911163|NCT00853385|474963139|FG004|Overall Study|Lack of Efficacy|6|||
131911164|NCT00853385|474963135|FG000|Overall Study|Lost to Follow-up|2|||
131403726|NCT01357161|473099904|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
131403727|NCT01357161|473099905|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
131403728|NCT01357161|473099906|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
131403729|NCT01357161|473099904|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
131403730|NCT01357161|473099905|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
131403731|NCT01357161|473099906|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
131403732|NCT01357161|473099904|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
131403733|NCT01357161|473099905|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
131403734|NCT01357161|473099906|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
131403735|NCT01357161|473099904|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
131403736|NCT01357161|473099905|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
131403737|NCT01357161|473099906|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
131403738|NCT01357161|473099904|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
131403739|NCT01357161|473099905|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
131403740|NCT01357161|473099906|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
131403741|NCT01357161|473099904|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
131403742|NCT01357161|473099905|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
131403743|NCT01357161|473099906|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
131403744|NCT01357161|473099904|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
131403745|NCT01357161|473099905|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
131403746|NCT01357161|473099906|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
131403747|NCT01448824|473101455|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403748|NCT01448824|473101456|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403749|NCT01448824|473101457|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403750|NCT01448824|473101458|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403751|NCT01448824|473101459|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403752|NCT01448824|473101460|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403753|NCT01448824|473101461|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
131403754|NCT01448824|473101462|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
131403755|NCT01448824|473101455|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
131403756|NCT01448824|473101456|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
131403757|NCT01448824|473101457|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
131403758|NCT01448824|473101458|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
131403759|NCT01448824|473101459|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
131403760|NCT01448824|473101460|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
131403761|NCT01448824|473101461|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
131403762|NCT01448824|473101462|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
131403763|NCT01448824|473101455|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403764|NCT01448824|473101456|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403765|NCT01448824|473101457|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403766|NCT01448824|473101458|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403767|NCT01448824|473101459|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403768|NCT01448824|473101460|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
131403769|NCT01448824|473101461|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403770|NCT01448824|473101462|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
131403771|NCT01448824|473101455|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
131403772|NCT01448824|473101456|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
131403773|NCT01448824|473101457|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
131403774|NCT01448824|473101458|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
131403775|NCT01448824|473101459|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
131403776|NCT01448824|473101460|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
131403777|NCT01448824|473101461|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
131403778|NCT01448824|473101462|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
131403779|NCT01448824|473101455|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403780|NCT01448824|473101456|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403781|NCT01448824|473101457|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403782|NCT01448824|473101458|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403783|NCT01448824|473101459|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403784|NCT01448824|473101460|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403785|NCT01448824|473101461|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
131403786|NCT01448824|473101462|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
131403787|NCT01448824|473101455|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403788|NCT01448824|473101456|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403789|NCT01448824|473101457|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403790|NCT01448824|473101458|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403791|NCT01448824|473101459|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403792|NCT01448824|473101460|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403793|NCT01448824|473101461|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
131403794|NCT01448824|473101462|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
131403795|NCT01448824|473101455|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403796|NCT01448824|473101456|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403797|NCT01448824|473101457|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403798|NCT01448824|473101458|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403799|NCT01448824|473101459|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403800|NCT01448824|473101460|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403801|NCT01448824|473101461|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
131403802|NCT01448824|473101462|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
131403803|NCT01448824|473101455|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403804|NCT01448824|473101456|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403805|NCT01448824|473101457|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403806|NCT01448824|473101458|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403807|NCT01448824|473101459|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403808|NCT01448824|473101460|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403809|NCT01448824|473101461|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
131403810|NCT01448824|473101462|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
131403811|NCT01995669|473101465|FG000|Overall Study|Progression|2|||
131403812|NCT01995669|473101466|FG001|Overall Study|Progression|1|||
131403813|NCT01995669|473101467|FG002|Overall Study|Progression|1|||
131403814|NCT01995669|473101468|FG003|Overall Study|Progression|13|||
131403815|NCT01995669|473101465|FG000|Overall Study|Adverse Event|0|||
131403816|NCT01995669|473101466|FG001|Overall Study|Adverse Event|0|||
131403817|NCT01995669|473101467|FG002|Overall Study|Adverse Event|0|||
131403818|NCT01995669|473101468|FG003|Overall Study|Adverse Event|3|||
131403819|NCT01995669|473101465|FG000|Overall Study|Death|0|||
131403820|NCT01995669|473101466|FG001|Overall Study|Death|0|||
131403821|NCT01995669|473101467|FG002|Overall Study|Death|0|||
131403822|NCT01995669|473101468|FG003|Overall Study|Death|6|||
131403823|NCT01995669|473101465|FG000|Overall Study|Withdrawal by Subject|0|||
131403824|NCT01995669|473101466|FG001|Overall Study|Withdrawal by Subject|0|||
131403825|NCT01995669|473101467|FG002|Overall Study|Withdrawal by Subject|0|||
131403826|NCT01995669|473101468|FG003|Overall Study|Withdrawal by Subject|6|||
131403827|NCT01995669|473101465|FG000|Overall Study|Insurance Expired|0|||
131403828|NCT01995669|473101466|FG001|Overall Study|Insurance Expired|0|||
131403829|NCT01995669|473101467|FG002|Overall Study|Insurance Expired|0|||
131451245|NCT02105662|473281493|FG000|Overall Study|Withdrawal by Subject|1|||
131451246|NCT01528969|473281502|FG000|Overall Study|absent from the school at baseline|2|||
131403830|NCT01995669|473101468|FG003|Overall Study|Insurance Expired|1|||
131403831|NCT02998203|473101469|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
131403832|NCT02998203|473101470|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
131403833|NCT02998203|473101469|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
131403834|NCT02998203|473101470|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
131403835|NCT00789581|473101471|FG000|AC Therapy|Adverse Event|2|||
131403836|NCT00789581|473101472|FG001|AC Therapy|Adverse Event|3|||
131403837|NCT00789581|473101471|FG000|AC Therapy|Withdrawal by Subject|4|||
131911165|NCT00853385|474963136|FG001|Overall Study|Lost to Follow-up|1|||
131911166|NCT00853385|474963137|FG002|Overall Study|Lost to Follow-up|0|||
131911167|NCT00853385|474963138|FG003|Overall Study|Lost to Follow-up|0|||
131911168|NCT00853385|474963139|FG004|Overall Study|Lost to Follow-up|0|||
131911169|NCT00853385|474963135|FG000|Overall Study|Withdrawal by Subject|4|||
131911170|NCT00853385|474963136|FG001|Overall Study|Withdrawal by Subject|2|||
131911171|NCT00853385|474963137|FG002|Overall Study|Withdrawal by Subject|0|||
131911172|NCT00853385|474963138|FG003|Overall Study|Withdrawal by Subject|1|||
131911173|NCT00853385|474963139|FG004|Overall Study|Withdrawal by Subject|1|||
131911174|NCT00853385|474963135|FG000|Overall Study|Other|18|||
131911175|NCT00853385|474963136|FG001|Overall Study|Other|9|||
131911176|NCT00853385|474963137|FG002|Overall Study|Other|4|||
131911177|NCT00853385|474963138|FG003|Overall Study|Other|4|||
131911178|NCT00853385|474963139|FG004|Overall Study|Other|12|||
131911179|NCT01901185|474963140|FG000|Overall Study|Withdrawal by Subject|2|||
131911180|NCT04759131|474963143|FG000|Overall Study|Investigator's discretion|1|||
131911181|NCT04759131|474963144|FG001|Overall Study|Investigator's discretion|0|||
131911182|NCT04759131|474963143|FG000|Overall Study|Subject withdrawal|1|||
131911183|NCT04759131|474963144|FG001|Overall Study|Subject withdrawal|0|||
131911184|NCT02592824|474963152|FG000|Overall Study|Protocol Violation|5|||
131911185|NCT02592824|474963153|FG001|Overall Study|Protocol Violation|3|||
131911186|NCT02592824|474963152|FG000|Overall Study|Lost to Follow-up|2|||
131911187|NCT02592824|474963153|FG001|Overall Study|Lost to Follow-up|1|||
131911188|NCT05233761|474963154|FG000|Treatment Period A|Withdrawal by Subject|12|||
131911189|NCT05233761|474963155|FG001|Treatment Period A|Withdrawal by Subject|10|||
131911190|NCT05233761|474963154|FG000|Treatment Period A|Lost to Follow-up|6|||
131911191|NCT05233761|474963155|FG001|Treatment Period A|Lost to Follow-up|12|||
131911192|NCT05233761|474963154|FG000|Treatment Period A|Protocol Violation|8|||
131911193|NCT05233761|474963155|FG001|Treatment Period A|Protocol Violation|15|||
131403838|NCT00789581|473101472|FG001|AC Therapy|Withdrawal by Subject|7|||
131403839|NCT00789581|473101471|FG000|AC Therapy|Disease recurrence|3|||
131403840|NCT00789581|473101472|FG001|AC Therapy|Disease recurrence|1|||
131403841|NCT00789581|473101471|FG000|AC Therapy|Intercurrent Illness|1|||
131403842|NCT00789581|473101472|FG001|AC Therapy|Intercurrent Illness|0|||
131403843|NCT00789581|473101471|FG000|AC Therapy|Never Treated|1|||
131403844|NCT00789581|473101472|FG001|AC Therapy|Never Treated|4|||
131403845|NCT00789581|473101471|FG000|AC Therapy|Other|0|||
131403846|NCT00789581|473101472|FG001|AC Therapy|Other|2|||
131403847|NCT00789581|473101471|FG000|Adjuvant Therapy|Never treated|2|||
131403848|NCT00789581|473101472|FG001|Adjuvant Therapy|Never treated|2|||
131403849|NCT00789581|473101471|FG000|Adjuvant Therapy|Adverse Event|20|||
131403850|NCT00789581|473101472|FG001|Adjuvant Therapy|Adverse Event|44|||
131403851|NCT00789581|473101471|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
131403852|NCT00789581|473101472|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
131403853|NCT00789581|473101471|FG000|Adjuvant Therapy|Disease recurrence|2|||
131403854|NCT00789581|473101472|FG001|Adjuvant Therapy|Disease recurrence|1|||
131403855|NCT00789581|473101471|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
131403856|NCT00789581|473101472|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
131403857|NCT00789581|473101471|FG000|Adjuvant Therapy|Protocol Violation|1|||
131403858|NCT00789581|473101472|FG001|Adjuvant Therapy|Protocol Violation|1|||
131403859|NCT00789581|473101471|FG000|Adjuvant Therapy|Other|0|||
131403860|NCT00789581|473101472|FG001|Adjuvant Therapy|Other|1|||
131403861|NCT02688088|473101476|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
131403862|NCT02688088|473101477|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
131403863|NCT02688088|473101478|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
131403864|NCT02688088|473101479|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
131403865|NCT02688088|473101480|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
131403866|NCT02688088|473101476|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
131403867|NCT02688088|473101477|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
131403868|NCT02688088|473101478|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
131403869|NCT02688088|473101479|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
131403870|NCT02688088|473101480|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
131403871|NCT02688088|473101476|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
131403872|NCT02688088|473101477|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
131451247|NCT01528969|473281503|FG001|Overall Study|absent from the school at baseline|0|||
131403873|NCT02688088|473101478|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
131403874|NCT02688088|473101479|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
131403875|NCT02688088|473101480|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
131451248|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
131451249|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
131451250|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
131911194|NCT00869960|474963156|FG000|Overall Study|Lost to Follow-up|2|||
131911195|NCT01654276|474963163|FG000|Overall Study|Lack of Efficacy|1|||
131911196|NCT01654276|474963163|FG000|Overall Study|Lost to Follow-up|4|||
131911197|NCT01654276|474963163|FG000|Overall Study|Withdrawal by Subject|1|||
131911198|NCT01991795|474963164|FG000|Overall Study|Lost to Follow-up|6|||
131451251|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
131451252|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
131451253|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
131451254|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
131845854|NCT00229723|474718113|FG005|Concomitant Phase|Adverse Event|1|||
131845855|NCT00229723|474718114|FG006|Concomitant Phase|Adverse Event|2|||
131403876|NCT02688088|473101476|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
131403877|NCT02688088|473101477|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
131403878|NCT02688088|473101478|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
131403879|NCT02688088|473101479|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
131403880|NCT02688088|473101480|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
131403881|NCT02688088|473101476|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
131403882|NCT02688088|473101477|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
131845856|NCT00229723|474718108|FG000|Concomitant Phase|Objective disease progression|0|||
131403883|NCT02688088|473101478|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
131403884|NCT02688088|473101479|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
131403885|NCT02688088|473101480|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
131403886|NCT02688088|473101476|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
131403887|NCT02688088|473101477|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
131403888|NCT02688088|473101478|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
131403889|NCT02688088|473101479|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
131403890|NCT02688088|473101480|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
131403891|NCT02688088|473101476|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
131403892|NCT02688088|473101477|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
131403893|NCT02688088|473101478|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
131403894|NCT02688088|473101479|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
131403895|NCT02688088|473101480|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
131403896|NCT02688088|473101476|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
131403897|NCT02688088|473101477|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
131403898|NCT02688088|473101478|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
131403899|NCT02688088|473101479|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
131403900|NCT02688088|473101480|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
131403901|NCT02688088|473101476|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
131403902|NCT02688088|473101477|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
131403903|NCT02688088|473101478|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
131403904|NCT02688088|473101479|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
131403905|NCT02688088|473101480|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
131403906|NCT04021524|473101483|FG000|Overall Study|Change in surgical intervention|0|||
131403907|NCT04021524|473101484|FG001|Overall Study|Change in surgical intervention|1|||
131403908|NCT05275010|473101485|FG000|Overall Study|Reason Not Specified|4|||
131403909|NCT05275010|473101486|FG001|Overall Study|Reason Not Specified|1|||
131403910|NCT05275010|473101485|FG000|Overall Study|Withdrawal by Subject|1|||
131403911|NCT05275010|473101486|FG001|Overall Study|Withdrawal by Subject|0|||
131403912|NCT05275010|473101485|FG000|Overall Study|Lost to Follow-up|0|||
131403913|NCT05275010|473101486|FG001|Overall Study|Lost to Follow-up|1|||
131403914|NCT00730041|473101487|FG000|Overall Study|Lost to Follow-up|0|||
131403915|NCT00730041|473101488|FG001|Overall Study|Lost to Follow-up|2|||
131403916|NCT05526781|473101489|FG000|Overall Study|Lost to Follow-up|1|||
131403917|NCT01921218|473101490|FG000|Overall Study|Death|2|||
131403918|NCT01921218|473101491|FG001|Overall Study|Death|1|||
131403919|NCT01921218|473101490|FG000|Overall Study|Withdrawal by Subject|0|||
131403920|NCT01921218|473101491|FG001|Overall Study|Withdrawal by Subject|2|||
131403921|NCT01921218|473101490|FG000|Overall Study|Kidney transplant|1|||
131403922|NCT01921218|473101491|FG001|Overall Study|Kidney transplant|1|||
131403923|NCT02449889|473101492|FG000|Overall Study|Adverse Event|1|||
131403924|NCT02449889|473101493|FG001|Overall Study|Adverse Event|2|||
131403925|NCT02449889|473101494|FG002|Overall Study|Adverse Event|0|||
131403926|NCT02449889|473101492|FG000|Overall Study|Protocol Violation|0|||
131403927|NCT02449889|473101493|FG001|Overall Study|Protocol Violation|4|||
131403928|NCT02449889|473101494|FG002|Overall Study|Protocol Violation|1|||
131845857|NCT00229723|474718109|FG001|Concomitant Phase|Objective disease progression|0|||
131845858|NCT00229723|474718110|FG002|Concomitant Phase|Objective disease progression|0|||
131845859|NCT00229723|474718111|FG003|Concomitant Phase|Objective disease progression|0|||
131845860|NCT00229723|474718112|FG004|Concomitant Phase|Objective disease progression|0|||
131403929|NCT03327220|473101495|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
131403930|NCT03327220|473101496|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
131403931|NCT03327220|473101495|FG000|Overall Study|Investigator Decision|2|||
131845861|NCT00229723|474718113|FG005|Concomitant Phase|Objective disease progression|0|||
131845862|NCT00229723|474718114|FG006|Concomitant Phase|Objective disease progression|0|||
131845863|NCT00229723|474718108|FG000|Concomitant Phase|Clinical progression|0|||
131403932|NCT03327220|473101496|FG001|Overall Study|Investigator Decision|0|||
131403933|NCT03327220|473101495|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
131403934|NCT03327220|473101496|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
131403935|NCT03327220|473101495|FG000|Overall Study|Fungal infection|1|||
131403936|NCT03327220|473101496|FG001|Overall Study|Fungal infection|0|||
131403937|NCT03327220|473101495|FG000|Overall Study|Discharged to Rehabilitation|0|||
131403938|NCT03327220|473101496|FG001|Overall Study|Discharged to Rehabilitation|1|||
131403939|NCT03327220|473101495|FG000|Overall Study|Missing|1|||
131403940|NCT03327220|473101496|FG001|Overall Study|Missing|0|||
131403941|NCT00368836|473101499|FG000|Phase II|Screen Failure|1|||
131403942|NCT00368836|473101499|FG000|Phase II|Withdrawal by Subject|1|||
131403943|NCT00368836|473101499|FG000|Phase II|unable to collect blood and/or breath|17|||
131403944|NCT00368836|473101499|FG000|Phase II|Protocol Violation|2|||
131403945|NCT00693017|473101500|FG000|Overall Study|Sponsor Decision|2|||
131403946|NCT00693017|473101501|FG001|Overall Study|Sponsor Decision|1|||
131403947|NCT00693017|473101500|FG000|Overall Study|Death|0|||
131403948|NCT00693017|473101501|FG001|Overall Study|Death|1|||
131403949|NCT01082874|473101502|FG000|Overall Study|Lost to Follow-up|10|||
131403950|NCT01082874|473101503|FG001|Overall Study|Lost to Follow-up|10|||
131403951|NCT01082874|473101504|FG002|Overall Study|Lost to Follow-up|6|||
131403952|NCT01082874|473101505|FG003|Overall Study|Lost to Follow-up|10|||
131403953|NCT01082874|473101502|FG000|Overall Study|Withdrawal by Subject|1|||
131403954|NCT01082874|473101503|FG001|Overall Study|Withdrawal by Subject|2|||
131403955|NCT01082874|473101504|FG002|Overall Study|Withdrawal by Subject|5|||
131403956|NCT01082874|473101505|FG003|Overall Study|Withdrawal by Subject|3|||
131403957|NCT00090142|473101507|FG000|Treatment Period I|Lost to Follow-up|1|||
131403958|NCT00090142|473101508|FG001|Treatment Period I|Lost to Follow-up|2|||
131403959|NCT00090142|473101507|FG000|Treatment Period I|Protocol Violation|2|||
131403960|NCT00090142|473101508|FG001|Treatment Period I|Protocol Violation|0|||
131403961|NCT00090142|473101507|FG000|Treatment Period I|Withdrawal by Subject|2|||
131403962|NCT00090142|473101508|FG001|Treatment Period I|Withdrawal by Subject|0|||
131403963|NCT00090142|473101507|FG000|Treatment Period I|Other|0|||
131403964|NCT00090142|473101508|FG001|Treatment Period I|Other|1|||
131403965|NCT00090142|473101507|FG000|Treatment Period II|Other|1|||
131403966|NCT00090142|473101508|FG001|Treatment Period II|Other|0|||
131403967|NCT02442310|473101509|FG000|Overall Study|Adverse Event|2|||
131403968|NCT02442310|473101509|FG000|Overall Study|Withdrawal by Subject|1|||
131403969|NCT00688324|473101510|FG000|Overall Study|Withdrawal by Subject|2|||
131403970|NCT00688324|473101510|FG000|Overall Study|Physician Decision|5|||
131403971|NCT00688324|473101510|FG000|Overall Study|Lost to Follow-up|1|||
131403972|NCT00006046|473101517|FG000|Overall Study|Adverse Event|3|||
131403973|NCT00006046|473101518|FG001|Overall Study|Adverse Event|0|||
131403974|NCT00006046|473101519|FG002|Overall Study|Adverse Event|0|||
131403975|NCT00006046|473101520|FG003|Overall Study|Adverse Event|0|||
131403976|NCT00006046|473101521|FG004|Overall Study|Adverse Event|0|||
131403977|NCT00006046|473101517|FG000|Overall Study|Disease Progression|2|||
131403978|NCT00006046|473101518|FG001|Overall Study|Disease Progression|0|||
131403979|NCT00006046|473101519|FG002|Overall Study|Disease Progression|0|||
131403980|NCT00006046|473101520|FG003|Overall Study|Disease Progression|0|||
131403981|NCT00006046|473101521|FG004|Overall Study|Disease Progression|0|||
131403982|NCT03176472|473101522|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
131403983|NCT03176472|473101523|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
131403984|NCT03176472|473101522|FG000|Double Blind Treatment Period|Adverse Event|0|||
131403985|NCT03176472|473101523|FG001|Double Blind Treatment Period|Adverse Event|5|||
131403986|NCT03176472|473101522|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
131403987|NCT03176472|473101523|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131403988|NCT03176472|473101522|FG000|Double Blind Treatment Period|Physician Decision|0|||
131403989|NCT03176472|473101523|FG001|Double Blind Treatment Period|Physician Decision|1|||
131403990|NCT03176472|473101522|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131403991|NCT03176472|473101523|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131403992|NCT03176472|473101522|FG000|Double Blind Treatment Period|Not Provided|1|||
131403993|NCT03176472|473101523|FG001|Double Blind Treatment Period|Not Provided|0|||
131403994|NCT03176472|473101522|FG000|Open Label Extension|Withdrawal by Subject|3|||
131845864|NCT00229723|474718109|FG001|Concomitant Phase|Clinical progression|0|||
131845865|NCT00229723|474718110|FG002|Concomitant Phase|Clinical progression|0|||
131845866|NCT00229723|474718111|FG003|Concomitant Phase|Clinical progression|0|||
131845867|NCT00229723|474718112|FG004|Concomitant Phase|Clinical progression|0|||
131845868|NCT00229723|474718113|FG005|Concomitant Phase|Clinical progression|0|||
131403995|NCT03176472|473101523|FG001|Open Label Extension|Withdrawal by Subject|4|||
131403996|NCT03176472|473101522|FG000|Open Label Extension|Adverse Event|2|||
131451255|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
131845869|NCT00229723|474718114|FG006|Concomitant Phase|Clinical progression|1|||
131845870|NCT00229723|474718108|FG000|Concomitant Phase|Lost to Follow-up|0|||
131403997|NCT03176472|473101523|FG001|Open Label Extension|Adverse Event|4|||
131403998|NCT03176472|473101522|FG000|Open Label Extension|Lost to Follow-up|1|||
131403999|NCT03176472|473101523|FG001|Open Label Extension|Lost to Follow-up|2|||
131911199|NCT01991795|474963165|FG001|Overall Study|Lost to Follow-up|4|||
131845871|NCT00229723|474718109|FG001|Concomitant Phase|Lost to Follow-up|0|||
131845872|NCT00229723|474718110|FG002|Concomitant Phase|Lost to Follow-up|0|||
131845873|NCT00229723|474718111|FG003|Concomitant Phase|Lost to Follow-up|0|||
131845874|NCT00229723|474718112|FG004|Concomitant Phase|Lost to Follow-up|1|||
131845875|NCT00229723|474718113|FG005|Concomitant Phase|Lost to Follow-up|0|||
131404000|NCT03176472|473101522|FG000|Open Label Extension|Protocol Violation|0|||
131404001|NCT03176472|473101523|FG001|Open Label Extension|Protocol Violation|1|||
131404002|NCT03176472|473101522|FG000|Open Label Extension|Not Provided|2|||
131404003|NCT03176472|473101523|FG001|Open Label Extension|Not Provided|1|||
131404004|NCT00596154|473101524|FG000|Overall Study|Not Evaluable|2|||
131404005|NCT00642369|473101528|FG000|Overall Study|Adverse Event|2|||
131404006|NCT00642369|473101529|FG001|Overall Study|Adverse Event|3|||
131404007|NCT00642369|473101528|FG000|Overall Study|Withdrawal by Subject|1|||
131404008|NCT00642369|473101529|FG001|Overall Study|Withdrawal by Subject|0|||
131404009|NCT00642369|473101528|FG000|Overall Study|misdiagnosis|0|||
131404010|NCT00642369|473101529|FG001|Overall Study|misdiagnosis|1|||
131404011|NCT00642369|473101528|FG000|Overall Study|Lack of Efficacy|2|||
131404012|NCT00642369|473101529|FG001|Overall Study|Lack of Efficacy|2|||
131404013|NCT00847665|473101530|FG000|Overall Study|Withdrawal by Subject|1|||
131404014|NCT00847665|473101531|FG001|Overall Study|Withdrawal by Subject|0|||
131404015|NCT00585546|473101538|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
131404016|NCT00585546|473101538|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
131404017|NCT04154345|473101545|FG000|Overall Study|Covid-19 pandemic|4|||
131404018|NCT03622112|473101548|FG000|Overall Study|Withdrawal by Subject|6|||
131404019|NCT03622112|473101549|FG001|Overall Study|Withdrawal by Subject|2|||
131404020|NCT03622112|473101550|FG002|Overall Study|Withdrawal by Subject|4|||
131404021|NCT03622112|473101551|FG003|Overall Study|Withdrawal by Subject|2|||
131404022|NCT03622112|473101552|FG004|Overall Study|Withdrawal by Subject|1|||
131404023|NCT03622112|473101553|FG005|Overall Study|Withdrawal by Subject|2|||
131404024|NCT03622112|473101554|FG006|Overall Study|Withdrawal by Subject|2|||
131404025|NCT03622112|473101548|FG000|Overall Study|Death|0|||
131404026|NCT03622112|473101549|FG001|Overall Study|Death|0|||
131404027|NCT03622112|473101550|FG002|Overall Study|Death|0|||
131404028|NCT03622112|473101551|FG003|Overall Study|Death|1|||
131404029|NCT03622112|473101552|FG004|Overall Study|Death|0|||
131404030|NCT03622112|473101553|FG005|Overall Study|Death|0|||
131404031|NCT03622112|473101554|FG006|Overall Study|Death|0|||
131404032|NCT03622112|473101548|FG000|Overall Study|Lost to Follow-up|1|||
131404033|NCT03622112|473101549|FG001|Overall Study|Lost to Follow-up|1|||
131404034|NCT03622112|473101550|FG002|Overall Study|Lost to Follow-up|0|||
131404035|NCT03622112|473101551|FG003|Overall Study|Lost to Follow-up|0|||
131404036|NCT03622112|473101552|FG004|Overall Study|Lost to Follow-up|0|||
131404037|NCT03622112|473101553|FG005|Overall Study|Lost to Follow-up|0|||
131404038|NCT03622112|473101554|FG006|Overall Study|Lost to Follow-up|0|||
131404039|NCT03622112|473101548|FG000|Overall Study|Study-specific withdrawal criteria|10|||
131845876|NCT00229723|474718114|FG006|Concomitant Phase|Lost to Follow-up|0|||
131845877|NCT00229723|474718108|FG000|Concomitant Phase|Informed consent withdrawn|3|||
131845878|NCT00229723|474718109|FG001|Concomitant Phase|Informed consent withdrawn|2|||
131845879|NCT00229723|474718110|FG002|Concomitant Phase|Informed consent withdrawn|0|||
131845880|NCT00229723|474718111|FG003|Concomitant Phase|Informed consent withdrawn|2|||
131845881|NCT00229723|474718112|FG004|Concomitant Phase|Informed consent withdrawn|0|||
131845882|NCT00229723|474718113|FG005|Concomitant Phase|Informed consent withdrawn|0|||
131845883|NCT00229723|474718114|FG006|Concomitant Phase|Informed consent withdrawn|0|||
131845884|NCT00229723|474718108|FG000|Concomitant Phase|Severe non-compliance|0|||
131845885|NCT00229723|474718109|FG001|Concomitant Phase|Severe non-compliance|1|||
131845886|NCT00229723|474718110|FG002|Concomitant Phase|Severe non-compliance|0|||
131845887|NCT00229723|474718111|FG003|Concomitant Phase|Severe non-compliance|0|||
131845888|NCT00229723|474718112|FG004|Concomitant Phase|Severe non-compliance|1|||
131845889|NCT00229723|474718113|FG005|Concomitant Phase|Severe non-compliance|0|||
131845890|NCT00229723|474718114|FG006|Concomitant Phase|Severe non-compliance|0|||
131845891|NCT00229723|474718108|FG000|Concomitant Phase|Other|3|||
131845892|NCT00229723|474718109|FG001|Concomitant Phase|Other|0|||
131845893|NCT00229723|474718110|FG002|Concomitant Phase|Other|1|||
131845894|NCT00229723|474718111|FG003|Concomitant Phase|Other|1|||
131845895|NCT00229723|474718112|FG004|Concomitant Phase|Other|0|||
131845896|NCT00229723|474718113|FG005|Concomitant Phase|Other|2|||
131404040|NCT03622112|473101549|FG001|Overall Study|Study-specific withdrawal criteria|8|||
131845897|NCT00229723|474718114|FG006|Concomitant Phase|Other|0|||
131845898|NCT00229723|474718108|FG000|Maintenance Phase|Adverse Event|7|||
131845899|NCT00229723|474718109|FG001|Maintenance Phase|Adverse Event|2|||
131404041|NCT03622112|473101550|FG002|Overall Study|Study-specific withdrawal criteria|7|||
131845900|NCT00229723|474718110|FG002|Maintenance Phase|Adverse Event|1|||
131845901|NCT00229723|474718111|FG003|Maintenance Phase|Adverse Event|4|||
131845902|NCT00229723|474718112|FG004|Maintenance Phase|Adverse Event|7|||
131404042|NCT03622112|473101551|FG003|Overall Study|Study-specific withdrawal criteria|6|||
131404043|NCT03622112|473101552|FG004|Overall Study|Study-specific withdrawal criteria|4|||
131404044|NCT03622112|473101553|FG005|Overall Study|Study-specific withdrawal criteria|18|||
131404045|NCT03622112|473101554|FG006|Overall Study|Study-specific withdrawal criteria|4|||
131404046|NCT03622112|473101548|FG000|Overall Study|Protocol Violation|2|||
131404047|NCT03622112|473101549|FG001|Overall Study|Protocol Violation|0|||
131404048|NCT03622112|473101550|FG002|Overall Study|Protocol Violation|1|||
131404049|NCT03622112|473101551|FG003|Overall Study|Protocol Violation|1|||
131404050|NCT03622112|473101552|FG004|Overall Study|Protocol Violation|0|||
131404051|NCT03622112|473101553|FG005|Overall Study|Protocol Violation|0|||
131404052|NCT03622112|473101554|FG006|Overall Study|Protocol Violation|0|||
131404053|NCT03622112|473101548|FG000|Overall Study|Adverse Event|6|||
131404054|NCT03622112|473101549|FG001|Overall Study|Adverse Event|8|||
131404055|NCT03622112|473101550|FG002|Overall Study|Adverse Event|4|||
131404056|NCT03622112|473101551|FG003|Overall Study|Adverse Event|11|||
131404057|NCT03622112|473101552|FG004|Overall Study|Adverse Event|4|||
131404058|NCT03622112|473101553|FG005|Overall Study|Adverse Event|20|||
131404059|NCT03622112|473101554|FG006|Overall Study|Adverse Event|2|||
131404060|NCT03622112|473101548|FG000|Overall Study|Reason not specified|0|||
131404061|NCT03622112|473101549|FG001|Overall Study|Reason not specified|1|||
131404062|NCT03622112|473101550|FG002|Overall Study|Reason not specified|0|||
131404063|NCT03622112|473101551|FG003|Overall Study|Reason not specified|1|||
131404064|NCT03622112|473101552|FG004|Overall Study|Reason not specified|1|||
131404065|NCT03622112|473101553|FG005|Overall Study|Reason not specified|2|||
131404066|NCT03622112|473101554|FG006|Overall Study|Reason not specified|1|||
131404067|NCT02210689|473101555|FG000|Overall Study|Withdrawal by Subject|7|||
131404068|NCT02210689|473101556|FG001|Overall Study|Withdrawal by Subject|4|||
131404069|NCT02210689|473101557|FG002|Overall Study|Withdrawal by Subject|2|||
131404070|NCT02210689|473101555|FG000|Overall Study|Adverse Event|0|||
131404071|NCT02210689|473101556|FG001|Overall Study|Adverse Event|1|||
131404072|NCT02210689|473101557|FG002|Overall Study|Adverse Event|0|||
131404073|NCT02210689|473101555|FG000|Overall Study|Protocol Violation|1|||
131404074|NCT02210689|473101556|FG001|Overall Study|Protocol Violation|0|||
131404075|NCT02210689|473101557|FG002|Overall Study|Protocol Violation|0|||
131451256|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
131845903|NCT00229723|474718113|FG005|Maintenance Phase|Adverse Event|5|||
131845904|NCT00229723|474718114|FG006|Maintenance Phase|Adverse Event|2|||
131845905|NCT00229723|474718108|FG000|Maintenance Phase|Objective disease progression|5|||
131845906|NCT00229723|474718109|FG001|Maintenance Phase|Objective disease progression|5|||
131845907|NCT00229723|474718110|FG002|Maintenance Phase|Objective disease progression|3|||
131845908|NCT00229723|474718111|FG003|Maintenance Phase|Objective disease progression|6|||
131845909|NCT00229723|474718112|FG004|Maintenance Phase|Objective disease progression|2|||
131845910|NCT00229723|474718113|FG005|Maintenance Phase|Objective disease progression|9|||
131845911|NCT00229723|474718114|FG006|Maintenance Phase|Objective disease progression|5|||
131845912|NCT00229723|474718108|FG000|Maintenance Phase|Clinical progression|4|||
131845913|NCT00229723|474718109|FG001|Maintenance Phase|Clinical progression|1|||
131845914|NCT00229723|474718110|FG002|Maintenance Phase|Clinical progression|2|||
131845915|NCT00229723|474718111|FG003|Maintenance Phase|Clinical progression|2|||
131845916|NCT00229723|474718112|FG004|Maintenance Phase|Clinical progression|1|||
131845917|NCT00229723|474718113|FG005|Maintenance Phase|Clinical progression|1|||
131845918|NCT00229723|474718114|FG006|Maintenance Phase|Clinical progression|1|||
131845919|NCT00229723|474718108|FG000|Maintenance Phase|Lost to Follow-up|0|||
131845920|NCT00229723|474718109|FG001|Maintenance Phase|Lost to Follow-up|1|||
131845921|NCT00229723|474718110|FG002|Maintenance Phase|Lost to Follow-up|2|||
131845922|NCT00229723|474718111|FG003|Maintenance Phase|Lost to Follow-up|2|||
131845923|NCT00229723|474718112|FG004|Maintenance Phase|Lost to Follow-up|0|||
131845924|NCT00229723|474718113|FG005|Maintenance Phase|Lost to Follow-up|0|||
131845925|NCT00229723|474718114|FG006|Maintenance Phase|Lost to Follow-up|1|||
131845926|NCT00229723|474718108|FG000|Maintenance Phase|Informed consent withdrawn|1|||
131845927|NCT00229723|474718109|FG001|Maintenance Phase|Informed consent withdrawn|0|||
131845928|NCT00229723|474718110|FG002|Maintenance Phase|Informed consent withdrawn|0|||
131845929|NCT00229723|474718111|FG003|Maintenance Phase|Informed consent withdrawn|1|||
131845930|NCT00229723|474718112|FG004|Maintenance Phase|Informed consent withdrawn|1|||
131845931|NCT00229723|474718113|FG005|Maintenance Phase|Informed consent withdrawn|1|||
131845932|NCT00229723|474718114|FG006|Maintenance Phase|Informed consent withdrawn|0|||
131845933|NCT00229723|474718108|FG000|Maintenance Phase|Severe non-compliance|3|||
131845934|NCT00229723|474718109|FG001|Maintenance Phase|Severe non-compliance|1|||
131845935|NCT00229723|474718110|FG002|Maintenance Phase|Severe non-compliance|0|||
131845936|NCT00229723|474718111|FG003|Maintenance Phase|Severe non-compliance|0|||
131404076|NCT02210689|473101555|FG000|Overall Study|Lost to Follow-up|11|||
131404077|NCT02210689|473101556|FG001|Overall Study|Lost to Follow-up|9|||
131404078|NCT02210689|473101557|FG002|Overall Study|Lost to Follow-up|5|||
131404079|NCT02210689|473101555|FG000|Overall Study|Pregnancy|0|||
131404080|NCT02210689|473101556|FG001|Overall Study|Pregnancy|1|||
131404081|NCT02210689|473101557|FG002|Overall Study|Pregnancy|0|||
131451257|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
131451258|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
131404082|NCT02210689|473101555|FG000|Overall Study|Lack of Efficacy|0|||
131404083|NCT02210689|473101556|FG001|Overall Study|Lack of Efficacy|1|||
131911200|NCT01991795|474963164|FG000|Overall Study|Withdrawal by Subject|117|||
131911201|NCT01991795|474963165|FG001|Overall Study|Withdrawal by Subject|94|||
131911202|NCT01991795|474963164|FG000|Overall Study|Site prematurely closed by sponsor|26|||
131911203|NCT01991795|474963165|FG001|Overall Study|Site prematurely closed by sponsor|25|||
131911204|NCT03344757|474963166|FG000|Overall Study|Withdrawal by Subject|18|||
131911205|NCT03344757|474963167|FG001|Overall Study|Withdrawal by Subject|16|||
131911206|NCT03344757|474963166|FG000|Overall Study|Lost to Follow-up|0|||
131911207|NCT03344757|474963167|FG001|Overall Study|Lost to Follow-up|2|||
131911208|NCT04798027|474963173|FG000|Overall Study|Protocol Violation|0|||
131911209|NCT04798027|474963174|FG001|Overall Study|Protocol Violation|0|||
131911210|NCT04798027|474963175|FG002|Overall Study|Protocol Violation|0|||
131911211|NCT04798027|474963176|FG003|Overall Study|Protocol Violation|0|||
131911212|NCT04798027|474963177|FG004|Overall Study|Protocol Violation|1|||
131911213|NCT04798027|474963178|FG005|Overall Study|Protocol Violation|0|||
131911214|NCT04798027|474963179|FG006|Overall Study|Protocol Violation|0|||
131911215|NCT04798027|474963180|FG007|Overall Study|Protocol Violation|1|||
131911216|NCT04798027|474963181|FG008|Overall Study|Protocol Violation|0|||
131911217|NCT04798027|474963173|FG000|Overall Study|Withdrawal by Subject|1|||
131911218|NCT04798027|474963174|FG001|Overall Study|Withdrawal by Subject|0|||
131911219|NCT04798027|474963175|FG002|Overall Study|Withdrawal by Subject|1|||
131911220|NCT04798027|474963176|FG003|Overall Study|Withdrawal by Subject|1|||
131911221|NCT04798027|474963177|FG004|Overall Study|Withdrawal by Subject|1|||
131911222|NCT04798027|474963178|FG005|Overall Study|Withdrawal by Subject|1|||
131911223|NCT04798027|474963179|FG006|Overall Study|Withdrawal by Subject|3|||
131911224|NCT04798027|474963180|FG007|Overall Study|Withdrawal by Subject|2|||
131911225|NCT04798027|474963181|FG008|Overall Study|Withdrawal by Subject|2|||
131911226|NCT04798027|474963173|FG000|Overall Study|Lost to Follow-up|1|||
131911227|NCT04798027|474963174|FG001|Overall Study|Lost to Follow-up|3|||
131911228|NCT04798027|474963175|FG002|Overall Study|Lost to Follow-up|0|||
131911229|NCT04798027|474963176|FG003|Overall Study|Lost to Follow-up|0|||
131911230|NCT04798027|474963177|FG004|Overall Study|Lost to Follow-up|0|||
131911231|NCT04798027|474963178|FG005|Overall Study|Lost to Follow-up|1|||
131911232|NCT04798027|474963179|FG006|Overall Study|Lost to Follow-up|0|||
131911233|NCT04798027|474963180|FG007|Overall Study|Lost to Follow-up|0|||
131911234|NCT04798027|474963181|FG008|Overall Study|Lost to Follow-up|1|||
131911235|NCT04798027|474963173|FG000|Overall Study|Withdrawal by Sponsor|8|||
131911236|NCT04798027|474963174|FG001|Overall Study|Withdrawal by Sponsor|22|||
131911237|NCT04798027|474963175|FG002|Overall Study|Withdrawal by Sponsor|9|||
131911238|NCT04798027|474963176|FG003|Overall Study|Withdrawal by Sponsor|26|||
131911239|NCT04798027|474963177|FG004|Overall Study|Withdrawal by Sponsor|24|||
131911240|NCT04798027|474963178|FG005|Overall Study|Withdrawal by Sponsor|11|||
131911241|NCT04798027|474963179|FG006|Overall Study|Withdrawal by Sponsor|25|||
131911242|NCT04798027|474963180|FG007|Overall Study|Withdrawal by Sponsor|26|||
131911243|NCT04798027|474963181|FG008|Overall Study|Withdrawal by Sponsor|11|||
131911244|NCT03104374|474963182|FG000|Period 1|Adverse Event|7|||
131911245|NCT03104374|474963183|FG001|Period 1|Adverse Event|7|||
131911246|NCT03104374|474963184|FG002|Period 1|Adverse Event|12|||
131911247|NCT03104374|474963185|FG003|Period 1|Adverse Event|14|||
131911248|NCT03104374|474963182|FG000|Period 1|Withdrawal by Subject|18|||
131911249|NCT03104374|474963183|FG001|Period 1|Withdrawal by Subject|9|||
131911250|NCT03104374|474963184|FG002|Period 1|Withdrawal by Subject|10|||
131404084|NCT02210689|473101557|FG002|Overall Study|Lack of Efficacy|5|||
131404085|NCT02210689|473101555|FG000|Overall Study|Prohibited medication|2|||
131404086|NCT02210689|473101556|FG001|Overall Study|Prohibited medication|8|||
131404087|NCT02210689|473101557|FG002|Overall Study|Prohibited medication|1|||
131404088|NCT02210689|473101555|FG000|Overall Study|Negative Nugent score at baseline|6|||
131404089|NCT02210689|473101556|FG001|Overall Study|Negative Nugent score at baseline|2|||
131404090|NCT02210689|473101557|FG002|Overall Study|Negative Nugent score at baseline|2|||
131404091|NCT02210689|473101555|FG000|Overall Study|Other|25|||
131404092|NCT02210689|473101556|FG001|Overall Study|Other|21|||
131404093|NCT02210689|473101557|FG002|Overall Study|Other|8|||
131404094|NCT00866047|473101558|FG000|Treatment Period|Progressive disease|13|||
131404095|NCT00866047|473101558|FG000|Treatment Period|Adverse Event|16|||
131404096|NCT00866047|473101558|FG000|Treatment Period|Physician Decision|14|||
131911251|NCT03104374|474963185|FG003|Period 1|Withdrawal by Subject|17|||
131911252|NCT03104374|474963182|FG000|Period 1|Lost to Follow-up|4|||
131911253|NCT03104374|474963183|FG001|Period 1|Lost to Follow-up|4|||
131911254|NCT03104374|474963184|FG002|Period 1|Lost to Follow-up|6|||
131911255|NCT03104374|474963185|FG003|Period 1|Lost to Follow-up|8|||
131911256|NCT03104374|474963182|FG000|Period 1|Lack of Efficacy|6|||
131911257|NCT03104374|474963183|FG001|Period 1|Lack of Efficacy|7|||
131911258|NCT03104374|474963184|FG002|Period 1|Lack of Efficacy|12|||
131404097|NCT00866047|473101558|FG000|Treatment Period|Withdrawal by Subject|5|||
131911259|NCT03104374|474963185|FG003|Period 1|Lack of Efficacy|6|||
131911260|NCT03104374|474963182|FG000|Period 1|Other|2|||
131911261|NCT03104374|474963183|FG001|Period 1|Other|2|||
131911262|NCT03104374|474963184|FG002|Period 1|Other|4|||
131911263|NCT03104374|474963185|FG003|Period 1|Other|7|||
131911264|NCT03104374|474963182|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
131451259|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
131451260|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
131451261|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
131451262|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
131451263|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131451264|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131451265|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131845937|NCT00229723|474718112|FG004|Maintenance Phase|Severe non-compliance|1|||
131845938|NCT00229723|474718113|FG005|Maintenance Phase|Severe non-compliance|0|||
131845939|NCT00229723|474718114|FG006|Maintenance Phase|Severe non-compliance|0|||
131845940|NCT00229723|474718108|FG000|Maintenance Phase|Other|5|||
131845941|NCT00229723|474718109|FG001|Maintenance Phase|Other|4|||
131845942|NCT00229723|474718110|FG002|Maintenance Phase|Other|1|||
131845943|NCT00229723|474718111|FG003|Maintenance Phase|Other|2|||
131845944|NCT00229723|474718112|FG004|Maintenance Phase|Other|3|||
131845945|NCT00229723|474718113|FG005|Maintenance Phase|Other|3|||
131845946|NCT00229723|474718114|FG006|Maintenance Phase|Other|1|||
131845947|NCT00735397|474718117|FG000|Overall Study|Adverse Event|194|||
131845948|NCT00735397|474718117|FG000|Overall Study|Lost to Follow-up|33|||
131845949|NCT00735397|474718117|FG000|Overall Study|Participant choice|252|||
131845950|NCT00735397|474718117|FG000|Overall Study|Inadequate therapeutic effect|202|||
131845951|NCT00735397|474718117|FG000|Overall Study|Administrative/Other|502|||
131845952|NCT03016975|474718122|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
131845953|NCT03016975|474718123|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
131845954|NCT03016975|474718124|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
131845955|NCT03016975|474718122|FG000|At 6 Months Follow-up|Death|2|||
131845956|NCT03016975|474718123|FG001|At 6 Months Follow-up|Death|0|||
131845957|NCT03016975|474718124|FG002|At 6 Months Follow-up|Death|0|||
131845958|NCT03016975|474718122|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
131845959|NCT03016975|474718123|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
131845960|NCT03016975|474718124|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
131845961|NCT03016975|474718122|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
131845962|NCT03016975|474718123|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
131845963|NCT03016975|474718124|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
131845964|NCT03016975|474718122|FG000|At 6 Months Follow-up|Aborted implant|1|||
131845965|NCT03016975|474718123|FG001|At 6 Months Follow-up|Aborted implant|0|||
131845966|NCT03016975|474718124|FG002|At 6 Months Follow-up|Aborted implant|0|||
131845967|NCT03016975|474718122|FG000|At 2 Year Follow-up|Death|1|||
131845968|NCT03016975|474718123|FG001|At 2 Year Follow-up|Death|0|||
131845969|NCT03016975|474718124|FG002|At 2 Year Follow-up|Death|0|||
131845970|NCT03016975|474718122|FG000|At 3 Year Follow-up|Death|1|||
131845971|NCT03016975|474718123|FG001|At 3 Year Follow-up|Death|0|||
131845972|NCT03016975|474718124|FG002|At 3 Year Follow-up|Death|0|||
131845973|NCT03016975|474718122|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
131845974|NCT03016975|474718123|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
131845975|NCT03016975|474718124|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
131845976|NCT03016975|474718122|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
131845977|NCT03016975|474718123|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
131845978|NCT03016975|474718124|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
131845979|NCT01590797|474718127|FG000|Overall Study|Adverse Event|4|||
131845980|NCT01590797|474718128|FG001|Overall Study|Adverse Event|3|||
131845981|NCT01590797|474718127|FG000|Overall Study|Lack of Efficacy|0|||
131845982|NCT01590797|474718128|FG001|Overall Study|Lack of Efficacy|2|||
131845983|NCT01590797|474718127|FG000|Overall Study|Lost to Follow-up|0|||
131845984|NCT01590797|474718128|FG001|Overall Study|Lost to Follow-up|1|||
131845985|NCT01590797|474718127|FG000|Overall Study|Protocol Violation|4|||
131845986|NCT01590797|474718128|FG001|Overall Study|Protocol Violation|1|||
131845987|NCT01590797|474718127|FG000|Overall Study|Withdrawal by Subject|7|||
131845988|NCT01590797|474718128|FG001|Overall Study|Withdrawal by Subject|5|||
131845989|NCT01590797|474718127|FG000|Overall Study|Other Protocol Specified Criteria|2|||
131845990|NCT01590797|474718128|FG001|Overall Study|Other Protocol Specified Criteria|4|||
131845991|NCT01559389|474718132|FG000|Overall Study|Withdrawal by Subject|20|||
131845992|NCT01559389|474718133|FG001|Overall Study|Withdrawal by Subject|20|||
131845993|NCT02871492|474718134|FG000|Overall Study|Lost to Follow-up|6|||
131845994|NCT02871492|474718135|FG001|Overall Study|Lost to Follow-up|3|||
131845995|NCT02871492|474718136|FG002|Overall Study|Lost to Follow-up|5|||
131845996|NCT02871492|474718134|FG000|Overall Study|Withdrawal by Subject|0|||
131845997|NCT02871492|474718135|FG001|Overall Study|Withdrawal by Subject|0|||
131845998|NCT02871492|474718136|FG002|Overall Study|Withdrawal by Subject|1|||
131845999|NCT01228019|474718137|FG000|Overall Study|Dose Violation|70|||
131846000|NCT01228019|474718137|FG000|Overall Study|Duplicate enrollment|1|||
131846001|NCT01228019|474718137|FG000|Overall Study|Missing pre-treatment data|72|||
131846002|NCT01228019|474718137|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
131846003|NCT01228019|474718137|FG000|Overall Study|Violation of Entry Criterion|9|||
131846004|NCT03503864|474718139|FG000|Overall Study|Protocol Violation|6|||
131451266|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
131846005|NCT03503864|474718139|FG000|Overall Study|Withdrawal by Subject|7|||
131846006|NCT04642365|474718149|FG000|Overall Study|Death|3|||
131846007|NCT04642365|474718150|FG001|Overall Study|Death|2|||
131846008|NCT04642365|474718151|FG002|Overall Study|Death|4|||
131404098|NCT00866047|473101558|FG000|Follow-up Period|Lost to Follow-up|5|||
131404099|NCT01610713|473101559|FG000|Overall Study|Adverse Event|3|||
131404100|NCT01610713|473101560|FG001|Overall Study|Adverse Event|0|||
131404101|NCT01610713|473101559|FG000|Overall Study|Lack of Efficacy|1|||
131404102|NCT01610713|473101560|FG001|Overall Study|Lack of Efficacy|0|||
131404103|NCT01610713|473101559|FG000|Overall Study|low mood and poor motivation|1|||
131404104|NCT01610713|473101560|FG001|Overall Study|low mood and poor motivation|0|||
131404105|NCT01610713|473101559|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
131404106|NCT01610713|473101560|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
131404107|NCT01610713|473101559|FG000|Overall Study|Lost to Follow-up|0|||
131404108|NCT01610713|473101560|FG001|Overall Study|Lost to Follow-up|1|||
131404109|NCT03770728|473101562|FG000|Overall Study|Adverse Event|1|||
131404110|NCT03770728|473101563|FG001|Overall Study|Adverse Event|0|||
131404111|NCT03770728|473101564|FG002|Overall Study|Adverse Event|1|||
131404112|NCT03770728|473101565|FG003|Overall Study|Adverse Event|0|||
131404113|NCT03770728|473101562|FG000|Overall Study|Poor compliance to protocol|0|||
131404114|NCT03770728|473101563|FG001|Overall Study|Poor compliance to protocol|0|||
131404115|NCT03770728|473101564|FG002|Overall Study|Poor compliance to protocol|1|||
131404116|NCT03770728|473101565|FG003|Overall Study|Poor compliance to protocol|0|||
131404117|NCT03770728|473101562|FG000|Overall Study|Withdrawal by Subject|13|||
131404118|NCT03770728|473101563|FG001|Overall Study|Withdrawal by Subject|8|||
131404119|NCT03770728|473101564|FG002|Overall Study|Withdrawal by Subject|9|||
131404120|NCT03770728|473101565|FG003|Overall Study|Withdrawal by Subject|13|||
131404121|NCT03770728|473101562|FG000|Overall Study|Other than specified|24|||
131404122|NCT03770728|473101563|FG001|Overall Study|Other than specified|23|||
131404123|NCT03770728|473101564|FG002|Overall Study|Other than specified|21|||
131404124|NCT03770728|473101565|FG003|Overall Study|Other than specified|22|||
131404125|NCT00503776|473101566|FG000|Overall Study|Withdrawal by Subject|1|||
131404126|NCT00503776|473101567|FG001|Overall Study|Withdrawal by Subject|0|||
131404127|NCT00503776|473101568|FG002|Overall Study|Withdrawal by Subject|1|||
131404128|NCT00503776|473101569|FG003|Overall Study|Withdrawal by Subject|1|||
131404129|NCT00503776|473101566|FG000|Overall Study|Physician Decision|0|||
131404130|NCT00503776|473101567|FG001|Overall Study|Physician Decision|0|||
131404131|NCT00503776|473101568|FG002|Overall Study|Physician Decision|1|||
131404132|NCT00503776|473101569|FG003|Overall Study|Physician Decision|1|||
131404133|NCT02778555|473101570|FG000|Overall Study|Withdrawal by Subject|55|||
131404134|NCT02778555|473101571|FG001|Overall Study|Withdrawal by Subject|32|||
131404135|NCT02778555|473101572|FG002|Overall Study|Withdrawal by Subject|107|||
131404136|NCT02379988|473101573|FG000|Overall Study|Not eligible|1|||
131404137|NCT01534260|473101574|FG000|Overall Study|Adverse Event|1|||
131404138|NCT01534260|473101575|FG001|Overall Study|Adverse Event|8|||
131404139|NCT01534260|473101574|FG000|Overall Study|Death|2|||
131404140|NCT01534260|473101575|FG001|Overall Study|Death|0|||
131404141|NCT01534260|473101574|FG000|Overall Study|Lack of Efficacy|1|||
131404142|NCT01534260|473101575|FG001|Overall Study|Lack of Efficacy|1|||
131404143|NCT01534260|473101574|FG000|Overall Study|Withdrawal by Subject|1|||
131404144|NCT01534260|473101575|FG001|Overall Study|Withdrawal by Subject|3|||
131404145|NCT01534260|473101574|FG000|Overall Study|Disease Progression|8|||
131404146|NCT01534260|473101575|FG001|Overall Study|Disease Progression|6|||
131404147|NCT01534260|473101574|FG000|Overall Study|Physician Decision|3|||
131404148|NCT01534260|473101575|FG001|Overall Study|Physician Decision|1|||
131404149|NCT01534260|473101574|FG000|Overall Study|No treatment, per protocol|0|||
131404150|NCT01534260|473101575|FG001|Overall Study|No treatment, per protocol|1|||
131404151|NCT01639339|473101578|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
131404152|NCT01639339|473101579|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
131404153|NCT01639339|473101578|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
131404154|NCT01639339|473101579|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
131404155|NCT01639339|473101578|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
131404156|NCT01639339|473101579|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
131404157|NCT01639339|473101578|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
131404158|NCT01639339|473101579|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
131404159|NCT01639339|473101578|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
131404160|NCT01639339|473101579|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
131404161|NCT01639339|473101578|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
131404162|NCT01639339|473101579|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
131404163|NCT01639339|473101578|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
131404164|NCT01639339|473101579|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
131404165|NCT01639339|473101578|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
131404166|NCT01639339|473101579|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
131846009|NCT04642365|474718152|FG003|Overall Study|Death|5|||
131404167|NCT01639339|473101578|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
131404168|NCT01639339|473101579|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
131404169|NCT01639339|473101578|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
131846010|NCT04642365|474718153|FG004|Overall Study|Death|5|||
131846011|NCT04642365|474718154|FG005|Overall Study|Death|3|||
131846012|NCT04642365|474718155|FG006|Overall Study|Death|2|||
131846013|NCT04642365|474718156|FG007|Overall Study|Death|1|||
131846014|NCT04642365|474718149|FG000|Overall Study|Physician Decision|1|||
131846015|NCT04642365|474718150|FG001|Overall Study|Physician Decision|0|||
131846016|NCT04642365|474718151|FG002|Overall Study|Physician Decision|0|||
131846017|NCT04642365|474718152|FG003|Overall Study|Physician Decision|0|||
131846018|NCT04642365|474718153|FG004|Overall Study|Physician Decision|0|||
131846019|NCT04642365|474718154|FG005|Overall Study|Physician Decision|0|||
131846020|NCT04642365|474718155|FG006|Overall Study|Physician Decision|0|||
131846021|NCT04642365|474718156|FG007|Overall Study|Physician Decision|0|||
131846022|NCT04642365|474718149|FG000|Overall Study|Progressive Disease|1|||
131846023|NCT04642365|474718150|FG001|Overall Study|Progressive Disease|1|||
131846024|NCT04642365|474718151|FG002|Overall Study|Progressive Disease|1|||
131846025|NCT04642365|474718152|FG003|Overall Study|Progressive Disease|0|||
131846026|NCT04642365|474718153|FG004|Overall Study|Progressive Disease|0|||
131846027|NCT04642365|474718154|FG005|Overall Study|Progressive Disease|0|||
131846028|NCT04642365|474718155|FG006|Overall Study|Progressive Disease|1|||
131846029|NCT04642365|474718156|FG007|Overall Study|Progressive Disease|0|||
131846030|NCT04642365|474718149|FG000|Overall Study|Study Terminated By Sponsor|0|||
131846031|NCT04642365|474718150|FG001|Overall Study|Study Terminated By Sponsor|2|||
131846032|NCT04642365|474718151|FG002|Overall Study|Study Terminated By Sponsor|1|||
131846033|NCT04642365|474718152|FG003|Overall Study|Study Terminated By Sponsor|1|||
131846034|NCT04642365|474718153|FG004|Overall Study|Study Terminated By Sponsor|1|||
131846035|NCT04642365|474718154|FG005|Overall Study|Study Terminated By Sponsor|2|||
131846036|NCT04642365|474718155|FG006|Overall Study|Study Terminated By Sponsor|2|||
131846037|NCT04642365|474718156|FG007|Overall Study|Study Terminated By Sponsor|1|||
131846038|NCT04642365|474718149|FG000|Overall Study|Symptomatic Deterioration|1|||
131846039|NCT04642365|474718150|FG001|Overall Study|Symptomatic Deterioration|1|||
131846040|NCT04642365|474718151|FG002|Overall Study|Symptomatic Deterioration|0|||
131846041|NCT04642365|474718152|FG003|Overall Study|Symptomatic Deterioration|0|||
131846042|NCT04642365|474718153|FG004|Overall Study|Symptomatic Deterioration|0|||
131846043|NCT04642365|474718154|FG005|Overall Study|Symptomatic Deterioration|1|||
131846044|NCT04642365|474718155|FG006|Overall Study|Symptomatic Deterioration|0|||
131846045|NCT04642365|474718156|FG007|Overall Study|Symptomatic Deterioration|0|||
131846046|NCT04642365|474718149|FG000|Overall Study|Withdrawal by Subject|0|||
131846047|NCT04642365|474718150|FG001|Overall Study|Withdrawal by Subject|0|||
131846048|NCT04642365|474718151|FG002|Overall Study|Withdrawal by Subject|1|||
131846049|NCT04642365|474718152|FG003|Overall Study|Withdrawal by Subject|1|||
131846050|NCT04642365|474718153|FG004|Overall Study|Withdrawal by Subject|0|||
131846051|NCT04642365|474718154|FG005|Overall Study|Withdrawal by Subject|0|||
131846052|NCT04642365|474718155|FG006|Overall Study|Withdrawal by Subject|2|||
131846053|NCT04642365|474718156|FG007|Overall Study|Withdrawal by Subject|0|||
131846054|NCT04642365|474718149|FG000|Overall Study|Adverse Event|0|||
131846055|NCT04642365|474718150|FG001|Overall Study|Adverse Event|0|||
131846056|NCT04642365|474718151|FG002|Overall Study|Adverse Event|0|||
131404170|NCT01639339|473101579|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
131404171|NCT03022097|473101581|FG000|Overall Study|Adverse Event|3|||
131404172|NCT03022097|473101582|FG001|Overall Study|Adverse Event|4|||
131404173|NCT03022097|473101583|FG002|Overall Study|Adverse Event|1|||
131404174|NCT03022097|473101584|FG003|Overall Study|Adverse Event|3|||
131404175|NCT03022097|473101581|FG000|Overall Study|Progressive Disease|2|||
131404176|NCT03022097|473101582|FG001|Overall Study|Progressive Disease|0|||
131404177|NCT03022097|473101583|FG002|Overall Study|Progressive Disease|5|||
131404178|NCT03022097|473101584|FG003|Overall Study|Progressive Disease|2|||
131404179|NCT03022097|473101581|FG000|Overall Study|Lack of Efficacy|0|||
131846057|NCT04642365|474718152|FG003|Overall Study|Adverse Event|0|||
131846058|NCT04642365|474718153|FG004|Overall Study|Adverse Event|0|||
131846059|NCT04642365|474718154|FG005|Overall Study|Adverse Event|0|||
131846060|NCT04642365|474718155|FG006|Overall Study|Adverse Event|0|||
131846061|NCT04642365|474718156|FG007|Overall Study|Adverse Event|1|||
131846062|NCT01144715|474718157|FG000|Overall Study|Lost to Follow-up|2|||
131846063|NCT01144715|474718158|FG001|Overall Study|Lost to Follow-up|1|||
131846064|NCT01144715|474718157|FG000|Overall Study|Withdrawal by Subject|2|||
131846065|NCT01144715|474718158|FG001|Overall Study|Withdrawal by Subject|1|||
131846066|NCT01144715|474718157|FG000|Overall Study|Adverse Event|0|||
131404180|NCT03022097|473101582|FG001|Overall Study|Lack of Efficacy|0|||
131404181|NCT03022097|473101583|FG002|Overall Study|Lack of Efficacy|3|||
131404182|NCT03022097|473101584|FG003|Overall Study|Lack of Efficacy|3|||
131451267|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131846067|NCT01144715|474718158|FG001|Overall Study|Adverse Event|1|||
131846068|NCT06281171|474718159|FG000|Timepoint 2|Lost to Follow-up|6|||
131846069|NCT06281171|474718160|FG001|Timepoint 2|Lost to Follow-up|4|||
131846070|NCT06281171|474718159|FG000|Timepoint 3|Lost to Follow-up|0|||
131404183|NCT03022097|473101581|FG000|Overall Study|Protocol Violation|1|||
131404184|NCT03022097|473101582|FG001|Overall Study|Protocol Violation|0|||
131404185|NCT03022097|473101583|FG002|Overall Study|Protocol Violation|1|||
131404186|NCT03022097|473101584|FG003|Overall Study|Protocol Violation|0|||
131404187|NCT03022097|473101581|FG000|Overall Study|Withdrawal by Subject|11|||
131404188|NCT03022097|473101582|FG001|Overall Study|Withdrawal by Subject|13|||
131404189|NCT03022097|473101583|FG002|Overall Study|Withdrawal by Subject|15|||
131404190|NCT03022097|473101584|FG003|Overall Study|Withdrawal by Subject|21|||
131404191|NCT03022097|473101581|FG000|Overall Study|Lost to Follow-up|0|||
131404192|NCT03022097|473101582|FG001|Overall Study|Lost to Follow-up|0|||
131404193|NCT03022097|473101583|FG002|Overall Study|Lost to Follow-up|1|||
131404194|NCT03022097|473101584|FG003|Overall Study|Lost to Follow-up|1|||
131404195|NCT03022097|473101581|FG000|Overall Study|Other|4|||
131404196|NCT03022097|473101582|FG001|Overall Study|Other|1|||
131404197|NCT03022097|473101583|FG002|Overall Study|Other|6|||
131404198|NCT03022097|473101584|FG003|Overall Study|Other|4|||
131404199|NCT03022097|473101581|FG000|Overall Study|Due to COVID-19 pandemic|0|||
131404200|NCT03022097|473101582|FG001|Overall Study|Due to COVID-19 pandemic|1|||
131404201|NCT03022097|473101583|FG002|Overall Study|Due to COVID-19 pandemic|0|||
131404202|NCT03022097|473101584|FG003|Overall Study|Due to COVID-19 pandemic|0|||
131404203|NCT05593913|473101589|FG000|Overall Study|Insufficient image quality|39|||
131404204|NCT04470908|473101592|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
131404205|NCT04376684|473101593|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
131404206|NCT04376684|473101594|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
131404207|NCT04376684|473101595|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
131404208|NCT04376684|473101596|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
131404209|NCT04376684|473101593|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
131404210|NCT04376684|473101594|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
131404211|NCT04376684|473101595|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
131404212|NCT04376684|473101596|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
131404213|NCT04376684|473101593|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
131404214|NCT04376684|473101594|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
131404215|NCT04376684|473101595|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
131404216|NCT04376684|473101596|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
131404217|NCT04376684|473101593|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
131404218|NCT04376684|473101594|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
131404219|NCT04376684|473101595|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
131404220|NCT04376684|473101596|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
131404221|NCT04376684|473101593|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
131404222|NCT04376684|473101594|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
131404223|NCT04376684|473101595|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
131404224|NCT04376684|473101596|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
131404225|NCT04376684|473101593|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
131404226|NCT04376684|473101594|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
131404227|NCT04376684|473101595|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
131404228|NCT04376684|473101596|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
131404229|NCT04376684|473101593|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
131404230|NCT04376684|473101594|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
131404231|NCT04376684|473101595|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
131404232|NCT04376684|473101596|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
131404233|NCT02979093|473101599|FG000|First Scan Session|Scanning data problems|1|||
131404234|NCT02979093|473101600|FG001|First Scan Session|Scanning data problems|2|||
131404235|NCT02979093|473101601|FG002|First Scan Session|Scanning data problems|2|||
131404236|NCT02979093|473101602|FG003|First Scan Session|Scanning data problems|0|||
131404237|NCT02979093|473101599|FG000|Second Scan Session|Scanning data problems|3|||
131404238|NCT02979093|473101600|FG001|Second Scan Session|Scanning data problems|0|||
131404239|NCT02979093|473101601|FG002|Second Scan Session|Scanning data problems|1|||
131404240|NCT02979093|473101602|FG003|Second Scan Session|Scanning data problems|3|||
131404241|NCT04173260|473101603|FG000|Overall Study|Early termination|4|||
131404242|NCT02136680|473101606|FG000|Overall Study|No Longer Interested|1|||
131404243|NCT02136680|473101607|FG001|Overall Study|No Longer Interested|1|||
131846071|NCT06281171|474718160|FG001|Timepoint 3|Lost to Follow-up|5|||
131404244|NCT02136680|473101606|FG000|Overall Study|No longer receiving care at clinic|3|||
131404245|NCT02136680|473101607|FG001|Overall Study|No longer receiving care at clinic|5|||
131404246|NCT02136680|473101606|FG000|Overall Study|Moved away|5|||
131404247|NCT02136680|473101607|FG001|Overall Study|Moved away|4|||
131404248|NCT02136680|473101606|FG000|Overall Study|Unable to schedule|17|||
131404249|NCT02136680|473101607|FG001|Overall Study|Unable to schedule|16|||
131404250|NCT02136680|473101606|FG000|Overall Study|Study ended before interview due|6|||
131404251|NCT02136680|473101607|FG001|Overall Study|Study ended before interview due|3|||
131404252|NCT01457014|473101608|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
131404253|NCT01457014|473101609|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
131404254|NCT01457014|473101610|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
131451268|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131404255|NCT01457014|473101611|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
131404256|NCT01457014|473101608|FG000|First Night|Withdrawal by Subject|3|||
131404257|NCT01457014|473101609|FG001|First Night|Withdrawal by Subject|0|||
131404258|NCT01457014|473101610|FG002|First Night|Withdrawal by Subject|0|||
131404259|NCT01457014|473101611|FG003|First Night|Withdrawal by Subject|0|||
131404260|NCT05463744|473101612|FG000|Treatment Period|Withdrawal by Subject|19|||
131404261|NCT05463744|473101613|FG001|Treatment Period|Withdrawal by Subject|16|||
131404262|NCT05463744|473101612|FG000|Treatment Period|Adverse Event|4|||
131404263|NCT05463744|473101613|FG001|Treatment Period|Adverse Event|4|||
131404264|NCT05463744|473101612|FG000|Treatment Period|Pregnancy|0|||
131404265|NCT05463744|473101613|FG001|Treatment Period|Pregnancy|3|||
131404266|NCT05463744|473101612|FG000|Treatment Period|Lost to Follow-up|1|||
131404267|NCT05463744|473101613|FG001|Treatment Period|Lost to Follow-up|3|||
131404268|NCT05463744|473101612|FG000|Treatment Period|Inadvertent enrollment|2|||
131404269|NCT05463744|473101613|FG001|Treatment Period|Inadvertent enrollment|1|||
131404270|NCT05463744|473101612|FG000|Treatment Period|Death|0|||
131404271|NCT05463744|473101613|FG001|Treatment Period|Death|1|||
131404272|NCT05463744|473101612|FG000|Treatment Period|Non-compliance with Study Drug|1|||
131404273|NCT05463744|473101613|FG001|Treatment Period|Non-compliance with Study Drug|0|||
131404274|NCT05463744|473101612|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
131404275|NCT05463744|473101613|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
131404276|NCT05463744|473101612|FG000|Treatment Period|Physician Decision|0|||
131404277|NCT05463744|473101613|FG001|Treatment Period|Physician Decision|1|||
131404278|NCT05463744|473101612|FG000|Follow-Up Period|Withdrawal by Subject|3|||
131404279|NCT05463744|473101613|FG001|Follow-Up Period|Withdrawal by Subject|1|||
131404280|NCT05463744|473101612|FG000|Follow-Up Period|Lost to Follow-up|1|||
131404281|NCT05463744|473101613|FG001|Follow-Up Period|Lost to Follow-up|1|||
131404282|NCT02825420|473101616|FG000|Overall Study|Death|30|||
131404283|NCT02825420|473101617|FG001|Overall Study|Death|12|||
131404284|NCT02825420|473101616|FG000|Overall Study|Progressive disease|6|||
131404285|NCT02825420|473101617|FG001|Overall Study|Progressive disease|1|||
131404286|NCT02825420|473101616|FG000|Overall Study|Lost to Follow-up|2|||
131404287|NCT02825420|473101617|FG001|Overall Study|Lost to Follow-up|2|||
131404288|NCT02825420|473101616|FG000|Overall Study|Withdrawal by Subject|1|||
131404289|NCT02825420|473101617|FG001|Overall Study|Withdrawal by Subject|1|||
131404290|NCT02825420|473101616|FG000|Overall Study|Protocol amendment not signed|1|||
131404291|NCT02825420|473101617|FG001|Overall Study|Protocol amendment not signed|1|||
131404292|NCT02825420|473101616|FG000|Overall Study|Physician Decision|1|||
131404293|NCT02825420|473101617|FG001|Overall Study|Physician Decision|0|||
131404294|NCT02825420|473101616|FG000|Overall Study|Did not receive PLD|2|||
131404295|NCT02825420|473101617|FG001|Overall Study|Did not receive PLD|0|||
131404296|NCT04027049|473101618|FG000|Overall Study|Withdrawn by family|1|||
131404297|NCT04027049|473101619|FG001|Overall Study|Withdrawn by family|0|||
131404298|NCT04027049|473101618|FG000|Overall Study|Participant safety|1|||
131404299|NCT04027049|473101619|FG001|Overall Study|Participant safety|0|||
131404300|NCT04143217|473103684|FG000|Overall Study|Withdrawal by Subject|42|||
131404301|NCT04143217|473103684|FG000|Overall Study|Adverse Event|29|||
131404302|NCT04143217|473103684|FG000|Overall Study|Lost to Follow-up|29|||
131404303|NCT04143217|473103684|FG000|Overall Study|Lack of Efficacy|15|||
131404304|NCT04143217|473103684|FG000|Overall Study|Physician Decision|1|||
131404305|NCT04143217|473103684|FG000|Overall Study|Non-Compliance With Study Drug|6|||
131404306|NCT04143217|473103684|FG000|Overall Study|Other, Multiple Categories|11|||
131404307|NCT02264665|473103685|FG000|Overall Study|Other|0|||
131404308|NCT02264665|473103686|FG001|Overall Study|Other|0|||
131404309|NCT02264665|473103687|FG002|Overall Study|Other|3|||
131404310|NCT02264665|473103688|FG003|Overall Study|Other|0|||
131404311|NCT02264665|473103689|FG004|Overall Study|Other|0|||
131404312|NCT02264665|473103690|FG005|Overall Study|Other|0|||
131404313|NCT02264665|473103691|FG006|Overall Study|Other|0|||
131404314|NCT02264665|473103685|FG000|Overall Study|Death|9|||
131404315|NCT02264665|473103686|FG001|Overall Study|Death|8|||
131404316|NCT02264665|473103687|FG002|Overall Study|Death|13|||
131404317|NCT02264665|473103688|FG003|Overall Study|Death|5|||
131404318|NCT02264665|473103689|FG004|Overall Study|Death|0|||
131404319|NCT02264665|473103690|FG005|Overall Study|Death|0|||
131404320|NCT02264665|473103691|FG006|Overall Study|Death|1|||
131404321|NCT02264665|473103685|FG000|Overall Study|Lost to Follow-up|1|||
131404322|NCT02264665|473103686|FG001|Overall Study|Lost to Follow-up|0|||
131404323|NCT02264665|473103687|FG002|Overall Study|Lost to Follow-up|2|||
131404324|NCT02264665|473103688|FG003|Overall Study|Lost to Follow-up|1|||
131451269|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
131451270|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
131451271|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
131451272|NCT01106690|473281504|FG000|Core Period: Baseline to Week 26|Other|10|||
131404325|NCT02264665|473103689|FG004|Overall Study|Lost to Follow-up|0|||
131404326|NCT02264665|473103690|FG005|Overall Study|Lost to Follow-up|0|||
131404327|NCT02264665|473103691|FG006|Overall Study|Lost to Follow-up|0|||
131404328|NCT02264665|473103685|FG000|Overall Study|Participant decision|0|||
131404329|NCT02264665|473103686|FG001|Overall Study|Participant decision|0|||
131404330|NCT02264665|473103687|FG002|Overall Study|Participant decision|0|||
131404331|NCT02264665|473103688|FG003|Overall Study|Participant decision|1|||
131404332|NCT02264665|473103689|FG004|Overall Study|Participant decision|0|||
131404333|NCT02264665|473103690|FG005|Overall Study|Participant decision|0|||
131404334|NCT02264665|473103691|FG006|Overall Study|Participant decision|0|||
131404335|NCT02264665|473103685|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
131404336|NCT02264665|473103686|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
131404337|NCT02264665|473103687|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
131404338|NCT02264665|473103688|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
131404339|NCT02264665|473103689|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
131404340|NCT02264665|473103690|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
131404341|NCT02264665|473103691|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
131404342|NCT02264665|473103685|FG000|Overall Study|Data Missing|0|||
131404343|NCT02264665|473103686|FG001|Overall Study|Data Missing|0|||
131404344|NCT02264665|473103687|FG002|Overall Study|Data Missing|1|||
131404345|NCT02264665|473103688|FG003|Overall Study|Data Missing|0|||
131404346|NCT02264665|473103689|FG004|Overall Study|Data Missing|0|||
131404347|NCT02264665|473103690|FG005|Overall Study|Data Missing|0|||
131404348|NCT02264665|473103691|FG006|Overall Study|Data Missing|0|||
131404349|NCT01468207|473103697|FG000|Treatment Period 1|Adverse Event|1|||
131404350|NCT01468207|473103698|FG001|Treatment Period 1|Adverse Event|0|||
131404351|NCT01468207|473103699|FG002|Treatment Period 1|Adverse Event|0|||
131404352|NCT01468207|473103700|FG003|Treatment Period 1|Adverse Event|0|||
131404353|NCT01468207|473103701|FG004|Treatment Period 1|Adverse Event|0|||
131404354|NCT01468207|473103702|FG005|Treatment Period 1|Adverse Event|0|||
131404355|NCT01468207|473103697|FG000|Treatment Period 1|Protocol Violation|1|||
131404356|NCT01468207|473103698|FG001|Treatment Period 1|Protocol Violation|1|||
131404357|NCT01468207|473103699|FG002|Treatment Period 1|Protocol Violation|0|||
131404358|NCT01468207|473103700|FG003|Treatment Period 1|Protocol Violation|0|||
131404359|NCT01468207|473103701|FG004|Treatment Period 1|Protocol Violation|0|||
131404360|NCT01468207|473103702|FG005|Treatment Period 1|Protocol Violation|0|||
131404361|NCT01468207|473103697|FG000|Treatment Period 1|Withdrawal by Subject|5|||
131404362|NCT01468207|473103698|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131404363|NCT01468207|473103699|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131404364|NCT01468207|473103700|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131404365|NCT01468207|473103701|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131404366|NCT01468207|473103702|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131404367|NCT01468207|473103697|FG000|Treatment Period 1|Lost to Follow-up|2|||
131404368|NCT01468207|473103698|FG001|Treatment Period 1|Lost to Follow-up|1|||
131404369|NCT01468207|473103699|FG002|Treatment Period 1|Lost to Follow-up|0|||
131404370|NCT01468207|473103700|FG003|Treatment Period 1|Lost to Follow-up|0|||
131404371|NCT01468207|473103701|FG004|Treatment Period 1|Lost to Follow-up|0|||
131404372|NCT01468207|473103702|FG005|Treatment Period 1|Lost to Follow-up|0|||
131404373|NCT01468207|473103697|FG000|Treatment Period 1|Other|0|||
131404374|NCT01468207|473103698|FG001|Treatment Period 1|Other|2|||
131404375|NCT01468207|473103699|FG002|Treatment Period 1|Other|0|||
131404376|NCT01468207|473103700|FG003|Treatment Period 1|Other|0|||
131404377|NCT01468207|473103701|FG004|Treatment Period 1|Other|0|||
131404378|NCT01468207|473103702|FG005|Treatment Period 1|Other|0|||
131404379|NCT01468207|473103697|FG000|Treatment Period 2|Adverse Event|0|||
131404380|NCT01468207|473103698|FG001|Treatment Period 2|Adverse Event|0|||
131404381|NCT01468207|473103699|FG002|Treatment Period 2|Adverse Event|6|||
131404382|NCT01468207|473103700|FG003|Treatment Period 2|Adverse Event|1|||
131404383|NCT01468207|473103701|FG004|Treatment Period 2|Adverse Event|2|||
131404384|NCT01468207|473103702|FG005|Treatment Period 2|Adverse Event|1|||
131404385|NCT01468207|473103697|FG000|Treatment Period 2|Lack of Efficacy|0|||
131404386|NCT01468207|473103698|FG001|Treatment Period 2|Lack of Efficacy|0|||
131404387|NCT01468207|473103699|FG002|Treatment Period 2|Lack of Efficacy|1|||
131404388|NCT01468207|473103700|FG003|Treatment Period 2|Lack of Efficacy|1|||
131404389|NCT01468207|473103701|FG004|Treatment Period 2|Lack of Efficacy|0|||
131404390|NCT01468207|473103702|FG005|Treatment Period 2|Lack of Efficacy|2|||
131404391|NCT01468207|473103697|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131404392|NCT01468207|473103698|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131404393|NCT01468207|473103699|FG002|Treatment Period 2|Withdrawal by Subject|5|||
131404394|NCT01468207|473103700|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131404395|NCT01468207|473103701|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131404396|NCT01468207|473103702|FG005|Treatment Period 2|Withdrawal by Subject|2|||
131404397|NCT01468207|473103697|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
131404398|NCT01468207|473103698|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
131404399|NCT01468207|473103699|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
131404400|NCT01468207|473103700|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
131404401|NCT01468207|473103701|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
131404402|NCT01468207|473103702|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
131404403|NCT01468207|473103697|FG000|Treatment Period 2|Lost to Follow-up|0|||
131404404|NCT01468207|473103698|FG001|Treatment Period 2|Lost to Follow-up|0|||
131404405|NCT01468207|473103699|FG002|Treatment Period 2|Lost to Follow-up|5|||
131451273|NCT01106690|473281505|FG001|Core Period: Baseline to Week 26|Other|2|||
131451274|NCT01106690|473281506|FG002|Core Period: Baseline to Week 26|Other|6|||
131451275|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
131451276|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
131451277|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
131451278|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131451279|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131451280|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131451281|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131451282|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
131451283|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
131451284|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
131451285|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
131451286|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
131451287|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
131451288|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
131451289|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131451290|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Other|8|||
131451291|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Other|3|||
131451292|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Other|4|||
131451293|NCT01106690|473281504|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
131451294|NCT01106690|473281505|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131451295|NCT01106690|473281506|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131451296|NCT00998296|473281507|FG000|Overall Study|Progressive disease|0|||
131451297|NCT00998296|473281508|FG001|Overall Study|Progressive disease|1|||
131451298|NCT00998296|473281509|FG002|Overall Study|Progressive disease|0|||
131451299|NCT00998296|473281510|FG003|Overall Study|Progressive disease|0|||
131451300|NCT00998296|473281511|FG004|Overall Study|Progressive disease|0|||
131846072|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
131846073|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
131846074|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
131846075|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
131846076|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
131846077|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
131846078|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
131846079|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
131846080|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
131846081|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
131846082|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
131846083|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
131846084|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
131846085|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
131846086|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
131846087|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
131846088|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
131846089|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
131846090|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
131846091|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
131846092|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
131846093|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
131846094|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
131846095|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
131846096|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
131846097|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
131846098|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
131451301|NCT00998296|473281512|FG005|Overall Study|Progressive disease|0|||
131846099|NCT02552212|474718161|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
131846100|NCT02552212|474718162|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
131846101|NCT02552212|474718163|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
131846102|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
131846103|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
131846104|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
131846105|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
131451302|NCT00998296|473281513|FG006|Overall Study|Progressive disease|1|||
131451303|NCT00998296|473281514|FG007|Overall Study|Progressive disease|0|||
131451304|NCT00998296|473281515|FG008|Overall Study|Progressive disease|0|||
131846106|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
131846107|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
131451305|NCT00998296|473281516|FG009|Overall Study|Progressive disease|14|||
131451306|NCT00998296|473281517|FG010|Overall Study|Progressive disease|5|||
131451307|NCT00998296|473281507|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
131451308|NCT00998296|473281508|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
131451309|NCT00998296|473281509|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
131911265|NCT03104374|474963183|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
131911266|NCT03104374|474963184|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
131911267|NCT03104374|474963185|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
131911268|NCT03104374|474963182|FG000|Period 2|Adverse Event|4|||
131911269|NCT03104374|474963183|FG001|Period 2|Adverse Event|7|||
131911270|NCT03104374|474963184|FG002|Period 2|Adverse Event|10|||
131911271|NCT03104374|474963185|FG003|Period 2|Adverse Event|10|||
131911272|NCT03104374|474963182|FG000|Period 2|Withdrawal by Subject|3|||
131911273|NCT03104374|474963183|FG001|Period 2|Withdrawal by Subject|7|||
131911274|NCT03104374|474963184|FG002|Period 2|Withdrawal by Subject|13|||
131911275|NCT03104374|474963185|FG003|Period 2|Withdrawal by Subject|16|||
131911276|NCT03104374|474963182|FG000|Period 2|Lost to Follow-up|2|||
131911277|NCT03104374|474963183|FG001|Period 2|Lost to Follow-up|2|||
131911278|NCT03104374|474963184|FG002|Period 2|Lost to Follow-up|3|||
131911279|NCT03104374|474963185|FG003|Period 2|Lost to Follow-up|5|||
131911280|NCT03104374|474963182|FG000|Period 2|Lack of Efficacy|2|||
131911281|NCT03104374|474963183|FG001|Period 2|Lack of Efficacy|4|||
131911282|NCT03104374|474963184|FG002|Period 2|Lack of Efficacy|7|||
131911283|NCT03104374|474963185|FG003|Period 2|Lack of Efficacy|4|||
131911284|NCT03104374|474963182|FG000|Period 2|COVID-19 Infection|0|||
131911285|NCT03104374|474963183|FG001|Period 2|COVID-19 Infection|0|||
131911286|NCT03104374|474963184|FG002|Period 2|COVID-19 Infection|1|||
131911287|NCT03104374|474963185|FG003|Period 2|COVID-19 Infection|0|||
131911288|NCT03104374|474963182|FG000|Period 2|Other|3|||
131911289|NCT03104374|474963183|FG001|Period 2|Other|2|||
131911290|NCT03104374|474963184|FG002|Period 2|Other|2|||
131911291|NCT03104374|474963185|FG003|Period 2|Other|4|||
131911292|NCT02121210|474963188|FG000|Overall Study|Adverse Event|5|||
131911293|NCT02121210|474963189|FG001|Overall Study|Adverse Event|7|||
131911294|NCT02121210|474963188|FG000|Overall Study|Lack of Efficacy|2|||
131911295|NCT02121210|474963189|FG001|Overall Study|Lack of Efficacy|0|||
131911296|NCT02121210|474963188|FG000|Overall Study|Other than specified above|0|||
131911297|NCT02121210|474963189|FG001|Overall Study|Other than specified above|2|||
131911298|NCT04609514|474963190|FG000|Overall Study|Lost to Follow-up|5|||
131911299|NCT04609514|474963191|FG001|Overall Study|Lost to Follow-up|4|||
131911300|NCT04609514|474963190|FG000|Overall Study|Withdrawal by PI|0|||
131911301|NCT04609514|474963191|FG001|Overall Study|Withdrawal by PI|2|||
131911302|NCT00909870|474963192|FG000|Overall Study|Adverse Event|13|||
131911303|NCT00909870|474963193|FG001|Overall Study|Adverse Event|7|||
131911304|NCT00909870|474963192|FG000|Overall Study|Protocol Violation|1|||
131911305|NCT00909870|474963193|FG001|Overall Study|Protocol Violation|2|||
131911306|NCT00909870|474963192|FG000|Overall Study|Withdrawal by Subject|5|||
131911307|NCT00909870|474963193|FG001|Overall Study|Withdrawal by Subject|8|||
131911308|NCT00909870|474963192|FG000|Overall Study|Lost to Follow-up|3|||
131911309|NCT00909870|474963193|FG001|Overall Study|Lost to Follow-up|3|||
131911310|NCT00909870|474963192|FG000|Overall Study|Physician Decision|0|||
131911311|NCT00909870|474963193|FG001|Overall Study|Physician Decision|2|||
131911312|NCT00909870|474963192|FG000|Overall Study|Other|1|||
131911313|NCT00909870|474963193|FG001|Overall Study|Other|5|||
131911314|NCT01316575|474963196|FG000|Overall Study|Withdrawal by Subject|2|||
131911315|NCT01316575|474963197|FG001|Overall Study|Withdrawal by Subject|0|||
131911316|NCT01316575|474963196|FG000|Overall Study|Required alternate treatment|0|||
131451310|NCT00998296|473281510|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
131451311|NCT00998296|473281511|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
131451312|NCT00998296|473281512|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
131451313|NCT00998296|473281513|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
131451314|NCT00998296|473281514|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
131911317|NCT01316575|474963197|FG001|Overall Study|Required alternate treatment|1|||
131911318|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
131911319|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
131911320|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911321|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911322|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911323|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131451315|NCT00998296|473281515|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
131911324|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911325|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911326|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911327|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
131911328|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
131404406|NCT01468207|473103700|FG003|Treatment Period 2|Lost to Follow-up|1|||
131404407|NCT01468207|473103701|FG004|Treatment Period 2|Lost to Follow-up|0|||
131404408|NCT01468207|473103702|FG005|Treatment Period 2|Lost to Follow-up|0|||
131404409|NCT01468207|473103697|FG000|Treatment Period 2|Other|0|||
131404410|NCT01468207|473103698|FG001|Treatment Period 2|Other|0|||
131404411|NCT01468207|473103699|FG002|Treatment Period 2|Other|5|||
131404412|NCT01468207|473103700|FG003|Treatment Period 2|Other|1|||
131404413|NCT01468207|473103701|FG004|Treatment Period 2|Other|1|||
131404414|NCT01468207|473103702|FG005|Treatment Period 2|Other|2|||
131404415|NCT00539513|473103705|FG000|Overall Study|Withdrawal by Subject|2|||
131404416|NCT00539513|473103706|FG001|Overall Study|Withdrawal by Subject|1|||
131404417|NCT00539513|473103705|FG000|Overall Study|Lost to Follow-up|0|||
131404418|NCT00539513|473103706|FG001|Overall Study|Lost to Follow-up|1|||
131911329|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
131911330|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131911331|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131911332|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131911333|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131911334|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131911335|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131911336|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131404419|NCT01328041|473103707|FG000|Overall Study|Adverse Event|7|||
131846108|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
131846109|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
131846110|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
131846111|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
131846112|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
131846113|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
131846114|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
131846115|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
131846116|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
131846117|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
131846118|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
131846119|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
131846120|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
131846121|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
131846122|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
131846123|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
131846124|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
131846125|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
131846126|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
131846127|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
131846128|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
131846129|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
131846130|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
131911337|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
131404420|NCT01328041|473103707|FG000|Overall Study|Lack of Efficacy|27|||
131404421|NCT01328041|473103707|FG000|Overall Study|Protocol Violation|7|||
131404422|NCT01328041|473103707|FG000|Overall Study|Lost to Follow-up|7|||
131404423|NCT01328041|473103707|FG000|Overall Study|Physician Decision|2|||
131404424|NCT01328041|473103707|FG000|Overall Study|Withdrawal by Subject|7|||
131404425|NCT00113399|473103710|FG000|Overall Study|Death|1|||
131404426|NCT00113399|473103711|FG001|Overall Study|Death|1|||
131404427|NCT00113399|473103710|FG000|Overall Study|Withdrawal by Subject|1|||
131404428|NCT00113399|473103711|FG001|Overall Study|Withdrawal by Subject|2|||
131404429|NCT00113399|473103710|FG000|Overall Study|Complete Response|0|||
131404430|NCT00113399|473103711|FG001|Overall Study|Complete Response|1|||
131404431|NCT00113399|473103710|FG000|Overall Study|Other|0|||
131404432|NCT00113399|473103711|FG001|Overall Study|Other|1|||
131404433|NCT01779856|473103713|FG000|Overall Study|Withdrawal by Subject|15|||
131404434|NCT01779856|473103713|FG000|Overall Study|Death|3|||
131846131|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
131846132|NCT02552212|474718161|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
131404435|NCT01779856|473103713|FG000|Overall Study|Physician Decision|1|||
131404436|NCT01779856|473103713|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
131404437|NCT01779856|473103713|FG000|Overall Study|Delays in scheduling implant|1|||
131404438|NCT01779856|473103713|FG000|Overall Study|Subject ineligible for Implant|2|||
131404439|NCT01535599|473103714|FG000|Overall Study|Adverse Event|6|||
131404440|NCT01535599|473103715|FG001|Overall Study|Adverse Event|15|||
131404441|NCT01535599|473103714|FG000|Overall Study|Lost to Follow-up|3|||
131404442|NCT01535599|473103715|FG001|Overall Study|Lost to Follow-up|4|||
131404443|NCT01535599|473103714|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
131404444|NCT01535599|473103715|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
131404445|NCT01535599|473103714|FG000|Overall Study|Treatment Failure|33|||
131404446|NCT01535599|473103715|FG001|Overall Study|Treatment Failure|66|||
131404447|NCT01535599|473103714|FG000|Overall Study|BL Culture + for Group A Strep|0|||
131404448|NCT01535599|473103715|FG001|Overall Study|BL Culture + for Group A Strep|1|||
131404449|NCT01535599|473103714|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
131404450|NCT01535599|473103715|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
131404451|NCT01535599|473103714|FG000|Overall Study|Randomized in Error|2|||
131404452|NCT01535599|473103715|FG001|Overall Study|Randomized in Error|4|||
131404453|NCT01535599|473103714|FG000|Overall Study|Did not use product|1|||
131404454|NCT01535599|473103715|FG001|Overall Study|Did not use product|0|||
131404455|NCT01535599|473103714|FG000|Overall Study|Other|1|||
131404456|NCT01535599|473103715|FG001|Overall Study|Other|0|||
131451316|NCT00998296|473281516|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
131846133|NCT02552212|474718162|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
131846134|NCT02552212|474718163|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
131846135|NCT00205803|474718170|FG000|Infant Series|Lost to Follow-up|10|||
131846136|NCT00205803|474718171|FG001|Infant Series|Lost to Follow-up|4|||
131846137|NCT00205803|474718170|FG000|Infant Series|Withdrawal by Subject|2|||
131846138|NCT00205803|474718171|FG001|Infant Series|Withdrawal by Subject|5|||
131846139|NCT00205803|474718170|FG000|Infant Series|Physician Decision|3|||
131846140|NCT00205803|474718171|FG001|Infant Series|Physician Decision|1|||
131846141|NCT00205803|474718170|FG000|Infant Series|Protocol Violation|1|||
131846142|NCT00205803|474718171|FG001|Infant Series|Protocol Violation|0|||
131846143|NCT00205803|474718170|FG000|Infant Series|Lost Kaiser coverage|0|||
131846144|NCT00205803|474718171|FG001|Infant Series|Lost Kaiser coverage|1|||
131846145|NCT00205803|474718170|FG000|Infant Series|Non-compliant|1|||
131846146|NCT00205803|474718171|FG001|Infant Series|Non-compliant|0|||
131846147|NCT00205803|474718170|FG000|Infant Series|Sponsor request|1|||
131846148|NCT00205803|474718171|FG001|Infant Series|Sponsor request|0|||
131846149|NCT00205803|474718170|FG000|After Infant Series|Adverse Event|1|||
131846150|NCT00205803|474718171|FG001|After Infant Series|Adverse Event|1|||
131846151|NCT00205803|474718170|FG000|After Infant Series|Protocol Violation|1|||
131846152|NCT00205803|474718171|FG001|After Infant Series|Protocol Violation|1|||
131846153|NCT00205803|474718170|FG000|After Infant Series|Lost to Follow-up|2|||
131846154|NCT00205803|474718171|FG001|After Infant Series|Lost to Follow-up|1|||
131846155|NCT00205803|474718170|FG000|After Infant Series|Physician Decision|3|||
131846156|NCT00205803|474718171|FG001|After Infant Series|Physician Decision|2|||
131846157|NCT00205803|474718170|FG000|After Infant Series|Withdrawal by Subject|1|||
131846158|NCT00205803|474718171|FG001|After Infant Series|Withdrawal by Subject|4|||
131846159|NCT00205803|474718170|FG000|After Infant Series|Other|10|||
131846160|NCT00205803|474718171|FG001|After Infant Series|Other|4|||
131846161|NCT00205803|474718170|FG000|Toddler Dose|Lost to Follow-up|2|||
131846162|NCT00205803|474718171|FG001|Toddler Dose|Lost to Follow-up|3|||
131846163|NCT02369458|474718173|FG000|Overall Study|Determined to be not eligible|1|||
131846164|NCT02369458|474718174|FG001|Overall Study|Determined to be not eligible|0|||
131846165|NCT04572893|474718175|FG000|Part A|Adverse Event|1|||
131846166|NCT04572893|474718176|FG001|Part A|Adverse Event|0|||
131846167|NCT04572893|474718177|FG002|Part A|Adverse Event|0|||
131846168|NCT04572893|474718178|FG003|Part A|Adverse Event|0|||
131846169|NCT04572893|474718179|FG004|Part A|Adverse Event|0|||
131846170|NCT04572893|474718180|FG005|Part A|Adverse Event|0|||
131846171|NCT04572893|474718181|FG006|Part A|Adverse Event|0|||
131846172|NCT04572893|474718175|FG000|Part B|Withdrawal by Subject|0|||
131846173|NCT04572893|474718176|FG001|Part B|Withdrawal by Subject|0|||
131846174|NCT04572893|474718177|FG002|Part B|Withdrawal by Subject|0|||
131846175|NCT04572893|474718178|FG003|Part B|Withdrawal by Subject|0|||
131846176|NCT04572893|474718179|FG004|Part B|Withdrawal by Subject|0|||
131846177|NCT04572893|474718180|FG005|Part B|Withdrawal by Subject|1|||
131846178|NCT04572893|474718181|FG006|Part B|Withdrawal by Subject|0|||
131846179|NCT04572893|474718175|FG000|Part B|Study terminated by sponsor|0|||
131846180|NCT04572893|474718176|FG001|Part B|Study terminated by sponsor|0|||
131846181|NCT04572893|474718177|FG002|Part B|Study terminated by sponsor|0|||
131846182|NCT04572893|474718178|FG003|Part B|Study terminated by sponsor|0|||
131846183|NCT04572893|474718179|FG004|Part B|Study terminated by sponsor|7|||
131846184|NCT04572893|474718180|FG005|Part B|Study terminated by sponsor|5|||
131846185|NCT04572893|474718181|FG006|Part B|Study terminated by sponsor|3|||
131846186|NCT04572893|474718175|FG000|Part B|Lost to Follow-up|0|||
131846187|NCT04572893|474718176|FG001|Part B|Lost to Follow-up|0|||
131846188|NCT04572893|474718177|FG002|Part B|Lost to Follow-up|0|||
131846189|NCT04572893|474718178|FG003|Part B|Lost to Follow-up|0|||
131846190|NCT04572893|474718179|FG004|Part B|Lost to Follow-up|0|||
131846191|NCT04572893|474718180|FG005|Part B|Lost to Follow-up|0|||
131846192|NCT04572893|474718181|FG006|Part B|Lost to Follow-up|1|||
131846193|NCT04572893|474718175|FG000|Part B|Adverse Event|0|||
131846194|NCT04572893|474718176|FG001|Part B|Adverse Event|0|||
131846195|NCT04572893|474718177|FG002|Part B|Adverse Event|0|||
131846196|NCT04572893|474718178|FG003|Part B|Adverse Event|0|||
131846197|NCT04572893|474718179|FG004|Part B|Adverse Event|1|||
131911338|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
131911339|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911340|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911341|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911342|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911343|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911344|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911345|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911346|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911347|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
131911348|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
131911349|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
131911350|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911351|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911352|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911353|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911354|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911355|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911356|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911357|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
131911358|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
131911359|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
131911360|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911361|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911362|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911363|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911364|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911365|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911366|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911367|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
131911368|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
131911369|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
131911370|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911371|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911372|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911373|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911374|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911375|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911376|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911377|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
131911378|NCT01232283|474963198|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
131911379|NCT01232283|474963199|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
131404457|NCT01535599|473103714|FG000|Overall Study|Stopped medication|0|||
131404458|NCT01535599|473103715|FG001|Overall Study|Stopped medication|1|||
131404459|NCT01535599|473103714|FG000|Overall Study|Noncompliance|0|||
131404460|NCT01535599|473103715|FG001|Overall Study|Noncompliance|1|||
131404461|NCT04043234|473103716|FG000|Overall Study|Lost to Follow-up|1|||
131404462|NCT04043234|473103716|FG000|Overall Study|Withdrawal by Subject|1|||
131404463|NCT01694121|473103721|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
131404464|NCT01694121|473103722|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
131404465|NCT00521599|473103723|FG000|Overall Study|Adverse Event|5|||
131404466|NCT00521599|473103724|FG001|Overall Study|Adverse Event|7|||
131404467|NCT00521599|473103725|FG002|Overall Study|Adverse Event|6|||
131404468|NCT00521599|473103723|FG000|Overall Study|Treatment Failure|8|||
131404469|NCT00521599|473103724|FG001|Overall Study|Treatment Failure|9|||
131404470|NCT00521599|473103725|FG002|Overall Study|Treatment Failure|22|||
131404471|NCT00521599|473103723|FG000|Overall Study|Lost to Follow-up|2|||
131404472|NCT00521599|473103724|FG001|Overall Study|Lost to Follow-up|1|||
131404473|NCT00521599|473103725|FG002|Overall Study|Lost to Follow-up|2|||
131404474|NCT00521599|473103723|FG000|Overall Study|Withdrawal by Subject|3|||
131404475|NCT00521599|473103724|FG001|Overall Study|Withdrawal by Subject|5|||
131404476|NCT00521599|473103725|FG002|Overall Study|Withdrawal by Subject|1|||
131404477|NCT00521599|473103723|FG000|Overall Study|Withdrawal by subject treatment related|3|||
131404478|NCT00521599|473103724|FG001|Overall Study|Withdrawal by subject treatment related|1|||
131404479|NCT00521599|473103725|FG002|Overall Study|Withdrawal by subject treatment related|2|||
131404480|NCT00521599|473103723|FG000|Overall Study|Protocol Violation|2|||
131404481|NCT00521599|473103724|FG001|Overall Study|Protocol Violation|4|||
131451317|NCT00998296|473281517|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
131451318|NCT00998296|473281507|FG000|Overall Study|Other adverse event|0|||
131451319|NCT00998296|473281508|FG001|Overall Study|Other adverse event|0|||
131451320|NCT00998296|473281509|FG002|Overall Study|Other adverse event|0|||
131451321|NCT00998296|473281510|FG003|Overall Study|Other adverse event|0|||
131451322|NCT00998296|473281511|FG004|Overall Study|Other adverse event|1|||
131451323|NCT00998296|473281512|FG005|Overall Study|Other adverse event|0|||
131451324|NCT00998296|473281513|FG006|Overall Study|Other adverse event|0|||
131451325|NCT00998296|473281514|FG007|Overall Study|Other adverse event|0|||
131451326|NCT00998296|473281515|FG008|Overall Study|Other adverse event|0|||
131451327|NCT00998296|473281516|FG009|Overall Study|Other adverse event|1|||
131451328|NCT00998296|473281517|FG010|Overall Study|Other adverse event|2|||
131451329|NCT00998296|473281507|FG000|Overall Study|Refused to continue taking trial med.|0|||
131451330|NCT00998296|473281508|FG001|Overall Study|Refused to continue taking trial med.|0|||
131451331|NCT00998296|473281509|FG002|Overall Study|Refused to continue taking trial med.|0|||
131451332|NCT00998296|473281510|FG003|Overall Study|Refused to continue taking trial med.|0|||
131451333|NCT00998296|473281511|FG004|Overall Study|Refused to continue taking trial med.|0|||
131451334|NCT00998296|473281512|FG005|Overall Study|Refused to continue taking trial med.|0|||
131451335|NCT00998296|473281513|FG006|Overall Study|Refused to continue taking trial med.|0|||
131451336|NCT00998296|473281514|FG007|Overall Study|Refused to continue taking trial med.|0|||
131451337|NCT00998296|473281515|FG008|Overall Study|Refused to continue taking trial med.|0|||
131451338|NCT00998296|473281516|FG009|Overall Study|Refused to continue taking trial med.|2|||
131451339|NCT00998296|473281517|FG010|Overall Study|Refused to continue taking trial med.|0|||
131451340|NCT00998296|473281507|FG000|Overall Study|Reason other than those specified above|0|||
131451341|NCT00998296|473281508|FG001|Overall Study|Reason other than those specified above|0|||
131451342|NCT00998296|473281509|FG002|Overall Study|Reason other than those specified above|0|||
131451343|NCT00998296|473281510|FG003|Overall Study|Reason other than those specified above|0|||
131451344|NCT00998296|473281511|FG004|Overall Study|Reason other than those specified above|0|||
131451345|NCT00998296|473281512|FG005|Overall Study|Reason other than those specified above|0|||
131451346|NCT00998296|473281513|FG006|Overall Study|Reason other than those specified above|0|||
131451347|NCT00998296|473281514|FG007|Overall Study|Reason other than those specified above|0|||
131451348|NCT00998296|473281515|FG008|Overall Study|Reason other than those specified above|0|||
131451349|NCT00998296|473281516|FG009|Overall Study|Reason other than those specified above|1|||
131451350|NCT00998296|473281517|FG010|Overall Study|Reason other than those specified above|0|||
131451351|NCT03219528|473281525|FG000|Overall Study|Lost to Follow-up|5|||
131451352|NCT03219528|473281526|FG001|Overall Study|Lost to Follow-up|4|||
131451353|NCT03219528|473281525|FG000|Overall Study|Withdrawal by Subject|4|||
131451354|NCT03219528|473281526|FG001|Overall Study|Withdrawal by Subject|4|||
131451355|NCT02120898|473281529|FG000|Overall Study|Withdrawal by Subject|4|||
131451356|NCT02120898|473281530|FG001|Overall Study|Withdrawal by Subject|2|||
131451357|NCT02120898|473281531|FG002|Overall Study|Withdrawal by Subject|2|||
131451358|NCT02120898|473281529|FG000|Overall Study|Non-compliance with study drug|3|||
131451359|NCT02120898|473281530|FG001|Overall Study|Non-compliance with study drug|0|||
131451360|NCT02120898|473281531|FG002|Overall Study|Non-compliance with study drug|0|||
131451361|NCT02120898|473281529|FG000|Overall Study|Adverse Event|1|||
131451362|NCT02120898|473281530|FG001|Overall Study|Adverse Event|2|||
131451363|NCT02120898|473281531|FG002|Overall Study|Adverse Event|1|||
131451364|NCT02120898|473281529|FG000|Overall Study|Protocol Violation|1|||
131451365|NCT02120898|473281530|FG001|Overall Study|Protocol Violation|2|||
131451366|NCT02120898|473281531|FG002|Overall Study|Protocol Violation|0|||
131451367|NCT02120898|473281529|FG000|Overall Study|Lost to Follow-up|0|||
131451368|NCT02120898|473281530|FG001|Overall Study|Lost to Follow-up|0|||
131451369|NCT02120898|473281531|FG002|Overall Study|Lost to Follow-up|1|||
131451370|NCT00196313|473281532|FG000|Overall Study|Protocol Violation|2|||
131451371|NCT00196313|473281533|FG001|Overall Study|Protocol Violation|3|||
131451372|NCT00196313|473281532|FG000|Overall Study|Withdrawal by Subject|3|||
131451373|NCT00196313|473281533|FG001|Overall Study|Withdrawal by Subject|1|||
131451374|NCT00196313|473281532|FG000|Overall Study|Adverse Event|3|||
131451375|NCT00196313|473281533|FG001|Overall Study|Adverse Event|1|||
131451376|NCT00196313|473281532|FG000|Overall Study|Subject Pregnant|1|||
131451377|NCT00196313|473281533|FG001|Overall Study|Subject Pregnant|1|||
131451378|NCT00196313|473281532|FG000|Overall Study|Lost to Follow-up|2|||
131846198|NCT04572893|474718180|FG005|Part B|Adverse Event|1|||
131846199|NCT04572893|474718181|FG006|Part B|Adverse Event|0|||
131846200|NCT02478320|474718182|FG000|Overall Study|Adverse Event|2|||
131451379|NCT00196313|473281533|FG001|Overall Study|Lost to Follow-up|2|||
131451380|NCT04085289|473281534|FG000|Overall Study|Withdrawal by Subject|0|||
131451381|NCT04085289|473281535|FG001|Overall Study|Withdrawal by Subject|0|||
131451382|NCT04085289|473281536|FG002|Overall Study|Withdrawal by Subject|1|||
131451383|NCT04614974|473281539|FG000|Overall Study|Lost to Follow-up|14|||
131451384|NCT04614974|473281540|FG001|Overall Study|Lost to Follow-up|11|||
131451385|NCT01635153|473281541|FG000|Overall Study|Lost to Follow-up|40|||
131451386|NCT01635153|473281542|FG001|Overall Study|Lost to Follow-up|43|||
131846201|NCT02478320|474718183|FG001|Overall Study|Adverse Event|0|||
131846202|NCT02478320|474718182|FG000|Overall Study|Death|1|||
131911380|NCT01232283|474963200|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911381|NCT01232283|474963201|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911382|NCT01232283|474963202|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911383|NCT01232283|474963203|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911384|NCT01232283|474963204|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911385|NCT01232283|474963205|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911386|NCT01232283|474963206|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911387|NCT01232283|474963207|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
131911388|NCT01232283|474963198|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911389|NCT01232283|474963199|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911390|NCT01232283|474963200|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
131911391|NCT01232283|474963201|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
131911392|NCT01232283|474963202|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911393|NCT01232283|474963203|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911394|NCT01232283|474963204|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911395|NCT01232283|474963205|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911396|NCT01232283|474963206|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911397|NCT01232283|474963207|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
131911398|NCT01232283|474963198|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911399|NCT01232283|474963199|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911400|NCT01232283|474963200|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
131911401|NCT01232283|474963201|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
131911402|NCT01232283|474963202|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911403|NCT01232283|474963203|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911404|NCT01232283|474963204|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911405|NCT01232283|474963205|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911406|NCT01232283|474963206|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911407|NCT01232283|474963207|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
131911408|NCT01232283|474963198|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911409|NCT01232283|474963199|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911410|NCT01232283|474963200|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
131911411|NCT01232283|474963201|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911412|NCT01232283|474963202|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911413|NCT01232283|474963203|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911414|NCT01232283|474963204|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911415|NCT01232283|474963205|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911416|NCT01232283|474963206|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911417|NCT01232283|474963207|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
131911418|NCT01232283|474963198|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911419|NCT01232283|474963199|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911420|NCT01232283|474963200|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
131911421|NCT01232283|474963201|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
131911422|NCT01232283|474963202|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911423|NCT01232283|474963203|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911424|NCT01232283|474963204|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911425|NCT01232283|474963205|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911426|NCT01232283|474963206|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911427|NCT01232283|474963207|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
131911428|NCT01232283|474963198|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911429|NCT01232283|474963199|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911430|NCT01232283|474963200|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
131911431|NCT01232283|474963201|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
131911432|NCT01232283|474963202|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911433|NCT01232283|474963203|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911434|NCT01232283|474963204|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911435|NCT01232283|474963205|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911436|NCT01232283|474963206|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911437|NCT01232283|474963207|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
131911438|NCT01232283|474963198|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
131911439|NCT01232283|474963199|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
131911440|NCT01232283|474963200|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
131911441|NCT01232283|474963201|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
131911442|NCT01232283|474963202|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
131911443|NCT01232283|474963203|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
131911444|NCT01232283|474963204|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
131911445|NCT01232283|474963205|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
131911446|NCT01232283|474963206|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
131911447|NCT01232283|474963207|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
131846203|NCT02478320|474718183|FG001|Overall Study|Death|0|||
131846204|NCT02478320|474718182|FG000|Overall Study|Lack of Efficacy|4|||
131846205|NCT02478320|474718183|FG001|Overall Study|Lack of Efficacy|0|||
131846206|NCT02478320|474718182|FG000|Overall Study|Withdrawal by Subject|2|||
131846207|NCT02478320|474718183|FG001|Overall Study|Withdrawal by Subject|0|||
131846208|NCT02478320|474718182|FG000|Overall Study|Screen Failure|3|||
131846209|NCT02478320|474718183|FG001|Overall Study|Screen Failure|0|||
131846210|NCT03255655|474718184|FG000|Overall Study|Lost to Follow-up|7|||
131846211|NCT03255655|474718185|FG001|Overall Study|Lost to Follow-up|4|||
131846212|NCT04428333|474718188|FG000|Overall Study|Physician Decision|5|||
131846213|NCT04428333|474718189|FG001|Overall Study|Physician Decision|6|||
131846214|NCT04428333|474718188|FG000|Overall Study|Withdrawal by Subject|1|||
131846215|NCT04428333|474718189|FG001|Overall Study|Withdrawal by Subject|3|||
131846216|NCT04428333|474718188|FG000|Overall Study|Study Terminated By Sponsor|14|||
131846217|NCT04428333|474718189|FG001|Overall Study|Study Terminated By Sponsor|16|||
131846218|NCT04853992|474718190|FG000|Treatment Period A|Adverse Event|0|||
131846219|NCT04853992|474718191|FG001|Treatment Period A|Adverse Event|1|||
131846220|NCT04853992|474718190|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
131846221|NCT04853992|474718191|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
131846222|NCT03582826|474718192|FG000|Overall Study|Lost to Follow-up|39|||
131846223|NCT03582826|474718193|FG001|Overall Study|Lost to Follow-up|0|||
131846224|NCT03582826|474718192|FG000|Overall Study|Withdrawal by Subject|2|||
131846225|NCT03582826|474718193|FG001|Overall Study|Withdrawal by Subject|0|||
131846226|NCT02269163|474718194|FG000|Overall Study|Lost to Follow-up|1|||
131846227|NCT02269163|474718195|FG001|Overall Study|Lost to Follow-up|0|||
131846228|NCT02269163|474718194|FG000|Overall Study|Major protocol violation|0|||
131846229|NCT02269163|474718195|FG001|Overall Study|Major protocol violation|1|||
131846230|NCT02269163|474718194|FG000|Overall Study|Other|2|||
131846231|NCT02269163|474718195|FG001|Overall Study|Other|2|||
131846232|NCT02269163|474718194|FG000|Overall Study|Withdrawal by Subject|0|||
131846233|NCT02269163|474718195|FG001|Overall Study|Withdrawal by Subject|3|||
131846234|NCT02269163|474718194|FG000|Overall Study|Physician Decision|0|||
131846235|NCT02269163|474718195|FG001|Overall Study|Physician Decision|1|||
131846236|NCT03480386|474718196|FG000|Overall Study|Did not complete measures at 3-months|17|||
131846237|NCT03480386|474718197|FG001|Overall Study|Did not complete measures at 3-months|14|||
131846238|NCT03480386|474718196|FG000|Overall Study|No baseline measures|11|||
131846239|NCT03480386|474718197|FG001|Overall Study|No baseline measures|14|||
131846240|NCT03480386|474718196|FG000|Overall Study|Death|0|||
131846241|NCT03480386|474718197|FG001|Overall Study|Death|5|||
131846242|NCT03480386|474718196|FG000|Overall Study|Withdrawal by Subject|12|||
131846243|NCT03480386|474718197|FG001|Overall Study|Withdrawal by Subject|8|||
131846244|NCT03480386|474718196|FG000|Overall Study|Lost to Follow-up|2|||
131846245|NCT03480386|474718197|FG001|Overall Study|Lost to Follow-up|1|||
131846246|NCT03480386|474718196|FG000|Overall Study|Complicating disease|0|||
131846247|NCT03480386|474718197|FG001|Overall Study|Complicating disease|1|||
131846248|NCT03480386|474718196|FG000|Overall Study|Disease progression|3|||
131846249|NCT03480386|474718197|FG001|Overall Study|Disease progression|0|||
131846250|NCT03480386|474718196|FG000|Overall Study|Became ineligible|0|||
131846251|NCT03480386|474718197|FG001|Overall Study|Became ineligible|2|||
131846252|NCT00574912|474718198|FG000|Overall Study|Could not place IV lines.|3|||
131846253|NCT00574912|474718198|FG000|Overall Study|scheduling conflicts|3|||
131846254|NCT00574912|474718198|FG000|Overall Study|Physician Decision|2|||
131846255|NCT02551666|474718203|FG000|Overall Study|Withdrawal by Subject|1|||
131846256|NCT02551666|474718204|FG001|Overall Study|Withdrawal by Subject|3|||
131846257|NCT00805467|474720089|FG000|Overall Study|Lack of Efficacy|0|||
131846258|NCT00805467|474720090|FG001|Overall Study|Lack of Efficacy|8|||
131846259|NCT00805467|474720091|FG002|Overall Study|Lack of Efficacy|13|||
131846260|NCT00805467|474720092|FG003|Overall Study|Lack of Efficacy|86|||
131846261|NCT00805467|474720089|FG000|Overall Study|Lost to Follow-up|0|||
131846262|NCT00805467|474720090|FG001|Overall Study|Lost to Follow-up|1|||
131846263|NCT00805467|474720091|FG002|Overall Study|Lost to Follow-up|7|||
131846264|NCT00805467|474720092|FG003|Overall Study|Lost to Follow-up|21|||
131846265|NCT00805467|474720089|FG000|Overall Study|Withdrawal by Subject|0|||
131846266|NCT00805467|474720090|FG001|Overall Study|Withdrawal by Subject|6|||
131846267|NCT00805467|474720091|FG002|Overall Study|Withdrawal by Subject|45|||
131846268|NCT00805467|474720092|FG003|Overall Study|Withdrawal by Subject|50|||
131846269|NCT00805467|474720089|FG000|Overall Study|Protocol Violation|0|||
131846270|NCT00805467|474720090|FG001|Overall Study|Protocol Violation|3|||
131846271|NCT00805467|474720091|FG002|Overall Study|Protocol Violation|0|||
131846272|NCT00805467|474720092|FG003|Overall Study|Protocol Violation|5|||
131846273|NCT00805467|474720089|FG000|Overall Study|Adverse Event|0|||
131846274|NCT00805467|474720090|FG001|Overall Study|Adverse Event|13|||
131846275|NCT00805467|474720091|FG002|Overall Study|Adverse Event|26|||
131846276|NCT00805467|474720092|FG003|Overall Study|Adverse Event|57|||
131846277|NCT00805467|474720089|FG000|Overall Study|Death|0|||
131846278|NCT00805467|474720090|FG001|Overall Study|Death|2|||
131846279|NCT00805467|474720091|FG002|Overall Study|Death|7|||
131846280|NCT00805467|474720092|FG003|Overall Study|Death|5|||
131846281|NCT00805467|474720089|FG000|Overall Study|Physician Decision|0|||
131451387|NCT01263197|473281560|FG000|First Intervention (Period 1)|Adverse Event|0|||
131451388|NCT01263197|473281561|FG001|First Intervention (Period 1)|Adverse Event|0|||
131451389|NCT01263197|473281562|FG002|First Intervention (Period 1)|Adverse Event|0|||
131451390|NCT01263197|473281563|FG003|First Intervention (Period 1)|Adverse Event|0|||
131451391|NCT01263197|473281564|FG004|First Intervention (Period 1)|Adverse Event|0|||
131451392|NCT01263197|473281565|FG005|First Intervention (Period 1)|Adverse Event|1|||
131451393|NCT01263197|473281560|FG000|Washout Period 1|Protocol Violation|0|||
131451394|NCT01263197|473281561|FG001|Washout Period 1|Protocol Violation|0|||
131451395|NCT01263197|473281562|FG002|Washout Period 1|Protocol Violation|0|||
131451396|NCT01263197|473281563|FG003|Washout Period 1|Protocol Violation|0|||
131451397|NCT01263197|473281564|FG004|Washout Period 1|Protocol Violation|1|||
131451398|NCT01263197|473281565|FG005|Washout Period 1|Protocol Violation|0|||
131451399|NCT01263197|473281560|FG000|Washout Period 2|Physician Decision|0|||
131451400|NCT01263197|473281561|FG001|Washout Period 2|Physician Decision|0|||
131451401|NCT01263197|473281562|FG002|Washout Period 2|Physician Decision|0|||
131451402|NCT01263197|473281563|FG003|Washout Period 2|Physician Decision|0|||
131451403|NCT01263197|473281564|FG004|Washout Period 2|Physician Decision|0|||
131451404|NCT01263197|473281565|FG005|Washout Period 2|Physician Decision|1|||
131451405|NCT01263197|473281560|FG000|Washout Period 2|Protocol Violation|0|||
131451406|NCT01263197|473281561|FG001|Washout Period 2|Protocol Violation|0|||
131451407|NCT01263197|473281562|FG002|Washout Period 2|Protocol Violation|0|||
131451408|NCT01263197|473281563|FG003|Washout Period 2|Protocol Violation|1|||
131451409|NCT01263197|473281564|FG004|Washout Period 2|Protocol Violation|0|||
131451410|NCT01263197|473281565|FG005|Washout Period 2|Protocol Violation|0|||
131451411|NCT01263197|473281560|FG000|Third Intervention (Period 3)|Adverse Event|0|||
131451412|NCT01263197|473281561|FG001|Third Intervention (Period 3)|Adverse Event|1|||
131451413|NCT01263197|473281562|FG002|Third Intervention (Period 3)|Adverse Event|0|||
131451414|NCT01263197|473281563|FG003|Third Intervention (Period 3)|Adverse Event|0|||
131451415|NCT01263197|473281564|FG004|Third Intervention (Period 3)|Adverse Event|0|||
131451416|NCT01263197|473281565|FG005|Third Intervention (Period 3)|Adverse Event|0|||
131451417|NCT02454517|473281566|FG000|Overall Study|Withdrawal by Subject|3|||
131451418|NCT02454517|473281567|FG001|Overall Study|Withdrawal by Subject|0|||
131451419|NCT02454517|473281566|FG000|Overall Study|Lost to Follow-up|4|||
131451420|NCT02454517|473281567|FG001|Overall Study|Lost to Follow-up|7|||
131451421|NCT02454517|473281566|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
131451422|NCT02454517|473281567|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
131451423|NCT00473382|473281568|FG000|Core Study|Adverse Event|3|||
131451424|NCT00473382|473281569|FG001|Core Study|Adverse Event|1|||
131451425|NCT00473382|473281570|FG002|Core Study|Adverse Event|1|||
131451426|NCT00473382|473281568|FG000|Core Study|Death|3|||
131451427|NCT00473382|473281569|FG001|Core Study|Death|5|||
131451428|NCT00473382|473281570|FG002|Core Study|Death|10|||
131451429|NCT00473382|473281568|FG000|Core Study|Lost to Follow-up|3|||
131451430|NCT00473382|473281569|FG001|Core Study|Lost to Follow-up|3|||
131451431|NCT00473382|473281570|FG002|Core Study|Lost to Follow-up|3|||
131451432|NCT00473382|473281568|FG000|Core Study|Physician Decision|1|||
131451433|NCT00473382|473281569|FG001|Core Study|Physician Decision|2|||
131451434|NCT00473382|473281570|FG002|Core Study|Physician Decision|2|||
131451435|NCT00473382|473281568|FG000|Core Study|Subject non-compliance|5|||
131451436|NCT00473382|473281569|FG001|Core Study|Subject non-compliance|2|||
131451437|NCT00473382|473281570|FG002|Core Study|Subject non-compliance|1|||
131451438|NCT00473382|473281568|FG000|Core Study|Subject needed other treatment|1|||
131451439|NCT00473382|473281569|FG001|Core Study|Subject needed other treatment|3|||
131451440|NCT00473382|473281570|FG002|Core Study|Subject needed other treatment|2|||
131451441|NCT00473382|473281568|FG000|Core Study|Subject's decision|12|||
131451442|NCT00473382|473281569|FG001|Core Study|Subject's decision|11|||
131451443|NCT00473382|473281570|FG002|Core Study|Subject's decision|10|||
131451444|NCT00473382|473281568|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
131451445|NCT00473382|473281569|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
131451446|NCT00473382|473281570|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
131846282|NCT00805467|474720090|FG001|Overall Study|Physician Decision|1|||
131846283|NCT00805467|474720091|FG002|Overall Study|Physician Decision|2|||
131846284|NCT00805467|474720092|FG003|Overall Study|Physician Decision|6|||
131846285|NCT00805467|474720089|FG000|Overall Study|Not reported|0|||
131846286|NCT00805467|474720090|FG001|Overall Study|Not reported|0|||
131846287|NCT00805467|474720091|FG002|Overall Study|Not reported|3|||
131451447|NCT00473382|473281568|FG000|Open-label Extension Through Month 48|Death|1|||
131451448|NCT00473382|473281569|FG001|Open-label Extension Through Month 48|Death|3|||
131451449|NCT00473382|473281570|FG002|Open-label Extension Through Month 48|Death|3|||
131451450|NCT00473382|473281568|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
131451451|NCT00473382|473281569|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
131451452|NCT00473382|473281570|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
131451453|NCT00473382|473281568|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
131451454|NCT00473382|473281569|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
131846288|NCT00805467|474720092|FG003|Overall Study|Not reported|7|||
131846289|NCT00213135|474720095|FG000|Overall Study|Adverse Event|9|||
131846290|NCT00213135|474720096|FG001|Overall Study|Adverse Event|5|||
131846291|NCT00213135|474720097|FG002|Overall Study|Adverse Event|5|||
131846292|NCT00213135|474720095|FG000|Overall Study|Lost to Follow-up|11|||
131846293|NCT00213135|474720096|FG001|Overall Study|Lost to Follow-up|8|||
131846294|NCT00213135|474720097|FG002|Overall Study|Lost to Follow-up|4|||
131846295|NCT00213135|474720095|FG000|Overall Study|Protocol Violation|4|||
131846296|NCT00213135|474720096|FG001|Overall Study|Protocol Violation|4|||
131846297|NCT00213135|474720097|FG002|Overall Study|Protocol Violation|10|||
131846298|NCT00213135|474720095|FG000|Overall Study|Death|1|||
131846299|NCT00213135|474720096|FG001|Overall Study|Death|1|||
131846300|NCT00213135|474720097|FG002|Overall Study|Death|2|||
131846301|NCT00213135|474720095|FG000|Overall Study|Disease progression|4|||
131846302|NCT00213135|474720096|FG001|Overall Study|Disease progression|5|||
131846303|NCT00213135|474720097|FG002|Overall Study|Disease progression|21|||
131846304|NCT00213135|474720095|FG000|Overall Study|Other|21|||
131451455|NCT00473382|473281570|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
131846305|NCT00213135|474720096|FG001|Overall Study|Other|12|||
131846306|NCT00213135|474720097|FG002|Overall Study|Other|15|||
131846307|NCT00660907|474720101|FG000|Overall Study|Incorrect Enrollment|1|||
131846308|NCT00660907|474720102|FG001|Overall Study|Incorrect Enrollment|1|||
131846309|NCT00660907|474720101|FG000|Overall Study|Adverse Event|33|||
131846310|NCT00660907|474720102|FG001|Overall Study|Adverse Event|19|||
131846311|NCT00660907|474720101|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
131846312|NCT00660907|474720102|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
131846313|NCT00660907|474720101|FG000|Overall Study|Withdrawal by Subject|23|||
131846314|NCT00660907|474720102|FG001|Overall Study|Withdrawal by Subject|32|||
131846315|NCT00660907|474720101|FG000|Overall Study|Lost to Follow-up|3|||
131846316|NCT00660907|474720102|FG001|Overall Study|Lost to Follow-up|3|||
131846317|NCT00660907|474720101|FG000|Overall Study|Poor/Non-Compliance|5|||
131846318|NCT00660907|474720102|FG001|Overall Study|Poor/Non-Compliance|1|||
131846319|NCT00660907|474720101|FG000|Overall Study|Safety|1|||
131846320|NCT00660907|474720102|FG001|Overall Study|Safety|0|||
131846321|NCT00660907|474720101|FG000|Overall Study|Death|1|||
131846322|NCT00660907|474720102|FG001|Overall Study|Death|3|||
131846323|NCT00660907|474720101|FG000|Overall Study|Various|11|||
131846324|NCT00660907|474720102|FG001|Overall Study|Various|8|||
131846325|NCT04975191|474720105|FG000|Overall Study|Protocol Violation|1|||
131846326|NCT04975191|474720106|FG001|Overall Study|Protocol Violation|2|||
131846327|NCT04975191|474720107|FG002|Overall Study|Protocol Violation|2|||
131846328|NCT04975191|474720108|FG003|Overall Study|Protocol Violation|2|||
131846329|NCT04975191|474720105|FG000|Overall Study|Lost to Follow-up|13|||
131846330|NCT04975191|474720106|FG001|Overall Study|Lost to Follow-up|3|||
131846331|NCT04975191|474720107|FG002|Overall Study|Lost to Follow-up|8|||
131846332|NCT04975191|474720108|FG003|Overall Study|Lost to Follow-up|8|||
131846333|NCT00359801|474720116|FG000|Overall Study|Lost to Follow-up|72|||
131846334|NCT00359801|474720117|FG001|Overall Study|Lost to Follow-up|58|||
131846335|NCT00359801|474720116|FG000|Overall Study|Withdrawal by Subject|143|||
131846336|NCT00359801|474720117|FG001|Overall Study|Withdrawal by Subject|96|||
131846337|NCT00359801|474720116|FG000|Overall Study|Other|66|||
131846338|NCT00359801|474720117|FG001|Overall Study|Other|46|||
131846339|NCT00359801|474720116|FG000|Overall Study|Final Status Unknown: missing data|7|||
131846340|NCT00359801|474720117|FG001|Overall Study|Final Status Unknown: missing data|4|||
131846341|NCT00359801|474720116|FG000|Overall Study|Sponsor Decision|17|||
131846342|NCT00359801|474720117|FG001|Overall Study|Sponsor Decision|16|||
131846343|NCT02618759|474720127|FG000|Overall Study|Lost to Follow-up|0|||
131846344|NCT02618759|474720128|FG001|Overall Study|Lost to Follow-up|1|||
131846345|NCT02618759|474720127|FG000|Overall Study|Withdrawal by Subject|1|||
131846346|NCT02618759|474720128|FG001|Overall Study|Withdrawal by Subject|0|||
131846347|NCT02618759|474720127|FG000|Overall Study|Other Reasons|1|||
131846348|NCT02618759|474720128|FG001|Overall Study|Other Reasons|4|||
131846349|NCT02500043|474720131|FG000|Overall Study|Randomized, but not Treated|2|||
131846350|NCT02500043|474720132|FG001|Overall Study|Randomized, but not Treated|2|||
131846351|NCT02500043|474720131|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
131846352|NCT02500043|474720132|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
131846353|NCT02500043|474720131|FG000|Overall Study|Adverse Event|33|||
131846354|NCT02500043|474720132|FG001|Overall Study|Adverse Event|11|||
131846355|NCT02500043|474720131|FG000|Overall Study|Clinical Progression|54|||
131846356|NCT02500043|474720132|FG001|Overall Study|Clinical Progression|35|||
131846357|NCT02500043|474720131|FG000|Overall Study|Radiological Progression|192|||
131846358|NCT02500043|474720132|FG001|Overall Study|Radiological Progression|110|||
131846359|NCT02500043|474720131|FG000|Overall Study|Physician's Decision|11|||
131846360|NCT02500043|474720132|FG001|Overall Study|Physician's Decision|3|||
131846361|NCT02500043|474720131|FG000|Overall Study|Withdrawal by Subject|14|||
131846362|NCT02500043|474720132|FG001|Overall Study|Withdrawal by Subject|4|||
131846363|NCT02500043|474720131|FG000|Overall Study|Death|11|||
131846364|NCT02500043|474720132|FG001|Overall Study|Death|2|||
131846365|NCT02500043|474720131|FG000|Overall Study|Protocol Deviation|1|||
131846366|NCT02500043|474720132|FG001|Overall Study|Protocol Deviation|0|||
131846367|NCT02856555|474720133|FG000|Overall Study|Adverse Event|1|||
131451456|NCT00473382|473281568|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
131451457|NCT00473382|473281569|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
131451458|NCT00473382|473281570|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
131451459|NCT00473382|473281568|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
131451460|NCT00473382|473281569|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
131451461|NCT00473382|473281570|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
131451462|NCT00473382|473281568|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
131451463|NCT00473382|473281569|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
131451464|NCT00473382|473281570|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
131451465|NCT00473382|473281568|FG000|Open-label Extension Through Month 60|Death|1|||
131451466|NCT00473382|473281569|FG001|Open-label Extension Through Month 60|Death|7|||
131451467|NCT00473382|473281570|FG002|Open-label Extension Through Month 60|Death|4|||
131846368|NCT02856555|474720134|FG001|Overall Study|Adverse Event|0|||
131846369|NCT02856555|474720135|FG002|Overall Study|Adverse Event|0|||
131846370|NCT02856555|474720133|FG000|Overall Study|Lost to Follow-up|1|||
131846371|NCT02856555|474720134|FG001|Overall Study|Lost to Follow-up|3|||
131846372|NCT02856555|474720135|FG002|Overall Study|Lost to Follow-up|0|||
131846373|NCT02856555|474720133|FG000|Overall Study|Withdrawal by Subject|3|||
131846374|NCT02856555|474720134|FG001|Overall Study|Withdrawal by Subject|0|||
131846375|NCT02856555|474720135|FG002|Overall Study|Withdrawal by Subject|0|||
131846376|NCT02856555|474720133|FG000|Overall Study|Randomized but Never Treated|0|||
131846377|NCT02856555|474720134|FG001|Overall Study|Randomized but Never Treated|1|||
131846378|NCT02856555|474720135|FG002|Overall Study|Randomized but Never Treated|0|||
131846379|NCT03333941|474720136|FG000|Overall Study|Lost to Follow-up|10|||
131846380|NCT03333941|474720136|FG000|Overall Study|Death|2|||
131846381|NCT03333941|474720136|FG000|Overall Study|Adverse Event|1|||
131846382|NCT02932306|474720137|FG000|Overall Study|Withdrawal by Subject|16|||
131846383|NCT02932306|474720138|FG001|Overall Study|Withdrawal by Subject|25|||
131846384|NCT02932306|474720137|FG000|Overall Study|Adverse Event|3|||
131846385|NCT02932306|474720138|FG001|Overall Study|Adverse Event|0|||
131846386|NCT02932306|474720137|FG000|Overall Study|Pregnancy|2|||
131846387|NCT02932306|474720138|FG001|Overall Study|Pregnancy|0|||
131846388|NCT02932306|474720137|FG000|Overall Study|Protocol Violation|1|||
131846389|NCT02932306|474720138|FG001|Overall Study|Protocol Violation|1|||
131846390|NCT02932306|474720137|FG000|Overall Study|Noncompliance with Study Drug|1|||
131846391|NCT02932306|474720138|FG001|Overall Study|Noncompliance with Study Drug|1|||
131846392|NCT02932306|474720137|FG000|Overall Study|Lost to Follow-up|36|||
131846393|NCT02932306|474720138|FG001|Overall Study|Lost to Follow-up|40|||
131846394|NCT02932306|474720137|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
131846395|NCT02932306|474720138|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
131846396|NCT02932306|474720137|FG000|Overall Study|Lack of Efficacy|0|||
131846397|NCT02932306|474720138|FG001|Overall Study|Lack of Efficacy|2|||
131846398|NCT02932306|474720137|FG000|Overall Study|Worsening condition|2|||
131846399|NCT02932306|474720138|FG001|Overall Study|Worsening condition|0|||
131846400|NCT02932306|474720137|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
131846401|NCT02932306|474720138|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
131846402|NCT05776862|474720139|FG000|Overall Study|Adverse Event|0|||
131846403|NCT05776862|474720140|FG001|Overall Study|Adverse Event|1|||
131846404|NCT05776862|474720139|FG000|Overall Study|non-compliance|1|||
131846405|NCT05776862|474720140|FG001|Overall Study|non-compliance|0|||
131846406|NCT03151408|474720141|FG000|Overall Study|Adverse Event|24|||
131846407|NCT03151408|474720142|FG001|Overall Study|Adverse Event|23|||
131846408|NCT03151408|474720141|FG000|Overall Study|Death|46|||
131846409|NCT03151408|474720142|FG001|Overall Study|Death|26|||
131846410|NCT03151408|474720141|FG000|Overall Study|Physician Decision|13|||
131451468|NCT00473382|473281568|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
131846411|NCT03151408|474720142|FG001|Overall Study|Physician Decision|19|||
131846412|NCT03151408|474720141|FG000|Overall Study|Withdrawal by Subject|16|||
131846413|NCT03151408|474720142|FG001|Overall Study|Withdrawal by Subject|20|||
131846414|NCT03151408|474720141|FG000|Overall Study|Progressive disease|45|||
131846415|NCT03151408|474720142|FG001|Overall Study|Progressive disease|61|||
131846416|NCT03151408|474720141|FG000|Overall Study|non-compliance by patient|1|||
131846417|NCT03151408|474720142|FG001|Overall Study|non-compliance by patient|0|||
131846418|NCT03151408|474720141|FG000|Overall Study|other reasons|56|||
131846419|NCT03151408|474720142|FG001|Overall Study|other reasons|52|||
131846420|NCT03151408|474720141|FG000|Overall Study|randomized and not treated|2|||
131846421|NCT03151408|474720142|FG001|Overall Study|randomized and not treated|2|||
131846422|NCT01696058|474720148|FG000|Overall Study|Adverse Event|21|||
131846423|NCT01696058|474720149|FG001|Overall Study|Adverse Event|11|||
131846424|NCT01696058|474720148|FG000|Overall Study|Lack of Efficacy|2|||
131846425|NCT01696058|474720149|FG001|Overall Study|Lack of Efficacy|3|||
131846426|NCT01696058|474720148|FG000|Overall Study|Protocol Violation|9|||
131846427|NCT01696058|474720149|FG001|Overall Study|Protocol Violation|3|||
131846428|NCT01696058|474720148|FG000|Overall Study|Lost to Follow-up|2|||
131846429|NCT01696058|474720149|FG001|Overall Study|Lost to Follow-up|5|||
131846430|NCT01696058|474720148|FG000|Overall Study|Withdrawal by Subject|4|||
131846431|NCT01696058|474720149|FG001|Overall Study|Withdrawal by Subject|6|||
131846432|NCT01696058|474720148|FG000|Overall Study|Other reason prematurely discontinued|5|||
131846433|NCT01696058|474720149|FG001|Overall Study|Other reason prematurely discontinued|3|||
131846434|NCT05384171|474720150|FG000|Overall Study|Lost to Follow-up|9|||
131846435|NCT05384171|474720151|FG001|Overall Study|Lost to Follow-up|9|||
131846436|NCT05384171|474720150|FG000|Overall Study|Withdrawal by Subject|3|||
131846437|NCT05384171|474720151|FG001|Overall Study|Withdrawal by Subject|0|||
131846438|NCT00749892|474720152|FG000|Overall Study|Withdrawal by Subject|3|||
131846439|NCT00780910|474720153|FG000|Overall Study|Adverse Event|2|||
131846440|NCT01111825|474720156|FG000|Overall Study|Withdrawal by Subject|0|||
131846441|NCT01111825|474720157|FG001|Overall Study|Withdrawal by Subject|0|||
131846442|NCT01111825|474720158|FG002|Overall Study|Withdrawal by Subject|1|||
131846443|NCT01111825|474720159|FG003|Overall Study|Withdrawal by Subject|0|||
131846444|NCT01111825|474720156|FG000|Overall Study|Lost to Follow-up|0|||
131846445|NCT01111825|474720157|FG001|Overall Study|Lost to Follow-up|0|||
131846446|NCT01111825|474720158|FG002|Overall Study|Lost to Follow-up|3|||
131846447|NCT01111825|474720159|FG003|Overall Study|Lost to Follow-up|1|||
131846448|NCT01111825|474720156|FG000|Overall Study|Adverse Event|2|||
131846449|NCT01111825|474720157|FG001|Overall Study|Adverse Event|1|||
131846450|NCT01111825|474720158|FG002|Overall Study|Adverse Event|4|||
131846451|NCT01111825|474720159|FG003|Overall Study|Adverse Event|0|||
131846452|NCT01111825|474720156|FG000|Overall Study|Disease Progression|1|||
131846453|NCT01111825|474720157|FG001|Overall Study|Disease Progression|0|||
131846454|NCT01111825|474720158|FG002|Overall Study|Disease Progression|0|||
131846455|NCT01111825|474720159|FG003|Overall Study|Disease Progression|0|||
131846456|NCT01111825|474720156|FG000|Overall Study|Discontinuation by Sponsor|0|||
131846457|NCT01111825|474720157|FG001|Overall Study|Discontinuation by Sponsor|0|||
131846458|NCT01111825|474720158|FG002|Overall Study|Discontinuation by Sponsor|0|||
131846459|NCT01111825|474720159|FG003|Overall Study|Discontinuation by Sponsor|20|||
131846460|NCT00106964|474720160|FG000|Overall Study|Lost to Follow-up|8|||
131846461|NCT00106964|474720161|FG001|Overall Study|Lost to Follow-up|6|||
131846462|NCT00106964|474720162|FG002|Overall Study|Lost to Follow-up|2|||
131846463|NCT00106964|474720160|FG000|Overall Study|Pregnancy|2|||
131846464|NCT00106964|474720161|FG001|Overall Study|Pregnancy|3|||
131846465|NCT00106964|474720162|FG002|Overall Study|Pregnancy|2|||
131846466|NCT00106964|474720160|FG000|Overall Study|Death|1|||
131846467|NCT00106964|474720161|FG001|Overall Study|Death|1|||
131846468|NCT00106964|474720162|FG002|Overall Study|Death|0|||
131846469|NCT00106964|474720160|FG000|Overall Study|Incarceration|0|||
131846470|NCT00106964|474720161|FG001|Overall Study|Incarceration|1|||
131846471|NCT00106964|474720162|FG002|Overall Study|Incarceration|0|||
131846472|NCT00106964|474720160|FG000|Overall Study|Site Funding Terminated|0|||
131846473|NCT00106964|474720161|FG001|Overall Study|Site Funding Terminated|1|||
131846474|NCT00106964|474720162|FG002|Overall Study|Site Funding Terminated|1|||
131846475|NCT00106964|474720160|FG000|Overall Study|Failure to adhere|2|||
131846476|NCT00106964|474720161|FG001|Overall Study|Failure to adhere|0|||
131846477|NCT00106964|474720162|FG002|Overall Study|Failure to adhere|0|||
131846478|NCT00106964|474720160|FG000|Overall Study|Did not meet eligibility criteria|0|||
131846479|NCT00106964|474720161|FG001|Overall Study|Did not meet eligibility criteria|2|||
131846480|NCT00106964|474720162|FG002|Overall Study|Did not meet eligibility criteria|2|||
131846481|NCT00106964|474720160|FG000|Overall Study|Required disallowed medication|0|||
131846482|NCT00106964|474720161|FG001|Overall Study|Required disallowed medication|1|||
131846483|NCT00106964|474720162|FG002|Overall Study|Required disallowed medication|0|||
131846484|NCT03207243|474720165|FG000|Overall Study|Adverse Event|2|||
131846485|NCT03207243|474720166|FG001|Overall Study|Adverse Event|2|||
131846486|NCT03207243|474720165|FG000|Overall Study|Loss of Asthma Control|47|||
131846487|NCT03207243|474720166|FG001|Overall Study|Loss of Asthma Control|31|||
131846488|NCT03207243|474720165|FG000|Overall Study|Withdrawal by Subject|2|||
131846489|NCT03207243|474720166|FG001|Overall Study|Withdrawal by Subject|4|||
131846490|NCT03207243|474720165|FG000|Overall Study|Physician Decision|1|||
131846491|NCT03207243|474720166|FG001|Overall Study|Physician Decision|1|||
131846492|NCT03207243|474720165|FG000|Overall Study|Lost to Follow-up|0|||
131846493|NCT03207243|474720166|FG001|Overall Study|Lost to Follow-up|1|||
131846494|NCT03207243|474720165|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
131846495|NCT03207243|474720166|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
131846496|NCT03207243|474720165|FG000|Overall Study|Protocol Violation|0|||
131846497|NCT03207243|474720166|FG001|Overall Study|Protocol Violation|3|||
131846498|NCT02794246|474720169|FG000|Overall Study|Withdrawal by Subject|2|||
131846499|NCT02794246|474720169|FG000|Overall Study|Physician Decision|4|||
131911448|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131846500|NCT01994291|474720170|FG000|Overall Study|Adverse Event|4|||
131911449|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131846501|NCT01994291|474720171|FG001|Overall Study|Adverse Event|1|||
131846502|NCT01994291|474720172|FG002|Overall Study|Adverse Event|3|||
131846503|NCT01994291|474720170|FG000|Overall Study|Lost to Follow-up|1|||
131846504|NCT01994291|474720171|FG001|Overall Study|Lost to Follow-up|1|||
131846505|NCT01994291|474720172|FG002|Overall Study|Lost to Follow-up|0|||
131846506|NCT01994291|474720170|FG000|Overall Study|Does not meet entrance criteria|1|||
131846507|NCT01994291|474720171|FG001|Overall Study|Does not meet entrance criteria|0|||
131846508|NCT01994291|474720172|FG002|Overall Study|Does not meet entrance criteria|0|||
131846509|NCT01994291|474720170|FG000|Overall Study|Medication error without associated AE|1|||
131846510|NCT01994291|474720171|FG001|Overall Study|Medication error without associated AE|0|||
131846511|NCT01994291|474720172|FG002|Overall Study|Medication error without associated AE|1|||
131846512|NCT01994291|474720170|FG000|Overall Study|Protocol Violation|1|||
131846513|NCT01994291|474720171|FG001|Overall Study|Protocol Violation|0|||
131846514|NCT01994291|474720172|FG002|Overall Study|Protocol Violation|0|||
131846515|NCT01994291|474720170|FG000|Overall Study|Withdrawal by Subject|6|||
131846516|NCT01994291|474720171|FG001|Overall Study|Withdrawal by Subject|3|||
131846517|NCT01994291|474720172|FG002|Overall Study|Withdrawal by Subject|5|||
131846518|NCT01994291|474720170|FG000|Overall Study|Other|1|||
131846519|NCT01994291|474720171|FG001|Overall Study|Other|2|||
131846520|NCT01994291|474720172|FG002|Overall Study|Other|0|||
131846521|NCT01775189|474720173|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131846522|NCT01775189|474720174|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
131846523|NCT01775189|474720175|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131846524|NCT01775189|474720176|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131846525|NCT01775189|474720177|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131846526|NCT01775189|474720178|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131846527|NCT01775189|474720179|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
131846528|NCT01775189|474720173|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131846529|NCT01775189|474720174|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
131846530|NCT01775189|474720175|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131846531|NCT01775189|474720176|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131846532|NCT01775189|474720177|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131846533|NCT01775189|474720178|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131846534|NCT01775189|474720179|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
131846535|NCT01775189|474720173|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
131846536|NCT01775189|474720174|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
131846537|NCT01775189|474720175|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
131846538|NCT01775189|474720176|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
131846539|NCT01775189|474720177|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
131846540|NCT01775189|474720178|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
131846541|NCT01775189|474720179|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
131846542|NCT01775189|474720173|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
131846543|NCT01775189|474720174|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
131846544|NCT01775189|474720175|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
131846545|NCT01775189|474720176|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
131846546|NCT01775189|474720177|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
131846547|NCT01775189|474720178|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
131846548|NCT01775189|474720179|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
131846549|NCT01775189|474720173|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
131846550|NCT01775189|474720174|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
131846551|NCT01775189|474720175|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
131846552|NCT01775189|474720176|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
131846553|NCT01775189|474720177|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
131846554|NCT01775189|474720178|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
131846555|NCT01775189|474720179|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
131404482|NCT00521599|473103725|FG002|Overall Study|Protocol Violation|2|||
131404483|NCT00521599|473103723|FG000|Overall Study|Did not meet protocol eligibility|2|||
131404484|NCT00521599|473103724|FG001|Overall Study|Did not meet protocol eligibility|2|||
131404485|NCT00521599|473103725|FG002|Overall Study|Did not meet protocol eligibility|1|||
131404486|NCT01778049|473103726|FG000|Open Label Treatment Period|Adverse Event|5|||
131404487|NCT01778049|473103727|FG001|Open Label Treatment Period|Adverse Event|15|||
131404488|NCT01778049|473103728|FG002|Open Label Treatment Period|Adverse Event|0|||
131404489|NCT01778049|473103729|FG003|Open Label Treatment Period|Adverse Event|0|||
131404490|NCT01778049|473103730|FG004|Open Label Treatment Period|Adverse Event|0|||
131404491|NCT01778049|473103731|FG005|Open Label Treatment Period|Adverse Event|0|||
131404492|NCT01778049|473103726|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
131451469|NCT00473382|473281569|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
131846556|NCT01775189|474720173|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
131846557|NCT01775189|474720174|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
131846558|NCT01775189|474720175|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
131846559|NCT01775189|474720176|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
131846560|NCT01775189|474720177|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
131846561|NCT01775189|474720178|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
131404493|NCT01778049|473103727|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
131846562|NCT01775189|474720179|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
131846563|NCT00856375|474720180|FG000|Overall Study|Other|0|||
131846564|NCT00856375|474720181|FG001|Overall Study|Other|1|||
131846565|NCT00856375|474720180|FG000|Overall Study|Death|32|||
131846566|NCT00856375|474720181|FG001|Overall Study|Death|30|||
131846567|NCT00856375|474720180|FG000|Overall Study|Sponsor Terminated Study|7|||
131846568|NCT00856375|474720181|FG001|Overall Study|Sponsor Terminated Study|7|||
131846569|NCT00856375|474720180|FG000|Overall Study|Withdrawal by Subject|2|||
131846570|NCT00856375|474720181|FG001|Overall Study|Withdrawal by Subject|1|||
131846571|NCT00856375|474720180|FG000|Overall Study|Lost to Follow-up|1|||
131911450|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131846572|NCT00856375|474720181|FG001|Overall Study|Lost to Follow-up|2|||
131846573|NCT00811928|474720186|FG000|Overall Study|AEs and SAEs Including Death|7|||
131846574|NCT00811928|474720187|FG001|Overall Study|AEs and SAEs Including Death|11|||
131911451|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131911452|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
131911453|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
131911454|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131911455|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
131911456|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131911457|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
131911458|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911459|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911460|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911461|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911462|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
131911463|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911464|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
131911465|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
131911466|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911467|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
131911468|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
131911469|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
131911470|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
131911471|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
131911472|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
131911473|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
131911474|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
131911475|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
131911476|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
131911477|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
131911478|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911479|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911480|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911481|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911482|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
131911483|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911484|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911485|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911486|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911487|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
131911488|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911489|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911490|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911491|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911492|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
131911493|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911494|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
131911495|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
131911496|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911497|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
131911498|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911499|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911500|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131846575|NCT00811928|474720186|FG000|Overall Study|Withdrawal by Subject|18|||
131846576|NCT00811928|474720187|FG001|Overall Study|Withdrawal by Subject|12|||
131846577|NCT00811928|474720186|FG000|Overall Study|Did Not Take Study Drug|3|||
131846578|NCT00811928|474720187|FG001|Overall Study|Did Not Take Study Drug|0|||
131846579|NCT00811928|474720186|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
131846580|NCT00811928|474720187|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
131846581|NCT00811928|474720186|FG000|Overall Study|Investigator Decision|2|||
131846582|NCT00811928|474720187|FG001|Overall Study|Investigator Decision|1|||
131846583|NCT00811928|474720186|FG000|Overall Study|Poor Compliance|2|||
131846584|NCT00811928|474720187|FG001|Overall Study|Poor Compliance|5|||
131846585|NCT00171951|474720188|FG000|Overall Study|Adverse Event|1|||
131846586|NCT00171951|474720188|FG000|Overall Study|Abnormal Laboratory Values|2|||
131846587|NCT00171951|474720188|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131846588|NCT00171951|474720188|FG000|Overall Study|Participants Withdrew Consent|3|||
131846589|NCT00171951|474720188|FG000|Overall Study|New Cancer Therapy|5|||
131846590|NCT00171951|474720188|FG000|Overall Study|Reason not Specified|2|||
131846591|NCT00396812|474720189|FG000|Overall Study|Physician Decision|1|||
131846592|NCT03136965|474720196|FG000|Overall Study|Lost to Follow-up|0|||
131846593|NCT03136965|474720197|FG001|Overall Study|Lost to Follow-up|1|||
131846594|NCT03136965|474720198|FG002|Overall Study|Lost to Follow-up|0|||
131846595|NCT02910063|474720201|FG000|Phase 2|Withdrawal by Subject|3|||
131846596|NCT02910063|474720202|FG001|Phase 2|Withdrawal by Subject|0|||
131846597|NCT02910063|474720203|FG002|Phase 2|Withdrawal by Subject|0|||
131846598|NCT02910063|474720201|FG000|Phase 2|Lost to Follow-up|1|||
131846599|NCT02910063|474720202|FG001|Phase 2|Lost to Follow-up|0|||
131846600|NCT02910063|474720203|FG002|Phase 2|Lost to Follow-up|0|||
131846601|NCT02910063|474720201|FG000|Phase 2|Death|24|||
131846602|NCT02910063|474720202|FG001|Phase 2|Death|0|||
131846603|NCT02910063|474720203|FG002|Phase 2|Death|0|||
131846604|NCT03496610|474720204|FG000|Overall Study|Lost to Follow-up|3|||
131846605|NCT03496610|474720205|FG001|Overall Study|Lost to Follow-up|2|||
131846606|NCT03496610|474720204|FG000|Overall Study|Physician Decision|1|||
131846607|NCT03496610|474720205|FG001|Overall Study|Physician Decision|0|||
131846608|NCT03496610|474720204|FG000|Overall Study|Withdrawal by Subject|1|||
131846609|NCT03496610|474720205|FG001|Overall Study|Withdrawal by Subject|0|||
131846610|NCT04435184|474720206|FG000|Overall Study|follow-up blood draws missing|3|||
131846611|NCT04435184|474720207|FG001|Overall Study|follow-up blood draws missing|5|||
131846612|NCT02714426|474720208|FG000|Overall Study|Withdrawal by Subject|2|||
131846613|NCT02714426|474720209|FG001|Overall Study|Withdrawal by Subject|2|||
131846614|NCT04693416|474720213|FG000|Overall Study|Lost to Follow-up|13|||
131846615|NCT04693416|474720214|FG001|Overall Study|Lost to Follow-up|0|||
131846616|NCT00474266|474720215|FG000|Overall Study|Withdrawal by Subject|7|||
131846617|NCT00474266|474720216|FG001|Overall Study|Withdrawal by Subject|20|||
131846618|NCT00474266|474720217|FG002|Overall Study|Withdrawal by Subject|4|||
131846619|NCT00474266|474720218|FG003|Overall Study|Withdrawal by Subject|7|||
131846620|NCT03456453|474720222|FG000|Overall Study|Withdrawal by Subject|2|||
131404494|NCT01778049|473103728|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
131404495|NCT01778049|473103729|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
131404496|NCT01778049|473103730|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
131404497|NCT01778049|473103731|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
131404498|NCT01778049|473103726|FG000|Open Label Treatment Period|Protocol Violation|5|||
131404499|NCT01778049|473103727|FG001|Open Label Treatment Period|Protocol Violation|5|||
131404500|NCT01778049|473103728|FG002|Open Label Treatment Period|Protocol Violation|0|||
131404501|NCT01778049|473103729|FG003|Open Label Treatment Period|Protocol Violation|0|||
131404502|NCT01778049|473103730|FG004|Open Label Treatment Period|Protocol Violation|0|||
131404503|NCT01778049|473103731|FG005|Open Label Treatment Period|Protocol Violation|0|||
131404504|NCT01778049|473103726|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
131404505|NCT01778049|473103727|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
131404506|NCT01778049|473103728|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
131404507|NCT01778049|473103729|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
131404508|NCT01778049|473103730|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
131404509|NCT01778049|473103731|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
131404510|NCT01778049|473103726|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
131404511|NCT01778049|473103727|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
131404512|NCT01778049|473103728|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
131404513|NCT01778049|473103729|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
131846621|NCT03456453|474720223|FG001|Overall Study|Withdrawal by Subject|0|||
131846622|NCT03456453|474720222|FG000|Overall Study|Not released to community|1|||
131846623|NCT03456453|474720223|FG001|Overall Study|Not released to community|5|||
131846624|NCT03456453|474720222|FG000|Overall Study|Lost to Follow-up|0|||
131846625|NCT03456453|474720223|FG001|Overall Study|Lost to Follow-up|2|||
131846626|NCT00642278|474720224|FG000|Overall Study|Adverse Event|2|||
131846627|NCT00642278|474720225|FG001|Overall Study|Adverse Event|1|||
131846628|NCT00642278|474720226|FG002|Overall Study|Adverse Event|3|||
131404514|NCT01778049|473103730|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
131846629|NCT00642278|474720227|FG003|Overall Study|Adverse Event|1|||
131846630|NCT00642278|474720228|FG004|Overall Study|Adverse Event|2|||
131846631|NCT00642278|474720229|FG005|Overall Study|Adverse Event|2|||
131846632|NCT00642278|474720230|FG006|Overall Study|Adverse Event|0|||
131846633|NCT00642278|474720224|FG000|Overall Study|Lack of Efficacy|0|||
131846634|NCT00642278|474720225|FG001|Overall Study|Lack of Efficacy|1|||
131846635|NCT00642278|474720226|FG002|Overall Study|Lack of Efficacy|0|||
131846636|NCT00642278|474720227|FG003|Overall Study|Lack of Efficacy|0|||
131846637|NCT00642278|474720228|FG004|Overall Study|Lack of Efficacy|0|||
131846638|NCT00642278|474720229|FG005|Overall Study|Lack of Efficacy|0|||
131846639|NCT00642278|474720230|FG006|Overall Study|Lack of Efficacy|0|||
131846640|NCT00642278|474720224|FG000|Overall Study|Lost to Follow-up|5|||
131846641|NCT00642278|474720225|FG001|Overall Study|Lost to Follow-up|1|||
131846642|NCT00642278|474720226|FG002|Overall Study|Lost to Follow-up|0|||
131846643|NCT00642278|474720227|FG003|Overall Study|Lost to Follow-up|1|||
131846644|NCT00642278|474720228|FG004|Overall Study|Lost to Follow-up|0|||
131846645|NCT00642278|474720229|FG005|Overall Study|Lost to Follow-up|1|||
131846646|NCT00642278|474720230|FG006|Overall Study|Lost to Follow-up|1|||
131846647|NCT00642278|474720224|FG000|Overall Study|Physician Decision|0|||
131846648|NCT00642278|474720225|FG001|Overall Study|Physician Decision|0|||
131846649|NCT00642278|474720226|FG002|Overall Study|Physician Decision|0|||
131846650|NCT00642278|474720227|FG003|Overall Study|Physician Decision|1|||
131846651|NCT00642278|474720228|FG004|Overall Study|Physician Decision|0|||
131846652|NCT00642278|474720229|FG005|Overall Study|Physician Decision|0|||
131846653|NCT00642278|474720230|FG006|Overall Study|Physician Decision|0|||
131846654|NCT00642278|474720224|FG000|Overall Study|Protocol Violation|0|||
131846655|NCT00642278|474720225|FG001|Overall Study|Protocol Violation|0|||
131846656|NCT00642278|474720226|FG002|Overall Study|Protocol Violation|1|||
131846657|NCT00642278|474720227|FG003|Overall Study|Protocol Violation|1|||
131846658|NCT00642278|474720228|FG004|Overall Study|Protocol Violation|0|||
131846659|NCT00642278|474720229|FG005|Overall Study|Protocol Violation|1|||
131846660|NCT00642278|474720230|FG006|Overall Study|Protocol Violation|2|||
131846661|NCT00642278|474720224|FG000|Overall Study|Withdrawal by Subject|1|||
131846662|NCT00642278|474720225|FG001|Overall Study|Withdrawal by Subject|1|||
131846663|NCT00642278|474720226|FG002|Overall Study|Withdrawal by Subject|1|||
131846664|NCT00642278|474720227|FG003|Overall Study|Withdrawal by Subject|3|||
131846665|NCT00642278|474720228|FG004|Overall Study|Withdrawal by Subject|6|||
131846666|NCT00642278|474720229|FG005|Overall Study|Withdrawal by Subject|2|||
131846667|NCT00642278|474720230|FG006|Overall Study|Withdrawal by Subject|2|||
131846668|NCT00642278|474720224|FG000|Overall Study|Noncompliance with study drug regimen|0|||
131846669|NCT00642278|474720225|FG001|Overall Study|Noncompliance with study drug regimen|0|||
131846670|NCT00642278|474720226|FG002|Overall Study|Noncompliance with study drug regimen|0|||
131846671|NCT00642278|474720227|FG003|Overall Study|Noncompliance with study drug regimen|1|||
131846672|NCT00642278|474720228|FG004|Overall Study|Noncompliance with study drug regimen|0|||
131846673|NCT00642278|474720229|FG005|Overall Study|Noncompliance with study drug regimen|0|||
131846674|NCT00642278|474720230|FG006|Overall Study|Noncompliance with study drug regimen|0|||
131846675|NCT00642278|474720224|FG000|Overall Study|Other|2|||
131846676|NCT00642278|474720225|FG001|Overall Study|Other|1|||
131846677|NCT00642278|474720226|FG002|Overall Study|Other|0|||
131846678|NCT00642278|474720227|FG003|Overall Study|Other|1|||
131846679|NCT00642278|474720228|FG004|Overall Study|Other|0|||
131846680|NCT00642278|474720229|FG005|Overall Study|Other|1|||
131846681|NCT00642278|474720230|FG006|Overall Study|Other|0|||
131846682|NCT00090363|474720231|FG000|Overall Study|Lost to Follow-up|1|||
131846683|NCT00090363|474720232|FG001|Overall Study|Lost to Follow-up|2|||
131846684|NCT00090363|474720233|FG002|Overall Study|Lost to Follow-up|1|||
131846685|NCT00090363|474720231|FG000|Overall Study|Withdrawal by Subject|7|||
131846686|NCT00090363|474720232|FG001|Overall Study|Withdrawal by Subject|7|||
131846687|NCT00090363|474720233|FG002|Overall Study|Withdrawal by Subject|6|||
131846688|NCT00090363|474720231|FG000|Overall Study|Study-specific discontinuation criteria|75|||
131846689|NCT00090363|474720232|FG001|Overall Study|Study-specific discontinuation criteria|74|||
131846690|NCT00090363|474720233|FG002|Overall Study|Study-specific discontinuation criteria|62|||
131846691|NCT00090363|474720231|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131846692|NCT00090363|474720232|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131846693|NCT00090363|474720233|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
131846694|NCT00090363|474720231|FG000|Overall Study|Consent expired|7|||
131846695|NCT00090363|474720232|FG001|Overall Study|Consent expired|10|||
131846696|NCT00090363|474720233|FG002|Overall Study|Consent expired|9|||
131846697|NCT00090363|474720231|FG000|Overall Study|Reasons not specified|2|||
131846698|NCT00090363|474720232|FG001|Overall Study|Reasons not specified|1|||
131846699|NCT00090363|474720233|FG002|Overall Study|Reasons not specified|1|||
131846700|NCT00090363|474720231|FG000|Overall Study|Continuing on study off treatment|14|||
131846701|NCT00090363|474720232|FG001|Overall Study|Continuing on study off treatment|13|||
131846702|NCT00090363|474720233|FG002|Overall Study|Continuing on study off treatment|16|||
131846703|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
131846704|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
131846705|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
131846706|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
131846707|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
131846708|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
131846709|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
131846710|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
131846711|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
131846712|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
131846713|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
131846714|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
131846715|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
131846716|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
131846717|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
131846718|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
131846719|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131846720|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131846721|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131846722|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131846723|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
131846724|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
131846725|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
131846726|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
131846727|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
131846728|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
131846729|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
131846730|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
131846731|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
131846732|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
131846733|NCT03713619|474720234|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
131846734|NCT03713619|474720235|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
131846735|NCT03713619|474720236|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
131846736|NCT03713619|474720237|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
131846737|NCT03713619|474720238|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
131846738|NCT03713619|474720234|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
131846739|NCT03713619|474720235|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
131846740|NCT03713619|474720236|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
131846741|NCT03713619|474720237|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
131846742|NCT03713619|474720238|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
131846743|NCT03713619|474720234|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
131846744|NCT03713619|474720235|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131846745|NCT03713619|474720236|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131846746|NCT03713619|474720237|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
131846747|NCT03713619|474720238|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131846748|NCT03713619|474720234|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
131846749|NCT03713619|474720235|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
131846750|NCT03713619|474720236|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
131846751|NCT03713619|474720237|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
131846752|NCT03713619|474720238|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
131846753|NCT03713619|474720234|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
131846754|NCT03713619|474720235|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
131846755|NCT03713619|474720236|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
131846756|NCT03713619|474720237|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
131846757|NCT03713619|474720238|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
131846758|NCT03713619|474720234|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
131846759|NCT03713619|474720235|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
131911501|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911502|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131404515|NCT01778049|473103731|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
131404516|NCT01778049|473103726|FG000|Open Label Treatment Period|Not treated|2|||
131404517|NCT01778049|473103727|FG001|Open Label Treatment Period|Not treated|1|||
131404518|NCT01778049|473103728|FG002|Open Label Treatment Period|Not treated|0|||
131404519|NCT01778049|473103729|FG003|Open Label Treatment Period|Not treated|0|||
131404520|NCT01778049|473103730|FG004|Open Label Treatment Period|Not treated|0|||
131404521|NCT01778049|473103731|FG005|Open Label Treatment Period|Not treated|0|||
131404522|NCT01778049|473103726|FG000|Open Label Treatment Period|Other reason not defined above|77|||
131404523|NCT01778049|473103727|FG001|Open Label Treatment Period|Other reason not defined above|94|||
131404524|NCT01778049|473103728|FG002|Open Label Treatment Period|Other reason not defined above|0|||
131404525|NCT01778049|473103729|FG003|Open Label Treatment Period|Other reason not defined above|0|||
131404526|NCT01778049|473103730|FG004|Open Label Treatment Period|Other reason not defined above|0|||
131404527|NCT01778049|473103731|FG005|Open Label Treatment Period|Other reason not defined above|0|||
131911503|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911504|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911505|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
131911506|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911507|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
131911508|NCT01232283|474963198|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911509|NCT01232283|474963199|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911510|NCT01232283|474963200|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911511|NCT01232283|474963201|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911512|NCT01232283|474963202|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911513|NCT01232283|474963203|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
131911514|NCT01232283|474963204|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911515|NCT01232283|474963205|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911516|NCT01232283|474963206|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911517|NCT01232283|474963207|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
131911518|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911519|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911520|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911521|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911522|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911523|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911524|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911525|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
131911526|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
131404528|NCT01778049|473103726|FG000|Double Blind Treatment Period|Adverse Event|0|||
131404529|NCT01778049|473103727|FG001|Double Blind Treatment Period|Adverse Event|0|||
131846760|NCT03713619|474720236|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
131846761|NCT03713619|474720237|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
131846762|NCT03713619|474720238|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
131846763|NCT03713619|474720234|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
131846764|NCT03713619|474720235|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
131846765|NCT03713619|474720236|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
131846766|NCT03713619|474720237|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
131846767|NCT03713619|474720238|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
131846768|NCT00121134|474720242|FG000|Overall Study|Progression of Disease|5|||
131846769|NCT00121134|474720243|FG001|Overall Study|Progression of Disease|3|||
131846770|NCT00121134|474720244|FG002|Overall Study|Progression of Disease|4|||
131846771|NCT00121134|474720245|FG003|Overall Study|Progression of Disease|2|||
131846772|NCT00121134|474720242|FG000|Overall Study|Toxicity|4|||
131846773|NCT00121134|474720243|FG001|Overall Study|Toxicity|7|||
131846774|NCT00121134|474720244|FG002|Overall Study|Toxicity|13|||
131846775|NCT00121134|474720245|FG003|Overall Study|Toxicity|5|||
131846776|NCT00121134|474720242|FG000|Overall Study|Physician Decision|6|||
131846777|NCT00121134|474720243|FG001|Overall Study|Physician Decision|4|||
131846778|NCT00121134|474720244|FG002|Overall Study|Physician Decision|4|||
131846779|NCT00121134|474720245|FG003|Overall Study|Physician Decision|1|||
131846780|NCT00121134|474720242|FG000|Overall Study|Treatment Delay|1|||
131846781|NCT00121134|474720243|FG001|Overall Study|Treatment Delay|0|||
131846782|NCT00121134|474720244|FG002|Overall Study|Treatment Delay|0|||
131846783|NCT00121134|474720245|FG003|Overall Study|Treatment Delay|0|||
131846784|NCT00121134|474720242|FG000|Overall Study|Intercurrent Illness|0|||
131846785|NCT00121134|474720243|FG001|Overall Study|Intercurrent Illness|0|||
131846786|NCT00121134|474720244|FG002|Overall Study|Intercurrent Illness|0|||
131846787|NCT00121134|474720245|FG003|Overall Study|Intercurrent Illness|1|||
131846788|NCT00121134|474720242|FG000|Overall Study|Patient Personal Reasons|0|||
131846789|NCT00121134|474720243|FG001|Overall Study|Patient Personal Reasons|1|||
131846790|NCT00121134|474720244|FG002|Overall Study|Patient Personal Reasons|0|||
131846791|NCT00121134|474720245|FG003|Overall Study|Patient Personal Reasons|0|||
131846792|NCT00857584|474720257|FG000|Overall Study|Lack of Efficacy|1|||
131846793|NCT00857584|474720258|FG001|Overall Study|Lack of Efficacy|2|||
131846794|NCT00857584|474720257|FG000|Overall Study|Adverse Event|2|||
131846795|NCT00857584|474720258|FG001|Overall Study|Adverse Event|2|||
131846796|NCT00857584|474720257|FG000|Overall Study|Physician Decision|1|||
131846797|NCT00857584|474720258|FG001|Overall Study|Physician Decision|1|||
131846798|NCT01102374|474720261|FG000|Overall Study|Death|9|||
131846799|NCT01102374|474720262|FG001|Overall Study|Death|13|||
131846800|NCT01102374|474720261|FG000|Overall Study|Lost to Follow-up|7|||
131846801|NCT01102374|474720262|FG001|Overall Study|Lost to Follow-up|6|||
131911527|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
131911528|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911529|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131846802|NCT00418821|474720263|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
131846803|NCT02071849|474720264|FG000|6-month Primary Endpoint|Did not receive device|4|||
131846804|NCT02071849|474720264|FG000|6-month Primary Endpoint|Adverse Event|1|||
131846805|NCT02071849|474720264|FG000|2-year Extended Follow-up|Adverse Event|1|||
131846806|NCT04619992|474720265|FG000|Overall Study|Withdrawal by Subject|1|||
131846807|NCT04619992|474720266|FG001|Overall Study|Withdrawal by Subject|0|||
131846808|NCT01908907|474721768|FG000|Overall Study|Physician Decision|1|||
131846809|NCT01908907|474721769|FG001|Overall Study|Physician Decision|0|||
131846810|NCT01908907|474721768|FG000|Overall Study|Protocol Violation|1|||
131846811|NCT01908907|474721769|FG001|Overall Study|Protocol Violation|0|||
131846812|NCT00761657|474721770|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
131846813|NCT00761657|474721771|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
131846814|NCT00761657|474721772|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
131846815|NCT00761657|474721773|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
131846816|NCT00761657|474721774|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
131846817|NCT00761657|474721775|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
131846818|NCT00761657|474721776|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
131846819|NCT00761657|474721777|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
131846820|NCT00761657|474721778|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
131846821|NCT00761657|474721770|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846822|NCT00761657|474721771|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846823|NCT00761657|474721772|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
131846824|NCT00761657|474721773|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
131846825|NCT00761657|474721774|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846826|NCT00761657|474721775|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846827|NCT00761657|474721776|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846828|NCT00761657|474721777|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846829|NCT00761657|474721778|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
131846830|NCT00761657|474721770|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
131846831|NCT00761657|474721771|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
131846832|NCT00761657|474721772|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
131404530|NCT01778049|473103728|FG002|Double Blind Treatment Period|Adverse Event|4|||
131846833|NCT00761657|474721773|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
131846834|NCT00761657|474721774|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
131846835|NCT00761657|474721775|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
131846836|NCT00761657|474721776|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
131846837|NCT00761657|474721777|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
131846838|NCT00761657|474721778|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
131846839|NCT00761657|474721770|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
131846840|NCT00761657|474721771|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
131846841|NCT00761657|474721772|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
131846842|NCT00761657|474721773|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
131846843|NCT00761657|474721774|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
131846844|NCT00761657|474721775|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
131846845|NCT00761657|474721776|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
131846846|NCT00761657|474721777|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
131846847|NCT00761657|474721778|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
131846848|NCT01396512|474721779|FG000|Overall Study|Withdrawal by Subject|0|||
131846849|NCT01396512|474721780|FG001|Overall Study|Withdrawal by Subject|1|||
131846850|NCT02755649|474721781|FG000|Overall Study|Transitioned into OLE study|99|||
131846851|NCT02755649|474721782|FG001|Overall Study|Transitioned into OLE study|98|||
131846852|NCT02755649|474721783|FG002|Overall Study|Transitioned into OLE study|100|||
131846853|NCT02755649|474721781|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
131846854|NCT02755649|474721782|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
131846855|NCT02755649|474721783|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
131846856|NCT02755649|474721781|FG000|Overall Study|Physician Decision|0|||
131846857|NCT02755649|474721782|FG001|Overall Study|Physician Decision|0|||
131846858|NCT02755649|474721783|FG002|Overall Study|Physician Decision|2|||
131846859|NCT02755649|474721781|FG000|Overall Study|Withdrawal by Subject|0|||
131846860|NCT02755649|474721782|FG001|Overall Study|Withdrawal by Subject|1|||
131846861|NCT02755649|474721783|FG002|Overall Study|Withdrawal by Subject|0|||
131404531|NCT01778049|473103729|FG003|Double Blind Treatment Period|Adverse Event|5|||
131404532|NCT01778049|473103730|FG004|Double Blind Treatment Period|Adverse Event|3|||
131404533|NCT01778049|473103731|FG005|Double Blind Treatment Period|Adverse Event|2|||
131846862|NCT02755649|474721781|FG000|Overall Study|Undecided|1|||
131846863|NCT02755649|474721782|FG001|Overall Study|Undecided|0|||
131846864|NCT02755649|474721783|FG002|Overall Study|Undecided|0|||
131846865|NCT03301649|474721784|FG000|Overall Study|Need alternate therapy due to live lice|17|||
131846866|NCT03301649|474721785|FG001|Overall Study|Need alternate therapy due to live lice|25|||
131846867|NCT03301649|474721786|FG002|Overall Study|Need alternate therapy due to live lice|81|||
131846868|NCT03301649|474721784|FG000|Overall Study|Lost to Follow-up|11|||
131846869|NCT03301649|474721785|FG001|Overall Study|Lost to Follow-up|11|||
131846870|NCT03301649|474721786|FG002|Overall Study|Lost to Follow-up|3|||
131846871|NCT03301649|474721784|FG000|Overall Study|Protocol Violation|0|||
131846872|NCT03301649|474721785|FG001|Overall Study|Protocol Violation|1|||
131846873|NCT03301649|474721786|FG002|Overall Study|Protocol Violation|1|||
131404534|NCT01778049|473103726|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
131404535|NCT01778049|473103727|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
131846874|NCT03301649|474721784|FG000|Overall Study|Withdrawal by Subject|10|||
131846875|NCT03301649|474721785|FG001|Overall Study|Withdrawal by Subject|4|||
131846876|NCT03301649|474721786|FG002|Overall Study|Withdrawal by Subject|0|||
131846877|NCT03301649|474721784|FG000|Overall Study|Other than specified|5|||
131846878|NCT03301649|474721785|FG001|Overall Study|Other than specified|3|||
131846879|NCT03301649|474721786|FG002|Overall Study|Other than specified|0|||
131846880|NCT00837473|474721787|FG000|Overall Study|Lost to Follow-up|1|||
131846881|NCT00837473|474721787|FG000|Overall Study|Withdrawal by Subject|2|||
131846882|NCT01635218|474721788|FG000|Overall Study|Lost to Follow-up|3|||
131846883|NCT01635218|474721789|FG001|Overall Study|Lost to Follow-up|7|||
131846884|NCT01635218|474721790|FG002|Overall Study|Lost to Follow-up|6|||
131846885|NCT03559400|474721791|FG000|Overall Study|Lost to Follow-up|9|||
131846886|NCT03559400|474721792|FG001|Overall Study|Lost to Follow-up|7|||
131846887|NCT03559400|474721791|FG000|Overall Study|Death|0|||
131846888|NCT03559400|474721792|FG001|Overall Study|Death|2|||
131846889|NCT04933968|474721793|FG000|Overall Study|Adverse Event|0|||
131846890|NCT04933968|474721794|FG001|Overall Study|Adverse Event|0|||
131846891|NCT04933968|474721795|FG002|Overall Study|Adverse Event|1|||
131846892|NCT04933968|474721796|FG003|Overall Study|Adverse Event|1|||
131846893|NCT04933968|474721797|FG004|Overall Study|Adverse Event|0|||
131846894|NCT04933968|474721798|FG005|Overall Study|Adverse Event|0|||
131846895|NCT04933968|474721793|FG000|Overall Study|Lost to Follow-up|1|||
131846896|NCT04933968|474721794|FG001|Overall Study|Lost to Follow-up|0|||
131846897|NCT04933968|474721795|FG002|Overall Study|Lost to Follow-up|1|||
131846898|NCT04933968|474721796|FG003|Overall Study|Lost to Follow-up|0|||
131846899|NCT04933968|474721797|FG004|Overall Study|Lost to Follow-up|0|||
131846900|NCT04933968|474721798|FG005|Overall Study|Lost to Follow-up|0|||
131846901|NCT04933968|474721793|FG000|Overall Study|Randomized not treated|1|||
131846902|NCT04933968|474721794|FG001|Overall Study|Randomized not treated|0|||
131846903|NCT04933968|474721795|FG002|Overall Study|Randomized not treated|0|||
131846904|NCT04933968|474721796|FG003|Overall Study|Randomized not treated|0|||
131846905|NCT04933968|474721797|FG004|Overall Study|Randomized not treated|0|||
131846906|NCT04933968|474721798|FG005|Overall Study|Randomized not treated|0|||
131846907|NCT04933968|474721793|FG000|Overall Study|Sponsor terminated study|0|||
131846908|NCT04933968|474721794|FG001|Overall Study|Sponsor terminated study|0|||
131846909|NCT04933968|474721795|FG002|Overall Study|Sponsor terminated study|0|||
131846910|NCT04933968|474721796|FG003|Overall Study|Sponsor terminated study|1|||
131846911|NCT04933968|474721797|FG004|Overall Study|Sponsor terminated study|2|||
131846912|NCT04933968|474721798|FG005|Overall Study|Sponsor terminated study|0|||
131846913|NCT04933968|474721793|FG000|Overall Study|Other|0|||
131846914|NCT04933968|474721794|FG001|Overall Study|Other|0|||
131846915|NCT04933968|474721795|FG002|Overall Study|Other|0|||
131846916|NCT04933968|474721796|FG003|Overall Study|Other|1|||
131846917|NCT04933968|474721797|FG004|Overall Study|Other|0|||
131846918|NCT04933968|474721798|FG005|Overall Study|Other|0|||
131846919|NCT04933968|474721793|FG000|Overall Study|Missing|1|||
131846920|NCT04933968|474721794|FG001|Overall Study|Missing|3|||
131846921|NCT04933968|474721795|FG002|Overall Study|Missing|2|||
131846922|NCT04933968|474721796|FG003|Overall Study|Missing|1|||
131846923|NCT04933968|474721797|FG004|Overall Study|Missing|1|||
131846924|NCT04933968|474721798|FG005|Overall Study|Missing|0|||
131846925|NCT01724489|474721799|FG000|Overall Study|Adverse Event|8|||
131846926|NCT01724489|474721800|FG001|Overall Study|Adverse Event|3|||
131846927|NCT01724489|474721799|FG000|Overall Study|Surgery, medication|1|||
131846928|NCT01724489|474721800|FG001|Overall Study|Surgery, medication|1|||
131846929|NCT01724489|474721799|FG000|Overall Study|Lost to Follow-up|1|||
131846930|NCT01724489|474721800|FG001|Overall Study|Lost to Follow-up|2|||
131846931|NCT01724489|474721799|FG000|Overall Study|Withdrawal by Subject|6|||
131846932|NCT01724489|474721800|FG001|Overall Study|Withdrawal by Subject|6|||
131846933|NCT04576923|474721801|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
131846934|NCT02679235|474721804|FG000|Overall Study|Withdrawal by Subject|3|||
131846935|NCT02679235|474721804|FG000|Overall Study|Adverse Event|1|||
131846936|NCT01473524|474721805|FG000|DB Phase|Adverse Event|4|||
131846937|NCT01473524|474721806|FG001|DB Phase|Adverse Event|8|||
131846938|NCT01473524|474721807|FG002|DB Phase|Adverse Event|2|||
131846939|NCT01473524|474721808|FG003|DB Phase|Adverse Event|0|||
131846940|NCT01473524|474721809|FG004|DB Phase|Adverse Event|0|||
131846941|NCT01473524|474721810|FG005|DB Phase|Adverse Event|0|||
131846942|NCT01473524|474721805|FG000|DB Phase|Death|1|||
131846943|NCT01473524|474721806|FG001|DB Phase|Death|0|||
131846944|NCT01473524|474721807|FG002|DB Phase|Death|0|||
131846945|NCT01473524|474721808|FG003|DB Phase|Death|0|||
131404536|NCT01778049|473103728|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
131846946|NCT01473524|474721809|FG004|DB Phase|Death|0|||
131846947|NCT01473524|474721810|FG005|DB Phase|Death|0|||
131846948|NCT01473524|474721805|FG000|DB Phase|Withdrawal by Subject|2|||
131846949|NCT01473524|474721806|FG001|DB Phase|Withdrawal by Subject|1|||
131846950|NCT01473524|474721807|FG002|DB Phase|Withdrawal by Subject|1|||
131846951|NCT01473524|474721808|FG003|DB Phase|Withdrawal by Subject|0|||
131846952|NCT01473524|474721809|FG004|DB Phase|Withdrawal by Subject|0|||
131846953|NCT01473524|474721810|FG005|DB Phase|Withdrawal by Subject|0|||
131846954|NCT01473524|474721805|FG000|LTSE Phase|Withdrawal by Subject|0|||
131846955|NCT01473524|474721806|FG001|LTSE Phase|Withdrawal by Subject|0|||
131846956|NCT01473524|474721807|FG002|LTSE Phase|Withdrawal by Subject|0|||
131846957|NCT01473524|474721808|FG003|LTSE Phase|Withdrawal by Subject|3|||
131846958|NCT01473524|474721809|FG004|LTSE Phase|Withdrawal by Subject|3|||
131846959|NCT01473524|474721810|FG005|LTSE Phase|Withdrawal by Subject|6|||
131846960|NCT01473524|474721805|FG000|LTSE Phase|Death|0|||
131846961|NCT01473524|474721806|FG001|LTSE Phase|Death|0|||
131846962|NCT01473524|474721807|FG002|LTSE Phase|Death|0|||
131846963|NCT01473524|474721808|FG003|LTSE Phase|Death|0|||
131846964|NCT01473524|474721809|FG004|LTSE Phase|Death|1|||
131846965|NCT01473524|474721810|FG005|LTSE Phase|Death|0|||
131846966|NCT01473524|474721805|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
131846967|NCT01473524|474721806|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
131846968|NCT01473524|474721807|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
131846969|NCT01473524|474721808|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
131846970|NCT01473524|474721809|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
131846971|NCT01473524|474721810|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
131846972|NCT01473524|474721805|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
131846973|NCT01473524|474721806|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
131846974|NCT01473524|474721807|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
131846975|NCT01473524|474721808|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
131846976|NCT01473524|474721809|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
131846977|NCT01473524|474721810|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
131846978|NCT01473524|474721805|FG000|LTSE Phase|Lost to Follow-up|0|||
131846979|NCT01473524|474721806|FG001|LTSE Phase|Lost to Follow-up|0|||
131846980|NCT01473524|474721807|FG002|LTSE Phase|Lost to Follow-up|0|||
131846981|NCT01473524|474721808|FG003|LTSE Phase|Lost to Follow-up|1|||
131846982|NCT01473524|474721809|FG004|LTSE Phase|Lost to Follow-up|3|||
131846983|NCT01473524|474721810|FG005|LTSE Phase|Lost to Follow-up|2|||
131846984|NCT01473524|474721805|FG000|LTSE Phase|Principal Investigator Decision|0|||
131846985|NCT01473524|474721806|FG001|LTSE Phase|Principal Investigator Decision|0|||
131846986|NCT01473524|474721807|FG002|LTSE Phase|Principal Investigator Decision|0|||
131846987|NCT01473524|474721808|FG003|LTSE Phase|Principal Investigator Decision|1|||
131846988|NCT01473524|474721809|FG004|LTSE Phase|Principal Investigator Decision|1|||
131846989|NCT01473524|474721810|FG005|LTSE Phase|Principal Investigator Decision|3|||
131846990|NCT01473524|474721805|FG000|LTSE Phase|Liver Transplantation|0|||
131846991|NCT01473524|474721806|FG001|LTSE Phase|Liver Transplantation|0|||
131846992|NCT01473524|474721807|FG002|LTSE Phase|Liver Transplantation|0|||
131846993|NCT01473524|474721808|FG003|LTSE Phase|Liver Transplantation|0|||
131846994|NCT01473524|474721809|FG004|LTSE Phase|Liver Transplantation|0|||
131846995|NCT01473524|474721810|FG005|LTSE Phase|Liver Transplantation|1|||
131846996|NCT01473524|474721805|FG000|LTSE Phase|Pregnancy|0|||
131846997|NCT01473524|474721806|FG001|LTSE Phase|Pregnancy|0|||
131846998|NCT01473524|474721807|FG002|LTSE Phase|Pregnancy|0|||
131846999|NCT01473524|474721808|FG003|LTSE Phase|Pregnancy|1|||
131847000|NCT01473524|474721809|FG004|LTSE Phase|Pregnancy|0|||
131847001|NCT01473524|474721810|FG005|LTSE Phase|Pregnancy|0|||
131847002|NCT01473524|474721805|FG000|LTSE Phase|Protocol Violation|0|||
131847003|NCT01473524|474721806|FG001|LTSE Phase|Protocol Violation|0|||
131847004|NCT01473524|474721807|FG002|LTSE Phase|Protocol Violation|0|||
131847005|NCT01473524|474721808|FG003|LTSE Phase|Protocol Violation|0|||
131847006|NCT01473524|474721809|FG004|LTSE Phase|Protocol Violation|0|||
131847007|NCT01473524|474721810|FG005|LTSE Phase|Protocol Violation|1|||
131847008|NCT02383810|474721811|FG000|Overall Study|Physician Decision|1|||
131847009|NCT02383810|474721812|FG001|Overall Study|Physician Decision|1|||
131847010|NCT02383810|474721813|FG002|Overall Study|Physician Decision|0|||
131404537|NCT01778049|473103729|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
131404538|NCT01778049|473103730|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
131847011|NCT02383810|474721814|FG003|Overall Study|Physician Decision|0|||
131847012|NCT02383810|474721815|FG004|Overall Study|Physician Decision|0|||
131847013|NCT02383810|474721816|FG005|Overall Study|Physician Decision|0|||
131847014|NCT02383810|474721817|FG006|Overall Study|Physician Decision|0|||
131847015|NCT02383810|474721818|FG007|Overall Study|Physician Decision|0|||
131847016|NCT02383810|474721811|FG000|Overall Study|Withdrawal by Subject|2|||
131847017|NCT02383810|474721812|FG001|Overall Study|Withdrawal by Subject|3|||
131847018|NCT02383810|474721813|FG002|Overall Study|Withdrawal by Subject|3|||
131847019|NCT02383810|474721814|FG003|Overall Study|Withdrawal by Subject|3|||
131847020|NCT02383810|474721815|FG004|Overall Study|Withdrawal by Subject|0|||
131847021|NCT02383810|474721816|FG005|Overall Study|Withdrawal by Subject|0|||
131847022|NCT02383810|474721817|FG006|Overall Study|Withdrawal by Subject|0|||
131847023|NCT02383810|474721818|FG007|Overall Study|Withdrawal by Subject|0|||
131847024|NCT02383810|474721811|FG000|Overall Study|Adverse Event|0|||
131847025|NCT02383810|474721812|FG001|Overall Study|Adverse Event|2|||
131847026|NCT02383810|474721813|FG002|Overall Study|Adverse Event|4|||
131847027|NCT02383810|474721814|FG003|Overall Study|Adverse Event|5|||
131911530|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911531|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911532|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911533|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911534|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911535|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
131911536|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
131911537|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
131911538|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911539|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911540|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911541|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911542|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131404539|NCT01778049|473103731|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
131404540|NCT01778049|473103726|FG000|Double Blind Treatment Period|Protocol Violation|0|||
131404541|NCT01778049|473103727|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131404542|NCT01778049|473103728|FG002|Double Blind Treatment Period|Protocol Violation|2|||
131404543|NCT01778049|473103729|FG003|Double Blind Treatment Period|Protocol Violation|0|||
131404544|NCT01778049|473103730|FG004|Double Blind Treatment Period|Protocol Violation|0|||
131404545|NCT01778049|473103731|FG005|Double Blind Treatment Period|Protocol Violation|0|||
131404546|NCT01778049|473103726|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
131404547|NCT01778049|473103727|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131404548|NCT01778049|473103728|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
131404549|NCT01778049|473103729|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
131404550|NCT01778049|473103730|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
131404551|NCT01778049|473103731|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
131404552|NCT01778049|473103726|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131404553|NCT01778049|473103727|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
131404554|NCT01778049|473103728|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
131404555|NCT01778049|473103729|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
131404556|NCT01778049|473103730|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131404557|NCT01778049|473103731|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
131404558|NCT01778049|473103726|FG000|Double Blind Treatment Period|Not treated|0|||
131404559|NCT01778049|473103727|FG001|Double Blind Treatment Period|Not treated|0|||
131404560|NCT01778049|473103728|FG002|Double Blind Treatment Period|Not treated|0|||
131404561|NCT01778049|473103729|FG003|Double Blind Treatment Period|Not treated|2|||
131404562|NCT01778049|473103730|FG004|Double Blind Treatment Period|Not treated|2|||
131404563|NCT01778049|473103731|FG005|Double Blind Treatment Period|Not treated|0|||
131847028|NCT02383810|474721815|FG004|Overall Study|Adverse Event|0|||
131847029|NCT02383810|474721816|FG005|Overall Study|Adverse Event|1|||
131847030|NCT02383810|474721817|FG006|Overall Study|Adverse Event|1|||
131847031|NCT02383810|474721818|FG007|Overall Study|Adverse Event|0|||
131847032|NCT02383810|474721811|FG000|Overall Study|Lost to Follow-up|0|||
131847033|NCT02383810|474721812|FG001|Overall Study|Lost to Follow-up|1|||
131911543|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911544|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911545|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
131911546|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
131911547|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
131911548|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911549|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911550|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911551|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911552|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911553|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911554|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911555|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
131911556|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
131911557|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
131911558|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131911559|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131911560|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131911561|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131911562|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131847034|NCT02383810|474721813|FG002|Overall Study|Lost to Follow-up|0|||
131847035|NCT02383810|474721814|FG003|Overall Study|Lost to Follow-up|1|||
131847036|NCT02383810|474721815|FG004|Overall Study|Lost to Follow-up|0|||
131847037|NCT02383810|474721816|FG005|Overall Study|Lost to Follow-up|0|||
131847038|NCT02383810|474721817|FG006|Overall Study|Lost to Follow-up|0|||
131847039|NCT02383810|474721818|FG007|Overall Study|Lost to Follow-up|0|||
131847040|NCT02383810|474721811|FG000|Overall Study|other|0|||
131847041|NCT02383810|474721812|FG001|Overall Study|other|0|||
131847042|NCT02383810|474721813|FG002|Overall Study|other|0|||
131847043|NCT02383810|474721814|FG003|Overall Study|other|2|||
131847044|NCT02383810|474721815|FG004|Overall Study|other|0|||
131847045|NCT02383810|474721816|FG005|Overall Study|other|0|||
131847046|NCT02383810|474721817|FG006|Overall Study|other|0|||
131847047|NCT02383810|474721818|FG007|Overall Study|other|0|||
131847048|NCT02383810|474721811|FG000|Overall Study|subject did not receive study treatment|0|||
131847049|NCT02383810|474721812|FG001|Overall Study|subject did not receive study treatment|1|||
131847050|NCT02383810|474721813|FG002|Overall Study|subject did not receive study treatment|0|||
131847051|NCT02383810|474721814|FG003|Overall Study|subject did not receive study treatment|0|||
131847052|NCT02383810|474721815|FG004|Overall Study|subject did not receive study treatment|0|||
131847053|NCT02383810|474721816|FG005|Overall Study|subject did not receive study treatment|0|||
131847054|NCT02383810|474721817|FG006|Overall Study|subject did not receive study treatment|0|||
131847055|NCT02383810|474721818|FG007|Overall Study|subject did not receive study treatment|0|||
131847056|NCT00282919|474721819|FG000|Overall Study|Lack of Efficacy|4|||
131847057|NCT00282919|474721819|FG000|Overall Study|Withdrawal by Subject|1|||
131847058|NCT00282919|474721819|FG000|Overall Study|Asymptomatic Parasitemia|2|||
131847059|NCT02540850|474721822|FG000|Overall Study|Lost to Follow-up|69|||
131847060|NCT02540850|474721823|FG001|Overall Study|Lost to Follow-up|66|||
131847061|NCT02540850|474721824|FG002|Overall Study|Lost to Follow-up|34|||
131847062|NCT02861014|474721826|FG000|Primary Analysis|Adverse Event|7|||
131847063|NCT02861014|474721826|FG000|Primary Analysis|Death|1|||
131847064|NCT02861014|474721826|FG000|Primary Analysis|Lack of Efficacy|3|||
131847065|NCT02861014|474721826|FG000|Primary Analysis|Physician Decision|2|||
131847066|NCT02861014|474721826|FG000|Primary Analysis|Pregnancy|4|||
131847067|NCT02861014|474721826|FG000|Primary Analysis|Protocol Violation|2|||
131847068|NCT02861014|474721826|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
131847069|NCT02861014|474721826|FG000|Primary Analysis|Withdrawal by Subject|14|||
131847070|NCT02861014|474721826|FG000|Primary Analysis|Commercial ocrelizumab|3|||
131847071|NCT02861014|474721826|FG000|Safety Follow-up|Adverse Event|1|||
131847072|NCT02861014|474721826|FG000|Safety Follow-up|Pregnancy|1|||
131847073|NCT02861014|474721826|FG000|Safety Follow-up|Withdrawal by Subject|9|||
131847074|NCT02861014|474721826|FG000|Safety Follow-up|Study terminated by sponsor|1|||
131847075|NCT02861014|474721826|FG000|Safety Follow-up|Physician Decision|1|||
131847076|NCT02861014|474721826|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
131847077|NCT02861014|474721826|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
131847078|NCT00926783|474721827|FG000|Overall Study|Incomplete CFAE Procedures|3|||
131847079|NCT00926783|474721828|FG001|Overall Study|Incomplete CFAE Procedures|3|||
131847080|NCT02549027|474721830|FG000|Washout After Period 4|Withdrawal by Subject|0|||
131847081|NCT02549027|474721831|FG001|Washout After Period 4|Withdrawal by Subject|1|||
131847082|NCT02549027|474721832|FG002|Washout After Period 4|Withdrawal by Subject|1|||
131847083|NCT02549027|474721833|FG003|Washout After Period 4|Withdrawal by Subject|1|||
131847084|NCT02549027|474721834|FG004|Washout After Period 4|Withdrawal by Subject|0|||
131847085|NCT02549027|474721835|FG005|Washout After Period 4|Withdrawal by Subject|0|||
131847086|NCT02549027|474721830|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
131911563|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131847087|NCT02549027|474721831|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
131847088|NCT02549027|474721832|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
131847089|NCT02549027|474721833|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
131847090|NCT02549027|474721834|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
131847091|NCT02549027|474721835|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
131911564|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131847092|NCT02278055|474721836|FG000|Overall Study|Adverse Event|1|||
131847093|NCT02278055|474721836|FG000|Overall Study|Lost to Follow-up|1|||
131847094|NCT02278055|474721836|FG000|Overall Study|Withdrawal by Subject|2|||
131847095|NCT02278055|474721836|FG000|Overall Study|Progressive Disease|4|||
131847096|NCT02186834|474721837|FG000|Dose Escalation|Death|0|||
131847097|NCT02186834|474721838|FG001|Dose Escalation|Death|0|||
131847098|NCT02186834|474721839|FG002|Dose Escalation|Death|0|||
131847099|NCT02186834|474721840|FG003|Dose Escalation|Death|1|||
131847100|NCT02186834|474721841|FG004|Dose Escalation|Death|0|||
131847101|NCT02186834|474721842|FG005|Dose Escalation|Death|0|||
131847102|NCT02186834|474721837|FG000|Treatment at RP2D|Died prior to treatment|0|||
131911565|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
131911566|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
131911567|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
131911568|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131847103|NCT02186834|474721838|FG001|Treatment at RP2D|Died prior to treatment|0|||
131847104|NCT02186834|474721839|FG002|Treatment at RP2D|Died prior to treatment|0|||
131847105|NCT02186834|474721840|FG003|Treatment at RP2D|Died prior to treatment|0|||
131911569|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911570|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911571|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911572|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911573|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911574|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911575|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911576|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
131911577|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
131911578|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131911579|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131911580|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131911581|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131847106|NCT02186834|474721841|FG004|Treatment at RP2D|Died prior to treatment|0|||
131847107|NCT02186834|474721842|FG005|Treatment at RP2D|Died prior to treatment|1|||
131847108|NCT01421511|474721846|FG000|Overall Study|Lost to Follow-up|11|||
131847109|NCT01421511|474721847|FG001|Overall Study|Lost to Follow-up|14|||
131847110|NCT01421511|474721846|FG000|Overall Study|Randomized but didn't receive study drug|1|||
131847111|NCT01421511|474721847|FG001|Overall Study|Randomized but didn't receive study drug|7|||
131847112|NCT01421511|474721846|FG000|Overall Study|Physician Decision|0|||
131847113|NCT01421511|474721847|FG001|Overall Study|Physician Decision|1|||
131847114|NCT01421511|474721846|FG000|Overall Study|Withdrawal by Subject|6|||
131847115|NCT01421511|474721847|FG001|Overall Study|Withdrawal by Subject|5|||
131847116|NCT01421511|474721846|FG000|Overall Study|Death|1|||
131847117|NCT01421511|474721847|FG001|Overall Study|Death|1|||
131847118|NCT04581369|474721848|FG000|Overall Study|Death|7|||
131847119|NCT04581369|474721849|FG001|Overall Study|Death|6|||
131847120|NCT04581369|474721850|FG002|Overall Study|Death|0|||
131847121|NCT04581369|474721848|FG000|Overall Study|Lost to Follow-up|7|||
131847122|NCT04581369|474721849|FG001|Overall Study|Lost to Follow-up|3|||
131911582|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131911583|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131847123|NCT04581369|474721850|FG002|Overall Study|Lost to Follow-up|0|||
131847124|NCT04581369|474721848|FG000|Overall Study|liver transplant|2|||
131847125|NCT04581369|474721849|FG001|Overall Study|liver transplant|2|||
131847126|NCT04581369|474721850|FG002|Overall Study|liver transplant|0|||
131847127|NCT04581369|474721848|FG000|Overall Study|transitioned to hospice care|0|||
131847128|NCT04581369|474721849|FG001|Overall Study|transitioned to hospice care|5|||
131847129|NCT04581369|474721850|FG002|Overall Study|transitioned to hospice care|0|||
131847130|NCT00168818|474721854|FG000|Overall Study|Adverse Event|23|||
131847131|NCT00168818|474721855|FG001|Overall Study|Adverse Event|29|||
131847132|NCT00168818|474721856|FG002|Overall Study|Adverse Event|31|||
131847133|NCT00168818|474721854|FG000|Overall Study|Protocol Violation|16|||
131847134|NCT00168818|474721855|FG001|Overall Study|Protocol Violation|11|||
131847135|NCT00168818|474721856|FG002|Overall Study|Protocol Violation|11|||
131847136|NCT00168818|474721854|FG000|Overall Study|Lost to Follow-up|13|||
131847137|NCT00168818|474721855|FG001|Overall Study|Lost to Follow-up|4|||
131847138|NCT00168818|474721856|FG002|Overall Study|Lost to Follow-up|15|||
131847139|NCT00168818|474721854|FG000|Overall Study|Withdrawal by Subject|43|||
131847140|NCT00168818|474721855|FG001|Overall Study|Withdrawal by Subject|41|||
131847141|NCT00168818|474721856|FG002|Overall Study|Withdrawal by Subject|37|||
131847142|NCT00168818|474721854|FG000|Overall Study|Other|22|||
131847143|NCT00168818|474721855|FG001|Overall Study|Other|24|||
131847144|NCT00168818|474721856|FG002|Overall Study|Other|30|||
131847145|NCT00168818|474721854|FG000|Treatment|Adverse Event|77|||
131847146|NCT00168818|474721855|FG001|Treatment|Adverse Event|89|||
131847147|NCT00168818|474721856|FG002|Treatment|Adverse Event|68|||
131847148|NCT00168818|474721854|FG000|Treatment|Protocol Violation|8|||
131847149|NCT00168818|474721855|FG001|Treatment|Protocol Violation|11|||
131847150|NCT00168818|474721856|FG002|Treatment|Protocol Violation|11|||
131847151|NCT00168818|474721854|FG000|Treatment|Lost to Follow-up|0|||
131847152|NCT00168818|474721855|FG001|Treatment|Lost to Follow-up|2|||
131847153|NCT00168818|474721856|FG002|Treatment|Lost to Follow-up|1|||
131847154|NCT00168818|474721854|FG000|Treatment|Withdrawal by Subject|25|||
131847155|NCT00168818|474721855|FG001|Treatment|Withdrawal by Subject|20|||
131847156|NCT00168818|474721856|FG002|Treatment|Withdrawal by Subject|22|||
131847157|NCT00168818|474721854|FG000|Treatment|Other|23|||
131847158|NCT00168818|474721855|FG001|Treatment|Other|29|||
131847159|NCT00168818|474721856|FG002|Treatment|Other|31|||
131847160|NCT04602546|474721859|FG000|Overall Study|Training|2|||
131911584|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131847161|NCT04602546|474721860|FG001|Overall Study|Training|2|||
131847162|NCT04602546|474721861|FG002|Overall Study|Training|1|||
131847163|NCT04602546|474721862|FG003|Overall Study|Training|2|||
131847164|NCT04602546|474721863|FG004|Overall Study|Training|0|||
131847165|NCT04602546|474721859|FG000|Overall Study|Randomized with disqualified data|2|||
131847166|NCT04602546|474721860|FG001|Overall Study|Randomized with disqualified data|0|||
131847167|NCT04602546|474721861|FG002|Overall Study|Randomized with disqualified data|2|||
131847168|NCT04602546|474721862|FG003|Overall Study|Randomized with disqualified data|5|||
131847169|NCT04602546|474721863|FG004|Overall Study|Randomized with disqualified data|3|||
131847170|NCT00741286|474721869|FG000|Overall Study|Lost to Follow-up|15|||
131847171|NCT00741286|474721870|FG001|Overall Study|Lost to Follow-up|10|||
131847172|NCT00741286|474721869|FG000|Overall Study|Adverse Event|1|||
131847173|NCT00741286|474721870|FG001|Overall Study|Adverse Event|6|||
131847174|NCT00741286|474721869|FG000|Overall Study|Protocol Violation|3|||
131847175|NCT00741286|474721870|FG001|Overall Study|Protocol Violation|2|||
131847176|NCT00741286|474721869|FG000|Overall Study|Primary Outcome|1|||
131847177|NCT00741286|474721870|FG001|Overall Study|Primary Outcome|1|||
131847178|NCT01831258|474721871|FG000|Overall Study|Withdrawal by Subject|2|||
131847179|NCT01831258|474721872|FG001|Overall Study|Withdrawal by Subject|1|||
131847180|NCT01831258|474721871|FG000|Overall Study|Lost to Follow-up|3|||
131847181|NCT01831258|474721872|FG001|Overall Study|Lost to Follow-up|2|||
131847182|NCT01661062|474721873|FG000|Overall Study|Completed Treatment Off Study|3|||
131847183|NCT01661062|474721873|FG000|Overall Study|Withdrawal by Subject|2|||
131847184|NCT02015065|474721876|FG000|Overall Study|Death on study|1|||
131847185|NCT02015065|474721877|FG001|Overall Study|Death on study|2|||
131847186|NCT02015065|474721878|FG002|Overall Study|Death on study|1|||
131847187|NCT00233402|474721879|FG000|Overall Study|No pathology data|12|||
131847188|NCT00233402|474721880|FG001|Overall Study|No pathology data|9|||
131847189|NCT00233402|474721879|FG000|Overall Study|No Ta/T1|89|||
131847190|NCT00233402|474721880|FG001|Overall Study|No Ta/T1|94|||
131847191|NCT00233402|474721879|FG000|Overall Study|Lost to follow up etc|3|||
131847192|NCT00233402|474721880|FG001|Overall Study|Lost to follow up etc|21|||
131847193|NCT02087189|474721883|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
131847194|NCT01189487|474721884|FG000|Overall Study|Lack of Efficacy|2|||
131847195|NCT01189487|474721884|FG000|Overall Study|Adverse Event|1|||
131847196|NCT04630158|474721885|FG000|Overall Study|Adverse Event|1|||
131847197|NCT04630158|474721886|FG001|Overall Study|Adverse Event|1|||
131847198|NCT04630158|474721887|FG002|Overall Study|Adverse Event|1|||
131847199|NCT04630158|474721885|FG000|Overall Study|Physician Decision|0|||
131847200|NCT04630158|474721886|FG001|Overall Study|Physician Decision|2|||
131847201|NCT04630158|474721887|FG002|Overall Study|Physician Decision|0|||
131847202|NCT04630158|474721885|FG000|Overall Study|Protocol Violation|1|||
131847203|NCT04630158|474721886|FG001|Overall Study|Protocol Violation|0|||
131847204|NCT04630158|474721887|FG002|Overall Study|Protocol Violation|1|||
131847205|NCT04630158|474721885|FG000|Overall Study|Withdrawal by Subject|2|||
131847206|NCT04630158|474721886|FG001|Overall Study|Withdrawal by Subject|1|||
131847207|NCT04630158|474721887|FG002|Overall Study|Withdrawal by Subject|2|||
131847208|NCT03485365|474721892|FG000|Overall Study|Protocol Violation|0|||
131847209|NCT03485365|474721893|FG001|Overall Study|Protocol Violation|0|||
131847210|NCT03485365|474721894|FG002|Overall Study|Protocol Violation|0|||
131847211|NCT03485365|474721895|FG003|Overall Study|Protocol Violation|1|||
131847212|NCT03485365|474721896|FG004|Overall Study|Protocol Violation|0|||
131847213|NCT03485365|474721897|FG005|Overall Study|Protocol Violation|0|||
131847214|NCT03485365|474721898|FG006|Overall Study|Protocol Violation|1|||
131847215|NCT03485365|474721899|FG007|Overall Study|Protocol Violation|0|||
131847216|NCT03485365|474721900|FG008|Overall Study|Protocol Violation|0|||
131847217|NCT04868968|474721903|FG000|Overall Study|Lost to Follow-up|1|||
131847218|NCT00843635|474721906|FG000|Overall Study|Adverse Event|2|||
131847219|NCT00843635|474721907|FG001|Overall Study|Adverse Event|2|||
131847220|NCT00843635|474721908|FG002|Overall Study|Adverse Event|0|||
131847221|NCT00813800|474721909|FG000|Overall Study|Screen Failure after Consent|2|||
131847222|NCT00813800|474721909|FG000|Overall Study|Adverse Event|1|||
131847223|NCT00813800|474721909|FG000|Overall Study|Worsening of depression|2|||
131847224|NCT00813800|474721909|FG000|Overall Study|Physician Decision|1|||
131847225|NCT01860677|474721910|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
131847226|NCT01860677|474721911|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
131847227|NCT00896480|474721912|FG000|Overall Study|Disease progression/recurrence|21|||
131847228|NCT05038800|474721914|FG000|Overall Study|Death|1|||
131847229|NCT05038800|474721915|FG001|Overall Study|Death|1|||
131847230|NCT05038800|474721916|FG002|Overall Study|Death|5|||
131847231|NCT05038800|474721917|FG003|Overall Study|Death|3|||
131847232|NCT05038800|474721918|FG004|Overall Study|Death|1|||
131847233|NCT05038800|474721914|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131847234|NCT05038800|474721915|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131847235|NCT05038800|474721916|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131847236|NCT05038800|474721917|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131847237|NCT05038800|474721918|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131847238|NCT05038800|474721914|FG000|Overall Study|Lack of Efficacy|0|||
131847239|NCT05038800|474721915|FG001|Overall Study|Lack of Efficacy|0|||
131847240|NCT05038800|474721916|FG002|Overall Study|Lack of Efficacy|0|||
131847241|NCT05038800|474721917|FG003|Overall Study|Lack of Efficacy|0|||
131847242|NCT05038800|474721918|FG004|Overall Study|Lack of Efficacy|1|||
131847243|NCT00197496|474721919|FG000|Baseline to Discharge|not interested|1|||
131847244|NCT00197496|474721920|FG001|Baseline to Discharge|not interested|0|||
131847245|NCT00197496|474721919|FG000|Baseline to Discharge|MRSA|1|||
131847246|NCT00197496|474721920|FG001|Baseline to Discharge|MRSA|0|||
131847247|NCT00197496|474721919|FG000|Baseline to Discharge|Physician Decision|0|||
131847248|NCT00197496|474721920|FG001|Baseline to Discharge|Physician Decision|1|||
131847249|NCT00197496|474721919|FG000|Baseline to Discharge|Protocol Violation|0|||
131847250|NCT00197496|474721920|FG001|Baseline to Discharge|Protocol Violation|1|||
131847251|NCT00197496|474721919|FG000|Follow-up|Lost to Follow-up|2|||
131847252|NCT00197496|474721920|FG001|Follow-up|Lost to Follow-up|1|||
131847253|NCT00259272|474721922|FG000|Overall Study|Adverse Event|2|||
131847254|NCT00259272|474721923|FG001|Overall Study|Adverse Event|1|||
131847255|NCT00259272|474721924|FG002|Overall Study|Adverse Event|0|||
131847256|NCT00259272|474721925|FG003|Overall Study|Adverse Event|3|||
131847257|NCT00259272|474721922|FG000|Overall Study|Lack of Efficacy|5|||
131847258|NCT00259272|474721923|FG001|Overall Study|Lack of Efficacy|1|||
131847259|NCT00259272|474721924|FG002|Overall Study|Lack of Efficacy|2|||
131847260|NCT00259272|474721925|FG003|Overall Study|Lack of Efficacy|6|||
131847261|NCT00259272|474721922|FG000|Overall Study|Physician Decision|1|||
131847262|NCT00259272|474721923|FG001|Overall Study|Physician Decision|2|||
131847263|NCT00259272|474721924|FG002|Overall Study|Physician Decision|1|||
131847264|NCT00259272|474721925|FG003|Overall Study|Physician Decision|3|||
131847265|NCT00259272|474721922|FG000|Overall Study|Protocol Violation|2|||
131847266|NCT00259272|474721923|FG001|Overall Study|Protocol Violation|0|||
131847267|NCT00259272|474721924|FG002|Overall Study|Protocol Violation|0|||
131847268|NCT00259272|474721925|FG003|Overall Study|Protocol Violation|1|||
131847269|NCT00259272|474721922|FG000|Overall Study|Sponsor Decision|0|||
131847270|NCT00259272|474721923|FG001|Overall Study|Sponsor Decision|1|||
131847271|NCT00259272|474721924|FG002|Overall Study|Sponsor Decision|0|||
131847272|NCT00259272|474721925|FG003|Overall Study|Sponsor Decision|0|||
131847273|NCT00259272|474721922|FG000|Overall Study|Withdrawal by Subject|4|||
131847274|NCT00259272|474721923|FG001|Overall Study|Withdrawal by Subject|2|||
131847275|NCT00259272|474721924|FG002|Overall Study|Withdrawal by Subject|2|||
131847276|NCT00259272|474721925|FG003|Overall Study|Withdrawal by Subject|7|||
131847277|NCT00259272|474721922|FG000|Overall Study|Lost to Follow-up|1|||
131847278|NCT00259272|474721923|FG001|Overall Study|Lost to Follow-up|0|||
131847279|NCT00259272|474721924|FG002|Overall Study|Lost to Follow-up|0|||
131847280|NCT00259272|474721925|FG003|Overall Study|Lost to Follow-up|1|||
131847281|NCT00658021|474721926|FG000|28-Week Treatment Period|Adverse Event|3|||
131847282|NCT00658021|474721927|FG001|28-Week Treatment Period|Adverse Event|1|||
131847283|NCT00658021|474721928|FG002|28-Week Treatment Period|Adverse Event|0|||
131847284|NCT00658021|474721926|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
131847285|NCT00658021|474721927|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
131847286|NCT00658021|474721928|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
131847287|NCT00658021|474721926|FG000|28-Week Treatment Period|Protocol Violation|0|||
131847288|NCT00658021|474721927|FG001|28-Week Treatment Period|Protocol Violation|2|||
131847289|NCT00658021|474721928|FG002|28-Week Treatment Period|Protocol Violation|1|||
131847290|NCT00658021|474721926|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
131847291|NCT00658021|474721927|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
131847292|NCT00658021|474721928|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
131847293|NCT00658021|474721926|FG000|28-Week Treatment Period|Physician Decision|1|||
131847294|NCT00658021|474721927|FG001|28-Week Treatment Period|Physician Decision|2|||
131847295|NCT00658021|474721928|FG002|28-Week Treatment Period|Physician Decision|1|||
131847296|NCT00658021|474721926|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
131847297|NCT00658021|474721927|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
131847298|NCT00658021|474721928|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
131847299|NCT00658021|474721926|FG000|28-Week Treatment Period|Loss of glucose control|1|||
131847300|NCT00658021|474721927|FG001|28-Week Treatment Period|Loss of glucose control|1|||
131847301|NCT00658021|474721928|FG002|28-Week Treatment Period|Loss of glucose control|10|||
131847302|NCT00658021|474721926|FG000|28-Week Treatment Period|Other|2|||
131847303|NCT00658021|474721927|FG001|28-Week Treatment Period|Other|3|||
131847304|NCT00658021|474721928|FG002|28-Week Treatment Period|Other|1|||
131847305|NCT00658021|474721926|FG000|28-Week Treatment Period|Did not receive treatment|2|||
131847306|NCT00658021|474721927|FG001|28-Week Treatment Period|Did not receive treatment|0|||
131847307|NCT00658021|474721928|FG002|28-Week Treatment Period|Did not receive treatment|0|||
131847308|NCT00658021|474721926|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
131847309|NCT00658021|474721927|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
131847310|NCT00658021|474721928|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
131847311|NCT00658021|474721926|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
131847312|NCT00658021|474721927|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
131847313|NCT00658021|474721928|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
131847314|NCT04123561|474721936|FG000|Overall Study|Lost to Follow-up|20|||
131847315|NCT04123561|474721937|FG001|Overall Study|Lost to Follow-up|12|||
131847316|NCT04123561|474721938|FG002|Overall Study|Lost to Follow-up|5|||
131847317|NCT04123561|474721936|FG000|Overall Study|Withdrawal by Subject|9|||
131847318|NCT04123561|474721937|FG001|Overall Study|Withdrawal by Subject|7|||
131451470|NCT00473382|473281570|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
131451471|NCT00473382|473281568|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
131451472|NCT00473382|473281569|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
131451473|NCT00473382|473281570|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
131451474|NCT00473382|473281568|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
131451475|NCT00473382|473281569|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
131451476|NCT00473382|473281570|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
131451477|NCT00473382|473281568|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
131451478|NCT00473382|473281569|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
131451479|NCT00473382|473281570|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
131451480|NCT01134055|473281571|FG000|Overall Study|Adverse Event|5|||
131451481|NCT01134055|473281572|FG001|Overall Study|Adverse Event|2|||
131451482|NCT01134055|473281573|FG002|Overall Study|Adverse Event|2|||
131451483|NCT01134055|473281574|FG003|Overall Study|Adverse Event|2|||
131451484|NCT01134055|473281575|FG004|Overall Study|Adverse Event|5|||
131451485|NCT01134055|473281576|FG005|Overall Study|Adverse Event|7|||
131451486|NCT01134055|473281577|FG006|Overall Study|Adverse Event|2|||
131847319|NCT04123561|474721938|FG002|Overall Study|Withdrawal by Subject|9|||
131847320|NCT04123561|474721936|FG000|Overall Study|Lack of Efficacy|7|||
131847321|NCT04123561|474721937|FG001|Overall Study|Lack of Efficacy|8|||
131847322|NCT04123561|474721938|FG002|Overall Study|Lack of Efficacy|6|||
131847323|NCT04123561|474721936|FG000|Overall Study|Adverse Event|5|||
131847324|NCT04123561|474721937|FG001|Overall Study|Adverse Event|2|||
131847325|NCT04123561|474721938|FG002|Overall Study|Adverse Event|3|||
131847326|NCT04123561|474721936|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
131847327|NCT04123561|474721937|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
131847328|NCT04123561|474721938|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
131847329|NCT04123561|474721936|FG000|Overall Study|Death|0|||
131847330|NCT04123561|474721937|FG001|Overall Study|Death|0|||
131847331|NCT04123561|474721938|FG002|Overall Study|Death|1|||
131847332|NCT04123561|474721936|FG000|Overall Study|Protocol Violation|0|||
131847333|NCT04123561|474721937|FG001|Overall Study|Protocol Violation|1|||
131847334|NCT04123561|474721938|FG002|Overall Study|Protocol Violation|0|||
131847335|NCT03462459|474721943|FG000|Overall Study|Death|1|||
131847336|NCT03462459|474721944|FG001|Overall Study|Death|0|||
131847337|NCT03462459|474721943|FG000|Overall Study|Lack of Efficacy|2|||
131847338|NCT03462459|474721944|FG001|Overall Study|Lack of Efficacy|4|||
131847339|NCT03462459|474721943|FG000|Overall Study|Lost to Follow-up|1|||
131847340|NCT03462459|474721944|FG001|Overall Study|Lost to Follow-up|3|||
131847341|NCT03462459|474721943|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
131847342|NCT03462459|474721944|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
131847343|NCT03462459|474721943|FG000|Overall Study|Withdrawal by Subject|3|||
131847344|NCT03462459|474721944|FG001|Overall Study|Withdrawal by Subject|2|||
131847345|NCT03462459|474721943|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
131847346|NCT03462459|474721944|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
131847347|NCT03132155|474723555|FG000|Overall Study|Lack of Efficacy|6|||
131847348|NCT03132155|474723555|FG000|Overall Study|Lost to Follow-up|1|||
131847349|NCT03132155|474723555|FG000|Overall Study|Withdrawal by Subject|1|||
131847350|NCT00270855|474723562|FG000|Overall Study|Withdrawal by Subject|8|||
131847351|NCT00270855|474723563|FG001|Overall Study|Withdrawal by Subject|8|||
131847352|NCT02152605|474723567|FG000|Overall Study|Adverse Event|6|||
131847353|NCT02152605|474723568|FG001|Overall Study|Adverse Event|8|||
131847354|NCT02152605|474723567|FG000|Overall Study|Lack of Efficacy|7|||
131847355|NCT02152605|474723568|FG001|Overall Study|Lack of Efficacy|4|||
131847356|NCT02152605|474723567|FG000|Overall Study|Protocol deviation|1|||
131847357|NCT02152605|474723568|FG001|Overall Study|Protocol deviation|4|||
131847358|NCT02152605|474723567|FG000|Overall Study|Lost to Follow-up|1|||
131847359|NCT02152605|474723568|FG001|Overall Study|Lost to Follow-up|0|||
131847360|NCT02152605|474723567|FG000|Overall Study|Withdrew consent|4|||
131847361|NCT02152605|474723568|FG001|Overall Study|Withdrew consent|2|||
131847362|NCT03262038|474723569|FG000|Overall Study|Withdrawal by Subject|0|||
131847363|NCT03262038|474723570|FG001|Overall Study|Withdrawal by Subject|1|||
131847364|NCT00923273|474723571|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
131451487|NCT01134055|473281571|FG000|Overall Study|Lost to Follow-up|0|||
131847365|NCT00923273|474723572|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
131847366|NCT00923273|474723573|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
131847367|NCT00923273|474723574|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
131847368|NCT00923273|474723575|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
131847369|NCT00923273|474723571|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
131847370|NCT00923273|474723572|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
131451488|NCT01134055|473281572|FG001|Overall Study|Lost to Follow-up|1|||
131451489|NCT01134055|473281573|FG002|Overall Study|Lost to Follow-up|0|||
131847371|NCT00923273|474723573|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
131847372|NCT00923273|474723574|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
131847373|NCT00923273|474723575|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
131847374|NCT00094861|474723576|FG000|Overall Study|Adverse Event|5|||
131847375|NCT00094861|474723577|FG001|Overall Study|Adverse Event|2|||
131847376|NCT00094861|474723576|FG000|Overall Study|Withdrawal by Subject|5|||
131847377|NCT00094861|474723577|FG001|Overall Study|Withdrawal by Subject|3|||
131847378|NCT00094861|474723576|FG000|Overall Study|Physician Decision|1|||
131847379|NCT00094861|474723577|FG001|Overall Study|Physician Decision|1|||
131847380|NCT00094861|474723576|FG000|Overall Study|Lost to Follow-up|0|||
131847381|NCT00094861|474723577|FG001|Overall Study|Lost to Follow-up|1|||
131847382|NCT00094861|474723576|FG000|Overall Study|Death|4|||
131847383|NCT00094861|474723577|FG001|Overall Study|Death|2|||
131847384|NCT00094861|474723576|FG000|Overall Study|Other|3|||
131847385|NCT00094861|474723577|FG001|Overall Study|Other|0|||
131847386|NCT00509366|474723578|FG000|Overall Study|Not Treated (Screen Failure)|1|||
131847387|NCT00509366|474723579|FG001|Overall Study|Not Treated (Screen Failure)|1|||
131847388|NCT00509366|474723580|FG002|Overall Study|Not Treated (Screen Failure)|1|||
131847389|NCT00509366|474723581|FG003|Overall Study|Not Treated (Screen Failure)|0|||
131847390|NCT00509366|474723582|FG004|Overall Study|Not Treated (Screen Failure)|0|||
131847391|NCT00264550|474723583|FG000|Overall Study|Death|0|||
131847392|NCT00264550|474723584|FG001|Overall Study|Death|3|||
131847393|NCT00264550|474723585|FG002|Overall Study|Death|0|||
131847394|NCT00264550|474723586|FG003|Overall Study|Death|0|||
131847395|NCT00264550|474723583|FG000|Overall Study|Lost to Follow-up|3|||
131847396|NCT00264550|474723584|FG001|Overall Study|Lost to Follow-up|1|||
131847397|NCT00264550|474723585|FG002|Overall Study|Lost to Follow-up|1|||
131847398|NCT00264550|474723586|FG003|Overall Study|Lost to Follow-up|1|||
131847399|NCT00264550|474723583|FG000|Overall Study|Adverse Event|23|||
131847400|NCT00264550|474723584|FG001|Overall Study|Adverse Event|18|||
131847401|NCT00264550|474723585|FG002|Overall Study|Adverse Event|9|||
131847402|NCT00264550|474723586|FG003|Overall Study|Adverse Event|14|||
131847403|NCT00264550|474723583|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131847404|NCT00264550|474723584|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
131847405|NCT00264550|474723585|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
131847406|NCT00264550|474723586|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
131847407|NCT00264550|474723583|FG000|Overall Study|Discontinued oral study agent|0|||
131847408|NCT00264550|474723584|FG001|Overall Study|Discontinued oral study agent|1|||
131847409|NCT00264550|474723585|FG002|Overall Study|Discontinued oral study agent|0|||
131847410|NCT00264550|474723586|FG003|Overall Study|Discontinued oral study agent|0|||
131847411|NCT00264550|474723583|FG000|Overall Study|Other|13|||
131847412|NCT00264550|474723584|FG001|Overall Study|Other|7|||
131847413|NCT00264550|474723585|FG002|Overall Study|Other|3|||
131847414|NCT00264550|474723586|FG003|Overall Study|Other|9|||
131847415|NCT01439009|474723591|FG000|Overall Study|Physician Decision|5|||
131847416|NCT01439009|474723592|FG001|Overall Study|Physician Decision|3|||
131847417|NCT01439009|474723591|FG000|Overall Study|Protocol Violation|2|||
131847418|NCT01439009|474723592|FG001|Overall Study|Protocol Violation|0|||
131847419|NCT01439009|474723591|FG000|Overall Study|Deviation of exclusion criteria|1|||
131847420|NCT01439009|474723592|FG001|Overall Study|Deviation of exclusion criteria|0|||
131847421|NCT02564887|474723599|FG000|Overall Study|Lost to Follow-up|6|||
131847422|NCT02564887|474723600|FG001|Overall Study|Lost to Follow-up|0|||
131847423|NCT02052011|474723601|FG000|Overall Study|Lost to Follow-up|3|||
131847424|NCT02052011|474723602|FG001|Overall Study|Lost to Follow-up|0|||
131847425|NCT02052011|474723601|FG000|Overall Study|Withdrawal by Subject|1|||
131847426|NCT02052011|474723602|FG001|Overall Study|Withdrawal by Subject|2|||
131847427|NCT00000620|474723603|FG000|Overall Study|Death|86|||
131451490|NCT01134055|473281574|FG003|Overall Study|Lost to Follow-up|1|||
131847428|NCT00000620|474723604|FG001|Overall Study|Death|67|||
131847429|NCT00000620|474723605|FG002|Overall Study|Death|112|||
131847430|NCT00000620|474723606|FG003|Overall Study|Death|126|||
131847431|NCT00000620|474723607|FG004|Overall Study|Death|64|||
131847432|NCT00000620|474723608|FG005|Overall Study|Death|77|||
131847433|NCT00000620|474723609|FG006|Overall Study|Death|91|||
131847434|NCT00000620|474723610|FG007|Overall Study|Death|95|||
131847435|NCT00000620|474723603|FG000|Overall Study|Lost to Follow-up|14|||
131847436|NCT00000620|474723604|FG001|Overall Study|Lost to Follow-up|14|||
131847437|NCT00000620|474723605|FG002|Overall Study|Lost to Follow-up|14|||
131847438|NCT00000620|474723606|FG003|Overall Study|Lost to Follow-up|14|||
131847439|NCT00000620|474723607|FG004|Overall Study|Lost to Follow-up|15|||
131847440|NCT00000620|474723608|FG005|Overall Study|Lost to Follow-up|15|||
131847441|NCT00000620|474723609|FG006|Overall Study|Lost to Follow-up|13|||
131847442|NCT00000620|474723610|FG007|Overall Study|Lost to Follow-up|14|||
131847443|NCT00000620|474723603|FG000|Overall Study|Withdrawal by Subject|40|||
131847444|NCT00000620|474723604|FG001|Overall Study|Withdrawal by Subject|27|||
131451491|NCT01134055|473281575|FG004|Overall Study|Lost to Follow-up|0|||
131847445|NCT00000620|474723605|FG002|Overall Study|Withdrawal by Subject|28|||
131847446|NCT00000620|474723606|FG003|Overall Study|Withdrawal by Subject|27|||
131847447|NCT00000620|474723607|FG004|Overall Study|Withdrawal by Subject|30|||
131847448|NCT00000620|474723608|FG005|Overall Study|Withdrawal by Subject|32|||
131847449|NCT00000620|474723609|FG006|Overall Study|Withdrawal by Subject|32|||
131847450|NCT00000620|474723610|FG007|Overall Study|Withdrawal by Subject|21|||
131847451|NCT00000620|474723603|FG000|Overall Study|missed closeout visit|22|||
131847452|NCT00000620|474723604|FG001|Overall Study|missed closeout visit|28|||
131847453|NCT00000620|474723605|FG002|Overall Study|missed closeout visit|16|||
131847454|NCT00000620|474723606|FG003|Overall Study|missed closeout visit|11|||
131847455|NCT00000620|474723607|FG004|Overall Study|missed closeout visit|26|||
131847456|NCT00000620|474723608|FG005|Overall Study|missed closeout visit|28|||
131847457|NCT00000620|474723609|FG006|Overall Study|missed closeout visit|13|||
131847458|NCT00000620|474723610|FG007|Overall Study|missed closeout visit|16|||
131847459|NCT01851330|474723611|FG000|Overall Study|Lack of Efficacy|10|||
131847460|NCT01851330|474723612|FG001|Overall Study|Lack of Efficacy|9|||
131847461|NCT01851330|474723613|FG002|Overall Study|Lack of Efficacy|2|||
131847462|NCT01851330|474723611|FG000|Overall Study|Lost to Follow-up|1|||
131847463|NCT01851330|474723612|FG001|Overall Study|Lost to Follow-up|6|||
131847464|NCT01851330|474723613|FG002|Overall Study|Lost to Follow-up|9|||
131847465|NCT01851330|474723611|FG000|Overall Study|Withdrew Consent|2|||
131847466|NCT01851330|474723612|FG001|Overall Study|Withdrew Consent|1|||
131847467|NCT01851330|474723613|FG002|Overall Study|Withdrew Consent|0|||
131847468|NCT01851330|474723611|FG000|Overall Study|Investigator's Discretion|0|||
131847469|NCT01851330|474723612|FG001|Overall Study|Investigator's Discretion|0|||
131847470|NCT01851330|474723613|FG002|Overall Study|Investigator's Discretion|1|||
131847471|NCT01199016|474723614|FG000|Overall Study|No longer meets eligibility criteria|4|||
131847472|NCT01199016|474723614|FG000|Overall Study|Entrance criteria|5|||
131847473|NCT01199016|474723614|FG000|Overall Study|Protocol Violation|9|||
131847474|NCT01199016|474723614|FG000|Overall Study|Other|13|||
131847475|NCT01199016|474723614|FG000|Overall Study|Withdrawal by Subject|21|||
131847476|NCT01199016|474723614|FG000|Overall Study|Lost to Follow-up|25|||
131847477|NCT02960490|474723623|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
131847478|NCT02960490|474723624|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
131847479|NCT02960490|474723625|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847480|NCT02960490|474723626|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847481|NCT02960490|474723627|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847482|NCT02960490|474723628|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847483|NCT02960490|474723629|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847484|NCT02960490|474723630|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847485|NCT02960490|474723631|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847486|NCT02960490|474723632|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
131847487|NCT02960490|474723623|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847488|NCT02960490|474723624|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
131847489|NCT02960490|474723625|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847490|NCT02960490|474723626|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847491|NCT02960490|474723627|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847492|NCT02960490|474723628|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847493|NCT02960490|474723629|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847494|NCT02960490|474723630|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847495|NCT02960490|474723631|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847496|NCT02960490|474723632|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131847497|NCT02960490|474723623|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
131847498|NCT02960490|474723624|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
131847499|NCT02960490|474723625|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847500|NCT02960490|474723626|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847501|NCT02960490|474723627|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847502|NCT02960490|474723628|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847503|NCT02960490|474723629|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847504|NCT02960490|474723630|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847505|NCT02960490|474723631|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847506|NCT02960490|474723632|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131847507|NCT02960490|474723623|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
131847508|NCT02960490|474723624|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
131847509|NCT02960490|474723625|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847510|NCT02960490|474723626|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847511|NCT02960490|474723627|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847512|NCT02960490|474723628|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847513|NCT02960490|474723629|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847514|NCT02960490|474723630|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131911585|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131451492|NCT01134055|473281576|FG005|Overall Study|Lost to Follow-up|0|||
131451493|NCT01134055|473281577|FG006|Overall Study|Lost to Follow-up|0|||
131451494|NCT01134055|473281571|FG000|Overall Study|Withdrawal by Subject|3|||
131451495|NCT01134055|473281572|FG001|Overall Study|Withdrawal by Subject|3|||
131451496|NCT01134055|473281573|FG002|Overall Study|Withdrawal by Subject|1|||
131451497|NCT01134055|473281574|FG003|Overall Study|Withdrawal by Subject|2|||
131847515|NCT02960490|474723631|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847516|NCT02960490|474723632|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
131847517|NCT02960490|474723623|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847518|NCT02960490|474723624|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847519|NCT02960490|474723625|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
131847520|NCT02960490|474723626|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
131847521|NCT02960490|474723627|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847522|NCT02960490|474723628|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
131847523|NCT02960490|474723629|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847524|NCT02960490|474723630|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847525|NCT02960490|474723631|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847526|NCT02960490|474723632|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
131847527|NCT02960490|474723623|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847528|NCT02960490|474723624|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847529|NCT02960490|474723625|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
131847530|NCT02960490|474723626|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847531|NCT02960490|474723627|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
131847532|NCT02960490|474723628|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847533|NCT02960490|474723629|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847534|NCT02960490|474723630|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847535|NCT02960490|474723631|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847536|NCT02960490|474723632|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
131847537|NCT02960490|474723623|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
131847538|NCT02960490|474723624|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
131847539|NCT02960490|474723625|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
131847540|NCT02960490|474723626|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
131847541|NCT02960490|474723627|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
131847542|NCT02960490|474723628|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
131847543|NCT02960490|474723629|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
131847544|NCT02960490|474723630|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
131847545|NCT02960490|474723631|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
131847546|NCT02960490|474723632|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
131847547|NCT02960490|474723623|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847548|NCT02960490|474723624|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847549|NCT02960490|474723625|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847550|NCT02960490|474723626|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847551|NCT02960490|474723627|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847552|NCT02960490|474723628|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847553|NCT02960490|474723629|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
131847554|NCT02960490|474723630|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
131847555|NCT02960490|474723631|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
131847556|NCT02960490|474723632|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
131847557|NCT02960490|474723623|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847558|NCT02960490|474723624|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847559|NCT02960490|474723625|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847560|NCT02960490|474723626|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847561|NCT02960490|474723627|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847562|NCT02960490|474723628|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847563|NCT02960490|474723629|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847564|NCT02960490|474723630|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
131847565|NCT02960490|474723631|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131847566|NCT02960490|474723632|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
131451498|NCT01134055|473281575|FG004|Overall Study|Withdrawal by Subject|0|||
131451499|NCT01134055|473281576|FG005|Overall Study|Withdrawal by Subject|0|||
131451500|NCT01134055|473281577|FG006|Overall Study|Withdrawal by Subject|8|||
131451501|NCT01134055|473281571|FG000|Overall Study|Protocol Violation|0|||
131451502|NCT01134055|473281572|FG001|Overall Study|Protocol Violation|0|||
131451503|NCT01134055|473281573|FG002|Overall Study|Protocol Violation|0|||
131847567|NCT02960490|474723623|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
131847568|NCT02960490|474723624|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
131847569|NCT02960490|474723625|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
131911586|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
131847570|NCT02960490|474723626|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
131847571|NCT02960490|474723627|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
131847572|NCT02960490|474723628|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
131847573|NCT02960490|474723629|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
131847574|NCT02960490|474723630|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
131847575|NCT02960490|474723631|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
131847576|NCT02960490|474723632|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
131847577|NCT02960490|474723623|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847578|NCT02960490|474723624|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847579|NCT02960490|474723625|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847580|NCT02960490|474723626|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847581|NCT02960490|474723627|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847582|NCT02960490|474723628|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847583|NCT02960490|474723629|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
131847584|NCT02960490|474723630|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847585|NCT02960490|474723631|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847586|NCT02960490|474723632|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
131847587|NCT02960490|474723623|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847588|NCT02960490|474723624|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847589|NCT02960490|474723625|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
131911587|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
131911588|NCT01232283|474963198|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911589|NCT01232283|474963199|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911590|NCT01232283|474963200|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911591|NCT01232283|474963201|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911592|NCT01232283|474963202|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911593|NCT01232283|474963203|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911594|NCT01232283|474963204|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911595|NCT01232283|474963205|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
131911596|NCT01232283|474963206|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
131911597|NCT01232283|474963207|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
131911598|NCT02792504|474963210|FG000|Overall Study|Lost to Follow-up|24|||
131911599|NCT02792504|474963210|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
131911600|NCT00848497|474963217|FG000|Overall Study|Screen failure|2|||
131911601|NCT00848497|474963218|FG001|Overall Study|Screen failure|0|||
131911602|NCT00848497|474963217|FG000|Overall Study|Withdrawal by Subject|0|||
131911603|NCT00848497|474963218|FG001|Overall Study|Withdrawal by Subject|1|||
131911604|NCT02966834|474963219|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
131911605|NCT02966834|474963220|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
131911606|NCT02966834|474963221|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
131911607|NCT02966834|474963222|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
131911608|NCT02966834|474963223|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
131911609|NCT02966834|474963224|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
131911610|NCT02966834|474963219|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
131911611|NCT02966834|474963220|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131911612|NCT02966834|474963221|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131911613|NCT02966834|474963222|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131911614|NCT02966834|474963223|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131911615|NCT02966834|474963224|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131911616|NCT02966834|474963219|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
131911617|NCT02966834|474963220|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
131911618|NCT02966834|474963221|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
131911619|NCT02966834|474963222|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
131911620|NCT02966834|474963223|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
131911621|NCT02966834|474963224|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
131911622|NCT02966834|474963219|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
131911623|NCT02966834|474963220|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
131911624|NCT02966834|474963221|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
131911625|NCT02966834|474963222|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
131911626|NCT02966834|474963223|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
131911627|NCT02966834|474963224|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
131911628|NCT02966834|474963219|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131847590|NCT02960490|474723626|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847591|NCT02960490|474723627|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847592|NCT02960490|474723628|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
131911629|NCT02966834|474963220|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131451504|NCT01134055|473281574|FG003|Overall Study|Protocol Violation|1|||
131451505|NCT01134055|473281575|FG004|Overall Study|Protocol Violation|1|||
131451506|NCT01134055|473281576|FG005|Overall Study|Protocol Violation|0|||
131451507|NCT01134055|473281577|FG006|Overall Study|Protocol Violation|0|||
131451508|NCT01134055|473281571|FG000|Overall Study|Physician Decision|0|||
131451509|NCT01134055|473281572|FG001|Overall Study|Physician Decision|0|||
131451510|NCT01134055|473281573|FG002|Overall Study|Physician Decision|0|||
131451511|NCT01134055|473281574|FG003|Overall Study|Physician Decision|0|||
131451512|NCT01134055|473281575|FG004|Overall Study|Physician Decision|0|||
131451513|NCT01134055|473281576|FG005|Overall Study|Physician Decision|0|||
131451514|NCT01134055|473281577|FG006|Overall Study|Physician Decision|1|||
131451515|NCT00499083|473281578|FG000|Overall Study|Not evaluable|3|||
131451516|NCT01012440|473281579|FG000|Overall Study|Withdrawal by Subject|2|||
131451517|NCT00594815|473281580|FG000|Overall Study|Never Treated|3|||
131451518|NCT00594815|473281580|FG000|Overall Study|Withdrawal by Subject|2|||
131451519|NCT00594815|473281580|FG000|Overall Study|Toxicity|4|||
131451520|NCT00477386|473281582|FG000|Overall Study|Adverse Event|4|||
131451521|NCT00477386|473281583|FG001|Overall Study|Adverse Event|8|||
131451522|NCT00477386|473281582|FG000|Overall Study|Disease progression, relapse|3|||
131451523|NCT00477386|473281583|FG001|Overall Study|Disease progression, relapse|4|||
131451524|NCT00477386|473281582|FG000|Overall Study|Disease progression, refractory|1|||
131451525|NCT00477386|473281583|FG001|Overall Study|Disease progression, refractory|3|||
131451526|NCT00477386|473281582|FG000|Overall Study|Other|1|||
131451527|NCT00477386|473281583|FG001|Overall Study|Other|2|||
131847593|NCT02960490|474723629|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847594|NCT02960490|474723630|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
131847595|NCT02960490|474723631|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847596|NCT02960490|474723632|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
131847597|NCT02368314|474723635|FG000|Overall Study|Withdrawal by Subject|2|||
131847598|NCT02368314|474723636|FG001|Overall Study|Withdrawal by Subject|1|||
131847599|NCT02368314|474723635|FG000|Overall Study|Adverse Event|1|||
131847600|NCT02368314|474723636|FG001|Overall Study|Adverse Event|2|||
131847601|NCT02842073|474723641|FG000|Overall Study|Withdrawal by Subject|1|||
131847602|NCT00195338|474723642|FG000|Overall Study|Lost to Follow-up|2|||
131847603|NCT00195338|474723642|FG000|Overall Study|Adverse Event|5|||
131847604|NCT00195338|474723642|FG000|Overall Study|Lack of Efficacy|1|||
131847605|NCT00195338|474723642|FG000|Overall Study|Early closure of the site|4|||
131847606|NCT01085357|474723645|FG000|Overall Study|Adverse Event|1|||
131847607|NCT01085357|474723646|FG001|Overall Study|Adverse Event|1|||
131847608|NCT01085357|474723645|FG000|Overall Study|Subject Decision|4|||
131847609|NCT01085357|474723646|FG001|Overall Study|Subject Decision|3|||
131847610|NCT01085357|474723645|FG000|Overall Study|Investigator Decision|1|||
131847611|NCT01085357|474723646|FG001|Overall Study|Investigator Decision|1|||
131847612|NCT01085357|474723645|FG000|Overall Study|Death|11|||
131847613|NCT01085357|474723646|FG001|Overall Study|Death|1|||
131847614|NCT01085357|474723645|FG000|Overall Study|Lost to Follow-up|2|||
131847615|NCT01085357|474723646|FG001|Overall Study|Lost to Follow-up|0|||
131847616|NCT00314951|474723652|FG000|Treatment|Didn't meet criteria for mITT population|16|||
131847617|NCT00314951|474723653|FG001|Treatment|Didn't meet criteria for mITT population|11|||
131847618|NCT00314951|474723652|FG000|Follow-up|mITT failure|44|||
131847619|NCT00314951|474723653|FG001|Follow-up|mITT failure|34|||
131847620|NCT05320887|474723654|FG000|Overall Study|Lost to Follow-up|0|||
131847621|NCT05320887|474723655|FG001|Overall Study|Lost to Follow-up|3|||
131847622|NCT05320887|474723656|FG002|Overall Study|Lost to Follow-up|0|||
131847623|NCT05320887|474723657|FG003|Overall Study|Lost to Follow-up|0|||
131847624|NCT02289456|474723658|FG000|Induction Period|Death|2|||
131847625|NCT02289456|474723658|FG000|Induction Period|Adverse Event|11|||
131847626|NCT02289456|474723658|FG000|Induction Period|Progressive Disease (PD)|4|||
131847627|NCT02289456|474723658|FG000|Induction Period|Symptomatic Deterioration|4|||
131847628|NCT02289456|474723658|FG000|Induction Period|Withdrawal by Subject|2|||
131847629|NCT02289456|474723658|FG000|Induction Period|Miscellaneous|1|||
131847630|NCT02289456|474723658|FG000|Monotherapy Period|Death|1|||
131847631|NCT02289456|474723658|FG000|Monotherapy Period|Adverse Event|1|||
131847632|NCT02289456|474723658|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
131847633|NCT02289456|474723658|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
131847634|NCT02289456|474723658|FG000|Monotherapy Period|Withdrawal by Subject|2|||
131847635|NCT02289456|474723658|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
131451528|NCT00477386|473281582|FG000|Overall Study|Physician Decision|1|||
131847636|NCT02289456|474723658|FG000|Monotherapy Period|Miscellaneous|1|||
131451529|NCT00477386|473281583|FG001|Overall Study|Physician Decision|0|||
131451530|NCT00477386|473281582|FG000|Overall Study|Withdrawal by Subject|1|||
131451531|NCT00477386|473281583|FG001|Overall Study|Withdrawal by Subject|0|||
131847637|NCT00863772|474723661|FG000|Overall Study|Adverse Event|1|||
131847638|NCT00863772|474723662|FG001|Overall Study|Adverse Event|4|||
131847639|NCT00863772|474723663|FG002|Overall Study|Adverse Event|0|||
131847640|NCT00863772|474723661|FG000|Overall Study|Lack of Efficacy|4|||
131847641|NCT00863772|474723662|FG001|Overall Study|Lack of Efficacy|2|||
131451532|NCT02207088|473281584|FG000|Overall Study|Adverse Event|2|||
131451533|NCT01812252|473281585|FG000|Overall Study|Persistent Disease|1|||
131451534|NCT01812252|473281586|FG001|Overall Study|Persistent Disease|0|||
131451535|NCT01812252|473281585|FG000|Overall Study|Not transplanted|11|||
131451536|NCT01812252|473281586|FG001|Overall Study|Not transplanted|11|||
131451537|NCT01812252|473281585|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
131451538|NCT01812252|473281586|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
131451539|NCT01812252|473281585|FG000|Overall Study|Withdrawal by Subject|1|||
131451540|NCT01812252|473281586|FG001|Overall Study|Withdrawal by Subject|1|||
131451541|NCT01812252|473281585|FG000|Overall Study|Screen Failure|1|||
131451542|NCT01812252|473281586|FG001|Overall Study|Screen Failure|0|||
131451543|NCT02284243|473281590|FG000|Overall Study|Lack of Efficacy|3|||
131451544|NCT02284243|473281591|FG001|Overall Study|Lack of Efficacy|3|||
131451545|NCT02284243|473281590|FG000|Overall Study|Adverse Event|1|||
131451546|NCT02284243|473281591|FG001|Overall Study|Adverse Event|0|||
131451547|NCT04269889|473281593|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
131451548|NCT04634253|473281594|FG000|Overall Study|Adverse Event|1|||
131451549|NCT04634253|473281595|FG001|Overall Study|Adverse Event|1|||
131451550|NCT04634253|473281596|FG002|Overall Study|Adverse Event|0|||
131451551|NCT04634253|473281594|FG000|Overall Study|Physician Decision|0|||
131451552|NCT04634253|473281595|FG001|Overall Study|Physician Decision|1|||
131451553|NCT04634253|473281596|FG002|Overall Study|Physician Decision|0|||
131911630|NCT02966834|474963221|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131847642|NCT00863772|474723663|FG002|Overall Study|Lack of Efficacy|4|||
131847643|NCT00863772|474723661|FG000|Overall Study|Lost to Follow-up|5|||
131847644|NCT00863772|474723662|FG001|Overall Study|Lost to Follow-up|1|||
131847645|NCT00863772|474723663|FG002|Overall Study|Lost to Follow-up|1|||
131847646|NCT00863772|474723661|FG000|Overall Study|Protocol Violation|2|||
131847647|NCT00863772|474723662|FG001|Overall Study|Protocol Violation|0|||
131847648|NCT00863772|474723663|FG002|Overall Study|Protocol Violation|2|||
131847649|NCT00863772|474723661|FG000|Overall Study|Withdrawal by Subject|4|||
131847650|NCT00863772|474723662|FG001|Overall Study|Withdrawal by Subject|7|||
131847651|NCT00863772|474723663|FG002|Overall Study|Withdrawal by Subject|5|||
131847652|NCT00863772|474723661|FG000|Overall Study|Study terminated by sponsor|44|||
131847653|NCT00863772|474723662|FG001|Overall Study|Study terminated by sponsor|45|||
131847654|NCT00863772|474723663|FG002|Overall Study|Study terminated by sponsor|36|||
131847655|NCT00863772|474723661|FG000|Overall Study|Entered extension study|6|||
131847656|NCT00863772|474723662|FG001|Overall Study|Entered extension study|4|||
131847657|NCT00863772|474723663|FG002|Overall Study|Entered extension study|9|||
131847658|NCT00863772|474723661|FG000|Overall Study|Other|1|||
131847659|NCT00863772|474723662|FG001|Overall Study|Other|2|||
131847660|NCT00863772|474723663|FG002|Overall Study|Other|4|||
131847661|NCT00863772|474723661|FG000|Overall Study|Randomized but not Treated|1|||
131847662|NCT00863772|474723662|FG001|Overall Study|Randomized but not Treated|0|||
131847663|NCT00863772|474723663|FG002|Overall Study|Randomized but not Treated|0|||
131847664|NCT03553576|474723664|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
131847665|NCT03553576|474723665|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
131847666|NCT03553576|474723664|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
131847667|NCT03553576|474723665|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
131847668|NCT03553576|474723664|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
131847669|NCT03553576|474723665|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
131847670|NCT03553576|474723664|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
131847671|NCT03553576|474723665|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
131451554|NCT04634253|473281594|FG000|Overall Study|Withdrawal by Subject|1|||
131451555|NCT04634253|473281595|FG001|Overall Study|Withdrawal by Subject|0|||
131451556|NCT04634253|473281596|FG002|Overall Study|Withdrawal by Subject|3|||
131451557|NCT03155841|473281597|FG000|Overall Study|Protocol Violation|3|||
131451558|NCT03155841|473281598|FG001|Overall Study|Protocol Violation|4|||
131451559|NCT01499355|473281599|FG000|Run-In Period|Study Termination|15|||
131911631|NCT02966834|474963222|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
131847672|NCT03553576|474723664|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
131847673|NCT03553576|474723665|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
131847674|NCT03553576|474723664|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
131847675|NCT03553576|474723665|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
131847676|NCT03553576|474723664|FG000|Overall Study|Physician Decision|2|||
131847677|NCT03553576|474723665|FG001|Overall Study|Physician Decision|5|||
131847678|NCT01671332|474723666|FG000|Overall Study|Withdrawal by Subject|1|||
131847679|NCT01671332|474723667|FG001|Overall Study|Withdrawal by Subject|1|||
131451560|NCT01499355|473281600|FG001|Run-In Period|Study Termination|0|||
131451561|NCT01499355|473281601|FG002|Run-In Period|Study Termination|0|||
131451562|NCT01499355|473281602|FG003|Run-In Period|Study Termination|0|||
131911632|NCT02966834|474963223|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131911633|NCT02966834|474963224|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131911634|NCT02966834|474963219|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
131911635|NCT02966834|474963220|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
131911636|NCT02966834|474963221|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
131911637|NCT02966834|474963222|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
131911638|NCT02966834|474963223|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
131911639|NCT02966834|474963224|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
131911640|NCT01020123|474963226|FG000|Main Period|Withdrawal by Subject|6|||
131911641|NCT01020123|474963227|FG001|Main Period|Withdrawal by Subject|5|||
131911642|NCT01020123|474963228|FG002|Main Period|Withdrawal by Subject|3|||
131911643|NCT01020123|474963229|FG003|Main Period|Withdrawal by Subject|1|||
131911644|NCT01020123|474963230|FG004|Main Period|Withdrawal by Subject|6|||
131911645|NCT01020123|474963231|FG005|Main Period|Withdrawal by Subject|3|||
131911646|NCT01020123|474963232|FG006|Main Period|Withdrawal by Subject|2|||
131911647|NCT01020123|474963226|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
131911648|NCT01020123|474963227|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
131911649|NCT01020123|474963228|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
131911650|NCT01020123|474963229|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
131911651|NCT01020123|474963230|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
131911652|NCT01020123|474963231|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
131911653|NCT01020123|474963232|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
131911654|NCT01020123|474963226|FG000|Main Period|Adverse Event|5|||
131911655|NCT01020123|474963227|FG001|Main Period|Adverse Event|2|||
131911656|NCT01020123|474963228|FG002|Main Period|Adverse Event|2|||
131911657|NCT01020123|474963229|FG003|Main Period|Adverse Event|1|||
131911658|NCT01020123|474963230|FG004|Main Period|Adverse Event|1|||
131911659|NCT01020123|474963231|FG005|Main Period|Adverse Event|2|||
131911660|NCT01020123|474963232|FG006|Main Period|Adverse Event|1|||
131911661|NCT01020123|474963226|FG000|Main Period|Protocol Violation|4|||
131911662|NCT01020123|474963227|FG001|Main Period|Protocol Violation|4|||
131911663|NCT01020123|474963228|FG002|Main Period|Protocol Violation|2|||
131911664|NCT01020123|474963229|FG003|Main Period|Protocol Violation|5|||
131911665|NCT01020123|474963230|FG004|Main Period|Protocol Violation|2|||
131911666|NCT01020123|474963231|FG005|Main Period|Protocol Violation|3|||
131911667|NCT01020123|474963232|FG006|Main Period|Protocol Violation|2|||
131911668|NCT01020123|474963226|FG000|Main Period|Lost to Follow-up|0|||
131911669|NCT01020123|474963227|FG001|Main Period|Lost to Follow-up|2|||
131911670|NCT01020123|474963228|FG002|Main Period|Lost to Follow-up|0|||
131911671|NCT01020123|474963229|FG003|Main Period|Lost to Follow-up|0|||
131847680|NCT02728843|474723668|FG000|Overall Study|Adverse Event|0|||
131847681|NCT02728843|474723669|FG001|Overall Study|Adverse Event|2|||
131847682|NCT02728843|474723670|FG002|Overall Study|Adverse Event|3|||
131847683|NCT02728843|474723671|FG003|Overall Study|Adverse Event|1|||
131847684|NCT02728843|474723672|FG004|Overall Study|Adverse Event|2|||
131847685|NCT02728843|474723668|FG000|Overall Study|Lack of Efficacy|0|||
131847686|NCT02728843|474723669|FG001|Overall Study|Lack of Efficacy|1|||
131847687|NCT02728843|474723670|FG002|Overall Study|Lack of Efficacy|1|||
131847688|NCT02728843|474723671|FG003|Overall Study|Lack of Efficacy|0|||
131847689|NCT02728843|474723672|FG004|Overall Study|Lack of Efficacy|0|||
131847690|NCT02728843|474723668|FG000|Overall Study|Protocol Violation|2|||
131847691|NCT02728843|474723669|FG001|Overall Study|Protocol Violation|0|||
131847692|NCT02728843|474723670|FG002|Overall Study|Protocol Violation|4|||
131847693|NCT02728843|474723671|FG003|Overall Study|Protocol Violation|2|||
131847694|NCT02728843|474723672|FG004|Overall Study|Protocol Violation|2|||
131847695|NCT02728843|474723668|FG000|Overall Study|Withdrawal by Subject|1|||
131847696|NCT02728843|474723669|FG001|Overall Study|Withdrawal by Subject|0|||
131847697|NCT02728843|474723670|FG002|Overall Study|Withdrawal by Subject|0|||
131911672|NCT01020123|474963230|FG004|Main Period|Lost to Follow-up|0|||
131911673|NCT01020123|474963231|FG005|Main Period|Lost to Follow-up|0|||
131911674|NCT01020123|474963232|FG006|Main Period|Lost to Follow-up|0|||
131911675|NCT01020123|474963226|FG000|Main Period|Unclasified|2|||
131911676|NCT01020123|474963227|FG001|Main Period|Unclasified|0|||
131911677|NCT01020123|474963228|FG002|Main Period|Unclasified|1|||
131911678|NCT01020123|474963229|FG003|Main Period|Unclasified|0|||
131911679|NCT01020123|474963230|FG004|Main Period|Unclasified|1|||
131847698|NCT02728843|474723671|FG003|Overall Study|Withdrawal by Subject|1|||
131911680|NCT01020123|474963231|FG005|Main Period|Unclasified|3|||
131911681|NCT01020123|474963232|FG006|Main Period|Unclasified|6|||
131911682|NCT01020123|474963226|FG000|Extention Period|Withdrawal by Subject|2|||
131911683|NCT01020123|474963227|FG001|Extention Period|Withdrawal by Subject|1|||
131847699|NCT02728843|474723672|FG004|Overall Study|Withdrawal by Subject|0|||
131847700|NCT02728843|474723668|FG000|Overall Study|Use of rescue medication|0|||
131847701|NCT02728843|474723669|FG001|Overall Study|Use of rescue medication|2|||
131847702|NCT02728843|474723670|FG002|Overall Study|Use of rescue medication|0|||
131911684|NCT01020123|474963228|FG002|Extention Period|Withdrawal by Subject|1|||
131911685|NCT01020123|474963229|FG003|Extention Period|Withdrawal by Subject|0|||
131911686|NCT01020123|474963230|FG004|Extention Period|Withdrawal by Subject|0|||
131451563|NCT01499355|473281599|FG000|Run-In Period|Other|3|||
131847703|NCT02728843|474723671|FG003|Overall Study|Use of rescue medication|2|||
131847704|NCT02728843|474723672|FG004|Overall Study|Use of rescue medication|1|||
131847705|NCT00351533|474723675|FG000|Overall Study|Extubated before first BAL|1|||
131847706|NCT00351533|474723676|FG001|Overall Study|Extubated before first BAL|0|||
131847707|NCT00351533|474723675|FG000|Overall Study|Lost to Follow-up|1|||
131847708|NCT00351533|474723676|FG001|Overall Study|Lost to Follow-up|3|||
131847709|NCT00351533|474723675|FG000|Overall Study|Physician Decision|0|||
131847710|NCT00351533|474723676|FG001|Overall Study|Physician Decision|1|||
131847711|NCT00351533|474723675|FG000|Overall Study|Withdrawal by Subject|0|||
131847712|NCT00351533|474723676|FG001|Overall Study|Withdrawal by Subject|1|||
131847713|NCT01104792|474723677|FG000|Overall Study|Adverse Event|77|||
131847714|NCT01104792|474723677|FG000|Overall Study|Insufficient Therapeutic Response|22|||
131847715|NCT01104792|474723677|FG000|Overall Study|Protocol Violation|45|||
131847716|NCT01104792|474723677|FG000|Overall Study|Withdrawal of Consent|179|||
131847717|NCT01104792|474723677|FG000|Overall Study|Lost to Follow-up|43|||
131847718|NCT01104792|474723677|FG000|Overall Study|Reasons Not Specified|27|||
131847719|NCT01104792|474723677|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
131847720|NCT00103610|474723681|FG000|Overall Study|Entered Rescue Procedure|10|||
131847721|NCT00103610|474723682|FG001|Overall Study|Entered Rescue Procedure|52|||
131847722|NCT00103610|474723681|FG000|Overall Study|Death|16|||
131847723|NCT00103610|474723682|FG001|Overall Study|Death|12|||
131847724|NCT00103610|474723681|FG000|Overall Study|Elective Withdrawal|4|||
131847725|NCT00103610|474723682|FG001|Overall Study|Elective Withdrawal|0|||
131847726|NCT00103610|474723681|FG000|Overall Study|Lost to Follow-up|3|||
131847727|NCT00103610|474723682|FG001|Overall Study|Lost to Follow-up|1|||
131847728|NCT00103610|474723681|FG000|Overall Study|Adverse Event|2|||
131847729|NCT00103610|474723682|FG001|Overall Study|Adverse Event|2|||
131847730|NCT00103610|474723681|FG000|Overall Study|Other|2|||
131847731|NCT00103610|474723682|FG001|Overall Study|Other|7|||
131847732|NCT00103610|474723681|FG000|Overall Study|Failed mobilization|1|||
131847733|NCT00103610|474723682|FG001|Overall Study|Failed mobilization|5|||
131847734|NCT00103610|474723681|FG000|Overall Study|Noncompliance|0|||
131847735|NCT00103610|474723682|FG001|Overall Study|Noncompliance|1|||
131847736|NCT02092467|474723683|FG000|Overall Study|Death|49|||
131847737|NCT02092467|474723684|FG001|Overall Study|Death|66|||
131847738|NCT02092467|474723685|FG002|Overall Study|Death|38|||
131847739|NCT02092467|474723683|FG000|Overall Study|Lost to Follow-up|38|||
131847740|NCT02092467|474723684|FG001|Overall Study|Lost to Follow-up|35|||
131847741|NCT02092467|474723685|FG002|Overall Study|Lost to Follow-up|40|||
131847742|NCT02092467|474723683|FG000|Overall Study|Global Deterioration of Health Status|1|||
131847743|NCT02092467|474723684|FG001|Overall Study|Global Deterioration of Health Status|0|||
131847744|NCT02092467|474723685|FG002|Overall Study|Global Deterioration of Health Status|0|||
131847745|NCT02092467|474723683|FG000|Overall Study|Other|32|||
131847746|NCT02092467|474723684|FG001|Overall Study|Other|30|||
131847747|NCT02092467|474723685|FG002|Overall Study|Other|24|||
131847748|NCT02092467|474723683|FG000|Overall Study|Withdrawal by Subject|282|||
131847749|NCT02092467|474723684|FG001|Overall Study|Withdrawal by Subject|327|||
131847750|NCT02092467|474723685|FG002|Overall Study|Withdrawal by Subject|289|||
131847751|NCT02092467|474723683|FG000|Overall Study|Randomized but not treated|2|||
131847752|NCT02092467|474723684|FG001|Overall Study|Randomized but not treated|1|||
131847753|NCT02092467|474723685|FG002|Overall Study|Randomized but not treated|7|||
131847754|NCT02952898|474723690|FG000|Overall Study|Withdrawal by Subject|10|||
131847755|NCT02952898|474723691|FG001|Overall Study|Withdrawal by Subject|8|||
131847756|NCT02952898|474723692|FG002|Overall Study|Withdrawal by Subject|8|||
131847757|NCT02952898|474723690|FG000|Overall Study|Adverse Event|8|||
131847758|NCT02952898|474723691|FG001|Overall Study|Adverse Event|8|||
131847759|NCT02952898|474723692|FG002|Overall Study|Adverse Event|3|||
131847760|NCT02952898|474723690|FG000|Overall Study|Lost to Follow-up|3|||
131847761|NCT02952898|474723691|FG001|Overall Study|Lost to Follow-up|2|||
131847762|NCT02952898|474723692|FG002|Overall Study|Lost to Follow-up|2|||
131847763|NCT02952898|474723690|FG000|Overall Study|Non-compliance with study drug|1|||
131847764|NCT02952898|474723691|FG001|Overall Study|Non-compliance with study drug|1|||
131847765|NCT02952898|474723692|FG002|Overall Study|Non-compliance with study drug|2|||
131847766|NCT04844762|474723695|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847767|NCT04844762|474723696|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847768|NCT04844762|474723697|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
131847769|NCT04844762|474723698|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847770|NCT04844762|474723699|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847771|NCT04844762|474723700|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847772|NCT04844762|474723695|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
131847773|NCT04844762|474723696|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
131847774|NCT04844762|474723697|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
131847775|NCT04844762|474723698|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
131847776|NCT04844762|474723699|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
131847777|NCT04844762|474723700|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
131847778|NCT04844762|474723695|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847779|NCT04844762|474723696|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847780|NCT04844762|474723697|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
131847781|NCT04844762|474723698|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
131847782|NCT04844762|474723699|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847783|NCT04844762|474723700|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
131847784|NCT04844762|474723695|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847785|NCT04844762|474723696|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847786|NCT04844762|474723697|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
131847787|NCT04844762|474723698|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
131847788|NCT04844762|474723699|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
131847789|NCT04844762|474723700|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847790|NCT04844762|474723695|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
131847791|NCT04844762|474723696|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
131847792|NCT04844762|474723697|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847793|NCT04844762|474723698|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847794|NCT04844762|474723699|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847795|NCT04844762|474723700|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847796|NCT04844762|474723695|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
131847797|NCT04844762|474723696|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847798|NCT04844762|474723697|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847799|NCT04844762|474723698|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847800|NCT04844762|474723699|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847801|NCT04844762|474723700|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847802|NCT04844762|474723695|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847803|NCT04844762|474723696|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847804|NCT04844762|474723697|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847805|NCT04844762|474723698|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847806|NCT04844762|474723699|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
131847807|NCT04844762|474723700|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
131847808|NCT04844762|474723695|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
131847809|NCT04844762|474723696|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847810|NCT04844762|474723697|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847811|NCT04844762|474723698|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847812|NCT04844762|474723699|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847813|NCT04844762|474723700|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
131847814|NCT04844762|474723695|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
131847815|NCT04844762|474723696|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847816|NCT04844762|474723697|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847817|NCT04844762|474723698|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847818|NCT04844762|474723699|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
131847819|NCT04844762|474723700|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
131847820|NCT04844762|474723695|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131847821|NCT04844762|474723696|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
131847822|NCT04844762|474723697|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131847823|NCT04844762|474723698|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131847824|NCT04844762|474723699|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131847825|NCT04844762|474723700|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131847826|NCT04844762|474723695|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
131847827|NCT04844762|474723696|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
131847828|NCT04844762|474723697|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
131847829|NCT04844762|474723698|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
131847830|NCT04844762|474723699|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
131847831|NCT04844762|474723700|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
131847832|NCT04400682|474723703|FG000|Period 1|Withdrawal by Subject|1|||
131847833|NCT04400682|474723704|FG001|Period 1|Withdrawal by Subject|4|||
131847834|NCT02293863|474723705|FG000|Overall Study|Death|4|||
131847835|NCT02293863|474723706|FG001|Overall Study|Death|6|||
131847836|NCT02293863|474723707|FG002|Overall Study|Death|4|||
131847837|NCT02293863|474723705|FG000|Overall Study|Lost to Follow-up|2|||
131847838|NCT02293863|474723706|FG001|Overall Study|Lost to Follow-up|2|||
131847839|NCT02293863|474723707|FG002|Overall Study|Lost to Follow-up|2|||
131847840|NCT02293863|474723705|FG000|Overall Study|Withdrawal by Subject|3|||
131847841|NCT02293863|474723706|FG001|Overall Study|Withdrawal by Subject|3|||
131847842|NCT02293863|474723707|FG002|Overall Study|Withdrawal by Subject|1|||
131847843|NCT02293863|474723705|FG000|Overall Study|Reason Not Specified|0|||
131847844|NCT02293863|474723706|FG001|Overall Study|Reason Not Specified|2|||
131847845|NCT02293863|474723707|FG002|Overall Study|Reason Not Specified|2|||
131847846|NCT00477633|474723714|FG000|Overall Study|Did not receive treatment|23|||
131847847|NCT00477633|474723714|FG000|Overall Study|Adverse Event|143|||
131847848|NCT00477633|474723714|FG000|Overall Study|Pregnancy|23|||
131847849|NCT00477633|474723714|FG000|Overall Study|Lost to Follow-up|271|||
131847850|NCT00477633|474723714|FG000|Overall Study|Withdrawal by Subject|149|||
131847851|NCT00477633|474723714|FG000|Overall Study|Protocol Violation|25|||
131847852|NCT00477633|474723714|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
131847853|NCT00602641|474725988|FG000|Overall Study|Never started protocol therapy|6|||
131847854|NCT00602641|474725989|FG001|Overall Study|Never started protocol therapy|2|||
131847855|NCT00602641|474725988|FG000|Overall Study|Still on treatment at time of analysis|8|||
131847856|NCT00602641|474725989|FG001|Overall Study|Still on treatment at time of analysis|15|||
131847857|NCT00602641|474725988|FG000|Overall Study|Adverse Event|62|||
131847858|NCT00602641|474725989|FG001|Overall Study|Adverse Event|53|||
131847859|NCT00602641|474725988|FG000|Overall Study|Disease progression|38|||
131847860|NCT00602641|474725989|FG001|Overall Study|Disease progression|55|||
131847861|NCT00602641|474725988|FG000|Overall Study|Death|6|||
131847862|NCT00602641|474725989|FG001|Overall Study|Death|5|||
131847863|NCT00602641|474725988|FG000|Overall Study|Withdrawal by Subject|15|||
131847864|NCT00602641|474725989|FG001|Overall Study|Withdrawal by Subject|12|||
131847865|NCT00602641|474725988|FG000|Overall Study|Alternative therapy|5|||
131847866|NCT00602641|474725989|FG001|Overall Study|Alternative therapy|2|||
131847867|NCT00602641|474725988|FG000|Overall Study|Other Complicating Disease|5|||
131847868|NCT00602641|474725989|FG001|Overall Study|Other Complicating Disease|2|||
131847869|NCT00602641|474725988|FG000|Overall Study|Physician Decision|5|||
131847870|NCT00602641|474725989|FG001|Overall Study|Physician Decision|4|||
131847871|NCT00602641|474725988|FG000|Overall Study|Administrative Closure|1|||
131847872|NCT00602641|474725989|FG001|Overall Study|Administrative Closure|1|||
131847873|NCT00602641|474725988|FG000|Overall Study|Other|3|||
131847874|NCT00602641|474725989|FG001|Overall Study|Other|1|||
131847875|NCT00478244|474725990|FG000|Overall Study|Did not receive transplant|1|||
131847876|NCT02929056|474725991|FG000|Overall Study|Lost to Follow-up|0|||
131847877|NCT02929056|474725992|FG001|Overall Study|Lost to Follow-up|1|||
131847878|NCT02925403|474725993|FG000|Overall Study|Lost to Follow-up|0|||
131847879|NCT02925403|474725994|FG001|Overall Study|Lost to Follow-up|1|||
131847880|NCT02899195|474725999|FG000|Concurrent Durvalumab|Adverse Event|4|||
131847881|NCT02899195|474725999|FG000|Concurrent Durvalumab|Physician Decision|1|||
131847882|NCT02899195|474725999|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
131847883|NCT02899195|474725999|FG000|Concurrent Durvalumab|Progressive Disease|5|||
131847884|NCT02899195|474725999|FG000|Maintenance Durvalumab|Adverse Event|1|||
131847885|NCT02899195|474725999|FG000|Maintenance Durvalumab|Physician Decision|1|||
131847886|NCT02899195|474725999|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
131847887|NCT02899195|474725999|FG000|Maintenance Durvalumab|Progressive Disease|31|||
131847888|NCT03156504|474726000|FG000|Overall Study|Withdrawal by Subject|1|||
131847889|NCT00450801|474726001|FG000|Overall Study|Death|1|||
131847890|NCT03452137|474726002|FG000|Overall Study|Death|67|||
131847891|NCT03452137|474726003|FG001|Overall Study|Death|70|||
131847892|NCT03452137|474726002|FG000|Overall Study|Lost to Follow-up|4|||
131847893|NCT03452137|474726003|FG001|Overall Study|Lost to Follow-up|2|||
131847894|NCT03452137|474726002|FG000|Overall Study|Physician Decision|0|||
131847895|NCT03452137|474726003|FG001|Overall Study|Physician Decision|1|||
131847896|NCT03452137|474726002|FG000|Overall Study|Study Terminated by Sponsor|120|||
131847897|NCT03452137|474726003|FG001|Overall Study|Study Terminated by Sponsor|121|||
131847898|NCT03452137|474726002|FG000|Overall Study|Withdrawal by Subject|12|||
131847899|NCT03452137|474726003|FG001|Overall Study|Withdrawal by Subject|9|||
131847900|NCT00587860|474726004|FG000|Overall Study|Lost to Follow-up|2|||
131847901|NCT00587860|474726005|FG001|Overall Study|Lost to Follow-up|2|||
131847902|NCT00587860|474726004|FG000|Overall Study|Withdrawal by Subject|3|||
131847903|NCT00587860|474726005|FG001|Overall Study|Withdrawal by Subject|3|||
131847904|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
131847905|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
131847906|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
131847907|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
131847908|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
131847909|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
131847910|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
131847911|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
131847912|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
131847913|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
131847914|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
131847915|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
131847916|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
131847917|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
131847918|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
131847919|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
131451564|NCT01499355|473281600|FG001|Run-In Period|Other|0|||
131451565|NCT01499355|473281601|FG002|Run-In Period|Other|0|||
131847920|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
131847921|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
131847922|NCT00261443|474726006|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
131847923|NCT00261443|474726007|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
131847924|NCT00261443|474726008|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
131847925|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
131847926|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
131847927|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
131847928|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
131847929|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
131847930|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
131847931|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
131847932|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
131847933|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
131847934|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
131847935|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
131847936|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
131847937|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
131847938|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
131847939|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
131847940|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
131847941|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
131847942|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
131847943|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
131847944|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
131847945|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
131847946|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
131847947|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
131847948|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
131847949|NCT00261443|474726006|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
131847950|NCT00261443|474726007|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
131847951|NCT00261443|474726008|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
131847952|NCT00261443|474726006|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
131847953|NCT00261443|474726007|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
131847954|NCT00261443|474726008|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
131847955|NCT00261443|474726006|FG000|3: Assessment of Relapse|Adverse Event|0|||
131847956|NCT00261443|474726007|FG001|3: Assessment of Relapse|Adverse Event|15|||
131847957|NCT00261443|474726008|FG002|3: Assessment of Relapse|Adverse Event|19|||
131847958|NCT00261443|474726006|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
131847959|NCT00261443|474726007|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
131847960|NCT00261443|474726008|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
131847961|NCT00261443|474726006|FG000|3: Assessment of Relapse|Death|0|||
131847962|NCT00261443|474726007|FG001|3: Assessment of Relapse|Death|0|||
131847963|NCT00261443|474726008|FG002|3: Assessment of Relapse|Death|1|||
131847964|NCT00261443|474726006|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
131847965|NCT00261443|474726007|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
131847966|NCT00261443|474726008|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
131847967|NCT00261443|474726006|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
131847968|NCT00261443|474726007|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
131847969|NCT00261443|474726008|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
131847970|NCT00261443|474726006|FG000|3: Assessment of Relapse|Pregnancy|0|||
131847971|NCT00261443|474726007|FG001|3: Assessment of Relapse|Pregnancy|2|||
131847972|NCT00261443|474726008|FG002|3: Assessment of Relapse|Pregnancy|1|||
131451566|NCT01499355|473281602|FG003|Run-In Period|Other|0|||
131451567|NCT01499355|473281599|FG000|Run-In Period|Death|2|||
131451568|NCT01499355|473281600|FG001|Run-In Period|Death|0|||
131451569|NCT01499355|473281601|FG002|Run-In Period|Death|0|||
131451570|NCT01499355|473281602|FG003|Run-In Period|Death|0|||
131451571|NCT01499355|473281599|FG000|Run-In Period|Investigator Decision|2|||
131451572|NCT01499355|473281600|FG001|Run-In Period|Investigator Decision|0|||
131451573|NCT01499355|473281601|FG002|Run-In Period|Investigator Decision|0|||
131451574|NCT01499355|473281602|FG003|Run-In Period|Investigator Decision|0|||
131847973|NCT00261443|474726006|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
131847974|NCT00261443|474726007|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
131451575|NCT01499355|473281599|FG000|Run-In Period|Consent Withdrawn|1|||
131451576|NCT01499355|473281600|FG001|Run-In Period|Consent Withdrawn|0|||
131451577|NCT01499355|473281601|FG002|Run-In Period|Consent Withdrawn|0|||
131847975|NCT00261443|474726008|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
131847976|NCT00261443|474726006|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
131847977|NCT00261443|474726007|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
131847978|NCT00261443|474726008|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
131847979|NCT00261443|474726006|FG000|3: Assessment of Relapse|Other Reasons|0|||
131847980|NCT00261443|474726007|FG001|3: Assessment of Relapse|Other Reasons|4|||
131847981|NCT00261443|474726008|FG002|3: Assessment of Relapse|Other Reasons|3|||
131847982|NCT00261443|474726006|FG000|4: Extension Phase|Adverse Event|0|||
131847983|NCT00261443|474726007|FG001|4: Extension Phase|Adverse Event|1|||
131847984|NCT00261443|474726008|FG002|4: Extension Phase|Adverse Event|0|||
131847985|NCT00261443|474726006|FG000|4: Extension Phase|Withdrawal by Subject|0|||
131847986|NCT00261443|474726007|FG001|4: Extension Phase|Withdrawal by Subject|1|||
131847987|NCT00261443|474726008|FG002|4: Extension Phase|Withdrawal by Subject|2|||
131847988|NCT00261443|474726006|FG000|4: Extension Phase|Lost to Follow-up|0|||
131847989|NCT00261443|474726007|FG001|4: Extension Phase|Lost to Follow-up|1|||
131847990|NCT00261443|474726008|FG002|4: Extension Phase|Lost to Follow-up|0|||
131847991|NCT01286753|474726011|FG000|Overall Study|Adverse Event|7|||
131847992|NCT01286753|474726012|FG001|Overall Study|Adverse Event|6|||
131847993|NCT01286753|474726011|FG000|Overall Study|Progression|11|||
131847994|NCT01286753|474726012|FG001|Overall Study|Progression|13|||
131847995|NCT01286753|474726011|FG000|Overall Study|Refused Treatment|1|||
131847996|NCT01286753|474726012|FG001|Overall Study|Refused Treatment|0|||
131847997|NCT01286753|474726011|FG000|Overall Study|Withdrawal of Consent|0|||
131847998|NCT01286753|474726012|FG001|Overall Study|Withdrawal of Consent|2|||
131847999|NCT01286753|474726011|FG000|Overall Study|Discontinued to Join Extension Study|6|||
131848000|NCT01286753|474726012|FG001|Overall Study|Discontinued to Join Extension Study|4|||
131848001|NCT01286753|474726011|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
131848002|NCT01286753|474726012|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
131848003|NCT01371747|474726020|FG000|Overall Study|Adverse Event|4|||
131848004|NCT01371747|474726021|FG001|Overall Study|Adverse Event|2|||
131848005|NCT01371747|474726022|FG002|Overall Study|Adverse Event|7|||
131848006|NCT01371747|474726023|FG003|Overall Study|Adverse Event|2|||
131848007|NCT01371747|474726024|FG004|Overall Study|Adverse Event|2|||
131848008|NCT01371747|474726025|FG005|Overall Study|Adverse Event|2|||
131848009|NCT01371747|474726020|FG000|Overall Study|Death|1|||
131848010|NCT01371747|474726021|FG001|Overall Study|Death|0|||
131848011|NCT01371747|474726022|FG002|Overall Study|Death|4|||
131848012|NCT01371747|474726023|FG003|Overall Study|Death|1|||
131848013|NCT01371747|474726024|FG004|Overall Study|Death|2|||
131848014|NCT01371747|474726025|FG005|Overall Study|Death|0|||
131848015|NCT01371747|474726020|FG000|Overall Study|Abnormal Renal Function|0|||
131848016|NCT01371747|474726021|FG001|Overall Study|Abnormal Renal Function|2|||
131848017|NCT01371747|474726022|FG002|Overall Study|Abnormal Renal Function|0|||
131848018|NCT01371747|474726023|FG003|Overall Study|Abnormal Renal Function|1|||
131848019|NCT01371747|474726024|FG004|Overall Study|Abnormal Renal Function|0|||
131848020|NCT01371747|474726025|FG005|Overall Study|Abnormal Renal Function|1|||
131848021|NCT01371747|474726020|FG000|Overall Study|High Serum Potassium Results|1|||
131848022|NCT01371747|474726021|FG001|Overall Study|High Serum Potassium Results|1|||
131848023|NCT01371747|474726022|FG002|Overall Study|High Serum Potassium Results|1|||
131848024|NCT01371747|474726023|FG003|Overall Study|High Serum Potassium Results|2|||
131848025|NCT01371747|474726024|FG004|Overall Study|High Serum Potassium Results|0|||
131848026|NCT01371747|474726025|FG005|Overall Study|High Serum Potassium Results|2|||
131848027|NCT01371747|474726020|FG000|Overall Study|Low Serum Potassium Results|1|||
131848028|NCT01371747|474726021|FG001|Overall Study|Low Serum Potassium Results|1|||
131848029|NCT01371747|474726022|FG002|Overall Study|Low Serum Potassium Results|1|||
131848030|NCT01371747|474726023|FG003|Overall Study|Low Serum Potassium Results|1|||
131848031|NCT01371747|474726024|FG004|Overall Study|Low Serum Potassium Results|0|||
131848032|NCT01371747|474726025|FG005|Overall Study|Low Serum Potassium Results|3|||
131848033|NCT01371747|474726020|FG000|Overall Study|Protocol Violation|0|||
131848034|NCT01371747|474726021|FG001|Overall Study|Protocol Violation|0|||
131848035|NCT01371747|474726022|FG002|Overall Study|Protocol Violation|1|||
131848036|NCT01371747|474726023|FG003|Overall Study|Protocol Violation|0|||
131848037|NCT01371747|474726024|FG004|Overall Study|Protocol Violation|0|||
131848038|NCT01371747|474726025|FG005|Overall Study|Protocol Violation|0|||
131848039|NCT01371747|474726020|FG000|Overall Study|Non-Compliance|3|||
131848040|NCT01371747|474726021|FG001|Overall Study|Non-Compliance|4|||
131848041|NCT01371747|474726022|FG002|Overall Study|Non-Compliance|3|||
131848042|NCT01371747|474726023|FG003|Overall Study|Non-Compliance|0|||
131848043|NCT01371747|474726024|FG004|Overall Study|Non-Compliance|0|||
131848044|NCT01371747|474726025|FG005|Overall Study|Non-Compliance|1|||
131848045|NCT01371747|474726020|FG000|Overall Study|Physician Decision|0|||
131848046|NCT01371747|474726021|FG001|Overall Study|Physician Decision|0|||
131848047|NCT01371747|474726022|FG002|Overall Study|Physician Decision|0|||
131848048|NCT01371747|474726023|FG003|Overall Study|Physician Decision|0|||
131848049|NCT01371747|474726024|FG004|Overall Study|Physician Decision|1|||
131848050|NCT01371747|474726025|FG005|Overall Study|Physician Decision|0|||
131848051|NCT01371747|474726020|FG000|Overall Study|Withdrawal by Subject|6|||
131451578|NCT01499355|473281602|FG003|Run-In Period|Consent Withdrawn|0|||
131451579|NCT01499355|473281599|FG000|Run-In Period|Adverse Event|8|||
131451580|NCT01499355|473281600|FG001|Run-In Period|Adverse Event|0|||
131451581|NCT01499355|473281601|FG002|Run-In Period|Adverse Event|0|||
131451582|NCT01499355|473281602|FG003|Run-In Period|Adverse Event|0|||
131451583|NCT01499355|473281599|FG000|Double-Blind Period|Adverse Event|0|||
131451584|NCT01499355|473281600|FG001|Double-Blind Period|Adverse Event|2|||
131451585|NCT01499355|473281601|FG002|Double-Blind Period|Adverse Event|3|||
131451586|NCT01499355|473281602|FG003|Double-Blind Period|Adverse Event|2|||
131451587|NCT01499355|473281599|FG000|Double-Blind Period|Study Termination|0|||
131451588|NCT01499355|473281600|FG001|Double-Blind Period|Study Termination|18|||
131451589|NCT01499355|473281601|FG002|Double-Blind Period|Study Termination|16|||
131451590|NCT01499355|473281602|FG003|Double-Blind Period|Study Termination|14|||
131451591|NCT01499355|473281599|FG000|Double-Blind Period|Other|0|||
131451592|NCT01499355|473281600|FG001|Double-Blind Period|Other|1|||
131451593|NCT01499355|473281601|FG002|Double-Blind Period|Other|2|||
131451594|NCT01499355|473281602|FG003|Double-Blind Period|Other|2|||
131451595|NCT01499355|473281599|FG000|Double-Blind Period|Death|0|||
131451596|NCT01499355|473281600|FG001|Double-Blind Period|Death|1|||
131451597|NCT01499355|473281601|FG002|Double-Blind Period|Death|0|||
131451598|NCT01499355|473281602|FG003|Double-Blind Period|Death|0|||
131451599|NCT01499355|473281599|FG000|Double-Blind Period|Investigator Decision|0|||
131451600|NCT01499355|473281600|FG001|Double-Blind Period|Investigator Decision|0|||
131451601|NCT01499355|473281601|FG002|Double-Blind Period|Investigator Decision|3|||
131451602|NCT01499355|473281602|FG003|Double-Blind Period|Investigator Decision|3|||
131451603|NCT01499355|473281599|FG000|Double-Blind Period|Consent Withdrawn|0|||
131451604|NCT01499355|473281600|FG001|Double-Blind Period|Consent Withdrawn|0|||
131451605|NCT01499355|473281601|FG002|Double-Blind Period|Consent Withdrawn|1|||
131451606|NCT01499355|473281602|FG003|Double-Blind Period|Consent Withdrawn|2|||
131451607|NCT01499355|473281599|FG000|Double-Blind Period|Lost to Follow-up|0|||
131451608|NCT01499355|473281600|FG001|Double-Blind Period|Lost to Follow-up|1|||
131451609|NCT01499355|473281601|FG002|Double-Blind Period|Lost to Follow-up|0|||
131451610|NCT01499355|473281602|FG003|Double-Blind Period|Lost to Follow-up|0|||
131451611|NCT01526733|473281603|FG000|Phase 1|Protocol Violation|1|||
131451612|NCT01526733|473281604|FG001|Phase 1|Protocol Violation|0|||
131451613|NCT01526733|473281603|FG000|Phase 1|Withdrawal by Subject|1|||
131451614|NCT01526733|473281604|FG001|Phase 1|Withdrawal by Subject|1|||
131451615|NCT02699749|473281609|FG000|Overall Study|Other|0|||
131451616|NCT02699749|473281610|FG001|Overall Study|Other|0|||
131451617|NCT02699749|473281611|FG002|Overall Study|Other|2|||
131451618|NCT02699749|473281612|FG003|Overall Study|Other|0|||
131451619|NCT02699749|473281613|FG004|Overall Study|Other|0|||
131451620|NCT02699749|473281614|FG005|Overall Study|Other|1|||
131451621|NCT02699749|473281615|FG006|Overall Study|Other|1|||
131451622|NCT02699749|473281616|FG007|Overall Study|Other|0|||
131451623|NCT02699749|473281617|FG008|Overall Study|Other|0|||
131451624|NCT02699749|473281618|FG009|Overall Study|Other|0|||
131451625|NCT02699749|473281619|FG010|Overall Study|Other|1|||
131451626|NCT02699749|473281620|FG011|Overall Study|Other|0|||
131451627|NCT02699749|473281621|FG012|Overall Study|Other|0|||
131451628|NCT02699749|473281622|FG013|Overall Study|Other|0|||
131451629|NCT02699749|473281609|FG000|Overall Study|Progressive Disease|3|||
131451630|NCT02699749|473281610|FG001|Overall Study|Progressive Disease|3|||
131451631|NCT02699749|473281611|FG002|Overall Study|Progressive Disease|14|||
131451632|NCT02699749|473281612|FG003|Overall Study|Progressive Disease|3|||
131451633|NCT02699749|473281613|FG004|Overall Study|Progressive Disease|3|||
131451634|NCT02699749|473281614|FG005|Overall Study|Progressive Disease|7|||
131451635|NCT02699749|473281615|FG006|Overall Study|Progressive Disease|5|||
131451636|NCT02699749|473281616|FG007|Overall Study|Progressive Disease|5|||
131451637|NCT02699749|473281617|FG008|Overall Study|Progressive Disease|6|||
131451638|NCT02699749|473281618|FG009|Overall Study|Progressive Disease|6|||
131451639|NCT02699749|473281619|FG010|Overall Study|Progressive Disease|5|||
131451640|NCT02699749|473281620|FG011|Overall Study|Progressive Disease|4|||
131451641|NCT02699749|473281621|FG012|Overall Study|Progressive Disease|3|||
131848052|NCT01371747|474726021|FG001|Overall Study|Withdrawal by Subject|12|||
131848053|NCT01371747|474726022|FG002|Overall Study|Withdrawal by Subject|5|||
131848054|NCT01371747|474726023|FG003|Overall Study|Withdrawal by Subject|2|||
131451642|NCT02699749|473281622|FG013|Overall Study|Progressive Disease|5|||
131451643|NCT02699749|473281609|FG000|Overall Study|Death|0|||
131451644|NCT02699749|473281610|FG001|Overall Study|Death|0|||
131451645|NCT02699749|473281611|FG002|Overall Study|Death|0|||
131451646|NCT02699749|473281612|FG003|Overall Study|Death|0|||
131451647|NCT02699749|473281613|FG004|Overall Study|Death|0|||
131451648|NCT02699749|473281614|FG005|Overall Study|Death|0|||
131451649|NCT02699749|473281615|FG006|Overall Study|Death|0|||
131451650|NCT02699749|473281616|FG007|Overall Study|Death|0|||
131451651|NCT02699749|473281617|FG008|Overall Study|Death|0|||
131451652|NCT02699749|473281618|FG009|Overall Study|Death|0|||
131451653|NCT02699749|473281619|FG010|Overall Study|Death|0|||
131451654|NCT02699749|473281620|FG011|Overall Study|Death|0|||
131451655|NCT02699749|473281621|FG012|Overall Study|Death|0|||
131451656|NCT02699749|473281622|FG013|Overall Study|Death|1|||
131911687|NCT01020123|474963231|FG005|Extention Period|Withdrawal by Subject|0|||
131848055|NCT01371747|474726024|FG004|Overall Study|Withdrawal by Subject|2|||
131848056|NCT01371747|474726025|FG005|Overall Study|Withdrawal by Subject|4|||
131848057|NCT01371747|474726020|FG000|Overall Study|Other Reasons|2|||
131848058|NCT01371747|474726021|FG001|Overall Study|Other Reasons|1|||
131848059|NCT01371747|474726022|FG002|Overall Study|Other Reasons|2|||
131848060|NCT01371747|474726023|FG003|Overall Study|Other Reasons|0|||
131848061|NCT01371747|474726024|FG004|Overall Study|Other Reasons|0|||
131848062|NCT01371747|474726025|FG005|Overall Study|Other Reasons|1|||
131848063|NCT02094417|474726029|FG000|Overall Study|Adverse Event|0|||
131848064|NCT02094417|474726030|FG001|Overall Study|Adverse Event|0|||
131848065|NCT02094417|474726031|FG002|Overall Study|Adverse Event|0|||
131848066|NCT02094417|474726032|FG003|Overall Study|Adverse Event|1|||
131848067|NCT02094417|474726029|FG000|Overall Study|Eligibility criteria|0|||
131848068|NCT02094417|474726030|FG001|Overall Study|Eligibility criteria|1|||
131848069|NCT02094417|474726031|FG002|Overall Study|Eligibility criteria|0|||
131848070|NCT02094417|474726032|FG003|Overall Study|Eligibility criteria|0|||
131848071|NCT02094417|474726029|FG000|Overall Study|No responder|4|||
131848072|NCT02094417|474726030|FG001|Overall Study|No responder|4|||
131848073|NCT02094417|474726031|FG002|Overall Study|No responder|4|||
131848074|NCT02094417|474726032|FG003|Overall Study|No responder|3|||
131848075|NCT02094417|474726029|FG000|Overall Study|Unable to conduct observations or assess|0|||
131848076|NCT02094417|474726030|FG001|Overall Study|Unable to conduct observations or assess|1|||
131848077|NCT02094417|474726031|FG002|Overall Study|Unable to conduct observations or assess|0|||
131848078|NCT02094417|474726032|FG003|Overall Study|Unable to conduct observations or assess|0|||
131848079|NCT02094417|474726029|FG000|Overall Study|Withdrawal by Subject|1|||
131848080|NCT02094417|474726030|FG001|Overall Study|Withdrawal by Subject|2|||
131848081|NCT02094417|474726031|FG002|Overall Study|Withdrawal by Subject|1|||
131848082|NCT02094417|474726032|FG003|Overall Study|Withdrawal by Subject|3|||
131848083|NCT00580788|474726033|FG000|Overall Study|Adverse Event|0|||
131848084|NCT00580788|474726034|FG001|Overall Study|Adverse Event|0|||
131848085|NCT00580788|474726035|FG002|Overall Study|Adverse Event|0|||
131848086|NCT00580788|474726036|FG003|Overall Study|Adverse Event|1|||
131848087|NCT01564537|474726039|FG000|Overall Study|Site Terminated by Sponsor|1|||
131848088|NCT01564537|474726040|FG001|Overall Study|Site Terminated by Sponsor|0|||
131848089|NCT01564537|474726039|FG000|Overall Study|Withdrawal by Subject|12|||
131848090|NCT01564537|474726040|FG001|Overall Study|Withdrawal by Subject|14|||
131848091|NCT01564537|474726039|FG000|Overall Study|Lost to Follow-up|7|||
131848092|NCT01564537|474726040|FG001|Overall Study|Lost to Follow-up|3|||
131848093|NCT01564537|474726039|FG000|Overall Study|Reason not specified|81|||
131848094|NCT01564537|474726040|FG001|Overall Study|Reason not specified|82|||
131848095|NCT03760185|474726041|FG000|Overall Study|Lost to Follow-up|1|||
131848096|NCT03760185|474726042|FG001|Overall Study|Lost to Follow-up|1|||
131848097|NCT01377987|474726043|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
131848098|NCT01377987|474726044|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
131848099|NCT04611529|474726045|FG000|2-day Follow up|Lost to Follow-up|5|||
131848100|NCT04611529|474726046|FG001|2-day Follow up|Lost to Follow-up|6|||
131848101|NCT04611529|474726047|FG002|2-day Follow up|Lost to Follow-up|3|||
131848102|NCT00253448|474726048|FG000|Overall Study|Withdrawal by Subject|1|||
131848103|NCT02648932|474726049|FG000|Overall Study|No transplant|3|||
131848104|NCT02648932|474726050|FG001|Overall Study|No transplant|1|||
131848105|NCT01307111|474726053|FG000|IUD Insertion|Lost to Follow-up|2|||
131848106|NCT01307111|474726054|FG001|IUD Insertion|Lost to Follow-up|0|||
131848107|NCT01307111|474726053|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
131848108|NCT01307111|474726054|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
131848109|NCT01333397|474726061|FG000|Overall Study|Lost to Follow-up|1|||
131848110|NCT01333397|474726062|FG001|Overall Study|Lost to Follow-up|0|||
131848111|NCT01333397|474726063|FG002|Overall Study|Lost to Follow-up|0|||
131848112|NCT01333397|474726064|FG003|Overall Study|Lost to Follow-up|1|||
131848113|NCT01333397|474726065|FG004|Overall Study|Lost to Follow-up|0|||
131848114|NCT03717012|474726068|FG000|Overall Study|Due to trial termination|1|||
131848115|NCT03717012|474726069|FG001|Overall Study|Due to trial termination|2|||
131848116|NCT03717012|474726068|FG000|Overall Study|Protocol Violation|0|||
131848117|NCT03717012|474726069|FG001|Overall Study|Protocol Violation|2|||
131848118|NCT03717012|474726068|FG000|Overall Study|Adverse Event|0|||
131848119|NCT03717012|474726069|FG001|Overall Study|Adverse Event|1|||
131848120|NCT03717012|474726068|FG000|Overall Study|Lung transplant|0|||
131848121|NCT03717012|474726069|FG001|Overall Study|Lung transplant|1|||
131848122|NCT02640690|474726070|FG000|Overall Study|Lost to Follow-up|7|||
131848123|NCT02640690|474726071|FG001|Overall Study|Lost to Follow-up|7|||
131848124|NCT02640690|474726070|FG000|Overall Study|Withdrawal by Subject|16|||
131848125|NCT02640690|474726071|FG001|Overall Study|Withdrawal by Subject|20|||
131848126|NCT02640690|474726070|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
131848127|NCT02640690|474726071|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
131848128|NCT00920790|474726072|FG000|Overall Study|aggravation of general condition|14|||
131848129|NCT02892149|474726080|FG000|Overall Study|Death|262|||
131848130|NCT02892149|474726081|FG001|Overall Study|Death|278|||
131848131|NCT02892149|474726080|FG000|Overall Study|Withdrawal by Subject|53|||
131848132|NCT02892149|474726081|FG001|Overall Study|Withdrawal by Subject|47|||
131848133|NCT02892149|474726080|FG000|Overall Study|Lost to Follow-up|37|||
131848134|NCT02892149|474726081|FG001|Overall Study|Lost to Follow-up|31|||
131848135|NCT00478426|474726118|FG000|Overall Study|Withdrawal by Subject|1|||
131848136|NCT00789737|474726119|FG000|Overall Study|Withdrawal by Subject|13|||
131848137|NCT00789737|474726120|FG001|Overall Study|Withdrawal by Subject|22|||
131848138|NCT00789737|474726119|FG000|Overall Study|Lost to Follow-up|10|||
131848139|NCT00789737|474726120|FG001|Overall Study|Lost to Follow-up|14|||
131848140|NCT00789737|474726119|FG000|Overall Study|Adverse Event|8|||
131848141|NCT00789737|474726120|FG001|Overall Study|Adverse Event|8|||
131848142|NCT00789737|474726119|FG000|Overall Study|Protocol Violation|3|||
131848143|NCT00789737|474726120|FG001|Overall Study|Protocol Violation|0|||
131848144|NCT00789737|474726119|FG000|Overall Study|Lack of Efficacy|3|||
131848145|NCT00789737|474726120|FG001|Overall Study|Lack of Efficacy|0|||
131848146|NCT00789737|474726119|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
131848147|NCT00789737|474726120|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
131848148|NCT00789737|474726119|FG000|Overall Study|Other|11|||
131848149|NCT00789737|474726120|FG001|Overall Study|Other|7|||
131848150|NCT03489109|474726127|FG000|Overall Study|Lost to Follow-up|1|||
131848151|NCT03489109|474726128|FG001|Overall Study|Lost to Follow-up|2|||
131848152|NCT00384930|474726129|FG000|Overall Study|Adverse Event|5|||
131848153|NCT00384930|474726130|FG001|Overall Study|Adverse Event|4|||
131848154|NCT00384930|474726131|FG002|Overall Study|Adverse Event|12|||
131848155|NCT00384930|474726132|FG003|Overall Study|Adverse Event|11|||
131848156|NCT00384930|474726133|FG004|Overall Study|Adverse Event|14|||
131848157|NCT00384930|474726129|FG000|Overall Study|Entry Criteria Not Met|2|||
131848158|NCT00384930|474726130|FG001|Overall Study|Entry Criteria Not Met|6|||
131848159|NCT00384930|474726131|FG002|Overall Study|Entry Criteria Not Met|7|||
131848160|NCT00384930|474726132|FG003|Overall Study|Entry Criteria Not Met|8|||
131848161|NCT00384930|474726133|FG004|Overall Study|Entry Criteria Not Met|4|||
131848162|NCT00384930|474726129|FG000|Overall Study|Lack of Efficacy|1|||
131848163|NCT00384930|474726130|FG001|Overall Study|Lack of Efficacy|1|||
131848164|NCT00384930|474726131|FG002|Overall Study|Lack of Efficacy|2|||
131848165|NCT00384930|474726132|FG003|Overall Study|Lack of Efficacy|1|||
131848166|NCT00384930|474726133|FG004|Overall Study|Lack of Efficacy|2|||
131848167|NCT00384930|474726129|FG000|Overall Study|Lost to Follow-up|5|||
131848168|NCT00384930|474726130|FG001|Overall Study|Lost to Follow-up|3|||
131848169|NCT00384930|474726131|FG002|Overall Study|Lost to Follow-up|0|||
131848170|NCT00384930|474726132|FG003|Overall Study|Lost to Follow-up|4|||
131848171|NCT00384930|474726133|FG004|Overall Study|Lost to Follow-up|6|||
131848172|NCT00384930|474726129|FG000|Overall Study|Physician Decision|0|||
131848173|NCT00384930|474726130|FG001|Overall Study|Physician Decision|1|||
131848174|NCT00384930|474726131|FG002|Overall Study|Physician Decision|1|||
131848175|NCT00384930|474726132|FG003|Overall Study|Physician Decision|0|||
131848176|NCT00384930|474726133|FG004|Overall Study|Physician Decision|1|||
131848177|NCT00384930|474726129|FG000|Overall Study|Protocol Violation|1|||
131848178|NCT00384930|474726130|FG001|Overall Study|Protocol Violation|0|||
131848179|NCT00384930|474726131|FG002|Overall Study|Protocol Violation|1|||
131848180|NCT00384930|474726132|FG003|Overall Study|Protocol Violation|6|||
131848181|NCT00384930|474726133|FG004|Overall Study|Protocol Violation|4|||
131848182|NCT00384930|474726129|FG000|Overall Study|Sponsor Decision|3|||
131848183|NCT00384930|474726130|FG001|Overall Study|Sponsor Decision|4|||
131848184|NCT00384930|474726131|FG002|Overall Study|Sponsor Decision|0|||
131848185|NCT00384930|474726132|FG003|Overall Study|Sponsor Decision|5|||
131848186|NCT00384930|474726133|FG004|Overall Study|Sponsor Decision|0|||
131848187|NCT00384930|474726129|FG000|Overall Study|Withdrawal by Subject|9|||
131848188|NCT00384930|474726130|FG001|Overall Study|Withdrawal by Subject|7|||
131848189|NCT00384930|474726131|FG002|Overall Study|Withdrawal by Subject|7|||
131848190|NCT00384930|474726132|FG003|Overall Study|Withdrawal by Subject|6|||
131848191|NCT00384930|474726133|FG004|Overall Study|Withdrawal by Subject|16|||
131848192|NCT00384930|474726129|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
131848193|NCT00384930|474726130|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
131848194|NCT00384930|474726131|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
131848195|NCT00384930|474726132|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
131848196|NCT00384930|474726133|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
131848197|NCT02752087|474726136|FG000|Washout|Physician Decision|1|||
131848198|NCT02752087|474726137|FG001|Washout|Physician Decision|0|||
131848199|NCT01547130|474726138|FG000|Overall Study|Lost to Follow-up|9|||
131848200|NCT01547130|474726139|FG001|Overall Study|Lost to Follow-up|5|||
131848201|NCT03301623|474726140|FG000|Overall Study|Death|3|||
131848202|NCT03301623|474726141|FG001|Overall Study|Death|1|||
131848203|NCT03301623|474726140|FG000|Overall Study|Withdrawal by Subject|11|||
131848204|NCT03301623|474726141|FG001|Overall Study|Withdrawal by Subject|13|||
131848205|NCT03301623|474726140|FG000|Overall Study|Lost to Follow-up|3|||
131848206|NCT03301623|474726141|FG001|Overall Study|Lost to Follow-up|1|||
131848207|NCT01806506|474726142|FG000|Overall Study|Lost to Follow-up|2|||
131848208|NCT01806506|474726143|FG001|Overall Study|Lost to Follow-up|1|||
131848209|NCT01374269|474726150|FG000|Overall Study|Withdrawal by Subject|4|||
131848210|NCT01374269|474726151|FG001|Overall Study|Withdrawal by Subject|0|||
131848211|NCT01374269|474726150|FG000|Overall Study|Lost to Follow-up|1|||
131848212|NCT01374269|474726151|FG001|Overall Study|Lost to Follow-up|3|||
131848213|NCT01374269|474726150|FG000|Overall Study|closed research|1|||
131848214|NCT01374269|474726151|FG001|Overall Study|closed research|2|||
131451657|NCT02699749|473281609|FG000|Overall Study|Lost to Follow-up|0|||
131451658|NCT02699749|473281610|FG001|Overall Study|Lost to Follow-up|0|||
131451659|NCT02699749|473281611|FG002|Overall Study|Lost to Follow-up|0|||
131451660|NCT02699749|473281612|FG003|Overall Study|Lost to Follow-up|0|||
131451661|NCT02699749|473281613|FG004|Overall Study|Lost to Follow-up|0|||
131451662|NCT02699749|473281614|FG005|Overall Study|Lost to Follow-up|1|||
131451663|NCT02699749|473281615|FG006|Overall Study|Lost to Follow-up|0|||
131451664|NCT02699749|473281616|FG007|Overall Study|Lost to Follow-up|1|||
131848215|NCT00996892|474726153|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
131848216|NCT00996892|474726154|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
131848217|NCT00996892|474726155|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
131848218|NCT00996892|474726156|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
131848219|NCT00996892|474726157|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
131848220|NCT00996892|474726158|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
131848221|NCT00996892|474726159|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
131848222|NCT00996892|474726160|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
131848223|NCT00996892|474726161|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
131848224|NCT00996892|474726162|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
131848225|NCT00996892|474726163|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
131848226|NCT00996892|474726164|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
131848227|NCT00996892|474726165|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
131848228|NCT00996892|474726166|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
131848229|NCT00996892|474726167|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
131848230|NCT00996892|474726168|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
131848231|NCT00996892|474726169|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
131848232|NCT00996892|474726170|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
131848233|NCT00996892|474726171|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
131848234|NCT00996892|474726172|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
131848235|NCT00996892|474726153|FG000|Dose-Escalation Stage 1|Death|1|||
131848236|NCT00996892|474726154|FG001|Dose-Escalation Stage 1|Death|0|||
131848237|NCT00996892|474726155|FG002|Dose-Escalation Stage 1|Death|0|||
131848238|NCT00996892|474726156|FG003|Dose-Escalation Stage 1|Death|0|||
131848239|NCT00996892|474726157|FG004|Dose-Escalation Stage 1|Death|0|||
131848240|NCT00996892|474726158|FG005|Dose-Escalation Stage 1|Death|1|||
131848241|NCT00996892|474726159|FG006|Dose-Escalation Stage 1|Death|0|||
131848242|NCT00996892|474726160|FG007|Dose-Escalation Stage 1|Death|0|||
131848243|NCT00996892|474726161|FG008|Dose-Escalation Stage 1|Death|0|||
131848244|NCT00996892|474726162|FG009|Dose-Escalation Stage 1|Death|0|||
131848245|NCT00996892|474726163|FG010|Dose-Escalation Stage 1|Death|0|||
131848246|NCT00996892|474726164|FG011|Dose-Escalation Stage 1|Death|0|||
131848247|NCT00996892|474726165|FG012|Dose-Escalation Stage 1|Death|0|||
131848248|NCT00996892|474726166|FG013|Dose-Escalation Stage 1|Death|0|||
131848249|NCT00996892|474726167|FG014|Dose-Escalation Stage 1|Death|0|||
131848250|NCT00996892|474726168|FG015|Dose-Escalation Stage 1|Death|0|||
131848251|NCT00996892|474726169|FG016|Dose-Escalation Stage 1|Death|0|||
131848252|NCT00996892|474726170|FG017|Dose-Escalation Stage 1|Death|0|||
131848253|NCT00996892|474726171|FG018|Dose-Escalation Stage 1|Death|0|||
131848254|NCT00996892|474726172|FG019|Dose-Escalation Stage 1|Death|0|||
131848255|NCT00996892|474726153|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
131848256|NCT00996892|474726154|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
131848257|NCT00996892|474726155|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
131848258|NCT00996892|474726156|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
131848259|NCT00996892|474726157|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
131848260|NCT00996892|474726158|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
131848261|NCT00996892|474726159|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
131848262|NCT00996892|474726160|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
131848263|NCT00996892|474726161|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
131848264|NCT00996892|474726162|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
131848265|NCT00996892|474726163|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
131848266|NCT00996892|474726164|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
131848267|NCT00996892|474726165|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
131848268|NCT00996892|474726166|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
131848269|NCT00996892|474726167|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
131848270|NCT00996892|474726168|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
131848271|NCT00996892|474726169|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
131848272|NCT00996892|474726170|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
131848273|NCT00996892|474726171|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
131848274|NCT00996892|474726172|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
131848275|NCT00996892|474726153|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131451665|NCT02699749|473281617|FG008|Overall Study|Lost to Follow-up|0|||
131848276|NCT00996892|474726154|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
131848277|NCT00996892|474726155|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848278|NCT00996892|474726156|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
131848279|NCT00996892|474726157|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
131848280|NCT00996892|474726158|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
131848281|NCT00996892|474726159|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
131848282|NCT00996892|474726160|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848283|NCT00996892|474726161|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848284|NCT00996892|474726162|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848285|NCT00996892|474726163|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848286|NCT00996892|474726164|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848287|NCT00996892|474726165|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848288|NCT00996892|474726166|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848289|NCT00996892|474726167|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848290|NCT00996892|474726168|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848291|NCT00996892|474726169|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848292|NCT00996892|474726170|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848293|NCT00996892|474726171|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848294|NCT00996892|474726172|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131848295|NCT00996892|474726153|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
131848296|NCT00996892|474726154|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
131848297|NCT00996892|474726155|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
131848298|NCT00996892|474726156|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
131848299|NCT00996892|474726157|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
131848300|NCT00996892|474726158|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
131848301|NCT00996892|474726159|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
131848302|NCT00996892|474726160|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
131848303|NCT00996892|474726161|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
131848304|NCT00996892|474726162|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
131848305|NCT00996892|474726163|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
131848306|NCT00996892|474726164|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
131848307|NCT00996892|474726165|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
131848308|NCT00996892|474726166|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
131848309|NCT00996892|474726167|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
131848310|NCT00996892|474726168|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
131848311|NCT00996892|474726169|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
131848312|NCT00996892|474726170|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
131848313|NCT00996892|474726171|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
131848314|NCT00996892|474726172|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
131848315|NCT00996892|474726153|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
131848316|NCT00996892|474726154|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
131848317|NCT00996892|474726155|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
131848318|NCT00996892|474726156|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
131848319|NCT00996892|474726157|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
131848320|NCT00996892|474726158|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
131848321|NCT00996892|474726159|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
131848322|NCT00996892|474726160|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
131848323|NCT00996892|474726161|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
131848324|NCT00996892|474726162|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
131848325|NCT00996892|474726163|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
131848326|NCT00996892|474726164|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
131848327|NCT00996892|474726165|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
131848328|NCT00996892|474726166|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
131848329|NCT00996892|474726167|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
131848330|NCT00996892|474726168|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
131848331|NCT00996892|474726169|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
131848332|NCT00996892|474726170|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
131848333|NCT00996892|474726171|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
131848334|NCT00996892|474726172|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
131848335|NCT00996892|474726153|FG000|Dose-Escalation Stage 1A|Death|0|||
131848336|NCT00996892|474726154|FG001|Dose-Escalation Stage 1A|Death|0|||
131848337|NCT00996892|474726155|FG002|Dose-Escalation Stage 1A|Death|0|||
131848338|NCT00996892|474726156|FG003|Dose-Escalation Stage 1A|Death|0|||
131848339|NCT00996892|474726157|FG004|Dose-Escalation Stage 1A|Death|0|||
131848340|NCT00996892|474726158|FG005|Dose-Escalation Stage 1A|Death|0|||
131848341|NCT00996892|474726159|FG006|Dose-Escalation Stage 1A|Death|0|||
131848342|NCT00996892|474726160|FG007|Dose-Escalation Stage 1A|Death|0|||
131848343|NCT00996892|474726161|FG008|Dose-Escalation Stage 1A|Death|0|||
131848344|NCT00996892|474726162|FG009|Dose-Escalation Stage 1A|Death|2|||
131848345|NCT00996892|474726163|FG010|Dose-Escalation Stage 1A|Death|0|||
131848346|NCT00996892|474726164|FG011|Dose-Escalation Stage 1A|Death|1|||
131848347|NCT00996892|474726165|FG012|Dose-Escalation Stage 1A|Death|1|||
131848348|NCT00996892|474726166|FG013|Dose-Escalation Stage 1A|Death|0|||
131848349|NCT00996892|474726167|FG014|Dose-Escalation Stage 1A|Death|0|||
131848350|NCT00996892|474726168|FG015|Dose-Escalation Stage 1A|Death|0|||
131848351|NCT00996892|474726169|FG016|Dose-Escalation Stage 1A|Death|0|||
131848352|NCT00996892|474726170|FG017|Dose-Escalation Stage 1A|Death|0|||
131848353|NCT00996892|474726171|FG018|Dose-Escalation Stage 1A|Death|0|||
131848354|NCT00996892|474726172|FG019|Dose-Escalation Stage 1A|Death|0|||
131848355|NCT00996892|474726153|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
131848356|NCT00996892|474726154|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
131848357|NCT00996892|474726155|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
131848358|NCT00996892|474726156|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
131848359|NCT00996892|474726157|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
131848360|NCT00996892|474726158|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
131848361|NCT00996892|474726159|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
131848362|NCT00996892|474726160|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
131848363|NCT00996892|474726161|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
131848364|NCT00996892|474726162|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
131848365|NCT00996892|474726163|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
131848366|NCT00996892|474726164|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
131848367|NCT00996892|474726165|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
131848368|NCT00996892|474726166|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
131848369|NCT00996892|474726167|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
131848370|NCT00996892|474726168|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
131848371|NCT00996892|474726169|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
131848372|NCT00996892|474726170|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
131848373|NCT00996892|474726171|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
131848374|NCT00996892|474726172|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
131848375|NCT00996892|474726153|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848376|NCT00996892|474726154|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848377|NCT00996892|474726155|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848378|NCT00996892|474726156|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848379|NCT00996892|474726157|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848380|NCT00996892|474726158|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848381|NCT00996892|474726159|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848382|NCT00996892|474726160|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848383|NCT00996892|474726161|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848384|NCT00996892|474726162|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
131848385|NCT00996892|474726163|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
131848386|NCT00996892|474726164|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
131848387|NCT00996892|474726165|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
131848388|NCT00996892|474726166|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848389|NCT00996892|474726167|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848390|NCT00996892|474726168|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848391|NCT00996892|474726169|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848392|NCT00996892|474726170|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848393|NCT00996892|474726171|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848394|NCT00996892|474726172|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131848395|NCT00996892|474726153|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
131848396|NCT00996892|474726154|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
131848397|NCT00996892|474726155|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
131848398|NCT00996892|474726156|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
131848399|NCT00996892|474726157|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
131848400|NCT00996892|474726158|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
131848401|NCT00996892|474726159|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
131848402|NCT00996892|474726160|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
131848403|NCT00996892|474726161|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
131848404|NCT00996892|474726162|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
131848405|NCT00996892|474726163|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
131848406|NCT00996892|474726164|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
131848407|NCT00996892|474726165|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
131848408|NCT00996892|474726166|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
131848409|NCT00996892|474726167|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
131848410|NCT00996892|474726168|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
131848411|NCT00996892|474726169|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
131848412|NCT00996892|474726170|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
131848413|NCT00996892|474726171|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
131848414|NCT00996892|474726172|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
131848415|NCT00996892|474726153|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
131848416|NCT00996892|474726154|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
131848417|NCT00996892|474726155|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
131848418|NCT00996892|474726156|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
131848419|NCT00996892|474726157|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
131848420|NCT00996892|474726158|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
131848421|NCT00996892|474726159|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
131848422|NCT00996892|474726160|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
131848423|NCT00996892|474726161|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
131848424|NCT00996892|474726162|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
131848425|NCT00996892|474726163|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
131848426|NCT00996892|474726164|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
131848427|NCT00996892|474726165|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
131848428|NCT00996892|474726166|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
131848429|NCT00996892|474726167|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
131848430|NCT00996892|474726168|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
131848431|NCT00996892|474726169|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
131848432|NCT00996892|474726170|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
131848433|NCT00996892|474726171|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
131848434|NCT00996892|474726172|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
131848435|NCT00996892|474726153|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
131848436|NCT00996892|474726154|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
131848437|NCT00996892|474726155|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
131848438|NCT00996892|474726156|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
131848439|NCT00996892|474726157|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
131848440|NCT00996892|474726158|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
131848441|NCT00996892|474726159|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
131848442|NCT00996892|474726160|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
131848443|NCT00996892|474726161|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
131848444|NCT00996892|474726162|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
131848445|NCT00996892|474726163|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
131848446|NCT00996892|474726164|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
131848447|NCT00996892|474726165|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
131848448|NCT00996892|474726166|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
131848449|NCT00996892|474726167|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
131848450|NCT00996892|474726168|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
131848451|NCT00996892|474726169|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
131848452|NCT00996892|474726170|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
131848453|NCT00996892|474726171|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
131848454|NCT00996892|474726172|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
131848455|NCT00996892|474726153|FG000|Expansion Stage 2|Adverse Event|0|||
131848456|NCT00996892|474726154|FG001|Expansion Stage 2|Adverse Event|0|||
131848457|NCT00996892|474726155|FG002|Expansion Stage 2|Adverse Event|0|||
131848458|NCT00996892|474726156|FG003|Expansion Stage 2|Adverse Event|0|||
131848459|NCT00996892|474726157|FG004|Expansion Stage 2|Adverse Event|0|||
131848460|NCT00996892|474726158|FG005|Expansion Stage 2|Adverse Event|0|||
131848461|NCT00996892|474726159|FG006|Expansion Stage 2|Adverse Event|0|||
131848462|NCT00996892|474726160|FG007|Expansion Stage 2|Adverse Event|0|||
131848463|NCT00996892|474726161|FG008|Expansion Stage 2|Adverse Event|0|||
131848464|NCT00996892|474726162|FG009|Expansion Stage 2|Adverse Event|0|||
131848465|NCT00996892|474726163|FG010|Expansion Stage 2|Adverse Event|0|||
131848466|NCT00996892|474726164|FG011|Expansion Stage 2|Adverse Event|0|||
131848467|NCT00996892|474726165|FG012|Expansion Stage 2|Adverse Event|0|||
131848468|NCT00996892|474726166|FG013|Expansion Stage 2|Adverse Event|0|||
131848469|NCT00996892|474726167|FG014|Expansion Stage 2|Adverse Event|0|||
131848470|NCT00996892|474726168|FG015|Expansion Stage 2|Adverse Event|0|||
131848471|NCT00996892|474726169|FG016|Expansion Stage 2|Adverse Event|0|||
131848472|NCT00996892|474726170|FG017|Expansion Stage 2|Adverse Event|0|||
131848473|NCT00996892|474726171|FG018|Expansion Stage 2|Adverse Event|3|||
131848474|NCT00996892|474726172|FG019|Expansion Stage 2|Adverse Event|0|||
131848475|NCT00996892|474726153|FG000|Expansion Stage 2|Death|0|||
131848476|NCT00996892|474726154|FG001|Expansion Stage 2|Death|0|||
131848477|NCT00996892|474726155|FG002|Expansion Stage 2|Death|0|||
131848478|NCT00996892|474726156|FG003|Expansion Stage 2|Death|0|||
131848479|NCT00996892|474726157|FG004|Expansion Stage 2|Death|0|||
131848480|NCT00996892|474726158|FG005|Expansion Stage 2|Death|0|||
131848481|NCT00996892|474726159|FG006|Expansion Stage 2|Death|0|||
131848482|NCT00996892|474726160|FG007|Expansion Stage 2|Death|0|||
131848483|NCT00996892|474726161|FG008|Expansion Stage 2|Death|0|||
131848484|NCT00996892|474726162|FG009|Expansion Stage 2|Death|0|||
131848485|NCT00996892|474726163|FG010|Expansion Stage 2|Death|0|||
131848486|NCT00996892|474726164|FG011|Expansion Stage 2|Death|0|||
131848487|NCT00996892|474726165|FG012|Expansion Stage 2|Death|0|||
131848488|NCT00996892|474726166|FG013|Expansion Stage 2|Death|0|||
131848489|NCT00996892|474726167|FG014|Expansion Stage 2|Death|0|||
131848490|NCT00996892|474726168|FG015|Expansion Stage 2|Death|0|||
131848491|NCT00996892|474726169|FG016|Expansion Stage 2|Death|0|||
131848492|NCT00996892|474726170|FG017|Expansion Stage 2|Death|0|||
131848493|NCT00996892|474726171|FG018|Expansion Stage 2|Death|2|||
131848494|NCT00996892|474726172|FG019|Expansion Stage 2|Death|0|||
131848495|NCT00996892|474726153|FG000|Expansion Stage 2|Physician Decision|0|||
131848496|NCT00996892|474726154|FG001|Expansion Stage 2|Physician Decision|0|||
131451666|NCT02699749|473281618|FG009|Overall Study|Lost to Follow-up|0|||
131451667|NCT02699749|473281619|FG010|Overall Study|Lost to Follow-up|0|||
131451668|NCT02699749|473281620|FG011|Overall Study|Lost to Follow-up|0|||
131451669|NCT02699749|473281621|FG012|Overall Study|Lost to Follow-up|0|||
131451670|NCT02699749|473281622|FG013|Overall Study|Lost to Follow-up|0|||
131451671|NCT01310075|473281623|FG000|Overall Study|Lost to Follow-up|1|||
131451672|NCT01310075|473281624|FG001|Overall Study|Lost to Follow-up|0|||
131451673|NCT01310075|473281623|FG000|Overall Study|Physician Decision|10|||
131451674|NCT01310075|473281624|FG001|Overall Study|Physician Decision|7|||
131451675|NCT01310075|473281623|FG000|Overall Study|Protocol Violation|2|||
131451676|NCT01310075|473281624|FG001|Overall Study|Protocol Violation|2|||
131451677|NCT01310075|473281623|FG000|Overall Study|Withdrawal by Subject|1|||
131451678|NCT01310075|473281624|FG001|Overall Study|Withdrawal by Subject|1|||
131451679|NCT02395081|473281625|FG000|Overall Study|Withdrawal by Subject|1|||
131451680|NCT02395081|473281626|FG001|Overall Study|Withdrawal by Subject|1|||
131451681|NCT02395081|473281627|FG002|Overall Study|Withdrawal by Subject|0|||
131451682|NCT02395081|473281625|FG000|Overall Study|Moved where blood couldn't be collected|4|||
131451683|NCT02395081|473281626|FG001|Overall Study|Moved where blood couldn't be collected|1|||
131451684|NCT02395081|473281627|FG002|Overall Study|Moved where blood couldn't be collected|3|||
131451685|NCT02395081|473281625|FG000|Overall Study|Fetal Loss|2|||
131451686|NCT02395081|473281626|FG001|Overall Study|Fetal Loss|3|||
131451687|NCT02395081|473281627|FG002|Overall Study|Fetal Loss|1|||
131451688|NCT02991040|473281628|FG000|Overall Study|Withdrawal by Subject|2|||
131451689|NCT02991040|473281628|FG000|Overall Study|Lost to Follow-up|2|||
131451690|NCT01869764|473281630|FG000|Overall Study|Withdrawal by Subject|0|||
131451691|NCT01869764|473281631|FG001|Overall Study|Withdrawal by Subject|2|||
131451692|NCT01286480|473281632|FG000|Overall Study|Withdrawal by Subject|5|||
131451693|NCT01286480|473281633|FG001|Overall Study|Withdrawal by Subject|3|||
131451694|NCT01626872|473281634|FG000|Overall Study|Physician Decision|13|||
131451695|NCT01626872|473281635|FG001|Overall Study|Physician Decision|9|||
131451696|NCT01626872|473281636|FG002|Overall Study|Physician Decision|6|||
131451697|NCT01626872|473281634|FG000|Overall Study|Withdrawal by Subject|19|||
131451698|NCT01626872|473281635|FG001|Overall Study|Withdrawal by Subject|27|||
131451699|NCT01626872|473281636|FG002|Overall Study|Withdrawal by Subject|8|||
131451700|NCT01626872|473281634|FG000|Overall Study|Adverse Event (including Death)|20|||
131451701|NCT01626872|473281635|FG001|Overall Study|Adverse Event (including Death)|28|||
131451702|NCT01626872|473281636|FG002|Overall Study|Adverse Event (including Death)|8|||
131451703|NCT01626872|473281634|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
131451704|NCT01626872|473281635|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
131451705|NCT01626872|473281636|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
131451706|NCT01696188|473281637|FG000|Overall Study|Protocol Violation|1|||
131451707|NCT01696188|473281638|FG001|Overall Study|Protocol Violation|1|||
131848497|NCT00996892|474726155|FG002|Expansion Stage 2|Physician Decision|0|||
131848498|NCT00996892|474726156|FG003|Expansion Stage 2|Physician Decision|0|||
131848499|NCT00996892|474726157|FG004|Expansion Stage 2|Physician Decision|0|||
131848500|NCT00996892|474726158|FG005|Expansion Stage 2|Physician Decision|0|||
131848501|NCT00996892|474726159|FG006|Expansion Stage 2|Physician Decision|0|||
131848502|NCT00996892|474726160|FG007|Expansion Stage 2|Physician Decision|0|||
131848503|NCT00996892|474726161|FG008|Expansion Stage 2|Physician Decision|0|||
131848504|NCT00996892|474726162|FG009|Expansion Stage 2|Physician Decision|0|||
131848505|NCT00996892|474726163|FG010|Expansion Stage 2|Physician Decision|0|||
131848506|NCT00996892|474726164|FG011|Expansion Stage 2|Physician Decision|0|||
131848507|NCT00996892|474726165|FG012|Expansion Stage 2|Physician Decision|0|||
131848508|NCT00996892|474726166|FG013|Expansion Stage 2|Physician Decision|0|||
131848509|NCT00996892|474726167|FG014|Expansion Stage 2|Physician Decision|0|||
131848510|NCT00996892|474726168|FG015|Expansion Stage 2|Physician Decision|0|||
131848511|NCT00996892|474726169|FG016|Expansion Stage 2|Physician Decision|0|||
131848512|NCT00996892|474726170|FG017|Expansion Stage 2|Physician Decision|0|||
131848513|NCT00996892|474726171|FG018|Expansion Stage 2|Physician Decision|1|||
131848514|NCT00996892|474726172|FG019|Expansion Stage 2|Physician Decision|0|||
131848515|NCT00996892|474726153|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
131848516|NCT00996892|474726154|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
131848517|NCT00996892|474726155|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
131848518|NCT00996892|474726156|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
131848519|NCT00996892|474726157|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
131848520|NCT00996892|474726158|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
131451708|NCT00960999|473281639|FG000|Overall Study|Withdrawal by Subject|1|||
131451709|NCT00960999|473281640|FG001|Overall Study|Withdrawal by Subject|0|||
131451710|NCT00960999|473281639|FG000|Overall Study|Protocol Violation|5|||
131451711|NCT00960999|473281640|FG001|Overall Study|Protocol Violation|2|||
131451712|NCT00960999|473281639|FG000|Overall Study|RT dose constraints not met|2|||
131451713|NCT00960999|473281640|FG001|Overall Study|RT dose constraints not met|0|||
131451714|NCT00888940|473281641|FG000|Overall Study|Adverse Event|12|||
131451715|NCT00888940|473281642|FG001|Overall Study|Adverse Event|3|||
131848521|NCT00996892|474726159|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
131848522|NCT00996892|474726160|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
131848523|NCT00996892|474726161|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
131848524|NCT00996892|474726162|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
131848525|NCT00996892|474726163|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
131848526|NCT00996892|474726164|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
131848527|NCT00996892|474726165|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
131848528|NCT00996892|474726166|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
131848529|NCT00996892|474726167|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
131848530|NCT00996892|474726168|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
131848531|NCT00996892|474726169|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
131848532|NCT00996892|474726170|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
131848533|NCT00996892|474726171|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
131848534|NCT00996892|474726172|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
131848535|NCT00996892|474726153|FG000|Expansion Stage 2|Disease Progression|0|||
131848536|NCT00996892|474726154|FG001|Expansion Stage 2|Disease Progression|0|||
131848537|NCT00996892|474726155|FG002|Expansion Stage 2|Disease Progression|0|||
131848538|NCT00996892|474726156|FG003|Expansion Stage 2|Disease Progression|0|||
131848539|NCT00996892|474726157|FG004|Expansion Stage 2|Disease Progression|0|||
131911688|NCT01020123|474963232|FG006|Extention Period|Withdrawal by Subject|0|||
131911689|NCT01020123|474963226|FG000|Extention Period|Adverse Event|0|||
131911690|NCT01020123|474963227|FG001|Extention Period|Adverse Event|0|||
131911691|NCT01020123|474963228|FG002|Extention Period|Adverse Event|0|||
131911692|NCT01020123|474963229|FG003|Extention Period|Adverse Event|1|||
131911693|NCT01020123|474963230|FG004|Extention Period|Adverse Event|0|||
131911694|NCT01020123|474963231|FG005|Extention Period|Adverse Event|0|||
131911695|NCT01020123|474963232|FG006|Extention Period|Adverse Event|0|||
131911696|NCT01020123|474963226|FG000|Extention Period|Protocol Violation|1|||
131911697|NCT01020123|474963227|FG001|Extention Period|Protocol Violation|1|||
131848540|NCT00996892|474726158|FG005|Expansion Stage 2|Disease Progression|0|||
131848541|NCT00996892|474726159|FG006|Expansion Stage 2|Disease Progression|0|||
131848542|NCT00996892|474726160|FG007|Expansion Stage 2|Disease Progression|0|||
131848543|NCT00996892|474726161|FG008|Expansion Stage 2|Disease Progression|0|||
131911698|NCT01020123|474963228|FG002|Extention Period|Protocol Violation|1|||
131911699|NCT01020123|474963229|FG003|Extention Period|Protocol Violation|0|||
131848544|NCT00996892|474726162|FG009|Expansion Stage 2|Disease Progression|0|||
131848545|NCT00996892|474726163|FG010|Expansion Stage 2|Disease Progression|0|||
131848546|NCT00996892|474726164|FG011|Expansion Stage 2|Disease Progression|0|||
131848547|NCT00996892|474726165|FG012|Expansion Stage 2|Disease Progression|0|||
131848548|NCT00996892|474726166|FG013|Expansion Stage 2|Disease Progression|0|||
131848549|NCT00996892|474726167|FG014|Expansion Stage 2|Disease Progression|0|||
131848550|NCT00996892|474726168|FG015|Expansion Stage 2|Disease Progression|0|||
131848551|NCT00996892|474726169|FG016|Expansion Stage 2|Disease Progression|0|||
131848552|NCT00996892|474726170|FG017|Expansion Stage 2|Disease Progression|0|||
131848553|NCT00996892|474726171|FG018|Expansion Stage 2|Disease Progression|28|||
131848554|NCT00996892|474726172|FG019|Expansion Stage 2|Disease Progression|0|||
131848555|NCT00996892|474726153|FG000|Expansion Stage 2A|Adverse Event|0|||
131848556|NCT00996892|474726154|FG001|Expansion Stage 2A|Adverse Event|0|||
131848557|NCT00996892|474726155|FG002|Expansion Stage 2A|Adverse Event|0|||
131848558|NCT00996892|474726156|FG003|Expansion Stage 2A|Adverse Event|0|||
131848559|NCT00996892|474726157|FG004|Expansion Stage 2A|Adverse Event|0|||
131848560|NCT00996892|474726158|FG005|Expansion Stage 2A|Adverse Event|0|||
131848561|NCT00996892|474726159|FG006|Expansion Stage 2A|Adverse Event|0|||
131848562|NCT00996892|474726160|FG007|Expansion Stage 2A|Adverse Event|0|||
131848563|NCT00996892|474726161|FG008|Expansion Stage 2A|Adverse Event|0|||
131848564|NCT00996892|474726162|FG009|Expansion Stage 2A|Adverse Event|0|||
131848565|NCT00996892|474726163|FG010|Expansion Stage 2A|Adverse Event|0|||
131911700|NCT01020123|474963230|FG004|Extention Period|Protocol Violation|0|||
131911701|NCT01020123|474963231|FG005|Extention Period|Protocol Violation|0|||
131911702|NCT01020123|474963232|FG006|Extention Period|Protocol Violation|1|||
131911703|NCT01020123|474963226|FG000|Extention Period|Lost to Follow-up|0|||
131911704|NCT01020123|474963227|FG001|Extention Period|Lost to Follow-up|0|||
131911705|NCT01020123|474963228|FG002|Extention Period|Lost to Follow-up|0|||
131911706|NCT01020123|474963229|FG003|Extention Period|Lost to Follow-up|0|||
131848566|NCT00996892|474726164|FG011|Expansion Stage 2A|Adverse Event|0|||
131911707|NCT01020123|474963230|FG004|Extention Period|Lost to Follow-up|0|||
131848567|NCT00996892|474726165|FG012|Expansion Stage 2A|Adverse Event|0|||
131911708|NCT01020123|474963231|FG005|Extention Period|Lost to Follow-up|2|||
131911709|NCT01020123|474963232|FG006|Extention Period|Lost to Follow-up|0|||
131848568|NCT00996892|474726166|FG013|Expansion Stage 2A|Adverse Event|0|||
131848569|NCT00996892|474726167|FG014|Expansion Stage 2A|Adverse Event|0|||
131911710|NCT03370172|474965161|FG000|Overall Study|Withdrawal by Subject|0|||
131911711|NCT03370172|474965162|FG001|Overall Study|Withdrawal by Subject|1|||
131848570|NCT00996892|474726168|FG015|Expansion Stage 2A|Adverse Event|0|||
131848571|NCT00996892|474726169|FG016|Expansion Stage 2A|Adverse Event|0|||
131848572|NCT00996892|474726170|FG017|Expansion Stage 2A|Adverse Event|0|||
131848573|NCT00996892|474726171|FG018|Expansion Stage 2A|Adverse Event|0|||
131911712|NCT03729362|474965163|FG000|Overall Study|Withdrawal by Subject|2|||
131911713|NCT03729362|474965164|FG001|Overall Study|Withdrawal by Subject|0|||
131911714|NCT03729362|474965163|FG000|Overall Study|Physician Decision|1|||
131451716|NCT00888940|473281641|FG000|Overall Study|Lost to Follow-up|5|||
131451717|NCT00888940|473281642|FG001|Overall Study|Lost to Follow-up|5|||
131451718|NCT00888940|473281641|FG000|Overall Study|Randomized Not Treated|11|||
131451719|NCT00888940|473281642|FG001|Overall Study|Randomized Not Treated|13|||
131451720|NCT02668393|473281644|FG000|Overall Study|Progressive disease|6|||
131451721|NCT02668393|473281645|FG001|Overall Study|Progressive disease|3|||
131451722|NCT02668393|473281644|FG000|Overall Study|Adverse Event|0|||
131451723|NCT02668393|473281645|FG001|Overall Study|Adverse Event|2|||
131451724|NCT02668393|473281644|FG000|Overall Study|Withdrawal from the trial|0|||
131451725|NCT02668393|473281645|FG001|Overall Study|Withdrawal from the trial|1|||
131451726|NCT02668393|473281644|FG000|Overall Study|Lack of benefit and side effects|1|||
131451727|NCT02668393|473281645|FG001|Overall Study|Lack of benefit and side effects|0|||
131451728|NCT02141204|473281646|FG000|Overall Study|Lost to Follow-up|2|||
131451729|NCT02141204|473281647|FG001|Overall Study|Lost to Follow-up|1|||
131451730|NCT02141204|473281646|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
131451731|NCT02141204|473281647|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
131451732|NCT02141204|473281646|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
131451733|NCT02141204|473281647|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
131451734|NCT02141204|473281646|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
131451735|NCT02141204|473281647|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
131451736|NCT02876601|473281648|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
131451737|NCT02876601|473281649|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
131451738|NCT02876601|473281650|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
131451739|NCT02876601|473281651|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
131451740|NCT00354432|473281654|FG000|Overall Study|Adverse Event|3|||
131451741|NCT00354432|473281655|FG001|Overall Study|Adverse Event|1|||
131451742|NCT00354432|473281656|FG002|Overall Study|Adverse Event|5|||
131451743|NCT00354432|473281657|FG003|Overall Study|Adverse Event|5|||
131451744|NCT00354432|473281654|FG000|Overall Study|Off/Toxicity|3|||
131451745|NCT00354432|473281655|FG001|Overall Study|Off/Toxicity|7|||
131451746|NCT00354432|473281656|FG002|Overall Study|Off/Toxicity|5|||
131451747|NCT00354432|473281657|FG003|Overall Study|Off/Toxicity|5|||
131451748|NCT02736578|473281658|FG000|Overall Study|Adverse Event|1|||
131451749|NCT02736578|473281659|FG001|Overall Study|Adverse Event|0|||
131451750|NCT02827877|473281662|FG000|Overall Study|Withdrawal by Subject|1|||
131451751|NCT00145158|473282969|FG000|Overall Study|premature withdrawal|2|||
131451752|NCT00145158|473282970|FG001|Overall Study|premature withdrawal|3|||
131451753|NCT03252925|473282971|FG000|Overall Study|Withdrawal by Subject|1|||
131451754|NCT03252925|473282972|FG001|Overall Study|Withdrawal by Subject|0|||
131451755|NCT03252925|473282971|FG000|Overall Study|Protocol Violation|6|||
131451756|NCT03252925|473282972|FG001|Overall Study|Protocol Violation|0|||
131451757|NCT03252925|473282971|FG000|Overall Study|Adverse Event|1|||
131451758|NCT03252925|473282972|FG001|Overall Study|Adverse Event|0|||
131451759|NCT03252925|473282971|FG000|Overall Study|Lost to Follow-up|6|||
131451760|NCT03252925|473282972|FG001|Overall Study|Lost to Follow-up|6|||
131451761|NCT00499616|473282973|FG000|Overall Study|Death|1|||
131451762|NCT00499616|473282974|FG001|Overall Study|Death|5|||
131451763|NCT00499616|473282975|FG002|Overall Study|Death|3|||
131451764|NCT00499616|473282976|FG003|Overall Study|Death|1|||
131848574|NCT00996892|474726172|FG019|Expansion Stage 2A|Adverse Event|8|||
131848575|NCT00996892|474726153|FG000|Expansion Stage 2A|Physician Decision|0|||
131848576|NCT00996892|474726154|FG001|Expansion Stage 2A|Physician Decision|0|||
131848577|NCT00996892|474726155|FG002|Expansion Stage 2A|Physician Decision|0|||
131848578|NCT00996892|474726156|FG003|Expansion Stage 2A|Physician Decision|0|||
131848579|NCT00996892|474726157|FG004|Expansion Stage 2A|Physician Decision|0|||
131848580|NCT00996892|474726158|FG005|Expansion Stage 2A|Physician Decision|0|||
131848581|NCT00996892|474726159|FG006|Expansion Stage 2A|Physician Decision|0|||
131911715|NCT03729362|474965164|FG001|Overall Study|Physician Decision|0|||
131911716|NCT03729362|474965163|FG000|Overall Study|COVID-19 Pandemic|1|||
131451765|NCT00499616|473282973|FG000|Overall Study|Lack of Efficacy|5|||
131451766|NCT00499616|473282974|FG001|Overall Study|Lack of Efficacy|0|||
131451767|NCT00499616|473282975|FG002|Overall Study|Lack of Efficacy|19|||
131451768|NCT00499616|473282976|FG003|Overall Study|Lack of Efficacy|0|||
131451769|NCT00499616|473282973|FG000|Overall Study|Lost to Follow-up|0|||
131451770|NCT00499616|473282974|FG001|Overall Study|Lost to Follow-up|0|||
131451771|NCT00499616|473282975|FG002|Overall Study|Lost to Follow-up|1|||
131451772|NCT00499616|473282976|FG003|Overall Study|Lost to Follow-up|0|||
131451773|NCT00499616|473282973|FG000|Overall Study|Physician Decision|6|||
131451774|NCT00499616|473282974|FG001|Overall Study|Physician Decision|16|||
131451775|NCT00499616|473282975|FG002|Overall Study|Physician Decision|9|||
131451776|NCT00499616|473282976|FG003|Overall Study|Physician Decision|0|||
131451777|NCT00499616|473282973|FG000|Overall Study|Withdrawal by Subject|1|||
131451778|NCT00499616|473282974|FG001|Overall Study|Withdrawal by Subject|0|||
131451779|NCT00499616|473282975|FG002|Overall Study|Withdrawal by Subject|1|||
131848582|NCT00996892|474726160|FG007|Expansion Stage 2A|Physician Decision|0|||
131911717|NCT03729362|474965164|FG001|Overall Study|COVID-19 Pandemic|0|||
131848583|NCT00996892|474726161|FG008|Expansion Stage 2A|Physician Decision|0|||
131451780|NCT00499616|473282976|FG003|Overall Study|Withdrawal by Subject|0|||
131451781|NCT00499616|473282973|FG000|Overall Study|Ineligible|1|||
131451782|NCT00499616|473282974|FG001|Overall Study|Ineligible|2|||
131451783|NCT00499616|473282975|FG002|Overall Study|Ineligible|0|||
131451784|NCT00499616|473282976|FG003|Overall Study|Ineligible|15|||
131451785|NCT00499616|473282973|FG000|Overall Study|Not evaluable|0|||
131451786|NCT00499616|473282974|FG001|Overall Study|Not evaluable|0|||
131451787|NCT00499616|473282975|FG002|Overall Study|Not evaluable|0|||
131451788|NCT00499616|473282976|FG003|Overall Study|Not evaluable|41|||
131451789|NCT00499616|473282973|FG000|Overall Study|Patient/Parent Refusal|1|||
131451790|NCT00499616|473282974|FG001|Overall Study|Patient/Parent Refusal|5|||
131451791|NCT00499616|473282975|FG002|Overall Study|Patient/Parent Refusal|3|||
131451792|NCT00499616|473282976|FG003|Overall Study|Patient/Parent Refusal|0|||
131451793|NCT00123422|473282977|FG000|Overall Study|Physician Decision|2|||
131451794|NCT00123422|473282978|FG001|Overall Study|Physician Decision|2|||
131451795|NCT00123422|473282979|FG002|Overall Study|Physician Decision|6|||
131451796|NCT00123422|473282977|FG000|Overall Study|Withdrawal by Subject|1|||
131451797|NCT00123422|473282978|FG001|Overall Study|Withdrawal by Subject|2|||
131451798|NCT00123422|473282979|FG002|Overall Study|Withdrawal by Subject|2|||
131451799|NCT00123422|473282977|FG000|Overall Study|Lost to Follow-up|1|||
131451800|NCT00123422|473282978|FG001|Overall Study|Lost to Follow-up|2|||
131451801|NCT00123422|473282979|FG002|Overall Study|Lost to Follow-up|2|||
131848584|NCT00996892|474726162|FG009|Expansion Stage 2A|Physician Decision|0|||
131848585|NCT00996892|474726163|FG010|Expansion Stage 2A|Physician Decision|0|||
131848586|NCT00996892|474726164|FG011|Expansion Stage 2A|Physician Decision|0|||
131848587|NCT00996892|474726165|FG012|Expansion Stage 2A|Physician Decision|0|||
131848588|NCT00996892|474726166|FG013|Expansion Stage 2A|Physician Decision|0|||
131848589|NCT00996892|474726167|FG014|Expansion Stage 2A|Physician Decision|0|||
131848590|NCT00996892|474726168|FG015|Expansion Stage 2A|Physician Decision|0|||
131848591|NCT00996892|474726169|FG016|Expansion Stage 2A|Physician Decision|0|||
131848592|NCT00996892|474726170|FG017|Expansion Stage 2A|Physician Decision|0|||
131848593|NCT00996892|474726171|FG018|Expansion Stage 2A|Physician Decision|0|||
131848594|NCT00996892|474726172|FG019|Expansion Stage 2A|Physician Decision|2|||
131848595|NCT00996892|474726153|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
131848596|NCT00996892|474726154|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
131848597|NCT00996892|474726155|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
131848598|NCT00996892|474726156|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
131848599|NCT00996892|474726157|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
131848600|NCT00996892|474726158|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
131848601|NCT00996892|474726159|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
131848602|NCT00996892|474726160|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
131848603|NCT00996892|474726161|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
131848604|NCT00996892|474726162|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
131848605|NCT00996892|474726163|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
131848606|NCT00996892|474726164|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
131848607|NCT00996892|474726165|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
131848608|NCT00996892|474726166|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
131848609|NCT00996892|474726167|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
131848610|NCT00996892|474726168|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
131848611|NCT00996892|474726169|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
131848612|NCT00996892|474726170|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
131848613|NCT00996892|474726171|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
131848614|NCT00996892|474726172|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
131848615|NCT00996892|474726153|FG000|Expansion Stage 2A|Disease Progression|0|||
131848616|NCT00996892|474726154|FG001|Expansion Stage 2A|Disease Progression|0|||
131848617|NCT00996892|474726155|FG002|Expansion Stage 2A|Disease Progression|0|||
131848618|NCT00996892|474726156|FG003|Expansion Stage 2A|Disease Progression|0|||
131848619|NCT00996892|474726157|FG004|Expansion Stage 2A|Disease Progression|0|||
131848620|NCT00996892|474726158|FG005|Expansion Stage 2A|Disease Progression|0|||
131848621|NCT00996892|474726159|FG006|Expansion Stage 2A|Disease Progression|0|||
131451802|NCT04555616|473282982|FG000|Overall Study|Death|1|||
131451803|NCT04555616|473282983|FG001|Overall Study|Death|0|||
131451804|NCT04555616|473282984|FG002|Overall Study|Death|1|||
131451805|NCT04555616|473282982|FG000|Overall Study|Withdrawal by Subject|2|||
131451806|NCT04555616|473282983|FG001|Overall Study|Withdrawal by Subject|1|||
131451807|NCT04555616|473282984|FG002|Overall Study|Withdrawal by Subject|0|||
131451808|NCT01938716|473282985|FG000|Overall Study|Physician Decision|2|||
131848622|NCT00996892|474726160|FG007|Expansion Stage 2A|Disease Progression|0|||
131848623|NCT00996892|474726161|FG008|Expansion Stage 2A|Disease Progression|0|||
131848624|NCT00996892|474726162|FG009|Expansion Stage 2A|Disease Progression|0|||
131848625|NCT00996892|474726163|FG010|Expansion Stage 2A|Disease Progression|0|||
131848626|NCT00996892|474726164|FG011|Expansion Stage 2A|Disease Progression|0|||
131848627|NCT00996892|474726165|FG012|Expansion Stage 2A|Disease Progression|0|||
131848628|NCT00996892|474726166|FG013|Expansion Stage 2A|Disease Progression|0|||
131848629|NCT00996892|474726167|FG014|Expansion Stage 2A|Disease Progression|0|||
131848630|NCT00996892|474726168|FG015|Expansion Stage 2A|Disease Progression|0|||
131848631|NCT00996892|474726169|FG016|Expansion Stage 2A|Disease Progression|0|||
131848632|NCT00996892|474726170|FG017|Expansion Stage 2A|Disease Progression|0|||
131848633|NCT00996892|474726171|FG018|Expansion Stage 2A|Disease Progression|0|||
131848634|NCT00996892|474726172|FG019|Expansion Stage 2A|Disease Progression|31|||
131848635|NCT01653912|474726173|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
131848636|NCT01653912|474726174|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
131848637|NCT01653912|474726175|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
131848638|NCT01653912|474726176|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
131848639|NCT01653912|474726177|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
131848640|NCT01653912|474726178|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
131848641|NCT01653912|474726173|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
131848642|NCT01653912|474726174|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
131848643|NCT01653912|474726175|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
131848644|NCT01653912|474726176|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
131848645|NCT01653912|474726177|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
131848646|NCT01653912|474726178|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
131848647|NCT01653912|474726173|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
131848648|NCT01653912|474726174|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
131848649|NCT01653912|474726175|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
131848650|NCT01653912|474726176|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
131848651|NCT01653912|474726177|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
131848652|NCT01653912|474726178|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
131848653|NCT01653912|474726173|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848654|NCT01653912|474726174|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848655|NCT01653912|474726175|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848656|NCT01653912|474726176|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
131848657|NCT01653912|474726177|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848658|NCT01653912|474726178|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848659|NCT01653912|474726173|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
131848660|NCT01653912|474726174|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
131848661|NCT01653912|474726175|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
131848662|NCT01653912|474726176|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
131848663|NCT01653912|474726177|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
131848664|NCT01653912|474726178|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
131848665|NCT01653912|474726173|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
131848666|NCT01653912|474726174|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
131848667|NCT01653912|474726175|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
131848668|NCT01653912|474726176|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
131848669|NCT01653912|474726177|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
131848670|NCT01653912|474726178|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
131848671|NCT01653912|474726173|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848672|NCT01653912|474726174|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848673|NCT01653912|474726175|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848674|NCT01653912|474726176|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848675|NCT01653912|474726177|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
131848676|NCT01653912|474726178|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
131848677|NCT00278889|474726179|FG000|Overall Study|Withdrawal by Subject|0|||
131848678|NCT00278889|474726180|FG001|Overall Study|Withdrawal by Subject|5|||
131848679|NCT00278889|474726181|FG002|Overall Study|Withdrawal by Subject|3|||
131848680|NCT00278889|474726179|FG000|Overall Study|Lost to Follow-up|1|||
131848681|NCT00278889|474726180|FG001|Overall Study|Lost to Follow-up|1|||
131848682|NCT00278889|474726181|FG002|Overall Study|Lost to Follow-up|0|||
131848683|NCT00278889|474726179|FG000|Overall Study|Death|24|||
131848684|NCT00278889|474726180|FG001|Overall Study|Death|21|||
131848685|NCT00278889|474726181|FG002|Overall Study|Death|17|||
131848686|NCT01987479|474726182|FG000|Overall Study|Protocol Violation|1|||
131848687|NCT01987479|474726182|FG000|Overall Study|Physician Decision|2|||
131848688|NCT01987479|474726182|FG000|Overall Study|Participant/legal guardian decision|1|||
131848689|NCT01987479|474726182|FG000|Overall Study|Other|5|||
131848690|NCT01987479|474726182|FG000|Overall Study|Lost to Follow-up|1|||
131848691|NCT01987479|474726182|FG000|Overall Study|Adverse Event|7|||
131848692|NCT04042376|474726183|FG000|Overall Study|Withdrawal by Subject|1|||
131848693|NCT04042376|474726183|FG000|Overall Study|Death|3|||
131848694|NCT03408639|474727914|FG000|Overall Study|Death|5|||
131848695|NCT03408639|474727915|FG001|Overall Study|Death|5|||
131848696|NCT03408639|474727914|FG000|Overall Study|Lost to Follow-up|1|||
131848697|NCT03408639|474727915|FG001|Overall Study|Lost to Follow-up|4|||
131848698|NCT03408639|474727914|FG000|Overall Study|Withdrawal by Subject|2|||
131848699|NCT03408639|474727915|FG001|Overall Study|Withdrawal by Subject|7|||
131848700|NCT03408639|474727914|FG000|Overall Study|Physician Decision|3|||
131848701|NCT03408639|474727915|FG001|Overall Study|Physician Decision|6|||
131848702|NCT02245412|474727918|FG000|Treatment Period|Death|1|||
131848703|NCT02245412|474727919|FG001|Treatment Period|Death|1|||
131451809|NCT01938716|473282985|FG000|Overall Study|Withdrawal by Subject|2|||
131451810|NCT01358721|473282986|FG000|Overall Study|Withdrawal by Subject|0|||
131451811|NCT01358721|473282987|FG001|Overall Study|Withdrawal by Subject|0|||
131451812|NCT01358721|473282988|FG002|Overall Study|Withdrawal by Subject|0|||
131451813|NCT01358721|473282989|FG003|Overall Study|Withdrawal by Subject|1|||
131451814|NCT01358721|473282986|FG000|Overall Study|Death|0|||
131451815|NCT01358721|473282987|FG001|Overall Study|Death|2|||
131451816|NCT01358721|473282988|FG002|Overall Study|Death|0|||
131451817|NCT01358721|473282989|FG003|Overall Study|Death|0|||
131451818|NCT01358721|473282986|FG000|Overall Study|Study Drug Toxicity|1|||
131451819|NCT01358721|473282987|FG001|Overall Study|Study Drug Toxicity|3|||
131451820|NCT01358721|473282988|FG002|Overall Study|Study Drug Toxicity|4|||
131451821|NCT01358721|473282989|FG003|Overall Study|Study Drug Toxicity|5|||
131451822|NCT01358721|473282986|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
131451823|NCT01358721|473282987|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
131451824|NCT01358721|473282988|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
131451825|NCT01358721|473282989|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
131451826|NCT01358721|473282986|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
131451827|NCT01358721|473282987|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
131451828|NCT01358721|473282988|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
131451829|NCT01358721|473282989|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
131451830|NCT01358721|473282986|FG000|Overall Study|Adverse Event related to study drug|1|||
131451831|NCT01358721|473282987|FG001|Overall Study|Adverse Event related to study drug|0|||
131451832|NCT01358721|473282988|FG002|Overall Study|Adverse Event related to study drug|0|||
131451833|NCT01358721|473282989|FG003|Overall Study|Adverse Event related to study drug|1|||
131451834|NCT01358721|473282986|FG000|Overall Study|Disease Progression|19|||
131451835|NCT01358721|473282987|FG001|Overall Study|Disease Progression|15|||
131451836|NCT01358721|473282988|FG002|Overall Study|Disease Progression|17|||
131451837|NCT01358721|473282989|FG003|Overall Study|Disease Progression|15|||
131451838|NCT01358721|473282986|FG000|Overall Study|Out of State/Unmet Criteria|0|||
131451839|NCT01358721|473282987|FG001|Overall Study|Out of State/Unmet Criteria|0|||
131451840|NCT01358721|473282988|FG002|Overall Study|Out of State/Unmet Criteria|1|||
131451841|NCT01358721|473282989|FG003|Overall Study|Out of State/Unmet Criteria|0|||
131451842|NCT01908803|473282990|FG000|Overall Study|Adverse Event|1|||
131451843|NCT01908803|473282991|FG001|Overall Study|Adverse Event|0|||
131451844|NCT01908803|473282990|FG000|Overall Study|Physician Decision|0|||
131451845|NCT01908803|473282991|FG001|Overall Study|Physician Decision|1|||
131451846|NCT01908803|473282990|FG000|Overall Study|Withdrawal by Subject|1|||
131848704|NCT02245412|474727920|FG002|Treatment Period|Death|0|||
131848705|NCT02245412|474727918|FG000|Treatment Period|Physician Decision|1|||
131848706|NCT02245412|474727919|FG001|Treatment Period|Physician Decision|1|||
131848707|NCT02245412|474727920|FG002|Treatment Period|Physician Decision|0|||
131848708|NCT02245412|474727918|FG000|Treatment Period|Withdrawal by Subject|2|||
131848709|NCT02245412|474727919|FG001|Treatment Period|Withdrawal by Subject|1|||
131848710|NCT02245412|474727920|FG002|Treatment Period|Withdrawal by Subject|0|||
131848711|NCT02245412|474727918|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
131848712|NCT02245412|474727919|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
131848713|NCT02245412|474727920|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
131848714|NCT02245412|474727918|FG000|Follow-Up Period|Death|4|||
131848715|NCT02245412|474727919|FG001|Follow-Up Period|Death|2|||
131848716|NCT02245412|474727920|FG002|Follow-Up Period|Death|1|||
131848717|NCT02245412|474727918|FG000|Follow-Up Period|Physician Decision|1|||
131848718|NCT02245412|474727919|FG001|Follow-Up Period|Physician Decision|0|||
131848719|NCT02245412|474727920|FG002|Follow-Up Period|Physician Decision|0|||
131848720|NCT02245412|474727918|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
131848721|NCT02245412|474727919|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
131848722|NCT02245412|474727920|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
131848723|NCT00459043|474727921|FG000|Overall Study|Withdrawal by Subject|1|||
131848724|NCT00459043|474727922|FG001|Overall Study|Withdrawal by Subject|0|||
131848725|NCT00402116|474727923|FG000|Overall Study|Jaw infection after surgery-other|1|||
131848726|NCT00402116|474727924|FG001|Overall Study|Jaw infection after surgery-other|0|||
131848727|NCT00402116|474727925|FG002|Overall Study|Jaw infection after surgery-other|0|||
131848728|NCT00402116|474727923|FG000|Overall Study|Withdrawal by Subject|1|||
131848729|NCT00402116|474727924|FG001|Overall Study|Withdrawal by Subject|0|||
131848730|NCT00402116|474727925|FG002|Overall Study|Withdrawal by Subject|5|||
131848731|NCT00402116|474727923|FG000|Overall Study|Treatment completed per protocol|1|||
131848732|NCT00402116|474727924|FG001|Overall Study|Treatment completed per protocol|1|||
131848733|NCT00402116|474727925|FG002|Overall Study|Treatment completed per protocol|2|||
131451847|NCT01908803|473282991|FG001|Overall Study|Withdrawal by Subject|0|||
131451848|NCT01908803|473282990|FG000|Overall Study|Randomization Error|1|||
131451849|NCT01908803|473282991|FG001|Overall Study|Randomization Error|0|||
131451850|NCT01908803|473282990|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
131451851|NCT01908803|473282991|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
131848734|NCT00402116|474727923|FG000|Overall Study|other complicating disease|0|||
131848735|NCT00402116|474727924|FG001|Overall Study|other complicating disease|0|||
131848736|NCT00402116|474727925|FG002|Overall Study|other complicating disease|2|||
131848737|NCT00402116|474727923|FG000|Overall Study|Disease Progression|0|||
131848738|NCT00402116|474727924|FG001|Overall Study|Disease Progression|4|||
131848739|NCT00402116|474727925|FG002|Overall Study|Disease Progression|38|||
131848740|NCT00402116|474727923|FG000|Overall Study|mistaken thrombocytopenia|0|||
131848741|NCT00402116|474727924|FG001|Overall Study|mistaken thrombocytopenia|0|||
131848742|NCT00402116|474727925|FG002|Overall Study|mistaken thrombocytopenia|1|||
131848743|NCT00402116|474727923|FG000|Overall Study|decline related hyponatremia/tumor|0|||
131848744|NCT00402116|474727924|FG001|Overall Study|decline related hyponatremia/tumor|0|||
131848745|NCT00402116|474727925|FG002|Overall Study|decline related hyponatremia/tumor|1|||
131848746|NCT00402116|474727923|FG000|Overall Study|Adverse Event|0|||
131848747|NCT00402116|474727924|FG001|Overall Study|Adverse Event|1|||
131848748|NCT00402116|474727925|FG002|Overall Study|Adverse Event|6|||
131848749|NCT04971187|474727926|FG000|Overall Study|Screen failures|2|||
131848750|NCT01443728|474727927|FG000|Overall Study|Lost to Follow-up|2|||
131848751|NCT01443728|474727928|FG001|Overall Study|Lost to Follow-up|0|||
131848752|NCT01443728|474727927|FG000|Overall Study|Withdrawal by Subject|1|||
131848753|NCT01443728|474727928|FG001|Overall Study|Withdrawal by Subject|1|||
131848754|NCT01443728|474727927|FG000|Overall Study|Adverse Event|0|||
131848755|NCT01443728|474727928|FG001|Overall Study|Adverse Event|2|||
131848756|NCT01403051|474727929|FG000|Overall Study|Protocol Violation|2|||
131848757|NCT01403051|474727930|FG001|Overall Study|Protocol Violation|0|||
131451852|NCT00867815|473282992|FG000|Overall Study|Lost to Follow-up|1|||
131848758|NCT01403051|474727929|FG000|Overall Study|Death|1|||
131848759|NCT01403051|474727930|FG001|Overall Study|Death|0|||
131848760|NCT01403051|474727929|FG000|Overall Study|Withdrawal by Subject|2|||
131848761|NCT01403051|474727930|FG001|Overall Study|Withdrawal by Subject|1|||
131848762|NCT01403051|474727929|FG000|Overall Study|Lost to Follow-up|5|||
131848763|NCT01403051|474727930|FG001|Overall Study|Lost to Follow-up|5|||
131848764|NCT02135614|474727936|FG000|Overall Study|Randomized but Not Treated|2|||
131848765|NCT02135614|474727937|FG001|Overall Study|Randomized but Not Treated|1|||
131848766|NCT02135614|474727936|FG000|Overall Study|Adverse Event|0|||
131848767|NCT02135614|474727937|FG001|Overall Study|Adverse Event|1|||
131848768|NCT02135614|474727936|FG000|Overall Study|Death|1|||
131848769|NCT02135614|474727937|FG001|Overall Study|Death|0|||
131848770|NCT02135614|474727936|FG000|Overall Study|Investigator's Discretion|0|||
131848771|NCT02135614|474727937|FG001|Overall Study|Investigator's Discretion|1|||
131848772|NCT02135614|474727936|FG000|Overall Study|Withdrew Consent|2|||
131848773|NCT02135614|474727937|FG001|Overall Study|Withdrew Consent|2|||
131848774|NCT02135614|474727936|FG000|Overall Study|Lost to Follow-up|3|||
131848775|NCT02135614|474727937|FG001|Overall Study|Lost to Follow-up|0|||
131848776|NCT03743415|474727938|FG000|Overall Study|Death|5|||
131848777|NCT03743415|474727939|FG001|Overall Study|Death|3|||
131848778|NCT03743415|474727940|FG002|Overall Study|Death|1|||
131848779|NCT03743415|474727941|FG003|Overall Study|Death|4|||
131848780|NCT03743415|474727942|FG004|Overall Study|Death|0|||
131848781|NCT03743415|474727943|FG005|Overall Study|Death|0|||
131848782|NCT03743415|474727944|FG006|Overall Study|Death|0|||
131848783|NCT03743415|474727945|FG007|Overall Study|Death|0|||
131848784|NCT03743415|474727946|FG008|Overall Study|Death|1|||
131848785|NCT03743415|474727947|FG009|Overall Study|Death|0|||
131848786|NCT03743415|474727938|FG000|Overall Study|Withdrawal by Subject|1|||
131848787|NCT03743415|474727939|FG001|Overall Study|Withdrawal by Subject|0|||
131848788|NCT03743415|474727940|FG002|Overall Study|Withdrawal by Subject|4|||
131848789|NCT03743415|474727941|FG003|Overall Study|Withdrawal by Subject|5|||
131848790|NCT03743415|474727942|FG004|Overall Study|Withdrawal by Subject|5|||
131848791|NCT03743415|474727943|FG005|Overall Study|Withdrawal by Subject|2|||
131848792|NCT03743415|474727944|FG006|Overall Study|Withdrawal by Subject|2|||
131848793|NCT03743415|474727945|FG007|Overall Study|Withdrawal by Subject|5|||
131848794|NCT03743415|474727946|FG008|Overall Study|Withdrawal by Subject|9|||
131848795|NCT03743415|474727947|FG009|Overall Study|Withdrawal by Subject|10|||
131848796|NCT03743415|474727938|FG000|Overall Study|Lost to Follow-up|2|||
131848797|NCT03743415|474727939|FG001|Overall Study|Lost to Follow-up|0|||
131848798|NCT03743415|474727940|FG002|Overall Study|Lost to Follow-up|2|||
131848799|NCT03743415|474727941|FG003|Overall Study|Lost to Follow-up|1|||
131848800|NCT03743415|474727942|FG004|Overall Study|Lost to Follow-up|1|||
131848801|NCT03743415|474727943|FG005|Overall Study|Lost to Follow-up|0|||
131848802|NCT03743415|474727944|FG006|Overall Study|Lost to Follow-up|1|||
131848803|NCT03743415|474727945|FG007|Overall Study|Lost to Follow-up|4|||
131848804|NCT03743415|474727946|FG008|Overall Study|Lost to Follow-up|13|||
131848805|NCT03743415|474727947|FG009|Overall Study|Lost to Follow-up|13|||
131848806|NCT02906358|474727951|FG000|Overall Study|Withdrawal by Subject|10|||
131848807|NCT02906358|474727952|FG001|Overall Study|Withdrawal by Subject|7|||
131848808|NCT02906358|474727951|FG000|Overall Study|Lost to Follow-up|12|||
131848809|NCT02906358|474727952|FG001|Overall Study|Lost to Follow-up|15|||
131848810|NCT02119819|474727954|FG000|Overall Study|Adverse Event|3|||
131848811|NCT02119819|474727955|FG001|Overall Study|Adverse Event|1|||
131848812|NCT02119819|474727956|FG002|Overall Study|Adverse Event|2|||
131848813|NCT02119819|474727957|FG003|Overall Study|Adverse Event|3|||
131848814|NCT02119819|474727958|FG004|Overall Study|Adverse Event|0|||
131848815|NCT02119819|474727959|FG005|Overall Study|Adverse Event|1|||
131848816|NCT02119819|474727954|FG000|Overall Study|Lack of Efficacy|0|||
131848817|NCT02119819|474727955|FG001|Overall Study|Lack of Efficacy|0|||
131848818|NCT02119819|474727956|FG002|Overall Study|Lack of Efficacy|0|||
131848819|NCT02119819|474727957|FG003|Overall Study|Lack of Efficacy|0|||
131848820|NCT02119819|474727958|FG004|Overall Study|Lack of Efficacy|0|||
131848821|NCT02119819|474727959|FG005|Overall Study|Lack of Efficacy|1|||
131848822|NCT02119819|474727954|FG000|Overall Study|Lost to Follow-up|0|||
131848823|NCT02119819|474727955|FG001|Overall Study|Lost to Follow-up|0|||
131848824|NCT02119819|474727956|FG002|Overall Study|Lost to Follow-up|1|||
131848825|NCT02119819|474727957|FG003|Overall Study|Lost to Follow-up|2|||
131848826|NCT02119819|474727958|FG004|Overall Study|Lost to Follow-up|1|||
131848827|NCT02119819|474727959|FG005|Overall Study|Lost to Follow-up|2|||
131848828|NCT02119819|474727954|FG000|Overall Study|Physician Decision|1|||
131848829|NCT02119819|474727955|FG001|Overall Study|Physician Decision|1|||
131848830|NCT02119819|474727956|FG002|Overall Study|Physician Decision|0|||
131848831|NCT02119819|474727957|FG003|Overall Study|Physician Decision|0|||
131848832|NCT02119819|474727958|FG004|Overall Study|Physician Decision|0|||
131848833|NCT02119819|474727959|FG005|Overall Study|Physician Decision|1|||
131848834|NCT02119819|474727954|FG000|Overall Study|Withdrawal by Subject|5|||
131848835|NCT02119819|474727955|FG001|Overall Study|Withdrawal by Subject|3|||
131848836|NCT02119819|474727956|FG002|Overall Study|Withdrawal by Subject|0|||
131848837|NCT02119819|474727957|FG003|Overall Study|Withdrawal by Subject|0|||
131848838|NCT02119819|474727958|FG004|Overall Study|Withdrawal by Subject|6|||
131848839|NCT02119819|474727959|FG005|Overall Study|Withdrawal by Subject|10|||
131848840|NCT02119819|474727954|FG000|Overall Study|Jury Duty|0|||
131848841|NCT02119819|474727955|FG001|Overall Study|Jury Duty|0|||
131848842|NCT02119819|474727956|FG002|Overall Study|Jury Duty|1|||
131848843|NCT02119819|474727957|FG003|Overall Study|Jury Duty|0|||
131848844|NCT02119819|474727958|FG004|Overall Study|Jury Duty|0|||
131848845|NCT02119819|474727959|FG005|Overall Study|Jury Duty|0|||
131848846|NCT02119819|474727954|FG000|Overall Study|Protocol Violation|0|||
131848847|NCT02119819|474727955|FG001|Overall Study|Protocol Violation|0|||
131848848|NCT02119819|474727956|FG002|Overall Study|Protocol Violation|0|||
131848849|NCT02119819|474727957|FG003|Overall Study|Protocol Violation|1|||
131848850|NCT02119819|474727958|FG004|Overall Study|Protocol Violation|0|||
131848851|NCT02119819|474727959|FG005|Overall Study|Protocol Violation|0|||
131848852|NCT02119819|474727954|FG000|Overall Study|Left the city to get a job|0|||
131911718|NCT03729362|474965163|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
131911719|NCT03729362|474965164|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
131911720|NCT03729362|474965163|FG000|Overall Study|Adverse Event|0|||
131911721|NCT03729362|474965164|FG001|Overall Study|Adverse Event|1|||
131911722|NCT03729362|474965163|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
131911723|NCT03729362|474965164|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
131911724|NCT01171534|474965171|FG000|Overall Study|Lost to Follow-up|0|||
131911725|NCT01171534|474965172|FG001|Overall Study|Lost to Follow-up|2|||
131911726|NCT01171534|474965171|FG000|Overall Study|screen failure|0|||
131911727|NCT01171534|474965172|FG001|Overall Study|screen failure|1|||
131911728|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
131911729|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
131911730|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
131848853|NCT02119819|474727955|FG001|Overall Study|Left the city to get a job|0|||
131848854|NCT02119819|474727956|FG002|Overall Study|Left the city to get a job|0|||
131848855|NCT02119819|474727957|FG003|Overall Study|Left the city to get a job|1|||
131848856|NCT02119819|474727958|FG004|Overall Study|Left the city to get a job|0|||
131848857|NCT02119819|474727959|FG005|Overall Study|Left the city to get a job|0|||
131848858|NCT02699684|474727960|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
131911731|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
131911732|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
131848859|NCT02699684|474727961|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
131848860|NCT01145508|474727962|FG000|Overall Study|Adverse Event|1|||
131848861|NCT01145508|474727963|FG001|Overall Study|Adverse Event|0|||
131848862|NCT01145508|474727962|FG000|Overall Study|Death|1|||
131848863|NCT01145508|474727963|FG001|Overall Study|Death|0|||
131848864|NCT01145508|474727962|FG000|Overall Study|Physician Decision|2|||
131848865|NCT01145508|474727963|FG001|Overall Study|Physician Decision|1|||
131848866|NCT01145508|474727962|FG000|Overall Study|Never started treatment|1|||
131848867|NCT01145508|474727963|FG001|Overall Study|Never started treatment|1|||
131848868|NCT02045147|474727964|FG000|Overall Study|Withdrawal by Subject|2|||
131848869|NCT02045147|474727965|FG001|Overall Study|Withdrawal by Subject|0|||
131848870|NCT02045147|474727966|FG002|Overall Study|Withdrawal by Subject|0|||
131848871|NCT02045147|474727967|FG003|Overall Study|Withdrawal by Subject|0|||
131848872|NCT02045147|474727968|FG004|Overall Study|Withdrawal by Subject|0|||
131848873|NCT02045147|474727969|FG005|Overall Study|Withdrawal by Subject|0|||
131848874|NCT02045147|474727970|FG006|Overall Study|Withdrawal by Subject|0|||
131848875|NCT02045147|474727971|FG007|Overall Study|Withdrawal by Subject|1|||
131848876|NCT02045147|474727964|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
131848877|NCT02045147|474727965|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
131848878|NCT02045147|474727966|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
131848879|NCT02045147|474727967|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
131848880|NCT02045147|474727968|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
131848881|NCT02045147|474727969|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
131848882|NCT02045147|474727970|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
131848883|NCT02045147|474727971|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
131848884|NCT04839692|474727972|FG000|Overall Study|Withdrawal by Subject|0|||
131848885|NCT04839692|474727973|FG001|Overall Study|Withdrawal by Subject|3|||
131848886|NCT04839692|474727972|FG000|Overall Study|Physician Decision|1|||
131848887|NCT04839692|474727973|FG001|Overall Study|Physician Decision|0|||
131848888|NCT03146962|474727974|FG000|Overall Study|Lost to Follow-up|1|||
131848889|NCT03146962|474727975|FG001|Overall Study|Lost to Follow-up|1|||
131848890|NCT03146962|474727976|FG002|Overall Study|Lost to Follow-up|0|||
131848891|NCT03146962|474727977|FG003|Overall Study|Lost to Follow-up|0|||
131848892|NCT03146962|474727978|FG004|Overall Study|Lost to Follow-up|0|||
131848893|NCT03146962|474727979|FG005|Overall Study|Lost to Follow-up|0|||
131848894|NCT03146962|474727980|FG006|Overall Study|Lost to Follow-up|0|||
131848895|NCT03146962|474727981|FG007|Overall Study|Lost to Follow-up|0|||
131848896|NCT03146962|474727982|FG008|Overall Study|Lost to Follow-up|0|||
131848897|NCT03146962|474727983|FG009|Overall Study|Lost to Follow-up|0|||
131848898|NCT03146962|474727974|FG000|Overall Study|Adverse Event|0|||
131848899|NCT03146962|474727975|FG001|Overall Study|Adverse Event|3|||
131848900|NCT03146962|474727976|FG002|Overall Study|Adverse Event|0|||
131848901|NCT03146962|474727977|FG003|Overall Study|Adverse Event|0|||
131848902|NCT03146962|474727978|FG004|Overall Study|Adverse Event|0|||
131848903|NCT03146962|474727979|FG005|Overall Study|Adverse Event|0|||
131848904|NCT03146962|474727980|FG006|Overall Study|Adverse Event|0|||
131848905|NCT03146962|474727981|FG007|Overall Study|Adverse Event|1|||
131848906|NCT03146962|474727982|FG008|Overall Study|Adverse Event|0|||
131848907|NCT03146962|474727983|FG009|Overall Study|Adverse Event|0|||
131848908|NCT03146962|474727974|FG000|Overall Study|Withdrawal by Subject|0|||
131848909|NCT03146962|474727975|FG001|Overall Study|Withdrawal by Subject|0|||
131848910|NCT03146962|474727976|FG002|Overall Study|Withdrawal by Subject|0|||
131848911|NCT03146962|474727977|FG003|Overall Study|Withdrawal by Subject|0|||
131848912|NCT03146962|474727978|FG004|Overall Study|Withdrawal by Subject|1|||
131848913|NCT03146962|474727979|FG005|Overall Study|Withdrawal by Subject|0|||
131848914|NCT03146962|474727980|FG006|Overall Study|Withdrawal by Subject|0|||
131848915|NCT03146962|474727981|FG007|Overall Study|Withdrawal by Subject|0|||
131848916|NCT03146962|474727982|FG008|Overall Study|Withdrawal by Subject|0|||
131848917|NCT03146962|474727983|FG009|Overall Study|Withdrawal by Subject|0|||
131848918|NCT03146962|474727974|FG000|Overall Study|Death|0|||
131848919|NCT03146962|474727975|FG001|Overall Study|Death|1|||
131848920|NCT03146962|474727976|FG002|Overall Study|Death|0|||
131848921|NCT03146962|474727977|FG003|Overall Study|Death|0|||
131848922|NCT03146962|474727978|FG004|Overall Study|Death|0|||
131848923|NCT03146962|474727979|FG005|Overall Study|Death|0|||
131848924|NCT03146962|474727980|FG006|Overall Study|Death|0|||
131848925|NCT03146962|474727981|FG007|Overall Study|Death|0|||
131848926|NCT03146962|474727982|FG008|Overall Study|Death|0|||
131848927|NCT03146962|474727983|FG009|Overall Study|Death|0|||
131848928|NCT03146962|474727974|FG000|Overall Study|COVID Precautions|1|||
131848929|NCT03146962|474727975|FG001|Overall Study|COVID Precautions|0|||
131848930|NCT03146962|474727976|FG002|Overall Study|COVID Precautions|0|||
131848931|NCT03146962|474727977|FG003|Overall Study|COVID Precautions|0|||
131848932|NCT03146962|474727978|FG004|Overall Study|COVID Precautions|0|||
131848933|NCT03146962|474727979|FG005|Overall Study|COVID Precautions|0|||
131848934|NCT03146962|474727980|FG006|Overall Study|COVID Precautions|0|||
131848935|NCT03146962|474727981|FG007|Overall Study|COVID Precautions|0|||
131848936|NCT03146962|474727982|FG008|Overall Study|COVID Precautions|0|||
131848937|NCT03146962|474727983|FG009|Overall Study|COVID Precautions|0|||
131848938|NCT03146962|474727974|FG000|Overall Study|Physician Decision|0|||
131848939|NCT03146962|474727975|FG001|Overall Study|Physician Decision|0|||
131848940|NCT03146962|474727976|FG002|Overall Study|Physician Decision|0|||
131848941|NCT03146962|474727977|FG003|Overall Study|Physician Decision|0|||
131848942|NCT03146962|474727978|FG004|Overall Study|Physician Decision|0|||
131848943|NCT03146962|474727979|FG005|Overall Study|Physician Decision|0|||
131848944|NCT03146962|474727980|FG006|Overall Study|Physician Decision|0|||
131848945|NCT03146962|474727981|FG007|Overall Study|Physician Decision|0|||
131848946|NCT03146962|474727982|FG008|Overall Study|Physician Decision|0|||
131848947|NCT03146962|474727983|FG009|Overall Study|Physician Decision|1|||
131848948|NCT03146962|474727974|FG000|Overall Study|Started New Treatment|0|||
131848949|NCT03146962|474727975|FG001|Overall Study|Started New Treatment|1|||
131848950|NCT03146962|474727976|FG002|Overall Study|Started New Treatment|0|||
131848951|NCT03146962|474727977|FG003|Overall Study|Started New Treatment|0|||
131848952|NCT03146962|474727978|FG004|Overall Study|Started New Treatment|0|||
131848953|NCT03146962|474727979|FG005|Overall Study|Started New Treatment|0|||
131848954|NCT03146962|474727980|FG006|Overall Study|Started New Treatment|0|||
131848955|NCT03146962|474727981|FG007|Overall Study|Started New Treatment|0|||
131848956|NCT03146962|474727982|FG008|Overall Study|Started New Treatment|0|||
131848957|NCT03146962|474727983|FG009|Overall Study|Started New Treatment|0|||
131848958|NCT04497948|474727986|FG000|Overall Study|Death|2|||
131848959|NCT02246114|474727987|FG000|Overall Study|miscarriage|1|||
131848960|NCT02246114|474727988|FG001|Overall Study|miscarriage|0|||
131848961|NCT00696787|474727991|FG000|Overall Study|Adverse Event|1|||
131848962|NCT00696787|474727992|FG001|Overall Study|Adverse Event|0|||
131848963|NCT00696787|474727993|FG002|Overall Study|Adverse Event|6|||
131848964|NCT00696787|474727991|FG000|Overall Study|Discontinuation by Sponsor|9|||
131848965|NCT00696787|474727992|FG001|Overall Study|Discontinuation by Sponsor|13|||
131848966|NCT00696787|474727993|FG002|Overall Study|Discontinuation by Sponsor|14|||
131848967|NCT00696787|474727991|FG000|Overall Study|Lack of Efficacy|0|||
131848968|NCT00696787|474727992|FG001|Overall Study|Lack of Efficacy|1|||
131848969|NCT00696787|474727993|FG002|Overall Study|Lack of Efficacy|0|||
131848970|NCT00696787|474727991|FG000|Overall Study|Lost to Follow-up|4|||
131848971|NCT00696787|474727992|FG001|Overall Study|Lost to Follow-up|0|||
131848972|NCT00696787|474727993|FG002|Overall Study|Lost to Follow-up|3|||
131848973|NCT00696787|474727991|FG000|Overall Study|Withdrawal by Subject|0|||
131848974|NCT00696787|474727992|FG001|Overall Study|Withdrawal by Subject|3|||
131848975|NCT00696787|474727993|FG002|Overall Study|Withdrawal by Subject|2|||
131848976|NCT00696787|474727991|FG000|Overall Study|Failed to return|1|||
131848977|NCT00696787|474727992|FG001|Overall Study|Failed to return|3|||
131848978|NCT00696787|474727993|FG002|Overall Study|Failed to return|1|||
131848979|NCT00129389|474727998|FG000|Overall Study|Adverse Event|19|||
131848980|NCT00129389|474727999|FG001|Overall Study|Adverse Event|87|||
131848981|NCT00129389|474727998|FG000|Overall Study|Death|0|||
131848982|NCT00129389|474727999|FG001|Overall Study|Death|1|||
131848983|NCT00129389|474727998|FG000|Overall Study|Lost to Follow-up|2|||
131848984|NCT00129389|474727999|FG001|Overall Study|Lost to Follow-up|1|||
131848985|NCT00129389|474727998|FG000|Overall Study|Physician Decision|0|||
131848986|NCT00129389|474727999|FG001|Overall Study|Physician Decision|4|||
131848987|NCT00129389|474727998|FG000|Overall Study|Protocol Violation|0|||
131848988|NCT00129389|474727999|FG001|Overall Study|Protocol Violation|6|||
131848989|NCT00129389|474727998|FG000|Overall Study|Withdrawal by Subject|9|||
131848990|NCT00129389|474727999|FG001|Overall Study|Withdrawal by Subject|23|||
131848991|NCT00129389|474727998|FG000|Overall Study|Relapse|1|||
131848992|NCT00129389|474727999|FG001|Overall Study|Relapse|0|||
131848993|NCT00129389|474727998|FG000|Overall Study|Not eligible|1|||
131848994|NCT00129389|474727999|FG001|Overall Study|Not eligible|2|||
131848995|NCT00129389|474727998|FG000|Overall Study|Crossed to the other arm|1|||
131848996|NCT00129389|474727999|FG001|Overall Study|Crossed to the other arm|16|||
131848997|NCT00976911|474728001|FG000|Overall Study|Withdrawal by Subject|4|||
131848998|NCT00976911|474728002|FG001|Overall Study|Withdrawal by Subject|6|||
131848999|NCT00976911|474728001|FG000|Overall Study|Death|138|||
131849000|NCT00976911|474728002|FG001|Overall Study|Death|126|||
131849001|NCT00976911|474728001|FG000|Overall Study|Adverse Event|0|||
131849002|NCT00976911|474728002|FG001|Overall Study|Adverse Event|1|||
131849003|NCT00976911|474728001|FG000|Overall Study|Protocol Violation|2|||
131849004|NCT00976911|474728002|FG001|Overall Study|Protocol Violation|0|||
131849005|NCT00976911|474728001|FG000|Overall Study|Other|8|||
131849006|NCT00976911|474728002|FG001|Overall Study|Other|9|||
131849007|NCT00976911|474728001|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
131849008|NCT00976911|474728002|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
131849009|NCT01191944|474728003|FG000|Overall Study|Adverse Event|11|||
131849010|NCT01191944|474728004|FG001|Overall Study|Adverse Event|12|||
131849011|NCT01191944|474728003|FG000|Overall Study|Protocol Violation|1|||
131849012|NCT01191944|474728004|FG001|Overall Study|Protocol Violation|2|||
131849013|NCT01191944|474728003|FG000|Overall Study|Withdrawal by Subject|4|||
131849014|NCT01191944|474728004|FG001|Overall Study|Withdrawal by Subject|2|||
131849015|NCT01191944|474728003|FG000|Overall Study|Other|1|||
131849016|NCT01191944|474728004|FG001|Overall Study|Other|3|||
131849017|NCT02954991|474728005|FG000|Overall Study|Death|92|||
131849018|NCT02954991|474728006|FG001|Overall Study|Death|11|||
131849019|NCT02954991|474728007|FG002|Overall Study|Death|2|||
131849020|NCT02954991|474728005|FG000|Overall Study|Lost to Follow-up|3|||
131849021|NCT02954991|474728006|FG001|Overall Study|Lost to Follow-up|2|||
131849022|NCT02954991|474728007|FG002|Overall Study|Lost to Follow-up|0|||
131849023|NCT02954991|474728005|FG000|Overall Study|Withdrawal by Subject|9|||
131849024|NCT02954991|474728006|FG001|Overall Study|Withdrawal by Subject|8|||
131849025|NCT02954991|474728007|FG002|Overall Study|Withdrawal by Subject|1|||
131849026|NCT02954991|474728005|FG000|Overall Study|Study Terminated by Sponsor|18|||
131849027|NCT02954991|474728006|FG001|Overall Study|Study Terminated by Sponsor|10|||
131849028|NCT02954991|474728007|FG002|Overall Study|Study Terminated by Sponsor|1|||
131849029|NCT02954991|474728005|FG000|Overall Study|Miscellaneous|2|||
131849030|NCT02954991|474728006|FG001|Overall Study|Miscellaneous|1|||
131849031|NCT02954991|474728007|FG002|Overall Study|Miscellaneous|1|||
131849032|NCT00576316|474728008|FG000|Overall Study|Adverse Event|9|||
131849033|NCT00576316|474728008|FG000|Overall Study|Withdrawal by Subject|2|||
131849034|NCT00576316|474728008|FG000|Overall Study|Protocol Violation|9|||
131451853|NCT00001213|473282993|FG000|Overall Study|Death|18|||
131451854|NCT01554241|473282994|FG000|Overall Study|Death|3|||
131451855|NCT01554241|473282995|FG001|Overall Study|Death|1|||
131451856|NCT01554241|473282996|FG002|Overall Study|Death|1|||
131451857|NCT01554241|473282997|FG003|Overall Study|Death|0|||
131451858|NCT01554241|473282994|FG000|Overall Study|protocol specified renal stone|0|||
131451859|NCT01554241|473282995|FG001|Overall Study|protocol specified renal stone|0|||
131451860|NCT01554241|473282996|FG002|Overall Study|protocol specified renal stone|0|||
131451861|NCT01554241|473282997|FG003|Overall Study|protocol specified renal stone|1|||
131451862|NCT01554241|473282994|FG000|Overall Study|protocol specified change in eGFR|0|||
131451863|NCT01554241|473282995|FG001|Overall Study|protocol specified change in eGFR|0|||
131451864|NCT01554241|473282996|FG002|Overall Study|protocol specified change in eGFR|1|||
131451865|NCT01554241|473282997|FG003|Overall Study|protocol specified change in eGFR|0|||
131451866|NCT01554241|473282994|FG000|Overall Study|Withdrawal by Subject|0|||
131451867|NCT01554241|473282995|FG001|Overall Study|Withdrawal by Subject|0|||
131451868|NCT01554241|473282996|FG002|Overall Study|Withdrawal by Subject|2|||
131451869|NCT01554241|473282997|FG003|Overall Study|Withdrawal by Subject|0|||
131451870|NCT00372593|473283004|FG000|Overall Study|Adverse Event|43|||
131451871|NCT00372593|473283005|FG001|Overall Study|Adverse Event|45|||
131451872|NCT00372593|473283006|FG002|Overall Study|Adverse Event|0|||
131451873|NCT00372593|473283004|FG000|Overall Study|Death|16|||
131849035|NCT02552303|474728009|FG000|Allocation|Withdrawal by Subject|2|||
131849036|NCT02552303|474728010|FG001|Allocation|Withdrawal by Subject|1|||
131849037|NCT02552303|474728011|FG002|Allocation|Withdrawal by Subject|1|||
131849038|NCT02552303|474728012|FG003|Allocation|Withdrawal by Subject|1|||
131849039|NCT02552303|474728009|FG000|Allocation|ineligible|1|||
131849040|NCT02552303|474728010|FG001|Allocation|ineligible|1|||
131849041|NCT02552303|474728011|FG002|Allocation|ineligible|0|||
131849042|NCT02552303|474728012|FG003|Allocation|ineligible|0|||
131849043|NCT02552303|474728009|FG000|Follow-Up|Lost to Follow-up|0|||
131849044|NCT02552303|474728010|FG001|Follow-Up|Lost to Follow-up|0|||
131849045|NCT02552303|474728011|FG002|Follow-Up|Lost to Follow-up|1|||
131849046|NCT02552303|474728012|FG003|Follow-Up|Lost to Follow-up|0|||
131451874|NCT00372593|473283005|FG001|Overall Study|Death|20|||
131451875|NCT00372593|473283006|FG002|Overall Study|Death|1|||
131849047|NCT02552303|474728009|FG000|Follow-Up|ineligible|0|||
131849048|NCT02552303|474728010|FG001|Follow-Up|ineligible|2|||
131849049|NCT02552303|474728011|FG002|Follow-Up|ineligible|0|||
131849050|NCT02552303|474728012|FG003|Follow-Up|ineligible|0|||
131849051|NCT00603837|474728017|FG000|Overall Study|Physician Decision|3|||
131849052|NCT00603837|474728018|FG001|Overall Study|Physician Decision|0|||
131849053|NCT00425373|474728080|FG000|Overall Study|Adverse Event|2|||
131849054|NCT00425373|474728081|FG001|Overall Study|Adverse Event|2|||
131849055|NCT00425373|474728082|FG002|Overall Study|Adverse Event|0|||
131849056|NCT00425373|474728083|FG003|Overall Study|Adverse Event|1|||
131849057|NCT00425373|474728084|FG004|Overall Study|Adverse Event|4|||
131849058|NCT00425373|474728085|FG005|Overall Study|Adverse Event|6|||
131849059|NCT00425373|474728086|FG006|Overall Study|Adverse Event|2|||
131849060|NCT00425373|474728087|FG007|Overall Study|Adverse Event|3|||
131849061|NCT00425373|474728088|FG008|Overall Study|Adverse Event|8|||
131849062|NCT00425373|474728080|FG000|Overall Study|Lost to Follow-up|0|||
131849063|NCT00425373|474728081|FG001|Overall Study|Lost to Follow-up|1|||
131849064|NCT00425373|474728082|FG002|Overall Study|Lost to Follow-up|0|||
131849065|NCT00425373|474728083|FG003|Overall Study|Lost to Follow-up|0|||
131849066|NCT00425373|474728084|FG004|Overall Study|Lost to Follow-up|1|||
131849067|NCT00425373|474728085|FG005|Overall Study|Lost to Follow-up|0|||
131849068|NCT00425373|474728086|FG006|Overall Study|Lost to Follow-up|0|||
131849069|NCT00425373|474728087|FG007|Overall Study|Lost to Follow-up|0|||
131849070|NCT00425373|474728088|FG008|Overall Study|Lost to Follow-up|0|||
131849071|NCT00425373|474728080|FG000|Overall Study|Protocol Violation|1|||
131849072|NCT00425373|474728081|FG001|Overall Study|Protocol Violation|0|||
131849073|NCT00425373|474728082|FG002|Overall Study|Protocol Violation|1|||
131849074|NCT00425373|474728083|FG003|Overall Study|Protocol Violation|0|||
131849075|NCT00425373|474728084|FG004|Overall Study|Protocol Violation|0|||
131849076|NCT00425373|474728085|FG005|Overall Study|Protocol Violation|0|||
131849077|NCT00425373|474728086|FG006|Overall Study|Protocol Violation|0|||
131451876|NCT00372593|473283004|FG000|Overall Study|Lack of Efficacy|82|||
131451877|NCT00372593|473283005|FG001|Overall Study|Lack of Efficacy|71|||
131451878|NCT00372593|473283006|FG002|Overall Study|Lack of Efficacy|2|||
131451879|NCT00372593|473283004|FG000|Overall Study|Lost to Follow-up|1|||
131849078|NCT00425373|474728087|FG007|Overall Study|Protocol Violation|5|||
131849079|NCT00425373|474728088|FG008|Overall Study|Protocol Violation|3|||
131849080|NCT00425373|474728080|FG000|Overall Study|Withdrawal by Subject|2|||
131849081|NCT00425373|474728081|FG001|Overall Study|Withdrawal by Subject|0|||
131849082|NCT00425373|474728082|FG002|Overall Study|Withdrawal by Subject|2|||
131849083|NCT00425373|474728083|FG003|Overall Study|Withdrawal by Subject|1|||
131849084|NCT00425373|474728084|FG004|Overall Study|Withdrawal by Subject|4|||
131849085|NCT00425373|474728085|FG005|Overall Study|Withdrawal by Subject|0|||
131849086|NCT00425373|474728086|FG006|Overall Study|Withdrawal by Subject|2|||
131849087|NCT00425373|474728087|FG007|Overall Study|Withdrawal by Subject|2|||
131849088|NCT00425373|474728088|FG008|Overall Study|Withdrawal by Subject|2|||
131849089|NCT00425373|474728080|FG000|Overall Study|Lack of Efficacy|0|||
131849090|NCT00425373|474728081|FG001|Overall Study|Lack of Efficacy|0|||
131849091|NCT00425373|474728082|FG002|Overall Study|Lack of Efficacy|0|||
131849092|NCT00425373|474728083|FG003|Overall Study|Lack of Efficacy|0|||
131849093|NCT00425373|474728084|FG004|Overall Study|Lack of Efficacy|1|||
131849094|NCT00425373|474728085|FG005|Overall Study|Lack of Efficacy|3|||
131849095|NCT00425373|474728086|FG006|Overall Study|Lack of Efficacy|3|||
131849096|NCT00425373|474728087|FG007|Overall Study|Lack of Efficacy|0|||
131849097|NCT00425373|474728088|FG008|Overall Study|Lack of Efficacy|5|||
131849098|NCT01275729|474728089|FG000|Overall Study|Death|3|||
131849099|NCT01275729|474728089|FG000|Overall Study|Withdrawal by Subject|1|||
131849100|NCT02252406|474728090|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
131849101|NCT02252406|474728091|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
131849102|NCT02252406|474728090|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
131849103|NCT02252406|474728091|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
131849104|NCT02252406|474728090|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
131849105|NCT02252406|474728091|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
131849106|NCT02252406|474728090|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
131849107|NCT02252406|474728091|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
131849108|NCT02252406|474728090|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
131849109|NCT02252406|474728091|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
131849110|NCT00789035|474728097|FG000|Overall Study|Adverse Event|0|||
131849111|NCT00789035|474728098|FG001|Overall Study|Adverse Event|2|||
131849112|NCT00789035|474728099|FG002|Overall Study|Adverse Event|0|||
131849113|NCT00789035|474728100|FG003|Overall Study|Adverse Event|1|||
131849114|NCT00789035|474728101|FG004|Overall Study|Adverse Event|3|||
131849115|NCT00789035|474728097|FG000|Overall Study|Lack of Efficacy|3|||
131849116|NCT00789035|474728098|FG001|Overall Study|Lack of Efficacy|0|||
131849117|NCT00789035|474728099|FG002|Overall Study|Lack of Efficacy|0|||
131849118|NCT00789035|474728100|FG003|Overall Study|Lack of Efficacy|0|||
131849119|NCT00789035|474728101|FG004|Overall Study|Lack of Efficacy|2|||
131849120|NCT00789035|474728097|FG000|Overall Study|Protocol Violation|1|||
131849121|NCT00789035|474728098|FG001|Overall Study|Protocol Violation|0|||
131849122|NCT00789035|474728099|FG002|Overall Study|Protocol Violation|0|||
131849123|NCT00789035|474728100|FG003|Overall Study|Protocol Violation|0|||
131849124|NCT00789035|474728101|FG004|Overall Study|Protocol Violation|0|||
131849125|NCT00789035|474728097|FG000|Overall Study|Withdrawal by Subject|0|||
131849126|NCT00789035|474728098|FG001|Overall Study|Withdrawal by Subject|2|||
131849127|NCT00789035|474728099|FG002|Overall Study|Withdrawal by Subject|0|||
131849128|NCT00789035|474728100|FG003|Overall Study|Withdrawal by Subject|0|||
131849129|NCT00789035|474728101|FG004|Overall Study|Withdrawal by Subject|0|||
131849130|NCT00789035|474728097|FG000|Overall Study|Other reason not defined above|2|||
131849131|NCT00789035|474728098|FG001|Overall Study|Other reason not defined above|3|||
131849132|NCT00789035|474728099|FG002|Overall Study|Other reason not defined above|1|||
131849133|NCT00789035|474728100|FG003|Overall Study|Other reason not defined above|0|||
131849134|NCT00789035|474728101|FG004|Overall Study|Other reason not defined above|1|||
131849135|NCT01520870|474728104|FG000|Overall Study|Withdrawal by Subject|2|||
131849136|NCT01118975|474728105|FG000|Overall Study|Adverse Event|0|||
131849137|NCT01118975|474728106|FG001|Overall Study|Adverse Event|1|||
131849138|NCT04411914|474728107|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
131849139|NCT04411914|474728108|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
131849140|NCT01721317|474728109|FG000|Overall Study|Study Closed / Terminated|2|||
131849141|NCT01721317|474728110|FG001|Overall Study|Study Closed / Terminated|2|||
131849142|NCT01721317|474728109|FG000|Overall Study|Physician Decision|0|||
131849143|NCT01721317|474728110|FG001|Overall Study|Physician Decision|1|||
131849144|NCT01721317|474728109|FG000|Overall Study|Withdrawal by Subject|0|||
131849145|NCT01721317|474728110|FG001|Overall Study|Withdrawal by Subject|1|||
131849146|NCT02806024|474728125|FG000|Overall Study|Night Delivery|1|||
131849147|NCT02806024|474728126|FG001|Overall Study|Night Delivery|1|||
131849148|NCT02806024|474728125|FG000|Overall Study|DVT during antepartum admission|0|||
131849149|NCT02806024|474728126|FG001|Overall Study|DVT during antepartum admission|1|||
131849150|NCT01994850|474728127|FG000|Overall Study|Physician Decision|1|||
131849151|NCT01994850|474728127|FG000|Overall Study|Withdrawal by Subject|1|||
131849152|NCT02290223|474728130|FG000|6 Months|Lost to Follow-up|9|||
131849153|NCT02290223|474728131|FG001|6 Months|Lost to Follow-up|6|||
131849154|NCT02290223|474728130|FG000|6 Months|Withdrawal by Subject|5|||
131849155|NCT02290223|474728131|FG001|6 Months|Withdrawal by Subject|0|||
131849156|NCT02290223|474728130|FG000|6 Months|deceased (not related to study)|2|||
131849157|NCT02290223|474728131|FG001|6 Months|deceased (not related to study)|0|||
131849158|NCT02290223|474728130|FG000|12 Months|Lost to Follow-up|16|||
131849159|NCT02290223|474728131|FG001|12 Months|Lost to Follow-up|10|||
131849160|NCT02290223|474728130|FG000|12 Months|Refusal|0|||
131849161|NCT02290223|474728131|FG001|12 Months|Refusal|1|||
131849162|NCT00534404|474728132|FG000|Overall Study|Death|0|||
131849163|NCT00534404|474728133|FG001|Overall Study|Death|0|||
131849164|NCT00534404|474728134|FG002|Overall Study|Death|2|||
131849165|NCT00534404|474728132|FG000|Overall Study|Withdrawal by Subject|8|||
131849166|NCT00534404|474728133|FG001|Overall Study|Withdrawal by Subject|2|||
131849167|NCT00534404|474728134|FG002|Overall Study|Withdrawal by Subject|38|||
131849168|NCT00534404|474728132|FG000|Overall Study|Removed by study staff|2|||
131849169|NCT00534404|474728133|FG001|Overall Study|Removed by study staff|3|||
131849170|NCT00534404|474728134|FG002|Overall Study|Removed by study staff|1|||
131849171|NCT00534404|474728132|FG000|Overall Study|Lost to Follow-up|170|||
131849172|NCT00534404|474728133|FG001|Overall Study|Lost to Follow-up|138|||
131849173|NCT00534404|474728134|FG002|Overall Study|Lost to Follow-up|201|||
131849174|NCT02785952|474728138|FG000|Overall Study|Adverse Event|31|||
131849175|NCT02785952|474728139|FG001|Overall Study|Adverse Event|19|||
131849176|NCT02785952|474728138|FG000|Overall Study|Refusal unrelated to adverse events|10|||
131849177|NCT02785952|474728139|FG001|Overall Study|Refusal unrelated to adverse events|5|||
131849178|NCT02785952|474728138|FG000|Overall Study|Disease progression/relapse|61|||
131849179|NCT02785952|474728139|FG001|Overall Study|Disease progression/relapse|89|||
131849180|NCT02785952|474728138|FG000|Overall Study|Death|11|||
131849181|NCT02785952|474728139|FG001|Overall Study|Death|7|||
131849182|NCT02785952|474728138|FG000|Overall Study|Other- not protocol specified|6|||
131849183|NCT02785952|474728139|FG001|Overall Study|Other- not protocol specified|4|||
131849184|NCT02785952|474728138|FG000|Overall Study|On protocol treatment|6|||
131849185|NCT02785952|474728139|FG001|Overall Study|On protocol treatment|3|||
131849186|NCT03597464|474728140|FG000|Overall Study|Withdrawal by Subject|4|||
131849187|NCT03597464|474728141|FG001|Overall Study|Withdrawal by Subject|5|||
131849188|NCT03597464|474728140|FG000|Overall Study|Lost to Follow-up|3|||
131849189|NCT03597464|474728141|FG001|Overall Study|Lost to Follow-up|1|||
131849190|NCT03597464|474728140|FG000|Overall Study|Pregnancy|3|||
131849191|NCT03597464|474728141|FG001|Overall Study|Pregnancy|1|||
131849192|NCT03597464|474728140|FG000|Overall Study|Lack of Efficacy|2|||
131849193|NCT03597464|474728141|FG001|Overall Study|Lack of Efficacy|0|||
131849194|NCT03597464|474728140|FG000|Overall Study|Physician Decision|2|||
131849195|NCT03597464|474728141|FG001|Overall Study|Physician Decision|2|||
131849196|NCT03597464|474728140|FG000|Overall Study|Protocol Violation|1|||
131849197|NCT03597464|474728141|FG001|Overall Study|Protocol Violation|1|||
131849198|NCT03597464|474728140|FG000|Overall Study|Adverse Event|0|||
131849199|NCT03597464|474728141|FG001|Overall Study|Adverse Event|2|||
131849200|NCT03597464|474728140|FG000|Overall Study|Death|0|||
131849201|NCT03597464|474728141|FG001|Overall Study|Death|3|||
131849202|NCT02542605|474728144|FG000|Part B: Challenge Phase|Sponsor decision|1|||
131849203|NCT02542605|474728145|FG001|Part B: Challenge Phase|Sponsor decision|0|||
131849204|NCT02542605|474728146|FG002|Part B: Challenge Phase|Sponsor decision|0|||
131849205|NCT02542605|474728144|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
131849206|NCT02542605|474728145|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
131849207|NCT02542605|474728146|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
131849208|NCT02682927|474728147|FG000|Overall Study|Adverse Event|0|||
131849209|NCT02682927|474728148|FG001|Overall Study|Adverse Event|0|||
131849210|NCT02682927|474728149|FG002|Overall Study|Adverse Event|5|||
131849211|NCT02682927|474728150|FG003|Overall Study|Adverse Event|1|||
131849212|NCT02682927|474728151|FG004|Overall Study|Adverse Event|0|||
131849213|NCT02682927|474728152|FG005|Overall Study|Adverse Event|2|||
131849214|NCT02682927|474728147|FG000|Overall Study|Death|0|||
131849215|NCT02682927|474728148|FG001|Overall Study|Death|0|||
131849216|NCT02682927|474728149|FG002|Overall Study|Death|0|||
131849217|NCT02682927|474728150|FG003|Overall Study|Death|1|||
131849218|NCT02682927|474728151|FG004|Overall Study|Death|0|||
131849219|NCT02682927|474728152|FG005|Overall Study|Death|0|||
131849220|NCT02682927|474728147|FG000|Overall Study|Lack of Efficacy|1|||
131849221|NCT02682927|474728148|FG001|Overall Study|Lack of Efficacy|0|||
131451880|NCT00372593|473283005|FG001|Overall Study|Lost to Follow-up|0|||
131451881|NCT00372593|473283006|FG002|Overall Study|Lost to Follow-up|0|||
131451882|NCT00372593|473283004|FG000|Overall Study|Physician Decision|42|||
131451883|NCT00372593|473283005|FG001|Overall Study|Physician Decision|41|||
131849222|NCT02682927|474728149|FG002|Overall Study|Lack of Efficacy|0|||
131849223|NCT02682927|474728150|FG003|Overall Study|Lack of Efficacy|1|||
131849224|NCT02682927|474728151|FG004|Overall Study|Lack of Efficacy|0|||
131849225|NCT02682927|474728152|FG005|Overall Study|Lack of Efficacy|0|||
131849226|NCT02682927|474728147|FG000|Overall Study|Other|0|||
131849227|NCT02682927|474728148|FG001|Overall Study|Other|0|||
131849228|NCT02682927|474728149|FG002|Overall Study|Other|0|||
131849229|NCT02682927|474728150|FG003|Overall Study|Other|2|||
131849230|NCT02682927|474728151|FG004|Overall Study|Other|0|||
131849231|NCT02682927|474728152|FG005|Overall Study|Other|0|||
131451884|NCT00372593|473283006|FG002|Overall Study|Physician Decision|0|||
131849232|NCT02682927|474728147|FG000|Overall Study|Withdrawal by Subject|2|||
131849233|NCT02682927|474728148|FG001|Overall Study|Withdrawal by Subject|0|||
131849234|NCT02682927|474728149|FG002|Overall Study|Withdrawal by Subject|1|||
131849235|NCT02682927|474728150|FG003|Overall Study|Withdrawal by Subject|0|||
131849236|NCT02682927|474728151|FG004|Overall Study|Withdrawal by Subject|1|||
131849237|NCT02682927|474728152|FG005|Overall Study|Withdrawal by Subject|1|||
131849238|NCT04998851|474730537|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
131849239|NCT04998851|474730538|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
131849240|NCT04998851|474730537|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
131849241|NCT04998851|474730538|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
131849242|NCT00070499|474730539|FG000|Overall Study|Adverse Event|6|||
131849243|NCT00070499|474730540|FG001|Overall Study|Adverse Event|6|||
131849244|NCT00070499|474730541|FG002|Overall Study|Adverse Event|19|||
131849245|NCT00070499|474730542|FG003|Overall Study|Adverse Event|15|||
131849246|NCT00070499|474730539|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
131849247|NCT00070499|474730540|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
131849248|NCT00070499|474730541|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
131849249|NCT00070499|474730542|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
131849250|NCT00070499|474730539|FG000|Overall Study|Progression/relapse|4|||
131849251|NCT00070499|474730540|FG001|Overall Study|Progression/relapse|2|||
131849252|NCT00070499|474730541|FG002|Overall Study|Progression/relapse|1|||
131849253|NCT00070499|474730542|FG003|Overall Study|Progression/relapse|4|||
131849254|NCT00070499|474730539|FG000|Overall Study|Death|1|||
131849255|NCT00070499|474730540|FG001|Overall Study|Death|1|||
131849256|NCT00070499|474730541|FG002|Overall Study|Death|1|||
131849257|NCT00070499|474730542|FG003|Overall Study|Death|2|||
131849258|NCT00070499|474730539|FG000|Overall Study|Other - not protocol specified|7|||
131849259|NCT00070499|474730540|FG001|Overall Study|Other - not protocol specified|3|||
131849260|NCT00070499|474730541|FG002|Overall Study|Other - not protocol specified|12|||
131849261|NCT00070499|474730542|FG003|Overall Study|Other - not protocol specified|20|||
131849262|NCT00070499|474730539|FG000|Overall Study|Still on protocol treatment|10|||
131849263|NCT00070499|474730540|FG001|Overall Study|Still on protocol treatment|4|||
131849264|NCT00070499|474730541|FG002|Overall Study|Still on protocol treatment|79|||
131849265|NCT00070499|474730542|FG003|Overall Study|Still on protocol treatment|57|||
131849266|NCT00070499|474730539|FG000|Overall Study|Did not start treatment|1|||
131849267|NCT00070499|474730540|FG001|Overall Study|Did not start treatment|0|||
131849268|NCT00070499|474730541|FG002|Overall Study|Did not start treatment|0|||
131849269|NCT00070499|474730542|FG003|Overall Study|Did not start treatment|2|||
131849270|NCT00070499|474730539|FG000|Overall Study|Not eligible|2|||
131849271|NCT00070499|474730540|FG001|Overall Study|Not eligible|5|||
131849272|NCT00070499|474730541|FG002|Overall Study|Not eligible|3|||
131849273|NCT00070499|474730542|FG003|Overall Study|Not eligible|2|||
131849274|NCT02883049|474730543|FG000|Induction|Adverse Event|52|||
131849275|NCT02883049|474730544|FG001|Induction|Adverse Event|2|||
131849276|NCT02883049|474730545|FG002|Induction|Adverse Event|0|||
131849277|NCT02883049|474730546|FG003|Induction|Adverse Event|0|||
131849278|NCT02883049|474730547|FG004|Induction|Adverse Event|0|||
131849279|NCT02883049|474730548|FG005|Induction|Adverse Event|0|||
131849280|NCT02883049|474730549|FG006|Induction|Adverse Event|0|||
131849281|NCT02883049|474730550|FG007|Induction|Adverse Event|0|||
131849282|NCT02883049|474730551|FG008|Induction|Adverse Event|0|||
131849283|NCT02883049|474730552|FG009|Induction|Adverse Event|0|||
131849284|NCT02883049|474730553|FG010|Induction|Adverse Event|0|||
131849285|NCT02883049|474730554|FG011|Induction|Adverse Event|0|||
131849286|NCT02883049|474730555|FG012|Induction|Adverse Event|0|||
131849287|NCT02883049|474730556|FG013|Induction|Adverse Event|0|||
131849288|NCT02883049|474730557|FG014|Induction|Adverse Event|0|||
131849289|NCT02883049|474730558|FG015|Induction|Adverse Event|0|||
131849290|NCT02883049|474730543|FG000|Induction|Death|76|||
131849291|NCT02883049|474730544|FG001|Induction|Death|8|||
131849292|NCT02883049|474730545|FG002|Induction|Death|0|||
131849293|NCT02883049|474730546|FG003|Induction|Death|0|||
131849294|NCT02883049|474730547|FG004|Induction|Death|0|||
131849295|NCT02883049|474730548|FG005|Induction|Death|0|||
131849296|NCT02883049|474730549|FG006|Induction|Death|0|||
131849297|NCT02883049|474730550|FG007|Induction|Death|0|||
131849298|NCT02883049|474730551|FG008|Induction|Death|0|||
131849299|NCT02883049|474730552|FG009|Induction|Death|0|||
131849300|NCT02883049|474730553|FG010|Induction|Death|0|||
131849301|NCT02883049|474730554|FG011|Induction|Death|0|||
131849302|NCT02883049|474730555|FG012|Induction|Death|0|||
131849303|NCT02883049|474730556|FG013|Induction|Death|0|||
131849304|NCT02883049|474730557|FG014|Induction|Death|0|||
131849305|NCT02883049|474730558|FG015|Induction|Death|0|||
131849306|NCT02883049|474730543|FG000|Induction|Lost to Follow-up|2|||
131849307|NCT02883049|474730544|FG001|Induction|Lost to Follow-up|0|||
131849308|NCT02883049|474730545|FG002|Induction|Lost to Follow-up|0|||
131849309|NCT02883049|474730546|FG003|Induction|Lost to Follow-up|0|||
131849310|NCT02883049|474730547|FG004|Induction|Lost to Follow-up|0|||
131849311|NCT02883049|474730548|FG005|Induction|Lost to Follow-up|0|||
131849312|NCT02883049|474730549|FG006|Induction|Lost to Follow-up|0|||
131849313|NCT02883049|474730550|FG007|Induction|Lost to Follow-up|0|||
131849314|NCT02883049|474730551|FG008|Induction|Lost to Follow-up|0|||
131849315|NCT02883049|474730552|FG009|Induction|Lost to Follow-up|0|||
131849316|NCT02883049|474730553|FG010|Induction|Lost to Follow-up|0|||
131849317|NCT02883049|474730554|FG011|Induction|Lost to Follow-up|0|||
131849318|NCT02883049|474730555|FG012|Induction|Lost to Follow-up|0|||
131849319|NCT02883049|474730556|FG013|Induction|Lost to Follow-up|0|||
131849320|NCT02883049|474730557|FG014|Induction|Lost to Follow-up|0|||
131911733|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
131849321|NCT02883049|474730558|FG015|Induction|Lost to Follow-up|0|||
131849322|NCT02883049|474730543|FG000|Induction|Physician Decision|1407|||
131849323|NCT02883049|474730544|FG001|Induction|Physician Decision|8|||
131849324|NCT02883049|474730545|FG002|Induction|Physician Decision|0|||
131849325|NCT02883049|474730546|FG003|Induction|Physician Decision|0|||
131849326|NCT02883049|474730547|FG004|Induction|Physician Decision|0|||
131849327|NCT02883049|474730548|FG005|Induction|Physician Decision|0|||
131849328|NCT02883049|474730549|FG006|Induction|Physician Decision|0|||
131849329|NCT02883049|474730550|FG007|Induction|Physician Decision|0|||
131849330|NCT02883049|474730551|FG008|Induction|Physician Decision|0|||
131849331|NCT02883049|474730552|FG009|Induction|Physician Decision|0|||
131849332|NCT02883049|474730553|FG010|Induction|Physician Decision|0|||
131849333|NCT02883049|474730554|FG011|Induction|Physician Decision|0|||
131849334|NCT02883049|474730555|FG012|Induction|Physician Decision|0|||
131849335|NCT02883049|474730556|FG013|Induction|Physician Decision|0|||
131849336|NCT02883049|474730557|FG014|Induction|Physician Decision|0|||
131849337|NCT02883049|474730558|FG015|Induction|Physician Decision|0|||
131849338|NCT02883049|474730543|FG000|Induction|Protocol Violation|6|||
131849339|NCT02883049|474730544|FG001|Induction|Protocol Violation|0|||
131849340|NCT02883049|474730545|FG002|Induction|Protocol Violation|0|||
131849341|NCT02883049|474730546|FG003|Induction|Protocol Violation|0|||
131849342|NCT02883049|474730547|FG004|Induction|Protocol Violation|0|||
131849343|NCT02883049|474730548|FG005|Induction|Protocol Violation|0|||
131849344|NCT02883049|474730549|FG006|Induction|Protocol Violation|0|||
131849345|NCT02883049|474730550|FG007|Induction|Protocol Violation|0|||
131849346|NCT02883049|474730551|FG008|Induction|Protocol Violation|0|||
131849347|NCT02883049|474730552|FG009|Induction|Protocol Violation|0|||
131849348|NCT02883049|474730553|FG010|Induction|Protocol Violation|0|||
131849349|NCT02883049|474730554|FG011|Induction|Protocol Violation|0|||
131849350|NCT02883049|474730555|FG012|Induction|Protocol Violation|0|||
131849351|NCT02883049|474730556|FG013|Induction|Protocol Violation|0|||
131849352|NCT02883049|474730557|FG014|Induction|Protocol Violation|0|||
131849353|NCT02883049|474730558|FG015|Induction|Protocol Violation|0|||
131849354|NCT02883049|474730543|FG000|Induction|Withdrawal by Subject|6|||
131849355|NCT02883049|474730544|FG001|Induction|Withdrawal by Subject|0|||
131849356|NCT02883049|474730545|FG002|Induction|Withdrawal by Subject|0|||
131849357|NCT02883049|474730546|FG003|Induction|Withdrawal by Subject|0|||
131849358|NCT02883049|474730547|FG004|Induction|Withdrawal by Subject|0|||
131849359|NCT02883049|474730548|FG005|Induction|Withdrawal by Subject|0|||
131849360|NCT02883049|474730549|FG006|Induction|Withdrawal by Subject|0|||
131849361|NCT02883049|474730550|FG007|Induction|Withdrawal by Subject|0|||
131849362|NCT02883049|474730551|FG008|Induction|Withdrawal by Subject|0|||
131849363|NCT02883049|474730552|FG009|Induction|Withdrawal by Subject|0|||
131849364|NCT02883049|474730553|FG010|Induction|Withdrawal by Subject|0|||
131849365|NCT02883049|474730554|FG011|Induction|Withdrawal by Subject|0|||
131849366|NCT02883049|474730555|FG012|Induction|Withdrawal by Subject|0|||
131849367|NCT02883049|474730556|FG013|Induction|Withdrawal by Subject|0|||
131849368|NCT02883049|474730557|FG014|Induction|Withdrawal by Subject|0|||
131849369|NCT02883049|474730558|FG015|Induction|Withdrawal by Subject|0|||
131849370|NCT02883049|474730543|FG000|Induction|Ineligible|35|||
131849371|NCT02883049|474730544|FG001|Induction|Ineligible|1|||
131849372|NCT02883049|474730545|FG002|Induction|Ineligible|0|||
131849373|NCT02883049|474730546|FG003|Induction|Ineligible|0|||
131849374|NCT02883049|474730547|FG004|Induction|Ineligible|0|||
131849375|NCT02883049|474730548|FG005|Induction|Ineligible|0|||
131849376|NCT02883049|474730549|FG006|Induction|Ineligible|0|||
131849377|NCT02883049|474730550|FG007|Induction|Ineligible|0|||
131849378|NCT02883049|474730551|FG008|Induction|Ineligible|0|||
131849379|NCT02883049|474730552|FG009|Induction|Ineligible|0|||
131849380|NCT02883049|474730553|FG010|Induction|Ineligible|0|||
131849381|NCT02883049|474730554|FG011|Induction|Ineligible|0|||
131849382|NCT02883049|474730555|FG012|Induction|Ineligible|0|||
131849383|NCT02883049|474730556|FG013|Induction|Ineligible|0|||
131849384|NCT02883049|474730557|FG014|Induction|Ineligible|0|||
131849385|NCT02883049|474730558|FG015|Induction|Ineligible|0|||
131849386|NCT02883049|474730543|FG000|Induction|Refusal of further protocol therapy|466|||
131849387|NCT02883049|474730544|FG001|Induction|Refusal of further protocol therapy|2|||
131849388|NCT02883049|474730545|FG002|Induction|Refusal of further protocol therapy|0|||
131849389|NCT02883049|474730546|FG003|Induction|Refusal of further protocol therapy|0|||
131849390|NCT02883049|474730547|FG004|Induction|Refusal of further protocol therapy|0|||
131849391|NCT02883049|474730548|FG005|Induction|Refusal of further protocol therapy|0|||
131849392|NCT02883049|474730549|FG006|Induction|Refusal of further protocol therapy|0|||
131849393|NCT02883049|474730550|FG007|Induction|Refusal of further protocol therapy|0|||
131911734|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
131911735|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
131849394|NCT02883049|474730551|FG008|Induction|Refusal of further protocol therapy|0|||
131849395|NCT02883049|474730552|FG009|Induction|Refusal of further protocol therapy|0|||
131849396|NCT02883049|474730553|FG010|Induction|Refusal of further protocol therapy|0|||
131849397|NCT02883049|474730554|FG011|Induction|Refusal of further protocol therapy|0|||
131849398|NCT02883049|474730555|FG012|Induction|Refusal of further protocol therapy|0|||
131849399|NCT02883049|474730556|FG013|Induction|Refusal of further protocol therapy|0|||
131849400|NCT02883049|474730557|FG014|Induction|Refusal of further protocol therapy|0|||
131849401|NCT02883049|474730558|FG015|Induction|Refusal of further protocol therapy|0|||
131849402|NCT02883049|474730543|FG000|Induction|Identified as Ph+ patients|279|||
131849403|NCT02883049|474730544|FG001|Induction|Identified as Ph+ patients|1|||
131849404|NCT02883049|474730545|FG002|Induction|Identified as Ph+ patients|0|||
131849405|NCT02883049|474730546|FG003|Induction|Identified as Ph+ patients|0|||
131849406|NCT02883049|474730547|FG004|Induction|Identified as Ph+ patients|0|||
131849407|NCT02883049|474730548|FG005|Induction|Identified as Ph+ patients|0|||
131849408|NCT02883049|474730549|FG006|Induction|Identified as Ph+ patients|0|||
131849409|NCT02883049|474730550|FG007|Induction|Identified as Ph+ patients|0|||
131849410|NCT02883049|474730551|FG008|Induction|Identified as Ph+ patients|0|||
131849411|NCT02883049|474730552|FG009|Induction|Identified as Ph+ patients|0|||
131849412|NCT02883049|474730553|FG010|Induction|Identified as Ph+ patients|0|||
131849413|NCT02883049|474730554|FG011|Induction|Identified as Ph+ patients|0|||
131849414|NCT02883049|474730555|FG012|Induction|Identified as Ph+ patients|0|||
131849415|NCT02883049|474730556|FG013|Induction|Identified as Ph+ patients|0|||
131849416|NCT02883049|474730557|FG014|Induction|Identified as Ph+ patients|0|||
131849417|NCT02883049|474730558|FG015|Induction|Identified as Ph+ patients|0|||
131849418|NCT02883049|474730543|FG000|Induction|M3 Marrow at Day29|8|||
131849419|NCT02883049|474730544|FG001|Induction|M3 Marrow at Day29|1|||
131849420|NCT02883049|474730545|FG002|Induction|M3 Marrow at Day29|0|||
131849421|NCT02883049|474730546|FG003|Induction|M3 Marrow at Day29|0|||
131849422|NCT02883049|474730547|FG004|Induction|M3 Marrow at Day29|0|||
131849423|NCT02883049|474730548|FG005|Induction|M3 Marrow at Day29|0|||
131849424|NCT02883049|474730549|FG006|Induction|M3 Marrow at Day29|0|||
131849425|NCT02883049|474730550|FG007|Induction|M3 Marrow at Day29|0|||
131849426|NCT02883049|474730551|FG008|Induction|M3 Marrow at Day29|0|||
131849427|NCT02883049|474730552|FG009|Induction|M3 Marrow at Day29|0|||
131849428|NCT02883049|474730553|FG010|Induction|M3 Marrow at Day29|0|||
131849429|NCT02883049|474730554|FG011|Induction|M3 Marrow at Day29|0|||
131849430|NCT02883049|474730555|FG012|Induction|M3 Marrow at Day29|0|||
131849431|NCT02883049|474730556|FG013|Induction|M3 Marrow at Day29|0|||
131849432|NCT02883049|474730557|FG014|Induction|M3 Marrow at Day29|0|||
131849433|NCT02883049|474730558|FG015|Induction|M3 Marrow at Day29|0|||
131849434|NCT02883049|474730543|FG000|Induction|Inevaluable|33|||
131849435|NCT02883049|474730544|FG001|Induction|Inevaluable|1|||
131849436|NCT02883049|474730545|FG002|Induction|Inevaluable|0|||
131849437|NCT02883049|474730546|FG003|Induction|Inevaluable|0|||
131849438|NCT02883049|474730547|FG004|Induction|Inevaluable|0|||
131849439|NCT02883049|474730548|FG005|Induction|Inevaluable|0|||
131849440|NCT02883049|474730549|FG006|Induction|Inevaluable|0|||
131849441|NCT02883049|474730550|FG007|Induction|Inevaluable|0|||
131849442|NCT02883049|474730551|FG008|Induction|Inevaluable|0|||
131849443|NCT02883049|474730552|FG009|Induction|Inevaluable|0|||
131849444|NCT02883049|474730553|FG010|Induction|Inevaluable|0|||
131849445|NCT02883049|474730554|FG011|Induction|Inevaluable|0|||
131849446|NCT02883049|474730555|FG012|Induction|Inevaluable|0|||
131849447|NCT02883049|474730556|FG013|Induction|Inevaluable|0|||
131849448|NCT02883049|474730557|FG014|Induction|Inevaluable|0|||
131911736|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
131911737|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
131911738|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
131911739|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
131911740|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
131911741|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
131911742|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
131849449|NCT02883049|474730558|FG015|Induction|Inevaluable|0|||
131849450|NCT02883049|474730543|FG000|Induction|Identified as VHR at end of Induction|244|||
131849451|NCT02883049|474730544|FG001|Induction|Identified as VHR at end of Induction|0|||
131849452|NCT02883049|474730545|FG002|Induction|Identified as VHR at end of Induction|0|||
131849453|NCT02883049|474730546|FG003|Induction|Identified as VHR at end of Induction|0|||
131849454|NCT02883049|474730547|FG004|Induction|Identified as VHR at end of Induction|0|||
131849455|NCT02883049|474730548|FG005|Induction|Identified as VHR at end of Induction|0|||
131849456|NCT02883049|474730549|FG006|Induction|Identified as VHR at end of Induction|0|||
131849457|NCT02883049|474730550|FG007|Induction|Identified as VHR at end of Induction|0|||
131849458|NCT02883049|474730551|FG008|Induction|Identified as VHR at end of Induction|0|||
131849459|NCT02883049|474730552|FG009|Induction|Identified as VHR at end of Induction|0|||
131849460|NCT02883049|474730553|FG010|Induction|Identified as VHR at end of Induction|0|||
131849461|NCT02883049|474730554|FG011|Induction|Identified as VHR at end of Induction|0|||
131849462|NCT02883049|474730555|FG012|Induction|Identified as VHR at end of Induction|0|||
131849463|NCT02883049|474730556|FG013|Induction|Identified as VHR at end of Induction|0|||
131849464|NCT02883049|474730557|FG014|Induction|Identified as VHR at end of Induction|0|||
131849465|NCT02883049|474730558|FG015|Induction|Identified as VHR at end of Induction|0|||
131849466|NCT02883049|474730543|FG000|Induction|Moved to another non-COG institution|3|||
131849467|NCT02883049|474730544|FG001|Induction|Moved to another non-COG institution|0|||
131849468|NCT02883049|474730545|FG002|Induction|Moved to another non-COG institution|0|||
131849469|NCT02883049|474730546|FG003|Induction|Moved to another non-COG institution|0|||
131849470|NCT02883049|474730547|FG004|Induction|Moved to another non-COG institution|0|||
131849471|NCT02883049|474730548|FG005|Induction|Moved to another non-COG institution|0|||
131849472|NCT02883049|474730549|FG006|Induction|Moved to another non-COG institution|0|||
131849473|NCT02883049|474730550|FG007|Induction|Moved to another non-COG institution|0|||
131849474|NCT02883049|474730551|FG008|Induction|Moved to another non-COG institution|0|||
131849475|NCT02883049|474730552|FG009|Induction|Moved to another non-COG institution|0|||
131849476|NCT02883049|474730553|FG010|Induction|Moved to another non-COG institution|0|||
131849477|NCT02883049|474730554|FG011|Induction|Moved to another non-COG institution|0|||
131849478|NCT02883049|474730555|FG012|Induction|Moved to another non-COG institution|0|||
131849479|NCT02883049|474730556|FG013|Induction|Moved to another non-COG institution|0|||
131849480|NCT02883049|474730557|FG014|Induction|Moved to another non-COG institution|0|||
131849481|NCT02883049|474730558|FG015|Induction|Moved to another non-COG institution|0|||
131849482|NCT02883049|474730543|FG000|Induction|Randomization closed|41|||
131849483|NCT02883049|474730544|FG001|Induction|Randomization closed|0|||
131849484|NCT02883049|474730545|FG002|Induction|Randomization closed|0|||
131849485|NCT02883049|474730546|FG003|Induction|Randomization closed|0|||
131849486|NCT02883049|474730547|FG004|Induction|Randomization closed|0|||
131849487|NCT02883049|474730548|FG005|Induction|Randomization closed|0|||
131849488|NCT02883049|474730549|FG006|Induction|Randomization closed|0|||
131849489|NCT02883049|474730550|FG007|Induction|Randomization closed|0|||
131849490|NCT02883049|474730551|FG008|Induction|Randomization closed|0|||
131849491|NCT02883049|474730552|FG009|Induction|Randomization closed|0|||
131849492|NCT02883049|474730553|FG010|Induction|Randomization closed|0|||
131849493|NCT02883049|474730554|FG011|Induction|Randomization closed|0|||
131849494|NCT02883049|474730555|FG012|Induction|Randomization closed|0|||
131849495|NCT02883049|474730556|FG013|Induction|Randomization closed|0|||
131849496|NCT02883049|474730557|FG014|Induction|Randomization closed|0|||
131849497|NCT02883049|474730558|FG015|Induction|Randomization closed|0|||
131849498|NCT02883049|474730543|FG000|Induction|MRD negative|36|||
131849499|NCT02883049|474730544|FG001|Induction|MRD negative|0|||
131849500|NCT02883049|474730545|FG002|Induction|MRD negative|0|||
131849501|NCT02883049|474730546|FG003|Induction|MRD negative|0|||
131849502|NCT02883049|474730547|FG004|Induction|MRD negative|0|||
131849503|NCT02883049|474730548|FG005|Induction|MRD negative|0|||
131849504|NCT02883049|474730549|FG006|Induction|MRD negative|0|||
131849505|NCT02883049|474730550|FG007|Induction|MRD negative|0|||
131849506|NCT02883049|474730551|FG008|Induction|MRD negative|0|||
131849507|NCT02883049|474730552|FG009|Induction|MRD negative|0|||
131849508|NCT02883049|474730553|FG010|Induction|MRD negative|0|||
131849509|NCT02883049|474730554|FG011|Induction|MRD negative|0|||
131849510|NCT02883049|474730555|FG012|Induction|MRD negative|0|||
131849511|NCT02883049|474730556|FG013|Induction|MRD negative|0|||
131849512|NCT02883049|474730557|FG014|Induction|MRD negative|0|||
131849513|NCT02883049|474730558|FG015|Induction|MRD negative|0|||
131849514|NCT02883049|474730543|FG000|Induction|Identified as HR patients|165|||
131849515|NCT02883049|474730544|FG001|Induction|Identified as HR patients|0|||
131849516|NCT02883049|474730545|FG002|Induction|Identified as HR patients|0|||
131849517|NCT02883049|474730546|FG003|Induction|Identified as HR patients|0|||
131849518|NCT02883049|474730547|FG004|Induction|Identified as HR patients|0|||
131849519|NCT02883049|474730548|FG005|Induction|Identified as HR patients|0|||
131849520|NCT02883049|474730549|FG006|Induction|Identified as HR patients|0|||
131849521|NCT02883049|474730550|FG007|Induction|Identified as HR patients|0|||
131849522|NCT02883049|474730551|FG008|Induction|Identified as HR patients|0|||
131849523|NCT02883049|474730552|FG009|Induction|Identified as HR patients|0|||
131849524|NCT02883049|474730553|FG010|Induction|Identified as HR patients|0|||
131849525|NCT02883049|474730554|FG011|Induction|Identified as HR patients|0|||
131849526|NCT02883049|474730555|FG012|Induction|Identified as HR patients|0|||
131849527|NCT02883049|474730556|FG013|Induction|Identified as HR patients|0|||
131849528|NCT02883049|474730557|FG014|Induction|Identified as HR patients|0|||
131849529|NCT02883049|474730558|FG015|Induction|Identified as HR patients|0|||
131849530|NCT02883049|474730543|FG000|Induction|Developed SMN|0|||
131849531|NCT02883049|474730544|FG001|Induction|Developed SMN|1|||
131849532|NCT02883049|474730545|FG002|Induction|Developed SMN|0|||
131849533|NCT02883049|474730546|FG003|Induction|Developed SMN|0|||
131849534|NCT02883049|474730547|FG004|Induction|Developed SMN|0|||
131849535|NCT02883049|474730548|FG005|Induction|Developed SMN|0|||
131849536|NCT02883049|474730549|FG006|Induction|Developed SMN|0|||
131849537|NCT02883049|474730550|FG007|Induction|Developed SMN|0|||
131849538|NCT02883049|474730551|FG008|Induction|Developed SMN|0|||
131849539|NCT02883049|474730552|FG009|Induction|Developed SMN|0|||
131849540|NCT02883049|474730553|FG010|Induction|Developed SMN|0|||
131849541|NCT02883049|474730554|FG011|Induction|Developed SMN|0|||
131849542|NCT02883049|474730555|FG012|Induction|Developed SMN|0|||
131849543|NCT02883049|474730556|FG013|Induction|Developed SMN|0|||
131849544|NCT02883049|474730557|FG014|Induction|Developed SMN|0|||
131849545|NCT02883049|474730558|FG015|Induction|Developed SMN|0|||
131849546|NCT02883049|474730543|FG000|Induction|Enrolled onto another COG study|72|||
131911743|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
131911744|NCT00849056|474965173|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
131911745|NCT00849056|474965174|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
131911746|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
131911747|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
131911748|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
131911749|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
131911750|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
131911751|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
131911752|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
131911753|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
131911754|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
131911755|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
131911756|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
131911757|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
131911758|NCT00849056|474965173|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
131911759|NCT00849056|474965174|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
131911760|NCT00548327|474965175|FG000|Overall Study|Adverse Event|0|||
131911761|NCT00548327|474965176|FG001|Overall Study|Adverse Event|1|||
131911762|NCT03255187|474965177|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
131911763|NCT03255187|474965178|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
131911764|NCT03255187|474965177|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
131911765|NCT03255187|474965178|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
131911766|NCT00375752|474965179|FG000|Overall Study|Lack of Efficacy|4|||
131911767|NCT00375752|474965180|FG001|Overall Study|Lack of Efficacy|4|||
131911768|NCT00375752|474965179|FG000|Overall Study|Adverse Event|1|||
131911769|NCT00375752|474965180|FG001|Overall Study|Adverse Event|6|||
131911770|NCT00375752|474965179|FG000|Overall Study|Withdrawal by Subject|6|||
131911771|NCT00375752|474965180|FG001|Overall Study|Withdrawal by Subject|1|||
131911772|NCT00375752|474965179|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
131911773|NCT00375752|474965180|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
131911774|NCT00375752|474965179|FG000|Overall Study|Protocol Violation|0|||
131911775|NCT00375752|474965180|FG001|Overall Study|Protocol Violation|2|||
131911776|NCT00375752|474965179|FG000|Overall Study|Administrative Problems|0|||
131911777|NCT00375752|474965180|FG001|Overall Study|Administrative Problems|1|||
131911778|NCT00109343|474965184|FG000|Overall Study|Adverse Event|1|||
131911779|NCT00109343|474965185|FG001|Overall Study|Adverse Event|0|||
131911780|NCT00109343|474965186|FG002|Overall Study|Adverse Event|2|||
131911781|NCT00109343|474965184|FG000|Overall Study|Lack of Efficacy|1|||
131911782|NCT00109343|474965185|FG001|Overall Study|Lack of Efficacy|0|||
131911783|NCT00109343|474965186|FG002|Overall Study|Lack of Efficacy|0|||
131911784|NCT00109343|474965184|FG000|Overall Study|Lost to Follow-up|35|||
131451885|NCT00372593|473283004|FG000|Overall Study|Ineligible|20|||
131451886|NCT00372593|473283005|FG001|Overall Study|Ineligible|21|||
131849547|NCT02883049|474730544|FG001|Induction|Enrolled onto another COG study|0|||
131849548|NCT02883049|474730545|FG002|Induction|Enrolled onto another COG study|0|||
131849549|NCT02883049|474730546|FG003|Induction|Enrolled onto another COG study|0|||
131849550|NCT02883049|474730547|FG004|Induction|Enrolled onto another COG study|0|||
131849551|NCT02883049|474730548|FG005|Induction|Enrolled onto another COG study|0|||
131849552|NCT02883049|474730549|FG006|Induction|Enrolled onto another COG study|0|||
131849553|NCT02883049|474730550|FG007|Induction|Enrolled onto another COG study|0|||
131849554|NCT02883049|474730551|FG008|Induction|Enrolled onto another COG study|0|||
131849555|NCT02883049|474730552|FG009|Induction|Enrolled onto another COG study|0|||
131849556|NCT02883049|474730553|FG010|Induction|Enrolled onto another COG study|0|||
131849557|NCT02883049|474730554|FG011|Induction|Enrolled onto another COG study|0|||
131849558|NCT02883049|474730555|FG012|Induction|Enrolled onto another COG study|0|||
131849559|NCT02883049|474730556|FG013|Induction|Enrolled onto another COG study|0|||
131849560|NCT02883049|474730557|FG014|Induction|Enrolled onto another COG study|0|||
131849561|NCT02883049|474730558|FG015|Induction|Enrolled onto another COG study|0|||
131849562|NCT02883049|474730543|FG000|Induction|Incomplete induction data|17|||
131849563|NCT02883049|474730544|FG001|Induction|Incomplete induction data|0|||
131849564|NCT02883049|474730545|FG002|Induction|Incomplete induction data|0|||
131849565|NCT02883049|474730546|FG003|Induction|Incomplete induction data|0|||
131849566|NCT02883049|474730547|FG004|Induction|Incomplete induction data|0|||
131849567|NCT02883049|474730548|FG005|Induction|Incomplete induction data|0|||
131911785|NCT00109343|474965185|FG001|Overall Study|Lost to Follow-up|20|||
131451887|NCT00372593|473283006|FG002|Overall Study|Ineligible|1|||
131849568|NCT02883049|474730549|FG006|Induction|Incomplete induction data|0|||
131911786|NCT00109343|474965186|FG002|Overall Study|Lost to Follow-up|14|||
131911787|NCT00109343|474965184|FG000|Overall Study|Protocol Violation|1|||
131911788|NCT00109343|474965185|FG001|Overall Study|Protocol Violation|2|||
131911789|NCT00109343|474965186|FG002|Overall Study|Protocol Violation|2|||
131911790|NCT00109343|474965184|FG000|Overall Study|Withdrawal by Subject|15|||
131849569|NCT02883049|474730550|FG007|Induction|Incomplete induction data|0|||
131451888|NCT00433004|473283007|FG000|Overall Study|Lost to Follow-up|5|||
131451889|NCT00433004|473283008|FG001|Overall Study|Lost to Follow-up|7|||
131451890|NCT03534180|473283009|FG000|Overall Study|Withdrawal by Subject|1|||
131451891|NCT00241839|473283012|FG000|Overall Study|Withdrawal by Subject|18|||
131451892|NCT00241839|473283013|FG001|Overall Study|Withdrawal by Subject|17|||
131451893|NCT00241839|473283012|FG000|Overall Study|Adverse Event|1|||
131451894|NCT00241839|473283013|FG001|Overall Study|Adverse Event|1|||
131451895|NCT00831181|473283016|FG000|Overall Study|Adverse Event|12|||
131451896|NCT01662102|473283017|FG000|Overall Study|Sponsor's decision|1|||
131451897|NCT01662102|473283018|FG001|Overall Study|Sponsor's decision|0|||
131451898|NCT02863419|473283019|FG000|Overall Study|Lost to Follow-up|0|||
131451899|NCT02863419|473283020|FG001|Overall Study|Lost to Follow-up|1|||
131451900|NCT02863419|473283021|FG002|Overall Study|Lost to Follow-up|4|||
131451901|NCT02863419|473283019|FG000|Overall Study|Withdrawal by Subject|5|||
131451902|NCT02863419|473283020|FG001|Overall Study|Withdrawal by Subject|5|||
131451903|NCT02863419|473283021|FG002|Overall Study|Withdrawal by Subject|3|||
131451904|NCT02863419|473283019|FG000|Overall Study|Died|3|||
131451905|NCT02863419|473283020|FG001|Overall Study|Died|4|||
131451906|NCT02863419|473283021|FG002|Overall Study|Died|1|||
131451907|NCT01967576|473283024|FG000|Overall Study|Withdrawal by Subject|3|||
131451908|NCT01967576|473283024|FG000|Overall Study|Progressed/Removed from treatment|1|||
131451909|NCT01967576|473283024|FG000|Overall Study|Study closing at site|1|||
131451910|NCT01967576|473283024|FG000|Overall Study|Adverse Event|1|||
131451911|NCT01967576|473283024|FG000|Overall Study|Refused further treatment|1|||
131451912|NCT03196349|473283025|FG000|Overall Study|Did not receive study drug|0|||
131451913|NCT03196349|473283026|FG001|Overall Study|Did not receive study drug|1|||
131451914|NCT03196349|473283027|FG002|Overall Study|Did not receive study drug|2|||
131451915|NCT03196349|473283025|FG000|Overall Study|No data entered|2|||
131451916|NCT03196349|473283026|FG001|Overall Study|No data entered|4|||
131451917|NCT03196349|473283027|FG002|Overall Study|No data entered|0|||
131451918|NCT03196349|473283025|FG000|Overall Study|Study Terminated early|15|||
131451919|NCT03196349|473283026|FG001|Overall Study|Study Terminated early|9|||
131451920|NCT03196349|473283027|FG002|Overall Study|Study Terminated early|11|||
131451921|NCT03967444|473283028|FG000|Overall Study|Lost to Follow-up|1|||
131451922|NCT03967444|473283029|FG001|Overall Study|Lost to Follow-up|2|||
131451923|NCT01821118|473283036|FG000|Overall Study|Death|0|||
131451924|NCT01821118|473283037|FG001|Overall Study|Death|1|||
131451925|NCT01605799|473283038|FG000|Overall Study|Withdrawal by Subject|2|||
131451926|NCT01605799|473283039|FG001|Overall Study|Withdrawal by Subject|1|||
131451927|NCT00345358|473283040|FG000|Primary Vaccination Phase|Other|0|||
131451928|NCT00345358|473283041|FG001|Primary Vaccination Phase|Other|1|||
131451929|NCT00345358|473283042|FG002|Primary Vaccination Phase|Other|1|||
131451930|NCT00345358|473283043|FG003|Primary Vaccination Phase|Other|0|||
131451931|NCT00345358|473283040|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
131451932|NCT00345358|473283041|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
131451933|NCT00345358|473283042|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
131451934|NCT00345358|473283043|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
131451935|NCT00345358|473283040|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
131849570|NCT02883049|474730551|FG008|Induction|Incomplete induction data|0|||
131849571|NCT02883049|474730552|FG009|Induction|Incomplete induction data|0|||
131849572|NCT02883049|474730553|FG010|Induction|Incomplete induction data|0|||
131849573|NCT02883049|474730554|FG011|Induction|Incomplete induction data|0|||
131849574|NCT02883049|474730555|FG012|Induction|Incomplete induction data|0|||
131849575|NCT02883049|474730556|FG013|Induction|Incomplete induction data|0|||
131849576|NCT02883049|474730557|FG014|Induction|Incomplete induction data|0|||
131849577|NCT02883049|474730558|FG015|Induction|Incomplete induction data|0|||
131849578|NCT02883049|474730543|FG000|Post Induction|Adverse Event|0|||
131849579|NCT02883049|474730544|FG001|Post Induction|Adverse Event|0|||
131849580|NCT02883049|474730545|FG002|Post Induction|Adverse Event|0|||
131849581|NCT02883049|474730546|FG003|Post Induction|Adverse Event|7|||
131849582|NCT02883049|474730547|FG004|Post Induction|Adverse Event|8|||
131849583|NCT02883049|474730548|FG005|Post Induction|Adverse Event|3|||
131849584|NCT02883049|474730549|FG006|Post Induction|Adverse Event|4|||
131849585|NCT02883049|474730550|FG007|Post Induction|Adverse Event|5|||
131849586|NCT02883049|474730551|FG008|Post Induction|Adverse Event|6|||
131849587|NCT02883049|474730552|FG009|Post Induction|Adverse Event|7|||
131451936|NCT00345358|473283041|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
131451937|NCT00345358|473283042|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
131849588|NCT02883049|474730553|FG010|Post Induction|Adverse Event|2|||
131849589|NCT02883049|474730554|FG011|Post Induction|Adverse Event|2|||
131451938|NCT00345358|473283043|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
131451939|NCT00345358|473283040|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
131451940|NCT00345358|473283041|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
131451941|NCT00345358|473283042|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
131451942|NCT00345358|473283043|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
131849590|NCT02883049|474730555|FG012|Post Induction|Adverse Event|0|||
131849591|NCT02883049|474730556|FG013|Post Induction|Adverse Event|0|||
131849592|NCT02883049|474730557|FG014|Post Induction|Adverse Event|5|||
131849593|NCT02883049|474730558|FG015|Post Induction|Adverse Event|2|||
131849594|NCT02883049|474730543|FG000|Post Induction|Death|0|||
131849595|NCT02883049|474730544|FG001|Post Induction|Death|0|||
131849596|NCT02883049|474730545|FG002|Post Induction|Death|0|||
131849597|NCT02883049|474730546|FG003|Post Induction|Death|9|||
131849598|NCT02883049|474730547|FG004|Post Induction|Death|9|||
131849599|NCT02883049|474730548|FG005|Post Induction|Death|0|||
131911791|NCT00109343|474965185|FG001|Overall Study|Withdrawal by Subject|11|||
131911792|NCT00109343|474965186|FG002|Overall Study|Withdrawal by Subject|10|||
131911793|NCT00109343|474965184|FG000|Overall Study|Subject Moved|6|||
131911794|NCT00109343|474965185|FG001|Overall Study|Subject Moved|2|||
131911795|NCT00109343|474965186|FG002|Overall Study|Subject Moved|1|||
131911796|NCT00109343|474965184|FG000|Overall Study|Other|5|||
131911797|NCT00109343|474965185|FG001|Overall Study|Other|2|||
131911798|NCT00109343|474965186|FG002|Overall Study|Other|1|||
131911799|NCT00961064|474965187|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
131911800|NCT00961064|474965187|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
131911801|NCT00961064|474965187|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
131911802|NCT00961064|474965187|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
131911803|NCT00961064|474965187|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
131911804|NCT00961064|474965187|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
131911805|NCT00961064|474965187|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
131911806|NCT00961064|474965187|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
131911807|NCT01294046|474965188|FG000|Overall Study|Infection and surgical explant|1|||
131911808|NCT01294046|474965188|FG000|Overall Study|Eligibility criteria expanded|1|||
131911809|NCT01294046|474965188|FG000|Overall Study|Stimulation response inadqequate|1|||
131911810|NCT00761319|474965189|FG000|Overall Study|Protocol Violation|21|||
131911811|NCT00761319|474965190|FG001|Overall Study|Protocol Violation|14|||
131911812|NCT00761319|474965189|FG000|Overall Study|Adverse Event|11|||
131911813|NCT00761319|474965190|FG001|Overall Study|Adverse Event|7|||
131911814|NCT00761319|474965189|FG000|Overall Study|Withdrawal by Subject|8|||
131911815|NCT00761319|474965190|FG001|Overall Study|Withdrawal by Subject|7|||
131911816|NCT00761319|474965189|FG000|Overall Study|Noncompliance|4|||
131911817|NCT00761319|474965190|FG001|Overall Study|Noncompliance|3|||
131911818|NCT00761319|474965189|FG000|Overall Study|Lost to Follow-up|1|||
131911819|NCT00761319|474965190|FG001|Overall Study|Lost to Follow-up|1|||
131911820|NCT00761319|474965189|FG000|Overall Study|Nonspecified|2|||
131911821|NCT00761319|474965190|FG001|Overall Study|Nonspecified|2|||
131911822|NCT00761319|474965189|FG000|Overall Study|Missing|1|||
131911823|NCT00761319|474965190|FG001|Overall Study|Missing|0|||
131911824|NCT03261401|474965191|FG000|Overall Study|Withdrawal by Subject|0|||
131911825|NCT03261401|474965192|FG001|Overall Study|Withdrawal by Subject|0|||
131911826|NCT03261401|474965193|FG002|Overall Study|Withdrawal by Subject|0|||
131911827|NCT03261401|474965194|FG003|Overall Study|Withdrawal by Subject|0|||
131911828|NCT03261401|474965195|FG004|Overall Study|Withdrawal by Subject|0|||
131911829|NCT03261401|474965196|FG005|Overall Study|Withdrawal by Subject|1|||
131911830|NCT03261401|474965197|FG006|Overall Study|Withdrawal by Subject|0|||
131911831|NCT03261401|474965198|FG007|Overall Study|Withdrawal by Subject|0|||
131911832|NCT03261401|474965199|FG008|Overall Study|Withdrawal by Subject|0|||
131911833|NCT03261401|474965200|FG009|Overall Study|Withdrawal by Subject|0|||
131911834|NCT03261401|474965201|FG010|Overall Study|Withdrawal by Subject|0|||
131911835|NCT03261401|474965202|FG011|Overall Study|Withdrawal by Subject|0|||
131911836|NCT03261401|474965203|FG012|Overall Study|Withdrawal by Subject|0|||
131911837|NCT03261401|474965191|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
131911838|NCT03261401|474965192|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
131911839|NCT03261401|474965193|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
131911840|NCT03261401|474965194|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
131911841|NCT03261401|474965195|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
131911842|NCT03261401|474965196|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
131911843|NCT03261401|474965197|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
131911844|NCT03261401|474965198|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
131911845|NCT03261401|474965199|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
131849600|NCT02883049|474730549|FG006|Post Induction|Death|1|||
131849601|NCT02883049|474730550|FG007|Post Induction|Death|6|||
131911846|NCT03261401|474965200|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
131911847|NCT03261401|474965201|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
131849602|NCT02883049|474730551|FG008|Post Induction|Death|5|||
131849603|NCT02883049|474730552|FG009|Post Induction|Death|3|||
131849604|NCT02883049|474730553|FG010|Post Induction|Death|1|||
131849605|NCT02883049|474730554|FG011|Post Induction|Death|0|||
131911848|NCT03261401|474965202|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
131911849|NCT03261401|474965203|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
131849606|NCT02883049|474730555|FG012|Post Induction|Death|1|||
131849607|NCT02883049|474730556|FG013|Post Induction|Death|1|||
131849608|NCT02883049|474730557|FG014|Post Induction|Death|10|||
131849609|NCT02883049|474730558|FG015|Post Induction|Death|2|||
131911850|NCT01715298|474965204|FG000|Overall Study|Lost to Follow-up|0|||
131911851|NCT01715298|474965205|FG001|Overall Study|Lost to Follow-up|2|||
131911852|NCT01715298|474965204|FG000|Overall Study|Patient/guardian decision|7|||
131911853|NCT01715298|474965205|FG001|Overall Study|Patient/guardian decision|9|||
131911854|NCT01499511|474965210|FG000|Overall Study|Death|1|||
131911855|NCT01499511|474965211|FG001|Overall Study|Death|0|||
131911856|NCT00726453|474965213|FG000|Primary Enrollment Group|Death|18|||
131911857|NCT00726453|474965214|FG001|Primary Enrollment Group|Death|0|||
131849610|NCT02883049|474730543|FG000|Post Induction|Lost to Follow-up|0|||
131849611|NCT02883049|474730544|FG001|Post Induction|Lost to Follow-up|0|||
131451943|NCT00345358|473283040|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
131451944|NCT00345358|473283041|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
131849612|NCT02883049|474730545|FG002|Post Induction|Lost to Follow-up|0|||
131849613|NCT02883049|474730546|FG003|Post Induction|Lost to Follow-up|0|||
131849614|NCT02883049|474730547|FG004|Post Induction|Lost to Follow-up|1|||
131849615|NCT02883049|474730548|FG005|Post Induction|Lost to Follow-up|1|||
131849616|NCT02883049|474730549|FG006|Post Induction|Lost to Follow-up|0|||
131849617|NCT02883049|474730550|FG007|Post Induction|Lost to Follow-up|0|||
131849618|NCT02883049|474730551|FG008|Post Induction|Lost to Follow-up|3|||
131849619|NCT02883049|474730552|FG009|Post Induction|Lost to Follow-up|0|||
131849620|NCT02883049|474730553|FG010|Post Induction|Lost to Follow-up|1|||
131849621|NCT02883049|474730554|FG011|Post Induction|Lost to Follow-up|0|||
131849622|NCT02883049|474730555|FG012|Post Induction|Lost to Follow-up|0|||
131911858|NCT00726453|474965213|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
131911859|NCT00726453|474965214|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
131451945|NCT00345358|473283042|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
131849623|NCT02883049|474730556|FG013|Post Induction|Lost to Follow-up|0|||
131451946|NCT00345358|473283043|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
131451947|NCT00345358|473283040|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
131451948|NCT00345358|473283041|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
131451949|NCT00345358|473283042|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
131451950|NCT00345358|473283043|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
131451951|NCT00607373|473283044|FG000|Treatment Period|Adverse Event|0|||
131451952|NCT00607373|473283045|FG001|Treatment Period|Adverse Event|4|||
131451953|NCT00607373|473283044|FG000|Treatment Period|Physician Decision|0|||
131451954|NCT00607373|473283045|FG001|Treatment Period|Physician Decision|1|||
131451955|NCT00607373|473283044|FG000|Treatment Period|Withdrawal by Subject|0|||
131451956|NCT00607373|473283045|FG001|Treatment Period|Withdrawal by Subject|1|||
131451957|NCT00607373|473283044|FG000|Follow-up Period|Other|0|||
131451958|NCT00607373|473283045|FG001|Follow-up Period|Other|1|||
131451959|NCT00607373|473283044|FG000|Follow-up Period|Protocol Violation|0|||
131451960|NCT00607373|473283045|FG001|Follow-up Period|Protocol Violation|1|||
131451961|NCT00607373|473283044|FG000|Follow-up Period|Withdrawal by Subject|1|||
131451962|NCT00607373|473283045|FG001|Follow-up Period|Withdrawal by Subject|3|||
131451963|NCT01918306|473283046|FG000|Overall Study|progresive disease|4|||
131451964|NCT01918306|473283047|FG001|Overall Study|progresive disease|0|||
131451965|NCT01918306|473283048|FG002|Overall Study|progresive disease|1|||
131451966|NCT01918306|473283049|FG003|Overall Study|progresive disease|1|||
131451967|NCT01918306|473283046|FG000|Overall Study|Withdrawal by Subject|0|||
131451968|NCT01918306|473283047|FG001|Overall Study|Withdrawal by Subject|0|||
131451969|NCT01918306|473283048|FG002|Overall Study|Withdrawal by Subject|0|||
131451970|NCT01918306|473283049|FG003|Overall Study|Withdrawal by Subject|2|||
131451971|NCT01918306|473283046|FG000|Overall Study|neutropenia|1|||
131451972|NCT01918306|473283047|FG001|Overall Study|neutropenia|0|||
131451973|NCT01918306|473283048|FG002|Overall Study|neutropenia|0|||
131451974|NCT01918306|473283049|FG003|Overall Study|neutropenia|0|||
131451975|NCT01918306|473283046|FG000|Overall Study|Lack of Efficacy|1|||
131451976|NCT01918306|473283047|FG001|Overall Study|Lack of Efficacy|0|||
131451977|NCT01918306|473283048|FG002|Overall Study|Lack of Efficacy|0|||
131849624|NCT02883049|474730557|FG014|Post Induction|Lost to Follow-up|0|||
131911860|NCT00726453|474965213|FG000|38 mm Length Group|Death|0|||
131911861|NCT00726453|474965214|FG001|38 mm Length Group|Death|3|||
131911862|NCT00977197|474965216|FG000|Overall Study|Withdrawal by Subject|3|||
131451978|NCT01918306|473283049|FG003|Overall Study|Lack of Efficacy|0|||
131451979|NCT01918306|473283046|FG000|Overall Study|progress disease, crossover|0|||
131849625|NCT02883049|474730558|FG015|Post Induction|Lost to Follow-up|0|||
131849626|NCT02883049|474730543|FG000|Post Induction|Physician Decision|0|||
131849627|NCT02883049|474730544|FG001|Post Induction|Physician Decision|0|||
131849628|NCT02883049|474730545|FG002|Post Induction|Physician Decision|0|||
131451980|NCT01918306|473283047|FG001|Overall Study|progress disease, crossover|0|||
131451981|NCT01918306|473283048|FG002|Overall Study|progress disease, crossover|1|||
131451982|NCT01918306|473283049|FG003|Overall Study|progress disease, crossover|0|||
131849629|NCT02883049|474730546|FG003|Post Induction|Physician Decision|27|||
131911863|NCT00977197|474965217|FG001|Overall Study|Withdrawal by Subject|4|||
131911864|NCT00977197|474965216|FG000|Overall Study|Adverse Event|3|||
131451983|NCT02170077|473283051|FG000|Overall Study|Withdrawal by Subject|3|||
131911865|NCT00977197|474965217|FG001|Overall Study|Adverse Event|1|||
131911866|NCT00977197|474965216|FG000|Overall Study|Lack of Efficacy|1|||
131451984|NCT02170077|473283052|FG001|Overall Study|Withdrawal by Subject|4|||
131451985|NCT02170077|473283053|FG002|Overall Study|Withdrawal by Subject|2|||
131451986|NCT02170077|473283051|FG000|Overall Study|Adverse Event|4|||
131451987|NCT02170077|473283052|FG001|Overall Study|Adverse Event|4|||
131451988|NCT02170077|473283053|FG002|Overall Study|Adverse Event|4|||
131451989|NCT02170077|473283051|FG000|Overall Study|Lost to Follow-up|0|||
131451990|NCT02170077|473283052|FG001|Overall Study|Lost to Follow-up|1|||
131451991|NCT02170077|473283053|FG002|Overall Study|Lost to Follow-up|0|||
131451992|NCT02170077|473283051|FG000|Overall Study|Exclusion criteria|2|||
131451993|NCT02170077|473283052|FG001|Overall Study|Exclusion criteria|2|||
131451994|NCT02170077|473283053|FG002|Overall Study|Exclusion criteria|5|||
131451995|NCT02170077|473283051|FG000|Overall Study|Exacerbation of seizures|0|||
131451996|NCT02170077|473283052|FG001|Overall Study|Exacerbation of seizures|2|||
131451997|NCT02170077|473283053|FG002|Overall Study|Exacerbation of seizures|1|||
131451998|NCT01958164|473283054|FG000|Overall Study|Adverse Event|0|||
131451999|NCT01958164|473283055|FG001|Overall Study|Adverse Event|2|||
131452000|NCT01958164|473283054|FG000|Overall Study|Lost to Follow-up|2|||
131452001|NCT01958164|473283055|FG001|Overall Study|Lost to Follow-up|3|||
131452002|NCT02963506|473283058|FG000|Double-Blind Period|Adverse Event|0|||
131452003|NCT02963506|473283059|FG001|Double-Blind Period|Adverse Event|0|||
131452004|NCT02963506|473283060|FG002|Double-Blind Period|Adverse Event|1|||
131452005|NCT02963506|473283061|FG003|Double-Blind Period|Adverse Event|0|||
131452006|NCT02963506|473283062|FG004|Double-Blind Period|Adverse Event|0|||
131452007|NCT02963506|473283063|FG005|Double-Blind Period|Adverse Event|0|||
131452008|NCT02963506|473283064|FG006|Double-Blind Period|Adverse Event|0|||
131452009|NCT02963506|473283065|FG007|Double-Blind Period|Adverse Event|0|||
131452010|NCT02963506|473283066|FG008|Double-Blind Period|Adverse Event|0|||
131452011|NCT02963506|473283067|FG009|Double-Blind Period|Adverse Event|0|||
131452012|NCT02963506|473283068|FG010|Double-Blind Period|Adverse Event|0|||
131452013|NCT02963506|473283069|FG011|Double-Blind Period|Adverse Event|0|||
131452014|NCT02963506|473283070|FG012|Double-Blind Period|Adverse Event|0|||
131452015|NCT02963506|473283058|FG000|Double-Blind Period|Death|0|||
131452016|NCT02963506|473283059|FG001|Double-Blind Period|Death|0|||
131452017|NCT02963506|473283060|FG002|Double-Blind Period|Death|0|||
131452018|NCT02963506|473283061|FG003|Double-Blind Period|Death|1|||
131452019|NCT02963506|473283062|FG004|Double-Blind Period|Death|0|||
131452020|NCT02963506|473283063|FG005|Double-Blind Period|Death|0|||
131452021|NCT02963506|473283064|FG006|Double-Blind Period|Death|0|||
131452022|NCT02963506|473283065|FG007|Double-Blind Period|Death|0|||
131452023|NCT02963506|473283066|FG008|Double-Blind Period|Death|0|||
131452024|NCT02963506|473283067|FG009|Double-Blind Period|Death|0|||
131452025|NCT02963506|473283068|FG010|Double-Blind Period|Death|0|||
131452026|NCT02963506|473283069|FG011|Double-Blind Period|Death|0|||
131452027|NCT02963506|473283070|FG012|Double-Blind Period|Death|0|||
131452028|NCT02963506|473283058|FG000|Double-Blind Period|Lost to Follow-up|0|||
131452029|NCT02963506|473283059|FG001|Double-Blind Period|Lost to Follow-up|1|||
131452030|NCT02963506|473283060|FG002|Double-Blind Period|Lost to Follow-up|0|||
131452031|NCT02963506|473283061|FG003|Double-Blind Period|Lost to Follow-up|0|||
131452032|NCT02963506|473283062|FG004|Double-Blind Period|Lost to Follow-up|0|||
131452033|NCT02963506|473283063|FG005|Double-Blind Period|Lost to Follow-up|0|||
131452034|NCT02963506|473283064|FG006|Double-Blind Period|Lost to Follow-up|0|||
131452035|NCT02963506|473283065|FG007|Double-Blind Period|Lost to Follow-up|0|||
131452036|NCT02963506|473283066|FG008|Double-Blind Period|Lost to Follow-up|0|||
131452037|NCT02963506|473283067|FG009|Double-Blind Period|Lost to Follow-up|0|||
131849630|NCT02883049|474730547|FG004|Post Induction|Physician Decision|27|||
131849631|NCT02883049|474730548|FG005|Post Induction|Physician Decision|23|||
131849632|NCT02883049|474730549|FG006|Post Induction|Physician Decision|30|||
131849633|NCT02883049|474730550|FG007|Post Induction|Physician Decision|56|||
131849634|NCT02883049|474730551|FG008|Post Induction|Physician Decision|85|||
131849635|NCT02883049|474730552|FG009|Post Induction|Physician Decision|12|||
131849636|NCT02883049|474730553|FG010|Post Induction|Physician Decision|5|||
131849637|NCT02883049|474730554|FG011|Post Induction|Physician Decision|14|||
131849638|NCT02883049|474730555|FG012|Post Induction|Physician Decision|1|||
131452038|NCT02963506|473283068|FG010|Double-Blind Period|Lost to Follow-up|0|||
131452039|NCT02963506|473283069|FG011|Double-Blind Period|Lost to Follow-up|0|||
131452040|NCT02963506|473283070|FG012|Double-Blind Period|Lost to Follow-up|0|||
131452041|NCT02963506|473283058|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131452042|NCT02963506|473283059|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131452043|NCT02963506|473283060|FG002|Double-Blind Period|Withdrawal by Subject|1|||
131849639|NCT02883049|474730556|FG013|Post Induction|Physician Decision|11|||
131849640|NCT02883049|474730557|FG014|Post Induction|Physician Decision|19|||
131452044|NCT02963506|473283061|FG003|Double-Blind Period|Withdrawal by Subject|1|||
131452045|NCT02963506|473283062|FG004|Double-Blind Period|Withdrawal by Subject|0|||
131452046|NCT02963506|473283063|FG005|Double-Blind Period|Withdrawal by Subject|0|||
131452047|NCT02963506|473283064|FG006|Double-Blind Period|Withdrawal by Subject|0|||
131452048|NCT02963506|473283065|FG007|Double-Blind Period|Withdrawal by Subject|0|||
131452049|NCT02963506|473283066|FG008|Double-Blind Period|Withdrawal by Subject|0|||
131452050|NCT02963506|473283067|FG009|Double-Blind Period|Withdrawal by Subject|0|||
131452051|NCT02963506|473283068|FG010|Double-Blind Period|Withdrawal by Subject|0|||
131849641|NCT02883049|474730558|FG015|Post Induction|Physician Decision|5|||
131452052|NCT02963506|473283069|FG011|Double-Blind Period|Withdrawal by Subject|0|||
131452053|NCT02963506|473283070|FG012|Double-Blind Period|Withdrawal by Subject|0|||
131452054|NCT02963506|473283058|FG000|Double-Blind Period|No compliance|0|||
131452055|NCT02963506|473283059|FG001|Double-Blind Period|No compliance|1|||
131452056|NCT02963506|473283060|FG002|Double-Blind Period|No compliance|0|||
131452057|NCT02963506|473283061|FG003|Double-Blind Period|No compliance|0|||
131452058|NCT02963506|473283062|FG004|Double-Blind Period|No compliance|0|||
131452059|NCT02963506|473283063|FG005|Double-Blind Period|No compliance|0|||
131452060|NCT02963506|473283064|FG006|Double-Blind Period|No compliance|0|||
131452061|NCT02963506|473283065|FG007|Double-Blind Period|No compliance|0|||
131452062|NCT02963506|473283066|FG008|Double-Blind Period|No compliance|0|||
131452063|NCT02963506|473283067|FG009|Double-Blind Period|No compliance|0|||
131452064|NCT02963506|473283068|FG010|Double-Blind Period|No compliance|0|||
131452065|NCT02963506|473283069|FG011|Double-Blind Period|No compliance|0|||
131452066|NCT02963506|473283070|FG012|Double-Blind Period|No compliance|0|||
131452067|NCT02963506|473283058|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452068|NCT02963506|473283059|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
131452069|NCT02963506|473283060|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452070|NCT02963506|473283061|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452071|NCT02963506|473283062|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452072|NCT02963506|473283063|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452073|NCT02963506|473283064|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452074|NCT02963506|473283065|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452075|NCT02963506|473283066|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452076|NCT02963506|473283067|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452077|NCT02963506|473283068|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452078|NCT02963506|473283069|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452079|NCT02963506|473283070|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131452080|NCT02963506|473283058|FG000|Dose-Blind Period|Adverse Event|0|||
131452081|NCT02963506|473283059|FG001|Dose-Blind Period|Adverse Event|0|||
131452082|NCT02963506|473283060|FG002|Dose-Blind Period|Adverse Event|0|||
131452083|NCT02963506|473283061|FG003|Dose-Blind Period|Adverse Event|0|||
131452084|NCT02963506|473283062|FG004|Dose-Blind Period|Adverse Event|0|||
131452085|NCT02963506|473283063|FG005|Dose-Blind Period|Adverse Event|1|||
131452086|NCT02963506|473283064|FG006|Dose-Blind Period|Adverse Event|3|||
131452087|NCT02963506|473283065|FG007|Dose-Blind Period|Adverse Event|2|||
131452088|NCT02963506|473283066|FG008|Dose-Blind Period|Adverse Event|2|||
131452089|NCT02963506|473283067|FG009|Dose-Blind Period|Adverse Event|2|||
131452090|NCT02963506|473283068|FG010|Dose-Blind Period|Adverse Event|1|||
131452091|NCT02963506|473283069|FG011|Dose-Blind Period|Adverse Event|1|||
131452092|NCT02963506|473283070|FG012|Dose-Blind Period|Adverse Event|6|||
131452093|NCT02963506|473283058|FG000|Dose-Blind Period|Lack of Efficacy|0|||
131452094|NCT02963506|473283059|FG001|Dose-Blind Period|Lack of Efficacy|0|||
131452095|NCT02963506|473283060|FG002|Dose-Blind Period|Lack of Efficacy|0|||
131452096|NCT02963506|473283061|FG003|Dose-Blind Period|Lack of Efficacy|0|||
131452097|NCT02963506|473283062|FG004|Dose-Blind Period|Lack of Efficacy|0|||
131452098|NCT02963506|473283063|FG005|Dose-Blind Period|Lack of Efficacy|0|||
131452099|NCT02963506|473283064|FG006|Dose-Blind Period|Lack of Efficacy|0|||
131452100|NCT02963506|473283065|FG007|Dose-Blind Period|Lack of Efficacy|1|||
131452101|NCT02963506|473283066|FG008|Dose-Blind Period|Lack of Efficacy|0|||
131452102|NCT02963506|473283067|FG009|Dose-Blind Period|Lack of Efficacy|1|||
131452103|NCT02963506|473283068|FG010|Dose-Blind Period|Lack of Efficacy|0|||
131452104|NCT02963506|473283069|FG011|Dose-Blind Period|Lack of Efficacy|0|||
131452105|NCT02963506|473283070|FG012|Dose-Blind Period|Lack of Efficacy|0|||
131452106|NCT02963506|473283058|FG000|Dose-Blind Period|Lost to Follow-up|0|||
131452107|NCT02963506|473283059|FG001|Dose-Blind Period|Lost to Follow-up|0|||
131452108|NCT02963506|473283060|FG002|Dose-Blind Period|Lost to Follow-up|0|||
131452109|NCT02963506|473283061|FG003|Dose-Blind Period|Lost to Follow-up|0|||
131849642|NCT02883049|474730543|FG000|Post Induction|Protocol Violation|0|||
131849643|NCT02883049|474730544|FG001|Post Induction|Protocol Violation|0|||
131849644|NCT02883049|474730545|FG002|Post Induction|Protocol Violation|0|||
131849645|NCT02883049|474730546|FG003|Post Induction|Protocol Violation|0|||
131849646|NCT02883049|474730547|FG004|Post Induction|Protocol Violation|0|||
131849647|NCT02883049|474730548|FG005|Post Induction|Protocol Violation|0|||
131849648|NCT02883049|474730549|FG006|Post Induction|Protocol Violation|0|||
131849649|NCT02883049|474730550|FG007|Post Induction|Protocol Violation|1|||
131452110|NCT02963506|473283062|FG004|Dose-Blind Period|Lost to Follow-up|0|||
131911867|NCT00977197|474965217|FG001|Overall Study|Lack of Efficacy|0|||
131452111|NCT02963506|473283063|FG005|Dose-Blind Period|Lost to Follow-up|1|||
131452112|NCT02963506|473283064|FG006|Dose-Blind Period|Lost to Follow-up|0|||
131452113|NCT02963506|473283065|FG007|Dose-Blind Period|Lost to Follow-up|0|||
131452114|NCT02963506|473283066|FG008|Dose-Blind Period|Lost to Follow-up|1|||
131849650|NCT02883049|474730551|FG008|Post Induction|Protocol Violation|0|||
131849651|NCT02883049|474730552|FG009|Post Induction|Protocol Violation|0|||
131452115|NCT02963506|473283067|FG009|Dose-Blind Period|Lost to Follow-up|0|||
131849652|NCT02883049|474730553|FG010|Post Induction|Protocol Violation|0|||
131452116|NCT02963506|473283068|FG010|Dose-Blind Period|Lost to Follow-up|0|||
131452117|NCT02963506|473283069|FG011|Dose-Blind Period|Lost to Follow-up|1|||
131452118|NCT02963506|473283070|FG012|Dose-Blind Period|Lost to Follow-up|0|||
131452119|NCT02963506|473283058|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
131452120|NCT02963506|473283059|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
131452121|NCT02963506|473283060|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
131452122|NCT02963506|473283061|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
131452123|NCT02963506|473283062|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
131452124|NCT02963506|473283063|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
131452125|NCT02963506|473283064|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
131452126|NCT02963506|473283065|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
131452127|NCT02963506|473283066|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
131452128|NCT02963506|473283067|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
131452129|NCT02963506|473283068|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
131452130|NCT02963506|473283069|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
131452131|NCT02963506|473283070|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
131452132|NCT02963506|473283058|FG000|Dose-Blind Period|Sponsor decision|0|||
131452133|NCT02963506|473283059|FG001|Dose-Blind Period|Sponsor decision|0|||
131452134|NCT02963506|473283060|FG002|Dose-Blind Period|Sponsor decision|0|||
131452135|NCT02963506|473283061|FG003|Dose-Blind Period|Sponsor decision|0|||
131452136|NCT02963506|473283062|FG004|Dose-Blind Period|Sponsor decision|0|||
131452137|NCT02963506|473283063|FG005|Dose-Blind Period|Sponsor decision|1|||
131452138|NCT02963506|473283064|FG006|Dose-Blind Period|Sponsor decision|0|||
131452139|NCT02963506|473283065|FG007|Dose-Blind Period|Sponsor decision|0|||
131452140|NCT02963506|473283066|FG008|Dose-Blind Period|Sponsor decision|0|||
131452141|NCT02963506|473283067|FG009|Dose-Blind Period|Sponsor decision|0|||
131452142|NCT02963506|473283068|FG010|Dose-Blind Period|Sponsor decision|0|||
131849653|NCT02883049|474730554|FG011|Post Induction|Protocol Violation|0|||
131849654|NCT02883049|474730555|FG012|Post Induction|Protocol Violation|0|||
131849655|NCT02883049|474730556|FG013|Post Induction|Protocol Violation|0|||
131849656|NCT02883049|474730557|FG014|Post Induction|Protocol Violation|0|||
131849657|NCT02883049|474730558|FG015|Post Induction|Protocol Violation|0|||
131849658|NCT02883049|474730543|FG000|Post Induction|Withdrawal by Subject|0|||
131849659|NCT02883049|474730544|FG001|Post Induction|Withdrawal by Subject|0|||
131849660|NCT02883049|474730545|FG002|Post Induction|Withdrawal by Subject|0|||
131849661|NCT02883049|474730546|FG003|Post Induction|Withdrawal by Subject|5|||
131849662|NCT02883049|474730547|FG004|Post Induction|Withdrawal by Subject|2|||
131849663|NCT02883049|474730548|FG005|Post Induction|Withdrawal by Subject|1|||
131849664|NCT02883049|474730549|FG006|Post Induction|Withdrawal by Subject|0|||
131849665|NCT02883049|474730550|FG007|Post Induction|Withdrawal by Subject|0|||
131849666|NCT02883049|474730551|FG008|Post Induction|Withdrawal by Subject|2|||
131849667|NCT02883049|474730552|FG009|Post Induction|Withdrawal by Subject|0|||
131849668|NCT02883049|474730553|FG010|Post Induction|Withdrawal by Subject|1|||
131849669|NCT02883049|474730554|FG011|Post Induction|Withdrawal by Subject|1|||
131849670|NCT02883049|474730555|FG012|Post Induction|Withdrawal by Subject|0|||
131849671|NCT02883049|474730556|FG013|Post Induction|Withdrawal by Subject|0|||
131849672|NCT02883049|474730557|FG014|Post Induction|Withdrawal by Subject|1|||
131849673|NCT02883049|474730558|FG015|Post Induction|Withdrawal by Subject|0|||
131849674|NCT02883049|474730543|FG000|Post Induction|Ineligible|0|||
131849675|NCT02883049|474730544|FG001|Post Induction|Ineligible|0|||
131849676|NCT02883049|474730545|FG002|Post Induction|Ineligible|2|||
131849677|NCT02883049|474730546|FG003|Post Induction|Ineligible|0|||
131849678|NCT02883049|474730547|FG004|Post Induction|Ineligible|0|||
131849679|NCT02883049|474730548|FG005|Post Induction|Ineligible|0|||
131849680|NCT02883049|474730549|FG006|Post Induction|Ineligible|1|||
131849681|NCT02883049|474730550|FG007|Post Induction|Ineligible|0|||
131849682|NCT02883049|474730551|FG008|Post Induction|Ineligible|0|||
131849683|NCT02883049|474730552|FG009|Post Induction|Ineligible|0|||
131849684|NCT02883049|474730553|FG010|Post Induction|Ineligible|1|||
131849685|NCT02883049|474730554|FG011|Post Induction|Ineligible|0|||
131849686|NCT02883049|474730555|FG012|Post Induction|Ineligible|0|||
131849687|NCT02883049|474730556|FG013|Post Induction|Ineligible|0|||
131849688|NCT02883049|474730557|FG014|Post Induction|Ineligible|0|||
131849689|NCT02883049|474730558|FG015|Post Induction|Ineligible|1|||
131849690|NCT02883049|474730543|FG000|Post Induction|Refusal of further protocol therapy|0|||
131452143|NCT02963506|473283069|FG011|Dose-Blind Period|Sponsor decision|0|||
131452144|NCT02963506|473283070|FG012|Dose-Blind Period|Sponsor decision|0|||
131452145|NCT02963506|473283058|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131849691|NCT02883049|474730544|FG001|Post Induction|Refusal of further protocol therapy|0|||
131849692|NCT02883049|474730545|FG002|Post Induction|Refusal of further protocol therapy|0|||
131849693|NCT02883049|474730546|FG003|Post Induction|Refusal of further protocol therapy|11|||
131849694|NCT02883049|474730547|FG004|Post Induction|Refusal of further protocol therapy|15|||
131849695|NCT02883049|474730548|FG005|Post Induction|Refusal of further protocol therapy|9|||
131849696|NCT02883049|474730549|FG006|Post Induction|Refusal of further protocol therapy|13|||
131849697|NCT02883049|474730550|FG007|Post Induction|Refusal of further protocol therapy|5|||
131849698|NCT02883049|474730551|FG008|Post Induction|Refusal of further protocol therapy|21|||
131911868|NCT00977197|474965216|FG000|Overall Study|Lost to Follow-up|1|||
131849699|NCT02883049|474730552|FG009|Post Induction|Refusal of further protocol therapy|7|||
131849700|NCT02883049|474730553|FG010|Post Induction|Refusal of further protocol therapy|0|||
131849701|NCT02883049|474730554|FG011|Post Induction|Refusal of further protocol therapy|7|||
131849702|NCT02883049|474730555|FG012|Post Induction|Refusal of further protocol therapy|3|||
131849703|NCT02883049|474730556|FG013|Post Induction|Refusal of further protocol therapy|0|||
131849704|NCT02883049|474730557|FG014|Post Induction|Refusal of further protocol therapy|4|||
131849705|NCT02883049|474730558|FG015|Post Induction|Refusal of further protocol therapy|1|||
131849706|NCT02883049|474730543|FG000|Post Induction|Inevaluable|0|||
131849707|NCT02883049|474730544|FG001|Post Induction|Inevaluable|0|||
131849708|NCT02883049|474730545|FG002|Post Induction|Inevaluable|0|||
131849709|NCT02883049|474730546|FG003|Post Induction|Inevaluable|1|||
131849710|NCT02883049|474730547|FG004|Post Induction|Inevaluable|1|||
131849711|NCT02883049|474730548|FG005|Post Induction|Inevaluable|2|||
131849712|NCT02883049|474730549|FG006|Post Induction|Inevaluable|7|||
131849713|NCT02883049|474730550|FG007|Post Induction|Inevaluable|6|||
131849714|NCT02883049|474730551|FG008|Post Induction|Inevaluable|4|||
131849715|NCT02883049|474730552|FG009|Post Induction|Inevaluable|4|||
131849716|NCT02883049|474730553|FG010|Post Induction|Inevaluable|1|||
131849717|NCT02883049|474730554|FG011|Post Induction|Inevaluable|1|||
131849718|NCT02883049|474730555|FG012|Post Induction|Inevaluable|2|||
131849719|NCT02883049|474730556|FG013|Post Induction|Inevaluable|0|||
131849720|NCT02883049|474730557|FG014|Post Induction|Inevaluable|0|||
131849721|NCT02883049|474730558|FG015|Post Induction|Inevaluable|1|||
131849722|NCT02883049|474730543|FG000|Post Induction|Moved to another non-COG institution|0|||
131849723|NCT02883049|474730544|FG001|Post Induction|Moved to another non-COG institution|0|||
131849724|NCT02883049|474730545|FG002|Post Induction|Moved to another non-COG institution|0|||
131849725|NCT02883049|474730546|FG003|Post Induction|Moved to another non-COG institution|0|||
131849726|NCT02883049|474730547|FG004|Post Induction|Moved to another non-COG institution|0|||
131849727|NCT02883049|474730548|FG005|Post Induction|Moved to another non-COG institution|0|||
131849728|NCT02883049|474730549|FG006|Post Induction|Moved to another non-COG institution|0|||
131849729|NCT02883049|474730550|FG007|Post Induction|Moved to another non-COG institution|2|||
131849730|NCT02883049|474730551|FG008|Post Induction|Moved to another non-COG institution|2|||
131849731|NCT02883049|474730552|FG009|Post Induction|Moved to another non-COG institution|0|||
131849732|NCT02883049|474730553|FG010|Post Induction|Moved to another non-COG institution|0|||
131849733|NCT02883049|474730554|FG011|Post Induction|Moved to another non-COG institution|1|||
131849734|NCT02883049|474730555|FG012|Post Induction|Moved to another non-COG institution|0|||
131849735|NCT02883049|474730556|FG013|Post Induction|Moved to another non-COG institution|0|||
131849736|NCT02883049|474730557|FG014|Post Induction|Moved to another non-COG institution|0|||
131849737|NCT02883049|474730558|FG015|Post Induction|Moved to another non-COG institution|0|||
131849738|NCT02883049|474730543|FG000|Post Induction|Randomization closed|0|||
131849739|NCT02883049|474730544|FG001|Post Induction|Randomization closed|0|||
131849740|NCT02883049|474730545|FG002|Post Induction|Randomization closed|0|||
131849741|NCT02883049|474730546|FG003|Post Induction|Randomization closed|0|||
131849742|NCT02883049|474730547|FG004|Post Induction|Randomization closed|0|||
131849743|NCT02883049|474730548|FG005|Post Induction|Randomization closed|0|||
131849744|NCT02883049|474730549|FG006|Post Induction|Randomization closed|0|||
131849745|NCT02883049|474730550|FG007|Post Induction|Randomization closed|20|||
131849746|NCT02883049|474730551|FG008|Post Induction|Randomization closed|0|||
131849747|NCT02883049|474730552|FG009|Post Induction|Randomization closed|0|||
131849748|NCT02883049|474730553|FG010|Post Induction|Randomization closed|0|||
131849749|NCT02883049|474730554|FG011|Post Induction|Randomization closed|0|||
131849750|NCT02883049|474730555|FG012|Post Induction|Randomization closed|0|||
131849751|NCT02883049|474730556|FG013|Post Induction|Randomization closed|0|||
131849752|NCT02883049|474730557|FG014|Post Induction|Randomization closed|0|||
131849753|NCT02883049|474730558|FG015|Post Induction|Randomization closed|0|||
131849754|NCT02883049|474730543|FG000|Post Induction|MRD negative|0|||
131849755|NCT02883049|474730544|FG001|Post Induction|MRD negative|0|||
131849756|NCT02883049|474730545|FG002|Post Induction|MRD negative|0|||
131849757|NCT02883049|474730546|FG003|Post Induction|MRD negative|0|||
131849758|NCT02883049|474730547|FG004|Post Induction|MRD negative|0|||
131849759|NCT02883049|474730548|FG005|Post Induction|MRD negative|0|||
131849760|NCT02883049|474730549|FG006|Post Induction|MRD negative|0|||
131849761|NCT02883049|474730550|FG007|Post Induction|MRD negative|11|||
131849762|NCT02883049|474730551|FG008|Post Induction|MRD negative|0|||
131849763|NCT02883049|474730552|FG009|Post Induction|MRD negative|0|||
131849764|NCT02883049|474730553|FG010|Post Induction|MRD negative|0|||
131452146|NCT02963506|473283059|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131849765|NCT02883049|474730554|FG011|Post Induction|MRD negative|0|||
131849766|NCT02883049|474730555|FG012|Post Induction|MRD negative|0|||
131849767|NCT02883049|474730556|FG013|Post Induction|MRD negative|0|||
131849768|NCT02883049|474730557|FG014|Post Induction|MRD negative|0|||
131849769|NCT02883049|474730558|FG015|Post Induction|MRD negative|0|||
131849770|NCT02883049|474730543|FG000|Post Induction|Developed SMN|0|||
131849771|NCT02883049|474730544|FG001|Post Induction|Developed SMN|0|||
131849772|NCT02883049|474730545|FG002|Post Induction|Developed SMN|0|||
131849773|NCT02883049|474730546|FG003|Post Induction|Developed SMN|0|||
131849774|NCT02883049|474730547|FG004|Post Induction|Developed SMN|1|||
131849775|NCT02883049|474730548|FG005|Post Induction|Developed SMN|0|||
131849776|NCT02883049|474730549|FG006|Post Induction|Developed SMN|1|||
131849777|NCT02883049|474730550|FG007|Post Induction|Developed SMN|0|||
131849778|NCT02883049|474730551|FG008|Post Induction|Developed SMN|0|||
131849779|NCT02883049|474730552|FG009|Post Induction|Developed SMN|0|||
131849780|NCT02883049|474730553|FG010|Post Induction|Developed SMN|1|||
131849781|NCT02883049|474730554|FG011|Post Induction|Developed SMN|1|||
131849782|NCT02883049|474730555|FG012|Post Induction|Developed SMN|0|||
131849783|NCT02883049|474730556|FG013|Post Induction|Developed SMN|0|||
131849784|NCT02883049|474730557|FG014|Post Induction|Developed SMN|1|||
131849785|NCT02883049|474730558|FG015|Post Induction|Developed SMN|0|||
131849786|NCT02883049|474730543|FG000|Post Induction|Enrolled onto another COG study|0|||
131849787|NCT02883049|474730544|FG001|Post Induction|Enrolled onto another COG study|0|||
131849788|NCT02883049|474730545|FG002|Post Induction|Enrolled onto another COG study|0|||
131849789|NCT02883049|474730546|FG003|Post Induction|Enrolled onto another COG study|1|||
131849790|NCT02883049|474730547|FG004|Post Induction|Enrolled onto another COG study|1|||
131849791|NCT02883049|474730548|FG005|Post Induction|Enrolled onto another COG study|0|||
131849792|NCT02883049|474730549|FG006|Post Induction|Enrolled onto another COG study|0|||
131849793|NCT02883049|474730550|FG007|Post Induction|Enrolled onto another COG study|4|||
131849794|NCT02883049|474730551|FG008|Post Induction|Enrolled onto another COG study|0|||
131849795|NCT02883049|474730552|FG009|Post Induction|Enrolled onto another COG study|0|||
131849796|NCT02883049|474730553|FG010|Post Induction|Enrolled onto another COG study|0|||
131849797|NCT02883049|474730554|FG011|Post Induction|Enrolled onto another COG study|2|||
131849798|NCT02883049|474730555|FG012|Post Induction|Enrolled onto another COG study|0|||
131849799|NCT02883049|474730556|FG013|Post Induction|Enrolled onto another COG study|1|||
131849800|NCT02883049|474730557|FG014|Post Induction|Enrolled onto another COG study|0|||
131849801|NCT02883049|474730558|FG015|Post Induction|Enrolled onto another COG study|0|||
131849802|NCT02883049|474730543|FG000|Post Induction|Recurrent leukemia|0|||
131849803|NCT02883049|474730544|FG001|Post Induction|Recurrent leukemia|0|||
131849804|NCT02883049|474730545|FG002|Post Induction|Recurrent leukemia|0|||
131849805|NCT02883049|474730546|FG003|Post Induction|Recurrent leukemia|17|||
131849806|NCT02883049|474730547|FG004|Post Induction|Recurrent leukemia|12|||
131849807|NCT02883049|474730548|FG005|Post Induction|Recurrent leukemia|4|||
131849808|NCT02883049|474730549|FG006|Post Induction|Recurrent leukemia|1|||
131849809|NCT02883049|474730550|FG007|Post Induction|Recurrent leukemia|13|||
131849810|NCT02883049|474730551|FG008|Post Induction|Recurrent leukemia|27|||
131849811|NCT02883049|474730552|FG009|Post Induction|Recurrent leukemia|5|||
131849812|NCT02883049|474730553|FG010|Post Induction|Recurrent leukemia|3|||
131849813|NCT02883049|474730554|FG011|Post Induction|Recurrent leukemia|12|||
131849814|NCT02883049|474730555|FG012|Post Induction|Recurrent leukemia|1|||
131849815|NCT02883049|474730556|FG013|Post Induction|Recurrent leukemia|1|||
131849816|NCT02883049|474730557|FG014|Post Induction|Recurrent leukemia|9|||
131849817|NCT02883049|474730558|FG015|Post Induction|Recurrent leukemia|3|||
131849818|NCT02883049|474730543|FG000|Post Induction|Induction Failure|0|||
131849819|NCT02883049|474730544|FG001|Post Induction|Induction Failure|0|||
131849820|NCT02883049|474730545|FG002|Post Induction|Induction Failure|0|||
131849821|NCT02883049|474730546|FG003|Post Induction|Induction Failure|0|||
131849822|NCT02883049|474730547|FG004|Post Induction|Induction Failure|0|||
131849823|NCT02883049|474730548|FG005|Post Induction|Induction Failure|0|||
131849824|NCT02883049|474730549|FG006|Post Induction|Induction Failure|0|||
131849825|NCT02883049|474730550|FG007|Post Induction|Induction Failure|2|||
131849826|NCT02883049|474730551|FG008|Post Induction|Induction Failure|2|||
131849827|NCT02883049|474730552|FG009|Post Induction|Induction Failure|0|||
131849828|NCT02883049|474730553|FG010|Post Induction|Induction Failure|0|||
131849829|NCT02883049|474730554|FG011|Post Induction|Induction Failure|0|||
131849830|NCT02883049|474730555|FG012|Post Induction|Induction Failure|0|||
131849831|NCT02883049|474730556|FG013|Post Induction|Induction Failure|2|||
131849832|NCT02883049|474730557|FG014|Post Induction|Induction Failure|0|||
131849833|NCT02883049|474730558|FG015|Post Induction|Induction Failure|0|||
131849834|NCT01392963|474730561|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
131849835|NCT01392963|474730562|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
131849836|NCT01392963|474730561|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
131849837|NCT01392963|474730562|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
131849838|NCT01392963|474730561|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
131849839|NCT01392963|474730562|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
131849840|NCT00369486|474730563|FG000|4-Week Visit|Missed visit|2|||
131849841|NCT00369486|474730564|FG001|4-Week Visit|Missed visit|2|||
131849842|NCT00369486|474730565|FG002|4-Week Visit|Missed visit|0|||
131849843|NCT00369486|474730566|FG003|4-Week Visit|Missed visit|2|||
131849844|NCT00369486|474730567|FG004|4-Week Visit|Missed visit|1|||
131849845|NCT00369486|474730563|FG000|4-Week Visit|Dropped|0|||
131849846|NCT00369486|474730564|FG001|4-Week Visit|Dropped|0|||
131849847|NCT00369486|474730565|FG002|4-Week Visit|Dropped|1|||
131849848|NCT00369486|474730566|FG003|4-Week Visit|Dropped|0|||
131849849|NCT00369486|474730567|FG004|4-Week Visit|Dropped|0|||
131849850|NCT00369486|474730563|FG000|8-Week Visit|Missed visit|0|||
131452147|NCT02963506|473283060|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452148|NCT02963506|473283061|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452149|NCT02963506|473283062|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452150|NCT02963506|473283063|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452151|NCT02963506|473283064|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452152|NCT02963506|473283065|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452153|NCT02963506|473283066|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452154|NCT02963506|473283067|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452155|NCT02963506|473283068|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452156|NCT02963506|473283069|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
131452157|NCT02963506|473283070|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
131452158|NCT01780974|473283071|FG000|Overall Study|Death|1|||
131452159|NCT01780974|473283072|FG001|Overall Study|Death|0|||
131452160|NCT01780974|473283071|FG000|Overall Study|Adverse Event|1|||
131452161|NCT01780974|473283072|FG001|Overall Study|Adverse Event|3|||
131452162|NCT01724346|473283073|FG000|Overall Study|Death|42|||
131452163|NCT01724346|473283074|FG001|Overall Study|Death|42|||
131452164|NCT01724346|473283073|FG000|Overall Study|Lost to Follow-up|5|||
131452165|NCT01724346|473283074|FG001|Overall Study|Lost to Follow-up|1|||
131452166|NCT01724346|473283073|FG000|Overall Study|Withdrawal by Subject|27|||
131452167|NCT01724346|473283074|FG001|Overall Study|Withdrawal by Subject|19|||
131452168|NCT01724346|473283073|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
131452169|NCT01724346|473283074|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
131452170|NCT00828204|473283077|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
131452171|NCT00828204|473283078|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
131452172|NCT00828204|473283077|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
131452173|NCT00828204|473283078|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
131452174|NCT00828204|473283077|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
131452175|NCT00828204|473283078|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
131452176|NCT00828204|473283077|FG000|Main Study: After Study Restart|Adverse Event|0|||
131452177|NCT00828204|473283078|FG001|Main Study: After Study Restart|Adverse Event|2|||
131452178|NCT00828204|473283077|FG000|Main Study: After Study Restart|Noncompliance|0|||
131452179|NCT00828204|473283078|FG001|Main Study: After Study Restart|Noncompliance|1|||
131452180|NCT00828204|473283077|FG000|Extension Study|Lost to Follow-up|0|||
131452181|NCT00828204|473283078|FG001|Extension Study|Lost to Follow-up|1|||
131452182|NCT00828204|473283077|FG000|Extension Study|Physician Decision|0|||
131911869|NCT00977197|474965217|FG001|Overall Study|Lost to Follow-up|3|||
131911870|NCT00977197|474965216|FG000|Overall Study|Nonadherence|1|||
131911871|NCT00977197|474965217|FG001|Overall Study|Nonadherence|1|||
131911872|NCT00915525|474965220|FG000|Overall Study|Protocol Violation|9|||
131911873|NCT00915525|474965221|FG001|Overall Study|Protocol Violation|4|||
131911874|NCT00915525|474965220|FG000|Overall Study|Withdrawal by Subject|59|||
131911875|NCT00915525|474965221|FG001|Overall Study|Withdrawal by Subject|21|||
131911876|NCT00915525|474965220|FG000|Overall Study|Lost to Follow-up|27|||
131911877|NCT00915525|474965221|FG001|Overall Study|Lost to Follow-up|16|||
131911878|NCT00915525|474965220|FG000|Overall Study|Pregnancy|2|||
131911879|NCT00915525|474965221|FG001|Overall Study|Pregnancy|0|||
131911880|NCT00915525|474965220|FG000|Overall Study|Lack of Efficacy|15|||
131452183|NCT00828204|473283078|FG001|Extension Study|Physician Decision|2|||
131452184|NCT00750438|473283081|FG000|Overall Study|Protocol Violation|4|||
131452185|NCT00750438|473283082|FG001|Overall Study|Protocol Violation|1|||
131452186|NCT00750438|473283081|FG000|Overall Study|Physician Decision|2|||
131849851|NCT00369486|474730564|FG001|8-Week Visit|Missed visit|1|||
131849852|NCT00369486|474730565|FG002|8-Week Visit|Missed visit|0|||
131849853|NCT00369486|474730566|FG003|8-Week Visit|Missed visit|0|||
131849854|NCT00369486|474730567|FG004|8-Week Visit|Missed visit|1|||
131849855|NCT00369486|474730563|FG000|8-Week Visit|Dropped|0|||
131849856|NCT00369486|474730564|FG001|8-Week Visit|Dropped|0|||
131849857|NCT00369486|474730565|FG002|8-Week Visit|Dropped|0|||
131849858|NCT00369486|474730566|FG003|8-Week Visit|Dropped|1|||
131849859|NCT00369486|474730567|FG004|8-Week Visit|Dropped|0|||
131849860|NCT00369486|474730563|FG000|17-Week Visit|Missed visit|0|||
131849861|NCT00369486|474730564|FG001|17-Week Visit|Missed visit|0|||
131849862|NCT00369486|474730565|FG002|17-Week Visit|Missed visit|1|||
131849863|NCT00369486|474730566|FG003|17-Week Visit|Missed visit|1|||
131911881|NCT00915525|474965221|FG001|Overall Study|Lack of Efficacy|32|||
131452187|NCT00750438|473283082|FG001|Overall Study|Physician Decision|2|||
131452188|NCT00750438|473283081|FG000|Overall Study|Withdrawal by Subject|1|||
131452189|NCT00750438|473283082|FG001|Overall Study|Withdrawal by Subject|1|||
131452190|NCT00928408|473283087|FG000|Overall Study|Other|2|||
131452191|NCT00928408|473283087|FG000|Overall Study|Withdrawal by Subject|4|||
131452192|NCT00928408|473283087|FG000|Overall Study|Death|5|||
131849864|NCT00369486|474730567|FG004|17-Week Visit|Missed visit|1|||
131849865|NCT00369486|474730563|FG000|34-Week Visit|Dropped|0|||
131849866|NCT00369486|474730564|FG001|34-Week Visit|Dropped|1|||
131849867|NCT00369486|474730565|FG002|34-Week Visit|Dropped|1|||
131911882|NCT00915525|474965220|FG000|Overall Study|Adverse Event|29|||
131911883|NCT00915525|474965221|FG001|Overall Study|Adverse Event|13|||
131849868|NCT00369486|474730566|FG003|34-Week Visit|Dropped|3|||
131849869|NCT00369486|474730567|FG004|34-Week Visit|Dropped|3|||
131849870|NCT04778904|474730568|FG000|Overall Study|Protocol Violation|1|||
131849871|NCT04778904|474730569|FG001|Overall Study|Protocol Violation|0|||
131849872|NCT04778904|474730570|FG002|Overall Study|Protocol Violation|0|||
131849873|NCT04778904|474730571|FG003|Overall Study|Protocol Violation|0|||
131849874|NCT04778904|474730568|FG000|Overall Study|Withdrawal by Subject|0|||
131849875|NCT04778904|474730569|FG001|Overall Study|Withdrawal by Subject|0|||
131849876|NCT04778904|474730570|FG002|Overall Study|Withdrawal by Subject|1|||
131849877|NCT04778904|474730571|FG003|Overall Study|Withdrawal by Subject|0|||
131849878|NCT05048329|474730578|FG000|Overall Study|Withdrawal by Subject|1|||
131849879|NCT05048329|474730578|FG000|Overall Study|Screenfail|1|||
131849880|NCT02856802|474730579|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
131849881|NCT02856802|474730580|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
131849882|NCT02856802|474730579|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
131849883|NCT02856802|474730580|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
131849884|NCT02856802|474730579|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
131849885|NCT02856802|474730580|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
131849886|NCT02856802|474730579|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
131849887|NCT02856802|474730580|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
131849888|NCT02856802|474730579|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
131849889|NCT02856802|474730580|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
131849890|NCT02856802|474730579|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
131849891|NCT02856802|474730580|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
131849892|NCT04138043|474730581|FG000|Overall Study|Withdrawal by Subject|0|||
131849893|NCT04138043|474730582|FG001|Overall Study|Withdrawal by Subject|1|||
131849894|NCT03772717|474730583|FG000|Overall Study|Withdrawal by Subject|2|||
131849895|NCT04981717|474730591|FG000|Overall Study|Protocol Violation|0|||
131849896|NCT04981717|474730592|FG001|Overall Study|Protocol Violation|3|||
131849897|NCT04981717|474730591|FG000|Overall Study|Adverse Event|1|||
131849898|NCT04981717|474730592|FG001|Overall Study|Adverse Event|3|||
131849899|NCT04981717|474730591|FG000|Overall Study|Pregnancy|1|||
131849900|NCT04981717|474730592|FG001|Overall Study|Pregnancy|0|||
131849901|NCT04981717|474730591|FG000|Overall Study|Physician Decision|1|||
131849902|NCT04981717|474730592|FG001|Overall Study|Physician Decision|0|||
131849903|NCT04981717|474730591|FG000|Overall Study|Sponsor Request|157|||
131849904|NCT04981717|474730592|FG001|Overall Study|Sponsor Request|172|||
131849905|NCT04981717|474730591|FG000|Overall Study|Lost to Follow-up|4|||
131849906|NCT04981717|474730592|FG001|Overall Study|Lost to Follow-up|5|||
131849907|NCT04981717|474730591|FG000|Overall Study|Withdrawal by Subject|50|||
131849908|NCT04981717|474730592|FG001|Overall Study|Withdrawal by Subject|37|||
131849909|NCT00887289|474730594|FG000|Overall Study|Lack of Efficacy|14|||
131849910|NCT00887289|474730594|FG000|Overall Study|Adverse Event|27|||
131849911|NCT00887289|474730594|FG000|Overall Study|Withdrawal by Subject|26|||
131849912|NCT00887289|474730594|FG000|Overall Study|Lost to Follow-up|8|||
131849913|NCT00887289|474730594|FG000|Overall Study|Other|20|||
131849914|NCT00459355|474730595|FG000|Overall Study|Subject no longer met inc criteria|20|||
131849915|NCT00459355|474730596|FG001|Overall Study|Subject no longer met inc criteria|18|||
131849916|NCT00287586|474730597|FG000|Overall Study|Withdrew Consent|19|||
131849917|NCT00287586|474730598|FG001|Overall Study|Withdrew Consent|30|||
131849918|NCT00287586|474730597|FG000|Overall Study|Lost to Follow-up|5|||
131849919|NCT00287586|474730598|FG001|Overall Study|Lost to Follow-up|4|||
131849920|NCT00287586|474730597|FG000|Overall Study|Death|2|||
131849921|NCT00287586|474730598|FG001|Overall Study|Death|3|||
131849922|NCT00287586|474730597|FG000|Overall Study|Elevated Hematocrit|3|||
131849923|NCT00287586|474730598|FG001|Overall Study|Elevated Hematocrit|0|||
131849924|NCT00287586|474730597|FG000|Overall Study|Rash|3|||
131849925|NCT00287586|474730598|FG001|Overall Study|Rash|0|||
131849926|NCT00287586|474730597|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
131849927|NCT00287586|474730598|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
131849928|NCT00287586|474730597|FG000|Overall Study|Stroke|2|||
131849929|NCT00287586|474730598|FG001|Overall Study|Stroke|0|||
131849930|NCT00287586|474730597|FG000|Overall Study|Myocardial Infarction|1|||
131849931|NCT00287586|474730598|FG001|Overall Study|Myocardial Infarction|0|||
131452193|NCT00928408|473283087|FG000|Overall Study|Lost to Follow-up|12|||
131849932|NCT00287586|474730597|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
131849933|NCT00287586|474730598|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
131849934|NCT00287586|474730597|FG000|Overall Study|Cognitive Impairment|1|||
131849935|NCT00287586|474730598|FG001|Overall Study|Cognitive Impairment|0|||
131849936|NCT00287586|474730597|FG000|Overall Study|Pancreatic Cancer|1|||
131849937|NCT00287586|474730598|FG001|Overall Study|Pancreatic Cancer|3|||
131849938|NCT00287586|474730597|FG000|Overall Study|Sleep Apnea|1|||
131849939|NCT00287586|474730598|FG001|Overall Study|Sleep Apnea|0|||
131849940|NCT00287586|474730597|FG000|Overall Study|Shoulder Pain|1|||
131849941|NCT00287586|474730598|FG001|Overall Study|Shoulder Pain|0|||
131849942|NCT00287586|474730597|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
131849943|NCT00287586|474730598|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
131849944|NCT00287586|474730597|FG000|Overall Study|Nonadherence|1|||
131849945|NCT00287586|474730598|FG001|Overall Study|Nonadherence|1|||
131849946|NCT00287586|474730597|FG000|Overall Study|Enrolled in Another Study|1|||
131849947|NCT00287586|474730598|FG001|Overall Study|Enrolled in Another Study|0|||
131849948|NCT00287586|474730597|FG000|Overall Study|Major Depression|0|||
131849949|NCT00287586|474730598|FG001|Overall Study|Major Depression|2|||
131849950|NCT00287586|474730597|FG000|Overall Study|Lung Cancer|0|||
131849951|NCT00287586|474730598|FG001|Overall Study|Lung Cancer|2|||
131849952|NCT00287586|474730597|FG000|Overall Study|Elevated IPSS Score|0|||
131849953|NCT00287586|474730598|FG001|Overall Study|Elevated IPSS Score|1|||
131849954|NCT00287586|474730597|FG000|Overall Study|Retroperitoneal Cancer|0|||
131849955|NCT00287586|474730598|FG001|Overall Study|Retroperitoneal Cancer|1|||
131849956|NCT00287586|474730597|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
131849957|NCT00287586|474730598|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
131849958|NCT00287586|474730597|FG000|Overall Study|Mood Swings and Irritability|0|||
131849959|NCT00287586|474730598|FG001|Overall Study|Mood Swings and Irritability|1|||
131849960|NCT00287586|474730597|FG000|Overall Study|Bradycardia|0|||
131849961|NCT00287586|474730598|FG001|Overall Study|Bradycardia|1|||
131849962|NCT00287586|474730597|FG000|Overall Study|Itchy Swollen Eyes|0|||
131849963|NCT00287586|474730598|FG001|Overall Study|Itchy Swollen Eyes|1|||
131849964|NCT00287586|474730597|FG000|Overall Study|Recurrent Melanoma|0|||
131849965|NCT00287586|474730598|FG001|Overall Study|Recurrent Melanoma|1|||
131849966|NCT02242045|474730600|FG000|Overall Study|Investigator's Discretion|1|||
131849967|NCT02242045|474730600|FG000|Overall Study|Progressive Disease|2|||
131849968|NCT02242045|474730600|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
131849969|NCT02242045|474730600|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
131849970|NCT02473523|474730601|FG000|Overall Study|Death|1|||
131849971|NCT02473523|474730601|FG000|Overall Study|Lost to Follow-up|1|||
131849972|NCT01266031|474730610|FG000|Overall Study|Not treated|0|||
131849973|NCT01266031|474730611|FG001|Overall Study|Not treated|3|||
131849974|NCT01266031|474730612|FG002|Overall Study|Not treated|2|||
131849975|NCT01434810|474730613|FG000|Overall Study|Did not receive treatment|11|||
131849976|NCT01434810|474730614|FG001|Overall Study|Did not receive treatment|3|||
131849977|NCT01434810|474730613|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
131849978|NCT01434810|474730614|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
131849979|NCT04893018|474730616|FG000|Overall Study|Lost to Follow-up|1|||
131849980|NCT04893018|474730617|FG001|Overall Study|Lost to Follow-up|0|||
131849981|NCT04893018|474730616|FG000|Overall Study|Withdrawal by Subject|2|||
131849982|NCT04893018|474730617|FG001|Overall Study|Withdrawal by Subject|0|||
131849983|NCT04893018|474730616|FG000|Overall Study|Study Terminated|1|||
131849984|NCT04893018|474730617|FG001|Overall Study|Study Terminated|2|||
131849985|NCT00447876|474730619|FG000|Overall Study|Withdrawal by Subject|1|||
131849986|NCT00447876|474730620|FG001|Overall Study|Withdrawal by Subject|4|||
131849987|NCT00447876|474730619|FG000|Overall Study|Lost to Follow-up|1|||
131849988|NCT00447876|474730620|FG001|Overall Study|Lost to Follow-up|0|||
131849989|NCT00447876|474730619|FG000|Overall Study|Deterioration of symptomology|1|||
131849990|NCT00447876|474730620|FG001|Overall Study|Deterioration of symptomology|0|||
131849991|NCT02439970|474730624|FG000|Overall Study|Study Terminated|2|||
131849992|NCT02439970|474730625|FG001|Overall Study|Study Terminated|3|||
131849993|NCT02952586|474730626|FG000|Lead-In Phase (7 Days)|Death|0|||
131849994|NCT02952586|474730627|FG001|Lead-In Phase (7 Days)|Death|1|||
131849995|NCT02952586|474730626|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
131849996|NCT02952586|474730627|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
131849997|NCT02952586|474730626|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
131849998|NCT02952586|474730627|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
131849999|NCT02952586|474730626|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
131850000|NCT02952586|474730627|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
131850001|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
131850002|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
131850003|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
131850004|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
131850005|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
131850006|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
131850007|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
131850008|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
131850009|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
131850010|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
131850011|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
131850012|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
131850013|NCT02952586|474730626|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
131850014|NCT02952586|474730627|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
131850015|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Death|3|||
131850016|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Death|8|||
131850017|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
131911884|NCT00915525|474965220|FG000|Overall Study|Missing|12|||
131911885|NCT00915525|474965221|FG001|Overall Study|Missing|1|||
131911886|NCT00915525|474965220|FG000|Overall Study|Other Reason|35|||
131911887|NCT00915525|474965221|FG001|Overall Study|Other Reason|12|||
131911888|NCT00915525|474965220|FG000|Overall Study|Site Closed|27|||
131911889|NCT00915525|474965221|FG001|Overall Study|Site Closed|9|||
131911890|NCT00915525|474965220|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
131911891|NCT00915525|474965221|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
131911892|NCT00915525|474965220|FG000|Overall Study|Study Burden|28|||
131911893|NCT00915525|474965221|FG001|Overall Study|Study Burden|12|||
131911894|NCT00915525|474965220|FG000|Overall Study|Non-Compliance|3|||
131911895|NCT00915525|474965221|FG001|Overall Study|Non-Compliance|1|||
131911896|NCT00915525|474965220|FG000|Overall Study|Patient Moved|15|||
131911897|NCT00915525|474965221|FG001|Overall Study|Patient Moved|9|||
131911898|NCT02842866|474965222|FG000|Overall Study|Serious Adverse Event|0|||
131911899|NCT02842866|474965223|FG001|Overall Study|Serious Adverse Event|1|||
131911900|NCT02842866|474965222|FG000|Overall Study|Protocol Violation|4|||
131911901|NCT02842866|474965223|FG001|Overall Study|Protocol Violation|2|||
131911902|NCT02842866|474965222|FG000|Overall Study|Lost to Follow-up|2|||
131911903|NCT02842866|474965223|FG001|Overall Study|Lost to Follow-up|0|||
131911904|NCT02842866|474965222|FG000|Overall Study|Withdrawal by Subject|1|||
131911905|NCT02842866|474965223|FG001|Overall Study|Withdrawal by Subject|0|||
131911906|NCT00941928|474965224|FG000|Overall Study|Withdrawal by Subject|1|||
131911907|NCT00941928|474965224|FG000|Overall Study|Disease Progression|1|||
131911908|NCT00577408|474965225|FG000|Overall Study|Stopped attending study visits|9|||
131911909|NCT00577408|474965226|FG001|Overall Study|Stopped attending study visits|11|||
131911910|NCT00577408|474965225|FG000|Overall Study|Continued opioid use|3|||
131911911|NCT00577408|474965226|FG001|Overall Study|Continued opioid use|2|||
131911912|NCT00577408|474965225|FG000|Overall Study|Non-compliance with study meds|0|||
131911913|NCT00577408|474965226|FG001|Overall Study|Non-compliance with study meds|3|||
131911914|NCT00577408|474965225|FG000|Overall Study|Refused Oral Naltrexone|0|||
131911915|NCT00577408|474965226|FG001|Overall Study|Refused Oral Naltrexone|1|||
131911916|NCT00577408|474965225|FG000|Overall Study|Moved out of state|0|||
131911917|NCT00577408|474965226|FG001|Overall Study|Moved out of state|1|||
131911918|NCT00577408|474965225|FG000|Overall Study|Scheduling Issues|0|||
131911919|NCT00577408|474965226|FG001|Overall Study|Scheduling Issues|3|||
131911920|NCT00577408|474965225|FG000|Overall Study|Death|0|||
131911921|NCT00577408|474965226|FG001|Overall Study|Death|1|||
131911922|NCT00577408|474965225|FG000|Overall Study|Psychiatric hospitalization|0|||
131911923|NCT00577408|474965226|FG001|Overall Study|Psychiatric hospitalization|1|||
131850018|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
131850019|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
131850020|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
131850021|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
131850022|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
131850023|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
131850024|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
131850025|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
131850026|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
131850027|NCT02952586|474730626|FG000|CRT for Cisplatin (63 Days)|Other|1|||
131850028|NCT02952586|474730627|FG001|CRT for Cisplatin (63 Days)|Other|1|||
131850029|NCT02952586|474730626|FG000|CRT for IMRT (63 Days)|Death|5|||
131850030|NCT02952586|474730627|FG001|CRT for IMRT (63 Days)|Death|8|||
131850031|NCT02952586|474730626|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
131850032|NCT02952586|474730627|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
131850033|NCT02952586|474730626|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
131850034|NCT02952586|474730627|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
131850035|NCT02952586|474730626|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
131850036|NCT02952586|474730627|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
131850037|NCT02952586|474730626|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
131850038|NCT02952586|474730627|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
131850039|NCT02952586|474730626|FG000|CRT for IMRT (63 Days)|Other|1|||
131850040|NCT02952586|474730627|FG001|CRT for IMRT (63 Days)|Other|0|||
131850041|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Death|17|||
131911924|NCT00656617|474965227|FG000|Overall Study|Adverse Event|1|||
131911925|NCT00656617|474965227|FG000|Overall Study|Death|2|||
131911926|NCT00656617|474965227|FG000|Overall Study|Insurance Issues|2|||
131911927|NCT00656617|474965227|FG000|Overall Study|Move to different clinical trial|2|||
131911928|NCT02765035|474965243|FG000|First Intervention (90 Days)|Adverse Event|1|||
131911929|NCT02765035|474965244|FG001|First Intervention (90 Days)|Adverse Event|1|||
131911930|NCT02765035|474965243|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
131911931|NCT02765035|474965244|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
131850042|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Death|11|||
131850043|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
131850044|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
131850045|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
131850046|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
131850047|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
131850048|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
131850049|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
131850050|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
131850051|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
131850052|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
131850053|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
131850054|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
131850055|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
131850056|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
131850057|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Other|2|||
131850058|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Other|1|||
131850059|NCT02952586|474730626|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
131850060|NCT02952586|474730627|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
131850061|NCT02952586|474730626|FG000|Follow-Up Phase (90 Days)|Death|12|||
131850062|NCT02952586|474730627|FG001|Follow-Up Phase (90 Days)|Death|10|||
131850063|NCT02952586|474730626|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
131850064|NCT02952586|474730627|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
131850065|NCT02952586|474730626|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
131850066|NCT02952586|474730627|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
131850067|NCT02952586|474730626|FG000|Follow-Up Phase (90 Days)|Other|7|||
131850068|NCT02952586|474730627|FG001|Follow-Up Phase (90 Days)|Other|5|||
131850069|NCT02952586|474730626|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
131850070|NCT02952586|474730627|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
131850071|NCT02952586|474730626|FG000|LT Follow-up (up to 45 Months)|Death|51|||
131850072|NCT02952586|474730627|FG001|LT Follow-up (up to 45 Months)|Death|31|||
131850073|NCT02952586|474730626|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
131850074|NCT02952586|474730627|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
131850075|NCT02952586|474730626|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
131850076|NCT02952586|474730627|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
131850077|NCT02952586|474730626|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
131850078|NCT02952586|474730627|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
131850079|NCT00492778|474730628|FG000|Overall Study|Ineligible by Pathology Review|8|||
131850080|NCT00492778|474730629|FG001|Overall Study|Ineligible by Pathology Review|1|||
131850081|NCT02910011|474730632|FG000|Overall Study|Physician Decision|2|||
131850082|NCT02463357|474730633|FG000|Overall Study|Withdrawal by Subject|1|||
131850083|NCT02463357|474730634|FG001|Overall Study|Withdrawal by Subject|0|||
131850084|NCT02463357|474730635|FG002|Overall Study|Withdrawal by Subject|0|||
131850085|NCT02463357|474730636|FG003|Overall Study|Withdrawal by Subject|0|||
131850086|NCT02463357|474730637|FG004|Overall Study|Withdrawal by Subject|0|||
131850087|NCT02463357|474730633|FG000|Overall Study|Withdrawal by Subject|0|||
131850088|NCT02463357|474730634|FG001|Overall Study|Withdrawal by Subject|0|||
131850089|NCT02463357|474730635|FG002|Overall Study|Withdrawal by Subject|0|||
131850090|NCT02463357|474730636|FG003|Overall Study|Withdrawal by Subject|0|||
131850091|NCT02463357|474730637|FG004|Overall Study|Withdrawal by Subject|1|||
131850092|NCT01371539|474730638|FG000|Period One: One Week|Lost to Follow-up|0|||
131850093|NCT01371539|474730639|FG001|Period One: One Week|Lost to Follow-up|1|||
131850094|NCT01371539|474730638|FG000|Period Two: One Week|Lost to Follow-up|0|||
131850095|NCT01371539|474730639|FG001|Period Two: One Week|Lost to Follow-up|1|||
131850096|NCT01371539|474730638|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
131850097|NCT01371539|474730639|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
131850098|NCT01371539|474730638|FG000|Period Two: One Week|Time/job conflict|0|||
131850099|NCT01371539|474730639|FG001|Period Two: One Week|Time/job conflict|1|||
131850100|NCT01399658|474730640|FG000|Overall Study|Ineligible|1|||
131850101|NCT01399658|474730640|FG000|Overall Study|Machine Technical Issue|3|||
131850102|NCT01399658|474730640|FG000|Overall Study|Alternative therapy|1|||
131850103|NCT01399658|474730640|FG000|Overall Study|No reason given|1|||
131850104|NCT02460679|474730641|FG000|Overall Study|Investigator Decision|1|||
131850105|NCT02460679|474730641|FG000|Overall Study|Withdrawal by Subject|4|||
131850106|NCT02620579|474730642|FG000|Overall Study|Physician Decision|0|||
131850107|NCT02620579|474730643|FG001|Overall Study|Physician Decision|0|||
131850108|NCT02620579|474730644|FG002|Overall Study|Physician Decision|0|||
131911932|NCT02349386|474965245|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
131850109|NCT02620579|474730645|FG003|Overall Study|Physician Decision|1|||
131850110|NCT02620579|474730642|FG000|Overall Study|Withdrawal by Subject|0|||
131850111|NCT02620579|474730643|FG001|Overall Study|Withdrawal by Subject|1|||
131850112|NCT02620579|474730644|FG002|Overall Study|Withdrawal by Subject|1|||
131850113|NCT02620579|474730645|FG003|Overall Study|Withdrawal by Subject|0|||
131850114|NCT00796107|474730651|FG000|Overall Study|Lack of Efficacy|1|||
131850115|NCT00796107|474730651|FG000|Overall Study|Progressive Disease|5|||
131911933|NCT02349386|474965246|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
131911934|NCT02349386|474965247|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
131911935|NCT02349386|474965248|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
131911936|NCT02349386|474965245|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
131911937|NCT02349386|474965246|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
131911938|NCT02349386|474965247|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
131911939|NCT02349386|474965248|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
131911940|NCT02349386|474965245|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
131911941|NCT02349386|474965246|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
131911942|NCT02349386|474965247|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
131911943|NCT02349386|474965248|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
131911944|NCT02349386|474965245|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
131911945|NCT02349386|474965246|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
131911946|NCT02349386|474965247|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
131911947|NCT02349386|474965248|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
131911948|NCT02349386|474965245|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
131911949|NCT02349386|474965246|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
131850116|NCT01098474|474730652|FG000|Active Phase|Other|0|||
131850117|NCT01098474|474730653|FG001|Active Phase|Other|0|||
131850118|NCT01098474|474730654|FG002|Active Phase|Other|3|||
131850119|NCT01098474|474730655|FG003|Active Phase|Other|0|||
131850120|NCT01098474|474730656|FG004|Active Phase|Other|0|||
131850121|NCT01098474|474730657|FG005|Active Phase|Other|0|||
131850122|NCT01098474|474730652|FG000|Active Phase|Withdrawal by Subject|1|||
131850123|NCT01098474|474730653|FG001|Active Phase|Withdrawal by Subject|1|||
131850124|NCT01098474|474730654|FG002|Active Phase|Withdrawal by Subject|2|||
131850125|NCT01098474|474730655|FG003|Active Phase|Withdrawal by Subject|0|||
131850126|NCT01098474|474730656|FG004|Active Phase|Withdrawal by Subject|0|||
131850127|NCT01098474|474730657|FG005|Active Phase|Withdrawal by Subject|0|||
131850128|NCT01098474|474730652|FG000|Active Phase|Lost to Follow-up|1|||
131850129|NCT01098474|474730653|FG001|Active Phase|Lost to Follow-up|0|||
131850130|NCT01098474|474730654|FG002|Active Phase|Lost to Follow-up|0|||
131850131|NCT01098474|474730655|FG003|Active Phase|Lost to Follow-up|0|||
131850132|NCT01098474|474730656|FG004|Active Phase|Lost to Follow-up|0|||
131850133|NCT01098474|474730657|FG005|Active Phase|Lost to Follow-up|0|||
131850134|NCT01098474|474730652|FG000|Follow Up Phase|Travelled out of study area|0|||
131850135|NCT01098474|474730653|FG001|Follow Up Phase|Travelled out of study area|0|||
131850136|NCT01098474|474730654|FG002|Follow Up Phase|Travelled out of study area|0|||
131850137|NCT01098474|474730655|FG003|Follow Up Phase|Travelled out of study area|0|||
131850138|NCT01098474|474730656|FG004|Follow Up Phase|Travelled out of study area|1|||
131850139|NCT01098474|474730657|FG005|Follow Up Phase|Travelled out of study area|0|||
131850140|NCT01098474|474730652|FG000|Follow Up Phase|Other|0|||
131850141|NCT01098474|474730653|FG001|Follow Up Phase|Other|0|||
131850142|NCT01098474|474730654|FG002|Follow Up Phase|Other|0|||
131850143|NCT01098474|474730655|FG003|Follow Up Phase|Other|0|||
131850144|NCT01098474|474730656|FG004|Follow Up Phase|Other|0|||
131850145|NCT01098474|474730657|FG005|Follow Up Phase|Other|4|||
131850146|NCT01098474|474730652|FG000|Follow Up Phase|Withdrawal by Subject|0|||
131850147|NCT01098474|474730653|FG001|Follow Up Phase|Withdrawal by Subject|0|||
131850148|NCT01098474|474730654|FG002|Follow Up Phase|Withdrawal by Subject|0|||
131850149|NCT01098474|474730655|FG003|Follow Up Phase|Withdrawal by Subject|2|||
131850150|NCT01098474|474730656|FG004|Follow Up Phase|Withdrawal by Subject|0|||
131850151|NCT01098474|474730657|FG005|Follow Up Phase|Withdrawal by Subject|1|||
131850152|NCT01098474|474730652|FG000|Follow Up Phase|Lost to Follow-up|0|||
131850153|NCT01098474|474730653|FG001|Follow Up Phase|Lost to Follow-up|0|||
131850154|NCT01098474|474730654|FG002|Follow Up Phase|Lost to Follow-up|0|||
131850155|NCT01098474|474730655|FG003|Follow Up Phase|Lost to Follow-up|0|||
131850156|NCT01098474|474730656|FG004|Follow Up Phase|Lost to Follow-up|1|||
131850157|NCT01098474|474730657|FG005|Follow Up Phase|Lost to Follow-up|0|||
131850158|NCT03280381|474730660|FG000|Overall Study|Physician Decision|0|||
131850159|NCT03280381|474730661|FG001|Overall Study|Physician Decision|2|||
131850160|NCT00895414|474730664|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
131850161|NCT00895414|474730665|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
131850162|NCT00895414|474730664|FG000|First Intervention (14 Days)|Physician Decision|0|||
131850163|NCT00895414|474730665|FG001|First Intervention (14 Days)|Physician Decision|1|||
131850164|NCT00252239|474730666|FG000|Overall Study|Withdrawal by Subject|1|||
131850165|NCT00252239|474730667|FG001|Overall Study|Withdrawal by Subject|0|||
131850166|NCT00252239|474730668|FG002|Overall Study|Withdrawal by Subject|0|||
131850167|NCT00252239|474730669|FG003|Overall Study|Withdrawal by Subject|1|||
131850168|NCT00252239|474730666|FG000|Overall Study|Lost to Follow-up|0|||
131850169|NCT00252239|474730667|FG001|Overall Study|Lost to Follow-up|0|||
131850170|NCT00252239|474730668|FG002|Overall Study|Lost to Follow-up|2|||
131850171|NCT00252239|474730669|FG003|Overall Study|Lost to Follow-up|0|||
131911950|NCT02349386|474965247|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
131452194|NCT00536744|473283088|FG000|Overall Study|Adverse Event|13|||
131452195|NCT00536744|473283089|FG001|Overall Study|Adverse Event|10|||
131452196|NCT00536744|473283088|FG000|Overall Study|Death|2|||
131452197|NCT00536744|473283089|FG001|Overall Study|Death|1|||
131452198|NCT00536744|473283088|FG000|Overall Study|Physician Decision|3|||
131452199|NCT00536744|473283089|FG001|Overall Study|Physician Decision|1|||
131452200|NCT00536744|473283088|FG000|Overall Study|Lost to Follow-up|3|||
131452201|NCT00536744|473283089|FG001|Overall Study|Lost to Follow-up|5|||
131452202|NCT00536744|473283088|FG000|Overall Study|Withdrawal by Subject|7|||
131452203|NCT00536744|473283089|FG001|Overall Study|Withdrawal by Subject|8|||
131452204|NCT00536744|473283088|FG000|Overall Study|PI tried alternative treatment|1|||
131452205|NCT00536744|473283089|FG001|Overall Study|PI tried alternative treatment|3|||
131452206|NCT00787644|473283090|FG000|Overall Study|Lost to Follow-up|1|||
131452207|NCT00787644|473283091|FG001|Overall Study|Lost to Follow-up|1|||
131452208|NCT00787644|473283090|FG000|Overall Study|Withdrawal by Subject|1|||
131452209|NCT00787644|473283091|FG001|Overall Study|Withdrawal by Subject|1|||
131452210|NCT01642589|473283095|FG000|Overall Study|Withdrawal by Subject|1|||
131452211|NCT01642589|473283096|FG001|Overall Study|Withdrawal by Subject|1|||
131452212|NCT00256997|473283101|FG000|Overall Study|Protocol Violation|1|||
131850172|NCT01822366|474730670|FG000|Overall Study|Lost to Follow-up|5|||
131850173|NCT01822366|474730671|FG001|Overall Study|Lost to Follow-up|1|||
131850174|NCT01822366|474730672|FG002|Overall Study|Lost to Follow-up|5|||
131850175|NCT01822366|474730673|FG003|Overall Study|Lost to Follow-up|1|||
131850176|NCT01822366|474730670|FG000|Overall Study|Withdrawal by Subject|0|||
131850177|NCT01822366|474730671|FG001|Overall Study|Withdrawal by Subject|6|||
131850178|NCT01822366|474730672|FG002|Overall Study|Withdrawal by Subject|0|||
131850179|NCT01822366|474730673|FG003|Overall Study|Withdrawal by Subject|6|||
131850180|NCT01822366|474730670|FG000|Overall Study|Partial Intervention Completion|0|||
131850181|NCT01822366|474730671|FG001|Overall Study|Partial Intervention Completion|15|||
131850182|NCT01822366|474730672|FG002|Overall Study|Partial Intervention Completion|0|||
131850183|NCT01822366|474730673|FG003|Overall Study|Partial Intervention Completion|15|||
131850184|NCT02181790|474730674|FG000|Overall Study|study terminated|2|||
131850185|NCT02181790|474730675|FG001|Overall Study|study terminated|0|||
131850186|NCT04988087|474730678|FG000|Overall Study|Adverse Event|4|||
131850187|NCT04988087|474730679|FG001|Overall Study|Adverse Event|0|||
131850188|NCT04988087|474730680|FG002|Overall Study|Adverse Event|0|||
131850189|NCT04988087|474730681|FG003|Overall Study|Adverse Event|0|||
131850190|NCT04988087|474730678|FG000|Overall Study|Withdrawal by Subject|1|||
131850191|NCT04988087|474730679|FG001|Overall Study|Withdrawal by Subject|1|||
131850192|NCT04988087|474730680|FG002|Overall Study|Withdrawal by Subject|0|||
131850193|NCT04988087|474730681|FG003|Overall Study|Withdrawal by Subject|0|||
131850194|NCT04988087|474730678|FG000|Overall Study|Technical problems|7|||
131850195|NCT04988087|474730679|FG001|Overall Study|Technical problems|9|||
131850196|NCT04988087|474730680|FG002|Overall Study|Technical problems|1|||
131850197|NCT04988087|474730681|FG003|Overall Study|Technical problems|2|||
131850198|NCT02458287|474730682|FG000|Overall Study|Adverse Event|0|||
131850199|NCT02458287|474730683|FG001|Overall Study|Adverse Event|0|||
131850200|NCT02458287|474730684|FG002|Overall Study|Adverse Event|0|||
131850201|NCT02458287|474730685|FG003|Overall Study|Adverse Event|1|||
131911951|NCT02349386|474965248|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
131911952|NCT02349386|474965245|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
131850202|NCT02458287|474730682|FG000|Overall Study|Lost to Follow-up|0|||
131850203|NCT02458287|474730683|FG001|Overall Study|Lost to Follow-up|1|||
131850204|NCT02458287|474730684|FG002|Overall Study|Lost to Follow-up|1|||
131850205|NCT02458287|474730685|FG003|Overall Study|Lost to Follow-up|0|||
131850206|NCT02458287|474730682|FG000|Overall Study|Protocol Violation|0|||
131850207|NCT02458287|474730683|FG001|Overall Study|Protocol Violation|1|||
131850208|NCT02458287|474730684|FG002|Overall Study|Protocol Violation|0|||
131850209|NCT02458287|474730685|FG003|Overall Study|Protocol Violation|0|||
131850210|NCT02458287|474730682|FG000|Overall Study|Withdrawal by Subject|0|||
131850211|NCT02458287|474730683|FG001|Overall Study|Withdrawal by Subject|2|||
131850212|NCT02458287|474730684|FG002|Overall Study|Withdrawal by Subject|2|||
131850213|NCT02458287|474730685|FG003|Overall Study|Withdrawal by Subject|1|||
131850214|NCT02458287|474730682|FG000|Overall Study|Relocated Out of State|0|||
131850215|NCT02458287|474730683|FG001|Overall Study|Relocated Out of State|0|||
131850216|NCT02458287|474730684|FG002|Overall Study|Relocated Out of State|0|||
131452213|NCT00256997|473283102|FG001|Overall Study|Protocol Violation|4|||
131850217|NCT02458287|474730685|FG003|Overall Study|Relocated Out of State|1|||
131850218|NCT02613182|474730686|FG000|Overall Study|Death|6|||
131850219|NCT02613182|474730686|FG000|Overall Study|Physician Decision|1|||
131850220|NCT02613182|474730686|FG000|Overall Study|Study Terminated by Sponsor|21|||
131850221|NCT02613182|474730686|FG000|Overall Study|Withdrawal by Subject|6|||
131850222|NCT03968978|474730687|FG000|Overall Study|Adverse Event|1|||
131850223|NCT03968978|474730688|FG001|Overall Study|Adverse Event|0|||
131850224|NCT00025259|474730690|FG000|Overall Study|Death|1|||
131452214|NCT00256997|473283101|FG000|Overall Study|Lack of Efficacy|1|||
131452215|NCT00256997|473283102|FG001|Overall Study|Lack of Efficacy|4|||
131452216|NCT00256997|473283101|FG000|Overall Study|Death|2|||
131452217|NCT00256997|473283102|FG001|Overall Study|Death|0|||
131452218|NCT00256997|473283101|FG000|Overall Study|Adverse Event|4|||
131452219|NCT00256997|473283102|FG001|Overall Study|Adverse Event|0|||
131452220|NCT00256997|473283101|FG000|Overall Study|Lost to Follow-up|3|||
131452221|NCT00256997|473283102|FG001|Overall Study|Lost to Follow-up|5|||
131452222|NCT00256997|473283101|FG000|Overall Study|Withdrawal by Subject|13|||
131452223|NCT00256997|473283102|FG001|Overall Study|Withdrawal by Subject|3|||
131452224|NCT00256997|473283101|FG000|Overall Study|Started but not treated|2|||
131452225|NCT00256997|473283102|FG001|Overall Study|Started but not treated|0|||
131452226|NCT00256997|473283101|FG000|Overall Study|Other|5|||
131452227|NCT00256997|473283102|FG001|Overall Study|Other|8|||
131452228|NCT00256997|473283101|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
131452229|NCT00256997|473283102|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
131452230|NCT00256997|473283101|FG000|Overall Study|Participant Non-compliant|3|||
131452231|NCT00256997|473283102|FG001|Overall Study|Participant Non-compliant|6|||
131452232|NCT00256997|473283101|FG000|Overall Study|Investigator Withdrew Participant|2|||
131452233|NCT00256997|473283102|FG001|Overall Study|Investigator Withdrew Participant|1|||
131452234|NCT04163016|473283103|FG000|Enrollment|Adverse Event|1|||
131452235|NCT04163016|473283104|FG001|Enrollment|Adverse Event|0|||
131452236|NCT04163016|473283105|FG002|Enrollment|Adverse Event|0|||
131452237|NCT04163016|473283106|FG003|Enrollment|Adverse Event|0|||
131452238|NCT04163016|473283103|FG000|Treatment|Adverse Event|0|||
131452239|NCT04163016|473283104|FG001|Treatment|Adverse Event|1|||
131452240|NCT04163016|473283105|FG002|Treatment|Adverse Event|0|||
131452241|NCT04163016|473283106|FG003|Treatment|Adverse Event|0|||
131452242|NCT04163016|473283103|FG000|Treatment|Withdrawal by Subject|0|||
131452243|NCT04163016|473283104|FG001|Treatment|Withdrawal by Subject|2|||
131452244|NCT04163016|473283105|FG002|Treatment|Withdrawal by Subject|0|||
131452245|NCT04163016|473283106|FG003|Treatment|Withdrawal by Subject|0|||
131452246|NCT04163016|473283103|FG000|Treatment|Indeterminate TB-test|0|||
131452247|NCT04163016|473283104|FG001|Treatment|Indeterminate TB-test|0|||
131850225|NCT00025259|474730691|FG001|Overall Study|Death|3|||
131850226|NCT00025259|474730692|FG002|Overall Study|Death|0|||
131850227|NCT00025259|474730693|FG003|Overall Study|Death|3|||
131850228|NCT00025259|474730694|FG004|Overall Study|Death|0|||
131850229|NCT00025259|474730695|FG005|Overall Study|Death|1|||
131850230|NCT00025259|474730696|FG006|Overall Study|Death|2|||
131850231|NCT00025259|474730690|FG000|Overall Study|Lack of Efficacy|2|||
131850232|NCT00025259|474730691|FG001|Overall Study|Lack of Efficacy|46|||
131850233|NCT00025259|474730692|FG002|Overall Study|Lack of Efficacy|60|||
131850234|NCT00025259|474730693|FG003|Overall Study|Lack of Efficacy|78|||
131850235|NCT00025259|474730694|FG004|Overall Study|Lack of Efficacy|11|||
131850236|NCT00025259|474730695|FG005|Overall Study|Lack of Efficacy|30|||
131850237|NCT00025259|474730696|FG006|Overall Study|Lack of Efficacy|38|||
131850238|NCT00025259|474730690|FG000|Overall Study|Lost to Follow-up|2|||
131850239|NCT00025259|474730691|FG001|Overall Study|Lost to Follow-up|9|||
131850240|NCT00025259|474730692|FG002|Overall Study|Lost to Follow-up|13|||
131850241|NCT00025259|474730693|FG003|Overall Study|Lost to Follow-up|13|||
131850242|NCT00025259|474730694|FG004|Overall Study|Lost to Follow-up|1|||
131850243|NCT00025259|474730695|FG005|Overall Study|Lost to Follow-up|3|||
131850244|NCT00025259|474730696|FG006|Overall Study|Lost to Follow-up|1|||
131850245|NCT00025259|474730690|FG000|Overall Study|Physician Decision|12|||
131850246|NCT00025259|474730691|FG001|Overall Study|Physician Decision|1|||
131850247|NCT00025259|474730692|FG002|Overall Study|Physician Decision|0|||
131850248|NCT00025259|474730693|FG003|Overall Study|Physician Decision|5|||
131850249|NCT00025259|474730694|FG004|Overall Study|Physician Decision|4|||
131850250|NCT00025259|474730695|FG005|Overall Study|Physician Decision|2|||
131850251|NCT00025259|474730696|FG006|Overall Study|Physician Decision|1|||
131850252|NCT00025259|474730690|FG000|Overall Study|Protocol Violation|3|||
131850253|NCT00025259|474730691|FG001|Overall Study|Protocol Violation|2|||
131452248|NCT04163016|473283105|FG002|Treatment|Indeterminate TB-test|0|||
131850254|NCT00025259|474730692|FG002|Overall Study|Protocol Violation|2|||
131850255|NCT00025259|474730693|FG003|Overall Study|Protocol Violation|1|||
131850256|NCT00025259|474730694|FG004|Overall Study|Protocol Violation|2|||
131850257|NCT00025259|474730695|FG005|Overall Study|Protocol Violation|1|||
131850258|NCT00025259|474730696|FG006|Overall Study|Protocol Violation|3|||
131850259|NCT00025259|474730690|FG000|Overall Study|Withdrawal by Subject|9|||
131850260|NCT00025259|474730691|FG001|Overall Study|Withdrawal by Subject|27|||
131452249|NCT04163016|473283106|FG003|Treatment|Indeterminate TB-test|1|||
131452250|NCT04163016|473283103|FG000|Treatment|Participant did not want to continue in study|0|||
131850261|NCT00025259|474730692|FG002|Overall Study|Withdrawal by Subject|6|||
131452251|NCT04163016|473283104|FG001|Treatment|Participant did not want to continue in study|0|||
131452252|NCT04163016|473283105|FG002|Treatment|Participant did not want to continue in study|0|||
131452253|NCT04163016|473283106|FG003|Treatment|Participant did not want to continue in study|1|||
131452254|NCT01967238|473283107|FG000|Overall Study|Adverse Event|1|||
131850262|NCT00025259|474730693|FG003|Overall Study|Withdrawal by Subject|14|||
131850263|NCT00025259|474730694|FG004|Overall Study|Withdrawal by Subject|11|||
131850264|NCT00025259|474730695|FG005|Overall Study|Withdrawal by Subject|8|||
131850265|NCT00025259|474730696|FG006|Overall Study|Withdrawal by Subject|3|||
131452255|NCT01967238|473283108|FG001|Overall Study|Adverse Event|1|||
131452256|NCT01967238|473283109|FG002|Overall Study|Adverse Event|0|||
131452257|NCT01967238|473283107|FG000|Overall Study|Lost to Follow-up|1|||
131452258|NCT01967238|473283108|FG001|Overall Study|Lost to Follow-up|0|||
131452259|NCT01967238|473283109|FG002|Overall Study|Lost to Follow-up|1|||
131452260|NCT01967238|473283107|FG000|Overall Study|Withdrawal by Subject|0|||
131452261|NCT01967238|473283108|FG001|Overall Study|Withdrawal by Subject|0|||
131452262|NCT01967238|473283109|FG002|Overall Study|Withdrawal by Subject|1|||
131452263|NCT05232682|473283110|FG000|Overall Study|Lost to Follow-up|2|||
131452264|NCT03387085|473283111|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
131452265|NCT01864603|473284525|FG000|Stage 2|DSMB design modification|86056|||
131452266|NCT01864603|473284526|FG001|Stage 2|DSMB design modification|92558|||
131452267|NCT02446899|473284527|FG000|Overall Study|Adverse Event|4|||
131452268|NCT02446899|473284528|FG001|Overall Study|Adverse Event|7|||
131452269|NCT02446899|473284527|FG000|Overall Study|Condition Under Investigation Worsened|1|||
131452270|NCT02446899|473284528|FG001|Overall Study|Condition Under Investigation Worsened|4|||
131452271|NCT02446899|473284527|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
131452272|NCT02446899|473284528|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
131452273|NCT02446899|473284527|FG000|Overall Study|Lack of Efficacy|2|||
131452274|NCT02446899|473284528|FG001|Overall Study|Lack of Efficacy|8|||
131452275|NCT02446899|473284527|FG000|Overall Study|Lost to Follow-up|1|||
131452276|NCT02446899|473284528|FG001|Overall Study|Lost to Follow-up|3|||
131452277|NCT02446899|473284527|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
131452278|NCT02446899|473284528|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
131850266|NCT00025259|474730690|FG000|Overall Study|Ineligible|14|||
131850267|NCT00025259|474730691|FG001|Overall Study|Ineligible|1|||
131850268|NCT00025259|474730692|FG002|Overall Study|Ineligible|0|||
131850269|NCT00025259|474730693|FG003|Overall Study|Ineligible|0|||
131850270|NCT00025259|474730694|FG004|Overall Study|Ineligible|6|||
131850271|NCT00025259|474730695|FG005|Overall Study|Ineligible|0|||
131850272|NCT00025259|474730696|FG006|Overall Study|Ineligible|1|||
131850273|NCT00025259|474730690|FG000|Overall Study|Randomization error|1|||
131850274|NCT00025259|474730691|FG001|Overall Study|Randomization error|0|||
131850275|NCT00025259|474730692|FG002|Overall Study|Randomization error|0|||
131850276|NCT00025259|474730693|FG003|Overall Study|Randomization error|0|||
131850277|NCT00025259|474730694|FG004|Overall Study|Randomization error|1|||
131850278|NCT00025259|474730695|FG005|Overall Study|Randomization error|7|||
131850279|NCT00025259|474730696|FG006|Overall Study|Randomization error|2|||
131850280|NCT00025259|474730690|FG000|Overall Study|Adverse Event|1|||
131850281|NCT00025259|474730691|FG001|Overall Study|Adverse Event|0|||
131850282|NCT00025259|474730692|FG002|Overall Study|Adverse Event|0|||
131850283|NCT00025259|474730693|FG003|Overall Study|Adverse Event|0|||
131850284|NCT00025259|474730694|FG004|Overall Study|Adverse Event|0|||
131850285|NCT00025259|474730695|FG005|Overall Study|Adverse Event|0|||
131850286|NCT00025259|474730696|FG006|Overall Study|Adverse Event|0|||
131850287|NCT01449370|474730697|FG000|Overall Study|Disease Progression|5|||
131850288|NCT01449370|474730698|FG001|Overall Study|Disease Progression|4|||
131850289|NCT01449370|474730699|FG002|Overall Study|Disease Progression|8|||
131850290|NCT01449370|474730700|FG003|Overall Study|Disease Progression|3|||
131850291|NCT01449370|474730701|FG004|Overall Study|Disease Progression|3|||
131850292|NCT01449370|474730702|FG005|Overall Study|Disease Progression|3|||
131850293|NCT01449370|474730703|FG006|Overall Study|Disease Progression|3|||
131850294|NCT01449370|474730704|FG007|Overall Study|Disease Progression|2|||
131850295|NCT01449370|474730705|FG008|Overall Study|Disease Progression|9|||
131850296|NCT01449370|474730706|FG009|Overall Study|Disease Progression|1|||
131850297|NCT01449370|474730707|FG010|Overall Study|Disease Progression|3|||
131850298|NCT01449370|474730708|FG011|Overall Study|Disease Progression|3|||
131911953|NCT02349386|474965246|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
131911954|NCT02349386|474965247|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
131911955|NCT02349386|474965248|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
131911956|NCT01712178|474965249|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
131911957|NCT01712178|474965250|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
131911958|NCT01712178|474965249|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
131850299|NCT01449370|474730709|FG012|Overall Study|Disease Progression|2|||
131452279|NCT02446899|473284527|FG000|Overall Study|Withdrawal by Subject|11|||
131452280|NCT02446899|473284528|FG001|Overall Study|Withdrawal by Subject|19|||
131452281|NCT02446899|473284527|FG000|Overall Study|Miscellaneous|5|||
131850300|NCT01449370|474730710|FG013|Overall Study|Disease Progression|8|||
131850301|NCT01449370|474730711|FG014|Overall Study|Disease Progression|3|||
131850302|NCT01449370|474730712|FG015|Overall Study|Disease Progression|1|||
131850303|NCT01449370|474730713|FG016|Overall Study|Disease Progression|4|||
131850304|NCT01449370|474730714|FG017|Overall Study|Disease Progression|3|||
131452282|NCT02446899|473284528|FG001|Overall Study|Miscellaneous|4|||
131452283|NCT02446899|473284527|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
131452284|NCT02446899|473284528|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
131850305|NCT01449370|474730715|FG018|Overall Study|Disease Progression|1|||
131850306|NCT01449370|474730716|FG019|Overall Study|Disease Progression|2|||
131850307|NCT01449370|474730717|FG020|Overall Study|Disease Progression|5|||
131850308|NCT01449370|474730718|FG021|Overall Study|Disease Progression|2|||
131850309|NCT01449370|474730719|FG022|Overall Study|Disease Progression|3|||
131850310|NCT01449370|474730720|FG023|Overall Study|Disease Progression|7|||
131850311|NCT01449370|474730721|FG024|Overall Study|Disease Progression|3|||
131850312|NCT01449370|474730697|FG000|Overall Study|Adverse Event|1|||
131850313|NCT01449370|474730698|FG001|Overall Study|Adverse Event|2|||
131850314|NCT01449370|474730699|FG002|Overall Study|Adverse Event|0|||
131850315|NCT01449370|474730700|FG003|Overall Study|Adverse Event|1|||
131850316|NCT01449370|474730701|FG004|Overall Study|Adverse Event|0|||
131850317|NCT01449370|474730702|FG005|Overall Study|Adverse Event|0|||
131850318|NCT01449370|474730703|FG006|Overall Study|Adverse Event|0|||
131911959|NCT01712178|474965250|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
131911960|NCT01712178|474965249|FG000|Overall Study|Lost to Follow-up|0|||
131911961|NCT01712178|474965250|FG001|Overall Study|Lost to Follow-up|1|||
131850319|NCT01449370|474730704|FG007|Overall Study|Adverse Event|0|||
131850320|NCT01449370|474730705|FG008|Overall Study|Adverse Event|1|||
131850321|NCT01449370|474730706|FG009|Overall Study|Adverse Event|1|||
131850322|NCT01449370|474730707|FG010|Overall Study|Adverse Event|0|||
131850323|NCT01449370|474730708|FG011|Overall Study|Adverse Event|0|||
131850324|NCT01449370|474730709|FG012|Overall Study|Adverse Event|0|||
131850325|NCT01449370|474730710|FG013|Overall Study|Adverse Event|2|||
131850326|NCT01449370|474730711|FG014|Overall Study|Adverse Event|0|||
131850327|NCT01449370|474730712|FG015|Overall Study|Adverse Event|1|||
131850328|NCT01449370|474730713|FG016|Overall Study|Adverse Event|0|||
131850329|NCT01449370|474730714|FG017|Overall Study|Adverse Event|0|||
131850330|NCT01449370|474730715|FG018|Overall Study|Adverse Event|1|||
131850331|NCT01449370|474730716|FG019|Overall Study|Adverse Event|1|||
131850332|NCT01449370|474730717|FG020|Overall Study|Adverse Event|0|||
131850333|NCT01449370|474730718|FG021|Overall Study|Adverse Event|1|||
131850334|NCT01449370|474730719|FG022|Overall Study|Adverse Event|0|||
131850335|NCT01449370|474730720|FG023|Overall Study|Adverse Event|1|||
131850336|NCT01449370|474730721|FG024|Overall Study|Adverse Event|3|||
131850337|NCT01449370|474730697|FG000|Overall Study|Participant Decision|0|||
131850338|NCT01449370|474730698|FG001|Overall Study|Participant Decision|0|||
131850339|NCT01449370|474730699|FG002|Overall Study|Participant Decision|0|||
131850340|NCT01449370|474730700|FG003|Overall Study|Participant Decision|0|||
131850341|NCT01449370|474730701|FG004|Overall Study|Participant Decision|0|||
131850342|NCT01449370|474730702|FG005|Overall Study|Participant Decision|0|||
131850343|NCT01449370|474730703|FG006|Overall Study|Participant Decision|0|||
131850344|NCT01449370|474730704|FG007|Overall Study|Participant Decision|1|||
131850345|NCT01449370|474730705|FG008|Overall Study|Participant Decision|1|||
131850346|NCT01449370|474730706|FG009|Overall Study|Participant Decision|0|||
131850347|NCT01449370|474730707|FG010|Overall Study|Participant Decision|0|||
131850348|NCT01449370|474730708|FG011|Overall Study|Participant Decision|0|||
131850349|NCT01449370|474730709|FG012|Overall Study|Participant Decision|1|||
131850350|NCT01449370|474730710|FG013|Overall Study|Participant Decision|1|||
131850351|NCT01449370|474730711|FG014|Overall Study|Participant Decision|0|||
131850352|NCT01449370|474730712|FG015|Overall Study|Participant Decision|1|||
131850353|NCT01449370|474730713|FG016|Overall Study|Participant Decision|3|||
131850354|NCT01449370|474730714|FG017|Overall Study|Participant Decision|0|||
131850355|NCT01449370|474730715|FG018|Overall Study|Participant Decision|1|||
131850356|NCT01449370|474730716|FG019|Overall Study|Participant Decision|0|||
131850357|NCT01449370|474730717|FG020|Overall Study|Participant Decision|0|||
131850358|NCT01449370|474730718|FG021|Overall Study|Participant Decision|1|||
131850359|NCT01449370|474730719|FG022|Overall Study|Participant Decision|0|||
131850360|NCT01449370|474730720|FG023|Overall Study|Participant Decision|0|||
131850361|NCT01449370|474730721|FG024|Overall Study|Participant Decision|1|||
131850362|NCT01449370|474730697|FG000|Overall Study|Lost to Follow-up|0|||
131850363|NCT01449370|474730698|FG001|Overall Study|Lost to Follow-up|0|||
131850364|NCT01449370|474730699|FG002|Overall Study|Lost to Follow-up|0|||
131850365|NCT01449370|474730700|FG003|Overall Study|Lost to Follow-up|0|||
131850366|NCT01449370|474730701|FG004|Overall Study|Lost to Follow-up|0|||
131850367|NCT01449370|474730702|FG005|Overall Study|Lost to Follow-up|0|||
131850368|NCT01449370|474730703|FG006|Overall Study|Lost to Follow-up|0|||
131850369|NCT01449370|474730704|FG007|Overall Study|Lost to Follow-up|0|||
131850370|NCT01449370|474730705|FG008|Overall Study|Lost to Follow-up|0|||
131850371|NCT01449370|474730706|FG009|Overall Study|Lost to Follow-up|0|||
131850372|NCT01449370|474730707|FG010|Overall Study|Lost to Follow-up|0|||
131850373|NCT01449370|474730708|FG011|Overall Study|Lost to Follow-up|0|||
131850374|NCT01449370|474730709|FG012|Overall Study|Lost to Follow-up|0|||
131850375|NCT01449370|474730710|FG013|Overall Study|Lost to Follow-up|0|||
131850376|NCT01449370|474730711|FG014|Overall Study|Lost to Follow-up|0|||
131850377|NCT01449370|474730712|FG015|Overall Study|Lost to Follow-up|0|||
131850378|NCT01449370|474730713|FG016|Overall Study|Lost to Follow-up|0|||
131850379|NCT01449370|474730714|FG017|Overall Study|Lost to Follow-up|0|||
131850380|NCT01449370|474730715|FG018|Overall Study|Lost to Follow-up|0|||
131850381|NCT01449370|474730716|FG019|Overall Study|Lost to Follow-up|0|||
131850382|NCT01449370|474730717|FG020|Overall Study|Lost to Follow-up|1|||
131850383|NCT01449370|474730718|FG021|Overall Study|Lost to Follow-up|0|||
131850384|NCT01449370|474730719|FG022|Overall Study|Lost to Follow-up|0|||
131850385|NCT01449370|474730720|FG023|Overall Study|Lost to Follow-up|0|||
131850386|NCT01449370|474730721|FG024|Overall Study|Lost to Follow-up|0|||
131850387|NCT01449370|474730697|FG000|Overall Study|Other|0|||
131850388|NCT01449370|474730698|FG001|Overall Study|Other|0|||
131850389|NCT01449370|474730699|FG002|Overall Study|Other|0|||
131850390|NCT01449370|474730700|FG003|Overall Study|Other|0|||
131850391|NCT01449370|474730701|FG004|Overall Study|Other|0|||
131850392|NCT01449370|474730702|FG005|Overall Study|Other|0|||
131850393|NCT01449370|474730703|FG006|Overall Study|Other|0|||
131850394|NCT01449370|474730704|FG007|Overall Study|Other|0|||
131850395|NCT01449370|474730705|FG008|Overall Study|Other|1|||
131850396|NCT01449370|474730706|FG009|Overall Study|Other|1|||
131850397|NCT01449370|474730707|FG010|Overall Study|Other|0|||
131850398|NCT01449370|474730708|FG011|Overall Study|Other|0|||
131850399|NCT01449370|474730709|FG012|Overall Study|Other|0|||
131850400|NCT01449370|474730710|FG013|Overall Study|Other|0|||
131850401|NCT01449370|474730711|FG014|Overall Study|Other|0|||
131850402|NCT01449370|474730712|FG015|Overall Study|Other|0|||
131850403|NCT01449370|474730713|FG016|Overall Study|Other|0|||
131850404|NCT01449370|474730714|FG017|Overall Study|Other|0|||
131850405|NCT01449370|474730715|FG018|Overall Study|Other|0|||
131850406|NCT01449370|474730716|FG019|Overall Study|Other|0|||
131850407|NCT01449370|474730717|FG020|Overall Study|Other|0|||
131850408|NCT01449370|474730718|FG021|Overall Study|Other|0|||
131850409|NCT01449370|474730719|FG022|Overall Study|Other|1|||
131850410|NCT01449370|474730720|FG023|Overall Study|Other|1|||
131850411|NCT01449370|474730721|FG024|Overall Study|Other|0|||
131850412|NCT01449370|474730697|FG000|Overall Study|Medication Prohibited by Protocol|0|||
131850413|NCT01449370|474730698|FG001|Overall Study|Medication Prohibited by Protocol|0|||
131850414|NCT01449370|474730699|FG002|Overall Study|Medication Prohibited by Protocol|0|||
131850415|NCT01449370|474730700|FG003|Overall Study|Medication Prohibited by Protocol|0|||
131850416|NCT01449370|474730701|FG004|Overall Study|Medication Prohibited by Protocol|0|||
131850417|NCT01449370|474730702|FG005|Overall Study|Medication Prohibited by Protocol|0|||
131850418|NCT01449370|474730703|FG006|Overall Study|Medication Prohibited by Protocol|0|||
131850419|NCT01449370|474730704|FG007|Overall Study|Medication Prohibited by Protocol|0|||
131850420|NCT01449370|474730705|FG008|Overall Study|Medication Prohibited by Protocol|0|||
131850421|NCT01449370|474730706|FG009|Overall Study|Medication Prohibited by Protocol|0|||
131850422|NCT01449370|474730707|FG010|Overall Study|Medication Prohibited by Protocol|0|||
131850423|NCT01449370|474730708|FG011|Overall Study|Medication Prohibited by Protocol|0|||
131850424|NCT01449370|474730709|FG012|Overall Study|Medication Prohibited by Protocol|0|||
131850425|NCT01449370|474730710|FG013|Overall Study|Medication Prohibited by Protocol|0|||
131850426|NCT01449370|474730711|FG014|Overall Study|Medication Prohibited by Protocol|0|||
131850427|NCT01449370|474730712|FG015|Overall Study|Medication Prohibited by Protocol|0|||
131850428|NCT01449370|474730713|FG016|Overall Study|Medication Prohibited by Protocol|0|||
131850429|NCT01449370|474730714|FG017|Overall Study|Medication Prohibited by Protocol|0|||
131850430|NCT01449370|474730715|FG018|Overall Study|Medication Prohibited by Protocol|0|||
131850431|NCT01449370|474730716|FG019|Overall Study|Medication Prohibited by Protocol|0|||
131850432|NCT01449370|474730717|FG020|Overall Study|Medication Prohibited by Protocol|0|||
131850433|NCT01449370|474730718|FG021|Overall Study|Medication Prohibited by Protocol|0|||
131850434|NCT01449370|474730719|FG022|Overall Study|Medication Prohibited by Protocol|0|||
131850435|NCT01449370|474730720|FG023|Overall Study|Medication Prohibited by Protocol|1|||
131850436|NCT01449370|474730721|FG024|Overall Study|Medication Prohibited by Protocol|0|||
131850437|NCT01449370|474730697|FG000|Overall Study|Death|0|||
131850438|NCT01449370|474730698|FG001|Overall Study|Death|0|||
131850439|NCT01449370|474730699|FG002|Overall Study|Death|0|||
131850440|NCT01449370|474730700|FG003|Overall Study|Death|0|||
131850441|NCT01449370|474730701|FG004|Overall Study|Death|0|||
131850442|NCT01449370|474730702|FG005|Overall Study|Death|0|||
131850443|NCT01449370|474730703|FG006|Overall Study|Death|0|||
131850444|NCT01449370|474730704|FG007|Overall Study|Death|0|||
131850445|NCT01449370|474730705|FG008|Overall Study|Death|0|||
131850446|NCT01449370|474730706|FG009|Overall Study|Death|0|||
131850447|NCT01449370|474730707|FG010|Overall Study|Death|0|||
131850448|NCT01449370|474730708|FG011|Overall Study|Death|0|||
131850449|NCT01449370|474730709|FG012|Overall Study|Death|0|||
131850450|NCT01449370|474730710|FG013|Overall Study|Death|0|||
131850451|NCT01449370|474730711|FG014|Overall Study|Death|0|||
131850452|NCT01449370|474730712|FG015|Overall Study|Death|0|||
131850453|NCT01449370|474730713|FG016|Overall Study|Death|0|||
131850454|NCT01449370|474730714|FG017|Overall Study|Death|0|||
131850455|NCT01449370|474730715|FG018|Overall Study|Death|0|||
131850456|NCT01449370|474730716|FG019|Overall Study|Death|0|||
131850457|NCT01449370|474730717|FG020|Overall Study|Death|0|||
131850458|NCT01449370|474730718|FG021|Overall Study|Death|0|||
131850459|NCT01449370|474730719|FG022|Overall Study|Death|0|||
131850460|NCT01449370|474730720|FG023|Overall Study|Death|0|||
131850461|NCT01449370|474730721|FG024|Overall Study|Death|1|||
131850462|NCT00908310|474730724|FG000|Overall Study|Death|37|||
131850463|NCT00908310|474730724|FG000|Overall Study|Withdrawal by Subject|7|||
131850464|NCT00908310|474730724|FG000|Overall Study|Lost to Follow-up|7|||
131452285|NCT01499277|473284529|FG000|Overall Study|Adverse Event|3|||
131452286|NCT01499277|473284530|FG001|Overall Study|Adverse Event|6|||
131452287|NCT01499277|473284529|FG000|Overall Study|Death|3|||
131452288|NCT01499277|473284530|FG001|Overall Study|Death|2|||
131452289|NCT01499277|473284529|FG000|Overall Study|Lost to Follow-up|15|||
131452290|NCT01499277|473284530|FG001|Overall Study|Lost to Follow-up|8|||
131452291|NCT01499277|473284529|FG000|Overall Study|Protocol Violation|2|||
131452292|NCT01499277|473284530|FG001|Overall Study|Protocol Violation|3|||
131850465|NCT00908310|474730724|FG000|Overall Study|Screening failure|5|||
131850466|NCT00908310|474730724|FG000|Overall Study|Other reasons|4|||
131850467|NCT01004003|474730725|FG000|Overall Study|Progressive disease|2|||
131850468|NCT01004003|474730726|FG001|Overall Study|Progressive disease|1|||
131850469|NCT01004003|474730727|FG002|Overall Study|Progressive disease|1|||
131850470|NCT01004003|474730728|FG003|Overall Study|Progressive disease|0|||
131850471|NCT01004003|474730729|FG004|Overall Study|Progressive disease|2|||
131850472|NCT01004003|474730730|FG005|Overall Study|Progressive disease|1|||
131850473|NCT01004003|474730731|FG006|Overall Study|Progressive disease|1|||
131850474|NCT01004003|474730732|FG007|Overall Study|Progressive disease|39|||
131850475|NCT01004003|474730733|FG008|Overall Study|Progressive disease|22|||
131850476|NCT01004003|474730725|FG000|Overall Study|Adverse Event|4|||
131850477|NCT01004003|474730726|FG001|Overall Study|Adverse Event|2|||
131850478|NCT01004003|474730727|FG002|Overall Study|Adverse Event|3|||
131850479|NCT01004003|474730728|FG003|Overall Study|Adverse Event|3|||
131850480|NCT01004003|474730729|FG004|Overall Study|Adverse Event|2|||
131850481|NCT01004003|474730730|FG005|Overall Study|Adverse Event|2|||
131850482|NCT01004003|474730731|FG006|Overall Study|Adverse Event|7|||
131850483|NCT01004003|474730732|FG007|Overall Study|Adverse Event|21|||
131850484|NCT01004003|474730733|FG008|Overall Study|Adverse Event|6|||
131850485|NCT01004003|474730725|FG000|Overall Study|Refused to continue taking trial med.|0|||
131850486|NCT01004003|474730726|FG001|Overall Study|Refused to continue taking trial med.|0|||
131850487|NCT01004003|474730727|FG002|Overall Study|Refused to continue taking trial med.|0|||
131850488|NCT01004003|474730728|FG003|Overall Study|Refused to continue taking trial med.|0|||
131850489|NCT01004003|474730729|FG004|Overall Study|Refused to continue taking trial med.|0|||
131850490|NCT01004003|474730730|FG005|Overall Study|Refused to continue taking trial med.|0|||
131850491|NCT01004003|474730731|FG006|Overall Study|Refused to continue taking trial med.|0|||
131850492|NCT01004003|474730732|FG007|Overall Study|Refused to continue taking trial med.|0|||
131850493|NCT01004003|474730733|FG008|Overall Study|Refused to continue taking trial med.|2|||
131850494|NCT01004003|474730725|FG000|Overall Study|Other|0|||
131850495|NCT01004003|474730726|FG001|Overall Study|Other|0|||
131850496|NCT01004003|474730727|FG002|Overall Study|Other|0|||
131850497|NCT01004003|474730728|FG003|Overall Study|Other|0|||
131850498|NCT01004003|474730729|FG004|Overall Study|Other|0|||
131850499|NCT01004003|474730730|FG005|Overall Study|Other|1|||
131850500|NCT01004003|474730731|FG006|Overall Study|Other|0|||
131850501|NCT01004003|474730732|FG007|Overall Study|Other|0|||
131850502|NCT01004003|474730733|FG008|Overall Study|Other|0|||
131850503|NCT03371459|474730734|FG000|Washout|Lost to Follow-up|0|||
131850504|NCT03371459|474730735|FG001|Washout|Lost to Follow-up|1|||
131850505|NCT00315731|474730742|FG000|Overall Study|Lost to Follow-up|1|||
131850506|NCT00315731|474730742|FG000|Overall Study|Death|5|||
131850507|NCT04614246|474730743|FG000|Overall Study|Adverse Event|0|||
131850508|NCT04614246|474730744|FG001|Overall Study|Adverse Event|1|||
131850509|NCT04614246|474730745|FG002|Overall Study|Adverse Event|1|||
131850510|NCT04614246|474730746|FG003|Overall Study|Adverse Event|2|||
131850511|NCT04614246|474730747|FG004|Overall Study|Adverse Event|1|||
131850512|NCT04614246|474730743|FG000|Overall Study|Lost to Follow-up|0|||
131850513|NCT04614246|474730744|FG001|Overall Study|Lost to Follow-up|1|||
131850514|NCT04614246|474730745|FG002|Overall Study|Lost to Follow-up|0|||
131850515|NCT04614246|474730746|FG003|Overall Study|Lost to Follow-up|1|||
131850516|NCT04614246|474730747|FG004|Overall Study|Lost to Follow-up|3|||
131850517|NCT04614246|474730743|FG000|Overall Study|Other reason|0|||
131850518|NCT04614246|474730744|FG001|Overall Study|Other reason|1|||
131850519|NCT04614246|474730745|FG002|Overall Study|Other reason|2|||
131850520|NCT04614246|474730746|FG003|Overall Study|Other reason|0|||
131850521|NCT04614246|474730747|FG004|Overall Study|Other reason|0|||
131850522|NCT04614246|474730743|FG000|Overall Study|Withdrawal by Subject|4|||
131850523|NCT04614246|474730744|FG001|Overall Study|Withdrawal by Subject|2|||
131452293|NCT01499277|473284529|FG000|Overall Study|Withdrawal by Subject|16|||
131452294|NCT01499277|473284530|FG001|Overall Study|Withdrawal by Subject|6|||
131850524|NCT04614246|474730745|FG002|Overall Study|Withdrawal by Subject|4|||
131850525|NCT04614246|474730746|FG003|Overall Study|Withdrawal by Subject|3|||
131850526|NCT04614246|474730747|FG004|Overall Study|Withdrawal by Subject|4|||
131850527|NCT04614246|474730743|FG000|Overall Study|Physician Decision|0|||
131850528|NCT04614246|474730744|FG001|Overall Study|Physician Decision|2|||
131850529|NCT04614246|474730745|FG002|Overall Study|Physician Decision|1|||
131850530|NCT04614246|474730746|FG003|Overall Study|Physician Decision|0|||
131850531|NCT04614246|474730747|FG004|Overall Study|Physician Decision|0|||
131452295|NCT01499277|473284529|FG000|Overall Study|Lack of therapeutic response and other|8|||
131850532|NCT04614246|474730743|FG000|Overall Study|Study terminated by sponsor|10|||
131911962|NCT00091819|474965251|FG000|Overall Study|Adverse Event|1|||
131911963|NCT00091819|474965252|FG001|Overall Study|Adverse Event|1|||
131452296|NCT01499277|473284530|FG001|Overall Study|Lack of therapeutic response and other|7|||
131452297|NCT02974543|473284531|FG000|Overall Study|Withdrawal by Subject|1|||
131452298|NCT02974543|473284532|FG001|Overall Study|Withdrawal by Subject|0|||
131452299|NCT00742235|473284533|FG000|Overall Study|Lost to Follow-up|0|||
131452300|NCT00742235|473284534|FG001|Overall Study|Lost to Follow-up|31|||
131452301|NCT01237899|473284535|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
131452302|NCT01237899|473284536|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
131452303|NCT01237899|473284537|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
131452304|NCT01237899|473284538|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
131452305|NCT01237899|473284539|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
131452306|NCT01237899|473284540|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
131452307|NCT01237899|473284541|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
131452308|NCT01237899|473284542|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
131452309|NCT01237899|473284543|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
131452310|NCT01237899|473284544|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
131452311|NCT01237899|473284545|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
131452312|NCT00790088|473284546|FG000|Overall Study|Protocol Violation|11|||
131452313|NCT00790088|473284546|FG000|Overall Study|Withdrawal by Subject|17|||
131452314|NCT00790088|473284546|FG000|Overall Study|Lost to Follow-up|7|||
131452315|NCT00790088|473284546|FG000|Overall Study|Physician Decision|4|||
131452316|NCT02636595|473284548|FG000|Overall Study|Lost to Follow-up|1|||
131452317|NCT02636595|473284548|FG000|Overall Study|Other|1|||
131452318|NCT04730271|473284549|FG000|Overall Study|Adverse Event|0|||
131452319|NCT04730271|473284550|FG001|Overall Study|Adverse Event|2|||
131452320|NCT04730271|473284549|FG000|Overall Study|Withdrawal by Subject|1|||
131452321|NCT04730271|473284550|FG001|Overall Study|Withdrawal by Subject|1|||
131452322|NCT04730271|473284549|FG000|Overall Study|Protocol Violation|7|||
131452323|NCT04730271|473284550|FG001|Overall Study|Protocol Violation|13|||
131452324|NCT04730271|473284549|FG000|Overall Study|Lost to Follow-up|3|||
131452325|NCT04730271|473284550|FG001|Overall Study|Lost to Follow-up|3|||
131452326|NCT04730271|473284549|FG000|Overall Study|Death|1|||
131452327|NCT04730271|473284550|FG001|Overall Study|Death|0|||
131850533|NCT04614246|474730744|FG001|Overall Study|Study terminated by sponsor|15|||
131850534|NCT04614246|474730745|FG002|Overall Study|Study terminated by sponsor|12|||
131850535|NCT04614246|474730746|FG003|Overall Study|Study terminated by sponsor|13|||
131850536|NCT04614246|474730747|FG004|Overall Study|Study terminated by sponsor|9|||
131911964|NCT00091819|474965251|FG000|Overall Study|Death|4|||
131850537|NCT04614246|474730743|FG000|Overall Study|Pregnancy|2|||
131850538|NCT04614246|474730744|FG001|Overall Study|Pregnancy|0|||
131850539|NCT04614246|474730745|FG002|Overall Study|Pregnancy|1|||
131850540|NCT04614246|474730746|FG003|Overall Study|Pregnancy|0|||
131850541|NCT04614246|474730747|FG004|Overall Study|Pregnancy|0|||
131850542|NCT01680497|474730748|FG000|Overall Study|Lost to Follow-up|2|||
131850543|NCT00725205|474730749|FG000|Overall Study|Adverse Event|22|||
131850544|NCT00725205|474730749|FG000|Overall Study|Investigator Discontinued|1|||
131850545|NCT00725205|474730749|FG000|Overall Study|Non-compliance With Protocol|14|||
131850546|NCT00725205|474730749|FG000|Overall Study|Other|8|||
131850547|NCT00725205|474730749|FG000|Overall Study|Protocol Defined Clinical Event|1|||
131850548|NCT00725205|474730749|FG000|Overall Study|Treatment Failure|41|||
131850549|NCT05819203|474730751|FG000|Overall Study|Protocol Violation|1|||
131850550|NCT05819203|474730752|FG001|Overall Study|Protocol Violation|2|||
131850551|NCT05819203|474730751|FG000|Overall Study|Withdrawal by Subject|1|||
131850552|NCT05819203|474730752|FG001|Overall Study|Withdrawal by Subject|0|||
131850553|NCT04784533|474730753|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
131850554|NCT04784533|474730754|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
131850555|NCT04784533|474730755|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850556|NCT04784533|474730756|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850557|NCT04784533|474730757|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850558|NCT04784533|474730758|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850559|NCT04784533|474730759|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850560|NCT04784533|474730760|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850561|NCT04784533|474730761|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131850562|NCT04784533|474730762|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
131452328|NCT02578706|473284556|FG000|Overall Study|Withdrawal by Subject|1|||
131452329|NCT02578706|473284557|FG001|Overall Study|Withdrawal by Subject|0|||
131452330|NCT02578706|473284558|FG002|Overall Study|Withdrawal by Subject|0|||
131452331|NCT02578706|473284556|FG000|Overall Study|Lost to Follow-up|0|||
131452332|NCT02578706|473284557|FG001|Overall Study|Lost to Follow-up|4|||
131452333|NCT02578706|473284558|FG002|Overall Study|Lost to Follow-up|0|||
131452334|NCT02578706|473284556|FG000|Overall Study|Physician Decision|0|||
131850563|NCT04784533|474730753|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
131911965|NCT00091819|474965252|FG001|Overall Study|Death|5|||
131911966|NCT00091819|474965251|FG000|Overall Study|Lost to Follow-up|26|||
131911967|NCT00091819|474965252|FG001|Overall Study|Lost to Follow-up|23|||
131911968|NCT00091819|474965251|FG000|Overall Study|Withdrawal by Subject|5|||
131911969|NCT00091819|474965252|FG001|Overall Study|Withdrawal by Subject|8|||
131911970|NCT00091819|474965251|FG000|Overall Study|Protocol Violation|1|||
131911971|NCT00091819|474965252|FG001|Overall Study|Protocol Violation|2|||
131911972|NCT00091819|474965251|FG000|Overall Study|Other|2|||
131911973|NCT00091819|474965252|FG001|Overall Study|Other|3|||
131911974|NCT00091819|474965251|FG000|Overall Study|Never received study treatment|3|||
131911975|NCT00091819|474965252|FG001|Overall Study|Never received study treatment|4|||
131911976|NCT00984867|474965253|FG000|Overall Study|Adverse Event|3|||
131911977|NCT00984867|474965254|FG001|Overall Study|Adverse Event|7|||
131911978|NCT00984867|474965253|FG000|Overall Study|Death|1|||
131911979|NCT00984867|474965254|FG001|Overall Study|Death|0|||
131911980|NCT00984867|474965253|FG000|Overall Study|Withdrawal by Subject|13|||
131911981|NCT00984867|474965254|FG001|Overall Study|Withdrawal by Subject|4|||
131911982|NCT00984867|474965253|FG000|Overall Study|Lost to Follow-up|3|||
131911983|NCT00984867|474965254|FG001|Overall Study|Lost to Follow-up|4|||
131911984|NCT00984867|474965253|FG000|Overall Study|Poor/non-compliance|0|||
131911985|NCT00984867|474965254|FG001|Overall Study|Poor/non-compliance|1|||
131911986|NCT00984867|474965253|FG000|Overall Study|Subject no longer meets study criteria|1|||
131911987|NCT00984867|474965254|FG001|Overall Study|Subject no longer meets study criteria|1|||
131911988|NCT00984867|474965253|FG000|Overall Study|site closing|1|||
131911989|NCT00984867|474965254|FG001|Overall Study|site closing|0|||
131911990|NCT00984867|474965253|FG000|Overall Study|lack of efficacy and subject compliance|1|||
131911991|NCT00984867|474965254|FG001|Overall Study|lack of efficacy and subject compliance|0|||
131911992|NCT00634504|474965259|FG000|Overall Study|Protocol Violation|1|||
131911993|NCT00634504|474965260|FG001|Overall Study|Protocol Violation|0|||
131911994|NCT05001620|474965263|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
131911995|NCT05001620|474965264|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
131911996|NCT00676143|474965265|FG000|Overall Study|Adverse Event|34|||
131911997|NCT00676143|474965266|FG001|Overall Study|Adverse Event|60|||
131911998|NCT00676143|474965265|FG000|Overall Study|Death|4|||
131911999|NCT00676143|474965266|FG001|Overall Study|Death|4|||
131850564|NCT04784533|474730754|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
131850565|NCT04784533|474730755|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850566|NCT04784533|474730756|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850567|NCT04784533|474730757|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850568|NCT04784533|474730758|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850569|NCT04784533|474730759|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850570|NCT04784533|474730760|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850571|NCT04784533|474730761|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131912000|NCT00676143|474965265|FG000|Overall Study|Lack of Efficacy|0|||
131912001|NCT00676143|474965266|FG001|Overall Study|Lack of Efficacy|6|||
131912002|NCT00676143|474965265|FG000|Overall Study|Lost to Follow-up|0|||
131850572|NCT04784533|474730762|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
131850573|NCT04784533|474730753|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850574|NCT04784533|474730754|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
131850575|NCT04784533|474730755|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850576|NCT04784533|474730756|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850577|NCT04784533|474730757|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850578|NCT04784533|474730758|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850579|NCT04784533|474730759|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850580|NCT04784533|474730760|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131850581|NCT04784533|474730761|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131452335|NCT02578706|473284557|FG001|Overall Study|Physician Decision|1|||
131850582|NCT04784533|474730762|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
131912003|NCT00676143|474965266|FG001|Overall Study|Lost to Follow-up|13|||
131912004|NCT00676143|474965265|FG000|Overall Study|Physician Decision|5|||
131912005|NCT00676143|474965266|FG001|Overall Study|Physician Decision|8|||
131452336|NCT02578706|473284558|FG002|Overall Study|Physician Decision|0|||
131850583|NCT04784533|474730753|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
131912006|NCT00676143|474965265|FG000|Overall Study|Protocol Violation|4|||
131912007|NCT00676143|474965266|FG001|Overall Study|Protocol Violation|8|||
131912008|NCT00676143|474965265|FG000|Overall Study|Withdrawal by Subject|24|||
131912009|NCT00676143|474965266|FG001|Overall Study|Withdrawal by Subject|42|||
131912010|NCT00676143|474965265|FG000|Overall Study|Discontinuation of study by sponsor|65|||
131912011|NCT00676143|474965266|FG001|Overall Study|Discontinuation of study by sponsor|88|||
131912012|NCT00676143|474965265|FG000|Overall Study|Failed to return|2|||
131912013|NCT00676143|474965266|FG001|Overall Study|Failed to return|1|||
131912014|NCT00676143|474965265|FG000|Overall Study|Loss of caregiver|5|||
131452337|NCT02015637|473284560|FG000|Overall Study|Lost to Follow-up|3|||
131850584|NCT04784533|474730754|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850585|NCT04784533|474730755|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850586|NCT04784533|474730756|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850587|NCT04784533|474730757|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850588|NCT04784533|474730758|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850589|NCT04784533|474730759|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850590|NCT04784533|474730760|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850591|NCT04784533|474730761|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850592|NCT04784533|474730762|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131850593|NCT04784533|474730753|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
131850594|NCT04784533|474730754|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
131850595|NCT04784533|474730755|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850596|NCT04784533|474730756|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850597|NCT04784533|474730757|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850598|NCT04784533|474730758|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850599|NCT04784533|474730759|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850600|NCT04784533|474730760|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850601|NCT04784533|474730761|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850602|NCT04784533|474730762|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
131850603|NCT04784533|474730753|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
131850604|NCT04784533|474730754|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
131850605|NCT04784533|474730755|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850606|NCT04784533|474730756|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850607|NCT04784533|474730757|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850608|NCT04784533|474730758|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850609|NCT04784533|474730759|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850610|NCT04784533|474730760|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850611|NCT04784533|474730761|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850612|NCT04784533|474730762|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
131850613|NCT04784533|474730753|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850614|NCT04784533|474730754|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850615|NCT04784533|474730755|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
131850616|NCT04784533|474730756|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850617|NCT04784533|474730757|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850618|NCT04784533|474730758|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850619|NCT04784533|474730759|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850620|NCT04784533|474730760|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850621|NCT04784533|474730761|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850622|NCT04784533|474730762|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131850623|NCT04784533|474730753|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850624|NCT04784533|474730754|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850625|NCT04784533|474730755|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850626|NCT04784533|474730756|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850627|NCT04784533|474730757|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850628|NCT04784533|474730758|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850629|NCT04784533|474730759|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850630|NCT04784533|474730760|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850631|NCT04784533|474730761|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
131850632|NCT04784533|474730762|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131850633|NCT04784533|474730753|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850634|NCT04784533|474730754|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850635|NCT04784533|474730755|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850636|NCT04784533|474730756|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850637|NCT04784533|474730757|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850638|NCT04784533|474730758|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850639|NCT04784533|474730759|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850640|NCT04784533|474730760|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
131850641|NCT04784533|474730761|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
131850642|NCT04784533|474730762|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
131850643|NCT00340678|474730770|FG000|Overall Study|Lost to Follow-up|1|||
131850644|NCT00340678|474730771|FG001|Overall Study|Lost to Follow-up|0|||
131850645|NCT00340678|474730772|FG002|Overall Study|Lost to Follow-up|0|||
131850646|NCT00340678|474730773|FG003|Overall Study|Lost to Follow-up|0|||
131850647|NCT00708227|474730774|FG000|Overall Study|Physician Decision|0|||
131850648|NCT00708227|474730775|FG001|Overall Study|Physician Decision|3|||
131850649|NCT00708227|474730776|FG002|Overall Study|Physician Decision|1|||
131850650|NCT00708227|474730777|FG003|Overall Study|Physician Decision|2|||
131850651|NCT00708227|474730774|FG000|Overall Study|Withdrawal by Subject|1|||
131912015|NCT00676143|474965266|FG001|Overall Study|Loss of caregiver|3|||
131850652|NCT00708227|474730775|FG001|Overall Study|Withdrawal by Subject|2|||
131850653|NCT00708227|474730776|FG002|Overall Study|Withdrawal by Subject|0|||
131850654|NCT00708227|474730777|FG003|Overall Study|Withdrawal by Subject|1|||
131850655|NCT04007991|474730778|FG000|Overall Study|Withdrawal by Subject|1|||
131850656|NCT04007991|474730779|FG001|Overall Study|Withdrawal by Subject|1|||
131850657|NCT04007991|474730778|FG000|Overall Study|Physician Decision|1|||
131850658|NCT04007991|474730779|FG001|Overall Study|Physician Decision|1|||
131850659|NCT04007991|474730778|FG000|Overall Study|Non-compliance with Study Drug|0|||
131912016|NCT00676143|474965265|FG000|Overall Study|Other|11|||
131912017|NCT00676143|474965266|FG001|Overall Study|Other|20|||
131912018|NCT00676143|474965265|FG000|Overall Study|Participant participation unknown|1|||
131912019|NCT00676143|474965266|FG001|Overall Study|Participant participation unknown|4|||
131912020|NCT00676143|474965265|FG000|Overall Study|Vasogenic edema recurrence|1|||
131912021|NCT00676143|474965266|FG001|Overall Study|Vasogenic edema recurrence|3|||
131912022|NCT00481676|474965267|FG000|Overall Study|Adverse Event|0|||
131912023|NCT00481676|474965268|FG001|Overall Study|Adverse Event|1|||
131912024|NCT00481676|474965267|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131912025|NCT00481676|474965268|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131912026|NCT00481676|474965267|FG000|Overall Study|Administrative problem|1|||
131912027|NCT00481676|474965268|FG001|Overall Study|Administrative problem|0|||
131452338|NCT02015637|473284561|FG001|Overall Study|Lost to Follow-up|5|||
131850660|NCT04007991|474730779|FG001|Overall Study|Non-compliance with Study Drug|1|||
131850661|NCT04007991|474730778|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
131850662|NCT04007991|474730779|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
131850663|NCT04007991|474730778|FG000|Overall Study|Adverse event, non-fatal|5|||
131850664|NCT04007991|474730779|FG001|Overall Study|Adverse event, non-fatal|0|||
131850665|NCT04007991|474730778|FG000|Overall Study|Lost to Follow-up|2|||
131850666|NCT04007991|474730779|FG001|Overall Study|Lost to Follow-up|1|||
131850667|NCT05314816|474730780|FG000|Overall Study|Lost to Follow-up|5|||
131850668|NCT05314816|474730781|FG001|Overall Study|Lost to Follow-up|0|||
131850669|NCT05314816|474730782|FG002|Overall Study|Lost to Follow-up|1|||
131850670|NCT05314816|474730780|FG000|Overall Study|Protocol Violation|13|||
131850671|NCT05314816|474730781|FG001|Overall Study|Protocol Violation|8|||
131850672|NCT05314816|474730782|FG002|Overall Study|Protocol Violation|0|||
131850673|NCT01200069|474732237|FG000|Overall Study|Withdrawal by Subject|0|||
131850674|NCT01200069|474732238|FG001|Overall Study|Withdrawal by Subject|1|||
131850675|NCT01924754|474732249|FG000|Overall Study|Lost to Follow-up|1|||
131850676|NCT01924754|474732250|FG001|Overall Study|Lost to Follow-up|2|||
131850677|NCT01924754|474732251|FG002|Overall Study|Lost to Follow-up|1|||
131850678|NCT01924754|474732249|FG000|Overall Study|Pregnancy|0|||
131850679|NCT01924754|474732250|FG001|Overall Study|Pregnancy|1|||
131850680|NCT01924754|474732251|FG002|Overall Study|Pregnancy|2|||
131850681|NCT03092219|474732252|FG000|Overall Study|Protocol Violation|7|||
131850682|NCT03092219|474732253|FG001|Overall Study|Protocol Violation|4|||
131850683|NCT02207634|474732254|FG000|Overall Study|Withdrawal by Subject|21|||
131850684|NCT02207634|474732255|FG001|Overall Study|Withdrawal by Subject|31|||
131850685|NCT02207634|474732254|FG000|Overall Study|Lost to Follow-up|1|||
131850686|NCT02207634|474732255|FG001|Overall Study|Lost to Follow-up|0|||
131850687|NCT00591773|474732256|FG000|Overall Study|Adverse Event|9|||
131850688|NCT00591773|474732257|FG001|Overall Study|Adverse Event|9|||
131850689|NCT00591773|474732258|FG002|Overall Study|Adverse Event|6|||
131850690|NCT00591773|474732256|FG000|Overall Study|Protocol Violation|2|||
131850691|NCT00591773|474732257|FG001|Overall Study|Protocol Violation|3|||
131850692|NCT00591773|474732258|FG002|Overall Study|Protocol Violation|0|||
131850693|NCT00591773|474732256|FG000|Overall Study|Lost to Follow-up|1|||
131850694|NCT00591773|474732257|FG001|Overall Study|Lost to Follow-up|4|||
131850695|NCT00591773|474732258|FG002|Overall Study|Lost to Follow-up|1|||
131850696|NCT00591773|474732256|FG000|Overall Study|Withdrawal by Subject|2|||
131850697|NCT00591773|474732257|FG001|Overall Study|Withdrawal by Subject|5|||
131850698|NCT00591773|474732258|FG002|Overall Study|Withdrawal by Subject|3|||
131850699|NCT00591773|474732256|FG000|Overall Study|Lack of Efficacy|1|||
131850700|NCT00591773|474732257|FG001|Overall Study|Lack of Efficacy|2|||
131850701|NCT00591773|474732258|FG002|Overall Study|Lack of Efficacy|2|||
131912028|NCT03937778|474965269|FG000|Overall Study|Withdrawal by Subject|1|||
131912029|NCT03937778|474965269|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
131850702|NCT00591773|474732256|FG000|Overall Study|Other|1|||
131850703|NCT00591773|474732257|FG001|Overall Study|Other|1|||
131850704|NCT00591773|474732258|FG002|Overall Study|Other|4|||
131850705|NCT02114385|474732274|FG000|Overall Study|Withdrawal by Subject|3|||
131850706|NCT02114385|474732275|FG001|Overall Study|Withdrawal by Subject|2|||
131850707|NCT02114385|474732274|FG000|Overall Study|Lost to Follow-up|0|||
131850708|NCT02114385|474732275|FG001|Overall Study|Lost to Follow-up|6|||
131850709|NCT02533180|474732276|FG000|Overall Study|Death|0|||
131850710|NCT02533180|474732277|FG001|Overall Study|Death|2|||
131850711|NCT02533180|474732276|FG000|Overall Study|Lost to Follow-up|0|||
131850712|NCT02533180|474732277|FG001|Overall Study|Lost to Follow-up|1|||
131850713|NCT02533180|474732276|FG000|Overall Study|Physician Decision|0|||
131850714|NCT02533180|474732277|FG001|Overall Study|Physician Decision|1|||
131452339|NCT02015637|473284560|FG000|Overall Study|Adverse Event|3|||
131452340|NCT02015637|473284561|FG001|Overall Study|Adverse Event|0|||
131452341|NCT02015637|473284560|FG000|Overall Study|Did not take study drug|2|||
131452342|NCT02015637|473284561|FG001|Overall Study|Did not take study drug|0|||
131452343|NCT02223858|473284564|FG000|Overall Study|Death|1|||
131452344|NCT02223858|473284565|FG001|Overall Study|Death|1|||
131452345|NCT02223858|473284564|FG000|Overall Study|Lost to Follow-up|6|||
131452346|NCT02223858|473284565|FG001|Overall Study|Lost to Follow-up|11|||
131452347|NCT02223858|473284564|FG000|Overall Study|Withdrawal by Subject|8|||
131452348|NCT02223858|473284565|FG001|Overall Study|Withdrawal by Subject|5|||
131452349|NCT02223858|473284564|FG000|Overall Study|Refused|9|||
131452350|NCT02223858|473284565|FG001|Overall Study|Refused|9|||
131452351|NCT04455815|473284568|FG000|Randomisation Phase|Adverse Event|1|||
131452352|NCT04455815|473284569|FG001|Randomisation Phase|Adverse Event|0|||
131452353|NCT04455815|473284568|FG000|Treatment Phase|Adverse Event|0|||
131452354|NCT04455815|473284569|FG001|Treatment Phase|Adverse Event|1|||
131452355|NCT04455815|473284568|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
131850715|NCT02533180|474732276|FG000|Overall Study|Withdrawal by Subject|2|||
131850716|NCT02533180|474732277|FG001|Overall Study|Withdrawal by Subject|5|||
131850717|NCT02533180|474732276|FG000|Overall Study|Screen Failure|37|||
131850718|NCT02533180|474732277|FG001|Overall Study|Screen Failure|0|||
131850719|NCT02533180|474732276|FG000|Overall Study|Protocol Deviation|0|||
131850720|NCT02533180|474732277|FG001|Overall Study|Protocol Deviation|1|||
131850721|NCT02533180|474732276|FG000|Overall Study|Non-compliance|0|||
131850722|NCT02533180|474732277|FG001|Overall Study|Non-compliance|1|||
131850723|NCT00005957|474732278|FG000|Overall Study|No treated|3|||
131850724|NCT00005957|474732279|FG001|Overall Study|No treated|9|||
131850725|NCT00005957|474732278|FG000|Overall Study|Crossover to the other arm|5|||
131850726|NCT00005957|474732279|FG001|Overall Study|Crossover to the other arm|19|||
131850727|NCT01609023|474732280|FG000|Overall Study|Lack of Efficacy|3|||
131850728|NCT01609023|474732280|FG000|Overall Study|Withdrawal by Subject|4|||
131850729|NCT01609023|474732280|FG000|Overall Study|Lost to Follow-up|8|||
131850730|NCT01609023|474732280|FG000|Overall Study|Toxicity|3|||
131850731|NCT01609023|474732280|FG000|Overall Study|Disease progression|10|||
131850732|NCT01609023|474732280|FG000|Overall Study|Physician Decision|2|||
131850733|NCT01609023|474732280|FG000|Overall Study|Death|2|||
131850734|NCT01609023|474732280|FG000|Overall Study|Personal reasons|1|||
131850735|NCT02047734|474732281|FG000|Overall Study|Adverse Event|18|||
131850736|NCT02047734|474732282|FG001|Overall Study|Adverse Event|13|||
131850737|NCT02047734|474732283|FG002|Overall Study|Adverse Event|13|||
131850738|NCT02047734|474732281|FG000|Overall Study|Lack of Efficacy|4|||
131850739|NCT02047734|474732282|FG001|Overall Study|Lack of Efficacy|5|||
131850740|NCT02047734|474732283|FG002|Overall Study|Lack of Efficacy|1|||
131850741|NCT02047734|474732281|FG000|Overall Study|Protocol Violation|3|||
131850742|NCT02047734|474732282|FG001|Overall Study|Protocol Violation|1|||
131850743|NCT02047734|474732283|FG002|Overall Study|Protocol Violation|1|||
131850744|NCT02047734|474732281|FG000|Overall Study|Lost to Follow-up|1|||
131850745|NCT02047734|474732282|FG001|Overall Study|Lost to Follow-up|4|||
131850746|NCT02047734|474732283|FG002|Overall Study|Lost to Follow-up|0|||
131850747|NCT02047734|474732281|FG000|Overall Study|Death|0|||
131850748|NCT02047734|474732282|FG001|Overall Study|Death|1|||
131850749|NCT02047734|474732283|FG002|Overall Study|Death|0|||
131850750|NCT02047734|474732281|FG000|Overall Study|Withdrawal by Subject|30|||
131850751|NCT02047734|474732282|FG001|Overall Study|Withdrawal by Subject|31|||
131850752|NCT02047734|474732283|FG002|Overall Study|Withdrawal by Subject|19|||
131850753|NCT02047734|474732281|FG000|Overall Study|Physician Decision|7|||
131850754|NCT02047734|474732282|FG001|Overall Study|Physician Decision|6|||
131850755|NCT02047734|474732283|FG002|Overall Study|Physician Decision|5|||
131850756|NCT02047734|474732281|FG000|Overall Study|Miscellaneous|2|||
131850757|NCT02047734|474732282|FG001|Overall Study|Miscellaneous|4|||
131452356|NCT04455815|473284569|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
131452357|NCT04455815|473284568|FG000|Treatment Phase|Withdrawal by Subject|1|||
131452358|NCT04455815|473284569|FG001|Treatment Phase|Withdrawal by Subject|1|||
131452359|NCT02106390|473284570|FG000|Overall Study|Withdrawal by Subject|15|||
131912030|NCT00819039|474965270|FG000|Overall Study|Physician Decision|1|||
131912031|NCT00819039|474965271|FG001|Overall Study|Physician Decision|0|||
131452360|NCT02106390|473284571|FG001|Overall Study|Withdrawal by Subject|16|||
131452361|NCT02106390|473284572|FG002|Overall Study|Withdrawal by Subject|15|||
131452362|NCT02106390|473284570|FG000|Overall Study|Lost to Follow-up|25|||
131850758|NCT02047734|474732283|FG002|Overall Study|Miscellaneous|6|||
131850759|NCT02047734|474732281|FG000|Overall Study|Did Not Receive Study Drug|2|||
131850760|NCT02047734|474732282|FG001|Overall Study|Did Not Receive Study Drug|4|||
131850761|NCT02047734|474732283|FG002|Overall Study|Did Not Receive Study Drug|1|||
131850762|NCT00799825|474732288|FG000|Overall Study|Adverse Event|1|||
131850763|NCT00799825|474732288|FG000|Overall Study|Withdrawal by Subject|6|||
131452363|NCT02106390|473284571|FG001|Overall Study|Lost to Follow-up|20|||
131850764|NCT00799825|474732288|FG000|Overall Study|Lost to Follow-up|38|||
131850765|NCT00799825|474732288|FG000|Overall Study|Pregnancy|3|||
131850766|NCT03066258|474732292|FG000|Overall Study|Death|1|||
131850767|NCT03066258|474732293|FG001|Overall Study|Death|0|||
131850768|NCT03066258|474732294|FG002|Overall Study|Death|0|||
131850769|NCT03066258|474732295|FG003|Overall Study|Death|0|||
131850770|NCT03066258|474732296|FG004|Overall Study|Death|1|||
131912032|NCT00819039|474965272|FG002|Overall Study|Physician Decision|1|||
131912033|NCT00819039|474965270|FG000|Overall Study|Protocol Violation|1|||
131912034|NCT00819039|474965271|FG001|Overall Study|Protocol Violation|0|||
131850771|NCT02165735|474732297|FG000|Overall Study|Lost to Follow-up|12|||
131850772|NCT02165735|474732298|FG001|Overall Study|Lost to Follow-up|10|||
131850773|NCT02165735|474732297|FG000|Overall Study|Withdrawal by Subject|3|||
131850774|NCT02165735|474732298|FG001|Overall Study|Withdrawal by Subject|0|||
131850775|NCT02165735|474732297|FG000|Overall Study|Participant indicated lack of time|1|||
131850776|NCT02165735|474732298|FG001|Overall Study|Participant indicated lack of time|3|||
131850777|NCT02165735|474732297|FG000|Overall Study|Protocol Violation|0|||
131850778|NCT02165735|474732298|FG001|Overall Study|Protocol Violation|1|||
131850779|NCT02784795|474732299|FG000|Overall Study|Progressive Disease|2|||
131850780|NCT02784795|474732300|FG001|Overall Study|Progressive Disease|1|||
131850781|NCT02784795|474732301|FG002|Overall Study|Progressive Disease|1|||
131850782|NCT02784795|474732302|FG003|Overall Study|Progressive Disease|0|||
131912035|NCT00819039|474965272|FG002|Overall Study|Protocol Violation|0|||
131912036|NCT01513590|474965273|FG000|Overall Study|Adverse Event|2|||
131912037|NCT01513590|474965274|FG001|Overall Study|Adverse Event|3|||
131912038|NCT01513590|474965273|FG000|Overall Study|Withdrawal Criteria|3|||
131912039|NCT01513590|474965274|FG001|Overall Study|Withdrawal Criteria|0|||
131912040|NCT01513590|474965273|FG000|Overall Study|Unclassified|5|||
131912041|NCT01513590|474965274|FG001|Overall Study|Unclassified|10|||
131912042|NCT01240694|474965275|FG000|Overall Study|Adverse Event|9|||
131912043|NCT01240694|474965275|FG000|Overall Study|Lack of Efficacy|6|||
131912044|NCT01240694|474965275|FG000|Overall Study|Withdrawal by Subject|6|||
131912045|NCT01240694|474965275|FG000|Overall Study|Protocol Violation|2|||
131912046|NCT01240694|474965275|FG000|Overall Study|Lost to Follow-up|2|||
131850783|NCT02784795|474732303|FG004|Overall Study|Progressive Disease|2|||
131850784|NCT02784795|474732304|FG005|Overall Study|Progressive Disease|0|||
131850785|NCT02784795|474732305|FG006|Overall Study|Progressive Disease|2|||
131850786|NCT02784795|474732306|FG007|Overall Study|Progressive Disease|0|||
131850787|NCT02784795|474732307|FG008|Overall Study|Progressive Disease|0|||
131850788|NCT02784795|474732308|FG009|Overall Study|Progressive Disease|0|||
131850789|NCT02784795|474732309|FG010|Overall Study|Progressive Disease|1|||
131850790|NCT02784795|474732310|FG011|Overall Study|Progressive Disease|0|||
131850791|NCT02784795|474732299|FG000|Overall Study|Adverse Event|1|||
131850792|NCT02784795|474732300|FG001|Overall Study|Adverse Event|0|||
131850793|NCT02784795|474732301|FG002|Overall Study|Adverse Event|0|||
131850794|NCT02784795|474732302|FG003|Overall Study|Adverse Event|1|||
131850795|NCT02784795|474732303|FG004|Overall Study|Adverse Event|0|||
131850796|NCT02784795|474732304|FG005|Overall Study|Adverse Event|0|||
131850797|NCT02784795|474732305|FG006|Overall Study|Adverse Event|1|||
131850798|NCT02784795|474732306|FG007|Overall Study|Adverse Event|0|||
131850799|NCT02784795|474732307|FG008|Overall Study|Adverse Event|0|||
131850800|NCT02784795|474732308|FG009|Overall Study|Adverse Event|0|||
131850801|NCT02784795|474732309|FG010|Overall Study|Adverse Event|0|||
131850802|NCT02784795|474732310|FG011|Overall Study|Adverse Event|2|||
131850803|NCT02784795|474732299|FG000|Overall Study|Withdrawal by Subject|1|||
131850804|NCT02784795|474732300|FG001|Overall Study|Withdrawal by Subject|0|||
131850805|NCT02784795|474732301|FG002|Overall Study|Withdrawal by Subject|2|||
131850806|NCT02784795|474732302|FG003|Overall Study|Withdrawal by Subject|1|||
131850807|NCT02784795|474732303|FG004|Overall Study|Withdrawal by Subject|3|||
131850808|NCT02784795|474732304|FG005|Overall Study|Withdrawal by Subject|0|||
131850809|NCT02784795|474732305|FG006|Overall Study|Withdrawal by Subject|0|||
131850810|NCT02784795|474732306|FG007|Overall Study|Withdrawal by Subject|1|||
131850811|NCT02784795|474732307|FG008|Overall Study|Withdrawal by Subject|0|||
131850812|NCT02784795|474732308|FG009|Overall Study|Withdrawal by Subject|0|||
131850813|NCT02784795|474732309|FG010|Overall Study|Withdrawal by Subject|0|||
131850814|NCT02784795|474732310|FG011|Overall Study|Withdrawal by Subject|2|||
131850815|NCT02784795|474732299|FG000|Overall Study|Death|0|||
131850816|NCT02784795|474732300|FG001|Overall Study|Death|0|||
131850817|NCT02784795|474732301|FG002|Overall Study|Death|0|||
131850818|NCT02784795|474732302|FG003|Overall Study|Death|0|||
131850819|NCT02784795|474732303|FG004|Overall Study|Death|1|||
131850820|NCT02784795|474732304|FG005|Overall Study|Death|0|||
131912047|NCT01240694|474965275|FG000|Overall Study|Other than specified|3|||
131850821|NCT02784795|474732305|FG006|Overall Study|Death|0|||
131850822|NCT02784795|474732306|FG007|Overall Study|Death|0|||
131850823|NCT02784795|474732307|FG008|Overall Study|Death|0|||
131850824|NCT02784795|474732308|FG009|Overall Study|Death|0|||
131850825|NCT02784795|474732309|FG010|Overall Study|Death|0|||
131850826|NCT02784795|474732310|FG011|Overall Study|Death|0|||
131850827|NCT02784795|474732299|FG000|Overall Study|Physician Decision|0|||
131850828|NCT02784795|474732300|FG001|Overall Study|Physician Decision|0|||
131850829|NCT02784795|474732301|FG002|Overall Study|Physician Decision|0|||
131912048|NCT01240694|474965275|FG000|Overall Study|Withdrawn due to early study termination|107|||
131912049|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
131452364|NCT02106390|473284572|FG002|Overall Study|Lost to Follow-up|13|||
131452365|NCT02106390|473284570|FG000|Overall Study|Other: Administrative Reason|8|||
131452366|NCT02106390|473284571|FG001|Overall Study|Other: Administrative Reason|5|||
131452367|NCT02106390|473284572|FG002|Overall Study|Other: Administrative Reason|12|||
131452368|NCT02106390|473284570|FG000|Overall Study|Other: Unspecified|1|||
131452369|NCT02106390|473284571|FG001|Overall Study|Other: Unspecified|4|||
131452370|NCT02106390|473284572|FG002|Overall Study|Other: Unspecified|2|||
131850830|NCT02784795|474732302|FG003|Overall Study|Physician Decision|0|||
131912050|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
131452371|NCT02106390|473284570|FG000|Overall Study|Adverse Event|0|||
131452372|NCT02106390|473284571|FG001|Overall Study|Adverse Event|2|||
131452373|NCT02106390|473284572|FG002|Overall Study|Adverse Event|1|||
131452374|NCT02106390|473284570|FG000|Overall Study|Protocol Violation|0|||
131452375|NCT02106390|473284571|FG001|Overall Study|Protocol Violation|1|||
131452376|NCT02106390|473284572|FG002|Overall Study|Protocol Violation|0|||
131452377|NCT03198507|473284573|FG000|Overall Study|Withdrawal by Subject|1|||
131452378|NCT03198507|473284574|FG001|Overall Study|Withdrawal by Subject|0|||
131452379|NCT01470326|473284577|FG000|Overall Study|Protocol Violation|32|||
131452380|NCT01470326|473284577|FG000|Overall Study|No Drug Administration Information|2|||
131452381|NCT01470326|473284577|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
131452382|NCT01166282|473284578|FG000|Open-label Period|Adverse Event|0|||
131452383|NCT01166282|473284579|FG001|Open-label Period|Adverse Event|0|||
131452384|NCT01166282|473284580|FG002|Open-label Period|Adverse Event|6|||
131452385|NCT01166282|473284578|FG000|Open-label Period|Withdrawal by Subject|0|||
131452386|NCT01166282|473284579|FG001|Open-label Period|Withdrawal by Subject|0|||
131452387|NCT01166282|473284580|FG002|Open-label Period|Withdrawal by Subject|4|||
131452388|NCT01166282|473284578|FG000|Open-label Period|Lack of Efficacy|0|||
131452389|NCT01166282|473284579|FG001|Open-label Period|Lack of Efficacy|0|||
131452390|NCT01166282|473284580|FG002|Open-label Period|Lack of Efficacy|2|||
131452391|NCT01166282|473284578|FG000|Open-label Period|Remission|0|||
131452392|NCT01166282|473284579|FG001|Open-label Period|Remission|0|||
131452393|NCT01166282|473284580|FG002|Open-label Period|Remission|4|||
131452394|NCT01166282|473284578|FG000|Open-label Period|Irregular Compliance|0|||
131452395|NCT01166282|473284579|FG001|Open-label Period|Irregular Compliance|0|||
131452396|NCT01166282|473284580|FG002|Open-label Period|Irregular Compliance|1|||
131452397|NCT02577718|473284581|FG000|Overall Study|Death|6|||
131452398|NCT02577718|473284581|FG000|Overall Study|Withdrawal by Subject|2|||
131452399|NCT01995838|473284582|FG000|Overall Study|Lost to Follow-up|0|||
131452400|NCT01995838|473284583|FG001|Overall Study|Lost to Follow-up|1|||
131452401|NCT01995838|473284584|FG002|Overall Study|Lost to Follow-up|0|||
131452402|NCT01995838|473284585|FG003|Overall Study|Lost to Follow-up|0|||
131850831|NCT02784795|474732303|FG004|Overall Study|Physician Decision|0|||
131850832|NCT02784795|474732304|FG005|Overall Study|Physician Decision|0|||
131850833|NCT02784795|474732305|FG006|Overall Study|Physician Decision|1|||
131850834|NCT02784795|474732306|FG007|Overall Study|Physician Decision|0|||
131850835|NCT02784795|474732307|FG008|Overall Study|Physician Decision|0|||
131850836|NCT02784795|474732308|FG009|Overall Study|Physician Decision|0|||
131850837|NCT02784795|474732309|FG010|Overall Study|Physician Decision|0|||
131850838|NCT02784795|474732310|FG011|Overall Study|Physician Decision|0|||
131850839|NCT00626561|474732311|FG000|Overall Study|Withdrawal by Subject|2|||
131850840|NCT00626561|474732311|FG000|Overall Study|Disease Progression|2|||
131850841|NCT00595309|474732312|FG000|Overall Study|Lost to Follow-up|1|||
131850842|NCT00595309|474732312|FG000|Overall Study|planned vaccination against yellow fever|1|||
131850843|NCT00595309|474732312|FG000|Overall Study|acute infection after V0|1|||
131850844|NCT00595309|474732312|FG000|Overall Study|personal reason|1|||
131850845|NCT00101283|474732315|FG000|Overall Study|Withdrawal by Subject|0|||
131850846|NCT00101283|474732316|FG001|Overall Study|Withdrawal by Subject|1|||
131850847|NCT00101283|474732315|FG000|Overall Study|Insurance Refusal|0|||
131850848|NCT00101283|474732316|FG001|Overall Study|Insurance Refusal|1|||
131850849|NCT00101283|474732315|FG000|Overall Study|Prostate Cancer Recurrence|0|||
131850850|NCT00101283|474732316|FG001|Overall Study|Prostate Cancer Recurrence|1|||
131912051|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
131850851|NCT00398866|474732323|FG000|Overall Study|Adverse Event|1|||
131850852|NCT00398866|474732324|FG001|Overall Study|Adverse Event|0|||
131850853|NCT00398866|474732325|FG002|Overall Study|Adverse Event|0|||
131850854|NCT00398866|474732323|FG000|Overall Study|Lack of Efficacy|0|||
131850855|NCT00398866|474732324|FG001|Overall Study|Lack of Efficacy|0|||
131850856|NCT00398866|474732325|FG002|Overall Study|Lack of Efficacy|1|||
131452403|NCT01995838|473284586|FG004|Overall Study|Lost to Follow-up|0|||
131452404|NCT01995838|473284587|FG005|Overall Study|Lost to Follow-up|0|||
131452405|NCT01995838|473284588|FG006|Overall Study|Lost to Follow-up|1|||
131452406|NCT01995838|473284582|FG000|Overall Study|Participant choice|2|||
131452407|NCT01995838|473284583|FG001|Overall Study|Participant choice|0|||
131452408|NCT01995838|473284584|FG002|Overall Study|Participant choice|0|||
131452409|NCT01995838|473284585|FG003|Overall Study|Participant choice|0|||
131452410|NCT01995838|473284586|FG004|Overall Study|Participant choice|0|||
131452411|NCT01995838|473284587|FG005|Overall Study|Participant choice|1|||
131452412|NCT01995838|473284588|FG006|Overall Study|Participant choice|1|||
131850857|NCT00398866|474732323|FG000|Overall Study|Lost to Follow-up|7|||
131850858|NCT00398866|474732324|FG001|Overall Study|Lost to Follow-up|6|||
131850859|NCT00398866|474732325|FG002|Overall Study|Lost to Follow-up|4|||
131850860|NCT00398866|474732323|FG000|Overall Study|Withdrawal by Subject|5|||
131850861|NCT00398866|474732324|FG001|Overall Study|Withdrawal by Subject|1|||
131850862|NCT00398866|474732325|FG002|Overall Study|Withdrawal by Subject|2|||
131850863|NCT00398866|474732323|FG000|Overall Study|Unable to complete requirements of study|1|||
131850864|NCT00398866|474732324|FG001|Overall Study|Unable to complete requirements of study|1|||
131850865|NCT00398866|474732325|FG002|Overall Study|Unable to complete requirements of study|1|||
131850866|NCT00182325|474732334|FG000|Overall Study|Lost to Follow-up|7|||
131850867|NCT00182325|474732335|FG001|Overall Study|Lost to Follow-up|7|||
131850868|NCT00182325|474732334|FG000|Overall Study|Miscarriage|5|||
131850869|NCT00182325|474732335|FG001|Overall Study|Miscarriage|3|||
131850870|NCT00182325|474732334|FG000|Overall Study|Did not complete survey|22|||
131850871|NCT00182325|474732335|FG001|Overall Study|Did not complete survey|43|||
131850872|NCT01420965|474732340|FG000|Overall Study|Withdrawal by Subject|1|||
131850873|NCT01420965|474732341|FG001|Overall Study|Withdrawal by Subject|0|||
131850874|NCT01420965|474732342|FG002|Overall Study|Withdrawal by Subject|0|||
131850875|NCT01420965|474732340|FG000|Overall Study|Adverse Event|0|||
131850876|NCT01420965|474732341|FG001|Overall Study|Adverse Event|1|||
131850877|NCT01420965|474732342|FG002|Overall Study|Adverse Event|0|||
131850878|NCT00339144|474732347|FG000|Overall Study|Disease progression|5|||
131850879|NCT00339144|474732348|FG001|Overall Study|Disease progression|2|||
131850880|NCT00339144|474732349|FG002|Overall Study|Disease progression|2|||
131850881|NCT00339144|474732347|FG000|Overall Study|Study drug toxicity|3|||
131850882|NCT00339144|474732348|FG001|Overall Study|Study drug toxicity|1|||
131850883|NCT00339144|474732349|FG002|Overall Study|Study drug toxicity|1|||
131850884|NCT00339144|474732347|FG000|Overall Study|Participant's request to discontinuation|1|||
131850885|NCT00339144|474732348|FG001|Overall Study|Participant's request to discontinuation|0|||
131850886|NCT00339144|474732349|FG002|Overall Study|Participant's request to discontinuation|1|||
131850887|NCT01890434|474732350|FG000|Overall Study|Adverse Event|8|||
131850888|NCT01890434|474732350|FG000|Overall Study|PCI at external hospital|1|||
131850889|NCT01890434|474732350|FG000|Overall Study|Assessment discrepancy|1|||
131850890|NCT01890434|474732350|FG000|Overall Study|CRC didn't contact participant for FU|1|||
131850891|NCT01890434|474732350|FG000|Overall Study|Could not get whole set of images|1|||
131850892|NCT01890434|474732350|FG000|Overall Study|Decline to return for GSPECT|1|||
131850893|NCT01890434|474732350|FG000|Overall Study|GSPECT at rest was not done|1|||
131850894|NCT01890434|474732350|FG000|Overall Study|Participant didn't complete MRI|1|||
131850895|NCT01890434|474732350|FG000|Overall Study|Uncontactable by phone|1|||
131850896|NCT01890434|474732350|FG000|Overall Study|Moved out of position|1|||
131850897|NCT01890434|474732350|FG000|Overall Study|Unable to contact|1|||
131850898|NCT01890434|474732350|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
131850899|NCT02655666|474732353|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
131850900|NCT01267994|474732354|FG000|Overall Study|Adverse Event|2|||
131850901|NCT03837743|474732355|FG000|Overall Study|Adverse Event|1|||
131850902|NCT03837743|474732355|FG000|Overall Study|Withdrawal by Subject|2|||
131850903|NCT02257385|474732357|FG000|Overall Study|Adverse Event|12|||
131850904|NCT02257385|474732358|FG001|Overall Study|Adverse Event|8|||
131850905|NCT02257385|474732357|FG000|Overall Study|Lack of Efficacy|1|||
131850906|NCT02257385|474732358|FG001|Overall Study|Lack of Efficacy|2|||
131850907|NCT02257385|474732357|FG000|Overall Study|Protocol Violation|5|||
131850908|NCT02257385|474732358|FG001|Overall Study|Protocol Violation|7|||
131850909|NCT02257385|474732357|FG000|Overall Study|Lost to Follow-up|0|||
131850910|NCT02257385|474732358|FG001|Overall Study|Lost to Follow-up|1|||
131850911|NCT02257385|474732357|FG000|Overall Study|Withdrawal by Subject|4|||
131850912|NCT02257385|474732358|FG001|Overall Study|Withdrawal by Subject|4|||
131850913|NCT05199090|474732361|FG000|Overall Study|Adverse Event|1|||
131850914|NCT05199090|474732362|FG001|Overall Study|Adverse Event|4|||
131850915|NCT05199090|474732363|FG002|Overall Study|Adverse Event|0|||
131850916|NCT05199090|474732364|FG003|Overall Study|Adverse Event|0|||
131850917|NCT05199090|474732365|FG004|Overall Study|Adverse Event|0|||
131850918|NCT05199090|474732366|FG005|Overall Study|Adverse Event|0|||
131850919|NCT05199090|474732361|FG000|Overall Study|Lost to Follow-up|1|||
131850920|NCT05199090|474732362|FG001|Overall Study|Lost to Follow-up|0|||
131850921|NCT05199090|474732363|FG002|Overall Study|Lost to Follow-up|1|||
131850922|NCT05199090|474732364|FG003|Overall Study|Lost to Follow-up|4|||
131850923|NCT05199090|474732365|FG004|Overall Study|Lost to Follow-up|0|||
131850924|NCT05199090|474732366|FG005|Overall Study|Lost to Follow-up|5|||
131850925|NCT05199090|474732361|FG000|Overall Study|Physician Decision|0|||
131850926|NCT05199090|474732362|FG001|Overall Study|Physician Decision|0|||
131850927|NCT05199090|474732363|FG002|Overall Study|Physician Decision|0|||
131850928|NCT05199090|474732364|FG003|Overall Study|Physician Decision|0|||
131850929|NCT05199090|474732365|FG004|Overall Study|Physician Decision|0|||
131850930|NCT05199090|474732366|FG005|Overall Study|Physician Decision|1|||
131850931|NCT05199090|474732361|FG000|Overall Study|Study terminated by sponsor|0|||
131850932|NCT05199090|474732362|FG001|Overall Study|Study terminated by sponsor|6|||
131850933|NCT05199090|474732363|FG002|Overall Study|Study terminated by sponsor|0|||
131850934|NCT05199090|474732364|FG003|Overall Study|Study terminated by sponsor|0|||
131452413|NCT01995838|473284582|FG000|Overall Study|Adverse Event|0|||
131452414|NCT01995838|473284583|FG001|Overall Study|Adverse Event|0|||
131452415|NCT01995838|473284584|FG002|Overall Study|Adverse Event|0|||
131452416|NCT01995838|473284585|FG003|Overall Study|Adverse Event|0|||
131452417|NCT01995838|473284586|FG004|Overall Study|Adverse Event|0|||
131452418|NCT01995838|473284587|FG005|Overall Study|Adverse Event|0|||
131452419|NCT01995838|473284588|FG006|Overall Study|Adverse Event|1|||
131452420|NCT01995838|473284582|FG000|Overall Study|Withdrawal by Subject|0|||
131452421|NCT01995838|473284583|FG001|Overall Study|Withdrawal by Subject|0|||
131452422|NCT01995838|473284584|FG002|Overall Study|Withdrawal by Subject|0|||
131452423|NCT01995838|473284585|FG003|Overall Study|Withdrawal by Subject|0|||
131452424|NCT01995838|473284586|FG004|Overall Study|Withdrawal by Subject|1|||
131452425|NCT01995838|473284587|FG005|Overall Study|Withdrawal by Subject|0|||
131452426|NCT01995838|473284588|FG006|Overall Study|Withdrawal by Subject|0|||
131452427|NCT01995838|473284582|FG000|Overall Study|Other|3|||
131452428|NCT01995838|473284583|FG001|Overall Study|Other|1|||
131452429|NCT01995838|473284584|FG002|Overall Study|Other|0|||
131452430|NCT01995838|473284585|FG003|Overall Study|Other|2|||
131452431|NCT01995838|473284586|FG004|Overall Study|Other|1|||
131452432|NCT01995838|473284587|FG005|Overall Study|Other|1|||
131452433|NCT01995838|473284588|FG006|Overall Study|Other|2|||
131452434|NCT00380367|473284595|FG000|Overall Study|Lost to Follow-up|1|||
131452435|NCT00380367|473284595|FG000|Overall Study|Withdrawal by Subject|1|||
131452436|NCT00392769|473284597|FG000|Overall Study|Clinical Deterioration|9|||
131452437|NCT00392769|473284597|FG000|Overall Study|Adverse Event|1|||
131452438|NCT01519921|473284604|FG000|Overall Study|Adverse Event|10|||
131452439|NCT01519921|473284605|FG001|Overall Study|Adverse Event|9|||
131452440|NCT01519921|473284604|FG000|Overall Study|Lack of Efficacy|4|||
131452441|NCT01519921|473284605|FG001|Overall Study|Lack of Efficacy|3|||
131452442|NCT01519921|473284604|FG000|Overall Study|Withdrawal by Subject|3|||
131452443|NCT01519921|473284605|FG001|Overall Study|Withdrawal by Subject|0|||
131452444|NCT01519921|473284604|FG000|Overall Study|Lost to Follow-up|2|||
131452445|NCT01519921|473284605|FG001|Overall Study|Lost to Follow-up|1|||
131452446|NCT01519921|473284604|FG000|Overall Study|Treatment refusal|2|||
131452447|NCT01519921|473284605|FG001|Overall Study|Treatment refusal|1|||
131452448|NCT01519921|473284604|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
131452449|NCT01519921|473284605|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
131452450|NCT00125164|473284612|FG000|Overall Study|Adverse Event|0|||
131452451|NCT00125164|473284613|FG001|Overall Study|Adverse Event|0|||
131452452|NCT00125164|473284614|FG002|Overall Study|Adverse Event|2|||
131452453|NCT00125164|473284615|FG003|Overall Study|Adverse Event|4|||
131452454|NCT00125164|473284612|FG000|Overall Study|Lost to Follow-up|0|||
131452455|NCT00125164|473284613|FG001|Overall Study|Lost to Follow-up|0|||
131452456|NCT00125164|473284614|FG002|Overall Study|Lost to Follow-up|1|||
131452457|NCT00125164|473284615|FG003|Overall Study|Lost to Follow-up|1|||
131452458|NCT00125164|473284612|FG000|Overall Study|Withdrawal by Subject|2|||
131452459|NCT00125164|473284613|FG001|Overall Study|Withdrawal by Subject|0|||
131452460|NCT00125164|473284614|FG002|Overall Study|Withdrawal by Subject|1|||
131452461|NCT00125164|473284615|FG003|Overall Study|Withdrawal by Subject|1|||
131452462|NCT01339052|473284616|FG000|Overall Study|Disease progression|13|||
131452463|NCT01339052|473284617|FG001|Overall Study|Disease progression|46|||
131452464|NCT01339052|473284616|FG000|Overall Study|Adverse Event|1|||
131452465|NCT01339052|473284617|FG001|Overall Study|Adverse Event|1|||
131452466|NCT01339052|473284616|FG000|Overall Study|Withdrawal by Subject|0|||
131452467|NCT01339052|473284617|FG001|Overall Study|Withdrawal by Subject|3|||
131452468|NCT01339052|473284616|FG000|Overall Study|Physician Decision|1|||
131912052|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
131912053|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
131912054|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
131912055|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
131452469|NCT01339052|473284617|FG001|Overall Study|Physician Decision|0|||
131452470|NCT02637037|473284618|FG000|Overall Study|Positive drug screen at admission|1|||
131452471|NCT02637037|473284619|FG001|Overall Study|Positive drug screen at admission|0|||
131452472|NCT02637037|473284618|FG000|Overall Study|Withdrawal by Subject|2|||
131452473|NCT02637037|473284619|FG001|Overall Study|Withdrawal by Subject|1|||
131452474|NCT02637037|473284618|FG000|Overall Study|Adverse Event|1|||
131452475|NCT02637037|473284619|FG001|Overall Study|Adverse Event|0|||
131452476|NCT01469377|473284622|FG000|Overall Study|Protocol Deviation|7|||
131452477|NCT01469377|473284623|FG001|Overall Study|Protocol Deviation|10|||
131452478|NCT01469377|473284624|FG002|Overall Study|Protocol Deviation|10|||
131452479|NCT01469377|473284622|FG000|Overall Study|Lost to Follow-up|3|||
131452480|NCT01469377|473284623|FG001|Overall Study|Lost to Follow-up|2|||
131452481|NCT01469377|473284624|FG002|Overall Study|Lost to Follow-up|5|||
131452482|NCT01469377|473284622|FG000|Overall Study|Withdrawal of Consent|12|||
131452483|NCT01469377|473284623|FG001|Overall Study|Withdrawal of Consent|14|||
131452484|NCT01469377|473284624|FG002|Overall Study|Withdrawal of Consent|15|||
131452485|NCT01469377|473284622|FG000|Overall Study|Adverse Event|8|||
131452486|NCT01469377|473284623|FG001|Overall Study|Adverse Event|18|||
131452487|NCT01469377|473284624|FG002|Overall Study|Adverse Event|36|||
131912056|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
131912057|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
131912058|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
131912059|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Death|3|||
131912060|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Death|1|||
131912061|NCT01056276|474965276|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
131912062|NCT01056276|474965277|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
131912063|NCT01056276|474965276|FG000|Maintenance Therapy|Toxicity|0|||
131912064|NCT01056276|474965277|FG001|Maintenance Therapy|Toxicity|2|||
131912065|NCT01056276|474965276|FG000|Maintenance Therapy|Progressive Disease|0|||
131912066|NCT01056276|474965277|FG001|Maintenance Therapy|Progressive Disease|9|||
131912067|NCT01056276|474965276|FG000|Maintenance Therapy|Physician Decision|0|||
131912068|NCT01056276|474965277|FG001|Maintenance Therapy|Physician Decision|1|||
131912069|NCT01056276|474965276|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
131912070|NCT01056276|474965277|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
131912071|NCT01056276|474965276|FG000|Maintenance Therapy|Intercurrent Illness|0|||
131912072|NCT01056276|474965277|FG001|Maintenance Therapy|Intercurrent Illness|1|||
131912073|NCT01056276|474965276|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
131912074|NCT01056276|474965277|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
131912075|NCT01881425|474965278|FG000|Overall Study|Death|5|||
131912076|NCT01881425|474965279|FG001|Overall Study|Death|1|||
131912077|NCT01881425|474965278|FG000|Overall Study|Withdrawal by Subject|8|||
131912078|NCT01881425|474965279|FG001|Overall Study|Withdrawal by Subject|3|||
131912079|NCT01881425|474965278|FG000|Overall Study|Physician Decision|2|||
131912080|NCT01881425|474965279|FG001|Overall Study|Physician Decision|1|||
131912081|NCT01881425|474965278|FG000|Overall Study|Adverse Event|3|||
131912082|NCT01881425|474965279|FG001|Overall Study|Adverse Event|0|||
131912083|NCT01881425|474965278|FG000|Overall Study|General Anesthesia panic attack|0|||
131912084|NCT01881425|474965279|FG001|Overall Study|General Anesthesia panic attack|1|||
131912085|NCT01881425|474965278|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
131912086|NCT01881425|474965279|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
131912087|NCT01881425|474965278|FG000|Overall Study|Lost to Follow-up|7|||
131912088|NCT01881425|474965279|FG001|Overall Study|Lost to Follow-up|2|||
131912089|NCT01200355|474965280|FG000|Overall Study|Death|7|||
131912090|NCT01200355|474965281|FG001|Overall Study|Death|2|||
131912091|NCT04424901|474965282|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
131912092|NCT04424901|474965283|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
131912093|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
131912094|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
131912095|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
131912096|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
131912097|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
131912098|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
131912099|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
131912100|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
131912101|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
131912102|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
131912103|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
131912104|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
131912105|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
131912106|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
131912107|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
131912108|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
131912109|NCT00410163|474965284|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
131912110|NCT00410163|474965285|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
131912111|NCT00410163|474965284|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
131912112|NCT00410163|474965285|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
131912113|NCT00410163|474965284|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
131912114|NCT00410163|474965285|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
131912115|NCT00410163|474965284|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
131912116|NCT00410163|474965285|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
131912117|NCT00410163|474965284|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
131912118|NCT00410163|474965285|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
131912119|NCT00410163|474965284|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
131912120|NCT00410163|474965285|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
131912121|NCT00797563|474965286|FG000|Overall Study|Adverse Event|1|||
131912122|NCT00688597|474965287|FG000|Overall Study|Adverse Event|2|||
131912123|NCT00688597|474965288|FG001|Overall Study|Adverse Event|0|||
131912124|NCT00688597|474965289|FG002|Overall Study|Adverse Event|0|||
131912125|NCT00688597|474965287|FG000|Overall Study|Physician Decision|1|||
131912126|NCT00688597|474965288|FG001|Overall Study|Physician Decision|0|||
131912127|NCT00688597|474965289|FG002|Overall Study|Physician Decision|0|||
131912128|NCT05853120|474965290|FG000|Overall Study|Lost to Follow-up|4|||
131912129|NCT05853120|474965291|FG001|Overall Study|Lost to Follow-up|4|||
131912130|NCT05853120|474965290|FG000|Overall Study|Physician Decision|3|||
131912131|NCT05853120|474965291|FG001|Overall Study|Physician Decision|0|||
131912132|NCT05853120|474965290|FG000|Overall Study|Withdrawal by Subject|5|||
131912133|NCT05853120|474965291|FG001|Overall Study|Withdrawal by Subject|2|||
131912134|NCT03692949|474965292|FG000|Overall Study|Lost to Follow-up|0|||
131912135|NCT03692949|474965293|FG001|Overall Study|Lost to Follow-up|0|||
131912136|NCT03692949|474965294|FG002|Overall Study|Lost to Follow-up|0|||
131912137|NCT03692949|474965295|FG003|Overall Study|Lost to Follow-up|0|||
131912138|NCT03692949|474965296|FG004|Overall Study|Lost to Follow-up|0|||
131912139|NCT03692949|474965297|FG005|Overall Study|Lost to Follow-up|0|||
131912140|NCT03692949|474965298|FG006|Overall Study|Lost to Follow-up|0|||
131912141|NCT03692949|474965299|FG007|Overall Study|Lost to Follow-up|1|||
131912142|NCT02855268|474965300|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
131912143|NCT02855268|474965301|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
131912144|NCT02855268|474965300|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
131912145|NCT02855268|474965301|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
131912146|NCT02855268|474965300|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
131912147|NCT02855268|474965301|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
131912148|NCT02855268|474965300|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
131912149|NCT02855268|474965301|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
131912150|NCT02855268|474965300|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
131912151|NCT02855268|474965301|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
131912152|NCT02855268|474965300|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
131912153|NCT02855268|474965301|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
131912154|NCT00465517|474965302|FG000|Overall Study|Adverse Event|7|||
131912155|NCT00465517|474965303|FG001|Overall Study|Adverse Event|3|||
131912156|NCT00465517|474965302|FG000|Overall Study|Lost to Follow-up|1|||
131912157|NCT00465517|474965303|FG001|Overall Study|Lost to Follow-up|0|||
131912158|NCT00465517|474965302|FG000|Overall Study|Withdrawal by Subject|4|||
131912159|NCT00465517|474965303|FG001|Overall Study|Withdrawal by Subject|1|||
131912160|NCT01604785|474965306|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
131912161|NCT01604785|474965307|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
131912162|NCT04058717|474965311|FG000|Randomization Period|Lost to Follow-up|2|||
131912163|NCT04058717|474965312|FG001|Randomization Period|Lost to Follow-up|3|||
131912164|NCT04058717|474965313|FG002|Randomization Period|Lost to Follow-up|4|||
131912165|NCT04058717|474965314|FG003|Randomization Period|Lost to Follow-up|4|||
131912166|NCT04058717|474965311|FG000|Randomization Period|Withdrawal by Subject|1|||
131912167|NCT04058717|474965312|FG001|Randomization Period|Withdrawal by Subject|3|||
131912168|NCT04058717|474965313|FG002|Randomization Period|Withdrawal by Subject|3|||
131912169|NCT04058717|474965314|FG003|Randomization Period|Withdrawal by Subject|3|||
131912170|NCT04058717|474965311|FG000|Randomization Period|PI decision|0|||
131912171|NCT04058717|474965312|FG001|Randomization Period|PI decision|1|||
131912172|NCT04058717|474965313|FG002|Randomization Period|PI decision|0|||
131850935|NCT05199090|474732365|FG004|Overall Study|Study terminated by sponsor|0|||
131850936|NCT05199090|474732366|FG005|Overall Study|Study terminated by sponsor|5|||
131850937|NCT05199090|474732361|FG000|Overall Study|Subject decision|0|||
131850938|NCT05199090|474732362|FG001|Overall Study|Subject decision|4|||
131850939|NCT05199090|474732363|FG002|Overall Study|Subject decision|0|||
131850940|NCT05199090|474732364|FG003|Overall Study|Subject decision|2|||
131850941|NCT05199090|474732365|FG004|Overall Study|Subject decision|5|||
131850942|NCT05199090|474732366|FG005|Overall Study|Subject decision|2|||
131850943|NCT03276078|474732367|FG000|Overall Study|Adverse Event|1|||
131850944|NCT01210612|474732369|FG000|Overall Study|Withdrawal by Subject|0|||
131850945|NCT01210612|474732370|FG001|Overall Study|Withdrawal by Subject|2|||
131850946|NCT02552732|474732371|FG000|Overall Study|Lost to Follow-up|2|||
131850947|NCT02552732|474732371|FG000|Overall Study|Physician Decision|1|||
131850948|NCT02552732|474732371|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
131912173|NCT04058717|474965314|FG003|Randomization Period|PI decision|0|||
131912174|NCT01035138|474965315|FG000|Overall Study|Adverse Event|4|||
131912175|NCT01035138|474965316|FG001|Overall Study|Adverse Event|0|||
131912176|NCT01035138|474965317|FG002|Overall Study|Adverse Event|2|||
131912177|NCT01035138|474965315|FG000|Overall Study|Caregiver Decision|2|||
131912178|NCT01035138|474965316|FG001|Overall Study|Caregiver Decision|0|||
131912179|NCT01035138|474965317|FG002|Overall Study|Caregiver Decision|1|||
131912180|NCT01035138|474965315|FG000|Overall Study|Withdrawal by Subject|1|||
131912181|NCT01035138|474965316|FG001|Overall Study|Withdrawal by Subject|0|||
131850949|NCT02552732|474732371|FG000|Overall Study|Withdrawal by Subject|6|||
131850950|NCT00086281|474732374|FG000|Phase 1|Adverse Event|0|||
131912182|NCT01035138|474965317|FG002|Overall Study|Withdrawal by Subject|0|||
131912183|NCT01035138|474965315|FG000|Overall Study|Physician Decision|0|||
131850951|NCT00086281|474732375|FG001|Phase 1|Adverse Event|0|||
131850952|NCT00086281|474732376|FG002|Phase 1|Adverse Event|0|||
131452488|NCT01469377|473284622|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131452489|NCT01469377|473284623|FG001|Overall Study|Insufficient Therapeutic Response|4|||
131452490|NCT01469377|473284624|FG002|Overall Study|Insufficient Therapeutic Response|0|||
131452491|NCT01469377|473284622|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131452492|NCT01469377|473284623|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131452493|NCT01469377|473284624|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131452494|NCT01733680|473284625|FG000|Overall Study|Withdrawal by Subject|0|||
131452495|NCT01733680|473284626|FG001|Overall Study|Withdrawal by Subject|1|||
131452496|NCT02565108|473284633|FG000|Overall Study|Adverse Event|1|||
131452497|NCT02565108|473284634|FG001|Overall Study|Adverse Event|0|||
131452498|NCT02565108|473284633|FG000|Overall Study|Withdrew Consent|1|||
131452499|NCT02565108|473284634|FG001|Overall Study|Withdrew Consent|0|||
131452500|NCT00760617|473284635|FG000|Overall Study|Adverse Event|5|||
131452501|NCT00760617|473284636|FG001|Overall Study|Adverse Event|2|||
131452502|NCT00760617|473284637|FG002|Overall Study|Adverse Event|0|||
131452503|NCT00760617|473284635|FG000|Overall Study|Lost to Follow-up|0|||
131452504|NCT00760617|473284636|FG001|Overall Study|Lost to Follow-up|0|||
131452505|NCT00760617|473284637|FG002|Overall Study|Lost to Follow-up|5|||
131452506|NCT02908672|473284638|FG000|Run-in Period|Death|12|||
131452507|NCT02908672|473284639|FG001|Run-in Period|Death|10|||
131452508|NCT02908672|473284640|FG002|Run-in Period|Death|0|||
131452509|NCT02908672|473284641|FG003|Run-in Period|Death|0|||
131452510|NCT02908672|473284638|FG000|Run-in Period|Lost to Follow-up|1|||
131452511|NCT02908672|473284639|FG001|Run-in Period|Lost to Follow-up|1|||
131452512|NCT02908672|473284640|FG002|Run-in Period|Lost to Follow-up|0|||
131452513|NCT02908672|473284641|FG003|Run-in Period|Lost to Follow-up|0|||
131452514|NCT02908672|473284638|FG000|Run-in Period|Reason Not Specified|2|||
131452515|NCT02908672|473284639|FG001|Run-in Period|Reason Not Specified|0|||
131452516|NCT02908672|473284640|FG002|Run-in Period|Reason Not Specified|0|||
131452517|NCT02908672|473284641|FG003|Run-in Period|Reason Not Specified|0|||
131850953|NCT00086281|474732377|FG003|Phase 1|Adverse Event|0|||
131850954|NCT00086281|474732378|FG004|Phase 1|Adverse Event|0|||
131850955|NCT00086281|474732379|FG005|Phase 1|Adverse Event|0|||
131850956|NCT00086281|474732380|FG006|Phase 1|Adverse Event|0|||
131850957|NCT00086281|474732381|FG007|Phase 1|Adverse Event|0|||
131850958|NCT00086281|474732382|FG008|Phase 1|Adverse Event|0|||
131850959|NCT00086281|474732383|FG009|Phase 1|Adverse Event|1|||
131850960|NCT00086281|474732384|FG010|Phase 1|Adverse Event|2|||
131850961|NCT00086281|474732385|FG011|Phase 1|Adverse Event|1|||
131850962|NCT00086281|474732386|FG012|Phase 1|Adverse Event|1|||
131850963|NCT00086281|474732387|FG013|Phase 1|Adverse Event|1|||
131850964|NCT00086281|474732388|FG014|Phase 1|Adverse Event|2|||
131850965|NCT00086281|474732374|FG000|Phase 1|Protocol Violation|0|||
131850966|NCT00086281|474732375|FG001|Phase 1|Protocol Violation|0|||
131850967|NCT00086281|474732376|FG002|Phase 1|Protocol Violation|0|||
131850968|NCT00086281|474732377|FG003|Phase 1|Protocol Violation|0|||
131850969|NCT00086281|474732378|FG004|Phase 1|Protocol Violation|0|||
131850970|NCT00086281|474732379|FG005|Phase 1|Protocol Violation|0|||
131850971|NCT00086281|474732380|FG006|Phase 1|Protocol Violation|0|||
131850972|NCT00086281|474732381|FG007|Phase 1|Protocol Violation|0|||
131850973|NCT00086281|474732382|FG008|Phase 1|Protocol Violation|0|||
131850974|NCT00086281|474732383|FG009|Phase 1|Protocol Violation|0|||
131850975|NCT00086281|474732384|FG010|Phase 1|Protocol Violation|1|||
131850976|NCT00086281|474732385|FG011|Phase 1|Protocol Violation|0|||
131850977|NCT00086281|474732386|FG012|Phase 1|Protocol Violation|0|||
131850978|NCT00086281|474732387|FG013|Phase 1|Protocol Violation|0|||
131850979|NCT00086281|474732388|FG014|Phase 1|Protocol Violation|0|||
131850980|NCT00086281|474732374|FG000|Phase 1|Serious Adverse Event|0|||
131850981|NCT00086281|474732375|FG001|Phase 1|Serious Adverse Event|0|||
131850982|NCT00086281|474732376|FG002|Phase 1|Serious Adverse Event|0|||
131850983|NCT00086281|474732377|FG003|Phase 1|Serious Adverse Event|0|||
131850984|NCT00086281|474732378|FG004|Phase 1|Serious Adverse Event|0|||
131850985|NCT00086281|474732379|FG005|Phase 1|Serious Adverse Event|0|||
131452518|NCT02908672|473284638|FG000|Run-in Period|Protocol Violation|1|||
131452519|NCT02908672|473284639|FG001|Run-in Period|Protocol Violation|1|||
131452520|NCT02908672|473284640|FG002|Run-in Period|Protocol Violation|0|||
131452521|NCT02908672|473284641|FG003|Run-in Period|Protocol Violation|0|||
131452522|NCT02908672|473284638|FG000|Run-in Period|Study Ended by Sponsor|5|||
131850986|NCT00086281|474732380|FG006|Phase 1|Serious Adverse Event|0|||
131850987|NCT00086281|474732381|FG007|Phase 1|Serious Adverse Event|0|||
131452523|NCT02908672|473284639|FG001|Run-in Period|Study Ended by Sponsor|1|||
131452524|NCT02908672|473284640|FG002|Run-in Period|Study Ended by Sponsor|0|||
131452525|NCT02908672|473284641|FG003|Run-in Period|Study Ended by Sponsor|0|||
131850988|NCT00086281|474732382|FG008|Phase 1|Serious Adverse Event|0|||
131850989|NCT00086281|474732383|FG009|Phase 1|Serious Adverse Event|0|||
131850990|NCT00086281|474732384|FG010|Phase 1|Serious Adverse Event|0|||
131850991|NCT00086281|474732385|FG011|Phase 1|Serious Adverse Event|0|||
131850992|NCT00086281|474732386|FG012|Phase 1|Serious Adverse Event|0|||
131850993|NCT00086281|474732387|FG013|Phase 1|Serious Adverse Event|0|||
131850994|NCT00086281|474732388|FG014|Phase 1|Serious Adverse Event|1|||
131850995|NCT00086281|474732374|FG000|Phase 2|Adverse Event|0|||
131850996|NCT00086281|474732375|FG001|Phase 2|Adverse Event|0|||
131850997|NCT00086281|474732376|FG002|Phase 2|Adverse Event|0|||
131850998|NCT00086281|474732377|FG003|Phase 2|Adverse Event|0|||
131850999|NCT00086281|474732378|FG004|Phase 2|Adverse Event|0|||
131851000|NCT00086281|474732379|FG005|Phase 2|Adverse Event|0|||
131851001|NCT00086281|474732380|FG006|Phase 2|Adverse Event|0|||
131851002|NCT00086281|474732381|FG007|Phase 2|Adverse Event|0|||
131851003|NCT00086281|474732382|FG008|Phase 2|Adverse Event|0|||
131851004|NCT00086281|474732383|FG009|Phase 2|Adverse Event|0|||
131851005|NCT00086281|474732384|FG010|Phase 2|Adverse Event|0|||
131851006|NCT00086281|474732385|FG011|Phase 2|Adverse Event|0|||
131851007|NCT00086281|474732386|FG012|Phase 2|Adverse Event|1|||
131851008|NCT00086281|474732387|FG013|Phase 2|Adverse Event|1|||
131851009|NCT00086281|474732388|FG014|Phase 2|Adverse Event|0|||
131851010|NCT01589497|474732389|FG000|Overall Study|Withdrawal by Subject|0|||
131851011|NCT01589497|474732390|FG001|Overall Study|Withdrawal by Subject|1|||
131851012|NCT01589497|474732391|FG002|Overall Study|Withdrawal by Subject|0|||
131851013|NCT01589497|474732392|FG003|Overall Study|Withdrawal by Subject|1|||
131851014|NCT01589497|474732389|FG000|Overall Study|Death|1|||
131851015|NCT01589497|474732390|FG001|Overall Study|Death|0|||
131851016|NCT01589497|474732391|FG002|Overall Study|Death|0|||
131851017|NCT01589497|474732392|FG003|Overall Study|Death|0|||
131851018|NCT01589497|474732389|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
131851019|NCT01589497|474732390|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
131851020|NCT01589497|474732391|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
131851021|NCT01589497|474732392|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
131851022|NCT02185053|474732396|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
131851023|NCT02185053|474732397|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
131851024|NCT02185053|474732398|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
131851025|NCT02185053|474732396|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
131851026|NCT02185053|474732397|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
131851027|NCT02185053|474732398|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
131851028|NCT02185053|474732396|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
131851029|NCT02185053|474732397|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
131851030|NCT02185053|474732398|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
131851031|NCT02185053|474732396|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
131851032|NCT02185053|474732397|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
131851033|NCT02185053|474732398|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
131851034|NCT02185053|474732396|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
131851035|NCT02185053|474732397|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
131851036|NCT02185053|474732398|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
131851037|NCT02185053|474732396|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
131851038|NCT02185053|474732397|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
131851039|NCT02185053|474732398|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
131851040|NCT02185053|474732396|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
131851041|NCT02185053|474732397|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
131851042|NCT02185053|474732398|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
131851043|NCT02185053|474732396|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
131851044|NCT02185053|474732397|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
131851045|NCT02185053|474732398|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
131851046|NCT02521376|474732399|FG000|Overall Study|Enrolled, But Not Treated|1|||
131851047|NCT02521376|474732400|FG001|Overall Study|Enrolled, But Not Treated|0|||
131851048|NCT02521376|474732401|FG002|Overall Study|Enrolled, But Not Treated|0|||
131851049|NCT02521376|474732402|FG003|Overall Study|Enrolled, But Not Treated|0|||
131851050|NCT03316547|474732409|FG000|Overall Study|Death|3|||
131851051|NCT03316547|474732410|FG001|Overall Study|Death|1|||
131851052|NCT03316547|474732409|FG000|Overall Study|Lost to Follow-up|6|||
131851053|NCT03316547|474732410|FG001|Overall Study|Lost to Follow-up|6|||
131851054|NCT03316547|474732409|FG000|Overall Study|Withdrawal by Subject|3|||
131851055|NCT03316547|474732410|FG001|Overall Study|Withdrawal by Subject|2|||
131851056|NCT03316547|474732409|FG000|Overall Study|Transfer to another hospital|6|||
131851057|NCT03316547|474732410|FG001|Overall Study|Transfer to another hospital|4|||
131851058|NCT06390826|474733498|FG000|Overall Study|Never Start Protocol Therapy|1|||
131851059|NCT06390826|474733498|FG000|Overall Study|Adverse Event|1|||
131851060|NCT06390826|474733498|FG000|Overall Study|Disease Progression|8|||
131851061|NCT01810302|474733499|FG000|Overall Study|Death|1|||
131851062|NCT01810302|474733500|FG001|Overall Study|Death|0|||
131851063|NCT01810302|474733499|FG000|Overall Study|Physician Decision|0|||
131851064|NCT01810302|474733500|FG001|Overall Study|Physician Decision|1|||
131851065|NCT01659125|474733504|FG000|Overall Study|Withdrawal by Subject|2|||
131851066|NCT01659125|474733504|FG000|Overall Study|Lost to Follow-up|7|||
131851067|NCT01659125|474733504|FG000|Overall Study|Technical Problem|1|||
131851068|NCT01659125|474733504|FG000|Overall Study|Time Constraints|2|||
131851069|NCT01659125|474733504|FG000|Overall Study|Failed to Start Treatment|2|||
131851070|NCT02126826|474733505|FG000|Overall Study|Withdrawal by Subject|0|||
131851071|NCT02126826|474733506|FG001|Overall Study|Withdrawal by Subject|0|||
131851072|NCT02126826|474733507|FG002|Overall Study|Withdrawal by Subject|0|||
131851073|NCT02126826|474733508|FG003|Overall Study|Withdrawal by Subject|1|||
131851074|NCT02126826|474733509|FG004|Overall Study|Withdrawal by Subject|0|||
131851075|NCT02126826|474733510|FG005|Overall Study|Withdrawal by Subject|0|||
131851076|NCT02126826|474733511|FG006|Overall Study|Withdrawal by Subject|0|||
131851077|NCT02111603|474733513|FG000|Overall Study|Withdrawal by Subject|1|||
131851078|NCT03106987|474733514|FG000|Overall Study|Death|37|||
131851079|NCT03106987|474733515|FG001|Overall Study|Death|22|||
131851080|NCT03106987|474733516|FG002|Overall Study|Death|12|||
131851081|NCT03106987|474733517|FG003|Overall Study|Death|8|||
131851082|NCT03106987|474733514|FG000|Overall Study|Lost to Follow-up|2|||
131851083|NCT03106987|474733515|FG001|Overall Study|Lost to Follow-up|0|||
131851084|NCT03106987|474733516|FG002|Overall Study|Lost to Follow-up|2|||
131851085|NCT03106987|474733517|FG003|Overall Study|Lost to Follow-up|2|||
131851086|NCT03106987|474733514|FG000|Overall Study|Withdrawal by Subject|5|||
131851087|NCT03106987|474733515|FG001|Overall Study|Withdrawal by Subject|1|||
131851088|NCT03106987|474733516|FG002|Overall Study|Withdrawal by Subject|4|||
131851089|NCT03106987|474733517|FG003|Overall Study|Withdrawal by Subject|1|||
131851090|NCT03336528|474733518|FG000|Overall Study|Protocol Violation|1|||
131851091|NCT03336528|474733519|FG001|Overall Study|Protocol Violation|1|||
131851092|NCT03336528|474733518|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
131851093|NCT03336528|474733519|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
131851094|NCT03336528|474733518|FG000|Overall Study|Did not receive study medication|1|||
131851095|NCT03336528|474733519|FG001|Overall Study|Did not receive study medication|2|||
131851096|NCT01174043|474733521|FG000|Overall Study|Disease progression|5|||
131851097|NCT01174043|474733521|FG000|Overall Study|Adverse Event|3|||
131851098|NCT01174043|474733521|FG000|Overall Study|Death|1|||
131851099|NCT01174043|474733521|FG000|Overall Study|Withdrawal by Subject|2|||
131851100|NCT02681510|474733522|FG000|Overall Study|Withdrawal by Subject|1|||
131851101|NCT02681510|474733522|FG000|Overall Study|Lost to Follow-up|9|||
131851102|NCT00958893|474733526|FG000|Overall Study|Study prematurely terminated|4|||
131851103|NCT00741338|474733533|FG000|Overall Study|Adverse Event|0|||
131851104|NCT00741338|474733534|FG001|Overall Study|Adverse Event|1|||
131851105|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
131851106|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
131851107|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
131851108|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
131851109|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
131851110|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
131851111|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
131851112|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
131851113|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
131851114|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
131851115|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
131851116|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
131851117|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
131851118|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
131851119|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
131851120|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
131851121|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
131851122|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
131851123|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
131851124|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
131851125|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
131851126|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131851127|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
131851128|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131851129|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131851130|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
131851131|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
131851132|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
131851133|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
131851134|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
131851135|NCT03713632|474733535|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
131851136|NCT03713632|474733536|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
131851137|NCT03713632|474733537|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
131851138|NCT03713632|474733538|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
131851139|NCT03713632|474733539|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
131851140|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
131851141|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
131452526|NCT02908672|473284638|FG000|Run-in Period|Withdrawal by Subject|3|||
131452527|NCT02908672|473284639|FG001|Run-in Period|Withdrawal by Subject|9|||
131452528|NCT02908672|473284640|FG002|Run-in Period|Withdrawal by Subject|0|||
131452529|NCT02908672|473284641|FG003|Run-in Period|Withdrawal by Subject|0|||
131452530|NCT02908672|473284638|FG000|Triple Combination Period|Death|0|||
131452531|NCT02908672|473284639|FG001|Triple Combination Period|Death|0|||
131452532|NCT02908672|473284640|FG002|Triple Combination Period|Death|150|||
131452533|NCT02908672|473284641|FG003|Triple Combination Period|Death|127|||
131452534|NCT02908672|473284638|FG000|Triple Combination Period|Lost to Follow-up|0|||
131452535|NCT02908672|473284639|FG001|Triple Combination Period|Lost to Follow-up|0|||
131452536|NCT02908672|473284640|FG002|Triple Combination Period|Lost to Follow-up|6|||
131452537|NCT02908672|473284641|FG003|Triple Combination Period|Lost to Follow-up|8|||
131452538|NCT02908672|473284638|FG000|Triple Combination Period|Reason Not Specified|0|||
131452539|NCT02908672|473284639|FG001|Triple Combination Period|Reason Not Specified|0|||
131452540|NCT02908672|473284640|FG002|Triple Combination Period|Reason Not Specified|0|||
131452541|NCT02908672|473284641|FG003|Triple Combination Period|Reason Not Specified|1|||
131452542|NCT02908672|473284638|FG000|Triple Combination Period|Physician Decision|0|||
131851142|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
131851143|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
131851144|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
131851145|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
131851146|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
131851147|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
131851148|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
131851149|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
131851150|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
131851151|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
131851152|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
131851153|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
131851154|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
131851155|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
131851156|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
131851157|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
131851158|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
131851159|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
131851160|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
131851161|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
131851162|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
131851163|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
131851164|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
131851165|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
131851166|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
131851167|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
131851168|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
131851169|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
131851170|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Death|0|||
131851171|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Death|1|||
131851172|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Death|0|||
131851173|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Death|0|||
131851174|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Death|0|||
131851175|NCT03713632|474733535|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131851176|NCT03713632|474733536|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
131851177|NCT03713632|474733537|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131851178|NCT03713632|474733538|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131851179|NCT03713632|474733539|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131851180|NCT00606632|474733542|FG000|Overall Study|Withdrawal by Subject|13|||
131851181|NCT00606632|474733542|FG000|Overall Study|Miscellaneous reasons|9|||
131851182|NCT00704132|474733543|FG000|Overall Study|Clinical Adverse Experience|1|||
131851183|NCT00704132|474733544|FG001|Overall Study|Clinical Adverse Experience|0|||
131851184|NCT00704132|474733543|FG000|Overall Study|Lack of Efficacy|0|||
131851185|NCT00704132|474733544|FG001|Overall Study|Lack of Efficacy|1|||
131851186|NCT00704132|474733543|FG000|Overall Study|Withdrawal by Subject|0|||
131851187|NCT00704132|474733544|FG001|Overall Study|Withdrawal by Subject|1|||
131851188|NCT00442962|474733545|FG000|Overall Study|Pregnancy|1|||
131851189|NCT00442962|474733545|FG000|Overall Study|Lost to Follow-up|7|||
131851190|NCT03633825|474733546|FG000|Enrollment|Did not post on network|5066|||
131851191|NCT03633825|474733547|FG001|Enrollment|Did not post on network|5080|||
131851192|NCT03633825|474733546|FG000|Enrollment|Post not classified as crisis|13967|||
131452543|NCT02908672|473284639|FG001|Triple Combination Period|Physician Decision|0|||
131452544|NCT02908672|473284640|FG002|Triple Combination Period|Physician Decision|1|||
131452545|NCT02908672|473284641|FG003|Triple Combination Period|Physician Decision|1|||
131404564|NCT01778049|473103726|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
131404565|NCT01778049|473103727|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
131404566|NCT01778049|473103728|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
131404567|NCT01778049|473103729|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
131404568|NCT01778049|473103730|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
131404569|NCT01778049|473103731|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
131404570|NCT03773133|473103732|FG000|Overall Study|Screen Failure|8|||
131404571|NCT02928029|473103733|FG000|Overall Study|Withdrawal by Subject|0|||
131404572|NCT02928029|473103734|FG001|Overall Study|Withdrawal by Subject|1|||
131404573|NCT02928029|473103733|FG000|Overall Study|Radiological progression|1|||
131404574|NCT02928029|473103734|FG001|Overall Study|Radiological progression|0|||
131404575|NCT02928029|473103733|FG000|Overall Study|Clinical progression|1|||
131404576|NCT02928029|473103734|FG001|Overall Study|Clinical progression|2|||
131404577|NCT02928029|473103733|FG000|Overall Study|AE not related to clinical progression|1|||
131404578|NCT02928029|473103734|FG001|Overall Study|AE not related to clinical progression|1|||
131404579|NCT00107315|473103741|FG000|Overall Study|Disease Progression|9|||
131404580|NCT00107315|473103741|FG000|Overall Study|Adverse Event|4|||
131404581|NCT00107315|473103741|FG000|Overall Study|Withdrawal by Subject|2|||
131452546|NCT02908672|473284638|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
131851193|NCT03633825|474733547|FG001|Enrollment|Post not classified as crisis|13757|||
131912184|NCT01035138|474965316|FG001|Overall Study|Physician Decision|0|||
131912185|NCT01035138|474965317|FG002|Overall Study|Physician Decision|1|||
131912186|NCT01035138|474965315|FG000|Overall Study|Sponsor Decision|66|||
131912187|NCT01035138|474965316|FG001|Overall Study|Sponsor Decision|60|||
131912188|NCT01035138|474965317|FG002|Overall Study|Sponsor Decision|42|||
131912189|NCT01035138|474965315|FG000|Overall Study|Lost to Follow-up|0|||
131912190|NCT01035138|474965316|FG001|Overall Study|Lost to Follow-up|0|||
131851194|NCT03633825|474733546|FG000|Follow up|Lost to Follow-up|478|||
131851195|NCT03633825|474733547|FG001|Follow up|Lost to Follow-up|450|||
131851196|NCT02756208|474733548|FG000|Overall Study|Withdrawal by Subject|1|||
131851197|NCT02756208|474733549|FG001|Overall Study|Withdrawal by Subject|0|||
131851198|NCT02756208|474733550|FG002|Overall Study|Withdrawal by Subject|1|||
131851199|NCT02756208|474733551|FG003|Overall Study|Withdrawal by Subject|3|||
131851200|NCT02756208|474733548|FG000|Overall Study|Lost to Follow-up|3|||
131851201|NCT02756208|474733549|FG001|Overall Study|Lost to Follow-up|1|||
131851202|NCT02756208|474733550|FG002|Overall Study|Lost to Follow-up|1|||
131851203|NCT02756208|474733551|FG003|Overall Study|Lost to Follow-up|1|||
131851204|NCT02756208|474733548|FG000|Overall Study|Physician Decision|1|||
131851205|NCT02756208|474733549|FG001|Overall Study|Physician Decision|0|||
131851206|NCT02756208|474733550|FG002|Overall Study|Physician Decision|0|||
131851207|NCT02756208|474733551|FG003|Overall Study|Physician Decision|0|||
131851208|NCT02756208|474733548|FG000|Overall Study|Protocol Violation|0|||
131851209|NCT02756208|474733549|FG001|Overall Study|Protocol Violation|1|||
131851210|NCT02756208|474733550|FG002|Overall Study|Protocol Violation|0|||
131851211|NCT02756208|474733551|FG003|Overall Study|Protocol Violation|0|||
131851212|NCT04841577|474733552|FG000|Overall Study|Adverse Event|5|||
131851213|NCT04841577|474733553|FG001|Overall Study|Adverse Event|10|||
131851214|NCT04841577|474733552|FG000|Overall Study|Lost to Follow-up|8|||
131851215|NCT04841577|474733553|FG001|Overall Study|Lost to Follow-up|7|||
131851216|NCT04841577|474733552|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
131851217|NCT04841577|474733553|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
131851218|NCT04841577|474733552|FG000|Overall Study|Other|0|||
131851219|NCT04841577|474733553|FG001|Overall Study|Other|1|||
131851220|NCT00214383|474733554|FG000|Overall Study|Lost to Follow-up|16|||
131851221|NCT00214383|474733555|FG001|Overall Study|Lost to Follow-up|26|||
131851222|NCT00879411|474733556|FG000|Overall Study|lost to follow-up (non-AE)|162|||
131851223|NCT02508935|474733557|FG000|Overall Study|Withdrawal by Subject|1|||
131851224|NCT02508935|474733557|FG000|Overall Study|Withdrawal by Caregiver|8|||
131851225|NCT02508935|474733557|FG000|Overall Study|Pain Score <4|1|||
131851226|NCT02508935|474733557|FG000|Overall Study|Emesis|3|||
131851227|NCT02508935|474733557|FG000|Overall Study|Adverse Event|3|||
131851228|NCT02508935|474733557|FG000|Overall Study|Protocol Violation|1|||
131851229|NCT02508935|474733557|FG000|Overall Study|Physician Decision|1|||
131851230|NCT02508935|474733557|FG000|Overall Study|Trial terminated by sponsor|5|||
131851231|NCT01973595|474733558|FG000|Washout|Withdrawal by Subject|1|||
131912191|NCT01035138|474965317|FG002|Overall Study|Lost to Follow-up|1|||
131912192|NCT01799889|474966524|FG000|Overall Study|Adverse Event|4|||
131912193|NCT01799889|474966525|FG001|Overall Study|Adverse Event|4|||
131912194|NCT01799889|474966526|FG002|Overall Study|Adverse Event|5|||
131851232|NCT01973595|474733559|FG001|Washout|Withdrawal by Subject|0|||
131851233|NCT01973595|474733560|FG002|Washout|Withdrawal by Subject|1|||
131851234|NCT01973595|474733561|FG003|Washout|Withdrawal by Subject|0|||
131851235|NCT01141205|474733563|FG000|Overall Study|Physician Decision|1|||
131851236|NCT01141205|474733564|FG001|Overall Study|Physician Decision|1|||
131851237|NCT01141205|474733563|FG000|Overall Study|Lost to Follow-up|1|||
131912195|NCT01799889|474966527|FG003|Overall Study|Adverse Event|1|||
131912196|NCT01799889|474966528|FG004|Overall Study|Adverse Event|11|||
131452547|NCT02908672|473284639|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
131452548|NCT02908672|473284640|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
131452549|NCT02908672|473284641|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
131452550|NCT02908672|473284638|FG000|Triple Combination Period|Withdrawal by Subject|0|||
131452551|NCT02908672|473284639|FG001|Triple Combination Period|Withdrawal by Subject|0|||
131452552|NCT02908672|473284640|FG002|Triple Combination Period|Withdrawal by Subject|13|||
131452553|NCT02908672|473284641|FG003|Triple Combination Period|Withdrawal by Subject|16|||
131452554|NCT01185080|473284642|FG000|Overall Study|Adverse Event|1|||
131452555|NCT01185080|473284643|FG001|Overall Study|Adverse Event|1|||
131452556|NCT01185080|473284644|FG002|Overall Study|Adverse Event|0|||
131452557|NCT01185080|473284642|FG000|Overall Study|Personal reasons|0|||
131452558|NCT01185080|473284643|FG001|Overall Study|Personal reasons|0|||
131452559|NCT01185080|473284644|FG002|Overall Study|Personal reasons|1|||
131452560|NCT01104311|473284645|FG000|Overall Study|Withdrawal by Subject|6|||
131452561|NCT01104311|473284646|FG001|Overall Study|Withdrawal by Subject|6|||
131452562|NCT01104311|473284645|FG000|Overall Study|Protocol Violation|0|||
131452563|NCT01104311|473284646|FG001|Overall Study|Protocol Violation|1|||
131452564|NCT01104311|473284645|FG000|Overall Study|Physician Decision|2|||
131452565|NCT01104311|473284646|FG001|Overall Study|Physician Decision|2|||
131452566|NCT01104311|473284645|FG000|Overall Study|low compliance|1|||
131452567|NCT01104311|473284646|FG001|Overall Study|low compliance|1|||
131452568|NCT01104311|473284645|FG000|Overall Study|Adverse Event|1|||
131452569|NCT01104311|473284646|FG001|Overall Study|Adverse Event|2|||
131452570|NCT00807001|473285998|FG000|Overall Study|Non-compliance|0|||
131452571|NCT00807001|473285999|FG001|Overall Study|Non-compliance|1|||
131452572|NCT00807001|473286000|FG002|Overall Study|Non-compliance|0|||
131452573|NCT00807001|473286001|FG003|Overall Study|Non-compliance|0|||
131452574|NCT00807001|473286002|FG004|Overall Study|Non-compliance|0|||
131452575|NCT01705509|473286004|FG000|Inclusion CPET|Screen Failure|5|||
131452576|NCT01705509|473286004|FG000|Inclusion CPET|Withdrawal by Subject|2|||
131452577|NCT01705509|473286004|FG000|CPET w/ Ranexa|Screen Failure|2|||
131452578|NCT01227018|473286005|FG000|Overall Study|Disease progression|9|||
131452579|NCT01227018|473286005|FG000|Overall Study|Toxicity|2|||
131452580|NCT01227018|473286005|FG000|Overall Study|Withdrew after beginning treatment|4|||
131452581|NCT02736890|473286006|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
131452582|NCT02736890|473286007|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
131452583|NCT02736890|473286006|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
131452584|NCT02736890|473286007|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
131452585|NCT02904954|473286008|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
131452586|NCT02904954|473286009|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
131452587|NCT02904954|473286008|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
131452588|NCT02904954|473286009|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
131452589|NCT02904954|473286008|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
131452590|NCT02904954|473286009|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
131452591|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Recurrence|2|||
131452592|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Recurrence|0|||
131452593|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Adverse Event|2|||
131452594|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Adverse Event|6|||
131452595|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Participant wishes|12|||
131452596|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Participant wishes|7|||
131452597|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Physician Decision|2|||
131452598|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Physician Decision|1|||
131452599|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
131452600|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
131452601|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Death|0|||
131452602|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Death|1|||
131452603|NCT02904954|473286008|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
131452604|NCT02904954|473286009|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
131452605|NCT05097963|473286010|FG000|Overall Study|Protocol Violation|13|||
131452606|NCT05097963|473286010|FG000|Overall Study|Withdrawal by Subject|21|||
131452607|NCT02873702|473286013|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
131452608|NCT02873702|473286014|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
131452609|NCT02873702|473286015|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
131452610|NCT02873702|473286016|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
131452611|NCT02873702|473286013|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
131452612|NCT02873702|473286014|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
131452613|NCT02873702|473286015|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
131452614|NCT02873702|473286016|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
131452615|NCT02873702|473286013|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
131452616|NCT02873702|473286014|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
131452617|NCT02873702|473286015|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
131452618|NCT02873702|473286016|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
131452619|NCT02873702|473286013|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
131452620|NCT02873702|473286014|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
131851238|NCT01141205|474733564|FG001|Overall Study|Lost to Follow-up|0|||
131851239|NCT01141205|474733563|FG000|Overall Study|Withdrawal by Subject|1|||
131851240|NCT01141205|474733564|FG001|Overall Study|Withdrawal by Subject|1|||
131851241|NCT01275430|474733566|FG000|Overall Study|Adverse Event|1|||
131851242|NCT01275430|474733566|FG000|Overall Study|No Contrast Injection|6|||
131851243|NCT01275430|474733566|FG000|Overall Study|Device Malfunction|1|||
131851244|NCT01275430|474733566|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
131851245|NCT04759768|474733570|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
131851246|NCT04759768|474733571|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
131851247|NCT04759768|474733570|FG000|Washout (7 Days)|Physician Decision|0|||
131851248|NCT04759768|474733571|FG001|Washout (7 Days)|Physician Decision|1|||
131851249|NCT02996487|474733572|FG000|Overall Study|Lost to Follow-up|1|||
131851250|NCT02996487|474733573|FG001|Overall Study|Lost to Follow-up|1|||
131851251|NCT02996487|474733574|FG002|Overall Study|Lost to Follow-up|0|||
131851252|NCT02996487|474733572|FG000|Overall Study|Death|0|||
131851253|NCT02996487|474733573|FG001|Overall Study|Death|1|||
131851254|NCT02996487|474733574|FG002|Overall Study|Death|0|||
131851255|NCT02996487|474733572|FG000|Overall Study|Withdrawal by Subject|2|||
131851256|NCT02996487|474733573|FG001|Overall Study|Withdrawal by Subject|3|||
131851257|NCT02996487|474733574|FG002|Overall Study|Withdrawal by Subject|0|||
131851258|NCT02800642|474733575|FG000|Overall Study|Death|3|||
131851259|NCT02800642|474733575|FG000|Overall Study|Other|10|||
131851260|NCT02800642|474733575|FG000|Overall Study|Physician Decision|2|||
131851261|NCT02800642|474733575|FG000|Overall Study|Adverse Event|6|||
131851262|NCT02800642|474733575|FG000|Overall Study|Withdrawal by Subject|3|||
131851263|NCT02800642|474733575|FG000|Overall Study|Lost to Follow-up|1|||
131851264|NCT02027428|474733576|FG000|Induction|Never treated|7|||
131851265|NCT02027428|474733577|FG001|Induction|Never treated|0|||
131851266|NCT02027428|474733578|FG002|Induction|Never treated|0|||
131851267|NCT02027428|474733576|FG000|Induction|Progressive disease|77|||
131851268|NCT02027428|474733577|FG001|Induction|Progressive disease|0|||
131851269|NCT02027428|474733578|FG002|Induction|Progressive disease|0|||
131851270|NCT02027428|474733576|FG000|Induction|Adverse Event|51|||
131851271|NCT02027428|474733577|FG001|Induction|Adverse Event|0|||
131851272|NCT02027428|474733578|FG002|Induction|Adverse Event|0|||
131851273|NCT02027428|474733576|FG000|Induction|Withdrawal by Subject|22|||
131851274|NCT02027428|474733577|FG001|Induction|Withdrawal by Subject|0|||
131851275|NCT02027428|474733578|FG002|Induction|Withdrawal by Subject|0|||
131851276|NCT02027428|474733576|FG000|Induction|Death|21|||
131851277|NCT02027428|474733577|FG001|Induction|Death|0|||
131851278|NCT02027428|474733578|FG002|Induction|Death|0|||
131851279|NCT02027428|474733576|FG000|Induction|Symptomatic deterioration|16|||
131851280|NCT02027428|474733577|FG001|Induction|Symptomatic deterioration|0|||
131851281|NCT02027428|474733578|FG002|Induction|Symptomatic deterioration|0|||
131851282|NCT02027428|474733576|FG000|Induction|Study terminated by sponsor|12|||
131851283|NCT02027428|474733577|FG001|Induction|Study terminated by sponsor|0|||
131851284|NCT02027428|474733578|FG002|Induction|Study terminated by sponsor|0|||
131851285|NCT02027428|474733576|FG000|Induction|Protocol Violation|1|||
131851286|NCT02027428|474733577|FG001|Induction|Protocol Violation|0|||
131851287|NCT02027428|474733578|FG002|Induction|Protocol Violation|0|||
131851288|NCT02027428|474733576|FG000|Induction|Miscellaneous|14|||
131851289|NCT02027428|474733577|FG001|Induction|Miscellaneous|0|||
131851290|NCT02027428|474733578|FG002|Induction|Miscellaneous|0|||
131851291|NCT02027428|474733576|FG000|Induction|Induction Treatment Ongoing|4|||
131851292|NCT02027428|474733577|FG001|Induction|Induction Treatment Ongoing|0|||
131851293|NCT02027428|474733578|FG002|Induction|Induction Treatment Ongoing|0|||
131851294|NCT02027428|474733576|FG000|Maintenance|Death|0|||
131851295|NCT02027428|474733577|FG001|Maintenance|Death|3|||
131851296|NCT02027428|474733578|FG002|Maintenance|Death|2|||
131851297|NCT02027428|474733576|FG000|Maintenance|Adverse Event|0|||
131851298|NCT02027428|474733577|FG001|Maintenance|Adverse Event|21|||
131851299|NCT02027428|474733578|FG002|Maintenance|Adverse Event|1|||
131851300|NCT02027428|474733576|FG000|Maintenance|Progressive disease|0|||
131851301|NCT02027428|474733577|FG001|Maintenance|Progressive disease|84|||
131851302|NCT02027428|474733578|FG002|Maintenance|Progressive disease|47|||
131851303|NCT02027428|474733576|FG000|Maintenance|Symptomatic deterioration|0|||
131851304|NCT02027428|474733577|FG001|Maintenance|Symptomatic deterioration|4|||
131452621|NCT02873702|473286015|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
131851305|NCT02027428|474733578|FG002|Maintenance|Symptomatic deterioration|1|||
131851306|NCT02027428|474733576|FG000|Maintenance|Withdrawal by Subject|0|||
131851307|NCT02027428|474733577|FG001|Maintenance|Withdrawal by Subject|6|||
131851308|NCT02027428|474733578|FG002|Maintenance|Withdrawal by Subject|5|||
131851309|NCT02027428|474733576|FG000|Maintenance|Protocol Violation|0|||
131912197|NCT01799889|474966529|FG005|Overall Study|Adverse Event|1|||
131851310|NCT02027428|474733577|FG001|Maintenance|Protocol Violation|0|||
131851311|NCT02027428|474733578|FG002|Maintenance|Protocol Violation|1|||
131851312|NCT02027428|474733576|FG000|Maintenance|Other|0|||
131851313|NCT02027428|474733577|FG001|Maintenance|Other|6|||
131851314|NCT02027428|474733578|FG002|Maintenance|Other|3|||
131851315|NCT02027428|474733576|FG000|Survival Follow-up|Death|0|||
131851316|NCT02027428|474733577|FG001|Survival Follow-up|Death|78|||
131851317|NCT02027428|474733578|FG002|Survival Follow-up|Death|45|||
131851318|NCT02027428|474733576|FG000|Survival Follow-up|Lost to Follow-up|0|||
131851319|NCT02027428|474733577|FG001|Survival Follow-up|Lost to Follow-up|1|||
131851320|NCT02027428|474733578|FG002|Survival Follow-up|Lost to Follow-up|1|||
131851321|NCT01130597|474733586|FG000|Overall Study|Protocol-specified (High K+)|1|||
131851322|NCT01130597|474733586|FG000|Overall Study|Adverse Event|4|||
131851323|NCT01130597|474733586|FG000|Overall Study|Death|1|||
131851324|NCT01130597|474733586|FG000|Overall Study|Protocol Violation|1|||
131851325|NCT05794503|474733587|FG000|Overall Study|Operation Cancelled|2|||
131851326|NCT05794503|474733588|FG001|Overall Study|Operation Cancelled|0|||
131851327|NCT05794503|474733587|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
131851328|NCT05794503|474733588|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
131851329|NCT05794503|474733587|FG000|Overall Study|Protocol Violation|1|||
131851330|NCT05794503|474733588|FG001|Overall Study|Protocol Violation|0|||
131851331|NCT03052127|474733589|FG000|Overall Study|Withdrawal by Subject|0|||
131851332|NCT03052127|474733590|FG001|Overall Study|Withdrawal by Subject|0|||
131851333|NCT03052127|474733591|FG002|Overall Study|Withdrawal by Subject|0|||
131851334|NCT03052127|474733592|FG003|Overall Study|Withdrawal by Subject|0|||
131851335|NCT03052127|474733593|FG004|Overall Study|Withdrawal by Subject|0|||
131851336|NCT03052127|474733594|FG005|Overall Study|Withdrawal by Subject|0|||
131851337|NCT03052127|474733595|FG006|Overall Study|Withdrawal by Subject|0|||
131851338|NCT03052127|474733596|FG007|Overall Study|Withdrawal by Subject|1|||
131851339|NCT03052127|474733597|FG008|Overall Study|Withdrawal by Subject|1|||
131851340|NCT03052127|474733598|FG009|Overall Study|Withdrawal by Subject|1|||
131851341|NCT03052127|474733599|FG010|Overall Study|Withdrawal by Subject|0|||
131851342|NCT03052127|474733600|FG011|Overall Study|Withdrawal by Subject|0|||
131851343|NCT03052127|474733589|FG000|Overall Study|Discontinuation by Sponsor|0|||
131851344|NCT03052127|474733590|FG001|Overall Study|Discontinuation by Sponsor|0|||
131851345|NCT03052127|474733591|FG002|Overall Study|Discontinuation by Sponsor|0|||
131851346|NCT03052127|474733592|FG003|Overall Study|Discontinuation by Sponsor|0|||
131851347|NCT03052127|474733593|FG004|Overall Study|Discontinuation by Sponsor|0|||
131851348|NCT03052127|474733594|FG005|Overall Study|Discontinuation by Sponsor|0|||
131851349|NCT03052127|474733595|FG006|Overall Study|Discontinuation by Sponsor|0|||
131851350|NCT03052127|474733596|FG007|Overall Study|Discontinuation by Sponsor|0|||
131851351|NCT03052127|474733597|FG008|Overall Study|Discontinuation by Sponsor|4|||
131851352|NCT03052127|474733598|FG009|Overall Study|Discontinuation by Sponsor|2|||
131851353|NCT03052127|474733599|FG010|Overall Study|Discontinuation by Sponsor|5|||
131851354|NCT03052127|474733600|FG011|Overall Study|Discontinuation by Sponsor|13|||
131851355|NCT03052127|474733589|FG000|Overall Study|Inability to comply with trial requirements|0|||
131851356|NCT03052127|474733590|FG001|Overall Study|Inability to comply with trial requirements|0|||
131851357|NCT03052127|474733591|FG002|Overall Study|Inability to comply with trial requirements|1|||
131851358|NCT03052127|474733592|FG003|Overall Study|Inability to comply with trial requirements|0|||
131851359|NCT03052127|474733593|FG004|Overall Study|Inability to comply with trial requirements|0|||
131851360|NCT03052127|474733594|FG005|Overall Study|Inability to comply with trial requirements|0|||
131851361|NCT03052127|474733595|FG006|Overall Study|Inability to comply with trial requirements|0|||
131851362|NCT03052127|474733596|FG007|Overall Study|Inability to comply with trial requirements|0|||
131851363|NCT03052127|474733597|FG008|Overall Study|Inability to comply with trial requirements|0|||
131851364|NCT03052127|474733598|FG009|Overall Study|Inability to comply with trial requirements|0|||
131851365|NCT03052127|474733599|FG010|Overall Study|Inability to comply with trial requirements|0|||
131851366|NCT03052127|474733600|FG011|Overall Study|Inability to comply with trial requirements|0|||
131851367|NCT03052127|474733589|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
131851368|NCT03052127|474733590|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851369|NCT03052127|474733591|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851370|NCT03052127|474733592|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851371|NCT03052127|474733593|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
131851372|NCT03052127|474733594|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
131851373|NCT03052127|474733595|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
131851374|NCT03052127|474733596|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851375|NCT03052127|474733597|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851376|NCT03052127|474733598|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851377|NCT03052127|474733599|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851378|NCT03052127|474733600|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131851379|NCT03694327|474733601|FG000|Overall Study|Lost to Follow-up|13|||
131851380|NCT03694327|474733602|FG001|Overall Study|Lost to Follow-up|23|||
131851381|NCT00143247|474733603|FG000|Overall Study|Death|8|||
131851382|NCT00143247|474733603|FG000|Overall Study|Adverse Event|19|||
131851383|NCT00143247|474733603|FG000|Overall Study|Lack of Efficacy|3|||
131851384|NCT00143247|474733603|FG000|Overall Study|Withdrawal by Subject|55|||
131851385|NCT00143247|474733603|FG000|Overall Study|Study terminated by sponsor|31|||
131851386|NCT00143247|474733603|FG000|Overall Study|Protocol Violation|15|||
131851387|NCT00143247|474733603|FG000|Overall Study|Lost to Follow-up|12|||
131851388|NCT00143247|474733603|FG000|Overall Study|following inaccurate lab adverse event|1|||
131851389|NCT00143247|474733603|FG000|Overall Study|Other|12|||
131851390|NCT02766283|474733604|FG000|Overall Study|Lost to Follow-up|27|||
131851391|NCT00721227|474733605|FG000|Overall Study|Lost to Follow-up|3|||
131851392|NCT00721227|474733606|FG001|Overall Study|Lost to Follow-up|0|||
131851393|NCT00721227|474733605|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
131851394|NCT00721227|474733606|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
131851395|NCT03654599|474733612|FG000|Overall Study|Lost to Follow-up|14|||
131851396|NCT03654599|474733613|FG001|Overall Study|Lost to Follow-up|12|||
131851397|NCT03654599|474733612|FG000|Overall Study|Death|8|||
131851398|NCT03654599|474733613|FG001|Overall Study|Death|6|||
131851399|NCT03654599|474733612|FG000|Overall Study|Withdrawal by Subject|6|||
131851400|NCT03654599|474733613|FG001|Overall Study|Withdrawal by Subject|4|||
131851401|NCT01243775|474733614|FG000|Overall Study|Withdrawal by Subject|2|||
131851402|NCT05833139|474735515|FG000|Study Period 2|Adverse Event|1|||
131851403|NCT02567435|474735518|FG000|Overall Study|Death|1|||
131851404|NCT02567435|474735519|FG001|Overall Study|Death|1|||
131452622|NCT02873702|473286016|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
131452623|NCT02873702|473286013|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
131452624|NCT02873702|473286014|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
131452625|NCT02873702|473286015|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
131452626|NCT02873702|473286016|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
131452627|NCT02948634|473286022|FG000|Overall Study|Lack of efficacy and study suspended|10|||
131452628|NCT02948634|473286023|FG001|Overall Study|Lack of efficacy and study suspended|2|||
131452629|NCT04050202|473286036|FG000|Overall Study|Lost to Follow-up|2|||
131851405|NCT02567435|474735520|FG002|Overall Study|Death|0|||
131851406|NCT02567435|474735521|FG003|Overall Study|Death|0|||
131851407|NCT02567435|474735518|FG000|Overall Study|Ineligible|1|||
131851408|NCT02567435|474735519|FG001|Overall Study|Ineligible|3|||
131851409|NCT02567435|474735520|FG002|Overall Study|Ineligible|0|||
131851410|NCT02567435|474735521|FG003|Overall Study|Ineligible|0|||
131851411|NCT02567435|474735518|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
131851412|NCT02567435|474735519|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
131851413|NCT02567435|474735520|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
131851414|NCT02567435|474735521|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
131851415|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #1|24|||
131851416|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #1|0|||
131851417|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
131851418|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
131851419|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851420|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851421|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
131851422|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
131851423|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
131851424|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
131851425|NCT03888066|474735522|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851426|NCT03888066|474735523|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851427|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851428|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851429|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
131851430|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
131851431|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851432|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851433|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
131851434|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851435|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #2|5|||
131851436|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #2|0|||
131851437|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
131851438|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
131851439|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
131851440|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
131851441|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
131851442|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
131851443|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #3|11|||
131851444|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #3|0|||
131851445|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
131851446|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
131851447|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
131851448|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
131851449|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851450|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851451|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #4|3|||
131851452|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #4|0|||
131851453|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
131851454|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
131851455|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
131851456|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
131851457|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
131851458|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
131851459|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
131851460|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
131851461|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
131851462|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851463|NCT03888066|474735522|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
131851464|NCT03888066|474735523|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
131851465|NCT03888066|474735522|FG000|Run-in Phase|AE (Adverse Event)|17|||
131851466|NCT03888066|474735523|FG001|Run-in Phase|AE (Adverse Event)|0|||
131851467|NCT03888066|474735522|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
131851468|NCT03888066|474735523|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
131851469|NCT03888066|474735522|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851470|NCT03888066|474735523|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851471|NCT03888066|474735522|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131851472|NCT03888066|474735523|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851473|NCT03888066|474735522|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
131851474|NCT03888066|474735523|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
131851475|NCT03888066|474735522|FG000|Run-in Phase|Withdrawal by Subject|43|||
131851476|NCT03888066|474735523|FG001|Run-in Phase|Withdrawal by Subject|0|||
131851477|NCT03888066|474735522|FG000|Run-in Phase|AE; Physician Decision|1|||
131851478|NCT03888066|474735523|FG001|Run-in Phase|AE; Physician Decision|0|||
131851479|NCT03888066|474735522|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
131851480|NCT03888066|474735523|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131851481|NCT03888066|474735522|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
131851482|NCT03888066|474735523|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
131851483|NCT03888066|474735522|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
131851484|NCT03888066|474735523|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
131851485|NCT03888066|474735522|FG000|Run-in Phase|Death|1|||
131851486|NCT03888066|474735523|FG001|Run-in Phase|Death|0|||
131851487|NCT03888066|474735522|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
131851488|NCT03888066|474735523|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
131851489|NCT03888066|474735522|FG000|Run-in Phase|Physician Decision|1|||
131851490|NCT03888066|474735523|FG001|Run-in Phase|Physician Decision|0|||
131851491|NCT03888066|474735522|FG000|Run-in Phase|Protocol Violation|13|||
131851492|NCT03888066|474735523|FG001|Run-in Phase|Protocol Violation|0|||
131851493|NCT03888066|474735522|FG000|Run-in Phase|Sponsor Request|34|||
131851494|NCT03888066|474735523|FG001|Run-in Phase|Sponsor Request|0|||
131851495|NCT03888066|474735522|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
131851496|NCT03888066|474735523|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
131851497|NCT03888066|474735522|FG000|Run-in Phase|Withdrawal Of Consent|1|||
131851498|NCT03888066|474735523|FG001|Run-in Phase|Withdrawal Of Consent|0|||
131851499|NCT03888066|474735522|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
131851500|NCT03888066|474735523|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
131851501|NCT03888066|474735522|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
131851502|NCT03888066|474735523|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
131851503|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
131851504|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
131851505|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
131851506|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
131851507|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
131851508|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
131851509|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
131851510|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
131851511|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
131851512|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
131851513|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
131912198|NCT01799889|474966530|FG006|Overall Study|Adverse Event|5|||
131912199|NCT01799889|474966531|FG007|Overall Study|Adverse Event|2|||
131912200|NCT01799889|474966532|FG008|Overall Study|Adverse Event|3|||
131912201|NCT01799889|474966533|FG009|Overall Study|Adverse Event|1|||
131912202|NCT01799889|474966534|FG010|Overall Study|Adverse Event|1|||
131912203|NCT01799889|474966535|FG011|Overall Study|Adverse Event|0|||
131912204|NCT01799889|474966524|FG000|Overall Study|Death|1|||
131912205|NCT01799889|474966525|FG001|Overall Study|Death|0|||
131912206|NCT01799889|474966526|FG002|Overall Study|Death|5|||
131912207|NCT01799889|474966527|FG003|Overall Study|Death|3|||
131404582|NCT02509039|473103744|FG000|Overall Study|Adverse Event|0|||
131404583|NCT02509039|473103745|FG001|Overall Study|Adverse Event|1|||
131404584|NCT02509039|473103746|FG002|Overall Study|Adverse Event|1|||
131404585|NCT02509039|473103747|FG003|Overall Study|Adverse Event|1|||
131912208|NCT01799889|474966528|FG004|Overall Study|Death|1|||
131912209|NCT01799889|474966529|FG005|Overall Study|Death|0|||
131912210|NCT01799889|474966530|FG006|Overall Study|Death|0|||
131912211|NCT01799889|474966531|FG007|Overall Study|Death|0|||
131912212|NCT01799889|474966532|FG008|Overall Study|Death|1|||
131912213|NCT01799889|474966533|FG009|Overall Study|Death|0|||
131912214|NCT01799889|474966534|FG010|Overall Study|Death|1|||
131912215|NCT01799889|474966535|FG011|Overall Study|Death|0|||
131404586|NCT02509039|473103744|FG000|Overall Study|Withdrawal by Subject|0|||
131404587|NCT02509039|473103745|FG001|Overall Study|Withdrawal by Subject|0|||
131404588|NCT02509039|473103746|FG002|Overall Study|Withdrawal by Subject|1|||
131404589|NCT02509039|473103747|FG003|Overall Study|Withdrawal by Subject|0|||
131404590|NCT02509039|473103744|FG000|Overall Study|Progressive disease|2|||
131404591|NCT02509039|473103745|FG001|Overall Study|Progressive disease|2|||
131404592|NCT02509039|473103746|FG002|Overall Study|Progressive disease|1|||
131404593|NCT02509039|473103747|FG003|Overall Study|Progressive disease|5|||
131404594|NCT02509039|473103744|FG000|Overall Study|Study terminated by Sponsor|1|||
131404595|NCT02509039|473103745|FG001|Overall Study|Study terminated by Sponsor|0|||
131404596|NCT02509039|473103746|FG002|Overall Study|Study terminated by Sponsor|0|||
131404597|NCT02509039|473103747|FG003|Overall Study|Study terminated by Sponsor|0|||
131404598|NCT05427539|473103752|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
131404599|NCT05427539|473103753|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
131404600|NCT05427539|473103752|FG000|Period 1|Withdrawal by Subject|1|||
131404601|NCT05427539|473103753|FG001|Period 1|Withdrawal by Subject|0|||
131404602|NCT00543296|473103754|FG000|Overall Study|Physician Decision|7|||
131404603|NCT00934947|473103755|FG000|Overall Study|Adverse Event|0|||
131404604|NCT00934947|473103756|FG001|Overall Study|Adverse Event|2|||
131404605|NCT01703208|473103757|FG000|Overall Study|Death|61|||
131404606|NCT01703208|473103758|FG001|Overall Study|Death|48|||
131404607|NCT01703208|473103757|FG000|Overall Study|Lack of Efficacy|1|||
131404608|NCT01703208|473103758|FG001|Overall Study|Lack of Efficacy|2|||
131404609|NCT01703208|473103757|FG000|Overall Study|Lost to Follow-up|68|||
131404610|NCT01703208|473103758|FG001|Overall Study|Lost to Follow-up|62|||
131404611|NCT01703208|473103757|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131404612|NCT01703208|473103758|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131404613|NCT01703208|473103757|FG000|Overall Study|Excluded Medication|1|||
131404614|NCT01703208|473103758|FG001|Overall Study|Excluded Medication|2|||
131404615|NCT01703208|473103757|FG000|Overall Study|Site Discontinued Study Participation|23|||
131404616|NCT01703208|473103758|FG001|Overall Study|Site Discontinued Study Participation|27|||
131404617|NCT01703208|473103757|FG000|Overall Study|Physician Decision|11|||
131404618|NCT01703208|473103758|FG001|Overall Study|Physician Decision|13|||
131404619|NCT01703208|473103757|FG000|Overall Study|Progressive disease|2|||
131404620|NCT01703208|473103758|FG001|Overall Study|Progressive disease|2|||
131404621|NCT01703208|473103757|FG000|Overall Study|Protocol Violation|1|||
131452630|NCT00220636|473286040|FG000|Overall Study|Withdrawal by Subject|4|||
131452631|NCT00330967|473286041|FG000|Overall Study|Withdrawal by Subject|0|||
131452632|NCT00330967|473286042|FG001|Overall Study|Withdrawal by Subject|5|||
131404622|NCT01703208|473103758|FG001|Overall Study|Protocol Violation|1|||
131404623|NCT01703208|473103757|FG000|Overall Study|Study Terminated by Sponsor|1710|||
131404624|NCT01703208|473103758|FG001|Overall Study|Study Terminated by Sponsor|1716|||
131404625|NCT01703208|473103757|FG000|Overall Study|Withdrawal by Subject|205|||
131404626|NCT01703208|473103758|FG001|Overall Study|Withdrawal by Subject|209|||
131404627|NCT01703208|473103757|FG000|Overall Study|Adverse Event|14|||
131404628|NCT01703208|473103758|FG001|Overall Study|Adverse Event|19|||
131404629|NCT01703208|473103757|FG000|Overall Study|Technical Problems|0|||
131404630|NCT01703208|473103758|FG001|Overall Study|Technical Problems|1|||
131404631|NCT01703208|473103757|FG000|Overall Study|Protocol Deviation|2|||
131404632|NCT01703208|473103758|FG001|Overall Study|Protocol Deviation|0|||
131404633|NCT02359045|473103759|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
131452633|NCT00330967|473286041|FG000|Overall Study|Physician Decision|0|||
131452634|NCT00330967|473286042|FG001|Overall Study|Physician Decision|9|||
131404634|NCT02359045|473103760|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131404635|NCT02359045|473103759|FG000|Overall Study|Lost to Follow-up|1|||
131404636|NCT02359045|473103760|FG001|Overall Study|Lost to Follow-up|1|||
131912216|NCT01799889|474966524|FG000|Overall Study|Lack of Efficacy|1|||
131912217|NCT01799889|474966525|FG001|Overall Study|Lack of Efficacy|1|||
131851514|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
131851515|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
131851516|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
131851517|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
131851518|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
131851519|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
131851520|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
131851521|NCT03888066|474735522|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
131851522|NCT03888066|474735523|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
131851523|NCT03278626|474735524|FG000|Overall Study|Death|2|||
131851524|NCT03278626|474735524|FG000|Overall Study|Toxicity|1|||
131851525|NCT03278626|474735524|FG000|Overall Study|Disease Progression|2|||
131851526|NCT05013008|474735525|FG000|Overall Study|Exclusion from mBFAS|5|||
131851527|NCT05013008|474735526|FG001|Overall Study|Exclusion from mBFAS|25|||
131851528|NCT02077140|474735527|FG000|Overall Study|Lost to Follow-up|4|||
131851529|NCT02077140|474735528|FG001|Overall Study|Lost to Follow-up|1|||
131851530|NCT02077140|474735529|FG002|Overall Study|Lost to Follow-up|2|||
131851531|NCT02077140|474735530|FG003|Overall Study|Lost to Follow-up|2|||
131851532|NCT02077140|474735531|FG004|Overall Study|Lost to Follow-up|3|||
131851533|NCT02077140|474735527|FG000|Overall Study|Withdrawal by Subject|0|||
131851534|NCT02077140|474735528|FG001|Overall Study|Withdrawal by Subject|1|||
131851535|NCT02077140|474735529|FG002|Overall Study|Withdrawal by Subject|0|||
131851536|NCT02077140|474735530|FG003|Overall Study|Withdrawal by Subject|2|||
131851537|NCT02077140|474735531|FG004|Overall Study|Withdrawal by Subject|2|||
131851538|NCT03965689|474735534|FG000|Overall Study|Too sick to get study intervention|2|||
131851539|NCT03022084|474735541|FG000|Overall Study|Lost to Follow-up|2|||
131851540|NCT03022084|474735542|FG001|Overall Study|Lost to Follow-up|3|||
131851541|NCT01762800|474735543|FG000|Overall Study|Adverse Event|8|||
131851542|NCT01762800|474735544|FG001|Overall Study|Adverse Event|13|||
131851543|NCT01762800|474735543|FG000|Overall Study|Lack of Efficacy|3|||
131851544|NCT01762800|474735544|FG001|Overall Study|Lack of Efficacy|2|||
131851545|NCT01762800|474735543|FG000|Overall Study|Study Closed/Terminated|0|||
131851546|NCT01762800|474735544|FG001|Overall Study|Study Closed/Terminated|1|||
131851547|NCT01762800|474735543|FG000|Overall Study|Physician Decision|1|||
131851548|NCT01762800|474735544|FG001|Overall Study|Physician Decision|1|||
131851549|NCT01762800|474735543|FG000|Overall Study|Withdrawal by Subject|7|||
131851550|NCT01762800|474735544|FG001|Overall Study|Withdrawal by Subject|4|||
131851551|NCT02640482|474735545|FG000|Overall Study|Lost to Follow-up|3|||
131851552|NCT02640482|474735546|FG001|Overall Study|Lost to Follow-up|0|||
131851553|NCT01173120|474735548|FG000|Overall Study|Lack of Efficacy|2|||
131851554|NCT01173120|474735548|FG000|Overall Study|Lost to Follow-up|1|||
131851555|NCT01173120|474735548|FG000|Overall Study|Participant Decision|2|||
131851556|NCT01173120|474735548|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
131851557|NCT01173120|474735548|FG000|Overall Study|Switch-Participant Decision|12|||
131851558|NCT01173120|474735548|FG000|Overall Study|Switch-Difficulty With Device|12|||
131851559|NCT00517881|474735549|FG000|Overall Study|Protocol Violation|2|||
131851560|NCT00517881|474735549|FG000|Overall Study|Adverse Event|1|||
131851561|NCT00517881|474735549|FG000|Overall Study|Renal transplantation|2|||
131851562|NCT02013817|474735554|FG000|Overall Study|Adverse Event|12|||
131851563|NCT02013817|474735554|FG000|Overall Study|Withdrawal by Subject|4|||
131851564|NCT02013817|474735554|FG000|Overall Study|Death|2|||
131851565|NCT02013817|474735554|FG000|Overall Study|Other|9|||
131851566|NCT02437903|474735558|FG000|Overall Study|Adverse Event|1|||
131851567|NCT02437903|474735558|FG000|Overall Study|Withdrawal by Subject|1|||
131851568|NCT02437903|474735558|FG000|Overall Study|Lost to Follow-up|3|||
131851569|NCT01753297|474735561|FG000|Overall Study|Lost to Follow-up|7|||
131851570|NCT01753297|474735562|FG001|Overall Study|Lost to Follow-up|2|||
131851571|NCT01753297|474735561|FG000|Overall Study|Withdrawal by Subject|26|||
131851572|NCT01753297|474735562|FG001|Overall Study|Withdrawal by Subject|23|||
131851573|NCT01753297|474735561|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
131851574|NCT01753297|474735562|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
131851575|NCT01753297|474735561|FG000|Overall Study|Death|0|||
131851576|NCT01753297|474735562|FG001|Overall Study|Death|2|||
131851577|NCT01753297|474735561|FG000|Overall Study|Did not attend end of study visit|7|||
131851578|NCT01753297|474735562|FG001|Overall Study|Did not attend end of study visit|8|||
131851579|NCT00230178|474735563|FG000|Overall Study|Adverse Event|1|||
131851580|NCT00230178|474735564|FG001|Overall Study|Adverse Event|5|||
131851581|NCT00230178|474735565|FG002|Overall Study|Adverse Event|2|||
131851582|NCT00230178|474735563|FG000|Overall Study|Withdrawal by Subject|0|||
131851583|NCT00230178|474735564|FG001|Overall Study|Withdrawal by Subject|0|||
131851584|NCT00230178|474735565|FG002|Overall Study|Withdrawal by Subject|1|||
131851585|NCT00230178|474735563|FG000|Overall Study|Various other reasons|3|||
131851586|NCT00230178|474735564|FG001|Overall Study|Various other reasons|2|||
131851587|NCT00230178|474735565|FG002|Overall Study|Various other reasons|4|||
131851588|NCT00582010|474735574|FG000|Overall Study|Death|0|||
131851589|NCT00582010|474735575|FG001|Overall Study|Death|1|||
131851590|NCT01645787|474735579|FG000|Washout (2 Weeks)|Adverse Event|1|||
131851591|NCT01645787|474735580|FG001|Washout (2 Weeks)|Adverse Event|0|||
131851592|NCT04315506|474735582|FG000|Overall Study|Lost to Follow-up|74|||
131851593|NCT04315506|474735583|FG001|Overall Study|Lost to Follow-up|82|||
131851594|NCT04315506|474735582|FG000|Overall Study|Withdrawal by Subject|8|||
131851595|NCT04315506|474735583|FG001|Overall Study|Withdrawal by Subject|8|||
131851596|NCT04315506|474735582|FG000|Overall Study|Physician Decision|0|||
131851597|NCT04315506|474735583|FG001|Overall Study|Physician Decision|1|||
131851598|NCT02604407|474735589|FG000|Overall Study|Adverse Event|0|||
131851599|NCT02604407|474735590|FG001|Overall Study|Adverse Event|7|||
131851600|NCT02604407|474735591|FG002|Overall Study|Adverse Event|5|||
131851601|NCT02604407|474735589|FG000|Overall Study|Protocol Violation|2|||
131851602|NCT02604407|474735590|FG001|Overall Study|Protocol Violation|0|||
131851603|NCT02604407|474735591|FG002|Overall Study|Protocol Violation|0|||
131851604|NCT02604407|474735589|FG000|Overall Study|Withdrawal by Subject|3|||
131851605|NCT02604407|474735590|FG001|Overall Study|Withdrawal by Subject|3|||
131851606|NCT02604407|474735591|FG002|Overall Study|Withdrawal by Subject|5|||
131851607|NCT02604407|474735589|FG000|Overall Study|Lost to Follow-up|2|||
131851608|NCT02604407|474735590|FG001|Overall Study|Lost to Follow-up|1|||
131851609|NCT02604407|474735591|FG002|Overall Study|Lost to Follow-up|2|||
131851610|NCT02604407|474735589|FG000|Overall Study|Lack of Efficacy|1|||
131851611|NCT02604407|474735590|FG001|Overall Study|Lack of Efficacy|0|||
131851612|NCT02604407|474735591|FG002|Overall Study|Lack of Efficacy|0|||
131851613|NCT02604407|474735589|FG000|Overall Study|Other|3|||
131851614|NCT02604407|474735590|FG001|Overall Study|Other|1|||
131851615|NCT02604407|474735591|FG002|Overall Study|Other|4|||
131851616|NCT02481869|474735592|FG000|Overall Study|Lost to Follow-up|3|||
131851617|NCT02481869|474735593|FG001|Overall Study|Lost to Follow-up|4|||
131851618|NCT02481869|474735592|FG000|Overall Study|Withdrawal by Subject|2|||
131851619|NCT02481869|474735593|FG001|Overall Study|Withdrawal by Subject|0|||
131851620|NCT00711880|474735594|FG000|Overall Study|Adverse Event|11|||
131851621|NCT00711880|474735595|FG001|Overall Study|Adverse Event|2|||
131851622|NCT00711880|474735594|FG000|Overall Study|Patient non-compliance|1|||
131851623|NCT00711880|474735595|FG001|Overall Study|Patient non-compliance|0|||
131851624|NCT00711880|474735594|FG000|Overall Study|Lack of Efficacy|1|||
131851625|NCT00711880|474735595|FG001|Overall Study|Lack of Efficacy|5|||
131851626|NCT03908437|474735598|FG000|Overall Study|Death|0|||
131851627|NCT03908437|474735599|FG001|Overall Study|Death|1|||
131851628|NCT03908437|474735598|FG000|Overall Study|Lost to Follow-up|31|||
131851629|NCT03908437|474735599|FG001|Overall Study|Lost to Follow-up|24|||
131851630|NCT05445492|474735600|FG000|Overall Study|Physician Decision|1|||
131851631|NCT00191191|474735601|FG000|Overall Study|Entry Criteria Exclusion|2|||
131851632|NCT00191191|474735602|FG001|Overall Study|Entry Criteria Exclusion|0|||
131851633|NCT00191191|474735601|FG000|Overall Study|Treated with Another Systemic Agent|1|||
131851634|NCT00191191|474735602|FG001|Overall Study|Treated with Another Systemic Agent|1|||
131851635|NCT00191191|474735601|FG000|Overall Study|Adverse Event|11|||
131851636|NCT00191191|474735602|FG001|Overall Study|Adverse Event|21|||
131851637|NCT00191191|474735601|FG000|Overall Study|Progressive Disease|84|||
131851638|NCT00191191|474735602|FG001|Overall Study|Progressive Disease|72|||
131851639|NCT00191191|474735601|FG000|Overall Study|Toxicity After Dose Reduction|7|||
131851640|NCT00191191|474735602|FG001|Overall Study|Toxicity After Dose Reduction|8|||
131851641|NCT00191191|474735601|FG000|Overall Study|Family/Caregiver Decision|5|||
131851642|NCT00191191|474735602|FG001|Overall Study|Family/Caregiver Decision|7|||
131851643|NCT00191191|474735601|FG000|Overall Study|Lost to Follow-up|1|||
131851644|NCT00191191|474735602|FG001|Overall Study|Lost to Follow-up|0|||
131851645|NCT00191191|474735601|FG000|Overall Study|Physician Decision|3|||
131851646|NCT00191191|474735602|FG001|Overall Study|Physician Decision|2|||
131851647|NCT00191191|474735601|FG000|Overall Study|Good Clinical Practice Violation|0|||
131851648|NCT00191191|474735602|FG001|Overall Study|Good Clinical Practice Violation|1|||
131851649|NCT02585778|474735603|FG000|Overall Study|Adverse Event|17|||
131851650|NCT02585778|474735604|FG001|Overall Study|Adverse Event|4|||
131851651|NCT02585778|474735603|FG000|Overall Study|Participant did not wish to continue|9|||
131851652|NCT02585778|474735604|FG001|Overall Study|Participant did not wish to continue|4|||
131851653|NCT02585778|474735603|FG000|Overall Study|Poor compliance to study protocol|0|||
131851654|NCT02585778|474735604|FG001|Overall Study|Poor compliance to study protocol|2|||
131851655|NCT02585778|474735603|FG000|Overall Study|Death|0|||
131851656|NCT02585778|474735604|FG001|Overall Study|Death|1|||
131851657|NCT02585778|474735603|FG000|Overall Study|Randomized but not treated|1|||
131452635|NCT05661409|473286045|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
131851658|NCT02585778|474735604|FG001|Overall Study|Randomized but not treated|2|||
131851659|NCT02585778|474735603|FG000|Overall Study|Other than specified above|6|||
131851660|NCT02585778|474735604|FG001|Overall Study|Other than specified above|2|||
131851661|NCT01295320|474735611|FG000|Overall Study|Adverse Event|2|||
131851662|NCT01295320|474735611|FG000|Overall Study|Lost to Follow-up|4|||
131851663|NCT01295320|474735611|FG000|Overall Study|Withdrawal by Subject|2|||
131851664|NCT01295320|474735611|FG000|Overall Study|Subject was bedridden|1|||
131851665|NCT01295320|474735611|FG000|Overall Study|Unable to travel|1|||
131851666|NCT00652340|474735612|FG000|Overall Study|Had not progressed.|4|||
131404637|NCT02359045|473103759|FG000|Overall Study|Adverse Event|0|||
131404638|NCT02359045|473103760|FG001|Overall Study|Adverse Event|1|||
131404639|NCT00367744|473103767|FG000|Overall Study|Lost to Follow-up|4|||
131851667|NCT00652340|474735613|FG001|Overall Study|Had not progressed.|3|||
131851668|NCT03682107|474735614|FG000|Overall Study|Withdrawal by Subject|0|||
131851669|NCT03682107|474735615|FG001|Overall Study|Withdrawal by Subject|1|||
131851670|NCT03682107|474735616|FG002|Overall Study|Withdrawal by Subject|0|||
131851671|NCT03682107|474735617|FG003|Overall Study|Withdrawal by Subject|0|||
131851672|NCT03682107|474735618|FG004|Overall Study|Withdrawal by Subject|0|||
131851673|NCT04342819|474735619|FG000|Overall Study|Declined|4|||
131851674|NCT04342819|474735619|FG000|Overall Study|Not meeeting selection criteria|1|||
131851675|NCT01569295|474735620|FG000|Overall Study|Progressive Disease|75|||
131851676|NCT01569295|474735621|FG001|Overall Study|Progressive Disease|139|||
131851677|NCT01569295|474735620|FG000|Overall Study|Adverse Event|39|||
131851678|NCT01569295|474735621|FG001|Overall Study|Adverse Event|14|||
131851679|NCT01569295|474735620|FG000|Overall Study|Withdrawal by Subject|25|||
131851680|NCT01569295|474735621|FG001|Overall Study|Withdrawal by Subject|12|||
131851681|NCT01569295|474735620|FG000|Overall Study|Death|19|||
131851682|NCT01569295|474735621|FG001|Overall Study|Death|15|||
131851683|NCT01569295|474735620|FG000|Overall Study|Physician Decision|13|||
131851684|NCT01569295|474735621|FG001|Overall Study|Physician Decision|18|||
131851685|NCT01569295|474735620|FG000|Overall Study|Study Terminated by Sponsor|24|||
131851686|NCT01569295|474735621|FG001|Overall Study|Study Terminated by Sponsor|2|||
131851687|NCT01569295|474735620|FG000|Overall Study|Other Reason not Specified|3|||
131851688|NCT01569295|474735621|FG001|Overall Study|Other Reason not Specified|5|||
131851689|NCT01569295|474735620|FG000|Overall Study|Non-Compliance with Study Drug|6|||
131851690|NCT01569295|474735621|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131851691|NCT01569295|474735620|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
131851692|NCT01569295|474735621|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
131851693|NCT01569295|474735620|FG000|Overall Study|Lost to Follow-up|1|||
131851694|NCT01569295|474735621|FG001|Overall Study|Lost to Follow-up|1|||
131851695|NCT03597295|474735622|FG000|Overall Study|Death|70|||
131851696|NCT03597295|474735622|FG000|Overall Study|Lost to Follow-up|7|||
131851697|NCT00710866|474735623|FG000|Overall Study|Protocol Violation|5|||
131851698|NCT00710866|474735624|FG001|Overall Study|Protocol Violation|4|||
131851699|NCT00710866|474735623|FG000|Overall Study|Withdrawal by Subject|2|||
131851700|NCT00710866|474735624|FG001|Overall Study|Withdrawal by Subject|1|||
131851701|NCT00710866|474735623|FG000|Overall Study|Lost to Follow-up|1|||
131851702|NCT00710866|474735624|FG001|Overall Study|Lost to Follow-up|0|||
131851703|NCT00710866|474735623|FG000|Overall Study|Failed to meet eligibility|1|||
131851704|NCT00710866|474735624|FG001|Overall Study|Failed to meet eligibility|1|||
131851705|NCT04324021|474735626|FG000|Overall Study|Adverse Event|1|||
131851706|NCT04324021|474735627|FG001|Overall Study|Adverse Event|0|||
131851707|NCT04324021|474735628|FG002|Overall Study|Adverse Event|0|||
131851708|NCT04324021|474735626|FG000|Overall Study|Lack of Efficacy|0|||
131851709|NCT04324021|474735627|FG001|Overall Study|Lack of Efficacy|0|||
131851710|NCT04324021|474735628|FG002|Overall Study|Lack of Efficacy|1|||
131851711|NCT04324021|474735626|FG000|Overall Study|Death|1|||
131851712|NCT04324021|474735627|FG001|Overall Study|Death|1|||
131851713|NCT04324021|474735628|FG002|Overall Study|Death|0|||
131851714|NCT03097991|474735629|FG000|Overall Study|Didn't meet study criteria|8|||
131851715|NCT03097991|474735630|FG001|Overall Study|Didn't meet study criteria|0|||
131851716|NCT03097991|474735629|FG000|Overall Study|Withdrawal by Subject|12|||
131851717|NCT03097991|474735630|FG001|Overall Study|Withdrawal by Subject|6|||
131851718|NCT03097991|474735629|FG000|Overall Study|Death of Baby|3|||
131851719|NCT03097991|474735630|FG001|Overall Study|Death of Baby|1|||
131851720|NCT03097991|474735629|FG000|Overall Study|Lost to Follow-up|24|||
131851721|NCT03097991|474735630|FG001|Overall Study|Lost to Follow-up|38|||
131851722|NCT03097991|474735629|FG000|Overall Study|Adverse Event|3|||
131851723|NCT03097991|474735630|FG001|Overall Study|Adverse Event|5|||
131851724|NCT00246324|474735631|FG000|Overall Study|Withdrawal by Subject|1|||
131851725|NCT02006732|474735632|FG000|Overall Study|Adverse Event|10|||
131851726|NCT02006732|474735633|FG001|Overall Study|Adverse Event|7|||
131851727|NCT02006732|474735634|FG002|Overall Study|Adverse Event|4|||
131851728|NCT02006732|474735635|FG003|Overall Study|Adverse Event|2|||
131851729|NCT02006732|474735632|FG000|Overall Study|Lack of Efficacy|6|||
131851730|NCT02006732|474735633|FG001|Overall Study|Lack of Efficacy|3|||
131851731|NCT02006732|474735634|FG002|Overall Study|Lack of Efficacy|1|||
131851732|NCT02006732|474735635|FG003|Overall Study|Lack of Efficacy|1|||
131851733|NCT02006732|474735632|FG000|Overall Study|Protocol Violation|1|||
131851734|NCT02006732|474735633|FG001|Overall Study|Protocol Violation|1|||
131851735|NCT02006732|474735634|FG002|Overall Study|Protocol Violation|0|||
131404640|NCT00367744|473103768|FG001|Overall Study|Lost to Follow-up|5|||
131851736|NCT02006732|474735635|FG003|Overall Study|Protocol Violation|0|||
131851737|NCT02006732|474735632|FG000|Overall Study|Lost to Follow-up|0|||
131851738|NCT02006732|474735633|FG001|Overall Study|Lost to Follow-up|1|||
131851739|NCT02006732|474735634|FG002|Overall Study|Lost to Follow-up|0|||
131851740|NCT02006732|474735635|FG003|Overall Study|Lost to Follow-up|0|||
131404641|NCT01451931|473103775|FG000|Overall Study|Lost to Follow-up|17|||
131851741|NCT02006732|474735632|FG000|Overall Study|Withdrawal by Subject|3|||
131851742|NCT02006732|474735633|FG001|Overall Study|Withdrawal by Subject|0|||
131851743|NCT02006732|474735634|FG002|Overall Study|Withdrawal by Subject|4|||
131851744|NCT02006732|474735635|FG003|Overall Study|Withdrawal by Subject|1|||
131851745|NCT01464931|474735636|FG000|Overall Study|Withdrawal by Subject|1|||
131851746|NCT01464931|474735637|FG001|Overall Study|Withdrawal by Subject|0|||
131851747|NCT01982812|474735640|FG000|Overall Study|Death|1|||
131851748|NCT01982812|474735641|FG001|Overall Study|Death|5|||
131851749|NCT01982812|474735640|FG000|Overall Study|Adverse Event|0|||
131851750|NCT01982812|474735641|FG001|Overall Study|Adverse Event|5|||
131851751|NCT00338728|474735648|FG000|Overall Study|Screen Failure|14|||
131851752|NCT02933255|474735657|FG000|Overall Study|Discontinued due to study closure.|1|||
131851753|NCT02933255|474735658|FG001|Overall Study|Discontinued due to study closure.|0|||
131851754|NCT04803305|474735659|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
131851755|NCT04803305|474735660|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
131851756|NCT04803305|474735659|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
131851757|NCT04803305|474735660|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
131851758|NCT04803305|474735659|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
131851759|NCT04803305|474735660|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
131851760|NCT04803305|474735659|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
131851761|NCT04803305|474735660|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
131851762|NCT04803305|474735659|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
131851763|NCT04803305|474735660|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
131851764|NCT04803305|474735659|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
131851765|NCT04803305|474735660|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
131851766|NCT04803305|474735659|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
131851767|NCT04803305|474735660|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
131851768|NCT04803305|474735659|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
131851769|NCT04803305|474735660|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
131851770|NCT02759692|474735662|FG000|Period 1|Test article no longer available|1|||
131851771|NCT02759692|474735663|FG001|Period 1|Test article no longer available|1|||
131851772|NCT02759692|474735662|FG000|Period 1|No longer meets eligibility criteria.|1|||
131851773|NCT02759692|474735663|FG001|Period 1|No longer meets eligibility criteria.|0|||
131851774|NCT02759692|474735662|FG000|Period 1|Miss-Randomized|1|||
131851775|NCT02759692|474735663|FG001|Period 1|Miss-Randomized|1|||
131851776|NCT02759692|474735662|FG000|Period 2|Lost to Follow-up|1|||
131851777|NCT02759692|474735663|FG001|Period 2|Lost to Follow-up|0|||
131851778|NCT02759692|474735662|FG000|Period 2|Test article no longer available|0|||
131851779|NCT02759692|474735663|FG001|Period 2|Test article no longer available|1|||
131851780|NCT00912912|474735665|FG000|Overall Study|Withdrawal by Subject|1|||
131851781|NCT00912912|474735665|FG000|Overall Study|Disease Progression|3|||
131851782|NCT02447744|474735666|FG000|Overall Study|Withdrawal by Subject|3|||
131851783|NCT02447744|474735667|FG001|Overall Study|Withdrawal by Subject|1|||
131851784|NCT02447744|474735666|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
131851785|NCT02447744|474735667|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
131851786|NCT00306995|474735668|FG000|Study Part I|Withdrawal by Subject|0|||
131851787|NCT00306995|474735669|FG001|Study Part I|Withdrawal by Subject|0|||
131851788|NCT00306995|474735670|FG002|Study Part I|Withdrawal by Subject|0|||
131851789|NCT00306995|474735671|FG003|Study Part I|Withdrawal by Subject|0|||
131851790|NCT00306995|474735672|FG004|Study Part I|Withdrawal by Subject|0|||
131851791|NCT00306995|474735673|FG005|Study Part I|Withdrawal by Subject|0|||
131851792|NCT00306995|474735674|FG006|Study Part I|Withdrawal by Subject|1|||
131851793|NCT00306995|474735668|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
131851794|NCT00306995|474735669|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
131851795|NCT00306995|474735670|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
131851796|NCT00306995|474735671|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
131851797|NCT00306995|474735672|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
131851798|NCT00306995|474735673|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
131851799|NCT00306995|474735674|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
131851800|NCT05422625|474735675|FG000|Overall Study|Withdrawal by Subject|1|||
131851801|NCT05422625|474735676|FG001|Overall Study|Withdrawal by Subject|0|||
131851802|NCT06400238|474737877|FG000|Overall Study|Started Protocol Therapy|2|||
131851803|NCT06400238|474737877|FG000|Overall Study|Adverse Event|1|||
131851804|NCT06400238|474737877|FG000|Overall Study|Death|1|||
131851805|NCT06400238|474737877|FG000|Overall Study|Disease Progression|27|||
131851806|NCT06400238|474737877|FG000|Overall Study|Withdrawal by Subject|2|||
131851807|NCT06400238|474737877|FG000|Overall Study|Physician Decision|2|||
131851808|NCT02017015|474737878|FG000|Overall Study|Adverse Event|9|||
131851809|NCT02017015|474737878|FG000|Overall Study|Withdrawal by Subject|21|||
131851810|NCT02017015|474737878|FG000|Overall Study|Death|4|||
131851811|NCT02017015|474737878|FG000|Overall Study|Progressive Disease|31|||
131851812|NCT02017015|474737878|FG000|Overall Study|Non-compliance with study drug|2|||
131851813|NCT02017015|474737878|FG000|Overall Study|Physician Decision|2|||
131851814|NCT03996447|474737879|FG000|First MRI Examination|Adverse Event|2|||
131851815|NCT03996447|474737880|FG001|First MRI Examination|Adverse Event|0|||
131851816|NCT03996447|474737879|FG000|First MRI Examination|Withdrawal by Subject|1|||
131851817|NCT03996447|474737880|FG001|First MRI Examination|Withdrawal by Subject|2|||
131851818|NCT03996447|474737879|FG000|First MRI Examination|Protocol Violation|0|||
131851819|NCT03996447|474737880|FG001|First MRI Examination|Protocol Violation|1|||
131851820|NCT03996447|474737879|FG000|Washout|Adverse Event|2|||
131851821|NCT03996447|474737880|FG001|Washout|Adverse Event|0|||
131851822|NCT03996447|474737879|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
131851823|NCT03996447|474737880|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
131851824|NCT03996447|474737879|FG000|Washout|Withdrawal by Subject|0|||
131851825|NCT03996447|474737880|FG001|Washout|Withdrawal by Subject|1|||
131851826|NCT03996447|474737879|FG000|Washout|Other reason|1|||
131851827|NCT03996447|474737880|FG001|Washout|Other reason|1|||
131851828|NCT04158245|474737881|FG000|Overall Study|Lost to Follow-up|1|||
131851829|NCT02291510|474737882|FG000|Overall Study|Adverse Event|0|||
131851830|NCT02291510|474737883|FG001|Overall Study|Adverse Event|0|||
131851831|NCT02291510|474737884|FG002|Overall Study|Adverse Event|0|||
131851832|NCT02291510|474737885|FG003|Overall Study|Adverse Event|1|||
131851833|NCT06390839|474737886|FG000|Overall Study|Ineligible|2|||
131851834|NCT06390839|474737886|FG000|Overall Study|Never start protocol therapy|3|||
131851835|NCT06390839|474737886|FG000|Overall Study|Adverse Event|1|||
131851836|NCT06390839|474737886|FG000|Overall Study|Alternative therapy|2|||
131851837|NCT06390839|474737886|FG000|Overall Study|Death|3|||
131851838|NCT06390839|474737886|FG000|Overall Study|Disease progression|28|||
131851839|NCT06390839|474737886|FG000|Overall Study|Withdrawal by Subject|2|||
131851840|NCT06390839|474737886|FG000|Overall Study|Complicating disease|1|||
131851841|NCT06390839|474737886|FG000|Overall Study|Noncompliance|1|||
131851842|NCT04458922|474737887|FG000|Overall Study|Withdrawal by Subject|1|||
131851843|NCT04458922|474737888|FG001|Overall Study|Withdrawal by Subject|0|||
131851844|NCT04458922|474737889|FG002|Overall Study|Withdrawal by Subject|2|||
131851845|NCT04458922|474737887|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
131851846|NCT04458922|474737888|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
131851847|NCT04458922|474737889|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
131851848|NCT04458922|474737887|FG000|Overall Study|Adverse Event|1|||
131851849|NCT04458922|474737888|FG001|Overall Study|Adverse Event|0|||
131851850|NCT04458922|474737889|FG002|Overall Study|Adverse Event|0|||
131851851|NCT04458922|474737887|FG000|Overall Study|Started new study|0|||
131851852|NCT04458922|474737888|FG001|Overall Study|Started new study|0|||
131851853|NCT04458922|474737889|FG002|Overall Study|Started new study|1|||
131851854|NCT04458922|474737887|FG000|Overall Study|Progressive disease|6|||
131851855|NCT04458922|474737888|FG001|Overall Study|Progressive disease|8|||
131851856|NCT04458922|474737889|FG002|Overall Study|Progressive disease|2|||
131851857|NCT04458922|474737887|FG000|Overall Study|Death|1|||
131851858|NCT04458922|474737888|FG001|Overall Study|Death|0|||
131851859|NCT04458922|474737889|FG002|Overall Study|Death|2|||
131851860|NCT04458922|474737887|FG000|Overall Study|Participant started chemotherapy|0|||
131851861|NCT04458922|474737888|FG001|Overall Study|Participant started chemotherapy|1|||
131851862|NCT04458922|474737889|FG002|Overall Study|Participant started chemotherapy|0|||
131851863|NCT06351371|474737891|FG000|Overall Study|Mutation Status Not Confirmed|9|||
131851864|NCT06351371|474737891|FG000|Overall Study|Ineligible|1|||
131851865|NCT06351371|474737891|FG000|Overall Study|Adverse Event|4|||
131851866|NCT06351371|474737891|FG000|Overall Study|Death|1|||
131851867|NCT06351371|474737891|FG000|Overall Study|Disease progression|14|||
131851868|NCT06351371|474737891|FG000|Overall Study|Withdrawal by Subject|3|||
131851869|NCT06351371|474737891|FG000|Overall Study|Physician Decision|3|||
131851870|NCT01207583|474737892|FG000|Overall Study|Withdrawal by Subject|0|||
131851871|NCT01207583|474737893|FG001|Overall Study|Withdrawal by Subject|3|||
131851872|NCT01207583|474737894|FG002|Overall Study|Withdrawal by Subject|1|||
131851873|NCT01207583|474737892|FG000|Overall Study|Participant failed to return|1|||
131851874|NCT01207583|474737893|FG001|Overall Study|Participant failed to return|0|||
131851875|NCT01207583|474737894|FG002|Overall Study|Participant failed to return|0|||
131851876|NCT01207583|474737892|FG000|Overall Study|Lost to Follow-up|0|||
131851877|NCT01207583|474737893|FG001|Overall Study|Lost to Follow-up|2|||
131851878|NCT01207583|474737894|FG002|Overall Study|Lost to Follow-up|0|||
131851879|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
131851880|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
131851881|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
131851882|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
131851883|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
131851884|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
131851885|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
131851886|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
131851887|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
131851888|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
131851889|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
131851890|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
131851891|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
131452636|NCT05661409|473286046|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
131452637|NCT05661409|473286047|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
131452638|NCT05661409|473286048|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
131452639|NCT05661409|473286049|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
131452640|NCT05661409|473286050|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
131452641|NCT05661409|473286045|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
131452642|NCT05661409|473286046|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
131452643|NCT05661409|473286047|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
131452644|NCT05661409|473286048|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
131452645|NCT05661409|473286049|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
131452646|NCT05661409|473286050|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
131452647|NCT05661409|473286045|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
131452648|NCT05661409|473286046|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
131452649|NCT05661409|473286047|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
131452650|NCT05661409|473286048|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
131452651|NCT05661409|473286049|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
131452652|NCT05661409|473286050|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
131452653|NCT05661409|473286045|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
131452654|NCT05661409|473286046|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
131452655|NCT05661409|473286047|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
131452656|NCT05661409|473286048|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
131452657|NCT05661409|473286049|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
131452658|NCT05661409|473286050|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
131452659|NCT05661409|473286045|FG000|Overall Study|Miscommu-nication about administration|0|||
131452660|NCT05661409|473286046|FG001|Overall Study|Miscommu-nication about administration|0|||
131452661|NCT05661409|473286047|FG002|Overall Study|Miscommu-nication about administration|0|||
131452662|NCT05661409|473286048|FG003|Overall Study|Miscommu-nication about administration|0|||
131452663|NCT05661409|473286049|FG004|Overall Study|Miscommu-nication about administration|0|||
131452664|NCT05661409|473286050|FG005|Overall Study|Miscommu-nication about administration|1|||
131452665|NCT04439136|473286051|FG000|Overall Study|Ineligible|1|||
131851892|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
131851893|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
131851894|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
131851895|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
131851896|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
131851897|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
131851898|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
131851899|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
131851900|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
131851901|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
131851902|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
131851903|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
131851904|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
131851905|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
131851906|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
131851907|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
131851908|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
131851909|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
131851910|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
131851911|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
131851912|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
131851913|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
131851914|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
131851915|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
131851916|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
131851917|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
131851918|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
131851919|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851920|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851921|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851922|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
131851923|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851924|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851925|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851926|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851927|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851928|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
131851929|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
131851930|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
131404642|NCT01451931|473103776|FG001|Overall Study|Lost to Follow-up|36|||
131404643|NCT01451931|473103777|FG002|Overall Study|Lost to Follow-up|21|||
131404644|NCT01451931|473103775|FG000|Overall Study|Withdrawal by Subject|16|||
131404645|NCT01451931|473103776|FG001|Overall Study|Withdrawal by Subject|22|||
131404646|NCT01451931|473103777|FG002|Overall Study|Withdrawal by Subject|22|||
131404647|NCT01271712|473103778|FG000|Double Blind Treatment|Death|2|||
131404648|NCT01271712|473103779|FG001|Double Blind Treatment|Death|0|||
131404649|NCT01271712|473103778|FG000|Double Blind Treatment|Lack of Efficacy|1|||
131404650|NCT01271712|473103779|FG001|Double Blind Treatment|Lack of Efficacy|0|||
131404651|NCT01271712|473103778|FG000|Double Blind Treatment|Adverse Event|9|||
131404652|NCT01271712|473103779|FG001|Double Blind Treatment|Adverse Event|4|||
131404653|NCT01271712|473103778|FG000|Double Blind Treatment|Progressive disease|23|||
131404654|NCT01271712|473103779|FG001|Double Blind Treatment|Progressive disease|3|||
131404655|NCT01271712|473103778|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
131912218|NCT01799889|474966526|FG002|Overall Study|Lack of Efficacy|0|||
131912219|NCT01799889|474966527|FG003|Overall Study|Lack of Efficacy|1|||
131912220|NCT01799889|474966528|FG004|Overall Study|Lack of Efficacy|2|||
131912221|NCT01799889|474966529|FG005|Overall Study|Lack of Efficacy|2|||
131912222|NCT01799889|474966530|FG006|Overall Study|Lack of Efficacy|0|||
131912223|NCT01799889|474966531|FG007|Overall Study|Lack of Efficacy|0|||
131912224|NCT01799889|474966532|FG008|Overall Study|Lack of Efficacy|2|||
131912225|NCT01799889|474966533|FG009|Overall Study|Lack of Efficacy|0|||
131912226|NCT01799889|474966534|FG010|Overall Study|Lack of Efficacy|1|||
131912227|NCT01799889|474966535|FG011|Overall Study|Lack of Efficacy|0|||
131912228|NCT01799889|474966524|FG000|Overall Study|Lost to Follow-up|0|||
131912229|NCT01799889|474966525|FG001|Overall Study|Lost to Follow-up|1|||
131912230|NCT01799889|474966526|FG002|Overall Study|Lost to Follow-up|0|||
131912231|NCT01799889|474966527|FG003|Overall Study|Lost to Follow-up|0|||
131912232|NCT01799889|474966528|FG004|Overall Study|Lost to Follow-up|0|||
131912233|NCT01799889|474966529|FG005|Overall Study|Lost to Follow-up|0|||
131912234|NCT01799889|474966530|FG006|Overall Study|Lost to Follow-up|0|||
131912235|NCT01799889|474966531|FG007|Overall Study|Lost to Follow-up|0|||
131912236|NCT01799889|474966532|FG008|Overall Study|Lost to Follow-up|0|||
131912237|NCT01799889|474966533|FG009|Overall Study|Lost to Follow-up|0|||
131912238|NCT01799889|474966534|FG010|Overall Study|Lost to Follow-up|0|||
131912239|NCT01799889|474966535|FG011|Overall Study|Lost to Follow-up|0|||
131912240|NCT01799889|474966524|FG000|Overall Study|Physician Decision|3|||
131912241|NCT01799889|474966525|FG001|Overall Study|Physician Decision|2|||
131912242|NCT01799889|474966526|FG002|Overall Study|Physician Decision|4|||
131912243|NCT01799889|474966527|FG003|Overall Study|Physician Decision|4|||
131912244|NCT01799889|474966528|FG004|Overall Study|Physician Decision|5|||
131912245|NCT01799889|474966529|FG005|Overall Study|Physician Decision|5|||
131912246|NCT01799889|474966530|FG006|Overall Study|Physician Decision|5|||
131912247|NCT01799889|474966531|FG007|Overall Study|Physician Decision|2|||
131912248|NCT01799889|474966532|FG008|Overall Study|Physician Decision|6|||
131912249|NCT01799889|474966533|FG009|Overall Study|Physician Decision|0|||
131912250|NCT01799889|474966534|FG010|Overall Study|Physician Decision|0|||
131912251|NCT01799889|474966535|FG011|Overall Study|Physician Decision|1|||
131912252|NCT01799889|474966524|FG000|Overall Study|Progressive Disease|30|||
131912253|NCT01799889|474966525|FG001|Overall Study|Progressive Disease|26|||
131912254|NCT01799889|474966526|FG002|Overall Study|Progressive Disease|25|||
131912255|NCT01799889|474966527|FG003|Overall Study|Progressive Disease|30|||
131912256|NCT01799889|474966528|FG004|Overall Study|Progressive Disease|23|||
131912257|NCT01799889|474966529|FG005|Overall Study|Progressive Disease|9|||
131912258|NCT01799889|474966530|FG006|Overall Study|Progressive Disease|8|||
131912259|NCT01799889|474966531|FG007|Overall Study|Progressive Disease|13|||
131912260|NCT01799889|474966532|FG008|Overall Study|Progressive Disease|18|||
131912261|NCT01799889|474966533|FG009|Overall Study|Progressive Disease|5|||
131912262|NCT01799889|474966534|FG010|Overall Study|Progressive Disease|3|||
131912263|NCT01799889|474966535|FG011|Overall Study|Progressive Disease|1|||
131912264|NCT01799889|474966524|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
131912265|NCT01799889|474966525|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
131912266|NCT01799889|474966526|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
131912267|NCT01799889|474966527|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
131912268|NCT01799889|474966528|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
131912269|NCT01799889|474966529|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
131912270|NCT01799889|474966530|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
131912271|NCT01799889|474966531|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
131912272|NCT01799889|474966532|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
131912273|NCT01799889|474966533|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
131912274|NCT01799889|474966534|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
131912275|NCT01799889|474966535|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
131912276|NCT01799889|474966524|FG000|Overall Study|Study Terminated By Sponsor|1|||
131912277|NCT01799889|474966525|FG001|Overall Study|Study Terminated By Sponsor|0|||
131404656|NCT01271712|473103779|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
131912278|NCT01799889|474966526|FG002|Overall Study|Study Terminated By Sponsor|0|||
131912279|NCT01799889|474966527|FG003|Overall Study|Study Terminated By Sponsor|0|||
131912280|NCT01799889|474966528|FG004|Overall Study|Study Terminated By Sponsor|2|||
131851931|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
131851932|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
131851933|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
131851934|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
131851935|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
131851936|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
131851937|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
131851938|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
131851939|NCT03104400|474737895|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851940|NCT03104400|474737896|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851941|NCT03104400|474737897|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851942|NCT03104400|474737898|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
131851943|NCT03104400|474737899|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851944|NCT03104400|474737900|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851945|NCT03104400|474737901|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851946|NCT03104400|474737902|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851947|NCT03104400|474737903|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851948|NCT03104400|474737904|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
131851949|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
131851950|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
131851951|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
131851952|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
131851953|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
131851954|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
131851955|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
131851956|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
131851957|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
131851958|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
131851959|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
131851960|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
131851961|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
131851962|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
131851963|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
131851964|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
131851965|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
131851966|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
131851967|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
131851968|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
131851969|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
131851970|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
131851971|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
131851972|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
131851973|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
131851974|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
131851975|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
131851976|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
131851977|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
131851978|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
131851979|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
131851980|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
131851981|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
131851982|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
131851983|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
131851984|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
131851985|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
131851986|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
131851987|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
131851988|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
131851989|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851990|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851991|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851992|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851993|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851994|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851995|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
131851996|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131851997|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
131851998|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
131851999|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852000|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852001|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852002|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852003|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852004|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852005|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852006|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
131852007|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
131852008|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131852009|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
131852010|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
131852011|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
131852012|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
131852013|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
131852014|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
131852015|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
131852016|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
131852017|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
131852018|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
131852019|NCT03104400|474737895|FG000|Period 2 Week 56 - 260)|Other|0|||
131852020|NCT03104400|474737896|FG001|Period 2 Week 56 - 260)|Other|0|||
131852021|NCT03104400|474737897|FG002|Period 2 Week 56 - 260)|Other|0|||
131852022|NCT03104400|474737898|FG003|Period 2 Week 56 - 260)|Other|0|||
131852023|NCT03104400|474737899|FG004|Period 2 Week 56 - 260)|Other|0|||
131852024|NCT03104400|474737900|FG005|Period 2 Week 56 - 260)|Other|0|||
131852025|NCT03104400|474737901|FG006|Period 2 Week 56 - 260)|Other|0|||
131852026|NCT03104400|474737902|FG007|Period 2 Week 56 - 260)|Other|0|||
131852027|NCT03104400|474737903|FG008|Period 2 Week 56 - 260)|Other|1|||
131852028|NCT03104400|474737904|FG009|Period 2 Week 56 - 260)|Other|1|||
131852029|NCT03348631|474737905|FG000|Overall Study|Not Eligible, No treatment|0|||
131852030|NCT03348631|474737906|FG001|Overall Study|Not Eligible, No treatment|1|||
131852031|NCT03348631|474737905|FG000|Overall Study|Not Eligible, Treated|2|||
131852032|NCT03348631|474737906|FG001|Overall Study|Not Eligible, Treated|0|||
131852033|NCT03348631|474737905|FG000|Overall Study|Eligible, No Treatment|1|||
131852034|NCT03348631|474737906|FG001|Overall Study|Eligible, No Treatment|0|||
131852035|NCT04974749|474737907|FG000|Overall Study|Withdrawal by Subject|2|||
131852036|NCT04974749|474737907|FG000|Overall Study|Gestation|1|||
131852037|NCT03348163|474737924|FG000|Overall Study|Withdrawal by Subject|2|||
131852038|NCT03348163|474737925|FG001|Overall Study|Withdrawal by Subject|0|||
131852039|NCT02370238|474737926|FG000|Overall Study|Death|42|||
131852040|NCT02370238|474737927|FG001|Overall Study|Death|35|||
131852041|NCT02370238|474737926|FG000|Overall Study|Lost to Follow-up|1|||
131852042|NCT02370238|474737927|FG001|Overall Study|Lost to Follow-up|3|||
131852043|NCT02370238|474737926|FG000|Overall Study|Withdrawal by Subject|2|||
131852044|NCT02370238|474737927|FG001|Overall Study|Withdrawal by Subject|6|||
131852045|NCT02370238|474737926|FG000|Overall Study|Other|2|||
131852046|NCT02370238|474737927|FG001|Overall Study|Other|1|||
131852047|NCT02789137|474737930|FG000|Overall Study|Dropped out/Died|58|||
131852048|NCT00445432|474737931|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
131852049|NCT00445432|474737932|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
131852050|NCT00445432|474737933|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
131852051|NCT00445432|474737934|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
131852052|NCT00445432|474737931|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
131852053|NCT00445432|474737932|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
131852054|NCT00445432|474737933|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
131852055|NCT00445432|474737934|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
131852056|NCT00445432|474737931|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
131852057|NCT00445432|474737932|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
131852058|NCT00445432|474737933|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
131852059|NCT00445432|474737934|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
131852060|NCT00445432|474737931|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
131852061|NCT00445432|474737932|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
131852062|NCT00445432|474737933|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
131852063|NCT00445432|474737934|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
131852064|NCT00445432|474737931|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
131852065|NCT00445432|474737932|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
131852066|NCT00445432|474737933|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
131852067|NCT00445432|474737934|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
131852068|NCT00445432|474737931|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
131852069|NCT00445432|474737932|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
131852070|NCT00445432|474737933|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
131852071|NCT00445432|474737934|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
131852072|NCT00445432|474737931|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
131852073|NCT00445432|474737932|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
131852074|NCT00445432|474737933|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
131452666|NCT04439136|473286051|FG000|Overall Study|Never Started Treatment|2|||
131452667|NCT04439136|473286051|FG000|Overall Study|Adverse Event|4|||
131452668|NCT04439136|473286051|FG000|Overall Study|Death|3|||
131452669|NCT04439136|473286051|FG000|Overall Study|Disease Progression|27|||
131452670|NCT04439136|473286051|FG000|Overall Study|Alternative Therapy|1|||
131452671|NCT04439136|473286051|FG000|Overall Study|Increased Tumor Burden|1|||
131452672|NCT04439136|473286051|FG000|Overall Study|Symptomatic Detrioration|1|||
131452673|NCT04329806|473286052|FG000|Overall Study|Physician Decision|3|||
131452674|NCT04329806|473286053|FG001|Overall Study|Physician Decision|4|||
131452675|NCT02362282|473286056|FG000|Overall Study|Withdrawal by Subject|1|||
131452676|NCT02362282|473286057|FG001|Overall Study|Withdrawal by Subject|0|||
131452677|NCT02194985|473286058|FG000|Overall Study|Adverse Event|1|||
131452678|NCT02194985|473286058|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
131452679|NCT02194985|473286058|FG000|Overall Study|Physician Decision|4|||
131452680|NCT02194985|473286058|FG000|Overall Study|Lost to Follow-up|1|||
131452681|NCT02194985|473286058|FG000|Overall Study|Withdrawal by Subject|2|||
131452682|NCT02561832|473286061|FG000|Overall Study|Withdrawal by Subject|1|||
131452683|NCT02561832|473286062|FG001|Overall Study|Withdrawal by Subject|1|||
131452684|NCT02561832|473286061|FG000|Overall Study|Adverse Event|3|||
131452685|NCT02561832|473286062|FG001|Overall Study|Adverse Event|0|||
131452686|NCT02561832|473286061|FG000|Overall Study|Disease progression|3|||
131452687|NCT02561832|473286062|FG001|Overall Study|Disease progression|3|||
131452688|NCT00439517|473286063|FG000|Overall Study|Subject on treatment|1|||
131452689|NCT00439517|473286064|FG001|Overall Study|Subject on treatment|0|||
131452690|NCT00439517|473286063|FG000|Overall Study|Subject in survival follow-up|1|||
131452691|NCT00439517|473286064|FG001|Overall Study|Subject in survival follow-up|0|||
131452692|NCT02304367|473286067|FG000|Overall Study|Lack of Response to Bruosumab|1|||
131452693|NCT02304367|473286067|FG000|Overall Study|Sponsor Decision|3|||
131452694|NCT02304367|473286067|FG000|Overall Study|Death|2|||
131452695|NCT02304367|473286067|FG000|Overall Study|Physician Decision|1|||
131452696|NCT02304367|473286067|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
131452697|NCT00318643|473286073|FG000|Overall Study|Adverse Event|0|||
131452698|NCT00318643|473286074|FG001|Overall Study|Adverse Event|0|||
131452699|NCT00318643|473286075|FG002|Overall Study|Adverse Event|0|||
131452700|NCT00318643|473286076|FG003|Overall Study|Adverse Event|0|||
131452701|NCT00318643|473286077|FG004|Overall Study|Adverse Event|1|||
131452702|NCT00318643|473286073|FG000|Overall Study|Participant's Decision|0|||
131452703|NCT00318643|473286074|FG001|Overall Study|Participant's Decision|0|||
131452704|NCT00318643|473286075|FG002|Overall Study|Participant's Decision|0|||
131452705|NCT00318643|473286076|FG003|Overall Study|Participant's Decision|0|||
131452706|NCT00318643|473286077|FG004|Overall Study|Participant's Decision|1|||
131452707|NCT00318643|473286073|FG000|Overall Study|Investigator's Decision|0|||
131452708|NCT00318643|473286074|FG001|Overall Study|Investigator's Decision|0|||
131452709|NCT00318643|473286075|FG002|Overall Study|Investigator's Decision|0|||
131452710|NCT00318643|473286076|FG003|Overall Study|Investigator's Decision|0|||
131452711|NCT00318643|473286077|FG004|Overall Study|Investigator's Decision|1|||
131452712|NCT00060840|473286080|FG000|Overall Study|Change in surgical plan|2|||
131452713|NCT00060840|473286081|FG001|Overall Study|Change in surgical plan|6|||
131452714|NCT00060840|473286080|FG000|Overall Study|Death|0|||
131452715|NCT00060840|473286081|FG001|Overall Study|Death|1|||
131452716|NCT00060840|473286080|FG000|Overall Study|Withdrawal by Subject|0|||
131452717|NCT00060840|473286081|FG001|Overall Study|Withdrawal by Subject|1|||
131452718|NCT00060840|473286080|FG000|Overall Study|Subinvestigator unavailable|0|||
131452719|NCT00060840|473286081|FG001|Overall Study|Subinvestigator unavailable|1|||
131452720|NCT00060840|473286080|FG000|Overall Study|Physician Decision|1|||
131452721|NCT00060840|473286081|FG001|Overall Study|Physician Decision|0|||
131452722|NCT00060840|473286080|FG000|Overall Study|Other|1|||
131452723|NCT00060840|473286081|FG001|Overall Study|Other|0|||
131452724|NCT00357006|473286082|FG000|Overall Study|Lost to Follow-up|1|||
131452725|NCT00357006|473286083|FG001|Overall Study|Lost to Follow-up|2|||
131452726|NCT00357006|473286084|FG002|Overall Study|Lost to Follow-up|1|||
131452727|NCT00357006|473286082|FG000|Overall Study|Withdrawal by Subject|1|||
131452728|NCT00357006|473286083|FG001|Overall Study|Withdrawal by Subject|3|||
131452729|NCT00357006|473286084|FG002|Overall Study|Withdrawal by Subject|2|||
131452730|NCT00976560|473286085|FG000|Overall Study|Adverse Event|5|||
131452731|NCT00976560|473286086|FG001|Overall Study|Adverse Event|5|||
131452732|NCT00976560|473286085|FG000|Overall Study|Lack of Efficacy|3|||
131452733|NCT00976560|473286086|FG001|Overall Study|Lack of Efficacy|5|||
131452734|NCT00976560|473286085|FG000|Overall Study|Protocol Violation|1|||
131452735|NCT00976560|473286086|FG001|Overall Study|Protocol Violation|0|||
131452736|NCT00976560|473286085|FG000|Overall Study|Lost to Follow-up|1|||
131452737|NCT00976560|473286086|FG001|Overall Study|Lost to Follow-up|0|||
131452738|NCT00976560|473286085|FG000|Overall Study|Physician Decision|2|||
131452739|NCT00976560|473286086|FG001|Overall Study|Physician Decision|0|||
131452740|NCT00976560|473286085|FG000|Overall Study|Withdrawal by Subject|2|||
131452741|NCT00976560|473286086|FG001|Overall Study|Withdrawal by Subject|3|||
131452742|NCT03710161|473286087|FG000|Overall Study|Study halted due to COVID pandemic|3|||
131452743|NCT03710161|473286088|FG001|Overall Study|Study halted due to COVID pandemic|2|||
131452744|NCT01216189|473286089|FG000|Overall Study|Lost to Follow-up|21|||
131452745|NCT01216189|473286090|FG001|Overall Study|Lost to Follow-up|3|||
131452746|NCT01216189|473286089|FG000|Overall Study|Death|4|||
131452747|NCT01216189|473286090|FG001|Overall Study|Death|2|||
131452748|NCT04308291|473286096|FG000|Run-In Phase|Withdrawal by Subject|4|||
131452749|NCT04308291|473286096|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
131452750|NCT04308291|473286096|FG000|Study Phase 6-M|Physician Decision|2|||
131452751|NCT04308291|473286096|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
131452752|NCT04308291|473286096|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
131452753|NCT04308291|473286096|FG000|Study Phase 12-M|Physician Decision|2|||
131452754|NCT04308291|473286096|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
131452755|NCT04411667|473286099|FG000|Overall Study|Physician Decision|1|||
131452756|NCT04411667|473286100|FG001|Overall Study|Physician Decision|0|||
131452757|NCT00067002|473286101|FG000|Overall Study|Early Death|1|||
131452758|NCT00067002|473286102|FG001|Overall Study|Early Death|2|||
131452759|NCT00067002|473286101|FG000|Overall Study|Delayed|1|||
131452760|NCT00067002|473286102|FG001|Overall Study|Delayed|1|||
131452761|NCT00067002|473286101|FG000|Overall Study|Graft Failure|5|||
131452762|NCT00067002|473286102|FG001|Overall Study|Graft Failure|6|||
131452763|NCT00714870|473286106|FG000|Overall Study|Lost to Follow-up|22|||
131452764|NCT00714870|473286107|FG001|Overall Study|Lost to Follow-up|5|||
131452765|NCT00714870|473286106|FG000|Overall Study|patient unable to come b/c back pain|1|||
131452766|NCT00714870|473286107|FG001|Overall Study|patient unable to come b/c back pain|0|||
131452767|NCT00714870|473286106|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
131452768|NCT00714870|473286107|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
131452769|NCT03399552|473286108|FG000|Overall Study|No evidence of disease|1|||
131452770|NCT03399552|473286108|FG000|Overall Study|Unevaluable|1|||
131452771|NCT02357368|473286109|FG000|Overall Study|Lost to Follow-up|0|||
131452772|NCT02357368|473286110|FG001|Overall Study|Lost to Follow-up|0|||
131452773|NCT02357368|473286111|FG002|Overall Study|Lost to Follow-up|0|||
131452774|NCT02357368|473286112|FG003|Overall Study|Lost to Follow-up|1|||
131452775|NCT02357368|473286109|FG000|Overall Study|Pregnancy|3|||
131452776|NCT02357368|473286110|FG001|Overall Study|Pregnancy|2|||
131452777|NCT02357368|473286111|FG002|Overall Study|Pregnancy|0|||
131452778|NCT02357368|473286112|FG003|Overall Study|Pregnancy|0|||
131852075|NCT00445432|474737934|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
131852076|NCT01482312|474737935|FG000|Period 1, 90 Minutes of Wear|Other|1|||
131852077|NCT01482312|474737936|FG001|Period 1, 90 Minutes of Wear|Other|0|||
131852078|NCT01482312|474737937|FG002|Period 1, 90 Minutes of Wear|Other|0|||
131852079|NCT01482312|474737935|FG000|Period 2, 90 Minutes of Wear|Other|1|||
131852080|NCT01482312|474737936|FG001|Period 2, 90 Minutes of Wear|Other|0|||
131852081|NCT01482312|474737937|FG002|Period 2, 90 Minutes of Wear|Other|0|||
131852082|NCT01699815|474737938|FG000|Overall Study|Protocol Violation|4|||
131852083|NCT01699815|474737939|FG001|Overall Study|Protocol Violation|7|||
131852084|NCT01699815|474737938|FG000|Overall Study|record could not be located|1|||
131852085|NCT01699815|474737939|FG001|Overall Study|record could not be located|0|||
131852086|NCT01699815|474737938|FG000|Overall Study|Adverse Event|0|||
131852087|NCT01699815|474737939|FG001|Overall Study|Adverse Event|1|||
131852088|NCT00356525|474737940|FG000|Overall Study|Progressive Disease|8|||
131852089|NCT00356525|474737941|FG001|Overall Study|Progressive Disease|5|||
131852090|NCT00356525|474737942|FG002|Overall Study|Progressive Disease|4|||
131852091|NCT00356525|474737943|FG003|Overall Study|Progressive Disease|2|||
131852092|NCT00356525|474737940|FG000|Overall Study|Adverse Event|1|||
131852093|NCT00356525|474737941|FG001|Overall Study|Adverse Event|3|||
131852094|NCT00356525|474737942|FG002|Overall Study|Adverse Event|1|||
131852095|NCT00356525|474737943|FG003|Overall Study|Adverse Event|1|||
131852096|NCT00356525|474737940|FG000|Overall Study|Lost to Follow-up|1|||
131852097|NCT00356525|474737941|FG001|Overall Study|Lost to Follow-up|0|||
131852098|NCT00356525|474737942|FG002|Overall Study|Lost to Follow-up|0|||
131852099|NCT00356525|474737943|FG003|Overall Study|Lost to Follow-up|0|||
131852100|NCT00356525|474737940|FG000|Overall Study|Physician Decision|2|||
131852101|NCT00356525|474737941|FG001|Overall Study|Physician Decision|2|||
131852102|NCT00356525|474737942|FG002|Overall Study|Physician Decision|2|||
131852103|NCT00356525|474737943|FG003|Overall Study|Physician Decision|1|||
131452779|NCT02357368|473286109|FG000|Overall Study|Withdrawal by Subject|3|||
131452780|NCT02357368|473286110|FG001|Overall Study|Withdrawal by Subject|1|||
131452781|NCT02357368|473286111|FG002|Overall Study|Withdrawal by Subject|1|||
131452782|NCT02357368|473286112|FG003|Overall Study|Withdrawal by Subject|2|||
131452783|NCT02377817|473286113|FG000|Overall Study|Transportation/childcare barriers.|2|||
131452784|NCT02377817|473286114|FG001|Overall Study|Transportation/childcare barriers.|0|||
131852104|NCT00356525|474737940|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
131852105|NCT00356525|474737941|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
131852106|NCT00356525|474737942|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
131852107|NCT00356525|474737943|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
131852108|NCT00356525|474737940|FG000|Overall Study|Withdrawal by Subject|1|||
131852109|NCT00356525|474737941|FG001|Overall Study|Withdrawal by Subject|1|||
131852110|NCT00356525|474737942|FG002|Overall Study|Withdrawal by Subject|0|||
131852111|NCT00356525|474737943|FG003|Overall Study|Withdrawal by Subject|3|||
131452785|NCT02377817|473286113|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
131452786|NCT02377817|473286114|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
131452787|NCT03895840|473286115|FG000|Overall Study|Withdrawal by Subject|21|||
131452788|NCT01931566|473286116|FG000|Overall Study|Randomized But Not Treated|6|||
131452789|NCT01931566|473286117|FG001|Overall Study|Randomized But Not Treated|9|||
131452790|NCT01931566|473286118|FG002|Overall Study|Randomized But Not Treated|14|||
131452791|NCT01931566|473286116|FG000|Overall Study|Adverse Event|37|||
131452792|NCT01931566|473286117|FG001|Overall Study|Adverse Event|167|||
131452793|NCT01931566|473286118|FG002|Overall Study|Adverse Event|132|||
131452794|NCT01931566|473286116|FG000|Overall Study|Major Protocol Deviation|5|||
131452795|NCT01931566|473286117|FG001|Overall Study|Major Protocol Deviation|14|||
131452796|NCT01931566|473286118|FG002|Overall Study|Major Protocol Deviation|21|||
131452797|NCT01931566|473286116|FG000|Overall Study|Lost to Follow-up|3|||
131452798|NCT01931566|473286117|FG001|Overall Study|Lost to Follow-up|26|||
131452799|NCT01931566|473286118|FG002|Overall Study|Lost to Follow-up|23|||
131452800|NCT01931566|473286116|FG000|Overall Study|Voluntary Withdrawal|78|||
131452801|NCT01931566|473286117|FG001|Overall Study|Voluntary Withdrawal|245|||
131452802|NCT01931566|473286118|FG002|Overall Study|Voluntary Withdrawal|225|||
131452803|NCT01931566|473286116|FG000|Overall Study|Study Termination|289|||
131452804|NCT01931566|473286117|FG001|Overall Study|Study Termination|968|||
131852112|NCT00356525|474737940|FG000|Overall Study|Death|0|||
131452805|NCT01931566|473286118|FG002|Overall Study|Study Termination|1037|||
131452806|NCT01931566|473286116|FG000|Overall Study|Reason Not Specified|11|||
131452807|NCT01931566|473286117|FG001|Overall Study|Reason Not Specified|47|||
131452808|NCT01931566|473286118|FG002|Overall Study|Reason Not Specified|53|||
131452809|NCT01931566|473286116|FG000|Overall Study|Missing|0|||
131452810|NCT01931566|473286117|FG001|Overall Study|Missing|0|||
131452811|NCT01931566|473286118|FG002|Overall Study|Missing|1|||
131452812|NCT04625101|473286122|FG000|Overall Study|Withdrawal by Subject|0|||
131452813|NCT04625101|473286123|FG001|Overall Study|Withdrawal by Subject|1|||
131452814|NCT04625101|473286122|FG000|Overall Study|Protocol Deviation|1|||
131452815|NCT04625101|473286123|FG001|Overall Study|Protocol Deviation|0|||
131452816|NCT02817464|473286124|FG000|Overall Study|Lost to Follow-up|1|||
131452817|NCT02817464|473286125|FG001|Overall Study|Lost to Follow-up|0|||
131452818|NCT02817464|473286124|FG000|Overall Study|Discontinued early due to personal decision|1|||
131452819|NCT02817464|473286125|FG001|Overall Study|Discontinued early due to personal decision|1|||
131452820|NCT02453711|473286126|FG000|Overall Study|Withdrawal by Subject|5|||
131452821|NCT02453711|473286127|FG001|Overall Study|Withdrawal by Subject|4|||
131452822|NCT02453711|473286128|FG002|Overall Study|Withdrawal by Subject|6|||
131452823|NCT02453711|473286129|FG003|Overall Study|Withdrawal by Subject|4|||
131452824|NCT02453711|473286130|FG004|Overall Study|Withdrawal by Subject|1|||
131452825|NCT02453711|473286131|FG005|Overall Study|Withdrawal by Subject|1|||
131452826|NCT02453711|473286132|FG006|Overall Study|Withdrawal by Subject|0|||
131452827|NCT02453711|473286133|FG007|Overall Study|Withdrawal by Subject|1|||
131452828|NCT02453711|473286134|FG008|Overall Study|Withdrawal by Subject|7|||
131452829|NCT02453711|473286126|FG000|Overall Study|Lost to Follow-up|5|||
131452830|NCT02453711|473286127|FG001|Overall Study|Lost to Follow-up|3|||
131452831|NCT02453711|473286128|FG002|Overall Study|Lost to Follow-up|2|||
131452832|NCT02453711|473286129|FG003|Overall Study|Lost to Follow-up|3|||
131452833|NCT02453711|473286130|FG004|Overall Study|Lost to Follow-up|1|||
131452834|NCT02453711|473286131|FG005|Overall Study|Lost to Follow-up|5|||
131452835|NCT02453711|473286132|FG006|Overall Study|Lost to Follow-up|2|||
131452836|NCT02453711|473286133|FG007|Overall Study|Lost to Follow-up|6|||
131452837|NCT02453711|473286134|FG008|Overall Study|Lost to Follow-up|6|||
131452838|NCT02453711|473286126|FG000|Overall Study|Death|0|||
131452839|NCT02453711|473286127|FG001|Overall Study|Death|0|||
131452840|NCT02453711|473286128|FG002|Overall Study|Death|0|||
131452841|NCT02453711|473286129|FG003|Overall Study|Death|0|||
131452842|NCT02453711|473286130|FG004|Overall Study|Death|0|||
131452843|NCT02453711|473286131|FG005|Overall Study|Death|0|||
131452844|NCT02453711|473286132|FG006|Overall Study|Death|1|||
131452845|NCT02453711|473286133|FG007|Overall Study|Death|0|||
131452846|NCT02453711|473286134|FG008|Overall Study|Death|0|||
131452847|NCT02453711|473286126|FG000|Overall Study|Unclassified|1|||
131452848|NCT02453711|473286127|FG001|Overall Study|Unclassified|0|||
131452849|NCT02453711|473286128|FG002|Overall Study|Unclassified|1|||
131452850|NCT02453711|473286129|FG003|Overall Study|Unclassified|0|||
131452851|NCT02453711|473286130|FG004|Overall Study|Unclassified|0|||
131452852|NCT02453711|473286131|FG005|Overall Study|Unclassified|0|||
131452853|NCT02453711|473286132|FG006|Overall Study|Unclassified|0|||
131852113|NCT00356525|474737941|FG001|Overall Study|Death|0|||
131452854|NCT02453711|473286133|FG007|Overall Study|Unclassified|0|||
131452855|NCT02453711|473286134|FG008|Overall Study|Unclassified|0|||
131452856|NCT01273519|473286135|FG000|Overall Study|Adverse Event|3|||
131452857|NCT01273519|473286136|FG001|Overall Study|Adverse Event|0|||
131452858|NCT01273519|473286137|FG002|Overall Study|Adverse Event|0|||
131452859|NCT01273519|473286135|FG000|Overall Study|Lost to Follow-up|2|||
131452860|NCT01273519|473286136|FG001|Overall Study|Lost to Follow-up|1|||
131852114|NCT00356525|474737942|FG002|Overall Study|Death|0|||
131852115|NCT00356525|474737943|FG003|Overall Study|Death|1|||
131452861|NCT01273519|473286137|FG002|Overall Study|Lost to Follow-up|3|||
131452862|NCT01273519|473286135|FG000|Overall Study|Lack of Efficacy|8|||
131452863|NCT01273519|473286136|FG001|Overall Study|Lack of Efficacy|3|||
131452864|NCT01273519|473286137|FG002|Overall Study|Lack of Efficacy|4|||
131452865|NCT01273519|473286135|FG000|Overall Study|Other|6|||
131452866|NCT01273519|473286136|FG001|Overall Study|Other|1|||
131452867|NCT01273519|473286137|FG002|Overall Study|Other|1|||
131452868|NCT03695367|473286138|FG000|Overall Study|Missed the Day 28 visit.|1|||
131452869|NCT03695367|473286139|FG001|Overall Study|Missed the Day 28 visit.|0|||
131452870|NCT03695367|473286138|FG000|Overall Study|Lost to Follow-up|0|||
131452871|NCT03695367|473286139|FG001|Overall Study|Lost to Follow-up|1|||
131452872|NCT03695367|473286138|FG000|Overall Study|Withdrawal by Subject|0|||
131452873|NCT03695367|473286139|FG001|Overall Study|Withdrawal by Subject|1|||
131452874|NCT03695367|473286138|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
131452875|NCT03695367|473286139|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
131452876|NCT02302339|473286142|FG000|Overall Study|Lost to Follow-up|1|||
131452877|NCT02302339|473286143|FG001|Overall Study|Lost to Follow-up|0|||
131452878|NCT02302339|473286144|FG002|Overall Study|Lost to Follow-up|0|||
131452879|NCT02302339|473286145|FG003|Overall Study|Lost to Follow-up|0|||
131452880|NCT02302339|473286142|FG000|Overall Study|Withdrawal by Subject|0|||
131452881|NCT02302339|473286143|FG001|Overall Study|Withdrawal by Subject|2|||
131452882|NCT02302339|473286144|FG002|Overall Study|Withdrawal by Subject|1|||
131452883|NCT02302339|473286145|FG003|Overall Study|Withdrawal by Subject|0|||
131452884|NCT03207763|473288272|FG000|Overall Study|Lost to Follow-up|1|||
131452885|NCT03207763|473288273|FG001|Overall Study|Lost to Follow-up|0|||
131452886|NCT02605122|473288274|FG000|Overall Study|Withdrawal by Subject|4|||
131452887|NCT02605122|473288275|FG001|Overall Study|Withdrawal by Subject|1|||
131452888|NCT02605122|473288274|FG000|Overall Study|Lost to Follow-up|1|||
131452889|NCT02605122|473288275|FG001|Overall Study|Lost to Follow-up|1|||
131452890|NCT00684060|473288276|FG000|Overall Study|Lost to Follow-up|1|||
131452891|NCT00684060|473288277|FG001|Overall Study|Lost to Follow-up|0|||
131452892|NCT00684060|473288276|FG000|Overall Study|New stenosis identified|1|||
131452893|NCT00684060|473288277|FG001|Overall Study|New stenosis identified|0|||
131452894|NCT00684060|473288276|FG000|Overall Study|Unable to collect MRI|1|||
131452895|NCT00684060|473288277|FG001|Overall Study|Unable to collect MRI|2|||
131452896|NCT00684060|473288276|FG000|Overall Study|Death|0|||
131452897|NCT00684060|473288277|FG001|Overall Study|Death|1|||
131452898|NCT00702715|473288282|FG000|Overall Study|Lost to Follow-up|1|||
131452899|NCT00702715|473288283|FG001|Overall Study|Lost to Follow-up|0|||
131452900|NCT03751657|473288284|FG000|Overall Study|Physician Decision|0|||
131452901|NCT03751657|473288285|FG001|Overall Study|Physician Decision|1|||
131452902|NCT03751657|473288284|FG000|Overall Study|Withdrawal by Subject|1|||
131452903|NCT03751657|473288285|FG001|Overall Study|Withdrawal by Subject|1|||
131452904|NCT03751657|473288284|FG000|Overall Study|Lost to Follow-up|2|||
131452905|NCT03751657|473288285|FG001|Overall Study|Lost to Follow-up|1|||
131452906|NCT01250145|473288293|FG000|Overall Study|Adverse Event|2|||
131452907|NCT01250145|473288294|FG001|Overall Study|Adverse Event|1|||
131452908|NCT01250145|473288293|FG000|Overall Study|Withdrawal by Subject|0|||
131452909|NCT01250145|473288294|FG001|Overall Study|Withdrawal by Subject|4|||
131452910|NCT02273596|473288297|FG000|24-Week Treatment Period|Adverse Event|3|||
131452911|NCT02273596|473288297|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
131452912|NCT02273596|473288297|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
131452913|NCT02273596|473288297|FG000|24-Week Treatment Period|Physician Decision|1|||
131452914|NCT02273596|473288297|FG000|24-Week Treatment Period|Protocol Deviation|1|||
131452915|NCT02273596|473288297|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
131452916|NCT02273596|473288297|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
131452917|NCT02273596|473288297|FG000|Extension Period|Lost to Follow-up|1|||
131452918|NCT02273596|473288297|FG000|Extension Period|Protocol Deviation|1|||
131452919|NCT02604160|473288298|FG000|Overall Study|Protocol Violation|0|||
131452920|NCT02604160|473288299|FG001|Overall Study|Protocol Violation|1|||
131452921|NCT02604160|473288298|FG000|Overall Study|Physician Decision|0|||
131452922|NCT02604160|473288299|FG001|Overall Study|Physician Decision|1|||
131452923|NCT01596062|473288300|FG000|Overall Study|Adverse Event|1|||
131452924|NCT01596062|473288301|FG001|Overall Study|Adverse Event|0|||
131452925|NCT01596062|473288302|FG002|Overall Study|Adverse Event|2|||
131452926|NCT01596062|473288300|FG000|Overall Study|Lack of Efficacy|0|||
131452927|NCT01596062|473288301|FG001|Overall Study|Lack of Efficacy|0|||
131452928|NCT01596062|473288302|FG002|Overall Study|Lack of Efficacy|1|||
131452929|NCT02139592|473288303|FG000|Overall Study|Case Report Forms Uncollected|8|||
131852116|NCT00356525|474737940|FG000|Overall Study|Sponsor Decision|0|||
131852117|NCT00356525|474737941|FG001|Overall Study|Sponsor Decision|0|||
131452930|NCT01069900|473288305|FG000|Overall Study|Technical problems|0|||
131452931|NCT01069900|473288306|FG001|Overall Study|Technical problems|1|||
131852118|NCT00356525|474737942|FG002|Overall Study|Sponsor Decision|0|||
131452932|NCT01069900|473288305|FG000|Overall Study|Lost to Follow-up|7|||
131452933|NCT01069900|473288306|FG001|Overall Study|Lost to Follow-up|1|||
131852119|NCT00356525|474737943|FG003|Overall Study|Sponsor Decision|1|||
131852120|NCT03607487|474737944|FG000|Overall Study|Withdrawal by Subject|2|||
131852121|NCT03607487|474737945|FG001|Overall Study|Withdrawal by Subject|0|||
131852122|NCT03607487|474737946|FG002|Overall Study|Withdrawal by Subject|0|||
131852123|NCT03607487|474737947|FG003|Overall Study|Withdrawal by Subject|1|||
131852124|NCT01884337|474737948|FG000|Treatment|Adverse Event|2|||
131852125|NCT01884337|474737949|FG001|Treatment|Adverse Event|2|||
131852126|NCT01884337|474737948|FG000|Treatment|Subj. request to discont. treatment|2|||
131852127|NCT01884337|474737949|FG001|Treatment|Subj. request to discont. treatment|0|||
131852128|NCT01884337|474737948|FG000|Follow-up Period|Lost to Follow-up|1|||
131852129|NCT01884337|474737949|FG001|Follow-up Period|Lost to Follow-up|1|||
131852130|NCT00428116|474737950|FG000|Overall Study|Death|1|||
131852131|NCT00428116|474737951|FG001|Overall Study|Death|0|||
131852132|NCT00428116|474737950|FG000|Overall Study|Withdrawal by Subject|1|||
131852133|NCT00428116|474737951|FG001|Overall Study|Withdrawal by Subject|0|||
131852134|NCT00428116|474737950|FG000|Overall Study|Lost to Follow-up|1|||
131852135|NCT00428116|474737951|FG001|Overall Study|Lost to Follow-up|0|||
131852136|NCT02455518|474737952|FG000|Overall Study|Protocol Violation|0|||
131852137|NCT02455518|474737953|FG001|Overall Study|Protocol Violation|1|||
131852138|NCT02455518|474737954|FG002|Overall Study|Protocol Violation|1|||
131852139|NCT02455518|474737955|FG003|Overall Study|Protocol Violation|3|||
131852140|NCT01038297|474737956|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
131852141|NCT01038297|474737957|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
131852142|NCT01038297|474737958|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
131852143|NCT02125877|474737961|FG000|Overall Study|Physician Decision|1|||
131852144|NCT02125877|474737962|FG001|Overall Study|Physician Decision|0|||
131852145|NCT02125877|474737961|FG000|Overall Study|Death|0|||
131852146|NCT02125877|474737962|FG001|Overall Study|Death|1|||
131852147|NCT02125877|474737961|FG000|Overall Study|Administrative problems|0|||
131852148|NCT02125877|474737962|FG001|Overall Study|Administrative problems|1|||
131852149|NCT02125877|474737961|FG000|Overall Study|Participant/guardian decision|0|||
131852150|NCT02125877|474737962|FG001|Overall Study|Participant/guardian decision|2|||
131852151|NCT02125877|474737961|FG000|Overall Study|Withdrawal by Subject|2|||
131852152|NCT02125877|474737962|FG001|Overall Study|Withdrawal by Subject|1|||
131852153|NCT02125877|474737961|FG000|Overall Study|Protocol deviation|4|||
131852154|NCT02125877|474737962|FG001|Overall Study|Protocol deviation|1|||
131852155|NCT02125877|474737961|FG000|Overall Study|Adverse Event|6|||
131852156|NCT02125877|474737962|FG001|Overall Study|Adverse Event|4|||
131852157|NCT01685840|474737979|FG000|Overall Study|Death|77|||
131852158|NCT01685840|474737980|FG001|Overall Study|Death|66|||
131852159|NCT01685840|474737979|FG000|Overall Study|Lost to Follow-up|27|||
131852160|NCT01685840|474737980|FG001|Overall Study|Lost to Follow-up|25|||
131852161|NCT01685840|474737979|FG000|Overall Study|Physician Decision|3|||
131852162|NCT01685840|474737980|FG001|Overall Study|Physician Decision|7|||
131852163|NCT01685840|474737979|FG000|Overall Study|Withdrawal by Subject|14|||
131852164|NCT01685840|474737980|FG001|Overall Study|Withdrawal by Subject|17|||
131852165|NCT01685840|474737979|FG000|Overall Study|Futility|197|||
131852166|NCT01685840|474737980|FG001|Overall Study|Futility|200|||
131852167|NCT01685840|474737979|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
131852168|NCT01685840|474737980|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
131852169|NCT04036110|474737984|FG000|Overall Study|Lost to Follow-up|3|||
131852170|NCT04036110|474737985|FG001|Overall Study|Lost to Follow-up|2|||
131852171|NCT04036110|474737986|FG002|Overall Study|Lost to Follow-up|1|||
131852172|NCT04036110|474737984|FG000|Overall Study|Study Suspended|4|||
131852173|NCT04036110|474737985|FG001|Overall Study|Study Suspended|5|||
131852174|NCT04036110|474737986|FG002|Overall Study|Study Suspended|1|||
131852175|NCT01128543|474737992|FG000|Overall Study|Withdrawal by Subject|3|||
131852176|NCT01128543|474737992|FG000|Overall Study|Protocol Violation|1|||
131852177|NCT00396565|474737995|FG000|Overall Study|Physician Decision|3|||
131852178|NCT00396565|474737996|FG001|Overall Study|Physician Decision|1|||
131852179|NCT00396565|474737997|FG002|Overall Study|Physician Decision|2|||
131852180|NCT00396565|474737995|FG000|Overall Study|Adverse Event|5|||
131852181|NCT00396565|474737996|FG001|Overall Study|Adverse Event|13|||
131852182|NCT00396565|474737997|FG002|Overall Study|Adverse Event|3|||
131852183|NCT00396565|474737995|FG000|Overall Study|Withdrawal by Subject|8|||
131852184|NCT00396565|474737996|FG001|Overall Study|Withdrawal by Subject|13|||
131852185|NCT00396565|474737997|FG002|Overall Study|Withdrawal by Subject|1|||
131852186|NCT00396565|474737995|FG000|Overall Study|Lack of Efficacy|32|||
131852187|NCT00396565|474737996|FG001|Overall Study|Lack of Efficacy|64|||
131852188|NCT00396565|474737997|FG002|Overall Study|Lack of Efficacy|11|||
131852189|NCT04487067|474737999|FG000|Overall Study|Adverse Event|3|||
131852190|NCT04487067|474737999|FG000|Overall Study|Death Other Than Progressive Disease|60|||
131852191|NCT04487067|474737999|FG000|Overall Study|Death Due To Progressive Disease|40|||
131852192|NCT04487067|474737999|FG000|Overall Study|Lost to Follow-up|3|||
131852193|NCT04487067|474737999|FG000|Overall Study|Progressive Disease|1|||
131852194|NCT04487067|474737999|FG000|Overall Study|Protocol Violation|3|||
131852195|NCT04487067|474737999|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
131852196|NCT04487067|474737999|FG000|Overall Study|Withdrawal by Subject|15|||
131852197|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
131452934|NCT01069900|473288305|FG000|Overall Study|Withdrawal by Subject|6|||
131452935|NCT01069900|473288306|FG001|Overall Study|Withdrawal by Subject|1|||
131452936|NCT01069900|473288305|FG000|Overall Study|Protocol Violation|4|||
131452937|NCT01069900|473288306|FG001|Overall Study|Protocol Violation|1|||
131452938|NCT01069900|473288305|FG000|Overall Study|Insufficient Therapeutic effect|1|||
131452939|NCT01069900|473288306|FG001|Overall Study|Insufficient Therapeutic effect|0|||
131452940|NCT02687191|473288307|FG000|Overall Study|Death|0|||
131452941|NCT02687191|473288308|FG001|Overall Study|Death|1|||
131452942|NCT02687191|473288309|FG002|Overall Study|Death|1|||
131452943|NCT02687191|473288310|FG003|Overall Study|Death|0|||
131452944|NCT02687191|473288311|FG004|Overall Study|Death|1|||
131452945|NCT02687191|473288312|FG005|Overall Study|Death|1|||
131452946|NCT02687191|473288307|FG000|Overall Study|Withdrawal by Subject|0|||
131452947|NCT02687191|473288308|FG001|Overall Study|Withdrawal by Subject|0|||
131452948|NCT02687191|473288309|FG002|Overall Study|Withdrawal by Subject|0|||
131452949|NCT02687191|473288310|FG003|Overall Study|Withdrawal by Subject|1|||
131452950|NCT02687191|473288311|FG004|Overall Study|Withdrawal by Subject|0|||
131452951|NCT02687191|473288312|FG005|Overall Study|Withdrawal by Subject|0|||
131852198|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
131852199|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
131852200|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Death|1|||
131852201|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Death|3|||
131852202|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Death|1|||
131852203|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
131852204|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
131852205|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
131852206|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
131852207|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
131852208|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
131852209|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
131852210|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
131852211|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
131852212|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
131852213|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
131852214|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
131852215|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
131852216|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
131852217|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
131852218|NCT00299130|474738000|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
131852219|NCT00299130|474738001|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
131852220|NCT00299130|474738002|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
131852221|NCT00299130|474738000|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
131852222|NCT00299130|474738001|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
131852223|NCT00299130|474738002|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
131852224|NCT00299130|474738000|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
131852225|NCT00299130|474738001|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
131852226|NCT00299130|474738002|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
131852227|NCT00299130|474738000|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
131852228|NCT00299130|474738001|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
131852229|NCT00299130|474738002|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
131852230|NCT00299130|474738000|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
131852231|NCT00299130|474738001|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
131852232|NCT00299130|474738002|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
131852233|NCT00299130|474738000|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
131852234|NCT00299130|474738001|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
131852235|NCT00299130|474738002|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
131852236|NCT00299130|474738000|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
131852237|NCT00299130|474738001|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
131852238|NCT00299130|474738002|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
131852239|NCT00299130|474738000|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
131852240|NCT00299130|474738001|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
131852241|NCT00299130|474738002|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
131852242|NCT00299130|474738000|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
131852243|NCT00299130|474738001|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
131452952|NCT03180840|473288313|FG000|Overall Study|Withdrawal by Subject|1|||
131452953|NCT01413204|473288314|FG000|Overall Study|Adverse Event|1|||
131852244|NCT00299130|474738002|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
131452954|NCT01413204|473288315|FG001|Overall Study|Adverse Event|2|||
131452955|NCT01413204|473288316|FG002|Overall Study|Adverse Event|2|||
131452956|NCT01413204|473288314|FG000|Overall Study|Physician Decision|3|||
131452957|NCT01413204|473288315|FG001|Overall Study|Physician Decision|0|||
131852245|NCT00299130|474738000|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
131852246|NCT00299130|474738001|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
131852247|NCT00299130|474738002|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
131852248|NCT02211417|474738003|FG000|Overall Study|Withdrawal by Subject|11|||
131852249|NCT02211417|474738004|FG001|Overall Study|Withdrawal by Subject|8|||
131852250|NCT02211417|474738003|FG000|Overall Study|Protocol Violation|1|||
131852251|NCT02211417|474738004|FG001|Overall Study|Protocol Violation|0|||
131852252|NCT02211417|474738003|FG000|Overall Study|Pregnancy|0|||
131852253|NCT02211417|474738004|FG001|Overall Study|Pregnancy|1|||
131912281|NCT01799889|474966529|FG005|Overall Study|Study Terminated By Sponsor|1|||
131912282|NCT01799889|474966530|FG006|Overall Study|Study Terminated By Sponsor|0|||
131912283|NCT01799889|474966531|FG007|Overall Study|Study Terminated By Sponsor|2|||
131404657|NCT01271712|473103778|FG000|Double Blind Treatment|Non compliance with study drug|2|||
131852254|NCT02211417|474738003|FG000|Overall Study|Lost to Follow-up|2|||
131852255|NCT02211417|474738004|FG001|Overall Study|Lost to Follow-up|3|||
131852256|NCT02211417|474738003|FG000|Overall Study|Adverse Event|1|||
131852257|NCT02211417|474738004|FG001|Overall Study|Adverse Event|4|||
131852258|NCT01198132|474738005|FG000|Overall Study|Withdrawal by Subject|4|||
131852259|NCT01198132|474738006|FG001|Overall Study|Withdrawal by Subject|5|||
131852260|NCT01198132|474738005|FG000|Overall Study|Physician Decision|5|||
131852261|NCT01198132|474738006|FG001|Overall Study|Physician Decision|4|||
131852262|NCT01198132|474738005|FG000|Overall Study|Other Unspecified|3|||
131852263|NCT01198132|474738006|FG001|Overall Study|Other Unspecified|6|||
131852264|NCT01198132|474738005|FG000|Overall Study|Lack of Efficacy|2|||
131852265|NCT01198132|474738006|FG001|Overall Study|Lack of Efficacy|3|||
131852266|NCT01198132|474738005|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
131852267|NCT01198132|474738006|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
131852268|NCT01198132|474738005|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
131852269|NCT01198132|474738006|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
131852270|NCT01198132|474738005|FG000|Overall Study|Adverse Event|0|||
131852271|NCT01198132|474738006|FG001|Overall Study|Adverse Event|1|||
131852272|NCT01198132|474738005|FG000|Overall Study|Protocol Violation|1|||
131852273|NCT01198132|474738006|FG001|Overall Study|Protocol Violation|0|||
131852274|NCT03516513|474738009|FG000|Overall Study|Withdrawal by Subject|2|||
131852275|NCT03516513|474738010|FG001|Overall Study|Withdrawal by Subject|2|||
131852276|NCT03516513|474738011|FG002|Overall Study|Withdrawal by Subject|0|||
131852277|NCT03516513|474738012|FG003|Overall Study|Withdrawal by Subject|0|||
131852278|NCT01098487|474738014|FG000|Overall Study|Adverse Event|22|||
131852279|NCT01098487|474738014|FG000|Overall Study|Lack of Efficacy|11|||
131852280|NCT01098487|474738014|FG000|Overall Study|Withdrawal by Subject|7|||
131852281|NCT01098487|474738014|FG000|Overall Study|Lost to Follow-up|3|||
131852282|NCT01098487|474738014|FG000|Overall Study|Physician Decision|1|||
131852283|NCT00345631|474738015|FG000|Overall Study|Withdrawal by Subject|1|||
131852284|NCT00345631|474738016|FG001|Overall Study|Withdrawal by Subject|0|||
131852285|NCT00345631|474738017|FG002|Overall Study|Withdrawal by Subject|1|||
131852286|NCT00345631|474738015|FG000|Overall Study|Adverse Event|0|||
131852287|NCT00345631|474738016|FG001|Overall Study|Adverse Event|1|||
131852288|NCT00345631|474738017|FG002|Overall Study|Adverse Event|0|||
131852289|NCT00345631|474738015|FG000|Overall Study|Lost to Follow-up|3|||
131852290|NCT00345631|474738016|FG001|Overall Study|Lost to Follow-up|7|||
131852291|NCT00345631|474738017|FG002|Overall Study|Lost to Follow-up|4|||
131852292|NCT00345631|474738015|FG000|Overall Study|Other reasons|0|||
131852293|NCT00345631|474738016|FG001|Overall Study|Other reasons|0|||
131852294|NCT00345631|474738017|FG002|Overall Study|Other reasons|1|||
131852295|NCT01301729|474738018|FG000|Overall Study|Withdrawal by Subject|2|||
131852296|NCT01301729|474738018|FG000|Overall Study|Participant did not Return for Treatment|1|||
131852297|NCT01301729|474738018|FG000|Overall Study|Violated Selection Criteria|1|||
131852298|NCT03071276|474738019|FG000|Overall Study|Adverse Event|1|||
131852299|NCT03071276|474738019|FG000|Overall Study|Lack of Efficacy|14|||
131852300|NCT03390426|474738020|FG000|Overall Study|Protocol Violation|0|||
131852301|NCT03390426|474738021|FG001|Overall Study|Protocol Violation|1|||
131852302|NCT00548093|474738026|FG000|Overall Study|Death|33|||
131404658|NCT01271712|473103779|FG001|Double Blind Treatment|Non compliance with study drug|0|||
131404659|NCT01271712|473103778|FG000|Double Blind Treatment|receive no study drug|1|||
131404660|NCT01271712|473103779|FG001|Double Blind Treatment|receive no study drug|0|||
131404661|NCT01271712|473103778|FG000|Open Label Treatment|Death|6|||
131404662|NCT01271712|473103779|FG001|Open Label Treatment|Death|5|||
131404663|NCT01271712|473103778|FG000|Open Label Treatment|Withdrawal by Subject|6|||
131404664|NCT01271712|473103779|FG001|Open Label Treatment|Withdrawal by Subject|11|||
131404665|NCT01271712|473103778|FG000|Open Label Treatment|Physician Decision|2|||
131404666|NCT01271712|473103779|FG001|Open Label Treatment|Physician Decision|0|||
131404667|NCT01271712|473103778|FG000|Open Label Treatment|Adverse Event|14|||
131404668|NCT01271712|473103779|FG001|Open Label Treatment|Adverse Event|8|||
131404669|NCT01271712|473103778|FG000|Open Label Treatment|Progressive disease|59|||
131404670|NCT01271712|473103779|FG001|Open Label Treatment|Progressive disease|32|||
131452958|NCT01413204|473288316|FG002|Overall Study|Physician Decision|2|||
131452959|NCT01413204|473288314|FG000|Overall Study|Withdrawal by Subject|1|||
131452960|NCT01413204|473288315|FG001|Overall Study|Withdrawal by Subject|4|||
131452961|NCT01413204|473288316|FG002|Overall Study|Withdrawal by Subject|4|||
131452962|NCT01413204|473288314|FG000|Overall Study|Clearly not eligible for the study|0|||
131452963|NCT01413204|473288315|FG001|Overall Study|Clearly not eligible for the study|0|||
131452964|NCT01413204|473288316|FG002|Overall Study|Clearly not eligible for the study|1|||
131452965|NCT01413204|473288314|FG000|Overall Study|Fasting plasma glucose level increased|1|||
131452966|NCT01413204|473288315|FG001|Overall Study|Fasting plasma glucose level increased|0|||
131452967|NCT01413204|473288316|FG002|Overall Study|Fasting plasma glucose level increased|10|||
131452968|NCT00753649|473288317|FG000|Overall Study|Migrated/moved from study area|1|||
131452969|NCT00753649|473288318|FG001|Overall Study|Migrated/moved from study area|0|||
131452970|NCT00753649|473288317|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
131452971|NCT00753649|473288318|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
131452972|NCT00753649|473288317|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
131452973|NCT00753649|473288318|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
131452974|NCT00753649|473288317|FG000|Overall Study|Protocol Violation|2|||
131452975|NCT00753649|473288318|FG001|Overall Study|Protocol Violation|0|||
131452976|NCT01039376|473288319|FG000|Overall Study|Lost to Follow-up|5|||
131452977|NCT01039376|473288320|FG001|Overall Study|Lost to Follow-up|12|||
131452978|NCT01039376|473288319|FG000|Overall Study|Physician Decision|15|||
131452979|NCT01039376|473288320|FG001|Overall Study|Physician Decision|10|||
131452980|NCT01039376|473288319|FG000|Overall Study|Withdrawal by Subject|20|||
131452981|NCT01039376|473288320|FG001|Overall Study|Withdrawal by Subject|32|||
131452982|NCT01039376|473288319|FG000|Overall Study|Study terminated by Sponsor|90|||
131452983|NCT01039376|473288320|FG001|Overall Study|Study terminated by Sponsor|72|||
131452984|NCT01255436|473288323|FG000|Overall Study|Lost to Follow-up|178|||
131452985|NCT01255436|473288324|FG001|Overall Study|Lost to Follow-up|191|||
131452986|NCT01255436|473288323|FG000|Overall Study|Death, stroke, or MI|4|||
131452987|NCT01255436|473288324|FG001|Overall Study|Death, stroke, or MI|3|||
131452988|NCT04816669|473288325|FG000|Part 1|Adverse Event|1|||
131452989|NCT04816669|473288326|FG001|Part 1|Adverse Event|1|||
131452990|NCT04816669|473288327|FG002|Part 1|Adverse Event|0|||
131452991|NCT04816669|473288328|FG003|Part 1|Adverse Event|0|||
131452992|NCT04816669|473288325|FG000|Part 1|Lost to Follow-up|2|||
131452993|NCT04816669|473288326|FG001|Part 1|Lost to Follow-up|2|||
131452994|NCT04816669|473288327|FG002|Part 1|Lost to Follow-up|0|||
131452995|NCT04816669|473288328|FG003|Part 1|Lost to Follow-up|0|||
131452996|NCT04816669|473288325|FG000|Part 1|Protocol Violation|0|||
131452997|NCT04816669|473288326|FG001|Part 1|Protocol Violation|1|||
131452998|NCT04816669|473288327|FG002|Part 1|Protocol Violation|0|||
131452999|NCT04816669|473288328|FG003|Part 1|Protocol Violation|0|||
131453000|NCT04816669|473288325|FG000|Part 1|Withdrawal by Subject|1|||
131453001|NCT04816669|473288326|FG001|Part 1|Withdrawal by Subject|2|||
131453002|NCT04816669|473288327|FG002|Part 1|Withdrawal by Subject|0|||
131453003|NCT04816669|473288328|FG003|Part 1|Withdrawal by Subject|0|||
131453004|NCT04816669|473288325|FG000|Part 2|Other|0|||
131453005|NCT04816669|473288326|FG001|Part 2|Other|0|||
131453006|NCT04816669|473288327|FG002|Part 2|Other|1|||
131453007|NCT04816669|473288328|FG003|Part 2|Other|0|||
131453008|NCT04816669|473288325|FG000|Part 2|Withdrawal by Subject|0|||
131453009|NCT04816669|473288326|FG001|Part 2|Withdrawal by Subject|0|||
131453010|NCT04816669|473288327|FG002|Part 2|Withdrawal by Subject|0|||
131453011|NCT04816669|473288328|FG003|Part 2|Withdrawal by Subject|1|||
131453012|NCT04816669|473288325|FG000|Part 2|Lost to Follow-up|0|||
131453013|NCT04816669|473288326|FG001|Part 2|Lost to Follow-up|0|||
131453014|NCT04816669|473288327|FG002|Part 2|Lost to Follow-up|1|||
131453015|NCT04816669|473288328|FG003|Part 2|Lost to Follow-up|0|||
131453016|NCT01229267|473288329|FG000|Overall Study|Adverse Event|4|||
131453017|NCT01229267|473288330|FG001|Overall Study|Adverse Event|6|||
131453018|NCT01229267|473288331|FG002|Overall Study|Adverse Event|3|||
131453019|NCT01229267|473288332|FG003|Overall Study|Adverse Event|2|||
131453020|NCT01229267|473288333|FG004|Overall Study|Adverse Event|10|||
131453021|NCT01229267|473288329|FG000|Overall Study|Death|40|||
131453022|NCT01229267|473288330|FG001|Overall Study|Death|37|||
131453023|NCT01229267|473288331|FG002|Overall Study|Death|35|||
131453024|NCT01229267|473288332|FG003|Overall Study|Death|13|||
131852303|NCT00548093|474738027|FG001|Overall Study|Death|13|||
131852304|NCT00548093|474738026|FG000|Overall Study|Lost to Follow-up|3|||
131852305|NCT00548093|474738027|FG001|Overall Study|Lost to Follow-up|1|||
131453025|NCT01229267|473288333|FG004|Overall Study|Death|103|||
131453026|NCT01229267|473288329|FG000|Overall Study|Withdrawal by Subject|23|||
131453027|NCT01229267|473288330|FG001|Overall Study|Withdrawal by Subject|22|||
131453028|NCT01229267|473288331|FG002|Overall Study|Withdrawal by Subject|32|||
131852306|NCT00548093|474738026|FG000|Overall Study|Objective progression or relapse|1|||
131453029|NCT01229267|473288332|FG003|Overall Study|Withdrawal by Subject|14|||
131453030|NCT01229267|473288333|FG004|Overall Study|Withdrawal by Subject|59|||
131453031|NCT01229267|473288329|FG000|Overall Study|Protocol Violation|0|||
131453032|NCT01229267|473288330|FG001|Overall Study|Protocol Violation|1|||
131852307|NCT00548093|474738027|FG001|Overall Study|Objective progression or relapse|1|||
131852308|NCT00548093|474738026|FG000|Overall Study|Other|11|||
131852309|NCT00548093|474738027|FG001|Overall Study|Other|1|||
131852310|NCT00548093|474738026|FG000|Overall Study|Withdrawal by Subject|1|||
131852311|NCT00548093|474738027|FG001|Overall Study|Withdrawal by Subject|0|||
131852312|NCT00548093|474738026|FG000|Overall Study|Completed post-treatment follow-up|1|||
131852313|NCT00548093|474738027|FG001|Overall Study|Completed post-treatment follow-up|0|||
131852314|NCT02516553|474738028|FG000|Overall Study|Progressive disease|2|||
131852315|NCT02516553|474738029|FG001|Overall Study|Progressive disease|2|||
131852316|NCT02516553|474738030|FG002|Overall Study|Progressive disease|3|||
131852317|NCT02516553|474738031|FG003|Overall Study|Progressive disease|5|||
131852318|NCT02516553|474738032|FG004|Overall Study|Progressive disease|3|||
131852319|NCT02516553|474738033|FG005|Overall Study|Progressive disease|0|||
131852320|NCT02516553|474738034|FG006|Overall Study|Progressive disease|5|||
131852321|NCT02516553|474738035|FG007|Overall Study|Progressive disease|5|||
131852322|NCT02516553|474738036|FG008|Overall Study|Progressive disease|11|||
131852323|NCT02516553|474738037|FG009|Overall Study|Progressive disease|3|||
131852324|NCT02516553|474738038|FG010|Overall Study|Progressive disease|10|||
131852325|NCT02516553|474738039|FG011|Overall Study|Progressive disease|8|||
131852326|NCT02516553|474738040|FG012|Overall Study|Progressive disease|8|||
131852327|NCT02516553|474738041|FG013|Overall Study|Progressive disease|2|||
131852328|NCT02516553|474738042|FG014|Overall Study|Progressive disease|2|||
131852329|NCT02516553|474738043|FG015|Overall Study|Progressive disease|2|||
131852330|NCT02516553|474738044|FG016|Overall Study|Progressive disease|1|||
131852331|NCT02516553|474738045|FG017|Overall Study|Progressive disease|9|||
131852332|NCT02516553|474738046|FG018|Overall Study|Progressive disease|12|||
131852333|NCT02516553|474738047|FG019|Overall Study|Progressive disease|7|||
131852334|NCT02516553|474738048|FG020|Overall Study|Progressive disease|16|||
131852335|NCT02516553|474738049|FG021|Overall Study|Progressive disease|18|||
131852336|NCT02516553|474738028|FG000|Overall Study|Dose limiting toxicity|0|||
131852337|NCT02516553|474738029|FG001|Overall Study|Dose limiting toxicity|0|||
131852338|NCT02516553|474738030|FG002|Overall Study|Dose limiting toxicity|0|||
131852339|NCT02516553|474738031|FG003|Overall Study|Dose limiting toxicity|0|||
131852340|NCT02516553|474738032|FG004|Overall Study|Dose limiting toxicity|3|||
131852341|NCT02516553|474738033|FG005|Overall Study|Dose limiting toxicity|1|||
131852342|NCT02516553|474738034|FG006|Overall Study|Dose limiting toxicity|1|||
131852343|NCT02516553|474738035|FG007|Overall Study|Dose limiting toxicity|0|||
131852344|NCT02516553|474738036|FG008|Overall Study|Dose limiting toxicity|1|||
131852345|NCT02516553|474738037|FG009|Overall Study|Dose limiting toxicity|0|||
131852346|NCT02516553|474738038|FG010|Overall Study|Dose limiting toxicity|0|||
131852347|NCT02516553|474738039|FG011|Overall Study|Dose limiting toxicity|1|||
131852348|NCT02516553|474738040|FG012|Overall Study|Dose limiting toxicity|0|||
131852349|NCT02516553|474738041|FG013|Overall Study|Dose limiting toxicity|1|||
131852350|NCT02516553|474738042|FG014|Overall Study|Dose limiting toxicity|0|||
131852351|NCT02516553|474738043|FG015|Overall Study|Dose limiting toxicity|0|||
131852352|NCT02516553|474738044|FG016|Overall Study|Dose limiting toxicity|1|||
131852353|NCT02516553|474738045|FG017|Overall Study|Dose limiting toxicity|1|||
131852354|NCT02516553|474738046|FG018|Overall Study|Dose limiting toxicity|0|||
131852355|NCT02516553|474738047|FG019|Overall Study|Dose limiting toxicity|2|||
131852356|NCT02516553|474738048|FG020|Overall Study|Dose limiting toxicity|0|||
131852357|NCT02516553|474738049|FG021|Overall Study|Dose limiting toxicity|0|||
131852358|NCT02516553|474738028|FG000|Overall Study|Other Adverse Events|0|||
131852359|NCT02516553|474738029|FG001|Overall Study|Other Adverse Events|0|||
131852360|NCT02516553|474738030|FG002|Overall Study|Other Adverse Events|0|||
131852361|NCT02516553|474738031|FG003|Overall Study|Other Adverse Events|1|||
131852362|NCT02516553|474738032|FG004|Overall Study|Other Adverse Events|0|||
131852363|NCT02516553|474738033|FG005|Overall Study|Other Adverse Events|1|||
131852364|NCT02516553|474738034|FG006|Overall Study|Other Adverse Events|0|||
131852365|NCT02516553|474738035|FG007|Overall Study|Other Adverse Events|0|||
131852366|NCT02516553|474738036|FG008|Overall Study|Other Adverse Events|0|||
131852367|NCT02516553|474738037|FG009|Overall Study|Other Adverse Events|1|||
131852368|NCT02516553|474738038|FG010|Overall Study|Other Adverse Events|3|||
131852369|NCT02516553|474738039|FG011|Overall Study|Other Adverse Events|2|||
131852370|NCT02516553|474738040|FG012|Overall Study|Other Adverse Events|0|||
131852371|NCT02516553|474738041|FG013|Overall Study|Other Adverse Events|1|||
131852372|NCT02516553|474738042|FG014|Overall Study|Other Adverse Events|0|||
131852373|NCT02516553|474738043|FG015|Overall Study|Other Adverse Events|0|||
131852374|NCT02516553|474738044|FG016|Overall Study|Other Adverse Events|0|||
131852375|NCT02516553|474738045|FG017|Overall Study|Other Adverse Events|2|||
131852376|NCT02516553|474738046|FG018|Overall Study|Other Adverse Events|1|||
131852377|NCT02516553|474738047|FG019|Overall Study|Other Adverse Events|2|||
131852378|NCT02516553|474738048|FG020|Overall Study|Other Adverse Events|2|||
131852379|NCT02516553|474738049|FG021|Overall Study|Other Adverse Events|1|||
131852380|NCT02516553|474738028|FG000|Overall Study|Refused to continue trial medication|0|||
131852381|NCT02516553|474738029|FG001|Overall Study|Refused to continue trial medication|0|||
131852382|NCT02516553|474738030|FG002|Overall Study|Refused to continue trial medication|0|||
131852383|NCT02516553|474738031|FG003|Overall Study|Refused to continue trial medication|0|||
131404671|NCT01271712|473103778|FG000|Open Label Treatment|transferred to rollover study|1|||
131404672|NCT01271712|473103779|FG001|Open Label Treatment|transferred to rollover study|0|||
131404673|NCT01271712|473103778|FG000|Open Label Treatment|Non-compliance with study drug|1|||
131404674|NCT01271712|473103779|FG001|Open Label Treatment|Non-compliance with study drug|0|||
131404675|NCT01271712|473103778|FG000|Open Label Treatment|Protocol Violation|0|||
131404676|NCT01271712|473103779|FG001|Open Label Treatment|Protocol Violation|1|||
131404677|NCT01271712|473103778|FG000|Open Label Treatment|Switching to other therapy|2|||
131404678|NCT01271712|473103779|FG001|Open Label Treatment|Switching to other therapy|1|||
131404679|NCT01271712|473103778|FG000|Safety Follow-up|Death|11|||
131404680|NCT01271712|473103779|FG001|Safety Follow-up|Death|7|||
131404681|NCT01271712|473103778|FG000|Safety Follow-up|Withdrawal by Subject|4|||
131404682|NCT01271712|473103779|FG001|Safety Follow-up|Withdrawal by Subject|2|||
131404683|NCT01271712|473103778|FG000|Safety Follow-up|Protocol Violation|1|||
131404684|NCT01271712|473103779|FG001|Safety Follow-up|Protocol Violation|1|||
131404685|NCT01271712|473103778|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
131404686|NCT01271712|473103779|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
131404687|NCT01271712|473103778|FG000|Safety Follow-up|No follow-up|1|||
131404688|NCT01271712|473103779|FG001|Safety Follow-up|No follow-up|1|||
131404689|NCT01271712|473103778|FG000|Safety Follow-up|Progressive disease|1|||
131404690|NCT01271712|473103779|FG001|Safety Follow-up|Progressive disease|0|||
131404691|NCT01271712|473103778|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
131852384|NCT02516553|474738032|FG004|Overall Study|Refused to continue trial medication|0|||
131852385|NCT02516553|474738033|FG005|Overall Study|Refused to continue trial medication|0|||
131852386|NCT02516553|474738034|FG006|Overall Study|Refused to continue trial medication|0|||
131852387|NCT02516553|474738035|FG007|Overall Study|Refused to continue trial medication|0|||
131852388|NCT02516553|474738036|FG008|Overall Study|Refused to continue trial medication|0|||
131852389|NCT02516553|474738037|FG009|Overall Study|Refused to continue trial medication|0|||
131852390|NCT02516553|474738038|FG010|Overall Study|Refused to continue trial medication|1|||
131852391|NCT02516553|474738039|FG011|Overall Study|Refused to continue trial medication|0|||
131852392|NCT02516553|474738040|FG012|Overall Study|Refused to continue trial medication|0|||
131852393|NCT02516553|474738041|FG013|Overall Study|Refused to continue trial medication|0|||
131852394|NCT02516553|474738042|FG014|Overall Study|Refused to continue trial medication|0|||
131852395|NCT02516553|474738043|FG015|Overall Study|Refused to continue trial medication|0|||
131852396|NCT02516553|474738044|FG016|Overall Study|Refused to continue trial medication|0|||
131852397|NCT02516553|474738045|FG017|Overall Study|Refused to continue trial medication|0|||
131852398|NCT02516553|474738046|FG018|Overall Study|Refused to continue trial medication|1|||
131852399|NCT02516553|474738047|FG019|Overall Study|Refused to continue trial medication|0|||
131852400|NCT02516553|474738048|FG020|Overall Study|Refused to continue trial medication|0|||
131852401|NCT02516553|474738049|FG021|Overall Study|Refused to continue trial medication|1|||
131852402|NCT02516553|474738028|FG000|Overall Study|other reasons than listed|0|||
131852403|NCT02516553|474738029|FG001|Overall Study|other reasons than listed|0|||
131852404|NCT02516553|474738030|FG002|Overall Study|other reasons than listed|0|||
131852405|NCT02516553|474738031|FG003|Overall Study|other reasons than listed|0|||
131852406|NCT02516553|474738032|FG004|Overall Study|other reasons than listed|0|||
131852407|NCT02516553|474738033|FG005|Overall Study|other reasons than listed|0|||
131852408|NCT02516553|474738034|FG006|Overall Study|other reasons than listed|0|||
131852409|NCT02516553|474738035|FG007|Overall Study|other reasons than listed|1|||
131852410|NCT02516553|474738036|FG008|Overall Study|other reasons than listed|1|||
131852411|NCT02516553|474738037|FG009|Overall Study|other reasons than listed|0|||
131852412|NCT02516553|474738038|FG010|Overall Study|other reasons than listed|1|||
131852413|NCT02516553|474738039|FG011|Overall Study|other reasons than listed|1|||
131852414|NCT02516553|474738040|FG012|Overall Study|other reasons than listed|0|||
131852415|NCT02516553|474738041|FG013|Overall Study|other reasons than listed|0|||
131852416|NCT02516553|474738042|FG014|Overall Study|other reasons than listed|0|||
131852417|NCT02516553|474738043|FG015|Overall Study|other reasons than listed|0|||
131852418|NCT02516553|474738044|FG016|Overall Study|other reasons than listed|0|||
131852419|NCT02516553|474738045|FG017|Overall Study|other reasons than listed|0|||
131852420|NCT02516553|474738046|FG018|Overall Study|other reasons than listed|0|||
131852421|NCT02516553|474738047|FG019|Overall Study|other reasons than listed|0|||
131852422|NCT02516553|474738048|FG020|Overall Study|other reasons than listed|2|||
131852423|NCT02516553|474738049|FG021|Overall Study|other reasons than listed|2|||
131404692|NCT01271712|473103779|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
131852424|NCT02924727|474738050|FG000|Overall Study|Withdrawal by Subject|2|||
131852425|NCT02924727|474738051|FG001|Overall Study|Withdrawal by Subject|4|||
131852426|NCT02924727|474738050|FG000|Overall Study|Lost to Follow-up|2|||
131852427|NCT02924727|474738051|FG001|Overall Study|Lost to Follow-up|5|||
131852428|NCT02924727|474738050|FG000|Overall Study|Death|221|||
131852429|NCT02924727|474738051|FG001|Overall Study|Death|247|||
131404693|NCT00096226|473103782|FG000|Overall Study|Ineligible|2|||
131453033|NCT01229267|473288331|FG002|Overall Study|Protocol Violation|0|||
131404694|NCT00096226|473103782|FG000|Overall Study|Protocol treatment not started|1|||
131404695|NCT01666119|473103783|FG000|Overall Study|Adverse Event|6|||
131404696|NCT01666119|473103783|FG000|Overall Study|Withdrawal by Subject|16|||
131404697|NCT01666119|473103783|FG000|Overall Study|Lost to Follow-up|7|||
131852430|NCT02924727|474738050|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
131852431|NCT02924727|474738051|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
131852432|NCT00307437|474738052|FG000|Controlled Period|Adverse Event|7|||
131852433|NCT00307437|474738053|FG001|Controlled Period|Adverse Event|2|||
131852434|NCT00307437|474738054|FG002|Controlled Period|Adverse Event|5|||
131852435|NCT00307437|474738055|FG003|Controlled Period|Adverse Event|0|||
131852436|NCT00307437|474738056|FG004|Controlled Period|Adverse Event|0|||
131852437|NCT00307437|474738057|FG005|Controlled Period|Adverse Event|0|||
131852438|NCT00307437|474738058|FG006|Controlled Period|Adverse Event|0|||
131852439|NCT00307437|474738052|FG000|Controlled Period|Death|0|||
131852440|NCT00307437|474738053|FG001|Controlled Period|Death|0|||
131852441|NCT00307437|474738054|FG002|Controlled Period|Death|1|||
131852442|NCT00307437|474738055|FG003|Controlled Period|Death|0|||
131852443|NCT00307437|474738056|FG004|Controlled Period|Death|0|||
131852444|NCT00307437|474738057|FG005|Controlled Period|Death|0|||
131852445|NCT00307437|474738058|FG006|Controlled Period|Death|0|||
131852446|NCT00307437|474738052|FG000|Controlled Period|Lack of Efficacy|2|||
131852447|NCT00307437|474738053|FG001|Controlled Period|Lack of Efficacy|0|||
131852448|NCT00307437|474738054|FG002|Controlled Period|Lack of Efficacy|0|||
131852449|NCT00307437|474738055|FG003|Controlled Period|Lack of Efficacy|0|||
131852450|NCT00307437|474738056|FG004|Controlled Period|Lack of Efficacy|0|||
131852451|NCT00307437|474738057|FG005|Controlled Period|Lack of Efficacy|0|||
131852452|NCT00307437|474738058|FG006|Controlled Period|Lack of Efficacy|0|||
131852453|NCT00307437|474738052|FG000|Controlled Period|Lost to Follow-up|2|||
131852454|NCT00307437|474738053|FG001|Controlled Period|Lost to Follow-up|3|||
131852455|NCT00307437|474738054|FG002|Controlled Period|Lost to Follow-up|0|||
131852456|NCT00307437|474738055|FG003|Controlled Period|Lost to Follow-up|0|||
131852457|NCT00307437|474738056|FG004|Controlled Period|Lost to Follow-up|0|||
131852458|NCT00307437|474738057|FG005|Controlled Period|Lost to Follow-up|0|||
131852459|NCT00307437|474738058|FG006|Controlled Period|Lost to Follow-up|0|||
131852460|NCT00307437|474738052|FG000|Controlled Period|Other|5|||
131852461|NCT00307437|474738053|FG001|Controlled Period|Other|1|||
131852462|NCT00307437|474738054|FG002|Controlled Period|Other|3|||
131852463|NCT00307437|474738055|FG003|Controlled Period|Other|0|||
131852464|NCT00307437|474738056|FG004|Controlled Period|Other|0|||
131852465|NCT00307437|474738057|FG005|Controlled Period|Other|0|||
131852466|NCT00307437|474738058|FG006|Controlled Period|Other|0|||
131852467|NCT00307437|474738052|FG000|After Controlled Period|Adverse Event|0|||
131852468|NCT00307437|474738053|FG001|After Controlled Period|Adverse Event|0|||
131852469|NCT00307437|474738054|FG002|After Controlled Period|Adverse Event|0|||
131852470|NCT00307437|474738055|FG003|After Controlled Period|Adverse Event|18|||
131852471|NCT00307437|474738056|FG004|After Controlled Period|Adverse Event|16|||
131852472|NCT00307437|474738057|FG005|After Controlled Period|Adverse Event|31|||
131852473|NCT00307437|474738058|FG006|After Controlled Period|Adverse Event|40|||
131852474|NCT00307437|474738052|FG000|After Controlled Period|Death|0|||
131852475|NCT00307437|474738053|FG001|After Controlled Period|Death|0|||
131852476|NCT00307437|474738054|FG002|After Controlled Period|Death|0|||
131852477|NCT00307437|474738055|FG003|After Controlled Period|Death|3|||
131852478|NCT00307437|474738056|FG004|After Controlled Period|Death|1|||
131852479|NCT00307437|474738057|FG005|After Controlled Period|Death|1|||
131852480|NCT00307437|474738058|FG006|After Controlled Period|Death|3|||
131852481|NCT00307437|474738052|FG000|After Controlled Period|Lack of Efficacy|0|||
131852482|NCT00307437|474738053|FG001|After Controlled Period|Lack of Efficacy|0|||
131852483|NCT00307437|474738054|FG002|After Controlled Period|Lack of Efficacy|0|||
131852484|NCT00307437|474738055|FG003|After Controlled Period|Lack of Efficacy|15|||
131852485|NCT00307437|474738056|FG004|After Controlled Period|Lack of Efficacy|17|||
131852486|NCT00307437|474738057|FG005|After Controlled Period|Lack of Efficacy|37|||
131852487|NCT00307437|474738058|FG006|After Controlled Period|Lack of Efficacy|24|||
131852488|NCT00307437|474738052|FG000|After Controlled Period|Lost to Follow-up|0|||
131852489|NCT00307437|474738053|FG001|After Controlled Period|Lost to Follow-up|0|||
131404698|NCT01666119|473103783|FG000|Overall Study|non compliance with study medication, pa|18|||
131852490|NCT00307437|474738054|FG002|After Controlled Period|Lost to Follow-up|0|||
131852491|NCT00307437|474738055|FG003|After Controlled Period|Lost to Follow-up|7|||
131852492|NCT00307437|474738056|FG004|After Controlled Period|Lost to Follow-up|12|||
131852493|NCT00307437|474738057|FG005|After Controlled Period|Lost to Follow-up|13|||
131852494|NCT00307437|474738058|FG006|After Controlled Period|Lost to Follow-up|18|||
131852495|NCT00307437|474738052|FG000|After Controlled Period|Other|0|||
131852496|NCT00307437|474738053|FG001|After Controlled Period|Other|0|||
131852497|NCT00307437|474738054|FG002|After Controlled Period|Other|0|||
131852498|NCT00307437|474738055|FG003|After Controlled Period|Other|15|||
131852499|NCT00307437|474738056|FG004|After Controlled Period|Other|9|||
131404699|NCT01666119|473103783|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
131404700|NCT04003207|473103791|FG000|Overall Study|Protocol Violation|1|||
131852500|NCT00307437|474738057|FG005|After Controlled Period|Other|40|||
131852501|NCT00307437|474738058|FG006|After Controlled Period|Other|28|||
131852502|NCT00509795|474738059|FG000|Overall Study|Adverse Event|4|||
131852503|NCT00509795|474738060|FG001|Overall Study|Adverse Event|3|||
131852504|NCT00509795|474738061|FG002|Overall Study|Adverse Event|5|||
131852505|NCT00509795|474738062|FG003|Overall Study|Adverse Event|4|||
131852506|NCT00509795|474738059|FG000|Overall Study|Death|3|||
131852507|NCT00509795|474738060|FG001|Overall Study|Death|1|||
131852508|NCT00509795|474738061|FG002|Overall Study|Death|2|||
131852509|NCT00509795|474738062|FG003|Overall Study|Death|7|||
131852510|NCT00509795|474738059|FG000|Overall Study|Lack of Efficacy|0|||
131852511|NCT00509795|474738060|FG001|Overall Study|Lack of Efficacy|0|||
131852512|NCT00509795|474738061|FG002|Overall Study|Lack of Efficacy|2|||
131852513|NCT00509795|474738062|FG003|Overall Study|Lack of Efficacy|2|||
131852514|NCT00509795|474738059|FG000|Overall Study|Lost to Follow-up|1|||
131852515|NCT00509795|474738060|FG001|Overall Study|Lost to Follow-up|2|||
131852516|NCT00509795|474738061|FG002|Overall Study|Lost to Follow-up|4|||
131852517|NCT00509795|474738062|FG003|Overall Study|Lost to Follow-up|4|||
131852518|NCT00509795|474738059|FG000|Overall Study|OTHER|1|||
131852519|NCT00509795|474738060|FG001|Overall Study|OTHER|0|||
131852520|NCT00509795|474738061|FG002|Overall Study|OTHER|4|||
131852521|NCT00509795|474738062|FG003|Overall Study|OTHER|1|||
131852522|NCT00509795|474738059|FG000|Overall Study|Protocol Violation|3|||
131852523|NCT00509795|474738060|FG001|Overall Study|Protocol Violation|0|||
131852524|NCT00509795|474738061|FG002|Overall Study|Protocol Violation|3|||
131852525|NCT00509795|474738062|FG003|Overall Study|Protocol Violation|1|||
131852526|NCT00509795|474738059|FG000|Overall Study|Withdrawal by Subject|10|||
131852527|NCT00509795|474738060|FG001|Overall Study|Withdrawal by Subject|5|||
131852528|NCT00509795|474738061|FG002|Overall Study|Withdrawal by Subject|7|||
131852529|NCT00509795|474738062|FG003|Overall Study|Withdrawal by Subject|8|||
131852530|NCT00352417|474738065|FG000|Overall Study|Adverse Event|1|||
131852531|NCT00352417|474738066|FG001|Overall Study|Adverse Event|0|||
131852532|NCT00352417|474738065|FG000|Overall Study|Protocol Violation|0|||
131852533|NCT00352417|474738066|FG001|Overall Study|Protocol Violation|2|||
131852534|NCT00352417|474738065|FG000|Overall Study|Withdrawal by Subject|1|||
131852535|NCT00352417|474738066|FG001|Overall Study|Withdrawal by Subject|2|||
131852536|NCT00352417|474738065|FG000|Overall Study|Lost to Follow-up|1|||
131852537|NCT00352417|474738066|FG001|Overall Study|Lost to Follow-up|0|||
131852538|NCT00352417|474738065|FG000|Overall Study|Schedule Change|2|||
131852539|NCT00352417|474738066|FG001|Overall Study|Schedule Change|1|||
131852540|NCT03207867|474738067|FG000|Overall Study|Adverse Event|1|||
131852541|NCT03207867|474738068|FG001|Overall Study|Adverse Event|0|||
131852542|NCT03207867|474738069|FG002|Overall Study|Adverse Event|1|||
131852543|NCT03207867|474738070|FG003|Overall Study|Adverse Event|0|||
131852544|NCT03207867|474738071|FG004|Overall Study|Adverse Event|0|||
131852545|NCT03207867|474738072|FG005|Overall Study|Adverse Event|2|||
131852546|NCT03207867|474738073|FG006|Overall Study|Adverse Event|1|||
131852547|NCT03207867|474738074|FG007|Overall Study|Adverse Event|1|||
131852548|NCT03207867|474738075|FG008|Overall Study|Adverse Event|2|||
131852549|NCT03207867|474738076|FG009|Overall Study|Adverse Event|2|||
131852550|NCT03207867|474738077|FG010|Overall Study|Adverse Event|0|||
131852551|NCT03207867|474738078|FG011|Overall Study|Adverse Event|0|||
131852552|NCT03207867|474738079|FG012|Overall Study|Adverse Event|0|||
131852553|NCT03207867|474738080|FG013|Overall Study|Adverse Event|0|||
131852554|NCT03207867|474738081|FG014|Overall Study|Adverse Event|0|||
131852555|NCT03207867|474738082|FG015|Overall Study|Adverse Event|0|||
131852556|NCT03207867|474738083|FG016|Overall Study|Adverse Event|3|||
131852557|NCT03207867|474738084|FG017|Overall Study|Adverse Event|1|||
131852558|NCT03207867|474738085|FG018|Overall Study|Adverse Event|2|||
131852559|NCT03207867|474738086|FG019|Overall Study|Adverse Event|1|||
131852560|NCT03207867|474738087|FG020|Overall Study|Adverse Event|0|||
131852561|NCT03207867|474738088|FG021|Overall Study|Adverse Event|0|||
131852562|NCT03207867|474738089|FG022|Overall Study|Adverse Event|0|||
131852563|NCT03207867|474738090|FG023|Overall Study|Adverse Event|0|||
131453034|NCT01229267|473288332|FG003|Overall Study|Protocol Violation|0|||
131852564|NCT03207867|474738067|FG000|Overall Study|Death|0|||
131852565|NCT03207867|474738068|FG001|Overall Study|Death|0|||
131852566|NCT03207867|474738069|FG002|Overall Study|Death|0|||
131852567|NCT03207867|474738070|FG003|Overall Study|Death|0|||
131453035|NCT01229267|473288333|FG004|Overall Study|Protocol Violation|0|||
131852568|NCT03207867|474738071|FG004|Overall Study|Death|0|||
131852569|NCT03207867|474738072|FG005|Overall Study|Death|1|||
131852570|NCT03207867|474738073|FG006|Overall Study|Death|0|||
131852571|NCT03207867|474738074|FG007|Overall Study|Death|3|||
131852572|NCT03207867|474738075|FG008|Overall Study|Death|1|||
131453036|NCT01229267|473288329|FG000|Overall Study|Progressive disease|0|||
131852573|NCT03207867|474738076|FG009|Overall Study|Death|2|||
131852574|NCT03207867|474738077|FG010|Overall Study|Death|0|||
131852575|NCT03207867|474738078|FG011|Overall Study|Death|1|||
131852576|NCT03207867|474738079|FG012|Overall Study|Death|0|||
131852577|NCT03207867|474738080|FG013|Overall Study|Death|1|||
131852578|NCT03207867|474738081|FG014|Overall Study|Death|0|||
131852579|NCT03207867|474738082|FG015|Overall Study|Death|0|||
131852580|NCT03207867|474738083|FG016|Overall Study|Death|0|||
131852581|NCT03207867|474738084|FG017|Overall Study|Death|2|||
131852582|NCT03207867|474738085|FG018|Overall Study|Death|0|||
131852583|NCT03207867|474738086|FG019|Overall Study|Death|1|||
131852584|NCT03207867|474738087|FG020|Overall Study|Death|0|||
131852585|NCT03207867|474738088|FG021|Overall Study|Death|0|||
131852586|NCT03207867|474738089|FG022|Overall Study|Death|0|||
131852587|NCT03207867|474738090|FG023|Overall Study|Death|0|||
131852588|NCT03207867|474738067|FG000|Overall Study|Physician Decision|3|||
131852589|NCT03207867|474738068|FG001|Overall Study|Physician Decision|5|||
131852590|NCT03207867|474738069|FG002|Overall Study|Physician Decision|0|||
131852591|NCT03207867|474738070|FG003|Overall Study|Physician Decision|3|||
131852592|NCT03207867|474738071|FG004|Overall Study|Physician Decision|2|||
131852593|NCT03207867|474738072|FG005|Overall Study|Physician Decision|0|||
131852594|NCT03207867|474738073|FG006|Overall Study|Physician Decision|0|||
131852595|NCT03207867|474738074|FG007|Overall Study|Physician Decision|0|||
131852596|NCT03207867|474738075|FG008|Overall Study|Physician Decision|4|||
131852597|NCT03207867|474738076|FG009|Overall Study|Physician Decision|2|||
131852598|NCT03207867|474738077|FG010|Overall Study|Physician Decision|0|||
131852599|NCT03207867|474738078|FG011|Overall Study|Physician Decision|4|||
131852600|NCT03207867|474738079|FG012|Overall Study|Physician Decision|0|||
131852601|NCT03207867|474738080|FG013|Overall Study|Physician Decision|0|||
131852602|NCT03207867|474738081|FG014|Overall Study|Physician Decision|2|||
131852603|NCT03207867|474738082|FG015|Overall Study|Physician Decision|1|||
131852604|NCT03207867|474738083|FG016|Overall Study|Physician Decision|1|||
131852605|NCT03207867|474738084|FG017|Overall Study|Physician Decision|2|||
131852606|NCT03207867|474738085|FG018|Overall Study|Physician Decision|1|||
131852607|NCT03207867|474738086|FG019|Overall Study|Physician Decision|3|||
131852608|NCT03207867|474738087|FG020|Overall Study|Physician Decision|0|||
131852609|NCT03207867|474738088|FG021|Overall Study|Physician Decision|0|||
131852610|NCT03207867|474738089|FG022|Overall Study|Physician Decision|0|||
131852611|NCT03207867|474738090|FG023|Overall Study|Physician Decision|0|||
131852612|NCT03207867|474738067|FG000|Overall Study|Progressive Disease|7|||
131852613|NCT03207867|474738068|FG001|Overall Study|Progressive Disease|7|||
131852614|NCT03207867|474738069|FG002|Overall Study|Progressive Disease|9|||
131852615|NCT03207867|474738070|FG003|Overall Study|Progressive Disease|10|||
131852616|NCT03207867|474738071|FG004|Overall Study|Progressive Disease|11|||
131852617|NCT03207867|474738072|FG005|Overall Study|Progressive Disease|10|||
131852618|NCT03207867|474738073|FG006|Overall Study|Progressive Disease|9|||
131852619|NCT03207867|474738074|FG007|Overall Study|Progressive Disease|8|||
131852620|NCT03207867|474738075|FG008|Overall Study|Progressive Disease|19|||
131852621|NCT03207867|474738076|FG009|Overall Study|Progressive Disease|23|||
131852622|NCT03207867|474738077|FG010|Overall Study|Progressive Disease|2|||
131852623|NCT03207867|474738078|FG011|Overall Study|Progressive Disease|24|||
131852624|NCT03207867|474738079|FG012|Overall Study|Progressive Disease|3|||
131852625|NCT03207867|474738080|FG013|Overall Study|Progressive Disease|11|||
131852626|NCT03207867|474738081|FG014|Overall Study|Progressive Disease|9|||
131852627|NCT03207867|474738082|FG015|Overall Study|Progressive Disease|5|||
131852628|NCT03207867|474738083|FG016|Overall Study|Progressive Disease|10|||
131852629|NCT03207867|474738084|FG017|Overall Study|Progressive Disease|14|||
131852630|NCT03207867|474738085|FG018|Overall Study|Progressive Disease|13|||
131852631|NCT03207867|474738086|FG019|Overall Study|Progressive Disease|14|||
131852632|NCT03207867|474738087|FG020|Overall Study|Progressive Disease|6|||
131852633|NCT03207867|474738088|FG021|Overall Study|Progressive Disease|3|||
131852634|NCT03207867|474738089|FG022|Overall Study|Progressive Disease|3|||
131852635|NCT03207867|474738090|FG023|Overall Study|Progressive Disease|3|||
131852636|NCT03207867|474738067|FG000|Overall Study|Patient/guardian Decision|0|||
131852637|NCT03207867|474738068|FG001|Overall Study|Patient/guardian Decision|0|||
131852638|NCT03207867|474738069|FG002|Overall Study|Patient/guardian Decision|1|||
131852639|NCT03207867|474738070|FG003|Overall Study|Patient/guardian Decision|1|||
131852640|NCT03207867|474738071|FG004|Overall Study|Patient/guardian Decision|1|||
131852641|NCT03207867|474738072|FG005|Overall Study|Patient/guardian Decision|2|||
131852642|NCT03207867|474738073|FG006|Overall Study|Patient/guardian Decision|1|||
131852643|NCT03207867|474738074|FG007|Overall Study|Patient/guardian Decision|0|||
131852644|NCT03207867|474738075|FG008|Overall Study|Patient/guardian Decision|1|||
131852645|NCT03207867|474738076|FG009|Overall Study|Patient/guardian Decision|0|||
131852646|NCT03207867|474738077|FG010|Overall Study|Patient/guardian Decision|0|||
131453037|NCT01229267|473288330|FG001|Overall Study|Progressive disease|0|||
131852647|NCT03207867|474738078|FG011|Overall Study|Patient/guardian Decision|1|||
131852648|NCT03207867|474738079|FG012|Overall Study|Patient/guardian Decision|0|||
131852649|NCT03207867|474738080|FG013|Overall Study|Patient/guardian Decision|1|||
131852650|NCT03207867|474738081|FG014|Overall Study|Patient/guardian Decision|2|||
131852651|NCT03207867|474738082|FG015|Overall Study|Patient/guardian Decision|0|||
131852652|NCT03207867|474738083|FG016|Overall Study|Patient/guardian Decision|1|||
131852653|NCT03207867|474738084|FG017|Overall Study|Patient/guardian Decision|3|||
131852654|NCT03207867|474738085|FG018|Overall Study|Patient/guardian Decision|4|||
131852655|NCT03207867|474738086|FG019|Overall Study|Patient/guardian Decision|1|||
131852656|NCT03207867|474738087|FG020|Overall Study|Patient/guardian Decision|0|||
131852657|NCT03207867|474738088|FG021|Overall Study|Patient/guardian Decision|0|||
131852658|NCT03207867|474738089|FG022|Overall Study|Patient/guardian Decision|0|||
131852659|NCT03207867|474738090|FG023|Overall Study|Patient/guardian Decision|0|||
131852660|NCT04324073|474740174|FG000|Overall Study|withdrew consent|0|||
131852661|NCT04324073|474740175|FG001|Overall Study|withdrew consent|4|||
131852662|NCT04324073|474740176|FG002|Overall Study|withdrew consent|2|||
131852663|NCT04324073|474740177|FG003|Overall Study|withdrew consent|8|||
131852664|NCT03922529|474740178|FG000|Overall Study|Withdrawal by Subject|13|||
131852665|NCT03922529|474740179|FG001|Overall Study|Withdrawal by Subject|12|||
131852666|NCT03922529|474740178|FG000|Overall Study|Death|7|||
131852667|NCT03922529|474740179|FG001|Overall Study|Death|12|||
131852668|NCT03922529|474740178|FG000|Overall Study|Lost to Follow-up|12|||
131852669|NCT03922529|474740179|FG001|Overall Study|Lost to Follow-up|19|||
131852670|NCT03922529|474740178|FG000|Overall Study|Adverse Event|1|||
131852671|NCT03922529|474740179|FG001|Overall Study|Adverse Event|0|||
131852672|NCT03922529|474740178|FG000|Overall Study|Death after withdrawal|1|||
131852673|NCT03922529|474740179|FG001|Overall Study|Death after withdrawal|0|||
131852674|NCT03922529|474740178|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
131852675|NCT03922529|474740179|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
131852676|NCT03922529|474740178|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
131852677|NCT03922529|474740179|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
131852678|NCT02506153|474740180|FG000|Overall Study|Adverse Event|359|||
131852679|NCT02506153|474740181|FG001|Overall Study|Adverse Event|114|||
131852680|NCT02506153|474740180|FG000|Overall Study|Refused unrelated to adverse event|127|||
131852681|NCT02506153|474740181|FG001|Overall Study|Refused unrelated to adverse event|18|||
131852682|NCT02506153|474740180|FG000|Overall Study|Progression/relapse|91|||
131852683|NCT02506153|474740181|FG001|Overall Study|Progression/relapse|136|||
131852684|NCT02506153|474740180|FG000|Overall Study|Death|2|||
131852685|NCT02506153|474740181|FG001|Overall Study|Death|1|||
131852686|NCT02506153|474740180|FG000|Overall Study|Other - not protocol specified|23|||
131852687|NCT02506153|474740181|FG001|Overall Study|Other - not protocol specified|12|||
131852688|NCT01277601|474740188|FG000|Overall Study|Adverse Event|5|||
131852689|NCT01277601|474740189|FG001|Overall Study|Adverse Event|3|||
131852690|NCT01277601|474740190|FG002|Overall Study|Adverse Event|0|||
131852691|NCT01277601|474740191|FG003|Overall Study|Adverse Event|7|||
131852692|NCT01277601|474740188|FG000|Overall Study|Withdrawal by Subject|18|||
131852693|NCT01277601|474740189|FG001|Overall Study|Withdrawal by Subject|21|||
131852694|NCT01277601|474740190|FG002|Overall Study|Withdrawal by Subject|8|||
131852695|NCT01277601|474740191|FG003|Overall Study|Withdrawal by Subject|17|||
131852696|NCT01277601|474740188|FG000|Overall Study|Lost to Follow-up|7|||
131852697|NCT01277601|474740189|FG001|Overall Study|Lost to Follow-up|9|||
131852698|NCT01277601|474740190|FG002|Overall Study|Lost to Follow-up|4|||
131852699|NCT01277601|474740191|FG003|Overall Study|Lost to Follow-up|2|||
131852700|NCT01277601|474740188|FG000|Overall Study|Physician Decision|3|||
131852701|NCT01277601|474740189|FG001|Overall Study|Physician Decision|5|||
131852702|NCT01277601|474740190|FG002|Overall Study|Physician Decision|1|||
131852703|NCT01277601|474740191|FG003|Overall Study|Physician Decision|6|||
131852704|NCT01277601|474740188|FG000|Overall Study|Pregnancy|2|||
131852705|NCT01277601|474740189|FG001|Overall Study|Pregnancy|2|||
131852706|NCT01277601|474740190|FG002|Overall Study|Pregnancy|4|||
131852707|NCT01277601|474740191|FG003|Overall Study|Pregnancy|1|||
131852708|NCT01277601|474740188|FG000|Overall Study|Noncompliance with Study Drug|1|||
131852709|NCT01277601|474740189|FG001|Overall Study|Noncompliance with Study Drug|3|||
131852710|NCT01277601|474740190|FG002|Overall Study|Noncompliance with Study Drug|2|||
131852711|NCT01277601|474740191|FG003|Overall Study|Noncompliance with Study Drug|0|||
131852712|NCT01277601|474740188|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
131852713|NCT01277601|474740189|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
131852714|NCT01277601|474740190|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
131852715|NCT01277601|474740191|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
131852716|NCT01277601|474740188|FG000|Overall Study|Protocol Violation|0|||
131852717|NCT01277601|474740189|FG001|Overall Study|Protocol Violation|2|||
131852718|NCT01277601|474740190|FG002|Overall Study|Protocol Violation|5|||
131852719|NCT01277601|474740191|FG003|Overall Study|Protocol Violation|0|||
131852720|NCT01277601|474740188|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
131852721|NCT01277601|474740189|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
131852722|NCT01277601|474740190|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
131852723|NCT01277601|474740191|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
131852724|NCT04034927|474740192|FG000|Overall Study|Adverse Event|4|||
131852725|NCT04034927|474740193|FG001|Overall Study|Adverse Event|9|||
131852726|NCT04034927|474740192|FG000|Overall Study|Death|0|||
131852727|NCT04034927|474740193|FG001|Overall Study|Death|1|||
131852728|NCT04034927|474740192|FG000|Overall Study|Withdrawal by Subject|0|||
131852729|NCT04034927|474740193|FG001|Overall Study|Withdrawal by Subject|3|||
131852730|NCT04034927|474740192|FG000|Overall Study|Still on Treatment|2|||
131852731|NCT04034927|474740193|FG001|Overall Study|Still on Treatment|1|||
131852732|NCT04034927|474740192|FG000|Overall Study|Other|1|||
131852733|NCT04034927|474740193|FG001|Overall Study|Other|1|||
131852734|NCT03765788|474740195|FG000|Overall Study|Subject decision|2|||
131852735|NCT03765788|474740196|FG001|Overall Study|Subject decision|3|||
131852736|NCT03765788|474740195|FG000|Overall Study|Physician Decision|2|||
131852737|NCT03765788|474740196|FG001|Overall Study|Physician Decision|4|||
131453038|NCT01229267|473288331|FG002|Overall Study|Progressive disease|0|||
131453039|NCT01229267|473288332|FG003|Overall Study|Progressive disease|0|||
131453040|NCT01229267|473288333|FG004|Overall Study|Progressive disease|1|||
131453041|NCT01229267|473288329|FG000|Overall Study|Physician Decision|8|||
131453042|NCT01229267|473288330|FG001|Overall Study|Physician Decision|11|||
131453043|NCT01229267|473288331|FG002|Overall Study|Physician Decision|8|||
131453044|NCT01229267|473288332|FG003|Overall Study|Physician Decision|3|||
131453045|NCT01229267|473288333|FG004|Overall Study|Physician Decision|25|||
131453046|NCT01229267|473288329|FG000|Overall Study|Lost to Follow-up|6|||
131453047|NCT01229267|473288330|FG001|Overall Study|Lost to Follow-up|5|||
131453048|NCT01229267|473288331|FG002|Overall Study|Lost to Follow-up|8|||
131453049|NCT01229267|473288332|FG003|Overall Study|Lost to Follow-up|3|||
131453050|NCT01229267|473288333|FG004|Overall Study|Lost to Follow-up|22|||
131453051|NCT03830892|473288338|FG000|Overall Study|Physician Decision|2|||
131453052|NCT03830892|473288339|FG001|Overall Study|Physician Decision|3|||
131453053|NCT03830892|473288338|FG000|Overall Study|Study terminated due to COVID|4|||
131453054|NCT03830892|473288339|FG001|Overall Study|Study terminated due to COVID|0|||
131453055|NCT03830892|473288338|FG000|Overall Study|Protocol Violation|0|||
131453056|NCT03830892|473288339|FG001|Overall Study|Protocol Violation|1|||
131453057|NCT03830892|473288338|FG000|Overall Study|Withdrawal by Subject|0|||
131453058|NCT03830892|473288339|FG001|Overall Study|Withdrawal by Subject|2|||
131453059|NCT05782179|473288342|FG000|Overall Study|Adverse Event|0|||
131453060|NCT05782179|473288343|FG001|Overall Study|Adverse Event|0|||
131453061|NCT05782179|473288344|FG002|Overall Study|Adverse Event|2|||
131453062|NCT05782179|473288345|FG003|Overall Study|Adverse Event|0|||
131453063|NCT05782179|473288346|FG004|Overall Study|Adverse Event|0|||
131453064|NCT05782179|473288347|FG005|Overall Study|Adverse Event|0|||
131453065|NCT03682770|473288352|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
131453066|NCT03682770|473288353|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
131453067|NCT03682770|473288354|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
131453068|NCT03682770|473288355|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
131453069|NCT03682770|473288356|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
131453070|NCT03682770|473288357|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
131453071|NCT03682770|473288358|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
131453072|NCT03682770|473288352|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
131453073|NCT03682770|473288353|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
131453074|NCT03682770|473288354|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
131453075|NCT03682770|473288355|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
131453076|NCT03682770|473288356|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
131453077|NCT03682770|473288357|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
131453078|NCT03682770|473288358|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
131453079|NCT03682770|473288352|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
131453080|NCT03682770|473288353|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
131453081|NCT03682770|473288354|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
131453082|NCT03682770|473288355|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
131453083|NCT03682770|473288356|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
131453084|NCT03682770|473288357|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
131453085|NCT03682770|473288358|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
131453086|NCT03682770|473288352|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
131453087|NCT03682770|473288353|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
131453088|NCT03682770|473288354|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
131453089|NCT03682770|473288355|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
131453090|NCT03682770|473288356|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
131453091|NCT03682770|473288357|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
131453092|NCT03682770|473288358|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
131404701|NCT03099174|473103794|FG000|Overall Study|Withdrawal by Subject|0|||
131404702|NCT03099174|473103795|FG001|Overall Study|Withdrawal by Subject|0|||
131404703|NCT03099174|473103796|FG002|Overall Study|Withdrawal by Subject|1|||
131404704|NCT03099174|473103797|FG003|Overall Study|Withdrawal by Subject|0|||
131404705|NCT03099174|473103798|FG004|Overall Study|Withdrawal by Subject|2|||
131404706|NCT03099174|473103799|FG005|Overall Study|Withdrawal by Subject|2|||
131404707|NCT03099174|473103800|FG006|Overall Study|Withdrawal by Subject|1|||
131404708|NCT03099174|473103801|FG007|Overall Study|Withdrawal by Subject|4|||
131404709|NCT03099174|473103794|FG000|Overall Study|Adverse Event|0|||
131453093|NCT03682770|473288352|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
131453094|NCT03682770|473288353|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
131453095|NCT03682770|473288354|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
131453096|NCT03682770|473288355|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
131404710|NCT03099174|473103795|FG001|Overall Study|Adverse Event|1|||
131404711|NCT03099174|473103796|FG002|Overall Study|Adverse Event|1|||
131404712|NCT03099174|473103797|FG003|Overall Study|Adverse Event|2|||
131852738|NCT03765788|474740195|FG000|Overall Study|Death|0|||
131852739|NCT03765788|474740196|FG001|Overall Study|Death|1|||
131852740|NCT03765788|474740195|FG000|Overall Study|Lost to Follow-up|1|||
131852741|NCT03765788|474740196|FG001|Overall Study|Lost to Follow-up|0|||
131852742|NCT03203850|474740197|FG000|Overall Study|Subject/guardian decision|4|||
131852743|NCT03203850|474740198|FG001|Overall Study|Subject/guardian decision|3|||
131852744|NCT03203850|474740197|FG000|Overall Study|Adverse Event|3|||
131852745|NCT03203850|474740198|FG001|Overall Study|Adverse Event|0|||
131852746|NCT03203850|474740197|FG000|Overall Study|Death|1|||
131852747|NCT03203850|474740198|FG001|Overall Study|Death|0|||
131852748|NCT04856930|474740199|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
131852749|NCT04856930|474740200|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
131852750|NCT04856930|474740201|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
131852751|NCT04856930|474740199|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
131852752|NCT04856930|474740200|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
131852753|NCT04856930|474740201|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
131852754|NCT04856930|474740199|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
131852755|NCT04856930|474740200|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
131852756|NCT04856930|474740201|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
131852757|NCT04856930|474740199|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
131852758|NCT04856930|474740200|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
131852759|NCT04856930|474740201|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
131852760|NCT04856930|474740199|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
131852761|NCT04856930|474740200|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
131852762|NCT04856930|474740201|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
131852763|NCT04856930|474740199|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
131852764|NCT04856930|474740200|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
131852765|NCT04856930|474740201|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
131852766|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
131852767|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
131852768|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
131852769|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
131852770|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
131852771|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
131852772|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
131852773|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
131852774|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
131852775|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
131852776|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
131852777|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
131852778|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
131852779|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
131852780|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
131852781|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
131852782|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
131852783|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
131852784|NCT04856930|474740199|FG000|Extension Period (16 Weeks)|Other than specified|0|||
131852785|NCT04856930|474740200|FG001|Extension Period (16 Weeks)|Other than specified|0|||
131852786|NCT04856930|474740201|FG002|Extension Period (16 Weeks)|Other than specified|1|||
131852787|NCT04856930|474740199|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
131852788|NCT04856930|474740200|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
131852789|NCT04856930|474740201|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
131852790|NCT04856930|474740199|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
131852791|NCT04856930|474740200|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
131852792|NCT04856930|474740201|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
131852793|NCT04856930|474740199|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
131852794|NCT04856930|474740200|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
131852795|NCT04856930|474740201|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
131852796|NCT04856930|474740199|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
131852797|NCT04856930|474740200|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
131852798|NCT04856930|474740201|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
131852799|NCT00678210|474740203|FG000|Overall Study|Adverse Event|1|||
131852800|NCT00678210|474740204|FG001|Overall Study|Adverse Event|2|||
131852801|NCT00678210|474740205|FG002|Overall Study|Adverse Event|3|||
131852802|NCT00678210|474740206|FG003|Overall Study|Adverse Event|3|||
131852803|NCT00678210|474740203|FG000|Overall Study|Lack of Efficacy|2|||
131852804|NCT00678210|474740204|FG001|Overall Study|Lack of Efficacy|3|||
131852805|NCT00678210|474740205|FG002|Overall Study|Lack of Efficacy|1|||
131852806|NCT00678210|474740206|FG003|Overall Study|Lack of Efficacy|9|||
131852807|NCT00678210|474740203|FG000|Overall Study|Lost to Follow-up|4|||
131404713|NCT03099174|473103798|FG004|Overall Study|Adverse Event|5|||
131404714|NCT03099174|473103799|FG005|Overall Study|Adverse Event|3|||
131404715|NCT03099174|473103800|FG006|Overall Study|Adverse Event|6|||
131404716|NCT03099174|473103801|FG007|Overall Study|Adverse Event|4|||
131404717|NCT03099174|473103794|FG000|Overall Study|Other than listed|6|||
131404718|NCT03099174|473103795|FG001|Overall Study|Other than listed|6|||
131404719|NCT03099174|473103796|FG002|Overall Study|Other than listed|5|||
131404720|NCT03099174|473103797|FG003|Overall Study|Other than listed|6|||
131404721|NCT03099174|473103798|FG004|Overall Study|Other than listed|19|||
131404722|NCT03099174|473103799|FG005|Overall Study|Other than listed|10|||
131404723|NCT03099174|473103800|FG006|Overall Study|Other than listed|26|||
131404724|NCT03099174|473103801|FG007|Overall Study|Other than listed|23|||
131404725|NCT02378298|473103803|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
131404726|NCT02378298|473103804|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
131404727|NCT02378298|473103805|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
131404728|NCT02378298|473103803|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
131404729|NCT02378298|473103804|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
131404730|NCT02378298|473103805|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
131404731|NCT02378298|473103803|FG000|Surveillance (19-68 Weeks)|Death|1|||
131404732|NCT02378298|473103804|FG001|Surveillance (19-68 Weeks)|Death|0|||
131404733|NCT02378298|473103805|FG002|Surveillance (19-68 Weeks)|Death|0|||
131404734|NCT02308163|473103806|FG000|Overall Study|Not fulfill eligible criteria|1|||
131404735|NCT02308163|473103807|FG001|Overall Study|Not fulfill eligible criteria|2|||
131404736|NCT02308163|473103808|FG002|Overall Study|Not fulfill eligible criteria|0|||
131404737|NCT02308163|473103809|FG003|Overall Study|Not fulfill eligible criteria|1|||
131404738|NCT02308163|473103810|FG004|Overall Study|Not fulfill eligible criteria|1|||
131404739|NCT02308163|473103806|FG000|Overall Study|Adverse Event|9|||
131404740|NCT02308163|473103807|FG001|Overall Study|Adverse Event|5|||
131404741|NCT02308163|473103808|FG002|Overall Study|Adverse Event|2|||
131404742|NCT02308163|473103809|FG003|Overall Study|Adverse Event|2|||
131404743|NCT02308163|473103810|FG004|Overall Study|Adverse Event|11|||
131404744|NCT02308163|473103806|FG000|Overall Study|Lack of Efficacy|11|||
131404745|NCT02308163|473103807|FG001|Overall Study|Lack of Efficacy|3|||
131404746|NCT02308163|473103808|FG002|Overall Study|Lack of Efficacy|8|||
131404747|NCT02308163|473103809|FG003|Overall Study|Lack of Efficacy|4|||
131404748|NCT02308163|473103810|FG004|Overall Study|Lack of Efficacy|6|||
131404749|NCT02308163|473103806|FG000|Overall Study|Withdrawal of consent|2|||
131404750|NCT02308163|473103807|FG001|Overall Study|Withdrawal of consent|3|||
131404751|NCT02308163|473103808|FG002|Overall Study|Withdrawal of consent|0|||
131404752|NCT02308163|473103809|FG003|Overall Study|Withdrawal of consent|2|||
131404753|NCT02308163|473103810|FG004|Overall Study|Withdrawal of consent|6|||
131404754|NCT02308163|473103806|FG000|Overall Study|Protocol Violation|3|||
131404755|NCT02308163|473103807|FG001|Overall Study|Protocol Violation|3|||
131404756|NCT02308163|473103808|FG002|Overall Study|Protocol Violation|3|||
131404757|NCT02308163|473103809|FG003|Overall Study|Protocol Violation|2|||
131404758|NCT02308163|473103810|FG004|Overall Study|Protocol Violation|5|||
131404759|NCT02308163|473103806|FG000|Overall Study|Lab data met discontinuation criteria|3|||
131404760|NCT02308163|473103807|FG001|Overall Study|Lab data met discontinuation criteria|0|||
131404761|NCT02308163|473103808|FG002|Overall Study|Lab data met discontinuation criteria|0|||
131404762|NCT02308163|473103809|FG003|Overall Study|Lab data met discontinuation criteria|2|||
131404763|NCT02308163|473103810|FG004|Overall Study|Lab data met discontinuation criteria|0|||
131404764|NCT02308163|473103806|FG000|Overall Study|Miscellaneous|2|||
131404765|NCT02308163|473103807|FG001|Overall Study|Miscellaneous|2|||
131404766|NCT02308163|473103808|FG002|Overall Study|Miscellaneous|1|||
131404767|NCT02308163|473103809|FG003|Overall Study|Miscellaneous|0|||
131404768|NCT02308163|473103810|FG004|Overall Study|Miscellaneous|5|||
131404769|NCT03941964|473103812|FG000|Overall Study|Adverse Event|1|||
131404770|NCT03941964|473103813|FG001|Overall Study|Adverse Event|8|||
131404771|NCT03941964|473103812|FG000|Overall Study|Progressive disease|7|||
131404772|NCT03941964|473103813|FG001|Overall Study|Progressive disease|3|||
131404773|NCT03941964|473103812|FG000|Overall Study|Lack of Efficacy|0|||
131404774|NCT03941964|473103813|FG001|Overall Study|Lack of Efficacy|1|||
131404775|NCT03941964|473103812|FG000|Overall Study|Death|3|||
131404776|NCT03941964|473103813|FG001|Overall Study|Death|1|||
131404777|NCT03941964|473103812|FG000|Overall Study|Withdrew consent|1|||
131404778|NCT03941964|473103813|FG001|Overall Study|Withdrew consent|3|||
131404779|NCT03941964|473103812|FG000|Overall Study|Physician Decision|9|||
131404780|NCT03941964|473103813|FG001|Overall Study|Physician Decision|2|||
131404781|NCT03941964|473103812|FG000|Overall Study|Other, not specified|2|||
131404782|NCT03941964|473103813|FG001|Overall Study|Other, not specified|1|||
131404783|NCT00118846|473103815|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
131404784|NCT00118846|473103816|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
131404785|NCT00118846|473103815|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
131404786|NCT00118846|473103816|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
131404787|NCT00118846|473103815|FG000|Overall Study|Physician Decision|1|||
131404788|NCT00118846|473103816|FG001|Overall Study|Physician Decision|0|||
131404789|NCT00118846|473103815|FG000|Overall Study|Medical condition|2|||
131404790|NCT00118846|473103816|FG001|Overall Study|Medical condition|2|||
131404791|NCT00118846|473103815|FG000|Overall Study|Lost to Follow-up|0|||
131404792|NCT00118846|473103816|FG001|Overall Study|Lost to Follow-up|2|||
131404793|NCT00118846|473103815|FG000|Overall Study|Personal reason|4|||
131404794|NCT00118846|473103816|FG001|Overall Study|Personal reason|5|||
131404795|NCT00443053|473103817|FG000|Overall Study|Adverse Event|2|||
131404796|NCT00443053|473103818|FG001|Overall Study|Adverse Event|1|||
131404797|NCT00443053|473103817|FG000|Overall Study|Withdrawal by Subject|9|||
131404798|NCT00443053|473103818|FG001|Overall Study|Withdrawal by Subject|18|||
131404799|NCT00443053|473103817|FG000|Overall Study|Lost to Follow-up|4|||
131404800|NCT00443053|473103818|FG001|Overall Study|Lost to Follow-up|5|||
131404801|NCT00443053|473103817|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
131404802|NCT00443053|473103818|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
131404803|NCT00443053|473103817|FG000|Overall Study|Noncompliance|2|||
131404804|NCT00443053|473103818|FG001|Overall Study|Noncompliance|1|||
131404805|NCT00443053|473103817|FG000|Overall Study|Other|3|||
131404806|NCT00443053|473103818|FG001|Overall Study|Other|4|||
131404807|NCT00443053|473103817|FG000|Overall Study|Physician Decision|0|||
131404808|NCT00443053|473103818|FG001|Overall Study|Physician Decision|4|||
131404809|NCT00541866|473103819|FG000|Overall Study|Adverse Event|3|||
131404810|NCT00541866|473103820|FG001|Overall Study|Adverse Event|0|||
131404811|NCT00541866|473103821|FG002|Overall Study|Adverse Event|0|||
131404812|NCT00541866|473103822|FG003|Overall Study|Adverse Event|0|||
131404813|NCT00541866|473103823|FG004|Overall Study|Adverse Event|0|||
131404814|NCT00541866|473103819|FG000|Overall Study|Death|1|||
131404815|NCT00541866|473103820|FG001|Overall Study|Death|0|||
131404816|NCT00541866|473103821|FG002|Overall Study|Death|0|||
131404817|NCT00541866|473103822|FG003|Overall Study|Death|0|||
131404818|NCT00541866|473103823|FG004|Overall Study|Death|0|||
131404819|NCT00541866|473103819|FG000|Overall Study|Lack of Efficacy|19|||
131404820|NCT00541866|473103820|FG001|Overall Study|Lack of Efficacy|15|||
131404821|NCT00541866|473103821|FG002|Overall Study|Lack of Efficacy|10|||
131404822|NCT00541866|473103822|FG003|Overall Study|Lack of Efficacy|12|||
131404823|NCT00541866|473103823|FG004|Overall Study|Lack of Efficacy|14|||
131404824|NCT00541866|473103819|FG000|Overall Study|Not Reported or Other|11|||
131404825|NCT00541866|473103820|FG001|Overall Study|Not Reported or Other|3|||
131404826|NCT00541866|473103821|FG002|Overall Study|Not Reported or Other|3|||
131404827|NCT00541866|473103822|FG003|Overall Study|Not Reported or Other|3|||
131404828|NCT00541866|473103823|FG004|Overall Study|Not Reported or Other|1|||
131404829|NCT00541866|473103819|FG000|Overall Study|Physician Decision|0|||
131404830|NCT00541866|473103820|FG001|Overall Study|Physician Decision|0|||
131404831|NCT00541866|473103821|FG002|Overall Study|Physician Decision|2|||
131404832|NCT00541866|473103822|FG003|Overall Study|Physician Decision|1|||
131404833|NCT00541866|473103823|FG004|Overall Study|Physician Decision|0|||
131404834|NCT01327053|473103824|FG000|Overall Study|Adverse Event|23|||
131404835|NCT01327053|473103825|FG001|Overall Study|Adverse Event|57|||
131404836|NCT01327053|473103824|FG000|Overall Study|Patient/guardian decision|11|||
131404837|NCT01327053|473103825|FG001|Overall Study|Patient/guardian decision|35|||
131404838|NCT01327053|473103824|FG000|Overall Study|Physician Decision|10|||
131404839|NCT01327053|473103825|FG001|Overall Study|Physician Decision|14|||
131404840|NCT01327053|473103824|FG000|Overall Study|Death|1|||
131912284|NCT01799889|474966532|FG008|Overall Study|Study Terminated By Sponsor|1|||
131404841|NCT01327053|473103825|FG001|Overall Study|Death|5|||
131404842|NCT01327053|473103824|FG000|Overall Study|Lost to Follow-up|2|||
131404843|NCT01327053|473103825|FG001|Overall Study|Lost to Follow-up|4|||
131404844|NCT01327053|473103824|FG000|Overall Study|Non-compliance with study treatment|0|||
131404845|NCT01327053|473103825|FG001|Overall Study|Non-compliance with study treatment|5|||
131404846|NCT01327053|473103824|FG000|Overall Study|Study terminated by Sponsor|1|||
131404847|NCT01327053|473103825|FG001|Overall Study|Study terminated by Sponsor|3|||
131404848|NCT01327053|473103824|FG000|Overall Study|Progressive disease|31|||
131852808|NCT00678210|474740204|FG001|Overall Study|Lost to Follow-up|2|||
131852809|NCT00678210|474740205|FG002|Overall Study|Lost to Follow-up|0|||
131852810|NCT00678210|474740206|FG003|Overall Study|Lost to Follow-up|1|||
131852811|NCT00678210|474740203|FG000|Overall Study|Withdrawal by Subject|3|||
131852812|NCT00678210|474740204|FG001|Overall Study|Withdrawal by Subject|4|||
131852813|NCT00678210|474740205|FG002|Overall Study|Withdrawal by Subject|1|||
131852814|NCT00678210|474740206|FG003|Overall Study|Withdrawal by Subject|7|||
131852815|NCT00678210|474740203|FG000|Overall Study|Other|1|||
131852816|NCT00678210|474740204|FG001|Overall Study|Other|0|||
131852817|NCT00678210|474740205|FG002|Overall Study|Other|1|||
131852818|NCT00678210|474740206|FG003|Overall Study|Other|0|||
131852819|NCT04825912|474740207|FG000|Overall Study|Death|3|||
131852820|NCT04825912|474740207|FG000|Overall Study|Withdrawal by Subject|1|||
131852821|NCT00974922|474740208|FG000|Overall Study|study terminated|24|||
131852822|NCT01009814|474740209|FG000|Overall Study|No longer met study criteria|1|||
131852823|NCT01009814|474740210|FG001|Overall Study|No longer met study criteria|1|||
131852824|NCT01009814|474740211|FG002|Overall Study|No longer met study criteria|0|||
131404849|NCT01327053|473103825|FG001|Overall Study|Progressive disease|26|||
131404850|NCT01327053|473103824|FG000|Overall Study|Protocol Violation|0|||
131404851|NCT01327053|473103825|FG001|Overall Study|Protocol Violation|1|||
131404852|NCT01327053|473103824|FG000|Overall Study|Untreated|0|||
131404853|NCT01327053|473103825|FG001|Overall Study|Untreated|1|||
131404854|NCT01574157|473103826|FG000|Overall Study|Withdrawal by Subject|4|||
131404855|NCT01574157|473103827|FG001|Overall Study|Withdrawal by Subject|5|||
131404856|NCT01574157|473103826|FG000|Overall Study|Lost to Follow-up|0|||
131404857|NCT01574157|473103827|FG001|Overall Study|Lost to Follow-up|3|||
131404858|NCT00721578|473103828|FG000|Overall Study|Death|1|||
131404859|NCT00721578|473103829|FG001|Overall Study|Death|1|||
131404860|NCT00721578|473103828|FG000|Overall Study|Withdrawal by Subject|1|||
131404861|NCT00721578|473103829|FG001|Overall Study|Withdrawal by Subject|1|||
131404862|NCT05032690|473103830|FG000|Period 1|Adverse Event|0|||
131404863|NCT05032690|473103831|FG001|Period 1|Adverse Event|1|||
131404864|NCT05032690|473103832|FG002|Period 1|Adverse Event|0|||
131404865|NCT05032690|473103833|FG003|Period 1|Adverse Event|0|||
131404866|NCT05032690|473103830|FG000|Period 1|Withdrawal by Subject|1|||
131404867|NCT05032690|473103831|FG001|Period 1|Withdrawal by Subject|0|||
131404868|NCT05032690|473103832|FG002|Period 1|Withdrawal by Subject|0|||
131404869|NCT05032690|473103833|FG003|Period 1|Withdrawal by Subject|0|||
131404870|NCT05032690|473103830|FG000|Period 1|No longer meets eligibility criteria|0|||
131404871|NCT05032690|473103831|FG001|Period 1|No longer meets eligibility criteria|1|||
131404872|NCT05032690|473103832|FG002|Period 1|No longer meets eligibility criteria|0|||
131404873|NCT05032690|473103833|FG003|Period 1|No longer meets eligibility criteria|0|||
131404874|NCT05032690|473103830|FG000|Period 2|Adverse Event|1|||
131404875|NCT05032690|473103831|FG001|Period 2|Adverse Event|0|||
131404876|NCT05032690|473103832|FG002|Period 2|Adverse Event|0|||
131404877|NCT05032690|473103833|FG003|Period 2|Adverse Event|0|||
131404878|NCT05032690|473103830|FG000|Period 2|Withdrawal by Subject|0|||
131404879|NCT05032690|473103831|FG001|Period 2|Withdrawal by Subject|1|||
131404880|NCT05032690|473103832|FG002|Period 2|Withdrawal by Subject|0|||
131404881|NCT05032690|473103833|FG003|Period 2|Withdrawal by Subject|0|||
131404882|NCT05032690|473103830|FG000|Period 2|No longer meets eligibility criteria|0|||
131404883|NCT05032690|473103831|FG001|Period 2|No longer meets eligibility criteria|1|||
131404884|NCT05032690|473103832|FG002|Period 2|No longer meets eligibility criteria|0|||
131404885|NCT05032690|473103833|FG003|Period 2|No longer meets eligibility criteria|0|||
131404886|NCT05032690|473103830|FG000|Period 3|Adverse Event|0|||
131404887|NCT05032690|473103831|FG001|Period 3|Adverse Event|1|||
131404888|NCT05032690|473103832|FG002|Period 3|Adverse Event|0|||
131404889|NCT05032690|473103833|FG003|Period 3|Adverse Event|0|||
131404890|NCT02298179|473103834|FG000|Overall Study|Lost to Follow-up|0|||
131404891|NCT02298179|473103835|FG001|Overall Study|Lost to Follow-up|0|||
131404892|NCT02298179|473103836|FG002|Overall Study|Lost to Follow-up|1|||
131404893|NCT02298179|473103837|FG003|Overall Study|Lost to Follow-up|0|||
131404894|NCT02298179|473103838|FG004|Overall Study|Lost to Follow-up|0|||
131404895|NCT02298179|473103839|FG005|Overall Study|Lost to Follow-up|0|||
131404896|NCT02298179|473103840|FG006|Overall Study|Lost to Follow-up|0|||
131404897|NCT02298179|473103841|FG007|Overall Study|Lost to Follow-up|1|||
131404898|NCT02298179|473103842|FG008|Overall Study|Lost to Follow-up|0|||
131404899|NCT02298179|473103843|FG009|Overall Study|Lost to Follow-up|0|||
131404900|NCT02298179|473103844|FG010|Overall Study|Lost to Follow-up|0|||
131404901|NCT02298179|473103845|FG011|Overall Study|Lost to Follow-up|0|||
131404902|NCT00983515|473105383|FG000|Ritonavir Alone|liver panel out of range|6|||
131404903|NCT00983515|473105383|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
131404904|NCT01730339|473105384|FG000|Overall Study|Withdrawal by Subject|3|||
131404905|NCT01730339|473105385|FG001|Overall Study|Withdrawal by Subject|2|||
131404906|NCT01730339|473105384|FG000|Overall Study|Lost to Follow-up|1|||
131404907|NCT01730339|473105385|FG001|Overall Study|Lost to Follow-up|1|||
131404908|NCT01730339|473105384|FG000|Overall Study|Un-specified|1|||
131404909|NCT01730339|473105385|FG001|Overall Study|Un-specified|0|||
131852825|NCT01009814|474740212|FG003|Overall Study|No longer met study criteria|0|||
131852826|NCT01009814|474740213|FG004|Overall Study|No longer met study criteria|0|||
131852827|NCT00618371|474740214|FG000|Overall Study|Withdrawal by Subject|2|||
131852828|NCT00113763|474740217|FG000|Overall Study|Adverse Event|5|||
131852829|NCT00113763|474740218|FG001|Overall Study|Adverse Event|2|||
131852830|NCT00113763|474740217|FG000|Overall Study|Disease Progression|28|||
131852831|NCT00113763|474740218|FG001|Overall Study|Disease Progression|14|||
131404910|NCT01145352|473105386|FG000|Overall Study|Found to have been registered twice|6|||
131404911|NCT01145352|473105386|FG000|Overall Study|Treated before marketing approval|4|||
131404912|NCT01145352|473105386|FG000|Overall Study|Syringe formulation was used|1|||
131404913|NCT03095027|473105387|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
131404914|NCT03095027|473105388|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
131404915|NCT01962987|473105391|FG000|Overall Study|Adverse Event|4|||
131404916|NCT01962987|473105392|FG001|Overall Study|Adverse Event|4|||
131404917|NCT01962987|473105393|FG002|Overall Study|Adverse Event|0|||
131404918|NCT01962987|473105391|FG000|Overall Study|Lost to Follow-up|0|||
131404919|NCT01962987|473105392|FG001|Overall Study|Lost to Follow-up|0|||
131852832|NCT00113763|474740217|FG000|Overall Study|Lost to Follow-up|10|||
131852833|NCT00113763|474740218|FG001|Overall Study|Lost to Follow-up|0|||
131852834|NCT00113763|474740217|FG000|Overall Study|Withdrawal by Subject|1|||
131852835|NCT00113763|474740218|FG001|Overall Study|Withdrawal by Subject|4|||
131852836|NCT00113763|474740217|FG000|Overall Study|Other|27|||
131852837|NCT00113763|474740218|FG001|Overall Study|Other|6|||
131852838|NCT00113763|474740217|FG000|Overall Study|Non-compliance|1|||
131852839|NCT00113763|474740218|FG001|Overall Study|Non-compliance|0|||
131852840|NCT00113763|474740217|FG000|Overall Study|Ongoing|1|||
131852841|NCT00113763|474740218|FG001|Overall Study|Ongoing|0|||
131852842|NCT02847260|474740219|FG000|Overall Study|Adverse Event|3|||
131852843|NCT02847260|474740219|FG000|Overall Study|Withdrawal by Subject|2|||
131852844|NCT02847260|474740219|FG000|Overall Study|Clinical Deterioration|1|||
131852845|NCT02847260|474740219|FG000|Overall Study|Physician Decision|1|||
131852846|NCT01383707|474740220|FG000|Overall Study|Consent withdrawal|6|||
131852847|NCT01383707|474740220|FG000|Overall Study|Death|19|||
131852848|NCT01383707|474740220|FG000|Overall Study|Other|8|||
131852849|NCT01383707|474740220|FG000|Overall Study|Sponsor's decision|2|||
131852850|NCT01383707|474740220|FG000|Overall Study|Adverse Event|14|||
131852851|NCT01383707|474740220|FG000|Overall Study|Progressive disease|23|||
131852852|NCT03698019|474740221|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
131852853|NCT03698019|474740222|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
131852854|NCT03698019|474740221|FG000|Step 1: Registration|Withdrawal by Subject|7|||
131852855|NCT03698019|474740222|FG001|Step 1: Registration|Withdrawal by Subject|2|||
131852856|NCT03698019|474740221|FG000|Step 1: Registration|Toxicity|0|||
131852857|NCT03698019|474740222|FG001|Step 1: Registration|Toxicity|1|||
131852858|NCT03698019|474740221|FG000|Step 1: Registration|Disease Progression|0|||
131852859|NCT03698019|474740222|FG001|Step 1: Registration|Disease Progression|12|||
131852860|NCT03698019|474740221|FG000|Step 1: Registration|Co-morbidities|0|||
131852861|NCT03698019|474740222|FG001|Step 1: Registration|Co-morbidities|1|||
131852862|NCT03698019|474740221|FG000|Step 1: Registration|Scheduling Issues|1|||
131852863|NCT03698019|474740222|FG001|Step 1: Registration|Scheduling Issues|0|||
131852864|NCT03698019|474740221|FG000|Step 1: Registration|Participant Refusal|0|||
131852865|NCT03698019|474740222|FG001|Step 1: Registration|Participant Refusal|1|||
131852866|NCT03698019|474740221|FG000|Step 2: Surgery|Participant Refusal|2|||
131852867|NCT03698019|474740222|FG001|Step 2: Surgery|Participant Refusal|1|||
131852868|NCT03698019|474740221|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
131852869|NCT03698019|474740222|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
131852870|NCT03698019|474740221|FG000|Step 2: Surgery|Metastatic Disease|16|||
131852871|NCT03698019|474740222|FG001|Step 2: Surgery|Metastatic Disease|9|||
131852872|NCT03698019|474740221|FG000|Step 2: Surgery|Residual Disease|2|||
131852873|NCT03698019|474740222|FG001|Step 2: Surgery|Residual Disease|1|||
131852874|NCT03698019|474740221|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
131852875|NCT03698019|474740222|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
131852876|NCT03698019|474740221|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
131852877|NCT03698019|474740222|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
131852878|NCT03698019|474740221|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
131852879|NCT03698019|474740222|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
131852880|NCT03698019|474740221|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
131852881|NCT03698019|474740222|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
131852882|NCT03698019|474740221|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
131852883|NCT03698019|474740222|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
131852884|NCT03698019|474740221|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
131852885|NCT03698019|474740222|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
131852886|NCT03698019|474740221|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
131852887|NCT03698019|474740222|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
131852888|NCT03698019|474740221|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
131852889|NCT03698019|474740222|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
131852890|NCT00588770|474740223|FG000|Overall Study|Disease progression|85|||
131852891|NCT00588770|474740224|FG001|Overall Study|Disease progression|68|||
131852892|NCT00588770|474740223|FG000|Overall Study|Adverse Event|29|||
131852893|NCT00588770|474740224|FG001|Overall Study|Adverse Event|58|||
131852894|NCT00588770|474740223|FG000|Overall Study|Death|13|||
131852895|NCT00588770|474740224|FG001|Overall Study|Death|22|||
131852896|NCT00588770|474740223|FG000|Overall Study|Withdrawal by Subject|15|||
131852897|NCT00588770|474740224|FG001|Overall Study|Withdrawal by Subject|25|||
131852898|NCT00588770|474740223|FG000|Overall Study|Alternative therapy|2|||
131852899|NCT00588770|474740224|FG001|Overall Study|Alternative therapy|4|||
131852900|NCT00588770|474740223|FG000|Overall Study|Other complicating disease|3|||
131852901|NCT00588770|474740224|FG001|Overall Study|Other complicating disease|2|||
131852902|NCT00588770|474740223|FG000|Overall Study|Not start protocol therapy|0|||
131852903|NCT00588770|474740224|FG001|Overall Study|Not start protocol therapy|9|||
131852904|NCT00588770|474740223|FG000|Overall Study|Lack of Efficacy|8|||
131852905|NCT00588770|474740224|FG001|Overall Study|Lack of Efficacy|10|||
131852906|NCT00588770|474740223|FG000|Overall Study|Physician discretion|2|||
131852907|NCT00588770|474740224|FG001|Overall Study|Physician discretion|0|||
131453097|NCT03682770|473288356|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
131453098|NCT03682770|473288357|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
131453099|NCT03682770|473288358|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
131453100|NCT03682770|473288352|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
131453101|NCT03682770|473288353|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
131453102|NCT03682770|473288354|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
131453103|NCT03682770|473288355|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
131453104|NCT03682770|473288356|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
131453105|NCT03682770|473288357|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
131453106|NCT03682770|473288358|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
131453107|NCT03682770|473288352|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
131453108|NCT03682770|473288353|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
131453109|NCT03682770|473288354|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
131453110|NCT03682770|473288355|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
131453111|NCT03682770|473288356|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
131453112|NCT03682770|473288357|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
131453113|NCT03682770|473288358|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
131453114|NCT03682770|473288352|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
131453115|NCT03682770|473288353|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
131453116|NCT03682770|473288354|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
131453117|NCT03682770|473288355|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
131453118|NCT03682770|473288356|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
131453119|NCT03682770|473288357|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
131453120|NCT03682770|473288358|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
131453121|NCT03682770|473288352|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
131453122|NCT03682770|473288353|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
131453123|NCT03682770|473288354|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
131453124|NCT03682770|473288355|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
131453125|NCT03682770|473288356|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
131453126|NCT03682770|473288357|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
131453127|NCT03682770|473288358|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
131453128|NCT03682770|473288352|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
131453129|NCT03682770|473288353|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
131453130|NCT03682770|473288354|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
131453131|NCT03682770|473288355|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
131453132|NCT03682770|473288356|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
131453133|NCT03682770|473288357|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
131453134|NCT03682770|473288358|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
131453135|NCT03682770|473288352|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
131453136|NCT03682770|473288353|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
131453137|NCT03682770|473288354|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
131453138|NCT03682770|473288355|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
131453139|NCT03682770|473288356|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
131453140|NCT03682770|473288357|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
131453141|NCT03682770|473288358|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
131453142|NCT03682770|473288352|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
131453143|NCT03682770|473288353|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
131453144|NCT03682770|473288354|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
131453145|NCT03682770|473288355|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
131453146|NCT03682770|473288356|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
131453147|NCT03682770|473288357|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
131453148|NCT03682770|473288358|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
131453149|NCT03599089|473288359|FG000|Overall Study|Lost to Follow-up|1|||
131453150|NCT03599089|473288360|FG001|Overall Study|Lost to Follow-up|0|||
131453151|NCT03599089|473288361|FG002|Overall Study|Lost to Follow-up|0|||
131453152|NCT03599089|473288362|FG003|Overall Study|Lost to Follow-up|0|||
131453153|NCT03599089|473288359|FG000|Overall Study|Withdrawal by Subject|2|||
131453154|NCT03599089|473288360|FG001|Overall Study|Withdrawal by Subject|1|||
131453155|NCT03599089|473288361|FG002|Overall Study|Withdrawal by Subject|0|||
131453156|NCT03599089|473288362|FG003|Overall Study|Withdrawal by Subject|0|||
131852908|NCT00588770|474740223|FG000|Overall Study|Patient non-compliance|2|||
131852909|NCT00588770|474740224|FG001|Overall Study|Patient non-compliance|2|||
131852910|NCT01856192|474740225|FG000|Overall Study|Adverse Event|12|||
131453157|NCT03599089|473288359|FG000|Overall Study|Lack of Efficacy|0|||
131453158|NCT03599089|473288360|FG001|Overall Study|Lack of Efficacy|0|||
131453159|NCT03599089|473288361|FG002|Overall Study|Lack of Efficacy|1|||
131404920|NCT01962987|473105393|FG002|Overall Study|Lost to Follow-up|1|||
131404921|NCT01962987|473105391|FG000|Overall Study|Non compliance with dosing requirements|4|||
131404922|NCT01962987|473105392|FG001|Overall Study|Non compliance with dosing requirements|2|||
131404923|NCT01962987|473105393|FG002|Overall Study|Non compliance with dosing requirements|0|||
131404924|NCT01962987|473105391|FG000|Overall Study|Miscellaneous|1|||
131404925|NCT01962987|473105392|FG001|Overall Study|Miscellaneous|9|||
131404926|NCT01962987|473105393|FG002|Overall Study|Miscellaneous|2|||
131404927|NCT01962987|473105391|FG000|Overall Study|Restricted medication|5|||
131404928|NCT01962987|473105392|FG001|Overall Study|Restricted medication|1|||
131404929|NCT01962987|473105393|FG002|Overall Study|Restricted medication|1|||
131404930|NCT01962987|473105391|FG000|Overall Study|Serious Adverse Event|1|||
131404931|NCT01962987|473105392|FG001|Overall Study|Serious Adverse Event|0|||
131404932|NCT01962987|473105393|FG002|Overall Study|Serious Adverse Event|0|||
131404933|NCT01962987|473105391|FG000|Overall Study|Withdrawal by Subject|11|||
131404934|NCT01962987|473105392|FG001|Overall Study|Withdrawal by Subject|10|||
131404935|NCT01962987|473105393|FG002|Overall Study|Withdrawal by Subject|6|||
131404936|NCT01962987|473105391|FG000|Overall Study|Randomized in Error|4|||
131404937|NCT01962987|473105392|FG001|Overall Study|Randomized in Error|2|||
131404938|NCT01962987|473105393|FG002|Overall Study|Randomized in Error|2|||
131404939|NCT01967823|473105394|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
131404940|NCT03002818|473105395|FG000|Overall Study|Decision of the investigator|1|||
131404941|NCT00711113|473105402|FG000|Overall Study|Lost to Follow-up|9|||
131404942|NCT00711113|473105402|FG000|Overall Study|Implant lost|2|||
131404943|NCT01606787|473105409|FG000|Overall Study|Withdrawal by Subject|4|||
131404944|NCT01606787|473105410|FG001|Overall Study|Withdrawal by Subject|5|||
131404945|NCT01606787|473105409|FG000|Overall Study|Surgery canceled|0|||
131404946|NCT01606787|473105410|FG001|Overall Study|Surgery canceled|2|||
131852911|NCT01856192|474740226|FG001|Overall Study|Adverse Event|4|||
131852912|NCT01856192|474740225|FG000|Overall Study|Alternative therapy|0|||
131852913|NCT01856192|474740226|FG001|Overall Study|Alternative therapy|3|||
131852914|NCT01856192|474740225|FG000|Overall Study|Death|3|||
131852915|NCT01856192|474740226|FG001|Overall Study|Death|5|||
131852916|NCT01856192|474740225|FG000|Overall Study|Lack of Efficacy|0|||
131852917|NCT01856192|474740226|FG001|Overall Study|Lack of Efficacy|5|||
131852918|NCT01856192|474740225|FG000|Overall Study|Withdrawal by Subject|1|||
131852919|NCT01856192|474740226|FG001|Overall Study|Withdrawal by Subject|1|||
131852920|NCT01856192|474740225|FG000|Overall Study|Other diseases|1|||
131852921|NCT01856192|474740226|FG001|Overall Study|Other diseases|0|||
131852922|NCT01856192|474740225|FG000|Overall Study|Never started treatment|7|||
131852923|NCT01856192|474740226|FG001|Overall Study|Never started treatment|5|||
131852924|NCT01856192|474740225|FG000|Overall Study|Path ineligible|20|||
131852925|NCT01856192|474740226|FG001|Overall Study|Path ineligible|34|||
131852926|NCT01856192|474740225|FG000|Overall Study|Non-path ineligible|2|||
131852927|NCT01856192|474740226|FG001|Overall Study|Non-path ineligible|2|||
131852928|NCT01856192|474740225|FG000|Overall Study|Physician Decision|1|||
131852929|NCT01856192|474740226|FG001|Overall Study|Physician Decision|1|||
131852930|NCT01856192|474740225|FG000|Overall Study|Suspicion of progressive disease|1|||
131852931|NCT01856192|474740226|FG001|Overall Study|Suspicion of progressive disease|0|||
131852932|NCT01856192|474740225|FG000|Overall Study|Non-compliance|1|||
131852933|NCT01856192|474740226|FG001|Overall Study|Non-compliance|0|||
131852934|NCT02642042|474740227|FG000|Overall Study|Adverse Event|22|||
131852935|NCT02642042|474740227|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131852936|NCT02642042|474740227|FG000|Overall Study|Progression/Relapse|28|||
131852937|NCT02642042|474740227|FG000|Overall Study|Death|1|||
131852938|NCT02642042|474740227|FG000|Overall Study|Not Protocol Specified|2|||
131852939|NCT02129608|474740228|FG000|Overall Study|Lost to Follow-up|0|||
131852940|NCT02129608|474740229|FG001|Overall Study|Lost to Follow-up|1|||
131852941|NCT02129608|474740230|FG002|Overall Study|Lost to Follow-up|1|||
131852942|NCT02129608|474740228|FG000|Overall Study|Withdrawal by Subject|0|||
131852943|NCT02129608|474740229|FG001|Overall Study|Withdrawal by Subject|0|||
131852944|NCT02129608|474740230|FG002|Overall Study|Withdrawal by Subject|2|||
131852945|NCT00451204|474740231|FG000|Overall Study|Adverse Event|4|||
131852946|NCT00451204|474740232|FG001|Overall Study|Adverse Event|6|||
131852947|NCT00451204|474740231|FG000|Overall Study|Lack of Efficacy|4|||
131852948|NCT00451204|474740232|FG001|Overall Study|Lack of Efficacy|4|||
131852949|NCT00451204|474740231|FG000|Overall Study|Lost to Follow-up|4|||
131852950|NCT00451204|474740232|FG001|Overall Study|Lost to Follow-up|4|||
131852951|NCT00451204|474740231|FG000|Overall Study|Protocol Violation|1|||
131852952|NCT00451204|474740232|FG001|Overall Study|Protocol Violation|0|||
131852953|NCT00451204|474740231|FG000|Overall Study|Patient refusal|8|||
131852954|NCT00451204|474740232|FG001|Overall Study|Patient refusal|4|||
131852955|NCT00451204|474740231|FG000|Overall Study|Other|1|||
131852956|NCT00451204|474740232|FG001|Overall Study|Other|2|||
131852957|NCT03055624|474740233|FG000|Overall Study|Study closed|9|||
131852958|NCT01582152|474740234|FG000|Overall Study|Disease Progression|4|||
131852959|NCT01582152|474740235|FG001|Overall Study|Disease Progression|5|||
131852960|NCT01582152|474740234|FG000|Overall Study|Adverse Event|2|||
131852961|NCT01582152|474740235|FG001|Overall Study|Adverse Event|1|||
131852962|NCT00794339|474740241|FG000|Overall Study|Withdrawal by Subject|3|||
131852963|NCT00794339|474740241|FG000|Overall Study|Ineligible|4|||
131852964|NCT00794339|474740241|FG000|Overall Study|Tx prior to ATSM|3|||
131852965|NCT00794339|474740241|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
131852966|NCT00794339|474740241|FG000|Overall Study|Tx not per protocol|1|||
131852967|NCT01611857|474740242|FG000|Overall Study|Withdrawal by Subject|0|||
131852968|NCT01611857|474740243|FG001|Overall Study|Withdrawal by Subject|2|||
131852969|NCT04414618|474740258|FG000|Overall Study|Death|3|||
131852970|NCT04414618|474740259|FG001|Overall Study|Death|3|||
131852971|NCT04414618|474740258|FG000|Overall Study|Withdrawal by Subject|2|||
131852972|NCT04414618|474740259|FG001|Overall Study|Withdrawal by Subject|1|||
131852973|NCT04414618|474740258|FG000|Overall Study|Lost to Follow-up|2|||
131852974|NCT04414618|474740259|FG001|Overall Study|Lost to Follow-up|3|||
131852975|NCT04414618|474740258|FG000|Overall Study|Physician Decision|1|||
131852976|NCT04414618|474740259|FG001|Overall Study|Physician Decision|0|||
131852977|NCT00362336|474740260|FG000|Overall Study|Serious Adverse Event|1|||
131852978|NCT00362336|474740261|FG001|Overall Study|Serious Adverse Event|0|||
131852979|NCT00362336|474740262|FG002|Overall Study|Serious Adverse Event|1|||
131852980|NCT00362336|474740260|FG000|Overall Study|Protocol Violation|0|||
131852981|NCT00362336|474740261|FG001|Overall Study|Protocol Violation|0|||
131852982|NCT00362336|474740262|FG002|Overall Study|Protocol Violation|1|||
131852983|NCT00362336|474740260|FG000|Overall Study|Lost to Follow-up|6|||
131852984|NCT00362336|474740261|FG001|Overall Study|Lost to Follow-up|4|||
131852985|NCT00362336|474740262|FG002|Overall Study|Lost to Follow-up|0|||
131852986|NCT00362336|474740260|FG000|Overall Study|Withdrawal by Subject|3|||
131852987|NCT00362336|474740261|FG001|Overall Study|Withdrawal by Subject|3|||
131852988|NCT00362336|474740262|FG002|Overall Study|Withdrawal by Subject|1|||
131852989|NCT00658879|474740263|FG000|Overall Study|Protocol Violation|1|||
131852990|NCT01121562|474740264|FG000|Overall Study|Objective progression or relapse|8|||
131852991|NCT01121562|474740264|FG000|Overall Study|Withdrawal by Subject|1|||
131852992|NCT01121562|474740264|FG000|Overall Study|Adverse Event|1|||
131852993|NCT01121562|474740264|FG000|Overall Study|Sponsor Decision|1|||
131852994|NCT01121562|474740264|FG000|Overall Study|Met study discontinuation criteria|1|||
131852995|NCT00616421|474740265|FG000|Overall Study|Withdrawal by Subject|9|||
131852996|NCT00616421|474740266|FG001|Overall Study|Withdrawal by Subject|11|||
131852997|NCT00616421|474740267|FG002|Overall Study|Withdrawal by Subject|8|||
131852998|NCT00616421|474740265|FG000|Overall Study|Lost to Follow-up|12|||
131852999|NCT00616421|474740266|FG001|Overall Study|Lost to Follow-up|26|||
131853000|NCT00616421|474740267|FG002|Overall Study|Lost to Follow-up|30|||
131853001|NCT00616421|474740265|FG000|Overall Study|Inappropriate enrollment|3|||
131853002|NCT00616421|474740266|FG001|Overall Study|Inappropriate enrollment|0|||
131853003|NCT00616421|474740267|FG002|Overall Study|Inappropriate enrollment|1|||
131853004|NCT00616421|474740265|FG000|Overall Study|Administrative reason|1|||
131853005|NCT00616421|474740266|FG001|Overall Study|Administrative reason|0|||
131853006|NCT00616421|474740267|FG002|Overall Study|Administrative reason|0|||
131853007|NCT00616421|474740265|FG000|Overall Study|Protocol Violation|0|||
131853008|NCT00616421|474740266|FG001|Overall Study|Protocol Violation|1|||
131853009|NCT00616421|474740267|FG002|Overall Study|Protocol Violation|2|||
131853010|NCT00616421|474740265|FG000|Overall Study|Unable to classify|1|||
131853011|NCT00616421|474740266|FG001|Overall Study|Unable to classify|0|||
131853012|NCT00616421|474740267|FG002|Overall Study|Unable to classify|0|||
131853013|NCT02661217|474740268|FG000|Overall Study|Physician Decision|12|||
131853014|NCT02661217|474740269|FG001|Overall Study|Physician Decision|15|||
131853015|NCT02661217|474740268|FG000|Overall Study|Lost to Follow-up|1|||
131853016|NCT02661217|474740269|FG001|Overall Study|Lost to Follow-up|4|||
131853017|NCT02661217|474740268|FG000|Overall Study|Protocol Deviation|0|||
131853018|NCT02661217|474740269|FG001|Overall Study|Protocol Deviation|4|||
131853019|NCT02661217|474740268|FG000|Overall Study|Non-compliance with study treatment|5|||
131853020|NCT02661217|474740269|FG001|Overall Study|Non-compliance with study treatment|5|||
131853021|NCT02661217|474740268|FG000|Overall Study|Death|21|||
131853022|NCT02661217|474740269|FG001|Overall Study|Death|15|||
131853023|NCT02661217|474740268|FG000|Overall Study|Adverse Event|10|||
131853024|NCT02661217|474740269|FG001|Overall Study|Adverse Event|8|||
131853025|NCT02661217|474740268|FG000|Overall Study|Withdrawal by Subject|15|||
131853026|NCT02661217|474740269|FG001|Overall Study|Withdrawal by Subject|19|||
131404947|NCT05289271|473105413|FG000|Overall Study|Mistakenly allocated, untreated|1|||
131853027|NCT02661217|474740268|FG000|Overall Study|Did not enter follow-up epoch|7|||
131853028|NCT02661217|474740269|FG001|Overall Study|Did not enter follow-up epoch|10|||
131853029|NCT02661217|474740268|FG000|Overall Study|Death - no study drug received|1|||
131853030|NCT02661217|474740269|FG001|Overall Study|Death - no study drug received|2|||
131853031|NCT02661217|474740268|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
131853032|NCT02661217|474740269|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
131404948|NCT05289271|473105414|FG001|Overall Study|Mistakenly allocated, untreated|0|||
131853033|NCT02075515|474740270|FG000|Overall Study|Serious Adverse Event|1|||
131853034|NCT02075515|474740271|FG001|Overall Study|Serious Adverse Event|1|||
131853035|NCT02075515|474740272|FG002|Overall Study|Serious Adverse Event|1|||
131404949|NCT01257568|473105416|FG000|Overall Study|Lost to Follow-up|2|||
131853036|NCT02075515|474740270|FG000|Overall Study|Non-Serious Adverse Event|0|||
131853037|NCT02075515|474740271|FG001|Overall Study|Non-Serious Adverse Event|1|||
131853038|NCT02075515|474740272|FG002|Overall Study|Non-Serious Adverse Event|0|||
131853039|NCT02075515|474740270|FG000|Overall Study|Withdrawal by Subject|2|||
131853040|NCT02075515|474740271|FG001|Overall Study|Withdrawal by Subject|0|||
131853041|NCT02075515|474740272|FG002|Overall Study|Withdrawal by Subject|1|||
131853042|NCT02075515|474740270|FG000|Overall Study|Lost to Follow-up|1|||
131853043|NCT02075515|474740271|FG001|Overall Study|Lost to Follow-up|3|||
131853044|NCT02075515|474740272|FG002|Overall Study|Lost to Follow-up|6|||
131853045|NCT00378573|474740275|FG000|Treatment Period|Adverse Event|9|||
131853046|NCT00378573|474740275|FG000|Treatment Period|Physician Decision|1|||
131853047|NCT00378573|474740275|FG000|Treatment Period|Withdrawal by Subject|2|||
131853048|NCT00378573|474740275|FG000|Treatment Period|Disease Progression|4|||
131853049|NCT00378573|474740275|FG000|Treatment Period|Sponsor decision to close study|1|||
131853050|NCT00378573|474740275|FG000|Follow-up|Death|12|||
131853051|NCT00378573|474740275|FG000|Follow-up|Lost to Follow-up|1|||
131853052|NCT00378573|474740275|FG000|Follow-up|Withdrawal by Subject|1|||
131853053|NCT03593395|474740276|FG000|Overall Study|Lost to Follow-up|48|||
131853054|NCT03593395|474740277|FG001|Overall Study|Lost to Follow-up|3|||
131853055|NCT03593395|474740276|FG000|Overall Study|Withdrawal by Subject|5|||
131853056|NCT03593395|474740277|FG001|Overall Study|Withdrawal by Subject|24|||
131853057|NCT03593395|474740276|FG000|Overall Study|Death|2|||
131853058|NCT03593395|474740277|FG001|Overall Study|Death|3|||
131853059|NCT03593395|474740276|FG000|Overall Study|Physician Decision|0|||
131853060|NCT03593395|474740277|FG001|Overall Study|Physician Decision|6|||
131853061|NCT03593395|474740276|FG000|Overall Study|Participant Relocated|19|||
131853062|NCT03593395|474740277|FG001|Overall Study|Participant Relocated|3|||
131853063|NCT03593395|474740276|FG000|Overall Study|No Information|1|||
131853064|NCT03593395|474740277|FG001|Overall Study|No Information|7|||
131853065|NCT01524978|474740278|FG000|Overall Study|Other|16|||
131853066|NCT01524978|474740279|FG001|Overall Study|Other|2|||
131853067|NCT01524978|474740280|FG002|Overall Study|Other|1|||
131853068|NCT01524978|474740281|FG003|Overall Study|Other|2|||
131853069|NCT01524978|474740282|FG004|Overall Study|Other|1|||
131853070|NCT01524978|474740283|FG005|Overall Study|Other|3|||
131853071|NCT01524978|474740284|FG006|Overall Study|Other|17|||
131853072|NCT01524978|474740285|FG007|Overall Study|Other|1|||
131853073|NCT01524978|474740286|FG008|Overall Study|Other|2|||
131853074|NCT01524978|474740287|FG009|Overall Study|Other|2|||
131853075|NCT01524978|474740288|FG010|Overall Study|Other|5|||
131853076|NCT01524978|474740278|FG000|Overall Study|Withdrawal by Subject|12|||
131853077|NCT01524978|474740279|FG001|Overall Study|Withdrawal by Subject|0|||
131853078|NCT01524978|474740280|FG002|Overall Study|Withdrawal by Subject|1|||
131853079|NCT01524978|474740281|FG003|Overall Study|Withdrawal by Subject|1|||
131853080|NCT01524978|474740282|FG004|Overall Study|Withdrawal by Subject|3|||
131853081|NCT01524978|474740283|FG005|Overall Study|Withdrawal by Subject|1|||
131853082|NCT01524978|474740284|FG006|Overall Study|Withdrawal by Subject|6|||
131853083|NCT01524978|474740285|FG007|Overall Study|Withdrawal by Subject|2|||
131853084|NCT01524978|474740286|FG008|Overall Study|Withdrawal by Subject|4|||
131853085|NCT01524978|474740287|FG009|Overall Study|Withdrawal by Subject|0|||
131853086|NCT01524978|474740288|FG010|Overall Study|Withdrawal by Subject|5|||
131853087|NCT01524978|474740278|FG000|Overall Study|Lost to Follow-up|0|||
131853088|NCT01524978|474740279|FG001|Overall Study|Lost to Follow-up|0|||
131853089|NCT01524978|474740280|FG002|Overall Study|Lost to Follow-up|3|||
131853090|NCT01524978|474740281|FG003|Overall Study|Lost to Follow-up|0|||
131853091|NCT01524978|474740282|FG004|Overall Study|Lost to Follow-up|1|||
131853092|NCT01524978|474740283|FG005|Overall Study|Lost to Follow-up|1|||
131853093|NCT01524978|474740284|FG006|Overall Study|Lost to Follow-up|2|||
131853094|NCT01524978|474740285|FG007|Overall Study|Lost to Follow-up|0|||
131853095|NCT01524978|474740286|FG008|Overall Study|Lost to Follow-up|1|||
131853096|NCT01524978|474740287|FG009|Overall Study|Lost to Follow-up|1|||
131853097|NCT01524978|474740288|FG010|Overall Study|Lost to Follow-up|1|||
131853098|NCT01524978|474740278|FG000|Overall Study|Death|34|||
131853099|NCT01524978|474740279|FG001|Overall Study|Death|2|||
131853100|NCT01524978|474740280|FG002|Overall Study|Death|5|||
131853101|NCT01524978|474740281|FG003|Overall Study|Death|24|||
131853102|NCT01524978|474740282|FG004|Overall Study|Death|4|||
131853103|NCT01524978|474740283|FG005|Overall Study|Death|4|||
131853104|NCT01524978|474740284|FG006|Overall Study|Death|1|||
131853105|NCT01524978|474740285|FG007|Overall Study|Death|9|||
131853106|NCT01524978|474740286|FG008|Overall Study|Death|5|||
131853107|NCT01524978|474740287|FG009|Overall Study|Death|6|||
131853108|NCT01524978|474740288|FG010|Overall Study|Death|17|||
131853109|NCT01372748|474740289|FG000|Overall Study|Lost to Follow-up|16|||
131853110|NCT01372748|474740290|FG001|Overall Study|Lost to Follow-up|34|||
131853111|NCT01372748|474740289|FG000|Overall Study|Withdrawal by Subject|7|||
131853112|NCT01372748|474740290|FG001|Overall Study|Withdrawal by Subject|5|||
131853113|NCT00134901|474740291|FG000|Overall Study|Lost to Follow-up|5|||
131853114|NCT00134901|474740292|FG001|Overall Study|Lost to Follow-up|5|||
131853115|NCT00134901|474740291|FG000|Overall Study|discontinued intervention|12|||
131853116|NCT00134901|474740292|FG001|Overall Study|discontinued intervention|10|||
131404950|NCT01257568|473105416|FG000|Overall Study|Withdrawal by Subject|6|||
131404951|NCT01257568|473105416|FG000|Overall Study|Terminated|1|||
131404952|NCT01257568|473105416|FG000|Overall Study|Component Revision|24|||
131404953|NCT03392883|473105417|FG000|Overall Study|Lost to Follow-up|122|||
131404954|NCT03392883|473105418|FG001|Overall Study|Lost to Follow-up|13|||
131404955|NCT03392883|473105419|FG002|Overall Study|Lost to Follow-up|9|||
131404956|NCT03392883|473105417|FG000|Overall Study|Death|4|||
131404957|NCT03392883|473105418|FG001|Overall Study|Death|0|||
131404958|NCT03392883|473105419|FG002|Overall Study|Death|0|||
131404959|NCT03392883|473105417|FG000|Overall Study|Lack of Efficacy|29|||
131404960|NCT03392883|473105418|FG001|Overall Study|Lack of Efficacy|0|||
131404961|NCT03392883|473105419|FG002|Overall Study|Lack of Efficacy|0|||
131404962|NCT03392883|473105417|FG000|Overall Study|Withdrawal by Subject|180|||
131404963|NCT03392883|473105418|FG001|Overall Study|Withdrawal by Subject|0|||
131404964|NCT03392883|473105419|FG002|Overall Study|Withdrawal by Subject|0|||
131404965|NCT03392883|473105417|FG000|Overall Study|Adverse Event|1|||
131404966|NCT03392883|473105418|FG001|Overall Study|Adverse Event|0|||
131404967|NCT03392883|473105419|FG002|Overall Study|Adverse Event|0|||
131404968|NCT00132691|473105429|FG000|Overall Study|Lost to Follow-up|5|||
131404969|NCT00132691|473105430|FG001|Overall Study|Lost to Follow-up|8|||
131404970|NCT00132691|473105429|FG000|Overall Study|Missed 2-year visit|4|||
131404971|NCT00132691|473105430|FG001|Overall Study|Missed 2-year visit|4|||
131404972|NCT00132691|473105429|FG000|Overall Study|Death|2|||
131404973|NCT00132691|473105430|FG001|Overall Study|Death|0|||
131404974|NCT01739933|473105431|FG000|Overall Study|Death|89|||
131404975|NCT01739933|473105432|FG001|Overall Study|Death|86|||
131404976|NCT01739933|473105431|FG000|Overall Study|Withdrawal by Subject|10|||
131404977|NCT01739933|473105432|FG001|Overall Study|Withdrawal by Subject|8|||
131404978|NCT01739933|473105431|FG000|Overall Study|Lost to Follow-up|3|||
131404979|NCT01739933|473105432|FG001|Overall Study|Lost to Follow-up|10|||
131404980|NCT01739933|473105431|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
131404981|NCT01739933|473105432|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
131404982|NCT04098367|473105433|FG000|Overall Study|Adverse Event|0|||
131404983|NCT04098367|473105434|FG001|Overall Study|Adverse Event|0|||
131404984|NCT04098367|473105435|FG002|Overall Study|Adverse Event|1|||
131404985|NCT04098367|473105433|FG000|Overall Study|Lost to Follow-up|1|||
131404986|NCT04098367|473105434|FG001|Overall Study|Lost to Follow-up|5|||
131404987|NCT04098367|473105435|FG002|Overall Study|Lost to Follow-up|2|||
131404988|NCT04098367|473105433|FG000|Overall Study|Withdrawal by Subject|0|||
131404989|NCT04098367|473105434|FG001|Overall Study|Withdrawal by Subject|0|||
131404990|NCT04098367|473105435|FG002|Overall Study|Withdrawal by Subject|1|||
131404991|NCT04098367|473105433|FG000|Overall Study|Sick . Could not attend visit|1|||
131404992|NCT04098367|473105434|FG001|Overall Study|Sick . Could not attend visit|0|||
131404993|NCT04098367|473105435|FG002|Overall Study|Sick . Could not attend visit|0|||
131404994|NCT01231321|473105441|FG000|Overall Study|Adverse Event|3|||
131912285|NCT01799889|474966533|FG009|Overall Study|Study Terminated By Sponsor|1|||
131912286|NCT01799889|474966534|FG010|Overall Study|Study Terminated By Sponsor|0|||
131912287|NCT01799889|474966535|FG011|Overall Study|Study Terminated By Sponsor|0|||
131912288|NCT01799889|474966524|FG000|Overall Study|Withdrawal by Subject|1|||
131912289|NCT01799889|474966525|FG001|Overall Study|Withdrawal by Subject|6|||
131912290|NCT01799889|474966526|FG002|Overall Study|Withdrawal by Subject|4|||
131912291|NCT01799889|474966527|FG003|Overall Study|Withdrawal by Subject|0|||
131912292|NCT01799889|474966528|FG004|Overall Study|Withdrawal by Subject|5|||
131912293|NCT01799889|474966529|FG005|Overall Study|Withdrawal by Subject|1|||
131912294|NCT01799889|474966530|FG006|Overall Study|Withdrawal by Subject|3|||
131912295|NCT01799889|474966531|FG007|Overall Study|Withdrawal by Subject|1|||
131912296|NCT01799889|474966532|FG008|Overall Study|Withdrawal by Subject|2|||
131912297|NCT01799889|474966533|FG009|Overall Study|Withdrawal by Subject|1|||
131912298|NCT01799889|474966534|FG010|Overall Study|Withdrawal by Subject|1|||
131912299|NCT01799889|474966535|FG011|Overall Study|Withdrawal by Subject|1|||
131912300|NCT01799889|474966524|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131912301|NCT01799889|474966525|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131912302|NCT01799889|474966526|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131912303|NCT01799889|474966527|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131912304|NCT01799889|474966528|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131912305|NCT01799889|474966529|FG005|Overall Study|Non-Compliance With Study Drug|1|||
131912306|NCT01799889|474966530|FG006|Overall Study|Non-Compliance With Study Drug|0|||
131912307|NCT01799889|474966531|FG007|Overall Study|Non-Compliance With Study Drug|0|||
131912308|NCT01799889|474966532|FG008|Overall Study|Non-Compliance With Study Drug|0|||
131912309|NCT01799889|474966533|FG009|Overall Study|Non-Compliance With Study Drug|0|||
131912310|NCT01799889|474966534|FG010|Overall Study|Non-Compliance With Study Drug|0|||
131912311|NCT01799889|474966535|FG011|Overall Study|Non-Compliance With Study Drug|0|||
131912312|NCT03944616|474966537|FG000|Overall Study|Lost to Follow-up|0|||
131404995|NCT01231321|473105441|FG000|Overall Study|Lack of Efficacy|2|||
131404996|NCT00908115|473105442|FG000|Overall Study|Other|14|||
131404997|NCT01728077|473105443|FG000|Overall Study|Lack of Efficacy|3|||
131404998|NCT01728077|473105444|FG001|Overall Study|Lack of Efficacy|1|||
131853117|NCT00185588|474740293|FG000|Overall Study|Adverse Event|3|||
131853118|NCT00185588|474740294|FG001|Overall Study|Adverse Event|1|||
131853119|NCT00185588|474740295|FG002|Overall Study|Adverse Event|4|||
131853120|NCT00185588|474740296|FG003|Overall Study|Adverse Event|2|||
131853121|NCT00185588|474740293|FG000|Overall Study|Lost to Follow-up|0|||
131853122|NCT00185588|474740294|FG001|Overall Study|Lost to Follow-up|0|||
131853123|NCT00185588|474740295|FG002|Overall Study|Lost to Follow-up|1|||
131853124|NCT00185588|474740296|FG003|Overall Study|Lost to Follow-up|2|||
131853125|NCT00185588|474740293|FG000|Overall Study|Withdrawal by Subject|0|||
131853126|NCT00185588|474740294|FG001|Overall Study|Withdrawal by Subject|1|||
131853127|NCT00185588|474740295|FG002|Overall Study|Withdrawal by Subject|0|||
131853128|NCT00185588|474740296|FG003|Overall Study|Withdrawal by Subject|0|||
131853129|NCT00185588|474740293|FG000|Overall Study|Physician Decision|0|||
131853130|NCT00185588|474740294|FG001|Overall Study|Physician Decision|0|||
131853131|NCT00185588|474740295|FG002|Overall Study|Physician Decision|1|||
131853132|NCT00185588|474740296|FG003|Overall Study|Physician Decision|0|||
131853133|NCT04238650|474740297|FG000|Overall Study|Withdrawal by Subject|0|||
131853134|NCT04238650|474740298|FG001|Overall Study|Withdrawal by Subject|1|||
131853135|NCT04289363|474740299|FG000|Overall Study|Lost to Follow-up|14|||
131853136|NCT04289363|474740300|FG001|Overall Study|Lost to Follow-up|0|||
131853137|NCT02287922|474740301|FG000|Overall Study|Adverse Event|1|||
131853138|NCT02287922|474740302|FG001|Overall Study|Adverse Event|1|||
131853139|NCT02287922|474740303|FG002|Overall Study|Adverse Event|3|||
131853140|NCT02287922|474740304|FG003|Overall Study|Adverse Event|4|||
131853141|NCT02287922|474740301|FG000|Overall Study|Withdrawal by Subject|1|||
131853142|NCT02287922|474740302|FG001|Overall Study|Withdrawal by Subject|1|||
131853143|NCT02287922|474740303|FG002|Overall Study|Withdrawal by Subject|1|||
131853144|NCT02287922|474740304|FG003|Overall Study|Withdrawal by Subject|2|||
131853145|NCT02287922|474740301|FG000|Overall Study|Lost to Follow-up|0|||
131853146|NCT02287922|474740302|FG001|Overall Study|Lost to Follow-up|0|||
131853147|NCT02287922|474740303|FG002|Overall Study|Lost to Follow-up|1|||
131853148|NCT02287922|474740304|FG003|Overall Study|Lost to Follow-up|0|||
131853149|NCT02287922|474740301|FG000|Overall Study|Sponsor's decision|0|||
131853150|NCT02287922|474740302|FG001|Overall Study|Sponsor's decision|0|||
131853151|NCT02287922|474740303|FG002|Overall Study|Sponsor's decision|0|||
131853152|NCT02287922|474740304|FG003|Overall Study|Sponsor's decision|1|||
131853153|NCT02287922|474740301|FG000|Overall Study|Other|1|||
131853154|NCT02287922|474740302|FG001|Overall Study|Other|0|||
131853155|NCT02287922|474740303|FG002|Overall Study|Other|2|||
131853156|NCT02287922|474740304|FG003|Overall Study|Other|0|||
131853157|NCT04152291|474740305|FG000|Overall Study|Covid-19 restrictions|27|||
131853158|NCT04152291|474740305|FG000|Overall Study|Withdrawal by Subject|3|||
131853159|NCT01755091|474740306|FG000|Overall Study|Withdrawal by Subject|6|||
131853160|NCT01755091|474740307|FG001|Overall Study|Withdrawal by Subject|1|||
131853161|NCT01755091|474740308|FG002|Overall Study|Withdrawal by Subject|3|||
131853162|NCT01755091|474740306|FG000|Overall Study|Adverse Event|1|||
131853163|NCT01755091|474740307|FG001|Overall Study|Adverse Event|1|||
131853164|NCT01755091|474740308|FG002|Overall Study|Adverse Event|1|||
131853165|NCT01755091|474740306|FG000|Overall Study|Lost to Follow-up|1|||
131853166|NCT01755091|474740307|FG001|Overall Study|Lost to Follow-up|0|||
131853167|NCT01755091|474740308|FG002|Overall Study|Lost to Follow-up|1|||
131853168|NCT01755091|474740306|FG000|Overall Study|Physician Decision|1|||
131853169|NCT01755091|474740307|FG001|Overall Study|Physician Decision|1|||
131853170|NCT01755091|474740308|FG002|Overall Study|Physician Decision|2|||
131853171|NCT06385483|474740309|FG000|Overall Study|Withdrawal by Subject|2|||
131853172|NCT06385483|474740309|FG000|Overall Study|Never start protocol therapy|2|||
131853173|NCT06385483|474740309|FG000|Overall Study|Disease progression|15|||
131853174|NCT04739800|474740310|FG000|Overall Study|Adverse Event|2|||
131853175|NCT04739800|474740311|FG001|Overall Study|Adverse Event|1|||
131853176|NCT04739800|474740312|FG002|Overall Study|Adverse Event|4|||
131853177|NCT04739800|474740313|FG003|Overall Study|Adverse Event|5|||
131853178|NCT04739800|474740310|FG000|Overall Study|Never Treated|2|||
131853179|NCT04739800|474740311|FG001|Overall Study|Never Treated|0|||
131853180|NCT04739800|474740312|FG002|Overall Study|Never Treated|1|||
131853181|NCT04739800|474740313|FG003|Overall Study|Never Treated|1|||
131853182|NCT04739800|474740310|FG000|Overall Study|On Treatment|5|||
131853183|NCT04739800|474740311|FG001|Overall Study|On Treatment|9|||
131853184|NCT04739800|474740312|FG002|Overall Study|On Treatment|9|||
131853185|NCT04739800|474740313|FG003|Overall Study|On Treatment|9|||
131853186|NCT04739800|474740310|FG000|Overall Study|Symptomatic Deterioration|1|||
131853187|NCT04739800|474740311|FG001|Overall Study|Symptomatic Deterioration|1|||
131853188|NCT04739800|474740312|FG002|Overall Study|Symptomatic Deterioration|3|||
131853189|NCT04739800|474740313|FG003|Overall Study|Symptomatic Deterioration|0|||
131853190|NCT04739800|474740310|FG000|Overall Study|Withdrawal by Subject|1|||
131853191|NCT04739800|474740311|FG001|Overall Study|Withdrawal by Subject|2|||
131853192|NCT04739800|474740312|FG002|Overall Study|Withdrawal by Subject|1|||
131853193|NCT04739800|474740313|FG003|Overall Study|Withdrawal by Subject|3|||
131853194|NCT04739800|474740310|FG000|Overall Study|Other Reason|1|||
131853195|NCT04739800|474740311|FG001|Overall Study|Other Reason|3|||
131453160|NCT03599089|473288362|FG003|Overall Study|Lack of Efficacy|2|||
131453161|NCT03214666|473288363|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
131453162|NCT03214666|473288364|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
131453163|NCT03214666|473288365|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
131453164|NCT03214666|473288366|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
131453165|NCT03214666|473288367|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
131453166|NCT03214666|473288368|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
131453167|NCT00526071|473288369|FG000|Overall Study|Adverse Event|1|||
131453168|NCT00526071|473288369|FG000|Overall Study|Withdrawal by Subject|1|||
131453169|NCT00526071|473288369|FG000|Overall Study|Lack of Response to Study Drug|4|||
131453170|NCT01415882|473288374|FG000|Overall Study|Ineligible|1|||
131453171|NCT01415882|473288375|FG001|Overall Study|Ineligible|0|||
131453172|NCT01415882|473288376|FG002|Overall Study|Ineligible|0|||
131453173|NCT01415882|473288377|FG003|Overall Study|Ineligible|3|||
131453174|NCT01415882|473288378|FG004|Overall Study|Ineligible|0|||
131453175|NCT01415882|473288374|FG000|Overall Study|Withdrawal by Subject|0|||
131453176|NCT01415882|473288375|FG001|Overall Study|Withdrawal by Subject|1|||
131453177|NCT01415882|473288376|FG002|Overall Study|Withdrawal by Subject|0|||
131453178|NCT01415882|473288377|FG003|Overall Study|Withdrawal by Subject|1|||
131453179|NCT01415882|473288378|FG004|Overall Study|Withdrawal by Subject|0|||
131453180|NCT03339219|473288382|FG000|Overall Study|Death|12|||
131453181|NCT03339219|473288382|FG000|Overall Study|Site Terminated by Sponsor|22|||
131453182|NCT03339219|473288382|FG000|Overall Study|Withdrawal by Subject|1|||
131453183|NCT01932437|473288384|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
131453184|NCT01932437|473288385|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
131453185|NCT01932437|473288386|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
131453186|NCT01932437|473288387|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
131453187|NCT01932437|473288388|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
131453188|NCT01932437|473288389|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
131453189|NCT00074490|473288390|FG000|Overall Study|Progressive malignancy|0|||
131453190|NCT00074490|473288391|FG001|Overall Study|Progressive malignancy|7|||
131453191|NCT00074490|473288392|FG002|Overall Study|Progressive malignancy|0|||
131453192|NCT00074490|473288393|FG003|Overall Study|Progressive malignancy|0|||
131453193|NCT00074490|473288394|FG004|Overall Study|Progressive malignancy|3|||
131453194|NCT00074490|473288395|FG005|Overall Study|Progressive malignancy|0|||
131453195|NCT01354314|473288398|FG000|Overall Study|Lost to Follow-up|1|||
131453196|NCT01354314|473288399|FG001|Overall Study|Lost to Follow-up|0|||
131453197|NCT01354314|473288400|FG002|Overall Study|Lost to Follow-up|1|||
131453198|NCT01354314|473288401|FG003|Overall Study|Lost to Follow-up|1|||
131453199|NCT01354314|473288398|FG000|Overall Study|Withdrawal by Subject|0|||
131453200|NCT01354314|473288399|FG001|Overall Study|Withdrawal by Subject|0|||
131453201|NCT01354314|473288400|FG002|Overall Study|Withdrawal by Subject|1|||
131453202|NCT01354314|473288401|FG003|Overall Study|Withdrawal by Subject|0|||
131453203|NCT01354314|473288398|FG000|Overall Study|Adverse Event|0|||
131453204|NCT01354314|473288399|FG001|Overall Study|Adverse Event|0|||
131453205|NCT01354314|473288400|FG002|Overall Study|Adverse Event|0|||
131453206|NCT01354314|473288401|FG003|Overall Study|Adverse Event|1|||
131453207|NCT01354314|473288398|FG000|Overall Study|Protocol Violation|1|||
131453208|NCT01354314|473288399|FG001|Overall Study|Protocol Violation|1|||
131453209|NCT01354314|473288400|FG002|Overall Study|Protocol Violation|0|||
131453210|NCT01354314|473288401|FG003|Overall Study|Protocol Violation|0|||
131453211|NCT01354314|473288398|FG000|Overall Study|Less than 90% Adherence|4|||
131453212|NCT01354314|473288399|FG001|Overall Study|Less than 90% Adherence|2|||
131453213|NCT01354314|473288400|FG002|Overall Study|Less than 90% Adherence|6|||
131453214|NCT01354314|473288401|FG003|Overall Study|Less than 90% Adherence|4|||
131453215|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
131453216|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
131453217|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
131453218|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
131453219|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
131453220|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
131453221|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
131453222|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
131453223|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
131453224|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453225|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
131453226|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453227|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453228|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453229|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
131453230|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
131453231|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
131853196|NCT04739800|474740312|FG002|Overall Study|Other Reason|5|||
131853197|NCT04739800|474740313|FG003|Overall Study|Other Reason|4|||
131853198|NCT02779855|474740314|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
131853199|NCT02779855|474740315|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
131853200|NCT02779855|474740316|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
131853201|NCT01590277|474740327|FG000|Overall Study|Withdrawal by Subject|3|||
131853202|NCT01590277|474740327|FG000|Overall Study|Withdrawal by Subject|2|||
131853203|NCT01590277|474740327|FG000|Overall Study|Withdrawal by Subject|1|||
131853204|NCT01590277|474740327|FG000|Overall Study|Withdrawal by Subject|1|||
131853205|NCT04386616|474740328|FG000|Overall Study|Death|22|||
131853206|NCT04386616|474740329|FG001|Overall Study|Death|22|||
131853207|NCT04386616|474740330|FG002|Overall Study|Death|21|||
131853208|NCT04386616|474740328|FG000|Overall Study|Lost to Follow-up|5|||
131853209|NCT04386616|474740329|FG001|Overall Study|Lost to Follow-up|8|||
131853210|NCT04386616|474740330|FG002|Overall Study|Lost to Follow-up|6|||
131853211|NCT04386616|474740328|FG000|Overall Study|Withdrawal by Subject|2|||
131853212|NCT04386616|474740329|FG001|Overall Study|Withdrawal by Subject|4|||
131853213|NCT04386616|474740330|FG002|Overall Study|Withdrawal by Subject|1|||
131853214|NCT04386616|474740328|FG000|Overall Study|Adverse Event|1|||
131853215|NCT04386616|474740329|FG001|Overall Study|Adverse Event|1|||
131853216|NCT04386616|474740330|FG002|Overall Study|Adverse Event|0|||
131853217|NCT01377012|474740331|FG000|Core Study|Study terminated by Sponsor|47|||
131853218|NCT01377012|474740332|FG001|Core Study|Study terminated by Sponsor|54|||
131853219|NCT01377012|474740333|FG002|Core Study|Study terminated by Sponsor|46|||
131853220|NCT01377012|474740331|FG000|Core Study|Technical problems|1|||
131853221|NCT01377012|474740332|FG001|Core Study|Technical problems|0|||
131853222|NCT01377012|474740333|FG002|Core Study|Technical problems|0|||
131853223|NCT01377012|474740331|FG000|Core Study|Withdrawal by Subject|15|||
131853224|NCT01377012|474740332|FG001|Core Study|Withdrawal by Subject|23|||
131853225|NCT01377012|474740333|FG002|Core Study|Withdrawal by Subject|18|||
131853226|NCT01377012|474740331|FG000|Core Study|Protocol Violation|7|||
131853227|NCT01377012|474740332|FG001|Core Study|Protocol Violation|3|||
131853228|NCT01377012|474740333|FG002|Core Study|Protocol Violation|2|||
131853229|NCT01377012|474740331|FG000|Core Study|Pregnancy|0|||
131853230|NCT01377012|474740332|FG001|Core Study|Pregnancy|0|||
131853231|NCT01377012|474740333|FG002|Core Study|Pregnancy|1|||
131853232|NCT01377012|474740331|FG000|Core Study|Physician Decision|5|||
131853233|NCT01377012|474740332|FG001|Core Study|Physician Decision|4|||
131853234|NCT01377012|474740333|FG002|Core Study|Physician Decision|10|||
131853235|NCT01377012|474740331|FG000|Core Study|Non-Compliant with study treatment|0|||
131853236|NCT01377012|474740332|FG001|Core Study|Non-Compliant with study treatment|0|||
131853237|NCT01377012|474740333|FG002|Core Study|Non-Compliant with study treatment|1|||
131853238|NCT01377012|474740331|FG000|Core Study|No Longer require treatment|0|||
131853239|NCT01377012|474740332|FG001|Core Study|No Longer require treatment|0|||
131853240|NCT01377012|474740333|FG002|Core Study|No Longer require treatment|1|||
131853241|NCT01377012|474740331|FG000|Core Study|Lost to Follow-up|7|||
131853242|NCT01377012|474740332|FG001|Core Study|Lost to Follow-up|5|||
131853243|NCT01377012|474740333|FG002|Core Study|Lost to Follow-up|4|||
131853244|NCT01377012|474740331|FG000|Core Study|Lack of Efficacy|41|||
131853245|NCT01377012|474740332|FG001|Core Study|Lack of Efficacy|28|||
131853246|NCT01377012|474740333|FG002|Core Study|Lack of Efficacy|37|||
131853247|NCT01377012|474740331|FG000|Core Study|Death|1|||
131853248|NCT01377012|474740332|FG001|Core Study|Death|1|||
131853249|NCT01377012|474740333|FG002|Core Study|Death|1|||
131853250|NCT01377012|474740331|FG000|Core Study|Adverse Event|10|||
131853251|NCT01377012|474740332|FG001|Core Study|Adverse Event|14|||
131853252|NCT01377012|474740333|FG002|Core Study|Adverse Event|13|||
131853253|NCT01377012|474740331|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
131853254|NCT01377012|474740332|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
131853255|NCT01377012|474740333|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
131853256|NCT01377012|474740331|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
131853257|NCT01377012|474740332|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
131853258|NCT01377012|474740333|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
131853259|NCT01377012|474740331|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
131853260|NCT01377012|474740332|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
131853261|NCT01377012|474740333|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
131853262|NCT01377012|474740331|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
131853263|NCT01377012|474740332|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
131853264|NCT01377012|474740333|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
131853265|NCT01377012|474740331|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
131853266|NCT01377012|474740332|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
131853267|NCT01377012|474740333|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
131853268|NCT01377012|474740331|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
131853269|NCT01377012|474740332|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
131853270|NCT01377012|474740333|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
131853271|NCT04380961|474740336|FG000|Overall Study|Lost to Follow-up|17|||
131853272|NCT04380961|474740337|FG001|Overall Study|Lost to Follow-up|11|||
131853273|NCT04380961|474740336|FG000|Overall Study|Withdrawal by Subject|3|||
131853274|NCT04380961|474740337|FG001|Overall Study|Withdrawal by Subject|0|||
131853275|NCT04380961|474740336|FG000|Overall Study|Death|22|||
131853276|NCT04380961|474740337|FG001|Overall Study|Death|16|||
131853277|NCT04380961|474740336|FG000|Overall Study|Other|1|||
131853278|NCT04380961|474740337|FG001|Overall Study|Other|0|||
131853279|NCT04380961|474740336|FG000|Overall Study|Randomized but Not Treated|1|||
131853280|NCT04380961|474740337|FG001|Overall Study|Randomized but Not Treated|2|||
131853281|NCT00805961|474740338|FG000|Modality Therapy|Withdrawal by Subject|1|||
131853282|NCT00805961|474740338|FG000|Modality Therapy|Adverse Event|1|||
131853283|NCT00805961|474740338|FG000|Modality Therapy|Disease Progression|2|||
131853284|NCT00805961|474740338|FG000|Treatment-Free Interval|Adverse Event|3|||
131853285|NCT00805961|474740338|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
131853286|NCT00805961|474740338|FG000|Treatment-Free Interval|Physician Decision|1|||
131853287|NCT00805961|474740338|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
131853288|NCT00805961|474740338|FG000|Maintenance Treatment|Lack of Efficacy|13|||
131853289|NCT00805961|474740338|FG000|Maintenance Treatment|Intercurrent Illness|7|||
131853290|NCT00805961|474740338|FG000|Maintenance Treatment|Adverse Event|6|||
131853291|NCT00805961|474740338|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
131853292|NCT00805961|474740338|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
131853293|NCT00805961|474740338|FG000|Maintenance Treatment|Withdrawn Consent|1|||
131853294|NCT01862484|474740339|FG000|Overall Study|Lack of Efficacy|1|||
131853295|NCT01862484|474740340|FG001|Overall Study|Lack of Efficacy|1|||
131853296|NCT01862484|474740339|FG000|Overall Study|Lost to Follow-up|1|||
131853297|NCT01862484|474740340|FG001|Overall Study|Lost to Follow-up|2|||
131853298|NCT01862484|474740339|FG000|Overall Study|Protocol Violation|0|||
131853299|NCT01862484|474740340|FG001|Overall Study|Protocol Violation|2|||
131853300|NCT01862484|474740339|FG000|Overall Study|Withdrawal by Subject|0|||
131853301|NCT01862484|474740340|FG001|Overall Study|Withdrawal by Subject|3|||
131853302|NCT01632280|474740341|FG000|Overall Study|Withdrawal by Subject|1|||
131853303|NCT01632280|474740342|FG001|Overall Study|Withdrawal by Subject|0|||
131853304|NCT00993421|474740343|FG000|Overall Study|Adverse Event|2|||
131853305|NCT00993421|474740344|FG001|Overall Study|Adverse Event|7|||
131853306|NCT00993421|474740345|FG002|Overall Study|Adverse Event|6|||
131853307|NCT00993421|474740346|FG003|Overall Study|Adverse Event|9|||
131853308|NCT00993421|474740347|FG004|Overall Study|Adverse Event|5|||
131853309|NCT00993421|474740348|FG005|Overall Study|Adverse Event|7|||
131853310|NCT00993421|474740349|FG006|Overall Study|Adverse Event|1|||
131853311|NCT00993421|474740343|FG000|Overall Study|Sponsor Decision|36|||
131853312|NCT00993421|474740344|FG001|Overall Study|Sponsor Decision|31|||
131853313|NCT00993421|474740345|FG002|Overall Study|Sponsor Decision|28|||
131853314|NCT00993421|474740346|FG003|Overall Study|Sponsor Decision|30|||
131853315|NCT00993421|474740347|FG004|Overall Study|Sponsor Decision|38|||
131853316|NCT00993421|474740348|FG005|Overall Study|Sponsor Decision|30|||
131853317|NCT00993421|474740349|FG006|Overall Study|Sponsor Decision|29|||
131853318|NCT00993421|474740343|FG000|Overall Study|Lost to Follow-up|3|||
131853319|NCT00993421|474740344|FG001|Overall Study|Lost to Follow-up|5|||
131853320|NCT00993421|474740345|FG002|Overall Study|Lost to Follow-up|5|||
131853321|NCT00993421|474740346|FG003|Overall Study|Lost to Follow-up|0|||
131853322|NCT00993421|474740347|FG004|Overall Study|Lost to Follow-up|0|||
131853323|NCT00993421|474740348|FG005|Overall Study|Lost to Follow-up|0|||
131853324|NCT00993421|474740349|FG006|Overall Study|Lost to Follow-up|6|||
131853325|NCT00993421|474740343|FG000|Overall Study|Withdrawal by Subject|3|||
131853326|NCT00993421|474740344|FG001|Overall Study|Withdrawal by Subject|2|||
131853327|NCT00993421|474740345|FG002|Overall Study|Withdrawal by Subject|3|||
131853328|NCT00993421|474740346|FG003|Overall Study|Withdrawal by Subject|3|||
131853329|NCT00993421|474740347|FG004|Overall Study|Withdrawal by Subject|3|||
131853330|NCT00993421|474740348|FG005|Overall Study|Withdrawal by Subject|5|||
131853331|NCT00993421|474740349|FG006|Overall Study|Withdrawal by Subject|3|||
131853332|NCT00993421|474740343|FG000|Overall Study|Death|0|||
131853333|NCT00993421|474740344|FG001|Overall Study|Death|0|||
131853334|NCT00993421|474740345|FG002|Overall Study|Death|0|||
131853335|NCT00993421|474740346|FG003|Overall Study|Death|0|||
131853336|NCT00993421|474740347|FG004|Overall Study|Death|0|||
131853337|NCT00993421|474740348|FG005|Overall Study|Death|0|||
131853338|NCT00993421|474740349|FG006|Overall Study|Death|1|||
131853339|NCT00993421|474740343|FG000|Overall Study|Entry Criteria Exclusion|0|||
131853340|NCT00993421|474740344|FG001|Overall Study|Entry Criteria Exclusion|0|||
131853341|NCT00993421|474740345|FG002|Overall Study|Entry Criteria Exclusion|1|||
131853342|NCT00993421|474740346|FG003|Overall Study|Entry Criteria Exclusion|3|||
131853343|NCT00993421|474740347|FG004|Overall Study|Entry Criteria Exclusion|0|||
131853344|NCT00993421|474740348|FG005|Overall Study|Entry Criteria Exclusion|1|||
131853345|NCT00993421|474740349|FG006|Overall Study|Entry Criteria Exclusion|0|||
131853346|NCT00993421|474740343|FG000|Overall Study|Physician Decision|0|||
131853347|NCT00993421|474740344|FG001|Overall Study|Physician Decision|0|||
131853348|NCT00993421|474740345|FG002|Overall Study|Physician Decision|0|||
131853349|NCT00993421|474740346|FG003|Overall Study|Physician Decision|0|||
131912313|NCT03944616|474966538|FG001|Overall Study|Lost to Follow-up|2|||
131853350|NCT00993421|474740347|FG004|Overall Study|Physician Decision|0|||
131912314|NCT01721798|474966541|FG000|Overall Study|Death|0|||
131912315|NCT01721798|474966542|FG001|Overall Study|Death|0|||
131912316|NCT01721798|474966543|FG002|Overall Study|Death|1|||
131912317|NCT01721798|474966544|FG003|Overall Study|Death|1|||
131912318|NCT01721798|474966541|FG000|Overall Study|Lost to Follow-up|2|||
131912319|NCT01721798|474966542|FG001|Overall Study|Lost to Follow-up|2|||
131912320|NCT01721798|474966543|FG002|Overall Study|Lost to Follow-up|9|||
131912321|NCT01721798|474966544|FG003|Overall Study|Lost to Follow-up|9|||
131912322|NCT01721798|474966541|FG000|Overall Study|Pregnancy|0|||
131912323|NCT01721798|474966542|FG001|Overall Study|Pregnancy|0|||
131912324|NCT01721798|474966543|FG002|Overall Study|Pregnancy|1|||
131912325|NCT01721798|474966544|FG003|Overall Study|Pregnancy|1|||
131912326|NCT01721798|474966541|FG000|Overall Study|Withdrawal by Subject|1|||
131912327|NCT01721798|474966542|FG001|Overall Study|Withdrawal by Subject|0|||
131912328|NCT01721798|474966543|FG002|Overall Study|Withdrawal by Subject|2|||
131912329|NCT01721798|474966544|FG003|Overall Study|Withdrawal by Subject|1|||
131912330|NCT01721798|474966541|FG000|Overall Study|Not eligible for 24 month visit|1|||
131912331|NCT01721798|474966542|FG001|Overall Study|Not eligible for 24 month visit|0|||
131912332|NCT01721798|474966543|FG002|Overall Study|Not eligible for 24 month visit|8|||
131912333|NCT01721798|474966544|FG003|Overall Study|Not eligible for 24 month visit|7|||
131912334|NCT02194465|474966545|FG000|Overall Study|Adverse Event|6|||
131912335|NCT02194465|474966546|FG001|Overall Study|Adverse Event|1|||
131404999|NCT01728077|473105443|FG000|Overall Study|Lost to Follow-up|1|||
131405000|NCT01728077|473105444|FG001|Overall Study|Lost to Follow-up|0|||
131405001|NCT01728077|473105443|FG000|Overall Study|Subject choice|2|||
131405002|NCT01728077|473105444|FG001|Overall Study|Subject choice|3|||
131405003|NCT01728077|473105443|FG000|Overall Study|Death|0|||
131405004|NCT01728077|473105444|FG001|Overall Study|Death|1|||
131405005|NCT01728077|473105443|FG000|Overall Study|Patient moving|1|||
131405006|NCT01728077|473105444|FG001|Overall Study|Patient moving|0|||
131405007|NCT01728077|473105443|FG000|Overall Study|Non compliance|1|||
131405008|NCT01728077|473105444|FG001|Overall Study|Non compliance|0|||
131405009|NCT00347438|473105449|FG000|Overall Study|Withdrawal by Subject|1|||
131405010|NCT00347438|473105449|FG000|Overall Study|Physician Decision|1|||
131405011|NCT00322023|473105450|FG000|Overall Study|various|0|||
131405012|NCT00322023|473105451|FG001|Overall Study|various|2|||
131405013|NCT00322023|473105452|FG002|Overall Study|various|6|||
131405014|NCT00523705|473105453|FG000|Overall Study|No time for study.|0|||
131405015|NCT00523705|473105454|FG001|Overall Study|No time for study.|1|||
131405016|NCT00396136|473105455|FG000|Overall Study|Death|43|||
131912336|NCT02194465|474966547|FG002|Overall Study|Adverse Event|4|||
131912337|NCT02194465|474966548|FG003|Overall Study|Adverse Event|4|||
131912338|NCT02194465|474966549|FG004|Overall Study|Adverse Event|4|||
131912339|NCT02194465|474966550|FG005|Overall Study|Adverse Event|2|||
131912340|NCT02194465|474966551|FG006|Overall Study|Adverse Event|0|||
131912341|NCT02194465|474966545|FG000|Overall Study|Lost to Follow-up|0|||
131912342|NCT02194465|474966546|FG001|Overall Study|Lost to Follow-up|0|||
131912343|NCT02194465|474966547|FG002|Overall Study|Lost to Follow-up|0|||
131912344|NCT02194465|474966548|FG003|Overall Study|Lost to Follow-up|1|||
131912345|NCT02194465|474966549|FG004|Overall Study|Lost to Follow-up|0|||
131912346|NCT02194465|474966550|FG005|Overall Study|Lost to Follow-up|1|||
131912347|NCT02194465|474966551|FG006|Overall Study|Lost to Follow-up|0|||
131912348|NCT02194465|474966545|FG000|Overall Study|Physician Decision|1|||
131912349|NCT02194465|474966546|FG001|Overall Study|Physician Decision|0|||
131912350|NCT02194465|474966547|FG002|Overall Study|Physician Decision|0|||
131912351|NCT02194465|474966548|FG003|Overall Study|Physician Decision|0|||
131912352|NCT02194465|474966549|FG004|Overall Study|Physician Decision|0|||
131912353|NCT02194465|474966550|FG005|Overall Study|Physician Decision|0|||
131405017|NCT00396136|473105455|FG000|Overall Study|Withdrawal by Subject|59|||
131405018|NCT00396136|473105455|FG000|Overall Study|Lost to Follow-up|15|||
131405019|NCT00396136|473105455|FG000|Overall Study|Study device explanted|8|||
131405020|NCT03960580|473105456|FG000|Overall Study|Adverse Event|2|||
131405021|NCT03960580|473105457|FG001|Overall Study|Adverse Event|1|||
131405022|NCT03960580|473105458|FG002|Overall Study|Adverse Event|1|||
131405023|NCT03960580|473105456|FG000|Overall Study|Lost to Follow-up|1|||
131405024|NCT03960580|473105457|FG001|Overall Study|Lost to Follow-up|0|||
131405025|NCT03960580|473105458|FG002|Overall Study|Lost to Follow-up|0|||
131405026|NCT03960580|473105456|FG000|Overall Study|Lack of Efficacy|2|||
131405027|NCT03960580|473105457|FG001|Overall Study|Lack of Efficacy|1|||
131405028|NCT03960580|473105458|FG002|Overall Study|Lack of Efficacy|0|||
131405029|NCT03960580|473105456|FG000|Overall Study|Protocol Violation|0|||
131405030|NCT03960580|473105457|FG001|Overall Study|Protocol Violation|0|||
131405031|NCT03960580|473105458|FG002|Overall Study|Protocol Violation|1|||
131405032|NCT03960580|473105456|FG000|Overall Study|Withdrawal by Subject|1|||
131405033|NCT03960580|473105457|FG001|Overall Study|Withdrawal by Subject|1|||
131405034|NCT03960580|473105458|FG002|Overall Study|Withdrawal by Subject|1|||
131405035|NCT03960580|473105456|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
131405036|NCT03960580|473105457|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
131912354|NCT02194465|474966551|FG006|Overall Study|Physician Decision|0|||
131912355|NCT02194465|474966545|FG000|Overall Study|Protocol Violation|1|||
131853351|NCT00993421|474740348|FG005|Overall Study|Physician Decision|1|||
131853352|NCT00993421|474740349|FG006|Overall Study|Physician Decision|1|||
131853353|NCT00993421|474740343|FG000|Overall Study|Protocol Violation|0|||
131853354|NCT00993421|474740344|FG001|Overall Study|Protocol Violation|0|||
131853355|NCT00993421|474740345|FG002|Overall Study|Protocol Violation|0|||
131853356|NCT00993421|474740346|FG003|Overall Study|Protocol Violation|0|||
131853357|NCT00993421|474740347|FG004|Overall Study|Protocol Violation|0|||
131853358|NCT00993421|474740348|FG005|Overall Study|Protocol Violation|2|||
131853359|NCT00993421|474740349|FG006|Overall Study|Protocol Violation|1|||
131853360|NCT00451178|474740350|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
131853361|NCT00451178|474740351|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
131853362|NCT00451178|474740350|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
131853363|NCT00451178|474740351|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
131853364|NCT00451178|474740350|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
131853365|NCT00451178|474740351|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
131853366|NCT00451178|474740350|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
131853367|NCT00451178|474740351|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
131853368|NCT00451178|474740350|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
131853369|NCT00451178|474740351|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
131853370|NCT00451178|474740350|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
131853371|NCT00451178|474740351|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
131853372|NCT00451178|474740350|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
131853373|NCT00451178|474740351|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
131853374|NCT00451178|474740350|FG000|Prior to Maintenance Therapy|PD|2|||
131853375|NCT00451178|474740351|FG001|Prior to Maintenance Therapy|PD|0|||
131853376|NCT00451178|474740350|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
131853377|NCT00451178|474740351|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
131853378|NCT00451178|474740350|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
131853379|NCT00451178|474740351|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
131853380|NCT00451178|474740350|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
131853381|NCT00451178|474740351|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
131853382|NCT00451178|474740350|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
131853383|NCT00451178|474740351|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
131853384|NCT00451178|474740350|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
131853385|NCT00451178|474740351|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
131853386|NCT00451178|474740350|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
131853387|NCT00451178|474740351|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
131853388|NCT00451178|474740350|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
131853389|NCT00451178|474740351|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
131853390|NCT02215967|474740352|FG000|Overall Study|Patient became ineligible for treatment|0|||
131853391|NCT02215967|474740353|FG001|Overall Study|Patient became ineligible for treatment|0|||
131853392|NCT02215967|474740354|FG002|Overall Study|Patient became ineligible for treatment|0|||
131853393|NCT02215967|474740355|FG003|Overall Study|Patient became ineligible for treatment|3|||
131853394|NCT02215967|474740352|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
131853395|NCT02215967|474740353|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
131853396|NCT02215967|474740354|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
131853397|NCT02215967|474740355|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
131853398|NCT03514017|474740359|FG000|Overall Study|Death|1|||
131853399|NCT03514017|474740359|FG000|Overall Study|Adverse Event|1|||
131853400|NCT00371033|474741648|FG000|Overall Study|Lost to Follow-up|3|||
131853401|NCT00371033|474741649|FG001|Overall Study|Lost to Follow-up|2|||
131853402|NCT00371033|474741648|FG000|Overall Study|No longer interested|2|||
131853403|NCT00371033|474741649|FG001|Overall Study|No longer interested|0|||
131853404|NCT00371033|474741648|FG000|Overall Study|Uknown|3|||
131853405|NCT00371033|474741649|FG001|Overall Study|Uknown|1|||
131853406|NCT02260570|474741650|FG000|Overall Study|Withdrawal by Subject|2|||
131853407|NCT02260570|474741651|FG001|Overall Study|Withdrawal by Subject|1|||
131853408|NCT02260570|474741650|FG000|Overall Study|Physician Decision|1|||
131853409|NCT02260570|474741651|FG001|Overall Study|Physician Decision|1|||
131853410|NCT01575548|474741652|FG000|Overall Study|Adverse Event|15|||
131853411|NCT01575548|474741653|FG001|Overall Study|Adverse Event|2|||
131853412|NCT01575548|474741652|FG000|Overall Study|Disease progression|12|||
131853413|NCT01575548|474741653|FG001|Overall Study|Disease progression|25|||
131853414|NCT01575548|474741652|FG000|Overall Study|Death|1|||
131853415|NCT01575548|474741653|FG001|Overall Study|Death|0|||
131853416|NCT01575548|474741652|FG000|Overall Study|Other complicating disease|1|||
131853417|NCT01575548|474741653|FG001|Overall Study|Other complicating disease|0|||
131853418|NCT01575548|474741652|FG000|Overall Study|Withdrawal by Subject|7|||
131853419|NCT01575548|474741653|FG001|Overall Study|Withdrawal by Subject|3|||
131853420|NCT01575548|474741652|FG000|Overall Study|Noncompliance|1|||
131853421|NCT01575548|474741653|FG001|Overall Study|Noncompliance|0|||
131853422|NCT01575548|474741652|FG000|Overall Study|Anticipated surgery|0|||
131853423|NCT01575548|474741653|FG001|Overall Study|Anticipated surgery|1|||
131453232|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
131853424|NCT01575548|474741652|FG000|Overall Study|Never started protocol therapy|3|||
131853425|NCT01575548|474741653|FG001|Overall Study|Never started protocol therapy|2|||
131853426|NCT04175912|474741654|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
131853427|NCT04175912|474741655|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
131853428|NCT04175912|474741654|FG000|Overall Study|Adverse Event|0|||
131853429|NCT04175912|474741655|FG001|Overall Study|Adverse Event|3|||
131853430|NCT04175912|474741654|FG000|Overall Study|Never started treatment|3|||
131853431|NCT04175912|474741655|FG001|Overall Study|Never started treatment|3|||
131853432|NCT04175912|474741654|FG000|Overall Study|Death|0|||
131853433|NCT04175912|474741655|FG001|Overall Study|Death|1|||
131853434|NCT01708954|474741656|FG000|Step 1|Disease progression|26|||
131853435|NCT01708954|474741657|FG001|Step 1|Disease progression|17|||
131853436|NCT01708954|474741658|FG002|Step 1|Disease progression|14|||
131853437|NCT01708954|474741656|FG000|Step 1|Adverse Event|3|||
131853438|NCT01708954|474741657|FG001|Step 1|Adverse Event|11|||
131853439|NCT01708954|474741658|FG002|Step 1|Adverse Event|13|||
131853440|NCT01708954|474741656|FG000|Step 1|Death|3|||
131853441|NCT01708954|474741657|FG001|Step 1|Death|2|||
131853442|NCT01708954|474741658|FG002|Step 1|Death|3|||
131853443|NCT01708954|474741656|FG000|Step 1|Withdrawal by Subject|2|||
131853444|NCT01708954|474741657|FG001|Step 1|Withdrawal by Subject|5|||
131853445|NCT01708954|474741658|FG002|Step 1|Withdrawal by Subject|3|||
131853446|NCT01708954|474741656|FG000|Step 1|Other complicating disease|0|||
131853447|NCT01708954|474741657|FG001|Step 1|Other complicating disease|2|||
131853448|NCT01708954|474741658|FG002|Step 1|Other complicating disease|0|||
131853449|NCT01708954|474741656|FG000|Step 1|Crossed over to Step 2|2|||
131853450|NCT01708954|474741657|FG001|Step 1|Crossed over to Step 2|0|||
131853451|NCT01708954|474741658|FG002|Step 1|Crossed over to Step 2|0|||
131853452|NCT01708954|474741656|FG000|Step 1|Symptomatic deterioration|1|||
131853453|NCT01708954|474741657|FG001|Step 1|Symptomatic deterioration|0|||
131853454|NCT01708954|474741658|FG002|Step 1|Symptomatic deterioration|1|||
131853455|NCT01708954|474741656|FG000|Step 1|Off-treatment reason not submitted|1|||
131853456|NCT01708954|474741657|FG001|Step 1|Off-treatment reason not submitted|1|||
131853457|NCT01708954|474741658|FG002|Step 1|Off-treatment reason not submitted|1|||
131853458|NCT01708954|474741656|FG000|Step 1|Ineligible or never received treatment|4|||
131853459|NCT01708954|474741657|FG001|Step 1|Ineligible or never received treatment|2|||
131853460|NCT01708954|474741658|FG002|Step 1|Ineligible or never received treatment|8|||
131853461|NCT01708954|474741656|FG000|Step 2|Disease progression|9|||
131453233|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
131453234|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
131453235|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
131453236|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
131453237|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
131453238|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
131453239|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
131453240|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
131453241|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
131453242|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
131453243|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
131453244|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
131453245|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
131453246|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
131453247|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
131453248|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
131453249|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
131453250|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
131496721|NCT02289690|473446359|FG000|Overall Study|Sponsor Discontinued Study|0|||
131853462|NCT01708954|474741657|FG001|Step 2|Disease progression|4|||
131853463|NCT01708954|474741658|FG002|Step 2|Disease progression|0|||
131853464|NCT01708954|474741656|FG000|Step 2|Adverse Event|3|||
131853465|NCT01708954|474741657|FG001|Step 2|Adverse Event|2|||
131853466|NCT01708954|474741658|FG002|Step 2|Adverse Event|0|||
131853467|NCT01708954|474741656|FG000|Step 2|Withdrawal by Subject|1|||
131853468|NCT01708954|474741657|FG001|Step 2|Withdrawal by Subject|1|||
131853469|NCT01708954|474741658|FG002|Step 2|Withdrawal by Subject|0|||
131853470|NCT06400251|474741659|FG000|Overall Study|Never Start Protocol Therapy|1|||
131853471|NCT06400251|474741659|FG000|Overall Study|Ineligible|2|||
131853472|NCT06400251|474741659|FG000|Overall Study|Mutation Status Not Confirmed|3|||
131853473|NCT06400251|474741659|FG000|Overall Study|Disease Progression|25|||
131853474|NCT06400251|474741659|FG000|Overall Study|Adverse Event|1|||
131853475|NCT06400251|474741659|FG000|Overall Study|Complicating Disease|1|||
131853476|NCT06400251|474741659|FG000|Overall Study|Physician Decision|2|||
131853477|NCT02794870|474741663|FG000|Overall Study|Withdrawal by Subject|2|||
131853478|NCT02794870|474741664|FG001|Overall Study|Withdrawal by Subject|0|||
131405037|NCT03960580|473105458|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
131405038|NCT01165320|473105463|FG000|Overall Study|Clinical adverse experience|2|||
131405039|NCT01165320|473105464|FG001|Overall Study|Clinical adverse experience|1|||
131405040|NCT01165320|473105465|FG002|Overall Study|Clinical adverse experience|0|||
131405041|NCT01165320|473105463|FG000|Overall Study|Laboratory adverse experience|1|||
131405042|NCT01165320|473105464|FG001|Overall Study|Laboratory adverse experience|0|||
131405043|NCT01165320|473105465|FG002|Overall Study|Laboratory adverse experience|0|||
131405044|NCT01165320|473105463|FG000|Overall Study|Lack of Efficacy|0|||
131405045|NCT01165320|473105464|FG001|Overall Study|Lack of Efficacy|2|||
131405046|NCT01165320|473105465|FG002|Overall Study|Lack of Efficacy|0|||
131405047|NCT01165320|473105463|FG000|Overall Study|Reason unknown|0|||
131405048|NCT01165320|473105464|FG001|Overall Study|Reason unknown|1|||
131405049|NCT01165320|473105465|FG002|Overall Study|Reason unknown|0|||
131405050|NCT00385944|473105466|FG000|1st Maintenance Dose Period|Physician Decision|1|||
131405051|NCT00385944|473105467|FG001|1st Maintenance Dose Period|Physician Decision|0|||
131405052|NCT00385944|473105468|FG002|1st Maintenance Dose Period|Physician Decision|0|||
131405053|NCT00385944|473105466|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
131405054|NCT00385944|473105467|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
131405055|NCT00385944|473105468|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
131405056|NCT00385944|473105466|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
131405057|NCT00385944|473105467|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
131405058|NCT00385944|473105468|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
131405059|NCT00385944|473105466|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
131405060|NCT00385944|473105467|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
131405061|NCT00385944|473105468|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
131405062|NCT01155466|473105469|FG000|Overall Study|Adverse Event|13|||
131405063|NCT01155466|473105470|FG001|Overall Study|Adverse Event|15|||
131405064|NCT01155466|473105471|FG002|Overall Study|Adverse Event|6|||
131405065|NCT01155466|473105472|FG003|Overall Study|Adverse Event|17|||
131405066|NCT01155466|473105473|FG004|Overall Study|Adverse Event|18|||
131405067|NCT01155466|473105469|FG000|Overall Study|Lost to Follow-up|0|||
131405068|NCT01155466|473105470|FG001|Overall Study|Lost to Follow-up|0|||
131405069|NCT01155466|473105471|FG002|Overall Study|Lost to Follow-up|0|||
131405070|NCT01155466|473105472|FG003|Overall Study|Lost to Follow-up|0|||
131405071|NCT01155466|473105473|FG004|Overall Study|Lost to Follow-up|2|||
131405072|NCT01155466|473105469|FG000|Overall Study|Withdrawal by Subject|7|||
131405073|NCT01155466|473105470|FG001|Overall Study|Withdrawal by Subject|5|||
131405074|NCT01155466|473105471|FG002|Overall Study|Withdrawal by Subject|9|||
131405075|NCT01155466|473105472|FG003|Overall Study|Withdrawal by Subject|4|||
131405076|NCT01155466|473105473|FG004|Overall Study|Withdrawal by Subject|4|||
131405077|NCT01155466|473105469|FG000|Overall Study|Protocol Violation|0|||
131405078|NCT01155466|473105470|FG001|Overall Study|Protocol Violation|0|||
131405079|NCT01155466|473105471|FG002|Overall Study|Protocol Violation|2|||
131405080|NCT01155466|473105472|FG003|Overall Study|Protocol Violation|0|||
131405081|NCT01155466|473105473|FG004|Overall Study|Protocol Violation|1|||
131405082|NCT01155466|473105469|FG000|Overall Study|Administrative|0|||
131405083|NCT01155466|473105470|FG001|Overall Study|Administrative|3|||
131405084|NCT01155466|473105471|FG002|Overall Study|Administrative|0|||
131405085|NCT01155466|473105472|FG003|Overall Study|Administrative|0|||
131405086|NCT01155466|473105473|FG004|Overall Study|Administrative|0|||
131405087|NCT01155466|473105469|FG000|Overall Study|Randomized not treated|2|||
131853479|NCT04172597|474741666|FG000|Overall Study|Disease Progression|0|||
131853480|NCT04172597|474741667|FG001|Overall Study|Disease Progression|0|||
131853481|NCT04172597|474741668|FG002|Overall Study|Disease Progression|0|||
131853482|NCT04172597|474741669|FG003|Overall Study|Disease Progression|0|||
131853483|NCT04172597|474741670|FG004|Overall Study|Disease Progression|1|||
131853484|NCT00196326|474741673|FG000|Overall Study|Did not meet protocol requirements|64|||
131853485|NCT00196326|474741673|FG000|Overall Study|Non-compliance with the protocol|81|||
131853486|NCT00196326|474741673|FG000|Overall Study|Physician Decision|3|||
131853487|NCT00196326|474741673|FG000|Overall Study|Withdrawal by Subject|225|||
131853488|NCT00196326|474741673|FG000|Overall Study|Adverse Event|253|||
131853489|NCT00196326|474741673|FG000|Overall Study|Pregnancy|34|||
131853490|NCT00196326|474741673|FG000|Overall Study|Lost to Follow-up|304|||
131853491|NCT00196326|474741673|FG000|Overall Study|Other|22|||
131853492|NCT02797171|474741674|FG000|Overall Study|Lost to Follow-up|2|||
131853493|NCT02797171|474741675|FG001|Overall Study|Lost to Follow-up|0|||
131853494|NCT02797171|474741676|FG002|Overall Study|Lost to Follow-up|2|||
131853495|NCT02797171|474741677|FG003|Overall Study|Lost to Follow-up|1|||
131853496|NCT02797171|474741678|FG004|Overall Study|Lost to Follow-up|2|||
131853497|NCT02797171|474741679|FG005|Overall Study|Lost to Follow-up|0|||
131853498|NCT02797171|474741674|FG000|Overall Study|Withdrawal by Subject|1|||
131405088|NCT01155466|473105470|FG001|Overall Study|Randomized not treated|2|||
131405089|NCT01155466|473105471|FG002|Overall Study|Randomized not treated|3|||
131405090|NCT01155466|473105472|FG003|Overall Study|Randomized not treated|0|||
131853499|NCT02797171|474741675|FG001|Overall Study|Withdrawal by Subject|1|||
131853500|NCT02797171|474741676|FG002|Overall Study|Withdrawal by Subject|0|||
131853501|NCT02797171|474741677|FG003|Overall Study|Withdrawal by Subject|0|||
131853502|NCT02797171|474741678|FG004|Overall Study|Withdrawal by Subject|0|||
131853503|NCT02797171|474741679|FG005|Overall Study|Withdrawal by Subject|0|||
131853504|NCT02797171|474741674|FG000|Overall Study|Protocol Violation|1|||
131853505|NCT02797171|474741675|FG001|Overall Study|Protocol Violation|0|||
131853506|NCT02797171|474741676|FG002|Overall Study|Protocol Violation|0|||
131853507|NCT02797171|474741677|FG003|Overall Study|Protocol Violation|0|||
131853508|NCT02797171|474741678|FG004|Overall Study|Protocol Violation|0|||
131853509|NCT02797171|474741679|FG005|Overall Study|Protocol Violation|0|||
131853510|NCT02797171|474741674|FG000|Overall Study|Participant unable to adhere|0|||
131853511|NCT02797171|474741675|FG001|Overall Study|Participant unable to adhere|1|||
131853512|NCT02797171|474741676|FG002|Overall Study|Participant unable to adhere|0|||
131853513|NCT02797171|474741677|FG003|Overall Study|Participant unable to adhere|0|||
131853514|NCT02797171|474741678|FG004|Overall Study|Participant unable to adhere|0|||
131853515|NCT02797171|474741679|FG005|Overall Study|Participant unable to adhere|0|||
131853516|NCT02797171|474741674|FG000|Overall Study|Not Randomized|0|||
131853517|NCT02797171|474741675|FG001|Overall Study|Not Randomized|0|||
131853518|NCT02797171|474741676|FG002|Overall Study|Not Randomized|0|||
131853519|NCT02797171|474741677|FG003|Overall Study|Not Randomized|0|||
131853520|NCT02797171|474741678|FG004|Overall Study|Not Randomized|0|||
131853521|NCT02797171|474741679|FG005|Overall Study|Not Randomized|1|||
131853522|NCT02540083|474741680|FG000|Overall Study|Withdrawal by Subject|16|||
131853523|NCT03993379|474741681|FG000|Overall Study|The study was terminated early due to business decision.|0|||
131853524|NCT03993379|474741682|FG001|Overall Study|The study was terminated early due to business decision.|2|||
131853525|NCT03993379|474741683|FG002|Overall Study|The study was terminated early due to business decision.|0|||
131853526|NCT03993379|474741684|FG003|Overall Study|The study was terminated early due to business decision.|0|||
131853527|NCT03993379|474741681|FG000|Overall Study|Withdrawal by Subject|0|||
131853528|NCT03993379|474741682|FG001|Overall Study|Withdrawal by Subject|1|||
131853529|NCT03993379|474741683|FG002|Overall Study|Withdrawal by Subject|0|||
131853530|NCT03993379|474741684|FG003|Overall Study|Withdrawal by Subject|0|||
131853531|NCT01427608|474741685|FG000|Overall Study|Death|1|||
131853532|NCT01427608|474741686|FG001|Overall Study|Death|0|||
131853533|NCT01427608|474741685|FG000|Overall Study|Withdrawal by Subject|7|||
131853534|NCT01427608|474741686|FG001|Overall Study|Withdrawal by Subject|3|||
131853535|NCT01427608|474741685|FG000|Overall Study|Relapsed-all cause|13|||
131853536|NCT01427608|474741686|FG001|Overall Study|Relapsed-all cause|34|||
131853537|NCT01427608|474741685|FG000|Overall Study|Events not attributed to study meds|0|||
131853538|NCT01427608|474741686|FG001|Overall Study|Events not attributed to study meds|1|||
131853539|NCT03790657|474741687|FG000|Overall Study|Adverse Event|1|||
131853540|NCT03790657|474741688|FG001|Overall Study|Adverse Event|1|||
131853541|NCT03790657|474741687|FG000|Overall Study|Withdrawal by Subject|1|||
131853542|NCT03790657|474741688|FG001|Overall Study|Withdrawal by Subject|1|||
131853543|NCT01807065|474741689|FG000|Overall Study|Receive no sip-T due to IV access|1|||
131853544|NCT01807065|474741690|FG001|Overall Study|Receive no sip-T due to IV access|1|||
131853545|NCT05246670|474741695|FG000|Overall Study|Withdrawal by Subject|2|||
131853546|NCT05246670|474741696|FG001|Overall Study|Withdrawal by Subject|3|||
131853547|NCT05246670|474741697|FG002|Overall Study|Withdrawal by Subject|0|||
131853548|NCT05246670|474741698|FG003|Overall Study|Withdrawal by Subject|1|||
131853549|NCT05246670|474741695|FG000|Overall Study|Adverse Event|0|||
131853550|NCT05246670|474741696|FG001|Overall Study|Adverse Event|0|||
131853551|NCT05246670|474741697|FG002|Overall Study|Adverse Event|1|||
131853552|NCT05246670|474741698|FG003|Overall Study|Adverse Event|0|||
131853553|NCT05246670|474741695|FG000|Overall Study|Physician Decision|1|||
131853554|NCT05246670|474741696|FG001|Overall Study|Physician Decision|0|||
131853555|NCT05246670|474741697|FG002|Overall Study|Physician Decision|0|||
131853556|NCT05246670|474741698|FG003|Overall Study|Physician Decision|0|||
131853557|NCT05246670|474741695|FG000|Overall Study|Protocol Violation|1|||
131853558|NCT05246670|474741696|FG001|Overall Study|Protocol Violation|0|||
131853559|NCT05246670|474741697|FG002|Overall Study|Protocol Violation|0|||
131853560|NCT05246670|474741698|FG003|Overall Study|Protocol Violation|0|||
131853561|NCT03154125|474741699|FG000|Overall Study|Lost to Follow-up|11|||
131853562|NCT03154125|474741700|FG001|Overall Study|Lost to Follow-up|11|||
131853563|NCT03154125|474741701|FG002|Overall Study|Lost to Follow-up|0|||
131853564|NCT03154125|474741699|FG000|Overall Study|Withdrawal by Subject|49|||
131853565|NCT03154125|474741700|FG001|Overall Study|Withdrawal by Subject|55|||
131853566|NCT03154125|474741701|FG002|Overall Study|Withdrawal by Subject|8|||
131853567|NCT03154125|474741699|FG000|Overall Study|Physician Decision|13|||
131853568|NCT03154125|474741700|FG001|Overall Study|Physician Decision|6|||
131853569|NCT03154125|474741701|FG002|Overall Study|Physician Decision|0|||
131853570|NCT03154125|474741699|FG000|Overall Study|Protocol Violation|3|||
131853571|NCT03154125|474741700|FG001|Overall Study|Protocol Violation|5|||
131853572|NCT03154125|474741701|FG002|Overall Study|Protocol Violation|0|||
131853573|NCT00799058|474741702|FG000|Overall Study|Withdrawal by Subject|2|||
131853574|NCT00799058|474741703|FG001|Overall Study|Withdrawal by Subject|2|||
131853575|NCT00799058|474741704|FG002|Overall Study|Withdrawal by Subject|2|||
131853576|NCT00799058|474741702|FG000|Overall Study|Lost to Follow-up|1|||
131453251|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453252|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453253|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453254|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453255|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131853577|NCT00799058|474741703|FG001|Overall Study|Lost to Follow-up|2|||
131405091|NCT01155466|473105473|FG004|Overall Study|Randomized not treated|2|||
131405092|NCT00590824|473105474|FG000|Overall Study|Disease could not be resected|0|||
131405093|NCT00590824|473105475|FG001|Overall Study|Disease could not be resected|2|||
131405094|NCT00590824|473105476|FG002|Overall Study|Disease could not be resected|1|||
131405095|NCT00590824|473105477|FG003|Overall Study|Disease could not be resected|0|||
131405096|NCT00590824|473105474|FG000|Overall Study|Adverse Event|0|||
131405097|NCT00590824|473105475|FG001|Overall Study|Adverse Event|0|||
131405098|NCT00590824|473105476|FG002|Overall Study|Adverse Event|0|||
131405099|NCT00590824|473105477|FG003|Overall Study|Adverse Event|1|||
131405100|NCT00791479|473105483|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
131405101|NCT00791479|473105484|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
131405102|NCT00791479|473105485|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
131405103|NCT00791479|473105486|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
131405104|NCT00791479|473105487|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
131405105|NCT00791479|473105488|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
131405106|NCT00791479|473105483|FG000|Overall Study|Adverse Event|0|||
131405107|NCT00791479|473105484|FG001|Overall Study|Adverse Event|1|||
131405108|NCT00791479|473105485|FG002|Overall Study|Adverse Event|0|||
131405109|NCT00791479|473105486|FG003|Overall Study|Adverse Event|2|||
131405110|NCT00791479|473105487|FG004|Overall Study|Adverse Event|0|||
131405111|NCT00791479|473105488|FG005|Overall Study|Adverse Event|1|||
131405112|NCT00791479|473105483|FG000|Overall Study|Lost to Follow-up|0|||
131405113|NCT00791479|473105484|FG001|Overall Study|Lost to Follow-up|1|||
131405114|NCT00791479|473105485|FG002|Overall Study|Lost to Follow-up|0|||
131405115|NCT00791479|473105486|FG003|Overall Study|Lost to Follow-up|0|||
131405116|NCT00791479|473105487|FG004|Overall Study|Lost to Follow-up|0|||
131405117|NCT00791479|473105488|FG005|Overall Study|Lost to Follow-up|1|||
131405118|NCT00791479|473105483|FG000|Overall Study|Protocol Violation|2|||
131405119|NCT00791479|473105484|FG001|Overall Study|Protocol Violation|1|||
131405120|NCT00791479|473105485|FG002|Overall Study|Protocol Violation|0|||
131405121|NCT00791479|473105486|FG003|Overall Study|Protocol Violation|1|||
131405122|NCT00791479|473105487|FG004|Overall Study|Protocol Violation|0|||
131405123|NCT00791479|473105488|FG005|Overall Study|Protocol Violation|0|||
131405124|NCT00791479|473105483|FG000|Overall Study|Withdrawal by Subject|0|||
131405125|NCT00791479|473105484|FG001|Overall Study|Withdrawal by Subject|0|||
131405126|NCT00791479|473105485|FG002|Overall Study|Withdrawal by Subject|0|||
131405127|NCT00791479|473105486|FG003|Overall Study|Withdrawal by Subject|1|||
131405128|NCT00791479|473105487|FG004|Overall Study|Withdrawal by Subject|0|||
131405129|NCT00791479|473105488|FG005|Overall Study|Withdrawal by Subject|1|||
131405130|NCT03136497|473105489|FG000|Overall Study|Screen Failure|1|||
131405131|NCT03136497|473105490|FG001|Overall Study|Screen Failure|0|||
131405132|NCT03136497|473105491|FG002|Overall Study|Screen Failure|0|||
131405133|NCT00557310|473105492|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
131405134|NCT00557310|473105492|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
131405135|NCT00557310|473105492|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
131405136|NCT00557310|473105492|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
131405137|NCT00557310|473105492|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
131405138|NCT00557310|473105492|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
131405139|NCT03276026|473105495|FG000|Overall Study|Protocol Violation|1|||
131405140|NCT03276026|473105496|FG001|Overall Study|Protocol Violation|0|||
131405141|NCT04049266|473105500|FG000|Overall Study|Adverse Event|16|||
131405142|NCT04049266|473105501|FG001|Overall Study|Adverse Event|9|||
131405143|NCT04049266|473105500|FG000|Overall Study|Non-compliance with study drug|0|||
131405144|NCT04049266|473105501|FG001|Overall Study|Non-compliance with study drug|3|||
131405145|NCT04049266|473105500|FG000|Overall Study|Withdrawal by Subject|6|||
131405146|NCT04049266|473105501|FG001|Overall Study|Withdrawal by Subject|10|||
131405147|NCT04049266|473105500|FG000|Overall Study|Lost to Follow-up|2|||
131405148|NCT04049266|473105501|FG001|Overall Study|Lost to Follow-up|2|||
131405149|NCT04049266|473105500|FG000|Overall Study|Progressive disease|11|||
131405150|NCT04049266|473105501|FG001|Overall Study|Progressive disease|2|||
131405151|NCT04049266|473105500|FG000|Overall Study|Physician Decision|1|||
131405152|NCT04049266|473105501|FG001|Overall Study|Physician Decision|0|||
131405153|NCT04049266|473105500|FG000|Overall Study|Patient moved out of state|1|||
131405154|NCT04049266|473105501|FG001|Overall Study|Patient moved out of state|0|||
131405155|NCT02437409|473105502|FG000|Overall Study|Withdrawal by Subject|3|||
131405156|NCT02437409|473105502|FG000|Overall Study|Screening failure|12|||
131405157|NCT01944098|473105503|FG000|Overall Study|Physician Decision|1|||
131405158|NCT01944098|473105504|FG001|Overall Study|Physician Decision|0|||
131853578|NCT00799058|474741704|FG002|Overall Study|Lost to Follow-up|1|||
131853579|NCT00799058|474741702|FG000|Overall Study|Adverse Event|0|||
131853580|NCT00799058|474741703|FG001|Overall Study|Adverse Event|2|||
131853581|NCT00799058|474741704|FG002|Overall Study|Adverse Event|0|||
131853582|NCT00799058|474741702|FG000|Overall Study|Pregnancy|1|||
131853583|NCT00799058|474741703|FG001|Overall Study|Pregnancy|0|||
131853584|NCT00799058|474741704|FG002|Overall Study|Pregnancy|0|||
131853585|NCT00799058|474741702|FG000|Overall Study|Not adherent|3|||
131853586|NCT00799058|474741703|FG001|Overall Study|Not adherent|2|||
131853587|NCT00799058|474741704|FG002|Overall Study|Not adherent|1|||
131853588|NCT00799058|474741702|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
131853589|NCT00799058|474741703|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
131853590|NCT00799058|474741704|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
131853591|NCT00799058|474741702|FG000|Overall Study|IP dispensing error|1|||
131853592|NCT00799058|474741703|FG001|Overall Study|IP dispensing error|0|||
131853593|NCT00799058|474741704|FG002|Overall Study|IP dispensing error|0|||
131853594|NCT00799058|474741702|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
131853595|NCT00799058|474741703|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
131853596|NCT00799058|474741704|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
131853597|NCT00799058|474741702|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
131853598|NCT00799058|474741703|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
131853599|NCT00799058|474741704|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
131853600|NCT00799058|474741702|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
131853601|NCT00799058|474741703|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
131853602|NCT00799058|474741704|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
131853603|NCT00799058|474741702|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
131853604|NCT00799058|474741703|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
131853605|NCT00799058|474741704|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
131853606|NCT03639779|474741705|FG000|Overall Study|Lost to Follow-up|1|||
131853607|NCT02088697|474741706|FG000|Period I|Physician Decision|1|||
131853608|NCT02088697|474741707|FG001|Period I|Physician Decision|4|||
131853609|NCT02088697|474741706|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
131853610|NCT02088697|474741707|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
131853611|NCT00462904|474741708|FG000|Overall Study|Lost to Follow-up|1|||
131853612|NCT05219448|474741709|FG000|Overall Study|Lost to Follow-up|9|||
131853613|NCT05219448|474741710|FG001|Overall Study|Lost to Follow-up|0|||
131853614|NCT00911300|474741714|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
131853615|NCT00911300|474741715|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
131853616|NCT00911300|474741714|FG000|Overall Study|Death|1|||
131853617|NCT00911300|474741715|FG001|Overall Study|Death|0|||
131853618|NCT00911300|474741714|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
131853619|NCT00911300|474741715|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
131853620|NCT00911300|474741714|FG000|Overall Study|Adverse Event|14|||
131853621|NCT00911300|474741715|FG001|Overall Study|Adverse Event|6|||
131853622|NCT00911300|474741714|FG000|Overall Study|Protocol Violation|3|||
131853623|NCT00911300|474741715|FG001|Overall Study|Protocol Violation|2|||
131853624|NCT00911300|474741714|FG000|Overall Study|Consent Withdrawn|4|||
131853625|NCT00911300|474741715|FG001|Overall Study|Consent Withdrawn|12|||
131853626|NCT00911300|474741714|FG000|Overall Study|Coronary Angiography Performed|1|||
131853627|NCT00911300|474741715|FG001|Overall Study|Coronary Angiography Performed|0|||
131853628|NCT00911300|474741714|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
131853629|NCT00911300|474741715|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
131853630|NCT00911300|474741714|FG000|Overall Study|Received Commercial Treatment|1|||
131853631|NCT00911300|474741715|FG001|Overall Study|Received Commercial Treatment|0|||
131853632|NCT00911300|474741714|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
131853633|NCT00911300|474741715|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
131853634|NCT00911300|474741714|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
131853635|NCT00911300|474741715|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
131853636|NCT00911300|474741714|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
131853637|NCT00911300|474741715|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
131853638|NCT00911300|474741714|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
131853639|NCT00911300|474741715|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
131853640|NCT00911300|474741714|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
131853641|NCT00911300|474741715|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
131853642|NCT00911300|474741714|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
131853643|NCT00911300|474741715|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
131853644|NCT00911300|474741714|FG000|Overall Study|International Normalized Ratio Too High|0|||
131853645|NCT00911300|474741715|FG001|Overall Study|International Normalized Ratio Too High|1|||
131853646|NCT00911300|474741714|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
131405159|NCT00350272|473105505|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
131405160|NCT00350272|473105506|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
131405161|NCT00350272|473105505|FG000|Blinded 12-Week Treatment|Death|1|||
131405162|NCT00350272|473105506|FG001|Blinded 12-Week Treatment|Death|0|||
131405163|NCT00350272|473105505|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
131405164|NCT00350272|473105506|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
131405165|NCT00350272|473105505|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
131405166|NCT00350272|473105506|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
131405167|NCT00350272|473105505|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
131405168|NCT00350272|473105506|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
131405169|NCT00350272|473105505|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
131405170|NCT00350272|473105506|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
131405171|NCT00350272|473105505|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
131405172|NCT00350272|473105506|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
131405173|NCT00350272|473105505|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
131405174|NCT00350272|473105506|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
131405175|NCT00350272|473105505|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
131912356|NCT02194465|474966546|FG001|Overall Study|Protocol Violation|1|||
131912357|NCT02194465|474966547|FG002|Overall Study|Protocol Violation|2|||
131405176|NCT00350272|473105506|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
131853647|NCT00911300|474741715|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
131853648|NCT00911300|474741714|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
131853649|NCT00911300|474741715|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
131853650|NCT00911300|474741714|FG000|Overall Study|Physician Decision|0|||
131853651|NCT00911300|474741715|FG001|Overall Study|Physician Decision|1|||
131853652|NCT00911300|474741714|FG000|Overall Study|Treatment Stopped by Mistake|0|||
131853653|NCT00911300|474741715|FG001|Overall Study|Treatment Stopped by Mistake|1|||
131853654|NCT00911300|474741714|FG000|Overall Study|Randomized; No Study Medication Received|0|||
131853655|NCT00911300|474741715|FG001|Overall Study|Randomized; No Study Medication Received|2|||
131853656|NCT05124691|474741716|FG000|Phase II|Eligibility criteria|0|||
131853657|NCT05124691|474741717|FG001|Phase II|Eligibility criteria|1|||
131853658|NCT05124691|474741718|FG002|Phase II|Eligibility criteria|0|||
131853659|NCT05124691|474741716|FG000|Phase II|Withdrawal by Subject|6|||
131853660|NCT05124691|474741717|FG001|Phase II|Withdrawal by Subject|2|||
131853661|NCT05124691|474741718|FG002|Phase II|Withdrawal by Subject|3|||
131853662|NCT05124691|474741716|FG000|Phase III|Withdrawal by Subject|6|||
131853663|NCT05124691|474741717|FG001|Phase III|Withdrawal by Subject|4|||
131853664|NCT05124691|474741718|FG002|Phase III|Withdrawal by Subject|4|||
131853665|NCT05124691|474741716|FG000|Phase III|Lost to Follow-up|1|||
131853666|NCT05124691|474741717|FG001|Phase III|Lost to Follow-up|0|||
131853667|NCT05124691|474741718|FG002|Phase III|Lost to Follow-up|0|||
131853668|NCT00490841|474741728|FG000|Overall Study|Death|5|||
131853669|NCT00490841|474741728|FG000|Overall Study|Withdrawal by Subject|4|||
131853670|NCT00490841|474741728|FG000|Overall Study|Lost to Follow-up|1|||
131853671|NCT00490841|474741728|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
131853672|NCT00447993|474741731|FG000|Overall Study|Lost to Follow-up|0|||
131853673|NCT00447993|474741732|FG001|Overall Study|Lost to Follow-up|0|||
131853674|NCT00447993|474741733|FG002|Overall Study|Lost to Follow-up|2|||
131853675|NCT00447993|474741734|FG003|Overall Study|Lost to Follow-up|2|||
131853676|NCT00447993|474741731|FG000|Overall Study|Withdrawal by Subject|0|||
131853677|NCT00447993|474741732|FG001|Overall Study|Withdrawal by Subject|0|||
131853678|NCT00447993|474741733|FG002|Overall Study|Withdrawal by Subject|2|||
131853679|NCT00447993|474741734|FG003|Overall Study|Withdrawal by Subject|2|||
131853680|NCT01885195|474741739|FG000|Overall Study|Adverse Event|29|||
131853681|NCT01885195|474741739|FG000|Overall Study|Death|1|||
131853682|NCT01885195|474741739|FG000|Overall Study|Disease Progression|67|||
131853683|NCT01885195|474741739|FG000|Overall Study|Protocol Deviation|2|||
131853684|NCT01885195|474741739|FG000|Overall Study|Physician Decision|3|||
131853685|NCT01885195|474741739|FG000|Overall Study|Patient/guardian decision|8|||
131853686|NCT02503787|474741740|FG000|Enrollment|Withdrawal by Subject|6|||
131853687|NCT02503787|474741740|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
131453256|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453257|NCT05019521|473288404|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
131453258|NCT05019521|473288405|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453259|NCT05019521|473288406|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
131453260|NCT05019521|473288407|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
131453261|NCT05019521|473288408|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453262|NCT05019521|473288409|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453263|NCT05019521|473288410|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453264|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
131453265|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
131453266|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
131453267|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
131453268|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
131453269|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
131453270|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
131453271|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
131453272|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
131453273|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
131453274|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453275|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453276|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131453277|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
131453278|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
131453279|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
131453280|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
131453281|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
131453282|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
131453283|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
131453284|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
131453285|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
131453286|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
131453287|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
131453288|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
131453289|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
131453290|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
131453291|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
131453292|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
131453293|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
131453294|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
131453295|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
131453296|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
131453297|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
131453298|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
131453299|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453300|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453301|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453302|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453303|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453304|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
131453305|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
131453306|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
131453307|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
131853688|NCT02503787|474741740|FG000|Enrollment|Physician Decision|2|||
131853689|NCT02503787|474741740|FG000|Enrollment|Insurance issue|2|||
131853690|NCT02503787|474741740|FG000|Enrollment|Lost to Follow-up|1|||
131853691|NCT02503787|474741740|FG000|Enrollment|Study closure|1|||
131853692|NCT02503787|474741740|FG000|Enrollment|Adverse Event|1|||
131853693|NCT02503787|474741740|FG000|Enrollment|Protocol Violation|1|||
131853694|NCT02503787|474741740|FG000|Enrollment|Inability to implant system|1|||
131853695|NCT02503787|474741740|FG000|Enrollment|Unable to be programmed|1|||
131853696|NCT02503787|474741740|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
131853697|NCT02503787|474741740|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
131853698|NCT02503787|474741740|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
131853699|NCT02503787|474741740|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
131853700|NCT02503787|474741740|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
131853701|NCT02503787|474741740|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
131853702|NCT04700137|474741741|FG000|Overall Study|Lost to Follow-up|1|||
131853703|NCT04700137|474741742|FG001|Overall Study|Lost to Follow-up|6|||
131453308|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
131853704|NCT04700137|474741743|FG002|Overall Study|Lost to Follow-up|1|||
131853705|NCT04700137|474741744|FG003|Overall Study|Lost to Follow-up|1|||
131853706|NCT04700137|474741741|FG000|Overall Study|Withdrawal by Subject|0|||
131853707|NCT04700137|474741742|FG001|Overall Study|Withdrawal by Subject|0|||
131853708|NCT04700137|474741743|FG002|Overall Study|Withdrawal by Subject|1|||
131853709|NCT04700137|474741744|FG003|Overall Study|Withdrawal by Subject|0|||
131853710|NCT04700137|474741741|FG000|Overall Study|Death|0|||
131853711|NCT04700137|474741742|FG001|Overall Study|Death|0|||
131853712|NCT04700137|474741743|FG002|Overall Study|Death|1|||
131853713|NCT04700137|474741744|FG003|Overall Study|Death|0|||
131853714|NCT04787627|474741745|FG000|Overall Study|Withdrawal by Subject|3|||
131853715|NCT04787627|474741746|FG001|Overall Study|Withdrawal by Subject|0|||
131853716|NCT04787627|474741745|FG000|Overall Study|Physician Decision|2|||
131853717|NCT04787627|474741746|FG001|Overall Study|Physician Decision|0|||
131853718|NCT04787627|474741745|FG000|Overall Study|Excluded|0|||
131853719|NCT04787627|474741746|FG001|Overall Study|Excluded|1|||
131453309|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453310|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453311|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
131453312|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
131453313|NCT05019521|473288404|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
131453314|NCT05019521|473288405|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
131912358|NCT02194465|474966548|FG003|Overall Study|Protocol Violation|1|||
131912359|NCT02194465|474966549|FG004|Overall Study|Protocol Violation|1|||
131405177|NCT00350272|473105505|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
131405178|NCT00350272|473105506|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
131405179|NCT00350272|473105505|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
131405180|NCT00350272|473105506|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
131405181|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
131405182|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
131405183|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Death|0|||
131405184|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Death|0|||
131405185|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
131405186|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
131405187|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
131405188|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
131405189|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
131405190|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
131405191|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
131405192|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
131405193|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
131405194|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
131405195|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
131405196|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
131405197|NCT00433160|473105513|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
131405198|NCT00433160|473105514|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
131405199|NCT00433160|473105513|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
131405200|NCT00433160|473105514|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
131405201|NCT00433160|473105513|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
131405202|NCT00433160|473105514|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
131405203|NCT00433160|473105513|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
131405204|NCT00433160|473105514|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
131405205|NCT00433160|473105513|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
131405206|NCT00433160|473105514|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
131405207|NCT00433160|473105513|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
131405208|NCT00433160|473105514|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
131405209|NCT00433160|473105513|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
131405210|NCT00433160|473105514|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
131405211|NCT00433160|473105513|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
131453315|NCT05019521|473288406|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
131453316|NCT05019521|473288407|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
131853720|NCT00174954|474741748|FG000|Overall Study|Adverse Event|2|||
131853721|NCT00174954|474741748|FG000|Overall Study|No tophi found in MRI|1|||
131853722|NCT00174954|474741748|FG000|Overall Study|Physician Decision|1|||
131853723|NCT00839254|474741749|FG000|Overall Study|Protocol Violation|0|||
131853724|NCT00839254|474741750|FG001|Overall Study|Protocol Violation|1|||
131853725|NCT00839254|474741751|FG002|Overall Study|Protocol Violation|1|||
131853726|NCT00839254|474741752|FG003|Overall Study|Protocol Violation|1|||
131853727|NCT00839254|474741753|FG004|Overall Study|Protocol Violation|0|||
131853728|NCT00839254|474741754|FG005|Overall Study|Protocol Violation|0|||
131853729|NCT00839254|474741755|FG006|Overall Study|Protocol Violation|1|||
131853730|NCT00839254|474741756|FG007|Overall Study|Protocol Violation|2|||
131853731|NCT00839254|474741749|FG000|Overall Study|Physician Decision|0|||
131853732|NCT00839254|474741750|FG001|Overall Study|Physician Decision|1|||
131853733|NCT00839254|474741751|FG002|Overall Study|Physician Decision|0|||
131853734|NCT00839254|474741752|FG003|Overall Study|Physician Decision|0|||
131853735|NCT00839254|474741753|FG004|Overall Study|Physician Decision|0|||
131853736|NCT00839254|474741754|FG005|Overall Study|Physician Decision|0|||
131853737|NCT00839254|474741755|FG006|Overall Study|Physician Decision|0|||
131853738|NCT00839254|474741756|FG007|Overall Study|Physician Decision|1|||
131912360|NCT02194465|474966550|FG005|Overall Study|Protocol Violation|0|||
131405212|NCT00433160|473105514|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
131853739|NCT00839254|474741749|FG000|Overall Study|Wrong treatment number allocation|0|||
131853740|NCT00839254|474741750|FG001|Overall Study|Wrong treatment number allocation|1|||
131853741|NCT00839254|474741751|FG002|Overall Study|Wrong treatment number allocation|0|||
131853742|NCT00839254|474741752|FG003|Overall Study|Wrong treatment number allocation|0|||
131853743|NCT00839254|474741753|FG004|Overall Study|Wrong treatment number allocation|0|||
131853744|NCT00839254|474741754|FG005|Overall Study|Wrong treatment number allocation|1|||
131853745|NCT00839254|474741755|FG006|Overall Study|Wrong treatment number allocation|0|||
131853746|NCT00839254|474741756|FG007|Overall Study|Wrong treatment number allocation|0|||
131853747|NCT00839254|474741749|FG000|Overall Study|Adverse Event|12|||
131853748|NCT00839254|474741750|FG001|Overall Study|Adverse Event|6|||
131853749|NCT00839254|474741751|FG002|Overall Study|Adverse Event|3|||
131853750|NCT00839254|474741752|FG003|Overall Study|Adverse Event|5|||
131853751|NCT00839254|474741753|FG004|Overall Study|Adverse Event|2|||
131853752|NCT00839254|474741754|FG005|Overall Study|Adverse Event|1|||
131853753|NCT00839254|474741755|FG006|Overall Study|Adverse Event|0|||
131853754|NCT00839254|474741756|FG007|Overall Study|Adverse Event|1|||
131853755|NCT00839254|474741749|FG000|Overall Study|Withdrawal by Subject|87|||
131853756|NCT00839254|474741750|FG001|Overall Study|Withdrawal by Subject|53|||
131853757|NCT00839254|474741751|FG002|Overall Study|Withdrawal by Subject|54|||
131853758|NCT00839254|474741752|FG003|Overall Study|Withdrawal by Subject|32|||
131853759|NCT00839254|474741753|FG004|Overall Study|Withdrawal by Subject|27|||
131853760|NCT00839254|474741754|FG005|Overall Study|Withdrawal by Subject|15|||
131853761|NCT00839254|474741755|FG006|Overall Study|Withdrawal by Subject|22|||
131853762|NCT00839254|474741756|FG007|Overall Study|Withdrawal by Subject|9|||
131853763|NCT00839254|474741749|FG000|Overall Study|Wrong group allocation|0|||
131853764|NCT00839254|474741750|FG001|Overall Study|Wrong group allocation|0|||
131853765|NCT00839254|474741751|FG002|Overall Study|Wrong group allocation|0|||
131853766|NCT00839254|474741752|FG003|Overall Study|Wrong group allocation|0|||
131853767|NCT00839254|474741753|FG004|Overall Study|Wrong group allocation|0|||
131853768|NCT00839254|474741754|FG005|Overall Study|Wrong group allocation|0|||
131853769|NCT00839254|474741755|FG006|Overall Study|Wrong group allocation|1|||
131853770|NCT00839254|474741756|FG007|Overall Study|Wrong group allocation|0|||
131853771|NCT00839254|474741749|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
131853772|NCT00839254|474741750|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
131853773|NCT00839254|474741751|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
131853774|NCT00839254|474741752|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
131853775|NCT00839254|474741753|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
131853776|NCT00839254|474741754|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
131853777|NCT00839254|474741755|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
131853778|NCT00839254|474741756|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
131853779|NCT00839254|474741749|FG000|Overall Study|Withdrawn due to non-compliance|2|||
131853780|NCT00839254|474741750|FG001|Overall Study|Withdrawn due to non-compliance|0|||
131853781|NCT00839254|474741751|FG002|Overall Study|Withdrawn due to non-compliance|0|||
131853782|NCT00839254|474741752|FG003|Overall Study|Withdrawn due to non-compliance|0|||
131853783|NCT00839254|474741753|FG004|Overall Study|Withdrawn due to non-compliance|0|||
131853784|NCT00839254|474741754|FG005|Overall Study|Withdrawn due to non-compliance|0|||
131853785|NCT00839254|474741755|FG006|Overall Study|Withdrawn due to non-compliance|0|||
131853786|NCT00839254|474741756|FG007|Overall Study|Withdrawn due to non-compliance|0|||
131853787|NCT00839254|474741749|FG000|Overall Study|Lost to Follow-up|51|||
131853788|NCT00839254|474741750|FG001|Overall Study|Lost to Follow-up|30|||
131853789|NCT00839254|474741751|FG002|Overall Study|Lost to Follow-up|32|||
131853790|NCT00839254|474741752|FG003|Overall Study|Lost to Follow-up|24|||
131853791|NCT00839254|474741753|FG004|Overall Study|Lost to Follow-up|8|||
131853792|NCT00839254|474741754|FG005|Overall Study|Lost to Follow-up|8|||
131853793|NCT00839254|474741755|FG006|Overall Study|Lost to Follow-up|4|||
131853794|NCT00839254|474741756|FG007|Overall Study|Lost to Follow-up|2|||
131853795|NCT04597632|474741758|FG000|Overall Study|Withdrawal by Subject|10|||
131853796|NCT04597632|474741758|FG000|Overall Study|Lost to Follow-up|1|||
131853797|NCT04597632|474741758|FG000|Overall Study|Death|1|||
131853798|NCT04597632|474741758|FG000|Overall Study|Adverse Event|5|||
131853799|NCT01320150|474741759|FG000|Overall Study|Protocol Violation|15|||
131853800|NCT01320150|474741759|FG000|Overall Study|Withdrawal by Subject|5|||
131853801|NCT01320150|474741759|FG000|Overall Study|Death|2|||
131853802|NCT01320150|474741759|FG000|Overall Study|Lost to Follow-up|44|||
131853803|NCT00919854|474741760|FG000|Overall Study|Adverse Event|1|||
131853804|NCT00985491|474741763|FG000|Overall Study|Adverse Event|8|||
131853805|NCT00985491|474741763|FG000|Overall Study|device migration|7|||
131853806|NCT00985491|474741763|FG000|Overall Study|Withdrawal by Subject|1|||
131853807|NCT00985491|474741763|FG000|Overall Study|implant failure|3|||
131853808|NCT01893346|474741766|FG000|Overall Study|Lost to Follow-up|0|||
131853809|NCT01893346|474741767|FG001|Overall Study|Lost to Follow-up|1|||
131853810|NCT01893346|474741768|FG002|Overall Study|Lost to Follow-up|0|||
131853811|NCT01893346|474741769|FG003|Overall Study|Lost to Follow-up|0|||
131853812|NCT01893346|474741766|FG000|Overall Study|Protocol Violation|1|||
131853813|NCT01893346|474741767|FG001|Overall Study|Protocol Violation|0|||
131853814|NCT01893346|474741768|FG002|Overall Study|Protocol Violation|0|||
131853815|NCT01893346|474741769|FG003|Overall Study|Protocol Violation|0|||
131853816|NCT01893346|474741766|FG000|Overall Study|Withdrawal by Subject|2|||
131853817|NCT01893346|474741767|FG001|Overall Study|Withdrawal by Subject|0|||
131853818|NCT01893346|474741768|FG002|Overall Study|Withdrawal by Subject|0|||
131853819|NCT01893346|474741769|FG003|Overall Study|Withdrawal by Subject|0|||
131853820|NCT00489827|474741774|FG000|Overall Study|Intraoperative exclusion criteria|1|||
131853821|NCT00489827|474741775|FG001|Overall Study|Intraoperative exclusion criteria|1|||
131853822|NCT00489827|474741774|FG000|Overall Study|Intraoperative exclusion criteria|1|||
131853823|NCT00489827|474741775|FG001|Overall Study|Intraoperative exclusion criteria|1|||
131405213|NCT02080481|473105515|FG000|Overall Study|Never received a block.|1|||
131405214|NCT02080481|473105516|FG001|Overall Study|Never received a block.|0|||
131405215|NCT02226198|473106744|FG000|Lead-in Phase|Protocol Violation|1|||
131405216|NCT02226198|473106745|FG001|Lead-in Phase|Protocol Violation|0|||
131405217|NCT02226198|473106746|FG002|Lead-in Phase|Protocol Violation|0|||
131405218|NCT02226198|473106744|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
131405219|NCT02226198|473106745|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
131405220|NCT02226198|473106746|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
131405221|NCT01440517|473106748|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
131405222|NCT01288612|473106750|FG000|Overall Study|Unable to contact|11|||
131405223|NCT01288612|473106751|FG001|Overall Study|Unable to contact|16|||
131405224|NCT01288612|473106752|FG002|Overall Study|Unable to contact|20|||
131405225|NCT01288612|473106750|FG000|Overall Study|Declined|78|||
131405226|NCT01288612|473106751|FG001|Overall Study|Declined|63|||
131405227|NCT01288612|473106752|FG002|Overall Study|Declined|62|||
131405228|NCT01288612|473106750|FG000|Overall Study|Unable to intubate|0|||
131405229|NCT01288612|473106751|FG001|Overall Study|Unable to intubate|3|||
131405230|NCT01288612|473106752|FG002|Overall Study|Unable to intubate|0|||
131405231|NCT00840060|473106753|FG000|Overall Study|Withdrawal by Subject|1|||
131405232|NCT00840060|473106754|FG001|Overall Study|Withdrawal by Subject|0|||
131405233|NCT00840060|473106753|FG000|Overall Study|Change in emotional/behavioral status|0|||
131405234|NCT00840060|473106754|FG001|Overall Study|Change in emotional/behavioral status|1|||
131405235|NCT00871923|473106755|FG000|Overall Study|Death|1|||
131405236|NCT00871923|473106755|FG000|Overall Study|Withdrawal by Subject|1|||
131405237|NCT01263015|473106760|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
131405238|NCT01263015|473106761|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
131405239|NCT01263015|473106760|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
131405240|NCT01263015|473106761|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
131405241|NCT01263015|473106760|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
131405242|NCT01263015|473106761|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
131405243|NCT01263015|473106760|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
131405244|NCT01263015|473106761|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
131405245|NCT01263015|473106760|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
131405246|NCT01263015|473106761|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
131405247|NCT01263015|473106760|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
131405248|NCT01263015|473106761|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
131405249|NCT01263015|473106760|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
131405250|NCT01263015|473106761|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
131405251|NCT01263015|473106760|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
131405252|NCT01263015|473106761|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
131405253|NCT01263015|473106760|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
131405254|NCT01263015|473106761|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
131405255|NCT01263015|473106760|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
131405256|NCT01263015|473106761|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
131405257|NCT01263015|473106760|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
131405258|NCT01263015|473106761|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
131405259|NCT01263015|473106760|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
131405260|NCT01263015|473106761|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
131405261|NCT05599451|473106762|FG000|Overall Study|Not randomized|11|||
131405262|NCT05599451|473106763|FG001|Overall Study|Not randomized|0|||
131405263|NCT05599451|473106764|FG002|Overall Study|Not randomized|0|||
131405264|NCT05599451|473106765|FG003|Overall Study|Not randomized|0|||
131405265|NCT05599451|473106766|FG004|Overall Study|Not randomized|0|||
131405266|NCT05599451|473106762|FG000|Overall Study|Physician Decision|0|||
131405267|NCT05599451|473106763|FG001|Overall Study|Physician Decision|0|||
131405268|NCT05599451|473106764|FG002|Overall Study|Physician Decision|0|||
131453317|NCT05019521|473288408|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
131405269|NCT05599451|473106765|FG003|Overall Study|Physician Decision|1|||
131405270|NCT05599451|473106766|FG004|Overall Study|Physician Decision|0|||
131405271|NCT02723006|473106767|FG000|Overall Study|Withdrawal by Subject|0|||
131853824|NCT02296931|474741776|FG000|Overall Study|Protocol Violation|0|||
131853825|NCT02296931|474741777|FG001|Overall Study|Protocol Violation|2|||
131853826|NCT03736031|474741781|FG000|Overall Study|Death|2|||
131405272|NCT02723006|473106768|FG001|Overall Study|Withdrawal by Subject|1|||
131405273|NCT02723006|473106769|FG002|Overall Study|Withdrawal by Subject|1|||
131405274|NCT02723006|473106767|FG000|Overall Study|Study Terminated by Sponsor|1|||
131405275|NCT02723006|473106768|FG001|Overall Study|Study Terminated by Sponsor|6|||
131405276|NCT02723006|473106769|FG002|Overall Study|Study Terminated by Sponsor|6|||
131405277|NCT00496483|473106770|FG000|Overall Study|Not dosed|9|||
131405278|NCT00496483|473106770|FG000|Overall Study|Adverse Event|2|||
131405279|NCT00496483|473106770|FG000|Overall Study|Lack of Efficacy|1|||
131405280|NCT00303446|473106771|FG000|Overall Study|Withdrawal by Subject|2|||
131405281|NCT00303446|473106772|FG001|Overall Study|Withdrawal by Subject|2|||
131405282|NCT00303446|473106771|FG000|Overall Study|Death|0|||
131405283|NCT00303446|473106772|FG001|Overall Study|Death|1|||
131405284|NCT00303446|473106771|FG000|Overall Study|Physician Decision|0|||
131405285|NCT00303446|473106772|FG001|Overall Study|Physician Decision|1|||
131405286|NCT04258995|473106773|FG000|Overall Study|Lost to Follow-up|1|||
131405287|NCT04258995|473106774|FG001|Overall Study|Lost to Follow-up|1|||
131405288|NCT00642174|473106785|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
131405289|NCT00642174|473106786|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
131405290|NCT00896363|473106787|FG000|Overall Study|Adverse Event|3|||
131405291|NCT00896363|473106788|FG001|Overall Study|Adverse Event|4|||
131405292|NCT00896363|473106789|FG002|Overall Study|Adverse Event|2|||
131405293|NCT00896363|473106787|FG000|Overall Study|Lack of Efficacy|0|||
131405294|NCT00896363|473106788|FG001|Overall Study|Lack of Efficacy|2|||
131405295|NCT00896363|473106789|FG002|Overall Study|Lack of Efficacy|1|||
131405296|NCT00896363|473106787|FG000|Overall Study|Withdrawal by Subject|3|||
131405297|NCT00896363|473106788|FG001|Overall Study|Withdrawal by Subject|5|||
131405298|NCT00896363|473106789|FG002|Overall Study|Withdrawal by Subject|5|||
131405299|NCT00316693|473106794|FG000|Overall Study|Adverse Event|6|||
131405300|NCT00316693|473106795|FG001|Overall Study|Adverse Event|1|||
131405301|NCT00316693|473106794|FG000|Overall Study|Protocol Violation|1|||
131405302|NCT00316693|473106795|FG001|Overall Study|Protocol Violation|0|||
131405303|NCT00316693|473106794|FG000|Overall Study|Withdrawal by Subject|6|||
131405304|NCT00316693|473106795|FG001|Overall Study|Withdrawal by Subject|6|||
131405305|NCT00316693|473106794|FG000|Overall Study|Lost to Follow-up|26|||
131405306|NCT00316693|473106795|FG001|Overall Study|Lost to Follow-up|34|||
131405307|NCT00316693|473106794|FG000|Overall Study|Other|38|||
131405308|NCT00316693|473106795|FG001|Overall Study|Other|44|||
131405309|NCT00413894|473106797|FG000|Overall Study|Withdrawal by Subject|10|||
131405310|NCT00413894|473106797|FG000|Overall Study|Administrative Reasons|1|||
131405311|NCT00413894|473106797|FG000|Overall Study|Hb <10 grams/deciliter|12|||
131405312|NCT00413894|473106797|FG000|Overall Study|Adverse Event|28|||
131405313|NCT00413894|473106797|FG000|Overall Study|Protocol Violation|11|||
131405314|NCT00413894|473106797|FG000|Overall Study|Other|18|||
131405315|NCT04225676|473106798|FG000|Overall Study|Physician Decision|1|||
131405316|NCT04225676|473106798|FG000|Overall Study|Lack of Efficacy|1|||
131405317|NCT04225676|473106798|FG000|Overall Study|Study terminated by sponsor|3|||
131405318|NCT03245736|473106799|FG000|Overall Study|Adverse Event|1|||
131405319|NCT03245736|473106799|FG000|Overall Study|Progressive Disease|4|||
131405320|NCT01942161|473106800|FG000|Overall Study|Adverse Event|1|||
131405321|NCT01942161|473106801|FG001|Overall Study|Adverse Event|2|||
131405322|NCT01942161|473106802|FG002|Overall Study|Adverse Event|5|||
131405323|NCT01942161|473106800|FG000|Overall Study|Physician Decision|3|||
131912361|NCT02194465|474966551|FG006|Overall Study|Protocol Violation|0|||
131405324|NCT01942161|473106801|FG001|Overall Study|Physician Decision|1|||
131405325|NCT01942161|473106802|FG002|Overall Study|Physician Decision|0|||
131405326|NCT01942161|473106800|FG000|Overall Study|Protocol Violation|1|||
131405327|NCT01942161|473106801|FG001|Overall Study|Protocol Violation|0|||
131405328|NCT01942161|473106802|FG002|Overall Study|Protocol Violation|0|||
131405329|NCT01942161|473106800|FG000|Overall Study|Withdrawal by Subject|3|||
131405330|NCT01942161|473106801|FG001|Overall Study|Withdrawal by Subject|3|||
131405331|NCT01942161|473106802|FG002|Overall Study|Withdrawal by Subject|1|||
131405332|NCT02251717|473106806|FG000|Overall Study|Adverse Event|0|||
131405333|NCT02251717|473106807|FG001|Overall Study|Adverse Event|1|||
131405334|NCT02251717|473106806|FG000|Overall Study|Withdrew Consent|1|||
131405335|NCT02251717|473106807|FG001|Overall Study|Withdrew Consent|0|||
131405336|NCT03356977|473106808|FG000|Overall Study|Lost to Follow-up|3|||
131405337|NCT03356977|473106808|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131405338|NCT00354107|473106817|FG000|Overall Study|Adverse Event|2|||
131405339|NCT00354107|473106817|FG000|Overall Study|Physician Decision|2|||
131405340|NCT00354107|473106817|FG000|Overall Study|Withdrawal by Subject|1|||
131405341|NCT04686084|473106821|FG000|Overall Study|Lost to Follow-up|1|||
131405342|NCT05479097|473106824|FG000|Overall Study|Withdrawal by Subject|2|||
131405343|NCT03894969|473106827|FG000|Overall Study|Adverse Event|0|||
131405344|NCT03894969|473106828|FG001|Overall Study|Adverse Event|2|||
131405345|NCT03894969|473106829|FG002|Overall Study|Adverse Event|0|||
131405346|NCT03894969|473106830|FG003|Overall Study|Adverse Event|1|||
131405347|NCT03894969|473106831|FG004|Overall Study|Adverse Event|2|||
131405348|NCT03894969|473106827|FG000|Overall Study|Lost to Follow-up|3|||
131405349|NCT03894969|473106828|FG001|Overall Study|Lost to Follow-up|1|||
131853827|NCT03736031|474741782|FG001|Overall Study|Death|4|||
131853828|NCT03736031|474741781|FG000|Overall Study|Lost to Follow-up|21|||
131853829|NCT03736031|474741782|FG001|Overall Study|Lost to Follow-up|2|||
131853830|NCT03736031|474741781|FG000|Overall Study|Withdrawal by Subject|9|||
131853831|NCT03736031|474741782|FG001|Overall Study|Withdrawal by Subject|0|||
131853832|NCT01290302|474743634|FG000|Overall Study|Adverse Event|2|||
131853833|NCT01290302|474743635|FG001|Overall Study|Adverse Event|0|||
131853834|NCT01290302|474743634|FG000|Overall Study|Withdrawal by Subject|1|||
131853835|NCT01290302|474743635|FG001|Overall Study|Withdrawal by Subject|0|||
131853836|NCT01290302|474743634|FG000|Overall Study|Physician Decision|0|||
131853837|NCT01290302|474743635|FG001|Overall Study|Physician Decision|2|||
131853838|NCT01290302|474743634|FG000|Overall Study|Expiration of time for screening window|1|||
131853839|NCT01290302|474743635|FG001|Overall Study|Expiration of time for screening window|0|||
131853840|NCT01496976|474743636|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
131853841|NCT05938621|474743637|FG000|Overall Study|Lost to Follow-up|1|||
131853842|NCT05938621|474743638|FG001|Overall Study|Lost to Follow-up|5|||
131853843|NCT05938621|474743639|FG002|Overall Study|Lost to Follow-up|2|||
131853844|NCT05938621|474743640|FG003|Overall Study|Lost to Follow-up|2|||
131853845|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
131853846|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
131853847|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
131853848|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
131853849|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
131853850|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
131853851|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
131853852|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
131853853|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
131853854|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
131853855|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
131853856|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
131853857|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
131853858|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
131853859|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
131853860|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
131853861|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
131853862|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
131853863|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
131853864|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
131853865|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
131853866|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
131853867|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
131853868|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
131853869|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
131853870|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
131853871|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
131853872|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
131853873|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
131853874|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
131853875|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
131853876|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
131853877|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
131853878|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
131853879|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
131853880|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
131853881|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
131853882|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
131853883|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
131853884|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
131853885|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
131853886|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
131853887|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
131853888|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
131853889|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
131853890|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
131853891|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131405350|NCT03894969|473106829|FG002|Overall Study|Lost to Follow-up|1|||
131405351|NCT03894969|473106830|FG003|Overall Study|Lost to Follow-up|0|||
131405352|NCT03894969|473106831|FG004|Overall Study|Lost to Follow-up|0|||
131405353|NCT03894969|473106827|FG000|Overall Study|Withdrawal by Subject|2|||
131405354|NCT03894969|473106828|FG001|Overall Study|Withdrawal by Subject|1|||
131405355|NCT03894969|473106829|FG002|Overall Study|Withdrawal by Subject|3|||
131405356|NCT03894969|473106830|FG003|Overall Study|Withdrawal by Subject|4|||
131405357|NCT03894969|473106831|FG004|Overall Study|Withdrawal by Subject|8|||
131405358|NCT03894969|473106827|FG000|Overall Study|Other|0|||
131405359|NCT03894969|473106828|FG001|Overall Study|Other|0|||
131405360|NCT03894969|473106829|FG002|Overall Study|Other|0|||
131405361|NCT03894969|473106830|FG003|Overall Study|Other|0|||
131405362|NCT03894969|473106831|FG004|Overall Study|Other|3|||
131405363|NCT03894969|473106827|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
131405364|NCT03894969|473106828|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
131405365|NCT03894969|473106829|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
131405366|NCT03894969|473106830|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
131405367|NCT03894969|473106831|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
131912362|NCT02194465|474966545|FG000|Overall Study|Withdrawal by Subject|1|||
131912363|NCT02194465|474966546|FG001|Overall Study|Withdrawal by Subject|3|||
131912364|NCT02194465|474966547|FG002|Overall Study|Withdrawal by Subject|1|||
131912365|NCT02194465|474966548|FG003|Overall Study|Withdrawal by Subject|2|||
131912366|NCT02194465|474966549|FG004|Overall Study|Withdrawal by Subject|2|||
131912367|NCT02194465|474966550|FG005|Overall Study|Withdrawal by Subject|1|||
131912368|NCT02194465|474966551|FG006|Overall Study|Withdrawal by Subject|2|||
131912369|NCT02194465|474966545|FG000|Overall Study|Discontinued follow-up period|0|||
131912370|NCT02194465|474966546|FG001|Overall Study|Discontinued follow-up period|2|||
131912371|NCT02194465|474966547|FG002|Overall Study|Discontinued follow-up period|1|||
131912372|NCT02194465|474966548|FG003|Overall Study|Discontinued follow-up period|0|||
131912373|NCT02194465|474966549|FG004|Overall Study|Discontinued follow-up period|2|||
131912374|NCT02194465|474966550|FG005|Overall Study|Discontinued follow-up period|0|||
131912375|NCT02194465|474966551|FG006|Overall Study|Discontinued follow-up period|0|||
131912376|NCT01408641|474966552|FG000|Overall Study|Physician Decision|1|||
131912377|NCT01408641|474966553|FG001|Overall Study|Physician Decision|0|||
131912378|NCT00576758|474966554|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
131912379|NCT00576758|474966555|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
131912380|NCT00576758|474966554|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
131912381|NCT00576758|474966555|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
131912382|NCT00576758|474966554|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
131912383|NCT00576758|474966555|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
131912384|NCT00576758|474966554|FG000|Induction Treatment Period|Death|1|||
131912385|NCT00576758|474966555|FG001|Induction Treatment Period|Death|0|||
131912386|NCT00576758|474966554|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
131853892|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853893|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853894|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853895|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853896|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853897|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853898|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
131853899|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853900|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
131853901|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853902|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853903|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853904|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853905|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853906|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853907|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853908|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853909|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853910|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
131853911|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853912|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853913|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853914|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853915|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131405368|NCT03894969|473106827|FG000|Overall Study|Solicited Adverse Event|0|||
131405369|NCT03894969|473106828|FG001|Overall Study|Solicited Adverse Event|1|||
131405370|NCT03894969|473106829|FG002|Overall Study|Solicited Adverse Event|0|||
131405371|NCT03894969|473106830|FG003|Overall Study|Solicited Adverse Event|0|||
131405372|NCT03894969|473106831|FG004|Overall Study|Solicited Adverse Event|0|||
131405373|NCT00468676|473106833|FG000|Overall Study|Lost to Follow-up|14|||
131853916|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
131853917|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
131853918|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853919|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853920|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853921|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853922|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853923|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853924|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853925|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
131853926|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
131853927|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853928|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853929|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853930|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853931|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853932|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853933|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131853934|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131405374|NCT00468676|473106834|FG001|Overall Study|Lost to Follow-up|11|||
131853935|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
131853936|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131853937|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131853938|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131853939|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131405375|NCT00468676|473106833|FG000|Overall Study|Death|2|||
131405376|NCT00468676|473106834|FG001|Overall Study|Death|1|||
131405377|NCT03006458|473106837|FG000|First Intervention|Unsatisfied Vision|0|||
131405378|NCT03006458|473106838|FG001|First Intervention|Unsatisfied Vision|3|||
131405379|NCT00578877|473106844|FG000|Overall Study|Lost to Follow-up|8|||
131853940|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131853941|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131853942|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131853943|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
131405380|NCT00578877|473106845|FG001|Overall Study|Lost to Follow-up|10|||
131405381|NCT00578877|473106844|FG000|Overall Study|early discontinue|61|||
131405382|NCT00578877|473106845|FG001|Overall Study|early discontinue|101|||
131405383|NCT00578877|473106844|FG000|Overall Study|did not provide follow-up data|12|||
131405384|NCT00578877|473106845|FG001|Overall Study|did not provide follow-up data|17|||
131405385|NCT00737568|473106850|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
131405386|NCT00737568|473106851|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
131405387|NCT00737568|473106850|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
131405388|NCT00737568|473106851|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
131405389|NCT00737568|473106850|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
131405390|NCT00737568|473106851|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
131405391|NCT00737568|473106850|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
131405392|NCT00737568|473106851|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
131405393|NCT00737568|473106850|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
131405394|NCT00737568|473106851|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
131405395|NCT00737568|473106850|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
131405396|NCT00737568|473106851|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
131405397|NCT00737568|473106850|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
131405398|NCT00737568|473106851|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
131405399|NCT00737568|473106850|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
131405400|NCT00737568|473106851|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
131405401|NCT00737568|473106850|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
131405402|NCT00737568|473106851|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
131405403|NCT02910401|473106854|FG000|Overall Study|Study closure Study closure|0|||
131405404|NCT02910401|473106855|FG001|Overall Study|Study closure Study closure|0|||
131405405|NCT02910401|473106856|FG002|Overall Study|Study closure Study closure|2|||
131405406|NCT02910401|473106854|FG000|Overall Study|Physician Decision|1|||
131405407|NCT02910401|473106855|FG001|Overall Study|Physician Decision|0|||
131453318|NCT05019521|473288409|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
131405408|NCT02910401|473106856|FG002|Overall Study|Physician Decision|0|||
131853944|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853945|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
131853946|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
131853947|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853948|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853949|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853950|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853951|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853952|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131853953|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
131853954|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
131853955|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853956|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853957|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853958|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853959|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853960|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853961|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
131853962|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853963|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
131853964|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853965|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853966|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853967|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853968|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853969|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853970|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
131853971|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853972|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
131853973|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853974|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853975|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853976|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853977|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853978|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853979|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
131853980|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853981|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853982|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
131853983|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853984|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853985|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853986|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853987|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853988|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
131853989|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853990|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853991|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
131853992|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853993|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853994|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853995|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853996|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853997|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131853998|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131853999|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131854000|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
131854001|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131854002|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131854003|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131912387|NCT00576758|474966555|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
131912388|NCT00576758|474966554|FG000|Induction Treatment Period|Withdrew consent|1|||
131912389|NCT00576758|474966555|FG001|Induction Treatment Period|Withdrew consent|0|||
131912390|NCT00576758|474966554|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
131912391|NCT00576758|474966555|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
131405409|NCT03300024|473106857|FG000|Overall Study|Physician Decision|4|||
131405410|NCT03300024|473106858|FG001|Overall Study|Physician Decision|6|||
131405411|NCT03222973|473106861|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
131405412|NCT03222973|473106862|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
131405413|NCT03222973|473106863|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
131405414|NCT03222973|473106864|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
131405415|NCT03222973|473106861|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
131405416|NCT03222973|473106862|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
131405417|NCT03222973|473106863|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
131405418|NCT03222973|473106864|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
131405419|NCT03222973|473106861|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
131405420|NCT03222973|473106862|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
131405421|NCT03222973|473106863|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
131405422|NCT03222973|473106864|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
131405423|NCT03222973|473106861|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
131405424|NCT03222973|473106862|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
131405425|NCT03222973|473106863|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
131405426|NCT03222973|473106864|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
131405427|NCT03222973|473106861|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
131405428|NCT03222973|473106862|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
131405429|NCT03222973|473106863|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
131405430|NCT03222973|473106864|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
131405431|NCT03222973|473106861|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
131405432|NCT03222973|473106862|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
131405433|NCT03222973|473106863|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
131405434|NCT03222973|473106864|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
131405435|NCT03222973|473106861|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
131405436|NCT03222973|473106862|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
131405437|NCT03222973|473106863|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
131405438|NCT03222973|473106864|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
131405439|NCT03222973|473106861|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
131405440|NCT03222973|473106862|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
131405441|NCT03222973|473106863|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
131405442|NCT03222973|473106864|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
131405443|NCT03222973|473106861|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
131405444|NCT03222973|473106862|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
131405445|NCT03222973|473106863|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
131405446|NCT03222973|473106864|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
131405447|NCT03222973|473106861|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
131405448|NCT03222973|473106862|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
131405449|NCT03222973|473106863|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
131405450|NCT03222973|473106864|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
131405451|NCT03222973|473106861|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
131405452|NCT03222973|473106862|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
131405453|NCT03222973|473106863|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
131405454|NCT03222973|473106864|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
131405455|NCT03222973|473106861|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
131405456|NCT03222973|473106862|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
131405457|NCT03222973|473106863|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
131405458|NCT03222973|473106864|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
131405459|NCT03551665|473106865|FG000|Overall Study|Lost to Follow-up|11|||
131405460|NCT03551665|473106866|FG001|Overall Study|Lost to Follow-up|2|||
131405461|NCT00428220|473108884|FG000|Overall Study|Participant died|8|||
131405462|NCT00428220|473108884|FG000|Overall Study|Global deterioration of health status|7|||
131405463|NCT00428220|473108884|FG000|Overall Study|Lost to Follow-up|4|||
131405464|NCT00428220|473108884|FG000|Overall Study|Objective progression or relapse|123|||
131405465|NCT00428220|473108884|FG000|Overall Study|Participant refused continued treatment|7|||
131405466|NCT00428220|473108884|FG000|Overall Study|Adverse Event|51|||
131405467|NCT00428220|473108884|FG000|Overall Study|Other|23|||
131405468|NCT00378599|473108885|FG000|Overall Study|Adverse Event|38|||
131405469|NCT00378599|473108885|FG000|Overall Study|Protocol Violation|2|||
131405470|NCT00378599|473108885|FG000|Overall Study|Treatment failure|7|||
131405471|NCT00378599|473108885|FG000|Overall Study|Withdrawal by Subject|5|||
131405472|NCT03920293|473108886|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
131405473|NCT03920293|473108887|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
131453319|NCT05019521|473288410|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
131453320|NCT01147874|473288411|FG000|Overall Study|Adverse Event|5|||
131453321|NCT01147874|473288411|FG000|Overall Study|Investigator's Request|1|||
131453322|NCT01147874|473288411|FG000|Overall Study|Lost to Follow-up|25|||
131453323|NCT01147874|473288411|FG000|Overall Study|Other|5|||
131453324|NCT01147874|473288411|FG000|Overall Study|Protocol Violation|5|||
131453325|NCT01147874|473288411|FG000|Overall Study|Sponsor's Decision|2|||
131453326|NCT01147874|473288411|FG000|Overall Study|Withdrawal by Subject|24|||
131453327|NCT00467753|473288420|FG000|Overall Study|Lost to Follow-up|1|||
131453328|NCT00467753|473288421|FG001|Overall Study|Lost to Follow-up|2|||
131453329|NCT00467753|473288420|FG000|Overall Study|Adverse Event|2|||
131453330|NCT00467753|473288421|FG001|Overall Study|Adverse Event|0|||
131453331|NCT02175030|473288422|FG000|Overall Study|Failed screen after consent|7|||
131453332|NCT02175030|473288423|FG001|Overall Study|Failed screen after consent|6|||
131453333|NCT02175030|473288422|FG000|Overall Study|Failed IUD Insertion|20|||
131453334|NCT02175030|473288423|FG001|Overall Study|Failed IUD Insertion|21|||
131453335|NCT02175030|473288422|FG000|Overall Study|Physician Decision|1|||
131453336|NCT02175030|473288423|FG001|Overall Study|Physician Decision|1|||
131453337|NCT02175030|473288422|FG000|Overall Study|Lost to Follow-up|6|||
131453338|NCT02175030|473288423|FG001|Overall Study|Lost to Follow-up|6|||
131453339|NCT02175030|473288422|FG000|Overall Study|Withdrawal by Subject|1|||
131453340|NCT02175030|473288423|FG001|Overall Study|Withdrawal by Subject|4|||
131453341|NCT02533453|473288424|FG000|Overall Study|Adverse Event|6|||
131453342|NCT02533453|473288424|FG000|Overall Study|Protocol Violation|1|||
131453343|NCT02533453|473288424|FG000|Overall Study|Withdrawal by Subject|2|||
131453344|NCT04292899|473288427|FG000|Overall Study|Death|21|||
131453345|NCT04292899|473288428|FG001|Overall Study|Death|28|||
131453346|NCT04292899|473288429|FG002|Overall Study|Death|188|||
131453347|NCT04292899|473288430|FG003|Overall Study|Death|371|||
131453348|NCT04292899|473288427|FG000|Overall Study|Lost to Follow-up|8|||
131453349|NCT04292899|473288428|FG001|Overall Study|Lost to Follow-up|4|||
131453350|NCT04292899|473288429|FG002|Overall Study|Lost to Follow-up|22|||
131453351|NCT04292899|473288430|FG003|Overall Study|Lost to Follow-up|235|||
131453352|NCT04292899|473288427|FG000|Overall Study|Withdrew consent|1|||
131453353|NCT04292899|473288428|FG001|Overall Study|Withdrew consent|0|||
131453354|NCT04292899|473288429|FG002|Overall Study|Withdrew consent|11|||
131453355|NCT04292899|473288430|FG003|Overall Study|Withdrew consent|32|||
131453356|NCT04292899|473288427|FG000|Overall Study|Adverse Event|2|||
131453357|NCT04292899|473288428|FG001|Overall Study|Adverse Event|1|||
131453358|NCT04292899|473288429|FG002|Overall Study|Adverse Event|2|||
131453359|NCT04292899|473288430|FG003|Overall Study|Adverse Event|2|||
131453360|NCT04292899|473288427|FG000|Overall Study|Investigator's Discretion|0|||
131453361|NCT04292899|473288428|FG001|Overall Study|Investigator's Discretion|0|||
131453362|NCT04292899|473288429|FG002|Overall Study|Investigator's Discretion|0|||
131453363|NCT04292899|473288430|FG003|Overall Study|Investigator's Discretion|3|||
131453364|NCT04292899|473288427|FG000|Overall Study|Non-compliance With Study Drug|0|||
131453365|NCT04292899|473288428|FG001|Overall Study|Non-compliance With Study Drug|0|||
131453366|NCT04292899|473288429|FG002|Overall Study|Non-compliance With Study Drug|0|||
131453367|NCT04292899|473288430|FG003|Overall Study|Non-compliance With Study Drug|1|||
131912392|NCT00576758|474966554|FG000|Extension Treatment Period|Death|1|||
131912393|NCT00576758|474966555|FG001|Extension Treatment Period|Death|1|||
131912394|NCT00576758|474966554|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
131912395|NCT00576758|474966555|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
131912396|NCT00576758|474966554|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
131912397|NCT00576758|474966555|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
131912398|NCT00576758|474966554|FG000|Extension Treatment Period|Administrative/Other|3|||
131912399|NCT00576758|474966555|FG001|Extension Treatment Period|Administrative/Other|1|||
131912400|NCT00576758|474966554|FG000|Follow-up Period|Administrative/Other|6|||
131912401|NCT00576758|474966555|FG001|Follow-up Period|Administrative/Other|8|||
131912402|NCT00576758|474966554|FG000|Follow-up Period|Death|3|||
131912403|NCT00576758|474966555|FG001|Follow-up Period|Death|3|||
131453368|NCT04292899|473288427|FG000|Overall Study|Protocol Violation|0|||
131453369|NCT04292899|473288428|FG001|Overall Study|Protocol Violation|0|||
131912404|NCT00576758|474966554|FG000|Follow-up Period|Insufficient therapeutic response|16|||
131912405|NCT00576758|474966555|FG001|Follow-up Period|Insufficient therapeutic response|5|||
131912406|NCT00576758|474966554|FG000|Follow-up Period|Withdrew consent|2|||
131912407|NCT00576758|474966555|FG001|Follow-up Period|Withdrew consent|1|||
131453370|NCT04292899|473288429|FG002|Overall Study|Protocol Violation|0|||
131453371|NCT04292899|473288430|FG003|Overall Study|Protocol Violation|1|||
131453372|NCT01209325|473288436|FG000|Overall Study|Lost to Follow-up|24|||
131453373|NCT01209325|473288436|FG000|Overall Study|Adverse Event|1|||
131453374|NCT01209325|473288436|FG000|Overall Study|Relocated|3|||
131453375|NCT01209325|473288436|FG000|Overall Study|Refusal after starting therapy|8|||
131453376|NCT01209325|473288436|FG000|Overall Study|Protocol Violation|4|||
131912408|NCT00089648|474966556|FG000|Overall Study|Adverse Event|7|||
131453377|NCT01209325|473288436|FG000|Overall Study|Refusal prior to therapy|1|||
131453378|NCT01209325|473288436|FG000|Overall Study|Incarceration|2|||
131453379|NCT00396253|473288437|FG000|Overall Study|Protocol Violation|1|||
131453380|NCT00396253|473288437|FG000|Overall Study|Withdrawal by Subject|7|||
131453381|NCT00396253|473288437|FG000|Overall Study|Death|3|||
131453382|NCT00396253|473288437|FG000|Overall Study|Physician Decision|1|||
131453383|NCT00396253|473288437|FG000|Overall Study|Change in eligibility status|1|||
131453384|NCT05340478|473288439|FG000|Overall Study|Scheduling Issues|10|||
131453385|NCT05340478|473288440|FG001|Overall Study|Scheduling Issues|4|||
131453386|NCT05340478|473288439|FG000|Overall Study|Neither member of dyad started treatment|2|||
131453387|NCT05340478|473288440|FG001|Overall Study|Neither member of dyad started treatment|2|||
131453388|NCT05340478|473288439|FG000|Overall Study|Withdrawn from study|2|||
131453389|NCT05340478|473288440|FG001|Overall Study|Withdrawn from study|2|||
131453390|NCT05340478|473288439|FG000|Overall Study|Lost to Follow-up|1|||
131453391|NCT05340478|473288440|FG001|Overall Study|Lost to Follow-up|4|||
131453392|NCT02506244|473288443|FG000|Overall Study|Did not undergo active monitoring|458|||
131453393|NCT02506244|473288444|FG001|Overall Study|Did not undergo active monitoring|459|||
131453394|NCT02506244|473288445|FG002|Overall Study|Did not undergo active monitoring|0|||
131453395|NCT00314795|473288446|FG000|Overall Study|Adverse Event|8|||
131453396|NCT00314795|473288446|FG000|Overall Study|Death|4|||
131453397|NCT00314795|473288446|FG000|Overall Study|Reason not Specified|3|||
131453398|NCT00314795|473288446|FG000|Overall Study|Renal Transplant|3|||
131453399|NCT00314795|473288446|FG000|Overall Study|Participants Withdrew Consent|2|||
131453400|NCT02541604|473288450|FG000|Overall Study|Death|6|||
131453401|NCT02541604|473288451|FG001|Overall Study|Death|5|||
131453402|NCT02541604|473288452|FG002|Overall Study|Death|7|||
131453403|NCT02541604|473288453|FG003|Overall Study|Death|2|||
131453404|NCT02541604|473288454|FG004|Overall Study|Death|9|||
131453405|NCT02541604|473288455|FG005|Overall Study|Death|8|||
131453406|NCT02541604|473288456|FG006|Overall Study|Death|9|||
131453407|NCT02541604|473288457|FG007|Overall Study|Death|9|||
131453408|NCT02541604|473288458|FG008|Overall Study|Death|3|||
131453409|NCT02541604|473288459|FG009|Overall Study|Death|4|||
131453410|NCT02541604|473288460|FG010|Overall Study|Death|2|||
131453411|NCT02541604|473288461|FG011|Overall Study|Death|3|||
131453412|NCT02541604|473288450|FG000|Overall Study|Lost to Follow-up|2|||
131453413|NCT02541604|473288451|FG001|Overall Study|Lost to Follow-up|0|||
131453414|NCT02541604|473288452|FG002|Overall Study|Lost to Follow-up|1|||
131453415|NCT02541604|473288453|FG003|Overall Study|Lost to Follow-up|0|||
131453416|NCT02541604|473288454|FG004|Overall Study|Lost to Follow-up|0|||
131453417|NCT02541604|473288455|FG005|Overall Study|Lost to Follow-up|1|||
131854004|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131854005|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131854006|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131854007|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854008|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854009|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854010|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854011|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854012|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854013|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
131854014|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854015|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131854016|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
131854017|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
131854018|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131854019|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131854020|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131854021|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131854022|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131453418|NCT02541604|473288456|FG006|Overall Study|Lost to Follow-up|1|||
131453419|NCT02541604|473288457|FG007|Overall Study|Lost to Follow-up|0|||
131453420|NCT02541604|473288458|FG008|Overall Study|Lost to Follow-up|0|||
131453421|NCT02541604|473288459|FG009|Overall Study|Lost to Follow-up|0|||
131453422|NCT02541604|473288460|FG010|Overall Study|Lost to Follow-up|0|||
131453423|NCT02541604|473288461|FG011|Overall Study|Lost to Follow-up|0|||
131453424|NCT02541604|473288450|FG000|Overall Study|Withdrawal by Subject|2|||
131453425|NCT02541604|473288451|FG001|Overall Study|Withdrawal by Subject|0|||
131453426|NCT02541604|473288452|FG002|Overall Study|Withdrawal by Subject|1|||
131453427|NCT02541604|473288453|FG003|Overall Study|Withdrawal by Subject|0|||
131453428|NCT02541604|473288454|FG004|Overall Study|Withdrawal by Subject|1|||
131453429|NCT02541604|473288455|FG005|Overall Study|Withdrawal by Subject|1|||
131453430|NCT02541604|473288456|FG006|Overall Study|Withdrawal by Subject|0|||
131854023|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131854024|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
131854025|NCT03598790|474743641|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854026|NCT03598790|474743642|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854027|NCT03598790|474743643|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
131854028|NCT03598790|474743644|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854029|NCT03598790|474743645|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854030|NCT03598790|474743646|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854031|NCT03598790|474743647|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854032|NCT03598790|474743648|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854033|NCT03598790|474743649|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131854034|NCT03598790|474743641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131854035|NCT03598790|474743642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131854036|NCT03598790|474743643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131854037|NCT03598790|474743644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
131854038|NCT03598790|474743645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
131854039|NCT03598790|474743646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
131854040|NCT03598790|474743647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131854041|NCT03598790|474743648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131854042|NCT03598790|474743649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131854043|NCT03598790|474743641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854044|NCT03598790|474743642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854045|NCT03598790|474743643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854046|NCT03598790|474743644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
131854047|NCT03598790|474743645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854048|NCT03598790|474743646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854049|NCT03598790|474743647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854050|NCT03598790|474743648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854051|NCT03598790|474743649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
131854052|NCT03598790|474743641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131854053|NCT03598790|474743642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131854054|NCT03598790|474743643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131854055|NCT03598790|474743644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
131854056|NCT03598790|474743645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131854057|NCT03598790|474743646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131854058|NCT03598790|474743647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131405474|NCT03920293|473108886|FG000|Randomized-Controlled Period|Physician Decision|1|||
131854059|NCT03598790|474743648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131854060|NCT03598790|474743649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131405475|NCT03920293|473108887|FG001|Randomized-Controlled Period|Physician Decision|2|||
131405476|NCT03920293|473108886|FG000|Randomized-Controlled Period|Adverse Event|0|||
131405477|NCT03920293|473108887|FG001|Randomized-Controlled Period|Adverse Event|2|||
131405478|NCT03920293|473108886|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
131405479|NCT03920293|473108887|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
131405480|NCT03920293|473108886|FG000|Randomized-Controlled Period|Death|2|||
131405481|NCT03920293|473108887|FG001|Randomized-Controlled Period|Death|0|||
131405482|NCT03920293|473108886|FG000|Randomized-Controlled Period|Protocol Violation|1|||
131405483|NCT03920293|473108887|FG001|Randomized-Controlled Period|Protocol Violation|0|||
131405484|NCT03920293|473108886|FG000|Randomized-Controlled Period|Noncompliance|1|||
131405485|NCT03920293|473108887|FG001|Randomized-Controlled Period|Noncompliance|0|||
131405486|NCT03920293|473108886|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
131405487|NCT03920293|473108887|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
131405488|NCT03920293|473108886|FG000|Open- Label Extension Period|Death|3|||
131405489|NCT03920293|473108887|FG001|Open- Label Extension Period|Death|3|||
131405490|NCT03920293|473108886|FG000|Open- Label Extension Period|Physician Decision|5|||
131405491|NCT03920293|473108887|FG001|Open- Label Extension Period|Physician Decision|3|||
131405492|NCT03920293|473108886|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
131854061|NCT03598790|474743641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854062|NCT03598790|474743642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854063|NCT03598790|474743643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854064|NCT03598790|474743644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
131854065|NCT03598790|474743645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
131854066|NCT03598790|474743646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854067|NCT03598790|474743647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854068|NCT03598790|474743648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854069|NCT03598790|474743649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
131854070|NCT03598790|474743641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854071|NCT03598790|474743642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854072|NCT03598790|474743643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854073|NCT03598790|474743644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
131854074|NCT03598790|474743645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854075|NCT03598790|474743646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854076|NCT03598790|474743647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854077|NCT03598790|474743648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854078|NCT03598790|474743649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131854079|NCT05292183|474743655|FG000|Overall Study|Adverse Event|1|||
131854080|NCT03631199|474743657|FG000|Overall Study|Progressive disease|9|||
131854081|NCT03631199|474743658|FG001|Overall Study|Progressive disease|5|||
131854082|NCT03631199|474743659|FG002|Overall Study|Progressive disease|5|||
131854083|NCT03631199|474743660|FG003|Overall Study|Progressive disease|149|||
131854084|NCT03631199|474743661|FG004|Overall Study|Progressive disease|148|||
131854085|NCT03631199|474743657|FG000|Overall Study|Physician Decision|0|||
131854086|NCT03631199|474743658|FG001|Overall Study|Physician Decision|2|||
131854087|NCT03631199|474743659|FG002|Overall Study|Physician Decision|3|||
131854088|NCT03631199|474743660|FG003|Overall Study|Physician Decision|19|||
131854089|NCT03631199|474743661|FG004|Overall Study|Physician Decision|13|||
131854090|NCT03631199|474743657|FG000|Overall Study|Adverse Event|1|||
131854091|NCT03631199|474743658|FG001|Overall Study|Adverse Event|1|||
131854092|NCT03631199|474743659|FG002|Overall Study|Adverse Event|0|||
131854093|NCT03631199|474743660|FG003|Overall Study|Adverse Event|28|||
131854094|NCT03631199|474743661|FG004|Overall Study|Adverse Event|29|||
131854095|NCT03631199|474743657|FG000|Overall Study|Death|0|||
131854096|NCT03631199|474743658|FG001|Overall Study|Death|1|||
131854097|NCT03631199|474743659|FG002|Overall Study|Death|0|||
131854098|NCT03631199|474743660|FG003|Overall Study|Death|35|||
131854099|NCT03631199|474743661|FG004|Overall Study|Death|48|||
131854100|NCT03631199|474743657|FG000|Overall Study|Subject decision|0|||
131854101|NCT03631199|474743658|FG001|Overall Study|Subject decision|1|||
131854102|NCT03631199|474743659|FG002|Overall Study|Subject decision|0|||
131854103|NCT03631199|474743660|FG003|Overall Study|Subject decision|12|||
131854104|NCT03631199|474743661|FG004|Overall Study|Subject decision|12|||
131854105|NCT03631199|474743657|FG000|Overall Study|No treated|0|||
131854106|NCT03631199|474743658|FG001|Overall Study|No treated|0|||
131854107|NCT03631199|474743659|FG002|Overall Study|No treated|0|||
131854108|NCT03631199|474743660|FG003|Overall Study|No treated|0|||
131854109|NCT03631199|474743661|FG004|Overall Study|No treated|1|||
131854110|NCT03631199|474743657|FG000|Overall Study|Treatment ongoing|0|||
131854111|NCT03631199|474743658|FG001|Overall Study|Treatment ongoing|1|||
131854112|NCT03631199|474743659|FG002|Overall Study|Treatment ongoing|1|||
131854113|NCT03631199|474743660|FG003|Overall Study|Treatment ongoing|76|||
131854114|NCT03631199|474743661|FG004|Overall Study|Treatment ongoing|71|||
131854115|NCT03631199|474743657|FG000|Overall Study|Guardian decision|0|||
131854116|NCT03631199|474743658|FG001|Overall Study|Guardian decision|0|||
131854117|NCT03631199|474743659|FG002|Overall Study|Guardian decision|0|||
131854118|NCT03631199|474743660|FG003|Overall Study|Guardian decision|1|||
131854119|NCT03631199|474743661|FG004|Overall Study|Guardian decision|1|||
131854120|NCT01272037|474743662|FG000|Overall Study|Death|25|||
131854121|NCT01272037|474743663|FG001|Overall Study|Death|28|||
131854122|NCT01272037|474743662|FG000|Overall Study|Adverse Event|12|||
131854123|NCT01272037|474743663|FG001|Overall Study|Adverse Event|7|||
131854124|NCT01272037|474743662|FG000|Overall Study|Withdrawal by Subject|175|||
131854125|NCT01272037|474743663|FG001|Overall Study|Withdrawal by Subject|93|||
131854126|NCT01272037|474743662|FG000|Overall Study|Disease progression|70|||
131854127|NCT01272037|474743663|FG001|Overall Study|Disease progression|111|||
131854128|NCT01272037|474743662|FG000|Overall Study|Other reason|42|||
131854129|NCT01272037|474743663|FG001|Overall Study|Other reason|41|||
131854130|NCT01272037|474743662|FG000|Overall Study|Delinquent data|24|||
131854131|NCT01272037|474743663|FG001|Overall Study|Delinquent data|19|||
131854132|NCT01272037|474743662|FG000|Overall Study|Reason under review|33|||
131854133|NCT01272037|474743663|FG001|Overall Study|Reason under review|29|||
131854134|NCT01272037|474743662|FG000|Overall Study|On treatment|626|||
131854135|NCT01272037|474743663|FG001|Overall Study|On treatment|632|||
131854136|NCT01769456|474743664|FG000|Overall Study|Lost to Follow-up|19|||
131854137|NCT01769456|474743664|FG000|Overall Study|Withdrawal by Subject|3|||
131854138|NCT01769456|474743664|FG000|Overall Study|Did not receive PCC intervention|6|||
131854139|NCT01769456|474743664|FG000|Overall Study|Moved out of the area|3|||
131854140|NCT01769456|474743664|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
131854141|NCT01769456|474743664|FG000|Overall Study|Parental request to youth to withdraw|1|||
131854142|NCT00064987|474743669|FG000|Overall Study|Physician Decision|3|||
131854143|NCT00064987|474743670|FG001|Overall Study|Physician Decision|0|||
131854144|NCT01977417|474743678|FG000|Overall Study|Adverse Event|1|||
131854145|NCT01977417|474743679|FG001|Overall Study|Adverse Event|0|||
131854146|NCT01977417|474743678|FG000|Overall Study|Withdrawal by Subject|2|||
131854147|NCT01977417|474743679|FG001|Overall Study|Withdrawal by Subject|4|||
131854148|NCT01977417|474743678|FG000|Overall Study|Female enrollment goal met|0|||
131854149|NCT01977417|474743679|FG001|Overall Study|Female enrollment goal met|2|||
131854150|NCT01692626|474743680|FG000|Overall Study|Death|0|||
131854151|NCT01692626|474743681|FG001|Overall Study|Death|1|||
131854152|NCT01692626|474743680|FG000|Overall Study|Adverse Event|2|||
131854153|NCT01692626|474743681|FG001|Overall Study|Adverse Event|3|||
131854154|NCT01692626|474743680|FG000|Overall Study|Protocol Violation|1|||
131854155|NCT01692626|474743681|FG001|Overall Study|Protocol Violation|2|||
131854156|NCT01692626|474743680|FG000|Overall Study|Withdrawal by Subject|1|||
131854157|NCT01692626|474743681|FG001|Overall Study|Withdrawal by Subject|0|||
131854158|NCT00855894|474743682|FG000|Overall Study|Death|31|||
131854159|NCT00855894|474743682|FG000|Overall Study|Patient's decision|1|||
131854160|NCT00855894|474743682|FG000|Overall Study|Disease progression|1|||
131854161|NCT04976621|474743683|FG000|Overall Study|Lost to Follow-up|2|||
131854162|NCT04976621|474743684|FG001|Overall Study|Lost to Follow-up|1|||
131854163|NCT04976621|474743683|FG000|Overall Study|Withdrawal by Subject|1|||
131854164|NCT04976621|474743684|FG001|Overall Study|Withdrawal by Subject|0|||
131854165|NCT01625988|474743696|FG000|Overall Study|Lost to Follow-up|5|||
131854166|NCT01625988|474743697|FG001|Overall Study|Lost to Follow-up|6|||
131854167|NCT01625988|474743696|FG000|Overall Study|Withdrawal by Subject|8|||
131854168|NCT01625988|474743697|FG001|Overall Study|Withdrawal by Subject|3|||
131854169|NCT01625988|474743696|FG000|Overall Study|Adverse Event|0|||
131854170|NCT01625988|474743697|FG001|Overall Study|Adverse Event|1|||
131854171|NCT01625988|474743696|FG000|Overall Study|Lack of Efficacy|0|||
131854172|NCT01625988|474743697|FG001|Overall Study|Lack of Efficacy|1|||
131854173|NCT01625988|474743696|FG000|Overall Study|Randomized Inappropriately|1|||
131854174|NCT01625988|474743697|FG001|Overall Study|Randomized Inappropriately|0|||
131854175|NCT01625988|474743696|FG000|Overall Study|Protocol Violation|0|||
131854176|NCT01625988|474743697|FG001|Overall Study|Protocol Violation|2|||
131854177|NCT01495702|474743698|FG000|Randomized Phase|Randomized But Not Treated|1|||
131854178|NCT01495702|474743699|FG001|Randomized Phase|Randomized But Not Treated|4|||
131854179|NCT01495702|474743698|FG000|Randomized Phase|Adverse Event|2|||
131854180|NCT01495702|474743699|FG001|Randomized Phase|Adverse Event|2|||
131854181|NCT01495702|474743698|FG000|Randomized Phase|Death|1|||
131854182|NCT01495702|474743699|FG001|Randomized Phase|Death|0|||
131854183|NCT01495702|474743698|FG000|Randomized Phase|Lack of Efficacy|2|||
131854184|NCT01495702|474743699|FG001|Randomized Phase|Lack of Efficacy|0|||
131854185|NCT01495702|474743698|FG000|Randomized Phase|Investigators Discretion|2|||
131854186|NCT01495702|474743699|FG001|Randomized Phase|Investigators Discretion|0|||
131854187|NCT01495702|474743698|FG000|Randomized Phase|Withdrew Consent|10|||
131854188|NCT01495702|474743699|FG001|Randomized Phase|Withdrew Consent|18|||
131854189|NCT01495702|474743698|FG000|Randomized Phase|Lost to Follow-up|4|||
131854190|NCT01495702|474743699|FG001|Randomized Phase|Lost to Follow-up|3|||
131854191|NCT01495702|474743698|FG000|Randomized Phase|Participant Noncompliance|1|||
131854192|NCT01495702|474743699|FG001|Randomized Phase|Participant Noncompliance|0|||
131854193|NCT01495702|474743698|FG000|Randomized Phase|Protocol Violation|3|||
131854194|NCT01495702|474743699|FG001|Randomized Phase|Protocol Violation|1|||
131854195|NCT04152863|474743700|FG000|Overall Study|Death|13|||
131854196|NCT04152863|474743701|FG001|Overall Study|Death|12|||
131854197|NCT04152863|474743702|FG002|Overall Study|Death|7|||
131854198|NCT04152863|474743700|FG000|Overall Study|Physician Decision|1|||
131854199|NCT04152863|474743701|FG001|Overall Study|Physician Decision|1|||
131854200|NCT04152863|474743702|FG002|Overall Study|Physician Decision|1|||
131854201|NCT04152863|474743700|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
131854202|NCT04152863|474743701|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
131854203|NCT04152863|474743702|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
131854204|NCT04152863|474743700|FG000|Overall Study|Withdrawal by Subject|2|||
131854205|NCT04152863|474743701|FG001|Overall Study|Withdrawal by Subject|1|||
131854206|NCT04152863|474743702|FG002|Overall Study|Withdrawal by Subject|3|||
131854207|NCT01644617|474743703|FG000|Overall Study|Withdrawal by Subject|3|||
131854208|NCT01644617|474743704|FG001|Overall Study|Withdrawal by Subject|4|||
131854209|NCT01644617|474743705|FG002|Overall Study|Withdrawal by Subject|1|||
131854210|NCT01644617|474743703|FG000|Overall Study|Lost to Follow-up|0|||
131405493|NCT03920293|473108887|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
131854211|NCT01644617|474743704|FG001|Overall Study|Lost to Follow-up|1|||
131854212|NCT01644617|474743705|FG002|Overall Study|Lost to Follow-up|0|||
131854213|NCT01644617|474743703|FG000|Overall Study|Adverse Event|3|||
131854214|NCT01644617|474743704|FG001|Overall Study|Adverse Event|0|||
131854215|NCT01644617|474743705|FG002|Overall Study|Adverse Event|6|||
131854216|NCT05223920|474743709|FG000|Overall Study|Adverse Event|6|||
131854217|NCT05223920|474743710|FG001|Overall Study|Adverse Event|3|||
131405494|NCT01691885|473108888|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
131405495|NCT01691885|473108889|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
131912409|NCT00089648|474966556|FG000|Overall Study|Withdrawal by Subject|1|||
131912410|NCT00089648|474966556|FG000|Overall Study|Lack of Efficacy|33|||
131912411|NCT00423605|474966557|FG000|Overall Study|Adverse Event|129|||
131912412|NCT00423605|474966557|FG000|Overall Study|Withdrawal by Subject|36|||
131912413|NCT00423605|474966557|FG000|Overall Study|Lost to Follow-up|15|||
131912414|NCT00423605|474966557|FG000|Overall Study|Lack of Efficacy|38|||
131912415|NCT00423605|474966557|FG000|Overall Study|Sponsor Decision|3|||
131912416|NCT00423605|474966557|FG000|Overall Study|Physician Decision|8|||
131912417|NCT00423605|474966557|FG000|Overall Study|Protocol Violation|7|||
131912418|NCT00423605|474966557|FG000|Overall Study|Not one of the pre-specified options|5|||
131912419|NCT03183908|474966560|FG000|Overall Study|Missing Symptom Diary Data|0|||
131912420|NCT03183908|474966561|FG001|Overall Study|Missing Symptom Diary Data|2|||
131912421|NCT03738696|474966562|FG000|Overall Study|Withdrawal by Subject|0|||
131912422|NCT03738696|474966563|FG001|Overall Study|Withdrawal by Subject|1|||
131912423|NCT03738696|474966562|FG000|Overall Study|Lost to Follow-up|8|||
131912424|NCT03738696|474966563|FG001|Overall Study|Lost to Follow-up|14|||
131912425|NCT02566005|474966566|FG000|Overall Study|vaginal bleeding|0|||
131405496|NCT01691885|473108888|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
131405497|NCT01691885|473108889|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
131405498|NCT00996281|473108892|FG000|Overall Study|Adverse Event|75|||
131405499|NCT00996281|473108893|FG001|Overall Study|Adverse Event|37|||
131405500|NCT00996281|473108892|FG000|Overall Study|Major Protocol Deviation|6|||
131405501|NCT00996281|473108893|FG001|Overall Study|Major Protocol Deviation|7|||
131405502|NCT00996281|473108892|FG000|Overall Study|Lost to Follow-up|14|||
131405503|NCT00996281|473108893|FG001|Overall Study|Lost to Follow-up|16|||
131405504|NCT00996281|473108892|FG000|Overall Study|Withdrawal by Subject|31|||
131405505|NCT00996281|473108893|FG001|Overall Study|Withdrawal by Subject|20|||
131405506|NCT00996281|473108892|FG000|Overall Study|Lack of Efficacy|0|||
131405507|NCT00996281|473108893|FG001|Overall Study|Lack of Efficacy|2|||
131405508|NCT00996281|473108892|FG000|Overall Study|Other|5|||
131405509|NCT00996281|473108893|FG001|Overall Study|Other|7|||
131405510|NCT03575065|473108896|FG000|Overall Study|Death|31|||
131405511|NCT03575065|473108897|FG001|Overall Study|Death|12|||
131405512|NCT03575065|473108896|FG000|Overall Study|Sponsor's Decision|28|||
131405513|NCT03575065|473108897|FG001|Overall Study|Sponsor's Decision|13|||
131405514|NCT03575065|473108896|FG000|Overall Study|Withdrawal by Subject|2|||
131405515|NCT03575065|473108897|FG001|Overall Study|Withdrawal by Subject|1|||
131405516|NCT03575065|473108896|FG000|Overall Study|Lost to Follow-up|1|||
131405517|NCT03575065|473108897|FG001|Overall Study|Lost to Follow-up|0|||
131405518|NCT02323126|473108902|FG000|Overall Study|Patient / guardian decision|0|||
131405519|NCT02323126|473108903|FG001|Overall Study|Patient / guardian decision|1|||
131405520|NCT02323126|473108904|FG002|Overall Study|Patient / guardian decision|2|||
131405521|NCT02323126|473108902|FG000|Overall Study|Progressive disease|14|||
131405522|NCT02323126|473108903|FG001|Overall Study|Progressive disease|8|||
131405523|NCT02323126|473108904|FG002|Overall Study|Progressive disease|14|||
131405524|NCT02323126|473108902|FG000|Overall Study|Physician Decision|0|||
131405525|NCT02323126|473108903|FG001|Overall Study|Physician Decision|1|||
131405526|NCT02323126|473108904|FG002|Overall Study|Physician Decision|3|||
131405527|NCT02323126|473108902|FG000|Overall Study|Death|1|||
131405528|NCT02323126|473108903|FG001|Overall Study|Death|1|||
131405529|NCT02323126|473108904|FG002|Overall Study|Death|4|||
131405530|NCT02323126|473108902|FG000|Overall Study|Adverse Event|3|||
131405531|NCT02323126|473108903|FG001|Overall Study|Adverse Event|5|||
131405532|NCT02323126|473108904|FG002|Overall Study|Adverse Event|7|||
131405533|NCT01685801|473108905|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
131405534|NCT01685801|473108906|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
131405535|NCT01685801|473108907|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
131405536|NCT01685801|473108908|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
131405537|NCT01685801|473108905|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
131405538|NCT01685801|473108906|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
131405539|NCT01685801|473108907|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
131405540|NCT01685801|473108908|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
131405541|NCT03447314|473108912|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
131405542|NCT03447314|473108913|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
131405543|NCT03447314|473108914|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
131405544|NCT03447314|473108915|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
131405545|NCT03447314|473108916|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
131405546|NCT03447314|473108917|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
131405547|NCT03447314|473108918|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
131405548|NCT03447314|473108919|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405549|NCT03447314|473108920|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405550|NCT03447314|473108921|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405551|NCT03447314|473108922|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
131405552|NCT03447314|473108923|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
131405553|NCT03447314|473108924|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131912426|NCT02566005|474966567|FG001|Overall Study|vaginal bleeding|1|||
131912427|NCT02566005|474966566|FG000|Overall Study|received foley|8|||
131453431|NCT02541604|473288457|FG007|Overall Study|Withdrawal by Subject|0|||
131854218|NCT05223920|474743709|FG000|Overall Study|Death|2|||
131854219|NCT05223920|474743710|FG001|Overall Study|Death|0|||
131854220|NCT05223920|474743709|FG000|Overall Study|Disease Progression|1|||
131854221|NCT05223920|474743710|FG001|Overall Study|Disease Progression|2|||
131854222|NCT05223920|474743709|FG000|Overall Study|Physician Decision|1|||
131854223|NCT05223920|474743710|FG001|Overall Study|Physician Decision|2|||
131854224|NCT05223920|474743709|FG000|Overall Study|Sponsor decision|11|||
131854225|NCT05223920|474743710|FG001|Overall Study|Sponsor decision|9|||
131854226|NCT05223920|474743709|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
131854227|NCT05223920|474743710|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
131854228|NCT05223920|474743709|FG000|Overall Study|Subject decision|1|||
131854229|NCT05223920|474743710|FG001|Overall Study|Subject decision|0|||
131854230|NCT05223920|474743709|FG000|Overall Study|Withdrawal by Subject|1|||
131854231|NCT05223920|474743710|FG001|Overall Study|Withdrawal by Subject|6|||
131453432|NCT02541604|473288458|FG008|Overall Study|Withdrawal by Subject|1|||
131453433|NCT02541604|473288459|FG009|Overall Study|Withdrawal by Subject|0|||
131453434|NCT02541604|473288460|FG010|Overall Study|Withdrawal by Subject|0|||
131453435|NCT02541604|473288461|FG011|Overall Study|Withdrawal by Subject|0|||
131453436|NCT02541604|473288450|FG000|Overall Study|Study Terminated by Sponsor|1|||
131453437|NCT02541604|473288451|FG001|Overall Study|Study Terminated by Sponsor|4|||
131453438|NCT02541604|473288452|FG002|Overall Study|Study Terminated by Sponsor|2|||
131453439|NCT02541604|473288453|FG003|Overall Study|Study Terminated by Sponsor|1|||
131453440|NCT02541604|473288454|FG004|Overall Study|Study Terminated by Sponsor|0|||
131453441|NCT02541604|473288455|FG005|Overall Study|Study Terminated by Sponsor|0|||
131453442|NCT02541604|473288456|FG006|Overall Study|Study Terminated by Sponsor|0|||
131453443|NCT02541604|473288457|FG007|Overall Study|Study Terminated by Sponsor|0|||
131453444|NCT02541604|473288458|FG008|Overall Study|Study Terminated by Sponsor|0|||
131453445|NCT02541604|473288459|FG009|Overall Study|Study Terminated by Sponsor|0|||
131453446|NCT02541604|473288460|FG010|Overall Study|Study Terminated by Sponsor|0|||
131453447|NCT02541604|473288461|FG011|Overall Study|Study Terminated by Sponsor|0|||
131453448|NCT02541604|473288450|FG000|Overall Study|Medical condition may jeopardize safety|0|||
131453449|NCT02541604|473288451|FG001|Overall Study|Medical condition may jeopardize safety|0|||
131453450|NCT02541604|473288452|FG002|Overall Study|Medical condition may jeopardize safety|0|||
131854232|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
131854233|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
131854234|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
131854235|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
131854236|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
131854237|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
131854238|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
131854239|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
131854240|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
131854241|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
131854242|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
131854243|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
131854244|NCT02422797|474743711|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
131854245|NCT02422797|474743712|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
131854246|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
131854247|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
131854248|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
131854249|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
131854250|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
131854251|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
131854252|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
131854253|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
131854254|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
131854255|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
131854256|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
131854257|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
131854258|NCT02422797|474743711|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
131854259|NCT02422797|474743712|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
131854260|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
131854261|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
131854262|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
131854263|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
131453451|NCT02541604|473288453|FG003|Overall Study|Medical condition may jeopardize safety|0|||
131453452|NCT02541604|473288454|FG004|Overall Study|Medical condition may jeopardize safety|0|||
131453453|NCT02541604|473288455|FG005|Overall Study|Medical condition may jeopardize safety|0|||
131854264|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
131854265|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
131854266|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
131854267|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
131854268|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
131854269|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
131854270|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
131854271|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
131854272|NCT02422797|474743711|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
131854273|NCT02422797|474743712|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
131854274|NCT04071405|474743713|FG000|Overall Study|Protocol Violation|3|||
131854275|NCT00403585|474743714|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
131854276|NCT00403585|474743714|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
131854277|NCT00403585|474743714|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
131854278|NCT03971474|474743717|FG000|Overall Study|Adverse Event|11|||
131854279|NCT03971474|474743718|FG001|Overall Study|Adverse Event|7|||
131854280|NCT03971474|474743717|FG000|Overall Study|Refusal unrelated to adverse event|5|||
131854281|NCT03971474|474743718|FG001|Overall Study|Refusal unrelated to adverse event|1|||
131854282|NCT03971474|474743717|FG000|Overall Study|Progression/relapse|40|||
131854283|NCT03971474|474743718|FG001|Overall Study|Progression/relapse|47|||
131854284|NCT03971474|474743717|FG000|Overall Study|Death|6|||
131854285|NCT03971474|474743718|FG001|Overall Study|Death|3|||
131854286|NCT03971474|474743717|FG000|Overall Study|Other - not protocol specified|5|||
131854287|NCT03971474|474743718|FG001|Overall Study|Other - not protocol specified|4|||
131854288|NCT03971474|474743717|FG000|Overall Study|On treatment|0|||
131854289|NCT03971474|474743718|FG001|Overall Study|On treatment|7|||
131854290|NCT00261950|474743719|FG000|Overall Study|Lost to Follow-up|2|||
131854291|NCT00261950|474743719|FG000|Overall Study|Death|6|||
131854292|NCT00261950|474743719|FG000|Overall Study|Withdrawal by Subject|5|||
131854293|NCT00261950|474743719|FG000|Overall Study|Other|1|||
131854294|NCT00261950|474743719|FG000|Overall Study|Physician Decision|1|||
131854295|NCT00261950|474743719|FG000|Overall Study|Protocol specified Criteria|11|||
131854296|NCT00577863|474743720|FG000|Overall Study|Adverse Event|4|||
131854297|NCT00577863|474743721|FG001|Overall Study|Adverse Event|2|||
131854298|NCT00577863|474743720|FG000|Overall Study|Death|1|||
131854299|NCT00577863|474743721|FG001|Overall Study|Death|0|||
131854300|NCT00577863|474743720|FG000|Overall Study|Lost to Follow-up|2|||
131854301|NCT00577863|474743721|FG001|Overall Study|Lost to Follow-up|2|||
131854302|NCT00577863|474743720|FG000|Overall Study|Entry Criteria Exclusion|1|||
131854303|NCT00577863|474743721|FG001|Overall Study|Entry Criteria Exclusion|0|||
131854304|NCT00577863|474743720|FG000|Overall Study|Withdrawal by Subject|0|||
131854305|NCT00577863|474743721|FG001|Overall Study|Withdrawal by Subject|2|||
131854306|NCT00577863|474743720|FG000|Overall Study|Sponsor Decision|2|||
131854307|NCT00577863|474743721|FG001|Overall Study|Sponsor Decision|7|||
131854308|NCT00577863|474743720|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
131854309|NCT00577863|474743721|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
131854310|NCT00810511|474743729|FG000|Overall Study|Protocol Violation|0|||
131854311|NCT00810511|474743730|FG001|Overall Study|Protocol Violation|1|||
131854312|NCT00810511|474743729|FG000|Overall Study|Lack of Efficacy|9|||
131854313|NCT00810511|474743730|FG001|Overall Study|Lack of Efficacy|1|||
131854314|NCT00810511|474743729|FG000|Overall Study|death in the family|0|||
131854315|NCT00810511|474743730|FG001|Overall Study|death in the family|1|||
131854316|NCT00810511|474743729|FG000|Overall Study|Lost to Follow-up|1|||
131854317|NCT00810511|474743730|FG001|Overall Study|Lost to Follow-up|0|||
131854318|NCT00810511|474743729|FG000|Overall Study|deposits on contact lens|0|||
131854319|NCT00810511|474743730|FG001|Overall Study|deposits on contact lens|1|||
131854320|NCT05211726|474743731|FG000|Overall Study|Withdrawal by Subject|2|||
131854321|NCT05211726|474743732|FG001|Overall Study|Withdrawal by Subject|3|||
131854322|NCT05211726|474743731|FG000|Overall Study|Protocol Violation|0|||
131405554|NCT03447314|473108925|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405555|NCT03447314|473108926|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405556|NCT03447314|473108927|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405557|NCT03447314|473108928|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405558|NCT03447314|473108929|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
131405559|NCT03447314|473108912|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
131854323|NCT05211726|474743732|FG001|Overall Study|Protocol Violation|1|||
131854324|NCT03509467|474743733|FG000|Overall Study|Withdrawal by Subject|5|||
131854325|NCT03509467|474743734|FG001|Overall Study|Withdrawal by Subject|1|||
131854326|NCT03509467|474743735|FG002|Overall Study|Withdrawal by Subject|6|||
131854327|NCT03509467|474743736|FG003|Overall Study|Withdrawal by Subject|7|||
131854328|NCT03509467|474743737|FG004|Overall Study|Withdrawal by Subject|10|||
131854329|NCT03509467|474743738|FG005|Overall Study|Withdrawal by Subject|10|||
131854330|NCT03509467|474743739|FG006|Overall Study|Withdrawal by Subject|10|||
131854331|NCT03509467|474743740|FG007|Overall Study|Withdrawal by Subject|10|||
131453454|NCT02541604|473288456|FG006|Overall Study|Medical condition may jeopardize safety|0|||
131453455|NCT02541604|473288457|FG007|Overall Study|Medical condition may jeopardize safety|1|||
131453456|NCT02541604|473288458|FG008|Overall Study|Medical condition may jeopardize safety|0|||
131453457|NCT02541604|473288459|FG009|Overall Study|Medical condition may jeopardize safety|0|||
131453458|NCT02541604|473288460|FG010|Overall Study|Medical condition may jeopardize safety|0|||
131453459|NCT02541604|473288461|FG011|Overall Study|Medical condition may jeopardize safety|0|||
131453460|NCT01077050|473289900|FG000|Overall Study|Subjects signed ICF could not be located|1|||
131453461|NCT01077050|473289900|FG000|Overall Study|Screen failure|8|||
131453462|NCT03894813|473289901|FG000|Overall Study|Adverse Event|1|||
131453463|NCT03894813|473289902|FG001|Overall Study|Adverse Event|1|||
131453464|NCT03894813|473289901|FG000|Overall Study|Lack of Efficacy|3|||
131453465|NCT03894813|473289902|FG001|Overall Study|Lack of Efficacy|3|||
131453466|NCT03894813|473289901|FG000|Overall Study|Lost to Follow-up|1|||
131453467|NCT03894813|473289902|FG001|Overall Study|Lost to Follow-up|0|||
131453468|NCT03894813|473289901|FG000|Overall Study|Pregnancy|2|||
131453469|NCT03894813|473289902|FG001|Overall Study|Pregnancy|1|||
131453470|NCT03894813|473289901|FG000|Overall Study|Protocol Violation|3|||
131453471|NCT03894813|473289902|FG001|Overall Study|Protocol Violation|7|||
131453472|NCT03894813|473289901|FG000|Overall Study|Withdrawal by Subject|1|||
131453473|NCT03894813|473289902|FG001|Overall Study|Withdrawal by Subject|3|||
131453474|NCT03894813|473289901|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
131453475|NCT03894813|473289902|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
131453476|NCT03773796|473289903|FG000|Overall Study|Adverse Event|1|||
131453477|NCT03773796|473289903|FG000|Overall Study|Withdrawal by Subject|1|||
131453478|NCT03773796|473289903|FG000|Overall Study|Lack of Efficacy|1|||
131453479|NCT00854113|473289904|FG000|Overall Study|Adverse Event|0|||
131453480|NCT00854113|473289905|FG001|Overall Study|Adverse Event|0|||
131453481|NCT00854113|473289906|FG002|Overall Study|Adverse Event|0|||
131453482|NCT00854113|473289907|FG003|Overall Study|Adverse Event|0|||
131453483|NCT00854113|473289908|FG004|Overall Study|Adverse Event|0|||
131453484|NCT00854113|473289909|FG005|Overall Study|Adverse Event|0|||
131453485|NCT00854113|473289910|FG006|Overall Study|Adverse Event|0|||
131854332|NCT03509467|474743733|FG000|Overall Study|Death|0|||
131854333|NCT03509467|474743734|FG001|Overall Study|Death|0|||
131854334|NCT03509467|474743735|FG002|Overall Study|Death|2|||
131854335|NCT03509467|474743736|FG003|Overall Study|Death|2|||
131854336|NCT03509467|474743737|FG004|Overall Study|Death|1|||
131854337|NCT03509467|474743738|FG005|Overall Study|Death|0|||
131854338|NCT03509467|474743739|FG006|Overall Study|Death|1|||
131405560|NCT03447314|473108913|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405561|NCT03447314|473108914|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
131405562|NCT03447314|473108915|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405563|NCT03447314|473108916|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405564|NCT03447314|473108917|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
131405565|NCT03447314|473108918|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
131405566|NCT03447314|473108919|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405567|NCT03447314|473108920|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405568|NCT03447314|473108921|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405569|NCT03447314|473108922|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405570|NCT03447314|473108923|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405571|NCT03447314|473108924|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405572|NCT03447314|473108925|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405573|NCT03447314|473108926|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405574|NCT03447314|473108927|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405575|NCT03447314|473108928|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405576|NCT03447314|473108929|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
131405577|NCT03447314|473108912|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405578|NCT03447314|473108913|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405579|NCT03447314|473108914|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
131405580|NCT03447314|473108915|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405581|NCT03447314|473108916|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405582|NCT03447314|473108917|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405583|NCT03447314|473108918|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405584|NCT03447314|473108919|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405585|NCT03447314|473108920|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405586|NCT03447314|473108921|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405587|NCT03447314|473108922|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405588|NCT03447314|473108923|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405589|NCT03447314|473108924|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405590|NCT03447314|473108925|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131854339|NCT03509467|474743740|FG007|Overall Study|Death|0|||
131854340|NCT03509467|474743733|FG000|Overall Study|Proxy Withdrawal|0|||
131854341|NCT03509467|474743734|FG001|Overall Study|Proxy Withdrawal|0|||
131854342|NCT03509467|474743735|FG002|Overall Study|Proxy Withdrawal|0|||
131854343|NCT03509467|474743736|FG003|Overall Study|Proxy Withdrawal|0|||
131854344|NCT03509467|474743737|FG004|Overall Study|Proxy Withdrawal|0|||
131854345|NCT03509467|474743738|FG005|Overall Study|Proxy Withdrawal|0|||
131854346|NCT03509467|474743739|FG006|Overall Study|Proxy Withdrawal|0|||
131854347|NCT03509467|474743740|FG007|Overall Study|Proxy Withdrawal|1|||
131854348|NCT04223752|474743743|FG000|Overall Study|Participant enrolled in error|0|||
131854349|NCT04223752|474743744|FG001|Overall Study|Participant enrolled in error|0|||
131854350|NCT04223752|474743745|FG002|Overall Study|Participant enrolled in error|0|||
131854351|NCT04223752|474743746|FG003|Overall Study|Participant enrolled in error|0|||
131854352|NCT04223752|474743747|FG004|Overall Study|Participant enrolled in error|1|||
131854353|NCT04223752|474743743|FG000|Overall Study|Death|0|||
131854354|NCT04223752|474743744|FG001|Overall Study|Death|0|||
131854355|NCT04223752|474743745|FG002|Overall Study|Death|0|||
131854356|NCT04223752|474743746|FG003|Overall Study|Death|2|||
131854357|NCT04223752|474743747|FG004|Overall Study|Death|1|||
131854358|NCT04759703|474743748|FG000|Overall Study|Withdrawal by Subject|4|||
131854359|NCT04759703|474743749|FG001|Overall Study|Withdrawal by Subject|9|||
131854360|NCT04759703|474743748|FG000|Overall Study|Adverse Event|1|||
131854361|NCT04759703|474743749|FG001|Overall Study|Adverse Event|0|||
131854362|NCT04759703|474743748|FG000|Overall Study|Lost to Follow-up|2|||
131854363|NCT04759703|474743749|FG001|Overall Study|Lost to Follow-up|0|||
131854364|NCT04186845|474743752|FG000|Overall Study|Death|2|||
131854365|NCT04186845|474743752|FG000|Overall Study|Lost to Follow-up|1|||
131854366|NCT04186845|474743752|FG000|Overall Study|Physician Decision|1|||
131854367|NCT04186845|474743752|FG000|Overall Study|Protocol Violation|1|||
131854368|NCT04186845|474743752|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
131854369|NCT04186845|474743752|FG000|Overall Study|Biopsy ordered but not done|1|||
131854370|NCT04186845|474743752|FG000|Overall Study|It was previously confirmed|1|||
131854371|NCT04186845|474743752|FG000|Overall Study|Patient cancelled scheduled scans|2|||
131854372|NCT04186845|474743752|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
131854373|NCT04186845|474743752|FG000|Overall Study|Subject refused confirmatory imaging|1|||
131854374|NCT04186845|474743752|FG000|Overall Study|Too small to biopsy|1|||
131854375|NCT01814553|474743755|FG000|Overall Study|PD per clinical progression|6|||
131854376|NCT01814553|474743756|FG001|Overall Study|PD per clinical progression|8|||
131854377|NCT01814553|474743755|FG000|Overall Study|Other Adverse Event|4|||
131854378|NCT01814553|474743756|FG001|Overall Study|Other Adverse Event|5|||
131854379|NCT01814553|474743755|FG000|Overall Study|Withdrawal by Subject|1|||
131854380|NCT01814553|474743756|FG001|Overall Study|Withdrawal by Subject|1|||
131854381|NCT01814553|474743755|FG000|Overall Study|Other than stated|7|||
131854382|NCT01814553|474743756|FG001|Overall Study|Other than stated|8|||
131854383|NCT04138823|474743757|FG000|Overall Study|Clinical disease progression|0|||
131854384|NCT04138823|474743758|FG001|Overall Study|Clinical disease progression|0|||
131854385|NCT04138823|474743759|FG002|Overall Study|Clinical disease progression|1|||
131854386|NCT04138823|474743757|FG000|Overall Study|Objective disease progression|3|||
131854387|NCT04138823|474743758|FG001|Overall Study|Objective disease progression|2|||
131854388|NCT04138823|474743759|FG002|Overall Study|Objective disease progression|5|||
131854389|NCT03290079|474743760|FG000|Overall Study|Death|2|||
131854390|NCT02676765|474743761|FG000|Overall Study|Lost to Follow-up|0|||
131854391|NCT02676765|474743762|FG001|Overall Study|Lost to Follow-up|1|||
131854392|NCT02374346|474743763|FG000|Overall Study|operated or discharged during weekend|48|||
131854393|NCT01941498|474743766|FG000|Overall Study|Relocated out of state|1|||
131854394|NCT05299528|474743769|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
131854395|NCT05299528|474743770|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
131854396|NCT05299528|474743771|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
131854397|NCT05299528|474743772|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
131854398|NCT05299528|474743773|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
131854399|NCT05299528|474743774|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
131854400|NCT05299528|474743775|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
131854401|NCT05299528|474743769|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
131854402|NCT05299528|474743770|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
131854403|NCT05299528|474743771|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
131854404|NCT05299528|474743772|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
131854405|NCT05299528|474743773|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
131854406|NCT05299528|474743774|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
131854407|NCT05299528|474743775|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
131854408|NCT05299528|474743769|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
131854409|NCT05299528|474743770|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
131854410|NCT05299528|474743771|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
131854411|NCT05299528|474743772|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
131854412|NCT05299528|474743773|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
131854413|NCT05299528|474743774|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
131854414|NCT05299528|474743775|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
131854415|NCT04877457|474743776|FG000|Overall Study|Early termination of study due to low enrollment|2|||
131854416|NCT04877457|474743777|FG001|Overall Study|Early termination of study due to low enrollment|1|||
131854417|NCT04697069|474743782|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
131854418|NCT04697069|474743783|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
131854419|NCT04697069|474743782|FG000|Overall Study|Study termination|2|||
131854420|NCT04697069|474743783|FG001|Overall Study|Study termination|1|||
131854421|NCT05180227|474743784|FG000|Overall Study|Hypertension at screening|1|||
131854422|NCT05180227|474743784|FG000|Overall Study|Lost to Follow-up|1|||
131854423|NCT03548337|474743785|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
131854424|NCT03548337|474743786|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
131854425|NCT03548337|474743785|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
131854426|NCT03548337|474743786|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
131854427|NCT03548337|474743785|FG000|Infant Series|Lost to Follow-up|2|||
131854428|NCT03548337|474743786|FG001|Infant Series|Lost to Follow-up|1|||
131854429|NCT03548337|474743785|FG000|Infant Series|Adverse Event|0|||
131854430|NCT03548337|474743786|FG001|Infant Series|Adverse Event|2|||
131854431|NCT03548337|474743785|FG000|Infant Series|Randomized but Not Vaccinated|1|||
131854432|NCT03548337|474743786|FG001|Infant Series|Randomized but Not Vaccinated|0|||
131854433|NCT03548337|474743785|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
131854434|NCT03548337|474743786|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
131854435|NCT01954745|474743788|FG000|Overall Study|Radiological Progression|11|||
131854436|NCT01954745|474743788|FG000|Overall Study|Clinical Progression|5|||
131854437|NCT01954745|474743788|FG000|Overall Study|Adverse Event|2|||
131854438|NCT01954745|474743788|FG000|Overall Study|Death|1|||
131854439|NCT02839707|474743789|FG000|Phase I|Not eligible for analysis|9|||
131854440|NCT02839707|474743790|FG001|Phase I|Not eligible for analysis|0|||
131854441|NCT02839707|474743791|FG002|Phase I|Not eligible for analysis|0|||
131854442|NCT02839707|474743789|FG000|Phase II|Not treated according to protocol|4|||
131854443|NCT02839707|474743790|FG001|Phase II|Not treated according to protocol|0|||
131854444|NCT02839707|474743791|FG002|Phase II|Not treated according to protocol|2|||
131854445|NCT02839707|474743789|FG000|Phase III|Not treated according to protocol|0|||
131854446|NCT02839707|474743790|FG001|Phase III|Not treated according to protocol|0|||
131854447|NCT02839707|474743791|FG002|Phase III|Not treated according to protocol|4|||
131854448|NCT06419907|474745668|FG000|Overall Study|Protocol Violation|0|||
131854449|NCT06419907|474745669|FG001|Overall Study|Protocol Violation|3|||
131854450|NCT06419907|474745670|FG002|Overall Study|Protocol Violation|0|||
131854451|NCT06419907|474745671|FG003|Overall Study|Protocol Violation|1|||
131854452|NCT06419907|474745668|FG000|Overall Study|Lost to Follow-up|0|||
131854453|NCT06419907|474745669|FG001|Overall Study|Lost to Follow-up|0|||
131854454|NCT06419907|474745670|FG002|Overall Study|Lost to Follow-up|2|||
131854455|NCT06419907|474745671|FG003|Overall Study|Lost to Follow-up|1|||
131854456|NCT05929651|474745674|FG000|Overall Study|Protocol Deviation|1|||
131854457|NCT05929651|474745674|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
131854458|NCT05026177|474745675|FG000|Overall Study|Adverse Event|33|||
131854459|NCT05026177|474745676|FG001|Overall Study|Adverse Event|33|||
131854460|NCT05026177|474745677|FG002|Overall Study|Adverse Event|17|||
131854461|NCT05026177|474745675|FG000|Overall Study|Lost to Follow-up|7|||
131854462|NCT05026177|474745676|FG001|Overall Study|Lost to Follow-up|6|||
131854463|NCT05026177|474745677|FG002|Overall Study|Lost to Follow-up|8|||
131854464|NCT05026177|474745675|FG000|Overall Study|Noncompliance with study drug|6|||
131854465|NCT05026177|474745676|FG001|Overall Study|Noncompliance with study drug|2|||
131854466|NCT05026177|474745677|FG002|Overall Study|Noncompliance with study drug|1|||
131854467|NCT05026177|474745675|FG000|Overall Study|Physician Decision|4|||
131854468|NCT05026177|474745676|FG001|Overall Study|Physician Decision|1|||
131854469|NCT05026177|474745677|FG002|Overall Study|Physician Decision|0|||
131854470|NCT05026177|474745675|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
131854471|NCT05026177|474745676|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
131854472|NCT05026177|474745677|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
131854473|NCT05026177|474745675|FG000|Overall Study|Withdrawal by Subject|53|||
131854474|NCT05026177|474745676|FG001|Overall Study|Withdrawal by Subject|51|||
131854475|NCT05026177|474745677|FG002|Overall Study|Withdrawal by Subject|55|||
131854476|NCT05026177|474745675|FG000|Overall Study|Protocol Violation|0|||
131854477|NCT05026177|474745676|FG001|Overall Study|Protocol Violation|1|||
131854478|NCT05026177|474745677|FG002|Overall Study|Protocol Violation|0|||
131854479|NCT05026177|474745675|FG000|Overall Study|Study terminated by sponsor|70|||
131854480|NCT05026177|474745676|FG001|Overall Study|Study terminated by sponsor|74|||
131854481|NCT05026177|474745677|FG002|Overall Study|Study terminated by sponsor|67|||
131854482|NCT05026177|474745675|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
131405591|NCT03447314|473108926|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405592|NCT03447314|473108927|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405593|NCT03447314|473108928|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131405594|NCT03447314|473108929|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
131912428|NCT02566005|474966567|FG001|Overall Study|received foley|0|||
131912429|NCT02566005|474966566|FG000|Overall Study|did not receive foley|0|||
131912430|NCT02566005|474966567|FG001|Overall Study|did not receive foley|1|||
131912431|NCT02566005|474966566|FG000|Overall Study|labor after randomization|0|||
131912432|NCT02566005|474966567|FG001|Overall Study|labor after randomization|4|||
131912433|NCT03617588|474966568|FG000|Overall Study|Withdrawal by Subject|1|||
131912434|NCT03617588|474966569|FG001|Overall Study|Withdrawal by Subject|0|||
131912435|NCT01294514|474966570|FG000|Overall Study|Excluded due to Arrhythmia|1|||
131912436|NCT03482024|474966577|FG000|Overall Study|Physician Decision|1|||
131912437|NCT03482024|474966578|FG001|Overall Study|Physician Decision|0|||
131912438|NCT03482024|474966579|FG002|Overall Study|Physician Decision|0|||
131912439|NCT03482024|474966580|FG003|Overall Study|Physician Decision|0|||
131405595|NCT03447314|473108912|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131854483|NCT05026177|474745676|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
131854484|NCT05026177|474745677|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
131854485|NCT05026177|474745675|FG000|Overall Study|Starting alternative treatment|0|||
131854486|NCT05026177|474745676|FG001|Overall Study|Starting alternative treatment|1|||
131854487|NCT05026177|474745677|FG002|Overall Study|Starting alternative treatment|1|||
131854488|NCT05026177|474745675|FG000|Overall Study|Noncompliance with study procedures|0|||
131854489|NCT05026177|474745676|FG001|Overall Study|Noncompliance with study procedures|1|||
131854490|NCT05026177|474745677|FG002|Overall Study|Noncompliance with study procedures|1|||
131854491|NCT05026177|474745675|FG000|Overall Study|Met stopping criteria|0|||
131854492|NCT05026177|474745676|FG001|Overall Study|Met stopping criteria|0|||
131854493|NCT05026177|474745677|FG002|Overall Study|Met stopping criteria|1|||
131854494|NCT05026177|474745675|FG000|Overall Study|Health issues preventing continuation|0|||
131854495|NCT05026177|474745676|FG001|Overall Study|Health issues preventing continuation|0|||
131854496|NCT05026177|474745677|FG002|Overall Study|Health issues preventing continuation|1|||
131854497|NCT05026177|474745675|FG000|Overall Study|Randomized in error, not treated|0|||
131854498|NCT05026177|474745676|FG001|Overall Study|Randomized in error, not treated|0|||
131854499|NCT05026177|474745677|FG002|Overall Study|Randomized in error, not treated|2|||
131854500|NCT02586688|474745678|FG000|Overall Study|Lost to Follow-up|2|||
131854501|NCT02586688|474745679|FG001|Overall Study|Lost to Follow-up|1|||
131854502|NCT02586688|474745678|FG000|Overall Study|Withdrawal by Subject|1|||
131854503|NCT02586688|474745679|FG001|Overall Study|Withdrawal by Subject|1|||
131854504|NCT02586688|474745678|FG000|Overall Study|Adverse Event|3|||
131854505|NCT02586688|474745679|FG001|Overall Study|Adverse Event|1|||
131854506|NCT04856917|474745680|FG000|Overall Study|Withdrawal by Subject|4|||
131854507|NCT04856917|474745681|FG001|Overall Study|Withdrawal by Subject|3|||
131854508|NCT04856917|474745682|FG002|Overall Study|Withdrawal by Subject|1|||
131854509|NCT04856917|474745680|FG000|Overall Study|Lost to Follow-up|3|||
131854510|NCT04856917|474745681|FG001|Overall Study|Lost to Follow-up|1|||
131854511|NCT04856917|474745682|FG002|Overall Study|Lost to Follow-up|1|||
131854512|NCT04856917|474745680|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
131854513|NCT04856917|474745681|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
131854514|NCT04856917|474745682|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
131854515|NCT04856917|474745680|FG000|Overall Study|Other|1|||
131854516|NCT04856917|474745681|FG001|Overall Study|Other|1|||
131854517|NCT04856917|474745682|FG002|Overall Study|Other|0|||
131854518|NCT01169337|474745683|FG000|Overall Study|Lack of Efficacy|5|||
131854519|NCT01169337|474745684|FG001|Overall Study|Lack of Efficacy|7|||
131854520|NCT01169337|474745685|FG002|Overall Study|Lack of Efficacy|0|||
131854521|NCT01169337|474745683|FG000|Overall Study|Adverse Event|12|||
131854522|NCT01169337|474745684|FG001|Overall Study|Adverse Event|18|||
131854523|NCT01169337|474745685|FG002|Overall Study|Adverse Event|0|||
131854524|NCT01169337|474745683|FG000|Overall Study|Death|2|||
131854525|NCT01169337|474745684|FG001|Overall Study|Death|0|||
131854526|NCT01169337|474745685|FG002|Overall Study|Death|0|||
131854527|NCT01169337|474745683|FG000|Overall Study|Withdrawal by Subject|11|||
131854528|NCT01169337|474745684|FG001|Overall Study|Withdrawal by Subject|11|||
131854529|NCT01169337|474745685|FG002|Overall Study|Withdrawal by Subject|6|||
131854530|NCT01169337|474745683|FG000|Overall Study|Noncompliance|2|||
131854531|NCT01169337|474745684|FG001|Overall Study|Noncompliance|0|||
131405596|NCT03447314|473108913|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405597|NCT03447314|473108914|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
131405598|NCT03447314|473108915|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405599|NCT03447314|473108916|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131854532|NCT01169337|474745685|FG002|Overall Study|Noncompliance|0|||
131854533|NCT01169337|474745683|FG000|Overall Study|Other complicating disease|1|||
131854534|NCT01169337|474745684|FG001|Overall Study|Other complicating disease|1|||
131453486|NCT00854113|473289911|FG007|Overall Study|Adverse Event|2|||
131854535|NCT01169337|474745685|FG002|Overall Study|Other complicating disease|0|||
131854536|NCT01169337|474745683|FG000|Overall Study|Physician Decision|1|||
131854537|NCT01169337|474745684|FG001|Overall Study|Physician Decision|5|||
131854538|NCT01169337|474745685|FG002|Overall Study|Physician Decision|0|||
131854539|NCT01169337|474745683|FG000|Overall Study|Alternative therapy|0|||
131854540|NCT01169337|474745684|FG001|Overall Study|Alternative therapy|2|||
131854541|NCT01169337|474745685|FG002|Overall Study|Alternative therapy|0|||
131854542|NCT01169337|474745683|FG000|Overall Study|Changed hospital|0|||
131854543|NCT01169337|474745684|FG001|Overall Study|Changed hospital|1|||
131854544|NCT01169337|474745685|FG002|Overall Study|Changed hospital|0|||
131854545|NCT01169337|474745683|FG000|Overall Study|Never started treatment|0|||
131854546|NCT01169337|474745684|FG001|Overall Study|Never started treatment|2|||
131854547|NCT01169337|474745685|FG002|Overall Study|Never started treatment|0|||
131854548|NCT01169337|474745683|FG000|Overall Study|Reason not reported|1|||
131854549|NCT01169337|474745684|FG001|Overall Study|Reason not reported|0|||
131854550|NCT01169337|474745685|FG002|Overall Study|Reason not reported|0|||
131854551|NCT01169337|474745683|FG000|Overall Study|Continuing lenalidomide|9|||
131854552|NCT01169337|474745684|FG001|Overall Study|Continuing lenalidomide|43|||
131854553|NCT01169337|474745685|FG002|Overall Study|Continuing lenalidomide|0|||
131854554|NCT01433055|474745686|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
131854555|NCT01433055|474745687|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
131854556|NCT01433055|474745686|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
131854557|NCT01433055|474745687|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
131854558|NCT02717455|474745688|FG000|Overall Study|Adverse Event|1|||
131854559|NCT02717455|474745689|FG001|Overall Study|Adverse Event|0|||
131854560|NCT02717455|474745690|FG002|Overall Study|Adverse Event|0|||
131854561|NCT02717455|474745691|FG003|Overall Study|Adverse Event|2|||
131854562|NCT02717455|474745692|FG004|Overall Study|Adverse Event|2|||
131854563|NCT02717455|474745693|FG005|Overall Study|Adverse Event|2|||
131854564|NCT02717455|474745688|FG000|Overall Study|Withdrawal by Subject|1|||
131854565|NCT02717455|474745689|FG001|Overall Study|Withdrawal by Subject|1|||
131854566|NCT02717455|474745690|FG002|Overall Study|Withdrawal by Subject|0|||
131854567|NCT02717455|474745691|FG003|Overall Study|Withdrawal by Subject|2|||
131854568|NCT02717455|474745692|FG004|Overall Study|Withdrawal by Subject|2|||
131854569|NCT02717455|474745693|FG005|Overall Study|Withdrawal by Subject|1|||
131854570|NCT02717455|474745688|FG000|Overall Study|Death|1|||
131854571|NCT02717455|474745689|FG001|Overall Study|Death|0|||
131854572|NCT02717455|474745690|FG002|Overall Study|Death|0|||
131854573|NCT02717455|474745691|FG003|Overall Study|Death|0|||
131854574|NCT02717455|474745692|FG004|Overall Study|Death|1|||
131854575|NCT02717455|474745693|FG005|Overall Study|Death|0|||
131854576|NCT02717455|474745688|FG000|Overall Study|Did not receive study drug|0|||
131854577|NCT02717455|474745689|FG001|Overall Study|Did not receive study drug|0|||
131854578|NCT02717455|474745690|FG002|Overall Study|Did not receive study drug|0|||
131854579|NCT02717455|474745691|FG003|Overall Study|Did not receive study drug|1|||
131854580|NCT02717455|474745692|FG004|Overall Study|Did not receive study drug|0|||
131854581|NCT02717455|474745693|FG005|Overall Study|Did not receive study drug|1|||
131854582|NCT02717455|474745688|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
131854583|NCT02717455|474745689|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
131854584|NCT02717455|474745690|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
131854585|NCT02717455|474745691|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
131854586|NCT02717455|474745692|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
131854587|NCT02717455|474745693|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
131854588|NCT02717455|474745688|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
131854589|NCT02717455|474745689|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
131854590|NCT02717455|474745690|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
131854591|NCT02717455|474745691|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
131854592|NCT02717455|474745692|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
131854593|NCT02717455|474745693|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
131854594|NCT03573830|474745697|FG000|Overall Study|Dropped without completing treatment|0|||
131854595|NCT03573830|474745698|FG001|Overall Study|Dropped without completing treatment|7|||
131854596|NCT03573830|474745697|FG000|Overall Study|Lost to Follow-up|4|||
131854597|NCT03573830|474745698|FG001|Overall Study|Lost to Follow-up|0|||
131854598|NCT00233948|474745703|FG000|Overall Study|Adverse Event|1|||
131854599|NCT00233948|474745704|FG001|Overall Study|Adverse Event|0|||
131405600|NCT03447314|473108917|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131854600|NCT00233948|474745705|FG002|Overall Study|Adverse Event|0|||
131854601|NCT00233948|474745706|FG003|Overall Study|Adverse Event|0|||
131854602|NCT00233948|474745707|FG004|Overall Study|Adverse Event|0|||
131854603|NCT00233948|474745708|FG005|Overall Study|Adverse Event|0|||
131854604|NCT02465398|474745711|FG000|Overall Study|Death|7|||
131854605|NCT02465398|474745711|FG000|Overall Study|Revision|7|||
131854606|NCT02465398|474745711|FG000|Overall Study|did not receive study device|1|||
131453487|NCT00854113|473289912|FG008|Overall Study|Adverse Event|0|||
131405601|NCT03447314|473108918|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405602|NCT03447314|473108919|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405603|NCT03447314|473108920|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405604|NCT03447314|473108921|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405605|NCT03447314|473108922|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405606|NCT03447314|473108923|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405607|NCT03447314|473108924|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405608|NCT03447314|473108925|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405609|NCT03447314|473108926|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405610|NCT03447314|473108927|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405611|NCT03447314|473108928|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405612|NCT03447314|473108929|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
131405613|NCT03447314|473108912|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405614|NCT03447314|473108913|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405615|NCT03447314|473108914|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405616|NCT03447314|473108915|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405617|NCT03447314|473108916|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405618|NCT03447314|473108917|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405619|NCT03447314|473108918|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405620|NCT03447314|473108919|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405621|NCT03447314|473108920|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405622|NCT03447314|473108921|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405623|NCT03447314|473108922|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
131405624|NCT03447314|473108923|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405625|NCT03447314|473108924|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405626|NCT03447314|473108925|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405627|NCT03447314|473108926|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405628|NCT03447314|473108927|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405629|NCT03447314|473108928|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405630|NCT03447314|473108929|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
131405631|NCT03447314|473108912|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405632|NCT03447314|473108913|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405633|NCT03447314|473108914|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405634|NCT03447314|473108915|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
131405635|NCT03447314|473108916|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405636|NCT03447314|473108917|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
131405637|NCT03447314|473108918|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405638|NCT03447314|473108919|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405639|NCT03447314|473108920|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405640|NCT03447314|473108921|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405641|NCT03447314|473108922|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405642|NCT03447314|473108923|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405643|NCT03447314|473108924|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405644|NCT03447314|473108925|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405645|NCT03447314|473108926|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405646|NCT03447314|473108927|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405647|NCT03447314|473108928|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405648|NCT03447314|473108929|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
131405649|NCT04600076|473108933|FG000|Overall Study|Lost to Follow-up|3|||
131405650|NCT00252694|473108934|FG000|Overall Study|Withdrawal by Subject|83|||
131405651|NCT00252694|473108935|FG001|Overall Study|Withdrawal by Subject|91|||
131405652|NCT00252694|473108934|FG000|Overall Study|Death|36|||
131405653|NCT00252694|473108935|FG001|Overall Study|Death|34|||
131405654|NCT00252694|473108934|FG000|Overall Study|Mostly Lost to Follow Up|8|||
131405655|NCT00252694|473108935|FG001|Overall Study|Mostly Lost to Follow Up|13|||
131405656|NCT00252694|473108934|FG000|Overall Study|Patient Moving|17|||
131405657|NCT00252694|473108935|FG001|Overall Study|Patient Moving|16|||
131405658|NCT02891681|473108936|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
131453488|NCT00854113|473289913|FG009|Overall Study|Adverse Event|0|||
131453489|NCT00854113|473289914|FG010|Overall Study|Adverse Event|0|||
131453490|NCT00854113|473289904|FG000|Overall Study|Withdrawal by Subject|0|||
131453491|NCT00854113|473289905|FG001|Overall Study|Withdrawal by Subject|0|||
131453492|NCT00854113|473289906|FG002|Overall Study|Withdrawal by Subject|0|||
131453493|NCT00854113|473289907|FG003|Overall Study|Withdrawal by Subject|0|||
131453494|NCT00854113|473289908|FG004|Overall Study|Withdrawal by Subject|0|||
131453495|NCT00854113|473289909|FG005|Overall Study|Withdrawal by Subject|0|||
131453496|NCT00854113|473289910|FG006|Overall Study|Withdrawal by Subject|0|||
131453497|NCT00854113|473289911|FG007|Overall Study|Withdrawal by Subject|1|||
131453498|NCT00854113|473289912|FG008|Overall Study|Withdrawal by Subject|1|||
131453499|NCT00854113|473289913|FG009|Overall Study|Withdrawal by Subject|0|||
131453500|NCT00854113|473289914|FG010|Overall Study|Withdrawal by Subject|0|||
131453501|NCT03805659|473289915|FG000|Overall Study|Withdrawal by Subject|0|||
131405659|NCT02891681|473108937|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
131405660|NCT02891681|473108938|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
131405661|NCT02891681|473108936|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
131405662|NCT02891681|473108937|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
131405663|NCT02891681|473108938|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
131405664|NCT02891681|473108936|FG000|Overall Study|Taken off study after first imaging appointment|1|||
131405665|NCT02891681|473108937|FG001|Overall Study|Taken off study after first imaging appointment|0|||
131405666|NCT02891681|473108938|FG002|Overall Study|Taken off study after first imaging appointment|0|||
131405667|NCT00957944|473108953|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
131405668|NCT00957944|473108954|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
131405669|NCT01468233|473108956|FG000|Treatment Period 1|Adverse Event|5|||
131405670|NCT01468233|473108957|FG001|Treatment Period 1|Adverse Event|3|||
131912440|NCT03482024|474966581|FG004|Overall Study|Physician Decision|0|||
131912441|NCT04796415|474966582|FG000|Overall Study|not interested|12|||
131912442|NCT04796415|474966582|FG000|Overall Study|health issue|8|||
131912443|NCT04796415|474966582|FG000|Overall Study|Other|4|||
131912444|NCT04796415|474966582|FG000|Overall Study|discharged from home health service|3|||
131912445|NCT04796415|474966582|FG000|Overall Study|re-hospitalization|2|||
131405671|NCT01468233|473108958|FG002|Treatment Period 1|Adverse Event|0|||
131405672|NCT01468233|473108959|FG003|Treatment Period 1|Adverse Event|0|||
131912446|NCT04796415|474966582|FG000|Overall Study|moving to nursing home|1|||
131912447|NCT04796415|474966582|FG000|Overall Study|lost contact|1|||
131912448|NCT00147238|474966589|FG000|Overall Study|Inevaluable|8|||
131912449|NCT04810962|474966590|FG000|Overall Study|Adverse Event|0|||
131912450|NCT04810962|474966591|FG001|Overall Study|Adverse Event|1|||
131912451|NCT04810962|474966590|FG000|Overall Study|Lost to Follow-up|2|||
131912452|NCT04810962|474966591|FG001|Overall Study|Lost to Follow-up|1|||
131912453|NCT04810962|474966590|FG000|Overall Study|Physician Decision|1|||
131912454|NCT04810962|474966591|FG001|Overall Study|Physician Decision|0|||
131912455|NCT04810962|474966590|FG000|Overall Study|Withdrawal by Subject|1|||
131854607|NCT02465398|474745711|FG000|Overall Study|Withdrawal by Subject|1|||
131854608|NCT02465398|474745711|FG000|Overall Study|Lost to Follow-up|14|||
131854609|NCT05244122|474745712|FG000|Overall Study|Withdrawal by Subject|318|||
131854610|NCT02969382|474745721|FG000|Overall Study|Adverse Event|8|||
131854611|NCT02969382|474745722|FG001|Overall Study|Adverse Event|10|||
131854612|NCT02969382|474745721|FG000|Overall Study|Lack of Efficacy|4|||
131854613|NCT02969382|474745722|FG001|Overall Study|Lack of Efficacy|5|||
131854614|NCT02969382|474745721|FG000|Overall Study|Death|0|||
131854615|NCT02969382|474745722|FG001|Overall Study|Death|1|||
131854616|NCT02969382|474745721|FG000|Overall Study|PROTOCOL DEVIATION|0|||
131854617|NCT02969382|474745722|FG001|Overall Study|PROTOCOL DEVIATION|1|||
131854618|NCT02969382|474745721|FG000|Overall Study|Withdrawal by Subject|14|||
131854619|NCT02969382|474745722|FG001|Overall Study|Withdrawal by Subject|9|||
131854620|NCT01214655|474745723|FG000|Part A|Progressive Disease|7|||
131854621|NCT01214655|474745724|FG001|Part A|Progressive Disease|0|||
131854622|NCT01214655|474745725|FG002|Part A|Progressive Disease|0|||
131854623|NCT01214655|474745723|FG000|Part A|Physician Decision|1|||
131405673|NCT01468233|473108960|FG004|Treatment Period 1|Adverse Event|0|||
131405674|NCT01468233|473108961|FG005|Treatment Period 1|Adverse Event|0|||
131453502|NCT03805659|473289916|FG001|Overall Study|Withdrawal by Subject|1|||
131854624|NCT01214655|474745724|FG001|Part A|Physician Decision|0|||
131405675|NCT01468233|473108956|FG000|Treatment Period 1|Withdrawal by Subject|3|||
131453503|NCT01675544|473289920|FG000|Overall Study|Withdrawal by Subject|2|||
131854625|NCT01214655|474745725|FG002|Part A|Physician Decision|0|||
131854626|NCT01214655|474745723|FG000|Part B|Progressive disease|0|||
131854627|NCT01214655|474745724|FG001|Part B|Progressive disease|10|||
131854628|NCT01214655|474745725|FG002|Part B|Progressive disease|0|||
131405676|NCT01468233|473108957|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131405677|NCT01468233|473108958|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131854629|NCT01214655|474745723|FG000|Part B|Death|0|||
131854630|NCT01214655|474745724|FG001|Part B|Death|1|||
131854631|NCT01214655|474745725|FG002|Part B|Death|0|||
131912456|NCT04810962|474966591|FG001|Overall Study|Withdrawal by Subject|3|||
131405678|NCT01468233|473108959|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131405679|NCT01468233|473108960|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131405680|NCT01468233|473108961|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131405681|NCT01468233|473108956|FG000|Treatment Period 1|Lost to Follow-up|3|||
131405682|NCT01468233|473108957|FG001|Treatment Period 1|Lost to Follow-up|0|||
131405683|NCT01468233|473108958|FG002|Treatment Period 1|Lost to Follow-up|0|||
131405684|NCT01468233|473108959|FG003|Treatment Period 1|Lost to Follow-up|0|||
131405685|NCT01468233|473108960|FG004|Treatment Period 1|Lost to Follow-up|0|||
131405686|NCT01468233|473108961|FG005|Treatment Period 1|Lost to Follow-up|0|||
131405687|NCT01468233|473108956|FG000|Treatment Period 1|Other|1|||
131405688|NCT01468233|473108957|FG001|Treatment Period 1|Other|1|||
131405689|NCT01468233|473108958|FG002|Treatment Period 1|Other|0|||
131405690|NCT01468233|473108959|FG003|Treatment Period 1|Other|0|||
131405691|NCT01468233|473108960|FG004|Treatment Period 1|Other|0|||
131405692|NCT01468233|473108961|FG005|Treatment Period 1|Other|0|||
131405693|NCT01468233|473108956|FG000|Treatment Period 2|Adverse Event|0|||
131405694|NCT01468233|473108957|FG001|Treatment Period 2|Adverse Event|0|||
131405695|NCT01468233|473108958|FG002|Treatment Period 2|Adverse Event|3|||
131405696|NCT01468233|473108959|FG003|Treatment Period 2|Adverse Event|0|||
131405697|NCT01468233|473108960|FG004|Treatment Period 2|Adverse Event|2|||
131405698|NCT01468233|473108961|FG005|Treatment Period 2|Adverse Event|1|||
131405699|NCT01468233|473108956|FG000|Treatment Period 2|Lack of Efficacy|0|||
131405700|NCT01468233|473108957|FG001|Treatment Period 2|Lack of Efficacy|0|||
131405701|NCT01468233|473108958|FG002|Treatment Period 2|Lack of Efficacy|9|||
131405702|NCT01468233|473108959|FG003|Treatment Period 2|Lack of Efficacy|2|||
131405703|NCT01468233|473108960|FG004|Treatment Period 2|Lack of Efficacy|0|||
131405704|NCT01468233|473108961|FG005|Treatment Period 2|Lack of Efficacy|1|||
131405705|NCT01468233|473108956|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131405706|NCT01468233|473108957|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131405707|NCT01468233|473108958|FG002|Treatment Period 2|Withdrawal by Subject|9|||
131405708|NCT01468233|473108959|FG003|Treatment Period 2|Withdrawal by Subject|1|||
131405709|NCT01468233|473108960|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131405710|NCT01468233|473108961|FG005|Treatment Period 2|Withdrawal by Subject|1|||
131405711|NCT01468233|473108956|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
131405712|NCT01468233|473108957|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
131405713|NCT01468233|473108958|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
131405714|NCT01468233|473108959|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
131405715|NCT01468233|473108960|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
131405716|NCT01468233|473108961|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
131405717|NCT01468233|473108956|FG000|Treatment Period 2|Lost to Follow-up|0|||
131405718|NCT01468233|473108957|FG001|Treatment Period 2|Lost to Follow-up|0|||
131405719|NCT01468233|473108958|FG002|Treatment Period 2|Lost to Follow-up|3|||
131405720|NCT01468233|473108959|FG003|Treatment Period 2|Lost to Follow-up|0|||
131405721|NCT01468233|473108960|FG004|Treatment Period 2|Lost to Follow-up|2|||
131405722|NCT01468233|473108961|FG005|Treatment Period 2|Lost to Follow-up|0|||
131405723|NCT01468233|473108956|FG000|Treatment Period 2|Other|0|||
131405724|NCT01468233|473108957|FG001|Treatment Period 2|Other|0|||
131405725|NCT01468233|473108958|FG002|Treatment Period 2|Other|3|||
131405726|NCT01468233|473108959|FG003|Treatment Period 2|Other|0|||
131405727|NCT01468233|473108960|FG004|Treatment Period 2|Other|1|||
131405728|NCT01468233|473108961|FG005|Treatment Period 2|Other|0|||
131405729|NCT00522418|473108962|FG000|Overall Study|Local IRB Consent Violation|5|||
131405730|NCT00522418|473108963|FG001|Overall Study|Local IRB Consent Violation|5|||
131405731|NCT00522418|473108962|FG000|Overall Study|Early Study Termination|46|||
131405732|NCT00522418|473108963|FG001|Overall Study|Early Study Termination|47|||
131405733|NCT00522418|473108962|FG000|Overall Study|Noncompliance|2|||
131405734|NCT00522418|473108963|FG001|Overall Study|Noncompliance|2|||
131405735|NCT00522418|473108962|FG000|Overall Study|Reason Not Specified|3|||
131405736|NCT00522418|473108963|FG001|Overall Study|Reason Not Specified|1|||
131405737|NCT00522418|473108962|FG000|Overall Study|Consent Withdraw|1|||
131405738|NCT00522418|473108963|FG001|Overall Study|Consent Withdraw|2|||
131405739|NCT00522418|473108962|FG000|Overall Study|Lack of Efficacy|0|||
131405740|NCT00522418|473108963|FG001|Overall Study|Lack of Efficacy|1|||
131405741|NCT01482169|473108964|FG000|Overall Study|Physician Decision|2|||
131405742|NCT00457821|473108969|FG000|Part 2|Withdrawal by Subject|0|||
131405743|NCT00457821|473108970|FG001|Part 2|Withdrawal by Subject|0|||
131405744|NCT00457821|473108971|FG002|Part 2|Withdrawal by Subject|0|||
131405745|NCT00457821|473108972|FG003|Part 2|Withdrawal by Subject|0|||
131405746|NCT00457821|473108973|FG004|Part 2|Withdrawal by Subject|0|||
131405747|NCT00457821|473108974|FG005|Part 2|Withdrawal by Subject|0|||
131405748|NCT00457821|473108975|FG006|Part 2|Withdrawal by Subject|0|||
131405749|NCT00457821|473108976|FG007|Part 2|Withdrawal by Subject|1|||
131405750|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
131405751|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
131405752|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
131405753|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
131405754|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
131453504|NCT01788358|473289922|FG000|Overall Study|Other|11|||
131453505|NCT01788358|473289922|FG000|Overall Study|Logistical difficulties|1|||
131453506|NCT01788358|473289922|FG000|Overall Study|Lost to Follow-up|5|||
131453507|NCT01788358|473289922|FG000|Overall Study|Protocol Violation|3|||
131453508|NCT01788358|473289922|FG000|Overall Study|Withdrawal by Subject|26|||
131453509|NCT01788358|473289922|FG000|Overall Study|Lack of Efficacy|1|||
131453510|NCT01788358|473289922|FG000|Overall Study|Adverse Event|51|||
131453511|NCT03675321|473289925|FG000|Overall Study|Lack of Efficacy|2|||
131453512|NCT03675321|473289926|FG001|Overall Study|Lack of Efficacy|2|||
131453513|NCT03675321|473289925|FG000|Overall Study|Withdrawal by Subject|1|||
131453514|NCT03675321|473289926|FG001|Overall Study|Withdrawal by Subject|3|||
131453515|NCT01491607|473289930|FG000|Overall Study|Lost to Follow-up|7|||
131453516|NCT01491607|473289930|FG000|Overall Study|Withdrawal by Subject|3|||
131453517|NCT01317277|473289931|FG000|Overall Study|Lost to Follow-up|3|||
131453518|NCT01317277|473289932|FG001|Overall Study|Lost to Follow-up|1|||
131453519|NCT01317277|473289931|FG000|Overall Study|Lost MEMS|1|||
131453520|NCT01317277|473289932|FG001|Overall Study|Lost MEMS|1|||
131453521|NCT01317277|473289931|FG000|Overall Study|Unable to comply with intervention|1|||
131453522|NCT01317277|473289932|FG001|Overall Study|Unable to comply with intervention|0|||
131453523|NCT01317277|473289931|FG000|Overall Study|Withdrawal by Subject|1|||
131453524|NCT01317277|473289932|FG001|Overall Study|Withdrawal by Subject|0|||
131453525|NCT01317277|473289931|FG000|Overall Study|Adverse Event|1|||
131453526|NCT01317277|473289932|FG001|Overall Study|Adverse Event|0|||
131453527|NCT00774566|473289933|FG000|Overall Study|Protocol Violation|18|||
131453528|NCT00774566|473289934|FG001|Overall Study|Protocol Violation|15|||
131453529|NCT01262989|473289941|FG000|Period 1|Lost to Follow-up|1|||
131453530|NCT01262989|473289942|FG001|Period 1|Lost to Follow-up|1|||
131453531|NCT01262989|473289941|FG000|Period 1|Intercurrent disease|0|||
131453532|NCT01262989|473289942|FG001|Period 1|Intercurrent disease|1|||
131453533|NCT01262989|473289941|FG000|Period 1|Positive answer for exclusion criteria|0|||
131453534|NCT01262989|473289942|FG001|Period 1|Positive answer for exclusion criteria|1|||
131453535|NCT01262989|473289941|FG000|Period 2|Intercurrent disease|0|||
131453536|NCT01262989|473289942|FG001|Period 2|Intercurrent disease|1|||
131453537|NCT00470275|473289943|FG000|Overall Study|Death|1|||
131453538|NCT00470275|473289943|FG000|Overall Study|Lack of Efficacy|7|||
131453539|NCT00470275|473289943|FG000|Overall Study|Withdrawal by Subject|2|||
131453540|NCT03048578|473289944|FG000|Overall Study|Withdrawal by Subject|5|||
131453541|NCT03048578|473289945|FG001|Overall Study|Withdrawal by Subject|6|||
131453542|NCT03048578|473289944|FG000|Overall Study|Lost to Follow-up|22|||
131453543|NCT03048578|473289945|FG001|Overall Study|Lost to Follow-up|10|||
131453544|NCT03048578|473289944|FG000|Overall Study|Adverse Event|1|||
131453545|NCT03048578|473289945|FG001|Overall Study|Adverse Event|2|||
131453546|NCT03048578|473289944|FG000|Overall Study|Terminated|3|||
131453547|NCT03048578|473289945|FG001|Overall Study|Terminated|2|||
131453548|NCT02500797|473289948|FG000|Overall Study|Cancel (rapid disease progression)|0|||
131453549|NCT02500797|473289949|FG001|Overall Study|Cancel (rapid disease progression)|0|||
131453550|NCT02500797|473289950|FG002|Overall Study|Cancel (rapid disease progression)|0|||
131453551|NCT02500797|473289951|FG003|Overall Study|Cancel (rapid disease progression)|0|||
131405755|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
131405756|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
131405757|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
131405758|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
131405759|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
131405760|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
131405761|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
131405762|NCT01632241|473108977|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
131405763|NCT01632241|473108978|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
131453552|NCT02500797|473289952|FG004|Overall Study|Cancel (rapid disease progression)|1|||
131453553|NCT02500797|473289953|FG005|Overall Study|Cancel (rapid disease progression)|1|||
131453554|NCT02500797|473289954|FG006|Overall Study|Cancel (rapid disease progression)|0|||
131405764|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
131405765|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
131453555|NCT02500797|473289955|FG007|Overall Study|Cancel (rapid disease progression)|0|||
131453556|NCT02500797|473289948|FG000|Overall Study|Withdrawal by Subject|1|||
131453557|NCT02500797|473289949|FG001|Overall Study|Withdrawal by Subject|0|||
131453558|NCT02500797|473289950|FG002|Overall Study|Withdrawal by Subject|0|||
131453559|NCT02500797|473289951|FG003|Overall Study|Withdrawal by Subject|0|||
131453560|NCT02500797|473289952|FG004|Overall Study|Withdrawal by Subject|0|||
131453561|NCT02500797|473289953|FG005|Overall Study|Withdrawal by Subject|0|||
131453562|NCT02500797|473289954|FG006|Overall Study|Withdrawal by Subject|0|||
131453563|NCT02500797|473289955|FG007|Overall Study|Withdrawal by Subject|0|||
131453564|NCT02722499|473289956|FG000|Overall Study|Lost to Follow-up|2|||
131453565|NCT02722499|473289957|FG001|Overall Study|Lost to Follow-up|0|||
131453566|NCT02722499|473289958|FG002|Overall Study|Lost to Follow-up|1|||
131453567|NCT03566485|473289968|FG000|Overall Study|Disease progression|5|||
131405766|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
131854632|NCT01214655|474745723|FG000|Part B|Withdrawal by Subject|0|||
131854633|NCT01214655|474745724|FG001|Part B|Withdrawal by Subject|2|||
131854634|NCT01214655|474745725|FG002|Part B|Withdrawal by Subject|0|||
131854635|NCT01214655|474745723|FG000|Part C|Progressive Disease|0|||
131854636|NCT01214655|474745724|FG001|Part C|Progressive Disease|0|||
131854637|NCT01214655|474745725|FG002|Part C|Progressive Disease|5|||
131854638|NCT01214655|474745723|FG000|Part C|Death|0|||
131854639|NCT01214655|474745724|FG001|Part C|Death|0|||
131854640|NCT01214655|474745725|FG002|Part C|Death|1|||
131854641|NCT01214655|474745723|FG000|Part C|Physician Decision|0|||
131854642|NCT01214655|474745724|FG001|Part C|Physician Decision|0|||
131854643|NCT01214655|474745725|FG002|Part C|Physician Decision|1|||
131854644|NCT00764881|474745726|FG000|Overall Study|Adverse Event|5|||
131854645|NCT00764881|474745727|FG001|Overall Study|Adverse Event|1|||
131854646|NCT00764881|474745726|FG000|Overall Study|Withdrawal by Subject|1|||
131854647|NCT00764881|474745727|FG001|Overall Study|Withdrawal by Subject|3|||
131854648|NCT00764881|474745726|FG000|Overall Study|Protocol Violation|2|||
131854649|NCT00764881|474745727|FG001|Overall Study|Protocol Violation|2|||
131854650|NCT00764881|474745726|FG000|Overall Study|Lost to Follow-up|2|||
131854651|NCT00764881|474745727|FG001|Overall Study|Lost to Follow-up|0|||
131854652|NCT00764881|474745726|FG000|Overall Study|Noncompliant|1|||
131854653|NCT00764881|474745727|FG001|Overall Study|Noncompliant|0|||
131854654|NCT00764881|474745726|FG000|Overall Study|Accidentally discontinued study drug|1|||
131854655|NCT00764881|474745727|FG001|Overall Study|Accidentally discontinued study drug|0|||
131854656|NCT00764881|474745726|FG000|Overall Study|Wished to become pregnant|1|||
131854657|NCT00764881|474745727|FG001|Overall Study|Wished to become pregnant|0|||
131854658|NCT00764881|474745726|FG000|Overall Study|Carcinoma detected|1|||
131854659|NCT00764881|474745727|FG001|Overall Study|Carcinoma detected|0|||
131854660|NCT00764881|474745726|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
131854661|NCT00764881|474745727|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
131854662|NCT00764881|474745726|FG000|Overall Study|no treatment or no observation|2|||
131854663|NCT00764881|474745727|FG001|Overall Study|no treatment or no observation|2|||
131854664|NCT01023035|474745736|FG000|Treatment Period|Adverse Event|27|||
131854665|NCT01023035|474745737|FG001|Treatment Period|Adverse Event|32|||
131854666|NCT01023035|474745738|FG002|Treatment Period|Adverse Event|50|||
131854667|NCT01023035|474745736|FG000|Treatment Period|Non-Medical Reasons|19|||
131854668|NCT01023035|474745737|FG001|Treatment Period|Non-Medical Reasons|22|||
131854669|NCT01023035|474745738|FG002|Treatment Period|Non-Medical Reasons|44|||
131854670|NCT01023035|474745736|FG000|Treatment Period|Treatment Failure|26|||
131854671|NCT01023035|474745737|FG001|Treatment Period|Treatment Failure|31|||
131854672|NCT01023035|474745738|FG002|Treatment Period|Treatment Failure|24|||
131854673|NCT01023035|474745736|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
131854674|NCT01023035|474745737|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
131854675|NCT01023035|474745738|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
131854676|NCT01023035|474745736|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
131854677|NCT01023035|474745737|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
131854678|NCT01023035|474745738|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
131854679|NCT01937871|474745741|FG000|Overall Study|Adverse Event|6|||
131854680|NCT01937871|474745742|FG001|Overall Study|Adverse Event|6|||
131854681|NCT01937871|474745743|FG002|Overall Study|Adverse Event|2|||
131854682|NCT01937871|474745741|FG000|Overall Study|Lost to Follow-up|8|||
131854683|NCT01937871|474745742|FG001|Overall Study|Lost to Follow-up|2|||
131854684|NCT01937871|474745743|FG002|Overall Study|Lost to Follow-up|4|||
131854685|NCT01937871|474745741|FG000|Overall Study|Withdrawal by Subject|9|||
131854686|NCT01937871|474745742|FG001|Overall Study|Withdrawal by Subject|6|||
131854687|NCT01937871|474745743|FG002|Overall Study|Withdrawal by Subject|4|||
131854688|NCT01937871|474745741|FG000|Overall Study|Physician Decision|0|||
131854689|NCT01937871|474745742|FG001|Overall Study|Physician Decision|1|||
131854690|NCT01937871|474745743|FG002|Overall Study|Physician Decision|0|||
131854691|NCT01937871|474745741|FG000|Overall Study|Entry Criteria Not Met|1|||
131854692|NCT01937871|474745742|FG001|Overall Study|Entry Criteria Not Met|2|||
131854693|NCT01937871|474745743|FG002|Overall Study|Entry Criteria Not Met|1|||
131854694|NCT02413229|474745744|FG000|Overall Study|Adverse Event|0|||
131854695|NCT02413229|474745745|FG001|Overall Study|Adverse Event|0|||
131854696|NCT02413229|474745746|FG002|Overall Study|Adverse Event|0|||
131854697|NCT02413229|474745747|FG003|Overall Study|Adverse Event|1|||
131854698|NCT02413229|474745748|FG004|Overall Study|Adverse Event|0|||
131854699|NCT02413229|474745749|FG005|Overall Study|Adverse Event|0|||
131854700|NCT02413229|474745750|FG006|Overall Study|Adverse Event|0|||
131854701|NCT02413229|474745751|FG007|Overall Study|Adverse Event|1|||
131854702|NCT02413229|474745744|FG000|Overall Study|Lost to Follow-up|0|||
131854703|NCT02413229|474745745|FG001|Overall Study|Lost to Follow-up|0|||
131854704|NCT02413229|474745746|FG002|Overall Study|Lost to Follow-up|1|||
131854705|NCT02413229|474745747|FG003|Overall Study|Lost to Follow-up|0|||
131854706|NCT02413229|474745748|FG004|Overall Study|Lost to Follow-up|2|||
131854707|NCT02413229|474745749|FG005|Overall Study|Lost to Follow-up|0|||
131453568|NCT03566485|473289969|FG001|Overall Study|Disease progression|4|||
131854708|NCT02413229|474745750|FG006|Overall Study|Lost to Follow-up|0|||
131854709|NCT02413229|474745751|FG007|Overall Study|Lost to Follow-up|0|||
131854710|NCT02413229|474745744|FG000|Overall Study|Withdrawal by Subject|1|||
131854711|NCT02413229|474745745|FG001|Overall Study|Withdrawal by Subject|1|||
131854712|NCT02413229|474745746|FG002|Overall Study|Withdrawal by Subject|0|||
131854713|NCT02413229|474745747|FG003|Overall Study|Withdrawal by Subject|0|||
131854714|NCT02413229|474745748|FG004|Overall Study|Withdrawal by Subject|1|||
131854715|NCT02413229|474745749|FG005|Overall Study|Withdrawal by Subject|0|||
131854716|NCT02413229|474745750|FG006|Overall Study|Withdrawal by Subject|0|||
131854717|NCT02413229|474745751|FG007|Overall Study|Withdrawal by Subject|2|||
131854718|NCT02413229|474745744|FG000|Overall Study|Progressive Disease|0|||
131854719|NCT02413229|474745745|FG001|Overall Study|Progressive Disease|0|||
131854720|NCT02413229|474745746|FG002|Overall Study|Progressive Disease|0|||
131854721|NCT02413229|474745747|FG003|Overall Study|Progressive Disease|0|||
131854722|NCT02413229|474745748|FG004|Overall Study|Progressive Disease|0|||
131854723|NCT02413229|474745749|FG005|Overall Study|Progressive Disease|0|||
131854724|NCT02413229|474745750|FG006|Overall Study|Progressive Disease|0|||
131854725|NCT02413229|474745751|FG007|Overall Study|Progressive Disease|1|||
131854726|NCT00668317|474745752|FG000|Overall Study|Adverse Event|2|||
131854727|NCT03668808|474745754|FG000|First Intervention|Withdrawal by Subject|2|||
131854728|NCT03668808|474745755|FG001|First Intervention|Withdrawal by Subject|2|||
131854729|NCT02288325|474745764|FG000|Run-in Period|Adverse Event|48|||
131854730|NCT02288325|474745765|FG001|Run-in Period|Adverse Event|0|||
131854731|NCT02288325|474745766|FG002|Run-in Period|Adverse Event|0|||
131854732|NCT02288325|474745764|FG000|Run-in Period|Lack of Efficacy|16|||
131854733|NCT02288325|474745765|FG001|Run-in Period|Lack of Efficacy|0|||
131854734|NCT02288325|474745766|FG002|Run-in Period|Lack of Efficacy|0|||
131854735|NCT02288325|474745764|FG000|Run-in Period|Withdrawal of Consent|28|||
131854736|NCT02288325|474745765|FG001|Run-in Period|Withdrawal of Consent|0|||
131854737|NCT02288325|474745766|FG002|Run-in Period|Withdrawal of Consent|0|||
131854738|NCT02288325|474745764|FG000|Run-in Period|Lost to Follow-up|25|||
131854739|NCT02288325|474745765|FG001|Run-in Period|Lost to Follow-up|0|||
131854740|NCT02288325|474745766|FG002|Run-in Period|Lost to Follow-up|0|||
131854741|NCT02288325|474745764|FG000|Run-in Period|Protocol Violation|17|||
131854742|NCT02288325|474745765|FG001|Run-in Period|Protocol Violation|0|||
131854743|NCT02288325|474745766|FG002|Run-in Period|Protocol Violation|0|||
131854744|NCT02288325|474745764|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
131854745|NCT02288325|474745765|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
131854746|NCT02288325|474745766|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
131854747|NCT02288325|474745764|FG000|Run-in Period|Reason not Specified|8|||
131854748|NCT02288325|474745765|FG001|Run-in Period|Reason not Specified|0|||
131854749|NCT02288325|474745766|FG002|Run-in Period|Reason not Specified|0|||
131854750|NCT02288325|474745764|FG000|Stabilization Period|Adverse Event|13|||
131854751|NCT02288325|474745765|FG001|Stabilization Period|Adverse Event|0|||
131854752|NCT02288325|474745766|FG002|Stabilization Period|Adverse Event|0|||
131854753|NCT02288325|474745764|FG000|Stabilization Period|Lack of Efficacy|22|||
131854754|NCT02288325|474745765|FG001|Stabilization Period|Lack of Efficacy|0|||
131854755|NCT02288325|474745766|FG002|Stabilization Period|Lack of Efficacy|0|||
131854756|NCT02288325|474745764|FG000|Stabilization Period|Withdrawal of Consent|23|||
131854757|NCT02288325|474745765|FG001|Stabilization Period|Withdrawal of Consent|0|||
131854758|NCT02288325|474745766|FG002|Stabilization Period|Withdrawal of Consent|0|||
131854759|NCT02288325|474745764|FG000|Stabilization Period|Lost to Follow-up|12|||
131854760|NCT02288325|474745765|FG001|Stabilization Period|Lost to Follow-up|0|||
131854761|NCT02288325|474745766|FG002|Stabilization Period|Lost to Follow-up|0|||
131854762|NCT02288325|474745764|FG000|Stabilization Period|Protocol Violation|8|||
131854763|NCT02288325|474745765|FG001|Stabilization Period|Protocol Violation|0|||
131854764|NCT02288325|474745766|FG002|Stabilization Period|Protocol Violation|0|||
131405767|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
131405768|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
131405769|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
131405770|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
131854765|NCT02288325|474745764|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
131854766|NCT02288325|474745765|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
131854767|NCT02288325|474745766|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
131854768|NCT02288325|474745764|FG000|Stabilization Period|Reason not Specified|15|||
131854769|NCT02288325|474745765|FG001|Stabilization Period|Reason not Specified|0|||
131854770|NCT02288325|474745766|FG002|Stabilization Period|Reason not Specified|0|||
131854771|NCT02288325|474745764|FG000|Double-blind Treatment Period|Adverse Event|0|||
131854772|NCT02288325|474745765|FG001|Double-blind Treatment Period|Adverse Event|2|||
131405771|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
131405772|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
131405773|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
131854773|NCT02288325|474745766|FG002|Double-blind Treatment Period|Adverse Event|5|||
131854774|NCT02288325|474745764|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
131854775|NCT02288325|474745765|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
131405774|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
131405775|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
131405776|NCT01632241|473108977|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
131405777|NCT01632241|473108978|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
131405778|NCT00855933|473108990|FG000|Overall Study|Withdrawal by Subject|0|||
131405779|NCT00855933|473108991|FG001|Overall Study|Withdrawal by Subject|1|||
131405780|NCT00951080|473108992|FG000|Overall Study|Adverse Event|3|||
131405781|NCT00951080|473108993|FG001|Overall Study|Adverse Event|3|||
131405782|NCT00951080|473108992|FG000|Overall Study|Lost to Follow-up|0|||
131405783|NCT00951080|473108993|FG001|Overall Study|Lost to Follow-up|1|||
131405784|NCT00951080|473108992|FG000|Overall Study|Physician Decision|4|||
131405785|NCT00951080|473108993|FG001|Overall Study|Physician Decision|1|||
131405786|NCT00951080|473108992|FG000|Overall Study|Other|19|||
131405787|NCT00951080|473108993|FG001|Overall Study|Other|22|||
131405788|NCT01960998|473108994|FG000|Overall Study|Lost to Follow-up|3|||
131405789|NCT01960998|473108995|FG001|Overall Study|Lost to Follow-up|7|||
131405790|NCT01960998|473108994|FG000|Overall Study|Death|0|||
131405791|NCT01960998|473108995|FG001|Overall Study|Death|1|||
131405792|NCT01960998|473108994|FG000|Overall Study|Withdrawal by Subject|8|||
131405793|NCT01960998|473108995|FG001|Overall Study|Withdrawal by Subject|2|||
131405794|NCT01960998|473108994|FG000|Overall Study|lost computer access|0|||
131405795|NCT01960998|473108995|FG001|Overall Study|lost computer access|1|||
131405796|NCT00759356|473108996|FG000|Overall Study|Adverse Event|0|||
131405797|NCT00759356|473108997|FG001|Overall Study|Adverse Event|1|||
131405798|NCT00759356|473108996|FG000|Overall Study|Withdrawal by Subject|0|||
131405799|NCT00759356|473108997|FG001|Overall Study|Withdrawal by Subject|2|||
131405800|NCT00759356|473108996|FG000|Overall Study|Subject was unable to return|1|||
131405801|NCT00759356|473108997|FG001|Overall Study|Subject was unable to return|0|||
131405802|NCT02851407|473108998|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131405803|NCT02851407|473108999|FG001|Overall Study|Withdrawal by parent/guardian|7|||
131405804|NCT02851407|473108998|FG000|Overall Study|Protocol deviation|0|||
131405805|NCT02851407|473108999|FG001|Overall Study|Protocol deviation|1|||
131405806|NCT02851407|473108998|FG000|Overall Study|Transferred to another hospital to continue|1|||
131405807|NCT02851407|473108999|FG001|Overall Study|Transferred to another hospital to continue|0|||
131405808|NCT02851407|473108998|FG000|Overall Study|Other Death|30|||
131405809|NCT02851407|473108999|FG001|Overall Study|Other Death|20|||
131405810|NCT02851407|473108998|FG000|Overall Study|Adverse event, serious fatal|6|||
131405811|NCT02851407|473108999|FG001|Overall Study|Adverse event, serious fatal|8|||
131405812|NCT02851407|473108998|FG000|Overall Study|Consent withdrawn by participant|5|||
131405813|NCT02851407|473108999|FG001|Overall Study|Consent withdrawn by participant|3|||
131405814|NCT02851407|473108998|FG000|Overall Study|Screen failure|2|||
131405815|NCT02851407|473108999|FG001|Overall Study|Screen failure|1|||
131405816|NCT02851407|473108998|FG000|Overall Study|Disease relapse|9|||
131405817|NCT02851407|473108999|FG001|Overall Study|Disease relapse|6|||
131405818|NCT02851407|473108998|FG000|Overall Study|Physician Decision|7|||
131405819|NCT02851407|473108999|FG001|Overall Study|Physician Decision|6|||
131405820|NCT02851407|473108998|FG000|Overall Study|Transferred to hospital closer to home|0|||
131405821|NCT02851407|473108999|FG001|Overall Study|Transferred to hospital closer to home|1|||
131405822|NCT02851407|473108998|FG000|Overall Study|Enrolled in an investigational study|0|||
131405823|NCT02851407|473108999|FG001|Overall Study|Enrolled in an investigational study|1|||
131405824|NCT02851407|473108998|FG000|Overall Study|Early recovery|1|||
131405825|NCT02851407|473108999|FG001|Overall Study|Early recovery|0|||
131854776|NCT02288325|474745766|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
131854777|NCT02288325|474745764|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131854778|NCT02288325|474745765|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
131854779|NCT02288325|474745766|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
131854780|NCT02288325|474745764|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131854781|NCT02288325|474745765|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131854782|NCT02288325|474745766|FG002|Double-blind Treatment Period|Protocol Violation|2|||
131854783|NCT02288325|474745764|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
131854784|NCT02288325|474745765|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
131854785|NCT02288325|474745766|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
131854786|NCT02288325|474745764|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
131405826|NCT02851407|473108998|FG000|Overall Study|Adverse event, non-fatal|7|||
131854787|NCT02288325|474745765|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
131405827|NCT02851407|473108999|FG001|Overall Study|Adverse event, non-fatal|5|||
131405828|NCT02851407|473108998|FG000|Overall Study|Lost to Follow-up|0|||
131405829|NCT02851407|473108999|FG001|Overall Study|Lost to Follow-up|2|||
131405830|NCT01713283|473109003|FG000|Overall Study|Lack of Efficacy|10|||
131405831|NCT01713283|473109004|FG001|Overall Study|Lack of Efficacy|2|||
131405832|NCT01713283|473109003|FG000|Overall Study|Lost to Follow-up|1|||
131405833|NCT01713283|473109004|FG001|Overall Study|Lost to Follow-up|1|||
131405834|NCT02403635|473109005|FG000|Overall Study|Not eligible|9|||
131854788|NCT02288325|474745766|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
131405835|NCT00835640|473109009|FG000|Second Intervention|Protocol Violation|1|||
131453569|NCT03566485|473289968|FG000|Overall Study|Clinical progression|0|||
131453570|NCT03566485|473289969|FG001|Overall Study|Clinical progression|1|||
131453571|NCT03566485|473289968|FG000|Overall Study|Toxicity|0|||
131453572|NCT03566485|473289969|FG001|Overall Study|Toxicity|2|||
131453573|NCT04999852|473289970|FG000|Overall Study|Withdrawal by Subject|11|||
131453574|NCT04999852|473289971|FG001|Overall Study|Withdrawal by Subject|1|||
131453575|NCT04999852|473289970|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
131453576|NCT04999852|473289971|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
131854789|NCT02829918|474745781|FG000|Overall Study|Death|2|||
131405836|NCT00835640|473109010|FG001|Second Intervention|Protocol Violation|0|||
131405837|NCT01904149|473109011|FG000|Overall Study|Adverse Event|3|||
131405838|NCT01904149|473109012|FG001|Overall Study|Adverse Event|4|||
131405839|NCT01904149|473109013|FG002|Overall Study|Adverse Event|0|||
131405840|NCT01904149|473109014|FG003|Overall Study|Adverse Event|1|||
131405841|NCT01904149|473109015|FG004|Overall Study|Adverse Event|1|||
131405842|NCT01904149|473109016|FG005|Overall Study|Adverse Event|2|||
131405843|NCT01904149|473109011|FG000|Overall Study|Lack of Efficacy|0|||
131405844|NCT01904149|473109012|FG001|Overall Study|Lack of Efficacy|3|||
131405845|NCT01904149|473109013|FG002|Overall Study|Lack of Efficacy|1|||
131405846|NCT01904149|473109014|FG003|Overall Study|Lack of Efficacy|3|||
131405847|NCT01904149|473109015|FG004|Overall Study|Lack of Efficacy|3|||
131405848|NCT01904149|473109016|FG005|Overall Study|Lack of Efficacy|1|||
131405849|NCT01904149|473109011|FG000|Overall Study|Withdrawal by Subject|1|||
131405850|NCT01904149|473109012|FG001|Overall Study|Withdrawal by Subject|3|||
131405851|NCT01904149|473109013|FG002|Overall Study|Withdrawal by Subject|1|||
131405852|NCT01904149|473109014|FG003|Overall Study|Withdrawal by Subject|0|||
131405853|NCT01904149|473109015|FG004|Overall Study|Withdrawal by Subject|1|||
131405854|NCT01904149|473109016|FG005|Overall Study|Withdrawal by Subject|0|||
131405855|NCT01904149|473109011|FG000|Overall Study|Protocol Violation|0|||
131405856|NCT01904149|473109012|FG001|Overall Study|Protocol Violation|1|||
131405857|NCT01904149|473109013|FG002|Overall Study|Protocol Violation|0|||
131405858|NCT01904149|473109014|FG003|Overall Study|Protocol Violation|0|||
131405859|NCT01904149|473109015|FG004|Overall Study|Protocol Violation|0|||
131405860|NCT01904149|473109016|FG005|Overall Study|Protocol Violation|0|||
131405861|NCT01904149|473109011|FG000|Overall Study|non compliance with study drug|1|||
131405862|NCT01904149|473109012|FG001|Overall Study|non compliance with study drug|0|||
131854790|NCT02829918|474745781|FG000|Overall Study|Withdrawal by Subject|4|||
131854791|NCT02829918|474745781|FG000|Overall Study|Adverse Event|1|||
131854792|NCT02829918|474745781|FG000|Overall Study|Progression|1|||
131854793|NCT05061420|474745786|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
131854794|NCT05061420|474745787|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
131854795|NCT05061420|474745788|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
131854796|NCT05061420|474745786|FG000|Overall Study|Progressive disease|11|||
131854797|NCT05061420|474745787|FG001|Overall Study|Progressive disease|15|||
131854798|NCT05061420|474745788|FG002|Overall Study|Progressive disease|14|||
131854799|NCT05061420|474745786|FG000|Overall Study|Withdrawal by Subject|2|||
131854800|NCT05061420|474745787|FG001|Overall Study|Withdrawal by Subject|0|||
131854801|NCT05061420|474745788|FG002|Overall Study|Withdrawal by Subject|1|||
131854802|NCT05061420|474745786|FG000|Overall Study|Not related to COVID-19|2|||
131854803|NCT05061420|474745787|FG001|Overall Study|Not related to COVID-19|0|||
131854804|NCT05061420|474745788|FG002|Overall Study|Not related to COVID-19|0|||
131854805|NCT04868500|474745789|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
131854806|NCT04868500|474745790|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
131854807|NCT04868500|474745789|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
131854808|NCT04868500|474745790|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
131854809|NCT02859142|474745791|FG000|Overall Study|Adverse Event|1|||
131854810|NCT02859142|474745792|FG001|Overall Study|Adverse Event|2|||
131854811|NCT02859142|474745791|FG000|Overall Study|Lost to Follow-up|1|||
131854812|NCT02859142|474745792|FG001|Overall Study|Lost to Follow-up|4|||
131854813|NCT02859142|474745791|FG000|Overall Study|Withdrawal by Subject|2|||
131405863|NCT01904149|473109013|FG002|Overall Study|non compliance with study drug|0|||
131405864|NCT01904149|473109014|FG003|Overall Study|non compliance with study drug|0|||
131405865|NCT01904149|473109015|FG004|Overall Study|non compliance with study drug|0|||
131405866|NCT01904149|473109016|FG005|Overall Study|non compliance with study drug|0|||
131405867|NCT00812006|473109017|FG000|Overall Study|Lost to Follow-up|0|||
131405868|NCT00812006|473109018|FG001|Overall Study|Lost to Follow-up|0|||
131405869|NCT00812006|473109019|FG002|Overall Study|Lost to Follow-up|2|||
131405870|NCT00812006|473109017|FG000|Overall Study|Physician Decision|0|||
131405871|NCT00812006|473109018|FG001|Overall Study|Physician Decision|0|||
131405872|NCT00812006|473109019|FG002|Overall Study|Physician Decision|1|||
131453577|NCT04939415|473289972|FG000|Overall Study|Withdrawal by Subject|1|||
131453578|NCT04939415|473289973|FG001|Overall Study|Withdrawal by Subject|3|||
131854814|NCT02859142|474745792|FG001|Overall Study|Withdrawal by Subject|0|||
131405873|NCT00812006|473109017|FG000|Overall Study|Withdrawal by Subject|2|||
131405874|NCT00812006|473109018|FG001|Overall Study|Withdrawal by Subject|1|||
131453579|NCT04939415|473289972|FG000|Overall Study|Lost to Follow-up|0|||
131453580|NCT04939415|473289973|FG001|Overall Study|Lost to Follow-up|2|||
131453581|NCT03610269|473289975|FG000|Overall Study|Physician Decision|10|||
131453582|NCT03610269|473289975|FG000|Overall Study|Protocol Violation|1|||
131453583|NCT03610269|473289975|FG000|Overall Study|Unable to draw blood|1|||
131453584|NCT03610269|473289975|FG000|Overall Study|Screen fail|4|||
131453585|NCT00478023|473289976|FG000|Overall Study|Adverse Event|11|||
131453586|NCT00478023|473289977|FG001|Overall Study|Adverse Event|7|||
131453587|NCT00478023|473289978|FG002|Overall Study|Adverse Event|8|||
131453588|NCT00478023|473289979|FG003|Overall Study|Adverse Event|14|||
131453589|NCT00478023|473289980|FG004|Overall Study|Adverse Event|6|||
131453590|NCT00478023|473289976|FG000|Overall Study|Death|1|||
131453591|NCT00478023|473289977|FG001|Overall Study|Death|0|||
131453592|NCT00478023|473289978|FG002|Overall Study|Death|0|||
131453593|NCT00478023|473289979|FG003|Overall Study|Death|0|||
131453594|NCT00478023|473289980|FG004|Overall Study|Death|0|||
131453595|NCT00478023|473289976|FG000|Overall Study|Lack of Efficacy|11|||
131453596|NCT00478023|473289977|FG001|Overall Study|Lack of Efficacy|10|||
131453597|NCT00478023|473289978|FG002|Overall Study|Lack of Efficacy|4|||
131453598|NCT00478023|473289979|FG003|Overall Study|Lack of Efficacy|5|||
131453599|NCT00478023|473289980|FG004|Overall Study|Lack of Efficacy|41|||
131453600|NCT00478023|473289976|FG000|Overall Study|Lost to Follow-up|3|||
131453601|NCT00478023|473289977|FG001|Overall Study|Lost to Follow-up|1|||
131453602|NCT00478023|473289978|FG002|Overall Study|Lost to Follow-up|1|||
131453603|NCT00478023|473289979|FG003|Overall Study|Lost to Follow-up|1|||
131453604|NCT00478023|473289980|FG004|Overall Study|Lost to Follow-up|0|||
131453605|NCT00478023|473289976|FG000|Overall Study|Withdrawal by Subject|2|||
131453606|NCT00478023|473289977|FG001|Overall Study|Withdrawal by Subject|3|||
131453607|NCT00478023|473289978|FG002|Overall Study|Withdrawal by Subject|2|||
131453608|NCT00478023|473289979|FG003|Overall Study|Withdrawal by Subject|4|||
131453609|NCT00478023|473289980|FG004|Overall Study|Withdrawal by Subject|5|||
131453610|NCT00478023|473289976|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
131453611|NCT00478023|473289977|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
131453612|NCT00478023|473289978|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
131453613|NCT00478023|473289979|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
131453614|NCT00478023|473289980|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
131453615|NCT00611026|473289982|FG000|Randomized to Double-blind Treatment|Not treated|2|||
131453616|NCT00611026|473289983|FG001|Randomized to Double-blind Treatment|Not treated|1|||
131453617|NCT00611026|473289984|FG002|Randomized to Double-blind Treatment|Not treated|3|||
131854815|NCT02859142|474745791|FG000|Overall Study|Scheduling difficulties|0|||
131854816|NCT02859142|474745792|FG001|Overall Study|Scheduling difficulties|3|||
131854817|NCT03340974|474745793|FG000|Completion of Study -Long Term Follow up|Death|8|||
131854818|NCT03340974|474745794|FG001|Completion of Study -Long Term Follow up|Death|5|||
131854819|NCT03340974|474745795|FG002|Completion of Study -Long Term Follow up|Death|5|||
131854820|NCT03340974|474745796|FG003|Completion of Study -Long Term Follow up|Death|7|||
131854821|NCT03340974|474745793|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
131854822|NCT03340974|474745794|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
131854823|NCT03340974|474745795|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
131854824|NCT03340974|474745796|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
131854825|NCT03340974|474745793|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
131854826|NCT03340974|474745794|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
131854827|NCT03340974|474745795|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
131854828|NCT03340974|474745796|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
131854829|NCT03340974|474745793|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
131854830|NCT03340974|474745794|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
131854831|NCT03340974|474745795|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
131854832|NCT03340974|474745796|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
131854833|NCT02466685|474745797|FG000|Overall Study|Adverse Event|5|||
131854834|NCT02466685|474745798|FG001|Overall Study|Adverse Event|2|||
131854835|NCT02466685|474745797|FG000|Overall Study|Lost to Follow-up|1|||
131854836|NCT02466685|474745798|FG001|Overall Study|Lost to Follow-up|1|||
131854837|NCT02466685|474745797|FG000|Overall Study|Withdrawal by Subject|1|||
131854838|NCT02466685|474745798|FG001|Overall Study|Withdrawal by Subject|0|||
131854839|NCT02466685|474745797|FG000|Overall Study|Physician Decision|1|||
131854840|NCT02466685|474745798|FG001|Overall Study|Physician Decision|1|||
131854841|NCT04807400|474745799|FG000|Overall Study|Adverse Event|2|||
131453618|NCT00611026|473289982|FG000|Double-blind Treatment Period|Death|1|||
131453619|NCT00611026|473289983|FG001|Double-blind Treatment Period|Death|0|||
131453620|NCT00611026|473289984|FG002|Double-blind Treatment Period|Death|0|||
131453621|NCT00611026|473289982|FG000|Double-blind Treatment Period|Adverse Event|9|||
131453622|NCT00611026|473289983|FG001|Double-blind Treatment Period|Adverse Event|28|||
131854842|NCT04807400|474745800|FG001|Overall Study|Adverse Event|3|||
131854843|NCT04807400|474745801|FG002|Overall Study|Adverse Event|3|||
131453623|NCT00611026|473289984|FG002|Double-blind Treatment Period|Adverse Event|46|||
131854844|NCT04807400|474745799|FG000|Overall Study|Death|2|||
131854845|NCT04807400|474745800|FG001|Overall Study|Death|0|||
131854846|NCT04807400|474745801|FG002|Overall Study|Death|0|||
131854847|NCT04807400|474745799|FG000|Overall Study|Lost to Follow-up|8|||
131854848|NCT04807400|474745800|FG001|Overall Study|Lost to Follow-up|6|||
131854849|NCT04807400|474745801|FG002|Overall Study|Lost to Follow-up|6|||
131854850|NCT04807400|474745799|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131854851|NCT04807400|474745800|FG001|Overall Study|Non-Compliance With Study Drug|4|||
131854852|NCT04807400|474745801|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131405875|NCT00812006|473109019|FG002|Overall Study|Withdrawal by Subject|1|||
131405876|NCT00812006|473109017|FG000|Overall Study|Lack of Qualifying Event|4|||
131405877|NCT00812006|473109018|FG001|Overall Study|Lack of Qualifying Event|2|||
131405878|NCT00812006|473109019|FG002|Overall Study|Lack of Qualifying Event|2|||
131405879|NCT00068250|473109020|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
131405880|NCT00068250|473109021|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
131405881|NCT00068250|473109022|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
131405882|NCT00068250|473109023|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
131405883|NCT00235391|473109024|FG000|Overall Study|Adverse Event|4|||
131405884|NCT00235391|473109025|FG001|Overall Study|Adverse Event|5|||
131405885|NCT00235391|473109026|FG002|Overall Study|Adverse Event|10|||
131405886|NCT00235391|473109027|FG003|Overall Study|Adverse Event|72|||
131405887|NCT00235391|473109028|FG004|Overall Study|Adverse Event|5|||
131405888|NCT00235391|473109029|FG005|Overall Study|Adverse Event|2|||
131405889|NCT00235391|473109024|FG000|Overall Study|Abnormal laboratory value(s)|3|||
131405890|NCT00235391|473109025|FG001|Overall Study|Abnormal laboratory value(s)|5|||
131405891|NCT00235391|473109026|FG002|Overall Study|Abnormal laboratory value(s)|4|||
131405892|NCT00235391|473109027|FG003|Overall Study|Abnormal laboratory value(s)|27|||
131405893|NCT00235391|473109028|FG004|Overall Study|Abnormal laboratory value(s)|1|||
131405894|NCT00235391|473109029|FG005|Overall Study|Abnormal laboratory value(s)|2|||
131405895|NCT00235391|473109024|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131405896|NCT00235391|473109025|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131854853|NCT04807400|474745799|FG000|Overall Study|Participant Decision|20|||
131854854|NCT04807400|474745800|FG001|Overall Study|Participant Decision|19|||
131854855|NCT04807400|474745801|FG002|Overall Study|Participant Decision|26|||
131854856|NCT04807400|474745799|FG000|Overall Study|Physician Decision|0|||
131854857|NCT04807400|474745800|FG001|Overall Study|Physician Decision|1|||
131854858|NCT04807400|474745801|FG002|Overall Study|Physician Decision|0|||
131854859|NCT04807400|474745799|FG000|Overall Study|Protocol Violation|4|||
131854860|NCT04807400|474745800|FG001|Overall Study|Protocol Violation|3|||
131854861|NCT04807400|474745801|FG002|Overall Study|Protocol Violation|7|||
131854862|NCT04807400|474745799|FG000|Overall Study|Withdrawal by Subject|13|||
131854863|NCT04807400|474745800|FG001|Overall Study|Withdrawal by Subject|9|||
131854864|NCT04807400|474745801|FG002|Overall Study|Withdrawal by Subject|20|||
131854865|NCT04807400|474745799|FG000|Overall Study|Mis-randomized|1|||
131854866|NCT04807400|474745800|FG001|Overall Study|Mis-randomized|0|||
131854867|NCT04807400|474745801|FG002|Overall Study|Mis-randomized|0|||
131854868|NCT01332292|474745805|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
131854869|NCT01332292|474745806|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
131854870|NCT01332292|474745805|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131854871|NCT01332292|474745806|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131854872|NCT01332292|474745805|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
131854873|NCT01332292|474745806|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
131854874|NCT01911273|474745808|FG000|Overall Study|Progression of Disease|1|||
131854875|NCT01911273|474745809|FG001|Overall Study|Progression of Disease|0|||
131854876|NCT01911273|474745808|FG000|Overall Study|Withdrawal by Subject|0|||
131405897|NCT00235391|473109026|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131854877|NCT01911273|474745809|FG001|Overall Study|Withdrawal by Subject|2|||
131854878|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
131854879|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Off-label use|283|||
131854880|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
131854881|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
131854882|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
131854883|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
131854884|NCT01070953|474745810|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
131854885|NCT01070953|474745810|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
131854886|NCT01070953|474745810|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
131854887|NCT01070953|474745810|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
131405898|NCT00235391|473109027|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
131854888|NCT01957176|474745811|FG000|Overall Study|Adverse Event|2|||
131854889|NCT01957176|474745812|FG001|Overall Study|Adverse Event|0|||
131405899|NCT00235391|473109028|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
131405900|NCT00235391|473109029|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
131405901|NCT00235391|473109024|FG000|Overall Study|Condition no longer requires treatment|3|||
131854890|NCT01957176|474745811|FG000|Overall Study|Physician Decision|2|||
131854891|NCT01957176|474745812|FG001|Overall Study|Physician Decision|1|||
131854892|NCT01957176|474745811|FG000|Overall Study|Withdrawal by Subject|1|||
131405902|NCT00235391|473109025|FG001|Overall Study|Condition no longer requires treatment|0|||
131405903|NCT00235391|473109026|FG002|Overall Study|Condition no longer requires treatment|0|||
131405904|NCT00235391|473109027|FG003|Overall Study|Condition no longer requires treatment|11|||
131854893|NCT01957176|474745812|FG001|Overall Study|Withdrawal by Subject|0|||
131854894|NCT02359994|474745813|FG000|Overall Population Study|Adverse Event|1|||
131854895|NCT02359994|474745814|FG001|Overall Population Study|Adverse Event|1|||
131854896|NCT02359994|474745813|FG000|Overall Population Study|Death|1|||
131854897|NCT02359994|474745814|FG001|Overall Population Study|Death|5|||
131405905|NCT00235391|473109028|FG004|Overall Study|Condition no longer requires treatment|1|||
131405906|NCT00235391|473109029|FG005|Overall Study|Condition no longer requires treatment|0|||
131405907|NCT00235391|473109024|FG000|Overall Study|Protocol deviation|0|||
131405908|NCT00235391|473109025|FG001|Overall Study|Protocol deviation|0|||
131854898|NCT02359994|474745813|FG000|Overall Population Study|Lost to Follow-up|1|||
131854899|NCT02359994|474745814|FG001|Overall Population Study|Lost to Follow-up|1|||
131854900|NCT02359994|474745813|FG000|Overall Population Study|Withdrawal by Subject|1|||
131854901|NCT02359994|474745814|FG001|Overall Population Study|Withdrawal by Subject|0|||
131854902|NCT02359994|474745813|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
131854903|NCT02359994|474745814|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
131854904|NCT02359994|474745813|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
131405909|NCT00235391|473109026|FG002|Overall Study|Protocol deviation|1|||
131405910|NCT00235391|473109027|FG003|Overall Study|Protocol deviation|11|||
131405911|NCT00235391|473109028|FG004|Overall Study|Protocol deviation|0|||
131405912|NCT00235391|473109029|FG005|Overall Study|Protocol deviation|0|||
131405913|NCT00235391|473109024|FG000|Overall Study|Withdrawal by Subject|2|||
131405914|NCT00235391|473109025|FG001|Overall Study|Withdrawal by Subject|3|||
131405915|NCT00235391|473109026|FG002|Overall Study|Withdrawal by Subject|3|||
131405916|NCT00235391|473109027|FG003|Overall Study|Withdrawal by Subject|61|||
131405917|NCT00235391|473109028|FG004|Overall Study|Withdrawal by Subject|5|||
131405918|NCT00235391|473109029|FG005|Overall Study|Withdrawal by Subject|0|||
131405919|NCT00235391|473109024|FG000|Overall Study|Lost to Follow-up|0|||
131405920|NCT00235391|473109025|FG001|Overall Study|Lost to Follow-up|3|||
131405921|NCT00235391|473109026|FG002|Overall Study|Lost to Follow-up|3|||
131405922|NCT00235391|473109027|FG003|Overall Study|Lost to Follow-up|16|||
131405923|NCT00235391|473109028|FG004|Overall Study|Lost to Follow-up|0|||
131405924|NCT00235391|473109029|FG005|Overall Study|Lost to Follow-up|0|||
131405925|NCT00235391|473109024|FG000|Overall Study|Administrative problems|0|||
131405926|NCT00235391|473109025|FG001|Overall Study|Administrative problems|0|||
131405927|NCT00235391|473109026|FG002|Overall Study|Administrative problems|0|||
131405928|NCT00235391|473109027|FG003|Overall Study|Administrative problems|1|||
131405929|NCT00235391|473109028|FG004|Overall Study|Administrative problems|0|||
131405930|NCT00235391|473109029|FG005|Overall Study|Administrative problems|0|||
131405931|NCT00235391|473109024|FG000|Overall Study|Death|0|||
131405932|NCT00235391|473109025|FG001|Overall Study|Death|0|||
131405933|NCT00235391|473109026|FG002|Overall Study|Death|1|||
131405934|NCT00235391|473109027|FG003|Overall Study|Death|4|||
131405935|NCT00235391|473109028|FG004|Overall Study|Death|0|||
131854905|NCT02359994|474745814|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
131854906|NCT02359994|474745813|FG000|Extended Oncology 24-Month Survival|Death|19|||
131854907|NCT02359994|474745814|FG001|Extended Oncology 24-Month Survival|Death|21|||
131854908|NCT02359994|474745813|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
131854909|NCT02359994|474745814|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
131854910|NCT01823835|474745817|FG000|Overall Study|Adverse Event|0|||
131854911|NCT01823835|474745818|FG001|Overall Study|Adverse Event|0|||
131854912|NCT01823835|474745819|FG002|Overall Study|Adverse Event|0|||
131854913|NCT01823835|474745820|FG003|Overall Study|Adverse Event|0|||
131854914|NCT01823835|474745821|FG004|Overall Study|Adverse Event|1|||
131854915|NCT01823835|474745822|FG005|Overall Study|Adverse Event|0|||
131405936|NCT00235391|473109029|FG005|Overall Study|Death|0|||
131912457|NCT04810962|474966590|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
131912458|NCT04810962|474966591|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
131912459|NCT00297167|474966592|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
131912460|NCT00297167|474966593|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
131912461|NCT00297167|474966594|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
131912462|NCT00297167|474966592|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
131912463|NCT00297167|474966593|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
131912464|NCT00297167|474966594|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
131912465|NCT03185208|474966597|FG000|Overall Study|Did not start study medication|0|||
131912466|NCT03185208|474966598|FG001|Overall Study|Did not start study medication|3|||
131854916|NCT01823835|474745823|FG006|Overall Study|Adverse Event|1|||
131854917|NCT01823835|474745824|FG007|Overall Study|Adverse Event|0|||
131854918|NCT01823835|474745825|FG008|Overall Study|Adverse Event|0|||
131854919|NCT01823835|474745826|FG009|Overall Study|Adverse Event|0|||
131854920|NCT01823835|474745827|FG010|Overall Study|Adverse Event|1|||
131854921|NCT01823835|474745828|FG011|Overall Study|Adverse Event|2|||
131854922|NCT01823835|474745829|FG012|Overall Study|Adverse Event|0|||
131854923|NCT01823835|474745830|FG013|Overall Study|Adverse Event|0|||
131854924|NCT01823835|474745831|FG014|Overall Study|Adverse Event|0|||
131854925|NCT01823835|474745817|FG000|Overall Study|Physician Decision|0|||
131854926|NCT01823835|474745818|FG001|Overall Study|Physician Decision|0|||
131854927|NCT01823835|474745819|FG002|Overall Study|Physician Decision|0|||
131854928|NCT01823835|474745820|FG003|Overall Study|Physician Decision|0|||
131854929|NCT01823835|474745821|FG004|Overall Study|Physician Decision|0|||
131854930|NCT01823835|474745822|FG005|Overall Study|Physician Decision|0|||
131854931|NCT01823835|474745823|FG006|Overall Study|Physician Decision|0|||
131854932|NCT01823835|474745824|FG007|Overall Study|Physician Decision|0|||
131854933|NCT01823835|474745825|FG008|Overall Study|Physician Decision|0|||
131854934|NCT01823835|474745826|FG009|Overall Study|Physician Decision|0|||
131854935|NCT01823835|474745827|FG010|Overall Study|Physician Decision|0|||
131854936|NCT01823835|474745828|FG011|Overall Study|Physician Decision|2|||
131854937|NCT01823835|474745829|FG012|Overall Study|Physician Decision|0|||
131854938|NCT01823835|474745830|FG013|Overall Study|Physician Decision|0|||
131854939|NCT01823835|474745831|FG014|Overall Study|Physician Decision|0|||
131854940|NCT01823835|474745817|FG000|Overall Study|Progressive Disease|3|||
131854941|NCT01823835|474745818|FG001|Overall Study|Progressive Disease|4|||
131854942|NCT01823835|474745819|FG002|Overall Study|Progressive Disease|3|||
131854943|NCT01823835|474745820|FG003|Overall Study|Progressive Disease|6|||
131854944|NCT01823835|474745821|FG004|Overall Study|Progressive Disease|4|||
131854945|NCT01823835|474745822|FG005|Overall Study|Progressive Disease|6|||
131854946|NCT01823835|474745823|FG006|Overall Study|Progressive Disease|5|||
131854947|NCT01823835|474745824|FG007|Overall Study|Progressive Disease|3|||
131854948|NCT01823835|474745825|FG008|Overall Study|Progressive Disease|3|||
131854949|NCT01823835|474745826|FG009|Overall Study|Progressive Disease|18|||
131854950|NCT01823835|474745827|FG010|Overall Study|Progressive Disease|8|||
131854951|NCT01823835|474745828|FG011|Overall Study|Progressive Disease|46|||
131854952|NCT01823835|474745829|FG012|Overall Study|Progressive Disease|18|||
131854953|NCT01823835|474745830|FG013|Overall Study|Progressive Disease|4|||
131854954|NCT01823835|474745831|FG014|Overall Study|Progressive Disease|6|||
131854955|NCT01823835|474745817|FG000|Overall Study|Study Termination|0|||
131854956|NCT01823835|474745818|FG001|Overall Study|Study Termination|0|||
131854957|NCT01823835|474745819|FG002|Overall Study|Study Termination|0|||
131854958|NCT01823835|474745820|FG003|Overall Study|Study Termination|0|||
131854959|NCT01823835|474745821|FG004|Overall Study|Study Termination|1|||
131854960|NCT01823835|474745822|FG005|Overall Study|Study Termination|0|||
131854961|NCT01823835|474745823|FG006|Overall Study|Study Termination|0|||
131854962|NCT01823835|474745824|FG007|Overall Study|Study Termination|0|||
131854963|NCT01823835|474745825|FG008|Overall Study|Study Termination|0|||
131854964|NCT01823835|474745826|FG009|Overall Study|Study Termination|0|||
131854965|NCT01823835|474745827|FG010|Overall Study|Study Termination|0|||
131854966|NCT01823835|474745828|FG011|Overall Study|Study Termination|1|||
131854967|NCT01823835|474745829|FG012|Overall Study|Study Termination|0|||
131854968|NCT01823835|474745830|FG013|Overall Study|Study Termination|0|||
131854969|NCT01823835|474745831|FG014|Overall Study|Study Termination|0|||
131854970|NCT01823835|474745817|FG000|Overall Study|Withdrawal by Subject|0|||
131854971|NCT01823835|474745818|FG001|Overall Study|Withdrawal by Subject|0|||
131854972|NCT01823835|474745819|FG002|Overall Study|Withdrawal by Subject|1|||
131854973|NCT01823835|474745820|FG003|Overall Study|Withdrawal by Subject|0|||
131854974|NCT01823835|474745821|FG004|Overall Study|Withdrawal by Subject|0|||
131854975|NCT01823835|474745822|FG005|Overall Study|Withdrawal by Subject|0|||
131854976|NCT01823835|474745823|FG006|Overall Study|Withdrawal by Subject|0|||
131854977|NCT01823835|474745824|FG007|Overall Study|Withdrawal by Subject|0|||
131854978|NCT01823835|474745825|FG008|Overall Study|Withdrawal by Subject|0|||
131854979|NCT01823835|474745826|FG009|Overall Study|Withdrawal by Subject|1|||
131854980|NCT01823835|474745827|FG010|Overall Study|Withdrawal by Subject|1|||
131854981|NCT01823835|474745828|FG011|Overall Study|Withdrawal by Subject|2|||
131854982|NCT01823835|474745829|FG012|Overall Study|Withdrawal by Subject|1|||
131854983|NCT01823835|474745830|FG013|Overall Study|Withdrawal by Subject|0|||
131854984|NCT01823835|474745831|FG014|Overall Study|Withdrawal by Subject|0|||
131854985|NCT03017612|474745832|FG000|Overall Study|Adverse Event|2|||
131854986|NCT04895982|474745833|FG000|Overall Study|Withdrawal by Subject|0|||
131854987|NCT04895982|474745834|FG001|Overall Study|Withdrawal by Subject|0|||
131854988|NCT04895982|474745835|FG002|Overall Study|Withdrawal by Subject|0|||
131854989|NCT04895982|474745836|FG003|Overall Study|Withdrawal by Subject|0|||
131854990|NCT04895982|474745837|FG004|Overall Study|Withdrawal by Subject|0|||
131854991|NCT04895982|474745838|FG005|Overall Study|Withdrawal by Subject|1|||
131854992|NCT04895982|474745839|FG006|Overall Study|Withdrawal by Subject|1|||
131854993|NCT04895982|474745840|FG007|Overall Study|Withdrawal by Subject|0|||
131854994|NCT04895982|474745841|FG008|Overall Study|Withdrawal by Subject|0|||
131854995|NCT04895982|474745842|FG009|Overall Study|Withdrawal by Subject|1|||
131854996|NCT04895982|474745843|FG010|Overall Study|Withdrawal by Subject|0|||
131854997|NCT04895982|474745844|FG011|Overall Study|Withdrawal by Subject|1|||
131854998|NCT04895982|474745833|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131854999|NCT04895982|474745834|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131855000|NCT04895982|474745835|FG002|Overall Study|Withdrawal by parent/guardian|3|||
131855001|NCT04895982|474745836|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131855002|NCT04895982|474745837|FG004|Overall Study|Withdrawal by parent/guardian|3|||
131855003|NCT04895982|474745838|FG005|Overall Study|Withdrawal by parent/guardian|2|||
131855004|NCT04895982|474745839|FG006|Overall Study|Withdrawal by parent/guardian|1|||
131855005|NCT04895982|474745840|FG007|Overall Study|Withdrawal by parent/guardian|0|||
131855006|NCT04895982|474745841|FG008|Overall Study|Withdrawal by parent/guardian|3|||
131855007|NCT04895982|474745842|FG009|Overall Study|Withdrawal by parent/guardian|0|||
131855008|NCT04895982|474745843|FG010|Overall Study|Withdrawal by parent/guardian|0|||
131855009|NCT04895982|474745844|FG011|Overall Study|Withdrawal by parent/guardian|0|||
131855010|NCT04895982|474745833|FG000|Overall Study|Other|0|||
131855011|NCT04895982|474745834|FG001|Overall Study|Other|0|||
131855012|NCT04895982|474745835|FG002|Overall Study|Other|1|||
131855013|NCT04895982|474745836|FG003|Overall Study|Other|1|||
131855014|NCT04895982|474745837|FG004|Overall Study|Other|0|||
131855015|NCT04895982|474745838|FG005|Overall Study|Other|0|||
131855016|NCT04895982|474745839|FG006|Overall Study|Other|0|||
131855017|NCT04895982|474745840|FG007|Overall Study|Other|0|||
131855018|NCT04895982|474745841|FG008|Overall Study|Other|0|||
131855019|NCT04895982|474745842|FG009|Overall Study|Other|1|||
131855020|NCT04895982|474745843|FG010|Overall Study|Other|0|||
131855021|NCT04895982|474745844|FG011|Overall Study|Other|0|||
131855022|NCT04895982|474745833|FG000|Overall Study|Protocol Violation|0|||
131855023|NCT04895982|474745834|FG001|Overall Study|Protocol Violation|0|||
131855024|NCT04895982|474745835|FG002|Overall Study|Protocol Violation|1|||
131855025|NCT04895982|474745836|FG003|Overall Study|Protocol Violation|1|||
131855026|NCT04895982|474745837|FG004|Overall Study|Protocol Violation|1|||
131855027|NCT04895982|474745838|FG005|Overall Study|Protocol Violation|0|||
131855028|NCT04895982|474745839|FG006|Overall Study|Protocol Violation|0|||
131855029|NCT04895982|474745840|FG007|Overall Study|Protocol Violation|1|||
131855030|NCT04895982|474745841|FG008|Overall Study|Protocol Violation|0|||
131855031|NCT04895982|474745842|FG009|Overall Study|Protocol Violation|0|||
131855032|NCT04895982|474745843|FG010|Overall Study|Protocol Violation|0|||
131855033|NCT04895982|474745844|FG011|Overall Study|Protocol Violation|0|||
131855034|NCT04895982|474745833|FG000|Overall Study|Lost to Follow-up|0|||
131855035|NCT04895982|474745834|FG001|Overall Study|Lost to Follow-up|0|||
131855036|NCT04895982|474745835|FG002|Overall Study|Lost to Follow-up|1|||
131855037|NCT04895982|474745836|FG003|Overall Study|Lost to Follow-up|0|||
131855038|NCT04895982|474745837|FG004|Overall Study|Lost to Follow-up|0|||
131855039|NCT04895982|474745838|FG005|Overall Study|Lost to Follow-up|1|||
131855040|NCT04895982|474745839|FG006|Overall Study|Lost to Follow-up|0|||
131855041|NCT04895982|474745840|FG007|Overall Study|Lost to Follow-up|0|||
131855042|NCT04895982|474745841|FG008|Overall Study|Lost to Follow-up|1|||
131855043|NCT04895982|474745842|FG009|Overall Study|Lost to Follow-up|0|||
131855044|NCT04895982|474745843|FG010|Overall Study|Lost to Follow-up|0|||
131855045|NCT04895982|474745844|FG011|Overall Study|Lost to Follow-up|0|||
131855046|NCT04895982|474745833|FG000|Overall Study|Refused further study procedures|0|||
131855047|NCT04895982|474745834|FG001|Overall Study|Refused further study procedures|0|||
131855048|NCT04895982|474745835|FG002|Overall Study|Refused further study procedures|1|||
131855049|NCT04895982|474745836|FG003|Overall Study|Refused further study procedures|0|||
131855050|NCT04895982|474745837|FG004|Overall Study|Refused further study procedures|0|||
131855051|NCT04895982|474745838|FG005|Overall Study|Refused further study procedures|0|||
131855052|NCT04895982|474745839|FG006|Overall Study|Refused further study procedures|0|||
131855053|NCT04895982|474745840|FG007|Overall Study|Refused further study procedures|0|||
131855054|NCT04895982|474745841|FG008|Overall Study|Refused further study procedures|0|||
131855055|NCT04895982|474745842|FG009|Overall Study|Refused further study procedures|0|||
131855056|NCT04895982|474745843|FG010|Overall Study|Refused further study procedures|0|||
131855057|NCT04895982|474745844|FG011|Overall Study|Refused further study procedures|0|||
131912467|NCT03834350|474966599|FG000|Overall Study|Withdrawal by Subject|1|||
131912468|NCT02410629|474966600|FG000|Overall Study|Family cannot commit to the study|2|||
131912469|NCT02410629|474966601|FG001|Overall Study|Family cannot commit to the study|1|||
131912470|NCT02410629|474966600|FG000|Overall Study|Subject returned to work|1|||
131912471|NCT02410629|474966601|FG001|Overall Study|Subject returned to work|0|||
131912472|NCT02410629|474966600|FG000|Overall Study|Subject moved back to home country|0|||
131912473|NCT02410629|474966601|FG001|Overall Study|Subject moved back to home country|1|||
131912474|NCT02410629|474966600|FG000|Overall Study|Subject underwent heart surgery|0|||
131912475|NCT02410629|474966601|FG001|Overall Study|Subject underwent heart surgery|1|||
131912476|NCT02765165|474966602|FG000|Treatment Period|Progressive disease|3|||
131912477|NCT02765165|474966603|FG001|Treatment Period|Progressive disease|2|||
131912478|NCT02765165|474966604|FG002|Treatment Period|Progressive disease|3|||
131912479|NCT02765165|474966605|FG003|Treatment Period|Progressive disease|3|||
131855058|NCT01059786|474747781|FG000|Overall Study|Did not receive 6 cycles.|0|||
131855059|NCT01059786|474747782|FG001|Overall Study|Did not receive 6 cycles.|0|||
131855060|NCT01059786|474747783|FG002|Overall Study|Did not receive 6 cycles.|4|||
131855061|NCT01059786|474747784|FG003|Overall Study|Did not receive 6 cycles.|1|||
131855062|NCT01059786|474747785|FG004|Overall Study|Did not receive 6 cycles.|0|||
131855063|NCT04460885|474747786|FG000|Overall Study|Withdrawal by Subject|6|||
131855064|NCT04460885|474747787|FG001|Overall Study|Withdrawal by Subject|8|||
131855065|NCT04460885|474747786|FG000|Overall Study|Site closure|1|||
131855066|NCT04460885|474747787|FG001|Overall Study|Site closure|0|||
131855067|NCT04460885|474747786|FG000|Overall Study|Death|5|||
131855068|NCT04460885|474747787|FG001|Overall Study|Death|4|||
131855069|NCT04460885|474747786|FG000|Overall Study|Physician Decision|2|||
131855070|NCT04460885|474747787|FG001|Overall Study|Physician Decision|1|||
131855071|NCT04460885|474747786|FG000|Overall Study|Lost to Follow-up|4|||
131855072|NCT04460885|474747787|FG001|Overall Study|Lost to Follow-up|4|||
131855073|NCT04559347|474747788|FG000|Overall Study|Death|1|||
131855074|NCT04559347|474747789|FG001|Overall Study|Death|0|||
131855075|NCT04559347|474747788|FG000|Overall Study|Thoracotomy conversion|1|||
131855076|NCT04559347|474747789|FG001|Overall Study|Thoracotomy conversion|1|||
131855077|NCT04559347|474747788|FG000|Overall Study|Provider unavailable|2|||
131855078|NCT04559347|474747789|FG001|Overall Study|Provider unavailable|1|||
131855079|NCT04559347|474747788|FG000|Overall Study|Other|2|||
131855080|NCT04559347|474747789|FG001|Overall Study|Other|1|||
131855081|NCT03560037|474747791|FG000|Overall Study|Protocol Violation|1|||
131855082|NCT03560037|474747792|FG001|Overall Study|Protocol Violation|0|||
131855083|NCT03560037|474747791|FG000|Overall Study|Physician Decision|0|||
131855084|NCT03560037|474747792|FG001|Overall Study|Physician Decision|1|||
131855085|NCT03816878|474747795|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
131855086|NCT03816878|474747796|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
131855087|NCT03816878|474747795|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
131855088|NCT03816878|474747796|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
131855089|NCT03355469|474747797|FG000|Overall Study|COVID-19|3|||
131855090|NCT03355469|474747798|FG001|Overall Study|COVID-19|2|||
131855091|NCT03355469|474747799|FG002|Overall Study|COVID-19|3|||
131855092|NCT03355469|474747800|FG003|Overall Study|COVID-19|3|||
131855093|NCT03355469|474747797|FG000|Overall Study|Lost to Follow-up|1|||
131855094|NCT03355469|474747798|FG001|Overall Study|Lost to Follow-up|0|||
131855095|NCT03355469|474747799|FG002|Overall Study|Lost to Follow-up|1|||
131855096|NCT03355469|474747800|FG003|Overall Study|Lost to Follow-up|0|||
131855097|NCT03355469|474747797|FG000|Overall Study|Withdrawal by Subject|2|||
131855098|NCT03355469|474747798|FG001|Overall Study|Withdrawal by Subject|1|||
131855099|NCT03355469|474747799|FG002|Overall Study|Withdrawal by Subject|0|||
131855100|NCT03355469|474747800|FG003|Overall Study|Withdrawal by Subject|3|||
131855101|NCT01708941|474747801|FG000|Overall Study|Adverse Event|4|||
131855102|NCT01708941|474747802|FG001|Overall Study|Adverse Event|6|||
131855103|NCT01708941|474747803|FG002|Overall Study|Adverse Event|1|||
131855104|NCT01708941|474747804|FG003|Overall Study|Adverse Event|0|||
131855105|NCT01708941|474747801|FG000|Overall Study|Death|1|||
131855106|NCT01708941|474747802|FG001|Overall Study|Death|1|||
131855107|NCT01708941|474747803|FG002|Overall Study|Death|2|||
131855108|NCT01708941|474747804|FG003|Overall Study|Death|14|||
131855109|NCT01708941|474747801|FG000|Overall Study|Withdrawal by Subject|1|||
131855110|NCT01708941|474747802|FG001|Overall Study|Withdrawal by Subject|0|||
131855111|NCT01708941|474747803|FG002|Overall Study|Withdrawal by Subject|3|||
131855112|NCT01708941|474747804|FG003|Overall Study|Withdrawal by Subject|4|||
131855113|NCT01708941|474747801|FG000|Overall Study|Disease progression|9|||
131855114|NCT01708941|474747802|FG001|Overall Study|Disease progression|10|||
131855115|NCT01708941|474747803|FG002|Overall Study|Disease progression|8|||
131855116|NCT01708941|474747804|FG003|Overall Study|Disease progression|0|||
131855117|NCT01708941|474747801|FG000|Overall Study|Alternative therapy|0|||
131855118|NCT01708941|474747802|FG001|Overall Study|Alternative therapy|0|||
131855119|NCT01708941|474747803|FG002|Overall Study|Alternative therapy|2|||
131855120|NCT01708941|474747804|FG003|Overall Study|Alternative therapy|0|||
131855121|NCT01708941|474747801|FG000|Overall Study|Ineligible and never started treatment|1|||
131855122|NCT01708941|474747802|FG001|Overall Study|Ineligible and never started treatment|0|||
131855123|NCT01708941|474747803|FG002|Overall Study|Ineligible and never started treatment|1|||
131855124|NCT01708941|474747804|FG003|Overall Study|Ineligible and never started treatment|0|||
131855125|NCT01708941|474747801|FG000|Overall Study|Never started treatment|2|||
131855126|NCT01708941|474747802|FG001|Overall Study|Never started treatment|1|||
131855127|NCT01708941|474747803|FG002|Overall Study|Never started treatment|0|||
131855128|NCT01708941|474747804|FG003|Overall Study|Never started treatment|0|||
131855129|NCT01708941|474747801|FG000|Overall Study|Ineligible|0|||
131855130|NCT01708941|474747802|FG001|Overall Study|Ineligible|0|||
131855131|NCT01708941|474747803|FG002|Overall Study|Ineligible|2|||
131855132|NCT01708941|474747804|FG003|Overall Study|Ineligible|0|||
131855133|NCT02048813|474747805|FG000|Overall Study|Still on treatment|279|||
131855134|NCT02048813|474747806|FG001|Overall Study|Still on treatment|0|||
131855135|NCT02048813|474747805|FG000|Overall Study|Adverse Event|40|||
131855136|NCT02048813|474747806|FG001|Overall Study|Adverse Event|38|||
131855137|NCT02048813|474747805|FG000|Overall Study|Disease progression|13|||
131855138|NCT02048813|474747806|FG001|Overall Study|Disease progression|3|||
131855139|NCT02048813|474747805|FG000|Overall Study|Withdrawal by Subject|7|||
131855140|NCT02048813|474747806|FG001|Overall Study|Withdrawal by Subject|8|||
131855141|NCT02048813|474747805|FG000|Overall Study|Death|2|||
131855142|NCT02048813|474747806|FG001|Overall Study|Death|1|||
131855143|NCT02048813|474747805|FG000|Overall Study|Complication|2|||
131855144|NCT02048813|474747806|FG001|Overall Study|Complication|2|||
131855145|NCT02048813|474747805|FG000|Overall Study|Non-protocol therapy|0|||
131855146|NCT02048813|474747806|FG001|Overall Study|Non-protocol therapy|1|||
131855147|NCT02048813|474747805|FG000|Overall Study|Second primary cancer|2|||
131855148|NCT02048813|474747806|FG001|Overall Study|Second primary cancer|0|||
131855149|NCT02048813|474747805|FG000|Overall Study|Insurance|2|||
131855150|NCT02048813|474747806|FG001|Overall Study|Insurance|0|||
131855151|NCT02048813|474747805|FG000|Overall Study|Wound infection/healing|2|||
131855152|NCT02048813|474747806|FG001|Overall Study|Wound infection/healing|0|||
131855153|NCT02048813|474747805|FG000|Overall Study|Missed appointment|3|||
131855154|NCT02048813|474747806|FG001|Overall Study|Missed appointment|0|||
131855155|NCT02048813|474747805|FG000|Overall Study|Never started treatment|2|||
131855156|NCT02048813|474747806|FG001|Overall Study|Never started treatment|17|||
131855157|NCT02454608|474747807|FG000|Double-Blind Period|Lack of Efficacy|0|||
131855158|NCT02454608|474747808|FG001|Double-Blind Period|Lack of Efficacy|2|||
131855159|NCT02454608|474747809|FG002|Double-Blind Period|Lack of Efficacy|0|||
131855160|NCT02454608|474747807|FG000|Open Label Period|Lost to Follow-up|0|||
131855161|NCT02454608|474747808|FG001|Open Label Period|Lost to Follow-up|0|||
131855162|NCT02454608|474747809|FG002|Open Label Period|Lost to Follow-up|11|||
131855163|NCT02454608|474747807|FG000|Open Label Period|Withdrawal by Subject|0|||
131855164|NCT02454608|474747808|FG001|Open Label Period|Withdrawal by Subject|0|||
131855165|NCT02454608|474747809|FG002|Open Label Period|Withdrawal by Subject|8|||
131855166|NCT05256134|474747812|FG000|Overall Study|Study Terminated by Sponsor|11|||
131855167|NCT05256134|474747813|FG001|Overall Study|Study Terminated by Sponsor|10|||
131855168|NCT05256134|474747812|FG000|Overall Study|Withdrawal by Subject|1|||
131855169|NCT05256134|474747813|FG001|Overall Study|Withdrawal by Subject|3|||
131855170|NCT01567462|474747814|FG000|Overall Study|Withdrawal by Subject|4|||
131855171|NCT01567462|474747815|FG001|Overall Study|Withdrawal by Subject|7|||
131855172|NCT00886015|474747818|FG000|Overall Study|Death|0|||
131855173|NCT00886015|474747819|FG001|Overall Study|Death|2|||
131855174|NCT02548156|474747824|FG000|Washout Period 1|Lost to Follow-up|0|||
131855175|NCT02548156|474747825|FG001|Washout Period 1|Lost to Follow-up|0|||
131855176|NCT02548156|474747826|FG002|Washout Period 1|Lost to Follow-up|0|||
131855177|NCT02548156|474747827|FG003|Washout Period 1|Lost to Follow-up|0|||
131855178|NCT02548156|474747828|FG004|Washout Period 1|Lost to Follow-up|1|||
131855179|NCT02548156|474747829|FG005|Washout Period 1|Lost to Follow-up|0|||
131855180|NCT05490771|474747833|FG000|Overall Study|Disease progression|18|||
131855181|NCT05490771|474747833|FG000|Overall Study|Adverse Event|3|||
131855182|NCT05490771|474747833|FG000|Overall Study|Other complicating disease|1|||
131855183|NCT05490771|474747833|FG000|Overall Study|Withdrawal by Subject|3|||
131855184|NCT05490771|474747833|FG000|Overall Study|Physician Decision|1|||
131855185|NCT05490771|474747833|FG000|Overall Study|Still on treatment|2|||
131855186|NCT05490771|474747833|FG000|Overall Study|Never start protocol therapy|5|||
131855187|NCT05490771|474747833|FG000|Overall Study|Ineligible|2|||
131855188|NCT01720225|474747834|FG000|Overall Study|Withdrawal by Subject|0|||
131855189|NCT01720225|474747835|FG001|Overall Study|Withdrawal by Subject|1|||
131855190|NCT01720225|474747834|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
131855191|NCT01720225|474747835|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
131855192|NCT00369941|474747838|FG000|Overall Study|Never Treated|1|||
131855193|NCT00369941|474747839|FG001|Overall Study|Never Treated|2|||
131855194|NCT00369941|474747838|FG000|Overall Study|Adverse Event|14|||
131855195|NCT00369941|474747839|FG001|Overall Study|Adverse Event|28|||
131855196|NCT00369941|474747838|FG000|Overall Study|Lack of Efficacy|6|||
131855197|NCT00369941|474747839|FG001|Overall Study|Lack of Efficacy|10|||
131855198|NCT00369941|474747838|FG000|Overall Study|Lost to Follow-up|12|||
131855199|NCT00369941|474747839|FG001|Overall Study|Lost to Follow-up|22|||
131855200|NCT00369941|474747838|FG000|Overall Study|Protocol Violation|5|||
131855201|NCT00369941|474747839|FG001|Overall Study|Protocol Violation|3|||
131855202|NCT00369941|474747838|FG000|Overall Study|Withdrawal by Subject|5|||
131405937|NCT03349645|473109030|FG000|Overall Study|Sponsor Terminated Study|75|||
131405938|NCT03349645|473109030|FG000|Overall Study|Withdrawal by Subject|4|||
131855203|NCT00369941|474747839|FG001|Overall Study|Withdrawal by Subject|18|||
131855204|NCT00369941|474747838|FG000|Overall Study|Pregnancy|4|||
131855205|NCT00369941|474747839|FG001|Overall Study|Pregnancy|2|||
131855206|NCT00369941|474747838|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
131855207|NCT00369941|474747839|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
131855208|NCT00369941|474747838|FG000|Overall Study|Moved|11|||
131855209|NCT00369941|474747839|FG001|Overall Study|Moved|5|||
131855210|NCT00369941|474747838|FG000|Overall Study|Treatment with Prohibited Medication|3|||
131405939|NCT03349645|473109030|FG000|Overall Study|Protocol Violation|1|||
131453624|NCT00611026|473289982|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
131453625|NCT00611026|473289983|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
131453626|NCT00611026|473289984|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
131453627|NCT00611026|473289982|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
131453628|NCT00611026|473289983|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
131453629|NCT00611026|473289984|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
131453630|NCT00611026|473289982|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
131453631|NCT00611026|473289983|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
131453632|NCT00611026|473289984|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
131453633|NCT00611026|473289982|FG000|Double-blind Treatment Period|Other|13|||
131453634|NCT00611026|473289983|FG001|Double-blind Treatment Period|Other|20|||
131453635|NCT00611026|473289984|FG002|Double-blind Treatment Period|Other|18|||
131453636|NCT00885534|473289986|FG000|Overall Study|Patient deemed ineligible|1|||
131453637|NCT01160822|473289989|FG000|Overall Study|Adverse Event|0|||
131453638|NCT01160822|473289990|FG001|Overall Study|Adverse Event|0|||
131453639|NCT01160822|473289991|FG002|Overall Study|Adverse Event|0|||
131453640|NCT01160822|473289992|FG003|Overall Study|Adverse Event|0|||
131453641|NCT01160822|473289993|FG004|Overall Study|Adverse Event|1|||
131453642|NCT01160822|473289994|FG005|Overall Study|Adverse Event|2|||
131453643|NCT01160822|473289995|FG006|Overall Study|Adverse Event|5|||
131453644|NCT01160822|473289989|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131453645|NCT01160822|473289990|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131453646|NCT01160822|473289991|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131453647|NCT01160822|473289992|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131453648|NCT01160822|473289993|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
131453649|NCT01160822|473289994|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
131453650|NCT01160822|473289995|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
131453651|NCT01160822|473289989|FG000|Overall Study|Withdrawal by Subject|0|||
131453652|NCT01160822|473289990|FG001|Overall Study|Withdrawal by Subject|0|||
131453653|NCT01160822|473289991|FG002|Overall Study|Withdrawal by Subject|0|||
131453654|NCT01160822|473289992|FG003|Overall Study|Withdrawal by Subject|0|||
131453655|NCT01160822|473289993|FG004|Overall Study|Withdrawal by Subject|0|||
131453656|NCT01160822|473289994|FG005|Overall Study|Withdrawal by Subject|0|||
131453657|NCT01160822|473289995|FG006|Overall Study|Withdrawal by Subject|1|||
131453658|NCT01160822|473289989|FG000|Overall Study|Lost to Follow-up|0|||
131453659|NCT01160822|473289990|FG001|Overall Study|Lost to Follow-up|0|||
131453660|NCT01160822|473289991|FG002|Overall Study|Lost to Follow-up|0|||
131453661|NCT01160822|473289992|FG003|Overall Study|Lost to Follow-up|0|||
131453662|NCT01160822|473289993|FG004|Overall Study|Lost to Follow-up|1|||
131453663|NCT01160822|473289994|FG005|Overall Study|Lost to Follow-up|0|||
131453664|NCT01160822|473289995|FG006|Overall Study|Lost to Follow-up|0|||
131453665|NCT01160822|473289989|FG000|Overall Study|Administrative problems|0|||
131453666|NCT01160822|473289990|FG001|Overall Study|Administrative problems|0|||
131453667|NCT01160822|473289991|FG002|Overall Study|Administrative problems|0|||
131453668|NCT01160822|473289992|FG003|Overall Study|Administrative problems|0|||
131453669|NCT01160822|473289993|FG004|Overall Study|Administrative problems|1|||
131453670|NCT01160822|473289994|FG005|Overall Study|Administrative problems|0|||
131453671|NCT01160822|473289995|FG006|Overall Study|Administrative problems|0|||
131453672|NCT01160822|473289989|FG000|Overall Study|Protocol deviation|0|||
131453673|NCT01160822|473289990|FG001|Overall Study|Protocol deviation|0|||
131453674|NCT01160822|473289991|FG002|Overall Study|Protocol deviation|0|||
131453675|NCT01160822|473289992|FG003|Overall Study|Protocol deviation|0|||
131453676|NCT01160822|473289993|FG004|Overall Study|Protocol deviation|2|||
131453677|NCT01160822|473289994|FG005|Overall Study|Protocol deviation|0|||
131453678|NCT01160822|473289995|FG006|Overall Study|Protocol deviation|0|||
131453679|NCT02527421|473289997|FG000|Overall Study|Withdrawal by Subject|1|||
131453680|NCT02527421|473289998|FG001|Overall Study|Withdrawal by Subject|0|||
131453681|NCT02116205|473289999|FG000|Overall Study|Withdrawal by Subject|2|||
131912480|NCT02765165|474966606|FG004|Treatment Period|Progressive disease|4|||
131912481|NCT02765165|474966607|FG005|Treatment Period|Progressive disease|2|||
131453682|NCT02116205|473290000|FG001|Overall Study|Withdrawal by Subject|4|||
131453683|NCT02116205|473290001|FG002|Overall Study|Withdrawal by Subject|1|||
131453684|NCT02116205|473290002|FG003|Overall Study|Withdrawal by Subject|3|||
131453685|NCT02116205|473289999|FG000|Overall Study|Lost to Follow-up|0|||
131453686|NCT02116205|473290000|FG001|Overall Study|Lost to Follow-up|2|||
131453687|NCT02116205|473290001|FG002|Overall Study|Lost to Follow-up|1|||
131912482|NCT02765165|474966608|FG006|Treatment Period|Progressive disease|2|||
131912483|NCT02765165|474966602|FG000|Treatment Period|Physician Decision|0|||
131912484|NCT02765165|474966603|FG001|Treatment Period|Physician Decision|1|||
131912485|NCT02765165|474966604|FG002|Treatment Period|Physician Decision|0|||
131912486|NCT02765165|474966605|FG003|Treatment Period|Physician Decision|0|||
131912487|NCT02765165|474966606|FG004|Treatment Period|Physician Decision|0|||
131912488|NCT02765165|474966607|FG005|Treatment Period|Physician Decision|0|||
131912489|NCT02765165|474966608|FG006|Treatment Period|Physician Decision|0|||
131912490|NCT02765165|474966602|FG000|Treatment Period|Adverse Event|0|||
131912491|NCT02765165|474966603|FG001|Treatment Period|Adverse Event|1|||
131855211|NCT00369941|474747839|FG001|Overall Study|Treatment with Prohibited Medication|1|||
131855212|NCT00369941|474747838|FG000|Overall Study|Employment Interfered with Study Visits|1|||
131855213|NCT00369941|474747839|FG001|Overall Study|Employment Interfered with Study Visits|0|||
131855214|NCT00369941|474747838|FG000|Overall Study|Study Site Terminated|2|||
131855215|NCT00369941|474747839|FG001|Overall Study|Study Site Terminated|0|||
131855216|NCT00369941|474747838|FG000|Overall Study|Miscellaneous|3|||
131855217|NCT00369941|474747839|FG001|Overall Study|Miscellaneous|3|||
131855218|NCT02964312|474747843|FG000|Overall Study|Lost to Follow-up|28|||
131855219|NCT02964312|474747843|FG000|Overall Study|Withdrawal by Subject|11|||
131855220|NCT02964312|474747843|FG000|Overall Study|Lack of Efficacy|10|||
131855221|NCT02964312|474747843|FG000|Overall Study|Did not consent to long-term FU|14|||
131855222|NCT02964312|474747843|FG000|Overall Study|Death|1|||
131855223|NCT02862730|474747844|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131855224|NCT02862730|474747845|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131855225|NCT02862730|474747846|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
131855226|NCT02862730|474747847|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131855227|NCT02862730|474747848|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131855228|NCT02862730|474747849|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131855229|NCT02862730|474747850|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131855230|NCT02862730|474747844|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
131855231|NCT02862730|474747845|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
131855232|NCT02862730|474747846|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
131855233|NCT02862730|474747847|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
131855234|NCT02862730|474747848|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
131855235|NCT02862730|474747849|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
131855236|NCT02862730|474747850|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
131855237|NCT02862730|474747844|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131855238|NCT02862730|474747845|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131855239|NCT02862730|474747846|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
131855240|NCT02862730|474747847|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131855241|NCT02862730|474747848|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
131855242|NCT02862730|474747849|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131855243|NCT02862730|474747850|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131855244|NCT02862730|474747844|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
131855245|NCT02862730|474747845|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
131855246|NCT02862730|474747846|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
131855247|NCT02862730|474747847|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
131855248|NCT02862730|474747848|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
131855249|NCT02862730|474747849|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
131855250|NCT02862730|474747850|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
131855251|NCT03126435|474747852|FG000|Overall Study|Death|90|||
131855252|NCT03126435|474747853|FG001|Overall Study|Death|84|||
131855253|NCT03126435|474747852|FG000|Overall Study|Lost to Follow-up|4|||
131855254|NCT03126435|474747853|FG001|Overall Study|Lost to Follow-up|3|||
131855255|NCT03126435|474747852|FG000|Overall Study|Physician Decision|0|||
131855256|NCT03126435|474747853|FG001|Overall Study|Physician Decision|1|||
131855257|NCT03126435|474747852|FG000|Overall Study|Withdrawal by Subject|6|||
131855258|NCT03126435|474747853|FG001|Overall Study|Withdrawal by Subject|12|||
131855259|NCT03126435|474747852|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
131855260|NCT03126435|474747853|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
131855261|NCT02121652|474747854|FG000|Overall Study|Lost to Follow-up|2|||
131855262|NCT02121652|474747855|FG001|Overall Study|Lost to Follow-up|1|||
131855263|NCT02121652|474747854|FG000|Overall Study|Death|1|||
131855264|NCT02121652|474747855|FG001|Overall Study|Death|0|||
131855265|NCT02121652|474747854|FG000|Overall Study|Withdrawal by Subject|3|||
131855266|NCT02121652|474747855|FG001|Overall Study|Withdrawal by Subject|3|||
131855267|NCT02276807|474747856|FG000|Overall Study|Withdrawal by Subject|8|||
131855268|NCT02276807|474747857|FG001|Overall Study|Withdrawal by Subject|7|||
131855269|NCT02276807|474747856|FG000|Overall Study|Lost to Follow-up|10|||
131855270|NCT02276807|474747857|FG001|Overall Study|Lost to Follow-up|10|||
131855271|NCT01153425|474747866|FG000|Overall Study|Withdrawal by Subject|3|||
131855272|NCT01153425|474747867|FG001|Overall Study|Withdrawal by Subject|3|||
131855273|NCT00524420|474747874|FG000|Overall Study|Lack of Efficacy|1|||
131855274|NCT00524420|474747875|FG001|Overall Study|Lack of Efficacy|0|||
131855275|NCT01090414|474747876|FG000|Study 101-99|Progressive Disease|28|||
131855276|NCT01090414|474747877|FG001|Study 101-99|Progressive Disease|48|||
131855277|NCT01090414|474747878|FG002|Study 101-99|Progressive Disease|10|||
131855278|NCT01090414|474747879|FG003|Study 101-99|Progressive Disease|4|||
131855279|NCT01090414|474747876|FG000|Study 101-99|Adverse Event|10|||
131855280|NCT01090414|474747877|FG001|Study 101-99|Adverse Event|28|||
131855281|NCT01090414|474747878|FG002|Study 101-99|Adverse Event|18|||
131855282|NCT01090414|474747879|FG003|Study 101-99|Adverse Event|0|||
131405940|NCT03349645|473109030|FG000|Overall Study|Other|2|||
131405941|NCT00580034|473109036|FG000|Overall Study|Toxicity|10|||
131405942|NCT00580034|473109037|FG001|Overall Study|Toxicity|0|||
131405943|NCT01939002|473109038|FG000|Overall Study|Adverse Event|13|||
131405944|NCT01939002|473109039|FG001|Overall Study|Adverse Event|13|||
131405945|NCT01939002|473109038|FG000|Overall Study|Withdrawal by Subject|5|||
131405946|NCT01939002|473109039|FG001|Overall Study|Withdrawal by Subject|3|||
131405947|NCT01939002|473109038|FG000|Overall Study|Other|1|||
131405948|NCT01939002|473109039|FG001|Overall Study|Other|2|||
131405949|NCT00098748|473109043|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
131405950|NCT00098748|473109044|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
131405951|NCT00098748|473109045|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
131405952|NCT00098748|473109043|FG000|Received Study Treatment|Death|2|||
131405953|NCT00098748|473109044|FG001|Received Study Treatment|Death|1|||
131405954|NCT00098748|473109045|FG002|Received Study Treatment|Death|2|||
131405955|NCT00098748|473109043|FG000|Received Study Treatment|Adverse Event|1|||
131405956|NCT00098748|473109044|FG001|Received Study Treatment|Adverse Event|2|||
131405957|NCT00098748|473109045|FG002|Received Study Treatment|Adverse Event|5|||
131405958|NCT00098748|473109043|FG000|Received Study Treatment|Lack of Efficacy|40|||
131405959|NCT00098748|473109044|FG001|Received Study Treatment|Lack of Efficacy|27|||
131405960|NCT00098748|473109045|FG002|Received Study Treatment|Lack of Efficacy|27|||
131405961|NCT00098748|473109043|FG000|Received Study Treatment|Other|2|||
131405962|NCT00098748|473109044|FG001|Received Study Treatment|Other|2|||
131405963|NCT00098748|473109045|FG002|Received Study Treatment|Other|6|||
131405964|NCT00098748|473109043|FG000|Received Study Treatment|Subject defaulted|3|||
131405965|NCT00098748|473109044|FG001|Received Study Treatment|Subject defaulted|4|||
131405966|NCT00098748|473109045|FG002|Received Study Treatment|Subject defaulted|4|||
131405967|NCT00098748|473109043|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
131405968|NCT00098748|473109044|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
131405969|NCT00098748|473109045|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
131405970|NCT00098748|473109043|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
131405971|NCT00098748|473109044|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
131405972|NCT00098748|473109045|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
131405973|NCT00098748|473109043|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
131405974|NCT00098748|473109044|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
131405975|NCT00098748|473109045|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
131405976|NCT00098748|473109043|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
131405977|NCT00098748|473109044|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
131405978|NCT00098748|473109045|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
131405979|NCT00098748|473109043|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
131405980|NCT00098748|473109044|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
131405981|NCT00098748|473109045|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
131405982|NCT00570037|473109046|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
131405983|NCT00570037|473109047|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
131405984|NCT02499900|473109048|FG000|Core Study Period|Other|1|||
131405985|NCT02499900|473109049|FG001|Core Study Period|Other|4|||
131405986|NCT02499900|473109048|FG000|Core Study Period|Lost to Follow-up|1|||
131405987|NCT02499900|473109049|FG001|Core Study Period|Lost to Follow-up|2|||
131405988|NCT02499900|473109048|FG000|Core Study Period|Per sponsor request|0|||
131405989|NCT02499900|473109049|FG001|Core Study Period|Per sponsor request|1|||
131405990|NCT02499900|473109048|FG000|Core Study Period|Pregnancy|1|||
131405991|NCT02499900|473109049|FG001|Core Study Period|Pregnancy|0|||
131405992|NCT02499900|473109048|FG000|Core Study Period|Protocol Violation|3|||
131405993|NCT02499900|473109049|FG001|Core Study Period|Protocol Violation|0|||
131405994|NCT02499900|473109048|FG000|Core Study Period|Withdrawal by Subject|11|||
131405995|NCT02499900|473109049|FG001|Core Study Period|Withdrawal by Subject|10|||
131405996|NCT02499900|473109048|FG000|Core Study Period|Adverse Event|18|||
131453688|NCT02116205|473290002|FG003|Overall Study|Lost to Follow-up|2|||
131453689|NCT02116205|473289999|FG000|Overall Study|Physician Decision|0|||
131453690|NCT02116205|473290000|FG001|Overall Study|Physician Decision|1|||
131453691|NCT02116205|473290001|FG002|Overall Study|Physician Decision|1|||
131453692|NCT02116205|473290002|FG003|Overall Study|Physician Decision|1|||
131453693|NCT02116205|473289999|FG000|Overall Study|Exclusion criteria|0|||
131453694|NCT02116205|473290000|FG001|Overall Study|Exclusion criteria|0|||
131405997|NCT02499900|473109049|FG001|Core Study Period|Adverse Event|14|||
131405998|NCT02499900|473109048|FG000|Core Study Period|Death|0|||
131405999|NCT02499900|473109049|FG001|Core Study Period|Death|1|||
131406000|NCT02499900|473109048|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
131406001|NCT02499900|473109049|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
131406002|NCT02499900|473109048|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
131406003|NCT02499900|473109049|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
131406004|NCT02499900|473109048|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
131453695|NCT02116205|473290001|FG002|Overall Study|Exclusion criteria|1|||
131406005|NCT02499900|473109049|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
131406006|NCT02499900|473109048|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
131406007|NCT02499900|473109049|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
131406008|NCT02499900|473109048|FG000|Extension Study Period|Adverse Event|2|||
131406009|NCT02499900|473109049|FG001|Extension Study Period|Adverse Event|4|||
131406010|NCT02499900|473109048|FG000|Extension Study Period|Withdrawal by Subject|5|||
131406011|NCT02499900|473109049|FG001|Extension Study Period|Withdrawal by Subject|2|||
131406012|NCT02499900|473109048|FG000|Extension Study Period|Physician Decision|2|||
131406013|NCT02499900|473109049|FG001|Extension Study Period|Physician Decision|5|||
131406014|NCT02499900|473109048|FG000|Extension Study Period|Pregnancy|1|||
131406015|NCT02499900|473109049|FG001|Extension Study Period|Pregnancy|2|||
131406016|NCT02499900|473109048|FG000|Extension Study Period|Lost to Follow-up|2|||
131406017|NCT02499900|473109049|FG001|Extension Study Period|Lost to Follow-up|5|||
131406018|NCT02499900|473109048|FG000|Extension Study Period|Other|0|||
131406019|NCT02499900|473109049|FG001|Extension Study Period|Other|2|||
131406020|NCT03385265|473109050|FG000|Overall Study|Withdrawal by Subject|5|||
131406021|NCT03385265|473109051|FG001|Overall Study|Withdrawal by Subject|2|||
131406022|NCT03385265|473109052|FG002|Overall Study|Withdrawal by Subject|5|||
131406023|NCT03385265|473109053|FG003|Overall Study|Withdrawal by Subject|2|||
131406024|NCT02439450|473109055|FG000|Overall Study|Adverse Event|4|||
131406025|NCT02439450|473109056|FG001|Overall Study|Adverse Event|1|||
131406026|NCT02439450|473109057|FG002|Overall Study|Adverse Event|0|||
131406027|NCT02439450|473109058|FG003|Overall Study|Adverse Event|0|||
131406028|NCT02439450|473109055|FG000|Overall Study|Withdrawal by Subject|1|||
131406029|NCT02439450|473109056|FG001|Overall Study|Withdrawal by Subject|2|||
131406030|NCT02439450|473109057|FG002|Overall Study|Withdrawal by Subject|0|||
131406031|NCT02439450|473109058|FG003|Overall Study|Withdrawal by Subject|0|||
131406032|NCT02439450|473109055|FG000|Overall Study|Death|3|||
131406033|NCT02439450|473109056|FG001|Overall Study|Death|0|||
131406034|NCT02439450|473109057|FG002|Overall Study|Death|0|||
131406035|NCT02439450|473109058|FG003|Overall Study|Death|1|||
131406036|NCT02439450|473109055|FG000|Overall Study|Progressive Disease|18|||
131406037|NCT02439450|473109056|FG001|Overall Study|Progressive Disease|41|||
131406038|NCT02439450|473109057|FG002|Overall Study|Progressive Disease|2|||
131406039|NCT02439450|473109058|FG003|Overall Study|Progressive Disease|3|||
131406040|NCT01081301|473109059|FG000|Overall Study|Bereaved|3|||
131406041|NCT01081301|473109059|FG000|Overall Study|Too busy|5|||
131406042|NCT01081301|473109059|FG000|Overall Study|Patient too ill|2|||
131406043|NCT01081301|473109059|FG000|Overall Study|Lost to Follow-up|4|||
131406044|NCT00853125|473109062|FG000|Overall Study|Study participant's donor was CMV +|1|||
131406045|NCT03023826|473109064|FG000|Period 1|Withdrawal by Subject|0|||
131406046|NCT03023826|473109065|FG001|Period 1|Withdrawal by Subject|0|||
131406047|NCT03023826|473109066|FG002|Period 1|Withdrawal by Subject|0|||
131406048|NCT03023826|473109067|FG003|Period 1|Withdrawal by Subject|0|||
131406049|NCT03023826|473109068|FG004|Period 1|Withdrawal by Subject|1|||
131406050|NCT03023826|473109069|FG005|Period 1|Withdrawal by Subject|0|||
131406051|NCT00549900|473111152|FG000|Overall Study|Adverse Event|1|||
131406052|NCT02982018|473111153|FG000|Overall Study|Incorrect Lens Dispensed|1|||
131406053|NCT02982018|473111154|FG001|Overall Study|Incorrect Lens Dispensed|0|||
131406054|NCT02982018|473111153|FG000|Overall Study|Protocol Violation|1|||
131406055|NCT02982018|473111154|FG001|Overall Study|Protocol Violation|1|||
131406056|NCT02982018|473111153|FG000|Overall Study|Adverse Event|1|||
131406057|NCT02982018|473111154|FG001|Overall Study|Adverse Event|1|||
131406058|NCT02982018|473111153|FG000|Overall Study|Lens Discomfort|2|||
131406059|NCT02982018|473111154|FG001|Overall Study|Lens Discomfort|0|||
131406060|NCT02982018|473111153|FG000|Overall Study|Withdrawal by Subject|0|||
131406061|NCT02982018|473111154|FG001|Overall Study|Withdrawal by Subject|1|||
131406062|NCT03283098|473111155|FG000|Overall Study|Withdrawal by Subject|0|||
131406063|NCT03283098|473111156|FG001|Overall Study|Withdrawal by Subject|1|||
131406064|NCT00445939|473111160|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
131406065|NCT00445939|473111161|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
131406066|NCT00445939|473111162|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
131406067|NCT00445939|473111163|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
131406068|NCT00445939|473111160|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
131406069|NCT00445939|473111161|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
131406070|NCT00445939|473111162|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
131406071|NCT00445939|473111163|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
131406072|NCT00798317|473111167|FG000|Overall Study|Physician Decision|0|||
131406073|NCT00798317|473111168|FG001|Overall Study|Physician Decision|1|||
131406074|NCT00798317|473111167|FG000|Overall Study|Withdrawal by Subject|5|||
131406075|NCT00798317|473111168|FG001|Overall Study|Withdrawal by Subject|4|||
131406076|NCT00798317|473111167|FG000|Overall Study|Lost to Follow-up|2|||
131406077|NCT00798317|473111168|FG001|Overall Study|Lost to Follow-up|2|||
131406078|NCT00798317|473111167|FG000|Overall Study|Adverse Event|2|||
131406079|NCT00798317|473111168|FG001|Overall Study|Adverse Event|0|||
131406080|NCT00798317|473111167|FG000|Overall Study|Death|1|||
131406081|NCT00798317|473111168|FG001|Overall Study|Death|0|||
131406082|NCT00416715|473111169|FG000|Overall Study|Not evaluable for joint aches|7|||
131855283|NCT01090414|474747876|FG000|Study 101-99|Investigator Request|1|||
131855284|NCT01090414|474747877|FG001|Study 101-99|Investigator Request|11|||
131855285|NCT01090414|474747878|FG002|Study 101-99|Investigator Request|4|||
131855286|NCT01090414|474747879|FG003|Study 101-99|Investigator Request|0|||
131855287|NCT01090414|474747876|FG000|Study 101-99|Death|3|||
131855288|NCT01090414|474747877|FG001|Study 101-99|Death|8|||
131855289|NCT01090414|474747878|FG002|Study 101-99|Death|1|||
131855290|NCT01090414|474747879|FG003|Study 101-99|Death|0|||
131855291|NCT01090414|474747876|FG000|Study 101-99|Sponsor Discontinued Study|0|||
131855292|NCT01090414|474747877|FG001|Study 101-99|Sponsor Discontinued Study|7|||
131855293|NCT01090414|474747878|FG002|Study 101-99|Sponsor Discontinued Study|5|||
131855294|NCT01090414|474747879|FG003|Study 101-99|Sponsor Discontinued Study|0|||
131855295|NCT01090414|474747876|FG000|Study 101-99|Other (Unknown Reasons)|3|||
131855296|NCT01090414|474747877|FG001|Study 101-99|Other (Unknown Reasons)|3|||
131855297|NCT01090414|474747878|FG002|Study 101-99|Other (Unknown Reasons)|0|||
131855298|NCT01090414|474747879|FG003|Study 101-99|Other (Unknown Reasons)|0|||
131855299|NCT01090414|474747876|FG000|Study 101-99|Withdrew Consent|0|||
131855300|NCT01090414|474747877|FG001|Study 101-99|Withdrew Consent|2|||
131855301|NCT01090414|474747878|FG002|Study 101-99|Withdrew Consent|3|||
131855302|NCT01090414|474747879|FG003|Study 101-99|Withdrew Consent|1|||
131855303|NCT01090414|474747876|FG000|Study 101-99|Participant Request|3|||
131855304|NCT01090414|474747877|FG001|Study 101-99|Participant Request|1|||
131855305|NCT01090414|474747878|FG002|Study 101-99|Participant Request|0|||
131855306|NCT01090414|474747879|FG003|Study 101-99|Participant Request|0|||
131855307|NCT02652949|474747887|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
131855308|NCT02652949|474747887|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
131855309|NCT02652949|474747887|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
131855310|NCT02652949|474747887|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
131855311|NCT02652949|474747887|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
131855312|NCT02652949|474747887|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
131855313|NCT02652949|474747887|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
131855314|NCT02652949|474747887|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
131855315|NCT02652949|474747887|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
131855316|NCT02652949|474747887|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
131855317|NCT02652949|474747887|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
131855318|NCT02652949|474747887|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
131855319|NCT02652949|474747887|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
131855320|NCT02652949|474747887|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
131855321|NCT02652949|474747887|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
131855322|NCT02652949|474747887|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
131855323|NCT02652949|474747887|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
131855324|NCT03594071|474747888|FG000|Overall Study|Re-operation|3|||
131855325|NCT03594071|474747888|FG000|Overall Study|Missed visit|2|||
131855326|NCT03022370|474747889|FG000|Overall Study|Death|6|||
131855327|NCT03022370|474747890|FG001|Overall Study|Death|12|||
131855328|NCT03022370|474747889|FG000|Overall Study|Lost to Follow-up|174|||
131855329|NCT03022370|474747890|FG001|Overall Study|Lost to Follow-up|109|||
131855330|NCT00699816|474747893|FG000|Overall Study|Protocol Violation|1|||
131855331|NCT00699816|474747894|FG001|Overall Study|Protocol Violation|3|||
131855332|NCT02454933|474747897|FG000|Overall Study|Progressive disease|10|||
131855333|NCT02454933|474747898|FG001|Overall Study|Progressive disease|7|||
131855334|NCT02454933|474747897|FG000|Overall Study|Adverse Event|1|||
131855335|NCT02454933|474747898|FG001|Overall Study|Adverse Event|1|||
131855336|NCT02454933|474747897|FG000|Overall Study|Withdrawal by Subject|0|||
131855337|NCT02454933|474747898|FG001|Overall Study|Withdrawal by Subject|3|||
131855338|NCT02454933|474747897|FG000|Overall Study|Lost to Follow-up|1|||
131855339|NCT02454933|474747898|FG001|Overall Study|Lost to Follow-up|0|||
131855340|NCT01526655|474747901|FG000|Overall Study|Withdrawal by Subject|0|||
131855341|NCT01526655|474747902|FG001|Overall Study|Withdrawal by Subject|1|||
131855342|NCT00280735|474747903|FG000|Overall Study|Adverse Event|5|||
131855343|NCT00280735|474747903|FG000|Overall Study|Lack of Efficacy|3|||
131855344|NCT00280735|474747903|FG000|Overall Study|Withdrawal by Subject|8|||
131855345|NCT00280735|474747903|FG000|Overall Study|Intercurrent Illness|2|||
131855346|NCT04753216|474747904|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
131855347|NCT04753216|474747904|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
131855348|NCT04753216|474747904|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
131855349|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
131855350|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Death|1|||
131855351|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
131406083|NCT00416715|473111169|FG000|Overall Study|Vitamin D levels not evaluable|8|||
131855352|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
131406084|NCT00489736|473111170|FG000|Overall Study|Lack of Efficacy|53|||
131406085|NCT00489736|473111171|FG001|Overall Study|Lack of Efficacy|14|||
131406086|NCT00489736|473111170|FG000|Overall Study|Adverse Event|32|||
131406087|NCT00489736|473111171|FG001|Overall Study|Adverse Event|45|||
131406088|NCT00489736|473111170|FG000|Overall Study|Poor compliance|6|||
131406089|NCT00489736|473111171|FG001|Overall Study|Poor compliance|2|||
131406090|NCT00489736|473111170|FG000|Overall Study|Not coded/ Not pre-specified|5|||
131406091|NCT00489736|473111171|FG001|Overall Study|Not coded/ Not pre-specified|8|||
131406092|NCT03812185|473111175|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
131406093|NCT02576535|473111188|FG000|Overall Study|Withdrawal by Subject|2|||
131406094|NCT02545517|473111189|FG000|Overall Study|Death|2|||
131406095|NCT02545517|473111190|FG001|Overall Study|Death|2|||
131406096|NCT02545517|473111191|FG002|Overall Study|Death|1|||
131406097|NCT02545517|473111189|FG000|Overall Study|Lost to Follow-up|14|||
131406098|NCT02545517|473111190|FG001|Overall Study|Lost to Follow-up|13|||
131406099|NCT02545517|473111191|FG002|Overall Study|Lost to Follow-up|17|||
131406100|NCT02545517|473111189|FG000|Overall Study|Protocol Violation|0|||
131406101|NCT02545517|473111190|FG001|Overall Study|Protocol Violation|1|||
131406102|NCT02545517|473111191|FG002|Overall Study|Protocol Violation|1|||
131406103|NCT02545517|473111189|FG000|Overall Study|Withdrawal by Subject|5|||
131406104|NCT02545517|473111190|FG001|Overall Study|Withdrawal by Subject|8|||
131406105|NCT02545517|473111191|FG002|Overall Study|Withdrawal by Subject|9|||
131406106|NCT02545517|473111189|FG000|Overall Study|Administrative reason|5|||
131406107|NCT02545517|473111190|FG001|Overall Study|Administrative reason|6|||
131406108|NCT02545517|473111191|FG002|Overall Study|Administrative reason|10|||
131406109|NCT02545517|473111189|FG000|Overall Study|Other|2|||
131406110|NCT02545517|473111190|FG001|Overall Study|Other|4|||
131406111|NCT02545517|473111191|FG002|Overall Study|Other|3|||
131406112|NCT01529515|473111192|FG000|TRANSITION PHASE|Adverse Event|16|||
131406113|NCT01529515|473111193|FG001|TRANSITION PHASE|Adverse Event|0|||
131406114|NCT01529515|473111194|FG002|TRANSITION PHASE|Adverse Event|0|||
131406115|NCT01529515|473111195|FG003|TRANSITION PHASE|Adverse Event|0|||
131406116|NCT01529515|473111192|FG000|TRANSITION PHASE|Death|1|||
131406117|NCT01529515|473111193|FG001|TRANSITION PHASE|Death|0|||
131406118|NCT01529515|473111194|FG002|TRANSITION PHASE|Death|0|||
131406119|NCT01529515|473111195|FG003|TRANSITION PHASE|Death|0|||
131406120|NCT01529515|473111192|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
131406121|NCT01529515|473111193|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
131406122|NCT01529515|473111194|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
131406123|NCT01529515|473111195|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
131406124|NCT01529515|473111192|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
131406125|NCT01529515|473111193|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
131406126|NCT01529515|473111194|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
131406127|NCT01529515|473111195|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
131406128|NCT01529515|473111192|FG000|TRANSITION PHASE|Protocol Violation|4|||
131406129|NCT01529515|473111193|FG001|TRANSITION PHASE|Protocol Violation|0|||
131406130|NCT01529515|473111194|FG002|TRANSITION PHASE|Protocol Violation|0|||
131406131|NCT01529515|473111195|FG003|TRANSITION PHASE|Protocol Violation|0|||
131406132|NCT01529515|473111192|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
131406133|NCT01529515|473111193|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
131406134|NCT01529515|473111194|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
131406135|NCT01529515|473111195|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
131406136|NCT01529515|473111192|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
131406137|NCT01529515|473111193|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
131406138|NCT01529515|473111194|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
131406139|NCT01529515|473111195|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
131406140|NCT01529515|473111192|FG000|TRANSITION PHASE|Other|9|||
131406141|NCT01529515|473111193|FG001|TRANSITION PHASE|Other|0|||
131406142|NCT01529515|473111194|FG002|TRANSITION PHASE|Other|0|||
131406143|NCT01529515|473111195|FG003|TRANSITION PHASE|Other|0|||
131406144|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Adverse Event|0|||
131855353|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
131855354|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
131855355|NCT02001987|474747906|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
131855356|NCT02001987|474747906|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
131855357|NCT02001987|474747906|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
131855358|NCT02001987|474747906|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
131855359|NCT02001987|474747906|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
131855360|NCT02001987|474747906|FG000|LTE Period (52 Weeks)|Other|3|||
131406145|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Adverse Event|10|||
131406146|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Adverse Event|0|||
131912492|NCT02765165|474966604|FG002|Treatment Period|Adverse Event|0|||
131912493|NCT02765165|474966605|FG003|Treatment Period|Adverse Event|0|||
131912494|NCT02765165|474966606|FG004|Treatment Period|Adverse Event|0|||
131912495|NCT02765165|474966607|FG005|Treatment Period|Adverse Event|0|||
131453696|NCT02116205|473290002|FG003|Overall Study|Exclusion criteria|0|||
131912496|NCT02765165|474966608|FG006|Treatment Period|Adverse Event|0|||
131912497|NCT02765165|474966602|FG000|Treatment Period|Withdrawal by Subject|0|||
131912498|NCT02765165|474966603|FG001|Treatment Period|Withdrawal by Subject|0|||
131406147|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Adverse Event|0|||
131453697|NCT02752165|473290008|FG000|Overall Study|Withdrawal by Subject|6|||
131855361|NCT03138655|474747907|FG000|Overall Study|Adverse Event|2|||
131855362|NCT03138655|474747908|FG001|Overall Study|Adverse Event|1|||
131855363|NCT03138655|474747909|FG002|Overall Study|Adverse Event|2|||
131855364|NCT03138655|474747910|FG003|Overall Study|Adverse Event|1|||
131855365|NCT03138655|474747911|FG004|Overall Study|Adverse Event|1|||
131855366|NCT03138655|474747912|FG005|Overall Study|Adverse Event|4|||
131855367|NCT03138655|474747913|FG006|Overall Study|Adverse Event|2|||
131855368|NCT03138655|474747914|FG007|Overall Study|Adverse Event|2|||
131855369|NCT03138655|474747907|FG000|Overall Study|Withdrawal by Subject|0|||
131855370|NCT03138655|474747908|FG001|Overall Study|Withdrawal by Subject|1|||
131855371|NCT03138655|474747909|FG002|Overall Study|Withdrawal by Subject|0|||
131855372|NCT03138655|474747910|FG003|Overall Study|Withdrawal by Subject|0|||
131855373|NCT03138655|474747911|FG004|Overall Study|Withdrawal by Subject|0|||
131855374|NCT03138655|474747912|FG005|Overall Study|Withdrawal by Subject|0|||
131855375|NCT03138655|474747913|FG006|Overall Study|Withdrawal by Subject|1|||
131855376|NCT03138655|474747914|FG007|Overall Study|Withdrawal by Subject|0|||
131855377|NCT03138655|474747907|FG000|Overall Study|Reason not Specified|1|||
131855378|NCT03138655|474747908|FG001|Overall Study|Reason not Specified|0|||
131855379|NCT03138655|474747909|FG002|Overall Study|Reason not Specified|0|||
131855380|NCT03138655|474747910|FG003|Overall Study|Reason not Specified|2|||
131855381|NCT03138655|474747911|FG004|Overall Study|Reason not Specified|1|||
131855382|NCT03138655|474747912|FG005|Overall Study|Reason not Specified|1|||
131855383|NCT03138655|474747913|FG006|Overall Study|Reason not Specified|0|||
131855384|NCT03138655|474747914|FG007|Overall Study|Reason not Specified|0|||
131855385|NCT03656744|474747917|FG000|Overall Study|Adverse Event|1|||
131855386|NCT03656744|474747918|FG001|Overall Study|Adverse Event|4|||
131855387|NCT03656744|474747919|FG002|Overall Study|Adverse Event|1|||
131855388|NCT03656744|474747917|FG000|Overall Study|Protocol Violation|1|||
131855389|NCT03656744|474747918|FG001|Overall Study|Protocol Violation|0|||
131855390|NCT03656744|474747919|FG002|Overall Study|Protocol Violation|0|||
131855391|NCT03656744|474747917|FG000|Overall Study|Lost to Follow-up|2|||
131855392|NCT03656744|474747918|FG001|Overall Study|Lost to Follow-up|2|||
131855393|NCT03656744|474747919|FG002|Overall Study|Lost to Follow-up|0|||
131855394|NCT03656744|474747917|FG000|Overall Study|Withdrawal by Subject|0|||
131855395|NCT03656744|474747918|FG001|Overall Study|Withdrawal by Subject|1|||
131855396|NCT03656744|474747919|FG002|Overall Study|Withdrawal by Subject|0|||
131855397|NCT03656744|474747917|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
131855398|NCT03656744|474747918|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
131855399|NCT03656744|474747919|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
131855400|NCT01277211|474747920|FG000|Overall Study|Adverse Event|60|||
131855401|NCT01277211|474747921|FG001|Overall Study|Adverse Event|22|||
131855402|NCT01277211|474747920|FG000|Overall Study|Pregnancy|9|||
131855403|NCT01277211|474747921|FG001|Overall Study|Pregnancy|4|||
131855404|NCT01277211|474747920|FG000|Overall Study|Lost to Follow-up|14|||
131855405|NCT01277211|474747921|FG001|Overall Study|Lost to Follow-up|9|||
131855406|NCT01277211|474747920|FG000|Overall Study|Did not wish to continue|17|||
131855407|NCT01277211|474747921|FG001|Overall Study|Did not wish to continue|0|||
131855408|NCT01277211|474747920|FG000|Overall Study|Withdrew Consent|9|||
131855409|NCT01277211|474747921|FG001|Overall Study|Withdrew Consent|9|||
131855410|NCT01277211|474747920|FG000|Overall Study|Non-compliance with protocol|13|||
131855411|NCT01277211|474747921|FG001|Overall Study|Non-compliance with protocol|4|||
131855412|NCT01277211|474747920|FG000|Overall Study|Did not meet protocol eligibility|1|||
131855413|NCT01277211|474747921|FG001|Overall Study|Did not meet protocol eligibility|0|||
131855414|NCT01277211|474747920|FG000|Overall Study|Administrative|3|||
131855415|NCT01277211|474747921|FG001|Overall Study|Administrative|0|||
131855416|NCT01277211|474747920|FG000|Overall Study|Pregnancy wish|0|||
131855417|NCT01277211|474747921|FG001|Overall Study|Pregnancy wish|2|||
131855418|NCT01277211|474747920|FG000|Overall Study|Discontinued prior to treatment|24|||
131855419|NCT01277211|474747921|FG001|Overall Study|Discontinued prior to treatment|13|||
131855420|NCT00879086|474747922|FG000|Overall Study|Adverse Event|3|||
131855421|NCT00879086|474747923|FG001|Overall Study|Adverse Event|15|||
131855422|NCT00879086|474747922|FG000|Overall Study|Participant choice|2|||
131855423|NCT00879086|474747923|FG001|Overall Study|Participant choice|2|||
131855424|NCT00879086|474747922|FG000|Overall Study|Progression of disease|40|||
131855425|NCT00879086|474747923|FG001|Overall Study|Progression of disease|26|||
131855426|NCT00879086|474747922|FG000|Overall Study|Withdrawal of consent|2|||
131855427|NCT00879086|474747923|FG001|Overall Study|Withdrawal of consent|1|||
131855428|NCT00879086|474747922|FG000|Overall Study|Other|4|||
131855429|NCT00879086|474747923|FG001|Overall Study|Other|6|||
131855430|NCT00879086|474747922|FG000|Overall Study|Death|1|||
131855431|NCT00879086|474747923|FG001|Overall Study|Death|2|||
131855432|NCT04650204|474747924|FG000|Overall Study|Study was Terminated|2|||
131855433|NCT04650204|474747925|FG001|Overall Study|Study was Terminated|1|||
131855434|NCT01330303|474747926|FG000|Period 1|Adverse Event|1|||
131855435|NCT01330303|474747927|FG001|Period 1|Adverse Event|0|||
131855436|NCT01330303|474747926|FG000|Period 1|Protocol Violation|0|||
131855437|NCT01330303|474747927|FG001|Period 1|Protocol Violation|1|||
131453698|NCT02752165|473290009|FG001|Overall Study|Withdrawal by Subject|6|||
131453699|NCT02752165|473290008|FG000|Overall Study|Protocol Violation|6|||
131453700|NCT02752165|473290009|FG001|Overall Study|Protocol Violation|5|||
131453701|NCT02752165|473290008|FG000|Overall Study|Lost to Follow-up|33|||
131453702|NCT02752165|473290009|FG001|Overall Study|Lost to Follow-up|38|||
131453703|NCT01704599|473290011|FG000|Overall Study|Adverse Event|1|||
131453704|NCT02840461|473290012|FG000|Overall Study|Adverse Event|1|||
131453705|NCT02840461|473290013|FG001|Overall Study|Adverse Event|5|||
131453706|NCT02840461|473290014|FG002|Overall Study|Adverse Event|3|||
131453707|NCT02840461|473290012|FG000|Overall Study|Lost to Follow-up|10|||
131453708|NCT02840461|473290013|FG001|Overall Study|Lost to Follow-up|7|||
131453709|NCT02840461|473290014|FG002|Overall Study|Lost to Follow-up|6|||
131453710|NCT02840461|473290012|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
131453711|NCT02840461|473290013|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
131453712|NCT02840461|473290014|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
131453713|NCT02840461|473290012|FG000|Overall Study|Protocol Violation|2|||
131453714|NCT02840461|473290013|FG001|Overall Study|Protocol Violation|3|||
131453715|NCT02840461|473290014|FG002|Overall Study|Protocol Violation|1|||
131453716|NCT02840461|473290012|FG000|Overall Study|Withdrawal by Subject|10|||
131453717|NCT02840461|473290013|FG001|Overall Study|Withdrawal by Subject|6|||
131453718|NCT02840461|473290014|FG002|Overall Study|Withdrawal by Subject|2|||
131453719|NCT02840461|473290012|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
131453720|NCT02840461|473290013|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
131453721|NCT02840461|473290014|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
131453722|NCT01737502|473290017|FG000|Phase I|Disease progression|2|||
131453723|NCT01737502|473290018|FG001|Phase I|Disease progression|3|||
131453724|NCT01737502|473290017|FG000|Phase I|Complicating disease|1|||
131453725|NCT01737502|473290018|FG001|Phase I|Complicating disease|0|||
131453726|NCT01737502|473290017|FG000|Phase II|Adverse Event|0|||
131453727|NCT01737502|473290018|FG001|Phase II|Adverse Event|3|||
131453728|NCT01737502|473290017|FG000|Phase II|Disease progression|0|||
131453729|NCT01737502|473290018|FG001|Phase II|Disease progression|18|||
131453730|NCT01737502|473290017|FG000|Phase II|Death|0|||
131453731|NCT01737502|473290018|FG001|Phase II|Death|1|||
131453732|NCT01737502|473290017|FG000|Phase II|Transition to hospice care|0|||
131453733|NCT01737502|473290018|FG001|Phase II|Transition to hospice care|1|||
131453734|NCT01615029|473290021|FG000|Overall Study|Adverse Event|0|||
131453735|NCT01615029|473290022|FG001|Overall Study|Adverse Event|0|||
131453736|NCT01615029|473290023|FG002|Overall Study|Adverse Event|0|||
131453737|NCT01615029|473290024|FG003|Overall Study|Adverse Event|0|||
131453738|NCT01615029|473290025|FG004|Overall Study|Adverse Event|1|||
131453739|NCT01615029|473290021|FG000|Overall Study|Death|0|||
131453740|NCT01615029|473290022|FG001|Overall Study|Death|0|||
131453741|NCT01615029|473290023|FG002|Overall Study|Death|0|||
131453742|NCT01615029|473290024|FG003|Overall Study|Death|0|||
131453743|NCT01615029|473290025|FG004|Overall Study|Death|1|||
131453744|NCT01615029|473290021|FG000|Overall Study|Lost to Follow-up|0|||
131453745|NCT01615029|473290022|FG001|Overall Study|Lost to Follow-up|0|||
131453746|NCT01615029|473290023|FG002|Overall Study|Lost to Follow-up|0|||
131453747|NCT01615029|473290024|FG003|Overall Study|Lost to Follow-up|0|||
131453748|NCT01615029|473290025|FG004|Overall Study|Lost to Follow-up|1|||
131453749|NCT01615029|473290021|FG000|Overall Study|Progressive disease|2|||
131453750|NCT01615029|473290022|FG001|Overall Study|Progressive disease|1|||
131453751|NCT01615029|473290023|FG002|Overall Study|Progressive disease|1|||
131453752|NCT01615029|473290024|FG003|Overall Study|Progressive disease|1|||
131453753|NCT01615029|473290025|FG004|Overall Study|Progressive disease|5|||
131453754|NCT01615029|473290021|FG000|Overall Study|Physician Decision|0|||
131453755|NCT01615029|473290022|FG001|Overall Study|Physician Decision|0|||
131453756|NCT01615029|473290023|FG002|Overall Study|Physician Decision|0|||
131453757|NCT01615029|473290024|FG003|Overall Study|Physician Decision|0|||
131453758|NCT01615029|473290025|FG004|Overall Study|Physician Decision|1|||
131453759|NCT01615029|473290021|FG000|Overall Study|Ongoing|1|||
131453760|NCT01615029|473290022|FG001|Overall Study|Ongoing|2|||
131453761|NCT01615029|473290023|FG002|Overall Study|Ongoing|3|||
131453762|NCT01615029|473290024|FG003|Overall Study|Ongoing|2|||
131453763|NCT01615029|473290025|FG004|Overall Study|Ongoing|23|||
131453764|NCT04672655|473290026|FG000|Overall Study|Lost to Follow-up|12|||
131453765|NCT04672655|473290027|FG001|Overall Study|Lost to Follow-up|17|||
131453766|NCT04672655|473290026|FG000|Overall Study|Withdrawal by Subject|1|||
131453767|NCT04672655|473290027|FG001|Overall Study|Withdrawal by Subject|0|||
131453768|NCT04672655|473290026|FG000|Overall Study|Withdrawal by Study|1|||
131453769|NCT04672655|473290027|FG001|Overall Study|Withdrawal by Study|0|||
131453770|NCT00802945|473290030|FG000|Overall Study|Death|27|||
131453771|NCT00802945|473290031|FG001|Overall Study|Death|23|||
131453772|NCT00802945|473290030|FG000|Overall Study|Terminated by sponsor|8|||
131453773|NCT00802945|473290031|FG001|Overall Study|Terminated by sponsor|12|||
131453774|NCT00494676|473290032|FG000|Allocation|Withdrawal by Subject|2|||
131453775|NCT00494676|473290033|FG001|Allocation|Withdrawal by Subject|4|||
131453776|NCT00494676|473290032|FG000|First Intervention|Withdrawal by Subject|1|||
131453777|NCT00494676|473290033|FG001|First Intervention|Withdrawal by Subject|3|||
131912499|NCT02765165|474966604|FG002|Treatment Period|Withdrawal by Subject|0|||
131453778|NCT00494676|473290032|FG000|Second Intervention|Withdrawal by Subject|1|||
131453779|NCT00494676|473290033|FG001|Second Intervention|Withdrawal by Subject|1|||
131453780|NCT03843541|473290034|FG000|Overall Study|Adverse Event|4|||
131453781|NCT03843541|473290035|FG001|Overall Study|Adverse Event|2|||
131453782|NCT03843541|473290036|FG002|Overall Study|Adverse Event|3|||
131453783|NCT03843541|473290034|FG000|Overall Study|Death|1|||
131453784|NCT03843541|473290035|FG001|Overall Study|Death|0|||
131453785|NCT03843541|473290036|FG002|Overall Study|Death|0|||
131453786|NCT03843541|473290034|FG000|Overall Study|Lack of adherence to study medication|0|||
131453787|NCT03843541|473290035|FG001|Overall Study|Lack of adherence to study medication|0|||
131453788|NCT03843541|473290036|FG002|Overall Study|Lack of adherence to study medication|1|||
131453789|NCT03843541|473290034|FG000|Overall Study|Physician Decision|1|||
131453790|NCT03843541|473290035|FG001|Overall Study|Physician Decision|2|||
131453791|NCT03843541|473290036|FG002|Overall Study|Physician Decision|2|||
131453792|NCT03843541|473290034|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
131453793|NCT03843541|473290035|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
131453794|NCT03843541|473290036|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
131453795|NCT03843541|473290034|FG000|Overall Study|Withdrawal by Subject|6|||
131453796|NCT03843541|473290035|FG001|Overall Study|Withdrawal by Subject|9|||
131453797|NCT03843541|473290036|FG002|Overall Study|Withdrawal by Subject|7|||
131453798|NCT03843541|473290034|FG000|Overall Study|Administration of rescue mucolytic|0|||
131453799|NCT03843541|473290035|FG001|Overall Study|Administration of rescue mucolytic|0|||
131453800|NCT03843541|473290036|FG002|Overall Study|Administration of rescue mucolytic|1|||
131453801|NCT03843541|473290034|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
131453802|NCT03843541|473290035|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
131453803|NCT03843541|473290036|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
131453804|NCT05307692|473290040|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
131453805|NCT05307692|473290041|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
131453806|NCT05307692|473290042|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
131453807|NCT05307692|473290043|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
131855438|NCT01330303|474747926|FG000|Period 1|Withdrawal by Subject|0|||
131855439|NCT01330303|474747927|FG001|Period 1|Withdrawal by Subject|1|||
131855440|NCT01107197|474747928|FG000|Overall Study|Death|12|||
131855441|NCT01107197|474747929|FG001|Overall Study|Death|10|||
131855442|NCT01107197|474747928|FG000|Overall Study|Lost to Follow-up|5|||
131855443|NCT01107197|474747929|FG001|Overall Study|Lost to Follow-up|8|||
131855444|NCT01107197|474747928|FG000|Overall Study|Withdrawal by Subject|3|||
131855445|NCT01107197|474747929|FG001|Overall Study|Withdrawal by Subject|5|||
131855446|NCT02445963|474747930|FG000|Overall Study|Lost to Follow-up|1|||
131855447|NCT02445963|474747931|FG001|Overall Study|Lost to Follow-up|0|||
131855448|NCT02445963|474747932|FG002|Overall Study|Lost to Follow-up|0|||
131855449|NCT02445963|474747933|FG003|Overall Study|Lost to Follow-up|0|||
131855450|NCT02445963|474747930|FG000|Overall Study|Change in employment|1|||
131855451|NCT02445963|474747931|FG001|Overall Study|Change in employment|0|||
131855452|NCT02445963|474747932|FG002|Overall Study|Change in employment|0|||
131855453|NCT02445963|474747933|FG003|Overall Study|Change in employment|0|||
131855454|NCT02445963|474747930|FG000|Overall Study|Symptoms post-vaccination|0|||
131855455|NCT02445963|474747931|FG001|Overall Study|Symptoms post-vaccination|0|||
131855456|NCT02445963|474747932|FG002|Overall Study|Symptoms post-vaccination|1|||
131855457|NCT02445963|474747933|FG003|Overall Study|Symptoms post-vaccination|0|||
131855458|NCT01449812|474747937|FG000|Overall Study|Migrated/moved from study area|1|||
131855459|NCT01449812|474747938|FG001|Overall Study|Migrated/moved from study area|0|||
131855460|NCT01449812|474747939|FG002|Overall Study|Migrated/moved from study area|0|||
131855461|NCT01449812|474747937|FG000|Overall Study|Withdrawal by Subject|0|||
131855462|NCT01449812|474747938|FG001|Overall Study|Withdrawal by Subject|0|||
131855463|NCT01449812|474747939|FG002|Overall Study|Withdrawal by Subject|1|||
131855464|NCT01449812|474747937|FG000|Overall Study|Lost to Follow-up|1|||
131855465|NCT01449812|474747938|FG001|Overall Study|Lost to Follow-up|0|||
131855466|NCT01449812|474747939|FG002|Overall Study|Lost to Follow-up|0|||
131855467|NCT01855828|474747940|FG000|Overall Study|Adverse Event|1|||
131912500|NCT02765165|474966605|FG003|Treatment Period|Withdrawal by Subject|0|||
131912501|NCT02765165|474966606|FG004|Treatment Period|Withdrawal by Subject|2|||
131453808|NCT05307692|473290040|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
131453809|NCT05307692|473290041|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
131855468|NCT01855828|474747940|FG000|Overall Study|Withdrawal by Subject|1|||
131855469|NCT01866098|474747941|FG000|Overall Study|Lost to Follow-up|11|||
131855470|NCT01866098|474747942|FG001|Overall Study|Lost to Follow-up|18|||
131855471|NCT01866098|474747943|FG002|Overall Study|Lost to Follow-up|13|||
131855472|NCT01866098|474747941|FG000|Overall Study|Physician Decision|0|||
131855473|NCT01866098|474747942|FG001|Overall Study|Physician Decision|1|||
131855474|NCT01866098|474747943|FG002|Overall Study|Physician Decision|2|||
131855475|NCT01866098|474747941|FG000|Overall Study|Adverse Event|1|||
131855476|NCT01866098|474747942|FG001|Overall Study|Adverse Event|5|||
131855477|NCT01866098|474747943|FG002|Overall Study|Adverse Event|4|||
131855478|NCT01866098|474747941|FG000|Overall Study|Protocol Violation|1|||
131855479|NCT01866098|474747942|FG001|Overall Study|Protocol Violation|0|||
131855480|NCT01866098|474747943|FG002|Overall Study|Protocol Violation|0|||
131855481|NCT01866098|474747941|FG000|Overall Study|Withdrawal by Subject|1|||
131855482|NCT01866098|474747942|FG001|Overall Study|Withdrawal by Subject|2|||
131855483|NCT01866098|474747943|FG002|Overall Study|Withdrawal by Subject|0|||
131855484|NCT01866098|474747941|FG000|Overall Study|Unrelated Hospitalization|2|||
131855485|NCT01866098|474747942|FG001|Overall Study|Unrelated Hospitalization|0|||
131855486|NCT01866098|474747943|FG002|Overall Study|Unrelated Hospitalization|1|||
131855487|NCT01866098|474747941|FG000|Overall Study|Non-compliance|1|||
131855488|NCT01866098|474747942|FG001|Overall Study|Non-compliance|0|||
131855489|NCT01866098|474747943|FG002|Overall Study|Non-compliance|1|||
131855490|NCT01866098|474747941|FG000|Overall Study|Pregnancy|2|||
131855491|NCT01866098|474747942|FG001|Overall Study|Pregnancy|0|||
131855492|NCT01866098|474747943|FG002|Overall Study|Pregnancy|0|||
131855493|NCT01866098|474747941|FG000|Overall Study|Death|0|||
131855494|NCT01866098|474747942|FG001|Overall Study|Death|1|||
131855495|NCT01866098|474747943|FG002|Overall Study|Death|0|||
131855496|NCT04239027|474747948|FG000|Overall Study|Adverse Event|4|||
131855497|NCT04239027|474747948|FG000|Overall Study|Withdrawal by Subject|9|||
131855498|NCT04239027|474747948|FG000|Overall Study|Death|1|||
131855499|NCT04239027|474747948|FG000|Overall Study|Physician Decision|9|||
131855500|NCT04239027|474747948|FG000|Overall Study|Lost to Follow-up|2|||
131855501|NCT04239027|474747948|FG000|Overall Study|Lack of Efficacy|1|||
131855502|NCT03449446|474747949|FG000|Overall Study|Randomized but Never Treated|0|||
131855503|NCT03449446|474747950|FG001|Overall Study|Randomized but Never Treated|0|||
131855504|NCT03449446|474747951|FG002|Overall Study|Randomized but Never Treated|1|||
131855505|NCT03449446|474747952|FG003|Overall Study|Randomized but Never Treated|1|||
131855506|NCT03449446|474747953|FG004|Overall Study|Randomized but Never Treated|1|||
131855507|NCT03449446|474747954|FG005|Overall Study|Randomized but Never Treated|0|||
131855508|NCT03449446|474747955|FG006|Overall Study|Randomized but Never Treated|0|||
131855509|NCT03449446|474747949|FG000|Overall Study|Unknown Reason|33|||
131855510|NCT03449446|474747950|FG001|Overall Study|Unknown Reason|1|||
131855511|NCT03449446|474747951|FG002|Overall Study|Unknown Reason|1|||
131855512|NCT03449446|474747952|FG003|Overall Study|Unknown Reason|1|||
131855513|NCT03449446|474747953|FG004|Overall Study|Unknown Reason|2|||
131855514|NCT03449446|474747954|FG005|Overall Study|Unknown Reason|2|||
131855515|NCT03449446|474747955|FG006|Overall Study|Unknown Reason|0|||
131855516|NCT03449446|474747949|FG000|Overall Study|Withdrew Consent|1|||
131855517|NCT03449446|474747950|FG001|Overall Study|Withdrew Consent|3|||
131855518|NCT03449446|474747951|FG002|Overall Study|Withdrew Consent|1|||
131855519|NCT03449446|474747952|FG003|Overall Study|Withdrew Consent|4|||
131855520|NCT03449446|474747953|FG004|Overall Study|Withdrew Consent|4|||
131855521|NCT03449446|474747954|FG005|Overall Study|Withdrew Consent|4|||
131855522|NCT03449446|474747955|FG006|Overall Study|Withdrew Consent|1|||
131855523|NCT03449446|474747949|FG000|Overall Study|Adverse Event|1|||
131855524|NCT03449446|474747950|FG001|Overall Study|Adverse Event|2|||
131855525|NCT03449446|474747951|FG002|Overall Study|Adverse Event|1|||
131406148|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
131406149|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
131406150|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
131406151|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
131406152|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
131406153|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
131406154|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
131406155|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
131406156|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
131406157|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
131406158|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
131406159|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
131406160|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
131453810|NCT05307692|473290042|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
131855526|NCT03449446|474747952|FG003|Overall Study|Adverse Event|0|||
131855527|NCT03449446|474747953|FG004|Overall Study|Adverse Event|0|||
131855528|NCT03449446|474747954|FG005|Overall Study|Adverse Event|2|||
131855529|NCT03449446|474747955|FG006|Overall Study|Adverse Event|0|||
131855530|NCT03449446|474747949|FG000|Overall Study|Lost to Follow-up|0|||
131406161|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
131406162|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
131406163|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
131406164|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
131855531|NCT03449446|474747950|FG001|Overall Study|Lost to Follow-up|0|||
131855532|NCT03449446|474747951|FG002|Overall Study|Lost to Follow-up|2|||
131855533|NCT03449446|474747952|FG003|Overall Study|Lost to Follow-up|1|||
131855534|NCT03449446|474747953|FG004|Overall Study|Lost to Follow-up|3|||
131855535|NCT03449446|474747954|FG005|Overall Study|Lost to Follow-up|0|||
131855536|NCT03449446|474747955|FG006|Overall Study|Lost to Follow-up|0|||
131855537|NCT03449446|474747949|FG000|Overall Study|Investigator's Discretion|0|||
131855538|NCT03449446|474747950|FG001|Overall Study|Investigator's Discretion|1|||
131855539|NCT03449446|474747951|FG002|Overall Study|Investigator's Discretion|1|||
131855540|NCT03449446|474747952|FG003|Overall Study|Investigator's Discretion|2|||
131855541|NCT03449446|474747953|FG004|Overall Study|Investigator's Discretion|0|||
131855542|NCT03449446|474747954|FG005|Overall Study|Investigator's Discretion|0|||
131855543|NCT03449446|474747955|FG006|Overall Study|Investigator's Discretion|0|||
131855544|NCT03449446|474747949|FG000|Overall Study|Non Compliance with Study Drug|1|||
131855545|NCT03449446|474747950|FG001|Overall Study|Non Compliance with Study Drug|0|||
131855546|NCT03449446|474747951|FG002|Overall Study|Non Compliance with Study Drug|0|||
131855547|NCT03449446|474747952|FG003|Overall Study|Non Compliance with Study Drug|0|||
131855548|NCT03449446|474747953|FG004|Overall Study|Non Compliance with Study Drug|0|||
131855549|NCT03449446|474747954|FG005|Overall Study|Non Compliance with Study Drug|0|||
131855550|NCT03449446|474747955|FG006|Overall Study|Non Compliance with Study Drug|0|||
131855551|NCT03449446|474747949|FG000|Overall Study|Protocol Violation|0|||
131855552|NCT03449446|474747950|FG001|Overall Study|Protocol Violation|0|||
131855553|NCT03449446|474747951|FG002|Overall Study|Protocol Violation|0|||
131855554|NCT03449446|474747952|FG003|Overall Study|Protocol Violation|0|||
131855555|NCT03449446|474747953|FG004|Overall Study|Protocol Violation|1|||
131855556|NCT03449446|474747954|FG005|Overall Study|Protocol Violation|1|||
131855557|NCT03449446|474747955|FG006|Overall Study|Protocol Violation|0|||
131855558|NCT03449446|474747949|FG000|Overall Study|Death|0|||
131855559|NCT03449446|474747950|FG001|Overall Study|Death|0|||
131855560|NCT03449446|474747951|FG002|Overall Study|Death|0|||
131855561|NCT03449446|474747952|FG003|Overall Study|Death|0|||
131855562|NCT03449446|474747953|FG004|Overall Study|Death|1|||
131855563|NCT03449446|474747954|FG005|Overall Study|Death|0|||
131855564|NCT03449446|474747955|FG006|Overall Study|Death|0|||
131855565|NCT02108912|474747972|FG000|Overall Study|Lost to Follow-up|1|||
131855566|NCT02108912|474747973|FG001|Overall Study|Lost to Follow-up|1|||
131855567|NCT02108912|474747972|FG000|Overall Study|lack of transportation|1|||
131855568|NCT02108912|474747973|FG001|Overall Study|lack of transportation|0|||
131855569|NCT02108912|474747972|FG000|Overall Study|high blood pressure|1|||
131855570|NCT02108912|474747973|FG001|Overall Study|high blood pressure|0|||
131855571|NCT03999996|474749828|FG000|Prior to Booster|Adverse Event|2|||
131855572|NCT03999996|474749829|FG001|Prior to Booster|Adverse Event|0|||
131855573|NCT03999996|474749830|FG002|Prior to Booster|Adverse Event|0|||
131855574|NCT03999996|474749831|FG003|Prior to Booster|Adverse Event|0|||
131855575|NCT03999996|474749828|FG000|Prior to Booster|Lost to Follow-up|17|||
131855576|NCT03999996|474749829|FG001|Prior to Booster|Lost to Follow-up|22|||
131855577|NCT03999996|474749830|FG002|Prior to Booster|Lost to Follow-up|0|||
131855578|NCT03999996|474749831|FG003|Prior to Booster|Lost to Follow-up|0|||
131855579|NCT03999996|474749828|FG000|Prior to Booster|Withdrawal of Consent|51|||
131855580|NCT03999996|474749829|FG001|Prior to Booster|Withdrawal of Consent|8|||
131855581|NCT03999996|474749830|FG002|Prior to Booster|Withdrawal of Consent|0|||
131855582|NCT03999996|474749831|FG003|Prior to Booster|Withdrawal of Consent|0|||
131855583|NCT03999996|474749828|FG000|Prior to Booster|Death|0|||
131855584|NCT03999996|474749829|FG001|Prior to Booster|Death|1|||
131855585|NCT03999996|474749830|FG002|Prior to Booster|Death|0|||
131855586|NCT03999996|474749831|FG003|Prior to Booster|Death|0|||
131855587|NCT03999996|474749828|FG000|Prior to Booster|Reason Not Specified|27|||
131855588|NCT03999996|474749829|FG001|Prior to Booster|Reason Not Specified|4|||
131855589|NCT03999996|474749830|FG002|Prior to Booster|Reason Not Specified|0|||
131855590|NCT03999996|474749831|FG003|Prior to Booster|Reason Not Specified|0|||
131855591|NCT03999996|474749828|FG000|Booster Phase|Lost to Follow-up|0|||
131855592|NCT03999996|474749829|FG001|Booster Phase|Lost to Follow-up|0|||
131855593|NCT03999996|474749830|FG002|Booster Phase|Lost to Follow-up|3|||
131855594|NCT03999996|474749831|FG003|Booster Phase|Lost to Follow-up|3|||
131855595|NCT03999996|474749828|FG000|Booster Phase|Withdrawal of Consent|0|||
131855596|NCT03999996|474749829|FG001|Booster Phase|Withdrawal of Consent|0|||
131855597|NCT03999996|474749830|FG002|Booster Phase|Withdrawal of Consent|0|||
131855598|NCT03999996|474749831|FG003|Booster Phase|Withdrawal of Consent|1|||
131855599|NCT03999996|474749828|FG000|Booster Phase|Reason Not Specified|0|||
131855600|NCT03999996|474749829|FG001|Booster Phase|Reason Not Specified|0|||
131855601|NCT03999996|474749830|FG002|Booster Phase|Reason Not Specified|0|||
131855602|NCT03999996|474749831|FG003|Booster Phase|Reason Not Specified|1|||
131855603|NCT00733005|474749834|FG000|Overall Study|Adverse Event|0|||
131855604|NCT00733005|474749835|FG001|Overall Study|Adverse Event|1|||
131855605|NCT00733005|474749834|FG000|Overall Study|Treatment Failure|0|||
131855606|NCT00733005|474749835|FG001|Overall Study|Treatment Failure|1|||
131855607|NCT00733005|474749834|FG000|Overall Study|Withdrawal by Subject|0|||
131855608|NCT00733005|474749835|FG001|Overall Study|Withdrawal by Subject|1|||
131855609|NCT00733005|474749834|FG000|Overall Study|Protocol Violation|2|||
131855610|NCT00733005|474749835|FG001|Overall Study|Protocol Violation|0|||
131855611|NCT00266630|474749836|FG000|Overall Study|Adverse Event|8|||
131855612|NCT00266630|474749837|FG001|Overall Study|Adverse Event|6|||
131855613|NCT00266630|474749836|FG000|Overall Study|Lack of Efficacy|1|||
131855614|NCT00266630|474749837|FG001|Overall Study|Lack of Efficacy|4|||
131855615|NCT00266630|474749836|FG000|Overall Study|Entry Criteria not met|1|||
131855616|NCT00266630|474749837|FG001|Overall Study|Entry Criteria not met|0|||
131855617|NCT00266630|474749836|FG000|Overall Study|Protocol Violation|1|||
131855618|NCT00266630|474749837|FG001|Overall Study|Protocol Violation|3|||
131855619|NCT00266630|474749836|FG000|Overall Study|Physician Decision|1|||
131855620|NCT00266630|474749837|FG001|Overall Study|Physician Decision|2|||
131855621|NCT00266630|474749836|FG000|Overall Study|Withdrawal by Subject|10|||
131855622|NCT00266630|474749837|FG001|Overall Study|Withdrawal by Subject|2|||
131855623|NCT00266630|474749836|FG000|Overall Study|Lost to Follow-up|1|||
131855624|NCT00266630|474749837|FG001|Overall Study|Lost to Follow-up|0|||
131855625|NCT00266630|474749836|FG000|Overall Study|Other|19|||
131855626|NCT00266630|474749837|FG001|Overall Study|Other|11|||
131855627|NCT03410056|474749838|FG000|Overall Study|Decision by Sponsor|0|||
131855628|NCT03410056|474749839|FG001|Overall Study|Decision by Sponsor|0|||
131855629|NCT03410056|474749840|FG002|Overall Study|Decision by Sponsor|3|||
131855630|NCT03410056|474749841|FG003|Overall Study|Decision by Sponsor|0|||
131855631|NCT03410056|474749842|FG004|Overall Study|Decision by Sponsor|0|||
131855632|NCT03410056|474749843|FG005|Overall Study|Decision by Sponsor|0|||
131855633|NCT03410056|474749844|FG006|Overall Study|Decision by Sponsor|0|||
131855634|NCT03410056|474749838|FG000|Overall Study|Withdrawal by Subject|0|||
131855635|NCT03410056|474749839|FG001|Overall Study|Withdrawal by Subject|2|||
131855636|NCT03410056|474749840|FG002|Overall Study|Withdrawal by Subject|5|||
131855637|NCT03410056|474749841|FG003|Overall Study|Withdrawal by Subject|5|||
131855638|NCT03410056|474749842|FG004|Overall Study|Withdrawal by Subject|0|||
131855639|NCT03410056|474749843|FG005|Overall Study|Withdrawal by Subject|0|||
131855640|NCT03410056|474749844|FG006|Overall Study|Withdrawal by Subject|0|||
131855641|NCT03284723|474749845|FG000|Overall Study|Death|0|||
131855642|NCT03284723|474749846|FG001|Overall Study|Death|0|||
131855643|NCT03284723|474749847|FG002|Overall Study|Death|0|||
131855644|NCT03284723|474749848|FG003|Overall Study|Death|1|||
131855645|NCT03284723|474749849|FG004|Overall Study|Death|0|||
131406165|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
131406166|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
131406167|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
131406168|NCT01529515|473111192|FG000|MAINTENANCE PHASE|Other|0|||
131406169|NCT01529515|473111193|FG001|MAINTENANCE PHASE|Other|10|||
131406170|NCT01529515|473111194|FG002|MAINTENANCE PHASE|Other|0|||
131406171|NCT01529515|473111195|FG003|MAINTENANCE PHASE|Other|0|||
131406172|NCT01529515|473111192|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
131406173|NCT01529515|473111193|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
131406174|NCT01529515|473111194|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
131406175|NCT01529515|473111195|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
131406176|NCT01529515|473111192|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
131406177|NCT01529515|473111193|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
131406178|NCT01529515|473111194|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
131406179|NCT01529515|473111195|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
131406180|NCT01529515|473111192|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
131406181|NCT01529515|473111193|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
131406182|NCT01529515|473111194|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
131406183|NCT01529515|473111195|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
131406184|NCT01529515|473111192|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
131406185|NCT01529515|473111193|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
131406186|NCT01529515|473111194|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
131406187|NCT01529515|473111195|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
131406188|NCT01529515|473111192|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
131406189|NCT01529515|473111193|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
131406190|NCT01529515|473111194|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
131406191|NCT01529515|473111195|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
131406192|NCT01529515|473111192|FG000|DOUBLE BLIND PHASE|Other|0|||
131406193|NCT01529515|473111193|FG001|DOUBLE BLIND PHASE|Other|0|||
131406194|NCT01529515|473111194|FG002|DOUBLE BLIND PHASE|Other|9|||
131406195|NCT01529515|473111195|FG003|DOUBLE BLIND PHASE|Other|2|||
131406196|NCT03334851|473111199|FG000|Overall Study|Other|0|||
131406197|NCT03334851|473111200|FG001|Overall Study|Other|0|||
131406198|NCT03334851|473111201|FG002|Overall Study|Other|0|||
131406199|NCT03334851|473111202|FG003|Overall Study|Other|0|||
131406200|NCT03334851|473111203|FG004|Overall Study|Other|0|||
131406201|NCT03334851|473111204|FG005|Overall Study|Other|0|||
131406202|NCT03334851|473111205|FG006|Overall Study|Other|0|||
131406203|NCT03334851|473111206|FG007|Overall Study|Other|1|||
131406204|NCT03334851|473111207|FG008|Overall Study|Other|0|||
131406205|NCT03334851|473111208|FG009|Overall Study|Other|0|||
131406206|NCT03334851|473111209|FG010|Overall Study|Other|0|||
131406207|NCT03334851|473111210|FG011|Overall Study|Other|0|||
131406208|NCT03334851|473111211|FG012|Overall Study|Other|0|||
131406209|NCT03334851|473111199|FG000|Overall Study|Adverse Event|0|||
131406210|NCT03334851|473111200|FG001|Overall Study|Adverse Event|0|||
131406211|NCT03334851|473111201|FG002|Overall Study|Adverse Event|0|||
131406212|NCT03334851|473111202|FG003|Overall Study|Adverse Event|0|||
131406213|NCT03334851|473111203|FG004|Overall Study|Adverse Event|0|||
131406214|NCT03334851|473111204|FG005|Overall Study|Adverse Event|0|||
131406215|NCT03334851|473111205|FG006|Overall Study|Adverse Event|0|||
131406216|NCT03334851|473111206|FG007|Overall Study|Adverse Event|1|||
131406217|NCT03334851|473111207|FG008|Overall Study|Adverse Event|0|||
131406218|NCT03334851|473111208|FG009|Overall Study|Adverse Event|0|||
131406219|NCT03334851|473111209|FG010|Overall Study|Adverse Event|0|||
131406220|NCT03334851|473111210|FG011|Overall Study|Adverse Event|0|||
131406221|NCT03334851|473111211|FG012|Overall Study|Adverse Event|0|||
131406222|NCT03334851|473111199|FG000|Overall Study|Withdrawal by Subject|0|||
131406223|NCT03334851|473111200|FG001|Overall Study|Withdrawal by Subject|0|||
131406224|NCT03334851|473111201|FG002|Overall Study|Withdrawal by Subject|0|||
131406225|NCT03334851|473111202|FG003|Overall Study|Withdrawal by Subject|0|||
131406226|NCT03334851|473111203|FG004|Overall Study|Withdrawal by Subject|0|||
131406227|NCT03334851|473111204|FG005|Overall Study|Withdrawal by Subject|0|||
131406228|NCT03334851|473111205|FG006|Overall Study|Withdrawal by Subject|0|||
131406229|NCT03334851|473111206|FG007|Overall Study|Withdrawal by Subject|0|||
131406230|NCT03334851|473111207|FG008|Overall Study|Withdrawal by Subject|0|||
131406231|NCT03334851|473111208|FG009|Overall Study|Withdrawal by Subject|0|||
131406232|NCT03334851|473111209|FG010|Overall Study|Withdrawal by Subject|1|||
131406233|NCT03334851|473111210|FG011|Overall Study|Withdrawal by Subject|0|||
131406234|NCT03334851|473111211|FG012|Overall Study|Withdrawal by Subject|1|||
131406235|NCT03334851|473111199|FG000|Overall Study|Lost to Follow-up|0|||
131406236|NCT03334851|473111200|FG001|Overall Study|Lost to Follow-up|0|||
131406237|NCT03334851|473111201|FG002|Overall Study|Lost to Follow-up|0|||
131406238|NCT03334851|473111202|FG003|Overall Study|Lost to Follow-up|0|||
131406239|NCT03334851|473111203|FG004|Overall Study|Lost to Follow-up|0|||
131406240|NCT03334851|473111204|FG005|Overall Study|Lost to Follow-up|0|||
131406241|NCT03334851|473111205|FG006|Overall Study|Lost to Follow-up|0|||
131406242|NCT03334851|473111206|FG007|Overall Study|Lost to Follow-up|0|||
131406243|NCT03334851|473111207|FG008|Overall Study|Lost to Follow-up|0|||
131406244|NCT03334851|473111208|FG009|Overall Study|Lost to Follow-up|0|||
131406245|NCT03334851|473111209|FG010|Overall Study|Lost to Follow-up|2|||
131406246|NCT03334851|473111210|FG011|Overall Study|Lost to Follow-up|1|||
131406247|NCT03334851|473111211|FG012|Overall Study|Lost to Follow-up|0|||
131406248|NCT01069861|473111212|FG000|Overall Study|Death|1|||
131406249|NCT01069861|473111212|FG000|Overall Study|Adverse Event|1|||
131406250|NCT01069861|473111212|FG000|Overall Study|Did not meet entrance criteria|1|||
131406251|NCT03555981|473111214|FG000|Overall Study|Lost to Follow-up|0|||
131406252|NCT03555981|473111215|FG001|Overall Study|Lost to Follow-up|2|||
131406253|NCT03272828|473111216|FG000|Overall Study|Lost to Follow-up|7|||
131406254|NCT03272828|473111217|FG001|Overall Study|Lost to Follow-up|7|||
131406255|NCT03272828|473111216|FG000|Overall Study|Withdrawal by Subject|2|||
131406256|NCT03272828|473111217|FG001|Overall Study|Withdrawal by Subject|0|||
131406257|NCT03272828|473111216|FG000|Overall Study|Deceased|1|||
131406258|NCT03272828|473111217|FG001|Overall Study|Deceased|1|||
131406259|NCT03272828|473111216|FG000|Overall Study|Failed implant|1|||
131406260|NCT03272828|473111217|FG001|Overall Study|Failed implant|2|||
131406261|NCT03505788|473111218|FG000|Overall Study|Lost to Follow-up|2|||
131406262|NCT03505788|473111219|FG001|Overall Study|Lost to Follow-up|1|||
131406263|NCT03505788|473111218|FG000|Overall Study|Withdrawal by Subject|1|||
131406264|NCT03505788|473111219|FG001|Overall Study|Withdrawal by Subject|3|||
131406265|NCT03505788|473111218|FG000|Overall Study|Physician Decision|0|||
131406266|NCT03505788|473111219|FG001|Overall Study|Physician Decision|1|||
131406267|NCT03350256|473111220|FG000|Overall Study|Inclusion/exclusion violation|4|||
131406268|NCT03350256|473111220|FG000|Overall Study|Recommended for other therapies|2|||
131406269|NCT03350256|473111220|FG000|Overall Study|Protocol Violation|3|||
131406270|NCT03350256|473111220|FG000|Overall Study|Non compliance|2|||
131406271|NCT03350256|473111220|FG000|Overall Study|Denial by insurance|1|||
131406272|NCT03350256|473111220|FG000|Overall Study|Adverse Event|2|||
131406273|NCT03350256|473111220|FG000|Overall Study|Trial failure|12|||
131406274|NCT03350256|473111220|FG000|Overall Study|Did not proceed to permanent implant|3|||
131406275|NCT03350256|473111220|FG000|Overall Study|Withdrawal by Subject|3|||
131406276|NCT03350256|473111220|FG000|Overall Study|Subject moving out of state|1|||
131406277|NCT03350256|473111220|FG000|Overall Study|Lost to Follow-up|1|||
131406278|NCT03350256|473111220|FG000|Overall Study|Lack of Efficacy|2|||
131406279|NCT00666588|473111221|FG000|Overall Study|ineligible|2|||
131406280|NCT00666588|473111222|FG001|Overall Study|ineligible|0|||
131406281|NCT00666588|473111223|FG002|Overall Study|ineligible|0|||
131406282|NCT00666588|473111224|FG003|Overall Study|ineligible|2|||
131406283|NCT00666588|473111221|FG000|Overall Study|inevaluable|2|||
131406284|NCT00666588|473111222|FG001|Overall Study|inevaluable|0|||
131406285|NCT00666588|473111223|FG002|Overall Study|inevaluable|0|||
131406286|NCT00666588|473111224|FG003|Overall Study|inevaluable|0|||
131406287|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
131406288|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
131406289|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
131855646|NCT03284723|474749850|FG005|Overall Study|Death|0|||
131453811|NCT05307692|473290043|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
131453812|NCT05307692|473290040|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
131453813|NCT05307692|473290041|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
131453814|NCT05307692|473290042|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
131453815|NCT05307692|473290043|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
131453816|NCT05307692|473290040|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
131453817|NCT05307692|473290041|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
131453818|NCT05307692|473290042|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
131453819|NCT05307692|473290043|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
131453820|NCT05307692|473290040|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
131453821|NCT05307692|473290041|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
131406290|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
131406291|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
131406292|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
131406293|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
131406294|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
131406295|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
131406296|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
131406297|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Other|1|||
131406298|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Other|1|||
131406299|NCT02075047|473111225|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
131406300|NCT02075047|473111226|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
131406301|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
131406302|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
131406303|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
131406304|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
131406305|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
131406306|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
131406307|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
131406308|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
131406309|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
131406310|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
131406311|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Other|1|||
131406312|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Other|2|||
131406313|NCT02075047|473111225|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
131406314|NCT02075047|473111226|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
131406315|NCT01007123|473111227|FG000|Overall Study|Adverse Event|3|||
131406316|NCT01007123|473111228|FG001|Overall Study|Adverse Event|4|||
131453822|NCT05307692|473290042|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
131453823|NCT05307692|473290043|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
131453824|NCT05307692|473290040|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
131855647|NCT03284723|474749851|FG006|Overall Study|Death|1|||
131855648|NCT03284723|474749852|FG007|Overall Study|Death|0|||
131855649|NCT03284723|474749853|FG008|Overall Study|Death|0|||
131855650|NCT03284723|474749854|FG009|Overall Study|Death|2|||
131855651|NCT03284723|474749855|FG010|Overall Study|Death|1|||
131855652|NCT03284723|474749856|FG011|Overall Study|Death|0|||
131855653|NCT03284723|474749845|FG000|Overall Study|Lost to Follow-up|0|||
131855654|NCT03284723|474749846|FG001|Overall Study|Lost to Follow-up|0|||
131855655|NCT03284723|474749847|FG002|Overall Study|Lost to Follow-up|0|||
131855656|NCT03284723|474749848|FG003|Overall Study|Lost to Follow-up|0|||
131855657|NCT03284723|474749849|FG004|Overall Study|Lost to Follow-up|0|||
131855658|NCT03284723|474749850|FG005|Overall Study|Lost to Follow-up|2|||
131855659|NCT03284723|474749851|FG006|Overall Study|Lost to Follow-up|1|||
131855660|NCT03284723|474749852|FG007|Overall Study|Lost to Follow-up|0|||
131855661|NCT03284723|474749853|FG008|Overall Study|Lost to Follow-up|0|||
131855662|NCT03284723|474749854|FG009|Overall Study|Lost to Follow-up|2|||
131855663|NCT03284723|474749855|FG010|Overall Study|Lost to Follow-up|0|||
131855664|NCT03284723|474749856|FG011|Overall Study|Lost to Follow-up|0|||
131855665|NCT03284723|474749845|FG000|Overall Study|Study Terminated By Sponsor|0|||
131855666|NCT03284723|474749846|FG001|Overall Study|Study Terminated By Sponsor|0|||
131855667|NCT03284723|474749847|FG002|Overall Study|Study Terminated By Sponsor|0|||
131855668|NCT03284723|474749848|FG003|Overall Study|Study Terminated By Sponsor|0|||
131855669|NCT03284723|474749849|FG004|Overall Study|Study Terminated By Sponsor|1|||
131855670|NCT03284723|474749850|FG005|Overall Study|Study Terminated By Sponsor|0|||
131855671|NCT03284723|474749851|FG006|Overall Study|Study Terminated By Sponsor|0|||
131406317|NCT01007123|473111229|FG002|Overall Study|Adverse Event|7|||
131406318|NCT01007123|473111230|FG003|Overall Study|Adverse Event|1|||
131406319|NCT01007123|473111227|FG000|Overall Study|Lack of Efficacy|1|||
131406320|NCT01007123|473111228|FG001|Overall Study|Lack of Efficacy|0|||
131855672|NCT03284723|474749852|FG007|Overall Study|Study Terminated By Sponsor|0|||
131855673|NCT03284723|474749853|FG008|Overall Study|Study Terminated By Sponsor|1|||
131855674|NCT03284723|474749854|FG009|Overall Study|Study Terminated By Sponsor|1|||
131855675|NCT03284723|474749855|FG010|Overall Study|Study Terminated By Sponsor|1|||
131855676|NCT03284723|474749856|FG011|Overall Study|Study Terminated By Sponsor|1|||
131855677|NCT03284723|474749845|FG000|Overall Study|Withdrawal by Subject|0|||
131855678|NCT03284723|474749846|FG001|Overall Study|Withdrawal by Subject|0|||
131855679|NCT03284723|474749847|FG002|Overall Study|Withdrawal by Subject|0|||
131855680|NCT03284723|474749848|FG003|Overall Study|Withdrawal by Subject|0|||
131855681|NCT03284723|474749849|FG004|Overall Study|Withdrawal by Subject|5|||
131855682|NCT03284723|474749850|FG005|Overall Study|Withdrawal by Subject|3|||
131855683|NCT03284723|474749851|FG006|Overall Study|Withdrawal by Subject|1|||
131855684|NCT03284723|474749852|FG007|Overall Study|Withdrawal by Subject|0|||
131855685|NCT03284723|474749853|FG008|Overall Study|Withdrawal by Subject|6|||
131855686|NCT03284723|474749854|FG009|Overall Study|Withdrawal by Subject|0|||
131855687|NCT03284723|474749855|FG010|Overall Study|Withdrawal by Subject|3|||
131855688|NCT03284723|474749856|FG011|Overall Study|Withdrawal by Subject|1|||
131855689|NCT03284723|474749845|FG000|Overall Study|Other|1|||
131855690|NCT03284723|474749846|FG001|Overall Study|Other|0|||
131855691|NCT03284723|474749847|FG002|Overall Study|Other|1|||
131855692|NCT03284723|474749848|FG003|Overall Study|Other|0|||
131855693|NCT03284723|474749849|FG004|Overall Study|Other|1|||
131855694|NCT03284723|474749850|FG005|Overall Study|Other|0|||
131855695|NCT03284723|474749851|FG006|Overall Study|Other|0|||
131855696|NCT03284723|474749852|FG007|Overall Study|Other|0|||
131855697|NCT03284723|474749853|FG008|Overall Study|Other|0|||
131855698|NCT03284723|474749854|FG009|Overall Study|Other|0|||
131855699|NCT03284723|474749855|FG010|Overall Study|Other|1|||
131855700|NCT03284723|474749856|FG011|Overall Study|Other|0|||
131855701|NCT03284723|474749845|FG000|Overall Study|Adverse Event|0|||
131855702|NCT03284723|474749846|FG001|Overall Study|Adverse Event|0|||
131855703|NCT03284723|474749847|FG002|Overall Study|Adverse Event|0|||
131855704|NCT03284723|474749848|FG003|Overall Study|Adverse Event|0|||
131855705|NCT03284723|474749849|FG004|Overall Study|Adverse Event|0|||
131855706|NCT03284723|474749850|FG005|Overall Study|Adverse Event|0|||
131855707|NCT03284723|474749851|FG006|Overall Study|Adverse Event|0|||
131855708|NCT03284723|474749852|FG007|Overall Study|Adverse Event|0|||
131855709|NCT03284723|474749853|FG008|Overall Study|Adverse Event|1|||
131855710|NCT03284723|474749854|FG009|Overall Study|Adverse Event|0|||
131855711|NCT03284723|474749855|FG010|Overall Study|Adverse Event|0|||
131855712|NCT03284723|474749856|FG011|Overall Study|Adverse Event|0|||
131855713|NCT00615199|474749857|FG000|Overall Study|Adverse Event|3|||
131855714|NCT00615199|474749858|FG001|Overall Study|Adverse Event|1|||
131855715|NCT00615199|474749859|FG002|Overall Study|Adverse Event|1|||
131855716|NCT00615199|474749860|FG003|Overall Study|Adverse Event|0|||
131855717|NCT00615199|474749857|FG000|Overall Study|Lack of Efficacy|2|||
131855718|NCT00615199|474749858|FG001|Overall Study|Lack of Efficacy|0|||
131855719|NCT00615199|474749859|FG002|Overall Study|Lack of Efficacy|0|||
131855720|NCT00615199|474749860|FG003|Overall Study|Lack of Efficacy|1|||
131406321|NCT01007123|473111229|FG002|Overall Study|Lack of Efficacy|1|||
131855721|NCT00615199|474749857|FG000|Overall Study|Lost to Follow-up|1|||
131855722|NCT00615199|474749858|FG001|Overall Study|Lost to Follow-up|0|||
131855723|NCT00615199|474749859|FG002|Overall Study|Lost to Follow-up|0|||
131855724|NCT00615199|474749860|FG003|Overall Study|Lost to Follow-up|0|||
131855725|NCT00615199|474749857|FG000|Overall Study|Other|0|||
131855726|NCT00615199|474749858|FG001|Overall Study|Other|0|||
131855727|NCT00615199|474749859|FG002|Overall Study|Other|0|||
131855728|NCT00615199|474749860|FG003|Overall Study|Other|1|||
131855729|NCT00615199|474749857|FG000|Overall Study|Withdrawal by Subject|2|||
131855730|NCT00615199|474749858|FG001|Overall Study|Withdrawal by Subject|1|||
131855731|NCT00615199|474749859|FG002|Overall Study|Withdrawal by Subject|0|||
131855732|NCT00615199|474749860|FG003|Overall Study|Withdrawal by Subject|0|||
131855733|NCT01068262|474749874|FG000|Overall Study|Adverse Event|2|||
131855734|NCT01068262|474749875|FG001|Overall Study|Adverse Event|0|||
131855735|NCT01068262|474749876|FG002|Overall Study|Adverse Event|1|||
131855736|NCT01068262|474749877|FG003|Overall Study|Adverse Event|0|||
131855737|NCT01068262|474749874|FG000|Overall Study|Protocol Violation|1|||
131855738|NCT01068262|474749875|FG001|Overall Study|Protocol Violation|0|||
131855739|NCT01068262|474749876|FG002|Overall Study|Protocol Violation|0|||
131855740|NCT01068262|474749877|FG003|Overall Study|Protocol Violation|0|||
131855741|NCT01068262|474749874|FG000|Overall Study|Withdrawal by Subject|0|||
131855742|NCT01068262|474749875|FG001|Overall Study|Withdrawal by Subject|1|||
131855743|NCT01068262|474749876|FG002|Overall Study|Withdrawal by Subject|0|||
131855744|NCT01068262|474749877|FG003|Overall Study|Withdrawal by Subject|0|||
131406322|NCT01007123|473111230|FG003|Overall Study|Lack of Efficacy|4|||
131855745|NCT00444587|474749880|FG000|Overall Study|Death|2|||
131855746|NCT00444587|474749881|FG001|Overall Study|Death|1|||
131855747|NCT00444587|474749880|FG000|Overall Study|Progression of the disease|73|||
131855748|NCT00444587|474749881|FG001|Overall Study|Progression of the disease|8|||
131855749|NCT00444587|474749880|FG000|Overall Study|Refused treatment/did not cooperate|4|||
131855750|NCT00444587|474749881|FG001|Overall Study|Refused treatment/did not cooperate|1|||
131855751|NCT00444587|474749880|FG000|Overall Study|Investigator decision|3|||
131855752|NCT00444587|474749881|FG001|Overall Study|Investigator decision|0|||
131855753|NCT00444587|474749880|FG000|Overall Study|Protocol Violation|1|||
131855754|NCT00444587|474749881|FG001|Overall Study|Protocol Violation|0|||
131855755|NCT00444587|474749880|FG000|Overall Study|Missing|0|||
131855756|NCT00444587|474749881|FG001|Overall Study|Missing|5|||
131855757|NCT02301390|474749890|FG000|Overall Study|Withdrawal by Subject|3|||
131855758|NCT02301390|474749891|FG001|Overall Study|Withdrawal by Subject|5|||
131855759|NCT02301390|474749890|FG000|Overall Study|Protocol Violation|1|||
131855760|NCT02301390|474749891|FG001|Overall Study|Protocol Violation|0|||
131855761|NCT02301390|474749890|FG000|Overall Study|Physician Decision|1|||
131855762|NCT02301390|474749891|FG001|Overall Study|Physician Decision|0|||
131855763|NCT02301390|474749890|FG000|Overall Study|Lost to Follow-up|0|||
131855764|NCT02301390|474749891|FG001|Overall Study|Lost to Follow-up|1|||
131855765|NCT02301390|474749890|FG000|Overall Study|Death|2|||
131855766|NCT02301390|474749891|FG001|Overall Study|Death|2|||
131855767|NCT02301390|474749890|FG000|Overall Study|Procedure not completed|0|||
131855768|NCT02301390|474749891|FG001|Overall Study|Procedure not completed|4|||
131855769|NCT02301390|474749890|FG000|Overall Study|Missed multiple visits|1|||
131855770|NCT02301390|474749891|FG001|Overall Study|Missed multiple visits|1|||
131855771|NCT02301390|474749890|FG000|Overall Study|study terminated|2|||
131855772|NCT02301390|474749891|FG001|Overall Study|study terminated|0|||
131855773|NCT01027702|474749892|FG000|Overall Study|Received subsequent therapy|1|||
131855774|NCT01027702|474749893|FG001|Overall Study|Received subsequent therapy|2|||
131855775|NCT01027702|474749894|FG002|Overall Study|Received subsequent therapy|0|||
131855776|NCT01027702|474749895|FG003|Overall Study|Received subsequent therapy|4|||
131855777|NCT01027702|474749896|FG004|Overall Study|Received subsequent therapy|1|||
131855778|NCT01027702|474749897|FG005|Overall Study|Received subsequent therapy|0|||
131855779|NCT01027702|474749898|FG006|Overall Study|Received subsequent therapy|1|||
131855780|NCT01027702|474749892|FG000|Overall Study|Death|0|||
131855781|NCT01027702|474749893|FG001|Overall Study|Death|0|||
131855782|NCT01027702|474749894|FG002|Overall Study|Death|1|||
131855783|NCT01027702|474749895|FG003|Overall Study|Death|0|||
131855784|NCT01027702|474749896|FG004|Overall Study|Death|0|||
131855785|NCT01027702|474749897|FG005|Overall Study|Death|0|||
131855786|NCT01027702|474749898|FG006|Overall Study|Death|0|||
131855787|NCT00661193|474749899|FG000|Overall Study|Adverse Event|2|||
131855788|NCT00661193|474749900|FG001|Overall Study|Adverse Event|1|||
131855789|NCT00661193|474749899|FG000|Overall Study|Withdrawal by Subject|3|||
131855790|NCT00661193|474749900|FG001|Overall Study|Withdrawal by Subject|1|||
131855791|NCT00661193|474749899|FG000|Overall Study|Progression|27|||
131855792|NCT00661193|474749900|FG001|Overall Study|Progression|24|||
131855793|NCT00661193|474749899|FG000|Overall Study|Not protocol specified|1|||
131855794|NCT00661193|474749900|FG001|Overall Study|Not protocol specified|0|||
131855795|NCT03685344|474749901|FG000|Overall Study|Withdrawal by Subject|1|||
131855796|NCT03685344|474749902|FG001|Overall Study|Withdrawal by Subject|1|||
131855797|NCT03685344|474749903|FG002|Overall Study|Withdrawal by Subject|2|||
131855798|NCT03685344|474749904|FG003|Overall Study|Withdrawal by Subject|0|||
131855799|NCT03685344|474749901|FG000|Overall Study|Physician Decision|1|||
131855800|NCT03685344|474749902|FG001|Overall Study|Physician Decision|1|||
131855801|NCT03685344|474749903|FG002|Overall Study|Physician Decision|5|||
131855802|NCT03685344|474749904|FG003|Overall Study|Physician Decision|0|||
131855803|NCT03685344|474749901|FG000|Overall Study|Death|1|||
131855804|NCT03685344|474749902|FG001|Overall Study|Death|1|||
131855805|NCT03685344|474749903|FG002|Overall Study|Death|0|||
131855806|NCT03685344|474749904|FG003|Overall Study|Death|0|||
131855807|NCT02932462|474749905|FG000|Overall Study|Adverse Event|1|||
131855808|NCT02932462|474749906|FG001|Overall Study|Adverse Event|2|||
131855809|NCT02932462|474749905|FG000|Overall Study|Lost to Follow-up|4|||
131855810|NCT02932462|474749906|FG001|Overall Study|Lost to Follow-up|1|||
131855811|NCT02932462|474749905|FG000|Overall Study|Protocol Violation|0|||
131855812|NCT02932462|474749906|FG001|Overall Study|Protocol Violation|5|||
131855813|NCT02932462|474749905|FG000|Overall Study|Withdrawal by Subject|1|||
131855814|NCT02932462|474749906|FG001|Overall Study|Withdrawal by Subject|4|||
131855815|NCT02932462|474749905|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131855816|NCT02932462|474749906|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131855817|NCT02932462|474749905|FG000|Overall Study|Progressive Disease|1|||
131855818|NCT02932462|474749906|FG001|Overall Study|Progressive Disease|0|||
131855819|NCT00560391|474749909|FG000|Overall Study|Still on treatment|0|||
131855820|NCT00560391|474749910|FG001|Overall Study|Still on treatment|0|||
131855821|NCT00560391|474749911|FG002|Overall Study|Still on treatment|0|||
131855822|NCT00560391|474749912|FG003|Overall Study|Still on treatment|1|||
131855823|NCT00560391|474749913|FG004|Overall Study|Still on treatment|2|||
131855824|NCT02071225|474749921|FG000|Overall Study|Withdrawal of Consent|2|||
131855825|NCT02071225|474749921|FG000|Overall Study|Protocol Deviation|1|||
131855826|NCT02071225|474749921|FG000|Overall Study|Lost to Follow-up|2|||
131855827|NCT02071225|474749921|FG000|Overall Study|Death|25|||
131855828|NCT01895777|474749922|FG000|Overall Study|Adverse Event|1|||
131855829|NCT01895777|474749923|FG001|Overall Study|Adverse Event|2|||
131855830|NCT01895777|474749922|FG000|Overall Study|Lost to Follow-up|2|||
131855831|NCT01895777|474749923|FG001|Overall Study|Lost to Follow-up|0|||
131855832|NCT01895777|474749922|FG000|Overall Study|Not treated|1|||
131855833|NCT01895777|474749923|FG001|Overall Study|Not treated|0|||
131855834|NCT01895777|474749922|FG000|Overall Study|Other reasons|3|||
131855835|NCT01895777|474749923|FG001|Overall Study|Other reasons|2|||
131855836|NCT01895777|474749922|FG000|Overall Study|Non-compliance with the CTP|2|||
131855837|NCT01895777|474749923|FG001|Overall Study|Non-compliance with the CTP|1|||
131855838|NCT01965860|474749924|FG000|Overall Study|Pregnancy|1|||
131855839|NCT01965860|474749925|FG001|Overall Study|Pregnancy|0|||
131855840|NCT01965860|474749926|FG002|Overall Study|Pregnancy|1|||
131855841|NCT01965860|474749924|FG000|Overall Study|Logistics|1|||
131855842|NCT01965860|474749925|FG001|Overall Study|Logistics|0|||
131855843|NCT01965860|474749926|FG002|Overall Study|Logistics|0|||
131855844|NCT02064296|474749927|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
131855845|NCT02064296|474749928|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
131406323|NCT01007123|473111227|FG000|Overall Study|Protocol Violation|1|||
131406324|NCT01007123|473111228|FG001|Overall Study|Protocol Violation|1|||
131406325|NCT01007123|473111229|FG002|Overall Study|Protocol Violation|2|||
131406326|NCT01007123|473111230|FG003|Overall Study|Protocol Violation|1|||
131406327|NCT01007123|473111227|FG000|Overall Study|Withdrawal by Subject|1|||
131406328|NCT01007123|473111228|FG001|Overall Study|Withdrawal by Subject|0|||
131406329|NCT01007123|473111229|FG002|Overall Study|Withdrawal by Subject|1|||
131406330|NCT01007123|473111230|FG003|Overall Study|Withdrawal by Subject|0|||
131406331|NCT01007123|473111227|FG000|Overall Study|Lost to Follow-up|0|||
131406332|NCT01007123|473111228|FG001|Overall Study|Lost to Follow-up|1|||
131406333|NCT01007123|473111229|FG002|Overall Study|Lost to Follow-up|0|||
131406334|NCT01007123|473111230|FG003|Overall Study|Lost to Follow-up|0|||
131406335|NCT02324205|473111233|FG000|Overall Study|Withdrawal by Subject|37|||
131406336|NCT01774097|473111236|FG000|Overall Study|Withdrawal by Subject|1|||
131406337|NCT01774097|473111237|FG001|Overall Study|Withdrawal by Subject|1|||
131406338|NCT01774097|473111236|FG000|Overall Study|Adverse Event|1|||
131406339|NCT01774097|473111237|FG001|Overall Study|Adverse Event|1|||
131406340|NCT00613925|473111238|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
131406341|NCT00613925|473111239|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
131406342|NCT01920568|473111247|FG000|Overall Study|Adverse Event|27|||
131406343|NCT01920568|473111248|FG001|Overall Study|Adverse Event|8|||
131406344|NCT01920568|473111247|FG000|Overall Study|Protocol Violation|5|||
131406345|NCT01920568|473111248|FG001|Overall Study|Protocol Violation|3|||
131406346|NCT01920568|473111247|FG000|Overall Study|Lost to Follow-up|2|||
131406347|NCT01920568|473111248|FG001|Overall Study|Lost to Follow-up|2|||
131406348|NCT01920568|473111247|FG000|Overall Study|Physician Decision|13|||
131406349|NCT01920568|473111248|FG001|Overall Study|Physician Decision|4|||
131406350|NCT01920568|473111247|FG000|Overall Study|Withdrawal by Subject|79|||
131406351|NCT01920568|473111248|FG001|Overall Study|Withdrawal by Subject|55|||
131406352|NCT01920568|473111247|FG000|Overall Study|Death due to disease progression|25|||
131406353|NCT01920568|473111248|FG001|Overall Study|Death due to disease progression|12|||
131406354|NCT03664674|473111251|FG000|Overall Study|Adverse Event|1|||
131406355|NCT03664674|473111252|FG001|Overall Study|Adverse Event|1|||
131406356|NCT03664674|473111251|FG000|Overall Study|Physician Decision|0|||
131406357|NCT03664674|473111252|FG001|Overall Study|Physician Decision|1|||
131406358|NCT03664674|473111251|FG000|Overall Study|Withdrawal by Subject|2|||
131406359|NCT03664674|473111252|FG001|Overall Study|Withdrawal by Subject|0|||
131406360|NCT02174523|473111253|FG000|Overall Study|Withdrawal by Subject|1|||
131406361|NCT02174523|473111254|FG001|Overall Study|Withdrawal by Subject|0|||
131406362|NCT00794365|473111255|FG000|Overall Study|Lost to Follow-up|38|||
131406363|NCT00794365|473111255|FG000|Overall Study|Other|17|||
131406364|NCT00794365|473111255|FG000|Overall Study|Poor Compliance|11|||
131406365|NCT00794365|473111255|FG000|Overall Study|Adverse Event|10|||
131406366|NCT00794365|473111255|FG000|Overall Study|Lack of Efficacy|3|||
131406367|NCT00856206|473111256|FG000|Overall Study|Protocol Violation|6|||
131406368|NCT00856206|473111257|FG001|Overall Study|Protocol Violation|18|||
131406369|NCT00856206|473111256|FG000|Overall Study|Adverse Event|10|||
131406370|NCT00856206|473111257|FG001|Overall Study|Adverse Event|46|||
131406371|NCT00856206|473111256|FG000|Overall Study|Lack of Efficacy|1|||
131406372|NCT00856206|473111257|FG001|Overall Study|Lack of Efficacy|2|||
131406373|NCT00856206|473111256|FG000|Overall Study|Withdrawal by Subject|15|||
131406374|NCT00856206|473111257|FG001|Overall Study|Withdrawal by Subject|36|||
131406375|NCT00856206|473111256|FG000|Overall Study|Lost to Follow-up|13|||
131406376|NCT00856206|473111257|FG001|Overall Study|Lost to Follow-up|39|||
131406377|NCT00856206|473111256|FG000|Overall Study|Death|2|||
131406378|NCT00856206|473111257|FG001|Overall Study|Death|2|||
131406379|NCT00856206|473111256|FG000|Overall Study|Decision by the Sponsor|4|||
131406380|NCT00856206|473111257|FG001|Overall Study|Decision by the Sponsor|8|||
131406381|NCT00856206|473111256|FG000|Overall Study|Other than specified above|3|||
131406382|NCT00856206|473111257|FG001|Overall Study|Other than specified above|10|||
131406383|NCT02780856|473111258|FG000|Overall Study|Lost to Follow-up|1|||
131406384|NCT00230282|473111259|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
131406385|NCT00230282|473111259|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
131855846|NCT02064296|474749929|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
131855847|NCT02064296|474749927|FG000|Intervention|Withdrawal by Subject|0|||
131855848|NCT02064296|474749928|FG001|Intervention|Withdrawal by Subject|1|||
131855849|NCT02064296|474749929|FG002|Intervention|Withdrawal by Subject|2|||
131855850|NCT03735121|474749934|FG000|Overall Study|Death|3|||
131855851|NCT03735121|474749935|FG001|Overall Study|Death|6|||
131855852|NCT03735121|474749936|FG002|Overall Study|Death|8|||
131855853|NCT03735121|474749937|FG003|Overall Study|Death|37|||
131855854|NCT03735121|474749938|FG004|Overall Study|Death|86|||
131855855|NCT03735121|474749934|FG000|Overall Study|Withdrawal by Subject|1|||
131855856|NCT03735121|474749935|FG001|Overall Study|Withdrawal by Subject|1|||
131855857|NCT03735121|474749936|FG002|Overall Study|Withdrawal by Subject|3|||
131855858|NCT03735121|474749937|FG003|Overall Study|Withdrawal by Subject|4|||
131855859|NCT03735121|474749938|FG004|Overall Study|Withdrawal by Subject|2|||
131855860|NCT03735121|474749934|FG000|Overall Study|Progressive Disease|0|||
131855861|NCT03735121|474749935|FG001|Overall Study|Progressive Disease|0|||
131855862|NCT03735121|474749936|FG002|Overall Study|Progressive Disease|1|||
131855863|NCT03735121|474749937|FG003|Overall Study|Progressive Disease|0|||
131855864|NCT03735121|474749938|FG004|Overall Study|Progressive Disease|0|||
131855865|NCT03735121|474749934|FG000|Overall Study|Lost to Follow-up|0|||
131855866|NCT03735121|474749935|FG001|Overall Study|Lost to Follow-up|0|||
131855867|NCT03735121|474749936|FG002|Overall Study|Lost to Follow-up|0|||
131855868|NCT03735121|474749937|FG003|Overall Study|Lost to Follow-up|0|||
131855869|NCT03735121|474749938|FG004|Overall Study|Lost to Follow-up|1|||
131855870|NCT03735121|474749934|FG000|Overall Study|Ongoing|3|||
131855871|NCT03735121|474749935|FG001|Overall Study|Ongoing|3|||
131855872|NCT03735121|474749936|FG002|Overall Study|Ongoing|26|||
131855873|NCT03735121|474749937|FG003|Overall Study|Ongoing|83|||
131855874|NCT03735121|474749938|FG004|Overall Study|Ongoing|158|||
131855875|NCT00344448|474749942|FG000|Screening|Withdrawal by Subject|0|||
131855876|NCT00344448|474749943|FG001|Screening|Withdrawal by Subject|1|||
131855877|NCT00344448|474749942|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
131855878|NCT00344448|474749943|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
131855879|NCT00344448|474749942|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
131855880|NCT00344448|474749943|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
131855881|NCT00344448|474749942|FG000|Open Label|Withdrawal by Subject|1|||
131855882|NCT00344448|474749943|FG001|Open Label|Withdrawal by Subject|1|||
131855883|NCT00344448|474749942|FG000|Open Label|Study terminated|1|||
131855884|NCT00344448|474749943|FG001|Open Label|Study terminated|0|||
131855885|NCT02565511|474749950|FG000|Overall Study|Study terminated by Sponsor|35|||
131855886|NCT02565511|474749951|FG001|Overall Study|Study terminated by Sponsor|22|||
131855887|NCT02565511|474749952|FG002|Overall Study|Study terminated by Sponsor|235|||
131855888|NCT02565511|474749953|FG003|Overall Study|Study terminated by Sponsor|156|||
131855889|NCT02565511|474749950|FG000|Overall Study|Withdrawal by Subject|3|||
131855890|NCT02565511|474749951|FG001|Overall Study|Withdrawal by Subject|0|||
131855891|NCT02565511|474749952|FG002|Overall Study|Withdrawal by Subject|12|||
131855892|NCT02565511|474749953|FG003|Overall Study|Withdrawal by Subject|5|||
131855893|NCT02565511|474749950|FG000|Overall Study|Adverse Event|0|||
131855894|NCT02565511|474749951|FG001|Overall Study|Adverse Event|0|||
131406386|NCT00230282|473111259|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
131406387|NCT00230282|473111259|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
131406388|NCT03372460|473111260|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
131406389|NCT03372460|473111261|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
131406390|NCT01170065|473111266|FG000|Overall Study|Adverse Event|17|||
131855895|NCT02565511|474749952|FG002|Overall Study|Adverse Event|1|||
131855896|NCT02565511|474749953|FG003|Overall Study|Adverse Event|1|||
131855897|NCT02565511|474749950|FG000|Overall Study|Lost to Follow-up|4|||
131855898|NCT02565511|474749951|FG001|Overall Study|Lost to Follow-up|1|||
131855899|NCT02565511|474749952|FG002|Overall Study|Lost to Follow-up|0|||
131855900|NCT02565511|474749953|FG003|Overall Study|Lost to Follow-up|1|||
131855901|NCT02565511|474749950|FG000|Overall Study|Physician Decision|0|||
131855902|NCT02565511|474749951|FG001|Overall Study|Physician Decision|0|||
131855903|NCT02565511|474749952|FG002|Overall Study|Physician Decision|0|||
131855904|NCT02565511|474749953|FG003|Overall Study|Physician Decision|1|||
131406391|NCT01170065|473111267|FG001|Overall Study|Adverse Event|50|||
131855905|NCT02565511|474749950|FG000|Overall Study|Protocol deviation|0|||
131855906|NCT02565511|474749951|FG001|Overall Study|Protocol deviation|0|||
131855907|NCT02565511|474749952|FG002|Overall Study|Protocol deviation|3|||
131855908|NCT02565511|474749953|FG003|Overall Study|Protocol deviation|0|||
131855909|NCT03910673|474749958|FG000|Overall Study|Adverse Event|0|||
131855910|NCT03910673|474749959|FG001|Overall Study|Adverse Event|0|||
131855911|NCT03910673|474749960|FG002|Overall Study|Adverse Event|0|||
131855912|NCT03910673|474749961|FG003|Overall Study|Adverse Event|2|||
131855913|NCT03910673|474749962|FG004|Overall Study|Adverse Event|0|||
131855914|NCT03172494|474749963|FG000|Overall Study|Adverse Event|5|||
131855915|NCT03172494|474749964|FG001|Overall Study|Adverse Event|1|||
131855916|NCT03172494|474749965|FG002|Overall Study|Adverse Event|15|||
131855917|NCT03172494|474749963|FG000|Overall Study|Protocol Violation|3|||
131855918|NCT03172494|474749964|FG001|Overall Study|Protocol Violation|2|||
131855919|NCT03172494|474749965|FG002|Overall Study|Protocol Violation|1|||
131855920|NCT03172494|474749963|FG000|Overall Study|Lack of Efficacy|0|||
131855921|NCT03172494|474749964|FG001|Overall Study|Lack of Efficacy|0|||
131855922|NCT03172494|474749965|FG002|Overall Study|Lack of Efficacy|4|||
131855923|NCT03172494|474749963|FG000|Overall Study|Pregnancy|0|||
131855924|NCT03172494|474749964|FG001|Overall Study|Pregnancy|1|||
131406392|NCT01170065|473111268|FG002|Overall Study|Adverse Event|10|||
131406393|NCT01170065|473111266|FG000|Overall Study|Lost to Follow-up|1|||
131406394|NCT01170065|473111267|FG001|Overall Study|Lost to Follow-up|4|||
131406395|NCT01170065|473111268|FG002|Overall Study|Lost to Follow-up|1|||
131406396|NCT01170065|473111266|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
131406397|NCT01170065|473111267|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
131406398|NCT01170065|473111268|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
131406399|NCT01170065|473111266|FG000|Overall Study|Reason other than specified|3|||
131406400|NCT01170065|473111267|FG001|Overall Study|Reason other than specified|8|||
131406401|NCT01170065|473111268|FG002|Overall Study|Reason other than specified|3|||
131406402|NCT01170065|473111266|FG000|Overall Study|Ongoing after planned observation time|5|||
131406403|NCT01170065|473111267|FG001|Overall Study|Ongoing after planned observation time|26|||
131406404|NCT01170065|473111268|FG002|Overall Study|Ongoing after planned observation time|10|||
131406405|NCT02752958|473111271|FG000|Overall Study|Adverse Event|3|||
131406406|NCT02752958|473111271|FG000|Overall Study|Lost to Follow-up|1|||
131406407|NCT02752958|473111271|FG000|Overall Study|Protocol Violation|1|||
131406408|NCT02752958|473111271|FG000|Overall Study|Withdrawal by Subject|2|||
131406409|NCT02752958|473111271|FG000|Overall Study|Other (Reason not specified)|2|||
131406410|NCT03746600|473111272|FG000|Overall Study|Withdrawal by Subject|3|||
131406411|NCT03746600|473111273|FG001|Overall Study|Withdrawal by Subject|3|||
131406412|NCT03746600|473111272|FG000|Overall Study|dismissed from study|1|||
131406413|NCT03746600|473111273|FG001|Overall Study|dismissed from study|0|||
131406414|NCT03746600|473111272|FG000|Overall Study|Lost to Follow-up|1|||
131406415|NCT03746600|473111273|FG001|Overall Study|Lost to Follow-up|0|||
131406416|NCT00717522|473111274|FG000|Overall Study|Disease Progression|5|||
131406417|NCT00717522|473111274|FG000|Overall Study|Adverse Event|1|||
131406418|NCT00717522|473111274|FG000|Overall Study|Death|1|||
131406419|NCT02182440|473111275|FG000|Overall Study|Adverse Event|0|||
131406420|NCT02182440|473111276|FG001|Overall Study|Adverse Event|1|||
131406421|NCT02182440|473111277|FG002|Overall Study|Adverse Event|0|||
131406422|NCT02182440|473111278|FG003|Overall Study|Adverse Event|0|||
131406423|NCT02182440|473111275|FG000|Overall Study|Death|31|||
131406424|NCT02182440|473111276|FG001|Overall Study|Death|8|||
131406425|NCT02182440|473111277|FG002|Overall Study|Death|5|||
131406426|NCT02182440|473111278|FG003|Overall Study|Death|16|||
131406427|NCT02182440|473111275|FG000|Overall Study|Protocol Violation|0|||
131406428|NCT02182440|473111276|FG001|Overall Study|Protocol Violation|1|||
131406429|NCT02182440|473111277|FG002|Overall Study|Protocol Violation|0|||
131406430|NCT02182440|473111278|FG003|Overall Study|Protocol Violation|0|||
131406431|NCT02182440|473111275|FG000|Overall Study|Physician Decision|1|||
131406432|NCT02182440|473111276|FG001|Overall Study|Physician Decision|0|||
131406433|NCT02182440|473111277|FG002|Overall Study|Physician Decision|0|||
131406434|NCT02182440|473111278|FG003|Overall Study|Physician Decision|0|||
131406435|NCT02182440|473111275|FG000|Overall Study|Withdrawal by Subject|1|||
131406436|NCT02182440|473111276|FG001|Overall Study|Withdrawal by Subject|1|||
131406437|NCT02182440|473111277|FG002|Overall Study|Withdrawal by Subject|3|||
131406438|NCT02182440|473111278|FG003|Overall Study|Withdrawal by Subject|4|||
131406439|NCT02182440|473111275|FG000|Overall Study|different, e.g adm other hospital|12|||
131406440|NCT02182440|473111276|FG001|Overall Study|different, e.g adm other hospital|3|||
131406441|NCT02182440|473111277|FG002|Overall Study|different, e.g adm other hospital|3|||
131406442|NCT02182440|473111278|FG003|Overall Study|different, e.g adm other hospital|10|||
131406443|NCT00072293|473111279|FG000|Overall Study|Lost to Follow-up|1|||
131855925|NCT03172494|474749965|FG002|Overall Study|Pregnancy|0|||
131855926|NCT03172494|474749963|FG000|Overall Study|Withdrawal by Subject|10|||
131855927|NCT03172494|474749964|FG001|Overall Study|Withdrawal by Subject|8|||
131406444|NCT00072293|473111280|FG001|Overall Study|Lost to Follow-up|1|||
131406445|NCT00072293|473111279|FG000|Overall Study|Withdrawal by Subject|0|||
131406446|NCT00072293|473111280|FG001|Overall Study|Withdrawal by Subject|1|||
131406447|NCT01166958|473111281|FG000|Overall Study|Withdrawal by Subject|1|||
131406448|NCT01166958|473111282|FG001|Overall Study|Withdrawal by Subject|0|||
131406449|NCT04209114|473111283|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
131406450|NCT04209114|473111284|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
131406451|NCT04209114|473111285|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
131406452|NCT04209114|473111283|FG000|Pre-Treatment Phase|Other reasons|0|||
131406453|NCT04209114|473111284|FG001|Pre-Treatment Phase|Other reasons|0|||
131406454|NCT04209114|473111285|FG002|Pre-Treatment Phase|Other reasons|1|||
131406455|NCT04209114|473111283|FG000|Pre-Treatment Phase|Death|0|||
131406456|NCT04209114|473111284|FG001|Pre-Treatment Phase|Death|0|||
131855928|NCT03172494|474749965|FG002|Overall Study|Withdrawal by Subject|8|||
131855929|NCT03172494|474749963|FG000|Overall Study|Severe hypoglycaemic episode|0|||
131406457|NCT04209114|473111285|FG002|Pre-Treatment Phase|Death|1|||
131406458|NCT04209114|473111283|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
131855930|NCT03172494|474749964|FG001|Overall Study|Severe hypoglycaemic episode|0|||
131855931|NCT03172494|474749965|FG002|Overall Study|Severe hypoglycaemic episode|1|||
131855932|NCT03172494|474749963|FG000|Overall Study|Non-compliance towards treatment|2|||
131855933|NCT03172494|474749964|FG001|Overall Study|Non-compliance towards treatment|0|||
131855934|NCT03172494|474749965|FG002|Overall Study|Non-compliance towards treatment|0|||
131855935|NCT01450683|474749966|FG000|Overall Study|Adverse Event|2|||
131855936|NCT00852202|474749970|FG000|Overall Study|Adverse Event|2|||
131855937|NCT00852202|474749971|FG001|Overall Study|Adverse Event|3|||
131855938|NCT00852202|474749972|FG002|Overall Study|Adverse Event|7|||
131855939|NCT00852202|474749970|FG000|Overall Study|Lack of Efficacy|4|||
131855940|NCT00852202|474749971|FG001|Overall Study|Lack of Efficacy|1|||
131855941|NCT00852202|474749972|FG002|Overall Study|Lack of Efficacy|2|||
131855942|NCT00852202|474749970|FG000|Overall Study|Protocol Violation|2|||
131855943|NCT00852202|474749971|FG001|Overall Study|Protocol Violation|2|||
131855944|NCT00852202|474749972|FG002|Overall Study|Protocol Violation|7|||
131855945|NCT00852202|474749970|FG000|Overall Study|Withdrawal by Subject|3|||
131855946|NCT00852202|474749971|FG001|Overall Study|Withdrawal by Subject|1|||
131855947|NCT00852202|474749972|FG002|Overall Study|Withdrawal by Subject|2|||
131855948|NCT00852202|474749970|FG000|Overall Study|Lost to Follow-up|5|||
131855949|NCT00852202|474749971|FG001|Overall Study|Lost to Follow-up|5|||
131855950|NCT00852202|474749972|FG002|Overall Study|Lost to Follow-up|6|||
131855951|NCT00852202|474749970|FG000|Overall Study|pregnancy,moving away and surgery|1|||
131855952|NCT00852202|474749971|FG001|Overall Study|pregnancy,moving away and surgery|0|||
131855953|NCT00852202|474749972|FG002|Overall Study|pregnancy,moving away and surgery|2|||
131855954|NCT05022212|474749975|FG000|Overall Study|Lost to Follow-up|0|||
131855955|NCT05022212|474749976|FG001|Overall Study|Lost to Follow-up|2|||
131855956|NCT02890355|474749977|FG000|Overall Study|Adverse Event|5|||
131855957|NCT02890355|474749978|FG001|Overall Study|Adverse Event|5|||
131855958|NCT02890355|474749977|FG000|Overall Study|Refusal unrelated to adverse event|5|||
131855959|NCT02890355|474749978|FG001|Overall Study|Refusal unrelated to adverse event|10|||
131855960|NCT02890355|474749977|FG000|Overall Study|Progression/relapse|46|||
131855961|NCT02890355|474749978|FG001|Overall Study|Progression/relapse|39|||
131855962|NCT02890355|474749977|FG000|Overall Study|Not protocol specified|3|||
131855963|NCT02890355|474749978|FG001|Overall Study|Not protocol specified|4|||
131855964|NCT01950390|474749979|FG000|Overall Study|Never started treatment|3|||
131855965|NCT01950390|474749980|FG001|Overall Study|Never started treatment|2|||
131855966|NCT01950390|474749979|FG000|Overall Study|Disease progression|45|||
131855967|NCT01950390|474749980|FG001|Overall Study|Disease progression|52|||
131855968|NCT01950390|474749979|FG000|Overall Study|Adverse Event|22|||
131855969|NCT01950390|474749980|FG001|Overall Study|Adverse Event|16|||
131855970|NCT01950390|474749979|FG000|Overall Study|Death|5|||
131855971|NCT01950390|474749980|FG001|Overall Study|Death|3|||
131855972|NCT01950390|474749979|FG000|Overall Study|Withdrawal by Subject|5|||
131855973|NCT01950390|474749980|FG001|Overall Study|Withdrawal by Subject|1|||
131855974|NCT01950390|474749979|FG000|Overall Study|Alternative therapy|0|||
131855975|NCT01950390|474749980|FG001|Overall Study|Alternative therapy|3|||
131855976|NCT01950390|474749979|FG000|Overall Study|Complicating disease|1|||
131855977|NCT01950390|474749980|FG001|Overall Study|Complicating disease|0|||
131855978|NCT01950390|474749979|FG000|Overall Study|On treatment|1|||
131855979|NCT01950390|474749980|FG001|Overall Study|On treatment|0|||
131855980|NCT01950390|474749979|FG000|Overall Study|Symptomatic deterioration|2|||
131855981|NCT01950390|474749980|FG001|Overall Study|Symptomatic deterioration|1|||
131855982|NCT01950390|474749979|FG000|Overall Study|Physician Decision|0|||
131855983|NCT01950390|474749980|FG001|Overall Study|Physician Decision|4|||
131855984|NCT01950390|474749979|FG000|Overall Study|Lack of clinical benefit|0|||
131855985|NCT01950390|474749980|FG001|Overall Study|Lack of clinical benefit|1|||
131855986|NCT01950390|474749979|FG000|Overall Study|Maintained PR and moved to observation only|0|||
131406459|NCT04209114|473111284|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
131406460|NCT04209114|473111285|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
131855987|NCT01950390|474749980|FG001|Overall Study|Maintained PR and moved to observation only|1|||
131406461|NCT04209114|473111283|FG000|Treatment Phase|Other reasons|5|||
131406462|NCT04209114|473111284|FG001|Treatment Phase|Other reasons|3|||
131855988|NCT02694328|474749981|FG000|Overall Study|Adverse Event|27|||
131855989|NCT02694328|474749982|FG001|Overall Study|Adverse Event|33|||
131855990|NCT02694328|474749981|FG000|Overall Study|Withdrawal by Subject|27|||
131855991|NCT02694328|474749982|FG001|Overall Study|Withdrawal by Subject|23|||
131855992|NCT02694328|474749981|FG000|Overall Study|Lost to Follow-up|26|||
131406463|NCT04209114|473111285|FG002|Treatment Phase|Other reasons|0|||
131855993|NCT02694328|474749982|FG001|Overall Study|Lost to Follow-up|22|||
131855994|NCT02694328|474749981|FG000|Overall Study|Noncompliant with study drug|11|||
131855995|NCT02694328|474749982|FG001|Overall Study|Noncompliant with study drug|8|||
131855996|NCT02694328|474749981|FG000|Overall Study|Incarceration|1|||
131855997|NCT02694328|474749982|FG001|Overall Study|Incarceration|1|||
131855998|NCT02694328|474749981|FG000|Overall Study|Lack of Efficacy|1|||
131855999|NCT02694328|474749982|FG001|Overall Study|Lack of Efficacy|2|||
131856000|NCT02694328|474749981|FG000|Overall Study|Pregnancy|1|||
131856001|NCT02694328|474749982|FG001|Overall Study|Pregnancy|1|||
131856002|NCT02694328|474749981|FG000|Overall Study|Protocol Violation|6|||
131856003|NCT02694328|474749982|FG001|Overall Study|Protocol Violation|5|||
131856004|NCT02694328|474749981|FG000|Overall Study|Abnormal Laboratory Value|0|||
131856005|NCT02694328|474749982|FG001|Overall Study|Abnormal Laboratory Value|3|||
131856006|NCT01260701|474749984|FG000|Overall Study|Adverse Event|9|||
131856007|NCT01260701|474749984|FG000|Overall Study|Withdrawal by Subject|2|||
131856008|NCT01260701|474749984|FG000|Overall Study|Progression|53|||
131856009|NCT01260701|474749984|FG000|Overall Study|Death|2|||
131856010|NCT01260701|474749984|FG000|Overall Study|Not protocol specified|3|||
131856011|NCT01260701|474749984|FG000|Overall Study|Under review|1|||
131856012|NCT01260701|474749984|FG000|Overall Study|Ineligible|4|||
131856013|NCT01260701|474749984|FG000|Overall Study|Did not begin protocol therapy|1|||
131856014|NCT00720382|474749985|FG000|Overall Study|Adverse Event|54|||
131856015|NCT00720382|474749986|FG001|Overall Study|Adverse Event|17|||
131856016|NCT00720382|474749985|FG000|Overall Study|Lack of Efficacy|18|||
131856017|NCT00720382|474749986|FG001|Overall Study|Lack of Efficacy|7|||
131856018|NCT00720382|474749985|FG000|Overall Study|Non-Compliance|15|||
131856019|NCT00720382|474749986|FG001|Overall Study|Non-Compliance|5|||
131856020|NCT00720382|474749985|FG000|Overall Study|Withdrawal by Subject|47|||
131856021|NCT00720382|474749986|FG001|Overall Study|Withdrawal by Subject|11|||
131856022|NCT00720382|474749985|FG000|Overall Study|Lost to Follow-up|28|||
131856023|NCT00720382|474749986|FG001|Overall Study|Lost to Follow-up|14|||
131856024|NCT00720382|474749985|FG000|Overall Study|administrative|14|||
131856025|NCT00720382|474749986|FG001|Overall Study|administrative|5|||
131856026|NCT05192889|474749987|FG000|Block 1: All Eligible Patients|Death|2|||
131856027|NCT05192889|474749988|FG001|Block 1: All Eligible Patients|Death|0|||
131856028|NCT05192889|474749989|FG002|Block 1: All Eligible Patients|Death|0|||
131856029|NCT05192889|474749987|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
131856030|NCT05192889|474749988|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
131856031|NCT05192889|474749989|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
131856032|NCT05192889|474749987|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
131856033|NCT05192889|474749988|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
131856034|NCT05192889|474749989|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
131856035|NCT04205812|474751774|FG000|Randomized Treatment Period|Ongoing|28|||
131856036|NCT04205812|474751775|FG001|Randomized Treatment Period|Ongoing|138|||
131856037|NCT04205812|474751774|FG000|Randomized Treatment Period|Death|94|||
131856038|NCT04205812|474751775|FG001|Randomized Treatment Period|Death|226|||
131856039|NCT04205812|474751774|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
131856040|NCT04205812|474751775|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
131856041|NCT04205812|474751774|FG000|Randomized Treatment Period|Physician Decision|1|||
131856042|NCT04205812|474751775|FG001|Randomized Treatment Period|Physician Decision|4|||
131856043|NCT04205812|474751774|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
131856044|NCT04205812|474751775|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
131856045|NCT04205812|474751774|FG000|Randomized Treatment Period|Progressive Disease|0|||
131856046|NCT04205812|474751775|FG001|Randomized Treatment Period|Progressive Disease|1|||
131856047|NCT04205812|474751774|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
131856048|NCT04205812|474751775|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
131856049|NCT04205812|474751774|FG000|Monotherapy Treatment Period|Ongoing|17|||
131856050|NCT04205812|474751775|FG001|Monotherapy Treatment Period|Ongoing|0|||
131856051|NCT04205812|474751774|FG000|Monotherapy Treatment Period|Death|39|||
131856052|NCT04205812|474751775|FG001|Monotherapy Treatment Period|Death|0|||
131856053|NCT04205812|474751774|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
131856054|NCT04205812|474751775|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
131856055|NCT04205812|474751774|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
131856056|NCT04205812|474751775|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
131406464|NCT04209114|473111283|FG000|Treatment Phase|Lost to Follow-up|1|||
131856057|NCT05221320|474751776|FG000|Overall Study|Lack of Efficacy|3|||
131856058|NCT05221320|474751777|FG001|Overall Study|Lack of Efficacy|7|||
131856059|NCT05221320|474751778|FG002|Overall Study|Lack of Efficacy|10|||
131856060|NCT05221320|474751779|FG003|Overall Study|Lack of Efficacy|1|||
131856061|NCT05221320|474751780|FG004|Overall Study|Lack of Efficacy|0|||
131856062|NCT05221320|474751781|FG005|Overall Study|Lack of Efficacy|0|||
131856063|NCT05221320|474751776|FG000|Overall Study|Physician Decision|1|||
131856064|NCT05221320|474751777|FG001|Overall Study|Physician Decision|0|||
131406465|NCT04209114|473111284|FG001|Treatment Phase|Lost to Follow-up|0|||
131856065|NCT05221320|474751778|FG002|Overall Study|Physician Decision|3|||
131856066|NCT05221320|474751779|FG003|Overall Study|Physician Decision|1|||
131856067|NCT05221320|474751780|FG004|Overall Study|Physician Decision|0|||
131406466|NCT04209114|473111285|FG002|Treatment Phase|Lost to Follow-up|0|||
131406467|NCT04209114|473111283|FG000|Treatment Phase|Participant withdrew consent|1|||
131406468|NCT04209114|473111284|FG001|Treatment Phase|Participant withdrew consent|0|||
131406469|NCT04209114|473111285|FG002|Treatment Phase|Participant withdrew consent|0|||
131406470|NCT04209114|473111283|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
131406471|NCT04209114|473111284|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
131856068|NCT05221320|474751781|FG005|Overall Study|Physician Decision|0|||
131856069|NCT05221320|474751776|FG000|Overall Study|Withdrawal by Subject|0|||
131856070|NCT05221320|474751777|FG001|Overall Study|Withdrawal by Subject|3|||
131856071|NCT05221320|474751778|FG002|Overall Study|Withdrawal by Subject|1|||
131856072|NCT05221320|474751779|FG003|Overall Study|Withdrawal by Subject|0|||
131856073|NCT05221320|474751780|FG004|Overall Study|Withdrawal by Subject|0|||
131856074|NCT05221320|474751781|FG005|Overall Study|Withdrawal by Subject|0|||
131856075|NCT05221320|474751776|FG000|Overall Study|Death|0|||
131856076|NCT05221320|474751777|FG001|Overall Study|Death|5|||
131856077|NCT05221320|474751778|FG002|Overall Study|Death|6|||
131856078|NCT05221320|474751779|FG003|Overall Study|Death|0|||
131856079|NCT05221320|474751780|FG004|Overall Study|Death|1|||
131856080|NCT05221320|474751781|FG005|Overall Study|Death|0|||
131856081|NCT06473519|474751782|FG000|Overall Study|Lost to Follow-up|2|||
131856082|NCT06473519|474751783|FG001|Overall Study|Lost to Follow-up|5|||
131856083|NCT06473519|474751782|FG000|Overall Study|Withdrawal by Subject|1|||
131856084|NCT06473519|474751783|FG001|Overall Study|Withdrawal by Subject|4|||
131856085|NCT06473519|474751782|FG000|Overall Study|Randomized but not vaccinated|1|||
131856086|NCT06473519|474751783|FG001|Overall Study|Randomized but not vaccinated|2|||
131856087|NCT02514447|474751785|FG000|Overall Study|Withdrawal by Subject|3|||
131856088|NCT02514447|474751786|FG001|Overall Study|Withdrawal by Subject|1|||
131856089|NCT02514447|474751787|FG002|Overall Study|Withdrawal by Subject|1|||
131856090|NCT02514447|474751788|FG003|Overall Study|Withdrawal by Subject|0|||
131856091|NCT02514447|474751789|FG004|Overall Study|Withdrawal by Subject|0|||
131856092|NCT02514447|474751790|FG005|Overall Study|Withdrawal by Subject|0|||
131856093|NCT02514447|474751791|FG006|Overall Study|Withdrawal by Subject|0|||
131856094|NCT02514447|474751792|FG007|Overall Study|Withdrawal by Subject|1|||
131856095|NCT02514447|474751793|FG008|Overall Study|Withdrawal by Subject|1|||
131856096|NCT02514447|474751785|FG000|Overall Study|Death|24|||
131856097|NCT02514447|474751786|FG001|Overall Study|Death|28|||
131856098|NCT02514447|474751787|FG002|Overall Study|Death|29|||
131856099|NCT02514447|474751788|FG003|Overall Study|Death|0|||
131856100|NCT02514447|474751789|FG004|Overall Study|Death|3|||
131856101|NCT02514447|474751790|FG005|Overall Study|Death|4|||
131856102|NCT02514447|474751791|FG006|Overall Study|Death|8|||
131856103|NCT02514447|474751792|FG007|Overall Study|Death|6|||
131856104|NCT02514447|474751793|FG008|Overall Study|Death|5|||
131856105|NCT02514447|474751785|FG000|Overall Study|Lost to Follow-up|1|||
131856106|NCT02514447|474751786|FG001|Overall Study|Lost to Follow-up|0|||
131856107|NCT02514447|474751787|FG002|Overall Study|Lost to Follow-up|0|||
131856108|NCT02514447|474751788|FG003|Overall Study|Lost to Follow-up|0|||
131856109|NCT02514447|474751789|FG004|Overall Study|Lost to Follow-up|0|||
131856110|NCT02514447|474751790|FG005|Overall Study|Lost to Follow-up|0|||
131856111|NCT02514447|474751791|FG006|Overall Study|Lost to Follow-up|0|||
131856112|NCT02514447|474751792|FG007|Overall Study|Lost to Follow-up|0|||
131856113|NCT02514447|474751793|FG008|Overall Study|Lost to Follow-up|1|||
131856114|NCT02514447|474751785|FG000|Overall Study|Sponsor Termination of Study|0|||
131856115|NCT02514447|474751786|FG001|Overall Study|Sponsor Termination of Study|1|||
131856116|NCT02514447|474751787|FG002|Overall Study|Sponsor Termination of Study|1|||
131856117|NCT02514447|474751788|FG003|Overall Study|Sponsor Termination of Study|0|||
131856118|NCT02514447|474751789|FG004|Overall Study|Sponsor Termination of Study|0|||
131856119|NCT02514447|474751790|FG005|Overall Study|Sponsor Termination of Study|0|||
131856120|NCT02514447|474751791|FG006|Overall Study|Sponsor Termination of Study|0|||
131406472|NCT04209114|473111285|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
131856121|NCT02514447|474751792|FG007|Overall Study|Sponsor Termination of Study|0|||
131856122|NCT02514447|474751793|FG008|Overall Study|Sponsor Termination of Study|0|||
131856123|NCT02514447|474751785|FG000|Overall Study|Study completion per Investigator|1|||
131856124|NCT02514447|474751786|FG001|Overall Study|Study completion per Investigator|0|||
131856125|NCT02514447|474751787|FG002|Overall Study|Study completion per Investigator|1|||
131856126|NCT02514447|474751788|FG003|Overall Study|Study completion per Investigator|2|||
131856127|NCT02514447|474751789|FG004|Overall Study|Study completion per Investigator|0|||
131856128|NCT02514447|474751790|FG005|Overall Study|Study completion per Investigator|0|||
131856129|NCT02514447|474751791|FG006|Overall Study|Study completion per Investigator|0|||
131856130|NCT02514447|474751792|FG007|Overall Study|Study completion per Investigator|0|||
131856131|NCT02514447|474751793|FG008|Overall Study|Study completion per Investigator|1|||
131856132|NCT02731638|474751795|FG000|Overall Study|Lost to Follow-up|6|||
131856133|NCT02731638|474751796|FG001|Overall Study|Lost to Follow-up|9|||
131856134|NCT05626231|474751797|FG000|Provider Enrollment|Worked part-time|4|||
131856135|NCT05626231|474751797|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
131856136|NCT05626231|474751797|FG000|Provider Enrollment|Non-clinical employee|1|||
131856137|NCT05626231|474751797|FG000|Provider Enrollment|Provider does not see clients|3|||
131856138|NCT05626231|474751797|FG000|Provider Enrollment|Other|5|||
131856139|NCT02653625|474751798|FG000|Overall Study|Adverse Event|1|||
131856140|NCT02653625|474751798|FG000|Overall Study|Non-compliance with Study Drug|1|||
131856141|NCT02653625|474751798|FG000|Overall Study|Protocol Violation|1|||
131856142|NCT02653625|474751798|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
131856143|NCT01499095|474751799|FG000|Overall Study|Randomized But Not Treated|1|||
131406473|NCT04209114|473111283|FG000|Treatment Phase|Death|4|||
131406474|NCT04209114|473111284|FG001|Treatment Phase|Death|1|||
131406475|NCT04209114|473111285|FG002|Treatment Phase|Death|0|||
131406476|NCT04209114|473111283|FG000|Treatment Phase|Study drug toxicity|4|||
131406477|NCT04209114|473111284|FG001|Treatment Phase|Study drug toxicity|6|||
131406478|NCT04209114|473111285|FG002|Treatment Phase|Study drug toxicity|0|||
131406479|NCT04209114|473111283|FG000|Treatment Phase|Disease progression|6|||
131406480|NCT04209114|473111284|FG001|Treatment Phase|Disease progression|9|||
131406481|NCT04209114|473111285|FG002|Treatment Phase|Disease progression|0|||
131406482|NCT02981407|473111295|FG000|Overall Study|Withdrawal by Subject|2|||
131406483|NCT02981407|473111296|FG001|Overall Study|Withdrawal by Subject|0|||
131406484|NCT01444027|473111299|FG000|Overall Study|Withdrawal by Subject|4|||
131406485|NCT01444027|473111300|FG001|Overall Study|Withdrawal by Subject|10|||
131856144|NCT01499095|474751800|FG001|Overall Study|Randomized But Not Treated|1|||
131856145|NCT01499095|474751799|FG000|Overall Study|Adverse Event|12|||
131856146|NCT01499095|474751800|FG001|Overall Study|Adverse Event|7|||
131856147|NCT01499095|474751799|FG000|Overall Study|Lack of Efficacy|2|||
131856148|NCT01499095|474751800|FG001|Overall Study|Lack of Efficacy|1|||
131856149|NCT01499095|474751799|FG000|Overall Study|Protocol Violation|6|||
131856150|NCT01499095|474751800|FG001|Overall Study|Protocol Violation|7|||
131856151|NCT01499095|474751799|FG000|Overall Study|Received Rescue Therapy|32|||
131856152|NCT01499095|474751800|FG001|Overall Study|Received Rescue Therapy|40|||
131856153|NCT01499095|474751799|FG000|Overall Study|Diverse Reasons|22|||
131856154|NCT01499095|474751800|FG001|Overall Study|Diverse Reasons|25|||
131856155|NCT01499095|474751799|FG000|Overall Study|Lost to Follow-up|6|||
131856156|NCT01499095|474751800|FG001|Overall Study|Lost to Follow-up|4|||
131856157|NCT01499095|474751799|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
131856158|NCT01499095|474751800|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
131856159|NCT01499095|474751799|FG000|Overall Study|Hypoglycemia|3|||
131856160|NCT01499095|474751800|FG001|Overall Study|Hypoglycemia|1|||
131856161|NCT01499095|474751799|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
131856162|NCT01499095|474751800|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
131856163|NCT01499095|474751799|FG000|Overall Study|Change in Injection Schedule|2|||
131856164|NCT01499095|474751800|FG001|Overall Study|Change in Injection Schedule|0|||
131856165|NCT01499095|474751799|FG000|Overall Study|Perceived Lack of Efficacy|1|||
131856166|NCT01499095|474751800|FG001|Overall Study|Perceived Lack of Efficacy|1|||
131856167|NCT02762929|474751801|FG000|Overall Study|Adverse Event|0|||
131856168|NCT02762929|474751802|FG001|Overall Study|Adverse Event|0|||
131856169|NCT02762929|474751803|FG002|Overall Study|Adverse Event|0|||
131856170|NCT02762929|474751804|FG003|Overall Study|Adverse Event|1|||
131856171|NCT02762929|474751805|FG004|Overall Study|Adverse Event|0|||
131856172|NCT02762929|474751806|FG005|Overall Study|Adverse Event|0|||
131856173|NCT02762929|474751801|FG000|Overall Study|Lost to Follow-up|1|||
131856174|NCT02762929|474751802|FG001|Overall Study|Lost to Follow-up|2|||
131856175|NCT02762929|474751803|FG002|Overall Study|Lost to Follow-up|0|||
131856176|NCT02762929|474751804|FG003|Overall Study|Lost to Follow-up|1|||
131856177|NCT02762929|474751805|FG004|Overall Study|Lost to Follow-up|0|||
131856178|NCT02762929|474751806|FG005|Overall Study|Lost to Follow-up|0|||
131856179|NCT02762929|474751801|FG000|Overall Study|Withdrawal by Subject|0|||
131856180|NCT02762929|474751802|FG001|Overall Study|Withdrawal by Subject|1|||
131856181|NCT02762929|474751803|FG002|Overall Study|Withdrawal by Subject|0|||
131856182|NCT02762929|474751804|FG003|Overall Study|Withdrawal by Subject|0|||
131856183|NCT02762929|474751805|FG004|Overall Study|Withdrawal by Subject|0|||
131856184|NCT02762929|474751806|FG005|Overall Study|Withdrawal by Subject|0|||
131856185|NCT02762929|474751801|FG000|Overall Study|exclusionary medication disclosed late|0|||
131856186|NCT02762929|474751802|FG001|Overall Study|exclusionary medication disclosed late|0|||
131856187|NCT02762929|474751803|FG002|Overall Study|exclusionary medication disclosed late|0|||
131856188|NCT02762929|474751804|FG003|Overall Study|exclusionary medication disclosed late|1|||
131406486|NCT01444027|473111301|FG002|Overall Study|Withdrawal by Subject|24|||
131406487|NCT01444027|473111299|FG000|Overall Study|Lost to Follow-up|26|||
131406488|NCT01444027|473111300|FG001|Overall Study|Lost to Follow-up|20|||
131406489|NCT01444027|473111301|FG002|Overall Study|Lost to Follow-up|14|||
131406490|NCT00953680|473111307|FG000|Period 1|Withdrawal by Subject|0|||
131406491|NCT00953680|473111308|FG001|Period 1|Withdrawal by Subject|1|||
131856189|NCT02762929|474751805|FG004|Overall Study|exclusionary medication disclosed late|0|||
131856190|NCT02762929|474751806|FG005|Overall Study|exclusionary medication disclosed late|0|||
131856191|NCT01473407|474751807|FG000|Overall Study|Physician Decision|1|||
131856192|NCT01473407|474751808|FG001|Overall Study|Physician Decision|4|||
131856193|NCT01473407|474751807|FG000|Overall Study|Lost to Follow-up|10|||
131856194|NCT01473407|474751808|FG001|Overall Study|Lost to Follow-up|4|||
131856195|NCT01473407|474751807|FG000|Overall Study|Adverse Event|8|||
131856196|NCT01473407|474751808|FG001|Overall Study|Adverse Event|8|||
131856197|NCT01473407|474751807|FG000|Overall Study|Randomization Error|3|||
131856198|NCT01473407|474751808|FG001|Overall Study|Randomization Error|1|||
131856199|NCT01473407|474751807|FG000|Overall Study|Withdrawal by Subject|4|||
131856200|NCT01473407|474751808|FG001|Overall Study|Withdrawal by Subject|7|||
131406492|NCT01360398|473111309|FG000|Overall Study|Withdrawal by Subject|14|||
131406493|NCT01360398|473111309|FG000|Overall Study|Other|7|||
131406494|NCT01360398|473111309|FG000|Overall Study|Migrated/moved from study area|1|||
131406495|NCT00737711|473111310|FG000|Overall Study|Adverse Event|2|||
131406496|NCT00737711|473111310|FG000|Overall Study|Death|8|||
131856201|NCT01473407|474751807|FG000|Overall Study|Kidney Transplant|7|||
131856202|NCT01473407|474751808|FG001|Overall Study|Kidney Transplant|6|||
131856203|NCT01473407|474751807|FG000|Overall Study|Vacation/Travel|1|||
131856204|NCT01473407|474751808|FG001|Overall Study|Vacation/Travel|1|||
131406497|NCT00737711|473111310|FG000|Overall Study|Failure to return|4|||
131406498|NCT00737711|473111310|FG000|Overall Study|Protocol Violation|1|||
131406499|NCT00737711|473111310|FG000|Overall Study|Withdrawal by Subject|5|||
131406500|NCT00737711|473111310|FG000|Overall Study|Blood transfusion|6|||
131406501|NCT00737711|473111310|FG000|Overall Study|Other|5|||
131406502|NCT00624780|473111314|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
131406503|NCT00624780|473111315|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
131406504|NCT00624780|473111316|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
131406505|NCT00624780|473111317|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
131406506|NCT00624780|473111318|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
131406507|NCT00624780|473111319|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
131406508|NCT00624780|473111314|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
131406509|NCT00624780|473111315|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
131406510|NCT00624780|473111316|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
131406511|NCT00624780|473111317|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
131406512|NCT00624780|473111318|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
131406513|NCT00624780|473111319|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
131406514|NCT00624780|473111314|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
131406515|NCT00624780|473111315|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
131406516|NCT00624780|473111316|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
131406517|NCT00624780|473111317|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
131406518|NCT00624780|473111318|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
131406519|NCT00624780|473111319|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
131406520|NCT00624780|473111314|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
131406521|NCT00624780|473111315|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
131406522|NCT00624780|473111316|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
131406523|NCT00624780|473111317|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
131406524|NCT00624780|473111318|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
131406525|NCT00624780|473111319|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
131406526|NCT00624780|473111314|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
131406527|NCT00624780|473111315|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
131406528|NCT00624780|473111316|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
131856205|NCT01473407|474751807|FG000|Overall Study|Elevated Hemoglobin|1|||
131856206|NCT01473407|474751808|FG001|Overall Study|Elevated Hemoglobin|0|||
131856207|NCT01473407|474751807|FG000|Overall Study|Patient Received Aranesp|1|||
131856208|NCT01473407|474751808|FG001|Overall Study|Patient Received Aranesp|0|||
131856209|NCT01473407|474751807|FG000|Overall Study|Patient Lost Green Card Status|1|||
131856210|NCT01473407|474751808|FG001|Overall Study|Patient Lost Green Card Status|0|||
131856211|NCT01473407|474751807|FG000|Overall Study|Temperature Excursion|2|||
131856212|NCT01473407|474751808|FG001|Overall Study|Temperature Excursion|3|||
131856213|NCT01473407|474751807|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
131856214|NCT01473407|474751808|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
131856215|NCT01473407|474751807|FG000|Overall Study|Sponsor's Decision|10|||
131856216|NCT01473407|474751808|FG001|Overall Study|Sponsor's Decision|10|||
131856217|NCT01473407|474751807|FG000|Overall Study|Site Closure|1|||
131406529|NCT00624780|473111317|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
131406530|NCT00624780|473111318|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
131406531|NCT00624780|473111319|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
131406532|NCT00624780|473111314|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
131406533|NCT00624780|473111315|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
131406534|NCT00624780|473111316|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
131406535|NCT00624780|473111317|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
131912502|NCT02765165|474966607|FG005|Treatment Period|Withdrawal by Subject|0|||
131912503|NCT02765165|474966608|FG006|Treatment Period|Withdrawal by Subject|0|||
131912504|NCT02765165|474966602|FG000|Treatment Period|Study terminated|0|||
131406536|NCT00624780|473111318|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
131856218|NCT01473407|474751808|FG001|Overall Study|Site Closure|0|||
131856219|NCT02738138|474751812|FG000|Overall Study|Adverse Event|0|||
131856220|NCT02738138|474751813|FG001|Overall Study|Adverse Event|1|||
131856221|NCT02738138|474751812|FG000|Overall Study|Lost to Follow-up|2|||
131856222|NCT02738138|474751813|FG001|Overall Study|Lost to Follow-up|0|||
131856223|NCT02738138|474751812|FG000|Overall Study|Other - not further specified|1|||
131856224|NCT02738138|474751813|FG001|Overall Study|Other - not further specified|0|||
131856225|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Other|34|||
131406537|NCT00624780|473111319|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
131912505|NCT02765165|474966603|FG001|Treatment Period|Study terminated|0|||
131912506|NCT02765165|474966604|FG002|Treatment Period|Study terminated|0|||
131912507|NCT02765165|474966605|FG003|Treatment Period|Study terminated|0|||
131912508|NCT02765165|474966606|FG004|Treatment Period|Study terminated|0|||
131912509|NCT02765165|474966607|FG005|Treatment Period|Study terminated|1|||
131912510|NCT02765165|474966608|FG006|Treatment Period|Study terminated|2|||
131912511|NCT02765165|474966602|FG000|Post-treatment Follow-up|Death|1|||
131912512|NCT02765165|474966603|FG001|Post-treatment Follow-up|Death|2|||
131912513|NCT02765165|474966604|FG002|Post-treatment Follow-up|Death|1|||
131912514|NCT02765165|474966605|FG003|Post-treatment Follow-up|Death|1|||
131912515|NCT02765165|474966606|FG004|Post-treatment Follow-up|Death|1|||
131912516|NCT02765165|474966607|FG005|Post-treatment Follow-up|Death|1|||
131912517|NCT02765165|474966608|FG006|Post-treatment Follow-up|Death|0|||
131912518|NCT02765165|474966602|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
131856226|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Other|0|||
131856227|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Other|0|||
131856228|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Other|0|||
131856229|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Death|14|||
131856230|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Death|0|||
131856231|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Death|0|||
131856232|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Death|0|||
131856233|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
131856234|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
131856235|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
131856236|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
131856237|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
131856238|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
131856239|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
131856240|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
131856241|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
131856242|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
131856243|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
131856244|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
131856245|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
131856246|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
131856247|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
131856248|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
131856249|NCT01995513|474751819|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
131856250|NCT01995513|474751820|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
131856251|NCT01995513|474751821|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
131856252|NCT01995513|474751822|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
131856253|NCT01995513|474751819|FG000|Period 1: Second Open Label Treatment|Other|0|||
131856254|NCT01995513|474751820|FG001|Period 1: Second Open Label Treatment|Other|2|||
131856255|NCT01995513|474751821|FG002|Period 1: Second Open Label Treatment|Other|0|||
131856256|NCT01995513|474751822|FG003|Period 1: Second Open Label Treatment|Other|0|||
131856257|NCT01995513|474751819|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
131856258|NCT01995513|474751820|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
131856259|NCT01995513|474751821|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
131856260|NCT01995513|474751822|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
131856261|NCT01995513|474751819|FG000|Period 2: Double Blind Treatment|Death|0|||
131856262|NCT01995513|474751820|FG001|Period 2: Double Blind Treatment|Death|0|||
131856263|NCT01995513|474751821|FG002|Period 2: Double Blind Treatment|Death|0|||
131856264|NCT01995513|474751822|FG003|Period 2: Double Blind Treatment|Death|1|||
131856265|NCT01995513|474751819|FG000|Period 2: Double Blind Treatment|Other|0|||
131856266|NCT01995513|474751820|FG001|Period 2: Double Blind Treatment|Other|0|||
131856267|NCT01995513|474751821|FG002|Period 2: Double Blind Treatment|Other|3|||
131912519|NCT02765165|474966603|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
131912520|NCT02765165|474966604|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
131912521|NCT02765165|474966605|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
131856268|NCT01995513|474751822|FG003|Period 2: Double Blind Treatment|Other|3|||
131856269|NCT01995513|474751819|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
131856270|NCT01995513|474751820|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
131856271|NCT01995513|474751821|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
131856272|NCT01995513|474751822|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
131856273|NCT01995513|474751819|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
131912522|NCT02765165|474966606|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
131912523|NCT02765165|474966607|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
131912524|NCT02765165|474966608|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
131856274|NCT01995513|474751820|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
131856275|NCT01995513|474751821|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
131856276|NCT01995513|474751822|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
131856277|NCT01995513|474751819|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
131856278|NCT01995513|474751820|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
131856279|NCT01995513|474751821|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
131856280|NCT01995513|474751822|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
131856281|NCT01995513|474751819|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
131856282|NCT01995513|474751820|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
131856283|NCT01995513|474751821|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
131856284|NCT01995513|474751822|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
131856285|NCT01232452|474751823|FG000|Overall Study|Adverse Event|17|||
131856286|NCT01232452|474751824|FG001|Overall Study|Adverse Event|15|||
131856287|NCT01232452|474751823|FG000|Overall Study|Withdrawal by Subject|11|||
131856288|NCT01232452|474751824|FG001|Overall Study|Withdrawal by Subject|8|||
131856289|NCT01232452|474751823|FG000|Overall Study|Physician Decision|8|||
131856290|NCT01232452|474751824|FG001|Overall Study|Physician Decision|12|||
131856291|NCT01232452|474751823|FG000|Overall Study|Protocol entry criterion not met|0|||
131856292|NCT01232452|474751824|FG001|Overall Study|Protocol entry criterion not met|2|||
131856293|NCT01232452|474751823|FG000|Overall Study|Sponsor Decision|3|||
131856294|NCT01232452|474751824|FG001|Overall Study|Sponsor Decision|1|||
131856295|NCT01232452|474751823|FG000|Overall Study|Protocol Violation|0|||
131856296|NCT01232452|474751824|FG001|Overall Study|Protocol Violation|1|||
131856297|NCT04108299|474751826|FG000|Overall Study|Not interested in participating|2|||
131856298|NCT04108299|474751827|FG001|Overall Study|Not interested in participating|1|||
131856299|NCT04108299|474751828|FG002|Overall Study|Not interested in participating|2|||
131856300|NCT04108299|474751829|FG003|Overall Study|Not interested in participating|1|||
131856301|NCT00247676|474751830|FG000|Overall Study|Death|5|||
131856302|NCT00247676|474751830|FG000|Overall Study|Adverse Event|11|||
131856303|NCT00247676|474751830|FG000|Overall Study|Lack of Efficacy|15|||
131856304|NCT00247676|474751830|FG000|Overall Study|Other|3|||
131856305|NCT00247676|474751830|FG000|Overall Study|Withdrawal by Subject|2|||
131856306|NCT00662649|474751831|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
131856307|NCT00662649|474751832|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
131856308|NCT00662649|474751833|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
131856309|NCT00662649|474751834|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
131856310|NCT00662649|474751835|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
131856311|NCT00662649|474751831|FG000|Core Study (24 Months)|Adverse Event|22|||
131856312|NCT00662649|474751832|FG001|Core Study (24 Months)|Adverse Event|13|||
131856313|NCT00662649|474751833|FG002|Core Study (24 Months)|Adverse Event|18|||
131856314|NCT00662649|474751834|FG003|Core Study (24 Months)|Adverse Event|0|||
131856315|NCT00662649|474751835|FG004|Core Study (24 Months)|Adverse Event|0|||
131856316|NCT00662649|474751831|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
131856317|NCT00662649|474751832|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
131856318|NCT00662649|474751833|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
131856319|NCT00662649|474751834|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
131856320|NCT00662649|474751835|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
131856321|NCT00662649|474751831|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
131856322|NCT00662649|474751832|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
131856323|NCT00662649|474751833|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
131856324|NCT00662649|474751834|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
131856325|NCT00662649|474751835|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
131856326|NCT00662649|474751831|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
131856327|NCT00662649|474751832|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
131856328|NCT00662649|474751833|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
131856329|NCT00662649|474751834|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
131856330|NCT00662649|474751835|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
131856331|NCT00662649|474751831|FG000|Core Study (24 Months)|Protocol Violation|5|||
131856332|NCT00662649|474751832|FG001|Core Study (24 Months)|Protocol Violation|5|||
131856333|NCT00662649|474751833|FG002|Core Study (24 Months)|Protocol Violation|4|||
131856334|NCT00662649|474751834|FG003|Core Study (24 Months)|Protocol Violation|0|||
131856335|NCT00662649|474751835|FG004|Core Study (24 Months)|Protocol Violation|0|||
131856336|NCT00662649|474751831|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
131856337|NCT00662649|474751832|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
131856338|NCT00662649|474751833|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
131856339|NCT00662649|474751834|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
131856340|NCT00662649|474751835|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
131856341|NCT00662649|474751831|FG000|Core Study (24 Months)|Death|1|||
131856342|NCT00662649|474751832|FG001|Core Study (24 Months)|Death|0|||
131856343|NCT00662649|474751833|FG002|Core Study (24 Months)|Death|2|||
131856344|NCT00662649|474751834|FG003|Core Study (24 Months)|Death|0|||
131856345|NCT00662649|474751835|FG004|Core Study (24 Months)|Death|0|||
131856346|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
131856347|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
131856348|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
131856349|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
131856350|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
131856351|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
131856352|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
131856353|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
131856354|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
131856355|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
131856356|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
131856357|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
131856358|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
131856359|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
131856360|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
131856361|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
131856362|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
131856363|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
131856364|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
131856365|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
131856366|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
131856367|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
131856368|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
131856369|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
131856370|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
131856371|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
131856372|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
131856373|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
131856374|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
131856375|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
131856376|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
131856377|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
131856378|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
131856379|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
131856380|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
131856381|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
131856382|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
131856383|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
131856384|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
131856385|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
131856386|NCT00662649|474751831|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
131856387|NCT00662649|474751832|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
131856388|NCT00662649|474751833|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
131856389|NCT00662649|474751834|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
131856390|NCT00662649|474751835|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
131856391|NCT01750190|474751842|FG000|Overall Study|Adverse Event|47|||
131856392|NCT01750190|474751843|FG001|Overall Study|Adverse Event|19|||
131856393|NCT01750190|474751842|FG000|Overall Study|Death|38|||
131856394|NCT01750190|474751843|FG001|Overall Study|Death|11|||
131856395|NCT01750190|474751842|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
131856396|NCT01750190|474751843|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
131856397|NCT01750190|474751842|FG000|Overall Study|Lost to Follow-up|28|||
131856398|NCT01750190|474751843|FG001|Overall Study|Lost to Follow-up|7|||
131856399|NCT01750190|474751842|FG000|Overall Study|Physician Decision|16|||
131856400|NCT01750190|474751843|FG001|Overall Study|Physician Decision|17|||
131856401|NCT01750190|474751842|FG000|Overall Study|Protocol Violation|6|||
131856402|NCT01750190|474751843|FG001|Overall Study|Protocol Violation|5|||
131856403|NCT01750190|474751842|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
131856404|NCT01750190|474751843|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
131856405|NCT01750190|474751842|FG000|Overall Study|Withdrawal by Subject|83|||
131856406|NCT01750190|474751843|FG001|Overall Study|Withdrawal by Subject|89|||
131856407|NCT01750190|474751842|FG000|Overall Study|Kidney Transplant|8|||
131856408|NCT01750190|474751843|FG001|Overall Study|Kidney Transplant|4|||
131856409|NCT01750190|474751842|FG000|Overall Study|Dialysis|22|||
131856410|NCT01750190|474751843|FG001|Overall Study|Dialysis|8|||
131856411|NCT01750190|474751842|FG000|Overall Study|Other than Specified|13|||
131856412|NCT01750190|474751843|FG001|Overall Study|Other than Specified|4|||
131856413|NCT02955212|474751844|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
131856414|NCT02955212|474751845|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
131856415|NCT02955212|474751844|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
131856416|NCT02955212|474751845|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
131856417|NCT02955212|474751844|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
131856418|NCT02955212|474751845|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
131856419|NCT02955212|474751844|FG000|Period 1: Double-blind Treatment Period|Other|3|||
131856420|NCT02955212|474751845|FG001|Period 1: Double-blind Treatment Period|Other|2|||
131856421|NCT02955212|474751844|FG000|Period 2: Open-label Extension|Adverse Event|11|||
131856422|NCT02955212|474751845|FG001|Period 2: Open-label Extension|Adverse Event|7|||
131856423|NCT02955212|474751844|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
131856424|NCT02955212|474751845|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
131856425|NCT02955212|474751844|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
131856426|NCT02955212|474751845|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
131856427|NCT02955212|474751844|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
131856428|NCT02955212|474751845|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
131856429|NCT02955212|474751844|FG000|Period 2: Open-label Extension|Other|2|||
131856430|NCT02955212|474751845|FG001|Period 2: Open-label Extension|Other|4|||
131856431|NCT02009722|474751846|FG000|Overall Study|Protocol Violation|1|||
131856432|NCT02009722|474751847|FG001|Overall Study|Protocol Violation|2|||
131856433|NCT02009722|474751846|FG000|Overall Study|Did not receive intervention|0|||
131856434|NCT02009722|474751847|FG001|Overall Study|Did not receive intervention|1|||
131856435|NCT03519087|474751856|FG000|Clinic Evaluation|Physician Decision|15|||
131856436|NCT03519087|474751857|FG001|Clinic Evaluation|Physician Decision|18|||
131856437|NCT03519087|474751858|FG002|Clinic Evaluation|Physician Decision|0|||
131856438|NCT03519087|474751859|FG003|Clinic Evaluation|Physician Decision|0|||
131856439|NCT03519087|474751860|FG004|Clinic Evaluation|Physician Decision|0|||
131856440|NCT03519087|474751856|FG000|Clinic Evaluation|Protocol Violation|1|||
131856441|NCT03519087|474751857|FG001|Clinic Evaluation|Protocol Violation|0|||
131856442|NCT03519087|474751858|FG002|Clinic Evaluation|Protocol Violation|0|||
131856443|NCT03519087|474751859|FG003|Clinic Evaluation|Protocol Violation|0|||
131856444|NCT03519087|474751860|FG004|Clinic Evaluation|Protocol Violation|0|||
131856445|NCT03519087|474751856|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
131856446|NCT03519087|474751857|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
131856447|NCT03519087|474751858|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
131856448|NCT03519087|474751859|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
131856449|NCT03519087|474751860|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
131856450|NCT03519087|474751856|FG000|Re-randomization for Treatment|Not appropriate|2|||
131856451|NCT03519087|474751857|FG001|Re-randomization for Treatment|Not appropriate|3|||
131856452|NCT03519087|474751858|FG002|Re-randomization for Treatment|Not appropriate|0|||
131856453|NCT03519087|474751859|FG003|Re-randomization for Treatment|Not appropriate|0|||
131856454|NCT03519087|474751860|FG004|Re-randomization for Treatment|Not appropriate|0|||
131856455|NCT03519087|474751856|FG000|Laboratory Testing|Lost to Follow-up|0|||
131856456|NCT03519087|474751857|FG001|Laboratory Testing|Lost to Follow-up|0|||
131856457|NCT03519087|474751858|FG002|Laboratory Testing|Lost to Follow-up|2|||
131856458|NCT03519087|474751859|FG003|Laboratory Testing|Lost to Follow-up|3|||
131856459|NCT03519087|474751860|FG004|Laboratory Testing|Lost to Follow-up|6|||
131856460|NCT03519087|474751856|FG000|Laboratory Testing|Protocol Violation|0|||
131856461|NCT03519087|474751857|FG001|Laboratory Testing|Protocol Violation|0|||
131856462|NCT03519087|474751858|FG002|Laboratory Testing|Protocol Violation|0|||
131856463|NCT03519087|474751859|FG003|Laboratory Testing|Protocol Violation|1|||
131856464|NCT03519087|474751860|FG004|Laboratory Testing|Protocol Violation|0|||
131856465|NCT01137071|474751861|FG000|Overall Study|Disease Progression|11|||
131856466|NCT01137071|474751861|FG000|Overall Study|Withdrawal by Subject|2|||
131856467|NCT01137071|474751861|FG000|Overall Study|Wrongly Included|1|||
131856468|NCT00796757|474751862|FG000|Overall Study|Withdrawal by Subject|14|||
131856469|NCT00796757|474751862|FG000|Overall Study|Death|61|||
131856470|NCT00796757|474751862|FG000|Overall Study|Protocol Violation|1|||
131856471|NCT00796757|474751862|FG000|Overall Study|Participant noncompliance|1|||
131856472|NCT00796757|474751862|FG000|Overall Study|Investigator's decision|2|||
131856473|NCT00796757|474751862|FG000|Overall Study|Other|7|||
131856474|NCT02324582|474751863|FG000|Overall Study|Screen Failures|0|||
131856475|NCT02324582|474751864|FG001|Overall Study|Screen Failures|5|||
131856476|NCT01487525|474751867|FG000|Overall Study|Withdrawal by Subject|0|||
131856477|NCT01487525|474751868|FG001|Overall Study|Withdrawal by Subject|1|||
131856478|NCT02123446|474751869|FG000|Washout Period (1 Day)|Physician Decision|1|||
131856479|NCT02123446|474751870|FG001|Washout Period (1 Day)|Physician Decision|0|||
131856480|NCT04388553|474751871|FG000|Overall Study|Protocol Violation|1|||
131856481|NCT04388553|474751872|FG001|Overall Study|Protocol Violation|0|||
131856482|NCT04604795|474751873|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
131856483|NCT04604795|474751874|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
131856484|NCT04604795|474751875|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856485|NCT04604795|474751876|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856486|NCT04604795|474751877|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856487|NCT04604795|474751878|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856488|NCT04604795|474751879|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856489|NCT04604795|474751880|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856490|NCT04604795|474751881|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856491|NCT04604795|474751882|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131856492|NCT04604795|474751873|FG000|Part B: Up to Day 14|Adverse Event|0|||
131856493|NCT04604795|474751874|FG001|Part B: Up to Day 14|Adverse Event|0|||
131856494|NCT04604795|474751875|FG002|Part B: Up to Day 14|Adverse Event|0|||
131856495|NCT04604795|474751876|FG003|Part B: Up to Day 14|Adverse Event|0|||
131856496|NCT04604795|474751877|FG004|Part B: Up to Day 14|Adverse Event|2|||
131856497|NCT04604795|474751878|FG005|Part B: Up to Day 14|Adverse Event|1|||
131856498|NCT04604795|474751879|FG006|Part B: Up to Day 14|Adverse Event|0|||
131856499|NCT04604795|474751880|FG007|Part B: Up to Day 14|Adverse Event|0|||
131856500|NCT04604795|474751881|FG008|Part B: Up to Day 14|Adverse Event|0|||
131856501|NCT04604795|474751882|FG009|Part B: Up to Day 14|Adverse Event|0|||
131856502|NCT04604795|474751873|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856503|NCT04604795|474751874|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856504|NCT04604795|474751875|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856505|NCT04604795|474751876|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856506|NCT04604795|474751877|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856507|NCT04604795|474751878|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856508|NCT04604795|474751879|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856509|NCT04604795|474751880|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856510|NCT04604795|474751881|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
131856511|NCT04604795|474751882|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
131856512|NCT04604795|474751873|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856513|NCT04604795|474751874|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856514|NCT04604795|474751875|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856515|NCT04604795|474751876|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856516|NCT04604795|474751877|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856517|NCT04604795|474751878|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856518|NCT04604795|474751879|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856519|NCT04604795|474751880|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856520|NCT04604795|474751881|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
131856521|NCT04604795|474751882|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131856522|NCT04604795|474751873|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856523|NCT04604795|474751874|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856524|NCT04604795|474751875|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856525|NCT04604795|474751876|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856526|NCT04604795|474751877|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856527|NCT04604795|474751878|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856528|NCT04604795|474751879|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856529|NCT04604795|474751880|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856530|NCT04604795|474751881|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
131856531|NCT04604795|474751882|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
131856532|NCT04604795|474751873|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856533|NCT04604795|474751874|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856534|NCT04604795|474751875|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856535|NCT04604795|474751876|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856536|NCT04604795|474751877|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856537|NCT04604795|474751878|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856538|NCT04604795|474751879|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856539|NCT04604795|474751880|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856540|NCT04604795|474751881|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
131856541|NCT04604795|474751882|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
131856542|NCT04502212|474751888|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
131856543|NCT04502212|474751888|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
131856544|NCT00111241|474751889|FG000|Overall Study|Lost to Follow-up|1|||
131856545|NCT00111241|474751890|FG001|Overall Study|Lost to Follow-up|0|||
131856546|NCT00111241|474751889|FG000|Overall Study|Withdrawal by Subject|4|||
131856547|NCT00111241|474751890|FG001|Overall Study|Withdrawal by Subject|0|||
131856548|NCT00111241|474751889|FG000|Overall Study|Protocol Violation|9|||
131856549|NCT00111241|474751890|FG001|Overall Study|Protocol Violation|8|||
131856550|NCT00111241|474751889|FG000|Overall Study|Adverse Event|1|||
131856551|NCT00111241|474751890|FG001|Overall Study|Adverse Event|0|||
131856552|NCT02096744|474751895|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
131856553|NCT02096744|474751896|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
131856554|NCT02096744|474751895|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
131856555|NCT02096744|474751896|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
131856556|NCT02096744|474751895|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
131856557|NCT02096744|474751896|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
131856558|NCT00952731|474751902|FG000|Overall Study|Drug supply expired|1|||
131856559|NCT00952731|474751903|FG001|Overall Study|Drug supply expired|0|||
131856560|NCT02517463|474751911|FG000|Overall Study|Lost to Follow-up|5|||
131856561|NCT02517463|474751912|FG001|Overall Study|Lost to Follow-up|2|||
131856562|NCT02764151|474751922|FG000|Overall Study|Subject refused further follow-up|0|||
131856563|NCT02764151|474751923|FG001|Overall Study|Subject refused further follow-up|0|||
131856564|NCT02764151|474751924|FG002|Overall Study|Subject refused further follow-up|0|||
131856565|NCT02764151|474751925|FG003|Overall Study|Subject refused further follow-up|1|||
131856566|NCT02764151|474751922|FG000|Overall Study|Other|0|||
131856567|NCT02764151|474751923|FG001|Overall Study|Other|0|||
131856568|NCT02764151|474751924|FG002|Overall Study|Other|0|||
131856569|NCT02764151|474751925|FG003|Overall Study|Other|2|||
131856570|NCT01959295|474751926|FG000|Overall Study|Adverse Event|2|||
131856571|NCT01959295|474751927|FG001|Overall Study|Adverse Event|0|||
131856572|NCT01959295|474751926|FG000|Overall Study|Lost to Follow-up|0|||
131856573|NCT01959295|474751927|FG001|Overall Study|Lost to Follow-up|2|||
131856574|NCT01959295|474751926|FG000|Overall Study|Physician Decision|2|||
131856575|NCT01959295|474751927|FG001|Overall Study|Physician Decision|3|||
131856576|NCT01959295|474751926|FG000|Overall Study|Protocol Violation|16|||
131856577|NCT01959295|474751927|FG001|Overall Study|Protocol Violation|5|||
131856578|NCT01959295|474751926|FG000|Overall Study|Withdrawal by Subject|3|||
131856579|NCT01959295|474751927|FG001|Overall Study|Withdrawal by Subject|1|||
131856580|NCT01959295|474751926|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
131856581|NCT01959295|474751927|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
131856582|NCT01682811|474751929|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131856583|NCT01682811|474751930|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131856584|NCT01682811|474751931|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131856585|NCT01682811|474751932|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131856586|NCT01682811|474751933|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
131856587|NCT01682811|474751934|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131856588|NCT01682811|474751935|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131856589|NCT01682811|474751929|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
131856590|NCT01682811|474751930|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
131856591|NCT01682811|474751931|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
131856592|NCT01682811|474751932|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
131856593|NCT01682811|474751933|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
131856594|NCT01682811|474751934|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
131856595|NCT01682811|474751935|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
131856596|NCT01682811|474751929|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
131856597|NCT01682811|474751930|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
131856598|NCT01682811|474751931|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
131856599|NCT01682811|474751932|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
131856600|NCT01682811|474751933|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
131856601|NCT01682811|474751934|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
131856602|NCT01682811|474751935|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
131856603|NCT01682811|474751929|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
131856604|NCT01682811|474751930|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
131856605|NCT01682811|474751931|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
131856606|NCT01682811|474751932|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
131856607|NCT01682811|474751933|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
131856608|NCT01682811|474751934|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
131856609|NCT01682811|474751935|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
131912525|NCT02765165|474966602|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
131912526|NCT02765165|474966603|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
131856610|NCT04903288|474753403|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
131856611|NCT04903288|474753403|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
131856612|NCT04903288|474753403|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
131856613|NCT04903288|474753403|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
131856614|NCT05878093|474753408|FG000|Overall Study|Withdrawal by Subject|3|||
131856615|NCT05878093|474753409|FG001|Overall Study|Withdrawal by Subject|1|||
131856616|NCT03690388|474753412|FG000|Overall Study|Adverse Event|8|||
131856617|NCT03690388|474753413|FG001|Overall Study|Adverse Event|1|||
131856618|NCT03690388|474753412|FG000|Overall Study|Radiographic Progression|14|||
131856619|NCT03690388|474753413|FG001|Overall Study|Radiographic Progression|29|||
131856620|NCT03690388|474753412|FG000|Overall Study|Clinical deterioration|10|||
131856621|NCT03690388|474753413|FG001|Overall Study|Clinical deterioration|6|||
131856622|NCT03690388|474753412|FG000|Overall Study|Withdrawal by Subject|2|||
131856623|NCT03690388|474753413|FG001|Overall Study|Withdrawal by Subject|0|||
131856624|NCT03690388|474753412|FG000|Overall Study|Lack of Efficacy|1|||
131856625|NCT03690388|474753413|FG001|Overall Study|Lack of Efficacy|0|||
131856626|NCT03690388|474753412|FG000|Overall Study|Lost to Follow-up|1|||
131856627|NCT03690388|474753413|FG001|Overall Study|Lost to Follow-up|0|||
131856628|NCT04100018|474753415|FG000|Pre-Treatment Period|Not Reported|0|||
131856629|NCT04100018|474753416|FG001|Pre-Treatment Period|Not Reported|4|||
131856630|NCT04100018|474753415|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
131856631|NCT04100018|474753416|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
131856632|NCT04100018|474753415|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
131856633|NCT04100018|474753416|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
131856634|NCT04100018|474753415|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
131856635|NCT04100018|474753416|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131856636|NCT04100018|474753415|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
131856637|NCT04100018|474753416|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
131856638|NCT04100018|474753415|FG000|Treatment Period|Ongoing Treatment|1|||
131856639|NCT04100018|474753416|FG001|Treatment Period|Ongoing Treatment|0|||
131856640|NCT04100018|474753415|FG000|Treatment Period|Other Reason|26|||
131856641|NCT04100018|474753416|FG001|Treatment Period|Other Reason|37|||
131856642|NCT04100018|474753415|FG000|Treatment Period|Completed treatment as per protocol|1|||
131856643|NCT04100018|474753416|FG001|Treatment Period|Completed treatment as per protocol|2|||
131856644|NCT04100018|474753415|FG000|Treatment Period|Maximum clinical benefit|3|||
131856645|NCT04100018|474753416|FG001|Treatment Period|Maximum clinical benefit|0|||
131856646|NCT04100018|474753415|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
131856647|NCT04100018|474753416|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
131856648|NCT04100018|474753415|FG000|Treatment Period|Study drug toxicity|67|||
131856649|NCT04100018|474753416|FG001|Treatment Period|Study drug toxicity|28|||
131856650|NCT04100018|474753415|FG000|Treatment Period|Disease Progression|284|||
131856651|NCT04100018|474753416|FG001|Treatment Period|Disease Progression|327|||
131856652|NCT04100018|474753415|FG000|Treatment Period|Administrative reasons by sponsor|16|||
131856653|NCT04100018|474753416|FG001|Treatment Period|Administrative reasons by sponsor|30|||
131856654|NCT04100018|474753415|FG000|Treatment Period|Poor/Non-Compliance|1|||
131856655|NCT04100018|474753416|FG001|Treatment Period|Poor/Non-Compliance|0|||
131856656|NCT04100018|474753415|FG000|Treatment Period|Lost to Follow-up|2|||
131856657|NCT04100018|474753416|FG001|Treatment Period|Lost to Follow-up|2|||
131856658|NCT04100018|474753415|FG000|Treatment Period|Death|16|||
131856659|NCT04100018|474753416|FG001|Treatment Period|Death|11|||
131856660|NCT04100018|474753415|FG000|Treatment Period|Participant withdrew consent|10|||
131856661|NCT04100018|474753416|FG001|Treatment Period|Participant withdrew consent|10|||
131856662|NCT04100018|474753415|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
131856663|NCT04100018|474753416|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
131856664|NCT04100018|474753415|FG000|Treatment Period|Adverse Event|14|||
131856665|NCT04100018|474753416|FG001|Treatment Period|Adverse Event|6|||
131856666|NCT04100018|474753415|FG000|Treatment Period|Lack of Efficacy|4|||
131856667|NCT04100018|474753416|FG001|Treatment Period|Lack of Efficacy|2|||
131856668|NCT05377749|474753421|FG000|3 Weeks|Lost to Follow-up|2|||
131856669|NCT05377749|474753422|FG001|3 Weeks|Lost to Follow-up|4|||
131912527|NCT02765165|474966604|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
131912528|NCT02765165|474966605|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
131912529|NCT02765165|474966606|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
131912530|NCT02765165|474966607|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
131912531|NCT02765165|474966608|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
131912532|NCT02765165|474966602|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
131912533|NCT02765165|474966603|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
131856670|NCT05377749|474753421|FG000|3 Weeks|Withdrawal by Subject|1|||
131856671|NCT05377749|474753422|FG001|3 Weeks|Withdrawal by Subject|1|||
131856672|NCT02090725|474753423|FG000|Overall Study|Withdrawal by Subject|1|||
131856673|NCT02090725|474753423|FG000|Overall Study|participants moved from area|3|||
131856674|NCT04358081|474753424|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
131856675|NCT04358081|474753425|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
131856676|NCT04358081|474753426|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
131856677|NCT04358081|474753424|FG000|Treatment Phase of Study|Adverse Event|1|||
131856678|NCT04358081|474753425|FG001|Treatment Phase of Study|Adverse Event|0|||
131856679|NCT04358081|474753426|FG002|Treatment Phase of Study|Adverse Event|1|||
131856680|NCT04358081|474753424|FG000|Treatment Phase of Study|Physician Decision|2|||
131856681|NCT04358081|474753425|FG001|Treatment Phase of Study|Physician Decision|0|||
131856682|NCT04358081|474753426|FG002|Treatment Phase of Study|Physician Decision|1|||
131856683|NCT04358081|474753424|FG000|Treatment Phase of Study|Protocol Violation|1|||
131856684|NCT04358081|474753425|FG001|Treatment Phase of Study|Protocol Violation|0|||
131856685|NCT04358081|474753426|FG002|Treatment Phase of Study|Protocol Violation|0|||
131856686|NCT04358081|474753424|FG000|Study Completion Phase|Death|0|||
131856687|NCT04358081|474753425|FG001|Study Completion Phase|Death|0|||
131856688|NCT04358081|474753426|FG002|Study Completion Phase|Death|1|||
131912534|NCT02765165|474966604|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
131912535|NCT02765165|474966605|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
131912536|NCT02765165|474966606|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
131912537|NCT02765165|474966607|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
131912538|NCT02765165|474966608|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
131912539|NCT02765165|474966602|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
131912540|NCT02765165|474966603|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
131912541|NCT02765165|474966604|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
131912542|NCT02765165|474966605|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
131912543|NCT02765165|474966606|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
131912544|NCT02765165|474966607|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
131912545|NCT02765165|474966608|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
131912546|NCT02765165|474966602|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
131912547|NCT02765165|474966603|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
131912548|NCT02765165|474966604|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
131912549|NCT02765165|474966605|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
131406538|NCT00624780|473111314|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
131406539|NCT00624780|473111315|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
131406540|NCT00624780|473111316|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
131406541|NCT00624780|473111317|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
131406542|NCT00624780|473111318|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
131406543|NCT00624780|473111319|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
131406544|NCT00624780|473111314|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
131406545|NCT00624780|473111315|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
131406546|NCT00624780|473111316|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
131406547|NCT00624780|473111317|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
131406548|NCT00624780|473111318|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
131406549|NCT00624780|473111319|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
131406550|NCT00624780|473111314|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
131406551|NCT00624780|473111315|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
131406552|NCT00624780|473111316|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
131406553|NCT00624780|473111317|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
131406554|NCT00624780|473111318|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
131406555|NCT00624780|473111319|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
131406556|NCT00624780|473111314|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
131406557|NCT00624780|473111315|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
131856689|NCT04358081|474753424|FG000|Study Completion Phase|Lost to Follow-up|1|||
131856690|NCT04358081|474753425|FG001|Study Completion Phase|Lost to Follow-up|0|||
131856691|NCT04358081|474753426|FG002|Study Completion Phase|Lost to Follow-up|1|||
131856692|NCT02656303|474753427|FG000|Overall Study|Adverse Event|3|||
131856693|NCT02656303|474753428|FG001|Overall Study|Adverse Event|2|||
131856694|NCT02656303|474753429|FG002|Overall Study|Adverse Event|0|||
131856695|NCT02656303|474753427|FG000|Overall Study|Death|12|||
131856696|NCT02656303|474753428|FG001|Overall Study|Death|4|||
131856697|NCT02656303|474753429|FG002|Overall Study|Death|1|||
131856698|NCT02656303|474753427|FG000|Overall Study|Lack of Efficacy|1|||
131856699|NCT02656303|474753428|FG001|Overall Study|Lack of Efficacy|0|||
131856700|NCT02656303|474753429|FG002|Overall Study|Lack of Efficacy|0|||
131856701|NCT02656303|474753427|FG000|Overall Study|Non-Compliance with Study|1|||
131856702|NCT02656303|474753428|FG001|Overall Study|Non-Compliance with Study|1|||
131856703|NCT02656303|474753429|FG002|Overall Study|Non-Compliance with Study|0|||
131856704|NCT02656303|474753427|FG000|Overall Study|Investigator Decision|2|||
131856705|NCT02656303|474753428|FG001|Overall Study|Investigator Decision|1|||
131856706|NCT02656303|474753429|FG002|Overall Study|Investigator Decision|0|||
131856707|NCT02656303|474753427|FG000|Overall Study|Progressive Disease|25|||
131856708|NCT02656303|474753428|FG001|Overall Study|Progressive Disease|14|||
131856709|NCT02656303|474753429|FG002|Overall Study|Progressive Disease|10|||
131856710|NCT02656303|474753427|FG000|Overall Study|Study Terminated by Sponsor|20|||
131856711|NCT02656303|474753428|FG001|Overall Study|Study Terminated by Sponsor|7|||
131856712|NCT02656303|474753429|FG002|Overall Study|Study Terminated by Sponsor|5|||
131856713|NCT02656303|474753427|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
131406558|NCT00624780|473111316|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
131406559|NCT00624780|473111317|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
131406560|NCT00624780|473111318|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
131406561|NCT00624780|473111319|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
131406562|NCT00624780|473111314|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
131406563|NCT00624780|473111315|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
131406564|NCT00624780|473111316|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
131856714|NCT02656303|474753428|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
131856715|NCT02656303|474753429|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
131912550|NCT02765165|474966606|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
131856716|NCT02656303|474753427|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
131856717|NCT02656303|474753428|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
131856718|NCT02656303|474753429|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
131856719|NCT02656303|474753427|FG000|Overall Study|Reason not Specified|1|||
131856720|NCT02656303|474753428|FG001|Overall Study|Reason not Specified|1|||
131856721|NCT02656303|474753429|FG002|Overall Study|Reason not Specified|2|||
131856722|NCT01842438|474753432|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
131856723|NCT01842438|474753433|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
131856724|NCT01842438|474753432|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
131856725|NCT01842438|474753433|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
131856726|NCT01842438|474753432|FG000|T2: 6month Follow-up|Death|0|||
131856727|NCT01842438|474753433|FG001|T2: 6month Follow-up|Death|1|||
131856728|NCT00782626|474753434|FG000|Overall Study|Adverse Event|1|||
131856729|NCT00782626|474753434|FG000|Overall Study|Progressive Disease|5|||
131856730|NCT00782626|474753434|FG000|Overall Study|Other Complicating Disease|1|||
131856731|NCT04909853|474753435|FG000|Part 1|Assigned but not treated|0|||
131856732|NCT04909853|474753436|FG001|Part 1|Assigned but not treated|0|||
131856733|NCT04909853|474753437|FG002|Part 1|Assigned but not treated|1|||
131856734|NCT04909853|474753438|FG003|Part 1|Assigned but not treated|0|||
131856735|NCT04909853|474753435|FG000|Part 2|Adverse Event|0|||
131856736|NCT04909853|474753436|FG001|Part 2|Adverse Event|0|||
131856737|NCT04909853|474753437|FG002|Part 2|Adverse Event|0|||
131856738|NCT04909853|474753438|FG003|Part 2|Adverse Event|1|||
131856739|NCT00077207|474753440|FG000|Overall Study|Adverse Event|5|||
131856740|NCT00077207|474753440|FG000|Overall Study|Lack of Efficacy|12|||
131856741|NCT00077207|474753440|FG000|Overall Study|Physician Decision|6|||
131856742|NCT00077207|474753440|FG000|Overall Study|Withdrawal by Subject|6|||
131856743|NCT00077207|474753440|FG000|Overall Study|Ineligible|1|||
131856744|NCT01811472|474753441|FG000|Overall Study|Adverse Event|1|||
131856745|NCT01811472|474753442|FG001|Overall Study|Adverse Event|0|||
131856746|NCT01811472|474753443|FG002|Overall Study|Adverse Event|4|||
131856747|NCT01811472|474753441|FG000|Overall Study|Lost to Follow-up|0|||
131856748|NCT01811472|474753442|FG001|Overall Study|Lost to Follow-up|0|||
131856749|NCT01811472|474753443|FG002|Overall Study|Lost to Follow-up|1|||
131856750|NCT01811472|474753441|FG000|Overall Study|Subject/guardian decision|1|||
131856751|NCT01811472|474753442|FG001|Overall Study|Subject/guardian decision|0|||
131856752|NCT01811472|474753443|FG002|Overall Study|Subject/guardian decision|0|||
131856753|NCT03280264|474753444|FG000|Overall Study|Adverse Event|1|||
131856754|NCT03280264|474753444|FG000|Overall Study|Physician Decision|1|||
131856755|NCT03280264|474753444|FG000|Overall Study|Withdrawal by Subject|1|||
131856756|NCT00114140|474753445|FG000|Overall Study|Protocol Violation|7|||
131856757|NCT00666328|474753449|FG000|Overall Study|Death|2|||
131856758|NCT00666328|474753449|FG000|Overall Study|Lost to Follow-up|2|||
131856759|NCT00666328|474753449|FG000|Overall Study|No longer met eligibility criteria|1|||
131856760|NCT02232984|474753450|FG000|Overall Study|Withdrawal by Subject|5|||
131856761|NCT02232984|474753450|FG000|Overall Study|Death|1|||
131856762|NCT02232984|474753450|FG000|Overall Study|Investigator withdrawal|10|||
131856763|NCT02232984|474753450|FG000|Overall Study|Device implant unsuccessful|53|||
131856764|NCT02232984|474753450|FG000|Overall Study|not disclosed by site|7|||
131856765|NCT02232984|474753450|FG000|Overall Study|Protocol Violation|1|||
131856766|NCT03934541|474753453|FG000|Overall Study|Study Terminated by Sponsor|0|||
131856767|NCT03934541|474753454|FG001|Overall Study|Study Terminated by Sponsor|1|||
131856768|NCT03934541|474753455|FG002|Overall Study|Study Terminated by Sponsor|0|||
131856769|NCT03934541|474753456|FG003|Overall Study|Study Terminated by Sponsor|0|||
131856770|NCT02673775|474753457|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
131856771|NCT02673775|474753458|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
131856772|NCT02673775|474753457|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
131856773|NCT02673775|474753458|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
131856774|NCT02673775|474753457|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
131406565|NCT00624780|473111317|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
131406566|NCT00624780|473111318|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
131406567|NCT00624780|473111319|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
131406568|NCT00624780|473111314|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
131406569|NCT00624780|473111315|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
131406570|NCT00624780|473111316|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
131406571|NCT00624780|473111317|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
131406572|NCT00624780|473111318|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
131406573|NCT00624780|473111319|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
131406574|NCT00624780|473111314|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
131406575|NCT00624780|473111315|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
131856775|NCT02673775|474753458|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
131856776|NCT02673775|474753457|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
131856777|NCT02673775|474753458|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
131856778|NCT03151304|474753459|FG000|Overall Study|Termination of study by Sponsor|23|||
131406576|NCT00624780|473111316|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
131406577|NCT00624780|473111317|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
131406578|NCT00624780|473111318|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
131406579|NCT00624780|473111319|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
131406580|NCT00624780|473111314|FG000|Follow-up (Week 26)|Death|0|||
131406581|NCT00624780|473111315|FG001|Follow-up (Week 26)|Death|0|||
131406582|NCT00624780|473111316|FG002|Follow-up (Week 26)|Death|1|||
131406583|NCT00624780|473111317|FG003|Follow-up (Week 26)|Death|0|||
131406584|NCT00624780|473111318|FG004|Follow-up (Week 26)|Death|0|||
131406585|NCT00624780|473111319|FG005|Follow-up (Week 26)|Death|0|||
131406586|NCT00624780|473111314|FG000|Follow-up (Week 26)|Adverse Event|0|||
131406587|NCT00624780|473111315|FG001|Follow-up (Week 26)|Adverse Event|0|||
131406588|NCT00624780|473111316|FG002|Follow-up (Week 26)|Adverse Event|0|||
131406589|NCT00624780|473111317|FG003|Follow-up (Week 26)|Adverse Event|0|||
131406590|NCT00624780|473111318|FG004|Follow-up (Week 26)|Adverse Event|1|||
131406591|NCT00624780|473111319|FG005|Follow-up (Week 26)|Adverse Event|0|||
131406592|NCT00624780|473111314|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
131406593|NCT00624780|473111315|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
131406594|NCT00624780|473111316|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
131406595|NCT00624780|473111317|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
131406596|NCT00624780|473111318|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
131406597|NCT00624780|473111319|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
131406598|NCT00624780|473111314|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
131406599|NCT00624780|473111315|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
131912551|NCT02765165|474966607|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
131912552|NCT02765165|474966608|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
131912553|NCT01206764|474966609|FG000|Overall Study|Adverse Event|20|||
131912554|NCT01206764|474966609|FG000|Overall Study|Abnormal laboratory value|2|||
131912555|NCT01206764|474966609|FG000|Overall Study|Abnormal test procedure result|1|||
131912556|NCT01206764|474966609|FG000|Overall Study|Patient withdrew consent|5|||
131912557|NCT01206764|474966609|FG000|Overall Study|Lost to Follow-up|6|||
131912558|NCT01206764|474966609|FG000|Overall Study|Death|11|||
131912559|NCT01206764|474966609|FG000|Overall Study|New cancer therapy|2|||
131912560|NCT01206764|474966609|FG000|Overall Study|Disease progression|88|||
131912561|NCT01206764|474966609|FG000|Overall Study|Protocol deviation|3|||
131912562|NCT01186770|474966610|FG000|Overall Study|Ineligibility|0|||
131912563|NCT01186770|474966611|FG001|Overall Study|Ineligibility|0|||
131912564|NCT01186770|474966612|FG002|Overall Study|Ineligibility|2|||
131912565|NCT01186770|474966613|FG003|Overall Study|Ineligibility|0|||
131912566|NCT01186770|474966610|FG000|Overall Study|Protocol Violation|7|||
131912567|NCT01186770|474966611|FG001|Overall Study|Protocol Violation|9|||
131912568|NCT01186770|474966612|FG002|Overall Study|Protocol Violation|12|||
131406600|NCT00624780|473111316|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
131406601|NCT00624780|473111317|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
131406602|NCT00624780|473111318|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
131406603|NCT00624780|473111319|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
131406604|NCT00624780|473111314|FG000|Follow-up (Week 26)|Other|1|||
131406605|NCT00624780|473111315|FG001|Follow-up (Week 26)|Other|1|||
131406606|NCT00624780|473111316|FG002|Follow-up (Week 26)|Other|0|||
131406607|NCT00624780|473111317|FG003|Follow-up (Week 26)|Other|0|||
131406608|NCT00624780|473111318|FG004|Follow-up (Week 26)|Other|0|||
131406609|NCT00624780|473111319|FG005|Follow-up (Week 26)|Other|0|||
131406610|NCT01514240|473113311|FG000|Overall Study|Adverse Event|4|||
131406611|NCT01514240|473113312|FG001|Overall Study|Adverse Event|4|||
131406612|NCT01514240|473113311|FG000|Overall Study|Subject Decision|2|||
131406613|NCT01514240|473113312|FG001|Overall Study|Subject Decision|7|||
131406614|NCT01103063|473113313|FG000|Overall Study|Adverse Event|3|||
131406615|NCT01103063|473113314|FG001|Overall Study|Adverse Event|1|||
131406616|NCT01103063|473113313|FG000|Overall Study|Lost to Follow-up|68|||
131406617|NCT01103063|473113314|FG001|Overall Study|Lost to Follow-up|51|||
131406618|NCT01103063|473113313|FG000|Overall Study|Withdrawal by Subject|60|||
131406619|NCT01103063|473113314|FG001|Overall Study|Withdrawal by Subject|15|||
131406620|NCT01103063|473113313|FG000|Overall Study|Other|16|||
131406621|NCT01103063|473113314|FG001|Overall Study|Other|11|||
131406622|NCT01103063|473113313|FG000|Overall Study|Protocol Violation|1|||
131406623|NCT01103063|473113314|FG001|Overall Study|Protocol Violation|0|||
131406624|NCT01103063|473113313|FG000|Overall Study|Study terminated by Sponsor|326|||
131406625|NCT01103063|473113314|FG001|Overall Study|Study terminated by Sponsor|342|||
131406626|NCT01103063|473113313|FG000|Overall Study|Death|3|||
131406627|NCT01103063|473113314|FG001|Overall Study|Death|1|||
131453825|NCT05307692|473290041|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
131406628|NCT04035564|473113317|FG000|Overall Study|Protocol Violation|1|||
131406629|NCT04035564|473113318|FG001|Overall Study|Protocol Violation|2|||
131406630|NCT04035564|473113317|FG000|Overall Study|No laboratory available|2|||
131406631|NCT04035564|473113318|FG001|Overall Study|No laboratory available|2|||
131406632|NCT04035564|473113317|FG000|Overall Study|Guardian declined consent|1|||
131406633|NCT04035564|473113318|FG001|Overall Study|Guardian declined consent|2|||
131406634|NCT02754141|473113319|FG000|Overall Study|Disease progression|11|||
131406635|NCT02754141|473113320|FG001|Overall Study|Disease progression|7|||
131856779|NCT03151304|474753459|FG000|Overall Study|missing|3|||
131856780|NCT03151304|474753459|FG000|Overall Study|Withdrawal by Subject|8|||
131856781|NCT03151304|474753459|FG000|Overall Study|multiple reasons|30|||
131856782|NCT04194645|474753462|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856783|NCT04194645|474753463|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856784|NCT04194645|474753464|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856785|NCT04194645|474753465|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856786|NCT04194645|474753466|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856787|NCT04194645|474753467|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856788|NCT04194645|474753468|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856789|NCT04194645|474753469|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856790|NCT04194645|474753470|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856791|NCT04194645|474753471|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
131856792|NCT04194645|474753472|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856793|NCT04194645|474753473|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856794|NCT04194645|474753474|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856795|NCT04194645|474753475|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131856796|NCT04194645|474753476|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
131406636|NCT02754141|473113321|FG002|Overall Study|Disease progression|8|||
131406637|NCT02754141|473113322|FG003|Overall Study|Disease progression|5|||
131406638|NCT02754141|473113323|FG004|Overall Study|Disease progression|7|||
131406639|NCT02754141|473113324|FG005|Overall Study|Disease progression|7|||
131406640|NCT02754141|473113325|FG006|Overall Study|Disease progression|7|||
131406641|NCT02754141|473113326|FG007|Overall Study|Disease progression|6|||
131406642|NCT02754141|473113327|FG008|Overall Study|Disease progression|11|||
131406643|NCT02754141|473113328|FG009|Overall Study|Disease progression|16|||
131406644|NCT02754141|473113329|FG010|Overall Study|Disease progression|18|||
131406645|NCT02754141|473113330|FG011|Overall Study|Disease progression|13|||
131406646|NCT02754141|473113331|FG012|Overall Study|Disease progression|10|||
131406647|NCT02754141|473113332|FG013|Overall Study|Disease progression|12|||
131406648|NCT02754141|473113333|FG014|Overall Study|Disease progression|12|||
131406649|NCT02754141|473113334|FG015|Overall Study|Disease progression|14|||
131406650|NCT02754141|473113335|FG016|Overall Study|Disease progression|0|||
131406651|NCT02754141|473113336|FG017|Overall Study|Disease progression|1|||
131406652|NCT02754141|473113319|FG000|Overall Study|Study drug toxicity|1|||
131406653|NCT02754141|473113320|FG001|Overall Study|Study drug toxicity|1|||
131406654|NCT02754141|473113321|FG002|Overall Study|Study drug toxicity|0|||
131406655|NCT02754141|473113322|FG003|Overall Study|Study drug toxicity|0|||
131406656|NCT02754141|473113323|FG004|Overall Study|Study drug toxicity|0|||
131406657|NCT02754141|473113324|FG005|Overall Study|Study drug toxicity|0|||
131406658|NCT02754141|473113325|FG006|Overall Study|Study drug toxicity|0|||
131406659|NCT02754141|473113326|FG007|Overall Study|Study drug toxicity|0|||
131406660|NCT02754141|473113327|FG008|Overall Study|Study drug toxicity|0|||
131406661|NCT02754141|473113328|FG009|Overall Study|Study drug toxicity|0|||
131406662|NCT02754141|473113329|FG010|Overall Study|Study drug toxicity|2|||
131406663|NCT02754141|473113330|FG011|Overall Study|Study drug toxicity|1|||
131406664|NCT02754141|473113331|FG012|Overall Study|Study drug toxicity|1|||
131406665|NCT02754141|473113332|FG013|Overall Study|Study drug toxicity|0|||
131406666|NCT02754141|473113333|FG014|Overall Study|Study drug toxicity|0|||
131406667|NCT02754141|473113334|FG015|Overall Study|Study drug toxicity|0|||
131406668|NCT02754141|473113335|FG016|Overall Study|Study drug toxicity|0|||
131406669|NCT02754141|473113336|FG017|Overall Study|Study drug toxicity|0|||
131406670|NCT02754141|473113319|FG000|Overall Study|AE unrelated to study drug|1|||
131406671|NCT02754141|473113320|FG001|Overall Study|AE unrelated to study drug|1|||
131406672|NCT02754141|473113321|FG002|Overall Study|AE unrelated to study drug|0|||
131406673|NCT02754141|473113322|FG003|Overall Study|AE unrelated to study drug|1|||
131406674|NCT02754141|473113323|FG004|Overall Study|AE unrelated to study drug|3|||
131406675|NCT02754141|473113324|FG005|Overall Study|AE unrelated to study drug|2|||
131406676|NCT02754141|473113325|FG006|Overall Study|AE unrelated to study drug|1|||
131406677|NCT02754141|473113326|FG007|Overall Study|AE unrelated to study drug|0|||
131406678|NCT02754141|473113327|FG008|Overall Study|AE unrelated to study drug|0|||
131406679|NCT02754141|473113328|FG009|Overall Study|AE unrelated to study drug|0|||
131856797|NCT03076775|474753477|FG000|Overall Study|Lost to Follow-up|1|||
131406680|NCT02754141|473113329|FG010|Overall Study|AE unrelated to study drug|0|||
131406681|NCT02754141|473113330|FG011|Overall Study|AE unrelated to study drug|0|||
131406682|NCT02754141|473113331|FG012|Overall Study|AE unrelated to study drug|0|||
131406683|NCT02754141|473113332|FG013|Overall Study|AE unrelated to study drug|0|||
131406684|NCT02754141|473113333|FG014|Overall Study|AE unrelated to study drug|0|||
131406685|NCT02754141|473113334|FG015|Overall Study|AE unrelated to study drug|0|||
131406686|NCT02754141|473113335|FG016|Overall Study|AE unrelated to study drug|0|||
131406687|NCT02754141|473113336|FG017|Overall Study|AE unrelated to study drug|0|||
131406688|NCT02754141|473113319|FG000|Overall Study|Request to discontinue|0|||
131406689|NCT02754141|473113320|FG001|Overall Study|Request to discontinue|0|||
131406690|NCT02754141|473113321|FG002|Overall Study|Request to discontinue|0|||
131406691|NCT02754141|473113322|FG003|Overall Study|Request to discontinue|0|||
131406692|NCT02754141|473113323|FG004|Overall Study|Request to discontinue|0|||
131406693|NCT02754141|473113324|FG005|Overall Study|Request to discontinue|0|||
131406694|NCT02754141|473113325|FG006|Overall Study|Request to discontinue|0|||
131856798|NCT03076775|474753478|FG001|Overall Study|Lost to Follow-up|0|||
131856799|NCT01783886|474753479|FG000|Overall Study|Lost to Follow-up|0|||
131856800|NCT01783886|474753480|FG001|Overall Study|Lost to Follow-up|3|||
131856801|NCT01783886|474753481|FG002|Overall Study|Lost to Follow-up|0|||
131856802|NCT01783886|474753479|FG000|Overall Study|Protocol deviation|0|||
131856803|NCT01783886|474753480|FG001|Overall Study|Protocol deviation|0|||
131856804|NCT01783886|474753481|FG002|Overall Study|Protocol deviation|2|||
131856805|NCT01783886|474753479|FG000|Overall Study|Withdrawal of consent by participant|1|||
131856806|NCT01783886|474753480|FG001|Overall Study|Withdrawal of consent by participant|3|||
131856807|NCT01783886|474753481|FG002|Overall Study|Withdrawal of consent by participant|4|||
131856808|NCT01783886|474753479|FG000|Overall Study|Adverse Event|4|||
131856809|NCT01783886|474753480|FG001|Overall Study|Adverse Event|5|||
131856810|NCT01783886|474753481|FG002|Overall Study|Adverse Event|4|||
131856811|NCT04542057|474753482|FG000|Overall Study|Death|3|||
131856812|NCT04542057|474753483|FG001|Overall Study|Death|1|||
131856813|NCT04542057|474753482|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
131856814|NCT04542057|474753483|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
131856815|NCT04542057|474753482|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
131856816|NCT04542057|474753483|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
131856817|NCT04542057|474753482|FG000|Overall Study|Adverse Event|15|||
131856818|NCT04542057|474753483|FG001|Overall Study|Adverse Event|6|||
131856819|NCT04542057|474753482|FG000|Overall Study|COVID-19 adverse event|6|||
131856820|NCT04542057|474753483|FG001|Overall Study|COVID-19 adverse event|4|||
131856821|NCT04542057|474753482|FG000|Overall Study|Lack of Efficacy|2|||
131856822|NCT04542057|474753483|FG001|Overall Study|Lack of Efficacy|5|||
131856823|NCT04542057|474753482|FG000|Overall Study|Study terminated by sponsor|1|||
131856824|NCT04542057|474753483|FG001|Overall Study|Study terminated by sponsor|0|||
131856825|NCT04542057|474753482|FG000|Overall Study|Investigator discretion|2|||
131856826|NCT04542057|474753483|FG001|Overall Study|Investigator discretion|1|||
131856827|NCT04542057|474753482|FG000|Overall Study|Withdrawal by Subject|52|||
131856828|NCT04542057|474753483|FG001|Overall Study|Withdrawal by Subject|30|||
131856829|NCT04542057|474753482|FG000|Overall Study|Lost to Follow-up|8|||
131856830|NCT04542057|474753483|FG001|Overall Study|Lost to Follow-up|11|||
131856831|NCT04542057|474753482|FG000|Overall Study|Other|2|||
131856832|NCT04542057|474753483|FG001|Overall Study|Other|2|||
131856833|NCT00104572|474753484|FG000|Overall Study|Withdrawal by Subject|3|||
131856834|NCT00104572|474753485|FG001|Overall Study|Withdrawal by Subject|3|||
131856835|NCT00104572|474753486|FG002|Overall Study|Withdrawal by Subject|0|||
131856836|NCT00098774|474753489|FG000|Overall Study|Adverse Event|2|||
131856837|NCT00098774|474753489|FG000|Overall Study|Disease Progression|9|||
131856838|NCT00098774|474753489|FG000|Overall Study|Withdrawal by Subject|1|||
131856839|NCT00098774|474753489|FG000|Overall Study|Failed (to respond) during induction|4|||
131856840|NCT00098774|474753489|FG000|Overall Study|Physician Decision|2|||
131856841|NCT02290405|474753490|FG000|Overall Study|Withdrawal by Subject|1|||
131856842|NCT02290405|474753491|FG001|Overall Study|Withdrawal by Subject|0|||
131856843|NCT02016183|474753492|FG000|Overall Study|Case Report Forms Uncollected|13|||
131856844|NCT02016183|474753492|FG000|Overall Study|Protocol Violation|52|||
131856845|NCT00996489|474753493|FG000|Overall Study|Device failure|45|||
131856846|NCT00996489|474753493|FG000|Overall Study|Discontinued|116|||
131856847|NCT03142191|474753494|FG000|Placebo Controlled Period|Death|0|||
131856848|NCT03142191|474753495|FG001|Placebo Controlled Period|Death|1|||
131856849|NCT03142191|474753496|FG002|Placebo Controlled Period|Death|1|||
131856850|NCT03142191|474753497|FG003|Placebo Controlled Period|Death|0|||
131856851|NCT03142191|474753498|FG004|Placebo Controlled Period|Death|0|||
131856852|NCT03142191|474753494|FG000|Placebo Controlled Period|Adverse Event|4|||
131856853|NCT03142191|474753495|FG001|Placebo Controlled Period|Adverse Event|5|||
131856854|NCT03142191|474753496|FG002|Placebo Controlled Period|Adverse Event|1|||
131856855|NCT03142191|474753497|FG003|Placebo Controlled Period|Adverse Event|0|||
131406695|NCT02754141|473113326|FG007|Overall Study|Request to discontinue|0|||
131406696|NCT02754141|473113327|FG008|Overall Study|Request to discontinue|1|||
131406697|NCT02754141|473113328|FG009|Overall Study|Request to discontinue|0|||
131406698|NCT02754141|473113329|FG010|Overall Study|Request to discontinue|0|||
131856856|NCT03142191|474753498|FG004|Placebo Controlled Period|Adverse Event|0|||
131856857|NCT03142191|474753494|FG000|Placebo Controlled Period|Progressive Disease|1|||
131856858|NCT03142191|474753495|FG001|Placebo Controlled Period|Progressive Disease|0|||
131856859|NCT03142191|474753496|FG002|Placebo Controlled Period|Progressive Disease|1|||
131856860|NCT03142191|474753497|FG003|Placebo Controlled Period|Progressive Disease|0|||
131856861|NCT03142191|474753498|FG004|Placebo Controlled Period|Progressive Disease|0|||
131856862|NCT03142191|474753494|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
131856863|NCT03142191|474753495|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
131856864|NCT03142191|474753496|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
131856865|NCT03142191|474753497|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
131856866|NCT03142191|474753498|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
131912569|NCT01186770|474966613|FG003|Overall Study|Protocol Violation|14|||
131406699|NCT02754141|473113330|FG011|Overall Study|Request to discontinue|0|||
131856867|NCT03142191|474753494|FG000|Placebo Controlled Period|Other Reasons|1|||
131856868|NCT03142191|474753495|FG001|Placebo Controlled Period|Other Reasons|0|||
131856869|NCT03142191|474753496|FG002|Placebo Controlled Period|Other Reasons|0|||
131856870|NCT03142191|474753497|FG003|Placebo Controlled Period|Other Reasons|0|||
131856871|NCT03142191|474753498|FG004|Placebo Controlled Period|Other Reasons|0|||
131856872|NCT03142191|474753494|FG000|Active Treatment Extension Period|Death|2|||
131856873|NCT03142191|474753495|FG001|Active Treatment Extension Period|Death|1|||
131856874|NCT03142191|474753496|FG002|Active Treatment Extension Period|Death|1|||
131856875|NCT03142191|474753497|FG003|Active Treatment Extension Period|Death|1|||
131856876|NCT03142191|474753498|FG004|Active Treatment Extension Period|Death|0|||
131856877|NCT03142191|474753494|FG000|Active Treatment Extension Period|Adverse Event|6|||
131856878|NCT03142191|474753495|FG001|Active Treatment Extension Period|Adverse Event|5|||
131856879|NCT03142191|474753496|FG002|Active Treatment Extension Period|Adverse Event|4|||
131856880|NCT03142191|474753497|FG003|Active Treatment Extension Period|Adverse Event|1|||
131856881|NCT03142191|474753498|FG004|Active Treatment Extension Period|Adverse Event|0|||
131856882|NCT03142191|474753494|FG000|Active Treatment Extension Period|Progressive Disease|10|||
131856883|NCT03142191|474753495|FG001|Active Treatment Extension Period|Progressive Disease|5|||
131856884|NCT03142191|474753496|FG002|Active Treatment Extension Period|Progressive Disease|4|||
131856885|NCT03142191|474753497|FG003|Active Treatment Extension Period|Progressive Disease|1|||
131856886|NCT03142191|474753498|FG004|Active Treatment Extension Period|Progressive Disease|2|||
131856887|NCT03142191|474753494|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
131856888|NCT03142191|474753495|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
131856889|NCT03142191|474753496|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
131856890|NCT03142191|474753497|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
131856891|NCT03142191|474753498|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
131856892|NCT03142191|474753494|FG000|Active Treatment Extension Period|Physician Decision|2|||
131856893|NCT03142191|474753495|FG001|Active Treatment Extension Period|Physician Decision|0|||
131856894|NCT03142191|474753496|FG002|Active Treatment Extension Period|Physician Decision|0|||
131856895|NCT03142191|474753497|FG003|Active Treatment Extension Period|Physician Decision|0|||
131856896|NCT03142191|474753498|FG004|Active Treatment Extension Period|Physician Decision|0|||
131856897|NCT03142191|474753494|FG000|Active Treatment Extension Period|Other Reasons|3|||
131856898|NCT03142191|474753495|FG001|Active Treatment Extension Period|Other Reasons|3|||
131856899|NCT03142191|474753496|FG002|Active Treatment Extension Period|Other Reasons|3|||
131856900|NCT03142191|474753497|FG003|Active Treatment Extension Period|Other Reasons|8|||
131856901|NCT03142191|474753498|FG004|Active Treatment Extension Period|Other Reasons|3|||
131856902|NCT03142191|474753494|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
131856903|NCT03142191|474753495|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
131856904|NCT03142191|474753496|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
131856905|NCT03142191|474753497|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
131856906|NCT03142191|474753498|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
131856907|NCT00770328|474753501|FG000|Overall Study|Adverse Event|11|||
131856908|NCT00770328|474753502|FG001|Overall Study|Adverse Event|2|||
131856909|NCT00770328|474753501|FG000|Overall Study|Lost to Follow-up|2|||
131856910|NCT00770328|474753502|FG001|Overall Study|Lost to Follow-up|2|||
131856911|NCT03452943|474753503|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
131856912|NCT03452943|474753504|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
131856913|NCT03452943|474753503|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
131856914|NCT03452943|474753504|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
131856915|NCT03452943|474753503|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
131856916|NCT03452943|474753504|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
131856917|NCT03452943|474753503|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
131856918|NCT03452943|474753504|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
131856919|NCT03452943|474753503|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
131856920|NCT03452943|474753504|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
131856921|NCT03452943|474753503|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
131856922|NCT03452943|474753504|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
131856923|NCT01130493|474753505|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
131856924|NCT01130493|474753506|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
131856925|NCT01130493|474753507|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
131856926|NCT01130493|474753505|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
131856927|NCT01130493|474753506|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
131856928|NCT01130493|474753507|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
131856929|NCT01130493|474753505|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
131856930|NCT01130493|474753506|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
131856931|NCT01130493|474753507|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
131856932|NCT01130493|474753505|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
131856933|NCT01130493|474753506|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
131856934|NCT01130493|474753507|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
131856935|NCT01130493|474753505|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
131856936|NCT01130493|474753506|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
131856937|NCT01130493|474753507|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
131856938|NCT01130493|474753505|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
131856939|NCT01130493|474753506|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
131856940|NCT01130493|474753507|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
131856941|NCT01130493|474753505|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
131856942|NCT01130493|474753506|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
131856943|NCT01130493|474753507|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
131856944|NCT01130493|474753505|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
131856945|NCT01130493|474753506|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
131856946|NCT01130493|474753507|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
131856947|NCT01130493|474753505|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
131856948|NCT01130493|474753506|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
131856949|NCT01130493|474753507|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
131856950|NCT01130493|474753505|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
131856951|NCT01130493|474753506|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
131856952|NCT01130493|474753507|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
131856953|NCT01130493|474753505|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
131856954|NCT01130493|474753506|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
131856955|NCT01130493|474753507|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
131856956|NCT01130493|474753505|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
131856957|NCT01130493|474753506|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
131912570|NCT01186770|474966610|FG000|Overall Study|Adverse Event|2|||
131912571|NCT01186770|474966611|FG001|Overall Study|Adverse Event|9|||
131912572|NCT01186770|474966612|FG002|Overall Study|Adverse Event|7|||
131912573|NCT01186770|474966613|FG003|Overall Study|Adverse Event|9|||
131912574|NCT01186770|474966610|FG000|Overall Study|Withdrawal by Subject|15|||
131912575|NCT01186770|474966611|FG001|Overall Study|Withdrawal by Subject|13|||
131912576|NCT01186770|474966612|FG002|Overall Study|Withdrawal by Subject|11|||
131912577|NCT01186770|474966613|FG003|Overall Study|Withdrawal by Subject|17|||
131912578|NCT01186770|474966610|FG000|Overall Study|Lost to Follow-up|10|||
131912579|NCT01186770|474966611|FG001|Overall Study|Lost to Follow-up|6|||
131912580|NCT01186770|474966612|FG002|Overall Study|Lost to Follow-up|14|||
131912581|NCT01186770|474966613|FG003|Overall Study|Lost to Follow-up|9|||
131912582|NCT01186770|474966610|FG000|Overall Study|Insufficient response to treatment|7|||
131912583|NCT01186770|474966611|FG001|Overall Study|Insufficient response to treatment|8|||
131912584|NCT01186770|474966612|FG002|Overall Study|Insufficient response to treatment|5|||
131912585|NCT01186770|474966613|FG003|Overall Study|Insufficient response to treatment|7|||
131912586|NCT01186770|474966610|FG000|Overall Study|Other than specified|0|||
131912587|NCT01186770|474966611|FG001|Overall Study|Other than specified|1|||
131912588|NCT01186770|474966612|FG002|Overall Study|Other than specified|1|||
131912589|NCT01186770|474966613|FG003|Overall Study|Other than specified|2|||
131912590|NCT02567188|474966614|FG000|Overall Study|Death|10|||
131912591|NCT02567188|474966614|FG000|Overall Study|Terminated Mircera Treatment|9|||
131912592|NCT02567188|474966614|FG000|Overall Study|Lost to Follow-up|5|||
131912593|NCT02567188|474966614|FG000|Overall Study|Adverse Event|1|||
131912594|NCT02567188|474966614|FG000|Overall Study|Withdrawal by Subject|1|||
131912595|NCT02567188|474966614|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
131912596|NCT02567188|474966614|FG000|Overall Study|Moved and Changed Clinic|1|||
131912597|NCT02567188|474966614|FG000|Overall Study|Started Hemodialysis|2|||
131912598|NCT02567188|474966614|FG000|Overall Study|Protocol Violation|5|||
131912599|NCT00321763|474966618|FG000|Overall Study|Adverse Event|1|||
131912600|NCT00321763|474966619|FG001|Overall Study|Adverse Event|1|||
131912601|NCT00321763|474966620|FG002|Overall Study|Adverse Event|0|||
131912602|NCT00321763|474966621|FG003|Overall Study|Adverse Event|1|||
131912603|NCT00321763|474966618|FG000|Overall Study|Withdrawal by Subject|2|||
131912604|NCT00321763|474966619|FG001|Overall Study|Withdrawal by Subject|0|||
131912605|NCT00321763|474966620|FG002|Overall Study|Withdrawal by Subject|1|||
131912606|NCT00321763|474966621|FG003|Overall Study|Withdrawal by Subject|0|||
131912607|NCT00321763|474966618|FG000|Overall Study|Lost to Follow-up|3|||
131912608|NCT00321763|474966619|FG001|Overall Study|Lost to Follow-up|1|||
131912609|NCT00321763|474966620|FG002|Overall Study|Lost to Follow-up|5|||
131912610|NCT00321763|474966621|FG003|Overall Study|Lost to Follow-up|4|||
131912611|NCT01572792|474966623|FG000|Lead-in Study|Lost to Follow-up|5|||
131912612|NCT01572792|474966624|FG001|Lead-in Study|Lost to Follow-up|9|||
131912613|NCT01572792|474966625|FG002|Lead-in Study|Lost to Follow-up|4|||
131912614|NCT01572792|474966626|FG003|Lead-in Study|Lost to Follow-up|2|||
131912615|NCT01572792|474966627|FG004|Lead-in Study|Lost to Follow-up|4|||
131912616|NCT01572792|474966623|FG000|Lead-in Study|Withdrawal by Subject|22|||
131912617|NCT01572792|474966624|FG001|Lead-in Study|Withdrawal by Subject|11|||
131912618|NCT01572792|474966625|FG002|Lead-in Study|Withdrawal by Subject|12|||
131912619|NCT01572792|474966626|FG003|Lead-in Study|Withdrawal by Subject|24|||
131856958|NCT01130493|474753507|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
131856959|NCT01130493|474753505|FG000|Part 2: OLE|Adverse Event|0|||
131856960|NCT01130493|474753506|FG001|Part 2: OLE|Adverse Event|2|||
131856961|NCT01130493|474753507|FG002|Part 2: OLE|Adverse Event|1|||
131856962|NCT01130493|474753505|FG000|Part 2: OLE|Withdrawal by Subject|0|||
131856963|NCT01130493|474753506|FG001|Part 2: OLE|Withdrawal by Subject|1|||
131856964|NCT01130493|474753507|FG002|Part 2: OLE|Withdrawal by Subject|4|||
131856965|NCT02286843|474753510|FG000|Overall Study|Not Treated|4|||
131856966|NCT02286843|474753510|FG000|Overall Study|Protocol Violation|1|||
131856967|NCT02286843|474753510|FG000|Overall Study|Withdrawal by Subject|1|||
131856968|NCT03164616|474753512|FG000|Overall Study|Death|250|||
131856969|NCT03164616|474753513|FG001|Overall Study|Death|264|||
131856970|NCT03164616|474753514|FG002|Overall Study|Death|279|||
131856971|NCT03164616|474753512|FG000|Overall Study|Lost to Follow-up|2|||
131856972|NCT03164616|474753513|FG001|Overall Study|Lost to Follow-up|2|||
131856973|NCT03164616|474753514|FG002|Overall Study|Lost to Follow-up|2|||
131856974|NCT03164616|474753512|FG000|Overall Study|Withdrawal by Subject|6|||
131856975|NCT03164616|474753513|FG001|Overall Study|Withdrawal by Subject|7|||
131856976|NCT03164616|474753514|FG002|Overall Study|Withdrawal by Subject|16|||
131406700|NCT02754141|473113331|FG012|Overall Study|Request to discontinue|0|||
131856977|NCT02593110|474753515|FG000|Overall Study|Withdrawal by Subject|0|||
131856978|NCT02593110|474753516|FG001|Overall Study|Withdrawal by Subject|3|||
131856979|NCT02593110|474753517|FG002|Overall Study|Withdrawal by Subject|3|||
131856980|NCT02593110|474753518|FG003|Overall Study|Withdrawal by Subject|2|||
131856981|NCT02593110|474753515|FG000|Overall Study|Death|0|||
131856982|NCT02593110|474753516|FG001|Overall Study|Death|0|||
131856983|NCT02593110|474753517|FG002|Overall Study|Death|1|||
131856984|NCT02593110|474753518|FG003|Overall Study|Death|0|||
131856985|NCT03086551|474753519|FG000|First Intervention|Failure to meet inclusion criterion|1|||
131856986|NCT03086551|474753520|FG001|First Intervention|Failure to meet inclusion criterion|0|||
131856987|NCT03086551|474753519|FG000|First Intervention|Lost to Follow-up|0|||
131856988|NCT03086551|474753520|FG001|First Intervention|Lost to Follow-up|1|||
131856989|NCT03086551|474753519|FG000|Washout|Lost to Follow-up|1|||
131856990|NCT03086551|474753520|FG001|Washout|Lost to Follow-up|2|||
131856991|NCT03086551|474753519|FG000|Washout|Withdrawal by Subject|2|||
131406701|NCT02754141|473113332|FG013|Overall Study|Request to discontinue|1|||
131912620|NCT01572792|474966627|FG004|Lead-in Study|Withdrawal by Subject|11|||
131912621|NCT01572792|474966623|FG000|Lead-in Study|Protocol Violation|19|||
131406702|NCT02754141|473113333|FG014|Overall Study|Request to discontinue|1|||
131406703|NCT02754141|473113334|FG015|Overall Study|Request to discontinue|0|||
131406704|NCT02754141|473113335|FG016|Overall Study|Request to discontinue|0|||
131406705|NCT02754141|473113336|FG017|Overall Study|Request to discontinue|0|||
131406706|NCT02754141|473113319|FG000|Overall Study|Withdrew consent|0|||
131406707|NCT02754141|473113320|FG001|Overall Study|Withdrew consent|0|||
131856992|NCT03086551|474753520|FG001|Washout|Withdrawal by Subject|1|||
131856993|NCT00625872|474753523|FG000|Overall Study|Withdrawal by Subject|1|||
131856994|NCT00625872|474753524|FG001|Overall Study|Withdrawal by Subject|0|||
131856995|NCT00625872|474753523|FG000|Overall Study|Does not meet inclusion criteria|1|||
131856996|NCT00625872|474753524|FG001|Overall Study|Does not meet inclusion criteria|0|||
131856997|NCT00625872|474753523|FG000|Overall Study|Terminated by sponsor|2|||
131856998|NCT00625872|474753524|FG001|Overall Study|Terminated by sponsor|5|||
131856999|NCT00625872|474753523|FG000|Overall Study|Randomized but not treated|0|||
131857000|NCT00625872|474753524|FG001|Overall Study|Randomized but not treated|1|||
131406708|NCT02754141|473113321|FG002|Overall Study|Withdrew consent|0|||
131406709|NCT02754141|473113322|FG003|Overall Study|Withdrew consent|0|||
131406710|NCT02754141|473113323|FG004|Overall Study|Withdrew consent|0|||
131406711|NCT02754141|473113324|FG005|Overall Study|Withdrew consent|0|||
131406712|NCT02754141|473113325|FG006|Overall Study|Withdrew consent|0|||
131857001|NCT04208750|474753525|FG000|Overall Study|Lost to Follow-up|16|||
131857002|NCT04208750|474753526|FG001|Overall Study|Lost to Follow-up|15|||
131857003|NCT02201277|474753527|FG000|Overall Study|Death|3|||
131857004|NCT02201277|474753528|FG001|Overall Study|Death|4|||
131857005|NCT02201277|474753527|FG000|Overall Study|Lost to Follow-up|2|||
131857006|NCT02201277|474753528|FG001|Overall Study|Lost to Follow-up|1|||
131857007|NCT02201277|474753527|FG000|Overall Study|Failed retrieval|1|||
131857008|NCT02201277|474753528|FG001|Overall Study|Failed retrieval|0|||
131857009|NCT02201277|474753527|FG000|Overall Study|Physician Decision|1|||
131857010|NCT02201277|474753528|FG001|Overall Study|Physician Decision|0|||
131857011|NCT03485352|474753529|FG000|Overall Study|Lost to Follow-up|9|||
131857012|NCT01512160|474753530|FG000|Overall Study|Lost to Follow-up|1|||
131857013|NCT01512160|474753531|FG001|Overall Study|Lost to Follow-up|0|||
131857014|NCT01512160|474753532|FG002|Overall Study|Lost to Follow-up|0|||
131857015|NCT01512160|474753533|FG003|Overall Study|Lost to Follow-up|0|||
131857016|NCT01512160|474753530|FG000|Overall Study|Withdrawal by Subject|1|||
131857017|NCT01512160|474753531|FG001|Overall Study|Withdrawal by Subject|0|||
131406713|NCT02754141|473113326|FG007|Overall Study|Withdrew consent|0|||
131406714|NCT02754141|473113327|FG008|Overall Study|Withdrew consent|0|||
131406715|NCT02754141|473113328|FG009|Overall Study|Withdrew consent|1|||
131857018|NCT01512160|474753532|FG002|Overall Study|Withdrawal by Subject|0|||
131857019|NCT01512160|474753533|FG003|Overall Study|Withdrawal by Subject|1|||
131857020|NCT02163057|474753535|FG000|Overall Study|Participant Refusal to Continue|2|||
131857021|NCT02163057|474753536|FG001|Overall Study|Participant Refusal to Continue|2|||
131857022|NCT02163057|474753535|FG000|Overall Study|Participant Significant Noncompliance|0|||
131857023|NCT02163057|474753536|FG001|Overall Study|Participant Significant Noncompliance|1|||
131857024|NCT02163057|474753535|FG000|Overall Study|Progression of Disease|1|||
131857025|NCT02163057|474753536|FG001|Overall Study|Progression of Disease|2|||
131857026|NCT01128179|474753537|FG000|Overall Study|Death|1|||
131857027|NCT01128179|474753538|FG001|Overall Study|Death|0|||
131857028|NCT01128179|474753537|FG000|Overall Study|Protocol Violation|1|||
131857029|NCT01128179|474753538|FG001|Overall Study|Protocol Violation|0|||
131857030|NCT03130777|474755035|FG000|Overall Study|Death|0|||
131857031|NCT03130777|474755036|FG001|Overall Study|Death|1|||
131857032|NCT03130777|474755035|FG000|Overall Study|Did not meet eligibility criteria|1|||
131857033|NCT03130777|474755036|FG001|Overall Study|Did not meet eligibility criteria|0|||
131857034|NCT02498613|474755037|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
131857035|NCT02498613|474755038|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
131857036|NCT02498613|474755039|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
131857037|NCT02498613|474755040|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
131857038|NCT02498613|474755037|FG000|Overall Study|Withdrawal by Subject|3|||
131857039|NCT02498613|474755038|FG001|Overall Study|Withdrawal by Subject|1|||
131857040|NCT02498613|474755039|FG002|Overall Study|Withdrawal by Subject|0|||
131857041|NCT02498613|474755040|FG003|Overall Study|Withdrawal by Subject|0|||
131857042|NCT05168202|474755041|FG000|Overall Study|Progressive Disease|4|||
131857043|NCT05168202|474755042|FG001|Overall Study|Progressive Disease|4|||
131857044|NCT05168202|474755043|FG002|Overall Study|Progressive Disease|2|||
131857045|NCT05168202|474755044|FG003|Overall Study|Progressive Disease|3|||
131857046|NCT05168202|474755045|FG004|Overall Study|Progressive Disease|2|||
131857047|NCT05168202|474755046|FG005|Overall Study|Progressive Disease|3|||
131857048|NCT05168202|474755047|FG006|Overall Study|Progressive Disease|2|||
131857049|NCT05168202|474755041|FG000|Overall Study|Adverse Event|2|||
131857050|NCT05168202|474755042|FG001|Overall Study|Adverse Event|1|||
131857051|NCT05168202|474755043|FG002|Overall Study|Adverse Event|4|||
131857052|NCT05168202|474755044|FG003|Overall Study|Adverse Event|4|||
131857053|NCT05168202|474755045|FG004|Overall Study|Adverse Event|3|||
131857054|NCT05168202|474755046|FG005|Overall Study|Adverse Event|2|||
131857055|NCT05168202|474755047|FG006|Overall Study|Adverse Event|0|||
131857056|NCT05168202|474755041|FG000|Overall Study|Lack of Efficacy|0|||
131857057|NCT05168202|474755042|FG001|Overall Study|Lack of Efficacy|1|||
131857058|NCT05168202|474755043|FG002|Overall Study|Lack of Efficacy|1|||
131857059|NCT05168202|474755044|FG003|Overall Study|Lack of Efficacy|0|||
131857060|NCT05168202|474755045|FG004|Overall Study|Lack of Efficacy|1|||
131857061|NCT05168202|474755046|FG005|Overall Study|Lack of Efficacy|2|||
131857062|NCT05168202|474755047|FG006|Overall Study|Lack of Efficacy|2|||
131857063|NCT05168202|474755041|FG000|Overall Study|Withdrawal by Subject|0|||
131857064|NCT05168202|474755042|FG001|Overall Study|Withdrawal by Subject|0|||
131857065|NCT05168202|474755043|FG002|Overall Study|Withdrawal by Subject|1|||
131857066|NCT05168202|474755044|FG003|Overall Study|Withdrawal by Subject|1|||
131857067|NCT05168202|474755045|FG004|Overall Study|Withdrawal by Subject|1|||
131857068|NCT05168202|474755046|FG005|Overall Study|Withdrawal by Subject|1|||
131857069|NCT05168202|474755047|FG006|Overall Study|Withdrawal by Subject|0|||
131857070|NCT05168202|474755041|FG000|Overall Study|Disease Relapse|0|||
131857071|NCT05168202|474755042|FG001|Overall Study|Disease Relapse|1|||
131857072|NCT05168202|474755043|FG002|Overall Study|Disease Relapse|0|||
131857073|NCT05168202|474755044|FG003|Overall Study|Disease Relapse|1|||
131857074|NCT05168202|474755045|FG004|Overall Study|Disease Relapse|1|||
131857075|NCT05168202|474755046|FG005|Overall Study|Disease Relapse|0|||
131857076|NCT05168202|474755047|FG006|Overall Study|Disease Relapse|0|||
131857077|NCT05168202|474755041|FG000|Overall Study|Other Reasons|0|||
131857078|NCT05168202|474755042|FG001|Overall Study|Other Reasons|0|||
131857079|NCT05168202|474755043|FG002|Overall Study|Other Reasons|0|||
131857080|NCT05168202|474755044|FG003|Overall Study|Other Reasons|0|||
131857081|NCT05168202|474755045|FG004|Overall Study|Other Reasons|0|||
131857082|NCT05168202|474755046|FG005|Overall Study|Other Reasons|2|||
131857083|NCT05168202|474755047|FG006|Overall Study|Other Reasons|1|||
131857084|NCT05168202|474755041|FG000|Overall Study|Physician Decision|0|||
131857085|NCT05168202|474755042|FG001|Overall Study|Physician Decision|1|||
131857086|NCT05168202|474755043|FG002|Overall Study|Physician Decision|1|||
131857087|NCT05168202|474755044|FG003|Overall Study|Physician Decision|0|||
131857088|NCT05168202|474755045|FG004|Overall Study|Physician Decision|0|||
131857089|NCT05168202|474755046|FG005|Overall Study|Physician Decision|0|||
131857090|NCT05168202|474755047|FG006|Overall Study|Physician Decision|0|||
131857091|NCT05168202|474755041|FG000|Overall Study|Study Terminated by Sponsor|0|||
131857092|NCT05168202|474755042|FG001|Overall Study|Study Terminated by Sponsor|0|||
131857093|NCT05168202|474755043|FG002|Overall Study|Study Terminated by Sponsor|0|||
131857094|NCT05168202|474755044|FG003|Overall Study|Study Terminated by Sponsor|1|||
131857095|NCT05168202|474755045|FG004|Overall Study|Study Terminated by Sponsor|0|||
131857096|NCT05168202|474755046|FG005|Overall Study|Study Terminated by Sponsor|0|||
131857097|NCT05168202|474755047|FG006|Overall Study|Study Terminated by Sponsor|0|||
131857098|NCT06195930|474755050|FG000|Overall Study|Adverse Event|4|||
131857099|NCT03041311|474755053|FG000|Overall Study|Death|39|||
131857100|NCT03041311|474755054|FG001|Overall Study|Death|42|||
131857101|NCT03041311|474755053|FG000|Overall Study|Lost to Follow-up|0|||
131857102|NCT03041311|474755054|FG001|Overall Study|Lost to Follow-up|1|||
131857103|NCT03041311|474755053|FG000|Overall Study|Withdrawal by Subject|8|||
131857104|NCT03041311|474755054|FG001|Overall Study|Withdrawal by Subject|5|||
131857105|NCT03041311|474755053|FG000|Overall Study|Sponsor Terminated Study|2|||
131857106|NCT03041311|474755054|FG001|Overall Study|Sponsor Terminated Study|4|||
131857107|NCT03041311|474755053|FG000|Overall Study|Disease Progression|3|||
131857108|NCT03041311|474755054|FG001|Overall Study|Disease Progression|1|||
131857109|NCT03041311|474755053|FG000|Overall Study|Randomized in error, did not receive drug|2|||
131857110|NCT03041311|474755054|FG001|Overall Study|Randomized in error, did not receive drug|0|||
131857111|NCT04054765|474755058|FG000|Baseline|Withdrawal by Subject|5|||
131857112|NCT04054765|474755059|FG001|Baseline|Withdrawal by Subject|3|||
131857113|NCT04054765|474755058|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
131857114|NCT04054765|474755059|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
131857115|NCT04054765|474755058|FG000|3-month Follow up|Withdrawal by Subject|0|||
131857116|NCT04054765|474755059|FG001|3-month Follow up|Withdrawal by Subject|3|||
131857117|NCT04054765|474755058|FG000|6-month Follow up|Lost to Follow-up|32|||
131857118|NCT04054765|474755059|FG001|6-month Follow up|Lost to Follow-up|32|||
131857119|NCT04182490|474755060|FG000|Overall Study|Withdrawal by Subject|3|||
131857120|NCT04182490|474755061|FG001|Overall Study|Withdrawal by Subject|3|||
131857121|NCT04182490|474755060|FG000|Overall Study|Lost to Follow-up|0|||
131857122|NCT04182490|474755061|FG001|Overall Study|Lost to Follow-up|1|||
131857123|NCT04182490|474755060|FG000|Overall Study|Physician Decision|0|||
131857124|NCT04182490|474755061|FG001|Overall Study|Physician Decision|1|||
131857125|NCT00853099|474755062|FG000|Double-blind Period|Adverse Event|7|||
131857126|NCT00853099|474755063|FG001|Double-blind Period|Adverse Event|9|||
131857127|NCT00853099|474755064|FG002|Double-blind Period|Adverse Event|13|||
131857128|NCT00853099|474755065|FG003|Double-blind Period|Adverse Event|0|||
131857129|NCT00853099|474755062|FG000|Double-blind Period|Withdrawal by Subject|2|||
131857130|NCT00853099|474755063|FG001|Double-blind Period|Withdrawal by Subject|3|||
131857131|NCT00853099|474755064|FG002|Double-blind Period|Withdrawal by Subject|0|||
131857132|NCT00853099|474755065|FG003|Double-blind Period|Withdrawal by Subject|0|||
131857133|NCT00853099|474755062|FG000|Double-blind Period|Lack of Efficacy|14|||
131857134|NCT00853099|474755063|FG001|Double-blind Period|Lack of Efficacy|17|||
131857135|NCT00853099|474755064|FG002|Double-blind Period|Lack of Efficacy|16|||
131857136|NCT00853099|474755065|FG003|Double-blind Period|Lack of Efficacy|0|||
131857137|NCT00853099|474755062|FG000|Double-blind Period|Other|0|||
131857138|NCT00853099|474755063|FG001|Double-blind Period|Other|0|||
131857139|NCT00853099|474755064|FG002|Double-blind Period|Other|1|||
131857140|NCT00853099|474755065|FG003|Double-blind Period|Other|0|||
131857141|NCT00853099|474755062|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
131857142|NCT00853099|474755063|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
131857143|NCT00853099|474755064|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
131857144|NCT00853099|474755065|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
131857145|NCT00853099|474755062|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
131857146|NCT00853099|474755063|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
131857147|NCT00853099|474755064|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
131857148|NCT00853099|474755065|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
131857149|NCT00853099|474755062|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
131857150|NCT00853099|474755063|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
131857151|NCT00853099|474755064|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
131857152|NCT00853099|474755065|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
131857153|NCT00853099|474755062|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
131857154|NCT00853099|474755063|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
131857155|NCT00853099|474755064|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
131857156|NCT00853099|474755065|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
131857157|NCT00853099|474755062|FG000|Double-blind + Open-label Periods|Other|0|||
131857158|NCT00853099|474755063|FG001|Double-blind + Open-label Periods|Other|0|||
131857159|NCT00853099|474755064|FG002|Double-blind + Open-label Periods|Other|0|||
131857160|NCT00853099|474755065|FG003|Double-blind + Open-label Periods|Other|6|||
131857161|NCT04123405|474755072|FG000|Overall Study|Adverse Event|1|||
131857162|NCT04123405|474755073|FG001|Overall Study|Adverse Event|2|||
131857163|NCT04123405|474755074|FG002|Overall Study|Adverse Event|3|||
131857164|NCT04123405|474755075|FG003|Overall Study|Adverse Event|3|||
131857165|NCT04123405|474755072|FG000|Overall Study|Exclusion criteria met|1|||
131857166|NCT04123405|474755073|FG001|Overall Study|Exclusion criteria met|2|||
131857167|NCT04123405|474755074|FG002|Overall Study|Exclusion criteria met|0|||
131857168|NCT04123405|474755075|FG003|Overall Study|Exclusion criteria met|2|||
131857169|NCT04123405|474755072|FG000|Overall Study|Withdrawal by Subject|1|||
131857170|NCT04123405|474755073|FG001|Overall Study|Withdrawal by Subject|3|||
131857171|NCT04123405|474755074|FG002|Overall Study|Withdrawal by Subject|0|||
131857172|NCT04123405|474755075|FG003|Overall Study|Withdrawal by Subject|2|||
131857173|NCT04123405|474755072|FG000|Overall Study|Contact to subject lost|0|||
131857174|NCT04123405|474755073|FG001|Overall Study|Contact to subject lost|0|||
131857175|NCT04123405|474755074|FG002|Overall Study|Contact to subject lost|0|||
131857176|NCT04123405|474755075|FG003|Overall Study|Contact to subject lost|1|||
131857177|NCT04123405|474755072|FG000|Overall Study|screening failure|1|||
131857178|NCT04123405|474755073|FG001|Overall Study|screening failure|0|||
131406716|NCT02754141|473113329|FG010|Overall Study|Withdrew consent|0|||
131406717|NCT02754141|473113330|FG011|Overall Study|Withdrew consent|0|||
131406718|NCT02754141|473113331|FG012|Overall Study|Withdrew consent|0|||
131406719|NCT02754141|473113332|FG013|Overall Study|Withdrew consent|0|||
131857179|NCT04123405|474755074|FG002|Overall Study|screening failure|0|||
131857180|NCT04123405|474755075|FG003|Overall Study|screening failure|0|||
131857181|NCT05024747|474755076|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
131857182|NCT05024747|474755077|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
131857183|NCT05024747|474755076|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
131857184|NCT05024747|474755077|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
131857185|NCT05024747|474755076|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
131857186|NCT05024747|474755077|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
131857187|NCT00545714|474755078|FG000|Induction Phase (6 Months)|Physician Decision|3|||
131857188|NCT00545714|474755078|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
131857189|NCT00545714|474755078|FG000|Induction Phase (6 Months)|Disease Progression|1|||
131857190|NCT00545714|474755078|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
131857191|NCT00545714|474755078|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
131857192|NCT00545714|474755078|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
131857193|NCT00545714|474755078|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
131857194|NCT00545714|474755078|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
131857195|NCT00545714|474755078|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
131857196|NCT00545714|474755078|FG000|Maintenance Phase (36 Months)|Death|2|||
131857197|NCT04428034|474755079|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
131857198|NCT02556801|474755080|FG000|Overall Study|Lost to Follow-up|1|||
131857199|NCT02556801|474755081|FG001|Overall Study|Lost to Follow-up|0|||
131857200|NCT02556801|474755082|FG002|Overall Study|Lost to Follow-up|2|||
131857201|NCT02556801|474755083|FG003|Overall Study|Lost to Follow-up|0|||
131857202|NCT02556801|474755080|FG000|Overall Study|Withdrawal by Subject|1|||
131857203|NCT02556801|474755081|FG001|Overall Study|Withdrawal by Subject|1|||
131857204|NCT02556801|474755082|FG002|Overall Study|Withdrawal by Subject|1|||
131857205|NCT02556801|474755083|FG003|Overall Study|Withdrawal by Subject|0|||
131857206|NCT02556801|474755080|FG000|Overall Study|Protocol Violation|0|||
131857207|NCT02556801|474755081|FG001|Overall Study|Protocol Violation|3|||
131857208|NCT02556801|474755082|FG002|Overall Study|Protocol Violation|1|||
131857209|NCT02556801|474755083|FG003|Overall Study|Protocol Violation|1|||
131857210|NCT02556801|474755080|FG000|Overall Study|Adverse Event|0|||
131857211|NCT02556801|474755081|FG001|Overall Study|Adverse Event|2|||
131857212|NCT02556801|474755082|FG002|Overall Study|Adverse Event|0|||
131857213|NCT02556801|474755083|FG003|Overall Study|Adverse Event|3|||
131857214|NCT02556801|474755080|FG000|Overall Study|Pregnancy|0|||
131857215|NCT02556801|474755081|FG001|Overall Study|Pregnancy|1|||
131857216|NCT02556801|474755082|FG002|Overall Study|Pregnancy|0|||
131406720|NCT02754141|473113333|FG014|Overall Study|Withdrew consent|0|||
131406721|NCT02754141|473113334|FG015|Overall Study|Withdrew consent|0|||
131406722|NCT02754141|473113335|FG016|Overall Study|Withdrew consent|0|||
131406723|NCT02754141|473113336|FG017|Overall Study|Withdrew consent|0|||
131406724|NCT02754141|473113319|FG000|Overall Study|Maximum clinical benefit|0|||
131406725|NCT02754141|473113320|FG001|Overall Study|Maximum clinical benefit|0|||
131406726|NCT02754141|473113321|FG002|Overall Study|Maximum clinical benefit|0|||
131406727|NCT02754141|473113322|FG003|Overall Study|Maximum clinical benefit|1|||
131406728|NCT02754141|473113323|FG004|Overall Study|Maximum clinical benefit|0|||
131406729|NCT02754141|473113324|FG005|Overall Study|Maximum clinical benefit|0|||
131857217|NCT02556801|474755083|FG003|Overall Study|Pregnancy|0|||
131857218|NCT02556801|474755080|FG000|Overall Study|Personal reasons patient|0|||
131857219|NCT02556801|474755081|FG001|Overall Study|Personal reasons patient|0|||
131857220|NCT02556801|474755082|FG002|Overall Study|Personal reasons patient|0|||
131406730|NCT02754141|473113325|FG006|Overall Study|Maximum clinical benefit|0|||
131857221|NCT02556801|474755083|FG003|Overall Study|Personal reasons patient|1|||
131857222|NCT01342081|474755088|FG000|Overall Study|Did not receive allocated intervention|0|||
131857223|NCT01342081|474755089|FG001|Overall Study|Did not receive allocated intervention|0|||
131857224|NCT01342081|474755090|FG002|Overall Study|Did not receive allocated intervention|1|||
131857225|NCT01342081|474755088|FG000|Overall Study|Adverse Event|1|||
131857226|NCT01342081|474755089|FG001|Overall Study|Adverse Event|0|||
131857227|NCT01342081|474755090|FG002|Overall Study|Adverse Event|0|||
131857228|NCT01342081|474755088|FG000|Overall Study|Physician Decision|0|||
131406731|NCT02754141|473113326|FG007|Overall Study|Maximum clinical benefit|0|||
131857229|NCT01342081|474755089|FG001|Overall Study|Physician Decision|1|||
131857230|NCT01342081|474755090|FG002|Overall Study|Physician Decision|0|||
131406732|NCT02754141|473113327|FG008|Overall Study|Maximum clinical benefit|0|||
131857231|NCT01342081|474755088|FG000|Overall Study|Withdrawal by Subject|1|||
131857232|NCT01342081|474755089|FG001|Overall Study|Withdrawal by Subject|1|||
131857233|NCT01342081|474755090|FG002|Overall Study|Withdrawal by Subject|0|||
131857234|NCT02790437|474755091|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
131857235|NCT02790437|474755092|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
131857236|NCT02790437|474755091|FG000|Overall Study|Adverse Event|1|||
131857237|NCT02790437|474755092|FG001|Overall Study|Adverse Event|0|||
131857238|NCT02790437|474755091|FG000|Overall Study|Withdrawal by Subject|1|||
131857239|NCT02790437|474755092|FG001|Overall Study|Withdrawal by Subject|0|||
131857240|NCT01202175|474755093|FG000|Overall Study|Lost to Follow-up|2|||
131857241|NCT01202175|474755093|FG000|Overall Study|Withdrawal by Subject|1|||
131857242|NCT01202175|474755093|FG000|Overall Study|Adverse Event|2|||
131857243|NCT01349192|474755094|FG000|Overall Study|Protocol Violation|0|||
131857244|NCT01349192|474755095|FG001|Overall Study|Protocol Violation|1|||
131857245|NCT01349192|474755094|FG000|Overall Study|Withdrawal by Subject|0|||
131857246|NCT01349192|474755095|FG001|Overall Study|Withdrawal by Subject|2|||
131857247|NCT01349192|474755094|FG000|Overall Study|Lost to Follow-up|1|||
131857248|NCT01349192|474755095|FG001|Overall Study|Lost to Follow-up|3|||
131857249|NCT01349192|474755094|FG000|Overall Study|Failure to adhere to Protocol|2|||
131857250|NCT01349192|474755095|FG001|Overall Study|Failure to adhere to Protocol|0|||
131857251|NCT03749330|474755096|FG000|Overall Study|Clinicians left work in the CICU|0|||
131857252|NCT03749330|474755097|FG001|Overall Study|Clinicians left work in the CICU|2|||
131857253|NCT03749330|474755098|FG002|Overall Study|Clinicians left work in the CICU|0|||
131857254|NCT03749330|474755099|FG003|Overall Study|Clinicians left work in the CICU|0|||
131857255|NCT03749330|474755100|FG004|Overall Study|Clinicians left work in the CICU|0|||
131857256|NCT03749330|474755101|FG005|Overall Study|Clinicians left work in the CICU|0|||
131857257|NCT03908125|474755109|FG000|Overall Study|Withdrawal by Subject|92|||
131857258|NCT03908125|474755109|FG000|Overall Study|Lost to Follow-up|8|||
131857259|NCT02815995|474755110|FG000|Overall Study|Disease Progression|3|||
131857260|NCT02815995|474755111|FG001|Overall Study|Disease Progression|7|||
131857261|NCT02815995|474755112|FG002|Overall Study|Disease Progression|2|||
131857262|NCT02815995|474755113|FG003|Overall Study|Disease Progression|4|||
131857263|NCT02815995|474755114|FG004|Overall Study|Disease Progression|3|||
131857264|NCT02815995|474755115|FG005|Overall Study|Disease Progression|9|||
131857265|NCT02815995|474755116|FG006|Overall Study|Disease Progression|3|||
131857266|NCT02815995|474755117|FG007|Overall Study|Disease Progression|1|||
131857267|NCT02815995|474755110|FG000|Overall Study|Adverse Event|1|||
131857268|NCT02815995|474755111|FG001|Overall Study|Adverse Event|2|||
131857269|NCT02815995|474755112|FG002|Overall Study|Adverse Event|2|||
131857270|NCT02815995|474755113|FG003|Overall Study|Adverse Event|0|||
131857271|NCT02815995|474755114|FG004|Overall Study|Adverse Event|0|||
131857272|NCT02815995|474755115|FG005|Overall Study|Adverse Event|1|||
131857273|NCT02815995|474755116|FG006|Overall Study|Adverse Event|0|||
131857274|NCT02815995|474755117|FG007|Overall Study|Adverse Event|0|||
131857275|NCT02815995|474755110|FG000|Overall Study|Pregnancy|0|||
131857276|NCT02815995|474755111|FG001|Overall Study|Pregnancy|0|||
131857277|NCT02815995|474755112|FG002|Overall Study|Pregnancy|0|||
131857278|NCT02815995|474755113|FG003|Overall Study|Pregnancy|0|||
131857279|NCT02815995|474755114|FG004|Overall Study|Pregnancy|0|||
131857280|NCT02815995|474755115|FG005|Overall Study|Pregnancy|0|||
131857281|NCT02815995|474755116|FG006|Overall Study|Pregnancy|1|||
131857282|NCT02815995|474755117|FG007|Overall Study|Pregnancy|0|||
131857283|NCT01071915|474755120|FG000|Overall Study|Adverse Event|3|||
131857284|NCT01071915|474755120|FG000|Overall Study|Physician Decision|2|||
131857285|NCT01071915|474755120|FG000|Overall Study|Withdrawal by Subject|2|||
131857286|NCT01071915|474755120|FG000|Overall Study|Miscellaneous Reasons|2|||
131857287|NCT03571828|474755125|FG000|Overall Study|Withdrawal by Subject|1|||
131857288|NCT03571828|474755126|FG001|Overall Study|Withdrawal by Subject|0|||
131857289|NCT03571828|474755125|FG000|Overall Study|Decision by sponsor|5|||
131857290|NCT03571828|474755126|FG001|Overall Study|Decision by sponsor|1|||
131857291|NCT03571828|474755125|FG000|Overall Study|Death|2|||
131857292|NCT03571828|474755126|FG001|Overall Study|Death|0|||
131857293|NCT00535405|474755129|FG000|Overall Study|Adverse Event|6|||
131857294|NCT00535405|474755130|FG001|Overall Study|Adverse Event|8|||
131857295|NCT00535405|474755131|FG002|Overall Study|Adverse Event|3|||
131857296|NCT00535405|474755132|FG003|Overall Study|Adverse Event|8|||
131857297|NCT00535405|474755133|FG004|Overall Study|Adverse Event|6|||
131857298|NCT00535405|474755129|FG000|Overall Study|Lost to Follow-up|1|||
131857299|NCT00535405|474755130|FG001|Overall Study|Lost to Follow-up|3|||
131857300|NCT00535405|474755131|FG002|Overall Study|Lost to Follow-up|3|||
131857301|NCT00535405|474755132|FG003|Overall Study|Lost to Follow-up|2|||
131857302|NCT00535405|474755133|FG004|Overall Study|Lost to Follow-up|1|||
131857303|NCT00535405|474755129|FG000|Overall Study|Physician Decision|3|||
131857304|NCT00535405|474755130|FG001|Overall Study|Physician Decision|2|||
131857305|NCT00535405|474755131|FG002|Overall Study|Physician Decision|0|||
131857306|NCT00535405|474755132|FG003|Overall Study|Physician Decision|1|||
131857307|NCT00535405|474755133|FG004|Overall Study|Physician Decision|1|||
131857308|NCT00535405|474755129|FG000|Overall Study|Protocol Violation|2|||
131857309|NCT00535405|474755130|FG001|Overall Study|Protocol Violation|2|||
131857310|NCT00535405|474755131|FG002|Overall Study|Protocol Violation|2|||
131857311|NCT00535405|474755132|FG003|Overall Study|Protocol Violation|1|||
131857312|NCT00535405|474755133|FG004|Overall Study|Protocol Violation|0|||
131857313|NCT00535405|474755129|FG000|Overall Study|Withdrawal by Subject|5|||
131857314|NCT00535405|474755130|FG001|Overall Study|Withdrawal by Subject|11|||
131857315|NCT00535405|474755131|FG002|Overall Study|Withdrawal by Subject|10|||
131857316|NCT00535405|474755132|FG003|Overall Study|Withdrawal by Subject|10|||
131857317|NCT00535405|474755133|FG004|Overall Study|Withdrawal by Subject|8|||
131857318|NCT00940316|474755134|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
131857319|NCT00940316|474755135|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
131857320|NCT00940316|474755136|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
131857321|NCT00940316|474755134|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
131857322|NCT00940316|474755135|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
131857323|NCT00940316|474755136|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
131857324|NCT00940316|474755134|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
131857325|NCT00940316|474755135|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
131857326|NCT00940316|474755136|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
131857327|NCT00940316|474755134|FG000|Treated After Cycle 5|Adverse Event|0|||
131857328|NCT00940316|474755135|FG001|Treated After Cycle 5|Adverse Event|0|||
131857329|NCT00940316|474755136|FG002|Treated After Cycle 5|Adverse Event|1|||
131857330|NCT00940316|474755134|FG000|Treated After Cycle 5|Progressive disease|0|||
131857331|NCT00940316|474755135|FG001|Treated After Cycle 5|Progressive disease|1|||
131857332|NCT00940316|474755136|FG002|Treated After Cycle 5|Progressive disease|0|||
131857333|NCT03404674|474755138|FG000|Overall Study|Inability to Attend Future Visits|0|||
131857334|NCT03404674|474755139|FG001|Overall Study|Inability to Attend Future Visits|1|||
131857335|NCT03404674|474755140|FG002|Overall Study|Inability to Attend Future Visits|1|||
131857336|NCT03404674|474755141|FG003|Overall Study|Inability to Attend Future Visits|0|||
131857337|NCT03404674|474755142|FG004|Overall Study|Inability to Attend Future Visits|0|||
131857338|NCT03404674|474755143|FG005|Overall Study|Inability to Attend Future Visits|0|||
131857339|NCT03404674|474755138|FG000|Overall Study|Behavioral Problems|0|||
131857340|NCT03404674|474755139|FG001|Overall Study|Behavioral Problems|0|||
131857341|NCT03404674|474755140|FG002|Overall Study|Behavioral Problems|1|||
131857342|NCT03404674|474755141|FG003|Overall Study|Behavioral Problems|0|||
131857343|NCT03404674|474755142|FG004|Overall Study|Behavioral Problems|0|||
131857344|NCT03404674|474755143|FG005|Overall Study|Behavioral Problems|0|||
131857345|NCT03404674|474755138|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
131857346|NCT03404674|474755139|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
131857347|NCT03404674|474755140|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
131857348|NCT03404674|474755141|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
131857349|NCT03404674|474755142|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
131857350|NCT03404674|474755143|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
131857351|NCT02536846|474755146|FG000|Overall Study|Withdrawal by Subject|1|||
131857352|NCT00143390|474755152|FG000|Overall Study|Death|2|||
131857353|NCT00143390|474755153|FG001|Overall Study|Death|0|||
131857354|NCT00143390|474755152|FG000|Overall Study|Not meeting entry criteria|2|||
131857355|NCT00143390|474755153|FG001|Overall Study|Not meeting entry criteria|5|||
131857356|NCT00143390|474755152|FG000|Overall Study|Withdrawal by Subject|4|||
131857357|NCT00143390|474755153|FG001|Overall Study|Withdrawal by Subject|4|||
131857358|NCT00143390|474755152|FG000|Overall Study|Progressive disease|119|||
131857359|NCT00143390|474755153|FG001|Overall Study|Progressive disease|115|||
131857360|NCT00143390|474755152|FG000|Overall Study|Protocol Violation|2|||
131857361|NCT00143390|474755153|FG001|Overall Study|Protocol Violation|0|||
131857362|NCT00143390|474755152|FG000|Overall Study|Study termination|10|||
131857363|NCT00143390|474755153|FG001|Overall Study|Study termination|15|||
131857364|NCT00143390|474755152|FG000|Overall Study|Adverse Event|9|||
131857365|NCT00143390|474755153|FG001|Overall Study|Adverse Event|8|||
131857366|NCT00143390|474755152|FG000|Overall Study|Other|1|||
131857367|NCT00143390|474755153|FG001|Overall Study|Other|2|||
131857368|NCT00041132|474755154|FG000|Overall Study|Adverse Event|19|||
131857369|NCT00041132|474755154|FG000|Overall Study|Death|1|||
131857370|NCT00041132|474755154|FG000|Overall Study|Not Eligible|7|||
131857371|NCT00041132|474755154|FG000|Overall Study|Withdrawal by Subject|1|||
131857372|NCT00041132|474755154|FG000|Overall Study|Physician Decision|2|||
131857373|NCT02729909|474755158|FG000|Overall Study|Lost to Follow-up|0|||
131857374|NCT02729909|474755159|FG001|Overall Study|Lost to Follow-up|1|||
131857375|NCT02729909|474755158|FG000|Overall Study|Lack of Efficacy|0|||
131857376|NCT02729909|474755159|FG001|Overall Study|Lack of Efficacy|2|||
131857377|NCT02729909|474755158|FG000|Overall Study|Significant Protocol Deviation|0|||
131857378|NCT02729909|474755159|FG001|Overall Study|Significant Protocol Deviation|2|||
131857379|NCT02729909|474755158|FG000|Overall Study|Voluntary Withdrawal|1|||
131857380|NCT02729909|474755159|FG001|Overall Study|Voluntary Withdrawal|0|||
131857381|NCT01625091|474755160|FG000|Intervention|Death|1|||
131857382|NCT01625091|474755161|FG001|Intervention|Death|1|||
131857383|NCT01625091|474755160|FG000|Intervention|Withdrawal by Subject|4|||
131857384|NCT01625091|474755161|FG001|Intervention|Withdrawal by Subject|1|||
131406733|NCT02754141|473113328|FG009|Overall Study|Maximum clinical benefit|0|||
131406734|NCT02754141|473113329|FG010|Overall Study|Maximum clinical benefit|0|||
131406735|NCT02754141|473113330|FG011|Overall Study|Maximum clinical benefit|0|||
131406736|NCT02754141|473113331|FG012|Overall Study|Maximum clinical benefit|0|||
131406737|NCT02754141|473113332|FG013|Overall Study|Maximum clinical benefit|0|||
131406738|NCT02754141|473113333|FG014|Overall Study|Maximum clinical benefit|0|||
131406739|NCT02754141|473113334|FG015|Overall Study|Maximum clinical benefit|0|||
131406740|NCT02754141|473113335|FG016|Overall Study|Maximum clinical benefit|0|||
131406741|NCT02754141|473113336|FG017|Overall Study|Maximum clinical benefit|0|||
131406742|NCT02754141|473113319|FG000|Overall Study|No longer meets study criteria|0|||
131406743|NCT02754141|473113320|FG001|Overall Study|No longer meets study criteria|0|||
131406744|NCT02754141|473113321|FG002|Overall Study|No longer meets study criteria|0|||
131406745|NCT02754141|473113322|FG003|Overall Study|No longer meets study criteria|1|||
131406746|NCT02754141|473113323|FG004|Overall Study|No longer meets study criteria|0|||
131406747|NCT02754141|473113324|FG005|Overall Study|No longer meets study criteria|0|||
131406748|NCT02754141|473113325|FG006|Overall Study|No longer meets study criteria|0|||
131406749|NCT02754141|473113326|FG007|Overall Study|No longer meets study criteria|0|||
131406750|NCT02754141|473113327|FG008|Overall Study|No longer meets study criteria|0|||
131406751|NCT02754141|473113328|FG009|Overall Study|No longer meets study criteria|0|||
131406752|NCT02754141|473113329|FG010|Overall Study|No longer meets study criteria|0|||
131406753|NCT02754141|473113330|FG011|Overall Study|No longer meets study criteria|0|||
131406754|NCT02754141|473113331|FG012|Overall Study|No longer meets study criteria|0|||
131406755|NCT02754141|473113332|FG013|Overall Study|No longer meets study criteria|0|||
131406756|NCT02754141|473113333|FG014|Overall Study|No longer meets study criteria|0|||
131406757|NCT02754141|473113334|FG015|Overall Study|No longer meets study criteria|0|||
131406758|NCT02754141|473113335|FG016|Overall Study|No longer meets study criteria|0|||
131406759|NCT02754141|473113336|FG017|Overall Study|No longer meets study criteria|0|||
131406760|NCT02754141|473113319|FG000|Overall Study|Other reasons|0|||
131406761|NCT02754141|473113320|FG001|Overall Study|Other reasons|0|||
131406762|NCT02754141|473113321|FG002|Overall Study|Other reasons|0|||
131406763|NCT02754141|473113322|FG003|Overall Study|Other reasons|0|||
131912622|NCT01572792|474966624|FG001|Lead-in Study|Protocol Violation|10|||
131912623|NCT01572792|474966625|FG002|Lead-in Study|Protocol Violation|12|||
131912624|NCT01572792|474966626|FG003|Lead-in Study|Protocol Violation|13|||
131912625|NCT01572792|474966627|FG004|Lead-in Study|Protocol Violation|21|||
131912626|NCT01572792|474966623|FG000|Lead-in Study|Lack of Efficacy|20|||
131912627|NCT01572792|474966624|FG001|Lead-in Study|Lack of Efficacy|5|||
131912628|NCT01572792|474966625|FG002|Lead-in Study|Lack of Efficacy|4|||
131912629|NCT01572792|474966626|FG003|Lead-in Study|Lack of Efficacy|8|||
131406764|NCT02754141|473113323|FG004|Overall Study|Other reasons|0|||
131406765|NCT02754141|473113324|FG005|Overall Study|Other reasons|0|||
131406766|NCT02754141|473113325|FG006|Overall Study|Other reasons|0|||
131406767|NCT02754141|473113326|FG007|Overall Study|Other reasons|1|||
131406768|NCT02754141|473113327|FG008|Overall Study|Other reasons|0|||
131406769|NCT02754141|473113328|FG009|Overall Study|Other reasons|0|||
131406770|NCT02754141|473113329|FG010|Overall Study|Other reasons|0|||
131406771|NCT02754141|473113330|FG011|Overall Study|Other reasons|0|||
131406772|NCT02754141|473113331|FG012|Overall Study|Other reasons|2|||
131406773|NCT02754141|473113332|FG013|Overall Study|Other reasons|0|||
131406774|NCT02754141|473113333|FG014|Overall Study|Other reasons|0|||
131406775|NCT02754141|473113334|FG015|Overall Study|Other reasons|0|||
131406776|NCT02754141|473113335|FG016|Overall Study|Other reasons|0|||
131406777|NCT02754141|473113336|FG017|Overall Study|Other reasons|0|||
131406778|NCT02754141|473113319|FG000|Overall Study|Completed treatment as per protocol|0|||
131406779|NCT02754141|473113320|FG001|Overall Study|Completed treatment as per protocol|1|||
131406780|NCT02754141|473113321|FG002|Overall Study|Completed treatment as per protocol|0|||
131406781|NCT02754141|473113322|FG003|Overall Study|Completed treatment as per protocol|0|||
131406782|NCT02754141|473113323|FG004|Overall Study|Completed treatment as per protocol|0|||
131406783|NCT02754141|473113324|FG005|Overall Study|Completed treatment as per protocol|0|||
131406784|NCT02754141|473113325|FG006|Overall Study|Completed treatment as per protocol|0|||
131406785|NCT02754141|473113326|FG007|Overall Study|Completed treatment as per protocol|0|||
131406786|NCT02754141|473113327|FG008|Overall Study|Completed treatment as per protocol|0|||
131406787|NCT02754141|473113328|FG009|Overall Study|Completed treatment as per protocol|0|||
131406788|NCT02754141|473113329|FG010|Overall Study|Completed treatment as per protocol|0|||
131406789|NCT02754141|473113330|FG011|Overall Study|Completed treatment as per protocol|0|||
131406790|NCT02754141|473113331|FG012|Overall Study|Completed treatment as per protocol|1|||
131406791|NCT02754141|473113332|FG013|Overall Study|Completed treatment as per protocol|0|||
131406792|NCT02754141|473113333|FG014|Overall Study|Completed treatment as per protocol|0|||
131406793|NCT02754141|473113334|FG015|Overall Study|Completed treatment as per protocol|0|||
131406794|NCT02754141|473113335|FG016|Overall Study|Completed treatment as per protocol|0|||
131406795|NCT02754141|473113336|FG017|Overall Study|Completed treatment as per protocol|0|||
131406796|NCT02754141|473113319|FG000|Overall Study|Not completing monotherapy|0|||
131912630|NCT01572792|474966627|FG004|Lead-in Study|Lack of Efficacy|10|||
131912631|NCT01572792|474966623|FG000|Lead-in Study|Adverse Event|21|||
131912632|NCT01572792|474966624|FG001|Lead-in Study|Adverse Event|21|||
131406797|NCT02754141|473113320|FG001|Overall Study|Not completing monotherapy|0|||
131406798|NCT02754141|473113321|FG002|Overall Study|Not completing monotherapy|0|||
131406799|NCT02754141|473113322|FG003|Overall Study|Not completing monotherapy|0|||
131406800|NCT02754141|473113323|FG004|Overall Study|Not completing monotherapy|0|||
131406801|NCT02754141|473113324|FG005|Overall Study|Not completing monotherapy|0|||
131406802|NCT02754141|473113325|FG006|Overall Study|Not completing monotherapy|0|||
131406803|NCT02754141|473113326|FG007|Overall Study|Not completing monotherapy|0|||
131406804|NCT02754141|473113327|FG008|Overall Study|Not completing monotherapy|0|||
131406805|NCT02754141|473113328|FG009|Overall Study|Not completing monotherapy|0|||
131406806|NCT02754141|473113329|FG010|Overall Study|Not completing monotherapy|0|||
131406807|NCT02754141|473113330|FG011|Overall Study|Not completing monotherapy|0|||
131406808|NCT02754141|473113331|FG012|Overall Study|Not completing monotherapy|0|||
131406809|NCT02754141|473113332|FG013|Overall Study|Not completing monotherapy|1|||
131406810|NCT02754141|473113333|FG014|Overall Study|Not completing monotherapy|0|||
131406811|NCT02754141|473113334|FG015|Overall Study|Not completing monotherapy|0|||
131406812|NCT02754141|473113335|FG016|Overall Study|Not completing monotherapy|0|||
131406813|NCT02754141|473113336|FG017|Overall Study|Not completing monotherapy|0|||
131406814|NCT03361189|473113337|FG000|Overall Study|Received heart transplant|1|||
131406815|NCT03361189|473113338|FG001|Overall Study|Received heart transplant|0|||
131406816|NCT03361189|473113337|FG000|Overall Study|Pacemake replacement|0|||
131406817|NCT03361189|473113338|FG001|Overall Study|Pacemake replacement|1|||
131406818|NCT03344549|473113339|FG000|Overall Study|Withdrawal by Subject|3|||
131406819|NCT03344549|473113340|FG001|Overall Study|Withdrawal by Subject|2|||
131406820|NCT03344549|473113339|FG000|Overall Study|Dialysis|2|||
131406821|NCT03344549|473113340|FG001|Overall Study|Dialysis|0|||
131406822|NCT03344549|473113339|FG000|Overall Study|Cancer|1|||
131406823|NCT03344549|473113340|FG001|Overall Study|Cancer|0|||
131406824|NCT03344549|473113339|FG000|Overall Study|Lack of electronic device|1|||
131406825|NCT03344549|473113340|FG001|Overall Study|Lack of electronic device|0|||
131406826|NCT03344549|473113339|FG000|Overall Study|Transportation difficulty|0|||
131406827|NCT03344549|473113340|FG001|Overall Study|Transportation difficulty|13|||
131406828|NCT03333252|473113341|FG000|Overall Study|Adverse Event|10|||
131406829|NCT03333252|473113342|FG001|Overall Study|Adverse Event|6|||
131406830|NCT03333252|473113343|FG002|Overall Study|Adverse Event|5|||
131406831|NCT03333252|473113344|FG003|Overall Study|Adverse Event|2|||
131406832|NCT03333252|473113341|FG000|Overall Study|Death|1|||
131406833|NCT03333252|473113342|FG001|Overall Study|Death|3|||
131406834|NCT03333252|473113343|FG002|Overall Study|Death|0|||
131406835|NCT03333252|473113344|FG003|Overall Study|Death|0|||
131406836|NCT03333252|473113341|FG000|Overall Study|Lack of Efficacy|8|||
131406837|NCT03333252|473113342|FG001|Overall Study|Lack of Efficacy|4|||
131406838|NCT03333252|473113343|FG002|Overall Study|Lack of Efficacy|0|||
131406839|NCT03333252|473113344|FG003|Overall Study|Lack of Efficacy|7|||
131406840|NCT03333252|473113341|FG000|Overall Study|Lost to Follow-up|0|||
131406841|NCT03333252|473113342|FG001|Overall Study|Lost to Follow-up|5|||
131406842|NCT03333252|473113343|FG002|Overall Study|Lost to Follow-up|9|||
131406843|NCT03333252|473113344|FG003|Overall Study|Lost to Follow-up|3|||
131406844|NCT03333252|473113341|FG000|Overall Study|Withdrawal by Subject|14|||
131406845|NCT03333252|473113342|FG001|Overall Study|Withdrawal by Subject|24|||
131406846|NCT03333252|473113343|FG002|Overall Study|Withdrawal by Subject|11|||
131406847|NCT03333252|473113344|FG003|Overall Study|Withdrawal by Subject|17|||
131406848|NCT01187446|473113349|FG000|Overall Study|Patient started non-protocol therapy|0|||
131406849|NCT01187446|473113350|FG001|Overall Study|Patient started non-protocol therapy|1|||
131406850|NCT00149994|473113355|FG000|Overall Study|Administrative problems:|1|||
131406851|NCT00149994|473113356|FG001|Overall Study|Administrative problems:|0|||
131406852|NCT00149994|473113355|FG000|Overall Study|Protocol Violation|0|||
131406853|NCT00149994|473113356|FG001|Overall Study|Protocol Violation|1|||
131406854|NCT04195438|473113361|FG000|Overall Study|Withdrawal by Subject|1|||
131406855|NCT01342965|473113362|FG000|Overall Study|Death|58|||
131406856|NCT01342965|473113363|FG001|Overall Study|Death|57|||
131406857|NCT01342965|473113362|FG000|Overall Study|Lost to Follow-up|5|||
131406858|NCT01342965|473113363|FG001|Overall Study|Lost to Follow-up|3|||
131406859|NCT01342965|473113362|FG000|Overall Study|Other Reasons- Unspecified|44|||
131406860|NCT01342965|473113363|FG001|Overall Study|Other Reasons- Unspecified|38|||
131406861|NCT01342965|473113362|FG000|Overall Study|Withdrawal by Subject|2|||
131406862|NCT01342965|473113363|FG001|Overall Study|Withdrawal by Subject|9|||
131406863|NCT03538444|473113376|FG000|Overall Study|opioid withdrawal|1|||
131406864|NCT03538444|473113377|FG001|Overall Study|opioid withdrawal|0|||
131406865|NCT04584346|473113378|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
131406866|NCT04584346|473113379|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
131406867|NCT03640052|473113380|FG000|Overall Study|Lost to Follow-up|0|||
131406868|NCT03640052|473113381|FG001|Overall Study|Lost to Follow-up|1|||
131406869|NCT03640052|473113382|FG002|Overall Study|Lost to Follow-up|0|||
131406870|NCT03640052|473113383|FG003|Overall Study|Lost to Follow-up|0|||
131406871|NCT03640052|473113384|FG004|Overall Study|Lost to Follow-up|0|||
131406872|NCT04422561|473113385|FG000|Overall Study|Lost to Follow-up|25|||
131406873|NCT04422561|473113386|FG001|Overall Study|Lost to Follow-up|11|||
131406874|NCT04239222|473113389|FG000|Baseline|Withdrawal by Subject|0|||
131857385|NCT01625091|474755160|FG000|Intervention|Adverse Event|0|||
131857386|NCT01625091|474755161|FG001|Intervention|Adverse Event|2|||
131857387|NCT01625091|474755160|FG000|Intervention|Lost to Follow-up|4|||
131857388|NCT01625091|474755161|FG001|Intervention|Lost to Follow-up|4|||
131857389|NCT01625091|474755160|FG000|Intervention|Study termination|2|||
131857390|NCT01625091|474755161|FG001|Intervention|Study termination|3|||
131857391|NCT01625091|474755160|FG000|Post-intervention|Death|0|||
131857392|NCT01625091|474755161|FG001|Post-intervention|Death|1|||
131857393|NCT01625091|474755160|FG000|Post-intervention|Lost to Follow-up|2|||
131857394|NCT01625091|474755161|FG001|Post-intervention|Lost to Follow-up|0|||
131857395|NCT01625091|474755160|FG000|Post-intervention|Study termination|2|||
131857396|NCT01625091|474755161|FG001|Post-intervention|Study termination|1|||
131857397|NCT00768248|474755165|FG000|Overall Study|Research coordinator didn't collect data|1|||
131857398|NCT00768248|474755166|FG001|Overall Study|Research coordinator didn't collect data|1|||
131857399|NCT01547390|474755167|FG000|Overall Study|Withdrawal by Subject|10|||
131857400|NCT01547390|474755168|FG001|Overall Study|Withdrawal by Subject|7|||
131857401|NCT01547390|474755167|FG000|Overall Study|termination of pregnancy|0|||
131857402|NCT01547390|474755168|FG001|Overall Study|termination of pregnancy|1|||
131857403|NCT01547390|474755167|FG000|Overall Study|Lost to Follow-up|0|||
131857404|NCT01547390|474755168|FG001|Overall Study|Lost to Follow-up|2|||
131857405|NCT01547390|474755167|FG000|Overall Study|Adverse Event|3|||
131857406|NCT01547390|474755168|FG001|Overall Study|Adverse Event|0|||
131406875|NCT04239222|473113390|FG001|Baseline|Withdrawal by Subject|0|||
131406876|NCT04239222|473113391|FG002|Baseline|Withdrawal by Subject|1|||
131406877|NCT04239222|473113392|FG003|Baseline|Withdrawal by Subject|1|||
131406878|NCT04239222|473113389|FG000|First Foot Assignment|Withdrawal by Subject|0|||
131406879|NCT04239222|473113390|FG001|First Foot Assignment|Withdrawal by Subject|0|||
131406880|NCT04239222|473113391|FG002|First Foot Assignment|Withdrawal by Subject|1|||
131406881|NCT04239222|473113392|FG003|First Foot Assignment|Withdrawal by Subject|0|||
131406882|NCT04239222|473113389|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
131406883|NCT04239222|473113390|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
131406884|NCT04239222|473113391|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
131406885|NCT04239222|473113392|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
131406886|NCT00790647|473113400|FG000|Overall Study|Adverse Event|1|||
131406887|NCT02701777|473113401|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
131406888|NCT02701777|473113402|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
131406889|NCT02701777|473113403|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
131406890|NCT02701777|473113404|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
131406891|NCT02701777|473113401|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
131406892|NCT02701777|473113402|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
131406893|NCT02701777|473113403|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
131406894|NCT02701777|473113404|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
131406895|NCT01774253|473113405|FG000|Overall Study|Lack of Efficacy|4|||
131406896|NCT01774253|473113405|FG000|Overall Study|Physician Decision|2|||
131406897|NCT01774253|473113405|FG000|Overall Study|Withdrawal by Subject|2|||
131406898|NCT01774253|473113405|FG000|Overall Study|Death|1|||
131406899|NCT00772369|473113406|FG000|Overall Study|Did not return record release form|1|||
131406900|NCT00554619|473113407|FG000|Overall Study|Adverse Event|1|||
131406901|NCT00554619|473113407|FG000|Overall Study|Physician Decision|1|||
131406902|NCT00554619|473113407|FG000|Overall Study|Liver Function Test Abnormality|1|||
131406903|NCT01571284|473113410|FG000|Overall Study|Participant's decision|84|||
131857407|NCT04917861|474755169|FG000|Main Study (196 Days)|Adverse Event|0|||
131857408|NCT04917861|474755170|FG001|Main Study (196 Days)|Adverse Event|1|||
131912633|NCT01572792|474966625|FG002|Lead-in Study|Adverse Event|22|||
131912634|NCT01572792|474966626|FG003|Lead-in Study|Adverse Event|16|||
131912635|NCT01572792|474966627|FG004|Lead-in Study|Adverse Event|14|||
131912636|NCT01572792|474966623|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
131912637|NCT01572792|474966624|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
131912638|NCT01572792|474966625|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
131912639|NCT01572792|474966626|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
131912640|NCT01572792|474966627|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
131912641|NCT01572792|474966623|FG000|Extension Study|Lost to Follow-up|6|||
131912642|NCT01572792|474966624|FG001|Extension Study|Lost to Follow-up|2|||
131912643|NCT01572792|474966625|FG002|Extension Study|Lost to Follow-up|0|||
131912644|NCT01572792|474966626|FG003|Extension Study|Lost to Follow-up|3|||
131912645|NCT01572792|474966627|FG004|Extension Study|Lost to Follow-up|3|||
131912646|NCT01572792|474966623|FG000|Extension Study|Withdrawal by Subject|7|||
131912647|NCT01572792|474966624|FG001|Extension Study|Withdrawal by Subject|6|||
131912648|NCT01572792|474966625|FG002|Extension Study|Withdrawal by Subject|11|||
131912649|NCT01572792|474966626|FG003|Extension Study|Withdrawal by Subject|8|||
131912650|NCT01572792|474966627|FG004|Extension Study|Withdrawal by Subject|14|||
131912651|NCT01572792|474966623|FG000|Extension Study|Protocol Violation|0|||
131912652|NCT01572792|474966624|FG001|Extension Study|Protocol Violation|4|||
131912653|NCT01572792|474966625|FG002|Extension Study|Protocol Violation|3|||
131857409|NCT04917861|474755171|FG002|Main Study (196 Days)|Adverse Event|0|||
131857410|NCT04917861|474755172|FG003|Main Study (196 Days)|Adverse Event|0|||
131857411|NCT04917861|474755169|FG000|Main Study (196 Days)|Death|0|||
131857412|NCT04917861|474755170|FG001|Main Study (196 Days)|Death|0|||
131857413|NCT04917861|474755171|FG002|Main Study (196 Days)|Death|0|||
131857414|NCT04917861|474755172|FG003|Main Study (196 Days)|Death|1|||
131857415|NCT04917861|474755169|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
131857416|NCT04917861|474755170|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
131857417|NCT04917861|474755171|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
131857418|NCT04917861|474755172|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
131857419|NCT04917861|474755169|FG000|Main Study (196 Days)|Physician Decision|0|||
131857420|NCT04917861|474755170|FG001|Main Study (196 Days)|Physician Decision|0|||
131857421|NCT04917861|474755171|FG002|Main Study (196 Days)|Physician Decision|0|||
131857422|NCT04917861|474755172|FG003|Main Study (196 Days)|Physician Decision|1|||
131857423|NCT04917861|474755169|FG000|Main Study (196 Days)|Pregnancy|1|||
131857424|NCT04917861|474755170|FG001|Main Study (196 Days)|Pregnancy|1|||
131857425|NCT04917861|474755171|FG002|Main Study (196 Days)|Pregnancy|0|||
131857426|NCT04917861|474755172|FG003|Main Study (196 Days)|Pregnancy|0|||
131857427|NCT04917861|474755169|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
131857428|NCT04917861|474755170|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
131857429|NCT04917861|474755171|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
131857430|NCT04917861|474755172|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
131857431|NCT04917861|474755169|FG000|Main Study (196 Days)|Other Than Specified|1|||
131857432|NCT04917861|474755170|FG001|Main Study (196 Days)|Other Than Specified|0|||
131857433|NCT04917861|474755171|FG002|Main Study (196 Days)|Other Than Specified|1|||
131857434|NCT04917861|474755172|FG003|Main Study (196 Days)|Other Than Specified|2|||
131857435|NCT04917861|474755169|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
131857436|NCT04917861|474755170|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
131857437|NCT04917861|474755171|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
131857438|NCT04917861|474755172|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
131857439|NCT04917861|474755169|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
131857440|NCT04917861|474755170|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
131857441|NCT04917861|474755171|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
131857442|NCT04917861|474755172|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
131857443|NCT04917861|474755169|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
131857444|NCT04917861|474755170|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
131857445|NCT04917861|474755171|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
131857446|NCT04917861|474755172|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
131857447|NCT04917861|474755169|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
131857448|NCT04917861|474755170|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
131857449|NCT04917861|474755171|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
131857450|NCT04917861|474755172|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
131857451|NCT04917861|474755169|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
131857452|NCT04917861|474755170|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
131857453|NCT04917861|474755171|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
131857454|NCT04917861|474755172|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
131857455|NCT04917861|474755169|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
131857456|NCT04917861|474755170|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
131857457|NCT04917861|474755171|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
131857458|NCT04917861|474755172|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
131857459|NCT06389487|474755173|FG000|Overall Study|Lost to Follow-up|9|||
131857460|NCT06389487|474755174|FG001|Overall Study|Lost to Follow-up|5|||
131857461|NCT06389487|474755175|FG002|Overall Study|Lost to Follow-up|13|||
131857462|NCT06389487|474755173|FG000|Overall Study|Protocol Violation|0|||
131857463|NCT06389487|474755174|FG001|Overall Study|Protocol Violation|0|||
131857464|NCT06389487|474755175|FG002|Overall Study|Protocol Violation|2|||
131857465|NCT06389487|474755173|FG000|Overall Study|Withdrawal by Subject|2|||
131857466|NCT06389487|474755174|FG001|Overall Study|Withdrawal by Subject|2|||
131857467|NCT06389487|474755175|FG002|Overall Study|Withdrawal by Subject|1|||
131857468|NCT06389487|474755173|FG000|Overall Study|Other|1|||
131857469|NCT06389487|474755174|FG001|Overall Study|Other|0|||
131857470|NCT06389487|474755175|FG002|Overall Study|Other|1|||
131857471|NCT03300817|474757261|FG000|Overall Study|Withdrawal by Subject|1|||
131857472|NCT03300817|474757261|FG000|Overall Study|Adverse Event|1|||
131857473|NCT03300817|474757261|FG000|Overall Study|Subject Found to be Ineligible|2|||
131857474|NCT03729596|474757264|FG000|Overall Study|Death|3|||
131857475|NCT03729596|474757265|FG001|Overall Study|Death|5|||
131857476|NCT03729596|474757266|FG002|Overall Study|Death|4|||
131857477|NCT03729596|474757267|FG003|Overall Study|Death|1|||
131857478|NCT03729596|474757268|FG004|Overall Study|Death|0|||
131857479|NCT03729596|474757269|FG005|Overall Study|Death|34|||
131857480|NCT03729596|474757270|FG006|Overall Study|Death|18|||
131857481|NCT03729596|474757271|FG007|Overall Study|Death|14|||
131857482|NCT03729596|474757272|FG008|Overall Study|Death|19|||
131912654|NCT01572792|474966626|FG003|Extension Study|Protocol Violation|4|||
131912655|NCT01572792|474966627|FG004|Extension Study|Protocol Violation|3|||
131912656|NCT01572792|474966623|FG000|Extension Study|Lack of Efficacy|2|||
131912657|NCT01572792|474966624|FG001|Extension Study|Lack of Efficacy|3|||
131912658|NCT01572792|474966625|FG002|Extension Study|Lack of Efficacy|3|||
131912659|NCT01572792|474966626|FG003|Extension Study|Lack of Efficacy|2|||
131912660|NCT01572792|474966627|FG004|Extension Study|Lack of Efficacy|2|||
131912661|NCT01572792|474966623|FG000|Extension Study|Adverse Event|7|||
131912662|NCT01572792|474966624|FG001|Extension Study|Adverse Event|6|||
131912663|NCT01572792|474966625|FG002|Extension Study|Adverse Event|5|||
131912664|NCT01572792|474966626|FG003|Extension Study|Adverse Event|6|||
131912665|NCT01572792|474966627|FG004|Extension Study|Adverse Event|4|||
131912666|NCT01572792|474966623|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
131912667|NCT01572792|474966624|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
131912668|NCT01572792|474966625|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
131912669|NCT01572792|474966626|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
131912670|NCT01572792|474966627|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
131912671|NCT01129128|474966628|FG000|Overall Study|Lost to Follow-up|2|||
131912672|NCT01129128|474966629|FG001|Overall Study|Lost to Follow-up|2|||
131912673|NCT01129128|474966630|FG002|Overall Study|Lost to Follow-up|1|||
131912674|NCT01129128|474966628|FG000|Overall Study|Protocol Violation|0|||
131912675|NCT01129128|474966629|FG001|Overall Study|Protocol Violation|1|||
131912676|NCT01129128|474966630|FG002|Overall Study|Protocol Violation|0|||
131406904|NCT01571284|473113410|FG000|Overall Study|Lost to Follow-up|3|||
131857483|NCT03729596|474757273|FG009|Overall Study|Death|9|||
131857484|NCT03729596|474757264|FG000|Overall Study|Lost to Follow-up|0|||
131857485|NCT03729596|474757265|FG001|Overall Study|Lost to Follow-up|0|||
131857486|NCT03729596|474757266|FG002|Overall Study|Lost to Follow-up|0|||
131857487|NCT03729596|474757267|FG003|Overall Study|Lost to Follow-up|0|||
131857488|NCT03729596|474757268|FG004|Overall Study|Lost to Follow-up|0|||
131857489|NCT03729596|474757269|FG005|Overall Study|Lost to Follow-up|0|||
131857490|NCT03729596|474757270|FG006|Overall Study|Lost to Follow-up|1|||
131857491|NCT03729596|474757271|FG007|Overall Study|Lost to Follow-up|0|||
131857492|NCT03729596|474757272|FG008|Overall Study|Lost to Follow-up|0|||
131857493|NCT03729596|474757273|FG009|Overall Study|Lost to Follow-up|1|||
131857494|NCT03729596|474757264|FG000|Overall Study|protocol amendment|0|||
131857495|NCT03729596|474757265|FG001|Overall Study|protocol amendment|1|||
131857496|NCT03729596|474757266|FG002|Overall Study|protocol amendment|3|||
131857497|NCT03729596|474757267|FG003|Overall Study|protocol amendment|6|||
131857498|NCT03729596|474757268|FG004|Overall Study|protocol amendment|5|||
131857499|NCT03729596|474757269|FG005|Overall Study|protocol amendment|0|||
131857500|NCT03729596|474757270|FG006|Overall Study|protocol amendment|0|||
131857501|NCT03729596|474757271|FG007|Overall Study|protocol amendment|0|||
131857502|NCT03729596|474757272|FG008|Overall Study|protocol amendment|0|||
131857503|NCT03729596|474757273|FG009|Overall Study|protocol amendment|0|||
131857504|NCT03729596|474757264|FG000|Overall Study|Withdrawal by Subject|0|||
131857505|NCT03729596|474757265|FG001|Overall Study|Withdrawal by Subject|0|||
131857506|NCT03729596|474757266|FG002|Overall Study|Withdrawal by Subject|0|||
131857507|NCT03729596|474757267|FG003|Overall Study|Withdrawal by Subject|0|||
131857508|NCT03729596|474757268|FG004|Overall Study|Withdrawal by Subject|0|||
131857509|NCT03729596|474757269|FG005|Overall Study|Withdrawal by Subject|4|||
131857510|NCT03729596|474757270|FG006|Overall Study|Withdrawal by Subject|2|||
131857511|NCT03729596|474757271|FG007|Overall Study|Withdrawal by Subject|3|||
131857512|NCT03729596|474757272|FG008|Overall Study|Withdrawal by Subject|2|||
131857513|NCT03729596|474757273|FG009|Overall Study|Withdrawal by Subject|3|||
131857514|NCT03729596|474757264|FG000|Overall Study|study terminated by sponsor|0|||
131857515|NCT03729596|474757265|FG001|Overall Study|study terminated by sponsor|0|||
131857516|NCT03729596|474757266|FG002|Overall Study|study terminated by sponsor|0|||
131857517|NCT03729596|474757267|FG003|Overall Study|study terminated by sponsor|0|||
131857518|NCT03729596|474757268|FG004|Overall Study|study terminated by sponsor|1|||
131857519|NCT03729596|474757269|FG005|Overall Study|study terminated by sponsor|3|||
131857520|NCT03729596|474757270|FG006|Overall Study|study terminated by sponsor|0|||
131857521|NCT03729596|474757271|FG007|Overall Study|study terminated by sponsor|1|||
131857522|NCT03729596|474757272|FG008|Overall Study|study terminated by sponsor|0|||
131857523|NCT03729596|474757273|FG009|Overall Study|study terminated by sponsor|0|||
131857524|NCT03713593|474757274|FG000|Overall Study|Sponsor Decision|73|||
131857525|NCT03713593|474757275|FG001|Overall Study|Sponsor Decision|41|||
131857526|NCT03713593|474757274|FG000|Overall Study|Lost to Follow-up|2|||
131857527|NCT03713593|474757275|FG001|Overall Study|Lost to Follow-up|1|||
131857528|NCT03713593|474757274|FG000|Overall Study|Death|314|||
131857529|NCT03713593|474757275|FG001|Overall Study|Death|349|||
131857530|NCT03713593|474757274|FG000|Overall Study|Withdrawal by Subject|6|||
131857531|NCT03713593|474757275|FG001|Overall Study|Withdrawal by Subject|8|||
131912677|NCT01129128|474966628|FG000|Overall Study|Withdrawal by Subject|0|||
131912678|NCT01129128|474966629|FG001|Overall Study|Withdrawal by Subject|1|||
131912679|NCT01129128|474966630|FG002|Overall Study|Withdrawal by Subject|3|||
131912680|NCT01129128|474966628|FG000|Overall Study|Physician Decision|1|||
131912681|NCT01129128|474966629|FG001|Overall Study|Physician Decision|0|||
131912682|NCT01129128|474966630|FG002|Overall Study|Physician Decision|0|||
131912683|NCT00961415|474966631|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
131912684|NCT00961415|474966632|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
131912685|NCT00961415|474966633|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
131912686|NCT00961415|474966631|FG000|Induction Treatment Phase|Death|77|||
131912687|NCT00961415|474966632|FG001|Induction Treatment Phase|Death|0|||
131912688|NCT00961415|474966633|FG002|Induction Treatment Phase|Death|0|||
131912689|NCT00961415|474966631|FG000|Induction Treatment Phase|Protocol Violation|1|||
131912690|NCT00961415|474966632|FG001|Induction Treatment Phase|Protocol Violation|0|||
131912691|NCT00961415|474966633|FG002|Induction Treatment Phase|Protocol Violation|0|||
131912692|NCT00961415|474966631|FG000|Induction Treatment Phase|Physician Decision|2|||
131912693|NCT00961415|474966632|FG001|Induction Treatment Phase|Physician Decision|0|||
131912694|NCT00961415|474966633|FG002|Induction Treatment Phase|Physician Decision|0|||
131857532|NCT04653454|474757276|FG000|Overall Study|Withdrawal by Subject|1|||
131857533|NCT04653454|474757276|FG000|Overall Study|Physician Decision|40|||
131857534|NCT03620708|474757277|FG000|Overall Study|Lost to Follow-up|1|||
131857535|NCT03620708|474757278|FG001|Overall Study|Lost to Follow-up|1|||
131857536|NCT03620708|474757279|FG002|Overall Study|Lost to Follow-up|2|||
131857537|NCT03620708|474757277|FG000|Overall Study|Withdrawal by Subject|0|||
131857538|NCT03620708|474757278|FG001|Overall Study|Withdrawal by Subject|0|||
131857539|NCT03620708|474757279|FG002|Overall Study|Withdrawal by Subject|1|||
131857540|NCT05126693|474757280|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
131857541|NCT05126693|474757281|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
131857542|NCT05126693|474757280|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
131857543|NCT05126693|474757281|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
131857544|NCT05126693|474757280|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
131857545|NCT05126693|474757281|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
131857546|NCT04011722|474757285|FG000|30 Days|Death|5|||
131857547|NCT04011722|474757286|FG001|30 Days|Death|1|||
131857548|NCT04011722|474757285|FG000|1 Year|Death|13|||
131857549|NCT04011722|474757286|FG001|1 Year|Death|5|||
131857550|NCT04011722|474757285|FG000|1 Year|Withdrawal by Subject|8|||
131857551|NCT04011722|474757286|FG001|1 Year|Withdrawal by Subject|2|||
131857552|NCT04011722|474757285|FG000|1 Year|Missed Visit|6|||
131912695|NCT00961415|474966631|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
131912696|NCT00961415|474966632|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
131912697|NCT00961415|474966633|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
131912698|NCT00961415|474966631|FG000|Induction Treatment Phase|Other Reason|5|||
131912699|NCT00961415|474966632|FG001|Induction Treatment Phase|Other Reason|0|||
131912700|NCT00961415|474966633|FG002|Induction Treatment Phase|Other Reason|0|||
131912701|NCT00961415|474966631|FG000|Maintenance Treatment Phase|Death|0|||
131912702|NCT00961415|474966632|FG001|Maintenance Treatment Phase|Death|42|||
131912703|NCT00961415|474966633|FG002|Maintenance Treatment Phase|Death|34|||
131912704|NCT00961415|474966631|FG000|Maintenance Treatment Phase|Investigators decision|0|||
131912705|NCT00961415|474966632|FG001|Maintenance Treatment Phase|Investigators decision|2|||
131912706|NCT00961415|474966633|FG002|Maintenance Treatment Phase|Investigators decision|0|||
131912707|NCT00961415|474966631|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131912708|NCT00961415|474966632|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
131912709|NCT00961415|474966633|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
131912710|NCT00961415|474966631|FG000|Maintenance Treatment Phase|Other reason|0|||
131912711|NCT00961415|474966632|FG001|Maintenance Treatment Phase|Other reason|1|||
131912712|NCT00961415|474966633|FG002|Maintenance Treatment Phase|Other reason|3|||
131912713|NCT04478266|474966642|FG000|Overall Study|Adverse Event|20|||
131912714|NCT04478266|474966643|FG001|Overall Study|Adverse Event|21|||
131912715|NCT04478266|474966642|FG000|Overall Study|Progressive disease|146|||
131912716|NCT04478266|474966643|FG001|Overall Study|Progressive disease|168|||
131912717|NCT04478266|474966642|FG000|Overall Study|Poor compliance to protocol|1|||
131912718|NCT04478266|474966643|FG001|Overall Study|Poor compliance to protocol|0|||
131912719|NCT04478266|474966642|FG000|Overall Study|Withdrawal by Subject|19|||
131912720|NCT04478266|474966643|FG001|Overall Study|Withdrawal by Subject|16|||
131912721|NCT04478266|474966642|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
131912722|NCT04478266|474966643|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
131912723|NCT04478266|474966642|FG000|Overall Study|Study terminated by sponsor|33|||
131912724|NCT04478266|474966643|FG001|Overall Study|Study terminated by sponsor|35|||
131912725|NCT04478266|474966642|FG000|Overall Study|Other: unspecified|5|||
131857553|NCT04011722|474757286|FG001|1 Year|Missed Visit|1|||
131857554|NCT04011722|474757285|FG000|1 Year|Pending Visit|0|||
131857555|NCT04011722|474757286|FG001|1 Year|Pending Visit|11|||
131857556|NCT04011722|474757285|FG000|1 Year|Not Yet Due|0|||
131857557|NCT04011722|474757286|FG001|1 Year|Not Yet Due|9|||
131857558|NCT04011722|474757285|FG000|2 Year|Death|16|||
131912726|NCT04478266|474966643|FG001|Overall Study|Other: unspecified|7|||
131912727|NCT04478266|474966642|FG000|Overall Study|Randomized but not treated|1|||
131912728|NCT04478266|474966643|FG001|Overall Study|Randomized but not treated|1|||
131912729|NCT00671788|474966644|FG000|Overall Study|Adverse Event|8|||
131912730|NCT00671788|474966644|FG000|Overall Study|Refused further treatment|3|||
131912731|NCT00671788|474966644|FG000|Overall Study|Ineligible|1|||
131912732|NCT00671788|474966644|FG000|Overall Study|MD Decision|1|||
131912733|NCT00671788|474966644|FG000|Overall Study|Other|1|||
131912734|NCT00834041|474966650|FG000|Overall Study|Withdrawal by Subject|1|||
131912735|NCT00834041|474966651|FG001|Overall Study|Withdrawal by Subject|0|||
131912736|NCT00834041|474966650|FG000|Overall Study|Lost to Follow-up|0|||
131912737|NCT00834041|474966651|FG001|Overall Study|Lost to Follow-up|1|||
131912738|NCT03074500|474966652|FG000|Overall Study|Lost to Follow-up|1|||
131912739|NCT03074500|474966653|FG001|Overall Study|Lost to Follow-up|0|||
131912740|NCT03074500|474966654|FG002|Overall Study|Lost to Follow-up|0|||
131912741|NCT03074500|474966652|FG000|Overall Study|Lack of Efficacy|0|||
131912742|NCT03074500|474966653|FG001|Overall Study|Lack of Efficacy|1|||
131912743|NCT03074500|474966654|FG002|Overall Study|Lack of Efficacy|0|||
131912744|NCT03074500|474966652|FG000|Overall Study|Adverse Event|0|||
131912745|NCT03074500|474966653|FG001|Overall Study|Adverse Event|0|||
131912746|NCT03074500|474966654|FG002|Overall Study|Adverse Event|1|||
131912747|NCT05399680|474967703|FG000|Overall Study|Lost to Follow-up|1|||
131912748|NCT05399680|474967704|FG001|Overall Study|Lost to Follow-up|0|||
131912749|NCT05399680|474967703|FG000|Overall Study|Death|0|||
131912750|NCT05399680|474967704|FG001|Overall Study|Death|1|||
131912751|NCT02659865|474967709|FG000|Period 1|Withdrawal by Subject|1|||
131912752|NCT02659865|474967710|FG001|Period 1|Withdrawal by Subject|0|||
131912753|NCT02659865|474967711|FG002|Period 1|Withdrawal by Subject|0|||
131912754|NCT02659865|474967712|FG003|Period 1|Withdrawal by Subject|0|||
131912755|NCT02659865|474967713|FG004|Period 1|Withdrawal by Subject|0|||
131912756|NCT02659865|474967709|FG000|Period 1|Adverse Event|0|||
131912757|NCT02659865|474967710|FG001|Period 1|Adverse Event|0|||
131912758|NCT02659865|474967711|FG002|Period 1|Adverse Event|0|||
131912759|NCT02659865|474967712|FG003|Period 1|Adverse Event|0|||
131912760|NCT02659865|474967713|FG004|Period 1|Adverse Event|1|||
131912761|NCT03979313|474967716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
131912762|NCT03979313|474967717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
131912763|NCT03979313|474967716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
131912764|NCT03979313|474967717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
131912765|NCT03979313|474967716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
131912766|NCT03979313|474967717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
131912767|NCT03979313|474967716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
131912768|NCT03979313|474967717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
131912769|NCT03979313|474967716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
131912770|NCT03979313|474967717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
131406905|NCT01571284|473113410|FG000|Overall Study|Enrolled but not treated|2|||
131406906|NCT01571284|473113410|FG000|Overall Study|Other than specified above|80|||
131406907|NCT00075725|473113411|FG000|Overall Study|Adverse Event|6|||
131406908|NCT00075725|473113412|FG001|Overall Study|Adverse Event|6|||
131406909|NCT00075725|473113413|FG002|Overall Study|Adverse Event|20|||
131406910|NCT00075725|473113414|FG003|Overall Study|Adverse Event|8|||
131406911|NCT00075725|473113415|FG004|Overall Study|Adverse Event|4|||
131406912|NCT00075725|473113416|FG005|Overall Study|Adverse Event|38|||
131406913|NCT00075725|473113417|FG006|Overall Study|Adverse Event|3|||
131406914|NCT00075725|473113418|FG007|Overall Study|Adverse Event|51|||
131406915|NCT00075725|473113419|FG008|Overall Study|Adverse Event|15|||
131406916|NCT00075725|473113420|FG009|Overall Study|Adverse Event|4|||
131406917|NCT00075725|473113421|FG010|Overall Study|Adverse Event|2|||
131406918|NCT00075725|473113422|FG011|Overall Study|Adverse Event|2|||
131406919|NCT00075725|473113411|FG000|Overall Study|Death|3|||
131406920|NCT00075725|473113412|FG001|Overall Study|Death|5|||
131406921|NCT00075725|473113413|FG002|Overall Study|Death|10|||
131406922|NCT00075725|473113414|FG003|Overall Study|Death|2|||
131406923|NCT00075725|473113415|FG004|Overall Study|Death|3|||
131406924|NCT00075725|473113416|FG005|Overall Study|Death|25|||
131406925|NCT00075725|473113417|FG006|Overall Study|Death|4|||
131406926|NCT00075725|473113418|FG007|Overall Study|Death|22|||
131406927|NCT00075725|473113419|FG008|Overall Study|Death|14|||
131406928|NCT00075725|473113420|FG009|Overall Study|Death|4|||
131406929|NCT00075725|473113421|FG010|Overall Study|Death|3|||
131406930|NCT00075725|473113422|FG011|Overall Study|Death|0|||
131406931|NCT00075725|473113411|FG000|Overall Study|Lost to Follow-up|1|||
131406932|NCT00075725|473113412|FG001|Overall Study|Lost to Follow-up|1|||
131406933|NCT00075725|473113413|FG002|Overall Study|Lost to Follow-up|4|||
131406934|NCT00075725|473113414|FG003|Overall Study|Lost to Follow-up|1|||
131406935|NCT00075725|473113415|FG004|Overall Study|Lost to Follow-up|0|||
131912771|NCT03979313|474967716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
131912772|NCT03979313|474967717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
131912773|NCT03979313|474967716|FG000|All Subjects|Any Other Reason|16|||
131912774|NCT03979313|474967717|FG001|All Subjects|Any Other Reason|23|||
131912775|NCT03979313|474967716|FG000|All Subjects|Covid-19|1|||
131912776|NCT03979313|474967717|FG001|All Subjects|Covid-19|3|||
131912777|NCT03979313|474967716|FG000|All Subjects|Withdrawal by Subject|35|||
131912778|NCT03979313|474967717|FG001|All Subjects|Withdrawal by Subject|44|||
131912779|NCT03979313|474967716|FG000|All Subjects|Death|0|||
131406936|NCT00075725|473113416|FG005|Overall Study|Lost to Follow-up|13|||
131406937|NCT00075725|473113417|FG006|Overall Study|Lost to Follow-up|2|||
131406938|NCT00075725|473113418|FG007|Overall Study|Lost to Follow-up|4|||
131406939|NCT00075725|473113419|FG008|Overall Study|Lost to Follow-up|1|||
131912780|NCT03979313|474967717|FG001|All Subjects|Death|5|||
131857559|NCT04011722|474757286|FG001|2 Year|Death|1|||
131857560|NCT04011722|474757285|FG000|2 Year|Withdrawal by Subject|10|||
131857561|NCT04011722|474757286|FG001|2 Year|Withdrawal by Subject|1|||
131857562|NCT04011722|474757285|FG000|2 Year|Missed Visit|9|||
131857563|NCT04011722|474757286|FG001|2 Year|Missed Visit|0|||
131857564|NCT04011722|474757285|FG000|2 Year|Visit Pending|1|||
131857565|NCT04011722|474757286|FG001|2 Year|Visit Pending|3|||
131857566|NCT04011722|474757285|FG000|2 Year|Not Yet Due|43|||
131857567|NCT04011722|474757286|FG001|2 Year|Not Yet Due|54|||
131857568|NCT04011722|474757285|FG000|3 Year|Death|10|||
131857569|NCT04011722|474757286|FG001|3 Year|Death|0|||
131857570|NCT04011722|474757285|FG000|3 Year|Withdrawal by Subject|2|||
131857571|NCT04011722|474757286|FG001|3 Year|Withdrawal by Subject|0|||
131857572|NCT04011722|474757285|FG000|3 Year|Missed Visit|2|||
131857573|NCT04011722|474757286|FG001|3 Year|Missed Visit|0|||
131857574|NCT04011722|474757285|FG000|3 Year|Pending Visit|34|||
131857575|NCT04011722|474757286|FG001|3 Year|Pending Visit|0|||
131857576|NCT04011722|474757285|FG000|3 Year|Not Yet Due|99|||
131857577|NCT04011722|474757286|FG001|3 Year|Not Yet Due|0|||
131857578|NCT05109611|474757287|FG000|Overall Study|Adverse Event|13|||
131857579|NCT05109611|474757288|FG001|Overall Study|Adverse Event|10|||
131857580|NCT05109611|474757287|FG000|Overall Study|Withdrawal by Subject|1|||
131857581|NCT05109611|474757288|FG001|Overall Study|Withdrawal by Subject|0|||
131857582|NCT05109611|474757287|FG000|Overall Study|Lost to Follow-up|1|||
131857583|NCT05109611|474757288|FG001|Overall Study|Lost to Follow-up|2|||
131857584|NCT05109611|474757287|FG000|Overall Study|Protocol Violation|0|||
131857585|NCT05109611|474757288|FG001|Overall Study|Protocol Violation|4|||
131857586|NCT05109611|474757287|FG000|Overall Study|Information unavailable|1|||
131857587|NCT05109611|474757288|FG001|Overall Study|Information unavailable|1|||
131857588|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
131857589|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
131857590|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
131857591|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
131857592|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
131857593|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
131857594|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
131857595|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
131857596|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
131857597|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
131857598|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
131857599|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
131857600|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
131857601|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
131857602|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
131857603|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
131857604|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
131857605|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
131857606|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
131857607|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
131857608|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
131857609|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
131857610|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
131857611|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
131857612|NCT01130532|474757289|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
131857613|NCT01130532|474757290|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
131857614|NCT01130532|474757291|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
131857615|NCT01130532|474757292|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
131857616|NCT01130532|474757289|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
131912781|NCT03979313|474967716|FG000|All Subjects|Lost to Follow-up|28|||
131912782|NCT03979313|474967717|FG001|All Subjects|Lost to Follow-up|61|||
131912783|NCT02690727|474967721|FG000|Overall Study|Adverse Event|2|||
131912784|NCT02690727|474967722|FG001|Overall Study|Adverse Event|2|||
131912785|NCT02911116|474967727|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131857617|NCT01130532|474757290|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
131912786|NCT02911116|474967728|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131912787|NCT02911116|474967727|FG000|Overall Study|Lost to Follow-up|0|||
131912788|NCT02911116|474967728|FG001|Overall Study|Lost to Follow-up|1|||
131406940|NCT00075725|473113420|FG009|Overall Study|Lost to Follow-up|0|||
131857618|NCT01130532|474757291|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
131857619|NCT01130532|474757292|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
131857620|NCT01130532|474757289|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
131857621|NCT01130532|474757290|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
131912789|NCT02110693|474967729|FG000|Overall Study|Withdrawal by Subject|6|||
131857622|NCT01130532|474757291|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
131857623|NCT01130532|474757292|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
131857624|NCT01130532|474757289|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
131857625|NCT01130532|474757290|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
131857626|NCT01130532|474757291|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
131857627|NCT01130532|474757292|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
131857628|NCT01130532|474757289|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
131857629|NCT01130532|474757290|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
131857630|NCT01130532|474757291|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
131857631|NCT01130532|474757292|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
131857632|NCT02366689|474757293|FG000|Overall Study|Withdrawal by Subject|1|||
131406941|NCT00075725|473113421|FG010|Overall Study|Lost to Follow-up|0|||
131406942|NCT00075725|473113422|FG011|Overall Study|Lost to Follow-up|0|||
131406943|NCT00075725|473113411|FG000|Overall Study|Physician Decision|2|||
131406944|NCT00075725|473113412|FG001|Overall Study|Physician Decision|6|||
131406945|NCT00075725|473113413|FG002|Overall Study|Physician Decision|5|||
131406946|NCT00075725|473113414|FG003|Overall Study|Physician Decision|8|||
131406947|NCT00075725|473113415|FG004|Overall Study|Physician Decision|4|||
131406948|NCT00075725|473113416|FG005|Overall Study|Physician Decision|19|||
131406949|NCT00075725|473113417|FG006|Overall Study|Physician Decision|3|||
131406950|NCT00075725|473113418|FG007|Overall Study|Physician Decision|17|||
131406951|NCT00075725|473113419|FG008|Overall Study|Physician Decision|5|||
131406952|NCT00075725|473113420|FG009|Overall Study|Physician Decision|0|||
131406953|NCT00075725|473113421|FG010|Overall Study|Physician Decision|1|||
131406954|NCT00075725|473113422|FG011|Overall Study|Physician Decision|0|||
131406955|NCT00075725|473113411|FG000|Overall Study|Pregnancy|0|||
131406956|NCT00075725|473113412|FG001|Overall Study|Pregnancy|0|||
131406957|NCT00075725|473113413|FG002|Overall Study|Pregnancy|0|||
131406958|NCT00075725|473113414|FG003|Overall Study|Pregnancy|0|||
131406959|NCT00075725|473113415|FG004|Overall Study|Pregnancy|0|||
131406960|NCT00075725|473113416|FG005|Overall Study|Pregnancy|1|||
131406961|NCT00075725|473113417|FG006|Overall Study|Pregnancy|0|||
131406962|NCT00075725|473113418|FG007|Overall Study|Pregnancy|1|||
131406963|NCT00075725|473113419|FG008|Overall Study|Pregnancy|0|||
131406964|NCT00075725|473113420|FG009|Overall Study|Pregnancy|0|||
131406965|NCT00075725|473113421|FG010|Overall Study|Pregnancy|0|||
131406966|NCT00075725|473113422|FG011|Overall Study|Pregnancy|0|||
131406967|NCT00075725|473113411|FG000|Overall Study|Protocol Violation|1|||
131406968|NCT00075725|473113412|FG001|Overall Study|Protocol Violation|1|||
131406969|NCT00075725|473113413|FG002|Overall Study|Protocol Violation|0|||
131406970|NCT00075725|473113414|FG003|Overall Study|Protocol Violation|3|||
131406971|NCT00075725|473113415|FG004|Overall Study|Protocol Violation|3|||
131406972|NCT00075725|473113416|FG005|Overall Study|Protocol Violation|2|||
131406973|NCT00075725|473113417|FG006|Overall Study|Protocol Violation|1|||
131406974|NCT00075725|473113418|FG007|Overall Study|Protocol Violation|2|||
131406975|NCT00075725|473113419|FG008|Overall Study|Protocol Violation|3|||
131406976|NCT00075725|473113420|FG009|Overall Study|Protocol Violation|0|||
131406977|NCT00075725|473113421|FG010|Overall Study|Protocol Violation|0|||
131406978|NCT00075725|473113422|FG011|Overall Study|Protocol Violation|1|||
131406979|NCT00075725|473113411|FG000|Overall Study|Withdrawal by Subject|12|||
131406980|NCT00075725|473113412|FG001|Overall Study|Withdrawal by Subject|3|||
131912790|NCT02110693|474967730|FG001|Overall Study|Withdrawal by Subject|7|||
131912791|NCT02110693|474967729|FG000|Overall Study|skipped assessment|15|||
131912792|NCT02110693|474967730|FG001|Overall Study|skipped assessment|18|||
131912793|NCT02110693|474967729|FG000|Overall Study|technical difficulties|6|||
131912794|NCT02110693|474967730|FG001|Overall Study|technical difficulties|4|||
131912795|NCT02110693|474967729|FG000|Overall Study|Other|1|||
131912796|NCT02110693|474967730|FG001|Overall Study|Other|0|||
131912797|NCT00805532|474967731|FG000|Overall Study|invalid data|0|||
131912798|NCT00805532|474967732|FG001|Overall Study|invalid data|1|||
131912799|NCT01859741|474967733|FG000|Overall Study|Death|3|||
131912800|NCT01859741|474967734|FG001|Overall Study|Death|2|||
131912801|NCT01859741|474967735|FG002|Overall Study|Death|4|||
131912802|NCT01859741|474967736|FG003|Overall Study|Death|3|||
131912803|NCT01859741|474967737|FG004|Overall Study|Death|5|||
131406981|NCT00075725|473113413|FG002|Overall Study|Withdrawal by Subject|6|||
131406982|NCT00075725|473113414|FG003|Overall Study|Withdrawal by Subject|10|||
131406983|NCT00075725|473113415|FG004|Overall Study|Withdrawal by Subject|6|||
131406984|NCT00075725|473113416|FG005|Overall Study|Withdrawal by Subject|27|||
131406985|NCT00075725|473113417|FG006|Overall Study|Withdrawal by Subject|7|||
131406986|NCT00075725|473113418|FG007|Overall Study|Withdrawal by Subject|31|||
131406987|NCT00075725|473113419|FG008|Overall Study|Withdrawal by Subject|10|||
131406988|NCT00075725|473113420|FG009|Overall Study|Withdrawal by Subject|2|||
131406989|NCT00075725|473113421|FG010|Overall Study|Withdrawal by Subject|0|||
131406990|NCT00075725|473113422|FG011|Overall Study|Withdrawal by Subject|0|||
131406991|NCT00075725|473113411|FG000|Overall Study|Disease Progression, all other reasons|17|||
131406992|NCT00075725|473113412|FG001|Overall Study|Disease Progression, all other reasons|5|||
131406993|NCT00075725|473113413|FG002|Overall Study|Disease Progression, all other reasons|33|||
131857633|NCT02366689|474757294|FG001|Overall Study|Withdrawal by Subject|0|||
131857634|NCT02366689|474757295|FG002|Overall Study|Withdrawal by Subject|1|||
131857635|NCT02366689|474757293|FG000|Overall Study|Lost to Follow-up|3|||
131857636|NCT02366689|474757294|FG001|Overall Study|Lost to Follow-up|2|||
131857637|NCT02366689|474757295|FG002|Overall Study|Lost to Follow-up|0|||
131857638|NCT02366689|474757293|FG000|Overall Study|Pregnancy|0|||
131857639|NCT02366689|474757294|FG001|Overall Study|Pregnancy|1|||
131857640|NCT02366689|474757295|FG002|Overall Study|Pregnancy|1|||
131857641|NCT03283566|474757296|FG000|Overall Study|Lost to Follow-up|1|||
131857642|NCT03283566|474757297|FG001|Overall Study|Lost to Follow-up|2|||
131857643|NCT00970593|474757302|FG000|Overall Study|Adverse Event|1|||
131857644|NCT00970593|474757303|FG001|Overall Study|Adverse Event|1|||
131857645|NCT00970593|474757304|FG002|Overall Study|Adverse Event|0|||
131857646|NCT00970593|474757305|FG003|Overall Study|Adverse Event|0|||
131857647|NCT00970593|474757306|FG004|Overall Study|Adverse Event|0|||
131857648|NCT00970593|474757307|FG005|Overall Study|Adverse Event|0|||
131857649|NCT00970593|474757308|FG006|Overall Study|Adverse Event|0|||
131857650|NCT00970593|474757302|FG000|Overall Study|Discontinuation of study by sponsor|0|||
131857651|NCT00970593|474757303|FG001|Overall Study|Discontinuation of study by sponsor|0|||
131857652|NCT00970593|474757304|FG002|Overall Study|Discontinuation of study by sponsor|5|||
131857653|NCT00970593|474757305|FG003|Overall Study|Discontinuation of study by sponsor|0|||
131857654|NCT00970593|474757306|FG004|Overall Study|Discontinuation of study by sponsor|0|||
131857655|NCT00970593|474757307|FG005|Overall Study|Discontinuation of study by sponsor|0|||
131857656|NCT00970593|474757308|FG006|Overall Study|Discontinuation of study by sponsor|2|||
131857657|NCT00970593|474757302|FG000|Overall Study|Withdrawal by Subject|0|||
131857658|NCT00970593|474757303|FG001|Overall Study|Withdrawal by Subject|0|||
131857659|NCT00970593|474757304|FG002|Overall Study|Withdrawal by Subject|1|||
131857660|NCT00970593|474757305|FG003|Overall Study|Withdrawal by Subject|0|||
131857661|NCT00970593|474757306|FG004|Overall Study|Withdrawal by Subject|0|||
131857662|NCT00970593|474757307|FG005|Overall Study|Withdrawal by Subject|0|||
131857663|NCT00970593|474757308|FG006|Overall Study|Withdrawal by Subject|0|||
131857664|NCT00470535|474757321|FG000|Overall Study|Disease Progression|13|||
131857665|NCT00470535|474757321|FG000|Overall Study|Withdrawal by Subject|1|||
131857666|NCT00470535|474757321|FG000|Overall Study|Adverse Event|1|||
131857667|NCT00470535|474757321|FG000|Overall Study|Death|1|||
131857668|NCT00470535|474757321|FG000|Overall Study|Other|2|||
131857669|NCT01026194|474757322|FG000|Period 1：Double Blind Period|Adverse Event|2|||
131857670|NCT01026194|474757323|FG001|Period 1：Double Blind Period|Adverse Event|1|||
131857671|NCT01026194|474757322|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
131857672|NCT01026194|474757323|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
131857673|NCT01026194|474757322|FG000|Period 1：Double Blind Period|Physician Decision|0|||
131857674|NCT01026194|474757323|FG001|Period 1：Double Blind Period|Physician Decision|4|||
131857675|NCT01026194|474757322|FG000|Period 2：Open-label Period|Adverse Event|4|||
131857676|NCT01026194|474757323|FG001|Period 2：Open-label Period|Adverse Event|5|||
131857677|NCT01026194|474757322|FG000|Period 2：Open-label Period|Physician Decision|3|||
131857678|NCT01026194|474757323|FG001|Period 2：Open-label Period|Physician Decision|1|||
131857679|NCT01026194|474757322|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
131857680|NCT01026194|474757323|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
131857681|NCT02070965|474757328|FG000|Overall Study|Lost to Follow-up|0|||
131857682|NCT02070965|474757329|FG001|Overall Study|Lost to Follow-up|1|||
131857683|NCT02070965|474757330|FG002|Overall Study|Lost to Follow-up|0|||
131857684|NCT02070965|474757328|FG000|Overall Study|Withdrawal by Subject|1|||
131857685|NCT02070965|474757329|FG001|Overall Study|Withdrawal by Subject|1|||
131857686|NCT02070965|474757330|FG002|Overall Study|Withdrawal by Subject|1|||
131857687|NCT02070965|474757328|FG000|Overall Study|Subject moved|1|||
131857688|NCT02070965|474757329|FG001|Overall Study|Subject moved|0|||
131857689|NCT02070965|474757330|FG002|Overall Study|Subject moved|0|||
131857690|NCT02515331|474757331|FG000|Overall Study|Withdrawal by Subject|0|||
131857691|NCT02515331|474757332|FG001|Overall Study|Withdrawal by Subject|0|||
131857692|NCT02515331|474757333|FG002|Overall Study|Withdrawal by Subject|1|||
131857693|NCT02515331|474757331|FG000|Overall Study|Protocol deviation|0|||
131857694|NCT02515331|474757332|FG001|Overall Study|Protocol deviation|0|||
131857695|NCT02515331|474757333|FG002|Overall Study|Protocol deviation|3|||
131857696|NCT02515331|474757331|FG000|Overall Study|Adverse Event|2|||
131857697|NCT02515331|474757332|FG001|Overall Study|Adverse Event|0|||
131857698|NCT02515331|474757333|FG002|Overall Study|Adverse Event|0|||
131857699|NCT00124748|474757334|FG000|Overall Study|Adverse Event|8|||
131857700|NCT00124748|474757335|FG001|Overall Study|Adverse Event|39|||
131857701|NCT00124748|474757334|FG000|Overall Study|Abnormal laboratory Value|2|||
131857702|NCT00124748|474757335|FG001|Overall Study|Abnormal laboratory Value|2|||
131857703|NCT00124748|474757334|FG000|Overall Study|Abnormal Procedure|0|||
131857704|NCT00124748|474757335|FG001|Overall Study|Abnormal Procedure|1|||
131857705|NCT00124748|474757334|FG000|Overall Study|Lack of Efficacy|20|||
131857706|NCT00124748|474757335|FG001|Overall Study|Lack of Efficacy|41|||
131857707|NCT00124748|474757334|FG000|Overall Study|No longer requires study drug|1|||
131857708|NCT00124748|474757335|FG001|Overall Study|No longer requires study drug|1|||
131857709|NCT00124748|474757334|FG000|Overall Study|Protocol Violation|3|||
131857710|NCT00124748|474757335|FG001|Overall Study|Protocol Violation|1|||
131406994|NCT00075725|473113414|FG003|Overall Study|Disease Progression, all other reasons|6|||
131406995|NCT00075725|473113415|FG004|Overall Study|Disease Progression, all other reasons|21|||
131406996|NCT00075725|473113416|FG005|Overall Study|Disease Progression, all other reasons|59|||
131406997|NCT00075725|473113417|FG006|Overall Study|Disease Progression, all other reasons|20|||
131406998|NCT00075725|473113418|FG007|Overall Study|Disease Progression, all other reasons|46|||
131406999|NCT00075725|473113419|FG008|Overall Study|Disease Progression, all other reasons|21|||
131407000|NCT00075725|473113420|FG009|Overall Study|Disease Progression, all other reasons|4|||
131407001|NCT00075725|473113421|FG010|Overall Study|Disease Progression, all other reasons|0|||
131407002|NCT00075725|473113422|FG011|Overall Study|Disease Progression, all other reasons|5|||
131407003|NCT00075725|473113411|FG000|Overall Study|Patient off treatment|0|||
131407004|NCT00075725|473113412|FG001|Overall Study|Patient off treatment|0|||
131407005|NCT00075725|473113413|FG002|Overall Study|Patient off treatment|1|||
131407006|NCT00075725|473113414|FG003|Overall Study|Patient off treatment|2|||
131407007|NCT00075725|473113415|FG004|Overall Study|Patient off treatment|1|||
131407008|NCT00075725|473113416|FG005|Overall Study|Patient off treatment|0|||
131407009|NCT00075725|473113417|FG006|Overall Study|Patient off treatment|0|||
131407010|NCT00075725|473113418|FG007|Overall Study|Patient off treatment|2|||
131407011|NCT00075725|473113419|FG008|Overall Study|Patient off treatment|1|||
131407012|NCT00075725|473113420|FG009|Overall Study|Patient off treatment|0|||
131407013|NCT00075725|473113421|FG010|Overall Study|Patient off treatment|0|||
131407014|NCT00075725|473113422|FG011|Overall Study|Patient off treatment|0|||
131407015|NCT00075725|473113411|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
131407016|NCT00075725|473113412|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
131407017|NCT00075725|473113413|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
131407018|NCT00075725|473113414|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
131407019|NCT00075725|473113415|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
131857711|NCT00124748|474757334|FG000|Overall Study|Withdrawal by Subject|5|||
131857712|NCT00124748|474757335|FG001|Overall Study|Withdrawal by Subject|15|||
131857713|NCT00124748|474757334|FG000|Overall Study|Lost to Follow-up|2|||
131857714|NCT00124748|474757335|FG001|Overall Study|Lost to Follow-up|7|||
131857715|NCT00124748|474757334|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
131857716|NCT00124748|474757335|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
131857717|NCT00124748|474757334|FG000|Overall Study|Death|1|||
131857718|NCT00124748|474757335|FG001|Overall Study|Death|3|||
131857719|NCT03889886|474757340|FG000|Overall Study|Other|0|||
131857720|NCT03889886|474757341|FG001|Overall Study|Other|1|||
131857721|NCT03889886|474757342|FG002|Overall Study|Other|0|||
131857722|NCT03889886|474757343|FG003|Overall Study|Other|1|||
131857723|NCT03889886|474757340|FG000|Overall Study|Withdrawal by Subject|0|||
131857724|NCT03889886|474757341|FG001|Overall Study|Withdrawal by Subject|0|||
131857725|NCT03889886|474757342|FG002|Overall Study|Withdrawal by Subject|1|||
131857726|NCT03889886|474757343|FG003|Overall Study|Withdrawal by Subject|0|||
131857727|NCT03889886|474757340|FG000|Overall Study|Adverse Event|0|||
131857728|NCT03889886|474757341|FG001|Overall Study|Adverse Event|0|||
131857729|NCT03889886|474757342|FG002|Overall Study|Adverse Event|0|||
131857730|NCT03889886|474757343|FG003|Overall Study|Adverse Event|6|||
131857731|NCT04176250|474757344|FG000|Overall Study|Adverse Event|0|||
131857732|NCT04176250|474757345|FG001|Overall Study|Adverse Event|1|||
131857733|NCT04176250|474757346|FG002|Overall Study|Adverse Event|0|||
131857734|NCT04176250|474757347|FG003|Overall Study|Adverse Event|1|||
131857735|NCT04176250|474757348|FG004|Overall Study|Adverse Event|0|||
131857736|NCT04176250|474757349|FG005|Overall Study|Adverse Event|1|||
131857737|NCT04176250|474757344|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
131857738|NCT04176250|474757345|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
131857739|NCT04176250|474757346|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
131857740|NCT04176250|474757347|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
131857741|NCT04176250|474757348|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
131857742|NCT04176250|474757349|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
131857743|NCT04176250|474757344|FG000|Overall Study|Withdrawal by Subject|0|||
131857744|NCT04176250|474757345|FG001|Overall Study|Withdrawal by Subject|0|||
131857745|NCT04176250|474757346|FG002|Overall Study|Withdrawal by Subject|0|||
131857746|NCT04176250|474757347|FG003|Overall Study|Withdrawal by Subject|0|||
131407020|NCT00075725|473113416|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
131407021|NCT00075725|473113417|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
131407022|NCT00075725|473113418|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
131407023|NCT00075725|473113419|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
131857747|NCT04176250|474757348|FG004|Overall Study|Withdrawal by Subject|0|||
131857748|NCT04176250|474757349|FG005|Overall Study|Withdrawal by Subject|1|||
131857749|NCT04176250|474757344|FG000|Overall Study|Randomized in error|0|||
131857750|NCT04176250|474757345|FG001|Overall Study|Randomized in error|0|||
131857751|NCT04176250|474757346|FG002|Overall Study|Randomized in error|0|||
131857752|NCT04176250|474757347|FG003|Overall Study|Randomized in error|0|||
131857753|NCT04176250|474757348|FG004|Overall Study|Randomized in error|1|||
131857754|NCT04176250|474757349|FG005|Overall Study|Randomized in error|0|||
131857755|NCT01973439|474757352|FG000|Overall Study|Lost samples from one PK Day|2|||
131857756|NCT01973439|474757352|FG000|Overall Study|Vomiting after commencing once daily|1|||
131857757|NCT01973439|474757352|FG000|Overall Study|PK curve incomplete|2|||
131857758|NCT02262325|474757354|FG000|Overall Study|Death|16|||
131857759|NCT02262325|474757354|FG000|Overall Study|Lost to Follow-up|1|||
131857760|NCT03885661|474757357|FG000|Overall Study|Withdrawal by Subject|0|||
131857761|NCT03885661|474757358|FG001|Overall Study|Withdrawal by Subject|1|||
131857762|NCT03885661|474757357|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
131857763|NCT03885661|474757358|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
131857764|NCT05064397|474757359|FG000|Overall Study|Adverse Event|4|||
131857765|NCT05064397|474757359|FG000|Overall Study|Lack of Efficacy|12|||
131857766|NCT05064397|474757359|FG000|Overall Study|Withdrawal by Subject|3|||
131857767|NCT05064397|474757359|FG000|Overall Study|Lost to Follow-up|1|||
131857768|NCT05064397|474757359|FG000|Overall Study|Other reasons|3|||
131857769|NCT00769379|474757362|FG000|Overall Study|No follow up data mapped to Other.|3|||
131857770|NCT00769379|474757363|FG001|Overall Study|No follow up data mapped to Other.|13|||
131857771|NCT02441686|474757364|FG000|Induction|Adverse Event|4|||
131857772|NCT02441686|474757364|FG000|Induction|Complicating disease|1|||
131857773|NCT02441686|474757364|FG000|Induction|Physician Decision|1|||
131857774|NCT02441686|474757364|FG000|Induction|Withdrawal by Subject|1|||
131857775|NCT02441686|474757364|FG000|Induction|Did not receive treatment|1|||
131857776|NCT02441686|474757364|FG000|Maintenance|Remaining on Treatment|23|||
131857777|NCT02441686|474757364|FG000|Maintenance|Physician Decision|1|||
131857778|NCT02441686|474757364|FG000|Maintenance|Adverse Event|3|||
131857779|NCT02441686|474757364|FG000|Maintenance|Progressive Disease|10|||
131857780|NCT02441686|474757364|FG000|Maintenance|Withdrawal by Subject|1|||
131857781|NCT03541317|474757369|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
131857782|NCT03541317|474757370|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
131857783|NCT03541317|474757371|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
131857784|NCT03541317|474757372|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
131857785|NCT03541317|474757373|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
131857786|NCT03541317|474757374|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
131857787|NCT02969044|474757375|FG000|Overall Study|Withdrawal by Subject|2|||
131857788|NCT02969044|474757376|FG001|Overall Study|Withdrawal by Subject|6|||
131857789|NCT02969044|474757375|FG000|Overall Study|Adverse Event|3|||
131857790|NCT02969044|474757376|FG001|Overall Study|Adverse Event|0|||
131857791|NCT04728802|474757377|FG000|Overall Study|Withdrawal by Subject|4|||
131857792|NCT04728802|474757378|FG001|Overall Study|Withdrawal by Subject|20|||
131857793|NCT04728802|474757377|FG000|Overall Study|Physician Decision|7|||
131857794|NCT04728802|474757378|FG001|Overall Study|Physician Decision|7|||
131857795|NCT04728802|474757377|FG000|Overall Study|Protocol Violation|10|||
131857796|NCT04728802|474757378|FG001|Overall Study|Protocol Violation|4|||
131857797|NCT04728802|474757377|FG000|Overall Study|Transfer|1|||
131857798|NCT04728802|474757378|FG001|Overall Study|Transfer|0|||
131857799|NCT04728802|474757377|FG000|Overall Study|Death|4|||
131857800|NCT04728802|474757378|FG001|Overall Study|Death|5|||
131857801|NCT04728802|474757377|FG000|Overall Study|Other|3|||
131857802|NCT04728802|474757378|FG001|Overall Study|Other|0|||
131857803|NCT01176513|474757379|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
131857804|NCT02553772|474757393|FG000|Overall Study|Adverse Event|2|||
131857805|NCT02553772|474757394|FG001|Overall Study|Adverse Event|3|||
131857806|NCT02553772|474757393|FG000|Overall Study|Lost to Follow-up|2|||
131857807|NCT02553772|474757394|FG001|Overall Study|Lost to Follow-up|1|||
131857808|NCT02553772|474757393|FG000|Overall Study|Withdrawal of Consent|1|||
131857809|NCT02553772|474757394|FG001|Overall Study|Withdrawal of Consent|1|||
131857810|NCT02553772|474757393|FG000|Overall Study|Lack of Efficacy|1|||
131857811|NCT02553772|474757394|FG001|Overall Study|Lack of Efficacy|0|||
131857812|NCT02553772|474757393|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131857813|NCT02553772|474757394|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131857814|NCT05724589|474757395|FG000|Overall Study|Lost to Follow-up|1|||
131857815|NCT00786409|474757396|FG000|Overall Study|Withdrawal by Subject|2|||
131857816|NCT00786409|474757396|FG000|Overall Study|Adverse Event|2|||
131857817|NCT00786409|474757396|FG000|Overall Study|Pregnancy|2|||
131857818|NCT00786409|474757396|FG000|Overall Study|Lost to Follow-up|1|||
131407024|NCT00075725|473113420|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
131857819|NCT00610129|474757397|FG000|Overall Study|Not treated since patients ineligible|3|||
131857820|NCT02273388|474757400|FG000|Overall Study|Adverse Event|0|||
131857821|NCT02273388|474757401|FG001|Overall Study|Adverse Event|0|||
131857822|NCT02273388|474757402|FG002|Overall Study|Adverse Event|0|||
131857823|NCT02273388|474757403|FG003|Overall Study|Adverse Event|0|||
131857824|NCT02273388|474757404|FG004|Overall Study|Adverse Event|0|||
131857825|NCT02273388|474757405|FG005|Overall Study|Adverse Event|0|||
131857826|NCT02273388|474757406|FG006|Overall Study|Adverse Event|1|||
131857827|NCT02273388|474757407|FG007|Overall Study|Adverse Event|2|||
131857828|NCT02273388|474757408|FG008|Overall Study|Adverse Event|0|||
131857829|NCT02273388|474757409|FG009|Overall Study|Adverse Event|0|||
131857830|NCT02273388|474757410|FG010|Overall Study|Adverse Event|0|||
131857831|NCT02273388|474757411|FG011|Overall Study|Adverse Event|0|||
131857832|NCT02273388|474757400|FG000|Overall Study|Adverse Event study disease worse|4|||
131857833|NCT02273388|474757401|FG001|Overall Study|Adverse Event study disease worse|3|||
131857834|NCT02273388|474757402|FG002|Overall Study|Adverse Event study disease worse|3|||
131857835|NCT02273388|474757403|FG003|Overall Study|Adverse Event study disease worse|2|||
131857836|NCT02273388|474757404|FG004|Overall Study|Adverse Event study disease worse|4|||
131857837|NCT02273388|474757405|FG005|Overall Study|Adverse Event study disease worse|3|||
131857838|NCT02273388|474757406|FG006|Overall Study|Adverse Event study disease worse|14|||
131857839|NCT02273388|474757407|FG007|Overall Study|Adverse Event study disease worse|6|||
131857840|NCT02273388|474757408|FG008|Overall Study|Adverse Event study disease worse|6|||
131857841|NCT02273388|474757409|FG009|Overall Study|Adverse Event study disease worse|5|||
131857842|NCT02273388|474757410|FG010|Overall Study|Adverse Event study disease worse|10|||
131857843|NCT02273388|474757411|FG011|Overall Study|Adverse Event study disease worse|1|||
131857844|NCT02273388|474757400|FG000|Overall Study|Sponsor decision|0|||
131857845|NCT02273388|474757401|FG001|Overall Study|Sponsor decision|0|||
131857846|NCT02273388|474757402|FG002|Overall Study|Sponsor decision|0|||
131857847|NCT02273388|474757403|FG003|Overall Study|Sponsor decision|0|||
131857848|NCT02273388|474757404|FG004|Overall Study|Sponsor decision|0|||
131857849|NCT02273388|474757405|FG005|Overall Study|Sponsor decision|0|||
131857850|NCT02273388|474757406|FG006|Overall Study|Sponsor decision|0|||
131857851|NCT02273388|474757407|FG007|Overall Study|Sponsor decision|0|||
131857852|NCT02273388|474757408|FG008|Overall Study|Sponsor decision|0|||
131857853|NCT02273388|474757409|FG009|Overall Study|Sponsor decision|0|||
131857854|NCT02273388|474757410|FG010|Overall Study|Sponsor decision|0|||
131857855|NCT02273388|474757411|FG011|Overall Study|Sponsor decision|1|||
131857856|NCT03180645|474757413|FG000|Overall Study|Adverse Event|0|||
131857857|NCT03180645|474757414|FG001|Overall Study|Adverse Event|1|||
131857858|NCT03180645|474757415|FG002|Overall Study|Adverse Event|2|||
131857859|NCT00489255|474757416|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
131857860|NCT00489255|474757417|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
131857861|NCT00489255|474757416|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
131857862|NCT00489255|474757417|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
131857863|NCT00489255|474757416|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
131857864|NCT00489255|474757417|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
131857865|NCT00489255|474757416|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
131857866|NCT00489255|474757417|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
131857867|NCT00489255|474757416|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
131857868|NCT00489255|474757417|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
131857869|NCT00489255|474757416|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
131857870|NCT00489255|474757417|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
131857871|NCT00489255|474757416|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
131857872|NCT00489255|474757417|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
131857873|NCT00489255|474757416|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
131857874|NCT00489255|474757417|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
131857875|NCT00489255|474757416|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
131857876|NCT00489255|474757417|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
131857877|NCT00489255|474757416|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
131857878|NCT00489255|474757417|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
131857879|NCT02905032|474757422|FG000|Overall Study|Withdrawal by Subject|2|||
131857880|NCT02905032|474757423|FG001|Overall Study|Withdrawal by Subject|0|||
131857881|NCT02905032|474757424|FG002|Overall Study|Withdrawal by Subject|0|||
131857882|NCT02905032|474757422|FG000|Overall Study|Protocol Violation|6|||
131857883|NCT02905032|474757423|FG001|Overall Study|Protocol Violation|12|||
131857884|NCT02905032|474757424|FG002|Overall Study|Protocol Violation|0|||
131407025|NCT00075725|473113421|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
131407026|NCT00075725|473113422|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
131407027|NCT00075725|473113411|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
131407028|NCT00075725|473113412|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
131857885|NCT00866359|474757425|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
131857886|NCT00866359|474757426|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
131857887|NCT00866359|474757427|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
131857888|NCT00866359|474757428|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
131857889|NCT00866359|474757425|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
131857890|NCT00866359|474757426|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
131857891|NCT00866359|474757427|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
131857892|NCT00866359|474757428|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
131857893|NCT00866359|474757425|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
131857894|NCT00866359|474757426|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
131407029|NCT00075725|473113413|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
131407030|NCT00075725|473113414|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
131857895|NCT00866359|474757427|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
131857896|NCT00866359|474757428|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
131857897|NCT00866359|474757425|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
131857898|NCT00866359|474757426|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
131857899|NCT00866359|474757427|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
131857900|NCT00866359|474757428|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
131857901|NCT00866359|474757425|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
131857902|NCT00866359|474757426|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
131857903|NCT00866359|474757427|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
131857904|NCT00866359|474757428|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
131857905|NCT00866359|474757425|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
131857906|NCT00866359|474757426|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
131857907|NCT00866359|474757427|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
131857908|NCT00866359|474757428|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
131857909|NCT01459783|474757430|FG000|Baseline to 6 Months|Death|1|||
131857910|NCT01459783|474757431|FG001|Baseline to 6 Months|Death|0|||
131857911|NCT01459783|474757430|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
131857912|NCT01459783|474757431|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
131857913|NCT01459783|474757430|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
131857914|NCT01459783|474757431|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
131857915|NCT01459783|474757430|FG000|6 Months to 12 Months|Death|0|||
131857916|NCT01459783|474757431|FG001|6 Months to 12 Months|Death|1|||
131857917|NCT01459783|474757430|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
131857918|NCT01459783|474757431|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
131857919|NCT01459783|474757430|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
131857920|NCT01459783|474757431|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
131857921|NCT01459783|474757430|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
131857922|NCT01459783|474757431|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
131857923|NCT06018129|474757433|FG000|Overall Study|Death|1|||
131857924|NCT06018129|474757434|FG001|Overall Study|Death|1|||
131857925|NCT06018129|474757435|FG002|Overall Study|Death|2|||
131857926|NCT06018129|474757433|FG000|Overall Study|Sponsor Decision|2|||
131857927|NCT06018129|474757434|FG001|Overall Study|Sponsor Decision|2|||
131857928|NCT06018129|474757435|FG002|Overall Study|Sponsor Decision|1|||
131857929|NCT05061134|474759214|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
131857930|NCT05061134|474759215|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
131407031|NCT00075725|473113415|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
131407032|NCT00075725|473113416|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
131857931|NCT05061134|474759216|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
131857932|NCT05061134|474759214|FG000|Overall Study|Subject not treated|0|||
131857933|NCT05061134|474759215|FG001|Overall Study|Subject not treated|0|||
131407033|NCT00075725|473113417|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
131407034|NCT00075725|473113418|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
131407035|NCT00075725|473113419|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
131407036|NCT00075725|473113420|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
131407037|NCT00075725|473113421|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
131407038|NCT00075725|473113422|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
131407039|NCT00075725|473113411|FG000|Overall Study|Pt non compliant with therapy|2|||
131407040|NCT00075725|473113412|FG001|Overall Study|Pt non compliant with therapy|1|||
131407041|NCT00075725|473113413|FG002|Overall Study|Pt non compliant with therapy|1|||
131407042|NCT00075725|473113414|FG003|Overall Study|Pt non compliant with therapy|0|||
131857934|NCT05061134|474759216|FG002|Overall Study|Subject not treated|2|||
131857935|NCT05061134|474759214|FG000|Overall Study|Other|0|||
131857936|NCT05061134|474759215|FG001|Overall Study|Other|0|||
131857937|NCT05061134|474759216|FG002|Overall Study|Other|9|||
131857938|NCT05061134|474759214|FG000|Overall Study|Withdrawal by Subject|9|||
131857939|NCT05061134|474759215|FG001|Overall Study|Withdrawal by Subject|8|||
131857940|NCT05061134|474759216|FG002|Overall Study|Withdrawal by Subject|5|||
131857941|NCT05061134|474759214|FG000|Overall Study|Study Terminated by Sponsor|22|||
131857942|NCT05061134|474759215|FG001|Overall Study|Study Terminated by Sponsor|14|||
131857943|NCT05061134|474759216|FG002|Overall Study|Study Terminated by Sponsor|7|||
131857944|NCT05061134|474759214|FG000|Overall Study|Progressive Disease|1|||
131857945|NCT05061134|474759215|FG001|Overall Study|Progressive Disease|2|||
131857946|NCT05061134|474759216|FG002|Overall Study|Progressive Disease|0|||
131407043|NCT00075725|473113415|FG004|Overall Study|Pt non compliant with therapy|2|||
131857947|NCT05061134|474759214|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
131857948|NCT05061134|474759215|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
131857949|NCT05061134|474759216|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
131857950|NCT05061134|474759214|FG000|Overall Study|Lost to Follow-up|1|||
131407044|NCT00075725|473113416|FG005|Overall Study|Pt non compliant with therapy|14|||
131407045|NCT00075725|473113417|FG006|Overall Study|Pt non compliant with therapy|2|||
131407046|NCT00075725|473113418|FG007|Overall Study|Pt non compliant with therapy|5|||
131857951|NCT05061134|474759215|FG001|Overall Study|Lost to Follow-up|0|||
131857952|NCT05061134|474759216|FG002|Overall Study|Lost to Follow-up|0|||
131857953|NCT05061134|474759214|FG000|Overall Study|Physician Decision|1|||
131857954|NCT05061134|474759215|FG001|Overall Study|Physician Decision|1|||
131857955|NCT05061134|474759216|FG002|Overall Study|Physician Decision|0|||
131857956|NCT05061134|474759214|FG000|Overall Study|Disease progression|1|||
131857957|NCT05061134|474759215|FG001|Overall Study|Disease progression|0|||
131857958|NCT05061134|474759216|FG002|Overall Study|Disease progression|0|||
131857959|NCT05061134|474759214|FG000|Overall Study|Death|43|||
131857960|NCT05061134|474759215|FG001|Overall Study|Death|23|||
131857961|NCT05061134|474759216|FG002|Overall Study|Death|14|||
131857962|NCT05061134|474759214|FG000|Overall Study|Database lock|2|||
131857963|NCT05061134|474759215|FG001|Overall Study|Database lock|0|||
131857964|NCT05061134|474759216|FG002|Overall Study|Database lock|0|||
131857965|NCT06082843|474759220|FG000|Overall Study|Withdrawal by Subject|0|||
131857966|NCT06082843|474759221|FG001|Overall Study|Withdrawal by Subject|2|||
131857967|NCT06082843|474759220|FG000|Overall Study|Study terminated by sponsor|12|||
131857968|NCT06082843|474759221|FG001|Overall Study|Study terminated by sponsor|8|||
131857969|NCT00001521|474759227|FG000|Overall Study|Withdrawal by Subject|3|||
131857970|NCT00001521|474759228|FG001|Overall Study|Withdrawal by Subject|3|||
131857971|NCT00001521|474759227|FG000|Overall Study|Physician Decision|1|||
131857972|NCT00001521|474759228|FG001|Overall Study|Physician Decision|1|||
131857973|NCT00001521|474759227|FG000|Overall Study|Noncompliant|6|||
131857974|NCT00001521|474759228|FG001|Overall Study|Noncompliant|3|||
131857975|NCT04848480|474759233|FG000|Main Phase (26 Weeks)|Death|1|||
131857976|NCT04848480|474759234|FG001|Main Phase (26 Weeks)|Death|0|||
131857977|NCT04848480|474759233|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
131857978|NCT04848480|474759234|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
131857979|NCT04848480|474759233|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
131857980|NCT04848480|474759234|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
131857981|NCT04848480|474759233|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
131857982|NCT04848480|474759234|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
131857983|NCT04848480|474759233|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
131857984|NCT04848480|474759234|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
131857985|NCT04848480|474759233|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
131857986|NCT04848480|474759234|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
131857987|NCT03176134|474759235|FG000|Overall Study|Lost to Follow-up|0|||
131857988|NCT03176134|474759236|FG001|Overall Study|Lost to Follow-up|2|||
131857989|NCT03176134|474759237|FG002|Overall Study|Lost to Follow-up|0|||
131857990|NCT03176134|474759238|FG003|Overall Study|Lost to Follow-up|0|||
131857991|NCT03176134|474759239|FG004|Overall Study|Lost to Follow-up|0|||
131857992|NCT03176134|474759240|FG005|Overall Study|Lost to Follow-up|0|||
131857993|NCT03176134|474759241|FG006|Overall Study|Lost to Follow-up|0|||
131857994|NCT03176134|474759242|FG007|Overall Study|Lost to Follow-up|0|||
131857995|NCT03176134|474759235|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131857996|NCT03176134|474759236|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131857997|NCT03176134|474759237|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
131857998|NCT03176134|474759238|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131857999|NCT03176134|474759239|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131858000|NCT03176134|474759240|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131858001|NCT03176134|474759241|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
131858002|NCT03176134|474759242|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
131858003|NCT01368497|474759245|FG000|Overall Study|Lost to Follow-up|2|||
131858004|NCT05989672|474759247|FG000|Overall Study|Adverse Event|3|||
131858005|NCT05989672|474759248|FG001|Overall Study|Adverse Event|0|||
131858006|NCT05989672|474759249|FG002|Overall Study|Adverse Event|0|||
131858007|NCT00443729|474759250|FG000|Overall Study|Never Treated|0|||
131858008|NCT00443729|474759251|FG001|Overall Study|Never Treated|1|||
131858009|NCT00443729|474759250|FG000|Overall Study|Lack of Efficacy|4|||
131858010|NCT00443729|474759251|FG001|Overall Study|Lack of Efficacy|2|||
131858011|NCT00443729|474759250|FG000|Overall Study|Lost to Follow-up|0|||
131858012|NCT00443729|474759251|FG001|Overall Study|Lost to Follow-up|1|||
131858013|NCT00443729|474759250|FG000|Overall Study|Physician Decision|2|||
131858014|NCT00443729|474759251|FG001|Overall Study|Physician Decision|1|||
131858015|NCT00443729|474759250|FG000|Overall Study|Protocol Violation|1|||
131858016|NCT00443729|474759251|FG001|Overall Study|Protocol Violation|1|||
131858017|NCT00443729|474759250|FG000|Overall Study|Withdrawal by Subject|3|||
131858018|NCT00443729|474759251|FG001|Overall Study|Withdrawal by Subject|1|||
131858019|NCT03718832|474759254|FG000|Analysis Sample|Withdrawal by Subject|18|||
131858020|NCT03718832|474759255|FG001|Analysis Sample|Withdrawal by Subject|15|||
131858021|NCT03718832|474759254|FG000|Analysis Sample|Legal hold on data|1|||
131858022|NCT03718832|474759255|FG001|Analysis Sample|Legal hold on data|0|||
131858023|NCT03718832|474759254|FG000|Analysis Sample|Participant from treated household|0|||
131858024|NCT03718832|474759255|FG001|Analysis Sample|Participant from treated household|1|||
131858025|NCT03718832|474759254|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
131858026|NCT03718832|474759255|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
131858027|NCT03288714|474759261|FG000|Overall Study|Lost to Follow-up|2|||
131858028|NCT03288714|474759262|FG001|Overall Study|Lost to Follow-up|1|||
131407047|NCT00075725|473113419|FG008|Overall Study|Pt non compliant with therapy|3|||
131407048|NCT00075725|473113420|FG009|Overall Study|Pt non compliant with therapy|0|||
131407049|NCT00075725|473113421|FG010|Overall Study|Pt non compliant with therapy|0|||
131407050|NCT00075725|473113422|FG011|Overall Study|Pt non compliant with therapy|0|||
131407051|NCT00075725|473113411|FG000|Overall Study|Pt age out of range for treatment|0|||
131407052|NCT00075725|473113412|FG001|Overall Study|Pt age out of range for treatment|1|||
131407053|NCT00075725|473113413|FG002|Overall Study|Pt age out of range for treatment|0|||
131407054|NCT00075725|473113414|FG003|Overall Study|Pt age out of range for treatment|0|||
131407055|NCT00075725|473113415|FG004|Overall Study|Pt age out of range for treatment|0|||
131407056|NCT00075725|473113416|FG005|Overall Study|Pt age out of range for treatment|1|||
131407057|NCT00075725|473113417|FG006|Overall Study|Pt age out of range for treatment|0|||
131407058|NCT00075725|473113418|FG007|Overall Study|Pt age out of range for treatment|1|||
131407059|NCT00075725|473113419|FG008|Overall Study|Pt age out of range for treatment|0|||
131407060|NCT00075725|473113420|FG009|Overall Study|Pt age out of range for treatment|0|||
131407061|NCT00075725|473113421|FG010|Overall Study|Pt age out of range for treatment|0|||
131407062|NCT00075725|473113422|FG011|Overall Study|Pt age out of range for treatment|0|||
131407063|NCT00075725|473113411|FG000|Overall Study|Insurance issues|0|||
131407064|NCT00075725|473113412|FG001|Overall Study|Insurance issues|1|||
131407065|NCT00075725|473113413|FG002|Overall Study|Insurance issues|0|||
131407066|NCT00075725|473113414|FG003|Overall Study|Insurance issues|1|||
131453826|NCT05307692|473290042|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
131453827|NCT05307692|473290043|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
131453828|NCT05307692|473290040|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
131453829|NCT05307692|473290041|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
131858029|NCT03288714|474759261|FG000|Overall Study|Non-compliance with study schedule|2|||
131858030|NCT03288714|474759262|FG001|Overall Study|Non-compliance with study schedule|0|||
131858031|NCT03288714|474759261|FG000|Overall Study|Withdrawal by Subject|3|||
131858032|NCT03288714|474759262|FG001|Overall Study|Withdrawal by Subject|1|||
131407067|NCT00075725|473113415|FG004|Overall Study|Insurance issues|1|||
131407068|NCT00075725|473113416|FG005|Overall Study|Insurance issues|1|||
131407069|NCT00075725|473113417|FG006|Overall Study|Insurance issues|0|||
131407070|NCT00075725|473113418|FG007|Overall Study|Insurance issues|1|||
131407071|NCT00075725|473113419|FG008|Overall Study|Insurance issues|0|||
131407072|NCT00075725|473113420|FG009|Overall Study|Insurance issues|0|||
131407073|NCT00075725|473113421|FG010|Overall Study|Insurance issues|0|||
131407074|NCT00075725|473113422|FG011|Overall Study|Insurance issues|0|||
131407075|NCT00075725|473113411|FG000|Overall Study|MRD positive after extended ind|0|||
131407076|NCT00075725|473113412|FG001|Overall Study|MRD positive after extended ind|1|||
131858033|NCT03288714|474759261|FG000|Overall Study|Clinical Worsening|2|||
131858034|NCT03288714|474759262|FG001|Overall Study|Clinical Worsening|1|||
131858035|NCT03288714|474759261|FG000|Overall Study|Adverse Event|1|||
131858036|NCT03288714|474759262|FG001|Overall Study|Adverse Event|0|||
131858037|NCT04882241|474759264|FG000|Overall Study|Ongoing in study|46|||
131858038|NCT04882241|474759265|FG001|Overall Study|Ongoing in study|48|||
131858039|NCT04882241|474759266|FG002|Overall Study|Ongoing in study|0|||
131858040|NCT04882241|474759267|FG003|Overall Study|Ongoing in study|0|||
131858041|NCT04882241|474759264|FG000|Overall Study|Death|13|||
131858042|NCT04882241|474759265|FG001|Overall Study|Death|13|||
131858043|NCT04882241|474759266|FG002|Overall Study|Death|0|||
131858044|NCT04882241|474759267|FG003|Overall Study|Death|0|||
131858045|NCT00322712|474759275|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
131858046|NCT04747470|474759285|FG000|Overall Study|Death|0|||
131858047|NCT04747470|474759286|FG001|Overall Study|Death|3|||
131858048|NCT04747470|474759287|FG002|Overall Study|Death|2|||
131858049|NCT04747470|474759288|FG003|Overall Study|Death|2|||
131858050|NCT04747470|474759289|FG004|Overall Study|Death|2|||
131858051|NCT04747470|474759290|FG005|Overall Study|Death|0|||
131858052|NCT04747470|474759291|FG006|Overall Study|Death|0|||
131858053|NCT04747470|474759292|FG007|Overall Study|Death|0|||
131858054|NCT04747470|474759293|FG008|Overall Study|Death|0|||
131858055|NCT04747470|474759294|FG009|Overall Study|Death|0|||
131858056|NCT04747470|474759295|FG010|Overall Study|Death|0|||
131407077|NCT00075725|473113413|FG002|Overall Study|MRD positive after extended ind|1|||
131407078|NCT00075725|473113414|FG003|Overall Study|MRD positive after extended ind|0|||
131407079|NCT00075725|473113415|FG004|Overall Study|MRD positive after extended ind|1|||
131407080|NCT00075725|473113416|FG005|Overall Study|MRD positive after extended ind|2|||
131407081|NCT00075725|473113417|FG006|Overall Study|MRD positive after extended ind|0|||
131407082|NCT00075725|473113418|FG007|Overall Study|MRD positive after extended ind|1|||
131407083|NCT00075725|473113419|FG008|Overall Study|MRD positive after extended ind|0|||
131407084|NCT00075725|473113420|FG009|Overall Study|MRD positive after extended ind|0|||
131407085|NCT00075725|473113421|FG010|Overall Study|MRD positive after extended ind|0|||
131858057|NCT04747470|474759285|FG000|Overall Study|Withdrew Consent|0|||
131858058|NCT04747470|474759286|FG001|Overall Study|Withdrew Consent|0|||
131858059|NCT04747470|474759287|FG002|Overall Study|Withdrew Consent|0|||
131858060|NCT04747470|474759288|FG003|Overall Study|Withdrew Consent|1|||
131858061|NCT04747470|474759289|FG004|Overall Study|Withdrew Consent|0|||
131858062|NCT04747470|474759290|FG005|Overall Study|Withdrew Consent|0|||
131858063|NCT04747470|474759291|FG006|Overall Study|Withdrew Consent|0|||
131858064|NCT04747470|474759292|FG007|Overall Study|Withdrew Consent|0|||
131858065|NCT04747470|474759293|FG008|Overall Study|Withdrew Consent|0|||
131858066|NCT04747470|474759294|FG009|Overall Study|Withdrew Consent|0|||
131858067|NCT04747470|474759295|FG010|Overall Study|Withdrew Consent|0|||
131858068|NCT04747470|474759285|FG000|Overall Study|Study Terminated by Sponsor|0|||
131858069|NCT04747470|474759286|FG001|Overall Study|Study Terminated by Sponsor|0|||
131858070|NCT04747470|474759287|FG002|Overall Study|Study Terminated by Sponsor|1|||
131858071|NCT04747470|474759288|FG003|Overall Study|Study Terminated by Sponsor|0|||
131858072|NCT04747470|474759289|FG004|Overall Study|Study Terminated by Sponsor|2|||
131858073|NCT04747470|474759290|FG005|Overall Study|Study Terminated by Sponsor|0|||
131858074|NCT04747470|474759291|FG006|Overall Study|Study Terminated by Sponsor|0|||
131858075|NCT04747470|474759292|FG007|Overall Study|Study Terminated by Sponsor|0|||
131858076|NCT04747470|474759293|FG008|Overall Study|Study Terminated by Sponsor|0|||
131858077|NCT04747470|474759294|FG009|Overall Study|Study Terminated by Sponsor|0|||
131858078|NCT04747470|474759295|FG010|Overall Study|Study Terminated by Sponsor|0|||
131858079|NCT04688671|474759299|FG000|Overall Study|Adverse Event|3|||
131858080|NCT04688671|474759300|FG001|Overall Study|Adverse Event|1|||
131858081|NCT04688671|474759299|FG000|Overall Study|Withdrawal by Subject|3|||
131858082|NCT04688671|474759300|FG001|Overall Study|Withdrawal by Subject|1|||
131858083|NCT04688671|474759299|FG000|Overall Study|Lack of Efficacy|1|||
131858084|NCT04688671|474759300|FG001|Overall Study|Lack of Efficacy|1|||
131858085|NCT04688671|474759299|FG000|Overall Study|Protocol Violation|1|||
131858086|NCT04688671|474759300|FG001|Overall Study|Protocol Violation|0|||
131858087|NCT04688671|474759299|FG000|Overall Study|Lost to Follow-up|0|||
131858088|NCT04688671|474759300|FG001|Overall Study|Lost to Follow-up|1|||
131858089|NCT04720053|474759301|FG000|Overall Study|Lost to Follow-up|12|||
131858090|NCT01942993|474759302|FG000|Overall Study|Lost to Follow-up|1|||
131858091|NCT01942993|474759302|FG000|Overall Study|Physician Decision|1|||
131858092|NCT01350271|474759303|FG000|Overall Study|Lost to Follow-up|21|||
131858093|NCT01350271|474759304|FG001|Overall Study|Lost to Follow-up|17|||
131858094|NCT01350271|474759305|FG002|Overall Study|Lost to Follow-up|26|||
131858095|NCT02906670|474759309|FG000|Cohort 1, QW|Radiological Progression|1|||
131858096|NCT02906670|474759310|FG001|Cohort 1, QW|Radiological Progression|0|||
131858097|NCT02906670|474759311|FG002|Cohort 1, QW|Radiological Progression|0|||
131858098|NCT02906670|474759312|FG003|Cohort 1, QW|Radiological Progression|0|||
131858099|NCT02906670|474759313|FG004|Cohort 1, QW|Radiological Progression|0|||
131858100|NCT02906670|474759314|FG005|Cohort 1, QW|Radiological Progression|0|||
131858101|NCT02906670|474759315|FG006|Cohort 1, QW|Radiological Progression|0|||
131858102|NCT02906670|474759316|FG007|Cohort 1, QW|Radiological Progression|0|||
131858103|NCT02906670|474759317|FG008|Cohort 1, QW|Radiological Progression|0|||
131858104|NCT02906670|474759318|FG009|Cohort 1, QW|Radiological Progression|0|||
131858105|NCT02906670|474759309|FG000|Cohort 2, QW|Radiological Progression|0|||
131858106|NCT02906670|474759310|FG001|Cohort 2, QW|Radiological Progression|1|||
131858107|NCT02906670|474759311|FG002|Cohort 2, QW|Radiological Progression|0|||
131858108|NCT02906670|474759312|FG003|Cohort 2, QW|Radiological Progression|0|||
131858109|NCT02906670|474759313|FG004|Cohort 2, QW|Radiological Progression|0|||
131858110|NCT02906670|474759314|FG005|Cohort 2, QW|Radiological Progression|0|||
131858111|NCT02906670|474759315|FG006|Cohort 2, QW|Radiological Progression|0|||
131858112|NCT02906670|474759316|FG007|Cohort 2, QW|Radiological Progression|0|||
131858113|NCT02906670|474759317|FG008|Cohort 2, QW|Radiological Progression|0|||
131858114|NCT02906670|474759318|FG009|Cohort 2, QW|Radiological Progression|0|||
131858115|NCT02906670|474759309|FG000|Cohort 3, QW|Radiological Progression|0|||
131858116|NCT02906670|474759310|FG001|Cohort 3, QW|Radiological Progression|0|||
131858117|NCT02906670|474759311|FG002|Cohort 3, QW|Radiological Progression|2|||
131858118|NCT02906670|474759312|FG003|Cohort 3, QW|Radiological Progression|0|||
131858119|NCT02906670|474759313|FG004|Cohort 3, QW|Radiological Progression|0|||
131858120|NCT02906670|474759314|FG005|Cohort 3, QW|Radiological Progression|0|||
131858121|NCT02906670|474759315|FG006|Cohort 3, QW|Radiological Progression|0|||
131858122|NCT02906670|474759316|FG007|Cohort 3, QW|Radiological Progression|0|||
131858123|NCT02906670|474759317|FG008|Cohort 3, QW|Radiological Progression|0|||
131858124|NCT02906670|474759318|FG009|Cohort 3, QW|Radiological Progression|0|||
131858125|NCT02906670|474759309|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858126|NCT02906670|474759310|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858127|NCT02906670|474759311|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
131858128|NCT02906670|474759312|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858129|NCT02906670|474759313|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858130|NCT02906670|474759314|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858131|NCT02906670|474759315|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858132|NCT02906670|474759316|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858133|NCT02906670|474759317|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858134|NCT02906670|474759318|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
131858135|NCT02906670|474759309|FG000|Cohort 4, Q2W|Radiological Progression|0|||
131858136|NCT02906670|474759310|FG001|Cohort 4, Q2W|Radiological Progression|0|||
131858137|NCT02906670|474759311|FG002|Cohort 4, Q2W|Radiological Progression|0|||
131858138|NCT02906670|474759312|FG003|Cohort 4, Q2W|Radiological Progression|0|||
131858139|NCT02906670|474759313|FG004|Cohort 4, Q2W|Radiological Progression|0|||
131858140|NCT02906670|474759314|FG005|Cohort 4, Q2W|Radiological Progression|1|||
131858141|NCT02906670|474759315|FG006|Cohort 4, Q2W|Radiological Progression|0|||
131858142|NCT02906670|474759316|FG007|Cohort 4, Q2W|Radiological Progression|0|||
131858143|NCT02906670|474759317|FG008|Cohort 4, Q2W|Radiological Progression|0|||
131858144|NCT02906670|474759318|FG009|Cohort 4, Q2W|Radiological Progression|0|||
131858145|NCT02906670|474759309|FG000|Cohort 4, Q2W|Clinical Progression|0|||
131858146|NCT02906670|474759310|FG001|Cohort 4, Q2W|Clinical Progression|0|||
131858147|NCT02906670|474759311|FG002|Cohort 4, Q2W|Clinical Progression|0|||
131858148|NCT02906670|474759312|FG003|Cohort 4, Q2W|Clinical Progression|0|||
131858149|NCT02906670|474759313|FG004|Cohort 4, Q2W|Clinical Progression|0|||
131858150|NCT02906670|474759314|FG005|Cohort 4, Q2W|Clinical Progression|2|||
131858151|NCT02906670|474759315|FG006|Cohort 4, Q2W|Clinical Progression|0|||
131858152|NCT02906670|474759316|FG007|Cohort 4, Q2W|Clinical Progression|0|||
131858153|NCT02906670|474759317|FG008|Cohort 4, Q2W|Clinical Progression|0|||
131858154|NCT02906670|474759318|FG009|Cohort 4, Q2W|Clinical Progression|0|||
131858155|NCT02906670|474759309|FG000|Cohort 5, Q2W|Radiological Progression|0|||
131858156|NCT02906670|474759310|FG001|Cohort 5, Q2W|Radiological Progression|0|||
131858157|NCT02906670|474759311|FG002|Cohort 5, Q2W|Radiological Progression|0|||
131858158|NCT02906670|474759312|FG003|Cohort 5, Q2W|Radiological Progression|0|||
131858159|NCT02906670|474759313|FG004|Cohort 5, Q2W|Radiological Progression|0|||
131407086|NCT00075725|473113422|FG011|Overall Study|MRD positive after extended ind|0|||
131858160|NCT02906670|474759314|FG005|Cohort 5, Q2W|Radiological Progression|0|||
131858161|NCT02906670|474759315|FG006|Cohort 5, Q2W|Radiological Progression|4|||
131858162|NCT02906670|474759316|FG007|Cohort 5, Q2W|Radiological Progression|0|||
131858163|NCT02906670|474759317|FG008|Cohort 5, Q2W|Radiological Progression|0|||
131858164|NCT02906670|474759318|FG009|Cohort 5, Q2W|Radiological Progression|0|||
131858165|NCT02906670|474759309|FG000|Cohort 5, Q2W|Clinical Progression|0|||
131858166|NCT02906670|474759310|FG001|Cohort 5, Q2W|Clinical Progression|0|||
131858167|NCT02906670|474759311|FG002|Cohort 5, Q2W|Clinical Progression|0|||
131858168|NCT02906670|474759312|FG003|Cohort 5, Q2W|Clinical Progression|0|||
131858169|NCT02906670|474759313|FG004|Cohort 5, Q2W|Clinical Progression|0|||
131858170|NCT02906670|474759314|FG005|Cohort 5, Q2W|Clinical Progression|0|||
131858171|NCT02906670|474759315|FG006|Cohort 5, Q2W|Clinical Progression|1|||
131858172|NCT02906670|474759316|FG007|Cohort 5, Q2W|Clinical Progression|0|||
131858173|NCT02906670|474759317|FG008|Cohort 5, Q2W|Clinical Progression|0|||
131858174|NCT02906670|474759318|FG009|Cohort 5, Q2W|Clinical Progression|0|||
131858175|NCT02906670|474759309|FG000|Cohort 5, Q2W|Adverse Event|0|||
131858176|NCT02906670|474759310|FG001|Cohort 5, Q2W|Adverse Event|0|||
131858177|NCT02906670|474759311|FG002|Cohort 5, Q2W|Adverse Event|0|||
131858178|NCT02906670|474759312|FG003|Cohort 5, Q2W|Adverse Event|0|||
131858179|NCT02906670|474759313|FG004|Cohort 5, Q2W|Adverse Event|0|||
131858180|NCT02906670|474759314|FG005|Cohort 5, Q2W|Adverse Event|0|||
131407087|NCT00075725|473113411|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
131407088|NCT00075725|473113412|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
131407089|NCT00075725|473113413|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
131407090|NCT00075725|473113414|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
131407091|NCT00075725|473113415|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
131407092|NCT00075725|473113416|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
131407093|NCT00075725|473113417|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
131407094|NCT00075725|473113418|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
131407095|NCT00075725|473113419|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
131407096|NCT00075725|473113420|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
131407097|NCT00075725|473113421|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
131407098|NCT00075725|473113422|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
131858181|NCT02906670|474759315|FG006|Cohort 5, Q2W|Adverse Event|1|||
131858182|NCT02906670|474759316|FG007|Cohort 5, Q2W|Adverse Event|0|||
131858183|NCT02906670|474759317|FG008|Cohort 5, Q2W|Adverse Event|0|||
131858184|NCT02906670|474759318|FG009|Cohort 5, Q2W|Adverse Event|0|||
131858185|NCT02906670|474759309|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858186|NCT02906670|474759310|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131407099|NCT00075725|473113411|FG000|Overall Study|Inevaluable|1|||
131407100|NCT00075725|473113412|FG001|Overall Study|Inevaluable|1|||
131407101|NCT00075725|473113413|FG002|Overall Study|Inevaluable|4|||
131407102|NCT00075725|473113414|FG003|Overall Study|Inevaluable|2|||
131407103|NCT00075725|473113415|FG004|Overall Study|Inevaluable|2|||
131407104|NCT00075725|473113416|FG005|Overall Study|Inevaluable|9|||
131407105|NCT00075725|473113417|FG006|Overall Study|Inevaluable|1|||
131858187|NCT02906670|474759311|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858188|NCT02906670|474759312|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131407106|NCT00075725|473113418|FG007|Overall Study|Inevaluable|11|||
131858189|NCT02906670|474759313|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858190|NCT02906670|474759314|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858191|NCT02906670|474759315|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
131407107|NCT00075725|473113419|FG008|Overall Study|Inevaluable|2|||
131407108|NCT00075725|473113420|FG009|Overall Study|Inevaluable|0|||
131407109|NCT00075725|473113421|FG010|Overall Study|Inevaluable|1|||
131407110|NCT00075725|473113422|FG011|Overall Study|Inevaluable|0|||
131407111|NCT00075725|473113411|FG000|Overall Study|Other|4|||
131407112|NCT00075725|473113412|FG001|Overall Study|Other|2|||
131858192|NCT02906670|474759316|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858193|NCT02906670|474759317|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858194|NCT02906670|474759318|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
131858195|NCT02906670|474759309|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
131858196|NCT02906670|474759310|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
131858197|NCT02906670|474759311|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
131858198|NCT02906670|474759312|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
131858199|NCT02906670|474759313|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
131858200|NCT02906670|474759314|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
131858201|NCT02906670|474759315|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
131858202|NCT02906670|474759316|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
131858203|NCT02906670|474759317|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
131858204|NCT02906670|474759318|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
131858205|NCT02906670|474759309|FG000|Cohort 5P, Q2W|Adverse Event|0|||
131858206|NCT02906670|474759310|FG001|Cohort 5P, Q2W|Adverse Event|0|||
131858207|NCT02906670|474759311|FG002|Cohort 5P, Q2W|Adverse Event|0|||
131858208|NCT02906670|474759312|FG003|Cohort 5P, Q2W|Adverse Event|0|||
131858209|NCT02906670|474759313|FG004|Cohort 5P, Q2W|Adverse Event|0|||
131858210|NCT02906670|474759314|FG005|Cohort 5P, Q2W|Adverse Event|0|||
131858211|NCT02906670|474759315|FG006|Cohort 5P, Q2W|Adverse Event|0|||
131858212|NCT02906670|474759316|FG007|Cohort 5P, Q2W|Adverse Event|1|||
131858213|NCT02906670|474759317|FG008|Cohort 5P, Q2W|Adverse Event|0|||
131858214|NCT02906670|474759318|FG009|Cohort 5P, Q2W|Adverse Event|0|||
131858215|NCT02906670|474759309|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
131858216|NCT02906670|474759310|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
131858217|NCT02906670|474759311|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
131858218|NCT02906670|474759312|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
131858219|NCT02906670|474759313|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
131858220|NCT02906670|474759314|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
131407113|NCT00075725|473113413|FG002|Overall Study|Other|1|||
131407114|NCT00075725|473113414|FG003|Overall Study|Other|1|||
131407115|NCT00075725|473113415|FG004|Overall Study|Other|1|||
131407116|NCT00075725|473113416|FG005|Overall Study|Other|4|||
131407117|NCT00075725|473113417|FG006|Overall Study|Other|2|||
131407118|NCT00075725|473113418|FG007|Overall Study|Other|9|||
131912804|NCT01859741|474967738|FG005|Overall Study|Death|4|||
131912805|NCT01859741|474967739|FG006|Overall Study|Death|51|||
131912806|NCT01859741|474967740|FG007|Overall Study|Death|51|||
131912807|NCT01859741|474967733|FG000|Overall Study|Lost to Follow-up|0|||
131912808|NCT01859741|474967734|FG001|Overall Study|Lost to Follow-up|0|||
131912809|NCT01859741|474967735|FG002|Overall Study|Lost to Follow-up|0|||
131912810|NCT01859741|474967736|FG003|Overall Study|Lost to Follow-up|0|||
131912811|NCT01859741|474967737|FG004|Overall Study|Lost to Follow-up|0|||
131407119|NCT00075725|473113419|FG008|Overall Study|Other|2|||
131407120|NCT00075725|473113420|FG009|Overall Study|Other|1|||
131407121|NCT00075725|473113421|FG010|Overall Study|Other|0|||
131407122|NCT00075725|473113422|FG011|Overall Study|Other|3|||
131407123|NCT00075725|473113411|FG000|Overall Study|Pt trying to find a BM donor|0|||
131407124|NCT00075725|473113412|FG001|Overall Study|Pt trying to find a BM donor|1|||
131407125|NCT00075725|473113413|FG002|Overall Study|Pt trying to find a BM donor|0|||
131407126|NCT00075725|473113414|FG003|Overall Study|Pt trying to find a BM donor|0|||
131407127|NCT00075725|473113415|FG004|Overall Study|Pt trying to find a BM donor|0|||
131407128|NCT00075725|473113416|FG005|Overall Study|Pt trying to find a BM donor|0|||
131407129|NCT00075725|473113417|FG006|Overall Study|Pt trying to find a BM donor|0|||
131407130|NCT00075725|473113418|FG007|Overall Study|Pt trying to find a BM donor|0|||
131407131|NCT00075725|473113419|FG008|Overall Study|Pt trying to find a BM donor|0|||
131858221|NCT02906670|474759315|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
131858222|NCT02906670|474759316|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
131858223|NCT02906670|474759317|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
131858224|NCT02906670|474759318|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
131858225|NCT02906670|474759309|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
131912812|NCT01859741|474967738|FG005|Overall Study|Lost to Follow-up|1|||
131858226|NCT02906670|474759310|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
131912813|NCT01859741|474967739|FG006|Overall Study|Lost to Follow-up|0|||
131858227|NCT02906670|474759311|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
131912814|NCT01859741|474967740|FG007|Overall Study|Lost to Follow-up|4|||
131912815|NCT01859741|474967733|FG000|Overall Study|Withdrawal by Subject|0|||
131912816|NCT01859741|474967734|FG001|Overall Study|Withdrawal by Subject|1|||
131912817|NCT01859741|474967735|FG002|Overall Study|Withdrawal by Subject|2|||
131912818|NCT01859741|474967736|FG003|Overall Study|Withdrawal by Subject|0|||
131912819|NCT01859741|474967737|FG004|Overall Study|Withdrawal by Subject|0|||
131407132|NCT00075725|473113420|FG009|Overall Study|Pt trying to find a BM donor|0|||
131912820|NCT01859741|474967738|FG005|Overall Study|Withdrawal by Subject|1|||
131912821|NCT01859741|474967739|FG006|Overall Study|Withdrawal by Subject|1|||
131407133|NCT00075725|473113421|FG010|Overall Study|Pt trying to find a BM donor|0|||
131407134|NCT00075725|473113422|FG011|Overall Study|Pt trying to find a BM donor|0|||
131858228|NCT02906670|474759312|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
131858229|NCT02906670|474759313|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
131858230|NCT02906670|474759314|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
131858231|NCT02906670|474759315|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
131858232|NCT02906670|474759316|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
131858233|NCT02906670|474759317|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
131858234|NCT02906670|474759318|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
131858235|NCT02906670|474759309|FG000|Cohort 4P, QW|Radiological Progression|0|||
131858236|NCT02906670|474759310|FG001|Cohort 4P, QW|Radiological Progression|0|||
131858237|NCT02906670|474759311|FG002|Cohort 4P, QW|Radiological Progression|0|||
131858238|NCT02906670|474759312|FG003|Cohort 4P, QW|Radiological Progression|3|||
131858239|NCT02906670|474759313|FG004|Cohort 4P, QW|Radiological Progression|0|||
131858240|NCT02906670|474759314|FG005|Cohort 4P, QW|Radiological Progression|0|||
131858241|NCT02906670|474759315|FG006|Cohort 4P, QW|Radiological Progression|0|||
131858242|NCT02906670|474759316|FG007|Cohort 4P, QW|Radiological Progression|0|||
131858243|NCT02906670|474759317|FG008|Cohort 4P, QW|Radiological Progression|0|||
131858244|NCT02906670|474759318|FG009|Cohort 4P, QW|Radiological Progression|0|||
131858245|NCT02906670|474759309|FG000|Cohort 7P, Q2W|Adverse Event|0|||
131858246|NCT02906670|474759310|FG001|Cohort 7P, Q2W|Adverse Event|0|||
131858247|NCT02906670|474759311|FG002|Cohort 7P, Q2W|Adverse Event|0|||
131858248|NCT02906670|474759312|FG003|Cohort 7P, Q2W|Adverse Event|0|||
131858249|NCT02906670|474759313|FG004|Cohort 7P, Q2W|Adverse Event|0|||
131858250|NCT02906670|474759314|FG005|Cohort 7P, Q2W|Adverse Event|0|||
131858251|NCT02906670|474759315|FG006|Cohort 7P, Q2W|Adverse Event|0|||
131858252|NCT02906670|474759316|FG007|Cohort 7P, Q2W|Adverse Event|0|||
131858253|NCT02906670|474759317|FG008|Cohort 7P, Q2W|Adverse Event|0|||
131858254|NCT02906670|474759318|FG009|Cohort 7P, Q2W|Adverse Event|1|||
131858255|NCT02906670|474759309|FG000|Cohort 7P, Q2W|Physician Decision|0|||
131407135|NCT00075725|473113411|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
131407136|NCT00075725|473113412|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
131407137|NCT00075725|473113413|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
131407138|NCT00075725|473113414|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
131407139|NCT00075725|473113415|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
131407140|NCT00075725|473113416|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
131407141|NCT00075725|473113417|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
131407142|NCT00075725|473113418|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
131407143|NCT00075725|473113419|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
131407144|NCT00075725|473113420|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
131407145|NCT00075725|473113421|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
131407146|NCT00075725|473113422|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
131407147|NCT00075725|473113411|FG000|Overall Study|Unsuccessful institutional transfer|0|||
131407148|NCT00075725|473113412|FG001|Overall Study|Unsuccessful institutional transfer|0|||
131407149|NCT00075725|473113413|FG002|Overall Study|Unsuccessful institutional transfer|2|||
131407150|NCT00075725|473113414|FG003|Overall Study|Unsuccessful institutional transfer|0|||
131407151|NCT00075725|473113415|FG004|Overall Study|Unsuccessful institutional transfer|0|||
131407152|NCT00075725|473113416|FG005|Overall Study|Unsuccessful institutional transfer|0|||
131407153|NCT00075725|473113417|FG006|Overall Study|Unsuccessful institutional transfer|0|||
131407154|NCT00075725|473113418|FG007|Overall Study|Unsuccessful institutional transfer|0|||
131407155|NCT00075725|473113419|FG008|Overall Study|Unsuccessful institutional transfer|0|||
131407156|NCT00075725|473113420|FG009|Overall Study|Unsuccessful institutional transfer|1|||
131407157|NCT00075725|473113421|FG010|Overall Study|Unsuccessful institutional transfer|0|||
131407158|NCT00075725|473113422|FG011|Overall Study|Unsuccessful institutional transfer|0|||
131407159|NCT00075725|473113411|FG000|Overall Study|specimen(s) not submitted|0|||
131407160|NCT00075725|473113412|FG001|Overall Study|specimen(s) not submitted|0|||
131407161|NCT00075725|473113413|FG002|Overall Study|specimen(s) not submitted|2|||
131407162|NCT00075725|473113414|FG003|Overall Study|specimen(s) not submitted|0|||
131407163|NCT00075725|473113415|FG004|Overall Study|specimen(s) not submitted|0|||
131407164|NCT00075725|473113416|FG005|Overall Study|specimen(s) not submitted|0|||
131407165|NCT00075725|473113417|FG006|Overall Study|specimen(s) not submitted|0|||
131407166|NCT00075725|473113418|FG007|Overall Study|specimen(s) not submitted|0|||
131407167|NCT00075725|473113419|FG008|Overall Study|specimen(s) not submitted|0|||
131407168|NCT00075725|473113420|FG009|Overall Study|specimen(s) not submitted|0|||
131407169|NCT00075725|473113421|FG010|Overall Study|specimen(s) not submitted|0|||
131407170|NCT00075725|473113422|FG011|Overall Study|specimen(s) not submitted|0|||
131858256|NCT02906670|474759310|FG001|Cohort 7P, Q2W|Physician Decision|0|||
131858257|NCT02906670|474759311|FG002|Cohort 7P, Q2W|Physician Decision|0|||
131858258|NCT02906670|474759312|FG003|Cohort 7P, Q2W|Physician Decision|0|||
131858259|NCT02906670|474759313|FG004|Cohort 7P, Q2W|Physician Decision|0|||
131858260|NCT02906670|474759314|FG005|Cohort 7P, Q2W|Physician Decision|0|||
131407171|NCT00075725|473113411|FG000|Overall Study|Pt went to transplant|0|||
131407172|NCT00075725|473113412|FG001|Overall Study|Pt went to transplant|0|||
131407173|NCT00075725|473113413|FG002|Overall Study|Pt went to transplant|0|||
131407174|NCT00075725|473113414|FG003|Overall Study|Pt went to transplant|1|||
131407175|NCT00075725|473113415|FG004|Overall Study|Pt went to transplant|0|||
131407176|NCT00075725|473113416|FG005|Overall Study|Pt went to transplant|1|||
131407177|NCT00075725|473113417|FG006|Overall Study|Pt went to transplant|0|||
131407178|NCT00075725|473113418|FG007|Overall Study|Pt went to transplant|0|||
131407179|NCT00075725|473113419|FG008|Overall Study|Pt went to transplant|0|||
131407180|NCT00075725|473113420|FG009|Overall Study|Pt went to transplant|0|||
131407181|NCT00075725|473113421|FG010|Overall Study|Pt went to transplant|0|||
131407182|NCT00075725|473113422|FG011|Overall Study|Pt went to transplant|0|||
131407183|NCT00075725|473113411|FG000|Overall Study|Pt received additional steroids|0|||
131407184|NCT00075725|473113412|FG001|Overall Study|Pt received additional steroids|0|||
131407185|NCT00075725|473113413|FG002|Overall Study|Pt received additional steroids|0|||
131407186|NCT00075725|473113414|FG003|Overall Study|Pt received additional steroids|1|||
131912822|NCT01859741|474967740|FG007|Overall Study|Withdrawal by Subject|1|||
131912823|NCT01859741|474967733|FG000|Overall Study|Study Terminated by Sponsor|0|||
131912824|NCT01859741|474967734|FG001|Overall Study|Study Terminated by Sponsor|0|||
131912825|NCT01859741|474967735|FG002|Overall Study|Study Terminated by Sponsor|0|||
131912826|NCT01859741|474967736|FG003|Overall Study|Study Terminated by Sponsor|0|||
131912827|NCT01859741|474967737|FG004|Overall Study|Study Terminated by Sponsor|1|||
131912828|NCT01859741|474967738|FG005|Overall Study|Study Terminated by Sponsor|0|||
131912829|NCT01859741|474967739|FG006|Overall Study|Study Terminated by Sponsor|16|||
131912830|NCT01859741|474967740|FG007|Overall Study|Study Terminated by Sponsor|14|||
131912831|NCT01859741|474967733|FG000|Overall Study|Other|0|||
131407187|NCT00075725|473113415|FG004|Overall Study|Pt received additional steroids|0|||
131407188|NCT00075725|473113416|FG005|Overall Study|Pt received additional steroids|0|||
131407189|NCT00075725|473113417|FG006|Overall Study|Pt received additional steroids|0|||
131407190|NCT00075725|473113418|FG007|Overall Study|Pt received additional steroids|0|||
131407191|NCT00075725|473113419|FG008|Overall Study|Pt received additional steroids|0|||
131407192|NCT00075725|473113420|FG009|Overall Study|Pt received additional steroids|0|||
131407193|NCT00075725|473113421|FG010|Overall Study|Pt received additional steroids|0|||
131407194|NCT00075725|473113422|FG011|Overall Study|Pt received additional steroids|0|||
131407195|NCT00075725|473113411|FG000|Overall Study|Pt relocated|0|||
131407196|NCT00075725|473113412|FG001|Overall Study|Pt relocated|0|||
131407197|NCT00075725|473113413|FG002|Overall Study|Pt relocated|0|||
131407198|NCT00075725|473113414|FG003|Overall Study|Pt relocated|2|||
131407199|NCT00075725|473113415|FG004|Overall Study|Pt relocated|0|||
131407200|NCT00075725|473113416|FG005|Overall Study|Pt relocated|1|||
131407201|NCT00075725|473113417|FG006|Overall Study|Pt relocated|1|||
131407202|NCT00075725|473113418|FG007|Overall Study|Pt relocated|2|||
131407203|NCT00075725|473113419|FG008|Overall Study|Pt relocated|1|||
131407204|NCT00075725|473113420|FG009|Overall Study|Pt relocated|0|||
131407205|NCT00075725|473113421|FG010|Overall Study|Pt relocated|0|||
131407206|NCT00075725|473113422|FG011|Overall Study|Pt relocated|0|||
131407207|NCT00075725|473113411|FG000|Overall Study|Institution Terminated|0|||
131407208|NCT00075725|473113412|FG001|Overall Study|Institution Terminated|0|||
131407209|NCT00075725|473113413|FG002|Overall Study|Institution Terminated|0|||
131407210|NCT00075725|473113414|FG003|Overall Study|Institution Terminated|0|||
131407211|NCT00075725|473113415|FG004|Overall Study|Institution Terminated|1|||
131407212|NCT00075725|473113416|FG005|Overall Study|Institution Terminated|0|||
131407213|NCT00075725|473113417|FG006|Overall Study|Institution Terminated|0|||
131407214|NCT00075725|473113418|FG007|Overall Study|Institution Terminated|3|||
131407215|NCT00075725|473113419|FG008|Overall Study|Institution Terminated|0|||
131407216|NCT00075725|473113420|FG009|Overall Study|Institution Terminated|0|||
131407217|NCT00075725|473113421|FG010|Overall Study|Institution Terminated|0|||
131407218|NCT00075725|473113422|FG011|Overall Study|Institution Terminated|0|||
131407219|NCT00075725|473113411|FG000|Overall Study|Study Closure|1|||
131407220|NCT00075725|473113412|FG001|Overall Study|Study Closure|0|||
131407221|NCT00075725|473113413|FG002|Overall Study|Study Closure|0|||
131407222|NCT00075725|473113414|FG003|Overall Study|Study Closure|0|||
131407223|NCT00075725|473113415|FG004|Overall Study|Study Closure|1|||
131407224|NCT00075725|473113416|FG005|Overall Study|Study Closure|3|||
131407225|NCT00075725|473113417|FG006|Overall Study|Study Closure|0|||
131453830|NCT05307692|473290042|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
131453831|NCT05307692|473290043|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
131407226|NCT00075725|473113418|FG007|Overall Study|Study Closure|1|||
131407227|NCT00075725|473113419|FG008|Overall Study|Study Closure|0|||
131407228|NCT00075725|473113420|FG009|Overall Study|Study Closure|0|||
131407229|NCT00075725|473113421|FG010|Overall Study|Study Closure|0|||
131407230|NCT00075725|473113422|FG011|Overall Study|Study Closure|0|||
131407231|NCT00075725|473113411|FG000|Overall Study|Other complications|0|||
131407232|NCT00075725|473113412|FG001|Overall Study|Other complications|0|||
131407233|NCT00075725|473113413|FG002|Overall Study|Other complications|0|||
131407234|NCT00075725|473113414|FG003|Overall Study|Other complications|0|||
131858261|NCT02906670|474759315|FG006|Cohort 7P, Q2W|Physician Decision|0|||
131858262|NCT02906670|474759316|FG007|Cohort 7P, Q2W|Physician Decision|0|||
131858263|NCT02906670|474759317|FG008|Cohort 7P, Q2W|Physician Decision|0|||
131858264|NCT02906670|474759318|FG009|Cohort 7P, Q2W|Physician Decision|1|||
131858265|NCT02906670|474759309|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858266|NCT02906670|474759310|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858267|NCT02906670|474759311|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858268|NCT02906670|474759312|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858269|NCT02906670|474759313|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858270|NCT02906670|474759314|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858271|NCT02906670|474759315|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858272|NCT02906670|474759316|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858273|NCT02906670|474759317|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
131858274|NCT02906670|474759318|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
131858275|NCT02906670|474759309|FG000|Cohort 5P, QW|Radiological Progression|0|||
131858276|NCT02906670|474759310|FG001|Cohort 5P, QW|Radiological Progression|0|||
131858277|NCT02906670|474759311|FG002|Cohort 5P, QW|Radiological Progression|0|||
131858278|NCT02906670|474759312|FG003|Cohort 5P, QW|Radiological Progression|0|||
131858279|NCT02906670|474759313|FG004|Cohort 5P, QW|Radiological Progression|3|||
131858280|NCT02906670|474759314|FG005|Cohort 5P, QW|Radiological Progression|0|||
131858281|NCT02906670|474759315|FG006|Cohort 5P, QW|Radiological Progression|0|||
131858282|NCT02906670|474759316|FG007|Cohort 5P, QW|Radiological Progression|0|||
131858283|NCT02906670|474759317|FG008|Cohort 5P, QW|Radiological Progression|0|||
131858284|NCT02906670|474759318|FG009|Cohort 5P, QW|Radiological Progression|0|||
131858285|NCT01928472|474759319|FG000|Overall Study|Death|0|||
131858286|NCT01928472|474759320|FG001|Overall Study|Death|0|||
131858287|NCT01928472|474759321|FG002|Overall Study|Death|1|||
131858288|NCT01928472|474759322|FG003|Overall Study|Death|0|||
131858289|NCT01928472|474759319|FG000|Overall Study|Withdrawal by Subject|4|||
131858290|NCT01928472|474759320|FG001|Overall Study|Withdrawal by Subject|4|||
131858291|NCT01928472|474759321|FG002|Overall Study|Withdrawal by Subject|1|||
131858292|NCT01928472|474759322|FG003|Overall Study|Withdrawal by Subject|2|||
131858293|NCT01928472|474759319|FG000|Overall Study|Lost to Follow-up|2|||
131858294|NCT01928472|474759320|FG001|Overall Study|Lost to Follow-up|3|||
131858295|NCT01928472|474759321|FG002|Overall Study|Lost to Follow-up|4|||
131858296|NCT01928472|474759322|FG003|Overall Study|Lost to Follow-up|0|||
131858297|NCT01928472|474759319|FG000|Overall Study|Administrative Reason|2|||
131858298|NCT01928472|474759320|FG001|Overall Study|Administrative Reason|1|||
131858299|NCT01928472|474759321|FG002|Overall Study|Administrative Reason|0|||
131858300|NCT01928472|474759322|FG003|Overall Study|Administrative Reason|0|||
131858301|NCT01928472|474759319|FG000|Overall Study|Unclassified|0|||
131858302|NCT01928472|474759320|FG001|Overall Study|Unclassified|0|||
131858303|NCT01928472|474759321|FG002|Overall Study|Unclassified|1|||
131858304|NCT01928472|474759322|FG003|Overall Study|Unclassified|0|||
131858305|NCT04471428|474759326|FG000|Overall Study|Withdrawal by Subject|29|||
131858306|NCT04471428|474759327|FG001|Overall Study|Withdrawal by Subject|1|||
131858307|NCT04471428|474759326|FG000|Overall Study|Physician Decision|0|||
131858308|NCT04471428|474759327|FG001|Overall Study|Physician Decision|1|||
131858309|NCT04471428|474759326|FG000|Overall Study|Reason Not Specified|0|||
131858310|NCT04471428|474759327|FG001|Overall Study|Reason Not Specified|2|||
131858311|NCT04471428|474759326|FG000|Overall Study|Death|106|||
131858312|NCT04471428|474759327|FG001|Overall Study|Death|114|||
131858313|NCT04471428|474759326|FG000|Overall Study|Ongoing in the study|45|||
131858314|NCT04471428|474759327|FG001|Overall Study|Ongoing in the study|68|||
131858315|NCT01042093|474759330|FG000|Overall Study|Protocol Violation|2|||
131858316|NCT01042093|474759331|FG001|Overall Study|Protocol Violation|2|||
131858317|NCT01042093|474759332|FG002|Overall Study|Protocol Violation|2|||
131858318|NCT01042093|474759333|FG003|Overall Study|Protocol Violation|3|||
131858319|NCT01042093|474759330|FG000|Overall Study|Withdrawal by Subject|0|||
131858320|NCT01042093|474759331|FG001|Overall Study|Withdrawal by Subject|0|||
131858321|NCT01042093|474759332|FG002|Overall Study|Withdrawal by Subject|0|||
131858322|NCT01042093|474759333|FG003|Overall Study|Withdrawal by Subject|1|||
131858323|NCT04331808|474759334|FG000|Overall Study|Withdrew consent|1|||
131858324|NCT04331808|474759335|FG001|Overall Study|Withdrew consent|0|||
131858325|NCT04331808|474759336|FG002|Overall Study|Withdrew consent|2|||
131858326|NCT04331808|474759337|FG003|Overall Study|Withdrew consent|3|||
131858327|NCT01184079|474759341|FG000|Overall Study|Lost to Follow-up|14|||
131858328|NCT01184079|474759342|FG001|Overall Study|Lost to Follow-up|2|||
131858329|NCT04233073|474759343|FG000|Overall Study|Death|5|||
131858330|NCT02198963|474759344|FG000|Overall Study|Adverse Event|1|||
131858331|NCT02198963|474759344|FG000|Overall Study|Withdrawal by Subject|6|||
131858332|NCT00995774|474759346|FG000|Training Period 2|Withdrawal by Subject|2|||
131858333|NCT00995774|474759347|FG001|Training Period 2|Withdrawal by Subject|0|||
131858334|NCT01808573|474759348|FG000|Overall Study|Death|212|||
131858335|NCT01808573|474759349|FG001|Overall Study|Death|240|||
131858336|NCT01808573|474759348|FG000|Overall Study|Withdrawal by Subject|12|||
131858337|NCT01808573|474759349|FG001|Overall Study|Withdrawal by Subject|10|||
131407235|NCT00075725|473113415|FG004|Overall Study|Other complications|0|||
131407236|NCT00075725|473113416|FG005|Overall Study|Other complications|1|||
131407237|NCT00075725|473113417|FG006|Overall Study|Other complications|0|||
131407238|NCT00075725|473113418|FG007|Overall Study|Other complications|0|||
131407239|NCT00075725|473113419|FG008|Overall Study|Other complications|0|||
131407240|NCT00075725|473113420|FG009|Overall Study|Other complications|0|||
131407241|NCT00075725|473113421|FG010|Overall Study|Other complications|0|||
131407242|NCT00075725|473113422|FG011|Overall Study|Other complications|0|||
131407243|NCT00075725|473113411|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
131407244|NCT00075725|473113412|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
131407245|NCT00075725|473113413|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
131407246|NCT00075725|473113414|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
131407247|NCT00075725|473113415|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
131407248|NCT00075725|473113416|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
131407249|NCT00075725|473113417|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
131407250|NCT00075725|473113418|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
131407251|NCT00075725|473113419|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
131407252|NCT00075725|473113420|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
131407253|NCT00075725|473113421|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
131407254|NCT00075725|473113422|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
131407255|NCT00075725|473113411|FG000|Overall Study|Pt incarcerated|0|||
131407256|NCT00075725|473113412|FG001|Overall Study|Pt incarcerated|0|||
131407257|NCT00075725|473113413|FG002|Overall Study|Pt incarcerated|0|||
131407258|NCT00075725|473113414|FG003|Overall Study|Pt incarcerated|0|||
131407259|NCT00075725|473113415|FG004|Overall Study|Pt incarcerated|0|||
131407260|NCT00075725|473113416|FG005|Overall Study|Pt incarcerated|0|||
131407261|NCT00075725|473113417|FG006|Overall Study|Pt incarcerated|0|||
131407262|NCT00075725|473113418|FG007|Overall Study|Pt incarcerated|1|||
131407263|NCT00075725|473113419|FG008|Overall Study|Pt incarcerated|0|||
131407264|NCT00075725|473113420|FG009|Overall Study|Pt incarcerated|0|||
131407265|NCT00075725|473113421|FG010|Overall Study|Pt incarcerated|0|||
131407266|NCT00075725|473113422|FG011|Overall Study|Pt incarcerated|0|||
131407267|NCT02240368|473113423|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
131407268|NCT02240368|473113424|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
131407269|NCT02240368|473113425|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
131407270|NCT02240368|473113423|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
131407271|NCT02240368|473113424|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
131407272|NCT02240368|473113425|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
131407273|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Death|1|||
131407274|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Death|1|||
131407275|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Death|0|||
131407276|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Death|0|||
131407277|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Death|1|||
131407278|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Death|0|||
131407279|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Death|0|||
131407280|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Death|0|||
131407281|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Death|0|||
131407282|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Death|0|||
131407283|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
131407284|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
131407285|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
131407286|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
131407287|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
131407288|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
131407289|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
131407290|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
131407291|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
131407292|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
131407293|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407294|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407295|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407296|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407297|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
131407298|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407299|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407300|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407301|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407302|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
131407303|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
131407304|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407305|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407306|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407307|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131858338|NCT01808573|474759348|FG000|Overall Study|Lost to Follow-up|3|||
131858339|NCT01808573|474759349|FG001|Overall Study|Lost to Follow-up|0|||
131858340|NCT01808573|474759348|FG000|Overall Study|Discontinuation of study by sponsor|79|||
131858341|NCT01808573|474759349|FG001|Overall Study|Discontinuation of study by sponsor|64|||
131858342|NCT01808573|474759348|FG000|Overall Study|Randomized in Error|1|||
131858343|NCT01808573|474759349|FG001|Overall Study|Randomized in Error|0|||
131858344|NCT01523002|474759352|FG000|Period 1|Withdrawal by Subject|1|||
131858345|NCT01523002|474759353|FG001|Period 1|Withdrawal by Subject|3|||
131858346|NCT01523002|474759352|FG000|Period 1|Lost to Follow-up|1|||
131858347|NCT01523002|474759353|FG001|Period 1|Lost to Follow-up|0|||
131858348|NCT01523002|474759352|FG000|Period 1|Adverse Event|0|||
131858349|NCT01523002|474759353|FG001|Period 1|Adverse Event|8|||
131858350|NCT01523002|474759352|FG000|Period 2|Withdrawal by Subject|4|||
131858351|NCT01523002|474759353|FG001|Period 2|Withdrawal by Subject|1|||
131858352|NCT01523002|474759352|FG000|Period 2|Adverse Event|2|||
131858353|NCT01523002|474759353|FG001|Period 2|Adverse Event|5|||
131858354|NCT01523002|474759352|FG000|Period 3|Withdrawal by Subject|1|||
131858355|NCT01523002|474759353|FG001|Period 3|Withdrawal by Subject|0|||
131858356|NCT01523002|474759352|FG000|Period 3|Adverse Event|3|||
131858357|NCT01523002|474759353|FG001|Period 3|Adverse Event|0|||
131858358|NCT01256502|474759355|FG000|Overall Study|Had scaffold removed|4|||
131858359|NCT01256502|474759355|FG000|Overall Study|Personal reasons|5|||
131858360|NCT01256502|474759355|FG000|Overall Study|Protocol deviation|1|||
131858361|NCT03953612|474759356|FG000|Overall Study|Randomized but did not start|1|||
131858362|NCT03953612|474759357|FG001|Overall Study|Randomized but did not start|1|||
131858363|NCT03953612|474759358|FG002|Overall Study|Randomized but did not start|1|||
131858364|NCT03953612|474759356|FG000|Overall Study|Withdrawal by Subject|2|||
131858365|NCT03953612|474759357|FG001|Overall Study|Withdrawal by Subject|1|||
131858366|NCT03953612|474759358|FG002|Overall Study|Withdrawal by Subject|0|||
131858367|NCT03200717|474759374|FG000|Overall Study|Progressive disease|24|||
131858368|NCT03200717|474759375|FG001|Overall Study|Progressive disease|5|||
131858369|NCT03200717|474759374|FG000|Overall Study|Adverse Event|11|||
131858370|NCT03200717|474759375|FG001|Overall Study|Adverse Event|8|||
131858371|NCT03200717|474759374|FG000|Overall Study|Physician Decision|3|||
131858372|NCT03200717|474759375|FG001|Overall Study|Physician Decision|2|||
131858373|NCT03200717|474759374|FG000|Overall Study|Death|2|||
131858374|NCT03200717|474759375|FG001|Overall Study|Death|0|||
131858375|NCT03200717|474759374|FG000|Overall Study|Subject/Guardian Decision|1|||
131858376|NCT03200717|474759375|FG001|Overall Study|Subject/Guardian Decision|0|||
131858377|NCT01461538|474759376|FG000|Overall Study|Death|15|||
131858378|NCT01461538|474759377|FG001|Overall Study|Death|6|||
131858379|NCT01461538|474759378|FG002|Overall Study|Death|2|||
131858380|NCT01461538|474759376|FG000|Overall Study|Study Stopped by Sponsor|2|||
131858381|NCT01461538|474759377|FG001|Overall Study|Study Stopped by Sponsor|1|||
131858382|NCT01461538|474759378|FG002|Overall Study|Study Stopped by Sponsor|0|||
131858383|NCT01461538|474759376|FG000|Overall Study|Withdrawal by Subject|1|||
131858384|NCT01461538|474759377|FG001|Overall Study|Withdrawal by Subject|1|||
131858385|NCT01461538|474759378|FG002|Overall Study|Withdrawal by Subject|0|||
131858386|NCT00141778|474759379|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
131858387|NCT00141778|474759380|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
131858388|NCT00141778|474759381|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
131858389|NCT00141778|474759379|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
131858390|NCT00141778|474759380|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
131858391|NCT00141778|474759381|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
131858392|NCT00141778|474759379|FG000|Started Study Medication|Withdrawal by Subject|0|||
131858393|NCT00141778|474759380|FG001|Started Study Medication|Withdrawal by Subject|2|||
131858394|NCT00141778|474759381|FG002|Started Study Medication|Withdrawal by Subject|0|||
131858395|NCT00141778|474759379|FG000|Started Study Medication|Difficulty Swallowing|0|||
131858396|NCT00141778|474759380|FG001|Started Study Medication|Difficulty Swallowing|1|||
131858397|NCT00141778|474759381|FG002|Started Study Medication|Difficulty Swallowing|0|||
131858398|NCT00141778|474759379|FG000|Started Study Medication|Chest Discomfort|0|||
131858399|NCT00141778|474759380|FG001|Started Study Medication|Chest Discomfort|0|||
131858400|NCT00141778|474759381|FG002|Started Study Medication|Chest Discomfort|1|||
131858401|NCT02603146|474760954|FG000|Overall Study|Lost to Follow-up|5|||
131858402|NCT02603146|474760955|FG001|Overall Study|Lost to Follow-up|6|||
131407308|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131858403|NCT02603146|474760954|FG000|Overall Study|Withdrawal by Subject|8|||
131858404|NCT02603146|474760955|FG001|Overall Study|Withdrawal by Subject|10|||
131858405|NCT02603146|474760954|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
131858406|NCT02603146|474760955|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
131858407|NCT02603146|474760954|FG000|Overall Study|Participant moved|2|||
131858408|NCT02603146|474760955|FG001|Overall Study|Participant moved|0|||
131858409|NCT02603146|474760954|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
131858410|NCT02603146|474760955|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
131858411|NCT03493685|474760956|FG000|Overall Study|Death|4|||
131858412|NCT03493685|474760957|FG001|Overall Study|Death|3|||
131858413|NCT03493685|474760956|FG000|Overall Study|Lost to Follow-up|3|||
131858414|NCT03493685|474760957|FG001|Overall Study|Lost to Follow-up|2|||
131858415|NCT03493685|474760956|FG000|Overall Study|Physician Decision|2|||
131858416|NCT03493685|474760957|FG001|Overall Study|Physician Decision|0|||
131858417|NCT03493685|474760956|FG000|Overall Study|Withdrawal by Subject|7|||
131858418|NCT03493685|474760957|FG001|Overall Study|Withdrawal by Subject|11|||
131858419|NCT04452669|474760958|FG000|Overall Study|Death|1|||
131858420|NCT04452669|474760959|FG001|Overall Study|Death|4|||
131858421|NCT00265759|474760960|FG000|Overall Study|Withdrawal by Subject|0|||
131858422|NCT00265759|474760961|FG001|Overall Study|Withdrawal by Subject|1|||
131858423|NCT00265759|474760962|FG002|Overall Study|Withdrawal by Subject|2|||
131858424|NCT00265759|474760963|FG003|Overall Study|Withdrawal by Subject|2|||
131858425|NCT00265759|474760960|FG000|Overall Study|Cancel|0|||
131858426|NCT00265759|474760961|FG001|Overall Study|Cancel|0|||
131858427|NCT00265759|474760962|FG002|Overall Study|Cancel|0|||
131858428|NCT00265759|474760963|FG003|Overall Study|Cancel|3|||
131858429|NCT00265759|474760960|FG000|Overall Study|Ineligible|0|||
131858430|NCT00265759|474760961|FG001|Overall Study|Ineligible|0|||
131858431|NCT00265759|474760962|FG002|Overall Study|Ineligible|0|||
131858432|NCT00265759|474760963|FG003|Overall Study|Ineligible|1|||
131858433|NCT00265759|474760960|FG000|Overall Study|Bilateral disease|0|||
131858434|NCT00265759|474760961|FG001|Overall Study|Bilateral disease|0|||
131858435|NCT00265759|474760962|FG002|Overall Study|Bilateral disease|0|||
131858436|NCT00265759|474760963|FG003|Overall Study|Bilateral disease|2|||
131858437|NCT00265759|474760960|FG000|Overall Study|Discontinued due to intolerability|0|||
131858438|NCT00265759|474760961|FG001|Overall Study|Discontinued due to intolerability|0|||
131858439|NCT00265759|474760962|FG002|Overall Study|Discontinued due to intolerability|0|||
131858440|NCT00265759|474760963|FG003|Overall Study|Discontinued due to intolerability|1|||
131858441|NCT04467840|474760964|FG000|Overall Study|Death|35|||
131858442|NCT04467840|474760965|FG001|Overall Study|Death|39|||
131858443|NCT04467840|474760964|FG000|Overall Study|Withdrawal by Subject|8|||
131858444|NCT04467840|474760965|FG001|Overall Study|Withdrawal by Subject|4|||
131858445|NCT04467840|474760964|FG000|Overall Study|Adverse Event|2|||
131858446|NCT04467840|474760965|FG001|Overall Study|Adverse Event|0|||
131858447|NCT04467840|474760964|FG000|Overall Study|Lost to Follow-up|1|||
131858448|NCT04467840|474760965|FG001|Overall Study|Lost to Follow-up|3|||
131858449|NCT04467840|474760964|FG000|Overall Study|Physician Decision|1|||
131858450|NCT04467840|474760965|FG001|Overall Study|Physician Decision|0|||
131858451|NCT04467840|474760964|FG000|Overall Study|Other|1|||
131858452|NCT04467840|474760965|FG001|Overall Study|Other|5|||
131858453|NCT04467840|474760964|FG000|Overall Study|Missing study completion status|3|||
131858454|NCT04467840|474760965|FG001|Overall Study|Missing study completion status|1|||
131858455|NCT05201794|474760968|FG000|Overall Study|Withdrawal by Subject|13|||
131858456|NCT05201794|474760969|FG001|Overall Study|Withdrawal by Subject|12|||
131858457|NCT05201794|474760970|FG002|Overall Study|Withdrawal by Subject|14|||
131858458|NCT05201794|474760971|FG003|Overall Study|Withdrawal by Subject|0|||
131858459|NCT05201794|474760968|FG000|Overall Study|Adverse Event|5|||
131858460|NCT05201794|474760969|FG001|Overall Study|Adverse Event|5|||
131858461|NCT05201794|474760970|FG002|Overall Study|Adverse Event|4|||
131858462|NCT05201794|474760971|FG003|Overall Study|Adverse Event|0|||
131858463|NCT05201794|474760968|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
131858464|NCT05201794|474760969|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131858465|NCT05201794|474760970|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
131858466|NCT05201794|474760971|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131858467|NCT05201794|474760968|FG000|Overall Study|Non-Compliance With Study Drug|2|||
131858468|NCT05201794|474760969|FG001|Overall Study|Non-Compliance With Study Drug|3|||
131858469|NCT05201794|474760970|FG002|Overall Study|Non-Compliance With Study Drug|3|||
131858470|NCT05201794|474760971|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131858471|NCT05201794|474760968|FG000|Overall Study|Physician Decision|1|||
131858472|NCT05201794|474760969|FG001|Overall Study|Physician Decision|3|||
131858473|NCT05201794|474760970|FG002|Overall Study|Physician Decision|2|||
131858474|NCT05201794|474760971|FG003|Overall Study|Physician Decision|0|||
131858475|NCT05201794|474760968|FG000|Overall Study|Lost to Follow-up|2|||
131858476|NCT05201794|474760969|FG001|Overall Study|Lost to Follow-up|2|||
131858477|NCT05201794|474760970|FG002|Overall Study|Lost to Follow-up|0|||
131858478|NCT05201794|474760971|FG003|Overall Study|Lost to Follow-up|0|||
131858479|NCT05201794|474760968|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
131858480|NCT05201794|474760969|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
131858481|NCT05201794|474760970|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
131858482|NCT05201794|474760971|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
131858483|NCT05201794|474760968|FG000|Overall Study|Protocol Violation|2|||
131858484|NCT05201794|474760969|FG001|Overall Study|Protocol Violation|0|||
131858485|NCT05201794|474760970|FG002|Overall Study|Protocol Violation|1|||
131858486|NCT05201794|474760971|FG003|Overall Study|Protocol Violation|0|||
131453832|NCT05307692|473290040|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
131858487|NCT05201794|474760968|FG000|Overall Study|Death|1|||
131858488|NCT05201794|474760969|FG001|Overall Study|Death|0|||
131858489|NCT05201794|474760970|FG002|Overall Study|Death|0|||
131858490|NCT05201794|474760971|FG003|Overall Study|Death|0|||
131407309|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407310|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407311|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407312|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
131407313|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
131407314|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407315|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407316|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
131407317|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
131407318|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407319|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407320|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407321|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407322|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
131407323|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
131407324|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131407325|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131912832|NCT01859741|474967734|FG001|Overall Study|Other|0|||
131407326|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
131407327|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131912833|NCT01859741|474967735|FG002|Overall Study|Other|0|||
131912834|NCT01859741|474967736|FG003|Overall Study|Other|0|||
131912835|NCT01859741|474967737|FG004|Overall Study|Other|0|||
131912836|NCT01859741|474967738|FG005|Overall Study|Other|0|||
131912837|NCT01859741|474967739|FG006|Overall Study|Other|2|||
131912838|NCT01859741|474967740|FG007|Overall Study|Other|0|||
131912839|NCT02412657|474967744|FG000|Overall Study|Lost to Follow-up|1|||
131912840|NCT02412657|474967745|FG001|Overall Study|Lost to Follow-up|0|||
131912841|NCT02412657|474967746|FG002|Overall Study|Lost to Follow-up|0|||
131912842|NCT02412657|474967744|FG000|Overall Study|Protocol Violation|0|||
131912843|NCT02412657|474967745|FG001|Overall Study|Protocol Violation|2|||
131912844|NCT02412657|474967746|FG002|Overall Study|Protocol Violation|3|||
131912845|NCT02701634|474967751|FG000|Overall Study|Adverse Event|2|||
131912846|NCT02701634|474967752|FG001|Overall Study|Adverse Event|3|||
131912847|NCT02701634|474967751|FG000|Overall Study|Death|1|||
131407328|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131407329|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131407330|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131407331|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131407332|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
131407333|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
131407334|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
131407335|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
131407336|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
131407337|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
131407338|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
131407339|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
131407340|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
131407341|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
131407342|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
131407343|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
131407344|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
131407345|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
131407346|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407347|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
131407348|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407349|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407350|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407351|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407352|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407353|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
131407354|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131407355|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131912848|NCT02701634|474967752|FG001|Overall Study|Death|0|||
131912849|NCT02701634|474967751|FG000|Overall Study|Investigator's Discretion|7|||
131912850|NCT02701634|474967752|FG001|Overall Study|Investigator's Discretion|4|||
131912851|NCT02701634|474967751|FG000|Overall Study|Study terminated by Sponsor|15|||
131407356|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
131407357|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
131407358|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131407359|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131407360|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131407361|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131407362|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
131407363|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407364|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407365|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407366|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407367|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407368|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407369|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407370|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407371|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407372|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407373|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407374|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407375|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
131407376|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407377|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
131407378|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407379|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407380|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407381|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407382|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407383|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
131407384|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
131407385|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
131407386|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
131407387|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
131407388|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
131407389|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
131407390|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
131407391|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
131407392|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
131407393|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407394|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131858491|NCT05201794|474760968|FG000|Overall Study|Site Terminated By Sponsor|0|||
131858492|NCT05201794|474760969|FG001|Overall Study|Site Terminated By Sponsor|1|||
131858493|NCT05201794|474760970|FG002|Overall Study|Site Terminated By Sponsor|0|||
131858494|NCT05201794|474760971|FG003|Overall Study|Site Terminated By Sponsor|0|||
131858495|NCT05201794|474760968|FG000|Overall Study|Other|3|||
131858496|NCT05201794|474760969|FG001|Overall Study|Other|3|||
131858497|NCT05201794|474760970|FG002|Overall Study|Other|3|||
131858498|NCT05201794|474760971|FG003|Overall Study|Other|0|||
131858499|NCT05201794|474760968|FG000|Overall Study|Randomized But Not Treated|1|||
131858500|NCT05201794|474760969|FG001|Overall Study|Randomized But Not Treated|2|||
131858501|NCT05201794|474760970|FG002|Overall Study|Randomized But Not Treated|1|||
131858502|NCT05201794|474760971|FG003|Overall Study|Randomized But Not Treated|0|||
131858503|NCT00118157|474760976|FG000|Overall Study|Adverse Event|2|||
131858504|NCT00118157|474760976|FG000|Overall Study|Death|8|||
131858505|NCT00118157|474760976|FG000|Overall Study|Withdrawal by Subject|2|||
131858506|NCT03989102|474760977|FG000|Year 1|Withdrawal by Subject|6|||
131858507|NCT03989102|474760978|FG001|Year 1|Withdrawal by Subject|2|||
131858508|NCT03989102|474760979|FG002|Year 1|Withdrawal by Subject|7|||
131858509|NCT03989102|474760977|FG000|Year 1|Lost to Follow-up|5|||
131407395|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407396|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
131407397|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
131407398|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407399|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407400|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407401|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407402|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407403|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
131407404|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407405|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
131407406|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
131407407|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
131407408|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407409|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407410|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407411|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407412|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407413|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
131407414|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407415|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407416|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407417|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
131407418|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407419|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407420|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407421|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407422|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
131407423|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407424|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407425|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407426|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407427|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
131858510|NCT03989102|474760978|FG001|Year 1|Lost to Follow-up|2|||
131858511|NCT03989102|474760979|FG002|Year 1|Lost to Follow-up|5|||
131858512|NCT03989102|474760977|FG000|Year 1|Subject met withdrawal criteria|1|||
131858513|NCT03989102|474760978|FG001|Year 1|Subject met withdrawal criteria|0|||
131858514|NCT03989102|474760979|FG002|Year 1|Subject met withdrawal criteria|1|||
131858515|NCT03989102|474760977|FG000|Year 2|Lost to Follow-up|7|||
131858516|NCT03989102|474760978|FG001|Year 2|Lost to Follow-up|3|||
131858517|NCT03989102|474760979|FG002|Year 2|Lost to Follow-up|4|||
131858518|NCT03989102|474760977|FG000|Year 2|Withdrawal by Subject|3|||
131858519|NCT03989102|474760978|FG001|Year 2|Withdrawal by Subject|1|||
131858520|NCT03989102|474760979|FG002|Year 2|Withdrawal by Subject|2|||
131858521|NCT03989102|474760977|FG000|Year 2|Subject non-compliant|3|||
131858522|NCT03989102|474760978|FG001|Year 2|Subject non-compliant|2|||
131858523|NCT03989102|474760979|FG002|Year 2|Subject non-compliant|0|||
131858524|NCT03989102|474760977|FG000|Year 2|Travel|1|||
131858525|NCT03989102|474760978|FG001|Year 2|Travel|0|||
131858526|NCT03989102|474760979|FG002|Year 2|Travel|1|||
131858527|NCT03989102|474760977|FG000|Year 2|P16 missing|4|||
131858528|NCT03989102|474760978|FG001|Year 2|P16 missing|2|||
131858529|NCT03989102|474760979|FG002|Year 2|P16 missing|1|||
131858530|NCT03989102|474760977|FG000|Year 2|P11 missing|1|||
131858531|NCT03989102|474760978|FG001|Year 2|P11 missing|3|||
131858532|NCT03989102|474760979|FG002|Year 2|P11 missing|7|||
131858533|NCT03989102|474760977|FG000|Year 2|Definitive displacement outside the study site|0|||
131858534|NCT03989102|474760978|FG001|Year 2|Definitive displacement outside the study site|1|||
131858535|NCT03989102|474760979|FG002|Year 2|Definitive displacement outside the study site|0|||
131858536|NCT03989102|474760977|FG000|Year 2|Subject missed last study visit|0|||
131858537|NCT03989102|474760978|FG001|Year 2|Subject missed last study visit|1|||
131858538|NCT03989102|474760979|FG002|Year 2|Subject missed last study visit|0|||
131858539|NCT03989102|474760977|FG000|Year 2|Death|0|||
131858540|NCT03989102|474760978|FG001|Year 2|Death|1|||
131407428|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407429|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407430|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407431|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407432|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407433|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407434|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
131453833|NCT05307692|473290041|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
131453834|NCT05307692|473290042|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
131453835|NCT05307692|473290043|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
131453836|NCT05767749|473290047|FG000|Overall Study|Withdrawal by Subject|0|||
131858541|NCT03989102|474760979|FG002|Year 2|Death|0|||
131858542|NCT03989102|474760977|FG000|Year 2|Subject not reachable|0|||
131407435|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407436|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407437|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
131407438|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407439|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407440|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407441|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407442|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
131407443|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
131407444|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407445|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407446|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407447|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
131407448|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407449|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407450|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407451|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407452|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
131407453|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
131407454|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407455|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
131407456|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407457|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
131407458|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407459|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407460|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407461|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407462|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
131407463|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Other|5|||
131407464|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Other|1|||
131407465|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Other|0|||
131407466|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Other|3|||
131407467|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Other|0|||
131407468|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Other|0|||
131407469|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Other|0|||
131407470|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Other|0|||
131858543|NCT03989102|474760978|FG001|Year 2|Subject not reachable|0|||
131858544|NCT03989102|474760979|FG002|Year 2|Subject not reachable|1|||
131858545|NCT03989102|474760977|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
131858546|NCT03989102|474760978|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
131858547|NCT03989102|474760979|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
131912852|NCT02701634|474967752|FG001|Overall Study|Study terminated by Sponsor|17|||
131858548|NCT03989102|474760977|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
131858549|NCT03989102|474760978|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
131912853|NCT02701634|474967751|FG000|Overall Study|Withdrew Consent|6|||
131912854|NCT02701634|474967752|FG001|Overall Study|Withdrew Consent|7|||
131912855|NCT02701634|474967751|FG000|Overall Study|Randomized but not treated|1|||
131912856|NCT02701634|474967752|FG001|Overall Study|Randomized but not treated|0|||
131912857|NCT01033136|474967753|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
131912858|NCT01033136|474967754|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
131912859|NCT00630292|474967755|FG000|Overall Study|Withdrawal by Subject|1|||
131912860|NCT00142415|474967758|FG000|Overall Study|Physician Decision|0|||
131912861|NCT00142415|474967759|FG001|Overall Study|Physician Decision|0|||
131912862|NCT00142415|474967760|FG002|Overall Study|Physician Decision|0|||
131912863|NCT00142415|474967761|FG003|Overall Study|Physician Decision|0|||
131912864|NCT00142415|474967762|FG004|Overall Study|Physician Decision|1|||
131858550|NCT03989102|474760979|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
131858551|NCT03989102|474760977|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
131858552|NCT03989102|474760978|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
131858553|NCT03989102|474760979|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
131858554|NCT03989102|474760977|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
131858555|NCT03989102|474760978|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
131858556|NCT03989102|474760979|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
131858557|NCT03989102|474760977|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
131858558|NCT03989102|474760978|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
131912865|NCT00142415|474967763|FG005|Overall Study|Physician Decision|2|||
131912866|NCT01189266|474967766|FG000|Overall Study|Adverse Event|1|||
131912867|NCT01189266|474967767|FG001|Overall Study|Adverse Event|0|||
131912868|NCT01189266|474967768|FG002|Overall Study|Adverse Event|5|||
131912869|NCT01189266|474967766|FG000|Overall Study|Death|0|||
131912870|NCT01189266|474967767|FG001|Overall Study|Death|0|||
131912871|NCT01189266|474967768|FG002|Overall Study|Death|5|||
131912872|NCT01189266|474967766|FG000|Overall Study|Lack of Efficacy|4|||
131912873|NCT01189266|474967767|FG001|Overall Study|Lack of Efficacy|5|||
131912874|NCT01189266|474967768|FG002|Overall Study|Lack of Efficacy|44|||
131912875|NCT01189266|474967766|FG000|Overall Study|Physician Decision|0|||
131912876|NCT01189266|474967767|FG001|Overall Study|Physician Decision|0|||
131912877|NCT01189266|474967768|FG002|Overall Study|Physician Decision|1|||
131912878|NCT01189266|474967766|FG000|Overall Study|Protocol Violation|0|||
131912879|NCT01189266|474967767|FG001|Overall Study|Protocol Violation|1|||
131912880|NCT01189266|474967768|FG002|Overall Study|Protocol Violation|1|||
131912881|NCT01189266|474967766|FG000|Overall Study|Withdrawal by Subject|0|||
131912882|NCT01189266|474967767|FG001|Overall Study|Withdrawal by Subject|0|||
131912883|NCT01189266|474967768|FG002|Overall Study|Withdrawal by Subject|1|||
131912884|NCT01189266|474967766|FG000|Overall Study|Patient refuses further therapy|1|||
131858559|NCT03989102|474760979|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
131858560|NCT03989102|474760977|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
131858561|NCT03989102|474760978|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
131858562|NCT03989102|474760979|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
131858563|NCT02760004|474760982|FG000|Overall Study|Lost to Follow-up|13|||
131858564|NCT02760004|474760983|FG001|Overall Study|Lost to Follow-up|22|||
131858565|NCT02203357|474760986|FG000|Overall Study|Lost to Follow-up|58|||
131858566|NCT02203357|474760987|FG001|Overall Study|Lost to Follow-up|66|||
131858567|NCT02203357|474760988|FG002|Overall Study|Lost to Follow-up|70|||
131858568|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
131858569|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
131858570|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
131858571|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858572|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
131858573|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
131858574|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858575|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858576|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858577|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858578|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858579|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858580|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858581|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858582|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858583|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858584|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
131858585|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
131858586|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858587|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
131858588|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
131858589|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
131858590|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
131858591|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858592|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858593|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858594|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858595|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131407471|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Other|0|||
131407472|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Other|0|||
131858596|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858597|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858598|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131912885|NCT01189266|474967767|FG001|Overall Study|Patient refuses further therapy|0|||
131858599|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858600|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858601|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
131858602|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
131858603|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
131858604|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
131858605|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
131858606|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
131858607|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
131858608|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858609|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858610|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858611|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858612|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858613|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858614|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858615|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858616|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858617|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858618|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
131858619|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858620|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
131858621|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
131858622|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858623|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
131858624|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
131858625|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858626|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858627|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858628|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858629|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858630|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858631|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858632|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858633|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858634|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858635|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
131858636|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858637|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858638|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
131858639|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
131858640|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858641|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858642|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858643|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858644|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858645|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858646|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858647|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858648|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858649|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858650|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858651|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858652|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
131858653|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858654|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858655|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858656|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858657|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
131858658|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858659|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858660|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858661|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858662|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858663|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858664|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858665|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858666|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858667|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858668|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858669|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
131858670|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858671|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
131858672|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858673|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858674|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858675|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858676|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858677|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858678|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858679|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858680|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858681|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858682|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858683|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858684|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858685|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858686|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
131858687|NCT00758524|474760989|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858688|NCT00758524|474760990|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
131858689|NCT00758524|474760991|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858690|NCT00758524|474760992|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858691|NCT00758524|474760993|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858692|NCT00758524|474760994|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858693|NCT00758524|474760995|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858694|NCT00758524|474760996|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858695|NCT00758524|474760997|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858696|NCT00758524|474760998|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858697|NCT00758524|474760999|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858698|NCT00758524|474761000|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858699|NCT00758524|474761001|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858700|NCT00758524|474761002|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858701|NCT00758524|474761003|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858702|NCT00758524|474761004|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858703|NCT00758524|474761005|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
131858704|NCT00758524|474760989|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858705|NCT00758524|474760990|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858706|NCT00758524|474760991|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858707|NCT00758524|474760992|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858708|NCT00758524|474760993|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858709|NCT00758524|474760994|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858710|NCT00758524|474760995|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858711|NCT00758524|474760996|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858712|NCT00758524|474760997|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
131858713|NCT00758524|474760998|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858714|NCT00758524|474760999|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858715|NCT00758524|474761000|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858716|NCT00758524|474761001|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858717|NCT00758524|474761002|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858718|NCT00758524|474761003|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858719|NCT00758524|474761004|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858720|NCT00758524|474761005|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
131858721|NCT00758524|474760989|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858722|NCT00758524|474760990|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858723|NCT00758524|474760991|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858724|NCT00758524|474760992|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858725|NCT00758524|474760993|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858726|NCT00758524|474760994|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858727|NCT00758524|474760995|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
131858728|NCT00758524|474760996|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131912886|NCT01189266|474967768|FG002|Overall Study|Patient refuses further therapy|7|||
131912887|NCT01189266|474967766|FG000|Overall Study|No treatment|0|||
131912888|NCT01189266|474967767|FG001|Overall Study|No treatment|0|||
131912889|NCT01189266|474967768|FG002|Overall Study|No treatment|1|||
131912890|NCT04009837|474967769|FG000|Overall Study|Withdrawal by Subject|5|||
131858729|NCT00758524|474760997|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858730|NCT00758524|474760998|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858731|NCT00758524|474760999|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858732|NCT00758524|474761000|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858733|NCT00758524|474761001|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858734|NCT00758524|474761002|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858735|NCT00758524|474761003|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858736|NCT00758524|474761004|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858737|NCT00758524|474761005|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
131858738|NCT00276484|474761006|FG000|Overall Study|Adverse Event|4|||
131858739|NCT00276484|474761007|FG001|Overall Study|Adverse Event|7|||
131858740|NCT00276484|474761006|FG000|Overall Study|Lost to Follow-up|1|||
131858741|NCT00276484|474761007|FG001|Overall Study|Lost to Follow-up|1|||
131858742|NCT00276484|474761006|FG000|Overall Study|Protocol Violation|0|||
131858743|NCT00276484|474761007|FG001|Overall Study|Protocol Violation|1|||
131858744|NCT00276484|474761006|FG000|Overall Study|Withdrawal by Subject|4|||
131858745|NCT00276484|474761007|FG001|Overall Study|Withdrawal by Subject|3|||
131858746|NCT00276484|474761006|FG000|Overall Study|Could not take time off work|0|||
131858747|NCT00276484|474761007|FG001|Overall Study|Could not take time off work|1|||
131858748|NCT01431079|474761011|FG000|Overall Study|Lost to Follow-up|35|||
131858749|NCT01431079|474761012|FG001|Overall Study|Lost to Follow-up|39|||
131858750|NCT01626690|474761014|FG000|Overall Study|Protocol Violation|1|||
131858751|NCT01626690|474761015|FG001|Overall Study|Protocol Violation|0|||
131858752|NCT01626690|474761014|FG000|Overall Study|Adverse Event|1|||
131858753|NCT01626690|474761015|FG001|Overall Study|Adverse Event|0|||
131858754|NCT02038010|474761019|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
131858755|NCT02038010|474761020|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
131858756|NCT02038010|474761021|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
131858757|NCT02038010|474761022|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
131858758|NCT02038010|474761019|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
131858759|NCT02038010|474761020|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
131858760|NCT02038010|474761021|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
131858761|NCT02038010|474761022|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
131858762|NCT02038010|474761019|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
131858763|NCT02038010|474761020|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
131858764|NCT02038010|474761021|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
131858765|NCT02038010|474761022|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
131858766|NCT02038010|474761019|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
131858767|NCT02038010|474761020|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
131858768|NCT02038010|474761021|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
131858769|NCT02038010|474761022|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
131858770|NCT02038010|474761019|FG000|Follow Up|Death|4|||
131858771|NCT02038010|474761020|FG001|Follow Up|Death|3|||
131912891|NCT04009837|474967770|FG001|Overall Study|Withdrawal by Subject|4|||
131858772|NCT02038010|474761021|FG002|Follow Up|Death|0|||
131912892|NCT04009837|474967769|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
131912893|NCT04009837|474967770|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
131912894|NCT03530696|474967773|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
131912895|NCT03530696|474967774|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
131912896|NCT02472353|474967775|FG000|Overall Study|Lost to Follow-up|1|||
131912897|NCT02472353|474967776|FG001|Overall Study|Lost to Follow-up|1|||
131912898|NCT02472353|474967775|FG000|Overall Study|Withdrawal by Subject|2|||
131912899|NCT02472353|474967776|FG001|Overall Study|Withdrawal by Subject|1|||
131912900|NCT02472353|474967775|FG000|Overall Study|Study Termination|1|||
131912901|NCT02472353|474967776|FG001|Overall Study|Study Termination|4|||
131912902|NCT03416179|474967777|FG000|Overall Study|Death|90|||
131858773|NCT02038010|474761022|FG003|Follow Up|Death|0|||
131858774|NCT02038010|474761019|FG000|Follow Up|Other|3|||
131858775|NCT02038010|474761020|FG001|Follow Up|Other|0|||
131858776|NCT02038010|474761021|FG002|Follow Up|Other|0|||
131858777|NCT02038010|474761022|FG003|Follow Up|Other|0|||
131858778|NCT00110396|474761023|FG000|Overall Study|Adverse Event|15|||
131858779|NCT00110396|474761023|FG000|Overall Study|Lost to Follow-up|1|||
131858780|NCT00110396|474761023|FG000|Overall Study|Administration of plasmapheresis|1|||
131912903|NCT03416179|474967778|FG001|Overall Study|Death|87|||
131912904|NCT03416179|474967779|FG002|Overall Study|Death|117|||
131912905|NCT03416179|474967780|FG003|Overall Study|Death|113|||
131912906|NCT03416179|474967777|FG000|Overall Study|Withdrawal by Subject|15|||
131912907|NCT03416179|474967778|FG001|Overall Study|Withdrawal by Subject|20|||
131912908|NCT03416179|474967779|FG002|Overall Study|Withdrawal by Subject|6|||
131912909|NCT03416179|474967780|FG003|Overall Study|Withdrawal by Subject|9|||
131912910|NCT03416179|474967777|FG000|Overall Study|Lost to Follow-up|1|||
131912911|NCT03416179|474967778|FG001|Overall Study|Lost to Follow-up|1|||
131912912|NCT03416179|474967779|FG002|Overall Study|Lost to Follow-up|0|||
131912913|NCT03416179|474967780|FG003|Overall Study|Lost to Follow-up|3|||
131912914|NCT03416179|474967777|FG000|Overall Study|Study participation terminated by Sponsor|93|||
131912915|NCT03416179|474967778|FG001|Overall Study|Study participation terminated by Sponsor|91|||
131912916|NCT03416179|474967779|FG002|Overall Study|Study participation terminated by Sponsor|26|||
131912917|NCT03416179|474967780|FG003|Overall Study|Study participation terminated by Sponsor|31|||
131912918|NCT03416179|474967777|FG000|Overall Study|Other|2|||
131912919|NCT03416179|474967778|FG001|Overall Study|Other|3|||
131912920|NCT03416179|474967779|FG002|Overall Study|Other|1|||
131912921|NCT03416179|474967780|FG003|Overall Study|Other|0|||
131912922|NCT00639509|474967790|FG000|Overall Study|Death|1|||
131912923|NCT01933594|474967791|FG000|Overall Study|Lost to Follow-up|1|||
131912924|NCT01933594|474967792|FG001|Overall Study|Lost to Follow-up|0|||
131912925|NCT01933594|474967793|FG002|Overall Study|Lost to Follow-up|0|||
131912926|NCT01933594|474967794|FG003|Overall Study|Lost to Follow-up|0|||
131912927|NCT01933594|474967795|FG004|Overall Study|Lost to Follow-up|1|||
131912928|NCT01933594|474967796|FG005|Overall Study|Lost to Follow-up|0|||
131912929|NCT01933594|474967791|FG000|Overall Study|Ineligible for subsequent study step|0|||
131912930|NCT01933594|474967792|FG001|Overall Study|Ineligible for subsequent study step|0|||
131912931|NCT01933594|474967793|FG002|Overall Study|Ineligible for subsequent study step|0|||
131912932|NCT01933594|474967794|FG003|Overall Study|Ineligible for subsequent study step|0|||
131912933|NCT01933594|474967795|FG004|Overall Study|Ineligible for subsequent study step|1|||
131912934|NCT01933594|474967796|FG005|Overall Study|Ineligible for subsequent study step|0|||
131912935|NCT05049122|474967797|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
131912936|NCT05049122|474967797|FG000|Overall Study|Participant moved|1|||
131912937|NCT05049122|474967797|FG000|Overall Study|At the direction of the doctor|1|||
131912938|NCT05722015|474967806|FG000|Overall Study|Death|57|||
131912939|NCT05722015|474967807|FG001|Overall Study|Death|37|||
131912940|NCT05722015|474967806|FG000|Overall Study|Lost to Follow-up|1|||
131912941|NCT05722015|474967807|FG001|Overall Study|Lost to Follow-up|0|||
131912942|NCT05722015|474967806|FG000|Overall Study|Withdrawal by Subject|5|||
131912943|NCT05722015|474967807|FG001|Overall Study|Withdrawal by Subject|1|||
131858781|NCT00110396|474761023|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
131858782|NCT00110396|474761023|FG000|Overall Study|Lack of Efficacy|1|||
131858783|NCT00110396|474761023|FG000|Overall Study|Decided not to continue treatment|1|||
131858784|NCT00110396|474761023|FG000|Overall Study|Patient non-compliance|1|||
131858785|NCT00110396|474761023|FG000|Overall Study|Patient refused to continue|1|||
131858786|NCT00110396|474761023|FG000|Overall Study|Patient refused to participate|1|||
131858787|NCT00110396|474761023|FG000|Overall Study|Patient will|1|||
131858788|NCT00110396|474761023|FG000|Overall Study|Patient's decision|1|||
131858789|NCT00110396|474761023|FG000|Overall Study|Participation in MS vaccine study|1|||
131912944|NCT05722015|474967806|FG000|Overall Study|Participants Ongoing|188|||
131912945|NCT05722015|474967807|FG001|Overall Study|Participants Ongoing|88|||
131912946|NCT04513366|474967808|FG000|Treatment Phase|Withdrawal by Subject|6|||
131912947|NCT04513366|474967809|FG001|Treatment Phase|Withdrawal by Subject|8|||
131912948|NCT04513366|474967810|FG002|Treatment Phase|Withdrawal by Subject|3|||
131912949|NCT04513366|474967808|FG000|Treatment Phase|Lost to Follow-up|1|||
131912950|NCT04513366|474967809|FG001|Treatment Phase|Lost to Follow-up|2|||
131912951|NCT04513366|474967810|FG002|Treatment Phase|Lost to Follow-up|5|||
131912952|NCT04513366|474967808|FG000|Treatment Phase|Other than Specified|1|||
131912953|NCT04513366|474967809|FG001|Treatment Phase|Other than Specified|0|||
131912954|NCT04513366|474967810|FG002|Treatment Phase|Other than Specified|2|||
131912955|NCT04513366|474967808|FG000|Treatment Phase|Physician Decision|2|||
131912956|NCT04513366|474967809|FG001|Treatment Phase|Physician Decision|0|||
131912957|NCT04513366|474967810|FG002|Treatment Phase|Physician Decision|0|||
131912958|NCT04513366|474967808|FG000|Treatment Phase|Adverse Event|0|||
131912959|NCT04513366|474967809|FG001|Treatment Phase|Adverse Event|1|||
131407473|NCT03352557|473113426|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
131858790|NCT00110396|474761023|FG000|Overall Study|Pregnancy|1|||
131858791|NCT00110396|474761023|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
131912960|NCT04513366|474967810|FG002|Treatment Phase|Adverse Event|1|||
131912961|NCT04513366|474967808|FG000|Extension Phase|Withdrawal by Subject|3|||
131912962|NCT04513366|474967809|FG001|Extension Phase|Withdrawal by Subject|1|||
131912963|NCT04513366|474967810|FG002|Extension Phase|Withdrawal by Subject|1|||
131912964|NCT04513366|474967808|FG000|Extension Phase|Other than Specified|4|||
131912965|NCT04513366|474967809|FG001|Extension Phase|Other than Specified|0|||
131912966|NCT04513366|474967810|FG002|Extension Phase|Other than Specified|1|||
131912967|NCT04513366|474967808|FG000|Extension Phase|Lost to Follow-up|1|||
131912968|NCT04513366|474967809|FG001|Extension Phase|Lost to Follow-up|1|||
131912969|NCT04513366|474967810|FG002|Extension Phase|Lost to Follow-up|1|||
131912970|NCT04513366|474967808|FG000|Extension Phase|Sponsor Decision|0|||
131858792|NCT00110396|474761023|FG000|Overall Study|Protocol Violation|2|||
131858793|NCT00110396|474761023|FG000|Overall Study|Patient refused to come back|1|||
131858794|NCT00110396|474761023|FG000|Overall Study|The patient has refused|2|||
131858795|NCT00110396|474761023|FG000|Overall Study|The patient has refused to visit site|1|||
131858796|NCT00110396|474761023|FG000|Overall Study|Patient is to be administered copaxone|1|||
131858797|NCT01269918|474761024|FG000|Overall Study|Did not receive study drug|0|||
131858798|NCT01269918|474761025|FG001|Overall Study|Did not receive study drug|3|||
131912971|NCT04513366|474967809|FG001|Extension Phase|Sponsor Decision|1|||
131912972|NCT04513366|474967810|FG002|Extension Phase|Sponsor Decision|0|||
131912973|NCT04513366|474967808|FG000|Extension Phase|Death|0|||
131912974|NCT04513366|474967809|FG001|Extension Phase|Death|1|||
131912975|NCT04513366|474967810|FG002|Extension Phase|Death|0|||
131912976|NCT04513366|474967808|FG000|Extension Phase|Adverse Event|0|||
131912977|NCT04513366|474967809|FG001|Extension Phase|Adverse Event|0|||
131912978|NCT04513366|474967810|FG002|Extension Phase|Adverse Event|1|||
131912979|NCT02657551|474967813|FG000|Overall Study|Adverse Event|2|||
131912980|NCT02657551|474967813|FG000|Overall Study|Withdrawal by Subject|1|||
131912981|NCT02657551|474967813|FG000|Overall Study|Non-Compliance|1|||
131912982|NCT02657551|474967813|FG000|Overall Study|Progression / Relapse|4|||
131912983|NCT01832766|474967815|FG000|Washout|Lost to Follow-up|0|||
131912984|NCT01832766|474967816|FG001|Washout|Lost to Follow-up|1|||
131912985|NCT02916927|474967817|FG000|Overall Study|Discharged prior to study drug receipt|0|||
131912986|NCT02916927|474967818|FG001|Overall Study|Discharged prior to study drug receipt|2|||
131912987|NCT02916927|474967817|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
131912988|NCT02916927|474967818|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
131912989|NCT02916927|474967817|FG000|Overall Study|Withdrawal before first time point|1|||
131912990|NCT02916927|474967818|FG001|Overall Study|Withdrawal before first time point|0|||
131912991|NCT00655889|474967819|FG000|Overall Study|Inadequate cell growth|1|||
131912992|NCT00655889|474967819|FG000|Overall Study|Protocol Violation|1|||
131912993|NCT04585893|474967826|FG000|Overall Study|Death|1|||
131912994|NCT04585893|474967827|FG001|Overall Study|Death|0|||
131912995|NCT01366092|474967828|FG000|Overall Study|Progressive cGVHD|2|||
131912996|NCT01366092|474967828|FG000|Overall Study|Physician Decision|1|||
131912997|NCT01366092|474967828|FG000|Overall Study|Withdrawal by Subject|1|||
131912998|NCT03608163|474967829|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
131912999|NCT03608163|474967830|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
131913000|NCT04530630|474969269|FG000|Overall Study|Physician Decision|1|||
131913001|NCT03675308|474969272|FG000|Overall Study|Adverse Event|3|||
131913002|NCT03675308|474969273|FG001|Overall Study|Adverse Event|2|||
131913003|NCT03675308|474969272|FG000|Overall Study|Withdrawal by Subject|6|||
131913004|NCT03675308|474969273|FG001|Overall Study|Withdrawal by Subject|4|||
131913005|NCT03675308|474969272|FG000|Overall Study|Lost to Follow-up|3|||
131407474|NCT03352557|473113427|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407475|NCT03352557|473113428|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407476|NCT03352557|473113429|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407477|NCT03352557|473113430|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
131407478|NCT03352557|473113431|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407479|NCT03352557|473113432|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407480|NCT03352557|473113433|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407481|NCT03352557|473113434|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407482|NCT03352557|473113435|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
131407483|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Death|0|||
131407484|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Death|0|||
131407485|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Death|0|||
131407486|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Death|0|||
131407487|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Death|0|||
131407488|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Death|1|||
131858799|NCT01308424|474761027|FG000|Baseline Eligibility|Screen Failures|71|||
131858800|NCT01308424|474761028|FG001|Baseline Eligibility|Screen Failures|0|||
131858801|NCT01308424|474761029|FG002|Baseline Eligibility|Screen Failures|0|||
131858802|NCT01308424|474761027|FG000|Randomization|Adverse Event|0|||
131858803|NCT01308424|474761028|FG001|Randomization|Adverse Event|1|||
131858804|NCT01308424|474761029|FG002|Randomization|Adverse Event|1|||
131858805|NCT01308424|474761027|FG000|Randomization|Lost to Follow-up|0|||
131913006|NCT03675308|474969273|FG001|Overall Study|Lost to Follow-up|0|||
131407489|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Death|0|||
131407490|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Death|1|||
131407491|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Death|1|||
131407492|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Death|1|||
131407493|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407494|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131913007|NCT03675308|474969272|FG000|Overall Study|Lack of Efficacy|1|||
131913008|NCT03675308|474969273|FG001|Overall Study|Lack of Efficacy|1|||
131913009|NCT03675308|474969272|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
131913010|NCT03675308|474969273|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
131913011|NCT03675308|474969272|FG000|Overall Study|Other|0|||
131407495|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407496|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407497|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407498|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
131407499|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407500|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407501|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407502|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
131407503|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131407504|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131858806|NCT01308424|474761028|FG001|Randomization|Lost to Follow-up|1|||
131858807|NCT01308424|474761029|FG002|Randomization|Lost to Follow-up|0|||
131858808|NCT01308424|474761027|FG000|Randomization|Physician Decision|0|||
131858809|NCT01308424|474761028|FG001|Randomization|Physician Decision|1|||
131858810|NCT01308424|474761029|FG002|Randomization|Physician Decision|1|||
131858811|NCT03762239|474761030|FG000|Overall Study|Appointment to the doctor|1|||
131858812|NCT03762239|474761031|FG001|Overall Study|Appointment to the doctor|1|||
131858813|NCT00129545|474761041|FG000|Overall Study|Death|5|||
131858814|NCT00129545|474761042|FG001|Overall Study|Death|60|||
131858815|NCT00129545|474761043|FG002|Overall Study|Death|44|||
131858816|NCT00129545|474761041|FG000|Overall Study|Withdrawal by Subject|3|||
131858817|NCT00129545|474761042|FG001|Overall Study|Withdrawal by Subject|18|||
131858818|NCT00129545|474761043|FG002|Overall Study|Withdrawal by Subject|44|||
131858819|NCT00129545|474761041|FG000|Overall Study|Lost to Follow-up|2|||
131858820|NCT00129545|474761042|FG001|Overall Study|Lost to Follow-up|22|||
131858821|NCT00129545|474761043|FG002|Overall Study|Lost to Follow-up|13|||
131858822|NCT00129545|474761041|FG000|Overall Study|Physician Decision|0|||
131858823|NCT00129545|474761042|FG001|Overall Study|Physician Decision|3|||
131858824|NCT00129545|474761043|FG002|Overall Study|Physician Decision|10|||
131858825|NCT00129545|474761041|FG000|Overall Study|Device not implanted|16|||
131858826|NCT00129545|474761042|FG001|Overall Study|Device not implanted|61|||
131858827|NCT00129545|474761043|FG002|Overall Study|Device not implanted|0|||
131858828|NCT04660331|474761044|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
131858829|NCT04660331|474761045|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
131858830|NCT04660331|474761046|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
131858831|NCT03624192|474761051|FG000|Overall Study|Lost to Follow-up|1|||
131858832|NCT03624192|474761052|FG001|Overall Study|Lost to Follow-up|1|||
131858833|NCT01841593|474761053|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
131858834|NCT01841593|474761054|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
131858835|NCT01841593|474761053|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
131858836|NCT01841593|474761054|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
131858837|NCT02635984|474761055|FG000|Overall Study|Lost to Follow-up|2|||
131858838|NCT02635984|474761056|FG001|Overall Study|Lost to Follow-up|4|||
131858839|NCT02635984|474761055|FG000|Overall Study|Study Arm Closed|1|||
131858840|NCT02635984|474761056|FG001|Overall Study|Study Arm Closed|0|||
131858841|NCT00307086|474761057|FG000|Overall Study|ineligible|5|||
131858842|NCT01640249|474761060|FG000|Period 1|Withdrawal by Subject|1|||
131858843|NCT01640249|474761061|FG001|Period 1|Withdrawal by Subject|0|||
131858844|NCT01640249|474761062|FG002|Period 1|Withdrawal by Subject|0|||
131858845|NCT01640249|474761063|FG003|Period 1|Withdrawal by Subject|0|||
131858846|NCT01640249|474761064|FG004|Period 1|Withdrawal by Subject|0|||
131858847|NCT01640249|474761065|FG005|Period 1|Withdrawal by Subject|1|||
131858848|NCT01640249|474761066|FG006|Period 1|Withdrawal by Subject|0|||
131858849|NCT01870778|474761071|FG000|Overall Study|Withdrawal by Subject|8|||
131858850|NCT01870778|474761072|FG001|Overall Study|Withdrawal by Subject|7|||
131858851|NCT01870778|474761071|FG000|Overall Study|Lost to Follow-up|0|||
131858852|NCT01870778|474761072|FG001|Overall Study|Lost to Follow-up|2|||
131858853|NCT00065156|474761073|FG000|Overall Study|Adverse Event|37|||
131858854|NCT00065156|474761073|FG000|Overall Study|Lack of Efficacy|52|||
131858855|NCT00065156|474761073|FG000|Overall Study|Withdrawal by Subject|8|||
131858856|NCT00065156|474761073|FG000|Overall Study|Lost to Follow-up|1|||
131858857|NCT00065156|474761073|FG000|Overall Study|Death|11|||
131858858|NCT00065156|474761073|FG000|Overall Study|Study Closed by Sponsor|2|||
131858859|NCT00065156|474761073|FG000|Overall Study|Disease Progression|7|||
131858860|NCT00065156|474761073|FG000|Overall Study|Investigator Decision|2|||
131858861|NCT00065156|474761073|FG000|Overall Study|Non-Compliance|2|||
131858862|NCT00065156|474761073|FG000|Overall Study|Loss of Response|1|||
131407505|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131858863|NCT00065156|474761073|FG000|Overall Study|Secondary Malign Disease|1|||
131858864|NCT00312338|474761074|FG000|Overall Study|Adverse Event|7|||
131858865|NCT00312338|474761075|FG001|Overall Study|Adverse Event|2|||
131407506|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131858866|NCT00312338|474761074|FG000|Overall Study|Lost to Follow-up|9|||
131858867|NCT00312338|474761075|FG001|Overall Study|Lost to Follow-up|1|||
131858868|NCT00312338|474761074|FG000|Overall Study|Withdrawal by Subject|4|||
131858869|NCT00312338|474761075|FG001|Overall Study|Withdrawal by Subject|0|||
131407507|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131407508|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131407509|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131407510|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131407511|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
131407512|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
131407513|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
131407514|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
131407515|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
131407516|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
131407517|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
131407518|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
131407519|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
131407520|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
131407521|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
131407522|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
131407523|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407524|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407525|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407526|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407527|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407528|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
131407529|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
131407530|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
131407531|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
131407532|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
131407533|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407534|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407535|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407536|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407537|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407538|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407539|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407540|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407541|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
131407542|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
131407543|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
131407544|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
131407545|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
131913012|NCT03675308|474969273|FG001|Overall Study|Other|1|||
131913013|NCT01288430|474969277|FG000|Part 1|Progressive disease|2|||
131407546|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
131858870|NCT00312338|474761074|FG000|Overall Study|Subsequent infection|2|||
131858871|NCT00312338|474761075|FG001|Overall Study|Subsequent infection|0|||
131858872|NCT00262028|474761076|FG000|Overall Study|Withdrawal by Subject|6|||
131858873|NCT00262028|474761077|FG001|Overall Study|Withdrawal by Subject|3|||
131858874|NCT00262028|474761078|FG002|Overall Study|Withdrawal by Subject|6|||
131858875|NCT00262028|474761079|FG003|Overall Study|Withdrawal by Subject|5|||
131858876|NCT00262028|474761080|FG004|Overall Study|Withdrawal by Subject|2|||
131858877|NCT00262028|474761081|FG005|Overall Study|Withdrawal by Subject|3|||
131858878|NCT00262028|474761082|FG006|Overall Study|Withdrawal by Subject|5|||
131858879|NCT00262028|474761083|FG007|Overall Study|Withdrawal by Subject|7|||
131858880|NCT00262028|474761084|FG008|Overall Study|Withdrawal by Subject|2|||
131858881|NCT00262028|474761076|FG000|Overall Study|Lost to Follow-up|7|||
131858882|NCT00262028|474761077|FG001|Overall Study|Lost to Follow-up|7|||
131858883|NCT00262028|474761078|FG002|Overall Study|Lost to Follow-up|5|||
131858884|NCT00262028|474761079|FG003|Overall Study|Lost to Follow-up|5|||
131858885|NCT00262028|474761080|FG004|Overall Study|Lost to Follow-up|4|||
131858886|NCT00262028|474761081|FG005|Overall Study|Lost to Follow-up|3|||
131858887|NCT00262028|474761082|FG006|Overall Study|Lost to Follow-up|3|||
131858888|NCT00262028|474761083|FG007|Overall Study|Lost to Follow-up|5|||
131858889|NCT00262028|474761084|FG008|Overall Study|Lost to Follow-up|6|||
131858890|NCT00262028|474761076|FG000|Overall Study|Administrative Reason|11|||
131858891|NCT00262028|474761077|FG001|Overall Study|Administrative Reason|14|||
131858892|NCT00262028|474761078|FG002|Overall Study|Administrative Reason|9|||
131858893|NCT00262028|474761079|FG003|Overall Study|Administrative Reason|12|||
131858894|NCT00262028|474761080|FG004|Overall Study|Administrative Reason|6|||
131858895|NCT00262028|474761081|FG005|Overall Study|Administrative Reason|7|||
131858896|NCT00262028|474761082|FG006|Overall Study|Administrative Reason|4|||
131858897|NCT00262028|474761083|FG007|Overall Study|Administrative Reason|6|||
131858898|NCT00262028|474761084|FG008|Overall Study|Administrative Reason|10|||
131858899|NCT00262028|474761076|FG000|Overall Study|Protocol Violation|0|||
131858900|NCT00262028|474761077|FG001|Overall Study|Protocol Violation|0|||
131858901|NCT00262028|474761078|FG002|Overall Study|Protocol Violation|0|||
131858902|NCT00262028|474761079|FG003|Overall Study|Protocol Violation|1|||
131858903|NCT00262028|474761080|FG004|Overall Study|Protocol Violation|0|||
131858904|NCT00262028|474761081|FG005|Overall Study|Protocol Violation|0|||
131858905|NCT00262028|474761082|FG006|Overall Study|Protocol Violation|0|||
131858906|NCT00262028|474761083|FG007|Overall Study|Protocol Violation|0|||
131858907|NCT00262028|474761084|FG008|Overall Study|Protocol Violation|0|||
131858908|NCT00262028|474761076|FG000|Overall Study|Unable to classify|0|||
131858909|NCT00262028|474761077|FG001|Overall Study|Unable to classify|3|||
131858910|NCT00262028|474761078|FG002|Overall Study|Unable to classify|0|||
131858911|NCT00262028|474761079|FG003|Overall Study|Unable to classify|0|||
131858912|NCT00262028|474761080|FG004|Overall Study|Unable to classify|0|||
131858913|NCT00262028|474761081|FG005|Overall Study|Unable to classify|0|||
131858914|NCT00262028|474761082|FG006|Overall Study|Unable to classify|0|||
131858915|NCT00262028|474761083|FG007|Overall Study|Unable to classify|0|||
131858916|NCT00262028|474761084|FG008|Overall Study|Unable to classify|1|||
131858917|NCT02308124|474761085|FG000|Overall Study|Lost to Follow-up|6|||
131858918|NCT02308124|474761086|FG001|Overall Study|Lost to Follow-up|6|||
131858919|NCT02308124|474761087|FG002|Overall Study|Lost to Follow-up|6|||
131858920|NCT02308124|474761085|FG000|Overall Study|Adverse Event|0|||
131858921|NCT02308124|474761086|FG001|Overall Study|Adverse Event|2|||
131858922|NCT02308124|474761087|FG002|Overall Study|Adverse Event|2|||
131858923|NCT01329900|474761100|FG000|Overall Study|Elevated creatinine/renal function|1|||
131858924|NCT01876446|474761107|FG000|Overall Study|Death|0|||
131858925|NCT01876446|474761108|FG001|Overall Study|Death|1|||
131858926|NCT01876446|474761107|FG000|Overall Study|Withdrawal by Subject|1|||
131858927|NCT01876446|474761108|FG001|Overall Study|Withdrawal by Subject|2|||
131858928|NCT01876446|474761107|FG000|Overall Study|Physician Decision|1|||
131858929|NCT01876446|474761108|FG001|Overall Study|Physician Decision|3|||
131858930|NCT00822692|474761111|FG000|Overall Study|Lost to Follow-up|17|||
131858931|NCT00822692|474761112|FG001|Overall Study|Lost to Follow-up|25|||
131858932|NCT03629184|474761113|FG000|Overall Study|Withdrawal by Subject|2|||
131858933|NCT03629184|474761114|FG001|Overall Study|Withdrawal by Subject|1|||
131858934|NCT03629184|474761113|FG000|Overall Study|Physician Decision|1|||
131858935|NCT03629184|474761114|FG001|Overall Study|Physician Decision|0|||
131858936|NCT01245283|474761116|FG000|Overall Study|Lost to Follow-up|14|||
131858937|NCT01245283|474761117|FG001|Overall Study|Lost to Follow-up|11|||
131858938|NCT01245283|474761118|FG002|Overall Study|Lost to Follow-up|11|||
131858939|NCT01610492|474761121|FG000|Overall Study|Adverse Event|1|||
131858940|NCT01610492|474761121|FG000|Overall Study|Lack of Efficacy|3|||
131858941|NCT01610492|474761121|FG000|Overall Study|Other: Reached stopping criteria|1|||
131858942|NCT01610492|474761121|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
131858943|NCT01982955|474761122|FG000|Overall Study|Randomized but not treated|0|||
131858944|NCT01982955|474761123|FG001|Overall Study|Randomized but not treated|0|||
131858945|NCT01982955|474761124|FG002|Overall Study|Randomized but not treated|0|||
131858946|NCT01982955|474761125|FG003|Overall Study|Randomized but not treated|1|||
131858947|NCT01982955|474761126|FG004|Overall Study|Randomized but not treated|0|||
131858948|NCT03642262|474762884|FG000|Period 1|Withdrawal by Subject|1|||
131858949|NCT03642262|474762885|FG001|Period 1|Withdrawal by Subject|1|||
131858950|NCT03642262|474762884|FG000|Period 1|Adverse Event|0|||
131858951|NCT03642262|474762885|FG001|Period 1|Adverse Event|1|||
131858952|NCT04515147|474762886|FG000|Overall Study|Withdrawal by Subject|1|||
131858953|NCT04515147|474762887|FG001|Overall Study|Withdrawal by Subject|0|||
131858954|NCT04515147|474762888|FG002|Overall Study|Withdrawal by Subject|10|||
131858955|NCT04515147|474762889|FG003|Overall Study|Withdrawal by Subject|18|||
131858956|NCT04515147|474762890|FG004|Overall Study|Withdrawal by Subject|1|||
131858957|NCT04515147|474762891|FG005|Overall Study|Withdrawal by Subject|8|||
131858958|NCT04515147|474762886|FG000|Overall Study|Lost to Follow-up|0|||
131858959|NCT04515147|474762887|FG001|Overall Study|Lost to Follow-up|1|||
131858960|NCT04515147|474762888|FG002|Overall Study|Lost to Follow-up|5|||
131858961|NCT04515147|474762889|FG003|Overall Study|Lost to Follow-up|6|||
131858962|NCT04515147|474762890|FG004|Overall Study|Lost to Follow-up|2|||
131858963|NCT04515147|474762891|FG005|Overall Study|Lost to Follow-up|1|||
131858964|NCT04515147|474762886|FG000|Overall Study|Adverse Event|0|||
131858965|NCT04515147|474762887|FG001|Overall Study|Adverse Event|0|||
131858966|NCT04515147|474762888|FG002|Overall Study|Adverse Event|0|||
131858967|NCT04515147|474762889|FG003|Overall Study|Adverse Event|2|||
131858968|NCT04515147|474762890|FG004|Overall Study|Adverse Event|0|||
131858969|NCT04515147|474762891|FG005|Overall Study|Adverse Event|0|||
131858970|NCT04515147|474762886|FG000|Overall Study|Miscellaneous|0|||
131858971|NCT04515147|474762887|FG001|Overall Study|Miscellaneous|0|||
131858972|NCT04515147|474762888|FG002|Overall Study|Miscellaneous|0|||
131858973|NCT04515147|474762889|FG003|Overall Study|Miscellaneous|1|||
131858974|NCT04515147|474762890|FG004|Overall Study|Miscellaneous|0|||
131858975|NCT04515147|474762891|FG005|Overall Study|Miscellaneous|1|||
131858976|NCT03052751|474762892|FG000|Dosing Period 1|Adverse Event|0|||
131858977|NCT03052751|474762893|FG001|Dosing Period 1|Adverse Event|1|||
131858978|NCT03052751|474762894|FG002|Dosing Period 1|Adverse Event|0|||
131858979|NCT03052751|474762895|FG003|Dosing Period 1|Adverse Event|0|||
131858980|NCT03052751|474762896|FG004|Dosing Period 1|Adverse Event|0|||
131858981|NCT03052751|474762897|FG005|Dosing Period 1|Adverse Event|0|||
131858982|NCT03052751|474762892|FG000|Dosing Period 2|Adverse Event|0|||
131858983|NCT03052751|474762893|FG001|Dosing Period 2|Adverse Event|0|||
131858984|NCT03052751|474762894|FG002|Dosing Period 2|Adverse Event|3|||
131858985|NCT03052751|474762895|FG003|Dosing Period 2|Adverse Event|0|||
131858986|NCT03052751|474762896|FG004|Dosing Period 2|Adverse Event|0|||
131858987|NCT03052751|474762897|FG005|Dosing Period 2|Adverse Event|0|||
131858988|NCT03052751|474762892|FG000|Observation Period|Adverse Event|0|||
131858989|NCT03052751|474762893|FG001|Observation Period|Adverse Event|0|||
131858990|NCT03052751|474762894|FG002|Observation Period|Adverse Event|0|||
131858991|NCT03052751|474762895|FG003|Observation Period|Adverse Event|0|||
131858992|NCT03052751|474762896|FG004|Observation Period|Adverse Event|1|||
131858993|NCT03052751|474762897|FG005|Observation Period|Adverse Event|0|||
131858994|NCT02719184|474762898|FG000|Overall Study|Other than listed|1|||
131858995|NCT02719184|474762899|FG001|Overall Study|Other than listed|12|||
131858996|NCT02719184|474762900|FG002|Overall Study|Other than listed|13|||
131858997|NCT02719184|474762901|FG003|Overall Study|Other than listed|22|||
131858998|NCT02719184|474762902|FG004|Overall Study|Other than listed|9|||
131858999|NCT02719184|474762898|FG000|Overall Study|Withdrawal by Subject|5|||
131859000|NCT02719184|474762899|FG001|Overall Study|Withdrawal by Subject|3|||
131859001|NCT02719184|474762900|FG002|Overall Study|Withdrawal by Subject|6|||
131859002|NCT02719184|474762901|FG003|Overall Study|Withdrawal by Subject|6|||
131859003|NCT02719184|474762902|FG004|Overall Study|Withdrawal by Subject|0|||
131859004|NCT02719184|474762898|FG000|Overall Study|Lost to Follow-up|0|||
131859005|NCT02719184|474762899|FG001|Overall Study|Lost to Follow-up|4|||
131859006|NCT02719184|474762900|FG002|Overall Study|Lost to Follow-up|1|||
131859007|NCT02719184|474762901|FG003|Overall Study|Lost to Follow-up|3|||
131859008|NCT02719184|474762902|FG004|Overall Study|Lost to Follow-up|0|||
131859009|NCT02719184|474762898|FG000|Overall Study|Protocol Violation|0|||
131859010|NCT02719184|474762899|FG001|Overall Study|Protocol Violation|3|||
131859011|NCT02719184|474762900|FG002|Overall Study|Protocol Violation|0|||
131859012|NCT02719184|474762901|FG003|Overall Study|Protocol Violation|2|||
131859013|NCT02719184|474762902|FG004|Overall Study|Protocol Violation|0|||
131859014|NCT02719184|474762898|FG000|Overall Study|Adverse Event|0|||
131859015|NCT02719184|474762899|FG001|Overall Study|Adverse Event|0|||
131859016|NCT02719184|474762900|FG002|Overall Study|Adverse Event|0|||
131859017|NCT02719184|474762901|FG003|Overall Study|Adverse Event|3|||
131859018|NCT02719184|474762902|FG004|Overall Study|Adverse Event|0|||
131859019|NCT02439216|474762903|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
131859020|NCT02439216|474762904|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859021|NCT02439216|474762905|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859022|NCT02439216|474762906|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859023|NCT02439216|474762907|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859024|NCT02439216|474762908|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859025|NCT02439216|474762909|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859026|NCT02439216|474762910|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859027|NCT02439216|474762911|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
131859028|NCT02439216|474762903|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859029|NCT02439216|474762904|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859030|NCT02439216|474762905|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859031|NCT02439216|474762906|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859032|NCT02439216|474762907|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859033|NCT02439216|474762908|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859034|NCT02439216|474762909|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131859035|NCT02439216|474762910|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
131859036|NCT02439216|474762911|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
131407547|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
131407548|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
131859037|NCT02439216|474762903|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131407549|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
131859038|NCT02439216|474762904|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131859039|NCT02439216|474762905|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131859040|NCT02439216|474762906|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131859041|NCT02439216|474762907|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131859042|NCT02439216|474762908|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131859043|NCT02439216|474762909|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
131859044|NCT02439216|474762910|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
131859045|NCT02439216|474762911|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
131859046|NCT02439216|474762903|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859047|NCT02439216|474762904|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859048|NCT02439216|474762905|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859049|NCT02439216|474762906|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859050|NCT02439216|474762907|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859051|NCT02439216|474762908|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859052|NCT02439216|474762909|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131407550|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
131407551|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
131407552|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
131407553|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407554|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407555|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407556|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407557|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407558|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407559|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407560|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
131407561|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
131407562|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
131407563|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407564|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407565|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407566|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407567|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407568|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407569|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131913014|NCT01288430|474969278|FG001|Part 1|Progressive disease|1|||
131913015|NCT01288430|474969279|FG002|Part 1|Progressive disease|1|||
131913016|NCT01288430|474969280|FG003|Part 1|Progressive disease|6|||
131913017|NCT01288430|474969281|FG004|Part 1|Progressive disease|2|||
131913018|NCT01288430|474969282|FG005|Part 1|Progressive disease|4|||
131913019|NCT01288430|474969283|FG006|Part 1|Progressive disease|2|||
131913020|NCT01288430|474969284|FG007|Part 1|Progressive disease|0|||
131913021|NCT01288430|474969285|FG008|Part 1|Progressive disease|0|||
131407570|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
131407571|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407572|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
131407573|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407574|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407575|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407576|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407577|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407578|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407579|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407580|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
131407581|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407582|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
131407583|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407584|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407585|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131434001|NCT00985465|473214594|FG001|Overall Study|Considered to be part of the other group|1|||
131859053|NCT02439216|474762910|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
131859054|NCT02439216|474762911|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
131859055|NCT02439216|474762903|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859056|NCT02439216|474762904|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859057|NCT02439216|474762905|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859058|NCT02439216|474762906|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859059|NCT02439216|474762907|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859060|NCT02439216|474762908|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859061|NCT02439216|474762909|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
131859062|NCT02439216|474762910|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
131859063|NCT02439216|474762911|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
131859064|NCT02094300|474762912|FG000|Overall Study|Death|7|||
131859065|NCT02094300|474762912|FG000|Overall Study|Lost to Follow-up|10|||
131859066|NCT02094300|474762912|FG000|Overall Study|Still be eligible for follow-up|3|||
131859067|NCT02288312|474762916|FG000|Overall Study|Pregnancy|1|||
131859068|NCT02288312|474762917|FG001|Overall Study|Pregnancy|0|||
131859069|NCT02288312|474762918|FG002|Overall Study|Pregnancy|0|||
131859070|NCT00485264|474762923|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
131859071|NCT00485264|474762924|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
131859072|NCT00485264|474762925|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
131859073|NCT00485264|474762926|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
131859074|NCT00485264|474762927|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
131859075|NCT00485264|474762928|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
131859076|NCT00485264|474762923|FG000|Overall Study|Death|1|||
131859077|NCT00485264|474762924|FG001|Overall Study|Death|0|||
131859078|NCT00485264|474762925|FG002|Overall Study|Death|0|||
131859079|NCT00485264|474762926|FG003|Overall Study|Death|0|||
131859080|NCT00485264|474762927|FG004|Overall Study|Death|1|||
131859081|NCT00485264|474762928|FG005|Overall Study|Death|0|||
131859082|NCT00485264|474762923|FG000|Overall Study|Adverse Event|1|||
131859083|NCT00485264|474762924|FG001|Overall Study|Adverse Event|0|||
131859084|NCT00485264|474762925|FG002|Overall Study|Adverse Event|2|||
131859085|NCT00485264|474762926|FG003|Overall Study|Adverse Event|3|||
131859086|NCT00485264|474762927|FG004|Overall Study|Adverse Event|1|||
131859087|NCT00485264|474762928|FG005|Overall Study|Adverse Event|3|||
131859088|NCT00485264|474762923|FG000|Overall Study|Pregnancy|4|||
131859089|NCT00485264|474762924|FG001|Overall Study|Pregnancy|0|||
131859090|NCT00485264|474762925|FG002|Overall Study|Pregnancy|0|||
131859091|NCT00485264|474762926|FG003|Overall Study|Pregnancy|0|||
131859092|NCT00485264|474762927|FG004|Overall Study|Pregnancy|0|||
131859093|NCT00485264|474762928|FG005|Overall Study|Pregnancy|0|||
131859094|NCT00485264|474762923|FG000|Overall Study|Disallowed Medication|0|||
131859095|NCT00485264|474762924|FG001|Overall Study|Disallowed Medication|0|||
131859096|NCT00485264|474762925|FG002|Overall Study|Disallowed Medication|0|||
131859097|NCT00485264|474762926|FG003|Overall Study|Disallowed Medication|0|||
131859098|NCT00485264|474762927|FG004|Overall Study|Disallowed Medication|0|||
131407586|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407587|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407588|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407589|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407590|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
131407591|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
131407592|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
131407593|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407594|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407595|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407596|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407597|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407598|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
131407599|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407600|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131407601|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
131407602|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
131859099|NCT00485264|474762928|FG005|Overall Study|Disallowed Medication|1|||
131859100|NCT00485264|474762923|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
131859101|NCT00485264|474762924|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
131859102|NCT00485264|474762925|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
131859103|NCT00485264|474762926|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
131859104|NCT00485264|474762927|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
131859105|NCT00485264|474762928|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
131859106|NCT00485264|474762923|FG000|Overall Study|Lack of Efficacy|0|||
131859107|NCT00485264|474762924|FG001|Overall Study|Lack of Efficacy|1|||
131859108|NCT00485264|474762925|FG002|Overall Study|Lack of Efficacy|0|||
131859109|NCT00485264|474762926|FG003|Overall Study|Lack of Efficacy|0|||
131859110|NCT00485264|474762927|FG004|Overall Study|Lack of Efficacy|0|||
131859111|NCT00485264|474762928|FG005|Overall Study|Lack of Efficacy|0|||
131859112|NCT00485264|474762923|FG000|Overall Study|Guardian Consent Withdrawn|1|||
131859113|NCT00485264|474762924|FG001|Overall Study|Guardian Consent Withdrawn|0|||
131859114|NCT00485264|474762925|FG002|Overall Study|Guardian Consent Withdrawn|0|||
131859115|NCT00485264|474762926|FG003|Overall Study|Guardian Consent Withdrawn|0|||
131859116|NCT00485264|474762927|FG004|Overall Study|Guardian Consent Withdrawn|1|||
131859117|NCT00485264|474762928|FG005|Overall Study|Guardian Consent Withdrawn|0|||
131859118|NCT00485264|474762923|FG000|Overall Study|Physician Decision|0|||
131859119|NCT00485264|474762924|FG001|Overall Study|Physician Decision|2|||
131859120|NCT00485264|474762925|FG002|Overall Study|Physician Decision|0|||
131859121|NCT00485264|474762926|FG003|Overall Study|Physician Decision|0|||
131859122|NCT00485264|474762927|FG004|Overall Study|Physician Decision|0|||
131859123|NCT00485264|474762928|FG005|Overall Study|Physician Decision|0|||
131859124|NCT00485264|474762923|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
131859125|NCT00485264|474762924|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
131859126|NCT00485264|474762925|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
131859127|NCT00485264|474762926|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
131859128|NCT00485264|474762927|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
131859129|NCT00485264|474762928|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
131859130|NCT00485264|474762923|FG000|Overall Study|Not Able to Attend Clinic|5|||
131859131|NCT00485264|474762924|FG001|Overall Study|Not Able to Attend Clinic|0|||
131859132|NCT00485264|474762925|FG002|Overall Study|Not Able to Attend Clinic|0|||
131859133|NCT00485264|474762926|FG003|Overall Study|Not Able to Attend Clinic|1|||
131859134|NCT00485264|474762927|FG004|Overall Study|Not Able to Attend Clinic|1|||
131859135|NCT00485264|474762928|FG005|Overall Study|Not Able to Attend Clinic|2|||
131859136|NCT00485264|474762923|FG000|Overall Study|Non-Compliant|17|||
131859137|NCT00485264|474762924|FG001|Overall Study|Non-Compliant|2|||
131859138|NCT00485264|474762925|FG002|Overall Study|Non-Compliant|1|||
131859139|NCT00485264|474762926|FG003|Overall Study|Non-Compliant|0|||
131859140|NCT00485264|474762927|FG004|Overall Study|Non-Compliant|1|||
131859141|NCT00485264|474762928|FG005|Overall Study|Non-Compliant|0|||
131859142|NCT00485264|474762923|FG000|Overall Study|Lost to Follow-up|2|||
131859143|NCT00485264|474762924|FG001|Overall Study|Lost to Follow-up|1|||
131859144|NCT00485264|474762925|FG002|Overall Study|Lost to Follow-up|1|||
131859145|NCT00485264|474762926|FG003|Overall Study|Lost to Follow-up|0|||
131859146|NCT00485264|474762927|FG004|Overall Study|Lost to Follow-up|0|||
131859147|NCT00485264|474762928|FG005|Overall Study|Lost to Follow-up|1|||
131859148|NCT00485264|474762923|FG000|Overall Study|Other Reason|3|||
131859149|NCT00485264|474762924|FG001|Overall Study|Other Reason|0|||
131859150|NCT00485264|474762925|FG002|Overall Study|Other Reason|0|||
131859151|NCT00485264|474762926|FG003|Overall Study|Other Reason|0|||
131859152|NCT00485264|474762927|FG004|Overall Study|Other Reason|0|||
131859153|NCT00485264|474762928|FG005|Overall Study|Other Reason|0|||
131859154|NCT00654095|474762930|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
131859155|NCT00654095|474762930|FG000|Overall Study|Elevated triglyceride level (2)|1|||
131859156|NCT00654095|474762930|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
131859157|NCT00654095|474762930|FG000|Overall Study|Adverse Event|11|||
131859158|NCT00654095|474762930|FG000|Overall Study|Withdrawal by Subject|5|||
131859159|NCT00654095|474762930|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
131859160|NCT00654095|474762930|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
131859161|NCT00654095|474762930|FG000|Overall Study|Did not meet inclusion criteria|1|||
131859162|NCT02414958|474762941|FG000|Overall Study|Adverse Event|6|||
131859163|NCT02414958|474762942|FG001|Overall Study|Adverse Event|6|||
131859164|NCT02414958|474762943|FG002|Overall Study|Adverse Event|3|||
131859165|NCT02414958|474762941|FG000|Overall Study|Protocol Violation|10|||
131859166|NCT02414958|474762942|FG001|Overall Study|Protocol Violation|3|||
131859167|NCT02414958|474762943|FG002|Overall Study|Protocol Violation|1|||
131407603|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131859168|NCT02414958|474762941|FG000|Overall Study|Lost to Follow-up|7|||
131859169|NCT02414958|474762942|FG001|Overall Study|Lost to Follow-up|4|||
131859170|NCT02414958|474762943|FG002|Overall Study|Lost to Follow-up|0|||
131859171|NCT02414958|474762941|FG000|Overall Study|Withdrawal by Subject|5|||
131859172|NCT02414958|474762942|FG001|Overall Study|Withdrawal by Subject|3|||
131859173|NCT02414958|474762943|FG002|Overall Study|Withdrawal by Subject|5|||
131859174|NCT02414958|474762941|FG000|Overall Study|Other than specified|4|||
131859175|NCT02414958|474762942|FG001|Overall Study|Other than specified|4|||
131859176|NCT02414958|474762943|FG002|Overall Study|Other than specified|5|||
131859177|NCT00245466|474762944|FG000|Overall Study|Adverse Event|2|||
131434002|NCT04701333|473214595|FG000|Overall Study|Lost to Follow-up|3|||
131859178|NCT00245466|474762945|FG001|Overall Study|Adverse Event|8|||
131859179|NCT00245466|474762946|FG002|Overall Study|Adverse Event|4|||
131859180|NCT00245466|474762944|FG000|Overall Study|Low prostate specific antigen suppr|16|||
131859181|NCT00245466|474762945|FG001|Overall Study|Low prostate specific antigen suppr|14|||
131859182|NCT00245466|474762946|FG002|Overall Study|Low prostate specific antigen suppr|5|||
131859183|NCT00245466|474762944|FG000|Overall Study|Insufficient testosterone suppr|12|||
131859184|NCT00245466|474762945|FG001|Overall Study|Insufficient testosterone suppr|12|||
131859185|NCT00245466|474762946|FG002|Overall Study|Insufficient testosterone suppr|21|||
131859186|NCT00245466|474762944|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
131859187|NCT00245466|474762945|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
131859188|NCT00245466|474762946|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
131859189|NCT00245466|474762944|FG000|Overall Study|Withdrawal by Subject|2|||
131859190|NCT00245466|474762945|FG001|Overall Study|Withdrawal by Subject|2|||
131859191|NCT00245466|474762946|FG002|Overall Study|Withdrawal by Subject|1|||
131859192|NCT00245466|474762944|FG000|Overall Study|Lost to Follow-up|3|||
131859193|NCT00245466|474762945|FG001|Overall Study|Lost to Follow-up|0|||
131859194|NCT00245466|474762946|FG002|Overall Study|Lost to Follow-up|0|||
131859195|NCT00245466|474762944|FG000|Overall Study|Disease progression|0|||
131859196|NCT00245466|474762945|FG001|Overall Study|Disease progression|3|||
131859197|NCT00245466|474762946|FG002|Overall Study|Disease progression|1|||
131407604|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131859198|NCT00245466|474762944|FG000|Overall Study|Protocol Violation|1|||
131859199|NCT00245466|474762945|FG001|Overall Study|Protocol Violation|2|||
131859200|NCT00245466|474762946|FG002|Overall Study|Protocol Violation|2|||
131859201|NCT00245466|474762944|FG000|Overall Study|Death|0|||
131859202|NCT00245466|474762945|FG001|Overall Study|Death|2|||
131407605|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131407606|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131407607|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131407608|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131407609|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131407610|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131407611|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
131859203|NCT00245466|474762946|FG002|Overall Study|Death|0|||
131859204|NCT00245466|474762944|FG000|Overall Study|Administrative reasons|0|||
131859205|NCT00245466|474762945|FG001|Overall Study|Administrative reasons|1|||
131859206|NCT00245466|474762946|FG002|Overall Study|Administrative reasons|0|||
131859207|NCT01958437|474762947|FG000|Overall Study|Incidental MRI findings|0|||
131859208|NCT01958437|474762948|FG001|Overall Study|Incidental MRI findings|0|||
131859209|NCT01958437|474762949|FG002|Overall Study|Incidental MRI findings|1|||
131859210|NCT01958437|474762950|FG003|Overall Study|Incidental MRI findings|1|||
131859211|NCT04886596|474762953|FG000|Overall Study|Adverse Event|442|||
131859212|NCT04886596|474762954|FG001|Overall Study|Adverse Event|441|||
131859213|NCT04886596|474762953|FG000|Overall Study|Lost to Follow-up|448|||
131859214|NCT04886596|474762954|FG001|Overall Study|Lost to Follow-up|465|||
131859215|NCT04886596|474762953|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
131859216|NCT04886596|474762954|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
131859217|NCT04886596|474762953|FG000|Overall Study|Migrated/moved from the study area|201|||
131859218|NCT04886596|474762954|FG001|Overall Study|Migrated/moved from the study area|184|||
131859219|NCT04886596|474762953|FG000|Overall Study|Other|298|||
131859220|NCT04886596|474762954|FG001|Overall Study|Other|326|||
131859221|NCT00948155|474762958|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
131859222|NCT00948155|474762959|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
131859223|NCT00948155|474762958|FG000|Washout 14 Days|Lost to Follow-up|1|||
131859224|NCT00948155|474762959|FG001|Washout 14 Days|Lost to Follow-up|2|||
131859225|NCT04620746|474762960|FG000|Overall Study|Adverse Event|2|||
131859226|NCT04620746|474762961|FG001|Overall Study|Adverse Event|0|||
131859227|NCT04620746|474762960|FG000|Overall Study|Uniterpretable skin test|1|||
131859228|NCT04620746|474762961|FG001|Overall Study|Uniterpretable skin test|0|||
131407612|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
131859229|NCT04620746|474762960|FG000|Overall Study|Withdrawal by Subject|0|||
131859230|NCT04620746|474762961|FG001|Overall Study|Withdrawal by Subject|1|||
131859231|NCT03473925|474762962|FG000|Overall Study|Death|48|||
131407613|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131407614|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131859232|NCT03473925|474762963|FG001|Overall Study|Death|44|||
131859233|NCT03473925|474762962|FG000|Overall Study|Sponsor Decision|2|||
131407615|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131453837|NCT05767749|473290048|FG001|Overall Study|Withdrawal by Subject|0|||
131859234|NCT03473925|474762963|FG001|Overall Study|Sponsor Decision|7|||
131859235|NCT03473925|474762962|FG000|Overall Study|Withdrawal by Subject|1|||
131859236|NCT03473925|474762963|FG001|Overall Study|Withdrawal by Subject|3|||
131859237|NCT03473925|474762962|FG000|Overall Study|Not Treated|1|||
131859238|NCT03473925|474762963|FG001|Overall Study|Not Treated|1|||
131859239|NCT03411863|474762964|FG000|Overall Study|Withdrawal by Subject|3|||
131859240|NCT03411863|474762965|FG001|Overall Study|Withdrawal by Subject|1|||
131859241|NCT03411863|474762964|FG000|Overall Study|Physician Decision|0|||
131859242|NCT03411863|474762965|FG001|Overall Study|Physician Decision|1|||
131859243|NCT05767905|474762970|FG000|Overall Study|Adverse Event|0|||
131859244|NCT05767905|474762971|FG001|Overall Study|Adverse Event|0|||
131859245|NCT05767905|474762972|FG002|Overall Study|Adverse Event|1|||
131859246|NCT02756611|474762974|FG000|Overall Study|Death|70|||
131859247|NCT02756611|474762974|FG000|Overall Study|Withdrawal by Subject|2|||
131859248|NCT02756611|474762974|FG000|Overall Study|Lost to Follow-up|3|||
131407616|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131407617|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131407618|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131407619|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131407620|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
131407621|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
131407622|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
131407623|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407624|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407625|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407626|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407627|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407628|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407629|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407630|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
131407631|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
131407632|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
131407633|NCT03352557|473113426|FG000|LTE Period: Week 80 to Week 173|Other|0|||
131407634|NCT03352557|473113427|FG001|LTE Period: Week 80 to Week 173|Other|0|||
131407635|NCT03352557|473113428|FG002|LTE Period: Week 80 to Week 173|Other|0|||
131407636|NCT03352557|473113429|FG003|LTE Period: Week 80 to Week 173|Other|0|||
131407637|NCT03352557|473113430|FG004|LTE Period: Week 80 to Week 173|Other|0|||
131407638|NCT03352557|473113431|FG005|LTE Period: Week 80 to Week 173|Other|0|||
131407639|NCT03352557|473113432|FG006|LTE Period: Week 80 to Week 173|Other|0|||
131407640|NCT03352557|473113433|FG007|LTE Period: Week 80 to Week 173|Other|1|||
131407641|NCT03352557|473113434|FG008|LTE Period: Week 80 to Week 173|Other|0|||
131407642|NCT03352557|473113435|FG009|LTE Period: Week 80 to Week 173|Other|0|||
131407643|NCT04065074|473113441|FG000|Overall Study|Adverse Event|1|||
131407644|NCT04065074|473113441|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
131407645|NCT00916058|473113442|FG000|Phase 1|Screen Failure|0|||
131407646|NCT00916058|473113443|FG001|Phase 1|Screen Failure|0|||
131407647|NCT00916058|473113444|FG002|Phase 1|Screen Failure|0|||
131407648|NCT00916058|473113445|FG003|Phase 1|Screen Failure|0|||
131407649|NCT00916058|473113446|FG004|Phase 1|Screen Failure|0|||
131407650|NCT00916058|473113447|FG005|Phase 1|Screen Failure|1|||
131407651|NCT00916058|473113448|FG006|Phase 1|Screen Failure|0|||
131407652|NCT00916058|473113442|FG000|Phase 2|Screen Failure|0|||
131407653|NCT00916058|473113443|FG001|Phase 2|Screen Failure|0|||
131407654|NCT00916058|473113444|FG002|Phase 2|Screen Failure|0|||
131407655|NCT00916058|473113445|FG003|Phase 2|Screen Failure|0|||
131407656|NCT00916058|473113446|FG004|Phase 2|Screen Failure|0|||
131407657|NCT00916058|473113447|FG005|Phase 2|Screen Failure|0|||
131407658|NCT00916058|473113448|FG006|Phase 2|Screen Failure|3|||
131407659|NCT00871117|473113449|FG000|Overall Study|Lost to Follow-up|5|||
131407660|NCT00871117|473113450|FG001|Overall Study|Lost to Follow-up|6|||
131407661|NCT00871117|473113449|FG000|Overall Study|Other|0|||
131407662|NCT00871117|473113450|FG001|Overall Study|Other|4|||
131407663|NCT03958656|473113451|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
131407664|NCT03958656|473113452|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
131407665|NCT03958656|473113453|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
131407666|NCT03958656|473113454|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
131407667|NCT03958656|473113451|FG000|Overall Study|No longer meets eligibility criteria|0|||
131407668|NCT03958656|473113452|FG001|Overall Study|No longer meets eligibility criteria|0|||
131407669|NCT03958656|473113453|FG002|Overall Study|No longer meets eligibility criteria|1|||
131407670|NCT03958656|473113454|FG003|Overall Study|No longer meets eligibility criteria|0|||
131407671|NCT03958656|473113451|FG000|Overall Study|Started anti-cancer treatment|0|||
131407672|NCT03958656|473113452|FG001|Overall Study|Started anti-cancer treatment|0|||
131407673|NCT03958656|473113453|FG002|Overall Study|Started anti-cancer treatment|1|||
131407674|NCT03958656|473113454|FG003|Overall Study|Started anti-cancer treatment|0|||
131407675|NCT03444766|473113455|FG000|Overall Study|Other Reasons|2|||
131859249|NCT02756611|474762974|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
131407676|NCT03444766|473113455|FG000|Overall Study|Participant Withdrew Consent|5|||
131407677|NCT03444766|473113455|FG000|Overall Study|Lost to Follow-up|2|||
131407678|NCT03444766|473113455|FG000|Overall Study|Death|2|||
131407679|NCT03444766|473113455|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
131407680|NCT03444766|473113455|FG000|Overall Study|Disease Progression|49|||
131407681|NCT01767493|473113456|FG000|Overall Study|screen failures|3|||
131859250|NCT02756611|474762974|FG000|Overall Study|Other|10|||
131859251|NCT03125798|474762975|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
131859252|NCT03125798|474762976|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
131859253|NCT03125798|474762975|FG000|Overall Study|Conversion to thoracotomy|7|||
131859254|NCT03125798|474762976|FG001|Overall Study|Conversion to thoracotomy|7|||
131859255|NCT04583735|474762980|FG000|Double-masked Treatment Period|Adverse Event|0|||
131859256|NCT04583735|474762981|FG001|Double-masked Treatment Period|Adverse Event|1|||
131859257|NCT04583735|474762980|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
131859258|NCT04583735|474762981|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
131859259|NCT04583735|474762980|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
131859260|NCT04583735|474762981|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
131859261|NCT04583735|474762980|FG000|Open-label Treatment Period|Adverse Event|1|||
131859262|NCT04583735|474762981|FG001|Open-label Treatment Period|Adverse Event|1|||
131859263|NCT04583735|474762980|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
131859264|NCT04583735|474762981|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131859265|NCT04583735|474762980|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131859266|NCT04583735|474762981|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
131859267|NCT01215136|474762982|FG000|Overall Study|Adverse Event|2|||
131859268|NCT01215136|474762983|FG001|Overall Study|Adverse Event|9|||
131859269|NCT01215136|474762982|FG000|Overall Study|Disease Progression|3|||
131859270|NCT01215136|474762983|FG001|Overall Study|Disease Progression|14|||
131859271|NCT01215136|474762982|FG000|Overall Study|Symptomatic Deterioration|1|||
131859272|NCT01215136|474762983|FG001|Overall Study|Symptomatic Deterioration|1|||
131859273|NCT01215136|474762982|FG000|Overall Study|Death|0|||
131859274|NCT01215136|474762983|FG001|Overall Study|Death|2|||
131859275|NCT01215136|474762982|FG000|Overall Study|Withdrawal by Subject|0|||
131859276|NCT01215136|474762983|FG001|Overall Study|Withdrawal by Subject|1|||
131859277|NCT00613171|474762984|FG000|Overall Study|Adverse Event|7|||
131859278|NCT00613171|474762984|FG000|Overall Study|Withdrawal by Subject|3|||
131859279|NCT00613171|474762984|FG000|Overall Study|Reason not Specified|4|||
131859280|NCT01197911|474762985|FG000|Overall Study|Adverse Event|0|||
131859281|NCT01197911|474762986|FG001|Overall Study|Adverse Event|0|||
131859282|NCT01197911|474762987|FG002|Overall Study|Adverse Event|1|||
131859283|NCT01169350|474762989|FG000|Overall Study|Physician Decision|3|||
131859284|NCT01169350|474762989|FG000|Overall Study|Lost to Follow-up|2|||
131859285|NCT04870710|474762993|FG000|Overall Study|Lost to Follow-up|3|||
131859286|NCT00281957|474762997|FG000|Overall Study|Adverse Event|7|||
131859287|NCT00281957|474762998|FG001|Overall Study|Adverse Event|2|||
131859288|NCT00281957|474762997|FG000|Overall Study|Death|1|||
131859289|NCT00281957|474762998|FG001|Overall Study|Death|0|||
131859290|NCT00281957|474762997|FG000|Overall Study|Progression/relapse|47|||
131859291|NCT00281957|474762998|FG001|Overall Study|Progression/relapse|35|||
131859292|NCT00281957|474762997|FG000|Overall Study|Not protocol specified|8|||
131859293|NCT00281957|474762998|FG001|Overall Study|Not protocol specified|1|||
131859294|NCT00281957|474762997|FG000|Overall Study|Not eligible|1|||
131859295|NCT00281957|474762998|FG001|Overall Study|Not eligible|2|||
131859296|NCT00281957|474762997|FG000|Overall Study|Did not start treatment|3|||
131859297|NCT00281957|474762998|FG001|Overall Study|Did not start treatment|1|||
131859298|NCT00281957|474762997|FG000|Overall Study|Refusal unrelated to adverse events|0|||
131859299|NCT00281957|474762998|FG001|Overall Study|Refusal unrelated to adverse events|1|||
131859300|NCT05101343|474762999|FG000|Overall Study|Withdrawal by Subject|2|||
131859301|NCT05101343|474763000|FG001|Overall Study|Withdrawal by Subject|1|||
131859302|NCT02046603|474763001|FG000|Overall Study|Other|11|||
131859303|NCT02046603|474763002|FG001|Overall Study|Other|66|||
131859304|NCT02046603|474763001|FG000|Overall Study|Protocol Violation|0|||
131859305|NCT02046603|474763002|FG001|Overall Study|Protocol Violation|1|||
131859306|NCT02046603|474763001|FG000|Overall Study|Participant/legal guardian decision|1|||
131859307|NCT02046603|474763002|FG001|Overall Study|Participant/legal guardian decision|3|||
131407682|NCT02275117|473113457|FG000|Overall Study|Adverse Event|0|||
131859308|NCT02046603|474763001|FG000|Overall Study|Physician Decision|2|||
131859309|NCT02046603|474763002|FG001|Overall Study|Physician Decision|1|||
131859310|NCT02046603|474763001|FG000|Overall Study|Lost to Follow-up|1|||
131859311|NCT02046603|474763002|FG001|Overall Study|Lost to Follow-up|2|||
131859312|NCT02046603|474763001|FG000|Overall Study|Death|0|||
131859313|NCT02046603|474763002|FG001|Overall Study|Death|1|||
131859314|NCT02046603|474763001|FG000|Overall Study|Adverse Event|0|||
131859315|NCT02046603|474763002|FG001|Overall Study|Adverse Event|1|||
131859316|NCT03447743|474763003|FG000|Overall Study|Withdrawal by Subject|2|||
131859317|NCT03447743|474763003|FG000|Overall Study|Lost to Follow-up|3|||
131859318|NCT03447743|474763003|FG000|Overall Study|Adverse Event|1|||
131859319|NCT03447743|474763003|FG000|Overall Study|Did not meet criteria to continue|1|||
131859320|NCT00193050|474763004|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
131407683|NCT02275117|473113458|FG001|Overall Study|Adverse Event|0|||
131407684|NCT02275117|473113459|FG002|Overall Study|Adverse Event|0|||
131407685|NCT02275117|473113460|FG003|Overall Study|Adverse Event|0|||
131407686|NCT02275117|473113461|FG004|Overall Study|Adverse Event|1|||
131407687|NCT02275117|473113457|FG000|Overall Study|Lack of Efficacy|6|||
131407688|NCT02275117|473113458|FG001|Overall Study|Lack of Efficacy|7|||
131407689|NCT02275117|473113459|FG002|Overall Study|Lack of Efficacy|5|||
131407690|NCT02275117|473113460|FG003|Overall Study|Lack of Efficacy|2|||
131407691|NCT02275117|473113461|FG004|Overall Study|Lack of Efficacy|10|||
131407692|NCT02275117|473113457|FG000|Overall Study|Lost to Follow-up|11|||
131407693|NCT02275117|473113458|FG001|Overall Study|Lost to Follow-up|16|||
131407694|NCT02275117|473113459|FG002|Overall Study|Lost to Follow-up|15|||
131407695|NCT02275117|473113460|FG003|Overall Study|Lost to Follow-up|16|||
131407696|NCT02275117|473113461|FG004|Overall Study|Lost to Follow-up|8|||
131407697|NCT02275117|473113457|FG000|Overall Study|Physician Decision|0|||
131407698|NCT02275117|473113458|FG001|Overall Study|Physician Decision|1|||
131407699|NCT02275117|473113459|FG002|Overall Study|Physician Decision|1|||
131913022|NCT01288430|474969286|FG009|Part 1|Progressive disease|0|||
131913023|NCT01288430|474969277|FG000|Part 1|Clinical disease progression|0|||
131913024|NCT01288430|474969278|FG001|Part 1|Clinical disease progression|0|||
131859321|NCT00193050|474763004|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
131913025|NCT01288430|474969279|FG002|Part 1|Clinical disease progression|1|||
131913026|NCT01288430|474969280|FG003|Part 1|Clinical disease progression|0|||
131913027|NCT01288430|474969281|FG004|Part 1|Clinical disease progression|0|||
131913028|NCT01288430|474969282|FG005|Part 1|Clinical disease progression|2|||
131913029|NCT01288430|474969283|FG006|Part 1|Clinical disease progression|2|||
131913030|NCT01288430|474969284|FG007|Part 1|Clinical disease progression|0|||
131913031|NCT01288430|474969285|FG008|Part 1|Clinical disease progression|0|||
131913032|NCT01288430|474969286|FG009|Part 1|Clinical disease progression|0|||
131859322|NCT00193050|474763004|FG000|Neoadjuvant Treatment|Physician Decision|2|||
131859323|NCT00193050|474763004|FG000|Neoadjuvant Treatment|Adverse Event|2|||
131859324|NCT00193050|474763004|FG000|Adjuvant|Physician Decision|5|||
131913033|NCT01288430|474969277|FG000|Part 1|Death due to disease progression|0|||
131407700|NCT02275117|473113460|FG003|Overall Study|Physician Decision|0|||
131407701|NCT02275117|473113461|FG004|Overall Study|Physician Decision|1|||
131407702|NCT02275117|473113457|FG000|Overall Study|Protocol Violation|1|||
131407703|NCT02275117|473113458|FG001|Overall Study|Protocol Violation|0|||
131407704|NCT02275117|473113459|FG002|Overall Study|Protocol Violation|1|||
131407705|NCT02275117|473113460|FG003|Overall Study|Protocol Violation|1|||
131407706|NCT02275117|473113461|FG004|Overall Study|Protocol Violation|0|||
131407707|NCT02275117|473113457|FG000|Overall Study|Withdrawal by Subject|6|||
131407708|NCT02275117|473113458|FG001|Overall Study|Withdrawal by Subject|4|||
131407709|NCT02275117|473113459|FG002|Overall Study|Withdrawal by Subject|7|||
131407710|NCT02275117|473113460|FG003|Overall Study|Withdrawal by Subject|3|||
131407711|NCT02275117|473113461|FG004|Overall Study|Withdrawal by Subject|3|||
131407712|NCT02275117|473113457|FG000|Overall Study|Terminated by Sponsor|4|||
131407713|NCT02275117|473113458|FG001|Overall Study|Terminated by Sponsor|4|||
131407714|NCT02275117|473113459|FG002|Overall Study|Terminated by Sponsor|4|||
131407715|NCT02275117|473113460|FG003|Overall Study|Terminated by Sponsor|6|||
131407716|NCT02275117|473113461|FG004|Overall Study|Terminated by Sponsor|4|||
131407717|NCT02275117|473113457|FG000|Overall Study|Worsening of Study Indication|0|||
131859325|NCT00193050|474763004|FG000|Adjuvant|Intercurrent Hospitalization|3|||
131859326|NCT00193050|474763004|FG000|Adjuvant|Lack of Efficacy|2|||
131859327|NCT00061932|474763005|FG000|Overall Study|Withdrawal by Subject|13|||
131859328|NCT00061932|474763006|FG001|Overall Study|Withdrawal by Subject|4|||
131859329|NCT03567980|474763007|FG000|Overall Study|Adverse Event|1|||
131859330|NCT04211831|474763010|FG000|Overall Study|Withdrawal by Subject|4|||
131859331|NCT04211831|474763011|FG001|Overall Study|Withdrawal by Subject|1|||
131859332|NCT04211831|474763012|FG002|Overall Study|Withdrawal by Subject|1|||
131859333|NCT04211831|474763010|FG000|Overall Study|Protocol Violation|0|||
131859334|NCT04211831|474763011|FG001|Overall Study|Protocol Violation|0|||
131859335|NCT04211831|474763012|FG002|Overall Study|Protocol Violation|1|||
131407718|NCT02275117|473113458|FG001|Overall Study|Worsening of Study Indication|1|||
131407719|NCT02275117|473113459|FG002|Overall Study|Worsening of Study Indication|2|||
131407720|NCT02275117|473113460|FG003|Overall Study|Worsening of Study Indication|0|||
131407721|NCT02275117|473113461|FG004|Overall Study|Worsening of Study Indication|0|||
131407722|NCT02275117|473113457|FG000|Overall Study|Study Burden|5|||
131407723|NCT02275117|473113458|FG001|Overall Study|Study Burden|4|||
131407724|NCT02275117|473113459|FG002|Overall Study|Study Burden|7|||
131407725|NCT02275117|473113460|FG003|Overall Study|Study Burden|5|||
131859336|NCT04211831|474763010|FG000|Overall Study|Adverse Event|0|||
131407726|NCT02275117|473113461|FG004|Overall Study|Study Burden|7|||
131407727|NCT02275117|473113457|FG000|Overall Study|Other|1|||
131407728|NCT02275117|473113458|FG001|Overall Study|Other|0|||
131407729|NCT02275117|473113459|FG002|Overall Study|Other|0|||
131407730|NCT02275117|473113460|FG003|Overall Study|Other|0|||
131407731|NCT02275117|473113461|FG004|Overall Study|Other|2|||
131407732|NCT01865812|473113462|FG000|Primary Treatment Phase|Adverse Event|2|||
131407733|NCT01865812|473113463|FG001|Primary Treatment Phase|Adverse Event|0|||
131407734|NCT01865812|473113462|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
131407735|NCT01865812|473113463|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
131407736|NCT01865812|473113462|FG000|Long-term Safety Extension Phase|Pruritus|0|||
131407737|NCT01865812|473113463|FG001|Long-term Safety Extension Phase|Pruritus|3|||
131859337|NCT04211831|474763011|FG001|Overall Study|Adverse Event|1|||
131859338|NCT04211831|474763012|FG002|Overall Study|Adverse Event|0|||
131859339|NCT04211831|474763010|FG000|Overall Study|Lack of Efficacy|0|||
131859340|NCT04211831|474763011|FG001|Overall Study|Lack of Efficacy|0|||
131859341|NCT04211831|474763012|FG002|Overall Study|Lack of Efficacy|1|||
131859342|NCT04211831|474763010|FG000|Overall Study|Lost to Follow-up|0|||
131859343|NCT04211831|474763011|FG001|Overall Study|Lost to Follow-up|0|||
131859344|NCT04211831|474763012|FG002|Overall Study|Lost to Follow-up|2|||
131859345|NCT04211831|474763010|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
131859346|NCT04211831|474763011|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
131859347|NCT04211831|474763012|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
131859348|NCT04211831|474763010|FG000|Overall Study|Other|0|||
131859349|NCT04211831|474763011|FG001|Overall Study|Other|1|||
131859350|NCT04211831|474763012|FG002|Overall Study|Other|0|||
131859351|NCT01256879|474763013|FG000|Overall Study|Withdrawal by Subject|1|||
131859352|NCT00397514|474763014|FG000|Overall Study|Withdrawal by Subject|1|||
131859353|NCT00397514|474763014|FG000|Overall Study|Pacing wire malfunction|1|||
131859354|NCT00397514|474763014|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
131859355|NCT00397514|474763014|FG000|Overall Study|early extubation|2|||
131859356|NCT00397514|474763014|FG000|Overall Study|poor echocardiographic windows|1|||
131859357|NCT00640315|474763015|FG000|Overall Study|Withdrawal by Subject|0|||
131859358|NCT00640315|474763016|FG001|Overall Study|Withdrawal by Subject|1|||
131859359|NCT02548143|474763018|FG000|Overall Study|Adverse Event|1|||
131859360|NCT02548143|474763019|FG001|Overall Study|Adverse Event|0|||
131859361|NCT02548143|474763018|FG000|Overall Study|Withdrawal by Subject|0|||
131859362|NCT02548143|474763019|FG001|Overall Study|Withdrawal by Subject|1|||
131859363|NCT05620082|474763023|FG000|Overall Study|Discharged before study end|1|||
131859364|NCT05620082|474763024|FG001|Overall Study|Discharged before study end|4|||
131859365|NCT05620082|474763025|FG002|Overall Study|Discharged before study end|0|||
131859366|NCT05620082|474763023|FG000|Overall Study|Moved to a different ward|1|||
131859367|NCT05620082|474763024|FG001|Overall Study|Moved to a different ward|0|||
131859368|NCT05620082|474763025|FG002|Overall Study|Moved to a different ward|0|||
131859369|NCT05620082|474763023|FG000|Overall Study|Feeling too unwell|1|||
131859370|NCT05620082|474763024|FG001|Overall Study|Feeling too unwell|0|||
131859371|NCT05620082|474763025|FG002|Overall Study|Feeling too unwell|0|||
131859372|NCT05525520|474765246|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
131859373|NCT05525520|474765247|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
131859374|NCT05525520|474765246|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
131859375|NCT05525520|474765247|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
131859376|NCT02721732|474765248|FG000|Overall Study|Adverse Event|2|||
131859377|NCT02721732|474765249|FG001|Overall Study|Adverse Event|0|||
131859378|NCT02721732|474765250|FG002|Overall Study|Adverse Event|2|||
131859379|NCT02721732|474765251|FG003|Overall Study|Adverse Event|0|||
131859380|NCT02721732|474765252|FG004|Overall Study|Adverse Event|1|||
131859381|NCT02721732|474765253|FG005|Overall Study|Adverse Event|0|||
131859382|NCT02721732|474765254|FG006|Overall Study|Adverse Event|1|||
131859383|NCT02721732|474765255|FG007|Overall Study|Adverse Event|0|||
131859384|NCT02721732|474765256|FG008|Overall Study|Adverse Event|1|||
131407738|NCT01865812|473113462|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
131407739|NCT01865812|473113463|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
131407740|NCT01865812|473113462|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
131407741|NCT01865812|473113463|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
131407742|NCT00724854|473113464|FG000|Overall Study|Lack of Efficacy|187|||
131407743|NCT00724854|473113465|FG001|Overall Study|Lack of Efficacy|13|||
131407744|NCT00724854|473113464|FG000|Overall Study|Lost to Follow-up|87|||
131407745|NCT00724854|473113465|FG001|Overall Study|Lost to Follow-up|10|||
131407746|NCT00724854|473113464|FG000|Overall Study|Adverse Event|62|||
131407747|NCT00724854|473113465|FG001|Overall Study|Adverse Event|4|||
131407748|NCT00724854|473113464|FG000|Overall Study|Other|42|||
131407749|NCT00724854|473113465|FG001|Overall Study|Other|3|||
131407750|NCT00724854|473113464|FG000|Overall Study|Death|11|||
131407751|NCT00724854|473113465|FG001|Overall Study|Death|0|||
131407752|NCT00724854|473113464|FG000|Overall Study|Change of treatment|7|||
131407753|NCT00724854|473113465|FG001|Overall Study|Change of treatment|0|||
131407754|NCT00724854|473113464|FG000|Overall Study|Withdrawal by Subject|5|||
131859385|NCT02721732|474765257|FG009|Overall Study|Adverse Event|1|||
131859386|NCT02721732|474765248|FG000|Overall Study|Death|0|||
131859387|NCT02721732|474765249|FG001|Overall Study|Death|0|||
131859388|NCT02721732|474765250|FG002|Overall Study|Death|0|||
131859389|NCT02721732|474765251|FG003|Overall Study|Death|0|||
131859390|NCT02721732|474765252|FG004|Overall Study|Death|1|||
131859391|NCT02721732|474765253|FG005|Overall Study|Death|0|||
131859392|NCT02721732|474765254|FG006|Overall Study|Death|1|||
131859393|NCT02721732|474765255|FG007|Overall Study|Death|0|||
131407755|NCT00724854|473113465|FG001|Overall Study|Withdrawal by Subject|0|||
131407756|NCT00724854|473113464|FG000|Overall Study|Adverse event + lack of efficacy|2|||
131407757|NCT00724854|473113465|FG001|Overall Study|Adverse event + lack of efficacy|1|||
131859394|NCT02721732|474765256|FG008|Overall Study|Death|0|||
131859395|NCT02721732|474765257|FG009|Overall Study|Death|1|||
131859396|NCT02721732|474765248|FG000|Overall Study|Lack of Efficacy|12|||
131859397|NCT02721732|474765249|FG001|Overall Study|Lack of Efficacy|11|||
131859398|NCT02721732|474765250|FG002|Overall Study|Lack of Efficacy|18|||
131859399|NCT02721732|474765251|FG003|Overall Study|Lack of Efficacy|5|||
131859400|NCT02721732|474765252|FG004|Overall Study|Lack of Efficacy|21|||
131859401|NCT02721732|474765253|FG005|Overall Study|Lack of Efficacy|2|||
131859402|NCT02721732|474765254|FG006|Overall Study|Lack of Efficacy|8|||
131407758|NCT02460783|473113466|FG000|Overall Study|Withdrawal by Subject|1|||
131407759|NCT02460783|473113467|FG001|Overall Study|Withdrawal by Subject|3|||
131407760|NCT02460783|473113466|FG000|Overall Study|Lost to Follow-up|1|||
131407761|NCT02460783|473113467|FG001|Overall Study|Lost to Follow-up|1|||
131407762|NCT01646645|473113468|FG000|Overall Study|No Treated|1|||
131407763|NCT01646645|473113468|FG000|Overall Study|Inevaluable Donor|29|||
131407764|NCT00405964|473113469|FG000|Overall Study|Treatment Failure|17|||
131407765|NCT00405964|473113470|FG001|Overall Study|Treatment Failure|45|||
131407766|NCT00405964|473113469|FG000|Overall Study|Adverse Event|7|||
131407767|NCT00405964|473113470|FG001|Overall Study|Adverse Event|16|||
131407768|NCT00405964|473113469|FG000|Overall Study|Lost to Follow-up|5|||
131407769|NCT00405964|473113470|FG001|Overall Study|Lost to Follow-up|5|||
131407770|NCT00405964|473113469|FG000|Overall Study|Withdrawal by Subject|19|||
131407771|NCT00405964|473113470|FG001|Overall Study|Withdrawal by Subject|23|||
131407772|NCT00405964|473113469|FG000|Overall Study|Protocol Violation|11|||
131407773|NCT00405964|473113470|FG001|Overall Study|Protocol Violation|6|||
131407774|NCT01416441|473113474|FG000|Overall Study|Lost to Follow-up|5|||
131407775|NCT01416441|473113474|FG000|Overall Study|Adverse Event|6|||
131407776|NCT01416441|473113474|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
131407777|NCT01416441|473113474|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
131407778|NCT01416441|473113474|FG000|Overall Study|Investigator Withdrew Subject|2|||
131407779|NCT01416441|473113474|FG000|Overall Study|Subject Withdrew Consent|12|||
131407780|NCT01416441|473113474|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
131407781|NCT02653495|473113475|FG000|Overall Study|Lost to Follow-up|2|||
131407782|NCT02653495|473113476|FG001|Overall Study|Lost to Follow-up|0|||
131407783|NCT02653495|473113475|FG000|Overall Study|Screening Failure|10|||
131407784|NCT02653495|473113476|FG001|Overall Study|Screening Failure|0|||
131434003|NCT04701333|473214596|FG001|Overall Study|Lost to Follow-up|7|||
131434004|NCT04701333|473214595|FG000|Overall Study|Withdrawal by Subject|0|||
131434005|NCT04701333|473214596|FG001|Overall Study|Withdrawal by Subject|1|||
131434006|NCT01292187|473214597|FG000|Overall Study|Adverse Event|10|||
131434007|NCT01292187|473214598|FG001|Overall Study|Adverse Event|5|||
131434008|NCT01292187|473214597|FG000|Overall Study|Withdrawal by Subject|6|||
131434009|NCT01292187|473214598|FG001|Overall Study|Withdrawal by Subject|5|||
131434010|NCT01292187|473214597|FG000|Overall Study|All other reasons|1|||
131434011|NCT01292187|473214598|FG001|Overall Study|All other reasons|3|||
131859403|NCT02721732|474765255|FG007|Overall Study|Lack of Efficacy|11|||
131859404|NCT02721732|474765256|FG008|Overall Study|Lack of Efficacy|10|||
131859405|NCT02721732|474765257|FG009|Overall Study|Lack of Efficacy|20|||
131859406|NCT02721732|474765248|FG000|Overall Study|Physician Decision|0|||
131859407|NCT02721732|474765249|FG001|Overall Study|Physician Decision|0|||
131859408|NCT02721732|474765250|FG002|Overall Study|Physician Decision|1|||
131859409|NCT02721732|474765251|FG003|Overall Study|Physician Decision|0|||
131859410|NCT02721732|474765252|FG004|Overall Study|Physician Decision|0|||
131859411|NCT02721732|474765253|FG005|Overall Study|Physician Decision|0|||
131859412|NCT02721732|474765254|FG006|Overall Study|Physician Decision|0|||
131859413|NCT02721732|474765255|FG007|Overall Study|Physician Decision|0|||
131859414|NCT02721732|474765256|FG008|Overall Study|Physician Decision|0|||
131859415|NCT02721732|474765257|FG009|Overall Study|Physician Decision|0|||
131859416|NCT02721732|474765248|FG000|Overall Study|Withdrawal by Subject|1|||
131859417|NCT02721732|474765249|FG001|Overall Study|Withdrawal by Subject|0|||
131859418|NCT02721732|474765250|FG002|Overall Study|Withdrawal by Subject|0|||
131859419|NCT02721732|474765251|FG003|Overall Study|Withdrawal by Subject|0|||
131859420|NCT02721732|474765252|FG004|Overall Study|Withdrawal by Subject|3|||
131859421|NCT02721732|474765253|FG005|Overall Study|Withdrawal by Subject|0|||
131859422|NCT02721732|474765254|FG006|Overall Study|Withdrawal by Subject|1|||
131859423|NCT02721732|474765255|FG007|Overall Study|Withdrawal by Subject|1|||
131859424|NCT02721732|474765256|FG008|Overall Study|Withdrawal by Subject|0|||
131859425|NCT02721732|474765257|FG009|Overall Study|Withdrawal by Subject|1|||
131859426|NCT02721732|474765248|FG000|Overall Study|Participant Choice|1|||
131859427|NCT02721732|474765249|FG001|Overall Study|Participant Choice|0|||
131434012|NCT01721161|473214604|FG000|Overall Study|Adverse Event|2|||
131434013|NCT01721161|473214605|FG001|Overall Study|Adverse Event|3|||
131434014|NCT01721161|473214604|FG000|Overall Study|Lost to Follow-up|1|||
131434015|NCT01721161|473214605|FG001|Overall Study|Lost to Follow-up|2|||
131434016|NCT01721161|473214604|FG000|Overall Study|Withdrawal by Subject|1|||
131434017|NCT01721161|473214605|FG001|Overall Study|Withdrawal by Subject|1|||
131434018|NCT01721161|473214604|FG000|Overall Study|Other|0|||
131434019|NCT01721161|473214605|FG001|Overall Study|Other|1|||
131434020|NCT01216202|473214606|FG000|Overall Study|Withdrawal by Subject|8|||
131859428|NCT02721732|474765250|FG002|Overall Study|Participant Choice|0|||
131859429|NCT02721732|474765251|FG003|Overall Study|Participant Choice|0|||
131859430|NCT02721732|474765252|FG004|Overall Study|Participant Choice|0|||
131859431|NCT02721732|474765253|FG005|Overall Study|Participant Choice|0|||
131859432|NCT02721732|474765254|FG006|Overall Study|Participant Choice|0|||
131859433|NCT02721732|474765255|FG007|Overall Study|Participant Choice|0|||
131859434|NCT02721732|474765256|FG008|Overall Study|Participant Choice|0|||
131859435|NCT02721732|474765257|FG009|Overall Study|Participant Choice|1|||
131859436|NCT02721732|474765248|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859437|NCT02721732|474765249|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859438|NCT02721732|474765250|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
131859439|NCT02721732|474765251|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859440|NCT02721732|474765252|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859441|NCT02721732|474765253|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859442|NCT02721732|474765254|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859443|NCT02721732|474765255|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859444|NCT02721732|474765256|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859445|NCT02721732|474765257|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
131859446|NCT02721732|474765248|FG000|Overall Study|Progression and withdrew consent|1|||
131859447|NCT02721732|474765249|FG001|Overall Study|Progression and withdrew consent|1|||
131859448|NCT02721732|474765250|FG002|Overall Study|Progression and withdrew consent|0|||
131859449|NCT02721732|474765251|FG003|Overall Study|Progression and withdrew consent|0|||
131859450|NCT02721732|474765252|FG004|Overall Study|Progression and withdrew consent|0|||
131859451|NCT02721732|474765253|FG005|Overall Study|Progression and withdrew consent|0|||
131859452|NCT02721732|474765254|FG006|Overall Study|Progression and withdrew consent|0|||
131859453|NCT02721732|474765255|FG007|Overall Study|Progression and withdrew consent|0|||
131859454|NCT02721732|474765256|FG008|Overall Study|Progression and withdrew consent|0|||
131859455|NCT02721732|474765257|FG009|Overall Study|Progression and withdrew consent|1|||
131859456|NCT02721732|474765248|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
131859457|NCT02721732|474765249|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
131859458|NCT02721732|474765250|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
131859459|NCT02721732|474765251|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
131859460|NCT02721732|474765252|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
131859461|NCT02721732|474765253|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
131859462|NCT02721732|474765254|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
131859463|NCT02721732|474765255|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
131859464|NCT02721732|474765256|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
131859465|NCT02721732|474765257|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
131859466|NCT03657797|474765258|FG000|Overall Study|Lost to Follow-up|0|||
131859467|NCT03657797|474765259|FG001|Overall Study|Lost to Follow-up|1|||
131859468|NCT03657797|474765260|FG002|Overall Study|Lost to Follow-up|1|||
131859469|NCT03657797|474765261|FG003|Overall Study|Lost to Follow-up|0|||
131859470|NCT03657797|474765258|FG000|Overall Study|Physician Decision|0|||
131859471|NCT03657797|474765259|FG001|Overall Study|Physician Decision|1|||
131859472|NCT03657797|474765260|FG002|Overall Study|Physician Decision|0|||
131859473|NCT03657797|474765261|FG003|Overall Study|Physician Decision|0|||
131859474|NCT03657797|474765258|FG000|Overall Study|Withdrawal by Subject|0|||
131859475|NCT03657797|474765259|FG001|Overall Study|Withdrawal by Subject|1|||
131859476|NCT03657797|474765260|FG002|Overall Study|Withdrawal by Subject|2|||
131859477|NCT03657797|474765261|FG003|Overall Study|Withdrawal by Subject|0|||
131859478|NCT03657797|474765258|FG000|Overall Study|Adverse Event|0|||
131859479|NCT03657797|474765259|FG001|Overall Study|Adverse Event|0|||
131859480|NCT03657797|474765260|FG002|Overall Study|Adverse Event|2|||
131859481|NCT03657797|474765261|FG003|Overall Study|Adverse Event|0|||
131859482|NCT00725283|474765265|FG000|Overall Study|Missing Code|3|||
131859483|NCT00725283|474765265|FG000|Overall Study|Death|5|||
131859484|NCT00725283|474765265|FG000|Overall Study|Other|6|||
131859485|NCT00725283|474765265|FG000|Overall Study|Withdrawal by Subject|10|||
131859486|NCT00711243|474765266|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
131859487|NCT00711243|474765267|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
131859488|NCT00711243|474765268|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
131859489|NCT00711243|474765269|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
131859490|NCT00711243|474765270|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
131859491|NCT00711243|474765271|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
131859492|NCT00711243|474765266|FG000|Reached First Response/4 Cycles|Death|0|||
131859493|NCT00711243|474765267|FG001|Reached First Response/4 Cycles|Death|0|||
131859494|NCT00711243|474765268|FG002|Reached First Response/4 Cycles|Death|0|||
131859495|NCT00711243|474765269|FG003|Reached First Response/4 Cycles|Death|0|||
131859496|NCT00711243|474765270|FG004|Reached First Response/4 Cycles|Death|0|||
131859497|NCT00711243|474765271|FG005|Reached First Response/4 Cycles|Death|2|||
131859498|NCT00711243|474765266|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
131859499|NCT00711243|474765267|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
131859500|NCT00711243|474765268|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
131859501|NCT00711243|474765269|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
131859502|NCT00711243|474765270|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
131859503|NCT00711243|474765271|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
131859504|NCT00711243|474765266|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
131859505|NCT00711243|474765267|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
131859506|NCT00711243|474765268|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
131859507|NCT00711243|474765269|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
131859508|NCT00711243|474765270|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
131859509|NCT00711243|474765271|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
131859510|NCT00711243|474765266|FG000|Treated Cycle 5 After First Response|Death|0|||
131859511|NCT00711243|474765267|FG001|Treated Cycle 5 After First Response|Death|0|||
131859512|NCT00711243|474765268|FG002|Treated Cycle 5 After First Response|Death|0|||
131859513|NCT00711243|474765269|FG003|Treated Cycle 5 After First Response|Death|0|||
131859514|NCT00711243|474765270|FG004|Treated Cycle 5 After First Response|Death|0|||
131859515|NCT00711243|474765271|FG005|Treated Cycle 5 After First Response|Death|2|||
131859516|NCT00711243|474765266|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
131859517|NCT00711243|474765267|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
131859518|NCT00711243|474765268|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
131859519|NCT00711243|474765269|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
131859520|NCT00711243|474765270|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
131859521|NCT00711243|474765271|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
131859522|NCT00711243|474765266|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
131859523|NCT00711243|474765267|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
131859524|NCT00711243|474765268|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
131859525|NCT00711243|474765269|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
131859526|NCT00711243|474765270|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
131859527|NCT00711243|474765271|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
131859528|NCT00696423|474765272|FG000|Overall Study|Lost to Follow-up|0|||
131859529|NCT00696423|474765273|FG001|Overall Study|Lost to Follow-up|5|||
131859530|NCT01402570|474765274|FG000|Overall Study|Adverse Event|1|||
131859531|NCT01321749|474765277|FG000|Overall Study|Lost to Follow-up|4|||
131859532|NCT01321749|474765278|FG001|Overall Study|Lost to Follow-up|11|||
131859533|NCT01321749|474765277|FG000|Overall Study|Protocol Violation|4|||
131859534|NCT01321749|474765278|FG001|Overall Study|Protocol Violation|7|||
131859535|NCT01321749|474765277|FG000|Overall Study|Withdrawal by Subject|5|||
131859536|NCT01321749|474765278|FG001|Overall Study|Withdrawal by Subject|4|||
131859537|NCT01276041|474765282|FG000|Overall Study|Adverse Event|2|||
131859538|NCT01276041|474765282|FG000|Overall Study|Protocol Violation|1|||
131859539|NCT00725491|474765283|FG000|Overall Study|Adverse Event|3|||
131859540|NCT00725491|474765284|FG001|Overall Study|Adverse Event|2|||
131859541|NCT00725491|474765283|FG000|Overall Study|Pregnancy|0|||
131859542|NCT00725491|474765284|FG001|Overall Study|Pregnancy|3|||
131859543|NCT00725491|474765283|FG000|Overall Study|Risk for hyperstimulation|2|||
131859544|NCT00725491|474765284|FG001|Overall Study|Risk for hyperstimulation|9|||
131859545|NCT00725491|474765283|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
131859546|NCT00725491|474765284|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
131859547|NCT00725491|474765283|FG000|Overall Study|Fertilization failure|0|||
131859548|NCT00725491|474765284|FG001|Overall Study|Fertilization failure|1|||
131859549|NCT00725491|474765283|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
131859550|NCT00725491|474765284|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
131859551|NCT02440464|474765289|FG000|Overall Study|Withdrawal by Subject|3|||
131859552|NCT02440464|474765290|FG001|Overall Study|Withdrawal by Subject|2|||
131859553|NCT00942357|474765295|FG000|Overall Study|Ineligible|37|||
131859554|NCT00942357|474765296|FG001|Overall Study|Ineligible|40|||
131859555|NCT03535740|474765297|FG000|Overall Study|Death|44|||
131859556|NCT03535740|474765297|FG000|Overall Study|Lost to Follow-up|1|||
131859557|NCT03535740|474765297|FG000|Overall Study|Withdrawal by Subject|13|||
131859558|NCT03535740|474765297|FG000|Overall Study|Site terminated by Sponsor|45|||
131859559|NCT05198518|474765302|FG000|Screening Visit|Deemed unable to participate|58|||
131859560|NCT05198518|474765303|FG001|Screening Visit|Deemed unable to participate|0|||
131859561|NCT05198518|474765304|FG002|Screening Visit|Deemed unable to participate|0|||
131859562|NCT03645863|474765305|FG000|Overall Study|Withdrawal by Subject|1|||
131859563|NCT03645863|474765306|FG001|Overall Study|Withdrawal by Subject|0|||
131859564|NCT03645863|474765307|FG002|Overall Study|Withdrawal by Subject|0|||
131859565|NCT00100828|474765310|FG000|Overall Study|Physician Decision|6|||
131859566|NCT00124917|474765311|FG000|Overall Study|Physician Decision|3|||
131859567|NCT03518008|474765312|FG000|Period 2, Second Week of Wear|Family emergency|0|||
131859568|NCT03518008|474765313|FG001|Period 2, Second Week of Wear|Family emergency|1|||
131859569|NCT00951496|474765314|FG000|Overall Study|Did not initiate study treatment|10|||
131859570|NCT00951496|474765315|FG001|Overall Study|Did not initiate study treatment|8|||
131859571|NCT00951496|474765316|FG002|Overall Study|Did not initiate study treatment|13|||
131859572|NCT01526057|474765317|FG000|Overall Study|Withdrawal by Subject|3|||
131859573|NCT01526057|474765318|FG001|Overall Study|Withdrawal by Subject|2|||
131859574|NCT01526057|474765319|FG002|Overall Study|Withdrawal by Subject|2|||
131859575|NCT01526057|474765317|FG000|Overall Study|Adverse Event|3|||
131859576|NCT01526057|474765318|FG001|Overall Study|Adverse Event|1|||
131859577|NCT01526057|474765319|FG002|Overall Study|Adverse Event|1|||
131859578|NCT01526057|474765317|FG000|Overall Study|Death|1|||
131859579|NCT01526057|474765318|FG001|Overall Study|Death|0|||
131859580|NCT01526057|474765319|FG002|Overall Study|Death|0|||
131859581|NCT01526057|474765317|FG000|Overall Study|Lost to Follow-up|1|||
131859582|NCT01526057|474765318|FG001|Overall Study|Lost to Follow-up|0|||
131859583|NCT01526057|474765319|FG002|Overall Study|Lost to Follow-up|1|||
131859584|NCT01526057|474765317|FG000|Overall Study|Other|1|||
131859585|NCT01526057|474765318|FG001|Overall Study|Other|0|||
131859586|NCT01526057|474765319|FG002|Overall Study|Other|1|||
131859587|NCT01526057|474765317|FG000|Overall Study|Protocol Violation|0|||
131407785|NCT00683917|473115178|FG000|Overall Study|Study prematurely terminated|10|||
131859588|NCT01526057|474765318|FG001|Overall Study|Protocol Violation|0|||
131859589|NCT01526057|474765319|FG002|Overall Study|Protocol Violation|1|||
131859590|NCT02289729|474765330|FG000|Overall Study|Lack of Efficacy|3|||
131859591|NCT02289729|474765330|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
131859592|NCT02289729|474765330|FG000|Overall Study|Withdrawal by Subject|1|||
131859593|NCT02289729|474765330|FG000|Overall Study|Death|1|||
131859594|NCT00476190|474765331|FG000|Overall Study|Ineligible|1|||
131859595|NCT00476190|474765332|FG001|Overall Study|Ineligible|1|||
131859596|NCT00476190|474765331|FG000|Overall Study|Induction Death|2|||
131859597|NCT00476190|474765332|FG001|Overall Study|Induction Death|0|||
131859598|NCT00476190|474765331|FG000|Overall Study|Induction Failure|2|||
131859599|NCT00476190|474765332|FG001|Overall Study|Induction Failure|4|||
131859600|NCT00476190|474765331|FG000|Overall Study|Lost to Follow-up|1|||
131859601|NCT00476190|474765332|FG001|Overall Study|Lost to Follow-up|0|||
131859602|NCT00476190|474765331|FG000|Overall Study|Relapse/Progression|5|||
131859603|NCT00476190|474765332|FG001|Overall Study|Relapse/Progression|2|||
131859604|NCT00476190|474765331|FG000|Overall Study|Remission Death|0|||
131859605|NCT00476190|474765332|FG001|Overall Study|Remission Death|1|||
131859606|NCT00476190|474765331|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
131859607|NCT00476190|474765332|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
131859608|NCT00476190|474765331|FG000|Overall Study|Withdrawal by Subject|6|||
131859609|NCT00476190|474765332|FG001|Overall Study|Withdrawal by Subject|2|||
131859610|NCT00476190|474765331|FG000|Overall Study|Other|9|||
131859611|NCT00476190|474765332|FG001|Overall Study|Other|10|||
131859612|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
131859613|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
131859614|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
131859615|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
131859616|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
131859617|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
131859618|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
131859619|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
131859620|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
131859621|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
131859622|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
131859623|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
131859624|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
131859625|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
131859626|NCT04338022|474765333|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
131859627|NCT04338022|474765334|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
131859628|NCT04338022|474765333|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
131859629|NCT04338022|474765334|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
131859630|NCT04338022|474765333|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
131859631|NCT04338022|474765334|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
131859632|NCT04338022|474765333|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
131859633|NCT04338022|474765334|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
131859634|NCT04338022|474765333|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
131859635|NCT04338022|474765334|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
131859636|NCT04338022|474765333|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
131859637|NCT04338022|474765334|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
131859638|NCT04338022|474765333|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
131859639|NCT04338022|474765334|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
131407786|NCT01170598|473115185|FG000|Overall Study|Withdrawal by Subject|1|||
131407787|NCT01170598|473115185|FG000|Overall Study|Death|3|||
131407788|NCT01170598|473115185|FG000|Overall Study|Lost to Follow-up|1|||
131407789|NCT01170598|473115185|FG000|Overall Study|Refused|1|||
131407790|NCT03549871|473115190|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
131859640|NCT02860546|474765338|FG000|Overall Study|Clinical Progression|6|||
131859641|NCT02860546|474765338|FG000|Overall Study|Radiological Progression|12|||
131859642|NCT02466321|474765339|FG000|Overall Study|Death|26|||
131859643|NCT02466321|474765339|FG000|Overall Study|Revision|6|||
131859644|NCT02466321|474765339|FG000|Overall Study|Lost to Follow-up|60|||
131859645|NCT02466321|474765339|FG000|Overall Study|Did not receive study device|1|||
131859646|NCT06071754|474765342|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
131859647|NCT02189837|474765346|FG000|Overall Study|Withdrawal by Subject|2|||
131859648|NCT02189837|474765347|FG001|Overall Study|Withdrawal by Subject|1|||
131859649|NCT02189837|474765348|FG002|Overall Study|Withdrawal by Subject|3|||
131859650|NCT02189837|474765349|FG003|Overall Study|Withdrawal by Subject|1|||
131859651|NCT02189837|474765346|FG000|Overall Study|Sponsor Decision|0|||
131859652|NCT02189837|474765347|FG001|Overall Study|Sponsor Decision|0|||
131859653|NCT02189837|474765348|FG002|Overall Study|Sponsor Decision|0|||
131859654|NCT02189837|474765349|FG003|Overall Study|Sponsor Decision|1|||
131859655|NCT00243412|474765350|FG000|Overall Study|Death|0|||
131859656|NCT00243412|474765351|FG001|Overall Study|Death|1|||
131859657|NCT00243412|474765350|FG000|Overall Study|Adverse Event|4|||
131859658|NCT00243412|474765351|FG001|Overall Study|Adverse Event|2|||
131859659|NCT00243412|474765350|FG000|Overall Study|Lost to Follow-up|0|||
131859660|NCT00243412|474765351|FG001|Overall Study|Lost to Follow-up|1|||
131859661|NCT00243412|474765350|FG000|Overall Study|Physician Decision|1|||
131859662|NCT00243412|474765351|FG001|Overall Study|Physician Decision|1|||
131859663|NCT00243412|474765350|FG000|Overall Study|Withdrawal by Subject|4|||
131859664|NCT00243412|474765351|FG001|Overall Study|Withdrawal by Subject|5|||
131859665|NCT00243412|474765350|FG000|Overall Study|Other|1|||
131859666|NCT00243412|474765351|FG001|Overall Study|Other|1|||
131859667|NCT03281876|474765360|FG000|Overall Study|Adverse Event|4|||
131859668|NCT03281876|474765361|FG001|Overall Study|Adverse Event|15|||
131859669|NCT03281876|474765360|FG000|Overall Study|Lost to Follow-up|1|||
131859670|NCT03281876|474765361|FG001|Overall Study|Lost to Follow-up|4|||
131859671|NCT03281876|474765360|FG000|Overall Study|Withdrawal by Subject|11|||
131859672|NCT03281876|474765361|FG001|Overall Study|Withdrawal by Subject|15|||
131859673|NCT03281876|474765360|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131859674|NCT03281876|474765361|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131859675|NCT03281876|474765360|FG000|Overall Study|OTHER|5|||
131859676|NCT03281876|474765361|FG001|Overall Study|OTHER|5|||
131859677|NCT02208089|474765362|FG000|Overall Study|Withdrawal by Subject|1|||
131859678|NCT02208089|474765363|FG001|Overall Study|Withdrawal by Subject|0|||
131859679|NCT02208089|474765362|FG000|Overall Study|Lost to Follow-up|6|||
131859680|NCT02208089|474765363|FG001|Overall Study|Lost to Follow-up|0|||
131859681|NCT02443740|474765364|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859682|NCT02443740|474765365|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859683|NCT02443740|474765366|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859684|NCT02443740|474765367|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
131407791|NCT03549871|473115191|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
131407792|NCT03549871|473115190|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
131407793|NCT03549871|473115191|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
131407794|NCT03549871|473115190|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
131407795|NCT03549871|473115191|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
131407796|NCT03549871|473115190|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
131407797|NCT03549871|473115191|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
131407798|NCT03549871|473115190|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
131407799|NCT03549871|473115191|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
131407800|NCT03549871|473115190|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
131434021|NCT01216202|473214607|FG001|Overall Study|Withdrawal by Subject|0|||
131913034|NCT01288430|474969278|FG001|Part 1|Death due to disease progression|0|||
131859685|NCT02443740|474765368|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
131913035|NCT01288430|474969279|FG002|Part 1|Death due to disease progression|0|||
131859686|NCT02443740|474765369|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
131859687|NCT02443740|474765370|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859688|NCT02443740|474765371|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859689|NCT02443740|474765372|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859690|NCT02443740|474765373|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859691|NCT02443740|474765374|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
131859692|NCT02443740|474765364|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
131859693|NCT02443740|474765365|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859694|NCT02443740|474765366|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859695|NCT02443740|474765367|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859696|NCT02443740|474765368|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859697|NCT02443740|474765369|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859698|NCT02443740|474765370|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
131859699|NCT02443740|474765371|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859700|NCT02443740|474765372|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859701|NCT02443740|474765373|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859702|NCT02443740|474765374|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
131859703|NCT02443740|474765364|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859704|NCT02443740|474765365|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859705|NCT02443740|474765366|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859706|NCT02443740|474765367|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859707|NCT02443740|474765368|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859708|NCT02443740|474765369|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
131859709|NCT02443740|474765370|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859710|NCT02443740|474765371|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859711|NCT02443740|474765372|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859712|NCT02443740|474765373|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859713|NCT02443740|474765374|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
131859714|NCT00456300|474765375|FG000|Overall Study|Adverse Event|1|||
131859715|NCT00456300|474765376|FG001|Overall Study|Adverse Event|0|||
131859716|NCT00683657|474765383|FG000|Overall Study|Adverse Event|0|||
131859717|NCT00683657|474765384|FG001|Overall Study|Adverse Event|1|||
131859718|NCT00683657|474765383|FG000|Overall Study|Subject Withdrew Consent|1|||
131859719|NCT00683657|474765384|FG001|Overall Study|Subject Withdrew Consent|0|||
131859720|NCT01074944|474765386|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
131859721|NCT01074944|474765387|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
131859722|NCT01074944|474765388|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
131859723|NCT01074944|474765389|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
131859724|NCT01074944|474765390|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
131859725|NCT01074944|474765386|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
131859726|NCT01074944|474765387|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
131859727|NCT01074944|474765388|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
131859728|NCT01074944|474765389|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
131859729|NCT01074944|474765390|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
131859730|NCT01074944|474765386|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
131859731|NCT01074944|474765387|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
131859732|NCT01074944|474765388|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
131859733|NCT01074944|474765389|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
131859734|NCT01074944|474765390|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
131859735|NCT01074944|474765386|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
131859736|NCT01074944|474765387|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
131859737|NCT01074944|474765388|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
131859738|NCT01074944|474765389|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
131859739|NCT01074944|474765390|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
131859740|NCT01074944|474765386|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
131859741|NCT01074944|474765387|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
131859742|NCT01074944|474765388|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
131859743|NCT01074944|474765389|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
131859744|NCT01074944|474765390|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
131859745|NCT01074944|474765386|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
131859746|NCT01074944|474765387|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
131859747|NCT01074944|474765388|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
131859748|NCT01074944|474765389|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
131859749|NCT01074944|474765390|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
131859750|NCT01074944|474765386|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
131859751|NCT01074944|474765387|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
131859752|NCT01074944|474765388|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
131859753|NCT01074944|474765389|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
131859754|NCT01074944|474765390|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
131859755|NCT01074944|474765386|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
131859756|NCT01074944|474765387|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
131859757|NCT01074944|474765388|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
131859758|NCT01074944|474765389|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
131859759|NCT01074944|474765390|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
131859760|NCT01074944|474765386|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
131859761|NCT01074944|474765387|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
131859762|NCT01074944|474765388|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
131859763|NCT01074944|474765389|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
131859764|NCT01074944|474765390|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
131859765|NCT01074944|474765386|FG000|Long Term Treatment|Adverse Event|0|||
131859766|NCT01074944|474765387|FG001|Long Term Treatment|Adverse Event|0|||
131859767|NCT01074944|474765388|FG002|Long Term Treatment|Adverse Event|0|||
131859768|NCT01074944|474765389|FG003|Long Term Treatment|Adverse Event|3|||
131859769|NCT01074944|474765390|FG004|Long Term Treatment|Adverse Event|0|||
131859770|NCT01074944|474765386|FG000|Long Term Treatment|Lost to Follow-up|0|||
131859771|NCT01074944|474765387|FG001|Long Term Treatment|Lost to Follow-up|0|||
131859772|NCT01074944|474765388|FG002|Long Term Treatment|Lost to Follow-up|0|||
131859773|NCT01074944|474765389|FG003|Long Term Treatment|Lost to Follow-up|2|||
131859774|NCT01074944|474765390|FG004|Long Term Treatment|Lost to Follow-up|0|||
131859775|NCT01074944|474765386|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
131859776|NCT01074944|474765387|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
131859777|NCT01074944|474765388|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
131859778|NCT01074944|474765389|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
131859779|NCT01074944|474765390|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
131859780|NCT01074944|474765386|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
131859781|NCT01074944|474765387|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
131859782|NCT01074944|474765388|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
131859783|NCT01074944|474765389|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
131859784|NCT01074944|474765390|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
131859785|NCT01074944|474765386|FG000|Long Term Treatment|Withdrawal by Subject|0|||
131859786|NCT01074944|474765387|FG001|Long Term Treatment|Withdrawal by Subject|0|||
131859787|NCT01074944|474765388|FG002|Long Term Treatment|Withdrawal by Subject|0|||
131859788|NCT01074944|474765389|FG003|Long Term Treatment|Withdrawal by Subject|2|||
131859789|NCT01074944|474765390|FG004|Long Term Treatment|Withdrawal by Subject|0|||
131859790|NCT01074944|474765386|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
131859791|NCT01074944|474765387|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
131859792|NCT01074944|474765388|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
131859793|NCT01074944|474765389|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
131859794|NCT01074944|474765390|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
131859795|NCT01074944|474765386|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
131859796|NCT01074944|474765387|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
131859797|NCT01074944|474765388|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
131859798|NCT01074944|474765389|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
131859799|NCT01074944|474765390|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
131859800|NCT02348112|474765393|FG000|Overall Study|Withdrawal by Subject|32|||
131859801|NCT02348112|474765394|FG001|Overall Study|Withdrawal by Subject|29|||
131859802|NCT02348112|474765393|FG000|Overall Study|Lost to Follow-up|24|||
131859803|NCT02348112|474765394|FG001|Overall Study|Lost to Follow-up|20|||
131859804|NCT02348112|474765393|FG000|Overall Study|Physician Decision|17|||
131859805|NCT02348112|474765394|FG001|Overall Study|Physician Decision|15|||
131859806|NCT02348112|474765393|FG000|Overall Study|Site closed due to PI leaving|0|||
131859807|NCT02348112|474765394|FG001|Overall Study|Site closed due to PI leaving|30|||
131859808|NCT02348112|474765393|FG000|Overall Study|Sponsor withdrawal|0|||
131859809|NCT02348112|474765394|FG001|Overall Study|Sponsor withdrawal|7|||
131859810|NCT02348112|474765393|FG000|Overall Study|Death|0|||
131859811|NCT02348112|474765394|FG001|Overall Study|Death|1|||
131859812|NCT01408043|474765395|FG000|Overall Study|unable to collect cells|1|||
131859813|NCT01998841|474765396|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
131859814|NCT01998841|474765397|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
131859815|NCT01998841|474765398|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
131859816|NCT01998841|474765399|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
131859817|NCT01998841|474765400|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
131859818|NCT01998841|474765396|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
131859819|NCT01998841|474765397|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
131859820|NCT01998841|474765398|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
131859821|NCT01998841|474765399|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
131859822|NCT01998841|474765400|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
131859823|NCT00739063|474765402|FG000|Overall Study|Screen failures|8|||
131859824|NCT04779879|474765403|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
131859825|NCT04779879|474765404|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
131859826|NCT04779879|474765405|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
131407801|NCT03549871|473115191|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
131859827|NCT04779879|474765406|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
131859828|NCT04779879|474765407|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
131859829|NCT04779879|474765408|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
131859830|NCT04779879|474765403|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
131859831|NCT04779879|474765404|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
131859832|NCT04779879|474765405|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
131859833|NCT04779879|474765406|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
131859834|NCT04779879|474765407|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
131859835|NCT04779879|474765408|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
131859836|NCT04779879|474765403|FG000|Part C: Up to Week 36|Death|0|||
131859837|NCT04779879|474765404|FG001|Part C: Up to Week 36|Death|0|||
131859838|NCT04779879|474765405|FG002|Part C: Up to Week 36|Death|0|||
131859839|NCT04779879|474765406|FG003|Part C: Up to Week 36|Death|0|||
131859840|NCT04779879|474765407|FG004|Part C: Up to Week 36|Death|0|||
131859841|NCT04779879|474765408|FG005|Part C: Up to Week 36|Death|1|||
131859842|NCT04779879|474765403|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
131859843|NCT04779879|474765404|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
131859844|NCT04779879|474765405|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
131859845|NCT04779879|474765406|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
131859846|NCT04779879|474765407|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
131859847|NCT04779879|474765408|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
131859848|NCT02461160|474765409|FG000|Overall Study|Lost to Follow-up|0|||
131859849|NCT02461160|474765410|FG001|Overall Study|Lost to Follow-up|0|||
131859850|NCT02461160|474765411|FG002|Overall Study|Lost to Follow-up|0|||
131859851|NCT02461160|474765412|FG003|Overall Study|Lost to Follow-up|0|||
131859852|NCT02461160|474765413|FG004|Overall Study|Lost to Follow-up|0|||
131859853|NCT02461160|474765414|FG005|Overall Study|Lost to Follow-up|0|||
131859854|NCT02461160|474765415|FG006|Overall Study|Lost to Follow-up|0|||
131859855|NCT02461160|474765416|FG007|Overall Study|Lost to Follow-up|1|||
131859856|NCT02461160|474765417|FG008|Overall Study|Lost to Follow-up|0|||
131859857|NCT02461160|474765418|FG009|Overall Study|Lost to Follow-up|0|||
131859858|NCT02461160|474765419|FG010|Overall Study|Lost to Follow-up|0|||
131859859|NCT02461160|474765420|FG011|Overall Study|Lost to Follow-up|0|||
131859860|NCT02461160|474765421|FG012|Overall Study|Lost to Follow-up|0|||
131859861|NCT02854527|474765422|FG000|Overall Study|Adverse Event|0|||
131859862|NCT02854527|474765423|FG001|Overall Study|Adverse Event|0|||
131859863|NCT02854527|474765424|FG002|Overall Study|Adverse Event|0|||
131859864|NCT02854527|474765425|FG003|Overall Study|Adverse Event|0|||
131859865|NCT02854527|474765426|FG004|Overall Study|Adverse Event|1|||
131859866|NCT02854527|474765427|FG005|Overall Study|Adverse Event|0|||
131859867|NCT02854527|474765428|FG006|Overall Study|Adverse Event|0|||
131859868|NCT02854527|474765429|FG007|Overall Study|Adverse Event|0|||
131859869|NCT02854527|474765430|FG008|Overall Study|Adverse Event|0|||
131859870|NCT02854527|474765431|FG009|Overall Study|Adverse Event|0|||
131859871|NCT02854527|474765422|FG000|Overall Study|Lost to Follow-up|0|||
131859872|NCT02854527|474765423|FG001|Overall Study|Lost to Follow-up|0|||
131859873|NCT02854527|474765424|FG002|Overall Study|Lost to Follow-up|0|||
131859874|NCT02854527|474765425|FG003|Overall Study|Lost to Follow-up|1|||
131859875|NCT02854527|474765426|FG004|Overall Study|Lost to Follow-up|0|||
131859876|NCT02854527|474765427|FG005|Overall Study|Lost to Follow-up|0|||
131859877|NCT02854527|474765428|FG006|Overall Study|Lost to Follow-up|0|||
131859878|NCT02854527|474765429|FG007|Overall Study|Lost to Follow-up|0|||
131859879|NCT02854527|474765430|FG008|Overall Study|Lost to Follow-up|0|||
131859880|NCT02854527|474765431|FG009|Overall Study|Lost to Follow-up|0|||
131859881|NCT02899962|474765432|FG000|Open-label Phase|Adverse Event|2|||
131859882|NCT02899962|474765433|FG001|Open-label Phase|Adverse Event|0|||
131859883|NCT02899962|474765434|FG002|Open-label Phase|Adverse Event|0|||
131859884|NCT02899962|474765432|FG000|Open-label Phase|Lost to Follow-up|9|||
131859885|NCT02899962|474765433|FG001|Open-label Phase|Lost to Follow-up|0|||
131859886|NCT02899962|474765434|FG002|Open-label Phase|Lost to Follow-up|0|||
131859887|NCT02899962|474765432|FG000|Open-label Phase|Other reasons|9|||
131859888|NCT02899962|474765433|FG001|Open-label Phase|Other reasons|0|||
131859889|NCT02899962|474765434|FG002|Open-label Phase|Other reasons|0|||
131859890|NCT02899962|474765432|FG000|Open-label Phase|Withdrawal by Subject|7|||
131859891|NCT02899962|474765433|FG001|Open-label Phase|Withdrawal by Subject|0|||
131859892|NCT02899962|474765434|FG002|Open-label Phase|Withdrawal by Subject|0|||
131859893|NCT02899962|474765432|FG000|Maintenance Phase|Adverse Event|0|||
131859894|NCT02899962|474765433|FG001|Maintenance Phase|Adverse Event|2|||
131859895|NCT02899962|474765434|FG002|Maintenance Phase|Adverse Event|1|||
131407802|NCT03549871|473115190|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
131859896|NCT02899962|474765432|FG000|Maintenance Phase|Death|0|||
131407803|NCT03549871|473115191|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
131859897|NCT02899962|474765433|FG001|Maintenance Phase|Death|0|||
131859898|NCT02899962|474765434|FG002|Maintenance Phase|Death|1|||
131859899|NCT02899962|474765432|FG000|Maintenance Phase|Lack of Efficacy|0|||
131859900|NCT02899962|474765433|FG001|Maintenance Phase|Lack of Efficacy|20|||
131859901|NCT02899962|474765434|FG002|Maintenance Phase|Lack of Efficacy|16|||
131859902|NCT02899962|474765432|FG000|Maintenance Phase|Lost to Follow-up|0|||
131859903|NCT02899962|474765433|FG001|Maintenance Phase|Lost to Follow-up|12|||
131859904|NCT02899962|474765434|FG002|Maintenance Phase|Lost to Follow-up|14|||
131859905|NCT02899962|474765432|FG000|Maintenance Phase|Other reasons|0|||
131859906|NCT02899962|474765433|FG001|Maintenance Phase|Other reasons|9|||
131859907|NCT02899962|474765434|FG002|Maintenance Phase|Other reasons|13|||
131859908|NCT02899962|474765432|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
131859909|NCT02899962|474765433|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
131859910|NCT02899962|474765434|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
131859911|NCT02899962|474765432|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
131859912|NCT02899962|474765433|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
131859913|NCT02899962|474765434|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
131859914|NCT02899962|474765432|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131859915|NCT02899962|474765433|FG001|Maintenance Phase|Withdrawal by Subject|30|||
131859916|NCT02899962|474765434|FG002|Maintenance Phase|Withdrawal by Subject|36|||
131859917|NCT03093259|474765441|FG000|Overall Study|Adverse Event|1|||
131859918|NCT03093259|474765442|FG001|Overall Study|Adverse Event|0|||
131859919|NCT03093259|474765441|FG000|Overall Study|Withdrawal by Subject|1|||
131859920|NCT03093259|474765442|FG001|Overall Study|Withdrawal by Subject|0|||
131859921|NCT02575833|474765443|FG000|Overall Study|Withdrawal by Subject|0|||
131859922|NCT02575833|474765444|FG001|Overall Study|Withdrawal by Subject|1|||
131859923|NCT02575833|474765443|FG000|Overall Study|Lost to Follow-up|1|||
131859924|NCT02575833|474765444|FG001|Overall Study|Lost to Follow-up|0|||
131859925|NCT02633787|474765445|FG000|Overall Study|Withdrawal by Subject|1|||
131859926|NCT02404805|474765446|FG000|Overall Study|Withdrawal by Subject|1|||
131859927|NCT02404805|474765447|FG001|Overall Study|Withdrawal by Subject|0|||
131859928|NCT02404805|474765448|FG002|Overall Study|Withdrawal by Subject|0|||
131859929|NCT02404805|474765449|FG003|Overall Study|Withdrawal by Subject|0|||
131859930|NCT02404805|474765450|FG004|Overall Study|Withdrawal by Subject|0|||
131859931|NCT02404805|474765451|FG005|Overall Study|Withdrawal by Subject|0|||
131859932|NCT00967330|474765453|FG000|Overall Study|Protocol Violation|3|||
131859933|NCT00967330|474765454|FG001|Overall Study|Protocol Violation|4|||
131859934|NCT00967330|474765453|FG000|Overall Study|Regular|10|||
131859935|NCT00967330|474765454|FG001|Overall Study|Regular|3|||
131859936|NCT00967330|474765453|FG000|Overall Study|Withdrawal by Subject|6|||
131859937|NCT00967330|474765454|FG001|Overall Study|Withdrawal by Subject|0|||
131859938|NCT00967330|474765453|FG000|Overall Study|Lost to Follow-up|1|||
131859939|NCT00967330|474765454|FG001|Overall Study|Lost to Follow-up|1|||
131859940|NCT00967330|474765453|FG000|Overall Study|Death|102|||
131859941|NCT00967330|474765454|FG001|Overall Study|Death|51|||
131859942|NCT00967330|474765453|FG000|Overall Study|Severe protocol deviation|0|||
131859943|NCT00967330|474765454|FG001|Overall Study|Severe protocol deviation|1|||
131859944|NCT02623725|474765456|FG000|Overall Study|Non compliance with protocol|9|||
131859945|NCT02623725|474765457|FG001|Overall Study|Non compliance with protocol|3|||
131859946|NCT02623725|474765456|FG000|Overall Study|Serious adverse event|0|||
131859947|NCT02623725|474765457|FG001|Overall Study|Serious adverse event|2|||
131859948|NCT02623725|474765456|FG000|Overall Study|Withdrawal by Subject|7|||
131859949|NCT02623725|474765457|FG001|Overall Study|Withdrawal by Subject|1|||
131859950|NCT04871776|474765458|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
131859951|NCT04871776|474765459|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
131407804|NCT03549871|473115190|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
131407805|NCT03549871|473115191|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
131407806|NCT03549871|473115190|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
131407807|NCT03549871|473115191|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
131407808|NCT03549871|473115190|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
131407809|NCT03549871|473115191|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
131407810|NCT03549871|473115190|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
131407811|NCT03549871|473115191|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
131407812|NCT01133626|473115193|FG000|Overall Study|Adverse Event|0|||
131407813|NCT01133626|473115194|FG001|Overall Study|Adverse Event|1|||
131407814|NCT01133626|473115195|FG002|Overall Study|Adverse Event|0|||
131407815|NCT01133626|473115193|FG000|Overall Study|Withdrawal by Subject|1|||
131407816|NCT01133626|473115194|FG001|Overall Study|Withdrawal by Subject|2|||
131407817|NCT01133626|473115195|FG002|Overall Study|Withdrawal by Subject|2|||
131407818|NCT01133626|473115193|FG000|Overall Study|Other|0|||
131407819|NCT01133626|473115194|FG001|Overall Study|Other|2|||
131859952|NCT04871776|474765460|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
131859953|NCT04871776|474765458|FG000|Overall Study|Did not meet eligibility criteria|1|||
131407820|NCT01133626|473115195|FG002|Overall Study|Other|0|||
131407821|NCT03199053|473115196|FG000|ST Period|Withdrawal by Subject|2|||
131407822|NCT03199053|473115197|FG001|ST Period|Withdrawal by Subject|4|||
131407823|NCT03199053|473115198|FG002|ST Period|Withdrawal by Subject|6|||
131859954|NCT04871776|474765459|FG001|Overall Study|Did not meet eligibility criteria|1|||
131859955|NCT04871776|474765460|FG002|Overall Study|Did not meet eligibility criteria|1|||
131859956|NCT02848001|474768048|FG000|Overall Study|other reasons|0|||
131859957|NCT02848001|474768049|FG001|Overall Study|other reasons|0|||
131859958|NCT02848001|474768050|FG002|Overall Study|other reasons|1|||
131859959|NCT02848001|474768051|FG003|Overall Study|other reasons|0|||
131859960|NCT02848001|474768052|FG004|Overall Study|other reasons|4|||
131859961|NCT02848001|474768053|FG005|Overall Study|other reasons|1|||
131859962|NCT02848001|474768054|FG006|Overall Study|other reasons|0|||
131859963|NCT02848001|474768055|FG007|Overall Study|other reasons|2|||
131859964|NCT02848001|474768056|FG008|Overall Study|other reasons|2|||
131859965|NCT02848001|474768057|FG009|Overall Study|other reasons|3|||
131859966|NCT02848001|474768058|FG010|Overall Study|other reasons|0|||
131859967|NCT02848001|474768059|FG011|Overall Study|other reasons|1|||
131859968|NCT02848001|474768060|FG012|Overall Study|other reasons|1|||
131859969|NCT02848001|474768061|FG013|Overall Study|other reasons|0|||
131859970|NCT02848001|474768062|FG014|Overall Study|other reasons|0|||
131859971|NCT02848001|474768063|FG015|Overall Study|other reasons|2|||
131859972|NCT02848001|474768064|FG016|Overall Study|other reasons|1|||
131859973|NCT02848001|474768048|FG000|Overall Study|Lack of Efficacy|0|||
131859974|NCT02848001|474768049|FG001|Overall Study|Lack of Efficacy|1|||
131859975|NCT02848001|474768050|FG002|Overall Study|Lack of Efficacy|1|||
131859976|NCT02848001|474768051|FG003|Overall Study|Lack of Efficacy|2|||
131859977|NCT02848001|474768052|FG004|Overall Study|Lack of Efficacy|3|||
131859978|NCT02848001|474768053|FG005|Overall Study|Lack of Efficacy|0|||
131859979|NCT02848001|474768054|FG006|Overall Study|Lack of Efficacy|1|||
131859980|NCT02848001|474768055|FG007|Overall Study|Lack of Efficacy|0|||
131859981|NCT02848001|474768056|FG008|Overall Study|Lack of Efficacy|0|||
131859982|NCT02848001|474768057|FG009|Overall Study|Lack of Efficacy|1|||
131859983|NCT02848001|474768058|FG010|Overall Study|Lack of Efficacy|0|||
131859984|NCT02848001|474768059|FG011|Overall Study|Lack of Efficacy|2|||
131859985|NCT02848001|474768060|FG012|Overall Study|Lack of Efficacy|0|||
131859986|NCT02848001|474768061|FG013|Overall Study|Lack of Efficacy|2|||
131859987|NCT02848001|474768062|FG014|Overall Study|Lack of Efficacy|2|||
131859988|NCT02848001|474768063|FG015|Overall Study|Lack of Efficacy|0|||
131859989|NCT02848001|474768064|FG016|Overall Study|Lack of Efficacy|0|||
131859990|NCT02848001|474768048|FG000|Overall Study|Progressive Disease|2|||
131859991|NCT02848001|474768049|FG001|Overall Study|Progressive Disease|1|||
131859992|NCT02848001|474768050|FG002|Overall Study|Progressive Disease|0|||
131859993|NCT02848001|474768051|FG003|Overall Study|Progressive Disease|4|||
131859994|NCT02848001|474768052|FG004|Overall Study|Progressive Disease|3|||
131859995|NCT02848001|474768053|FG005|Overall Study|Progressive Disease|0|||
131859996|NCT02848001|474768054|FG006|Overall Study|Progressive Disease|4|||
131859997|NCT02848001|474768055|FG007|Overall Study|Progressive Disease|1|||
131859998|NCT02848001|474768056|FG008|Overall Study|Progressive Disease|0|||
131859999|NCT02848001|474768057|FG009|Overall Study|Progressive Disease|2|||
131860000|NCT02848001|474768058|FG010|Overall Study|Progressive Disease|3|||
131860001|NCT02848001|474768059|FG011|Overall Study|Progressive Disease|2|||
131860002|NCT02848001|474768060|FG012|Overall Study|Progressive Disease|1|||
131860003|NCT02848001|474768061|FG013|Overall Study|Progressive Disease|0|||
131860004|NCT02848001|474768062|FG014|Overall Study|Progressive Disease|2|||
131860005|NCT02848001|474768063|FG015|Overall Study|Progressive Disease|4|||
131860006|NCT02848001|474768064|FG016|Overall Study|Progressive Disease|0|||
131860007|NCT02848001|474768048|FG000|Overall Study|Adverse Event|0|||
131860008|NCT02848001|474768049|FG001|Overall Study|Adverse Event|0|||
131860009|NCT02848001|474768050|FG002|Overall Study|Adverse Event|0|||
131860010|NCT02848001|474768051|FG003|Overall Study|Adverse Event|0|||
131860011|NCT02848001|474768052|FG004|Overall Study|Adverse Event|2|||
131860012|NCT02848001|474768053|FG005|Overall Study|Adverse Event|0|||
131860013|NCT02848001|474768054|FG006|Overall Study|Adverse Event|0|||
131860014|NCT02848001|474768055|FG007|Overall Study|Adverse Event|0|||
131860015|NCT02848001|474768056|FG008|Overall Study|Adverse Event|0|||
131860016|NCT02848001|474768057|FG009|Overall Study|Adverse Event|1|||
131860017|NCT02848001|474768058|FG010|Overall Study|Adverse Event|0|||
131860018|NCT02848001|474768059|FG011|Overall Study|Adverse Event|1|||
131860019|NCT02848001|474768060|FG012|Overall Study|Adverse Event|1|||
131860020|NCT02848001|474768061|FG013|Overall Study|Adverse Event|0|||
131407824|NCT03199053|473115196|FG000|ST Period|Withdrawal by parent/guardian|1|||
131860021|NCT02848001|474768062|FG014|Overall Study|Adverse Event|2|||
131860022|NCT02848001|474768063|FG015|Overall Study|Adverse Event|0|||
131860023|NCT02848001|474768064|FG016|Overall Study|Adverse Event|0|||
131860024|NCT02848001|474768048|FG000|Overall Study|Death|0|||
131860025|NCT02848001|474768049|FG001|Overall Study|Death|0|||
131860026|NCT02848001|474768050|FG002|Overall Study|Death|0|||
131860027|NCT02848001|474768051|FG003|Overall Study|Death|1|||
131860028|NCT02848001|474768052|FG004|Overall Study|Death|3|||
131860029|NCT02848001|474768053|FG005|Overall Study|Death|1|||
131860030|NCT02848001|474768054|FG006|Overall Study|Death|2|||
131860031|NCT02848001|474768055|FG007|Overall Study|Death|3|||
131860032|NCT02848001|474768056|FG008|Overall Study|Death|4|||
131860033|NCT02848001|474768057|FG009|Overall Study|Death|1|||
131860034|NCT02848001|474768058|FG010|Overall Study|Death|0|||
131860035|NCT02848001|474768059|FG011|Overall Study|Death|1|||
131860036|NCT02848001|474768060|FG012|Overall Study|Death|3|||
131860037|NCT02848001|474768061|FG013|Overall Study|Death|0|||
131860038|NCT02848001|474768062|FG014|Overall Study|Death|2|||
131860039|NCT02848001|474768063|FG015|Overall Study|Death|3|||
131860040|NCT02848001|474768064|FG016|Overall Study|Death|0|||
131860041|NCT02848001|474768048|FG000|Overall Study|Physician Decision|0|||
131860042|NCT02848001|474768049|FG001|Overall Study|Physician Decision|0|||
131860043|NCT02848001|474768050|FG002|Overall Study|Physician Decision|0|||
131860044|NCT02848001|474768051|FG003|Overall Study|Physician Decision|0|||
131860045|NCT02848001|474768052|FG004|Overall Study|Physician Decision|0|||
131860046|NCT02848001|474768053|FG005|Overall Study|Physician Decision|0|||
131860047|NCT02848001|474768054|FG006|Overall Study|Physician Decision|0|||
131860048|NCT02848001|474768055|FG007|Overall Study|Physician Decision|0|||
131860049|NCT02848001|474768056|FG008|Overall Study|Physician Decision|1|||
131860050|NCT02848001|474768057|FG009|Overall Study|Physician Decision|1|||
131860051|NCT02848001|474768058|FG010|Overall Study|Physician Decision|0|||
131860052|NCT02848001|474768059|FG011|Overall Study|Physician Decision|0|||
131860053|NCT02848001|474768060|FG012|Overall Study|Physician Decision|2|||
131860054|NCT02848001|474768061|FG013|Overall Study|Physician Decision|0|||
131860055|NCT02848001|474768062|FG014|Overall Study|Physician Decision|0|||
131453838|NCT05767749|473290049|FG002|Overall Study|Withdrawal by Subject|2|||
131453839|NCT05767749|473290050|FG003|Overall Study|Withdrawal by Subject|2|||
131453840|NCT05767749|473290051|FG004|Overall Study|Withdrawal by Subject|2|||
131453841|NCT05767749|473290052|FG005|Overall Study|Withdrawal by Subject|2|||
131453842|NCT03083873|473291790|FG000|Overall Study|Death|6|||
131453843|NCT03083873|473291791|FG001|Overall Study|Death|15|||
131453844|NCT03083873|473291792|FG002|Overall Study|Death|13|||
131453845|NCT03083873|473291793|FG003|Overall Study|Death|9|||
131860056|NCT02848001|474768063|FG015|Overall Study|Physician Decision|0|||
131860057|NCT02848001|474768064|FG016|Overall Study|Physician Decision|0|||
131860058|NCT02848001|474768048|FG000|Overall Study|Withdrawal by Subject|0|||
131860059|NCT02848001|474768049|FG001|Overall Study|Withdrawal by Subject|0|||
131860060|NCT02848001|474768050|FG002|Overall Study|Withdrawal by Subject|0|||
131860061|NCT02848001|474768051|FG003|Overall Study|Withdrawal by Subject|0|||
131860062|NCT02848001|474768052|FG004|Overall Study|Withdrawal by Subject|0|||
131860063|NCT02848001|474768053|FG005|Overall Study|Withdrawal by Subject|1|||
131860064|NCT02848001|474768054|FG006|Overall Study|Withdrawal by Subject|1|||
131860065|NCT02848001|474768055|FG007|Overall Study|Withdrawal by Subject|1|||
131860066|NCT02848001|474768056|FG008|Overall Study|Withdrawal by Subject|0|||
131860067|NCT02848001|474768057|FG009|Overall Study|Withdrawal by Subject|0|||
131860068|NCT02848001|474768058|FG010|Overall Study|Withdrawal by Subject|0|||
131860069|NCT02848001|474768059|FG011|Overall Study|Withdrawal by Subject|0|||
131860070|NCT02848001|474768060|FG012|Overall Study|Withdrawal by Subject|0|||
131860071|NCT02848001|474768061|FG013|Overall Study|Withdrawal by Subject|0|||
131860072|NCT02848001|474768062|FG014|Overall Study|Withdrawal by Subject|0|||
131860073|NCT02848001|474768063|FG015|Overall Study|Withdrawal by Subject|0|||
131860074|NCT02848001|474768064|FG016|Overall Study|Withdrawal by Subject|0|||
131860075|NCT01962103|474768072|FG000|Phase 1|Adverse Event|4|||
131860076|NCT01962103|474768073|FG001|Phase 1|Adverse Event|0|||
131860077|NCT01962103|474768074|FG002|Phase 1|Adverse Event|2|||
131860078|NCT01962103|474768075|FG003|Phase 1|Adverse Event|1|||
131860079|NCT01962103|474768076|FG004|Phase 1|Adverse Event|2|||
131860080|NCT01962103|474768077|FG005|Phase 1|Adverse Event|2|||
131860081|NCT01962103|474768078|FG006|Phase 1|Adverse Event|0|||
131860082|NCT01962103|474768079|FG007|Phase 1|Adverse Event|0|||
131860083|NCT01962103|474768080|FG008|Phase 1|Adverse Event|0|||
131860084|NCT01962103|474768072|FG000|Phase 1|Progressive Disease|8|||
131860085|NCT01962103|474768073|FG001|Phase 1|Progressive Disease|6|||
131860086|NCT01962103|474768074|FG002|Phase 1|Progressive Disease|8|||
131860087|NCT01962103|474768075|FG003|Phase 1|Progressive Disease|4|||
131407825|NCT03199053|473115197|FG001|ST Period|Withdrawal by parent/guardian|1|||
131407826|NCT03199053|473115198|FG002|ST Period|Withdrawal by parent/guardian|1|||
131407827|NCT03199053|473115196|FG000|ST Period|Lost to Follow-up|2|||
131407828|NCT03199053|473115197|FG001|ST Period|Lost to Follow-up|0|||
131407829|NCT03199053|473115198|FG002|ST Period|Lost to Follow-up|1|||
131407830|NCT03199053|473115196|FG000|LT Period|Withdrawal by Subject|1|||
131407831|NCT03199053|473115197|FG001|LT Period|Withdrawal by Subject|3|||
131407832|NCT03199053|473115198|FG002|LT Period|Withdrawal by Subject|3|||
131407833|NCT03199053|473115196|FG000|LT Period|Withdrawal by parent/guardian|0|||
131453846|NCT03083873|473291794|FG004|Overall Study|Death|0|||
131860088|NCT01962103|474768076|FG004|Phase 1|Progressive Disease|5|||
131860089|NCT01962103|474768077|FG005|Phase 1|Progressive Disease|4|||
131860090|NCT01962103|474768078|FG006|Phase 1|Progressive Disease|0|||
131860091|NCT01962103|474768079|FG007|Phase 1|Progressive Disease|0|||
131860092|NCT01962103|474768080|FG008|Phase 1|Progressive Disease|0|||
131407834|NCT03199053|473115197|FG001|LT Period|Withdrawal by parent/guardian|0|||
131453847|NCT03083873|473291790|FG000|Overall Study|Sponsor Terminated Study|0|||
131453848|NCT03083873|473291791|FG001|Overall Study|Sponsor Terminated Study|1|||
131860093|NCT01962103|474768072|FG000|Phase 1|Withdrawal by Subject|0|||
131860094|NCT01962103|474768073|FG001|Phase 1|Withdrawal by Subject|0|||
131860095|NCT01962103|474768074|FG002|Phase 1|Withdrawal by Subject|0|||
131860096|NCT01962103|474768075|FG003|Phase 1|Withdrawal by Subject|2|||
131860097|NCT01962103|474768076|FG004|Phase 1|Withdrawal by Subject|0|||
131860098|NCT01962103|474768077|FG005|Phase 1|Withdrawal by Subject|0|||
131860099|NCT01962103|474768078|FG006|Phase 1|Withdrawal by Subject|0|||
131860100|NCT01962103|474768079|FG007|Phase 1|Withdrawal by Subject|0|||
131860101|NCT01962103|474768080|FG008|Phase 1|Withdrawal by Subject|0|||
131860102|NCT01962103|474768072|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
131860103|NCT01962103|474768073|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
131860104|NCT01962103|474768074|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
131860105|NCT01962103|474768075|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
131860106|NCT01962103|474768076|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
131860107|NCT01962103|474768077|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
131860108|NCT01962103|474768078|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
131860109|NCT01962103|474768079|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
131860110|NCT01962103|474768080|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
131860111|NCT01962103|474768072|FG000|Phase 1|Physician Decision|0|||
131860112|NCT01962103|474768073|FG001|Phase 1|Physician Decision|0|||
131860113|NCT01962103|474768074|FG002|Phase 1|Physician Decision|0|||
131860114|NCT01962103|474768075|FG003|Phase 1|Physician Decision|1|||
131860115|NCT01962103|474768076|FG004|Phase 1|Physician Decision|0|||
131860116|NCT01962103|474768077|FG005|Phase 1|Physician Decision|0|||
131860117|NCT01962103|474768078|FG006|Phase 1|Physician Decision|0|||
131860118|NCT01962103|474768079|FG007|Phase 1|Physician Decision|0|||
131860119|NCT01962103|474768080|FG008|Phase 1|Physician Decision|0|||
131860120|NCT01962103|474768072|FG000|Phase 1|Symptomatic Deterioration|3|||
131860121|NCT01962103|474768073|FG001|Phase 1|Symptomatic Deterioration|2|||
131860122|NCT01962103|474768074|FG002|Phase 1|Symptomatic Deterioration|2|||
131860123|NCT01962103|474768075|FG003|Phase 1|Symptomatic Deterioration|2|||
131860124|NCT01962103|474768076|FG004|Phase 1|Symptomatic Deterioration|1|||
131860125|NCT01962103|474768077|FG005|Phase 1|Symptomatic Deterioration|1|||
131860126|NCT01962103|474768078|FG006|Phase 1|Symptomatic Deterioration|0|||
131860127|NCT01962103|474768079|FG007|Phase 1|Symptomatic Deterioration|0|||
131860128|NCT01962103|474768080|FG008|Phase 1|Symptomatic Deterioration|0|||
131860129|NCT01962103|474768072|FG000|Phase 1|Miscellaneous|1|||
131860130|NCT01962103|474768073|FG001|Phase 1|Miscellaneous|0|||
131860131|NCT01962103|474768074|FG002|Phase 1|Miscellaneous|0|||
131860132|NCT01962103|474768075|FG003|Phase 1|Miscellaneous|0|||
131860133|NCT01962103|474768076|FG004|Phase 1|Miscellaneous|0|||
131860134|NCT01962103|474768077|FG005|Phase 1|Miscellaneous|0|||
131860135|NCT01962103|474768078|FG006|Phase 1|Miscellaneous|0|||
131860136|NCT01962103|474768079|FG007|Phase 1|Miscellaneous|0|||
131860137|NCT01962103|474768080|FG008|Phase 1|Miscellaneous|0|||
131860138|NCT01962103|474768072|FG000|Phase 2|Adverse Event|0|||
131860139|NCT01962103|474768073|FG001|Phase 2|Adverse Event|0|||
131860140|NCT01962103|474768074|FG002|Phase 2|Adverse Event|0|||
131860141|NCT01962103|474768075|FG003|Phase 2|Adverse Event|0|||
131860142|NCT01962103|474768076|FG004|Phase 2|Adverse Event|0|||
131860143|NCT01962103|474768077|FG005|Phase 2|Adverse Event|0|||
131860144|NCT01962103|474768078|FG006|Phase 2|Adverse Event|1|||
131860145|NCT01962103|474768079|FG007|Phase 2|Adverse Event|0|||
131860146|NCT01962103|474768080|FG008|Phase 2|Adverse Event|3|||
131860147|NCT01962103|474768072|FG000|Phase 2|Progressive Disease|0|||
131860148|NCT01962103|474768073|FG001|Phase 2|Progressive Disease|0|||
131860149|NCT01962103|474768074|FG002|Phase 2|Progressive Disease|0|||
131860150|NCT01962103|474768075|FG003|Phase 2|Progressive Disease|0|||
131860151|NCT01962103|474768076|FG004|Phase 2|Progressive Disease|0|||
131860152|NCT01962103|474768077|FG005|Phase 2|Progressive Disease|0|||
131860153|NCT01962103|474768078|FG006|Phase 2|Progressive Disease|11|||
131860154|NCT01962103|474768079|FG007|Phase 2|Progressive Disease|12|||
131860155|NCT01962103|474768080|FG008|Phase 2|Progressive Disease|11|||
131860156|NCT01962103|474768072|FG000|Phase 2|Symptomatic Deterioration|0|||
131860157|NCT01962103|474768073|FG001|Phase 2|Symptomatic Deterioration|0|||
131860158|NCT01962103|474768074|FG002|Phase 2|Symptomatic Deterioration|0|||
131860159|NCT01962103|474768075|FG003|Phase 2|Symptomatic Deterioration|0|||
131860160|NCT01962103|474768076|FG004|Phase 2|Symptomatic Deterioration|0|||
131860161|NCT01962103|474768077|FG005|Phase 2|Symptomatic Deterioration|0|||
131860162|NCT01962103|474768078|FG006|Phase 2|Symptomatic Deterioration|2|||
131860163|NCT01962103|474768079|FG007|Phase 2|Symptomatic Deterioration|2|||
131860164|NCT01962103|474768080|FG008|Phase 2|Symptomatic Deterioration|0|||
131860165|NCT04179838|474768081|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
131860166|NCT04179838|474768082|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
131860167|NCT04179838|474768081|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
131860168|NCT04179838|474768082|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
131860169|NCT01290068|474768090|FG000|Overall Study|Adverse Event|1|||
131860170|NCT01290068|474768091|FG001|Overall Study|Adverse Event|3|||
131860171|NCT01290068|474768090|FG000|Overall Study|Lost to Follow-up|3|||
131860172|NCT01290068|474768091|FG001|Overall Study|Lost to Follow-up|0|||
131860173|NCT01290068|474768090|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
131860174|NCT01290068|474768091|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
131860175|NCT01290068|474768090|FG000|Overall Study|Other|3|||
131860176|NCT01290068|474768091|FG001|Overall Study|Other|1|||
131860177|NCT00513695|474768092|FG000|Overall Study|Discontinued therapy|2|||
131860178|NCT00513695|474768092|FG000|Overall Study|Progression prior to surgery|3|||
131860179|NCT00818766|474768099|FG000|Overall Study|Could not be Contacted on Day 28|11|||
131860180|NCT00818766|474768100|FG001|Overall Study|Could not be Contacted on Day 28|10|||
131860181|NCT00818766|474768099|FG000|Overall Study|Death|1|||
131860182|NCT00818766|474768100|FG001|Overall Study|Death|0|||
131860183|NCT00818766|474768099|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
131860184|NCT00818766|474768100|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
131860185|NCT01996241|474768101|FG000|Overall Study|Lost to Follow-up|252|||
131860186|NCT01996241|474768102|FG001|Overall Study|Lost to Follow-up|235|||
131860187|NCT01050530|474768111|FG000|Overall Study|Adverse Event|6|||
131860188|NCT01050530|474768112|FG001|Overall Study|Adverse Event|3|||
131407835|NCT03199053|473115198|FG002|LT Period|Withdrawal by parent/guardian|1|||
131407836|NCT03199053|473115196|FG000|LT Period|Lost to Follow-up|0|||
131913036|NCT01288430|474969280|FG003|Part 1|Death due to disease progression|0|||
131913037|NCT01288430|474969281|FG004|Part 1|Death due to disease progression|1|||
131913038|NCT01288430|474969282|FG005|Part 1|Death due to disease progression|0|||
131860189|NCT01050530|474768111|FG000|Overall Study|Lack of Efficacy|1|||
131860190|NCT01050530|474768112|FG001|Overall Study|Lack of Efficacy|4|||
131860191|NCT01050530|474768111|FG000|Overall Study|Withdrawal by Subject|0|||
131860192|NCT01050530|474768112|FG001|Overall Study|Withdrawal by Subject|3|||
131860193|NCT01050530|474768111|FG000|Overall Study|Protocol Violation|1|||
131860194|NCT01050530|474768112|FG001|Overall Study|Protocol Violation|0|||
131860195|NCT01495000|474768113|FG000|Overall Study|Lost to Follow-up|2|||
131860196|NCT01495000|474768114|FG001|Overall Study|Lost to Follow-up|2|||
131860197|NCT01495000|474768113|FG000|Overall Study|Protocol Violation|1|||
131860198|NCT01495000|474768114|FG001|Overall Study|Protocol Violation|0|||
131860199|NCT01495000|474768113|FG000|Overall Study|Withdrawal by Subject|10|||
131860200|NCT01495000|474768114|FG001|Overall Study|Withdrawal by Subject|10|||
131860201|NCT01514461|474768115|FG000|Overall Study|Adverse Event|2|||
131860202|NCT01514461|474768116|FG001|Overall Study|Adverse Event|1|||
131860203|NCT01514461|474768117|FG002|Overall Study|Adverse Event|3|||
131860204|NCT01514461|474768115|FG000|Overall Study|Physician Decision|1|||
131860205|NCT01514461|474768116|FG001|Overall Study|Physician Decision|1|||
131860206|NCT01514461|474768117|FG002|Overall Study|Physician Decision|0|||
131860207|NCT01514461|474768115|FG000|Overall Study|Patient/guardian decision|1|||
131860208|NCT01514461|474768116|FG001|Overall Study|Patient/guardian decision|1|||
131860209|NCT01514461|474768117|FG002|Overall Study|Patient/guardian decision|1|||
131860210|NCT01514461|474768115|FG000|Overall Study|Death|1|||
131860211|NCT01514461|474768116|FG001|Overall Study|Death|0|||
131860212|NCT01514461|474768117|FG002|Overall Study|Death|0|||
131860213|NCT03499067|474768118|FG000|First Intervention|Physician Decision|2|||
131860214|NCT03499067|474768119|FG001|First Intervention|Physician Decision|1|||
131860215|NCT03499067|474768118|FG000|First Intervention|Withdrawal by Subject|3|||
131860216|NCT03499067|474768119|FG001|First Intervention|Withdrawal by Subject|6|||
131860217|NCT02548832|474768120|FG000|Overall Study|Lost to Follow-up|2|||
131860218|NCT02548832|474768121|FG001|Overall Study|Lost to Follow-up|2|||
131860219|NCT02548832|474768122|FG002|Overall Study|Lost to Follow-up|2|||
131860220|NCT03565900|474768123|FG000|Overall Study|Disposition Unknown|4|||
131860221|NCT03565900|474768124|FG001|Overall Study|Disposition Unknown|1|||
131860222|NCT03565900|474768123|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131860223|NCT03565900|474768124|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
131860224|NCT03565900|474768123|FG000|Overall Study|Withdrawal by Subject|4|||
131860225|NCT03565900|474768124|FG001|Overall Study|Withdrawal by Subject|5|||
131860226|NCT03565900|474768123|FG000|Overall Study|Randomized By Mistake|0|||
131860227|NCT03565900|474768124|FG001|Overall Study|Randomized By Mistake|2|||
131860228|NCT03565900|474768123|FG000|Overall Study|Physician Decision|7|||
131860229|NCT03565900|474768124|FG001|Overall Study|Physician Decision|11|||
131860230|NCT03565900|474768123|FG000|Overall Study|Death|9|||
131860231|NCT03565900|474768124|FG001|Overall Study|Death|7|||
131860232|NCT03359850|474768132|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
131913039|NCT01288430|474969283|FG006|Part 1|Death due to disease progression|0|||
131913040|NCT01288430|474969284|FG007|Part 1|Death due to disease progression|0|||
131913041|NCT01288430|474969285|FG008|Part 1|Death due to disease progression|0|||
131913042|NCT01288430|474969286|FG009|Part 1|Death due to disease progression|0|||
131913043|NCT01288430|474969277|FG000|Part 1|Adverse Event|0|||
131913044|NCT01288430|474969278|FG001|Part 1|Adverse Event|0|||
131913045|NCT01288430|474969279|FG002|Part 1|Adverse Event|3|||
131407837|NCT03199053|473115197|FG001|LT Period|Lost to Follow-up|1|||
131860233|NCT03359850|474768133|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
131860234|NCT03359850|474768132|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
131913046|NCT01288430|474969280|FG003|Part 1|Adverse Event|1|||
131913047|NCT01288430|474969281|FG004|Part 1|Adverse Event|0|||
131913048|NCT01288430|474969282|FG005|Part 1|Adverse Event|0|||
131913049|NCT01288430|474969283|FG006|Part 1|Adverse Event|2|||
131860235|NCT03359850|474768133|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
131860236|NCT03359850|474768132|FG000|Extension Phase (Up to 28 Months)|Death|2|||
131860237|NCT03359850|474768133|FG001|Extension Phase (Up to 28 Months)|Death|4|||
131860238|NCT03359850|474768132|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
131913050|NCT01288430|474969284|FG007|Part 1|Adverse Event|0|||
131860239|NCT03359850|474768133|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
131860240|NCT03359850|474768132|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
131860241|NCT03359850|474768133|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
131860242|NCT01960257|474768141|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
131860243|NCT01960257|474768142|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
131860244|NCT01960257|474768143|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
131860245|NCT01960257|474768141|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
131860246|NCT01960257|474768142|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
131860247|NCT01960257|474768143|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
131860248|NCT01960257|474768141|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
131860249|NCT01960257|474768142|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
131860250|NCT01960257|474768143|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
131860251|NCT02002221|474768146|FG000|Overall Study|Adverse Event|2|||
131860252|NCT02002221|474768147|FG001|Overall Study|Adverse Event|1|||
131860253|NCT02002221|474768146|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131860254|NCT02002221|474768147|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131860255|NCT02002221|474768146|FG000|Overall Study|Patient withdrew consent|0|||
131860256|NCT02002221|474768147|FG001|Overall Study|Patient withdrew consent|1|||
131860257|NCT03347110|474768148|FG000|Overall Study|Other (Participant is incarcerated)|1|||
131860258|NCT03347110|474768148|FG000|Overall Study|Withdrawal by Subject|9|||
131860259|NCT03347110|474768148|FG000|Overall Study|Lost to Follow-up|1|||
131860260|NCT03347110|474768148|FG000|Overall Study|Lack of Efficacy|2|||
131860261|NCT03347110|474768148|FG000|Overall Study|Adverse Event, non-fatal|9|||
131860262|NCT02766335|474768152|FG000|Initial Registration|Adverse Event|6|||
131860263|NCT02766335|474768153|FG001|Initial Registration|Adverse Event|3|||
131860264|NCT02766335|474768154|FG002|Initial Registration|Adverse Event|0|||
131860265|NCT02766335|474768152|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
131860266|NCT02766335|474768153|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
131860267|NCT02766335|474768154|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
131860268|NCT02766335|474768152|FG000|Initial Registration|Progression/relapse|49|||
131860269|NCT02766335|474768153|FG001|Initial Registration|Progression/relapse|15|||
131860270|NCT02766335|474768154|FG002|Initial Registration|Progression/relapse|0|||
131860271|NCT02766335|474768152|FG000|Initial Registration|Death|1|||
131860272|NCT02766335|474768153|FG001|Initial Registration|Death|3|||
131860273|NCT02766335|474768154|FG002|Initial Registration|Death|0|||
131860274|NCT02766335|474768152|FG000|Initial Registration|not protocol specified|1|||
131860275|NCT02766335|474768153|FG001|Initial Registration|not protocol specified|9|||
131860276|NCT02766335|474768154|FG002|Initial Registration|not protocol specified|0|||
131860277|NCT02766335|474768152|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
131860278|NCT02766335|474768153|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
131860279|NCT02766335|474768154|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
131860280|NCT02766335|474768152|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
131860281|NCT02766335|474768153|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
131860282|NCT02766335|474768154|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
131860283|NCT03164551|474768158|FG000|Overall Study|Imaging discontinued prior completion|8|||
131860284|NCT03164551|474768159|FG001|Overall Study|Imaging discontinued prior completion|0|||
131860285|NCT03164551|474768158|FG000|Overall Study|Participant was non-compliant|1|||
131860286|NCT03164551|474768159|FG001|Overall Study|Participant was non-compliant|0|||
131860287|NCT03164551|474768158|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
131860288|NCT03164551|474768159|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
131860289|NCT03164551|474768158|FG000|Overall Study|Other|8|||
131860290|NCT03164551|474768159|FG001|Overall Study|Other|2|||
131860291|NCT01125917|474768162|FG000|Overall Study|Adverse Event|43|||
131860292|NCT01125917|474768162|FG000|Overall Study|Lost to Follow-up|23|||
131860293|NCT01125917|474768162|FG000|Overall Study|Withdrawal by Subject|31|||
131860294|NCT01125917|474768162|FG000|Overall Study|Administrative|223|||
131860295|NCT01125917|474768162|FG000|Overall Study|Lack of Efficacy|19|||
131860296|NCT04421131|474768165|FG000|Overall Study|Lost to Follow-up|1|||
131860297|NCT04421131|474768165|FG000|Overall Study|Protocol Violation|2|||
131860298|NCT04421131|474768165|FG000|Overall Study|App crashed|5|||
131860299|NCT02501928|474768166|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131860300|NCT02501928|474768167|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
131860301|NCT02501928|474768168|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
131860302|NCT02501928|474768169|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
131860303|NCT02501928|474768170|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
131860304|NCT02501928|474768171|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
131860305|NCT01320293|474768179|FG000|Overall Study|Lack of Efficacy|1|||
131860306|NCT01320293|474768179|FG000|Overall Study|Adverse Event|1|||
131860307|NCT03483012|474768182|FG000|Overall Study|Lack of Efficacy|6|||
131860308|NCT04782076|474768183|FG000|Overall Study|Family Emergency|1|||
131860309|NCT00729937|474768186|FG000|Overall Study|Lost to Follow-up|49|||
131860310|NCT00729937|474768187|FG001|Overall Study|Lost to Follow-up|58|||
131860311|NCT00729937|474768188|FG002|Overall Study|Lost to Follow-up|18|||
131407838|NCT03199053|473115198|FG002|LT Period|Lost to Follow-up|1|||
131860312|NCT00729937|474768189|FG003|Overall Study|Lost to Follow-up|33|||
131860313|NCT00729937|474768190|FG004|Overall Study|Lost to Follow-up|18|||
131860314|NCT00729937|474768191|FG005|Overall Study|Lost to Follow-up|23|||
131860315|NCT00729937|474768186|FG000|Overall Study|Physician Decision|7|||
131860316|NCT00729937|474768187|FG001|Overall Study|Physician Decision|16|||
131860317|NCT00729937|474768188|FG002|Overall Study|Physician Decision|2|||
131860318|NCT00729937|474768189|FG003|Overall Study|Physician Decision|0|||
131860319|NCT00729937|474768190|FG004|Overall Study|Physician Decision|5|||
131860320|NCT00729937|474768191|FG005|Overall Study|Physician Decision|8|||
131860321|NCT00729937|474768186|FG000|Overall Study|Death|1|||
131860322|NCT00729937|474768187|FG001|Overall Study|Death|0|||
131860323|NCT00729937|474768188|FG002|Overall Study|Death|1|||
131860324|NCT00729937|474768189|FG003|Overall Study|Death|0|||
131860325|NCT00729937|474768190|FG004|Overall Study|Death|0|||
131860326|NCT00729937|474768191|FG005|Overall Study|Death|1|||
131860327|NCT00729937|474768186|FG000|Overall Study|Withdrawal by Subject|3|||
131860328|NCT00729937|474768187|FG001|Overall Study|Withdrawal by Subject|5|||
131860329|NCT00729937|474768188|FG002|Overall Study|Withdrawal by Subject|6|||
131860330|NCT00729937|474768189|FG003|Overall Study|Withdrawal by Subject|0|||
131860331|NCT00729937|474768190|FG004|Overall Study|Withdrawal by Subject|4|||
131860332|NCT00729937|474768191|FG005|Overall Study|Withdrawal by Subject|2|||
131860333|NCT00729937|474768186|FG000|Overall Study|Randomized but not treated|12|||
131860334|NCT00729937|474768187|FG001|Overall Study|Randomized but not treated|6|||
131860335|NCT00729937|474768188|FG002|Overall Study|Randomized but not treated|1|||
131860336|NCT00729937|474768189|FG003|Overall Study|Randomized but not treated|0|||
131860337|NCT00729937|474768190|FG004|Overall Study|Randomized but not treated|1|||
131860338|NCT00729937|474768191|FG005|Overall Study|Randomized but not treated|3|||
131860339|NCT00729937|474768186|FG000|Overall Study|Did not meet eligibility criteria|2|||
131860340|NCT00729937|474768187|FG001|Overall Study|Did not meet eligibility criteria|1|||
131860341|NCT00729937|474768188|FG002|Overall Study|Did not meet eligibility criteria|0|||
131860342|NCT00729937|474768189|FG003|Overall Study|Did not meet eligibility criteria|0|||
131860343|NCT00729937|474768190|FG004|Overall Study|Did not meet eligibility criteria|0|||
131860344|NCT00729937|474768191|FG005|Overall Study|Did not meet eligibility criteria|0|||
131860345|NCT00729937|474768186|FG000|Overall Study|Incarcerated|0|||
131860346|NCT00729937|474768187|FG001|Overall Study|Incarcerated|2|||
131860347|NCT00729937|474768188|FG002|Overall Study|Incarcerated|1|||
131860348|NCT00729937|474768189|FG003|Overall Study|Incarcerated|1|||
131860349|NCT00729937|474768190|FG004|Overall Study|Incarcerated|0|||
131860350|NCT00729937|474768191|FG005|Overall Study|Incarcerated|0|||
131860351|NCT01478373|474768193|FG000|Treatment Phase|Protocol Violation|1|||
131860352|NCT01478373|474768193|FG000|Survival Phase|Adverse Event|8|||
131860353|NCT01478373|474768193|FG000|Survival Phase|Protocol Violation|1|||
131860354|NCT01478373|474768193|FG000|Survival Phase|crossover to another study|2|||
131860355|NCT01478373|474768193|FG000|Survival Phase|Progressive Disease|27|||
131860356|NCT02586155|474768201|FG000|Overall Study|Adverse Event|2|||
131860357|NCT02586155|474768202|FG001|Overall Study|Adverse Event|3|||
131860358|NCT02586155|474768201|FG000|Overall Study|Withdrawal by Subject|31|||
131860359|NCT02586155|474768202|FG001|Overall Study|Withdrawal by Subject|24|||
131860360|NCT02586155|474768201|FG000|Overall Study|Lost to Follow-up|7|||
131860361|NCT02586155|474768202|FG001|Overall Study|Lost to Follow-up|13|||
131860362|NCT02586155|474768201|FG000|Overall Study|Death|61|||
131860363|NCT02586155|474768202|FG001|Overall Study|Death|72|||
131860364|NCT02586155|474768201|FG000|Overall Study|Other reasons|26|||
131860365|NCT02586155|474768202|FG001|Overall Study|Other reasons|15|||
131860366|NCT02552121|474768203|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
131860367|NCT02552121|474768204|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860368|NCT02552121|474768205|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860369|NCT02552121|474768206|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860370|NCT02552121|474768207|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860371|NCT02552121|474768208|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860372|NCT02552121|474768209|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860373|NCT02552121|474768210|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
131860374|NCT02552121|474768203|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
131860375|NCT02552121|474768204|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860376|NCT02552121|474768205|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860377|NCT02552121|474768206|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860378|NCT02552121|474768207|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860379|NCT02552121|474768208|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860380|NCT02552121|474768209|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860381|NCT02552121|474768210|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
131860382|NCT02552121|474768203|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131860383|NCT02552121|474768204|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
131860384|NCT02552121|474768205|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131860385|NCT02552121|474768206|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131860386|NCT02552121|474768207|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131913051|NCT01288430|474969285|FG008|Part 1|Adverse Event|0|||
131860387|NCT02552121|474768208|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131860388|NCT02552121|474768209|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131860389|NCT02552121|474768210|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
131860390|NCT02552121|474768203|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860391|NCT02552121|474768204|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
131860392|NCT02552121|474768205|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860393|NCT02552121|474768206|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860394|NCT02552121|474768207|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860395|NCT02552121|474768208|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860396|NCT02552121|474768209|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860397|NCT02552121|474768210|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
131860398|NCT02552121|474768203|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860399|NCT02552121|474768204|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
131860400|NCT02552121|474768205|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860401|NCT02552121|474768206|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860402|NCT02552121|474768207|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860403|NCT02552121|474768208|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860404|NCT02552121|474768209|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860405|NCT02552121|474768210|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
131860406|NCT02552121|474768203|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860407|NCT02552121|474768204|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
131860408|NCT02552121|474768205|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860409|NCT02552121|474768206|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860410|NCT02552121|474768207|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860411|NCT02552121|474768208|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860412|NCT02552121|474768209|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860413|NCT02552121|474768210|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
131860414|NCT02552121|474768203|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
131860415|NCT02552121|474768204|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
131860416|NCT02552121|474768205|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
131860417|NCT02552121|474768206|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
131860418|NCT02552121|474768207|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
131860419|NCT02552121|474768208|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
131860420|NCT02552121|474768209|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
131860421|NCT02552121|474768210|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
131860422|NCT02552121|474768203|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
131860423|NCT02552121|474768204|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
131860424|NCT02552121|474768205|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
131860425|NCT02552121|474768206|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
131860426|NCT02552121|474768207|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
131860427|NCT02552121|474768208|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
131860428|NCT02552121|474768209|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
131860429|NCT02552121|474768210|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
131860430|NCT02552121|474768203|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
131860431|NCT02552121|474768204|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
131860432|NCT02552121|474768205|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
131860433|NCT02552121|474768206|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
131860434|NCT02552121|474768207|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
131407839|NCT03199053|473115196|FG000|LT Period|Miscellaneous|0|||
131407840|NCT03199053|473115197|FG001|LT Period|Miscellaneous|0|||
131407841|NCT03199053|473115198|FG002|LT Period|Miscellaneous|2|||
131407842|NCT03199053|473115196|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
131407843|NCT03199053|473115197|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
131407844|NCT03199053|473115198|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
131407845|NCT03199053|473115196|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
131860435|NCT02552121|474768208|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
131860436|NCT02552121|474768209|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
131860437|NCT02552121|474768210|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
131860438|NCT02552121|474768203|FG000|Part 2: Cohort Expansion|Death|0|||
131860439|NCT02552121|474768204|FG001|Part 2: Cohort Expansion|Death|0|||
131407846|NCT03199053|473115197|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
131407847|NCT03199053|473115198|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
131860440|NCT02552121|474768205|FG002|Part 2: Cohort Expansion|Death|1|||
131860441|NCT02552121|474768206|FG003|Part 2: Cohort Expansion|Death|0|||
131860442|NCT02552121|474768207|FG004|Part 2: Cohort Expansion|Death|0|||
131860443|NCT02552121|474768208|FG005|Part 2: Cohort Expansion|Death|0|||
131860444|NCT02552121|474768209|FG006|Part 2: Cohort Expansion|Death|0|||
131860445|NCT02552121|474768210|FG007|Part 2: Cohort Expansion|Death|0|||
131407848|NCT03199053|473115196|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
131407849|NCT03199053|473115197|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
131434022|NCT01216202|473214606|FG000|Overall Study|Death|0|||
131860446|NCT00972595|474768211|FG000|Period 1|Adverse Event|1|||
131860447|NCT00972595|474768212|FG001|Period 1|Adverse Event|0|||
131860448|NCT01821807|474768215|FG000|Overall Study|Lost to Follow-up|3|||
131860449|NCT01821807|474768216|FG001|Overall Study|Lost to Follow-up|1|||
131860450|NCT00550459|474768218|FG000|Overall Study|Adverse Event|0|||
131860451|NCT00550459|474768219|FG001|Overall Study|Adverse Event|2|||
131860452|NCT00550459|474768218|FG000|Overall Study|Withdrawal by Subject|1|||
131860453|NCT00550459|474768219|FG001|Overall Study|Withdrawal by Subject|1|||
131860454|NCT00445146|474768220|FG000|Overall Study|Withdrew Consent|29|||
131860455|NCT00445146|474768220|FG000|Overall Study|Lack of Efficacy|28|||
131860456|NCT00445146|474768220|FG000|Overall Study|Investigator's Discretion|22|||
131860457|NCT00445146|474768220|FG000|Overall Study|Adverse Event|13|||
131860458|NCT00445146|474768220|FG000|Overall Study|Lost to Follow-up|13|||
131860459|NCT00445146|474768220|FG000|Overall Study|Death|9|||
131860460|NCT00445146|474768220|FG000|Overall Study|Protocol Violation|4|||
131860461|NCT00445146|474768220|FG000|Overall Study|Pregnancy|1|||
131860462|NCT02572570|474769450|FG000|Overall Study|Study Terminated|27|||
131860463|NCT02763046|474769451|FG000|Overall Study|Adverse Event|5|||
131860464|NCT02763046|474769452|FG001|Overall Study|Adverse Event|4|||
131860465|NCT02763046|474769453|FG002|Overall Study|Adverse Event|0|||
131860466|NCT02763046|474769451|FG000|Overall Study|Lack of Efficacy|1|||
131860467|NCT02763046|474769452|FG001|Overall Study|Lack of Efficacy|1|||
131860468|NCT02763046|474769453|FG002|Overall Study|Lack of Efficacy|3|||
131860469|NCT02763046|474769451|FG000|Overall Study|Physician Decision|1|||
131860470|NCT02763046|474769452|FG001|Overall Study|Physician Decision|0|||
131860471|NCT02763046|474769453|FG002|Overall Study|Physician Decision|1|||
131860472|NCT02763046|474769451|FG000|Overall Study|Subject/guardian decision|2|||
131860473|NCT02763046|474769452|FG001|Overall Study|Subject/guardian decision|0|||
131860474|NCT02763046|474769453|FG002|Overall Study|Subject/guardian decision|4|||
131860475|NCT01417156|474769456|FG000|Overall Study|Adverse Event|12|||
131860476|NCT01417156|474769456|FG000|Overall Study|Protocol Violation|2|||
131860477|NCT00086684|474769457|FG000|Overall Study|Adverse Event|12|||
131860478|NCT00086684|474769458|FG001|Overall Study|Adverse Event|17|||
131860479|NCT00086684|474769459|FG002|Overall Study|Adverse Event|14|||
131860480|NCT00086684|474769457|FG000|Overall Study|Lack of Efficacy|6|||
131860481|NCT00086684|474769458|FG001|Overall Study|Lack of Efficacy|6|||
131860482|NCT00086684|474769459|FG002|Overall Study|Lack of Efficacy|5|||
131860483|NCT00086684|474769457|FG000|Overall Study|Lost to Follow-up|15|||
131860484|NCT00086684|474769458|FG001|Overall Study|Lost to Follow-up|8|||
131860485|NCT00086684|474769459|FG002|Overall Study|Lost to Follow-up|10|||
131860486|NCT00086684|474769457|FG000|Overall Study|Protocol Violation|8|||
131860487|NCT00086684|474769458|FG001|Overall Study|Protocol Violation|3|||
131860488|NCT00086684|474769459|FG002|Overall Study|Protocol Violation|0|||
131860489|NCT00086684|474769457|FG000|Overall Study|Withdrawal by Subject|0|||
131860490|NCT00086684|474769458|FG001|Overall Study|Withdrawal by Subject|4|||
131860491|NCT00086684|474769459|FG002|Overall Study|Withdrawal by Subject|10|||
131860492|NCT00086684|474769457|FG000|Overall Study|NONCOMPLIANCE|5|||
131860493|NCT00086684|474769458|FG001|Overall Study|NONCOMPLIANCE|7|||
131860494|NCT00086684|474769459|FG002|Overall Study|NONCOMPLIANCE|6|||
131860495|NCT00086684|474769457|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131860496|NCT00086684|474769458|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
131860497|NCT00086684|474769459|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
131860498|NCT00086684|474769457|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
131860499|NCT00086684|474769458|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
131860500|NCT00086684|474769459|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
131860501|NCT00086684|474769457|FG000|Overall Study|Other|4|||
131860502|NCT00086684|474769458|FG001|Overall Study|Other|2|||
131860503|NCT00086684|474769459|FG002|Overall Study|Other|3|||
131860504|NCT01067105|474769462|FG000|Overall Study|Adverse Event|14|||
131860505|NCT01067105|474769462|FG000|Overall Study|Protocol Violation|48|||
131860506|NCT01067105|474769462|FG000|Overall Study|Withdrawal by Subject|36|||
131860507|NCT01067105|474769462|FG000|Overall Study|Lost to Follow-up|6|||
131860508|NCT01067105|474769462|FG000|Overall Study|Physician Decision|6|||
131860509|NCT01067105|474769462|FG000|Overall Study|Other|31|||
131860510|NCT02302833|474769465|FG000|Overall Study|Lost to Follow-up|3|||
131860511|NCT05017246|474769466|FG000|Overall Study|Withdrawal by Subject|5|||
131860512|NCT05017246|474769467|FG001|Overall Study|Withdrawal by Subject|3|||
131860513|NCT05017246|474769466|FG000|Overall Study|Determined to be ineligible|0|||
131860514|NCT05017246|474769467|FG001|Overall Study|Determined to be ineligible|1|||
131860515|NCT05017246|474769466|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
131860516|NCT05017246|474769467|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
131860517|NCT05017246|474769466|FG000|Overall Study|Technical failure|1|||
131860518|NCT05017246|474769467|FG001|Overall Study|Technical failure|3|||
131860519|NCT02058069|474769468|FG000|Overall Study|Exclusion due to implant size|5|||
131860520|NCT02058069|474769468|FG000|Overall Study|Withdrawal by Subject|6|||
131860521|NCT02105467|474769469|FG000|Period 1|Lost to Follow-up|1|||
131860522|NCT02105467|474769470|FG001|Period 1|Lost to Follow-up|0|||
131860523|NCT02105467|474769469|FG000|Period 1|Death|1|||
131860524|NCT02105467|474769470|FG001|Period 1|Death|0|||
131860525|NCT02105467|474769469|FG000|Period 2|Lost to Follow-up|1|||
131860526|NCT02105467|474769470|FG001|Period 2|Lost to Follow-up|0|||
131860527|NCT02105467|474769469|FG000|Period 2|Death|1|||
131860528|NCT02105467|474769470|FG001|Period 2|Death|0|||
131860529|NCT02105467|474769469|FG000|Period 2|Withdrawal by Subject|0|||
131860530|NCT02105467|474769470|FG001|Period 2|Withdrawal by Subject|2|||
131860531|NCT02105467|474769469|FG000|Period 3|Lost to Follow-up|0|||
131860532|NCT02105467|474769470|FG001|Period 3|Lost to Follow-up|1|||
131860533|NCT02676882|474769475|FG000|Overall Study|Adverse Event|1|||
131860534|NCT02676882|474769476|FG001|Overall Study|Adverse Event|0|||
131860535|NCT02676882|474769475|FG000|Overall Study|Lost to Follow-up|1|||
131860536|NCT02676882|474769476|FG001|Overall Study|Lost to Follow-up|0|||
131860537|NCT02676882|474769475|FG000|Overall Study|Withdrawal by Subject|1|||
131860538|NCT02676882|474769476|FG001|Overall Study|Withdrawal by Subject|2|||
131860539|NCT02568072|474769477|FG000|Overall Study|Unavailable for appointment|23|||
131860540|NCT02568072|474769477|FG000|Overall Study|Unable to contact|3|||
131860541|NCT02568072|474769477|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
131860542|NCT02568072|474769477|FG000|Overall Study|Withdrawal by Subject|1|||
131860543|NCT02568072|474769477|FG000|Overall Study|Sustained injury, marathon not run|24|||
131860544|NCT00958828|474769479|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
131860545|NCT00958828|474769480|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
131860546|NCT00958828|474769479|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
131860547|NCT00958828|474769480|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
131860548|NCT02687451|474769481|FG000|Overall Study|Withdrawal by Subject|1|||
131860549|NCT02687451|474769482|FG001|Overall Study|Withdrawal by Subject|0|||
131860550|NCT02687451|474769483|FG002|Overall Study|Withdrawal by Subject|0|||
131860551|NCT02687451|474769484|FG003|Overall Study|Withdrawal by Subject|0|||
131860552|NCT02687451|474769485|FG004|Overall Study|Withdrawal by Subject|0|||
131860553|NCT02687451|474769486|FG005|Overall Study|Withdrawal by Subject|1|||
131860554|NCT01125189|474769493|FG000|Treatment Period|Lack of Efficacy|15|||
131860555|NCT01125189|474769494|FG001|Treatment Period|Lack of Efficacy|18|||
131860556|NCT01125189|474769495|FG002|Treatment Period|Lack of Efficacy|25|||
131860557|NCT01125189|474769493|FG000|Treatment Period|Adverse Event|7|||
131860558|NCT01125189|474769494|FG001|Treatment Period|Adverse Event|8|||
131860559|NCT01125189|474769495|FG002|Treatment Period|Adverse Event|8|||
131860560|NCT01125189|474769493|FG000|Treatment Period|Withdrawal by Subject|3|||
131860561|NCT01125189|474769494|FG001|Treatment Period|Withdrawal by Subject|1|||
131860562|NCT01125189|474769495|FG002|Treatment Period|Withdrawal by Subject|1|||
131860563|NCT01125189|474769493|FG000|Treatment Period|Death|1|||
131860564|NCT01125189|474769494|FG001|Treatment Period|Death|0|||
131860565|NCT01125189|474769495|FG002|Treatment Period|Death|0|||
131860566|NCT01125189|474769493|FG000|Treatment Period|Lost to Follow-up|1|||
131860567|NCT01125189|474769494|FG001|Treatment Period|Lost to Follow-up|2|||
131860568|NCT01125189|474769495|FG002|Treatment Period|Lost to Follow-up|1|||
131860569|NCT01125189|474769493|FG000|Treatment Period|Poor compliance/noncompliance|0|||
131860570|NCT01125189|474769494|FG001|Treatment Period|Poor compliance/noncompliance|1|||
131860571|NCT01125189|474769495|FG002|Treatment Period|Poor compliance/noncompliance|0|||
131860572|NCT01125189|474769493|FG000|Treatment Period|Participants requested to discontinue|1|||
131860573|NCT01125189|474769494|FG001|Treatment Period|Participants requested to discontinue|3|||
131860574|NCT01125189|474769495|FG002|Treatment Period|Participants requested to discontinue|4|||
131860575|NCT01125189|474769493|FG000|Treatment Period|Other reasons|1|||
131860576|NCT01125189|474769494|FG001|Treatment Period|Other reasons|1|||
131860577|NCT01125189|474769495|FG002|Treatment Period|Other reasons|0|||
131860578|NCT01125189|474769493|FG000|Treatment Period|Completed 24 week treatment period only|2|||
131860579|NCT01125189|474769494|FG001|Treatment Period|Completed 24 week treatment period only|1|||
131860580|NCT01125189|474769495|FG002|Treatment Period|Completed 24 week treatment period only|2|||
131860581|NCT01125189|474769493|FG000|Follow up Period|Withdrawal by Subject|3|||
131860582|NCT01125189|474769494|FG001|Follow up Period|Withdrawal by Subject|2|||
131860583|NCT01125189|474769495|FG002|Follow up Period|Withdrawal by Subject|5|||
131860584|NCT01125189|474769493|FG000|Follow up Period|Death|1|||
131860585|NCT01125189|474769494|FG001|Follow up Period|Death|0|||
131860586|NCT01125189|474769495|FG002|Follow up Period|Death|0|||
131860587|NCT01125189|474769493|FG000|Follow up Period|Lost to Follow-up|12|||
131860588|NCT01125189|474769494|FG001|Follow up Period|Lost to Follow-up|9|||
131860589|NCT01125189|474769495|FG002|Follow up Period|Lost to Follow-up|6|||
131860590|NCT01125189|474769493|FG000|Follow up Period|Other reasons|4|||
131860591|NCT01125189|474769494|FG001|Follow up Period|Other reasons|4|||
131860592|NCT01125189|474769495|FG002|Follow up Period|Other reasons|5|||
131860593|NCT00927589|474769496|FG000|Overall Study|Death|1|||
131860594|NCT00927589|474769496|FG000|Overall Study|Physician Decision|1|||
131860595|NCT00927589|474769496|FG000|Overall Study|Withdrawal by Subject|3|||
131860596|NCT00927589|474769496|FG000|Overall Study|Adverse Event|2|||
131860597|NCT00927589|474769496|FG000|Overall Study|Disease Progression|8|||
131860598|NCT00927589|474769496|FG000|Overall Study|Non-compliance|1|||
131860599|NCT00707239|474769497|FG000|Overall Study|Adverse Event|5|||
131860600|NCT00707239|474769498|FG001|Overall Study|Adverse Event|3|||
131860601|NCT00707239|474769499|FG002|Overall Study|Adverse Event|2|||
131860602|NCT00707239|474769497|FG000|Overall Study|Death|3|||
131860603|NCT00707239|474769498|FG001|Overall Study|Death|1|||
131860604|NCT00707239|474769499|FG002|Overall Study|Death|3|||
131860605|NCT00707239|474769497|FG000|Overall Study|Physician Decision|1|||
131860606|NCT00707239|474769498|FG001|Overall Study|Physician Decision|1|||
131860607|NCT00707239|474769499|FG002|Overall Study|Physician Decision|2|||
131860608|NCT00707239|474769497|FG000|Overall Study|Protocol Violation|0|||
131860609|NCT00707239|474769498|FG001|Overall Study|Protocol Violation|0|||
131860610|NCT00707239|474769499|FG002|Overall Study|Protocol Violation|1|||
131860611|NCT00707239|474769497|FG000|Overall Study|Lack of Efficacy|1|||
131860612|NCT00707239|474769498|FG001|Overall Study|Lack of Efficacy|2|||
131860613|NCT00707239|474769499|FG002|Overall Study|Lack of Efficacy|0|||
131860614|NCT00707239|474769497|FG000|Overall Study|Randomized, but not treated|1|||
131860615|NCT00707239|474769498|FG001|Overall Study|Randomized, but not treated|1|||
131860616|NCT00707239|474769499|FG002|Overall Study|Randomized, but not treated|1|||
131860617|NCT00707239|474769497|FG000|Overall Study|Other|8|||
131860618|NCT00707239|474769498|FG001|Overall Study|Other|3|||
131860619|NCT00707239|474769499|FG002|Overall Study|Other|5|||
131860620|NCT01518322|474769500|FG000|Overall Study|FeNO measurement was missing|13|||
131860621|NCT02088177|474769501|FG000|Overall Study|Lost to Follow-up|3|||
131860622|NCT01778530|474769506|FG000|Overall Study|Progression on study|1|||
131860623|NCT01778530|474769506|FG000|Overall Study|Adverse event/side effect|1|||
131860624|NCT03472014|474769507|FG000|Overall Study|Lost to Follow-up|4|||
131860625|NCT02792517|474769508|FG000|Overall Study|Withdrawal by Subject|10|||
131860626|NCT02792517|474769508|FG000|Overall Study|Decision by Sponsor|7|||
131860627|NCT02792517|474769508|FG000|Overall Study|Lost to Follow-up|3|||
131860628|NCT01894919|474769509|FG000|Overall Study|Withdrawal by Subject|1|||
131860629|NCT01894919|474769510|FG001|Overall Study|Withdrawal by Subject|0|||
131860630|NCT01894919|474769511|FG002|Overall Study|Withdrawal by Subject|0|||
131860631|NCT01894919|474769512|FG003|Overall Study|Withdrawal by Subject|0|||
131860632|NCT01894919|474769513|FG004|Overall Study|Withdrawal by Subject|1|||
131860633|NCT01894919|474769514|FG005|Overall Study|Withdrawal by Subject|0|||
131860634|NCT01894919|474769515|FG006|Overall Study|Withdrawal by Subject|0|||
131860635|NCT01894919|474769516|FG007|Overall Study|Withdrawal by Subject|0|||
131860636|NCT01894919|474769517|FG008|Overall Study|Withdrawal by Subject|0|||
131860637|NCT01894919|474769518|FG009|Overall Study|Withdrawal by Subject|1|||
131860638|NCT01894919|474769519|FG010|Overall Study|Withdrawal by Subject|1|||
131860639|NCT01894919|474769520|FG011|Overall Study|Withdrawal by Subject|0|||
131860640|NCT01894919|474769521|FG012|Overall Study|Withdrawal by Subject|0|||
131860641|NCT01894919|474769509|FG000|Overall Study|Adverse Event|0|||
131860642|NCT01894919|474769510|FG001|Overall Study|Adverse Event|0|||
131860643|NCT01894919|474769511|FG002|Overall Study|Adverse Event|0|||
131860644|NCT01894919|474769512|FG003|Overall Study|Adverse Event|0|||
131860645|NCT01894919|474769513|FG004|Overall Study|Adverse Event|0|||
131860646|NCT01894919|474769514|FG005|Overall Study|Adverse Event|0|||
131860647|NCT01894919|474769515|FG006|Overall Study|Adverse Event|0|||
131860648|NCT01894919|474769516|FG007|Overall Study|Adverse Event|0|||
131860649|NCT01894919|474769517|FG008|Overall Study|Adverse Event|0|||
131860650|NCT01894919|474769518|FG009|Overall Study|Adverse Event|0|||
131860651|NCT01894919|474769519|FG010|Overall Study|Adverse Event|1|||
131860652|NCT01894919|474769520|FG011|Overall Study|Adverse Event|0|||
131860653|NCT01894919|474769521|FG012|Overall Study|Adverse Event|0|||
131860654|NCT01894919|474769509|FG000|Overall Study|Other-Unspecified|1|||
131860655|NCT01894919|474769510|FG001|Overall Study|Other-Unspecified|0|||
131860656|NCT01894919|474769511|FG002|Overall Study|Other-Unspecified|0|||
131860657|NCT01894919|474769512|FG003|Overall Study|Other-Unspecified|0|||
131860658|NCT01894919|474769513|FG004|Overall Study|Other-Unspecified|0|||
131860659|NCT01894919|474769514|FG005|Overall Study|Other-Unspecified|0|||
131860660|NCT01894919|474769515|FG006|Overall Study|Other-Unspecified|0|||
131860661|NCT01894919|474769516|FG007|Overall Study|Other-Unspecified|0|||
131860662|NCT01894919|474769517|FG008|Overall Study|Other-Unspecified|0|||
131860663|NCT01894919|474769518|FG009|Overall Study|Other-Unspecified|0|||
131860664|NCT01894919|474769519|FG010|Overall Study|Other-Unspecified|0|||
131860665|NCT01894919|474769520|FG011|Overall Study|Other-Unspecified|0|||
131860666|NCT01894919|474769521|FG012|Overall Study|Other-Unspecified|0|||
131860667|NCT01894919|474769509|FG000|Overall Study|Lost to Follow-up|0|||
131860668|NCT01894919|474769510|FG001|Overall Study|Lost to Follow-up|0|||
131860669|NCT01894919|474769511|FG002|Overall Study|Lost to Follow-up|0|||
131860670|NCT01894919|474769512|FG003|Overall Study|Lost to Follow-up|0|||
131860671|NCT01894919|474769513|FG004|Overall Study|Lost to Follow-up|2|||
131860672|NCT01894919|474769514|FG005|Overall Study|Lost to Follow-up|0|||
131860673|NCT01894919|474769515|FG006|Overall Study|Lost to Follow-up|0|||
131860674|NCT01894919|474769516|FG007|Overall Study|Lost to Follow-up|0|||
131860675|NCT01894919|474769517|FG008|Overall Study|Lost to Follow-up|0|||
131860676|NCT01894919|474769518|FG009|Overall Study|Lost to Follow-up|0|||
131860677|NCT01894919|474769519|FG010|Overall Study|Lost to Follow-up|0|||
131860678|NCT01894919|474769520|FG011|Overall Study|Lost to Follow-up|0|||
131860679|NCT01894919|474769521|FG012|Overall Study|Lost to Follow-up|0|||
131860680|NCT00882518|474769522|FG000|Overall Study|Adverse Event|9|||
131860681|NCT00882518|474769523|FG001|Overall Study|Adverse Event|18|||
131860682|NCT00882518|474769522|FG000|Overall Study|Withdrawal by Subject|9|||
131860683|NCT00882518|474769523|FG001|Overall Study|Withdrawal by Subject|13|||
131860684|NCT00882518|474769522|FG000|Overall Study|Lack of Efficacy|12|||
131860685|NCT00882518|474769523|FG001|Overall Study|Lack of Efficacy|9|||
131860686|NCT00882518|474769522|FG000|Overall Study|Severe non-compliance to protocol|3|||
131860687|NCT00882518|474769523|FG001|Overall Study|Severe non-compliance to protocol|1|||
131860688|NCT00882518|474769522|FG000|Overall Study|Incorrect enrolment|4|||
131860689|NCT00882518|474769523|FG001|Overall Study|Incorrect enrolment|2|||
131860690|NCT00882518|474769522|FG000|Overall Study|Central lab closure for National day|1|||
131860691|NCT00882518|474769523|FG001|Overall Study|Central lab closure for National day|0|||
131860692|NCT00882518|474769522|FG000|Overall Study|Allocating random number by mistake|0|||
131860693|NCT00882518|474769523|FG001|Overall Study|Allocating random number by mistake|1|||
131860694|NCT03711188|474769524|FG000|Overall Study|Disease progression|11|||
131860695|NCT03711188|474769524|FG000|Overall Study|Adverse Event|1|||
131860696|NCT01433471|474769527|FG000|Overall Study|Withdrawal by Subject|0|||
131860697|NCT01433471|474769528|FG001|Overall Study|Withdrawal by Subject|1|||
131860698|NCT03743051|474769533|FG000|Overall Study|Adverse Event|5|||
131860699|NCT03743051|474769534|FG001|Overall Study|Adverse Event|9|||
131860700|NCT03743051|474769533|FG000|Overall Study|Death|27|||
131860701|NCT03743051|474769534|FG001|Overall Study|Death|26|||
131860702|NCT03743051|474769533|FG000|Overall Study|Lost to Follow-up|4|||
131860703|NCT03743051|474769534|FG001|Overall Study|Lost to Follow-up|8|||
131860704|NCT03743051|474769533|FG000|Overall Study|Withdrawal by Subject|32|||
131860705|NCT03743051|474769534|FG001|Overall Study|Withdrawal by Subject|19|||
131860706|NCT03743051|474769533|FG000|Overall Study|Physician Decision|10|||
131860707|NCT03743051|474769534|FG001|Overall Study|Physician Decision|15|||
131860708|NCT03743051|474769533|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
131860709|NCT03743051|474769534|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
131860710|NCT02137252|474769535|FG000|Overall Study|trial terminated early|2|||
131860711|NCT02137252|474769536|FG001|Overall Study|trial terminated early|1|||
131860712|NCT00711087|474769539|FG000|Overall Study|Lost to Follow-up|1|||
131860713|NCT00711087|474769540|FG001|Overall Study|Lost to Follow-up|0|||
131860714|NCT00811733|474769541|FG000|Overall Study|Investigator Discretion|10|||
131860715|NCT00811733|474769542|FG001|Overall Study|Investigator Discretion|8|||
131860716|NCT00811733|474769541|FG000|Overall Study|Withdrawal by Subject|1|||
131860717|NCT00811733|474769542|FG001|Overall Study|Withdrawal by Subject|2|||
131860718|NCT00793871|474769543|FG000|Overall Study|Death|50|||
131860719|NCT00793871|474769543|FG000|Overall Study|Lost to Follow-up|3|||
131860720|NCT00793871|474769543|FG000|Overall Study|Study terminated by the Sponsor|7|||
131860721|NCT02500589|474769544|FG000|Overall Study|Withdrawal by Subject|11|||
131860722|NCT02500589|474769545|FG001|Overall Study|Withdrawal by Subject|14|||
131860723|NCT02500589|474769544|FG000|Overall Study|Lost to Follow-up|10|||
131860724|NCT02500589|474769545|FG001|Overall Study|Lost to Follow-up|12|||
131860725|NCT02500589|474769544|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
131860726|NCT02500589|474769545|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
131860727|NCT02500589|474769544|FG000|Overall Study|Death|7|||
131860728|NCT02500589|474769545|FG001|Overall Study|Death|5|||
131860729|NCT00856193|474769546|FG000|Period 2|Abnormal test procedure results|0|||
131860730|NCT00856193|474769547|FG001|Period 2|Abnormal test procedure results|1|||
131860731|NCT00856193|474769546|FG000|Period 2|Lost to Follow-up|0|||
131860732|NCT00856193|474769547|FG001|Period 2|Lost to Follow-up|1|||
131860733|NCT01113892|474769554|FG000|Overall Study|Lost to Follow-up|2|||
131860734|NCT01113892|474769555|FG001|Overall Study|Lost to Follow-up|2|||
131860735|NCT01113892|474769554|FG000|Overall Study|Withdrawal by Subject|1|||
131860736|NCT01113892|474769555|FG001|Overall Study|Withdrawal by Subject|1|||
131860737|NCT01113892|474769554|FG000|Overall Study|Death|2|||
131860738|NCT01113892|474769555|FG001|Overall Study|Death|4|||
131860739|NCT01113892|474769554|FG000|Overall Study|Graft no longer evaluable|9|||
131860740|NCT01113892|474769555|FG001|Overall Study|Graft no longer evaluable|9|||
131860741|NCT02569801|474769556|FG000|Overall Study|Withdrawal by Subject|9|||
131860742|NCT02569801|474769557|FG001|Overall Study|Withdrawal by Subject|9|||
131860743|NCT02569801|474769556|FG000|Overall Study|Sponsor Decision|13|||
131860744|NCT02569801|474769557|FG001|Overall Study|Sponsor Decision|14|||
131860745|NCT02569801|474769556|FG000|Overall Study|Progressive Disease|2|||
131860746|NCT02569801|474769557|FG001|Overall Study|Progressive Disease|7|||
131860747|NCT02569801|474769556|FG000|Overall Study|Lost to Follow-up|0|||
131860748|NCT02569801|474769557|FG001|Overall Study|Lost to Follow-up|1|||
131860749|NCT02569801|474769556|FG000|Overall Study|Death|12|||
131860750|NCT02569801|474769557|FG001|Overall Study|Death|4|||
131860751|NCT00838526|474769571|FG000|Overall Study|Adverse Event|3|||
131860752|NCT00838526|474769572|FG001|Overall Study|Adverse Event|12|||
131860753|NCT00838526|474769571|FG000|Overall Study|Lost to Follow-up|4|||
131860754|NCT00838526|474769572|FG001|Overall Study|Lost to Follow-up|12|||
131860755|NCT00838526|474769571|FG000|Overall Study|Withdrawal by Subject|4|||
131860756|NCT00838526|474769572|FG001|Overall Study|Withdrawal by Subject|5|||
131860757|NCT00838526|474769571|FG000|Overall Study|Lack of Efficacy|2|||
131407850|NCT03199053|473115198|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
131860758|NCT00838526|474769572|FG001|Overall Study|Lack of Efficacy|3|||
131860759|NCT00838526|474769571|FG000|Overall Study|Other|11|||
131860760|NCT00838526|474769572|FG001|Overall Study|Other|7|||
131860761|NCT00931411|474769573|FG000|First Intervention - 42 Days|Adverse Event|2|||
131860762|NCT00931411|474769574|FG001|First Intervention - 42 Days|Adverse Event|3|||
131860763|NCT00931411|474769573|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
131860764|NCT00931411|474769574|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
131860765|NCT00931411|474769573|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
131860766|NCT00931411|474769574|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
131860767|NCT01949662|474769583|FG000|Overall Study|Death|9|||
131860768|NCT01949662|474769584|FG001|Overall Study|Death|7|||
131860769|NCT01949662|474769583|FG000|Overall Study|Discharged before an agitation event|8|||
131860770|NCT01949662|474769584|FG001|Overall Study|Discharged before an agitation event|3|||
131860771|NCT01949662|474769583|FG000|Overall Study|Dropped out|1|||
131860772|NCT01949662|474769584|FG001|Overall Study|Dropped out|3|||
131860773|NCT01949662|474769583|FG000|Overall Study|Ineligible|0|||
131860774|NCT01949662|474769584|FG001|Overall Study|Ineligible|1|||
131860775|NCT03552380|474769587|FG000|Study Treatment|Disease Progression|3|||
131860776|NCT03552380|474769588|FG001|Study Treatment|Disease Progression|4|||
131860777|NCT03552380|474769587|FG000|Study Treatment|Adverse Event|2|||
131860778|NCT03552380|474769588|FG001|Study Treatment|Adverse Event|2|||
131860779|NCT03552380|474769587|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
131860780|NCT03552380|474769588|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
131860781|NCT03552380|474769587|FG000|Follow up|Death|3|||
131860782|NCT03552380|474769588|FG001|Follow up|Death|4|||
131860783|NCT03552380|474769587|FG000|Follow up|Site IRB terminated|0|||
131860784|NCT03552380|474769588|FG001|Follow up|Site IRB terminated|1|||
131860785|NCT01401452|474769589|FG000|Overall Study|Adverse reaction|9|||
131860786|NCT01401452|474769589|FG000|Overall Study|Lost to Follow-up|12|||
131860787|NCT01401452|474769589|FG000|Overall Study|Lack of Efficacy|30|||
131860788|NCT01401452|474769589|FG000|Overall Study|Participant developed breast cancer|1|||
131860789|NCT01401452|474769589|FG000|Overall Study|Tx stopped due to financial reasons|1|||
131860790|NCT01401452|474769589|FG000|Overall Study|Tx stopped by psychiatrist|1|||
131860791|NCT01401452|474769589|FG000|Overall Study|No more visits within the 36 wk followup|4|||
131860792|NCT01401452|474769589|FG000|Overall Study|Subject did not come to follow up visits|2|||
131860793|NCT01401452|474769589|FG000|Overall Study|Subject didn't return for routine visits|1|||
131860794|NCT01401452|474769589|FG000|Overall Study|Subject moved to another city|1|||
131860795|NCT01401452|474769589|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
131860796|NCT01401452|474769589|FG000|Overall Study|Psoriatic arthritis|1|||
131860797|NCT01401452|474769589|FG000|Overall Study|Participant stopped Tx|2|||
131860798|NCT01401452|474769589|FG000|Overall Study|Discontinuation for personal reasons|1|||
131860799|NCT01401452|474769589|FG000|Overall Study|Treatment failure|1|||
131860800|NCT01401452|474769589|FG000|Overall Study|Unsatisfactory output|1|||
131860801|NCT01401452|474769589|FG000|Overall Study|Subject withdrew because of Tx success|1|||
131860802|NCT01401452|474769589|FG000|Overall Study|Subject chose to discontinue treatment|1|||
131860803|NCT01401452|474769589|FG000|Overall Study|Participant withdrew consent|1|||
131860804|NCT01742897|474769590|FG000|Overall Study|Adverse Event|3|||
131860805|NCT01742897|474769590|FG000|Overall Study|Withdrawal by Subject|1|||
131860806|NCT01742897|474769590|FG000|Overall Study|Other|1|||
131860807|NCT00625820|474769591|FG000|Overall Study|Withdrawal by Subject|1|||
131860808|NCT02456740|474769593|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
131860809|NCT02456740|474769594|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
131860810|NCT02456740|474769595|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
131860811|NCT02456740|474769596|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
131860812|NCT02456740|474769597|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
131860813|NCT02456740|474769598|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
131860814|NCT02456740|474769599|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
131860815|NCT02456740|474769600|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
131860816|NCT02456740|474769601|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
131860817|NCT02456740|474769593|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
131860818|NCT02456740|474769594|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
131860819|NCT02456740|474769595|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
131860820|NCT02456740|474769596|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
131860821|NCT02456740|474769597|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
131860822|NCT02456740|474769598|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
131860823|NCT02456740|474769599|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
131860824|NCT02456740|474769600|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
131860825|NCT02456740|474769601|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
131860826|NCT02456740|474769593|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
131860827|NCT02456740|474769594|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
131860828|NCT02456740|474769595|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
131860829|NCT02456740|474769596|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
131860830|NCT02456740|474769597|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
131860831|NCT02456740|474769598|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
131860832|NCT02456740|474769599|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
131860833|NCT02456740|474769600|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
131860834|NCT02456740|474769601|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
131860835|NCT02456740|474769593|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
131860836|NCT02456740|474769594|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
131860837|NCT02456740|474769595|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
131860838|NCT02456740|474769596|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
131860839|NCT02456740|474769597|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
131860840|NCT02456740|474769598|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
131860841|NCT02456740|474769599|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
131860842|NCT02456740|474769600|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
131860843|NCT02456740|474769601|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
131860844|NCT02456740|474769593|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131860845|NCT02456740|474769594|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131860846|NCT02456740|474769595|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131860847|NCT02456740|474769596|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
131860848|NCT02456740|474769597|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
131860849|NCT02456740|474769598|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
131860850|NCT02456740|474769599|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
131860851|NCT02456740|474769600|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
131860852|NCT02456740|474769601|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
131860853|NCT02456740|474769593|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860854|NCT02456740|474769594|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860855|NCT02456740|474769595|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860856|NCT02456740|474769596|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860857|NCT02456740|474769597|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860858|NCT02456740|474769598|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860859|NCT02456740|474769599|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860860|NCT02456740|474769600|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
131860861|NCT02456740|474769601|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
131860862|NCT02456740|474769593|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131860863|NCT02456740|474769594|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131860864|NCT02456740|474769595|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131860865|NCT02456740|474769596|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
131860866|NCT02456740|474769597|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
131860867|NCT02456740|474769598|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
131860868|NCT02456740|474769599|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
131860869|NCT02456740|474769600|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
131860870|NCT02456740|474769601|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
131860871|NCT03759392|474769602|FG000|Overall Study|Adverse Event|12|||
131860872|NCT03759392|474769603|FG001|Overall Study|Adverse Event|4|||
131860873|NCT03759392|474769602|FG000|Overall Study|Death|2|||
131860874|NCT03759392|474769603|FG001|Overall Study|Death|1|||
131860875|NCT03759392|474769602|FG000|Overall Study|Withdrawal by Subject|2|||
131860876|NCT03759392|474769603|FG001|Overall Study|Withdrawal by Subject|0|||
131860877|NCT03759392|474769602|FG000|Overall Study|Protocol Violation|2|||
131860878|NCT03759392|474769603|FG001|Overall Study|Protocol Violation|0|||
131860879|NCT03759392|474769602|FG000|Overall Study|Physician Decision|0|||
131860880|NCT03759392|474769603|FG001|Overall Study|Physician Decision|1|||
131860881|NCT03759392|474769602|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
131860882|NCT03759392|474769603|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
131860883|NCT03759392|474769602|FG000|Overall Study|No longer able to take medicines|1|||
131860884|NCT03759392|474769603|FG001|Overall Study|No longer able to take medicines|0|||
131860885|NCT03759392|474769602|FG000|Overall Study|Stopped taking study drug|1|||
131860886|NCT03759392|474769603|FG001|Overall Study|Stopped taking study drug|0|||
131860887|NCT04720105|474769604|FG000|Overall Study|Lack of Efficacy|1|||
131860888|NCT04720105|474769604|FG000|Overall Study|Lost to Follow-up|1|||
131860889|NCT04720105|474769604|FG000|Overall Study|Withdrawal by Subject|3|||
131860890|NCT04135937|474769607|FG000|Overall Study|Lost to Follow-up|2|||
131860891|NCT04135937|474769607|FG000|Overall Study|Withdrawal by Subject|1|||
131860892|NCT04075487|474770798|FG000|Overall Study|Withdrawal by Subject|1|||
131860893|NCT00070564|474770801|FG000|Overall Study|Progression|2|||
131860894|NCT00070564|474770802|FG001|Overall Study|Progression|4|||
131860895|NCT00070564|474770803|FG002|Overall Study|Progression|7|||
131860896|NCT00070564|474770804|FG003|Overall Study|Progression|7|||
131860897|NCT00070564|474770805|FG004|Overall Study|Progression|1|||
131860898|NCT00070564|474770806|FG005|Overall Study|Progression|0|||
131860899|NCT00070564|474770801|FG000|Overall Study|Delinquent|1|||
131860900|NCT00070564|474770802|FG001|Overall Study|Delinquent|4|||
131860901|NCT00070564|474770803|FG002|Overall Study|Delinquent|2|||
131860902|NCT00070564|474770804|FG003|Overall Study|Delinquent|0|||
131860903|NCT00070564|474770805|FG004|Overall Study|Delinquent|0|||
131860904|NCT00070564|474770806|FG005|Overall Study|Delinquent|0|||
131860905|NCT00070564|474770801|FG000|Overall Study|Adverse Event|150|||
131860906|NCT00070564|474770802|FG001|Overall Study|Adverse Event|142|||
131860907|NCT00070564|474770803|FG002|Overall Study|Adverse Event|120|||
131860908|NCT00070564|474770804|FG003|Overall Study|Adverse Event|108|||
131860909|NCT00070564|474770805|FG004|Overall Study|Adverse Event|63|||
131860910|NCT00070564|474770806|FG005|Overall Study|Adverse Event|36|||
131860911|NCT00070564|474770801|FG000|Overall Study|Death|4|||
131860912|NCT00070564|474770802|FG001|Overall Study|Death|1|||
131860913|NCT00070564|474770803|FG002|Overall Study|Death|5|||
131860914|NCT00070564|474770804|FG003|Overall Study|Death|3|||
131860915|NCT00070564|474770805|FG004|Overall Study|Death|0|||
131860916|NCT00070564|474770806|FG005|Overall Study|Death|1|||
131860917|NCT00070564|474770801|FG000|Overall Study|Other, not protocol specified|17|||
131860918|NCT00070564|474770802|FG001|Overall Study|Other, not protocol specified|15|||
131860919|NCT00070564|474770803|FG002|Overall Study|Other, not protocol specified|14|||
131860920|NCT00070564|474770804|FG003|Overall Study|Other, not protocol specified|19|||
131860921|NCT00070564|474770805|FG004|Overall Study|Other, not protocol specified|6|||
131860922|NCT00070564|474770806|FG005|Overall Study|Other, not protocol specified|7|||
131860923|NCT00070564|474770801|FG000|Overall Study|Withdrawal by Subject|26|||
131860924|NCT00070564|474770802|FG001|Overall Study|Withdrawal by Subject|37|||
131860925|NCT00070564|474770803|FG002|Overall Study|Withdrawal by Subject|23|||
131860926|NCT00070564|474770804|FG003|Overall Study|Withdrawal by Subject|30|||
131860927|NCT00070564|474770805|FG004|Overall Study|Withdrawal by Subject|8|||
131860928|NCT00070564|474770806|FG005|Overall Study|Withdrawal by Subject|8|||
131860929|NCT00070564|474770801|FG000|Overall Study|Not reported|0|||
131860930|NCT00070564|474770802|FG001|Overall Study|Not reported|0|||
131860931|NCT00070564|474770803|FG002|Overall Study|Not reported|0|||
131860932|NCT00070564|474770804|FG003|Overall Study|Not reported|0|||
131860933|NCT00070564|474770805|FG004|Overall Study|Not reported|1|||
131860934|NCT00070564|474770806|FG005|Overall Study|Not reported|0|||
131860935|NCT05655546|474770807|FG000|Overall Study|Withdrawal by Subject|2|||
131860936|NCT05655546|474770808|FG001|Overall Study|Withdrawal by Subject|4|||
131860937|NCT01168232|474770809|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
131860938|NCT01168232|474770809|FG000|Overall Study|Ineligible- Wrong cell type|6|||
131860939|NCT01168232|474770809|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
131860940|NCT04576507|474770813|FG000|Overall Study|Adverse Event|4|||
131860941|NCT04576507|474770813|FG000|Overall Study|Withdrawal by Subject|1|||
131860942|NCT02115269|474770816|FG000|Overall Study|Lost to Follow-up|43|||
131860943|NCT02115269|474770816|FG000|Overall Study|Did not complete patient diary|3|||
131860944|NCT02115269|474770816|FG000|Overall Study|Moved to another city|7|||
131860945|NCT02115269|474770816|FG000|Overall Study|Withdrawal by Subject|2|||
131860946|NCT02115269|474770816|FG000|Overall Study|Didn't take study drug|2|||
131860947|NCT01557504|474770817|FG000|Overall Study|Physician Decision|1|||
131860948|NCT01557504|474770818|FG001|Overall Study|Physician Decision|0|||
131860949|NCT02750618|474770819|FG000|Overall Study|Withdrawal by Subject|1|||
131860950|NCT02493660|474770824|FG000|Overall Study|Physician Decision|0|||
131860951|NCT02493660|474770825|FG001|Overall Study|Physician Decision|1|||
131860952|NCT02493660|474770824|FG000|Overall Study|Adverse Event|4|||
131860953|NCT02493660|474770825|FG001|Overall Study|Adverse Event|2|||
131860954|NCT02493660|474770824|FG000|Overall Study|Withdrawal by Subject|2|||
131860955|NCT02493660|474770825|FG001|Overall Study|Withdrawal by Subject|3|||
131860956|NCT02493660|474770824|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
131860957|NCT02493660|474770825|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
131860958|NCT02493660|474770824|FG000|Overall Study|Protocol Violation|0|||
131860959|NCT02493660|474770825|FG001|Overall Study|Protocol Violation|1|||
131860960|NCT02493660|474770824|FG000|Overall Study|Death|0|||
131860961|NCT02493660|474770825|FG001|Overall Study|Death|1|||
131860962|NCT02493660|474770824|FG000|Overall Study|Lost to Follow-up|2|||
131860963|NCT02493660|474770825|FG001|Overall Study|Lost to Follow-up|4|||
131860964|NCT02392481|474770827|FG000|Overall Study|Adverse Event|0|||
131860965|NCT02392481|474770828|FG001|Overall Study|Adverse Event|0|||
131860966|NCT02392481|474770829|FG002|Overall Study|Adverse Event|1|||
131860967|NCT02392481|474770830|FG003|Overall Study|Adverse Event|2|||
131860968|NCT02392481|474770827|FG000|Overall Study|Withdrawal by Subject|0|||
131860969|NCT02392481|474770828|FG001|Overall Study|Withdrawal by Subject|0|||
131860970|NCT02392481|474770829|FG002|Overall Study|Withdrawal by Subject|1|||
131860971|NCT02392481|474770830|FG003|Overall Study|Withdrawal by Subject|0|||
131860972|NCT02502149|474770832|FG000|Intermediate|Discontinued prematurely|1|||
131860973|NCT02502149|474770833|FG001|Intermediate|Discontinued prematurely|0|||
131860974|NCT02502149|474770834|FG002|Intermediate|Discontinued prematurely|0|||
131860975|NCT02502149|474770835|FG003|Intermediate|Discontinued prematurely|0|||
131860976|NCT02502149|474770836|FG004|Intermediate|Discontinued prematurely|0|||
131860977|NCT02968576|474770837|FG000|Overall Study|Pregnancy|0|||
131860978|NCT02968576|474770838|FG001|Overall Study|Pregnancy|1|||
131860979|NCT00116779|474770841|FG000|Overall Study|Adverse Event|4|||
131860980|NCT00116779|474770842|FG001|Overall Study|Adverse Event|2|||
131860981|NCT00116779|474770841|FG000|Overall Study|Protocol Violation|1|||
131860982|NCT00116779|474770842|FG001|Overall Study|Protocol Violation|4|||
131860983|NCT00116779|474770841|FG000|Overall Study|Withdrawal by Subject|4|||
131860984|NCT00116779|474770842|FG001|Overall Study|Withdrawal by Subject|1|||
131860985|NCT00116779|474770841|FG000|Overall Study|Inadequate testosterone suppression|7|||
131860986|NCT00116779|474770842|FG001|Overall Study|Inadequate testosterone suppression|9|||
131860987|NCT00116779|474770841|FG000|Overall Study|Physician Decision|3|||
131860988|NCT00116779|474770842|FG001|Overall Study|Physician Decision|1|||
131860989|NCT00116779|474770841|FG000|Overall Study|Elevated PSA levels|2|||
131860990|NCT00116779|474770842|FG001|Overall Study|Elevated PSA levels|2|||
131860991|NCT01037218|474770843|FG000|Overall Study|Adverse Event|4|||
131860992|NCT01037218|474770844|FG001|Overall Study|Adverse Event|2|||
131860993|NCT01037218|474770845|FG002|Overall Study|Adverse Event|2|||
131860994|NCT01037218|474770846|FG003|Overall Study|Adverse Event|1|||
131860995|NCT01037218|474770843|FG000|Overall Study|Lack of Efficacy|0|||
131860996|NCT01037218|474770844|FG001|Overall Study|Lack of Efficacy|2|||
131860997|NCT01037218|474770845|FG002|Overall Study|Lack of Efficacy|1|||
131860998|NCT01037218|474770846|FG003|Overall Study|Lack of Efficacy|5|||
131860999|NCT01037218|474770843|FG000|Overall Study|Lost to Follow-up|3|||
131861000|NCT01037218|474770844|FG001|Overall Study|Lost to Follow-up|5|||
131861001|NCT01037218|474770845|FG002|Overall Study|Lost to Follow-up|4|||
131861002|NCT01037218|474770846|FG003|Overall Study|Lost to Follow-up|2|||
131861003|NCT01037218|474770843|FG000|Overall Study|Withdrawal by Subject|6|||
131861004|NCT01037218|474770844|FG001|Overall Study|Withdrawal by Subject|7|||
131861005|NCT01037218|474770845|FG002|Overall Study|Withdrawal by Subject|7|||
131861006|NCT01037218|474770846|FG003|Overall Study|Withdrawal by Subject|4|||
131861007|NCT01037218|474770843|FG000|Overall Study|Partner Withdrew Consent|0|||
131861008|NCT01037218|474770844|FG001|Overall Study|Partner Withdrew Consent|3|||
131861009|NCT01037218|474770845|FG002|Overall Study|Partner Withdrew Consent|2|||
131861010|NCT01037218|474770846|FG003|Overall Study|Partner Withdrew Consent|1|||
131861011|NCT01037218|474770843|FG000|Overall Study|Protocol Violation|0|||
131861012|NCT01037218|474770844|FG001|Overall Study|Protocol Violation|0|||
131861013|NCT01037218|474770845|FG002|Overall Study|Protocol Violation|2|||
131861014|NCT01037218|474770846|FG003|Overall Study|Protocol Violation|2|||
131861015|NCT01037218|474770843|FG000|Overall Study|Various|3|||
131861016|NCT01037218|474770844|FG001|Overall Study|Various|2|||
131861017|NCT01037218|474770845|FG002|Overall Study|Various|3|||
131861018|NCT01037218|474770846|FG003|Overall Study|Various|1|||
131861019|NCT02714218|474770849|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131861020|NCT02714218|474770850|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131861021|NCT02714218|474770851|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131861022|NCT02714218|474770849|FG000|Pre-Treatment Period|Other reasons|0|||
131861023|NCT02714218|474770850|FG001|Pre-Treatment Period|Other reasons|1|||
131861024|NCT02714218|474770851|FG002|Pre-Treatment Period|Other reasons|0|||
131861025|NCT02714218|474770849|FG000|Treatment Period|Disease Progression|55|||
131861026|NCT02714218|474770850|FG001|Treatment Period|Disease Progression|52|||
131861027|NCT02714218|474770851|FG002|Treatment Period|Disease Progression|14|||
131861028|NCT02714218|474770849|FG000|Treatment Period|Study drug toxicity|46|||
131861029|NCT02714218|474770850|FG001|Treatment Period|Study drug toxicity|70|||
131861030|NCT02714218|474770851|FG002|Treatment Period|Study drug toxicity|6|||
131861031|NCT02714218|474770849|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
131861032|NCT02714218|474770850|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
131861033|NCT02714218|474770851|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
131861034|NCT02714218|474770849|FG000|Treatment Period|Request to discontinue treatment|1|||
131861035|NCT02714218|474770850|FG001|Treatment Period|Request to discontinue treatment|4|||
131861036|NCT02714218|474770851|FG002|Treatment Period|Request to discontinue treatment|1|||
131861037|NCT02714218|474770849|FG000|Treatment Period|Participant withdrew consent|2|||
131861038|NCT02714218|474770850|FG001|Treatment Period|Participant withdrew consent|2|||
131861039|NCT02714218|474770851|FG002|Treatment Period|Participant withdrew consent|0|||
131861040|NCT02714218|474770849|FG000|Treatment Period|Maximum clinical benefit|4|||
131407851|NCT03199053|473115196|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
131407852|NCT03199053|473115197|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
131861041|NCT02714218|474770850|FG001|Treatment Period|Maximum clinical benefit|2|||
131861042|NCT02714218|474770851|FG002|Treatment Period|Maximum clinical benefit|0|||
131861043|NCT02714218|474770849|FG000|Treatment Period|Administrative reason by sponsor|2|||
131861044|NCT02714218|474770850|FG001|Treatment Period|Administrative reason by sponsor|1|||
131861045|NCT02714218|474770851|FG002|Treatment Period|Administrative reason by sponsor|0|||
131861046|NCT02714218|474770849|FG000|Treatment Period|Other reasons|6|||
131861047|NCT02714218|474770850|FG001|Treatment Period|Other reasons|6|||
131861048|NCT02714218|474770851|FG002|Treatment Period|Other reasons|0|||
131407853|NCT03199053|473115198|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
131861049|NCT02714218|474770849|FG000|Treatment Period|Completed treatment as per protocol|36|||
131913052|NCT01288430|474969286|FG009|Part 1|Adverse Event|0|||
131407854|NCT03298984|473115201|FG000|Overall Study|Physician Decision|1|||
131407855|NCT03298984|473115202|FG001|Overall Study|Physician Decision|0|||
131407856|NCT03298984|473115203|FG002|Overall Study|Physician Decision|0|||
131407857|NCT03298984|473115204|FG003|Overall Study|Physician Decision|6|||
131407858|NCT03298984|473115201|FG000|Overall Study|Lack of Efficacy|0|||
131407859|NCT03298984|473115202|FG001|Overall Study|Lack of Efficacy|1|||
131407860|NCT03298984|473115203|FG002|Overall Study|Lack of Efficacy|1|||
131407861|NCT03298984|473115204|FG003|Overall Study|Lack of Efficacy|4|||
131407862|NCT03298984|473115201|FG000|Overall Study|Relapsed disease (following remission)|0|||
131407863|NCT03298984|473115202|FG001|Overall Study|Relapsed disease (following remission)|0|||
131407864|NCT03298984|473115203|FG002|Overall Study|Relapsed disease (following remission)|1|||
131407865|NCT03298984|473115204|FG003|Overall Study|Relapsed disease (following remission)|1|||
131407866|NCT03298984|473115201|FG000|Overall Study|Adverse Event|0|||
131407867|NCT03298984|473115202|FG001|Overall Study|Adverse Event|0|||
131407868|NCT03298984|473115203|FG002|Overall Study|Adverse Event|0|||
131407869|NCT03298984|473115204|FG003|Overall Study|Adverse Event|1|||
131407870|NCT03298984|473115201|FG000|Overall Study|Death|0|||
131407871|NCT03298984|473115202|FG001|Overall Study|Death|0|||
131407872|NCT03298984|473115203|FG002|Overall Study|Death|0|||
131407873|NCT03298984|473115204|FG003|Overall Study|Death|2|||
131407874|NCT03298984|473115201|FG000|Overall Study|Insurance Company Decision|0|||
131407875|NCT03298984|473115202|FG001|Overall Study|Insurance Company Decision|0|||
131407876|NCT03298984|473115203|FG002|Overall Study|Insurance Company Decision|0|||
131407877|NCT03298984|473115204|FG003|Overall Study|Insurance Company Decision|1|||
131407878|NCT00294645|473115205|FG000|Overall Study|Death|10|||
131407879|NCT00294645|473115206|FG001|Overall Study|Death|18|||
131407880|NCT00294645|473115205|FG000|Overall Study|Lost to Follow-up|1|||
131407881|NCT00294645|473115206|FG001|Overall Study|Lost to Follow-up|10|||
131407882|NCT00294645|473115205|FG000|Overall Study|Withdrawal by Subject|18|||
131407883|NCT00294645|473115206|FG001|Overall Study|Withdrawal by Subject|34|||
131407884|NCT00294645|473115205|FG000|Overall Study|Physician Decision|15|||
131407885|NCT00294645|473115206|FG001|Overall Study|Physician Decision|20|||
131407886|NCT00294645|473115205|FG000|Overall Study|Other|4|||
131407887|NCT00294645|473115206|FG001|Overall Study|Other|10|||
131407888|NCT02509052|473115207|FG000|Overall Study|Non compliance|0|||
131407889|NCT02509052|473115208|FG001|Overall Study|Non compliance|0|||
131407890|NCT02509052|473115209|FG002|Overall Study|Non compliance|1|||
131407891|NCT01824823|473115210|FG000|Overall Study|Lack of Efficacy|1|||
131407892|NCT01824823|473115211|FG001|Overall Study|Lack of Efficacy|1|||
131407893|NCT01824823|473115210|FG000|Overall Study|Off-treatment reason not submitted|1|||
131407894|NCT01824823|473115211|FG001|Overall Study|Off-treatment reason not submitted|0|||
131407895|NCT03263923|473115212|FG000|Overall Study|Withdrawal by Subject|10|||
131407896|NCT03263923|473115213|FG001|Overall Study|Withdrawal by Subject|8|||
131407897|NCT03263923|473115212|FG000|Overall Study|Lost to Follow-up|15|||
131407898|NCT03263923|473115213|FG001|Overall Study|Lost to Follow-up|13|||
131407899|NCT02098369|473115214|FG000|Overall Study|Withdrawal by Subject|1|||
131407900|NCT02098369|473115215|FG001|Overall Study|Withdrawal by Subject|5|||
131407901|NCT02098369|473115216|FG002|Overall Study|Withdrawal by Subject|0|||
131407902|NCT02098369|473115214|FG000|Overall Study|Lost to Follow-up|5|||
131407903|NCT02098369|473115215|FG001|Overall Study|Lost to Follow-up|1|||
131407904|NCT02098369|473115216|FG002|Overall Study|Lost to Follow-up|3|||
131407905|NCT02098369|473115214|FG000|Overall Study|Death|1|||
131407906|NCT02098369|473115215|FG001|Overall Study|Death|1|||
131407907|NCT02098369|473115216|FG002|Overall Study|Death|1|||
131407908|NCT02098369|473115214|FG000|Overall Study|Other|0|||
131407909|NCT02098369|473115215|FG001|Overall Study|Other|2|||
131407910|NCT02098369|473115216|FG002|Overall Study|Other|1|||
131407911|NCT03362931|473115218|FG000|Overall Study|Adverse Event|1|||
131407912|NCT03362931|473115218|FG000|Overall Study|Death|2|||
131407913|NCT03305081|473115245|FG000|Overall Study|Lost to Follow-up|10|||
131407914|NCT03305081|473115246|FG001|Overall Study|Lost to Follow-up|15|||
131407915|NCT02437305|473115248|FG000|Overall Study|Lost to Follow-up|18|||
131407916|NCT02437305|473115249|FG001|Overall Study|Lost to Follow-up|12|||
131913053|NCT01288430|474969277|FG000|Part 1|Other|0|||
131913054|NCT01288430|474969278|FG001|Part 1|Other|2|||
131913055|NCT01288430|474969279|FG002|Part 1|Other|0|||
131913056|NCT01288430|474969280|FG003|Part 1|Other|0|||
131913057|NCT01288430|474969281|FG004|Part 1|Other|0|||
131407917|NCT01560637|473115250|FG000|Overall Study|Adverse Event|63|||
131407918|NCT01560637|473115250|FG000|Overall Study|Death|69|||
131407919|NCT01560637|473115250|FG000|Overall Study|Lost to Follow-up|8|||
131407920|NCT01560637|473115250|FG000|Overall Study|Protocol Violation|8|||
131407921|NCT01560637|473115250|FG000|Overall Study|Withdrawal by Subject|24|||
131407922|NCT01560637|473115250|FG000|Overall Study|Progressive Disease|20|||
131407923|NCT01560637|473115250|FG000|Overall Study|Other Reason Not Specified|6|||
131407924|NCT01185964|473115253|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
131407925|NCT01185964|473115254|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
131407926|NCT01185964|473115255|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
131407927|NCT01185964|473115256|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
131434023|NCT01216202|473214607|FG001|Overall Study|Death|2|||
131913058|NCT01288430|474969282|FG005|Part 1|Other|0|||
131407928|NCT01185964|473115253|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
131407929|NCT01185964|473115254|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
131407930|NCT01185964|473115255|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
131407931|NCT01185964|473115256|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
131407932|NCT01185964|473115253|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
131407933|NCT01185964|473115254|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
131407934|NCT01185964|473115255|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
131407935|NCT01185964|473115256|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
131407936|NCT01185964|473115253|FG000|Phase 1b and Phase 2|Adverse Event|1|||
131407937|NCT01185964|473115254|FG001|Phase 1b and Phase 2|Adverse Event|0|||
131407938|NCT01185964|473115255|FG002|Phase 1b and Phase 2|Adverse Event|2|||
131407939|NCT01185964|473115256|FG003|Phase 1b and Phase 2|Adverse Event|0|||
131407940|NCT01185964|473115253|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
131407941|NCT01185964|473115254|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
131407942|NCT01185964|473115255|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
131407943|NCT01185964|473115256|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
131407944|NCT01185964|473115253|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
131407945|NCT01185964|473115254|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
131407946|NCT01185964|473115255|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
131407947|NCT01185964|473115256|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
131407948|NCT01185964|473115253|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
131407949|NCT01185964|473115254|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
131407950|NCT01185964|473115255|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
131407951|NCT01185964|473115256|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
131407952|NCT01185964|473115253|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
131407953|NCT01185964|473115254|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
131407954|NCT01185964|473115255|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
131407955|NCT01185964|473115256|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
131861050|NCT02714218|474770850|FG001|Treatment Period|Completed treatment as per protocol|27|||
131861051|NCT02714218|474770851|FG002|Treatment Period|Completed treatment as per protocol|3|||
131861052|NCT02714218|474770849|FG000|Treatment Period|Not reported|9|||
131861053|NCT02714218|474770850|FG001|Treatment Period|Not reported|6|||
131861054|NCT02714218|474770851|FG002|Treatment Period|Not reported|0|||
131861055|NCT01199939|474770852|FG000|Overall Study|Adverse Event|4|||
131861056|NCT01199939|474770852|FG000|Overall Study|Protocol Violation|3|||
131861057|NCT01199939|474770852|FG000|Overall Study|Lost to Follow-up|2|||
131861058|NCT01199939|474770852|FG000|Overall Study|Reached a virologic endpoint|4|||
131861059|NCT03875508|474770855|FG000|Overall Study|Adverse Event|1|||
131861060|NCT03875508|474770855|FG000|Overall Study|Lost to Follow-up|8|||
131861061|NCT03875508|474770855|FG000|Overall Study|Lack of Efficacy|1|||
131861062|NCT03875508|474770855|FG000|Overall Study|Other, not specified|2|||
131861063|NCT02550561|474770856|FG000|Overall Study|Lost to Follow-up|5|||
131861064|NCT02550561|474770856|FG000|Overall Study|Withdrawal by Subject|1|||
131861065|NCT02394600|474770857|FG000|Overall Study|Adverse Event|3|||
131861066|NCT02394600|474770858|FG001|Overall Study|Adverse Event|0|||
131861067|NCT02394600|474770857|FG000|Overall Study|Lost to Follow-up|0|||
131861068|NCT02394600|474770858|FG001|Overall Study|Lost to Follow-up|1|||
131861069|NCT02394600|474770857|FG000|Overall Study|Withdrawal by Subject|0|||
131861070|NCT02394600|474770858|FG001|Overall Study|Withdrawal by Subject|1|||
131861071|NCT02394600|474770857|FG000|Overall Study|Protocol Violation|1|||
131861072|NCT02394600|474770858|FG001|Overall Study|Protocol Violation|0|||
131861073|NCT00428246|474770859|FG000|Overall Study|Withdrawal by Subject|0|||
131861074|NCT00428246|474770860|FG001|Overall Study|Withdrawal by Subject|0|||
131861075|NCT00428246|474770861|FG002|Overall Study|Withdrawal by Subject|1|||
131861076|NCT00428246|474770859|FG000|Overall Study|Adverse Event|1|||
131861077|NCT00428246|474770860|FG001|Overall Study|Adverse Event|0|||
131861078|NCT00428246|474770861|FG002|Overall Study|Adverse Event|0|||
131861079|NCT03442751|474770863|FG000|Overall Study|Withdrawal by Subject|3|||
131861080|NCT03442751|474770864|FG001|Overall Study|Withdrawal by Subject|1|||
131861081|NCT03442751|474770863|FG000|Overall Study|Lost to Follow-up|3|||
131861082|NCT03442751|474770864|FG001|Overall Study|Lost to Follow-up|0|||
131861083|NCT00470470|474770870|FG000|Overall Study|Adverse Event|2|||
131407956|NCT01920893|473115257|FG000|Overall Study|Adverse Event|5|||
131407957|NCT01920893|473115258|FG001|Overall Study|Adverse Event|2|||
131407958|NCT01920893|473115257|FG000|Overall Study|Lack of Efficacy|2|||
131407959|NCT01920893|473115258|FG001|Overall Study|Lack of Efficacy|0|||
131407960|NCT03762616|473115262|FG000|Overall Study|Protocol Violation|2|||
131434024|NCT01216202|473214606|FG000|Overall Study|Lost to Follow-up|14|||
131861084|NCT00470470|474770870|FG000|Overall Study|Death|2|||
131861085|NCT00470470|474770870|FG000|Overall Study|Not treated|1|||
131861086|NCT02452476|474770873|FG000|Overall Study|Death|4|||
131861087|NCT02452476|474770874|FG001|Overall Study|Death|7|||
131861088|NCT02452476|474770873|FG000|Overall Study|Lost to Follow-up|1|||
131861089|NCT02452476|474770874|FG001|Overall Study|Lost to Follow-up|1|||
131861090|NCT02452476|474770873|FG000|Overall Study|Physician Decision|1|||
131861091|NCT02452476|474770874|FG001|Overall Study|Physician Decision|1|||
131861092|NCT02452476|474770873|FG000|Overall Study|Not treated|5|||
131861093|NCT02452476|474770874|FG001|Overall Study|Not treated|1|||
131861094|NCT02072980|474770875|FG000|Period 2, Second Wear|Adverse Event|0|||
131861095|NCT02072980|474770876|FG001|Period 2, Second Wear|Adverse Event|1|||
131861096|NCT02431364|474770877|FG000|Overall Study|Adverse Event|0|||
131861097|NCT02431364|474770878|FG001|Overall Study|Adverse Event|1|||
131861098|NCT02431364|474770879|FG002|Overall Study|Adverse Event|0|||
131861099|NCT02431364|474770880|FG003|Overall Study|Adverse Event|0|||
131861100|NCT02431364|474770881|FG004|Overall Study|Adverse Event|0|||
131861101|NCT02431364|474770877|FG000|Overall Study|Randomized but never treated|0|||
131861102|NCT02431364|474770878|FG001|Overall Study|Randomized but never treated|0|||
131861103|NCT02431364|474770879|FG002|Overall Study|Randomized but never treated|0|||
131861104|NCT02431364|474770880|FG003|Overall Study|Randomized but never treated|1|||
131861105|NCT02431364|474770881|FG004|Overall Study|Randomized but never treated|0|||
131861106|NCT01112059|474770882|FG000|Overall Study|Withdrawal by Subject|1|||
131861107|NCT01112059|474770883|FG001|Overall Study|Withdrawal by Subject|0|||
131861108|NCT01757275|474770884|FG000|Overall Study|Lost to Follow-up|1|||
131861109|NCT01757275|474770885|FG001|Overall Study|Lost to Follow-up|2|||
131861110|NCT01757275|474770884|FG000|Overall Study|Adverse Event|3|||
131861111|NCT01757275|474770885|FG001|Overall Study|Adverse Event|3|||
131861112|NCT01757275|474770884|FG000|Overall Study|Withdrawal by Subject|2|||
131861113|NCT01757275|474770885|FG001|Overall Study|Withdrawal by Subject|4|||
131861114|NCT01757275|474770884|FG000|Overall Study|Not treated|3|||
131861115|NCT01757275|474770885|FG001|Overall Study|Not treated|4|||
131861116|NCT01133067|474770890|FG000|Overall Study|Death|136|||
131861117|NCT01133067|474770890|FG000|Overall Study|Lost to Follow-up|3|||
131861118|NCT02654054|474770892|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
131861119|NCT02654054|474770893|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
131861120|NCT02654054|474770894|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
131861121|NCT02654054|474770892|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
131861122|NCT02654054|474770893|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131861123|NCT02654054|474770894|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
131861124|NCT02654054|474770892|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
131861125|NCT02654054|474770893|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
131861126|NCT02654054|474770894|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
131861127|NCT02654054|474770892|FG000|Post-Treatment Follow-Up Period|Other|1|||
131861128|NCT02654054|474770893|FG001|Post-Treatment Follow-Up Period|Other|0|||
131861129|NCT02654054|474770894|FG002|Post-Treatment Follow-Up Period|Other|4|||
131861130|NCT02654054|474770892|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
131861131|NCT02654054|474770893|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
131861132|NCT02654054|474770894|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
131861133|NCT00273182|474770895|FG000|Overall Study|Death|450|||
131861134|NCT00273182|474770895|FG000|Overall Study|Lost to Follow-up|88|||
131861135|NCT00273182|474770895|FG000|Overall Study|Withdrawal by Subject|257|||
131861136|NCT00273182|474770895|FG000|Overall Study|Device/System Explant|154|||
131861137|NCT00273182|474770895|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
131861138|NCT00856492|474770896|FG000|Overall Study|Ineligible or withdrew consent|1|||
131861139|NCT00856492|474770897|FG001|Overall Study|Ineligible or withdrew consent|1|||
131861140|NCT00856492|474770898|FG002|Overall Study|Ineligible or withdrew consent|2|||
131861141|NCT03641469|474770901|FG000|Overall Study|Ineligible|2|||
131861142|NCT03641469|474770901|FG000|Overall Study|Withdrawal by Subject|5|||
131861143|NCT03641469|474770901|FG000|Overall Study|Physician Decision|1|||
131861144|NCT03641469|474770901|FG000|Overall Study|Protocol Violation|1|||
131861145|NCT03641469|474770901|FG000|Overall Study|Lost to Follow-up|2|||
131861146|NCT00955617|474770902|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
131861147|NCT00955617|474770903|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
131861148|NCT00955617|474770902|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
131861149|NCT00955617|474770903|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
131861150|NCT00955617|474770902|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
131861151|NCT00955617|474770903|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
131861152|NCT00955617|474770902|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
131861153|NCT00955617|474770903|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
131861154|NCT00868530|474770904|FG000|Overall Study|Adverse Event|3|||
131861155|NCT00868530|474770904|FG000|Overall Study|Lost to Follow-up|1|||
131861156|NCT00858273|474770905|FG000|Overall Study|Protocol Violation|3|||
131861157|NCT00858273|474770906|FG001|Overall Study|Protocol Violation|5|||
131861158|NCT04199104|474772304|FG000|Overall Study|Death|148|||
131861159|NCT04199104|474772305|FG001|Overall Study|Death|134|||
131861160|NCT04199104|474772304|FG000|Overall Study|Lost to Follow-up|1|||
131861161|NCT04199104|474772305|FG001|Overall Study|Lost to Follow-up|1|||
131861162|NCT04199104|474772304|FG000|Overall Study|Withdrawal by Subject|4|||
131861163|NCT04199104|474772305|FG001|Overall Study|Withdrawal by Subject|4|||
131861164|NCT04199104|474772304|FG000|Overall Study|Participants Ongoing|103|||
131861165|NCT04199104|474772305|FG001|Overall Study|Participants Ongoing|116|||
131861166|NCT05012098|474772310|FG000|Overall Study|Disease progression|5|||
131861167|NCT05012098|474772311|FG001|Overall Study|Disease progression|2|||
131861168|NCT05012098|474772310|FG000|Overall Study|Adverse Event|1|||
131861169|NCT05012098|474772311|FG001|Overall Study|Adverse Event|0|||
131861170|NCT05012098|474772310|FG000|Overall Study|Withdrawal by Subject|1|||
131861171|NCT05012098|474772311|FG001|Overall Study|Withdrawal by Subject|0|||
131861172|NCT05012098|474772310|FG000|Overall Study|Discontinuation per protocol|1|||
131861173|NCT05012098|474772311|FG001|Overall Study|Discontinuation per protocol|0|||
131861174|NCT01490086|474772312|FG000|Overall Study|Consent withdrawn|4|||
131861175|NCT01490086|474772313|FG001|Overall Study|Consent withdrawn|4|||
131861176|NCT01490086|474772314|FG002|Overall Study|Consent withdrawn|3|||
131861177|NCT01490086|474772315|FG003|Overall Study|Consent withdrawn|0|||
131861178|NCT01490086|474772316|FG004|Overall Study|Consent withdrawn|1|||
131861179|NCT01490086|474772312|FG000|Overall Study|Non-compliance|0|||
131861180|NCT01490086|474772313|FG001|Overall Study|Non-compliance|1|||
131861181|NCT01490086|474772314|FG002|Overall Study|Non-compliance|0|||
131861182|NCT01490086|474772315|FG003|Overall Study|Non-compliance|0|||
131861183|NCT01490086|474772316|FG004|Overall Study|Non-compliance|0|||
131861184|NCT01490086|474772312|FG000|Overall Study|Abnormal laboratory findings|1|||
131861185|NCT01490086|474772313|FG001|Overall Study|Abnormal laboratory findings|0|||
131861186|NCT01490086|474772314|FG002|Overall Study|Abnormal laboratory findings|0|||
131861187|NCT01490086|474772315|FG003|Overall Study|Abnormal laboratory findings|0|||
131861188|NCT01490086|474772316|FG004|Overall Study|Abnormal laboratory findings|0|||
131861189|NCT01490086|474772312|FG000|Overall Study|Lost to Follow-up|0|||
131861190|NCT01490086|474772313|FG001|Overall Study|Lost to Follow-up|0|||
131861191|NCT01490086|474772314|FG002|Overall Study|Lost to Follow-up|0|||
131861192|NCT01490086|474772315|FG003|Overall Study|Lost to Follow-up|0|||
131861193|NCT01490086|474772316|FG004|Overall Study|Lost to Follow-up|1|||
131861194|NCT01490086|474772312|FG000|Overall Study|Physician Decision|3|||
131861195|NCT01490086|474772313|FG001|Overall Study|Physician Decision|4|||
131861196|NCT01490086|474772314|FG002|Overall Study|Physician Decision|2|||
131861197|NCT01490086|474772315|FG003|Overall Study|Physician Decision|3|||
131861198|NCT01490086|474772316|FG004|Overall Study|Physician Decision|1|||
131861199|NCT01490086|474772312|FG000|Overall Study|Adverse Event|0|||
131861200|NCT01490086|474772313|FG001|Overall Study|Adverse Event|0|||
131861201|NCT01490086|474772314|FG002|Overall Study|Adverse Event|1|||
131861202|NCT01490086|474772315|FG003|Overall Study|Adverse Event|2|||
131861203|NCT01490086|474772316|FG004|Overall Study|Adverse Event|0|||
131861204|NCT01490086|474772312|FG000|Overall Study|Lack of Efficacy|0|||
131861205|NCT01490086|474772313|FG001|Overall Study|Lack of Efficacy|3|||
131861206|NCT01490086|474772314|FG002|Overall Study|Lack of Efficacy|1|||
131861207|NCT01490086|474772315|FG003|Overall Study|Lack of Efficacy|0|||
131861208|NCT01490086|474772316|FG004|Overall Study|Lack of Efficacy|8|||
131861209|NCT01490086|474772312|FG000|Overall Study|Worsening of symptoms|0|||
131861210|NCT01490086|474772313|FG001|Overall Study|Worsening of symptoms|1|||
131861211|NCT01490086|474772314|FG002|Overall Study|Worsening of symptoms|0|||
131861212|NCT01490086|474772315|FG003|Overall Study|Worsening of symptoms|1|||
131861213|NCT01490086|474772316|FG004|Overall Study|Worsening of symptoms|0|||
131861214|NCT01490086|474772312|FG000|Overall Study|Subject uncontrollable and abusive|0|||
131861215|NCT01490086|474772313|FG001|Overall Study|Subject uncontrollable and abusive|1|||
131861216|NCT01490086|474772314|FG002|Overall Study|Subject uncontrollable and abusive|0|||
131861217|NCT01490086|474772315|FG003|Overall Study|Subject uncontrollable and abusive|0|||
131861218|NCT01490086|474772316|FG004|Overall Study|Subject uncontrollable and abusive|0|||
131861219|NCT01490086|474772312|FG000|Overall Study|Subject left hospital|0|||
131861220|NCT01490086|474772313|FG001|Overall Study|Subject left hospital|1|||
131861221|NCT01490086|474772314|FG002|Overall Study|Subject left hospital|0|||
131861222|NCT01490086|474772315|FG003|Overall Study|Subject left hospital|1|||
131861223|NCT01490086|474772316|FG004|Overall Study|Subject left hospital|0|||
131861224|NCT00931528|474772317|FG000|Overall Study|Protocol Violation|9|||
131861225|NCT00931528|474772318|FG001|Overall Study|Protocol Violation|12|||
131861226|NCT00931528|474772317|FG000|Overall Study|Withdrawal by Subject|4|||
131861227|NCT00931528|474772318|FG001|Overall Study|Withdrawal by Subject|12|||
131861228|NCT00931528|474772317|FG000|Overall Study|Lost to Follow-up|6|||
131861229|NCT00931528|474772318|FG001|Overall Study|Lost to Follow-up|13|||
131861230|NCT00931528|474772317|FG000|Overall Study|Assessment outside of Time Frame|22|||
131861231|NCT00931528|474772318|FG001|Overall Study|Assessment outside of Time Frame|23|||
131861232|NCT01173523|474772327|FG000|Overall Study|Clinical Progression|1|||
131861233|NCT01173523|474772328|FG001|Overall Study|Clinical Progression|1|||
131861234|NCT01173523|474772327|FG000|Overall Study|Progressive Disease|10|||
131861235|NCT01173523|474772328|FG001|Overall Study|Progressive Disease|8|||
131861236|NCT01173523|474772327|FG000|Overall Study|Other|2|||
131861237|NCT01173523|474772328|FG001|Overall Study|Other|3|||
131861238|NCT00324987|474772329|FG000|Overall Study|Adverse Event|2|||
131861239|NCT00324987|474772330|FG001|Overall Study|Adverse Event|1|||
131861240|NCT00324987|474772329|FG000|Overall Study|Withdrawal by Subject|1|||
131434025|NCT01216202|473214607|FG001|Overall Study|Lost to Follow-up|0|||
131407961|NCT04465877|473115263|FG000|Overall Study|Noncompliant with study requirements|0|||
131861241|NCT00324987|474772330|FG001|Overall Study|Withdrawal by Subject|1|||
131861242|NCT00324987|474772329|FG000|Overall Study|Progression|1|||
131861243|NCT00324987|474772330|FG001|Overall Study|Progression|1|||
131861244|NCT00324987|474772329|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
131861245|NCT00324987|474772330|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
131861246|NCT02222922|474772331|FG000|Overall Study|Death|0|||
131861247|NCT02222922|474772332|FG001|Overall Study|Death|0|||
131861248|NCT02222922|474772333|FG002|Overall Study|Death|0|||
131861249|NCT02222922|474772334|FG003|Overall Study|Death|0|||
131861250|NCT02222922|474772335|FG004|Overall Study|Death|13|||
131861251|NCT02222922|474772336|FG005|Overall Study|Death|0|||
131861252|NCT02222922|474772337|FG006|Overall Study|Death|0|||
131861253|NCT02222922|474772338|FG007|Overall Study|Death|0|||
131861254|NCT02222922|474772339|FG008|Overall Study|Death|2|||
131861255|NCT02222922|474772331|FG000|Overall Study|Lost to Follow-up|0|||
131861256|NCT02222922|474772332|FG001|Overall Study|Lost to Follow-up|0|||
131861257|NCT02222922|474772333|FG002|Overall Study|Lost to Follow-up|1|||
131861258|NCT02222922|474772334|FG003|Overall Study|Lost to Follow-up|0|||
131861259|NCT02222922|474772335|FG004|Overall Study|Lost to Follow-up|9|||
131861260|NCT02222922|474772336|FG005|Overall Study|Lost to Follow-up|1|||
131861261|NCT02222922|474772337|FG006|Overall Study|Lost to Follow-up|0|||
131861262|NCT02222922|474772338|FG007|Overall Study|Lost to Follow-up|0|||
131861263|NCT02222922|474772339|FG008|Overall Study|Lost to Follow-up|0|||
131861264|NCT02222922|474772331|FG000|Overall Study|Other|0|||
131861265|NCT02222922|474772332|FG001|Overall Study|Other|0|||
131861266|NCT02222922|474772333|FG002|Overall Study|Other|0|||
131861267|NCT02222922|474772334|FG003|Overall Study|Other|2|||
131861268|NCT02222922|474772335|FG004|Overall Study|Other|10|||
131861269|NCT02222922|474772336|FG005|Overall Study|Other|2|||
131861270|NCT02222922|474772337|FG006|Overall Study|Other|2|||
131861271|NCT02222922|474772338|FG007|Overall Study|Other|4|||
131861272|NCT02222922|474772339|FG008|Overall Study|Other|1|||
131861273|NCT02222922|474772331|FG000|Overall Study|Participant refused further follow-up|1|||
131861274|NCT02222922|474772332|FG001|Overall Study|Participant refused further follow-up|0|||
131861275|NCT02222922|474772333|FG002|Overall Study|Participant refused further follow-up|0|||
131861276|NCT02222922|474772334|FG003|Overall Study|Participant refused further follow-up|1|||
131861277|NCT02222922|474772335|FG004|Overall Study|Participant refused further follow-up|6|||
131861278|NCT02222922|474772336|FG005|Overall Study|Participant refused further follow-up|0|||
131861279|NCT02222922|474772337|FG006|Overall Study|Participant refused further follow-up|0|||
131861280|NCT02222922|474772338|FG007|Overall Study|Participant refused further follow-up|0|||
131861281|NCT02222922|474772339|FG008|Overall Study|Participant refused further follow-up|3|||
131861282|NCT01254643|474772340|FG000|Overall Study|Withdrawal by Subject|1|||
131861283|NCT01651117|474772351|FG000|Overall Study|Death|2|||
131861284|NCT01651117|474772352|FG001|Overall Study|Death|3|||
131861285|NCT01651117|474772353|FG002|Overall Study|Death|2|||
131861286|NCT01651117|474772354|FG003|Overall Study|Death|2|||
131861287|NCT03238651|474772358|FG000|Overall Study|Other|0|||
131861288|NCT03238651|474772359|FG001|Overall Study|Other|0|||
131861289|NCT03238651|474772360|FG002|Overall Study|Other|0|||
131861290|NCT03238651|474772361|FG003|Overall Study|Other|0|||
131861291|NCT03238651|474772362|FG004|Overall Study|Other|1|||
131861292|NCT03238651|474772358|FG000|Overall Study|Progressive Disease|2|||
131861293|NCT03238651|474772359|FG001|Overall Study|Progressive Disease|2|||
131861294|NCT03238651|474772360|FG002|Overall Study|Progressive Disease|2|||
131861295|NCT03238651|474772361|FG003|Overall Study|Progressive Disease|2|||
131861296|NCT03238651|474772362|FG004|Overall Study|Progressive Disease|0|||
131861297|NCT03238651|474772358|FG000|Overall Study|Withdrawal by Subject|0|||
131861298|NCT03238651|474772359|FG001|Overall Study|Withdrawal by Subject|1|||
131861299|NCT03238651|474772360|FG002|Overall Study|Withdrawal by Subject|0|||
131861300|NCT03238651|474772361|FG003|Overall Study|Withdrawal by Subject|1|||
131407962|NCT04465877|473115264|FG001|Overall Study|Noncompliant with study requirements|0|||
131861301|NCT03238651|474772362|FG004|Overall Study|Withdrawal by Subject|0|||
131861302|NCT03238651|474772358|FG000|Overall Study|Adverse Event|1|||
131407963|NCT04465877|473115265|FG002|Overall Study|Noncompliant with study requirements|1|||
131407964|NCT04465877|473115266|FG003|Overall Study|Noncompliant with study requirements|0|||
131407965|NCT02323204|473115267|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
131407966|NCT02323204|473115268|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
131861303|NCT03238651|474772359|FG001|Overall Study|Adverse Event|3|||
131861304|NCT03238651|474772360|FG002|Overall Study|Adverse Event|2|||
131861305|NCT03238651|474772361|FG003|Overall Study|Adverse Event|0|||
131861306|NCT03238651|474772362|FG004|Overall Study|Adverse Event|0|||
131861307|NCT00063934|474772364|FG000|Overall Study|Ineligible|1|||
131861308|NCT03652051|474772365|FG000|Stage 1|Adverse Event|0|||
131861309|NCT03652051|474772366|FG001|Stage 1|Adverse Event|5|||
131861310|NCT03652051|474772367|FG002|Stage 1|Adverse Event|7|||
131861311|NCT03652051|474772368|FG003|Stage 1|Adverse Event|1|||
131861312|NCT03652051|474772365|FG000|Stage 1|Withdrawal by Subject|0|||
131861313|NCT03652051|474772366|FG001|Stage 1|Withdrawal by Subject|0|||
131861314|NCT03652051|474772367|FG002|Stage 1|Withdrawal by Subject|1|||
131407967|NCT02323204|473115269|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
131407968|NCT02323204|473115270|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
131407969|NCT02323204|473115267|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
131407970|NCT02323204|473115268|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
131407971|NCT02323204|473115269|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
131407972|NCT02323204|473115270|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
131407973|NCT02323204|473115267|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
131913059|NCT01288430|474969283|FG006|Part 1|Other|1|||
131913060|NCT01288430|474969284|FG007|Part 1|Other|0|||
131913061|NCT01288430|474969285|FG008|Part 1|Other|0|||
131913062|NCT01288430|474969286|FG009|Part 1|Other|0|||
131913063|NCT01288430|474969277|FG000|Part 2|Progressive disease|0|||
131913064|NCT01288430|474969278|FG001|Part 2|Progressive disease|0|||
131913065|NCT01288430|474969279|FG002|Part 2|Progressive disease|0|||
131407974|NCT02323204|473115268|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
131407975|NCT02323204|473115269|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
131407976|NCT02323204|473115270|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
131407977|NCT02323204|473115267|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
131407978|NCT02323204|473115268|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
131407979|NCT02323204|473115269|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
131407980|NCT02323204|473115270|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
131407981|NCT02323204|473115267|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
131407982|NCT02323204|473115268|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
131407983|NCT02323204|473115269|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
131407984|NCT02323204|473115270|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
131407985|NCT02323204|473115267|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
131407986|NCT02323204|473115268|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
131407987|NCT02323204|473115269|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
131407988|NCT02323204|473115270|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
131407989|NCT02323204|473115267|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
131407990|NCT02323204|473115268|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
131407991|NCT02323204|473115269|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
131407992|NCT02323204|473115270|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
131407993|NCT02323204|473115267|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
131861315|NCT03652051|474772368|FG003|Stage 1|Withdrawal by Subject|0|||
131861316|NCT03652051|474772365|FG000|Stage 2|Adverse Event|0|||
131861317|NCT03652051|474772366|FG001|Stage 2|Adverse Event|2|||
131861318|NCT03652051|474772367|FG002|Stage 2|Adverse Event|1|||
131861319|NCT03652051|474772368|FG003|Stage 2|Adverse Event|0|||
131861320|NCT03652051|474772365|FG000|Stage 2|Protocol Violation|0|||
131861321|NCT03652051|474772366|FG001|Stage 2|Protocol Violation|1|||
131861322|NCT03652051|474772367|FG002|Stage 2|Protocol Violation|6|||
131861323|NCT03652051|474772368|FG003|Stage 2|Protocol Violation|0|||
131861324|NCT03652051|474772365|FG000|Stage 2|Lost to Follow-up|0|||
131861325|NCT03652051|474772366|FG001|Stage 2|Lost to Follow-up|2|||
131861326|NCT03652051|474772367|FG002|Stage 2|Lost to Follow-up|0|||
131861327|NCT03652051|474772368|FG003|Stage 2|Lost to Follow-up|3|||
131861328|NCT03652051|474772365|FG000|Stage 2|Withdrawal by Subject|0|||
131861329|NCT03652051|474772366|FG001|Stage 2|Withdrawal by Subject|11|||
131861330|NCT03652051|474772367|FG002|Stage 2|Withdrawal by Subject|9|||
131861331|NCT03652051|474772368|FG003|Stage 2|Withdrawal by Subject|3|||
131861332|NCT04341363|474772369|FG000|Overall Study|Adverse Event|1|||
131861333|NCT04341363|474772369|FG000|Overall Study|Withdrawal by Subject|1|||
131861334|NCT00840749|474772370|FG000|Overall Study|Death|1|||
131861335|NCT00840749|474772371|FG001|Overall Study|Death|2|||
131861336|NCT00840749|474772370|FG000|Overall Study|not treated on study arm|11|||
131861337|NCT00840749|474772371|FG001|Overall Study|not treated on study arm|11|||
131861338|NCT00840749|474772370|FG000|Overall Study|study closed|19|||
131861339|NCT00840749|474772371|FG001|Overall Study|study closed|14|||
131861340|NCT01686373|474772372|FG000|Overall Study|Lost to Follow-up|3|||
131861341|NCT01686373|474772373|FG001|Overall Study|Lost to Follow-up|0|||
131407994|NCT02323204|473115268|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
131407995|NCT02323204|473115269|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
131861342|NCT01686373|474772372|FG000|Overall Study|Withdrawal by Subject|0|||
131861343|NCT01686373|474772373|FG001|Overall Study|Withdrawal by Subject|1|||
131861344|NCT01686373|474772372|FG000|Overall Study|Adverse Event|0|||
131861345|NCT01686373|474772373|FG001|Overall Study|Adverse Event|1|||
131861346|NCT01960413|474772374|FG000|Overall Study|Withdrawal by Subject|1|||
131861347|NCT01960413|474772375|FG001|Overall Study|Withdrawal by Subject|1|||
131861348|NCT01960413|474772374|FG000|Overall Study|Physician Decision|1|||
131861349|NCT01960413|474772375|FG001|Overall Study|Physician Decision|0|||
131861350|NCT01960413|474772374|FG000|Overall Study|Lost to Follow-up|2|||
131913066|NCT01288430|474969280|FG003|Part 2|Progressive disease|0|||
131913067|NCT01288430|474969281|FG004|Part 2|Progressive disease|0|||
131407996|NCT02323204|473115270|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
131407997|NCT02323204|473115267|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
131407998|NCT02323204|473115268|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
131407999|NCT02323204|473115269|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
131408000|NCT02323204|473115270|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
131408001|NCT03440918|473115287|FG000|Overall Study|Protocol Violation|0|||
131408002|NCT03440918|473115288|FG001|Overall Study|Protocol Violation|16|||
131408003|NCT04962230|473115289|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
131408004|NCT04962230|473115289|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
131408005|NCT03576755|473115290|FG000|Overall Study|Withdrawal by Subject|1|||
131408006|NCT03576755|473115291|FG001|Overall Study|Withdrawal by Subject|0|||
131408007|NCT03576755|473115292|FG002|Overall Study|Withdrawal by Subject|0|||
131408008|NCT03576755|473115293|FG003|Overall Study|Withdrawal by Subject|0|||
131408009|NCT01396265|473115294|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
131408010|NCT03831880|473115295|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
131408011|NCT03831880|473115296|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
131408012|NCT03831880|473115295|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
131408013|NCT03831880|473115296|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
131408014|NCT01598753|473115301|FG000|Overall Study|Adverse Event|1|||
131408015|NCT01598753|473115302|FG001|Overall Study|Adverse Event|9|||
131408016|NCT01598753|473115303|FG002|Overall Study|Adverse Event|1|||
131408017|NCT01598753|473115304|FG003|Overall Study|Adverse Event|7|||
131408018|NCT01598753|473115301|FG000|Overall Study|Lost to Follow-up|4|||
131408019|NCT01598753|473115302|FG001|Overall Study|Lost to Follow-up|3|||
131408020|NCT01598753|473115303|FG002|Overall Study|Lost to Follow-up|7|||
131408021|NCT01598753|473115304|FG003|Overall Study|Lost to Follow-up|5|||
131408022|NCT01598753|473115301|FG000|Overall Study|Physician Decision|0|||
131408023|NCT01598753|473115302|FG001|Overall Study|Physician Decision|1|||
131408024|NCT01598753|473115303|FG002|Overall Study|Physician Decision|0|||
131408025|NCT01598753|473115304|FG003|Overall Study|Physician Decision|2|||
131408026|NCT01598753|473115301|FG000|Overall Study|Withdrawal by Subject|7|||
131408027|NCT01598753|473115302|FG001|Overall Study|Withdrawal by Subject|2|||
131408028|NCT01598753|473115303|FG002|Overall Study|Withdrawal by Subject|0|||
131408029|NCT01598753|473115304|FG003|Overall Study|Withdrawal by Subject|1|||
131408030|NCT04346108|473115305|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
131408031|NCT04346108|473115306|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
131408032|NCT04346108|473115307|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
131408033|NCT04346108|473115305|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
131408034|NCT04346108|473115306|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
131408035|NCT04346108|473115307|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
131408036|NCT02788201|473115308|FG000|Overall Study|Death|1|||
131408037|NCT02788201|473115309|FG001|Overall Study|Death|1|||
131408038|NCT02788201|473115310|FG002|Overall Study|Death|1|||
131408039|NCT02788201|473115311|FG003|Overall Study|Death|1|||
131408040|NCT02788201|473115312|FG004|Overall Study|Death|0|||
131408041|NCT02788201|473115313|FG005|Overall Study|Death|1|||
131913068|NCT01288430|474969282|FG005|Part 2|Progressive disease|0|||
131913069|NCT01288430|474969283|FG006|Part 2|Progressive disease|0|||
131913070|NCT01288430|474969284|FG007|Part 2|Progressive disease|8|||
131913071|NCT01288430|474969285|FG008|Part 2|Progressive disease|7|||
131913072|NCT01288430|474969286|FG009|Part 2|Progressive disease|2|||
131913073|NCT01288430|474969277|FG000|Part 2|Clinical disease progression|0|||
131408042|NCT02788201|473115308|FG000|Overall Study|Ineligible|0|||
131408043|NCT02788201|473115309|FG001|Overall Study|Ineligible|0|||
131408044|NCT02788201|473115310|FG002|Overall Study|Ineligible|0|||
131408045|NCT02788201|473115311|FG003|Overall Study|Ineligible|0|||
131408046|NCT02788201|473115312|FG004|Overall Study|Ineligible|0|||
131408047|NCT02788201|473115313|FG005|Overall Study|Ineligible|1|||
131408048|NCT02788201|473115308|FG000|Overall Study|Withdrawal by Subject|0|||
131408049|NCT02788201|473115309|FG001|Overall Study|Withdrawal by Subject|0|||
131408050|NCT02788201|473115310|FG002|Overall Study|Withdrawal by Subject|0|||
131408051|NCT02788201|473115311|FG003|Overall Study|Withdrawal by Subject|0|||
131408052|NCT02788201|473115312|FG004|Overall Study|Withdrawal by Subject|0|||
131408053|NCT02788201|473115313|FG005|Overall Study|Withdrawal by Subject|1|||
131408054|NCT01852825|473115314|FG000|Overall Study|Withdrawal by Subject|2|||
131408055|NCT01852825|473115315|FG001|Overall Study|Withdrawal by Subject|0|||
131408056|NCT01852825|473115316|FG002|Overall Study|Withdrawal by Subject|0|||
131408057|NCT04508751|473115322|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
131408058|NCT04508751|473115323|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
131408059|NCT04508751|473115324|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
131408060|NCT00977938|473115329|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
131408061|NCT00977938|473115330|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
131408062|NCT00977938|473115331|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
131408063|NCT00977938|473115332|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
131913074|NCT01288430|474969278|FG001|Part 2|Clinical disease progression|0|||
131861351|NCT01960413|474772375|FG001|Overall Study|Lost to Follow-up|0|||
131861352|NCT00791778|474772379|FG000|Double-blind Treatment|Adverse Event|49|||
131861353|NCT00791778|474772380|FG001|Double-blind Treatment|Adverse Event|9|||
131861354|NCT00791778|474772379|FG000|Double-blind Treatment|Physician Decision|6|||
131861355|NCT00791778|474772380|FG001|Double-blind Treatment|Physician Decision|26|||
131861356|NCT00791778|474772379|FG000|Double-blind Treatment|Protocol Violation|0|||
131861357|NCT00791778|474772380|FG001|Double-blind Treatment|Protocol Violation|4|||
131861358|NCT00791778|474772379|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
131861359|NCT00791778|474772380|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
131861360|NCT00791778|474772379|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
131861361|NCT00791778|474772380|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
131861362|NCT00791778|474772379|FG000|Follow-up|Withdrawal by Subject|3|||
131861363|NCT00791778|474772380|FG001|Follow-up|Withdrawal by Subject|0|||
131861364|NCT00791778|474772379|FG000|Follow-up|Lost to Follow-up|2|||
131861365|NCT00791778|474772380|FG001|Follow-up|Lost to Follow-up|1|||
131861366|NCT03335475|474772381|FG000|Overall Study|Did not wear accelerometer|4|||
131861367|NCT03335475|474772382|FG001|Overall Study|Did not wear accelerometer|0|||
131861368|NCT03335475|474772381|FG000|Overall Study|Withdrawal by Subject|0|||
131861369|NCT03335475|474772382|FG001|Overall Study|Withdrawal by Subject|1|||
131861370|NCT02603887|474772385|FG000|Stage 1|Adverse Event|4|||
131861371|NCT02603887|474772385|FG000|Stage 1|Disease progression|1|||
131861372|NCT02603887|474772385|FG000|Stage 2|FDA guidance|1|||
131861373|NCT01515423|474772388|FG000|Open Label Phase|Adverse Event|57|||
131861374|NCT01515423|474772389|FG001|Open Label Phase|Adverse Event|0|||
131861375|NCT01515423|474772390|FG002|Open Label Phase|Adverse Event|0|||
131861376|NCT01515423|474772388|FG000|Open Label Phase|Death|2|||
131861377|NCT01515423|474772389|FG001|Open Label Phase|Death|0|||
131861378|NCT01515423|474772390|FG002|Open Label Phase|Death|0|||
131861379|NCT01515423|474772388|FG000|Open Label Phase|Lack of Efficacy|117|||
131861380|NCT01515423|474772389|FG001|Open Label Phase|Lack of Efficacy|0|||
131861381|NCT01515423|474772390|FG002|Open Label Phase|Lack of Efficacy|0|||
131861382|NCT01515423|474772388|FG000|Open Label Phase|Lost to Follow-up|21|||
131861383|NCT01515423|474772389|FG001|Open Label Phase|Lost to Follow-up|0|||
131861384|NCT01515423|474772390|FG002|Open Label Phase|Lost to Follow-up|0|||
131861385|NCT01515423|474772388|FG000|Open Label Phase|Withdrawal by Subject|118|||
131861386|NCT01515423|474772389|FG001|Open Label Phase|Withdrawal by Subject|0|||
131861387|NCT01515423|474772390|FG002|Open Label Phase|Withdrawal by Subject|0|||
131861388|NCT01515423|474772388|FG000|Open Label Phase|excluded from DB Phase|70|||
131861389|NCT01515423|474772389|FG001|Open Label Phase|excluded from DB Phase|0|||
131861390|NCT01515423|474772390|FG002|Open Label Phase|excluded from DB Phase|0|||
131861391|NCT01515423|474772388|FG000|Open Label Phase|Other|28|||
131861392|NCT01515423|474772389|FG001|Open Label Phase|Other|0|||
131861393|NCT01515423|474772390|FG002|Open Label Phase|Other|0|||
131861394|NCT01515423|474772388|FG000|DOUBLE BLIND|Adverse Event|0|||
131861395|NCT01515423|474772389|FG001|DOUBLE BLIND|Adverse Event|15|||
131861396|NCT01515423|474772390|FG002|DOUBLE BLIND|Adverse Event|13|||
131861397|NCT01515423|474772388|FG000|DOUBLE BLIND|Death|0|||
131861398|NCT01515423|474772389|FG001|DOUBLE BLIND|Death|1|||
131861399|NCT01515423|474772390|FG002|DOUBLE BLIND|Death|2|||
131861400|NCT01515423|474772388|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
131861401|NCT01515423|474772389|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
131861402|NCT01515423|474772390|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
131861403|NCT01515423|474772388|FG000|DOUBLE BLIND|Pregnancy|0|||
131861404|NCT01515423|474772389|FG001|DOUBLE BLIND|Pregnancy|2|||
131861405|NCT01515423|474772390|FG002|DOUBLE BLIND|Pregnancy|0|||
131861406|NCT01515423|474772388|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
131861407|NCT01515423|474772389|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
131861408|NCT01515423|474772390|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
131861409|NCT01515423|474772388|FG000|DOUBLE BLIND|Other|0|||
131861410|NCT01515423|474772389|FG001|DOUBLE BLIND|Other|6|||
131861411|NCT01515423|474772390|FG002|DOUBLE BLIND|Other|12|||
131861412|NCT01515423|474772388|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
131861413|NCT01515423|474772389|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
131861414|NCT01515423|474772390|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
131861415|NCT02314026|474772391|FG000|Overall Study|Protocol Violation|28|||
131861416|NCT01532934|474772393|FG000|Overall Study|Lost to Follow-up|11|||
131861417|NCT01532934|474772394|FG001|Overall Study|Lost to Follow-up|11|||
131861418|NCT01532934|474772393|FG000|Overall Study|In controlled environment|3|||
131861419|NCT01532934|474772394|FG001|Overall Study|In controlled environment|2|||
131861420|NCT02291237|474772395|FG000|Overall Study|Study Terminated by Sponsor|72|||
131861421|NCT02291237|474772396|FG001|Overall Study|Study Terminated by Sponsor|67|||
131861422|NCT02291237|474772395|FG000|Overall Study|Adverse Event|1|||
131861423|NCT02291237|474772396|FG001|Overall Study|Adverse Event|3|||
131861424|NCT02291237|474772395|FG000|Overall Study|Investigator's Discretion|0|||
131861425|NCT02291237|474772396|FG001|Overall Study|Investigator's Discretion|3|||
131861426|NCT02291237|474772395|FG000|Overall Study|Withdrew Consent|11|||
131861427|NCT02291237|474772396|FG001|Overall Study|Withdrew Consent|11|||
131861428|NCT02291237|474772395|FG000|Overall Study|Lost to Follow-up|0|||
131861429|NCT02291237|474772396|FG001|Overall Study|Lost to Follow-up|2|||
131861430|NCT02291237|474772395|FG000|Overall Study|Subject Required Prohibited Medication|2|||
131861431|NCT02291237|474772396|FG001|Overall Study|Subject Required Prohibited Medication|0|||
131861432|NCT01149863|474772397|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
131861433|NCT01306305|474772398|FG000|Overall Study|Lost to Follow-up|1|||
131861434|NCT01306305|474772399|FG001|Overall Study|Lost to Follow-up|0|||
131861435|NCT01306305|474772398|FG000|Overall Study|Withdrew consent|1|||
131861436|NCT01306305|474772399|FG001|Overall Study|Withdrew consent|0|||
131861437|NCT03326193|474772400|FG000|Overall Study|Sponsor decision|35|||
131861438|NCT00699998|474772404|FG000|Overall Study|Withdrawal by Subject|194|||
131861439|NCT00699998|474772405|FG001|Overall Study|Withdrawal by Subject|83|||
131861440|NCT00699998|474772406|FG002|Overall Study|Withdrawal by Subject|202|||
131861441|NCT00699998|474772407|FG003|Overall Study|Withdrawal by Subject|80|||
131861442|NCT00699998|474772404|FG000|Overall Study|Physician Decision|3|||
131861443|NCT00699998|474772405|FG001|Overall Study|Physician Decision|2|||
131861444|NCT00699998|474772406|FG002|Overall Study|Physician Decision|1|||
131861445|NCT00699998|474772407|FG003|Overall Study|Physician Decision|1|||
131861446|NCT00699998|474772404|FG000|Overall Study|Lost to Follow-up|2|||
131861447|NCT00699998|474772405|FG001|Overall Study|Lost to Follow-up|1|||
131861448|NCT00699998|474772406|FG002|Overall Study|Lost to Follow-up|3|||
131861449|NCT00699998|474772407|FG003|Overall Study|Lost to Follow-up|1|||
131861450|NCT04052620|474772408|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
131861451|NCT04052620|474772409|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
131861452|NCT04052620|474772408|FG000|Overall Study|Withdrawal by Subject|1|||
131861453|NCT04052620|474772409|FG001|Overall Study|Withdrawal by Subject|0|||
131861454|NCT04052620|474772408|FG000|Overall Study|Lost to Follow-up|1|||
131861455|NCT04052620|474772409|FG001|Overall Study|Lost to Follow-up|1|||
131861456|NCT04052620|474772408|FG000|Overall Study|Adverse Event|1|||
131861457|NCT04052620|474772409|FG001|Overall Study|Adverse Event|0|||
131861458|NCT04052620|474772408|FG000|Overall Study|Subject did not meet study Criteria|0|||
131861459|NCT04052620|474772409|FG001|Overall Study|Subject did not meet study Criteria|1|||
131861460|NCT04052620|474772408|FG000|Overall Study|Screened failure, randomized by mistake|0|||
131861461|NCT04052620|474772409|FG001|Overall Study|Screened failure, randomized by mistake|1|||
131861462|NCT04052620|474772408|FG000|Overall Study|Personal reasons|2|||
131861463|NCT04052620|474772409|FG001|Overall Study|Personal reasons|4|||
131861464|NCT04052620|474772408|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
131861465|NCT04052620|474772409|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
131861466|NCT01406574|474772410|FG000|Overall Study|Adverse Event|0|||
131861467|NCT01406574|474772411|FG001|Overall Study|Adverse Event|0|||
131861468|NCT01406574|474772412|FG002|Overall Study|Adverse Event|1|||
131861469|NCT01406574|474772413|FG003|Overall Study|Adverse Event|3|||
131861470|NCT01406574|474772410|FG000|Overall Study|Physician Decision|0|||
131861471|NCT01406574|474772411|FG001|Overall Study|Physician Decision|0|||
131861472|NCT01406574|474772412|FG002|Overall Study|Physician Decision|0|||
131861473|NCT01406574|474772413|FG003|Overall Study|Physician Decision|1|||
131861474|NCT01406574|474772410|FG000|Overall Study|Withdrawal by Subject|0|||
131861475|NCT01406574|474772411|FG001|Overall Study|Withdrawal by Subject|1|||
131861476|NCT01406574|474772412|FG002|Overall Study|Withdrawal by Subject|0|||
131861477|NCT01406574|474772413|FG003|Overall Study|Withdrawal by Subject|0|||
131861478|NCT01406574|474772410|FG000|Overall Study|Definite progression of primary disease|1|||
131861479|NCT01406574|474772411|FG001|Overall Study|Definite progression of primary disease|0|||
131861480|NCT01406574|474772412|FG002|Overall Study|Definite progression of primary disease|0|||
131861481|NCT01406574|474772413|FG003|Overall Study|Definite progression of primary disease|0|||
131861482|NCT02201784|474772418|FG000|Overall Study|Failure to achieve adequate block|2|||
131861483|NCT02201784|474772419|FG001|Overall Study|Failure to achieve adequate block|0|||
131861484|NCT00916383|474772420|FG000|Overall Study|Adverse Event|1|||
131861485|NCT00916383|474772420|FG000|Overall Study|Death|1|||
131861486|NCT00916383|474772420|FG000|Overall Study|Protocol Violation|1|||
131861487|NCT00258960|474772421|FG000|Overall Study|Death|2|||
131861488|NCT00258960|474772421|FG000|Overall Study|Disease Progression|7|||
131861489|NCT00258960|474772421|FG000|Overall Study|Adverse Event|4|||
131861490|NCT00258960|474772421|FG000|Overall Study|Physician Decision|1|||
131861491|NCT00258960|474772421|FG000|Overall Study|Withdrawal by Subject|1|||
131861492|NCT00258960|474772421|FG000|Overall Study|Mistake|2|||
131861493|NCT03367819|474772424|FG000|Overall Study|Adverse Event|4|||
131861494|NCT03367819|474772425|FG001|Overall Study|Adverse Event|4|||
131861495|NCT03367819|474772424|FG000|Overall Study|Progressive Disease|15|||
131861496|NCT03367819|474772425|FG001|Overall Study|Progressive Disease|13|||
131861497|NCT03367819|474772424|FG000|Overall Study|Withdrawal by Subject|1|||
131861498|NCT03367819|474772425|FG001|Overall Study|Withdrawal by Subject|0|||
131861499|NCT03367819|474772424|FG000|Overall Study|Other|4|||
131861500|NCT03367819|474772425|FG001|Overall Study|Other|2|||
131861501|NCT02601014|474772426|FG000|Overall Study|Adverse Event|3|||
131861502|NCT02601014|474772427|FG001|Overall Study|Adverse Event|3|||
131861503|NCT02601014|474772426|FG000|Overall Study|Death|3|||
131861504|NCT02601014|474772427|FG001|Overall Study|Death|1|||
131861505|NCT02601014|474772426|FG000|Overall Study|Disease progression|4|||
131408064|NCT00977938|473115329|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
131408065|NCT00977938|473115330|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
131408066|NCT00977938|473115331|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
131408067|NCT00977938|473115332|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
131408068|NCT00977938|473115329|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
131408069|NCT00977938|473115330|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
131408070|NCT00977938|473115331|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
131408071|NCT00977938|473115332|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
131408072|NCT00977938|473115329|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
131408073|NCT00977938|473115330|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
131408074|NCT00977938|473115331|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
131408075|NCT00977938|473115332|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
131408076|NCT00977938|473115329|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
131408077|NCT00977938|473115330|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
131408078|NCT00977938|473115331|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
131408079|NCT00977938|473115332|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
131408080|NCT00977938|473115329|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
131408081|NCT00977938|473115330|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
131408082|NCT00977938|473115331|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
131408083|NCT00977938|473115332|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
131913075|NCT01288430|474969279|FG002|Part 2|Clinical disease progression|0|||
131913076|NCT01288430|474969280|FG003|Part 2|Clinical disease progression|0|||
131913077|NCT01288430|474969281|FG004|Part 2|Clinical disease progression|0|||
131913078|NCT01288430|474969282|FG005|Part 2|Clinical disease progression|0|||
131913079|NCT01288430|474969283|FG006|Part 2|Clinical disease progression|0|||
131913080|NCT01288430|474969284|FG007|Part 2|Clinical disease progression|2|||
131913081|NCT01288430|474969285|FG008|Part 2|Clinical disease progression|0|||
131913082|NCT01288430|474969286|FG009|Part 2|Clinical disease progression|0|||
131913083|NCT01288430|474969277|FG000|Part 2|Withdrawal by Subject|0|||
131913084|NCT01288430|474969278|FG001|Part 2|Withdrawal by Subject|0|||
131913085|NCT01288430|474969279|FG002|Part 2|Withdrawal by Subject|0|||
131913086|NCT01288430|474969280|FG003|Part 2|Withdrawal by Subject|0|||
131913087|NCT01288430|474969281|FG004|Part 2|Withdrawal by Subject|0|||
131913088|NCT01288430|474969282|FG005|Part 2|Withdrawal by Subject|0|||
131913089|NCT01288430|474969283|FG006|Part 2|Withdrawal by Subject|0|||
131913090|NCT01288430|474969284|FG007|Part 2|Withdrawal by Subject|1|||
131913091|NCT01288430|474969285|FG008|Part 2|Withdrawal by Subject|4|||
131913092|NCT01288430|474969286|FG009|Part 2|Withdrawal by Subject|0|||
131913093|NCT01288430|474969277|FG000|Part 2|Adverse Event|0|||
131913094|NCT01288430|474969278|FG001|Part 2|Adverse Event|0|||
131913095|NCT01288430|474969279|FG002|Part 2|Adverse Event|0|||
131913096|NCT01288430|474969280|FG003|Part 2|Adverse Event|0|||
131913097|NCT01288430|474969281|FG004|Part 2|Adverse Event|0|||
131913098|NCT01288430|474969282|FG005|Part 2|Adverse Event|0|||
131913099|NCT01288430|474969283|FG006|Part 2|Adverse Event|0|||
131913100|NCT01288430|474969284|FG007|Part 2|Adverse Event|1|||
131913101|NCT01288430|474969285|FG008|Part 2|Adverse Event|1|||
131913102|NCT01288430|474969286|FG009|Part 2|Adverse Event|0|||
131913103|NCT01288430|474969277|FG000|Part 2|Other|0|||
131913104|NCT01288430|474969278|FG001|Part 2|Other|0|||
131913105|NCT01288430|474969279|FG002|Part 2|Other|0|||
131913106|NCT01288430|474969280|FG003|Part 2|Other|0|||
131913107|NCT01288430|474969281|FG004|Part 2|Other|0|||
131913108|NCT01288430|474969282|FG005|Part 2|Other|0|||
131913109|NCT01288430|474969283|FG006|Part 2|Other|0|||
131913110|NCT01288430|474969284|FG007|Part 2|Other|0|||
131913111|NCT01288430|474969285|FG008|Part 2|Other|0|||
131913112|NCT01288430|474969286|FG009|Part 2|Other|1|||
131913113|NCT03836053|474969293|FG000|Overall Study|Protocol-specified criteria|0|||
131913114|NCT03836053|474969294|FG001|Overall Study|Protocol-specified criteria|2|||
131913115|NCT03836053|474969295|FG002|Overall Study|Protocol-specified criteria|1|||
131913116|NCT03836053|474969293|FG000|Overall Study|Death|1|||
131913117|NCT03836053|474969294|FG001|Overall Study|Death|6|||
131913118|NCT03836053|474969295|FG002|Overall Study|Death|4|||
131913119|NCT03836053|474969293|FG000|Overall Study|Withdrawal of consent from study|0|||
131913120|NCT03836053|474969294|FG001|Overall Study|Withdrawal of consent from study|0|||
131913121|NCT03836053|474969295|FG002|Overall Study|Withdrawal of consent from study|1|||
131913122|NCT03836053|474969293|FG000|Overall Study|Decision by sponsor|0|||
131913123|NCT03836053|474969294|FG001|Overall Study|Decision by sponsor|2|||
131913124|NCT03836053|474969295|FG002|Overall Study|Decision by sponsor|4|||
131408084|NCT02142283|473115333|FG000|Overall Study|Death|20|||
131408085|NCT02142283|473115334|FG001|Overall Study|Death|18|||
131913125|NCT00788671|474969296|FG000|Overall Study|Death|2|||
131913126|NCT00788671|474969296|FG000|Overall Study|Unable to biopsy|1|||
131913127|NCT00788671|474969296|FG000|Overall Study|Withdrawal by Subject|4|||
131913128|NCT00788671|474969296|FG000|Overall Study|IUD expulsed|1|||
131913129|NCT00788671|474969296|FG000|Overall Study|Lost to follow up|2|||
131913130|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
131913131|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
131913132|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
131913133|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Death|1|||
131913134|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Death|1|||
131913135|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Death|0|||
131913136|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
131913137|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
131913138|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
131913139|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
131913140|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
131913141|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
131913142|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
131913143|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
131913144|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
131913145|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
131913146|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
131913147|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
131913148|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
131913149|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
131913150|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
131913151|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
131913152|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
131913153|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
131913154|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
131913155|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
131913156|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
131913157|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
131913158|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
131913159|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
131913160|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Other|10|||
131913161|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Other|4|||
131913162|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Other|0|||
131913163|NCT04006457|474969297|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
131913164|NCT04006457|474969298|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
131913165|NCT04006457|474969299|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
131913166|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
131913167|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
131913168|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
131913169|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
131913170|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
131913171|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
131913172|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
131913173|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
131913174|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
131913175|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
131913176|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
131913177|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
131913178|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
131913179|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
131913180|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
131913181|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Other|2|||
131913182|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Other|3|||
131913183|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Other|0|||
131913184|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
131913185|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
131913186|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
131861506|NCT02601014|474772427|FG001|Overall Study|Disease progression|8|||
131861507|NCT02546986|474774363|FG000|Treatment Period|Progressive Disease|20|||
131861508|NCT02546986|474774364|FG001|Treatment Period|Progressive Disease|22|||
131861509|NCT02546986|474774363|FG000|Treatment Period|Adverse Event|14|||
131861510|NCT02546986|474774364|FG001|Treatment Period|Adverse Event|6|||
131861511|NCT02546986|474774363|FG000|Treatment Period|Symptomatic Deterioration|4|||
131861512|NCT02546986|474774364|FG001|Treatment Period|Symptomatic Deterioration|3|||
131861513|NCT02546986|474774363|FG000|Treatment Period|Death|3|||
131861514|NCT02546986|474774364|FG001|Treatment Period|Death|4|||
131861515|NCT02546986|474774363|FG000|Treatment Period|Physician Decision|1|||
131861516|NCT02546986|474774364|FG001|Treatment Period|Physician Decision|2|||
131861517|NCT02546986|474774363|FG000|Treatment Period|Protocol Violation|1|||
131861518|NCT02546986|474774364|FG001|Treatment Period|Protocol Violation|0|||
131861519|NCT02546986|474774363|FG000|Treatment Period|Withdrawal by Subject|1|||
131861520|NCT02546986|474774364|FG001|Treatment Period|Withdrawal by Subject|1|||
131861521|NCT02546986|474774363|FG000|Treatment Period|Non-compliance with Study Drug|0|||
131861522|NCT02546986|474774364|FG001|Treatment Period|Non-compliance with Study Drug|1|||
131861523|NCT02546986|474774363|FG000|Treatment Period|Study Terminated by Sponsor|0|||
131861524|NCT02546986|474774364|FG001|Treatment Period|Study Terminated by Sponsor|1|||
131861525|NCT02546986|474774363|FG000|Treatment Period|Miscellaneous|7|||
131861526|NCT02546986|474774364|FG001|Treatment Period|Miscellaneous|9|||
131861527|NCT02546986|474774363|FG000|Survival Follow-Up Phase|Missing Status|3|||
131861528|NCT02546986|474774364|FG001|Survival Follow-Up Phase|Missing Status|5|||
131861529|NCT02546986|474774363|FG000|Survival Follow-Up Phase|Death|18|||
131861530|NCT02546986|474774364|FG001|Survival Follow-Up Phase|Death|12|||
131861531|NCT02546986|474774363|FG000|Survival Follow-Up Phase|Alive|13|||
131861532|NCT02546986|474774364|FG001|Survival Follow-Up Phase|Alive|16|||
131861533|NCT02546986|474774363|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
131861534|NCT02546986|474774364|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
131861535|NCT05016960|474774365|FG000|Overall Study|Withdrawal by Subject|1|||
131861536|NCT05016960|474774366|FG001|Overall Study|Withdrawal by Subject|9|||
131861537|NCT04796961|474774367|FG000|Overall Study|Lost to Follow-up|10|||
131861538|NCT04796961|474774367|FG000|Overall Study|Withdrawal by Subject|3|||
131861539|NCT04796961|474774367|FG000|Overall Study|Left Organization|10|||
131861540|NCT03874117|474774370|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
131861541|NCT03874117|474774371|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
131913187|NCT04006457|474969297|FG000|Main Study: Treatment Period 2|Ongoing|86|||
131913188|NCT04006457|474969298|FG001|Main Study: Treatment Period 2|Ongoing|96|||
131913189|NCT04006457|474969299|FG002|Main Study: Treatment Period 2|Ongoing|0|||
131913190|NCT04006457|474969297|FG000|Main Study Observation Period|Adverse Event|1|||
131913191|NCT04006457|474969298|FG001|Main Study Observation Period|Adverse Event|1|||
131913192|NCT04006457|474969299|FG002|Main Study Observation Period|Adverse Event|0|||
131913193|NCT04006457|474969297|FG000|Main Study Observation Period|Lost to Follow-up|0|||
131913194|NCT04006457|474969298|FG001|Main Study Observation Period|Lost to Follow-up|1|||
131913195|NCT04006457|474969299|FG002|Main Study Observation Period|Lost to Follow-up|0|||
131913196|NCT04006457|474969297|FG000|Main Study Observation Period|Pregnancy|1|||
131913197|NCT04006457|474969298|FG001|Main Study Observation Period|Pregnancy|0|||
131913198|NCT04006457|474969299|FG002|Main Study Observation Period|Pregnancy|0|||
131913199|NCT04006457|474969297|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
131913200|NCT04006457|474969298|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
131861542|NCT03874117|474774370|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
131861543|NCT03874117|474774371|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
131861544|NCT03874117|474774370|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131861545|NCT03874117|474774371|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131861546|NCT03874117|474774370|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
131861547|NCT03874117|474774371|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
131861548|NCT03874117|474774370|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131861549|NCT03874117|474774371|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
131913201|NCT04006457|474969299|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
131913202|NCT04006457|474969297|FG000|Main Study Observation Period|Other|8|||
131861550|NCT05258773|474774372|FG000|Overall Study|Screen Failure|1|||
131861551|NCT05258773|474774373|FG001|Overall Study|Screen Failure|1|||
131861552|NCT05258773|474774372|FG000|Overall Study|Adverse Event|1|||
131861553|NCT05258773|474774373|FG001|Overall Study|Adverse Event|0|||
131861554|NCT05258773|474774372|FG000|Overall Study|Withdrawal by Subject|0|||
131861555|NCT05258773|474774373|FG001|Overall Study|Withdrawal by Subject|1|||
131861556|NCT06025721|474774377|FG000|Overall Study|Physician Decision|1|||
131861557|NCT06025721|474774377|FG000|Overall Study|Protocol Violation|1|||
131861558|NCT06025721|474774377|FG000|Overall Study|Incarceration|1|||
131861559|NCT04510090|474774378|FG000|FE-HS|Withdrawal by Subject|0|||
131861560|NCT04510090|474774379|FG001|FE-HS|Withdrawal by Subject|0|||
131861561|NCT04510090|474774380|FG002|FE-HS|Withdrawal by Subject|0|||
131861562|NCT04510090|474774381|FG003|FE-HS|Withdrawal by Subject|0|||
131861563|NCT04510090|474774382|FG004|FE-HS|Withdrawal by Subject|1|||
131913203|NCT04006457|474969298|FG001|Main Study Observation Period|Other|16|||
131913204|NCT04006457|474969299|FG002|Main Study Observation Period|Other|0|||
131861564|NCT04510090|474774383|FG005|FE-HS|Withdrawal by Subject|0|||
131861565|NCT04510090|474774384|FG006|FE-HS|Withdrawal by Subject|0|||
131861566|NCT04510090|474774385|FG007|FE-HS|Withdrawal by Subject|0|||
131861567|NCT05825404|474774386|FG000|First Intervention (Weeks 2-5)|Death|0|||
131861568|NCT05825404|474774387|FG001|First Intervention (Weeks 2-5)|Death|1|||
131861569|NCT05825404|474774386|FG000|Second Intervention (Weeks 8-11)|Death|0|||
131861570|NCT05825404|474774387|FG001|Second Intervention (Weeks 8-11)|Death|1|||
131861571|NCT01127256|474774388|FG000|Overall Study|Adverse Event|13|||
131861572|NCT01127256|474774389|FG001|Overall Study|Adverse Event|13|||
131861573|NCT01127256|474774388|FG000|Overall Study|Lack of Efficacy|4|||
131861574|NCT01127256|474774389|FG001|Overall Study|Lack of Efficacy|0|||
131861575|NCT01127256|474774388|FG000|Overall Study|Lost to Follow-up|16|||
131861576|NCT01127256|474774389|FG001|Overall Study|Lost to Follow-up|17|||
131861577|NCT01127256|474774388|FG000|Overall Study|Withdrawal by Subject|5|||
131861578|NCT01127256|474774389|FG001|Overall Study|Withdrawal by Subject|9|||
131913205|NCT04006457|474969297|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
131913206|NCT04006457|474969298|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
131913207|NCT04006457|474969299|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
131913208|NCT04006457|474969297|FG000|Main Study Observation Period|Ongoing|2|||
131913209|NCT04006457|474969298|FG001|Main Study Observation Period|Ongoing|1|||
131913210|NCT04006457|474969299|FG002|Main Study Observation Period|Ongoing|0|||
131913211|NCT04006457|474969297|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
131913212|NCT04006457|474969298|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
131913213|NCT04006457|474969299|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
131913214|NCT04486716|474969300|FG000|Core Phase|Subject decision|6|||
131913215|NCT04486716|474969300|FG000|Core Phase|Adverse Event|5|||
131913216|NCT04486716|474969300|FG000|Core Phase|Lost to Follow-up|1|||
131913217|NCT04486716|474969300|FG000|Core Phase|Physician Decision|1|||
131913218|NCT04486716|474969300|FG000|Core Phase|Enrolled subjects not treated|9|||
131913219|NCT05172609|474969301|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
131913220|NCT05172609|474969302|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
131913221|NCT05172609|474969301|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
131913222|NCT05172609|474969302|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
131913223|NCT05172609|474969301|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
131913224|NCT05172609|474969302|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
131913225|NCT02332707|474969303|FG000|Overall Study|Adverse Event|0|||
131913226|NCT02332707|474969304|FG001|Overall Study|Adverse Event|0|||
131913227|NCT02332707|474969305|FG002|Overall Study|Adverse Event|0|||
131913228|NCT02332707|474969306|FG003|Overall Study|Adverse Event|0|||
131913229|NCT02332707|474969307|FG004|Overall Study|Adverse Event|0|||
131913230|NCT02332707|474969308|FG005|Overall Study|Adverse Event|0|||
131913231|NCT02332707|474969309|FG006|Overall Study|Adverse Event|0|||
131913232|NCT02332707|474969310|FG007|Overall Study|Adverse Event|0|||
131913233|NCT02332707|474969311|FG008|Overall Study|Adverse Event|0|||
131913234|NCT02332707|474969312|FG009|Overall Study|Adverse Event|0|||
131913235|NCT02332707|474969313|FG010|Overall Study|Adverse Event|0|||
131913236|NCT02332707|474969314|FG011|Overall Study|Adverse Event|0|||
131913237|NCT02332707|474969315|FG012|Overall Study|Adverse Event|1|||
131913238|NCT02332707|474969316|FG013|Overall Study|Adverse Event|0|||
131913239|NCT02332707|474969317|FG014|Overall Study|Adverse Event|0|||
131913240|NCT02332707|474969318|FG015|Overall Study|Adverse Event|0|||
131861579|NCT01127256|474774388|FG000|Overall Study|Protocol Violation|1|||
131861580|NCT01127256|474774389|FG001|Overall Study|Protocol Violation|0|||
131861581|NCT01749826|474774390|FG000|Overall Study|Study Terminated|20|||
131861582|NCT01749826|474774391|FG001|Overall Study|Study Terminated|0|||
131861583|NCT00679211|474774392|FG000|Overall Study|Progressive disease|82|||
131861584|NCT00679211|474774392|FG000|Overall Study|Adverse Event|7|||
131861585|NCT00679211|474774392|FG000|Overall Study|Withdrawal by Subject|2|||
131861586|NCT00679211|474774392|FG000|Overall Study|Physician Decision|5|||
131861587|NCT00679211|474774392|FG000|Overall Study|Refused to undergo protocol procedures|1|||
131861588|NCT00679211|474774392|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
131861589|NCT00679211|474774392|FG000|Overall Study|Other|1|||
131861590|NCT01922037|474774393|FG000|Overall Study|Withdrawal by Subject|2|||
131861591|NCT01922037|474774394|FG001|Overall Study|Withdrawal by Subject|44|||
131861592|NCT01922037|474774393|FG000|Overall Study|Adverse Event|1|||
131861593|NCT01922037|474774394|FG001|Overall Study|Adverse Event|7|||
131861594|NCT01922037|474774393|FG000|Overall Study|Death|0|||
131861595|NCT01922037|474774394|FG001|Overall Study|Death|5|||
131861596|NCT01922037|474774393|FG000|Overall Study|Pregnancy|0|||
131861597|NCT01922037|474774394|FG001|Overall Study|Pregnancy|2|||
131861598|NCT01922037|474774393|FG000|Overall Study|Participant non-compliance|4|||
131861599|NCT01922037|474774394|FG001|Overall Study|Participant non-compliance|46|||
131861600|NCT01922037|474774393|FG000|Overall Study|Investigator/Sponsor decision|1|||
131861601|NCT01922037|474774394|FG001|Overall Study|Investigator/Sponsor decision|4|||
131861602|NCT01922037|474774393|FG000|Overall Study|Other unspecified|2|||
131861603|NCT01922037|474774394|FG001|Overall Study|Other unspecified|66|||
131861604|NCT01730053|474774395|FG000|Overall Study|Participant moved|0|||
131913241|NCT02332707|474969319|FG016|Overall Study|Adverse Event|0|||
131913242|NCT02332707|474969320|FG017|Overall Study|Adverse Event|0|||
131913243|NCT02332707|474969303|FG000|Overall Study|Lost to Follow-up|0|||
131913244|NCT02332707|474969304|FG001|Overall Study|Lost to Follow-up|0|||
131913245|NCT02332707|474969305|FG002|Overall Study|Lost to Follow-up|0|||
131913246|NCT02332707|474969306|FG003|Overall Study|Lost to Follow-up|0|||
131913247|NCT02332707|474969307|FG004|Overall Study|Lost to Follow-up|0|||
131913248|NCT02332707|474969308|FG005|Overall Study|Lost to Follow-up|1|||
131913249|NCT02332707|474969309|FG006|Overall Study|Lost to Follow-up|0|||
131913250|NCT02332707|474969310|FG007|Overall Study|Lost to Follow-up|0|||
131913251|NCT02332707|474969311|FG008|Overall Study|Lost to Follow-up|0|||
131913252|NCT02332707|474969312|FG009|Overall Study|Lost to Follow-up|0|||
131913253|NCT02332707|474969313|FG010|Overall Study|Lost to Follow-up|2|||
131913254|NCT02332707|474969314|FG011|Overall Study|Lost to Follow-up|0|||
131913255|NCT02332707|474969315|FG012|Overall Study|Lost to Follow-up|3|||
131913256|NCT02332707|474969316|FG013|Overall Study|Lost to Follow-up|0|||
131913257|NCT02332707|474969317|FG014|Overall Study|Lost to Follow-up|0|||
131913258|NCT02332707|474969318|FG015|Overall Study|Lost to Follow-up|0|||
131913259|NCT02332707|474969319|FG016|Overall Study|Lost to Follow-up|0|||
131913260|NCT02332707|474969320|FG017|Overall Study|Lost to Follow-up|0|||
131913261|NCT02332707|474969303|FG000|Overall Study|Physician Decision|0|||
131913262|NCT02332707|474969304|FG001|Overall Study|Physician Decision|0|||
131913263|NCT02332707|474969305|FG002|Overall Study|Physician Decision|0|||
131913264|NCT02332707|474969306|FG003|Overall Study|Physician Decision|1|||
131913265|NCT02332707|474969307|FG004|Overall Study|Physician Decision|0|||
131913266|NCT02332707|474969308|FG005|Overall Study|Physician Decision|0|||
131913267|NCT02332707|474969309|FG006|Overall Study|Physician Decision|0|||
131913268|NCT02332707|474969310|FG007|Overall Study|Physician Decision|0|||
131913269|NCT02332707|474969311|FG008|Overall Study|Physician Decision|0|||
131913270|NCT02332707|474969312|FG009|Overall Study|Physician Decision|0|||
131913271|NCT02332707|474969313|FG010|Overall Study|Physician Decision|0|||
131913272|NCT02332707|474969314|FG011|Overall Study|Physician Decision|0|||
131913273|NCT02332707|474969315|FG012|Overall Study|Physician Decision|1|||
131913274|NCT02332707|474969316|FG013|Overall Study|Physician Decision|0|||
131913275|NCT02332707|474969317|FG014|Overall Study|Physician Decision|0|||
131913276|NCT02332707|474969318|FG015|Overall Study|Physician Decision|0|||
131913277|NCT02332707|474969319|FG016|Overall Study|Physician Decision|0|||
131913278|NCT02332707|474969320|FG017|Overall Study|Physician Decision|0|||
131913279|NCT02332707|474969303|FG000|Overall Study|Withdrawal by Subject|0|||
131913280|NCT02332707|474969304|FG001|Overall Study|Withdrawal by Subject|0|||
131913281|NCT02332707|474969305|FG002|Overall Study|Withdrawal by Subject|1|||
131913282|NCT02332707|474969306|FG003|Overall Study|Withdrawal by Subject|0|||
131913283|NCT02332707|474969307|FG004|Overall Study|Withdrawal by Subject|0|||
131913284|NCT02332707|474969308|FG005|Overall Study|Withdrawal by Subject|0|||
131913285|NCT02332707|474969309|FG006|Overall Study|Withdrawal by Subject|0|||
131913286|NCT02332707|474969310|FG007|Overall Study|Withdrawal by Subject|0|||
131913287|NCT02332707|474969311|FG008|Overall Study|Withdrawal by Subject|0|||
131913288|NCT02332707|474969312|FG009|Overall Study|Withdrawal by Subject|3|||
131913289|NCT02332707|474969313|FG010|Overall Study|Withdrawal by Subject|0|||
131913290|NCT02332707|474969314|FG011|Overall Study|Withdrawal by Subject|0|||
131913291|NCT02332707|474969315|FG012|Overall Study|Withdrawal by Subject|0|||
131913292|NCT02332707|474969316|FG013|Overall Study|Withdrawal by Subject|0|||
131913293|NCT02332707|474969317|FG014|Overall Study|Withdrawal by Subject|0|||
131913294|NCT02332707|474969318|FG015|Overall Study|Withdrawal by Subject|0|||
131913295|NCT02332707|474969319|FG016|Overall Study|Withdrawal by Subject|0|||
131913296|NCT02332707|474969320|FG017|Overall Study|Withdrawal by Subject|0|||
131913297|NCT04761822|474969321|FG000|Overall Study|Adverse Event|3|||
131913298|NCT04761822|474969322|FG001|Overall Study|Adverse Event|1|||
131913299|NCT04761822|474969323|FG002|Overall Study|Adverse Event|1|||
131913300|NCT04761822|474969324|FG003|Overall Study|Adverse Event|3|||
131913301|NCT04761822|474969321|FG000|Overall Study|Lost to Follow-up|1|||
131913302|NCT04761822|474969322|FG001|Overall Study|Lost to Follow-up|0|||
131913303|NCT04761822|474969323|FG002|Overall Study|Lost to Follow-up|2|||
131913304|NCT04761822|474969324|FG003|Overall Study|Lost to Follow-up|3|||
131913305|NCT04761822|474969321|FG000|Overall Study|Physician Decision|0|||
131913306|NCT04761822|474969322|FG001|Overall Study|Physician Decision|1|||
131913307|NCT04761822|474969323|FG002|Overall Study|Physician Decision|0|||
131913308|NCT04761822|474969324|FG003|Overall Study|Physician Decision|0|||
131913309|NCT04761822|474969321|FG000|Overall Study|Withdrawal by Subject|3|||
131913310|NCT04761822|474969322|FG001|Overall Study|Withdrawal by Subject|8|||
131913311|NCT04761822|474969323|FG002|Overall Study|Withdrawal by Subject|1|||
131913312|NCT04761822|474969324|FG003|Overall Study|Withdrawal by Subject|11|||
131913313|NCT04761822|474969321|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
131913314|NCT04761822|474969322|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
131913315|NCT04761822|474969323|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
131913316|NCT04761822|474969324|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
131913317|NCT04761822|474969321|FG000|Overall Study|Participant requested unblinding|0|||
131913318|NCT04761822|474969322|FG001|Overall Study|Participant requested unblinding|0|||
131913319|NCT04761822|474969323|FG002|Overall Study|Participant requested unblinding|0|||
131913320|NCT04761822|474969324|FG003|Overall Study|Participant requested unblinding|1|||
131913321|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
131408086|NCT02142283|473115333|FG000|Overall Study|Withdrawal by Subject|1|||
131408087|NCT02142283|473115334|FG001|Overall Study|Withdrawal by Subject|3|||
131913322|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
131913323|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Death|1|||
131913324|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Death|3|||
131861605|NCT01730053|474774396|FG001|Overall Study|Participant moved|0|||
131861606|NCT01730053|474774397|FG002|Overall Study|Participant moved|1|||
131861607|NCT01730053|474774398|FG003|Overall Study|Participant moved|0|||
131861608|NCT01730053|474774399|FG004|Overall Study|Participant moved|0|||
131913325|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
131913326|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
131913327|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
131913328|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
131913329|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
131913330|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
131913331|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
131913332|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
131913333|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
131913334|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
131913335|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
131913336|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
131913337|NCT00362232|474969325|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
131913338|NCT00362232|474969326|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
131913339|NCT00362232|474969325|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
131913340|NCT00362232|474969326|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
131913341|NCT00362232|474969325|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
131913342|NCT00362232|474969326|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
131913343|NCT00362232|474969325|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
131913344|NCT00362232|474969326|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
131913345|NCT00362232|474969325|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
131913346|NCT00362232|474969326|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
131913347|NCT02233413|474969329|FG000|Overall Study|Lost to Follow-up|7|||
131913348|NCT02233413|474969330|FG001|Overall Study|Lost to Follow-up|9|||
131913349|NCT02233413|474969329|FG000|Overall Study|Withdrawal by Subject|4|||
131913350|NCT02233413|474969330|FG001|Overall Study|Withdrawal by Subject|5|||
131913351|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
131913352|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
131913353|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
131861609|NCT01730053|474774400|FG005|Overall Study|Participant moved|0|||
131861610|NCT01730053|474774395|FG000|Overall Study|Physician Decision|0|||
131861611|NCT01730053|474774396|FG001|Overall Study|Physician Decision|0|||
131861612|NCT01730053|474774397|FG002|Overall Study|Physician Decision|0|||
131861613|NCT01730053|474774398|FG003|Overall Study|Physician Decision|1|||
131861614|NCT01730053|474774399|FG004|Overall Study|Physician Decision|0|||
131861615|NCT01730053|474774400|FG005|Overall Study|Physician Decision|0|||
131861616|NCT01730053|474774395|FG000|Overall Study|Adverse Event|2|||
131861617|NCT01730053|474774396|FG001|Overall Study|Adverse Event|6|||
131861618|NCT01730053|474774397|FG002|Overall Study|Adverse Event|3|||
131861619|NCT01730053|474774398|FG003|Overall Study|Adverse Event|3|||
131861620|NCT01730053|474774399|FG004|Overall Study|Adverse Event|2|||
131861621|NCT01730053|474774400|FG005|Overall Study|Adverse Event|2|||
131861622|NCT01730053|474774395|FG000|Overall Study|Poor compliance to protocol|1|||
131861623|NCT01730053|474774396|FG001|Overall Study|Poor compliance to protocol|2|||
131861624|NCT01730053|474774397|FG002|Overall Study|Poor compliance to protocol|2|||
131861625|NCT01730053|474774398|FG003|Overall Study|Poor compliance to protocol|0|||
131861626|NCT01730053|474774399|FG004|Overall Study|Poor compliance to protocol|0|||
131861627|NCT01730053|474774400|FG005|Overall Study|Poor compliance to protocol|2|||
131861628|NCT01730053|474774395|FG000|Overall Study|Other than specified|2|||
131861629|NCT01730053|474774396|FG001|Overall Study|Other than specified|6|||
131861630|NCT01730053|474774397|FG002|Overall Study|Other than specified|5|||
131861631|NCT01730053|474774398|FG003|Overall Study|Other than specified|4|||
131861632|NCT01730053|474774399|FG004|Overall Study|Other than specified|7|||
131861633|NCT01730053|474774400|FG005|Overall Study|Other than specified|9|||
131861634|NCT01470248|474774402|FG000|Overall Study|Withdrawal by Subject|1|||
131861635|NCT05085834|474774403|FG000|Overall Study|Lost to Follow-up|9|||
131913354|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
131913355|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
131913356|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
131913357|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
131408088|NCT02374814|473115345|FG000|Overall Study|Lost to Follow-up|1|||
131408089|NCT02374814|473115346|FG001|Overall Study|Lost to Follow-up|1|||
131861636|NCT05085834|474774404|FG001|Overall Study|Lost to Follow-up|2|||
131861637|NCT05085834|474774403|FG000|Overall Study|Adverse Event|6|||
131861638|NCT05085834|474774404|FG001|Overall Study|Adverse Event|0|||
131861639|NCT05085834|474774403|FG000|Overall Study|Death|1|||
131861640|NCT05085834|474774404|FG001|Overall Study|Death|0|||
131861641|NCT05085834|474774403|FG000|Overall Study|Inability to swallow the pill|0|||
131861642|NCT05085834|474774404|FG001|Overall Study|Inability to swallow the pill|1|||
131861643|NCT05842967|474774405|FG000|Period 1: SSA|Adverse Event|1|||
131861644|NCT05842967|474774406|FG001|Period 1: SSA|Adverse Event|1|||
131861645|NCT05842967|474774407|FG002|Period 1: SSA|Adverse Event|0|||
131861646|NCT05842967|474774408|FG003|Period 1: SSA|Adverse Event|0|||
131861647|NCT05842967|474774405|FG000|Period 1: SSA|Death|1|||
131861648|NCT05842967|474774406|FG001|Period 1: SSA|Death|0|||
131861649|NCT05842967|474774407|FG002|Period 1: SSA|Death|0|||
131861650|NCT05842967|474774408|FG003|Period 1: SSA|Death|0|||
131861651|NCT05842967|474774405|FG000|Period 1: SSA|Lost to Follow-up|16|||
131861652|NCT05842967|474774406|FG001|Period 1: SSA|Lost to Follow-up|4|||
131861653|NCT05842967|474774407|FG002|Period 1: SSA|Lost to Follow-up|0|||
131861654|NCT05842967|474774408|FG003|Period 1: SSA|Lost to Follow-up|0|||
131861655|NCT05842967|474774405|FG000|Period 1: SSA|Physician Decision|1|||
131861656|NCT05842967|474774406|FG001|Period 1: SSA|Physician Decision|0|||
131861657|NCT05842967|474774407|FG002|Period 1: SSA|Physician Decision|0|||
131861658|NCT05842967|474774408|FG003|Period 1: SSA|Physician Decision|0|||
131861659|NCT05842967|474774405|FG000|Period 1: SSA|Withdrawal by Subject|2|||
131861660|NCT05842967|474774406|FG001|Period 1: SSA|Withdrawal by Subject|2|||
131861661|NCT05842967|474774407|FG002|Period 1: SSA|Withdrawal by Subject|0|||
131861662|NCT05842967|474774408|FG003|Period 1: SSA|Withdrawal by Subject|0|||
131861663|NCT05842967|474774405|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
131861664|NCT05842967|474774406|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
131861665|NCT05842967|474774407|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
131861666|NCT05842967|474774408|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
131861667|NCT05842967|474774405|FG000|Period 2: SSB|Adverse Event|0|||
131861668|NCT05842967|474774406|FG001|Period 2: SSB|Adverse Event|0|||
131861669|NCT05842967|474774407|FG002|Period 2: SSB|Adverse Event|2|||
131861670|NCT05842967|474774408|FG003|Period 2: SSB|Adverse Event|0|||
131861671|NCT05842967|474774405|FG000|Period 2: SSB|Lost to Follow-up|0|||
131861672|NCT05842967|474774406|FG001|Period 2: SSB|Lost to Follow-up|0|||
131861673|NCT05842967|474774407|FG002|Period 2: SSB|Lost to Follow-up|4|||
131861674|NCT05842967|474774408|FG003|Period 2: SSB|Lost to Follow-up|3|||
131861675|NCT05842967|474774405|FG000|Period 2: SSB|Withdrawal by Subject|0|||
131861676|NCT05842967|474774406|FG001|Period 2: SSB|Withdrawal by Subject|0|||
131861677|NCT05842967|474774407|FG002|Period 2: SSB|Withdrawal by Subject|1|||
131861678|NCT05842967|474774408|FG003|Period 2: SSB|Withdrawal by Subject|0|||
131861679|NCT05842967|474774405|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
131861680|NCT05842967|474774406|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
131861681|NCT05842967|474774407|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
131861682|NCT05842967|474774408|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
131861683|NCT05842967|474774405|FG000|Period 2: SSB|Protocol Violation|0|||
131913358|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
131913359|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
131913360|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
131913361|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
131913362|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
131913363|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
131913364|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
131913365|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
131913366|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
131913367|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
131913368|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
131913369|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
131913370|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
131913371|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
131913372|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
131913373|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
131913374|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
131861684|NCT05842967|474774406|FG001|Period 2: SSB|Protocol Violation|0|||
131861685|NCT05842967|474774407|FG002|Period 2: SSB|Protocol Violation|0|||
131913375|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
131861686|NCT05842967|474774408|FG003|Period 2: SSB|Protocol Violation|1|||
131861687|NCT01823328|474774410|FG000|Overall Study|Withdrawal by Subject|8|||
131861688|NCT01823328|474774411|FG001|Overall Study|Withdrawal by Subject|6|||
131861689|NCT02019472|474774412|FG000|Overall Study|Adverse Event|14|||
131861690|NCT02019472|474774413|FG001|Overall Study|Adverse Event|23|||
131861691|NCT02019472|474774414|FG002|Overall Study|Adverse Event|17|||
131861692|NCT02019472|474774412|FG000|Overall Study|Death|0|||
131861693|NCT02019472|474774413|FG001|Overall Study|Death|1|||
131861694|NCT02019472|474774414|FG002|Overall Study|Death|1|||
131861695|NCT02019472|474774412|FG000|Overall Study|Lack of Efficacy|7|||
131861696|NCT02019472|474774413|FG001|Overall Study|Lack of Efficacy|4|||
131861697|NCT02019472|474774414|FG002|Overall Study|Lack of Efficacy|4|||
131861698|NCT02019472|474774412|FG000|Overall Study|Lost to Follow-up|0|||
131861699|NCT02019472|474774413|FG001|Overall Study|Lost to Follow-up|2|||
131861700|NCT02019472|474774414|FG002|Overall Study|Lost to Follow-up|1|||
131861701|NCT02019472|474774412|FG000|Overall Study|Physician Decision|1|||
131861702|NCT02019472|474774413|FG001|Overall Study|Physician Decision|2|||
131861703|NCT02019472|474774414|FG002|Overall Study|Physician Decision|0|||
131861704|NCT02019472|474774412|FG000|Overall Study|Pregnancy|1|||
131861705|NCT02019472|474774413|FG001|Overall Study|Pregnancy|2|||
131861706|NCT02019472|474774414|FG002|Overall Study|Pregnancy|2|||
131861707|NCT02019472|474774412|FG000|Overall Study|Withdrawal by Subject|11|||
131861708|NCT02019472|474774413|FG001|Overall Study|Withdrawal by Subject|10|||
131861709|NCT02019472|474774414|FG002|Overall Study|Withdrawal by Subject|11|||
131861710|NCT02019472|474774412|FG000|Overall Study|Other|3|||
131861711|NCT02019472|474774413|FG001|Overall Study|Other|8|||
131861712|NCT02019472|474774414|FG002|Overall Study|Other|6|||
131861713|NCT02157935|474774415|FG000|Overall Study|Withdrawal by Subject|25|||
131861714|NCT02157935|474774416|FG001|Overall Study|Withdrawal by Subject|39|||
131861715|NCT02157935|474774415|FG000|Overall Study|Screen failure|1|||
131861716|NCT02157935|474774416|FG001|Overall Study|Screen failure|2|||
131861717|NCT02157935|474774415|FG000|Overall Study|Protocol Violation|1|||
131861718|NCT02157935|474774416|FG001|Overall Study|Protocol Violation|0|||
131861719|NCT02157935|474774415|FG000|Overall Study|Progressive disease|0|||
131861720|NCT02157935|474774416|FG001|Overall Study|Progressive disease|2|||
131861721|NCT02157935|474774415|FG000|Overall Study|Other|5|||
131861722|NCT02157935|474774416|FG001|Overall Study|Other|12|||
131861723|NCT02157935|474774415|FG000|Overall Study|Lack of Efficacy|0|||
131861724|NCT02157935|474774416|FG001|Overall Study|Lack of Efficacy|1|||
131861725|NCT02157935|474774415|FG000|Overall Study|Death|4|||
131861726|NCT02157935|474774416|FG001|Overall Study|Death|4|||
131861727|NCT02157935|474774415|FG000|Overall Study|Adverse Event|3|||
131861728|NCT02157935|474774416|FG001|Overall Study|Adverse Event|5|||
131861729|NCT02547428|474774417|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
131861730|NCT02547428|474774418|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
131861731|NCT02547428|474774417|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
131861732|NCT02547428|474774418|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
131861733|NCT02547428|474774417|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
131861734|NCT02547428|474774418|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
131861735|NCT02547428|474774417|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
131861736|NCT02547428|474774418|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
131861737|NCT02547428|474774417|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
131861738|NCT02547428|474774418|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
131861739|NCT02547428|474774417|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
131861740|NCT02547428|474774418|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
131861741|NCT02547428|474774417|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
131861742|NCT02547428|474774418|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
131861743|NCT02547428|474774417|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
131861744|NCT02547428|474774418|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
131861745|NCT01479465|474774419|FG000|Overall Study|Disease Progression|9|||
131861746|NCT01479465|474774420|FG001|Overall Study|Disease Progression|61|||
131861747|NCT01479465|474774421|FG002|Overall Study|Disease Progression|65|||
131861748|NCT01479465|474774422|FG003|Overall Study|Disease Progression|70|||
131861749|NCT01479465|474774419|FG000|Overall Study|Study Discontinued by Sponsor|0|||
131861750|NCT01479465|474774420|FG001|Overall Study|Study Discontinued by Sponsor|7|||
131861751|NCT01479465|474774421|FG002|Overall Study|Study Discontinued by Sponsor|5|||
131861752|NCT01479465|474774422|FG003|Overall Study|Study Discontinued by Sponsor|3|||
131861753|NCT01479465|474774419|FG000|Overall Study|Adverse Event|0|||
131861754|NCT01479465|474774420|FG001|Overall Study|Adverse Event|3|||
131861755|NCT01479465|474774421|FG002|Overall Study|Adverse Event|6|||
131861756|NCT01479465|474774422|FG003|Overall Study|Adverse Event|4|||
131861757|NCT01479465|474774419|FG000|Overall Study|Investigator Discretion|1|||
131861758|NCT01479465|474774420|FG001|Overall Study|Investigator Discretion|4|||
131861759|NCT01479465|474774421|FG002|Overall Study|Investigator Discretion|2|||
131861760|NCT01479465|474774422|FG003|Overall Study|Investigator Discretion|4|||
131861761|NCT01479465|474774419|FG000|Overall Study|Subject Request|1|||
131861762|NCT01479465|474774420|FG001|Overall Study|Subject Request|3|||
131861763|NCT01479465|474774421|FG002|Overall Study|Subject Request|4|||
131861764|NCT01479465|474774422|FG003|Overall Study|Subject Request|2|||
131861765|NCT01479465|474774419|FG000|Overall Study|Subject Withdrew Consent|0|||
131861766|NCT01479465|474774420|FG001|Overall Study|Subject Withdrew Consent|5|||
131861767|NCT01479465|474774421|FG002|Overall Study|Subject Withdrew Consent|2|||
131861768|NCT01479465|474774422|FG003|Overall Study|Subject Withdrew Consent|1|||
131861769|NCT01479465|474774419|FG000|Overall Study|Protocol Violation|0|||
131861770|NCT01479465|474774420|FG001|Overall Study|Protocol Violation|1|||
131861771|NCT01479465|474774421|FG002|Overall Study|Protocol Violation|1|||
131861772|NCT01479465|474774422|FG003|Overall Study|Protocol Violation|0|||
131861773|NCT01479465|474774419|FG000|Overall Study|Death|0|||
131861774|NCT01479465|474774420|FG001|Overall Study|Death|0|||
131861775|NCT01479465|474774421|FG002|Overall Study|Death|0|||
131861776|NCT01479465|474774422|FG003|Overall Study|Death|1|||
131861777|NCT01479465|474774419|FG000|Overall Study|Lost to Follow-up|0|||
131861778|NCT01479465|474774420|FG001|Overall Study|Lost to Follow-up|0|||
131861779|NCT01479465|474774421|FG002|Overall Study|Lost to Follow-up|1|||
131861780|NCT01479465|474774422|FG003|Overall Study|Lost to Follow-up|0|||
131861781|NCT01866826|474774427|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
131861782|NCT01866826|474774428|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
131861783|NCT01866826|474774427|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
131861784|NCT01866826|474774428|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
131861785|NCT01866826|474774427|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
131861786|NCT01866826|474774428|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
131861787|NCT00709995|474774429|FG000|Overall Study|Adverse Event|4|||
131861788|NCT00709995|474774430|FG001|Overall Study|Adverse Event|2|||
131861789|NCT00709995|474774429|FG000|Overall Study|Withdrawal by Subject|1|||
131861790|NCT00709995|474774430|FG001|Overall Study|Withdrawal by Subject|3|||
131861791|NCT00742209|474774435|FG000|Overall Study|Adverse Event|11|||
131861792|NCT00742209|474774436|FG001|Overall Study|Adverse Event|4|||
131861793|NCT00742209|474774437|FG002|Overall Study|Adverse Event|17|||
131861794|NCT00742209|474774438|FG003|Overall Study|Adverse Event|16|||
131861795|NCT00742209|474774439|FG004|Overall Study|Adverse Event|13|||
131861796|NCT00742209|474774435|FG000|Overall Study|Participant Withdrew Consent|8|||
131861797|NCT00742209|474774436|FG001|Overall Study|Participant Withdrew Consent|4|||
131861798|NCT00742209|474774437|FG002|Overall Study|Participant Withdrew Consent|14|||
131861799|NCT00742209|474774438|FG003|Overall Study|Participant Withdrew Consent|7|||
131861800|NCT00742209|474774439|FG004|Overall Study|Participant Withdrew Consent|4|||
131861801|NCT00742209|474774435|FG000|Overall Study|Protocol Violation|6|||
131861802|NCT00742209|474774436|FG001|Overall Study|Protocol Violation|5|||
131861803|NCT00742209|474774437|FG002|Overall Study|Protocol Violation|4|||
131861804|NCT00742209|474774438|FG003|Overall Study|Protocol Violation|5|||
131861805|NCT00742209|474774439|FG004|Overall Study|Protocol Violation|3|||
131861806|NCT00742209|474774435|FG000|Overall Study|Lost to Follow-up|3|||
131861807|NCT00742209|474774436|FG001|Overall Study|Lost to Follow-up|4|||
131861808|NCT00742209|474774437|FG002|Overall Study|Lost to Follow-up|5|||
131861809|NCT00742209|474774438|FG003|Overall Study|Lost to Follow-up|5|||
131861810|NCT00742209|474774439|FG004|Overall Study|Lost to Follow-up|3|||
131861811|NCT00742209|474774435|FG000|Overall Study|Lack of Efficacy|6|||
131861812|NCT00742209|474774436|FG001|Overall Study|Lack of Efficacy|1|||
131861813|NCT00742209|474774437|FG002|Overall Study|Lack of Efficacy|1|||
131861814|NCT00742209|474774438|FG003|Overall Study|Lack of Efficacy|3|||
131861815|NCT00742209|474774439|FG004|Overall Study|Lack of Efficacy|1|||
131861816|NCT00742209|474774435|FG000|Overall Study|Investigator Discretion|0|||
131861817|NCT00742209|474774436|FG001|Overall Study|Investigator Discretion|0|||
131861818|NCT00742209|474774437|FG002|Overall Study|Investigator Discretion|5|||
131861819|NCT00742209|474774438|FG003|Overall Study|Investigator Discretion|1|||
131861820|NCT00742209|474774439|FG004|Overall Study|Investigator Discretion|1|||
131861821|NCT00638508|474774443|FG000|Overall Study|Physician Decision|5|||
131861822|NCT00638508|474774444|FG001|Overall Study|Physician Decision|2|||
131861823|NCT00370552|474774445|FG000|Overall Study|Adverse Event|2|||
131861824|NCT00370552|474774446|FG001|Overall Study|Adverse Event|2|||
131861825|NCT00370552|474774447|FG002|Overall Study|Adverse Event|2|||
131861826|NCT00370552|474774445|FG000|Overall Study|Disease progression|23|||
131861827|NCT00370552|474774446|FG001|Overall Study|Disease progression|23|||
131861828|NCT00370552|474774447|FG002|Overall Study|Disease progression|15|||
131861829|NCT00370552|474774445|FG000|Overall Study|Maximum clinical benefit|3|||
131861830|NCT00370552|474774446|FG001|Overall Study|Maximum clinical benefit|5|||
131861831|NCT00370552|474774447|FG002|Overall Study|Maximum clinical benefit|5|||
131861832|NCT00370552|474774445|FG000|Overall Study|Poor or noncompliance|0|||
131861833|NCT00370552|474774446|FG001|Overall Study|Poor or noncompliance|0|||
131861834|NCT00370552|474774447|FG002|Overall Study|Poor or noncompliance|1|||
131861835|NCT00370552|474774445|FG000|Overall Study|Study drug toxicity|11|||
131861836|NCT00370552|474774446|FG001|Overall Study|Study drug toxicity|8|||
131861837|NCT00370552|474774447|FG002|Overall Study|Study drug toxicity|6|||
131861838|NCT00370552|474774445|FG000|Overall Study|Withdrawal by Subject|2|||
131861839|NCT00370552|474774446|FG001|Overall Study|Withdrawal by Subject|0|||
131861840|NCT00370552|474774447|FG002|Overall Study|Withdrawal by Subject|1|||
131861841|NCT00370552|474774445|FG000|Overall Study|Still on treatment|1|||
131861842|NCT00370552|474774446|FG001|Overall Study|Still on treatment|3|||
131861843|NCT00370552|474774447|FG002|Overall Study|Still on treatment|2|||
131861844|NCT00370552|474774445|FG000|Overall Study|Never treated|1|||
131861845|NCT00370552|474774446|FG001|Overall Study|Never treated|0|||
131861846|NCT00370552|474774447|FG002|Overall Study|Never treated|0|||
131861847|NCT00370552|474774445|FG000|Overall Study|Physician Decision|1|||
131861848|NCT00370552|474774446|FG001|Overall Study|Physician Decision|1|||
131861849|NCT00370552|474774447|FG002|Overall Study|Physician Decision|0|||
131861850|NCT00370552|474774445|FG000|Overall Study|Investigator decision|2|||
131861851|NCT00370552|474774446|FG001|Overall Study|Investigator decision|1|||
131861852|NCT00370552|474774447|FG002|Overall Study|Investigator decision|0|||
131861853|NCT00370552|474774445|FG000|Overall Study|High risk of allergic reaction|0|||
131861854|NCT00370552|474774446|FG001|Overall Study|High risk of allergic reaction|1|||
131861855|NCT00370552|474774447|FG002|Overall Study|High risk of allergic reaction|0|||
131861856|NCT00370552|474774445|FG000|Overall Study|Planned radiation for palliation|0|||
131861857|NCT00370552|474774446|FG001|Overall Study|Planned radiation for palliation|1|||
131861858|NCT00370552|474774447|FG002|Overall Study|Planned radiation for palliation|0|||
131861859|NCT00595621|474774448|FG000|Open Label Run in|Adverse Event|1|||
131861860|NCT00595621|474774449|FG001|Open Label Run in|Adverse Event|0|||
131861861|NCT00595621|474774448|FG000|Open Label Run in|Physician Decision|1|||
131861862|NCT00595621|474774449|FG001|Open Label Run in|Physician Decision|0|||
131861863|NCT00595621|474774448|FG000|Open Label Run in|Withdrawal by Subject|1|||
131861864|NCT00595621|474774449|FG001|Open Label Run in|Withdrawal by Subject|0|||
131861865|NCT00595621|474774448|FG000|Randomization and Study|Adverse Event|2|||
131861866|NCT00595621|474774449|FG001|Randomization and Study|Adverse Event|0|||
131861867|NCT00595621|474774448|FG000|Randomization and Study|Withdrawal by Subject|0|||
131861868|NCT00595621|474774449|FG001|Randomization and Study|Withdrawal by Subject|1|||
131861869|NCT03817125|474774450|FG000|Overall Study|Adverse Event|1|||
131861870|NCT03817125|474774451|FG001|Overall Study|Adverse Event|0|||
131861871|NCT03817125|474774450|FG000|Overall Study|Physician Decision|0|||
131861872|NCT03817125|474774451|FG001|Overall Study|Physician Decision|1|||
131861873|NCT03817125|474774450|FG000|Overall Study|Lack of Efficacy|1|||
131861874|NCT03817125|474774451|FG001|Overall Study|Lack of Efficacy|5|||
131861875|NCT00942084|474774452|FG000|Overall Study|Death|2|||
131861876|NCT05921903|474774453|FG000|Overall Study|Unsolicited non-SAE|0|||
131861877|NCT05921903|474774454|FG001|Overall Study|Unsolicited non-SAE|1|||
131861878|NCT05921903|474774455|FG002|Overall Study|Unsolicited non-SAE|0|||
131861879|NCT05921903|474774453|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
131861880|NCT05921903|474774454|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
131861881|NCT05921903|474774455|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
131861882|NCT05921903|474774453|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
131861883|NCT05921903|474774454|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
131861884|NCT05921903|474774455|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
131861885|NCT05366010|474774457|FG000|Overall Study|Withdrawal by Subject|1|||
131861886|NCT05366010|474774457|FG000|Overall Study|Protocol Violation|1|||
131861887|NCT05366010|474774457|FG000|Overall Study|Lost to Follow-up|2|||
131861888|NCT05366010|474774457|FG000|Overall Study|Screen Failure|2|||
131861889|NCT05317312|474774458|FG000|Overall Study|Withdrawal by Subject|0|||
131861890|NCT05317312|474774459|FG001|Overall Study|Withdrawal by Subject|1|||
131861891|NCT05317312|474774460|FG002|Overall Study|Withdrawal by Subject|0|||
131861892|NCT05317312|474774461|FG003|Overall Study|Withdrawal by Subject|0|||
131861893|NCT05317312|474774458|FG000|Overall Study|Lost to Follow-up|0|||
131861894|NCT05317312|474774459|FG001|Overall Study|Lost to Follow-up|0|||
131861895|NCT05317312|474774460|FG002|Overall Study|Lost to Follow-up|0|||
131861896|NCT05317312|474774461|FG003|Overall Study|Lost to Follow-up|1|||
131861897|NCT05317312|474774458|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
131861898|NCT05317312|474774459|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
131861899|NCT05317312|474774460|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
131861900|NCT05317312|474774461|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
131861901|NCT00235755|474774462|FG000|4-Week Titration Phase|Adverse Event|6|||
131861902|NCT00235755|474774463|FG001|4-Week Titration Phase|Adverse Event|14|||
131861903|NCT00235755|474774464|FG002|4-Week Titration Phase|Adverse Event|20|||
131861904|NCT00235755|474774462|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
131913376|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
131913377|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
131913378|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
131913379|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
131861905|NCT00235755|474774463|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
131861906|NCT00235755|474774464|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
131861907|NCT00235755|474774462|FG000|4-Week Titration Phase|Protocol Violation|2|||
131861908|NCT00235755|474774463|FG001|4-Week Titration Phase|Protocol Violation|2|||
131861909|NCT00235755|474774464|FG002|4-Week Titration Phase|Protocol Violation|1|||
131861910|NCT00235755|474774462|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
131861911|NCT00235755|474774463|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
131861912|NCT00235755|474774464|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
131861913|NCT00235755|474774462|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
131861914|NCT00235755|474774463|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
131861915|NCT00235755|474774464|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
131861916|NCT00235755|474774462|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
131861917|NCT00235755|474774463|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
131861918|NCT00235755|474774464|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
131913380|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
131861919|NCT00235755|474774462|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
131861920|NCT00235755|474774463|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
131861921|NCT00235755|474774464|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
131861922|NCT00235755|474774462|FG000|12-Week Maintenance Phase|Adverse Event|8|||
131861923|NCT00235755|474774463|FG001|12-Week Maintenance Phase|Adverse Event|12|||
131861924|NCT00235755|474774464|FG002|12-Week Maintenance Phase|Adverse Event|26|||
131861925|NCT00235755|474774462|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
131861926|NCT00235755|474774463|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
131861927|NCT00235755|474774464|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
131861928|NCT00235755|474774462|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
131861929|NCT00235755|474774463|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
131861930|NCT00235755|474774464|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
131861931|NCT00235755|474774462|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
131861932|NCT00235755|474774463|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
131861933|NCT00235755|474774464|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
131861934|NCT00235755|474774462|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
131861935|NCT00235755|474774463|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
131861936|NCT00235755|474774464|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
131861937|NCT00235755|474774462|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
131861938|NCT00235755|474774463|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
131861939|NCT00235755|474774464|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
131861940|NCT00586703|474774465|FG000|Overall Study|Death|12|||
131861941|NCT01422213|474774466|FG000|Overall Study|Adverse Event|8|||
131861942|NCT01422213|474774467|FG001|Overall Study|Adverse Event|7|||
131861943|NCT01422213|474774468|FG002|Overall Study|Adverse Event|11|||
131861944|NCT01422213|474774466|FG000|Overall Study|Lack of Efficacy|10|||
131861945|NCT01422213|474774467|FG001|Overall Study|Lack of Efficacy|2|||
131861946|NCT01422213|474774468|FG002|Overall Study|Lack of Efficacy|2|||
131861947|NCT01422213|474774466|FG000|Overall Study|Non-compliance with study drug|0|||
131861948|NCT01422213|474774467|FG001|Overall Study|Non-compliance with study drug|1|||
131861949|NCT01422213|474774468|FG002|Overall Study|Non-compliance with study drug|0|||
131861950|NCT01422213|474774466|FG000|Overall Study|Protocol Violation|0|||
131861951|NCT01422213|474774467|FG001|Overall Study|Protocol Violation|2|||
131861952|NCT01422213|474774468|FG002|Overall Study|Protocol Violation|4|||
131861953|NCT01422213|474774466|FG000|Overall Study|Withdrawal of Consent|7|||
131861954|NCT01422213|474774467|FG001|Overall Study|Withdrawal of Consent|3|||
131861955|NCT01422213|474774468|FG002|Overall Study|Withdrawal of Consent|5|||
131861956|NCT01422213|474774466|FG000|Overall Study|Lost to Follow-up|3|||
131861957|NCT01422213|474774467|FG001|Overall Study|Lost to Follow-up|3|||
131861958|NCT01422213|474774468|FG002|Overall Study|Lost to Follow-up|5|||
131861959|NCT01422213|474774466|FG000|Overall Study|Administrative or Other Reason(s)|5|||
131861960|NCT01422213|474774467|FG001|Overall Study|Administrative or Other Reason(s)|4|||
131861961|NCT01422213|474774468|FG002|Overall Study|Administrative or Other Reason(s)|2|||
131861962|NCT05271175|474774469|FG000|One Week Follow up|Lost to Follow-up|10|||
131861963|NCT05271175|474774470|FG001|One Week Follow up|Lost to Follow-up|7|||
131861964|NCT05271175|474774471|FG002|One Week Follow up|Lost to Follow-up|5|||
131861965|NCT05271175|474774469|FG000|One Month Follow up|Lost to Follow-up|12|||
131861966|NCT05271175|474774470|FG001|One Month Follow up|Lost to Follow-up|7|||
131861967|NCT05271175|474774471|FG002|One Month Follow up|Lost to Follow-up|9|||
131861968|NCT05271175|474774469|FG000|Six Months Follow up|Lost to Follow-up|8|||
131861969|NCT05271175|474774470|FG001|Six Months Follow up|Lost to Follow-up|2|||
131861970|NCT05271175|474774471|FG002|Six Months Follow up|Lost to Follow-up|2|||
131861971|NCT00991887|474774472|FG000|Overall Study|Lost to Follow-up|2|||
131861972|NCT00991887|474774473|FG001|Overall Study|Lost to Follow-up|1|||
131861973|NCT01964976|474774474|FG000|Overall Study|Protocol Violation|31|||
131861974|NCT00473590|474774475|FG000|Overall Study|Adverse Event|3|||
131861975|NCT00473590|474774476|FG001|Overall Study|Adverse Event|3|||
131861976|NCT00473590|474774475|FG000|Overall Study|Death|4|||
131861977|NCT00473590|474774476|FG001|Overall Study|Death|2|||
131861978|NCT00473590|474774475|FG000|Overall Study|Progression not resulting in death|24|||
131861979|NCT00473590|474774476|FG001|Overall Study|Progression not resulting in death|20|||
131861980|NCT00473590|474774475|FG000|Overall Study|Non-protocol-specified therapy|7|||
131861981|NCT00473590|474774476|FG001|Overall Study|Non-protocol-specified therapy|5|||
131861982|NCT00473590|474774475|FG000|Overall Study|Physician Decision|2|||
131861983|NCT00473590|474774476|FG001|Overall Study|Physician Decision|4|||
131861984|NCT00473590|474774475|FG000|Overall Study|Withdrawal by Subject|5|||
131861985|NCT00473590|474774476|FG001|Overall Study|Withdrawal by Subject|3|||
131861986|NCT00473590|474774475|FG000|Overall Study|Other|0|||
131861987|NCT00473590|474774476|FG001|Overall Study|Other|1|||
131861988|NCT00584454|474774479|FG000|Overall Study|Adverse Event|1|||
131861989|NCT00584454|474774479|FG000|Overall Study|Relocation|1|||
131861990|NCT00584454|474774479|FG000|Overall Study|Clinical Hold|2|||
131861991|NCT01168427|474774482|FG000|Overall Study|Patient exited prior to implant|1|||
131861992|NCT00982657|474774485|FG000|Overall Study|Death|1|||
131861993|NCT00982657|474774486|FG001|Overall Study|Death|0|||
131861994|NCT00982657|474774487|FG002|Overall Study|Death|1|||
131861995|NCT00982657|474774488|FG003|Overall Study|Death|1|||
131861996|NCT00982657|474774485|FG000|Overall Study|Withdrawal by Subject|0|||
131861997|NCT00982657|474774486|FG001|Overall Study|Withdrawal by Subject|0|||
131861998|NCT00982657|474774487|FG002|Overall Study|Withdrawal by Subject|1|||
131861999|NCT00982657|474774488|FG003|Overall Study|Withdrawal by Subject|3|||
131862000|NCT00982657|474774485|FG000|Overall Study|Other|0|||
131862001|NCT00982657|474774486|FG001|Overall Study|Other|0|||
131862002|NCT00982657|474774487|FG002|Overall Study|Other|0|||
131862003|NCT00982657|474774488|FG003|Overall Study|Other|4|||
131862004|NCT00982657|474774485|FG000|Overall Study|On going at date of cut-off|0|||
131862005|NCT00982657|474774486|FG001|Overall Study|On going at date of cut-off|0|||
131862006|NCT00982657|474774487|FG002|Overall Study|On going at date of cut-off|0|||
131862007|NCT00982657|474774488|FG003|Overall Study|On going at date of cut-off|1|||
131862008|NCT00725920|474774489|FG000|Overall Study|Lack of Efficacy|3|||
131862009|NCT00725920|474774490|FG001|Overall Study|Lack of Efficacy|6|||
131862010|NCT01891864|474774491|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
131862011|NCT01891864|474774492|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
131862012|NCT01891864|474774493|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
131862013|NCT01891864|474774494|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
131862014|NCT01891864|474774495|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
131862015|NCT01891864|474774496|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
131862016|NCT01891864|474774491|FG000|Treatment Period 1|Physician Decision|0|||
131862017|NCT01891864|474774492|FG001|Treatment Period 1|Physician Decision|1|||
131862018|NCT01891864|474774493|FG002|Treatment Period 1|Physician Decision|0|||
131862019|NCT01891864|474774494|FG003|Treatment Period 1|Physician Decision|0|||
131862020|NCT01891864|474774495|FG004|Treatment Period 1|Physician Decision|0|||
131862021|NCT01891864|474774496|FG005|Treatment Period 1|Physician Decision|0|||
131862022|NCT01891864|474774491|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
131862023|NCT01891864|474774492|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
131862024|NCT01891864|474774493|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
131862025|NCT01891864|474774494|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
131862026|NCT01891864|474774495|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
131862027|NCT01891864|474774496|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
131862028|NCT01891864|474774491|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
131862029|NCT01891864|474774492|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
131862030|NCT01891864|474774493|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
131862031|NCT01891864|474774494|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
131862032|NCT01891864|474774495|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
131862033|NCT01891864|474774496|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
131862034|NCT01891864|474774491|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131862035|NCT01891864|474774492|FG001|Treatment Period 1|Withdrawal by Subject|5|||
131862036|NCT01891864|474774493|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131862037|NCT01891864|474774494|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131862038|NCT01891864|474774495|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131862039|NCT01891864|474774496|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131862040|NCT01891864|474774491|FG000|Treatment Period 1|Lost to Follow-up|1|||
131862041|NCT01891864|474774492|FG001|Treatment Period 1|Lost to Follow-up|0|||
131862042|NCT01891864|474774493|FG002|Treatment Period 1|Lost to Follow-up|0|||
131862043|NCT01891864|474774494|FG003|Treatment Period 1|Lost to Follow-up|0|||
131862044|NCT01891864|474774495|FG004|Treatment Period 1|Lost to Follow-up|0|||
131862045|NCT01891864|474774496|FG005|Treatment Period 1|Lost to Follow-up|0|||
131862046|NCT01891864|474774491|FG000|Treatment Period 2|Protocol Violation|0|||
131862047|NCT01891864|474774492|FG001|Treatment Period 2|Protocol Violation|0|||
131862048|NCT01891864|474774493|FG002|Treatment Period 2|Protocol Violation|0|||
131862049|NCT01891864|474774494|FG003|Treatment Period 2|Protocol Violation|1|||
131862050|NCT01891864|474774495|FG004|Treatment Period 2|Protocol Violation|0|||
131862051|NCT01891864|474774496|FG005|Treatment Period 2|Protocol Violation|0|||
131862052|NCT01891864|474774491|FG000|Treatment Period 2|Physician Decision|0|||
131862053|NCT01891864|474774492|FG001|Treatment Period 2|Physician Decision|0|||
131862054|NCT01891864|474774493|FG002|Treatment Period 2|Physician Decision|1|||
131862055|NCT01891864|474774494|FG003|Treatment Period 2|Physician Decision|0|||
131862056|NCT01891864|474774495|FG004|Treatment Period 2|Physician Decision|0|||
131862057|NCT01891864|474774496|FG005|Treatment Period 2|Physician Decision|0|||
131862058|NCT01891864|474774491|FG000|Treatment Period 2|Site Termination|0|||
131862059|NCT01891864|474774492|FG001|Treatment Period 2|Site Termination|0|||
131862060|NCT01891864|474774493|FG002|Treatment Period 2|Site Termination|1|||
131862061|NCT01891864|474774494|FG003|Treatment Period 2|Site Termination|2|||
131862062|NCT01891864|474774495|FG004|Treatment Period 2|Site Termination|0|||
131862063|NCT01891864|474774496|FG005|Treatment Period 2|Site Termination|0|||
131862064|NCT01891864|474774491|FG000|Treatment Period 2|Lack of Efficacy|0|||
131862065|NCT01891864|474774492|FG001|Treatment Period 2|Lack of Efficacy|0|||
131862066|NCT01891864|474774493|FG002|Treatment Period 2|Lack of Efficacy|1|||
131862067|NCT01891864|474774494|FG003|Treatment Period 2|Lack of Efficacy|0|||
131862068|NCT01891864|474774495|FG004|Treatment Period 2|Lack of Efficacy|1|||
131862069|NCT01891864|474774496|FG005|Treatment Period 2|Lack of Efficacy|0|||
131862070|NCT01891864|474774491|FG000|Treatment Period 2|Adverse Event|0|||
131862071|NCT01891864|474774492|FG001|Treatment Period 2|Adverse Event|0|||
131862072|NCT01891864|474774493|FG002|Treatment Period 2|Adverse Event|1|||
131862073|NCT01891864|474774494|FG003|Treatment Period 2|Adverse Event|2|||
131862074|NCT01891864|474774495|FG004|Treatment Period 2|Adverse Event|0|||
131862075|NCT01891864|474774496|FG005|Treatment Period 2|Adverse Event|4|||
131862076|NCT01891864|474774491|FG000|Treatment Period 2|Termination of Site|0|||
131862077|NCT01891864|474774492|FG001|Treatment Period 2|Termination of Site|0|||
131862078|NCT01891864|474774493|FG002|Treatment Period 2|Termination of Site|0|||
131862079|NCT01891864|474774494|FG003|Treatment Period 2|Termination of Site|0|||
131862080|NCT01891864|474774495|FG004|Treatment Period 2|Termination of Site|2|||
131862081|NCT01891864|474774496|FG005|Treatment Period 2|Termination of Site|0|||
131862082|NCT01891864|474774491|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131862083|NCT01891864|474774492|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131862084|NCT01891864|474774493|FG002|Treatment Period 2|Withdrawal by Subject|3|||
131862085|NCT01891864|474774494|FG003|Treatment Period 2|Withdrawal by Subject|4|||
131862086|NCT01891864|474774495|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131862087|NCT01891864|474774496|FG005|Treatment Period 2|Withdrawal by Subject|1|||
131862088|NCT01891864|474774491|FG000|Extension Period|Lack of Efficacy|0|||
131862089|NCT01891864|474774492|FG001|Extension Period|Lack of Efficacy|0|||
131862090|NCT01891864|474774493|FG002|Extension Period|Lack of Efficacy|0|||
131862091|NCT01891864|474774494|FG003|Extension Period|Lack of Efficacy|1|||
131862092|NCT01891864|474774495|FG004|Extension Period|Lack of Efficacy|1|||
131862093|NCT01891864|474774496|FG005|Extension Period|Lack of Efficacy|0|||
131862094|NCT01891864|474774491|FG000|Extension Period|Pregnancy|0|||
131862095|NCT01891864|474774492|FG001|Extension Period|Pregnancy|0|||
131862096|NCT01891864|474774493|FG002|Extension Period|Pregnancy|1|||
131862097|NCT01891864|474774494|FG003|Extension Period|Pregnancy|0|||
131862098|NCT01891864|474774495|FG004|Extension Period|Pregnancy|0|||
131862099|NCT01891864|474774496|FG005|Extension Period|Pregnancy|0|||
131862100|NCT01891864|474774491|FG000|Extension Period|Adverse Event|0|||
131862101|NCT01891864|474774492|FG001|Extension Period|Adverse Event|0|||
131862102|NCT01891864|474774493|FG002|Extension Period|Adverse Event|4|||
131862103|NCT01891864|474774494|FG003|Extension Period|Adverse Event|2|||
131862104|NCT01891864|474774495|FG004|Extension Period|Adverse Event|2|||
131862105|NCT01891864|474774496|FG005|Extension Period|Adverse Event|0|||
131862106|NCT01891864|474774491|FG000|Extension Period|Withdrawal by Subject|0|||
131862107|NCT01891864|474774492|FG001|Extension Period|Withdrawal by Subject|0|||
131862108|NCT01891864|474774493|FG002|Extension Period|Withdrawal by Subject|1|||
131862109|NCT01891864|474774494|FG003|Extension Period|Withdrawal by Subject|2|||
131862110|NCT01891864|474774495|FG004|Extension Period|Withdrawal by Subject|4|||
131862111|NCT01891864|474774496|FG005|Extension Period|Withdrawal by Subject|0|||
131862112|NCT01891864|474774491|FG000|Extension Period|Lost to Follow-up|0|||
131862113|NCT01891864|474774492|FG001|Extension Period|Lost to Follow-up|0|||
131862114|NCT01891864|474774493|FG002|Extension Period|Lost to Follow-up|2|||
131862115|NCT01891864|474774494|FG003|Extension Period|Lost to Follow-up|0|||
131862116|NCT01891864|474774495|FG004|Extension Period|Lost to Follow-up|0|||
131862117|NCT01891864|474774496|FG005|Extension Period|Lost to Follow-up|0|||
131862118|NCT02698163|474774497|FG000|Overall Study|Lost to Follow-up|0|||
131862119|NCT02698163|474774498|FG001|Overall Study|Lost to Follow-up|1|||
131862120|NCT05373108|474774499|FG000|Overall Study|Withdrawal by Subject|2|||
131862121|NCT02892331|474774500|FG000|Overall Study|Withdrawal by Subject|0|||
131862122|NCT02892331|474774501|FG001|Overall Study|Withdrawal by Subject|1|||
131862123|NCT02892331|474774502|FG002|Overall Study|Withdrawal by Subject|1|||
131862124|NCT02892331|474774500|FG000|Overall Study|Sick family member|0|||
131862125|NCT02892331|474774501|FG001|Overall Study|Sick family member|0|||
131862126|NCT02892331|474774502|FG002|Overall Study|Sick family member|1|||
131862127|NCT02892331|474774500|FG000|Overall Study|Corona virus pandemic|1|||
131862128|NCT02892331|474774501|FG001|Overall Study|Corona virus pandemic|0|||
131862129|NCT02892331|474774502|FG002|Overall Study|Corona virus pandemic|1|||
131862130|NCT02892331|474774500|FG000|Overall Study|Lost to Follow-up|1|||
131862131|NCT02892331|474774501|FG001|Overall Study|Lost to Follow-up|0|||
131862132|NCT02892331|474774502|FG002|Overall Study|Lost to Follow-up|1|||
131862133|NCT02892331|474774500|FG000|Overall Study|Blood pressure was too elevated|0|||
131862134|NCT02892331|474774501|FG001|Overall Study|Blood pressure was too elevated|1|||
131862135|NCT02892331|474774502|FG002|Overall Study|Blood pressure was too elevated|0|||
131862136|NCT02892331|474774500|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
131862137|NCT02892331|474774501|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
131862138|NCT02892331|474774502|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
131862139|NCT00752128|474774506|FG000|Overall Study|Withdrawal by Subject|4|||
131862140|NCT00349973|474774507|FG000|Overall Study|Adverse Event|3|||
131862141|NCT00349973|474774508|FG001|Overall Study|Adverse Event|3|||
131862142|NCT00349973|474774507|FG000|Overall Study|Withdrawal by Subject|1|||
131913381|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
131913382|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
131913383|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
131913384|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
131862143|NCT00349973|474774508|FG001|Overall Study|Withdrawal by Subject|0|||
131862144|NCT02286713|474774513|FG000|One Week Follow-Up|Death|1|||
131862145|NCT02286713|474774514|FG001|One Week Follow-Up|Death|0|||
131862146|NCT02286713|474774513|FG000|One Week Follow-Up|Lost to Follow-up|17|||
131862147|NCT02286713|474774514|FG001|One Week Follow-Up|Lost to Follow-up|21|||
131862148|NCT02286713|474774513|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
131862149|NCT02286713|474774514|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
131862150|NCT02286713|474774513|FG000|Three Month Follow-Up|Death|1|||
131862151|NCT02286713|474774514|FG001|Three Month Follow-Up|Death|1|||
131862152|NCT02286713|474774513|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
131862153|NCT02286713|474774514|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
131862154|NCT02286713|474774513|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
131862155|NCT02286713|474774514|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
131862156|NCT02286713|474774513|FG000|Six Month Follow-Up|Death|2|||
131862157|NCT02286713|474774514|FG001|Six Month Follow-Up|Death|0|||
131862158|NCT02286713|474774513|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
131862159|NCT02286713|474774514|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
131862160|NCT04314037|474774515|FG000|Treatment Period 2|Adverse Event|1|||
131862161|NCT04314037|474774516|FG001|Treatment Period 2|Adverse Event|0|||
131862162|NCT04314037|474774515|FG000|Treatment Period 3|Protocol Violation|1|||
131862163|NCT04314037|474774516|FG001|Treatment Period 3|Protocol Violation|0|||
131862164|NCT04314037|474774515|FG000|Treatment Period 3|Adverse Event|0|||
131862165|NCT04314037|474774516|FG001|Treatment Period 3|Adverse Event|1|||
131862166|NCT00420420|474774517|FG000|Overall Study|Adverse Event|5|||
131862167|NCT00420420|474774518|FG001|Overall Study|Adverse Event|3|||
131862168|NCT00420420|474774517|FG000|Overall Study|Protocol Violation|1|||
131862169|NCT00420420|474774518|FG001|Overall Study|Protocol Violation|1|||
131862170|NCT00420420|474774517|FG000|Overall Study|Withdrawal by Subject|1|||
131862171|NCT00420420|474774518|FG001|Overall Study|Withdrawal by Subject|0|||
131862172|NCT00420420|474774517|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
131862173|NCT00420420|474774518|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
131862174|NCT03323398|474774521|FG000|Overall Study|Other than Specified|0|||
131862175|NCT03323398|474774522|FG001|Overall Study|Other than Specified|1|||
131862176|NCT03323398|474774523|FG002|Overall Study|Other than Specified|2|||
131862177|NCT03323398|474774524|FG003|Overall Study|Other than Specified|0|||
131862178|NCT03323398|474774525|FG004|Overall Study|Other than Specified|0|||
131862179|NCT03323398|474774526|FG005|Overall Study|Other than Specified|0|||
131862180|NCT03323398|474774527|FG006|Overall Study|Other than Specified|1|||
131862181|NCT03323398|474774528|FG007|Overall Study|Other than Specified|0|||
131862182|NCT03323398|474774529|FG008|Overall Study|Other than Specified|2|||
131862183|NCT03323398|474774521|FG000|Overall Study|Lost to Follow-up|1|||
131862184|NCT03323398|474774522|FG001|Overall Study|Lost to Follow-up|2|||
131862185|NCT03323398|474774523|FG002|Overall Study|Lost to Follow-up|1|||
131862186|NCT03323398|474774524|FG003|Overall Study|Lost to Follow-up|0|||
131862187|NCT03323398|474774525|FG004|Overall Study|Lost to Follow-up|0|||
131862188|NCT03323398|474774526|FG005|Overall Study|Lost to Follow-up|0|||
131862189|NCT03323398|474774527|FG006|Overall Study|Lost to Follow-up|0|||
131862190|NCT03323398|474774528|FG007|Overall Study|Lost to Follow-up|0|||
131862191|NCT03323398|474774529|FG008|Overall Study|Lost to Follow-up|0|||
131913385|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
131913386|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
131862192|NCT03323398|474774521|FG000|Overall Study|Death|4|||
131862193|NCT03323398|474774522|FG001|Overall Study|Death|6|||
131862194|NCT03323398|474774523|FG002|Overall Study|Death|2|||
131862195|NCT03323398|474774524|FG003|Overall Study|Death|2|||
131862196|NCT03323398|474774525|FG004|Overall Study|Death|1|||
131862197|NCT03323398|474774526|FG005|Overall Study|Death|2|||
131862198|NCT03323398|474774527|FG006|Overall Study|Death|0|||
131862199|NCT03323398|474774528|FG007|Overall Study|Death|0|||
131862200|NCT03323398|474774529|FG008|Overall Study|Death|6|||
131862201|NCT03323398|474774521|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
131862202|NCT03323398|474774522|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
131862203|NCT03323398|474774523|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
131862204|NCT03323398|474774524|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
131862205|NCT03323398|474774525|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
131862206|NCT03323398|474774526|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
131862207|NCT03323398|474774527|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
131862208|NCT03323398|474774528|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
131862209|NCT03323398|474774529|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
131862210|NCT03323398|474774521|FG000|Overall Study|Withdrawal by Subject|2|||
131862211|NCT03323398|474774522|FG001|Overall Study|Withdrawal by Subject|1|||
131913387|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
131913388|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
131913389|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
131913390|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
131913391|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
131913392|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
131913393|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
131913394|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
131913395|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
131913396|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
131913397|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
131913398|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
131913399|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
131913400|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
131913401|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
131913402|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
131913403|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
131913404|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
131913405|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
131913406|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
131913407|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
131913408|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
131913409|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
131913410|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
131913411|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
131913412|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
131913413|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
131913414|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
131913415|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
131913416|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
131913417|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
131913418|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
131913419|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
131913420|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
131913421|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
131913422|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
131913423|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
131913424|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
131913425|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
131913426|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
131913427|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
131913428|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
131913429|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
131913430|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
131913431|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
131913432|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
131913433|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
131913434|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
131913435|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
131913436|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
131913437|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
131913438|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
131913439|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
131913440|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
131913441|NCT00090103|474969331|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
131913442|NCT00090103|474969332|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
131913443|NCT00090103|474969333|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
131913444|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
131913445|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
131913446|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
131913447|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
131913448|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
131862212|NCT03323398|474774523|FG002|Overall Study|Withdrawal by Subject|3|||
131862213|NCT03323398|474774524|FG003|Overall Study|Withdrawal by Subject|0|||
131862214|NCT03323398|474774525|FG004|Overall Study|Withdrawal by Subject|0|||
131862215|NCT03323398|474774526|FG005|Overall Study|Withdrawal by Subject|1|||
131862216|NCT03323398|474774527|FG006|Overall Study|Withdrawal by Subject|0|||
131862217|NCT03323398|474774528|FG007|Overall Study|Withdrawal by Subject|0|||
131862218|NCT03323398|474774529|FG008|Overall Study|Withdrawal by Subject|0|||
131862219|NCT03323398|474774521|FG000|Overall Study|Participant was Put on Hospice|0|||
131862220|NCT03323398|474774522|FG001|Overall Study|Participant was Put on Hospice|0|||
131862221|NCT03323398|474774523|FG002|Overall Study|Participant was Put on Hospice|0|||
131862222|NCT03323398|474774524|FG003|Overall Study|Participant was Put on Hospice|0|||
131862223|NCT03323398|474774525|FG004|Overall Study|Participant was Put on Hospice|0|||
131862224|NCT03323398|474774526|FG005|Overall Study|Participant was Put on Hospice|0|||
131862225|NCT03323398|474774527|FG006|Overall Study|Participant was Put on Hospice|1|||
131862226|NCT03323398|474774528|FG007|Overall Study|Participant was Put on Hospice|0|||
131862227|NCT03323398|474774529|FG008|Overall Study|Participant was Put on Hospice|0|||
131862228|NCT03323398|474774521|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
131862229|NCT03323398|474774522|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
131862230|NCT03323398|474774523|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
131862231|NCT03323398|474774524|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
131862232|NCT03323398|474774525|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
131862233|NCT03323398|474774526|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
131862234|NCT03323398|474774527|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
131862235|NCT03323398|474774528|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
131862236|NCT03323398|474774529|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
131862237|NCT02235454|474774530|FG000|Overall Study|Withdrawal by Subject|2|||
131862238|NCT02325973|474776275|FG000|Overall Study|Death|5|||
131862239|NCT02325973|474776275|FG000|Overall Study|Withdrawal by subject or investigator|16|||
131862240|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
131862241|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
131862242|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
131862243|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
131862244|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
131862245|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
131862246|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
131862247|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
131862248|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
131862249|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
131862250|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
131862251|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
131862252|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
131862253|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
131862254|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
131862255|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
131862256|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
131862257|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
131862258|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
131862259|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
131862260|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
131862261|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
131862262|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
131862263|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
131862264|NCT02513160|474776277|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
131862265|NCT02513160|474776278|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
131862266|NCT02513160|474776279|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
131862267|NCT02513160|474776280|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
131862268|NCT02513160|474776277|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
131862269|NCT02513160|474776278|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
131862270|NCT02513160|474776279|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
131862271|NCT02513160|474776280|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
131862272|NCT02513160|474776277|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
131862273|NCT02513160|474776278|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
131862274|NCT02513160|474776279|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
131862275|NCT02513160|474776280|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
131862276|NCT02513160|474776277|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
131913449|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
131913450|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
131913451|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
131913452|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
131913453|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
131913454|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
131913455|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
131913456|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
131913457|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
131913458|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
131913459|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
131913460|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
131913461|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
131913462|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
131913463|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
131913464|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
131913465|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
131913466|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
131913467|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
131913468|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
131913469|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
131913470|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
131913471|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
131913472|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
131913473|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
131913474|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
131913475|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
131913476|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
131913477|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
131913478|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
131913479|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
131913480|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
131913481|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
131913482|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
131913483|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
131913484|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
131913485|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
131913486|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
131913487|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
131913488|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
131913489|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
131913490|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
131913491|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
131913492|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Death|1|||
131913493|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Death|0|||
131913494|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Death|1|||
131913495|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
131913496|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
131913497|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
131913498|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
131913499|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
131913500|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
131913501|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
131913502|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
131913503|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
131913504|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
131913505|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
131913506|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
131913507|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
131913508|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
131913509|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
131913510|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
131913511|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
131913512|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
131913513|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
131913514|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
131913515|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
131913516|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Depression|0|||
131913517|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Depression|1|||
131913518|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Depression|0|||
131913519|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
131913520|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
131913521|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
131913522|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Jailed|0|||
131913523|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Jailed|1|||
131913524|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Jailed|0|||
131913525|NCT00090103|474969331|FG000|16-Week Safety Follow-up Period|Other|0|||
131913526|NCT00090103|474969332|FG001|16-Week Safety Follow-up Period|Other|1|||
131862277|NCT02513160|474776278|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
131862278|NCT02513160|474776279|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
131862279|NCT02513160|474776280|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
131862280|NCT02513160|474776277|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
131862281|NCT02513160|474776278|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
131862282|NCT02513160|474776279|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
131913527|NCT00090103|474969333|FG002|16-Week Safety Follow-up Period|Other|0|||
131913528|NCT00947544|474969338|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
131913529|NCT00947544|474969339|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
131913530|NCT00300053|474969340|FG000|Overall Study|Patient/Caregiver Preference|2|||
131913531|NCT00300053|474969341|FG001|Overall Study|Patient/Caregiver Preference|2|||
131913532|NCT00300053|474969342|FG002|Overall Study|Patient/Caregiver Preference|3|||
131913533|NCT00300053|474969340|FG000|Overall Study|Death|0|||
131913534|NCT00300053|474969341|FG001|Overall Study|Death|0|||
131913535|NCT00300053|474969342|FG002|Overall Study|Death|3|||
131913536|NCT00300053|474969340|FG000|Overall Study|Lost to Follow-up|0|||
131913537|NCT00300053|474969341|FG001|Overall Study|Lost to Follow-up|1|||
131913538|NCT00300053|474969342|FG002|Overall Study|Lost to Follow-up|0|||
131913539|NCT01240746|474969343|FG000|Overall Study|Adverse Event|2|||
131913540|NCT01240746|474969344|FG001|Overall Study|Adverse Event|0|||
131913541|NCT01240746|474969345|FG002|Overall Study|Adverse Event|10|||
131913542|NCT01240746|474969343|FG000|Overall Study|Lost to Follow-up|23|||
131913543|NCT01240746|474969344|FG001|Overall Study|Lost to Follow-up|20|||
131913544|NCT01240746|474969345|FG002|Overall Study|Lost to Follow-up|102|||
131913545|NCT01240746|474969343|FG000|Overall Study|Protocol Violation|24|||
131913546|NCT01240746|474969344|FG001|Overall Study|Protocol Violation|15|||
131862283|NCT02513160|474776280|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
131862284|NCT02513160|474776277|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
131862285|NCT02513160|474776278|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
131862286|NCT02513160|474776279|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
131862287|NCT02513160|474776280|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
131862288|NCT03428958|474776283|FG000|Overall Study|Adverse Event|0|||
131862289|NCT03428958|474776284|FG001|Overall Study|Adverse Event|0|||
131862290|NCT03428958|474776285|FG002|Overall Study|Adverse Event|0|||
131862291|NCT03428958|474776286|FG003|Overall Study|Adverse Event|1|||
131862292|NCT03428958|474776287|FG004|Overall Study|Adverse Event|0|||
131862293|NCT03428958|474776288|FG005|Overall Study|Adverse Event|2|||
131862294|NCT03428958|474776289|FG006|Overall Study|Adverse Event|1|||
131862295|NCT03428958|474776290|FG007|Overall Study|Adverse Event|0|||
131862296|NCT03428958|474776291|FG008|Overall Study|Adverse Event|0|||
131862297|NCT03428958|474776292|FG009|Overall Study|Adverse Event|0|||
131862298|NCT03428958|474776293|FG010|Overall Study|Adverse Event|0|||
131862299|NCT03428958|474776294|FG011|Overall Study|Adverse Event|0|||
131862300|NCT03428958|474776295|FG012|Overall Study|Adverse Event|0|||
131862301|NCT03428958|474776296|FG013|Overall Study|Adverse Event|0|||
131862302|NCT03428958|474776297|FG014|Overall Study|Adverse Event|0|||
131862303|NCT03428958|474776298|FG015|Overall Study|Adverse Event|0|||
131862304|NCT03428958|474776299|FG016|Overall Study|Adverse Event|0|||
131913547|NCT01240746|474969345|FG002|Overall Study|Protocol Violation|72|||
131913548|NCT01240746|474969343|FG000|Overall Study|Withdrawal by Subject|10|||
131913549|NCT01240746|474969344|FG001|Overall Study|Withdrawal by Subject|13|||
131862305|NCT03428958|474776283|FG000|Overall Study|Clinical Progression|2|||
131913550|NCT01240746|474969345|FG002|Overall Study|Withdrawal by Subject|59|||
131862306|NCT03428958|474776284|FG001|Overall Study|Clinical Progression|3|||
131862307|NCT03428958|474776285|FG002|Overall Study|Clinical Progression|2|||
131862308|NCT03428958|474776286|FG003|Overall Study|Clinical Progression|1|||
131862309|NCT03428958|474776287|FG004|Overall Study|Clinical Progression|0|||
131862310|NCT03428958|474776288|FG005|Overall Study|Clinical Progression|2|||
131913551|NCT02472405|474969346|FG000|Overall Study|Lost to Follow-up|9|||
131913552|NCT02472405|474969346|FG000|Overall Study|Adverse Event|1|||
131913553|NCT01134042|474969350|FG000|Overall Study|Adverse Event|3|||
131913554|NCT01134042|474969351|FG001|Overall Study|Adverse Event|7|||
131862311|NCT03428958|474776289|FG006|Overall Study|Clinical Progression|0|||
131862312|NCT03428958|474776290|FG007|Overall Study|Clinical Progression|0|||
131862313|NCT03428958|474776291|FG008|Overall Study|Clinical Progression|0|||
131862314|NCT03428958|474776292|FG009|Overall Study|Clinical Progression|0|||
131862315|NCT03428958|474776293|FG010|Overall Study|Clinical Progression|0|||
131862316|NCT03428958|474776294|FG011|Overall Study|Clinical Progression|0|||
131862317|NCT03428958|474776295|FG012|Overall Study|Clinical Progression|0|||
131862318|NCT03428958|474776296|FG013|Overall Study|Clinical Progression|0|||
131862319|NCT03428958|474776297|FG014|Overall Study|Clinical Progression|0|||
131862320|NCT03428958|474776298|FG015|Overall Study|Clinical Progression|0|||
131862321|NCT03428958|474776299|FG016|Overall Study|Clinical Progression|0|||
131862322|NCT03428958|474776283|FG000|Overall Study|Progression per RECIST|6|||
131862323|NCT03428958|474776284|FG001|Overall Study|Progression per RECIST|6|||
131862324|NCT03428958|474776285|FG002|Overall Study|Progression per RECIST|7|||
131862325|NCT03428958|474776286|FG003|Overall Study|Progression per RECIST|4|||
131862326|NCT03428958|474776287|FG004|Overall Study|Progression per RECIST|0|||
131862327|NCT03428958|474776288|FG005|Overall Study|Progression per RECIST|7|||
131862328|NCT03428958|474776289|FG006|Overall Study|Progression per RECIST|8|||
131862329|NCT03428958|474776290|FG007|Overall Study|Progression per RECIST|0|||
131862330|NCT03428958|474776291|FG008|Overall Study|Progression per RECIST|0|||
131862331|NCT03428958|474776292|FG009|Overall Study|Progression per RECIST|0|||
131862332|NCT03428958|474776293|FG010|Overall Study|Progression per RECIST|0|||
131862333|NCT03428958|474776294|FG011|Overall Study|Progression per RECIST|0|||
131862334|NCT03428958|474776295|FG012|Overall Study|Progression per RECIST|1|||
131862335|NCT03428958|474776296|FG013|Overall Study|Progression per RECIST|0|||
131862336|NCT03428958|474776297|FG014|Overall Study|Progression per RECIST|0|||
131862337|NCT03428958|474776298|FG015|Overall Study|Progression per RECIST|0|||
131862338|NCT03428958|474776299|FG016|Overall Study|Progression per RECIST|0|||
131862339|NCT03428958|474776283|FG000|Overall Study|Death|2|||
131862340|NCT03428958|474776284|FG001|Overall Study|Death|2|||
131862341|NCT03428958|474776285|FG002|Overall Study|Death|0|||
131862342|NCT03428958|474776286|FG003|Overall Study|Death|0|||
131862343|NCT03428958|474776287|FG004|Overall Study|Death|0|||
131862344|NCT03428958|474776288|FG005|Overall Study|Death|7|||
131862345|NCT03428958|474776289|FG006|Overall Study|Death|9|||
131862346|NCT03428958|474776290|FG007|Overall Study|Death|6|||
131862347|NCT03428958|474776291|FG008|Overall Study|Death|0|||
131862348|NCT03428958|474776292|FG009|Overall Study|Death|0|||
131862349|NCT03428958|474776293|FG010|Overall Study|Death|3|||
131862350|NCT03428958|474776294|FG011|Overall Study|Death|0|||
131862351|NCT03428958|474776295|FG012|Overall Study|Death|4|||
131862352|NCT03428958|474776296|FG013|Overall Study|Death|0|||
131862353|NCT03428958|474776297|FG014|Overall Study|Death|0|||
131862354|NCT03428958|474776298|FG015|Overall Study|Death|0|||
131862355|NCT03428958|474776299|FG016|Overall Study|Death|0|||
131862356|NCT03428958|474776283|FG000|Overall Study|Lost to Follow-up|0|||
131862357|NCT03428958|474776284|FG001|Overall Study|Lost to Follow-up|0|||
131862358|NCT03428958|474776285|FG002|Overall Study|Lost to Follow-up|0|||
131862359|NCT03428958|474776286|FG003|Overall Study|Lost to Follow-up|0|||
131862360|NCT03428958|474776287|FG004|Overall Study|Lost to Follow-up|0|||
131862361|NCT03428958|474776288|FG005|Overall Study|Lost to Follow-up|1|||
131862362|NCT03428958|474776289|FG006|Overall Study|Lost to Follow-up|1|||
131862363|NCT03428958|474776290|FG007|Overall Study|Lost to Follow-up|0|||
131862364|NCT03428958|474776291|FG008|Overall Study|Lost to Follow-up|0|||
131862365|NCT03428958|474776292|FG009|Overall Study|Lost to Follow-up|0|||
131862366|NCT03428958|474776293|FG010|Overall Study|Lost to Follow-up|0|||
131862367|NCT03428958|474776294|FG011|Overall Study|Lost to Follow-up|0|||
131862368|NCT03428958|474776295|FG012|Overall Study|Lost to Follow-up|0|||
131862369|NCT03428958|474776296|FG013|Overall Study|Lost to Follow-up|0|||
131862370|NCT03428958|474776297|FG014|Overall Study|Lost to Follow-up|0|||
131862371|NCT03428958|474776298|FG015|Overall Study|Lost to Follow-up|0|||
131862372|NCT03428958|474776299|FG016|Overall Study|Lost to Follow-up|0|||
131862373|NCT03428958|474776283|FG000|Overall Study|Physician/Sponsor Decision|1|||
131862374|NCT03428958|474776284|FG001|Overall Study|Physician/Sponsor Decision|0|||
131862375|NCT03428958|474776285|FG002|Overall Study|Physician/Sponsor Decision|1|||
131862376|NCT03428958|474776286|FG003|Overall Study|Physician/Sponsor Decision|0|||
131862377|NCT03428958|474776287|FG004|Overall Study|Physician/Sponsor Decision|0|||
131862378|NCT03428958|474776288|FG005|Overall Study|Physician/Sponsor Decision|2|||
131913555|NCT01134042|474969352|FG002|Overall Study|Adverse Event|2|||
131862379|NCT03428958|474776289|FG006|Overall Study|Physician/Sponsor Decision|2|||
131862380|NCT03428958|474776290|FG007|Overall Study|Physician/Sponsor Decision|2|||
131862381|NCT03428958|474776291|FG008|Overall Study|Physician/Sponsor Decision|0|||
131862382|NCT03428958|474776292|FG009|Overall Study|Physician/Sponsor Decision|0|||
131862383|NCT03428958|474776293|FG010|Overall Study|Physician/Sponsor Decision|2|||
131913556|NCT01134042|474969350|FG000|Overall Study|Lack of Efficacy|21|||
131862384|NCT03428958|474776294|FG011|Overall Study|Physician/Sponsor Decision|0|||
131862385|NCT03428958|474776295|FG012|Overall Study|Physician/Sponsor Decision|4|||
131862386|NCT03428958|474776296|FG013|Overall Study|Physician/Sponsor Decision|0|||
131862387|NCT03428958|474776297|FG014|Overall Study|Physician/Sponsor Decision|0|||
131913557|NCT01134042|474969351|FG001|Overall Study|Lack of Efficacy|6|||
131913558|NCT01134042|474969352|FG002|Overall Study|Lack of Efficacy|18|||
131913559|NCT01134042|474969350|FG000|Overall Study|Protocol Violation|5|||
131913560|NCT01134042|474969351|FG001|Overall Study|Protocol Violation|3|||
131913561|NCT01134042|474969352|FG002|Overall Study|Protocol Violation|5|||
131913562|NCT01134042|474969350|FG000|Overall Study|Lost to Follow-up|2|||
131913563|NCT01134042|474969351|FG001|Overall Study|Lost to Follow-up|0|||
131913564|NCT01134042|474969352|FG002|Overall Study|Lost to Follow-up|1|||
131913565|NCT01134042|474969350|FG000|Overall Study|Physician Decision|4|||
131913566|NCT01134042|474969351|FG001|Overall Study|Physician Decision|8|||
131913567|NCT01134042|474969352|FG002|Overall Study|Physician Decision|1|||
131913568|NCT01134042|474969350|FG000|Overall Study|Withdrawal by Subject|13|||
131913569|NCT01134042|474969351|FG001|Overall Study|Withdrawal by Subject|4|||
131913570|NCT01134042|474969352|FG002|Overall Study|Withdrawal by Subject|7|||
131913571|NCT02471183|474969353|FG000|Main Treatment Period|Adverse Event|1|||
131913572|NCT02471183|474969353|FG000|Main Treatment Period|Withdrawal by Subject|1|||
131913573|NCT02471183|474969353|FG000|Extended Treatment Period|Lack of Efficacy|1|||
131913574|NCT00827567|474969361|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
131913575|NCT01461551|474969362|FG000|Overall Study|Physician Decision|2|||
131913576|NCT01461551|474969363|FG001|Overall Study|Physician Decision|1|||
131913577|NCT01461551|474969364|FG002|Overall Study|Physician Decision|2|||
131913578|NCT01155141|474969365|FG000|Overall Study|Withdrawal by Subject|1|||
131913579|NCT01155141|474969365|FG000|Overall Study|Screen Failure|1|||
131913580|NCT03473197|474969366|FG000|Overall Study|Adverse Event|4|||
131913581|NCT03473197|474969366|FG000|Overall Study|Lost to Follow-up|1|||
131913582|NCT03473197|474969366|FG000|Overall Study|Withdrawal by Subject|5|||
131913583|NCT00851591|474969367|FG000|Overall Study|Withdrawal by Subject|2|||
131913584|NCT00851591|474969368|FG001|Overall Study|Withdrawal by Subject|0|||
131913585|NCT02736617|474969369|FG000|Treatment|Adverse Event|1|||
131913586|NCT02736617|474969369|FG000|Treatment|Lack of Efficacy|1|||
131913587|NCT02736617|474969369|FG000|Treatment|Withdrawal by Subject|1|||
131913588|NCT02736617|474969369|FG000|Maintenance|Lack of Efficacy|4|||
131913589|NCT02736617|474969369|FG000|Maintenance|Physician Decision|1|||
131913590|NCT02469857|474969372|FG000|Overall Study|Death|24|||
131913591|NCT02469857|474969373|FG001|Overall Study|Death|29|||
131913592|NCT02469857|474969372|FG000|Overall Study|Discontinuation|1|||
131913593|NCT02469857|474969373|FG001|Overall Study|Discontinuation|3|||
131913594|NCT04154956|474969374|FG000|Overall Study|Death|109|||
131913595|NCT04154956|474969375|FG001|Overall Study|Death|110|||
131913596|NCT04154956|474969374|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
131913597|NCT04154956|474969375|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
131913598|NCT04154956|474969374|FG000|Overall Study|Withdrawal by Subject|1|||
131913599|NCT04154956|474969375|FG001|Overall Study|Withdrawal by Subject|7|||
131913600|NCT04154956|474969374|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
131913601|NCT04154956|474969375|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
131913602|NCT03620162|474969376|FG000|Overall Study|Physician Decision|4|||
131913603|NCT03620162|474969377|FG001|Overall Study|Physician Decision|0|||
131913604|NCT03620162|474969378|FG002|Overall Study|Physician Decision|1|||
131913605|NCT03620162|474969379|FG003|Overall Study|Physician Decision|0|||
131913606|NCT03620162|474969380|FG004|Overall Study|Physician Decision|2|||
131913607|NCT03620162|474969376|FG000|Overall Study|Lost to Follow-up|2|||
131913608|NCT03620162|474969377|FG001|Overall Study|Lost to Follow-up|6|||
131913609|NCT03620162|474969378|FG002|Overall Study|Lost to Follow-up|7|||
131913610|NCT03620162|474969379|FG003|Overall Study|Lost to Follow-up|3|||
131913611|NCT03620162|474969380|FG004|Overall Study|Lost to Follow-up|2|||
131913612|NCT03620162|474969376|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
131913613|NCT03620162|474969377|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
131913614|NCT03620162|474969378|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
131913615|NCT03620162|474969379|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
131913616|NCT03620162|474969380|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
131913617|NCT06438601|474969383|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
131913618|NCT06438601|474969384|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
131913619|NCT06438601|474969383|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
131913620|NCT06438601|474969384|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
131913621|NCT01311661|474969385|FG000|Overall Study|Adverse Event|2|||
131913622|NCT01311661|474969385|FG000|Overall Study|Protocol Violation|3|||
131913623|NCT01311661|474969385|FG000|Overall Study|Withdrawal by Subject|2|||
131913624|NCT01056536|474969386|FG000|Overall Study|Lost to Follow-up|202|||
131913625|NCT01056536|474969387|FG001|Overall Study|Lost to Follow-up|116|||
131913626|NCT01056536|474969388|FG002|Overall Study|Lost to Follow-up|248|||
131913627|NCT00720759|474969393|FG000|Overall Study|Lost to Follow-up|0|||
131913628|NCT00720759|474969394|FG001|Overall Study|Lost to Follow-up|1|||
131913629|NCT00720759|474969395|FG002|Overall Study|Lost to Follow-up|1|||
131913630|NCT00720759|474969396|FG003|Overall Study|Lost to Follow-up|0|||
131913631|NCT01277861|474969399|FG000|Overall Study|Physician Decision|2|||
131913632|NCT01277861|474969400|FG001|Overall Study|Physician Decision|2|||
131862388|NCT03428958|474776298|FG015|Overall Study|Physician/Sponsor Decision|0|||
131862389|NCT03428958|474776299|FG016|Overall Study|Physician/Sponsor Decision|0|||
131862390|NCT03428958|474776283|FG000|Overall Study|Withdrawal by Subject|0|||
131862391|NCT03428958|474776284|FG001|Overall Study|Withdrawal by Subject|0|||
131862392|NCT03428958|474776285|FG002|Overall Study|Withdrawal by Subject|2|||
131862393|NCT03428958|474776286|FG003|Overall Study|Withdrawal by Subject|0|||
131862394|NCT03428958|474776287|FG004|Overall Study|Withdrawal by Subject|0|||
131862395|NCT03428958|474776288|FG005|Overall Study|Withdrawal by Subject|2|||
131862396|NCT03428958|474776289|FG006|Overall Study|Withdrawal by Subject|4|||
131862397|NCT03428958|474776290|FG007|Overall Study|Withdrawal by Subject|1|||
131862398|NCT03428958|474776291|FG008|Overall Study|Withdrawal by Subject|0|||
131862399|NCT03428958|474776292|FG009|Overall Study|Withdrawal by Subject|0|||
131862400|NCT03428958|474776293|FG010|Overall Study|Withdrawal by Subject|0|||
131862401|NCT03428958|474776294|FG011|Overall Study|Withdrawal by Subject|0|||
131862402|NCT03428958|474776295|FG012|Overall Study|Withdrawal by Subject|0|||
131862403|NCT03428958|474776296|FG013|Overall Study|Withdrawal by Subject|0|||
131862404|NCT03428958|474776297|FG014|Overall Study|Withdrawal by Subject|0|||
131862405|NCT03428958|474776298|FG015|Overall Study|Withdrawal by Subject|0|||
131862406|NCT03428958|474776299|FG016|Overall Study|Withdrawal by Subject|0|||
131862407|NCT03018288|474776302|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
131862408|NCT03018288|474776303|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
131862409|NCT03018288|474776304|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
131862410|NCT03018288|474776305|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
131862411|NCT03018288|474776302|FG000|Overall Study|Participant withdrew consent.|0|||
131862412|NCT03018288|474776303|FG001|Overall Study|Participant withdrew consent.|0|||
131862413|NCT03018288|474776304|FG002|Overall Study|Participant withdrew consent.|1|||
131862414|NCT03018288|474776305|FG003|Overall Study|Participant withdrew consent.|0|||
131862415|NCT03018288|474776302|FG000|Overall Study|Switched to alternative treatment.|0|||
131862416|NCT03018288|474776303|FG001|Overall Study|Switched to alternative treatment.|0|||
131862417|NCT03018288|474776304|FG002|Overall Study|Switched to alternative treatment.|1|||
131862418|NCT03018288|474776305|FG003|Overall Study|Switched to alternative treatment.|0|||
131862419|NCT03018288|474776302|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
131862420|NCT03018288|474776303|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
131862421|NCT03018288|474776304|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
131862422|NCT03018288|474776305|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
131862423|NCT03018288|474776302|FG000|Overall Study|Screen failures|0|||
131862424|NCT03018288|474776303|FG001|Overall Study|Screen failures|0|||
131862425|NCT03018288|474776304|FG002|Overall Study|Screen failures|0|||
131862426|NCT03018288|474776305|FG003|Overall Study|Screen failures|51|||
131862427|NCT03018288|474776302|FG000|Overall Study|Chose treatment outside of UNC|0|||
131862428|NCT03018288|474776303|FG001|Overall Study|Chose treatment outside of UNC|0|||
131862429|NCT03018288|474776304|FG002|Overall Study|Chose treatment outside of UNC|0|||
131862430|NCT03018288|474776305|FG003|Overall Study|Chose treatment outside of UNC|1|||
131862431|NCT03018288|474776302|FG000|Overall Study|Unable to comply with protocol requirements|1|||
131862432|NCT03018288|474776303|FG001|Overall Study|Unable to comply with protocol requirements|1|||
131862433|NCT03018288|474776304|FG002|Overall Study|Unable to comply with protocol requirements|0|||
131862434|NCT03018288|474776305|FG003|Overall Study|Unable to comply with protocol requirements|1|||
131862435|NCT03018288|474776302|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
131862436|NCT03018288|474776303|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
131862437|NCT03018288|474776304|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
131862438|NCT03018288|474776305|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
131862439|NCT03018288|474776302|FG000|Overall Study|Physician Decision|0|||
131862440|NCT03018288|474776303|FG001|Overall Study|Physician Decision|0|||
131862441|NCT03018288|474776304|FG002|Overall Study|Physician Decision|0|||
131862442|NCT03018288|474776305|FG003|Overall Study|Physician Decision|1|||
131862443|NCT02243605|474776308|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
131862444|NCT02243605|474776309|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
131862445|NCT02243605|474776308|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
131862446|NCT02243605|474776309|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
131862447|NCT02243605|474776308|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
131862448|NCT02243605|474776309|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
131862449|NCT02243605|474776308|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
131862450|NCT02243605|474776309|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
131862451|NCT02243605|474776308|FG000|Stage 2 - Final Analysis Population|Progression|0|||
131862452|NCT02243605|474776309|FG001|Stage 2 - Final Analysis Population|Progression|1|||
131862453|NCT03511105|474776310|FG000|Overall Study|Adverse Event|1|||
131862454|NCT03511105|474776311|FG001|Overall Study|Adverse Event|0|||
131862455|NCT03511105|474776310|FG000|Overall Study|Withdrew consent|1|||
131862456|NCT03511105|474776311|FG001|Overall Study|Withdrew consent|0|||
131862457|NCT01002989|474776318|FG000|Overall Study|exclusion criteria, no consent|5|||
131913633|NCT00857389|474969401|FG000|Overall Study|Did not proceed to transplant|2|||
131913634|NCT01157845|474969402|FG000|Overall Study|Lost to Follow-up|5|||
131913635|NCT01157845|474969402|FG000|Overall Study|Withdrawal by Subject|12|||
131913636|NCT01157845|474969402|FG000|Overall Study|Physician Decision|3|||
131913637|NCT01157845|474969402|FG000|Overall Study|Protocol Violation|13|||
131913638|NCT01157845|474969402|FG000|Overall Study|Study was ended|1|||
131913639|NCT01157845|474969402|FG000|Overall Study|Device malfunction|1|||
131913640|NCT03311555|474969403|FG000|Overall Study|Adverse Event|1|||
131913641|NCT01963611|474971346|FG000|Overall Study|Adverse Event|1|||
131913642|NCT01963611|474971347|FG001|Overall Study|Adverse Event|1|||
131913643|NCT01963611|474971348|FG002|Overall Study|Adverse Event|3|||
131913644|NCT01963611|474971349|FG003|Overall Study|Adverse Event|4|||
131913645|NCT01963611|474971350|FG004|Overall Study|Adverse Event|3|||
131913646|NCT01963611|474971346|FG000|Overall Study|Protocol Violation|0|||
131913647|NCT01963611|474971347|FG001|Overall Study|Protocol Violation|0|||
131913648|NCT01963611|474971348|FG002|Overall Study|Protocol Violation|0|||
131913649|NCT01963611|474971349|FG003|Overall Study|Protocol Violation|1|||
131913650|NCT01963611|474971350|FG004|Overall Study|Protocol Violation|0|||
131913651|NCT01963611|474971346|FG000|Overall Study|Lack of Efficacy|0|||
131913652|NCT01963611|474971347|FG001|Overall Study|Lack of Efficacy|0|||
131913653|NCT01963611|474971348|FG002|Overall Study|Lack of Efficacy|0|||
131913654|NCT01963611|474971349|FG003|Overall Study|Lack of Efficacy|1|||
131913655|NCT01963611|474971350|FG004|Overall Study|Lack of Efficacy|0|||
131913656|NCT01963611|474971346|FG000|Overall Study|Withdrawal by Subject|3|||
131913657|NCT01963611|474971347|FG001|Overall Study|Withdrawal by Subject|2|||
131913658|NCT01963611|474971348|FG002|Overall Study|Withdrawal by Subject|1|||
131913659|NCT01963611|474971349|FG003|Overall Study|Withdrawal by Subject|1|||
131913660|NCT01963611|474971350|FG004|Overall Study|Withdrawal by Subject|3|||
131913661|NCT01963611|474971346|FG000|Overall Study|Other|47|||
131913662|NCT01963611|474971347|FG001|Overall Study|Other|46|||
131913663|NCT01963611|474971348|FG002|Overall Study|Other|48|||
131913664|NCT01963611|474971349|FG003|Overall Study|Other|45|||
131913665|NCT01963611|474971350|FG004|Overall Study|Other|45|||
131913666|NCT01126424|474971351|FG000|Overall Study|Adverse Event|0|||
131913667|NCT01126424|474971352|FG001|Overall Study|Adverse Event|0|||
131913668|NCT01126424|474971353|FG002|Overall Study|Adverse Event|0|||
131913669|NCT01126424|474971354|FG003|Overall Study|Adverse Event|0|||
131913670|NCT01126424|474971355|FG004|Overall Study|Adverse Event|1|||
131913671|NCT01126424|474971356|FG005|Overall Study|Adverse Event|0|||
131913672|NCT01126424|474971351|FG000|Overall Study|Withdrawal by Subject|0|||
131913673|NCT01126424|474971352|FG001|Overall Study|Withdrawal by Subject|0|||
131913674|NCT01126424|474971353|FG002|Overall Study|Withdrawal by Subject|1|||
131913675|NCT01126424|474971354|FG003|Overall Study|Withdrawal by Subject|3|||
131913676|NCT01126424|474971355|FG004|Overall Study|Withdrawal by Subject|1|||
131913677|NCT01126424|474971356|FG005|Overall Study|Withdrawal by Subject|0|||
131913678|NCT03801252|474971358|FG000|Overall Study|Protocol Violation|1|||
131913679|NCT03801252|474971359|FG001|Overall Study|Protocol Violation|2|||
131913680|NCT02328105|474971363|FG000|Overall Study|Death|6|||
131913681|NCT02328105|474971363|FG000|Overall Study|Withdrawal by Subject|1|||
131913682|NCT02328105|474971363|FG000|Overall Study|Still On Study in Follow-Up|4|||
131913683|NCT01588509|474971367|FG000|Overall Study|Lost to Follow-up|1|||
131913684|NCT01588509|474971368|FG001|Overall Study|Lost to Follow-up|0|||
131913685|NCT03345004|474971369|FG000|Overall Study|Physician Decision|1|||
131913686|NCT03345004|474971370|FG001|Overall Study|Physician Decision|0|||
131913687|NCT03345004|474971369|FG000|Overall Study|Withdrawal by Subject|0|||
131913688|NCT03345004|474971370|FG001|Overall Study|Withdrawal by Subject|1|||
131913689|NCT01983930|474971371|FG000|Overall Study|Withdrawal by Subject|9|||
131913690|NCT01983930|474971372|FG001|Overall Study|Withdrawal by Subject|8|||
131913691|NCT01983930|474971371|FG000|Overall Study|Adverse Event|0|||
131913692|NCT01983930|474971372|FG001|Overall Study|Adverse Event|1|||
131913693|NCT00393367|474971373|FG000|Overall Study|Protocol Violation|2|||
131913694|NCT00393367|474971374|FG001|Overall Study|Protocol Violation|5|||
131913695|NCT00393367|474971373|FG000|Overall Study|Withdrawal by Subject|0|||
131913696|NCT00393367|474971374|FG001|Overall Study|Withdrawal by Subject|2|||
131913697|NCT03286504|474971375|FG000|Overall Study|Lost to Follow-up|19|||
131913698|NCT03286504|474971376|FG001|Overall Study|Lost to Follow-up|16|||
131913699|NCT01432327|474971377|FG000|Posttest 3 Months|depression|3|||
131913700|NCT01432327|474971378|FG001|Posttest 3 Months|depression|0|||
131913701|NCT01432327|474971379|FG002|Posttest 3 Months|depression|0|||
131913702|NCT01432327|474971380|FG003|Posttest 3 Months|depression|0|||
131913703|NCT01432327|474971377|FG000|Posttest 3 Months|Lost to Follow-up|1|||
131913704|NCT01432327|474971378|FG001|Posttest 3 Months|Lost to Follow-up|0|||
131913705|NCT01432327|474971379|FG002|Posttest 3 Months|Lost to Follow-up|2|||
131913706|NCT01432327|474971380|FG003|Posttest 3 Months|Lost to Follow-up|1|||
131913707|NCT01432327|474971377|FG000|Posttest 3 Months|Allergic reaction|0|||
131913708|NCT01432327|474971378|FG001|Posttest 3 Months|Allergic reaction|2|||
131913709|NCT01432327|474971379|FG002|Posttest 3 Months|Allergic reaction|0|||
131913710|NCT01432327|474971380|FG003|Posttest 3 Months|Allergic reaction|0|||
131913711|NCT01432327|474971377|FG000|Posttest 6 Months|Lost to Follow-up|0|||
131913712|NCT01432327|474971378|FG001|Posttest 6 Months|Lost to Follow-up|0|||
131913713|NCT01432327|474971379|FG002|Posttest 6 Months|Lost to Follow-up|3|||
131913714|NCT01432327|474971380|FG003|Posttest 6 Months|Lost to Follow-up|2|||
131913715|NCT01432327|474971377|FG000|Posttest 6 Months|Allergic reaction|0|||
131913716|NCT01432327|474971378|FG001|Posttest 6 Months|Allergic reaction|0|||
131913717|NCT01432327|474971379|FG002|Posttest 6 Months|Allergic reaction|1|||
131913718|NCT01432327|474971380|FG003|Posttest 6 Months|Allergic reaction|0|||
131913719|NCT01432327|474971377|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
131913720|NCT01432327|474971378|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
131913721|NCT01432327|474971379|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
131913722|NCT01432327|474971380|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
131913723|NCT01432327|474971377|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
131913724|NCT01432327|474971378|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
131913725|NCT01432327|474971379|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
131913726|NCT01432327|474971380|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
131913727|NCT01432327|474971377|FG000|Posttest 1 Year|Lost to Follow-up|0|||
131913728|NCT01432327|474971378|FG001|Posttest 1 Year|Lost to Follow-up|0|||
131913729|NCT01432327|474971379|FG002|Posttest 1 Year|Lost to Follow-up|4|||
131913730|NCT01432327|474971380|FG003|Posttest 1 Year|Lost to Follow-up|2|||
131913731|NCT01432327|474971377|FG000|Posttest 1 Year|Allergic reaction|0|||
131913732|NCT01432327|474971378|FG001|Posttest 1 Year|Allergic reaction|0|||
131913733|NCT01432327|474971379|FG002|Posttest 1 Year|Allergic reaction|1|||
131913734|NCT01432327|474971380|FG003|Posttest 1 Year|Allergic reaction|1|||
131913735|NCT00141921|474971383|FG000|Overall Study|Remain on Study|28|||
131913736|NCT00141921|474971383|FG000|Overall Study|Withdrawal by Subject|42|||
131913737|NCT00141921|474971383|FG000|Overall Study|Lost to Follow-up|19|||
131913738|NCT00141921|474971383|FG000|Overall Study|Noncompliance|17|||
131913739|NCT00141921|474971383|FG000|Overall Study|Disease Progression|7|||
131913740|NCT00141921|474971383|FG000|Overall Study|Protocol Deviation|7|||
131913741|NCT00141921|474971383|FG000|Overall Study|Adverse Event|5|||
131913742|NCT00141921|474971383|FG000|Overall Study|Administrative Decision|2|||
131913743|NCT00141921|474971383|FG000|Overall Study|Pregnancy|4|||
131913744|NCT00141921|474971383|FG000|Overall Study|Ineligibility Determined|2|||
131913745|NCT00141921|474971383|FG000|Overall Study|Other|8|||
131913746|NCT02030600|474971386|FG000|Treatment Period 1|Adverse Event|5|||
131913747|NCT02030600|474971387|FG001|Treatment Period 1|Adverse Event|7|||
131913748|NCT02030600|474971386|FG000|Treatment Period 1|Lack of Efficacy|0|||
131913749|NCT02030600|474971387|FG001|Treatment Period 1|Lack of Efficacy|1|||
131913750|NCT02030600|474971386|FG000|Treatment Period 1|Lost to Follow-up|11|||
131913751|NCT02030600|474971387|FG001|Treatment Period 1|Lost to Follow-up|3|||
131913752|NCT02030600|474971386|FG000|Treatment Period 1|Protocol Violation|22|||
131913753|NCT02030600|474971387|FG001|Treatment Period 1|Protocol Violation|17|||
131913754|NCT02030600|474971386|FG000|Treatment Period 1|Withdrawal by Subject|13|||
131913755|NCT02030600|474971387|FG001|Treatment Period 1|Withdrawal by Subject|17|||
131913756|NCT02030600|474971386|FG000|Treatment Period 1|Casebook Unsigned|1|||
131913757|NCT02030600|474971387|FG001|Treatment Period 1|Casebook Unsigned|0|||
131913758|NCT02030600|474971386|FG000|Treatment Period 1|Unclassified|1|||
131913759|NCT02030600|474971387|FG001|Treatment Period 1|Unclassified|0|||
131913760|NCT02030600|474971386|FG000|Treatment Period 2|Adverse Event|4|||
131913761|NCT02030600|474971387|FG001|Treatment Period 2|Adverse Event|4|||
131913762|NCT02030600|474971386|FG000|Treatment Period 2|Lack of Efficacy|2|||
131913763|NCT02030600|474971387|FG001|Treatment Period 2|Lack of Efficacy|1|||
131913764|NCT02030600|474971386|FG000|Treatment Period 2|Lost to Follow-up|4|||
131913765|NCT02030600|474971387|FG001|Treatment Period 2|Lost to Follow-up|2|||
131913766|NCT02030600|474971386|FG000|Treatment Period 2|Protocol Violation|1|||
131913767|NCT02030600|474971387|FG001|Treatment Period 2|Protocol Violation|2|||
131913768|NCT02030600|474971386|FG000|Treatment Period 2|Withdrawal by Subject|13|||
131913769|NCT02030600|474971387|FG001|Treatment Period 2|Withdrawal by Subject|9|||
131913770|NCT02030600|474971386|FG000|Treatment Period 2|Unclassified|1|||
131913771|NCT02030600|474971387|FG001|Treatment Period 2|Unclassified|0|||
131913772|NCT01155323|474971388|FG000|First Intervention|exclusion criteria|1|||
131913773|NCT01155323|474971389|FG001|First Intervention|exclusion criteria|1|||
131913774|NCT01155323|474971388|FG000|Second Intervention|Lost to Follow-up|1|||
131913775|NCT01155323|474971389|FG001|Second Intervention|Lost to Follow-up|1|||
131913776|NCT02471339|474971391|FG000|Overall Study|Did not provide follow-up data|2|||
131913777|NCT02471339|474971392|FG001|Overall Study|Did not provide follow-up data|0|||
131913778|NCT00626639|474971400|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
131913779|NCT00626639|474971401|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
131913780|NCT00303186|474971402|FG000|Overall Study|Other|52|||
131913781|NCT00785629|474971406|FG000|Overall Study|Adverse Event|2|||
131913782|NCT00785629|474971407|FG001|Overall Study|Adverse Event|1|||
131913783|NCT00785629|474971408|FG002|Overall Study|Adverse Event|1|||
131913784|NCT00785629|474971409|FG003|Overall Study|Adverse Event|5|||
131913785|NCT00785629|474971406|FG000|Overall Study|Protocol Violation|1|||
131913786|NCT00785629|474971407|FG001|Overall Study|Protocol Violation|2|||
131913787|NCT00785629|474971408|FG002|Overall Study|Protocol Violation|4|||
131913788|NCT00785629|474971409|FG003|Overall Study|Protocol Violation|5|||
131913789|NCT00785629|474971406|FG000|Overall Study|administrative decision|5|||
131913790|NCT00785629|474971407|FG001|Overall Study|administrative decision|1|||
131913791|NCT00785629|474971408|FG002|Overall Study|administrative decision|3|||
131913792|NCT00785629|474971409|FG003|Overall Study|administrative decision|4|||
131913793|NCT00785629|474971406|FG000|Overall Study|Withdrawal by Subject|0|||
131913794|NCT00785629|474971407|FG001|Overall Study|Withdrawal by Subject|1|||
131913795|NCT00785629|474971408|FG002|Overall Study|Withdrawal by Subject|2|||
131913796|NCT00785629|474971409|FG003|Overall Study|Withdrawal by Subject|2|||
131913797|NCT02326883|474971411|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
131913798|NCT02326883|474971412|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
131913799|NCT02326883|474971413|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
131913800|NCT00937950|474971414|FG000|Overall Study|Withdrawal by Subject|23|||
131913801|NCT00937950|474971414|FG000|Overall Study|Migrated/moved from study area|27|||
131913802|NCT00937950|474971414|FG000|Overall Study|Lost to Follow-up|144|||
131913803|NCT00937950|474971414|FG000|Overall Study|Missing confirmed|4|||
131913804|NCT00937950|474971414|FG000|Overall Study|Other|18|||
131913805|NCT01137786|474971415|FG000|Overall Study|Lost to Follow-up|0|||
131913806|NCT01137786|474971416|FG001|Overall Study|Lost to Follow-up|2|||
131913807|NCT01137786|474971415|FG000|Overall Study|Withdrawal by Subject|1|||
131913808|NCT01137786|474971416|FG001|Overall Study|Withdrawal by Subject|1|||
131913809|NCT00460798|474971418|FG000|Overall Study|Death|59|||
131913810|NCT00460798|474971418|FG000|Overall Study|Adverse Event|27|||
131913811|NCT00460798|474971418|FG000|Overall Study|Lost to Follow-up|19|||
131913812|NCT00460798|474971418|FG000|Overall Study|Progressive Disease|99|||
131913813|NCT00460798|474971418|FG000|Overall Study|Other|27|||
131913814|NCT00460798|474971418|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
131913815|NCT00460798|474971418|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
131913816|NCT01898130|474971419|FG000|Treatment|Withdrawal by Subject|2|||
131913817|NCT01898130|474971419|FG000|Treatment|Progressive Disease|4|||
131913818|NCT01898130|474971419|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
131913819|NCT01281306|474971423|FG000|Overall Study|Lack of Efficacy|0|||
131913820|NCT01281306|474971424|FG001|Overall Study|Lack of Efficacy|1|||
131913821|NCT01281306|474971425|FG002|Overall Study|Lack of Efficacy|3|||
131913822|NCT01281306|474971426|FG003|Overall Study|Lack of Efficacy|0|||
131913823|NCT01281306|474971427|FG004|Overall Study|Lack of Efficacy|2|||
131913824|NCT01281306|474971428|FG005|Overall Study|Lack of Efficacy|0|||
131913825|NCT01281306|474971429|FG006|Overall Study|Lack of Efficacy|1|||
131913826|NCT01281306|474971423|FG000|Overall Study|Withdrawal by Subject|1|||
131913827|NCT01281306|474971424|FG001|Overall Study|Withdrawal by Subject|0|||
131913828|NCT01281306|474971425|FG002|Overall Study|Withdrawal by Subject|2|||
131913829|NCT01281306|474971426|FG003|Overall Study|Withdrawal by Subject|4|||
131913830|NCT01281306|474971427|FG004|Overall Study|Withdrawal by Subject|1|||
131913831|NCT01281306|474971428|FG005|Overall Study|Withdrawal by Subject|3|||
131913832|NCT01281306|474971429|FG006|Overall Study|Withdrawal by Subject|1|||
131913833|NCT01281306|474971423|FG000|Overall Study|Protocol deviation|0|||
131913834|NCT01281306|474971424|FG001|Overall Study|Protocol deviation|1|||
131913835|NCT01281306|474971425|FG002|Overall Study|Protocol deviation|1|||
131913836|NCT01281306|474971426|FG003|Overall Study|Protocol deviation|1|||
131913837|NCT01281306|474971427|FG004|Overall Study|Protocol deviation|1|||
131913838|NCT01281306|474971428|FG005|Overall Study|Protocol deviation|0|||
131913839|NCT01281306|474971429|FG006|Overall Study|Protocol deviation|0|||
131913840|NCT01281306|474971423|FG000|Overall Study|Condition no longer requires study drug|1|||
131862458|NCT02764762|474776319|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
131862459|NCT02764762|474776319|FG000|Overall Study|Lost to Follow-up|4|||
131862460|NCT02764762|474776319|FG000|Overall Study|Voluntary Withdrawal|8|||
131862461|NCT02764762|474776319|FG000|Overall Study|Site Termination|1|||
131862462|NCT02764762|474776319|FG000|Overall Study|Lack of Efficacy|16|||
131862463|NCT02764762|474776319|FG000|Overall Study|Reason not Specified|1|||
131862464|NCT01103180|474776320|FG000|Overall Study|Withdrawal by Subject|8|||
131862465|NCT01103180|474776321|FG001|Overall Study|Withdrawal by Subject|13|||
131862466|NCT01103180|474776320|FG000|Overall Study|Lost to Follow-up|13|||
131862467|NCT01103180|474776321|FG001|Overall Study|Lost to Follow-up|7|||
131862468|NCT01103180|474776320|FG000|Overall Study|Physician Decision|1|||
131862469|NCT01103180|474776321|FG001|Overall Study|Physician Decision|0|||
131862470|NCT01103180|474776320|FG000|Overall Study|Protocol Violation|0|||
131862471|NCT01103180|474776321|FG001|Overall Study|Protocol Violation|1|||
131862472|NCT02717507|474776322|FG000|Overall Study|Lost to Follow-up|5|||
131913841|NCT01281306|474971424|FG001|Overall Study|Condition no longer requires study drug|0|||
131913842|NCT01281306|474971425|FG002|Overall Study|Condition no longer requires study drug|0|||
131862473|NCT02717507|474776323|FG001|Overall Study|Lost to Follow-up|8|||
131862474|NCT02717507|474776322|FG000|Overall Study|Pregnancy|1|||
131862475|NCT02717507|474776323|FG001|Overall Study|Pregnancy|1|||
131913843|NCT01281306|474971426|FG003|Overall Study|Condition no longer requires study drug|0|||
131913844|NCT01281306|474971427|FG004|Overall Study|Condition no longer requires study drug|0|||
131862476|NCT02717507|474776322|FG000|Overall Study|Protocol Violation|2|||
131913845|NCT01281306|474971428|FG005|Overall Study|Condition no longer requires study drug|1|||
131913846|NCT01281306|474971429|FG006|Overall Study|Condition no longer requires study drug|1|||
131913847|NCT01281306|474971423|FG000|Overall Study|Lost to Follow-up|1|||
131913848|NCT01281306|474971424|FG001|Overall Study|Lost to Follow-up|0|||
131913849|NCT01281306|474971425|FG002|Overall Study|Lost to Follow-up|0|||
131862477|NCT02717507|474776323|FG001|Overall Study|Protocol Violation|2|||
131862478|NCT02717507|474776322|FG000|Overall Study|Withdrawal by Subject|20|||
131862479|NCT02717507|474776323|FG001|Overall Study|Withdrawal by Subject|20|||
131862480|NCT02717507|474776322|FG000|Overall Study|Relapse|1|||
131862481|NCT02717507|474776323|FG001|Overall Study|Relapse|1|||
131862482|NCT02717507|474776322|FG000|Overall Study|Cardiac Event|2|||
131862483|NCT02717507|474776323|FG001|Overall Study|Cardiac Event|6|||
131862484|NCT01439802|474776324|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
131862485|NCT01439802|474776324|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
131862486|NCT01998919|474776332|FG000|Overall Study|Death|2|||
131862487|NCT01998919|474776333|FG001|Overall Study|Death|2|||
131862488|NCT01998919|474776332|FG000|Overall Study|Adverse Event|0|||
131862489|NCT01998919|474776333|FG001|Overall Study|Adverse Event|5|||
131862490|NCT01998919|474776332|FG000|Overall Study|Disease progression|31|||
131862491|NCT01998919|474776333|FG001|Overall Study|Disease progression|22|||
131862492|NCT01998919|474776332|FG000|Overall Study|Withdrawal by Subject|2|||
131862493|NCT01998919|474776333|FG001|Overall Study|Withdrawal by Subject|4|||
131862494|NCT01998919|474776332|FG000|Overall Study|Lost to Follow-up|2|||
131862495|NCT01998919|474776333|FG001|Overall Study|Lost to Follow-up|0|||
131862496|NCT01998919|474776332|FG000|Overall Study|Other|5|||
131862497|NCT01998919|474776333|FG001|Overall Study|Other|2|||
131862498|NCT01068860|474776334|FG000|Overall Study|Withdrawal by Subject|0|||
131862499|NCT01068860|474776335|FG001|Overall Study|Withdrawal by Subject|0|||
131862500|NCT01068860|474776336|FG002|Overall Study|Withdrawal by Subject|0|||
131862501|NCT01068860|474776337|FG003|Overall Study|Withdrawal by Subject|0|||
131862502|NCT01068860|474776338|FG004|Overall Study|Withdrawal by Subject|0|||
131862503|NCT01068860|474776339|FG005|Overall Study|Withdrawal by Subject|2|||
131862504|NCT01068860|474776340|FG006|Overall Study|Withdrawal by Subject|0|||
131862505|NCT01068860|474776341|FG007|Overall Study|Withdrawal by Subject|0|||
131862506|NCT01068860|474776342|FG008|Overall Study|Withdrawal by Subject|0|||
131862507|NCT01068860|474776343|FG009|Overall Study|Withdrawal by Subject|3|||
131862508|NCT01068860|474776334|FG000|Overall Study|Administrative problems; misrandomized|0|||
131862509|NCT01068860|474776335|FG001|Overall Study|Administrative problems; misrandomized|0|||
131862510|NCT01068860|474776336|FG002|Overall Study|Administrative problems; misrandomized|0|||
131862511|NCT01068860|474776337|FG003|Overall Study|Administrative problems; misrandomized|1|||
131862512|NCT01068860|474776338|FG004|Overall Study|Administrative problems; misrandomized|0|||
131862513|NCT01068860|474776339|FG005|Overall Study|Administrative problems; misrandomized|0|||
131862514|NCT01068860|474776340|FG006|Overall Study|Administrative problems; misrandomized|0|||
131862515|NCT01068860|474776341|FG007|Overall Study|Administrative problems; misrandomized|0|||
131862516|NCT01068860|474776342|FG008|Overall Study|Administrative problems; misrandomized|0|||
131862517|NCT01068860|474776343|FG009|Overall Study|Administrative problems; misrandomized|1|||
131862518|NCT01068860|474776334|FG000|Overall Study|Lost to Follow-up|0|||
131862519|NCT01068860|474776335|FG001|Overall Study|Lost to Follow-up|1|||
131862520|NCT01068860|474776336|FG002|Overall Study|Lost to Follow-up|0|||
131862521|NCT01068860|474776337|FG003|Overall Study|Lost to Follow-up|0|||
131862522|NCT01068860|474776338|FG004|Overall Study|Lost to Follow-up|0|||
131862523|NCT01068860|474776339|FG005|Overall Study|Lost to Follow-up|0|||
131862524|NCT01068860|474776340|FG006|Overall Study|Lost to Follow-up|0|||
131862525|NCT01068860|474776341|FG007|Overall Study|Lost to Follow-up|0|||
131862526|NCT01068860|474776342|FG008|Overall Study|Lost to Follow-up|0|||
131862527|NCT01068860|474776343|FG009|Overall Study|Lost to Follow-up|0|||
131862528|NCT01321879|474776347|FG000|Overall Study|Lack of Efficacy|5|||
131862529|NCT01321879|474776347|FG000|Overall Study|Adverse Event|5|||
131862530|NCT01321879|474776347|FG000|Overall Study|Death|3|||
131862531|NCT01321879|474776347|FG000|Overall Study|Withdrawal by Subject|1|||
131913850|NCT01281306|474971426|FG003|Overall Study|Lost to Follow-up|2|||
131913851|NCT01281306|474971427|FG004|Overall Study|Lost to Follow-up|0|||
131913852|NCT01281306|474971428|FG005|Overall Study|Lost to Follow-up|0|||
131862532|NCT00897715|474776348|FG000|Overall Study|Lost to Follow-up|0|||
131408090|NCT02374814|473115347|FG002|Overall Study|Lost to Follow-up|0|||
131408091|NCT02374814|473115348|FG003|Overall Study|Lost to Follow-up|1|||
131862533|NCT00897715|474776349|FG001|Overall Study|Lost to Follow-up|1|||
131862534|NCT00897715|474776348|FG000|Overall Study|Physician Decision|1|||
131862535|NCT00897715|474776349|FG001|Overall Study|Physician Decision|0|||
131862536|NCT00897715|474776348|FG000|Overall Study|increased risk of infection|1|||
131862537|NCT00897715|474776349|FG001|Overall Study|increased risk of infection|0|||
131862538|NCT00513240|474776351|FG000|Overall Study|Did not have intended surgery|3|||
131862539|NCT00513240|474776352|FG001|Overall Study|Did not have intended surgery|0|||
131862540|NCT00513240|474776351|FG000|Overall Study|Death|3|||
131913853|NCT01281306|474971429|FG006|Overall Study|Lost to Follow-up|1|||
131913854|NCT01281306|474971423|FG000|Overall Study|Death|1|||
131408092|NCT02374814|473115349|FG004|Overall Study|Lost to Follow-up|0|||
131913855|NCT01281306|474971424|FG001|Overall Study|Death|0|||
131913856|NCT01281306|474971425|FG002|Overall Study|Death|0|||
131913857|NCT01281306|474971426|FG003|Overall Study|Death|0|||
131913858|NCT01281306|474971427|FG004|Overall Study|Death|0|||
131913859|NCT01281306|474971428|FG005|Overall Study|Death|0|||
131913860|NCT01281306|474971429|FG006|Overall Study|Death|0|||
131862541|NCT00513240|474776352|FG001|Overall Study|Death|3|||
131862542|NCT00513240|474776351|FG000|Overall Study|Withdrawal by Subject|7|||
131862543|NCT00513240|474776352|FG001|Overall Study|Withdrawal by Subject|4|||
131862544|NCT05263908|474776353|FG000|Overall Study|No informed consent for publication of study results|397|||
131862545|NCT05263908|474776353|FG000|Overall Study|CRF not collected|1|||
131862546|NCT01641640|474776354|FG000|Overall Study|Enrolled but not treated|1|||
131862547|NCT01641640|474776354|FG000|Overall Study|Efficacy failure|29|||
131862548|NCT01641640|474776354|FG000|Overall Study|Lost to Follow-up|3|||
131862549|NCT01641640|474776354|FG000|Overall Study|Withdrawal by Subject|2|||
131862550|NCT01641640|474776354|FG000|Overall Study|Adverse Event|1|||
131862551|NCT01234350|474776356|FG000|Overall Study|Adverse Event|277|||
131862552|NCT01234350|474776357|FG001|Overall Study|Adverse Event|92|||
131862553|NCT01234350|474776356|FG000|Overall Study|Withdrawal by Subject|61|||
131862554|NCT01234350|474776357|FG001|Overall Study|Withdrawal by Subject|36|||
131862555|NCT01234350|474776356|FG000|Overall Study|Lost to Follow-up|115|||
131862556|NCT01234350|474776357|FG001|Overall Study|Lost to Follow-up|47|||
131862557|NCT01234350|474776356|FG000|Overall Study|Covers a diverse set of reasons|234|||
131862558|NCT01234350|474776357|FG001|Overall Study|Covers a diverse set of reasons|92|||
131862559|NCT01930162|474776360|FG000|Overall Study|Abnormal test procedure result(s)|4|||
131862560|NCT01930162|474776360|FG000|Overall Study|Death|1|||
131862561|NCT01836471|474776367|FG000|Overall Study|Pregnancy|1|||
131862562|NCT01836471|474776368|FG001|Overall Study|Pregnancy|0|||
131862563|NCT01836471|474776369|FG002|Overall Study|Pregnancy|0|||
131862564|NCT01836471|474776370|FG003|Overall Study|Pregnancy|0|||
131862565|NCT01836471|474776371|FG004|Overall Study|Pregnancy|0|||
131862566|NCT01836471|474776367|FG000|Overall Study|Withdrawal by Subject|3|||
131862567|NCT01836471|474776368|FG001|Overall Study|Withdrawal by Subject|4|||
131862568|NCT01836471|474776369|FG002|Overall Study|Withdrawal by Subject|1|||
131862569|NCT01836471|474776370|FG003|Overall Study|Withdrawal by Subject|0|||
131862570|NCT01836471|474776371|FG004|Overall Study|Withdrawal by Subject|2|||
131862571|NCT01836471|474776367|FG000|Overall Study|Physician Decision|0|||
131862572|NCT01836471|474776368|FG001|Overall Study|Physician Decision|1|||
131862573|NCT01836471|474776369|FG002|Overall Study|Physician Decision|0|||
131862574|NCT01836471|474776370|FG003|Overall Study|Physician Decision|0|||
131862575|NCT01836471|474776371|FG004|Overall Study|Physician Decision|0|||
131862576|NCT01836471|474776367|FG000|Overall Study|Lost to Follow-up|0|||
131862577|NCT01836471|474776368|FG001|Overall Study|Lost to Follow-up|0|||
131862578|NCT01836471|474776369|FG002|Overall Study|Lost to Follow-up|0|||
131862579|NCT01836471|474776370|FG003|Overall Study|Lost to Follow-up|1|||
131862580|NCT01836471|474776371|FG004|Overall Study|Lost to Follow-up|1|||
131862581|NCT01836471|474776367|FG000|Overall Study|Adverse Event|6|||
131862582|NCT01836471|474776368|FG001|Overall Study|Adverse Event|3|||
131862583|NCT01836471|474776369|FG002|Overall Study|Adverse Event|1|||
131862584|NCT01836471|474776370|FG003|Overall Study|Adverse Event|1|||
131862585|NCT01836471|474776371|FG004|Overall Study|Adverse Event|2|||
131862586|NCT01836471|474776367|FG000|Overall Study|Non compliance with tx|1|||
131862587|NCT01836471|474776368|FG001|Overall Study|Non compliance with tx|1|||
131862588|NCT01836471|474776369|FG002|Overall Study|Non compliance with tx|0|||
131862589|NCT01836471|474776370|FG003|Overall Study|Non compliance with tx|0|||
131862590|NCT01836471|474776371|FG004|Overall Study|Non compliance with tx|0|||
131862591|NCT02285361|474776374|FG000|Overall Study|Protocol Violation|43|||
131862592|NCT02285361|474776374|FG000|Overall Study|Lost to Follow-up|5|||
131862593|NCT02285361|474776374|FG000|Overall Study|Not taken GIOTRIF|2|||
131862594|NCT02285361|474776374|FG000|Overall Study|Consented prior to the contract date|1|||
131913861|NCT01281306|474971423|FG000|Overall Study|Adverse Event|3|||
131913862|NCT01281306|474971424|FG001|Overall Study|Adverse Event|2|||
131862595|NCT03776357|474776377|FG000|Overall Study|Lost to Follow-up|3|||
131862596|NCT02755103|474776382|FG000|Overall Study|Lost to Follow-up|17|||
131862597|NCT02755103|474776383|FG001|Overall Study|Lost to Follow-up|15|||
131862598|NCT02755103|474776382|FG000|Overall Study|Death|0|||
131862599|NCT02755103|474776383|FG001|Overall Study|Death|1|||
131862600|NCT02755103|474776382|FG000|Overall Study|Physician Decision|0|||
131913863|NCT01281306|474971425|FG002|Overall Study|Adverse Event|2|||
131913864|NCT01281306|474971426|FG003|Overall Study|Adverse Event|3|||
131862601|NCT02755103|474776383|FG001|Overall Study|Physician Decision|1|||
131862602|NCT02755103|474776382|FG000|Overall Study|Pregnancy|0|||
131862603|NCT02755103|474776383|FG001|Overall Study|Pregnancy|1|||
131862604|NCT02755103|474776382|FG000|Overall Study|Withdrawal by Subject|3|||
131862605|NCT02755103|474776383|FG001|Overall Study|Withdrawal by Subject|0|||
131862606|NCT00658723|474776387|FG000|Overall Study|Lost to Follow-up|0|||
131862607|NCT00658723|474776388|FG001|Overall Study|Lost to Follow-up|2|||
131862608|NCT00658723|474776389|FG002|Overall Study|Lost to Follow-up|2|||
131862609|NCT00658723|474776387|FG000|Overall Study|Death|2|||
131913865|NCT01281306|474971427|FG004|Overall Study|Adverse Event|5|||
131913866|NCT01281306|474971428|FG005|Overall Study|Adverse Event|3|||
131913867|NCT01281306|474971429|FG006|Overall Study|Adverse Event|3|||
131913868|NCT01281306|474971423|FG000|Overall Study|Randomized in error|1|||
131913869|NCT01281306|474971424|FG001|Overall Study|Randomized in error|0|||
131913870|NCT01281306|474971425|FG002|Overall Study|Randomized in error|0|||
131913871|NCT01281306|474971426|FG003|Overall Study|Randomized in error|1|||
131913872|NCT01281306|474971427|FG004|Overall Study|Randomized in error|0|||
131913873|NCT01281306|474971428|FG005|Overall Study|Randomized in error|0|||
131913874|NCT01281306|474971429|FG006|Overall Study|Randomized in error|0|||
131913875|NCT02320396|474971430|FG000|Overall Study|Adverse Event|2|||
131913876|NCT02320396|474971431|FG001|Overall Study|Adverse Event|2|||
131913877|NCT02320396|474971430|FG000|Overall Study|Pregnancy|0|||
131913878|NCT02320396|474971431|FG001|Overall Study|Pregnancy|1|||
131913879|NCT02320396|474971430|FG000|Overall Study|Protocol Violation|0|||
131913880|NCT02320396|474971431|FG001|Overall Study|Protocol Violation|1|||
131913881|NCT02320396|474971430|FG000|Overall Study|Withdrawal by Subject|2|||
131913882|NCT02320396|474971431|FG001|Overall Study|Withdrawal by Subject|0|||
131913883|NCT02606253|474971432|FG000|Overall Study|Adverse Event|2|||
131913884|NCT02606253|474971433|FG001|Overall Study|Adverse Event|0|||
131913885|NCT02606253|474971434|FG002|Overall Study|Adverse Event|0|||
131913886|NCT02606253|474971432|FG000|Overall Study|Protocol Violation|2|||
131913887|NCT02606253|474971433|FG001|Overall Study|Protocol Violation|1|||
131913888|NCT02606253|474971434|FG002|Overall Study|Protocol Violation|0|||
131913889|NCT02606253|474971432|FG000|Overall Study|Physician Decision|1|||
131913890|NCT02606253|474971433|FG001|Overall Study|Physician Decision|1|||
131913891|NCT02606253|474971434|FG002|Overall Study|Physician Decision|0|||
131913892|NCT03331562|474971437|FG000|Overall Study|Adverse Event|2|||
131913893|NCT03331562|474971438|FG001|Overall Study|Adverse Event|0|||
131913894|NCT03331562|474971437|FG000|Overall Study|Death|1|||
131913895|NCT03331562|474971438|FG001|Overall Study|Death|0|||
131913896|NCT03718000|474971439|FG000|Overall Study|Relocation|2|||
131913897|NCT03718000|474971440|FG001|Overall Study|Relocation|4|||
131913898|NCT03718000|474971439|FG000|Overall Study|Pregnancy|0|||
131913899|NCT03718000|474971440|FG001|Overall Study|Pregnancy|1|||
131913900|NCT02475213|474971441|FG000|Overall Study|Adverse Event|2|||
131913901|NCT02475213|474971442|FG001|Overall Study|Adverse Event|0|||
131913902|NCT02475213|474971443|FG002|Overall Study|Adverse Event|0|||
131913903|NCT02475213|474971444|FG003|Overall Study|Adverse Event|1|||
131913904|NCT02475213|474971445|FG004|Overall Study|Adverse Event|1|||
131913905|NCT02475213|474971446|FG005|Overall Study|Adverse Event|4|||
131913906|NCT02475213|474971447|FG006|Overall Study|Adverse Event|6|||
131913907|NCT02475213|474971448|FG007|Overall Study|Adverse Event|2|||
131913908|NCT02475213|474971441|FG000|Overall Study|Physician Decision|1|||
131913909|NCT02475213|474971442|FG001|Overall Study|Physician Decision|1|||
131913910|NCT02475213|474971443|FG002|Overall Study|Physician Decision|1|||
131913911|NCT02475213|474971444|FG003|Overall Study|Physician Decision|0|||
131862610|NCT00658723|474776388|FG001|Overall Study|Death|1|||
131862611|NCT00658723|474776389|FG002|Overall Study|Death|4|||
131862612|NCT00658723|474776387|FG000|Overall Study|Scheduling Issue|1|||
131862613|NCT00658723|474776388|FG001|Overall Study|Scheduling Issue|1|||
131862614|NCT00658723|474776389|FG002|Overall Study|Scheduling Issue|0|||
131862615|NCT00658723|474776387|FG000|Overall Study|Withdrawal by Subject|1|||
131862616|NCT00658723|474776388|FG001|Overall Study|Withdrawal by Subject|0|||
131862617|NCT00658723|474776389|FG002|Overall Study|Withdrawal by Subject|1|||
131862618|NCT02411656|474776390|FG000|Overall Study|Adverse Event|4|||
131862619|NCT02411656|474776390|FG000|Overall Study|Clinical Progression|33|||
131862620|NCT06481709|474776391|FG000|Overall Study|Withdrawal by Subject|0|||
131862621|NCT06481709|474776392|FG001|Overall Study|Withdrawal by Subject|0|||
131862622|NCT06481709|474776393|FG002|Overall Study|Withdrawal by Subject|2|||
131862623|NCT06481709|474776394|FG003|Overall Study|Withdrawal by Subject|0|||
131862624|NCT03305848|474776395|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
131862625|NCT03305848|474776395|FG000|Overall Study|Physician Decision|2|||
131862626|NCT00789854|474776398|FG000|Overall Study|Adverse Event|28|||
131862627|NCT00789854|474776399|FG001|Overall Study|Adverse Event|23|||
131913912|NCT02475213|474971445|FG004|Overall Study|Physician Decision|0|||
131913913|NCT02475213|474971446|FG005|Overall Study|Physician Decision|1|||
131913914|NCT02475213|474971447|FG006|Overall Study|Physician Decision|4|||
131913915|NCT02475213|474971448|FG007|Overall Study|Physician Decision|0|||
131913916|NCT02475213|474971441|FG000|Overall Study|Progressive Disease|3|||
131913917|NCT02475213|474971442|FG001|Overall Study|Progressive Disease|2|||
131913918|NCT02475213|474971443|FG002|Overall Study|Progressive Disease|2|||
131913919|NCT02475213|474971444|FG003|Overall Study|Progressive Disease|13|||
131913920|NCT02475213|474971445|FG004|Overall Study|Progressive Disease|15|||
131913921|NCT02475213|474971446|FG005|Overall Study|Progressive Disease|25|||
131862628|NCT00789854|474776400|FG002|Overall Study|Adverse Event|18|||
131862629|NCT00789854|474776398|FG000|Overall Study|Lost to Follow-up|1|||
131862630|NCT00789854|474776399|FG001|Overall Study|Lost to Follow-up|1|||
131862631|NCT00789854|474776400|FG002|Overall Study|Lost to Follow-up|4|||
131913922|NCT02475213|474971447|FG006|Overall Study|Progressive Disease|30|||
131913923|NCT02475213|474971448|FG007|Overall Study|Progressive Disease|10|||
131913924|NCT02475213|474971441|FG000|Overall Study|Death|0|||
131408093|NCT02374814|473115350|FG005|Overall Study|Lost to Follow-up|0|||
131862632|NCT00789854|474776398|FG000|Overall Study|Withdrawal by Subject|9|||
131862633|NCT00789854|474776399|FG001|Overall Study|Withdrawal by Subject|6|||
131862634|NCT00789854|474776400|FG002|Overall Study|Withdrawal by Subject|17|||
131862635|NCT00789854|474776398|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131862636|NCT00789854|474776399|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
131862637|NCT00789854|474776400|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
131862638|NCT00789854|474776398|FG000|Overall Study|Severe non-compliance to the protocol|3|||
131862639|NCT00789854|474776399|FG001|Overall Study|Severe non-compliance to the protocol|0|||
131862640|NCT00789854|474776400|FG002|Overall Study|Severe non-compliance to the protocol|0|||
131862641|NCT00789854|474776398|FG000|Overall Study|Safety reasons|0|||
131862642|NCT00789854|474776399|FG001|Overall Study|Safety reasons|0|||
131862643|NCT00789854|474776400|FG002|Overall Study|Safety reasons|2|||
131862644|NCT00789854|474776398|FG000|Overall Study|Other|6|||
131862645|NCT00789854|474776399|FG001|Overall Study|Other|0|||
131862646|NCT00789854|474776400|FG002|Overall Study|Other|5|||
131862647|NCT00923013|474776401|FG000|Overall Study|Refused further treatment|0|||
131862648|NCT00923013|474776402|FG001|Overall Study|Refused further treatment|1|||
131862649|NCT00923013|474776403|FG002|Overall Study|Refused further treatment|2|||
131862650|NCT00923013|474776404|FG003|Overall Study|Refused further treatment|0|||
131862651|NCT00923013|474776405|FG004|Overall Study|Refused further treatment|0|||
131862652|NCT00923013|474776406|FG005|Overall Study|Refused further treatment|0|||
131862653|NCT00923013|474776401|FG000|Overall Study|Switched to alternative treatment|0|||
131862654|NCT00923013|474776402|FG001|Overall Study|Switched to alternative treatment|1|||
131862655|NCT00923013|474776403|FG002|Overall Study|Switched to alternative treatment|0|||
131862656|NCT00923013|474776404|FG003|Overall Study|Switched to alternative treatment|0|||
131862657|NCT00923013|474776405|FG004|Overall Study|Switched to alternative treatment|0|||
131862658|NCT00923013|474776406|FG005|Overall Study|Switched to alternative treatment|0|||
131862659|NCT00923013|474776401|FG000|Overall Study|Death on study|2|||
131862660|NCT00923013|474776402|FG001|Overall Study|Death on study|2|||
131862661|NCT00923013|474776403|FG002|Overall Study|Death on study|0|||
131862662|NCT00923013|474776404|FG003|Overall Study|Death on study|1|||
131862663|NCT00923013|474776405|FG004|Overall Study|Death on study|0|||
131862664|NCT00923013|474776406|FG005|Overall Study|Death on study|0|||
131862665|NCT01060072|474776408|FG000|Overall Study|Adverse Event|1|||
131862666|NCT01060072|474776409|FG001|Overall Study|Adverse Event|1|||
131862667|NCT01060072|474776408|FG000|Overall Study|Physician Decision|0|||
131862668|NCT01060072|474776409|FG001|Overall Study|Physician Decision|2|||
131862669|NCT01060072|474776408|FG000|Overall Study|Protocol Violation|0|||
131862670|NCT01060072|474776409|FG001|Overall Study|Protocol Violation|1|||
131862671|NCT01060072|474776408|FG000|Overall Study|Acute cholecystitis|1|||
131862672|NCT01060072|474776409|FG001|Overall Study|Acute cholecystitis|0|||
131862673|NCT01060072|474776408|FG000|Overall Study|Excluded Medications|0|||
131862674|NCT01060072|474776409|FG001|Overall Study|Excluded Medications|1|||
131862675|NCT02857816|474776412|FG000|Overall Study|Screen Failure|33|||
131862676|NCT02857816|474776412|FG000|Overall Study|Withdrawal by Subject|4|||
131862677|NCT02857816|474776412|FG000|Overall Study|Lost to Follow-up|1|||
131862678|NCT01147068|474776413|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
131862679|NCT01147068|474776414|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
131862680|NCT01147068|474776415|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
131862681|NCT01147068|474776416|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
131862682|NCT01147068|474776417|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
131862683|NCT01147068|474776418|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
131862684|NCT01147068|474776419|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
131862685|NCT01147068|474776413|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
131862686|NCT01147068|474776414|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
131862687|NCT01147068|474776415|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
131862688|NCT01147068|474776416|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
131862689|NCT01147068|474776417|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
131862690|NCT01147068|474776418|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
131862691|NCT01147068|474776419|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
131862692|NCT01147068|474776413|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
131862693|NCT01147068|474776414|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
131862694|NCT01147068|474776415|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
131862695|NCT01147068|474776416|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
131408094|NCT02374814|473115345|FG000|Overall Study|Withdrawal by Subject|0|||
131408095|NCT02374814|473115346|FG001|Overall Study|Withdrawal by Subject|0|||
131862696|NCT01147068|474776417|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
131862697|NCT01147068|474776418|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
131862698|NCT01147068|474776419|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
131862699|NCT01147068|474776413|FG000|Subjects That Received 2nd Dose|Other|0|||
131862700|NCT01147068|474776414|FG001|Subjects That Received 2nd Dose|Other|3|||
131862701|NCT01147068|474776415|FG002|Subjects That Received 2nd Dose|Other|3|||
131862702|NCT01147068|474776416|FG003|Subjects That Received 2nd Dose|Other|0|||
131862703|NCT01147068|474776417|FG004|Subjects That Received 2nd Dose|Other|1|||
131862704|NCT01147068|474776418|FG005|Subjects That Received 2nd Dose|Other|0|||
131862705|NCT01147068|474776419|FG006|Subjects That Received 2nd Dose|Other|0|||
131862706|NCT01147068|474776413|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
131862707|NCT01147068|474776414|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
131862708|NCT01147068|474776415|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
131862709|NCT01147068|474776416|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
131862710|NCT01147068|474776417|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
131862711|NCT01147068|474776418|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
131862712|NCT01147068|474776419|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
131862713|NCT01147068|474776413|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
131862714|NCT01147068|474776414|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
131862715|NCT01147068|474776415|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
131862716|NCT01147068|474776416|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
131862717|NCT01147068|474776417|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
131862718|NCT01147068|474776418|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
131862719|NCT01147068|474776419|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
131862720|NCT01147068|474776413|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
131862721|NCT01147068|474776414|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
131862722|NCT01147068|474776415|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
131862723|NCT01147068|474776416|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
131862724|NCT01147068|474776417|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
131862725|NCT01147068|474776418|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
131862726|NCT01147068|474776419|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
131862727|NCT01597778|474776421|FG000|Overall Study|Death|7|||
131862728|NCT01597778|474776422|FG001|Overall Study|Death|10|||
131862729|NCT01597778|474776421|FG000|Overall Study|Withdrawal by Subject|3|||
131862730|NCT01597778|474776422|FG001|Overall Study|Withdrawal by Subject|4|||
131862731|NCT01597778|474776421|FG000|Overall Study|Adverse Event|1|||
131862732|NCT01597778|474776422|FG001|Overall Study|Adverse Event|1|||
131862733|NCT01597778|474776421|FG000|Overall Study|Protocol Violation|1|||
131862734|NCT01597778|474776422|FG001|Overall Study|Protocol Violation|11|||
131862735|NCT01597778|474776421|FG000|Overall Study|Transplanted off protocol|2|||
131862736|NCT01597778|474776422|FG001|Overall Study|Transplanted off protocol|3|||
131862737|NCT01522456|474776432|FG000|Overall Study|Adverse Event|2|||
131862738|NCT01522456|474776432|FG000|Overall Study|Lost to Follow-up|2|||
131862739|NCT01522456|474776432|FG000|Overall Study|Withdrawal by Subject|2|||
131862740|NCT01522456|474776432|FG000|Overall Study|Pregnancy|1|||
131862741|NCT01522456|474776432|FG000|Overall Study|Tolerability Assessment|1|||
131862742|NCT03918629|474776433|FG000|Overall Study|Adverse Event|19|||
131862743|NCT03918629|474776434|FG001|Overall Study|Adverse Event|20|||
131862744|NCT03918629|474776433|FG000|Overall Study|Death|14|||
131862745|NCT03918629|474776434|FG001|Overall Study|Death|7|||
131862746|NCT03918629|474776433|FG000|Overall Study|Lost to Follow-up|36|||
131862747|NCT03918629|474776434|FG001|Overall Study|Lost to Follow-up|28|||
131862748|NCT03918629|474776433|FG000|Overall Study|Physician Decision|1|||
131862749|NCT03918629|474776434|FG001|Overall Study|Physician Decision|0|||
131862750|NCT03918629|474776433|FG000|Overall Study|Protocol Violation|7|||
131862751|NCT03918629|474776434|FG001|Overall Study|Protocol Violation|4|||
131862752|NCT03918629|474776433|FG000|Overall Study|Withdrawal by Subject|47|||
131862753|NCT03918629|474776434|FG001|Overall Study|Withdrawal by Subject|47|||
131862754|NCT03918629|474776433|FG000|Overall Study|Other|7|||
131862755|NCT03918629|474776434|FG001|Overall Study|Other|11|||
131862756|NCT03918629|474776433|FG000|Overall Study|Randomized but not vaccinated|2|||
131862757|NCT03918629|474776434|FG001|Overall Study|Randomized but not vaccinated|1|||
131862758|NCT01709500|474776438|FG000|Overall Study|Randomized but not treated|0|||
131913925|NCT02475213|474971442|FG001|Overall Study|Death|0|||
131862759|NCT01709500|474776439|FG001|Overall Study|Randomized but not treated|1|||
131862760|NCT01709500|474776438|FG000|Overall Study|Adverse Event|5|||
131862761|NCT01709500|474776439|FG001|Overall Study|Adverse Event|1|||
131862762|NCT01709500|474776438|FG000|Overall Study|Poor compliance to protocol|2|||
131862763|NCT01709500|474776439|FG001|Overall Study|Poor compliance to protocol|1|||
131862764|NCT01709500|474776438|FG000|Overall Study|Other|3|||
131862765|NCT01709500|474776439|FG001|Overall Study|Other|1|||
131862766|NCT01709500|474776438|FG000|Overall Study|Related to IMP administration|1|||
131862767|NCT01709500|474776439|FG001|Overall Study|Related to IMP administration|0|||
131862768|NCT01709500|474776438|FG000|Overall Study|Treatment ongoing|156|||
131862769|NCT01709500|474776439|FG001|Overall Study|Treatment ongoing|78|||
131862770|NCT03832686|474776440|FG000|Overall Study|Lost to Follow-up|6|||
131862771|NCT03832686|474776441|FG001|Overall Study|Lost to Follow-up|9|||
131862772|NCT03832686|474776440|FG000|Overall Study|Discontinued Intervention|5|||
131913926|NCT02475213|474971443|FG002|Overall Study|Death|0|||
131913927|NCT02475213|474971444|FG003|Overall Study|Death|0|||
131862773|NCT03832686|474776441|FG001|Overall Study|Discontinued Intervention|4|||
131862774|NCT02810457|474778092|FG000|Overall Study|Randomised but no treatment received|2|||
131862775|NCT02810457|474778093|FG001|Overall Study|Randomised but no treatment received|1|||
131862776|NCT02810457|474778092|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
131862777|NCT02810457|474778093|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
131862778|NCT02810457|474778092|FG000|Overall Study|Adverse Event|37|||
131862779|NCT02810457|474778093|FG001|Overall Study|Adverse Event|43|||
131862780|NCT02810457|474778092|FG000|Overall Study|Patient decision|31|||
131862781|NCT02810457|474778093|FG001|Overall Study|Patient decision|35|||
131862782|NCT02810457|474778092|FG000|Overall Study|Patient lost to follow-up|2|||
131862783|NCT02810457|474778093|FG001|Overall Study|Patient lost to follow-up|2|||
131862784|NCT02810457|474778092|FG000|Overall Study|Death|39|||
131862785|NCT02810457|474778093|FG001|Overall Study|Death|28|||
131862786|NCT02810457|474778092|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
131862787|NCT02810457|474778093|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
131862788|NCT02810457|474778092|FG000|Overall Study|Clinical progression|15|||
131862789|NCT02810457|474778093|FG001|Overall Study|Clinical progression|16|||
131862790|NCT02810457|474778092|FG000|Overall Study|Investigator decision|3|||
131862791|NCT02810457|474778093|FG001|Overall Study|Investigator decision|2|||
131862792|NCT02810457|474778092|FG000|Overall Study|Patient ineligibility|3|||
131862793|NCT02810457|474778093|FG001|Overall Study|Patient ineligibility|0|||
131862794|NCT02810457|474778092|FG000|Overall Study|Miscalculated PD|1|||
131862795|NCT02810457|474778093|FG001|Overall Study|Miscalculated PD|0|||
131862796|NCT02810457|474778092|FG000|Overall Study|Physician Decision|0|||
131862797|NCT02810457|474778093|FG001|Overall Study|Physician Decision|1|||
131862798|NCT02832687|474778094|FG000|Overall Study|Adverse Event|0|||
131862799|NCT02832687|474778095|FG001|Overall Study|Adverse Event|2|||
131862800|NCT03192488|474778096|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
131862801|NCT03192488|474778097|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
131862802|NCT03192488|474778098|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
131862803|NCT03192488|474778099|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
131862804|NCT03192488|474778100|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
131862805|NCT03192488|474778101|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
131862806|NCT03192488|474778096|FG000|Third Intervention (d1)|Adverse Event|0|||
131862807|NCT03192488|474778097|FG001|Third Intervention (d1)|Adverse Event|0|||
131862808|NCT03192488|474778098|FG002|Third Intervention (d1)|Adverse Event|0|||
131862809|NCT03192488|474778099|FG003|Third Intervention (d1)|Adverse Event|0|||
131862810|NCT03192488|474778100|FG004|Third Intervention (d1)|Adverse Event|1|||
131862811|NCT03192488|474778101|FG005|Third Intervention (d1)|Adverse Event|0|||
131862812|NCT01892501|474778102|FG000|Overall Study|Protocol Violation|2|||
131862813|NCT01892501|474778102|FG000|Overall Study|Puncture not carried out|9|||
131862814|NCT01892501|474778102|FG000|Overall Study|Radiological monitoring not carried out|5|||
131862815|NCT01892501|474778102|FG000|Overall Study|Non-contributory histological result|12|||
131862816|NCT04429503|474778107|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
131862817|NCT04429503|474778108|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
131862818|NCT04429503|474778109|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
131862819|NCT04429503|474778110|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
131862820|NCT04429503|474778111|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
131862821|NCT04429503|474778112|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
131862822|NCT04429503|474778107|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
131862823|NCT04429503|474778108|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
131862824|NCT04429503|474778109|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
131862825|NCT04429503|474778110|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
131862826|NCT04429503|474778111|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
131862827|NCT04429503|474778112|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
131862828|NCT04429503|474778107|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
131862829|NCT04429503|474778108|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
131913928|NCT02475213|474971445|FG004|Overall Study|Death|0|||
131862830|NCT04429503|474778109|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
131862831|NCT04429503|474778110|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
131862832|NCT04429503|474778111|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
131862833|NCT04429503|474778112|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
131862834|NCT04429503|474778107|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
131862835|NCT04429503|474778108|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
131862836|NCT04429503|474778109|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
131862837|NCT04429503|474778110|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
131862838|NCT04429503|474778111|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
131862839|NCT04429503|474778112|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
131862840|NCT04429503|474778107|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
131862841|NCT04429503|474778108|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
131862842|NCT04429503|474778109|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
131913929|NCT02475213|474971446|FG005|Overall Study|Death|4|||
131862843|NCT04429503|474778110|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
131862844|NCT04429503|474778111|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
131862845|NCT04429503|474778112|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
131862846|NCT04429503|474778107|FG000|Main Study (Up to Wk 96)|Death|9|||
131862847|NCT04429503|474778108|FG001|Main Study (Up to Wk 96)|Death|18|||
131862848|NCT04429503|474778109|FG002|Main Study (Up to Wk 96)|Death|5|||
131862849|NCT04429503|474778110|FG003|Main Study (Up to Wk 96)|Death|0|||
131862850|NCT04429503|474778111|FG004|Main Study (Up to Wk 96)|Death|0|||
131862851|NCT04429503|474778112|FG005|Main Study (Up to Wk 96)|Death|0|||
131862852|NCT04429503|474778107|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
131862853|NCT04429503|474778108|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
131862854|NCT04429503|474778109|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
131862855|NCT04429503|474778110|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
131862856|NCT04429503|474778111|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
131862857|NCT04429503|474778112|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
131862858|NCT04429503|474778107|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
131862859|NCT04429503|474778108|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
131862860|NCT04429503|474778109|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
131862861|NCT04429503|474778110|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
131862862|NCT04429503|474778111|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
131862863|NCT04429503|474778112|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
131862864|NCT04429503|474778107|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
131862865|NCT04429503|474778108|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
131862866|NCT04429503|474778109|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
131862867|NCT04429503|474778110|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
131862868|NCT04429503|474778111|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
131862869|NCT04429503|474778112|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
131862870|NCT04429503|474778107|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
131862871|NCT04429503|474778108|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
131862872|NCT04429503|474778109|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
131862873|NCT04429503|474778110|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
131862874|NCT04429503|474778111|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
131862875|NCT04429503|474778112|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
131862876|NCT04429503|474778107|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
131862877|NCT04429503|474778108|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
131862878|NCT04429503|474778109|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
131862879|NCT04429503|474778110|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
131862880|NCT04429503|474778111|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
131862881|NCT04429503|474778112|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
131862882|NCT04429503|474778107|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
131862883|NCT04429503|474778108|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
131862884|NCT04429503|474778109|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
131862885|NCT04429503|474778110|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
131862886|NCT04429503|474778111|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
131862887|NCT04429503|474778112|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
131862888|NCT05516108|474778113|FG000|Overall Study|Time Commitment|3|||
131862889|NCT05516108|474778114|FG001|Overall Study|Time Commitment|1|||
131862890|NCT05516108|474778113|FG000|Overall Study|Reason Unknown|2|||
131862891|NCT05516108|474778114|FG001|Overall Study|Reason Unknown|4|||
131862892|NCT03664232|474778115|FG000|Overall Study|Withdrawal by Subject|0|||
131862893|NCT03664232|474778116|FG001|Overall Study|Withdrawal by Subject|1|||
131862894|NCT03664232|474778117|FG002|Overall Study|Withdrawal by Subject|0|||
131862895|NCT03664232|474778118|FG003|Overall Study|Withdrawal by Subject|1|||
131862896|NCT03664232|474778115|FG000|Overall Study|Adverse Event|0|||
131862897|NCT03664232|474778116|FG001|Overall Study|Adverse Event|0|||
131862898|NCT03664232|474778117|FG002|Overall Study|Adverse Event|1|||
131862899|NCT03664232|474778118|FG003|Overall Study|Adverse Event|0|||
131862900|NCT03664232|474778115|FG000|Overall Study|Other-Non-compliance with study drug|0|||
131862901|NCT03664232|474778116|FG001|Overall Study|Other-Non-compliance with study drug|1|||
131862902|NCT03664232|474778117|FG002|Overall Study|Other-Non-compliance with study drug|0|||
131862903|NCT03664232|474778118|FG003|Overall Study|Other-Non-compliance with study drug|2|||
131862904|NCT03664232|474778115|FG000|Overall Study|Other-Unspecified|0|||
131862905|NCT03664232|474778116|FG001|Overall Study|Other-Unspecified|3|||
131862906|NCT03664232|474778117|FG002|Overall Study|Other-Unspecified|0|||
131862907|NCT03664232|474778118|FG003|Overall Study|Other-Unspecified|1|||
131862908|NCT03664232|474778115|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
131862909|NCT03664232|474778116|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
131862910|NCT03664232|474778117|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
131862911|NCT03664232|474778118|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
131913930|NCT02475213|474971447|FG006|Overall Study|Death|1|||
131913931|NCT02475213|474971448|FG007|Overall Study|Death|0|||
131862912|NCT02003209|474778119|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
131862913|NCT02003209|474778120|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
131862914|NCT03500198|474778121|FG000|Overall Study|Lost to Follow-up|0|||
131862915|NCT03500198|474778122|FG001|Overall Study|Lost to Follow-up|1|||
131862916|NCT00395629|474778128|FG000|Core Study|Adverse Event|0|||
131862917|NCT00395629|474778129|FG001|Core Study|Adverse Event|3|||
131862918|NCT00395629|474778130|FG002|Core Study|Adverse Event|4|||
131862919|NCT00395629|474778128|FG000|Core Study|Abnormal laboratory value(s)|0|||
131862920|NCT00395629|474778129|FG001|Core Study|Abnormal laboratory value(s)|0|||
131862921|NCT00395629|474778130|FG002|Core Study|Abnormal laboratory value(s)|1|||
131862922|NCT00395629|474778128|FG000|Core Study|Protocol Violation|1|||
131862923|NCT00395629|474778129|FG001|Core Study|Protocol Violation|0|||
131862924|NCT00395629|474778130|FG002|Core Study|Protocol Violation|0|||
131862925|NCT00395629|474778128|FG000|Core Study|Withdrawal by Subject|0|||
131862926|NCT00395629|474778129|FG001|Core Study|Withdrawal by Subject|1|||
131862927|NCT00395629|474778130|FG002|Core Study|Withdrawal by Subject|1|||
131862928|NCT00395629|474778128|FG000|Core Study|Lost to Follow-up|0|||
131862929|NCT00395629|474778129|FG001|Core Study|Lost to Follow-up|0|||
131862930|NCT00395629|474778130|FG002|Core Study|Lost to Follow-up|1|||
131862931|NCT00395629|474778128|FG000|Extension Study|Adverse Event|0|||
131862932|NCT00395629|474778129|FG001|Extension Study|Adverse Event|0|||
131862933|NCT00395629|474778130|FG002|Extension Study|Adverse Event|2|||
131862934|NCT00395629|474778128|FG000|Extension Study|Administrative problems|0|||
131862935|NCT00395629|474778129|FG001|Extension Study|Administrative problems|0|||
131862936|NCT00395629|474778130|FG002|Extension Study|Administrative problems|1|||
131862937|NCT01051960|474778131|FG000|Overall Study|Adverse Event|1|||
131862938|NCT03534687|474778132|FG000|Overall Study|Lost to Follow-up|7|||
131862939|NCT03534687|474778133|FG001|Overall Study|Lost to Follow-up|2|||
131862940|NCT02570308|474778136|FG000|Overall Study|Death|1|||
131862941|NCT02570308|474778137|FG001|Overall Study|Death|5|||
131862942|NCT02570308|474778138|FG002|Overall Study|Death|4|||
131862943|NCT02570308|474778139|FG003|Overall Study|Death|4|||
131862944|NCT02570308|474778140|FG004|Overall Study|Death|69|||
131862945|NCT02570308|474778136|FG000|Overall Study|Lost to Follow-up|0|||
131862946|NCT02570308|474778137|FG001|Overall Study|Lost to Follow-up|0|||
131862947|NCT02570308|474778138|FG002|Overall Study|Lost to Follow-up|0|||
131862948|NCT02570308|474778139|FG003|Overall Study|Lost to Follow-up|0|||
131862949|NCT02570308|474778140|FG004|Overall Study|Lost to Follow-up|2|||
131862950|NCT02570308|474778136|FG000|Overall Study|Withdrawal by Subject|0|||
131862951|NCT02570308|474778137|FG001|Overall Study|Withdrawal by Subject|0|||
131862952|NCT02570308|474778138|FG002|Overall Study|Withdrawal by Subject|0|||
131862953|NCT02570308|474778139|FG003|Overall Study|Withdrawal by Subject|0|||
131862954|NCT02570308|474778140|FG004|Overall Study|Withdrawal by Subject|1|||
131862955|NCT02570308|474778136|FG000|Overall Study|Other|0|||
131862956|NCT02570308|474778137|FG001|Overall Study|Other|0|||
131862957|NCT02570308|474778138|FG002|Overall Study|Other|0|||
131862958|NCT02570308|474778139|FG003|Overall Study|Other|0|||
131862959|NCT02570308|474778140|FG004|Overall Study|Other|2|||
131862960|NCT02069015|474778142|FG000|Overall Study|Lost to Follow-up|39|||
131862961|NCT02069015|474778143|FG001|Overall Study|Lost to Follow-up|32|||
131862962|NCT02069015|474778142|FG000|Overall Study|Withdrawal by Subject|1|||
131862963|NCT02069015|474778143|FG001|Overall Study|Withdrawal by Subject|1|||
131862964|NCT01082328|474778144|FG000|Overall Study|Adverse Event|1|||
131862965|NCT00031590|474778145|FG000|Overall Study|Adverse Event|1|||
131862966|NCT00031590|474778145|FG000|Overall Study|Withdrawal by parents|2|||
131862967|NCT05506046|474778146|FG000|Overall Study|Lost to Follow-up|89|||
131862968|NCT05506046|474778147|FG001|Overall Study|Lost to Follow-up|101|||
131862969|NCT05506046|474778148|FG002|Overall Study|Lost to Follow-up|102|||
131862970|NCT05506046|474778149|FG003|Overall Study|Lost to Follow-up|99|||
131862971|NCT03051100|474778151|FG000|Overall Study|Withdrawal by Subject|1|||
131862972|NCT03051100|474778152|FG001|Overall Study|Withdrawal by Subject|0|||
131862973|NCT02059135|474778153|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
131862974|NCT02059135|474778154|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
131862975|NCT02059135|474778153|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
131862976|NCT02059135|474778154|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
131862977|NCT02059135|474778153|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
131862978|NCT02059135|474778154|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
131862979|NCT02059135|474778153|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
131862980|NCT02059135|474778154|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
131862981|NCT02059135|474778153|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
131862982|NCT02059135|474778154|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
131862983|NCT02059135|474778153|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
131862984|NCT02059135|474778154|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
131862985|NCT02059135|474778153|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
131862986|NCT02059135|474778154|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
131862987|NCT02059135|474778153|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
131862988|NCT02059135|474778154|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
131862989|NCT02224157|474778156|FG000|Overall Study|Severe non-compliance to protocol|2|||
131862990|NCT02224157|474778157|FG001|Overall Study|Severe non-compliance to protocol|2|||
131862991|NCT02224157|474778156|FG000|Overall Study|Other|13|||
131862992|NCT02224157|474778157|FG001|Overall Study|Other|10|||
131862993|NCT02224157|474778156|FG000|Overall Study|Subject decision|58|||
131862994|NCT02224157|474778157|FG001|Overall Study|Subject decision|50|||
131862995|NCT02224157|474778156|FG000|Overall Study|Prematurely closed site|4|||
131862996|NCT02224157|474778157|FG001|Overall Study|Prematurely closed site|2|||
131862997|NCT02224157|474778156|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
131862998|NCT02224157|474778157|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
131862999|NCT02224157|474778156|FG000|Overall Study|Lost to Follow-up|27|||
131863000|NCT02224157|474778157|FG001|Overall Study|Lost to Follow-up|35|||
131863001|NCT02224157|474778156|FG000|Overall Study|Death|1|||
131863002|NCT02224157|474778157|FG001|Overall Study|Death|1|||
131863003|NCT02224157|474778156|FG000|Overall Study|Adverse Event|1|||
131863004|NCT02224157|474778157|FG001|Overall Study|Adverse Event|3|||
131863005|NCT05906628|474778160|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
131863006|NCT05906628|474778161|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
131863007|NCT05906628|474778160|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
131863008|NCT05906628|474778161|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
131863009|NCT05906628|474778160|FG000|16-Week DBVC Period|Protocol Violation|4|||
131863010|NCT05906628|474778161|FG001|16-Week DBVC Period|Protocol Violation|2|||
131863011|NCT05906628|474778160|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
131863012|NCT05906628|474778161|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
131863013|NCT05906628|474778160|FG000|16-Week OLE Period|Death|1|||
131863014|NCT05906628|474778161|FG001|16-Week OLE Period|Death|0|||
131863015|NCT05906628|474778160|FG000|16-Week OLE Period|Lost to Follow-up|1|||
131863016|NCT05906628|474778161|FG001|16-Week OLE Period|Lost to Follow-up|1|||
131863017|NCT05906628|474778160|FG000|16-Week OLE Period|Protocol Violation|0|||
131863018|NCT05906628|474778161|FG001|16-Week OLE Period|Protocol Violation|1|||
131863019|NCT05906628|474778160|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
131863020|NCT05906628|474778161|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
131863021|NCT04578535|474778162|FG000|Overall Study|Lost to Follow-up|1|||
131863022|NCT04578535|474778163|FG001|Overall Study|Lost to Follow-up|0|||
131863023|NCT04578535|474778164|FG002|Overall Study|Lost to Follow-up|0|||
131863024|NCT04578535|474778165|FG003|Overall Study|Lost to Follow-up|1|||
131863025|NCT04578535|474778166|FG004|Overall Study|Lost to Follow-up|0|||
131863026|NCT04578535|474778167|FG005|Overall Study|Lost to Follow-up|2|||
131863027|NCT04578535|474778162|FG000|Overall Study|Pregnancy|1|||
131863028|NCT04578535|474778163|FG001|Overall Study|Pregnancy|0|||
131863029|NCT04578535|474778164|FG002|Overall Study|Pregnancy|0|||
131863030|NCT04578535|474778165|FG003|Overall Study|Pregnancy|0|||
131863031|NCT04578535|474778166|FG004|Overall Study|Pregnancy|0|||
131863032|NCT04578535|474778167|FG005|Overall Study|Pregnancy|0|||
131863033|NCT04578535|474778162|FG000|Overall Study|Withdrawal by Subject|0|||
131863034|NCT04578535|474778163|FG001|Overall Study|Withdrawal by Subject|0|||
131863035|NCT04578535|474778164|FG002|Overall Study|Withdrawal by Subject|0|||
131863036|NCT04578535|474778165|FG003|Overall Study|Withdrawal by Subject|1|||
131863037|NCT04578535|474778166|FG004|Overall Study|Withdrawal by Subject|1|||
131863038|NCT04578535|474778167|FG005|Overall Study|Withdrawal by Subject|5|||
131863039|NCT04578535|474778162|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
131863040|NCT04578535|474778163|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
131863041|NCT04578535|474778164|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
131863042|NCT04578535|474778165|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
131863043|NCT04578535|474778166|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
131863044|NCT04578535|474778167|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
131863045|NCT00837148|474778168|FG000|Overall Study|Adverse Event|1|||
131863046|NCT00837148|474778168|FG000|Overall Study|Death|1|||
131863047|NCT02301169|474778169|FG000|Overall Study|Adverse Event|1|||
131408096|NCT02374814|473115347|FG002|Overall Study|Withdrawal by Subject|1|||
131863048|NCT02301169|474778170|FG001|Overall Study|Adverse Event|0|||
131863049|NCT00380874|474778171|FG000|Overall Study|Adverse Event|7|||
131863050|NCT00380874|474778172|FG001|Overall Study|Adverse Event|7|||
131863051|NCT00380874|474778171|FG000|Overall Study|Death|1|||
131863052|NCT00380874|474778172|FG001|Overall Study|Death|0|||
131863053|NCT00380874|474778171|FG000|Overall Study|Withdrawal by Subject|2|||
131863054|NCT00380874|474778172|FG001|Overall Study|Withdrawal by Subject|1|||
131863055|NCT00380874|474778171|FG000|Overall Study|Not related to study drug|3|||
131863056|NCT00380874|474778172|FG001|Overall Study|Not related to study drug|2|||
131863057|NCT03839628|474778173|FG000|Overall Study|Withdrawal by Subject|1|||
131863058|NCT01707290|474778178|FG000|Overall Study|Adverse event (AE)|1|||
131863059|NCT01707290|474778179|FG001|Overall Study|Adverse event (AE)|0|||
131863060|NCT01707290|474778178|FG000|Overall Study|Physician Decision|1|||
131863061|NCT01707290|474778179|FG001|Overall Study|Physician Decision|0|||
131863062|NCT01707290|474778178|FG000|Overall Study|Lost to Follow-up|3|||
131863063|NCT01707290|474778179|FG001|Overall Study|Lost to Follow-up|0|||
131863064|NCT01707290|474778178|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
131863065|NCT01707290|474778179|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
131863066|NCT01707290|474778178|FG000|Overall Study|Commercial drug available|60|||
131863067|NCT01707290|474778179|FG001|Overall Study|Commercial drug available|1|||
131863068|NCT01707290|474778178|FG000|Overall Study|Other unspecified|17|||
131863069|NCT01707290|474778179|FG001|Overall Study|Other unspecified|0|||
131863070|NCT01198470|474778180|FG000|Overall Study|Adverse Event|2|||
131863071|NCT02949973|474778181|FG000|Overall Study|Physician Decision|1|||
131863072|NCT00765102|474778182|FG000|Overall Study|Progressive disease|18|||
131863073|NCT00765102|474778182|FG000|Overall Study|Adverse Event|6|||
131863074|NCT00765102|474778182|FG000|Overall Study|Physician Decision|4|||
131863075|NCT00765102|474778182|FG000|Overall Study|Withdrawal by Subject|2|||
131863076|NCT00765102|474778182|FG000|Overall Study|Protocol Violation|1|||
131863077|NCT03181633|474778193|FG000|Overall Study|Withdrawal by Subject|1|||
131863078|NCT03181633|474778193|FG000|Overall Study|Missing follow-up visit|1|||
131863079|NCT02962648|474778194|FG000|Overall Study|Withdrawal by Subject|3|||
131863080|NCT02962648|474778194|FG000|Overall Study|Lost to Follow-up|3|||
131863081|NCT02962648|474778194|FG000|Overall Study|Physician Decision|1|||
131863082|NCT02962648|474778194|FG000|Overall Study|Subject had problems with transportation|2|||
131863083|NCT04383327|474778195|FG000|Overall Study|Lost to Follow-up|112|||
131863084|NCT04383327|474778196|FG001|Overall Study|Lost to Follow-up|14|||
131863085|NCT04383327|474778197|FG002|Overall Study|Lost to Follow-up|78|||
131863086|NCT04383327|474778198|FG003|Overall Study|Lost to Follow-up|13|||
131863087|NCT04383327|474778199|FG004|Overall Study|Lost to Follow-up|110|||
131863088|NCT04383327|474778200|FG005|Overall Study|Lost to Follow-up|13|||
131863089|NCT04383327|474778201|FG006|Overall Study|Lost to Follow-up|74|||
131863090|NCT04383327|474778202|FG007|Overall Study|Lost to Follow-up|13|||
131863091|NCT04383327|474778203|FG008|Overall Study|Lost to Follow-up|78|||
131863092|NCT04383327|474778204|FG009|Overall Study|Lost to Follow-up|10|||
131863093|NCT04383327|474778205|FG010|Overall Study|Lost to Follow-up|160|||
131863094|NCT04383327|474778206|FG011|Overall Study|Lost to Follow-up|13|||
131863095|NCT04837196|474778207|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
131863096|NCT04837196|474778208|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
131863097|NCT04837196|474778209|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
131863098|NCT04837196|474778210|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
131863099|NCT04837196|474778211|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
131863100|NCT04837196|474778207|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
131863101|NCT04837196|474778208|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
131863102|NCT04837196|474778209|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
131863103|NCT04837196|474778210|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
131863104|NCT04837196|474778211|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
131863105|NCT04837196|474778207|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
131863106|NCT04837196|474778208|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
131863107|NCT04837196|474778209|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
131863108|NCT04837196|474778210|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
131863109|NCT04837196|474778211|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
131863110|NCT04837196|474778207|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
131863111|NCT04837196|474778208|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
131863112|NCT04837196|474778209|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
131863113|NCT04837196|474778210|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
131863114|NCT04837196|474778211|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
131863115|NCT04837196|474778207|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
131863116|NCT04837196|474778208|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
131863117|NCT04837196|474778209|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
131863118|NCT04837196|474778210|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
131863119|NCT04837196|474778211|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
131863120|NCT04030299|474778212|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
131863121|NCT04030299|474778212|FG000|Overall Study|Withdrawal by Subject|3|||
131863122|NCT01565889|474778217|FG000|Part A|Withdrawal by Subject|1|||
131863123|NCT01565889|474778218|FG001|Part A|Withdrawal by Subject|0|||
131863124|NCT01565889|474778219|FG002|Part A|Withdrawal by Subject|0|||
131863125|NCT01565889|474778220|FG003|Part A|Withdrawal by Subject|0|||
131863126|NCT01565889|474778221|FG004|Part A|Withdrawal by Subject|0|||
131863127|NCT01565889|474778222|FG005|Part A|Withdrawal by Subject|0|||
131863128|NCT01565889|474778217|FG000|Part B|Withdrawal by Subject|0|||
131863129|NCT01565889|474778218|FG001|Part B|Withdrawal by Subject|0|||
131863130|NCT01565889|474778219|FG002|Part B|Withdrawal by Subject|0|||
131913932|NCT02475213|474971441|FG000|Overall Study|Protocol Violation|0|||
131913933|NCT02475213|474971442|FG001|Overall Study|Protocol Violation|0|||
131863131|NCT01565889|474778220|FG003|Part B|Withdrawal by Subject|0|||
131863132|NCT01565889|474778221|FG004|Part B|Withdrawal by Subject|0|||
131863133|NCT01565889|474778222|FG005|Part B|Withdrawal by Subject|1|||
131863134|NCT01565889|474778217|FG000|Part B|Lack of Efficacy|0|||
131863135|NCT01565889|474778218|FG001|Part B|Lack of Efficacy|0|||
131913934|NCT02475213|474971443|FG002|Overall Study|Protocol Violation|0|||
131913935|NCT02475213|474971444|FG003|Overall Study|Protocol Violation|0|||
131913936|NCT02475213|474971445|FG004|Overall Study|Protocol Violation|1|||
131913937|NCT02475213|474971446|FG005|Overall Study|Protocol Violation|0|||
131913938|NCT02475213|474971447|FG006|Overall Study|Protocol Violation|0|||
131913939|NCT02475213|474971448|FG007|Overall Study|Protocol Violation|0|||
131913940|NCT02475213|474971441|FG000|Overall Study|Withdrawal by Subject|0|||
131913941|NCT02475213|474971442|FG001|Overall Study|Withdrawal by Subject|0|||
131913942|NCT02475213|474971443|FG002|Overall Study|Withdrawal by Subject|0|||
131913943|NCT02475213|474971444|FG003|Overall Study|Withdrawal by Subject|1|||
131913944|NCT02475213|474971445|FG004|Overall Study|Withdrawal by Subject|0|||
131913945|NCT02475213|474971446|FG005|Overall Study|Withdrawal by Subject|2|||
131913946|NCT02475213|474971447|FG006|Overall Study|Withdrawal by Subject|2|||
131913947|NCT02475213|474971448|FG007|Overall Study|Withdrawal by Subject|0|||
131913948|NCT02475213|474971441|FG000|Overall Study|Other|0|||
131913949|NCT02475213|474971442|FG001|Overall Study|Other|0|||
131913950|NCT02475213|474971443|FG002|Overall Study|Other|0|||
131913951|NCT02475213|474971444|FG003|Overall Study|Other|1|||
131913952|NCT02475213|474971445|FG004|Overall Study|Other|3|||
131913953|NCT02475213|474971446|FG005|Overall Study|Other|1|||
131913954|NCT02475213|474971447|FG006|Overall Study|Other|0|||
131913955|NCT02475213|474971448|FG007|Overall Study|Other|0|||
131913956|NCT01682031|474971449|FG000|Overall Study|Withdrawal by Subject|0|||
131913957|NCT01682031|474971450|FG001|Overall Study|Withdrawal by Subject|1|||
131913958|NCT01682031|474971449|FG000|Overall Study|Adverse Event|0|||
131913959|NCT01682031|474971450|FG001|Overall Study|Adverse Event|2|||
131913960|NCT01682031|474971449|FG000|Overall Study|MRI results indicate increased nodul|0|||
131913961|NCT01682031|474971450|FG001|Overall Study|MRI results indicate increased nodul|1|||
131913962|NCT01682031|474971449|FG000|Overall Study|Patient could not swallow tablets|1|||
131913963|NCT01682031|474971450|FG001|Overall Study|Patient could not swallow tablets|0|||
131913964|NCT01682031|474971449|FG000|Overall Study|Patient stopped selenium on his own|0|||
131913965|NCT01682031|474971450|FG001|Overall Study|Patient stopped selenium on his own|1|||
131913966|NCT04666298|474971452|FG000|Overall Study|Subject decision|1|||
131913967|NCT04666298|474971453|FG001|Overall Study|Subject decision|0|||
131913968|NCT04666298|474971454|FG002|Overall Study|Subject decision|0|||
131913969|NCT04666298|474971455|FG003|Overall Study|Subject decision|2|||
131913970|NCT04666298|474971452|FG000|Overall Study|Death|1|||
131913971|NCT04666298|474971453|FG001|Overall Study|Death|0|||
131913972|NCT04666298|474971454|FG002|Overall Study|Death|0|||
131913973|NCT04666298|474971455|FG003|Overall Study|Death|0|||
131913974|NCT04666298|474971452|FG000|Overall Study|Lost to Follow-up|0|||
131913975|NCT04666298|474971453|FG001|Overall Study|Lost to Follow-up|0|||
131913976|NCT04666298|474971454|FG002|Overall Study|Lost to Follow-up|0|||
131913977|NCT04666298|474971455|FG003|Overall Study|Lost to Follow-up|1|||
131913978|NCT04666298|474971452|FG000|Overall Study|Physician Decision|0|||
131913979|NCT04666298|474971453|FG001|Overall Study|Physician Decision|0|||
131913980|NCT04666298|474971454|FG002|Overall Study|Physician Decision|0|||
131913981|NCT04666298|474971455|FG003|Overall Study|Physician Decision|1|||
131913982|NCT04666298|474971452|FG000|Overall Study|Protocol deviation|0|||
131913983|NCT04666298|474971453|FG001|Overall Study|Protocol deviation|0|||
131913984|NCT04666298|474971454|FG002|Overall Study|Protocol deviation|1|||
131913985|NCT04666298|474971455|FG003|Overall Study|Protocol deviation|0|||
131913986|NCT00844519|474971456|FG000|Overall Study|Withdrawal by Subject|1|||
131913987|NCT00844519|474971457|FG001|Overall Study|Withdrawal by Subject|1|||
131913988|NCT00844519|474971456|FG000|Overall Study|Adverse Event|1|||
131913989|NCT00844519|474971457|FG001|Overall Study|Adverse Event|0|||
131913990|NCT00226655|474971458|FG000|Overall Study|Death|13|||
131913991|NCT00226655|474971458|FG000|Overall Study|Withdrawal by Subject|15|||
131913992|NCT00226655|474971458|FG000|Overall Study|Adverse Event|35|||
131913993|NCT00226655|474971458|FG000|Overall Study|Physician Decision|6|||
131913994|NCT00226655|474971458|FG000|Overall Study|Clinical deterioration|10|||
131913995|NCT02763566|474971461|FG000|Overall Study|Lost to Follow-up|1|||
131913996|NCT02763566|474971462|FG001|Overall Study|Lost to Follow-up|4|||
131913997|NCT02763566|474971463|FG002|Overall Study|Lost to Follow-up|0|||
131913998|NCT02763566|474971464|FG003|Overall Study|Lost to Follow-up|1|||
131913999|NCT02763566|474971461|FG000|Overall Study|On study treatment at study conclusion|114|||
131914000|NCT02763566|474971462|FG001|Overall Study|On study treatment at study conclusion|34|||
131914001|NCT02763566|474971463|FG002|Overall Study|On study treatment at study conclusion|54|||
131914002|NCT02763566|474971464|FG003|Overall Study|On study treatment at study conclusion|13|||
131914003|NCT02763566|474971461|FG000|Overall Study|Withdrawal by Subject|3|||
131914004|NCT02763566|474971462|FG001|Overall Study|Withdrawal by Subject|1|||
131914005|NCT02763566|474971463|FG002|Overall Study|Withdrawal by Subject|0|||
131914006|NCT02763566|474971464|FG003|Overall Study|Withdrawal by Subject|0|||
131914007|NCT01285518|474971465|FG000|Overall Study|Lost to Follow-up|0|||
131914008|NCT01285518|474971466|FG001|Overall Study|Lost to Follow-up|0|||
131914009|NCT01285518|474971467|FG002|Overall Study|Lost to Follow-up|0|||
131914010|NCT01285518|474971468|FG003|Overall Study|Lost to Follow-up|0|||
131914011|NCT01285518|474971469|FG004|Overall Study|Lost to Follow-up|0|||
131914012|NCT01285518|474971470|FG005|Overall Study|Lost to Follow-up|1|||
131863136|NCT01565889|474778219|FG002|Part B|Lack of Efficacy|0|||
131863137|NCT01565889|474778220|FG003|Part B|Lack of Efficacy|0|||
131863138|NCT01565889|474778221|FG004|Part B|Lack of Efficacy|0|||
131863139|NCT01565889|474778222|FG005|Part B|Lack of Efficacy|2|||
131863140|NCT01565889|474778217|FG000|Part B|Lost to Follow-up|0|||
131863141|NCT01565889|474778218|FG001|Part B|Lost to Follow-up|0|||
131863142|NCT01565889|474778219|FG002|Part B|Lost to Follow-up|0|||
131863143|NCT01565889|474778220|FG003|Part B|Lost to Follow-up|0|||
131863144|NCT01565889|474778221|FG004|Part B|Lost to Follow-up|0|||
131863145|NCT01565889|474778222|FG005|Part B|Lost to Follow-up|1|||
131863146|NCT02723344|474778223|FG000|Overall Study|Lost to Follow-up|0|||
131863147|NCT02723344|474778224|FG001|Overall Study|Lost to Follow-up|4|||
131863148|NCT01530464|474778229|FG000|Washout (24h)|Withdrawal by Subject|1|||
131863149|NCT01530464|474778230|FG001|Washout (24h)|Withdrawal by Subject|0|||
131863150|NCT01530464|474778229|FG000|Washout (24h)|Withdrawal by Subject|0|||
131863151|NCT01530464|474778230|FG001|Washout (24h)|Withdrawal by Subject|1|||
131863152|NCT03539302|474778231|FG000|Overall Study|Spontaneous cardio version|0|||
131863153|NCT03539302|474778232|FG001|Overall Study|Spontaneous cardio version|0|||
131863154|NCT03539302|474778233|FG002|Overall Study|Spontaneous cardio version|0|||
131863155|NCT03539302|474778234|FG003|Overall Study|Spontaneous cardio version|0|||
131863156|NCT03539302|474778235|FG004|Overall Study|Spontaneous cardio version|0|||
131863157|NCT03539302|474778236|FG005|Overall Study|Spontaneous cardio version|1|||
131863158|NCT03539302|474778237|FG006|Overall Study|Spontaneous cardio version|1|||
131863159|NCT00740636|474778238|FG000|Overall Study|Adverse Event|0|||
131863160|NCT00740636|474778239|FG001|Overall Study|Adverse Event|2|||
131863161|NCT00740636|474778238|FG000|Overall Study|Patient Ineligible|0|||
131863162|NCT00740636|474778239|FG001|Overall Study|Patient Ineligible|1|||
131863163|NCT00740636|474778238|FG000|Overall Study|Patient Not Treated|0|||
131863164|NCT00740636|474778239|FG001|Overall Study|Patient Not Treated|1|||
131863165|NCT00740636|474778238|FG000|Overall Study|Progressive Disease|1|||
131863166|NCT00740636|474778239|FG001|Overall Study|Progressive Disease|0|||
131863167|NCT00740636|474778238|FG000|Overall Study|Death|1|||
131863168|NCT00740636|474778239|FG001|Overall Study|Death|0|||
131863169|NCT05479435|474778244|FG000|Overall Study|Withdrawal by Subject|1|||
131863170|NCT05479435|474778245|FG001|Overall Study|Withdrawal by Subject|0|||
131863171|NCT05479435|474778246|FG002|Overall Study|Withdrawal by Subject|0|||
131863172|NCT05479435|474778244|FG000|Overall Study|Covid 19|0|||
131863173|NCT05479435|474778245|FG001|Overall Study|Covid 19|0|||
131863174|NCT05479435|474778246|FG002|Overall Study|Covid 19|2|||
131863175|NCT01609790|474778247|FG000|Overall Study|Protocol Violation|1|||
131863176|NCT01609790|474778248|FG001|Overall Study|Protocol Violation|7|||
131863177|NCT01609790|474778249|FG002|Overall Study|Protocol Violation|8|||
131863178|NCT02844543|474780048|FG000|Overall Study|Withdrawal by Subject|4|||
131863179|NCT02844543|474780048|FG000|Overall Study|Did not meet eligibility criteria|1|||
131863180|NCT04710576|474780054|FG000|Overall Study|Participants still in the study|73|||
131863181|NCT04710576|474780055|FG001|Overall Study|Participants still in the study|70|||
131863182|NCT04710576|474780056|FG002|Overall Study|Participants still in the study|60|||
131863183|NCT04710576|474780054|FG000|Overall Study|Death|2|||
131863184|NCT04710576|474780055|FG001|Overall Study|Death|7|||
131863185|NCT04710576|474780056|FG002|Overall Study|Death|12|||
131863186|NCT04710576|474780054|FG000|Overall Study|Withdrawal by Subject|4|||
131863187|NCT04710576|474780055|FG001|Overall Study|Withdrawal by Subject|3|||
131863188|NCT04710576|474780056|FG002|Overall Study|Withdrawal by Subject|7|||
131863189|NCT04710576|474780054|FG000|Overall Study|Sponsor decision|1|||
131863190|NCT04710576|474780055|FG001|Overall Study|Sponsor decision|0|||
131863191|NCT04710576|474780056|FG002|Overall Study|Sponsor decision|0|||
131863192|NCT04581824|474780057|FG000|Overall Study|Lost to Follow-up|1|||
131863193|NCT04581824|474780058|FG001|Overall Study|Lost to Follow-up|0|||
131863194|NCT04581824|474780057|FG000|Overall Study|Withdrawal by Subject|2|||
131863195|NCT04581824|474780058|FG001|Overall Study|Withdrawal by Subject|7|||
131863196|NCT04581824|474780057|FG000|Overall Study|Study terminated by sponsor|37|||
131863197|NCT04581824|474780058|FG001|Overall Study|Study terminated by sponsor|23|||
131863198|NCT04796909|474780059|FG000|Overall Study|Withdrawal by Subject|1|||
131863199|NCT04796909|474780060|FG001|Overall Study|Withdrawal by Subject|1|||
131863200|NCT03879135|474780061|FG000|Overall Study|Physician Decision|0|||
131863201|NCT03879135|474780062|FG001|Overall Study|Physician Decision|0|||
131863202|NCT03879135|474780063|FG002|Overall Study|Physician Decision|0|||
131863203|NCT03879135|474780064|FG003|Overall Study|Physician Decision|1|||
131914013|NCT01285518|474971471|FG006|Overall Study|Lost to Follow-up|0|||
131453849|NCT03083873|473291792|FG002|Overall Study|Sponsor Terminated Study|2|||
131863204|NCT03879135|474780065|FG004|Overall Study|Physician Decision|0|||
131863205|NCT03879135|474780066|FG005|Overall Study|Physician Decision|0|||
131863206|NCT03879135|474780061|FG000|Overall Study|Withdrawal by Subject|0|||
131863207|NCT03879135|474780062|FG001|Overall Study|Withdrawal by Subject|0|||
131863208|NCT03879135|474780063|FG002|Overall Study|Withdrawal by Subject|0|||
131863209|NCT03879135|474780064|FG003|Overall Study|Withdrawal by Subject|0|||
131863210|NCT03879135|474780065|FG004|Overall Study|Withdrawal by Subject|0|||
131863211|NCT03879135|474780066|FG005|Overall Study|Withdrawal by Subject|1|||
131863212|NCT03879135|474780061|FG000|Overall Study|Site Closed by Sponsor|0|||
131863213|NCT03879135|474780062|FG001|Overall Study|Site Closed by Sponsor|0|||
131863214|NCT03879135|474780063|FG002|Overall Study|Site Closed by Sponsor|0|||
131863215|NCT03879135|474780064|FG003|Overall Study|Site Closed by Sponsor|1|||
131863216|NCT03879135|474780065|FG004|Overall Study|Site Closed by Sponsor|1|||
131863217|NCT03879135|474780066|FG005|Overall Study|Site Closed by Sponsor|0|||
131863218|NCT04162847|474780067|FG000|Overall Study|Withdrawal by Subject|7|||
131863219|NCT04162847|474780068|FG001|Overall Study|Withdrawal by Subject|1|||
131863220|NCT01415518|474780071|FG000|Overall Study|Withdrawal by Subject|2|||
131863221|NCT01415518|474780072|FG001|Overall Study|Withdrawal by Subject|12|||
131863222|NCT01415518|474780071|FG000|Overall Study|Protocol Violation|6|||
131863223|NCT01415518|474780072|FG001|Overall Study|Protocol Violation|8|||
131863224|NCT01415518|474780071|FG000|Overall Study|Lost to Follow-up|3|||
131863225|NCT01415518|474780072|FG001|Overall Study|Lost to Follow-up|5|||
131863226|NCT01415518|474780071|FG000|Overall Study|Adverse Event|3|||
131863227|NCT01415518|474780072|FG001|Overall Study|Adverse Event|4|||
131863228|NCT01415518|474780071|FG000|Overall Study|Death|1|||
131863229|NCT01415518|474780072|FG001|Overall Study|Death|1|||
131863230|NCT01415518|474780071|FG000|Overall Study|Condition under Investigation Worsened|1|||
131863231|NCT01415518|474780072|FG001|Overall Study|Condition under Investigation Worsened|1|||
131863232|NCT02068508|474780073|FG000|Overall Study|Case report forms uncollected|27|||
131863233|NCT02068508|474780073|FG000|Overall Study|Patient did not visit the study site|1|||
131863234|NCT02068508|474780073|FG000|Overall Study|Protocol Violation|4|||
131863235|NCT00813150|474780074|FG000|Treatment Period|Adverse Event|16|||
131863236|NCT00813150|474780075|FG001|Treatment Period|Adverse Event|15|||
131863237|NCT00813150|474780074|FG000|Treatment Period|Death|2|||
131863238|NCT00813150|474780075|FG001|Treatment Period|Death|0|||
131863239|NCT00813150|474780074|FG000|Treatment Period|Progressive disease|1|||
131863240|NCT00813150|474780075|FG001|Treatment Period|Progressive disease|0|||
131863241|NCT00813150|474780074|FG000|Treatment Period|Complete response|0|||
131863242|NCT00813150|474780075|FG001|Treatment Period|Complete response|1|||
131863243|NCT00813150|474780074|FG000|Treatment Period|Stable disease|1|||
131863244|NCT00813150|474780075|FG001|Treatment Period|Stable disease|2|||
131863245|NCT00813150|474780074|FG000|Treatment Period|Protocol Violation|3|||
131863246|NCT00813150|474780075|FG001|Treatment Period|Protocol Violation|4|||
131863247|NCT00813150|474780074|FG000|Treatment Period|Withdrawal by Subject|5|||
131863248|NCT00813150|474780075|FG001|Treatment Period|Withdrawal by Subject|3|||
131863249|NCT00813150|474780074|FG000|Treatment Period|Non compliance|0|||
131863250|NCT00813150|474780075|FG001|Treatment Period|Non compliance|1|||
131863251|NCT00813150|474780074|FG000|Treatment Period|Reason not specified|3|||
131863252|NCT00813150|474780075|FG001|Treatment Period|Reason not specified|4|||
131863253|NCT00813150|474780074|FG000|Treatment Period|Data not available|1|||
131863254|NCT00813150|474780075|FG001|Treatment Period|Data not available|2|||
131863255|NCT00813150|474780074|FG000|Long Term Follow-up|Death|0|||
131863256|NCT00813150|474780075|FG001|Long Term Follow-up|Death|4|||
131863257|NCT00813150|474780074|FG000|Long Term Follow-up|Other|0|||
131863258|NCT00813150|474780075|FG001|Long Term Follow-up|Other|3|||
131863259|NCT00813150|474780074|FG000|Long Term Follow-up|Lost to Follow-up|2|||
131863260|NCT00813150|474780075|FG001|Long Term Follow-up|Lost to Follow-up|0|||
131863261|NCT00813150|474780074|FG000|Long Term Follow-up|Progression/Relapse|22|||
131863262|NCT00813150|474780075|FG001|Long Term Follow-up|Progression/Relapse|24|||
131863263|NCT05423093|474780080|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
131863264|NCT05423093|474780080|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
131863265|NCT05423093|474780080|FG000|Attended Intervention Session|Lost to Follow-up|3|||
131863266|NCT05423093|474780080|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
131863267|NCT05423093|474780080|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
131863268|NCT05364931|474780081|FG000|Overall Study|Adverse Event|0|||
131863269|NCT05364931|474780082|FG001|Overall Study|Adverse Event|2|||
131863270|NCT05364931|474780083|FG002|Overall Study|Adverse Event|1|||
131863271|NCT05364931|474780084|FG003|Overall Study|Adverse Event|0|||
131863272|NCT05364931|474780081|FG000|Overall Study|Lost to Follow-up|1|||
131863273|NCT05364931|474780082|FG001|Overall Study|Lost to Follow-up|0|||
131863274|NCT05364931|474780083|FG002|Overall Study|Lost to Follow-up|0|||
131863275|NCT05364931|474780084|FG003|Overall Study|Lost to Follow-up|0|||
131863276|NCT05364931|474780081|FG000|Overall Study|Withdrawal by Subject|1|||
131863277|NCT05364931|474780082|FG001|Overall Study|Withdrawal by Subject|1|||
131863278|NCT05364931|474780083|FG002|Overall Study|Withdrawal by Subject|3|||
131863279|NCT05364931|474780084|FG003|Overall Study|Withdrawal by Subject|2|||
131863280|NCT05364931|474780081|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
131863281|NCT05364931|474780082|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
131863282|NCT05364931|474780083|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
131863283|NCT05364931|474780084|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
131863284|NCT05364931|474780081|FG000|Overall Study|Discontinued|1|||
131914014|NCT01285518|474971472|FG007|Overall Study|Lost to Follow-up|0|||
131863285|NCT05364931|474780082|FG001|Overall Study|Discontinued|0|||
131863286|NCT05364931|474780083|FG002|Overall Study|Discontinued|0|||
131863287|NCT05364931|474780084|FG003|Overall Study|Discontinued|0|||
131863288|NCT04173507|474780088|FG000|Overall Study|On Treatment|3|||
131863289|NCT04173507|474780088|FG000|Overall Study|Adverse Event|3|||
131863290|NCT04173507|474780088|FG000|Overall Study|Progression/Relapse|34|||
131863291|NCT04173507|474780088|FG000|Overall Study|Death|2|||
131863292|NCT04231825|474780089|FG000|Overall Study|Protocol Violation|3|||
131863293|NCT04231825|474780090|FG001|Overall Study|Protocol Violation|3|||
131863294|NCT04231825|474780089|FG000|Overall Study|Lost to Follow-up|0|||
131863295|NCT04231825|474780090|FG001|Overall Study|Lost to Follow-up|1|||
131863296|NCT02445248|474780091|FG000|Overall Study|Death|45|||
131863297|NCT02445248|474780092|FG001|Overall Study|Death|12|||
131863298|NCT02445248|474780091|FG000|Overall Study|Progressive disease|13|||
131863299|NCT02445248|474780092|FG001|Overall Study|Progressive disease|1|||
131863300|NCT02445248|474780091|FG000|Overall Study|Subject decision|8|||
131863301|NCT02445248|474780092|FG001|Overall Study|Subject decision|0|||
131863302|NCT02445248|474780091|FG000|Overall Study|Physician Decision|5|||
131863303|NCT02445248|474780092|FG001|Overall Study|Physician Decision|0|||
131863304|NCT02445248|474780091|FG000|Overall Study|Adverse Event|1|||
131863305|NCT02445248|474780092|FG001|Overall Study|Adverse Event|0|||
131863306|NCT02445248|474780091|FG000|Overall Study|Lost to Follow-up|1|||
131863307|NCT02445248|474780092|FG001|Overall Study|Lost to Follow-up|0|||
131863308|NCT01217112|474780093|FG000|Overall Study|Adverse Event|0|||
131863309|NCT01217112|474780094|FG001|Overall Study|Adverse Event|2|||
131863310|NCT01217112|474780095|FG002|Overall Study|Adverse Event|0|||
131863311|NCT01217112|474780096|FG003|Overall Study|Adverse Event|2|||
131863312|NCT01217112|474780097|FG004|Overall Study|Adverse Event|0|||
131863313|NCT01217112|474780093|FG000|Overall Study|Withdrawal by Subject|0|||
131863314|NCT01217112|474780094|FG001|Overall Study|Withdrawal by Subject|0|||
131863315|NCT01217112|474780095|FG002|Overall Study|Withdrawal by Subject|1|||
131863316|NCT01217112|474780096|FG003|Overall Study|Withdrawal by Subject|0|||
131863317|NCT01217112|474780097|FG004|Overall Study|Withdrawal by Subject|0|||
131863318|NCT01217112|474780093|FG000|Overall Study|Physician Decision|0|||
131863319|NCT01217112|474780094|FG001|Overall Study|Physician Decision|0|||
131863320|NCT01217112|474780095|FG002|Overall Study|Physician Decision|0|||
131863321|NCT01217112|474780096|FG003|Overall Study|Physician Decision|0|||
131863322|NCT01217112|474780097|FG004|Overall Study|Physician Decision|1|||
131863323|NCT02596971|474780100|FG000|Overall Study|Death|5|||
131863324|NCT02596971|474780101|FG001|Overall Study|Death|1|||
131863325|NCT02596971|474780102|FG002|Overall Study|Death|5|||
131863326|NCT02596971|474780100|FG000|Overall Study|Withdrawal by Subject|5|||
131863327|NCT02596971|474780101|FG001|Overall Study|Withdrawal by Subject|1|||
131863328|NCT02596971|474780102|FG002|Overall Study|Withdrawal by Subject|4|||
131863329|NCT01401361|474780103|FG000|Overall Study|Withdrawal by Subject|16|||
131863330|NCT01401361|474780103|FG000|Overall Study|Lack of Efficacy|6|||
131863331|NCT01401361|474780103|FG000|Overall Study|Physician Decision|1|||
131863332|NCT01401361|474780103|FG000|Overall Study|Lost to Follow-up|3|||
131863333|NCT01401361|474780103|FG000|Overall Study|Subject/family decision post procedure|2|||
131863334|NCT00595920|474780104|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
131863335|NCT00351468|474780105|FG000|Overall Study|Adverse Event|42|||
131863336|NCT00351468|474780105|FG000|Overall Study|Withdrawal by Subject|39|||
131863337|NCT00351468|474780105|FG000|Overall Study|Various -follow up w clinical team|39|||
131863338|NCT00351468|474780105|FG000|Overall Study|Lack of Efficacy|32|||
131863339|NCT00351468|474780105|FG000|Overall Study|Non-compliance|8|||
131863340|NCT00351468|474780105|FG000|Overall Study|Lost to Follow-up|4|||
131863341|NCT00351468|474780105|FG000|Overall Study|Protocol Violation|3|||
131863342|NCT03588910|474780106|FG000|Overall Study|Withdrawal by Subject|1|||
131863343|NCT03588910|474780107|FG001|Overall Study|Withdrawal by Subject|0|||
131863344|NCT03588910|474780106|FG000|Overall Study|Allergy|2|||
131863345|NCT03588910|474780107|FG001|Overall Study|Allergy|0|||
131863346|NCT03588910|474780106|FG000|Overall Study|Protocol Violation|0|||
131863347|NCT03588910|474780107|FG001|Overall Study|Protocol Violation|3|||
131863348|NCT03588910|474780106|FG000|Overall Study|Did not complete Day 1 Survey|5|||
131863349|NCT03588910|474780107|FG001|Overall Study|Did not complete Day 1 Survey|10|||
131863350|NCT03588910|474780106|FG000|Overall Study|Did not complete Day 7 Survey|5|||
131863351|NCT03588910|474780107|FG001|Overall Study|Did not complete Day 7 Survey|2|||
131863352|NCT02512302|474780108|FG000|Period 1|Adverse Event|0|||
131863353|NCT02512302|474780109|FG001|Period 1|Adverse Event|1|||
131863354|NCT02512302|474780110|FG002|Period 1|Adverse Event|0|||
131863355|NCT02512302|474780111|FG003|Period 1|Adverse Event|0|||
131863356|NCT02512302|474780112|FG004|Period 1|Adverse Event|0|||
131863357|NCT02512302|474780113|FG005|Period 1|Adverse Event|0|||
131863358|NCT02512302|474780114|FG006|Period 1|Adverse Event|0|||
131863359|NCT02512302|474780115|FG007|Period 1|Adverse Event|0|||
131863360|NCT02512302|474780116|FG008|Period 1|Adverse Event|0|||
131863361|NCT02512302|474780117|FG009|Period 1|Adverse Event|0|||
131863362|NCT02512302|474780108|FG000|Period 2|Adverse Event|0|||
131863363|NCT02512302|474780109|FG001|Period 2|Adverse Event|0|||
131863364|NCT02512302|474780110|FG002|Period 2|Adverse Event|0|||
131863365|NCT02512302|474780111|FG003|Period 2|Adverse Event|0|||
131863366|NCT02512302|474780112|FG004|Period 2|Adverse Event|0|||
131863367|NCT02512302|474780113|FG005|Period 2|Adverse Event|0|||
131863368|NCT02512302|474780114|FG006|Period 2|Adverse Event|0|||
131863369|NCT02512302|474780115|FG007|Period 2|Adverse Event|0|||
131863370|NCT02512302|474780116|FG008|Period 2|Adverse Event|0|||
131863371|NCT02512302|474780117|FG009|Period 2|Adverse Event|1|||
131863372|NCT02512302|474780108|FG000|Period 3|Lost to Follow-up|0|||
131863373|NCT02512302|474780109|FG001|Period 3|Lost to Follow-up|0|||
131863374|NCT02512302|474780110|FG002|Period 3|Lost to Follow-up|1|||
131863375|NCT02512302|474780111|FG003|Period 3|Lost to Follow-up|0|||
131863376|NCT02512302|474780112|FG004|Period 3|Lost to Follow-up|0|||
131863377|NCT02512302|474780113|FG005|Period 3|Lost to Follow-up|0|||
131863378|NCT02512302|474780114|FG006|Period 3|Lost to Follow-up|0|||
131863379|NCT02512302|474780115|FG007|Period 3|Lost to Follow-up|0|||
131863380|NCT02512302|474780116|FG008|Period 3|Lost to Follow-up|0|||
131863381|NCT02512302|474780117|FG009|Period 3|Lost to Follow-up|0|||
131863382|NCT02512302|474780108|FG000|Period 4|Adverse Event|0|||
131863383|NCT02512302|474780109|FG001|Period 4|Adverse Event|0|||
131863384|NCT02512302|474780110|FG002|Period 4|Adverse Event|0|||
131863385|NCT02512302|474780111|FG003|Period 4|Adverse Event|0|||
131863386|NCT02512302|474780112|FG004|Period 4|Adverse Event|0|||
131863387|NCT02512302|474780113|FG005|Period 4|Adverse Event|0|||
131863388|NCT02512302|474780114|FG006|Period 4|Adverse Event|1|||
131863389|NCT02512302|474780115|FG007|Period 4|Adverse Event|0|||
131863390|NCT02512302|474780116|FG008|Period 4|Adverse Event|0|||
131863391|NCT02512302|474780117|FG009|Period 4|Adverse Event|0|||
131863392|NCT00471822|474780118|FG000|Overall Study|Protocol Violation|2|||
131863393|NCT00683618|474780119|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
131863394|NCT00683618|474780120|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
131863395|NCT00683618|474780121|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
131863396|NCT00683618|474780119|FG000|Randomised Treatment Period|Protocol Violation|0|||
131863397|NCT00683618|474780120|FG001|Randomised Treatment Period|Protocol Violation|1|||
131863398|NCT00683618|474780121|FG002|Randomised Treatment Period|Protocol Violation|0|||
131863399|NCT00683618|474780119|FG000|Randomised Treatment Period|Adverse Event|2|||
131863400|NCT00683618|474780120|FG001|Randomised Treatment Period|Adverse Event|0|||
131863401|NCT00683618|474780121|FG002|Randomised Treatment Period|Adverse Event|2|||
131863402|NCT00683618|474780119|FG000|Randomised Treatment Period|Reason not provided|0|||
131863403|NCT00683618|474780120|FG001|Randomised Treatment Period|Reason not provided|0|||
131863404|NCT00683618|474780121|FG002|Randomised Treatment Period|Reason not provided|2|||
131863405|NCT00683618|474780119|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
131863406|NCT00683618|474780120|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131863407|NCT00683618|474780121|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
131863408|NCT00683618|474780119|FG000|Extension Treatment Period|Adverse Event|1|||
131863409|NCT00683618|474780120|FG001|Extension Treatment Period|Adverse Event|0|||
131863410|NCT00683618|474780121|FG002|Extension Treatment Period|Adverse Event|0|||
131863411|NCT00683618|474780119|FG000|Extension Treatment Period|Protocol Violation|1|||
131863412|NCT00683618|474780120|FG001|Extension Treatment Period|Protocol Violation|0|||
131863413|NCT00683618|474780121|FG002|Extension Treatment Period|Protocol Violation|0|||
131863414|NCT04067050|474780129|FG000|One Month|Lost to Follow-up|4|||
131863415|NCT04067050|474780130|FG001|One Month|Lost to Follow-up|0|||
131863416|NCT04067050|474780129|FG000|Two Month|Lost to Follow-up|1|||
131863417|NCT04067050|474780130|FG001|Two Month|Lost to Follow-up|0|||
131863418|NCT04067050|474780129|FG000|Two Month|Adverse Event|1|||
131863419|NCT04067050|474780130|FG001|Two Month|Adverse Event|0|||
131863420|NCT01062425|474780135|FG000|Overall Study|Protocol Violation|3|||
131863421|NCT01062425|474780136|FG001|Overall Study|Protocol Violation|6|||
131863422|NCT02342678|474780137|FG000|Overall Study|Lost to Follow-up|0|||
131863423|NCT02342678|474780138|FG001|Overall Study|Lost to Follow-up|1|||
131863424|NCT02342678|474780137|FG000|Overall Study|Too busy to complete study|0|||
131863425|NCT02342678|474780138|FG001|Overall Study|Too busy to complete study|2|||
131863426|NCT02342678|474780137|FG000|Overall Study|Family illness/emergency|0|||
131863427|NCT02342678|474780138|FG001|Overall Study|Family illness/emergency|1|||
131863428|NCT02342678|474780137|FG000|Overall Study|Illness/medical reason|1|||
131863429|NCT02342678|474780138|FG001|Overall Study|Illness/medical reason|1|||
131863430|NCT02383017|474780139|FG000|Overall Study|Injury Sustained Outside Study|1|||
131863431|NCT02383017|474780140|FG001|Overall Study|Injury Sustained Outside Study|0|||
131863432|NCT02383017|474780139|FG000|Overall Study|Compliance|3|||
131863433|NCT02383017|474780140|FG001|Overall Study|Compliance|2|||
131863434|NCT02383017|474780139|FG000|Overall Study|Found to be Hypogonadal|1|||
131863435|NCT02383017|474780140|FG001|Overall Study|Found to be Hypogonadal|0|||
131863436|NCT00460603|474780141|FG000|Phase 1|Death|1|||
131863437|NCT00460603|474780142|FG001|Phase 1|Death|0|||
131863438|NCT00460603|474780143|FG002|Phase 1|Death|0|||
131863439|NCT00460603|474780144|FG003|Phase 1|Death|2|||
131863440|NCT00460603|474780145|FG004|Phase 1|Death|0|||
131863441|NCT00460603|474780146|FG005|Phase 1|Death|0|||
131863442|NCT00460603|474780147|FG006|Phase 1|Death|0|||
131863443|NCT00460603|474780148|FG007|Phase 1|Death|0|||
131863444|NCT00460603|474780149|FG008|Phase 1|Death|1|||
131863445|NCT00460603|474780150|FG009|Phase 1|Death|0|||
131914015|NCT03805841|474971473|FG000|Overall Study|Clinical Progression|2|||
131914016|NCT03805841|474971474|FG001|Overall Study|Clinical Progression|0|||
131914017|NCT03805841|474971475|FG002|Overall Study|Clinical Progression|0|||
131914018|NCT03805841|474971473|FG000|Overall Study|Death|0|||
131914019|NCT03805841|474971474|FG001|Overall Study|Death|3|||
131914020|NCT03805841|474971475|FG002|Overall Study|Death|1|||
131914021|NCT03805841|474971473|FG000|Overall Study|Lost to Follow-up|0|||
131914022|NCT03805841|474971474|FG001|Overall Study|Lost to Follow-up|0|||
131914023|NCT03805841|474971475|FG002|Overall Study|Lost to Follow-up|1|||
131914024|NCT03805841|474971473|FG000|Overall Study|Withdrawal by Subject|2|||
131914025|NCT03805841|474971474|FG001|Overall Study|Withdrawal by Subject|3|||
131914026|NCT03805841|474971475|FG002|Overall Study|Withdrawal by Subject|0|||
131914027|NCT03805841|474971473|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
131914028|NCT03805841|474971474|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
131914029|NCT03805841|474971475|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
131914030|NCT00315445|474971481|FG000|Overall Study|Adverse Event|7|||
131914031|NCT00315445|474971482|FG001|Overall Study|Adverse Event|12|||
131914032|NCT00315445|474971483|FG002|Overall Study|Adverse Event|15|||
131914033|NCT00315445|474971481|FG000|Overall Study|Lack of Efficacy|16|||
131914034|NCT00315445|474971482|FG001|Overall Study|Lack of Efficacy|1|||
131914035|NCT00315445|474971483|FG002|Overall Study|Lack of Efficacy|7|||
131914036|NCT00315445|474971481|FG000|Overall Study|Lost to Follow-up|1|||
131914037|NCT00315445|474971482|FG001|Overall Study|Lost to Follow-up|0|||
131914038|NCT00315445|474971483|FG002|Overall Study|Lost to Follow-up|1|||
131914039|NCT00315445|474971481|FG000|Overall Study|Protocol Violation|2|||
131914040|NCT00315445|474971482|FG001|Overall Study|Protocol Violation|0|||
131914041|NCT00315445|474971483|FG002|Overall Study|Protocol Violation|1|||
131914042|NCT00315445|474971481|FG000|Overall Study|Other|1|||
131914043|NCT00315445|474971482|FG001|Overall Study|Other|3|||
131914044|NCT00315445|474971483|FG002|Overall Study|Other|0|||
131914045|NCT02460289|474971484|FG000|Overall Study|Adverse Event|1|||
131914046|NCT02460289|474971484|FG000|Overall Study|Withdrawal by Subject|8|||
131914047|NCT02460289|474971484|FG000|Overall Study|Lost to Follow-up|1|||
131914048|NCT01977846|474971485|FG000|Total Study - Prospective|Death|0|||
131914049|NCT01977846|474971486|FG001|Total Study - Prospective|Death|1|||
131914050|NCT01977846|474971485|FG000|Total Study - Prospective|Lost to Follow-up|0|||
131914051|NCT01977846|474971486|FG001|Total Study - Prospective|Lost to Follow-up|8|||
131914052|NCT01977846|474971485|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
131914053|NCT01977846|474971486|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
131914054|NCT01977846|474971485|FG000|Total Study - Prospective|Not available at time of visit|0|||
131914055|NCT01977846|474971486|FG001|Total Study - Prospective|Not available at time of visit|5|||
131914056|NCT01977846|474971485|FG000|Total Study - Prospective|No show|0|||
131914057|NCT01977846|474971486|FG001|Total Study - Prospective|No show|1|||
131914058|NCT01977846|474971485|FG000|Total Study - Prospective|Protocol Violation|0|||
131914059|NCT01977846|474971486|FG001|Total Study - Prospective|Protocol Violation|1|||
131408097|NCT02374814|473115348|FG003|Overall Study|Withdrawal by Subject|1|||
131408098|NCT02374814|473115349|FG004|Overall Study|Withdrawal by Subject|0|||
131408099|NCT02374814|473115350|FG005|Overall Study|Withdrawal by Subject|0|||
131863446|NCT00460603|474780151|FG010|Phase 1|Death|0|||
131863447|NCT00460603|474780152|FG011|Phase 1|Death|0|||
131863448|NCT00460603|474780141|FG000|Phase 1|Adverse Event|3|||
131863449|NCT00460603|474780142|FG001|Phase 1|Adverse Event|1|||
131863450|NCT00460603|474780143|FG002|Phase 1|Adverse Event|1|||
131863451|NCT00460603|474780144|FG003|Phase 1|Adverse Event|2|||
131863452|NCT00460603|474780145|FG004|Phase 1|Adverse Event|0|||
131408100|NCT00884039|473115351|FG000|Overall Study|Withdrawal by Subject|0|||
131408101|NCT00884039|473115352|FG001|Overall Study|Withdrawal by Subject|1|||
131863453|NCT00460603|474780146|FG005|Phase 1|Adverse Event|0|||
131863454|NCT00460603|474780147|FG006|Phase 1|Adverse Event|3|||
131863455|NCT00460603|474780148|FG007|Phase 1|Adverse Event|0|||
131863456|NCT00460603|474780149|FG008|Phase 1|Adverse Event|4|||
131863457|NCT00460603|474780150|FG009|Phase 1|Adverse Event|0|||
131863458|NCT00460603|474780151|FG010|Phase 1|Adverse Event|0|||
131914060|NCT00596635|474971492|FG000|Overall Study|Lost to Follow-up|0|||
131914061|NCT00596635|474971493|FG001|Overall Study|Lost to Follow-up|2|||
131914062|NCT00596635|474971494|FG002|Overall Study|Lost to Follow-up|0|||
131914063|NCT00596635|474971492|FG000|Overall Study|Treatment for symptomatic UTI|4|||
131914064|NCT00596635|474971493|FG001|Overall Study|Treatment for symptomatic UTI|6|||
131914065|NCT00596635|474971494|FG002|Overall Study|Treatment for symptomatic UTI|3|||
131914066|NCT00596635|474971492|FG000|Overall Study|Hip fracture|2|||
131914067|NCT00596635|474971493|FG001|Overall Study|Hip fracture|3|||
131914068|NCT00596635|474971494|FG002|Overall Study|Hip fracture|3|||
131408102|NCT00884039|473115351|FG000|Overall Study|Lack of Efficacy|2|||
131863459|NCT00460603|474780152|FG011|Phase 1|Adverse Event|0|||
131863460|NCT00460603|474780141|FG000|Phase 1|Lack of Efficacy|1|||
131863461|NCT00460603|474780142|FG001|Phase 1|Lack of Efficacy|0|||
131914069|NCT00596635|474971492|FG000|Overall Study|Could not provide urine specimen|1|||
131914070|NCT00596635|474971493|FG001|Overall Study|Could not provide urine specimen|2|||
131914071|NCT00596635|474971494|FG002|Overall Study|Could not provide urine specimen|2|||
131914072|NCT01101178|474971495|FG000|Period 1|Withdrawal by Subject|1|||
131914073|NCT01101178|474971496|FG001|Period 1|Withdrawal by Subject|2|||
131914074|NCT01101178|474971495|FG000|Period 1|Positive drug screen|1|||
131914075|NCT01101178|474971496|FG001|Period 1|Positive drug screen|1|||
131914076|NCT01101178|474971495|FG000|Period 1|Adverse Event|2|||
131914077|NCT01101178|474971496|FG001|Period 1|Adverse Event|1|||
131914078|NCT01101178|474971495|FG000|Period 2|Withdrawal by Subject|0|||
131914079|NCT01101178|474971496|FG001|Period 2|Withdrawal by Subject|1|||
131914080|NCT01850641|474971497|FG000|Overall Study|Physician Decision|1|||
131914081|NCT01850641|474971497|FG000|Overall Study|Decrease in serum phosphorus|1|||
131914082|NCT01850641|474971497|FG000|Overall Study|Decrease in serum calcium|2|||
131914083|NCT01850641|474971497|FG000|Overall Study|Increase in serum ferritin|1|||
131914084|NCT00141817|474971498|FG000|Overall Study|Protocol Violation|0|||
131914085|NCT00141817|474971499|FG001|Overall Study|Protocol Violation|0|||
131914086|NCT00141817|474971500|FG002|Overall Study|Protocol Violation|1|||
131914087|NCT00141817|474971501|FG003|Overall Study|Protocol Violation|0|||
131914088|NCT00141817|474971498|FG000|Overall Study|Parent request|1|||
131914089|NCT00141817|474971499|FG001|Overall Study|Parent request|0|||
131914090|NCT00141817|474971500|FG002|Overall Study|Parent request|0|||
131914091|NCT00141817|474971501|FG003|Overall Study|Parent request|0|||
131914092|NCT00846365|474971506|FG000|Overall Study|Adverse Event|20|||
131914093|NCT00846365|474971507|FG001|Overall Study|Adverse Event|30|||
131914094|NCT00846365|474971508|FG002|Overall Study|Adverse Event|11|||
131914095|NCT00846365|474971506|FG000|Overall Study|Protocol Violation|5|||
131914096|NCT00846365|474971507|FG001|Overall Study|Protocol Violation|4|||
131914097|NCT00846365|474971508|FG002|Overall Study|Protocol Violation|0|||
131914098|NCT00846365|474971506|FG000|Overall Study|Lost to Follow-up|8|||
131914099|NCT00846365|474971507|FG001|Overall Study|Lost to Follow-up|2|||
131914100|NCT00846365|474971508|FG002|Overall Study|Lost to Follow-up|5|||
131914101|NCT00846365|474971506|FG000|Overall Study|Withdrawal by Subject|11|||
131914102|NCT00846365|474971507|FG001|Overall Study|Withdrawal by Subject|11|||
131914103|NCT00846365|474971508|FG002|Overall Study|Withdrawal by Subject|9|||
131914104|NCT00846365|474971506|FG000|Overall Study|Pregnancy|1|||
131914105|NCT00846365|474971507|FG001|Overall Study|Pregnancy|0|||
131914106|NCT00846365|474971508|FG002|Overall Study|Pregnancy|0|||
131914107|NCT00846365|474971506|FG000|Overall Study|Lack of Efficacy|1|||
131914108|NCT00846365|474971507|FG001|Overall Study|Lack of Efficacy|1|||
131914109|NCT00846365|474971508|FG002|Overall Study|Lack of Efficacy|2|||
131914110|NCT00846365|474971506|FG000|Overall Study|Other|9|||
131914111|NCT00846365|474971507|FG001|Overall Study|Other|1|||
131914112|NCT00846365|474971508|FG002|Overall Study|Other|6|||
131914113|NCT01925417|474971511|FG000|Overall Study|Withdrawal by Subject|2|||
131914114|NCT01925417|474971511|FG000|Overall Study|Death|1|||
131914115|NCT03479905|474971512|FG000|Overall Study|Other airway method used|4|||
131914116|NCT03479905|474971513|FG001|Overall Study|Other airway method used|5|||
131914117|NCT03479905|474971514|FG002|Overall Study|Other airway method used|5|||
131914118|NCT00862992|474971515|FG000|Overall Study|Adverse Event|2|||
131914119|NCT00862992|474971516|FG001|Overall Study|Adverse Event|1|||
131914120|NCT00862992|474971517|FG002|Overall Study|Adverse Event|1|||
131914121|NCT00862992|474971515|FG000|Overall Study|Physician Decision|1|||
131914122|NCT00862992|474971516|FG001|Overall Study|Physician Decision|0|||
131914123|NCT00862992|474971517|FG002|Overall Study|Physician Decision|0|||
131914124|NCT00862992|474971515|FG000|Overall Study|Withdrawal by Subject|0|||
131914125|NCT00862992|474971516|FG001|Overall Study|Withdrawal by Subject|0|||
131914126|NCT00862992|474971517|FG002|Overall Study|Withdrawal by Subject|2|||
131914127|NCT02318940|474971518|FG000|Overall Study|lost the record|1|||
131914128|NCT02318940|474971519|FG001|Overall Study|lost the record|0|||
131914129|NCT01047319|474971520|FG000|Overall Study|Teva requested participant withdrawal|3|||
131914130|NCT01047319|474971521|FG001|Overall Study|Teva requested participant withdrawal|0|||
131408103|NCT00884039|473115352|FG001|Overall Study|Lack of Efficacy|0|||
131408104|NCT00624819|473115355|FG000|Follow-up Period: Year 4|Parents decision|0|||
131914131|NCT01047319|474971522|FG002|Overall Study|Teva requested participant withdrawal|1|||
131914132|NCT01047319|474971520|FG000|Overall Study|Protocol Violation|3|||
131914133|NCT01047319|474971521|FG001|Overall Study|Protocol Violation|2|||
131914134|NCT01047319|474971522|FG002|Overall Study|Protocol Violation|4|||
131914135|NCT01047319|474971520|FG000|Overall Study|Lack of Efficacy|4|||
131914136|NCT01047319|474971521|FG001|Overall Study|Lack of Efficacy|3|||
131914137|NCT01047319|474971522|FG002|Overall Study|Lack of Efficacy|3|||
131914138|NCT01047319|474971520|FG000|Overall Study|Death|5|||
131914139|NCT01047319|474971521|FG001|Overall Study|Death|1|||
131914140|NCT01047319|474971522|FG002|Overall Study|Death|5|||
131914141|NCT01047319|474971520|FG000|Overall Study|Pregnancy|13|||
131914142|NCT01047319|474971521|FG001|Overall Study|Pregnancy|8|||
131914143|NCT01047319|474971522|FG002|Overall Study|Pregnancy|8|||
131914144|NCT01047319|474971520|FG000|Overall Study|Physician Decision|12|||
131914145|NCT01047319|474971521|FG001|Overall Study|Physician Decision|9|||
131914146|NCT01047319|474971522|FG002|Overall Study|Physician Decision|10|||
131914147|NCT01047319|474971520|FG000|Overall Study|Lost to Follow-up|14|||
131914148|NCT01047319|474971521|FG001|Overall Study|Lost to Follow-up|10|||
131914149|NCT01047319|474971522|FG002|Overall Study|Lost to Follow-up|10|||
131914150|NCT01047319|474971520|FG000|Overall Study|Adverse Event|16|||
131914151|NCT01047319|474971521|FG001|Overall Study|Adverse Event|27|||
131914152|NCT01047319|474971522|FG002|Overall Study|Adverse Event|21|||
131914153|NCT01047319|474971520|FG000|Overall Study|Withdrawal by Subject|77|||
131914154|NCT01047319|474971521|FG001|Overall Study|Withdrawal by Subject|75|||
131914155|NCT01047319|474971522|FG002|Overall Study|Withdrawal by Subject|87|||
131914156|NCT01047319|474971520|FG000|Overall Study|Study terminated by Sponsor|198|||
131914157|NCT01047319|474971521|FG001|Overall Study|Study terminated by Sponsor|215|||
131914158|NCT01047319|474971522|FG002|Overall Study|Study terminated by Sponsor|203|||
131914159|NCT02696798|474971523|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
131914160|NCT02696798|474971524|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
131914161|NCT02696798|474971525|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
131914162|NCT02696798|474971523|FG000|Blinded Treatment Dosing Period|Death|0|||
131914163|NCT02696798|474971524|FG001|Blinded Treatment Dosing Period|Death|0|||
131914164|NCT02696798|474971525|FG002|Blinded Treatment Dosing Period|Death|1|||
131914165|NCT02696798|474971523|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
131914166|NCT02696798|474971524|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
131914167|NCT02696798|474971525|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
131914168|NCT02696798|474971523|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
131914169|NCT02696798|474971524|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
131914170|NCT02696798|474971525|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
131914171|NCT02696798|474971523|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
131914172|NCT02696798|474971524|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
131914173|NCT02696798|474971525|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
131914174|NCT02696798|474971523|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
131914175|NCT02696798|474971524|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
131914176|NCT02696798|474971525|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
131914177|NCT02696798|474971523|FG000|Extended Treatment Period|Adverse Event|1|||
131914178|NCT02696798|474971524|FG001|Extended Treatment Period|Adverse Event|4|||
131914179|NCT02696798|474971525|FG002|Extended Treatment Period|Adverse Event|5|||
131914180|NCT02696798|474971523|FG000|Extended Treatment Period|Lack of Efficacy|7|||
131914181|NCT02696798|474971524|FG001|Extended Treatment Period|Lack of Efficacy|2|||
131914182|NCT02696798|474971525|FG002|Extended Treatment Period|Lack of Efficacy|2|||
131914183|NCT02696798|474971523|FG000|Extended Treatment Period|Lost to Follow-up|1|||
131914184|NCT02696798|474971524|FG001|Extended Treatment Period|Lost to Follow-up|0|||
131914185|NCT02696798|474971525|FG002|Extended Treatment Period|Lost to Follow-up|0|||
131914186|NCT02696798|474971523|FG000|Extended Treatment Period|Physician Decision|0|||
131914187|NCT02696798|474971524|FG001|Extended Treatment Period|Physician Decision|1|||
131914188|NCT02696798|474971525|FG002|Extended Treatment Period|Physician Decision|0|||
131914189|NCT02696798|474971523|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
131914190|NCT02696798|474971524|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
131914191|NCT02696798|474971525|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
131914192|NCT02696798|474971523|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
131914193|NCT02696798|474971524|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
131914194|NCT02696798|474971525|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
131914195|NCT02696798|474971523|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
131914196|NCT02696798|474971524|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
131914197|NCT02696798|474971525|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
131914198|NCT02696798|474971523|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
131914199|NCT02696798|474971524|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
131914200|NCT02696798|474971525|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
131914201|NCT02696798|474971523|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
131914202|NCT02696798|474971524|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
131914203|NCT02696798|474971525|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
131914204|NCT02696798|474971523|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
131914205|NCT02696798|474971524|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
131914206|NCT02696798|474971525|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
131914207|NCT02696798|474971523|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
131914208|NCT02696798|474971524|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
131914209|NCT02696798|474971525|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
131914210|NCT03454555|474973041|FG000|Overall Study|Death|6|||
131914211|NCT03454555|474973042|FG001|Overall Study|Death|6|||
131914212|NCT03454555|474973041|FG000|Overall Study|Lost to Follow-up|31|||
131914213|NCT03454555|474973042|FG001|Overall Study|Lost to Follow-up|12|||
131914214|NCT03454555|474973041|FG000|Overall Study|Physician Decision|2|||
131914215|NCT03454555|474973042|FG001|Overall Study|Physician Decision|6|||
131914216|NCT03454555|474973041|FG000|Overall Study|Withdrawal by Subject|34|||
131914217|NCT03454555|474973042|FG001|Overall Study|Withdrawal by Subject|5|||
131408105|NCT00624819|473115356|FG001|Follow-up Period: Year 4|Parents decision|0|||
131914218|NCT03454555|474973041|FG000|Overall Study|Ineligible|1|||
131914219|NCT03454555|474973042|FG001|Overall Study|Ineligible|5|||
131914220|NCT01386385|474973043|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
131914221|NCT01386385|474973044|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914222|NCT01386385|474973045|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914223|NCT01386385|474973046|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914224|NCT01386385|474973047|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914225|NCT01386385|474973048|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914226|NCT01386385|474973049|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914227|NCT01386385|474973050|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
131914228|NCT01386385|474973043|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
131914229|NCT01386385|474973044|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914230|NCT01386385|474973045|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914231|NCT01386385|474973046|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914232|NCT01386385|474973047|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914233|NCT01386385|474973048|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914234|NCT01386385|474973049|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914235|NCT01386385|474973050|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
131914236|NCT01386385|474973043|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914237|NCT01386385|474973044|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914238|NCT01386385|474973045|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
131914239|NCT01386385|474973046|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914240|NCT01386385|474973047|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914241|NCT01386385|474973048|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914242|NCT01386385|474973049|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914243|NCT01386385|474973050|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
131914244|NCT01386385|474973043|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131914245|NCT01386385|474973044|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131914246|NCT01386385|474973045|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131914247|NCT01386385|474973046|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131914248|NCT01386385|474973047|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
131863462|NCT00460603|474780143|FG002|Phase 1|Lack of Efficacy|1|||
131863463|NCT00460603|474780144|FG003|Phase 1|Lack of Efficacy|2|||
131863464|NCT00460603|474780145|FG004|Phase 1|Lack of Efficacy|2|||
131863465|NCT00460603|474780146|FG005|Phase 1|Lack of Efficacy|2|||
131863466|NCT00460603|474780147|FG006|Phase 1|Lack of Efficacy|2|||
131863467|NCT00460603|474780148|FG007|Phase 1|Lack of Efficacy|2|||
131863468|NCT00460603|474780149|FG008|Phase 1|Lack of Efficacy|11|||
131863469|NCT00460603|474780150|FG009|Phase 1|Lack of Efficacy|0|||
131863470|NCT00460603|474780151|FG010|Phase 1|Lack of Efficacy|0|||
131863471|NCT00460603|474780152|FG011|Phase 1|Lack of Efficacy|0|||
131863472|NCT00460603|474780141|FG000|Phase 1|Withdrawal by Subject|1|||
131863473|NCT00460603|474780142|FG001|Phase 1|Withdrawal by Subject|2|||
131863474|NCT00460603|474780143|FG002|Phase 1|Withdrawal by Subject|1|||
131863475|NCT00460603|474780144|FG003|Phase 1|Withdrawal by Subject|1|||
131863476|NCT00460603|474780145|FG004|Phase 1|Withdrawal by Subject|3|||
131863477|NCT00460603|474780146|FG005|Phase 1|Withdrawal by Subject|0|||
131863478|NCT00460603|474780147|FG006|Phase 1|Withdrawal by Subject|1|||
131863479|NCT00460603|474780148|FG007|Phase 1|Withdrawal by Subject|0|||
131863480|NCT00460603|474780149|FG008|Phase 1|Withdrawal by Subject|2|||
131863481|NCT00460603|474780150|FG009|Phase 1|Withdrawal by Subject|0|||
131863482|NCT00460603|474780151|FG010|Phase 1|Withdrawal by Subject|0|||
131863483|NCT00460603|474780152|FG011|Phase 1|Withdrawal by Subject|0|||
131863484|NCT00460603|474780141|FG000|Phase 1|Other|0|||
131863485|NCT00460603|474780142|FG001|Phase 1|Other|3|||
131863486|NCT00460603|474780143|FG002|Phase 1|Other|1|||
131863487|NCT00460603|474780144|FG003|Phase 1|Other|1|||
131863488|NCT00460603|474780145|FG004|Phase 1|Other|1|||
131863489|NCT00460603|474780146|FG005|Phase 1|Other|2|||
131863490|NCT00460603|474780147|FG006|Phase 1|Other|0|||
131863491|NCT00460603|474780148|FG007|Phase 1|Other|1|||
131863492|NCT00460603|474780149|FG008|Phase 1|Other|0|||
131863493|NCT00460603|474780150|FG009|Phase 1|Other|0|||
131863494|NCT00460603|474780151|FG010|Phase 1|Other|0|||
131863495|NCT00460603|474780152|FG011|Phase 1|Other|0|||
131863496|NCT00460603|474780141|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863497|NCT00460603|474780142|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863498|NCT00460603|474780143|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863499|NCT00460603|474780144|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863500|NCT00460603|474780145|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863501|NCT00460603|474780146|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863502|NCT00460603|474780147|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863503|NCT00460603|474780148|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863504|NCT00460603|474780149|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863505|NCT00460603|474780150|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
131863506|NCT00460603|474780151|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863507|NCT00460603|474780152|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
131863508|NCT00460603|474780141|FG000|Phase 2|Adverse Event|0|||
131863509|NCT00460603|474780142|FG001|Phase 2|Adverse Event|0|||
131863510|NCT00460603|474780143|FG002|Phase 2|Adverse Event|0|||
131863511|NCT00460603|474780144|FG003|Phase 2|Adverse Event|0|||
131863512|NCT00460603|474780145|FG004|Phase 2|Adverse Event|0|||
131914249|NCT01386385|474973048|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131914250|NCT01386385|474973049|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131914251|NCT01386385|474973050|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
131863513|NCT00460603|474780146|FG005|Phase 2|Adverse Event|0|||
131863514|NCT00460603|474780147|FG006|Phase 2|Adverse Event|0|||
131863515|NCT00460603|474780148|FG007|Phase 2|Adverse Event|0|||
131863516|NCT00460603|474780149|FG008|Phase 2|Adverse Event|0|||
131863517|NCT00460603|474780150|FG009|Phase 2|Adverse Event|12|||
131863518|NCT00460603|474780151|FG010|Phase 2|Adverse Event|9|||
131863519|NCT00460603|474780152|FG011|Phase 2|Adverse Event|10|||
131863520|NCT00460603|474780141|FG000|Phase 2|Death|0|||
131863521|NCT00460603|474780142|FG001|Phase 2|Death|0|||
131863522|NCT00460603|474780143|FG002|Phase 2|Death|0|||
131863523|NCT00460603|474780144|FG003|Phase 2|Death|0|||
131863524|NCT00460603|474780145|FG004|Phase 2|Death|0|||
131863525|NCT00460603|474780146|FG005|Phase 2|Death|0|||
131863526|NCT00460603|474780147|FG006|Phase 2|Death|0|||
131863527|NCT00460603|474780148|FG007|Phase 2|Death|0|||
131863528|NCT00460603|474780149|FG008|Phase 2|Death|0|||
131863529|NCT00460603|474780150|FG009|Phase 2|Death|4|||
131863530|NCT00460603|474780151|FG010|Phase 2|Death|2|||
131863531|NCT00460603|474780152|FG011|Phase 2|Death|2|||
131863532|NCT00460603|474780141|FG000|Phase 2|Protocol Violation|0|||
131863533|NCT00460603|474780142|FG001|Phase 2|Protocol Violation|0|||
131863534|NCT00460603|474780143|FG002|Phase 2|Protocol Violation|0|||
131863535|NCT00460603|474780144|FG003|Phase 2|Protocol Violation|0|||
131863536|NCT00460603|474780145|FG004|Phase 2|Protocol Violation|0|||
131863537|NCT00460603|474780146|FG005|Phase 2|Protocol Violation|0|||
131863538|NCT00460603|474780147|FG006|Phase 2|Protocol Violation|0|||
131863539|NCT00460603|474780148|FG007|Phase 2|Protocol Violation|0|||
131863540|NCT00460603|474780149|FG008|Phase 2|Protocol Violation|0|||
131863541|NCT00460603|474780150|FG009|Phase 2|Protocol Violation|1|||
131863542|NCT00460603|474780151|FG010|Phase 2|Protocol Violation|1|||
131863543|NCT00460603|474780152|FG011|Phase 2|Protocol Violation|0|||
131863544|NCT00460603|474780141|FG000|Phase 2|Lost to Follow-up|0|||
131863545|NCT00460603|474780142|FG001|Phase 2|Lost to Follow-up|0|||
131863546|NCT00460603|474780143|FG002|Phase 2|Lost to Follow-up|0|||
131863547|NCT00460603|474780144|FG003|Phase 2|Lost to Follow-up|0|||
131863548|NCT00460603|474780145|FG004|Phase 2|Lost to Follow-up|0|||
131863549|NCT00460603|474780146|FG005|Phase 2|Lost to Follow-up|0|||
131863550|NCT00460603|474780147|FG006|Phase 2|Lost to Follow-up|0|||
131863551|NCT00460603|474780148|FG007|Phase 2|Lost to Follow-up|0|||
131863552|NCT00460603|474780149|FG008|Phase 2|Lost to Follow-up|0|||
131863553|NCT00460603|474780150|FG009|Phase 2|Lost to Follow-up|1|||
131863554|NCT00460603|474780151|FG010|Phase 2|Lost to Follow-up|0|||
131914252|NCT01386385|474973043|FG000|Phase II Concurrent CRT|Adverse Event|0|||
131914253|NCT01386385|474973044|FG001|Phase II Concurrent CRT|Adverse Event|0|||
131914254|NCT01386385|474973045|FG002|Phase II Concurrent CRT|Adverse Event|0|||
131863555|NCT00460603|474780152|FG011|Phase 2|Lost to Follow-up|0|||
131863556|NCT00460603|474780141|FG000|Phase 2|Other|0|||
131863557|NCT00460603|474780142|FG001|Phase 2|Other|0|||
131863558|NCT00460603|474780143|FG002|Phase 2|Other|0|||
131863559|NCT00460603|474780144|FG003|Phase 2|Other|0|||
131863560|NCT00460603|474780145|FG004|Phase 2|Other|0|||
131863561|NCT00460603|474780146|FG005|Phase 2|Other|0|||
131863562|NCT00460603|474780147|FG006|Phase 2|Other|0|||
131863563|NCT00460603|474780148|FG007|Phase 2|Other|0|||
131863564|NCT00460603|474780149|FG008|Phase 2|Other|0|||
131863565|NCT00460603|474780150|FG009|Phase 2|Other|6|||
131863566|NCT00460603|474780151|FG010|Phase 2|Other|16|||
131863567|NCT00460603|474780152|FG011|Phase 2|Other|7|||
131863568|NCT00460603|474780141|FG000|Phase 2|Objective Progression or Relapse|0|||
131863569|NCT00460603|474780142|FG001|Phase 2|Objective Progression or Relapse|0|||
131863570|NCT00460603|474780143|FG002|Phase 2|Objective Progression or Relapse|0|||
131863571|NCT00460603|474780144|FG003|Phase 2|Objective Progression or Relapse|0|||
131863572|NCT00460603|474780145|FG004|Phase 2|Objective Progression or Relapse|0|||
131863573|NCT00460603|474780146|FG005|Phase 2|Objective Progression or Relapse|0|||
131863574|NCT00460603|474780147|FG006|Phase 2|Objective Progression or Relapse|0|||
131914255|NCT01386385|474973046|FG003|Phase II Concurrent CRT|Adverse Event|0|||
131863575|NCT00460603|474780148|FG007|Phase 2|Objective Progression or Relapse|0|||
131863576|NCT00460603|474780149|FG008|Phase 2|Objective Progression or Relapse|0|||
131863577|NCT00460603|474780150|FG009|Phase 2|Objective Progression or Relapse|9|||
131863578|NCT00460603|474780151|FG010|Phase 2|Objective Progression or Relapse|10|||
131863579|NCT00460603|474780152|FG011|Phase 2|Objective Progression or Relapse|17|||
131863580|NCT00460603|474780141|FG000|Phase 2|Global Deterioration of Health Status|0|||
131863581|NCT00460603|474780142|FG001|Phase 2|Global Deterioration of Health Status|0|||
131863582|NCT00460603|474780143|FG002|Phase 2|Global Deterioration of Health Status|0|||
131863583|NCT00460603|474780144|FG003|Phase 2|Global Deterioration of Health Status|0|||
131863584|NCT00460603|474780145|FG004|Phase 2|Global Deterioration of Health Status|0|||
131863585|NCT00460603|474780146|FG005|Phase 2|Global Deterioration of Health Status|0|||
131863586|NCT00460603|474780147|FG006|Phase 2|Global Deterioration of Health Status|0|||
131863587|NCT00460603|474780148|FG007|Phase 2|Global Deterioration of Health Status|0|||
131863588|NCT00460603|474780149|FG008|Phase 2|Global Deterioration of Health Status|0|||
131863589|NCT00460603|474780150|FG009|Phase 2|Global Deterioration of Health Status|0|||
131863590|NCT00460603|474780151|FG010|Phase 2|Global Deterioration of Health Status|1|||
131863591|NCT00460603|474780152|FG011|Phase 2|Global Deterioration of Health Status|0|||
131863592|NCT00460603|474780141|FG000|Phase 2|Withdrawal by Subject|0|||
131863593|NCT00460603|474780142|FG001|Phase 2|Withdrawal by Subject|0|||
131863594|NCT00460603|474780143|FG002|Phase 2|Withdrawal by Subject|0|||
131863595|NCT00460603|474780144|FG003|Phase 2|Withdrawal by Subject|0|||
131863596|NCT00460603|474780145|FG004|Phase 2|Withdrawal by Subject|0|||
131863597|NCT00460603|474780146|FG005|Phase 2|Withdrawal by Subject|0|||
131863598|NCT00460603|474780147|FG006|Phase 2|Withdrawal by Subject|0|||
131863599|NCT00460603|474780148|FG007|Phase 2|Withdrawal by Subject|0|||
131863600|NCT00460603|474780149|FG008|Phase 2|Withdrawal by Subject|0|||
131863601|NCT00460603|474780150|FG009|Phase 2|Withdrawal by Subject|5|||
131863602|NCT00460603|474780151|FG010|Phase 2|Withdrawal by Subject|4|||
131863603|NCT00460603|474780152|FG011|Phase 2|Withdrawal by Subject|5|||
131863604|NCT00460603|474780141|FG000|Phase 2|Randomized, but not treated|0|||
131863605|NCT00460603|474780142|FG001|Phase 2|Randomized, but not treated|0|||
131863606|NCT00460603|474780143|FG002|Phase 2|Randomized, but not treated|0|||
131863607|NCT00460603|474780144|FG003|Phase 2|Randomized, but not treated|0|||
131863608|NCT00460603|474780145|FG004|Phase 2|Randomized, but not treated|0|||
131863609|NCT00460603|474780146|FG005|Phase 2|Randomized, but not treated|0|||
131863610|NCT00460603|474780147|FG006|Phase 2|Randomized, but not treated|0|||
131863611|NCT00460603|474780148|FG007|Phase 2|Randomized, but not treated|0|||
131863612|NCT00460603|474780149|FG008|Phase 2|Randomized, but not treated|0|||
131863613|NCT00460603|474780150|FG009|Phase 2|Randomized, but not treated|3|||
131863614|NCT00460603|474780151|FG010|Phase 2|Randomized, but not treated|0|||
131863615|NCT00460603|474780152|FG011|Phase 2|Randomized, but not treated|0|||
131863616|NCT03003962|474780153|FG000|Overall Study|Withdrawal by Subject|5|||
131863617|NCT03003962|474780154|FG001|Overall Study|Withdrawal by Subject|17|||
131863618|NCT03003962|474780153|FG000|Overall Study|Death|274|||
131863619|NCT03003962|474780154|FG001|Overall Study|Death|277|||
131863620|NCT03003962|474780153|FG000|Overall Study|Participants ongoing at DCO|55|||
131863621|NCT03003962|474780154|FG001|Overall Study|Participants ongoing at DCO|40|||
131863622|NCT00289848|474780155|FG000|Overall Study|Adverse Event|6|||
131863623|NCT00289848|474780156|FG001|Overall Study|Adverse Event|4|||
131863624|NCT00289848|474780155|FG000|Overall Study|Death|1|||
131863625|NCT00289848|474780156|FG001|Overall Study|Death|0|||
131863626|NCT00289848|474780155|FG000|Overall Study|Lack of Efficacy|20|||
131863627|NCT00289848|474780156|FG001|Overall Study|Lack of Efficacy|24|||
131863628|NCT00289848|474780155|FG000|Overall Study|Lost to Follow-up|3|||
131863629|NCT00289848|474780156|FG001|Overall Study|Lost to Follow-up|1|||
131863630|NCT00289848|474780155|FG000|Overall Study|Protocol Violation|5|||
131863631|NCT00289848|474780156|FG001|Overall Study|Protocol Violation|2|||
131863632|NCT00289848|474780155|FG000|Overall Study|Withdrawal by Subject|5|||
131863633|NCT00289848|474780156|FG001|Overall Study|Withdrawal by Subject|11|||
131863634|NCT00289848|474780155|FG000|Overall Study|Patient Moved|6|||
131863635|NCT00289848|474780156|FG001|Overall Study|Patient Moved|2|||
131863636|NCT00289848|474780155|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
131863637|NCT00289848|474780156|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
131863638|NCT03871543|474780159|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
131863639|NCT03871543|474780159|FG000|Period 1|Investigator Error|1|||
131863640|NCT03871543|474780159|FG000|Period 1|Protocol Violation|2|||
131863641|NCT03871543|474780159|FG000|Period 1|COVID-19 Related|1|||
131863642|NCT03871543|474780159|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
131863643|NCT03871543|474780159|FG000|Period 1|Withdrawal by Subject|10|||
131863644|NCT03871543|474780159|FG000|Period 2|Adverse Event|1|||
131863645|NCT03871543|474780159|FG000|Period 2|Withdrawal by Subject|1|||
131863646|NCT03428152|474780167|FG000|Overall Study|Physician Decision|4|||
131863647|NCT03428152|474780168|FG001|Overall Study|Physician Decision|2|||
131863648|NCT03428152|474780167|FG000|Overall Study|Protocol Violation|3|||
131863649|NCT03428152|474780168|FG001|Overall Study|Protocol Violation|5|||
131914256|NCT01386385|474973047|FG004|Phase II Concurrent CRT|Adverse Event|0|||
131863650|NCT03428152|474780167|FG000|Overall Study|Lack of Efficacy|0|||
131863651|NCT03428152|474780168|FG001|Overall Study|Lack of Efficacy|4|||
131863652|NCT04616612|474780172|FG000|Overall Study|Lost to Follow-up|6|||
131863653|NCT04616612|474780173|FG001|Overall Study|Lost to Follow-up|3|||
131863654|NCT04740918|474780174|FG000|Overall Study|Study Terminated by Sponsor|41|||
131863655|NCT04740918|474780175|FG001|Overall Study|Study Terminated by Sponsor|32|||
131863656|NCT04740918|474780174|FG000|Overall Study|Death|3|||
131863657|NCT04740918|474780175|FG001|Overall Study|Death|6|||
131863658|NCT04740918|474780174|FG000|Overall Study|Withdrawal by Subject|5|||
131863659|NCT04740918|474780175|FG001|Overall Study|Withdrawal by Subject|4|||
131863660|NCT04740918|474780174|FG000|Overall Study|Lost to Follow-up|1|||
131863661|NCT04740918|474780175|FG001|Overall Study|Lost to Follow-up|3|||
131863662|NCT04740918|474780174|FG000|Overall Study|Progressive disease|0|||
131914257|NCT01386385|474973048|FG005|Phase II Concurrent CRT|Adverse Event|0|||
131914258|NCT01386385|474973049|FG006|Phase II Concurrent CRT|Adverse Event|3|||
131914259|NCT01386385|474973050|FG007|Phase II Concurrent CRT|Adverse Event|3|||
131914260|NCT01386385|474973043|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131914261|NCT01386385|474973044|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131408106|NCT00624819|473115357|FG002|Follow-up Period: Year 4|Parents decision|1|||
131863663|NCT04740918|474780175|FG001|Overall Study|Progressive disease|1|||
131863664|NCT02524847|474780177|FG000|Overall Study|Adverse Event|4|||
131863665|NCT02524847|474780177|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
131863666|NCT02524847|474780177|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
131863667|NCT02524847|474780177|FG000|Overall Study|Death|1|||
131863668|NCT02524847|474780177|FG000|Overall Study|Reason not Specified|1|||
131863669|NCT01326845|474780178|FG000|Overall Study|Administrative Problems|5|||
131863670|NCT01326845|474780179|FG001|Overall Study|Administrative Problems|2|||
131863671|NCT01326845|474780178|FG000|Overall Study|Adverse Event|1|||
131863672|NCT01326845|474780179|FG001|Overall Study|Adverse Event|0|||
131863673|NCT01326845|474780178|FG000|Overall Study|Misisng|1|||
131863674|NCT01326845|474780179|FG001|Overall Study|Misisng|3|||
131863675|NCT04352101|474780180|FG000|Overall Study|Physician Decision|2|||
131863676|NCT04352101|474780181|FG001|Overall Study|Physician Decision|1|||
131863677|NCT04564092|474780189|FG000|Overall Study|Withdrawal by Subject|1|||
131863678|NCT02107131|474780192|FG000|Overall Study|Lost to Follow-up|4|||
131863679|NCT02107131|474780193|FG001|Overall Study|Lost to Follow-up|4|||
131863680|NCT02107131|474780192|FG000|Overall Study|Physician Decision|1|||
131863681|NCT02107131|474780193|FG001|Overall Study|Physician Decision|0|||
131863682|NCT02107131|474780192|FG000|Overall Study|Withdrawal by Subject|2|||
131863683|NCT02107131|474780193|FG001|Overall Study|Withdrawal by Subject|0|||
131863684|NCT02107131|474780192|FG000|Overall Study|mental instability|1|||
131863685|NCT02107131|474780193|FG001|Overall Study|mental instability|0|||
131863686|NCT02107131|474780192|FG000|Overall Study|Death|0|||
131863687|NCT02107131|474780193|FG001|Overall Study|Death|1|||
131863688|NCT02107131|474780192|FG000|Overall Study|Protocol Violation|0|||
131863689|NCT02107131|474780193|FG001|Overall Study|Protocol Violation|4|||
131863690|NCT02729025|474780194|FG000|Overall Study|Sponsor Decision|0|||
131863691|NCT02729025|474780195|FG001|Overall Study|Sponsor Decision|1|||
131863692|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Adverse Event|7|||
131863693|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
131863694|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Non-compliance|3|||
131863695|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Other|17|||
131863696|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Physician Decision|2|||
131863697|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Pregnancy|1|||
131863698|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
131863699|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
131863700|NCT05207865|474782220|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
131863701|NCT05207865|474782220|FG000|Follow-up Phase|Lost to Follow-up|1|||
131863702|NCT05207865|474782220|FG000|Follow-up Phase|Non-compliance|1|||
131863703|NCT05207865|474782220|FG000|Follow-up Phase|Not reported|2|||
131863704|NCT05207865|474782220|FG000|Follow-up Phase|Not collected|11|||
131863705|NCT03985800|474782226|FG000|Overall Study|Death|1|||
131863706|NCT03985800|474782227|FG001|Overall Study|Death|2|||
131863707|NCT03985800|474782226|FG000|Overall Study|Withdrawal by Subject|3|||
131863708|NCT03985800|474782227|FG001|Overall Study|Withdrawal by Subject|6|||
131863709|NCT03985800|474782226|FG000|Overall Study|Protocol Violation|2|||
131863710|NCT03985800|474782227|FG001|Overall Study|Protocol Violation|0|||
131863711|NCT03593525|474782239|FG000|Overall Study|Withdrawal by Subject|1|||
131863712|NCT03593525|474782240|FG001|Overall Study|Withdrawal by Subject|0|||
131863713|NCT03593525|474782239|FG000|Overall Study|Lost to Follow-up|7|||
131863714|NCT03593525|474782240|FG001|Overall Study|Lost to Follow-up|5|||
131863715|NCT03103087|474782248|FG000|Overall Study|Did not receive any study drug|1|||
131863716|NCT03103087|474782249|FG001|Overall Study|Did not receive any study drug|0|||
131863717|NCT03103087|474782250|FG002|Overall Study|Did not receive any study drug|0|||
131863718|NCT03103087|474782248|FG000|Overall Study|Protocol Violation|1|||
131863719|NCT03103087|474782249|FG001|Overall Study|Protocol Violation|2|||
131863720|NCT03103087|474782250|FG002|Overall Study|Protocol Violation|1|||
131863721|NCT03103087|474782248|FG000|Overall Study|Lack of Efficacy|2|||
131863722|NCT03103087|474782249|FG001|Overall Study|Lack of Efficacy|1|||
131863723|NCT03103087|474782250|FG002|Overall Study|Lack of Efficacy|1|||
131863724|NCT03103087|474782248|FG000|Overall Study|Pregnancy|0|||
131863725|NCT03103087|474782249|FG001|Overall Study|Pregnancy|0|||
131863726|NCT03103087|474782250|FG002|Overall Study|Pregnancy|1|||
131863727|NCT03103087|474782248|FG000|Overall Study|Adverse Event|2|||
131863728|NCT03103087|474782249|FG001|Overall Study|Adverse Event|15|||
131863729|NCT03103087|474782250|FG002|Overall Study|Adverse Event|6|||
131863730|NCT03103087|474782248|FG000|Overall Study|Withdrawal by Subject|13|||
131863731|NCT03103087|474782249|FG001|Overall Study|Withdrawal by Subject|6|||
131863732|NCT03103087|474782250|FG002|Overall Study|Withdrawal by Subject|6|||
131863733|NCT03103087|474782248|FG000|Overall Study|Lost to Follow-up|4|||
131863734|NCT03103087|474782249|FG001|Overall Study|Lost to Follow-up|2|||
131914262|NCT01386385|474973045|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131914263|NCT01386385|474973046|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131914264|NCT01386385|474973047|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131914265|NCT01386385|474973048|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131914266|NCT01386385|474973049|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
131914267|NCT01386385|474973050|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
131914268|NCT01386385|474973043|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
131914269|NCT01386385|474973044|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
131914270|NCT01386385|474973045|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
131914271|NCT01386385|474973046|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
131914272|NCT01386385|474973047|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
131914273|NCT01386385|474973048|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
131914274|NCT01386385|474973049|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
131914275|NCT01386385|474973050|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
131914276|NCT01386385|474973043|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914277|NCT01386385|474973044|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914278|NCT01386385|474973045|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914279|NCT01386385|474973046|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914280|NCT01386385|474973047|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914281|NCT01386385|474973048|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914282|NCT01386385|474973049|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
131914283|NCT01386385|474973050|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
131914284|NCT01386385|474973043|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
131914285|NCT01386385|474973044|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
131914286|NCT01386385|474973045|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
131914287|NCT01386385|474973046|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
131914288|NCT01386385|474973047|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
131914289|NCT01386385|474973048|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
131914290|NCT01386385|474973049|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
131914291|NCT01386385|474973050|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
131914292|NCT05399485|474973051|FG000|DBT Phase|Other|6|||
131914293|NCT05399485|474973052|FG001|DBT Phase|Other|5|||
131914294|NCT05399485|474973051|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
131914295|NCT05399485|474973052|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
131914296|NCT05399485|474973051|FG000|DBT Phase|Withdrawal by Subject|3|||
131914297|NCT05399485|474973052|FG001|DBT Phase|Withdrawal by Subject|2|||
131914298|NCT05399485|474973051|FG000|DBT Phase|Protocol Violation|2|||
131914299|NCT05399485|474973052|FG001|DBT Phase|Protocol Violation|1|||
131914300|NCT05399485|474973051|FG000|DBT Phase|Physician Decision|0|||
131914301|NCT05399485|474973052|FG001|DBT Phase|Physician Decision|1|||
131914302|NCT05399485|474973051|FG000|DBT Phase|Adverse Event|2|||
131914303|NCT05399485|474973052|FG001|DBT Phase|Adverse Event|1|||
131914304|NCT05399485|474973051|FG000|OLE Phase|Not reported|0|||
131914305|NCT05399485|474973052|FG001|OLE Phase|Not reported|1|||
131914306|NCT05399485|474973051|FG000|OLE Phase|Other|3|||
131914307|NCT05399485|474973052|FG001|OLE Phase|Other|3|||
131914308|NCT05399485|474973051|FG000|OLE Phase|Withdrawal by Subject|8|||
131914309|NCT05399485|474973052|FG001|OLE Phase|Withdrawal by Subject|5|||
131914310|NCT05399485|474973051|FG000|OLE Phase|Pregnancy|0|||
131914311|NCT05399485|474973052|FG001|OLE Phase|Pregnancy|1|||
131914312|NCT05399485|474973051|FG000|OLE Phase|Physician Decision|2|||
131914313|NCT05399485|474973052|FG001|OLE Phase|Physician Decision|0|||
131914314|NCT05399485|474973051|FG000|OLE Phase|Adverse Event|0|||
131914315|NCT05399485|474973052|FG001|OLE Phase|Adverse Event|1|||
131914316|NCT05399485|474973051|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
131914317|NCT05399485|474973052|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
131914318|NCT03405870|474973055|FG000|Overall Study|Withdrawal|1|||
131914319|NCT03405870|474973056|FG001|Overall Study|Withdrawal|0|||
131914320|NCT03405870|474973057|FG002|Overall Study|Withdrawal|1|||
131914321|NCT03405870|474973058|FG003|Overall Study|Withdrawal|0|||
131914322|NCT03405870|474973059|FG004|Overall Study|Withdrawal|0|||
131914323|NCT03405870|474973060|FG005|Overall Study|Withdrawal|0|||
131914324|NCT03405870|474973061|FG006|Overall Study|Withdrawal|1|||
131914325|NCT03405870|474973062|FG007|Overall Study|Withdrawal|0|||
131914326|NCT03737994|474973063|FG000|Overall Study|Withdrawal by Subject|0|||
131914327|NCT03737994|474973064|FG001|Overall Study|Withdrawal by Subject|0|||
131914328|NCT03737994|474973065|FG002|Overall Study|Withdrawal by Subject|0|||
131914329|NCT03737994|474973066|FG003|Overall Study|Withdrawal by Subject|0|||
131914330|NCT03737994|474973067|FG004|Overall Study|Withdrawal by Subject|0|||
131914331|NCT03737994|474973068|FG005|Overall Study|Withdrawal by Subject|0|||
131914332|NCT03737994|474973069|FG006|Overall Study|Withdrawal by Subject|1|||
131914333|NCT03846479|474973070|FG000|Overall Study|Death|8|||
131914334|NCT03846479|474973070|FG000|Overall Study|Lost to Follow-up|1|||
131914335|NCT01473134|474973071|FG000|Overall Study|Lost to Follow-up|21|||
131914336|NCT01473134|474973072|FG001|Overall Study|Lost to Follow-up|13|||
131914337|NCT01473134|474973071|FG000|Overall Study|Protocol Violation|32|||
131914338|NCT01473134|474973072|FG001|Overall Study|Protocol Violation|19|||
131914339|NCT01473134|474973071|FG000|Overall Study|Withdrawal by Subject|1|||
131914340|NCT01473134|474973072|FG001|Overall Study|Withdrawal by Subject|2|||
131914341|NCT01473134|474973071|FG000|Overall Study|Death|0|||
131914342|NCT01473134|474973072|FG001|Overall Study|Death|1|||
131914343|NCT01473134|474973071|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
131914344|NCT01473134|474973072|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
131914345|NCT05020015|474973079|FG000|Overall Study|Ongoing on study|1|||
131914346|NCT05020015|474973080|FG001|Overall Study|Ongoing on study|3|||
131914347|NCT05020015|474973081|FG002|Overall Study|Ongoing on study|4|||
131914348|NCT05020015|474973082|FG003|Overall Study|Ongoing on study|7|||
131914349|NCT05020015|474973079|FG000|Overall Study|Death|2|||
131914350|NCT05020015|474973080|FG001|Overall Study|Death|3|||
131914351|NCT05020015|474973081|FG002|Overall Study|Death|4|||
131914352|NCT05020015|474973082|FG003|Overall Study|Death|0|||
131914353|NCT05020015|474973079|FG000|Overall Study|Withdrawal by Subject|0|||
131914354|NCT05020015|474973080|FG001|Overall Study|Withdrawal by Subject|0|||
131914355|NCT05020015|474973081|FG002|Overall Study|Withdrawal by Subject|1|||
131914356|NCT05020015|474973082|FG003|Overall Study|Withdrawal by Subject|0|||
131914357|NCT05020015|474973079|FG000|Overall Study|Reason Not Specified|0|||
131914358|NCT05020015|474973080|FG001|Overall Study|Reason Not Specified|0|||
131914359|NCT05020015|474973081|FG002|Overall Study|Reason Not Specified|2|||
131914360|NCT05020015|474973082|FG003|Overall Study|Reason Not Specified|0|||
131914361|NCT04476043|474973085|FG000|Overall Study|Withdrawal by Subject|1|||
131914362|NCT04476043|474973086|FG001|Overall Study|Withdrawal by Subject|3|||
131914363|NCT04476043|474973087|FG002|Overall Study|Withdrawal by Subject|4|||
131914364|NCT04476043|474973088|FG003|Overall Study|Withdrawal by Subject|1|||
131914365|NCT04476043|474973085|FG000|Overall Study|Lost to Follow-up|1|||
131914366|NCT04476043|474973086|FG001|Overall Study|Lost to Follow-up|1|||
131914367|NCT04476043|474973087|FG002|Overall Study|Lost to Follow-up|2|||
131914368|NCT04476043|474973088|FG003|Overall Study|Lost to Follow-up|1|||
131914369|NCT04476043|474973085|FG000|Overall Study|Adverse Event|2|||
131914370|NCT04476043|474973086|FG001|Overall Study|Adverse Event|0|||
131914371|NCT04476043|474973087|FG002|Overall Study|Adverse Event|1|||
131914372|NCT04476043|474973088|FG003|Overall Study|Adverse Event|0|||
131914373|NCT04476043|474973085|FG000|Overall Study|Protocol Violation|0|||
131914374|NCT04476043|474973086|FG001|Overall Study|Protocol Violation|1|||
131914375|NCT04476043|474973087|FG002|Overall Study|Protocol Violation|0|||
131914376|NCT04476043|474973088|FG003|Overall Study|Protocol Violation|0|||
131914377|NCT06217380|474973089|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
131914378|NCT06217380|474973089|FG000|Overall Study|Physician Decision|1|||
131914379|NCT06217380|474973089|FG000|Overall Study|Withdrawal by Subject|2|||
131914380|NCT06633965|474973090|FG000|Overall Study|Withdrawal by Subject|0|||
131914381|NCT06633965|474973091|FG001|Overall Study|Withdrawal by Subject|1|||
131914382|NCT03095287|474973096|FG000|Overall Study|Treatment Failure|1|||
131914383|NCT03095287|474973096|FG000|Overall Study|Adverse Event|1|||
131914384|NCT02394275|474973099|FG000|Overall Study|Adverse Event|22|||
131914385|NCT02394275|474973099|FG000|Overall Study|Lost to Follow-up|7|||
131914386|NCT00614393|474973101|FG000|Overall Study|Adverse Event|20|||
131914387|NCT00614393|474973102|FG001|Overall Study|Adverse Event|2|||
131914388|NCT00614393|474973103|FG002|Overall Study|Adverse Event|3|||
131914389|NCT00614393|474973104|FG003|Overall Study|Adverse Event|13|||
131914390|NCT00614393|474973105|FG004|Overall Study|Adverse Event|21|||
131914391|NCT00614393|474973101|FG000|Overall Study|Lost to Follow-up|0|||
131914392|NCT00614393|474973102|FG001|Overall Study|Lost to Follow-up|0|||
131914393|NCT00614393|474973103|FG002|Overall Study|Lost to Follow-up|0|||
131914394|NCT00614393|474973104|FG003|Overall Study|Lost to Follow-up|1|||
131914395|NCT00614393|474973105|FG004|Overall Study|Lost to Follow-up|2|||
131914396|NCT00614393|474973101|FG000|Overall Study|Physician Decision|17|||
131914397|NCT00614393|474973102|FG001|Overall Study|Physician Decision|0|||
131914398|NCT00614393|474973103|FG002|Overall Study|Physician Decision|1|||
131914399|NCT00614393|474973104|FG003|Overall Study|Physician Decision|8|||
131914400|NCT00614393|474973105|FG004|Overall Study|Physician Decision|9|||
131914401|NCT00614393|474973101|FG000|Overall Study|Progressive Disease|118|||
131914402|NCT00614393|474973102|FG001|Overall Study|Progressive Disease|5|||
131914403|NCT00614393|474973103|FG002|Overall Study|Progressive Disease|5|||
131914404|NCT00614393|474973104|FG003|Overall Study|Progressive Disease|138|||
131914405|NCT00614393|474973105|FG004|Overall Study|Progressive Disease|130|||
131914406|NCT00614393|474973101|FG000|Overall Study|Protocol Violation|1|||
131914407|NCT00614393|474973102|FG001|Overall Study|Protocol Violation|0|||
131914408|NCT00614393|474973103|FG002|Overall Study|Protocol Violation|0|||
131914409|NCT00614393|474973104|FG003|Overall Study|Protocol Violation|0|||
131914410|NCT00614393|474973105|FG004|Overall Study|Protocol Violation|0|||
131914411|NCT00614393|474973101|FG000|Overall Study|Terminated by Sponsor|0|||
131914412|NCT00614393|474973102|FG001|Overall Study|Terminated by Sponsor|0|||
131914413|NCT00614393|474973103|FG002|Overall Study|Terminated by Sponsor|0|||
131914414|NCT00614393|474973104|FG003|Overall Study|Terminated by Sponsor|0|||
131914415|NCT00614393|474973105|FG004|Overall Study|Terminated by Sponsor|1|||
131863735|NCT03103087|474782250|FG002|Overall Study|Lost to Follow-up|7|||
131863736|NCT03103087|474782248|FG000|Overall Study|Other reason not reported|1|||
131863737|NCT03103087|474782249|FG001|Overall Study|Other reason not reported|3|||
131863738|NCT03103087|474782250|FG002|Overall Study|Other reason not reported|5|||
131863739|NCT03504397|474782251|FG000|Overall Study|Progressive Disease|151|||
131863740|NCT03504397|474782252|FG001|Overall Study|Progressive Disease|199|||
131863741|NCT03504397|474782251|FG000|Overall Study|Withdrawal by Subject|29|||
131863742|NCT03504397|474782252|FG001|Overall Study|Withdrawal by Subject|17|||
131863743|NCT03504397|474782251|FG000|Overall Study|Lost to Follow-up|1|||
131863744|NCT03504397|474782252|FG001|Overall Study|Lost to Follow-up|0|||
131863745|NCT03504397|474782251|FG000|Overall Study|Death|14|||
131863746|NCT03504397|474782252|FG001|Overall Study|Death|16|||
131863747|NCT03504397|474782251|FG000|Overall Study|Adverse Event|40|||
131863748|NCT03504397|474782252|FG001|Overall Study|Adverse Event|14|||
131863749|NCT03504397|474782251|FG000|Overall Study|miscellaneous|17|||
131863750|NCT03504397|474782252|FG001|Overall Study|miscellaneous|15|||
131863751|NCT03504397|474782251|FG000|Overall Study|Protocol deviation|1|||
131863752|NCT03504397|474782252|FG001|Overall Study|Protocol deviation|0|||
131863753|NCT03504397|474782251|FG000|Overall Study|Participants who did not take the study drug|4|||
131863754|NCT03504397|474782252|FG001|Overall Study|Participants who did not take the study drug|4|||
131863755|NCT00413699|474782253|FG000|Initial Period|Death|25|||
131863756|NCT00413699|474782254|FG001|Initial Period|Death|30|||
131863757|NCT00413699|474782255|FG002|Initial Period|Death|0|||
131863758|NCT00413699|474782253|FG000|Initial Period|Lack of Efficacy|59|||
131863759|NCT00413699|474782254|FG001|Initial Period|Lack of Efficacy|115|||
131863760|NCT00413699|474782255|FG002|Initial Period|Lack of Efficacy|0|||
131863761|NCT00413699|474782253|FG000|Initial Period|Lost to Follow-up|31|||
131863762|NCT00413699|474782254|FG001|Initial Period|Lost to Follow-up|101|||
131863763|NCT00413699|474782255|FG002|Initial Period|Lost to Follow-up|0|||
131863764|NCT00413699|474782253|FG000|Initial Period|Protocol Violation|38|||
131863765|NCT00413699|474782254|FG001|Initial Period|Protocol Violation|89|||
131863766|NCT00413699|474782255|FG002|Initial Period|Protocol Violation|0|||
131863767|NCT00413699|474782253|FG000|Initial Period|Pregnancy|10|||
131863768|NCT00413699|474782254|FG001|Initial Period|Pregnancy|8|||
131863769|NCT00413699|474782255|FG002|Initial Period|Pregnancy|0|||
131863770|NCT00413699|474782253|FG000|Initial Period|Did not meet entrance criteria|2|||
131863771|NCT00413699|474782254|FG001|Initial Period|Did not meet entrance criteria|2|||
131863772|NCT00413699|474782255|FG002|Initial Period|Did not meet entrance criteria|0|||
131863773|NCT00413699|474782253|FG000|Initial Period|Medication error without adverse event|0|||
131863774|NCT00413699|474782254|FG001|Initial Period|Medication error without adverse event|1|||
131863775|NCT00413699|474782255|FG002|Initial Period|Medication error without adverse event|0|||
131863776|NCT00413699|474782253|FG000|Initial Period|Study terminated by Sponsor|0|||
131863777|NCT00413699|474782254|FG001|Initial Period|Study terminated by Sponsor|1|||
131863778|NCT00413699|474782255|FG002|Initial Period|Study terminated by Sponsor|0|||
131863779|NCT00413699|474782253|FG000|Initial Period|Other|67|||
131863780|NCT00413699|474782254|FG001|Initial Period|Other|211|||
131863781|NCT00413699|474782255|FG002|Initial Period|Other|0|||
131863782|NCT00413699|474782253|FG000|Initial Period|Adverse event related to study drug|178|||
131863783|NCT00413699|474782254|FG001|Initial Period|Adverse event related to study drug|527|||
131863784|NCT00413699|474782255|FG002|Initial Period|Adverse event related to study drug|0|||
131863785|NCT00413699|474782253|FG000|Initial Period|Adverse event not related to study drug|113|||
131863786|NCT00413699|474782254|FG001|Initial Period|Adverse event not related to study drug|248|||
131863787|NCT00413699|474782255|FG002|Initial Period|Adverse event not related to study drug|0|||
131863788|NCT00413699|474782253|FG000|Initial Period|Missing end of study page|0|||
131914416|NCT00614393|474973101|FG000|Overall Study|Withdrawal by Subject|20|||
131914417|NCT00614393|474973102|FG001|Overall Study|Withdrawal by Subject|1|||
131863789|NCT00413699|474782254|FG001|Initial Period|Missing end of study page|4|||
131863790|NCT00413699|474782255|FG002|Initial Period|Missing end of study page|0|||
131863791|NCT00413699|474782253|FG000|Initial Period|No longer willing to participate|116|||
131863792|NCT00413699|474782254|FG001|Initial Period|No longer willing to participate|368|||
131863793|NCT00413699|474782255|FG002|Initial Period|No longer willing to participate|0|||
131863794|NCT00413699|474782253|FG000|Extension Period|No Longer Willing to Participate|0|||
131863795|NCT00413699|474782254|FG001|Extension Period|No Longer Willing to Participate|0|||
131863796|NCT00413699|474782255|FG002|Extension Period|No Longer Willing to Participate|2|||
131863797|NCT00413699|474782253|FG000|Extension Period|Protocol Violation|0|||
131863798|NCT00413699|474782254|FG001|Extension Period|Protocol Violation|0|||
131863799|NCT00413699|474782255|FG002|Extension Period|Protocol Violation|1|||
131863800|NCT00413699|474782253|FG000|Extension Period|Adverse Event|0|||
131863801|NCT00413699|474782254|FG001|Extension Period|Adverse Event|0|||
131863802|NCT00413699|474782255|FG002|Extension Period|Adverse Event|2|||
131863803|NCT00075816|474782256|FG000|Overall Study|Did not undergo transplantation|14|||
131863804|NCT00075816|474782257|FG001|Overall Study|Did not undergo transplantation|11|||
131863805|NCT00611923|474782258|FG000|Overall Study|Withdrawal by Subject|2|||
131863806|NCT00611923|474782259|FG001|Overall Study|Withdrawal by Subject|2|||
131863807|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
131914418|NCT00614393|474973103|FG002|Overall Study|Withdrawal by Subject|1|||
131914419|NCT00614393|474973104|FG003|Overall Study|Withdrawal by Subject|16|||
131914420|NCT00614393|474973105|FG004|Overall Study|Withdrawal by Subject|13|||
131914421|NCT00614393|474973101|FG000|Overall Study|Other|4|||
131914422|NCT00614393|474973102|FG001|Overall Study|Other|0|||
131914423|NCT00614393|474973103|FG002|Overall Study|Other|0|||
131914424|NCT00614393|474973104|FG003|Overall Study|Other|4|||
131914425|NCT00614393|474973105|FG004|Overall Study|Other|2|||
131914426|NCT00614393|474973101|FG000|Overall Study|Not Treated|0|||
131914427|NCT00614393|474973102|FG001|Overall Study|Not Treated|0|||
131914428|NCT00614393|474973103|FG002|Overall Study|Not Treated|0|||
131914429|NCT00614393|474973104|FG003|Overall Study|Not Treated|0|||
131914430|NCT00614393|474973105|FG004|Overall Study|Not Treated|2|||
131914431|NCT00855582|474973106|FG000|Overall Study|Adverse Event|2|||
131914432|NCT00855582|474973107|FG001|Overall Study|Adverse Event|6|||
131914433|NCT00855582|474973108|FG002|Overall Study|Adverse Event|3|||
131914434|NCT00855582|474973106|FG000|Overall Study|Death|1|||
131914435|NCT00855582|474973107|FG001|Overall Study|Death|0|||
131914436|NCT00855582|474973108|FG002|Overall Study|Death|0|||
131914437|NCT00855582|474973106|FG000|Overall Study|Lack of Efficacy|1|||
131914438|NCT00855582|474973107|FG001|Overall Study|Lack of Efficacy|3|||
131914439|NCT00855582|474973108|FG002|Overall Study|Lack of Efficacy|8|||
131914440|NCT00855582|474973106|FG000|Overall Study|Lost to Follow-up|1|||
131914441|NCT00855582|474973107|FG001|Overall Study|Lost to Follow-up|3|||
131914442|NCT00855582|474973108|FG002|Overall Study|Lost to Follow-up|1|||
131914443|NCT00855582|474973106|FG000|Overall Study|Physician Decision|0|||
131914444|NCT00855582|474973107|FG001|Overall Study|Physician Decision|0|||
131914445|NCT00855582|474973108|FG002|Overall Study|Physician Decision|1|||
131914446|NCT00855582|474973106|FG000|Overall Study|Protocol Violation|6|||
131914447|NCT00855582|474973107|FG001|Overall Study|Protocol Violation|2|||
131914448|NCT00855582|474973108|FG002|Overall Study|Protocol Violation|6|||
131914449|NCT00855582|474973106|FG000|Overall Study|Entry Criteria Not Met|8|||
131914450|NCT00855582|474973107|FG001|Overall Study|Entry Criteria Not Met|6|||
131914451|NCT00855582|474973108|FG002|Overall Study|Entry Criteria Not Met|3|||
131914452|NCT00855582|474973106|FG000|Overall Study|Withdrawal by Subject|7|||
131914453|NCT00855582|474973107|FG001|Overall Study|Withdrawal by Subject|4|||
131914454|NCT00855582|474973108|FG002|Overall Study|Withdrawal by Subject|8|||
131914455|NCT01013753|474973109|FG000|Overall Study|Adverse Event|8|||
131914456|NCT01013753|474973109|FG000|Overall Study|Protocol Violation|3|||
131914457|NCT01013753|474973109|FG000|Overall Study|Lost to Follow-up|1|||
131914458|NCT01013753|474973109|FG000|Overall Study|Withdrawal by Subject|2|||
131914459|NCT01013753|474973109|FG000|Overall Study|Other|2|||
131914460|NCT04757636|474973113|FG000|Overall Study|Adverse Event|25|||
131914461|NCT04757636|474973114|FG001|Overall Study|Adverse Event|8|||
131914462|NCT04757636|474973115|FG002|Overall Study|Adverse Event|11|||
131914463|NCT04757636|474973113|FG000|Overall Study|Death|9|||
131914464|NCT04757636|474973114|FG001|Overall Study|Death|12|||
131914465|NCT04757636|474973115|FG002|Overall Study|Death|6|||
131914466|NCT04757636|474973113|FG000|Overall Study|Lack of Efficacy|2|||
131914467|NCT04757636|474973114|FG001|Overall Study|Lack of Efficacy|0|||
131914468|NCT04757636|474973115|FG002|Overall Study|Lack of Efficacy|0|||
131914469|NCT04757636|474973113|FG000|Overall Study|Lost to Follow-up|1|||
131914470|NCT04757636|474973114|FG001|Overall Study|Lost to Follow-up|6|||
131914471|NCT04757636|474973115|FG002|Overall Study|Lost to Follow-up|7|||
131914472|NCT04757636|474973113|FG000|Overall Study|Physician Decision|1|||
131914473|NCT04757636|474973114|FG001|Overall Study|Physician Decision|3|||
131914474|NCT04757636|474973115|FG002|Overall Study|Physician Decision|4|||
131914475|NCT04757636|474973113|FG000|Overall Study|Withdrawal by Subject|20|||
131914476|NCT04757636|474973114|FG001|Overall Study|Withdrawal by Subject|23|||
131914477|NCT04757636|474973115|FG002|Overall Study|Withdrawal by Subject|18|||
131914478|NCT04757636|474973113|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
131914479|NCT04757636|474973114|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
131914480|NCT04757636|474973115|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
131914481|NCT04757636|474973113|FG000|Overall Study|Study Terminated by Sponsor|103|||
131914482|NCT04757636|474973114|FG001|Overall Study|Study Terminated by Sponsor|104|||
131914483|NCT04757636|474973115|FG002|Overall Study|Study Terminated by Sponsor|114|||
131914484|NCT04757636|474973113|FG000|Overall Study|Sponsor Decision|0|||
131914485|NCT04757636|474973114|FG001|Overall Study|Sponsor Decision|0|||
131914486|NCT04757636|474973115|FG002|Overall Study|Sponsor Decision|1|||
131914487|NCT04757636|474973113|FG000|Overall Study|Randomized in Error|0|||
131914488|NCT04757636|474973114|FG001|Overall Study|Randomized in Error|0|||
131914489|NCT04757636|474973115|FG002|Overall Study|Randomized in Error|2|||
131914490|NCT05350423|474973119|FG000|Overall Study|Lost to Follow-up|3|||
131914491|NCT05350423|474973120|FG001|Overall Study|Lost to Follow-up|3|||
131914492|NCT05350423|474973119|FG000|Overall Study|screen failure|5|||
131914493|NCT05350423|474973120|FG001|Overall Study|screen failure|6|||
131914494|NCT03320369|474973121|FG000|Overall Study|Adverse Event|1|||
131914495|NCT03320369|474973121|FG000|Overall Study|Withdrawal by Subject|2|||
131914496|NCT01732692|474973122|FG000|Overall Study|Adverse Event|0|||
131914497|NCT01732692|474973123|FG001|Overall Study|Adverse Event|1|||
131914498|NCT00435942|474973126|FG000|Overall Study|Death|17|||
131914499|NCT00435942|474973127|FG001|Overall Study|Death|10|||
131914500|NCT00435942|474973126|FG000|Overall Study|Withdrawal by Subject|2|||
131914501|NCT00435942|474973127|FG001|Overall Study|Withdrawal by Subject|0|||
131914502|NCT00435942|474973126|FG000|Overall Study|Lost to Follow-up|0|||
131914503|NCT00435942|474973127|FG001|Overall Study|Lost to Follow-up|16|||
131914504|NCT00435942|474973126|FG000|Overall Study|Conversion to Open Repair|1|||
131914505|NCT00435942|474973127|FG001|Overall Study|Conversion to Open Repair|0|||
131914506|NCT00435942|474973126|FG000|Overall Study|Technical Failure|3|||
131914507|NCT00435942|474973127|FG001|Overall Study|Technical Failure|0|||
131914508|NCT00435942|474973126|FG000|Overall Study|Other|0|||
131914509|NCT00435942|474973127|FG001|Overall Study|Other|1|||
131914510|NCT04491994|474973128|FG000|Overall Study|Withdrawal by Subject|10|||
131914511|NCT04491994|474973129|FG001|Overall Study|Withdrawal by Subject|5|||
131914512|NCT04491994|474973128|FG000|Overall Study|developed fever > 3 days|4|||
131914513|NCT04491994|474973129|FG001|Overall Study|developed fever > 3 days|1|||
131914514|NCT04491994|474973128|FG000|Overall Study|Protocol Violation|11|||
131914515|NCT04491994|474973129|FG001|Overall Study|Protocol Violation|2|||
131914516|NCT04491994|474973128|FG000|Overall Study|Lost to Follow-up|4|||
131914517|NCT04491994|474973129|FG001|Overall Study|Lost to Follow-up|3|||
131914518|NCT05522751|474973135|FG000|Overall Study|Adverse Event|1|||
131914519|NCT00505921|474973136|FG000|Overall Study|Ineligible|1|||
131914520|NCT00505921|474973136|FG000|Overall Study|Failed to Mobilize|8|||
131914521|NCT02441283|474973137|FG000|Overall Study|Withdrew consent|15|||
131914522|NCT02441283|474973137|FG000|Overall Study|Lost to Follow-up|42|||
131914523|NCT02441283|474973137|FG000|Overall Study|Death|1|||
131914524|NCT02441283|474973137|FG000|Overall Study|Other, not specified|32|||
131914525|NCT02382939|474973143|FG000|Overall Study|Adverse Event|1|||
131914526|NCT02382939|474973144|FG001|Overall Study|Adverse Event|1|||
131914527|NCT02382939|474973143|FG000|Overall Study|Withdrawal by Subject|2|||
131914528|NCT02382939|474973144|FG001|Overall Study|Withdrawal by Subject|2|||
131914529|NCT00537277|474973147|FG000|Overall Study|Adverse Event|1|||
131914530|NCT00537277|474973147|FG000|Overall Study|Lack of Efficacy|2|||
131914531|NCT00537277|474973147|FG000|Overall Study|Lost to Follow-up|12|||
131914532|NCT00537277|474973147|FG000|Overall Study|Protocol Violation|11|||
131914533|NCT00537277|474973147|FG000|Overall Study|Unclassified|4|||
131914534|NCT00537277|474973147|FG000|Overall Study|Inability to tolerate trial medication|4|||
131914535|NCT00537277|474973147|FG000|Overall Study|Non-compliance with trial procedures|15|||
131914536|NCT05383209|474973148|FG000|Overall Study|Adverse Event: Non-ocular|0|||
131914537|NCT05383209|474973149|FG001|Overall Study|Adverse Event: Non-ocular|1|||
131914538|NCT05383209|474973150|FG002|Overall Study|Adverse Event: Non-ocular|0|||
131914539|NCT05383209|474973148|FG000|Overall Study|Lost to Follow-up|2|||
131914540|NCT05383209|474973149|FG001|Overall Study|Lost to Follow-up|1|||
131914541|NCT05383209|474973150|FG002|Overall Study|Lost to Follow-up|4|||
131914542|NCT05383209|474973148|FG000|Overall Study|Withdrawal by Subject|2|||
131914543|NCT05383209|474973149|FG001|Overall Study|Withdrawal by Subject|0|||
131914544|NCT05383209|474973150|FG002|Overall Study|Withdrawal by Subject|1|||
131914545|NCT05383209|474973148|FG000|Overall Study|Death|1|||
131914546|NCT05383209|474973149|FG001|Overall Study|Death|0|||
131914547|NCT05383209|474973150|FG002|Overall Study|Death|0|||
131914548|NCT05383209|474973148|FG000|Overall Study|Other|0|||
131914549|NCT05383209|474973149|FG001|Overall Study|Other|1|||
131914550|NCT05383209|474973150|FG002|Overall Study|Other|0|||
131914551|NCT00717886|474973151|FG000|Overall Study|Withdrawal by Subject|3|||
131914552|NCT00717886|474973151|FG000|Overall Study|Treatment Failure|1|||
131914553|NCT00716417|474973152|FG000|Overall Study|Adverse Event|0|||
131914554|NCT00716417|474973153|FG001|Overall Study|Adverse Event|0|||
131914555|NCT00716417|474973154|FG002|Overall Study|Adverse Event|2|||
131914556|NCT00716417|474973155|FG003|Overall Study|Adverse Event|1|||
131914557|NCT00716417|474973156|FG004|Overall Study|Adverse Event|0|||
131914558|NCT00716417|474973157|FG005|Overall Study|Adverse Event|0|||
131914559|NCT00716417|474973158|FG006|Overall Study|Adverse Event|3|||
131914560|NCT00716417|474973159|FG007|Overall Study|Adverse Event|1|||
131914561|NCT00716417|474973160|FG008|Overall Study|Adverse Event|0|||
131914562|NCT00716417|474973161|FG009|Overall Study|Adverse Event|3|||
131914563|NCT00716417|474973152|FG000|Overall Study|Withdrawal by Subject|0|||
131914564|NCT00716417|474973153|FG001|Overall Study|Withdrawal by Subject|1|||
131914565|NCT00716417|474973154|FG002|Overall Study|Withdrawal by Subject|0|||
131914566|NCT00716417|474973155|FG003|Overall Study|Withdrawal by Subject|2|||
131408107|NCT00624819|473115358|FG003|Follow-up Period: Year 4|Parents decision|0|||
131408108|NCT00624819|473115355|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
131914567|NCT00716417|474973156|FG004|Overall Study|Withdrawal by Subject|0|||
131914568|NCT00716417|474973157|FG005|Overall Study|Withdrawal by Subject|0|||
131914569|NCT00716417|474973158|FG006|Overall Study|Withdrawal by Subject|1|||
131914570|NCT00716417|474973159|FG007|Overall Study|Withdrawal by Subject|0|||
131914571|NCT00716417|474973160|FG008|Overall Study|Withdrawal by Subject|0|||
131914572|NCT00716417|474973161|FG009|Overall Study|Withdrawal by Subject|0|||
131914573|NCT00716417|474973152|FG000|Overall Study|Progressive disease|3|||
131914574|NCT00716417|474973153|FG001|Overall Study|Progressive disease|5|||
131914575|NCT00716417|474973154|FG002|Overall Study|Progressive disease|3|||
131914576|NCT00716417|474973155|FG003|Overall Study|Progressive disease|8|||
131914577|NCT00716417|474973156|FG004|Overall Study|Progressive disease|0|||
131914578|NCT00716417|474973157|FG005|Overall Study|Progressive disease|3|||
131914579|NCT00716417|474973158|FG006|Overall Study|Progressive disease|3|||
131914580|NCT00716417|474973159|FG007|Overall Study|Progressive disease|1|||
131914581|NCT00716417|474973160|FG008|Overall Study|Progressive disease|5|||
131914582|NCT00716417|474973161|FG009|Overall Study|Progressive disease|0|||
131914583|NCT00716417|474973152|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
131914584|NCT00716417|474973153|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
131914585|NCT00716417|474973154|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
131914586|NCT00716417|474973155|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
131914587|NCT00716417|474973156|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
131914588|NCT00716417|474973157|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
131914589|NCT00716417|474973158|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
131914590|NCT00716417|474973159|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
131914591|NCT00716417|474973160|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
131914592|NCT00716417|474973161|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
131914593|NCT00716417|474973152|FG000|Overall Study|On patient request due to toxicities|0|||
131914594|NCT00716417|474973153|FG001|Overall Study|On patient request due to toxicities|0|||
131914595|NCT00716417|474973154|FG002|Overall Study|On patient request due to toxicities|0|||
131914596|NCT00716417|474973155|FG003|Overall Study|On patient request due to toxicities|0|||
131914597|NCT00716417|474973156|FG004|Overall Study|On patient request due to toxicities|0|||
131914598|NCT00716417|474973157|FG005|Overall Study|On patient request due to toxicities|0|||
131914599|NCT00716417|474973158|FG006|Overall Study|On patient request due to toxicities|0|||
131914600|NCT00716417|474973159|FG007|Overall Study|On patient request due to toxicities|1|||
131914601|NCT00716417|474973160|FG008|Overall Study|On patient request due to toxicities|0|||
131914602|NCT00716417|474973161|FG009|Overall Study|On patient request due to toxicities|0|||
131914603|NCT01553851|474973162|FG000|Overall Study|Adverse Event|2|||
131914604|NCT01553851|474973162|FG000|Overall Study|constipation|1|||
131914605|NCT01369433|474973163|FG000|Overall Study|Adverse Event|31|||
131914606|NCT01369433|474973164|FG001|Overall Study|Adverse Event|1|||
131914607|NCT01369433|474973163|FG000|Overall Study|Required significant surgical procedure|1|||
131914608|NCT01369433|474973164|FG001|Overall Study|Required significant surgical procedure|0|||
131914609|NCT01369433|474973163|FG000|Overall Study|Non-compliance|1|||
131914610|NCT01369433|474973164|FG001|Overall Study|Non-compliance|0|||
131914611|NCT01369433|474973163|FG000|Overall Study|Withdrawal by Subject|5|||
131914612|NCT01369433|474973164|FG001|Overall Study|Withdrawal by Subject|2|||
131914613|NCT01369433|474973163|FG000|Overall Study|Study terminated by Sponsor|67|||
131914614|NCT01369433|474973164|FG001|Overall Study|Study terminated by Sponsor|0|||
131914615|NCT01369433|474973163|FG000|Overall Study|Lost to Follow-up|1|||
131914616|NCT01369433|474973164|FG001|Overall Study|Lost to Follow-up|0|||
131914617|NCT01369433|474973163|FG000|Overall Study|Death|5|||
131914618|NCT01369433|474973164|FG001|Overall Study|Death|0|||
131914619|NCT01369433|474973163|FG000|Overall Study|Investigator discretion|6|||
131914620|NCT01369433|474973164|FG001|Overall Study|Investigator discretion|1|||
131914621|NCT01369433|474973163|FG000|Overall Study|Progressive Disease|92|||
131914622|NCT01369433|474973164|FG001|Overall Study|Progressive Disease|12|||
131914623|NCT02101294|474973166|FG000|Overall Study|Withdrawal by Subject|5|||
131914624|NCT02101294|474973166|FG000|Overall Study|Lost to Follow-up|6|||
131914625|NCT00390013|474973172|FG000|Phase 1|tired|0|||
131914626|NCT00390013|474973173|FG001|Phase 1|tired|0|||
131914627|NCT00390013|474973174|FG002|Phase 1|tired|0|||
131914628|NCT00390013|474973175|FG003|Phase 1|tired|1|||
131914629|NCT00390013|474973172|FG000|Phase 2 First Treatment|tired|1|||
131914630|NCT00390013|474973173|FG001|Phase 2 First Treatment|tired|0|||
131914631|NCT00390013|474973174|FG002|Phase 2 First Treatment|tired|0|||
131914632|NCT00390013|474973175|FG003|Phase 2 First Treatment|tired|0|||
131914633|NCT00390013|474973172|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
131914634|NCT00390013|474973173|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
131914635|NCT00390013|474973174|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
131914636|NCT00390013|474973175|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
131914637|NCT03188822|474973178|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
131914638|NCT03188822|474973178|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
131914639|NCT02164916|474973183|FG000|Overall Study|Adverse Event|3|||
131914640|NCT02164916|474973184|FG001|Overall Study|Adverse Event|8|||
131914641|NCT02164916|474973183|FG000|Overall Study|Death|1|||
131914642|NCT02164916|474973184|FG001|Overall Study|Death|1|||
131914643|NCT02164916|474973183|FG000|Overall Study|Refusal unrelated to adverse event|3|||
131914644|NCT02164916|474973184|FG001|Overall Study|Refusal unrelated to adverse event|7|||
131914645|NCT02164916|474973183|FG000|Overall Study|Progression|37|||
131914646|NCT02164916|474973184|FG001|Overall Study|Progression|26|||
131914647|NCT02164916|474973183|FG000|Overall Study|Not protocol specified|5|||
131914648|NCT02164916|474973184|FG001|Overall Study|Not protocol specified|1|||
131914649|NCT02164916|474973183|FG000|Overall Study|Reason under review|1|||
131914650|NCT02164916|474973184|FG001|Overall Study|Reason under review|6|||
131914651|NCT02164916|474973183|FG000|Overall Study|Not eligible|2|||
131914652|NCT02164916|474973184|FG001|Overall Study|Not eligible|5|||
131914653|NCT00127803|474973185|FG000|Overall Study|Adverse Event|2|||
131914654|NCT00127803|474973186|FG001|Overall Study|Adverse Event|0|||
131914655|NCT00127803|474973187|FG002|Overall Study|Adverse Event|0|||
131914656|NCT00127803|474973188|FG003|Overall Study|Adverse Event|0|||
131914657|NCT00127803|474973185|FG000|Overall Study|Withdrawal by Subject|1|||
131914658|NCT00127803|474973186|FG001|Overall Study|Withdrawal by Subject|0|||
131914659|NCT00127803|474973187|FG002|Overall Study|Withdrawal by Subject|0|||
131914660|NCT00127803|474973188|FG003|Overall Study|Withdrawal by Subject|0|||
131914661|NCT00127803|474973185|FG000|Overall Study|Lost to Follow-up|0|||
131914662|NCT00127803|474973186|FG001|Overall Study|Lost to Follow-up|0|||
131914663|NCT00127803|474973187|FG002|Overall Study|Lost to Follow-up|0|||
131914664|NCT00127803|474973188|FG003|Overall Study|Lost to Follow-up|1|||
131914665|NCT02774889|474973189|FG000|Overall Study|Lost to Follow-up|2|||
131914666|NCT02774889|474973190|FG001|Overall Study|Lost to Follow-up|1|||
131914667|NCT04584788|474973197|FG000|Overall Study|Physician Decision|8|||
131914668|NCT04584788|474973197|FG000|Overall Study|Withdrawal by Subject|1|||
131914669|NCT04584788|474973197|FG000|Overall Study|Adverse Event|3|||
131914670|NCT02097277|474974893|FG000|Overall Study|Subject no longer meets study criteria|0|||
131914671|NCT02097277|474974894|FG001|Overall Study|Subject no longer meets study criteria|1|||
131914672|NCT02097277|474974895|FG002|Overall Study|Subject no longer meets study criteria|0|||
131914673|NCT02097277|474974896|FG003|Overall Study|Subject no longer meets study criteria|1|||
131914674|NCT02097277|474974897|FG004|Overall Study|Subject no longer meets study criteria|0|||
131914675|NCT02097277|474974893|FG000|Overall Study|Subject request to discontinue treatment|0|||
131914676|NCT02097277|474974894|FG001|Overall Study|Subject request to discontinue treatment|0|||
131914677|NCT02097277|474974895|FG002|Overall Study|Subject request to discontinue treatment|0|||
131914678|NCT02097277|474974896|FG003|Overall Study|Subject request to discontinue treatment|0|||
131914679|NCT02097277|474974897|FG004|Overall Study|Subject request to discontinue treatment|1|||
131914680|NCT02097277|474974893|FG000|Overall Study|Lost to Follow-up|0|||
131914681|NCT02097277|474974894|FG001|Overall Study|Lost to Follow-up|1|||
131914682|NCT02097277|474974895|FG002|Overall Study|Lost to Follow-up|1|||
131914683|NCT02097277|474974896|FG003|Overall Study|Lost to Follow-up|0|||
131914684|NCT02097277|474974897|FG004|Overall Study|Lost to Follow-up|0|||
131914685|NCT02097277|474974893|FG000|Overall Study|Withdrawal by Subject|2|||
131914686|NCT02097277|474974894|FG001|Overall Study|Withdrawal by Subject|1|||
131914687|NCT02097277|474974895|FG002|Overall Study|Withdrawal by Subject|0|||
131914688|NCT02097277|474974896|FG003|Overall Study|Withdrawal by Subject|1|||
131914689|NCT02097277|474974897|FG004|Overall Study|Withdrawal by Subject|0|||
131914690|NCT02097277|474974893|FG000|Overall Study|Adverse Event|0|||
131914691|NCT02097277|474974894|FG001|Overall Study|Adverse Event|0|||
131914692|NCT02097277|474974895|FG002|Overall Study|Adverse Event|1|||
131914693|NCT02097277|474974896|FG003|Overall Study|Adverse Event|2|||
131914694|NCT02097277|474974897|FG004|Overall Study|Adverse Event|0|||
131914695|NCT01091259|474974900|FG000|Overall Study|Adverse Event|3|||
131914696|NCT01091259|474974900|FG000|Overall Study|Lack of Efficacy|2|||
131914697|NCT00671060|474974903|FG000|Overall Study|Protocol Violation|1|||
131914698|NCT00671060|474974904|FG001|Overall Study|Protocol Violation|0|||
131914699|NCT00671060|474974903|FG000|Overall Study|Physician Decision|0|||
131914700|NCT00671060|474974904|FG001|Overall Study|Physician Decision|1|||
131914701|NCT01541748|474974905|FG000|Overall Study|Lost to Follow-up|17|||
131914702|NCT01541748|474974905|FG000|Overall Study|Moved out of state|1|||
131914703|NCT01541748|474974905|FG000|Overall Study|Withdrawal by Subject|7|||
131914704|NCT01541748|474974905|FG000|Overall Study|Screen failure|5|||
131914705|NCT01541748|474974905|FG000|Overall Study|Did not receive study device|1|||
131914706|NCT06057064|474974906|FG000|Overall Study|Death|2|||
131914707|NCT06057064|474974907|FG001|Overall Study|Death|0|||
131914708|NCT06057064|474974906|FG000|Overall Study|Physician Decision|1|||
131914709|NCT06057064|474974907|FG001|Overall Study|Physician Decision|0|||
131914710|NCT06057064|474974906|FG000|Overall Study|Withdrawal by Subject|1|||
131914711|NCT06057064|474974907|FG001|Overall Study|Withdrawal by Subject|1|||
131914712|NCT02832037|474974908|FG000|Overall Study|Administrative reasons|0|||
131914713|NCT02832037|474974909|FG001|Overall Study|Administrative reasons|0|||
131914714|NCT02832037|474974910|FG002|Overall Study|Administrative reasons|1|||
131914715|NCT02832037|474974911|FG003|Overall Study|Administrative reasons|0|||
131914716|NCT02832037|474974912|FG004|Overall Study|Administrative reasons|0|||
131914717|NCT02832037|474974908|FG000|Overall Study|Protocol Violation|3|||
131914718|NCT02832037|474974909|FG001|Overall Study|Protocol Violation|0|||
131914719|NCT02832037|474974910|FG002|Overall Study|Protocol Violation|4|||
131914720|NCT02832037|474974911|FG003|Overall Study|Protocol Violation|1|||
131914721|NCT02832037|474974912|FG004|Overall Study|Protocol Violation|2|||
131453850|NCT03083873|473291793|FG003|Overall Study|Sponsor Terminated Study|3|||
131914722|NCT02832037|474974908|FG000|Overall Study|Lost to Follow-up|2|||
131914723|NCT02832037|474974909|FG001|Overall Study|Lost to Follow-up|0|||
131914724|NCT02832037|474974910|FG002|Overall Study|Lost to Follow-up|3|||
131914725|NCT02832037|474974911|FG003|Overall Study|Lost to Follow-up|0|||
131914726|NCT02832037|474974912|FG004|Overall Study|Lost to Follow-up|5|||
131863808|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
131863809|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
131863810|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
131863811|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
131863812|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
131863813|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
131863814|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
131863815|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
131863816|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
131863817|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
131863818|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
131863819|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
131863820|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
131863821|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
131863822|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
131863823|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
131863824|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
131863825|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
131863826|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
131863827|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
131863828|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
131863829|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
131863830|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
131863831|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
131863832|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
131863833|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
131863834|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
131863835|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
131863836|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
131863837|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
131863838|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
131863839|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
131863840|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
131863841|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
131863842|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
131863843|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
131863844|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
131863845|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
131863846|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
131863847|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
131863848|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
131863849|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
131863850|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
131863851|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
131863852|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
131863853|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
131863854|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
131863855|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
131863856|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
131863857|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
131863858|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
131863859|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Site closed|0|||
131863860|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Site closed|0|||
131863861|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Site closed|1|||
131914727|NCT02832037|474974908|FG000|Overall Study|Withdrawal by Subject|9|||
131863862|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Site closed|0|||
131863863|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
131863864|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
131863865|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
131863866|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
131863867|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
131863868|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
131863869|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
131863870|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
131863871|NCT00838903|474782260|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
131914728|NCT02832037|474974909|FG001|Overall Study|Withdrawal by Subject|8|||
131914729|NCT02832037|474974910|FG002|Overall Study|Withdrawal by Subject|0|||
131914730|NCT02832037|474974911|FG003|Overall Study|Withdrawal by Subject|4|||
131863872|NCT00838903|474782261|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
131863873|NCT00838903|474782262|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
131863874|NCT00838903|474782263|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
131863875|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
131863876|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
131863877|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
131863878|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
131863879|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
131863880|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
131863881|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
131863882|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
131863883|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
131863884|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
131863885|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
131863886|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
131863887|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
131863888|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
131863889|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
131863890|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
131863891|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
131863892|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
131863893|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
131863894|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
131863895|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
131863896|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
131863897|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
131863898|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
131863899|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
131863900|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
131863901|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
131863902|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
131863903|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
131863904|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
131863905|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
131863906|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
131863907|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
131863908|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
131863909|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
131863910|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
131863911|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
131863912|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
131863913|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
131863914|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
131863915|NCT00838903|474782260|FG000|Follow-up Period (8 Weeks)|Missing|1|||
131863916|NCT00838903|474782261|FG001|Follow-up Period (8 Weeks)|Missing|2|||
131863917|NCT00838903|474782262|FG002|Follow-up Period (8 Weeks)|Missing|1|||
131863918|NCT00838903|474782263|FG003|Follow-up Period (8 Weeks)|Missing|1|||
131863919|NCT04565145|474782264|FG000|Overall Study|Withdrawal by Subject|1|||
131914731|NCT02832037|474974912|FG004|Overall Study|Withdrawal by Subject|8|||
131914732|NCT02832037|474974908|FG000|Overall Study|Adverse Event|5|||
131914733|NCT02832037|474974909|FG001|Overall Study|Adverse Event|4|||
131914734|NCT02832037|474974910|FG002|Overall Study|Adverse Event|0|||
131914735|NCT02832037|474974911|FG003|Overall Study|Adverse Event|2|||
131914736|NCT02832037|474974912|FG004|Overall Study|Adverse Event|4|||
131914737|NCT03329989|474974913|FG000|Overall Study|Withdrawal by Subject|9|||
131914738|NCT03329989|474974913|FG000|Overall Study|Lost to Follow-up|8|||
131914739|NCT03329989|474974913|FG000|Overall Study|Adverse Event|5|||
131914740|NCT03329989|474974913|FG000|Overall Study|Protocol Violation|1|||
131914741|NCT04167462|474974918|FG000|Overall Study|Other reasons|3|||
131914742|NCT04167462|474974919|FG001|Overall Study|Other reasons|2|||
131914743|NCT04167462|474974918|FG000|Overall Study|Withdrawal by Subject|6|||
131408109|NCT00624819|473115356|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
131408110|NCT00624819|473115357|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
131863920|NCT04565145|474782265|FG001|Overall Study|Withdrawal by Subject|1|||
131863921|NCT03096314|474782266|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
131914744|NCT04167462|474974919|FG001|Overall Study|Withdrawal by Subject|7|||
131914745|NCT04167462|474974918|FG000|Overall Study|Adverse Event|4|||
131408111|NCT00624819|473115358|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
131863922|NCT03096314|474782267|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
131863923|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
131863924|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
131863925|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
131863926|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
131863927|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
131863928|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863929|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863930|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863931|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863932|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863933|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863934|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863935|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863936|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863937|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
131863938|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
131863939|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
131863940|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
131863941|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
131863942|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
131863943|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863944|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863945|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863946|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131914746|NCT04167462|474974919|FG001|Overall Study|Adverse Event|0|||
131914747|NCT04167462|474974918|FG000|Overall Study|Pregnancy|1|||
131914748|NCT04167462|474974919|FG001|Overall Study|Pregnancy|0|||
131914749|NCT04167462|474974918|FG000|Overall Study|Lack of Efficacy|0|||
131914750|NCT04167462|474974919|FG001|Overall Study|Lack of Efficacy|1|||
131914751|NCT01838876|474974920|FG000|Overall Study|Adverse Event|49|||
131914752|NCT01838876|474974920|FG000|Overall Study|Insufficient Therapeutic Response|10|||
131914753|NCT01838876|474974920|FG000|Overall Study|Protocol Violation|34|||
131914754|NCT01838876|474974920|FG000|Overall Study|Withdrawal of Consent|33|||
131914755|NCT01838876|474974920|FG000|Overall Study|Lost to Follow-up|21|||
131914756|NCT01838876|474974920|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
131914757|NCT01838876|474974920|FG000|Overall Study|Reason not Specified|7|||
131914758|NCT01838876|474974920|FG000|Overall Study|Did not meet eligibility criteria|78|||
131914759|NCT03881371|474974930|FG000|Overall Study|Adverse Event|8|||
131914760|NCT03881371|474974931|FG001|Overall Study|Adverse Event|9|||
131914761|NCT03881371|474974930|FG000|Overall Study|Death|1|||
131914762|NCT03881371|474974931|FG001|Overall Study|Death|0|||
131914763|NCT03881371|474974930|FG000|Overall Study|Lost to Follow-up|1|||
131914764|NCT03881371|474974931|FG001|Overall Study|Lost to Follow-up|0|||
131914765|NCT03881371|474974930|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131914766|NCT03881371|474974931|FG001|Overall Study|Non-Compliance with Study Drug|2|||
131914767|NCT03881371|474974930|FG000|Overall Study|Physician Decision|3|||
131914768|NCT03881371|474974931|FG001|Overall Study|Physician Decision|3|||
131914769|NCT03881371|474974930|FG000|Overall Study|Withdrawal by Subject|2|||
131914770|NCT03881371|474974931|FG001|Overall Study|Withdrawal by Subject|10|||
131914771|NCT03881371|474974930|FG000|Overall Study|Discontinuation from Study|1|||
131914772|NCT03881371|474974931|FG001|Overall Study|Discontinuation from Study|0|||
131914773|NCT00933933|474974935|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
131914774|NCT00933933|474974936|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
131914775|NCT00933933|474974937|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
131914776|NCT00933933|474974935|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
131914777|NCT00933933|474974936|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
131914778|NCT00933933|474974937|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
131914779|NCT01138046|474974938|FG000|Overall Study|Withdrawal due to death|6|||
131914780|NCT02178956|474974939|FG000|Overall Study|Lost to Follow-up|4|||
131914781|NCT02178956|474974940|FG001|Overall Study|Lost to Follow-up|4|||
131914782|NCT02178956|474974939|FG000|Overall Study|Sponsor terminated study|49|||
131914783|NCT02178956|474974940|FG001|Overall Study|Sponsor terminated study|58|||
131914784|NCT02178956|474974939|FG000|Overall Study|Withdrawal by Subject|15|||
131914785|NCT02178956|474974940|FG001|Overall Study|Withdrawal by Subject|11|||
131914786|NCT02178956|474974939|FG000|Overall Study|Various Reasons|3|||
131914787|NCT02178956|474974940|FG001|Overall Study|Various Reasons|5|||
131914788|NCT01900314|474974941|FG000|Overall Study|Lost to Follow-up|1|||
131914789|NCT01900314|474974942|FG001|Overall Study|Lost to Follow-up|0|||
131914790|NCT01900314|474974941|FG000|Overall Study|Protocol Violation|0|||
131914791|NCT01900314|474974942|FG001|Overall Study|Protocol Violation|1|||
131914792|NCT01900314|474974941|FG000|Overall Study|Withdrawal by Subject|3|||
131914793|NCT01900314|474974942|FG001|Overall Study|Withdrawal by Subject|3|||
131914794|NCT04225832|474974944|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
131914795|NCT04225832|474974945|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
131914796|NCT04225832|474974944|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
131914797|NCT04225832|474974945|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
131914798|NCT03282097|474974946|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
131914799|NCT03282097|474974947|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
131914800|NCT03282097|474974946|FG000|Intervention Visit Complete|Patient Death|13|||
131914801|NCT03282097|474974947|FG001|Intervention Visit Complete|Patient Death|15|||
131914802|NCT03282097|474974946|FG000|Intervention Visit Complete|Caregiver Death|0|||
131914803|NCT03282097|474974947|FG001|Intervention Visit Complete|Caregiver Death|3|||
131914804|NCT03282097|474974946|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
131914805|NCT03282097|474974947|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
131914806|NCT03282097|474974946|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
131914807|NCT03282097|474974947|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
131914808|NCT03282097|474974946|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
131914809|NCT03282097|474974947|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
131914810|NCT03282097|474974946|FG000|Primary Outcome Data Collection Complete|Missing|2|||
131914811|NCT03282097|474974947|FG001|Primary Outcome Data Collection Complete|Missing|3|||
131914812|NCT03282097|474974946|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
131914813|NCT03282097|474974947|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
131914814|NCT03282097|474974946|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
131914815|NCT03282097|474974947|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
131914816|NCT03282097|474974946|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
131914817|NCT03282097|474974947|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
131914818|NCT06001021|474974951|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
131914819|NCT06001021|474974952|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
131914820|NCT06001021|474974953|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
131914821|NCT06001021|474974954|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
131914822|NCT06001021|474974955|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
131914823|NCT06001021|474974956|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
131914824|NCT06001021|474974957|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
131914825|NCT06001021|474974951|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
131914826|NCT06001021|474974952|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
131914827|NCT06001021|474974953|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
131914828|NCT06001021|474974954|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
131914829|NCT06001021|474974955|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
131914830|NCT06001021|474974956|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
131914831|NCT06001021|474974957|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
131914832|NCT02755090|474974958|FG000|Overall Study|equipment malfunction|1|||
131914833|NCT02755090|474974959|FG001|Overall Study|equipment malfunction|0|||
131914834|NCT00207740|474974962|FG000|Overall Study|Adverse Event|4|||
131914835|NCT00207740|474974963|FG001|Overall Study|Adverse Event|14|||
131914836|NCT00207740|474974964|FG002|Overall Study|Adverse Event|14|||
131914837|NCT00207740|474974965|FG003|Overall Study|Adverse Event|11|||
131914838|NCT00207740|474974962|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131914839|NCT00207740|474974963|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131914840|NCT00207740|474974964|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131914841|NCT00207740|474974965|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
131408112|NCT01319721|473115361|FG000|Overall Study|Lost to Follow-up|1|||
131408113|NCT01319721|473115362|FG001|Overall Study|Lost to Follow-up|6|||
131914842|NCT00207740|474974962|FG000|Overall Study|Lost to Follow-up|0|||
131914843|NCT00207740|474974963|FG001|Overall Study|Lost to Follow-up|2|||
131914844|NCT00207740|474974964|FG002|Overall Study|Lost to Follow-up|1|||
131914845|NCT00207740|474974965|FG003|Overall Study|Lost to Follow-up|1|||
131914846|NCT00207740|474974962|FG000|Overall Study|Death|0|||
131914847|NCT00207740|474974963|FG001|Overall Study|Death|0|||
131914848|NCT00207740|474974964|FG002|Overall Study|Death|0|||
131914849|NCT00207740|474974965|FG003|Overall Study|Death|1|||
131914850|NCT00207740|474974962|FG000|Overall Study|Sponsor Directive|22|||
131914851|NCT00207740|474974963|FG001|Overall Study|Sponsor Directive|15|||
131914852|NCT00207740|474974964|FG002|Overall Study|Sponsor Directive|16|||
131914853|NCT00207740|474974965|FG003|Overall Study|Sponsor Directive|21|||
131914854|NCT00207740|474974962|FG000|Overall Study|Other|2|||
131914855|NCT00207740|474974963|FG001|Overall Study|Other|10|||
131914856|NCT00207740|474974964|FG002|Overall Study|Other|7|||
131914857|NCT00207740|474974965|FG003|Overall Study|Other|5|||
131914858|NCT04797169|474974966|FG000|Overall Study|Lost to Follow-up|84|||
131914859|NCT04797169|474974967|FG001|Overall Study|Lost to Follow-up|67|||
131914860|NCT04797169|474974966|FG000|Overall Study|Pregnancy|1|||
131914861|NCT04797169|474974967|FG001|Overall Study|Pregnancy|3|||
131914862|NCT04797169|474974966|FG000|Overall Study|Withdrawal by Subject|27|||
131914863|NCT04797169|474974967|FG001|Overall Study|Withdrawal by Subject|35|||
131914864|NCT03839641|474974976|FG000|Overall Study|Withdrawal by Subject|1|||
131914865|NCT03839641|474974977|FG001|Overall Study|Withdrawal by Subject|1|||
131914866|NCT00924898|474974979|FG000|Overall Study|Withdrawal by Subject|2|||
131914867|NCT00879658|474974980|FG000|Overall Study|Abnormal laboratory value(s)|3|||
131914868|NCT00879658|474974981|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131914869|NCT00879658|474974982|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131914870|NCT00879658|474974983|FG003|Overall Study|Abnormal laboratory value(s)|1|||
131914871|NCT00879658|474974984|FG004|Overall Study|Abnormal laboratory value(s)|0|||
131914872|NCT00879658|474974985|FG005|Overall Study|Abnormal laboratory value(s)|0|||
131914873|NCT00879658|474974986|FG006|Overall Study|Abnormal laboratory value(s)|0|||
131914874|NCT00879658|474974980|FG000|Overall Study|Administrative problems|2|||
131914875|NCT00879658|474974981|FG001|Overall Study|Administrative problems|1|||
131914876|NCT00879658|474974982|FG002|Overall Study|Administrative problems|0|||
131914877|NCT00879658|474974983|FG003|Overall Study|Administrative problems|1|||
131914878|NCT00879658|474974984|FG004|Overall Study|Administrative problems|0|||
131914879|NCT00879658|474974985|FG005|Overall Study|Administrative problems|0|||
131914880|NCT00879658|474974986|FG006|Overall Study|Administrative problems|0|||
131914881|NCT00879658|474974980|FG000|Overall Study|Adverse Event|6|||
131914882|NCT00879658|474974981|FG001|Overall Study|Adverse Event|4|||
131914883|NCT00879658|474974982|FG002|Overall Study|Adverse Event|3|||
131914884|NCT00879658|474974983|FG003|Overall Study|Adverse Event|1|||
131914885|NCT00879658|474974984|FG004|Overall Study|Adverse Event|2|||
131914886|NCT00879658|474974985|FG005|Overall Study|Adverse Event|0|||
131914887|NCT00879658|474974986|FG006|Overall Study|Adverse Event|0|||
131914888|NCT00879658|474974980|FG000|Overall Study|Protocol Violation|1|||
131914889|NCT00879658|474974981|FG001|Overall Study|Protocol Violation|0|||
131914890|NCT00879658|474974982|FG002|Overall Study|Protocol Violation|0|||
131914891|NCT00879658|474974983|FG003|Overall Study|Protocol Violation|0|||
131914892|NCT00879658|474974984|FG004|Overall Study|Protocol Violation|0|||
131914893|NCT00879658|474974985|FG005|Overall Study|Protocol Violation|0|||
131914894|NCT00879658|474974986|FG006|Overall Study|Protocol Violation|0|||
131914895|NCT00879658|474974980|FG000|Overall Study|Withdrawal by Subject|3|||
131914896|NCT00879658|474974981|FG001|Overall Study|Withdrawal by Subject|0|||
131914897|NCT00879658|474974982|FG002|Overall Study|Withdrawal by Subject|2|||
131914898|NCT00879658|474974983|FG003|Overall Study|Withdrawal by Subject|0|||
131914899|NCT00879658|474974984|FG004|Overall Study|Withdrawal by Subject|0|||
131914900|NCT00879658|474974985|FG005|Overall Study|Withdrawal by Subject|1|||
131914901|NCT00879658|474974986|FG006|Overall Study|Withdrawal by Subject|0|||
131914902|NCT00879658|474974980|FG000|Overall Study|Lack of Efficacy|0|||
131914903|NCT00879658|474974981|FG001|Overall Study|Lack of Efficacy|0|||
131914904|NCT00879658|474974982|FG002|Overall Study|Lack of Efficacy|2|||
131914905|NCT00879658|474974983|FG003|Overall Study|Lack of Efficacy|0|||
131914906|NCT00879658|474974984|FG004|Overall Study|Lack of Efficacy|0|||
131914907|NCT00879658|474974985|FG005|Overall Study|Lack of Efficacy|0|||
131914908|NCT00879658|474974986|FG006|Overall Study|Lack of Efficacy|0|||
131914909|NCT00879658|474974980|FG000|Overall Study|misrandomized (never received study med)|0|||
131914910|NCT00879658|474974981|FG001|Overall Study|misrandomized (never received study med)|0|||
131914911|NCT00879658|474974982|FG002|Overall Study|misrandomized (never received study med)|0|||
131914912|NCT00879658|474974983|FG003|Overall Study|misrandomized (never received study med)|1|||
131914913|NCT00879658|474974984|FG004|Overall Study|misrandomized (never received study med)|0|||
131914914|NCT00879658|474974985|FG005|Overall Study|misrandomized (never received study med)|0|||
131914915|NCT00879658|474974986|FG006|Overall Study|misrandomized (never received study med)|0|||
131914916|NCT00294658|474974987|FG000|Overall Study|Death|0|||
131914917|NCT00294658|474974988|FG001|Overall Study|Death|1|||
131914918|NCT00294658|474974987|FG000|Overall Study|Lost to Follow-up|4|||
131914919|NCT00294658|474974988|FG001|Overall Study|Lost to Follow-up|0|||
131914920|NCT00294658|474974987|FG000|Overall Study|Physician Decision|1|||
131914921|NCT00294658|474974988|FG001|Overall Study|Physician Decision|2|||
131914922|NCT00294658|474974987|FG000|Overall Study|Pregnancy|0|||
131914923|NCT00294658|474974988|FG001|Overall Study|Pregnancy|1|||
131914924|NCT00294658|474974987|FG000|Overall Study|Withdrawal by Subject|0|||
131914925|NCT00294658|474974988|FG001|Overall Study|Withdrawal by Subject|4|||
131914926|NCT00294658|474974987|FG000|Overall Study|Found to have invasive thymoma|1|||
131863947|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863948|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863949|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863950|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863951|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863952|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
131863953|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
131863954|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
131863955|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
131863956|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
131863957|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
131863958|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863959|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863960|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863961|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863962|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863963|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863964|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863965|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863966|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863967|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
131863968|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
131863969|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
131863970|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
131863971|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
131863972|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
131863973|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863974|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863975|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863976|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863977|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863978|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863979|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863980|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863981|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863982|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
131863983|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
131863984|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863985|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
131863986|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
131863987|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
131863988|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863989|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863990|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863991|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863992|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863993|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863994|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863995|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863996|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863997|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
131863998|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
131863999|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864000|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864001|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
131864002|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864003|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864004|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864005|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864006|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864007|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864008|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864009|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864010|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864011|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
131408114|NCT00509093|473118182|FG000|Overall Study|Adverse Event|10|||
131408115|NCT00509093|473118182|FG000|Overall Study|Disease Progression|9|||
131864012|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
131864013|NCT03334435|474782269|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864014|NCT03334435|474782270|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
131864015|NCT03334435|474782271|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
131864016|NCT03334435|474782272|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
131864017|NCT03334435|474782273|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
131864018|NCT03334435|474782274|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864019|NCT03334435|474782275|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864020|NCT03334435|474782276|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864021|NCT03334435|474782277|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864022|NCT03334435|474782278|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864023|NCT03334435|474782279|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864024|NCT03334435|474782280|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864025|NCT03334435|474782281|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864026|NCT03334435|474782282|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864027|NCT03334435|474782283|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
131864028|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
131864029|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
131864030|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
131864031|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
131864032|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
131864033|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
131864034|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
131864035|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
131864036|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
131864037|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
131864038|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
131864039|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
131864040|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
131864041|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
131864042|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
131864043|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
131864044|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
131864045|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
131864046|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
131864047|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
131864048|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
131864049|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
131864050|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
131864051|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
131864052|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
131864053|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
131864054|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
131864055|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
131864056|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
131864057|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
131864058|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
131864059|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
131864060|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
131864061|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
131864062|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
131864063|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
131864064|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
131864065|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
131864066|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
131864067|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
131864068|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
131864069|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
131864070|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
131914927|NCT00294658|474974988|FG001|Overall Study|Found to have invasive thymoma|0|||
131914928|NCT00294658|474974987|FG000|Overall Study|Patient and family were not satisfied|0|||
131914929|NCT00294658|474974988|FG001|Overall Study|Patient and family were not satisfied|1|||
131408116|NCT00509093|473118182|FG000|Overall Study|Transformed into MDS|1|||
131864071|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
131864072|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
131864073|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
131864074|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
131864075|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
131864076|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
131864077|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
131864078|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
131864079|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
131864080|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
131864081|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
131864082|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
131864083|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
131864084|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
131864085|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
131864086|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
131864087|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
131864088|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864089|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864090|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864091|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864092|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864093|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864094|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
131864095|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
131864096|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
131864097|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
131864098|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
131864099|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
131864100|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
131864101|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
131864102|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
131864103|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864104|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864105|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864106|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864107|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864108|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864109|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864110|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864111|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864112|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864113|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864114|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
131864115|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864116|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
131864117|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
131864118|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864119|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864120|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864121|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864122|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864123|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
131864124|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864125|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864126|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864127|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864128|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864129|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864130|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
131408117|NCT00509093|473118182|FG000|Overall Study|Withdrawal by Subject|3|||
131408118|NCT00509093|473118182|FG000|Overall Study|Physician Decision|1|||
131408119|NCT03187834|473118183|FG000|Overall Study|Lost to Follow-up|0|||
131914930|NCT00580840|474974989|FG000|Run-in|Adverse Event|17|||
131914931|NCT00580840|474974990|FG001|Run-in|Adverse Event|0|||
131914932|NCT00580840|474974991|FG002|Run-in|Adverse Event|0|||
131914933|NCT00580840|474974992|FG003|Run-in|Adverse Event|0|||
131914934|NCT00580840|474974989|FG000|Run-in|Lack of Efficacy|93|||
131914935|NCT00580840|474974990|FG001|Run-in|Lack of Efficacy|0|||
131914936|NCT00580840|474974991|FG002|Run-in|Lack of Efficacy|0|||
131914937|NCT00580840|474974992|FG003|Run-in|Lack of Efficacy|0|||
131914938|NCT00580840|474974989|FG000|Run-in|Loss of Efficacy|1|||
131914939|NCT00580840|474974990|FG001|Run-in|Loss of Efficacy|0|||
131914940|NCT00580840|474974991|FG002|Run-in|Loss of Efficacy|0|||
131914941|NCT00580840|474974992|FG003|Run-in|Loss of Efficacy|0|||
131914942|NCT00580840|474974989|FG000|Run-in|Lost to Follow-up|4|||
131914943|NCT00580840|474974990|FG001|Run-in|Lost to Follow-up|0|||
131914944|NCT00580840|474974991|FG002|Run-in|Lost to Follow-up|0|||
131914945|NCT00580840|474974992|FG003|Run-in|Lost to Follow-up|0|||
131914946|NCT00580840|474974989|FG000|Run-in|Withdrawal by Subject|5|||
131914947|NCT00580840|474974990|FG001|Run-in|Withdrawal by Subject|0|||
131914948|NCT00580840|474974991|FG002|Run-in|Withdrawal by Subject|0|||
131914949|NCT00580840|474974992|FG003|Run-in|Withdrawal by Subject|0|||
131914950|NCT00580840|474974989|FG000|Run-in|Other: Per Sponsor Request|2|||
131914951|NCT00580840|474974990|FG001|Run-in|Other: Per Sponsor Request|0|||
131914952|NCT00580840|474974991|FG002|Run-in|Other: Per Sponsor Request|0|||
131914953|NCT00580840|474974992|FG003|Run-in|Other: Per Sponsor Request|0|||
131914954|NCT00580840|474974989|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
131914955|NCT00580840|474974990|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
131914956|NCT00580840|474974991|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
131914957|NCT00580840|474974992|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
131914958|NCT00580840|474974989|FG000|Run-in|Other: Exclusionary Lab Value|1|||
131914959|NCT00580840|474974990|FG001|Run-in|Other: Exclusionary Lab Value|0|||
131914960|NCT00580840|474974991|FG002|Run-in|Other: Exclusionary Lab Value|0|||
131914961|NCT00580840|474974992|FG003|Run-in|Other: Exclusionary Lab Value|0|||
131914962|NCT00580840|474974989|FG000|Double-Blind|Adverse Event|0|||
131914963|NCT00580840|474974990|FG001|Double-Blind|Adverse Event|3|||
131914964|NCT00580840|474974991|FG002|Double-Blind|Adverse Event|4|||
131914965|NCT00580840|474974992|FG003|Double-Blind|Adverse Event|1|||
131914966|NCT00580840|474974989|FG000|Double-Blind|Loss of Efficacy|0|||
131914967|NCT00580840|474974990|FG001|Double-Blind|Loss of Efficacy|1|||
131914968|NCT00580840|474974991|FG002|Double-Blind|Loss of Efficacy|2|||
131914969|NCT00580840|474974992|FG003|Double-Blind|Loss of Efficacy|10|||
131914970|NCT00580840|474974989|FG000|Double-Blind|Lost to Follow-up|0|||
131914971|NCT00580840|474974990|FG001|Double-Blind|Lost to Follow-up|1|||
131914972|NCT00580840|474974991|FG002|Double-Blind|Lost to Follow-up|0|||
131914973|NCT00580840|474974992|FG003|Double-Blind|Lost to Follow-up|2|||
131914974|NCT00580840|474974989|FG000|Double-Blind|Withdrawal by Subject|0|||
131914975|NCT00580840|474974990|FG001|Double-Blind|Withdrawal by Subject|1|||
131453851|NCT03083873|473291794|FG004|Overall Study|Sponsor Terminated Study|0|||
131453852|NCT03083873|473291790|FG000|Overall Study|Lost to Follow-up|0|||
131914976|NCT00580840|474974991|FG002|Double-Blind|Withdrawal by Subject|2|||
131914977|NCT00580840|474974992|FG003|Double-Blind|Withdrawal by Subject|2|||
131914978|NCT00580840|474974989|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
131914979|NCT00580840|474974990|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
131914980|NCT00580840|474974991|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
131914981|NCT00580840|474974992|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
131914982|NCT00580840|474974989|FG000|Double-Blind|Other: Forbidden Medication|0|||
131914983|NCT00580840|474974990|FG001|Double-Blind|Other: Forbidden Medication|0|||
131914984|NCT00580840|474974991|FG002|Double-Blind|Other: Forbidden Medication|1|||
131914985|NCT00580840|474974992|FG003|Double-Blind|Other: Forbidden Medication|0|||
131914986|NCT01551173|474974993|FG000|Overall Study|Withdrawal by Subject|11|||
131914987|NCT01551173|474974994|FG001|Overall Study|Withdrawal by Subject|16|||
131914988|NCT01551173|474974993|FG000|Overall Study|Adverse Event|7|||
131914989|NCT01551173|474974994|FG001|Overall Study|Adverse Event|6|||
131914990|NCT01551173|474974993|FG000|Overall Study|Lost to Follow-up|5|||
131914991|NCT01551173|474974994|FG001|Overall Study|Lost to Follow-up|7|||
131914992|NCT01551173|474974993|FG000|Overall Study|Other|5|||
131914993|NCT01551173|474974994|FG001|Overall Study|Other|3|||
131914994|NCT04530344|474974995|FG000|Overall Study|Lost to Follow-up|3|||
131914995|NCT04530344|474974996|FG001|Overall Study|Lost to Follow-up|3|||
131914996|NCT04530344|474974997|FG002|Overall Study|Lost to Follow-up|3|||
131914997|NCT04530344|474974998|FG003|Overall Study|Lost to Follow-up|10|||
131914998|NCT04530344|474974995|FG000|Overall Study|Withdrawal by Subject|14|||
131914999|NCT04530344|474974996|FG001|Overall Study|Withdrawal by Subject|5|||
131915000|NCT04530344|474974997|FG002|Overall Study|Withdrawal by Subject|18|||
131453853|NCT03083873|473291791|FG001|Overall Study|Lost to Follow-up|1|||
131915001|NCT04530344|474974998|FG003|Overall Study|Withdrawal by Subject|33|||
131453854|NCT03083873|473291792|FG002|Overall Study|Lost to Follow-up|1|||
131915002|NCT04530344|474974995|FG000|Overall Study|Adverse Event|0|||
131915003|NCT04530344|474974996|FG001|Overall Study|Adverse Event|0|||
131915004|NCT04530344|474974997|FG002|Overall Study|Adverse Event|0|||
131915005|NCT04530344|474974998|FG003|Overall Study|Adverse Event|1|||
131915006|NCT04530344|474974995|FG000|Overall Study|Lack of Efficacy|0|||
131915007|NCT04530344|474974996|FG001|Overall Study|Lack of Efficacy|0|||
131915008|NCT04530344|474974997|FG002|Overall Study|Lack of Efficacy|0|||
131915009|NCT04530344|474974998|FG003|Overall Study|Lack of Efficacy|1|||
131915010|NCT04530344|474974995|FG000|Overall Study|Physician Decision|0|||
131915011|NCT04530344|474974996|FG001|Overall Study|Physician Decision|0|||
131915012|NCT04530344|474974997|FG002|Overall Study|Physician Decision|1|||
131915013|NCT04530344|474974998|FG003|Overall Study|Physician Decision|1|||
131915014|NCT04530344|474974995|FG000|Overall Study|Pregnancy|0|||
131915015|NCT04530344|474974996|FG001|Overall Study|Pregnancy|0|||
131915016|NCT04530344|474974997|FG002|Overall Study|Pregnancy|2|||
131915017|NCT04530344|474974998|FG003|Overall Study|Pregnancy|1|||
131915018|NCT04530344|474974995|FG000|Overall Study|Protocol Violation|0|||
131915019|NCT04530344|474974996|FG001|Overall Study|Protocol Violation|0|||
131915020|NCT04530344|474974997|FG002|Overall Study|Protocol Violation|0|||
131915021|NCT04530344|474974998|FG003|Overall Study|Protocol Violation|1|||
131915022|NCT04530344|474974995|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
131915023|NCT04530344|474974996|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
131915024|NCT04530344|474974997|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
131915025|NCT04530344|474974998|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
131915026|NCT04530344|474974995|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
131915027|NCT04530344|474974996|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
131915028|NCT04530344|474974997|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
131915029|NCT04530344|474974998|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
131915030|NCT04530344|474974995|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
131915031|NCT04530344|474974996|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
131915032|NCT04530344|474974997|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
131915033|NCT04530344|474974998|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
131915034|NCT04530344|474974995|FG000|Overall Study|Personal Reasons|0|||
131915035|NCT04530344|474974996|FG001|Overall Study|Personal Reasons|0|||
131915036|NCT04530344|474974997|FG002|Overall Study|Personal Reasons|0|||
131915037|NCT04530344|474974998|FG003|Overall Study|Personal Reasons|1|||
131915038|NCT04530344|474974995|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
131915039|NCT04530344|474974996|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
131915040|NCT04530344|474974997|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
131864131|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
131864132|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
131864133|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864134|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864135|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864136|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864137|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864138|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
131864139|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
131864140|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
131864141|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
131864142|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
131864143|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
131864144|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
131864145|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864146|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864147|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
131864148|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864149|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864150|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864151|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864152|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864153|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
131864154|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
131864155|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864156|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864157|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864158|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
131864159|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
131864160|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
131915041|NCT04530344|474974998|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
131915042|NCT01402700|474974999|FG000|Overall Study|Death|3|||
131915043|NCT01402700|474974999|FG000|Overall Study|Withdrawal by Subject|3|||
131915044|NCT01402700|474974999|FG000|Overall Study|Missed Visit|1|||
131915045|NCT01910441|474975001|FG000|Overall Study|Sponsor decision|0|||
131915046|NCT01910441|474975002|FG001|Overall Study|Sponsor decision|2|||
131915047|NCT01910441|474975001|FG000|Overall Study|Lost to Follow-up|6|||
131915048|NCT01910441|474975002|FG001|Overall Study|Lost to Follow-up|5|||
131915049|NCT01910441|474975001|FG000|Overall Study|Withdrawal by Subject|0|||
131915050|NCT01910441|474975002|FG001|Overall Study|Withdrawal by Subject|1|||
131915051|NCT01910441|474975001|FG000|Overall Study|Non-compliance|0|||
131915052|NCT01910441|474975002|FG001|Overall Study|Non-compliance|1|||
131915053|NCT01910441|474975001|FG000|Overall Study|Adverse Event|1|||
131915054|NCT01910441|474975002|FG001|Overall Study|Adverse Event|0|||
131915055|NCT01910441|474975001|FG000|Overall Study|Physician Decision|0|||
131915056|NCT01910441|474975002|FG001|Overall Study|Physician Decision|1|||
131915057|NCT02246777|474975005|FG000|Overall Study|Adverse Event|2|||
131915058|NCT02246777|474975005|FG000|Overall Study|Change of residence|1|||
131915059|NCT02401230|474975006|FG000|Overall Study|Adverse Event|3|||
131915060|NCT02401230|474975007|FG001|Overall Study|Adverse Event|2|||
131915061|NCT02401230|474975008|FG002|Overall Study|Adverse Event|0|||
131915062|NCT02401230|474975006|FG000|Overall Study|Withdrawal by Subject|2|||
131915063|NCT02401230|474975007|FG001|Overall Study|Withdrawal by Subject|1|||
131915064|NCT02401230|474975008|FG002|Overall Study|Withdrawal by Subject|1|||
131915065|NCT02401230|474975006|FG000|Overall Study|Lost to Follow-up|1|||
131915066|NCT02401230|474975007|FG001|Overall Study|Lost to Follow-up|3|||
131915067|NCT02401230|474975008|FG002|Overall Study|Lost to Follow-up|3|||
131915068|NCT00830765|474975009|FG000|Overall Study|Protocol Violation|3|||
131915069|NCT00830765|474975010|FG001|Overall Study|Protocol Violation|2|||
131915070|NCT01299909|474975011|FG000|Overall Study|Lost to Follow-up|22|||
131915071|NCT01299909|474975012|FG001|Overall Study|Lost to Follow-up|18|||
131915072|NCT01299909|474975013|FG002|Overall Study|Lost to Follow-up|17|||
131915073|NCT01811238|474975014|FG000|Overall Study|Withdrawal by Subject|42|||
131915074|NCT01811238|474975014|FG000|Overall Study|Adverse Event|25|||
131915075|NCT01811238|474975014|FG000|Overall Study|Protocol Violation|4|||
131915076|NCT01811238|474975014|FG000|Overall Study|Lack of Efficacy|4|||
131915077|NCT01811238|474975014|FG000|Overall Study|subject refused study medication|6|||
131915078|NCT02340949|474975015|FG000|Overall Study|Adverse Event|4|||
131915079|NCT02340949|474975016|FG001|Overall Study|Adverse Event|2|||
131915080|NCT02340949|474975015|FG000|Overall Study|Withdrawal by Subject|2|||
131915081|NCT02340949|474975016|FG001|Overall Study|Withdrawal by Subject|0|||
131915082|NCT02340949|474975015|FG000|Overall Study|Progression disease|6|||
131915083|NCT02340949|474975016|FG001|Overall Study|Progression disease|2|||
131915084|NCT02340949|474975015|FG000|Overall Study|Death|3|||
131915085|NCT02340949|474975016|FG001|Overall Study|Death|0|||
131915086|NCT02340949|474975015|FG000|Overall Study|Physician Decision|1|||
131915087|NCT02340949|474975016|FG001|Overall Study|Physician Decision|0|||
131915088|NCT01192178|474975017|FG000|Overall Study|Withdrawal by Subject|6|||
131915089|NCT01192178|474975018|FG001|Overall Study|Withdrawal by Subject|10|||
131915090|NCT01192178|474975017|FG000|Overall Study|Protocol Violation|10|||
131915091|NCT01192178|474975018|FG001|Overall Study|Protocol Violation|3|||
131915092|NCT01192178|474975017|FG000|Overall Study|Physician Decision|2|||
131915093|NCT01192178|474975018|FG001|Overall Study|Physician Decision|4|||
131915094|NCT01192178|474975017|FG000|Overall Study|Lost to Follow-up|3|||
131915095|NCT01192178|474975018|FG001|Overall Study|Lost to Follow-up|3|||
131915096|NCT01192178|474975017|FG000|Overall Study|Adverse Event|2|||
131915097|NCT01192178|474975018|FG001|Overall Study|Adverse Event|1|||
131915098|NCT01192178|474975017|FG000|Overall Study|Lack of Efficacy|1|||
131864161|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
131864162|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
131864163|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864164|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864165|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864166|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864167|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864168|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
131864169|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864170|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864171|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131915099|NCT01192178|474975018|FG001|Overall Study|Lack of Efficacy|2|||
131915100|NCT01155570|474975019|FG000|Overall Study|Adverse Event|39|||
131915101|NCT01155570|474975019|FG000|Overall Study|Lack of Efficacy|46|||
131915102|NCT01155570|474975019|FG000|Overall Study|Participant's Economic Reasons|17|||
131915103|NCT01155570|474975019|FG000|Overall Study|No Hospital Visits|7|||
131408120|NCT03187834|473118184|FG001|Overall Study|Lost to Follow-up|1|||
131915104|NCT01155570|474975019|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
131915105|NCT01155570|474975019|FG000|Overall Study|Adverse Event + Other Reasons|7|||
131915106|NCT01155570|474975019|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
131915107|NCT01155570|474975019|FG000|Overall Study|Other Reasons|23|||
131915108|NCT00296517|474975020|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
131864172|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864173|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
131864174|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864175|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864176|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
131864177|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
131864178|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864179|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864180|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864181|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864182|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864183|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864184|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864185|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
131864186|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
131864187|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864188|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
131864189|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
131864190|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
131864191|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864192|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
131864193|NCT03334435|474782269|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864194|NCT03334435|474782270|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864195|NCT03334435|474782271|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864196|NCT03334435|474782272|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864197|NCT03334435|474782273|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864198|NCT03334435|474782274|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864199|NCT03334435|474782275|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864200|NCT03334435|474782276|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864201|NCT03334435|474782277|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864202|NCT03334435|474782278|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864203|NCT03334435|474782279|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864204|NCT03334435|474782280|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
131864205|NCT03334435|474782281|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
131864206|NCT03334435|474782282|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
131864207|NCT03334435|474782283|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
131864208|NCT03922321|474782284|FG000|Overall Study|Participant Moved|1|||
131864209|NCT03922321|474782284|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
131864210|NCT03802825|474782285|FG000|Overall Study|Lost to follow-up for intervention|12|||
131864211|NCT03802825|474782286|FG001|Overall Study|Lost to follow-up for intervention|3|||
131864212|NCT03802825|474782285|FG000|Overall Study|Received only 1 component of intervention|0|||
131864213|NCT03802825|474782286|FG001|Overall Study|Received only 1 component of intervention|13|||
131864214|NCT01293695|474782295|FG000|Overall Study|Withdrawal by Subject|7|||
131864215|NCT01293695|474782296|FG001|Overall Study|Withdrawal by Subject|1|||
131864216|NCT01293695|474782295|FG000|Overall Study|Lost to Follow-up|8|||
131864217|NCT01293695|474782296|FG001|Overall Study|Lost to Follow-up|6|||
131864218|NCT00957801|474782297|FG000|Overall Study|Withdrawal by Subject|0|||
131864219|NCT00957801|474782298|FG001|Overall Study|Withdrawal by Subject|0|||
131864220|NCT00957801|474782299|FG002|Overall Study|Withdrawal by Subject|0|||
131864221|NCT00957801|474782300|FG003|Overall Study|Withdrawal by Subject|1|||
131864222|NCT01778855|474782301|FG000|Overall Study|Death|0|||
131864223|NCT01778855|474782302|FG001|Overall Study|Death|1|||
131864224|NCT00191477|474782303|FG000|Overall Study|Tumor Recurrence|49|||
131864225|NCT00191477|474782304|FG001|Overall Study|Tumor Recurrence|48|||
131864226|NCT00191477|474782303|FG000|Overall Study|Death, Study Disease|1|||
131864227|NCT00191477|474782304|FG001|Overall Study|Death, Study Disease|1|||
131864228|NCT00191477|474782303|FG000|Overall Study|Death, Other Cause|3|||
131864229|NCT00191477|474782304|FG001|Overall Study|Death, Other Cause|6|||
131864230|NCT00191477|474782303|FG000|Overall Study|Lost to Follow-up|23|||
131864231|NCT00191477|474782304|FG001|Overall Study|Lost to Follow-up|21|||
131864232|NCT00191477|474782303|FG000|Overall Study|Protocol Violation|1|||
131864233|NCT00191477|474782304|FG001|Overall Study|Protocol Violation|1|||
131864234|NCT00191477|474782303|FG000|Overall Study|Treatment Change|2|||
131864235|NCT00191477|474782304|FG001|Overall Study|Treatment Change|0|||
131864236|NCT00191477|474782303|FG000|Overall Study|Withdrawal by Subject|2|||
131864237|NCT00191477|474782304|FG001|Overall Study|Withdrawal by Subject|0|||
131864238|NCT00191477|474782303|FG000|Overall Study|Other|2|||
131864239|NCT00191477|474782304|FG001|Overall Study|Other|0|||
131864240|NCT00191477|474782303|FG000|Overall Study|Not Eligible|41|||
131864241|NCT00191477|474782304|FG001|Overall Study|Not Eligible|38|||
131864242|NCT00191477|474782303|FG000|Overall Study|Pathological Specimen Lost|1|||
131864243|NCT00191477|474782304|FG001|Overall Study|Pathological Specimen Lost|0|||
131864244|NCT00191477|474782303|FG000|Overall Study|Discontinued Prior to Instillation|13|||
131864245|NCT00191477|474782304|FG001|Overall Study|Discontinued Prior to Instillation|14|||
131864246|NCT01286467|474782309|FG000|Overall Study|Death|1|||
131864247|NCT01286467|474782310|FG001|Overall Study|Death|1|||
131864248|NCT01286467|474782311|FG002|Overall Study|Death|1|||
131864249|NCT01286467|474782312|FG003|Overall Study|Death|0|||
131864250|NCT01286467|474782309|FG000|Overall Study|Lost to Follow-up|0|||
131864251|NCT01286467|474782310|FG001|Overall Study|Lost to Follow-up|0|||
131864252|NCT01286467|474782311|FG002|Overall Study|Lost to Follow-up|0|||
131864253|NCT01286467|474782312|FG003|Overall Study|Lost to Follow-up|1|||
131864254|NCT01286467|474782309|FG000|Overall Study|Withdrawal by Subject|0|||
131864255|NCT01286467|474782310|FG001|Overall Study|Withdrawal by Subject|0|||
131864256|NCT01286467|474782311|FG002|Overall Study|Withdrawal by Subject|1|||
131864257|NCT01286467|474782312|FG003|Overall Study|Withdrawal by Subject|0|||
131864258|NCT01286467|474782309|FG000|Overall Study|Physician Decision|0|||
131864259|NCT01286467|474782310|FG001|Overall Study|Physician Decision|0|||
131864260|NCT01286467|474782311|FG002|Overall Study|Physician Decision|0|||
131864261|NCT01286467|474782312|FG003|Overall Study|Physician Decision|1|||
131864262|NCT01286467|474782309|FG000|Overall Study|Disease progression|3|||
131864263|NCT01286467|474782310|FG001|Overall Study|Disease progression|2|||
131864264|NCT01286467|474782311|FG002|Overall Study|Disease progression|2|||
131864265|NCT01286467|474782312|FG003|Overall Study|Disease progression|3|||
131864266|NCT01286467|474782309|FG000|Overall Study|Adverse Event|0|||
131864267|NCT01286467|474782310|FG001|Overall Study|Adverse Event|1|||
131864268|NCT01286467|474782311|FG002|Overall Study|Adverse Event|2|||
131864269|NCT01286467|474782312|FG003|Overall Study|Adverse Event|3|||
131864270|NCT01286467|474782309|FG000|Overall Study|Study drug stop longer than 14 days|0|||
131864271|NCT01286467|474782310|FG001|Overall Study|Study drug stop longer than 14 days|0|||
131864272|NCT01286467|474782311|FG002|Overall Study|Study drug stop longer than 14 days|1|||
131864273|NCT01286467|474782312|FG003|Overall Study|Study drug stop longer than 14 days|0|||
131864274|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
131864275|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
131864276|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
131864277|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864278|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864279|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864280|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864281|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
131864282|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
131864283|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
131864284|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
131864285|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
131864286|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
131864287|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
131864288|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
131864289|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864290|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
131864291|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864292|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864293|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864294|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864295|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
131864296|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864297|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
131864298|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864299|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864300|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864301|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864302|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
131864303|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
131864304|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
131864305|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131864306|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131915109|NCT00296517|474975021|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
131864307|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131864308|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131864309|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
131864310|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
131864311|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
131864312|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
131864313|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
131864314|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
131864315|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
131864316|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
131864317|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
131864318|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
131864319|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
131864320|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
131864321|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
131864322|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
131864323|NCT04242498|474782313|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864324|NCT04242498|474782314|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
131864325|NCT04242498|474782315|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
131864326|NCT04242498|474782316|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864327|NCT04242498|474782317|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864328|NCT04242498|474782318|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864329|NCT04242498|474782319|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864330|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864331|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864332|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864333|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864334|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
131864335|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
131864336|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
131864337|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864338|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864339|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864340|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864341|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
131864342|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
131864343|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
131864344|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864345|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864346|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864347|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864348|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864349|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
131864350|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
131864351|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
131864352|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
131864353|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
131864354|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
131864355|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
131864356|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
131864357|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
131864358|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
131864359|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
131864360|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
131864361|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
131864362|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
131864363|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
131864364|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
131864365|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
131864366|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
131864367|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
131864368|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
131864369|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
131915110|NCT00296517|474975020|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
131864370|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
131864371|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
131864372|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
131864373|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
131864374|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
131864375|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
131864376|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
131864377|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
131864378|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
131864379|NCT04242498|474782313|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
131864380|NCT04242498|474782314|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
131864381|NCT04242498|474782315|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
131864382|NCT04242498|474782316|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
131864383|NCT04242498|474782317|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
131864384|NCT04242498|474782318|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
131864385|NCT04242498|474782319|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
131864386|NCT04760626|474782320|FG000|Overall Study|Withdrawal by Subject|24|||
131864387|NCT04760626|474782321|FG001|Overall Study|Withdrawal by Subject|20|||
131864388|NCT04760626|474782320|FG000|Overall Study|Lost to Follow-up|14|||
131864389|NCT04760626|474782321|FG001|Overall Study|Lost to Follow-up|19|||
131864390|NCT04760626|474782320|FG000|Overall Study|Physician Decision|3|||
131864391|NCT04760626|474782321|FG001|Overall Study|Physician Decision|5|||
131864392|NCT04760626|474782320|FG000|Overall Study|Death|3|||
131864393|NCT04760626|474782321|FG001|Overall Study|Death|6|||
131864394|NCT04760626|474782320|FG000|Overall Study|Site closure|1|||
131864395|NCT04760626|474782321|FG001|Overall Study|Site closure|0|||
131864396|NCT03762265|474782324|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
131864397|NCT03762265|474782325|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
131864398|NCT03762265|474782324|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
131864399|NCT03762265|474782325|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
131864400|NCT03762265|474782324|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
131864401|NCT03762265|474782325|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
131864402|NCT03762265|474782324|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
131864403|NCT03762265|474782325|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
131864404|NCT03762265|474782324|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
131864405|NCT03762265|474782325|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
131864406|NCT03762265|474782324|FG000|BT Period: Weeks 1 to 37|Other|0|||
131864407|NCT03762265|474782325|FG001|BT Period: Weeks 1 to 37|Other|1|||
131864408|NCT03762265|474782324|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
131864409|NCT03762265|474782325|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
131864410|NCT03762265|474782324|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
131864411|NCT03762265|474782325|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
131864412|NCT03762265|474782324|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
131864413|NCT03762265|474782325|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
131864414|NCT03762265|474782324|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
131864415|NCT03762265|474782325|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
131864416|NCT03762265|474782324|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
131864417|NCT03762265|474782325|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
131864418|NCT03762265|474782324|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
131864419|NCT03762265|474782325|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
131864420|NCT03762265|474782324|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
131864421|NCT03762265|474782325|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
131864422|NCT03762265|474782324|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
131864423|NCT03762265|474782325|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
131864424|NCT03762265|474782324|FG000|LTE Period: Weeks 61 to 109|Other|1|||
131864425|NCT03762265|474782325|FG001|LTE Period: Weeks 61 to 109|Other|0|||
131864426|NCT00806403|474782328|FG000|Overall Study|Death|4|||
131864427|NCT00806403|474782329|FG001|Overall Study|Death|3|||
131864428|NCT01882985|474782330|FG000|Overall Study|Lost to Follow-up|1|||
131864429|NCT01882985|474782330|FG000|Overall Study|Withdrawal by Subject|1|||
131864430|NCT04129125|474782331|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
131864431|NCT04129125|474782331|FG000|Overall Study|Study device was not used|3|||
131864432|NCT01383174|474782332|FG000|3 Month Assessment|Death|0|||
131864433|NCT01383174|474782333|FG001|3 Month Assessment|Death|1|||
131864434|NCT01383174|474782332|FG000|3 Month Assessment|Lost to Follow-up|2|||
131864435|NCT01383174|474782333|FG001|3 Month Assessment|Lost to Follow-up|0|||
131864436|NCT01383174|474782332|FG000|3 Month Assessment|Refused to complete|4|||
131864437|NCT01383174|474782333|FG001|3 Month Assessment|Refused to complete|0|||
131864438|NCT01383174|474782332|FG000|6 Month Assessment|Lost to Follow-up|1|||
131864439|NCT01383174|474782333|FG001|6 Month Assessment|Lost to Follow-up|1|||
131864440|NCT01383174|474782332|FG000|6 Month Assessment|Refused to complete|4|||
131864441|NCT01383174|474782333|FG001|6 Month Assessment|Refused to complete|0|||
131864442|NCT01787292|474782334|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
131864443|NCT01787292|474782335|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
131864444|NCT01787292|474782334|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
131864445|NCT01787292|474782335|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
131864446|NCT01827111|474782336|FG000|Overall Study|Disease Progression|1|||
131864447|NCT02169271|474782337|FG000|Overall Study|Protocol Violation|1|||
131864448|NCT02169271|474782338|FG001|Overall Study|Protocol Violation|2|||
131864449|NCT05303194|474782339|FG000|Overall Study|Lost to Follow-up|1|||
131864450|NCT05303194|474782340|FG001|Overall Study|Lost to Follow-up|1|||
131864451|NCT05303194|474782339|FG000|Overall Study|Withdrawal by Subject|0|||
131864452|NCT05303194|474782340|FG001|Overall Study|Withdrawal by Subject|1|||
131864453|NCT01289678|474782341|FG000|Overall Study|Physician Decision|6|||
131864454|NCT00226499|474782342|FG000|Overall Study|Adverse Event|10|||
131864455|NCT00226499|474782343|FG001|Overall Study|Adverse Event|6|||
131864456|NCT00226499|474782344|FG002|Overall Study|Adverse Event|3|||
131864457|NCT00226499|474782342|FG000|Overall Study|Others|1064|||
131864458|NCT00226499|474782343|FG001|Overall Study|Others|1066|||
131864459|NCT00226499|474782344|FG002|Overall Study|Others|356|||
131864460|NCT00468819|474782345|FG000|Overall Study|Withdrawal by Subject|4|||
131864461|NCT00468819|474782346|FG001|Overall Study|Withdrawal by Subject|0|||
131864462|NCT00468819|474782347|FG002|Overall Study|Withdrawal by Subject|1|||
131864463|NCT00468819|474782345|FG000|Overall Study|Lost to Follow-up|0|||
131864464|NCT00468819|474782346|FG001|Overall Study|Lost to Follow-up|0|||
131864465|NCT00468819|474782347|FG002|Overall Study|Lost to Follow-up|1|||
131864466|NCT00468819|474782345|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
131864467|NCT00468819|474782346|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
131864468|NCT00468819|474782347|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
131864469|NCT02964247|474782348|FG000|Overall Study|Lost to Follow-up|2|||
131864470|NCT02964247|474782349|FG001|Overall Study|Lost to Follow-up|0|||
131864471|NCT02964247|474782348|FG000|Overall Study|Withdrawal by Subject|1|||
131864472|NCT02964247|474782349|FG001|Overall Study|Withdrawal by Subject|2|||
131864473|NCT01288079|474782355|FG000|Overall Study|Withdrawal by Subject|2|||
131864474|NCT01288079|474782356|FG001|Overall Study|Withdrawal by Subject|4|||
131864475|NCT01288079|474782357|FG002|Overall Study|Withdrawal by Subject|1|||
131864476|NCT01288079|474782358|FG003|Overall Study|Withdrawal by Subject|0|||
131864477|NCT01288079|474782355|FG000|Overall Study|Adverse Event|2|||
131864478|NCT01288079|474782356|FG001|Overall Study|Adverse Event|1|||
131864479|NCT01288079|474782357|FG002|Overall Study|Adverse Event|2|||
131864480|NCT01288079|474782358|FG003|Overall Study|Adverse Event|3|||
131864481|NCT01288079|474782355|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
131864482|NCT01288079|474782356|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
131864483|NCT01288079|474782357|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
131864484|NCT01288079|474782358|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
131864485|NCT01288079|474782355|FG000|Overall Study|Condition under Investigation Worsened|0|||
131864486|NCT01288079|474782356|FG001|Overall Study|Condition under Investigation Worsened|0|||
131864487|NCT01288079|474782357|FG002|Overall Study|Condition under Investigation Worsened|0|||
131864488|NCT01288079|474782358|FG003|Overall Study|Condition under Investigation Worsened|1|||
131864489|NCT01288079|474782355|FG000|Overall Study|Lack of Efficacy|2|||
131864490|NCT01288079|474782356|FG001|Overall Study|Lack of Efficacy|2|||
131864491|NCT01288079|474782357|FG002|Overall Study|Lack of Efficacy|0|||
131864492|NCT01288079|474782358|FG003|Overall Study|Lack of Efficacy|2|||
131864493|NCT01288079|474782355|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
131864494|NCT01288079|474782356|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
131864495|NCT01288079|474782357|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
131864496|NCT01288079|474782358|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
131864497|NCT01288079|474782355|FG000|Overall Study|Lost to Follow-up|1|||
131864498|NCT01288079|474782356|FG001|Overall Study|Lost to Follow-up|1|||
131864499|NCT01288079|474782357|FG002|Overall Study|Lost to Follow-up|1|||
131864500|NCT01288079|474782358|FG003|Overall Study|Lost to Follow-up|0|||
131864501|NCT01288079|474782355|FG000|Overall Study|Other or Study Termination|11|||
131864502|NCT01288079|474782356|FG001|Overall Study|Other or Study Termination|15|||
131864503|NCT01288079|474782357|FG002|Overall Study|Other or Study Termination|14|||
131864504|NCT01288079|474782358|FG003|Overall Study|Other or Study Termination|8|||
131864505|NCT00908544|474782359|FG000|Overall Study|Withdrawal by Subject|2|||
131864506|NCT00908544|474782360|FG001|Overall Study|Withdrawal by Subject|4|||
131864507|NCT00908544|474782359|FG000|Overall Study|Lack of Efficacy|0|||
131864508|NCT00908544|474782360|FG001|Overall Study|Lack of Efficacy|1|||
131864509|NCT00908544|474782359|FG000|Overall Study|Pregnancy|1|||
131864510|NCT00908544|474782360|FG001|Overall Study|Pregnancy|0|||
131864511|NCT00908544|474782359|FG000|Overall Study|Relocation abroad|1|||
131864512|NCT00908544|474782360|FG001|Overall Study|Relocation abroad|1|||
131864513|NCT00908544|474782359|FG000|Overall Study|Unable to visit sutdy center|1|||
131915111|NCT00296517|474975021|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
131864514|NCT00908544|474782360|FG001|Overall Study|Unable to visit sutdy center|0|||
131864515|NCT03170544|474782361|FG000|Part 1|Lost to Follow-up|1|||
131864516|NCT03170544|474782362|FG001|Part 1|Lost to Follow-up|0|||
131864517|NCT03170544|474782363|FG002|Part 1|Lost to Follow-up|0|||
131864518|NCT03170544|474782364|FG003|Part 1|Lost to Follow-up|0|||
131864519|NCT03170544|474782365|FG004|Part 1|Lost to Follow-up|0|||
131864520|NCT03170544|474782366|FG005|Part 1|Lost to Follow-up|0|||
131864521|NCT03170544|474782367|FG006|Part 1|Lost to Follow-up|0|||
131864522|NCT03170544|474782368|FG007|Part 1|Lost to Follow-up|0|||
131864523|NCT03170544|474782369|FG008|Part 1|Lost to Follow-up|0|||
131864524|NCT03170544|474782370|FG009|Part 1|Lost to Follow-up|0|||
131864525|NCT03170544|474782371|FG010|Part 1|Lost to Follow-up|0|||
131864526|NCT03170544|474782372|FG011|Part 1|Lost to Follow-up|0|||
131864527|NCT03170544|474782361|FG000|Part 1|Not treated|0|||
131864528|NCT03170544|474782362|FG001|Part 1|Not treated|0|||
131864529|NCT03170544|474782363|FG002|Part 1|Not treated|0|||
131864530|NCT03170544|474782364|FG003|Part 1|Not treated|1|||
131864531|NCT03170544|474782365|FG004|Part 1|Not treated|0|||
131864532|NCT03170544|474782366|FG005|Part 1|Not treated|0|||
131864533|NCT03170544|474782367|FG006|Part 1|Not treated|0|||
131864534|NCT03170544|474782368|FG007|Part 1|Not treated|0|||
131864535|NCT03170544|474782369|FG008|Part 1|Not treated|0|||
131864536|NCT03170544|474782370|FG009|Part 1|Not treated|0|||
131864537|NCT03170544|474782371|FG010|Part 1|Not treated|0|||
131864538|NCT03170544|474782372|FG011|Part 1|Not treated|0|||
131864539|NCT02387840|474782373|FG000|Overall Study|Death|0|||
131864540|NCT02387840|474782374|FG001|Overall Study|Death|0|||
131864541|NCT02387840|474782375|FG002|Overall Study|Death|0|||
131864542|NCT02387840|474782376|FG003|Overall Study|Death|0|||
131864543|NCT02387840|474782377|FG004|Overall Study|Death|0|||
131864544|NCT02387840|474782378|FG005|Overall Study|Death|1|||
131864545|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
131864546|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
131864547|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
131864548|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864549|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864550|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864551|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
131864552|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864553|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
131864554|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
131864555|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864556|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864557|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864558|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
131864559|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
131864560|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
131864561|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
131864562|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864563|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864564|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864565|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
131864566|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
131864567|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
131864568|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
131864569|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131864570|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131408121|NCT03187834|473118185|FG002|Overall Study|Lost to Follow-up|2|||
131864571|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131864572|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
131864573|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
131864574|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
131864575|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
131864576|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
131864577|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
131864578|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
131864579|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
131864580|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
131864581|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
131864582|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
131864583|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
131864584|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
131915112|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
131864585|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
131864586|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
131864587|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
131864588|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
131864589|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
131864590|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
131864591|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
131864592|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
131864593|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
131864594|NCT04242446|474783703|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864595|NCT04242446|474783704|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
131864596|NCT04242446|474783705|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
131864597|NCT04242446|474783706|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864598|NCT04242446|474783707|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864599|NCT04242446|474783708|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864600|NCT04242446|474783709|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
131864601|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864602|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864603|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
131864604|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
131864605|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
131864606|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
131864607|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
131864608|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864609|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864610|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
131864611|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
131864612|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
131864613|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
131864614|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
131864615|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864616|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864617|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
131864618|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
131864619|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
131864620|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
131864621|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
131864622|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
131864623|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
131864624|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
131864625|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
131864626|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
131864627|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
131864628|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
131864629|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
131864630|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
131864631|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
131864632|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
131864633|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
131864634|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
131864635|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
131864636|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
131864637|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
131864638|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
131864639|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
131864640|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
131915113|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
131915114|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
131915115|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
131453855|NCT03083873|473291793|FG003|Overall Study|Lost to Follow-up|0|||
131453856|NCT03083873|473291794|FG004|Overall Study|Lost to Follow-up|0|||
131453857|NCT03083873|473291790|FG000|Overall Study|Withdrawal by Subject|2|||
131453858|NCT03083873|473291791|FG001|Overall Study|Withdrawal by Subject|0|||
131864641|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
131864642|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
131864643|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
131864644|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
131864645|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
131864646|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
131864647|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
131864648|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
131864649|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
131864650|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
131864651|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
131864652|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
131864653|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
131864654|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
131864655|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
131864656|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
131864657|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
131864658|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
131864659|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
131864660|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
131864661|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
131864662|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
131864663|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
131864664|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
131864665|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
131864666|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
131864667|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
131864668|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
131864669|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
131864670|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
131864671|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
131864672|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
131864673|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
131864674|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
131864675|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
131864676|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
131864677|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
131864678|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
131864679|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
131864680|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
131864681|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
131864682|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
131864683|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
131864684|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
131864685|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
131864686|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
131864687|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
131864688|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
131864689|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
131864690|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
131864691|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
131453859|NCT03083873|473291792|FG002|Overall Study|Withdrawal by Subject|0|||
131915116|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
131915117|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
131915118|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
131915119|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
131915120|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
131915121|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
131915122|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
131915123|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
131915124|NCT00296517|474975020|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
131915125|NCT00296517|474975021|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
131915126|NCT00964782|474975025|FG000|Overall Study|Lost to Follow-up|1|||
131915127|NCT00964782|474975026|FG001|Overall Study|Lost to Follow-up|0|||
131915128|NCT01349595|474975030|FG000|Overall Study|Lack of funding|2|||
131915129|NCT01349595|474975031|FG001|Overall Study|Lack of funding|2|||
131915130|NCT02127671|474976904|FG000|Overall Study|Death|2|||
131915131|NCT02127671|474976905|FG001|Overall Study|Death|2|||
131915132|NCT02127671|474976904|FG000|Overall Study|Lost to Follow-up|4|||
131915133|NCT02127671|474976905|FG001|Overall Study|Lost to Follow-up|2|||
131915134|NCT02127671|474976904|FG000|Overall Study|Physician Decision|1|||
131915135|NCT02127671|474976905|FG001|Overall Study|Physician Decision|0|||
131915136|NCT02127671|474976904|FG000|Overall Study|incarceration|0|||
131915137|NCT02127671|474976905|FG001|Overall Study|incarceration|1|||
131915138|NCT02127671|474976904|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
131915139|NCT02127671|474976905|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
131915140|NCT03813654|474976907|FG000|Overall Study|Protocol Violation|0|||
131915141|NCT03813654|474976908|FG001|Overall Study|Protocol Violation|1|||
131915142|NCT03813654|474976909|FG002|Overall Study|Protocol Violation|2|||
131915143|NCT03813654|474976907|FG000|Overall Study|Withdrawal by Subject|1|||
131915144|NCT03813654|474976908|FG001|Overall Study|Withdrawal by Subject|0|||
131915145|NCT03813654|474976909|FG002|Overall Study|Withdrawal by Subject|0|||
131915146|NCT01208051|474976910|FG000|Total Enrollment|Withdrawal by Subject|0|||
131915147|NCT01208051|474976911|FG001|Total Enrollment|Withdrawal by Subject|1|||
131915148|NCT01208051|474976912|FG002|Total Enrollment|Withdrawal by Subject|0|||
131915149|NCT01208051|474976913|FG003|Total Enrollment|Withdrawal by Subject|0|||
131915150|NCT01208051|474976914|FG004|Total Enrollment|Withdrawal by Subject|2|||
131915151|NCT01208051|474976910|FG000|Total Enrollment|Brain metastases|0|||
131915152|NCT01208051|474976911|FG001|Total Enrollment|Brain metastases|0|||
131408122|NCT03187834|473118186|FG003|Overall Study|Lost to Follow-up|2|||
131408123|NCT03187834|473118183|FG000|Overall Study|Had invalid anthropometric measurements|5|||
131408124|NCT03187834|473118184|FG001|Overall Study|Had invalid anthropometric measurements|3|||
131408125|NCT03187834|473118185|FG002|Overall Study|Had invalid anthropometric measurements|4|||
131408126|NCT03187834|473118186|FG003|Overall Study|Had invalid anthropometric measurements|2|||
131408127|NCT00823212|473118190|FG000|Overall Study|Death|8|||
131408128|NCT00823212|473118191|FG001|Overall Study|Death|10|||
131864692|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
131864693|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
131864694|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
131864695|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
131864696|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
131864697|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
131864698|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
131864699|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
131864700|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
131864701|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
131864702|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
131864703|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
131864704|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
131915153|NCT01208051|474976912|FG002|Total Enrollment|Brain metastases|1|||
131915154|NCT01208051|474976913|FG003|Total Enrollment|Brain metastases|0|||
131915155|NCT01208051|474976914|FG004|Total Enrollment|Brain metastases|0|||
131915156|NCT02107898|474976917|FG000|Overall Study|Adverse Event|4|||
131915157|NCT02107898|474976918|FG001|Overall Study|Adverse Event|7|||
131915158|NCT02107898|474976917|FG000|Overall Study|Poor compliance to protocol|0|||
131915159|NCT02107898|474976918|FG001|Overall Study|Poor compliance to protocol|1|||
131915160|NCT02107898|474976917|FG000|Overall Study|Participant moved|0|||
131915161|NCT02107898|474976918|FG001|Overall Study|Participant moved|2|||
131915162|NCT02107898|474976917|FG000|Overall Study|Consent withdrawn by participant|2|||
131915163|NCT02107898|474976918|FG001|Overall Study|Consent withdrawn by participant|1|||
131915164|NCT02107898|474976917|FG000|Overall Study|Randomized but not treated|0|||
131915165|NCT02107898|474976918|FG001|Overall Study|Randomized but not treated|1|||
131408129|NCT00823212|473118190|FG000|Overall Study|Withdrawal by Subject|6|||
131864705|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
131864706|NCT04242446|474783703|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
131864707|NCT04242446|474783704|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
131864708|NCT04242446|474783705|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
131864709|NCT04242446|474783706|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
131864710|NCT04242446|474783707|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
131864711|NCT04242446|474783708|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
131864712|NCT04242446|474783709|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
131864713|NCT00739882|474783710|FG000|Double-blind Period|Adverse Event|1|||
131864714|NCT00739882|474783711|FG001|Double-blind Period|Adverse Event|2|||
131864715|NCT00739882|474783710|FG000|Double-blind Period|Protocol Violation|1|||
131864716|NCT00739882|474783711|FG001|Double-blind Period|Protocol Violation|0|||
131864717|NCT00739882|474783710|FG000|Double-blind Period|Lack of Efficacy|1|||
131864718|NCT00739882|474783711|FG001|Double-blind Period|Lack of Efficacy|1|||
131864719|NCT00739882|474783710|FG000|Double-blind Period|Other|16|||
131864720|NCT00739882|474783711|FG001|Double-blind Period|Other|8|||
131864721|NCT00739882|474783710|FG000|Open-label Period|Adverse Event|1|||
131864722|NCT00739882|474783711|FG001|Open-label Period|Adverse Event|0|||
131864723|NCT00739882|474783710|FG000|Open-label Period|Other|9|||
131864724|NCT00739882|474783711|FG001|Open-label Period|Other|5|||
131864725|NCT04021914|474783712|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
131864726|NCT02861586|474783713|FG000|Overall Study|Withdrawal by Subject|1|||
131864727|NCT02861586|474783714|FG001|Overall Study|Withdrawal by Subject|2|||
131864728|NCT02861586|474783715|FG002|Overall Study|Withdrawal by Subject|0|||
131864729|NCT02861586|474783716|FG003|Overall Study|Withdrawal by Subject|0|||
131864730|NCT02861586|474783717|FG004|Overall Study|Withdrawal by Subject|0|||
131864731|NCT02861586|474783718|FG005|Overall Study|Withdrawal by Subject|1|||
131864732|NCT02861586|474783719|FG006|Overall Study|Withdrawal by Subject|1|||
131864733|NCT02861586|474783720|FG007|Overall Study|Withdrawal by Subject|0|||
131864734|NCT02861586|474783713|FG000|Overall Study|Lost to Follow-up|3|||
131864735|NCT02861586|474783714|FG001|Overall Study|Lost to Follow-up|1|||
131864736|NCT02861586|474783715|FG002|Overall Study|Lost to Follow-up|1|||
131864737|NCT02861586|474783716|FG003|Overall Study|Lost to Follow-up|0|||
131864738|NCT02861586|474783717|FG004|Overall Study|Lost to Follow-up|0|||
131864739|NCT02861586|474783718|FG005|Overall Study|Lost to Follow-up|3|||
131864740|NCT02861586|474783719|FG006|Overall Study|Lost to Follow-up|0|||
131864741|NCT02861586|474783720|FG007|Overall Study|Lost to Follow-up|0|||
131864742|NCT02861586|474783713|FG000|Overall Study|Adverse Event|0|||
131864743|NCT02861586|474783714|FG001|Overall Study|Adverse Event|0|||
131864744|NCT02861586|474783715|FG002|Overall Study|Adverse Event|0|||
131864745|NCT02861586|474783716|FG003|Overall Study|Adverse Event|0|||
131864746|NCT02861586|474783717|FG004|Overall Study|Adverse Event|0|||
131864747|NCT02861586|474783718|FG005|Overall Study|Adverse Event|1|||
131864748|NCT02861586|474783719|FG006|Overall Study|Adverse Event|0|||
131864749|NCT02861586|474783720|FG007|Overall Study|Adverse Event|0|||
131864750|NCT00485732|474783721|FG000|Overall Study|Protocol Violation|1|||
131864751|NCT00485732|474783722|FG001|Overall Study|Protocol Violation|3|||
131864752|NCT00485732|474783721|FG000|Overall Study|Withdrawal by Subject|5|||
131864753|NCT00485732|474783722|FG001|Overall Study|Withdrawal by Subject|4|||
131864754|NCT00485732|474783721|FG000|Overall Study|Lost to Follow-up|2|||
131864755|NCT00485732|474783722|FG001|Overall Study|Lost to Follow-up|2|||
131864756|NCT01058642|474783727|FG000|Treatment Period 1|Adverse Event|0|||
131864757|NCT01058642|474783728|FG001|Treatment Period 1|Adverse Event|1|||
131864758|NCT01058642|474783729|FG002|Treatment Period 1|Adverse Event|1|||
131864759|NCT01058642|474783730|FG003|Treatment Period 1|Adverse Event|0|||
131864760|NCT01058642|474783727|FG000|Treatment Period 1|Physician Decision|0|||
131864761|NCT01058642|474783728|FG001|Treatment Period 1|Physician Decision|0|||
131864762|NCT01058642|474783729|FG002|Treatment Period 1|Physician Decision|1|||
131864763|NCT01058642|474783730|FG003|Treatment Period 1|Physician Decision|0|||
131864764|NCT01058642|474783727|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131864765|NCT01058642|474783728|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131864766|NCT01058642|474783729|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131864767|NCT01058642|474783730|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131864768|NCT01058642|474783727|FG000|Treatment Period 1|Lack of Efficacy|0|||
131864769|NCT01058642|474783728|FG001|Treatment Period 1|Lack of Efficacy|0|||
131864770|NCT01058642|474783729|FG002|Treatment Period 1|Lack of Efficacy|0|||
131864771|NCT01058642|474783730|FG003|Treatment Period 1|Lack of Efficacy|1|||
131864772|NCT01058642|474783727|FG000|Treatment Period 1|Protocol Violation|0|||
131864773|NCT01058642|474783728|FG001|Treatment Period 1|Protocol Violation|0|||
131864774|NCT01058642|474783729|FG002|Treatment Period 1|Protocol Violation|0|||
131864775|NCT01058642|474783730|FG003|Treatment Period 1|Protocol Violation|1|||
131864776|NCT01058642|474783727|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
131864777|NCT01058642|474783728|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
131864778|NCT01058642|474783729|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
131864779|NCT01058642|474783730|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
131864780|NCT03876743|474783731|FG000|Overall Study|Lost to Follow-up|6|||
131864781|NCT03876743|474783732|FG001|Overall Study|Lost to Follow-up|4|||
131864782|NCT03876743|474783733|FG002|Overall Study|Lost to Follow-up|4|||
131864783|NCT03876743|474783734|FG003|Overall Study|Lost to Follow-up|7|||
131864784|NCT00092118|474783735|FG000|Overall Study|Adverse Event|35|||
131864785|NCT00092118|474783736|FG001|Overall Study|Adverse Event|32|||
131864786|NCT00092118|474783735|FG000|Overall Study|Lack of Efficacy|12|||
131864787|NCT00092118|474783736|FG001|Overall Study|Lack of Efficacy|14|||
131864788|NCT00092118|474783735|FG000|Overall Study|Lost to Follow-up|4|||
131864789|NCT00092118|474783736|FG001|Overall Study|Lost to Follow-up|3|||
131864790|NCT00092118|474783735|FG000|Overall Study|Protocol Violation|23|||
131864791|NCT00092118|474783736|FG001|Overall Study|Protocol Violation|25|||
131864792|NCT00092118|474783735|FG000|Overall Study|Withdrawal by Subject|4|||
131864793|NCT00092118|474783736|FG001|Overall Study|Withdrawal by Subject|10|||
131864794|NCT00092118|474783735|FG000|Overall Study|Other|6|||
131864795|NCT00092118|474783736|FG001|Overall Study|Other|5|||
131864796|NCT01139125|474783737|FG000|Overall Study|Withdrawal by Subject|1|||
131864797|NCT03751098|474783738|FG000|Overall Study|Withdrawal by Subject|0|||
131864798|NCT03751098|474783739|FG001|Overall Study|Withdrawal by Subject|1|||
131864799|NCT01108718|474783745|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
131864800|NCT01108718|474783746|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
131864801|NCT03380429|474783747|FG000|Overall Study|Physician Decision|0|||
131864802|NCT03380429|474783748|FG001|Overall Study|Physician Decision|1|||
131864803|NCT03380429|474783749|FG002|Overall Study|Physician Decision|0|||
131864804|NCT03380429|474783750|FG003|Overall Study|Physician Decision|1|||
131864805|NCT03380429|474783751|FG004|Overall Study|Physician Decision|1|||
131864806|NCT03380429|474783747|FG000|Overall Study|Withdrawal by Subject|3|||
131864807|NCT03380429|474783748|FG001|Overall Study|Withdrawal by Subject|3|||
131864808|NCT03380429|474783749|FG002|Overall Study|Withdrawal by Subject|5|||
131864809|NCT03380429|474783750|FG003|Overall Study|Withdrawal by Subject|2|||
131864810|NCT03380429|474783751|FG004|Overall Study|Withdrawal by Subject|1|||
131864811|NCT03380429|474783747|FG000|Overall Study|Lost to Follow-up|0|||
131864812|NCT03380429|474783748|FG001|Overall Study|Lost to Follow-up|2|||
131864813|NCT03380429|474783749|FG002|Overall Study|Lost to Follow-up|4|||
131864814|NCT03380429|474783750|FG003|Overall Study|Lost to Follow-up|3|||
131864815|NCT03380429|474783751|FG004|Overall Study|Lost to Follow-up|1|||
131864816|NCT03380429|474783747|FG000|Overall Study|Protocol Violation|1|||
131864817|NCT03380429|474783748|FG001|Overall Study|Protocol Violation|0|||
131864818|NCT03380429|474783749|FG002|Overall Study|Protocol Violation|1|||
131864819|NCT03380429|474783750|FG003|Overall Study|Protocol Violation|0|||
131864820|NCT03380429|474783751|FG004|Overall Study|Protocol Violation|1|||
131864821|NCT03380429|474783747|FG000|Overall Study|Lack of Efficacy|0|||
131864822|NCT03380429|474783748|FG001|Overall Study|Lack of Efficacy|0|||
131864823|NCT03380429|474783749|FG002|Overall Study|Lack of Efficacy|0|||
131864824|NCT03380429|474783750|FG003|Overall Study|Lack of Efficacy|2|||
131864825|NCT03380429|474783751|FG004|Overall Study|Lack of Efficacy|1|||
131864826|NCT03380429|474783747|FG000|Overall Study|Adverse Event|1|||
131864827|NCT03380429|474783748|FG001|Overall Study|Adverse Event|1|||
131864828|NCT03380429|474783749|FG002|Overall Study|Adverse Event|1|||
131864829|NCT03380429|474783750|FG003|Overall Study|Adverse Event|2|||
131864830|NCT03380429|474783751|FG004|Overall Study|Adverse Event|0|||
131864831|NCT01924689|474783758|FG000|Overall Study|Death|0|||
131864832|NCT01924689|474783759|FG001|Overall Study|Death|1|||
131864833|NCT01924689|474783760|FG002|Overall Study|Death|0|||
131864834|NCT01924689|474783761|FG003|Overall Study|Death|1|||
131864835|NCT01924689|474783762|FG004|Overall Study|Death|0|||
131864836|NCT01924689|474783763|FG005|Overall Study|Death|0|||
131864837|NCT01924689|474783758|FG000|Overall Study|Disease progression|0|||
131864838|NCT01924689|474783759|FG001|Overall Study|Disease progression|0|||
131864839|NCT01924689|474783760|FG002|Overall Study|Disease progression|2|||
131864840|NCT01924689|474783761|FG003|Overall Study|Disease progression|0|||
131864841|NCT01924689|474783762|FG004|Overall Study|Disease progression|3|||
131864842|NCT01924689|474783763|FG005|Overall Study|Disease progression|2|||
131864843|NCT01924689|474783758|FG000|Overall Study|New therapy or study|3|||
131408130|NCT00823212|473118191|FG001|Overall Study|Withdrawal by Subject|1|||
131408131|NCT00823212|473118190|FG000|Overall Study|Incarcerated|0|||
131864844|NCT01924689|474783759|FG001|Overall Study|New therapy or study|2|||
131864845|NCT01924689|474783760|FG002|Overall Study|New therapy or study|1|||
131864846|NCT01924689|474783761|FG003|Overall Study|New therapy or study|4|||
131864847|NCT01924689|474783762|FG004|Overall Study|New therapy or study|2|||
131864848|NCT01924689|474783763|FG005|Overall Study|New therapy or study|0|||
131864849|NCT01924689|474783758|FG000|Overall Study|Withdrawal of consent|0|||
131864850|NCT01924689|474783759|FG001|Overall Study|Withdrawal of consent|0|||
131864851|NCT01924689|474783760|FG002|Overall Study|Withdrawal of consent|1|||
131864852|NCT01924689|474783761|FG003|Overall Study|Withdrawal of consent|1|||
131864853|NCT01924689|474783762|FG004|Overall Study|Withdrawal of consent|0|||
131864854|NCT01924689|474783763|FG005|Overall Study|Withdrawal of consent|0|||
131915166|NCT01283386|474976919|FG000|Overall Study|Death|2|||
131915167|NCT01283386|474976920|FG001|Overall Study|Death|0|||
131915168|NCT01283386|474976919|FG000|Overall Study|Withdrawal by Subject|2|||
131915169|NCT01283386|474976920|FG001|Overall Study|Withdrawal by Subject|1|||
131915170|NCT01283386|474976919|FG000|Overall Study|Relapse of underlying disease|1|||
131915171|NCT01283386|474976920|FG001|Overall Study|Relapse of underlying disease|3|||
131915172|NCT01283386|474976919|FG000|Overall Study|Progression of underlying disease|2|||
131915173|NCT01283386|474976920|FG001|Overall Study|Progression of underlying disease|7|||
131915174|NCT01283386|474976919|FG000|Overall Study|Reason not specified|1|||
131915175|NCT01283386|474976920|FG001|Overall Study|Reason not specified|0|||
131915176|NCT01283386|474976919|FG000|Overall Study|Protocol Violation|0|||
131915177|NCT01283386|474976920|FG001|Overall Study|Protocol Violation|1|||
131915178|NCT01531153|474976921|FG000|Overall Study|Withdrawal by Subject|10|||
131915179|NCT01531153|474976922|FG001|Overall Study|Withdrawal by Subject|9|||
131915180|NCT01531153|474976923|FG002|Overall Study|Withdrawal by Subject|15|||
131915181|NCT03483103|474976924|FG000|Pre-Treatment Phase|Other reasons|1|||
131915182|NCT03483103|474976924|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
131915183|NCT03483103|474976924|FG000|Pre-Treatment Phase|Disease-related complications|1|||
131915184|NCT03483103|474976924|FG000|Pre-Treatment Phase|Death|5|||
131915185|NCT03483103|474976924|FG000|Treatment Phase|Withdrawal by Subject|7|||
131915186|NCT03483103|474976924|FG000|Treatment Phase|Other reasons|1|||
131915187|NCT03483103|474976924|FG000|Treatment Phase|Death|23|||
131915188|NCT03483103|474976924|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
131915189|NCT03483103|474976924|FG000|Treatment Phase|Received nonconforming product|1|||
131915190|NCT00770367|474976925|FG000|First Intervention|Withdrawal by Subject|0|||
131915191|NCT00770367|474976926|FG001|First Intervention|Withdrawal by Subject|2|||
131915192|NCT00770367|474976925|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
131915193|NCT00770367|474976926|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
131915194|NCT00770367|474976925|FG000|Second Intervention|Lost to Follow-up|2|||
131864855|NCT01924689|474783758|FG000|Overall Study|Other|0|||
131864856|NCT01924689|474783759|FG001|Overall Study|Other|0|||
131864857|NCT01924689|474783760|FG002|Overall Study|Other|0|||
131864858|NCT01924689|474783761|FG003|Overall Study|Other|0|||
131864859|NCT01924689|474783762|FG004|Overall Study|Other|1|||
131864860|NCT01924689|474783763|FG005|Overall Study|Other|0|||
131864861|NCT03267212|474783764|FG000|First Intervention|Lost to Follow-up|0|||
131864862|NCT03267212|474783765|FG001|First Intervention|Lost to Follow-up|2|||
131864863|NCT03267212|474783764|FG000|First Intervention|Withdrawal by Subject|1|||
131864864|NCT03267212|474783765|FG001|First Intervention|Withdrawal by Subject|1|||
131864865|NCT03267212|474783764|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
131864866|NCT03267212|474783765|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
131864867|NCT00946920|474783768|FG000|Overall Study|Withdrawal by Subject|28|||
131864868|NCT00946920|474783769|FG001|Overall Study|Withdrawal by Subject|15|||
131864869|NCT00946920|474783768|FG000|Overall Study|Lost to Follow-up|2|||
131864870|NCT00946920|474783769|FG001|Overall Study|Lost to Follow-up|2|||
131864871|NCT00946920|474783768|FG000|Overall Study|Physician Decision|5|||
131864872|NCT00946920|474783769|FG001|Overall Study|Physician Decision|2|||
131864873|NCT00946920|474783768|FG000|Overall Study|Adverse Event|41|||
131864874|NCT00946920|474783769|FG001|Overall Study|Adverse Event|14|||
131864875|NCT00946920|474783768|FG000|Overall Study|Protocol Violation|16|||
131864876|NCT00946920|474783769|FG001|Overall Study|Protocol Violation|8|||
131864877|NCT00946920|474783768|FG000|Overall Study|Miscellaneous reasons|18|||
131864878|NCT00946920|474783769|FG001|Overall Study|Miscellaneous reasons|3|||
131864879|NCT01597973|474783770|FG000|Overall Study|Found ineligible before study medication started|4|||
131864880|NCT01597973|474783771|FG001|Overall Study|Found ineligible before study medication started|2|||
131915195|NCT00770367|474976926|FG001|Second Intervention|Lost to Follow-up|0|||
131915196|NCT02378181|474976928|FG000|Overall Study|Lost to Follow-up|2|||
131915197|NCT02378181|474976929|FG001|Overall Study|Lost to Follow-up|5|||
131915198|NCT02378181|474976928|FG000|Overall Study|Withdrawal by Subject|1|||
131915199|NCT02378181|474976929|FG001|Overall Study|Withdrawal by Subject|1|||
131915200|NCT02378181|474976928|FG000|Overall Study|Incarcerated|0|||
131915201|NCT02378181|474976929|FG001|Overall Study|Incarcerated|1|||
131915202|NCT00920816|474976930|FG000|Overall Study|Death|116|||
131915203|NCT00920816|474976931|FG001|Overall Study|Death|63|||
131915204|NCT00920816|474976932|FG002|Overall Study|Death|8|||
131915205|NCT00920816|474976933|FG003|Overall Study|Death|3|||
131915206|NCT00920816|474976930|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
131864881|NCT01597973|474783770|FG000|Overall Study|Eligible pathogen not confirmed|14|||
131864882|NCT01597973|474783771|FG001|Overall Study|Eligible pathogen not confirmed|15|||
131864883|NCT01597973|474783770|FG000|Overall Study|LAR not authorized to consent|0|||
131864884|NCT01597973|474783771|FG001|Overall Study|LAR not authorized to consent|1|||
131864885|NCT01597973|474783770|FG000|Overall Study|Ineligible due to early seizures|1|||
131864886|NCT01597973|474783771|FG001|Overall Study|Ineligible due to early seizures|0|||
131864887|NCT01597973|474783770|FG000|Overall Study|Ineligible due to non-target infection|1|||
131864888|NCT01597973|474783771|FG001|Overall Study|Ineligible due to non-target infection|1|||
131864889|NCT02174627|474783778|FG000|Overall Study|Missing|0|||
131864890|NCT02174627|474783779|FG001|Overall Study|Missing|1|||
131864891|NCT02174627|474783778|FG000|Overall Study|Incorrect enrolment before randomization|0|||
131864892|NCT02174627|474783779|FG001|Overall Study|Incorrect enrolment before randomization|1|||
131864893|NCT02174627|474783778|FG000|Overall Study|Participant decision|84|||
131864894|NCT02174627|474783779|FG001|Overall Study|Participant decision|128|||
131864895|NCT00071110|474783780|FG000|Overall Study|Protocol Violation|0|||
131864896|NCT00071110|474783781|FG001|Overall Study|Protocol Violation|4|||
131864897|NCT02166333|474783783|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
131864898|NCT02166333|474783784|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
131864899|NCT02166333|474783785|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
131864900|NCT02166333|474783786|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
131864901|NCT02166333|474783787|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
131864902|NCT02166333|474783788|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
131864903|NCT02166333|474783783|FG000|Stage 1|Death|4|||
131864904|NCT02166333|474783784|FG001|Stage 1|Death|0|||
131864905|NCT02166333|474783785|FG002|Stage 1|Death|2|||
131864906|NCT02166333|474783786|FG003|Stage 1|Death|0|||
131864907|NCT02166333|474783787|FG004|Stage 1|Death|3|||
131864908|NCT02166333|474783788|FG005|Stage 1|Death|2|||
131864909|NCT02166333|474783783|FG000|Stage 1|Lost to Follow-up|12|||
131864910|NCT02166333|474783784|FG001|Stage 1|Lost to Follow-up|0|||
131864911|NCT02166333|474783785|FG002|Stage 1|Lost to Follow-up|6|||
131864912|NCT02166333|474783786|FG003|Stage 1|Lost to Follow-up|0|||
131864913|NCT02166333|474783787|FG004|Stage 1|Lost to Follow-up|3|||
131864914|NCT02166333|474783788|FG005|Stage 1|Lost to Follow-up|3|||
131864915|NCT02166333|474783783|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
131864916|NCT02166333|474783784|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
131864917|NCT02166333|474783785|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
131864918|NCT02166333|474783786|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
131864919|NCT02166333|474783787|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
131864920|NCT02166333|474783788|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
131864921|NCT02166333|474783783|FG000|Stage 2|Death|4|||
131864922|NCT02166333|474783784|FG001|Stage 2|Death|2|||
131864923|NCT02166333|474783785|FG002|Stage 2|Death|1|||
131864924|NCT02166333|474783786|FG003|Stage 2|Death|0|||
131864925|NCT02166333|474783787|FG004|Stage 2|Death|0|||
131864926|NCT02166333|474783788|FG005|Stage 2|Death|1|||
131864927|NCT02166333|474783783|FG000|Stage 2|Lost to Follow-up|23|||
131864928|NCT02166333|474783784|FG001|Stage 2|Lost to Follow-up|4|||
131864929|NCT02166333|474783785|FG002|Stage 2|Lost to Follow-up|11|||
131864930|NCT02166333|474783786|FG003|Stage 2|Lost to Follow-up|9|||
131864931|NCT02166333|474783787|FG004|Stage 2|Lost to Follow-up|3|||
131864932|NCT02166333|474783788|FG005|Stage 2|Lost to Follow-up|6|||
131864933|NCT02259010|474783790|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
131864934|NCT01831635|474783791|FG000|Overall Study|Withdrawal by Subject|0|||
131864935|NCT01831635|474783792|FG001|Overall Study|Withdrawal by Subject|2|||
131864936|NCT01831635|474783793|FG002|Overall Study|Withdrawal by Subject|0|||
131864937|NCT03805412|474783796|FG000|Overall Study|Lost to Follow-up|0|||
131864938|NCT03805412|474783797|FG001|Overall Study|Lost to Follow-up|1|||
131864939|NCT02389829|474783810|FG000|Overall Study|Lost to Follow-up|0|||
131864940|NCT02389829|474783811|FG001|Overall Study|Lost to Follow-up|1|||
131864941|NCT02362360|474783812|FG000|Period 1|Lack of Efficacy|1|||
131864942|NCT02362360|474783813|FG001|Period 1|Lack of Efficacy|0|||
131864943|NCT02362360|474783812|FG000|Period 1|Withdrawal by Subject|2|||
131864944|NCT02362360|474783813|FG001|Period 1|Withdrawal by Subject|1|||
131864945|NCT02208362|474783814|FG000|Overall Study|Participant did not complete treatment|0|||
131864946|NCT02208362|474783815|FG001|Overall Study|Participant did not complete treatment|1|||
131864947|NCT02208362|474783816|FG002|Overall Study|Participant did not complete treatment|0|||
131864948|NCT02208362|474783817|FG003|Overall Study|Participant did not complete treatment|0|||
131864949|NCT02208362|474783818|FG004|Overall Study|Participant did not complete treatment|0|||
131864950|NCT02208362|474783819|FG005|Overall Study|Participant did not complete treatment|0|||
131864951|NCT02208362|474783820|FG006|Overall Study|Participant did not complete treatment|1|||
131864952|NCT02208362|474783821|FG007|Overall Study|Participant did not complete treatment|1|||
131864953|NCT02208362|474783822|FG008|Overall Study|Participant did not complete treatment|2|||
131864954|NCT02208362|474783823|FG009|Overall Study|Participant did not complete treatment|0|||
131864955|NCT02208362|474783824|FG010|Overall Study|Participant did not complete treatment|1|||
131864956|NCT02208362|474783825|FG011|Overall Study|Participant did not complete treatment|0|||
131864957|NCT02208362|474783814|FG000|Overall Study|Participant received disallowed treatment|0|||
131864958|NCT02208362|474783815|FG001|Overall Study|Participant received disallowed treatment|0|||
131864959|NCT02208362|474783816|FG002|Overall Study|Participant received disallowed treatment|0|||
131408132|NCT00823212|473118191|FG001|Overall Study|Incarcerated|1|||
131864960|NCT02208362|474783817|FG003|Overall Study|Participant received disallowed treatment|0|||
131864961|NCT02208362|474783818|FG004|Overall Study|Participant received disallowed treatment|0|||
131864962|NCT02208362|474783819|FG005|Overall Study|Participant received disallowed treatment|0|||
131864963|NCT02208362|474783820|FG006|Overall Study|Participant received disallowed treatment|0|||
131864964|NCT02208362|474783821|FG007|Overall Study|Participant received disallowed treatment|0|||
131864965|NCT02208362|474783822|FG008|Overall Study|Participant received disallowed treatment|1|||
131864966|NCT02208362|474783823|FG009|Overall Study|Participant received disallowed treatment|0|||
131864967|NCT02208362|474783824|FG010|Overall Study|Participant received disallowed treatment|0|||
131864968|NCT02208362|474783825|FG011|Overall Study|Participant received disallowed treatment|0|||
131864969|NCT03525678|474783830|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
131864970|NCT03525678|474783831|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
131864971|NCT03525678|474783832|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
131864972|NCT03525678|474783833|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
131864973|NCT03525678|474783834|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
131864974|NCT03525678|474783830|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
131864975|NCT03525678|474783831|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
131864976|NCT03525678|474783832|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
131864977|NCT03525678|474783833|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
131864978|NCT03525678|474783834|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
131864979|NCT03525678|474783830|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
131864980|NCT03525678|474783831|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
131864981|NCT03525678|474783832|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
131864982|NCT03525678|474783833|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
131864983|NCT03525678|474783834|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
131864984|NCT03525678|474783830|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
131864985|NCT03525678|474783831|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
131864986|NCT03525678|474783832|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
131864987|NCT03525678|474783833|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
131864988|NCT03525678|474783834|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
131864989|NCT03525678|474783830|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
131864990|NCT03525678|474783831|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
131864991|NCT03525678|474783832|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
131864992|NCT03525678|474783833|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
131864993|NCT03525678|474783834|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
131864994|NCT03525678|474783830|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
131864995|NCT03525678|474783831|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
131864996|NCT03525678|474783832|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
131864997|NCT03525678|474783833|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
131864998|NCT03525678|474783834|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
131864999|NCT02747108|474783835|FG000|Overall Study|Death|2|||
131865000|NCT02747108|474783836|FG001|Overall Study|Death|2|||
131865001|NCT02747108|474783835|FG000|Overall Study|Withdrawal by Subject|1|||
131865002|NCT02747108|474783836|FG001|Overall Study|Withdrawal by Subject|0|||
131865003|NCT02747108|474783835|FG000|Overall Study|Protocol Violation|2|||
131865004|NCT02747108|474783836|FG001|Overall Study|Protocol Violation|0|||
131865005|NCT04075825|474785071|FG000|Overall Study|Withdrawal by Subject|6|||
131865006|NCT04075825|474785072|FG001|Overall Study|Withdrawal by Subject|8|||
131865007|NCT04075825|474785071|FG000|Overall Study|Physician Decision|3|||
131865008|NCT04075825|474785072|FG001|Overall Study|Physician Decision|1|||
131865009|NCT04075825|474785071|FG000|Overall Study|Lost to Follow-up|5|||
131865010|NCT04075825|474785072|FG001|Overall Study|Lost to Follow-up|1|||
131865011|NCT04075825|474785071|FG000|Overall Study|Participation in New Clinical Trial|1|||
131865012|NCT04075825|474785072|FG001|Overall Study|Participation in New Clinical Trial|1|||
131865013|NCT04075825|474785071|FG000|Overall Study|Reason Not Specified|2|||
131865014|NCT04075825|474785072|FG001|Overall Study|Reason Not Specified|2|||
131865015|NCT03349060|474785073|FG000|Overall Study|Adverse Event|9|||
131865016|NCT03349060|474785074|FG001|Overall Study|Adverse Event|9|||
131865017|NCT03349060|474785075|FG002|Overall Study|Adverse Event|7|||
131865018|NCT03349060|474785073|FG000|Overall Study|Lack of Efficacy|1|||
131865019|NCT03349060|474785074|FG001|Overall Study|Lack of Efficacy|0|||
131865020|NCT03349060|474785075|FG002|Overall Study|Lack of Efficacy|2|||
131865021|NCT03349060|474785073|FG000|Overall Study|Lost to Follow-up|2|||
131408133|NCT00823212|473118190|FG000|Overall Study|Missed 12-month visit|21|||
131865022|NCT03349060|474785074|FG001|Overall Study|Lost to Follow-up|1|||
131865023|NCT03349060|474785075|FG002|Overall Study|Lost to Follow-up|1|||
131865024|NCT03349060|474785073|FG000|Overall Study|Protocol Violation|2|||
131865025|NCT03349060|474785074|FG001|Overall Study|Protocol Violation|2|||
131865026|NCT03349060|474785075|FG002|Overall Study|Protocol Violation|1|||
131865027|NCT03349060|474785073|FG000|Overall Study|Withdrawal by Subject|5|||
131865028|NCT03349060|474785074|FG001|Overall Study|Withdrawal by Subject|3|||
131865029|NCT03349060|474785075|FG002|Overall Study|Withdrawal by Subject|4|||
131865030|NCT03349060|474785073|FG000|Overall Study|Medication error,no linked adverse event|0|||
131915207|NCT00920816|474976931|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
131915208|NCT00920816|474976932|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
131915209|NCT00920816|474976933|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
131915210|NCT00920816|474976930|FG000|Overall Study|Global deterioration of health status|2|||
131915211|NCT00920816|474976931|FG001|Overall Study|Global deterioration of health status|0|||
131915212|NCT00920816|474976932|FG002|Overall Study|Global deterioration of health status|0|||
131915213|NCT00920816|474976933|FG003|Overall Study|Global deterioration of health status|0|||
131915214|NCT00920816|474976930|FG000|Overall Study|Objective progression or relapse|6|||
131915215|NCT00920816|474976931|FG001|Overall Study|Objective progression or relapse|2|||
131915216|NCT00920816|474976932|FG002|Overall Study|Objective progression or relapse|0|||
131915217|NCT00920816|474976933|FG003|Overall Study|Objective progression or relapse|0|||
131915218|NCT00920816|474976930|FG000|Overall Study|Other|26|||
131915219|NCT00920816|474976931|FG001|Overall Study|Other|15|||
131915220|NCT00920816|474976932|FG002|Overall Study|Other|1|||
131915221|NCT00920816|474976933|FG003|Overall Study|Other|2|||
131915222|NCT00920816|474976930|FG000|Overall Study|Lost to Follow-up|11|||
131915223|NCT00920816|474976931|FG001|Overall Study|Lost to Follow-up|2|||
131915224|NCT00920816|474976932|FG002|Overall Study|Lost to Follow-up|0|||
131915225|NCT00920816|474976933|FG003|Overall Study|Lost to Follow-up|0|||
131915226|NCT00920816|474976930|FG000|Overall Study|Adverse Event|1|||
131915227|NCT00920816|474976931|FG001|Overall Study|Adverse Event|1|||
131915228|NCT00920816|474976932|FG002|Overall Study|Adverse Event|1|||
131915229|NCT00920816|474976933|FG003|Overall Study|Adverse Event|0|||
131915230|NCT00920816|474976930|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
131915231|NCT00920816|474976931|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
131915232|NCT00920816|474976932|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
131915233|NCT00920816|474976933|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
131915234|NCT00920816|474976930|FG000|Overall Study|Randomized but not treated|3|||
131915235|NCT00920816|474976931|FG001|Overall Study|Randomized but not treated|0|||
131915236|NCT00920816|474976932|FG002|Overall Study|Randomized but not treated|0|||
131915237|NCT00920816|474976933|FG003|Overall Study|Randomized but not treated|0|||
131915238|NCT01180777|474976934|FG000|Overall Study|Protocol Violation|6|||
131915239|NCT01180777|474976934|FG000|Overall Study|Poor lens fit|4|||
131915240|NCT01180777|474976934|FG000|Overall Study|Lost to Follow-up|1|||
131915241|NCT01180777|474976934|FG000|Overall Study|Adverse Event|1|||
131915242|NCT03517137|474976937|FG000|Overall Study|Lack of Efficacy|1|||
131915243|NCT03517137|474976937|FG000|Overall Study|Adverse Event|2|||
131915244|NCT03517137|474976937|FG000|Overall Study|Withdrawal by Subject|2|||
131915245|NCT03517137|474976937|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
131915246|NCT01582451|474976938|FG000|Overall Study|Adverse Event|1|||
131915247|NCT01582451|474976939|FG001|Overall Study|Adverse Event|3|||
131915248|NCT01582451|474976938|FG000|Overall Study|Death|3|||
131915249|NCT01582451|474976939|FG001|Overall Study|Death|3|||
131915250|NCT01582451|474976938|FG000|Overall Study|Lost to Follow-up|0|||
131915251|NCT01582451|474976939|FG001|Overall Study|Lost to Follow-up|2|||
131915252|NCT01582451|474976938|FG000|Overall Study|Protocol Violation|11|||
131915253|NCT01582451|474976939|FG001|Overall Study|Protocol Violation|3|||
131915254|NCT01582451|474976938|FG000|Overall Study|Withdrawal by Subject|13|||
131915255|NCT01582451|474976939|FG001|Overall Study|Withdrawal by Subject|9|||
131915256|NCT01582451|474976938|FG000|Overall Study|Physician Decision|3|||
131915257|NCT01582451|474976939|FG001|Overall Study|Physician Decision|0|||
131915258|NCT01582451|474976938|FG000|Overall Study|Sponsor Decision|1|||
131915259|NCT01582451|474976939|FG001|Overall Study|Sponsor Decision|0|||
131915260|NCT00487188|474976943|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
131915261|NCT00487188|474976944|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
131915262|NCT00487188|474976945|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
131915263|NCT00487188|474976943|FG000|Induction Phase|Adverse Event|5|||
131915264|NCT00487188|474976944|FG001|Induction Phase|Adverse Event|0|||
131915265|NCT00487188|474976945|FG002|Induction Phase|Adverse Event|0|||
131915266|NCT00487188|474976943|FG000|Induction Phase|Lack of Efficacy|0|||
131915267|NCT00487188|474976944|FG001|Induction Phase|Lack of Efficacy|1|||
131915268|NCT00487188|474976945|FG002|Induction Phase|Lack of Efficacy|0|||
131915269|NCT00487188|474976943|FG000|Induction Phase|Protocol Violation|1|||
131915270|NCT00487188|474976944|FG001|Induction Phase|Protocol Violation|0|||
131915271|NCT00487188|474976945|FG002|Induction Phase|Protocol Violation|0|||
131915272|NCT00487188|474976943|FG000|Induction Phase|Refused Treatment|1|||
131915273|NCT00487188|474976944|FG001|Induction Phase|Refused Treatment|2|||
131915274|NCT00487188|474976945|FG002|Induction Phase|Refused Treatment|0|||
131915275|NCT00487188|474976943|FG000|Induction Phase|Lost to Follow-up|2|||
131915276|NCT00487188|474976944|FG001|Induction Phase|Lost to Follow-up|2|||
131915277|NCT00487188|474976945|FG002|Induction Phase|Lost to Follow-up|0|||
131915278|NCT00487188|474976943|FG000|Induction Phase|Administrative|0|||
131915279|NCT00487188|474976944|FG001|Induction Phase|Administrative|1|||
131915280|NCT00487188|474976945|FG002|Induction Phase|Administrative|0|||
131915281|NCT00487188|474976943|FG000|Maintenance Phase|Adverse Event|1|||
131915282|NCT00487188|474976944|FG001|Maintenance Phase|Adverse Event|0|||
131915283|NCT00487188|474976945|FG002|Maintenance Phase|Adverse Event|0|||
131915284|NCT00487188|474976943|FG000|Maintenance Phase|Death|1|||
131915285|NCT00487188|474976944|FG001|Maintenance Phase|Death|0|||
131915286|NCT00487188|474976945|FG002|Maintenance Phase|Death|0|||
131915287|NCT00487188|474976943|FG000|Maintenance Phase|Lost to Follow-up|1|||
131915288|NCT00487188|474976944|FG001|Maintenance Phase|Lost to Follow-up|0|||
131915289|NCT00487188|474976945|FG002|Maintenance Phase|Lost to Follow-up|0|||
131915290|NCT00487188|474976943|FG000|Maintenance Phase|Administrative|0|||
131915291|NCT00487188|474976944|FG001|Maintenance Phase|Administrative|0|||
131915292|NCT00487188|474976945|FG002|Maintenance Phase|Administrative|1|||
131915293|NCT03822416|474976948|FG000|Overall Study|Lost to Follow-up|1|||
131915294|NCT03822416|474976949|FG001|Overall Study|Lost to Follow-up|0|||
131915295|NCT03822416|474976948|FG000|Overall Study|Withdrawal by Subject|0|||
131915296|NCT03822416|474976949|FG001|Overall Study|Withdrawal by Subject|1|||
131915297|NCT01995201|474976952|FG000|From Baseline Until Week 24|Adverse Event|4|||
131915298|NCT01995201|474976953|FG001|From Baseline Until Week 24|Adverse Event|15|||
131915299|NCT01995201|474976954|FG002|From Baseline Until Week 24|Adverse Event|0|||
131915300|NCT01995201|474976955|FG003|From Baseline Until Week 24|Adverse Event|0|||
131915301|NCT01995201|474976956|FG004|From Baseline Until Week 24|Adverse Event|0|||
131915302|NCT01995201|474976957|FG005|From Baseline Until Week 24|Adverse Event|0|||
131915303|NCT01995201|474976958|FG006|From Baseline Until Week 24|Adverse Event|0|||
131915304|NCT01995201|474976952|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
131915305|NCT01995201|474976953|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
131915306|NCT01995201|474976954|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
131915307|NCT01995201|474976955|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
131915308|NCT01995201|474976956|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
131915309|NCT01995201|474976957|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
131915310|NCT01995201|474976958|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
131915311|NCT01995201|474976952|FG000|From Baseline Until Week 24|Death|0|||
131915312|NCT01995201|474976953|FG001|From Baseline Until Week 24|Death|1|||
131915313|NCT01995201|474976954|FG002|From Baseline Until Week 24|Death|0|||
131915314|NCT01995201|474976955|FG003|From Baseline Until Week 24|Death|0|||
131915315|NCT01995201|474976956|FG004|From Baseline Until Week 24|Death|0|||
131915316|NCT01995201|474976957|FG005|From Baseline Until Week 24|Death|0|||
131915317|NCT01995201|474976958|FG006|From Baseline Until Week 24|Death|0|||
131915318|NCT01995201|474976952|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
131915319|NCT01995201|474976953|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
131915320|NCT01995201|474976954|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
131915321|NCT01995201|474976955|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
131915322|NCT01995201|474976956|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
131915323|NCT01995201|474976957|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
131915324|NCT01995201|474976958|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
131915325|NCT01995201|474976952|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
131915326|NCT01995201|474976953|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
131915327|NCT01995201|474976954|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
131915328|NCT01995201|474976955|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
131915329|NCT01995201|474976956|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
131915330|NCT01995201|474976957|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
131915331|NCT01995201|474976958|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
131915332|NCT01995201|474976952|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
131915333|NCT01995201|474976953|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
131915334|NCT01995201|474976954|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
131915335|NCT01995201|474976955|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
131915336|NCT01995201|474976956|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
131915337|NCT01995201|474976957|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
131915338|NCT01995201|474976958|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
131915339|NCT01995201|474976952|FG000|From Baseline Until Week 24|Physician Decision|0|||
131915340|NCT01995201|474976953|FG001|From Baseline Until Week 24|Physician Decision|2|||
131915341|NCT01995201|474976954|FG002|From Baseline Until Week 24|Physician Decision|0|||
131915342|NCT01995201|474976955|FG003|From Baseline Until Week 24|Physician Decision|0|||
131915343|NCT01995201|474976956|FG004|From Baseline Until Week 24|Physician Decision|0|||
131915344|NCT01995201|474976957|FG005|From Baseline Until Week 24|Physician Decision|0|||
131915345|NCT01995201|474976958|FG006|From Baseline Until Week 24|Physician Decision|0|||
131915346|NCT01995201|474976952|FG000|From Baseline Until Week 24|Protocol Violation|0|||
131915347|NCT01995201|474976953|FG001|From Baseline Until Week 24|Protocol Violation|9|||
131915348|NCT01995201|474976954|FG002|From Baseline Until Week 24|Protocol Violation|0|||
131915349|NCT01995201|474976955|FG003|From Baseline Until Week 24|Protocol Violation|0|||
131915350|NCT01995201|474976956|FG004|From Baseline Until Week 24|Protocol Violation|0|||
131915351|NCT01995201|474976957|FG005|From Baseline Until Week 24|Protocol Violation|0|||
131915352|NCT01995201|474976958|FG006|From Baseline Until Week 24|Protocol Violation|0|||
131915353|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Adverse Event|0|||
131915354|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Adverse Event|0|||
131915355|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Adverse Event|2|||
131915356|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Adverse Event|1|||
131915357|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Adverse Event|1|||
131915358|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Adverse Event|3|||
131915359|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Adverse Event|1|||
131915360|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Death|0|||
131915361|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Death|0|||
131915362|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Death|0|||
131915363|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Death|0|||
131915364|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Death|0|||
131915365|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Death|2|||
131915366|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Death|0|||
131915367|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
131915368|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
131915369|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
131915370|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
131915371|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
131915372|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
131915373|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
131915374|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
131915375|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
131915376|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
131915377|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
131915378|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
131915379|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
131915380|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
131915381|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
131915382|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
131915383|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
131915384|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
131915385|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
131915386|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
131915387|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
131865031|NCT03349060|474785074|FG001|Overall Study|Medication error,no linked adverse event|0|||
131865032|NCT03349060|474785075|FG002|Overall Study|Medication error,no linked adverse event|1|||
131865033|NCT03349060|474785073|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131865034|NCT03349060|474785074|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
131865035|NCT03349060|474785075|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
131865036|NCT03349060|474785073|FG000|Overall Study|Other|2|||
131865037|NCT03349060|474785074|FG001|Overall Study|Other|1|||
131865038|NCT03349060|474785075|FG002|Overall Study|Other|0|||
131865039|NCT00955409|474785076|FG000|Overall Study|Lack of Efficacy|1|||
131865040|NCT00955409|474785077|FG001|Overall Study|Lack of Efficacy|0|||
131865041|NCT00955409|474785078|FG002|Overall Study|Lack of Efficacy|0|||
131865042|NCT00955409|474785079|FG003|Overall Study|Lack of Efficacy|0|||
131865043|NCT00955409|474785080|FG004|Overall Study|Lack of Efficacy|0|||
131865044|NCT00955409|474785081|FG005|Overall Study|Lack of Efficacy|0|||
131865045|NCT00955409|474785082|FG006|Overall Study|Lack of Efficacy|0|||
131865046|NCT00955409|474785083|FG007|Overall Study|Lack of Efficacy|0|||
131865047|NCT00955409|474785084|FG008|Overall Study|Lack of Efficacy|0|||
131865048|NCT00955409|474785085|FG009|Overall Study|Lack of Efficacy|0|||
131865049|NCT00955409|474785076|FG000|Overall Study|Withdrawal by Subject|1|||
131865050|NCT00955409|474785077|FG001|Overall Study|Withdrawal by Subject|0|||
131865051|NCT00955409|474785078|FG002|Overall Study|Withdrawal by Subject|5|||
131865052|NCT00955409|474785079|FG003|Overall Study|Withdrawal by Subject|2|||
131865053|NCT00955409|474785080|FG004|Overall Study|Withdrawal by Subject|0|||
131865054|NCT00955409|474785081|FG005|Overall Study|Withdrawal by Subject|0|||
131865055|NCT00955409|474785082|FG006|Overall Study|Withdrawal by Subject|2|||
131865056|NCT00955409|474785083|FG007|Overall Study|Withdrawal by Subject|0|||
131865057|NCT00955409|474785084|FG008|Overall Study|Withdrawal by Subject|1|||
131915388|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Physician Decision|0|||
131915389|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Physician Decision|0|||
131915390|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Physician Decision|0|||
131453860|NCT03083873|473291793|FG003|Overall Study|Withdrawal by Subject|0|||
131915391|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Physician Decision|0|||
131915392|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Physician Decision|1|||
131915393|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Physician Decision|0|||
131865058|NCT00955409|474785085|FG009|Overall Study|Withdrawal by Subject|0|||
131865059|NCT00955409|474785076|FG000|Overall Study|Caregiver Request|2|||
131865060|NCT00955409|474785077|FG001|Overall Study|Caregiver Request|0|||
131865061|NCT00955409|474785078|FG002|Overall Study|Caregiver Request|6|||
131865062|NCT00955409|474785079|FG003|Overall Study|Caregiver Request|5|||
131865063|NCT00955409|474785080|FG004|Overall Study|Caregiver Request|0|||
131915394|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Physician Decision|0|||
131915395|NCT01995201|474976952|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
131915396|NCT01995201|474976953|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
131915397|NCT01995201|474976954|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
131915398|NCT01995201|474976955|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
131915399|NCT01995201|474976956|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
131915400|NCT01995201|474976957|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
131915401|NCT01995201|474976958|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
131915402|NCT03329001|474976959|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
131915403|NCT03329001|474976960|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
131915404|NCT03329001|474976961|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
131915405|NCT03329001|474976962|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
131915406|NCT03329001|474976963|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
131915407|NCT03329001|474976964|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
131915408|NCT03329001|474976965|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
131915409|NCT03329001|474976966|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
131915410|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915411|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915412|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915413|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
131915414|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915415|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915416|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915417|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
131915418|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915419|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915420|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915421|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
131915422|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915423|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915424|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915425|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
131915426|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131915427|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131915428|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131915429|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
131915430|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131915431|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131865064|NCT00955409|474785081|FG005|Overall Study|Caregiver Request|2|||
131865065|NCT00955409|474785082|FG006|Overall Study|Caregiver Request|3|||
131865066|NCT00955409|474785083|FG007|Overall Study|Caregiver Request|1|||
131865067|NCT00955409|474785084|FG008|Overall Study|Caregiver Request|3|||
131865068|NCT00955409|474785085|FG009|Overall Study|Caregiver Request|0|||
131865069|NCT00955409|474785076|FG000|Overall Study|Investigator Request|0|||
131865070|NCT00955409|474785077|FG001|Overall Study|Investigator Request|0|||
131865071|NCT00955409|474785078|FG002|Overall Study|Investigator Request|1|||
131865072|NCT00955409|474785079|FG003|Overall Study|Investigator Request|0|||
131865073|NCT00955409|474785080|FG004|Overall Study|Investigator Request|0|||
131865074|NCT00955409|474785081|FG005|Overall Study|Investigator Request|0|||
131865075|NCT00955409|474785082|FG006|Overall Study|Investigator Request|0|||
131865076|NCT00955409|474785083|FG007|Overall Study|Investigator Request|0|||
131865077|NCT00955409|474785084|FG008|Overall Study|Investigator Request|0|||
131865078|NCT00955409|474785085|FG009|Overall Study|Investigator Request|0|||
131865079|NCT00955409|474785076|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
131865080|NCT00955409|474785077|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131865081|NCT00955409|474785078|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
131865082|NCT00955409|474785079|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
131865083|NCT00955409|474785080|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
131865084|NCT00955409|474785081|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
131865085|NCT00955409|474785082|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
131865086|NCT00955409|474785083|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
131865087|NCT00955409|474785084|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
131865088|NCT00955409|474785085|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
131865089|NCT00955409|474785076|FG000|Overall Study|Lost to Follow-up|0|||
131865090|NCT00955409|474785077|FG001|Overall Study|Lost to Follow-up|0|||
131915432|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131915433|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
131915434|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915435|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915436|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
131915437|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915438|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915439|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915440|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915441|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
131915442|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915443|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915444|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
131915445|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915446|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915447|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915448|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915449|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
131915450|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915451|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915452|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
131915453|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915454|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915455|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915456|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915457|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
131915458|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915459|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915460|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
131915461|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915462|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915463|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915464|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915465|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
131915466|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
131865091|NCT00955409|474785078|FG002|Overall Study|Lost to Follow-up|1|||
131865092|NCT00955409|474785079|FG003|Overall Study|Lost to Follow-up|0|||
131865093|NCT00955409|474785080|FG004|Overall Study|Lost to Follow-up|0|||
131865094|NCT00955409|474785081|FG005|Overall Study|Lost to Follow-up|0|||
131865095|NCT00955409|474785082|FG006|Overall Study|Lost to Follow-up|1|||
131865096|NCT00955409|474785083|FG007|Overall Study|Lost to Follow-up|0|||
131865097|NCT00955409|474785084|FG008|Overall Study|Lost to Follow-up|0|||
131865098|NCT00955409|474785085|FG009|Overall Study|Lost to Follow-up|0|||
131865099|NCT00955409|474785076|FG000|Overall Study|Failed to Return|2|||
131865100|NCT00955409|474785077|FG001|Overall Study|Failed to Return|0|||
131865101|NCT00955409|474785078|FG002|Overall Study|Failed to Return|0|||
131865102|NCT00955409|474785079|FG003|Overall Study|Failed to Return|0|||
131865103|NCT00955409|474785080|FG004|Overall Study|Failed to Return|0|||
131865104|NCT00955409|474785081|FG005|Overall Study|Failed to Return|0|||
131865105|NCT00955409|474785082|FG006|Overall Study|Failed to Return|0|||
131865106|NCT00955409|474785083|FG007|Overall Study|Failed to Return|2|||
131865107|NCT00955409|474785084|FG008|Overall Study|Failed to Return|0|||
131865108|NCT00955409|474785085|FG009|Overall Study|Failed to Return|0|||
131865109|NCT00955409|474785076|FG000|Overall Study|Adverse Event (AE)|2|||
131865110|NCT00955409|474785077|FG001|Overall Study|Adverse Event (AE)|0|||
131865111|NCT00955409|474785078|FG002|Overall Study|Adverse Event (AE)|0|||
131865112|NCT00955409|474785079|FG003|Overall Study|Adverse Event (AE)|0|||
131865113|NCT00955409|474785080|FG004|Overall Study|Adverse Event (AE)|0|||
131865114|NCT00955409|474785081|FG005|Overall Study|Adverse Event (AE)|1|||
131865115|NCT00955409|474785082|FG006|Overall Study|Adverse Event (AE)|2|||
131865116|NCT00955409|474785083|FG007|Overall Study|Adverse Event (AE)|0|||
131865117|NCT00955409|474785084|FG008|Overall Study|Adverse Event (AE)|2|||
131865118|NCT00955409|474785085|FG009|Overall Study|Adverse Event (AE)|0|||
131865119|NCT00955409|474785076|FG000|Overall Study|Reason not Specified|2|||
131865120|NCT00955409|474785077|FG001|Overall Study|Reason not Specified|1|||
131865121|NCT00955409|474785078|FG002|Overall Study|Reason not Specified|13|||
131865122|NCT00955409|474785079|FG003|Overall Study|Reason not Specified|1|||
131865123|NCT00955409|474785080|FG004|Overall Study|Reason not Specified|2|||
131865124|NCT00955409|474785081|FG005|Overall Study|Reason not Specified|0|||
131865125|NCT00955409|474785082|FG006|Overall Study|Reason not Specified|16|||
131865126|NCT00955409|474785083|FG007|Overall Study|Reason not Specified|0|||
131865127|NCT00955409|474785084|FG008|Overall Study|Reason not Specified|8|||
131865128|NCT00955409|474785085|FG009|Overall Study|Reason not Specified|1|||
131865129|NCT00803790|474785086|FG000|Period 1|Adverse Event|0|||
131865130|NCT00803790|474785087|FG001|Period 1|Adverse Event|1|||
131865131|NCT00803790|474785088|FG002|Period 1|Adverse Event|0|||
131865132|NCT00803790|474785089|FG003|Period 1|Adverse Event|0|||
131865133|NCT00803790|474785086|FG000|Period 1|Lost to Follow-up|1|||
131865134|NCT00803790|474785087|FG001|Period 1|Lost to Follow-up|2|||
131865135|NCT00803790|474785088|FG002|Period 1|Lost to Follow-up|0|||
131865136|NCT00803790|474785089|FG003|Period 1|Lost to Follow-up|0|||
131865137|NCT00803790|474785086|FG000|Period 1|Withdrawal by Subject|8|||
131865138|NCT00803790|474785087|FG001|Period 1|Withdrawal by Subject|6|||
131865139|NCT00803790|474785088|FG002|Period 1|Withdrawal by Subject|0|||
131865140|NCT00803790|474785089|FG003|Period 1|Withdrawal by Subject|0|||
131865141|NCT00803790|474785086|FG000|Period 1|positive drug screen or personal reasons|0|||
131865142|NCT00803790|474785087|FG001|Period 1|positive drug screen or personal reasons|3|||
131865143|NCT00803790|474785088|FG002|Period 1|positive drug screen or personal reasons|0|||
131865144|NCT00803790|474785089|FG003|Period 1|positive drug screen or personal reasons|4|||
131865145|NCT00803790|474785086|FG000|Period 1|Protocol Violation|0|||
131865146|NCT00803790|474785087|FG001|Period 1|Protocol Violation|0|||
131865147|NCT00803790|474785088|FG002|Period 1|Protocol Violation|1|||
131865148|NCT00803790|474785089|FG003|Period 1|Protocol Violation|0|||
131865149|NCT00803790|474785086|FG000|Period 2|Adverse Event|0|||
131865150|NCT00803790|474785087|FG001|Period 2|Adverse Event|0|||
131865151|NCT00803790|474785088|FG002|Period 2|Adverse Event|1|||
131865152|NCT00803790|474785089|FG003|Period 2|Adverse Event|1|||
131865153|NCT00803790|474785086|FG000|Period 2|Withdrawal by Subject|1|||
131865154|NCT00803790|474785087|FG001|Period 2|Withdrawal by Subject|0|||
131865155|NCT00803790|474785088|FG002|Period 2|Withdrawal by Subject|0|||
131865156|NCT00803790|474785089|FG003|Period 2|Withdrawal by Subject|0|||
131865157|NCT00803790|474785086|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
131865158|NCT00803790|474785087|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
131865159|NCT00803790|474785088|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
131865160|NCT00803790|474785089|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
131865161|NCT01880554|474785090|FG000|Overall Study|Protocol Violation|14|||
131865162|NCT01880554|474785090|FG000|Overall Study|Simon's design requirements|2|||
131865163|NCT05161481|474785091|FG000|Overall Study|Withdrawal of consent|0|||
131865164|NCT05161481|474785092|FG001|Overall Study|Withdrawal of consent|1|||
131865165|NCT05161481|474785093|FG002|Overall Study|Withdrawal of consent|1|||
131865166|NCT05161481|474785091|FG000|Overall Study|Study terminated by sponsor|3|||
131865167|NCT05161481|474785092|FG001|Overall Study|Study terminated by sponsor|3|||
131865168|NCT05161481|474785093|FG002|Overall Study|Study terminated by sponsor|2|||
131865169|NCT05161481|474785091|FG000|Overall Study|Adverse Event|3|||
131865170|NCT05161481|474785092|FG001|Overall Study|Adverse Event|0|||
131865171|NCT05161481|474785093|FG002|Overall Study|Adverse Event|6|||
131865172|NCT05161481|474785091|FG000|Overall Study|Randomised in error and was not treated|1|||
131865173|NCT05161481|474785092|FG001|Overall Study|Randomised in error and was not treated|0|||
131865174|NCT05161481|474785093|FG002|Overall Study|Randomised in error and was not treated|0|||
131865175|NCT05161481|474785091|FG000|Overall Study|Subject decision|0|||
131865176|NCT05161481|474785092|FG001|Overall Study|Subject decision|0|||
131865177|NCT05161481|474785093|FG002|Overall Study|Subject decision|1|||
131865178|NCT01662635|474785094|FG000|Overall Study|scarce samples for evaluation|30|||
131865179|NCT04570670|474785097|FG000|Overall Study|Withdrawal by Subject|1|||
131865180|NCT04570670|474785098|FG001|Overall Study|Withdrawal by Subject|0|||
131865181|NCT03318861|474785102|FG000|Overall Study|Death|2|||
131865182|NCT03318861|474785103|FG001|Overall Study|Death|3|||
131865183|NCT03318861|474785104|FG002|Overall Study|Death|3|||
131865184|NCT03318861|474785105|FG003|Overall Study|Death|2|||
131865185|NCT03318861|474785106|FG004|Overall Study|Death|2|||
131865186|NCT03318861|474785102|FG000|Overall Study|Enrolled But Never Treated|0|||
131865187|NCT03318861|474785103|FG001|Overall Study|Enrolled But Never Treated|1|||
131865188|NCT03318861|474785104|FG002|Overall Study|Enrolled But Never Treated|0|||
131865189|NCT03318861|474785105|FG003|Overall Study|Enrolled But Never Treated|1|||
131865190|NCT03318861|474785106|FG004|Overall Study|Enrolled But Never Treated|1|||
131865191|NCT03318861|474785102|FG000|Overall Study|Informed Consent Withdraw|0|||
131865192|NCT03318861|474785103|FG001|Overall Study|Informed Consent Withdraw|0|||
131865193|NCT03318861|474785104|FG002|Overall Study|Informed Consent Withdraw|0|||
131865194|NCT03318861|474785105|FG003|Overall Study|Informed Consent Withdraw|1|||
131865195|NCT03318861|474785106|FG004|Overall Study|Informed Consent Withdraw|0|||
131865196|NCT03318861|474785102|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
131865197|NCT03318861|474785103|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
131865198|NCT03318861|474785104|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
131865199|NCT03318861|474785105|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
131865200|NCT03318861|474785106|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
131865201|NCT00917852|474785107|FG000|Overall Study|Death|6|||
131865202|NCT02549859|474785109|FG000|Long-term 60 Hz DBS|Study Closed|1|||
131865203|NCT04335123|474785110|FG000|Overall Study|Withdrawal by Subject|2|||
131865204|NCT04335123|474785111|FG001|Overall Study|Withdrawal by Subject|0|||
131865205|NCT04335123|474785110|FG000|Overall Study|Physician Decision|2|||
131865206|NCT04335123|474785111|FG001|Overall Study|Physician Decision|0|||
131865207|NCT01283464|474785114|FG000|Overall Study|Lost to Follow-up|0|||
131865208|NCT01283464|474785115|FG001|Overall Study|Lost to Follow-up|1|||
131865209|NCT01283464|474785114|FG000|Overall Study|Withdrawal by Subject|1|||
131865210|NCT01283464|474785115|FG001|Overall Study|Withdrawal by Subject|0|||
131865211|NCT01283464|474785114|FG000|Overall Study|Physician Decision|1|||
131865212|NCT01283464|474785115|FG001|Overall Study|Physician Decision|0|||
131865213|NCT02626026|474785116|FG000|Overall Study|Randomized but Never Treated|0|||
131865214|NCT02626026|474785117|FG001|Overall Study|Randomized but Never Treated|0|||
131865215|NCT02626026|474785118|FG002|Overall Study|Randomized but Never Treated|0|||
131865216|NCT02626026|474785119|FG003|Overall Study|Randomized but Never Treated|0|||
131865217|NCT02626026|474785120|FG004|Overall Study|Randomized but Never Treated|1|||
131865218|NCT02626026|474785121|FG005|Overall Study|Randomized but Never Treated|0|||
131865219|NCT01568892|474785123|FG000|Open-label Phase|Adverse Event|2|||
131865220|NCT01568892|474785124|FG001|Open-label Phase|Adverse Event|0|||
131865221|NCT01568892|474785123|FG000|Open-label Phase|Lack of Efficacy|4|||
131865222|NCT01568892|474785124|FG001|Open-label Phase|Lack of Efficacy|2|||
131865223|NCT01568892|474785123|FG000|Open-label Phase|Lost to Follow-up|0|||
131865224|NCT01568892|474785124|FG001|Open-label Phase|Lost to Follow-up|1|||
131865225|NCT04177095|474785129|FG000|Overall Study|Withdrawal by Subject|3|||
131865226|NCT04177095|474785129|FG000|Overall Study|Screen Failure|3|||
131865227|NCT04177095|474785129|FG000|Overall Study|Problems with the Trugraf assay|1|||
131865228|NCT00777296|474785130|FG000|Overall Study|Adverse Event|0|||
131865229|NCT00777296|474785131|FG001|Overall Study|Adverse Event|1|||
131865230|NCT00777296|474785132|FG002|Overall Study|Adverse Event|0|||
131865231|NCT00777296|474785133|FG003|Overall Study|Adverse Event|1|||
131865232|NCT00777296|474785130|FG000|Overall Study|Withdrawal by Subject|1|||
131865233|NCT00777296|474785131|FG001|Overall Study|Withdrawal by Subject|0|||
131865234|NCT00777296|474785132|FG002|Overall Study|Withdrawal by Subject|0|||
131865235|NCT00777296|474785133|FG003|Overall Study|Withdrawal by Subject|0|||
131865236|NCT00777296|474785130|FG000|Overall Study|CRF form not completed|0|||
131865237|NCT00777296|474785131|FG001|Overall Study|CRF form not completed|0|||
131865238|NCT00777296|474785132|FG002|Overall Study|CRF form not completed|2|||
131865239|NCT00777296|474785133|FG003|Overall Study|CRF form not completed|0|||
131865240|NCT03889418|474785136|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
131865241|NCT03889418|474785137|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865242|NCT03889418|474785138|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865243|NCT03889418|474785139|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865244|NCT03889418|474785140|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865245|NCT03889418|474785141|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865246|NCT03889418|474785142|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865247|NCT03889418|474785143|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865248|NCT03889418|474785144|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865249|NCT03889418|474785145|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
131865250|NCT03889418|474785136|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865251|NCT03889418|474785137|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
131865252|NCT03889418|474785138|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
131865253|NCT03889418|474785139|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865254|NCT03889418|474785140|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865255|NCT03889418|474785141|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865256|NCT03889418|474785142|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865257|NCT03889418|474785143|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865258|NCT03889418|474785144|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865259|NCT03889418|474785145|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
131865260|NCT03889418|474785136|FG000|October-December 2019 (Month 7-9)|Death|0|||
131865261|NCT03889418|474785137|FG001|October-December 2019 (Month 7-9)|Death|0|||
131865262|NCT03889418|474785138|FG002|October-December 2019 (Month 7-9)|Death|0|||
131915467|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
131408134|NCT00823212|473118191|FG001|Overall Study|Missed 12-month visit|21|||
131915468|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
131915469|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
131915470|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
131915471|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
131915472|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
131915473|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
131915474|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915475|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915476|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
131915477|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915478|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915479|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915480|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915481|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
131915482|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
131915483|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
131915484|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
131915485|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
131915486|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
131915487|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
131915488|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
131915489|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
131915490|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
131915491|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
131915492|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
131915493|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
131915494|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
131915495|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
131915496|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
131915497|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
131915498|NCT03329001|474976959|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
131915499|NCT03329001|474976960|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
131915500|NCT03329001|474976961|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
131915501|NCT03329001|474976962|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
131915502|NCT03329001|474976963|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
131915503|NCT03329001|474976964|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
131915504|NCT03329001|474976965|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
131915505|NCT03329001|474976966|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
131915506|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915507|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915508|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915509|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
131915510|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915511|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915512|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915513|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
131915514|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915515|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915516|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915517|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
131915518|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915519|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915520|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915521|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
131915522|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131915523|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131915524|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
131915525|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131915526|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131915527|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131915528|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131453861|NCT03083873|473291794|FG004|Overall Study|Withdrawal by Subject|0|||
131453862|NCT03083873|473291790|FG000|Overall Study|Did Not Receive TIL|2|||
131453863|NCT03083873|473291791|FG001|Overall Study|Did Not Receive TIL|5|||
131453864|NCT03083873|473291792|FG002|Overall Study|Did Not Receive TIL|3|||
131453865|NCT03083873|473291793|FG003|Overall Study|Did Not Receive TIL|1|||
131453866|NCT03083873|473291794|FG004|Overall Study|Did Not Receive TIL|0|||
131453867|NCT01677377|473291795|FG000|Overall Study|Protocol Violation|1|||
131453868|NCT01677377|473291796|FG001|Overall Study|Protocol Violation|0|||
131453869|NCT01677377|473291797|FG002|Overall Study|Protocol Violation|0|||
131453870|NCT01677377|473291795|FG000|Overall Study|Lost to Follow-up|0|||
131453871|NCT01677377|473291796|FG001|Overall Study|Lost to Follow-up|1|||
131453872|NCT01677377|473291797|FG002|Overall Study|Lost to Follow-up|1|||
131865263|NCT03889418|474785139|FG003|October-December 2019 (Month 7-9)|Death|0|||
131865264|NCT03889418|474785140|FG004|October-December 2019 (Month 7-9)|Death|0|||
131865265|NCT03889418|474785141|FG005|October-December 2019 (Month 7-9)|Death|0|||
131865266|NCT03889418|474785142|FG006|October-December 2019 (Month 7-9)|Death|0|||
131865267|NCT03889418|474785143|FG007|October-December 2019 (Month 7-9)|Death|0|||
131865268|NCT03889418|474785144|FG008|October-December 2019 (Month 7-9)|Death|1|||
131865269|NCT03889418|474785145|FG009|October-December 2019 (Month 7-9)|Death|0|||
131865270|NCT03889418|474785136|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865271|NCT03889418|474785137|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865272|NCT03889418|474785138|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865273|NCT03889418|474785139|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
131865274|NCT03889418|474785140|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865275|NCT03889418|474785141|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865276|NCT03889418|474785142|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865277|NCT03889418|474785143|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
131865278|NCT03889418|474785144|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865279|NCT03889418|474785145|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
131865280|NCT03889418|474785136|FG000|April - June 2020 (Month 13-15)|Death|0|||
131865281|NCT03889418|474785137|FG001|April - June 2020 (Month 13-15)|Death|1|||
131865282|NCT03889418|474785138|FG002|April - June 2020 (Month 13-15)|Death|0|||
131865283|NCT03889418|474785139|FG003|April - June 2020 (Month 13-15)|Death|0|||
131865284|NCT03889418|474785140|FG004|April - June 2020 (Month 13-15)|Death|0|||
131865285|NCT03889418|474785141|FG005|April - June 2020 (Month 13-15)|Death|0|||
131865286|NCT03889418|474785142|FG006|April - June 2020 (Month 13-15)|Death|0|||
131865287|NCT03889418|474785143|FG007|April - June 2020 (Month 13-15)|Death|0|||
131865288|NCT03889418|474785144|FG008|April - June 2020 (Month 13-15)|Death|0|||
131865289|NCT03889418|474785145|FG009|April - June 2020 (Month 13-15)|Death|0|||
131865290|NCT03889418|474785136|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865291|NCT03889418|474785137|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865292|NCT03889418|474785138|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865293|NCT03889418|474785139|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
131865294|NCT03889418|474785140|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865295|NCT03889418|474785141|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865296|NCT03889418|474785142|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865297|NCT03889418|474785143|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865298|NCT03889418|474785144|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865299|NCT03889418|474785145|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
131865300|NCT03889418|474785136|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
131865301|NCT03889418|474785137|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
131865302|NCT03889418|474785138|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
131865303|NCT03889418|474785139|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
131865304|NCT03889418|474785140|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
131865305|NCT03889418|474785141|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
131865306|NCT03889418|474785142|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
131865307|NCT03889418|474785143|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
131865308|NCT03889418|474785144|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
131865309|NCT03889418|474785145|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
131865310|NCT03889418|474785136|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
131865311|NCT03889418|474785137|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
131865312|NCT03889418|474785138|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
131865313|NCT03889418|474785139|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
131865314|NCT03889418|474785140|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
131865315|NCT03889418|474785141|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
131865316|NCT03889418|474785142|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
131865317|NCT03889418|474785143|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
131865318|NCT03889418|474785144|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
131865319|NCT03889418|474785145|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
131865320|NCT01592786|474785147|FG000|Overall Study|Adverse Event|60|||
131865321|NCT01592786|474785147|FG000|Overall Study|Lack of Efficacy|19|||
131915529|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
131915530|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
131915531|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
131915532|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
131915533|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
131915534|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
131915535|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
131915536|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
131915537|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
131915538|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915539|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915540|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
131915541|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915542|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915543|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915544|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915545|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
131915546|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915547|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915548|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
131915549|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915550|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915551|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915552|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915553|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
131915554|NCT03329001|474976959|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915555|NCT03329001|474976960|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915556|NCT03329001|474976961|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915557|NCT03329001|474976962|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
131915558|NCT03329001|474976963|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915559|NCT03329001|474976964|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915560|NCT03329001|474976965|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915561|NCT03329001|474976966|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
131915562|NCT03329001|474976959|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131915563|NCT03329001|474976960|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131915564|NCT03329001|474976961|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131915565|NCT03329001|474976962|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131915566|NCT03329001|474976963|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131865322|NCT01592786|474785147|FG000|Overall Study|Protocol Violation|14|||
131865323|NCT01592786|474785147|FG000|Overall Study|Withdrawal by Subject|23|||
131865324|NCT01592786|474785147|FG000|Overall Study|Lost to Follow-up|19|||
131865325|NCT01592786|474785147|FG000|Overall Study|Other|3|||
131865326|NCT02172664|474785153|FG000|Overall Study|Lost to Follow-up|4|||
131865327|NCT02172664|474785154|FG001|Overall Study|Lost to Follow-up|4|||
131865328|NCT02172664|474785153|FG000|Overall Study|Death|1|||
131865329|NCT02172664|474785154|FG001|Overall Study|Death|1|||
131865330|NCT02172664|474785153|FG000|Overall Study|Moved out of area|1|||
131865331|NCT02172664|474785154|FG001|Overall Study|Moved out of area|1|||
131865332|NCT01909934|474785155|FG000|Overall Study|Withdrawal by Subject|3|||
131865333|NCT01909934|474785155|FG000|Overall Study|Lost to Follow-up|1|||
131865334|NCT01909934|474785155|FG000|Overall Study|Death|25|||
131865335|NCT01909934|474785155|FG000|Overall Study|Withdrawal of Informed Consent|1|||
131865336|NCT01909934|474785155|FG000|Overall Study|Reason Not Specified|1|||
131865337|NCT03810092|474785156|FG000|Overall Study|no ground support|17|||
131865338|NCT03810092|474785156|FG000|Overall Study|ADL not done at J0|16|||
131865339|NCT03810092|474785156|FG000|Overall Study|No hemoglobin measure at J5|27|||
131865340|NCT04426006|474785157|FG000|Inclusion|Protocol Violation|1|||
131865341|NCT04426006|474785157|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
131865342|NCT04426006|474785157|FG000|Inclusion|Blood sample at inclusion not done|1|||
131865343|NCT04426006|474785157|FG000|3 Months|Lost to Follow-up|17|||
131865344|NCT04426006|474785157|FG000|12 Months|Lost to Follow-up|38|||
131865345|NCT01139775|474785163|FG000|Overall Study|Adverse Event|0|||
131865346|NCT01139775|474785164|FG001|Overall Study|Adverse Event|6|||
131865347|NCT01139775|474785165|FG002|Overall Study|Adverse Event|2|||
131865348|NCT01139775|474785163|FG000|Overall Study|Protocol Violation|0|||
131915567|NCT03329001|474976964|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
131915568|NCT03329001|474976965|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131915569|NCT03329001|474976966|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
131915570|NCT03329001|474976959|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915571|NCT03329001|474976960|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915572|NCT03329001|474976961|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915573|NCT03329001|474976962|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915574|NCT03329001|474976963|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
131915575|NCT03329001|474976964|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915576|NCT03329001|474976965|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915577|NCT03329001|474976966|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
131915578|NCT03329001|474976959|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
131915579|NCT03329001|474976960|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
131915580|NCT03329001|474976961|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
131915581|NCT03329001|474976962|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
131915582|NCT03329001|474976963|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
131915583|NCT03329001|474976964|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
131915584|NCT03329001|474976965|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
131915585|NCT03329001|474976966|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
131915586|NCT03329001|474976959|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915587|NCT03329001|474976960|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915588|NCT03329001|474976961|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915589|NCT03329001|474976962|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915590|NCT03329001|474976963|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
131915591|NCT03329001|474976964|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915592|NCT03329001|474976965|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915593|NCT03329001|474976966|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
131915594|NCT03329001|474976959|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
131915595|NCT03329001|474976960|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
131915596|NCT03329001|474976961|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
131915597|NCT03329001|474976962|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
131915598|NCT03329001|474976963|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
131915599|NCT03329001|474976964|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
131915600|NCT03329001|474976965|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
131915601|NCT03329001|474976966|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
131915602|NCT03329001|474976959|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
131915603|NCT03329001|474976960|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
131915604|NCT03329001|474976961|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
131915605|NCT03329001|474976962|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
131915606|NCT03329001|474976963|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
131915607|NCT03329001|474976964|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
131915608|NCT03329001|474976965|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
131915609|NCT03329001|474976966|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
131915610|NCT03329001|474976959|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915611|NCT03329001|474976960|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915612|NCT03329001|474976961|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915613|NCT03329001|474976962|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915614|NCT03329001|474976963|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915615|NCT03329001|474976964|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915616|NCT03329001|474976965|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
131915617|NCT03329001|474976966|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
131915618|NCT03329001|474976959|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
131915619|NCT03329001|474976960|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
131915620|NCT03329001|474976961|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
131915621|NCT03329001|474976962|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
131915622|NCT03329001|474976963|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
131915623|NCT03329001|474976964|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
131915624|NCT03329001|474976965|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
131915625|NCT03329001|474976966|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
131915626|NCT03329001|474976959|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
131915627|NCT03329001|474976960|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
131915628|NCT03329001|474976961|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
131865349|NCT01139775|474785164|FG001|Overall Study|Protocol Violation|5|||
131865350|NCT01139775|474785165|FG002|Overall Study|Protocol Violation|0|||
131865351|NCT01139775|474785163|FG000|Overall Study|Withdrawal by Subject|1|||
131865352|NCT01139775|474785164|FG001|Overall Study|Withdrawal by Subject|0|||
131865353|NCT01139775|474785165|FG002|Overall Study|Withdrawal by Subject|2|||
131865354|NCT01139775|474785163|FG000|Overall Study|Physician Decision|0|||
131865355|NCT01139775|474785164|FG001|Overall Study|Physician Decision|2|||
131865356|NCT01139775|474785165|FG002|Overall Study|Physician Decision|2|||
131865357|NCT01753310|474785168|FG000|Overall Study|Entered into open label extension study|25|||
131865358|NCT01753310|474785169|FG001|Overall Study|Entered into open label extension study|22|||
131865359|NCT01753310|474785168|FG000|Overall Study|Adverse Event|1|||
131865360|NCT01753310|474785169|FG001|Overall Study|Adverse Event|0|||
131865361|NCT01753310|474785168|FG000|Overall Study|Lost to Follow-up|2|||
131865362|NCT01753310|474785169|FG001|Overall Study|Lost to Follow-up|0|||
131865363|NCT01753310|474785168|FG000|Overall Study|Subject decision|2|||
131865364|NCT01753310|474785169|FG001|Overall Study|Subject decision|2|||
131865365|NCT01753310|474785168|FG000|Overall Study|Sponsor decision|1|||
131865366|NCT01753310|474785169|FG001|Overall Study|Sponsor decision|0|||
131865367|NCT01753310|474785168|FG000|Overall Study|Withdrawal by Subject|1|||
131865368|NCT01753310|474785169|FG001|Overall Study|Withdrawal by Subject|0|||
131865369|NCT02946463|474785170|FG000|Primary Evaluation Period|Physician Decision|0|||
131865370|NCT02946463|474785171|FG001|Primary Evaluation Period|Physician Decision|1|||
131865371|NCT02946463|474785172|FG002|Primary Evaluation Period|Physician Decision|0|||
131865372|NCT02946463|474785173|FG003|Primary Evaluation Period|Physician Decision|0|||
131865373|NCT02946463|474785170|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
131865374|NCT02946463|474785171|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
131865375|NCT02946463|474785172|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
131865376|NCT02946463|474785173|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
131865377|NCT02946463|474785170|FG000|Extension Period|Death|4|||
131865378|NCT02946463|474785171|FG001|Extension Period|Death|4|||
131865379|NCT02946463|474785172|FG002|Extension Period|Death|0|||
131865380|NCT02946463|474785173|FG003|Extension Period|Death|0|||
131865381|NCT02946463|474785170|FG000|Extension Period|Withdrawal by Subject|4|||
131865382|NCT02946463|474785171|FG001|Extension Period|Withdrawal by Subject|3|||
131865383|NCT02946463|474785172|FG002|Extension Period|Withdrawal by Subject|0|||
131865384|NCT02946463|474785173|FG003|Extension Period|Withdrawal by Subject|0|||
131865385|NCT02946463|474785170|FG000|Extension Period|Other than specified|2|||
131865386|NCT02946463|474785171|FG001|Extension Period|Other than specified|3|||
131865387|NCT02946463|474785172|FG002|Extension Period|Other than specified|2|||
131865388|NCT02946463|474785173|FG003|Extension Period|Other than specified|0|||
131865389|NCT02946463|474785170|FG000|Extension Period|Physician Decision|1|||
131865390|NCT02946463|474785171|FG001|Extension Period|Physician Decision|4|||
131865391|NCT02946463|474785172|FG002|Extension Period|Physician Decision|0|||
131865392|NCT02946463|474785173|FG003|Extension Period|Physician Decision|0|||
131865393|NCT02946463|474785170|FG000|Extension Period|Pregnancy|3|||
131865394|NCT02946463|474785171|FG001|Extension Period|Pregnancy|1|||
131865395|NCT02946463|474785172|FG002|Extension Period|Pregnancy|0|||
131865396|NCT02946463|474785173|FG003|Extension Period|Pregnancy|0|||
131865397|NCT02946463|474785170|FG000|Extension Period|Adverse Event|1|||
131865398|NCT02946463|474785171|FG001|Extension Period|Adverse Event|2|||
131865399|NCT02946463|474785172|FG002|Extension Period|Adverse Event|0|||
131865400|NCT02946463|474785173|FG003|Extension Period|Adverse Event|0|||
131865401|NCT02946463|474785170|FG000|Extension Period|Lost to Follow-up|1|||
131865402|NCT02946463|474785171|FG001|Extension Period|Lost to Follow-up|0|||
131865403|NCT02946463|474785172|FG002|Extension Period|Lost to Follow-up|0|||
131865404|NCT02946463|474785173|FG003|Extension Period|Lost to Follow-up|0|||
131865405|NCT03193853|474785174|FG000|Overall Study|Death|6|||
131865406|NCT02022202|474785175|FG000|Overall Study|Withdrawal by Subject|2|||
131865407|NCT02022202|474785175|FG000|Overall Study|Disease Progression|3|||
131865408|NCT02022202|474785175|FG000|Overall Study|Desire go to immediately to surgery|3|||
131865409|NCT05581641|474785179|FG000|Overall Study|Withdrawal by Subject|0|||
131865410|NCT05581641|474785180|FG001|Overall Study|Withdrawal by Subject|1|||
131865411|NCT05581641|474785181|FG002|Overall Study|Withdrawal by Subject|3|||
131865412|NCT05581641|474785182|FG003|Overall Study|Withdrawal by Subject|1|||
131865413|NCT05581641|474785179|FG000|Overall Study|Lost to Follow-up|0|||
131865414|NCT05581641|474785180|FG001|Overall Study|Lost to Follow-up|1|||
131865415|NCT05581641|474785181|FG002|Overall Study|Lost to Follow-up|0|||
131865416|NCT05581641|474785182|FG003|Overall Study|Lost to Follow-up|1|||
131865417|NCT05581641|474785179|FG000|Overall Study|Protocol Violation|1|||
131865418|NCT05581641|474785180|FG001|Overall Study|Protocol Violation|0|||
131865419|NCT05581641|474785181|FG002|Overall Study|Protocol Violation|0|||
131915629|NCT03329001|474976962|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
131865420|NCT05581641|474785182|FG003|Overall Study|Protocol Violation|0|||
131865421|NCT05581641|474785179|FG000|Overall Study|Other|1|||
131865422|NCT05581641|474785180|FG001|Overall Study|Other|0|||
131865423|NCT05581641|474785181|FG002|Overall Study|Other|2|||
131865424|NCT05581641|474785182|FG003|Overall Study|Other|1|||
131915630|NCT03329001|474976963|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
131915631|NCT03329001|474976964|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
131915632|NCT03329001|474976965|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
131915633|NCT03329001|474976966|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
131915634|NCT00963235|474976970|FG000|Overall Study|Withdrawal by Subject|22|||
131915635|NCT00963235|474976970|FG000|Overall Study|Lost to Follow-up|14|||
131915636|NCT00963235|474976970|FG000|Overall Study|Failed to return|9|||
131915637|NCT00963235|474976970|FG000|Overall Study|Protocol Violation|7|||
131915638|NCT00963235|474976970|FG000|Overall Study|Adverse Event|5|||
131915639|NCT00963235|474976970|FG000|Overall Study|Physician Decision|2|||
131915640|NCT00963235|474976970|FG000|Overall Study|Other|1|||
131915641|NCT02709369|474976971|FG000|Overall Study|Lost to Follow-up|15|||
131915642|NCT02709369|474976971|FG000|Overall Study|Withdrawal by Subject|10|||
131915643|NCT02709369|474976971|FG000|Overall Study|Did not received intervention|2|||
131915644|NCT01104766|474976972|FG000|Overall Study|Did not meet inc/exc criteria|1|||
131915645|NCT01104766|474976973|FG001|Overall Study|Did not meet inc/exc criteria|0|||
131915646|NCT01104766|474976974|FG002|Overall Study|Did not meet inc/exc criteria|0|||
131915647|NCT01104766|474976975|FG003|Overall Study|Did not meet inc/exc criteria|0|||
131915648|NCT01104766|474976972|FG000|Overall Study|Adverse Event|17|||
131915649|NCT01104766|474976973|FG001|Overall Study|Adverse Event|15|||
131915650|NCT01104766|474976974|FG002|Overall Study|Adverse Event|20|||
131915651|NCT01104766|474976975|FG003|Overall Study|Adverse Event|14|||
131915652|NCT01104766|474976972|FG000|Overall Study|Lack of Efficacy|20|||
131915653|NCT01104766|474976973|FG001|Overall Study|Lack of Efficacy|15|||
131915654|NCT01104766|474976974|FG002|Overall Study|Lack of Efficacy|14|||
131915655|NCT01104766|474976975|FG003|Overall Study|Lack of Efficacy|8|||
131915656|NCT01104766|474976972|FG000|Overall Study|Protocol Violation|2|||
131915657|NCT01104766|474976973|FG001|Overall Study|Protocol Violation|0|||
131915658|NCT01104766|474976974|FG002|Overall Study|Protocol Violation|0|||
131915659|NCT01104766|474976975|FG003|Overall Study|Protocol Violation|0|||
131915660|NCT01104766|474976972|FG000|Overall Study|Withdrawal by Subject|17|||
131915661|NCT01104766|474976973|FG001|Overall Study|Withdrawal by Subject|19|||
131915662|NCT01104766|474976974|FG002|Overall Study|Withdrawal by Subject|25|||
131915663|NCT01104766|474976975|FG003|Overall Study|Withdrawal by Subject|15|||
131915664|NCT01104766|474976972|FG000|Overall Study|Lost to Follow-up|1|||
131915665|NCT01104766|474976973|FG001|Overall Study|Lost to Follow-up|2|||
131915666|NCT01104766|474976974|FG002|Overall Study|Lost to Follow-up|1|||
131915667|NCT01104766|474976975|FG003|Overall Study|Lost to Follow-up|1|||
131915668|NCT01341470|474976977|FG000|Overall Study|Sponsor decision|0|||
131915669|NCT01341470|474976978|FG001|Overall Study|Sponsor decision|0|||
131915670|NCT01341470|474976979|FG002|Overall Study|Sponsor decision|1|||
131915671|NCT01341470|474976980|FG003|Overall Study|Sponsor decision|1|||
131915672|NCT01341470|474976981|FG004|Overall Study|Sponsor decision|0|||
131915673|NCT01341470|474976982|FG005|Overall Study|Sponsor decision|1|||
131915674|NCT01136915|474976984|FG000|Overall Study|Lost to Follow-up|2|||
131915675|NCT01136915|474976985|FG001|Overall Study|Lost to Follow-up|0|||
131915676|NCT01136915|474976984|FG000|Overall Study|Exclusion criterion met|0|||
131915677|NCT01136915|474976985|FG001|Overall Study|Exclusion criterion met|1|||
131915678|NCT01756235|474976986|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
131915679|NCT03034967|474976995|FG000|Overall Study|Withdrawal by Subject|9|||
131915680|NCT03034967|474976996|FG001|Overall Study|Withdrawal by Subject|2|||
131915681|NCT03034967|474976997|FG002|Overall Study|Withdrawal by Subject|6|||
131915682|NCT03034967|474976998|FG003|Overall Study|Withdrawal by Subject|6|||
131915683|NCT03034967|474976999|FG004|Overall Study|Withdrawal by Subject|9|||
131915684|NCT03034967|474977000|FG005|Overall Study|Withdrawal by Subject|2|||
131915685|NCT03034967|474976995|FG000|Overall Study|Physician Decision|1|||
131915686|NCT03034967|474976996|FG001|Overall Study|Physician Decision|0|||
131915687|NCT03034967|474976997|FG002|Overall Study|Physician Decision|1|||
131915688|NCT03034967|474976998|FG003|Overall Study|Physician Decision|1|||
131915689|NCT03034967|474976999|FG004|Overall Study|Physician Decision|1|||
131915690|NCT03034967|474977000|FG005|Overall Study|Physician Decision|0|||
131915691|NCT03034967|474976995|FG000|Overall Study|Lost to Follow-up|0|||
131915692|NCT03034967|474976996|FG001|Overall Study|Lost to Follow-up|0|||
131915693|NCT03034967|474976997|FG002|Overall Study|Lost to Follow-up|0|||
131915694|NCT03034967|474976998|FG003|Overall Study|Lost to Follow-up|1|||
131915695|NCT03034967|474976999|FG004|Overall Study|Lost to Follow-up|0|||
131915696|NCT03034967|474977000|FG005|Overall Study|Lost to Follow-up|2|||
131915697|NCT03034967|474976995|FG000|Overall Study|Liver function test abnormality|0|||
131915698|NCT03034967|474976996|FG001|Overall Study|Liver function test abnormality|0|||
131915699|NCT03034967|474976997|FG002|Overall Study|Liver function test abnormality|1|||
131915700|NCT03034967|474976998|FG003|Overall Study|Liver function test abnormality|0|||
131915701|NCT03034967|474976999|FG004|Overall Study|Liver function test abnormality|0|||
131915702|NCT03034967|474977000|FG005|Overall Study|Liver function test abnormality|0|||
131915703|NCT03034967|474976995|FG000|Overall Study|Protocol Violation|1|||
131915704|NCT03034967|474976996|FG001|Overall Study|Protocol Violation|0|||
131915705|NCT03034967|474976997|FG002|Overall Study|Protocol Violation|0|||
131915706|NCT03034967|474976998|FG003|Overall Study|Protocol Violation|0|||
131915707|NCT03034967|474976999|FG004|Overall Study|Protocol Violation|0|||
131915708|NCT03034967|474977000|FG005|Overall Study|Protocol Violation|2|||
131915709|NCT03034967|474976995|FG000|Overall Study|Lack of Efficacy|0|||
131915710|NCT03034967|474976996|FG001|Overall Study|Lack of Efficacy|1|||
131915711|NCT03034967|474976997|FG002|Overall Study|Lack of Efficacy|2|||
131915712|NCT03034967|474976998|FG003|Overall Study|Lack of Efficacy|1|||
131915713|NCT03034967|474976999|FG004|Overall Study|Lack of Efficacy|1|||
131915714|NCT03034967|474977000|FG005|Overall Study|Lack of Efficacy|0|||
131915715|NCT03034967|474976995|FG000|Overall Study|Adverse Event, non-fatal|3|||
131915716|NCT03034967|474976996|FG001|Overall Study|Adverse Event, non-fatal|1|||
131915717|NCT03034967|474976997|FG002|Overall Study|Adverse Event, non-fatal|2|||
131915718|NCT03034967|474976998|FG003|Overall Study|Adverse Event, non-fatal|0|||
131915719|NCT03034967|474976999|FG004|Overall Study|Adverse Event, non-fatal|2|||
131915720|NCT03034967|474977000|FG005|Overall Study|Adverse Event, non-fatal|8|||
131915721|NCT03034967|474976995|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
131915722|NCT03034967|474976996|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
131915723|NCT03034967|474976997|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
131915724|NCT03034967|474976998|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
131915725|NCT03034967|474976999|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
131915726|NCT03034967|474977000|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
131865425|NCT05691712|474785187|FG000|Overall Study|Adverse Event|0|||
131865426|NCT05691712|474785188|FG001|Overall Study|Adverse Event|1|||
131865427|NCT05691712|474785189|FG002|Overall Study|Adverse Event|2|||
131865428|NCT05691712|474785190|FG003|Overall Study|Adverse Event|1|||
131865429|NCT05691712|474785187|FG000|Overall Study|Withdrawal by Subject|2|||
131865430|NCT05691712|474785188|FG001|Overall Study|Withdrawal by Subject|3|||
131865431|NCT05691712|474785189|FG002|Overall Study|Withdrawal by Subject|3|||
131865432|NCT05691712|474785190|FG003|Overall Study|Withdrawal by Subject|1|||
131865433|NCT05691712|474785187|FG000|Overall Study|Death|1|||
131865434|NCT05691712|474785188|FG001|Overall Study|Death|0|||
131865435|NCT05691712|474785189|FG002|Overall Study|Death|0|||
131865436|NCT05691712|474785190|FG003|Overall Study|Death|0|||
131865437|NCT05691712|474785187|FG000|Overall Study|Pregnancy|0|||
131865438|NCT05691712|474785188|FG001|Overall Study|Pregnancy|1|||
131865439|NCT05691712|474785189|FG002|Overall Study|Pregnancy|0|||
131865440|NCT05691712|474785190|FG003|Overall Study|Pregnancy|0|||
131865441|NCT05691712|474785187|FG000|Overall Study|Assigned Treatment by Mistake|1|||
131865442|NCT05691712|474785188|FG001|Overall Study|Assigned Treatment by Mistake|0|||
131865443|NCT05691712|474785189|FG002|Overall Study|Assigned Treatment by Mistake|0|||
131865444|NCT05691712|474785190|FG003|Overall Study|Assigned Treatment by Mistake|1|||
131865445|NCT00682786|474785193|FG000|Overall Study|Withdrawal by Subject|2|||
131865446|NCT00682786|474785194|FG001|Overall Study|Withdrawal by Subject|2|||
131865447|NCT00682786|474785193|FG000|Overall Study|Did not receive irinotecan|0|||
131865448|NCT00682786|474785194|FG001|Overall Study|Did not receive irinotecan|1|||
131865449|NCT00359424|474785197|FG000|Overall Study|Death|99|||
131865450|NCT00359424|474785198|FG001|Overall Study|Death|58|||
131865451|NCT00359424|474785197|FG000|Overall Study|Lost to Follow-up|19|||
131865452|NCT00359424|474785198|FG001|Overall Study|Lost to Follow-up|7|||
131865453|NCT00359424|474785197|FG000|Overall Study|Withdrawal by Subject|10|||
131865454|NCT00359424|474785198|FG001|Overall Study|Withdrawal by Subject|2|||
131865455|NCT00359424|474785197|FG000|Overall Study|follow up not conducted|2|||
131865456|NCT00359424|474785198|FG001|Overall Study|follow up not conducted|0|||
131865457|NCT03830333|474785201|FG000|Overall Study|Death|0|||
131865458|NCT03830333|474785202|FG001|Overall Study|Death|1|||
131865459|NCT03830333|474785201|FG000|Overall Study|Withdrawal by Subject|5|||
131865460|NCT03830333|474785202|FG001|Overall Study|Withdrawal by Subject|1|||
131865461|NCT03830333|474785201|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
131865462|NCT03830333|474785202|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
131865463|NCT00734994|474785203|FG000|Overall Study|Withdrawal by Subject|1|||
131865464|NCT05966584|474785204|FG000|Overall Study|Lost to Follow-up|1|||
131865465|NCT04563754|474786362|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
131865466|NCT04563754|474786363|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
131865467|NCT04563754|474786364|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
131915727|NCT04225039|474977011|FG000|Overall Study|Withdrawal by Subject|1|||
131915728|NCT04225039|474977012|FG001|Overall Study|Withdrawal by Subject|0|||
131865468|NCT04563754|474786362|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
131915729|NCT04225039|474977013|FG002|Overall Study|Withdrawal by Subject|0|||
131915730|NCT04225039|474977014|FG003|Overall Study|Withdrawal by Subject|1|||
131865469|NCT04563754|474786363|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
131865470|NCT04563754|474786364|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
131915731|NCT04225039|474977011|FG000|Overall Study|Currently active on study treatment|0|||
131865471|NCT04563754|474786362|FG000|Follow up|Lost to Follow-up|61|||
131915732|NCT04225039|474977012|FG001|Overall Study|Currently active on study treatment|1|||
131915733|NCT04225039|474977013|FG002|Overall Study|Currently active on study treatment|0|||
131865472|NCT04563754|474786363|FG001|Follow up|Lost to Follow-up|23|||
131865473|NCT04563754|474786364|FG002|Follow up|Lost to Follow-up|5|||
131865474|NCT04563754|474786362|FG000|Follow up|Death|0|||
131865475|NCT04563754|474786363|FG001|Follow up|Death|2|||
131865476|NCT04563754|474786364|FG002|Follow up|Death|0|||
131865477|NCT04563754|474786362|FG000|Follow up|Ongoing|0|||
131865478|NCT04563754|474786363|FG001|Follow up|Ongoing|28|||
131865479|NCT04563754|474786364|FG002|Follow up|Ongoing|0|||
131865480|NCT04023396|474786365|FG000|Overall Study|Adverse Event|16|||
131915734|NCT04225039|474977014|FG003|Overall Study|Currently active on study treatment|0|||
131915735|NCT04225039|474977011|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
131915736|NCT04225039|474977012|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
131915737|NCT04225039|474977013|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
131915738|NCT04225039|474977014|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
131915739|NCT04225039|474977011|FG000|Overall Study|Ineligible for treatment|0|||
131915740|NCT04225039|474977012|FG001|Overall Study|Ineligible for treatment|0|||
131915741|NCT04225039|474977013|FG002|Overall Study|Ineligible for treatment|0|||
131915742|NCT04225039|474977014|FG003|Overall Study|Ineligible for treatment|4|||
131915743|NCT02550795|474977018|FG000|Overall Study|Physician Decision|0|||
131915744|NCT02550795|474977019|FG001|Overall Study|Physician Decision|1|||
131915745|NCT02550795|474977020|FG002|Overall Study|Physician Decision|0|||
131915746|NCT02802228|474977022|FG000|Overall Study|Withdrawal by Subject|2|||
131915747|NCT02802228|474977023|FG001|Overall Study|Withdrawal by Subject|0|||
131915748|NCT02802228|474977022|FG000|Overall Study|Lost to Follow-up|1|||
131915749|NCT02802228|474977023|FG001|Overall Study|Lost to Follow-up|0|||
131915750|NCT02802228|474977022|FG000|Overall Study|Adverse Event|1|||
131915751|NCT02802228|474977023|FG001|Overall Study|Adverse Event|0|||
131915752|NCT02802228|474977022|FG000|Overall Study|Physician Decision|1|||
131915753|NCT02802228|474977023|FG001|Overall Study|Physician Decision|0|||
131915754|NCT02225587|474977024|FG000|Overall Study|Adverse Event|5|||
131915755|NCT02225587|474977025|FG001|Overall Study|Adverse Event|5|||
131915756|NCT02225587|474977024|FG000|Overall Study|Lost to Follow-up|5|||
131915757|NCT02225587|474977025|FG001|Overall Study|Lost to Follow-up|5|||
131915758|NCT02225587|474977024|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131915759|NCT02225587|474977025|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131915760|NCT02225587|474977024|FG000|Overall Study|Physician Decision|2|||
131915761|NCT02225587|474977025|FG001|Overall Study|Physician Decision|0|||
131915762|NCT02225587|474977024|FG000|Overall Study|Protocol Violation|1|||
131915763|NCT02225587|474977025|FG001|Overall Study|Protocol Violation|0|||
131915764|NCT02225587|474977024|FG000|Overall Study|Participant Moved|1|||
131915765|NCT02225587|474977025|FG001|Overall Study|Participant Moved|0|||
131915766|NCT02225587|474977024|FG000|Overall Study|Withdrawal by Subject|13|||
131915767|NCT02225587|474977025|FG001|Overall Study|Withdrawal by Subject|28|||
131915768|NCT03197129|474977028|FG000|Overall Study|did not answer the VPT: shyness|4|||
131915769|NCT03197129|474977029|FG001|Overall Study|did not answer the VPT: shyness|5|||
131915770|NCT01564407|474977030|FG000|Overall Study|Lost to Follow-up|0|||
131915771|NCT01564407|474977031|FG001|Overall Study|Lost to Follow-up|1|||
131915772|NCT01564407|474977032|FG002|Overall Study|Lost to Follow-up|0|||
131915773|NCT01564407|474977033|FG003|Overall Study|Lost to Follow-up|0|||
131915774|NCT01564407|474977034|FG004|Overall Study|Lost to Follow-up|0|||
131915775|NCT01564407|474977030|FG000|Overall Study|Withdrawal by Subject|0|||
131915776|NCT01564407|474977031|FG001|Overall Study|Withdrawal by Subject|1|||
131915777|NCT01564407|474977032|FG002|Overall Study|Withdrawal by Subject|0|||
131915778|NCT01564407|474977033|FG003|Overall Study|Withdrawal by Subject|0|||
131915779|NCT01564407|474977034|FG004|Overall Study|Withdrawal by Subject|0|||
131915780|NCT01564407|474977030|FG000|Overall Study|funding lost, study ended|0|||
131915781|NCT01564407|474977031|FG001|Overall Study|funding lost, study ended|0|||
131915782|NCT01564407|474977032|FG002|Overall Study|funding lost, study ended|0|||
131865481|NCT04023396|474786365|FG000|Overall Study|Death|1|||
131865482|NCT04023396|474786365|FG000|Overall Study|Lost to Follow-up|1|||
131865483|NCT04023396|474786365|FG000|Overall Study|Withdrawal by Subject|14|||
131915783|NCT01564407|474977033|FG003|Overall Study|funding lost, study ended|1|||
131865484|NCT04023396|474786365|FG000|Overall Study|Pregnancy|4|||
131865485|NCT04023396|474786365|FG000|Overall Study|Lack of Efficacy|3|||
131915784|NCT01564407|474977034|FG004|Overall Study|funding lost, study ended|0|||
131915785|NCT02879695|474977037|FG000|Overall Study|Did not start study treatment|2|||
131915786|NCT02879695|474977038|FG001|Overall Study|Did not start study treatment|0|||
131915787|NCT02879695|474977039|FG002|Overall Study|Did not start study treatment|3|||
131915788|NCT02879695|474977040|FG003|Overall Study|Did not start study treatment|0|||
131915789|NCT00157755|474977043|FG000|Overall Study|Death|2|||
131915790|NCT00157755|474977044|FG001|Overall Study|Death|3|||
131915791|NCT00157755|474977045|FG002|Overall Study|Death|3|||
131865486|NCT04023396|474786365|FG000|Overall Study|Physician Decision|4|||
131865487|NCT04023396|474786365|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
131915792|NCT00157755|474977046|FG003|Overall Study|Death|2|||
131408135|NCT00496197|473118192|FG000|Overall Study|Discontinued study due to death|43|||
131865488|NCT04815083|474786366|FG000|Overall Study|Physician Decision|1|||
131865489|NCT04815083|474786366|FG000|Overall Study|Study pause|2|||
131865490|NCT04815083|474786366|FG000|Overall Study|Screening failure|4|||
131865491|NCT04225715|474786369|FG000|Overall Study|Reason not Specified|1|||
131865492|NCT04225715|474786370|FG001|Overall Study|Reason not Specified|0|||
131865493|NCT04225715|474786371|FG002|Overall Study|Reason not Specified|0|||
131865494|NCT04225715|474786372|FG003|Overall Study|Reason not Specified|0|||
131865495|NCT04225715|474786373|FG004|Overall Study|Reason not Specified|0|||
131865496|NCT04225715|474786374|FG005|Overall Study|Reason not Specified|0|||
131865497|NCT04225715|474786375|FG006|Overall Study|Reason not Specified|0|||
131865498|NCT04225715|474786376|FG007|Overall Study|Reason not Specified|0|||
131865499|NCT04225715|474786377|FG008|Overall Study|Reason not Specified|0|||
131865500|NCT04225715|474786369|FG000|Overall Study|Protocol Violation|1|||
131865501|NCT04225715|474786370|FG001|Overall Study|Protocol Violation|0|||
131865502|NCT04225715|474786371|FG002|Overall Study|Protocol Violation|0|||
131865503|NCT04225715|474786372|FG003|Overall Study|Protocol Violation|0|||
131865504|NCT04225715|474786373|FG004|Overall Study|Protocol Violation|0|||
131865505|NCT04225715|474786374|FG005|Overall Study|Protocol Violation|9|||
131865506|NCT04225715|474786375|FG006|Overall Study|Protocol Violation|0|||
131865507|NCT04225715|474786376|FG007|Overall Study|Protocol Violation|0|||
131865508|NCT04225715|474786377|FG008|Overall Study|Protocol Violation|0|||
131865509|NCT04225715|474786369|FG000|Overall Study|Withdrawal by Subject|4|||
131865510|NCT04225715|474786370|FG001|Overall Study|Withdrawal by Subject|1|||
131865511|NCT04225715|474786371|FG002|Overall Study|Withdrawal by Subject|1|||
131865512|NCT04225715|474786372|FG003|Overall Study|Withdrawal by Subject|0|||
131865513|NCT04225715|474786373|FG004|Overall Study|Withdrawal by Subject|3|||
131865514|NCT04225715|474786374|FG005|Overall Study|Withdrawal by Subject|1|||
131865515|NCT04225715|474786375|FG006|Overall Study|Withdrawal by Subject|1|||
131865516|NCT04225715|474786376|FG007|Overall Study|Withdrawal by Subject|1|||
131865517|NCT04225715|474786377|FG008|Overall Study|Withdrawal by Subject|0|||
131865518|NCT04225715|474786369|FG000|Overall Study|Adverse Event|0|||
131865519|NCT04225715|474786370|FG001|Overall Study|Adverse Event|0|||
131865520|NCT04225715|474786371|FG002|Overall Study|Adverse Event|0|||
131865521|NCT04225715|474786372|FG003|Overall Study|Adverse Event|0|||
131865522|NCT04225715|474786373|FG004|Overall Study|Adverse Event|0|||
131865523|NCT04225715|474786374|FG005|Overall Study|Adverse Event|0|||
131865524|NCT04225715|474786375|FG006|Overall Study|Adverse Event|0|||
131865525|NCT04225715|474786376|FG007|Overall Study|Adverse Event|0|||
131865526|NCT04225715|474786377|FG008|Overall Study|Adverse Event|1|||
131865527|NCT04225715|474786369|FG000|Overall Study|Arm Terminated By Sponsor|0|||
131865528|NCT04225715|474786370|FG001|Overall Study|Arm Terminated By Sponsor|0|||
131865529|NCT04225715|474786371|FG002|Overall Study|Arm Terminated By Sponsor|0|||
131865530|NCT04225715|474786372|FG003|Overall Study|Arm Terminated By Sponsor|0|||
131865531|NCT04225715|474786373|FG004|Overall Study|Arm Terminated By Sponsor|0|||
131865532|NCT04225715|474786374|FG005|Overall Study|Arm Terminated By Sponsor|0|||
131865533|NCT04225715|474786375|FG006|Overall Study|Arm Terminated By Sponsor|0|||
131865534|NCT04225715|474786376|FG007|Overall Study|Arm Terminated By Sponsor|17|||
131865535|NCT04225715|474786377|FG008|Overall Study|Arm Terminated By Sponsor|18|||
131865536|NCT00471081|474786382|FG000|Active Phase|Protocol Violation|1|||
131865537|NCT00471081|474786383|FG001|Active Phase|Protocol Violation|1|||
131865538|NCT00471081|474786382|FG000|Active Phase|Withdrawal by Subject|0|||
131865539|NCT00471081|474786383|FG001|Active Phase|Withdrawal by Subject|3|||
131865540|NCT00471081|474786382|FG000|Active Phase|Lost to Follow-up|0|||
131865541|NCT00471081|474786383|FG001|Active Phase|Lost to Follow-up|1|||
131865542|NCT00471081|474786382|FG000|Active Phase|Lost health plan/insurance|1|||
131915793|NCT00157755|474977047|FG004|Overall Study|Death|0|||
131915794|NCT00157755|474977048|FG005|Overall Study|Death|0|||
131915795|NCT00157755|474977043|FG000|Overall Study|Lost to Follow-up|0|||
131915796|NCT00157755|474977044|FG001|Overall Study|Lost to Follow-up|0|||
131915797|NCT00157755|474977045|FG002|Overall Study|Lost to Follow-up|1|||
131915798|NCT00157755|474977046|FG003|Overall Study|Lost to Follow-up|0|||
131915799|NCT00157755|474977047|FG004|Overall Study|Lost to Follow-up|0|||
131453873|NCT01677377|473291795|FG000|Overall Study|Withdrawal by Subject|0|||
131865543|NCT00471081|474786383|FG001|Active Phase|Lost health plan/insurance|8|||
131865544|NCT00471081|474786382|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
131865545|NCT00471081|474786383|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
131865546|NCT00471081|474786382|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
131865547|NCT00471081|474786383|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
131865548|NCT00471081|474786382|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
131865549|NCT00471081|474786383|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
131865550|NCT02844933|474786384|FG000|Overall Study|Discontinued due to premature termination of study|3|||
131865551|NCT02844933|474786385|FG001|Overall Study|Discontinued due to premature termination of study|2|||
131865552|NCT05177484|474786386|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
131915800|NCT00157755|474977048|FG005|Overall Study|Lost to Follow-up|0|||
131915801|NCT00157755|474977043|FG000|Overall Study|Withdrawal by Subject|0|||
131915802|NCT00157755|474977044|FG001|Overall Study|Withdrawal by Subject|0|||
131915803|NCT00157755|474977045|FG002|Overall Study|Withdrawal by Subject|1|||
131915804|NCT00157755|474977046|FG003|Overall Study|Withdrawal by Subject|1|||
131915805|NCT00157755|474977047|FG004|Overall Study|Withdrawal by Subject|1|||
131915806|NCT00157755|474977048|FG005|Overall Study|Withdrawal by Subject|2|||
131915807|NCT00157755|474977043|FG000|Overall Study|Explant due to infection|0|||
131915808|NCT00157755|474977044|FG001|Overall Study|Explant due to infection|0|||
131915809|NCT00157755|474977045|FG002|Overall Study|Explant due to infection|1|||
131915810|NCT00157755|474977046|FG003|Overall Study|Explant due to infection|0|||
131915811|NCT00157755|474977047|FG004|Overall Study|Explant due to infection|0|||
131915812|NCT00157755|474977048|FG005|Overall Study|Explant due to infection|0|||
131915813|NCT00157755|474977043|FG000|Overall Study|Medical reason|0|||
131915814|NCT00157755|474977044|FG001|Overall Study|Medical reason|0|||
131915815|NCT00157755|474977045|FG002|Overall Study|Medical reason|1|||
131915816|NCT00157755|474977046|FG003|Overall Study|Medical reason|1|||
131915817|NCT00157755|474977047|FG004|Overall Study|Medical reason|0|||
131915818|NCT00157755|474977048|FG005|Overall Study|Medical reason|0|||
131915819|NCT00157755|474977043|FG000|Overall Study|Study site closure|0|||
131915820|NCT00157755|474977044|FG001|Overall Study|Study site closure|1|||
131915821|NCT00157755|474977045|FG002|Overall Study|Study site closure|0|||
131915822|NCT00157755|474977046|FG003|Overall Study|Study site closure|0|||
131915823|NCT00157755|474977047|FG004|Overall Study|Study site closure|0|||
131915824|NCT00157755|474977048|FG005|Overall Study|Study site closure|0|||
131915825|NCT00157755|474977043|FG000|Overall Study|Subject non-compliance|0|||
131915826|NCT00157755|474977044|FG001|Overall Study|Subject non-compliance|0|||
131915827|NCT00157755|474977045|FG002|Overall Study|Subject non-compliance|0|||
131915828|NCT00157755|474977046|FG003|Overall Study|Subject non-compliance|0|||
131915829|NCT00157755|474977047|FG004|Overall Study|Subject non-compliance|0|||
131915830|NCT00157755|474977048|FG005|Overall Study|Subject non-compliance|1|||
131915831|NCT00157755|474977043|FG000|Overall Study|Study completion|0|||
131915832|NCT00157755|474977044|FG001|Overall Study|Study completion|0|||
131915833|NCT00157755|474977045|FG002|Overall Study|Study completion|0|||
131915834|NCT00157755|474977046|FG003|Overall Study|Study completion|0|||
131915835|NCT00157755|474977047|FG004|Overall Study|Study completion|1|||
131915836|NCT00157755|474977048|FG005|Overall Study|Study completion|2|||
131915837|NCT04133909|474977051|FG000|Overall Study|Death|11|||
131915838|NCT04133909|474977052|FG001|Overall Study|Death|11|||
131915839|NCT04133909|474977051|FG000|Overall Study|Adverse Event|4|||
131915840|NCT04133909|474977052|FG001|Overall Study|Adverse Event|5|||
131915841|NCT04133909|474977051|FG000|Overall Study|Lost to Follow-up|3|||
131915842|NCT04133909|474977052|FG001|Overall Study|Lost to Follow-up|5|||
131915843|NCT04133909|474977051|FG000|Overall Study|Physician Decision|4|||
131915844|NCT04133909|474977052|FG001|Overall Study|Physician Decision|7|||
131915845|NCT04133909|474977051|FG000|Overall Study|Withdrawal by Subject|40|||
131915846|NCT04133909|474977052|FG001|Overall Study|Withdrawal by Subject|35|||
131915847|NCT04133909|474977051|FG000|Overall Study|Lack of Efficacy|2|||
131915848|NCT04133909|474977052|FG001|Overall Study|Lack of Efficacy|7|||
131915849|NCT04133909|474977051|FG000|Overall Study|Randomized in error|1|||
131915850|NCT04133909|474977052|FG001|Overall Study|Randomized in error|1|||
131915851|NCT01143324|474977055|FG000|Overall Study|Lost to Follow-up|11|||
131915852|NCT01143324|474977055|FG000|Overall Study|Withdrawal by Subject|4|||
131915853|NCT01143324|474977055|FG000|Overall Study|Explant of the device|4|||
131915854|NCT00858988|474977065|FG000|Analysis|Lactulose unable to be detected in urine|2|||
131915855|NCT00858988|474977066|FG001|Analysis|Lactulose unable to be detected in urine|1|||
131915856|NCT04817410|474979778|FG000|Overall Study|Withdrawal by Subject|5|||
131915857|NCT04817410|474979778|FG000|Overall Study|Physician Decision|3|||
131915858|NCT03595748|474979779|FG000|Overall Study|Death|11|||
131915859|NCT03595748|474979780|FG001|Overall Study|Death|12|||
131915860|NCT03595748|474979779|FG000|Overall Study|Withdrawal by Subject|28|||
131915861|NCT03595748|474979780|FG001|Overall Study|Withdrawal by Subject|29|||
131915862|NCT03595748|474979779|FG000|Overall Study|Protocol Violation|0|||
131915863|NCT03595748|474979780|FG001|Overall Study|Protocol Violation|1|||
131915864|NCT04809974|474979782|FG000|Lead-in Phase|Withdrawal by Subject|3|||
131915865|NCT04809974|474979783|FG001|Lead-in Phase|Withdrawal by Subject|0|||
131915866|NCT04809974|474979784|FG002|Lead-in Phase|Withdrawal by Subject|0|||
131915867|NCT04809974|474979782|FG000|Lead-in Phase|No longer eligible|11|||
131915868|NCT04809974|474979783|FG001|Lead-in Phase|No longer eligible|0|||
131915869|NCT04809974|474979784|FG002|Lead-in Phase|No longer eligible|0|||
131915870|NCT04809974|474979782|FG000|Randomized Phase|Lost to Follow-up|0|||
131915871|NCT04809974|474979783|FG001|Randomized Phase|Lost to Follow-up|1|||
131915872|NCT04809974|474979784|FG002|Randomized Phase|Lost to Follow-up|5|||
131915873|NCT04809974|474979782|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
131915874|NCT04809974|474979783|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
131915875|NCT04809974|474979784|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
131915876|NCT04809974|474979782|FG000|Randomized Phase|Adverse Event|0|||
131915877|NCT04809974|474979783|FG001|Randomized Phase|Adverse Event|1|||
131915878|NCT04809974|474979784|FG002|Randomized Phase|Adverse Event|4|||
131915879|NCT04809974|474979782|FG000|Randomized Phase|Withdrawal by Subject|0|||
131915880|NCT04809974|474979783|FG001|Randomized Phase|Withdrawal by Subject|0|||
131915881|NCT04809974|474979784|FG002|Randomized Phase|Withdrawal by Subject|5|||
131915882|NCT05493111|474979785|FG000|Overall Study|Adverse Event|3|||
131915883|NCT05493111|474979786|FG001|Overall Study|Adverse Event|4|||
131915884|NCT05493111|474979785|FG000|Overall Study|Withdrawal of Consent|19|||
131915885|NCT05493111|474979786|FG001|Overall Study|Withdrawal of Consent|10|||
131915886|NCT05493111|474979785|FG000|Overall Study|Non-compliance|1|||
131915887|NCT05493111|474979786|FG001|Overall Study|Non-compliance|1|||
131915888|NCT05493111|474979785|FG000|Overall Study|Lost to Follow-up|8|||
131915889|NCT05493111|474979786|FG001|Overall Study|Lost to Follow-up|1|||
131915890|NCT05493111|474979785|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
131915891|NCT05493111|474979786|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
131915892|NCT05493111|474979785|FG000|Overall Study|Withdrawal by Subject|1|||
131915893|NCT05493111|474979786|FG001|Overall Study|Withdrawal by Subject|1|||
131915894|NCT06125964|474979787|FG000|Overall Study|Lost to Follow-up|0|||
131915895|NCT06125964|474979788|FG001|Overall Study|Lost to Follow-up|1|||
131915896|NCT06125964|474979789|FG002|Overall Study|Lost to Follow-up|0|||
131915897|NCT06125964|474979790|FG003|Overall Study|Lost to Follow-up|0|||
131915898|NCT00549055|474979791|FG000|Overall Study|Adverse Event|4|||
131915899|NCT00549055|474979791|FG000|Overall Study|Lack of Efficacy|18|||
131915900|NCT00549055|474979791|FG000|Overall Study|Stabilization|5|||
131915901|NCT00549055|474979791|FG000|Overall Study|Progression to fibrosis|2|||
131865553|NCT05177484|474786387|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
131865554|NCT05177484|474786386|FG000|Overall Study|Inadvertently withdrawn|3|||
131865555|NCT05177484|474786387|FG001|Overall Study|Inadvertently withdrawn|1|||
131865556|NCT05177484|474786386|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
131865557|NCT05177484|474786387|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
131865558|NCT05486091|474786390|FG000|Overall Study|Withdrawal by Subject|1|||
131865559|NCT05486091|474786390|FG000|Overall Study|Lost to Follow-up|2|||
131865560|NCT03971071|474786391|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
131865561|NCT03971071|474786392|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
131865562|NCT03971071|474786393|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
131865563|NCT03971071|474786394|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
131865564|NCT03971071|474786395|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
131865565|NCT03971071|474786391|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
131865566|NCT03971071|474786392|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
131865567|NCT03971071|474786393|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
131865568|NCT03971071|474786394|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131865569|NCT03971071|474786395|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131865570|NCT03971071|474786391|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
131865571|NCT03971071|474786392|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
131865572|NCT03971071|474786393|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
131865573|NCT03971071|474786394|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
131865574|NCT03971071|474786395|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
131865575|NCT03971071|474786391|FG000|Open-label Treatment Period|Sponsor decision|0|||
131865576|NCT03971071|474786392|FG001|Open-label Treatment Period|Sponsor decision|0|||
131865577|NCT03971071|474786393|FG002|Open-label Treatment Period|Sponsor decision|0|||
131865578|NCT03971071|474786394|FG003|Open-label Treatment Period|Sponsor decision|0|||
131865579|NCT03971071|474786395|FG004|Open-label Treatment Period|Sponsor decision|1|||
131865580|NCT03971071|474786391|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
131865581|NCT03971071|474786392|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131865582|NCT03971071|474786393|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
131865583|NCT03971071|474786394|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
131865584|NCT03971071|474786395|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
131865585|NCT03971071|474786391|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131865586|NCT03971071|474786392|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
131865587|NCT03971071|474786393|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
131865588|NCT03971071|474786394|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
131865589|NCT03971071|474786395|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
131865590|NCT04537078|474786396|FG000|Overall Study|Protocol Violation|3|||
131865591|NCT04537078|474786397|FG001|Overall Study|Protocol Violation|2|||
131865592|NCT04537078|474786396|FG000|Overall Study|Lost to Follow-up|1|||
131865593|NCT04537078|474786397|FG001|Overall Study|Lost to Follow-up|0|||
131865594|NCT04537078|474786396|FG000|Overall Study|Withdrawal by Subject|0|||
131865595|NCT04537078|474786397|FG001|Overall Study|Withdrawal by Subject|1|||
131865596|NCT03922308|474786398|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
131865597|NCT03922308|474786399|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
131915902|NCT00549055|474979791|FG000|Overall Study|Decrease of size|1|||
131915903|NCT00549055|474979791|FG000|Overall Study|Active choroidal neovascula increased|1|||
131865598|NCT03922308|474786400|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
131865599|NCT03922308|474786398|FG000|Overall Study|Lost to Follow-up|1|||
131865600|NCT03922308|474786399|FG001|Overall Study|Lost to Follow-up|0|||
131865601|NCT03922308|474786400|FG002|Overall Study|Lost to Follow-up|0|||
131865602|NCT03922308|474786398|FG000|Overall Study|Reason not Specified|0|||
131865603|NCT03922308|474786399|FG001|Overall Study|Reason not Specified|2|||
131865604|NCT03922308|474786400|FG002|Overall Study|Reason not Specified|1|||
131865605|NCT01697748|474786401|FG000|Overall Study|ineligible skin incision|1|||
131865606|NCT01697748|474786402|FG001|Overall Study|ineligible skin incision|2|||
131865607|NCT01697748|474786401|FG000|Overall Study|ineligible uterine incision|4|||
131865608|NCT01697748|474786402|FG001|Overall Study|ineligible uterine incision|1|||
131865609|NCT01697748|474786401|FG000|Overall Study|Lost to Follow-up|53|||
131865610|NCT01697748|474786402|FG001|Overall Study|Lost to Follow-up|65|||
131865611|NCT01256450|474786403|FG000|Open-label Titration|Adverse Event|39|||
131865612|NCT01256450|474786404|FG001|Open-label Titration|Adverse Event|0|||
131865613|NCT01256450|474786405|FG002|Open-label Titration|Adverse Event|0|||
131865614|NCT01256450|474786403|FG000|Open-label Titration|Lost to Follow-up|7|||
131865615|NCT01256450|474786404|FG001|Open-label Titration|Lost to Follow-up|0|||
131865616|NCT01256450|474786405|FG002|Open-label Titration|Lost to Follow-up|0|||
131865617|NCT01256450|474786403|FG000|Open-label Titration|Lack of analgesic effect|30|||
131865618|NCT01256450|474786404|FG001|Open-label Titration|Lack of analgesic effect|0|||
131865619|NCT01256450|474786405|FG002|Open-label Titration|Lack of analgesic effect|0|||
131865620|NCT01256450|474786403|FG000|Open-label Titration|Non-compliance|9|||
131865621|NCT01256450|474786404|FG001|Open-label Titration|Non-compliance|0|||
131865622|NCT01256450|474786405|FG002|Open-label Titration|Non-compliance|0|||
131865623|NCT01256450|474786403|FG000|Open-label Titration|Screen failure|1|||
131865624|NCT01256450|474786404|FG001|Open-label Titration|Screen failure|0|||
131865625|NCT01256450|474786405|FG002|Open-label Titration|Screen failure|0|||
131865626|NCT01256450|474786403|FG000|Open-label Titration|Other|13|||
131865627|NCT01256450|474786404|FG001|Open-label Titration|Other|0|||
131865628|NCT01256450|474786405|FG002|Open-label Titration|Other|0|||
131865629|NCT01256450|474786403|FG000|Double-blind Treatment|Adverse Event|0|||
131865630|NCT01256450|474786404|FG001|Double-blind Treatment|Adverse Event|8|||
131865631|NCT01256450|474786405|FG002|Double-blind Treatment|Adverse Event|6|||
131865632|NCT01256450|474786403|FG000|Double-blind Treatment|Lost to Follow-up|0|||
131865633|NCT01256450|474786404|FG001|Double-blind Treatment|Lost to Follow-up|1|||
131865634|NCT01256450|474786405|FG002|Double-blind Treatment|Lost to Follow-up|7|||
131865635|NCT01256450|474786403|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
131865636|NCT01256450|474786404|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
131865637|NCT01256450|474786405|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
131865638|NCT01256450|474786403|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
131865639|NCT01256450|474786404|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
131865640|NCT01256450|474786405|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
131865641|NCT01256450|474786403|FG000|Double-blind Treatment|Non-compliance|0|||
131865642|NCT01256450|474786404|FG001|Double-blind Treatment|Non-compliance|5|||
131865643|NCT01256450|474786405|FG002|Double-blind Treatment|Non-compliance|4|||
131865644|NCT01256450|474786403|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
131865645|NCT01256450|474786404|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
131865646|NCT01256450|474786405|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
131865647|NCT01256450|474786403|FG000|Double-blind Treatment|Other|0|||
131865648|NCT01256450|474786404|FG001|Double-blind Treatment|Other|9|||
131865649|NCT01256450|474786405|FG002|Double-blind Treatment|Other|12|||
131865650|NCT01704495|474786406|FG000|Subjects Randomized|Other Reason|3|||
131865651|NCT01704495|474786407|FG001|Subjects Randomized|Other Reason|2|||
131865652|NCT01704495|474786408|FG002|Subjects Randomized|Other Reason|3|||
131865653|NCT01704495|474786409|FG003|Subjects Randomized|Other Reason|2|||
131865654|NCT01704495|474786406|FG000|Subjects Randomized|Discontinuation criteria met|4|||
131865655|NCT01704495|474786407|FG001|Subjects Randomized|Discontinuation criteria met|2|||
131865656|NCT01704495|474786408|FG002|Subjects Randomized|Discontinuation criteria met|2|||
131865657|NCT01704495|474786409|FG003|Subjects Randomized|Discontinuation criteria met|0|||
131865658|NCT01704495|474786406|FG000|Subjects Randomized|Adverse Event|8|||
131865659|NCT01704495|474786407|FG001|Subjects Randomized|Adverse Event|2|||
131865660|NCT01704495|474786408|FG002|Subjects Randomized|Adverse Event|0|||
131865661|NCT01704495|474786409|FG003|Subjects Randomized|Adverse Event|7|||
131865662|NCT01704495|474786406|FG000|Subjects Randomized|Withdrawal by Subject|5|||
131865663|NCT01704495|474786407|FG001|Subjects Randomized|Withdrawal by Subject|5|||
131865664|NCT01704495|474786408|FG002|Subjects Randomized|Withdrawal by Subject|5|||
131865665|NCT01704495|474786409|FG003|Subjects Randomized|Withdrawal by Subject|5|||
131865666|NCT01704495|474786406|FG000|Subjects Randomized|Protocol Violation|1|||
131865667|NCT01704495|474786407|FG001|Subjects Randomized|Protocol Violation|1|||
131865668|NCT01704495|474786408|FG002|Subjects Randomized|Protocol Violation|2|||
131865669|NCT01704495|474786409|FG003|Subjects Randomized|Protocol Violation|0|||
131865670|NCT01704495|474786406|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
131865671|NCT01704495|474786407|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
131865672|NCT01704495|474786408|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
131865673|NCT01704495|474786409|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
131865674|NCT01704495|474786406|FG000|Optional Safety Extension|Adverse Event|0|||
131865675|NCT01704495|474786407|FG001|Optional Safety Extension|Adverse Event|4|||
131865676|NCT01704495|474786408|FG002|Optional Safety Extension|Adverse Event|0|||
131915904|NCT00549055|474979791|FG000|Overall Study|Vitreous hemorrhage|1|||
131915905|NCT00549055|474979791|FG000|Overall Study|Growth choroidal neovascularisation|1|||
131915906|NCT00549055|474979791|FG000|Overall Study|Choroidal neovascularization|1|||
131915907|NCT00549055|474979791|FG000|Overall Study|Very low visual acuity (VA)|1|||
131915908|NCT00770809|474979796|FG000|Overall Study|Adverse Event|9|||
131915909|NCT00770809|474979797|FG001|Overall Study|Adverse Event|1|||
131915910|NCT00770809|474979798|FG002|Overall Study|Adverse Event|12|||
131915911|NCT00770809|474979796|FG000|Overall Study|Death|1|||
131915912|NCT00770809|474979797|FG001|Overall Study|Death|0|||
131915913|NCT00770809|474979798|FG002|Overall Study|Death|0|||
131915914|NCT00770809|474979796|FG000|Overall Study|Withdrawal by Subject|3|||
131915915|NCT00770809|474979797|FG001|Overall Study|Withdrawal by Subject|3|||
131915916|NCT00770809|474979798|FG002|Overall Study|Withdrawal by Subject|7|||
131915917|NCT00770809|474979796|FG000|Overall Study|Progression|2|||
131915918|NCT00770809|474979797|FG001|Overall Study|Progression|2|||
131915919|NCT00770809|474979798|FG002|Overall Study|Progression|0|||
131915920|NCT00770809|474979796|FG000|Overall Study|Complicating illness|0|||
131915921|NCT00770809|474979797|FG001|Overall Study|Complicating illness|0|||
131915922|NCT00770809|474979798|FG002|Overall Study|Complicating illness|1|||
131915923|NCT00770809|474979796|FG000|Overall Study|Other Medical Reasons|2|||
131915924|NCT00770809|474979797|FG001|Overall Study|Other Medical Reasons|4|||
131915925|NCT00770809|474979798|FG002|Overall Study|Other Medical Reasons|3|||
131915926|NCT02469233|474979799|FG000|Overall Study|Death|1|||
131915927|NCT02469233|474979800|FG001|Overall Study|Death|1|||
131915928|NCT02469233|474979799|FG000|Overall Study|Lost to post or 6 month follow up|7|||
131915929|NCT02469233|474979800|FG001|Overall Study|Lost to post or 6 month follow up|2|||
131915930|NCT03474107|474979801|FG000|Overall Study|Adverse Event|42|||
131915931|NCT03474107|474979802|FG001|Overall Study|Adverse Event|46|||
131915932|NCT03474107|474979801|FG000|Overall Study|Death|2|||
131915933|NCT03474107|474979802|FG001|Overall Study|Death|2|||
131915934|NCT03474107|474979801|FG000|Overall Study|Lost to Follow-up|0|||
131915935|NCT03474107|474979802|FG001|Overall Study|Lost to Follow-up|1|||
131915936|NCT03474107|474979801|FG000|Overall Study|Progressive Disease|177|||
131915937|NCT03474107|474979802|FG001|Overall Study|Progressive Disease|180|||
131915938|NCT03474107|474979801|FG000|Overall Study|Protocol Violation|1|||
131915939|NCT03474107|474979802|FG001|Overall Study|Protocol Violation|1|||
131915940|NCT03474107|474979801|FG000|Overall Study|Withdrawal by Subject|15|||
131915941|NCT03474107|474979802|FG001|Overall Study|Withdrawal by Subject|27|||
131915942|NCT03474107|474979801|FG000|Overall Study|Physician Decision|7|||
131915943|NCT03474107|474979802|FG001|Overall Study|Physician Decision|22|||
131915944|NCT03474107|474979801|FG000|Overall Study|Miscellaneous|1|||
131915945|NCT03474107|474979802|FG001|Overall Study|Miscellaneous|6|||
131915946|NCT01787838|474979803|FG000|Overall Study|refused|1413|||
131915947|NCT00782067|474979808|FG000|Overall Study|Adverse Event|35|||
131915948|NCT00782067|474979808|FG000|Overall Study|Subject withdrew consent|11|||
131915949|NCT00782067|474979808|FG000|Overall Study|Lost to Follow-up|2|||
131915950|NCT00782067|474979808|FG000|Overall Study|Administrative problems|14|||
131915951|NCT00782067|474979808|FG000|Overall Study|Death|9|||
131915952|NCT00782067|474979808|FG000|Overall Study|Disease progression|43|||
131915953|NCT00782067|474979808|FG000|Overall Study|Protocol deviation|2|||
131915954|NCT00764517|474979809|FG000|Overall Study|Adverse Event|9|||
131915955|NCT00764517|474979810|FG001|Overall Study|Adverse Event|3|||
131915956|NCT00764517|474979809|FG000|Overall Study|Death|3|||
131915957|NCT00764517|474979810|FG001|Overall Study|Death|11|||
131915958|NCT00764517|474979809|FG000|Overall Study|Physician Decision|3|||
131915959|NCT00764517|474979810|FG001|Overall Study|Physician Decision|0|||
131915960|NCT00973973|474979814|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
131915961|NCT00973973|474979815|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
131915962|NCT00973973|474979814|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
131915963|NCT00973973|474979815|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
131915964|NCT00973973|474979814|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
131915965|NCT00973973|474979815|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
131915966|NCT00973973|474979814|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
131915967|NCT00973973|474979815|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
131915968|NCT00973973|474979814|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
131915969|NCT00973973|474979815|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
131915970|NCT00973973|474979814|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
131915971|NCT00973973|474979815|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
131915972|NCT00973973|474979814|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
131915973|NCT00973973|474979815|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
131915974|NCT00973973|474979814|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
131915975|NCT00973973|474979815|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
131915976|NCT00973973|474979814|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
131915977|NCT00973973|474979815|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
131915978|NCT00973973|474979814|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
131865677|NCT01704495|474786409|FG003|Optional Safety Extension|Adverse Event|1|||
131865678|NCT01704495|474786406|FG000|Optional Safety Extension|Other reason|27|||
131865679|NCT01704495|474786407|FG001|Optional Safety Extension|Other reason|29|||
131865680|NCT01704495|474786408|FG002|Optional Safety Extension|Other reason|30|||
131865681|NCT01704495|474786409|FG003|Optional Safety Extension|Other reason|28|||
131865682|NCT01704495|474786406|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
131865683|NCT01704495|474786407|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
131865684|NCT01704495|474786408|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
131865685|NCT01704495|474786409|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
131865686|NCT03866512|474786410|FG000|Overall Study|Lost to Follow-up|1|||
131865687|NCT03866512|474786411|FG001|Overall Study|Lost to Follow-up|2|||
131865688|NCT03866512|474786412|FG002|Overall Study|Lost to Follow-up|1|||
131865689|NCT03866512|474786410|FG000|Overall Study|Cannulation issues|0|||
131865690|NCT03866512|474786411|FG001|Overall Study|Cannulation issues|1|||
131865691|NCT03866512|474786412|FG002|Overall Study|Cannulation issues|2|||
131865692|NCT03376789|474786420|FG000|Overall Study|Withdrawal by Subject|3|||
131865693|NCT03376789|474786421|FG001|Overall Study|Withdrawal by Subject|5|||
131865694|NCT03376789|474786420|FG000|Overall Study|Protocol Violation|0|||
131865695|NCT03376789|474786421|FG001|Overall Study|Protocol Violation|1|||
131865696|NCT03376789|474786420|FG000|Overall Study|Adverse Event|0|||
131865697|NCT03376789|474786421|FG001|Overall Study|Adverse Event|1|||
131865698|NCT03376789|474786420|FG000|Overall Study|Lost to Follow-up|1|||
131865699|NCT03376789|474786421|FG001|Overall Study|Lost to Follow-up|1|||
131865700|NCT03376789|474786420|FG000|Overall Study|Per sponsor due to noncompliance|1|||
131865701|NCT03376789|474786421|FG001|Overall Study|Per sponsor due to noncompliance|0|||
131865702|NCT03376789|474786420|FG000|Overall Study|Subject off study medication|0|||
131865703|NCT03376789|474786421|FG001|Overall Study|Subject off study medication|1|||
131865704|NCT01956773|474786429|FG000|Overall Study|Lost to Follow-up|628|||
131865705|NCT01956773|474786430|FG001|Overall Study|Lost to Follow-up|1|||
131865706|NCT02492867|474786433|FG000|Overall Study|Alternate therapy|1|||
131865707|NCT02492867|474786433|FG000|Overall Study|Withdrawal by Subject|2|||
131865708|NCT02492867|474786433|FG000|Overall Study|Disease progression after treatment started|1|||
131865709|NCT02492867|474786433|FG000|Overall Study|Death|1|||
131865710|NCT03296527|474786434|FG000|Overall Study|Adverse Event|15|||
131865711|NCT03296527|474786435|FG001|Overall Study|Adverse Event|33|||
131865712|NCT03296527|474786434|FG000|Overall Study|Protocol Deviation|4|||
131865713|NCT03296527|474786435|FG001|Overall Study|Protocol Deviation|0|||
131865714|NCT03296527|474786434|FG000|Overall Study|Participant withdrew consent|3|||
131865715|NCT03296527|474786435|FG001|Overall Study|Participant withdrew consent|1|||
131865716|NCT03296527|474786434|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
131865717|NCT03296527|474786435|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
131865718|NCT03296527|474786434|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
131865719|NCT03296527|474786435|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
131865720|NCT03296527|474786434|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
131865721|NCT03296527|474786435|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
131865722|NCT03296527|474786434|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
131865723|NCT03296527|474786435|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
131865724|NCT03296527|474786434|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
131865725|NCT03296527|474786435|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
131865726|NCT00122382|474786436|FG000|Double-Blind Study|Adverse Event|9|||
131865727|NCT00122382|474786437|FG001|Double-Blind Study|Adverse Event|11|||
131865728|NCT00122382|474786438|FG002|Double-Blind Study|Adverse Event|0|||
131865729|NCT00122382|474786436|FG000|Double-Blind Study|Death|2|||
131865730|NCT00122382|474786437|FG001|Double-Blind Study|Death|2|||
131865731|NCT00122382|474786438|FG002|Double-Blind Study|Death|0|||
131865732|NCT00122382|474786436|FG000|Double-Blind Study|Lack of Efficacy|0|||
131865733|NCT00122382|474786437|FG001|Double-Blind Study|Lack of Efficacy|8|||
131865734|NCT00122382|474786438|FG002|Double-Blind Study|Lack of Efficacy|0|||
131865735|NCT00122382|474786436|FG000|Double-Blind Study|Lost to Follow-up|2|||
131865736|NCT00122382|474786437|FG001|Double-Blind Study|Lost to Follow-up|1|||
131865737|NCT00122382|474786438|FG002|Double-Blind Study|Lost to Follow-up|0|||
131865738|NCT00122382|474786436|FG000|Double-Blind Study|Pregnancy|2|||
131865739|NCT00122382|474786437|FG001|Double-Blind Study|Pregnancy|0|||
131865740|NCT00122382|474786438|FG002|Double-Blind Study|Pregnancy|0|||
131865741|NCT00122382|474786436|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
131865742|NCT00122382|474786437|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
131865743|NCT00122382|474786438|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
131865744|NCT00122382|474786436|FG000|Double-Blind Study|Withdrawal of Consent|7|||
131865745|NCT00122382|474786437|FG001|Double-Blind Study|Withdrawal of Consent|3|||
131865746|NCT00122382|474786438|FG002|Double-Blind Study|Withdrawal of Consent|0|||
131865747|NCT00122382|474786436|FG000|Double-Blind Study|Protocol Violation|1|||
131865748|NCT00122382|474786437|FG001|Double-Blind Study|Protocol Violation|0|||
131865749|NCT00122382|474786438|FG002|Double-Blind Study|Protocol Violation|0|||
131865750|NCT00122382|474786436|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
131865751|NCT00122382|474786437|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
131865752|NCT00122382|474786438|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
131865753|NCT00122382|474786436|FG000|Double-Blind Study|Randomized but not treated|0|||
131865754|NCT00122382|474786437|FG001|Double-Blind Study|Randomized but not treated|2|||
131865755|NCT00122382|474786438|FG002|Double-Blind Study|Randomized but not treated|0|||
131865756|NCT00122382|474786436|FG000|Open-Label Study|Adverse Event|0|||
131865757|NCT00122382|474786437|FG001|Open-Label Study|Adverse Event|0|||
131865758|NCT00122382|474786438|FG002|Open-Label Study|Adverse Event|11|||
131865759|NCT00122382|474786436|FG000|Open-Label Study|Death|0|||
131865760|NCT00122382|474786437|FG001|Open-Label Study|Death|0|||
131865761|NCT00122382|474786438|FG002|Open-Label Study|Death|2|||
131865762|NCT00122382|474786436|FG000|Open-Label Study|Lack of Efficacy|0|||
131865763|NCT00122382|474786437|FG001|Open-Label Study|Lack of Efficacy|0|||
131865764|NCT00122382|474786438|FG002|Open-Label Study|Lack of Efficacy|3|||
131865765|NCT00122382|474786436|FG000|Open-Label Study|Lost to Follow-up|0|||
131865766|NCT00122382|474786437|FG001|Open-Label Study|Lost to Follow-up|0|||
131865767|NCT00122382|474786438|FG002|Open-Label Study|Lost to Follow-up|3|||
131865768|NCT00122382|474786436|FG000|Open-Label Study|Pregnancy|0|||
131865769|NCT00122382|474786437|FG001|Open-Label Study|Pregnancy|0|||
131865770|NCT00122382|474786438|FG002|Open-Label Study|Pregnancy|2|||
131865771|NCT00122382|474786436|FG000|Open-Label Study|Poor/Non-Compliance|0|||
131865772|NCT00122382|474786437|FG001|Open-Label Study|Poor/Non-Compliance|0|||
131865773|NCT00122382|474786438|FG002|Open-Label Study|Poor/Non-Compliance|1|||
131865774|NCT00122382|474786436|FG000|Open-Label Study|Withdrawal of Consent|0|||
131865775|NCT00122382|474786437|FG001|Open-Label Study|Withdrawal of Consent|0|||
131865776|NCT00122382|474786438|FG002|Open-Label Study|Withdrawal of Consent|4|||
131865777|NCT02040805|474786439|FG000|Overall Study|Lost to Follow-up|14|||
131865778|NCT02040805|474786440|FG001|Overall Study|Lost to Follow-up|9|||
131865779|NCT02040805|474786439|FG000|Overall Study|Withdrawal by Subject|28|||
131865780|NCT02040805|474786440|FG001|Overall Study|Withdrawal by Subject|41|||
131865781|NCT01213966|474786442|FG000|Overall Study|Protocol Violation|1|||
131865782|NCT01213966|474786443|FG001|Overall Study|Protocol Violation|0|||
131865783|NCT01213966|474786444|FG002|Overall Study|Protocol Violation|3|||
131865784|NCT01213966|474786445|FG003|Overall Study|Protocol Violation|1|||
131865785|NCT03591874|474786446|FG000|Overall Study|Adverse Event|4|||
131865786|NCT03591874|474786447|FG001|Overall Study|Adverse Event|0|||
131865787|NCT03591874|474786446|FG000|Overall Study|Withdrawal by Subject|2|||
131865788|NCT03591874|474786447|FG001|Overall Study|Withdrawal by Subject|1|||
131865789|NCT03591874|474786446|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
131865790|NCT03591874|474786447|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
131865791|NCT03591874|474786446|FG000|Overall Study|On Study at Time of Study Termination|12|||
131865792|NCT03591874|474786447|FG001|Overall Study|On Study at Time of Study Termination|6|||
131865793|NCT01591096|474786448|FG000|Overall Study|Adverse Event|1|||
131865794|NCT02859337|474786449|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
131865795|NCT02859337|474786450|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
131865796|NCT02859337|474786451|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
131865797|NCT02859337|474786449|FG000|Overall Study|Withdrawal by Subject|3|||
131865798|NCT02859337|474786450|FG001|Overall Study|Withdrawal by Subject|1|||
131865799|NCT02859337|474786451|FG002|Overall Study|Withdrawal by Subject|0|||
131865800|NCT02859337|474786449|FG000|Overall Study|Lost to Follow-up|1|||
131865801|NCT02859337|474786450|FG001|Overall Study|Lost to Follow-up|0|||
131865802|NCT02859337|474786451|FG002|Overall Study|Lost to Follow-up|0|||
131865803|NCT05514873|474786452|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
131865804|NCT05514873|474786452|FG000|Main Treatment Period|Adverse Event|2|||
131865805|NCT05514873|474786452|FG000|Extension Treatment Period|Lost to Follow-up|3|||
131865806|NCT00210210|474787275|FG000|Overall Study|Withdrawal by Subject|3|||
131865807|NCT00210210|474787276|FG001|Overall Study|Withdrawal by Subject|2|||
131865808|NCT00210210|474787275|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
131865809|NCT00210210|474787276|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
131865810|NCT01100086|474787277|FG000|Period 1|Withdrawal by Subject|1|||
131865811|NCT01100086|474787278|FG001|Period 1|Withdrawal by Subject|0|||
131865812|NCT02955355|474787281|FG000|Overall Study|Adverse Event|4|||
131865813|NCT02955355|474787281|FG000|Overall Study|Death|1|||
131865814|NCT02955355|474787281|FG000|Overall Study|Physician Decision|21|||
131865815|NCT02955355|474787281|FG000|Overall Study|Site Terminated by Sponsor|35|||
131865816|NCT02955355|474787281|FG000|Overall Study|Withdrawal by Subject|19|||
131865817|NCT02955355|474787281|FG000|Overall Study|Reason Not Specified|5|||
131865818|NCT02393950|474787284|FG000|Overall Study|Adverse Event|1|||
131865819|NCT02393950|474787285|FG001|Overall Study|Adverse Event|0|||
131865820|NCT02393950|474787284|FG000|Overall Study|Withdrawal by Subject|0|||
131865821|NCT02393950|474787285|FG001|Overall Study|Withdrawal by Subject|1|||
131865822|NCT00360282|474787286|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
131865823|NCT00360282|474787287|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
131865824|NCT00360282|474787288|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
131915979|NCT00973973|474979815|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
131915980|NCT00973973|474979814|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
131915981|NCT00973973|474979815|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
131915982|NCT00973973|474979814|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
131915983|NCT00973973|474979815|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
131915984|NCT02020941|474979816|FG000|Overall Study|Adverse Event|1|||
131915985|NCT02020941|474979816|FG000|Overall Study|Physician Decision|2|||
131915986|NCT02020941|474979816|FG000|Overall Study|Withdrawal by Subject|1|||
131915987|NCT02020941|474979816|FG000|Overall Study|Disease Progression|4|||
131915988|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
131915989|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
131915990|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
131915991|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
131915992|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
131915993|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
131915994|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
131915995|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
131915996|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
131915997|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
131915998|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
131915999|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
131916000|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
131916001|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
131916002|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
131916003|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
131916004|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
131916005|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
131916006|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
131916007|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
131916008|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
131916009|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
131916010|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
131916011|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
131916012|NCT00620542|474979818|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
131916013|NCT00620542|474979819|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
131916014|NCT00620542|474979820|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
131916015|NCT00620542|474979821|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
131916016|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
131916017|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
131916018|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
131916019|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
131916020|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
131916021|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
131916022|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
131916023|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
131916024|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
131916025|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
131916026|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
131916027|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
131916028|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
131916029|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
131916030|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
131916031|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
131916032|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
131916033|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
131916034|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
131916035|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
131916036|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
131916037|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
131916038|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
131916039|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
131916040|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
131916041|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
131916042|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
131916043|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
131916044|NCT00620542|474979818|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
131916045|NCT00620542|474979819|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
131916046|NCT00620542|474979820|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
131916047|NCT00620542|474979821|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
131916048|NCT01481779|474979822|FG000|Overall Study|Adverse Event|23|||
131916049|NCT01481779|474979823|FG001|Overall Study|Adverse Event|5|||
131916050|NCT01481779|474979822|FG000|Overall Study|Lost to Follow-up|3|||
131916051|NCT01481779|474979823|FG001|Overall Study|Lost to Follow-up|2|||
131916052|NCT01481779|474979822|FG000|Overall Study|Protocol Violation|2|||
131916053|NCT01481779|474979823|FG001|Overall Study|Protocol Violation|3|||
131916054|NCT01481779|474979822|FG000|Overall Study|Withdrawal by Subject|26|||
131916055|NCT01481779|474979823|FG001|Overall Study|Withdrawal by Subject|13|||
131916056|NCT01481779|474979822|FG000|Overall Study|Physician Decision|13|||
131916057|NCT01481779|474979823|FG001|Overall Study|Physician Decision|4|||
131916058|NCT01481779|474979822|FG000|Overall Study|Sponsor Decision|3|||
131916059|NCT01481779|474979823|FG001|Overall Study|Sponsor Decision|1|||
131916060|NCT03575364|474979831|FG000|Overall Study|Death|45|||
131916061|NCT03575364|474979831|FG000|Overall Study|Lost to Follow-up|114|||
131916062|NCT03575364|474979831|FG000|Overall Study|Withdrawal by Subject|21|||
131916063|NCT03575364|474979831|FG000|Overall Study|Physician Decision|11|||
131916064|NCT03575364|474979831|FG000|Overall Study|Subject Refused Follow-up|13|||
131916065|NCT03575364|474979831|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
131916066|NCT03575364|474979831|FG000|Overall Study|Patient moved out of the state|1|||
131916067|NCT03575364|474979831|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
131916068|NCT03575364|474979831|FG000|Overall Study|Patient is lost to follow up|1|||
131916069|NCT03575364|474979831|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
131916070|NCT01303419|474979832|FG000|Overall Study|Discontinuation of study|60|||
131916071|NCT01303419|474979832|FG000|Overall Study|Did not complete both imaging methods|5|||
131916072|NCT01303419|474979832|FG000|Overall Study|Did not meet all I/E after screening|31|||
131916073|NCT05376358|474979835|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
131916074|NCT05376358|474979836|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
131916075|NCT05376358|474979835|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
131916076|NCT05376358|474979836|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
131916077|NCT05376358|474979835|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
131916078|NCT05376358|474979836|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
131916079|NCT05376358|474979835|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
131916080|NCT05376358|474979836|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
131865825|NCT00360282|474787289|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
131865826|NCT00360282|474787286|FG000|Second Intervention|Adverse Event|0|||
131865827|NCT00360282|474787287|FG001|Second Intervention|Adverse Event|1|||
131865828|NCT00360282|474787288|FG002|Second Intervention|Adverse Event|0|||
131865829|NCT00360282|474787289|FG003|Second Intervention|Adverse Event|0|||
131865830|NCT03817853|474787290|FG000|Induction Phase|Adverse Event|5|||
131865831|NCT03817853|474787291|FG001|Induction Phase|Adverse Event|0|||
131865832|NCT03817853|474787292|FG002|Induction Phase|Adverse Event|0|||
131865833|NCT03817853|474787290|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
131865834|NCT03817853|474787291|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
131865835|NCT03817853|474787292|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
131865836|NCT03817853|474787290|FG000|Induction Phase|Physician Decision|2|||
131865837|NCT03817853|474787291|FG001|Induction Phase|Physician Decision|0|||
131865838|NCT03817853|474787292|FG002|Induction Phase|Physician Decision|0|||
131865839|NCT03817853|474787290|FG000|Induction Phase|Progressive Disease|6|||
131865840|NCT03817853|474787291|FG001|Induction Phase|Progressive Disease|0|||
131865841|NCT03817853|474787292|FG002|Induction Phase|Progressive Disease|0|||
131865842|NCT03817853|474787290|FG000|Induction Phase|Withdrawal by Subject|4|||
131865843|NCT03817853|474787291|FG001|Induction Phase|Withdrawal by Subject|0|||
131865844|NCT03817853|474787292|FG002|Induction Phase|Withdrawal by Subject|0|||
131865845|NCT03817853|474787290|FG000|Maintenance Phase|Adverse Event|0|||
131865846|NCT03817853|474787291|FG001|Maintenance Phase|Adverse Event|8|||
131865847|NCT03817853|474787292|FG002|Maintenance Phase|Adverse Event|0|||
131865848|NCT03817853|474787290|FG000|Maintenance Phase|Death|0|||
131865849|NCT03817853|474787291|FG001|Maintenance Phase|Death|5|||
131916081|NCT05376358|474979835|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
131916082|NCT05376358|474979836|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
131916083|NCT05376358|474979835|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
131916084|NCT05376358|474979836|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
131916085|NCT00311168|474979837|FG000|First Intervention|Withdrawal by Subject|2|||
131916086|NCT00311168|474979838|FG001|First Intervention|Withdrawal by Subject|2|||
131916087|NCT00311168|474979837|FG000|First Intervention|Lost to Follow-up|1|||
131865850|NCT03817853|474787292|FG002|Maintenance Phase|Death|0|||
131865851|NCT03817853|474787290|FG000|Maintenance Phase|Progressive Disease|0|||
131916088|NCT00311168|474979838|FG001|First Intervention|Lost to Follow-up|1|||
131916089|NCT00311168|474979837|FG000|First Intervention|Protocol Violation|1|||
131916090|NCT00311168|474979838|FG001|First Intervention|Protocol Violation|1|||
131916091|NCT00311168|474979837|FG000|First Intervention|Adverse Event|1|||
131916092|NCT00311168|474979838|FG001|First Intervention|Adverse Event|0|||
131916093|NCT00311168|474979837|FG000|First Intervention|Other|2|||
131916094|NCT00311168|474979838|FG001|First Intervention|Other|2|||
131916095|NCT00311168|474979837|FG000|Second Intervention|Lost to Follow-up|9|||
131916096|NCT00311168|474979838|FG001|Second Intervention|Lost to Follow-up|2|||
131916097|NCT00311168|474979837|FG000|Second Intervention|Withdrawal by Subject|0|||
131916098|NCT00311168|474979838|FG001|Second Intervention|Withdrawal by Subject|1|||
131916099|NCT00311168|474979837|FG000|Second Intervention|Other|1|||
131916100|NCT00311168|474979838|FG001|Second Intervention|Other|1|||
131916101|NCT01697579|474979841|FG000|Base Study-Cycle 1|Adverse Event|1|||
131916102|NCT01697579|474979842|FG001|Base Study-Cycle 1|Adverse Event|0|||
131916103|NCT01697579|474979843|FG002|Base Study-Cycle 1|Adverse Event|0|||
131916104|NCT01697579|474979844|FG003|Base Study-Cycle 1|Adverse Event|0|||
131916105|NCT01697579|474979845|FG004|Base Study-Cycle 1|Adverse Event|0|||
131916106|NCT01697579|474979846|FG005|Base Study-Cycle 1|Adverse Event|0|||
131916107|NCT01697579|474979847|FG006|Base Study-Cycle 1|Adverse Event|0|||
131916108|NCT01697579|474979841|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
131916109|NCT01697579|474979842|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
131916110|NCT01697579|474979843|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
131916111|NCT01697579|474979844|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
131916112|NCT01697579|474979845|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
131916113|NCT01697579|474979846|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
131916114|NCT01697579|474979847|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
131916115|NCT01697579|474979841|FG000|Base Study-Cycle 1|Protocol Violation|0|||
131916116|NCT01697579|474979842|FG001|Base Study-Cycle 1|Protocol Violation|0|||
131916117|NCT01697579|474979843|FG002|Base Study-Cycle 1|Protocol Violation|0|||
131916118|NCT01697579|474979844|FG003|Base Study-Cycle 1|Protocol Violation|0|||
131916119|NCT01697579|474979845|FG004|Base Study-Cycle 1|Protocol Violation|3|||
131916120|NCT01697579|474979846|FG005|Base Study-Cycle 1|Protocol Violation|0|||
131916121|NCT01697579|474979847|FG006|Base Study-Cycle 1|Protocol Violation|0|||
131916122|NCT01697579|474979841|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
131916123|NCT01697579|474979842|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
131916124|NCT01697579|474979843|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
131916125|NCT01697579|474979844|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
131916126|NCT01697579|474979845|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
131916127|NCT01697579|474979846|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
131916128|NCT01697579|474979847|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
131916129|NCT01697579|474979841|FG000|Base Study-Cycle 1|Technical Problems|0|||
131916130|NCT01697579|474979842|FG001|Base Study-Cycle 1|Technical Problems|0|||
131916131|NCT01697579|474979843|FG002|Base Study-Cycle 1|Technical Problems|1|||
131916132|NCT01697579|474979844|FG003|Base Study-Cycle 1|Technical Problems|1|||
131916133|NCT01697579|474979845|FG004|Base Study-Cycle 1|Technical Problems|0|||
131916134|NCT01697579|474979846|FG005|Base Study-Cycle 1|Technical Problems|0|||
131916135|NCT01697579|474979847|FG006|Base Study-Cycle 1|Technical Problems|0|||
131916136|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Death|0|||
131916137|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Death|0|||
131916138|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Death|0|||
131916139|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Death|0|||
131916140|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Death|0|||
131916141|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Death|0|||
131916142|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Death|2|||
131916143|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131916144|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131916145|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131916146|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131916147|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131916148|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
131916149|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
131916150|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
131916151|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
131916152|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
131916153|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
131916154|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
131916155|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
131916156|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
131916157|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
131916158|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
131408136|NCT00496197|473118192|FG000|Overall Study|Adverse Event|13|||
131916159|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
131916160|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
131916161|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
131916162|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
131916163|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
131916164|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
131916165|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
131916166|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
131916167|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
131916168|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
131916169|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
131916170|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
131916171|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
131916172|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
131916173|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
131916174|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
131916175|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
131916176|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
131916177|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
131916178|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
131916179|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
131916180|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
131916181|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
131916182|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
131916183|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
131916184|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
131916185|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
131916186|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
131916187|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
131916188|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
131916189|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
131916190|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
131916191|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
131916192|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
131916193|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
131916194|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
131916195|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
131916196|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
131916197|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
131916198|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
131916199|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
131916200|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
131916201|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
131916202|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
131916203|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
131916204|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
131916205|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
131916206|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
131916207|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
131916208|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
131916209|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
131916210|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
131916211|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
131916212|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
131916213|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
131916214|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
131916215|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
131916216|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
131916217|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
131916218|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
131916219|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
131916220|NCT01697579|474979841|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
131916221|NCT01697579|474979842|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
131916222|NCT01697579|474979843|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
131916223|NCT01697579|474979844|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
131916224|NCT01697579|474979845|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
131916225|NCT01697579|474979846|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
131916226|NCT01697579|474979847|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
131916227|NCT03965923|474979848|FG000|Overall Study|Withdrawal by Subject|1|||
131916228|NCT03965923|474979849|FG001|Overall Study|Withdrawal by Subject|2|||
131916229|NCT03965923|474979850|FG002|Overall Study|Withdrawal by Subject|3|||
131916230|NCT03965923|474979851|FG003|Overall Study|Withdrawal by Subject|1|||
131916231|NCT03965923|474979852|FG004|Overall Study|Withdrawal by Subject|2|||
131916232|NCT03965923|474979853|FG005|Overall Study|Withdrawal by Subject|0|||
131916233|NCT03965923|474979854|FG006|Overall Study|Withdrawal by Subject|4|||
131408137|NCT00496197|473118192|FG000|Overall Study|Does not meet entrance criteria|5|||
131865852|NCT03817853|474787291|FG001|Maintenance Phase|Progressive Disease|7|||
131865853|NCT03817853|474787292|FG002|Maintenance Phase|Progressive Disease|0|||
131865854|NCT03817853|474787290|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131865855|NCT03817853|474787291|FG001|Maintenance Phase|Withdrawal by Subject|2|||
131865856|NCT03817853|474787292|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131865857|NCT03817853|474787290|FG000|Maintenance Phase|Physician Decision|0|||
131865858|NCT03817853|474787291|FG001|Maintenance Phase|Physician Decision|1|||
131865859|NCT03817853|474787292|FG002|Maintenance Phase|Physician Decision|0|||
131865860|NCT03817853|474787290|FG000|Maintenance Phase|Various reasons|0|||
131865861|NCT03817853|474787291|FG001|Maintenance Phase|Various reasons|4|||
131865862|NCT03817853|474787292|FG002|Maintenance Phase|Various reasons|0|||
131865863|NCT03817853|474787290|FG000|Maintenance Phase|Protocol Deviation|0|||
131865864|NCT03817853|474787291|FG001|Maintenance Phase|Protocol Deviation|1|||
131865865|NCT03817853|474787292|FG002|Maintenance Phase|Protocol Deviation|0|||
131865866|NCT03817853|474787290|FG000|Follow-up Phase|Adverse Event|0|||
131865867|NCT03817853|474787291|FG001|Follow-up Phase|Adverse Event|0|||
131865868|NCT03817853|474787292|FG002|Follow-up Phase|Adverse Event|2|||
131865869|NCT03817853|474787290|FG000|Follow-up Phase|Death|0|||
131865870|NCT03817853|474787291|FG001|Follow-up Phase|Death|0|||
131865871|NCT03817853|474787292|FG002|Follow-up Phase|Death|1|||
131865872|NCT03817853|474787290|FG000|Follow-up Phase|Progressive Disease|0|||
131865873|NCT03817853|474787291|FG001|Follow-up Phase|Progressive Disease|0|||
131865874|NCT03817853|474787292|FG002|Follow-up Phase|Progressive Disease|3|||
131865875|NCT03817853|474787290|FG000|Follow-up Phase|Withdrawal by Subject|0|||
131865876|NCT03817853|474787291|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131865877|NCT03817853|474787292|FG002|Follow-up Phase|Withdrawal by Subject|1|||
131865878|NCT00314340|474787293|FG000|Overall Study|lost interest|1|||
131865879|NCT03252535|474787296|FG000|Overall Study|Withdrawal by Subject|1|||
131865880|NCT03252535|474787297|FG001|Overall Study|Withdrawal by Subject|0|||
131865881|NCT03252535|474787298|FG002|Overall Study|Withdrawal by Subject|0|||
131865882|NCT03252535|474787296|FG000|Overall Study|Physician Decision|0|||
131865883|NCT03252535|474787297|FG001|Overall Study|Physician Decision|1|||
131865884|NCT03252535|474787298|FG002|Overall Study|Physician Decision|0|||
131865885|NCT03252535|474787296|FG000|Overall Study|Met discontinuation criteria|0|||
131865886|NCT03252535|474787297|FG001|Overall Study|Met discontinuation criteria|1|||
131865887|NCT03252535|474787298|FG002|Overall Study|Met discontinuation criteria|0|||
131865888|NCT00997373|474787302|FG000|Overall Study|Withdrawal by Subject|5|||
131865889|NCT00997373|474787303|FG001|Overall Study|Withdrawal by Subject|0|||
131865890|NCT00997373|474787302|FG000|Overall Study|wrong tumor type|4|||
131865891|NCT00997373|474787303|FG001|Overall Study|wrong tumor type|0|||
131865892|NCT00997373|474787302|FG000|Overall Study|could not have hysterectomy|6|||
131865893|NCT00997373|474787303|FG001|Overall Study|could not have hysterectomy|0|||
131865894|NCT01346059|474787304|FG000|Overall Study|Withdrawal by Subject|1|||
131865895|NCT01346059|474787305|FG001|Overall Study|Withdrawal by Subject|0|||
131865896|NCT05600283|474787309|FG000|Overall Study|Withdrawal by Subject|3|||
131865897|NCT05600283|474787310|FG001|Overall Study|Withdrawal by Subject|8|||
131865898|NCT05600283|474787309|FG000|Overall Study|invalid individual swab|1|||
131865899|NCT05600283|474787310|FG001|Overall Study|invalid individual swab|0|||
131865900|NCT05600283|474787309|FG000|Overall Study|missing clinician collection|3|||
131865901|NCT05600283|474787310|FG001|Overall Study|missing clinician collection|0|||
131865902|NCT05600283|474787309|FG000|Overall Study|screening failure|0|||
131916234|NCT03965923|474979855|FG007|Overall Study|Withdrawal by Subject|3|||
131916235|NCT03965923|474979856|FG008|Overall Study|Withdrawal by Subject|4|||
131916236|NCT03965923|474979857|FG009|Overall Study|Withdrawal by Subject|0|||
131865903|NCT05600283|474787310|FG001|Overall Study|screening failure|2|||
131865904|NCT00450437|474787315|FG000|Overall Study|Withdrawal by Subject|10|||
131865905|NCT00450437|474787316|FG001|Overall Study|Withdrawal by Subject|2|||
131865906|NCT00450437|474787317|FG002|Overall Study|Withdrawal by Subject|0|||
131865907|NCT00450437|474787318|FG003|Overall Study|Withdrawal by Subject|1|||
131865908|NCT00450437|474787315|FG000|Overall Study|Lost to Follow-up|31|||
131865909|NCT00450437|474787316|FG001|Overall Study|Lost to Follow-up|12|||
131865910|NCT00450437|474787317|FG002|Overall Study|Lost to Follow-up|19|||
131865911|NCT00450437|474787318|FG003|Overall Study|Lost to Follow-up|9|||
131916237|NCT03965923|474979858|FG010|Overall Study|Withdrawal by Subject|2|||
131865912|NCT00450437|474787315|FG000|Overall Study|Protocol Violation|0|||
131865913|NCT00450437|474787316|FG001|Overall Study|Protocol Violation|1|||
131865914|NCT00450437|474787317|FG002|Overall Study|Protocol Violation|0|||
131865915|NCT00450437|474787318|FG003|Overall Study|Protocol Violation|1|||
131865916|NCT00450437|474787315|FG000|Overall Study|Inappropriate enrollment|4|||
131865917|NCT00450437|474787316|FG001|Overall Study|Inappropriate enrollment|1|||
131865918|NCT00450437|474787317|FG002|Overall Study|Inappropriate enrollment|3|||
131865919|NCT00450437|474787318|FG003|Overall Study|Inappropriate enrollment|0|||
131865920|NCT00450437|474787315|FG000|Overall Study|Administrative reason|0|||
131865921|NCT00450437|474787316|FG001|Overall Study|Administrative reason|0|||
131865922|NCT00450437|474787317|FG002|Overall Study|Administrative reason|1|||
131865923|NCT00450437|474787318|FG003|Overall Study|Administrative reason|0|||
131865924|NCT00450437|474787315|FG000|Overall Study|Unable to Classify|1|||
131865925|NCT00450437|474787316|FG001|Overall Study|Unable to Classify|0|||
131865926|NCT00450437|474787317|FG002|Overall Study|Unable to Classify|1|||
131865927|NCT00450437|474787318|FG003|Overall Study|Unable to Classify|0|||
131865928|NCT00503698|474787319|FG000|Overall Study|Protocol Violation|5|||
131865929|NCT00503698|474787320|FG001|Overall Study|Protocol Violation|6|||
131865930|NCT00503698|474787319|FG000|Overall Study|Adverse Event|52|||
131865931|NCT00503698|474787320|FG001|Overall Study|Adverse Event|41|||
131865932|NCT00503698|474787319|FG000|Overall Study|Death|1|||
131865933|NCT00503698|474787320|FG001|Overall Study|Death|0|||
131865934|NCT00503698|474787319|FG000|Overall Study|Lack of Efficacy|3|||
131865935|NCT00503698|474787320|FG001|Overall Study|Lack of Efficacy|4|||
131865936|NCT00503698|474787319|FG000|Overall Study|Trial terminated|216|||
131865937|NCT00503698|474787320|FG001|Overall Study|Trial terminated|253|||
131865938|NCT00503698|474787319|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
131865939|NCT00503698|474787320|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
131865940|NCT00503698|474787319|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
131865941|NCT00503698|474787320|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
131865942|NCT00503698|474787319|FG000|Overall Study|Any condition in exclusion criteria|4|||
131865943|NCT00503698|474787320|FG001|Overall Study|Any condition in exclusion criteria|6|||
131865944|NCT00503698|474787319|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
131865945|NCT00503698|474787320|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
131865946|NCT00503698|474787319|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
131865947|NCT00503698|474787320|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
131865948|NCT00503698|474787319|FG000|Overall Study|Critically ill|2|||
131865949|NCT00503698|474787320|FG001|Overall Study|Critically ill|0|||
131865950|NCT00503698|474787319|FG000|Overall Study|Unclassified|48|||
131865951|NCT00503698|474787320|FG001|Overall Study|Unclassified|32|||
131865952|NCT00503698|474787319|FG000|Overall Study|Not exposed to trial drug|11|||
131865953|NCT00503698|474787320|FG001|Overall Study|Not exposed to trial drug|6|||
131865954|NCT03644342|474787326|FG000|Overall Study|Adverse Event|2|||
131865955|NCT03644342|474787327|FG001|Overall Study|Adverse Event|0|||
131865956|NCT03644342|474787326|FG000|Overall Study|Protocol Violation|0|||
131865957|NCT03644342|474787327|FG001|Overall Study|Protocol Violation|1|||
131865958|NCT02462603|474787328|FG000|Overall Study|Investigator Decision|1|||
131865959|NCT02462603|474787328|FG000|Overall Study|Non-Compliance|1|||
131865960|NCT02462603|474787328|FG000|Overall Study|Withdrawal by Subject|2|||
131865961|NCT03194542|474787329|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
131865962|NCT03194542|474787330|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
131865963|NCT03194542|474787331|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
131865964|NCT03194542|474787332|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
131865965|NCT03194542|474787329|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
131865966|NCT03194542|474787330|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
131865967|NCT03194542|474787331|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
131865968|NCT03194542|474787332|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
131865969|NCT03194542|474787329|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
131865970|NCT03194542|474787330|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
131865971|NCT03194542|474787331|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
131865972|NCT03194542|474787332|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
131865973|NCT03194542|474787329|FG000|Overall Study|Loss of Response|4|||
131865974|NCT03194542|474787330|FG001|Overall Study|Loss of Response|2|||
131865975|NCT03194542|474787331|FG002|Overall Study|Loss of Response|3|||
131865976|NCT03194542|474787332|FG003|Overall Study|Loss of Response|4|||
131865977|NCT03194542|474787329|FG000|Overall Study|Physician Decision|0|||
131865978|NCT03194542|474787330|FG001|Overall Study|Physician Decision|1|||
131865979|NCT03194542|474787331|FG002|Overall Study|Physician Decision|0|||
131865980|NCT03194542|474787332|FG003|Overall Study|Physician Decision|0|||
131865981|NCT03194542|474787329|FG000|Overall Study|Lack of Efficacy|2|||
131865982|NCT03194542|474787330|FG001|Overall Study|Lack of Efficacy|2|||
131865983|NCT03194542|474787331|FG002|Overall Study|Lack of Efficacy|2|||
131865984|NCT03194542|474787332|FG003|Overall Study|Lack of Efficacy|6|||
131865985|NCT03194542|474787329|FG000|Overall Study|Withdrawal by Subject|2|||
131865986|NCT03194542|474787330|FG001|Overall Study|Withdrawal by Subject|1|||
131916238|NCT03965923|474979859|FG011|Overall Study|Withdrawal by Subject|0|||
131916239|NCT03965923|474979848|FG000|Overall Study|Lost to Follow-up|2|||
131916240|NCT03965923|474979849|FG001|Overall Study|Lost to Follow-up|1|||
131916241|NCT03965923|474979850|FG002|Overall Study|Lost to Follow-up|1|||
131916242|NCT03965923|474979851|FG003|Overall Study|Lost to Follow-up|0|||
131916243|NCT03965923|474979852|FG004|Overall Study|Lost to Follow-up|2|||
131916244|NCT03965923|474979853|FG005|Overall Study|Lost to Follow-up|1|||
131916245|NCT03965923|474979854|FG006|Overall Study|Lost to Follow-up|2|||
131916246|NCT03965923|474979855|FG007|Overall Study|Lost to Follow-up|1|||
131916247|NCT03965923|474979856|FG008|Overall Study|Lost to Follow-up|0|||
131916248|NCT03965923|474979857|FG009|Overall Study|Lost to Follow-up|2|||
131916249|NCT03965923|474979858|FG010|Overall Study|Lost to Follow-up|0|||
131916250|NCT03965923|474979859|FG011|Overall Study|Lost to Follow-up|0|||
131916251|NCT03965923|474979848|FG000|Overall Study|Death|0|||
131916252|NCT03965923|474979849|FG001|Overall Study|Death|0|||
131916253|NCT03965923|474979850|FG002|Overall Study|Death|0|||
131916254|NCT03965923|474979851|FG003|Overall Study|Death|0|||
131916255|NCT03965923|474979852|FG004|Overall Study|Death|0|||
131916256|NCT03965923|474979853|FG005|Overall Study|Death|0|||
131916257|NCT03965923|474979854|FG006|Overall Study|Death|0|||
131916258|NCT03965923|474979855|FG007|Overall Study|Death|1|||
131916259|NCT03965923|474979856|FG008|Overall Study|Death|4|||
131916260|NCT03965923|474979857|FG009|Overall Study|Death|0|||
131916261|NCT03965923|474979858|FG010|Overall Study|Death|4|||
131916262|NCT03965923|474979859|FG011|Overall Study|Death|0|||
131916263|NCT03965923|474979848|FG000|Overall Study|Other reason|0|||
131916264|NCT03965923|474979849|FG001|Overall Study|Other reason|0|||
131916265|NCT03965923|474979850|FG002|Overall Study|Other reason|0|||
131916266|NCT03965923|474979851|FG003|Overall Study|Other reason|1|||
131916267|NCT03965923|474979852|FG004|Overall Study|Other reason|0|||
131916268|NCT03965923|474979853|FG005|Overall Study|Other reason|0|||
131916269|NCT03965923|474979854|FG006|Overall Study|Other reason|0|||
131916270|NCT03965923|474979855|FG007|Overall Study|Other reason|0|||
131916271|NCT03965923|474979856|FG008|Overall Study|Other reason|0|||
131916272|NCT03965923|474979857|FG009|Overall Study|Other reason|0|||
131916273|NCT03965923|474979858|FG010|Overall Study|Other reason|2|||
131916274|NCT03965923|474979859|FG011|Overall Study|Other reason|0|||
131916275|NCT02452190|474979860|FG000|Overall Study|Withdrawal by Sponsor|1|||
131916276|NCT02452190|474979861|FG001|Overall Study|Withdrawal by Sponsor|3|||
131916277|NCT02452190|474979860|FG000|Overall Study|Pregnancy|1|||
131916278|NCT02452190|474979861|FG001|Overall Study|Pregnancy|0|||
131916279|NCT02452190|474979860|FG000|Overall Study|Investigator's Decision|2|||
131916280|NCT02452190|474979861|FG001|Overall Study|Investigator's Decision|0|||
131916281|NCT02452190|474979860|FG000|Overall Study|Lack of Efficacy|3|||
131916282|NCT02452190|474979861|FG001|Overall Study|Lack of Efficacy|1|||
131916283|NCT02452190|474979860|FG000|Overall Study|Lost to Follow-up|4|||
131916284|NCT02452190|474979861|FG001|Overall Study|Lost to Follow-up|3|||
131916285|NCT02452190|474979860|FG000|Overall Study|Adverse Event|2|||
131916286|NCT02452190|474979861|FG001|Overall Study|Adverse Event|5|||
131916287|NCT02452190|474979860|FG000|Overall Study|Withdrawal by Subject|20|||
131916288|NCT02452190|474979861|FG001|Overall Study|Withdrawal by Subject|11|||
131916289|NCT02452190|474979860|FG000|Overall Study|Noncompliance with study drug|1|||
131916290|NCT02452190|474979861|FG001|Overall Study|Noncompliance with study drug|0|||
131916291|NCT02452190|474979860|FG000|Overall Study|Participant traveled abroad|1|||
131916292|NCT02452190|474979861|FG001|Overall Study|Participant traveled abroad|0|||
131916293|NCT02452190|474979860|FG000|Overall Study|Death|0|||
131916294|NCT02452190|474979861|FG001|Overall Study|Death|1|||
131916295|NCT01044498|474979862|FG000|Overall Study|Withdrew consent|1|||
131916296|NCT01044498|474979863|FG001|Overall Study|Withdrew consent|1|||
131916297|NCT01044498|474979862|FG000|Overall Study|Adverse Event|1|||
131916298|NCT01044498|474979863|FG001|Overall Study|Adverse Event|1|||
131916299|NCT01044498|474979862|FG000|Overall Study|Other|1|||
131916300|NCT01044498|474979863|FG001|Overall Study|Other|0|||
131916301|NCT02327078|474979868|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
131916302|NCT02327078|474979869|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
131916303|NCT02327078|474979870|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
131916304|NCT02327078|474979871|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
131916305|NCT02327078|474979872|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
131916306|NCT02327078|474979873|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
131916307|NCT02327078|474979874|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
131916308|NCT02327078|474979875|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
131916309|NCT02327078|474979876|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
131916310|NCT02327078|474979868|FG000|Overall Study|Death|2|||
131916311|NCT02327078|474979869|FG001|Overall Study|Death|4|||
131916312|NCT02327078|474979870|FG002|Overall Study|Death|10|||
131916313|NCT02327078|474979871|FG003|Overall Study|Death|6|||
131916314|NCT02327078|474979872|FG004|Overall Study|Death|4|||
131916315|NCT02327078|474979873|FG005|Overall Study|Death|3|||
131865987|NCT03194542|474787331|FG002|Overall Study|Withdrawal by Subject|5|||
131865988|NCT03194542|474787332|FG003|Overall Study|Withdrawal by Subject|4|||
131865989|NCT03194542|474787329|FG000|Overall Study|Progressive Disease|1|||
131865990|NCT03194542|474787330|FG001|Overall Study|Progressive Disease|0|||
131865991|NCT03194542|474787331|FG002|Overall Study|Progressive Disease|1|||
131865992|NCT03194542|474787332|FG003|Overall Study|Progressive Disease|1|||
131865993|NCT03194542|474787329|FG000|Overall Study|Adverse Event|1|||
131865994|NCT03194542|474787330|FG001|Overall Study|Adverse Event|2|||
131865995|NCT03194542|474787331|FG002|Overall Study|Adverse Event|0|||
131865996|NCT03194542|474787332|FG003|Overall Study|Adverse Event|5|||
131865997|NCT03194542|474787329|FG000|Overall Study|Death|1|||
131865998|NCT03194542|474787330|FG001|Overall Study|Death|2|||
131865999|NCT03194542|474787331|FG002|Overall Study|Death|0|||
131866000|NCT03194542|474787332|FG003|Overall Study|Death|5|||
131866001|NCT03194542|474787329|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
131866002|NCT03194542|474787330|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
131866003|NCT03194542|474787331|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
131866004|NCT03194542|474787332|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
131866005|NCT04762160|474787333|FG000|Overall Study|Study terminated early due to business reasons|5|||
131866006|NCT03655405|474787335|FG000|Overall Study|Death after initial data collection|4|||
131866007|NCT03655405|474787336|FG001|Overall Study|Death after initial data collection|2|||
131866008|NCT03655405|474787335|FG000|Overall Study|Died before initial data collection|1|||
131866009|NCT03655405|474787336|FG001|Overall Study|Died before initial data collection|2|||
131866010|NCT03655405|474787335|FG000|Overall Study|Protocol Violation|0|||
131866011|NCT03655405|474787336|FG001|Overall Study|Protocol Violation|1|||
131866012|NCT01991743|474787339|FG000|Overall Study|external cephalic version not performed|0|||
131866013|NCT01991743|474787340|FG001|Overall Study|external cephalic version not performed|0|||
131866014|NCT01991743|474787341|FG002|Overall Study|external cephalic version not performed|1|||
131866015|NCT01991743|474787342|FG003|Overall Study|external cephalic version not performed|0|||
131866016|NCT01445730|474787343|FG000|Overall Study|Adverse Event|1|||
131866017|NCT01445730|474787343|FG000|Overall Study|For the advice of a dentist|1|||
131866018|NCT01445730|474787343|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
131866019|NCT01167140|474787346|FG000|Overall Study|Withdrawal by Subject|1|||
131866020|NCT01611883|474787347|FG000|Overall Study|Adverse Event|1|||
131866021|NCT01611883|474787348|FG001|Overall Study|Adverse Event|1|||
131866022|NCT00030901|474787351|FG000|Initial Registration|Ineligible|167|||
131866023|NCT00030901|474787352|FG001|Initial Registration|Ineligible|0|||
131866024|NCT00030901|474787353|FG002|Initial Registration|Ineligible|0|||
131866025|NCT00030901|474787351|FG000|Randomization|Adverse Event|0|||
131866026|NCT00030901|474787352|FG001|Randomization|Adverse Event|11|||
131866027|NCT00030901|474787353|FG002|Randomization|Adverse Event|7|||
131866028|NCT00030901|474787351|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
131866029|NCT00030901|474787352|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
131866030|NCT00030901|474787353|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
131866031|NCT00030901|474787351|FG000|Randomization|Progression/Relapse|0|||
131866032|NCT00030901|474787352|FG001|Randomization|Progression/Relapse|22|||
131866033|NCT00030901|474787353|FG002|Randomization|Progression/Relapse|21|||
131866034|NCT00030901|474787351|FG000|Randomization|Death|0|||
131866035|NCT00030901|474787352|FG001|Randomization|Death|1|||
131866036|NCT00030901|474787353|FG002|Randomization|Death|3|||
131866037|NCT00030901|474787351|FG000|Randomization|Other|0|||
131866038|NCT00030901|474787352|FG001|Randomization|Other|36|||
131866039|NCT00030901|474787353|FG002|Randomization|Other|33|||
131866040|NCT00030901|474787351|FG000|Randomization|Ineligible|0|||
131866041|NCT00030901|474787352|FG001|Randomization|Ineligible|15|||
131866042|NCT00030901|474787353|FG002|Randomization|Ineligible|14|||
131866043|NCT00571727|474787356|FG000|Overall Study|Did not enter in this study|1|||
131866044|NCT00571727|474787356|FG000|Overall Study|Non-compliance|4|||
131866045|NCT00571727|474787356|FG000|Overall Study|Lost to Follow-up|30|||
131866046|NCT00571727|474787356|FG000|Overall Study|Poor growth|1|||
131866047|NCT00571727|474787356|FG000|Overall Study|Parent/patient decision|2|||
131866048|NCT00571727|474787356|FG000|Overall Study|Participant transferred to commercial drug|14|||
131866049|NCT00571727|474787356|FG000|Overall Study|Unable to provide study drug|6|||
131866050|NCT00571727|474787356|FG000|Overall Study|On-treatment at end of study|8|||
131866051|NCT01622673|474787357|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131866052|NCT01622673|474787358|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131866053|NCT01622673|474787359|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131866054|NCT01622673|474787360|FG003|Treatment Period 1|Withdrawal by Subject|1|||
131866055|NCT01622673|474787361|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131866056|NCT01622673|474787362|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131866057|NCT01622673|474787357|FG000|Treatment Period 1|Protocol Violation|0|||
131866058|NCT01622673|474787358|FG001|Treatment Period 1|Protocol Violation|1|||
131866059|NCT01622673|474787359|FG002|Treatment Period 1|Protocol Violation|0|||
131916316|NCT02327078|474979874|FG006|Overall Study|Death|2|||
131916317|NCT02327078|474979875|FG007|Overall Study|Death|51|||
131916318|NCT02327078|474979876|FG008|Overall Study|Death|97|||
131916319|NCT02327078|474979868|FG000|Overall Study|Lost to Follow-up|0|||
131916320|NCT02327078|474979869|FG001|Overall Study|Lost to Follow-up|1|||
131916321|NCT02327078|474979870|FG002|Overall Study|Lost to Follow-up|1|||
131916322|NCT02327078|474979871|FG003|Overall Study|Lost to Follow-up|0|||
131916323|NCT02327078|474979872|FG004|Overall Study|Lost to Follow-up|0|||
131916324|NCT02327078|474979873|FG005|Overall Study|Lost to Follow-up|0|||
131916325|NCT02327078|474979874|FG006|Overall Study|Lost to Follow-up|0|||
131916326|NCT02327078|474979875|FG007|Overall Study|Lost to Follow-up|2|||
131916327|NCT02327078|474979876|FG008|Overall Study|Lost to Follow-up|5|||
131916328|NCT02327078|474979868|FG000|Overall Study|Site Terminated by Sponsor|1|||
131916329|NCT02327078|474979869|FG001|Overall Study|Site Terminated by Sponsor|0|||
131916330|NCT02327078|474979870|FG002|Overall Study|Site Terminated by Sponsor|1|||
131916331|NCT02327078|474979871|FG003|Overall Study|Site Terminated by Sponsor|4|||
131916332|NCT02327078|474979872|FG004|Overall Study|Site Terminated by Sponsor|0|||
131916333|NCT02327078|474979873|FG005|Overall Study|Site Terminated by Sponsor|0|||
131916334|NCT02327078|474979874|FG006|Overall Study|Site Terminated by Sponsor|0|||
131916335|NCT02327078|474979875|FG007|Overall Study|Site Terminated by Sponsor|11|||
131916336|NCT02327078|474979876|FG008|Overall Study|Site Terminated by Sponsor|25|||
131916337|NCT02327078|474979868|FG000|Overall Study|Physician Decision|0|||
131916338|NCT02327078|474979869|FG001|Overall Study|Physician Decision|0|||
131916339|NCT02327078|474979870|FG002|Overall Study|Physician Decision|0|||
131916340|NCT02327078|474979871|FG003|Overall Study|Physician Decision|1|||
131916341|NCT02327078|474979872|FG004|Overall Study|Physician Decision|0|||
131916342|NCT02327078|474979873|FG005|Overall Study|Physician Decision|0|||
131916343|NCT02327078|474979874|FG006|Overall Study|Physician Decision|0|||
131916344|NCT02327078|474979875|FG007|Overall Study|Physician Decision|0|||
131916345|NCT02327078|474979876|FG008|Overall Study|Physician Decision|1|||
131916346|NCT02327078|474979868|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
131916347|NCT02327078|474979869|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
131916348|NCT02327078|474979870|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
131916349|NCT02327078|474979871|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
131916350|NCT02327078|474979872|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
131916351|NCT02327078|474979873|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
131916352|NCT02327078|474979874|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
131916353|NCT02327078|474979875|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
131916354|NCT02327078|474979876|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
131916355|NCT02327078|474979868|FG000|Overall Study|Reason not Specified|0|||
131916356|NCT02327078|474979869|FG001|Overall Study|Reason not Specified|0|||
131916357|NCT02327078|474979870|FG002|Overall Study|Reason not Specified|0|||
131916358|NCT02327078|474979871|FG003|Overall Study|Reason not Specified|0|||
131916359|NCT02327078|474979872|FG004|Overall Study|Reason not Specified|0|||
131916360|NCT02327078|474979873|FG005|Overall Study|Reason not Specified|0|||
131916361|NCT02327078|474979874|FG006|Overall Study|Reason not Specified|0|||
131916362|NCT02327078|474979875|FG007|Overall Study|Reason not Specified|5|||
131916363|NCT02327078|474979876|FG008|Overall Study|Reason not Specified|12|||
131916364|NCT05513950|474979877|FG000|Overall Study|Not treated due to technical reasons|0|||
131916365|NCT05513950|474979878|FG001|Overall Study|Not treated due to technical reasons|0|||
131916366|NCT05513950|474979879|FG002|Overall Study|Not treated due to technical reasons|1|||
131916367|NCT05513950|474979880|FG003|Overall Study|Not treated due to technical reasons|0|||
131916368|NCT06001866|474979881|FG000|Overall Study|Withdrawal by Subject|0|||
131916369|NCT06001866|474979882|FG001|Overall Study|Withdrawal by Subject|2|||
131916370|NCT06001866|474979881|FG000|Overall Study|Protocol Violation|0|||
131916371|NCT06001866|474979882|FG001|Overall Study|Protocol Violation|2|||
131916372|NCT02903914|474979883|FG000|Overall Study|Adverse Event|0|||
131916373|NCT02903914|474979884|FG001|Overall Study|Adverse Event|0|||
131916374|NCT02903914|474979885|FG002|Overall Study|Adverse Event|1|||
131916375|NCT02903914|474979886|FG003|Overall Study|Adverse Event|0|||
131916376|NCT02903914|474979887|FG004|Overall Study|Adverse Event|0|||
131916377|NCT02903914|474979888|FG005|Overall Study|Adverse Event|0|||
131916378|NCT02903914|474979889|FG006|Overall Study|Adverse Event|2|||
131916379|NCT02903914|474979890|FG007|Overall Study|Adverse Event|0|||
131916380|NCT02903914|474979883|FG000|Overall Study|Withdrawal by Subject|3|||
131916381|NCT02903914|474979884|FG001|Overall Study|Withdrawal by Subject|1|||
131916382|NCT02903914|474979885|FG002|Overall Study|Withdrawal by Subject|28|||
131916383|NCT02903914|474979886|FG003|Overall Study|Withdrawal by Subject|0|||
131453874|NCT01677377|473291796|FG001|Overall Study|Withdrawal by Subject|0|||
131453875|NCT01677377|473291797|FG002|Overall Study|Withdrawal by Subject|3|||
131453876|NCT01677377|473291795|FG000|Overall Study|Lack of Efficacy|0|||
131453877|NCT01677377|473291796|FG001|Overall Study|Lack of Efficacy|0|||
131453878|NCT01677377|473291797|FG002|Overall Study|Lack of Efficacy|1|||
131916384|NCT02903914|474979887|FG004|Overall Study|Withdrawal by Subject|1|||
131916385|NCT02903914|474979888|FG005|Overall Study|Withdrawal by Subject|2|||
131916386|NCT02903914|474979889|FG006|Overall Study|Withdrawal by Subject|12|||
131916387|NCT02903914|474979890|FG007|Overall Study|Withdrawal by Subject|0|||
131916388|NCT02903914|474979883|FG000|Overall Study|Progressive Disease|1|||
131866060|NCT01622673|474787360|FG003|Treatment Period 1|Protocol Violation|0|||
131866061|NCT01622673|474787361|FG004|Treatment Period 1|Protocol Violation|0|||
131866062|NCT01622673|474787362|FG005|Treatment Period 1|Protocol Violation|0|||
131866063|NCT01622673|474787357|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131866064|NCT01622673|474787358|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131866065|NCT01622673|474787359|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131866066|NCT01622673|474787360|FG003|Treatment Period 2|Withdrawal by Subject|1|||
131866067|NCT01622673|474787361|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131866068|NCT01622673|474787362|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131866069|NCT01622673|474787357|FG000|Treatment Period 3|Protocol Violation|0|||
131866070|NCT01622673|474787358|FG001|Treatment Period 3|Protocol Violation|1|||
131866071|NCT01622673|474787359|FG002|Treatment Period 3|Protocol Violation|0|||
131866072|NCT01622673|474787360|FG003|Treatment Period 3|Protocol Violation|0|||
131866073|NCT01622673|474787361|FG004|Treatment Period 3|Protocol Violation|0|||
131866074|NCT01622673|474787362|FG005|Treatment Period 3|Protocol Violation|0|||
131866075|NCT03817190|474787363|FG000|Overall Study|Early Termination|13|||
131866076|NCT03817190|474787364|FG001|Overall Study|Early Termination|20|||
131866077|NCT03817190|474787363|FG000|Overall Study|Adverse Event|10|||
131866078|NCT03817190|474787364|FG001|Overall Study|Adverse Event|17|||
131866079|NCT03817190|474787363|FG000|Overall Study|Withdrawal by Subject|12|||
131866080|NCT03817190|474787364|FG001|Overall Study|Withdrawal by Subject|8|||
131866081|NCT03817190|474787363|FG000|Overall Study|Lost to Follow-up|11|||
131866082|NCT03817190|474787364|FG001|Overall Study|Lost to Follow-up|7|||
131866083|NCT03817190|474787363|FG000|Overall Study|Lack of Efficacy|7|||
131866084|NCT03817190|474787364|FG001|Overall Study|Lack of Efficacy|5|||
131866085|NCT03817190|474787363|FG000|Overall Study|Investigator Decision|5|||
131866086|NCT03817190|474787364|FG001|Overall Study|Investigator Decision|1|||
131866087|NCT03817190|474787363|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
131866088|NCT03817190|474787364|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
131866089|NCT03817190|474787363|FG000|Overall Study|Lack of Contact|1|||
131866090|NCT03817190|474787364|FG001|Overall Study|Lack of Contact|0|||
131866091|NCT03817190|474787363|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
131866092|NCT03817190|474787364|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
131866093|NCT04146012|474787365|FG000|Overall Study|Study Terminated|30|||
131866094|NCT04146012|474787366|FG001|Overall Study|Study Terminated|15|||
131866095|NCT01546025|474787369|FG000|Overall Study|Lost to Follow-up|0|||
131866096|NCT01546025|474787370|FG001|Overall Study|Lost to Follow-up|1|||
131866097|NCT05142722|474788594|FG000|Overall Study|Lost to Follow-up|16|||
131866098|NCT05142722|474788595|FG001|Overall Study|Lost to Follow-up|38|||
131866099|NCT05142722|474788594|FG000|Overall Study|Withdrawal by Subject|20|||
131866100|NCT05142722|474788595|FG001|Overall Study|Withdrawal by Subject|27|||
131866101|NCT05142722|474788594|FG000|Overall Study|Death|11|||
131866102|NCT05142722|474788595|FG001|Overall Study|Death|17|||
131866103|NCT05142722|474788594|FG000|Overall Study|Physician Decision|0|||
131866104|NCT05142722|474788595|FG001|Overall Study|Physician Decision|1|||
131866105|NCT05142722|474788594|FG000|Overall Study|Participant Moved Away|0|||
131866106|NCT05142722|474788595|FG001|Overall Study|Participant Moved Away|2|||
131866107|NCT05142722|474788594|FG000|Overall Study|Adverse Event|2|||
131866108|NCT05142722|474788595|FG001|Overall Study|Adverse Event|1|||
131866109|NCT05731700|474788596|FG000|Overall Study|Death|1|||
131866110|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
131866111|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
131866112|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
131866113|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
131866114|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
131866115|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
131866116|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
131866117|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
131866118|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
131866119|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
131866120|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
131866121|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
131866122|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
131866123|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
131866124|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
131866125|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
131866126|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
131408138|NCT00496197|473118192|FG000|Overall Study|Insufficient clinical response|3|||
131866127|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
131866128|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
131866129|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
131866130|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
131866131|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
131866132|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
131866133|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
131866134|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
131866135|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
131866136|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
131866137|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
131866138|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
131866139|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
131866140|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
131866141|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
131866142|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866143|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866144|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
131866145|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866146|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866147|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866148|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
131866149|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866150|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
131866151|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
131866152|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
131866153|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
131866154|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
131866155|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
131866156|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
131866157|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
131866158|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
131866159|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
131866160|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
131866161|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
131866162|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
131866163|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
131866164|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
131866165|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
131866166|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866167|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
131866168|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866169|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866170|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866171|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866172|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866173|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
131866174|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866175|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866176|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866177|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866178|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
131866179|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866180|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866181|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
131866182|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866183|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866184|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866185|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866186|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866187|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
131866188|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866189|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
131866190|NCT03896503|474788597|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
131866191|NCT03896503|474788598|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
131866192|NCT03896503|474788599|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
131866193|NCT03896503|474788600|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
131866194|NCT03896503|474788601|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
131866195|NCT03896503|474788602|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
131866196|NCT03896503|474788603|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
131866197|NCT03896503|474788604|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
131866198|NCT00437021|474788623|FG000|Overall Study|Adverse Event|0|||
131866199|NCT00437021|474788624|FG001|Overall Study|Adverse Event|0|||
131866200|NCT00437021|474788625|FG002|Overall Study|Adverse Event|0|||
131866201|NCT00437021|474788626|FG003|Overall Study|Adverse Event|0|||
131866202|NCT00437021|474788627|FG004|Overall Study|Adverse Event|0|||
131866203|NCT00437021|474788628|FG005|Overall Study|Adverse Event|0|||
131866204|NCT00437021|474788629|FG006|Overall Study|Adverse Event|1|||
131866205|NCT00437021|474788630|FG007|Overall Study|Adverse Event|0|||
131866206|NCT00437021|474788631|FG008|Overall Study|Adverse Event|0|||
131866207|NCT00437021|474788632|FG009|Overall Study|Adverse Event|0|||
131866208|NCT00437021|474788633|FG010|Overall Study|Adverse Event|0|||
131866209|NCT00437021|474788634|FG011|Overall Study|Adverse Event|0|||
131866210|NCT00437021|474788623|FG000|Overall Study|Lost to Follow-up|0|||
131866211|NCT00437021|474788624|FG001|Overall Study|Lost to Follow-up|3|||
131866212|NCT00437021|474788625|FG002|Overall Study|Lost to Follow-up|0|||
131866213|NCT00437021|474788626|FG003|Overall Study|Lost to Follow-up|0|||
131866214|NCT00437021|474788627|FG004|Overall Study|Lost to Follow-up|0|||
131866215|NCT00437021|474788628|FG005|Overall Study|Lost to Follow-up|2|||
131866216|NCT00437021|474788629|FG006|Overall Study|Lost to Follow-up|0|||
131866217|NCT00437021|474788630|FG007|Overall Study|Lost to Follow-up|1|||
131866218|NCT00437021|474788631|FG008|Overall Study|Lost to Follow-up|0|||
131866219|NCT00437021|474788632|FG009|Overall Study|Lost to Follow-up|0|||
131866220|NCT00437021|474788633|FG010|Overall Study|Lost to Follow-up|0|||
131866221|NCT00437021|474788634|FG011|Overall Study|Lost to Follow-up|0|||
131866222|NCT00437021|474788623|FG000|Overall Study|Withdrawal by Subject|2|||
131866223|NCT00437021|474788624|FG001|Overall Study|Withdrawal by Subject|1|||
131866224|NCT00437021|474788625|FG002|Overall Study|Withdrawal by Subject|0|||
131866225|NCT00437021|474788626|FG003|Overall Study|Withdrawal by Subject|0|||
131866226|NCT00437021|474788627|FG004|Overall Study|Withdrawal by Subject|0|||
131866227|NCT00437021|474788628|FG005|Overall Study|Withdrawal by Subject|0|||
131866228|NCT00437021|474788629|FG006|Overall Study|Withdrawal by Subject|0|||
131866229|NCT00437021|474788630|FG007|Overall Study|Withdrawal by Subject|0|||
131866230|NCT00437021|474788631|FG008|Overall Study|Withdrawal by Subject|0|||
131866231|NCT00437021|474788632|FG009|Overall Study|Withdrawal by Subject|0|||
131866232|NCT00437021|474788633|FG010|Overall Study|Withdrawal by Subject|0|||
131866233|NCT00437021|474788634|FG011|Overall Study|Withdrawal by Subject|0|||
131866234|NCT05734157|474788635|FG000|Overall Study|Death|3|||
131866235|NCT05734157|474788635|FG000|Overall Study|Withdrawal by Subject|2|||
131866236|NCT05734157|474788635|FG000|Overall Study|Lost to Follow-up|1|||
131866237|NCT05734157|474788635|FG000|Overall Study|Telephone call|3|||
131866238|NCT00536939|474788640|FG000|Overall Study|Withdrawal by Subject|1|||
131866239|NCT00536939|474788641|FG001|Overall Study|Withdrawal by Subject|0|||
131866240|NCT00536939|474788640|FG000|Overall Study|Other Complicating Disease|1|||
131866241|NCT00536939|474788641|FG001|Overall Study|Other Complicating Disease|0|||
131866242|NCT00729612|474788642|FG000|Overall Study|Non evaluable for response|10|||
131866243|NCT05266053|474788649|FG000|Overall Study|Withdrawal by Subject|8|||
131866244|NCT05266053|474788650|FG001|Overall Study|Withdrawal by Subject|4|||
131866245|NCT05344560|474788651|FG000|Period 1|Subject out of visit window|1|||
131866246|NCT05344560|474788652|FG001|Period 1|Subject out of visit window|1|||
131866247|NCT05344560|474788651|FG000|Period 2|Covid-19 Related|1|||
131866248|NCT05344560|474788652|FG001|Period 2|Covid-19 Related|0|||
131866249|NCT05344560|474788651|FG000|Period 2|Adverse Event|1|||
131866250|NCT05344560|474788652|FG001|Period 2|Adverse Event|0|||
131866251|NCT05344560|474788651|FG000|Period 2|Subject out of visit window|1|||
131866252|NCT05344560|474788652|FG001|Period 2|Subject out of visit window|1|||
131453879|NCT01677377|473291795|FG000|Overall Study|Pregnancy|0|||
131866253|NCT05344560|474788651|FG000|Period 3|Subject out of visit window|1|||
131866254|NCT05344560|474788652|FG001|Period 3|Subject out of visit window|0|||
131866255|NCT02996968|474788653|FG000|Overall Study|Withdrawal by Subject|1|||
131866256|NCT02996968|474788654|FG001|Overall Study|Withdrawal by Subject|0|||
131866257|NCT01620138|474788657|FG000|Overall Study|Withdrawal by Subject|3|||
131866258|NCT01620138|474788658|FG001|Overall Study|Withdrawal by Subject|0|||
131453880|NCT01677377|473291796|FG001|Overall Study|Pregnancy|0|||
131453881|NCT01677377|473291797|FG002|Overall Study|Pregnancy|1|||
131866259|NCT01620138|474788657|FG000|Overall Study|Lack of Efficacy|1|||
131866260|NCT01620138|474788658|FG001|Overall Study|Lack of Efficacy|0|||
131866261|NCT01620138|474788657|FG000|Overall Study|Adverse Event|2|||
131866262|NCT01620138|474788658|FG001|Overall Study|Adverse Event|0|||
131866263|NCT00449865|474788661|FG000|Overall Study|Withdrawal by Subject|110|||
131866264|NCT00449865|474788662|FG001|Overall Study|Withdrawal by Subject|110|||
131866265|NCT00449865|474788661|FG000|Overall Study|Lost to Follow-up|36|||
131866266|NCT00449865|474788662|FG001|Overall Study|Lost to Follow-up|37|||
131866267|NCT00449865|474788661|FG000|Overall Study|Physician Decision|13|||
131866268|NCT00449865|474788662|FG001|Overall Study|Physician Decision|12|||
131866269|NCT00449865|474788661|FG000|Overall Study|Death|31|||
131866270|NCT00449865|474788662|FG001|Overall Study|Death|40|||
131866271|NCT00449865|474788661|FG000|Overall Study|Protocol Violation|8|||
131866272|NCT00449865|474788662|FG001|Overall Study|Protocol Violation|7|||
131866273|NCT00449865|474788661|FG000|Overall Study|Study was stopped|324|||
131866274|NCT00449865|474788662|FG001|Overall Study|Study was stopped|328|||
131866275|NCT00444535|474788663|FG000|Overall Study|Withdrawal by Subject|5|||
131866276|NCT00444535|474788663|FG000|Overall Study|Physician Decision|5|||
131866277|NCT00444535|474788663|FG000|Overall Study|progressive disease|1|||
131866278|NCT00444535|474788663|FG000|Overall Study|Adverse Event|2|||
131866279|NCT05005507|474788665|FG000|Overall Study|Premature termination of study|1|||
131866280|NCT02556775|474788666|FG000|Overall Study|Withdrawal by Subject|1|||
131866281|NCT02556775|474788667|FG001|Overall Study|Withdrawal by Subject|0|||
131866282|NCT02556775|474788668|FG002|Overall Study|Withdrawal by Subject|1|||
131866283|NCT02556775|474788669|FG003|Overall Study|Withdrawal by Subject|0|||
131866284|NCT02556775|474788666|FG000|Overall Study|Lost to Follow-up|1|||
131866285|NCT02556775|474788667|FG001|Overall Study|Lost to Follow-up|0|||
131866286|NCT02556775|474788668|FG002|Overall Study|Lost to Follow-up|0|||
131866287|NCT02556775|474788669|FG003|Overall Study|Lost to Follow-up|0|||
131866288|NCT02025725|474788673|FG000|Overall Study|Adverse Event|5|||
131866289|NCT02025725|474788674|FG001|Overall Study|Adverse Event|0|||
131866290|NCT02025725|474788673|FG000|Overall Study|Lost to Follow-up|2|||
131866291|NCT02025725|474788674|FG001|Overall Study|Lost to Follow-up|0|||
131866292|NCT02025725|474788673|FG000|Overall Study|Protocol Violation|1|||
131866293|NCT02025725|474788674|FG001|Overall Study|Protocol Violation|1|||
131866294|NCT02025725|474788673|FG000|Overall Study|Withdrawal by Subject|3|||
131866295|NCT02025725|474788674|FG001|Overall Study|Withdrawal by Subject|2|||
131866296|NCT02025725|474788673|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
131866297|NCT02025725|474788674|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
131866298|NCT02867592|474788675|FG000|Overall Study|Adverse Event|3|||
131866299|NCT02867592|474788676|FG001|Overall Study|Adverse Event|0|||
131866300|NCT02867592|474788677|FG002|Overall Study|Adverse Event|2|||
131866301|NCT02867592|474788678|FG003|Overall Study|Adverse Event|1|||
131866302|NCT02867592|474788679|FG004|Overall Study|Adverse Event|1|||
131866303|NCT02867592|474788680|FG005|Overall Study|Adverse Event|5|||
131866304|NCT02867592|474788675|FG000|Overall Study|Death|0|||
131866305|NCT02867592|474788676|FG001|Overall Study|Death|0|||
131866306|NCT02867592|474788677|FG002|Overall Study|Death|0|||
131866307|NCT02867592|474788678|FG003|Overall Study|Death|1|||
131866308|NCT02867592|474788679|FG004|Overall Study|Death|0|||
131866309|NCT02867592|474788680|FG005|Overall Study|Death|1|||
131866310|NCT02867592|474788675|FG000|Overall Study|Lack of Efficacy|8|||
131866311|NCT02867592|474788676|FG001|Overall Study|Lack of Efficacy|10|||
131866312|NCT02867592|474788677|FG002|Overall Study|Lack of Efficacy|8|||
131866313|NCT02867592|474788678|FG003|Overall Study|Lack of Efficacy|8|||
131866314|NCT02867592|474788679|FG004|Overall Study|Lack of Efficacy|12|||
131866315|NCT02867592|474788680|FG005|Overall Study|Lack of Efficacy|17|||
131866316|NCT02867592|474788675|FG000|Overall Study|Physician Decision|1|||
131866317|NCT02867592|474788676|FG001|Overall Study|Physician Decision|2|||
131866318|NCT02867592|474788677|FG002|Overall Study|Physician Decision|2|||
131453882|NCT02656693|473291811|FG000|Overall Study|Pregnancy|1|||
131866319|NCT02867592|474788678|FG003|Overall Study|Physician Decision|0|||
131866320|NCT02867592|474788679|FG004|Overall Study|Physician Decision|5|||
131866321|NCT02867592|474788680|FG005|Overall Study|Physician Decision|1|||
131866322|NCT02867592|474788675|FG000|Overall Study|Protocol Violation|0|||
131866323|NCT02867592|474788676|FG001|Overall Study|Protocol Violation|0|||
131866324|NCT02867592|474788677|FG002|Overall Study|Protocol Violation|0|||
131866325|NCT02867592|474788678|FG003|Overall Study|Protocol Violation|0|||
131866326|NCT02867592|474788679|FG004|Overall Study|Protocol Violation|1|||
131866327|NCT02867592|474788680|FG005|Overall Study|Protocol Violation|1|||
131866328|NCT02867592|474788675|FG000|Overall Study|Withdrawal by Subject|0|||
131866329|NCT02867592|474788676|FG001|Overall Study|Withdrawal by Subject|1|||
131866330|NCT02867592|474788677|FG002|Overall Study|Withdrawal by Subject|0|||
131866331|NCT02867592|474788678|FG003|Overall Study|Withdrawal by Subject|1|||
131866332|NCT02867592|474788679|FG004|Overall Study|Withdrawal by Subject|3|||
131866333|NCT02867592|474788680|FG005|Overall Study|Withdrawal by Subject|3|||
131866334|NCT02867592|474788675|FG000|Overall Study|Ineligible|1|||
131866335|NCT02867592|474788676|FG001|Overall Study|Ineligible|1|||
131866336|NCT02867592|474788677|FG002|Overall Study|Ineligible|0|||
131866337|NCT02867592|474788678|FG003|Overall Study|Ineligible|0|||
131453883|NCT02656693|473291812|FG001|Overall Study|Pregnancy|1|||
131916389|NCT02903914|474979884|FG001|Overall Study|Progressive Disease|0|||
131916390|NCT02903914|474979885|FG002|Overall Study|Progressive Disease|4|||
131916391|NCT02903914|474979886|FG003|Overall Study|Progressive Disease|0|||
131916392|NCT02903914|474979887|FG004|Overall Study|Progressive Disease|0|||
131916393|NCT02903914|474979888|FG005|Overall Study|Progressive Disease|0|||
131916394|NCT02903914|474979889|FG006|Overall Study|Progressive Disease|2|||
131916395|NCT02903914|474979890|FG007|Overall Study|Progressive Disease|0|||
131916396|NCT02903914|474979883|FG000|Overall Study|Death|0|||
131916397|NCT02903914|474979884|FG001|Overall Study|Death|0|||
131916398|NCT02903914|474979885|FG002|Overall Study|Death|9|||
131916399|NCT02903914|474979886|FG003|Overall Study|Death|0|||
131916400|NCT02903914|474979887|FG004|Overall Study|Death|1|||
131916401|NCT02903914|474979888|FG005|Overall Study|Death|3|||
131916402|NCT02903914|474979889|FG006|Overall Study|Death|24|||
131916403|NCT02903914|474979890|FG007|Overall Study|Death|2|||
131916404|NCT02903914|474979883|FG000|Overall Study|Lost to Follow-up|0|||
131916405|NCT02903914|474979884|FG001|Overall Study|Lost to Follow-up|1|||
131916406|NCT02903914|474979885|FG002|Overall Study|Lost to Follow-up|0|||
131916407|NCT02903914|474979886|FG003|Overall Study|Lost to Follow-up|0|||
131916408|NCT02903914|474979887|FG004|Overall Study|Lost to Follow-up|2|||
131916409|NCT02903914|474979888|FG005|Overall Study|Lost to Follow-up|0|||
131916410|NCT02903914|474979889|FG006|Overall Study|Lost to Follow-up|1|||
131916411|NCT02903914|474979890|FG007|Overall Study|Lost to Follow-up|0|||
131916412|NCT02903914|474979883|FG000|Overall Study|Physician Decision|0|||
131916413|NCT02903914|474979884|FG001|Overall Study|Physician Decision|0|||
131916414|NCT02903914|474979885|FG002|Overall Study|Physician Decision|1|||
131916415|NCT02903914|474979886|FG003|Overall Study|Physician Decision|0|||
131916416|NCT02903914|474979887|FG004|Overall Study|Physician Decision|0|||
131916417|NCT02903914|474979888|FG005|Overall Study|Physician Decision|0|||
131916418|NCT02903914|474979889|FG006|Overall Study|Physician Decision|1|||
131916419|NCT02903914|474979890|FG007|Overall Study|Physician Decision|0|||
131916420|NCT02903914|474979883|FG000|Overall Study|Symptomatic Deterioration|0|||
131916421|NCT02903914|474979884|FG001|Overall Study|Symptomatic Deterioration|0|||
131916422|NCT02903914|474979885|FG002|Overall Study|Symptomatic Deterioration|1|||
131916423|NCT02903914|474979886|FG003|Overall Study|Symptomatic Deterioration|0|||
131916424|NCT02903914|474979887|FG004|Overall Study|Symptomatic Deterioration|0|||
131916425|NCT02903914|474979888|FG005|Overall Study|Symptomatic Deterioration|0|||
131916426|NCT02903914|474979889|FG006|Overall Study|Symptomatic Deterioration|0|||
131916427|NCT02903914|474979890|FG007|Overall Study|Symptomatic Deterioration|0|||
131916428|NCT02903914|474979883|FG000|Overall Study|New Cancer Therapy|2|||
131916429|NCT02903914|474979884|FG001|Overall Study|New Cancer Therapy|2|||
131916430|NCT02903914|474979885|FG002|Overall Study|New Cancer Therapy|21|||
131916431|NCT02903914|474979886|FG003|Overall Study|New Cancer Therapy|4|||
131916432|NCT02903914|474979887|FG004|Overall Study|New Cancer Therapy|3|||
131916433|NCT02903914|474979888|FG005|Overall Study|New Cancer Therapy|6|||
131916434|NCT02903914|474979889|FG006|Overall Study|New Cancer Therapy|56|||
131916435|NCT02903914|474979890|FG007|Overall Study|New Cancer Therapy|3|||
131916436|NCT02903914|474979883|FG000|Overall Study|Didn't Return to Site|1|||
131916437|NCT02903914|474979884|FG001|Overall Study|Didn't Return to Site|0|||
131916438|NCT02903914|474979885|FG002|Overall Study|Didn't Return to Site|1|||
131916439|NCT02903914|474979886|FG003|Overall Study|Didn't Return to Site|1|||
131916440|NCT02903914|474979887|FG004|Overall Study|Didn't Return to Site|0|||
131916441|NCT02903914|474979888|FG005|Overall Study|Didn't Return to Site|0|||
131916442|NCT02903914|474979889|FG006|Overall Study|Didn't Return to Site|2|||
131916443|NCT02903914|474979890|FG007|Overall Study|Didn't Return to Site|0|||
131916444|NCT02903914|474979883|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
131916445|NCT02903914|474979884|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
131916446|NCT02903914|474979885|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
131916447|NCT02903914|474979886|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
131916448|NCT02903914|474979887|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
131916449|NCT02903914|474979888|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
131916450|NCT02903914|474979889|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
131916451|NCT02903914|474979890|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
131916452|NCT02903914|474979883|FG000|Overall Study|Follow-up Did Not Occur|0|||
131916453|NCT02903914|474979884|FG001|Overall Study|Follow-up Did Not Occur|1|||
131916454|NCT02903914|474979885|FG002|Overall Study|Follow-up Did Not Occur|1|||
131916455|NCT02903914|474979886|FG003|Overall Study|Follow-up Did Not Occur|0|||
131916456|NCT02903914|474979887|FG004|Overall Study|Follow-up Did Not Occur|2|||
131916457|NCT02903914|474979888|FG005|Overall Study|Follow-up Did Not Occur|0|||
131916458|NCT02903914|474979889|FG006|Overall Study|Follow-up Did Not Occur|8|||
131916459|NCT02903914|474979890|FG007|Overall Study|Follow-up Did Not Occur|0|||
131916460|NCT02903914|474979883|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
131916461|NCT02903914|474979884|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
131916462|NCT02903914|474979885|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
131916463|NCT02903914|474979886|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
131916464|NCT02903914|474979887|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
131916465|NCT02903914|474979888|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
131866338|NCT02867592|474788679|FG004|Overall Study|Ineligible|2|||
131866339|NCT02867592|474788680|FG005|Overall Study|Ineligible|0|||
131866340|NCT02867592|474788675|FG000|Overall Study|No Treatment|1|||
131866341|NCT02867592|474788676|FG001|Overall Study|No Treatment|0|||
131866342|NCT02867592|474788677|FG002|Overall Study|No Treatment|0|||
131866343|NCT02867592|474788678|FG003|Overall Study|No Treatment|0|||
131866344|NCT02867592|474788679|FG004|Overall Study|No Treatment|0|||
131866345|NCT02867592|474788680|FG005|Overall Study|No Treatment|0|||
131866346|NCT02867592|474788675|FG000|Overall Study|Still on Therapy|0|||
131866347|NCT02867592|474788676|FG001|Overall Study|Still on Therapy|0|||
131866348|NCT02867592|474788677|FG002|Overall Study|Still on Therapy|0|||
131866349|NCT02867592|474788678|FG003|Overall Study|Still on Therapy|0|||
131866350|NCT02867592|474788679|FG004|Overall Study|Still on Therapy|1|||
131866351|NCT02867592|474788680|FG005|Overall Study|Still on Therapy|0|||
131866352|NCT02867592|474788675|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
131866353|NCT02867592|474788676|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
131866354|NCT02867592|474788677|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
131866355|NCT02867592|474788678|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
131866356|NCT02867592|474788679|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
131866357|NCT02867592|474788680|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
131866358|NCT02867592|474788675|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
131866359|NCT02867592|474788676|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
131866360|NCT02867592|474788677|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
131866361|NCT02867592|474788678|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
131866362|NCT02867592|474788679|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
131866363|NCT02867592|474788680|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
131866364|NCT00594165|474788681|FG000|Overall Study|Major protocol violation|1|||
131866365|NCT00594165|474788681|FG000|Overall Study|Lack of Efficacy|12|||
131866366|NCT00594165|474788681|FG000|Overall Study|Adverse Event|52|||
131866367|NCT00594165|474788681|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
131866368|NCT00594165|474788681|FG000|Overall Study|Subject withdrew consent|27|||
131866369|NCT00594165|474788681|FG000|Overall Study|Study ended per sponsor|102|||
131866370|NCT00594165|474788681|FG000|Overall Study|Lost to Follow-up|4|||
131866371|NCT00594165|474788681|FG000|Overall Study|Other: PI discretion|5|||
131866372|NCT00594165|474788681|FG000|Overall Study|Other: Subject moving|3|||
131866373|NCT00594165|474788681|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
131866374|NCT00594165|474788681|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
131866375|NCT00594165|474788681|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
131866376|NCT00594165|474788681|FG000|Overall Study|Other: Site terminated participation|2|||
131866377|NCT02269098|474788686|FG000|Overall Study|Lost to Follow-up|14|||
131866378|NCT02269098|474788687|FG001|Overall Study|Lost to Follow-up|9|||
131866379|NCT04390113|474788696|FG000|Overall Study|Not Treated|0|||
131866380|NCT04390113|474788697|FG001|Overall Study|Not Treated|1|||
131866381|NCT04390113|474788696|FG000|Overall Study|Adverse Event|1|||
131866382|NCT04390113|474788697|FG001|Overall Study|Adverse Event|0|||
131866383|NCT04390113|474788696|FG000|Overall Study|Death|2|||
131866384|NCT04390113|474788697|FG001|Overall Study|Death|1|||
131866385|NCT04390113|474788696|FG000|Overall Study|Physician Decision|1|||
131866386|NCT04390113|474788697|FG001|Overall Study|Physician Decision|3|||
131866387|NCT04390113|474788696|FG000|Overall Study|Study Terminated by Sponsor|5|||
131866388|NCT04390113|474788697|FG001|Overall Study|Study Terminated by Sponsor|3|||
131866389|NCT04390113|474788696|FG000|Overall Study|Withdrawal by Subject|10|||
131866390|NCT04390113|474788697|FG001|Overall Study|Withdrawal by Subject|5|||
131866391|NCT04390113|474788696|FG000|Overall Study|Other|1|||
131866392|NCT04390113|474788697|FG001|Overall Study|Other|0|||
131866393|NCT04390113|474788696|FG000|Overall Study|Missing|0|||
131866394|NCT04390113|474788697|FG001|Overall Study|Missing|1|||
131866395|NCT01806051|474788698|FG000|Overall Study|Withdrawal by Subject|6|||
131866396|NCT02576847|474788699|FG000|Overall Study|Adverse Event|27|||
131866397|NCT02576847|474788699|FG000|Overall Study|Lost to Follow-up|22|||
131866398|NCT02576847|474788699|FG000|Overall Study|Physician Decision|1|||
131866399|NCT02576847|474788699|FG000|Overall Study|Pregnancy|1|||
131866400|NCT02576847|474788699|FG000|Overall Study|Protocol Violation|3|||
131866401|NCT02576847|474788699|FG000|Overall Study|Withdrawal by Subject|78|||
131866402|NCT02576847|474788699|FG000|Overall Study|Other|5|||
131866403|NCT01205776|474788700|FG000|Overall Study|Lost to Follow-up|53|||
131866404|NCT01205776|474788701|FG001|Overall Study|Lost to Follow-up|61|||
131866405|NCT01205776|474788700|FG000|Overall Study|Withdrawal by Subject|11|||
131866406|NCT01205776|474788701|FG001|Overall Study|Withdrawal by Subject|34|||
131866407|NCT03581292|474788703|FG000|Overall Study|Physician Decision|9|||
131866408|NCT03581292|474788704|FG001|Overall Study|Physician Decision|5|||
131866409|NCT03581292|474788703|FG000|Overall Study|Withdrawal by Subject|3|||
131866410|NCT03581292|474788704|FG001|Overall Study|Withdrawal by Subject|0|||
131866411|NCT03581292|474788703|FG000|Overall Study|Withdrawal before Therapy Start|1|||
131866412|NCT03581292|474788704|FG001|Overall Study|Withdrawal before Therapy Start|0|||
131866413|NCT05468164|474790277|FG000|Treatment Period 4|Adverse Event|0|||
131866414|NCT05468164|474790278|FG001|Treatment Period 4|Adverse Event|0|||
131866415|NCT05468164|474790279|FG002|Treatment Period 4|Adverse Event|0|||
131866416|NCT05468164|474790280|FG003|Treatment Period 4|Adverse Event|1|||
131866417|NCT05573464|474790281|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
131866418|NCT05573464|474790282|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
131866419|NCT05573464|474790281|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
131866420|NCT05573464|474790282|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
131866421|NCT05573464|474790281|FG000|12-week Treatment Period|Protocol Violation|3|||
131866422|NCT05573464|474790282|FG001|12-week Treatment Period|Protocol Violation|1|||
131866423|NCT05573464|474790281|FG000|12-week Treatment Period|Physician Decision|1|||
131866424|NCT05573464|474790282|FG001|12-week Treatment Period|Physician Decision|2|||
131866425|NCT05573464|474790281|FG000|12-week Treatment Period|Lost to Follow-up|2|||
131866426|NCT05573464|474790282|FG001|12-week Treatment Period|Lost to Follow-up|0|||
131866427|NCT05573464|474790281|FG000|12-week Treatment Period|Adverse Event|20|||
131866428|NCT05573464|474790282|FG001|12-week Treatment Period|Adverse Event|9|||
131866429|NCT05573464|474790281|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
131866430|NCT05573464|474790282|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
131866431|NCT05573464|474790281|FG000|12-week Treatment Period|Randomised, not treated|0|||
131866432|NCT05573464|474790282|FG001|12-week Treatment Period|Randomised, not treated|1|||
131866433|NCT05573464|474790281|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
131866434|NCT05573464|474790282|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
131866435|NCT05573464|474790281|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
131866436|NCT05573464|474790282|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
131866437|NCT05573464|474790281|FG000|52-week Treatment Period|Protocol Violation|1|||
131866438|NCT05573464|474790282|FG001|52-week Treatment Period|Protocol Violation|1|||
131866439|NCT05573464|474790281|FG000|52-week Treatment Period|Physician Decision|2|||
131866440|NCT05573464|474790282|FG001|52-week Treatment Period|Physician Decision|2|||
131866441|NCT05573464|474790281|FG000|52-week Treatment Period|Lost to Follow-up|1|||
131866442|NCT05573464|474790282|FG001|52-week Treatment Period|Lost to Follow-up|1|||
131866443|NCT05573464|474790281|FG000|52-week Treatment Period|Adverse Event|11|||
131866444|NCT05573464|474790282|FG001|52-week Treatment Period|Adverse Event|8|||
131866445|NCT05573464|474790281|FG000|52-week Treatment Period|Death|1|||
131866446|NCT05573464|474790282|FG001|52-week Treatment Period|Death|1|||
131866447|NCT01467713|474790284|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
131866448|NCT01467713|474790285|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
131866449|NCT01467713|474790286|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
131866450|NCT01467713|474790287|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
131866451|NCT01467713|474790284|FG000|Overall Study|Major Protocol Deviation|2|||
131866452|NCT01467713|474790285|FG001|Overall Study|Major Protocol Deviation|4|||
131866453|NCT01467713|474790286|FG002|Overall Study|Major Protocol Deviation|4|||
131866454|NCT01467713|474790287|FG003|Overall Study|Major Protocol Deviation|1|||
131866455|NCT01467713|474790284|FG000|Overall Study|Lost to Follow-up|9|||
131866456|NCT01467713|474790285|FG001|Overall Study|Lost to Follow-up|12|||
131866457|NCT01467713|474790286|FG002|Overall Study|Lost to Follow-up|6|||
131866458|NCT01467713|474790287|FG003|Overall Study|Lost to Follow-up|9|||
131866459|NCT01467713|474790284|FG000|Overall Study|Voluntary Withdrawal|18|||
131866460|NCT01467713|474790285|FG001|Overall Study|Voluntary Withdrawal|14|||
131866461|NCT01467713|474790286|FG002|Overall Study|Voluntary Withdrawal|21|||
131866462|NCT01467713|474790287|FG003|Overall Study|Voluntary Withdrawal|20|||
131866463|NCT01467713|474790284|FG000|Overall Study|Study Termination|23|||
131866464|NCT01467713|474790285|FG001|Overall Study|Study Termination|33|||
131866465|NCT01467713|474790286|FG002|Overall Study|Study Termination|28|||
131866466|NCT01467713|474790287|FG003|Overall Study|Study Termination|29|||
131866467|NCT01467713|474790284|FG000|Overall Study|Pregnancy|0|||
131866468|NCT01467713|474790285|FG001|Overall Study|Pregnancy|1|||
131866469|NCT01467713|474790286|FG002|Overall Study|Pregnancy|1|||
131866470|NCT01467713|474790287|FG003|Overall Study|Pregnancy|3|||
131866471|NCT01467713|474790284|FG000|Overall Study|Relapse|35|||
131866472|NCT01467713|474790285|FG001|Overall Study|Relapse|25|||
131916466|NCT02903914|474979889|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
131916467|NCT02903914|474979890|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
131866473|NCT01467713|474790286|FG002|Overall Study|Relapse|28|||
131866474|NCT01467713|474790287|FG003|Overall Study|Relapse|35|||
131866475|NCT01467713|474790284|FG000|Overall Study|Reason not Specified|6|||
131916468|NCT02903914|474979883|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
131866476|NCT01467713|474790285|FG001|Overall Study|Reason not Specified|11|||
131866477|NCT01467713|474790286|FG002|Overall Study|Reason not Specified|8|||
131866478|NCT01467713|474790287|FG003|Overall Study|Reason not Specified|7|||
131866479|NCT04846569|474790288|FG000|Overall Study|Withdrawal by Subject|3|||
131866480|NCT04846569|474790289|FG001|Overall Study|Withdrawal by Subject|1|||
131916469|NCT02903914|474979884|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
131916470|NCT02903914|474979885|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
131916471|NCT02903914|474979886|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
131916472|NCT02903914|474979887|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
131916473|NCT02903914|474979888|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
131916474|NCT02903914|474979889|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
131916475|NCT02903914|474979890|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
131916476|NCT02903914|474979883|FG000|Overall Study|Clinical Disease Progression|0|||
131916477|NCT02903914|474979884|FG001|Overall Study|Clinical Disease Progression|0|||
131916478|NCT02903914|474979885|FG002|Overall Study|Clinical Disease Progression|2|||
131916479|NCT02903914|474979886|FG003|Overall Study|Clinical Disease Progression|0|||
131916480|NCT02903914|474979887|FG004|Overall Study|Clinical Disease Progression|0|||
131916481|NCT02903914|474979888|FG005|Overall Study|Clinical Disease Progression|0|||
131916482|NCT02903914|474979889|FG006|Overall Study|Clinical Disease Progression|0|||
131916483|NCT02903914|474979890|FG007|Overall Study|Clinical Disease Progression|0|||
131916484|NCT02903914|474979883|FG000|Overall Study|Completed Follow-up Period|0|||
131916485|NCT02903914|474979884|FG001|Overall Study|Completed Follow-up Period|0|||
131916486|NCT02903914|474979885|FG002|Overall Study|Completed Follow-up Period|6|||
131916487|NCT02903914|474979886|FG003|Overall Study|Completed Follow-up Period|2|||
131916488|NCT02903914|474979887|FG004|Overall Study|Completed Follow-up Period|1|||
131916489|NCT02903914|474979888|FG005|Overall Study|Completed Follow-up Period|0|||
131916490|NCT02903914|474979889|FG006|Overall Study|Completed Follow-up Period|9|||
131916491|NCT02903914|474979890|FG007|Overall Study|Completed Follow-up Period|1|||
131916492|NCT02903914|474979883|FG000|Overall Study|Taken off Treatment per Protocol|0|||
131916493|NCT02903914|474979884|FG001|Overall Study|Taken off Treatment per Protocol|0|||
131916494|NCT02903914|474979885|FG002|Overall Study|Taken off Treatment per Protocol|0|||
131916495|NCT02903914|474979886|FG003|Overall Study|Taken off Treatment per Protocol|0|||
131916496|NCT02903914|474979887|FG004|Overall Study|Taken off Treatment per Protocol|0|||
131916497|NCT02903914|474979888|FG005|Overall Study|Taken off Treatment per Protocol|1|||
131916498|NCT02903914|474979889|FG006|Overall Study|Taken off Treatment per Protocol|0|||
131916499|NCT02903914|474979890|FG007|Overall Study|Taken off Treatment per Protocol|0|||
131916500|NCT02903914|474979883|FG000|Overall Study|Refused Further Treatment/Contact|0|||
131916501|NCT02903914|474979884|FG001|Overall Study|Refused Further Treatment/Contact|0|||
131916502|NCT02903914|474979885|FG002|Overall Study|Refused Further Treatment/Contact|0|||
131916503|NCT02903914|474979886|FG003|Overall Study|Refused Further Treatment/Contact|0|||
131916504|NCT02903914|474979887|FG004|Overall Study|Refused Further Treatment/Contact|0|||
131916505|NCT02903914|474979888|FG005|Overall Study|Refused Further Treatment/Contact|0|||
131916506|NCT02903914|474979889|FG006|Overall Study|Refused Further Treatment/Contact|1|||
131916507|NCT02903914|474979890|FG007|Overall Study|Refused Further Treatment/Contact|0|||
131916508|NCT02903914|474979883|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916509|NCT02903914|474979884|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916510|NCT02903914|474979885|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916511|NCT02903914|474979886|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916512|NCT02903914|474979887|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916513|NCT02903914|474979888|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916514|NCT02903914|474979889|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
131916515|NCT02903914|474979890|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
131916516|NCT03112603|474979894|FG000|End of Randomization Period|Lost to Follow-up|3|||
131916517|NCT03112603|474979895|FG001|End of Randomization Period|Lost to Follow-up|0|||
131916518|NCT03112603|474979896|FG002|End of Randomization Period|Lost to Follow-up|0|||
131916519|NCT03112603|474979894|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
131916520|NCT03112603|474979895|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
131916521|NCT03112603|474979896|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
131916522|NCT03112603|474979894|FG000|End of Randomization Period|Physician Decision|43|||
131916523|NCT03112603|474979895|FG001|End of Randomization Period|Physician Decision|18|||
131916524|NCT03112603|474979896|FG002|End of Randomization Period|Physician Decision|0|||
131916525|NCT03112603|474979894|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
131916526|NCT03112603|474979895|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
131916527|NCT03112603|474979896|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
131916528|NCT03112603|474979894|FG000|End of Randomization Period|Death|10|||
131916529|NCT03112603|474979895|FG001|End of Randomization Period|Death|7|||
131916530|NCT03112603|474979896|FG002|End of Randomization Period|Death|0|||
131916531|NCT03112603|474979894|FG000|End of Randomization Period|Disease Relapse|12|||
131916532|NCT03112603|474979895|FG001|End of Randomization Period|Disease Relapse|7|||
131916533|NCT03112603|474979896|FG002|End of Randomization Period|Disease Relapse|0|||
131916534|NCT03112603|474979894|FG000|End of Randomization Period|Lack of Efficacy|25|||
131916535|NCT03112603|474979895|FG001|End of Randomization Period|Lack of Efficacy|77|||
131453884|NCT02656693|473291813|FG002|Overall Study|Pregnancy|1|||
131916536|NCT03112603|474979896|FG002|End of Randomization Period|Lack of Efficacy|0|||
131916537|NCT03112603|474979894|FG000|End of Randomization Period|Adverse Event|32|||
131916538|NCT03112603|474979895|FG001|End of Randomization Period|Adverse Event|12|||
131916539|NCT03112603|474979896|FG002|End of Randomization Period|Adverse Event|0|||
131916540|NCT03112603|474979894|FG000|End of Cross Over Period|Death|0|||
131916541|NCT03112603|474979895|FG001|End of Cross Over Period|Death|0|||
131916542|NCT03112603|474979896|FG002|End of Cross Over Period|Death|2|||
131916543|NCT03112603|474979894|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
131916544|NCT03112603|474979895|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
131916545|NCT03112603|474979896|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
131916546|NCT03112603|474979894|FG000|End of Cross Over Period|Physician Decision|0|||
131916547|NCT03112603|474979895|FG001|End of Cross Over Period|Physician Decision|0|||
131916548|NCT03112603|474979896|FG002|End of Cross Over Period|Physician Decision|29|||
131916549|NCT03112603|474979894|FG000|End of Cross Over Period|Lack of Efficacy|0|||
131916550|NCT03112603|474979895|FG001|End of Cross Over Period|Lack of Efficacy|0|||
131916551|NCT03112603|474979896|FG002|End of Cross Over Period|Lack of Efficacy|8|||
131916552|NCT03112603|474979894|FG000|End of Cross Over Period|Adverse Event|0|||
131916553|NCT03112603|474979895|FG001|End of Cross Over Period|Adverse Event|0|||
131916554|NCT03112603|474979896|FG002|End of Cross Over Period|Adverse Event|6|||
131916555|NCT03112603|474979894|FG000|End of Cross Over Period|Disease Relapse|0|||
131916556|NCT03112603|474979895|FG001|End of Cross Over Period|Disease Relapse|0|||
131916557|NCT03112603|474979896|FG002|End of Cross Over Period|Disease Relapse|2|||
131916558|NCT04725188|474979897|FG000|Overall Study|Death|72|||
131916559|NCT04725188|474979898|FG001|Overall Study|Death|69|||
131916560|NCT04725188|474979899|FG002|Overall Study|Death|76|||
131916561|NCT04725188|474979897|FG000|Overall Study|Lost to Follow-up|1|||
131916562|NCT04725188|474979898|FG001|Overall Study|Lost to Follow-up|0|||
131916563|NCT04725188|474979899|FG002|Overall Study|Lost to Follow-up|1|||
131916564|NCT04725188|474979897|FG000|Overall Study|Withdrawal by Subject|2|||
131916565|NCT04725188|474979898|FG001|Overall Study|Withdrawal by Subject|2|||
131916566|NCT04725188|474979899|FG002|Overall Study|Withdrawal by Subject|1|||
131916567|NCT04725188|474979897|FG000|Overall Study|Sponsor Decision|12|||
131916568|NCT04725188|474979898|FG001|Overall Study|Sponsor Decision|12|||
131916569|NCT04725188|474979899|FG002|Overall Study|Sponsor Decision|7|||
131916570|NCT02337829|474979900|FG000|Overall Study|Death|0|||
131916571|NCT02337829|474979901|FG001|Overall Study|Death|1|||
131916572|NCT02337829|474979902|FG002|Overall Study|Death|0|||
131916573|NCT02337829|474979903|FG003|Overall Study|Death|0|||
131916574|NCT02337829|474979900|FG000|Overall Study|Study terminated by sponsor|12|||
131916575|NCT02337829|474979901|FG001|Overall Study|Study terminated by sponsor|10|||
131916576|NCT02337829|474979902|FG002|Overall Study|Study terminated by sponsor|5|||
131916577|NCT02337829|474979903|FG003|Overall Study|Study terminated by sponsor|6|||
131916578|NCT02337829|474979900|FG000|Overall Study|discontinued for other reasons|6|||
131916579|NCT02337829|474979901|FG001|Overall Study|discontinued for other reasons|3|||
131916580|NCT02337829|474979902|FG002|Overall Study|discontinued for other reasons|1|||
131916581|NCT02337829|474979903|FG003|Overall Study|discontinued for other reasons|4|||
131916582|NCT03330197|474979904|FG000|Overall Study|Adverse Event|0|||
131916583|NCT03330197|474979905|FG001|Overall Study|Adverse Event|1|||
131916584|NCT03330197|474979904|FG000|Overall Study|Withdrawal by Subject|0|||
131916585|NCT03330197|474979905|FG001|Overall Study|Withdrawal by Subject|1|||
131916586|NCT04221490|474979906|FG000|At 30 Days Follow-up|Death|7|||
131916587|NCT04221490|474979906|FG000|At 30 Days Follow-up|Missed Visit|4|||
131916588|NCT04221490|474979906|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
131916589|NCT04221490|474979906|FG000|At 6 Months Follow-up|Death|9|||
131916590|NCT04221490|474979906|FG000|At 6 Months Follow-up|Physician Decision|1|||
131916591|NCT04221490|474979906|FG000|At 6 Months Follow-up|Missed Visit|8|||
131916592|NCT04221490|474979906|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
131916593|NCT00695019|474979912|FG000|Overall Study|Withdrawal by Subject|8|||
131916594|NCT00695019|474979913|FG001|Overall Study|Withdrawal by Subject|6|||
131916595|NCT00695019|474979914|FG002|Overall Study|Withdrawal by Subject|4|||
131916596|NCT00695019|474979912|FG000|Overall Study|Protocol Violation|1|||
131916597|NCT00695019|474979913|FG001|Overall Study|Protocol Violation|3|||
131916598|NCT00695019|474979914|FG002|Overall Study|Protocol Violation|1|||
131916599|NCT00695019|474979912|FG000|Overall Study|Lack of Efficacy|0|||
131916600|NCT00695019|474979913|FG001|Overall Study|Lack of Efficacy|0|||
131916601|NCT00695019|474979914|FG002|Overall Study|Lack of Efficacy|1|||
131916602|NCT00695019|474979912|FG000|Overall Study|Various|4|||
131916603|NCT00695019|474979913|FG001|Overall Study|Various|5|||
131916604|NCT00695019|474979914|FG002|Overall Study|Various|4|||
131916605|NCT02442349|474979915|FG000|Overall Study|Death|95|||
131916606|NCT02442349|474979915|FG000|Overall Study|Withdrawal by Subject|27|||
131916607|NCT02442349|474979915|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
131916608|NCT02442349|474979915|FG000|Overall Study|Lost to Follow-up|1|||
131916609|NCT03126110|474979916|FG000|Phase 1|Death|2|||
131916610|NCT03126110|474979917|FG001|Phase 1|Death|2|||
131916611|NCT03126110|474979918|FG002|Phase 1|Death|4|||
131916612|NCT03126110|474979919|FG003|Phase 1|Death|3|||
131916613|NCT03126110|474979920|FG004|Phase 1|Death|4|||
131916614|NCT03126110|474979921|FG005|Phase 1|Death|4|||
131916615|NCT03126110|474979922|FG006|Phase 1|Death|3|||
131916616|NCT03126110|474979923|FG007|Phase 1|Death|4|||
131916617|NCT03126110|474979924|FG008|Phase 1|Death|5|||
131916618|NCT03126110|474979925|FG009|Phase 1|Death|2|||
131916619|NCT03126110|474979926|FG010|Phase 1|Death|6|||
131916620|NCT03126110|474979927|FG011|Phase 1|Death|0|||
131916621|NCT03126110|474979928|FG012|Phase 1|Death|0|||
131916622|NCT03126110|474979929|FG013|Phase 1|Death|0|||
131916623|NCT03126110|474979930|FG014|Phase 1|Death|0|||
131916624|NCT03126110|474979931|FG015|Phase 1|Death|0|||
131916625|NCT03126110|474979932|FG016|Phase 1|Death|0|||
131916626|NCT03126110|474979916|FG000|Phase 1|Lost to Follow-up|0|||
131916627|NCT03126110|474979917|FG001|Phase 1|Lost to Follow-up|1|||
131916628|NCT03126110|474979918|FG002|Phase 1|Lost to Follow-up|0|||
131916629|NCT03126110|474979919|FG003|Phase 1|Lost to Follow-up|0|||
131916630|NCT03126110|474979920|FG004|Phase 1|Lost to Follow-up|0|||
131916631|NCT03126110|474979921|FG005|Phase 1|Lost to Follow-up|0|||
131916632|NCT03126110|474979922|FG006|Phase 1|Lost to Follow-up|0|||
131916633|NCT03126110|474979923|FG007|Phase 1|Lost to Follow-up|0|||
131916634|NCT03126110|474979924|FG008|Phase 1|Lost to Follow-up|1|||
131916635|NCT03126110|474979925|FG009|Phase 1|Lost to Follow-up|0|||
131916636|NCT03126110|474979926|FG010|Phase 1|Lost to Follow-up|0|||
131916637|NCT03126110|474979927|FG011|Phase 1|Lost to Follow-up|0|||
131916638|NCT03126110|474979928|FG012|Phase 1|Lost to Follow-up|0|||
131916639|NCT03126110|474979929|FG013|Phase 1|Lost to Follow-up|0|||
131916640|NCT03126110|474979930|FG014|Phase 1|Lost to Follow-up|0|||
131916641|NCT03126110|474979931|FG015|Phase 1|Lost to Follow-up|0|||
131916642|NCT03126110|474979932|FG016|Phase 1|Lost to Follow-up|0|||
131916643|NCT03126110|474979916|FG000|Phase 1|Withdrawal by Subject|1|||
131916644|NCT03126110|474979917|FG001|Phase 1|Withdrawal by Subject|0|||
131916645|NCT03126110|474979918|FG002|Phase 1|Withdrawal by Subject|0|||
131916646|NCT03126110|474979919|FG003|Phase 1|Withdrawal by Subject|1|||
131916647|NCT03126110|474979920|FG004|Phase 1|Withdrawal by Subject|1|||
131916648|NCT03126110|474979921|FG005|Phase 1|Withdrawal by Subject|0|||
131916649|NCT03126110|474979922|FG006|Phase 1|Withdrawal by Subject|0|||
131916650|NCT03126110|474979923|FG007|Phase 1|Withdrawal by Subject|0|||
131916651|NCT03126110|474979924|FG008|Phase 1|Withdrawal by Subject|2|||
131916652|NCT03126110|474979925|FG009|Phase 1|Withdrawal by Subject|1|||
131916653|NCT03126110|474979926|FG010|Phase 1|Withdrawal by Subject|0|||
131916654|NCT03126110|474979927|FG011|Phase 1|Withdrawal by Subject|0|||
131916655|NCT03126110|474979928|FG012|Phase 1|Withdrawal by Subject|0|||
131916656|NCT03126110|474979929|FG013|Phase 1|Withdrawal by Subject|0|||
131916657|NCT03126110|474979930|FG014|Phase 1|Withdrawal by Subject|0|||
131916658|NCT03126110|474979931|FG015|Phase 1|Withdrawal by Subject|0|||
131916659|NCT03126110|474979932|FG016|Phase 1|Withdrawal by Subject|0|||
131916660|NCT03126110|474979916|FG000|Phase 1|Safety follow-up no longer necessary|1|||
131916661|NCT03126110|474979917|FG001|Phase 1|Safety follow-up no longer necessary|0|||
131866481|NCT02954601|474790293|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
131866482|NCT02954601|474790294|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
131866483|NCT02954601|474790295|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
131866484|NCT02954601|474790296|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
131866485|NCT01611935|474790297|FG000|Overall Study|Family Declined Participation|1|||
131866486|NCT01611935|474790298|FG001|Overall Study|Family Declined Participation|0|||
131866487|NCT01735916|474790299|FG000|Overall Study|Subject not eligible to be randomized|11|||
131866488|NCT01735916|474790300|FG001|Overall Study|Subject not eligible to be randomized|0|||
131866489|NCT01735916|474790301|FG002|Overall Study|Subject not eligible to be randomized|0|||
131866490|NCT01735916|474790299|FG000|Overall Study|Early termination of study by sponsor|4|||
131866491|NCT01735916|474790300|FG001|Overall Study|Early termination of study by sponsor|19|||
131866492|NCT01735916|474790301|FG002|Overall Study|Early termination of study by sponsor|7|||
131866493|NCT01735916|474790299|FG000|Overall Study|Withdrawal by Subject|3|||
131866494|NCT01735916|474790300|FG001|Overall Study|Withdrawal by Subject|0|||
131408139|NCT00496197|473118192|FG000|Overall Study|Insufficient bacteriological response|10|||
131408140|NCT00496197|473118192|FG000|Overall Study|Lost to Follow-up|11|||
131408141|NCT00496197|473118192|FG000|Overall Study|Withdrawal by Subject|11|||
131916662|NCT03126110|474979918|FG002|Phase 1|Safety follow-up no longer necessary|0|||
131916663|NCT03126110|474979919|FG003|Phase 1|Safety follow-up no longer necessary|0|||
131916664|NCT03126110|474979920|FG004|Phase 1|Safety follow-up no longer necessary|0|||
131916665|NCT03126110|474979921|FG005|Phase 1|Safety follow-up no longer necessary|0|||
131916666|NCT03126110|474979922|FG006|Phase 1|Safety follow-up no longer necessary|0|||
131916667|NCT03126110|474979923|FG007|Phase 1|Safety follow-up no longer necessary|0|||
131916668|NCT03126110|474979924|FG008|Phase 1|Safety follow-up no longer necessary|0|||
131916669|NCT03126110|474979925|FG009|Phase 1|Safety follow-up no longer necessary|0|||
131453885|NCT02656693|473291811|FG000|Overall Study|Bariatric surgery|0|||
131916670|NCT03126110|474979926|FG010|Phase 1|Safety follow-up no longer necessary|0|||
131916671|NCT03126110|474979927|FG011|Phase 1|Safety follow-up no longer necessary|0|||
131916672|NCT03126110|474979928|FG012|Phase 1|Safety follow-up no longer necessary|0|||
131916673|NCT03126110|474979929|FG013|Phase 1|Safety follow-up no longer necessary|0|||
131916674|NCT03126110|474979930|FG014|Phase 1|Safety follow-up no longer necessary|0|||
131866495|NCT01735916|474790301|FG002|Overall Study|Withdrawal by Subject|0|||
131866496|NCT02275546|474790310|FG000|Treatment Period 2|Withdrawal by Subject|2|||
131866497|NCT02275546|474790311|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131866498|NCT02275546|474790310|FG000|Treatment Period 2|Protocol Violation|0|||
131866499|NCT02275546|474790311|FG001|Treatment Period 2|Protocol Violation|1|||
131866500|NCT02612623|474790315|FG000|Overall Study|Withdrawal by Subject|0|||
131866501|NCT02612623|474790316|FG001|Overall Study|Withdrawal by Subject|1|||
131866502|NCT02612623|474790317|FG002|Overall Study|Withdrawal by Subject|0|||
131866503|NCT02612623|474790318|FG003|Overall Study|Withdrawal by Subject|0|||
131866504|NCT02612623|474790315|FG000|Overall Study|Adverse Event|1|||
131866505|NCT02612623|474790316|FG001|Overall Study|Adverse Event|0|||
131866506|NCT02612623|474790317|FG002|Overall Study|Adverse Event|1|||
131916675|NCT03126110|474979931|FG015|Phase 1|Safety follow-up no longer necessary|0|||
131916676|NCT03126110|474979932|FG016|Phase 1|Safety follow-up no longer necessary|0|||
131916677|NCT03126110|474979916|FG000|Phase 1|Survival follow-up no longer necessary|0|||
131916678|NCT03126110|474979917|FG001|Phase 1|Survival follow-up no longer necessary|0|||
131916679|NCT03126110|474979918|FG002|Phase 1|Survival follow-up no longer necessary|1|||
131916680|NCT03126110|474979919|FG003|Phase 1|Survival follow-up no longer necessary|0|||
131916681|NCT03126110|474979920|FG004|Phase 1|Survival follow-up no longer necessary|0|||
131916682|NCT03126110|474979921|FG005|Phase 1|Survival follow-up no longer necessary|0|||
131916683|NCT03126110|474979922|FG006|Phase 1|Survival follow-up no longer necessary|0|||
131916684|NCT03126110|474979923|FG007|Phase 1|Survival follow-up no longer necessary|0|||
131916685|NCT03126110|474979924|FG008|Phase 1|Survival follow-up no longer necessary|0|||
131916686|NCT03126110|474979925|FG009|Phase 1|Survival follow-up no longer necessary|0|||
131916687|NCT03126110|474979926|FG010|Phase 1|Survival follow-up no longer necessary|0|||
131916688|NCT03126110|474979927|FG011|Phase 1|Survival follow-up no longer necessary|0|||
131916689|NCT03126110|474979928|FG012|Phase 1|Survival follow-up no longer necessary|0|||
131916690|NCT03126110|474979929|FG013|Phase 1|Survival follow-up no longer necessary|0|||
131916691|NCT03126110|474979930|FG014|Phase 1|Survival follow-up no longer necessary|0|||
131916692|NCT03126110|474979931|FG015|Phase 1|Survival follow-up no longer necessary|0|||
131916693|NCT03126110|474979932|FG016|Phase 1|Survival follow-up no longer necessary|0|||
131916694|NCT03126110|474979916|FG000|Phase 2|Study terminated by the sponsor|0|||
131916695|NCT03126110|474979917|FG001|Phase 2|Study terminated by the sponsor|0|||
131916696|NCT03126110|474979918|FG002|Phase 2|Study terminated by the sponsor|0|||
131916697|NCT03126110|474979919|FG003|Phase 2|Study terminated by the sponsor|0|||
131916698|NCT03126110|474979920|FG004|Phase 2|Study terminated by the sponsor|0|||
131916699|NCT03126110|474979921|FG005|Phase 2|Study terminated by the sponsor|0|||
131916700|NCT03126110|474979922|FG006|Phase 2|Study terminated by the sponsor|0|||
131916701|NCT03126110|474979923|FG007|Phase 2|Study terminated by the sponsor|0|||
131916702|NCT03126110|474979924|FG008|Phase 2|Study terminated by the sponsor|0|||
131916703|NCT03126110|474979925|FG009|Phase 2|Study terminated by the sponsor|0|||
131916704|NCT03126110|474979926|FG010|Phase 2|Study terminated by the sponsor|0|||
131916705|NCT03126110|474979927|FG011|Phase 2|Study terminated by the sponsor|0|||
131916706|NCT03126110|474979928|FG012|Phase 2|Study terminated by the sponsor|0|||
131916707|NCT03126110|474979929|FG013|Phase 2|Study terminated by the sponsor|4|||
131916708|NCT03126110|474979930|FG014|Phase 2|Study terminated by the sponsor|0|||
131916709|NCT03126110|474979931|FG015|Phase 2|Study terminated by the sponsor|0|||
131916710|NCT03126110|474979932|FG016|Phase 2|Study terminated by the sponsor|0|||
131916711|NCT03126110|474979916|FG000|Phase 2|Withdrawal by Subject|0|||
131916712|NCT03126110|474979917|FG001|Phase 2|Withdrawal by Subject|0|||
131916713|NCT03126110|474979918|FG002|Phase 2|Withdrawal by Subject|0|||
131916714|NCT03126110|474979919|FG003|Phase 2|Withdrawal by Subject|0|||
131916715|NCT03126110|474979920|FG004|Phase 2|Withdrawal by Subject|0|||
131916716|NCT03126110|474979921|FG005|Phase 2|Withdrawal by Subject|0|||
131916717|NCT03126110|474979922|FG006|Phase 2|Withdrawal by Subject|0|||
131916718|NCT03126110|474979923|FG007|Phase 2|Withdrawal by Subject|0|||
131916719|NCT03126110|474979924|FG008|Phase 2|Withdrawal by Subject|0|||
131916720|NCT03126110|474979925|FG009|Phase 2|Withdrawal by Subject|0|||
131916721|NCT03126110|474979926|FG010|Phase 2|Withdrawal by Subject|0|||
131916722|NCT03126110|474979927|FG011|Phase 2|Withdrawal by Subject|1|||
131453886|NCT02656693|473291812|FG001|Overall Study|Bariatric surgery|1|||
131866507|NCT02612623|474790318|FG003|Overall Study|Adverse Event|0|||
131866508|NCT00333983|474790319|FG000|Overall Study|Lost to Follow-up|2|||
131866509|NCT00333983|474790320|FG001|Overall Study|Lost to Follow-up|1|||
131866510|NCT00333983|474790321|FG002|Overall Study|Lost to Follow-up|0|||
131453887|NCT02656693|473291813|FG002|Overall Study|Bariatric surgery|2|||
131866511|NCT00333983|474790319|FG000|Overall Study|Adverse Event|1|||
131866512|NCT00333983|474790320|FG001|Overall Study|Adverse Event|1|||
131866513|NCT00333983|474790321|FG002|Overall Study|Adverse Event|1|||
131916723|NCT03126110|474979928|FG012|Phase 2|Withdrawal by Subject|3|||
131916724|NCT03126110|474979929|FG013|Phase 2|Withdrawal by Subject|3|||
131916725|NCT03126110|474979930|FG014|Phase 2|Withdrawal by Subject|2|||
131916726|NCT03126110|474979931|FG015|Phase 2|Withdrawal by Subject|1|||
131916727|NCT03126110|474979932|FG016|Phase 2|Withdrawal by Subject|0|||
131916728|NCT03126110|474979916|FG000|Phase 2|Lost to Follow-up|0|||
131916729|NCT03126110|474979917|FG001|Phase 2|Lost to Follow-up|0|||
131916730|NCT03126110|474979918|FG002|Phase 2|Lost to Follow-up|0|||
131916731|NCT03126110|474979919|FG003|Phase 2|Lost to Follow-up|0|||
131916732|NCT03126110|474979920|FG004|Phase 2|Lost to Follow-up|0|||
131916733|NCT03126110|474979921|FG005|Phase 2|Lost to Follow-up|0|||
131916734|NCT03126110|474979922|FG006|Phase 2|Lost to Follow-up|0|||
131916735|NCT03126110|474979923|FG007|Phase 2|Lost to Follow-up|0|||
131916736|NCT03126110|474979924|FG008|Phase 2|Lost to Follow-up|0|||
131916737|NCT03126110|474979925|FG009|Phase 2|Lost to Follow-up|0|||
131916738|NCT03126110|474979926|FG010|Phase 2|Lost to Follow-up|0|||
131916739|NCT03126110|474979927|FG011|Phase 2|Lost to Follow-up|1|||
131916740|NCT03126110|474979928|FG012|Phase 2|Lost to Follow-up|1|||
131916741|NCT03126110|474979929|FG013|Phase 2|Lost to Follow-up|1|||
131916742|NCT03126110|474979930|FG014|Phase 2|Lost to Follow-up|2|||
131916743|NCT03126110|474979931|FG015|Phase 2|Lost to Follow-up|0|||
131916744|NCT03126110|474979932|FG016|Phase 2|Lost to Follow-up|0|||
131916745|NCT03126110|474979916|FG000|Phase 2|Death|0|||
131916746|NCT03126110|474979917|FG001|Phase 2|Death|0|||
131916747|NCT03126110|474979918|FG002|Phase 2|Death|0|||
131916748|NCT03126110|474979919|FG003|Phase 2|Death|0|||
131916749|NCT03126110|474979920|FG004|Phase 2|Death|0|||
131916750|NCT03126110|474979921|FG005|Phase 2|Death|0|||
131916751|NCT03126110|474979922|FG006|Phase 2|Death|0|||
131916752|NCT03126110|474979923|FG007|Phase 2|Death|0|||
131916753|NCT03126110|474979924|FG008|Phase 2|Death|0|||
131916754|NCT03126110|474979925|FG009|Phase 2|Death|0|||
131916755|NCT03126110|474979926|FG010|Phase 2|Death|0|||
131916756|NCT03126110|474979927|FG011|Phase 2|Death|6|||
131916757|NCT03126110|474979928|FG012|Phase 2|Death|12|||
131916758|NCT03126110|474979929|FG013|Phase 2|Death|25|||
131916759|NCT03126110|474979930|FG014|Phase 2|Death|11|||
131916760|NCT03126110|474979931|FG015|Phase 2|Death|3|||
131916761|NCT03126110|474979932|FG016|Phase 2|Death|2|||
131916762|NCT03126110|474979916|FG000|Phase 2|Progressive Disease|0|||
131916763|NCT03126110|474979917|FG001|Phase 2|Progressive Disease|0|||
131916764|NCT03126110|474979918|FG002|Phase 2|Progressive Disease|0|||
131916765|NCT03126110|474979919|FG003|Phase 2|Progressive Disease|0|||
131916766|NCT03126110|474979920|FG004|Phase 2|Progressive Disease|0|||
131916767|NCT03126110|474979921|FG005|Phase 2|Progressive Disease|0|||
131916768|NCT03126110|474979922|FG006|Phase 2|Progressive Disease|0|||
131916769|NCT03126110|474979923|FG007|Phase 2|Progressive Disease|0|||
131916770|NCT03126110|474979924|FG008|Phase 2|Progressive Disease|0|||
131916771|NCT03126110|474979925|FG009|Phase 2|Progressive Disease|0|||
131916772|NCT03126110|474979926|FG010|Phase 2|Progressive Disease|0|||
131916773|NCT03126110|474979927|FG011|Phase 2|Progressive Disease|0|||
131916774|NCT03126110|474979928|FG012|Phase 2|Progressive Disease|0|||
131916775|NCT03126110|474979929|FG013|Phase 2|Progressive Disease|1|||
131916776|NCT03126110|474979930|FG014|Phase 2|Progressive Disease|0|||
131916777|NCT03126110|474979931|FG015|Phase 2|Progressive Disease|0|||
131916778|NCT03126110|474979932|FG016|Phase 2|Progressive Disease|0|||
131916779|NCT03126110|474979916|FG000|Phase 2|Started new treatment|0|||
131916780|NCT03126110|474979917|FG001|Phase 2|Started new treatment|0|||
131916781|NCT03126110|474979918|FG002|Phase 2|Started new treatment|0|||
131916782|NCT03126110|474979919|FG003|Phase 2|Started new treatment|0|||
131916783|NCT03126110|474979920|FG004|Phase 2|Started new treatment|0|||
131916784|NCT03126110|474979921|FG005|Phase 2|Started new treatment|0|||
131916785|NCT03126110|474979922|FG006|Phase 2|Started new treatment|0|||
131916786|NCT03126110|474979923|FG007|Phase 2|Started new treatment|0|||
131916787|NCT03126110|474979924|FG008|Phase 2|Started new treatment|0|||
131916788|NCT03126110|474979925|FG009|Phase 2|Started new treatment|0|||
131916789|NCT03126110|474979926|FG010|Phase 2|Started new treatment|0|||
131916790|NCT03126110|474979927|FG011|Phase 2|Started new treatment|0|||
131916791|NCT03126110|474979928|FG012|Phase 2|Started new treatment|0|||
131916792|NCT03126110|474979929|FG013|Phase 2|Started new treatment|0|||
131916793|NCT03126110|474979930|FG014|Phase 2|Started new treatment|1|||
131916794|NCT03126110|474979931|FG015|Phase 2|Started new treatment|0|||
131916795|NCT03126110|474979932|FG016|Phase 2|Started new treatment|0|||
131916796|NCT00314145|474979933|FG000|Overall Study|Withdrawal by Subject|8|||
131916797|NCT00314145|474979934|FG001|Overall Study|Withdrawal by Subject|10|||
131916798|NCT00314145|474979933|FG000|Overall Study|Lost to Follow-up|5|||
131916799|NCT00314145|474979934|FG001|Overall Study|Lost to Follow-up|12|||
131916800|NCT00314145|474979933|FG000|Overall Study|Physician Decision|3|||
131916801|NCT00314145|474979934|FG001|Overall Study|Physician Decision|4|||
131916802|NCT00314145|474979933|FG000|Overall Study|Adverse Event|0|||
131916803|NCT00314145|474979934|FG001|Overall Study|Adverse Event|3|||
131916804|NCT00314145|474979933|FG000|Overall Study|Protocol Violation|3|||
131916805|NCT00314145|474979934|FG001|Overall Study|Protocol Violation|0|||
131916806|NCT00314145|474979933|FG000|Overall Study|Sponsor Decision|2|||
131916807|NCT00314145|474979934|FG001|Overall Study|Sponsor Decision|0|||
131916808|NCT03507790|474979937|FG000|Overall Study|Adverse Event|0|||
131916809|NCT03507790|474979938|FG001|Overall Study|Adverse Event|11|||
131916810|NCT03507790|474979939|FG002|Overall Study|Adverse Event|3|||
131916811|NCT03507790|474979937|FG000|Overall Study|Withdrawal by Subject|2|||
131916812|NCT03507790|474979938|FG001|Overall Study|Withdrawal by Subject|0|||
131916813|NCT03507790|474979939|FG002|Overall Study|Withdrawal by Subject|0|||
131916814|NCT03507790|474979937|FG000|Overall Study|Subject moved to another location|1|||
131916815|NCT03507790|474979938|FG001|Overall Study|Subject moved to another location|2|||
131916816|NCT03507790|474979939|FG002|Overall Study|Subject moved to another location|0|||
131916817|NCT03507790|474979937|FG000|Overall Study|Non-compliance with study drug|0|||
131916818|NCT03507790|474979938|FG001|Overall Study|Non-compliance with study drug|0|||
131916819|NCT03507790|474979939|FG002|Overall Study|Non-compliance with study drug|1|||
131916820|NCT03507790|474979937|FG000|Overall Study|COVID 19 Pandemic|0|||
131916821|NCT03507790|474979938|FG001|Overall Study|COVID 19 Pandemic|1|||
131916822|NCT03507790|474979939|FG002|Overall Study|COVID 19 Pandemic|0|||
131916823|NCT03507790|474979937|FG000|Overall Study|Lost to Follow-up|0|||
131916824|NCT03507790|474979938|FG001|Overall Study|Lost to Follow-up|1|||
131916825|NCT03507790|474979939|FG002|Overall Study|Lost to Follow-up|0|||
131866514|NCT00333983|474790319|FG000|Overall Study|Withdrawal by Subject|0|||
131866515|NCT00333983|474790320|FG001|Overall Study|Withdrawal by Subject|3|||
131866516|NCT00333983|474790321|FG002|Overall Study|Withdrawal by Subject|1|||
131866517|NCT04227197|474790322|FG000|Randomization|Protocol Violation|1|||
131866518|NCT04227197|474790323|FG001|Randomization|Protocol Violation|0|||
131866519|NCT04227197|474790322|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
131866520|NCT04227197|474790323|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
131866521|NCT04227197|474790322|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
131866522|NCT04227197|474790323|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
131866523|NCT04227197|474790322|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
131866524|NCT04227197|474790323|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
131866525|NCT04227197|474790322|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
131866526|NCT04227197|474790323|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
131866527|NCT04227197|474790322|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
131866528|NCT04227197|474790323|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
131866529|NCT04227197|474790322|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
131866530|NCT04227197|474790323|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
131866531|NCT00570141|474790324|FG000|Overall Study|Adverse Event|1|||
131866532|NCT00570141|474790324|FG000|Overall Study|Missed visits|1|||
131866533|NCT00570141|474790324|FG000|Overall Study|Lost to Follow-up|1|||
131866534|NCT01209949|474790336|FG000|Overall Study|Lost to Follow-up|3|||
131866535|NCT02075203|474790347|FG000|Overall Study|Withdrawal by Subject|1|||
131866536|NCT02075203|474790348|FG001|Overall Study|Withdrawal by Subject|0|||
131866537|NCT02075203|474790349|FG002|Overall Study|Withdrawal by Subject|1|||
131866538|NCT02075203|474790347|FG000|Overall Study|Adverse Event|1|||
131866539|NCT02075203|474790348|FG001|Overall Study|Adverse Event|0|||
131866540|NCT02075203|474790349|FG002|Overall Study|Adverse Event|0|||
131866541|NCT02075203|474790347|FG000|Overall Study|participant refused to use contraception|1|||
131866542|NCT02075203|474790348|FG001|Overall Study|participant refused to use contraception|0|||
131866543|NCT02075203|474790349|FG002|Overall Study|participant refused to use contraception|0|||
131866544|NCT03214224|474790350|FG000|Overall Study|Protocol Violation|1|||
131866545|NCT03214224|474790350|FG000|Overall Study|Withdrawal by Subject|2|||
131866546|NCT03214224|474790350|FG000|Overall Study|Practice controls or therapists|6|||
131866547|NCT02712320|474790351|FG000|Overall Study|Lost to Follow-up|1|||
131866548|NCT02712320|474790351|FG000|Overall Study|Withdrawal by Subject|1|||
131866549|NCT02712320|474790351|FG000|Overall Study|Transferred to another facility|1|||
131866550|NCT02712320|474790351|FG000|Overall Study|Treating with the prohibited medications|2|||
131866551|NCT00568451|474790354|FG000|Overall Study|Disease Progression|0|||
131866552|NCT00568451|474790355|FG001|Overall Study|Disease Progression|0|||
131866553|NCT00568451|474790356|FG002|Overall Study|Disease Progression|2|||
131866554|NCT00568451|474790357|FG003|Overall Study|Disease Progression|7|||
131866555|NCT01343043|474790358|FG000|Overall Study|Disease progression before treatment|1|||
131866556|NCT01343043|474790359|FG001|Overall Study|Disease progression before treatment|0|||
131866557|NCT01343043|474790360|FG002|Overall Study|Disease progression before treatment|0|||
131866558|NCT01343043|474790361|FG003|Overall Study|Disease progression before treatment|0|||
131866559|NCT01343043|474790358|FG000|Overall Study|Withdrawal by Subject|1|||
131866560|NCT01343043|474790359|FG001|Overall Study|Withdrawal by Subject|0|||
131866561|NCT01343043|474790360|FG002|Overall Study|Withdrawal by Subject|0|||
131866562|NCT01343043|474790361|FG003|Overall Study|Withdrawal by Subject|0|||
131916826|NCT03507790|474979937|FG000|Overall Study|Discontinuation of the trial at the site|1|||
131916827|NCT03507790|474979938|FG001|Overall Study|Discontinuation of the trial at the site|1|||
131916828|NCT03507790|474979939|FG002|Overall Study|Discontinuation of the trial at the site|0|||
131916829|NCT03507790|474979937|FG000|Overall Study|Randomized in error|0|||
131916830|NCT03507790|474979938|FG001|Overall Study|Randomized in error|0|||
131866563|NCT01343043|474790358|FG000|Overall Study|Death|1|||
131866564|NCT01343043|474790359|FG001|Overall Study|Death|1|||
131866565|NCT01343043|474790360|FG002|Overall Study|Death|0|||
131866566|NCT01343043|474790361|FG003|Overall Study|Death|1|||
131866567|NCT02182843|474790370|FG000|Overall Study|Withdrawal by Subject|7|||
131866568|NCT02182843|474790370|FG000|Overall Study|Lost to Follow-up|2|||
131866569|NCT02182843|474790370|FG000|Overall Study|Adverse Event|1|||
131916831|NCT03507790|474979939|FG002|Overall Study|Randomized in error|1|||
131866570|NCT02375971|474790371|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
131866571|NCT02375971|474790372|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
131866572|NCT02375971|474790373|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
131866573|NCT02375971|474790371|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
131866574|NCT02375971|474790372|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
131866575|NCT02375971|474790373|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
131866576|NCT02375971|474790371|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
131866577|NCT02375971|474790372|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
131866578|NCT02375971|474790373|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
131866579|NCT02375971|474790371|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
131866580|NCT02375971|474790372|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
131866581|NCT02375971|474790373|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
131866582|NCT02375971|474790371|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
131866583|NCT02375971|474790372|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
131866584|NCT02375971|474790373|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
131866585|NCT02375971|474790371|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
131866586|NCT02375971|474790372|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
131866587|NCT02375971|474790373|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
131866588|NCT02375971|474790371|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
131866589|NCT02375971|474790372|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
131866590|NCT02375971|474790373|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
131866591|NCT02375971|474790371|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
131866592|NCT02375971|474790372|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
131866593|NCT02375971|474790373|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
131866594|NCT00832455|474790375|FG000|Overall Study|Adverse Event|13|||
131866595|NCT00832455|474790375|FG000|Overall Study|Lost to Follow-up|26|||
131866596|NCT00832455|474790375|FG000|Overall Study|Protocol Violation|4|||
131866597|NCT00832455|474790375|FG000|Overall Study|Withdrawal by Subject|17|||
131866598|NCT00832455|474790375|FG000|Overall Study|Screening Failure|2|||
131866599|NCT00832455|474790375|FG000|Overall Study|Stopped Medication|4|||
131866600|NCT00832455|474790375|FG000|Overall Study|Parent misunderstood study|1|||
131866601|NCT00832455|474790375|FG000|Overall Study|Parent dissatisfied|1|||
131866602|NCT00832455|474790375|FG000|Overall Study|No improvement|3|||
131866603|NCT00832455|474790375|FG000|Overall Study|Patient moved|1|||
131866604|NCT00558467|474790376|FG000|Overall Study|Adverse Event|1|||
131866605|NCT00558467|474790377|FG001|Overall Study|Adverse Event|2|||
131866606|NCT00558467|474790376|FG000|Overall Study|Lack of Efficacy|0|||
131866607|NCT00558467|474790377|FG001|Overall Study|Lack of Efficacy|1|||
131866608|NCT00558467|474790376|FG000|Overall Study|Patient moving out of state|0|||
131866609|NCT00558467|474790377|FG001|Overall Study|Patient moving out of state|1|||
131866610|NCT05047211|474790382|FG000|Overall Study|Lost to Follow-up|8|||
131866611|NCT05047211|474790383|FG001|Overall Study|Lost to Follow-up|5|||
131866612|NCT01262872|474790384|FG000|Step 2|Death|0|||
131866613|NCT01262872|474790385|FG001|Step 2|Death|0|||
131866614|NCT01262872|474790386|FG002|Step 2|Death|0|||
131866615|NCT01262872|474790387|FG003|Step 2|Death|1|||
131866616|NCT01262872|474790388|FG004|Step 2|Death|0|||
131866617|NCT01262872|474790389|FG005|Step 2|Death|2|||
131866618|NCT01262872|474790390|FG006|Step 2|Death|2|||
131866619|NCT01262872|474790391|FG007|Step 2|Death|1|||
131866620|NCT01262872|474790384|FG000|Step 2|Protocol Violation|0|||
131866621|NCT01262872|474790385|FG001|Step 2|Protocol Violation|0|||
131866622|NCT01262872|474790386|FG002|Step 2|Protocol Violation|1|||
131866623|NCT01262872|474790387|FG003|Step 2|Protocol Violation|0|||
131866624|NCT01262872|474790388|FG004|Step 2|Protocol Violation|0|||
131866625|NCT01262872|474790389|FG005|Step 2|Protocol Violation|0|||
131866626|NCT01262872|474790390|FG006|Step 2|Protocol Violation|3|||
131866627|NCT01262872|474790391|FG007|Step 2|Protocol Violation|1|||
131866628|NCT01262872|474790384|FG000|Step 2|Withdrawal by Subject|0|||
131866629|NCT01262872|474790385|FG001|Step 2|Withdrawal by Subject|0|||
131866630|NCT01262872|474790386|FG002|Step 2|Withdrawal by Subject|4|||
131866631|NCT01262872|474790387|FG003|Step 2|Withdrawal by Subject|6|||
131866632|NCT01262872|474790388|FG004|Step 2|Withdrawal by Subject|3|||
131866633|NCT01262872|474790389|FG005|Step 2|Withdrawal by Subject|1|||
131866634|NCT01262872|474790390|FG006|Step 2|Withdrawal by Subject|2|||
131866635|NCT01262872|474790391|FG007|Step 2|Withdrawal by Subject|1|||
131866636|NCT01262872|474790384|FG000|Step 2|Migrated/moved from study area|0|||
131866637|NCT01262872|474790385|FG001|Step 2|Migrated/moved from study area|0|||
131866638|NCT01262872|474790386|FG002|Step 2|Migrated/moved from study area|4|||
131866639|NCT01262872|474790387|FG003|Step 2|Migrated/moved from study area|3|||
131866640|NCT01262872|474790388|FG004|Step 2|Migrated/moved from study area|2|||
131866641|NCT01262872|474790389|FG005|Step 2|Migrated/moved from study area|6|||
131866642|NCT01262872|474790390|FG006|Step 2|Migrated/moved from study area|2|||
131866643|NCT01262872|474790391|FG007|Step 2|Migrated/moved from study area|3|||
131866644|NCT01804946|474790393|FG000|Overall Study|Protocol Violation|1|||
131866645|NCT01804946|474790394|FG001|Overall Study|Protocol Violation|0|||
131866646|NCT01804946|474790393|FG000|Overall Study|Adverse Event|0|||
131866647|NCT01804946|474790394|FG001|Overall Study|Adverse Event|1|||
131916832|NCT02296125|474979942|FG000|Overall Study|Withdrawal by Subject|18|||
131916833|NCT02296125|474979943|FG001|Overall Study|Withdrawal by Subject|8|||
131916834|NCT02296125|474979944|FG002|Overall Study|Withdrawal by Subject|6|||
131916835|NCT02296125|474979945|FG003|Overall Study|Withdrawal by Subject|2|||
131916836|NCT02296125|474979942|FG000|Overall Study|Adverse Event|41|||
131916837|NCT02296125|474979943|FG001|Overall Study|Adverse Event|52|||
131916838|NCT02296125|474979944|FG002|Overall Study|Adverse Event|9|||
131916839|NCT02296125|474979945|FG003|Overall Study|Adverse Event|4|||
131916840|NCT02296125|474979942|FG000|Overall Study|Severe non-compliance to protocol|0|||
131916841|NCT02296125|474979943|FG001|Overall Study|Severe non-compliance to protocol|1|||
131916842|NCT02296125|474979944|FG002|Overall Study|Severe non-compliance to protocol|0|||
131916843|NCT02296125|474979945|FG003|Overall Study|Severe non-compliance to protocol|0|||
131916844|NCT02296125|474979942|FG000|Overall Study|Condition under investigation worsened|153|||
131916845|NCT02296125|474979943|FG001|Overall Study|Condition under investigation worsened|199|||
131916846|NCT02296125|474979944|FG002|Overall Study|Condition under investigation worsened|39|||
131916847|NCT02296125|474979945|FG003|Overall Study|Condition under investigation worsened|56|||
131916848|NCT02296125|474979942|FG000|Overall Study|Any reason not specifically recorded|6|||
131866648|NCT01804946|474790393|FG000|Overall Study|Insufficient data available|0|||
131866649|NCT01804946|474790394|FG001|Overall Study|Insufficient data available|1|||
131866650|NCT01804946|474790393|FG000|Overall Study|Do not meet inclusion criteria|1|||
131866651|NCT01804946|474790394|FG001|Overall Study|Do not meet inclusion criteria|2|||
131866652|NCT00722137|474790396|FG000|Overall Study|Overt Disease Progression|5|||
131866653|NCT00722137|474790397|FG001|Overall Study|Overt Disease Progression|4|||
131866654|NCT00722137|474790396|FG000|Overall Study|Adverse Event|17|||
131866655|NCT00722137|474790397|FG001|Overall Study|Adverse Event|21|||
131866656|NCT00722137|474790396|FG000|Overall Study|Death|12|||
131866657|NCT00722137|474790397|FG001|Overall Study|Death|7|||
131866658|NCT00722137|474790396|FG000|Overall Study|Withdrawal by Subject|6|||
131866659|NCT00722137|474790397|FG001|Overall Study|Withdrawal by Subject|9|||
131866660|NCT00722137|474790396|FG000|Overall Study|Other Reason Unknown|3|||
131866661|NCT00722137|474790397|FG001|Overall Study|Other Reason Unknown|4|||
131866662|NCT00722137|474790396|FG000|Overall Study|Randomized But Not Treated|2|||
131866663|NCT00722137|474790397|FG001|Overall Study|Randomized But Not Treated|3|||
131866664|NCT00848718|474790398|FG000|Overall Study|Adverse Event|2|||
131866665|NCT00848718|474790399|FG001|Overall Study|Adverse Event|2|||
131866666|NCT00848718|474790400|FG002|Overall Study|Adverse Event|1|||
131866667|NCT00848718|474790401|FG003|Overall Study|Adverse Event|1|||
131866668|NCT00848718|474790402|FG004|Overall Study|Adverse Event|1|||
131866669|NCT00848718|474790403|FG005|Overall Study|Adverse Event|0|||
131866670|NCT00848718|474790404|FG006|Overall Study|Adverse Event|0|||
131866671|NCT00848718|474790405|FG007|Overall Study|Adverse Event|1|||
131866672|NCT00848718|474790406|FG008|Overall Study|Adverse Event|1|||
131866673|NCT00848718|474790407|FG009|Overall Study|Adverse Event|0|||
131866674|NCT00848718|474790408|FG010|Overall Study|Adverse Event|0|||
131866675|NCT00848718|474790409|FG011|Overall Study|Adverse Event|0|||
131866676|NCT00848718|474790410|FG012|Overall Study|Adverse Event|2|||
131866677|NCT00848718|474790398|FG000|Overall Study|Lack of Efficacy|0|||
131866678|NCT00848718|474790399|FG001|Overall Study|Lack of Efficacy|0|||
131866679|NCT00848718|474790400|FG002|Overall Study|Lack of Efficacy|1|||
131866680|NCT00848718|474790401|FG003|Overall Study|Lack of Efficacy|0|||
131866681|NCT00848718|474790402|FG004|Overall Study|Lack of Efficacy|0|||
131866682|NCT00848718|474790403|FG005|Overall Study|Lack of Efficacy|0|||
131866683|NCT00848718|474790404|FG006|Overall Study|Lack of Efficacy|1|||
131866684|NCT00848718|474790405|FG007|Overall Study|Lack of Efficacy|0|||
131866685|NCT00848718|474790406|FG008|Overall Study|Lack of Efficacy|0|||
131866686|NCT00848718|474790407|FG009|Overall Study|Lack of Efficacy|0|||
131866687|NCT00848718|474790408|FG010|Overall Study|Lack of Efficacy|0|||
131866688|NCT00848718|474790409|FG011|Overall Study|Lack of Efficacy|0|||
131866689|NCT00848718|474790410|FG012|Overall Study|Lack of Efficacy|0|||
131866690|NCT00848718|474790398|FG000|Overall Study|Physician Decision|0|||
131866691|NCT00848718|474790399|FG001|Overall Study|Physician Decision|1|||
131866692|NCT00848718|474790400|FG002|Overall Study|Physician Decision|0|||
131866693|NCT00848718|474790401|FG003|Overall Study|Physician Decision|0|||
131866694|NCT00848718|474790402|FG004|Overall Study|Physician Decision|1|||
131866695|NCT00848718|474790403|FG005|Overall Study|Physician Decision|1|||
131866696|NCT00848718|474790404|FG006|Overall Study|Physician Decision|0|||
131866697|NCT00848718|474790405|FG007|Overall Study|Physician Decision|0|||
131866698|NCT00848718|474790406|FG008|Overall Study|Physician Decision|1|||
131866699|NCT00848718|474790407|FG009|Overall Study|Physician Decision|2|||
131866700|NCT00848718|474790408|FG010|Overall Study|Physician Decision|0|||
131866701|NCT00848718|474790409|FG011|Overall Study|Physician Decision|0|||
131916849|NCT02296125|474979943|FG001|Overall Study|Any reason not specifically recorded|4|||
131916850|NCT02296125|474979944|FG002|Overall Study|Any reason not specifically recorded|2|||
131866702|NCT00848718|474790410|FG012|Overall Study|Physician Decision|1|||
131866703|NCT00848718|474790398|FG000|Overall Study|Progressive disease before treatment|1|||
131866704|NCT00848718|474790399|FG001|Overall Study|Progressive disease before treatment|5|||
131866705|NCT00848718|474790400|FG002|Overall Study|Progressive disease before treatment|1|||
131916851|NCT02296125|474979945|FG003|Overall Study|Any reason not specifically recorded|0|||
131916852|NCT01160614|474979946|FG000|Overall Study|Withdrawal by Subject|0|||
131916853|NCT01160614|474979947|FG001|Overall Study|Withdrawal by Subject|2|||
131916854|NCT03314935|474979948|FG000|Phase 1|Death|4|||
131916855|NCT03314935|474979949|FG001|Phase 1|Death|2|||
131916856|NCT03314935|474979950|FG002|Phase 1|Death|5|||
131916857|NCT03314935|474979951|FG003|Phase 1|Death|4|||
131916858|NCT03314935|474979952|FG004|Phase 1|Death|3|||
131916859|NCT03314935|474979953|FG005|Phase 1|Death|4|||
131916860|NCT03314935|474979954|FG006|Phase 1|Death|5|||
131916861|NCT03314935|474979955|FG007|Phase 1|Death|4|||
131916862|NCT03314935|474979956|FG008|Phase 1|Death|3|||
131916863|NCT03314935|474979957|FG009|Phase 1|Death|0|||
131916864|NCT03314935|474979958|FG010|Phase 1|Death|0|||
131916865|NCT03314935|474979959|FG011|Phase 1|Death|0|||
131916866|NCT03314935|474979960|FG012|Phase 1|Death|0|||
131916867|NCT03314935|474979961|FG013|Phase 1|Death|0|||
131916868|NCT03314935|474979962|FG014|Phase 1|Death|0|||
131916869|NCT03314935|474979948|FG000|Phase 1|Withdrawal by Subject|2|||
131916870|NCT03314935|474979949|FG001|Phase 1|Withdrawal by Subject|1|||
131916871|NCT03314935|474979950|FG002|Phase 1|Withdrawal by Subject|1|||
131916872|NCT03314935|474979951|FG003|Phase 1|Withdrawal by Subject|2|||
131916873|NCT03314935|474979952|FG004|Phase 1|Withdrawal by Subject|1|||
131916874|NCT03314935|474979953|FG005|Phase 1|Withdrawal by Subject|0|||
131916875|NCT03314935|474979954|FG006|Phase 1|Withdrawal by Subject|1|||
131916876|NCT03314935|474979955|FG007|Phase 1|Withdrawal by Subject|0|||
131916877|NCT03314935|474979956|FG008|Phase 1|Withdrawal by Subject|1|||
131916878|NCT03314935|474979957|FG009|Phase 1|Withdrawal by Subject|0|||
131916879|NCT03314935|474979958|FG010|Phase 1|Withdrawal by Subject|0|||
131916880|NCT03314935|474979959|FG011|Phase 1|Withdrawal by Subject|0|||
131916881|NCT03314935|474979960|FG012|Phase 1|Withdrawal by Subject|0|||
131916882|NCT03314935|474979961|FG013|Phase 1|Withdrawal by Subject|0|||
131916883|NCT03314935|474979962|FG014|Phase 1|Withdrawal by Subject|0|||
131916884|NCT03314935|474979948|FG000|Phase 1|Progressive Disease|2|||
131916885|NCT03314935|474979949|FG001|Phase 1|Progressive Disease|0|||
131916886|NCT03314935|474979950|FG002|Phase 1|Progressive Disease|0|||
131916887|NCT03314935|474979951|FG003|Phase 1|Progressive Disease|1|||
131916888|NCT03314935|474979952|FG004|Phase 1|Progressive Disease|0|||
131916889|NCT03314935|474979953|FG005|Phase 1|Progressive Disease|0|||
131916890|NCT03314935|474979954|FG006|Phase 1|Progressive Disease|0|||
131916891|NCT03314935|474979955|FG007|Phase 1|Progressive Disease|0|||
131916892|NCT03314935|474979956|FG008|Phase 1|Progressive Disease|0|||
131916893|NCT03314935|474979957|FG009|Phase 1|Progressive Disease|0|||
131916894|NCT03314935|474979958|FG010|Phase 1|Progressive Disease|0|||
131916895|NCT03314935|474979959|FG011|Phase 1|Progressive Disease|0|||
131916896|NCT03314935|474979960|FG012|Phase 1|Progressive Disease|0|||
131916897|NCT03314935|474979961|FG013|Phase 1|Progressive Disease|0|||
131916898|NCT03314935|474979962|FG014|Phase 1|Progressive Disease|0|||
131916899|NCT03314935|474979948|FG000|Phase 1|Study Terminated by Sponsor|0|||
131916900|NCT03314935|474979949|FG001|Phase 1|Study Terminated by Sponsor|1|||
131916901|NCT03314935|474979950|FG002|Phase 1|Study Terminated by Sponsor|0|||
131916902|NCT03314935|474979951|FG003|Phase 1|Study Terminated by Sponsor|0|||
131916903|NCT03314935|474979952|FG004|Phase 1|Study Terminated by Sponsor|0|||
131916904|NCT03314935|474979953|FG005|Phase 1|Study Terminated by Sponsor|0|||
131916905|NCT03314935|474979954|FG006|Phase 1|Study Terminated by Sponsor|0|||
131916906|NCT03314935|474979955|FG007|Phase 1|Study Terminated by Sponsor|0|||
131916907|NCT03314935|474979956|FG008|Phase 1|Study Terminated by Sponsor|1|||
131916908|NCT03314935|474979957|FG009|Phase 1|Study Terminated by Sponsor|0|||
131916909|NCT03314935|474979958|FG010|Phase 1|Study Terminated by Sponsor|0|||
131916910|NCT03314935|474979959|FG011|Phase 1|Study Terminated by Sponsor|0|||
131916911|NCT03314935|474979960|FG012|Phase 1|Study Terminated by Sponsor|0|||
131916912|NCT03314935|474979961|FG013|Phase 1|Study Terminated by Sponsor|0|||
131916913|NCT03314935|474979962|FG014|Phase 1|Study Terminated by Sponsor|0|||
131916914|NCT03314935|474979948|FG000|Phase 1|"Captured as Other in Database"|0|||
131916915|NCT03314935|474979949|FG001|Phase 1|"Captured as Other in Database"|2|||
131916916|NCT03314935|474979950|FG002|Phase 1|"Captured as Other in Database"|0|||
131916917|NCT03314935|474979951|FG003|Phase 1|"Captured as Other in Database"|0|||
131916918|NCT03314935|474979952|FG004|Phase 1|"Captured as Other in Database"|0|||
131916919|NCT03314935|474979953|FG005|Phase 1|"Captured as Other in Database"|0|||
131916920|NCT03314935|474979954|FG006|Phase 1|"Captured as Other in Database"|1|||
131916921|NCT03314935|474979955|FG007|Phase 1|"Captured as Other in Database"|1|||
131916922|NCT03314935|474979956|FG008|Phase 1|"Captured as Other in Database"|1|||
131916923|NCT03314935|474979957|FG009|Phase 1|"Captured as Other in Database"|0|||
131916924|NCT03314935|474979958|FG010|Phase 1|"Captured as Other in Database"|0|||
131916925|NCT03314935|474979959|FG011|Phase 1|"Captured as Other in Database"|0|||
131916926|NCT03314935|474979960|FG012|Phase 1|"Captured as Other in Database"|0|||
131916927|NCT03314935|474979961|FG013|Phase 1|"Captured as Other in Database"|0|||
131916928|NCT03314935|474979962|FG014|Phase 1|"Captured as Other in Database"|0|||
131916929|NCT03314935|474979948|FG000|Phase 1|Lost to Follow-up|0|||
131916930|NCT03314935|474979949|FG001|Phase 1|Lost to Follow-up|0|||
131916931|NCT03314935|474979950|FG002|Phase 1|Lost to Follow-up|0|||
131866706|NCT00848718|474790401|FG003|Overall Study|Progressive disease before treatment|3|||
131866707|NCT00848718|474790402|FG004|Overall Study|Progressive disease before treatment|4|||
131866708|NCT00848718|474790403|FG005|Overall Study|Progressive disease before treatment|4|||
131866709|NCT00848718|474790404|FG006|Overall Study|Progressive disease before treatment|2|||
131866710|NCT00848718|474790405|FG007|Overall Study|Progressive disease before treatment|1|||
131866711|NCT00848718|474790406|FG008|Overall Study|Progressive disease before treatment|2|||
131866712|NCT00848718|474790407|FG009|Overall Study|Progressive disease before treatment|7|||
131866713|NCT00848718|474790408|FG010|Overall Study|Progressive disease before treatment|3|||
131866714|NCT00848718|474790409|FG011|Overall Study|Progressive disease before treatment|6|||
131866715|NCT00848718|474790410|FG012|Overall Study|Progressive disease before treatment|2|||
131866716|NCT00848718|474790398|FG000|Overall Study|Protocol Violation|0|||
131866717|NCT00848718|474790399|FG001|Overall Study|Protocol Violation|1|||
131866718|NCT00848718|474790400|FG002|Overall Study|Protocol Violation|0|||
131866719|NCT00848718|474790401|FG003|Overall Study|Protocol Violation|0|||
131866720|NCT00848718|474790402|FG004|Overall Study|Protocol Violation|0|||
131866721|NCT00848718|474790403|FG005|Overall Study|Protocol Violation|0|||
131866722|NCT00848718|474790404|FG006|Overall Study|Protocol Violation|0|||
131866723|NCT00848718|474790405|FG007|Overall Study|Protocol Violation|1|||
131866724|NCT00848718|474790406|FG008|Overall Study|Protocol Violation|0|||
131866725|NCT00848718|474790407|FG009|Overall Study|Protocol Violation|0|||
131866726|NCT00848718|474790408|FG010|Overall Study|Protocol Violation|0|||
131866727|NCT00848718|474790409|FG011|Overall Study|Protocol Violation|0|||
131866728|NCT00848718|474790410|FG012|Overall Study|Protocol Violation|1|||
131866729|NCT00848718|474790398|FG000|Overall Study|Withdrawal by Subject|1|||
131866730|NCT00848718|474790399|FG001|Overall Study|Withdrawal by Subject|0|||
131866731|NCT00848718|474790400|FG002|Overall Study|Withdrawal by Subject|0|||
131866732|NCT00848718|474790401|FG003|Overall Study|Withdrawal by Subject|1|||
131866733|NCT00848718|474790402|FG004|Overall Study|Withdrawal by Subject|0|||
131866734|NCT00848718|474790403|FG005|Overall Study|Withdrawal by Subject|0|||
131866735|NCT00848718|474790404|FG006|Overall Study|Withdrawal by Subject|0|||
131866736|NCT00848718|474790405|FG007|Overall Study|Withdrawal by Subject|0|||
131866737|NCT00848718|474790406|FG008|Overall Study|Withdrawal by Subject|0|||
131866738|NCT00848718|474790407|FG009|Overall Study|Withdrawal by Subject|0|||
131866739|NCT00848718|474790408|FG010|Overall Study|Withdrawal by Subject|1|||
131866740|NCT00848718|474790409|FG011|Overall Study|Withdrawal by Subject|0|||
131866741|NCT00848718|474790410|FG012|Overall Study|Withdrawal by Subject|0|||
131866742|NCT00848718|474790398|FG000|Overall Study|Progressive disease during treatment|3|||
131866743|NCT00848718|474790399|FG001|Overall Study|Progressive disease during treatment|0|||
131866744|NCT00848718|474790400|FG002|Overall Study|Progressive disease during treatment|3|||
131866745|NCT00848718|474790401|FG003|Overall Study|Progressive disease during treatment|0|||
131866746|NCT00848718|474790402|FG004|Overall Study|Progressive disease during treatment|0|||
131866747|NCT00848718|474790403|FG005|Overall Study|Progressive disease during treatment|0|||
131866748|NCT00848718|474790404|FG006|Overall Study|Progressive disease during treatment|0|||
131866749|NCT00848718|474790405|FG007|Overall Study|Progressive disease during treatment|2|||
131866750|NCT00848718|474790406|FG008|Overall Study|Progressive disease during treatment|0|||
131866751|NCT00848718|474790407|FG009|Overall Study|Progressive disease during treatment|0|||
131866752|NCT00848718|474790408|FG010|Overall Study|Progressive disease during treatment|0|||
131866753|NCT00848718|474790409|FG011|Overall Study|Progressive disease during treatment|0|||
131866754|NCT00848718|474790410|FG012|Overall Study|Progressive disease during treatment|2|||
131866755|NCT02431676|474790412|FG000|Overall Study|no lab obtained|0|||
131866756|NCT02431676|474790413|FG001|Overall Study|no lab obtained|1|||
131866757|NCT02431676|474790414|FG002|Overall Study|no lab obtained|2|||
131866758|NCT00824772|474792267|FG000|Overall Study|Withdrawal by Subject|8|||
131866759|NCT00866281|474792268|FG000|Overall Study|Adverse Event|1|||
131866760|NCT00866281|474792269|FG001|Overall Study|Adverse Event|0|||
131866761|NCT00866281|474792268|FG000|Overall Study|Withdrawal by participants|3|||
131866762|NCT00866281|474792269|FG001|Overall Study|Withdrawal by participants|0|||
131866763|NCT00866281|474792268|FG000|Overall Study|Disease progression|3|||
131866764|NCT00866281|474792269|FG001|Overall Study|Disease progression|11|||
131866765|NCT00866281|474792268|FG000|Overall Study|New cancer therapy|0|||
131866766|NCT00866281|474792269|FG001|Overall Study|New cancer therapy|4|||
131866767|NCT01894841|474792272|FG000|Overall Study|Withdrawal by Subject|9|||
131866768|NCT01894841|474792273|FG001|Overall Study|Withdrawal by Subject|4|||
131866769|NCT01894841|474792272|FG000|Overall Study|Withdrawn by investigator|2|||
131866770|NCT01894841|474792273|FG001|Overall Study|Withdrawn by investigator|2|||
131866771|NCT01894841|474792272|FG000|Overall Study|Lost to Follow-up|7|||
131866772|NCT01894841|474792273|FG001|Overall Study|Lost to Follow-up|3|||
131866773|NCT00529087|474792279|FG000|Overall Study|Adverse Event|10|||
131866774|NCT00529087|474792280|FG001|Overall Study|Adverse Event|13|||
131866775|NCT00529087|474792281|FG002|Overall Study|Adverse Event|4|||
131866776|NCT00529087|474792279|FG000|Overall Study|Lost to Follow-up|6|||
131866777|NCT00529087|474792280|FG001|Overall Study|Lost to Follow-up|4|||
131866778|NCT00529087|474792281|FG002|Overall Study|Lost to Follow-up|1|||
131866779|NCT00529087|474792279|FG000|Overall Study|Protocol Violation|8|||
131916932|NCT03314935|474979951|FG003|Phase 1|Lost to Follow-up|0|||
131916933|NCT03314935|474979952|FG004|Phase 1|Lost to Follow-up|0|||
131916934|NCT03314935|474979953|FG005|Phase 1|Lost to Follow-up|0|||
131916935|NCT03314935|474979954|FG006|Phase 1|Lost to Follow-up|0|||
131916936|NCT03314935|474979955|FG007|Phase 1|Lost to Follow-up|0|||
131916937|NCT03314935|474979956|FG008|Phase 1|Lost to Follow-up|1|||
131916938|NCT03314935|474979957|FG009|Phase 1|Lost to Follow-up|0|||
131916939|NCT03314935|474979958|FG010|Phase 1|Lost to Follow-up|0|||
131916940|NCT03314935|474979959|FG011|Phase 1|Lost to Follow-up|0|||
131916941|NCT03314935|474979960|FG012|Phase 1|Lost to Follow-up|0|||
131916942|NCT03314935|474979961|FG013|Phase 1|Lost to Follow-up|0|||
131916943|NCT03314935|474979962|FG014|Phase 1|Lost to Follow-up|0|||
131916944|NCT03314935|474979948|FG000|Phase 2|Death|0|||
131916945|NCT03314935|474979949|FG001|Phase 2|Death|0|||
131916946|NCT03314935|474979950|FG002|Phase 2|Death|0|||
131916947|NCT03314935|474979951|FG003|Phase 2|Death|0|||
131916948|NCT03314935|474979952|FG004|Phase 2|Death|0|||
131916949|NCT03314935|474979953|FG005|Phase 2|Death|0|||
131916950|NCT03314935|474979954|FG006|Phase 2|Death|0|||
131916951|NCT03314935|474979955|FG007|Phase 2|Death|0|||
131916952|NCT03314935|474979956|FG008|Phase 2|Death|0|||
131916953|NCT03314935|474979957|FG009|Phase 2|Death|5|||
131916954|NCT03314935|474979958|FG010|Phase 2|Death|20|||
131916955|NCT03314935|474979959|FG011|Phase 2|Death|6|||
131916956|NCT03314935|474979960|FG012|Phase 2|Death|7|||
131916957|NCT03314935|474979961|FG013|Phase 2|Death|6|||
131916958|NCT03314935|474979962|FG014|Phase 2|Death|17|||
131916959|NCT03314935|474979948|FG000|Phase 2|Withdrawal by Subject|0|||
131916960|NCT03314935|474979949|FG001|Phase 2|Withdrawal by Subject|0|||
131916961|NCT03314935|474979950|FG002|Phase 2|Withdrawal by Subject|0|||
131916962|NCT03314935|474979951|FG003|Phase 2|Withdrawal by Subject|0|||
131916963|NCT03314935|474979952|FG004|Phase 2|Withdrawal by Subject|0|||
131916964|NCT03314935|474979953|FG005|Phase 2|Withdrawal by Subject|0|||
131916965|NCT03314935|474979954|FG006|Phase 2|Withdrawal by Subject|0|||
131916966|NCT03314935|474979955|FG007|Phase 2|Withdrawal by Subject|0|||
131916967|NCT03314935|474979956|FG008|Phase 2|Withdrawal by Subject|0|||
131916968|NCT03314935|474979957|FG009|Phase 2|Withdrawal by Subject|1|||
131916969|NCT03314935|474979958|FG010|Phase 2|Withdrawal by Subject|4|||
131916970|NCT03314935|474979959|FG011|Phase 2|Withdrawal by Subject|0|||
131916971|NCT03314935|474979960|FG012|Phase 2|Withdrawal by Subject|1|||
131916972|NCT03314935|474979961|FG013|Phase 2|Withdrawal by Subject|0|||
131916973|NCT03314935|474979962|FG014|Phase 2|Withdrawal by Subject|1|||
131916974|NCT03314935|474979948|FG000|Phase 2|Progressive Disease|0|||
131916975|NCT03314935|474979949|FG001|Phase 2|Progressive Disease|0|||
131916976|NCT03314935|474979950|FG002|Phase 2|Progressive Disease|0|||
131916977|NCT03314935|474979951|FG003|Phase 2|Progressive Disease|0|||
131916978|NCT03314935|474979952|FG004|Phase 2|Progressive Disease|0|||
131916979|NCT03314935|474979953|FG005|Phase 2|Progressive Disease|0|||
131916980|NCT03314935|474979954|FG006|Phase 2|Progressive Disease|0|||
131916981|NCT03314935|474979955|FG007|Phase 2|Progressive Disease|0|||
131916982|NCT03314935|474979956|FG008|Phase 2|Progressive Disease|0|||
131916983|NCT03314935|474979957|FG009|Phase 2|Progressive Disease|1|||
131916984|NCT03314935|474979958|FG010|Phase 2|Progressive Disease|1|||
131916985|NCT03314935|474979959|FG011|Phase 2|Progressive Disease|1|||
131916986|NCT03314935|474979960|FG012|Phase 2|Progressive Disease|2|||
131916987|NCT03314935|474979961|FG013|Phase 2|Progressive Disease|0|||
131916988|NCT03314935|474979962|FG014|Phase 2|Progressive Disease|1|||
131916989|NCT03314935|474979948|FG000|Phase 2|Study Terminated by Sponsor|0|||
131916990|NCT03314935|474979949|FG001|Phase 2|Study Terminated by Sponsor|0|||
131916991|NCT03314935|474979950|FG002|Phase 2|Study Terminated by Sponsor|0|||
131916992|NCT03314935|474979951|FG003|Phase 2|Study Terminated by Sponsor|0|||
131916993|NCT03314935|474979952|FG004|Phase 2|Study Terminated by Sponsor|0|||
131916994|NCT03314935|474979953|FG005|Phase 2|Study Terminated by Sponsor|0|||
131916995|NCT03314935|474979954|FG006|Phase 2|Study Terminated by Sponsor|0|||
131916996|NCT03314935|474979955|FG007|Phase 2|Study Terminated by Sponsor|0|||
131916997|NCT03314935|474979956|FG008|Phase 2|Study Terminated by Sponsor|0|||
131916998|NCT03314935|474979957|FG009|Phase 2|Study Terminated by Sponsor|0|||
131916999|NCT03314935|474979958|FG010|Phase 2|Study Terminated by Sponsor|7|||
131917000|NCT03314935|474979959|FG011|Phase 2|Study Terminated by Sponsor|2|||
131917001|NCT03314935|474979960|FG012|Phase 2|Study Terminated by Sponsor|1|||
131917002|NCT03314935|474979961|FG013|Phase 2|Study Terminated by Sponsor|4|||
131917003|NCT03314935|474979962|FG014|Phase 2|Study Terminated by Sponsor|4|||
131917004|NCT03314935|474979948|FG000|Phase 2|Lost to Follow-up|0|||
131917005|NCT03314935|474979949|FG001|Phase 2|Lost to Follow-up|0|||
131917006|NCT03314935|474979950|FG002|Phase 2|Lost to Follow-up|0|||
131917007|NCT03314935|474979951|FG003|Phase 2|Lost to Follow-up|0|||
131917008|NCT03314935|474979952|FG004|Phase 2|Lost to Follow-up|0|||
131917009|NCT03314935|474979953|FG005|Phase 2|Lost to Follow-up|0|||
131917010|NCT03314935|474979954|FG006|Phase 2|Lost to Follow-up|0|||
131917011|NCT03314935|474979955|FG007|Phase 2|Lost to Follow-up|0|||
131917012|NCT03314935|474979956|FG008|Phase 2|Lost to Follow-up|0|||
131917013|NCT03314935|474979957|FG009|Phase 2|Lost to Follow-up|1|||
131917014|NCT03314935|474979958|FG010|Phase 2|Lost to Follow-up|0|||
131917015|NCT03314935|474979959|FG011|Phase 2|Lost to Follow-up|0|||
131866780|NCT00529087|474792280|FG001|Overall Study|Protocol Violation|7|||
131408142|NCT00496197|473118192|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
131408143|NCT00496197|473118192|FG000|Overall Study|Other|14|||
131408144|NCT00496197|473118192|FG000|Overall Study|Protocol Violation|8|||
131866781|NCT00529087|474792281|FG002|Overall Study|Protocol Violation|6|||
131866782|NCT00529087|474792279|FG000|Overall Study|Withdrawal by Subject|3|||
131866783|NCT00529087|474792280|FG001|Overall Study|Withdrawal by Subject|3|||
131866784|NCT00529087|474792281|FG002|Overall Study|Withdrawal by Subject|3|||
131866785|NCT00529087|474792279|FG000|Overall Study|Protocol deviation|1|||
131866786|NCT00529087|474792280|FG001|Overall Study|Protocol deviation|1|||
131866787|NCT00529087|474792281|FG002|Overall Study|Protocol deviation|2|||
131866788|NCT00318474|474792282|FG000|Overall Study|Adverse Event|1|||
131866789|NCT00318474|474792283|FG001|Overall Study|Adverse Event|1|||
131866790|NCT00318474|474792282|FG000|Overall Study|Lost to Follow-up|0|||
131866791|NCT00318474|474792283|FG001|Overall Study|Lost to Follow-up|1|||
131866792|NCT00318474|474792282|FG000|Overall Study|Pregnancy|0|||
131866793|NCT00318474|474792283|FG001|Overall Study|Pregnancy|2|||
131866794|NCT00318474|474792282|FG000|Overall Study|Protocol Violation|1|||
131866795|NCT00318474|474792283|FG001|Overall Study|Protocol Violation|0|||
131866796|NCT00318474|474792282|FG000|Overall Study|Withdrawal by Subject|3|||
131866797|NCT00318474|474792283|FG001|Overall Study|Withdrawal by Subject|2|||
131866798|NCT00318474|474792282|FG000|Overall Study|Fall in GFR|3|||
131866799|NCT00318474|474792283|FG001|Overall Study|Fall in GFR|3|||
131866800|NCT00318474|474792282|FG000|Overall Study|Post-therapy hyperflycemia|0|||
131866801|NCT00318474|474792283|FG001|Overall Study|Post-therapy hyperflycemia|1|||
131866802|NCT00318474|474792282|FG000|Overall Study|Trial terminated|10|||
131866803|NCT00318474|474792283|FG001|Overall Study|Trial terminated|7|||
131866804|NCT01379768|474792297|FG000|Overall Study|Adverse Event|1|||
131866805|NCT01379768|474792298|FG001|Overall Study|Adverse Event|1|||
131866806|NCT01379768|474792299|FG002|Overall Study|Adverse Event|0|||
131866807|NCT01379768|474792297|FG000|Overall Study|Lost to Follow-up|2|||
131866808|NCT01379768|474792298|FG001|Overall Study|Lost to Follow-up|0|||
131866809|NCT01379768|474792299|FG002|Overall Study|Lost to Follow-up|0|||
131866810|NCT00708552|474792300|FG000|Overall Study|Adverse Event|10|||
131866811|NCT00708552|474792301|FG001|Overall Study|Adverse Event|3|||
131866812|NCT00708552|474792302|FG002|Overall Study|Adverse Event|4|||
131866813|NCT00708552|474792303|FG003|Overall Study|Adverse Event|6|||
131866814|NCT00708552|474792300|FG000|Overall Study|Lack of Efficacy|0|||
131866815|NCT00708552|474792301|FG001|Overall Study|Lack of Efficacy|4|||
131866816|NCT00708552|474792302|FG002|Overall Study|Lack of Efficacy|1|||
131866817|NCT00708552|474792303|FG003|Overall Study|Lack of Efficacy|0|||
131866818|NCT00708552|474792300|FG000|Overall Study|Protocol Violation|0|||
131866819|NCT00708552|474792301|FG001|Overall Study|Protocol Violation|0|||
131866820|NCT00708552|474792302|FG002|Overall Study|Protocol Violation|2|||
131866821|NCT00708552|474792303|FG003|Overall Study|Protocol Violation|4|||
131866822|NCT00708552|474792300|FG000|Overall Study|Lost to Follow-up|4|||
131866823|NCT00708552|474792301|FG001|Overall Study|Lost to Follow-up|2|||
131866824|NCT00708552|474792302|FG002|Overall Study|Lost to Follow-up|0|||
131866825|NCT00708552|474792303|FG003|Overall Study|Lost to Follow-up|1|||
131866826|NCT00708552|474792300|FG000|Overall Study|Physician Decision|1|||
131866827|NCT00708552|474792301|FG001|Overall Study|Physician Decision|2|||
131866828|NCT00708552|474792302|FG002|Overall Study|Physician Decision|0|||
131866829|NCT00708552|474792303|FG003|Overall Study|Physician Decision|0|||
131866830|NCT00708552|474792300|FG000|Overall Study|Withdrawal by Subject|12|||
131866831|NCT00708552|474792301|FG001|Overall Study|Withdrawal by Subject|7|||
131866832|NCT00708552|474792302|FG002|Overall Study|Withdrawal by Subject|8|||
131866833|NCT00708552|474792303|FG003|Overall Study|Withdrawal by Subject|10|||
131866834|NCT00455403|474792305|FG000|Overall Study|Lost to Follow-up|2|||
131866835|NCT00455403|474792306|FG001|Overall Study|Lost to Follow-up|1|||
131866836|NCT00455403|474792305|FG000|Overall Study|Withdrawal by Subject|1|||
131866837|NCT00455403|474792306|FG001|Overall Study|Withdrawal by Subject|3|||
131866838|NCT00455403|474792305|FG000|Overall Study|Protocol Violation|0|||
131866839|NCT00455403|474792306|FG001|Overall Study|Protocol Violation|2|||
131866840|NCT00350207|474792307|FG000|Overall Study|Adverse Event|5|||
131866841|NCT00350207|474792308|FG001|Overall Study|Adverse Event|2|||
131866842|NCT00350207|474792309|FG002|Overall Study|Adverse Event|2|||
131866843|NCT00350207|474792307|FG000|Overall Study|Lack of Efficacy|1|||
131866844|NCT00350207|474792308|FG001|Overall Study|Lack of Efficacy|0|||
131408145|NCT01344538|473118193|FG000|Overall Study|Adverse Event|1|||
131866845|NCT00350207|474792309|FG002|Overall Study|Lack of Efficacy|2|||
131866846|NCT00350207|474792307|FG000|Overall Study|Lost to Follow-up|1|||
131866847|NCT00350207|474792308|FG001|Overall Study|Lost to Follow-up|0|||
131866848|NCT00350207|474792309|FG002|Overall Study|Lost to Follow-up|1|||
131408146|NCT01344538|473118194|FG001|Overall Study|Adverse Event|1|||
131866849|NCT00350207|474792307|FG000|Overall Study|Withdrawal by Subject|0|||
131866850|NCT00350207|474792308|FG001|Overall Study|Withdrawal by Subject|1|||
131866851|NCT00350207|474792309|FG002|Overall Study|Withdrawal by Subject|1|||
131866852|NCT00350207|474792307|FG000|Overall Study|Other|1|||
131866853|NCT00350207|474792308|FG001|Overall Study|Other|3|||
131866854|NCT00350207|474792309|FG002|Overall Study|Other|1|||
131917016|NCT03314935|474979960|FG012|Phase 2|Lost to Follow-up|0|||
131917017|NCT03314935|474979961|FG013|Phase 2|Lost to Follow-up|0|||
131917018|NCT03314935|474979962|FG014|Phase 2|Lost to Follow-up|1|||
131917019|NCT03314935|474979948|FG000|Phase 2|Physician Decision|0|||
131917020|NCT03314935|474979949|FG001|Phase 2|Physician Decision|0|||
131917021|NCT03314935|474979950|FG002|Phase 2|Physician Decision|0|||
131917022|NCT03314935|474979951|FG003|Phase 2|Physician Decision|0|||
131917023|NCT03314935|474979952|FG004|Phase 2|Physician Decision|0|||
131917024|NCT03314935|474979953|FG005|Phase 2|Physician Decision|0|||
131917025|NCT03314935|474979954|FG006|Phase 2|Physician Decision|0|||
131917026|NCT03314935|474979955|FG007|Phase 2|Physician Decision|0|||
131917027|NCT03314935|474979956|FG008|Phase 2|Physician Decision|0|||
131917028|NCT03314935|474979957|FG009|Phase 2|Physician Decision|0|||
131917029|NCT03314935|474979958|FG010|Phase 2|Physician Decision|1|||
131917030|NCT03314935|474979959|FG011|Phase 2|Physician Decision|0|||
131917031|NCT03314935|474979960|FG012|Phase 2|Physician Decision|0|||
131917032|NCT03314935|474979961|FG013|Phase 2|Physician Decision|0|||
131917033|NCT03314935|474979962|FG014|Phase 2|Physician Decision|0|||
131917034|NCT05845619|474979963|FG000|Overall Study|duplicate enrollment|2|||
131917035|NCT05845619|474979964|FG001|Overall Study|duplicate enrollment|2|||
131917036|NCT05845619|474979965|FG002|Overall Study|duplicate enrollment|1|||
131917037|NCT03636477|474979969|FG000|Overall Study|Adverse Event|0|||
131917038|NCT03636477|474979970|FG001|Overall Study|Adverse Event|0|||
131917039|NCT03636477|474979971|FG002|Overall Study|Adverse Event|1|||
131917040|NCT03621592|474979972|FG000|Overall Study|Lost to Follow-up|1|||
131917041|NCT03621592|474979973|FG001|Overall Study|Lost to Follow-up|0|||
131917042|NCT03621592|474979972|FG000|Overall Study|Lack of Improvement|1|||
131917043|NCT03621592|474979973|FG001|Overall Study|Lack of Improvement|0|||
131917044|NCT03621592|474979972|FG000|Overall Study|Preference to receive wound care closer to home|1|||
131917045|NCT03621592|474979973|FG001|Overall Study|Preference to receive wound care closer to home|0|||
131917046|NCT03621592|474979972|FG000|Overall Study|Lack of healing|0|||
131917047|NCT03621592|474979973|FG001|Overall Study|Lack of healing|2|||
131917048|NCT02382380|474979975|FG000|Overall Study|Withdrawal by Subject|2|||
131917049|NCT02382380|474979976|FG001|Overall Study|Withdrawal by Subject|2|||
131917050|NCT02382380|474979975|FG000|Overall Study|Lost to Follow-up|0|||
131917051|NCT02382380|474979976|FG001|Overall Study|Lost to Follow-up|1|||
131917052|NCT05168800|474979977|FG000|Time 1 Survey|Did not start T1 survey|182|||
131917053|NCT05168800|474979978|FG001|Time 1 Survey|Did not start T1 survey|150|||
131917054|NCT05168800|474979979|FG002|Time 1 Survey|Did not start T1 survey|140|||
131917055|NCT05168800|474979977|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
131917056|NCT05168800|474979978|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
131917057|NCT05168800|474979979|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
131917058|NCT05168800|474979977|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
131917059|NCT05168800|474979978|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
131917060|NCT05168800|474979979|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
131917061|NCT05168800|474979977|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
131917062|NCT05168800|474979978|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
131917063|NCT05168800|474979979|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
131917064|NCT05168800|474979977|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
131917065|NCT05168800|474979978|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
131917066|NCT05168800|474979979|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
131917067|NCT05168800|474979977|FG000|Time 1 Survey|Withdrawal by Subject|6|||
131917068|NCT05168800|474979978|FG001|Time 1 Survey|Withdrawal by Subject|3|||
131917069|NCT05168800|474979979|FG002|Time 1 Survey|Withdrawal by Subject|2|||
131917070|NCT05168800|474979977|FG000|Time 2 Survey|Already excluded at Time 1|228|||
131917071|NCT05168800|474979978|FG001|Time 2 Survey|Already excluded at Time 1|202|||
131917072|NCT05168800|474979979|FG002|Time 2 Survey|Already excluded at Time 1|173|||
131917073|NCT05168800|474979977|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
131917074|NCT05168800|474979978|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
131917075|NCT05168800|474979979|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
131917076|NCT05168800|474979977|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
131917077|NCT05168800|474979978|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
131917078|NCT05168800|474979979|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
131917079|NCT05168800|474979977|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
131917080|NCT05168800|474979978|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
131917081|NCT05168800|474979979|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
131917082|NCT05168800|474979977|FG000|Time 2 Survey|Withdrawal by Subject|1|||
131917083|NCT05168800|474979978|FG001|Time 2 Survey|Withdrawal by Subject|0|||
131917084|NCT05168800|474979979|FG002|Time 2 Survey|Withdrawal by Subject|1|||
131917085|NCT05168800|474979977|FG000|Time 3 Survey|Already excluded at Time 1|228|||
131917086|NCT05168800|474979978|FG001|Time 3 Survey|Already excluded at Time 1|200|||
131917087|NCT05168800|474979979|FG002|Time 3 Survey|Already excluded at Time 1|173|||
131917088|NCT05168800|474979977|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
131917089|NCT05168800|474979978|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
131917090|NCT05168800|474979979|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
131917091|NCT05168800|474979977|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
131917092|NCT05168800|474979978|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
131917093|NCT05168800|474979979|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
131917094|NCT05168800|474979977|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
131917095|NCT05168800|474979978|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
131917096|NCT05168800|474979979|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
131917097|NCT05523297|474979982|FG000|Overall Study|Death|7|||
131917098|NCT05523297|474979983|FG001|Overall Study|Death|8|||
131917099|NCT05523297|474979982|FG000|Overall Study|Lost to Follow-up|2|||
131917100|NCT05523297|474979983|FG001|Overall Study|Lost to Follow-up|1|||
131917101|NCT03462680|474979986|FG000|Overall Study|Withdrawal by Subject|3|||
131917102|NCT03462680|474979987|FG001|Overall Study|Withdrawal by Subject|5|||
131917103|NCT00927472|474979988|FG000|Overall Study|Withdrawal by Subject|10|||
131917104|NCT00927472|474979989|FG001|Overall Study|Withdrawal by Subject|11|||
131917105|NCT00927472|474979988|FG000|Overall Study|Lost to Follow-up|1|||
131917106|NCT00927472|474979989|FG001|Overall Study|Lost to Follow-up|6|||
131917107|NCT00927472|474979988|FG000|Overall Study|Protocol Violation|0|||
131917108|NCT00927472|474979989|FG001|Overall Study|Protocol Violation|1|||
131917109|NCT00927472|474979988|FG000|Overall Study|Post treatment Assessment out of window|0|||
131917110|NCT00927472|474979989|FG001|Overall Study|Post treatment Assessment out of window|4|||
131917111|NCT04556097|474979990|FG000|Overall Study|Death|0|||
131917112|NCT04556097|474979991|FG001|Overall Study|Death|5|||
131917113|NCT04556097|474979992|FG002|Overall Study|Death|0|||
131917114|NCT04556097|474979993|FG003|Overall Study|Death|0|||
131917115|NCT04556097|474979990|FG000|Overall Study|No caregiver|43|||
131917116|NCT04556097|474979991|FG001|Overall Study|No caregiver|53|||
131917117|NCT04556097|474979992|FG002|Overall Study|No caregiver|0|||
131917118|NCT04556097|474979993|FG003|Overall Study|No caregiver|0|||
131917119|NCT04556097|474979990|FG000|Overall Study|Ineligible, SNF|2|||
131917120|NCT04556097|474979991|FG001|Overall Study|Ineligible, SNF|2|||
131917121|NCT04556097|474979992|FG002|Overall Study|Ineligible, SNF|0|||
131917122|NCT04556097|474979993|FG003|Overall Study|Ineligible, SNF|0|||
131917123|NCT04556097|474979990|FG000|Overall Study|Ineligible, health|3|||
131917124|NCT04556097|474979991|FG001|Overall Study|Ineligible, health|4|||
131917125|NCT04556097|474979992|FG002|Overall Study|Ineligible, health|0|||
131917126|NCT04556097|474979993|FG003|Overall Study|Ineligible, health|0|||
131917127|NCT04556097|474979990|FG000|Overall Study|Ineligible, language|0|||
131917128|NCT04556097|474979991|FG001|Overall Study|Ineligible, language|1|||
131917129|NCT04556097|474979992|FG002|Overall Study|Ineligible, language|0|||
131917130|NCT04556097|474979993|FG003|Overall Study|Ineligible, language|0|||
131917131|NCT04556097|474979990|FG000|Overall Study|Ineligible, no longer in care management|0|||
131917132|NCT04556097|474979991|FG001|Overall Study|Ineligible, no longer in care management|2|||
131917133|NCT04556097|474979992|FG002|Overall Study|Ineligible, no longer in care management|1|||
131917134|NCT04556097|474979993|FG003|Overall Study|Ineligible, no longer in care management|0|||
131917135|NCT04556097|474979990|FG000|Overall Study|No dementia|13|||
131917136|NCT04556097|474979991|FG001|Overall Study|No dementia|3|||
131917137|NCT04556097|474979992|FG002|Overall Study|No dementia|0|||
131917138|NCT04556097|474979993|FG003|Overall Study|No dementia|0|||
131917139|NCT04556097|474979990|FG000|Overall Study|Missing identifier|2|||
131917140|NCT04556097|474979991|FG001|Overall Study|Missing identifier|4|||
131917141|NCT04556097|474979992|FG002|Overall Study|Missing identifier|0|||
131917142|NCT04556097|474979993|FG003|Overall Study|Missing identifier|0|||
131917143|NCT04556097|474979990|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
131917144|NCT04556097|474979991|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
131917145|NCT04556097|474979992|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
131917146|NCT04556097|474979993|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
131917147|NCT02516241|474979994|FG000|Overall Study|Death|255|||
131917148|NCT02516241|474979995|FG001|Overall Study|Death|262|||
131917149|NCT02516241|474979996|FG002|Overall Study|Death|270|||
131917150|NCT02516241|474979994|FG000|Overall Study|Lost to Follow-up|1|||
131917151|NCT02516241|474979995|FG001|Overall Study|Lost to Follow-up|1|||
131917152|NCT02516241|474979996|FG002|Overall Study|Lost to Follow-up|3|||
131917153|NCT02516241|474979994|FG000|Overall Study|Withdrawal by Subject|2|||
131917154|NCT02516241|474979995|FG001|Overall Study|Withdrawal by Subject|7|||
131917155|NCT02516241|474979996|FG002|Overall Study|Withdrawal by Subject|12|||
131917156|NCT02516241|474979994|FG000|Overall Study|participants ongoing at data cut-off|84|||
131917157|NCT02516241|474979995|FG001|Overall Study|participants ongoing at data cut-off|76|||
131917158|NCT02516241|474979996|FG002|Overall Study|participants ongoing at data cut-off|59|||
131917159|NCT01431976|474981524|FG000|Overall Study|Adverse Event|6|||
131917160|NCT01431976|474981524|FG000|Overall Study|Lack of Efficacy|2|||
131917161|NCT01431976|474981524|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
131917162|NCT01431976|474981524|FG000|Overall Study|Physician Decision|1|||
131917163|NCT01431976|474981524|FG000|Overall Study|Withdrawal by Subject|1|||
131917164|NCT01136954|474981526|FG000|Overall Study|Adverse Event|3|||
131917165|NCT01136954|474981527|FG001|Overall Study|Adverse Event|2|||
131917166|NCT01136954|474981526|FG000|Overall Study|Withdrawal by Subject|6|||
131917167|NCT01136954|474981527|FG001|Overall Study|Withdrawal by Subject|2|||
131917168|NCT01136954|474981526|FG000|Overall Study|Lack of Efficacy|14|||
131866855|NCT00495391|474792310|FG000|Overall Study|Lack of Efficacy|34|||
131866856|NCT00495391|474792311|FG001|Overall Study|Lack of Efficacy|18|||
131917169|NCT01136954|474981527|FG001|Overall Study|Lack of Efficacy|13|||
131917170|NCT01136954|474981526|FG000|Overall Study|Physician Decision|0|||
131917171|NCT01136954|474981527|FG001|Overall Study|Physician Decision|1|||
131917172|NCT01136954|474981526|FG000|Overall Study|Other|1|||
131917173|NCT01136954|474981527|FG001|Overall Study|Other|3|||
131917174|NCT01970371|474981541|FG000|Overall Study|Death|8|||
131917175|NCT01970371|474981542|FG001|Overall Study|Death|13|||
131917176|NCT01970371|474981543|FG002|Overall Study|Death|12|||
131917177|NCT01970371|474981541|FG000|Overall Study|Lost to Follow-up|0|||
131917178|NCT01970371|474981542|FG001|Overall Study|Lost to Follow-up|0|||
131917179|NCT01970371|474981543|FG002|Overall Study|Lost to Follow-up|1|||
131917180|NCT02239328|474981544|FG000|Overall Study|Benign disease noted at time of surgery|6|||
131917181|NCT02239328|474981544|FG000|Overall Study|Equipment or website malfunction|2|||
131917182|NCT01348269|474981545|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
131917183|NCT01348269|474981546|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
131917184|NCT01348269|474981545|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
131917185|NCT01348269|474981546|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
131917186|NCT01348269|474981545|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
131917187|NCT01348269|474981546|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
131917188|NCT04727749|474981547|FG000|Overall Study|Lost to Follow-up|10|||
131917189|NCT04727749|474981548|FG001|Overall Study|Lost to Follow-up|3|||
131917190|NCT04115059|474981552|FG000|Overall Study|Withdrawal by Subject|1|||
131917191|NCT04115059|474981552|FG000|Overall Study|Lack of Efficacy|2|||
131917192|NCT06420232|474981554|FG000|Overall Study|Withdrawal by Subject|3|||
131917193|NCT02313155|474981555|FG000|Overall Study|Lost to Follow-up|0|||
131917194|NCT02313155|474981556|FG001|Overall Study|Lost to Follow-up|1|||
131917195|NCT00689936|474981557|FG000|Active Treatment Phase|Adverse Event|68|||
131917196|NCT00689936|474981558|FG001|Active Treatment Phase|Adverse Event|71|||
131917197|NCT00689936|474981559|FG002|Active Treatment Phase|Adverse Event|76|||
131917198|NCT00689936|474981557|FG000|Active Treatment Phase|Disease Progression|273|||
131917199|NCT00689936|474981558|FG001|Active Treatment Phase|Disease Progression|362|||
131917200|NCT00689936|474981559|FG002|Active Treatment Phase|Disease Progression|339|||
131917201|NCT00689936|474981557|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
131917202|NCT00689936|474981558|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
131917203|NCT00689936|474981559|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
131917204|NCT00689936|474981557|FG000|Active Treatment Phase|Death|60|||
131917205|NCT00689936|474981558|FG001|Active Treatment Phase|Death|28|||
131917206|NCT00689936|474981559|FG002|Active Treatment Phase|Death|37|||
131917207|NCT00689936|474981557|FG000|Active Treatment Phase|Lost to Follow-up|0|||
131917208|NCT00689936|474981558|FG001|Active Treatment Phase|Lost to Follow-up|2|||
131917209|NCT00689936|474981559|FG002|Active Treatment Phase|Lost to Follow-up|2|||
131866857|NCT00495391|474792310|FG000|Overall Study|Withdrawal by Subject|2|||
131866858|NCT00495391|474792311|FG001|Overall Study|Withdrawal by Subject|3|||
131866859|NCT00925704|474792315|FG000|First Intervention|Withdrew consent|0|||
131866860|NCT00925704|474792316|FG001|First Intervention|Withdrew consent|0|||
131866861|NCT00925704|474792317|FG002|First Intervention|Withdrew consent|0|||
131866862|NCT00925704|474792318|FG003|First Intervention|Withdrew consent|1|||
131866863|NCT00925704|474792319|FG004|First Intervention|Withdrew consent|1|||
131866864|NCT00925704|474792320|FG005|First Intervention|Withdrew consent|0|||
131866865|NCT00925704|474792315|FG000|Second Intervention|Withdrawal by Subject|1|||
131866866|NCT00925704|474792316|FG001|Second Intervention|Withdrawal by Subject|0|||
131866867|NCT00925704|474792317|FG002|Second Intervention|Withdrawal by Subject|0|||
131866868|NCT00925704|474792318|FG003|Second Intervention|Withdrawal by Subject|0|||
131866869|NCT00925704|474792319|FG004|Second Intervention|Withdrawal by Subject|1|||
131866870|NCT00925704|474792320|FG005|Second Intervention|Withdrawal by Subject|0|||
131866871|NCT00925704|474792315|FG000|Third Intervention|Withdrew consent|0|||
131917210|NCT00689936|474981557|FG000|Active Treatment Phase|Protocol Violation|2|||
131917211|NCT00689936|474981558|FG001|Active Treatment Phase|Protocol Violation|2|||
131917212|NCT00689936|474981559|FG002|Active Treatment Phase|Protocol Violation|4|||
131866872|NCT00925704|474792316|FG001|Third Intervention|Withdrew consent|0|||
131866873|NCT00925704|474792317|FG002|Third Intervention|Withdrew consent|0|||
131917213|NCT00689936|474981557|FG000|Active Treatment Phase|Study Close Out|64|||
131917214|NCT00689936|474981558|FG001|Active Treatment Phase|Study Close Out|26|||
131917215|NCT00689936|474981559|FG002|Active Treatment Phase|Study Close Out|21|||
131917216|NCT00689936|474981557|FG000|Active Treatment Phase|Miscellaneous|52|||
131917217|NCT00689936|474981558|FG001|Active Treatment Phase|Miscellaneous|34|||
131866874|NCT00925704|474792318|FG003|Third Intervention|Withdrew consent|0|||
131866875|NCT00925704|474792319|FG004|Third Intervention|Withdrew consent|0|||
131866876|NCT00925704|474792320|FG005|Third Intervention|Withdrew consent|1|||
131866877|NCT02044302|474792324|FG000|Overall Study|study terminated|2|||
131917218|NCT00689936|474981559|FG002|Active Treatment Phase|Miscellaneous|47|||
131917219|NCT00689936|474981557|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
131917220|NCT00689936|474981558|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
131917221|NCT00689936|474981559|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
131917222|NCT02213926|474981560|FG000|Overall Study|Death|59|||
131917223|NCT02213926|474981560|FG000|Overall Study|Withdrawal by Subject|10|||
131917224|NCT02213926|474981560|FG000|Overall Study|study terminated by sponsor|51|||
131917225|NCT02213926|474981560|FG000|Overall Study|Lost to Follow-up|3|||
131917226|NCT02213926|474981560|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
131917227|NCT03916926|474981562|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
131917228|NCT03916926|474981563|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
131917229|NCT03916926|474981562|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
131917230|NCT03916926|474981563|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
131917231|NCT03916926|474981562|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
131917232|NCT03916926|474981563|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
131917233|NCT03916926|474981562|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
131917234|NCT03916926|474981563|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
131917235|NCT01081951|474981564|FG000|Overall Study|Death|54|||
131917236|NCT01081951|474981565|FG001|Overall Study|Death|47|||
131917237|NCT01081951|474981564|FG000|Overall Study|Withdrawal by Subject|2|||
131917238|NCT01081951|474981565|FG001|Overall Study|Withdrawal by Subject|6|||
131917239|NCT01081951|474981564|FG000|Overall Study|Allocated treatment but did not take it|0|||
131917240|NCT01081951|474981565|FG001|Overall Study|Allocated treatment but did not take it|1|||
131917241|NCT01081951|474981564|FG000|Overall Study|Lost to Follow-up|0|||
131917242|NCT01081951|474981565|FG001|Overall Study|Lost to Follow-up|1|||
131917243|NCT03765073|474981567|FG000|Stage 1|Lost to Follow-up|1|||
131917244|NCT03765073|474981568|FG001|Stage 1|Lost to Follow-up|0|||
131917245|NCT03765073|474981569|FG002|Stage 1|Lost to Follow-up|0|||
131917246|NCT03765073|474981570|FG003|Stage 1|Lost to Follow-up|0|||
131917247|NCT03765073|474981571|FG004|Stage 1|Lost to Follow-up|0|||
131917248|NCT03765073|474981572|FG005|Stage 1|Lost to Follow-up|0|||
131917249|NCT03765073|474981573|FG006|Stage 1|Lost to Follow-up|0|||
131917250|NCT03765073|474981574|FG007|Stage 1|Lost to Follow-up|0|||
131917251|NCT03765073|474981575|FG008|Stage 1|Lost to Follow-up|0|||
131917252|NCT03765073|474981576|FG009|Stage 1|Lost to Follow-up|0|||
131917253|NCT03765073|474981577|FG010|Stage 1|Lost to Follow-up|0|||
131917254|NCT03765073|474981578|FG011|Stage 1|Lost to Follow-up|0|||
131917255|NCT03765073|474981579|FG012|Stage 1|Lost to Follow-up|0|||
131917256|NCT03765073|474981580|FG013|Stage 1|Lost to Follow-up|0|||
131917257|NCT03765073|474981581|FG014|Stage 1|Lost to Follow-up|0|||
131917258|NCT03765073|474981582|FG015|Stage 1|Lost to Follow-up|0|||
131917259|NCT03765073|474981583|FG016|Stage 1|Lost to Follow-up|0|||
131917260|NCT03765073|474981584|FG017|Stage 1|Lost to Follow-up|0|||
131917261|NCT03765073|474981585|FG018|Stage 1|Lost to Follow-up|0|||
131917262|NCT03765073|474981586|FG019|Stage 1|Lost to Follow-up|0|||
131917263|NCT03765073|474981587|FG020|Stage 1|Lost to Follow-up|0|||
131917264|NCT03765073|474981567|FG000|Stage 1|Withdrawal by participant|0|||
131917265|NCT03765073|474981568|FG001|Stage 1|Withdrawal by participant|1|||
131917266|NCT03765073|474981569|FG002|Stage 1|Withdrawal by participant|0|||
131917267|NCT03765073|474981570|FG003|Stage 1|Withdrawal by participant|0|||
131917268|NCT03765073|474981571|FG004|Stage 1|Withdrawal by participant|0|||
131917269|NCT03765073|474981572|FG005|Stage 1|Withdrawal by participant|0|||
131917270|NCT03765073|474981573|FG006|Stage 1|Withdrawal by participant|0|||
131917271|NCT03765073|474981574|FG007|Stage 1|Withdrawal by participant|0|||
131917272|NCT03765073|474981575|FG008|Stage 1|Withdrawal by participant|0|||
131917273|NCT03765073|474981576|FG009|Stage 1|Withdrawal by participant|0|||
131917274|NCT03765073|474981577|FG010|Stage 1|Withdrawal by participant|0|||
131917275|NCT03765073|474981578|FG011|Stage 1|Withdrawal by participant|0|||
131408147|NCT01344538|473118193|FG000|Overall Study|Lost to Follow-up|1|||
131408148|NCT01344538|473118194|FG001|Overall Study|Lost to Follow-up|0|||
131408149|NCT01655381|473118195|FG000|Overall Study|Investigator Decision|1|||
131408150|NCT01655381|473118195|FG000|Overall Study|Moved to Another City|1|||
131408151|NCT01655381|473118195|FG000|Overall Study|Insufficient Treatment Response|1|||
131917276|NCT03765073|474981579|FG012|Stage 1|Withdrawal by participant|0|||
131917277|NCT03765073|474981580|FG013|Stage 1|Withdrawal by participant|0|||
131917278|NCT03765073|474981581|FG014|Stage 1|Withdrawal by participant|0|||
131917279|NCT03765073|474981582|FG015|Stage 1|Withdrawal by participant|0|||
131917280|NCT03765073|474981583|FG016|Stage 1|Withdrawal by participant|0|||
131917281|NCT03765073|474981584|FG017|Stage 1|Withdrawal by participant|0|||
131917282|NCT03765073|474981585|FG018|Stage 1|Withdrawal by participant|0|||
131408152|NCT04979897|473118196|FG000|Overall Study|Death|1|||
131408153|NCT04979897|473118197|FG001|Overall Study|Death|8|||
131408154|NCT04979897|473118196|FG000|Overall Study|Lost to Follow-up|111|||
131408155|NCT04979897|473118197|FG001|Overall Study|Lost to Follow-up|56|||
131917283|NCT03765073|474981586|FG019|Stage 1|Withdrawal by participant|0|||
131917284|NCT03765073|474981587|FG020|Stage 1|Withdrawal by participant|0|||
131917285|NCT03765073|474981567|FG000|Stage 2|Death|0|||
131917286|NCT03765073|474981568|FG001|Stage 2|Death|0|||
131917287|NCT03765073|474981569|FG002|Stage 2|Death|0|||
131917288|NCT03765073|474981570|FG003|Stage 2|Death|0|||
131917289|NCT03765073|474981571|FG004|Stage 2|Death|0|||
131866878|NCT02044302|474792325|FG001|Overall Study|study terminated|0|||
131866879|NCT03207815|474792326|FG000|Overall Study|Protocol Violation|3|||
131866880|NCT03207815|474792327|FG001|Overall Study|Protocol Violation|1|||
131866881|NCT03207815|474792326|FG000|Overall Study|Adverse Event|1|||
131866882|NCT03207815|474792327|FG001|Overall Study|Adverse Event|2|||
131866883|NCT03207815|474792326|FG000|Overall Study|Lost to Follow-up|1|||
131866884|NCT03207815|474792327|FG001|Overall Study|Lost to Follow-up|2|||
131866885|NCT03207815|474792326|FG000|Overall Study|Investigator's Discretion|1|||
131866886|NCT03207815|474792327|FG001|Overall Study|Investigator's Discretion|1|||
131866887|NCT03207815|474792326|FG000|Overall Study|Lack of Efficacy|0|||
131866888|NCT03207815|474792327|FG001|Overall Study|Lack of Efficacy|1|||
131866889|NCT03207815|474792326|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
131866890|NCT03207815|474792327|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
131866891|NCT03207815|474792326|FG000|Overall Study|Withdrew Consent|1|||
131866892|NCT03207815|474792327|FG001|Overall Study|Withdrew Consent|0|||
131866893|NCT01671007|474792328|FG000|Overall Study|Other reasons than listed|166|||
131866894|NCT01671007|474792329|FG001|Overall Study|Other reasons than listed|373|||
131866895|NCT01671007|474792330|FG002|Overall Study|Other reasons than listed|197|||
131866896|NCT01671007|474792331|FG003|Overall Study|Other reasons than listed|228|||
131866897|NCT01671007|474792332|FG004|Overall Study|Other reasons than listed|14|||
131866898|NCT01671007|474792333|FG005|Overall Study|Other reasons than listed|71|||
131866899|NCT01671007|474792334|FG006|Overall Study|Other reasons than listed|17|||
131866900|NCT01671007|474792335|FG007|Overall Study|Other reasons than listed|66|||
131866901|NCT01671007|474792336|FG008|Overall Study|Other reasons than listed|0|||
131866902|NCT01671007|474792328|FG000|Overall Study|Withdrawal by Subject|36|||
131866903|NCT01671007|474792329|FG001|Overall Study|Withdrawal by Subject|59|||
131866904|NCT01671007|474792330|FG002|Overall Study|Withdrawal by Subject|53|||
131866905|NCT01671007|474792331|FG003|Overall Study|Withdrawal by Subject|58|||
131866906|NCT01671007|474792332|FG004|Overall Study|Withdrawal by Subject|4|||
131866907|NCT01671007|474792333|FG005|Overall Study|Withdrawal by Subject|15|||
131866908|NCT01671007|474792334|FG006|Overall Study|Withdrawal by Subject|1|||
131866909|NCT01671007|474792335|FG007|Overall Study|Withdrawal by Subject|19|||
131866910|NCT01671007|474792336|FG008|Overall Study|Withdrawal by Subject|0|||
131866911|NCT01671007|474792328|FG000|Overall Study|Lost to Follow-up|93|||
131866912|NCT01671007|474792329|FG001|Overall Study|Lost to Follow-up|142|||
131866913|NCT01671007|474792330|FG002|Overall Study|Lost to Follow-up|91|||
131866914|NCT01671007|474792331|FG003|Overall Study|Lost to Follow-up|63|||
131866915|NCT01671007|474792332|FG004|Overall Study|Lost to Follow-up|7|||
131866916|NCT01671007|474792333|FG005|Overall Study|Lost to Follow-up|20|||
131866917|NCT01671007|474792334|FG006|Overall Study|Lost to Follow-up|2|||
131866918|NCT01671007|474792335|FG007|Overall Study|Lost to Follow-up|28|||
131866919|NCT01671007|474792336|FG008|Overall Study|Lost to Follow-up|0|||
131866920|NCT01671007|474792328|FG000|Overall Study|No end of study case report form|3|||
131866921|NCT01671007|474792329|FG001|Overall Study|No end of study case report form|1|||
131866922|NCT01671007|474792330|FG002|Overall Study|No end of study case report form|0|||
131866923|NCT01671007|474792331|FG003|Overall Study|No end of study case report form|2|||
131866924|NCT01671007|474792332|FG004|Overall Study|No end of study case report form|0|||
131866925|NCT01671007|474792333|FG005|Overall Study|No end of study case report form|0|||
131866926|NCT01671007|474792334|FG006|Overall Study|No end of study case report form|0|||
131866927|NCT01671007|474792335|FG007|Overall Study|No end of study case report form|0|||
131866928|NCT01671007|474792336|FG008|Overall Study|No end of study case report form|0|||
131866929|NCT01671007|474792328|FG000|Overall Study|Not eligible|23|||
131866930|NCT01671007|474792329|FG001|Overall Study|Not eligible|76|||
131866931|NCT01671007|474792330|FG002|Overall Study|Not eligible|25|||
131866932|NCT01671007|474792331|FG003|Overall Study|Not eligible|17|||
131866933|NCT01671007|474792332|FG004|Overall Study|Not eligible|0|||
131866934|NCT01671007|474792333|FG005|Overall Study|Not eligible|6|||
131866935|NCT01671007|474792334|FG006|Overall Study|Not eligible|1|||
131866936|NCT01671007|474792335|FG007|Overall Study|Not eligible|19|||
131866937|NCT01671007|474792336|FG008|Overall Study|Not eligible|0|||
131866938|NCT00391768|474792337|FG000|Overall Study|Withdrawal by Subject|0|||
131866939|NCT00391768|474792338|FG001|Overall Study|Withdrawal by Subject|0|||
131866940|NCT00391768|474792339|FG002|Overall Study|Withdrawal by Subject|1|||
131866941|NCT00391768|474792340|FG003|Overall Study|Withdrawal by Subject|0|||
131866942|NCT00391768|474792341|FG004|Overall Study|Withdrawal by Subject|0|||
131866943|NCT00391768|474792342|FG005|Overall Study|Withdrawal by Subject|1|||
131866944|NCT00391768|474792343|FG006|Overall Study|Withdrawal by Subject|1|||
131866945|NCT00391768|474792337|FG000|Overall Study|Lost to Follow-up|0|||
131866946|NCT00391768|474792338|FG001|Overall Study|Lost to Follow-up|0|||
131866947|NCT00391768|474792339|FG002|Overall Study|Lost to Follow-up|0|||
131866948|NCT00391768|474792340|FG003|Overall Study|Lost to Follow-up|1|||
131866949|NCT00391768|474792341|FG004|Overall Study|Lost to Follow-up|2|||
131866950|NCT00391768|474792342|FG005|Overall Study|Lost to Follow-up|2|||
131866951|NCT00391768|474792343|FG006|Overall Study|Lost to Follow-up|3|||
131866952|NCT00406367|474792344|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
131866953|NCT00406367|474792345|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
131866954|NCT00406367|474792344|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
131917290|NCT03765073|474981572|FG005|Stage 2|Death|0|||
131917291|NCT03765073|474981573|FG006|Stage 2|Death|0|||
131917292|NCT03765073|474981574|FG007|Stage 2|Death|0|||
131917293|NCT03765073|474981575|FG008|Stage 2|Death|0|||
131917294|NCT03765073|474981576|FG009|Stage 2|Death|1|||
131917295|NCT03765073|474981577|FG010|Stage 2|Death|0|||
131917296|NCT03765073|474981578|FG011|Stage 2|Death|1|||
131917297|NCT03765073|474981579|FG012|Stage 2|Death|0|||
131917298|NCT03765073|474981580|FG013|Stage 2|Death|0|||
131917299|NCT03765073|474981581|FG014|Stage 2|Death|0|||
131917300|NCT03765073|474981582|FG015|Stage 2|Death|0|||
131917301|NCT03765073|474981583|FG016|Stage 2|Death|2|||
131917302|NCT03765073|474981584|FG017|Stage 2|Death|0|||
131917303|NCT03765073|474981585|FG018|Stage 2|Death|0|||
131917304|NCT03765073|474981586|FG019|Stage 2|Death|0|||
131917305|NCT03765073|474981587|FG020|Stage 2|Death|0|||
131917306|NCT03765073|474981567|FG000|Stage 2|Lost to Follow-up|0|||
131917307|NCT03765073|474981568|FG001|Stage 2|Lost to Follow-up|0|||
131917308|NCT03765073|474981569|FG002|Stage 2|Lost to Follow-up|0|||
131917309|NCT03765073|474981570|FG003|Stage 2|Lost to Follow-up|5|||
131917310|NCT03765073|474981571|FG004|Stage 2|Lost to Follow-up|1|||
131917311|NCT03765073|474981572|FG005|Stage 2|Lost to Follow-up|0|||
131917312|NCT03765073|474981573|FG006|Stage 2|Lost to Follow-up|3|||
131917313|NCT03765073|474981574|FG007|Stage 2|Lost to Follow-up|3|||
131917314|NCT03765073|474981575|FG008|Stage 2|Lost to Follow-up|1|||
131917315|NCT03765073|474981576|FG009|Stage 2|Lost to Follow-up|6|||
131917316|NCT03765073|474981577|FG010|Stage 2|Lost to Follow-up|5|||
131917317|NCT03765073|474981578|FG011|Stage 2|Lost to Follow-up|1|||
131917318|NCT03765073|474981579|FG012|Stage 2|Lost to Follow-up|1|||
131917319|NCT03765073|474981580|FG013|Stage 2|Lost to Follow-up|3|||
131917320|NCT03765073|474981581|FG014|Stage 2|Lost to Follow-up|3|||
131917321|NCT03765073|474981582|FG015|Stage 2|Lost to Follow-up|1|||
131917322|NCT03765073|474981583|FG016|Stage 2|Lost to Follow-up|6|||
131917323|NCT03765073|474981584|FG017|Stage 2|Lost to Follow-up|0|||
131917324|NCT03765073|474981585|FG018|Stage 2|Lost to Follow-up|0|||
131917325|NCT03765073|474981586|FG019|Stage 2|Lost to Follow-up|0|||
131917326|NCT03765073|474981587|FG020|Stage 2|Lost to Follow-up|0|||
131917327|NCT03765073|474981567|FG000|Stage 2|Other|0|||
131917328|NCT03765073|474981568|FG001|Stage 2|Other|0|||
131917329|NCT03765073|474981569|FG002|Stage 2|Other|0|||
131917330|NCT03765073|474981570|FG003|Stage 2|Other|0|||
131917331|NCT03765073|474981571|FG004|Stage 2|Other|0|||
131917332|NCT03765073|474981572|FG005|Stage 2|Other|0|||
131917333|NCT03765073|474981573|FG006|Stage 2|Other|0|||
131917334|NCT03765073|474981574|FG007|Stage 2|Other|1|||
131917335|NCT03765073|474981575|FG008|Stage 2|Other|1|||
131917336|NCT03765073|474981576|FG009|Stage 2|Other|3|||
131917337|NCT03765073|474981577|FG010|Stage 2|Other|0|||
131917338|NCT03765073|474981578|FG011|Stage 2|Other|0|||
131917339|NCT03765073|474981579|FG012|Stage 2|Other|0|||
131917340|NCT03765073|474981580|FG013|Stage 2|Other|0|||
131917341|NCT03765073|474981581|FG014|Stage 2|Other|0|||
131917342|NCT03765073|474981582|FG015|Stage 2|Other|1|||
131917343|NCT03765073|474981583|FG016|Stage 2|Other|2|||
131917344|NCT03765073|474981584|FG017|Stage 2|Other|0|||
131917345|NCT03765073|474981585|FG018|Stage 2|Other|0|||
131917346|NCT03765073|474981586|FG019|Stage 2|Other|0|||
131917347|NCT03765073|474981587|FG020|Stage 2|Other|0|||
131917348|NCT03765073|474981567|FG000|Stage 2|Withdrawal by parent/guardian|0|||
131917349|NCT03765073|474981568|FG001|Stage 2|Withdrawal by parent/guardian|0|||
131917350|NCT03765073|474981569|FG002|Stage 2|Withdrawal by parent/guardian|0|||
131408156|NCT04979897|473118196|FG000|Overall Study|Withdrawal by Subject|7|||
131408157|NCT04979897|473118197|FG001|Overall Study|Withdrawal by Subject|2|||
131917351|NCT03765073|474981570|FG003|Stage 2|Withdrawal by parent/guardian|0|||
131917352|NCT03765073|474981571|FG004|Stage 2|Withdrawal by parent/guardian|0|||
131917353|NCT03765073|474981572|FG005|Stage 2|Withdrawal by parent/guardian|0|||
131917354|NCT03765073|474981573|FG006|Stage 2|Withdrawal by parent/guardian|0|||
131917355|NCT03765073|474981574|FG007|Stage 2|Withdrawal by parent/guardian|0|||
131917356|NCT03765073|474981575|FG008|Stage 2|Withdrawal by parent/guardian|0|||
131917357|NCT03765073|474981576|FG009|Stage 2|Withdrawal by parent/guardian|0|||
131917358|NCT03765073|474981577|FG010|Stage 2|Withdrawal by parent/guardian|3|||
131917359|NCT03765073|474981578|FG011|Stage 2|Withdrawal by parent/guardian|3|||
131917360|NCT03765073|474981579|FG012|Stage 2|Withdrawal by parent/guardian|3|||
131917361|NCT03765073|474981580|FG013|Stage 2|Withdrawal by parent/guardian|1|||
131917362|NCT03765073|474981581|FG014|Stage 2|Withdrawal by parent/guardian|1|||
131917363|NCT03765073|474981582|FG015|Stage 2|Withdrawal by parent/guardian|0|||
131917364|NCT03765073|474981583|FG016|Stage 2|Withdrawal by parent/guardian|3|||
131917365|NCT03765073|474981584|FG017|Stage 2|Withdrawal by parent/guardian|0|||
131917366|NCT03765073|474981585|FG018|Stage 2|Withdrawal by parent/guardian|0|||
131917367|NCT03765073|474981586|FG019|Stage 2|Withdrawal by parent/guardian|0|||
131917368|NCT03765073|474981587|FG020|Stage 2|Withdrawal by parent/guardian|0|||
131917369|NCT03765073|474981567|FG000|Stage 2|Withdrawal by Subject|0|||
131917370|NCT03765073|474981568|FG001|Stage 2|Withdrawal by Subject|0|||
131917371|NCT03765073|474981569|FG002|Stage 2|Withdrawal by Subject|0|||
131917372|NCT03765073|474981570|FG003|Stage 2|Withdrawal by Subject|3|||
131917373|NCT03765073|474981571|FG004|Stage 2|Withdrawal by Subject|3|||
131917374|NCT03765073|474981572|FG005|Stage 2|Withdrawal by Subject|3|||
131917375|NCT03765073|474981573|FG006|Stage 2|Withdrawal by Subject|0|||
131917376|NCT03765073|474981574|FG007|Stage 2|Withdrawal by Subject|1|||
131917377|NCT03765073|474981575|FG008|Stage 2|Withdrawal by Subject|0|||
131917378|NCT03765073|474981576|FG009|Stage 2|Withdrawal by Subject|5|||
131917379|NCT03765073|474981577|FG010|Stage 2|Withdrawal by Subject|0|||
131917380|NCT03765073|474981578|FG011|Stage 2|Withdrawal by Subject|0|||
131917381|NCT03765073|474981579|FG012|Stage 2|Withdrawal by Subject|0|||
131917382|NCT03765073|474981580|FG013|Stage 2|Withdrawal by Subject|0|||
131917383|NCT03765073|474981581|FG014|Stage 2|Withdrawal by Subject|0|||
131917384|NCT03765073|474981582|FG015|Stage 2|Withdrawal by Subject|0|||
131917385|NCT03765073|474981583|FG016|Stage 2|Withdrawal by Subject|0|||
131917386|NCT03765073|474981584|FG017|Stage 2|Withdrawal by Subject|0|||
131917387|NCT03765073|474981585|FG018|Stage 2|Withdrawal by Subject|0|||
131917388|NCT03765073|474981586|FG019|Stage 2|Withdrawal by Subject|0|||
131917389|NCT03765073|474981587|FG020|Stage 2|Withdrawal by Subject|0|||
131917390|NCT03765073|474981567|FG000|Stage 3|Adverse Event|0|||
131917391|NCT03765073|474981568|FG001|Stage 3|Adverse Event|0|||
131917392|NCT03765073|474981569|FG002|Stage 3|Adverse Event|0|||
131917393|NCT03765073|474981570|FG003|Stage 3|Adverse Event|0|||
131917394|NCT03765073|474981571|FG004|Stage 3|Adverse Event|0|||
131917395|NCT03765073|474981572|FG005|Stage 3|Adverse Event|0|||
131917396|NCT03765073|474981573|FG006|Stage 3|Adverse Event|0|||
131917397|NCT03765073|474981574|FG007|Stage 3|Adverse Event|0|||
131917398|NCT03765073|474981575|FG008|Stage 3|Adverse Event|0|||
131917399|NCT03765073|474981576|FG009|Stage 3|Adverse Event|0|||
131917400|NCT03765073|474981577|FG010|Stage 3|Adverse Event|0|||
131917401|NCT03765073|474981578|FG011|Stage 3|Adverse Event|0|||
131917402|NCT03765073|474981579|FG012|Stage 3|Adverse Event|0|||
131917403|NCT03765073|474981580|FG013|Stage 3|Adverse Event|0|||
131917404|NCT03765073|474981581|FG014|Stage 3|Adverse Event|0|||
131917405|NCT03765073|474981582|FG015|Stage 3|Adverse Event|0|||
131917406|NCT03765073|474981583|FG016|Stage 3|Adverse Event|0|||
131917407|NCT03765073|474981584|FG017|Stage 3|Adverse Event|0|||
131917408|NCT03765073|474981585|FG018|Stage 3|Adverse Event|1|||
131917409|NCT03765073|474981586|FG019|Stage 3|Adverse Event|0|||
131408158|NCT03405935|473118198|FG000|Overall Study|Adverse Event|3|||
131408159|NCT03405935|473118198|FG000|Overall Study|Death|2|||
131408160|NCT03405935|473118198|FG000|Overall Study|Withdrawal by Subject|1|||
131866955|NCT00406367|474792345|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
131866956|NCT00406367|474792344|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
131866957|NCT00406367|474792345|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
131866958|NCT00406367|474792344|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
131866959|NCT00406367|474792345|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
131866960|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
131866961|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
131866962|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
131866963|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
131866964|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
131866965|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
131866966|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
131866967|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
131866968|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
131866969|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
131866970|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
131866971|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
131866972|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
131866973|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
131866974|NCT00406367|474792344|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
131866975|NCT00406367|474792345|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
131917410|NCT03765073|474981587|FG020|Stage 3|Adverse Event|0|||
131917411|NCT03765073|474981567|FG000|Stage 3|Death|0|||
131917412|NCT03765073|474981568|FG001|Stage 3|Death|0|||
131917413|NCT03765073|474981569|FG002|Stage 3|Death|0|||
131917414|NCT03765073|474981570|FG003|Stage 3|Death|0|||
131917415|NCT03765073|474981571|FG004|Stage 3|Death|0|||
131917416|NCT03765073|474981572|FG005|Stage 3|Death|0|||
131917417|NCT03765073|474981573|FG006|Stage 3|Death|0|||
131917418|NCT03765073|474981574|FG007|Stage 3|Death|0|||
131917419|NCT03765073|474981575|FG008|Stage 3|Death|0|||
131917420|NCT03765073|474981576|FG009|Stage 3|Death|0|||
131917421|NCT03765073|474981577|FG010|Stage 3|Death|0|||
131917422|NCT03765073|474981578|FG011|Stage 3|Death|0|||
131917423|NCT03765073|474981579|FG012|Stage 3|Death|0|||
131917424|NCT03765073|474981580|FG013|Stage 3|Death|0|||
131917425|NCT03765073|474981581|FG014|Stage 3|Death|0|||
131917426|NCT03765073|474981582|FG015|Stage 3|Death|0|||
131917427|NCT03765073|474981583|FG016|Stage 3|Death|0|||
131917428|NCT03765073|474981584|FG017|Stage 3|Death|0|||
131917429|NCT03765073|474981585|FG018|Stage 3|Death|0|||
131917430|NCT03765073|474981586|FG019|Stage 3|Death|3|||
131866976|NCT00171210|474792346|FG000|Overall Study|Adverse Event|16|||
131866977|NCT00171210|474792347|FG001|Overall Study|Adverse Event|27|||
131866978|NCT00171210|474792346|FG000|Overall Study|Abnormal laboratory value(s)|6|||
131866979|NCT00171210|474792347|FG001|Overall Study|Abnormal laboratory value(s)|3|||
131866980|NCT00171210|474792346|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131866981|NCT00171210|474792347|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131866982|NCT00171210|474792346|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
131866983|NCT00171210|474792347|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
131866984|NCT00171210|474792346|FG000|Overall Study|Protocol Violation|0|||
131866985|NCT00171210|474792347|FG001|Overall Study|Protocol Violation|2|||
131866986|NCT00171210|474792346|FG000|Overall Study|Withdrawal by Subject|32|||
131866987|NCT00171210|474792347|FG001|Overall Study|Withdrawal by Subject|30|||
131866988|NCT00171210|474792346|FG000|Overall Study|Lost to Follow-up|1|||
131866989|NCT00171210|474792347|FG001|Overall Study|Lost to Follow-up|0|||
131866990|NCT00171210|474792346|FG000|Overall Study|Administrative problems|1|||
131866991|NCT00171210|474792347|FG001|Overall Study|Administrative problems|1|||
131866992|NCT00171210|474792346|FG000|Overall Study|Death|2|||
131866993|NCT00171210|474792347|FG001|Overall Study|Death|3|||
131866994|NCT00171210|474792346|FG000|Overall Study|Stopped at end of core|0|||
131866995|NCT00171210|474792347|FG001|Overall Study|Stopped at end of core|32|||
131866996|NCT00171210|474792346|FG000|Overall Study|Stopped at end of extension 1|0|||
131866997|NCT00171210|474792347|FG001|Overall Study|Stopped at end of extension 1|1|||
131866998|NCT03187301|474792350|FG000|Titration Period|Adverse Event|0|||
131866999|NCT03187301|474792351|FG001|Titration Period|Adverse Event|0|||
131867000|NCT03187301|474792352|FG002|Titration Period|Adverse Event|0|||
131867001|NCT03187301|474792353|FG003|Titration Period|Adverse Event|0|||
131867002|NCT03187301|474792354|FG004|Titration Period|Adverse Event|0|||
131867003|NCT03187301|474792355|FG005|Titration Period|Adverse Event|0|||
131867004|NCT03187301|474792356|FG006|Titration Period|Adverse Event|5|||
131867005|NCT03187301|474792350|FG000|Titration Period|Withdrawal by Subject|0|||
131867006|NCT03187301|474792351|FG001|Titration Period|Withdrawal by Subject|0|||
131867007|NCT03187301|474792352|FG002|Titration Period|Withdrawal by Subject|0|||
131867008|NCT03187301|474792353|FG003|Titration Period|Withdrawal by Subject|0|||
131867009|NCT03187301|474792354|FG004|Titration Period|Withdrawal by Subject|0|||
131867010|NCT03187301|474792355|FG005|Titration Period|Withdrawal by Subject|0|||
131867011|NCT03187301|474792356|FG006|Titration Period|Withdrawal by Subject|1|||
131867012|NCT03187301|474792350|FG000|Titration Period|Exclusion Criteria Met|0|||
131867013|NCT03187301|474792351|FG001|Titration Period|Exclusion Criteria Met|0|||
131867014|NCT03187301|474792352|FG002|Titration Period|Exclusion Criteria Met|0|||
131867015|NCT03187301|474792353|FG003|Titration Period|Exclusion Criteria Met|0|||
131867016|NCT03187301|474792354|FG004|Titration Period|Exclusion Criteria Met|0|||
131867017|NCT03187301|474792355|FG005|Titration Period|Exclusion Criteria Met|0|||
131867018|NCT03187301|474792356|FG006|Titration Period|Exclusion Criteria Met|1|||
131867019|NCT03187301|474792350|FG000|Pre-Intervention|Withdrawal by Subject|1|||
131867020|NCT03187301|474792351|FG001|Pre-Intervention|Withdrawal by Subject|0|||
131867021|NCT03187301|474792352|FG002|Pre-Intervention|Withdrawal by Subject|0|||
131867022|NCT03187301|474792353|FG003|Pre-Intervention|Withdrawal by Subject|0|||
131867023|NCT03187301|474792354|FG004|Pre-Intervention|Withdrawal by Subject|0|||
131867024|NCT03187301|474792355|FG005|Pre-Intervention|Withdrawal by Subject|0|||
131867025|NCT03187301|474792356|FG006|Pre-Intervention|Withdrawal by Subject|0|||
131867026|NCT00891020|474792361|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
131867027|NCT00891020|474792362|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
131867028|NCT00891020|474792363|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
131867029|NCT00891020|474792361|FG000|24 Week Treatment Period|Death|0|||
131867030|NCT00891020|474792362|FG001|24 Week Treatment Period|Death|2|||
131867031|NCT00891020|474792363|FG002|24 Week Treatment Period|Death|0|||
131867032|NCT00891020|474792361|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
131867033|NCT00891020|474792362|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
131867034|NCT00891020|474792363|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
131867035|NCT00891020|474792361|FG000|24 Week Treatment Period|Failure to return|4|||
131867036|NCT00891020|474792362|FG001|24 Week Treatment Period|Failure to return|5|||
131867037|NCT00891020|474792363|FG002|24 Week Treatment Period|Failure to return|5|||
131867038|NCT00891020|474792361|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
131867039|NCT00891020|474792362|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
131867040|NCT00891020|474792363|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
131867041|NCT00891020|474792361|FG000|24 Week Treatment Period|Other protocol violation|1|||
131867042|NCT00891020|474792362|FG001|24 Week Treatment Period|Other protocol violation|1|||
131867043|NCT00891020|474792363|FG002|24 Week Treatment Period|Other protocol violation|2|||
131867044|NCT00891020|474792361|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
131867045|NCT00891020|474792362|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
131867046|NCT00891020|474792363|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
131867047|NCT00891020|474792361|FG000|24 Week Treatment Period|Withdrew consent|6|||
131917431|NCT03765073|474981587|FG020|Stage 3|Death|2|||
131917432|NCT03765073|474981567|FG000|Stage 3|Lost to Follow-up|0|||
131917433|NCT03765073|474981568|FG001|Stage 3|Lost to Follow-up|0|||
131917434|NCT03765073|474981569|FG002|Stage 3|Lost to Follow-up|0|||
131917435|NCT03765073|474981570|FG003|Stage 3|Lost to Follow-up|0|||
131917436|NCT03765073|474981571|FG004|Stage 3|Lost to Follow-up|0|||
131917437|NCT03765073|474981572|FG005|Stage 3|Lost to Follow-up|0|||
131917438|NCT03765073|474981573|FG006|Stage 3|Lost to Follow-up|0|||
131917439|NCT03765073|474981574|FG007|Stage 3|Lost to Follow-up|0|||
131917440|NCT03765073|474981575|FG008|Stage 3|Lost to Follow-up|0|||
131917441|NCT03765073|474981576|FG009|Stage 3|Lost to Follow-up|0|||
131917442|NCT03765073|474981577|FG010|Stage 3|Lost to Follow-up|0|||
131917443|NCT03765073|474981578|FG011|Stage 3|Lost to Follow-up|0|||
131917444|NCT03765073|474981579|FG012|Stage 3|Lost to Follow-up|0|||
131917445|NCT03765073|474981580|FG013|Stage 3|Lost to Follow-up|0|||
131917446|NCT03765073|474981581|FG014|Stage 3|Lost to Follow-up|0|||
131917447|NCT03765073|474981582|FG015|Stage 3|Lost to Follow-up|0|||
131917448|NCT03765073|474981583|FG016|Stage 3|Lost to Follow-up|0|||
131917449|NCT03765073|474981584|FG017|Stage 3|Lost to Follow-up|8|||
131917450|NCT03765073|474981585|FG018|Stage 3|Lost to Follow-up|5|||
131917451|NCT03765073|474981586|FG019|Stage 3|Lost to Follow-up|7|||
131917452|NCT03765073|474981587|FG020|Stage 3|Lost to Follow-up|4|||
131917453|NCT03765073|474981567|FG000|Stage 3|No longer meets eligibility criteria|0|||
131917454|NCT03765073|474981568|FG001|Stage 3|No longer meets eligibility criteria|0|||
131917455|NCT03765073|474981569|FG002|Stage 3|No longer meets eligibility criteria|0|||
131917456|NCT03765073|474981570|FG003|Stage 3|No longer meets eligibility criteria|0|||
131917457|NCT03765073|474981571|FG004|Stage 3|No longer meets eligibility criteria|0|||
131917458|NCT03765073|474981572|FG005|Stage 3|No longer meets eligibility criteria|0|||
131917459|NCT03765073|474981573|FG006|Stage 3|No longer meets eligibility criteria|0|||
131917460|NCT03765073|474981574|FG007|Stage 3|No longer meets eligibility criteria|0|||
131917461|NCT03765073|474981575|FG008|Stage 3|No longer meets eligibility criteria|0|||
131917462|NCT03765073|474981576|FG009|Stage 3|No longer meets eligibility criteria|0|||
131917463|NCT03765073|474981577|FG010|Stage 3|No longer meets eligibility criteria|0|||
131917464|NCT03765073|474981578|FG011|Stage 3|No longer meets eligibility criteria|0|||
131917465|NCT03765073|474981579|FG012|Stage 3|No longer meets eligibility criteria|0|||
131917466|NCT03765073|474981580|FG013|Stage 3|No longer meets eligibility criteria|0|||
131917467|NCT03765073|474981581|FG014|Stage 3|No longer meets eligibility criteria|0|||
131917468|NCT03765073|474981582|FG015|Stage 3|No longer meets eligibility criteria|0|||
131917469|NCT03765073|474981583|FG016|Stage 3|No longer meets eligibility criteria|0|||
131917470|NCT03765073|474981584|FG017|Stage 3|No longer meets eligibility criteria|0|||
131917471|NCT03765073|474981585|FG018|Stage 3|No longer meets eligibility criteria|1|||
131408161|NCT03405935|473118198|FG000|Overall Study|Lost to Follow-up|2|||
131408162|NCT01779869|473118199|FG000|Overall Study|Physician Decision|2|||
131408163|NCT00445848|473118200|FG000|Overall Study|Adverse Event|14|||
131867048|NCT00891020|474792362|FG001|24 Week Treatment Period|Withdrew consent|3|||
131867049|NCT00891020|474792363|FG002|24 Week Treatment Period|Withdrew consent|15|||
131867050|NCT00891020|474792361|FG000|24 Week Treatment Period|Administrative/Other|5|||
131867051|NCT00891020|474792362|FG001|24 Week Treatment Period|Administrative/Other|6|||
131867052|NCT00891020|474792363|FG002|24 Week Treatment Period|Administrative/Other|1|||
131867053|NCT00891020|474792361|FG000|Long-term Extension Period|Adverse Event|1|||
131867054|NCT00891020|474792362|FG001|Long-term Extension Period|Adverse Event|11|||
131867055|NCT00891020|474792363|FG002|Long-term Extension Period|Adverse Event|10|||
131867056|NCT00891020|474792361|FG000|Long-term Extension Period|Death|0|||
131867057|NCT00891020|474792362|FG001|Long-term Extension Period|Death|0|||
131867058|NCT00891020|474792363|FG002|Long-term Extension Period|Death|1|||
131867059|NCT00891020|474792361|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
131867060|NCT00891020|474792362|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
131867061|NCT00891020|474792363|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
131867062|NCT00891020|474792361|FG000|Long-term Extension Period|Protocol Violation|0|||
131867063|NCT00891020|474792362|FG001|Long-term Extension Period|Protocol Violation|1|||
131867064|NCT00891020|474792363|FG002|Long-term Extension Period|Protocol Violation|1|||
131867065|NCT00891020|474792361|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
131867066|NCT00891020|474792362|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
131867067|NCT00891020|474792363|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
131867068|NCT00891020|474792361|FG000|Long-term Extension Period|Failure to return|0|||
131867069|NCT00891020|474792362|FG001|Long-term Extension Period|Failure to return|2|||
131867070|NCT00891020|474792363|FG002|Long-term Extension Period|Failure to return|3|||
131867071|NCT00891020|474792361|FG000|Long-term Extension Period|Administrative|1|||
131867072|NCT00891020|474792362|FG001|Long-term Extension Period|Administrative|2|||
131917472|NCT03765073|474981586|FG019|Stage 3|No longer meets eligibility criteria|0|||
131917473|NCT03765073|474981587|FG020|Stage 3|No longer meets eligibility criteria|1|||
131917474|NCT03765073|474981567|FG000|Stage 3|Other|0|||
131917475|NCT03765073|474981568|FG001|Stage 3|Other|0|||
131917476|NCT03765073|474981569|FG002|Stage 3|Other|0|||
131917477|NCT03765073|474981570|FG003|Stage 3|Other|0|||
131917478|NCT03765073|474981571|FG004|Stage 3|Other|0|||
131917479|NCT03765073|474981572|FG005|Stage 3|Other|0|||
131917480|NCT03765073|474981573|FG006|Stage 3|Other|0|||
131917481|NCT03765073|474981574|FG007|Stage 3|Other|0|||
131867073|NCT00891020|474792363|FG002|Long-term Extension Period|Administrative|2|||
131867074|NCT00320710|474792371|FG000|Overall Study|Disease progression|24|||
131867075|NCT00320710|474792372|FG001|Overall Study|Disease progression|19|||
131867076|NCT00320710|474792373|FG002|Overall Study|Disease progression|2|||
131867077|NCT00320710|474792371|FG000|Overall Study|Death|10|||
131867078|NCT00320710|474792372|FG001|Overall Study|Death|7|||
131867079|NCT00320710|474792373|FG002|Overall Study|Death|1|||
131867080|NCT00320710|474792371|FG000|Overall Study|Administrative problems|1|||
131867081|NCT00320710|474792372|FG001|Overall Study|Administrative problems|2|||
131867082|NCT00320710|474792373|FG002|Overall Study|Administrative problems|0|||
131867083|NCT00320710|474792371|FG000|Overall Study|Withdrawal by Subject|20|||
131867084|NCT00320710|474792372|FG001|Overall Study|Withdrawal by Subject|26|||
131867085|NCT00320710|474792373|FG002|Overall Study|Withdrawal by Subject|1|||
131867086|NCT00320710|474792371|FG000|Overall Study|Protocol Violation|6|||
131867087|NCT00320710|474792372|FG001|Overall Study|Protocol Violation|5|||
131867088|NCT00320710|474792373|FG002|Overall Study|Protocol Violation|0|||
131867089|NCT00320710|474792371|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131867090|NCT00320710|474792372|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131867091|NCT00320710|474792373|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131867092|NCT00320710|474792371|FG000|Overall Study|Abnormal laboratory value(s)|12|||
131867093|NCT00320710|474792372|FG001|Overall Study|Abnormal laboratory value(s)|3|||
131867094|NCT00320710|474792373|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131867095|NCT00320710|474792371|FG000|Overall Study|Adverse Event|18|||
131867096|NCT00320710|474792372|FG001|Overall Study|Adverse Event|14|||
131867097|NCT00320710|474792373|FG002|Overall Study|Adverse Event|1|||
131867098|NCT00320710|474792371|FG000|Overall Study|Lost to Follow-up|1|||
131867099|NCT00320710|474792372|FG001|Overall Study|Lost to Follow-up|0|||
131867100|NCT00320710|474792373|FG002|Overall Study|Lost to Follow-up|0|||
131867101|NCT03448419|474792374|FG000|Overall Study|Adverse Event|10|||
131867102|NCT03448419|474792375|FG001|Overall Study|Adverse Event|9|||
131867103|NCT03448419|474792374|FG000|Overall Study|Lost to Follow-up|0|||
131867104|NCT03448419|474792375|FG001|Overall Study|Lost to Follow-up|2|||
131867105|NCT03448419|474792374|FG000|Overall Study|Withdrawal by Subject|3|||
131867106|NCT03448419|474792375|FG001|Overall Study|Withdrawal by Subject|1|||
131867107|NCT03448419|474792374|FG000|Overall Study|Not treated|0|||
131867108|NCT03448419|474792375|FG001|Overall Study|Not treated|1|||
131867109|NCT03448419|474792374|FG000|Overall Study|Patient did not attend all visits|0|||
131867110|NCT03448419|474792375|FG001|Overall Study|Patient did not attend all visits|2|||
131867111|NCT03448419|474792374|FG000|Overall Study|Withdrawn by Sponsor|0|||
131867112|NCT03448419|474792375|FG001|Overall Study|Withdrawn by Sponsor|1|||
131867113|NCT02841995|474792376|FG000|Overall Study|Disease progression|5|||
131867114|NCT02841995|474792377|FG001|Overall Study|Disease progression|11|||
131867115|NCT02841995|474792378|FG002|Overall Study|Disease progression|8|||
131867116|NCT02841995|474792376|FG000|Overall Study|Withdrawal by Subject|2|||
131867117|NCT02841995|474792377|FG001|Overall Study|Withdrawal by Subject|4|||
131867118|NCT02841995|474792378|FG002|Overall Study|Withdrawal by Subject|4|||
131867119|NCT02841995|474792376|FG000|Overall Study|Adverse Event|2|||
131867120|NCT02841995|474792377|FG001|Overall Study|Adverse Event|0|||
131867121|NCT02841995|474792378|FG002|Overall Study|Adverse Event|1|||
131867122|NCT02841995|474792376|FG000|Overall Study|Investigator decision|2|||
131867123|NCT02841995|474792377|FG001|Overall Study|Investigator decision|0|||
131867124|NCT02841995|474792378|FG002|Overall Study|Investigator decision|1|||
131867125|NCT02841995|474792376|FG000|Overall Study|Death|0|||
131867126|NCT02841995|474792377|FG001|Overall Study|Death|0|||
131867127|NCT02841995|474792378|FG002|Overall Study|Death|2|||
131867128|NCT02841995|474792376|FG000|Overall Study|Noncompliance to protocol|1|||
131867129|NCT02841995|474792377|FG001|Overall Study|Noncompliance to protocol|0|||
131867130|NCT02841995|474792378|FG002|Overall Study|Noncompliance to protocol|0|||
131867131|NCT02841995|474792376|FG000|Overall Study|Sponsor decision|1|||
131867132|NCT02841995|474792377|FG001|Overall Study|Sponsor decision|0|||
131867133|NCT02841995|474792378|FG002|Overall Study|Sponsor decision|0|||
131867134|NCT02841995|474792376|FG000|Overall Study|Other|4|||
131867135|NCT02841995|474792377|FG001|Overall Study|Other|1|||
131867136|NCT02841995|474792378|FG002|Overall Study|Other|5|||
131867137|NCT01703260|474792379|FG000|Overall Study|Adverse Event|1|||
131867138|NCT01703260|474792380|FG001|Overall Study|Adverse Event|2|||
131917482|NCT03765073|474981575|FG008|Stage 3|Other|0|||
131917483|NCT03765073|474981576|FG009|Stage 3|Other|0|||
131917484|NCT03765073|474981577|FG010|Stage 3|Other|0|||
131917485|NCT03765073|474981578|FG011|Stage 3|Other|0|||
131867139|NCT01703260|474792381|FG002|Overall Study|Adverse Event|2|||
131867140|NCT01703260|474792379|FG000|Overall Study|Lost to Follow-up|1|||
131867141|NCT01703260|474792380|FG001|Overall Study|Lost to Follow-up|0|||
131867142|NCT01703260|474792381|FG002|Overall Study|Lost to Follow-up|0|||
131867143|NCT01703260|474792379|FG000|Overall Study|Withdrawal by Subject|0|||
131867144|NCT01703260|474792380|FG001|Overall Study|Withdrawal by Subject|0|||
131867145|NCT01703260|474792381|FG002|Overall Study|Withdrawal by Subject|1|||
131917486|NCT03765073|474981579|FG012|Stage 3|Other|0|||
131917487|NCT03765073|474981580|FG013|Stage 3|Other|0|||
131917488|NCT03765073|474981581|FG014|Stage 3|Other|0|||
131917489|NCT03765073|474981582|FG015|Stage 3|Other|0|||
131917490|NCT03765073|474981583|FG016|Stage 3|Other|0|||
131917491|NCT03765073|474981584|FG017|Stage 3|Other|1|||
131917492|NCT03765073|474981585|FG018|Stage 3|Other|2|||
131917493|NCT03765073|474981586|FG019|Stage 3|Other|2|||
131917494|NCT03765073|474981587|FG020|Stage 3|Other|2|||
131917495|NCT03765073|474981567|FG000|Stage 3|Withdrawal by parent/guardian|0|||
131917496|NCT03765073|474981568|FG001|Stage 3|Withdrawal by parent/guardian|0|||
131917497|NCT03765073|474981569|FG002|Stage 3|Withdrawal by parent/guardian|0|||
131917498|NCT03765073|474981570|FG003|Stage 3|Withdrawal by parent/guardian|0|||
131917499|NCT03765073|474981571|FG004|Stage 3|Withdrawal by parent/guardian|0|||
131917500|NCT03765073|474981572|FG005|Stage 3|Withdrawal by parent/guardian|0|||
131917501|NCT03765073|474981573|FG006|Stage 3|Withdrawal by parent/guardian|0|||
131917502|NCT03765073|474981574|FG007|Stage 3|Withdrawal by parent/guardian|0|||
131917503|NCT03765073|474981575|FG008|Stage 3|Withdrawal by parent/guardian|0|||
131917504|NCT03765073|474981576|FG009|Stage 3|Withdrawal by parent/guardian|0|||
131917505|NCT03765073|474981577|FG010|Stage 3|Withdrawal by parent/guardian|0|||
131917506|NCT03765073|474981578|FG011|Stage 3|Withdrawal by parent/guardian|0|||
131917507|NCT03765073|474981579|FG012|Stage 3|Withdrawal by parent/guardian|0|||
131917508|NCT03765073|474981580|FG013|Stage 3|Withdrawal by parent/guardian|0|||
131917509|NCT03765073|474981581|FG014|Stage 3|Withdrawal by parent/guardian|0|||
131917510|NCT03765073|474981582|FG015|Stage 3|Withdrawal by parent/guardian|0|||
131917511|NCT03765073|474981583|FG016|Stage 3|Withdrawal by parent/guardian|0|||
131917512|NCT03765073|474981584|FG017|Stage 3|Withdrawal by parent/guardian|0|||
131917513|NCT03765073|474981585|FG018|Stage 3|Withdrawal by parent/guardian|0|||
131917514|NCT03765073|474981586|FG019|Stage 3|Withdrawal by parent/guardian|6|||
131917515|NCT03765073|474981587|FG020|Stage 3|Withdrawal by parent/guardian|9|||
131917516|NCT03765073|474981567|FG000|Stage 3|Withdrawal by Subject|0|||
131917517|NCT03765073|474981568|FG001|Stage 3|Withdrawal by Subject|0|||
131917518|NCT03765073|474981569|FG002|Stage 3|Withdrawal by Subject|0|||
131917519|NCT03765073|474981570|FG003|Stage 3|Withdrawal by Subject|0|||
131917520|NCT03765073|474981571|FG004|Stage 3|Withdrawal by Subject|0|||
131917521|NCT03765073|474981572|FG005|Stage 3|Withdrawal by Subject|0|||
131917522|NCT03765073|474981573|FG006|Stage 3|Withdrawal by Subject|0|||
131917523|NCT03765073|474981574|FG007|Stage 3|Withdrawal by Subject|0|||
131917524|NCT03765073|474981575|FG008|Stage 3|Withdrawal by Subject|0|||
131917525|NCT03765073|474981576|FG009|Stage 3|Withdrawal by Subject|0|||
131917526|NCT03765073|474981577|FG010|Stage 3|Withdrawal by Subject|0|||
131917527|NCT03765073|474981578|FG011|Stage 3|Withdrawal by Subject|0|||
131917528|NCT03765073|474981579|FG012|Stage 3|Withdrawal by Subject|0|||
131917529|NCT03765073|474981580|FG013|Stage 3|Withdrawal by Subject|0|||
131917530|NCT03765073|474981581|FG014|Stage 3|Withdrawal by Subject|0|||
131917531|NCT03765073|474981582|FG015|Stage 3|Withdrawal by Subject|0|||
131917532|NCT03765073|474981583|FG016|Stage 3|Withdrawal by Subject|0|||
131917533|NCT03765073|474981584|FG017|Stage 3|Withdrawal by Subject|8|||
131917534|NCT03765073|474981585|FG018|Stage 3|Withdrawal by Subject|11|||
131917535|NCT03765073|474981586|FG019|Stage 3|Withdrawal by Subject|0|||
131917536|NCT03765073|474981587|FG020|Stage 3|Withdrawal by Subject|0|||
131917537|NCT04537299|474981588|FG000|Overall Study|Withdrawal by Subject|2|||
131917538|NCT04537299|474981589|FG001|Overall Study|Withdrawal by Subject|0|||
131917539|NCT04537299|474981588|FG000|Overall Study|Protocol Violation|1|||
131917540|NCT04537299|474981589|FG001|Overall Study|Protocol Violation|1|||
131917541|NCT03806296|474981592|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
131917542|NCT03806296|474981593|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
131917543|NCT03806296|474981594|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
131917544|NCT03806296|474981592|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
131917545|NCT03806296|474981593|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
131917546|NCT03806296|474981594|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
131917547|NCT03806296|474981592|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
131917548|NCT03806296|474981593|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
131917549|NCT03806296|474981594|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
131917550|NCT00876343|474981601|FG000|Overall Study|Adverse Event|7|||
131917551|NCT00876343|474981602|FG001|Overall Study|Adverse Event|8|||
131917552|NCT00876343|474981603|FG002|Overall Study|Adverse Event|2|||
131917553|NCT00876343|474981601|FG000|Overall Study|Withdrawal by Subject|4|||
131917554|NCT00876343|474981602|FG001|Overall Study|Withdrawal by Subject|4|||
131917555|NCT00876343|474981603|FG002|Overall Study|Withdrawal by Subject|3|||
131917556|NCT00876343|474981601|FG000|Overall Study|Lack of Efficacy|0|||
131917557|NCT00876343|474981602|FG001|Overall Study|Lack of Efficacy|0|||
131917558|NCT00876343|474981603|FG002|Overall Study|Lack of Efficacy|1|||
131917559|NCT00876343|474981601|FG000|Overall Study|Protocol Violation|4|||
131917560|NCT00876343|474981602|FG001|Overall Study|Protocol Violation|1|||
131917561|NCT00876343|474981603|FG002|Overall Study|Protocol Violation|1|||
131917562|NCT00876343|474981601|FG000|Overall Study|Physician Decision|0|||
131917563|NCT00876343|474981602|FG001|Overall Study|Physician Decision|1|||
131917564|NCT00876343|474981603|FG002|Overall Study|Physician Decision|1|||
131867146|NCT01703260|474792379|FG000|Overall Study|Study Termination|1|||
131867147|NCT01703260|474792380|FG001|Overall Study|Study Termination|2|||
131867148|NCT01703260|474792381|FG002|Overall Study|Study Termination|0|||
131867149|NCT04548193|474792385|FG000|Overall Study|Lost to Follow-up|0|||
131867150|NCT04548193|474792386|FG001|Overall Study|Lost to Follow-up|1|||
131867151|NCT04548193|474792385|FG000|Overall Study|Death|0|||
131867152|NCT04548193|474792386|FG001|Overall Study|Death|1|||
131867153|NCT04548193|474792385|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
131867154|NCT04548193|474792386|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
131867155|NCT04548193|474792385|FG000|Overall Study|Withdrawal by Subject|2|||
131867156|NCT04548193|474792386|FG001|Overall Study|Withdrawal by Subject|2|||
131867157|NCT00630825|474792387|FG000|Overall Study|Adverse Event|4|||
131867158|NCT00630825|474792388|FG001|Overall Study|Adverse Event|4|||
131867159|NCT00630825|474792389|FG002|Overall Study|Adverse Event|3|||
131867160|NCT00630825|474792390|FG003|Overall Study|Adverse Event|1|||
131867161|NCT00630825|474792387|FG000|Overall Study|Entry Criteria Not Met|1|||
131867162|NCT00630825|474792388|FG001|Overall Study|Entry Criteria Not Met|0|||
131867163|NCT00630825|474792389|FG002|Overall Study|Entry Criteria Not Met|2|||
131867164|NCT00630825|474792390|FG003|Overall Study|Entry Criteria Not Met|1|||
131867165|NCT00630825|474792387|FG000|Overall Study|Lost to Follow-up|1|||
131867166|NCT00630825|474792388|FG001|Overall Study|Lost to Follow-up|1|||
131867167|NCT00630825|474792389|FG002|Overall Study|Lost to Follow-up|1|||
131867168|NCT00630825|474792390|FG003|Overall Study|Lost to Follow-up|1|||
131867169|NCT00630825|474792387|FG000|Overall Study|Physician Decision|1|||
131867170|NCT00630825|474792388|FG001|Overall Study|Physician Decision|0|||
131867171|NCT00630825|474792389|FG002|Overall Study|Physician Decision|0|||
131867172|NCT00630825|474792390|FG003|Overall Study|Physician Decision|0|||
131867173|NCT00630825|474792387|FG000|Overall Study|Withdrawal by Subject|2|||
131867174|NCT00630825|474792388|FG001|Overall Study|Withdrawal by Subject|2|||
131867175|NCT00630825|474792389|FG002|Overall Study|Withdrawal by Subject|2|||
131867176|NCT00630825|474792390|FG003|Overall Study|Withdrawal by Subject|3|||
131867177|NCT02275819|474792391|FG000|Overall Study|Adverse Event|0|||
131867178|NCT02275819|474792392|FG001|Overall Study|Adverse Event|1|||
131867179|NCT02211209|474792396|FG000|Overall Study|Investigator judgment|0|||
131867180|NCT02211209|474792397|FG001|Overall Study|Investigator judgment|1|||
131867181|NCT02211209|474792396|FG000|Overall Study|Voluntary withdrawal|1|||
131867182|NCT02211209|474792397|FG001|Overall Study|Voluntary withdrawal|4|||
131867183|NCT02211209|474792396|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
131867184|NCT02211209|474792397|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
131867185|NCT02211209|474792396|FG000|Overall Study|Reason Not Specified|1|||
131867186|NCT02211209|474792397|FG001|Overall Study|Reason Not Specified|0|||
131867187|NCT02792062|474792400|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
131867188|NCT02792062|474792401|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
131867189|NCT02792062|474792402|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
131867190|NCT02792062|474792403|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
131867191|NCT02792062|474792404|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
131867192|NCT02792062|474792405|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
131867193|NCT01741688|474792406|FG000|Overall Study|Lack of insurance coverage|2|||
131867194|NCT01741688|474792406|FG000|Overall Study|Withdrawal by Subject|1|||
131867195|NCT02220764|474792408|FG000|Overall Study|Lost to Follow-up|3|||
131867196|NCT02220764|474792409|FG001|Overall Study|Lost to Follow-up|1|||
131867197|NCT02220764|474792408|FG000|Overall Study|Death|1|||
131867198|NCT02220764|474792409|FG001|Overall Study|Death|0|||
131867199|NCT02198664|474792410|FG000|Overall Study|Adverse Event|2|||
131867200|NCT02198664|474792411|FG001|Overall Study|Adverse Event|0|||
131867201|NCT02198664|474792410|FG000|Overall Study|Withdrawal by Subject|11|||
131867202|NCT02198664|474792411|FG001|Overall Study|Withdrawal by Subject|8|||
131867203|NCT02198664|474792410|FG000|Overall Study|Failure to tolerate|2|||
131867204|NCT02198664|474792411|FG001|Overall Study|Failure to tolerate|0|||
131867205|NCT02198664|474792410|FG000|Overall Study|Not stated|1|||
131867206|NCT02198664|474792411|FG001|Overall Study|Not stated|0|||
131867207|NCT00365794|474792417|FG000|Overall Study|Withdrawal by Subject|2|||
131867208|NCT00745901|474792418|FG000|Overall Study|Adverse Event|3|||
131867209|NCT00745901|474792419|FG001|Overall Study|Adverse Event|4|||
131867210|NCT00745901|474792418|FG000|Overall Study|Protocol Violation|0|||
131867211|NCT00745901|474792419|FG001|Overall Study|Protocol Violation|1|||
131867212|NCT00745901|474792418|FG000|Overall Study|Withdrawal by Subject|1|||
131867213|NCT00745901|474792419|FG001|Overall Study|Withdrawal by Subject|0|||
131867214|NCT00745901|474792418|FG000|Overall Study|Lost to Follow-up|7|||
131867215|NCT00745901|474792419|FG001|Overall Study|Lost to Follow-up|4|||
131867216|NCT00745901|474792418|FG000|Overall Study|Pregnancy|2|||
131867217|NCT00745901|474792419|FG001|Overall Study|Pregnancy|4|||
131867218|NCT00745901|474792418|FG000|Overall Study|Lack of compliance|2|||
131867219|NCT00745901|474792419|FG001|Overall Study|Lack of compliance|2|||
131867220|NCT00745901|474792418|FG000|Overall Study|Patient's next menses did not start with|1|||
131867221|NCT00745901|474792419|FG001|Overall Study|Patient's next menses did not start with|0|||
131867222|NCT00745901|474792418|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
131867223|NCT00745901|474792419|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
131867224|NCT00745901|474792418|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
131867225|NCT00745901|474792419|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
131867226|NCT00745901|474792418|FG000|Overall Study|Patient didn't take any study medication|7|||
131867227|NCT00745901|474792419|FG001|Overall Study|Patient didn't take any study medication|3|||
131867228|NCT03270657|474794246|FG000|Overall Study|Withdrawal by Subject|1|||
131867229|NCT00162981|474794247|FG000|Overall Study|Adverse Event|2|||
131867230|NCT00162981|474794248|FG001|Overall Study|Adverse Event|5|||
131867231|NCT00162981|474794247|FG000|Overall Study|Withdrawal by Subject|1|||
131867232|NCT00162981|474794248|FG001|Overall Study|Withdrawal by Subject|1|||
131867233|NCT00162981|474794247|FG000|Overall Study|Physician Decision|1|||
131867234|NCT00162981|474794248|FG001|Overall Study|Physician Decision|0|||
131867235|NCT04509076|474794262|FG000|Overall Study|Withdrawal by Subject|1|||
131867236|NCT04509076|474794263|FG001|Overall Study|Withdrawal by Subject|2|||
131867237|NCT04509076|474794262|FG000|Overall Study|Lost to Follow-up|1|||
131867238|NCT04509076|474794263|FG001|Overall Study|Lost to Follow-up|2|||
131867239|NCT00502242|474794267|FG000|Overall Study|Lack of Efficacy|1|||
131867240|NCT00502242|474794268|FG001|Overall Study|Lack of Efficacy|11|||
131867241|NCT00502242|474794267|FG000|Overall Study|Adverse Event|31|||
131867242|NCT00502242|474794268|FG001|Overall Study|Adverse Event|20|||
131867243|NCT00502242|474794267|FG000|Overall Study|Physician Decision|2|||
131867244|NCT00502242|474794268|FG001|Overall Study|Physician Decision|3|||
131867245|NCT00502242|474794267|FG000|Overall Study|Other - Unspecified|8|||
131867246|NCT00502242|474794268|FG001|Overall Study|Other - Unspecified|14|||
131867247|NCT00502242|474794267|FG000|Overall Study|Protocol Violation|3|||
131867248|NCT00502242|474794268|FG001|Overall Study|Protocol Violation|1|||
131867249|NCT00502242|474794267|FG000|Overall Study|Withdrawal by Subject|6|||
131867250|NCT00502242|474794268|FG001|Overall Study|Withdrawal by Subject|7|||
131867251|NCT01812109|474794269|FG000|Overall Study|research personnel delay|16|||
131867252|NCT01812109|474794269|FG000|Overall Study|NIRS Unattainable|17|||
131867253|NCT03313180|474794270|FG000|Overall Study|Adverse Event|120|||
131867254|NCT03313180|474794270|FG000|Overall Study|Lost to Follow-up|3|||
131867255|NCT03313180|474794270|FG000|Overall Study|Withdrawal by Subject|39|||
131867256|NCT03313180|474794270|FG000|Overall Study|Other than listed above|15|||
131867257|NCT03313180|474794270|FG000|Overall Study|Covid-19 related|2|||
131867258|NCT01966120|474794271|FG000|Overall Study|Withdrawal by Subject|0|||
131867259|NCT01966120|474794272|FG001|Overall Study|Withdrawal by Subject|5|||
131867260|NCT01966120|474794271|FG000|Overall Study|Lost to Follow-up|1|||
131867261|NCT01966120|474794272|FG001|Overall Study|Lost to Follow-up|1|||
131867262|NCT00461630|474794273|FG000|Overall Study|Death|798|||
131867263|NCT00461630|474794274|FG001|Overall Study|Death|732|||
131867264|NCT00461630|474794273|FG000|Overall Study|Lost to Follow-up|108|||
131867265|NCT00461630|474794274|FG001|Overall Study|Lost to Follow-up|95|||
131867266|NCT04630002|474794275|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
131867267|NCT04630002|474794276|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
131867268|NCT04630002|474794277|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
131867269|NCT04630002|474794275|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
131867270|NCT04630002|474794276|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
131867271|NCT04630002|474794277|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
131867272|NCT04630002|474794275|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
131867273|NCT04630002|474794276|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
131867274|NCT04630002|474794277|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
131867275|NCT04630002|474794275|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
131867276|NCT04630002|474794276|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
131867277|NCT04630002|474794277|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
131867278|NCT04630002|474794275|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
131867279|NCT04630002|474794276|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
131867280|NCT04630002|474794277|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
131867281|NCT04630002|474794275|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
131867282|NCT04630002|474794276|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
131867283|NCT04630002|474794277|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
131867284|NCT04630002|474794275|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
131867285|NCT04630002|474794276|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
131867286|NCT04630002|474794277|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
131867287|NCT04630002|474794275|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
131867288|NCT04630002|474794276|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
131867289|NCT04630002|474794277|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
131867290|NCT00442897|474794278|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
131867291|NCT00442897|474794279|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
131867292|NCT00442897|474794278|FG000|Base Study (12 Week Follow-up)|Death|0|||
131867293|NCT00442897|474794279|FG001|Base Study (12 Week Follow-up)|Death|1|||
131917565|NCT00876343|474981601|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
131917566|NCT00876343|474981602|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
131917567|NCT00876343|474981603|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
131917568|NCT00876343|474981601|FG000|Overall Study|Change of residence or other commitments|2|||
131917569|NCT00876343|474981602|FG001|Overall Study|Change of residence or other commitments|2|||
131917570|NCT00876343|474981603|FG002|Overall Study|Change of residence or other commitments|3|||
131917571|NCT01933932|474981606|FG000|Overall Study|Death|173|||
131917572|NCT01933932|474981607|FG001|Overall Study|Death|163|||
131917573|NCT01933932|474981606|FG000|Overall Study|Withdrawal by Subject|11|||
131917574|NCT01933932|474981607|FG001|Overall Study|Withdrawal by Subject|14|||
131917575|NCT01933932|474981606|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131917576|NCT01933932|474981607|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131917577|NCT04235374|474981611|FG000|Overall Study|Death|91|||
131917578|NCT04235374|474981612|FG001|Overall Study|Death|91|||
131917579|NCT04235374|474981611|FG000|Overall Study|Refused|2|||
131917580|NCT04235374|474981612|FG001|Overall Study|Refused|2|||
131917581|NCT04235374|474981611|FG000|Overall Study|Unavailable|12|||
131917582|NCT04235374|474981612|FG001|Overall Study|Unavailable|3|||
131917583|NCT04235374|474981611|FG000|Overall Study|Withdrawal by Subject|0|||
131917584|NCT04235374|474981612|FG001|Overall Study|Withdrawal by Subject|1|||
131917585|NCT04235374|474981611|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
131917586|NCT04235374|474981612|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
131917587|NCT02864992|474981616|FG000|Overall Study|still on treatment|15|||
131917588|NCT02864992|474981617|FG001|Overall Study|still on treatment|1|||
131917589|NCT02864992|474981618|FG002|Overall Study|still on treatment|33|||
131917590|NCT02783274|474981619|FG000|Overall Study|Withdrawal by Subject|16|||
131917591|NCT02783274|474981619|FG000|Overall Study|Physician Decision|6|||
131917592|NCT02783274|474981619|FG000|Overall Study|Death|9|||
131917593|NCT02783274|474981619|FG000|Overall Study|Lost to Follow-up|22|||
131917594|NCT02783274|474981619|FG000|Overall Study|Other|22|||
131917595|NCT00724945|474981623|FG000|Period 1|non-compliance|1|||
131917596|NCT00724945|474981624|FG001|Period 1|non-compliance|0|||
131917597|NCT00724945|474981623|FG000|Period 1|Adverse Event|1|||
131917598|NCT00724945|474981624|FG001|Period 1|Adverse Event|1|||
131917599|NCT00724945|474981623|FG000|Period 1|Lost to Follow-up|1|||
131917600|NCT00724945|474981624|FG001|Period 1|Lost to Follow-up|0|||
131917601|NCT00724945|474981623|FG000|Period 2|lens comfort issue|3|||
131917602|NCT00724945|474981624|FG001|Period 2|lens comfort issue|0|||
131917603|NCT00724945|474981623|FG000|Period 2|lens physiology issue|1|||
131917604|NCT00724945|474981624|FG001|Period 2|lens physiology issue|0|||
131917605|NCT01525589|474981626|FG000|Overall Study|Non-treatment-related AE|1|||
131917606|NCT01525589|474981627|FG001|Overall Study|Non-treatment-related AE|0|||
131917607|NCT01525589|474981628|FG002|Overall Study|Non-treatment-related AE|0|||
131917608|NCT01525589|474981626|FG000|Overall Study|Progressive disease|48|||
131917609|NCT01525589|474981627|FG001|Overall Study|Progressive disease|15|||
131917610|NCT01525589|474981628|FG002|Overall Study|Progressive disease|29|||
131917611|NCT01525589|474981626|FG000|Overall Study|Never treated|2|||
131917612|NCT01525589|474981627|FG001|Overall Study|Never treated|0|||
131917613|NCT01525589|474981628|FG002|Overall Study|Never treated|0|||
131917614|NCT01525589|474981626|FG000|Overall Study|Physician Decision|4|||
131917615|NCT01525589|474981627|FG001|Overall Study|Physician Decision|2|||
131917616|NCT01525589|474981628|FG002|Overall Study|Physician Decision|2|||
131917617|NCT01525589|474981626|FG000|Overall Study|Death|0|||
131917618|NCT01525589|474981627|FG001|Overall Study|Death|0|||
131917619|NCT01525589|474981628|FG002|Overall Study|Death|2|||
131917620|NCT01525589|474981626|FG000|Overall Study|Treatment-related AE|1|||
131917621|NCT01525589|474981627|FG001|Overall Study|Treatment-related AE|1|||
131917622|NCT01525589|474981628|FG002|Overall Study|Treatment-related AE|2|||
131917623|NCT01525589|474981626|FG000|Overall Study|Other reasons|0|||
131917624|NCT01525589|474981627|FG001|Overall Study|Other reasons|1|||
131917625|NCT01525589|474981628|FG002|Overall Study|Other reasons|0|||
131917626|NCT01525589|474981626|FG000|Overall Study|Withdrawal by Subject|0|||
131917627|NCT01525589|474981627|FG001|Overall Study|Withdrawal by Subject|1|||
131917628|NCT01525589|474981628|FG002|Overall Study|Withdrawal by Subject|0|||
131917629|NCT04835441|474981629|FG000|Overall Study|Physician Decision|4|||
131917630|NCT04835441|474981630|FG001|Overall Study|Physician Decision|4|||
131917631|NCT04835441|474981629|FG000|Overall Study|Other|1|||
131917632|NCT04835441|474981630|FG001|Overall Study|Other|1|||
131917633|NCT04835441|474981629|FG000|Overall Study|Lost to Follow-up|0|||
131917634|NCT04835441|474981630|FG001|Overall Study|Lost to Follow-up|1|||
131917635|NCT06481579|474981631|FG000|Overall Study|Death|1|||
131917636|NCT06481579|474981632|FG001|Overall Study|Death|0|||
131917637|NCT06481579|474981631|FG000|Overall Study|Withdrawal by Subject|3|||
131917638|NCT06481579|474981632|FG001|Overall Study|Withdrawal by Subject|0|||
131917639|NCT06481579|474981631|FG000|Overall Study|Other|1|||
131917640|NCT06481579|474981632|FG001|Overall Study|Other|1|||
131917641|NCT05260008|474981633|FG000|Overall Study|Physician Decision|0|||
131917642|NCT05260008|474981634|FG001|Overall Study|Physician Decision|1|||
131917643|NCT05260008|474981635|FG002|Overall Study|Physician Decision|0|||
131867294|NCT00442897|474794278|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
131867295|NCT00442897|474794279|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
131867296|NCT00442897|474794278|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
131867297|NCT00442897|474794279|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
131867298|NCT00442897|474794278|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
131867299|NCT00442897|474794279|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
131867300|NCT00442897|474794278|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
131867301|NCT00442897|474794279|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
131867302|NCT00442897|474794278|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
131867303|NCT00442897|474794279|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
131867304|NCT00442897|474794278|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
131867305|NCT00442897|474794279|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
131867306|NCT04498182|474794280|FG000|Overall Study|Adverse Event|2|||
131867307|NCT04498182|474794281|FG001|Overall Study|Adverse Event|3|||
131867308|NCT04498182|474794282|FG002|Overall Study|Adverse Event|2|||
131867309|NCT04498182|474794280|FG000|Overall Study|Withdrawal of Consent|3|||
131867310|NCT04498182|474794281|FG001|Overall Study|Withdrawal of Consent|4|||
131867311|NCT04498182|474794282|FG002|Overall Study|Withdrawal of Consent|3|||
131867312|NCT04498182|474794280|FG000|Overall Study|Non-Compliant|1|||
131867313|NCT04498182|474794281|FG001|Overall Study|Non-Compliant|0|||
131867314|NCT04498182|474794282|FG002|Overall Study|Non-Compliant|1|||
131867315|NCT04498182|474794280|FG000|Overall Study|Lost to Follow-up|0|||
131867316|NCT04498182|474794281|FG001|Overall Study|Lost to Follow-up|0|||
131867317|NCT04498182|474794282|FG002|Overall Study|Lost to Follow-up|1|||
131867318|NCT04498182|474794280|FG000|Overall Study|Investigator Decision|0|||
131867319|NCT04498182|474794281|FG001|Overall Study|Investigator Decision|0|||
131867320|NCT04498182|474794282|FG002|Overall Study|Investigator Decision|1|||
131867321|NCT04498182|474794280|FG000|Overall Study|Protocol Violation|1|||
131867322|NCT04498182|474794281|FG001|Overall Study|Protocol Violation|0|||
131867323|NCT04498182|474794282|FG002|Overall Study|Protocol Violation|2|||
131867324|NCT00931255|474794287|FG000|Overall Study|Follow up biopsy not done|2|||
131867325|NCT00931255|474794288|FG001|Overall Study|Follow up biopsy not done|3|||
131867326|NCT01609296|474794296|FG000|Overall Study|Death|253|||
131867327|NCT01609296|474794296|FG000|Overall Study|Withdrawal by Subject|151|||
131867328|NCT01609296|474794296|FG000|Overall Study|Lost to Follow-up|21|||
131867329|NCT01609296|474794296|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
131867330|NCT01609296|474794296|FG000|Overall Study|missed visit but known to be alive|28|||
131867331|NCT00386360|474794299|FG000|Overall Study|Adverse Event|4|||
131867332|NCT00386360|474794300|FG001|Overall Study|Adverse Event|2|||
131867333|NCT00386360|474794299|FG000|Overall Study|Physician Decision|2|||
131867334|NCT00386360|474794300|FG001|Overall Study|Physician Decision|2|||
131867335|NCT00386360|474794299|FG000|Overall Study|Lost to Follow-up|0|||
131867336|NCT00386360|474794300|FG001|Overall Study|Lost to Follow-up|2|||
131867337|NCT00386360|474794299|FG000|Overall Study|Protocol Violation|0|||
131867338|NCT00386360|474794300|FG001|Overall Study|Protocol Violation|3|||
131867339|NCT00386360|474794299|FG000|Overall Study|Withdrawal by Subject|3|||
131867340|NCT00386360|474794300|FG001|Overall Study|Withdrawal by Subject|6|||
131867341|NCT00386360|474794299|FG000|Overall Study|Did not take any study medication|0|||
131867342|NCT00386360|474794300|FG001|Overall Study|Did not take any study medication|2|||
131867343|NCT02230904|474794301|FG000|Overall Study|Safety follow up could not take place|0|||
131867344|NCT02230904|474794302|FG001|Overall Study|Safety follow up could not take place|1|||
131867345|NCT01681212|474794303|FG000|Overall Study|No longer met study criteria|5|||
131867346|NCT01681212|474794303|FG000|Overall Study|Administrative reason by sponsor|1|||
131867347|NCT01464424|474794304|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
131867348|NCT01464424|474794305|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
131867349|NCT01464333|474794307|FG000|Overall Study|Adverse Event|34|||
131867350|NCT01464333|474794307|FG000|Overall Study|Lack of Efficacy|72|||
131867351|NCT01464333|474794307|FG000|Overall Study|Withdrawal by Subject|11|||
131867352|NCT01464333|474794307|FG000|Overall Study|Other|4|||
131917644|NCT05260008|474981636|FG003|Overall Study|Physician Decision|0|||
131917645|NCT01925794|474982944|FG000|180 Days|Death|2|||
131867353|NCT01464333|474794307|FG000|Overall Study|No Hospital Visit|42|||
131917646|NCT01925794|474982944|FG000|180 Days|Withdrawal by Subject|2|||
131867354|NCT02187198|474794310|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
131867355|NCT02187198|474794311|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
131867356|NCT02187198|474794310|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
131867357|NCT02187198|474794311|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
131867358|NCT00561392|474794312|FG000|Overall Study|Adverse Event|38|||
131867359|NCT00561392|474794312|FG000|Overall Study|Lack of Efficacy|2|||
131867360|NCT00561392|474794312|FG000|Overall Study|Protocol Violation|1|||
131917647|NCT01925794|474982944|FG000|270 Days|Death|2|||
131917648|NCT01925794|474982944|FG000|270 Days|Protocol Violation|3|||
131917649|NCT01901562|474982945|FG000|Overall Study|Protocol Violation|5|||
131917650|NCT01901562|474982945|FG000|Overall Study|Excluded intraoperatively|4|||
131867361|NCT00561392|474794312|FG000|Overall Study|Withdrawal by Subject|8|||
131867362|NCT00561392|474794312|FG000|Overall Study|Administrative problems|4|||
131867363|NCT01532518|474794313|FG000|Overall Study|Withdrawal by Subject|0|||
131867364|NCT01532518|474794314|FG001|Overall Study|Withdrawal by Subject|0|||
131867365|NCT01532518|474794315|FG002|Overall Study|Withdrawal by Subject|1|||
131867366|NCT01575834|474794316|FG000|Overall Study|Withdrawal by Subject|352|||
131867367|NCT01575834|474794317|FG001|Overall Study|Withdrawal by Subject|390|||
131867368|NCT01575834|474794316|FG000|Overall Study|Death|81|||
131867369|NCT01575834|474794317|FG001|Overall Study|Death|74|||
131867370|NCT01575834|474794316|FG000|Overall Study|Other|70|||
131867371|NCT01575834|474794317|FG001|Overall Study|Other|70|||
131867372|NCT01575834|474794316|FG000|Overall Study|Adverse Event|63|||
131867373|NCT01575834|474794317|FG001|Overall Study|Adverse Event|61|||
131867374|NCT01575834|474794316|FG000|Overall Study|Lost to Follow-up|55|||
131867375|NCT01575834|474794317|FG001|Overall Study|Lost to Follow-up|68|||
131867376|NCT01575834|474794316|FG000|Overall Study|Noncompliance|52|||
131867377|NCT01575834|474794317|FG001|Overall Study|Noncompliance|27|||
131867378|NCT01575834|474794316|FG000|Overall Study|Administrative decision|15|||
131867379|NCT01575834|474794317|FG001|Overall Study|Administrative decision|33|||
131867380|NCT01575834|474794316|FG000|Overall Study|Ineligibility Determined|5|||
131867381|NCT01575834|474794317|FG001|Overall Study|Ineligibility Determined|8|||
131867382|NCT01575834|474794316|FG000|Overall Study|Protocol Deviation|4|||
131867383|NCT01575834|474794317|FG001|Overall Study|Protocol Deviation|3|||
131867384|NCT01575834|474794316|FG000|Overall Study|Requirement for Alternative Therapy|2|||
131867385|NCT01575834|474794317|FG001|Overall Study|Requirement for Alternative Therapy|4|||
131867386|NCT02155283|474794318|FG000|Overall Study|Lost to Follow-up|3|||
131867387|NCT02155283|474794318|FG000|Overall Study|Withdrawal by Subject|1|||
131408164|NCT00445848|473118200|FG000|Overall Study|Withdrawal by Subject|4|||
131408165|NCT00445848|473118200|FG000|Overall Study|Progression|62|||
131408166|NCT00445848|473118200|FG000|Overall Study|Other-Not protocol specified|5|||
131408167|NCT00027378|473118201|FG000|Overall Study|Physician Decision|0|||
131408168|NCT00027378|473118202|FG001|Overall Study|Physician Decision|3|||
131867388|NCT02155283|474794318|FG000|Overall Study|Protocol Violation|3|||
131867389|NCT02282813|474794325|FG000|Overall Study|Withdrawal by Subject|4|||
131867390|NCT02282813|474794326|FG001|Overall Study|Withdrawal by Subject|5|||
131867391|NCT02282813|474794327|FG002|Overall Study|Withdrawal by Subject|0|||
131867392|NCT02282813|474794325|FG000|Overall Study|Adverse Event|3|||
131867393|NCT02282813|474794326|FG001|Overall Study|Adverse Event|10|||
131867394|NCT02282813|474794327|FG002|Overall Study|Adverse Event|1|||
131867395|NCT02282813|474794325|FG000|Overall Study|Subject non-compliance|1|||
131867396|NCT02282813|474794326|FG001|Overall Study|Subject non-compliance|4|||
131867397|NCT02282813|474794327|FG002|Overall Study|Subject non-compliance|0|||
131867398|NCT02282813|474794325|FG000|Overall Study|Physician Decision|0|||
131867399|NCT02282813|474794326|FG001|Overall Study|Physician Decision|3|||
131867400|NCT02282813|474794327|FG002|Overall Study|Physician Decision|1|||
131867401|NCT02282813|474794325|FG000|Overall Study|Lost to Follow-up|2|||
131867402|NCT02282813|474794326|FG001|Overall Study|Lost to Follow-up|0|||
131867403|NCT02282813|474794327|FG002|Overall Study|Lost to Follow-up|1|||
131408169|NCT05605691|473118203|FG000|Overall Study|Lost to Follow-up|1|||
131408170|NCT04706273|473118204|FG000|Overall Study|Withdrawal by Subject|27|||
131408171|NCT04706273|473118204|FG000|Overall Study|Physician Decision|1|||
131408172|NCT04706273|473118204|FG000|Overall Study|Lost to Follow-up|42|||
131408173|NCT04706273|473118204|FG000|Overall Study|Death|85|||
131408174|NCT04706273|473118204|FG000|Overall Study|Amputation that removes study device|2|||
131408175|NCT04706273|473118204|FG000|Overall Study|Surgical bypass|3|||
131453888|NCT03565497|473291819|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
131867404|NCT02282813|474794325|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
131867405|NCT02282813|474794326|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
131867406|NCT02282813|474794327|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
131408176|NCT04706273|473118204|FG000|Overall Study|Changing hospital|23|||
131408177|NCT04706273|473118204|FG000|Overall Study|Unable to attend hospital|2|||
131408178|NCT01369680|473118207|FG000|Overall Study|Lost to Follow-up|0|||
131408179|NCT01369680|473118208|FG001|Overall Study|Lost to Follow-up|0|||
131867407|NCT02282813|474794325|FG000|Overall Study|Lack of Efficacy|1|||
131867408|NCT02282813|474794326|FG001|Overall Study|Lack of Efficacy|0|||
131867409|NCT02282813|474794327|FG002|Overall Study|Lack of Efficacy|0|||
131867410|NCT02282813|474794325|FG000|Overall Study|Administrative reasons|0|||
131867411|NCT02282813|474794326|FG001|Overall Study|Administrative reasons|1|||
131867412|NCT02282813|474794327|FG002|Overall Study|Administrative reasons|0|||
131867413|NCT05000164|474794332|FG000|Overall Study|Adverse Event|1|||
131867414|NCT05000164|474794332|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
131867415|NCT05000164|474794332|FG000|Overall Study|Lens Discomfort|3|||
131867416|NCT05000164|474794332|FG000|Overall Study|Withdrew Consent during Study|2|||
131867417|NCT05000164|474794332|FG000|Overall Study|Subject Withdrawn by PI|2|||
131408180|NCT01369680|473118209|FG002|Overall Study|Lost to Follow-up|1|||
131408181|NCT01369680|473118210|FG003|Overall Study|Lost to Follow-up|2|||
131408182|NCT00585221|473118215|FG000|Overall Study|Protocol Violation|8|||
131408183|NCT02229214|473118225|FG000|Overall Study|Adverse Event|2|||
131917651|NCT00790036|474982946|FG000|Overall Study|Abnormal lab values|3|||
131917652|NCT00790036|474982947|FG001|Overall Study|Abnormal lab values|2|||
131917653|NCT00790036|474982946|FG000|Overall Study|Administrative problems|5|||
131917654|NCT00790036|474982947|FG001|Overall Study|Administrative problems|9|||
131917655|NCT00790036|474982946|FG000|Overall Study|Adverse Event|113|||
131917656|NCT00790036|474982947|FG001|Overall Study|Adverse Event|44|||
131917657|NCT00790036|474982946|FG000|Overall Study|Death|1|||
131917658|NCT00790036|474982947|FG001|Overall Study|Death|0|||
131917659|NCT00790036|474982946|FG000|Overall Study|Disease progression|24|||
131917660|NCT00790036|474982947|FG001|Overall Study|Disease progression|48|||
131917661|NCT00790036|474982946|FG000|Overall Study|Lost to Follow-up|1|||
131917662|NCT00790036|474982947|FG001|Overall Study|Lost to Follow-up|2|||
131917663|NCT00790036|474982946|FG000|Overall Study|Protocol Violation|10|||
131917664|NCT00790036|474982947|FG001|Overall Study|Protocol Violation|2|||
131917665|NCT00790036|474982946|FG000|Overall Study|Withdrawal by Subject|18|||
131917666|NCT00790036|474982947|FG001|Overall Study|Withdrawal by Subject|7|||
131917667|NCT00790036|474982946|FG000|Overall Study|Subject/guardian decision|20|||
131917668|NCT00790036|474982947|FG001|Overall Study|Subject/guardian decision|7|||
131917669|NCT00088153|474982954|FG000|Overall Study|Physician Decision|3|||
131917670|NCT00088153|474982955|FG001|Overall Study|Physician Decision|3|||
131917671|NCT00088153|474982954|FG000|Overall Study|Withdrawal by Subject|10|||
131917672|NCT00088153|474982955|FG001|Overall Study|Withdrawal by Subject|10|||
131917673|NCT00088153|474982954|FG000|Overall Study|Lost to Follow-up|11|||
131917674|NCT00088153|474982955|FG001|Overall Study|Lost to Follow-up|12|||
131917675|NCT00976027|474982957|FG000|Overall Study|Serious Adverse Event|36|||
131917676|NCT00976027|474982958|FG001|Overall Study|Serious Adverse Event|17|||
131917677|NCT00976027|474982957|FG000|Overall Study|Adverse Event|0|||
131917678|NCT00976027|474982958|FG001|Overall Study|Adverse Event|2|||
131917679|NCT00976027|474982957|FG000|Overall Study|Protocol Violation|60|||
131917680|NCT00976027|474982958|FG001|Overall Study|Protocol Violation|27|||
131917681|NCT00976027|474982957|FG000|Overall Study|Lost to Follow-up|208|||
131917682|NCT00976027|474982958|FG001|Overall Study|Lost to Follow-up|103|||
131917683|NCT00976027|474982957|FG000|Overall Study|Withdrawal by Subject|107|||
131917684|NCT00976027|474982958|FG001|Overall Study|Withdrawal by Subject|66|||
131917685|NCT04435626|474982963|FG000|Overall Study|Lost to Follow-up|1|||
131917686|NCT04435626|474982964|FG001|Overall Study|Lost to Follow-up|5|||
131917687|NCT04435626|474982963|FG000|Overall Study|Withdrawal by Subject|6|||
131917688|NCT04435626|474982964|FG001|Overall Study|Withdrawal by Subject|7|||
131917689|NCT04435626|474982963|FG000|Overall Study|major GCP violations|8|||
131917690|NCT04435626|474982964|FG001|Overall Study|major GCP violations|7|||
131917691|NCT01771107|474982970|FG000|Overall Study|Adverse Event|1|||
131917692|NCT01771107|474982971|FG001|Overall Study|Adverse Event|3|||
131917693|NCT01771107|474982970|FG000|Overall Study|Withdrawal by Subject|0|||
131917694|NCT01771107|474982971|FG001|Overall Study|Withdrawal by Subject|2|||
131917695|NCT01771107|474982970|FG000|Overall Study|Lost to Follow-up|0|||
131917696|NCT01771107|474982971|FG001|Overall Study|Lost to Follow-up|1|||
131917697|NCT01771107|474982970|FG000|Overall Study|participant moved|0|||
131917698|NCT01771107|474982971|FG001|Overall Study|participant moved|1|||
131917699|NCT01771107|474982970|FG000|Overall Study|Other|0|||
131917700|NCT01771107|474982971|FG001|Overall Study|Other|1|||
131917701|NCT05248386|474982976|FG000|Overall Study|Technical problems|0|||
131917702|NCT05248386|474982977|FG001|Overall Study|Technical problems|1|||
131917703|NCT05248386|474982976|FG000|Overall Study|Withdrawal by Subject|15|||
131917704|NCT05248386|474982977|FG001|Overall Study|Withdrawal by Subject|10|||
131917705|NCT05248386|474982976|FG000|Overall Study|Physician Decision|0|||
131917706|NCT05248386|474982977|FG001|Overall Study|Physician Decision|1|||
131917707|NCT05248386|474982976|FG000|Overall Study|Adverse Event|2|||
131917708|NCT05248386|474982977|FG001|Overall Study|Adverse Event|4|||
131917709|NCT05248386|474982976|FG000|Overall Study|Other|1|||
131917710|NCT05248386|474982977|FG001|Overall Study|Other|0|||
131917711|NCT05248386|474982976|FG000|Overall Study|Lack of Efficacy|14|||
131917712|NCT05248386|474982977|FG001|Overall Study|Lack of Efficacy|12|||
131917713|NCT04967222|474982979|FG000|Randomized|Lost to Follow-up|0|||
131917714|NCT04967222|474982980|FG001|Randomized|Lost to Follow-up|1|||
131408184|NCT02229214|473118226|FG001|Overall Study|Adverse Event|0|||
131408185|NCT02229214|473118225|FG000|Overall Study|Withdrawal by Subject|4|||
131408186|NCT02229214|473118226|FG001|Overall Study|Withdrawal by Subject|0|||
131917715|NCT04967222|474982981|FG002|Randomized|Lost to Follow-up|1|||
131917716|NCT04967222|474982979|FG000|Randomized|Physician Decision|0|||
131917717|NCT04967222|474982980|FG001|Randomized|Physician Decision|0|||
131917718|NCT04967222|474982981|FG002|Randomized|Physician Decision|1|||
131408187|NCT02927925|473118227|FG000|Overall Study|Death|16|||
131917719|NCT04967222|474982979|FG000|Randomized|Withdrawal by Subject|0|||
131917720|NCT04967222|474982980|FG001|Randomized|Withdrawal by Subject|0|||
131408188|NCT02927925|473118227|FG000|Overall Study|Physician Decision|1|||
131917721|NCT04967222|474982981|FG002|Randomized|Withdrawal by Subject|2|||
131917722|NCT04967222|474982979|FG000|Randomized|abnormal finding in MRI|0|||
131917723|NCT04967222|474982980|FG001|Randomized|abnormal finding in MRI|2|||
131917724|NCT04967222|474982981|FG002|Randomized|abnormal finding in MRI|0|||
131917725|NCT01295944|474982982|FG000|Overall Study|Switched to alternative treatment|1|||
131453889|NCT03565497|473291820|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
131453890|NCT03565497|473291821|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
131867418|NCT05000164|474794332|FG000|Overall Study|Other Fractured Test Article|1|||
131867419|NCT06509438|474794336|FG000|Overall Study|Adverse Event|1|||
131867420|NCT06509438|474794336|FG000|Overall Study|Lost to Follow-up|3|||
131867421|NCT03331796|474794337|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
131867422|NCT03331796|474794338|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
131867423|NCT03331796|474794339|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
131867424|NCT03331796|474794337|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
131867425|NCT03331796|474794338|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
131867426|NCT03331796|474794339|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
131867427|NCT03331796|474794337|FG000|Extended Follow-up|Adverse Event|1|||
131867428|NCT03331796|474794338|FG001|Extended Follow-up|Adverse Event|0|||
131867429|NCT03331796|474794339|FG002|Extended Follow-up|Adverse Event|1|||
131867430|NCT03331796|474794337|FG000|Extended Follow-up|Lost to Follow-up|0|||
131867431|NCT03331796|474794338|FG001|Extended Follow-up|Lost to Follow-up|0|||
131867432|NCT03331796|474794339|FG002|Extended Follow-up|Lost to Follow-up|1|||
131867433|NCT03331796|474794337|FG000|Extended Follow-up|Withdrawal by Subject|1|||
131867434|NCT03331796|474794338|FG001|Extended Follow-up|Withdrawal by Subject|0|||
131867435|NCT03331796|474794339|FG002|Extended Follow-up|Withdrawal by Subject|0|||
131867436|NCT03331796|474794337|FG000|Extended Follow-up|Termination of Funding|0|||
131867437|NCT03331796|474794338|FG001|Extended Follow-up|Termination of Funding|1|||
131867438|NCT03331796|474794339|FG002|Extended Follow-up|Termination of Funding|0|||
131867439|NCT01000155|474794340|FG000|Overall Study|Withdrawal by Subject|1|||
131867440|NCT01000155|474794340|FG000|Overall Study|Adverse Event|1|||
131867441|NCT00720213|474794343|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
131867442|NCT00720213|474794344|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
131867443|NCT00720213|474794345|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
131867444|NCT01252095|474794349|FG000|Overall Study|Disease progression|1|||
131867445|NCT01252095|474794350|FG001|Overall Study|Disease progression|0|||
131867446|NCT01420068|474794351|FG000|Overall Study|Administrative problems|1|||
131867447|NCT01420068|474794352|FG001|Overall Study|Administrative problems|3|||
131867448|NCT01420068|474794351|FG000|Overall Study|Withdrawal by Subject|1|||
131867449|NCT01420068|474794352|FG001|Overall Study|Withdrawal by Subject|2|||
131867450|NCT02554682|474794353|FG000|Overall Study|Lost to Follow-up|11|||
131867451|NCT02554682|474794354|FG001|Overall Study|Lost to Follow-up|9|||
131867452|NCT02554682|474794355|FG002|Overall Study|Lost to Follow-up|4|||
131867453|NCT02554682|474794356|FG003|Overall Study|Lost to Follow-up|3|||
131867454|NCT02554682|474794357|FG004|Overall Study|Lost to Follow-up|2|||
131867455|NCT02554682|474794358|FG005|Overall Study|Lost to Follow-up|1|||
131867456|NCT02554682|474794359|FG006|Overall Study|Lost to Follow-up|6|||
131867457|NCT02554682|474794360|FG007|Overall Study|Lost to Follow-up|6|||
131867458|NCT02554682|474794361|FG008|Overall Study|Lost to Follow-up|2|||
131867459|NCT02554682|474794362|FG009|Overall Study|Lost to Follow-up|2|||
131867460|NCT02554682|474794353|FG000|Overall Study|Withdrawal by Subject|2|||
131867461|NCT02554682|474794354|FG001|Overall Study|Withdrawal by Subject|1|||
131867462|NCT02554682|474794355|FG002|Overall Study|Withdrawal by Subject|0|||
131867463|NCT02554682|474794356|FG003|Overall Study|Withdrawal by Subject|0|||
131867464|NCT02554682|474794357|FG004|Overall Study|Withdrawal by Subject|0|||
131867465|NCT02554682|474794358|FG005|Overall Study|Withdrawal by Subject|0|||
131867466|NCT02554682|474794359|FG006|Overall Study|Withdrawal by Subject|0|||
131867467|NCT02554682|474794360|FG007|Overall Study|Withdrawal by Subject|0|||
131867468|NCT02554682|474794361|FG008|Overall Study|Withdrawal by Subject|0|||
131867469|NCT02554682|474794362|FG009|Overall Study|Withdrawal by Subject|0|||
131867470|NCT02554682|474794353|FG000|Overall Study|Physician Decision|2|||
131867471|NCT02554682|474794354|FG001|Overall Study|Physician Decision|2|||
131867472|NCT02554682|474794355|FG002|Overall Study|Physician Decision|0|||
131867473|NCT02554682|474794356|FG003|Overall Study|Physician Decision|0|||
131867474|NCT02554682|474794357|FG004|Overall Study|Physician Decision|0|||
131867475|NCT02554682|474794358|FG005|Overall Study|Physician Decision|0|||
131867476|NCT02554682|474794359|FG006|Overall Study|Physician Decision|0|||
131867477|NCT02554682|474794360|FG007|Overall Study|Physician Decision|0|||
131453891|NCT03565497|473291819|FG000|Overall Study|Lost to Follow-up|1|||
131867478|NCT02554682|474794361|FG008|Overall Study|Physician Decision|0|||
131867479|NCT02554682|474794362|FG009|Overall Study|Physician Decision|0|||
131867480|NCT00884117|474794365|FG000|Overall Study|Adverse Event|2|||
131867481|NCT00884117|474794365|FG000|Overall Study|Withdrawal by Subject|89|||
131867482|NCT00884117|474794365|FG000|Overall Study|Death|3|||
131867483|NCT00884117|474794365|FG000|Overall Study|Lost to Follow-up|143|||
131867484|NCT00884117|474794365|FG000|Overall Study|Other|12|||
131867485|NCT04830969|474794368|FG000|Overall Study|Withdrawal by Subject|6|||
131867486|NCT04830969|474794369|FG001|Overall Study|Withdrawal by Subject|2|||
131867487|NCT04830969|474794368|FG000|Overall Study|Protocol Violation|3|||
131867488|NCT04830969|474794369|FG001|Overall Study|Protocol Violation|9|||
131867489|NCT04830969|474794368|FG000|Overall Study|Lost to Follow-up|4|||
131867490|NCT04830969|474794369|FG001|Overall Study|Lost to Follow-up|4|||
131917726|NCT01295944|474982982|FG000|Overall Study|Ineligible|9|||
131917727|NCT01295944|474982982|FG000|Overall Study|Withdrawal by Subject|1|||
131917728|NCT01295944|474982982|FG000|Overall Study|Participant chose to be treated in Peru|1|||
131917729|NCT01295944|474982982|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
131917730|NCT01295944|474982982|FG000|Overall Study|Physician Decision|1|||
131917731|NCT01295944|474982982|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
131917732|NCT01295944|474982982|FG000|Overall Study|Disease progression|4|||
131917733|NCT01295944|474982982|FG000|Overall Study|Transferred care before starting new treatment|1|||
131917734|NCT03785366|474982990|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
131917735|NCT03785366|474982991|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
131917736|NCT03785366|474982990|FG000|Overall Study|Lost to Follow-up|1|||
131917737|NCT03785366|474982991|FG001|Overall Study|Lost to Follow-up|0|||
131917738|NCT03785366|474982990|FG000|Overall Study|Partial IUD Expulsion|0|||
131917739|NCT03785366|474982991|FG001|Overall Study|Partial IUD Expulsion|2|||
131917740|NCT03785366|474982990|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
131917741|NCT03785366|474982991|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
131917742|NCT03240874|474982992|FG000|Overall Study|Lost to Follow-up|0|||
131917743|NCT03240874|474982993|FG001|Overall Study|Lost to Follow-up|2|||
131917744|NCT03240874|474982994|FG002|Overall Study|Lost to Follow-up|4|||
131917745|NCT03240874|474982995|FG003|Overall Study|Lost to Follow-up|1|||
131917746|NCT05252702|474982996|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
131917747|NCT05252702|474982996|FG000|Overall Study|Death|16|||
131917748|NCT05252702|474982996|FG000|Overall Study|System explant|5|||
131917749|NCT05252702|474982996|FG000|Overall Study|Lost to Follow-up|1|||
131917750|NCT05252702|474982996|FG000|Overall Study|Withdrawn by investigator|1|||
131917751|NCT05252702|474982996|FG000|Overall Study|Visit not due|306|||
131917752|NCT05252702|474982996|FG000|Overall Study|Visit within window but not completed|92|||
131917753|NCT05252702|474982996|FG000|Overall Study|Unsuccessful implant|1|||
131917754|NCT04153864|474982997|FG000|Overall Study|Withdrawal by Subject|21|||
131917755|NCT04153864|474982998|FG001|Overall Study|Withdrawal by Subject|7|||
131917756|NCT04153864|474982999|FG002|Overall Study|Withdrawal by Subject|23|||
131917757|NCT04153864|474983000|FG003|Overall Study|Withdrawal by Subject|2|||
131917758|NCT04153864|474982997|FG000|Overall Study|Lost to Follow-up|4|||
131917759|NCT04153864|474982998|FG001|Overall Study|Lost to Follow-up|0|||
131917760|NCT04153864|474982999|FG002|Overall Study|Lost to Follow-up|3|||
131917761|NCT04153864|474983000|FG003|Overall Study|Lost to Follow-up|0|||
131917762|NCT04153864|474982997|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
131917763|NCT04153864|474982998|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
131917764|NCT04153864|474982999|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
131917765|NCT04153864|474983000|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
131917766|NCT04958707|474983001|FG000|Post Intervention|Withdrawal by Subject|1|||
131917767|NCT04958707|474983002|FG001|Post Intervention|Withdrawal by Subject|0|||
131917768|NCT04958707|474983003|FG002|Post Intervention|Withdrawal by Subject|0|||
131917769|NCT04958707|474983001|FG000|3 Months Follow- up|Lost to Follow-up|0|||
131917770|NCT04958707|474983002|FG001|3 Months Follow- up|Lost to Follow-up|3|||
131917771|NCT04958707|474983003|FG002|3 Months Follow- up|Lost to Follow-up|0|||
131917772|NCT04958707|474983001|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
131917773|NCT04958707|474983002|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
131917774|NCT04958707|474983003|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
131917775|NCT04279522|474983004|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
131917776|NCT04279522|474983005|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
131917777|NCT04279522|474983004|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
131917778|NCT04279522|474983005|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
131917779|NCT04279522|474983004|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
131917780|NCT04279522|474983005|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
131917781|NCT04279522|474983004|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
131917782|NCT04279522|474983005|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
131917783|NCT04279522|474983004|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
131917784|NCT04279522|474983005|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
131917785|NCT04279522|474983004|FG000|Period 2: Open Label Phase|Physician Decision|0|||
131917786|NCT04279522|474983005|FG001|Period 2: Open Label Phase|Physician Decision|3|||
131917787|NCT04279522|474983004|FG000|Period 2: Open Label Phase|Adverse Event|0|||
131917788|NCT04279522|474983005|FG001|Period 2: Open Label Phase|Adverse Event|1|||
131917789|NCT04279522|474983004|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
131917790|NCT04279522|474983005|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
131917791|NCT02629159|474983008|FG000|Overall Study|Adverse Event|17|||
131917792|NCT02629159|474983009|FG001|Overall Study|Adverse Event|20|||
131917793|NCT02629159|474983010|FG002|Overall Study|Adverse Event|22|||
131917794|NCT02629159|474983008|FG000|Overall Study|Withdrawal by Subject|22|||
131917795|NCT02629159|474983009|FG001|Overall Study|Withdrawal by Subject|11|||
131917796|NCT02629159|474983010|FG002|Overall Study|Withdrawal by Subject|15|||
131917797|NCT02629159|474983008|FG000|Overall Study|Lost to Follow-up|7|||
131867491|NCT01153815|474794374|FG000|Overall Study|Adverse Event|3|||
131867492|NCT01153815|474794375|FG001|Overall Study|Adverse Event|1|||
131867493|NCT01153815|474794374|FG000|Overall Study|Withdrawal by Subject|6|||
131867494|NCT01153815|474794375|FG001|Overall Study|Withdrawal by Subject|4|||
131867495|NCT01786993|474794376|FG000|Overall Study|Death|6|||
131867496|NCT01786993|474794377|FG001|Overall Study|Death|7|||
131867497|NCT01786993|474794376|FG000|Overall Study|Withdrawal by Subject|3|||
131867498|NCT01786993|474794377|FG001|Overall Study|Withdrawal by Subject|2|||
131867499|NCT01786993|474794376|FG000|Overall Study|Lost to Follow-up|0|||
131867500|NCT01786993|474794377|FG001|Overall Study|Lost to Follow-up|1|||
131867501|NCT01786993|474794376|FG000|Overall Study|Subject Non-Compliance|1|||
131867502|NCT01786993|474794377|FG001|Overall Study|Subject Non-Compliance|0|||
131867503|NCT01786993|474794376|FG000|Overall Study|System Explant|1|||
131867504|NCT01786993|474794377|FG001|Overall Study|System Explant|0|||
131867505|NCT01786993|474794376|FG000|Overall Study|Hospice Admission|1|||
131867506|NCT01786993|474794377|FG001|Overall Study|Hospice Admission|0|||
131867507|NCT01890122|474794378|FG000|Overall Study|Adverse Event|1|||
131867508|NCT01890122|474794379|FG001|Overall Study|Adverse Event|1|||
131867509|NCT01890122|474794380|FG002|Overall Study|Adverse Event|1|||
131867510|NCT01890122|474794381|FG003|Overall Study|Adverse Event|2|||
131867511|NCT01890122|474794378|FG000|Overall Study|Major Protocol Deviation|3|||
131867512|NCT01890122|474794379|FG001|Overall Study|Major Protocol Deviation|1|||
131867513|NCT01890122|474794380|FG002|Overall Study|Major Protocol Deviation|0|||
131867514|NCT01890122|474794381|FG003|Overall Study|Major Protocol Deviation|1|||
131867515|NCT01890122|474794378|FG000|Overall Study|Lost to Follow-up|0|||
131867516|NCT01890122|474794379|FG001|Overall Study|Lost to Follow-up|1|||
131867517|NCT01890122|474794380|FG002|Overall Study|Lost to Follow-up|2|||
131867518|NCT01890122|474794381|FG003|Overall Study|Lost to Follow-up|2|||
131867519|NCT01890122|474794378|FG000|Overall Study|Voluntary Withdrawal|8|||
131867520|NCT01890122|474794379|FG001|Overall Study|Voluntary Withdrawal|8|||
131867521|NCT01890122|474794380|FG002|Overall Study|Voluntary Withdrawal|2|||
131867522|NCT01890122|474794381|FG003|Overall Study|Voluntary Withdrawal|11|||
131867523|NCT01890122|474794378|FG000|Overall Study|Lack of Efficacy|14|||
131867524|NCT01890122|474794379|FG001|Overall Study|Lack of Efficacy|24|||
131867525|NCT01890122|474794380|FG002|Overall Study|Lack of Efficacy|7|||
131867526|NCT01890122|474794381|FG003|Overall Study|Lack of Efficacy|41|||
131867527|NCT01890122|474794378|FG000|Overall Study|Reason not Specified|0|||
131867528|NCT01890122|474794379|FG001|Overall Study|Reason not Specified|1|||
131867529|NCT01890122|474794380|FG002|Overall Study|Reason not Specified|1|||
131867530|NCT01890122|474794381|FG003|Overall Study|Reason not Specified|2|||
131867531|NCT01890122|474794378|FG000|Overall Study|Randomized but not Treated|1|||
131867532|NCT01890122|474794379|FG001|Overall Study|Randomized but not Treated|1|||
131867533|NCT01890122|474794380|FG002|Overall Study|Randomized but not Treated|0|||
131867534|NCT01890122|474794381|FG003|Overall Study|Randomized but not Treated|0|||
131867535|NCT04495829|474794388|FG000|Overall Study|Lost to Follow-up|2|||
131867536|NCT04495829|474794388|FG000|Overall Study|Inclusion criterion not met|3|||
131867537|NCT03859427|474794389|FG000|Overall Study|Withdrawal by Subject|4|||
131867538|NCT03859427|474794390|FG001|Overall Study|Withdrawal by Subject|7|||
131867539|NCT03859427|474794389|FG000|Overall Study|Decision by sponsor|0|||
131867540|NCT03859427|474794390|FG001|Overall Study|Decision by sponsor|3|||
131867541|NCT03859427|474794389|FG000|Overall Study|Lost to Follow-up|3|||
131867542|NCT03859427|474794390|FG001|Overall Study|Lost to Follow-up|2|||
131867543|NCT03859427|474794389|FG000|Overall Study|Death|22|||
131867544|NCT03859427|474794390|FG001|Overall Study|Death|25|||
131867545|NCT02503540|474794391|FG000|Overall Study|Death|2|||
131867546|NCT02503540|474794391|FG000|Overall Study|Withdrawal by Subject|1|||
131867547|NCT01662492|474794392|FG000|Overall Study|Other miscellaneous reasons.|1|||
131867548|NCT01662492|474794393|FG001|Overall Study|Other miscellaneous reasons.|0|||
131867549|NCT01662492|474794394|FG002|Overall Study|Other miscellaneous reasons.|1|||
131867550|NCT01662492|474794392|FG000|Overall Study|Withdrawal by Subject|0|||
131867551|NCT01662492|474794393|FG001|Overall Study|Withdrawal by Subject|0|||
131867552|NCT01662492|474794394|FG002|Overall Study|Withdrawal by Subject|1|||
131867553|NCT01662492|474794392|FG000|Overall Study|Protocol Violation|1|||
131867554|NCT01662492|474794393|FG001|Overall Study|Protocol Violation|0|||
131867555|NCT01662492|474794394|FG002|Overall Study|Protocol Violation|0|||
131867556|NCT01662492|474794392|FG000|Overall Study|Lost to Follow-up|0|||
131867557|NCT01662492|474794393|FG001|Overall Study|Lost to Follow-up|0|||
131867558|NCT01662492|474794394|FG002|Overall Study|Lost to Follow-up|2|||
131867559|NCT01662492|474794392|FG000|Overall Study|Lack of Efficacy|1|||
131867560|NCT01662492|474794393|FG001|Overall Study|Lack of Efficacy|1|||
131867561|NCT01662492|474794394|FG002|Overall Study|Lack of Efficacy|2|||
131867562|NCT01129557|474794397|FG000|Overall Study|Adverse Event|1|||
131867563|NCT01129557|474794398|FG001|Overall Study|Adverse Event|2|||
131867564|NCT01129557|474794399|FG002|Overall Study|Adverse Event|2|||
131867565|NCT01129557|474794397|FG000|Overall Study|Novartis terminated study early|3|||
131867566|NCT01129557|474794398|FG001|Overall Study|Novartis terminated study early|3|||
131867567|NCT01129557|474794399|FG002|Overall Study|Novartis terminated study early|2|||
131867568|NCT02418182|474794402|FG000|Overall Study|Unable to re-consent|18|||
131867569|NCT02418182|474794403|FG001|Overall Study|Unable to re-consent|15|||
131867570|NCT02418182|474794402|FG000|Overall Study|Lost to Follow-up|0|||
131867571|NCT02418182|474794403|FG001|Overall Study|Lost to Follow-up|2|||
131867572|NCT04955691|474797251|FG000|Period 2|Discontinued intervention|1|||
131867573|NCT04955691|474797252|FG001|Period 2|Discontinued intervention|2|||
131867574|NCT05795153|474797253|FG000|Overall Study|Adverse Event|2|||
131867575|NCT05795153|474797253|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131867576|NCT05795153|474797253|FG000|Overall Study|Lost to Follow-up|1|||
131867577|NCT05795153|474797253|FG000|Overall Study|Subject decision|2|||
131867578|NCT03760744|474797254|FG000|Overall Study|Lost to Follow-up|3|||
131867579|NCT03760744|474797255|FG001|Overall Study|Lost to Follow-up|0|||
131867580|NCT03769168|474797256|FG000|Overall Study|Adverse Event|0|||
131867581|NCT03769168|474797257|FG001|Overall Study|Adverse Event|1|||
131867582|NCT03769168|474797256|FG000|Overall Study|Lack of Efficacy|2|||
131867583|NCT03769168|474797257|FG001|Overall Study|Lack of Efficacy|4|||
131867584|NCT03769168|474797256|FG000|Overall Study|Post study access to treatment|3|||
131867585|NCT03769168|474797257|FG001|Overall Study|Post study access to treatment|11|||
131867586|NCT03769168|474797256|FG000|Overall Study|Physician Decision|1|||
131867587|NCT03769168|474797257|FG001|Overall Study|Physician Decision|4|||
131867588|NCT03769168|474797256|FG000|Overall Study|Subject Decision|2|||
131867589|NCT03769168|474797257|FG001|Overall Study|Subject Decision|4|||
131867590|NCT03769168|474797256|FG000|Overall Study|Guardian decision|1|||
131867591|NCT03769168|474797257|FG001|Overall Study|Guardian decision|0|||
131867592|NCT02141438|474797258|FG000|Overall Study|Death|1308|||
131867593|NCT02141438|474797258|FG000|Overall Study|Lost to Follow-up|84|||
131867594|NCT02141438|474797258|FG000|Overall Study|Withdrawal by Subject|52|||
131867595|NCT02141438|474797258|FG000|Overall Study|Physician Decision|1|||
131867596|NCT02141438|474797258|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
131867597|NCT05086744|474797261|FG000|Part A|Adverse Event|0|||
131867598|NCT05086744|474797262|FG001|Part A|Adverse Event|1|||
131867599|NCT05086744|474797261|FG000|Part A|Lack of Efficacy|3|||
131867600|NCT05086744|474797262|FG001|Part A|Lack of Efficacy|0|||
131867601|NCT05086744|474797261|FG000|Part A|Protocol deviation|1|||
131867602|NCT05086744|474797262|FG001|Part A|Protocol deviation|0|||
131867603|NCT05086744|474797261|FG000|Part A|Subject decision|1|||
131867604|NCT05086744|474797262|FG001|Part A|Subject decision|0|||
131867605|NCT05086744|474797261|FG000|Part B|Adverse Event|0|||
131867606|NCT05086744|474797262|FG001|Part B|Adverse Event|1|||
131867607|NCT05086744|474797261|FG000|Part B|Lack of Efficacy|0|||
131867608|NCT05086744|474797262|FG001|Part B|Lack of Efficacy|1|||
131867609|NCT05086744|474797261|FG000|Part B|Study terminated by sponsor|1|||
131867610|NCT05086744|474797262|FG001|Part B|Study terminated by sponsor|6|||
131867611|NCT04050462|474797263|FG000|Overall Study|Withdrawal by Subject|1|||
131867612|NCT04050462|474797264|FG001|Overall Study|Withdrawal by Subject|0|||
131867613|NCT04050462|474797265|FG002|Overall Study|Withdrawal by Subject|0|||
131867614|NCT03100903|474797268|FG000|Overall Study|Withdrawal by Subject|0|||
131867615|NCT03100903|474797269|FG001|Overall Study|Withdrawal by Subject|0|||
131867616|NCT03100903|474797270|FG002|Overall Study|Withdrawal by Subject|1|||
131867617|NCT04659993|474797271|FG000|Overall Study|Withdrawal by Subject|2|||
131867618|NCT04659993|474797271|FG000|Overall Study|Lost to Follow-up|2|||
131867619|NCT05151744|474797272|FG000|Overall Study|Adverse Event|6|||
131867620|NCT05151744|474797273|FG001|Overall Study|Adverse Event|2|||
131867621|NCT05151744|474797272|FG000|Overall Study|Death|1|||
131867622|NCT05151744|474797273|FG001|Overall Study|Death|2|||
131867623|NCT05151744|474797272|FG000|Overall Study|Lack of Efficacy|1|||
131867624|NCT05151744|474797273|FG001|Overall Study|Lack of Efficacy|1|||
131867625|NCT05151744|474797272|FG000|Overall Study|Lost to Follow-up|2|||
131867626|NCT05151744|474797273|FG001|Overall Study|Lost to Follow-up|2|||
131867627|NCT05151744|474797272|FG000|Overall Study|Need for Rescue Treatment|0|||
131867628|NCT05151744|474797273|FG001|Overall Study|Need for Rescue Treatment|1|||
131867629|NCT05151744|474797272|FG000|Overall Study|Non-compliance with Study Drug|0|||
131867630|NCT05151744|474797273|FG001|Overall Study|Non-compliance with Study Drug|1|||
131867631|NCT05151744|474797272|FG000|Overall Study|Reason not Specified|10|||
131867632|NCT05151744|474797273|FG001|Overall Study|Reason not Specified|0|||
131867633|NCT05151744|474797272|FG000|Overall Study|Physician Decision|2|||
131867634|NCT05151744|474797273|FG001|Overall Study|Physician Decision|1|||
131867635|NCT05151744|474797272|FG000|Overall Study|Protocol Violation|1|||
131408189|NCT02927925|473118227|FG000|Overall Study|Withdrawal by Subject|11|||
131867636|NCT05151744|474797273|FG001|Overall Study|Protocol Violation|0|||
131867637|NCT05151744|474797272|FG000|Overall Study|Withdrawal by Subject|6|||
131867638|NCT05151744|474797273|FG001|Overall Study|Withdrawal by Subject|3|||
131867639|NCT05228470|474797274|FG000|Overall Study|Death|6|||
131867640|NCT05228470|474797275|FG001|Overall Study|Death|11|||
131867641|NCT05228470|474797274|FG000|Overall Study|Withdrawal by Subject|1|||
131867642|NCT05228470|474797275|FG001|Overall Study|Withdrawal by Subject|8|||
131867643|NCT05228470|474797274|FG000|Overall Study|Ongoing|1|||
131867644|NCT05228470|474797275|FG001|Overall Study|Ongoing|11|||
131867645|NCT04053868|474797276|FG000|Overall Study|Withdrawal by Subject|1|||
131867646|NCT04053868|474797277|FG001|Overall Study|Withdrawal by Subject|0|||
131408190|NCT02927925|473118227|FG000|Overall Study|Other|3|||
131408191|NCT02927925|473118227|FG000|Overall Study|Disease progression at clinical cutoff|1|||
131408192|NCT01080768|473118228|FG000|Overall Study|Protocol Deviation|2|||
131408193|NCT01080768|473118229|FG001|Overall Study|Protocol Deviation|1|||
131408194|NCT00246025|473118230|FG000|Overall Study|Adverse Event|7|||
131408195|NCT00246025|473118231|FG001|Overall Study|Adverse Event|9|||
131867647|NCT04010240|474797280|FG000|Overall Study|IHC not performed|2299|||
131867648|NCT05400655|474797281|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
131867649|NCT05400655|474797282|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
131867650|NCT05400655|474797283|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
131867651|NCT05400655|474797284|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
131867652|NCT05400655|474797285|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
131867653|NCT05400655|474797286|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
131867654|NCT05400655|474797287|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
131867655|NCT05400655|474797288|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
131867656|NCT05400655|474797289|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
131867657|NCT05400655|474797290|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
131867658|NCT05400655|474797291|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
131867659|NCT05400655|474797292|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
131867660|NCT05400655|474797293|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
131867661|NCT05400655|474797294|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
131867662|NCT05400655|474797295|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
131867663|NCT05400655|474797296|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
131867664|NCT05400655|474797297|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
131867665|NCT05400655|474797298|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
131867666|NCT05400655|474797299|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
131867667|NCT05400655|474797300|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
131867668|NCT05400655|474797301|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
131867669|NCT05400655|474797302|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
131867670|NCT05400655|474797281|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867671|NCT05400655|474797282|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867672|NCT05400655|474797283|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867673|NCT05400655|474797284|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867674|NCT05400655|474797285|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867675|NCT05400655|474797286|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867676|NCT05400655|474797287|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867677|NCT05400655|474797288|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867678|NCT05400655|474797289|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867679|NCT05400655|474797290|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867680|NCT05400655|474797291|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867681|NCT05400655|474797292|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867682|NCT05400655|474797293|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
131867683|NCT05400655|474797294|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867684|NCT05400655|474797295|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867685|NCT05400655|474797296|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867686|NCT05400655|474797297|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
131867687|NCT05400655|474797298|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867688|NCT05400655|474797299|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
131867689|NCT05400655|474797300|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
131867690|NCT05400655|474797301|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867691|NCT05400655|474797302|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131867692|NCT05400655|474797281|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867693|NCT05400655|474797282|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867694|NCT05400655|474797283|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867695|NCT05400655|474797284|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867696|NCT05400655|474797285|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867697|NCT05400655|474797286|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867698|NCT05400655|474797287|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867699|NCT05400655|474797288|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867700|NCT05400655|474797289|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867701|NCT05400655|474797290|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867702|NCT05400655|474797291|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867703|NCT05400655|474797292|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867704|NCT05400655|474797293|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867705|NCT05400655|474797294|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
131867706|NCT05400655|474797295|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867707|NCT05400655|474797296|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867708|NCT05400655|474797297|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
131408196|NCT00246025|473118232|FG002|Overall Study|Adverse Event|9|||
131408197|NCT00246025|473118233|FG003|Overall Study|Adverse Event|10|||
131408198|NCT00246025|473118230|FG000|Overall Study|Withdrawal by Subject|3|||
131867709|NCT05400655|474797298|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867710|NCT05400655|474797299|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
131867711|NCT05400655|474797300|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131408199|NCT00246025|473118231|FG001|Overall Study|Withdrawal by Subject|0|||
131408200|NCT00246025|473118232|FG002|Overall Study|Withdrawal by Subject|1|||
131408201|NCT00246025|473118233|FG003|Overall Study|Withdrawal by Subject|2|||
131408202|NCT00246025|473118230|FG000|Overall Study|unsuitable medical history was found|0|||
131408203|NCT00246025|473118231|FG001|Overall Study|unsuitable medical history was found|0|||
131408204|NCT00246025|473118232|FG002|Overall Study|unsuitable medical history was found|0|||
131408205|NCT00246025|473118233|FG003|Overall Study|unsuitable medical history was found|1|||
131408206|NCT01643850|473118234|FG000|Overall Study|Withdrawal by Subject|0|||
131408207|NCT01643850|473118235|FG001|Overall Study|Withdrawal by Subject|0|||
131408208|NCT01643850|473118236|FG002|Overall Study|Withdrawal by Subject|0|||
131867712|NCT05400655|474797301|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867713|NCT05400655|474797302|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131867714|NCT05400655|474797281|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867715|NCT05400655|474797282|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867716|NCT05400655|474797283|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867717|NCT05400655|474797284|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867718|NCT05400655|474797285|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867719|NCT05400655|474797286|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867720|NCT05400655|474797287|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867721|NCT05400655|474797288|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867722|NCT05400655|474797289|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867723|NCT05400655|474797290|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867724|NCT05400655|474797291|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867725|NCT05400655|474797292|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867726|NCT05400655|474797293|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867727|NCT05400655|474797294|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867728|NCT05400655|474797295|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867729|NCT05400655|474797296|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867730|NCT05400655|474797297|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
131867731|NCT05400655|474797298|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
131867732|NCT05400655|474797299|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
131867733|NCT05400655|474797300|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131867734|NCT05400655|474797301|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
131867735|NCT05400655|474797302|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
131867736|NCT05400655|474797281|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867737|NCT05400655|474797282|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867738|NCT05400655|474797283|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867739|NCT05400655|474797284|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867740|NCT05400655|474797285|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867741|NCT05400655|474797286|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867742|NCT05400655|474797287|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867743|NCT05400655|474797288|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867744|NCT05400655|474797289|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867745|NCT05400655|474797290|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867746|NCT05400655|474797291|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867747|NCT05400655|474797292|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867748|NCT05400655|474797293|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867749|NCT05400655|474797294|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867750|NCT05400655|474797295|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867751|NCT05400655|474797296|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867752|NCT05400655|474797297|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867753|NCT05400655|474797298|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
131867754|NCT05400655|474797299|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
131867755|NCT05400655|474797300|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867756|NCT05400655|474797301|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867757|NCT05400655|474797302|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131867758|NCT05400655|474797281|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867759|NCT05400655|474797282|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867760|NCT05400655|474797283|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867761|NCT05400655|474797284|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867762|NCT05400655|474797285|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867763|NCT05400655|474797286|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867764|NCT05400655|474797287|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867765|NCT05400655|474797288|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867766|NCT05400655|474797289|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867767|NCT05400655|474797290|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867768|NCT05400655|474797291|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867769|NCT05400655|474797292|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867770|NCT05400655|474797293|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867771|NCT05400655|474797294|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867772|NCT05400655|474797295|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867773|NCT05400655|474797296|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867774|NCT05400655|474797297|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
131867775|NCT05400655|474797298|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131867776|NCT05400655|474797299|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
131867777|NCT05400655|474797300|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
131867778|NCT05400655|474797301|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
131867779|NCT05400655|474797302|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
131867780|NCT03771898|474797303|FG000|Overall Study|Adverse Event|1|||
131867781|NCT03771898|474797304|FG001|Overall Study|Adverse Event|0|||
131867782|NCT03771898|474797305|FG002|Overall Study|Adverse Event|0|||
131867783|NCT03771898|474797306|FG003|Overall Study|Adverse Event|0|||
131867784|NCT03771898|474797307|FG004|Overall Study|Adverse Event|0|||
131867785|NCT03771898|474797303|FG000|Overall Study|Lost to Follow-up|1|||
131867786|NCT03771898|474797304|FG001|Overall Study|Lost to Follow-up|1|||
131867787|NCT03771898|474797305|FG002|Overall Study|Lost to Follow-up|1|||
131867788|NCT03771898|474797306|FG003|Overall Study|Lost to Follow-up|0|||
131867789|NCT03771898|474797307|FG004|Overall Study|Lost to Follow-up|0|||
131867790|NCT03771898|474797303|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131867791|NCT03771898|474797304|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131867792|NCT03771898|474797305|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131867793|NCT03771898|474797306|FG003|Overall Study|Withdrawal by parent/guardian|0|||
131867794|NCT03771898|474797307|FG004|Overall Study|Withdrawal by parent/guardian|0|||
131867795|NCT03771898|474797303|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131867796|NCT03771898|474797304|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131867797|NCT03771898|474797305|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131867798|NCT03771898|474797306|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131867799|NCT03771898|474797307|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
131867800|NCT03263936|474797308|FG000|Overall Study|Adverse Event|0|||
131867801|NCT03263936|474797309|FG001|Overall Study|Adverse Event|1|||
131867802|NCT03263936|474797310|FG002|Overall Study|Adverse Event|0|||
131867803|NCT03263936|474797308|FG000|Overall Study|Death|0|||
131867804|NCT03263936|474797309|FG001|Overall Study|Death|1|||
131867805|NCT03263936|474797310|FG002|Overall Study|Death|0|||
131867806|NCT05343000|474797311|FG000|Overall Study|Physician Decision|2|||
131867807|NCT03123120|474797312|FG000|Overall Study|Lost to Follow-up|0|||
131867808|NCT03123120|474797313|FG001|Overall Study|Lost to Follow-up|1|||
131867809|NCT03123120|474797312|FG000|Overall Study|Withdrawal by Subject|0|||
131867810|NCT03123120|474797313|FG001|Overall Study|Withdrawal by Subject|1|||
131867811|NCT03135548|474797317|FG000|Overall Study|Lost to Follow-up|3|||
131867812|NCT03135548|474797318|FG001|Overall Study|Lost to Follow-up|0|||
131867813|NCT03135548|474797319|FG002|Overall Study|Lost to Follow-up|0|||
131867814|NCT03135548|474797317|FG000|Overall Study|Withdrawal by Subject|2|||
131867815|NCT03135548|474797318|FG001|Overall Study|Withdrawal by Subject|2|||
131867816|NCT03135548|474797319|FG002|Overall Study|Withdrawal by Subject|1|||
131867817|NCT03135548|474797317|FG000|Overall Study|Other than listed|0|||
131867818|NCT03135548|474797318|FG001|Overall Study|Other than listed|2|||
131867819|NCT03135548|474797319|FG002|Overall Study|Other than listed|2|||
131867820|NCT02632175|474797320|FG000|Overall Study|Withdrawal by Subject|6|||
131867821|NCT02632175|474797320|FG000|Overall Study|Lost to Follow-up|1|||
131867822|NCT02632175|474797320|FG000|Overall Study|Lack of Efficacy|18|||
131867823|NCT02632175|474797320|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
131867824|NCT02632175|474797320|FG000|Overall Study|Subject noncompliance|3|||
131867825|NCT02632175|474797320|FG000|Overall Study|other|2|||
131867826|NCT02088554|474797321|FG000|Overall Study|Exited before procedure|130|||
131867827|NCT02088554|474797321|FG000|Overall Study|Attempted but not implanted|31|||
131867828|NCT02088554|474797321|FG000|Overall Study|Implant not attempted|19|||
131867829|NCT02088554|474797321|FG000|Overall Study|Pending next visit|532|||
131867830|NCT02088554|474797321|FG000|Overall Study|Death|170|||
131867831|NCT02088554|474797321|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
131867832|NCT02088554|474797321|FG000|Overall Study|Lost to Follow-up|23|||
131867833|NCT02088554|474797321|FG000|Overall Study|Explanted|32|||
131867834|NCT02088554|474797321|FG000|Overall Study|Any other reason not covered by previous categories|11|||
131867835|NCT04623216|474797322|FG000|Overall Study|Death|5|||
131867836|NCT04623216|474797323|FG001|Overall Study|Death|2|||
131867837|NCT04623216|474797324|FG002|Overall Study|Death|0|||
131867838|NCT04623216|474797325|FG003|Overall Study|Death|0|||
131867839|NCT04623216|474797322|FG000|Overall Study|Terminated by Sponsor|3|||
131867840|NCT04623216|474797323|FG001|Overall Study|Terminated by Sponsor|2|||
131867841|NCT04623216|474797324|FG002|Overall Study|Terminated by Sponsor|2|||
131867842|NCT04623216|474797325|FG003|Overall Study|Terminated by Sponsor|0|||
131867843|NCT04623216|474797322|FG000|Overall Study|Physician Decision|1|||
131867844|NCT04623216|474797323|FG001|Overall Study|Physician Decision|0|||
131917798|NCT02629159|474983009|FG001|Overall Study|Lost to Follow-up|4|||
131917799|NCT02629159|474983010|FG002|Overall Study|Lost to Follow-up|5|||
131917800|NCT02629159|474983008|FG000|Overall Study|Lack of Efficacy|4|||
131917801|NCT02629159|474983009|FG001|Overall Study|Lack of Efficacy|0|||
131917802|NCT02629159|474983010|FG002|Overall Study|Lack of Efficacy|1|||
131917803|NCT02629159|474983008|FG000|Overall Study|Other|6|||
131917804|NCT02629159|474983009|FG001|Overall Study|Other|4|||
131917805|NCT02629159|474983010|FG002|Overall Study|Other|8|||
131917806|NCT04717557|474983023|FG000|Overall Study|Withdrawal by Subject|2|||
131917807|NCT04717557|474983024|FG001|Overall Study|Withdrawal by Subject|0|||
131917808|NCT04717557|474983023|FG000|Overall Study|Death|1|||
131917809|NCT04717557|474983024|FG001|Overall Study|Death|0|||
131917810|NCT05352399|474983025|FG000|Overall Study|Discontinued intervention|6|||
131917811|NCT01802281|474983026|FG000|Overall Study|Death|1|||
131917812|NCT01802281|474983027|FG001|Overall Study|Death|2|||
131917813|NCT01802281|474983026|FG000|Overall Study|Withdrawal by Subject|2|||
131917814|NCT01802281|474983027|FG001|Overall Study|Withdrawal by Subject|1|||
131917815|NCT01802281|474983026|FG000|Overall Study|Ineligible|5|||
131917816|NCT01802281|474983027|FG001|Overall Study|Ineligible|3|||
131917817|NCT02685735|474983028|FG000|Overall Study|Surgery Cancelled|4|||
131917818|NCT02685735|474983029|FG001|Overall Study|Surgery Cancelled|9|||
131917819|NCT02685735|474983028|FG000|Overall Study|Adverse Event|10|||
131917820|NCT02685735|474983029|FG001|Overall Study|Adverse Event|3|||
131917821|NCT02685735|474983028|FG000|Overall Study|Preop testing found to be incomplete|2|||
131917822|NCT02685735|474983029|FG001|Overall Study|Preop testing found to be incomplete|2|||
131917823|NCT02685735|474983028|FG000|Overall Study|Withdrawal by Subject|1|||
131917824|NCT02685735|474983029|FG001|Overall Study|Withdrawal by Subject|2|||
131917825|NCT02685735|474983028|FG000|Overall Study|Death|1|||
131917826|NCT02685735|474983029|FG001|Overall Study|Death|0|||
131917827|NCT05436613|474983034|FG000|Overall Study|Lost to Follow-up|9|||
131917828|NCT05436613|474983034|FG000|Overall Study|Withdrawal by Subject|3|||
131408209|NCT01643850|473118237|FG003|Overall Study|Withdrawal by Subject|0|||
131408210|NCT01643850|473118238|FG004|Overall Study|Withdrawal by Subject|1|||
131408211|NCT01643850|473118239|FG005|Overall Study|Withdrawal by Subject|0|||
131408212|NCT01643850|473118240|FG006|Overall Study|Withdrawal by Subject|0|||
131408213|NCT01643850|473118241|FG007|Overall Study|Withdrawal by Subject|0|||
131408214|NCT01643850|473118242|FG008|Overall Study|Withdrawal by Subject|0|||
131408215|NCT01643850|473118234|FG000|Overall Study|Lost to Follow-up|0|||
131408216|NCT01643850|473118235|FG001|Overall Study|Lost to Follow-up|0|||
131867845|NCT04623216|474797324|FG002|Overall Study|Physician Decision|0|||
131867846|NCT04623216|474797325|FG003|Overall Study|Physician Decision|0|||
131867847|NCT03521154|474797328|FG000|Overall Study|Ongoing study at data cut-off|111|||
131867848|NCT03521154|474797329|FG001|Overall Study|Ongoing study at data cut-off|52|||
131867849|NCT05386680|474797330|FG000|Overall Study|Guardian decision|2|||
131867850|NCT04632927|474797331|FG000|Overall Study|Adverse Event|0|||
131867851|NCT04632927|474797332|FG001|Overall Study|Adverse Event|1|||
131867852|NCT04632927|474797331|FG000|Overall Study|Lack of Efficacy|0|||
131867853|NCT04632927|474797332|FG001|Overall Study|Lack of Efficacy|4|||
131867854|NCT04632927|474797331|FG000|Overall Study|Loss of efficacy|0|||
131867855|NCT04632927|474797332|FG001|Overall Study|Loss of efficacy|1|||
131867856|NCT04632927|474797331|FG000|Overall Study|Non-compliance with study drug|0|||
131867857|NCT04632927|474797332|FG001|Overall Study|Non-compliance with study drug|1|||
131867858|NCT04632927|474797331|FG000|Overall Study|Physician Decision|0|||
131867859|NCT04632927|474797332|FG001|Overall Study|Physician Decision|1|||
131867860|NCT04632927|474797331|FG000|Overall Study|Subject decision|0|||
131867861|NCT04632927|474797332|FG001|Overall Study|Subject decision|1|||
131867862|NCT04632927|474797331|FG000|Overall Study|Withdrawal by Subject|0|||
131867863|NCT04632927|474797332|FG001|Overall Study|Withdrawal by Subject|1|||
131867864|NCT03827291|474797336|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
131917829|NCT04590963|474983037|FG000|Overall Study|Death|118|||
131917830|NCT04590963|474983038|FG001|Overall Study|Death|59|||
131917831|NCT04590963|474983037|FG000|Overall Study|Lost to Follow-up|1|||
131867865|NCT03827291|474797337|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
131867866|NCT04795466|474797338|FG000|Overall Study|Adverse Event|3|||
131917832|NCT04590963|474983038|FG001|Overall Study|Lost to Follow-up|1|||
131917833|NCT04590963|474983037|FG000|Overall Study|Progressive disease|0|||
131408217|NCT01643850|473118236|FG002|Overall Study|Lost to Follow-up|0|||
131408218|NCT01643850|473118237|FG003|Overall Study|Lost to Follow-up|0|||
131867867|NCT04795466|474797339|FG001|Overall Study|Adverse Event|1|||
131867868|NCT04795466|474797338|FG000|Overall Study|Physician Decision|1|||
131408219|NCT01643850|473118238|FG004|Overall Study|Lost to Follow-up|0|||
131408220|NCT01643850|473118239|FG005|Overall Study|Lost to Follow-up|0|||
131867869|NCT04795466|474797339|FG001|Overall Study|Physician Decision|0|||
131917834|NCT04590963|474983038|FG001|Overall Study|Progressive disease|1|||
131917835|NCT04590963|474983037|FG000|Overall Study|Study terminated by sponsor|103|||
131917836|NCT04590963|474983038|FG001|Overall Study|Study terminated by sponsor|50|||
131917837|NCT04590963|474983037|FG000|Overall Study|Withdrawal by Subject|15|||
131917838|NCT04590963|474983038|FG001|Overall Study|Withdrawal by Subject|8|||
131917839|NCT04590963|474983037|FG000|Overall Study|Ongoing at data cut-off|9|||
131917840|NCT04590963|474983038|FG001|Overall Study|Ongoing at data cut-off|4|||
131917841|NCT04590963|474983037|FG000|Overall Study|Screen failure|1|||
131917842|NCT04590963|474983038|FG001|Overall Study|Screen failure|0|||
131917843|NCT04738487|474983039|FG000|Overall Study|Participant Ongoing in Study|298|||
131917844|NCT04738487|474983040|FG001|Overall Study|Participant Ongoing in Study|297|||
131917845|NCT04738487|474983039|FG000|Overall Study|Withdrawal by Subject|7|||
131917846|NCT04738487|474983040|FG001|Overall Study|Withdrawal by Subject|9|||
131917847|NCT04738487|474983039|FG000|Overall Study|Lost to Follow-up|2|||
131917848|NCT04738487|474983040|FG001|Overall Study|Lost to Follow-up|0|||
131917849|NCT04738487|474983039|FG000|Overall Study|Death|287|||
131917850|NCT04738487|474983040|FG001|Overall Study|Death|306|||
131917851|NCT05350202|474983041|FG000|Visit 1 - Baseline|Not-treated|18|||
131917852|NCT05350202|474983042|FG001|Visit 1 - Baseline|Not-treated|0|||
131917853|NCT05350202|474983041|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
131867870|NCT04795466|474797338|FG000|Overall Study|Withdrawal by Subject|2|||
131867871|NCT04795466|474797339|FG001|Overall Study|Withdrawal by Subject|1|||
131867872|NCT03782792|474797340|FG000|Overall Study|Patient left the country|0|||
131867873|NCT03782792|474797341|FG001|Overall Study|Patient left the country|1|||
131867874|NCT03782792|474797340|FG000|Overall Study|Withdrawal by Subject|1|||
131867875|NCT03782792|474797341|FG001|Overall Study|Withdrawal by Subject|2|||
131867876|NCT04652726|474797344|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
131867877|NCT04652726|474797345|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
131867878|NCT04652726|474797346|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
131867879|NCT04652726|474797344|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
131867880|NCT04652726|474797345|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
131867881|NCT04652726|474797346|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
131867882|NCT01102257|474797352|FG000|Overall Study|Adverse Event|1|||
131867883|NCT01102257|474797353|FG001|Overall Study|Adverse Event|0|||
131867884|NCT01102257|474797352|FG000|Overall Study|Adverse Event|1|||
131867885|NCT01102257|474797353|FG001|Overall Study|Adverse Event|0|||
131867886|NCT04066244|474797359|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
131867887|NCT04066244|474797360|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
131867888|NCT04066244|474797361|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
131867889|NCT04066244|474797362|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
131867890|NCT04066244|474797363|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
131867891|NCT04066244|474797364|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
131867892|NCT04066244|474797359|FG000|Part 2 (Cohort 5)|Death|0|||
131867893|NCT04066244|474797360|FG001|Part 2 (Cohort 5)|Death|0|||
131867894|NCT04066244|474797361|FG002|Part 2 (Cohort 5)|Death|0|||
131867895|NCT04066244|474797362|FG003|Part 2 (Cohort 5)|Death|0|||
131867896|NCT04066244|474797363|FG004|Part 2 (Cohort 5)|Death|0|||
131867897|NCT04066244|474797364|FG005|Part 2 (Cohort 5)|Death|2|||
131867898|NCT04066244|474797359|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131867899|NCT04066244|474797360|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131867900|NCT04066244|474797361|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131867901|NCT04066244|474797362|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131867902|NCT04066244|474797363|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131867903|NCT04066244|474797364|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
131867904|NCT04066244|474797359|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131867905|NCT04066244|474797360|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131867906|NCT04066244|474797361|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131867907|NCT04066244|474797362|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131867908|NCT04066244|474797363|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
131867909|NCT04066244|474797364|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131867910|NCT03752970|474797365|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
131867911|NCT03752970|474797366|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
131867912|NCT03752970|474797367|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
131867913|NCT03752970|474797365|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
131867914|NCT03752970|474797366|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
131867915|NCT03752970|474797367|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
131917854|NCT05350202|474983042|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
131917855|NCT05350202|474983041|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
131867916|NCT03752970|474797365|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
131867917|NCT03752970|474797366|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
131867918|NCT03752970|474797367|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
131867919|NCT03752970|474797365|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
131867920|NCT03752970|474797366|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
131867921|NCT03752970|474797367|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
131917856|NCT05350202|474983042|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
131917857|NCT05350202|474983041|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
131917858|NCT05350202|474983042|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
131867922|NCT03752970|474797365|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
131867923|NCT03752970|474797366|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
131867924|NCT03752970|474797367|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
131867925|NCT03976362|474797371|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
131867926|NCT03976362|474797372|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
131867927|NCT03976362|474797373|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
131867928|NCT03976362|474797371|FG000|Induction Phase|Death|62|||
131867929|NCT03976362|474797372|FG001|Induction Phase|Death|0|||
131867930|NCT03976362|474797373|FG002|Induction Phase|Death|0|||
131867931|NCT03976362|474797371|FG000|Maintenance Phase|Participants Ongoing|0|||
131867932|NCT03976362|474797372|FG001|Maintenance Phase|Participants Ongoing|106|||
131867933|NCT03976362|474797373|FG002|Maintenance Phase|Participants Ongoing|103|||
131867934|NCT03976362|474797371|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131867935|NCT03976362|474797372|FG001|Maintenance Phase|Withdrawal by Subject|4|||
131867936|NCT03976362|474797373|FG002|Maintenance Phase|Withdrawal by Subject|4|||
131867937|NCT03976362|474797371|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
131867938|NCT03976362|474797372|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
131867939|NCT03976362|474797373|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
131867940|NCT03976362|474797371|FG000|Maintenance Phase|Death|0|||
131867941|NCT03976362|474797372|FG001|Maintenance Phase|Death|186|||
131867942|NCT03976362|474797373|FG002|Maintenance Phase|Death|187|||
131867943|NCT04767282|474797374|FG000|Overall Study|Refused or did not begin surveys|6|||
131867944|NCT04767282|474797375|FG001|Overall Study|Refused or did not begin surveys|2|||
131867945|NCT04767282|474797376|FG002|Overall Study|Refused or did not begin surveys|2|||
131867946|NCT04767282|474797374|FG000|Overall Study|Duplicate household previously enrolled|2|||
131867947|NCT04767282|474797375|FG001|Overall Study|Duplicate household previously enrolled|0|||
131867948|NCT04767282|474797376|FG002|Overall Study|Duplicate household previously enrolled|8|||
131867949|NCT04767282|474797374|FG000|Overall Study|Unable to confirm legal guardian|0|||
131867950|NCT04767282|474797375|FG001|Overall Study|Unable to confirm legal guardian|2|||
131867951|NCT04767282|474797376|FG002|Overall Study|Unable to confirm legal guardian|8|||
131867952|NCT04767282|474797374|FG000|Overall Study|Withdrawal by Subject|0|||
131867953|NCT04767282|474797375|FG001|Overall Study|Withdrawal by Subject|0|||
131867954|NCT04767282|474797376|FG002|Overall Study|Withdrawal by Subject|6|||
131867955|NCT04767282|474797374|FG000|Overall Study|Survey comprehension challenges|4|||
131867956|NCT04767282|474797375|FG001|Overall Study|Survey comprehension challenges|0|||
131867957|NCT04767282|474797376|FG002|Overall Study|Survey comprehension challenges|0|||
131867958|NCT01120184|474797377|FG000|Overall Study|Adverse Event|0|||
131867959|NCT01120184|474797378|FG001|Overall Study|Adverse Event|1|||
131867960|NCT01120184|474797379|FG002|Overall Study|Adverse Event|0|||
131867961|NCT01120184|474797377|FG000|Overall Study|Lost to Follow-up|13|||
131867962|NCT01120184|474797378|FG001|Overall Study|Lost to Follow-up|13|||
131867963|NCT01120184|474797379|FG002|Overall Study|Lost to Follow-up|11|||
131867964|NCT01120184|474797377|FG000|Overall Study|Physician Decision|9|||
131867965|NCT01120184|474797378|FG001|Overall Study|Physician Decision|1|||
131867966|NCT01120184|474797379|FG002|Overall Study|Physician Decision|3|||
131867967|NCT01120184|474797377|FG000|Overall Study|Reason not Specified|8|||
131867968|NCT01120184|474797378|FG001|Overall Study|Reason not Specified|3|||
131867969|NCT01120184|474797379|FG002|Overall Study|Reason not Specified|12|||
131867970|NCT01120184|474797377|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
131867971|NCT01120184|474797378|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
131867972|NCT01120184|474797379|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
131867973|NCT01120184|474797377|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
131867974|NCT01120184|474797378|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
131867975|NCT01120184|474797379|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
131867976|NCT01120184|474797377|FG000|Overall Study|Death|170|||
131867977|NCT01120184|474797378|FG001|Overall Study|Death|176|||
131867978|NCT01120184|474797379|FG002|Overall Study|Death|169|||
131867979|NCT02525783|474797380|FG000|Overall Study|Lost to Follow-up|10|||
131867980|NCT04003636|474797381|FG000|Overall Study|Death|409|||
131867981|NCT04003636|474797382|FG001|Overall Study|Death|443|||
131867982|NCT04003636|474797381|FG000|Overall Study|Lost to Follow-up|0|||
131867983|NCT04003636|474797382|FG001|Overall Study|Lost to Follow-up|1|||
131867984|NCT04003636|474797381|FG000|Overall Study|Withdrawal by Subject|5|||
131867985|NCT04003636|474797382|FG001|Overall Study|Withdrawal by Subject|2|||
131867986|NCT04003636|474797381|FG000|Overall Study|Participant On-going|119|||
131867987|NCT04003636|474797382|FG001|Overall Study|Participant On-going|90|||
131867988|NCT03048747|474797383|FG000|Overall Study|Adverse Event|2|||
131867989|NCT03048747|474797383|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
131867990|NCT03048747|474797383|FG000|Overall Study|Physician Decision|1|||
131867991|NCT00833105|474797398|FG000|Overall Study|Withdrawal by Subject|1|||
131867992|NCT00833105|474797398|FG000|Overall Study|Adverse Event|2|||
131867993|NCT03656068|474797399|FG000|Overall Study|Withdrawal by Subject|4|||
131867994|NCT03656068|474797399|FG000|Overall Study|Adverse Event|1|||
131867995|NCT05326529|474797400|FG000|Overall Study|Lack of Efficacy|0|||
131867996|NCT05326529|474797401|FG001|Overall Study|Lack of Efficacy|1|||
131867997|NCT05326529|474797402|FG002|Overall Study|Lack of Efficacy|0|||
131867998|NCT05326529|474797400|FG000|Overall Study|Physician Decision|0|||
131867999|NCT05326529|474797401|FG001|Overall Study|Physician Decision|0|||
131868000|NCT05326529|474797402|FG002|Overall Study|Physician Decision|2|||
131868001|NCT04878432|474797404|FG000|Overall Study|Adverse Event|1|||
131868002|NCT04878432|474797404|FG000|Overall Study|Death|2|||
131868003|NCT04878432|474797404|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131868004|NCT04878432|474797404|FG000|Overall Study|Withdrawal by Subject|6|||
131868005|NCT04878432|474797404|FG000|Overall Study|Progressive Disease|7|||
131868006|NCT04878432|474797404|FG000|Overall Study|New Therapy for Study Indication|7|||
131868007|NCT04878432|474797404|FG000|Overall Study|Physician Decision|11|||
131868008|NCT04541589|474797405|FG000|Treatment Period|Adverse Event|8|||
131868009|NCT04541589|474797406|FG001|Treatment Period|Adverse Event|2|||
131868010|NCT04541589|474797405|FG000|Treatment Period|Physician Decision|3|||
131868011|NCT04541589|474797406|FG001|Treatment Period|Physician Decision|1|||
131868012|NCT04541589|474797405|FG000|Treatment Period|Subject decision|7|||
131868013|NCT04541589|474797406|FG001|Treatment Period|Subject decision|4|||
131868014|NCT04541589|474797405|FG000|Treatment Period|Withdrawal by Subject|1|||
131868015|NCT04541589|474797406|FG001|Treatment Period|Withdrawal by Subject|0|||
131868016|NCT04541589|474797405|FG000|Safety Follow-up Period|Adverse Event|2|||
131868017|NCT04541589|474797406|FG001|Safety Follow-up Period|Adverse Event|1|||
131868018|NCT04541589|474797405|FG000|Safety Follow-up Period|Physician Decision|1|||
131868019|NCT04541589|474797406|FG001|Safety Follow-up Period|Physician Decision|0|||
131868020|NCT04541589|474797405|FG000|Safety Follow-up Period|Subject decision|5|||
131868021|NCT04541589|474797406|FG001|Safety Follow-up Period|Subject decision|3|||
131868022|NCT04541589|474797405|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
131868023|NCT04541589|474797406|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
131868024|NCT02770170|474797410|FG000|Overall Study|Withdrawal by Subject|0|||
131868025|NCT02770170|474797411|FG001|Overall Study|Withdrawal by Subject|0|||
131868026|NCT02770170|474797412|FG002|Overall Study|Withdrawal by Subject|0|||
131868027|NCT02770170|474797413|FG003|Overall Study|Withdrawal by Subject|2|||
131868028|NCT02770170|474797410|FG000|Overall Study|due to pregnancy|1|||
131868029|NCT02770170|474797411|FG001|Overall Study|due to pregnancy|0|||
131868030|NCT02770170|474797412|FG002|Overall Study|due to pregnancy|0|||
131868031|NCT02770170|474797413|FG003|Overall Study|due to pregnancy|0|||
131868032|NCT02770170|474797410|FG000|Overall Study|Lack of Efficacy|2|||
131868033|NCT02770170|474797411|FG001|Overall Study|Lack of Efficacy|0|||
131868034|NCT02770170|474797412|FG002|Overall Study|Lack of Efficacy|0|||
131868035|NCT02770170|474797413|FG003|Overall Study|Lack of Efficacy|1|||
131868036|NCT02770170|474797410|FG000|Overall Study|Adverse Event|4|||
131868037|NCT02770170|474797411|FG001|Overall Study|Adverse Event|3|||
131868038|NCT02770170|474797412|FG002|Overall Study|Adverse Event|5|||
131868039|NCT02770170|474797413|FG003|Overall Study|Adverse Event|3|||
131868040|NCT02770170|474797410|FG000|Overall Study|due to disease worsening|0|||
131868041|NCT02770170|474797411|FG001|Overall Study|due to disease worsening|0|||
131868042|NCT02770170|474797412|FG002|Overall Study|due to disease worsening|0|||
131868043|NCT02770170|474797413|FG003|Overall Study|due to disease worsening|1|||
131868044|NCT06028438|474797414|FG000|Overall Study|Adverse Event|3|||
131868045|NCT06028438|474797415|FG001|Overall Study|Adverse Event|9|||
131868046|NCT06028438|474797414|FG000|Overall Study|Lack of Efficacy|1|||
131868047|NCT06028438|474797415|FG001|Overall Study|Lack of Efficacy|1|||
131868048|NCT06028438|474797414|FG000|Overall Study|Lost to Follow-up|1|||
131868049|NCT06028438|474797415|FG001|Overall Study|Lost to Follow-up|0|||
131868050|NCT06028438|474797414|FG000|Overall Study|Withdrawal by Subject|1|||
131868051|NCT06028438|474797415|FG001|Overall Study|Withdrawal by Subject|0|||
131868052|NCT06028438|474797414|FG000|Overall Study|Other|3|||
131868053|NCT06028438|474797415|FG001|Overall Study|Other|3|||
131868054|NCT03581123|474797418|FG000|2-month Follow-up|Withdrawal by Subject|5|||
131868055|NCT03581123|474797419|FG001|2-month Follow-up|Withdrawal by Subject|4|||
131868056|NCT03581123|474797420|FG002|2-month Follow-up|Withdrawal by Subject|6|||
131868057|NCT03581123|474797421|FG003|2-month Follow-up|Withdrawal by Subject|4|||
131868058|NCT03581123|474797418|FG000|2-month Follow-up|Lost to Follow-up|8|||
131868059|NCT03581123|474797419|FG001|2-month Follow-up|Lost to Follow-up|1|||
131868060|NCT03581123|474797420|FG002|2-month Follow-up|Lost to Follow-up|2|||
131868061|NCT03581123|474797421|FG003|2-month Follow-up|Lost to Follow-up|2|||
131868062|NCT03581123|474797418|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
131868063|NCT03581123|474797419|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
131868064|NCT03581123|474797420|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
131868065|NCT03581123|474797421|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
131868066|NCT03581123|474797418|FG000|6-Month Follow-up|Lost to Follow-up|3|||
131868067|NCT03581123|474797419|FG001|6-Month Follow-up|Lost to Follow-up|3|||
131868068|NCT03581123|474797420|FG002|6-Month Follow-up|Lost to Follow-up|1|||
131868069|NCT03581123|474797421|FG003|6-Month Follow-up|Lost to Follow-up|1|||
131868070|NCT03581123|474797418|FG000|12-Month Follow-up|Lost to Follow-up|4|||
131868071|NCT03581123|474797419|FG001|12-Month Follow-up|Lost to Follow-up|3|||
131868072|NCT03581123|474797420|FG002|12-Month Follow-up|Lost to Follow-up|4|||
131917859|NCT05350202|474983041|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
131917860|NCT05350202|474983042|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
131917861|NCT05350202|474983041|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
131917862|NCT05350202|474983042|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
131917863|NCT05350202|474983041|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
131868073|NCT03581123|474797421|FG003|12-Month Follow-up|Lost to Follow-up|5|||
131868074|NCT02588612|474797424|FG000|Overall Study|Physician Decision|1|||
131868075|NCT02588612|474797424|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
131917864|NCT05350202|474983042|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
131917865|NCT04635423|474983043|FG000|Overall Study|Ongoing|493|||
131917866|NCT04635423|474983044|FG001|Overall Study|Ongoing|501|||
131917867|NCT04635423|474983043|FG000|Overall Study|Withdrawal by Subject|36|||
131917868|NCT04635423|474983044|FG001|Overall Study|Withdrawal by Subject|29|||
131917869|NCT05119569|474983047|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
131917870|NCT05119569|474983048|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
131917871|NCT05119569|474983049|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
131917872|NCT05119569|474983050|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
131917873|NCT05119569|474983047|FG000|Double Blind Treatment Phase|Adverse Event|6|||
131917874|NCT05119569|474983048|FG001|Double Blind Treatment Phase|Adverse Event|0|||
131917875|NCT05119569|474983049|FG002|Double Blind Treatment Phase|Adverse Event|0|||
131917876|NCT05119569|474983050|FG003|Double Blind Treatment Phase|Adverse Event|0|||
131917877|NCT05119569|474983047|FG000|Open Label Extension Phase|Ongoing in the study|0|||
131917878|NCT05119569|474983048|FG001|Open Label Extension Phase|Ongoing in the study|0|||
131917879|NCT05119569|474983049|FG002|Open Label Extension Phase|Ongoing in the study|65|||
131917880|NCT05119569|474983050|FG003|Open Label Extension Phase|Ongoing in the study|34|||
131917881|NCT04409002|474983056|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
131917882|NCT05032196|474983057|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
131917883|NCT05032196|474983058|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
131917884|NCT05032196|474983059|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
131917885|NCT05032196|474983060|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
131917886|NCT05032196|474983061|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
131917887|NCT05032196|474983062|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
131917888|NCT05032196|474983057|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
131917889|NCT05032196|474983058|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
131917890|NCT05032196|474983059|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
131917891|NCT05032196|474983060|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
131917892|NCT05032196|474983061|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
131917893|NCT05032196|474983062|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
131917894|NCT05032196|474983057|FG000|Period 2 (Multidose)|Physician Decision|0|||
131917895|NCT05032196|474983058|FG001|Period 2 (Multidose)|Physician Decision|0|||
131917896|NCT05032196|474983059|FG002|Period 2 (Multidose)|Physician Decision|0|||
131917897|NCT05032196|474983060|FG003|Period 2 (Multidose)|Physician Decision|0|||
131917898|NCT05032196|474983061|FG004|Period 2 (Multidose)|Physician Decision|1|||
131917899|NCT05032196|474983062|FG005|Period 2 (Multidose)|Physician Decision|0|||
131917900|NCT03069989|474983063|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
131917901|NCT03069989|474983064|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
131917902|NCT05578872|474983065|FG000|Overall Study|Withdrawal by Subject|2|||
131917903|NCT05578872|474983066|FG001|Overall Study|Withdrawal by Subject|1|||
131917904|NCT05578872|474983065|FG000|Overall Study|Adverse Event|1|||
131917905|NCT05578872|474983066|FG001|Overall Study|Adverse Event|1|||
131917906|NCT05578872|474983065|FG000|Overall Study|Physician Decision|1|||
131917907|NCT05578872|474983066|FG001|Overall Study|Physician Decision|2|||
131917908|NCT05578872|474983065|FG000|Overall Study|Progressive disease|10|||
131917909|NCT05578872|474983066|FG001|Overall Study|Progressive disease|9|||
131868076|NCT02588612|474797424|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
131868077|NCT02588612|474797424|FG000|Overall Study|Death prior to T-cell infusion|1|||
131868078|NCT03809663|474797425|FG000|Overall Study|Decision by sponsor|24|||
131868079|NCT03809663|474797426|FG001|Overall Study|Decision by sponsor|18|||
131868080|NCT03809663|474797427|FG002|Overall Study|Decision by sponsor|20|||
131868081|NCT03809663|474797428|FG003|Overall Study|Decision by sponsor|20|||
131868082|NCT03809663|474797429|FG004|Overall Study|Decision by sponsor|0|||
131917910|NCT05578872|474983065|FG000|Overall Study|Sponsor decision|0|||
131917911|NCT05578872|474983066|FG001|Overall Study|Sponsor decision|1|||
131917912|NCT05578872|474983065|FG000|Overall Study|Toxicity and Patient's decision|0|||
131917913|NCT05578872|474983066|FG001|Overall Study|Toxicity and Patient's decision|1|||
131917914|NCT05977868|474984090|FG000|Overall Study|Withdrawal by Subject|1|||
131917915|NCT05977868|474984091|FG001|Overall Study|Withdrawal by Subject|2|||
131408221|NCT01643850|473118240|FG006|Overall Study|Lost to Follow-up|1|||
131868083|NCT03809663|474797430|FG005|Overall Study|Decision by sponsor|0|||
131868084|NCT03809663|474797425|FG000|Overall Study|Withdrawal by Subject|26|||
131868085|NCT03809663|474797426|FG001|Overall Study|Withdrawal by Subject|22|||
131868086|NCT03809663|474797427|FG002|Overall Study|Withdrawal by Subject|27|||
131868087|NCT03809663|474797428|FG003|Overall Study|Withdrawal by Subject|26|||
131868088|NCT03809663|474797429|FG004|Overall Study|Withdrawal by Subject|0|||
131868089|NCT03809663|474797430|FG005|Overall Study|Withdrawal by Subject|0|||
131868090|NCT03809663|474797425|FG000|Overall Study|Lost to Follow-up|1|||
131868091|NCT03809663|474797426|FG001|Overall Study|Lost to Follow-up|4|||
131868092|NCT03809663|474797427|FG002|Overall Study|Lost to Follow-up|1|||
131868093|NCT03809663|474797428|FG003|Overall Study|Lost to Follow-up|1|||
131868094|NCT03809663|474797429|FG004|Overall Study|Lost to Follow-up|0|||
131868095|NCT03809663|474797430|FG005|Overall Study|Lost to Follow-up|0|||
131868096|NCT02042014|474797431|FG000|Overall Study|Adverse Event|1|||
131868097|NCT02042014|474797431|FG000|Overall Study|Physician Decision|7|||
131868098|NCT04610346|474797432|FG000|Overall Study|Withdrawal by Subject|1|||
131868099|NCT04610346|474797433|FG001|Overall Study|Withdrawal by Subject|1|||
131868100|NCT04610346|474797432|FG000|Overall Study|did not complete shelter onboarding|2|||
131868101|NCT04610346|474797433|FG001|Overall Study|did not complete shelter onboarding|1|||
131868102|NCT03309943|474797434|FG000|Overall Study|Withdrawal by Subject|0|||
131868103|NCT03309943|474797435|FG001|Overall Study|Withdrawal by Subject|1|||
131868104|NCT03309943|474797434|FG000|Overall Study|Inappropriate behavior towards staff|0|||
131868105|NCT03309943|474797435|FG001|Overall Study|Inappropriate behavior towards staff|1|||
131868106|NCT01372995|474797436|FG000|Overall Study|Spouse withdrew participant from study|0|||
131868107|NCT01372995|474797437|FG001|Overall Study|Spouse withdrew participant from study|1|||
131868108|NCT01372995|474797438|FG002|Overall Study|Spouse withdrew participant from study|0|||
131868109|NCT01372995|474797436|FG000|Overall Study|Physician Decision|0|||
131868110|NCT01372995|474797437|FG001|Overall Study|Physician Decision|0|||
131868111|NCT01372995|474797438|FG002|Overall Study|Physician Decision|1|||
131868112|NCT03123393|474797439|FG000|Overall Study|Study Terminated by Sponsor|6|||
131868113|NCT03123393|474797440|FG001|Overall Study|Study Terminated by Sponsor|9|||
131868114|NCT03123393|474797439|FG000|Overall Study|Withdrawal by Subject|2|||
131868115|NCT03123393|474797440|FG001|Overall Study|Withdrawal by Subject|1|||
131868116|NCT03123393|474797439|FG000|Overall Study|Reason not Specified|13|||
131868117|NCT03123393|474797440|FG001|Overall Study|Reason not Specified|13|||
131868118|NCT00558701|474797444|FG000|Overall Study|Protocol Deviations|1|||
131868119|NCT00558701|474797445|FG001|Overall Study|Protocol Deviations|4|||
131868120|NCT00427648|474797446|FG000|Overall Study|Protocol Violation|1|||
131868121|NCT00427648|474797447|FG001|Overall Study|Protocol Violation|2|||
131868122|NCT00427648|474797446|FG000|Overall Study|Adverse Event|0|||
131868123|NCT00427648|474797447|FG001|Overall Study|Adverse Event|1|||
131868124|NCT00105079|474797448|FG000|Overall Study|Adverse Event|5|||
131868125|NCT00105079|474797449|FG001|Overall Study|Adverse Event|12|||
131868126|NCT00105079|474797448|FG000|Overall Study|Death|3|||
131868127|NCT00105079|474797449|FG001|Overall Study|Death|1|||
131868128|NCT00105079|474797448|FG000|Overall Study|Lost to Follow-up|12|||
131868129|NCT00105079|474797449|FG001|Overall Study|Lost to Follow-up|12|||
131868130|NCT00105079|474797448|FG000|Overall Study|Lack of Efficacy|9|||
131868131|NCT00105079|474797449|FG001|Overall Study|Lack of Efficacy|3|||
131868132|NCT00105079|474797448|FG000|Overall Study|Refused treatment|6|||
131868133|NCT00105079|474797449|FG001|Overall Study|Refused treatment|4|||
131868134|NCT00105079|474797448|FG000|Overall Study|Violation of selection criteria at entry|0|||
131868135|NCT00105079|474797449|FG001|Overall Study|Violation of selection criteria at entry|2|||
131868136|NCT00105079|474797448|FG000|Overall Study|Protocol Violation|1|||
131868137|NCT00105079|474797449|FG001|Overall Study|Protocol Violation|0|||
131868138|NCT00105079|474797448|FG000|Overall Study|Other|3|||
131868139|NCT00105079|474797449|FG001|Overall Study|Other|1|||
131868140|NCT03822468|474797450|FG000|Treatment Period|Progressive disease|98|||
131868141|NCT03822468|474797451|FG001|Treatment Period|Progressive disease|94|||
131868142|NCT03822468|474797450|FG000|Treatment Period|Adverse Event|21|||
131868143|NCT03822468|474797451|FG001|Treatment Period|Adverse Event|24|||
131868144|NCT03822468|474797450|FG000|Treatment Period|Withdrawal by Subject|9|||
131868145|NCT03822468|474797451|FG001|Treatment Period|Withdrawal by Subject|5|||
131868146|NCT03822468|474797450|FG000|Treatment Period|Physician Decision|9|||
131868147|NCT03822468|474797451|FG001|Treatment Period|Physician Decision|7|||
131868148|NCT03822468|474797450|FG000|Treatment Period|Protocol Violation|2|||
131868149|NCT03822468|474797451|FG001|Treatment Period|Protocol Violation|1|||
131868150|NCT03822468|474797450|FG000|Treatment Period|Death|2|||
131868151|NCT03822468|474797451|FG001|Treatment Period|Death|3|||
131868152|NCT03822468|474797450|FG000|Treatment Period|Lost to Follow-up|1|||
131917916|NCT05977868|474984090|FG000|Overall Study|Transitioned to comfort care|1|||
131868153|NCT03822468|474797451|FG001|Treatment Period|Lost to Follow-up|1|||
131868154|NCT03822468|474797450|FG000|Treatment Period|Sponsor decision|46|||
131868155|NCT03822468|474797451|FG001|Treatment Period|Sponsor decision|53|||
131868156|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
131868157|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
131868158|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
131868159|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
131868160|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Death|1|||
131868161|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Death|0|||
131868162|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131868163|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131868164|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131868165|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131868166|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
131868167|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131868168|NCT03822468|474797450|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
131868169|NCT03822468|474797451|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
131868170|NCT04157348|474797452|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
131868171|NCT04157348|474797453|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
131868172|NCT04157348|474797452|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131868173|NCT04157348|474797453|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131868174|NCT04157348|474797452|FG000|Double-blind Treatment Period|Adverse Event|0|||
131868175|NCT04157348|474797453|FG001|Double-blind Treatment Period|Adverse Event|1|||
131868176|NCT04157348|474797452|FG000|Open-label Extension Period|Adverse Event|1|||
131868177|NCT04157348|474797453|FG001|Open-label Extension Period|Adverse Event|1|||
131868178|NCT04157348|474797452|FG000|Open-label Extension Period|Death|0|||
131868179|NCT04157348|474797453|FG001|Open-label Extension Period|Death|1|||
131868180|NCT04157348|474797452|FG000|Open-label Extension Period|Lack of Efficacy|2|||
131868181|NCT04157348|474797453|FG001|Open-label Extension Period|Lack of Efficacy|2|||
131868182|NCT04157348|474797452|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
131868183|NCT04157348|474797453|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
131868184|NCT04157348|474797452|FG000|Open-label Extension Period|Ongoing|60|||
131868185|NCT04157348|474797453|FG001|Open-label Extension Period|Ongoing|57|||
131868186|NCT04157348|474797452|FG000|Open-label Extension Period|other reasons|1|||
131868187|NCT04157348|474797453|FG001|Open-label Extension Period|other reasons|1|||
131868188|NCT04666259|474797456|FG000|Treatment Phase|Physician Decision|9|||
131868189|NCT04666259|474797457|FG001|Treatment Phase|Physician Decision|3|||
131868190|NCT04666259|474797458|FG002|Treatment Phase|Physician Decision|3|||
131868191|NCT04666259|474797456|FG000|Treatment Phase|Adverse Event|3|||
131868192|NCT04666259|474797457|FG001|Treatment Phase|Adverse Event|1|||
131868193|NCT04666259|474797458|FG002|Treatment Phase|Adverse Event|0|||
131868194|NCT04666259|474797456|FG000|Treatment Phase|Subject decision|1|||
131868195|NCT04666259|474797457|FG001|Treatment Phase|Subject decision|2|||
131868196|NCT04666259|474797458|FG002|Treatment Phase|Subject decision|0|||
131868197|NCT04666259|474797456|FG000|Treatment Phase|Progressive disease|0|||
131868198|NCT04666259|474797457|FG001|Treatment Phase|Progressive disease|1|||
131868199|NCT04666259|474797458|FG002|Treatment Phase|Progressive disease|0|||
131868200|NCT04666259|474797456|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
131868201|NCT04666259|474797457|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
131868202|NCT04666259|474797458|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
131868203|NCT04666259|474797456|FG000|Safety Follow-up Phase|Physician Decision|2|||
131868204|NCT04666259|474797457|FG001|Safety Follow-up Phase|Physician Decision|0|||
131868205|NCT04666259|474797458|FG002|Safety Follow-up Phase|Physician Decision|0|||
131868206|NCT04666259|474797456|FG000|Safety Follow-up Phase|Subject decision|1|||
131868207|NCT04666259|474797457|FG001|Safety Follow-up Phase|Subject decision|0|||
131868208|NCT04666259|474797458|FG002|Safety Follow-up Phase|Subject decision|0|||
131868209|NCT04666259|474797456|FG000|Safety Follow-up Phase|Death|0|||
131868210|NCT04666259|474797457|FG001|Safety Follow-up Phase|Death|1|||
131868211|NCT04666259|474797458|FG002|Safety Follow-up Phase|Death|0|||
131868212|NCT02632409|474797469|FG000|Randomized|AE unrelated to study Drug|0|||
131868213|NCT02632409|474797470|FG001|Randomized|AE unrelated to study Drug|1|||
131868214|NCT02632409|474797469|FG000|Randomized|Participant withdrew consent|2|||
131868215|NCT02632409|474797470|FG001|Randomized|Participant withdrew consent|1|||
131868216|NCT02632409|474797469|FG000|Randomized|No Longer meets study criteria|5|||
131868217|NCT02632409|474797470|FG001|Randomized|No Longer meets study criteria|0|||
131868218|NCT02632409|474797469|FG000|Randomized|other reasons|1|||
131868219|NCT02632409|474797470|FG001|Randomized|other reasons|0|||
131868220|NCT02632409|474797469|FG000|Treatment Period|Ongoing Treatment|20|||
131868221|NCT02632409|474797470|FG001|Treatment Period|Ongoing Treatment|21|||
131868222|NCT02632409|474797469|FG000|Treatment Period|Disease Recurrence|147|||
131868223|NCT02632409|474797470|FG001|Treatment Period|Disease Recurrence|90|||
131868224|NCT02632409|474797469|FG000|Treatment Period|Study Drug Toxicity|8|||
131868225|NCT02632409|474797470|FG001|Treatment Period|Study Drug Toxicity|49|||
131868226|NCT02632409|474797469|FG000|Treatment Period|Death|1|||
131917917|NCT05977868|474984091|FG001|Overall Study|Transitioned to comfort care|0|||
131408222|NCT01643850|473118241|FG007|Overall Study|Lost to Follow-up|0|||
131868227|NCT02632409|474797470|FG001|Treatment Period|Death|0|||
131868228|NCT02632409|474797469|FG000|Treatment Period|AE unrelated to study drug|15|||
131868229|NCT02632409|474797470|FG001|Treatment Period|AE unrelated to study drug|16|||
131868230|NCT02632409|474797469|FG000|Treatment Period|Request to discontinue treatment|4|||
131868231|NCT02632409|474797470|FG001|Treatment Period|Request to discontinue treatment|19|||
131917918|NCT00975923|474984097|FG000|Overall Study|Withdrawal by Subject|0|||
131917919|NCT00975923|474984098|FG001|Overall Study|Withdrawal by Subject|1|||
131917920|NCT04896385|474984099|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
131917921|NCT04896385|474984100|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
131917922|NCT04896385|474984101|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
131917923|NCT04896385|474984102|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
131868232|NCT02632409|474797469|FG000|Treatment Period|Participant withdrew consent|7|||
131868233|NCT02632409|474797470|FG001|Treatment Period|Participant withdrew consent|5|||
131868234|NCT02632409|474797469|FG000|Treatment Period|Lost to Follow-up|0|||
131868235|NCT02632409|474797470|FG001|Treatment Period|Lost to Follow-up|1|||
131868236|NCT02632409|474797469|FG000|Treatment Period|Maximum clinical benefit|1|||
131868237|NCT02632409|474797470|FG001|Treatment Period|Maximum clinical benefit|0|||
131868238|NCT02632409|474797469|FG000|Treatment Period|No longer meets study criteria|3|||
131868239|NCT02632409|474797470|FG001|Treatment Period|No longer meets study criteria|0|||
131868240|NCT02632409|474797469|FG000|Treatment Period|Administrative Reason by sponsor|0|||
131868241|NCT02632409|474797470|FG001|Treatment Period|Administrative Reason by sponsor|1|||
131868242|NCT02632409|474797469|FG000|Treatment Period|Other Reasons|10|||
131868243|NCT02632409|474797470|FG001|Treatment Period|Other Reasons|6|||
131868244|NCT04178122|474797471|FG000|Overall Study|Withdrawal by Subject|1|||
131868245|NCT04178122|474797472|FG001|Overall Study|Withdrawal by Subject|1|||
131868246|NCT04178122|474797471|FG000|Overall Study|Death|2|||
131868247|NCT04178122|474797472|FG001|Overall Study|Death|0|||
131868248|NCT04178122|474797471|FG000|Overall Study|Did not complete testing|3|||
131868249|NCT04178122|474797472|FG001|Overall Study|Did not complete testing|13|||
131868250|NCT04278417|474797473|FG000|Overall Study|Withdrawal by Subject|20|||
131868251|NCT04278417|474797474|FG001|Overall Study|Withdrawal by Subject|20|||
131868252|NCT04278417|474797473|FG000|Overall Study|Progressive disease|0|||
131868253|NCT04278417|474797474|FG001|Overall Study|Progressive disease|2|||
131868254|NCT04278417|474797473|FG000|Overall Study|Physician Decision|4|||
131868255|NCT04278417|474797474|FG001|Overall Study|Physician Decision|6|||
131868256|NCT04278417|474797473|FG000|Overall Study|Lost to Follow-up|11|||
131868257|NCT04278417|474797474|FG001|Overall Study|Lost to Follow-up|13|||
131868258|NCT04278417|474797473|FG000|Overall Study|Death|8|||
131868259|NCT04278417|474797474|FG001|Overall Study|Death|9|||
131868260|NCT04278417|474797473|FG000|Overall Study|Adverse Event|3|||
131868261|NCT04278417|474797474|FG001|Overall Study|Adverse Event|5|||
131868262|NCT02883062|474797475|FG000|Overall Study|Withdrawal by Subject|6|||
131868263|NCT02883062|474797476|FG001|Overall Study|Withdrawal by Subject|0|||
131868264|NCT01753570|474797477|FG000|Overall Study|Adverse Event|1|||
131868265|NCT01753570|474797478|FG001|Overall Study|Adverse Event|0|||
131868266|NCT01753570|474797479|FG002|Overall Study|Adverse Event|1|||
131868267|NCT01753570|474797477|FG000|Overall Study|Physician Decision|0|||
131868268|NCT01753570|474797478|FG001|Overall Study|Physician Decision|1|||
131868269|NCT01753570|474797479|FG002|Overall Study|Physician Decision|0|||
131868270|NCT01753570|474797477|FG000|Overall Study|Withdrawal by Subject|1|||
131868271|NCT01753570|474797478|FG001|Overall Study|Withdrawal by Subject|4|||
131868272|NCT01753570|474797479|FG002|Overall Study|Withdrawal by Subject|0|||
131868273|NCT01808066|474797480|FG000|Overall Study|Withdrawal by Subject|15|||
131868274|NCT04390763|474797481|FG000|Safety run-in Part|Adverse Event|4|||
131868275|NCT04390763|474797482|FG001|Safety run-in Part|Adverse Event|0|||
131868276|NCT04390763|474797483|FG002|Safety run-in Part|Adverse Event|0|||
131868277|NCT04390763|474797484|FG003|Safety run-in Part|Adverse Event|0|||
131868278|NCT04390763|474797481|FG000|Safety run-in Part|Physician Decision|1|||
131868279|NCT04390763|474797482|FG001|Safety run-in Part|Physician Decision|0|||
131868280|NCT04390763|474797483|FG002|Safety run-in Part|Physician Decision|0|||
131868281|NCT04390763|474797484|FG003|Safety run-in Part|Physician Decision|0|||
131868282|NCT04390763|474797481|FG000|Safety run-in Part|Progressive Disease|6|||
131868283|NCT04390763|474797482|FG001|Safety run-in Part|Progressive Disease|0|||
131868284|NCT04390763|474797483|FG002|Safety run-in Part|Progressive Disease|0|||
131868285|NCT04390763|474797484|FG003|Safety run-in Part|Progressive Disease|0|||
131868286|NCT04390763|474797481|FG000|Randomized Part|Adverse Event|0|||
131868287|NCT04390763|474797482|FG001|Randomized Part|Adverse Event|11|||
131868288|NCT04390763|474797483|FG002|Randomized Part|Adverse Event|5|||
131868289|NCT04390763|474797484|FG003|Randomized Part|Adverse Event|5|||
131868290|NCT04390763|474797481|FG000|Randomized Part|Death|0|||
131868291|NCT04390763|474797482|FG001|Randomized Part|Death|3|||
131868292|NCT04390763|474797483|FG002|Randomized Part|Death|4|||
131868293|NCT04390763|474797484|FG003|Randomized Part|Death|2|||
131868294|NCT04390763|474797481|FG000|Randomized Part|Physician Decision|0|||
131868295|NCT04390763|474797482|FG001|Randomized Part|Physician Decision|2|||
131868296|NCT04390763|474797483|FG002|Randomized Part|Physician Decision|2|||
131868297|NCT04390763|474797484|FG003|Randomized Part|Physician Decision|9|||
131868298|NCT04390763|474797481|FG000|Randomized Part|Progressive Disease|0|||
131868299|NCT04390763|474797482|FG001|Randomized Part|Progressive Disease|24|||
131868300|NCT04390763|474797483|FG002|Randomized Part|Progressive Disease|31|||
131868301|NCT04390763|474797484|FG003|Randomized Part|Progressive Disease|23|||
131868302|NCT04390763|474797481|FG000|Randomized Part|Study terminated by sponsor|0|||
131868303|NCT04390763|474797482|FG001|Randomized Part|Study terminated by sponsor|1|||
131868304|NCT04390763|474797483|FG002|Randomized Part|Study terminated by sponsor|0|||
131868305|NCT04390763|474797484|FG003|Randomized Part|Study terminated by sponsor|0|||
131868306|NCT04390763|474797481|FG000|Randomized Part|Participant Decision|0|||
131868307|NCT04390763|474797482|FG001|Randomized Part|Participant Decision|5|||
131868308|NCT04390763|474797483|FG002|Randomized Part|Participant Decision|7|||
131868309|NCT04390763|474797484|FG003|Randomized Part|Participant Decision|6|||
131868310|NCT04390763|474797481|FG000|Randomized Part|Not treated|0|||
131868311|NCT04390763|474797482|FG001|Randomized Part|Not treated|4|||
131868312|NCT04390763|474797483|FG002|Randomized Part|Not treated|2|||
131868313|NCT04390763|474797484|FG003|Randomized Part|Not treated|7|||
131868314|NCT04340843|474797485|FG000|Overall Study|Adverse Event|0|||
131868315|NCT04340843|474797486|FG001|Overall Study|Adverse Event|2|||
131868316|NCT04340843|474797485|FG000|Overall Study|Withdrawal by Subject|0|||
131868317|NCT04340843|474797486|FG001|Overall Study|Withdrawal by Subject|2|||
131868318|NCT03584854|474797489|FG000|Overall Study|Primary outcome not measured|1|||
131868319|NCT03584854|474797490|FG001|Overall Study|Primary outcome not measured|2|||
131868320|NCT04025879|474797491|FG000|Randomization|Participant withdrew consent|0|||
131868321|NCT04025879|474797492|FG001|Randomization|Participant withdrew consent|1|||
131868322|NCT04025879|474797491|FG000|Randomization|Participant no longer met study criteria|1|||
131868323|NCT04025879|474797492|FG001|Randomization|Participant no longer met study criteria|1|||
131453892|NCT03565497|473291820|FG001|Overall Study|Lost to Follow-up|1|||
131453893|NCT03565497|473291821|FG002|Overall Study|Lost to Follow-up|2|||
131453894|NCT03565497|473291819|FG000|Overall Study|Withdrawal by Subject|1|||
131453895|NCT03565497|473291820|FG001|Overall Study|Withdrawal by Subject|1|||
131453896|NCT03565497|473291821|FG002|Overall Study|Withdrawal by Subject|1|||
131453897|NCT02999672|473291822|FG000|Overall Study|Death|0|||
131453898|NCT02999672|473291823|FG001|Overall Study|Death|1|||
131453899|NCT02999672|473291822|FG000|Overall Study|Study Terminated by Sponsor|0|||
131453900|NCT02999672|473291823|FG001|Overall Study|Study Terminated by Sponsor|1|||
131453901|NCT02999672|473291822|FG000|Overall Study|Progressive Disease|9|||
131453902|NCT02999672|473291823|FG001|Overall Study|Progressive Disease|5|||
131453903|NCT02999672|473291822|FG000|Overall Study|Adverse Event|4|||
131453904|NCT02999672|473291823|FG001|Overall Study|Adverse Event|0|||
131868324|NCT04025879|474797491|FG000|Treatment|Ongoing treatment|10|||
131868325|NCT04025879|474797492|FG001|Treatment|Ongoing treatment|8|||
131868326|NCT04025879|474797491|FG000|Treatment|Disease progression/recurrence|36|||
131868327|NCT04025879|474797492|FG001|Treatment|Disease progression/recurrence|72|||
131868328|NCT04025879|474797491|FG000|Treatment|Study drug toxicity|36|||
131868329|NCT04025879|474797492|FG001|Treatment|Study drug toxicity|13|||
131868330|NCT04025879|474797491|FG000|Treatment|Death|2|||
131868331|NCT04025879|474797492|FG001|Treatment|Death|0|||
131868332|NCT04025879|474797491|FG000|Treatment|Adverse event unrelated to study drug|21|||
131868333|NCT04025879|474797492|FG001|Treatment|Adverse event unrelated to study drug|14|||
131868334|NCT04025879|474797491|FG000|Treatment|Participant request to discontinue study treatment|16|||
131868335|NCT04025879|474797492|FG001|Treatment|Participant request to discontinue study treatment|8|||
131868336|NCT04025879|474797491|FG000|Treatment|Participant withdrew consent|1|||
131868337|NCT04025879|474797492|FG001|Treatment|Participant withdrew consent|3|||
131868338|NCT04025879|474797491|FG000|Treatment|Participant no longer meets study criteria|3|||
131868339|NCT04025879|474797492|FG001|Treatment|Participant no longer meets study criteria|2|||
131868340|NCT04025879|474797491|FG000|Treatment|Lost to Follow-up|1|||
131868341|NCT04025879|474797492|FG001|Treatment|Lost to Follow-up|0|||
131868342|NCT04025879|474797491|FG000|Treatment|Other reasons|15|||
131868343|NCT04025879|474797492|FG001|Treatment|Other reasons|17|||
131868344|NCT04025879|474797491|FG000|Treatment|Administrative reason by sponsor|0|||
131868345|NCT04025879|474797492|FG001|Treatment|Administrative reason by sponsor|1|||
131868346|NCT04025879|474797491|FG000|Treatment|Not reported|2|||
131868347|NCT04025879|474797492|FG001|Treatment|Not reported|0|||
131868348|NCT03482635|474797493|FG000|Overall Study|Lack of Efficacy|0|||
131868349|NCT03482635|474797494|FG001|Overall Study|Lack of Efficacy|0|||
131453905|NCT01075685|473291824|FG000|Overall Study|Protocol Violation|9|||
131453906|NCT01075685|473291825|FG001|Overall Study|Protocol Violation|1|||
131453907|NCT01075685|473291824|FG000|Overall Study|Withdrawal by Subject|20|||
131453908|NCT01075685|473291825|FG001|Overall Study|Withdrawal by Subject|5|||
131868350|NCT03482635|474797495|FG002|Overall Study|Lack of Efficacy|1|||
131868351|NCT03482635|474797496|FG003|Overall Study|Lack of Efficacy|3|||
131868352|NCT03482635|474797493|FG000|Overall Study|Adverse Event|2|||
131868353|NCT03482635|474797494|FG001|Overall Study|Adverse Event|2|||
131453909|NCT01075685|473291824|FG000|Overall Study|Lost to Follow-up|563|||
131453910|NCT01075685|473291825|FG001|Overall Study|Lost to Follow-up|220|||
131868354|NCT03482635|474797495|FG002|Overall Study|Adverse Event|0|||
131868355|NCT03482635|474797496|FG003|Overall Study|Adverse Event|3|||
131868356|NCT03482635|474797493|FG000|Overall Study|Withdrawal by Subject|2|||
131868357|NCT03482635|474797494|FG001|Overall Study|Withdrawal by Subject|1|||
131868358|NCT03482635|474797495|FG002|Overall Study|Withdrawal by Subject|0|||
131868359|NCT03482635|474797496|FG003|Overall Study|Withdrawal by Subject|1|||
131453911|NCT02858362|473291828|FG000|Overall Study|Protocol Violation|0|||
131868360|NCT03482635|474797493|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
131868361|NCT03482635|474797494|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
131868362|NCT03482635|474797495|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
131868363|NCT03482635|474797496|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
131868364|NCT03482635|474797493|FG000|Overall Study|Not treated|0|||
131868365|NCT03482635|474797494|FG001|Overall Study|Not treated|0|||
131868366|NCT03482635|474797495|FG002|Overall Study|Not treated|0|||
131868367|NCT03482635|474797496|FG003|Overall Study|Not treated|1|||
131868368|NCT04681066|474797497|FG000|Overall Study|Lost to Follow-up|3|||
131868369|NCT04681066|474797498|FG001|Overall Study|Lost to Follow-up|1|||
131868370|NCT04681066|474797499|FG002|Overall Study|Lost to Follow-up|2|||
131868371|NCT04681066|474797500|FG003|Overall Study|Lost to Follow-up|1|||
131868372|NCT04681066|474797497|FG000|Overall Study|Withdrawal by Subject|2|||
131868373|NCT04681066|474797498|FG001|Overall Study|Withdrawal by Subject|1|||
131868374|NCT04681066|474797499|FG002|Overall Study|Withdrawal by Subject|0|||
131868375|NCT04681066|474797500|FG003|Overall Study|Withdrawal by Subject|3|||
131868376|NCT04681066|474797497|FG000|Overall Study|Death|0|||
131868377|NCT04681066|474797498|FG001|Overall Study|Death|1|||
131868378|NCT04681066|474797499|FG002|Overall Study|Death|0|||
131868379|NCT04681066|474797500|FG003|Overall Study|Death|0|||
131868380|NCT00979654|474797502|FG000|Overall Study|Lost to Follow-up|1|||
131868381|NCT00979654|474797502|FG000|Overall Study|Withdrawal by Subject|22|||
131868382|NCT00979654|474797502|FG000|Overall Study|Death|1|||
131868383|NCT00979654|474797502|FG000|Overall Study|Lack of Efficacy|6|||
131868384|NCT00979654|474797502|FG000|Overall Study|Adverse Event|1|||
131868385|NCT00979654|474797502|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
131868386|NCT00979654|474797502|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
131868387|NCT00979654|474797502|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
131868388|NCT00979654|474797502|FG000|Overall Study|Serious Adverse Event|1|||
131868389|NCT00979654|474797502|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
131868390|NCT01068678|474798957|FG000|Overall Study|Lack of Efficacy|3|||
131868391|NCT01068678|474798958|FG001|Overall Study|Lack of Efficacy|2|||
131868392|NCT01068678|474798957|FG000|Overall Study|Protocol Violation|5|||
131868393|NCT01068678|474798958|FG001|Overall Study|Protocol Violation|1|||
131868394|NCT01068678|474798957|FG000|Overall Study|Withdrawal criteria|12|||
131868395|NCT01068678|474798958|FG001|Overall Study|Withdrawal criteria|6|||
131868396|NCT01068678|474798957|FG000|Overall Study|Unclassified|18|||
131868397|NCT01068678|474798958|FG001|Overall Study|Unclassified|15|||
131868398|NCT00570687|474798961|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868399|NCT00570687|474798962|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868400|NCT00570687|474798963|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868401|NCT00570687|474798964|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868402|NCT00570687|474798965|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
131868403|NCT00570687|474798966|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
131868404|NCT00570687|474798967|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
131868405|NCT00570687|474798968|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
131868406|NCT00570687|474798969|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
131868407|NCT00570687|474798970|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
131868408|NCT00570687|474798961|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868409|NCT00570687|474798962|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868410|NCT00570687|474798963|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868411|NCT00570687|474798964|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868412|NCT00570687|474798965|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868413|NCT00570687|474798966|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868414|NCT00570687|474798967|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868415|NCT00570687|474798968|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868416|NCT00570687|474798969|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
131408223|NCT01643850|473118242|FG008|Overall Study|Lost to Follow-up|1|||
131408224|NCT01643850|473118234|FG000|Overall Study|Adverse Event|0|||
131868417|NCT00570687|474798970|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868418|NCT00570687|474798961|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868419|NCT00570687|474798962|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868420|NCT00570687|474798963|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868421|NCT00570687|474798964|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868422|NCT00570687|474798965|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868423|NCT00570687|474798966|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868424|NCT00570687|474798967|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
131868425|NCT00570687|474798968|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868426|NCT00570687|474798969|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868427|NCT00570687|474798970|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
131868428|NCT03055338|474798971|FG000|Overall Study|Lost to Follow-up|9|||
131868429|NCT03055338|474798972|FG001|Overall Study|Lost to Follow-up|2|||
131868430|NCT03055338|474798973|FG002|Overall Study|Lost to Follow-up|3|||
131408225|NCT01643850|473118235|FG001|Overall Study|Adverse Event|0|||
131868431|NCT03055338|474798971|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
131917924|NCT04896385|474984099|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
131917925|NCT04896385|474984100|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
131917926|NCT04896385|474984101|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
131917927|NCT04896385|474984102|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
131917928|NCT04896385|474984099|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
131917929|NCT04896385|474984100|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
131917930|NCT04896385|474984101|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
131917931|NCT04896385|474984102|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
131868432|NCT03055338|474798972|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
131868433|NCT03055338|474798973|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
131868434|NCT03055338|474798971|FG000|Overall Study|Physician Decision|0|||
131868435|NCT03055338|474798972|FG001|Overall Study|Physician Decision|0|||
131868436|NCT03055338|474798973|FG002|Overall Study|Physician Decision|2|||
131868437|NCT03055338|474798971|FG000|Overall Study|Withdrawal by Subject|9|||
131868438|NCT03055338|474798972|FG001|Overall Study|Withdrawal by Subject|8|||
131868439|NCT03055338|474798973|FG002|Overall Study|Withdrawal by Subject|7|||
131868440|NCT00975611|474798974|FG000|Overall Study|Screen Fail|16|||
131868441|NCT00975611|474798974|FG000|Overall Study|Physician Decision|1|||
131868442|NCT03058705|474798975|FG000|Overall Study|Withdrawal by Subject|2|||
131868443|NCT03058705|474798975|FG000|Overall Study|Physician Decision|2|||
131868444|NCT01682226|474798976|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
131868445|NCT01682226|474798976|FG000|Overall Study|Participants did not receive treatment|2|||
131868446|NCT01682226|474798976|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
131868447|NCT02159053|474798977|FG000|Overall Study|Death|2|||
131868448|NCT02159053|474798978|FG001|Overall Study|Death|0|||
131868449|NCT02159053|474798979|FG002|Overall Study|Death|1|||
131868450|NCT02159053|474798977|FG000|Overall Study|Physician Decision|0|||
131868451|NCT02159053|474798978|FG001|Overall Study|Physician Decision|1|||
131868452|NCT02159053|474798979|FG002|Overall Study|Physician Decision|1|||
131868453|NCT02159053|474798977|FG000|Overall Study|Lack of Efficacy|3|||
131868454|NCT02159053|474798978|FG001|Overall Study|Lack of Efficacy|4|||
131868455|NCT02159053|474798979|FG002|Overall Study|Lack of Efficacy|7|||
131868456|NCT02159053|474798977|FG000|Overall Study|Adverse Event|7|||
131868457|NCT02159053|474798978|FG001|Overall Study|Adverse Event|6|||
131868458|NCT02159053|474798979|FG002|Overall Study|Adverse Event|5|||
131868459|NCT02159053|474798977|FG000|Overall Study|Participants/guardian decision|8|||
131868460|NCT02159053|474798978|FG001|Overall Study|Participants/guardian decision|10|||
131868461|NCT02159053|474798979|FG002|Overall Study|Participants/guardian decision|6|||
131868462|NCT00457002|474798988|FG000|Overall Study|Death|40|||
131868463|NCT00457002|474798989|FG001|Overall Study|Death|47|||
131868464|NCT00457002|474798988|FG000|Overall Study|Adverse Event|284|||
131868465|NCT00457002|474798989|FG001|Overall Study|Adverse Event|260|||
131868466|NCT00457002|474798988|FG000|Overall Study|Withdrawal by Subject|299|||
131868467|NCT00457002|474798989|FG001|Overall Study|Withdrawal by Subject|271|||
131868468|NCT00457002|474798988|FG000|Overall Study|Lost to Follow-up|72|||
131868469|NCT00457002|474798989|FG001|Overall Study|Lost to Follow-up|71|||
131868470|NCT00457002|474798988|FG000|Overall Study|Poor/Non-compliance|46|||
131868471|NCT00457002|474798989|FG001|Overall Study|Poor/Non-compliance|33|||
131868472|NCT00457002|474798988|FG000|Overall Study|No longer met criteria|41|||
131868473|NCT00457002|474798989|FG001|Overall Study|No longer met criteria|37|||
131868474|NCT00457002|474798988|FG000|Overall Study|Administrative reason by Sponsor|1|||
131868475|NCT00457002|474798989|FG001|Overall Study|Administrative reason by Sponsor|0|||
131868476|NCT00457002|474798988|FG000|Overall Study|non-specified|29|||
131868477|NCT00457002|474798989|FG001|Overall Study|non-specified|38|||
131868478|NCT00457002|474798988|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
131868479|NCT00457002|474798989|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
131868480|NCT00454246|474798990|FG000|Overall Study|Adverse Event|2|||
131868481|NCT00454246|474798991|FG001|Overall Study|Adverse Event|2|||
131868482|NCT00454246|474798992|FG002|Overall Study|Adverse Event|0|||
131868483|NCT00454246|474798990|FG000|Overall Study|Violation of selection criteria at entry|6|||
131868484|NCT00454246|474798991|FG001|Overall Study|Violation of selection criteria at entry|0|||
131868485|NCT00454246|474798992|FG002|Overall Study|Violation of selection criteria at entry|0|||
131868486|NCT00454246|474798990|FG000|Overall Study|Protocol Violation|1|||
131868487|NCT00454246|474798991|FG001|Overall Study|Protocol Violation|0|||
131868488|NCT00454246|474798992|FG002|Overall Study|Protocol Violation|0|||
131868489|NCT00454246|474798990|FG000|Overall Study|Refused Treatment|1|||
131868490|NCT00454246|474798991|FG001|Overall Study|Refused Treatment|1|||
131917932|NCT04896385|474984099|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
131868491|NCT00454246|474798992|FG002|Overall Study|Refused Treatment|0|||
131868492|NCT00454246|474798990|FG000|Overall Study|Failure to return|1|||
131868493|NCT00454246|474798991|FG001|Overall Study|Failure to return|0|||
131868494|NCT00454246|474798992|FG002|Overall Study|Failure to return|0|||
131868495|NCT00454246|474798990|FG000|Overall Study|Early termination of study|62|||
131868496|NCT00454246|474798991|FG001|Overall Study|Early termination of study|26|||
131868497|NCT00454246|474798992|FG002|Overall Study|Early termination of study|9|||
131868498|NCT02283268|474798993|FG000|Overall Study|Withdrawal by Subject|1|||
131868499|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
131868500|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
131868501|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
131868502|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
131868503|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
131868504|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
131868505|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
131868506|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
131868507|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
131868508|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
131868509|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
131868510|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
131868511|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
131868512|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
131868513|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
131868514|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
131868515|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
131868516|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
131868517|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
131868518|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
131868519|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
131868520|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
131868521|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
131868522|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
131868523|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
131868524|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
131868525|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
131868526|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
131868527|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
131868528|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
131868529|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
131868530|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
131868531|NCT00506415|474799004|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
131868532|NCT00506415|474799005|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
131868533|NCT00506415|474799006|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
131868534|NCT00506415|474799007|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
131868535|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
131868536|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
131868537|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
131868538|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
131868539|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
131868540|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
131868541|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
131868542|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
131868543|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
131868544|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
131868545|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
131868546|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
131868547|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
131868548|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
131868549|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
131868550|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
131868551|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
131868552|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
131868553|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
131868554|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
131868555|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
131868556|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
131868557|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
131868558|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
131868559|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
131868560|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
131868561|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
131868562|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
131868563|NCT00506415|474799004|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
131868564|NCT00506415|474799005|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
131868565|NCT00506415|474799006|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
131868566|NCT00506415|474799007|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
131868567|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
131868568|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
131868569|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
131408226|NCT01643850|473118236|FG002|Overall Study|Adverse Event|0|||
131408227|NCT01643850|473118237|FG003|Overall Study|Adverse Event|0|||
131868570|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
131868571|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
131868572|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
131868573|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
131868574|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
131868575|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
131868576|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
131868577|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
131868578|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
131868579|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
131868580|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
131868581|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
131868582|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
131868583|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
131868584|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
131868585|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
131868586|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
131868587|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
131868588|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
131868589|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
131868590|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
131868591|NCT00506415|474799004|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
131868592|NCT00506415|474799005|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
131868593|NCT00506415|474799006|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
131868594|NCT00506415|474799007|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
131868595|NCT04578457|474799008|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
131868596|NCT04578457|474799008|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
131868597|NCT04578457|474799008|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
131868598|NCT04578457|474799008|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
131868599|NCT01297517|474799019|FG000|Overall Study|Adverse Event|21|||
131868600|NCT01297517|474799020|FG001|Overall Study|Adverse Event|7|||
131868601|NCT01297517|474799021|FG002|Overall Study|Adverse Event|16|||
131868602|NCT01297517|474799019|FG000|Overall Study|Lost to Follow-up|1|||
131868603|NCT01297517|474799020|FG001|Overall Study|Lost to Follow-up|0|||
131868604|NCT01297517|474799021|FG002|Overall Study|Lost to Follow-up|1|||
131868605|NCT01297517|474799019|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
131868606|NCT01297517|474799020|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
131868607|NCT01297517|474799021|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
131868608|NCT01297517|474799019|FG000|Overall Study|Noncompliance|1|||
131868609|NCT01297517|474799020|FG001|Overall Study|Noncompliance|0|||
131868610|NCT01297517|474799021|FG002|Overall Study|Noncompliance|0|||
131868611|NCT01297517|474799019|FG000|Overall Study|Protocol Violation|1|||
131868612|NCT01297517|474799020|FG001|Overall Study|Protocol Violation|1|||
131868613|NCT01297517|474799021|FG002|Overall Study|Protocol Violation|1|||
131868614|NCT01297517|474799019|FG000|Overall Study|Inadequate Control of IOP|1|||
131868615|NCT01297517|474799020|FG001|Overall Study|Inadequate Control of IOP|1|||
131868616|NCT01297517|474799021|FG002|Overall Study|Inadequate Control of IOP|2|||
131868617|NCT00628212|474799024|FG000|Overall Study|Adverse Event|2|||
131868618|NCT00628212|474799025|FG001|Overall Study|Adverse Event|0|||
131868619|NCT00628212|474799026|FG002|Overall Study|Adverse Event|1|||
131868620|NCT00628212|474799027|FG003|Overall Study|Adverse Event|2|||
131408228|NCT01643850|473118238|FG004|Overall Study|Adverse Event|1|||
131868621|NCT00628212|474799024|FG000|Overall Study|Physician Decision|1|||
131868622|NCT00628212|474799025|FG001|Overall Study|Physician Decision|1|||
131868623|NCT00628212|474799026|FG002|Overall Study|Physician Decision|2|||
131868624|NCT00628212|474799027|FG003|Overall Study|Physician Decision|3|||
131868625|NCT00789373|474799028|FG000|Induction|Adverse Event|64|||
131868626|NCT00789373|474799029|FG001|Induction|Adverse Event|0|||
131408229|NCT01643850|473118239|FG005|Overall Study|Adverse Event|0|||
131917933|NCT04896385|474984100|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
131917934|NCT04896385|474984101|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
131917935|NCT04896385|474984102|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
131917936|NCT04896385|474984099|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
131917937|NCT04896385|474984100|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
131917938|NCT04896385|474984101|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
131917939|NCT04896385|474984102|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
131917940|NCT04896385|474984099|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
131408230|NCT01643850|473118240|FG006|Overall Study|Adverse Event|0|||
131868627|NCT00789373|474799030|FG002|Induction|Adverse Event|0|||
131868628|NCT00789373|474799028|FG000|Induction|Death Due to study disease|24|||
131868629|NCT00789373|474799029|FG001|Induction|Death Due to study disease|0|||
131868630|NCT00789373|474799030|FG002|Induction|Death Due to study disease|0|||
131868631|NCT00789373|474799028|FG000|Induction|Death due to adverse event|19|||
131868632|NCT00789373|474799029|FG001|Induction|Death due to adverse event|0|||
131868633|NCT00789373|474799030|FG002|Induction|Death due to adverse event|0|||
131868634|NCT00789373|474799028|FG000|Induction|Death due to toxicity|11|||
131868635|NCT00789373|474799029|FG001|Induction|Death due to toxicity|0|||
131868636|NCT00789373|474799030|FG002|Induction|Death due to toxicity|0|||
131868637|NCT00789373|474799028|FG000|Induction|Death due to procedure|1|||
131868638|NCT00789373|474799029|FG001|Induction|Death due to procedure|0|||
131868639|NCT00789373|474799030|FG002|Induction|Death due to procedure|0|||
131868640|NCT00789373|474799028|FG000|Induction|Investigator decision|7|||
131868641|NCT00789373|474799029|FG001|Induction|Investigator decision|0|||
131868642|NCT00789373|474799030|FG002|Induction|Investigator decision|0|||
131868643|NCT00789373|474799028|FG000|Induction|Protocol entry criteria not met|9|||
131868644|NCT00789373|474799029|FG001|Induction|Protocol entry criteria not met|0|||
131868645|NCT00789373|474799030|FG002|Induction|Protocol entry criteria not met|0|||
131868646|NCT00789373|474799028|FG000|Induction|Lost to Follow-up|6|||
131868647|NCT00789373|474799029|FG001|Induction|Lost to Follow-up|0|||
131868648|NCT00789373|474799030|FG002|Induction|Lost to Follow-up|0|||
131868649|NCT00789373|474799028|FG000|Induction|Protocol Violation|1|||
131868650|NCT00789373|474799029|FG001|Induction|Protocol Violation|0|||
131868651|NCT00789373|474799030|FG002|Induction|Protocol Violation|0|||
131868652|NCT00789373|474799028|FG000|Induction|Progressive Disease|220|||
131868653|NCT00789373|474799029|FG001|Induction|Progressive Disease|0|||
131868654|NCT00789373|474799030|FG002|Induction|Progressive Disease|0|||
131868655|NCT00789373|474799028|FG000|Induction|Withdrawal by Subject|37|||
131868656|NCT00789373|474799029|FG001|Induction|Withdrawal by Subject|0|||
131868657|NCT00789373|474799030|FG002|Induction|Withdrawal by Subject|0|||
131868658|NCT00789373|474799028|FG000|Maintenance|Adverse Event|0|||
131868659|NCT00789373|474799029|FG001|Maintenance|Adverse Event|65|||
131868660|NCT00789373|474799030|FG002|Maintenance|Adverse Event|12|||
131868661|NCT00789373|474799028|FG000|Maintenance|Death due to study disease|0|||
131868662|NCT00789373|474799029|FG001|Maintenance|Death due to study disease|3|||
131868663|NCT00789373|474799030|FG002|Maintenance|Death due to study disease|1|||
131868664|NCT00789373|474799028|FG000|Maintenance|Death due to adverse event|0|||
131868665|NCT00789373|474799029|FG001|Maintenance|Death due to adverse event|4|||
131868666|NCT00789373|474799030|FG002|Maintenance|Death due to adverse event|1|||
131868667|NCT00789373|474799028|FG000|Maintenance|Death due to toxicity|0|||
131868668|NCT00789373|474799029|FG001|Maintenance|Death due to toxicity|1|||
131868669|NCT00789373|474799030|FG002|Maintenance|Death due to toxicity|2|||
131868670|NCT00789373|474799028|FG000|Maintenance|Investigator Decision|0|||
131868671|NCT00789373|474799029|FG001|Maintenance|Investigator Decision|4|||
131868672|NCT00789373|474799030|FG002|Maintenance|Investigator Decision|2|||
131868673|NCT00789373|474799028|FG000|Maintenance|Protocol entry criteria not met|0|||
131868674|NCT00789373|474799029|FG001|Maintenance|Protocol entry criteria not met|2|||
131868675|NCT00789373|474799030|FG002|Maintenance|Protocol entry criteria not met|0|||
131868676|NCT00789373|474799028|FG000|Maintenance|Lost to Follow-up|0|||
131868677|NCT00789373|474799029|FG001|Maintenance|Lost to Follow-up|2|||
131868678|NCT00789373|474799030|FG002|Maintenance|Lost to Follow-up|0|||
131868679|NCT00789373|474799028|FG000|Maintenance|Progressive Disease|0|||
131868680|NCT00789373|474799029|FG001|Maintenance|Progressive Disease|253|||
131868681|NCT00789373|474799030|FG002|Maintenance|Progressive Disease|152|||
131868682|NCT00789373|474799028|FG000|Maintenance|Withdrawal by Subject|0|||
131868683|NCT00789373|474799029|FG001|Maintenance|Withdrawal by Subject|21|||
131868684|NCT00789373|474799030|FG002|Maintenance|Withdrawal by Subject|8|||
131868685|NCT00789373|474799028|FG000|Maintenance|Sponsor Decision|0|||
131868686|NCT00789373|474799029|FG001|Maintenance|Sponsor Decision|0|||
131868687|NCT00789373|474799030|FG002|Maintenance|Sponsor Decision|2|||
131868688|NCT00789373|474799028|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
131868689|NCT00789373|474799029|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
131868690|NCT00789373|474799030|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
131868691|NCT00546377|474799031|FG000|Overall Study|Deemed ineligible|1|||
131868692|NCT00546377|474799031|FG000|Overall Study|Adverse Event|6|||
131868693|NCT03321968|474799032|FG000|Overall Study|Withdrawal by Subject|1|||
131868694|NCT03321968|474799033|FG001|Overall Study|Withdrawal by Subject|2|||
131917941|NCT04896385|474984100|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
131917942|NCT04896385|474984101|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
131917943|NCT04896385|474984102|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
131917944|NCT05291689|474984105|FG000|Overall Study|Adverse Event|3|||
131917945|NCT05291689|474984105|FG000|Overall Study|Lack of Efficacy|10|||
131917946|NCT05291689|474984105|FG000|Overall Study|Withdrawal by Subject|4|||
131917947|NCT01931098|474984106|FG000|Overall Study|Withdrawal by Subject|0|||
131917948|NCT01931098|474984107|FG001|Overall Study|Withdrawal by Subject|1|||
131917949|NCT01931098|474984106|FG000|Overall Study|Enrolled in different protocol|0|||
131917950|NCT01931098|474984107|FG001|Overall Study|Enrolled in different protocol|1|||
131917951|NCT01931098|474984106|FG000|Overall Study|Unable to begin trmt:active infection|0|||
131917952|NCT01931098|474984107|FG001|Overall Study|Unable to begin trmt:active infection|1|||
131917953|NCT01931098|474984106|FG000|Overall Study|Refused further treatment|0|||
131917954|NCT01931098|474984107|FG001|Overall Study|Refused further treatment|1|||
131917955|NCT02278354|474984108|FG000|Overall Study|Lost to Follow-up|2|||
131917956|NCT02278354|474984109|FG001|Overall Study|Lost to Follow-up|2|||
131917957|NCT02278354|474984108|FG000|Overall Study|Withdrawal by Subject|0|||
131917958|NCT02278354|474984109|FG001|Overall Study|Withdrawal by Subject|1|||
131917959|NCT02278354|474984108|FG000|Overall Study|<10 professional fights|2|||
131917960|NCT02278354|474984109|FG001|Overall Study|<10 professional fights|0|||
131917961|NCT02612155|474984111|FG000|Overall Study|Death|1|||
131917962|NCT02612155|474984112|FG001|Overall Study|Death|1|||
131917963|NCT02612155|474984111|FG000|Overall Study|Lost to Follow-up|2|||
131917964|NCT02612155|474984112|FG001|Overall Study|Lost to Follow-up|2|||
131917965|NCT02572167|474984115|FG000|Overall Study|Withdrawal by Subject|0|||
131917966|NCT02572167|474984116|FG001|Overall Study|Withdrawal by Subject|3|||
131917967|NCT02572167|474984117|FG002|Overall Study|Withdrawal by Subject|0|||
131917968|NCT02572167|474984115|FG000|Overall Study|Lost to Follow-up|2|||
131917969|NCT02572167|474984116|FG001|Overall Study|Lost to Follow-up|5|||
131917970|NCT02572167|474984117|FG002|Overall Study|Lost to Follow-up|3|||
131917971|NCT02572167|474984115|FG000|Overall Study|Death|0|||
131917972|NCT02572167|474984116|FG001|Overall Study|Death|8|||
131917973|NCT02572167|474984117|FG002|Overall Study|Death|3|||
131917974|NCT02572167|474984115|FG000|Overall Study|Did not meet inclusion criteria|0|||
131917975|NCT02572167|474984116|FG001|Overall Study|Did not meet inclusion criteria|0|||
131917976|NCT02572167|474984117|FG002|Overall Study|Did not meet inclusion criteria|1|||
131917977|NCT02572167|474984115|FG000|Overall Study|Study closure by Sponsor|4|||
131917978|NCT02572167|474984116|FG001|Overall Study|Study closure by Sponsor|40|||
131917979|NCT02572167|474984117|FG002|Overall Study|Study closure by Sponsor|24|||
131917980|NCT00569127|474984118|FG000|Overall Study|Adverse Event|57|||
131917981|NCT00569127|474984119|FG001|Overall Study|Adverse Event|47|||
131917982|NCT00569127|474984118|FG000|Overall Study|Withdrawal by Subject|13|||
131917983|NCT00569127|474984119|FG001|Overall Study|Withdrawal by Subject|27|||
131917984|NCT00569127|474984118|FG000|Overall Study|Progression|99|||
131917985|NCT00569127|474984119|FG001|Overall Study|Progression|100|||
131917986|NCT00569127|474984118|FG000|Overall Study|Death|4|||
131917987|NCT00569127|474984119|FG001|Overall Study|Death|3|||
131917988|NCT00569127|474984118|FG000|Overall Study|Other|20|||
131917989|NCT00569127|474984119|FG001|Overall Study|Other|19|||
131917990|NCT00569127|474984118|FG000|Overall Study|Lost to Follow-up|0|||
131917991|NCT00569127|474984119|FG001|Overall Study|Lost to Follow-up|3|||
131917992|NCT00569127|474984118|FG000|Overall Study|Not Eligible|14|||
131917993|NCT00569127|474984119|FG001|Overall Study|Not Eligible|11|||
131917994|NCT00569127|474984118|FG000|Overall Study|Still on Treatment|7|||
131917995|NCT00569127|474984119|FG001|Overall Study|Still on Treatment|3|||
131917996|NCT03036254|474984122|FG000|Overall Study|Adverse Event|6|||
131917997|NCT03036254|474984123|FG001|Overall Study|Adverse Event|4|||
131917998|NCT03036254|474984122|FG000|Overall Study|Death|3|||
131917999|NCT03036254|474984123|FG001|Overall Study|Death|1|||
131918000|NCT03036254|474984122|FG000|Overall Study|Lack of Efficacy|5|||
131918001|NCT03036254|474984123|FG001|Overall Study|Lack of Efficacy|1|||
131918002|NCT03036254|474984122|FG000|Overall Study|Withdrawal by Subject|3|||
131918003|NCT03036254|474984123|FG001|Overall Study|Withdrawal by Subject|5|||
131918004|NCT06354257|474984124|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131918005|NCT06354257|474984124|FG000|Treatment Period 2|Adverse Event|1|||
131918006|NCT03168672|474984125|FG000|Overall Study|Withdrawal by Subject|13|||
131918007|NCT03168672|474984125|FG000|Overall Study|Death|3|||
131918008|NCT03168672|474984125|FG000|Overall Study|Investigator's Decision|137|||
131918009|NCT03168672|474984125|FG000|Overall Study|Adverse Event|1|||
131918010|NCT03168672|474984125|FG000|Overall Study|Other|2|||
131918011|NCT03168672|474984125|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
131918012|NCT00433537|474984131|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
131918013|NCT00433537|474984132|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
131918014|NCT00433537|474984133|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
131918015|NCT00433537|474984131|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
131918016|NCT00433537|474984132|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
131918017|NCT00433537|474984133|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
131918018|NCT00433537|474984131|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
131918019|NCT00433537|474984132|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
131918020|NCT00433537|474984133|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
131918021|NCT00433537|474984131|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
131918022|NCT00433537|474984132|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
131918023|NCT00433537|474984133|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
131918024|NCT00433537|474984131|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
131918025|NCT00433537|474984132|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
131918026|NCT00433537|474984133|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
131918027|NCT00433537|474984131|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
131918028|NCT00433537|474984132|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
131918029|NCT00433537|474984133|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
131918030|NCT00433537|474984131|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
131918031|NCT00433537|474984132|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
131918032|NCT00433537|474984133|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
131918033|NCT00433537|474984131|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
131918034|NCT00433537|474984132|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
131918035|NCT00433537|474984133|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
131918036|NCT00433537|474984131|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
131918037|NCT00433537|474984132|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
131918038|NCT00433537|474984133|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
131918039|NCT01757847|474984134|FG000|Overall Study|Withdrawal by Subject|3|||
131918040|NCT01757847|474984135|FG001|Overall Study|Withdrawal by Subject|4|||
131918041|NCT00831844|474984141|FG000|Overall Study|Adverse Event|2|||
131918042|NCT00831844|474984142|FG001|Overall Study|Adverse Event|0|||
131918043|NCT00831844|474984143|FG002|Overall Study|Adverse Event|0|||
131918044|NCT00831844|474984144|FG003|Overall Study|Adverse Event|0|||
131918045|NCT00831844|474984145|FG004|Overall Study|Adverse Event|1|||
131918046|NCT00831844|474984146|FG005|Overall Study|Adverse Event|1|||
131918047|NCT00831844|474984147|FG006|Overall Study|Adverse Event|2|||
131918048|NCT00831844|474984148|FG007|Overall Study|Adverse Event|0|||
131918049|NCT00831844|474984149|FG008|Overall Study|Adverse Event|0|||
131918050|NCT00831844|474984150|FG009|Overall Study|Adverse Event|0|||
131918051|NCT00831844|474984141|FG000|Overall Study|Death|0|||
131918052|NCT00831844|474984142|FG001|Overall Study|Death|0|||
131918053|NCT00831844|474984143|FG002|Overall Study|Death|0|||
131918054|NCT00831844|474984144|FG003|Overall Study|Death|1|||
131918055|NCT00831844|474984145|FG004|Overall Study|Death|0|||
131918056|NCT00831844|474984146|FG005|Overall Study|Death|0|||
131918057|NCT00831844|474984147|FG006|Overall Study|Death|0|||
131918058|NCT00831844|474984148|FG007|Overall Study|Death|0|||
131918059|NCT00831844|474984149|FG008|Overall Study|Death|0|||
131918060|NCT00831844|474984150|FG009|Overall Study|Death|0|||
131918061|NCT00831844|474984141|FG000|Overall Study|Lack of Efficacy|8|||
131918062|NCT00831844|474984142|FG001|Overall Study|Lack of Efficacy|10|||
131918063|NCT00831844|474984143|FG002|Overall Study|Lack of Efficacy|15|||
131918064|NCT00831844|474984144|FG003|Overall Study|Lack of Efficacy|8|||
131918065|NCT00831844|474984145|FG004|Overall Study|Lack of Efficacy|11|||
131918066|NCT00831844|474984146|FG005|Overall Study|Lack of Efficacy|17|||
131918067|NCT00831844|474984147|FG006|Overall Study|Lack of Efficacy|8|||
131918068|NCT00831844|474984148|FG007|Overall Study|Lack of Efficacy|9|||
131918069|NCT00831844|474984149|FG008|Overall Study|Lack of Efficacy|7|||
131918070|NCT00831844|474984150|FG009|Overall Study|Lack of Efficacy|0|||
131918071|NCT00831844|474984141|FG000|Overall Study|Physician Decision|0|||
131918072|NCT00831844|474984142|FG001|Overall Study|Physician Decision|1|||
131918073|NCT00831844|474984143|FG002|Overall Study|Physician Decision|3|||
131918074|NCT00831844|474984144|FG003|Overall Study|Physician Decision|1|||
131918075|NCT00831844|474984145|FG004|Overall Study|Physician Decision|1|||
131918076|NCT00831844|474984146|FG005|Overall Study|Physician Decision|1|||
131918077|NCT00831844|474984147|FG006|Overall Study|Physician Decision|0|||
131918078|NCT00831844|474984148|FG007|Overall Study|Physician Decision|0|||
131918079|NCT00831844|474984149|FG008|Overall Study|Physician Decision|1|||
131918080|NCT00831844|474984150|FG009|Overall Study|Physician Decision|0|||
131918081|NCT00831844|474984141|FG000|Overall Study|Withdrawal by Subject|0|||
131918082|NCT00831844|474984142|FG001|Overall Study|Withdrawal by Subject|0|||
131918083|NCT00831844|474984143|FG002|Overall Study|Withdrawal by Subject|1|||
131918084|NCT00831844|474984144|FG003|Overall Study|Withdrawal by Subject|0|||
131918085|NCT00831844|474984145|FG004|Overall Study|Withdrawal by Subject|0|||
131918086|NCT00831844|474984146|FG005|Overall Study|Withdrawal by Subject|0|||
131918087|NCT00831844|474984147|FG006|Overall Study|Withdrawal by Subject|0|||
131918088|NCT00831844|474984148|FG007|Overall Study|Withdrawal by Subject|1|||
131918089|NCT00831844|474984149|FG008|Overall Study|Withdrawal by Subject|1|||
131918090|NCT00831844|474984150|FG009|Overall Study|Withdrawal by Subject|0|||
131918091|NCT00831844|474984141|FG000|Overall Study|Ineligible|0|||
131918092|NCT00831844|474984142|FG001|Overall Study|Ineligible|1|||
131918093|NCT00831844|474984143|FG002|Overall Study|Ineligible|1|||
131918094|NCT00831844|474984144|FG003|Overall Study|Ineligible|0|||
131868695|NCT03321968|474799034|FG002|Overall Study|Withdrawal by Subject|1|||
131868696|NCT03321968|474799032|FG000|Overall Study|Lost to Follow-up|2|||
131868697|NCT03321968|474799033|FG001|Overall Study|Lost to Follow-up|0|||
131868698|NCT03321968|474799034|FG002|Overall Study|Lost to Follow-up|1|||
131868699|NCT03321968|474799032|FG000|Overall Study|Other than specified|0|||
131868700|NCT03321968|474799033|FG001|Overall Study|Other than specified|0|||
131868701|NCT03321968|474799034|FG002|Overall Study|Other than specified|1|||
131868702|NCT00463047|474799039|FG000|Titration Period 1|Adverse Event|10|||
131868703|NCT00463047|474799040|FG001|Titration Period 1|Adverse Event|8|||
131868704|NCT00463047|474799039|FG000|Titration Period 1|Lack of Efficacy|10|||
131868705|NCT00463047|474799040|FG001|Titration Period 1|Lack of Efficacy|4|||
131868706|NCT00463047|474799039|FG000|Titration Period 1|Lost to Follow-up|2|||
131868707|NCT00463047|474799040|FG001|Titration Period 1|Lost to Follow-up|0|||
131868708|NCT00463047|474799039|FG000|Titration Period 1|Non-compliance with study medication|3|||
131868709|NCT00463047|474799040|FG001|Titration Period 1|Non-compliance with study medication|5|||
131868710|NCT00463047|474799039|FG000|Titration Period 1|Protocol Violation|5|||
131868711|NCT00463047|474799040|FG001|Titration Period 1|Protocol Violation|5|||
131868712|NCT00463047|474799039|FG000|Titration Period 1|Withdrawal by Subject|3|||
131868713|NCT00463047|474799040|FG001|Titration Period 1|Withdrawal by Subject|5|||
131868714|NCT00463047|474799039|FG000|Titration Period 1|Non-compliance procedures|4|||
131868715|NCT00463047|474799040|FG001|Titration Period 1|Non-compliance procedures|10|||
131868716|NCT00463047|474799039|FG000|Titration Period 1|Other|0|||
131868717|NCT00463047|474799040|FG001|Titration Period 1|Other|2|||
131868718|NCT00463047|474799039|FG000|Titration Period 2|Adverse Event|9|||
131868719|NCT00463047|474799040|FG001|Titration Period 2|Adverse Event|9|||
131868720|NCT00463047|474799039|FG000|Titration Period 2|Lack of Efficacy|6|||
131868721|NCT00463047|474799040|FG001|Titration Period 2|Lack of Efficacy|4|||
131868722|NCT00463047|474799039|FG000|Titration Period 2|Withdrawal by Subject|1|||
131868723|NCT00463047|474799040|FG001|Titration Period 2|Withdrawal by Subject|0|||
131868724|NCT00463047|474799039|FG000|Titration Period 2|Protocol Violation|2|||
131868725|NCT00463047|474799040|FG001|Titration Period 2|Protocol Violation|3|||
131868726|NCT00463047|474799039|FG000|Titration Period 2|Lost to Follow-up|1|||
131868727|NCT00463047|474799040|FG001|Titration Period 2|Lost to Follow-up|2|||
131868728|NCT00463047|474799039|FG000|Titration Period 2|Non-compliance study medication|4|||
131868729|NCT00463047|474799040|FG001|Titration Period 2|Non-compliance study medication|2|||
131868730|NCT00463047|474799039|FG000|Titration Period 2|Non-compliance procedures|4|||
131868731|NCT00463047|474799040|FG001|Titration Period 2|Non-compliance procedures|1|||
131868732|NCT00463047|474799039|FG000|Titration Period 2|Other|3|||
131868733|NCT00463047|474799040|FG001|Titration Period 2|Other|2|||
131868734|NCT00463047|474799039|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
131868735|NCT00463047|474799040|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
131868736|NCT00463047|474799039|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
131868737|NCT00463047|474799040|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
131868738|NCT00463047|474799039|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
131868739|NCT00463047|474799040|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
131868740|NCT00463047|474799039|FG000|Double-Blind Treatment Period 1|Other|1|||
131868741|NCT00463047|474799040|FG001|Double-Blind Treatment Period 1|Other|0|||
131868742|NCT00463047|474799039|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
131868743|NCT00463047|474799040|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
131868744|NCT00463047|474799039|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
131868745|NCT00463047|474799040|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
131868746|NCT00463047|474799039|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
131868747|NCT00463047|474799040|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
131868748|NCT03020992|474799044|FG000|Overall Study|Adverse Event|5|||
131868749|NCT03020992|474799044|FG000|Overall Study|Withdrawal by Subject|1|||
131868750|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
131868751|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
131868752|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
131868753|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
131868754|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Pregnancy|0|||
131868755|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Pregnancy|1|||
131868756|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
131868757|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
131868758|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
131868759|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
131868760|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
131868761|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
131868762|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Other|3|||
131868763|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Other|0|||
131868764|NCT01006122|474799047|FG000|First Double-blind Intervention Period|Adverse Event|0|||
131868765|NCT01006122|474799048|FG001|First Double-blind Intervention Period|Adverse Event|4|||
131868766|NCT01006122|474799047|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
131868767|NCT01006122|474799048|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
131868768|NCT01006122|474799047|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
131868769|NCT01006122|474799048|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
131868770|NCT01006122|474799047|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131868771|NCT01006122|474799048|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
131868772|NCT01006122|474799047|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131868773|NCT01006122|474799048|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
131868774|NCT01006122|474799047|FG000|Second Double-blind Intervention Period|Death|0|||
131868775|NCT01006122|474799048|FG001|Second Double-blind Intervention Period|Death|1|||
131868776|NCT00952068|474799053|FG000|Overall Study|Adverse Event|3|||
131868777|NCT00952068|474799053|FG000|Overall Study|Withdrawal by Subject|4|||
131868778|NCT05870371|474799054|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
131868779|NCT05870371|474799055|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
131868780|NCT02062450|474799059|FG000|Overall Study|No follow-up visit|124|||
131868781|NCT04495751|474799062|FG000|Overall Study|Withdrawal by Subject|1|||
131868782|NCT04495751|474799063|FG001|Overall Study|Withdrawal by Subject|0|||
131868783|NCT04495751|474799062|FG000|Overall Study|Lost to Follow-up|1|||
131868784|NCT04495751|474799063|FG001|Overall Study|Lost to Follow-up|0|||
131868785|NCT03289754|474799064|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
131868786|NCT04873934|474799065|FG000|Overall Study|Adverse Event|0|||
131868787|NCT04873934|474799066|FG001|Overall Study|Adverse Event|1|||
131868788|NCT04873934|474799065|FG000|Overall Study|Death|0|||
131868789|NCT04873934|474799066|FG001|Overall Study|Death|2|||
131868790|NCT04873934|474799065|FG000|Overall Study|Lost to Follow-up|13|||
131868791|NCT04873934|474799066|FG001|Overall Study|Lost to Follow-up|9|||
131868792|NCT04873934|474799065|FG000|Overall Study|Physician Decision|1|||
131868793|NCT04873934|474799066|FG001|Overall Study|Physician Decision|1|||
131868794|NCT04873934|474799065|FG000|Overall Study|Protocol deviation|2|||
131868795|NCT04873934|474799066|FG001|Overall Study|Protocol deviation|1|||
131868796|NCT04873934|474799065|FG000|Overall Study|Subject decision|1|||
131868797|NCT04873934|474799066|FG001|Overall Study|Subject decision|8|||
131868798|NCT04873934|474799065|FG000|Overall Study|Withdrew consent|0|||
131868799|NCT04873934|474799066|FG001|Overall Study|Withdrew consent|4|||
131868800|NCT04873934|474799065|FG000|Overall Study|Missing|1|||
131868801|NCT04873934|474799066|FG001|Overall Study|Missing|0|||
131868802|NCT04926831|474799068|FG000|Overall Study|Withdrawal by Subject|2|||
131868803|NCT04926831|474799068|FG000|Overall Study|Adverse Event|2|||
131868804|NCT02907177|474799069|FG000|Overall Study|Death|0|||
131868805|NCT02907177|474799070|FG001|Overall Study|Death|1|||
131868806|NCT02907177|474799069|FG000|Overall Study|Physician Decision|3|||
131868807|NCT02907177|474799070|FG001|Overall Study|Physician Decision|3|||
131868808|NCT02907177|474799069|FG000|Overall Study|Withdrawal by Subject|15|||
131868809|NCT02907177|474799070|FG001|Overall Study|Withdrawal by Subject|7|||
131868810|NCT02907177|474799069|FG000|Overall Study|Sponsor's Decision|50|||
131868811|NCT02907177|474799070|FG001|Overall Study|Sponsor's Decision|57|||
131868812|NCT04745689|474799071|FG000|Overall Study|Death|9|||
131868813|NCT04745689|474799072|FG001|Overall Study|Death|6|||
131868814|NCT04745689|474799071|FG000|Overall Study|Lost to Follow-up|1|||
131868815|NCT04745689|474799072|FG001|Overall Study|Lost to Follow-up|0|||
131868816|NCT04745689|474799071|FG000|Overall Study|Withdrawal by Subject|2|||
131868817|NCT04745689|474799072|FG001|Overall Study|Withdrawal by Subject|0|||
131868818|NCT04745689|474799071|FG000|Overall Study|Study terminated by sponsor|10|||
131868819|NCT04745689|474799072|FG001|Overall Study|Study terminated by sponsor|3|||
131868820|NCT04639219|474799073|FG000|Overall Study|Withdrawal by Subject|8|||
131868821|NCT04639219|474799073|FG000|Overall Study|Lost to Follow-up|6|||
131868822|NCT04639219|474799073|FG000|Overall Study|Death|55|||
131868823|NCT01537042|474799074|FG000|Overall Study|Adverse Event|0|||
131868824|NCT01537042|474799075|FG001|Overall Study|Adverse Event|2|||
131868825|NCT01537042|474799074|FG000|Overall Study|Lack of Efficacy|0|||
131868826|NCT01537042|474799075|FG001|Overall Study|Lack of Efficacy|1|||
131868827|NCT01537042|474799074|FG000|Overall Study|Protocol Violation|0|||
131868828|NCT01537042|474799075|FG001|Overall Study|Protocol Violation|1|||
131868829|NCT01537042|474799074|FG000|Overall Study|Other|0|||
131868830|NCT01537042|474799075|FG001|Overall Study|Other|1|||
131868831|NCT00669669|474799076|FG000|Overall Study|To late to start treatment|1|||
131868832|NCT03867201|474799077|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
131868833|NCT03867201|474799078|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
131868834|NCT03867201|474799077|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
131868835|NCT03867201|474799078|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
131868836|NCT03867201|474799077|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
131868837|NCT03867201|474799078|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
131868838|NCT03867201|474799077|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
131868839|NCT03867201|474799078|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
131868840|NCT03867201|474799077|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
131868841|NCT03867201|474799078|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
131918095|NCT00831844|474984145|FG004|Overall Study|Ineligible|1|||
131918096|NCT00831844|474984146|FG005|Overall Study|Ineligible|0|||
131918097|NCT00831844|474984147|FG006|Overall Study|Ineligible|0|||
131918098|NCT00831844|474984148|FG007|Overall Study|Ineligible|0|||
131918099|NCT00831844|474984149|FG008|Overall Study|Ineligible|0|||
131918100|NCT00831844|474984150|FG009|Overall Study|Ineligible|0|||
131918101|NCT05317546|474984151|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
131918102|NCT05317546|474984152|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
131918103|NCT03331250|474984153|FG000|Overall Study|Withdrawal by Subject|1|||
131918104|NCT04057365|474984154|FG000|Overall Study|Withdrawal by Subject|2|||
131918105|NCT04057365|474984155|FG001|Overall Study|Withdrawal by Subject|0|||
131918106|NCT01063114|474984156|FG000|Overall Study|Lost to Follow-up|1|||
131918107|NCT05556057|474984157|FG000|Overall Study|Lost to Follow-up|5|||
131918108|NCT05556057|474984158|FG001|Overall Study|Lost to Follow-up|4|||
131918109|NCT05556057|474984157|FG000|Overall Study|Withdrawal by Subject|0|||
131918110|NCT05556057|474984158|FG001|Overall Study|Withdrawal by Subject|2|||
131918111|NCT03488524|474984178|FG000|Overall Study|Withdrawal by Subject|51|||
131918112|NCT03488524|474984178|FG000|Overall Study|Death|19|||
131918113|NCT03488524|474984178|FG000|Overall Study|Study Sponsor|11|||
131918114|NCT03488524|474984178|FG000|Overall Study|Physician Decision|4|||
131918115|NCT03488524|474984178|FG000|Overall Study|Lost to Follow-up|3|||
131918116|NCT02390284|474984179|FG000|Overall Study|Physician Decision|0|||
131918117|NCT02390284|474984180|FG001|Overall Study|Physician Decision|0|||
131918118|NCT02390284|474984181|FG002|Overall Study|Physician Decision|9|||
131918119|NCT03980223|474984182|FG000|Overall Study|Lost to Follow-up|3|||
131918120|NCT03980223|474984183|FG001|Overall Study|Lost to Follow-up|7|||
131918121|NCT03980223|474984184|FG002|Overall Study|Lost to Follow-up|10|||
131918122|NCT03980223|474984185|FG003|Overall Study|Lost to Follow-up|8|||
131918123|NCT03980223|474984182|FG000|Overall Study|Withdrawal by Subject|0|||
131918124|NCT03980223|474984183|FG001|Overall Study|Withdrawal by Subject|0|||
131918125|NCT03980223|474984184|FG002|Overall Study|Withdrawal by Subject|1|||
131918126|NCT03980223|474984185|FG003|Overall Study|Withdrawal by Subject|2|||
131918127|NCT03980223|474984182|FG000|Overall Study|Physician Decision|0|||
131918128|NCT03980223|474984183|FG001|Overall Study|Physician Decision|0|||
131918129|NCT03980223|474984184|FG002|Overall Study|Physician Decision|1|||
131918130|NCT03980223|474984185|FG003|Overall Study|Physician Decision|0|||
131918131|NCT03980223|474984182|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
131918132|NCT03980223|474984183|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
131918133|NCT03980223|474984184|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
131918134|NCT03980223|474984185|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
131918135|NCT06239610|474984186|FG000|Overall Study|no usable migration data for minimum of one day|11|||
131918136|NCT01922934|474984190|FG000|Eligible Patients|Death|0|||
131918137|NCT01922934|474984191|FG001|Eligible Patients|Death|7|||
131918138|NCT01922934|474984190|FG000|Eligible Patients|Physician Decision|17|||
131918139|NCT01922934|474984191|FG001|Eligible Patients|Physician Decision|0|||
131918140|NCT01922934|474984190|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
131918141|NCT01922934|474984191|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
131918142|NCT01922934|474984190|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
131918143|NCT01922934|474984191|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
131918144|NCT01922934|474984190|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
131918145|NCT01922934|474984191|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
131918146|NCT01922934|474984190|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
131918147|NCT01922934|474984191|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
131918148|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
131918149|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
131918150|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
131918151|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
131918152|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
131918153|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
131918154|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
131918155|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
131918156|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
131918157|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
131918158|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
131918159|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
131918160|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
131918161|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
131918162|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
131918163|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
131408231|NCT01643850|473118241|FG007|Overall Study|Adverse Event|0|||
131408232|NCT01643850|473118242|FG008|Overall Study|Adverse Event|0|||
131868842|NCT03867201|474799077|FG000|Open-Label Period From Week 12|Adverse Event|5|||
131868843|NCT03867201|474799078|FG001|Open-Label Period From Week 12|Adverse Event|11|||
131868844|NCT03867201|474799077|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
131868845|NCT03867201|474799078|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
131868846|NCT03867201|474799077|FG000|Open-Label Period From Week 12|Physician Decision|6|||
131868847|NCT03867201|474799078|FG001|Open-Label Period From Week 12|Physician Decision|3|||
131868848|NCT03867201|474799077|FG000|Open-Label Period From Week 12|Pregnancy|2|||
131868849|NCT03867201|474799078|FG001|Open-Label Period From Week 12|Pregnancy|2|||
131868850|NCT03867201|474799077|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
131868851|NCT03867201|474799078|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
131868852|NCT03867201|474799077|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
131868853|NCT03867201|474799078|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
131868854|NCT03867201|474799077|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
131868855|NCT03867201|474799078|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
131868856|NCT03867201|474799077|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
131868857|NCT03867201|474799078|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
131868858|NCT05763875|474799081|FG000|Overall Study|Subject decision|5|||
131868859|NCT05763875|474799082|FG001|Overall Study|Subject decision|2|||
131868860|NCT05763875|474799083|FG002|Overall Study|Subject decision|1|||
131868861|NCT05763875|474799081|FG000|Overall Study|Lost to Follow-up|4|||
131868862|NCT05763875|474799082|FG001|Overall Study|Lost to Follow-up|1|||
131868863|NCT05763875|474799083|FG002|Overall Study|Lost to Follow-up|2|||
131868864|NCT05763875|474799081|FG000|Overall Study|Adverse Event|1|||
131868865|NCT05763875|474799082|FG001|Overall Study|Adverse Event|0|||
131868866|NCT05763875|474799083|FG002|Overall Study|Adverse Event|0|||
131868867|NCT04015518|474799084|FG000|Overall Study|Adverse Event|6|||
131868868|NCT04015518|474799085|FG001|Overall Study|Adverse Event|1|||
131868869|NCT04015518|474799086|FG002|Overall Study|Adverse Event|1|||
131868870|NCT04015518|474799087|FG003|Overall Study|Adverse Event|3|||
131868871|NCT04015518|474799088|FG004|Overall Study|Adverse Event|3|||
131868872|NCT04015518|474799084|FG000|Overall Study|Lack of Efficacy|1|||
131868873|NCT04015518|474799085|FG001|Overall Study|Lack of Efficacy|0|||
131868874|NCT04015518|474799086|FG002|Overall Study|Lack of Efficacy|1|||
131868875|NCT04015518|474799087|FG003|Overall Study|Lack of Efficacy|0|||
131868876|NCT04015518|474799088|FG004|Overall Study|Lack of Efficacy|4|||
131868877|NCT04015518|474799084|FG000|Overall Study|Lost to Follow-up|0|||
131868878|NCT04015518|474799085|FG001|Overall Study|Lost to Follow-up|0|||
131868879|NCT04015518|474799086|FG002|Overall Study|Lost to Follow-up|0|||
131868880|NCT04015518|474799087|FG003|Overall Study|Lost to Follow-up|0|||
131868881|NCT04015518|474799088|FG004|Overall Study|Lost to Follow-up|1|||
131868882|NCT04015518|474799084|FG000|Overall Study|Withdrawal by Subject|0|||
131868883|NCT04015518|474799085|FG001|Overall Study|Withdrawal by Subject|1|||
131868884|NCT04015518|474799086|FG002|Overall Study|Withdrawal by Subject|0|||
131868885|NCT04015518|474799087|FG003|Overall Study|Withdrawal by Subject|1|||
131868886|NCT04015518|474799088|FG004|Overall Study|Withdrawal by Subject|1|||
131868887|NCT04015518|474799084|FG000|Overall Study|Patient did not come for consecutive visits|0|||
131868888|NCT04015518|474799085|FG001|Overall Study|Patient did not come for consecutive visits|1|||
131868889|NCT04015518|474799086|FG002|Overall Study|Patient did not come for consecutive visits|0|||
131868890|NCT04015518|474799087|FG003|Overall Study|Patient did not come for consecutive visits|0|||
131868891|NCT04015518|474799088|FG004|Overall Study|Patient did not come for consecutive visits|0|||
131868892|NCT04015518|474799084|FG000|Overall Study|not willing to travel due to Covid-19|0|||
131868893|NCT04015518|474799085|FG001|Overall Study|not willing to travel due to Covid-19|0|||
131868894|NCT04015518|474799086|FG002|Overall Study|not willing to travel due to Covid-19|1|||
131868895|NCT04015518|474799087|FG003|Overall Study|not willing to travel due to Covid-19|0|||
131868896|NCT04015518|474799088|FG004|Overall Study|not willing to travel due to Covid-19|0|||
131868897|NCT04015518|474799084|FG000|Overall Study|Patient wants to discontinue treatment|0|||
131868898|NCT04015518|474799085|FG001|Overall Study|Patient wants to discontinue treatment|0|||
131868899|NCT04015518|474799086|FG002|Overall Study|Patient wants to discontinue treatment|0|||
131868900|NCT04015518|474799087|FG003|Overall Study|Patient wants to discontinue treatment|1|||
131868901|NCT04015518|474799088|FG004|Overall Study|Patient wants to discontinue treatment|0|||
131868902|NCT04015518|474799084|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
131868903|NCT04015518|474799085|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
131868904|NCT04015518|474799086|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
131868905|NCT04015518|474799087|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
131868906|NCT04015518|474799088|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
131868907|NCT04015518|474799084|FG000|Overall Study|Pregnancy|0|||
131408233|NCT01643850|473118234|FG000|Overall Study|Administrative Problems|0|||
131868908|NCT04015518|474799085|FG001|Overall Study|Pregnancy|0|||
131918164|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
131408234|NCT01643850|473118235|FG001|Overall Study|Administrative Problems|0|||
131918165|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
131918166|NCT01069939|474984196|FG000|Randomised and Included in the Analyses|Removal|1|||
131918167|NCT01069939|474984197|FG001|Randomised and Included in the Analyses|Removal|0|||
131918168|NCT05166876|474984198|FG000|Overall Study|Withdrawal by Subject|1|||
131918169|NCT05166876|474984199|FG001|Overall Study|Withdrawal by Subject|0|||
131918170|NCT05166876|474984200|FG002|Overall Study|Withdrawal by Subject|0|||
131918171|NCT00658528|474984201|FG000|Overall Study|Adverse Event|5|||
131918172|NCT00658528|474984202|FG001|Overall Study|Adverse Event|7|||
131918173|NCT00658528|474984201|FG000|Overall Study|Lost to Follow-up|14|||
131918174|NCT00658528|474984202|FG001|Overall Study|Lost to Follow-up|22|||
131918175|NCT00658528|474984201|FG000|Overall Study|Withdrawal by Subject|8|||
131918176|NCT00658528|474984202|FG001|Overall Study|Withdrawal by Subject|6|||
131918177|NCT00658528|474984201|FG000|Overall Study|Withdrawal of consent|5|||
131918178|NCT00658528|474984202|FG001|Overall Study|Withdrawal of consent|6|||
131918179|NCT00658528|474984201|FG000|Overall Study|Other|8|||
131918180|NCT00658528|474984202|FG001|Overall Study|Other|4|||
131918181|NCT01937299|474984203|FG000|Overall Study|Adverse Event|13|||
131918182|NCT01937299|474984204|FG001|Overall Study|Adverse Event|0|||
131918183|NCT01937299|474984203|FG000|Overall Study|Lack of Efficacy|0|||
131918184|NCT01937299|474984204|FG001|Overall Study|Lack of Efficacy|4|||
131918185|NCT01937299|474984203|FG000|Overall Study|Withdrawal by Subject|1|||
131918186|NCT01937299|474984204|FG001|Overall Study|Withdrawal by Subject|0|||
131918187|NCT01706328|474984217|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
131918188|NCT01706328|474984218|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131918189|NCT01706328|474984219|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131918190|NCT01706328|474984217|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
131918191|NCT01706328|474984218|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131918192|NCT01706328|474984219|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131918193|NCT01706328|474984217|FG000|2-week Run-in Period|Physician Decision|4|||
131918194|NCT01706328|474984218|FG001|2-week Run-in Period|Physician Decision|0|||
131918195|NCT01706328|474984219|FG002|2-week Run-in Period|Physician Decision|0|||
131918196|NCT01706328|474984217|FG000|2-week Run-in Period|Adverse Event|4|||
131918197|NCT01706328|474984218|FG001|2-week Run-in Period|Adverse Event|0|||
131918198|NCT01706328|474984219|FG002|2-week Run-in Period|Adverse Event|0|||
131918199|NCT01706328|474984217|FG000|2-week Run-in Period|Lost to Follow-up|2|||
131918200|NCT01706328|474984218|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131918201|NCT01706328|474984219|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131918202|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
131918203|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
131918204|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
131918205|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
131918206|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
131868909|NCT04015518|474799086|FG002|Overall Study|Pregnancy|0|||
131868910|NCT04015518|474799087|FG003|Overall Study|Pregnancy|0|||
131868911|NCT04015518|474799088|FG004|Overall Study|Pregnancy|1|||
131868912|NCT04015518|474799084|FG000|Overall Study|Personal reasons|1|||
131868913|NCT04015518|474799085|FG001|Overall Study|Personal reasons|0|||
131868914|NCT04015518|474799086|FG002|Overall Study|Personal reasons|0|||
131868915|NCT04015518|474799087|FG003|Overall Study|Personal reasons|0|||
131868916|NCT04015518|474799088|FG004|Overall Study|Personal reasons|1|||
131868917|NCT04015518|474799084|FG000|Overall Study|Withdrew consent|1|||
131868918|NCT04015518|474799085|FG001|Overall Study|Withdrew consent|0|||
131868919|NCT04015518|474799086|FG002|Overall Study|Withdrew consent|0|||
131868920|NCT04015518|474799087|FG003|Overall Study|Withdrew consent|0|||
131868921|NCT04015518|474799088|FG004|Overall Study|Withdrew consent|0|||
131868922|NCT04015518|474799084|FG000|Overall Study|Prostate carcinoma|1|||
131868923|NCT04015518|474799085|FG001|Overall Study|Prostate carcinoma|0|||
131868924|NCT04015518|474799086|FG002|Overall Study|Prostate carcinoma|0|||
131868925|NCT04015518|474799087|FG003|Overall Study|Prostate carcinoma|0|||
131868926|NCT04015518|474799088|FG004|Overall Study|Prostate carcinoma|0|||
131868927|NCT04015518|474799084|FG000|Overall Study|Could not keep appointments due to work|1|||
131868928|NCT04015518|474799085|FG001|Overall Study|Could not keep appointments due to work|0|||
131868929|NCT04015518|474799086|FG002|Overall Study|Could not keep appointments due to work|0|||
131868930|NCT04015518|474799087|FG003|Overall Study|Could not keep appointments due to work|0|||
131918207|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
131918208|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
131918209|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
131918210|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
131918211|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
131868931|NCT04015518|474799088|FG004|Overall Study|Could not keep appointments due to work|0|||
131868932|NCT03213704|474799089|FG000|Overall Study|Physician Decision|3|||
131868933|NCT03213704|474799089|FG000|Overall Study|Protocol Violation|1|||
131868934|NCT03213704|474799089|FG000|Overall Study|Progressive disease|4|||
131868935|NCT03474965|474799091|FG000|Overall Study|Pregnancy|1|||
131868936|NCT03474965|474799092|FG001|Overall Study|Pregnancy|0|||
131868937|NCT03474965|474799093|FG002|Overall Study|Pregnancy|0|||
131868938|NCT03474965|474799094|FG003|Overall Study|Pregnancy|0|||
131868939|NCT03474965|474799091|FG000|Overall Study|Lost to Follow-up|0|||
131868940|NCT03474965|474799092|FG001|Overall Study|Lost to Follow-up|0|||
131868941|NCT03474965|474799093|FG002|Overall Study|Lost to Follow-up|1|||
131868942|NCT03474965|474799094|FG003|Overall Study|Lost to Follow-up|0|||
131868943|NCT03474965|474799091|FG000|Overall Study|Death|1|||
131868944|NCT03474965|474799092|FG001|Overall Study|Death|0|||
131868945|NCT03474965|474799093|FG002|Overall Study|Death|0|||
131868946|NCT03474965|474799094|FG003|Overall Study|Death|0|||
131868947|NCT03474965|474799091|FG000|Overall Study|Adverse Event|1|||
131868948|NCT03474965|474799092|FG001|Overall Study|Adverse Event|0|||
131868949|NCT03474965|474799093|FG002|Overall Study|Adverse Event|0|||
131868950|NCT03474965|474799094|FG003|Overall Study|Adverse Event|1|||
131868951|NCT03474965|474799091|FG000|Overall Study|Physician Decision|3|||
131868952|NCT03474965|474799092|FG001|Overall Study|Physician Decision|1|||
131868953|NCT03474965|474799093|FG002|Overall Study|Physician Decision|2|||
131868954|NCT03474965|474799094|FG003|Overall Study|Physician Decision|0|||
131868955|NCT03474965|474799091|FG000|Overall Study|Participant Decision|7|||
131868956|NCT03474965|474799092|FG001|Overall Study|Participant Decision|0|||
131868957|NCT03474965|474799093|FG002|Overall Study|Participant Decision|1|||
131868958|NCT03474965|474799094|FG003|Overall Study|Participant Decision|0|||
131868959|NCT03474965|474799091|FG000|Overall Study|Guardian Decision|4|||
131868960|NCT03474965|474799092|FG001|Overall Study|Guardian Decision|2|||
131868961|NCT03474965|474799093|FG002|Overall Study|Guardian Decision|7|||
131868962|NCT03474965|474799094|FG003|Overall Study|Guardian Decision|2|||
131868963|NCT02151851|474800757|FG000|Overall Study|Lack of Efficacy|67|||
131868964|NCT02151851|474800758|FG001|Overall Study|Lack of Efficacy|94|||
131868965|NCT02151851|474800757|FG000|Overall Study|Protocol Violation|0|||
131868966|NCT02151851|474800758|FG001|Overall Study|Protocol Violation|1|||
131868967|NCT02151851|474800757|FG000|Overall Study|Withdrawal by Subject|2|||
131868968|NCT02151851|474800758|FG001|Overall Study|Withdrawal by Subject|5|||
131868969|NCT02151851|474800757|FG000|Overall Study|Medical impairment|1|||
131868970|NCT02151851|474800758|FG001|Overall Study|Medical impairment|0|||
131868971|NCT02151851|474800757|FG000|Overall Study|Low compliance to study visits|0|||
131868972|NCT02151851|474800758|FG001|Overall Study|Low compliance to study visits|1|||
131868973|NCT02151851|474800757|FG000|Overall Study|Subject entered into study in error|0|||
131868974|NCT02151851|474800758|FG001|Overall Study|Subject entered into study in error|1|||
131868975|NCT02151851|474800757|FG000|Overall Study|Adverse Event|6|||
131868976|NCT02151851|474800758|FG001|Overall Study|Adverse Event|28|||
131868977|NCT01540487|474800759|FG000|Overall Study|Protocol Violation|1|||
131868978|NCT01540487|474800760|FG001|Overall Study|Protocol Violation|0|||
131868979|NCT03503370|474800763|FG000|Overall Study|Death|3|||
131868980|NCT03503370|474800764|FG001|Overall Study|Death|1|||
131868981|NCT00298272|474800767|FG000|Double-blind Phase|Adverse Event|2|||
131868982|NCT00298272|474800768|FG001|Double-blind Phase|Adverse Event|0|||
131868983|NCT00298272|474800767|FG000|Double-blind Phase|Failure to Return|2|||
131868984|NCT00298272|474800768|FG001|Double-blind Phase|Failure to Return|0|||
131868985|NCT00298272|474800767|FG000|Double-blind Phase|Protocol Violation|2|||
131868986|NCT00298272|474800768|FG001|Double-blind Phase|Protocol Violation|0|||
131868987|NCT00298272|474800767|FG000|Double-blind Phase|Withdrawal by Subject|2|||
131868988|NCT00298272|474800768|FG001|Double-blind Phase|Withdrawal by Subject|0|||
131868989|NCT00298272|474800767|FG000|Open Label Retreatment Phase|Adverse Event|1|||
131868990|NCT00298272|474800768|FG001|Open Label Retreatment Phase|Adverse Event|2|||
131868991|NCT00298272|474800767|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
131868992|NCT00298272|474800768|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
131868993|NCT00298272|474800767|FG000|Open Label Retreatment Phase|Failure to Return|1|||
131868994|NCT00298272|474800768|FG001|Open Label Retreatment Phase|Failure to Return|0|||
131868995|NCT00298272|474800767|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
131868996|NCT00298272|474800768|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
131868997|NCT00298272|474800767|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
131868998|NCT00298272|474800768|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
131868999|NCT00298272|474800767|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
131869000|NCT00298272|474800768|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
131869001|NCT00298272|474800767|FG000|Safety Follow-up Phase|Failure to Return|1|||
131869002|NCT00298272|474800768|FG001|Safety Follow-up Phase|Failure to Return|1|||
131869003|NCT00298272|474800767|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
131869004|NCT00298272|474800768|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
131869005|NCT00298272|474800767|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
131869006|NCT00298272|474800768|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
131869007|NCT04168112|474800769|FG000|Overall Study|Lost to Follow-up|1|||
131869008|NCT04168112|474800770|FG001|Overall Study|Lost to Follow-up|0|||
131869009|NCT04168112|474800769|FG000|Overall Study|Withdrawal by Subject|1|||
131869010|NCT04168112|474800770|FG001|Overall Study|Withdrawal by Subject|0|||
131869011|NCT05253573|474800773|FG000|Overall Study|Death|1|||
131869012|NCT05253573|474800774|FG001|Overall Study|Death|0|||
131918212|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
131918213|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
131869013|NCT01436370|474800785|FG000|Overall Study|Lost to Follow-up|0|||
131869014|NCT01436370|474800786|FG001|Overall Study|Lost to Follow-up|0|||
131869015|NCT01436370|474800787|FG002|Overall Study|Lost to Follow-up|0|||
131869016|NCT01436370|474800788|FG003|Overall Study|Lost to Follow-up|0|||
131869017|NCT01436370|474800789|FG004|Overall Study|Lost to Follow-up|1|||
131869018|NCT01436370|474800790|FG005|Overall Study|Lost to Follow-up|0|||
131869019|NCT01436370|474800791|FG006|Overall Study|Lost to Follow-up|0|||
131869020|NCT01436370|474800792|FG007|Overall Study|Lost to Follow-up|0|||
131869021|NCT02395848|474800793|FG000|Overall Study|Lost to Follow-up|2|||
131869022|NCT02276560|474800794|FG000|Overall Study|Adverse Event|1|||
131869023|NCT02276560|474800795|FG001|Overall Study|Adverse Event|0|||
131869024|NCT02276560|474800796|FG002|Overall Study|Adverse Event|0|||
131869025|NCT01754129|474800797|FG000|Overall Study|Death|13|||
131869026|NCT01754129|474800797|FG000|Overall Study|Duodopa discontinuation|9|||
131869027|NCT01754129|474800797|FG000|Overall Study|Lost to Follow-up|7|||
131869028|NCT01754129|474800797|FG000|Overall Study|Withdrew consent|1|||
131869029|NCT01754129|474800797|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
131869030|NCT01780038|474800801|FG000|Overall Study|Lost to Follow-up|4|||
131869031|NCT01780038|474800802|FG001|Overall Study|Lost to Follow-up|1|||
131869032|NCT01085630|474800803|FG000|Overall Study|Insufficient data|1|||
131869033|NCT01085630|474800804|FG001|Overall Study|Insufficient data|0|||
131869034|NCT01085630|474800803|FG000|Overall Study|Ineligible|3|||
131869035|NCT01085630|474800804|FG001|Overall Study|Ineligible|0|||
131869042|NCT02877004|474800810|FG000|Overall Study|Pregnancy|0|||
131869043|NCT02877004|474800811|FG001|Overall Study|Pregnancy|0|||
131869044|NCT02877004|474800812|FG002|Overall Study|Pregnancy|1|||
131869045|NCT01017874|474800813|FG000|Overall Study|Withdrawal by Subject|23|||
131869046|NCT01017874|474800814|FG001|Overall Study|Withdrawal by Subject|20|||
131869047|NCT01017874|474800813|FG000|Overall Study|Sponsor decision|3|||
131869048|NCT01017874|474800814|FG001|Overall Study|Sponsor decision|1|||
131869049|NCT01017874|474800813|FG000|Overall Study|Lost to Follow-up|3|||
131869050|NCT01017874|474800814|FG001|Overall Study|Lost to Follow-up|2|||
131869051|NCT01017874|474800813|FG000|Overall Study|Physician Decision|1|||
131869052|NCT01017874|474800814|FG001|Overall Study|Physician Decision|3|||
131869053|NCT02356588|474800815|FG000|Overall Study|Lack of Efficacy|4|||
131869054|NCT02356588|474800816|FG001|Overall Study|Lack of Efficacy|10|||
131869055|NCT02356588|474800815|FG000|Overall Study|Adverse Event|0|||
131869056|NCT02356588|474800816|FG001|Overall Study|Adverse Event|2|||
131869057|NCT02356588|474800815|FG000|Overall Study|Withdrawal by Subject|1|||
131869058|NCT02356588|474800816|FG001|Overall Study|Withdrawal by Subject|0|||
131869059|NCT02356588|474800815|FG000|Overall Study|Protocol Violation|0|||
131869060|NCT02356588|474800816|FG001|Overall Study|Protocol Violation|1|||
131869061|NCT01346696|474800818|FG000|Overall Study|Death|1|||
131869062|NCT00507455|474800825|FG000|Overall Study|Adverse Event|3|||
131869063|NCT00507455|474800826|FG001|Overall Study|Adverse Event|3|||
131869064|NCT00507455|474800827|FG002|Overall Study|Adverse Event|6|||
131453912|NCT02858362|473291829|FG001|Overall Study|Protocol Violation|1|||
131869065|NCT00507455|474800825|FG000|Overall Study|Withdrawal by Subject|2|||
131869066|NCT00507455|474800826|FG001|Overall Study|Withdrawal by Subject|1|||
131869067|NCT00507455|474800827|FG002|Overall Study|Withdrawal by Subject|2|||
131869068|NCT00507455|474800825|FG000|Overall Study|Protocol Violation|4|||
131869069|NCT00507455|474800826|FG001|Overall Study|Protocol Violation|1|||
131869070|NCT00507455|474800827|FG002|Overall Study|Protocol Violation|1|||
131869071|NCT00507455|474800825|FG000|Overall Study|Lost to Follow-up|2|||
131869072|NCT00507455|474800826|FG001|Overall Study|Lost to Follow-up|0|||
131869073|NCT00507455|474800827|FG002|Overall Study|Lost to Follow-up|2|||
131869074|NCT00507455|474800825|FG000|Overall Study|Lack of Efficacy|0|||
131869075|NCT00507455|474800826|FG001|Overall Study|Lack of Efficacy|1|||
131869076|NCT00507455|474800827|FG002|Overall Study|Lack of Efficacy|0|||
131869077|NCT00507455|474800825|FG000|Overall Study|Other - miscellaneous reason|1|||
131869078|NCT00507455|474800826|FG001|Overall Study|Other - miscellaneous reason|0|||
131869079|NCT00507455|474800827|FG002|Overall Study|Other - miscellaneous reason|1|||
131869080|NCT03363776|474800834|FG000|Overall Study|Progressive disease|2|||
131869081|NCT03363776|474800835|FG001|Overall Study|Progressive disease|3|||
131869082|NCT03363776|474800836|FG002|Overall Study|Progressive disease|1|||
131869083|NCT03363776|474800834|FG000|Overall Study|Study drug toxicity|0|||
131869084|NCT03363776|474800835|FG001|Overall Study|Study drug toxicity|0|||
131869085|NCT03363776|474800836|FG002|Overall Study|Study drug toxicity|1|||
131869086|NCT03363776|474800834|FG000|Overall Study|Death|1|||
131869087|NCT03363776|474800835|FG001|Overall Study|Death|0|||
131453913|NCT02858362|473291830|FG002|Overall Study|Protocol Violation|0|||
131869088|NCT03363776|474800836|FG002|Overall Study|Death|0|||
131869089|NCT02861807|474800837|FG000|Overall Study|Lost to Follow-up|7|||
131869090|NCT02861807|474800838|FG001|Overall Study|Lost to Follow-up|6|||
131869091|NCT02861807|474800837|FG000|Overall Study|Withdrawal by Subject|5|||
131869092|NCT02861807|474800838|FG001|Overall Study|Withdrawal by Subject|8|||
131869093|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
131869094|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
131869095|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
131869096|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
131869097|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
131869098|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
131869099|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
131869100|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
131869101|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
131869102|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
131869103|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
131869104|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
131869105|NCT03493854|474800839|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
131869106|NCT03493854|474800840|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
131869107|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
131869108|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
131869109|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
131869110|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
131869111|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
131869112|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
131869113|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
131869114|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
131869115|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
131869116|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
131869117|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
131869118|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
131869119|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
131869120|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
131869121|NCT03493854|474800839|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
131869122|NCT03493854|474800840|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
131869123|NCT03493854|474800839|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
131869124|NCT03493854|474800840|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
131869125|NCT03493854|474800839|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
131869126|NCT03493854|474800840|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
131869127|NCT03493854|474800839|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
131869128|NCT03493854|474800840|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
131869129|NCT00739661|474800843|FG000|Overall Study|Adverse Event|2|||
131869130|NCT00739661|474800844|FG001|Overall Study|Adverse Event|0|||
131869131|NCT00739661|474800843|FG000|Overall Study|Physician decision to withdraw patient|1|||
131869132|NCT00739661|474800844|FG001|Overall Study|Physician decision to withdraw patient|0|||
131869133|NCT00739661|474800843|FG000|Overall Study|Patient decision to withdraw|9|||
131869134|NCT00739661|474800844|FG001|Overall Study|Patient decision to withdraw|4|||
131869135|NCT00739661|474800843|FG000|Overall Study|Disease progression, radiographic|33|||
131869136|NCT00739661|474800844|FG001|Overall Study|Disease progression, radiographic|37|||
131869137|NCT00739661|474800843|FG000|Overall Study|Reason for discontinuation not available|1|||
131869138|NCT00739661|474800844|FG001|Overall Study|Reason for discontinuation not available|1|||
131869139|NCT00410813|474800845|FG000|Overall Study|Adverse Event|6|||
131869140|NCT00410813|474800846|FG001|Overall Study|Adverse Event|11|||
131869141|NCT00410813|474800845|FG000|Overall Study|Progression|32|||
131869142|NCT00410813|474800846|FG001|Overall Study|Progression|21|||
131869143|NCT00410813|474800845|FG000|Overall Study|Not protocol specified|3|||
131869144|NCT00410813|474800846|FG001|Overall Study|Not protocol specified|4|||
131869145|NCT00410813|474800845|FG000|Overall Study|Ineligible|2|||
131869146|NCT00410813|474800846|FG001|Overall Study|Ineligible|4|||
131869147|NCT00410813|474800845|FG000|Overall Study|Death|0|||
131869148|NCT00410813|474800846|FG001|Overall Study|Death|2|||
131869149|NCT00529308|474800847|FG000|Overall Study|Withdrawal by Subject|1|||
131869150|NCT00529308|474800848|FG001|Overall Study|Withdrawal by Subject|1|||
131869151|NCT00812981|474800849|FG000|Overall Study|Other|0|||
131869152|NCT00812981|474800850|FG001|Overall Study|Other|1|||
131453914|NCT02858362|473291828|FG000|Overall Study|Withdrawal by Subject|1|||
131453915|NCT02858362|473291829|FG001|Overall Study|Withdrawal by Subject|0|||
131453916|NCT02858362|473291830|FG002|Overall Study|Withdrawal by Subject|0|||
131869153|NCT05343364|474800851|FG000|Overall Study|Miscellaneous|0|||
131869154|NCT05343364|474800852|FG001|Overall Study|Miscellaneous|1|||
131918214|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
131918215|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
131918216|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
131918217|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
131918218|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
131918219|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
131918220|NCT01706328|474984217|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131918221|NCT01706328|474984218|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
131918222|NCT01706328|474984219|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
131918223|NCT03018938|474984220|FG000|Overall Study|Death|0|||
131918224|NCT03018938|474984221|FG001|Overall Study|Death|1|||
131918225|NCT03018938|474984220|FG000|Overall Study|Lost to Follow-up|21|||
131918226|NCT03018938|474984221|FG001|Overall Study|Lost to Follow-up|32|||
131918227|NCT03018938|474984220|FG000|Overall Study|Withdrawal by Subject|38|||
131918228|NCT03018938|474984221|FG001|Overall Study|Withdrawal by Subject|45|||
131918229|NCT03018938|474984220|FG000|Overall Study|Physician Decision|3|||
131918230|NCT03018938|474984221|FG001|Overall Study|Physician Decision|2|||
131918231|NCT03018938|474984220|FG000|Overall Study|Sponsor Decision|0|||
131918232|NCT03018938|474984221|FG001|Overall Study|Sponsor Decision|1|||
131918233|NCT03018938|474984220|FG000|Overall Study|Screen failure-After randomization|4|||
131918234|NCT03018938|474984221|FG001|Overall Study|Screen failure-After randomization|2|||
131918235|NCT03018938|474984220|FG000|Overall Study|Not recorded|0|||
131918236|NCT03018938|474984221|FG001|Overall Study|Not recorded|2|||
131918237|NCT00191100|474984222|FG000|Overall Study|Adverse Event|18|||
131918238|NCT00191100|474984223|FG001|Overall Study|Adverse Event|1|||
131918239|NCT00191100|474984222|FG000|Overall Study|Lost to Follow-up|2|||
131918240|NCT00191100|474984223|FG001|Overall Study|Lost to Follow-up|0|||
131918241|NCT00191100|474984222|FG000|Overall Study|Patient Moved|0|||
131918242|NCT00191100|474984223|FG001|Overall Study|Patient Moved|1|||
131918243|NCT00191100|474984222|FG000|Overall Study|Withdrawal by Subject|9|||
131918244|NCT00191100|474984223|FG001|Overall Study|Withdrawal by Subject|3|||
131918245|NCT00191100|474984222|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
131918246|NCT00191100|474984223|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
131918247|NCT00191100|474984222|FG000|Overall Study|Clinical Relapse|2|||
131918248|NCT00191100|474984223|FG001|Overall Study|Clinical Relapse|1|||
131918249|NCT00191100|474984222|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
131918250|NCT00191100|474984223|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
131918251|NCT00191100|474984222|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
131918252|NCT00191100|474984223|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
131918253|NCT00191100|474984222|FG000|Overall Study|Physician Decision|3|||
131918254|NCT00191100|474984223|FG001|Overall Study|Physician Decision|1|||
131918255|NCT00191100|474984222|FG000|Overall Study|Death from Study Drug Toxicity|2|||
131918256|NCT00191100|474984223|FG001|Overall Study|Death from Study Drug Toxicity|0|||
131918257|NCT00191100|474984222|FG000|Overall Study|Protocol Violation|1|||
131918258|NCT00191100|474984223|FG001|Overall Study|Protocol Violation|1|||
131918259|NCT00191100|474984222|FG000|Overall Study|Death from Other Cause|1|||
131918260|NCT00191100|474984223|FG001|Overall Study|Death from Other Cause|0|||
131918261|NCT00191100|474984222|FG000|Overall Study|Reason Not Specified|0|||
131869155|NCT02268916|474800853|FG000|Overall Study|Lost to Follow-up|1|||
131869156|NCT02268916|474800854|FG001|Overall Study|Lost to Follow-up|1|||
131869157|NCT02268916|474800853|FG000|Overall Study|Withdrawal by Subject|6|||
131869158|NCT02268916|474800854|FG001|Overall Study|Withdrawal by Subject|5|||
131869159|NCT02268916|474800853|FG000|Overall Study|Participant did not have diabetes|1|||
131869160|NCT02268916|474800854|FG001|Overall Study|Participant did not have diabetes|0|||
131869161|NCT02268916|474800853|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
131869162|NCT02268916|474800854|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
131918262|NCT00191100|474984223|FG001|Overall Study|Reason Not Specified|1|||
131918263|NCT02916771|474984230|FG000|Overall Study|Withdrawal by Subject|9|||
131918264|NCT02916771|474984230|FG000|Overall Study|Physician Decision|1|||
131918265|NCT02916771|474984230|FG000|Overall Study|Began treatment for another active malignancy|1|||
131918266|NCT05696847|474985091|FG000|Overall Study|Withdrawal by Subject|1|||
131918267|NCT05696847|474985092|FG001|Overall Study|Withdrawal by Subject|0|||
131918268|NCT05696847|474985093|FG002|Overall Study|Withdrawal by Subject|0|||
131918269|NCT05696847|474985094|FG003|Overall Study|Withdrawal by Subject|0|||
131408235|NCT01643850|473118236|FG002|Overall Study|Administrative Problems|1|||
131869163|NCT02418949|474800855|FG000|Overall Study|Withdrawal by Subject|1|||
131869164|NCT02418949|474800856|FG001|Overall Study|Withdrawal by Subject|0|||
131869165|NCT02418949|474800857|FG002|Overall Study|Withdrawal by Subject|1|||
131918270|NCT05696847|474985095|FG004|Overall Study|Withdrawal by Subject|0|||
131918271|NCT05696847|474985096|FG005|Overall Study|Withdrawal by Subject|0|||
131918272|NCT05696847|474985091|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131918273|NCT05696847|474985092|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131869166|NCT02418949|474800858|FG003|Overall Study|Withdrawal by Subject|1|||
131918274|NCT05696847|474985093|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131918275|NCT05696847|474985094|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131918276|NCT05696847|474985095|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131918277|NCT05696847|474985096|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131918278|NCT05696847|474985091|FG000|Overall Study|Adverse Event|0|||
131918279|NCT05696847|474985092|FG001|Overall Study|Adverse Event|0|||
131918280|NCT05696847|474985093|FG002|Overall Study|Adverse Event|0|||
131918281|NCT05696847|474985094|FG003|Overall Study|Adverse Event|0|||
131918282|NCT05696847|474985095|FG004|Overall Study|Adverse Event|0|||
131918283|NCT05696847|474985096|FG005|Overall Study|Adverse Event|1|||
131918284|NCT05696847|474985091|FG000|Overall Study|Sponsor Decision|0|||
131918285|NCT05696847|474985092|FG001|Overall Study|Sponsor Decision|0|||
131918286|NCT05696847|474985093|FG002|Overall Study|Sponsor Decision|0|||
131918287|NCT05696847|474985094|FG003|Overall Study|Sponsor Decision|1|||
131918288|NCT05696847|474985095|FG004|Overall Study|Sponsor Decision|0|||
131918289|NCT05696847|474985096|FG005|Overall Study|Sponsor Decision|0|||
131918290|NCT03323502|474985097|FG000|Overall Study|Resident could not be linked to CMS data|594|||
131918291|NCT03323502|474985098|FG001|Overall Study|Resident could not be linked to CMS data|435|||
131918292|NCT03323502|474985097|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
131918293|NCT03323502|474985098|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
131918294|NCT03323502|474985097|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
131918295|NCT03323502|474985098|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
131918296|NCT03323502|474985097|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
131918297|NCT03323502|474985098|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
131918298|NCT03323502|474985097|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
131918299|NCT03323502|474985098|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
131918300|NCT04092777|474985099|FG000|Overall Study|Lost to Follow-up|28|||
131918301|NCT04092777|474985100|FG001|Overall Study|Lost to Follow-up|46|||
131918302|NCT04092777|474985099|FG000|Overall Study|Withdrawal by Subject|8|||
131918303|NCT04092777|474985100|FG001|Overall Study|Withdrawal by Subject|5|||
131918304|NCT04132050|474985108|FG000|Period I (Double-blind Period)|Adverse Event|3|||
131918305|NCT04132050|474985109|FG001|Period I (Double-blind Period)|Adverse Event|0|||
131918306|NCT04132050|474985108|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
131918307|NCT04132050|474985109|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
131918308|NCT04132050|474985108|FG000|R788 Treatment Period|Adverse Event|5|||
131918309|NCT04132050|474985109|FG001|R788 Treatment Period|Adverse Event|0|||
131918310|NCT04132050|474985108|FG000|R788 Treatment Period|Lack of Efficacy|5|||
131918311|NCT04132050|474985109|FG001|R788 Treatment Period|Lack of Efficacy|0|||
131918312|NCT04132050|474985108|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
131918313|NCT04132050|474985109|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
131918314|NCT04818112|474985122|FG000|Overall Study|Withdrawal by Subject|54|||
131918315|NCT04818112|474985123|FG001|Overall Study|Withdrawal by Subject|12|||
131918316|NCT04818112|474985122|FG000|Overall Study|Lost to Follow-up|38|||
131918317|NCT04818112|474985123|FG001|Overall Study|Lost to Follow-up|10|||
131918318|NCT05020743|474985124|FG000|Overall Study|Enrollment in Interventional Study|2|||
131918319|NCT05020743|474985125|FG001|Overall Study|Enrollment in Interventional Study|9|||
131918320|NCT05020743|474985126|FG002|Overall Study|Enrollment in Interventional Study|0|||
131918321|NCT05020743|474985124|FG000|Overall Study|Withdrawal by Subject|0|||
131918322|NCT05020743|474985125|FG001|Overall Study|Withdrawal by Subject|3|||
131918323|NCT05020743|474985126|FG002|Overall Study|Withdrawal by Subject|1|||
131918324|NCT05020743|474985124|FG000|Overall Study|Lost to Follow-up|1|||
131918325|NCT05020743|474985125|FG001|Overall Study|Lost to Follow-up|0|||
131918326|NCT05020743|474985126|FG002|Overall Study|Lost to Follow-up|0|||
131918327|NCT05020743|474985124|FG000|Overall Study|Study Termination by Sponsor|10|||
131918328|NCT05020743|474985125|FG001|Overall Study|Study Termination by Sponsor|11|||
131918329|NCT05020743|474985126|FG002|Overall Study|Study Termination by Sponsor|10|||
131918330|NCT01913353|474985127|FG000|Overall Study|Adverse Event|2|||
131918331|NCT01913353|474985128|FG001|Overall Study|Adverse Event|0|||
131918332|NCT01913353|474985127|FG000|Overall Study|Physician Decision|0|||
131918333|NCT01913353|474985128|FG001|Overall Study|Physician Decision|2|||
131918334|NCT01913353|474985127|FG000|Overall Study|Withdrawal by Subject|20|||
131918335|NCT01913353|474985128|FG001|Overall Study|Withdrawal by Subject|6|||
131918336|NCT01913353|474985127|FG000|Overall Study|multiple reasons|10|||
131918337|NCT01913353|474985128|FG001|Overall Study|multiple reasons|7|||
131918338|NCT00385840|474985129|FG000|Overall Study|Adverse Event|1|||
131918339|NCT00385840|474985130|FG001|Overall Study|Adverse Event|1|||
131918340|NCT00385840|474985129|FG000|Overall Study|Lost to Follow-up|3|||
131918341|NCT00385840|474985130|FG001|Overall Study|Lost to Follow-up|13|||
131408236|NCT01643850|473118237|FG003|Overall Study|Administrative Problems|0|||
131918342|NCT02335944|474985131|FG000|Treatment Phase|Progressive Disease|2|||
131918343|NCT02335944|474985132|FG001|Treatment Phase|Progressive Disease|5|||
131918344|NCT02335944|474985133|FG002|Treatment Phase|Progressive Disease|2|||
131869167|NCT02418949|474800855|FG000|Overall Study|Lost to Follow-up|1|||
131869168|NCT02418949|474800856|FG001|Overall Study|Lost to Follow-up|0|||
131869169|NCT02418949|474800857|FG002|Overall Study|Lost to Follow-up|1|||
131869170|NCT02418949|474800858|FG003|Overall Study|Lost to Follow-up|0|||
131869171|NCT02418949|474800855|FG000|Overall Study|Physician Decision|1|||
131869172|NCT02418949|474800856|FG001|Overall Study|Physician Decision|1|||
131869173|NCT02418949|474800857|FG002|Overall Study|Physician Decision|1|||
131869174|NCT02418949|474800858|FG003|Overall Study|Physician Decision|0|||
131869175|NCT03926117|474800859|FG000|Overall Study|Unclassified|1|||
131869176|NCT03926117|474800860|FG001|Overall Study|Unclassified|4|||
131869177|NCT03926117|474800861|FG002|Overall Study|Unclassified|1|||
131869178|NCT03926117|474800862|FG003|Overall Study|Unclassified|4|||
131869179|NCT03926117|474800859|FG000|Overall Study|Withdrawal by Subject|3|||
131869180|NCT03926117|474800860|FG001|Overall Study|Withdrawal by Subject|0|||
131869181|NCT03926117|474800861|FG002|Overall Study|Withdrawal by Subject|1|||
131869182|NCT03926117|474800862|FG003|Overall Study|Withdrawal by Subject|1|||
131869183|NCT03926117|474800859|FG000|Overall Study|Lost to Follow-up|0|||
131869184|NCT03926117|474800860|FG001|Overall Study|Lost to Follow-up|2|||
131869185|NCT03926117|474800861|FG002|Overall Study|Lost to Follow-up|1|||
131869186|NCT03926117|474800862|FG003|Overall Study|Lost to Follow-up|0|||
131869187|NCT03926117|474800859|FG000|Overall Study|Adverse Event|1|||
131869188|NCT03926117|474800860|FG001|Overall Study|Adverse Event|2|||
131869189|NCT03926117|474800861|FG002|Overall Study|Adverse Event|3|||
131869190|NCT03926117|474800862|FG003|Overall Study|Adverse Event|1|||
131869191|NCT03926117|474800859|FG000|Overall Study|Randomized but not treated|1|||
131869192|NCT03926117|474800860|FG001|Overall Study|Randomized but not treated|1|||
131869193|NCT03926117|474800861|FG002|Overall Study|Randomized but not treated|0|||
131869194|NCT03926117|474800862|FG003|Overall Study|Randomized but not treated|1|||
131869195|NCT04526288|474800865|FG000|Overall Study|Disease Progression|1|||
131869196|NCT04526288|474800866|FG001|Overall Study|Disease Progression|0|||
131869197|NCT02684097|474800869|FG000|Overall Study|Lack of Efficacy|13|||
131869198|NCT02684097|474800870|FG001|Overall Study|Lack of Efficacy|6|||
131869199|NCT00460811|474800871|FG000|Overall Study|Adverse Event|4|||
131869200|NCT00460811|474800872|FG001|Overall Study|Adverse Event|6|||
131869201|NCT00460811|474800873|FG002|Overall Study|Adverse Event|3|||
131869202|NCT00460811|474800874|FG003|Overall Study|Adverse Event|10|||
131869203|NCT00460811|474800875|FG004|Overall Study|Adverse Event|2|||
131869204|NCT00460811|474800871|FG000|Overall Study|Noncompliance|1|||
131869205|NCT00460811|474800872|FG001|Overall Study|Noncompliance|0|||
131869206|NCT00460811|474800873|FG002|Overall Study|Noncompliance|0|||
131869207|NCT00460811|474800874|FG003|Overall Study|Noncompliance|2|||
131869208|NCT00460811|474800875|FG004|Overall Study|Noncompliance|1|||
131869209|NCT00460811|474800871|FG000|Overall Study|Withdrawal by Subject|7|||
131869210|NCT00460811|474800872|FG001|Overall Study|Withdrawal by Subject|7|||
131869211|NCT00460811|474800873|FG002|Overall Study|Withdrawal by Subject|6|||
131869212|NCT00460811|474800874|FG003|Overall Study|Withdrawal by Subject|3|||
131869213|NCT00460811|474800875|FG004|Overall Study|Withdrawal by Subject|11|||
131869214|NCT00460811|474800871|FG000|Overall Study|Physician Decision|1|||
131869215|NCT00460811|474800872|FG001|Overall Study|Physician Decision|0|||
131869216|NCT00460811|474800873|FG002|Overall Study|Physician Decision|0|||
131869217|NCT00460811|474800874|FG003|Overall Study|Physician Decision|0|||
131869218|NCT00460811|474800875|FG004|Overall Study|Physician Decision|0|||
131869219|NCT00460811|474800871|FG000|Overall Study|Lost to Follow-up|3|||
131869220|NCT00460811|474800872|FG001|Overall Study|Lost to Follow-up|2|||
131869221|NCT00460811|474800873|FG002|Overall Study|Lost to Follow-up|5|||
131869222|NCT00460811|474800874|FG003|Overall Study|Lost to Follow-up|3|||
131869223|NCT00460811|474800875|FG004|Overall Study|Lost to Follow-up|6|||
131869224|NCT02748356|474800876|FG000|Overall Study|Withdrawal by Subject|1|||
131869225|NCT00237458|474800877|FG000|Overall Study|Lack of Efficacy|1|||
131869226|NCT00237458|474800877|FG000|Overall Study|Adverse Event|1|||
131869227|NCT00237458|474800877|FG000|Overall Study|Withdrawal by Subject|1|||
131869228|NCT00708461|474800880|FG000|Overall Study|Lost to Follow-up|18|||
131869229|NCT00708461|474800881|FG001|Overall Study|Lost to Follow-up|11|||
131869230|NCT00708461|474800880|FG000|Overall Study|Withdrawal by Subject|8|||
131869231|NCT00708461|474800881|FG001|Overall Study|Withdrawal by Subject|9|||
131869232|NCT00708461|474800880|FG000|Overall Study|left workforce|115|||
131869233|NCT00708461|474800881|FG001|Overall Study|left workforce|180|||
131869234|NCT01796392|474800886|FG000|Overall Study|Withdrawal by Subject|2|||
131869235|NCT01796392|474800887|FG001|Overall Study|Withdrawal by Subject|0|||
131869236|NCT01796392|474800886|FG000|Overall Study|Death|5|||
131869237|NCT01796392|474800887|FG001|Overall Study|Death|1|||
131869238|NCT01796392|474800886|FG000|Overall Study|Excluded for medical reasons|1|||
131869239|NCT01796392|474800887|FG001|Overall Study|Excluded for medical reasons|2|||
131869240|NCT01796392|474800886|FG000|Overall Study|Lost to Follow-up|1|||
131869241|NCT01796392|474800887|FG001|Overall Study|Lost to Follow-up|0|||
131869242|NCT02505217|474800888|FG000|Overall Study|Withdrawal by Subject|1|||
131869243|NCT02505217|474800889|FG001|Overall Study|Withdrawal by Subject|2|||
131869244|NCT00153179|474800897|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
131869245|NCT00153179|474800898|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
131918345|NCT02335944|474985134|FG003|Treatment Phase|Progressive Disease|11|||
131918346|NCT02335944|474985135|FG004|Treatment Phase|Progressive Disease|4|||
131918347|NCT02335944|474985136|FG005|Treatment Phase|Progressive Disease|25|||
131918348|NCT02335944|474985137|FG006|Treatment Phase|Progressive Disease|2|||
131918349|NCT02335944|474985138|FG007|Treatment Phase|Progressive Disease|30|||
131918350|NCT02335944|474985139|FG008|Treatment Phase|Progressive Disease|27|||
131918351|NCT02335944|474985140|FG009|Treatment Phase|Progressive Disease|0|||
131918352|NCT02335944|474985131|FG000|Treatment Phase|Adverse Event|2|||
131918353|NCT02335944|474985132|FG001|Treatment Phase|Adverse Event|0|||
131918354|NCT02335944|474985133|FG002|Treatment Phase|Adverse Event|0|||
131918355|NCT02335944|474985134|FG003|Treatment Phase|Adverse Event|2|||
131918356|NCT02335944|474985135|FG004|Treatment Phase|Adverse Event|1|||
131918357|NCT02335944|474985136|FG005|Treatment Phase|Adverse Event|15|||
131918358|NCT02335944|474985137|FG006|Treatment Phase|Adverse Event|0|||
131918359|NCT02335944|474985138|FG007|Treatment Phase|Adverse Event|5|||
131918360|NCT02335944|474985139|FG008|Treatment Phase|Adverse Event|7|||
131918361|NCT02335944|474985140|FG009|Treatment Phase|Adverse Event|0|||
131918362|NCT02335944|474985131|FG000|Treatment Phase|Physician Decision|0|||
131918363|NCT02335944|474985132|FG001|Treatment Phase|Physician Decision|0|||
131918364|NCT02335944|474985133|FG002|Treatment Phase|Physician Decision|0|||
131918365|NCT02335944|474985134|FG003|Treatment Phase|Physician Decision|1|||
131918366|NCT02335944|474985135|FG004|Treatment Phase|Physician Decision|0|||
131918367|NCT02335944|474985136|FG005|Treatment Phase|Physician Decision|6|||
131918368|NCT02335944|474985137|FG006|Treatment Phase|Physician Decision|1|||
131918369|NCT02335944|474985138|FG007|Treatment Phase|Physician Decision|2|||
131918370|NCT02335944|474985139|FG008|Treatment Phase|Physician Decision|1|||
131918371|NCT02335944|474985140|FG009|Treatment Phase|Physician Decision|0|||
131918372|NCT02335944|474985131|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
131918373|NCT02335944|474985132|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
131918374|NCT02335944|474985133|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
131918375|NCT02335944|474985134|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
131918376|NCT02335944|474985135|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
131918377|NCT02335944|474985136|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
131918378|NCT02335944|474985137|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
131918379|NCT02335944|474985138|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
131918380|NCT02335944|474985139|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
131918381|NCT02335944|474985140|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
131918382|NCT02335944|474985131|FG000|Treatment Phase|Subject/Guardian Decision|0|||
131918383|NCT02335944|474985132|FG001|Treatment Phase|Subject/Guardian Decision|0|||
131918384|NCT02335944|474985133|FG002|Treatment Phase|Subject/Guardian Decision|1|||
131918385|NCT02335944|474985134|FG003|Treatment Phase|Subject/Guardian Decision|0|||
131918386|NCT02335944|474985135|FG004|Treatment Phase|Subject/Guardian Decision|0|||
131918387|NCT02335944|474985136|FG005|Treatment Phase|Subject/Guardian Decision|1|||
131918388|NCT02335944|474985137|FG006|Treatment Phase|Subject/Guardian Decision|0|||
131918389|NCT02335944|474985138|FG007|Treatment Phase|Subject/Guardian Decision|4|||
131918390|NCT02335944|474985139|FG008|Treatment Phase|Subject/Guardian Decision|0|||
131918391|NCT02335944|474985140|FG009|Treatment Phase|Subject/Guardian Decision|0|||
131918392|NCT02335944|474985131|FG000|Post-treatment Follow-up|Progressive Disease|0|||
131918393|NCT02335944|474985132|FG001|Post-treatment Follow-up|Progressive Disease|0|||
131918394|NCT02335944|474985133|FG002|Post-treatment Follow-up|Progressive Disease|0|||
131918395|NCT02335944|474985134|FG003|Post-treatment Follow-up|Progressive Disease|1|||
131408237|NCT01643850|473118238|FG004|Overall Study|Administrative Problems|1|||
131408238|NCT01643850|473118239|FG005|Overall Study|Administrative Problems|0|||
131408239|NCT01643850|473118240|FG006|Overall Study|Administrative Problems|0|||
131408240|NCT01643850|473118241|FG007|Overall Study|Administrative Problems|0|||
131408241|NCT01643850|473118242|FG008|Overall Study|Administrative Problems|0|||
131408242|NCT03054350|473118243|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
131408243|NCT03054350|473118244|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
131869246|NCT00153179|474800899|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
131869247|NCT00153179|474800900|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
131869248|NCT03517540|474800903|FG000|Overall Study|Protocol Violation|2|||
131869249|NCT03517540|474800904|FG001|Overall Study|Protocol Violation|0|||
131869250|NCT03517540|474800905|FG002|Overall Study|Protocol Violation|0|||
131869251|NCT03517540|474800906|FG003|Overall Study|Protocol Violation|1|||
131869252|NCT03517540|474800903|FG000|Overall Study|Adverse Event|9|||
131869253|NCT03517540|474800904|FG001|Overall Study|Adverse Event|3|||
131918396|NCT02335944|474985135|FG004|Post-treatment Follow-up|Progressive Disease|0|||
131918397|NCT02335944|474985136|FG005|Post-treatment Follow-up|Progressive Disease|9|||
131918398|NCT02335944|474985137|FG006|Post-treatment Follow-up|Progressive Disease|0|||
131918399|NCT02335944|474985138|FG007|Post-treatment Follow-up|Progressive Disease|2|||
131869254|NCT03517540|474800905|FG002|Overall Study|Adverse Event|8|||
131869255|NCT03517540|474800906|FG003|Overall Study|Adverse Event|1|||
131918400|NCT02335944|474985139|FG008|Post-treatment Follow-up|Progressive Disease|3|||
131869256|NCT03517540|474800903|FG000|Overall Study|Withdrawal by Subject|3|||
131918401|NCT02335944|474985140|FG009|Post-treatment Follow-up|Progressive Disease|0|||
131918402|NCT02335944|474985131|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918403|NCT02335944|474985132|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918404|NCT02335944|474985133|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918405|NCT02335944|474985134|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918406|NCT02335944|474985135|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918407|NCT02335944|474985136|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
131918408|NCT02335944|474985137|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918409|NCT02335944|474985138|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918410|NCT02335944|474985139|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918411|NCT02335944|474985140|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
131918412|NCT02335944|474985131|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918413|NCT02335944|474985132|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918414|NCT02335944|474985133|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918415|NCT02335944|474985134|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918416|NCT02335944|474985135|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918417|NCT02335944|474985136|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918418|NCT02335944|474985137|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918419|NCT02335944|474985138|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
131918420|NCT02335944|474985139|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918421|NCT02335944|474985140|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
131918422|NCT02335944|474985131|FG000|Post-treatment Follow-up|Adverse Event|0|||
131918423|NCT02335944|474985132|FG001|Post-treatment Follow-up|Adverse Event|0|||
131918424|NCT02335944|474985133|FG002|Post-treatment Follow-up|Adverse Event|0|||
131918425|NCT02335944|474985134|FG003|Post-treatment Follow-up|Adverse Event|0|||
131918426|NCT02335944|474985135|FG004|Post-treatment Follow-up|Adverse Event|0|||
131918427|NCT02335944|474985136|FG005|Post-treatment Follow-up|Adverse Event|1|||
131918428|NCT02335944|474985137|FG006|Post-treatment Follow-up|Adverse Event|0|||
131918429|NCT02335944|474985138|FG007|Post-treatment Follow-up|Adverse Event|0|||
131918430|NCT02335944|474985139|FG008|Post-treatment Follow-up|Adverse Event|0|||
131918431|NCT02335944|474985140|FG009|Post-treatment Follow-up|Adverse Event|0|||
131453917|NCT02858362|473291828|FG000|Overall Study|Early Study Termination|0|||
131453918|NCT02858362|473291829|FG001|Overall Study|Early Study Termination|0|||
131453919|NCT02858362|473291830|FG002|Overall Study|Early Study Termination|3|||
131453920|NCT02858362|473291828|FG000|Overall Study|Lost to Follow-up|1|||
131453921|NCT02858362|473291829|FG001|Overall Study|Lost to Follow-up|0|||
131453922|NCT02858362|473291830|FG002|Overall Study|Lost to Follow-up|0|||
131918432|NCT02335944|474985131|FG000|Post-treatment Follow-up|Death|0|||
131918433|NCT02335944|474985132|FG001|Post-treatment Follow-up|Death|0|||
131918434|NCT02335944|474985133|FG002|Post-treatment Follow-up|Death|0|||
131918435|NCT02335944|474985134|FG003|Post-treatment Follow-up|Death|1|||
131918436|NCT02335944|474985135|FG004|Post-treatment Follow-up|Death|0|||
131918437|NCT02335944|474985136|FG005|Post-treatment Follow-up|Death|1|||
131918438|NCT02335944|474985137|FG006|Post-treatment Follow-up|Death|0|||
131918439|NCT02335944|474985138|FG007|Post-treatment Follow-up|Death|0|||
131918440|NCT02335944|474985139|FG008|Post-treatment Follow-up|Death|0|||
131918441|NCT02335944|474985140|FG009|Post-treatment Follow-up|Death|0|||
131918442|NCT02335944|474985131|FG000|Post-treatment Follow-up|Physician Decision|1|||
131918443|NCT02335944|474985132|FG001|Post-treatment Follow-up|Physician Decision|0|||
131918444|NCT02335944|474985133|FG002|Post-treatment Follow-up|Physician Decision|0|||
131918445|NCT02335944|474985134|FG003|Post-treatment Follow-up|Physician Decision|0|||
131918446|NCT02335944|474985135|FG004|Post-treatment Follow-up|Physician Decision|0|||
131918447|NCT02335944|474985136|FG005|Post-treatment Follow-up|Physician Decision|0|||
131918448|NCT02335944|474985137|FG006|Post-treatment Follow-up|Physician Decision|0|||
131918449|NCT02335944|474985138|FG007|Post-treatment Follow-up|Physician Decision|1|||
131918450|NCT02335944|474985139|FG008|Post-treatment Follow-up|Physician Decision|0|||
131918451|NCT02335944|474985140|FG009|Post-treatment Follow-up|Physician Decision|0|||
131918452|NCT00832975|474985141|FG000|Overall Study|Lost to Follow-up|7|||
131918453|NCT00832975|474985141|FG000|Overall Study|Protocol Violation|6|||
131918454|NCT00832975|474985141|FG000|Overall Study|Death|5|||
131918455|NCT00832975|474985141|FG000|Overall Study|Physician Decision|4|||
131918456|NCT00832975|474985141|FG000|Overall Study|Withdrawal by Subject|3|||
131918457|NCT00832975|474985141|FG000|Overall Study|Other reasons|14|||
131918458|NCT04603066|474985142|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
131918459|NCT04603066|474985143|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
131918460|NCT02406612|474985144|FG000|Overall Study|Screening Failure|3|||
131918461|NCT02406612|474985145|FG001|Overall Study|Screening Failure|0|||
131918462|NCT02406612|474985144|FG000|Overall Study|Intra-procedural Exclusion|1|||
131918463|NCT02406612|474985145|FG001|Overall Study|Intra-procedural Exclusion|3|||
131918464|NCT02406612|474985144|FG000|Overall Study|Guidewire Failure|0|||
131918465|NCT02406612|474985145|FG001|Overall Study|Guidewire Failure|1|||
131453923|NCT02813577|473291832|FG000|Overall Study|Study terminated|4|||
131453924|NCT02067676|473291833|FG000|Overall Study|Withdrawal by Subject|1|||
131453925|NCT02067676|473291834|FG001|Overall Study|Withdrawal by Subject|0|||
131918466|NCT01371981|474985146|FG000|Overall Study|Adverse Event|12|||
131918467|NCT01371981|474985147|FG001|Overall Study|Adverse Event|17|||
131918468|NCT01371981|474985148|FG002|Overall Study|Adverse Event|0|||
131918469|NCT01371981|474985149|FG003|Overall Study|Adverse Event|4|||
131918470|NCT01371981|474985150|FG004|Overall Study|Adverse Event|1|||
131918471|NCT01371981|474985151|FG005|Overall Study|Adverse Event|0|||
131918472|NCT01371981|474985146|FG000|Overall Study|Death|22|||
131918473|NCT01371981|474985147|FG001|Overall Study|Death|16|||
131918474|NCT01371981|474985148|FG002|Overall Study|Death|0|||
131918475|NCT01371981|474985149|FG003|Overall Study|Death|0|||
131918476|NCT01371981|474985150|FG004|Overall Study|Death|2|||
131918477|NCT01371981|474985151|FG005|Overall Study|Death|2|||
131918478|NCT01371981|474985146|FG000|Overall Study|Lack of Efficacy|69|||
131918479|NCT01371981|474985147|FG001|Overall Study|Lack of Efficacy|61|||
131918480|NCT01371981|474985148|FG002|Overall Study|Lack of Efficacy|4|||
131918481|NCT01371981|474985149|FG003|Overall Study|Lack of Efficacy|8|||
131918482|NCT01371981|474985150|FG004|Overall Study|Lack of Efficacy|5|||
131918483|NCT01371981|474985151|FG005|Overall Study|Lack of Efficacy|0|||
131918484|NCT01371981|474985146|FG000|Overall Study|Physician Decision|48|||
131918485|NCT01371981|474985147|FG001|Overall Study|Physician Decision|63|||
131869257|NCT03517540|474800904|FG001|Overall Study|Withdrawal by Subject|4|||
131918486|NCT01371981|474985148|FG002|Overall Study|Physician Decision|1|||
131918487|NCT01371981|474985149|FG003|Overall Study|Physician Decision|7|||
131918488|NCT01371981|474985150|FG004|Overall Study|Physician Decision|14|||
131918489|NCT01371981|474985151|FG005|Overall Study|Physician Decision|3|||
131918490|NCT01371981|474985146|FG000|Overall Study|Withdrawal by Subject|12|||
131918491|NCT01371981|474985147|FG001|Overall Study|Withdrawal by Subject|19|||
131918492|NCT01371981|474985148|FG002|Overall Study|Withdrawal by Subject|1|||
131918493|NCT01371981|474985149|FG003|Overall Study|Withdrawal by Subject|2|||
131918494|NCT01371981|474985150|FG004|Overall Study|Withdrawal by Subject|10|||
131918495|NCT01371981|474985151|FG005|Overall Study|Withdrawal by Subject|3|||
131918496|NCT01371981|474985146|FG000|Overall Study|Ineligible|19|||
131869258|NCT03517540|474800905|FG002|Overall Study|Withdrawal by Subject|1|||
131869259|NCT03517540|474800906|FG003|Overall Study|Withdrawal by Subject|3|||
131869260|NCT02712554|474800909|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
131869261|NCT02712554|474800910|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
131869262|NCT02712554|474800909|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
131869263|NCT02712554|474800910|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
131869264|NCT02712554|474800909|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
131869265|NCT02712554|474800910|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
131869266|NCT02712554|474800909|FG000|Part B: Qualification Phase|Adverse Event|0|||
131869267|NCT02712554|474800910|FG001|Part B: Qualification Phase|Adverse Event|1|||
131869268|NCT02712554|474800909|FG000|Part B: Treatment Phase|Adverse Event|0|||
131869269|NCT02712554|474800910|FG001|Part B: Treatment Phase|Adverse Event|1|||
131869270|NCT02712554|474800909|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
131869271|NCT02712554|474800910|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
131869272|NCT02712554|474800909|FG000|Part B: Treatment Phase|Other|0|||
131869273|NCT02712554|474800910|FG001|Part B: Treatment Phase|Other|1|||
131869274|NCT01779440|474800913|FG000|Overall Study|Withdrawal by Subject|3|||
131869275|NCT01779440|474800914|FG001|Overall Study|Withdrawal by Subject|5|||
131869276|NCT01205269|474800915|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
131869277|NCT01205269|474800916|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
131869278|NCT01205269|474800917|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
131869279|NCT01205269|474800918|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
131869280|NCT01205269|474800919|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
131869281|NCT01205269|474800920|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
131869282|NCT01408303|474800921|FG000|Overall Study|Adverse Event|3|||
131869283|NCT01408303|474800922|FG001|Overall Study|Adverse Event|7|||
131869284|NCT01408303|474800923|FG002|Overall Study|Adverse Event|2|||
131869285|NCT01408303|474800921|FG000|Overall Study|Lost to Follow-up|0|||
131869286|NCT01408303|474800922|FG001|Overall Study|Lost to Follow-up|1|||
131918497|NCT01371981|474985147|FG001|Overall Study|Ineligible|13|||
131918498|NCT01371981|474985148|FG002|Overall Study|Ineligible|0|||
131918499|NCT01371981|474985149|FG003|Overall Study|Ineligible|0|||
131869287|NCT01408303|474800923|FG002|Overall Study|Lost to Follow-up|2|||
131869288|NCT01408303|474800921|FG000|Overall Study|Withdrawal by Subject|2|||
131869289|NCT01408303|474800922|FG001|Overall Study|Withdrawal by Subject|3|||
131869290|NCT01408303|474800923|FG002|Overall Study|Withdrawal by Subject|1|||
131918500|NCT01371981|474985150|FG004|Overall Study|Ineligible|0|||
131918501|NCT01371981|474985151|FG005|Overall Study|Ineligible|4|||
131918502|NCT01371981|474985146|FG000|Overall Study|Did not start treatment|2|||
131918503|NCT01371981|474985147|FG001|Overall Study|Did not start treatment|3|||
131918504|NCT01371981|474985148|FG002|Overall Study|Did not start treatment|0|||
131918505|NCT01371981|474985149|FG003|Overall Study|Did not start treatment|0|||
131918506|NCT01371981|474985150|FG004|Overall Study|Did not start treatment|0|||
131918507|NCT01371981|474985151|FG005|Overall Study|Did not start treatment|2|||
131918508|NCT05759338|474985152|FG000|Overall Study|Withdrawal by Subject|3|||
131869291|NCT01408303|474800921|FG000|Overall Study|Protocol Violation|0|||
131869292|NCT01408303|474800922|FG001|Overall Study|Protocol Violation|1|||
131869293|NCT01408303|474800923|FG002|Overall Study|Protocol Violation|0|||
131869294|NCT01408303|474800921|FG000|Overall Study|Noncompliance|1|||
131869295|NCT01408303|474800922|FG001|Overall Study|Noncompliance|0|||
131869296|NCT01408303|474800923|FG002|Overall Study|Noncompliance|1|||
131869297|NCT01207687|474800924|FG000|Overall Study|Adverse Event|1|||
131869298|NCT01207687|474800924|FG000|Overall Study|Withdrawal by Subject|1|||
131869299|NCT01486446|474800925|FG000|Overall Study|Adverse Event|1|||
131869300|NCT01486446|474800926|FG001|Overall Study|Adverse Event|0|||
131869301|NCT00523848|474800927|FG000|Overall Study|Adverse Event|11|||
131869302|NCT00523848|474800927|FG000|Overall Study|Withdrawal by Subject|2|||
131869303|NCT00523848|474800927|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
131869304|NCT00523848|474800927|FG000|Overall Study|Disease Progression|5|||
131869305|NCT00523848|474800927|FG000|Overall Study|Other, unspecified|4|||
131869306|NCT01801865|474800928|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
131869307|NCT01801865|474800928|FG000|Overall Study|Physician Decision|7|||
131869308|NCT01367886|474800929|FG000|Overall Study|Lost to Follow-up|4|||
131869309|NCT01367886|474800929|FG000|Overall Study|Lack of Efficacy|2|||
131869310|NCT01367886|474800929|FG000|Overall Study|Death|1|||
131869311|NCT00985504|474800932|FG000|Acute Treatment Period|Adverse Event|3|||
131869312|NCT00985504|474800933|FG001|Acute Treatment Period|Adverse Event|4|||
131869313|NCT00985504|474800932|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
131869314|NCT00985504|474800933|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
131869315|NCT00985504|474800932|FG000|Acute Treatment Period|Protocol Violation|2|||
131869316|NCT00985504|474800933|FG001|Acute Treatment Period|Protocol Violation|0|||
131869317|NCT00985504|474800932|FG000|Acute Treatment Period|Sponsor Decision|0|||
131869318|NCT00985504|474800933|FG001|Acute Treatment Period|Sponsor Decision|1|||
131869319|NCT00985504|474800932|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
131869320|NCT00985504|474800933|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
131869321|NCT00985504|474800932|FG000|Optimization Period|Adverse Event|7|||
131869322|NCT00985504|474800933|FG001|Optimization Period|Adverse Event|9|||
131869323|NCT00985504|474800932|FG000|Optimization Period|Death|0|||
131869324|NCT00985504|474800933|FG001|Optimization Period|Death|1|||
131869325|NCT00985504|474800932|FG000|Optimization Period|Lack of Efficacy|5|||
131869326|NCT00985504|474800933|FG001|Optimization Period|Lack of Efficacy|3|||
131869327|NCT00985504|474800932|FG000|Optimization Period|Lost to Follow-up|0|||
131869328|NCT00985504|474800933|FG001|Optimization Period|Lost to Follow-up|1|||
131869329|NCT00985504|474800932|FG000|Optimization Period|Physician Decision|1|||
131869330|NCT00985504|474800933|FG001|Optimization Period|Physician Decision|0|||
131869331|NCT00985504|474800932|FG000|Optimization Period|Protocol Violation|3|||
131869332|NCT00985504|474800933|FG001|Optimization Period|Protocol Violation|1|||
131869333|NCT00985504|474800932|FG000|Optimization Period|Withdrawal by Subject|10|||
131869334|NCT00985504|474800933|FG001|Optimization Period|Withdrawal by Subject|8|||
131869335|NCT03711786|474800938|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
131869336|NCT03711786|474800939|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
131869337|NCT03711786|474800938|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
131869338|NCT03711786|474800939|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
131869339|NCT03711786|474800938|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
131869340|NCT03711786|474800939|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
131869341|NCT03711786|474800938|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
131869342|NCT03711786|474800939|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
131869343|NCT03711786|474800938|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
131869344|NCT03711786|474800939|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
131869345|NCT03711786|474800938|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
131869346|NCT03711786|474800939|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
131869347|NCT03379727|474800940|FG000|Overall Study|Lack of Efficacy|73|||
131869348|NCT03379727|474800940|FG000|Overall Study|Adverse Event|32|||
131869349|NCT03379727|474800940|FG000|Overall Study|Death|18|||
131869350|NCT03379727|474800940|FG000|Overall Study|Patient/guardian decision|17|||
131869351|NCT03379727|474800940|FG000|Overall Study|Physician Decision|104|||
131869352|NCT03379727|474800940|FG000|Overall Study|Protocol Violation|4|||
131869353|NCT03379727|474800940|FG000|Overall Study|Lost to Follow-up|1|||
131869354|NCT01777282|474800946|FG000|Overall Study|Persistent Hyperglycemia|0|||
131869355|NCT01777282|474800947|FG001|Overall Study|Persistent Hyperglycemia|0|||
131869356|NCT01777282|474800948|FG002|Overall Study|Persistent Hyperglycemia|1|||
131869357|NCT01777282|474800949|FG003|Overall Study|Persistent Hyperglycemia|0|||
131869358|NCT01777282|474800950|FG004|Overall Study|Persistent Hyperglycemia|0|||
131869359|NCT01777282|474800946|FG000|Overall Study|New Antidiabetic Medication|0|||
131869360|NCT01777282|474800947|FG001|Overall Study|New Antidiabetic Medication|0|||
131869361|NCT01777282|474800948|FG002|Overall Study|New Antidiabetic Medication|1|||
131869362|NCT01777282|474800949|FG003|Overall Study|New Antidiabetic Medication|0|||
131869363|NCT01777282|474800950|FG004|Overall Study|New Antidiabetic Medication|0|||
131869364|NCT01777282|474800946|FG000|Overall Study|Adverse Event|4|||
131869365|NCT01777282|474800947|FG001|Overall Study|Adverse Event|4|||
131869366|NCT01777282|474800948|FG002|Overall Study|Adverse Event|2|||
131869367|NCT01777282|474800949|FG003|Overall Study|Adverse Event|1|||
131869368|NCT01777282|474800950|FG004|Overall Study|Adverse Event|3|||
131869369|NCT01777282|474800946|FG000|Overall Study|Withdrawal by Subject|4|||
131869370|NCT01777282|474800947|FG001|Overall Study|Withdrawal by Subject|0|||
131869371|NCT01777282|474800948|FG002|Overall Study|Withdrawal by Subject|0|||
131869372|NCT01777282|474800949|FG003|Overall Study|Withdrawal by Subject|1|||
131869373|NCT01777282|474800950|FG004|Overall Study|Withdrawal by Subject|2|||
131869374|NCT01777282|474800946|FG000|Overall Study|Protocol Violation|2|||
131869375|NCT01777282|474800947|FG001|Overall Study|Protocol Violation|0|||
131869376|NCT01777282|474800948|FG002|Overall Study|Protocol Violation|1|||
131869377|NCT01777282|474800949|FG003|Overall Study|Protocol Violation|0|||
131869378|NCT01777282|474800950|FG004|Overall Study|Protocol Violation|2|||
131869379|NCT01777282|474800946|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
131869380|NCT01777282|474800947|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
131869381|NCT01777282|474800948|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
131869382|NCT01777282|474800949|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
131869383|NCT01777282|474800950|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
131869384|NCT00764660|474800951|FG000|Overall Study|Adverse Event|6|||
131869385|NCT00764660|474800952|FG001|Overall Study|Adverse Event|3|||
131869386|NCT00764660|474800951|FG000|Overall Study|Lost to Follow-up|3|||
131869387|NCT00764660|474800952|FG001|Overall Study|Lost to Follow-up|4|||
131869388|NCT00764660|474800951|FG000|Overall Study|Withdrawal by Subject|7|||
131869389|NCT00764660|474800952|FG001|Overall Study|Withdrawal by Subject|3|||
131869390|NCT00764660|474800951|FG000|Overall Study|Noncompliance With Protocol|5|||
131869391|NCT00764660|474800952|FG001|Overall Study|Noncompliance With Protocol|1|||
131869392|NCT00764660|474800951|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
131869393|NCT00764660|474800952|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
131869394|NCT03668119|474802595|FG000|Pre-treatment|Disease Progression|1|||
131869395|NCT03668119|474802596|FG001|Pre-treatment|Disease Progression|0|||
131869396|NCT03668119|474802595|FG000|Treatment|Disease Progression|76|||
131869397|NCT03668119|474802596|FG001|Treatment|Disease Progression|57|||
131869398|NCT03668119|474802595|FG000|Treatment|Study drug toxicity|19|||
131869399|NCT03668119|474802596|FG001|Treatment|Study drug toxicity|1|||
131869400|NCT03668119|474802595|FG000|Treatment|Death|3|||
131869401|NCT03668119|474802596|FG001|Treatment|Death|0|||
131869402|NCT03668119|474802595|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
131869403|NCT03668119|474802596|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
131869404|NCT03668119|474802595|FG000|Treatment|Withdrawal by Subject|1|||
131869405|NCT03668119|474802596|FG001|Treatment|Withdrawal by Subject|1|||
131869406|NCT03668119|474802595|FG000|Treatment|Participant request to discontinue study treatment|3|||
131869407|NCT03668119|474802596|FG001|Treatment|Participant request to discontinue study treatment|1|||
131869408|NCT03668119|474802595|FG000|Treatment|Maximum Clinical Benefit|0|||
131869409|NCT03668119|474802596|FG001|Treatment|Maximum Clinical Benefit|1|||
131869410|NCT03668119|474802595|FG000|Treatment|Participants completed treatment|27|||
131869411|NCT03668119|474802596|FG001|Treatment|Participants completed treatment|11|||
131869412|NCT03668119|474802595|FG000|Treatment|Other reasons|2|||
131869413|NCT03668119|474802596|FG001|Treatment|Other reasons|1|||
131869414|NCT05336227|474802597|FG000|Overall Study|Adverse Event|1|||
131869415|NCT05336227|474802598|FG001|Overall Study|Adverse Event|0|||
131869416|NCT05336227|474802597|FG000|Overall Study|Lost to Follow-up|2|||
131869417|NCT05336227|474802598|FG001|Overall Study|Lost to Follow-up|0|||
131869418|NCT05336227|474802597|FG000|Overall Study|Withdrawal by Subject|1|||
131869419|NCT05336227|474802598|FG001|Overall Study|Withdrawal by Subject|0|||
131869420|NCT00684411|474802601|FG000|Overall Study|New Primary Cancer|1|||
131869421|NCT00684411|474802601|FG000|Overall Study|Disease Progression|10|||
131869422|NCT00684411|474802601|FG000|Overall Study|Adverse Event|1|||
131869423|NCT01295671|474802602|FG000|Overall Study|Lost to Follow-up|4|||
131869424|NCT01295671|474802603|FG001|Overall Study|Lost to Follow-up|6|||
131869425|NCT01295671|474802604|FG002|Overall Study|Lost to Follow-up|3|||
131869426|NCT01295671|474802602|FG000|Overall Study|Withdrawal by Subject|3|||
131869427|NCT01295671|474802603|FG001|Overall Study|Withdrawal by Subject|1|||
131869428|NCT01295671|474802604|FG002|Overall Study|Withdrawal by Subject|0|||
131918509|NCT02924376|474985153|FG000|Overall Study|Progressive Disease|4|||
131869429|NCT02126579|474802605|FG000|Overall Study|disease progression|0|||
131869430|NCT02126579|474802606|FG001|Overall Study|disease progression|0|||
131869431|NCT02126579|474802607|FG002|Overall Study|disease progression|0|||
131869432|NCT02126579|474802608|FG003|Overall Study|disease progression|1|||
131869433|NCT02126579|474802609|FG004|Overall Study|disease progression|0|||
131869434|NCT02126579|474802610|FG005|Overall Study|disease progression|0|||
131869435|NCT02126579|474802611|FG006|Overall Study|disease progression|1|||
131869436|NCT02366637|474802618|FG000|First Intervention Period|Adverse Event|0|||
131869437|NCT02366637|474802619|FG001|First Intervention Period|Adverse Event|1|||
131869438|NCT02366637|474802618|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
131869439|NCT02366637|474802619|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
131869440|NCT02366637|474802618|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
131918510|NCT02924376|474985154|FG001|Overall Study|Progressive Disease|0|||
131918511|NCT02924376|474985155|FG002|Overall Study|Progressive Disease|1|||
131918512|NCT02924376|474985156|FG003|Overall Study|Progressive Disease|0|||
131918513|NCT02924376|474985153|FG000|Overall Study|Death|73|||
131918514|NCT02924376|474985154|FG001|Overall Study|Death|18|||
131918515|NCT02924376|474985155|FG002|Overall Study|Death|15|||
131918516|NCT02924376|474985156|FG003|Overall Study|Death|2|||
131918517|NCT02924376|474985153|FG000|Overall Study|Lost to Follow-up|3|||
131918518|NCT02924376|474985154|FG001|Overall Study|Lost to Follow-up|0|||
131918519|NCT02924376|474985155|FG002|Overall Study|Lost to Follow-up|0|||
131918520|NCT02924376|474985156|FG003|Overall Study|Lost to Follow-up|0|||
131918521|NCT02924376|474985153|FG000|Overall Study|Study Terminated by Sponsor|19|||
131918522|NCT02924376|474985154|FG001|Overall Study|Study Terminated by Sponsor|0|||
131918523|NCT02924376|474985155|FG002|Overall Study|Study Terminated by Sponsor|0|||
131918524|NCT02924376|474985156|FG003|Overall Study|Study Terminated by Sponsor|0|||
131918525|NCT02924376|474985153|FG000|Overall Study|Physician Decision|1|||
131918526|NCT02924376|474985154|FG001|Overall Study|Physician Decision|0|||
131918527|NCT02924376|474985155|FG002|Overall Study|Physician Decision|0|||
131918528|NCT02924376|474985156|FG003|Overall Study|Physician Decision|0|||
131918529|NCT02924376|474985153|FG000|Overall Study|Withdrawal by Subject|7|||
131918530|NCT02924376|474985154|FG001|Overall Study|Withdrawal by Subject|2|||
131918531|NCT02924376|474985155|FG002|Overall Study|Withdrawal by Subject|1|||
131918532|NCT02924376|474985156|FG003|Overall Study|Withdrawal by Subject|0|||
131918533|NCT02924376|474985153|FG000|Overall Study|Rolled Over to Another Study|1|||
131918534|NCT02924376|474985154|FG001|Overall Study|Rolled Over to Another Study|0|||
131918535|NCT02924376|474985155|FG002|Overall Study|Rolled Over to Another Study|0|||
131918536|NCT02924376|474985156|FG003|Overall Study|Rolled Over to Another Study|0|||
131869441|NCT02366637|474802619|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
131869442|NCT02609607|474802620|FG000|Overall Study|Lost to Follow-up|0|||
131869443|NCT02609607|474802621|FG001|Overall Study|Lost to Follow-up|1|||
131869444|NCT03168711|474802622|FG000|Overall Study|Adverse Event|2|||
131869445|NCT03168711|474802623|FG001|Overall Study|Adverse Event|0|||
131869446|NCT03168711|474802622|FG000|Overall Study|Withdrawal by Subject|0|||
131869447|NCT03168711|474802623|FG001|Overall Study|Withdrawal by Subject|1|||
131869448|NCT03168711|474802622|FG000|Overall Study|Death|0|||
131869449|NCT03168711|474802623|FG001|Overall Study|Death|1|||
131869450|NCT00651261|474802624|FG000|Overall Study|Adverse Event|32|||
131869451|NCT00651261|474802625|FG001|Overall Study|Adverse Event|22|||
131869452|NCT00651261|474802624|FG000|Overall Study|Death|18|||
131869453|NCT00651261|474802625|FG001|Overall Study|Death|18|||
131869454|NCT00651261|474802624|FG000|Overall Study|Withdrawal by Subject|22|||
131869455|NCT00651261|474802625|FG001|Overall Study|Withdrawal by Subject|40|||
131869456|NCT00651261|474802624|FG000|Overall Study|Induction failure|24|||
131869457|NCT00651261|474802625|FG001|Overall Study|Induction failure|35|||
131869458|NCT00651261|474802624|FG000|Overall Study|Disease progression|58|||
131869459|NCT00651261|474802625|FG001|Overall Study|Disease progression|58|||
131869460|NCT00651261|474802624|FG000|Overall Study|Alternative therapy|109|||
131869461|NCT00651261|474802625|FG001|Overall Study|Alternative therapy|107|||
131869462|NCT00651261|474802624|FG000|Overall Study|Other disease or participant decisions|23|||
131869463|NCT00651261|474802625|FG001|Overall Study|Other disease or participant decisions|23|||
131869464|NCT00651261|474802624|FG000|Overall Study|Never treated|5|||
131869465|NCT00651261|474802625|FG001|Overall Study|Never treated|3|||
131869466|NCT01609010|474802626|FG000|Overall Study|Stable disease (SD)|22|||
131869467|NCT01609010|474802627|FG001|Overall Study|Stable disease (SD)|16|||
131869468|NCT01609010|474802626|FG000|Overall Study|Progressive disease (PD)|8|||
131869469|NCT01609010|474802627|FG001|Overall Study|Progressive disease (PD)|10|||
131869470|NCT01609010|474802626|FG000|Overall Study|Adverse Event|3|||
131918537|NCT05253807|474985157|FG000|Overall Study|Death|1|||
131918538|NCT05253807|474985158|FG001|Overall Study|Death|4|||
131918539|NCT05253807|474985157|FG000|Overall Study|Withdrawal by Subject|1|||
131918540|NCT05253807|474985158|FG001|Overall Study|Withdrawal by Subject|0|||
131918541|NCT05253807|474985157|FG000|Overall Study|Study Terminated by Sponsor|1|||
131869471|NCT01609010|474802627|FG001|Overall Study|Adverse Event|6|||
131869472|NCT01609010|474802626|FG000|Overall Study|Withdrawal by Subject|2|||
131918542|NCT05253807|474985158|FG001|Overall Study|Study Terminated by Sponsor|1|||
131918543|NCT04611126|474985159|FG000|Overall Study|TIL expansion unsuccessful|1|||
131918544|NCT04611126|474985160|FG001|Overall Study|TIL expansion unsuccessful|0|||
131918545|NCT03459846|474985161|FG000|Overall Study|Death|52|||
131918546|NCT03459846|474985162|FG001|Overall Study|Death|46|||
131918547|NCT03459846|474985161|FG000|Overall Study|Study terminated by sponsor|24|||
131918548|NCT03459846|474985162|FG001|Overall Study|Study terminated by sponsor|28|||
131918549|NCT03459846|474985161|FG000|Overall Study|Withdrawal by Subject|2|||
131869473|NCT01609010|474802627|FG001|Overall Study|Withdrawal by Subject|2|||
131869474|NCT01609010|474802626|FG000|Overall Study|Other|2|||
131869475|NCT01609010|474802627|FG001|Overall Study|Other|0|||
131869476|NCT01609010|474802626|FG000|Overall Study|Other malignancy|1|||
131869477|NCT01609010|474802627|FG001|Overall Study|Other malignancy|0|||
131869478|NCT01609010|474802626|FG000|Overall Study|Pathology review|2|||
131869479|NCT01609010|474802627|FG001|Overall Study|Pathology review|1|||
131869480|NCT01609010|474802626|FG000|Overall Study|Protocol Violation|1|||
131869481|NCT01609010|474802627|FG001|Overall Study|Protocol Violation|1|||
131869482|NCT01609010|474802626|FG000|Overall Study|New cancer|1|||
131869483|NCT01609010|474802627|FG001|Overall Study|New cancer|0|||
131869484|NCT01609010|474802626|FG000|Overall Study|Lost to Follow-up|1|||
131869485|NCT01609010|474802627|FG001|Overall Study|Lost to Follow-up|1|||
131869486|NCT01134107|474802628|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
131869487|NCT01134107|474802629|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
131869488|NCT01134107|474802628|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
131869489|NCT01134107|474802629|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
131869490|NCT01134107|474802628|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
131869491|NCT01134107|474802629|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
131869492|NCT01134107|474802628|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
131869493|NCT01134107|474802629|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
131869494|NCT01134107|474802628|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
131869495|NCT01134107|474802629|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
131869496|NCT01134107|474802628|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
131869497|NCT01134107|474802629|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
131869498|NCT01134107|474802628|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
131869499|NCT01134107|474802629|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
131869500|NCT00687271|474802630|FG000|Overall Study|Adverse Event|1|||
131869501|NCT00687271|474802631|FG001|Overall Study|Adverse Event|3|||
131869502|NCT00687271|474802632|FG002|Overall Study|Adverse Event|1|||
131869503|NCT00687271|474802633|FG003|Overall Study|Adverse Event|0|||
131869504|NCT00687271|474802630|FG000|Overall Study|Lost to Follow-up|0|||
131869505|NCT00687271|474802631|FG001|Overall Study|Lost to Follow-up|1|||
131869506|NCT00687271|474802632|FG002|Overall Study|Lost to Follow-up|0|||
131869507|NCT00687271|474802633|FG003|Overall Study|Lost to Follow-up|0|||
131869508|NCT00687271|474802630|FG000|Overall Study|Protocol Violation|2|||
131869509|NCT00687271|474802631|FG001|Overall Study|Protocol Violation|1|||
131869510|NCT00687271|474802632|FG002|Overall Study|Protocol Violation|1|||
131869511|NCT00687271|474802633|FG003|Overall Study|Protocol Violation|0|||
131869512|NCT00687271|474802630|FG000|Overall Study|Withdrawal by Subject|0|||
131869513|NCT00687271|474802631|FG001|Overall Study|Withdrawal by Subject|1|||
131869514|NCT00687271|474802632|FG002|Overall Study|Withdrawal by Subject|3|||
131869515|NCT00687271|474802633|FG003|Overall Study|Withdrawal by Subject|0|||
131869516|NCT05483686|474802640|FG000|Overall Study|Lost to Follow-up|5|||
131869517|NCT05483686|474802641|FG001|Overall Study|Lost to Follow-up|7|||
131869518|NCT03351608|474802650|FG000|Overall Study|Lost to Follow-up|0|||
131869519|NCT03351608|474802651|FG001|Overall Study|Lost to Follow-up|1|||
131869520|NCT03351608|474802652|FG002|Overall Study|Lost to Follow-up|1|||
131869521|NCT03351608|474802653|FG003|Overall Study|Lost to Follow-up|1|||
131869522|NCT03351608|474802654|FG004|Overall Study|Lost to Follow-up|1|||
131869523|NCT03351608|474802650|FG000|Overall Study|Physician Decision|1|||
131869524|NCT03351608|474802651|FG001|Overall Study|Physician Decision|0|||
131869525|NCT03351608|474802652|FG002|Overall Study|Physician Decision|0|||
131869526|NCT03351608|474802653|FG003|Overall Study|Physician Decision|2|||
131869527|NCT03351608|474802654|FG004|Overall Study|Physician Decision|1|||
131869528|NCT03351608|474802650|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
131869529|NCT03351608|474802651|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
131869530|NCT03351608|474802652|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
131869531|NCT03351608|474802653|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
131869532|NCT03351608|474802654|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
131869533|NCT03351608|474802650|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131869534|NCT03351608|474802651|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131869535|NCT03351608|474802652|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131869536|NCT03351608|474802653|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131869537|NCT03351608|474802654|FG004|Overall Study|Withdrawal by parent/guardian|0|||
131869538|NCT03351608|474802650|FG000|Overall Study|Other|0|||
131869539|NCT03351608|474802651|FG001|Overall Study|Other|1|||
131869540|NCT03351608|474802652|FG002|Overall Study|Other|1|||
131869541|NCT03351608|474802653|FG003|Overall Study|Other|3|||
131869542|NCT03351608|474802654|FG004|Overall Study|Other|0|||
131869543|NCT02727478|474802655|FG000|Overall Study|Withdrawal by Subject|8|||
131869544|NCT02727478|474802656|FG001|Overall Study|Withdrawal by Subject|10|||
131869545|NCT02633293|474802657|FG000|Overall Study|Death|56|||
131869546|NCT02633293|474802657|FG000|Overall Study|Progressive Disease|12|||
131869547|NCT02633293|474802657|FG000|Overall Study|Adverse Event|29|||
131869548|NCT02633293|474802657|FG000|Overall Study|Withdrawal by Subject|41|||
131869549|NCT02633293|474802657|FG000|Overall Study|Protocol Violation|1|||
131869550|NCT02633293|474802657|FG000|Overall Study|Lost to Follow-up|1|||
131869551|NCT02633293|474802657|FG000|Overall Study|Study Terminated by Sponsor|24|||
131869552|NCT02633293|474802657|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
131434026|NCT01188772|473214618|FG000|Overall Study|Randomized but Not Treated|0|||
131869553|NCT02633293|474802657|FG000|Overall Study|Lung Transplant|5|||
131869554|NCT02633293|474802657|FG000|Overall Study|Lack of Efficacy|2|||
131869555|NCT02633293|474802657|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
131869556|NCT00808210|474802658|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
131869557|NCT00808210|474802659|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
131869558|NCT00808210|474802658|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
131869559|NCT00808210|474802659|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
131869560|NCT00808210|474802658|FG000|Double-Blind TX Period|Adverse Event|0|||
131869561|NCT00808210|474802659|FG001|Double-Blind TX Period|Adverse Event|1|||
131869562|NCT00808210|474802658|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
131869563|NCT00808210|474802659|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
131869564|NCT00808210|474802658|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
131869565|NCT00808210|474802659|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
131869566|NCT00808210|474802658|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
131869567|NCT00808210|474802659|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
131869568|NCT03877068|474802663|FG000|Overall Study|Physician Decision|9|||
131869569|NCT03877068|474802664|FG001|Overall Study|Physician Decision|3|||
131869570|NCT00778817|474802665|FG000|Overall Study|Adverse Event|2|||
131869571|NCT00778817|474802665|FG000|Overall Study|Withdrawal by Subject|2|||
131869572|NCT01418378|474802666|FG000|Overall Study|Death|1|||
131869573|NCT01418378|474802667|FG001|Overall Study|Death|2|||
131869574|NCT01418378|474802666|FG000|Overall Study|Physician Decision|0|||
131869575|NCT01418378|474802667|FG001|Overall Study|Physician Decision|1|||
131869576|NCT01418378|474802666|FG000|Overall Study|ligament imbalance|0|||
131869577|NCT01418378|474802667|FG001|Overall Study|ligament imbalance|1|||
131869578|NCT01418378|474802666|FG000|Overall Study|developed chronic myopathy|0|||
131869579|NCT01418378|474802667|FG001|Overall Study|developed chronic myopathy|1|||
131869580|NCT03150719|474802670|FG000|Overall Study|Adverse Event|0|||
131869581|NCT03150719|474802671|FG001|Overall Study|Adverse Event|1|||
131869582|NCT03150719|474802670|FG000|Overall Study|Death|0|||
131869583|NCT03150719|474802671|FG001|Overall Study|Death|1|||
131869584|NCT03150719|474802670|FG000|Overall Study|Other|1|||
131869585|NCT03150719|474802671|FG001|Overall Study|Other|0|||
131869586|NCT01790984|474802672|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
131869587|NCT01790984|474802673|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
131869588|NCT01790984|474802674|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
131869589|NCT01790984|474802675|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
131869590|NCT01051791|474802681|FG000|Overall Study|Failed screening|3|||
131869591|NCT01051791|474802681|FG000|Overall Study|Withdrawal by Subject|1|||
131869592|NCT00288626|474802682|FG000|Overall Study|Death|3|||
131869593|NCT00288626|474802682|FG000|Overall Study|Withdrawal by Subject|4|||
131869594|NCT01081769|474802684|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
131869595|NCT01081769|474802685|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
131869596|NCT01081769|474802684|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
131869597|NCT01081769|474802685|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
131869598|NCT01081769|474802684|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
131869599|NCT01081769|474802685|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
131869600|NCT01081769|474802684|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
131869601|NCT01081769|474802685|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
131869602|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Adverse Event|14|||
131869603|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Adverse Event|11|||
131869604|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Death|1|||
131869605|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Death|1|||
131869606|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
131869607|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
131869608|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
131869609|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
131869610|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Pregnancy|1|||
131869611|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Pregnancy|0|||
131869612|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
131869613|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
131869614|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
131869615|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
131869616|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Other|0|||
131869617|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Other|1|||
131869618|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Ineligibility|3|||
131869619|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Ineligibility|4|||
131869620|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
131869621|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
131869622|NCT01081769|474802684|FG000|CORE Intent-To-Treat|Patient Moved|2|||
131869623|NCT01081769|474802685|FG001|CORE Intent-To-Treat|Patient Moved|2|||
131869624|NCT02019264|474802686|FG000|Overall Study|Not treated|6|||
131869625|NCT02019264|474802687|FG001|Overall Study|Not treated|4|||
131918550|NCT03459846|474985162|FG001|Overall Study|Withdrawal by Subject|2|||
131918551|NCT06455111|474985165|FG000|Overall Study|Withdrawal by Subject|11|||
131918552|NCT06455111|474985166|FG001|Overall Study|Withdrawal by Subject|4|||
131918553|NCT00632359|474985172|FG000|Overall Study|Withdrawal by Subject|2|||
131918554|NCT06717399|474985173|FG000|Overall Study|Death|1|||
131918555|NCT00005047|474985778|FG000|Overall Study|Withdrawal by Subject|12|||
131918556|NCT00005047|474985779|FG001|Overall Study|Withdrawal by Subject|0|||
131918557|NCT00005047|474985780|FG002|Overall Study|Withdrawal by Subject|0|||
131869626|NCT02019264|474802686|FG000|Overall Study|Lost to Follow-up|50|||
131869627|NCT02019264|474802687|FG001|Overall Study|Lost to Follow-up|47|||
131869628|NCT02019264|474802686|FG000|Overall Study|Withdrawal by Subject|142|||
131869629|NCT02019264|474802687|FG001|Overall Study|Withdrawal by Subject|117|||
131869630|NCT02019264|474802686|FG000|Overall Study|Administrative reason|36|||
131869631|NCT02019264|474802687|FG001|Overall Study|Administrative reason|28|||
131869632|NCT02019264|474802686|FG000|Overall Study|Missing|14|||
131869633|NCT02019264|474802687|FG001|Overall Study|Missing|11|||
131869634|NCT02914613|474802688|FG000|Overall Study|Withdrawal by Subject|1|||
131869635|NCT02914613|474802689|FG001|Overall Study|Withdrawal by Subject|2|||
131869636|NCT02914613|474802688|FG000|Overall Study|Adverse Event|1|||
131869637|NCT02914613|474802689|FG001|Overall Study|Adverse Event|0|||
131869638|NCT01964222|474802693|FG000|Overall Study|Lost to Follow-up|7|||
131869639|NCT01964222|474802694|FG001|Overall Study|Lost to Follow-up|5|||
131869640|NCT01964222|474802693|FG000|Overall Study|Withdrawal by Subject|6|||
131869641|NCT01964222|474802694|FG001|Overall Study|Withdrawal by Subject|6|||
131869642|NCT01964222|474802693|FG000|Overall Study|Screening Failure|2|||
131869643|NCT01964222|474802694|FG001|Overall Study|Screening Failure|0|||
131869644|NCT01737710|474802695|FG000|Overall Study|Lost to Follow-up|0|||
131869645|NCT01737710|474802696|FG001|Overall Study|Lost to Follow-up|2|||
131869646|NCT01737710|474802697|FG002|Overall Study|Lost to Follow-up|2|||
131869647|NCT01737710|474802698|FG003|Overall Study|Lost to Follow-up|0|||
131869648|NCT01737710|474802699|FG004|Overall Study|Lost to Follow-up|0|||
131869649|NCT01737710|474802695|FG000|Overall Study|Withdrawal by Subject|1|||
131869650|NCT01737710|474802696|FG001|Overall Study|Withdrawal by Subject|1|||
131869651|NCT01737710|474802697|FG002|Overall Study|Withdrawal by Subject|1|||
131869652|NCT01737710|474802698|FG003|Overall Study|Withdrawal by Subject|0|||
131869653|NCT01737710|474802699|FG004|Overall Study|Withdrawal by Subject|0|||
131869654|NCT01737710|474802695|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
131869655|NCT01737710|474802696|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
131869656|NCT01737710|474802697|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
131869657|NCT01737710|474802698|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
131869658|NCT01737710|474802699|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
131869659|NCT02199795|474802704|FG000|Overall Study|no longer met inclusion criteria|1|||
131869660|NCT02199795|474802705|FG001|Overall Study|no longer met inclusion criteria|0|||
131869661|NCT02199795|474802704|FG000|Overall Study|withdrew due to shoulder pain|1|||
131869662|NCT02199795|474802705|FG001|Overall Study|withdrew due to shoulder pain|0|||
131869663|NCT05310071|474802716|FG000|Overall Study|Death|0|||
131869664|NCT05310071|474802717|FG001|Overall Study|Death|3|||
131869665|NCT05310071|474802716|FG000|Overall Study|Adverse Event|4|||
131869666|NCT05310071|474802717|FG001|Overall Study|Adverse Event|31|||
131869667|NCT05310071|474802716|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
131869668|NCT05310071|474802717|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
131869669|NCT05310071|474802716|FG000|Overall Study|Protocol Deviation|2|||
131869670|NCT05310071|474802717|FG001|Overall Study|Protocol Deviation|0|||
131869671|NCT05310071|474802716|FG000|Overall Study|Randomized by Mistake|0|||
131869672|NCT05310071|474802717|FG001|Overall Study|Randomized by Mistake|1|||
131869673|NCT05310071|474802716|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
131869674|NCT05310071|474802717|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
131869675|NCT05310071|474802716|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
131918558|NCT00005047|474985781|FG003|Overall Study|Withdrawal by Subject|0|||
131869676|NCT05310071|474802717|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
131869677|NCT05310071|474802716|FG000|Overall Study|Site Terminated by Sponsor|0|||
131869678|NCT05310071|474802717|FG001|Overall Study|Site Terminated by Sponsor|2|||
131869679|NCT05310071|474802716|FG000|Overall Study|Study Terminated by Sponsor|282|||
131918559|NCT00005047|474985778|FG000|Overall Study|Adverse Event|5|||
131869680|NCT05310071|474802717|FG001|Overall Study|Study Terminated by Sponsor|559|||
131869681|NCT05310071|474802716|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
131869682|NCT05310071|474802717|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
131869683|NCT05310071|474802716|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
131869684|NCT05310071|474802717|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
131869685|NCT05310071|474802716|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
131869686|NCT05310071|474802717|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
131918560|NCT00005047|474985779|FG001|Overall Study|Adverse Event|0|||
131918561|NCT00005047|474985780|FG002|Overall Study|Adverse Event|0|||
131918562|NCT00005047|474985781|FG003|Overall Study|Adverse Event|0|||
131869687|NCT05310071|474802716|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
131869688|NCT05310071|474802717|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
131869689|NCT05310071|474802716|FG000|Overall Study|Withdrawal by Participant - Other|25|||
131869690|NCT05310071|474802717|FG001|Overall Study|Withdrawal by Participant - Other|30|||
131869691|NCT05310071|474802716|FG000|Overall Study|Lost to Follow-up|2|||
131869692|NCT05310071|474802717|FG001|Overall Study|Lost to Follow-up|4|||
131869693|NCT05310071|474802716|FG000|Overall Study|Reason Not Specified|1|||
131869694|NCT05310071|474802717|FG001|Overall Study|Reason Not Specified|3|||
131869695|NCT02105987|474802718|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
131869696|NCT02105987|474802719|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
131869697|NCT02105987|474802720|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
131869698|NCT02105987|474802721|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
131869699|NCT02105987|474802722|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
131869700|NCT02105987|474802723|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
131869701|NCT02105987|474802718|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
131869702|NCT02105987|474802719|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
131869703|NCT02105987|474802720|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
131869704|NCT02105987|474802721|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
131869705|NCT02105987|474802722|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
131869706|NCT02105987|474802723|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
131869707|NCT02105987|474802718|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
131869708|NCT02105987|474802719|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
131869709|NCT02105987|474802720|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869710|NCT02105987|474802721|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869711|NCT02105987|474802722|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869712|NCT02105987|474802723|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869713|NCT02105987|474802718|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
131869714|NCT02105987|474802719|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
131869715|NCT02105987|474802720|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869716|NCT02105987|474802721|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869717|NCT02105987|474802722|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869718|NCT02105987|474802723|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869719|NCT02105987|474802718|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
131869720|NCT02105987|474802719|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
131869721|NCT02105987|474802720|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
131869722|NCT02105987|474802721|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
131869723|NCT02105987|474802722|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
131869724|NCT02105987|474802723|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
131869725|NCT02105987|474802718|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
131869726|NCT02105987|474802719|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
131869727|NCT02105987|474802720|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
131869728|NCT02105987|474802721|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
131869729|NCT02105987|474802722|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
131869730|NCT02105987|474802723|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
131869731|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
131869732|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
131869733|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
131869734|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
131869735|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
131869736|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
131869737|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
131869738|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
131869739|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
131869740|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
131869741|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
131869742|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
131869743|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869744|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869745|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
131869746|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
131869747|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869748|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
131869749|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869750|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869751|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
131869752|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
131869753|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131918563|NCT00005047|474985778|FG000|Overall Study|Lost to Follow-up|1|||
131918564|NCT00005047|474985779|FG001|Overall Study|Lost to Follow-up|0|||
131918565|NCT00005047|474985780|FG002|Overall Study|Lost to Follow-up|0|||
131918566|NCT00005047|474985781|FG003|Overall Study|Lost to Follow-up|0|||
131918567|NCT00005047|474985778|FG000|Overall Study|Lack of Efficacy|1|||
131918568|NCT00005047|474985779|FG001|Overall Study|Lack of Efficacy|0|||
131918569|NCT00005047|474985780|FG002|Overall Study|Lack of Efficacy|0|||
131918570|NCT00005047|474985781|FG003|Overall Study|Lack of Efficacy|0|||
131918571|NCT00098475|474985786|FG000|Step 1|Progressive disease|33|||
131918572|NCT00098475|474985787|FG001|Step 1|Progressive disease|35|||
131918573|NCT00098475|474985788|FG002|Step 1|Progressive disease|2|||
131918574|NCT00098475|474985789|FG003|Step 1|Progressive disease|1|||
131918575|NCT00098475|474985786|FG000|Step 1|Adverse Event|56|||
131918576|NCT00098475|474985787|FG001|Step 1|Adverse Event|37|||
131918577|NCT00098475|474985788|FG002|Step 1|Adverse Event|0|||
131918578|NCT00098475|474985789|FG003|Step 1|Adverse Event|1|||
131918579|NCT00098475|474985786|FG000|Step 1|Death|8|||
131918580|NCT00098475|474985787|FG001|Step 1|Death|5|||
131918581|NCT00098475|474985788|FG002|Step 1|Death|0|||
131918582|NCT00098475|474985789|FG003|Step 1|Death|1|||
131918583|NCT00098475|474985786|FG000|Step 1|Withdrawal by Subject|14|||
131918584|NCT00098475|474985787|FG001|Step 1|Withdrawal by Subject|11|||
131918585|NCT00098475|474985788|FG002|Step 1|Withdrawal by Subject|0|||
131918586|NCT00098475|474985789|FG003|Step 1|Withdrawal by Subject|0|||
131918587|NCT00098475|474985786|FG000|Step 1|Physician Decision|5|||
131918588|NCT00098475|474985787|FG001|Step 1|Physician Decision|2|||
131918589|NCT00098475|474985788|FG002|Step 1|Physician Decision|0|||
131918590|NCT00098475|474985789|FG003|Step 1|Physician Decision|0|||
131918591|NCT00098475|474985786|FG000|Step 1|Alternative therapy|31|||
131918592|NCT00098475|474985787|FG001|Step 1|Alternative therapy|43|||
131918593|NCT00098475|474985788|FG002|Step 1|Alternative therapy|1|||
131918594|NCT00098475|474985789|FG003|Step 1|Alternative therapy|0|||
131918595|NCT00098475|474985786|FG000|Step 1|Other disease|2|||
131453926|NCT02067676|473291835|FG002|Overall Study|Withdrawal by Subject|0|||
131869754|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
131869755|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
131869756|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
131869757|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
131869758|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
131869759|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
131869760|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
131869761|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
131869762|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
131869763|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
131869764|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
131869765|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
131869766|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
131869767|NCT02105987|474802718|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
131869768|NCT02105987|474802719|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
131869769|NCT02105987|474802720|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
131869770|NCT02105987|474802721|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
131869771|NCT02105987|474802722|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
131869772|NCT02105987|474802723|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
131869773|NCT02105987|474802718|FG000|Continuation Phase|Protocol Violation|0|||
131869774|NCT02105987|474802719|FG001|Continuation Phase|Protocol Violation|0|||
131869775|NCT02105987|474802720|FG002|Continuation Phase|Protocol Violation|0|||
131869776|NCT02105987|474802721|FG003|Continuation Phase|Protocol Violation|0|||
131869777|NCT02105987|474802722|FG004|Continuation Phase|Protocol Violation|1|||
131869778|NCT02105987|474802723|FG005|Continuation Phase|Protocol Violation|0|||
131869779|NCT01791894|474802724|FG000|Overall Study|Adverse Event|1|||
131869780|NCT00996125|474802726|FG000|Overall Study|Adverse Event|0|||
131869781|NCT00996125|474802727|FG001|Overall Study|Adverse Event|2|||
131869782|NCT00996125|474802726|FG000|Overall Study|Lost to Follow-up|1|||
131869783|NCT00996125|474802727|FG001|Overall Study|Lost to Follow-up|6|||
131869784|NCT00996125|474802726|FG000|Overall Study|Withdrawal by Subject|4|||
131869785|NCT00996125|474802727|FG001|Overall Study|Withdrawal by Subject|3|||
131869786|NCT04331067|474802728|FG000|Overall Study|Adverse Event|1|||
131869787|NCT04331067|474802729|FG001|Overall Study|Adverse Event|3|||
131869788|NCT04331067|474802730|FG002|Overall Study|Adverse Event|1|||
131918596|NCT00098475|474985787|FG001|Step 1|Other disease|1|||
131918597|NCT00098475|474985788|FG002|Step 1|Other disease|1|||
131918598|NCT00098475|474985789|FG003|Step 1|Other disease|0|||
131918599|NCT00098475|474985786|FG000|Step 1|Never started treatment|0|||
131918600|NCT00098475|474985787|FG001|Step 1|Never started treatment|2|||
131918601|NCT00098475|474985788|FG002|Step 1|Never started treatment|0|||
131918602|NCT00098475|474985789|FG003|Step 1|Never started treatment|0|||
131918603|NCT00098475|474985786|FG000|Step 1|Still on treatment as of this analysis|14|||
131918604|NCT00098475|474985787|FG001|Step 1|Still on treatment as of this analysis|27|||
131918605|NCT00098475|474985788|FG002|Step 1|Still on treatment as of this analysis|0|||
131918606|NCT00098475|474985789|FG003|Step 1|Still on treatment as of this analysis|0|||
131869789|NCT04331067|474802728|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
131869790|NCT04331067|474802729|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
131918607|NCT00098475|474985786|FG000|Step 1|Knee surgery|1|||
131918608|NCT00098475|474985787|FG001|Step 1|Knee surgery|0|||
131918609|NCT00098475|474985788|FG002|Step 1|Knee surgery|0|||
131918610|NCT00098475|474985789|FG003|Step 1|Knee surgery|0|||
131918611|NCT00098475|474985786|FG000|Step 1|Complications|1|||
131918612|NCT00098475|474985787|FG001|Step 1|Complications|0|||
131918613|NCT00098475|474985788|FG002|Step 1|Complications|0|||
131918614|NCT00098475|474985789|FG003|Step 1|Complications|0|||
131918615|NCT00098475|474985786|FG000|Step 1|Cannot comply due to other tx|0|||
131918616|NCT00098475|474985787|FG001|Step 1|Cannot comply due to other tx|1|||
131918617|NCT00098475|474985788|FG002|Step 1|Cannot comply due to other tx|0|||
131918618|NCT00098475|474985789|FG003|Step 1|Cannot comply due to other tx|0|||
131918619|NCT00098475|474985786|FG000|Step 1|Both patient and physician's decision|2|||
131918620|NCT00098475|474985787|FG001|Step 1|Both patient and physician's decision|1|||
131918621|NCT00098475|474985788|FG002|Step 1|Both patient and physician's decision|0|||
131918622|NCT00098475|474985789|FG003|Step 1|Both patient and physician's decision|0|||
131918623|NCT00098475|474985786|FG000|Step 1|Incorrect disease assessment|2|||
131918624|NCT00098475|474985787|FG001|Step 1|Incorrect disease assessment|0|||
131918625|NCT00098475|474985788|FG002|Step 1|Incorrect disease assessment|0|||
131918626|NCT00098475|474985789|FG003|Step 1|Incorrect disease assessment|0|||
131918627|NCT00098475|474985786|FG000|Step 1|Off treatment for > specified timeframe|1|||
131869791|NCT04331067|474802730|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
131869792|NCT02203721|474802731|FG000|Overall Study|Lost to Follow-up|1|||
131869793|NCT02203721|474802732|FG001|Overall Study|Lost to Follow-up|0|||
131869794|NCT02203721|474802731|FG000|Overall Study|Death|0|||
131869795|NCT02203721|474802732|FG001|Overall Study|Death|2|||
131869796|NCT02203721|474802731|FG000|Overall Study|Illness|0|||
131869797|NCT02203721|474802732|FG001|Overall Study|Illness|1|||
131869798|NCT04031846|474802733|FG000|Overall Study|Lost to Follow-up|4|||
131869799|NCT04031846|474802734|FG001|Overall Study|Lost to Follow-up|4|||
131869800|NCT04031846|474802733|FG000|Overall Study|Physician Decision|0|||
131869801|NCT04031846|474802734|FG001|Overall Study|Physician Decision|1|||
131869802|NCT04031846|474802733|FG000|Overall Study|Protocol Violation|1|||
131869803|NCT04031846|474802734|FG001|Overall Study|Protocol Violation|1|||
131869804|NCT04031846|474802733|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
131869805|NCT04031846|474802734|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
131869806|NCT06868654|474802735|FG000|Overall Study|Death|4|||
131869807|NCT06868654|474802736|FG001|Overall Study|Death|14|||
131869808|NCT06868654|474802735|FG000|Overall Study|Lost to Follow-up|0|||
131869809|NCT06868654|474802736|FG001|Overall Study|Lost to Follow-up|1|||
131869810|NCT06868654|474802735|FG000|Overall Study|Withdrawal by Subject|5|||
131869811|NCT06868654|474802736|FG001|Overall Study|Withdrawal by Subject|3|||
131869812|NCT06868654|474802735|FG000|Overall Study|Physician Decision|0|||
131869813|NCT06868654|474802736|FG001|Overall Study|Physician Decision|1|||
131869814|NCT06868654|474802735|FG000|Overall Study|Ongoing|23|||
131869815|NCT06868654|474802736|FG001|Overall Study|Ongoing|21|||
131869816|NCT01131455|474802741|FG000|Overall Study|Death of PI|6|||
131869817|NCT01131455|474802742|FG001|Overall Study|Death of PI|4|||
131869818|NCT01131455|474802743|FG002|Overall Study|Death of PI|0|||
131918628|NCT00098475|474985787|FG001|Step 1|Off treatment for > specified timeframe|1|||
131918629|NCT00098475|474985788|FG002|Step 1|Off treatment for > specified timeframe|0|||
131918630|NCT00098475|474985789|FG003|Step 1|Off treatment for > specified timeframe|0|||
131408244|NCT03054350|473118245|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
131408245|NCT03054350|473118246|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
131869819|NCT03103152|474802744|FG000|Overall Study|Physician Decision|5|||
131869820|NCT03103152|474802745|FG001|Overall Study|Physician Decision|2|||
131869821|NCT03103152|474802746|FG002|Overall Study|Physician Decision|6|||
131869822|NCT03103152|474802747|FG003|Overall Study|Physician Decision|3|||
131869823|NCT03103152|474802748|FG004|Overall Study|Physician Decision|3|||
131869824|NCT03103152|474802749|FG005|Overall Study|Physician Decision|1|||
131869825|NCT03103152|474802744|FG000|Overall Study|Protocol Violation|2|||
131869826|NCT03103152|474802745|FG001|Overall Study|Protocol Violation|2|||
131869827|NCT03103152|474802746|FG002|Overall Study|Protocol Violation|1|||
131869828|NCT03103152|474802747|FG003|Overall Study|Protocol Violation|2|||
131869829|NCT03103152|474802748|FG004|Overall Study|Protocol Violation|1|||
131869830|NCT03103152|474802749|FG005|Overall Study|Protocol Violation|1|||
131869831|NCT03103152|474802744|FG000|Overall Study|Inter-current illness|0|||
131869832|NCT03103152|474802745|FG001|Overall Study|Inter-current illness|0|||
131918631|NCT00098475|474985786|FG000|Step 1|Declining performance status|0|||
131918632|NCT00098475|474985787|FG001|Step 1|Declining performance status|1|||
131918633|NCT00098475|474985788|FG002|Step 1|Declining performance status|0|||
131918634|NCT00098475|474985789|FG003|Step 1|Declining performance status|0|||
131869833|NCT03103152|474802746|FG002|Overall Study|Inter-current illness|1|||
131918635|NCT00098475|474985786|FG000|Step 1|Insurance issue|0|||
131918636|NCT00098475|474985787|FG001|Step 1|Insurance issue|1|||
131918637|NCT00098475|474985788|FG002|Step 1|Insurance issue|0|||
131918638|NCT00098475|474985789|FG003|Step 1|Insurance issue|0|||
131918639|NCT00098475|474985786|FG000|Step 1|Rising paraprotein|0|||
131918640|NCT00098475|474985787|FG001|Step 1|Rising paraprotein|1|||
131918641|NCT00098475|474985788|FG002|Step 1|Rising paraprotein|0|||
131918642|NCT00098475|474985789|FG003|Step 1|Rising paraprotein|0|||
131918643|NCT00098475|474985786|FG000|Step 1|Referred to other physicians|0|||
131918644|NCT00098475|474985787|FG001|Step 1|Referred to other physicians|1|||
131918645|NCT00098475|474985788|FG002|Step 1|Referred to other physicians|0|||
131918646|NCT00098475|474985789|FG003|Step 1|Referred to other physicians|0|||
131918647|NCT00098475|474985786|FG000|Step 1|Criteria to continue treatment not met|0|||
131918648|NCT00098475|474985787|FG001|Step 1|Criteria to continue treatment not met|1|||
131869834|NCT03103152|474802747|FG003|Overall Study|Inter-current illness|0|||
131869835|NCT03103152|474802748|FG004|Overall Study|Inter-current illness|0|||
131869836|NCT03103152|474802749|FG005|Overall Study|Inter-current illness|0|||
131869837|NCT03103152|474802744|FG000|Overall Study|Death|0|||
131869838|NCT03103152|474802745|FG001|Overall Study|Death|1|||
131869839|NCT03103152|474802746|FG002|Overall Study|Death|0|||
131869840|NCT03103152|474802747|FG003|Overall Study|Death|0|||
131869841|NCT03103152|474802748|FG004|Overall Study|Death|0|||
131869842|NCT03103152|474802749|FG005|Overall Study|Death|0|||
131869843|NCT03103152|474802744|FG000|Overall Study|Adverse Event|0|||
131869844|NCT03103152|474802745|FG001|Overall Study|Adverse Event|0|||
131869845|NCT03103152|474802746|FG002|Overall Study|Adverse Event|1|||
131869846|NCT03103152|474802747|FG003|Overall Study|Adverse Event|0|||
131869847|NCT03103152|474802748|FG004|Overall Study|Adverse Event|0|||
131869848|NCT03103152|474802749|FG005|Overall Study|Adverse Event|1|||
131869849|NCT03103152|474802744|FG000|Overall Study|Withdrawal by Subject|1|||
131869850|NCT03103152|474802745|FG001|Overall Study|Withdrawal by Subject|0|||
131869851|NCT03103152|474802746|FG002|Overall Study|Withdrawal by Subject|1|||
131869852|NCT03103152|474802747|FG003|Overall Study|Withdrawal by Subject|1|||
131869853|NCT03103152|474802748|FG004|Overall Study|Withdrawal by Subject|1|||
131869854|NCT03103152|474802749|FG005|Overall Study|Withdrawal by Subject|1|||
131869855|NCT03103152|474802744|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
131869856|NCT03103152|474802745|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
131869857|NCT03103152|474802746|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
131869858|NCT03103152|474802747|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
131869859|NCT03103152|474802748|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
131869860|NCT03103152|474802749|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
131869861|NCT03103152|474802744|FG000|Overall Study|Unacceptable side effects|0|||
131869862|NCT03103152|474802745|FG001|Overall Study|Unacceptable side effects|0|||
131869863|NCT03103152|474802746|FG002|Overall Study|Unacceptable side effects|0|||
131869864|NCT03103152|474802747|FG003|Overall Study|Unacceptable side effects|0|||
131869865|NCT03103152|474802748|FG004|Overall Study|Unacceptable side effects|0|||
131869866|NCT03103152|474802749|FG005|Overall Study|Unacceptable side effects|1|||
131869867|NCT03103152|474802744|FG000|Overall Study|Lost to Follow-up|0|||
131869868|NCT03103152|474802745|FG001|Overall Study|Lost to Follow-up|1|||
131869869|NCT03103152|474802746|FG002|Overall Study|Lost to Follow-up|0|||
131869870|NCT03103152|474802747|FG003|Overall Study|Lost to Follow-up|1|||
131869871|NCT03103152|474802748|FG004|Overall Study|Lost to Follow-up|0|||
131869872|NCT03103152|474802749|FG005|Overall Study|Lost to Follow-up|1|||
131869873|NCT03103152|474802744|FG000|Overall Study|Testicular pain|0|||
131869874|NCT03103152|474802745|FG001|Overall Study|Testicular pain|0|||
131869875|NCT03103152|474802746|FG002|Overall Study|Testicular pain|0|||
131918649|NCT00098475|474985788|FG002|Step 1|Criteria to continue treatment not met|0|||
131869876|NCT03103152|474802747|FG003|Overall Study|Testicular pain|1|||
131869877|NCT03103152|474802748|FG004|Overall Study|Testicular pain|0|||
131869878|NCT03103152|474802749|FG005|Overall Study|Testicular pain|0|||
131869879|NCT00754234|474804506|FG000|Overall Study|Withdrawal by Subject|3|||
131869880|NCT00915018|474804507|FG000|Overall Study|Death|75|||
131869881|NCT00915018|474804508|FG001|Overall Study|Death|70|||
131869882|NCT00915018|474804507|FG000|Overall Study|Lost to Follow-up|10|||
131869883|NCT00915018|474804508|FG001|Overall Study|Lost to Follow-up|5|||
131869884|NCT00915018|474804507|FG000|Overall Study|Withdrawal by Subject|38|||
131869885|NCT00915018|474804508|FG001|Overall Study|Withdrawal by Subject|27|||
131869886|NCT00915018|474804507|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
131869887|NCT00915018|474804508|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
131869888|NCT00326716|474804509|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
131869889|NCT00326716|474804510|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
131869890|NCT00326716|474804511|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
131869891|NCT00326716|474804512|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
131918650|NCT00098475|474985789|FG003|Step 1|Criteria to continue treatment not met|0|||
131918651|NCT00098475|474985786|FG000|Step 1|Misinterpretation of lab data|0|||
131918652|NCT00098475|474985787|FG001|Step 1|Misinterpretation of lab data|1|||
131918653|NCT00098475|474985788|FG002|Step 1|Misinterpretation of lab data|0|||
131918654|NCT00098475|474985789|FG003|Step 1|Misinterpretation of lab data|0|||
131918655|NCT00098475|474985786|FG000|Step 1|Patient fell with fracture|1|||
131918656|NCT00098475|474985787|FG001|Step 1|Patient fell with fracture|0|||
131918657|NCT00098475|474985788|FG002|Step 1|Patient fell with fracture|0|||
131918658|NCT00098475|474985789|FG003|Step 1|Patient fell with fracture|0|||
131918659|NCT00098475|474985786|FG000|Step 1|Not documented|0|||
131918660|NCT00098475|474985787|FG001|Step 1|Not documented|1|||
131918661|NCT00098475|474985788|FG002|Step 1|Not documented|0|||
131918662|NCT00098475|474985789|FG003|Step 1|Not documented|0|||
131918663|NCT00098475|474985786|FG000|Step 2|Disease progression|1|||
131918664|NCT00098475|474985787|FG001|Step 2|Disease progression|4|||
131918665|NCT00098475|474985788|FG002|Step 2|Disease progression|0|||
131918666|NCT00098475|474985789|FG003|Step 2|Disease progression|0|||
131918667|NCT00098475|474985786|FG000|Step 2|Adverse Event|2|||
131918668|NCT00098475|474985787|FG001|Step 2|Adverse Event|0|||
131918669|NCT00098475|474985788|FG002|Step 2|Adverse Event|0|||
131918670|NCT00098475|474985789|FG003|Step 2|Adverse Event|0|||
131918671|NCT00098475|474985786|FG000|Step 2|Withdrawal by Subject|0|||
131918672|NCT00098475|474985787|FG001|Step 2|Withdrawal by Subject|2|||
131918673|NCT00098475|474985788|FG002|Step 2|Withdrawal by Subject|0|||
131918674|NCT00098475|474985789|FG003|Step 2|Withdrawal by Subject|0|||
131918675|NCT00098475|474985786|FG000|Step 2|Physician Decision|0|||
131918676|NCT00098475|474985787|FG001|Step 2|Physician Decision|1|||
131918677|NCT00098475|474985788|FG002|Step 2|Physician Decision|0|||
131918678|NCT00098475|474985789|FG003|Step 2|Physician Decision|0|||
131918679|NCT00098475|474985786|FG000|Step 2|Alternative therapy|1|||
131918680|NCT00098475|474985787|FG001|Step 2|Alternative therapy|2|||
131918681|NCT00098475|474985788|FG002|Step 2|Alternative therapy|0|||
131918682|NCT00098475|474985789|FG003|Step 2|Alternative therapy|0|||
131918683|NCT00098475|474985786|FG000|Step 2|Never started treatment|1|||
131918684|NCT00098475|474985787|FG001|Step 2|Never started treatment|1|||
131918685|NCT00098475|474985788|FG002|Step 2|Never started treatment|0|||
131918686|NCT00098475|474985789|FG003|Step 2|Never started treatment|0|||
131918687|NCT03976375|474985790|FG000|Overall Study|Death|158|||
131918688|NCT03976375|474985791|FG001|Overall Study|Death|160|||
131918689|NCT03976375|474985792|FG002|Overall Study|Death|42|||
131918690|NCT03976375|474985790|FG000|Overall Study|Lost to Follow-up|2|||
131918691|NCT03976375|474985791|FG001|Overall Study|Lost to Follow-up|1|||
131918692|NCT03976375|474985792|FG002|Overall Study|Lost to Follow-up|1|||
131918693|NCT03976375|474985790|FG000|Overall Study|Withdrawal by Subject|5|||
131918694|NCT03976375|474985791|FG001|Overall Study|Withdrawal by Subject|9|||
131918695|NCT03976375|474985792|FG002|Overall Study|Withdrawal by Subject|4|||
131918696|NCT03976375|474985790|FG000|Overall Study|Sponsor decision|20|||
131918697|NCT03976375|474985791|FG001|Overall Study|Sponsor decision|19|||
131918698|NCT03976375|474985792|FG002|Overall Study|Sponsor decision|1|||
131918699|NCT02466971|474985793|FG000|Overall Study|eligible and never treated|14|||
131918700|NCT02466971|474985794|FG001|Overall Study|eligible and never treated|20|||
131918701|NCT02466971|474985793|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
131918702|NCT02466971|474985794|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
131918703|NCT02466971|474985793|FG000|Overall Study|ineligible and treated|1|||
131918704|NCT02466971|474985794|FG001|Overall Study|ineligible and treated|0|||
131918705|NCT02466971|474985793|FG000|Overall Study|ineligible and never treated|0|||
131918706|NCT02466971|474985794|FG001|Overall Study|ineligible and never treated|1|||
131918707|NCT06187909|474985797|FG000|Overall Study|Withdrawal by Subject|2|||
131918708|NCT06187909|474985798|FG001|Overall Study|Withdrawal by Subject|2|||
131918709|NCT04017962|474985802|FG000|Overall Study|Death|2|||
131918710|NCT04017962|474985803|FG001|Overall Study|Death|0|||
131918711|NCT04017962|474985802|FG000|Overall Study|Lost to Follow-up|2|||
131918712|NCT04017962|474985803|FG001|Overall Study|Lost to Follow-up|0|||
131918713|NCT04017962|474985802|FG000|Overall Study|Physician Decision|1|||
131918714|NCT04017962|474985803|FG001|Overall Study|Physician Decision|0|||
131918715|NCT04017962|474985802|FG000|Overall Study|Discontinued LTV|5|||
131408246|NCT03054350|473118247|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
131918716|NCT04017962|474985803|FG001|Overall Study|Discontinued LTV|0|||
131918717|NCT01260948|474985805|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
131918718|NCT01260948|474985806|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
131918719|NCT01260948|474985805|FG000|Second Intervention|Emesis|0|||
131918720|NCT01260948|474985806|FG001|Second Intervention|Emesis|1|||
131918721|NCT00462462|474985807|FG000|Overall Study|Physician Decision|0|||
131918722|NCT00462462|474985808|FG001|Overall Study|Physician Decision|1|||
131918723|NCT01163617|474985809|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131918724|NCT01163617|474985810|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
131918725|NCT01163617|474985811|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131918726|NCT01163617|474985812|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131408247|NCT03054350|473118248|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
131918727|NCT01163617|474985813|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131918728|NCT01163617|474985814|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131918729|NCT01163617|474985815|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131918730|NCT01163617|474985816|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
131918731|NCT01163617|474985809|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918732|NCT01163617|474985810|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
131918733|NCT01163617|474985811|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918734|NCT01163617|474985812|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918735|NCT01163617|474985813|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918736|NCT01163617|474985814|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918737|NCT01163617|474985815|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918738|NCT01163617|474985816|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
131918739|NCT01163617|474985809|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918740|NCT01163617|474985810|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918741|NCT01163617|474985811|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
131918742|NCT01163617|474985812|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918743|NCT01163617|474985813|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918744|NCT01163617|474985814|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918745|NCT01163617|474985815|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918746|NCT01163617|474985816|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
131918747|NCT02875080|474985817|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
131918748|NCT02875080|474985818|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
131918749|NCT02875080|474985819|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
131918750|NCT02394756|474985820|FG000|Period 1|Lens Discomfort|0|||
131918751|NCT02394756|474985821|FG001|Period 1|Lens Discomfort|0|||
131918752|NCT02394756|474985822|FG002|Period 1|Lens Discomfort|0|||
131918753|NCT02394756|474985823|FG003|Period 1|Lens Discomfort|0|||
131918754|NCT02394756|474985824|FG004|Period 1|Lens Discomfort|0|||
131918755|NCT02394756|474985825|FG005|Period 1|Lens Discomfort|1|||
131918756|NCT02394756|474985820|FG000|Period 1|Withdrawal by Subject|0|||
131869892|NCT01954056|474804521|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
131869893|NCT01954056|474804522|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
131869894|NCT03674112|474804528|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
131869895|NCT03674112|474804529|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
131869896|NCT03674112|474804528|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
131869897|NCT03674112|474804529|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
131869898|NCT03674112|474804528|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
131869899|NCT03674112|474804529|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
131869900|NCT03674112|474804528|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
131869901|NCT03674112|474804529|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
131869902|NCT03674112|474804528|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
131869903|NCT03674112|474804529|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
131869904|NCT03674112|474804528|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
131869905|NCT03674112|474804529|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
131869906|NCT03674112|474804528|FG000|Follow-Up Period (≥3 Years)|Death|2|||
131869907|NCT03674112|474804529|FG001|Follow-Up Period (≥3 Years)|Death|0|||
131869908|NCT03674112|474804528|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
131869909|NCT03674112|474804529|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
131869910|NCT01106911|474804531|FG000|Overall Study|Physician Decision|2|||
131869911|NCT01106911|474804531|FG000|Overall Study|deemed ineligible after screening|3|||
131869912|NCT02677922|474804539|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
131869913|NCT02677922|474804540|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
131869914|NCT02677922|474804541|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
131869915|NCT02677922|474804542|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
131869916|NCT02677922|474804543|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
131869917|NCT02677922|474804544|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
131869918|NCT02677922|474804539|FG000|Treatment Period|Adverse Event|0|||
131869919|NCT02677922|474804540|FG001|Treatment Period|Adverse Event|0|||
131869920|NCT02677922|474804541|FG002|Treatment Period|Adverse Event|1|||
131869921|NCT02677922|474804542|FG003|Treatment Period|Adverse Event|3|||
131869922|NCT02677922|474804543|FG004|Treatment Period|Adverse Event|5|||
131869923|NCT02677922|474804544|FG005|Treatment Period|Adverse Event|2|||
131869924|NCT02677922|474804539|FG000|Treatment Period|Progressive Disease|1|||
131869925|NCT02677922|474804540|FG001|Treatment Period|Progressive Disease|1|||
131869926|NCT02677922|474804541|FG002|Treatment Period|Progressive Disease|0|||
131869927|NCT02677922|474804542|FG003|Treatment Period|Progressive Disease|0|||
131869928|NCT02677922|474804543|FG004|Treatment Period|Progressive Disease|8|||
131869929|NCT02677922|474804544|FG005|Treatment Period|Progressive Disease|7|||
131869930|NCT02677922|474804539|FG000|Treatment Period|Lack of Efficacy|0|||
131918757|NCT02394756|474985821|FG001|Period 1|Withdrawal by Subject|1|||
131869931|NCT02677922|474804540|FG001|Treatment Period|Lack of Efficacy|0|||
131869932|NCT02677922|474804541|FG002|Treatment Period|Lack of Efficacy|0|||
131869933|NCT02677922|474804542|FG003|Treatment Period|Lack of Efficacy|1|||
131869934|NCT02677922|474804543|FG004|Treatment Period|Lack of Efficacy|1|||
131869935|NCT02677922|474804544|FG005|Treatment Period|Lack of Efficacy|6|||
131869936|NCT02677922|474804539|FG000|Treatment Period|Withdrawal by Subject|0|||
131869937|NCT02677922|474804540|FG001|Treatment Period|Withdrawal by Subject|0|||
131869938|NCT02677922|474804541|FG002|Treatment Period|Withdrawal by Subject|1|||
131869939|NCT02677922|474804542|FG003|Treatment Period|Withdrawal by Subject|3|||
131869940|NCT02677922|474804543|FG004|Treatment Period|Withdrawal by Subject|5|||
131869941|NCT02677922|474804544|FG005|Treatment Period|Withdrawal by Subject|5|||
131869942|NCT02677922|474804539|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
131869943|NCT02677922|474804540|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
131869944|NCT02677922|474804541|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
131869945|NCT02677922|474804542|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
131869946|NCT02677922|474804543|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
131869947|NCT02677922|474804544|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
131869948|NCT02677922|474804539|FG000|Treatment Period|Disease Relapse|0|||
131869949|NCT02677922|474804540|FG001|Treatment Period|Disease Relapse|0|||
131869950|NCT02677922|474804541|FG002|Treatment Period|Disease Relapse|0|||
131869951|NCT02677922|474804542|FG003|Treatment Period|Disease Relapse|3|||
131869952|NCT02677922|474804543|FG004|Treatment Period|Disease Relapse|6|||
131869953|NCT02677922|474804544|FG005|Treatment Period|Disease Relapse|1|||
131869954|NCT02677922|474804539|FG000|Treatment Period|Allogeneic HSCT|1|||
131869955|NCT02677922|474804540|FG001|Treatment Period|Allogeneic HSCT|0|||
131869956|NCT02677922|474804541|FG002|Treatment Period|Allogeneic HSCT|0|||
131869957|NCT02677922|474804542|FG003|Treatment Period|Allogeneic HSCT|1|||
131869958|NCT02677922|474804543|FG004|Treatment Period|Allogeneic HSCT|4|||
131869959|NCT02677922|474804544|FG005|Treatment Period|Allogeneic HSCT|1|||
131869960|NCT02677922|474804539|FG000|Treatment Period|Other Reasons|0|||
131869961|NCT02677922|474804540|FG001|Treatment Period|Other Reasons|0|||
131869962|NCT02677922|474804541|FG002|Treatment Period|Other Reasons|0|||
131869963|NCT02677922|474804542|FG003|Treatment Period|Other Reasons|1|||
131869964|NCT02677922|474804543|FG004|Treatment Period|Other Reasons|3|||
131869965|NCT02677922|474804544|FG005|Treatment Period|Other Reasons|5|||
131869966|NCT02677922|474804539|FG000|Treatment Period|Death|0|||
131869967|NCT02677922|474804540|FG001|Treatment Period|Death|0|||
131869968|NCT02677922|474804541|FG002|Treatment Period|Death|0|||
131869969|NCT02677922|474804542|FG003|Treatment Period|Death|0|||
131869970|NCT02677922|474804543|FG004|Treatment Period|Death|12|||
131869971|NCT02677922|474804544|FG005|Treatment Period|Death|1|||
131869972|NCT02677922|474804539|FG000|Treatment Period|Non-compliance with Study Drug|0|||
131869973|NCT02677922|474804540|FG001|Treatment Period|Non-compliance with Study Drug|0|||
131869974|NCT02677922|474804541|FG002|Treatment Period|Non-compliance with Study Drug|0|||
131869975|NCT02677922|474804542|FG003|Treatment Period|Non-compliance with Study Drug|0|||
131869976|NCT02677922|474804543|FG004|Treatment Period|Non-compliance with Study Drug|1|||
131869977|NCT02677922|474804544|FG005|Treatment Period|Non-compliance with Study Drug|0|||
131869978|NCT02677922|474804539|FG000|Treatment Period|Physician Decision|0|||
131869979|NCT02677922|474804540|FG001|Treatment Period|Physician Decision|0|||
131869980|NCT02677922|474804541|FG002|Treatment Period|Physician Decision|0|||
131869981|NCT02677922|474804542|FG003|Treatment Period|Physician Decision|0|||
131869982|NCT02677922|474804543|FG004|Treatment Period|Physician Decision|0|||
131869983|NCT02677922|474804544|FG005|Treatment Period|Physician Decision|1|||
131869984|NCT02677922|474804539|FG000|Treatment Period|Symptomatic Deterioration|0|||
131869985|NCT02677922|474804540|FG001|Treatment Period|Symptomatic Deterioration|0|||
131869986|NCT02677922|474804541|FG002|Treatment Period|Symptomatic Deterioration|0|||
131869987|NCT02677922|474804542|FG003|Treatment Period|Symptomatic Deterioration|0|||
131869988|NCT02677922|474804543|FG004|Treatment Period|Symptomatic Deterioration|1|||
131869989|NCT02677922|474804544|FG005|Treatment Period|Symptomatic Deterioration|0|||
131869990|NCT00984542|474804557|FG000|Overall Study|disease progression|19|||
131869991|NCT00984542|474804557|FG000|Overall Study|toxicity|7|||
131869992|NCT00984542|474804557|FG000|Overall Study|Death|7|||
131869993|NCT00984542|474804557|FG000|Overall Study|complicating disease|3|||
131869994|NCT00984542|474804557|FG000|Overall Study|Withdrawal by Subject|3|||
131869995|NCT00984542|474804557|FG000|Overall Study|clinical deterioration|2|||
131869996|NCT01422889|474804558|FG000|Overall Study|No Data Entered for Study Stent|9|||
131869997|NCT03515811|474804563|FG000|Overall Study|Lost to Follow-up|2|||
131869998|NCT03515811|474804564|FG001|Overall Study|Lost to Follow-up|1|||
131869999|NCT03515811|474804563|FG000|Overall Study|Protocol Violation|1|||
131870000|NCT03515811|474804564|FG001|Overall Study|Protocol Violation|1|||
131870001|NCT03515811|474804563|FG000|Overall Study|Death|1|||
131870002|NCT03515811|474804564|FG001|Overall Study|Death|1|||
131870003|NCT03515811|474804563|FG000|Overall Study|Withdrawal by Subject|0|||
131870004|NCT03515811|474804564|FG001|Overall Study|Withdrawal by Subject|2|||
131870005|NCT03515811|474804563|FG000|Overall Study|Technical Problems|1|||
131918758|NCT02394756|474985822|FG002|Period 1|Withdrawal by Subject|1|||
131918759|NCT02394756|474985823|FG003|Period 1|Withdrawal by Subject|1|||
131918760|NCT02394756|474985824|FG004|Period 1|Withdrawal by Subject|0|||
131918761|NCT02394756|474985825|FG005|Period 1|Withdrawal by Subject|0|||
131918762|NCT02394756|474985820|FG000|Period 2|Unsatisfactory Visual Response|0|||
131918763|NCT02394756|474985821|FG001|Period 2|Unsatisfactory Visual Response|0|||
131918764|NCT02394756|474985822|FG002|Period 2|Unsatisfactory Visual Response|0|||
131918765|NCT02394756|474985823|FG003|Period 2|Unsatisfactory Visual Response|0|||
131918766|NCT02394756|474985824|FG004|Period 2|Unsatisfactory Visual Response|1|||
131918767|NCT02394756|474985825|FG005|Period 2|Unsatisfactory Visual Response|0|||
131918768|NCT00768053|474985826|FG000|Overall Study|Adverse Event|10|||
131918769|NCT00768053|474985826|FG000|Overall Study|Lost to Follow-up|1|||
131918770|NCT02811159|474985827|FG000|Treatment Course 1|Lost to Follow-up|1|||
131918771|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
131918772|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
131918773|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
131918774|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
131918775|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
131918776|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
131918777|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
131918778|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
131918779|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
131918780|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
131918781|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
131918782|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
131918783|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
131918784|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
131918785|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
131918786|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
131918787|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
131918788|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
131918789|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
131918790|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
131918791|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
131918792|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
131918793|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
131918794|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
131918795|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
131918796|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
131918797|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
131918798|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
131918799|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
131918800|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
131918801|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
131918802|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
131918803|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
131918804|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
131918805|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
131918806|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
131918807|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
131918808|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
131918809|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
131918810|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
131918811|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
131918812|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
131918813|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
131918814|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
131918815|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
131918816|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
131918817|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
131918818|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
131918819|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
131408248|NCT03054350|473118243|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
131408249|NCT03054350|473118244|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
131918820|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
131918821|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
131918822|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
131870006|NCT03515811|474804564|FG001|Overall Study|Technical Problems|0|||
131870007|NCT03515811|474804563|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
131870008|NCT03515811|474804564|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
131870009|NCT03515811|474804563|FG000|Overall Study|COVID-19|0|||
131870010|NCT03515811|474804564|FG001|Overall Study|COVID-19|1|||
131870011|NCT00488644|474804565|FG000|Overall Study|Not Eligible|1|||
131870012|NCT00488644|474804565|FG000|Overall Study|Not Evaluable|1|||
131870013|NCT02977572|474804566|FG000|Overall Study|Exclusion criterion|2|||
131870014|NCT02977572|474804567|FG001|Overall Study|Exclusion criterion|2|||
131870015|NCT05107492|474804568|FG000|Overall Study|Lost to Follow-up|1|||
131870016|NCT05107492|474804569|FG001|Overall Study|Lost to Follow-up|0|||
131870017|NCT04339062|474804571|FG000|Overall Study|Death|0|||
131870018|NCT04339062|474804572|FG001|Overall Study|Death|1|||
131870019|NCT01197534|474804573|FG000|Overall Study|Not reported|16|||
131870020|NCT01197534|474804574|FG001|Overall Study|Not reported|10|||
131870021|NCT01197534|474804575|FG002|Overall Study|Not reported|16|||
131870022|NCT01197534|474804573|FG000|Overall Study|Enrolment in long term extension|57|||
131870023|NCT01197534|474804574|FG001|Overall Study|Enrolment in long term extension|66|||
131870024|NCT01197534|474804575|FG002|Overall Study|Enrolment in long term extension|119|||
131870025|NCT01197534|474804573|FG000|Overall Study|Severe non-compliance to protocol|3|||
131870026|NCT01197534|474804574|FG001|Overall Study|Severe non-compliance to protocol|4|||
131870027|NCT01197534|474804575|FG002|Overall Study|Severe non-compliance to protocol|1|||
131870028|NCT01197534|474804573|FG000|Overall Study|Lack of therapeutic response|9|||
131870029|NCT01197534|474804574|FG001|Overall Study|Lack of therapeutic response|4|||
131870030|NCT01197534|474804575|FG002|Overall Study|Lack of therapeutic response|9|||
131870031|NCT01197534|474804573|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
131870032|NCT01197534|474804574|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
131870033|NCT01197534|474804575|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
131870034|NCT01197534|474804573|FG000|Overall Study|Lost to Follow-up|1|||
131870035|NCT01197534|474804574|FG001|Overall Study|Lost to Follow-up|4|||
131870036|NCT01197534|474804575|FG002|Overall Study|Lost to Follow-up|2|||
131870037|NCT01197534|474804573|FG000|Overall Study|Adverse Event|35|||
131870038|NCT01197534|474804574|FG001|Overall Study|Adverse Event|36|||
131870039|NCT01197534|474804575|FG002|Overall Study|Adverse Event|24|||
131870040|NCT02589639|474804589|FG000|Overall Study|Lost to Follow-up|1|||
131870041|NCT02589639|474804590|FG001|Overall Study|Lost to Follow-up|0|||
131870042|NCT02589639|474804591|FG002|Overall Study|Lost to Follow-up|0|||
131870043|NCT02589639|474804589|FG000|Overall Study|Protocol Violation|1|||
131870044|NCT02589639|474804590|FG001|Overall Study|Protocol Violation|0|||
131870045|NCT02589639|474804591|FG002|Overall Study|Protocol Violation|0|||
131870046|NCT02589639|474804589|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
131870047|NCT02589639|474804590|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
131870048|NCT02589639|474804591|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
131870049|NCT02589639|474804589|FG000|Overall Study|Adverse Event|4|||
131870050|NCT02589639|474804590|FG001|Overall Study|Adverse Event|5|||
131870051|NCT02589639|474804591|FG002|Overall Study|Adverse Event|3|||
131870052|NCT02589639|474804589|FG000|Overall Study|Other reason than specified above|1|||
131870053|NCT02589639|474804590|FG001|Overall Study|Other reason than specified above|2|||
131870054|NCT02589639|474804591|FG002|Overall Study|Other reason than specified above|1|||
131870055|NCT02589639|474804589|FG000|Overall Study|Not Treated|0|||
131870056|NCT02589639|474804590|FG001|Overall Study|Not Treated|3|||
131870057|NCT02589639|474804591|FG002|Overall Study|Not Treated|0|||
131870058|NCT02593097|474804592|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
131870059|NCT02593097|474804593|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
131870060|NCT02593097|474804592|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131870061|NCT02593097|474804593|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
131870062|NCT02593097|474804592|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
131870063|NCT02593097|474804593|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
131870064|NCT02593097|474804592|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
131870065|NCT02593097|474804593|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
131870066|NCT02593097|474804592|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
131870067|NCT02593097|474804593|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
131870068|NCT00703157|474804594|FG000|Overall Study|Lost to Follow-up|0|||
131870069|NCT00703157|474804595|FG001|Overall Study|Lost to Follow-up|1|||
131870070|NCT00703157|474804594|FG000|Overall Study|source data permanently lost/ other|4|||
131870071|NCT00703157|474804595|FG001|Overall Study|source data permanently lost/ other|1|||
131870072|NCT02522884|474804596|FG000|Overall Study|Withdrawal by Subject|6|||
131870073|NCT02522884|474804596|FG000|Overall Study|Death|3|||
131870074|NCT02522884|474804596|FG000|Overall Study|Missed 12-month Follow-up|9|||
131870075|NCT02630251|474804597|FG000|Overall Study|Physician Decision|0|||
131870076|NCT02630251|474804598|FG001|Overall Study|Physician Decision|0|||
131870077|NCT02630251|474804599|FG002|Overall Study|Physician Decision|1|||
131870078|NCT02630251|474804600|FG003|Overall Study|Physician Decision|0|||
131870079|NCT02968173|474804601|FG000|Overall Study|Withdrawal by Subject|1|||
131870080|NCT02670525|474804602|FG000|Overall Study|Death|94|||
131870081|NCT02670525|474804603|FG001|Overall Study|Death|14|||
131870082|NCT02670525|474804602|FG000|Overall Study|Lost to Follow-up|4|||
131870083|NCT02670525|474804603|FG001|Overall Study|Lost to Follow-up|1|||
131870084|NCT02670525|474804602|FG000|Overall Study|Subject withdrew consent|1|||
131870085|NCT02670525|474804603|FG001|Overall Study|Subject withdrew consent|0|||
131870086|NCT02670525|474804602|FG000|Overall Study|Unknown, data entry delayed|123|||
131870087|NCT02670525|474804603|FG001|Overall Study|Unknown, data entry delayed|78|||
131870088|NCT00591565|474804604|FG000|Overall Study|lost follow up, withdrawn|5|||
131870089|NCT03564119|474804608|FG000|Overall Study|Adverse Event|4|||
131870090|NCT03564119|474804609|FG001|Overall Study|Adverse Event|0|||
131870091|NCT03564119|474804608|FG000|Overall Study|Lost to Follow-up|1|||
131870092|NCT03564119|474804609|FG001|Overall Study|Lost to Follow-up|4|||
131870093|NCT03564119|474804608|FG000|Overall Study|Protocol Violation|1|||
131870094|NCT03564119|474804609|FG001|Overall Study|Protocol Violation|0|||
131870095|NCT03564119|474804608|FG000|Overall Study|Withdrawal by Subject|9|||
131870096|NCT03564119|474804609|FG001|Overall Study|Withdrawal by Subject|4|||
131870097|NCT03564119|474804608|FG000|Overall Study|Other Than Specified|0|||
131870098|NCT03564119|474804609|FG001|Overall Study|Other Than Specified|1|||
131870099|NCT00634036|474804610|FG000|Overall Study|Lost to Follow-up|1|||
131870100|NCT00634036|474804611|FG001|Overall Study|Lost to Follow-up|1|||
131870101|NCT00634036|474804610|FG000|Overall Study|Withdrawal by Subject|1|||
131870102|NCT00634036|474804611|FG001|Overall Study|Withdrawal by Subject|1|||
131870103|NCT03896022|474804612|FG000|Overall Study|Withdrawal by Subject|1|||
131870104|NCT03896022|474804613|FG001|Overall Study|Withdrawal by Subject|0|||
131870105|NCT03896022|474804614|FG002|Overall Study|Withdrawal by Subject|0|||
131870106|NCT03896022|474804612|FG000|Overall Study|Did not have procedure|3|||
131870107|NCT03896022|474804613|FG001|Overall Study|Did not have procedure|0|||
131870108|NCT03896022|474804614|FG002|Overall Study|Did not have procedure|0|||
131870109|NCT01863667|474804624|FG000|Overall Study|Adverse Event|1|||
131870110|NCT01863667|474804625|FG001|Overall Study|Adverse Event|0|||
131870111|NCT01863667|474804624|FG000|Overall Study|Study terminated by Sponsor|30|||
131870112|NCT01863667|474804625|FG001|Overall Study|Study terminated by Sponsor|30|||
131870113|NCT01863667|474804624|FG000|Overall Study|Withdrawal by Subject|2|||
131870114|NCT01863667|474804625|FG001|Overall Study|Withdrawal by Subject|2|||
131870115|NCT03627546|474804628|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
131870116|NCT03627546|474804629|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
131870117|NCT03627546|474804630|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
131870118|NCT03627546|474804628|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
131870119|NCT03627546|474804629|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
131870120|NCT03627546|474804630|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
131870121|NCT00615550|474804631|FG000|Overall Study|Lost to Follow-up|6|||
131870122|NCT00615550|474804632|FG001|Overall Study|Lost to Follow-up|1|||
131870123|NCT00564850|474804633|FG000|Overall Study|Protocol Violation|2|||
131870124|NCT02640664|474804634|FG000|Epoch 1|Withdrawal of informed consent|1|||
131870125|NCT02640664|474804635|FG001|Epoch 1|Withdrawal of informed consent|0|||
131870126|NCT02640664|474804636|FG002|Epoch 1|Withdrawal of informed consent|0|||
131870127|NCT02640664|474804634|FG000|Epoch 1|Death|0|||
131870128|NCT02640664|474804635|FG001|Epoch 1|Death|0|||
131870129|NCT02640664|474804636|FG002|Epoch 1|Death|1|||
131870130|NCT02640664|474804634|FG000|Epoch 2|Withdrawal of informed consent|3|||
131870131|NCT02640664|474804635|FG001|Epoch 2|Withdrawal of informed consent|4|||
131870132|NCT02640664|474804636|FG002|Epoch 2|Withdrawal of informed consent|2|||
131870133|NCT02640664|474804634|FG000|Epoch 2|Subject/guardian decision|0|||
131870134|NCT02640664|474804635|FG001|Epoch 2|Subject/guardian decision|2|||
131870135|NCT02640664|474804636|FG002|Epoch 2|Subject/guardian decision|2|||
131870136|NCT02640664|474804634|FG000|Epoch 2|Lost to Follow-up|3|||
131870137|NCT02640664|474804635|FG001|Epoch 2|Lost to Follow-up|4|||
131870138|NCT02640664|474804636|FG002|Epoch 2|Lost to Follow-up|1|||
131870139|NCT02640664|474804634|FG000|Epoch 2|Death|0|||
131870140|NCT02640664|474804635|FG001|Epoch 2|Death|0|||
131870141|NCT02640664|474804636|FG002|Epoch 2|Death|1|||
131870142|NCT00314327|474804637|FG000|Overall Study|Withdrawal by Subject|1|||
131870143|NCT02741076|474804638|FG000|Overall Study|Adverse Event|0|||
131870144|NCT02741076|474804639|FG001|Overall Study|Adverse Event|1|||
131870145|NCT02741076|474804640|FG002|Overall Study|Adverse Event|1|||
131870146|NCT02741076|474804641|FG003|Overall Study|Adverse Event|0|||
131870147|NCT02741076|474804638|FG000|Overall Study|Lack of Efficacy|1|||
131870148|NCT02741076|474804639|FG001|Overall Study|Lack of Efficacy|0|||
131870149|NCT02741076|474804640|FG002|Overall Study|Lack of Efficacy|0|||
131870150|NCT02741076|474804641|FG003|Overall Study|Lack of Efficacy|0|||
131870151|NCT02741076|474804638|FG000|Overall Study|Withdrawal by Subject|0|||
131870152|NCT02741076|474804639|FG001|Overall Study|Withdrawal by Subject|1|||
131870153|NCT02741076|474804640|FG002|Overall Study|Withdrawal by Subject|0|||
131870154|NCT02741076|474804641|FG003|Overall Study|Withdrawal by Subject|0|||
131408250|NCT03054350|473118245|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
131870155|NCT02741076|474804638|FG000|Overall Study|Sponsor Request|2|||
131870156|NCT02741076|474804639|FG001|Overall Study|Sponsor Request|3|||
131870157|NCT02741076|474804640|FG002|Overall Study|Sponsor Request|0|||
131870158|NCT02741076|474804641|FG003|Overall Study|Sponsor Request|1|||
131408251|NCT03054350|473118246|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
131408252|NCT03054350|473118247|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
131408253|NCT03054350|473118248|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
131408254|NCT03054350|473118243|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
131870159|NCT02741076|474804638|FG000|Overall Study|No additional information available|0|||
131870160|NCT02741076|474804639|FG001|Overall Study|No additional information available|0|||
131870161|NCT02741076|474804640|FG002|Overall Study|No additional information available|1|||
131870162|NCT02741076|474804641|FG003|Overall Study|No additional information available|1|||
131870163|NCT02965573|474804642|FG000|Overall Study|Lack of Efficacy|1|||
131870164|NCT02965573|474804643|FG001|Overall Study|Lack of Efficacy|0|||
131870165|NCT00315458|474804647|FG000|Overall Study|Administrative|0|||
131870166|NCT00315458|474804648|FG001|Overall Study|Administrative|3|||
131870167|NCT00315458|474804649|FG002|Overall Study|Administrative|8|||
131870168|NCT00315458|474804650|FG003|Overall Study|Administrative|21|||
131870169|NCT00315458|474804647|FG000|Overall Study|Adverse Event|2|||
131870170|NCT00315458|474804648|FG001|Overall Study|Adverse Event|4|||
131870171|NCT00315458|474804649|FG002|Overall Study|Adverse Event|23|||
131870172|NCT00315458|474804650|FG003|Overall Study|Adverse Event|3|||
131870173|NCT00315458|474804647|FG000|Overall Study|Lost to Follow-up|1|||
131870174|NCT00315458|474804648|FG001|Overall Study|Lost to Follow-up|2|||
131870175|NCT00315458|474804649|FG002|Overall Study|Lost to Follow-up|0|||
131870176|NCT00315458|474804650|FG003|Overall Study|Lost to Follow-up|2|||
131870177|NCT00315458|474804647|FG000|Overall Study|Withdrawal by Subject|0|||
131870178|NCT00315458|474804648|FG001|Overall Study|Withdrawal by Subject|3|||
131870179|NCT00315458|474804649|FG002|Overall Study|Withdrawal by Subject|0|||
131870180|NCT00315458|474804650|FG003|Overall Study|Withdrawal by Subject|2|||
131870181|NCT00315458|474804647|FG000|Overall Study|Lack of Efficacy|0|||
131870182|NCT00315458|474804648|FG001|Overall Study|Lack of Efficacy|0|||
131870183|NCT00315458|474804649|FG002|Overall Study|Lack of Efficacy|20|||
131870184|NCT00315458|474804650|FG003|Overall Study|Lack of Efficacy|1|||
131870185|NCT00315458|474804647|FG000|Overall Study|Did not qualify|0|||
131870186|NCT00315458|474804648|FG001|Overall Study|Did not qualify|0|||
131870187|NCT00315458|474804649|FG002|Overall Study|Did not qualify|1|||
131870188|NCT00315458|474804650|FG003|Overall Study|Did not qualify|0|||
131870189|NCT00987337|474804651|FG000|Overall Study|Adverse Event|10|||
131870190|NCT00987337|474804652|FG001|Overall Study|Adverse Event|9|||
131870191|NCT00987337|474804653|FG002|Overall Study|Adverse Event|8|||
131870192|NCT00987337|474804651|FG000|Overall Study|Insufficient Virologic Response|10|||
131870193|NCT00987337|474804652|FG001|Overall Study|Insufficient Virologic Response|7|||
131870194|NCT00987337|474804653|FG002|Overall Study|Insufficient Virologic Response|12|||
131870195|NCT00987337|474804651|FG000|Overall Study|Virologic Breakthrough|2|||
131870196|NCT00987337|474804652|FG001|Overall Study|Virologic Breakthrough|2|||
131870197|NCT00987337|474804653|FG002|Overall Study|Virologic Breakthrough|8|||
131870198|NCT00987337|474804651|FG000|Overall Study|Lost to Follow-up|10|||
131870199|NCT00987337|474804652|FG001|Overall Study|Lost to Follow-up|6|||
131870200|NCT00987337|474804653|FG002|Overall Study|Lost to Follow-up|2|||
131870201|NCT00987337|474804651|FG000|Overall Study|Withdrawal by Subject|6|||
131870202|NCT00987337|474804652|FG001|Overall Study|Withdrawal by Subject|9|||
131870203|NCT00987337|474804653|FG002|Overall Study|Withdrawal by Subject|9|||
131870204|NCT00987337|474804651|FG000|Overall Study|Other|0|||
131870205|NCT00987337|474804652|FG001|Overall Study|Other|2|||
131870206|NCT00987337|474804653|FG002|Overall Study|Other|5|||
131870207|NCT00987337|474804651|FG000|Overall Study|Protocol Violation|1|||
131870208|NCT00987337|474804652|FG001|Overall Study|Protocol Violation|0|||
131870209|NCT00987337|474804653|FG002|Overall Study|Protocol Violation|2|||
131870210|NCT00987337|474804651|FG000|Overall Study|Participant Relapsed|18|||
131870211|NCT00987337|474804652|FG001|Overall Study|Participant Relapsed|20|||
131870212|NCT00987337|474804653|FG002|Overall Study|Participant Relapsed|5|||
131870213|NCT00086619|474804656|FG000|Overall Study|Withdrawal by Subject|6|||
131870214|NCT00086619|474804657|FG001|Overall Study|Withdrawal by Subject|6|||
131870215|NCT00086619|474804656|FG000|Overall Study|Adverse Event|8|||
131870216|NCT00086619|474804657|FG001|Overall Study|Adverse Event|10|||
131870217|NCT00086619|474804656|FG000|Overall Study|Protocol Violation|1|||
131870218|NCT00086619|474804657|FG001|Overall Study|Protocol Violation|1|||
131870219|NCT00489918|474804658|FG000|Overall Study|Withdrawal by Subject|2|||
131870220|NCT00489918|474804659|FG001|Overall Study|Withdrawal by Subject|1|||
131870221|NCT00489918|474804660|FG002|Overall Study|Withdrawal by Subject|1|||
131870222|NCT00489918|474804661|FG003|Overall Study|Withdrawal by Subject|0|||
131870223|NCT00489918|474804662|FG004|Overall Study|Withdrawal by Subject|1|||
131870224|NCT00489918|474804658|FG000|Overall Study|Adverse Event|0|||
131870225|NCT00489918|474804659|FG001|Overall Study|Adverse Event|1|||
131870226|NCT00489918|474804660|FG002|Overall Study|Adverse Event|1|||
131870227|NCT00489918|474804661|FG003|Overall Study|Adverse Event|0|||
131870228|NCT00489918|474804662|FG004|Overall Study|Adverse Event|0|||
131870229|NCT00489918|474804658|FG000|Overall Study|Lost to Follow-up|0|||
131870230|NCT00489918|474804659|FG001|Overall Study|Lost to Follow-up|0|||
131870231|NCT00489918|474804660|FG002|Overall Study|Lost to Follow-up|1|||
131870232|NCT00489918|474804661|FG003|Overall Study|Lost to Follow-up|1|||
131870233|NCT00489918|474804662|FG004|Overall Study|Lost to Follow-up|0|||
131870234|NCT00489918|474804658|FG000|Overall Study|Physician Decision|0|||
131870235|NCT00489918|474804659|FG001|Overall Study|Physician Decision|0|||
131870236|NCT00489918|474804660|FG002|Overall Study|Physician Decision|1|||
131870237|NCT00489918|474804661|FG003|Overall Study|Physician Decision|0|||
131870238|NCT00489918|474804662|FG004|Overall Study|Physician Decision|0|||
131870239|NCT02748213|474804663|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
131870240|NCT02748213|474804664|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
131870241|NCT02748213|474804663|FG000|Overall Study|Abnormal Laboratory Test|1|||
131870242|NCT02748213|474804664|FG001|Overall Study|Abnormal Laboratory Test|0|||
131870243|NCT02748213|474804663|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
131870244|NCT02748213|474804664|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
131870245|NCT02748213|474804663|FG000|Overall Study|Death|5|||
131870246|NCT02748213|474804664|FG001|Overall Study|Death|3|||
131870247|NCT02748213|474804663|FG000|Overall Study|Insufficient Therapeutic Response|56|||
131870248|NCT02748213|474804664|FG001|Overall Study|Insufficient Therapeutic Response|57|||
131870249|NCT02748213|474804663|FG000|Overall Study|Violation of Selection Criteria|2|||
131870250|NCT02748213|474804664|FG001|Overall Study|Violation of Selection Criteria|0|||
131870251|NCT02748213|474804663|FG000|Overall Study|Protocol Violation|6|||
131870252|NCT02748213|474804664|FG001|Overall Study|Protocol Violation|4|||
131870253|NCT02748213|474804663|FG000|Overall Study|Refused Treatment*|6|||
131870254|NCT02748213|474804664|FG001|Overall Study|Refused Treatment*|6|||
131870255|NCT02748213|474804663|FG000|Overall Study|Failure to Return|1|||
131870256|NCT02748213|474804664|FG001|Overall Study|Failure to Return|0|||
131870257|NCT02748213|474804663|FG000|Overall Study|Other|30|||
131870258|NCT02748213|474804664|FG001|Overall Study|Other|29|||
131870259|NCT01209520|474804666|FG000|Overall Study|Withdrawal by Subject|3|||
131870260|NCT00961350|474804667|FG000|Overall Study|Adverse Event|18|||
131870261|NCT00961350|474804668|FG001|Overall Study|Adverse Event|33|||
131870262|NCT00961350|474804667|FG000|Overall Study|Withdrawal by Subject|10|||
131870263|NCT00961350|474804668|FG001|Overall Study|Withdrawal by Subject|10|||
131870264|NCT00961350|474804667|FG000|Overall Study|Lost to Follow-up|3|||
131870265|NCT00961350|474804668|FG001|Overall Study|Lost to Follow-up|3|||
131870266|NCT00961350|474804667|FG000|Overall Study|Misc|16|||
131870267|NCT00961350|474804668|FG001|Overall Study|Misc|21|||
131870268|NCT01500382|474804669|FG000|Washout Period|Study site went out of business|0|||
131870269|NCT01500382|474804670|FG001|Washout Period|Study site went out of business|0|||
131870270|NCT01500382|474804671|FG002|Washout Period|Study site went out of business|1|||
131870271|NCT01500382|474804672|FG003|Washout Period|Study site went out of business|0|||
131870272|NCT02134015|474804673|FG000|Overall Study|Protocol Violation|0|||
131870273|NCT02134015|474804674|FG001|Overall Study|Protocol Violation|1|||
131870274|NCT02134015|474804673|FG000|Overall Study|Death|2|||
131870275|NCT02134015|474804674|FG001|Overall Study|Death|1|||
131870276|NCT02134015|474804673|FG000|Overall Study|Reason not provided|1|||
131870277|NCT02134015|474804674|FG001|Overall Study|Reason not provided|2|||
131870278|NCT02134015|474804673|FG000|Overall Study|Clinical progression|14|||
131870279|NCT02134015|474804674|FG001|Overall Study|Clinical progression|7|||
131870280|NCT02134015|474804673|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
131870281|NCT02134015|474804674|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
131870282|NCT02134015|474804673|FG000|Overall Study|Study terminated by sponsor|2|||
131870283|NCT02134015|474804674|FG001|Overall Study|Study terminated by sponsor|3|||
131870284|NCT02134015|474804673|FG000|Overall Study|Adverse Event|9|||
131870285|NCT02134015|474804674|FG001|Overall Study|Adverse Event|10|||
131870286|NCT02134015|474804673|FG000|Overall Study|Withdrawal by Subject|3|||
131870287|NCT02134015|474804674|FG001|Overall Study|Withdrawal by Subject|7|||
131870288|NCT00550745|474804675|FG000|Overall Study|Death|20|||
131870289|NCT00550745|474804676|FG001|Overall Study|Death|16|||
131870290|NCT00550745|474804675|FG000|Overall Study|Lost to Follow-up|45|||
131870291|NCT00550745|474804676|FG001|Overall Study|Lost to Follow-up|30|||
131870292|NCT00550745|474804675|FG000|Overall Study|Physician Decision|0|||
131870293|NCT00550745|474804676|FG001|Overall Study|Physician Decision|2|||
131870294|NCT00550745|474804675|FG000|Overall Study|Protocol Violation|4|||
131870295|NCT00550745|474804676|FG001|Overall Study|Protocol Violation|2|||
131870296|NCT00550745|474804675|FG000|Overall Study|Withdrawal by Subject|17|||
131870297|NCT00550745|474804676|FG001|Overall Study|Withdrawal by Subject|10|||
131870298|NCT00550745|474804675|FG000|Overall Study|Screen failure|1|||
131870299|NCT00550745|474804676|FG001|Overall Study|Screen failure|0|||
131870300|NCT00347958|474806150|FG000|Overall Study|Adverse Event|1|||
131870301|NCT00347958|474806150|FG000|Overall Study|Protocol Violation|2|||
131870302|NCT00347958|474806150|FG000|Overall Study|Withdrawal by Subject|1|||
131870303|NCT02640950|474806152|FG000|Overall Study|Adverse Event|1|||
131870304|NCT02640950|474806152|FG000|Overall Study|Withdrawal by Subject|1|||
131870305|NCT00154284|474806153|FG000|Overall Study|Adverse Event|6|||
131870306|NCT00154284|474806154|FG001|Overall Study|Adverse Event|9|||
131870307|NCT00154284|474806153|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131870308|NCT00154284|474806154|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131870309|NCT00154284|474806153|FG000|Overall Study|Lack of Efficacy|1|||
131870310|NCT00154284|474806154|FG001|Overall Study|Lack of Efficacy|2|||
131870311|NCT00154284|474806153|FG000|Overall Study|Protocol Violation|0|||
131870312|NCT00154284|474806154|FG001|Overall Study|Protocol Violation|1|||
131870313|NCT01344824|474806155|FG000|Overall Study|Adverse Event|15|||
131870314|NCT01344824|474806155|FG000|Overall Study|Withdrawal by Subject|6|||
131870315|NCT01344824|474806155|FG000|Overall Study|Other complicating disease|1|||
131870316|NCT01344824|474806155|FG000|Overall Study|Progression|15|||
131870317|NCT00566020|474806156|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
131870318|NCT00566020|474806157|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
131870319|NCT00566020|474806156|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
131870320|NCT00566020|474806157|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
131870321|NCT00566020|474806156|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
131870322|NCT00566020|474806157|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
131870323|NCT00566020|474806156|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
131870324|NCT00566020|474806157|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
131870325|NCT00566020|474806156|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
131870326|NCT00566020|474806157|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
131870327|NCT00566020|474806156|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
131870328|NCT00566020|474806157|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
131870329|NCT04134767|474806160|FG000|Overall Study|Death|0|||
131870330|NCT04134767|474806161|FG001|Overall Study|Death|1|||
131870331|NCT04134767|474806160|FG000|Overall Study|Removed for harassing staff|0|||
131870332|NCT04134767|474806161|FG001|Overall Study|Removed for harassing staff|1|||
131870333|NCT04134767|474806160|FG000|Overall Study|Lost to Follow-up|44|||
131870334|NCT04134767|474806161|FG001|Overall Study|Lost to Follow-up|40|||
131870335|NCT00300885|474806162|FG000|Treatment|Adverse Event|134|||
131870336|NCT00300885|474806163|FG001|Treatment|Adverse Event|82|||
131870337|NCT00300885|474806162|FG000|Treatment|Death|20|||
131870338|NCT00300885|474806163|FG001|Treatment|Death|7|||
131870339|NCT00300885|474806162|FG000|Treatment|Lack of Efficacy|1|||
131870340|NCT00300885|474806163|FG001|Treatment|Lack of Efficacy|1|||
131870341|NCT00300885|474806162|FG000|Treatment|Lost to Follow-up|3|||
131870342|NCT00300885|474806163|FG001|Treatment|Lost to Follow-up|2|||
131870343|NCT00300885|474806162|FG000|Treatment|Physician Decision|4|||
131870344|NCT00300885|474806163|FG001|Treatment|Physician Decision|5|||
131870345|NCT00300885|474806162|FG000|Treatment|Protocol Violation|11|||
131870346|NCT00300885|474806163|FG001|Treatment|Protocol Violation|11|||
131870347|NCT00300885|474806162|FG000|Treatment|Withdrawal by Subject|26|||
131870348|NCT00300885|474806163|FG001|Treatment|Withdrawal by Subject|23|||
131870349|NCT00300885|474806162|FG000|Treatment|Disease progression|171|||
131870350|NCT00300885|474806163|FG001|Treatment|Disease progression|238|||
131870351|NCT00300885|474806162|FG000|Treatment|Random code broken (subject died)|0|||
131870352|NCT00300885|474806163|FG001|Treatment|Random code broken (subject died)|1|||
131870353|NCT00300885|474806162|FG000|Treatment|Non-compliant with study medication|3|||
131870354|NCT00300885|474806163|FG001|Treatment|Non-compliant with study medication|4|||
131870355|NCT00300885|474806162|FG000|Follow-up|Death|141|||
131870356|NCT00300885|474806163|FG001|Follow-up|Death|163|||
131870357|NCT00300885|474806162|FG000|Follow-up|Lost to Follow-up|11|||
131870358|NCT00300885|474806163|FG001|Follow-up|Lost to Follow-up|7|||
131870359|NCT00300885|474806162|FG000|Follow-up|Withdrawal by Subject|26|||
131870360|NCT00300885|474806163|FG001|Follow-up|Withdrawal by Subject|25|||
131870361|NCT02058537|474806164|FG000|Overall Study|Withdrawal by Subject|1|||
131870362|NCT02582242|474806165|FG000|Overall Study|Adverse Event|4|||
131870363|NCT02582242|474806166|FG001|Overall Study|Adverse Event|3|||
131870364|NCT02582242|474806165|FG000|Overall Study|Protocol Violation|3|||
131870365|NCT02582242|474806166|FG001|Overall Study|Protocol Violation|1|||
131870366|NCT02582242|474806165|FG000|Overall Study|Lost to Follow-up|0|||
131870367|NCT02582242|474806166|FG001|Overall Study|Lost to Follow-up|1|||
131870368|NCT02582242|474806165|FG000|Overall Study|Withdrawal by Subject|11|||
131870369|NCT02582242|474806166|FG001|Overall Study|Withdrawal by Subject|11|||
131870370|NCT02582242|474806165|FG000|Overall Study|Unclassified|2|||
131870371|NCT02582242|474806166|FG001|Overall Study|Unclassified|1|||
131870372|NCT02101736|474806167|FG000|Overall Study|Protocol Violation|3|||
131870373|NCT02101736|474806168|FG001|Overall Study|Protocol Violation|0|||
131870374|NCT02101736|474806167|FG000|Overall Study|Withdrawal by Subject|1|||
131870375|NCT02101736|474806168|FG001|Overall Study|Withdrawal by Subject|1|||
131870376|NCT00459290|474806169|FG000|Overall Study|Adverse Event|3|||
131870377|NCT00459290|474806169|FG000|Overall Study|Ineligible|2|||
131870378|NCT02309411|474806170|FG000|Overall Study|Physician Decision|1|||
131870379|NCT02309411|474806171|FG001|Overall Study|Physician Decision|0|||
131870380|NCT02309411|474806172|FG002|Overall Study|Physician Decision|0|||
131870381|NCT02309411|474806170|FG000|Overall Study|Withdrawal by Subject|1|||
131870382|NCT02309411|474806171|FG001|Overall Study|Withdrawal by Subject|1|||
131870383|NCT02309411|474806172|FG002|Overall Study|Withdrawal by Subject|0|||
131870384|NCT03656692|474806173|FG000|Overall Study|Worsening of disease activity|2|||
131870385|NCT03656692|474806173|FG000|Overall Study|Physician Decision|1|||
131870386|NCT02693106|474806174|FG000|Overall Study|No time|3|||
131870387|NCT00839800|474806175|FG000|Overall Study|Adverse Event|8|||
131870388|NCT00839800|474806176|FG001|Overall Study|Adverse Event|12|||
131918823|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
131918824|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
131918825|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
131918826|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
131918827|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
131918828|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
131918829|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
131918830|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
131918831|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
131918832|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
131918833|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
131918834|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
131918835|NCT00217737|474985831|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
131918836|NCT00217737|474985832|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
131918837|NCT00217737|474985833|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
131918838|NCT00217737|474985834|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
131918839|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
131918840|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
131918841|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
131918842|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
131918843|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
131918844|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
131918845|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
131918846|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
131918847|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Study suspension|0|||
131918848|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Study suspension|45|||
131918849|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Study suspension|0|||
131918850|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Study suspension|0|||
131918851|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
131918852|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
131918853|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
131918854|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
131918855|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Death|2|||
131918856|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Death|3|||
131918857|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Death|0|||
131918858|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Death|0|||
131918859|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
131918860|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
131918861|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
131918862|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
131918863|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
131918864|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
131918865|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
131918866|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
131918867|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
131918868|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
131918869|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
131918870|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
131918871|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
131918872|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
131918873|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
131918874|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
131918875|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
131453927|NCT02067676|473291836|FG003|Overall Study|Withdrawal by Subject|0|||
131453928|NCT02067676|473291837|FG004|Overall Study|Withdrawal by Subject|0|||
131918876|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
131918877|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
131918878|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
131918879|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
131918880|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
131918881|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
131918882|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
131918883|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
131918884|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
131453929|NCT02067676|473291838|FG005|Overall Study|Withdrawal by Subject|0|||
131870389|NCT00839800|474806175|FG000|Overall Study|Lost to Follow-up|31|||
131870390|NCT00839800|474806176|FG001|Overall Study|Lost to Follow-up|26|||
131870391|NCT00839800|474806175|FG000|Overall Study|Withdrawal by Subject|28|||
131870392|NCT00839800|474806176|FG001|Overall Study|Withdrawal by Subject|34|||
131870393|NCT00839800|474806175|FG000|Overall Study|Incorrect Enrolment|3|||
131870394|NCT00839800|474806176|FG001|Overall Study|Incorrect Enrolment|3|||
131870395|NCT00839800|474806175|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
131870396|NCT00839800|474806176|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
131870397|NCT00839800|474806175|FG000|Overall Study|Safety Reasons|2|||
131870398|NCT00839800|474806176|FG001|Overall Study|Safety Reasons|1|||
131870399|NCT00839800|474806175|FG000|Overall Study|Other|8|||
131870400|NCT00839800|474806176|FG001|Overall Study|Other|14|||
131870401|NCT00839800|474806175|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
131870402|NCT00839800|474806176|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
131870403|NCT01372618|474806180|FG000|Overall Study|PI Died. Study Terminated|9|||
131870404|NCT02801617|474806181|FG000|Overall Study|Protocol Violation|2|||
131870405|NCT02801617|474806182|FG001|Overall Study|Protocol Violation|6|||
131870406|NCT02176655|474806190|FG000|Overall Study|Subjects did not treat|6|||
131870407|NCT06110494|474806193|FG000|Overall Study|Protocol Violation|2|||
131870408|NCT06110494|474806194|FG001|Overall Study|Protocol Violation|0|||
131870409|NCT06110494|474806195|FG002|Overall Study|Protocol Violation|1|||
131870410|NCT06110494|474806193|FG000|Overall Study|Dixon's test for outlier analysis|1|||
131870411|NCT06110494|474806194|FG001|Overall Study|Dixon's test for outlier analysis|1|||
131870412|NCT06110494|474806195|FG002|Overall Study|Dixon's test for outlier analysis|0|||
131870413|NCT01464593|474806198|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
131870414|NCT02476578|474806207|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
131870415|NCT02476578|474806208|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
131870416|NCT02476578|474806207|FG000|Overall Study|Lost to Follow-up|6|||
131870417|NCT02476578|474806208|FG001|Overall Study|Lost to Follow-up|13|||
131870418|NCT04938180|474806209|FG000|Overall Study|Adverse Event|1|||
131870419|NCT01019694|474806214|FG000|Overall Study|Adverse Event|12|||
131870420|NCT01019694|474806215|FG001|Overall Study|Adverse Event|16|||
131870421|NCT01019694|474806216|FG002|Overall Study|Adverse Event|19|||
131870422|NCT01019694|474806214|FG000|Overall Study|Protocol Violation|2|||
131870423|NCT01019694|474806215|FG001|Overall Study|Protocol Violation|6|||
131870424|NCT01019694|474806216|FG002|Overall Study|Protocol Violation|4|||
131870425|NCT01019694|474806214|FG000|Overall Study|Lost to Follow-up|5|||
131870426|NCT01019694|474806215|FG001|Overall Study|Lost to Follow-up|3|||
131870427|NCT01019694|474806216|FG002|Overall Study|Lost to Follow-up|3|||
131870428|NCT01019694|474806214|FG000|Overall Study|Withdrawal by Subject|4|||
131870429|NCT01019694|474806215|FG001|Overall Study|Withdrawal by Subject|6|||
131870430|NCT01019694|474806216|FG002|Overall Study|Withdrawal by Subject|12|||
131870431|NCT01019694|474806214|FG000|Overall Study|Not treated|0|||
131870432|NCT01019694|474806215|FG001|Overall Study|Not treated|2|||
131870433|NCT01019694|474806216|FG002|Overall Study|Not treated|3|||
131870434|NCT01019694|474806214|FG000|Overall Study|Other reason (not specified)|1|||
131870435|NCT01019694|474806215|FG001|Overall Study|Other reason (not specified)|5|||
131870436|NCT01019694|474806216|FG002|Overall Study|Other reason (not specified)|6|||
131870437|NCT00026494|474806223|FG000|Overall Study|Withdrawal by Subject|1|||
131870438|NCT00026494|474806224|FG001|Overall Study|Withdrawal by Subject|0|||
131870439|NCT00026494|474806225|FG002|Overall Study|Withdrawal by Subject|1|||
131870440|NCT00026494|474806226|FG003|Overall Study|Withdrawal by Subject|0|||
131870441|NCT00026494|474806223|FG000|Overall Study|Patient non-compliance|1|||
131870442|NCT00026494|474806224|FG001|Overall Study|Patient non-compliance|0|||
131870443|NCT00026494|474806225|FG002|Overall Study|Patient non-compliance|0|||
131870444|NCT00026494|474806226|FG003|Overall Study|Patient non-compliance|0|||
131870445|NCT00026494|474806223|FG000|Overall Study|Patient not treated|0|||
131870446|NCT00026494|474806224|FG001|Overall Study|Patient not treated|0|||
131870447|NCT00026494|474806225|FG002|Overall Study|Patient not treated|2|||
131870448|NCT00026494|474806226|FG003|Overall Study|Patient not treated|0|||
131870449|NCT00026494|474806223|FG000|Overall Study|Clinical progression|0|||
131870450|NCT00026494|474806224|FG001|Overall Study|Clinical progression|0|||
131870451|NCT00026494|474806225|FG002|Overall Study|Clinical progression|3|||
131870452|NCT00026494|474806226|FG003|Overall Study|Clinical progression|0|||
131870453|NCT01684423|474806227|FG000|Overall Study|Withdrawal by Subject|0|||
131870454|NCT01684423|474806228|FG001|Overall Study|Withdrawal by Subject|0|||
131870455|NCT01684423|474806229|FG002|Overall Study|Withdrawal by Subject|1|||
131870456|NCT01684423|474806230|FG003|Overall Study|Withdrawal by Subject|0|||
131870457|NCT01684423|474806231|FG004|Overall Study|Withdrawal by Subject|0|||
131870458|NCT01455597|474806232|FG000|Overall Study|Adverse Event|7|||
131870459|NCT01455597|474806233|FG001|Overall Study|Adverse Event|0|||
131870460|NCT01455597|474806234|FG002|Overall Study|Adverse Event|5|||
131870461|NCT01455597|474806235|FG003|Overall Study|Adverse Event|1|||
131870462|NCT01455597|474806232|FG000|Overall Study|Lack of Efficacy|0|||
131453930|NCT00996333|473291839|FG000|Overall Study|Screen failure|1|||
131870463|NCT01455597|474806233|FG001|Overall Study|Lack of Efficacy|1|||
131870464|NCT01455597|474806234|FG002|Overall Study|Lack of Efficacy|2|||
131918885|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
131918886|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
131918887|NCT00217737|474985831|FG000|Step 2 Randomization/Registration|Other|1|||
131918888|NCT00217737|474985832|FG001|Step 2 Randomization/Registration|Other|2|||
131918889|NCT00217737|474985833|FG002|Step 2 Randomization/Registration|Other|0|||
131918890|NCT00217737|474985834|FG003|Step 2 Randomization/Registration|Other|0|||
131918891|NCT02293499|474986825|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
131918892|NCT02293499|474986826|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
131918893|NCT02293499|474986827|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
131918894|NCT02293499|474986825|FG000|Intervention - Camp|Withdrawal by Subject|3|||
131918895|NCT02293499|474986826|FG001|Intervention - Camp|Withdrawal by Subject|6|||
131918896|NCT02293499|474986827|FG002|Intervention - Camp|Withdrawal by Subject|2|||
131918897|NCT02293499|474986825|FG000|Intervention - Camp|these are those not showing up at camp|24|||
131918898|NCT02293499|474986826|FG001|Intervention - Camp|these are those not showing up at camp|28|||
131918899|NCT02293499|474986827|FG002|Intervention - Camp|these are those not showing up at camp|4|||
131918900|NCT02293499|474986825|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
131918901|NCT02293499|474986826|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
131918902|NCT02293499|474986827|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
131918903|NCT02293499|474986825|FG000|3 Month Follow Up|Lost to Follow-up|14|||
131918904|NCT02293499|474986826|FG001|3 Month Follow Up|Lost to Follow-up|15|||
131918905|NCT02293499|474986827|FG002|3 Month Follow Up|Lost to Follow-up|6|||
131918906|NCT02293499|474986825|FG000|6 Month Follow Up|Lost to Follow-up|17|||
131918907|NCT02293499|474986826|FG001|6 Month Follow Up|Lost to Follow-up|27|||
131918908|NCT02293499|474986827|FG002|6 Month Follow Up|Lost to Follow-up|6|||
131918909|NCT02293499|474986825|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
131918910|NCT02293499|474986826|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
131918911|NCT02293499|474986827|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
131918912|NCT02293499|474986825|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
131918913|NCT02293499|474986826|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
131918914|NCT02293499|474986827|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
131918915|NCT02293499|474986825|FG000|9 Month Follow Up|Lost to Follow-up|24|||
131918916|NCT02293499|474986826|FG001|9 Month Follow Up|Lost to Follow-up|28|||
131918917|NCT02293499|474986827|FG002|9 Month Follow Up|Lost to Follow-up|4|||
131918918|NCT02293499|474986825|FG000|12 Month Follow Up|Lost to Follow-up|26|||
131918919|NCT02293499|474986826|FG001|12 Month Follow Up|Lost to Follow-up|25|||
131918920|NCT02293499|474986827|FG002|12 Month Follow Up|Lost to Follow-up|6|||
131918921|NCT02293499|474986825|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
131918922|NCT02293499|474986826|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
131918923|NCT02293499|474986827|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
131918924|NCT02293499|474986825|FG000|15 Month Follow Up|Lost to Follow-up|22|||
131918925|NCT02293499|474986826|FG001|15 Month Follow Up|Lost to Follow-up|22|||
131918926|NCT02293499|474986827|FG002|15 Month Follow Up|Lost to Follow-up|7|||
131918927|NCT00690898|474986828|FG000|SCREENING|Screen failure|18|||
131918928|NCT00690898|474986828|FG000|TREATMENT|Adverse Event|3|||
131918929|NCT00690898|474986828|FG000|TREATMENT|Lack of Efficacy|18|||
131918930|NCT00690898|474986828|FG000|TREATMENT|Withdrawal by Subject|4|||
131918931|NCT00690898|474986828|FG000|TREATMENT|Other (not otherwise specified)|1|||
131918932|NCT04919161|474986831|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
131918933|NCT04919161|474986832|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
131918934|NCT04919161|474986831|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
131918935|NCT04919161|474986832|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
131918936|NCT04919161|474986831|FG000|Overall Study|Acute ankle sprain after session 1|0|||
131870465|NCT01455597|474806235|FG003|Overall Study|Lack of Efficacy|0|||
131870466|NCT01455597|474806232|FG000|Overall Study|Lost to Follow-up|3|||
131870467|NCT01455597|474806233|FG001|Overall Study|Lost to Follow-up|0|||
131870468|NCT01455597|474806234|FG002|Overall Study|Lost to Follow-up|2|||
131870469|NCT01455597|474806235|FG003|Overall Study|Lost to Follow-up|1|||
131870470|NCT01455597|474806232|FG000|Overall Study|Withdrew Consent|6|||
131870471|NCT01455597|474806233|FG001|Overall Study|Withdrew Consent|5|||
131870472|NCT01455597|474806234|FG002|Overall Study|Withdrew Consent|8|||
131870473|NCT01455597|474806235|FG003|Overall Study|Withdrew Consent|5|||
131870474|NCT01455597|474806232|FG000|Overall Study|Reason not Specified|1|||
131870475|NCT01455597|474806233|FG001|Overall Study|Reason not Specified|2|||
131918937|NCT04919161|474986832|FG001|Overall Study|Acute ankle sprain after session 1|1|||
131870476|NCT01455597|474806234|FG002|Overall Study|Reason not Specified|3|||
131870477|NCT01455597|474806235|FG003|Overall Study|Reason not Specified|3|||
131870478|NCT00441129|474806236|FG000|Overall Study|Withdrawal by Subject|6|||
131918938|NCT00712920|474986833|FG000|Overall Study|Adverse Event|3|||
131918939|NCT00712920|474986834|FG001|Overall Study|Adverse Event|4|||
131918940|NCT00712920|474986835|FG002|Overall Study|Adverse Event|7|||
131918941|NCT00712920|474986833|FG000|Overall Study|Withdrawal by Subject|4|||
131918942|NCT00712920|474986834|FG001|Overall Study|Withdrawal by Subject|2|||
131870479|NCT00441129|474806237|FG001|Overall Study|Withdrawal by Subject|14|||
131870480|NCT03412734|474806242|FG000|Overall Study|Incorrect labeling of samples|2|||
131870481|NCT03412734|474806243|FG001|Overall Study|Incorrect labeling of samples|0|||
131870482|NCT03412734|474806242|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
131870483|NCT03412734|474806243|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
131870484|NCT04747886|474806244|FG000|Overall Study|Withdrawal by Subject|1|||
131870485|NCT04747886|474806245|FG001|Overall Study|Withdrawal by Subject|4|||
131870486|NCT03850496|474806246|FG000|Overall Study|Withdrawal by Subject|1|||
131870487|NCT03850496|474806247|FG001|Overall Study|Withdrawal by Subject|0|||
131870488|NCT03850496|474806248|FG002|Overall Study|Withdrawal by Subject|0|||
131870489|NCT03850496|474806246|FG000|Overall Study|Lost to Follow-up|0|||
131870490|NCT03850496|474806247|FG001|Overall Study|Lost to Follow-up|1|||
131870491|NCT03850496|474806248|FG002|Overall Study|Lost to Follow-up|4|||
131870492|NCT03777436|474806252|FG000|Placebo-controlled Phase|Adverse Event|8|||
131870493|NCT03777436|474806253|FG001|Placebo-controlled Phase|Adverse Event|10|||
131870494|NCT03777436|474806254|FG002|Placebo-controlled Phase|Adverse Event|0|||
131870495|NCT03777436|474806252|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
131870496|NCT03777436|474806253|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
131870497|NCT03777436|474806254|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
131870498|NCT03777436|474806252|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
131870499|NCT03777436|474806253|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
131870500|NCT03777436|474806254|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
131870501|NCT03777436|474806252|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
131870502|NCT03777436|474806253|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
131870503|NCT03777436|474806254|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
131870504|NCT03777436|474806252|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
131870505|NCT03777436|474806253|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
131870506|NCT03777436|474806254|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
131870507|NCT03777436|474806252|FG000|Placebo-controlled Phase|Physician Decision|0|||
131870508|NCT03777436|474806253|FG001|Placebo-controlled Phase|Physician Decision|1|||
131870509|NCT03777436|474806254|FG002|Placebo-controlled Phase|Physician Decision|0|||
131870510|NCT03777436|474806252|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
131870511|NCT03777436|474806253|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
131870512|NCT03777436|474806254|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
131870513|NCT03777436|474806252|FG000|Apremilast Extension Phase|Adverse Event|0|||
131870514|NCT03777436|474806253|FG001|Apremilast Extension Phase|Adverse Event|0|||
131870515|NCT03777436|474806254|FG002|Apremilast Extension Phase|Adverse Event|6|||
131870516|NCT03777436|474806252|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
131870517|NCT03777436|474806253|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
131870518|NCT03777436|474806254|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
131870519|NCT03777436|474806252|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
131870520|NCT03777436|474806253|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
131870521|NCT03777436|474806254|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
131870522|NCT03777436|474806252|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
131870523|NCT03777436|474806253|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
131870524|NCT03777436|474806254|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
131870525|NCT03777436|474806252|FG000|Apremilast Extension Phase|Miscellaneous|0|||
131870526|NCT03777436|474806253|FG001|Apremilast Extension Phase|Miscellaneous|0|||
131870527|NCT03777436|474806254|FG002|Apremilast Extension Phase|Miscellaneous|1|||
131870528|NCT00869999|474806260|FG000|Overall Study|Withdrawal by Subject|1|||
131870529|NCT00869999|474806260|FG000|Overall Study|removed prior to starting therapy|1|||
131870530|NCT04478695|474806261|FG000|Overall Study|Death|1|||
131870531|NCT04478695|474806262|FG001|Overall Study|Death|0|||
131870532|NCT00644917|474806263|FG000|Overall Study|Withdrawal by Subject|2|||
131870533|NCT00402688|474806264|FG000|Overall Study|Adverse Event|12|||
131870534|NCT00402688|474806265|FG001|Overall Study|Adverse Event|9|||
131870535|NCT00402688|474806266|FG002|Overall Study|Adverse Event|3|||
131870536|NCT00402688|474806264|FG000|Overall Study|Withdrawal by Subject|3|||
131870537|NCT00402688|474806265|FG001|Overall Study|Withdrawal by Subject|1|||
131870538|NCT00402688|474806266|FG002|Overall Study|Withdrawal by Subject|1|||
131870539|NCT00402688|474806264|FG000|Overall Study|Physician Decision|0|||
131870540|NCT00402688|474806265|FG001|Overall Study|Physician Decision|0|||
131870541|NCT00402688|474806266|FG002|Overall Study|Physician Decision|1|||
131870542|NCT00402688|474806264|FG000|Overall Study|Lack of Efficacy|4|||
131870543|NCT00402688|474806265|FG001|Overall Study|Lack of Efficacy|4|||
131870544|NCT00402688|474806266|FG002|Overall Study|Lack of Efficacy|5|||
131870545|NCT00402688|474806264|FG000|Overall Study|Protocol Violation|1|||
131870546|NCT00402688|474806265|FG001|Overall Study|Protocol Violation|1|||
131408255|NCT03054350|473118244|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
131408256|NCT03054350|473118245|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
131870547|NCT00402688|474806266|FG002|Overall Study|Protocol Violation|1|||
131870548|NCT00402688|474806264|FG000|Overall Study|Lost to Follow-up|1|||
131870549|NCT00402688|474806265|FG001|Overall Study|Lost to Follow-up|0|||
131918943|NCT00712920|474986835|FG002|Overall Study|Withdrawal by Subject|1|||
131918944|NCT00712920|474986833|FG000|Overall Study|Lost to Follow-up|1|||
131918945|NCT00712920|474986834|FG001|Overall Study|Lost to Follow-up|4|||
131918946|NCT00712920|474986835|FG002|Overall Study|Lost to Follow-up|0|||
131918947|NCT00712920|474986833|FG000|Overall Study|Lack of Efficacy|1|||
131918948|NCT00712920|474986834|FG001|Overall Study|Lack of Efficacy|0|||
131918949|NCT00712920|474986835|FG002|Overall Study|Lack of Efficacy|1|||
131918950|NCT00712920|474986833|FG000|Overall Study|Other|5|||
131918951|NCT00712920|474986834|FG001|Overall Study|Other|7|||
131918952|NCT00712920|474986835|FG002|Overall Study|Other|3|||
131918953|NCT00712920|474986833|FG000|Overall Study|Non-compliance|3|||
131918954|NCT00712920|474986834|FG001|Overall Study|Non-compliance|0|||
131918955|NCT00712920|474986835|FG002|Overall Study|Non-compliance|0|||
131918956|NCT02489773|474986836|FG000|Overall Study|Lost to Follow-up|4|||
131918957|NCT02489773|474986837|FG001|Overall Study|Lost to Follow-up|1|||
131918958|NCT02489773|474986836|FG000|Overall Study|Physician Decision|1|||
131918959|NCT02489773|474986837|FG001|Overall Study|Physician Decision|0|||
131918960|NCT02489773|474986836|FG000|Overall Study|Withdrawal by Subject|1|||
131918961|NCT02489773|474986837|FG001|Overall Study|Withdrawal by Subject|0|||
131918962|NCT02489773|474986836|FG000|Overall Study|Leave the country or the state|1|||
131918963|NCT02489773|474986837|FG001|Overall Study|Leave the country or the state|1|||
131918964|NCT02696616|474986841|FG000|Overall Study|Adverse Event|0|||
131918965|NCT02696616|474986842|FG001|Overall Study|Adverse Event|1|||
131870550|NCT00402688|474806266|FG002|Overall Study|Lost to Follow-up|2|||
131870551|NCT00402688|474806264|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
131870552|NCT00402688|474806265|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
131870553|NCT00402688|474806266|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
131870554|NCT00402688|474806264|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
131870555|NCT00402688|474806265|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
131870556|NCT00402688|474806266|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
131870557|NCT00402688|474806264|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
131870558|NCT00402688|474806265|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
131870559|NCT00402688|474806266|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
131870560|NCT01136356|474806267|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
131870561|NCT01136356|474806268|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
131870562|NCT01136356|474806267|FG000|First 18-day Withdrawal|Physician Decision|1|||
131870563|NCT01136356|474806268|FG001|First 18-day Withdrawal|Physician Decision|0|||
131870564|NCT01136356|474806267|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
131870565|NCT01136356|474806268|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
131870566|NCT00758485|474806269|FG000|Overall Study|Lost to Follow-up|0|||
131870567|NCT00758485|474806270|FG001|Overall Study|Lost to Follow-up|1|||
131870568|NCT00758485|474806269|FG000|Overall Study|Not Treated|1|||
131870569|NCT00758485|474806270|FG001|Overall Study|Not Treated|2|||
131870570|NCT02347774|474806271|FG000|Study Participation|Lost to Follow-up|3|||
131870571|NCT02347774|474806272|FG001|Study Participation|Lost to Follow-up|6|||
131870572|NCT02347774|474806273|FG002|Study Participation|Lost to Follow-up|2|||
131870573|NCT02347774|474806271|FG000|Study Participation|Withdrawal by Subject|8|||
131870574|NCT02347774|474806272|FG001|Study Participation|Withdrawal by Subject|9|||
131870575|NCT02347774|474806273|FG002|Study Participation|Withdrawal by Subject|15|||
131870576|NCT02347774|474806271|FG000|Study Participation|Adverse Event|1|||
131870577|NCT02347774|474806272|FG001|Study Participation|Adverse Event|4|||
131870578|NCT02347774|474806273|FG002|Study Participation|Adverse Event|6|||
131870579|NCT02347774|474806271|FG000|Study Participation|withdrew consent|1|||
131870580|NCT02347774|474806272|FG001|Study Participation|withdrew consent|1|||
131870581|NCT02347774|474806273|FG002|Study Participation|withdrew consent|1|||
131870582|NCT02347774|474806271|FG000|Study Participation|Met Prolonged QT criteria|1|||
131870583|NCT02347774|474806272|FG001|Study Participation|Met Prolonged QT criteria|0|||
131870584|NCT02347774|474806273|FG002|Study Participation|Met Prolonged QT criteria|0|||
131870585|NCT02347774|474806271|FG000|Study Participation|non-compliance with study drug|0|||
131870586|NCT02347774|474806272|FG001|Study Participation|non-compliance with study drug|1|||
131870587|NCT02347774|474806273|FG002|Study Participation|non-compliance with study drug|0|||
131918966|NCT02696616|474986843|FG002|Overall Study|Adverse Event|0|||
131434027|NCT01188772|473214619|FG001|Overall Study|Randomized but Not Treated|1|||
131870588|NCT02347774|474806271|FG000|Study Participation|incarceration|1|||
131918967|NCT02696616|474986844|FG003|Overall Study|Adverse Event|0|||
131918968|NCT02696616|474986845|FG004|Overall Study|Adverse Event|0|||
131918969|NCT02696616|474986846|FG005|Overall Study|Adverse Event|0|||
131918970|NCT02696616|474986847|FG006|Overall Study|Adverse Event|0|||
131870589|NCT02347774|474806272|FG001|Study Participation|incarceration|0|||
131870590|NCT02347774|474806273|FG002|Study Participation|incarceration|0|||
131870591|NCT02347774|474806271|FG000|Study Participation|randomized in error|0|||
131870592|NCT02347774|474806272|FG001|Study Participation|randomized in error|0|||
131870593|NCT02347774|474806273|FG002|Study Participation|randomized in error|1|||
131870594|NCT02347774|474806271|FG000|On Study Treatment|Adverse Event|9|||
131918971|NCT01732783|474986850|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
131408257|NCT03054350|473118246|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
131408258|NCT03054350|473118247|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
131870595|NCT02347774|474806272|FG001|On Study Treatment|Adverse Event|15|||
131870596|NCT02347774|474806273|FG002|On Study Treatment|Adverse Event|19|||
131870597|NCT02347774|474806271|FG000|On Study Treatment|Lack of Efficacy|3|||
131870598|NCT02347774|474806272|FG001|On Study Treatment|Lack of Efficacy|0|||
131870599|NCT02347774|474806273|FG002|On Study Treatment|Lack of Efficacy|2|||
131870600|NCT02347774|474806271|FG000|On Study Treatment|non-complicance with study medication|0|||
131870601|NCT02347774|474806272|FG001|On Study Treatment|non-complicance with study medication|2|||
131870602|NCT02347774|474806273|FG002|On Study Treatment|non-complicance with study medication|0|||
131870603|NCT02347774|474806271|FG000|On Study Treatment|Protocol Violation|0|||
131870604|NCT02347774|474806272|FG001|On Study Treatment|Protocol Violation|0|||
131870605|NCT02347774|474806273|FG002|On Study Treatment|Protocol Violation|1|||
131870606|NCT02347774|474806271|FG000|On Study Treatment|withdrew consent|9|||
131870607|NCT02347774|474806272|FG001|On Study Treatment|withdrew consent|8|||
131870608|NCT02347774|474806273|FG002|On Study Treatment|withdrew consent|12|||
131870609|NCT02347774|474806271|FG000|On Study Treatment|Lost to Follow-up|2|||
131870610|NCT02347774|474806272|FG001|On Study Treatment|Lost to Follow-up|6|||
131870611|NCT02347774|474806273|FG002|On Study Treatment|Lost to Follow-up|1|||
131870612|NCT02347774|474806271|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
131870613|NCT02347774|474806272|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
131870614|NCT02347774|474806273|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
131870615|NCT02347774|474806271|FG000|On Study Treatment|ranomized in error|0|||
131870616|NCT02347774|474806272|FG001|On Study Treatment|ranomized in error|0|||
131870617|NCT02347774|474806273|FG002|On Study Treatment|ranomized in error|1|||
131870618|NCT00656292|474806274|FG000|Overall Study|Withdrawal by Subject|2|||
131870619|NCT00656292|474806275|FG001|Overall Study|Withdrawal by Subject|3|||
131870620|NCT00656292|474806274|FG000|Overall Study|Screen failure|1|||
131870621|NCT00656292|474806275|FG001|Overall Study|Screen failure|2|||
131870622|NCT00921557|474806276|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
131870623|NCT00921557|474806277|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
131870624|NCT00921557|474806278|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
131870625|NCT00921557|474806276|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
131870626|NCT00921557|474806277|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
131870627|NCT00921557|474806278|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
131870628|NCT00921557|474806276|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
131870629|NCT00921557|474806277|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
131870630|NCT00921557|474806278|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
131870631|NCT00921557|474806276|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
131870632|NCT00921557|474806277|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
131870633|NCT00921557|474806278|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
131870634|NCT00921557|474806276|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
131870635|NCT00921557|474806277|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
131870636|NCT00921557|474806278|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
131870637|NCT03259425|474806279|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
131870638|NCT02097238|474806284|FG000|Overall Study|Death|1|||
131870639|NCT02097238|474806284|FG000|Overall Study|Physician Decision|1|||
131870640|NCT02097238|474806284|FG000|Overall Study|Progressive Disease|17|||
131870641|NCT01814696|474806286|FG000|Overall Study|Withdrawal by Subject|1|||
131870642|NCT01814696|474806287|FG001|Overall Study|Withdrawal by Subject|0|||
131870643|NCT01814696|474806286|FG000|Overall Study|Randomized to wrong group|1|||
131870644|NCT01814696|474806287|FG001|Overall Study|Randomized to wrong group|0|||
131870645|NCT00954941|474806288|FG000|Overall Study|Received treatment at home|1|||
131870646|NCT00954941|474806289|FG001|Overall Study|Received treatment at home|0|||
131870647|NCT00954941|474806288|FG000|Overall Study|Withdrawal by Subject|1|||
131870648|NCT00954941|474806289|FG001|Overall Study|Withdrawal by Subject|0|||
131870649|NCT00954941|474806288|FG000|Overall Study|Insurance Denial|2|||
131870650|NCT00954941|474806289|FG001|Overall Study|Insurance Denial|2|||
131870651|NCT00954941|474806288|FG000|Overall Study|Physician Decision|2|||
131870652|NCT00954941|474806289|FG001|Overall Study|Physician Decision|2|||
131870653|NCT00954941|474806288|FG000|Overall Study|Ineligible|2|||
131870654|NCT00954941|474806289|FG001|Overall Study|Ineligible|2|||
131870655|NCT00954941|474806288|FG000|Overall Study|Adverse Event|0|||
131870656|NCT00954941|474806289|FG001|Overall Study|Adverse Event|1|||
131870657|NCT04432831|474808145|FG000|Overall Study|Withdrawal by Subject|24|||
131870658|NCT04432831|474808146|FG001|Overall Study|Withdrawal by Subject|28|||
131918972|NCT01732783|474986851|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
131870659|NCT04432831|474808147|FG002|Overall Study|Withdrawal by Subject|21|||
131870660|NCT04432831|474808145|FG000|Overall Study|Death|23|||
131870661|NCT04432831|474808146|FG001|Overall Study|Death|23|||
131870662|NCT04432831|474808147|FG002|Overall Study|Death|17|||
131870663|NCT04432831|474808145|FG000|Overall Study|Lost to Follow-up|15|||
131870664|NCT04432831|474808146|FG001|Overall Study|Lost to Follow-up|15|||
131870665|NCT04432831|474808147|FG002|Overall Study|Lost to Follow-up|12|||
131870666|NCT04432831|474808145|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
131870667|NCT04432831|474808146|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
131870668|NCT04432831|474808147|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
131870669|NCT04432831|474808145|FG000|Overall Study|Reason Not Specified|7|||
131870670|NCT04432831|474808146|FG001|Overall Study|Reason Not Specified|11|||
131870671|NCT04432831|474808147|FG002|Overall Study|Reason Not Specified|9|||
131870672|NCT04432831|474808145|FG000|Overall Study|Adverse Event|7|||
131870673|NCT04432831|474808146|FG001|Overall Study|Adverse Event|7|||
131870674|NCT04432831|474808147|FG002|Overall Study|Adverse Event|7|||
131870675|NCT04432831|474808145|FG000|Overall Study|Physician Decision|1|||
131870676|NCT04432831|474808146|FG001|Overall Study|Physician Decision|3|||
131870677|NCT04432831|474808147|FG002|Overall Study|Physician Decision|6|||
131870678|NCT04432831|474808145|FG000|Overall Study|Protocol Violation|1|||
131870679|NCT04432831|474808146|FG001|Overall Study|Protocol Violation|0|||
131870680|NCT04432831|474808147|FG002|Overall Study|Protocol Violation|2|||
131870681|NCT04432831|474808145|FG000|Overall Study|Pregnancy|0|||
131870682|NCT04432831|474808146|FG001|Overall Study|Pregnancy|1|||
131870683|NCT04432831|474808147|FG002|Overall Study|Pregnancy|0|||
131870684|NCT04432831|474808145|FG000|Overall Study|Lack of Efficacy|0|||
131870685|NCT04432831|474808146|FG001|Overall Study|Lack of Efficacy|0|||
131870686|NCT04432831|474808147|FG002|Overall Study|Lack of Efficacy|2|||
131870687|NCT00617890|474808148|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
131870688|NCT00617890|474808149|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
131870689|NCT00617890|474808150|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
131870690|NCT00617890|474808151|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
131870691|NCT00617890|474808148|FG000|Overall Study|Lack of Efficacy|23|||
131870692|NCT00617890|474808149|FG001|Overall Study|Lack of Efficacy|26|||
131870693|NCT00617890|474808150|FG002|Overall Study|Lack of Efficacy|30|||
131870694|NCT00617890|474808151|FG003|Overall Study|Lack of Efficacy|97|||
131870695|NCT00617890|474808148|FG000|Overall Study|Lost to Follow-up|0|||
131870696|NCT00617890|474808149|FG001|Overall Study|Lost to Follow-up|0|||
131870697|NCT00617890|474808150|FG002|Overall Study|Lost to Follow-up|1|||
131870698|NCT00617890|474808151|FG003|Overall Study|Lost to Follow-up|2|||
131870699|NCT00617890|474808148|FG000|Overall Study|Withdrawal by Subject|4|||
131870700|NCT00617890|474808149|FG001|Overall Study|Withdrawal by Subject|1|||
131870701|NCT00617890|474808150|FG002|Overall Study|Withdrawal by Subject|0|||
131870702|NCT00617890|474808151|FG003|Overall Study|Withdrawal by Subject|2|||
131870703|NCT00617890|474808148|FG000|Overall Study|Protocol Violation|2|||
131870704|NCT00617890|474808149|FG001|Overall Study|Protocol Violation|1|||
131870705|NCT00617890|474808150|FG002|Overall Study|Protocol Violation|0|||
131870706|NCT00617890|474808151|FG003|Overall Study|Protocol Violation|0|||
131870707|NCT00617890|474808148|FG000|Overall Study|Adverse Event|1|||
131870708|NCT00617890|474808149|FG001|Overall Study|Adverse Event|0|||
131870709|NCT00617890|474808150|FG002|Overall Study|Adverse Event|3|||
131870710|NCT00617890|474808151|FG003|Overall Study|Adverse Event|8|||
131870711|NCT00617890|474808148|FG000|Overall Study|Not treated|1|||
131870712|NCT00617890|474808149|FG001|Overall Study|Not treated|0|||
131870713|NCT00617890|474808150|FG002|Overall Study|Not treated|1|||
131870714|NCT00617890|474808151|FG003|Overall Study|Not treated|1|||
131918973|NCT01732783|474986852|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
131918974|NCT01732783|474986850|FG000|Overall Study|Death|13|||
131918975|NCT01732783|474986851|FG001|Overall Study|Death|4|||
131918976|NCT01732783|474986852|FG002|Overall Study|Death|1|||
131918977|NCT01732783|474986850|FG000|Overall Study|Lost to Follow-up|7|||
131918978|NCT01732783|474986851|FG001|Overall Study|Lost to Follow-up|1|||
131918979|NCT01732783|474986852|FG002|Overall Study|Lost to Follow-up|1|||
131918980|NCT01732783|474986850|FG000|Overall Study|Administrative Decision|8|||
131918981|NCT01732783|474986851|FG001|Overall Study|Administrative Decision|2|||
131918982|NCT01732783|474986852|FG002|Overall Study|Administrative Decision|1|||
131918983|NCT01732783|474986850|FG000|Overall Study|Withdrawal by Subject|1|||
131918984|NCT01732783|474986851|FG001|Overall Study|Withdrawal by Subject|0|||
131918985|NCT01732783|474986852|FG002|Overall Study|Withdrawal by Subject|0|||
131918986|NCT01500083|474986853|FG000|Overall Study|Adverse Event|4|||
131918987|NCT01500083|474986854|FG001|Overall Study|Adverse Event|17|||
131918988|NCT01500083|474986853|FG000|Overall Study|Death|0|||
131918989|NCT01500083|474986854|FG001|Overall Study|Death|2|||
131918990|NCT01500083|474986853|FG000|Overall Study|Lost to Follow-up|1|||
131918991|NCT01500083|474986854|FG001|Overall Study|Lost to Follow-up|0|||
131918992|NCT01500083|474986853|FG000|Overall Study|Withdrawal of Consent|0|||
131918993|NCT01500083|474986854|FG001|Overall Study|Withdrawal of Consent|1|||
131918994|NCT01500083|474986853|FG000|Overall Study|Disease Progression|2|||
131918995|NCT01500083|474986854|FG001|Overall Study|Disease Progression|10|||
131918996|NCT01500083|474986853|FG000|Overall Study|Investigator Discretion|3|||
131918997|NCT01500083|474986854|FG001|Overall Study|Investigator Discretion|8|||
131918998|NCT01500083|474986853|FG000|Overall Study|Other Reasons|2|||
131918999|NCT01500083|474986854|FG001|Overall Study|Other Reasons|5|||
131919000|NCT01555931|474986855|FG000|Overall Study|Lost to Follow-up|2|||
131919001|NCT01555931|474986856|FG001|Overall Study|Lost to Follow-up|5|||
131919002|NCT02299167|474986859|FG000|Overall Study|patients were excluded from the study|11|||
131919003|NCT03600428|474986860|FG000|Overall Study|Not eligible|0|||
131919004|NCT03600428|474986861|FG001|Overall Study|Not eligible|1|||
131919005|NCT03600428|474986860|FG000|Overall Study|Lost to Follow-up|5|||
131919006|NCT03600428|474986861|FG001|Overall Study|Lost to Follow-up|4|||
131919007|NCT03506477|474986862|FG000|Overall Study|Withdrawal by Subject|1|||
131919008|NCT03506477|474986863|FG001|Overall Study|Withdrawal by Subject|0|||
131919009|NCT02324153|474986864|FG000|Overall Study|Withdrawal by Subject|4|||
131919010|NCT02324153|474986865|FG001|Overall Study|Withdrawal by Subject|1|||
131919011|NCT02324153|474986864|FG000|Overall Study|Surgery postponed after randomization|3|||
131919012|NCT02324153|474986865|FG001|Overall Study|Surgery postponed after randomization|0|||
131919013|NCT02324153|474986864|FG000|Overall Study|Developed delirium preoperatively|1|||
131919014|NCT02324153|474986865|FG001|Overall Study|Developed delirium preoperatively|0|||
131919015|NCT02555878|474986866|FG000|Overall Study|Lost to Follow-up|2|||
131919016|NCT02555878|474986867|FG001|Overall Study|Lost to Follow-up|3|||
131919017|NCT02555878|474986866|FG000|Overall Study|Withdrawal by Subject|48|||
131919018|NCT02555878|474986867|FG001|Overall Study|Withdrawal by Subject|48|||
131919019|NCT02555878|474986866|FG000|Overall Study|Adverse Event|12|||
131919020|NCT02555878|474986867|FG001|Overall Study|Adverse Event|8|||
131919021|NCT02555878|474986866|FG000|Overall Study|Death|74|||
131919022|NCT02555878|474986867|FG001|Overall Study|Death|59|||
131919023|NCT02555878|474986866|FG000|Overall Study|Protocol Violation|1|||
131919024|NCT02555878|474986867|FG001|Overall Study|Protocol Violation|2|||
131919025|NCT02555878|474986866|FG000|Overall Study|Physician Decision|12|||
131919026|NCT02555878|474986867|FG001|Overall Study|Physician Decision|13|||
131919027|NCT02555878|474986866|FG000|Overall Study|Other|17|||
131919028|NCT02555878|474986867|FG001|Overall Study|Other|17|||
131919029|NCT00765076|474986868|FG000|Overall Study|Adverse Event|1|||
131919030|NCT00765076|474986869|FG001|Overall Study|Adverse Event|0|||
131919031|NCT00765076|474986870|FG002|Overall Study|Adverse Event|0|||
131919032|NCT00765076|474986868|FG000|Overall Study|Withdrawal by Subject|0|||
131919033|NCT00765076|474986869|FG001|Overall Study|Withdrawal by Subject|0|||
131919034|NCT00765076|474986870|FG002|Overall Study|Withdrawal by Subject|1|||
131919035|NCT01164475|474986871|FG000|Overall Study|Lack of Efficacy|1|||
131919036|NCT01164475|474986872|FG001|Overall Study|Lack of Efficacy|0|||
131919037|NCT01164475|474986871|FG000|Overall Study|Other|0|||
131919038|NCT01164475|474986872|FG001|Overall Study|Other|1|||
131919039|NCT01164475|474986871|FG000|Overall Study|Progressive disease|0|||
131919040|NCT01164475|474986872|FG001|Overall Study|Progressive disease|1|||
131919041|NCT01164475|474986871|FG000|Overall Study|Protocol Violation|1|||
131919042|NCT01164475|474986872|FG001|Overall Study|Protocol Violation|0|||
131919043|NCT02180867|474986884|FG000|Overall Study|Adverse Event|3|||
131919044|NCT02180867|474986885|FG001|Overall Study|Adverse Event|4|||
131919045|NCT02180867|474986886|FG002|Overall Study|Adverse Event|1|||
131919046|NCT02180867|474986887|FG003|Overall Study|Adverse Event|5|||
131919047|NCT02180867|474986888|FG004|Overall Study|Adverse Event|0|||
131919048|NCT02180867|474986889|FG005|Overall Study|Adverse Event|0|||
131919049|NCT02180867|474986890|FG006|Overall Study|Adverse Event|0|||
131919050|NCT02180867|474986884|FG000|Overall Study|Death|0|||
131919051|NCT02180867|474986885|FG001|Overall Study|Death|0|||
131919052|NCT02180867|474986886|FG002|Overall Study|Death|0|||
131919053|NCT02180867|474986887|FG003|Overall Study|Death|0|||
131919054|NCT02180867|474986888|FG004|Overall Study|Death|1|||
131919055|NCT02180867|474986889|FG005|Overall Study|Death|0|||
131919056|NCT02180867|474986890|FG006|Overall Study|Death|0|||
131919057|NCT02180867|474986884|FG000|Overall Study|Lack of Efficacy|0|||
131919058|NCT02180867|474986885|FG001|Overall Study|Lack of Efficacy|2|||
131919059|NCT02180867|474986886|FG002|Overall Study|Lack of Efficacy|0|||
131919060|NCT02180867|474986887|FG003|Overall Study|Lack of Efficacy|1|||
131919061|NCT02180867|474986888|FG004|Overall Study|Lack of Efficacy|6|||
131919062|NCT02180867|474986889|FG005|Overall Study|Lack of Efficacy|0|||
131919063|NCT02180867|474986890|FG006|Overall Study|Lack of Efficacy|1|||
131919064|NCT02180867|474986884|FG000|Overall Study|Physician Decision|1|||
131919065|NCT02180867|474986885|FG001|Overall Study|Physician Decision|3|||
131919066|NCT02180867|474986886|FG002|Overall Study|Physician Decision|1|||
131919067|NCT02180867|474986887|FG003|Overall Study|Physician Decision|10|||
131919068|NCT02180867|474986888|FG004|Overall Study|Physician Decision|9|||
131919069|NCT02180867|474986889|FG005|Overall Study|Physician Decision|3|||
131919070|NCT02180867|474986890|FG006|Overall Study|Physician Decision|4|||
131919071|NCT02180867|474986884|FG000|Overall Study|Withdrawal by Subject|0|||
131919072|NCT02180867|474986885|FG001|Overall Study|Withdrawal by Subject|0|||
131919073|NCT02180867|474986886|FG002|Overall Study|Withdrawal by Subject|0|||
131919074|NCT02180867|474986887|FG003|Overall Study|Withdrawal by Subject|1|||
131919075|NCT02180867|474986888|FG004|Overall Study|Withdrawal by Subject|1|||
131919076|NCT02180867|474986889|FG005|Overall Study|Withdrawal by Subject|0|||
131919077|NCT02180867|474986890|FG006|Overall Study|Withdrawal by Subject|0|||
131919078|NCT02180867|474986884|FG000|Overall Study|Ineligible|1|||
131919079|NCT02180867|474986885|FG001|Overall Study|Ineligible|2|||
131919080|NCT02180867|474986886|FG002|Overall Study|Ineligible|0|||
131919081|NCT02180867|474986887|FG003|Overall Study|Ineligible|3|||
131919082|NCT02180867|474986888|FG004|Overall Study|Ineligible|5|||
131919083|NCT02180867|474986889|FG005|Overall Study|Ineligible|0|||
131919084|NCT02180867|474986890|FG006|Overall Study|Ineligible|0|||
131919085|NCT02180867|474986884|FG000|Overall Study|Repeat Eligibility Studies|0|||
131919086|NCT02180867|474986885|FG001|Overall Study|Repeat Eligibility Studies|0|||
131919087|NCT02180867|474986886|FG002|Overall Study|Repeat Eligibility Studies|0|||
131919088|NCT02180867|474986887|FG003|Overall Study|Repeat Eligibility Studies|0|||
131919089|NCT02180867|474986888|FG004|Overall Study|Repeat Eligibility Studies|1|||
131919090|NCT02180867|474986889|FG005|Overall Study|Repeat Eligibility Studies|0|||
131919091|NCT02180867|474986890|FG006|Overall Study|Repeat Eligibility Studies|0|||
131919092|NCT02180867|474986884|FG000|Overall Study|Refusal of further protocol therapy|1|||
131919093|NCT02180867|474986885|FG001|Overall Study|Refusal of further protocol therapy|0|||
131919094|NCT02180867|474986886|FG002|Overall Study|Refusal of further protocol therapy|2|||
131919095|NCT02180867|474986887|FG003|Overall Study|Refusal of further protocol therapy|6|||
131919096|NCT02180867|474986888|FG004|Overall Study|Refusal of further protocol therapy|4|||
131919097|NCT02180867|474986889|FG005|Overall Study|Refusal of further protocol therapy|0|||
131919098|NCT02180867|474986890|FG006|Overall Study|Refusal of further protocol therapy|0|||
131919099|NCT02337686|474986891|FG000|Overall Study|Adverse Event|1|||
131919100|NCT02145390|474986892|FG000|Overall Study|Withdrawal by Subject|1|||
131919101|NCT00177671|474987301|FG000|Overall Study|Withdrawal by Subject|5|||
131919102|NCT00177671|474987302|FG001|Overall Study|Withdrawal by Subject|6|||
131919103|NCT00177671|474987301|FG000|Overall Study|medical complications|2|||
131919104|NCT00177671|474987302|FG001|Overall Study|medical complications|0|||
131919105|NCT00177671|474987301|FG000|Overall Study|Adverse Event|6|||
131919106|NCT00177671|474987302|FG001|Overall Study|Adverse Event|0|||
131919107|NCT00177671|474987301|FG000|Overall Study|Physician Decision|12|||
131919108|NCT00177671|474987302|FG001|Overall Study|Physician Decision|8|||
131919109|NCT04615507|474987305|FG000|Period 1|Covid-19 exposure|2|||
131919110|NCT04615507|474987306|FG001|Period 1|Covid-19 exposure|1|||
131919111|NCT04615507|474987305|FG000|Period 2|Covid-19 exposure|0|||
131919112|NCT04615507|474987306|FG001|Period 2|Covid-19 exposure|1|||
131919113|NCT04615507|474987305|FG000|Period 2|Protocol Violation|1|||
131919114|NCT04615507|474987306|FG001|Period 2|Protocol Violation|0|||
131919115|NCT04615507|474987305|FG000|Period 2|Withdrawal by Subject|1|||
131919116|NCT04615507|474987306|FG001|Period 2|Withdrawal by Subject|0|||
131919117|NCT04615507|474987305|FG000|Period 2|Adverse Event|0|||
131919118|NCT04615507|474987306|FG001|Period 2|Adverse Event|1|||
131919119|NCT04615507|474987305|FG000|Period 3|Covid-19 exposure|0|||
131919120|NCT04615507|474987306|FG001|Period 3|Covid-19 exposure|1|||
131919121|NCT02717611|474987307|FG000|Overall Study|Death|13|||
131919122|NCT02717611|474987307|FG000|Overall Study|Withdrawal by Subject|6|||
131919123|NCT02717611|474987307|FG000|Overall Study|Active, not recruiting|40|||
131919124|NCT02717611|474987307|FG000|Overall Study|Complicating disease|1|||
131919125|NCT04598828|474987308|FG000|Overall Study|Physician Decision|1|||
131919126|NCT04598828|474987309|FG001|Overall Study|Physician Decision|0|||
131919127|NCT04598828|474987308|FG000|Overall Study|Withdrawal by Subject|0|||
131919128|NCT04598828|474987309|FG001|Overall Study|Withdrawal by Subject|1|||
131919129|NCT04598828|474987308|FG000|Overall Study|Withdrawal by Subject|0|||
131919130|NCT04598828|474987309|FG001|Overall Study|Withdrawal by Subject|1|||
131919131|NCT00325416|474987310|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
131919132|NCT00325416|474987311|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
131919133|NCT00325416|474987310|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
131919134|NCT00325416|474987311|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
131919135|NCT00325416|474987310|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
131919136|NCT00325416|474987311|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
131919137|NCT00325416|474987310|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
131919138|NCT00325416|474987311|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
131919139|NCT00325416|474987310|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
131919140|NCT00325416|474987311|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
131919141|NCT00325416|474987310|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
131919142|NCT00325416|474987311|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
131919143|NCT04589650|474987312|FG000|Overall Study|Subject decision|6|||
131919144|NCT04589650|474987313|FG001|Overall Study|Subject decision|2|||
131919145|NCT04589650|474987314|FG002|Overall Study|Subject decision|2|||
131919146|NCT04589650|474987315|FG003|Overall Study|Subject decision|0|||
131919147|NCT04589650|474987316|FG004|Overall Study|Subject decision|0|||
131919148|NCT04589650|474987317|FG005|Overall Study|Subject decision|0|||
131919149|NCT04589650|474987312|FG000|Overall Study|Adverse Event|3|||
131919150|NCT04589650|474987313|FG001|Overall Study|Adverse Event|1|||
131919151|NCT04589650|474987314|FG002|Overall Study|Adverse Event|1|||
131919152|NCT04589650|474987315|FG003|Overall Study|Adverse Event|1|||
131919153|NCT04589650|474987316|FG004|Overall Study|Adverse Event|0|||
131919154|NCT04589650|474987317|FG005|Overall Study|Adverse Event|1|||
131919155|NCT04589650|474987312|FG000|Overall Study|Physician Decision|1|||
131919156|NCT04589650|474987313|FG001|Overall Study|Physician Decision|1|||
131919157|NCT04589650|474987314|FG002|Overall Study|Physician Decision|0|||
131870715|NCT00652626|474808154|FG000|Initial Treatment Phase|Adverse Event|0|||
131870716|NCT00652626|474808155|FG001|Initial Treatment Phase|Adverse Event|0|||
131870717|NCT00652626|474808156|FG002|Initial Treatment Phase|Adverse Event|0|||
131870718|NCT00652626|474808157|FG003|Initial Treatment Phase|Adverse Event|0|||
131870719|NCT00652626|474808158|FG004|Initial Treatment Phase|Adverse Event|1|||
131870720|NCT00652626|474808159|FG005|Initial Treatment Phase|Adverse Event|0|||
131870721|NCT00652626|474808160|FG006|Initial Treatment Phase|Adverse Event|0|||
131870722|NCT00652626|474808154|FG000|Initial Treatment Phase|Protocol Violation|0|||
131870723|NCT00652626|474808155|FG001|Initial Treatment Phase|Protocol Violation|0|||
131870724|NCT00652626|474808156|FG002|Initial Treatment Phase|Protocol Violation|0|||
131870725|NCT00652626|474808157|FG003|Initial Treatment Phase|Protocol Violation|1|||
131870726|NCT00652626|474808158|FG004|Initial Treatment Phase|Protocol Violation|0|||
131870727|NCT00652626|474808159|FG005|Initial Treatment Phase|Protocol Violation|0|||
131870728|NCT00652626|474808160|FG006|Initial Treatment Phase|Protocol Violation|0|||
131870729|NCT00652626|474808154|FG000|Initial Treatment Phase|Physician Decision|0|||
131870730|NCT00652626|474808155|FG001|Initial Treatment Phase|Physician Decision|0|||
131870731|NCT00652626|474808156|FG002|Initial Treatment Phase|Physician Decision|0|||
131870732|NCT00652626|474808157|FG003|Initial Treatment Phase|Physician Decision|0|||
131870733|NCT00652626|474808158|FG004|Initial Treatment Phase|Physician Decision|1|||
131870734|NCT00652626|474808159|FG005|Initial Treatment Phase|Physician Decision|0|||
131870735|NCT00652626|474808160|FG006|Initial Treatment Phase|Physician Decision|0|||
131870736|NCT00652626|474808154|FG000|Initial Treatment Phase|Sponsor Request|0|||
131870737|NCT00652626|474808155|FG001|Initial Treatment Phase|Sponsor Request|0|||
131870738|NCT00652626|474808156|FG002|Initial Treatment Phase|Sponsor Request|1|||
131870739|NCT00652626|474808157|FG003|Initial Treatment Phase|Sponsor Request|0|||
131870740|NCT00652626|474808158|FG004|Initial Treatment Phase|Sponsor Request|0|||
131870741|NCT00652626|474808159|FG005|Initial Treatment Phase|Sponsor Request|0|||
131870742|NCT00652626|474808160|FG006|Initial Treatment Phase|Sponsor Request|0|||
131870743|NCT00652626|474808154|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
131870744|NCT00652626|474808155|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
131870745|NCT00652626|474808156|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
131870746|NCT00652626|474808157|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
131870747|NCT00652626|474808158|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
131870748|NCT00652626|474808159|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
131870749|NCT00652626|474808160|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
131870750|NCT00652626|474808154|FG000|Extension Phase|Withdrawal by Subject|0|||
131870751|NCT00652626|474808155|FG001|Extension Phase|Withdrawal by Subject|0|||
131870752|NCT00652626|474808156|FG002|Extension Phase|Withdrawal by Subject|0|||
131870753|NCT00652626|474808157|FG003|Extension Phase|Withdrawal by Subject|0|||
131870754|NCT00652626|474808158|FG004|Extension Phase|Withdrawal by Subject|0|||
131870755|NCT00652626|474808159|FG005|Extension Phase|Withdrawal by Subject|2|||
131870756|NCT00652626|474808160|FG006|Extension Phase|Withdrawal by Subject|0|||
131870757|NCT00652626|474808154|FG000|Extension Phase|Adverse Event|0|||
131870758|NCT00652626|474808155|FG001|Extension Phase|Adverse Event|0|||
131870759|NCT00652626|474808156|FG002|Extension Phase|Adverse Event|0|||
131870760|NCT00652626|474808157|FG003|Extension Phase|Adverse Event|0|||
131870761|NCT00652626|474808158|FG004|Extension Phase|Adverse Event|0|||
131870762|NCT00652626|474808159|FG005|Extension Phase|Adverse Event|2|||
131870763|NCT00652626|474808160|FG006|Extension Phase|Adverse Event|1|||
131870764|NCT00652626|474808154|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
131870765|NCT00652626|474808155|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
131870766|NCT00652626|474808156|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
131870767|NCT00652626|474808157|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
131870768|NCT00652626|474808158|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
131870769|NCT00652626|474808159|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
131870770|NCT00652626|474808160|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
131870771|NCT00652626|474808154|FG000|Extension Phase|Physician Decision|0|||
131870772|NCT00652626|474808155|FG001|Extension Phase|Physician Decision|0|||
131870773|NCT00652626|474808156|FG002|Extension Phase|Physician Decision|0|||
131870774|NCT00652626|474808157|FG003|Extension Phase|Physician Decision|0|||
131870775|NCT00652626|474808158|FG004|Extension Phase|Physician Decision|0|||
131870776|NCT00652626|474808159|FG005|Extension Phase|Physician Decision|1|||
131870777|NCT00652626|474808160|FG006|Extension Phase|Physician Decision|1|||
131870778|NCT00652626|474808154|FG000|Extension Phase|Death|0|||
131408259|NCT03054350|473118248|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
131870779|NCT00652626|474808155|FG001|Extension Phase|Death|0|||
131870780|NCT00652626|474808156|FG002|Extension Phase|Death|0|||
131870781|NCT00652626|474808157|FG003|Extension Phase|Death|0|||
131870782|NCT00652626|474808158|FG004|Extension Phase|Death|0|||
131870783|NCT00652626|474808159|FG005|Extension Phase|Death|1|||
131870784|NCT00652626|474808160|FG006|Extension Phase|Death|1|||
131870785|NCT01623310|474808161|FG000|Overall Study|Adverse Event|21|||
131870786|NCT01623310|474808161|FG000|Overall Study|Lost to Follow-up|18|||
131870787|NCT01623310|474808161|FG000|Overall Study|Lack of Efficacy|6|||
131870788|NCT01623310|474808161|FG000|Overall Study|Protocol Violation|6|||
131408260|NCT03054350|473118243|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
131870789|NCT01623310|474808161|FG000|Overall Study|Withdrawal by Subject|25|||
131870790|NCT01623310|474808161|FG000|Overall Study|Became potentially child-bearing|1|||
131870791|NCT01623310|474808161|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
131870792|NCT01623310|474808161|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
131870793|NCT02898597|474808162|FG000|Overall Study|Protocol Violation|4|||
131870794|NCT02898597|474808163|FG001|Overall Study|Protocol Violation|2|||
131870795|NCT02898597|474808162|FG000|Overall Study|Lost to Follow-up|0|||
131870796|NCT02898597|474808163|FG001|Overall Study|Lost to Follow-up|9|||
131870797|NCT02898597|474808162|FG000|Overall Study|Death|0|||
131870798|NCT02898597|474808163|FG001|Overall Study|Death|1|||
131870799|NCT02530125|474808164|FG000|Completed Treatment|Early termination of study|1|||
131870800|NCT02530125|474808164|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
131870801|NCT01568034|474808165|FG000|Overall Study|Withdrawal by Subject|1|||
131870802|NCT01568034|474808166|FG001|Overall Study|Withdrawal by Subject|0|||
131870803|NCT01568034|474808167|FG002|Overall Study|Withdrawal by Subject|0|||
131870804|NCT01568034|474808168|FG003|Overall Study|Withdrawal by Subject|0|||
131870805|NCT06098339|474808169|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
131870806|NCT06098339|474808170|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
131870807|NCT06098339|474808169|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
131870808|NCT06098339|474808170|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
131870809|NCT02492984|474808171|FG000|Overall Study|Adverse Event|1|||
131870810|NCT02492984|474808172|FG001|Overall Study|Adverse Event|0|||
131870811|NCT02492984|474808171|FG000|Overall Study|Protocol Violation|1|||
131870812|NCT02492984|474808172|FG001|Overall Study|Protocol Violation|0|||
131870813|NCT02492984|474808171|FG000|Overall Study|Withdrawal by Subject|1|||
131870814|NCT02492984|474808172|FG001|Overall Study|Withdrawal by Subject|0|||
131870815|NCT02498444|474808173|FG000|Overall Study|Withdrawal by Subject|3|||
131870816|NCT02498444|474808174|FG001|Overall Study|Withdrawal by Subject|0|||
131870817|NCT02498444|474808173|FG000|Overall Study|Physician Decision|1|||
131870818|NCT02498444|474808174|FG001|Overall Study|Physician Decision|0|||
131870819|NCT02027545|474808175|FG000|Overall Study|Failed to sign HIPAA|0|||
131870820|NCT02027545|474808176|FG001|Overall Study|Failed to sign HIPAA|2|||
131870821|NCT02027545|474808175|FG000|Overall Study|Failed to attend study visit|2|||
131870822|NCT02027545|474808176|FG001|Overall Study|Failed to attend study visit|0|||
131870823|NCT02027545|474808175|FG000|Overall Study|Protocol Violation|1|||
131870824|NCT02027545|474808176|FG001|Overall Study|Protocol Violation|0|||
131870825|NCT02453334|474808177|FG000|Overall Study|Death|15|||
131870826|NCT02453334|474808178|FG001|Overall Study|Death|13|||
131870827|NCT02453334|474808177|FG000|Overall Study|Adverse Event|2|||
131870828|NCT02453334|474808178|FG001|Overall Study|Adverse Event|1|||
131870829|NCT02453334|474808177|FG000|Overall Study|Lost to Follow-up|5|||
131870830|NCT02453334|474808178|FG001|Overall Study|Lost to Follow-up|9|||
131870831|NCT02453334|474808177|FG000|Overall Study|Physician Decision|1|||
131870832|NCT02453334|474808178|FG001|Overall Study|Physician Decision|0|||
131870833|NCT02453334|474808177|FG000|Overall Study|Withdrawal by Subject|17|||
131870834|NCT02453334|474808178|FG001|Overall Study|Withdrawal by Subject|13|||
131870835|NCT02453334|474808177|FG000|Overall Study|Other reason|1|||
131870836|NCT02453334|474808178|FG001|Overall Study|Other reason|4|||
131870837|NCT04090060|474808181|FG000|Overall Study|Lost to Follow-up|76|||
131870838|NCT04090060|474808182|FG001|Overall Study|Lost to Follow-up|77|||
131870839|NCT03337113|474808183|FG000|Overall Study|Adverse Event|1|||
131870840|NCT03337113|474808184|FG001|Overall Study|Adverse Event|1|||
131870841|NCT03337113|474808185|FG002|Overall Study|Adverse Event|0|||
131870842|NCT03337113|474808186|FG003|Overall Study|Adverse Event|1|||
131870843|NCT03337113|474808183|FG000|Overall Study|Physician Decision|0|||
131870844|NCT03337113|474808184|FG001|Overall Study|Physician Decision|2|||
131870845|NCT03337113|474808185|FG002|Overall Study|Physician Decision|0|||
131870846|NCT03337113|474808186|FG003|Overall Study|Physician Decision|1|||
131870847|NCT03337113|474808183|FG000|Overall Study|Withdrawal by Subject|0|||
131870848|NCT03337113|474808184|FG001|Overall Study|Withdrawal by Subject|0|||
131870849|NCT03337113|474808185|FG002|Overall Study|Withdrawal by Subject|1|||
131870850|NCT03337113|474808186|FG003|Overall Study|Withdrawal by Subject|0|||
131870851|NCT03491462|474808191|FG000|Overall Study|Lost to Follow-up|2|||
131870852|NCT03491462|474808192|FG001|Overall Study|Lost to Follow-up|0|||
131870853|NCT03491462|474808191|FG000|Overall Study|Adverse Event|11|||
131870854|NCT03491462|474808192|FG001|Overall Study|Adverse Event|1|||
131870855|NCT03491462|474808191|FG000|Overall Study|Physician Decision|3|||
131870856|NCT03491462|474808192|FG001|Overall Study|Physician Decision|0|||
131870857|NCT03491462|474808191|FG000|Overall Study|Withdrawal by Subject|22|||
131870858|NCT03491462|474808192|FG001|Overall Study|Withdrawal by Subject|15|||
131870859|NCT00423332|474808193|FG000|Overall Study|Adverse Event|6|||
131870860|NCT00423332|474808194|FG001|Overall Study|Adverse Event|2|||
131870861|NCT00423332|474808193|FG000|Overall Study|Withdrawal by Subject|1|||
131870862|NCT00423332|474808194|FG001|Overall Study|Withdrawal by Subject|0|||
131870863|NCT00423332|474808193|FG000|Overall Study|Condition under investigation worsened|1|||
131919158|NCT04589650|474987315|FG003|Overall Study|Physician Decision|0|||
131919159|NCT04589650|474987316|FG004|Overall Study|Physician Decision|0|||
131919160|NCT04589650|474987317|FG005|Overall Study|Physician Decision|0|||
131919161|NCT04589650|474987312|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131919162|NCT04589650|474987313|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131919163|NCT04589650|474987314|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131919164|NCT04589650|474987315|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131919165|NCT04589650|474987316|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
131919166|NCT04589650|474987317|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
131919167|NCT04589650|474987312|FG000|Overall Study|Death|0|||
131919168|NCT04589650|474987313|FG001|Overall Study|Death|0|||
131919169|NCT04589650|474987314|FG002|Overall Study|Death|0|||
131919170|NCT04589650|474987315|FG003|Overall Study|Death|1|||
131919171|NCT04589650|474987316|FG004|Overall Study|Death|0|||
131919172|NCT04589650|474987317|FG005|Overall Study|Death|0|||
131919173|NCT04589650|474987312|FG000|Overall Study|Guardian Decision|0|||
131919174|NCT04589650|474987313|FG001|Overall Study|Guardian Decision|0|||
131919175|NCT04589650|474987314|FG002|Overall Study|Guardian Decision|0|||
131919176|NCT04589650|474987315|FG003|Overall Study|Guardian Decision|1|||
131919177|NCT04589650|474987316|FG004|Overall Study|Guardian Decision|0|||
131919178|NCT04589650|474987317|FG005|Overall Study|Guardian Decision|0|||
131919179|NCT03122106|474987320|FG000|Overall Study|Not enough tissue|1|||
131919180|NCT03122106|474987320|FG000|Overall Study|Disease progression during screening|2|||
131919181|NCT03122106|474987320|FG000|Overall Study|Poor RNA quality for vaccine|1|||
131919182|NCT01147458|474987322|FG000|First Intervention|Study terminated by sponsor|8|||
131919183|NCT01147458|474987323|FG001|First Intervention|Study terminated by sponsor|8|||
131919184|NCT01147458|474987324|FG002|First Intervention|Study terminated by sponsor|7|||
131919185|NCT01147458|474987325|FG003|First Intervention|Study terminated by sponsor|8|||
131870864|NCT00423332|474808194|FG001|Overall Study|Condition under investigation worsened|1|||
131870865|NCT00423332|474808193|FG000|Overall Study|Progressive at Week 6|0|||
131870866|NCT00423332|474808194|FG001|Overall Study|Progressive at Week 6|1|||
131870867|NCT00423332|474808193|FG000|Overall Study|Unblinded before 12 weeks|1|||
131870868|NCT00423332|474808194|FG001|Overall Study|Unblinded before 12 weeks|3|||
131870869|NCT04112043|474808195|FG000|Overall Study|Withdrawal by Subject|1|||
131870870|NCT04112043|474808196|FG001|Overall Study|Withdrawal by Subject|1|||
131870871|NCT04112043|474808197|FG002|Overall Study|Withdrawal by Subject|1|||
131870872|NCT04112043|474808195|FG000|Overall Study|Taking NR supplement|1|||
131870873|NCT04112043|474808196|FG001|Overall Study|Taking NR supplement|0|||
131870874|NCT04112043|474808197|FG002|Overall Study|Taking NR supplement|0|||
131870875|NCT04112043|474808195|FG000|Overall Study|Adverse Event|0|||
131870876|NCT04112043|474808196|FG001|Overall Study|Adverse Event|1|||
131870877|NCT04112043|474808197|FG002|Overall Study|Adverse Event|0|||
131870878|NCT04157296|474808198|FG000|Overall Study|Withdrawal by Subject|0|||
131870879|NCT04157296|474808199|FG001|Overall Study|Withdrawal by Subject|1|||
131870880|NCT04157296|474808198|FG000|Overall Study|Did not obtain second fMRI.|0|||
131870881|NCT04157296|474808199|FG001|Overall Study|Did not obtain second fMRI.|1|||
131870882|NCT04157296|474808198|FG000|Overall Study|MRI failed/no second fMRI|0|||
131870883|NCT04157296|474808199|FG001|Overall Study|MRI failed/no second fMRI|1|||
131870884|NCT01750697|474808202|FG000|Overall Study|Transferred Back to Local Hospital|1|||
131870885|NCT01750697|474808202|FG000|Overall Study|Physician and Family Decision|1|||
131870886|NCT01750697|474808202|FG000|Overall Study|Transferred to Adult Services|5|||
131870887|NCT01750697|474808202|FG000|Overall Study|Physician Decision|1|||
131870888|NCT01750697|474808202|FG000|Overall Study|Withdrawal by Subject|1|||
131870889|NCT01282372|474808212|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
131870890|NCT01282372|474808212|FG000|Overall Study|Lost to Follow-up|23|||
131870891|NCT01282372|474808212|FG000|Overall Study|Withdrawal by Subject|11|||
131870892|NCT01282372|474808212|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
131870893|NCT01282372|474808212|FG000|Overall Study|Death|1|||
131870894|NCT01282372|474808212|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
131919186|NCT01147458|474987322|FG000|First Intervention|Protocol Violation|2|||
131919187|NCT01147458|474987323|FG001|First Intervention|Protocol Violation|3|||
131870895|NCT01282372|474808212|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
131870896|NCT01282372|474808212|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
131919188|NCT01147458|474987324|FG002|First Intervention|Protocol Violation|2|||
131919189|NCT01147458|474987325|FG003|First Intervention|Protocol Violation|3|||
131919190|NCT01147458|474987322|FG000|First Intervention|Withdrawal by Subject|3|||
131919191|NCT01147458|474987323|FG001|First Intervention|Withdrawal by Subject|0|||
131870897|NCT01282372|474808212|FG000|Overall Study|Adverse Event|12|||
131870898|NCT01322490|474808213|FG000|Treatment Period|Adverse Event|12|||
131870899|NCT01322490|474808214|FG001|Treatment Period|Adverse Event|18|||
131870900|NCT01322490|474808215|FG002|Treatment Period|Adverse Event|15|||
131870901|NCT01322490|474808213|FG000|Treatment Period|Death|5|||
131919192|NCT01147458|474987324|FG002|First Intervention|Withdrawal by Subject|1|||
131919193|NCT01147458|474987325|FG003|First Intervention|Withdrawal by Subject|0|||
131919194|NCT01147458|474987322|FG000|First Intervention|Adverse Event|0|||
131919195|NCT01147458|474987323|FG001|First Intervention|Adverse Event|3|||
131919196|NCT01147458|474987324|FG002|First Intervention|Adverse Event|2|||
131919197|NCT01147458|474987325|FG003|First Intervention|Adverse Event|3|||
131919198|NCT01147458|474987322|FG000|First Intervention|Other|1|||
131919199|NCT01147458|474987323|FG001|First Intervention|Other|2|||
131919200|NCT01147458|474987324|FG002|First Intervention|Other|0|||
131919201|NCT01147458|474987325|FG003|First Intervention|Other|0|||
131919202|NCT01147458|474987322|FG000|Second Intervention|Study terminated by sponsor|7|||
131919203|NCT01147458|474987323|FG001|Second Intervention|Study terminated by sponsor|5|||
131919204|NCT01147458|474987324|FG002|Second Intervention|Study terminated by sponsor|5|||
131919205|NCT01147458|474987325|FG003|Second Intervention|Study terminated by sponsor|3|||
131919206|NCT01147458|474987322|FG000|Second Intervention|Protocol Violation|0|||
131919207|NCT01147458|474987323|FG001|Second Intervention|Protocol Violation|1|||
131919208|NCT01147458|474987324|FG002|Second Intervention|Protocol Violation|1|||
131870902|NCT01322490|474808214|FG001|Treatment Period|Death|7|||
131870903|NCT01322490|474808215|FG002|Treatment Period|Death|3|||
131870904|NCT01322490|474808213|FG000|Treatment Period|Lack of Efficacy|89|||
131870905|NCT01322490|474808214|FG001|Treatment Period|Lack of Efficacy|100|||
131870906|NCT01322490|474808215|FG002|Treatment Period|Lack of Efficacy|112|||
131870907|NCT01322490|474808213|FG000|Treatment Period|Physician Decision|0|||
131870908|NCT01322490|474808214|FG001|Treatment Period|Physician Decision|2|||
131870909|NCT01322490|474808215|FG002|Treatment Period|Physician Decision|1|||
131870910|NCT01322490|474808213|FG000|Treatment Period|Protocol Violation|7|||
131870911|NCT01322490|474808214|FG001|Treatment Period|Protocol Violation|5|||
131870912|NCT01322490|474808215|FG002|Treatment Period|Protocol Violation|4|||
131870913|NCT01322490|474808213|FG000|Treatment Period|Withdrawal by Subject|14|||
131870914|NCT01322490|474808214|FG001|Treatment Period|Withdrawal by Subject|16|||
131870915|NCT01322490|474808215|FG002|Treatment Period|Withdrawal by Subject|11|||
131870916|NCT01322490|474808213|FG000|Treatment Period|Non-compliance with study drug|0|||
131870917|NCT01322490|474808214|FG001|Treatment Period|Non-compliance with study drug|0|||
131870918|NCT01322490|474808215|FG002|Treatment Period|Non-compliance with study drug|1|||
131870919|NCT01322490|474808213|FG000|Treatment Period|Other per report|2|||
131870920|NCT01322490|474808214|FG001|Treatment Period|Other per report|2|||
131870921|NCT01322490|474808215|FG002|Treatment Period|Other per report|1|||
131870922|NCT01322490|474808213|FG000|Treatment Period|Randomized but Not Treated|3|||
131870923|NCT01322490|474808214|FG001|Treatment Period|Randomized but Not Treated|3|||
131870924|NCT01322490|474808215|FG002|Treatment Period|Randomized but Not Treated|5|||
131870925|NCT01322490|474808213|FG000|Long Term Follow-up Period|Death|235|||
131870926|NCT01322490|474808214|FG001|Long Term Follow-up Period|Death|239|||
131870927|NCT01322490|474808215|FG002|Long Term Follow-up Period|Death|236|||
131870928|NCT01322490|474808213|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
131870929|NCT01322490|474808214|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
131870930|NCT01322490|474808215|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
131870931|NCT01322490|474808213|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
131870932|NCT01322490|474808214|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
131870933|NCT01322490|474808215|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
131870934|NCT01322490|474808213|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
131870935|NCT01322490|474808214|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
131870936|NCT01322490|474808215|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
131870937|NCT01322490|474808213|FG000|Long Term Follow-up Period|Other per report|3|||
131870938|NCT01322490|474808214|FG001|Long Term Follow-up Period|Other per report|2|||
131870939|NCT01322490|474808215|FG002|Long Term Follow-up Period|Other per report|2|||
131870940|NCT01322490|474808213|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
131870941|NCT01322490|474808214|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
131870942|NCT01322490|474808215|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
131870943|NCT00568061|474808216|FG000|Overall Study|Inclusion / exclusion criteria|5|||
131919209|NCT01147458|474987325|FG003|Second Intervention|Protocol Violation|0|||
131919210|NCT01147458|474987322|FG000|Second Intervention|Withdrawal by Subject|0|||
131870944|NCT00568061|474808217|FG001|Overall Study|Inclusion / exclusion criteria|1|||
131870945|NCT00568061|474808216|FG000|Overall Study|Adverse Event|0|||
131870946|NCT00568061|474808217|FG001|Overall Study|Adverse Event|1|||
131870947|NCT05027451|474808218|FG000|Overall Study|Lost to Follow-up|1|||
131870948|NCT05027451|474808219|FG001|Overall Study|Lost to Follow-up|1|||
131870949|NCT00356148|474808222|FG000|Overall Study|Reoperation within 30 days|2|||
131870950|NCT00356148|474808223|FG001|Overall Study|Reoperation within 30 days|1|||
131870951|NCT02484456|474808224|FG000|Washout Period|Withdrawal by Subject|0|||
131919211|NCT01147458|474987323|FG001|Second Intervention|Withdrawal by Subject|1|||
131919212|NCT01147458|474987324|FG002|Second Intervention|Withdrawal by Subject|0|||
131919213|NCT01147458|474987325|FG003|Second Intervention|Withdrawal by Subject|0|||
131919214|NCT01147458|474987322|FG000|Second Intervention|Adverse Event|2|||
131870952|NCT02484456|474808225|FG001|Washout Period|Withdrawal by Subject|1|||
131870953|NCT02484456|474808224|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
131870954|NCT02484456|474808225|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
131870955|NCT02484456|474808224|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
131870956|NCT02484456|474808225|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
131919215|NCT01147458|474987323|FG001|Second Intervention|Adverse Event|0|||
131919216|NCT01147458|474987324|FG002|Second Intervention|Adverse Event|1|||
131919217|NCT01147458|474987325|FG003|Second Intervention|Adverse Event|1|||
131919218|NCT01147458|474987322|FG000|Second Intervention|Other|0|||
131919219|NCT01147458|474987323|FG001|Second Intervention|Other|0|||
131919220|NCT01147458|474987324|FG002|Second Intervention|Other|1|||
131919221|NCT01147458|474987325|FG003|Second Intervention|Other|0|||
131919222|NCT03550209|474987326|FG000|Overall Study|Lost to Follow-up|1|||
131919223|NCT03550209|474987327|FG001|Overall Study|Lost to Follow-up|0|||
131919224|NCT03550209|474987328|FG002|Overall Study|Lost to Follow-up|1|||
131919225|NCT03550209|474987329|FG003|Overall Study|Lost to Follow-up|0|||
131919226|NCT03550209|474987326|FG000|Overall Study|Withdrawal by Subject|0|||
131919227|NCT03550209|474987327|FG001|Overall Study|Withdrawal by Subject|3|||
131919228|NCT03550209|474987328|FG002|Overall Study|Withdrawal by Subject|1|||
131919229|NCT03550209|474987329|FG003|Overall Study|Withdrawal by Subject|2|||
131919230|NCT03550209|474987326|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
131919231|NCT03550209|474987327|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
131919232|NCT03550209|474987328|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
131919233|NCT03550209|474987329|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
131919234|NCT03244189|474987330|FG000|Overall Study|Death|0|||
131919235|NCT03244189|474987331|FG001|Overall Study|Death|2|||
131919236|NCT03244189|474987330|FG000|Overall Study|Lost to Follow-up|92|||
131919237|NCT03244189|474987331|FG001|Overall Study|Lost to Follow-up|107|||
131919238|NCT03244189|474987330|FG000|Overall Study|Physician Decision|4|||
131919239|NCT03244189|474987331|FG001|Overall Study|Physician Decision|2|||
131919240|NCT03244189|474987330|FG000|Overall Study|Pregnancy|7|||
131919241|NCT03244189|474987331|FG001|Overall Study|Pregnancy|5|||
131919242|NCT03244189|474987330|FG000|Overall Study|Protocol Violation|0|||
131919243|NCT03244189|474987331|FG001|Overall Study|Protocol Violation|2|||
131919244|NCT03244189|474987330|FG000|Overall Study|Withdrawal by Subject|45|||
131919245|NCT03244189|474987331|FG001|Overall Study|Withdrawal by Subject|23|||
131919246|NCT03244189|474987330|FG000|Overall Study|Technical Problems|2|||
131919247|NCT03244189|474987331|FG001|Overall Study|Technical Problems|0|||
131919248|NCT06170827|474987332|FG000|Overall Study|Withdrawal by Subject|1|||
131919249|NCT06170827|474987333|FG001|Overall Study|Withdrawal by Subject|1|||
131919250|NCT02872714|474987340|FG000|Overall Study|Progressive Disease|1|||
131919251|NCT02872714|474987341|FG001|Overall Study|Progressive Disease|2|||
131919252|NCT02872714|474987342|FG002|Overall Study|Progressive Disease|0|||
131919253|NCT02872714|474987343|FG003|Overall Study|Progressive Disease|0|||
131919254|NCT02872714|474987344|FG004|Overall Study|Progressive Disease|0|||
131919255|NCT02872714|474987340|FG000|Overall Study|Death|87|||
131919256|NCT02872714|474987341|FG001|Overall Study|Death|36|||
131919257|NCT02872714|474987342|FG002|Overall Study|Death|8|||
131919258|NCT02872714|474987343|FG003|Overall Study|Death|81|||
131870957|NCT02484456|474808224|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
131870958|NCT02484456|474808225|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
131870959|NCT01996254|474808228|FG000|Overall Study|Change in Eligibility|0|||
131870960|NCT01996254|474808229|FG001|Overall Study|Change in Eligibility|2|||
131870961|NCT01996254|474808230|FG002|Overall Study|Change in Eligibility|0|||
131870962|NCT01996254|474808228|FG000|Overall Study|Withdrawal by Subject|0|||
131870963|NCT01996254|474808229|FG001|Overall Study|Withdrawal by Subject|3|||
131870964|NCT01996254|474808230|FG002|Overall Study|Withdrawal by Subject|4|||
131870965|NCT01996254|474808228|FG000|Overall Study|Lost to Follow-up|1|||
131870966|NCT01996254|474808229|FG001|Overall Study|Lost to Follow-up|0|||
131870967|NCT01996254|474808230|FG002|Overall Study|Lost to Follow-up|4|||
131870968|NCT03348930|474808231|FG000|Washout (1 Week)|Lost to Follow-up|1|||
131870969|NCT03348930|474808232|FG001|Washout (1 Week)|Lost to Follow-up|1|||
131919259|NCT02872714|474987344|FG004|Overall Study|Death|2|||
131919260|NCT02872714|474987340|FG000|Overall Study|Lost to Follow-up|2|||
131919261|NCT02872714|474987341|FG001|Overall Study|Lost to Follow-up|1|||
131919262|NCT02872714|474987342|FG002|Overall Study|Lost to Follow-up|0|||
131919263|NCT02872714|474987343|FG003|Overall Study|Lost to Follow-up|3|||
131919264|NCT02872714|474987344|FG004|Overall Study|Lost to Follow-up|0|||
131919265|NCT02872714|474987340|FG000|Overall Study|Physician Decision|0|||
131919266|NCT02872714|474987341|FG001|Overall Study|Physician Decision|0|||
131919267|NCT02872714|474987342|FG002|Overall Study|Physician Decision|0|||
131870970|NCT02091089|474808267|FG000|Overall Study|Lost to Follow-up|2|||
131870971|NCT02929589|474808269|FG000|Overall Study|Withdrawal by Subject|1|||
131870972|NCT02929589|474808270|FG001|Overall Study|Withdrawal by Subject|0|||
131919268|NCT02872714|474987343|FG003|Overall Study|Physician Decision|1|||
131919269|NCT02872714|474987344|FG004|Overall Study|Physician Decision|0|||
131919270|NCT02872714|474987340|FG000|Overall Study|Withdrawal by Subject|1|||
131919271|NCT02872714|474987341|FG001|Overall Study|Withdrawal by Subject|3|||
131919272|NCT02872714|474987342|FG002|Overall Study|Withdrawal by Subject|0|||
131919273|NCT02872714|474987343|FG003|Overall Study|Withdrawal by Subject|2|||
131919274|NCT02872714|474987344|FG004|Overall Study|Withdrawal by Subject|0|||
131870973|NCT02929589|474808271|FG002|Overall Study|Withdrawal by Subject|0|||
131870974|NCT02929589|474808272|FG003|Overall Study|Withdrawal by Subject|0|||
131870975|NCT02929589|474808269|FG000|Overall Study|Physician Decision|2|||
131919275|NCT02872714|474987340|FG000|Overall Study|Captured as Other|2|||
131870976|NCT02929589|474808270|FG001|Overall Study|Physician Decision|0|||
131870977|NCT02929589|474808271|FG002|Overall Study|Physician Decision|0|||
131870978|NCT02929589|474808272|FG003|Overall Study|Physician Decision|0|||
131870979|NCT01580670|474808277|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
131870980|NCT01580670|474808277|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
131870981|NCT02097745|474808278|FG000|Overall Study|Adverse Event|25|||
131870982|NCT02097745|474808278|FG000|Overall Study|Death|16|||
131870983|NCT02097745|474808278|FG000|Overall Study|Failure to Return|14|||
131870984|NCT02097745|474808278|FG000|Overall Study|Administrative/Other|27|||
131870985|NCT02097745|474808278|FG000|Overall Study|Reason Not Specified|96|||
131870986|NCT00425750|474808279|FG000|Overall Study|Death|1|||
131870987|NCT00425750|474808279|FG000|Overall Study|Withdrawal by Subject|3|||
131870988|NCT00425750|474808279|FG000|Overall Study|Adverse Event|3|||
131870989|NCT00425750|474808279|FG000|Overall Study|Progression of disease|18|||
131870990|NCT01757184|474808280|FG000|Double-blind Period|Adverse Event|1|||
131870991|NCT01757184|474808281|FG001|Double-blind Period|Adverse Event|0|||
131870992|NCT01757184|474808282|FG002|Double-blind Period|Adverse Event|0|||
131870993|NCT01757184|474808283|FG003|Double-blind Period|Adverse Event|0|||
131870994|NCT01757184|474808280|FG000|Open-label Period|Lost to Follow-up|0|||
131870995|NCT01757184|474808281|FG001|Open-label Period|Lost to Follow-up|0|||
131870996|NCT01757184|474808282|FG002|Open-label Period|Lost to Follow-up|2|||
131870997|NCT01757184|474808283|FG003|Open-label Period|Lost to Follow-up|0|||
131870998|NCT01757184|474808280|FG000|Open-label Period|Withdrawal by Subject|0|||
131870999|NCT01757184|474808281|FG001|Open-label Period|Withdrawal by Subject|0|||
131871000|NCT01757184|474808282|FG002|Open-label Period|Withdrawal by Subject|1|||
131871001|NCT01757184|474808283|FG003|Open-label Period|Withdrawal by Subject|1|||
131871002|NCT01757184|474808280|FG000|Open-label Period|Discontinued by Sponsor|0|||
131871003|NCT01757184|474808281|FG001|Open-label Period|Discontinued by Sponsor|0|||
131871004|NCT01757184|474808282|FG002|Open-label Period|Discontinued by Sponsor|1|||
131871005|NCT01757184|474808283|FG003|Open-label Period|Discontinued by Sponsor|2|||
131871006|NCT00554515|474808284|FG000|Overall Study|Withdrawal by Subject|3|||
131871007|NCT00554515|474808284|FG000|Overall Study|Disease progression|52|||
131871008|NCT00554515|474808284|FG000|Overall Study|Physician Decision|18|||
131871009|NCT00554515|474808284|FG000|Overall Study|Withdrawal by Subject|11|||
131871010|NCT00554515|474808284|FG000|Overall Study|Adverse Event|9|||
131871011|NCT00554515|474808284|FG000|Overall Study|Death|2|||
131871012|NCT00554515|474808284|FG000|Overall Study|Achieved Stable Disease|7|||
131871013|NCT00554515|474808284|FG000|Overall Study|Other|1|||
131871014|NCT00554515|474808284|FG000|Overall Study|Misc|15|||
131871015|NCT01276756|474808287|FG000|Overall Study|Lost to Follow-up|2|||
131871016|NCT01276756|474808288|FG001|Overall Study|Lost to Follow-up|0|||
131871017|NCT01276756|474808287|FG000|Overall Study|Adverse Event|3|||
131871018|NCT01276756|474808288|FG001|Overall Study|Adverse Event|2|||
131871019|NCT00665431|474808296|FG000|Overall Study|Adverse Event|16|||
131871020|NCT00665431|474808297|FG001|Overall Study|Adverse Event|22|||
131871021|NCT00665431|474808298|FG002|Overall Study|Adverse Event|6|||
131871022|NCT00665431|474808296|FG000|Overall Study|Withdrawal by Subject|17|||
131871023|NCT00665431|474808297|FG001|Overall Study|Withdrawal by Subject|25|||
131871024|NCT00665431|474808298|FG002|Overall Study|Withdrawal by Subject|15|||
131871025|NCT00665431|474808296|FG000|Overall Study|Lost to Follow-up|3|||
131871026|NCT00665431|474808297|FG001|Overall Study|Lost to Follow-up|3|||
131871027|NCT00665431|474808298|FG002|Overall Study|Lost to Follow-up|1|||
131871028|NCT00665431|474808296|FG000|Overall Study|Other|4|||
131871029|NCT00665431|474808297|FG001|Overall Study|Other|7|||
131871030|NCT00665431|474808298|FG002|Overall Study|Other|2|||
131871031|NCT01052480|474808299|FG000|Overall Study|Lost to Follow-up|3|||
131871032|NCT01052480|474808300|FG001|Overall Study|Lost to Follow-up|3|||
131871033|NCT01052480|474808299|FG000|Overall Study|Protocol Violation|1|||
131871034|NCT01052480|474808300|FG001|Overall Study|Protocol Violation|0|||
131871035|NCT01052480|474808299|FG000|Overall Study|Withdrawal by Subject|3|||
131871036|NCT01052480|474808300|FG001|Overall Study|Withdrawal by Subject|7|||
131871037|NCT01052480|474808299|FG000|Overall Study|Physician Decision|0|||
131871038|NCT01052480|474808300|FG001|Overall Study|Physician Decision|2|||
131919276|NCT02872714|474987341|FG001|Overall Study|Captured as Other|0|||
131871039|NCT01052480|474808299|FG000|Overall Study|Death|1|||
131871040|NCT01052480|474808300|FG001|Overall Study|Death|5|||
131871041|NCT00529373|474808301|FG000|Base Study|Adverse Event|525|||
131871042|NCT00529373|474808302|FG001|Base Study|Adverse Event|470|||
131871043|NCT00529373|474808301|FG000|Base Study|Lack of Efficacy|16|||
131871044|NCT00529373|474808302|FG001|Base Study|Lack of Efficacy|75|||
131871045|NCT00529373|474808301|FG000|Base Study|Lost to Follow-up|221|||
131871046|NCT00529373|474808302|FG001|Base Study|Lost to Follow-up|208|||
131871047|NCT00529373|474808301|FG000|Base Study|Other Protocol Specified Criteria|19|||
131871048|NCT00529373|474808302|FG001|Base Study|Other Protocol Specified Criteria|20|||
131871049|NCT00529373|474808301|FG000|Base Study|Physician Decision|60|||
131871050|NCT00529373|474808302|FG001|Base Study|Physician Decision|52|||
131871051|NCT00529373|474808301|FG000|Base Study|Protocol Violation|48|||
131871052|NCT00529373|474808302|FG001|Base Study|Protocol Violation|38|||
131871053|NCT00529373|474808301|FG000|Base Study|Withdrawal by Subject|1062|||
131871054|NCT00529373|474808302|FG001|Base Study|Withdrawal by Subject|967|||
131871055|NCT00529373|474808301|FG000|Base Study|Did not continue into Extension|1795|||
131871056|NCT00529373|474808302|FG001|Base Study|Did not continue into Extension|2238|||
131871057|NCT00529373|474808301|FG000|First Extension Study|Adverse Event|162|||
131871058|NCT00529373|474808302|FG001|First Extension Study|Adverse Event|142|||
131871059|NCT00529373|474808301|FG000|First Extension Study|Lack of Efficacy|65|||
131871060|NCT00529373|474808302|FG001|First Extension Study|Lack of Efficacy|427|||
131871061|NCT00529373|474808301|FG000|First Extension Study|Lost to Follow-up|41|||
131871062|NCT00529373|474808302|FG001|First Extension Study|Lost to Follow-up|37|||
131871063|NCT00529373|474808301|FG000|First Extension Study|Other|27|||
131871064|NCT00529373|474808302|FG001|First Extension Study|Other|47|||
131871065|NCT00529373|474808301|FG000|First Extension Study|Physician Decision|50|||
131871066|NCT00529373|474808302|FG001|First Extension Study|Physician Decision|45|||
131871067|NCT00529373|474808301|FG000|First Extension Study|Protocol Violation|16|||
131871068|NCT00529373|474808302|FG001|First Extension Study|Protocol Violation|13|||
131871069|NCT00529373|474808301|FG000|First Extension Study|Withdrawal by Subject|296|||
131871070|NCT00529373|474808302|FG001|First Extension Study|Withdrawal by Subject|287|||
131871071|NCT00529373|474808301|FG000|First Extension Study|Disposition record non-existing|0|||
131871072|NCT00529373|474808302|FG001|First Extension Study|Disposition record non-existing|1|||
131871073|NCT00529373|474808301|FG000|First Extension Study|Discontinued after 5 years completion|208|||
131871074|NCT00529373|474808302|FG001|First Extension Study|Discontinued after 5 years completion|346|||
131871075|NCT00529373|474808301|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
131871076|NCT00529373|474808302|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
131871077|NCT00529373|474808301|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
131871078|NCT00529373|474808302|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
131871079|NCT00529373|474808301|FG000|Second Extension Study|Adverse Event|101|||
131871080|NCT00529373|474808302|FG001|Second Extension Study|Adverse Event|51|||
131871081|NCT00529373|474808301|FG000|Second Extension Study|Lack of Efficacy|7|||
131871082|NCT00529373|474808302|FG001|Second Extension Study|Lack of Efficacy|15|||
131871083|NCT00529373|474808301|FG000|Second Extension Study|Lost to Follow-up|18|||
131871084|NCT00529373|474808302|FG001|Second Extension Study|Lost to Follow-up|12|||
131871085|NCT00529373|474808301|FG000|Second Extension Study|Other|7|||
131871086|NCT00529373|474808302|FG001|Second Extension Study|Other|12|||
131871087|NCT00529373|474808301|FG000|Second Extension Study|Physician Decision|63|||
131871088|NCT00529373|474808302|FG001|Second Extension Study|Physician Decision|26|||
131871089|NCT00529373|474808301|FG000|Second Extension Study|Protocol Violation|2|||
131871090|NCT00529373|474808302|FG001|Second Extension Study|Protocol Violation|1|||
131871091|NCT00529373|474808301|FG000|Second Extension Study|Withdrawal by Subject|97|||
131919277|NCT02872714|474987342|FG002|Overall Study|Captured as Other|0|||
131919278|NCT02872714|474987343|FG003|Overall Study|Captured as Other|1|||
131919279|NCT02872714|474987344|FG004|Overall Study|Captured as Other|0|||
131919280|NCT01847209|474989186|FG000|Overall Study|Withdrawal by Subject|1|||
131919281|NCT01847209|474989186|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
131919282|NCT01991314|474989205|FG000|Overall Study|Adverse Event|5|||
131919283|NCT01991314|474989206|FG001|Overall Study|Adverse Event|1|||
131919284|NCT01991314|474989205|FG000|Overall Study|Lost to Follow-up|6|||
131919285|NCT01991314|474989206|FG001|Overall Study|Lost to Follow-up|10|||
131919286|NCT00970944|474989208|FG000|Overall Study|Death|1|||
131919287|NCT00970944|474989209|FG001|Overall Study|Death|0|||
131919288|NCT00970944|474989208|FG000|Overall Study|Physician Decision|0|||
131919289|NCT00970944|474989209|FG001|Overall Study|Physician Decision|2|||
131919290|NCT02008370|474989210|FG000|Overall Study|Lost to Follow-up|7|||
131919291|NCT00662259|474989211|FG000|Overall Study|Adverse Event|2|||
131919292|NCT00662259|474989212|FG001|Overall Study|Adverse Event|0|||
131919293|NCT00972738|474989213|FG000|Overall Study|Adverse Event|7|||
131919294|NCT00972738|474989214|FG001|Overall Study|Adverse Event|1|||
131919295|NCT00972738|474989215|FG002|Overall Study|Adverse Event|8|||
131919296|NCT00972738|474989213|FG000|Overall Study|Protocol Violation|2|||
131919297|NCT00972738|474989214|FG001|Overall Study|Protocol Violation|1|||
131919298|NCT00972738|474989215|FG002|Overall Study|Protocol Violation|3|||
131919299|NCT00972738|474989213|FG000|Overall Study|Lost to Follow-up|1|||
131919300|NCT00972738|474989214|FG001|Overall Study|Lost to Follow-up|0|||
131871092|NCT00529373|474808302|FG001|Second Extension Study|Withdrawal by Subject|75|||
131871093|NCT00529373|474808301|FG000|Second Extension Study|Status Missing|5|||
131871094|NCT00529373|474808302|FG001|Second Extension Study|Status Missing|5|||
131871095|NCT01266291|474808316|FG000|Overall Study|Adverse Event|1|||
131919301|NCT00972738|474989215|FG002|Overall Study|Lost to Follow-up|1|||
131919302|NCT00972738|474989213|FG000|Overall Study|Lack of Efficacy|5|||
131871096|NCT03291431|474808317|FG000|Overall Study|Protocol Violation|2|||
131871097|NCT03291431|474808318|FG001|Overall Study|Protocol Violation|1|||
131871098|NCT03291431|474808317|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
131871099|NCT03291431|474808318|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
131919303|NCT00972738|474989214|FG001|Overall Study|Lack of Efficacy|1|||
131919304|NCT00972738|474989215|FG002|Overall Study|Lack of Efficacy|11|||
131919305|NCT00972738|474989213|FG000|Overall Study|Withdrawal by Subject|5|||
131919306|NCT00972738|474989214|FG001|Overall Study|Withdrawal by Subject|1|||
131919307|NCT00972738|474989215|FG002|Overall Study|Withdrawal by Subject|4|||
131919308|NCT00972738|474989213|FG000|Overall Study|Moved|0|||
131919309|NCT00972738|474989214|FG001|Overall Study|Moved|0|||
131919310|NCT00972738|474989215|FG002|Overall Study|Moved|1|||
131919311|NCT00972738|474989213|FG000|Overall Study|Other|1|||
131919312|NCT00972738|474989214|FG001|Overall Study|Other|2|||
131919313|NCT00972738|474989215|FG002|Overall Study|Other|1|||
131919314|NCT03915067|474989219|FG000|Overall Study|Adverse Event|0|||
131919315|NCT03915067|474989220|FG001|Overall Study|Adverse Event|0|||
131919316|NCT03915067|474989221|FG002|Overall Study|Adverse Event|1|||
131919317|NCT03915067|474989219|FG000|Overall Study|Withdrawal by Subject|4|||
131919318|NCT03915067|474989220|FG001|Overall Study|Withdrawal by Subject|3|||
131919319|NCT03915067|474989221|FG002|Overall Study|Withdrawal by Subject|0|||
131919320|NCT03915067|474989219|FG000|Overall Study|Lost to Follow-up|3|||
131919321|NCT03915067|474989220|FG001|Overall Study|Lost to Follow-up|2|||
131919322|NCT03915067|474989221|FG002|Overall Study|Lost to Follow-up|0|||
131919323|NCT03915067|474989219|FG000|Overall Study|Protocol Deviation|0|||
131919324|NCT03915067|474989220|FG001|Overall Study|Protocol Deviation|0|||
131919325|NCT03915067|474989221|FG002|Overall Study|Protocol Deviation|1|||
131919326|NCT03915067|474989219|FG000|Overall Study|Covid-19 Related Issues|2|||
131919327|NCT03915067|474989220|FG001|Overall Study|Covid-19 Related Issues|4|||
131919328|NCT03915067|474989221|FG002|Overall Study|Covid-19 Related Issues|4|||
131919329|NCT03915067|474989219|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
131919330|NCT03915067|474989220|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
131919331|NCT03915067|474989221|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
131919332|NCT01033942|474989222|FG000|Overall Study|Withdrawal by Subject|1|||
131919333|NCT01033942|474989223|FG001|Overall Study|Withdrawal by Subject|1|||
131919334|NCT01033942|474989224|FG002|Overall Study|Withdrawal by Subject|1|||
131919335|NCT01033942|474989222|FG000|Overall Study|Lost to Follow-up|1|||
131919336|NCT01033942|474989223|FG001|Overall Study|Lost to Follow-up|0|||
131919337|NCT01033942|474989224|FG002|Overall Study|Lost to Follow-up|0|||
131919338|NCT01033942|474989222|FG000|Overall Study|Enrolled in Extension Study|0|||
131919339|NCT01033942|474989223|FG001|Overall Study|Enrolled in Extension Study|3|||
131919340|NCT01033942|474989224|FG002|Overall Study|Enrolled in Extension Study|0|||
131919341|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
131919342|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
131919343|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
131919344|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
131919345|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
131919346|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
131919347|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
131919348|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
131919349|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
131919350|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
131919351|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Death|0|||
131919352|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Death|0|||
131919353|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Death|1|||
131919354|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Death|0|||
131919355|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Death|0|||
131919356|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
131919357|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
131919358|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
131919359|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
131919360|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
131919361|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Other|2|||
131919362|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Other|1|||
131919363|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Other|0|||
131919364|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Other|0|||
131919365|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Other|0|||
131919366|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
131919367|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
131919368|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
131919369|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
131919370|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
131919371|NCT03317496|474989225|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
131919372|NCT03317496|474989226|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
131919373|NCT03317496|474989227|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
131919374|NCT03317496|474989228|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
131919375|NCT03317496|474989229|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
131919376|NCT03317496|474989225|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
131919377|NCT03317496|474989226|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
131919378|NCT03317496|474989227|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
131919379|NCT03317496|474989228|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
131919380|NCT03317496|474989229|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
131919381|NCT03317496|474989225|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
131919382|NCT03317496|474989226|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
131919383|NCT03317496|474989227|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
131919384|NCT03317496|474989228|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
131919385|NCT03317496|474989229|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
131919386|NCT03317496|474989225|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
131919387|NCT03317496|474989226|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
131919388|NCT03317496|474989227|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
131919389|NCT03317496|474989228|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
131919390|NCT03317496|474989229|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
131919391|NCT03317496|474989225|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
131919392|NCT03317496|474989226|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
131919393|NCT03317496|474989227|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
131919394|NCT03317496|474989228|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
131919395|NCT03317496|474989229|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
131919396|NCT03317496|474989225|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
131919397|NCT03317496|474989226|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
131919398|NCT03317496|474989227|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
131919399|NCT03317496|474989228|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
131919400|NCT03317496|474989229|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
131919401|NCT03317496|474989225|FG000|Phase 2: Treatment|Adverse Event|0|||
131919402|NCT03317496|474989226|FG001|Phase 2: Treatment|Adverse Event|0|||
131919403|NCT03317496|474989227|FG002|Phase 2: Treatment|Adverse Event|0|||
131919404|NCT03317496|474989228|FG003|Phase 2: Treatment|Adverse Event|0|||
131919405|NCT03317496|474989229|FG004|Phase 2: Treatment|Adverse Event|6|||
131919406|NCT03317496|474989225|FG000|Phase 2: Treatment|Progressive disease|0|||
131919407|NCT03317496|474989226|FG001|Phase 2: Treatment|Progressive disease|0|||
131919408|NCT03317496|474989227|FG002|Phase 2: Treatment|Progressive disease|0|||
131871100|NCT03291431|474808317|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
131871101|NCT03291431|474808318|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
131871102|NCT03850483|474808323|FG000|Treatment for Stage 1|Adverse Event|1|||
131871103|NCT03850483|474808324|FG001|Treatment for Stage 1|Adverse Event|1|||
131871104|NCT03850483|474808325|FG002|Treatment for Stage 1|Adverse Event|3|||
131871105|NCT03850483|474808326|FG003|Treatment for Stage 1|Adverse Event|0|||
131871106|NCT03850483|474808327|FG004|Treatment for Stage 1|Adverse Event|2|||
131871107|NCT03850483|474808328|FG005|Treatment for Stage 1|Adverse Event|0|||
131871108|NCT03850483|474808329|FG006|Treatment for Stage 1|Adverse Event|2|||
131871109|NCT03850483|474808330|FG007|Treatment for Stage 1|Adverse Event|2|||
131871110|NCT03850483|474808331|FG008|Treatment for Stage 1|Adverse Event|0|||
131919409|NCT03317496|474989228|FG003|Phase 2: Treatment|Progressive disease|0|||
131919410|NCT03317496|474989229|FG004|Phase 2: Treatment|Progressive disease|22|||
131919411|NCT03317496|474989225|FG000|Phase 2: Treatment|Other|0|||
131919412|NCT03317496|474989226|FG001|Phase 2: Treatment|Other|0|||
131919413|NCT03317496|474989227|FG002|Phase 2: Treatment|Other|0|||
131919414|NCT03317496|474989228|FG003|Phase 2: Treatment|Other|0|||
131919415|NCT03317496|474989229|FG004|Phase 2: Treatment|Other|4|||
131919416|NCT03317496|474989225|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
131919417|NCT03317496|474989226|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
131919418|NCT03317496|474989227|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
131919419|NCT03317496|474989228|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
131919420|NCT03317496|474989229|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
131919421|NCT03317496|474989225|FG000|Phase 2: Treatment|Physician Decision|0|||
131919422|NCT03317496|474989226|FG001|Phase 2: Treatment|Physician Decision|0|||
131919423|NCT03317496|474989227|FG002|Phase 2: Treatment|Physician Decision|0|||
131919424|NCT03317496|474989228|FG003|Phase 2: Treatment|Physician Decision|0|||
131919425|NCT03317496|474989229|FG004|Phase 2: Treatment|Physician Decision|1|||
131919426|NCT03317496|474989225|FG000|Phase 2: Treatment|Death|0|||
131919427|NCT03317496|474989226|FG001|Phase 2: Treatment|Death|0|||
131871111|NCT03850483|474808332|FG009|Treatment for Stage 1|Adverse Event|0|||
131871112|NCT03850483|474808323|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
131871113|NCT03850483|474808324|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
131871114|NCT03850483|474808325|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
131919428|NCT03317496|474989227|FG002|Phase 2: Treatment|Death|0|||
131919429|NCT03317496|474989228|FG003|Phase 2: Treatment|Death|0|||
131919430|NCT03317496|474989229|FG004|Phase 2: Treatment|Death|1|||
131919431|NCT03317496|474989225|FG000|Phase 2: Follow-up|Death|0|||
131919432|NCT03317496|474989226|FG001|Phase 2: Follow-up|Death|0|||
131919433|NCT03317496|474989227|FG002|Phase 2: Follow-up|Death|0|||
131919434|NCT03317496|474989228|FG003|Phase 2: Follow-up|Death|0|||
131919435|NCT03317496|474989229|FG004|Phase 2: Follow-up|Death|24|||
131871115|NCT03850483|474808326|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
131871116|NCT03850483|474808327|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
131919436|NCT03317496|474989225|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
131919437|NCT03317496|474989226|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
131919438|NCT03317496|474989227|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
131919439|NCT03317496|474989228|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
131919440|NCT03317496|474989229|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
131919441|NCT03317496|474989225|FG000|Phase 2: Follow-up|Other|0|||
131919442|NCT03317496|474989226|FG001|Phase 2: Follow-up|Other|0|||
131919443|NCT03317496|474989227|FG002|Phase 2: Follow-up|Other|0|||
131919444|NCT03317496|474989228|FG003|Phase 2: Follow-up|Other|0|||
131919445|NCT03317496|474989229|FG004|Phase 2: Follow-up|Other|1|||
131919446|NCT03317496|474989225|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
131919447|NCT03317496|474989226|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
131919448|NCT03317496|474989227|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
131919449|NCT03317496|474989228|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
131919450|NCT03317496|474989229|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
131871117|NCT03850483|474808328|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
131871118|NCT03850483|474808329|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
131871119|NCT03850483|474808330|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
131871120|NCT03850483|474808331|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
131871121|NCT03850483|474808332|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
131871122|NCT03850483|474808323|FG000|Treatment for Stage 1|Protocol Violation|1|||
131871123|NCT03850483|474808324|FG001|Treatment for Stage 1|Protocol Violation|0|||
131871124|NCT03850483|474808325|FG002|Treatment for Stage 1|Protocol Violation|0|||
131871125|NCT03850483|474808326|FG003|Treatment for Stage 1|Protocol Violation|0|||
131871126|NCT03850483|474808327|FG004|Treatment for Stage 1|Protocol Violation|0|||
131871127|NCT03850483|474808328|FG005|Treatment for Stage 1|Protocol Violation|0|||
131871128|NCT03850483|474808329|FG006|Treatment for Stage 1|Protocol Violation|1|||
131871129|NCT03850483|474808330|FG007|Treatment for Stage 1|Protocol Violation|0|||
131871130|NCT03850483|474808331|FG008|Treatment for Stage 1|Protocol Violation|0|||
131871131|NCT03850483|474808332|FG009|Treatment for Stage 1|Protocol Violation|0|||
131871132|NCT03850483|474808323|FG000|Treatment for Stage 1|Physician Decision|0|||
131871133|NCT03850483|474808324|FG001|Treatment for Stage 1|Physician Decision|0|||
131871134|NCT03850483|474808325|FG002|Treatment for Stage 1|Physician Decision|0|||
131871135|NCT03850483|474808326|FG003|Treatment for Stage 1|Physician Decision|0|||
131871136|NCT03850483|474808327|FG004|Treatment for Stage 1|Physician Decision|0|||
131871137|NCT03850483|474808328|FG005|Treatment for Stage 1|Physician Decision|1|||
131871138|NCT03850483|474808329|FG006|Treatment for Stage 1|Physician Decision|0|||
131871139|NCT03850483|474808330|FG007|Treatment for Stage 1|Physician Decision|0|||
131871140|NCT03850483|474808331|FG008|Treatment for Stage 1|Physician Decision|0|||
131871141|NCT03850483|474808332|FG009|Treatment for Stage 1|Physician Decision|0|||
131871142|NCT03850483|474808323|FG000|Treatment for Stage 1|Other|0|||
131871143|NCT03850483|474808324|FG001|Treatment for Stage 1|Other|0|||
131871144|NCT03850483|474808325|FG002|Treatment for Stage 1|Other|0|||
131871145|NCT03850483|474808326|FG003|Treatment for Stage 1|Other|0|||
131871146|NCT03850483|474808327|FG004|Treatment for Stage 1|Other|2|||
131871147|NCT03850483|474808328|FG005|Treatment for Stage 1|Other|1|||
131871148|NCT03850483|474808329|FG006|Treatment for Stage 1|Other|0|||
131871149|NCT03850483|474808330|FG007|Treatment for Stage 1|Other|0|||
131871150|NCT03850483|474808331|FG008|Treatment for Stage 1|Other|0|||
131871151|NCT03850483|474808332|FG009|Treatment for Stage 1|Other|0|||
131871152|NCT03850483|474808323|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871153|NCT03850483|474808324|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871154|NCT03850483|474808325|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
131871155|NCT03850483|474808326|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871156|NCT03850483|474808327|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871157|NCT03850483|474808328|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871158|NCT03850483|474808329|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871159|NCT03850483|474808330|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871160|NCT03850483|474808331|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871161|NCT03850483|474808332|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
131871162|NCT03850483|474808323|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871163|NCT03850483|474808324|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871164|NCT03850483|474808325|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871165|NCT03850483|474808326|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871166|NCT03850483|474808327|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131919451|NCT02693418|474989230|FG000|Overall Study|Lost to Follow-up|1|||
131919452|NCT02693418|474989231|FG001|Overall Study|Lost to Follow-up|2|||
131919453|NCT02693418|474989232|FG002|Overall Study|Lost to Follow-up|0|||
131919454|NCT02693418|474989233|FG003|Overall Study|Lost to Follow-up|0|||
131871167|NCT03850483|474808328|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
131871168|NCT03850483|474808329|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871169|NCT03850483|474808330|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871170|NCT03850483|474808331|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131871171|NCT03850483|474808332|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
131919455|NCT02693418|474989234|FG004|Overall Study|Lost to Follow-up|0|||
131919456|NCT02693418|474989230|FG000|Overall Study|Menses during study period|0|||
131919457|NCT02693418|474989231|FG001|Overall Study|Menses during study period|0|||
131919458|NCT02693418|474989232|FG002|Overall Study|Menses during study period|2|||
131919459|NCT02693418|474989233|FG003|Overall Study|Menses during study period|0|||
131919460|NCT02693418|474989234|FG004|Overall Study|Menses during study period|0|||
131919461|NCT02737618|474989235|FG000|Overall Study|Withdrawal by Subject|9|||
131919462|NCT01750346|474989242|FG000|Overall Study|Adverse Event|1|||
131919463|NCT01750346|474989243|FG001|Overall Study|Adverse Event|0|||
131919464|NCT01750346|474989244|FG002|Overall Study|Adverse Event|0|||
131919465|NCT01001104|474989250|FG000|Overall Study|Adverse Event|2|||
131919466|NCT01001104|474989251|FG001|Overall Study|Adverse Event|1|||
131919467|NCT01001104|474989252|FG002|Overall Study|Adverse Event|0|||
131919468|NCT01001104|474989253|FG003|Overall Study|Adverse Event|0|||
131919469|NCT01001104|474989250|FG000|Overall Study|Lost to Follow-up|0|||
131919470|NCT01001104|474989251|FG001|Overall Study|Lost to Follow-up|0|||
131919471|NCT01001104|474989252|FG002|Overall Study|Lost to Follow-up|1|||
131919472|NCT01001104|474989253|FG003|Overall Study|Lost to Follow-up|0|||
131919473|NCT01001104|474989250|FG000|Overall Study|Entry Criteria Not Met|0|||
131919474|NCT01001104|474989251|FG001|Overall Study|Entry Criteria Not Met|0|||
131919475|NCT01001104|474989252|FG002|Overall Study|Entry Criteria Not Met|0|||
131919476|NCT01001104|474989253|FG003|Overall Study|Entry Criteria Not Met|1|||
131919477|NCT01001104|474989250|FG000|Overall Study|Withdrawal by Subject|0|||
131919478|NCT01001104|474989251|FG001|Overall Study|Withdrawal by Subject|0|||
131919479|NCT01001104|474989252|FG002|Overall Study|Withdrawal by Subject|0|||
131919480|NCT01001104|474989253|FG003|Overall Study|Withdrawal by Subject|2|||
131919481|NCT02397837|474989255|FG000|Overall Study|Withdrawal by Subject|6|||
131919482|NCT02397837|474989256|FG001|Overall Study|Withdrawal by Subject|5|||
131919483|NCT02397837|474989255|FG000|Overall Study|Physician Decision|1|||
131919484|NCT02397837|474989256|FG001|Overall Study|Physician Decision|1|||
131919485|NCT00599313|474989257|FG000|Overall Study|Adverse Event|19|||
131919486|NCT00599313|474989257|FG000|Overall Study|Disease Progression|12|||
131919487|NCT00599313|474989257|FG000|Overall Study|Patient Request|4|||
131919488|NCT00599313|474989257|FG000|Overall Study|Ineligible|1|||
131919489|NCT02536794|474989258|FG000|Reached 1st Response Assessment|Adverse Event|2|||
131919490|NCT02536794|474989258|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
131919491|NCT02536794|474989258|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
131919492|NCT02536794|474989258|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
131919493|NCT02536794|474989258|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
131919494|NCT02536794|474989258|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
131919495|NCT00898807|474989271|FG000|Overall Study|Withdrawal by Subject|5|||
131919496|NCT00898807|474989272|FG001|Overall Study|Withdrawal by Subject|3|||
131919497|NCT00898807|474989271|FG000|Overall Study|Family pressure to discontinue|2|||
131919498|NCT00898807|474989272|FG001|Overall Study|Family pressure to discontinue|2|||
131919499|NCT00898807|474989271|FG000|Overall Study|Lost to Follow-up|1|||
131919500|NCT00898807|474989272|FG001|Overall Study|Lost to Follow-up|3|||
131919501|NCT00898807|474989271|FG000|Overall Study|Death|0|||
131919502|NCT00898807|474989272|FG001|Overall Study|Death|1|||
131919503|NCT00817063|474989273|FG000|Overall Study|Adverse Event|32|||
131919504|NCT00817063|474989274|FG001|Overall Study|Adverse Event|13|||
131919505|NCT00817063|474989273|FG000|Overall Study|Death|1|||
131919506|NCT00817063|474989274|FG001|Overall Study|Death|1|||
131919507|NCT00817063|474989273|FG000|Overall Study|Lack of Efficacy|33|||
131919508|NCT00817063|474989274|FG001|Overall Study|Lack of Efficacy|86|||
131919509|NCT00817063|474989273|FG000|Overall Study|Failure to Return|13|||
131919510|NCT00817063|474989274|FG001|Overall Study|Failure to Return|12|||
131919511|NCT00817063|474989273|FG000|Overall Study|Violation of Selection at Entry|7|||
131919512|NCT00817063|474989274|FG001|Overall Study|Violation of Selection at Entry|4|||
131919513|NCT00817063|474989273|FG000|Overall Study|Protocol Violation|3|||
131919514|NCT00817063|474989274|FG001|Overall Study|Protocol Violation|8|||
131919515|NCT00817063|474989273|FG000|Overall Study|Withdrawal by Subject|17|||
131919516|NCT00817063|474989274|FG001|Overall Study|Withdrawal by Subject|37|||
131919517|NCT00817063|474989273|FG000|Overall Study|Early Improvement|19|||
131919518|NCT00817063|474989274|FG001|Overall Study|Early Improvement|4|||
131919519|NCT00817063|474989273|FG000|Overall Study|Administrative|10|||
131919520|NCT00817063|474989274|FG001|Overall Study|Administrative|4|||
131919521|NCT00817063|474989273|FG000|Overall Study|Abnormality of Laboratory Test|2|||
131919522|NCT00817063|474989274|FG001|Overall Study|Abnormality of Laboratory Test|1|||
131919523|NCT01496456|474989275|FG000|Overall Study|Protocol Violation|1|||
131919524|NCT01496456|474989275|FG000|Overall Study|Lost to Follow-up|7|||
131919525|NCT02362451|474989276|FG000|Overall Study|Withdrawal by Subject|0|||
131919526|NCT02362451|474989277|FG001|Overall Study|Withdrawal by Subject|1|||
131919527|NCT02362451|474989276|FG000|Overall Study|Lack of Efficacy|2|||
131919528|NCT02362451|474989277|FG001|Overall Study|Lack of Efficacy|0|||
131919529|NCT02362451|474989276|FG000|Overall Study|Progression|1|||
131919530|NCT02362451|474989277|FG001|Overall Study|Progression|0|||
131919531|NCT02362451|474989276|FG000|Overall Study|Participant chose other therapy.|1|||
131919532|NCT02362451|474989277|FG001|Overall Study|Participant chose other therapy.|0|||
131871172|NCT03850483|474808323|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
131871173|NCT03850483|474808324|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
131871174|NCT03850483|474808325|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
131871175|NCT03850483|474808326|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
131871176|NCT03850483|474808327|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
131871177|NCT03850483|474808328|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
131871178|NCT03850483|474808329|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
131871179|NCT03850483|474808330|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
131871180|NCT03850483|474808331|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
131871181|NCT03850483|474808332|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
131871182|NCT03850483|474808323|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
131871183|NCT03850483|474808324|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
131871184|NCT03850483|474808325|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
131871185|NCT03850483|474808326|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
131871186|NCT03850483|474808327|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
131871187|NCT03850483|474808328|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
131871188|NCT03850483|474808329|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
131871189|NCT03850483|474808330|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
131871190|NCT03850483|474808331|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
131871191|NCT03850483|474808332|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
131871192|NCT03850483|474808323|FG000|Treatment for Stage 1|Death|0|||
131871193|NCT03850483|474808324|FG001|Treatment for Stage 1|Death|0|||
131871194|NCT03850483|474808325|FG002|Treatment for Stage 1|Death|0|||
131871195|NCT03850483|474808326|FG003|Treatment for Stage 1|Death|0|||
131871196|NCT03850483|474808327|FG004|Treatment for Stage 1|Death|0|||
131871197|NCT03850483|474808328|FG005|Treatment for Stage 1|Death|1|||
131871198|NCT03850483|474808329|FG006|Treatment for Stage 1|Death|0|||
131871199|NCT03850483|474808330|FG007|Treatment for Stage 1|Death|0|||
131871200|NCT03850483|474808331|FG008|Treatment for Stage 1|Death|0|||
131871201|NCT03850483|474808332|FG009|Treatment for Stage 1|Death|0|||
131871202|NCT03850483|474808323|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
131871203|NCT03850483|474808324|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
131871204|NCT03850483|474808325|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
131871205|NCT03850483|474808326|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
131871206|NCT03850483|474808327|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
131871207|NCT03850483|474808328|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
131871208|NCT03850483|474808329|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
131871209|NCT03850483|474808330|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
131871210|NCT03850483|474808331|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
131871211|NCT03850483|474808332|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
131871212|NCT03850483|474808323|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
131871213|NCT03850483|474808324|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
131871214|NCT03850483|474808325|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
131871215|NCT03850483|474808326|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
131871216|NCT03850483|474808327|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
131871217|NCT03850483|474808328|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
131871218|NCT03850483|474808329|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
131871219|NCT03850483|474808330|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
131871220|NCT03850483|474808331|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
131871221|NCT03850483|474808332|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
131871222|NCT03850483|474808323|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871223|NCT03850483|474808324|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871224|NCT03850483|474808325|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871225|NCT03850483|474808326|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871226|NCT03850483|474808327|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871227|NCT03850483|474808328|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871228|NCT03850483|474808329|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
131871229|NCT03850483|474808330|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
131871230|NCT03850483|474808331|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871231|NCT03850483|474808332|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
131871232|NCT03850483|474808323|FG000|Follow-up for Stage 1|Physician Decision|0|||
131871233|NCT03850483|474808324|FG001|Follow-up for Stage 1|Physician Decision|0|||
131871234|NCT03850483|474808325|FG002|Follow-up for Stage 1|Physician Decision|0|||
131871235|NCT03850483|474808326|FG003|Follow-up for Stage 1|Physician Decision|0|||
131871236|NCT03850483|474808327|FG004|Follow-up for Stage 1|Physician Decision|1|||
131871237|NCT03850483|474808328|FG005|Follow-up for Stage 1|Physician Decision|0|||
131871238|NCT03850483|474808329|FG006|Follow-up for Stage 1|Physician Decision|1|||
131871239|NCT03850483|474808330|FG007|Follow-up for Stage 1|Physician Decision|0|||
131871240|NCT03850483|474808331|FG008|Follow-up for Stage 1|Physician Decision|0|||
131871241|NCT03850483|474808332|FG009|Follow-up for Stage 1|Physician Decision|0|||
131871242|NCT03850483|474808323|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
131871243|NCT03850483|474808324|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
131871244|NCT03850483|474808325|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
131871245|NCT03850483|474808326|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
131871246|NCT03850483|474808327|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
131871247|NCT03850483|474808328|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
131871248|NCT03850483|474808329|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
131871249|NCT03850483|474808330|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
131871250|NCT03850483|474808331|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
131871251|NCT03850483|474808332|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
131871252|NCT03850483|474808323|FG000|Follow-up for Stage 1|Adverse Event|0|||
131871253|NCT03850483|474808324|FG001|Follow-up for Stage 1|Adverse Event|0|||
131871254|NCT03850483|474808325|FG002|Follow-up for Stage 1|Adverse Event|1|||
131871255|NCT03850483|474808326|FG003|Follow-up for Stage 1|Adverse Event|0|||
131871256|NCT03850483|474808327|FG004|Follow-up for Stage 1|Adverse Event|0|||
131871257|NCT03850483|474808328|FG005|Follow-up for Stage 1|Adverse Event|1|||
131871258|NCT03850483|474808329|FG006|Follow-up for Stage 1|Adverse Event|0|||
131871259|NCT03850483|474808330|FG007|Follow-up for Stage 1|Adverse Event|0|||
131871260|NCT03850483|474808331|FG008|Follow-up for Stage 1|Adverse Event|0|||
131871261|NCT03850483|474808332|FG009|Follow-up for Stage 1|Adverse Event|0|||
131871262|NCT03850483|474808323|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871263|NCT03850483|474808324|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
131871264|NCT03850483|474808325|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871265|NCT03850483|474808326|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871266|NCT03850483|474808327|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
131871267|NCT03850483|474808328|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
131871268|NCT03850483|474808329|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871269|NCT03850483|474808330|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871270|NCT03850483|474808331|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871271|NCT03850483|474808332|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
131871272|NCT03850483|474808323|FG000|Follow-up for Stage 1|Other|0|||
131871273|NCT03850483|474808324|FG001|Follow-up for Stage 1|Other|2|||
131871274|NCT03850483|474808325|FG002|Follow-up for Stage 1|Other|0|||
131871275|NCT03850483|474808326|FG003|Follow-up for Stage 1|Other|2|||
131871276|NCT03850483|474808327|FG004|Follow-up for Stage 1|Other|0|||
131871277|NCT03850483|474808328|FG005|Follow-up for Stage 1|Other|1|||
131871278|NCT03850483|474808329|FG006|Follow-up for Stage 1|Other|0|||
131871279|NCT03850483|474808330|FG007|Follow-up for Stage 1|Other|0|||
131871280|NCT03850483|474808331|FG008|Follow-up for Stage 1|Other|0|||
131871281|NCT03850483|474808332|FG009|Follow-up for Stage 1|Other|0|||
131871282|NCT03850483|474808323|FG000|Treatment for Stage 2|Adverse Event|0|||
131871283|NCT03850483|474808324|FG001|Treatment for Stage 2|Adverse Event|0|||
131871284|NCT03850483|474808325|FG002|Treatment for Stage 2|Adverse Event|0|||
131871285|NCT03850483|474808326|FG003|Treatment for Stage 2|Adverse Event|0|||
131871286|NCT03850483|474808327|FG004|Treatment for Stage 2|Adverse Event|0|||
131871287|NCT03850483|474808328|FG005|Treatment for Stage 2|Adverse Event|0|||
131871288|NCT03850483|474808329|FG006|Treatment for Stage 2|Adverse Event|0|||
131871289|NCT03850483|474808330|FG007|Treatment for Stage 2|Adverse Event|0|||
131871290|NCT03850483|474808331|FG008|Treatment for Stage 2|Adverse Event|0|||
131871291|NCT03850483|474808332|FG009|Treatment for Stage 2|Adverse Event|1|||
131871292|NCT03850483|474808323|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
131871293|NCT03850483|474808324|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
131871294|NCT03850483|474808325|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
131871295|NCT03850483|474808326|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
131871296|NCT03850483|474808327|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
131871297|NCT03850483|474808328|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
131871298|NCT03850483|474808329|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
131871299|NCT03850483|474808330|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
131871300|NCT03850483|474808331|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
131871301|NCT03850483|474808332|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
131871302|NCT03850483|474808323|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
131871303|NCT03850483|474808324|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
131871304|NCT03850483|474808325|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
131871305|NCT03850483|474808326|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
131871306|NCT03850483|474808327|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
131871307|NCT03850483|474808328|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
131871308|NCT03850483|474808329|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
131871309|NCT03850483|474808330|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
131871310|NCT03850483|474808331|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
131871311|NCT03850483|474808332|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
131871312|NCT03850483|474808323|FG000|Treatment for Stage 2|Physician Decision|0|||
131871313|NCT03850483|474808324|FG001|Treatment for Stage 2|Physician Decision|0|||
131871314|NCT03850483|474808325|FG002|Treatment for Stage 2|Physician Decision|0|||
131871315|NCT03850483|474808326|FG003|Treatment for Stage 2|Physician Decision|0|||
131871316|NCT03850483|474808327|FG004|Treatment for Stage 2|Physician Decision|0|||
131871317|NCT03850483|474808328|FG005|Treatment for Stage 2|Physician Decision|0|||
131871318|NCT03850483|474808329|FG006|Treatment for Stage 2|Physician Decision|0|||
131871319|NCT03850483|474808330|FG007|Treatment for Stage 2|Physician Decision|0|||
131871320|NCT03850483|474808331|FG008|Treatment for Stage 2|Physician Decision|0|||
131871321|NCT03850483|474808332|FG009|Treatment for Stage 2|Physician Decision|1|||
131871322|NCT03850483|474808323|FG000|Treatment for Stage 2|Protocol Violation|0|||
131871323|NCT03850483|474808324|FG001|Treatment for Stage 2|Protocol Violation|0|||
131871324|NCT03850483|474808325|FG002|Treatment for Stage 2|Protocol Violation|0|||
131871325|NCT03850483|474808326|FG003|Treatment for Stage 2|Protocol Violation|0|||
131871326|NCT03850483|474808327|FG004|Treatment for Stage 2|Protocol Violation|0|||
131871327|NCT03850483|474808328|FG005|Treatment for Stage 2|Protocol Violation|0|||
131871328|NCT03850483|474808329|FG006|Treatment for Stage 2|Protocol Violation|0|||
131871329|NCT03850483|474808330|FG007|Treatment for Stage 2|Protocol Violation|0|||
131871330|NCT03850483|474808331|FG008|Treatment for Stage 2|Protocol Violation|1|||
131871331|NCT03850483|474808332|FG009|Treatment for Stage 2|Protocol Violation|0|||
131871332|NCT03850483|474808323|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
131871333|NCT03850483|474808324|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
131871334|NCT03850483|474808325|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
131871335|NCT03850483|474808326|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
131871336|NCT03850483|474808327|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
131871337|NCT03850483|474808328|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
131871338|NCT03850483|474808329|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
131871339|NCT03850483|474808330|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
131871340|NCT03850483|474808331|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
131871341|NCT03850483|474808332|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
131871342|NCT03850483|474808323|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871343|NCT03850483|474808324|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871344|NCT03850483|474808325|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871345|NCT03850483|474808326|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871346|NCT03850483|474808327|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871347|NCT03850483|474808328|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871348|NCT03850483|474808329|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871349|NCT03850483|474808330|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871350|NCT03850483|474808331|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
131871351|NCT03850483|474808332|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
131871352|NCT03850483|474808323|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
131871353|NCT03850483|474808324|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
131871354|NCT03850483|474808325|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
131871355|NCT03850483|474808326|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
131871356|NCT03850483|474808327|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
131871357|NCT03850483|474808328|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
131871358|NCT03850483|474808329|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
131871359|NCT03850483|474808330|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
131871360|NCT03850483|474808331|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
131871361|NCT03850483|474808332|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
131871362|NCT03850483|474808323|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
131871363|NCT03850483|474808324|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
131871364|NCT03850483|474808325|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
131871365|NCT03850483|474808326|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
131871366|NCT03850483|474808327|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
131871367|NCT03850483|474808328|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
131871368|NCT03850483|474808329|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
131871369|NCT03850483|474808330|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
131871370|NCT03850483|474808331|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
131871371|NCT03850483|474808332|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
131871372|NCT03850483|474808323|FG000|Follow-up For Stage 2|Other|0|||
131871373|NCT03850483|474808324|FG001|Follow-up For Stage 2|Other|0|||
131871374|NCT03850483|474808325|FG002|Follow-up For Stage 2|Other|0|||
131871375|NCT03850483|474808326|FG003|Follow-up For Stage 2|Other|0|||
131871376|NCT03850483|474808327|FG004|Follow-up For Stage 2|Other|0|||
131871377|NCT03850483|474808328|FG005|Follow-up For Stage 2|Other|0|||
131871378|NCT03850483|474808329|FG006|Follow-up For Stage 2|Other|0|||
131871379|NCT03850483|474808330|FG007|Follow-up For Stage 2|Other|0|||
131871380|NCT03850483|474808331|FG008|Follow-up For Stage 2|Other|0|||
131871381|NCT03850483|474808332|FG009|Follow-up For Stage 2|Other|1|||
131871382|NCT03483961|474810327|FG000|Overall Study|Lost to Follow-up|7|||
131871383|NCT03483961|474810328|FG001|Overall Study|Lost to Follow-up|6|||
131871384|NCT03483961|474810329|FG002|Overall Study|Lost to Follow-up|6|||
131871385|NCT03483961|474810330|FG003|Overall Study|Lost to Follow-up|6|||
131871386|NCT03483961|474810331|FG004|Overall Study|Lost to Follow-up|6|||
131871387|NCT03483961|474810332|FG005|Overall Study|Lost to Follow-up|4|||
131871388|NCT03483961|474810333|FG006|Overall Study|Lost to Follow-up|4|||
131871389|NCT03483961|474810334|FG007|Overall Study|Lost to Follow-up|11|||
131871390|NCT03483961|474810335|FG008|Overall Study|Lost to Follow-up|1|||
131871391|NCT03483961|474810336|FG009|Overall Study|Lost to Follow-up|0|||
131871392|NCT03483961|474810327|FG000|Overall Study|Withdrawal by Subject|3|||
131408261|NCT03054350|473118244|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
131408262|NCT03054350|473118245|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
131408263|NCT03054350|473118246|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
131871393|NCT03483961|474810328|FG001|Overall Study|Withdrawal by Subject|4|||
131871394|NCT03483961|474810329|FG002|Overall Study|Withdrawal by Subject|5|||
131871395|NCT03483961|474810330|FG003|Overall Study|Withdrawal by Subject|3|||
131871396|NCT03483961|474810331|FG004|Overall Study|Withdrawal by Subject|4|||
131871397|NCT03483961|474810332|FG005|Overall Study|Withdrawal by Subject|2|||
131871398|NCT03483961|474810333|FG006|Overall Study|Withdrawal by Subject|1|||
131871399|NCT03483961|474810334|FG007|Overall Study|Withdrawal by Subject|2|||
131871400|NCT03483961|474810335|FG008|Overall Study|Withdrawal by Subject|1|||
131871401|NCT03483961|474810336|FG009|Overall Study|Withdrawal by Subject|0|||
131871402|NCT03483961|474810327|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
131871403|NCT03483961|474810328|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871404|NCT03483961|474810329|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871405|NCT03483961|474810330|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871406|NCT03483961|474810331|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871407|NCT03483961|474810332|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871408|NCT03483961|474810333|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871409|NCT03483961|474810334|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871410|NCT03483961|474810335|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871411|NCT03483961|474810336|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
131871412|NCT03483961|474810327|FG000|Overall Study|Adverse Event|0|||
131871413|NCT03483961|474810328|FG001|Overall Study|Adverse Event|0|||
131871414|NCT03483961|474810329|FG002|Overall Study|Adverse Event|1|||
131871415|NCT03483961|474810330|FG003|Overall Study|Adverse Event|0|||
131871416|NCT03483961|474810331|FG004|Overall Study|Adverse Event|0|||
131871417|NCT03483961|474810332|FG005|Overall Study|Adverse Event|0|||
131871418|NCT03483961|474810333|FG006|Overall Study|Adverse Event|0|||
131871419|NCT03483961|474810334|FG007|Overall Study|Adverse Event|0|||
131871420|NCT03483961|474810335|FG008|Overall Study|Adverse Event|0|||
131871421|NCT03483961|474810336|FG009|Overall Study|Adverse Event|0|||
131871422|NCT00356603|474810337|FG000|Overall Study|Other|6|||
131871423|NCT00356603|474810338|FG001|Overall Study|Other|3|||
131871424|NCT00728468|474810340|FG000|Overall Study|Enrolled but not treated|1|||
131871425|NCT00728468|474810340|FG000|Overall Study|Death|1|||
131871426|NCT00728468|474810340|FG000|Overall Study|Protocol Violation|4|||
131871427|NCT00728468|474810340|FG000|Overall Study|Objective progression or relapse|9|||
131871428|NCT00728468|474810340|FG000|Overall Study|Study terminated by sponsor|1|||
131871429|NCT01262287|474810341|FG000|Overall Study|Lost to Follow-up|2|||
131871430|NCT01262287|474810342|FG001|Overall Study|Lost to Follow-up|1|||
131871431|NCT00932373|474810343|FG000|Overall Study|Progressive disease|3|||
131871432|NCT00932373|474810344|FG001|Overall Study|Progressive disease|1|||
131871433|NCT00932373|474810345|FG002|Overall Study|Progressive disease|0|||
131871434|NCT00932373|474810346|FG003|Overall Study|Progressive disease|0|||
131871435|NCT00932373|474810347|FG004|Overall Study|Progressive disease|10|||
131871436|NCT00932373|474810348|FG005|Overall Study|Progressive disease|1|||
131871437|NCT00932373|474810349|FG006|Overall Study|Progressive disease|0|||
131871438|NCT00932373|474810350|FG007|Overall Study|Progressive disease|2|||
131871439|NCT00932373|474810351|FG008|Overall Study|Progressive disease|1|||
131871440|NCT00932373|474810352|FG009|Overall Study|Progressive disease|9|||
131871441|NCT00932373|474810353|FG010|Overall Study|Progressive disease|2|||
131871442|NCT00932373|474810343|FG000|Overall Study|Adverse Event|0|||
131871443|NCT00932373|474810344|FG001|Overall Study|Adverse Event|0|||
131871444|NCT00932373|474810345|FG002|Overall Study|Adverse Event|0|||
131871445|NCT00932373|474810346|FG003|Overall Study|Adverse Event|0|||
131871446|NCT00932373|474810347|FG004|Overall Study|Adverse Event|2|||
131871447|NCT00932373|474810348|FG005|Overall Study|Adverse Event|1|||
131871448|NCT00932373|474810349|FG006|Overall Study|Adverse Event|0|||
131871449|NCT00932373|474810350|FG007|Overall Study|Adverse Event|1|||
131871450|NCT00932373|474810351|FG008|Overall Study|Adverse Event|0|||
131871451|NCT00932373|474810352|FG009|Overall Study|Adverse Event|2|||
131871452|NCT00932373|474810353|FG010|Overall Study|Adverse Event|1|||
131871453|NCT00932373|474810343|FG000|Overall Study|Physician Decision|0|||
131871454|NCT00932373|474810344|FG001|Overall Study|Physician Decision|0|||
131871455|NCT00932373|474810345|FG002|Overall Study|Physician Decision|1|||
131871456|NCT00932373|474810346|FG003|Overall Study|Physician Decision|0|||
131871457|NCT00932373|474810347|FG004|Overall Study|Physician Decision|2|||
131871458|NCT00932373|474810348|FG005|Overall Study|Physician Decision|0|||
131871459|NCT00932373|474810349|FG006|Overall Study|Physician Decision|0|||
131871460|NCT00932373|474810350|FG007|Overall Study|Physician Decision|0|||
131871461|NCT00932373|474810351|FG008|Overall Study|Physician Decision|0|||
131871462|NCT00932373|474810352|FG009|Overall Study|Physician Decision|1|||
131871463|NCT00932373|474810353|FG010|Overall Study|Physician Decision|0|||
131871464|NCT00932373|474810343|FG000|Overall Study|Dose limiting toxicity|0|||
131871465|NCT00932373|474810344|FG001|Overall Study|Dose limiting toxicity|0|||
131871466|NCT00932373|474810345|FG002|Overall Study|Dose limiting toxicity|0|||
131871467|NCT00932373|474810346|FG003|Overall Study|Dose limiting toxicity|0|||
131871468|NCT00932373|474810347|FG004|Overall Study|Dose limiting toxicity|0|||
131871469|NCT00932373|474810348|FG005|Overall Study|Dose limiting toxicity|1|||
131871470|NCT00932373|474810349|FG006|Overall Study|Dose limiting toxicity|0|||
131871471|NCT00932373|474810350|FG007|Overall Study|Dose limiting toxicity|0|||
131871472|NCT00932373|474810351|FG008|Overall Study|Dose limiting toxicity|0|||
131871473|NCT00932373|474810352|FG009|Overall Study|Dose limiting toxicity|0|||
131871474|NCT00932373|474810353|FG010|Overall Study|Dose limiting toxicity|0|||
131871475|NCT00932373|474810343|FG000|Overall Study|Withdrawal by Subject|0|||
131871476|NCT00932373|474810344|FG001|Overall Study|Withdrawal by Subject|0|||
131871477|NCT00932373|474810345|FG002|Overall Study|Withdrawal by Subject|0|||
131871478|NCT00932373|474810346|FG003|Overall Study|Withdrawal by Subject|0|||
131871479|NCT00932373|474810347|FG004|Overall Study|Withdrawal by Subject|0|||
131871480|NCT00932373|474810348|FG005|Overall Study|Withdrawal by Subject|0|||
131871481|NCT00932373|474810349|FG006|Overall Study|Withdrawal by Subject|0|||
131871482|NCT00932373|474810350|FG007|Overall Study|Withdrawal by Subject|0|||
131871483|NCT00932373|474810351|FG008|Overall Study|Withdrawal by Subject|1|||
131871484|NCT00932373|474810352|FG009|Overall Study|Withdrawal by Subject|0|||
131871485|NCT00932373|474810353|FG010|Overall Study|Withdrawal by Subject|0|||
131871486|NCT00932373|474810343|FG000|Overall Study|Clinical progression|0|||
131871487|NCT00932373|474810344|FG001|Overall Study|Clinical progression|0|||
131871488|NCT00932373|474810345|FG002|Overall Study|Clinical progression|0|||
131871489|NCT00932373|474810346|FG003|Overall Study|Clinical progression|0|||
131871490|NCT00932373|474810347|FG004|Overall Study|Clinical progression|0|||
131871491|NCT00932373|474810348|FG005|Overall Study|Clinical progression|0|||
131871492|NCT00932373|474810349|FG006|Overall Study|Clinical progression|1|||
131871493|NCT00932373|474810350|FG007|Overall Study|Clinical progression|0|||
131871494|NCT00932373|474810351|FG008|Overall Study|Clinical progression|0|||
131871495|NCT00932373|474810352|FG009|Overall Study|Clinical progression|0|||
131871496|NCT00932373|474810353|FG010|Overall Study|Clinical progression|0|||
131871497|NCT00932373|474810343|FG000|Overall Study|Lack of Efficacy|0|||
131871498|NCT00932373|474810344|FG001|Overall Study|Lack of Efficacy|0|||
131871499|NCT00932373|474810345|FG002|Overall Study|Lack of Efficacy|0|||
131871500|NCT00932373|474810346|FG003|Overall Study|Lack of Efficacy|0|||
131871501|NCT00932373|474810347|FG004|Overall Study|Lack of Efficacy|0|||
131871502|NCT00932373|474810348|FG005|Overall Study|Lack of Efficacy|0|||
131871503|NCT00932373|474810349|FG006|Overall Study|Lack of Efficacy|0|||
131871504|NCT00932373|474810350|FG007|Overall Study|Lack of Efficacy|0|||
131871505|NCT00932373|474810351|FG008|Overall Study|Lack of Efficacy|0|||
131871506|NCT00932373|474810352|FG009|Overall Study|Lack of Efficacy|1|||
131871507|NCT00932373|474810353|FG010|Overall Study|Lack of Efficacy|0|||
131871508|NCT01637922|474810354|FG000|Overall Study|Adverse Event|0|||
131871509|NCT01637922|474810355|FG001|Overall Study|Adverse Event|1|||
131871510|NCT01637922|474810354|FG000|Overall Study|Protocol Violation|0|||
131871511|NCT01637922|474810355|FG001|Overall Study|Protocol Violation|1|||
131871512|NCT01637922|474810354|FG000|Overall Study|Withdrawal by Subject|0|||
131871513|NCT01637922|474810355|FG001|Overall Study|Withdrawal by Subject|3|||
131871514|NCT01637922|474810354|FG000|Overall Study|Lost to Follow-up|2|||
131871515|NCT01637922|474810355|FG001|Overall Study|Lost to Follow-up|0|||
131871516|NCT00638404|474810356|FG000|Overall Study|Physician Decision|8|||
131871517|NCT00638404|474810357|FG001|Overall Study|Physician Decision|0|||
131871518|NCT02509507|474810358|FG000|Overall Study|Death|21|||
131871519|NCT02509507|474810359|FG001|Overall Study|Death|3|||
131871520|NCT02509507|474810360|FG002|Overall Study|Death|22|||
131871521|NCT02509507|474810361|FG003|Overall Study|Death|14|||
131871522|NCT02509507|474810362|FG004|Overall Study|Death|8|||
131871523|NCT02509507|474810363|FG005|Overall Study|Death|12|||
131871524|NCT02509507|474810364|FG006|Overall Study|Death|5|||
131871525|NCT02509507|474810365|FG007|Overall Study|Death|4|||
131871526|NCT02509507|474810366|FG008|Overall Study|Death|8|||
131871527|NCT02509507|474810358|FG000|Overall Study|Lost to Follow-up|0|||
131871528|NCT02509507|474810359|FG001|Overall Study|Lost to Follow-up|1|||
131871529|NCT02509507|474810360|FG002|Overall Study|Lost to Follow-up|0|||
131871530|NCT02509507|474810361|FG003|Overall Study|Lost to Follow-up|0|||
131871531|NCT02509507|474810362|FG004|Overall Study|Lost to Follow-up|0|||
131871532|NCT02509507|474810363|FG005|Overall Study|Lost to Follow-up|2|||
131871533|NCT02509507|474810364|FG006|Overall Study|Lost to Follow-up|0|||
131871534|NCT02509507|474810365|FG007|Overall Study|Lost to Follow-up|0|||
131871535|NCT02509507|474810366|FG008|Overall Study|Lost to Follow-up|0|||
131871536|NCT02509507|474810358|FG000|Overall Study|Withdrawal by Subject|2|||
131871537|NCT02509507|474810359|FG001|Overall Study|Withdrawal by Subject|0|||
131871538|NCT02509507|474810360|FG002|Overall Study|Withdrawal by Subject|1|||
131871539|NCT02509507|474810361|FG003|Overall Study|Withdrawal by Subject|4|||
131871540|NCT02509507|474810362|FG004|Overall Study|Withdrawal by Subject|1|||
131871541|NCT02509507|474810363|FG005|Overall Study|Withdrawal by Subject|3|||
131871542|NCT02509507|474810364|FG006|Overall Study|Withdrawal by Subject|4|||
131408264|NCT03054350|473118247|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
131408265|NCT03054350|473118248|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
131408266|NCT00931723|473118252|FG000|Overall Study|Withdrawal by Subject|11|||
131408267|NCT00931723|473118253|FG001|Overall Study|Withdrawal by Subject|13|||
131871543|NCT02509507|474810365|FG007|Overall Study|Withdrawal by Subject|0|||
131871544|NCT02509507|474810366|FG008|Overall Study|Withdrawal by Subject|1|||
131871545|NCT02510664|474810370|FG000|Overall Study|Transferred Care|9|||
131871546|NCT02510664|474810371|FG001|Overall Study|Transferred Care|9|||
131871547|NCT02510664|474810372|FG002|Overall Study|Transferred Care|0|||
131871548|NCT02510664|474810370|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
131871549|NCT02510664|474810371|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
131871550|NCT02510664|474810372|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
131871551|NCT02510664|474810370|FG000|Overall Study|Time Constraints|1|||
131871552|NCT02510664|474810371|FG001|Overall Study|Time Constraints|1|||
131871553|NCT02510664|474810372|FG002|Overall Study|Time Constraints|0|||
131871554|NCT01164579|474810386|FG000|Overall Study|Lack of Efficacy|0|||
131871555|NCT01164579|474810387|FG001|Overall Study|Lack of Efficacy|0|||
131871556|NCT01164579|474810388|FG002|Overall Study|Lack of Efficacy|6|||
131871557|NCT01164579|474810386|FG000|Overall Study|Lost to Follow-up|1|||
131871558|NCT01164579|474810387|FG001|Overall Study|Lost to Follow-up|1|||
131871559|NCT01164579|474810388|FG002|Overall Study|Lost to Follow-up|0|||
131871560|NCT01164579|474810386|FG000|Overall Study|Withdrawal by Subject|2|||
131871561|NCT01164579|474810387|FG001|Overall Study|Withdrawal by Subject|5|||
131871562|NCT01164579|474810388|FG002|Overall Study|Withdrawal by Subject|3|||
131871563|NCT01164579|474810386|FG000|Overall Study|Protocol Violation|0|||
131871564|NCT01164579|474810387|FG001|Overall Study|Protocol Violation|1|||
131871565|NCT01164579|474810388|FG002|Overall Study|Protocol Violation|2|||
131871566|NCT01164579|474810386|FG000|Overall Study|Adverse Event|4|||
131871567|NCT01164579|474810387|FG001|Overall Study|Adverse Event|2|||
131871568|NCT01164579|474810388|FG002|Overall Study|Adverse Event|5|||
131871569|NCT01164579|474810386|FG000|Overall Study|Reason not specified|1|||
131871570|NCT01164579|474810387|FG001|Overall Study|Reason not specified|0|||
131871571|NCT01164579|474810388|FG002|Overall Study|Reason not specified|0|||
131871572|NCT00302328|474810392|FG000|Overall Study|Physician Decision|0|||
131871573|NCT00302328|474810393|FG001|Overall Study|Physician Decision|1|||
131871574|NCT00302328|474810394|FG002|Overall Study|Physician Decision|0|||
131871575|NCT00685399|474810409|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131871576|NCT00685399|474810410|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131871577|NCT00685399|474810411|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131871578|NCT00685399|474810412|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131871579|NCT00685399|474810413|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131871580|NCT00685399|474810414|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131871581|NCT00685399|474810415|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131871582|NCT00685399|474810416|FG007|Treatment Period 1|Withdrawal by Subject|0|||
131871583|NCT00685399|474810409|FG000|Treatment Period 1|Protocol Violation|1|||
131871584|NCT00685399|474810410|FG001|Treatment Period 1|Protocol Violation|0|||
131871585|NCT00685399|474810411|FG002|Treatment Period 1|Protocol Violation|0|||
131871586|NCT00685399|474810412|FG003|Treatment Period 1|Protocol Violation|0|||
131871587|NCT00685399|474810413|FG004|Treatment Period 1|Protocol Violation|0|||
131871588|NCT00685399|474810414|FG005|Treatment Period 1|Protocol Violation|0|||
131871589|NCT00685399|474810415|FG006|Treatment Period 1|Protocol Violation|0|||
131871590|NCT00685399|474810416|FG007|Treatment Period 1|Protocol Violation|0|||
131871591|NCT00685399|474810409|FG000|Treatment Period 1|Administrative|2|||
131871592|NCT00685399|474810410|FG001|Treatment Period 1|Administrative|0|||
131871593|NCT00685399|474810411|FG002|Treatment Period 1|Administrative|0|||
131871594|NCT00685399|474810412|FG003|Treatment Period 1|Administrative|0|||
131871595|NCT00685399|474810413|FG004|Treatment Period 1|Administrative|0|||
131871596|NCT00685399|474810414|FG005|Treatment Period 1|Administrative|0|||
131871597|NCT00685399|474810415|FG006|Treatment Period 1|Administrative|0|||
131871598|NCT00685399|474810416|FG007|Treatment Period 1|Administrative|0|||
131871599|NCT00685399|474810409|FG000|Treatment Period 1|Lack of Efficacy|1|||
131871600|NCT00685399|474810410|FG001|Treatment Period 1|Lack of Efficacy|0|||
131871601|NCT00685399|474810411|FG002|Treatment Period 1|Lack of Efficacy|0|||
131871602|NCT00685399|474810412|FG003|Treatment Period 1|Lack of Efficacy|0|||
131871603|NCT00685399|474810413|FG004|Treatment Period 1|Lack of Efficacy|0|||
131871604|NCT00685399|474810414|FG005|Treatment Period 1|Lack of Efficacy|0|||
131408268|NCT00931723|473118252|FG000|Overall Study|Adverse Event|6|||
131871605|NCT00685399|474810415|FG006|Treatment Period 1|Lack of Efficacy|0|||
131871606|NCT00685399|474810416|FG007|Treatment Period 1|Lack of Efficacy|0|||
131871607|NCT00685399|474810409|FG000|Treatment Period 2|Administrative Problems|0|||
131871608|NCT00685399|474810410|FG001|Treatment Period 2|Administrative Problems|2|||
131408269|NCT00931723|473118253|FG001|Overall Study|Adverse Event|13|||
131871609|NCT00685399|474810411|FG002|Treatment Period 2|Administrative Problems|1|||
131871610|NCT00685399|474810412|FG003|Treatment Period 2|Administrative Problems|0|||
131871611|NCT00685399|474810413|FG004|Treatment Period 2|Administrative Problems|0|||
131871612|NCT00685399|474810414|FG005|Treatment Period 2|Administrative Problems|0|||
131871613|NCT00685399|474810415|FG006|Treatment Period 2|Administrative Problems|0|||
131871614|NCT00685399|474810416|FG007|Treatment Period 2|Administrative Problems|0|||
131871615|NCT00685399|474810409|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131871616|NCT00685399|474810410|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131871617|NCT00685399|474810411|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131871618|NCT00685399|474810412|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131871619|NCT00685399|474810413|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131871620|NCT00685399|474810414|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131871621|NCT00685399|474810415|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131871622|NCT00685399|474810416|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131871623|NCT00685399|474810409|FG000|Treatment Period 2|Adverse Event|0|||
131871624|NCT00685399|474810410|FG001|Treatment Period 2|Adverse Event|0|||
131871625|NCT00685399|474810411|FG002|Treatment Period 2|Adverse Event|0|||
131871626|NCT00685399|474810412|FG003|Treatment Period 2|Adverse Event|0|||
131871627|NCT00685399|474810413|FG004|Treatment Period 2|Adverse Event|0|||
131871628|NCT00685399|474810414|FG005|Treatment Period 2|Adverse Event|1|||
131871629|NCT00685399|474810415|FG006|Treatment Period 2|Adverse Event|0|||
131871630|NCT00685399|474810416|FG007|Treatment Period 2|Adverse Event|0|||
131871631|NCT00685399|474810409|FG000|Treatment Period 2|Lack of Efficacy|0|||
131871632|NCT00685399|474810410|FG001|Treatment Period 2|Lack of Efficacy|10|||
131871633|NCT00685399|474810411|FG002|Treatment Period 2|Lack of Efficacy|2|||
131871634|NCT00685399|474810412|FG003|Treatment Period 2|Lack of Efficacy|0|||
131871635|NCT00685399|474810413|FG004|Treatment Period 2|Lack of Efficacy|0|||
131871636|NCT00685399|474810414|FG005|Treatment Period 2|Lack of Efficacy|1|||
131871637|NCT00685399|474810415|FG006|Treatment Period 2|Lack of Efficacy|0|||
131871638|NCT00685399|474810416|FG007|Treatment Period 2|Lack of Efficacy|0|||
131871639|NCT00685399|474810409|FG000|Extension|Administrative Issues|0|||
131871640|NCT00685399|474810410|FG001|Extension|Administrative Issues|0|||
131871641|NCT00685399|474810411|FG002|Extension|Administrative Issues|0|||
131871642|NCT00685399|474810412|FG003|Extension|Administrative Issues|1|||
131871643|NCT00685399|474810413|FG004|Extension|Administrative Issues|0|||
131871644|NCT00685399|474810414|FG005|Extension|Administrative Issues|0|||
131871645|NCT00685399|474810415|FG006|Extension|Administrative Issues|0|||
131871646|NCT00685399|474810416|FG007|Extension|Administrative Issues|0|||
131871647|NCT00685399|474810409|FG000|Extension|Withdrawal by Subject|0|||
131871648|NCT00685399|474810410|FG001|Extension|Withdrawal by Subject|0|||
131871649|NCT00685399|474810411|FG002|Extension|Withdrawal by Subject|0|||
131871650|NCT00685399|474810412|FG003|Extension|Withdrawal by Subject|1|||
131871651|NCT00685399|474810413|FG004|Extension|Withdrawal by Subject|0|||
131871652|NCT00685399|474810414|FG005|Extension|Withdrawal by Subject|0|||
131871653|NCT00685399|474810415|FG006|Extension|Withdrawal by Subject|0|||
131871654|NCT00685399|474810416|FG007|Extension|Withdrawal by Subject|0|||
131871655|NCT00685399|474810409|FG000|Extension|Protocol Violation|0|||
131871656|NCT00685399|474810410|FG001|Extension|Protocol Violation|0|||
131871657|NCT00685399|474810411|FG002|Extension|Protocol Violation|0|||
131871658|NCT00685399|474810412|FG003|Extension|Protocol Violation|1|||
131871659|NCT00685399|474810413|FG004|Extension|Protocol Violation|0|||
131871660|NCT00685399|474810414|FG005|Extension|Protocol Violation|0|||
131871661|NCT00685399|474810415|FG006|Extension|Protocol Violation|0|||
131871662|NCT00685399|474810416|FG007|Extension|Protocol Violation|0|||
131871663|NCT00685399|474810409|FG000|Extension|Lack of Efficacy|0|||
131871664|NCT00685399|474810410|FG001|Extension|Lack of Efficacy|0|||
131871665|NCT00685399|474810411|FG002|Extension|Lack of Efficacy|0|||
131871666|NCT00685399|474810412|FG003|Extension|Lack of Efficacy|2|||
131871667|NCT00685399|474810413|FG004|Extension|Lack of Efficacy|0|||
131871668|NCT00685399|474810414|FG005|Extension|Lack of Efficacy|0|||
131871669|NCT00685399|474810415|FG006|Extension|Lack of Efficacy|0|||
131871670|NCT00685399|474810416|FG007|Extension|Lack of Efficacy|0|||
131871671|NCT00685399|474810409|FG000|Extension|Adverse Event|0|||
131871672|NCT00685399|474810410|FG001|Extension|Adverse Event|0|||
131871673|NCT00685399|474810411|FG002|Extension|Adverse Event|0|||
131871674|NCT00685399|474810412|FG003|Extension|Adverse Event|2|||
131871675|NCT00685399|474810413|FG004|Extension|Adverse Event|0|||
131919533|NCT01879852|474989278|FG000|Overall Study|Withdrawal by Subject|2|||
131871676|NCT00685399|474810414|FG005|Extension|Adverse Event|0|||
131871677|NCT00685399|474810415|FG006|Extension|Adverse Event|0|||
131871678|NCT00685399|474810416|FG007|Extension|Adverse Event|0|||
131871679|NCT00927862|474810418|FG000|Overall Study|Missing data needed for endpt analyses|27|||
131871680|NCT00927862|474810419|FG001|Overall Study|Missing data needed for endpt analyses|45|||
131871681|NCT00820248|474810420|FG000|Overall Study|No treated|4|||
131871682|NCT00820248|474810421|FG001|Overall Study|No treated|1|||
131871683|NCT02237196|474810423|FG000|Overall Study|Adverse Event|0|||
131871684|NCT02237196|474810424|FG001|Overall Study|Adverse Event|1|||
131871685|NCT02237196|474810425|FG002|Overall Study|Adverse Event|1|||
131871686|NCT02237196|474810426|FG003|Overall Study|Adverse Event|0|||
131871687|NCT02237196|474810423|FG000|Overall Study|Lost to Follow-up|4|||
131871688|NCT02237196|474810424|FG001|Overall Study|Lost to Follow-up|2|||
131871689|NCT02237196|474810425|FG002|Overall Study|Lost to Follow-up|4|||
131871690|NCT02237196|474810426|FG003|Overall Study|Lost to Follow-up|6|||
131871691|NCT02237196|474810423|FG000|Overall Study|Physician Decision|2|||
131871692|NCT02237196|474810424|FG001|Overall Study|Physician Decision|0|||
131871693|NCT02237196|474810425|FG002|Overall Study|Physician Decision|0|||
131871694|NCT02237196|474810426|FG003|Overall Study|Physician Decision|1|||
131871695|NCT02237196|474810423|FG000|Overall Study|Pregnancy|0|||
131871696|NCT02237196|474810424|FG001|Overall Study|Pregnancy|0|||
131871697|NCT02237196|474810425|FG002|Overall Study|Pregnancy|1|||
131871698|NCT02237196|474810426|FG003|Overall Study|Pregnancy|1|||
131871699|NCT02237196|474810423|FG000|Overall Study|Withdrawal by Subject|1|||
131871700|NCT02237196|474810424|FG001|Overall Study|Withdrawal by Subject|1|||
131871701|NCT02237196|474810425|FG002|Overall Study|Withdrawal by Subject|4|||
131871702|NCT02237196|474810426|FG003|Overall Study|Withdrawal by Subject|1|||
131871703|NCT02237196|474810423|FG000|Overall Study|Site Error|1|||
131871704|NCT02237196|474810424|FG001|Overall Study|Site Error|2|||
131871705|NCT02237196|474810425|FG002|Overall Study|Site Error|0|||
131871706|NCT02237196|474810426|FG003|Overall Study|Site Error|2|||
131871707|NCT01562782|474810429|FG000|Overall Study|Withdrawal by Subject|3|||
131871708|NCT01562782|474810430|FG001|Overall Study|Withdrawal by Subject|3|||
131871709|NCT01562782|474810429|FG000|Overall Study|screen failure|1|||
131871710|NCT01562782|474810430|FG001|Overall Study|screen failure|2|||
131871711|NCT02049814|474810437|FG000|Overall Study|Reason not Specified|4|||
131871712|NCT02049814|474810438|FG001|Overall Study|Reason not Specified|3|||
131871713|NCT02049814|474810437|FG000|Overall Study|Pregnancy|1|||
131871714|NCT02049814|474810438|FG001|Overall Study|Pregnancy|0|||
131871715|NCT02049814|474810437|FG000|Overall Study|Lost to Follow-up|2|||
131871716|NCT02049814|474810438|FG001|Overall Study|Lost to Follow-up|3|||
131871717|NCT02049814|474810437|FG000|Overall Study|Serious Protocol Violation|5|||
131871718|NCT02049814|474810438|FG001|Overall Study|Serious Protocol Violation|7|||
131871719|NCT02049814|474810437|FG000|Overall Study|Study Termination|0|||
131871720|NCT02049814|474810438|FG001|Overall Study|Study Termination|1|||
131871721|NCT02049814|474810437|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
131871722|NCT02049814|474810438|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
131871723|NCT02049814|474810437|FG000|Overall Study|Voluntary withdrawal|9|||
131871724|NCT02049814|474810438|FG001|Overall Study|Voluntary withdrawal|8|||
131871725|NCT02527434|474810440|FG000|Overall Study|Lost to Follow-up|2|||
131871726|NCT02527434|474810441|FG001|Overall Study|Lost to Follow-up|2|||
131871727|NCT02527434|474810442|FG002|Overall Study|Lost to Follow-up|0|||
131871728|NCT02527434|474810440|FG000|Overall Study|Death|19|||
131871729|NCT02527434|474810441|FG001|Overall Study|Death|6|||
131871730|NCT02527434|474810442|FG002|Overall Study|Death|17|||
131871731|NCT02527434|474810440|FG000|Overall Study|Withdrawal by Subject|5|||
131871732|NCT02527434|474810441|FG001|Overall Study|Withdrawal by Subject|3|||
131871733|NCT02527434|474810442|FG002|Overall Study|Withdrawal by Subject|3|||
131871734|NCT02527434|474810440|FG000|Overall Study|Reason Not Specified|1|||
131871735|NCT02527434|474810441|FG001|Overall Study|Reason Not Specified|0|||
131871736|NCT02527434|474810442|FG002|Overall Study|Reason Not Specified|0|||
131871737|NCT02527434|474810440|FG000|Overall Study|Site closure|1|||
131871738|NCT02527434|474810441|FG001|Overall Study|Site closure|0|||
131871739|NCT02527434|474810442|FG002|Overall Study|Site closure|0|||
131871740|NCT00713258|474810443|FG000|Overall Study|Adverse Event|2|||
131871741|NCT00713258|474810444|FG001|Overall Study|Adverse Event|4|||
131871742|NCT00713258|474810443|FG000|Overall Study|Non-Compliance|2|||
131871743|NCT00713258|474810444|FG001|Overall Study|Non-Compliance|1|||
131871744|NCT00713258|474810443|FG000|Overall Study|Other|1|||
131871745|NCT00713258|474810444|FG001|Overall Study|Other|1|||
131871746|NCT01431716|474810445|FG000|Overall Study|Withdrawal of consent|1|||
131871747|NCT02693002|474810446|FG000|Overall Study|Withdrawal by Subject|1|||
131871748|NCT02693002|474810447|FG001|Overall Study|Withdrawal by Subject|0|||
131871749|NCT00708214|474810448|FG000|Overall Study|Other Adverse Event|3|||
131871750|NCT00708214|474810449|FG001|Overall Study|Other Adverse Event|6|||
131871751|NCT00708214|474810450|FG002|Overall Study|Other Adverse Event|2|||
131871752|NCT00708214|474810448|FG000|Overall Study|Other|0|||
131871753|NCT00708214|474810449|FG001|Overall Study|Other|1|||
131871754|NCT00708214|474810450|FG002|Overall Study|Other|1|||
131871755|NCT00708214|474810448|FG000|Overall Study|Progressive Disease|4|||
131871756|NCT00708214|474810449|FG001|Overall Study|Progressive Disease|6|||
131871757|NCT00708214|474810450|FG002|Overall Study|Progressive Disease|5|||
131871758|NCT02865499|474810451|FG000|Baseline|Adverse Event|1|||
131871759|NCT02865499|474810451|FG000|Baseline|Withdrawal by Subject|1|||
131871760|NCT00014495|474810453|FG000|Overall Study|Death|0|||
131871761|NCT00014495|474810454|FG001|Overall Study|Death|0|||
131871762|NCT00014495|474810455|FG002|Overall Study|Death|1|||
131871763|NCT00014495|474810456|FG003|Overall Study|Death|0|||
131871764|NCT00014495|474810453|FG000|Overall Study|Clinical deterioration|0|||
131871765|NCT00014495|474810454|FG001|Overall Study|Clinical deterioration|0|||
131871766|NCT00014495|474810455|FG002|Overall Study|Clinical deterioration|0|||
131871767|NCT00014495|474810456|FG003|Overall Study|Clinical deterioration|1|||
131871768|NCT02343939|474810461|FG000|Overall Study|Death|0|||
131871769|NCT02343939|474810462|FG001|Overall Study|Death|15|||
131871770|NCT02343939|474810463|FG002|Overall Study|Death|4|||
131871771|NCT02343939|474810464|FG003|Overall Study|Death|2|||
131871772|NCT02343939|474810465|FG004|Overall Study|Death|5|||
131871773|NCT02343939|474810466|FG005|Overall Study|Death|11|||
131871774|NCT02343939|474810467|FG006|Overall Study|Death|8|||
131871775|NCT02343939|474810468|FG007|Overall Study|Death|22|||
131871776|NCT02343939|474810469|FG008|Overall Study|Death|1|||
131871777|NCT02343939|474810461|FG000|Overall Study|Study terminated by sponsor|0|||
131871778|NCT02343939|474810462|FG001|Overall Study|Study terminated by sponsor|27|||
131871779|NCT02343939|474810463|FG002|Overall Study|Study terminated by sponsor|0|||
131871780|NCT02343939|474810464|FG003|Overall Study|Study terminated by sponsor|1|||
131871781|NCT02343939|474810465|FG004|Overall Study|Study terminated by sponsor|1|||
131871782|NCT02343939|474810466|FG005|Overall Study|Study terminated by sponsor|5|||
131871783|NCT02343939|474810467|FG006|Overall Study|Study terminated by sponsor|3|||
131871784|NCT02343939|474810468|FG007|Overall Study|Study terminated by sponsor|4|||
131871785|NCT02343939|474810469|FG008|Overall Study|Study terminated by sponsor|0|||
131871786|NCT02343939|474810461|FG000|Overall Study|Withdrew consent|3|||
131871787|NCT02343939|474810462|FG001|Overall Study|Withdrew consent|6|||
131871788|NCT02343939|474810463|FG002|Overall Study|Withdrew consent|1|||
131871789|NCT02343939|474810464|FG003|Overall Study|Withdrew consent|2|||
131871790|NCT02343939|474810465|FG004|Overall Study|Withdrew consent|2|||
131871791|NCT02343939|474810466|FG005|Overall Study|Withdrew consent|0|||
131871792|NCT02343939|474810467|FG006|Overall Study|Withdrew consent|0|||
131871793|NCT02343939|474810468|FG007|Overall Study|Withdrew consent|8|||
131871794|NCT02343939|474810469|FG008|Overall Study|Withdrew consent|6|||
131871795|NCT02343939|474810461|FG000|Overall Study|Treatment failure|0|||
131871796|NCT02343939|474810462|FG001|Overall Study|Treatment failure|0|||
131871797|NCT02343939|474810463|FG002|Overall Study|Treatment failure|0|||
131871798|NCT02343939|474810464|FG003|Overall Study|Treatment failure|0|||
131871799|NCT02343939|474810465|FG004|Overall Study|Treatment failure|0|||
131871800|NCT02343939|474810466|FG005|Overall Study|Treatment failure|0|||
131871801|NCT02343939|474810467|FG006|Overall Study|Treatment failure|2|||
131871802|NCT02343939|474810468|FG007|Overall Study|Treatment failure|1|||
131871803|NCT02343939|474810469|FG008|Overall Study|Treatment failure|0|||
131871804|NCT02343939|474810461|FG000|Overall Study|Investigator's discretion|0|||
131871805|NCT02343939|474810462|FG001|Overall Study|Investigator's discretion|0|||
131871806|NCT02343939|474810463|FG002|Overall Study|Investigator's discretion|0|||
131871807|NCT02343939|474810464|FG003|Overall Study|Investigator's discretion|1|||
131871808|NCT02343939|474810465|FG004|Overall Study|Investigator's discretion|0|||
131871809|NCT02343939|474810466|FG005|Overall Study|Investigator's discretion|0|||
131871810|NCT02343939|474810467|FG006|Overall Study|Investigator's discretion|1|||
131871811|NCT02343939|474810468|FG007|Overall Study|Investigator's discretion|0|||
131871812|NCT02343939|474810469|FG008|Overall Study|Investigator's discretion|0|||
131871813|NCT02343939|474810461|FG000|Overall Study|Adverse Event|0|||
131871814|NCT02343939|474810462|FG001|Overall Study|Adverse Event|0|||
131871815|NCT02343939|474810463|FG002|Overall Study|Adverse Event|0|||
131871816|NCT02343939|474810464|FG003|Overall Study|Adverse Event|0|||
131871817|NCT02343939|474810465|FG004|Overall Study|Adverse Event|0|||
131871818|NCT02343939|474810466|FG005|Overall Study|Adverse Event|1|||
131871819|NCT02343939|474810467|FG006|Overall Study|Adverse Event|0|||
131871820|NCT02343939|474810468|FG007|Overall Study|Adverse Event|0|||
131871821|NCT02343939|474810469|FG008|Overall Study|Adverse Event|0|||
131871822|NCT02343939|474810461|FG000|Overall Study|Never Treated With ENTO|0|||
131871823|NCT02343939|474810462|FG001|Overall Study|Never Treated With ENTO|0|||
131871824|NCT02343939|474810463|FG002|Overall Study|Never Treated With ENTO|0|||
131871825|NCT02343939|474810464|FG003|Overall Study|Never Treated With ENTO|0|||
131871826|NCT02343939|474810465|FG004|Overall Study|Never Treated With ENTO|0|||
131871827|NCT02343939|474810466|FG005|Overall Study|Never Treated With ENTO|0|||
131871828|NCT02343939|474810467|FG006|Overall Study|Never Treated With ENTO|1|||
131871829|NCT02343939|474810468|FG007|Overall Study|Never Treated With ENTO|2|||
131871830|NCT02343939|474810469|FG008|Overall Study|Never Treated With ENTO|0|||
131871831|NCT01303172|474810472|FG000|Overall Study|Physician Decision|9|||
131871832|NCT01303172|474810473|FG001|Overall Study|Physician Decision|6|||
131871833|NCT01303172|474810472|FG000|Overall Study|Adverse Event|5|||
131871834|NCT01303172|474810473|FG001|Overall Study|Adverse Event|2|||
131871835|NCT01303172|474810472|FG000|Overall Study|Withdrawal by Subject|4|||
131871836|NCT01303172|474810473|FG001|Overall Study|Withdrawal by Subject|2|||
131871837|NCT01303172|474810472|FG000|Overall Study|Death|20|||
131871838|NCT01303172|474810473|FG001|Overall Study|Death|7|||
131871839|NCT01303172|474810472|FG000|Overall Study|Lack of Efficacy|25|||
131871840|NCT01303172|474810473|FG001|Overall Study|Lack of Efficacy|17|||
131871841|NCT00462709|474810474|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
131871842|NCT00462709|474810474|FG000|Overall Study|Lost to Follow-up|10|||
131871843|NCT00462709|474810474|FG000|Overall Study|Withdrawal by Subject|8|||
131871844|NCT00462709|474810474|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
131871845|NCT00462709|474810474|FG000|Overall Study|Death|2|||
131871846|NCT00462709|474810474|FG000|Overall Study|Logistical reasons|2|||
131871847|NCT00462709|474810474|FG000|Overall Study|Physician Decision|1|||
131871848|NCT00462709|474810474|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
131871849|NCT02099110|474810480|FG000|Overall Study|Protocol Violation|2|||
131871850|NCT02099110|474810481|FG001|Overall Study|Protocol Violation|1|||
131871851|NCT02099110|474810482|FG002|Overall Study|Protocol Violation|0|||
131871852|NCT02099110|474810483|FG003|Overall Study|Protocol Violation|3|||
131871853|NCT02099110|474810484|FG004|Overall Study|Protocol Violation|1|||
131871854|NCT02099110|474810480|FG000|Overall Study|Participant moved|1|||
131871855|NCT02099110|474810481|FG001|Overall Study|Participant moved|1|||
131871856|NCT02099110|474810482|FG002|Overall Study|Participant moved|1|||
131871857|NCT02099110|474810483|FG003|Overall Study|Participant moved|0|||
131871858|NCT02099110|474810484|FG004|Overall Study|Participant moved|2|||
131871859|NCT02099110|474810480|FG000|Overall Study|Withdrawal by Subject|7|||
131871860|NCT02099110|474810481|FG001|Overall Study|Withdrawal by Subject|11|||
131871861|NCT02099110|474810482|FG002|Overall Study|Withdrawal by Subject|13|||
131871862|NCT02099110|474810483|FG003|Overall Study|Withdrawal by Subject|9|||
131871863|NCT02099110|474810484|FG004|Overall Study|Withdrawal by Subject|13|||
131871864|NCT02099110|474810480|FG000|Overall Study|Adverse Event|3|||
131871865|NCT02099110|474810481|FG001|Overall Study|Adverse Event|5|||
131871866|NCT02099110|474810482|FG002|Overall Study|Adverse Event|2|||
131871867|NCT02099110|474810483|FG003|Overall Study|Adverse Event|3|||
131871868|NCT02099110|474810484|FG004|Overall Study|Adverse Event|2|||
131871869|NCT02099110|474810480|FG000|Overall Study|Lost to Follow-up|6|||
131871870|NCT02099110|474810481|FG001|Overall Study|Lost to Follow-up|12|||
131871871|NCT02099110|474810482|FG002|Overall Study|Lost to Follow-up|11|||
131871872|NCT02099110|474810483|FG003|Overall Study|Lost to Follow-up|5|||
131871873|NCT02099110|474810484|FG004|Overall Study|Lost to Follow-up|6|||
131871874|NCT02099110|474810480|FG000|Overall Study|Death|0|||
131871875|NCT02099110|474810481|FG001|Overall Study|Death|1|||
131871876|NCT02099110|474810482|FG002|Overall Study|Death|0|||
131871877|NCT02099110|474810483|FG003|Overall Study|Death|0|||
131871878|NCT02099110|474810484|FG004|Overall Study|Death|0|||
131871879|NCT02099110|474810480|FG000|Overall Study|Screen failure|0|||
131871880|NCT02099110|474810481|FG001|Overall Study|Screen failure|0|||
131871881|NCT02099110|474810482|FG002|Overall Study|Screen failure|0|||
131871882|NCT02099110|474810483|FG003|Overall Study|Screen failure|0|||
131871883|NCT02099110|474810484|FG004|Overall Study|Screen failure|1|||
131871884|NCT02099110|474810480|FG000|Overall Study|Non-compliance with study drug|2|||
131871885|NCT02099110|474810481|FG001|Overall Study|Non-compliance with study drug|0|||
131871886|NCT02099110|474810482|FG002|Overall Study|Non-compliance with study drug|0|||
131871887|NCT02099110|474810483|FG003|Overall Study|Non-compliance with study drug|0|||
131871888|NCT02099110|474810484|FG004|Overall Study|Non-compliance with study drug|1|||
131871889|NCT02099110|474810480|FG000|Overall Study|Physician Decision|3|||
131871890|NCT02099110|474810481|FG001|Overall Study|Physician Decision|0|||
131871891|NCT02099110|474810482|FG002|Overall Study|Physician Decision|1|||
131871892|NCT02099110|474810483|FG003|Overall Study|Physician Decision|2|||
131871893|NCT02099110|474810484|FG004|Overall Study|Physician Decision|1|||
131871894|NCT02064816|474810485|FG000|Overall Study|Adverse Event|3|||
131871895|NCT02064816|474810486|FG001|Overall Study|Adverse Event|2|||
131871896|NCT02064816|474810485|FG000|Overall Study|Withdrawal by Subject|2|||
131871897|NCT02064816|474810486|FG001|Overall Study|Withdrawal by Subject|1|||
131871898|NCT02064816|474810485|FG000|Overall Study|Lost to Follow-up|2|||
131871899|NCT02064816|474810486|FG001|Overall Study|Lost to Follow-up|1|||
131871900|NCT02064816|474810485|FG000|Overall Study|Therapeutic failure|0|||
131871901|NCT02064816|474810486|FG001|Overall Study|Therapeutic failure|1|||
131871902|NCT02064816|474810485|FG000|Overall Study|Other|1|||
131871903|NCT02064816|474810486|FG001|Overall Study|Other|3|||
131871904|NCT04468347|474810491|FG000|Overall Study|Withdrawal by Subject|0|||
131871905|NCT04468347|474810492|FG001|Overall Study|Withdrawal by Subject|1|||
131871906|NCT04468347|474810493|FG002|Overall Study|Withdrawal by Subject|3|||
131871907|NCT04468347|474810494|FG003|Overall Study|Withdrawal by Subject|3|||
131871908|NCT04468347|474810491|FG000|Overall Study|Lost to Follow-up|0|||
131871909|NCT04468347|474810492|FG001|Overall Study|Lost to Follow-up|0|||
131871910|NCT04468347|474810493|FG002|Overall Study|Lost to Follow-up|1|||
131871911|NCT04468347|474810494|FG003|Overall Study|Lost to Follow-up|1|||
131871912|NCT04468347|474810491|FG000|Overall Study|Physician Decision|1|||
131871913|NCT04468347|474810492|FG001|Overall Study|Physician Decision|0|||
131871914|NCT04468347|474810493|FG002|Overall Study|Physician Decision|2|||
131871915|NCT04468347|474810494|FG003|Overall Study|Physician Decision|0|||
131871916|NCT04468347|474810491|FG000|Overall Study|Protocol Violation|1|||
131871917|NCT04468347|474810492|FG001|Overall Study|Protocol Violation|0|||
131871918|NCT04468347|474810493|FG002|Overall Study|Protocol Violation|0|||
131919534|NCT01879852|474989279|FG001|Overall Study|Withdrawal by Subject|0|||
131871919|NCT04468347|474810494|FG003|Overall Study|Protocol Violation|0|||
131871920|NCT01732458|474810495|FG000|Overall Study|Lost to Follow-up|0|||
131871921|NCT01732458|474810496|FG001|Overall Study|Lost to Follow-up|2|||
131871922|NCT01732458|474810497|FG002|Overall Study|Lost to Follow-up|0|||
131871923|NCT01732458|474810498|FG003|Overall Study|Lost to Follow-up|0|||
131871924|NCT01732458|474810495|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131871925|NCT01732458|474810496|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131871926|NCT01732458|474810497|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131919535|NCT02115386|474989280|FG000|Overall Study|Protocol Violation|1|||
131871927|NCT01732458|474810498|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131871928|NCT01732458|474810495|FG000|Overall Study|Physician Decision|1|||
131871929|NCT01732458|474810496|FG001|Overall Study|Physician Decision|2|||
131871930|NCT01732458|474810497|FG002|Overall Study|Physician Decision|2|||
131871931|NCT01732458|474810498|FG003|Overall Study|Physician Decision|0|||
131871932|NCT01732458|474810495|FG000|Overall Study|Protocol Violation|2|||
131871933|NCT01732458|474810496|FG001|Overall Study|Protocol Violation|0|||
131871934|NCT01732458|474810497|FG002|Overall Study|Protocol Violation|0|||
131871935|NCT01732458|474810498|FG003|Overall Study|Protocol Violation|2|||
131871936|NCT01732458|474810495|FG000|Overall Study|Screen Failure|0|||
131871937|NCT01732458|474810496|FG001|Overall Study|Screen Failure|1|||
131871938|NCT01732458|474810497|FG002|Overall Study|Screen Failure|0|||
131871939|NCT01732458|474810498|FG003|Overall Study|Screen Failure|0|||
131871940|NCT00994461|474810499|FG000|Overall Study|Adverse Event|2|||
131871941|NCT00994461|474810500|FG001|Overall Study|Adverse Event|1|||
131871942|NCT00994461|474810501|FG002|Overall Study|Adverse Event|0|||
131871943|NCT02887248|474810507|FG000|Overall Study|Withdrawal by Subject|1|||
131871944|NCT02887248|474810507|FG000|Overall Study|Adverse Event|1|||
131871945|NCT02887248|474810507|FG000|Overall Study|Progressive Disease|1|||
131871946|NCT03759587|474810508|FG000|Overall Study|Adverse Event|5|||
131871947|NCT03759587|474810508|FG000|Overall Study|Progressive Disease|10|||
131871948|NCT03759587|474810508|FG000|Overall Study|Site Terminated by Sponsor|3|||
131871949|NCT03759587|474810508|FG000|Overall Study|Withdrawal by Subject|1|||
131871950|NCT00454363|474810513|FG000|Overall Study|Adverse Event|1|||
131871951|NCT00454363|474810514|FG001|Overall Study|Adverse Event|2|||
131871952|NCT00454363|474810513|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
131871953|NCT00454363|474810514|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
131871954|NCT01554527|474810515|FG000|Overall Study|Withdrawal by Subject|1|||
131871955|NCT01554527|474810516|FG001|Overall Study|Withdrawal by Subject|0|||
131871956|NCT01554527|474810517|FG002|Overall Study|Withdrawal by Subject|3|||
131871957|NCT01554527|474810515|FG000|Overall Study|Lost to Follow-up|0|||
131871958|NCT01554527|474810516|FG001|Overall Study|Lost to Follow-up|0|||
131871959|NCT01554527|474810517|FG002|Overall Study|Lost to Follow-up|4|||
131871960|NCT01554527|474810515|FG000|Overall Study|Physician Decision|0|||
131871961|NCT01554527|474810516|FG001|Overall Study|Physician Decision|0|||
131871962|NCT01554527|474810517|FG002|Overall Study|Physician Decision|1|||
131871963|NCT01074268|474810518|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
131871964|NCT01074268|474810519|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
131871965|NCT01074268|474810518|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
131871966|NCT01074268|474810519|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
131871967|NCT01074268|474810518|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
131871968|NCT01074268|474810519|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
131871969|NCT01074268|474810518|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
131871970|NCT01074268|474810519|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
131871971|NCT01074268|474810518|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
131871972|NCT01074268|474810519|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
131871973|NCT01074268|474810518|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
131871974|NCT01074268|474810519|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
131871975|NCT01074268|474810518|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
131871976|NCT01074268|474810519|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
131871977|NCT01074268|474810518|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
131871978|NCT01074268|474810519|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
131871979|NCT01074268|474810518|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
131871980|NCT01074268|474810519|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
131871981|NCT02837731|474810524|FG000|Allocation|Admitted to General Floor|3|||
131871982|NCT02837731|474810525|FG001|Allocation|Admitted to General Floor|4|||
131871983|NCT02837731|474810524|FG000|Allocation|Immediate surgery/withdrew|2|||
131871984|NCT02837731|474810525|FG001|Allocation|Immediate surgery/withdrew|0|||
131871985|NCT02837731|474810524|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
131871986|NCT02837731|474810525|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
131871987|NCT02837731|474810524|FG000|Allocation|Withdrawal by Subject|2|||
131871988|NCT02837731|474810525|FG001|Allocation|Withdrawal by Subject|0|||
131871989|NCT02837731|474810524|FG000|Allocation|Device not available|1|||
131871990|NCT02837731|474810525|FG001|Allocation|Device not available|0|||
131871991|NCT02837731|474810524|FG000|Allocation|Protocol not implemented|7|||
131871992|NCT02837731|474810525|FG001|Allocation|Protocol not implemented|0|||
131871993|NCT02837731|474810524|FG000|Allocation|Moribund/Do not resuscitate|2|||
131871994|NCT02837731|474810525|FG001|Allocation|Moribund/Do not resuscitate|0|||
131871995|NCT02837731|474810524|FG000|Allocation|Did not meet sepsis criteria|1|||
131871996|NCT02837731|474810525|FG001|Allocation|Did not meet sepsis criteria|2|||
131871997|NCT02837731|474810524|FG000|Allocation|Known aortic abnormalities|0|||
131919536|NCT02115386|474989280|FG000|Overall Study|Administrative - trial was terminated|6|||
131871998|NCT02837731|474810525|FG001|Allocation|Known aortic abnormalities|1|||
131871999|NCT01119859|474810526|FG000|Overall Study|Adverse Event|9|||
131919537|NCT02493855|474989281|FG000|Overall Study|Non-compliance|1|||
131872000|NCT01119859|474810527|FG001|Overall Study|Adverse Event|10|||
131872001|NCT01119859|474810526|FG000|Overall Study|Death|2|||
131872002|NCT01119859|474810527|FG001|Overall Study|Death|0|||
131872003|NCT01119859|474810526|FG000|Overall Study|Insufficient therapeutic response|7|||
131872004|NCT01119859|474810527|FG001|Overall Study|Insufficient therapeutic response|14|||
131872005|NCT01119859|474810526|FG000|Overall Study|Refused treatment|3|||
131872006|NCT01119859|474810527|FG001|Overall Study|Refused treatment|6|||
131872007|NCT01119859|474810526|FG000|Overall Study|Failure to return|3|||
131872008|NCT01119859|474810527|FG001|Overall Study|Failure to return|0|||
131872009|NCT04200651|474810528|FG000|Overall Study|Moved to another country during follow-up|2|||
131872010|NCT04200651|474810529|FG001|Overall Study|Moved to another country during follow-up|2|||
131872011|NCT04200651|474810528|FG000|Overall Study|Lost to Follow-up|1|||
131872012|NCT04200651|474810529|FG001|Overall Study|Lost to Follow-up|3|||
131872013|NCT00757042|474810533|FG000|Overall Study|Lost to Follow-up|0|||
131872014|NCT00757042|474810534|FG001|Overall Study|Lost to Follow-up|0|||
131872015|NCT00757042|474810535|FG002|Overall Study|Lost to Follow-up|0|||
131872016|NCT00757042|474810536|FG003|Overall Study|Lost to Follow-up|0|||
131872017|NCT00757042|474810537|FG004|Overall Study|Lost to Follow-up|0|||
131872018|NCT00757042|474810538|FG005|Overall Study|Lost to Follow-up|0|||
131872019|NCT00757042|474810539|FG006|Overall Study|Lost to Follow-up|0|||
131872020|NCT00757042|474810540|FG007|Overall Study|Lost to Follow-up|0|||
131872021|NCT00757042|474810541|FG008|Overall Study|Lost to Follow-up|1|||
131872022|NCT00757042|474810542|FG009|Overall Study|Lost to Follow-up|0|||
131872023|NCT00757042|474810543|FG010|Overall Study|Lost to Follow-up|0|||
131872024|NCT00757042|474810533|FG000|Overall Study|Ineligibility Determined|0|||
131872025|NCT00757042|474810534|FG001|Overall Study|Ineligibility Determined|0|||
131872026|NCT00757042|474810535|FG002|Overall Study|Ineligibility Determined|0|||
131872027|NCT00757042|474810536|FG003|Overall Study|Ineligibility Determined|0|||
131872028|NCT00757042|474810537|FG004|Overall Study|Ineligibility Determined|0|||
131872029|NCT00757042|474810538|FG005|Overall Study|Ineligibility Determined|0|||
131872030|NCT00757042|474810539|FG006|Overall Study|Ineligibility Determined|0|||
131872031|NCT00757042|474810540|FG007|Overall Study|Ineligibility Determined|0|||
131872032|NCT00757042|474810541|FG008|Overall Study|Ineligibility Determined|0|||
131872033|NCT00757042|474810542|FG009|Overall Study|Ineligibility Determined|0|||
131872034|NCT00757042|474810543|FG010|Overall Study|Ineligibility Determined|1|||
131872035|NCT00757042|474810533|FG000|Overall Study|Withdrawal by Subject|0|||
131872036|NCT00757042|474810534|FG001|Overall Study|Withdrawal by Subject|0|||
131872037|NCT00757042|474810535|FG002|Overall Study|Withdrawal by Subject|0|||
131872038|NCT00757042|474810536|FG003|Overall Study|Withdrawal by Subject|0|||
131872039|NCT00757042|474810537|FG004|Overall Study|Withdrawal by Subject|0|||
131872040|NCT00757042|474810538|FG005|Overall Study|Withdrawal by Subject|0|||
131872041|NCT00757042|474810539|FG006|Overall Study|Withdrawal by Subject|0|||
131872042|NCT00757042|474810540|FG007|Overall Study|Withdrawal by Subject|0|||
131872043|NCT00757042|474810541|FG008|Overall Study|Withdrawal by Subject|0|||
131872044|NCT00757042|474810542|FG009|Overall Study|Withdrawal by Subject|1|||
131872045|NCT00757042|474810543|FG010|Overall Study|Withdrawal by Subject|0|||
131872046|NCT01870973|474810545|FG000|Overall Study|Lost to Follow-up|10|||
131872047|NCT01870973|474810546|FG001|Overall Study|Lost to Follow-up|3|||
131872048|NCT03691207|474812297|FG000|Overall Study|Death|41|||
131872049|NCT03691207|474812298|FG001|Overall Study|Death|26|||
131872050|NCT03691207|474812297|FG000|Overall Study|Lost to Follow-up|1|||
131872051|NCT03691207|474812298|FG001|Overall Study|Lost to Follow-up|1|||
131872052|NCT03691207|474812297|FG000|Overall Study|Withdrawal by Subject|2|||
131872053|NCT03691207|474812298|FG001|Overall Study|Withdrawal by Subject|8|||
131872054|NCT03691207|474812297|FG000|Overall Study|Sponsor decision|1|||
131872055|NCT03691207|474812298|FG001|Overall Study|Sponsor decision|7|||
131872056|NCT00740792|474812306|FG000|Overall Study|Adverse Event|3|||
131872057|NCT00740792|474812307|FG001|Overall Study|Adverse Event|1|||
131872058|NCT00740792|474812308|FG002|Overall Study|Adverse Event|1|||
131872059|NCT00740792|474812309|FG003|Overall Study|Adverse Event|3|||
131872060|NCT00740792|474812306|FG000|Overall Study|Lack of Efficacy|1|||
131872061|NCT00740792|474812307|FG001|Overall Study|Lack of Efficacy|1|||
131872062|NCT00740792|474812308|FG002|Overall Study|Lack of Efficacy|0|||
131872063|NCT00740792|474812309|FG003|Overall Study|Lack of Efficacy|3|||
131872064|NCT00740792|474812306|FG000|Overall Study|Lost to Follow-up|2|||
131872065|NCT00740792|474812307|FG001|Overall Study|Lost to Follow-up|1|||
131872066|NCT00740792|474812308|FG002|Overall Study|Lost to Follow-up|0|||
131872067|NCT00740792|474812309|FG003|Overall Study|Lost to Follow-up|0|||
131872068|NCT00740792|474812306|FG000|Overall Study|Protocol Violation|0|||
131872069|NCT00740792|474812307|FG001|Overall Study|Protocol Violation|1|||
131872070|NCT00740792|474812308|FG002|Overall Study|Protocol Violation|0|||
131872071|NCT00740792|474812309|FG003|Overall Study|Protocol Violation|2|||
131872072|NCT00740792|474812306|FG000|Overall Study|Withdrawal by Subject|1|||
131872073|NCT00740792|474812307|FG001|Overall Study|Withdrawal by Subject|1|||
131872074|NCT00740792|474812308|FG002|Overall Study|Withdrawal by Subject|0|||
131872075|NCT00740792|474812309|FG003|Overall Study|Withdrawal by Subject|0|||
131872076|NCT00740792|474812306|FG000|Overall Study|administrative|3|||
131872077|NCT00740792|474812307|FG001|Overall Study|administrative|3|||
131872078|NCT00740792|474812308|FG002|Overall Study|administrative|8|||
131872079|NCT00740792|474812309|FG003|Overall Study|administrative|2|||
131872080|NCT02035202|474812312|FG000|Overall Study|Lost to Follow-up|8|||
131872081|NCT02035202|474812313|FG001|Overall Study|Lost to Follow-up|16|||
131872082|NCT02035202|474812314|FG002|Overall Study|Lost to Follow-up|2|||
131872083|NCT00862823|474812324|FG000|First Intervention|Withdrawal by Subject|1|||
131872084|NCT00862823|474812325|FG001|First Intervention|Withdrawal by Subject|1|||
131872085|NCT01421225|474812326|FG000|Overall Study|Withdrawal by Subject|0|||
131872086|NCT01421225|474812327|FG001|Overall Study|Withdrawal by Subject|1|||
131872087|NCT02993250|474812328|FG000|Overall Study|Lost to Follow-up|0|||
131872088|NCT02993250|474812329|FG001|Overall Study|Lost to Follow-up|1|||
131872089|NCT02714595|474812331|FG000|Overall Study|Lost to Follow-up|1|||
131872090|NCT02714595|474812332|FG001|Overall Study|Lost to Follow-up|0|||
131872091|NCT02714595|474812331|FG000|Overall Study|Withdrawal by Subject|1|||
131872092|NCT02714595|474812332|FG001|Overall Study|Withdrawal by Subject|2|||
131872093|NCT02714595|474812331|FG000|Overall Study|Lack of Efficacy|0|||
131872094|NCT02714595|474812332|FG001|Overall Study|Lack of Efficacy|1|||
131872095|NCT02714595|474812331|FG000|Overall Study|Death|30|||
131872096|NCT02714595|474812332|FG001|Overall Study|Death|9|||
131872097|NCT02714595|474812331|FG000|Overall Study|Other-Miscellaneous|0|||
131872098|NCT02714595|474812332|FG001|Overall Study|Other-Miscellaneous|1|||
131872099|NCT01896128|474812333|FG000|Overall Study|Withdrawal by Subject|3|||
131872100|NCT01896128|474812334|FG001|Overall Study|Withdrawal by Subject|3|||
131872101|NCT01053663|474812335|FG000|Overall Study|Death|2|||
131872102|NCT01053663|474812335|FG000|Overall Study|Lost to Follow-up|1|||
131872103|NCT01053663|474812335|FG000|Overall Study|Poor IV Access|1|||
131872104|NCT01053663|474812335|FG000|Overall Study|Transferred to Another Hospital|1|||
131872105|NCT01053663|474812335|FG000|Overall Study|Negative Influenza Diagnosis|1|||
131872106|NCT03533114|474812336|FG000|Overall|Adverse Event|16|||
131872107|NCT03533114|474812337|FG001|Overall|Adverse Event|11|||
131872108|NCT03533114|474812336|FG000|Overall|Consent Withdrawal by Participant|7|||
131872109|NCT03533114|474812337|FG001|Overall|Consent Withdrawal by Participant|6|||
131872110|NCT03533114|474812336|FG000|Overall|Lack of Efficacy|5|||
131872111|NCT03533114|474812337|FG001|Overall|Lack of Efficacy|3|||
131872112|NCT03533114|474812336|FG000|Overall|Lost to Follow-up|1|||
131872113|NCT03533114|474812337|FG001|Overall|Lost to Follow-up|1|||
131872114|NCT03533114|474812336|FG000|Overall|Physician Decision|0|||
131872115|NCT03533114|474812337|FG001|Overall|Physician Decision|2|||
131872116|NCT03533114|474812336|FG000|Overall|Protocol deviation|1|||
131872117|NCT03533114|474812337|FG001|Overall|Protocol deviation|1|||
131872118|NCT03533114|474812336|FG000|Overall|Failure to meet randomization criteria|1|||
131872119|NCT03533114|474812337|FG001|Overall|Failure to meet randomization criteria|2|||
131872120|NCT03533114|474812336|FG000|Overall|Non-Compliance with study drug|0|||
131872121|NCT03533114|474812337|FG001|Overall|Non-Compliance with study drug|1|||
131872122|NCT03533114|474812336|FG000|Overall|Other|0|||
131872123|NCT03533114|474812337|FG001|Overall|Other|1|||
131872124|NCT03533114|474812336|FG000|Open Label Titration and Optimization|Adverse Event|11|||
131872125|NCT03533114|474812337|FG001|Open Label Titration and Optimization|Adverse Event|8|||
131872126|NCT03533114|474812336|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
131872127|NCT03533114|474812337|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
131872128|NCT03533114|474812336|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
131872129|NCT03533114|474812337|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
131872130|NCT03533114|474812336|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
131872131|NCT03533114|474812337|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
131872132|NCT03533114|474812336|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
131872133|NCT03533114|474812337|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
131872134|NCT03533114|474812336|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
131872135|NCT03533114|474812337|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
131872136|NCT03533114|474812336|FG000|Stable Dose|Adverse Event|0|||
131872137|NCT03533114|474812337|FG001|Stable Dose|Adverse Event|2|||
131872138|NCT03533114|474812336|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
131872139|NCT03533114|474812337|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
131872140|NCT03533114|474812336|FG000|Stable Dose|Lack of Efficacy|1|||
131872141|NCT03533114|474812337|FG001|Stable Dose|Lack of Efficacy|0|||
131872142|NCT03533114|474812336|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
131872143|NCT03533114|474812337|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
131872144|NCT03533114|474812336|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
131872145|NCT03533114|474812337|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
131872146|NCT03533114|474812336|FG000|Open-Label Safety Extension|Adverse Event|3|||
131872147|NCT03533114|474812337|FG001|Open-Label Safety Extension|Adverse Event|0|||
131872148|NCT03533114|474812336|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
131872149|NCT03533114|474812337|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
131872150|NCT03533114|474812336|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
131872151|NCT03533114|474812337|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
131872152|NCT03533114|474812336|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
131872153|NCT03533114|474812337|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
131872154|NCT03533114|474812336|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
131872155|NCT03533114|474812337|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
131872156|NCT01862250|474812338|FG000|Overall Study|Adverse Event|4|||
131872157|NCT02411396|474812339|FG000|Overall Study|Lost to Follow-up|31|||
131872158|NCT02411396|474812339|FG000|Overall Study|Death|10|||
131872159|NCT02423343|474812340|FG000|Overall Study|Withdrawal by Subject|0|||
131872160|NCT02423343|474812341|FG001|Overall Study|Withdrawal by Subject|1|||
131872161|NCT02423343|474812342|FG002|Overall Study|Withdrawal by Subject|0|||
131872162|NCT02423343|474812343|FG003|Overall Study|Withdrawal by Subject|0|||
131872163|NCT02423343|474812344|FG004|Overall Study|Withdrawal by Subject|0|||
131872164|NCT02423343|474812345|FG005|Overall Study|Withdrawal by Subject|0|||
131872165|NCT02423343|474812340|FG000|Overall Study|Progressive Disease|0|||
131872166|NCT02423343|474812341|FG001|Overall Study|Progressive Disease|0|||
131872167|NCT02423343|474812342|FG002|Overall Study|Progressive Disease|0|||
131872168|NCT02423343|474812343|FG003|Overall Study|Progressive Disease|0|||
131872169|NCT02423343|474812344|FG004|Overall Study|Progressive Disease|2|||
131872170|NCT02423343|474812345|FG005|Overall Study|Progressive Disease|0|||
131872171|NCT02423343|474812340|FG000|Overall Study|Adverse Event|0|||
131872172|NCT02423343|474812341|FG001|Overall Study|Adverse Event|0|||
131872173|NCT02423343|474812342|FG002|Overall Study|Adverse Event|0|||
131872174|NCT02423343|474812343|FG003|Overall Study|Adverse Event|0|||
131872175|NCT02423343|474812344|FG004|Overall Study|Adverse Event|2|||
131872176|NCT02423343|474812345|FG005|Overall Study|Adverse Event|0|||
131872177|NCT02423343|474812340|FG000|Overall Study|Death|0|||
131872178|NCT02423343|474812341|FG001|Overall Study|Death|0|||
131872179|NCT02423343|474812342|FG002|Overall Study|Death|0|||
131872180|NCT02423343|474812343|FG003|Overall Study|Death|0|||
131872181|NCT02423343|474812344|FG004|Overall Study|Death|1|||
131872182|NCT02423343|474812345|FG005|Overall Study|Death|0|||
131872183|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
131872184|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
131872185|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
131872186|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
131872187|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
131872188|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
131872189|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
131872190|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
131872191|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
131872192|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
131872193|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
131872194|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
131872195|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
131872196|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
131872197|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
131872198|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
131872199|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
131872200|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
131872201|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
131872202|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
131872203|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
131872204|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
131872205|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
131872206|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
131872207|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
131872208|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
131872209|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
131872210|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
131872211|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
131872212|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
131872213|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
131872214|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
131872215|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
131872216|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
131872217|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
131872218|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
131872219|NCT02016105|474812346|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
131872220|NCT02016105|474812347|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
131872221|NCT02016105|474812348|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
131872222|NCT02016105|474812349|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
131872223|NCT02016105|474812350|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
131872224|NCT02016105|474812351|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
131872225|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
131872226|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
131872227|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
131872228|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
131872229|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
131872230|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
131872231|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
131872232|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
131872233|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
131872234|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
131872235|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
131872236|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
131872237|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
131872238|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
131872239|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
131872240|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
131872241|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
131872242|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
131872243|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Death|0|||
131872244|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Death|0|||
131872245|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Death|0|||
131872246|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Death|0|||
131872247|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Death|0|||
131872248|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Death|1|||
131872249|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
131872250|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
131872251|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
131872252|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
131872253|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
131872254|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
131872255|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
131872256|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
131872257|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
131872258|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
131872259|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
131872260|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
131872261|NCT02016105|474812346|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
131872262|NCT02016105|474812347|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
131872263|NCT02016105|474812348|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
131872264|NCT02016105|474812349|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
131872265|NCT02016105|474812350|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
131872266|NCT02016105|474812351|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
131872267|NCT02016105|474812346|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
131872268|NCT02016105|474812347|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
131872269|NCT02016105|474812348|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
131872270|NCT02016105|474812349|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
131872271|NCT02016105|474812350|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
131872272|NCT02016105|474812351|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
131872273|NCT02016105|474812346|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
131872274|NCT02016105|474812347|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
131872275|NCT02016105|474812348|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
131872276|NCT02016105|474812349|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
131872277|NCT02016105|474812350|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
131872278|NCT02016105|474812351|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
131872279|NCT02016105|474812346|FG000|EXTENSION PERIOD|Adverse Event|0|||
131872280|NCT02016105|474812347|FG001|EXTENSION PERIOD|Adverse Event|0|||
131872281|NCT02016105|474812348|FG002|EXTENSION PERIOD|Adverse Event|2|||
131872282|NCT02016105|474812349|FG003|EXTENSION PERIOD|Adverse Event|0|||
131872283|NCT02016105|474812350|FG004|EXTENSION PERIOD|Adverse Event|1|||
131872284|NCT02016105|474812351|FG005|EXTENSION PERIOD|Adverse Event|0|||
131872285|NCT02016105|474812346|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
131872286|NCT02016105|474812347|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
131872287|NCT02016105|474812348|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
131872288|NCT02016105|474812349|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
131872289|NCT02016105|474812350|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
131872290|NCT02016105|474812351|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
131872291|NCT02016105|474812346|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
131872292|NCT02016105|474812347|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
131919538|NCT02493855|474989282|FG001|Overall Study|Non-compliance|0|||
131872293|NCT02016105|474812348|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
131872294|NCT02016105|474812349|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
131872295|NCT02016105|474812350|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
131872296|NCT02016105|474812351|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
131872297|NCT02016105|474812346|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
131872298|NCT02016105|474812347|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
131872299|NCT02016105|474812348|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
131872300|NCT02016105|474812349|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
131872301|NCT02016105|474812350|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
131872302|NCT02016105|474812351|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
131872303|NCT01860040|474812356|FG000|Overall Study|Withdrawal by Subject|1|||
131872304|NCT01860040|474812357|FG001|Overall Study|Withdrawal by Subject|0|||
131872305|NCT01931995|474812358|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
131408270|NCT00931723|473118252|FG000|Overall Study|Lithium found in blood|0|||
131408271|NCT00931723|473118253|FG001|Overall Study|Lithium found in blood|1|||
131408272|NCT00931723|473118252|FG000|Overall Study|Condition under investigation worsened|1|||
131408273|NCT00931723|473118253|FG001|Overall Study|Condition under investigation worsened|2|||
131408274|NCT00931723|473118252|FG000|Overall Study|Lost to Follow-up|1|||
131408275|NCT00931723|473118253|FG001|Overall Study|Lost to Follow-up|2|||
131872306|NCT01931995|474812359|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
131872307|NCT01931995|474812358|FG000|First Intervention (1 Day)|Physician Decision|1|||
131872308|NCT01931995|474812359|FG001|First Intervention (1 Day)|Physician Decision|1|||
131872309|NCT01931995|474812358|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
131872310|NCT01931995|474812359|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
131872311|NCT00403481|474812361|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
131872312|NCT00403481|474812361|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
131872313|NCT00403481|474812361|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
131872314|NCT00403481|474812361|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
131872315|NCT00403481|474812361|FG000|Olm 40 mg|Adverse Event|2|||
131872316|NCT00403481|474812361|FG000|Olm 40 mg|Protocol Violation|1|||
131872317|NCT00403481|474812361|FG000|Olm 40 mg|Withdrawal by Subject|1|||
131872318|NCT00403481|474812361|FG000|Olm 40 mg|Other|1|||
131872319|NCT00403481|474812361|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
131872320|NCT00403481|474812361|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
131872321|NCT00403481|474812361|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
131872322|NCT00403481|474812361|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
131872323|NCT00403481|474812361|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
131872324|NCT00403481|474812361|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
131872325|NCT00900159|474812368|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
131872326|NCT00900159|474812369|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
131872327|NCT03170362|474812370|FG000|Overall Study|Death|2|||
131872328|NCT03170362|474812371|FG001|Overall Study|Death|2|||
131872329|NCT03170362|474812370|FG000|Overall Study|Withdrawal by Subject|23|||
131872330|NCT03170362|474812371|FG001|Overall Study|Withdrawal by Subject|22|||
131872331|NCT03170362|474812370|FG000|Overall Study|Lost to Follow-up|187|||
131872332|NCT03170362|474812371|FG001|Overall Study|Lost to Follow-up|167|||
131872333|NCT04615403|474812372|FG000|Overall Study|Death|1|||
131872334|NCT03340454|474812373|FG000|Overall Study|Lost to Follow-up|0|||
131872335|NCT03340454|474812374|FG001|Overall Study|Lost to Follow-up|4|||
131872336|NCT01464164|474812375|FG000|Overall Study|Screen failure|0|||
131872337|NCT01464164|474812376|FG001|Overall Study|Screen failure|1|||
131872338|NCT01464164|474812377|FG002|Overall Study|Screen failure|2|||
131872339|NCT01464164|474812378|FG003|Overall Study|Screen failure|0|||
131872340|NCT01464164|474812379|FG004|Overall Study|Screen failure|0|||
131872341|NCT01464164|474812380|FG005|Overall Study|Screen failure|0|||
131872342|NCT01464164|474812381|FG006|Overall Study|Screen failure|0|||
131872343|NCT01464164|474812375|FG000|Overall Study|Physician Decision|0|||
131872344|NCT01464164|474812376|FG001|Overall Study|Physician Decision|1|||
131872345|NCT01464164|474812377|FG002|Overall Study|Physician Decision|0|||
131872346|NCT01464164|474812378|FG003|Overall Study|Physician Decision|0|||
131872347|NCT01464164|474812379|FG004|Overall Study|Physician Decision|0|||
131872348|NCT01464164|474812380|FG005|Overall Study|Physician Decision|0|||
131872349|NCT01464164|474812381|FG006|Overall Study|Physician Decision|2|||
131872350|NCT03682848|474812382|FG000|Overall Study|Withdrawal by Subject|2|||
131872351|NCT03682848|474812382|FG000|Overall Study|Site closed|5|||
131872352|NCT03682848|474812382|FG000|Overall Study|Protocol Deviation|1|||
131408276|NCT00931723|473118252|FG000|Overall Study|Study-specific discontinuation criteria|1|||
131872353|NCT03682848|474812382|FG000|Overall Study|Adverse Event|1|||
131872354|NCT00570063|474812383|FG000|Overall Study|Adverse Event|4|||
131872355|NCT00570063|474812384|FG001|Overall Study|Adverse Event|1|||
131408277|NCT00931723|473118253|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131872356|NCT00570063|474812383|FG000|Overall Study|Lack of Efficacy|0|||
131872357|NCT00570063|474812384|FG001|Overall Study|Lack of Efficacy|1|||
131872358|NCT00570063|474812383|FG000|Overall Study|Withdrawal by Subject|4|||
131872359|NCT00570063|474812384|FG001|Overall Study|Withdrawal by Subject|3|||
131872360|NCT00570063|474812383|FG000|Overall Study|Sponsor's Decision|7|||
131872361|NCT00570063|474812384|FG001|Overall Study|Sponsor's Decision|3|||
131872362|NCT00697463|474812385|FG000|Overall Study|Withdrawal by Subject|1|||
131872363|NCT03307252|474812386|FG000|Part 2, Period 1|Treatment not received|0|||
131872364|NCT03307252|474812387|FG001|Part 2, Period 1|Treatment not received|0|||
131872365|NCT03307252|474812388|FG002|Part 2, Period 1|Treatment not received|0|||
131872366|NCT03307252|474812389|FG003|Part 2, Period 1|Treatment not received|0|||
131872367|NCT03307252|474812390|FG004|Part 2, Period 1|Treatment not received|0|||
131408278|NCT00931723|473118252|FG000|Overall Study|Severe non-compliance to protocol|2|||
131872368|NCT03307252|474812391|FG005|Part 2, Period 1|Treatment not received|1|||
131872369|NCT03307252|474812392|FG006|Part 2, Period 1|Treatment not received|0|||
131872370|NCT03307252|474812393|FG007|Part 2, Period 1|Treatment not received|0|||
131872371|NCT03307252|474812394|FG008|Part 2, Period 1|Treatment not received|0|||
131872372|NCT03307252|474812395|FG009|Part 2, Period 1|Treatment not received|0|||
131872373|NCT03307252|474812396|FG010|Part 2, Period 1|Treatment not received|0|||
131872374|NCT03307252|474812386|FG000|Part 2, Period 3|Other than listed|0|||
131872375|NCT03307252|474812387|FG001|Part 2, Period 3|Other than listed|0|||
131872376|NCT03307252|474812388|FG002|Part 2, Period 3|Other than listed|0|||
131872377|NCT03307252|474812389|FG003|Part 2, Period 3|Other than listed|0|||
131872378|NCT03307252|474812390|FG004|Part 2, Period 3|Other than listed|1|||
131872379|NCT03307252|474812391|FG005|Part 2, Period 3|Other than listed|0|||
131872380|NCT03307252|474812392|FG006|Part 2, Period 3|Other than listed|0|||
131872381|NCT03307252|474812393|FG007|Part 2, Period 3|Other than listed|0|||
131872382|NCT03307252|474812394|FG008|Part 2, Period 3|Other than listed|0|||
131872383|NCT03307252|474812395|FG009|Part 2, Period 3|Other than listed|0|||
131872384|NCT03307252|474812396|FG010|Part 2, Period 3|Other than listed|0|||
131872385|NCT03307252|474812386|FG000|Part 2, Period 4|Other than listed|0|||
131872386|NCT03307252|474812387|FG001|Part 2, Period 4|Other than listed|0|||
131872387|NCT03307252|474812388|FG002|Part 2, Period 4|Other than listed|0|||
131872388|NCT03307252|474812389|FG003|Part 2, Period 4|Other than listed|0|||
131872389|NCT03307252|474812390|FG004|Part 2, Period 4|Other than listed|0|||
131872390|NCT03307252|474812391|FG005|Part 2, Period 4|Other than listed|0|||
131872391|NCT03307252|474812392|FG006|Part 2, Period 4|Other than listed|1|||
131872392|NCT03307252|474812393|FG007|Part 2, Period 4|Other than listed|0|||
131872393|NCT03307252|474812394|FG008|Part 2, Period 4|Other than listed|0|||
131872394|NCT03307252|474812395|FG009|Part 2, Period 4|Other than listed|0|||
131872395|NCT03307252|474812396|FG010|Part 2, Period 4|Other than listed|0|||
131872396|NCT03307252|474812386|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872397|NCT03307252|474812387|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872398|NCT03307252|474812388|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872399|NCT03307252|474812389|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872400|NCT03307252|474812390|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872401|NCT03307252|474812391|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872402|NCT03307252|474812392|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872403|NCT03307252|474812393|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872404|NCT03307252|474812394|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872405|NCT03307252|474812395|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
131872406|NCT03307252|474812396|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
131872407|NCT03482453|474812397|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872408|NCT03482453|474812398|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872409|NCT03482453|474812399|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872410|NCT03482453|474812400|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872411|NCT03482453|474812401|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872412|NCT03482453|474812402|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872413|NCT03482453|474812403|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872414|NCT03482453|474812404|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872415|NCT03482453|474812405|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872416|NCT03482453|474812406|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872417|NCT03482453|474812407|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
131872418|NCT03482453|474812408|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
131872419|NCT02568189|474812409|FG000|Overall Study|Protocol Violation|0|||
131872420|NCT02568189|474812410|FG001|Overall Study|Protocol Violation|0|||
131872421|NCT02568189|474812411|FG002|Overall Study|Protocol Violation|19|||
131872422|NCT02568189|474812412|FG003|Overall Study|Protocol Violation|18|||
131872423|NCT02157376|474812413|FG000|Overall Study|Death|10|||
131872424|NCT02157376|474812414|FG001|Overall Study|Death|4|||
131872425|NCT02157376|474812413|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131872426|NCT02157376|474812414|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131872427|NCT02157376|474812413|FG000|Overall Study|Withdrawal by Subject|3|||
131872428|NCT02157376|474812414|FG001|Overall Study|Withdrawal by Subject|8|||
131872429|NCT02157376|474812413|FG000|Overall Study|Not treated|8|||
131872430|NCT02157376|474812414|FG001|Overall Study|Not treated|3|||
131872431|NCT02157376|474812413|FG000|Overall Study|Investigator's misjudgement|1|||
131872432|NCT02157376|474812414|FG001|Overall Study|Investigator's misjudgement|2|||
131872433|NCT01578239|474812417|FG000|Treatment Period|Progressive Disease|19|||
131872434|NCT01578239|474812418|FG001|Treatment Period|Progressive Disease|64|||
131919539|NCT02493855|474989283|FG002|Overall Study|Non-compliance|0|||
131872435|NCT01578239|474812417|FG000|Treatment Period|Physician Decision|17|||
131872436|NCT01578239|474812418|FG001|Treatment Period|Physician Decision|17|||
131872437|NCT01578239|474812417|FG000|Treatment Period|Adverse Event|13|||
131872438|NCT01578239|474812418|FG001|Treatment Period|Adverse Event|10|||
131872439|NCT01578239|474812417|FG000|Treatment Period|Non-compliance|2|||
131872440|NCT01578239|474812418|FG001|Treatment Period|Non-compliance|0|||
131872441|NCT01578239|474812417|FG000|Treatment Period|Withdrawal by Subject|10|||
131872442|NCT01578239|474812418|FG001|Treatment Period|Withdrawal by Subject|9|||
131872443|NCT01578239|474812417|FG000|Treatment Period|Other|6|||
131872444|NCT01578239|474812418|FG001|Treatment Period|Other|1|||
131872445|NCT01578239|474812417|FG000|Long-term Follow-Up Period|Death|69|||
131872446|NCT01578239|474812418|FG001|Long-term Follow-Up Period|Death|64|||
131872447|NCT01578239|474812417|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
131872448|NCT01578239|474812418|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
131872449|NCT01578239|474812417|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
131872450|NCT01578239|474812418|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
131872451|NCT01578239|474812417|FG000|Long-term Follow-Up Period|Other|2|||
131872452|NCT01578239|474812418|FG001|Long-term Follow-Up Period|Other|2|||
131872453|NCT02347813|474812422|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
131872454|NCT02347813|474812423|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
131872455|NCT02347813|474812422|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
131872456|NCT02347813|474812423|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
131872457|NCT00603473|474812424|FG000|Overall Study|Adverse Event|4|||
131872458|NCT00603473|474812424|FG000|Overall Study|Lack of Efficacy|4|||
131872459|NCT00603473|474812424|FG000|Overall Study|Protocol Violation|1|||
131872460|NCT02644668|474812428|FG000|Overall Study|Adverse Event|2|||
131872461|NCT02644668|474812429|FG001|Overall Study|Adverse Event|0|||
131872462|NCT02644668|474812430|FG002|Overall Study|Adverse Event|1|||
131872463|NCT02644668|474812428|FG000|Overall Study|Protocol Violation|0|||
131872464|NCT02644668|474812429|FG001|Overall Study|Protocol Violation|0|||
131872465|NCT02644668|474812430|FG002|Overall Study|Protocol Violation|1|||
131872466|NCT02644668|474812428|FG000|Overall Study|Withdrawal by Subject|0|||
131872467|NCT02644668|474812429|FG001|Overall Study|Withdrawal by Subject|0|||
131872468|NCT02644668|474812430|FG002|Overall Study|Withdrawal by Subject|1|||
131872469|NCT01134939|474812431|FG000|Overall Study|Adverse Event|9|||
131872470|NCT01134939|474812432|FG001|Overall Study|Adverse Event|3|||
131872471|NCT01134939|474812433|FG002|Overall Study|Adverse Event|4|||
131872472|NCT01134939|474812434|FG003|Overall Study|Adverse Event|5|||
131872473|NCT01134939|474812435|FG004|Overall Study|Adverse Event|5|||
131872474|NCT01134939|474812436|FG005|Overall Study|Adverse Event|5|||
131872475|NCT01134939|474812437|FG006|Overall Study|Adverse Event|1|||
131872476|NCT01134939|474812438|FG007|Overall Study|Adverse Event|0|||
131872477|NCT01134939|474812431|FG000|Overall Study|Lack of Efficacy|2|||
131872478|NCT01134939|474812432|FG001|Overall Study|Lack of Efficacy|5|||
131872479|NCT01134939|474812433|FG002|Overall Study|Lack of Efficacy|1|||
131872480|NCT01134939|474812434|FG003|Overall Study|Lack of Efficacy|0|||
131872481|NCT01134939|474812435|FG004|Overall Study|Lack of Efficacy|3|||
131872482|NCT01134939|474812436|FG005|Overall Study|Lack of Efficacy|0|||
131872483|NCT01134939|474812437|FG006|Overall Study|Lack of Efficacy|1|||
131872484|NCT01134939|474812438|FG007|Overall Study|Lack of Efficacy|0|||
131872485|NCT01134939|474812431|FG000|Overall Study|Lost to Follow-up|2|||
131872486|NCT01134939|474812432|FG001|Overall Study|Lost to Follow-up|3|||
131872487|NCT01134939|474812433|FG002|Overall Study|Lost to Follow-up|0|||
131872488|NCT01134939|474812434|FG003|Overall Study|Lost to Follow-up|1|||
131872489|NCT01134939|474812435|FG004|Overall Study|Lost to Follow-up|2|||
131872490|NCT01134939|474812436|FG005|Overall Study|Lost to Follow-up|1|||
131872491|NCT01134939|474812437|FG006|Overall Study|Lost to Follow-up|0|||
131872492|NCT01134939|474812438|FG007|Overall Study|Lost to Follow-up|0|||
131872493|NCT01134939|474812431|FG000|Overall Study|Death|0|||
131872494|NCT01134939|474812432|FG001|Overall Study|Death|1|||
131872495|NCT01134939|474812433|FG002|Overall Study|Death|0|||
131872496|NCT01134939|474812434|FG003|Overall Study|Death|0|||
131872497|NCT01134939|474812435|FG004|Overall Study|Death|0|||
131872498|NCT01134939|474812436|FG005|Overall Study|Death|0|||
131872499|NCT01134939|474812437|FG006|Overall Study|Death|0|||
131872500|NCT01134939|474812438|FG007|Overall Study|Death|0|||
131872501|NCT01134939|474812431|FG000|Overall Study|Termination page not available|4|||
131872502|NCT01134939|474812432|FG001|Overall Study|Termination page not available|6|||
131872503|NCT01134939|474812433|FG002|Overall Study|Termination page not available|5|||
131872504|NCT01134939|474812434|FG003|Overall Study|Termination page not available|8|||
131872505|NCT01134939|474812435|FG004|Overall Study|Termination page not available|0|||
131872506|NCT01134939|474812436|FG005|Overall Study|Termination page not available|3|||
131872507|NCT01134939|474812437|FG006|Overall Study|Termination page not available|7|||
131872508|NCT01134939|474812438|FG007|Overall Study|Termination page not available|0|||
131872509|NCT03225105|474812441|FG000|Overall Study|Withdrawal by Subject|1|||
131872510|NCT03225105|474812442|FG001|Overall Study|Withdrawal by Subject|0|||
131872511|NCT03225105|474812443|FG002|Overall Study|Withdrawal by Subject|0|||
131872512|NCT03225105|474812444|FG003|Overall Study|Withdrawal by Subject|0|||
131872513|NCT03225105|474812441|FG000|Overall Study|Death|0|||
131872514|NCT03225105|474812442|FG001|Overall Study|Death|4|||
131872515|NCT03225105|474812443|FG002|Overall Study|Death|2|||
131872516|NCT03225105|474812444|FG003|Overall Study|Death|0|||
131872517|NCT03225105|474812441|FG000|Overall Study|Study termination per Sponsor Decision|2|||
131872518|NCT03225105|474812442|FG001|Overall Study|Study termination per Sponsor Decision|0|||
131872519|NCT03225105|474812443|FG002|Overall Study|Study termination per Sponsor Decision|3|||
131872520|NCT03225105|474812444|FG003|Overall Study|Study termination per Sponsor Decision|3|||
131872521|NCT02887183|474812449|FG000|Overall Study|Adverse Event|44|||
131872522|NCT02887183|474812449|FG000|Overall Study|Death|30|||
131872523|NCT02887183|474812449|FG000|Overall Study|Pregnancy|1|||
131872524|NCT02887183|474812449|FG000|Overall Study|Protocol Violation|6|||
131872525|NCT02887183|474812449|FG000|Overall Study|Technical Problems|2|||
131872526|NCT02887183|474812449|FG000|Overall Study|Lost to Follow-up|13|||
131872527|NCT02887183|474812449|FG000|Overall Study|Physician Decision|10|||
131872528|NCT02887183|474812449|FG000|Overall Study|Withdrawal by Subject|35|||
131872529|NCT01031680|474812450|FG000|Overall Study|Adverse Event|8|||
131872530|NCT01031680|474812451|FG001|Overall Study|Adverse Event|3|||
131872531|NCT01031680|474812450|FG000|Overall Study|Lost to Follow-up|2|||
131872532|NCT01031680|474812451|FG001|Overall Study|Lost to Follow-up|10|||
131872533|NCT01031680|474812450|FG000|Overall Study|Withdrawal by Subject|12|||
131872534|NCT01031680|474812451|FG001|Overall Study|Withdrawal by Subject|16|||
131872535|NCT01031680|474812450|FG000|Overall Study|Death|2|||
131872536|NCT01031680|474812451|FG001|Overall Study|Death|1|||
131872537|NCT01031680|474812450|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
131872538|NCT01031680|474812451|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
131872539|NCT01031680|474812450|FG000|Overall Study|Poor/Non-compliance|5|||
131872540|NCT01031680|474812451|FG001|Overall Study|Poor/Non-compliance|6|||
131872541|NCT01031680|474812450|FG000|Overall Study|Safety|1|||
131872542|NCT01031680|474812451|FG001|Overall Study|Safety|0|||
131872543|NCT01031680|474812450|FG000|Overall Study|Incorrect Enrolment|1|||
131872544|NCT01031680|474812451|FG001|Overall Study|Incorrect Enrolment|2|||
131872545|NCT01031680|474812450|FG000|Overall Study|Administrative Reason by Sponsor|0|||
131872546|NCT01031680|474812451|FG001|Overall Study|Administrative Reason by Sponsor|1|||
131872547|NCT01031680|474812450|FG000|Overall Study|Various|0|||
131872548|NCT01031680|474812451|FG001|Overall Study|Various|2|||
131872549|NCT02654977|474812455|FG000|Overall Study|Death|1|||
131872550|NCT02654977|474812455|FG000|Overall Study|Lost to Follow-up|1|||
131872551|NCT02654977|474812455|FG000|Overall Study|Adverse Event|1|||
131872552|NCT02654977|474812455|FG000|Overall Study|Withdrawal by Subject|1|||
131872553|NCT02654977|474812455|FG000|Overall Study|Lack of Efficacy|3|||
131872554|NCT01921101|474812456|FG000|Overall Study|Death|16|||
131872555|NCT01921101|474812457|FG001|Overall Study|Death|6|||
131872556|NCT01483027|474812458|FG000|Overall Study|Administrative Reasons|2|||
131872557|NCT01483027|474812459|FG001|Overall Study|Administrative Reasons|1|||
131872558|NCT01483027|474812458|FG000|Overall Study|Withdrawal by Subject|21|||
131872559|NCT01483027|474812459|FG001|Overall Study|Withdrawal by Subject|32|||
131872560|NCT01483027|474812458|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
131872561|NCT01483027|474812459|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
131872562|NCT01483027|474812458|FG000|Overall Study|Lost to Follow-up|1|||
131872563|NCT01483027|474812459|FG001|Overall Study|Lost to Follow-up|1|||
131872564|NCT01483027|474812458|FG000|Overall Study|Adverse Event|0|||
131872565|NCT01483027|474812459|FG001|Overall Study|Adverse Event|1|||
131872566|NCT01483027|474812458|FG000|Overall Study|Withdrawal by Subject|0|||
131872567|NCT01483027|474812459|FG001|Overall Study|Withdrawal by Subject|1|||
131872568|NCT00734162|474814068|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
131872569|NCT00734162|474814069|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
131872570|NCT00734162|474814070|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
131872571|NCT00734162|474814071|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
131872572|NCT00734162|474814068|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
131872573|NCT00734162|474814069|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
131872574|NCT00734162|474814070|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
131872575|NCT00734162|474814071|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
131872576|NCT00734162|474814068|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
131872577|NCT00734162|474814069|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
131872578|NCT00734162|474814070|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
131872579|NCT00734162|474814071|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
131872580|NCT00734162|474814068|FG000|Open-Label Phase|Withdrew Consent|1|||
131872581|NCT00734162|474814069|FG001|Open-Label Phase|Withdrew Consent|0|||
131872582|NCT00734162|474814070|FG002|Open-Label Phase|Withdrew Consent|1|||
131872583|NCT00734162|474814071|FG003|Open-Label Phase|Withdrew Consent|1|||
131872584|NCT00734162|474814068|FG000|Open-Label Phase|Lost to Follow-up|1|||
131872585|NCT00734162|474814069|FG001|Open-Label Phase|Lost to Follow-up|2|||
131872586|NCT00734162|474814070|FG002|Open-Label Phase|Lost to Follow-up|0|||
131872587|NCT00734162|474814071|FG003|Open-Label Phase|Lost to Follow-up|1|||
131872588|NCT00734162|474814068|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
131872589|NCT00734162|474814069|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
131872590|NCT00734162|474814070|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
131872591|NCT00734162|474814071|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
131872592|NCT01288937|474814072|FG000|Overall Study|Adverse Event|1|||
131872593|NCT01288937|474814073|FG001|Overall Study|Adverse Event|0|||
131872594|NCT02490371|474814074|FG000|Overall Study|Lost to Follow-up|1|||
131872595|NCT02490371|474814075|FG001|Overall Study|Lost to Follow-up|1|||
131872596|NCT00610155|474814076|FG000|Period 1|Withdrawal by Subject|0|||
131872597|NCT00610155|474814077|FG001|Period 1|Withdrawal by Subject|0|||
131872598|NCT00610155|474814078|FG002|Period 1|Withdrawal by Subject|1|||
131872599|NCT00610155|474814079|FG003|Period 1|Withdrawal by Subject|0|||
131872600|NCT00610155|474814080|FG004|Period 1|Withdrawal by Subject|0|||
131872601|NCT00610155|474814081|FG005|Period 1|Withdrawal by Subject|0|||
131872602|NCT00610155|474814076|FG000|Period 3|Adverse Event|1|||
131872603|NCT00610155|474814077|FG001|Period 3|Adverse Event|0|||
131872604|NCT00610155|474814078|FG002|Period 3|Adverse Event|0|||
131872605|NCT00610155|474814079|FG003|Period 3|Adverse Event|0|||
131872606|NCT00610155|474814080|FG004|Period 3|Adverse Event|0|||
131872607|NCT00610155|474814081|FG005|Period 3|Adverse Event|0|||
131872608|NCT01718535|474814082|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
131872609|NCT01718535|474814083|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
131872610|NCT01718535|474814084|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
131872611|NCT01718535|474814085|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
131872612|NCT01718535|474814086|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
131872613|NCT01718535|474814087|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
131872614|NCT01718535|474814088|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
131872615|NCT01718535|474814089|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
131872616|NCT01718535|474814090|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
131872617|NCT01718535|474814091|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
131872618|NCT01073605|474814092|FG000|Overall Study|Ongoing at Cutoff Date|1|||
131872619|NCT01073605|474814093|FG001|Overall Study|Ongoing at Cutoff Date|1|||
131872620|NCT01073605|474814094|FG002|Overall Study|Ongoing at Cutoff Date|0|||
131872621|NCT01073605|474814092|FG000|Overall Study|Adverse Event|2|||
131872622|NCT01073605|474814093|FG001|Overall Study|Adverse Event|1|||
131872623|NCT01073605|474814094|FG002|Overall Study|Adverse Event|0|||
131872624|NCT01073605|474814092|FG000|Overall Study|Lost to Follow-up|3|||
131872625|NCT01073605|474814093|FG001|Overall Study|Lost to Follow-up|4|||
131872626|NCT01073605|474814094|FG002|Overall Study|Lost to Follow-up|9|||
131872627|NCT01073605|474814092|FG000|Overall Study|Other|25|||
131872628|NCT01073605|474814093|FG001|Overall Study|Other|21|||
131872629|NCT01073605|474814094|FG002|Overall Study|Other|29|||
131872630|NCT01073605|474814092|FG000|Overall Study|Withdrawal by Subject|31|||
131872631|NCT01073605|474814093|FG001|Overall Study|Withdrawal by Subject|39|||
131872632|NCT01073605|474814094|FG002|Overall Study|Withdrawal by Subject|22|||
131872633|NCT01073605|474814092|FG000|Overall Study|Randomized But Not Treated|0|||
131872634|NCT01073605|474814093|FG001|Overall Study|Randomized But Not Treated|1|||
131872635|NCT01073605|474814094|FG002|Overall Study|Randomized But Not Treated|1|||
131872636|NCT03018080|474814095|FG000|Overall Study|Death|12|||
131872637|NCT03018080|474814096|FG001|Overall Study|Death|19|||
131872638|NCT00912743|474814097|FG000|Overall Study|Adverse Event|3|||
131872639|NCT00912743|474814098|FG001|Overall Study|Adverse Event|1|||
131872640|NCT00912743|474814097|FG000|Overall Study|Lack of Efficacy|9|||
131872641|NCT00912743|474814098|FG001|Overall Study|Lack of Efficacy|18|||
131872642|NCT00912743|474814097|FG000|Overall Study|Toxicity|0|||
131872643|NCT00912743|474814098|FG001|Overall Study|Toxicity|1|||
131872644|NCT00912743|474814097|FG000|Overall Study|End of treatment form was not collected|1|||
131872645|NCT00912743|474814098|FG001|Overall Study|End of treatment form was not collected|0|||
131872646|NCT00179660|474814100|FG000|Overall Study|Adverse Event|7|||
131872647|NCT00179660|474814100|FG000|Overall Study|Lack of therapeutic effect|28|||
131872648|NCT00179660|474814100|FG000|Overall Study|Withdrawal by Subject|2|||
131872649|NCT00179660|474814100|FG000|Overall Study|Lost to Follow-up|1|||
131872650|NCT00179660|474814100|FG000|Overall Study|Death|3|||
131872651|NCT00179660|474814100|FG000|Overall Study|Other - Unspecified|9|||
131872652|NCT02875613|474814103|FG000|Overall Study|Withdrawal by Subject|1|||
131872653|NCT02875613|474814103|FG000|Overall Study|Screen Failure|1|||
131872654|NCT00178685|474814104|FG000|Overall Study|Death|3|||
131872655|NCT00178685|474814105|FG001|Overall Study|Death|3|||
131872656|NCT00178685|474814106|FG002|Overall Study|Death|6|||
131872657|NCT00178685|474814104|FG000|Overall Study|Lost to Follow-up|100|||
131872658|NCT00178685|474814105|FG001|Overall Study|Lost to Follow-up|187|||
131872659|NCT00178685|474814106|FG002|Overall Study|Lost to Follow-up|183|||
131453931|NCT00996333|473291839|FG000|Overall Study|Withdrawal by Subject|1|||
131872660|NCT00178685|474814104|FG000|Overall Study|Withdrawal by Subject|8|||
131453932|NCT00996333|473291839|FG000|Overall Study|Death|4|||
131453933|NCT00996333|473291839|FG000|Overall Study|Adverse Event|1|||
131872661|NCT00178685|474814105|FG001|Overall Study|Withdrawal by Subject|14|||
131872662|NCT00178685|474814106|FG002|Overall Study|Withdrawal by Subject|7|||
131872663|NCT00267969|474814109|FG000|Controlled Period|Adverse Event|6|||
131872664|NCT00267969|474814110|FG001|Controlled Period|Adverse Event|0|||
131872665|NCT00267969|474814111|FG002|Controlled Period|Adverse Event|2|||
131872666|NCT00267969|474814112|FG003|Controlled Period|Adverse Event|0|||
131872667|NCT00267969|474814113|FG004|Controlled Period|Adverse Event|0|||
131872668|NCT00267969|474814114|FG005|Controlled Period|Adverse Event|0|||
131872669|NCT00267969|474814115|FG006|Controlled Period|Adverse Event|0|||
131872670|NCT00267969|474814109|FG000|Controlled Period|Lack of Efficacy|3|||
131872671|NCT00267969|474814110|FG001|Controlled Period|Lack of Efficacy|0|||
131872672|NCT00267969|474814111|FG002|Controlled Period|Lack of Efficacy|1|||
131872673|NCT00267969|474814112|FG003|Controlled Period|Lack of Efficacy|0|||
131872674|NCT00267969|474814113|FG004|Controlled Period|Lack of Efficacy|0|||
131872675|NCT00267969|474814114|FG005|Controlled Period|Lack of Efficacy|0|||
131872676|NCT00267969|474814115|FG006|Controlled Period|Lack of Efficacy|0|||
131872677|NCT00267969|474814109|FG000|Controlled Period|Lost to Follow-up|1|||
131872678|NCT00267969|474814110|FG001|Controlled Period|Lost to Follow-up|0|||
131872679|NCT00267969|474814111|FG002|Controlled Period|Lost to Follow-up|1|||
131872680|NCT00267969|474814112|FG003|Controlled Period|Lost to Follow-up|0|||
131872681|NCT00267969|474814113|FG004|Controlled Period|Lost to Follow-up|0|||
131872682|NCT00267969|474814114|FG005|Controlled Period|Lost to Follow-up|0|||
131872683|NCT00267969|474814115|FG006|Controlled Period|Lost to Follow-up|0|||
131872684|NCT00267969|474814109|FG000|Controlled Period|Randomized but not treated|0|||
131872685|NCT00267969|474814110|FG001|Controlled Period|Randomized but not treated|0|||
131872686|NCT00267969|474814111|FG002|Controlled Period|Randomized but not treated|1|||
131872687|NCT00267969|474814112|FG003|Controlled Period|Randomized but not treated|0|||
131872688|NCT00267969|474814113|FG004|Controlled Period|Randomized but not treated|0|||
131872689|NCT00267969|474814114|FG005|Controlled Period|Randomized but not treated|0|||
131872690|NCT00267969|474814115|FG006|Controlled Period|Randomized but not treated|0|||
131872691|NCT00267969|474814109|FG000|Controlled Period|Other|2|||
131872692|NCT00267969|474814110|FG001|Controlled Period|Other|1|||
131872693|NCT00267969|474814111|FG002|Controlled Period|Other|6|||
131872694|NCT00267969|474814112|FG003|Controlled Period|Other|0|||
131872695|NCT00267969|474814113|FG004|Controlled Period|Other|0|||
131872696|NCT00267969|474814114|FG005|Controlled Period|Other|0|||
131872697|NCT00267969|474814115|FG006|Controlled Period|Other|0|||
131872698|NCT00267969|474814109|FG000|After Controlled Period|Adverse Event|0|||
131872699|NCT00267969|474814110|FG001|After Controlled Period|Adverse Event|0|||
131872700|NCT00267969|474814111|FG002|After Controlled Period|Adverse Event|0|||
131872701|NCT00267969|474814112|FG003|After Controlled Period|Adverse Event|7|||
131872702|NCT00267969|474814113|FG004|After Controlled Period|Adverse Event|8|||
131872703|NCT00267969|474814114|FG005|After Controlled Period|Adverse Event|23|||
131872704|NCT00267969|474814115|FG006|After Controlled Period|Adverse Event|21|||
131872705|NCT00267969|474814109|FG000|After Controlled Period|Death|0|||
131872706|NCT00267969|474814110|FG001|After Controlled Period|Death|0|||
131872707|NCT00267969|474814111|FG002|After Controlled Period|Death|0|||
131872708|NCT00267969|474814112|FG003|After Controlled Period|Death|1|||
131872709|NCT00267969|474814113|FG004|After Controlled Period|Death|2|||
131872710|NCT00267969|474814114|FG005|After Controlled Period|Death|0|||
131872711|NCT00267969|474814115|FG006|After Controlled Period|Death|1|||
131872712|NCT00267969|474814109|FG000|After Controlled Period|Lack of Efficacy|0|||
131872713|NCT00267969|474814110|FG001|After Controlled Period|Lack of Efficacy|0|||
131872714|NCT00267969|474814111|FG002|After Controlled Period|Lack of Efficacy|0|||
131872715|NCT00267969|474814112|FG003|After Controlled Period|Lack of Efficacy|10|||
131872716|NCT00267969|474814113|FG004|After Controlled Period|Lack of Efficacy|6|||
131872717|NCT00267969|474814114|FG005|After Controlled Period|Lack of Efficacy|28|||
131872718|NCT00267969|474814115|FG006|After Controlled Period|Lack of Efficacy|15|||
131872719|NCT00267969|474814109|FG000|After Controlled Period|Lost to Follow-up|0|||
131872720|NCT00267969|474814110|FG001|After Controlled Period|Lost to Follow-up|0|||
131872721|NCT00267969|474814111|FG002|After Controlled Period|Lost to Follow-up|0|||
131872722|NCT00267969|474814112|FG003|After Controlled Period|Lost to Follow-up|5|||
131872723|NCT00267969|474814113|FG004|After Controlled Period|Lost to Follow-up|8|||
131872724|NCT00267969|474814114|FG005|After Controlled Period|Lost to Follow-up|9|||
131872725|NCT00267969|474814115|FG006|After Controlled Period|Lost to Follow-up|10|||
131872726|NCT00267969|474814109|FG000|After Controlled Period|Other|0|||
131872727|NCT00267969|474814110|FG001|After Controlled Period|Other|0|||
131872728|NCT00267969|474814111|FG002|After Controlled Period|Other|0|||
131872729|NCT00267969|474814112|FG003|After Controlled Period|Other|13|||
131872730|NCT00267969|474814113|FG004|After Controlled Period|Other|11|||
131872731|NCT00267969|474814114|FG005|After Controlled Period|Other|22|||
131408279|NCT00931723|473118253|FG001|Overall Study|Severe non-compliance to protocol|0|||
131408280|NCT00931723|473118252|FG000|Overall Study|Safety reasons|0|||
131408281|NCT00931723|473118253|FG001|Overall Study|Safety reasons|1|||
131408282|NCT00931723|473118252|FG000|Overall Study|Took prohibited concomitant medication|0|||
131408283|NCT00931723|473118253|FG001|Overall Study|Took prohibited concomitant medication|1|||
131872732|NCT00267969|474814115|FG006|After Controlled Period|Other|25|||
131872733|NCT02308540|474814120|FG000|Overall Study|Lost to Follow-up|0|||
131872734|NCT02308540|474814121|FG001|Overall Study|Lost to Follow-up|0|||
131872735|NCT02308540|474814122|FG002|Overall Study|Lost to Follow-up|0|||
131872736|NCT02308540|474814123|FG003|Overall Study|Lost to Follow-up|0|||
131872737|NCT02308540|474814124|FG004|Overall Study|Lost to Follow-up|0|||
131872738|NCT02308540|474814125|FG005|Overall Study|Lost to Follow-up|1|||
131872739|NCT02285166|474814126|FG000|Overall Study|Case Report Forms Uncollected|564|||
131872740|NCT02285166|474814126|FG000|Overall Study|Protocol Deviation|402|||
131872741|NCT00443079|474814127|FG000|Overall Study|Lost to Follow-up|0|||
131872742|NCT00443079|474814128|FG001|Overall Study|Lost to Follow-up|1|||
131872743|NCT02792192|474814129|FG000|Overall Study|Death|1|||
131872744|NCT02792192|474814130|FG001|Overall Study|Death|0|||
131872745|NCT02792192|474814131|FG002|Overall Study|Death|0|||
131872746|NCT02792192|474814132|FG003|Overall Study|Death|0|||
131872747|NCT02792192|474814129|FG000|Overall Study|Informed Consent Withdrawn|4|||
131872748|NCT02792192|474814130|FG001|Overall Study|Informed Consent Withdrawn|0|||
131872749|NCT02792192|474814131|FG002|Overall Study|Informed Consent Withdrawn|0|||
131872750|NCT02792192|474814132|FG003|Overall Study|Informed Consent Withdrawn|0|||
131872751|NCT02792192|474814129|FG000|Overall Study|Physician Decision|1|||
131872752|NCT02792192|474814130|FG001|Overall Study|Physician Decision|0|||
131872753|NCT02792192|474814131|FG002|Overall Study|Physician Decision|0|||
131872754|NCT02792192|474814132|FG003|Overall Study|Physician Decision|0|||
131872755|NCT02792192|474814129|FG000|Overall Study|Progressive Disease|0|||
131872756|NCT02792192|474814130|FG001|Overall Study|Progressive Disease|1|||
131872757|NCT02792192|474814131|FG002|Overall Study|Progressive Disease|0|||
131872758|NCT02792192|474814132|FG003|Overall Study|Progressive Disease|0|||
131872759|NCT02792192|474814129|FG000|Overall Study|Study Terminated By Sponsor|6|||
131872760|NCT02792192|474814130|FG001|Overall Study|Study Terminated By Sponsor|10|||
131872761|NCT02792192|474814131|FG002|Overall Study|Study Terminated By Sponsor|0|||
131872762|NCT02792192|474814132|FG003|Overall Study|Study Terminated By Sponsor|0|||
131872763|NCT02320058|474814133|FG000|Overall Study|Death|25|||
131872764|NCT02320058|474814134|FG001|Overall Study|Death|10|||
131872765|NCT02320058|474814133|FG000|Overall Study|Lost to Follow-up|4|||
131872766|NCT02320058|474814134|FG001|Overall Study|Lost to Follow-up|0|||
131872767|NCT02320058|474814133|FG000|Overall Study|Other reasons|4|||
131872768|NCT02320058|474814134|FG001|Overall Study|Other reasons|1|||
131872769|NCT02320058|474814133|FG000|Overall Study|Withdrawal by Subject|8|||
131872770|NCT02320058|474814134|FG001|Overall Study|Withdrawal by Subject|2|||
131872771|NCT02320058|474814133|FG000|Overall Study|Not reported|1|||
131872772|NCT02320058|474814134|FG001|Overall Study|Not reported|0|||
131872773|NCT01339923|474814135|FG000|Overall Study|Adverse Event|1|||
131872774|NCT01339923|474814136|FG001|Overall Study|Adverse Event|1|||
131872775|NCT01339923|474814137|FG002|Overall Study|Adverse Event|1|||
131872776|NCT01339923|474814138|FG003|Overall Study|Adverse Event|0|||
131872777|NCT01339923|474814139|FG004|Overall Study|Adverse Event|0|||
131872778|NCT01339923|474814140|FG005|Overall Study|Adverse Event|0|||
131872779|NCT01339923|474814141|FG006|Overall Study|Adverse Event|1|||
131872780|NCT01339923|474814135|FG000|Overall Study|Inappropriate Enrollment|1|||
131872781|NCT01339923|474814136|FG001|Overall Study|Inappropriate Enrollment|0|||
131872782|NCT01339923|474814137|FG002|Overall Study|Inappropriate Enrollment|0|||
131872783|NCT01339923|474814138|FG003|Overall Study|Inappropriate Enrollment|0|||
131872784|NCT01339923|474814139|FG004|Overall Study|Inappropriate Enrollment|0|||
131872785|NCT01339923|474814140|FG005|Overall Study|Inappropriate Enrollment|1|||
131872786|NCT01339923|474814141|FG006|Overall Study|Inappropriate Enrollment|0|||
131872787|NCT01339923|474814135|FG000|Overall Study|Lost to Follow-up|4|||
131872788|NCT01339923|474814136|FG001|Overall Study|Lost to Follow-up|4|||
131872789|NCT01339923|474814137|FG002|Overall Study|Lost to Follow-up|0|||
131872790|NCT01339923|474814138|FG003|Overall Study|Lost to Follow-up|3|||
131872791|NCT01339923|474814139|FG004|Overall Study|Lost to Follow-up|1|||
131872792|NCT01339923|474814140|FG005|Overall Study|Lost to Follow-up|1|||
131872793|NCT01339923|474814141|FG006|Overall Study|Lost to Follow-up|5|||
131872794|NCT01339923|474814135|FG000|Overall Study|Protocol Violation|0|||
131872795|NCT01339923|474814136|FG001|Overall Study|Protocol Violation|0|||
131872796|NCT01339923|474814137|FG002|Overall Study|Protocol Violation|0|||
131872797|NCT01339923|474814138|FG003|Overall Study|Protocol Violation|0|||
131872798|NCT01339923|474814139|FG004|Overall Study|Protocol Violation|0|||
131872799|NCT01339923|474814140|FG005|Overall Study|Protocol Violation|3|||
131872800|NCT01339923|474814141|FG006|Overall Study|Protocol Violation|1|||
131872801|NCT01339923|474814135|FG000|Overall Study|Unable to Classify|1|||
131872802|NCT01339923|474814136|FG001|Overall Study|Unable to Classify|0|||
131872803|NCT01339923|474814137|FG002|Overall Study|Unable to Classify|1|||
131872804|NCT01339923|474814138|FG003|Overall Study|Unable to Classify|0|||
131872805|NCT01339923|474814139|FG004|Overall Study|Unable to Classify|0|||
131872806|NCT01339923|474814140|FG005|Overall Study|Unable to Classify|1|||
131872807|NCT01339923|474814141|FG006|Overall Study|Unable to Classify|5|||
131872808|NCT01339923|474814135|FG000|Overall Study|Withdrawal by Subject|7|||
131872809|NCT01339923|474814136|FG001|Overall Study|Withdrawal by Subject|11|||
131872810|NCT01339923|474814137|FG002|Overall Study|Withdrawal by Subject|6|||
131872811|NCT01339923|474814138|FG003|Overall Study|Withdrawal by Subject|1|||
131872812|NCT01339923|474814139|FG004|Overall Study|Withdrawal by Subject|4|||
131872813|NCT01339923|474814140|FG005|Overall Study|Withdrawal by Subject|3|||
131872814|NCT01339923|474814141|FG006|Overall Study|Withdrawal by Subject|2|||
131872815|NCT00729157|474814142|FG000|Overall Study|Withdrawal by Subject|1|||
131872816|NCT01430403|474814148|FG000|Overall Study|Lost to Follow-up|5|||
131872817|NCT01430403|474814149|FG001|Overall Study|Lost to Follow-up|5|||
131872818|NCT01430403|474814150|FG002|Overall Study|Lost to Follow-up|3|||
131872819|NCT01430403|474814148|FG000|Overall Study|Physician Decision|1|||
131872820|NCT01430403|474814149|FG001|Overall Study|Physician Decision|0|||
131872821|NCT01430403|474814150|FG002|Overall Study|Physician Decision|0|||
131872822|NCT01430403|474814148|FG000|Overall Study|Protocol Violation|2|||
131872823|NCT01430403|474814149|FG001|Overall Study|Protocol Violation|3|||
131872824|NCT01430403|474814150|FG002|Overall Study|Protocol Violation|2|||
131872825|NCT01430403|474814148|FG000|Overall Study|Withdrawal by Subject|9|||
131872826|NCT01430403|474814149|FG001|Overall Study|Withdrawal by Subject|1|||
131872827|NCT01430403|474814150|FG002|Overall Study|Withdrawal by Subject|3|||
131872828|NCT04481789|474814151|FG000|Period 1|Withdrawal by Subject|1|||
131872829|NCT04481789|474814152|FG001|Period 1|Withdrawal by Subject|0|||
131872830|NCT04481789|474814153|FG002|Period 1|Withdrawal by Subject|0|||
131872831|NCT04481789|474814154|FG003|Period 1|Withdrawal by Subject|0|||
131872832|NCT04481789|474814155|FG004|Period 1|Withdrawal by Subject|0|||
131872833|NCT04481789|474814156|FG005|Period 1|Withdrawal by Subject|0|||
131872834|NCT03124407|474814163|FG000|Overall Study|Lost to Follow-up|1|||
131872835|NCT03124407|474814164|FG001|Overall Study|Lost to Follow-up|0|||
131872836|NCT03124407|474814165|FG002|Overall Study|Lost to Follow-up|0|||
131872837|NCT03124407|474814166|FG003|Overall Study|Lost to Follow-up|0|||
131872838|NCT03124407|474814163|FG000|Overall Study|Adverse Event|0|||
131872839|NCT03124407|474814164|FG001|Overall Study|Adverse Event|0|||
131872840|NCT03124407|474814165|FG002|Overall Study|Adverse Event|1|||
131872841|NCT03124407|474814166|FG003|Overall Study|Adverse Event|0|||
131872842|NCT00396656|474814167|FG000|First Treatment Period|Withdrawal by Subject|0|||
131872843|NCT00396656|474814168|FG001|First Treatment Period|Withdrawal by Subject|2|||
131872844|NCT00396656|474814167|FG000|Second Treatment Period|Adverse Event|0|||
131872845|NCT00396656|474814168|FG001|Second Treatment Period|Adverse Event|1|||
131872846|NCT02821754|474814169|FG000|Overall Study|Procedure not required prior to amendment change|13|||
131872847|NCT02821754|474814170|FG001|Overall Study|Procedure not required prior to amendment change|11|||
131872848|NCT02821754|474814171|FG002|Overall Study|Procedure not required prior to amendment change|0|||
131872849|NCT02821754|474814169|FG000|Overall Study|Participant's Clinical status|2|||
131872850|NCT02821754|474814170|FG001|Overall Study|Participant's Clinical status|0|||
131872851|NCT02821754|474814171|FG002|Overall Study|Participant's Clinical status|0|||
131872852|NCT02821754|474814169|FG000|Overall Study|Participant removed for noncompliance|1|||
131872853|NCT02821754|474814170|FG001|Overall Study|Participant removed for noncompliance|0|||
131872854|NCT02821754|474814171|FG002|Overall Study|Participant removed for noncompliance|0|||
131872855|NCT02821754|474814169|FG000|Overall Study|Drug not available.|0|||
131872856|NCT02821754|474814170|FG001|Overall Study|Drug not available.|0|||
131872857|NCT02821754|474814171|FG002|Overall Study|Drug not available.|1|||
131872858|NCT02821754|474814169|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
131872859|NCT02821754|474814170|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
131872860|NCT02821754|474814171|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
131872861|NCT02477332|474814181|FG000|Overall Study|Adverse Event|0|||
131872862|NCT02477332|474814182|FG001|Overall Study|Adverse Event|1|||
131872863|NCT02477332|474814183|FG002|Overall Study|Adverse Event|1|||
131872864|NCT02477332|474814184|FG003|Overall Study|Adverse Event|2|||
131872865|NCT02477332|474814185|FG004|Overall Study|Adverse Event|1|||
131872866|NCT02477332|474814186|FG005|Overall Study|Adverse Event|2|||
131872867|NCT02477332|474814181|FG000|Overall Study|Lack of Efficacy|1|||
131872868|NCT02477332|474814182|FG001|Overall Study|Lack of Efficacy|2|||
131872869|NCT02477332|474814183|FG002|Overall Study|Lack of Efficacy|1|||
131872870|NCT02477332|474814184|FG003|Overall Study|Lack of Efficacy|2|||
131872871|NCT02477332|474814185|FG004|Overall Study|Lack of Efficacy|1|||
131872872|NCT02477332|474814186|FG005|Overall Study|Lack of Efficacy|1|||
131872873|NCT02477332|474814181|FG000|Overall Study|Non-compliance with study treatment|0|||
131872874|NCT02477332|474814182|FG001|Overall Study|Non-compliance with study treatment|1|||
131872875|NCT02477332|474814183|FG002|Overall Study|Non-compliance with study treatment|2|||
131872876|NCT02477332|474814184|FG003|Overall Study|Non-compliance with study treatment|0|||
131872877|NCT02477332|474814185|FG004|Overall Study|Non-compliance with study treatment|0|||
131872878|NCT02477332|474814186|FG005|Overall Study|Non-compliance with study treatment|0|||
131872879|NCT02477332|474814181|FG000|Overall Study|Pregnancy|0|||
131872880|NCT02477332|474814182|FG001|Overall Study|Pregnancy|0|||
131872881|NCT02477332|474814183|FG002|Overall Study|Pregnancy|0|||
131872882|NCT02477332|474814184|FG003|Overall Study|Pregnancy|1|||
131872883|NCT02477332|474814185|FG004|Overall Study|Pregnancy|0|||
131872884|NCT02477332|474814186|FG005|Overall Study|Pregnancy|0|||
131872885|NCT02477332|474814181|FG000|Overall Study|Protocol Violation|2|||
131872886|NCT02477332|474814182|FG001|Overall Study|Protocol Violation|0|||
131872887|NCT02477332|474814183|FG002|Overall Study|Protocol Violation|3|||
131872888|NCT02477332|474814184|FG003|Overall Study|Protocol Violation|3|||
131872889|NCT02477332|474814185|FG004|Overall Study|Protocol Violation|1|||
131872890|NCT02477332|474814186|FG005|Overall Study|Protocol Violation|1|||
131872891|NCT02477332|474814181|FG000|Overall Study|Technical problems|0|||
131872892|NCT02477332|474814182|FG001|Overall Study|Technical problems|0|||
131872893|NCT02477332|474814183|FG002|Overall Study|Technical problems|1|||
131872894|NCT02477332|474814184|FG003|Overall Study|Technical problems|0|||
131872895|NCT02477332|474814185|FG004|Overall Study|Technical problems|0|||
131872896|NCT02477332|474814186|FG005|Overall Study|Technical problems|0|||
131872897|NCT02477332|474814181|FG000|Overall Study|Lost to Follow-up|0|||
131872898|NCT02477332|474814182|FG001|Overall Study|Lost to Follow-up|0|||
131872899|NCT02477332|474814183|FG002|Overall Study|Lost to Follow-up|2|||
131872900|NCT02477332|474814184|FG003|Overall Study|Lost to Follow-up|0|||
131872901|NCT02477332|474814185|FG004|Overall Study|Lost to Follow-up|0|||
131872902|NCT02477332|474814186|FG005|Overall Study|Lost to Follow-up|0|||
131872903|NCT02477332|474814181|FG000|Overall Study|Physician Decision|0|||
131872904|NCT02477332|474814182|FG001|Overall Study|Physician Decision|0|||
131872905|NCT02477332|474814183|FG002|Overall Study|Physician Decision|1|||
131872906|NCT02477332|474814184|FG003|Overall Study|Physician Decision|3|||
131872907|NCT02477332|474814185|FG004|Overall Study|Physician Decision|0|||
131872908|NCT02477332|474814186|FG005|Overall Study|Physician Decision|1|||
131872909|NCT02477332|474814181|FG000|Overall Study|Withdrawal by Subject|0|||
131872910|NCT02477332|474814182|FG001|Overall Study|Withdrawal by Subject|3|||
131872911|NCT02477332|474814183|FG002|Overall Study|Withdrawal by Subject|1|||
131872912|NCT02477332|474814184|FG003|Overall Study|Withdrawal by Subject|2|||
131872913|NCT02477332|474814185|FG004|Overall Study|Withdrawal by Subject|1|||
131872914|NCT02477332|474814186|FG005|Overall Study|Withdrawal by Subject|0|||
131872915|NCT02549287|474814187|FG000|Overall Study|Lost to Follow-up|65|||
131872916|NCT02549287|474814188|FG001|Overall Study|Lost to Follow-up|26|||
131872917|NCT02549287|474814187|FG000|Overall Study|Withdrawal by Subject|15|||
131872918|NCT02549287|474814188|FG001|Overall Study|Withdrawal by Subject|6|||
131872919|NCT03793842|474814189|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
131872920|NCT03793842|474814190|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
131872921|NCT03793842|474814189|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
131872922|NCT03793842|474814190|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
131872923|NCT00427921|474814191|FG000|Overall Study|Adverse Event|26|||
131872924|NCT00427921|474814191|FG000|Overall Study|Withdrawal by Subject|4|||
131872925|NCT00427921|474814191|FG000|Overall Study|Lost to Follow-up|2|||
131872926|NCT00427921|474814191|FG000|Overall Study|Other reason not specified|10|||
131872927|NCT00427921|474814191|FG000|Overall Study|Adverse Event + Hospitalization|1|||
131872928|NCT00427921|474814191|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
131872929|NCT00427921|474814191|FG000|Overall Study|Adverse Event + No Response|1|||
131872930|NCT00427921|474814191|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
131872931|NCT00427921|474814191|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
131872932|NCT00427921|474814191|FG000|Overall Study|Adverse Event + Lost Response|1|||
131872933|NCT00427921|474814191|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
131872934|NCT00427921|474814191|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
131872935|NCT01166438|474814192|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
131872936|NCT01166438|474814193|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
131872937|NCT01166438|474814192|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
131872938|NCT01166438|474814193|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
131872939|NCT01166438|474814192|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
131872940|NCT01166438|474814193|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
131872941|NCT01166438|474814192|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
131872942|NCT01166438|474814193|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
131872943|NCT01166438|474814192|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
131872944|NCT01166438|474814193|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
131872945|NCT01166438|474814192|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
131872946|NCT01166438|474814193|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
131872947|NCT01377922|474814200|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
131872948|NCT01377922|474814201|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
131872949|NCT00347009|474814202|FG000|Overall Study|Death|1|||
131872950|NCT00347009|474814202|FG000|Overall Study|Adverse Event|6|||
131872951|NCT00347009|474814202|FG000|Overall Study|Withdrawal by Subject|3|||
131872952|NCT00347009|474814202|FG000|Overall Study|Physician Decision|5|||
131872953|NCT00347009|474814202|FG000|Overall Study|Lost to Follow-up|4|||
131872954|NCT00347009|474814202|FG000|Overall Study|Protocol Violation|2|||
131872955|NCT00347009|474814202|FG000|Overall Study|Adverse Laboratory Experience|1|||
131872956|NCT00347009|474814202|FG000|Overall Study|Insufficient Viral Suppression|3|||
131872957|NCT00347009|474814202|FG000|Overall Study|Increased ALT/HBV DNA|1|||
131872958|NCT00347009|474814202|FG000|Overall Study|Serious Adverse Event|1|||
131872959|NCT00733421|474814204|FG000|Overall Study|Withdrawal by Subject|1|||
131872960|NCT00733421|474814205|FG001|Overall Study|Withdrawal by Subject|1|||
131872961|NCT02547220|474814208|FG000|Overall Study|Withdrawal by Subject|1|||
131872962|NCT02547220|474814209|FG001|Overall Study|Withdrawal by Subject|0|||
131872963|NCT02547220|474814208|FG000|Overall Study|Study terminated by sponsor|18|||
131872964|NCT02547220|474814209|FG001|Overall Study|Study terminated by sponsor|20|||
131872965|NCT00550043|474814210|FG000|Overall Study|Adverse Event|0|||
131872966|NCT00550043|474814211|FG001|Overall Study|Adverse Event|0|||
131872967|NCT00550043|474814212|FG002|Overall Study|Adverse Event|0|||
131872968|NCT00550043|474814213|FG003|Overall Study|Adverse Event|1|||
131872969|NCT00550043|474814214|FG004|Overall Study|Adverse Event|1|||
131872970|NCT00550043|474814210|FG000|Overall Study|Subject Withdrew Consent|0|||
131872971|NCT00550043|474814211|FG001|Overall Study|Subject Withdrew Consent|2|||
131872972|NCT00550043|474814212|FG002|Overall Study|Subject Withdrew Consent|1|||
131872973|NCT00550043|474814213|FG003|Overall Study|Subject Withdrew Consent|0|||
131872974|NCT00550043|474814214|FG004|Overall Study|Subject Withdrew Consent|0|||
131872975|NCT00550043|474814210|FG000|Overall Study|Other Reasons- Unspecified|0|||
131872976|NCT00550043|474814211|FG001|Overall Study|Other Reasons- Unspecified|1|||
131872977|NCT00550043|474814212|FG002|Overall Study|Other Reasons- Unspecified|0|||
131872978|NCT00550043|474814213|FG003|Overall Study|Other Reasons- Unspecified|1|||
131872979|NCT00550043|474814214|FG004|Overall Study|Other Reasons- Unspecified|0|||
131872980|NCT04185220|474814215|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
131872981|NCT04185220|474814216|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
131872982|NCT04185220|474814215|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
131872983|NCT04185220|474814216|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
131872984|NCT03478644|474814217|FG000|Phase 2|Withdrawal by Subject|2|||
131872985|NCT03478644|474814218|FG001|Phase 2|Withdrawal by Subject|1|||
131872986|NCT03478644|474814217|FG000|Phase 2|Lost to Follow-up|1|||
131872987|NCT03478644|474814218|FG001|Phase 2|Lost to Follow-up|0|||
131872988|NCT01029782|474814219|FG000|Overall Study|Lost to Follow-up|2|||
131872989|NCT01029782|474814220|FG001|Overall Study|Lost to Follow-up|2|||
131872990|NCT01029782|474814219|FG000|Overall Study|Diagnosis changed|1|||
131872991|NCT01029782|474814220|FG001|Overall Study|Diagnosis changed|1|||
131872992|NCT01029782|474814219|FG000|Overall Study|Adverse Event|0|||
131872993|NCT01029782|474814220|FG001|Overall Study|Adverse Event|1|||
131872994|NCT01029782|474814219|FG000|Overall Study|Physician Decision|0|||
131872995|NCT01029782|474814220|FG001|Overall Study|Physician Decision|1|||
131872996|NCT01029782|474814219|FG000|Overall Study|Protocol Violation|0|||
131872997|NCT01029782|474814220|FG001|Overall Study|Protocol Violation|2|||
131872998|NCT01029782|474814219|FG000|Overall Study|Withdrawal by Subject|0|||
131872999|NCT01029782|474814220|FG001|Overall Study|Withdrawal by Subject|1|||
131873000|NCT02195869|474814222|FG000|Overall Study|cGVHD Progression|5|||
131873001|NCT02195869|474814222|FG000|Overall Study|Malignancy Progression/relapse|2|||
131873002|NCT02195869|474814222|FG000|Overall Study|Adverse Event|15|||
131873003|NCT02195869|474814222|FG000|Overall Study|Withdrawal by Subject|7|||
131873004|NCT02195869|474814222|FG000|Overall Study|Physician Decision|4|||
131873005|NCT02195869|474814222|FG000|Overall Study|Study Terminated by Sponsor|7|||
131873006|NCT02195869|474814222|FG000|Overall Study|Noncompliance with study drug|2|||
131873007|NCT00789698|474814223|FG000|Overall Study|Lack of Efficacy|10|||
131873008|NCT00789698|474814224|FG001|Overall Study|Lack of Efficacy|4|||
131873009|NCT00789698|474814225|FG002|Overall Study|Lack of Efficacy|5|||
131873010|NCT00789698|474814226|FG003|Overall Study|Lack of Efficacy|18|||
131873011|NCT00789698|474814223|FG000|Overall Study|Adverse Event|5|||
131873012|NCT00789698|474814224|FG001|Overall Study|Adverse Event|5|||
131873013|NCT00789698|474814225|FG002|Overall Study|Adverse Event|3|||
131873014|NCT00789698|474814226|FG003|Overall Study|Adverse Event|4|||
131873015|NCT00789698|474814223|FG000|Overall Study|Lost to Follow-up|5|||
131873016|NCT00789698|474814224|FG001|Overall Study|Lost to Follow-up|5|||
131873017|NCT00789698|474814225|FG002|Overall Study|Lost to Follow-up|2|||
131873018|NCT00789698|474814226|FG003|Overall Study|Lost to Follow-up|9|||
131873019|NCT00789698|474814223|FG000|Overall Study|Protocol Violation|6|||
131873020|NCT00789698|474814224|FG001|Overall Study|Protocol Violation|1|||
131873021|NCT00789698|474814225|FG002|Overall Study|Protocol Violation|2|||
131873022|NCT00789698|474814226|FG003|Overall Study|Protocol Violation|1|||
131873023|NCT00789698|474814223|FG000|Overall Study|Withdrawal by Subject|14|||
131873024|NCT00789698|474814224|FG001|Overall Study|Withdrawal by Subject|15|||
131873025|NCT00789698|474814225|FG002|Overall Study|Withdrawal by Subject|12|||
131873026|NCT00789698|474814226|FG003|Overall Study|Withdrawal by Subject|19|||
131873027|NCT00789698|474814223|FG000|Overall Study|Administrative|0|||
131873028|NCT00789698|474814224|FG001|Overall Study|Administrative|3|||
131873029|NCT00789698|474814225|FG002|Overall Study|Administrative|3|||
131873030|NCT00789698|474814226|FG003|Overall Study|Administrative|1|||
131873031|NCT03300505|474815475|FG000|Overall Study|Death|0|||
131919540|NCT02493855|474989281|FG000|Overall Study|Adverse Event|0|||
131919541|NCT02493855|474989282|FG001|Overall Study|Adverse Event|1|||
131919542|NCT02493855|474989283|FG002|Overall Study|Adverse Event|0|||
131873032|NCT03300505|474815476|FG001|Overall Study|Death|1|||
131873033|NCT03300505|474815477|FG002|Overall Study|Death|0|||
131873034|NCT03300505|474815475|FG000|Overall Study|Withdrawal by Subject|0|||
131873035|NCT03300505|474815476|FG001|Overall Study|Withdrawal by Subject|1|||
131873036|NCT03300505|474815477|FG002|Overall Study|Withdrawal by Subject|1|||
131873037|NCT03300505|474815475|FG000|Overall Study|Sponsor Termination|0|||
131873038|NCT03300505|474815476|FG001|Overall Study|Sponsor Termination|1|||
131873039|NCT03300505|474815477|FG002|Overall Study|Sponsor Termination|0|||
131873040|NCT03300505|474815475|FG000|Overall Study|Adverse Event|0|||
131873041|NCT03300505|474815476|FG001|Overall Study|Adverse Event|0|||
131873042|NCT03300505|474815477|FG002|Overall Study|Adverse Event|2|||
131919543|NCT02493855|474989281|FG000|Overall Study|Withdrawal by Subject|1|||
131873043|NCT05119595|474815478|FG000|Overall Study|Death|1|||
131873044|NCT05119595|474815478|FG000|Overall Study|Lost to Follow-up|7|||
131873045|NCT00679029|474815479|FG000|Overall Study|Adverse Event|3|||
131873046|NCT00679029|474815479|FG000|Overall Study|Withdrawal by Subject|1|||
131873047|NCT00679029|474815479|FG000|Overall Study|Lost to Follow-up|1|||
131873048|NCT01108341|474815480|FG000|Overall Study|Death|2|||
131873049|NCT01108341|474815480|FG000|Overall Study|Withdrawal by Subject|1|||
131873050|NCT01108341|474815480|FG000|Overall Study|Lost to Follow-up|1|||
131873051|NCT01108341|474815480|FG000|Overall Study|Other|1|||
131873052|NCT04402138|474815483|FG000|Overall Study|Progressive Disease|2|||
131873053|NCT04402138|474815483|FG000|Overall Study|Adverse Event|1|||
131873054|NCT03056638|474815486|FG000|Overall Study|Death|1|||
131873055|NCT03056638|474815487|FG001|Overall Study|Death|0|||
131873056|NCT00468481|474815488|FG000|Overall Study|Adverse Event|13|||
131873057|NCT00468481|474815489|FG001|Overall Study|Adverse Event|3|||
131873058|NCT00468481|474815488|FG000|Overall Study|Lost to Follow-up|25|||
131873059|NCT00468481|474815489|FG001|Overall Study|Lost to Follow-up|8|||
131873060|NCT00468481|474815488|FG000|Overall Study|Pregnancy|2|||
131873061|NCT00468481|474815489|FG001|Overall Study|Pregnancy|0|||
131873062|NCT00468481|474815488|FG000|Overall Study|Protocol Violation|18|||
131873063|NCT00468481|474815489|FG001|Overall Study|Protocol Violation|8|||
131873064|NCT00468481|474815488|FG000|Overall Study|Withdrawal by Subject|12|||
131873065|NCT00468481|474815489|FG001|Overall Study|Withdrawal by Subject|3|||
131873066|NCT00468481|474815488|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
131873067|NCT00468481|474815489|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
131873068|NCT00468481|474815488|FG000|Overall Study|Prohibited Medication|1|||
131873069|NCT00468481|474815489|FG001|Overall Study|Prohibited Medication|1|||
131873070|NCT00468481|474815488|FG000|Overall Study|Egg Donor|1|||
131873071|NCT00468481|474815489|FG001|Overall Study|Egg Donor|0|||
131873072|NCT00468481|474815488|FG000|Overall Study|Moved out of area|4|||
131873073|NCT00468481|474815489|FG001|Overall Study|Moved out of area|1|||
131873074|NCT00468481|474815488|FG000|Overall Study|Non-Compliance|5|||
131873075|NCT00468481|474815489|FG001|Overall Study|Non-Compliance|0|||
131873076|NCT00468481|474815488|FG000|Overall Study|Other|6|||
131873077|NCT00468481|474815489|FG001|Overall Study|Other|0|||
131873078|NCT00596687|474815490|FG000|Overall Study|< 24 hours of insulin treatment|8|||
131873079|NCT00596687|474815491|FG001|Overall Study|< 24 hours of insulin treatment|6|||
131873080|NCT00596687|474815490|FG000|Overall Study|continuous insulin infusion during TPN|2|||
131873081|NCT00596687|474815491|FG001|Overall Study|continuous insulin infusion during TPN|1|||
131873082|NCT00596687|474815490|FG000|Overall Study|Withdrawal by Subject|3|||
131873083|NCT00596687|474815491|FG001|Overall Study|Withdrawal by Subject|1|||
131873084|NCT00596687|474815490|FG000|Overall Study|cancelled surgery|1|||
131873085|NCT00596687|474815491|FG001|Overall Study|cancelled surgery|1|||
131873086|NCT03831113|474815492|FG000|Overall Study|Withdrawal by Subject|0|||
131873087|NCT03831113|474815493|FG001|Overall Study|Withdrawal by Subject|2|||
131873088|NCT03831113|474815492|FG000|Overall Study|Protocol Violation|0|||
131873089|NCT03831113|474815493|FG001|Overall Study|Protocol Violation|9|||
131873090|NCT03508726|474815494|FG000|Overall Study|Withdrawal by Subject|0|||
131873091|NCT03508726|474815495|FG001|Overall Study|Withdrawal by Subject|1|||
131873092|NCT01515865|474815497|FG000|Part A (Open-label)|Other|3|||
131873093|NCT01515865|474815498|FG001|Part A (Open-label)|Other|0|||
131873094|NCT01515865|474815499|FG002|Part A (Open-label)|Other|0|||
131873095|NCT01515865|474815497|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
131873096|NCT01515865|474815498|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
131873097|NCT01515865|474815499|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
131873098|NCT01515865|474815497|FG000|Part B (Open-label)|Other|1|||
131873099|NCT01515865|474815498|FG001|Part B (Open-label)|Other|0|||
131873100|NCT01515865|474815499|FG002|Part B (Open-label)|Other|0|||
131873101|NCT01284348|474815502|FG000|Overall Study|Death|1|||
131873102|NCT01284348|474815503|FG001|Overall Study|Death|1|||
131873103|NCT01284348|474815502|FG000|Overall Study|Withdrew consent|0|||
131873104|NCT01284348|474815503|FG001|Overall Study|Withdrew consent|1|||
131873105|NCT01284348|474815502|FG000|Overall Study|Status not recorded|9|||
131873106|NCT01284348|474815503|FG001|Overall Study|Status not recorded|10|||
131873107|NCT03645395|474815510|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
131873108|NCT03645395|474815511|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
131873109|NCT03645395|474815512|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
131873110|NCT03645395|474815513|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
131873111|NCT03645395|474815510|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
131873112|NCT03645395|474815511|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
131873113|NCT03645395|474815512|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
131873114|NCT03645395|474815513|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
131453934|NCT00996333|473291839|FG000|Overall Study|Physician Decision|1|||
131873115|NCT03645395|474815510|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
131873116|NCT03645395|474815511|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
131873117|NCT03645395|474815512|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
131873118|NCT03645395|474815513|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
131873119|NCT03645395|474815510|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
131873120|NCT03645395|474815511|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
131873121|NCT03645395|474815512|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
131873122|NCT03645395|474815513|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
131873123|NCT01057810|474815514|FG000|Overall Study|Disease progression|156|||
131873124|NCT01057810|474815515|FG001|Overall Study|Disease progression|197|||
131873125|NCT01057810|474815514|FG000|Overall Study|Study drug toxicity|5|||
131873126|NCT01057810|474815515|FG001|Overall Study|Study drug toxicity|114|||
131873127|NCT01057810|474815514|FG000|Overall Study|Adverse event unrelated to study drug|13|||
131873128|NCT01057810|474815515|FG001|Overall Study|Adverse event unrelated to study drug|29|||
131873129|NCT01057810|474815514|FG000|Overall Study|Withdrawal by Subject|10|||
131873130|NCT01057810|474815515|FG001|Overall Study|Withdrawal by Subject|25|||
131873131|NCT01057810|474815514|FG000|Overall Study|Death|2|||
131873132|NCT01057810|474815515|FG001|Overall Study|Death|12|||
131873133|NCT01057810|474815514|FG000|Overall Study|Maximum clinical benefit|5|||
131873134|NCT01057810|474815515|FG001|Overall Study|Maximum clinical benefit|5|||
131873135|NCT01057810|474815514|FG000|Overall Study|Poor/non-compliance|0|||
131873136|NCT01057810|474815515|FG001|Overall Study|Poor/non-compliance|1|||
131873137|NCT01057810|474815514|FG000|Overall Study|No longer met study criteria|0|||
131873138|NCT01057810|474815515|FG001|Overall Study|No longer met study criteria|1|||
131873139|NCT01057810|474815514|FG000|Overall Study|Other|7|||
131873140|NCT01057810|474815515|FG001|Overall Study|Other|14|||
131873141|NCT02088905|474815516|FG000|Overall Study|Withdrawal by Subject|5|||
131873142|NCT02088905|474815517|FG001|Overall Study|Withdrawal by Subject|1|||
131873143|NCT01091662|474815518|FG000|Overall Study|Adverse Event|1|||
131873144|NCT01091662|474815519|FG001|Overall Study|Adverse Event|9|||
131873145|NCT01091662|474815518|FG000|Overall Study|Physician Decision|1|||
131873146|NCT01091662|474815519|FG001|Overall Study|Physician Decision|1|||
131873147|NCT01091662|474815518|FG000|Overall Study|Withdrawal by Subject|7|||
131873148|NCT01091662|474815519|FG001|Overall Study|Withdrawal by Subject|6|||
131873149|NCT01091662|474815518|FG000|Overall Study|met exit criteria|7|||
131873150|NCT01091662|474815519|FG001|Overall Study|met exit criteria|13|||
131873151|NCT01091662|474815518|FG000|Overall Study|met exclusion criteria|1|||
131873152|NCT01091662|474815519|FG001|Overall Study|met exclusion criteria|0|||
131873153|NCT01091662|474815518|FG000|Overall Study|Lost to Follow-up|0|||
131873154|NCT01091662|474815519|FG001|Overall Study|Lost to Follow-up|1|||
131873155|NCT01091662|474815518|FG000|Overall Study|Pregnancy|0|||
131873156|NCT01091662|474815519|FG001|Overall Study|Pregnancy|1|||
131873157|NCT01091662|474815518|FG000|Overall Study|Protocol Violation|0|||
131873158|NCT01091662|474815519|FG001|Overall Study|Protocol Violation|2|||
131873159|NCT01091662|474815518|FG000|Overall Study|unable to swallow capsule|0|||
131873160|NCT01091662|474815519|FG001|Overall Study|unable to swallow capsule|1|||
131873161|NCT04109391|474815520|FG000|Overall Study|Adverse Event|2|||
131873162|NCT04109391|474815521|FG001|Overall Study|Adverse Event|2|||
131873163|NCT04109391|474815522|FG002|Overall Study|Adverse Event|0|||
131873164|NCT04109391|474815520|FG000|Overall Study|Withdrawal by Subject|2|||
131873165|NCT04109391|474815521|FG001|Overall Study|Withdrawal by Subject|0|||
131873166|NCT04109391|474815522|FG002|Overall Study|Withdrawal by Subject|0|||
131873167|NCT04109391|474815520|FG000|Overall Study|Pregnancy|1|||
131873168|NCT04109391|474815521|FG001|Overall Study|Pregnancy|0|||
131873169|NCT04109391|474815522|FG002|Overall Study|Pregnancy|0|||
131873170|NCT04109391|474815520|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
131873171|NCT04109391|474815521|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
131408284|NCT00931723|473118252|FG000|Overall Study|Lack or insufficient theraputic response|2|||
131408285|NCT00931723|473118253|FG001|Overall Study|Lack or insufficient theraputic response|5|||
131408286|NCT00931723|473118252|FG000|Overall Study|Sponsor decision|1|||
131408287|NCT00931723|473118253|FG001|Overall Study|Sponsor decision|0|||
131873172|NCT04109391|474815522|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
131873173|NCT04109391|474815520|FG000|Overall Study|Lost to Follow-up|0|||
131408288|NCT00931723|473118252|FG000|Overall Study|Late hospital discharge|1|||
131873174|NCT04109391|474815521|FG001|Overall Study|Lost to Follow-up|0|||
131873175|NCT04109391|474815522|FG002|Overall Study|Lost to Follow-up|1|||
131873176|NCT04109391|474815520|FG000|Overall Study|Lack of Efficacy|2|||
131873177|NCT04109391|474815521|FG001|Overall Study|Lack of Efficacy|2|||
131408289|NCT00931723|473118253|FG001|Overall Study|Late hospital discharge|0|||
131408290|NCT01133405|473118254|FG000|Period 1|Withdrawal by Subject|0|||
131408291|NCT01133405|473118255|FG001|Period 1|Withdrawal by Subject|1|||
131408292|NCT01133405|473118256|FG002|Period 1|Withdrawal by Subject|0|||
131873178|NCT04109391|474815522|FG002|Overall Study|Lack of Efficacy|3|||
131873179|NCT01089608|474815525|FG000|Overall Study|Adverse Event|0|||
131873180|NCT01089608|474815526|FG001|Overall Study|Adverse Event|4|||
131873181|NCT01089608|474815525|FG000|Overall Study|Lost to Follow-up|0|||
131873182|NCT01089608|474815526|FG001|Overall Study|Lost to Follow-up|2|||
131873183|NCT00384839|474815527|FG000|Overall Study|Adverse Event|4|||
131873184|NCT00384839|474815527|FG000|Overall Study|Investigator Request|1|||
131873185|NCT00384839|474815527|FG000|Overall Study|Patient Request|1|||
131873186|NCT00384839|474815527|FG000|Overall Study|Ineligible|2|||
131873187|NCT02649439|474815528|FG000|Overall Study|Switched to alternative treatment|6|||
131873188|NCT02649439|474815529|FG001|Overall Study|Switched to alternative treatment|4|||
131873189|NCT02649439|474815528|FG000|Overall Study|Patient decision|1|||
131873190|NCT02649439|474815529|FG001|Overall Study|Patient decision|0|||
131873191|NCT02649439|474815528|FG000|Overall Study|Patient going out of country|1|||
131873192|NCT02649439|474815529|FG001|Overall Study|Patient going out of country|0|||
131873193|NCT02649439|474815528|FG000|Overall Study|To start finasteride|1|||
131873194|NCT02649439|474815529|FG001|Overall Study|To start finasteride|0|||
131873195|NCT02649439|474815528|FG000|Overall Study|Physician Decision|1|||
131873196|NCT02649439|474815529|FG001|Overall Study|Physician Decision|0|||
131873197|NCT02649439|474815528|FG000|Overall Study|Disease progression on study|12|||
131873198|NCT02649439|474815529|FG001|Overall Study|Disease progression on study|13|||
131873199|NCT02649439|474815528|FG000|Overall Study|Refused further treatment|1|||
131873200|NCT02649439|474815529|FG001|Overall Study|Refused further treatment|0|||
131873201|NCT02649439|474815528|FG000|Overall Study|Refused further follow up|2|||
131873202|NCT02649439|474815529|FG001|Overall Study|Refused further follow up|7|||
131873203|NCT02649439|474815528|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
131873204|NCT02649439|474815529|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
131873205|NCT02649439|474815528|FG000|Overall Study|No treatment, per protocol|1|||
131873206|NCT02649439|474815529|FG001|Overall Study|No treatment, per protocol|0|||
131873207|NCT02649439|474815528|FG000|Overall Study|PSA DT makes ineligible|0|||
131873208|NCT02649439|474815529|FG001|Overall Study|PSA DT makes ineligible|1|||
131873209|NCT02649439|474815528|FG000|Overall Study|Rising PSA No Mets|0|||
131873210|NCT02649439|474815529|FG001|Overall Study|Rising PSA No Mets|1|||
131873211|NCT02649439|474815528|FG000|Overall Study|Rising PSA|0|||
131873212|NCT02649439|474815529|FG001|Overall Study|Rising PSA|1|||
131873213|NCT02649439|474815528|FG000|Overall Study|Signed follow up protocol|0|||
131873214|NCT02649439|474815529|FG001|Overall Study|Signed follow up protocol|1|||
131873215|NCT00280397|474815530|FG000|Overall Study|Adverse Event|1|||
131873216|NCT02257489|474815533|FG000|Overall Study|Withdrawal by Subject|0|||
131873217|NCT02257489|474815534|FG001|Overall Study|Withdrawal by Subject|0|||
131873218|NCT02257489|474815535|FG002|Overall Study|Withdrawal by Subject|0|||
131873219|NCT02257489|474815536|FG003|Overall Study|Withdrawal by Subject|1|||
131873220|NCT02257489|474815537|FG004|Overall Study|Withdrawal by Subject|0|||
131873221|NCT02257489|474815538|FG005|Overall Study|Withdrawal by Subject|0|||
131873222|NCT02257489|474815539|FG006|Overall Study|Withdrawal by Subject|0|||
131873223|NCT02257489|474815540|FG007|Overall Study|Withdrawal by Subject|0|||
131873224|NCT02257489|474815541|FG008|Overall Study|Withdrawal by Subject|0|||
131873225|NCT00955955|474815542|FG000|Overall Study|Lost to Follow-up|2|||
131873226|NCT00955955|474815543|FG001|Overall Study|Lost to Follow-up|0|||
131873227|NCT00955955|474815544|FG002|Overall Study|Lost to Follow-up|0|||
131873228|NCT03423173|474815545|FG000|Overall Study|Randomized but not vaccinated|1|||
131873229|NCT03423173|474815546|FG001|Overall Study|Randomized but not vaccinated|0|||
131873230|NCT03423173|474815547|FG002|Overall Study|Randomized but not vaccinated|2|||
131873231|NCT03423173|474815548|FG003|Overall Study|Randomized but not vaccinated|1|||
131873232|NCT03423173|474815545|FG000|Overall Study|Adverse Event|1|||
131873233|NCT03423173|474815546|FG001|Overall Study|Adverse Event|1|||
131873234|NCT03423173|474815547|FG002|Overall Study|Adverse Event|1|||
131873235|NCT03423173|474815548|FG003|Overall Study|Adverse Event|1|||
131873236|NCT03423173|474815545|FG000|Overall Study|Lost to Follow-up|10|||
131873237|NCT03423173|474815546|FG001|Overall Study|Lost to Follow-up|19|||
131873238|NCT03423173|474815547|FG002|Overall Study|Lost to Follow-up|17|||
131873239|NCT03423173|474815548|FG003|Overall Study|Lost to Follow-up|22|||
131873240|NCT03423173|474815545|FG000|Overall Study|Withdrawal of consent|4|||
131873241|NCT03423173|474815546|FG001|Overall Study|Withdrawal of consent|10|||
131873242|NCT03423173|474815547|FG002|Overall Study|Withdrawal of consent|4|||
131873243|NCT03423173|474815548|FG003|Overall Study|Withdrawal of consent|5|||
131873244|NCT03423173|474815545|FG000|Overall Study|Death|1|||
131873245|NCT03423173|474815546|FG001|Overall Study|Death|0|||
131873246|NCT03423173|474815547|FG002|Overall Study|Death|0|||
131873247|NCT03423173|474815548|FG003|Overall Study|Death|0|||
131873248|NCT03423173|474815545|FG000|Overall Study|Reason not Specified|2|||
131873249|NCT03423173|474815546|FG001|Overall Study|Reason not Specified|5|||
131873250|NCT03423173|474815547|FG002|Overall Study|Reason not Specified|3|||
131873251|NCT03423173|474815548|FG003|Overall Study|Reason not Specified|1|||
131873252|NCT03852264|474815549|FG000|Third Research Visit|Lost to Follow-up|1|||
131873253|NCT03852264|474815550|FG001|Third Research Visit|Lost to Follow-up|0|||
131873254|NCT00090493|474815556|FG000|Overall Study|Physician Decision|2|||
131873255|NCT02071706|474815557|FG000|Overall Study|Adverse Event|1|||
131873256|NCT02071706|474815557|FG000|Overall Study|Withdrawal by Subject|2|||
131873257|NCT01908829|474815563|FG000|Overall Study|Adverse Event|13|||
131873258|NCT01908829|474815564|FG001|Overall Study|Adverse Event|11|||
131873259|NCT01908829|474815565|FG002|Overall Study|Adverse Event|13|||
131873260|NCT01908829|474815563|FG000|Overall Study|Lost to Follow-up|4|||
131873261|NCT01908829|474815564|FG001|Overall Study|Lost to Follow-up|2|||
131873262|NCT01908829|474815565|FG002|Overall Study|Lost to Follow-up|1|||
131873263|NCT01908829|474815563|FG000|Overall Study|Randomized no double-blind drug received|1|||
131873264|NCT01908829|474815564|FG001|Overall Study|Randomized no double-blind drug received|0|||
131873265|NCT01908829|474815565|FG002|Overall Study|Randomized no double-blind drug received|1|||
131873266|NCT01908829|474815563|FG000|Overall Study|Discontinued (no EoT page)|2|||
131873267|NCT01908829|474815564|FG001|Overall Study|Discontinued (no EoT page)|0|||
131873268|NCT01908829|474815565|FG002|Overall Study|Discontinued (no EoT page)|0|||
131873269|NCT01908829|474815563|FG000|Overall Study|Miscellaneous|0|||
131873270|NCT01908829|474815564|FG001|Overall Study|Miscellaneous|2|||
131873271|NCT01908829|474815565|FG002|Overall Study|Miscellaneous|0|||
131873272|NCT01908829|474815563|FG000|Overall Study|Protocol Violation|2|||
131873273|NCT01908829|474815564|FG001|Overall Study|Protocol Violation|2|||
131873274|NCT01908829|474815565|FG002|Overall Study|Protocol Violation|0|||
131873275|NCT01908829|474815563|FG000|Overall Study|Lack of Efficacy|1|||
131873276|NCT01908829|474815564|FG001|Overall Study|Lack of Efficacy|3|||
131873277|NCT01908829|474815565|FG002|Overall Study|Lack of Efficacy|2|||
131873278|NCT01908829|474815563|FG000|Overall Study|Withdrawal by Subject|26|||
131873279|NCT01908829|474815564|FG001|Overall Study|Withdrawal by Subject|29|||
131873280|NCT01908829|474815565|FG002|Overall Study|Withdrawal by Subject|22|||
131873281|NCT02247440|474815566|FG000|Overall Study|Withdrawal by Subject|1|||
131873282|NCT02247440|474815566|FG000|Overall Study|Lack of Efficacy|3|||
131873283|NCT02217410|474815567|FG000|Overall Study|Graft Loss|0|||
131873284|NCT02217410|474815568|FG001|Overall Study|Graft Loss|0|||
131873285|NCT02217410|474815569|FG002|Overall Study|Graft Loss|2|||
131873286|NCT02217410|474815567|FG000|Overall Study|Withdrawal by Subject|0|||
131873287|NCT02217410|474815568|FG001|Overall Study|Withdrawal by Subject|0|||
131873288|NCT02217410|474815569|FG002|Overall Study|Withdrawal by Subject|2|||
131873289|NCT02217410|474815567|FG000|Overall Study|Lost to Follow-up|0|||
131873290|NCT02217410|474815568|FG001|Overall Study|Lost to Follow-up|0|||
131873291|NCT02217410|474815569|FG002|Overall Study|Lost to Follow-up|1|||
131873292|NCT02217410|474815567|FG000|Overall Study|Lack of Efficacy|0|||
131873293|NCT02217410|474815568|FG001|Overall Study|Lack of Efficacy|1|||
131873294|NCT02217410|474815569|FG002|Overall Study|Lack of Efficacy|0|||
131873295|NCT02217410|474815567|FG000|Overall Study|Physician Decision|1|||
131873296|NCT02217410|474815568|FG001|Overall Study|Physician Decision|3|||
131873297|NCT02217410|474815569|FG002|Overall Study|Physician Decision|0|||
131873298|NCT00661609|474815571|FG000|Overall Study|Adverse Event|4|||
131873299|NCT00661609|474815571|FG000|Overall Study|Death|20|||
131873300|NCT00661609|474815571|FG000|Overall Study|Withdrawal by Subject|2|||
131873301|NCT00661609|474815571|FG000|Overall Study|PI Decision|1|||
131873302|NCT00661609|474815571|FG000|Overall Study|Survival follow up stage discontinued|11|||
131873303|NCT00661609|474815571|FG000|Overall Study|Disease progression|3|||
131873304|NCT00637000|474815572|FG000|Overall Study|Withdrawal by Subject|4|||
131873305|NCT00637000|474815573|FG001|Overall Study|Withdrawal by Subject|3|||
131873306|NCT01972438|474815576|FG000|Baseline-Month 3 Crossover Period|Death|1|||
131873307|NCT01972438|474815577|FG001|Baseline-Month 3 Crossover Period|Death|0|||
131873308|NCT01972438|474815576|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
131873309|NCT01972438|474815577|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
131873310|NCT01972438|474815576|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
131873311|NCT01972438|474815577|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
131873312|NCT01972438|474815576|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
131873313|NCT01972438|474815577|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
131873314|NCT01972438|474815576|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
131873315|NCT01972438|474815577|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
131873316|NCT01972438|474815576|FG000|Months 6-12 Study Period|Death|1|||
131873317|NCT01972438|474815577|FG001|Months 6-12 Study Period|Death|0|||
131873318|NCT01972438|474815576|FG000|Months 6-12 Study Period|Early Study Closure|2|||
131873319|NCT01972438|474815577|FG001|Months 6-12 Study Period|Early Study Closure|2|||
131873320|NCT01972438|474815576|FG000|Post Month 12 Study Period|Early Study Closure|3|||
131873321|NCT01972438|474815577|FG001|Post Month 12 Study Period|Early Study Closure|4|||
131873322|NCT01186692|474815580|FG000|Overall Study|Not Catheterized|11|||
131873323|NCT01186692|474815580|FG000|Overall Study|Futher testing contraindicated implant|19|||
131873324|NCT01186692|474815580|FG000|Overall Study|Adverse Event|2|||
131873325|NCT01068730|474817193|FG000|Period 3|Personal reason|1|||
131873326|NCT01068730|474817194|FG001|Period 3|Personal reason|0|||
131873327|NCT01068730|474817195|FG002|Period 3|Personal reason|0|||
131873328|NCT01068730|474817196|FG003|Period 3|Personal reason|0|||
131873329|NCT01068730|474817193|FG000|Period 4|Family emergency|0|||
131873330|NCT01068730|474817194|FG001|Period 4|Family emergency|1|||
131408293|NCT01133405|473118257|FG003|Period 1|Withdrawal by Subject|1|||
131873331|NCT01068730|474817195|FG002|Period 4|Family emergency|0|||
131873332|NCT01068730|474817196|FG003|Period 4|Family emergency|0|||
131873333|NCT00594100|474817200|FG000|Procedure|Technical Failure|9|||
131873334|NCT00594100|474817200|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
131873335|NCT00594100|474817200|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
131873336|NCT00594100|474817200|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
131873337|NCT01270464|474817201|FG000|Overall Study|Protocol Violation|4|||
131873338|NCT01270464|474817202|FG001|Overall Study|Protocol Violation|3|||
131873339|NCT01270464|474817203|FG002|Overall Study|Protocol Violation|2|||
131873340|NCT01270464|474817201|FG000|Overall Study|Lack of Efficacy|2|||
131873341|NCT01270464|474817202|FG001|Overall Study|Lack of Efficacy|3|||
131873342|NCT01270464|474817203|FG002|Overall Study|Lack of Efficacy|1|||
131873343|NCT01270464|474817201|FG000|Overall Study|Adverse Event|9|||
131873344|NCT01270464|474817202|FG001|Overall Study|Adverse Event|1|||
131873345|NCT01270464|474817203|FG002|Overall Study|Adverse Event|7|||
131873346|NCT01270464|474817201|FG000|Overall Study|Withdrawal by Subject|2|||
131873347|NCT01270464|474817202|FG001|Overall Study|Withdrawal by Subject|1|||
131873348|NCT01270464|474817203|FG002|Overall Study|Withdrawal by Subject|4|||
131873349|NCT01270464|474817201|FG000|Overall Study|Lost to Follow-up|2|||
131873350|NCT01270464|474817202|FG001|Overall Study|Lost to Follow-up|3|||
131873351|NCT01270464|474817203|FG002|Overall Study|Lost to Follow-up|1|||
131873352|NCT01270464|474817201|FG000|Overall Study|Other|1|||
131873353|NCT01270464|474817202|FG001|Overall Study|Other|1|||
131873354|NCT01270464|474817203|FG002|Overall Study|Other|3|||
131873355|NCT02448537|474817204|FG000|Overall Study|Withdrawal by Subject|1|||
131873356|NCT02448537|474817205|FG001|Overall Study|Withdrawal by Subject|1|||
131873357|NCT02448537|474817206|FG002|Overall Study|Withdrawal by Subject|1|||
131873358|NCT03981900|474817208|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
131873359|NCT03981900|474817208|FG000|Overall Study|Adverse Event|5|||
131873360|NCT03981900|474817208|FG000|Overall Study|Protocol Violation|1|||
131873361|NCT03981900|474817208|FG000|Overall Study|Withdrawal by Subject|7|||
131873362|NCT03981900|474817208|FG000|Overall Study|Lost to Follow-up|46|||
131873363|NCT03981900|474817208|FG000|Overall Study|Decision of the researcher|3|||
131873364|NCT03981900|474817208|FG000|Overall Study|Death|3|||
131873365|NCT03981900|474817208|FG000|Overall Study|Other|5|||
131873366|NCT04725812|474817212|FG000|Overall Study|Withdrawal by Subject|1|||
131873367|NCT04696055|474817217|FG000|Overall Study|Adverse Event|10|||
131873368|NCT04696055|474817218|FG001|Overall Study|Adverse Event|2|||
131873369|NCT04696055|474817217|FG000|Overall Study|Death|4|||
131873370|NCT04696055|474817218|FG001|Overall Study|Death|0|||
131873371|NCT04696055|474817217|FG000|Overall Study|Other|7|||
131873372|NCT04696055|474817218|FG001|Overall Study|Other|2|||
131873373|NCT04696055|474817217|FG000|Overall Study|Physician Decision|3|||
131873374|NCT04696055|474817218|FG001|Overall Study|Physician Decision|0|||
131873375|NCT04696055|474817217|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
131873376|NCT04696055|474817218|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
131873377|NCT04696055|474817217|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
131873378|NCT04696055|474817218|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
131873379|NCT04696055|474817217|FG000|Overall Study|Subject Decision|1|||
131873380|NCT04696055|474817218|FG001|Overall Study|Subject Decision|2|||
131873381|NCT03969901|474817219|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131873382|NCT03969901|474817220|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131873383|NCT03969901|474817221|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131873384|NCT03969901|474817222|FG003|Overall Study|Withdrawal by parent/guardian|0|||
131873385|NCT03969901|474817223|FG004|Overall Study|Withdrawal by parent/guardian|1|||
131873386|NCT03969901|474817224|FG005|Overall Study|Withdrawal by parent/guardian|0|||
131873387|NCT03969901|474817225|FG006|Overall Study|Withdrawal by parent/guardian|0|||
131408294|NCT01133405|473118258|FG004|Period 1|Withdrawal by Subject|0|||
131408295|NCT01133405|473118259|FG005|Period 1|Withdrawal by Subject|1|||
131408296|NCT01133405|473118260|FG006|Period 1|Withdrawal by Subject|0|||
131408297|NCT01133405|473118261|FG007|Period 1|Withdrawal by Subject|0|||
131873388|NCT03969901|474817226|FG007|Overall Study|Withdrawal by parent/guardian|1|||
131873389|NCT03969901|474817227|FG008|Overall Study|Withdrawal by parent/guardian|1|||
131873390|NCT03969901|474817228|FG009|Overall Study|Withdrawal by parent/guardian|0|||
131873391|NCT01560234|474817229|FG000|Overall Study|Lost to Follow-up|3|||
131873392|NCT01560234|474817230|FG001|Overall Study|Lost to Follow-up|0|||
131873393|NCT01560234|474817231|FG002|Overall Study|Lost to Follow-up|1|||
131873394|NCT01560234|474817232|FG003|Overall Study|Lost to Follow-up|0|||
131873395|NCT01560234|474817233|FG004|Overall Study|Lost to Follow-up|0|||
131873396|NCT01560234|474817234|FG005|Overall Study|Lost to Follow-up|2|||
131873397|NCT01560234|474817235|FG006|Overall Study|Lost to Follow-up|0|||
131873398|NCT01560234|474817236|FG007|Overall Study|Lost to Follow-up|2|||
131873399|NCT01163851|474817237|FG000|Overall Study|Site Closure|0|||
131873400|NCT01163851|474817238|FG001|Overall Study|Site Closure|1|||
131873401|NCT01163851|474817237|FG000|Overall Study|Enrolled but not treated|1|||
131408298|NCT01133405|473118262|FG008|Period 1|Withdrawal by Subject|0|||
131408299|NCT01133405|473118263|FG009|Period 1|Withdrawal by Subject|0|||
131408300|NCT01133405|473118254|FG000|Period 1|Physician Decision|0|||
131873402|NCT01163851|474817238|FG001|Overall Study|Enrolled but not treated|0|||
131873403|NCT00083759|474817240|FG000|Overall Study|Adverse Event|5|||
131873404|NCT00083759|474817241|FG001|Overall Study|Adverse Event|3|||
131873405|NCT00083759|474817240|FG000|Overall Study|Lost to Follow-up|1|||
131408301|NCT01133405|473118255|FG001|Period 1|Physician Decision|0|||
131873406|NCT00083759|474817241|FG001|Overall Study|Lost to Follow-up|0|||
131873407|NCT00083759|474817240|FG000|Overall Study|Death|1|||
131873408|NCT00083759|474817241|FG001|Overall Study|Death|1|||
131873409|NCT00083759|474817240|FG000|Overall Study|Inadequate Therapeutic Response|32|||
131873410|NCT00083759|474817241|FG001|Overall Study|Inadequate Therapeutic Response|35|||
131873411|NCT00083759|474817240|FG000|Overall Study|Subject Withdrew Consent|2|||
131873412|NCT00083759|474817241|FG001|Overall Study|Subject Withdrew Consent|2|||
131873413|NCT00083759|474817240|FG000|Overall Study|Non-Compliance|1|||
131873414|NCT00083759|474817241|FG001|Overall Study|Non-Compliance|0|||
131873415|NCT00083759|474817240|FG000|Overall Study|Sponsor's Discretion|28|||
131873416|NCT00083759|474817241|FG001|Overall Study|Sponsor's Discretion|29|||
131873417|NCT00083759|474817240|FG000|Overall Study|Other|14|||
131873418|NCT00083759|474817241|FG001|Overall Study|Other|13|||
131873419|NCT00619892|474817244|FG000|Overall Study|Adverse Event|3|||
131873420|NCT00619892|474817245|FG001|Overall Study|Adverse Event|0|||
131873421|NCT00619892|474817244|FG000|Overall Study|Lost to Follow-up|0|||
131873422|NCT00619892|474817245|FG001|Overall Study|Lost to Follow-up|1|||
131873423|NCT00619892|474817244|FG000|Overall Study|Intercurrent illness|0|||
131873424|NCT00619892|474817245|FG001|Overall Study|Intercurrent illness|1|||
131873425|NCT00379080|474817246|FG000|Overall Study|Withdrawal by Subject|0|||
131873426|NCT00379080|474817247|FG001|Overall Study|Withdrawal by Subject|4|||
131873427|NCT00379080|474817248|FG002|Overall Study|Withdrawal by Subject|0|||
131873428|NCT01222520|474817251|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
131873429|NCT01222520|474817252|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
131873430|NCT01222520|474817251|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
131873431|NCT01222520|474817252|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
131873432|NCT01222520|474817251|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
131873433|NCT01222520|474817252|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
131873434|NCT01222520|474817251|FG000|Double-blind Period|Adverse Event|0|||
131873435|NCT01222520|474817252|FG001|Double-blind Period|Adverse Event|1|||
131873436|NCT01222520|474817251|FG000|Double-blind Period|Lack of Efficacy|0|||
131873437|NCT01222520|474817252|FG001|Double-blind Period|Lack of Efficacy|1|||
131873438|NCT01222520|474817251|FG000|Double-blind Period|Study medication stolen|1|||
131873439|NCT01222520|474817252|FG001|Double-blind Period|Study medication stolen|0|||
131873440|NCT04606394|474817257|FG000|Overall Study|Withdrawal by Subject|3|||
131873441|NCT04606394|474817257|FG000|Overall Study|Exclusion criteria screen failure|12|||
131873442|NCT02920008|474817259|FG000|Overall Study|Death|117|||
131873443|NCT02920008|474817260|FG001|Overall Study|Death|127|||
131873444|NCT02920008|474817259|FG000|Overall Study|Withdrawal by Subject|3|||
131873445|NCT02920008|474817260|FG001|Overall Study|Withdrawal by Subject|6|||
131873446|NCT02920008|474817259|FG000|Overall Study|Lost to Follow-up|0|||
131873447|NCT02920008|474817260|FG001|Overall Study|Lost to Follow-up|1|||
131873448|NCT02737930|474817261|FG000|Overall Study|Withdrawal by Subject|0|||
131873449|NCT02737930|474817262|FG001|Overall Study|Withdrawal by Subject|1|||
131873450|NCT03169881|474817263|FG000|Overall Study|Incomplete Follow-up|10|||
131873451|NCT03169881|474817264|FG001|Overall Study|Incomplete Follow-up|15|||
131873452|NCT03169881|474817263|FG000|Overall Study|Lost to Follow-up|18|||
131873453|NCT03169881|474817264|FG001|Overall Study|Lost to Follow-up|20|||
131873454|NCT03169881|474817263|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
131873455|NCT03169881|474817264|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
131873456|NCT01028014|474817265|FG000|Overall Study|Lost to Follow-up|1|||
131873457|NCT01028014|474817266|FG001|Overall Study|Lost to Follow-up|2|||
131873458|NCT01028014|474817267|FG002|Overall Study|Lost to Follow-up|0|||
131408302|NCT01133405|473118256|FG002|Period 1|Physician Decision|0|||
131408303|NCT01133405|473118257|FG003|Period 1|Physician Decision|1|||
131873459|NCT01028014|474817268|FG003|Overall Study|Lost to Follow-up|1|||
131873460|NCT01028014|474817269|FG004|Overall Study|Lost to Follow-up|1|||
131873461|NCT01028014|474817270|FG005|Overall Study|Lost to Follow-up|2|||
131873462|NCT01127451|474817278|FG000|Overall Study|Other|2|||
131873463|NCT01127451|474817279|FG001|Overall Study|Other|1|||
131873464|NCT01127451|474817278|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
131873465|NCT01127451|474817279|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
131919544|NCT02493855|474989282|FG001|Overall Study|Withdrawal by Subject|0|||
131408304|NCT01133405|473118258|FG004|Period 1|Physician Decision|0|||
131873466|NCT01127451|474817278|FG000|Overall Study|Death|22|||
131873467|NCT01127451|474817279|FG001|Overall Study|Death|17|||
131873468|NCT01127451|474817278|FG000|Overall Study|Lost to Follow-up|3|||
131873469|NCT01127451|474817279|FG001|Overall Study|Lost to Follow-up|0|||
131873470|NCT01127451|474817278|FG000|Overall Study|Administrative Reason by Sponsor|2|||
131873471|NCT01127451|474817279|FG001|Overall Study|Administrative Reason by Sponsor|2|||
131873472|NCT02751450|474817280|FG000|Overall Study|Adverse Event|1|||
131873473|NCT02751450|474817281|FG001|Overall Study|Adverse Event|0|||
131873474|NCT01290679|474817282|FG000|Overall Study|Adverse Event|2|||
131873475|NCT01290679|474817283|FG001|Overall Study|Adverse Event|0|||
131873476|NCT01290679|474817282|FG000|Overall Study|Lost to Follow-up|8|||
131873477|NCT01290679|474817283|FG001|Overall Study|Lost to Follow-up|10|||
131873478|NCT01290679|474817282|FG000|Overall Study|Protocol Violation|0|||
131873479|NCT01290679|474817283|FG001|Overall Study|Protocol Violation|1|||
131873480|NCT01290679|474817282|FG000|Overall Study|Withdrawal by Subject|6|||
131873481|NCT01290679|474817283|FG001|Overall Study|Withdrawal by Subject|5|||
131873482|NCT01290679|474817282|FG000|Overall Study|Subject Entered Another Trial|0|||
131873483|NCT01290679|474817283|FG001|Overall Study|Subject Entered Another Trial|5|||
131873484|NCT00562302|474817284|FG000|Overall Study|Lost to Follow-up|3|||
131873485|NCT00562302|474817285|FG001|Overall Study|Lost to Follow-up|3|||
131873486|NCT00562302|474817284|FG000|Overall Study|Adverse Event|0|||
131873487|NCT00562302|474817285|FG001|Overall Study|Adverse Event|6|||
131873488|NCT00562302|474817284|FG000|Overall Study|Non-compliance|1|||
131873489|NCT00562302|474817285|FG001|Overall Study|Non-compliance|2|||
131873490|NCT00562302|474817284|FG000|Overall Study|Withdrawal by Subject|7|||
131873491|NCT00562302|474817285|FG001|Overall Study|Withdrawal by Subject|8|||
131873492|NCT00562302|474817284|FG000|Overall Study|Death|1|||
131873493|NCT00562302|474817285|FG001|Overall Study|Death|2|||
131873494|NCT00562302|474817284|FG000|Overall Study|Lung resection prior to study completion|7|||
131873495|NCT00562302|474817285|FG001|Overall Study|Lung resection prior to study completion|7|||
131873496|NCT00562302|474817284|FG000|Overall Study|Not stated|1|||
131873497|NCT00562302|474817285|FG001|Overall Study|Not stated|4|||
131873498|NCT01855243|474817286|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
131873499|NCT01855243|474817287|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
131873500|NCT01855243|474817288|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
131873501|NCT01704651|474817289|FG000|Overall Study|Pre-op withdrawal by subject|1|||
131873502|NCT01704651|474817290|FG001|Overall Study|Pre-op withdrawal by subject|1|||
131873503|NCT01704651|474817289|FG000|Overall Study|Pre-op change in treatment plan|1|||
131873504|NCT01704651|474817290|FG001|Overall Study|Pre-op change in treatment plan|4|||
131873505|NCT01704651|474817289|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
131873506|NCT01704651|474817290|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
131873507|NCT01704651|474817289|FG000|Overall Study|Post-op did not have laparotomy|2|||
131873508|NCT01704651|474817290|FG001|Overall Study|Post-op did not have laparotomy|1|||
131873509|NCT03315286|474817291|FG000|Overall Study|Lost to Follow-up|0|||
131873510|NCT03315286|474817292|FG001|Overall Study|Lost to Follow-up|3|||
131873511|NCT03315286|474817291|FG000|Overall Study|Withdrawal by Subject|1|||
131873512|NCT03315286|474817292|FG001|Overall Study|Withdrawal by Subject|0|||
131873513|NCT03315286|474817291|FG000|Overall Study|Protocol Violation|0|||
131873514|NCT03315286|474817292|FG001|Overall Study|Protocol Violation|1|||
131873515|NCT03075891|474817293|FG000|Overall Study|Withdrawal by Subject|3|||
131873516|NCT03075891|474817294|FG001|Overall Study|Withdrawal by Subject|6|||
131873517|NCT03075891|474817293|FG000|Overall Study|Lost to Follow-up|1|||
131873518|NCT03075891|474817294|FG001|Overall Study|Lost to Follow-up|0|||
131873519|NCT03075891|474817293|FG000|Overall Study|Pregnancy|3|||
131873520|NCT03075891|474817294|FG001|Overall Study|Pregnancy|1|||
131873521|NCT03075891|474817293|FG000|Overall Study|visits not performed (no time)|1|||
131873522|NCT03075891|474817294|FG001|Overall Study|visits not performed (no time)|0|||
131873523|NCT03075891|474817293|FG000|Overall Study|Drug abuse relapse issue|0|||
131873524|NCT03075891|474817294|FG001|Overall Study|Drug abuse relapse issue|1|||
131873525|NCT03075891|474817293|FG000|Overall Study|Participant requiring study withdrawal|0|||
131873526|NCT03075891|474817294|FG001|Overall Study|Participant requiring study withdrawal|1|||
131873527|NCT03075891|474817293|FG000|Overall Study|Adverse event, non-fatal|1|||
131873528|NCT03075891|474817294|FG001|Overall Study|Adverse event, non-fatal|4|||
131873529|NCT00828568|474817297|FG000|Randomized|Withdrawal by Subject|1|||
131873530|NCT00828568|474817298|FG001|Randomized|Withdrawal by Subject|0|||
131873531|NCT00828568|474817299|FG002|Randomized|Withdrawal by Subject|2|||
131873532|NCT00828568|474817297|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
131873533|NCT00828568|474817298|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
131873534|NCT00828568|474817299|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
131873535|NCT00828568|474817297|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
131873536|NCT00828568|474817298|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
131408305|NCT01133405|473118259|FG005|Period 1|Physician Decision|0|||
131408306|NCT01133405|473118260|FG006|Period 1|Physician Decision|0|||
131408307|NCT01133405|473118261|FG007|Period 1|Physician Decision|0|||
131408308|NCT01133405|473118262|FG008|Period 1|Physician Decision|0|||
131873537|NCT00828568|474817299|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
131873538|NCT00828568|474817297|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
131873539|NCT00828568|474817298|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
131873540|NCT00828568|474817299|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
131873541|NCT00828568|474817297|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
131873542|NCT00828568|474817298|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
131873543|NCT00828568|474817299|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
131873544|NCT00634803|474817300|FG000|Overall Study|Lost to Follow-up|6|||
131873545|NCT00634803|474817301|FG001|Overall Study|Lost to Follow-up|7|||
131408309|NCT01133405|473118263|FG009|Period 1|Physician Decision|0|||
131408310|NCT01133405|473118254|FG000|Period 1|Discontinued after randomization|1|||
131873546|NCT00634803|474817302|FG002|Overall Study|Lost to Follow-up|7|||
131873547|NCT00364923|474817303|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
131873548|NCT00364923|474817303|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
131873549|NCT03474731|474817304|FG000|Overall Study|Withdrawal by Subject|36|||
131873550|NCT03474731|474817305|FG001|Overall Study|Withdrawal by Subject|29|||
131873551|NCT03474731|474817306|FG002|Overall Study|Withdrawal by Subject|11|||
131873552|NCT03474731|474817307|FG003|Overall Study|Withdrawal by Subject|27|||
131873553|NCT03474731|474817304|FG000|Overall Study|COVID|0|||
131873554|NCT03474731|474817305|FG001|Overall Study|COVID|23|||
131873555|NCT03474731|474817306|FG002|Overall Study|COVID|0|||
131873556|NCT03474731|474817307|FG003|Overall Study|COVID|0|||
131873557|NCT03474731|474817304|FG000|Overall Study|Participant moved from area|1|||
131873558|NCT03474731|474817305|FG001|Overall Study|Participant moved from area|0|||
131873559|NCT03474731|474817306|FG002|Overall Study|Participant moved from area|0|||
131873560|NCT03474731|474817307|FG003|Overall Study|Participant moved from area|0|||
131873561|NCT03474731|474817304|FG000|Overall Study|Lost to Follow-up|11|||
131873562|NCT03474731|474817305|FG001|Overall Study|Lost to Follow-up|3|||
131873563|NCT03474731|474817306|FG002|Overall Study|Lost to Follow-up|18|||
131873564|NCT03474731|474817307|FG003|Overall Study|Lost to Follow-up|17|||
131873565|NCT03474731|474817304|FG000|Overall Study|Death|0|||
131873566|NCT03474731|474817305|FG001|Overall Study|Death|1|||
131873567|NCT03474731|474817306|FG002|Overall Study|Death|0|||
131873568|NCT03474731|474817307|FG003|Overall Study|Death|0|||
131873569|NCT03474731|474817304|FG000|Overall Study|Participant Removed|0|||
131873570|NCT03474731|474817305|FG001|Overall Study|Participant Removed|0|||
131873571|NCT03474731|474817306|FG002|Overall Study|Participant Removed|0|||
131873572|NCT03474731|474817307|FG003|Overall Study|Participant Removed|1|||
131873573|NCT00766636|474817308|FG000|Overall Study|Withdrawal by Subject|1|||
131873574|NCT00766636|474817309|FG001|Overall Study|Withdrawal by Subject|1|||
131873575|NCT00766636|474817308|FG000|Overall Study|Incomplete Treatment|0|||
131873576|NCT00766636|474817309|FG001|Overall Study|Incomplete Treatment|1|||
131873577|NCT00766636|474817308|FG000|Overall Study|Adverse Event|1|||
131873578|NCT00766636|474817309|FG001|Overall Study|Adverse Event|0|||
131873579|NCT00766636|474817308|FG000|Overall Study|Disease Progression|1|||
131873580|NCT00766636|474817309|FG001|Overall Study|Disease Progression|0|||
131873581|NCT04657198|474817310|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
131873582|NCT04657198|474817311|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
131873583|NCT04657198|474817312|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
131873584|NCT04087720|474817313|FG000|Overall Study|Withdrawal by Subject|2|||
131873585|NCT04087720|474817313|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
131873586|NCT03706430|474817316|FG000|Overall Study|No A-Line placed|5|||
131873587|NCT03706430|474817316|FG000|Overall Study|Subject had gel nail polish|1|||
131873588|NCT03706430|474817316|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
131873589|NCT03706430|474817316|FG000|Overall Study|Cancelled Case|6|||
131873590|NCT03706430|474817316|FG000|Overall Study|Physician Decision|2|||
131873591|NCT00520533|474817317|FG000|Overall Study|Death|1|||
131873592|NCT00520533|474817317|FG000|Overall Study|Suspension of the study for safety reasons|1|||
131873593|NCT00520533|474817317|FG000|Overall Study|Withdrawal by Subject|1|||
131873594|NCT00520533|474817317|FG000|Overall Study|Physician Decision|1|||
131873595|NCT01075256|474817318|FG000|Overall Study|Withdrawal by Subject|1|||
131873596|NCT01075256|474817319|FG001|Overall Study|Withdrawal by Subject|0|||
131873597|NCT01075256|474817320|FG002|Overall Study|Withdrawal by Subject|0|||
131873598|NCT00765336|474817321|FG000|Overall Study|Protocol Violation|4|||
131873599|NCT00765336|474817322|FG001|Overall Study|Protocol Violation|2|||
131873600|NCT00765336|474817321|FG000|Overall Study|Withdrawal by Subject|6|||
131873601|NCT00765336|474817322|FG001|Overall Study|Withdrawal by Subject|4|||
131873602|NCT00765336|474817321|FG000|Overall Study|Lost to Follow-up|7|||
131873603|NCT00765336|474817322|FG001|Overall Study|Lost to Follow-up|9|||
131873604|NCT00765336|474817321|FG000|Overall Study|Adverse Event|2|||
131873605|NCT00765336|474817322|FG001|Overall Study|Adverse Event|1|||
131873606|NCT00478777|474817323|FG000|Overall Study|Adverse Event|29|||
131873607|NCT00478777|474817323|FG000|Overall Study|Lack of Efficacy|23|||
131873608|NCT00478777|474817323|FG000|Overall Study|Withdrawal by Subject|4|||
131873609|NCT00478777|474817323|FG000|Overall Study|Death|3|||
131873610|NCT00478777|474817323|FG000|Overall Study|Protocol Violation|3|||
131873611|NCT00478777|474817323|FG000|Overall Study|Lost to Follow-up|3|||
131873612|NCT00478777|474817323|FG000|Overall Study|Physician Decision|1|||
131873613|NCT00478777|474817323|FG000|Overall Study|Intolerance of therapy|1|||
131873614|NCT00478777|474817323|FG000|Overall Study|Lack of compliance|1|||
131873615|NCT00478777|474817323|FG000|Overall Study|Lymphocytes infusion|1|||
131873616|NCT00478777|474817323|FG000|Overall Study|End of therapy|2|||
131873617|NCT00478777|474817323|FG000|Overall Study|Not treated with lenalidomide|6|||
131873618|NCT02858583|474817324|FG000|Overall Study|Declined consent|1|||
131873619|NCT02858583|474817325|FG001|Overall Study|Declined consent|1|||
131873620|NCT01218087|474817326|FG000|Overall Study|Death|2|||
131873621|NCT01218087|474817327|FG001|Overall Study|Death|1|||
131873622|NCT01218087|474817326|FG000|Overall Study|Withdrawal by Subject|5|||
131873623|NCT01218087|474817327|FG001|Overall Study|Withdrawal by Subject|0|||
131873624|NCT01218087|474817326|FG000|Overall Study|Transferred|8|||
131873625|NCT01218087|474817327|FG001|Overall Study|Transferred|5|||
131873626|NCT00596817|474817333|FG000|Open-label Period|Adverse Event|0|||
131873627|NCT00596817|474817334|FG001|Open-label Period|Adverse Event|49|||
131873628|NCT00596817|474817333|FG000|Open-label Period|Lack of Efficacy|0|||
131873629|NCT00596817|474817334|FG001|Open-label Period|Lack of Efficacy|33|||
131873630|NCT00596817|474817333|FG000|Open-label Period|Other Reasons|0|||
131873631|NCT00596817|474817334|FG001|Open-label Period|Other Reasons|65|||
131873632|NCT00596817|474817333|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
131873633|NCT00596817|474817334|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
131873634|NCT00596817|474817333|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
131873635|NCT00596817|474817334|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
131873636|NCT00596817|474817333|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
131873637|NCT00596817|474817334|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
131873638|NCT00596817|474817333|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
131873639|NCT00596817|474817334|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
131873640|NCT00596817|474817333|FG000|Double-blind Period|Adverse Event|5|||
131873641|NCT00596817|474817334|FG001|Double-blind Period|Adverse Event|16|||
131873642|NCT00596817|474817333|FG000|Double-blind Period|Lack of Efficacy|52|||
131873643|NCT00596817|474817334|FG001|Double-blind Period|Lack of Efficacy|28|||
131873644|NCT00596817|474817333|FG000|Double-blind Period|Non-compliance With Study Product|3|||
131873645|NCT00596817|474817334|FG001|Double-blind Period|Non-compliance With Study Product|4|||
131873646|NCT00596817|474817333|FG000|Double-blind Period|Protocol Violation|11|||
131873647|NCT00596817|474817334|FG001|Double-blind Period|Protocol Violation|8|||
131873648|NCT00596817|474817333|FG000|Double-blind Period|Withdrawal of Consent|7|||
131873649|NCT00596817|474817334|FG001|Double-blind Period|Withdrawal of Consent|3|||
131873650|NCT00596817|474817333|FG000|Double-blind Period|Lost to Follow-up|0|||
131873651|NCT00596817|474817334|FG001|Double-blind Period|Lost to Follow-up|2|||
131873652|NCT00596817|474817333|FG000|Double-blind Period|Other Reasons|10|||
131873653|NCT00596817|474817334|FG001|Double-blind Period|Other Reasons|18|||
131873654|NCT01314872|474817337|FG000|Treatment Period 1|Protocol Violation|2|||
131873655|NCT01314872|474817338|FG001|Treatment Period 1|Protocol Violation|1|||
131873656|NCT01314872|474817339|FG002|Treatment Period 1|Protocol Violation|1|||
131873657|NCT01314872|474817340|FG003|Treatment Period 1|Protocol Violation|0|||
131873658|NCT01314872|474817341|FG004|Treatment Period 1|Protocol Violation|1|||
131873659|NCT01314872|474817342|FG005|Treatment Period 1|Protocol Violation|0|||
131873660|NCT01314872|474817343|FG006|Treatment Period 1|Protocol Violation|0|||
131873661|NCT01314872|474817344|FG007|Treatment Period 1|Protocol Violation|0|||
131873662|NCT01314872|474817345|FG008|Treatment Period 1|Protocol Violation|0|||
131873663|NCT01314872|474817346|FG009|Treatment Period 1|Protocol Violation|1|||
131873664|NCT01314872|474817347|FG010|Treatment Period 1|Protocol Violation|1|||
131873665|NCT01314872|474817348|FG011|Treatment Period 1|Protocol Violation|0|||
131873666|NCT01314872|474817349|FG012|Treatment Period 1|Protocol Violation|0|||
131873667|NCT01314872|474817350|FG013|Treatment Period 1|Protocol Violation|0|||
131873668|NCT01314872|474817351|FG014|Treatment Period 1|Protocol Violation|0|||
131873669|NCT01314872|474817337|FG000|Treatment Period 1|Physician Decision|0|||
131873670|NCT01314872|474817338|FG001|Treatment Period 1|Physician Decision|1|||
131873671|NCT01314872|474817339|FG002|Treatment Period 1|Physician Decision|0|||
131919545|NCT02493855|474989283|FG002|Overall Study|Withdrawal by Subject|0|||
131873672|NCT01314872|474817340|FG003|Treatment Period 1|Physician Decision|1|||
131873673|NCT01314872|474817341|FG004|Treatment Period 1|Physician Decision|0|||
131873674|NCT01314872|474817342|FG005|Treatment Period 1|Physician Decision|0|||
131873675|NCT01314872|474817343|FG006|Treatment Period 1|Physician Decision|0|||
131873676|NCT01314872|474817344|FG007|Treatment Period 1|Physician Decision|0|||
131873677|NCT01314872|474817345|FG008|Treatment Period 1|Physician Decision|0|||
131919546|NCT02453048|474989284|FG000|Overall Study|Only part of initial 6 mo. study|0|||
131919547|NCT02453048|474989285|FG001|Overall Study|Only part of initial 6 mo. study|0|||
131919548|NCT02453048|474989286|FG002|Overall Study|Only part of initial 6 mo. study|0|||
131919549|NCT02453048|474989287|FG003|Overall Study|Only part of initial 6 mo. study|0|||
131919550|NCT02453048|474989288|FG004|Overall Study|Only part of initial 6 mo. study|6|||
131873678|NCT01314872|474817346|FG009|Treatment Period 1|Physician Decision|1|||
131873679|NCT01314872|474817347|FG010|Treatment Period 1|Physician Decision|0|||
131873680|NCT01314872|474817348|FG011|Treatment Period 1|Physician Decision|0|||
131873681|NCT01314872|474817349|FG012|Treatment Period 1|Physician Decision|0|||
131873682|NCT01314872|474817350|FG013|Treatment Period 1|Physician Decision|0|||
131873683|NCT01314872|474817351|FG014|Treatment Period 1|Physician Decision|0|||
131873684|NCT01314872|474817337|FG000|Treatment Period 1|Lack of Efficacy|1|||
131919551|NCT02453048|474989284|FG000|Overall Study|Lost to Follow-up|0|||
131919552|NCT02453048|474989285|FG001|Overall Study|Lost to Follow-up|1|||
131408311|NCT01133405|473118255|FG001|Period 1|Discontinued after randomization|0|||
131873685|NCT01314872|474817338|FG001|Treatment Period 1|Lack of Efficacy|0|||
131873686|NCT01314872|474817339|FG002|Treatment Period 1|Lack of Efficacy|0|||
131873687|NCT01314872|474817340|FG003|Treatment Period 1|Lack of Efficacy|0|||
131873688|NCT01314872|474817341|FG004|Treatment Period 1|Lack of Efficacy|0|||
131919553|NCT02453048|474989286|FG002|Overall Study|Lost to Follow-up|2|||
131919554|NCT02453048|474989287|FG003|Overall Study|Lost to Follow-up|0|||
131919555|NCT02453048|474989288|FG004|Overall Study|Lost to Follow-up|0|||
131919556|NCT03086343|474989290|FG000|Period 1|Adverse Event|7|||
131919557|NCT03086343|474989291|FG001|Period 1|Adverse Event|7|||
131919558|NCT03086343|474989292|FG002|Period 1|Adverse Event|0|||
131919559|NCT03086343|474989293|FG003|Period 1|Adverse Event|1|||
131919560|NCT03086343|474989290|FG000|Period 1|Withdrawal by Subject|6|||
131919561|NCT03086343|474989291|FG001|Period 1|Withdrawal by Subject|10|||
131919562|NCT03086343|474989292|FG002|Period 1|Withdrawal by Subject|0|||
131919563|NCT03086343|474989293|FG003|Period 1|Withdrawal by Subject|0|||
131919564|NCT03086343|474989290|FG000|Period 1|Lost to Follow-up|1|||
131919565|NCT03086343|474989291|FG001|Period 1|Lost to Follow-up|3|||
131919566|NCT03086343|474989292|FG002|Period 1|Lost to Follow-up|1|||
131919567|NCT03086343|474989293|FG003|Period 1|Lost to Follow-up|0|||
131919568|NCT03086343|474989290|FG000|Period 1|Other, Not Specified|10|||
131919569|NCT03086343|474989291|FG001|Period 1|Other, Not Specified|12|||
131919570|NCT03086343|474989292|FG002|Period 1|Other, Not Specified|2|||
131919571|NCT03086343|474989293|FG003|Period 1|Other, Not Specified|1|||
131919572|NCT03086343|474989290|FG000|Period 1|Missing|1|||
131919573|NCT03086343|474989291|FG001|Period 1|Missing|0|||
131919574|NCT03086343|474989292|FG002|Period 1|Missing|0|||
131919575|NCT03086343|474989293|FG003|Period 1|Missing|0|||
131919576|NCT03086343|474989290|FG000|Period 2|Adverse Event|20|||
131919577|NCT03086343|474989291|FG001|Period 2|Adverse Event|11|||
131919578|NCT03086343|474989292|FG002|Period 2|Adverse Event|1|||
131919579|NCT03086343|474989293|FG003|Period 2|Adverse Event|2|||
131919580|NCT03086343|474989290|FG000|Period 2|Withdrawal by Subject|15|||
131919581|NCT03086343|474989291|FG001|Period 2|Withdrawal by Subject|25|||
131919582|NCT03086343|474989292|FG002|Period 2|Withdrawal by Subject|2|||
131919583|NCT03086343|474989293|FG003|Period 2|Withdrawal by Subject|2|||
131919584|NCT03086343|474989290|FG000|Period 2|Lost to Follow-up|6|||
131919585|NCT03086343|474989291|FG001|Period 2|Lost to Follow-up|11|||
131919586|NCT03086343|474989292|FG002|Period 2|Lost to Follow-up|1|||
131919587|NCT03086343|474989293|FG003|Period 2|Lost to Follow-up|0|||
131919588|NCT03086343|474989290|FG000|Period 2|COVID-19 Infection|5|||
131919589|NCT03086343|474989291|FG001|Period 2|COVID-19 Infection|0|||
131919590|NCT03086343|474989292|FG002|Period 2|COVID-19 Infection|0|||
131919591|NCT03086343|474989293|FG003|Period 2|COVID-19 Infection|0|||
131919592|NCT03086343|474989290|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
131919593|NCT03086343|474989291|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
131919594|NCT03086343|474989292|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
131919595|NCT03086343|474989293|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
131919596|NCT03086343|474989290|FG000|Period 2|Other, Not Specified|23|||
131919597|NCT03086343|474989291|FG001|Period 2|Other, Not Specified|22|||
131919598|NCT03086343|474989292|FG002|Period 2|Other, Not Specified|2|||
131919599|NCT03086343|474989293|FG003|Period 2|Other, Not Specified|4|||
131919600|NCT00800540|474989296|FG000|Period One: 6 Weeks|Noncompliance|1|||
131919601|NCT00800540|474989297|FG001|Period One: 6 Weeks|Noncompliance|0|||
131919602|NCT00800540|474989296|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
131919603|NCT00800540|474989297|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
131919604|NCT00800540|474989296|FG000|Period 2: 6 Weeks|Adverse Event|0|||
131919605|NCT00800540|474989297|FG001|Period 2: 6 Weeks|Adverse Event|1|||
131919606|NCT01922011|474989298|FG000|Overall Study|Protocol Violation|0|||
131919607|NCT01922011|474989299|FG001|Overall Study|Protocol Violation|1|||
131919608|NCT01922011|474989298|FG000|Overall Study|Physician Decision|0|||
131919609|NCT01922011|474989299|FG001|Overall Study|Physician Decision|1|||
131919610|NCT01922011|474989298|FG000|Overall Study|Parent/Guardian Decision|3|||
131919611|NCT01922011|474989299|FG001|Overall Study|Parent/Guardian Decision|0|||
131919612|NCT01922011|474989298|FG000|Overall Study|Lost to Follow-up|0|||
131919613|NCT01922011|474989299|FG001|Overall Study|Lost to Follow-up|1|||
131919614|NCT01922011|474989298|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
131919615|NCT01922011|474989299|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
131919616|NCT01922011|474989298|FG000|Overall Study|Not Treated|1|||
131919617|NCT01922011|474989299|FG001|Overall Study|Not Treated|0|||
131919618|NCT01922011|474989298|FG000|Overall Study|Lack of willing home health agency|1|||
131919619|NCT01922011|474989299|FG001|Overall Study|Lack of willing home health agency|0|||
131919620|NCT01922011|474989298|FG000|Overall Study|Randomized in error|1|||
131919621|NCT01922011|474989299|FG001|Overall Study|Randomized in error|0|||
131919622|NCT04398134|474989300|FG000|Overall Study|Adverse Event|0|||
131919623|NCT04398134|474989301|FG001|Overall Study|Adverse Event|0|||
131919624|NCT04398134|474989302|FG002|Overall Study|Adverse Event|1|||
131919625|NCT04398134|474989303|FG003|Overall Study|Adverse Event|0|||
131919626|NCT04398134|474989300|FG000|Overall Study|Withdrawal by Subject|2|||
131919627|NCT04398134|474989301|FG001|Overall Study|Withdrawal by Subject|0|||
131919628|NCT04398134|474989302|FG002|Overall Study|Withdrawal by Subject|0|||
131919629|NCT04398134|474989303|FG003|Overall Study|Withdrawal by Subject|1|||
131919630|NCT04398134|474989300|FG000|Overall Study|Study Terminated by Sponsor|30|||
131919631|NCT04398134|474989301|FG001|Overall Study|Study Terminated by Sponsor|11|||
131919632|NCT04398134|474989302|FG002|Overall Study|Study Terminated by Sponsor|32|||
131919633|NCT04398134|474989303|FG003|Overall Study|Study Terminated by Sponsor|11|||
131919634|NCT00153920|474989305|FG000|Overall Study|Adverse Event|9|||
131919635|NCT00153920|474989305|FG000|Overall Study|Progressive Disease|9|||
131919636|NCT00153920|474989305|FG000|Overall Study|Physician Decision|3|||
131919637|NCT00153920|474989305|FG000|Overall Study|Lack of Response|3|||
131919638|NCT00153920|474989305|FG000|Overall Study|Death|2|||
131919639|NCT00153920|474989305|FG000|Overall Study|Withdrawal by Subject|1|||
131919640|NCT00153920|474989305|FG000|Overall Study|Non-Protocol Therapy|1|||
131919641|NCT00153920|474989305|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
131919642|NCT00153920|474989305|FG000|Overall Study|Progressive Disease before Trt|1|||
131919643|NCT02202616|474989309|FG000|Overall Study|Screen failed|24|||
131919644|NCT02202616|474989309|FG000|Overall Study|Adverse Event|32|||
131919645|NCT02202616|474989309|FG000|Overall Study|Protocol deviation|18|||
131919646|NCT02202616|474989309|FG000|Overall Study|Patient withdrew consent|12|||
131919647|NCT02202616|474989309|FG000|Overall Study|Lost to Follow-up|6|||
131919648|NCT02202616|474989309|FG000|Overall Study|Administrative problems|6|||
131919649|NCT02202616|474989309|FG000|Overall Study|Abnormal test procedure result|1|||
131919650|NCT02202616|474989309|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131919651|NCT01334515|474989312|FG000|Overall Study|Adverse Event|1|||
131919652|NCT01334515|474989313|FG001|Overall Study|Adverse Event|6|||
131919653|NCT01334515|474989312|FG000|Overall Study|Death|1|||
131919654|NCT01334515|474989313|FG001|Overall Study|Death|0|||
131919655|NCT01334515|474989312|FG000|Overall Study|Lack of Efficacy|8|||
131919656|NCT01334515|474989313|FG001|Overall Study|Lack of Efficacy|21|||
131919657|NCT01334515|474989312|FG000|Overall Study|Physician Decision|1|||
131919658|NCT01334515|474989313|FG001|Overall Study|Physician Decision|1|||
131919659|NCT01334515|474989312|FG000|Overall Study|Withdrawal by Subject|1|||
131919660|NCT01334515|474989313|FG001|Overall Study|Withdrawal by Subject|1|||
131919661|NCT04327271|474989314|FG000|Overall Study|Death|1|||
131919662|NCT04327271|474989315|FG001|Overall Study|Death|0|||
131919663|NCT04327271|474989314|FG000|Overall Study|Withdrawal by Subject|1|||
131919664|NCT04327271|474989315|FG001|Overall Study|Withdrawal by Subject|0|||
131919665|NCT04327271|474989314|FG000|Overall Study|randomization error (data capture)|4|||
131919666|NCT04327271|474989315|FG001|Overall Study|randomization error (data capture)|3|||
131919667|NCT01695746|474989316|FG000|Overall Study|Adverse Event|1|||
131919668|NCT01695746|474989316|FG000|Overall Study|Non-compliance by the participant|3|||
131919669|NCT01695746|474989316|FG000|Overall Study|Protocol Violation|5|||
131919670|NCT01695746|474989316|FG000|Overall Study|Participant not willing to participate|3|||
131919671|NCT02676973|474989317|FG000|Overall Study|Withdrawal by Subject|9|||
131919672|NCT02676973|474989318|FG001|Overall Study|Withdrawal by Subject|8|||
131919673|NCT02676973|474989319|FG002|Overall Study|Withdrawal by Subject|11|||
131919674|NCT02676973|474989317|FG000|Overall Study|Lost to Follow-up|8|||
131919675|NCT02676973|474989318|FG001|Overall Study|Lost to Follow-up|12|||
131919676|NCT02676973|474989319|FG002|Overall Study|Lost to Follow-up|8|||
131919677|NCT02676973|474989317|FG000|Overall Study|Death|2|||
131919678|NCT02676973|474989318|FG001|Overall Study|Death|1|||
131919679|NCT02676973|474989319|FG002|Overall Study|Death|5|||
131919680|NCT01078662|474989321|FG000|Overall Study|Death|41|||
131919681|NCT01078662|474989322|FG001|Overall Study|Death|103|||
131919682|NCT01078662|474989323|FG002|Overall Study|Death|18|||
131919683|NCT01078662|474989324|FG003|Overall Study|Death|5|||
131919684|NCT01078662|474989325|FG004|Overall Study|Death|8|||
131919685|NCT01078662|474989321|FG000|Overall Study|Patients reached data cut-off|12|||
131919686|NCT01078662|474989322|FG001|Overall Study|Patients reached data cut-off|53|||
131919687|NCT01078662|474989323|FG002|Overall Study|Patients reached data cut-off|2|||
131919688|NCT01078662|474989324|FG003|Overall Study|Patients reached data cut-off|2|||
131919689|NCT01078662|474989325|FG004|Overall Study|Patients reached data cut-off|3|||
131919690|NCT01078662|474989321|FG000|Overall Study|Withdrawal by Subject|4|||
131919691|NCT01078662|474989322|FG001|Overall Study|Withdrawal by Subject|11|||
131919692|NCT01078662|474989323|FG002|Overall Study|Withdrawal by Subject|1|||
131919693|NCT01078662|474989324|FG003|Overall Study|Withdrawal by Subject|0|||
131919694|NCT01078662|474989325|FG004|Overall Study|Withdrawal by Subject|0|||
131919695|NCT01078662|474989321|FG000|Overall Study|Protocol Violation|0|||
131919696|NCT01078662|474989322|FG001|Overall Study|Protocol Violation|1|||
131919697|NCT01078662|474989323|FG002|Overall Study|Protocol Violation|0|||
131919698|NCT01078662|474989324|FG003|Overall Study|Protocol Violation|0|||
131919699|NCT01078662|474989325|FG004|Overall Study|Protocol Violation|0|||
131919700|NCT01078662|474989321|FG000|Overall Study|Lost to Follow-up|1|||
131919701|NCT01078662|474989322|FG001|Overall Study|Lost to Follow-up|0|||
131919702|NCT01078662|474989323|FG002|Overall Study|Lost to Follow-up|0|||
131408312|NCT01133405|473118256|FG002|Period 1|Discontinued after randomization|0|||
131408313|NCT01133405|473118257|FG003|Period 1|Discontinued after randomization|0|||
131919703|NCT01078662|474989324|FG003|Overall Study|Lost to Follow-up|0|||
131919704|NCT01078662|474989325|FG004|Overall Study|Lost to Follow-up|0|||
131919705|NCT00700635|474989327|FG000|Overall Study|Adverse Event|1|||
131919706|NCT00700635|474989328|FG001|Overall Study|Adverse Event|0|||
131919707|NCT00700635|474989329|FG002|Overall Study|Adverse Event|0|||
131919708|NCT00700635|474989327|FG000|Overall Study|Lost to Follow-up|1|||
131919709|NCT00700635|474989328|FG001|Overall Study|Lost to Follow-up|3|||
131919710|NCT00700635|474989329|FG002|Overall Study|Lost to Follow-up|0|||
131919711|NCT00700635|474989327|FG000|Overall Study|Protocol Violation|2|||
131919712|NCT00700635|474989328|FG001|Overall Study|Protocol Violation|2|||
131919713|NCT00700635|474989329|FG002|Overall Study|Protocol Violation|0|||
131919714|NCT00700635|474989327|FG000|Overall Study|Withdrawal by Subject|7|||
131919715|NCT00700635|474989328|FG001|Overall Study|Withdrawal by Subject|3|||
131919716|NCT00700635|474989329|FG002|Overall Study|Withdrawal by Subject|1|||
131919717|NCT05172570|474989330|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
131919718|NCT05172570|474989331|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
131919719|NCT05172570|474989332|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
131919720|NCT05172570|474989330|FG000|Overall Study|PI Decision due to equipment shortages|0|||
131919721|NCT05172570|474989331|FG001|Overall Study|PI Decision due to equipment shortages|0|||
131919722|NCT05172570|474989332|FG002|Overall Study|PI Decision due to equipment shortages|1|||
131919723|NCT01202591|474989335|FG000|Overall Study|Adverse Event|2|||
131919724|NCT01202591|474989336|FG001|Overall Study|Adverse Event|1|||
131919725|NCT01202591|474989337|FG002|Overall Study|Adverse Event|4|||
131919726|NCT01202591|474989338|FG003|Overall Study|Adverse Event|4|||
131919727|NCT01202591|474989339|FG004|Overall Study|Adverse Event|0|||
131919728|NCT01202591|474989340|FG005|Overall Study|Adverse Event|0|||
131919729|NCT01202591|474989335|FG000|Overall Study|Other reason as per investigator|3|||
131919730|NCT01202591|474989336|FG001|Overall Study|Other reason as per investigator|4|||
131919731|NCT01202591|474989337|FG002|Overall Study|Other reason as per investigator|7|||
131919732|NCT01202591|474989338|FG003|Overall Study|Other reason as per investigator|3|||
131919733|NCT01202591|474989339|FG004|Overall Study|Other reason as per investigator|1|||
131919734|NCT01202591|474989340|FG005|Overall Study|Other reason as per investigator|3|||
131919735|NCT01202591|474989335|FG000|Overall Study|Withdrawal by Subject|0|||
131919736|NCT01202591|474989336|FG001|Overall Study|Withdrawal by Subject|0|||
131919737|NCT01202591|474989337|FG002|Overall Study|Withdrawal by Subject|0|||
131919738|NCT01202591|474989338|FG003|Overall Study|Withdrawal by Subject|0|||
131919739|NCT01202591|474989339|FG004|Overall Study|Withdrawal by Subject|2|||
131919740|NCT01202591|474989340|FG005|Overall Study|Withdrawal by Subject|1|||
131919741|NCT01202591|474989335|FG000|Overall Study|Objective Disease Progression|0|||
131919742|NCT01202591|474989336|FG001|Overall Study|Objective Disease Progression|0|||
131919743|NCT01202591|474989337|FG002|Overall Study|Objective Disease Progression|0|||
131919744|NCT01202591|474989338|FG003|Overall Study|Objective Disease Progression|0|||
131919745|NCT01202591|474989339|FG004|Overall Study|Objective Disease Progression|2|||
131919746|NCT01202591|474989340|FG005|Overall Study|Objective Disease Progression|0|||
131919747|NCT02830087|474989343|FG000|Overall Study|No study staff to follow-up patients|4|||
131919748|NCT02830087|474989344|FG001|Overall Study|No study staff to follow-up patients|4|||
131919749|NCT02830087|474989345|FG002|Overall Study|No study staff to follow-up patients|4|||
131919750|NCT02830087|474989346|FG003|Overall Study|No study staff to follow-up patients|3|||
131919751|NCT02830087|474989347|FG004|Overall Study|No study staff to follow-up patients|3|||
131919752|NCT02830087|474989348|FG005|Overall Study|No study staff to follow-up patients|3|||
131919753|NCT04937387|474989349|FG000|Overall Study|Adverse Event|1|||
131919754|NCT04937387|474989350|FG001|Overall Study|Adverse Event|0|||
131919755|NCT04937387|474989351|FG002|Overall Study|Adverse Event|2|||
131919756|NCT04937387|474989352|FG003|Overall Study|Adverse Event|0|||
131919757|NCT04937387|474989349|FG000|Overall Study|Lack of Efficacy|1|||
131919758|NCT04937387|474989350|FG001|Overall Study|Lack of Efficacy|0|||
131919759|NCT04937387|474989351|FG002|Overall Study|Lack of Efficacy|0|||
131919760|NCT04937387|474989352|FG003|Overall Study|Lack of Efficacy|1|||
131919761|NCT04937387|474989349|FG000|Overall Study|Withdrawal by Subject|1|||
131919762|NCT04937387|474989350|FG001|Overall Study|Withdrawal by Subject|0|||
131919763|NCT04937387|474989351|FG002|Overall Study|Withdrawal by Subject|1|||
131919764|NCT04937387|474989352|FG003|Overall Study|Withdrawal by Subject|1|||
131919765|NCT04937387|474989349|FG000|Overall Study|Randomized in error|0|||
131408314|NCT01133405|473118258|FG004|Period 1|Discontinued after randomization|0|||
131408315|NCT01133405|473118259|FG005|Period 1|Discontinued after randomization|0|||
131408316|NCT01133405|473118260|FG006|Period 1|Discontinued after randomization|1|||
131408317|NCT01133405|473118261|FG007|Period 1|Discontinued after randomization|0|||
131408318|NCT01133405|473118262|FG008|Period 1|Discontinued after randomization|0|||
131408319|NCT01133405|473118263|FG009|Period 1|Discontinued after randomization|0|||
131919766|NCT04937387|474989350|FG001|Overall Study|Randomized in error|0|||
131919767|NCT04937387|474989351|FG002|Overall Study|Randomized in error|0|||
131919768|NCT04937387|474989352|FG003|Overall Study|Randomized in error|1|||
131919769|NCT02583269|474989353|FG000|Overall Study|Patient hospitalized prior to start|1|||
131919770|NCT02583269|474989354|FG001|Overall Study|Patient hospitalized prior to start|0|||
131919771|NCT02583269|474989355|FG002|Overall Study|Patient hospitalized prior to start|0|||
131919772|NCT02583269|474989356|FG003|Overall Study|Patient hospitalized prior to start|0|||
131919773|NCT02583269|474989357|FG004|Overall Study|Patient hospitalized prior to start|0|||
131919774|NCT03611946|474989358|FG000|Overall Study|Withdrawal by Subject|0|||
131408320|NCT01133405|473118254|FG000|Period 1|Received drug only in period 2|0|||
131408321|NCT01133405|473118255|FG001|Period 1|Received drug only in period 2|1|||
131919775|NCT03611946|474989359|FG001|Overall Study|Withdrawal by Subject|0|||
131919776|NCT03611946|474989360|FG002|Overall Study|Withdrawal by Subject|1|||
131919777|NCT03611946|474989361|FG003|Overall Study|Withdrawal by Subject|0|||
131919778|NCT01373229|474990594|FG000|Overall Study|Death|3|||
131919779|NCT01373229|474990594|FG000|Overall Study|Physician Decision|3|||
131919780|NCT00143507|474990596|FG000|Overall Study|Death|572|||
131919781|NCT00143507|474990597|FG001|Overall Study|Death|547|||
131873689|NCT01314872|474817342|FG005|Treatment Period 1|Lack of Efficacy|1|||
131873690|NCT01314872|474817343|FG006|Treatment Period 1|Lack of Efficacy|0|||
131873691|NCT01314872|474817344|FG007|Treatment Period 1|Lack of Efficacy|2|||
131873692|NCT01314872|474817345|FG008|Treatment Period 1|Lack of Efficacy|0|||
131873693|NCT01314872|474817346|FG009|Treatment Period 1|Lack of Efficacy|0|||
131873694|NCT01314872|474817347|FG010|Treatment Period 1|Lack of Efficacy|0|||
131873695|NCT01314872|474817348|FG011|Treatment Period 1|Lack of Efficacy|0|||
131873696|NCT01314872|474817349|FG012|Treatment Period 1|Lack of Efficacy|0|||
131873697|NCT01314872|474817350|FG013|Treatment Period 1|Lack of Efficacy|0|||
131873698|NCT01314872|474817351|FG014|Treatment Period 1|Lack of Efficacy|0|||
131873699|NCT01314872|474817337|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
131873700|NCT01314872|474817338|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
131873701|NCT01314872|474817339|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
131873702|NCT01314872|474817340|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
131873703|NCT01314872|474817341|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
131873704|NCT01314872|474817342|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
131873705|NCT01314872|474817343|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
131873706|NCT01314872|474817344|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
131873707|NCT01314872|474817345|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
131873708|NCT01314872|474817346|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
131873709|NCT01314872|474817347|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
131873710|NCT01314872|474817348|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
131873711|NCT01314872|474817349|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
131873712|NCT01314872|474817350|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
131873713|NCT01314872|474817351|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
131873714|NCT01314872|474817337|FG000|Treatment Period 1|Withdrawal by Subject|3|||
131873715|NCT01314872|474817338|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131873716|NCT01314872|474817339|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131873717|NCT01314872|474817340|FG003|Treatment Period 1|Withdrawal by Subject|2|||
131873718|NCT01314872|474817341|FG004|Treatment Period 1|Withdrawal by Subject|3|||
131873719|NCT01314872|474817342|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131873720|NCT01314872|474817343|FG006|Treatment Period 1|Withdrawal by Subject|3|||
131873721|NCT01314872|474817344|FG007|Treatment Period 1|Withdrawal by Subject|2|||
131873722|NCT01314872|474817345|FG008|Treatment Period 1|Withdrawal by Subject|2|||
131873723|NCT01314872|474817346|FG009|Treatment Period 1|Withdrawal by Subject|2|||
131873724|NCT01314872|474817347|FG010|Treatment Period 1|Withdrawal by Subject|1|||
131873725|NCT01314872|474817348|FG011|Treatment Period 1|Withdrawal by Subject|0|||
131873726|NCT01314872|474817349|FG012|Treatment Period 1|Withdrawal by Subject|0|||
131873727|NCT01314872|474817350|FG013|Treatment Period 1|Withdrawal by Subject|0|||
131873728|NCT01314872|474817351|FG014|Treatment Period 1|Withdrawal by Subject|0|||
131873729|NCT01314872|474817337|FG000|Treatment Period 1|Lost to Follow-up|0|||
131873730|NCT01314872|474817338|FG001|Treatment Period 1|Lost to Follow-up|1|||
131873731|NCT01314872|474817339|FG002|Treatment Period 1|Lost to Follow-up|2|||
131873732|NCT01314872|474817340|FG003|Treatment Period 1|Lost to Follow-up|2|||
131873733|NCT01314872|474817341|FG004|Treatment Period 1|Lost to Follow-up|1|||
131873734|NCT01314872|474817342|FG005|Treatment Period 1|Lost to Follow-up|1|||
131873735|NCT01314872|474817343|FG006|Treatment Period 1|Lost to Follow-up|1|||
131873736|NCT01314872|474817344|FG007|Treatment Period 1|Lost to Follow-up|1|||
131873737|NCT01314872|474817345|FG008|Treatment Period 1|Lost to Follow-up|1|||
131873738|NCT01314872|474817346|FG009|Treatment Period 1|Lost to Follow-up|0|||
131873739|NCT01314872|474817347|FG010|Treatment Period 1|Lost to Follow-up|0|||
131873740|NCT01314872|474817348|FG011|Treatment Period 1|Lost to Follow-up|0|||
131873741|NCT01314872|474817349|FG012|Treatment Period 1|Lost to Follow-up|0|||
131873742|NCT01314872|474817350|FG013|Treatment Period 1|Lost to Follow-up|0|||
131873743|NCT01314872|474817351|FG014|Treatment Period 1|Lost to Follow-up|0|||
131873744|NCT01314872|474817337|FG000|Period 2|Protocol Violation|0|||
131873745|NCT01314872|474817338|FG001|Period 2|Protocol Violation|0|||
131873746|NCT01314872|474817339|FG002|Period 2|Protocol Violation|0|||
131873747|NCT01314872|474817340|FG003|Period 2|Protocol Violation|0|||
131873748|NCT01314872|474817341|FG004|Period 2|Protocol Violation|0|||
131919782|NCT00143507|474990596|FG000|Overall Study|Withdrawal by Subject|114|||
131919783|NCT00143507|474990597|FG001|Overall Study|Withdrawal by Subject|102|||
131919784|NCT00143507|474990596|FG000|Overall Study|Lost to Follow-up|1|||
131919785|NCT00143507|474990597|FG001|Overall Study|Lost to Follow-up|0|||
131873749|NCT01314872|474817342|FG005|Period 2|Protocol Violation|0|||
131873750|NCT01314872|474817343|FG006|Period 2|Protocol Violation|0|||
131873751|NCT01314872|474817344|FG007|Period 2|Protocol Violation|0|||
131919786|NCT00143507|474990596|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
131873752|NCT01314872|474817345|FG008|Period 2|Protocol Violation|0|||
131873753|NCT01314872|474817346|FG009|Period 2|Protocol Violation|0|||
131873754|NCT01314872|474817347|FG010|Period 2|Protocol Violation|0|||
131873755|NCT01314872|474817348|FG011|Period 2|Protocol Violation|3|||
131873756|NCT01314872|474817349|FG012|Period 2|Protocol Violation|3|||
131873757|NCT01314872|474817350|FG013|Period 2|Protocol Violation|2|||
131873758|NCT01314872|474817351|FG014|Period 2|Protocol Violation|0|||
131873759|NCT01314872|474817337|FG000|Period 2|Non-compliance with study drug|0|||
131873760|NCT01314872|474817338|FG001|Period 2|Non-compliance with study drug|0|||
131873761|NCT01314872|474817339|FG002|Period 2|Non-compliance with study drug|0|||
131873762|NCT01314872|474817340|FG003|Period 2|Non-compliance with study drug|0|||
131873763|NCT01314872|474817341|FG004|Period 2|Non-compliance with study drug|0|||
131873764|NCT01314872|474817342|FG005|Period 2|Non-compliance with study drug|0|||
131873765|NCT01314872|474817343|FG006|Period 2|Non-compliance with study drug|0|||
131873766|NCT01314872|474817344|FG007|Period 2|Non-compliance with study drug|0|||
131873767|NCT01314872|474817345|FG008|Period 2|Non-compliance with study drug|0|||
131873768|NCT01314872|474817346|FG009|Period 2|Non-compliance with study drug|0|||
131873769|NCT01314872|474817347|FG010|Period 2|Non-compliance with study drug|0|||
131873770|NCT01314872|474817348|FG011|Period 2|Non-compliance with study drug|3|||
131873771|NCT01314872|474817349|FG012|Period 2|Non-compliance with study drug|3|||
131873772|NCT01314872|474817350|FG013|Period 2|Non-compliance with study drug|1|||
131873773|NCT01314872|474817351|FG014|Period 2|Non-compliance with study drug|2|||
131873774|NCT01314872|474817337|FG000|Period 2|Lack of Efficacy|0|||
131873775|NCT01314872|474817338|FG001|Period 2|Lack of Efficacy|0|||
131873776|NCT01314872|474817339|FG002|Period 2|Lack of Efficacy|0|||
131873777|NCT01314872|474817340|FG003|Period 2|Lack of Efficacy|0|||
131873778|NCT01314872|474817341|FG004|Period 2|Lack of Efficacy|0|||
131873779|NCT01314872|474817342|FG005|Period 2|Lack of Efficacy|0|||
131873780|NCT01314872|474817343|FG006|Period 2|Lack of Efficacy|0|||
131873781|NCT01314872|474817344|FG007|Period 2|Lack of Efficacy|0|||
131873782|NCT01314872|474817345|FG008|Period 2|Lack of Efficacy|0|||
131873783|NCT01314872|474817346|FG009|Period 2|Lack of Efficacy|0|||
131873784|NCT01314872|474817347|FG010|Period 2|Lack of Efficacy|0|||
131873785|NCT01314872|474817348|FG011|Period 2|Lack of Efficacy|7|||
131873786|NCT01314872|474817349|FG012|Period 2|Lack of Efficacy|12|||
131873787|NCT01314872|474817350|FG013|Period 2|Lack of Efficacy|9|||
131873788|NCT01314872|474817351|FG014|Period 2|Lack of Efficacy|2|||
131873789|NCT01314872|474817337|FG000|Period 2|Pregnancy|0|||
131873790|NCT01314872|474817338|FG001|Period 2|Pregnancy|0|||
131873791|NCT01314872|474817339|FG002|Period 2|Pregnancy|0|||
131873792|NCT01314872|474817340|FG003|Period 2|Pregnancy|0|||
131873793|NCT01314872|474817341|FG004|Period 2|Pregnancy|0|||
131873794|NCT01314872|474817342|FG005|Period 2|Pregnancy|0|||
131873795|NCT01314872|474817343|FG006|Period 2|Pregnancy|0|||
131873796|NCT01314872|474817344|FG007|Period 2|Pregnancy|0|||
131873797|NCT01314872|474817345|FG008|Period 2|Pregnancy|0|||
131873798|NCT01314872|474817346|FG009|Period 2|Pregnancy|0|||
131873799|NCT01314872|474817347|FG010|Period 2|Pregnancy|0|||
131873800|NCT01314872|474817348|FG011|Period 2|Pregnancy|0|||
131873801|NCT01314872|474817349|FG012|Period 2|Pregnancy|0|||
131873802|NCT01314872|474817350|FG013|Period 2|Pregnancy|0|||
131873803|NCT01314872|474817351|FG014|Period 2|Pregnancy|1|||
131873804|NCT01314872|474817337|FG000|Period 2|Study terminated by Sponsor|0|||
131873805|NCT01314872|474817338|FG001|Period 2|Study terminated by Sponsor|0|||
131873806|NCT01314872|474817339|FG002|Period 2|Study terminated by Sponsor|0|||
131873807|NCT01314872|474817340|FG003|Period 2|Study terminated by Sponsor|0|||
131873808|NCT01314872|474817341|FG004|Period 2|Study terminated by Sponsor|0|||
131873809|NCT01314872|474817342|FG005|Period 2|Study terminated by Sponsor|0|||
131873810|NCT01314872|474817343|FG006|Period 2|Study terminated by Sponsor|0|||
131873811|NCT01314872|474817344|FG007|Period 2|Study terminated by Sponsor|0|||
131873812|NCT01314872|474817345|FG008|Period 2|Study terminated by Sponsor|0|||
131873813|NCT01314872|474817346|FG009|Period 2|Study terminated by Sponsor|0|||
131873814|NCT01314872|474817347|FG010|Period 2|Study terminated by Sponsor|0|||
131873815|NCT01314872|474817348|FG011|Period 2|Study terminated by Sponsor|2|||
131873816|NCT01314872|474817349|FG012|Period 2|Study terminated by Sponsor|2|||
131873817|NCT01314872|474817350|FG013|Period 2|Study terminated by Sponsor|3|||
131873818|NCT01314872|474817351|FG014|Period 2|Study terminated by Sponsor|0|||
131873819|NCT01314872|474817337|FG000|Period 2|Adverse event, non-fatal|0|||
131873820|NCT01314872|474817338|FG001|Period 2|Adverse event, non-fatal|0|||
131873821|NCT01314872|474817339|FG002|Period 2|Adverse event, non-fatal|0|||
131873822|NCT01314872|474817340|FG003|Period 2|Adverse event, non-fatal|0|||
131873823|NCT01314872|474817341|FG004|Period 2|Adverse event, non-fatal|0|||
131873824|NCT01314872|474817342|FG005|Period 2|Adverse event, non-fatal|0|||
131873825|NCT01314872|474817343|FG006|Period 2|Adverse event, non-fatal|0|||
131873826|NCT01314872|474817344|FG007|Period 2|Adverse event, non-fatal|0|||
131873827|NCT01314872|474817345|FG008|Period 2|Adverse event, non-fatal|0|||
131873828|NCT01314872|474817346|FG009|Period 2|Adverse event, non-fatal|0|||
131873829|NCT01314872|474817347|FG010|Period 2|Adverse event, non-fatal|0|||
131873830|NCT01314872|474817348|FG011|Period 2|Adverse event, non-fatal|13|||
131873831|NCT01314872|474817349|FG012|Period 2|Adverse event, non-fatal|16|||
131873832|NCT01314872|474817350|FG013|Period 2|Adverse event, non-fatal|24|||
131919787|NCT00143507|474990597|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
131919788|NCT00587457|474990598|FG000|Overall Study|Adverse Event|1|||
131919789|NCT00587457|474990599|FG001|Overall Study|Adverse Event|2|||
131919790|NCT00587457|474990600|FG002|Overall Study|Adverse Event|1|||
131919791|NCT00587457|474990598|FG000|Overall Study|Disease progression|2|||
131919792|NCT00587457|474990599|FG001|Overall Study|Disease progression|0|||
131873833|NCT01314872|474817351|FG014|Period 2|Adverse event, non-fatal|9|||
131873834|NCT01314872|474817337|FG000|Period 2|Withdrawal by Subject|0|||
131873835|NCT01314872|474817338|FG001|Period 2|Withdrawal by Subject|0|||
131873836|NCT01314872|474817339|FG002|Period 2|Withdrawal by Subject|0|||
131873837|NCT01314872|474817340|FG003|Period 2|Withdrawal by Subject|0|||
131873838|NCT01314872|474817341|FG004|Period 2|Withdrawal by Subject|0|||
131873839|NCT01314872|474817342|FG005|Period 2|Withdrawal by Subject|0|||
131873840|NCT01314872|474817343|FG006|Period 2|Withdrawal by Subject|0|||
131873841|NCT01314872|474817344|FG007|Period 2|Withdrawal by Subject|0|||
131873842|NCT01314872|474817345|FG008|Period 2|Withdrawal by Subject|0|||
131873843|NCT01314872|474817346|FG009|Period 2|Withdrawal by Subject|0|||
131873844|NCT01314872|474817347|FG010|Period 2|Withdrawal by Subject|0|||
131873845|NCT01314872|474817348|FG011|Period 2|Withdrawal by Subject|14|||
131873846|NCT01314872|474817349|FG012|Period 2|Withdrawal by Subject|17|||
131873847|NCT01314872|474817350|FG013|Period 2|Withdrawal by Subject|12|||
131873848|NCT01314872|474817351|FG014|Period 2|Withdrawal by Subject|4|||
131873849|NCT01314872|474817337|FG000|Period 2|Lost to Follow-up|0|||
131873850|NCT01314872|474817338|FG001|Period 2|Lost to Follow-up|0|||
131873851|NCT01314872|474817339|FG002|Period 2|Lost to Follow-up|0|||
131873852|NCT01314872|474817340|FG003|Period 2|Lost to Follow-up|0|||
131873853|NCT01314872|474817341|FG004|Period 2|Lost to Follow-up|0|||
131873854|NCT01314872|474817342|FG005|Period 2|Lost to Follow-up|0|||
131873855|NCT01314872|474817343|FG006|Period 2|Lost to Follow-up|0|||
131873856|NCT01314872|474817344|FG007|Period 2|Lost to Follow-up|0|||
131873857|NCT01314872|474817345|FG008|Period 2|Lost to Follow-up|0|||
131873858|NCT01314872|474817346|FG009|Period 2|Lost to Follow-up|0|||
131873859|NCT01314872|474817347|FG010|Period 2|Lost to Follow-up|0|||
131873860|NCT01314872|474817348|FG011|Period 2|Lost to Follow-up|6|||
131873861|NCT01314872|474817349|FG012|Period 2|Lost to Follow-up|7|||
131873862|NCT01314872|474817350|FG013|Period 2|Lost to Follow-up|2|||
131873863|NCT01314872|474817351|FG014|Period 2|Lost to Follow-up|6|||
131873864|NCT03232931|474818440|FG000|Overall Study|Physician Decision|1|||
131873865|NCT03232931|474818441|FG001|Overall Study|Physician Decision|1|||
131873866|NCT03232931|474818440|FG000|Overall Study|Withdrawal by Subject|6|||
131873867|NCT03232931|474818441|FG001|Overall Study|Withdrawal by Subject|0|||
131873868|NCT03232931|474818440|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
131873869|NCT03232931|474818441|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
131873870|NCT03232931|474818440|FG000|Overall Study|Parent did not record voice|1|||
131873871|NCT03232931|474818441|FG001|Overall Study|Parent did not record voice|2|||
131873872|NCT03232931|474818440|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
131873873|NCT03232931|474818441|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
131873874|NCT04925557|474818442|FG000|Overall Study|Study closed|5|||
131873875|NCT04925557|474818443|FG001|Overall Study|Study closed|3|||
131873876|NCT05488470|474818444|FG000|Overall Study|Physician Decision|2|||
131873877|NCT05488470|474818444|FG000|Overall Study|Withdrawal by Subject|1|||
131873878|NCT05488470|474818444|FG000|Overall Study|Death|1|||
131873879|NCT00068393|474818445|FG000|Overall Study|Adverse Event|2|||
131873880|NCT00068393|474818445|FG000|Overall Study|Death|3|||
131873881|NCT00068393|474818445|FG000|Overall Study|Withdrawal by Subject|3|||
131873882|NCT00068393|474818445|FG000|Overall Study|Alternative treatment|1|||
131873883|NCT00068393|474818445|FG000|Overall Study|Quality of life worsening|1|||
131873884|NCT04981470|474818452|FG000|Overall Study|Device failure in all 4 patients|4|||
131873885|NCT04390503|474818454|FG000|Overall Study|Physician Decision|2|||
131873886|NCT04390503|474818455|FG001|Overall Study|Physician Decision|1|||
131873887|NCT04390503|474818454|FG000|Overall Study|Adverse Event|1|||
131873888|NCT04390503|474818455|FG001|Overall Study|Adverse Event|0|||
131873889|NCT00078767|474818456|FG000|Overall Study|Withdrawal by Subject|1|||
131873890|NCT00078767|474818457|FG001|Overall Study|Withdrawal by Subject|1|||
131873891|NCT02282631|474818460|FG000|Overall Study|Lost to Follow-up|2|||
131873892|NCT02282631|474818461|FG001|Overall Study|Lost to Follow-up|0|||
131873893|NCT01736397|474818462|FG000|Overall Study|Lack of Efficacy|1|||
131873894|NCT01736397|474818463|FG001|Overall Study|Lack of Efficacy|11|||
131873895|NCT01736397|474818462|FG000|Overall Study|Withdrawal by Subject|6|||
131919793|NCT00587457|474990600|FG002|Overall Study|Disease progression|2|||
131919794|NCT00587457|474990598|FG000|Overall Study|Initiation of alternative therapy|0|||
131919795|NCT00587457|474990599|FG001|Overall Study|Initiation of alternative therapy|1|||
131873896|NCT01736397|474818463|FG001|Overall Study|Withdrawal by Subject|5|||
131873897|NCT01736397|474818462|FG000|Overall Study|Lost to Follow-up|0|||
131873898|NCT01736397|474818463|FG001|Overall Study|Lost to Follow-up|1|||
131873899|NCT01736397|474818462|FG000|Overall Study|Adverse Event|6|||
131873900|NCT01736397|474818463|FG001|Overall Study|Adverse Event|3|||
131873901|NCT01736397|474818462|FG000|Overall Study|Not stated|1|||
131873902|NCT01736397|474818463|FG001|Overall Study|Not stated|4|||
131873903|NCT05088603|474818464|FG000|Overall Study|Protocol Violation|6|||
131873904|NCT05088603|474818465|FG001|Overall Study|Protocol Violation|1|||
131873905|NCT01841762|474818467|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
131408322|NCT01133405|473118256|FG002|Period 1|Received drug only in period 2|0|||
131408323|NCT01133405|473118257|FG003|Period 1|Received drug only in period 2|2|||
131408324|NCT01133405|473118258|FG004|Period 1|Received drug only in period 2|0|||
131408325|NCT01133405|473118259|FG005|Period 1|Received drug only in period 2|1|||
131873906|NCT01841762|474818467|FG000|Treatment Period|Adverse Event|16|||
131873907|NCT01841762|474818467|FG000|Treatment Period|Death|1|||
131873908|NCT01841762|474818467|FG000|Treatment Period|Withdrawal by Subject|7|||
131873909|NCT01841762|474818467|FG000|Treatment Period|Lost to Follow-up|1|||
131873910|NCT01841762|474818467|FG000|Treatment Period|Physician Decision|2|||
131873911|NCT01841762|474818467|FG000|Treatment Period|Other, including non-compliance|5|||
131873912|NCT01841762|474818467|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
131873913|NCT01841762|474818467|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
131873914|NCT01841762|474818467|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
131873915|NCT01841762|474818467|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
131873916|NCT03260244|474818468|FG000|Overall Study|Death|19|||
131873917|NCT03260244|474818468|FG000|Overall Study|Lost to Follow-up|60|||
131873918|NCT03260244|474818468|FG000|Overall Study|Withdrawal by Subject|48|||
131873919|NCT03260244|474818468|FG000|Overall Study|Procedure Not Performed|21|||
131873920|NCT03260244|474818468|FG000|Overall Study|Enrollment Criteria Not Met|31|||
131873921|NCT03260244|474818468|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
131873922|NCT03260244|474818468|FG000|Overall Study|Subject Noncompliance|6|||
131873923|NCT03260244|474818468|FG000|Overall Study|No inducible Arrhythmia|2|||
131873924|NCT03260244|474818468|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
131873925|NCT03260244|474818468|FG000|Overall Study|Screen Failure|2|||
131873926|NCT03260244|474818468|FG000|Overall Study|Treated Off Label|69|||
131873927|NCT03260244|474818468|FG000|Overall Study|No Radiofrequency Ablation|14|||
131873928|NCT03528369|474818473|FG000|Overall Study|Withdrawal by Subject|2|||
131873929|NCT03528369|474818474|FG001|Overall Study|Withdrawal by Subject|0|||
131873930|NCT03528369|474818475|FG002|Overall Study|Withdrawal by Subject|0|||
131873931|NCT03528369|474818473|FG000|Overall Study|Lost to Follow-up|1|||
131873932|NCT03528369|474818474|FG001|Overall Study|Lost to Follow-up|0|||
131873933|NCT03528369|474818475|FG002|Overall Study|Lost to Follow-up|0|||
131873934|NCT03528369|474818473|FG000|Overall Study|Adverse Event|0|||
131873935|NCT03528369|474818474|FG001|Overall Study|Adverse Event|1|||
131873936|NCT03528369|474818475|FG002|Overall Study|Adverse Event|0|||
131873937|NCT02162719|474818476|FG000|Overall Study|Death|41|||
131873938|NCT02162719|474818477|FG001|Overall Study|Death|46|||
131919796|NCT00587457|474990600|FG002|Overall Study|Initiation of alternative therapy|0|||
131919797|NCT00587457|474990598|FG000|Overall Study|Undefined|0|||
131919798|NCT00587457|474990599|FG001|Overall Study|Undefined|0|||
131919799|NCT00587457|474990600|FG002|Overall Study|Undefined|1|||
131919800|NCT00587457|474990598|FG000|Overall Study|Development of neutralizing Abs|0|||
131919801|NCT00587457|474990599|FG001|Overall Study|Development of neutralizing Abs|0|||
131919802|NCT00587457|474990600|FG002|Overall Study|Development of neutralizing Abs|1|||
131919803|NCT03234881|474990601|FG000|Overall Study|Lost to Follow-up|9|||
131919804|NCT03234881|474990602|FG001|Overall Study|Lost to Follow-up|3|||
131919805|NCT00876395|474990603|FG000|Overall Study|Untreated|8|||
131919806|NCT00876395|474990604|FG001|Overall Study|Untreated|1|||
131919807|NCT00876395|474990603|FG000|Overall Study|Adverse Event|63|||
131919808|NCT00876395|474990604|FG001|Overall Study|Adverse Event|11|||
131919809|NCT00876395|474990603|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131919810|NCT00876395|474990604|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131919811|NCT00876395|474990603|FG000|Overall Study|Disease progression|259|||
131919812|NCT00876395|474990604|FG001|Overall Study|Disease progression|162|||
131919813|NCT00876395|474990603|FG000|Overall Study|New cancer therapy|25|||
131919814|NCT00876395|474990604|FG001|Overall Study|New cancer therapy|7|||
131919815|NCT00876395|474990603|FG000|Overall Study|Protocol Violation|5|||
131919816|NCT00876395|474990604|FG001|Overall Study|Protocol Violation|2|||
131408326|NCT01133405|473118260|FG006|Period 1|Received drug only in period 2|0|||
131873939|NCT02162719|474818476|FG000|Overall Study|Lost to Follow-up|1|||
131873940|NCT02162719|474818477|FG001|Overall Study|Lost to Follow-up|3|||
131873941|NCT02162719|474818476|FG000|Overall Study|Disease Progression|2|||
131873942|NCT02162719|474818477|FG001|Overall Study|Disease Progression|1|||
131873943|NCT02162719|474818476|FG000|Overall Study|Withdrawal by Subject|8|||
131919817|NCT00876395|474990603|FG000|Overall Study|Withdrawal by Subject|66|||
131919818|NCT00876395|474990604|FG001|Overall Study|Withdrawal by Subject|33|||
131919819|NCT00876395|474990603|FG000|Overall Study|Lost to Follow-up|2|||
131408327|NCT01133405|473118261|FG007|Period 1|Received drug only in period 2|0|||
131919820|NCT00876395|474990604|FG001|Overall Study|Lost to Follow-up|0|||
131919821|NCT00876395|474990603|FG000|Overall Study|Administrative problems|39|||
131919822|NCT00876395|474990604|FG001|Overall Study|Administrative problems|23|||
131408328|NCT01133405|473118262|FG008|Period 1|Received drug only in period 2|0|||
131408329|NCT01133405|473118263|FG009|Period 1|Received drug only in period 2|0|||
131408330|NCT01133405|473118254|FG000|Period 1|Received drug only in period 3|0|||
131408331|NCT01133405|473118255|FG001|Period 1|Received drug only in period 3|1|||
131408332|NCT01133405|473118256|FG002|Period 1|Received drug only in period 3|1|||
131408333|NCT01133405|473118257|FG003|Period 1|Received drug only in period 3|0|||
131408334|NCT01133405|473118258|FG004|Period 1|Received drug only in period 3|0|||
131408335|NCT01133405|473118259|FG005|Period 1|Received drug only in period 3|0|||
131873944|NCT02162719|474818477|FG001|Overall Study|Withdrawal by Subject|2|||
131873945|NCT02162719|474818476|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
131873946|NCT02162719|474818477|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
131873947|NCT03555565|474818478|FG000|Overall Study|Case Report Forms Uncollected|2|||
131873948|NCT03555565|474818478|FG000|Overall Study|Protocol Deviation|13|||
131873949|NCT04411810|474818484|FG000|Overall Study|Screen failure|1|||
131873950|NCT04411810|474818484|FG000|Overall Study|Withdrawal by Subject|1|||
131873951|NCT01920958|474818485|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
131873952|NCT03192306|474818488|FG000|Overall Study|Did not treat cold sore during study|149|||
131873953|NCT03192306|474818489|FG001|Overall Study|Did not treat cold sore during study|143|||
131873954|NCT03192306|474818488|FG000|Overall Study|Withdrawal by Subject|1|||
131873955|NCT03192306|474818489|FG001|Overall Study|Withdrawal by Subject|1|||
131873956|NCT03192306|474818488|FG000|Overall Study|Lost to Follow-up|1|||
131873957|NCT03192306|474818489|FG001|Overall Study|Lost to Follow-up|0|||
131873958|NCT03192306|474818488|FG000|Overall Study|Protocol Violation|1|||
131873959|NCT03192306|474818489|FG001|Overall Study|Protocol Violation|1|||
131873960|NCT02589626|474818497|FG000|Overall Study|Other than the reason specified|1|||
131873961|NCT02589626|474818498|FG001|Overall Study|Other than the reason specified|0|||
131873962|NCT02589626|474818497|FG000|Overall Study|Withdrawal by Subject|1|||
131873963|NCT02589626|474818498|FG001|Overall Study|Withdrawal by Subject|1|||
131873964|NCT02589626|474818497|FG000|Overall Study|Adverse Event|1|||
131873965|NCT02589626|474818498|FG001|Overall Study|Adverse Event|1|||
131873966|NCT00887315|474818500|FG000|Overall Study|Study termination|7|||
131873967|NCT00887315|474818501|FG001|Overall Study|Study termination|4|||
131873968|NCT00857896|474818506|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
131873969|NCT00930774|474818513|FG000|Overall Study|Withdrawal by Subject|1|||
131873970|NCT00930774|474818514|FG001|Overall Study|Withdrawal by Subject|9|||
131873971|NCT00930774|474818515|FG002|Overall Study|Withdrawal by Subject|2|||
131873972|NCT00930774|474818516|FG003|Overall Study|Withdrawal by Subject|0|||
131873973|NCT03200704|474818517|FG000|Overall Study|Withdrawal by Subject|1|||
131873974|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
131873975|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
131873976|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
131873977|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
131873978|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
131873979|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
131873980|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
131873981|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
131873982|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
131873983|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
131873984|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
131873985|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
131873986|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
131873987|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
131873988|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
131873989|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
131873990|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
131873991|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
131873992|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
131873993|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
131873994|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
131873995|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
131873996|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
131873997|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
131873998|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
131873999|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
131874000|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
131874001|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
131874002|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
131874003|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
131874004|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
131874005|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
131874006|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
131874007|NCT00839527|474818519|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
131919823|NCT00876395|474990603|FG000|Overall Study|Death|12|||
131919824|NCT00876395|474990604|FG001|Overall Study|Death|0|||
131919825|NCT03807843|474990605|FG000|Overall Study|Lost to Follow-up|1|||
131453935|NCT00996333|473291839|FG000|Overall Study|Other|5|||
131874008|NCT00839527|474818520|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
131874009|NCT00839527|474818521|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
131874010|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
131874011|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
131874012|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
131874013|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
131874014|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
131874015|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
131874016|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
131874017|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
131874018|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
131874019|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
131874020|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
131874021|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
131874022|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
131874023|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
131874024|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
131874025|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
131874026|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
131874027|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
131874028|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
131874029|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
131874030|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
131874031|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
131874032|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
131874033|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
131874034|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
131874035|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
131874036|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
131874037|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
131874038|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
131874039|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
131874040|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
131874041|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
131874042|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
131874043|NCT00839527|474818519|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
131874044|NCT00839527|474818520|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
131874045|NCT00839527|474818521|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
131874046|NCT00552396|474818533|FG000|Overall Study|protocol withdrawal criteria|3|||
131874047|NCT00552396|474818534|FG001|Overall Study|protocol withdrawal criteria|3|||
131874048|NCT00552396|474818535|FG002|Overall Study|protocol withdrawal criteria|3|||
131874049|NCT00552396|474818536|FG003|Overall Study|protocol withdrawal criteria|6|||
131874050|NCT00552396|474818537|FG004|Overall Study|protocol withdrawal criteria|3|||
131874051|NCT00552396|474818538|FG005|Overall Study|protocol withdrawal criteria|3|||
131874052|NCT00552396|474818539|FG006|Overall Study|protocol withdrawal criteria|9|||
131874053|NCT02553499|474818540|FG000|Overall Study|Adverse Event|0|||
131874054|NCT02553499|474818541|FG001|Overall Study|Adverse Event|0|||
131874055|NCT02553499|474818542|FG002|Overall Study|Adverse Event|0|||
131874056|NCT02553499|474818543|FG003|Overall Study|Adverse Event|0|||
131874057|NCT02553499|474818544|FG004|Overall Study|Adverse Event|0|||
131874058|NCT02553499|474818545|FG005|Overall Study|Adverse Event|0|||
131874059|NCT02553499|474818546|FG006|Overall Study|Adverse Event|1|||
131874060|NCT02553499|474818547|FG007|Overall Study|Adverse Event|1|||
131874061|NCT02553499|474818548|FG008|Overall Study|Adverse Event|0|||
131874062|NCT02553499|474818549|FG009|Overall Study|Adverse Event|0|||
131874063|NCT02553499|474818550|FG010|Overall Study|Adverse Event|0|||
131874064|NCT02553499|474818551|FG011|Overall Study|Adverse Event|0|||
131874065|NCT02553499|474818552|FG012|Overall Study|Adverse Event|0|||
131919826|NCT03807843|474990606|FG001|Overall Study|Lost to Follow-up|0|||
131919827|NCT01312129|474990607|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
131453936|NCT01301027|473291842|FG000|Overall Study|Physician Decision|2|||
131874066|NCT02553499|474818553|FG013|Overall Study|Adverse Event|1|||
131874067|NCT02553499|474818540|FG000|Overall Study|Death|0|||
131874068|NCT02553499|474818541|FG001|Overall Study|Death|1|||
131919828|NCT01312129|474990608|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
131919829|NCT00924651|474990611|FG000|Overall Study|Chemo started too soon|2|||
131919830|NCT00924651|474990612|FG001|Overall Study|Chemo started too soon|3|||
131919831|NCT00924651|474990611|FG000|Overall Study|No Reason|3|||
131919832|NCT00924651|474990612|FG001|Overall Study|No Reason|7|||
131919833|NCT00924651|474990611|FG000|Overall Study|Overwhelmed|6|||
131919834|NCT00924651|474990612|FG001|Overall Study|Overwhelmed|6|||
131919835|NCT00924651|474990611|FG000|Overall Study|Noncompliant|1|||
131919836|NCT00924651|474990612|FG001|Overall Study|Noncompliant|4|||
131919837|NCT00924651|474990611|FG000|Overall Study|Medical|1|||
131919838|NCT00924651|474990612|FG001|Overall Study|Medical|3|||
131919839|NCT00924651|474990611|FG000|Overall Study|Changed Mind|10|||
131919840|NCT00924651|474990612|FG001|Overall Study|Changed Mind|1|||
131919841|NCT00924651|474990611|FG000|Overall Study|Incomplete Form|2|||
131919842|NCT00924651|474990612|FG001|Overall Study|Incomplete Form|1|||
131919843|NCT00729586|474990613|FG000|Overall Study|Ineligible|0|||
131919844|NCT00729586|474990614|FG001|Overall Study|Ineligible|1|||
131919845|NCT00729586|474990613|FG000|Overall Study|never treated|1|||
131919846|NCT00729586|474990614|FG001|Overall Study|never treated|0|||
131919847|NCT02260986|474990618|FG000|Overall Study|Adverse Event|24|||
131919848|NCT02260986|474990619|FG001|Overall Study|Adverse Event|0|||
131919849|NCT02260986|474990620|FG002|Overall Study|Adverse Event|11|||
131919850|NCT02260986|474990618|FG000|Overall Study|Lack of Efficacy|27|||
131919851|NCT02260986|474990619|FG001|Overall Study|Lack of Efficacy|3|||
131919852|NCT02260986|474990620|FG002|Overall Study|Lack of Efficacy|0|||
131919853|NCT02260986|474990618|FG000|Overall Study|Protocol Violation|14|||
131919854|NCT02260986|474990619|FG001|Overall Study|Protocol Violation|5|||
131919855|NCT02260986|474990620|FG002|Overall Study|Protocol Violation|16|||
131919856|NCT02260986|474990618|FG000|Overall Study|Car accident|0|||
131919857|NCT02260986|474990619|FG001|Overall Study|Car accident|0|||
131919858|NCT02260986|474990620|FG002|Overall Study|Car accident|1|||
131919859|NCT02260986|474990618|FG000|Overall Study|Withdrawal by Subject|17|||
131919860|NCT02260986|474990619|FG001|Overall Study|Withdrawal by Subject|4|||
131919861|NCT02260986|474990620|FG002|Overall Study|Withdrawal by Subject|9|||
131919862|NCT02260986|474990618|FG000|Overall Study|Incorrect randomization|0|||
131919863|NCT02260986|474990619|FG001|Overall Study|Incorrect randomization|1|||
131919864|NCT02260986|474990620|FG002|Overall Study|Incorrect randomization|0|||
131919865|NCT02260986|474990618|FG000|Overall Study|Lack of investigation product supply|2|||
131919866|NCT02260986|474990619|FG001|Overall Study|Lack of investigation product supply|0|||
131919867|NCT02260986|474990620|FG002|Overall Study|Lack of investigation product supply|1|||
131919868|NCT02260986|474990618|FG000|Overall Study|Lost to Follow-up|4|||
131919869|NCT02260986|474990619|FG001|Overall Study|Lost to Follow-up|0|||
131919870|NCT02260986|474990620|FG002|Overall Study|Lost to Follow-up|3|||
131919871|NCT02260986|474990618|FG000|Overall Study|Pregnancy|2|||
131919872|NCT02260986|474990619|FG001|Overall Study|Pregnancy|0|||
131919873|NCT02260986|474990620|FG002|Overall Study|Pregnancy|0|||
131919874|NCT02034591|474990623|FG000|Overall Study|Withdrawal by Subject|0|||
131919875|NCT02034591|474990624|FG001|Overall Study|Withdrawal by Subject|0|||
131919876|NCT02034591|474990625|FG002|Overall Study|Withdrawal by Subject|0|||
131919877|NCT02034591|474990626|FG003|Overall Study|Withdrawal by Subject|0|||
131919878|NCT02034591|474990627|FG004|Overall Study|Withdrawal by Subject|1|||
131919879|NCT02034591|474990628|FG005|Overall Study|Withdrawal by Subject|0|||
131919880|NCT01793935|474990631|FG000|Overall Study|Pregnancy|1|||
131919881|NCT01793935|474990632|FG001|Overall Study|Pregnancy|0|||
131919882|NCT01793935|474990631|FG000|Overall Study|Protocol Violation|2|||
131919883|NCT01793935|474990632|FG001|Overall Study|Protocol Violation|1|||
131919884|NCT01793935|474990631|FG000|Overall Study|Adverse Event|2|||
131919885|NCT01793935|474990632|FG001|Overall Study|Adverse Event|0|||
131919886|NCT01793935|474990631|FG000|Overall Study|Patient did not take study medication|1|||
131919887|NCT01793935|474990632|FG001|Overall Study|Patient did not take study medication|1|||
131919888|NCT01793935|474990631|FG000|Overall Study|Lost to Follow-up|0|||
131919889|NCT01793935|474990632|FG001|Overall Study|Lost to Follow-up|1|||
131919890|NCT01121926|474990633|FG000|First Intervention Period|Adverse Event|1|||
131919891|NCT01121926|474990634|FG001|First Intervention Period|Adverse Event|0|||
131919892|NCT01121926|474990633|FG000|Washout Period|Adverse Event|0|||
131453937|NCT01301027|473291843|FG001|Overall Study|Physician Decision|0|||
131874069|NCT02553499|474818542|FG002|Overall Study|Death|1|||
131874070|NCT02553499|474818543|FG003|Overall Study|Death|0|||
131874071|NCT02553499|474818544|FG004|Overall Study|Death|1|||
131874072|NCT02553499|474818545|FG005|Overall Study|Death|2|||
131874073|NCT02553499|474818546|FG006|Overall Study|Death|0|||
131874074|NCT02553499|474818547|FG007|Overall Study|Death|0|||
131874075|NCT02553499|474818548|FG008|Overall Study|Death|0|||
131874076|NCT02553499|474818549|FG009|Overall Study|Death|0|||
131874077|NCT02553499|474818550|FG010|Overall Study|Death|1|||
131874078|NCT02553499|474818551|FG011|Overall Study|Death|0|||
131874079|NCT02553499|474818552|FG012|Overall Study|Death|0|||
131874080|NCT02553499|474818553|FG013|Overall Study|Death|0|||
131874081|NCT02553499|474818540|FG000|Overall Study|Lost to Follow-up|0|||
131874082|NCT02553499|474818541|FG001|Overall Study|Lost to Follow-up|0|||
131874083|NCT02553499|474818542|FG002|Overall Study|Lost to Follow-up|0|||
131874084|NCT02553499|474818543|FG003|Overall Study|Lost to Follow-up|0|||
131874085|NCT02553499|474818544|FG004|Overall Study|Lost to Follow-up|0|||
131874086|NCT02553499|474818545|FG005|Overall Study|Lost to Follow-up|0|||
131874087|NCT02553499|474818546|FG006|Overall Study|Lost to Follow-up|1|||
131874088|NCT02553499|474818547|FG007|Overall Study|Lost to Follow-up|0|||
131874089|NCT02553499|474818548|FG008|Overall Study|Lost to Follow-up|0|||
131874090|NCT02553499|474818549|FG009|Overall Study|Lost to Follow-up|0|||
131874091|NCT02553499|474818550|FG010|Overall Study|Lost to Follow-up|0|||
131874092|NCT02553499|474818551|FG011|Overall Study|Lost to Follow-up|0|||
131874093|NCT02553499|474818552|FG012|Overall Study|Lost to Follow-up|0|||
131874094|NCT02553499|474818553|FG013|Overall Study|Lost to Follow-up|0|||
131874095|NCT02553499|474818540|FG000|Overall Study|Physician Decision|0|||
131874096|NCT02553499|474818541|FG001|Overall Study|Physician Decision|1|||
131874097|NCT02553499|474818542|FG002|Overall Study|Physician Decision|1|||
131874098|NCT02553499|474818543|FG003|Overall Study|Physician Decision|0|||
131874099|NCT02553499|474818544|FG004|Overall Study|Physician Decision|1|||
131874100|NCT02553499|474818545|FG005|Overall Study|Physician Decision|0|||
131874101|NCT02553499|474818546|FG006|Overall Study|Physician Decision|0|||
131874102|NCT02553499|474818547|FG007|Overall Study|Physician Decision|1|||
131874103|NCT02553499|474818548|FG008|Overall Study|Physician Decision|1|||
131874104|NCT02553499|474818549|FG009|Overall Study|Physician Decision|2|||
131874105|NCT02553499|474818550|FG010|Overall Study|Physician Decision|1|||
131874106|NCT02553499|474818551|FG011|Overall Study|Physician Decision|3|||
131874107|NCT02553499|474818552|FG012|Overall Study|Physician Decision|1|||
131874108|NCT02553499|474818553|FG013|Overall Study|Physician Decision|0|||
131874109|NCT02553499|474818540|FG000|Overall Study|Progressive Disease|0|||
131874110|NCT02553499|474818541|FG001|Overall Study|Progressive Disease|0|||
131874111|NCT02553499|474818542|FG002|Overall Study|Progressive Disease|0|||
131874112|NCT02553499|474818543|FG003|Overall Study|Progressive Disease|2|||
131874113|NCT02553499|474818544|FG004|Overall Study|Progressive Disease|1|||
131874114|NCT02553499|474818545|FG005|Overall Study|Progressive Disease|1|||
131874115|NCT02553499|474818546|FG006|Overall Study|Progressive Disease|1|||
131874116|NCT02553499|474818547|FG007|Overall Study|Progressive Disease|0|||
131874117|NCT02553499|474818548|FG008|Overall Study|Progressive Disease|0|||
131874118|NCT02553499|474818549|FG009|Overall Study|Progressive Disease|1|||
131874119|NCT02553499|474818550|FG010|Overall Study|Progressive Disease|0|||
131874120|NCT02553499|474818551|FG011|Overall Study|Progressive Disease|0|||
131874121|NCT02553499|474818552|FG012|Overall Study|Progressive Disease|2|||
131874122|NCT02553499|474818553|FG013|Overall Study|Progressive Disease|1|||
131874123|NCT02553499|474818540|FG000|Overall Study|Study Terminated by Sponsor|0|||
131874124|NCT02553499|474818541|FG001|Overall Study|Study Terminated by Sponsor|0|||
131874125|NCT02553499|474818542|FG002|Overall Study|Study Terminated by Sponsor|0|||
131874126|NCT02553499|474818543|FG003|Overall Study|Study Terminated by Sponsor|0|||
131874127|NCT02553499|474818544|FG004|Overall Study|Study Terminated by Sponsor|0|||
131874128|NCT02553499|474818545|FG005|Overall Study|Study Terminated by Sponsor|0|||
131874129|NCT02553499|474818546|FG006|Overall Study|Study Terminated by Sponsor|0|||
131874130|NCT02553499|474818547|FG007|Overall Study|Study Terminated by Sponsor|0|||
131874131|NCT02553499|474818548|FG008|Overall Study|Study Terminated by Sponsor|1|||
131874132|NCT02553499|474818549|FG009|Overall Study|Study Terminated by Sponsor|0|||
131874133|NCT02553499|474818550|FG010|Overall Study|Study Terminated by Sponsor|0|||
131874134|NCT02553499|474818551|FG011|Overall Study|Study Terminated by Sponsor|0|||
131874135|NCT02553499|474818552|FG012|Overall Study|Study Terminated by Sponsor|0|||
131874136|NCT02553499|474818553|FG013|Overall Study|Study Terminated by Sponsor|0|||
131874137|NCT02553499|474818540|FG000|Overall Study|Withdrawal by Subject|2|||
131874138|NCT02553499|474818541|FG001|Overall Study|Withdrawal by Subject|0|||
131874139|NCT02553499|474818542|FG002|Overall Study|Withdrawal by Subject|0|||
131874140|NCT02553499|474818543|FG003|Overall Study|Withdrawal by Subject|0|||
131874141|NCT02553499|474818544|FG004|Overall Study|Withdrawal by Subject|0|||
131874142|NCT02553499|474818545|FG005|Overall Study|Withdrawal by Subject|0|||
131874143|NCT02553499|474818546|FG006|Overall Study|Withdrawal by Subject|0|||
131874144|NCT02553499|474818547|FG007|Overall Study|Withdrawal by Subject|1|||
131874145|NCT02553499|474818548|FG008|Overall Study|Withdrawal by Subject|1|||
131874146|NCT02553499|474818549|FG009|Overall Study|Withdrawal by Subject|0|||
131874147|NCT02553499|474818550|FG010|Overall Study|Withdrawal by Subject|1|||
131874148|NCT02553499|474818551|FG011|Overall Study|Withdrawal by Subject|0|||
131874149|NCT02553499|474818552|FG012|Overall Study|Withdrawal by Subject|0|||
131874150|NCT02553499|474818553|FG013|Overall Study|Withdrawal by Subject|0|||
131874151|NCT01323387|474818556|FG000|Overall Study|Withdrawal by Subject|41|||
131874152|NCT01323387|474818556|FG000|Overall Study|Radiographic Data Unavailable|1|||
131874153|NCT01323387|474818556|FG000|Overall Study|Revision|14|||
131874154|NCT01323387|474818556|FG000|Overall Study|Protocol Violation|12|||
131874155|NCT01323387|474818556|FG000|Overall Study|Randomized but Never Treated|16|||
131874156|NCT03319732|474818575|FG000|Overall Study|Adverse Event|40|||
131874157|NCT03319732|474818575|FG000|Overall Study|Withdrawal by Subject|50|||
131874158|NCT03319732|474818575|FG000|Overall Study|MS relapse|10|||
131874159|NCT03319732|474818575|FG000|Overall Study|reason not specified|5|||
131874160|NCT00767455|474818576|FG000|Overall Study|Investigator error|19|||
131874161|NCT03386994|474818577|FG000|Overall Study|Lung transplant|1|||
131874162|NCT03386994|474818577|FG000|Overall Study|Adverse Event|14|||
131874163|NCT03386994|474818577|FG000|Overall Study|Lost to Follow-up|4|||
131874164|NCT03386994|474818577|FG000|Overall Study|Withdrawal by Subject|3|||
131874165|NCT03386994|474818577|FG000|Overall Study|Death|16|||
131874166|NCT00593684|474820142|FG000|Overall Study|Death|2|||
131874167|NCT00593684|474820143|FG001|Overall Study|Death|1|||
131874168|NCT02564900|474820146|FG000|Dose Escalation|Progressive disease per RECIST|2|||
131874169|NCT02564900|474820147|FG001|Dose Escalation|Progressive disease per RECIST|3|||
131874170|NCT02564900|474820148|FG002|Dose Escalation|Progressive disease per RECIST|3|||
131874171|NCT02564900|474820149|FG003|Dose Escalation|Progressive disease per RECIST|3|||
131874172|NCT02564900|474820150|FG004|Dose Escalation|Progressive disease per RECIST|3|||
131874173|NCT02564900|474820151|FG005|Dose Escalation|Progressive disease per RECIST|1|||
131874174|NCT02564900|474820152|FG006|Dose Escalation|Progressive disease per RECIST|0|||
131874175|NCT02564900|474820153|FG007|Dose Escalation|Progressive disease per RECIST|0|||
131874176|NCT02564900|474820154|FG008|Dose Escalation|Progressive disease per RECIST|0|||
131874177|NCT02564900|474820155|FG009|Dose Escalation|Progressive disease per RECIST|0|||
131874178|NCT02564900|474820156|FG010|Dose Escalation|Progressive disease per RECIST|0|||
131874179|NCT02564900|474820157|FG011|Dose Escalation|Progressive disease per RECIST|0|||
131874180|NCT02564900|474820158|FG012|Dose Escalation|Progressive disease per RECIST|0|||
131874181|NCT02564900|474820159|FG013|Dose Escalation|Progressive disease per RECIST|0|||
131874182|NCT02564900|474820160|FG014|Dose Escalation|Progressive disease per RECIST|0|||
131874183|NCT02564900|474820146|FG000|Dose Escalation|Ongoing|1|||
131874184|NCT02564900|474820147|FG001|Dose Escalation|Ongoing|0|||
131874185|NCT02564900|474820148|FG002|Dose Escalation|Ongoing|0|||
131874186|NCT02564900|474820149|FG003|Dose Escalation|Ongoing|2|||
131874187|NCT02564900|474820150|FG004|Dose Escalation|Ongoing|2|||
131874188|NCT02564900|474820151|FG005|Dose Escalation|Ongoing|2|||
131874189|NCT02564900|474820152|FG006|Dose Escalation|Ongoing|0|||
131874190|NCT02564900|474820153|FG007|Dose Escalation|Ongoing|0|||
131874191|NCT02564900|474820154|FG008|Dose Escalation|Ongoing|0|||
131874192|NCT02564900|474820155|FG009|Dose Escalation|Ongoing|0|||
131874193|NCT02564900|474820156|FG010|Dose Escalation|Ongoing|0|||
131874194|NCT02564900|474820157|FG011|Dose Escalation|Ongoing|0|||
131874195|NCT02564900|474820158|FG012|Dose Escalation|Ongoing|0|||
131874196|NCT02564900|474820159|FG013|Dose Escalation|Ongoing|0|||
131874197|NCT02564900|474820160|FG014|Dose Escalation|Ongoing|0|||
131874198|NCT02564900|474820146|FG000|Dose Escalation|Adverse Event|0|||
131874199|NCT02564900|474820147|FG001|Dose Escalation|Adverse Event|0|||
131874200|NCT02564900|474820148|FG002|Dose Escalation|Adverse Event|0|||
131874201|NCT02564900|474820149|FG003|Dose Escalation|Adverse Event|1|||
131874202|NCT02564900|474820150|FG004|Dose Escalation|Adverse Event|1|||
131874203|NCT02564900|474820151|FG005|Dose Escalation|Adverse Event|3|||
131874204|NCT02564900|474820152|FG006|Dose Escalation|Adverse Event|0|||
131874205|NCT02564900|474820153|FG007|Dose Escalation|Adverse Event|0|||
131874206|NCT02564900|474820154|FG008|Dose Escalation|Adverse Event|0|||
131874207|NCT02564900|474820155|FG009|Dose Escalation|Adverse Event|0|||
131874208|NCT02564900|474820156|FG010|Dose Escalation|Adverse Event|0|||
131874209|NCT02564900|474820157|FG011|Dose Escalation|Adverse Event|0|||
131874210|NCT02564900|474820158|FG012|Dose Escalation|Adverse Event|0|||
131874211|NCT02564900|474820159|FG013|Dose Escalation|Adverse Event|0|||
131874212|NCT02564900|474820160|FG014|Dose Escalation|Adverse Event|0|||
131874213|NCT02564900|474820146|FG000|Dose Expansion|Progressive disease per RECIST|0|||
131874214|NCT02564900|474820147|FG001|Dose Expansion|Progressive disease per RECIST|0|||
131874215|NCT02564900|474820148|FG002|Dose Expansion|Progressive disease per RECIST|0|||
131874216|NCT02564900|474820149|FG003|Dose Expansion|Progressive disease per RECIST|0|||
131874217|NCT02564900|474820150|FG004|Dose Expansion|Progressive disease per RECIST|0|||
131874218|NCT02564900|474820151|FG005|Dose Expansion|Progressive disease per RECIST|0|||
131874219|NCT02564900|474820152|FG006|Dose Expansion|Progressive disease per RECIST|19|||
131874220|NCT02564900|474820153|FG007|Dose Expansion|Progressive disease per RECIST|17|||
131874221|NCT02564900|474820154|FG008|Dose Expansion|Progressive disease per RECIST|8|||
131874222|NCT02564900|474820155|FG009|Dose Expansion|Progressive disease per RECIST|16|||
131874223|NCT02564900|474820156|FG010|Dose Expansion|Progressive disease per RECIST|13|||
131874224|NCT02564900|474820157|FG011|Dose Expansion|Progressive disease per RECIST|19|||
131874225|NCT02564900|474820158|FG012|Dose Expansion|Progressive disease per RECIST|10|||
131874226|NCT02564900|474820159|FG013|Dose Expansion|Progressive disease per RECIST|13|||
131874227|NCT02564900|474820160|FG014|Dose Expansion|Progressive disease per RECIST|11|||
131919893|NCT01121926|474990634|FG001|Washout Period|Adverse Event|1|||
131874228|NCT02564900|474820146|FG000|Dose Expansion|Clinical progression|0|||
131874229|NCT02564900|474820147|FG001|Dose Expansion|Clinical progression|0|||
131874230|NCT02564900|474820148|FG002|Dose Expansion|Clinical progression|0|||
131874231|NCT02564900|474820149|FG003|Dose Expansion|Clinical progression|0|||
131874232|NCT02564900|474820150|FG004|Dose Expansion|Clinical progression|0|||
131874233|NCT02564900|474820151|FG005|Dose Expansion|Clinical progression|0|||
131874234|NCT02564900|474820152|FG006|Dose Expansion|Clinical progression|5|||
131874235|NCT02564900|474820153|FG007|Dose Expansion|Clinical progression|12|||
131874236|NCT02564900|474820154|FG008|Dose Expansion|Clinical progression|0|||
131919894|NCT01121926|474990633|FG000|Washout Period|Positive pregnancy test|0|||
131919895|NCT01121926|474990634|FG001|Washout Period|Positive pregnancy test|1|||
131919896|NCT00416949|474990636|FG000|Overall Study|Patients refused to participate|5|||
131919897|NCT02782468|474990637|FG000|Overall Study|Progressive Disease|2|||
131919898|NCT02782468|474990638|FG001|Overall Study|Progressive Disease|5|||
131919899|NCT02782468|474990639|FG002|Overall Study|Progressive Disease|0|||
131919900|NCT02782468|474990640|FG003|Overall Study|Progressive Disease|4|||
131919901|NCT02782468|474990637|FG000|Overall Study|Adverse Event|0|||
131919902|NCT02782468|474990638|FG001|Overall Study|Adverse Event|2|||
131919903|NCT02782468|474990639|FG002|Overall Study|Adverse Event|2|||
131919904|NCT02782468|474990640|FG003|Overall Study|Adverse Event|3|||
131919905|NCT02782468|474990637|FG000|Overall Study|Other|0|||
131919906|NCT02782468|474990638|FG001|Overall Study|Other|0|||
131919907|NCT02782468|474990639|FG002|Overall Study|Other|1|||
131919908|NCT02782468|474990640|FG003|Overall Study|Other|1|||
131919909|NCT02782468|474990637|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
131919910|NCT02782468|474990638|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
131919911|NCT02782468|474990639|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
131919912|NCT02782468|474990640|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
131919913|NCT02782468|474990637|FG000|Overall Study|Symptomatic Deterioration|0|||
131919914|NCT02782468|474990638|FG001|Overall Study|Symptomatic Deterioration|0|||
131919915|NCT02782468|474990639|FG002|Overall Study|Symptomatic Deterioration|0|||
131919916|NCT02782468|474990640|FG003|Overall Study|Symptomatic Deterioration|1|||
131919917|NCT02782468|474990637|FG000|Overall Study|Withdrawal by Subject|1|||
131919918|NCT02782468|474990638|FG001|Overall Study|Withdrawal by Subject|0|||
131919919|NCT02782468|474990639|FG002|Overall Study|Withdrawal by Subject|0|||
131919920|NCT02782468|474990640|FG003|Overall Study|Withdrawal by Subject|0|||
131919921|NCT00313170|474990641|FG000|Overall Study|Death|2|||
131919922|NCT00313170|474990642|FG001|Overall Study|Death|4|||
131919923|NCT00313170|474990643|FG002|Overall Study|Death|2|||
131919924|NCT00313170|474990641|FG000|Overall Study|Adverse Event|1|||
131919925|NCT00313170|474990642|FG001|Overall Study|Adverse Event|2|||
131919926|NCT00313170|474990643|FG002|Overall Study|Adverse Event|0|||
131919927|NCT00313170|474990641|FG000|Overall Study|Disease progression|31|||
131919928|NCT00313170|474990642|FG001|Overall Study|Disease progression|26|||
131919929|NCT00313170|474990643|FG002|Overall Study|Disease progression|27|||
131919930|NCT00313170|474990641|FG000|Overall Study|Withdrawal by Subject|1|||
131919931|NCT00313170|474990642|FG001|Overall Study|Withdrawal by Subject|0|||
131919932|NCT00313170|474990643|FG002|Overall Study|Withdrawal by Subject|1|||
131919933|NCT00313170|474990641|FG000|Overall Study|Incorrect enrollment|0|||
131919934|NCT00313170|474990642|FG001|Overall Study|Incorrect enrollment|2|||
131919935|NCT00313170|474990643|FG002|Overall Study|Incorrect enrollment|1|||
131919936|NCT00313170|474990641|FG000|Overall Study|Lost to Follow-up|0|||
131919937|NCT00313170|474990642|FG001|Overall Study|Lost to Follow-up|0|||
131919938|NCT00313170|474990643|FG002|Overall Study|Lost to Follow-up|1|||
131919939|NCT00313170|474990641|FG000|Overall Study|Progression (investigators opinion)|1|||
131919940|NCT00313170|474990642|FG001|Overall Study|Progression (investigators opinion)|0|||
131919941|NCT00313170|474990643|FG002|Overall Study|Progression (investigators opinion)|0|||
131919942|NCT00356590|474990645|FG000|Overall Study|Adverse Event|54|||
131919943|NCT00356590|474990645|FG000|Overall Study|Death|10|||
131919944|NCT00356590|474990645|FG000|Overall Study|Lost to Follow-up|35|||
131919945|NCT00356590|474990645|FG000|Overall Study|Physician Decision|46|||
131919946|NCT00356590|474990645|FG000|Overall Study|Withdrawal by Subject|41|||
131919947|NCT00356590|474990645|FG000|Overall Study|Completed month 12 only|2|||
131919948|NCT00356590|474990645|FG000|Overall Study|Protocol issues|6|||
131919949|NCT00356590|474990645|FG000|Overall Study|Response status|28|||
131919950|NCT00356590|474990645|FG000|Overall Study|Other|52|||
131919951|NCT00529035|474990646|FG000|Overall Study|Withdrawal by Subject|1|||
131919952|NCT03439514|474990647|FG000|Double-Blind Treatment Period|Other|4|||
131919953|NCT03439514|474990648|FG001|Double-Blind Treatment Period|Other|1|||
131919954|NCT03439514|474990647|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
131408336|NCT01133405|473118260|FG006|Period 1|Received drug only in period 3|0|||
131408337|NCT01133405|473118261|FG007|Period 1|Received drug only in period 3|0|||
131408338|NCT01133405|473118262|FG008|Period 1|Received drug only in period 3|0|||
131408339|NCT01133405|473118263|FG009|Period 1|Received drug only in period 3|0|||
131408340|NCT01133405|473118254|FG000|Period 2|Adverse Event|0|||
131919955|NCT03439514|474990648|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131919956|NCT03439514|474990647|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
131919957|NCT03439514|474990648|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
131919958|NCT03439514|474990647|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
131919959|NCT03439514|474990648|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
131919960|NCT03439514|474990647|FG000|Double-Blind Treatment Period|Death|1|||
131919961|NCT03439514|474990648|FG001|Double-Blind Treatment Period|Death|2|||
131919962|NCT01521364|474990649|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
131919963|NCT01521364|474990649|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
131919964|NCT02175758|474990650|FG000|Treatment Phase|Lost to Follow-up|0|||
131919965|NCT02175758|474990651|FG001|Treatment Phase|Lost to Follow-up|1|||
131919966|NCT02175758|474990652|FG002|Treatment Phase|Lost to Follow-up|0|||
131919967|NCT02175758|474990653|FG003|Treatment Phase|Lost to Follow-up|0|||
131919968|NCT02175758|474990654|FG004|Treatment Phase|Lost to Follow-up|0|||
131919969|NCT02175758|474990655|FG005|Treatment Phase|Lost to Follow-up|0|||
131919970|NCT02175758|474990650|FG000|Treatment Phase|Adverse Event|0|||
131919971|NCT02175758|474990651|FG001|Treatment Phase|Adverse Event|0|||
131919972|NCT02175758|474990652|FG002|Treatment Phase|Adverse Event|0|||
131919973|NCT02175758|474990653|FG003|Treatment Phase|Adverse Event|0|||
131919974|NCT02175758|474990654|FG004|Treatment Phase|Adverse Event|1|||
131919975|NCT02175758|474990655|FG005|Treatment Phase|Adverse Event|0|||
131919976|NCT01482221|474990660|FG000|Overall Study|Lack of Efficacy|1|||
131919977|NCT01482221|474990661|FG001|Overall Study|Lack of Efficacy|0|||
131919978|NCT01482221|474990662|FG002|Overall Study|Lack of Efficacy|1|||
131919979|NCT01482221|474990660|FG000|Overall Study|Lost to Follow-up|3|||
131919980|NCT01482221|474990661|FG001|Overall Study|Lost to Follow-up|2|||
131919981|NCT01482221|474990662|FG002|Overall Study|Lost to Follow-up|1|||
131919982|NCT01482221|474990660|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
131919983|NCT01482221|474990661|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
131919984|NCT01482221|474990662|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
131919985|NCT01482221|474990660|FG000|Overall Study|Condition under Investigation Worsened|3|||
131919986|NCT01482221|474990661|FG001|Overall Study|Condition under Investigation Worsened|2|||
131919987|NCT01482221|474990662|FG002|Overall Study|Condition under Investigation Worsened|4|||
131919988|NCT01482221|474990660|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
131919989|NCT01482221|474990661|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
131919990|NCT01482221|474990662|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
131919991|NCT01482221|474990660|FG000|Overall Study|Adverse Event|1|||
131919992|NCT01482221|474990661|FG001|Overall Study|Adverse Event|7|||
131919993|NCT01482221|474990662|FG002|Overall Study|Adverse Event|3|||
131919994|NCT01482221|474990660|FG000|Overall Study|Withdrawal by Subject|10|||
131919995|NCT01482221|474990661|FG001|Overall Study|Withdrawal by Subject|7|||
131919996|NCT01482221|474990662|FG002|Overall Study|Withdrawal by Subject|12|||
131919997|NCT01482221|474990660|FG000|Overall Study|Incorrect randomization|0|||
131919998|NCT01482221|474990661|FG001|Overall Study|Incorrect randomization|1|||
131919999|NCT01482221|474990662|FG002|Overall Study|Incorrect randomization|0|||
131920000|NCT01482221|474990660|FG000|Overall Study|Physician Decision|0|||
131920001|NCT01482221|474990661|FG001|Overall Study|Physician Decision|1|||
131920002|NCT01482221|474990662|FG002|Overall Study|Physician Decision|0|||
131920003|NCT01047501|474990664|FG000|Overall Study|Adverse Event|7|||
131920004|NCT01047501|474990665|FG001|Overall Study|Adverse Event|8|||
131920005|NCT01047501|474990666|FG002|Overall Study|Adverse Event|5|||
131920006|NCT01047501|474990664|FG000|Overall Study|Withdrew Consent|6|||
131920007|NCT01047501|474990665|FG001|Overall Study|Withdrew Consent|2|||
131920008|NCT01047501|474990666|FG002|Overall Study|Withdrew Consent|4|||
131920009|NCT01047501|474990664|FG000|Overall Study|Lost to Follow-up|0|||
131920010|NCT01047501|474990665|FG001|Overall Study|Lost to Follow-up|1|||
131920011|NCT01047501|474990666|FG002|Overall Study|Lost to Follow-up|1|||
131920012|NCT01047501|474990664|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
131920013|NCT01047501|474990665|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
131920014|NCT01047501|474990666|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
131920015|NCT01047501|474990664|FG000|Overall Study|Death|1|||
131920016|NCT01047501|474990665|FG001|Overall Study|Death|0|||
131920017|NCT01047501|474990666|FG002|Overall Study|Death|0|||
131920018|NCT01047501|474990664|FG000|Overall Study|Other discontinuation|1|||
131920019|NCT01047501|474990665|FG001|Overall Study|Other discontinuation|0|||
131920020|NCT01047501|474990666|FG002|Overall Study|Other discontinuation|1|||
131920021|NCT01047501|474990664|FG000|Overall Study|Investigator judgement|0|||
131920022|NCT01047501|474990665|FG001|Overall Study|Investigator judgement|0|||
131920023|NCT01047501|474990666|FG002|Overall Study|Investigator judgement|1|||
131920024|NCT03010501|474990667|FG000|Study Week 1|Withdrawal by Subject|2|||
131920025|NCT03010501|474990668|FG001|Study Week 1|Withdrawal by Subject|1|||
131408341|NCT01133405|473118255|FG001|Period 2|Adverse Event|0|||
131408342|NCT01133405|473118256|FG002|Period 2|Adverse Event|1|||
131408343|NCT01133405|473118257|FG003|Period 2|Adverse Event|0|||
131408344|NCT01133405|473118258|FG004|Period 2|Adverse Event|0|||
131408345|NCT01133405|473118259|FG005|Period 2|Adverse Event|0|||
131920026|NCT03010501|474990669|FG002|Study Week 1|Withdrawal by Subject|0|||
131920027|NCT03010501|474990670|FG003|Study Week 1|Withdrawal by Subject|2|||
131920028|NCT03010501|474990671|FG004|Study Week 1|Withdrawal by Subject|0|||
131920029|NCT03010501|474990672|FG005|Study Week 1|Withdrawal by Subject|0|||
131920030|NCT03010501|474990667|FG000|Study Week 3|Withdrawal by Subject|0|||
131920031|NCT03010501|474990668|FG001|Study Week 3|Withdrawal by Subject|0|||
131920032|NCT03010501|474990669|FG002|Study Week 3|Withdrawal by Subject|0|||
131920033|NCT03010501|474990670|FG003|Study Week 3|Withdrawal by Subject|1|||
131920034|NCT03010501|474990671|FG004|Study Week 3|Withdrawal by Subject|0|||
131920035|NCT03010501|474990672|FG005|Study Week 3|Withdrawal by Subject|0|||
131920036|NCT00640289|474990673|FG000|Overall Study|Death|3|||
131920037|NCT00640289|474990673|FG000|Overall Study|Withdrawal by Subject|1|||
131920038|NCT00640289|474990673|FG000|Overall Study|Lost to Follow-up|1|||
131920039|NCT00640289|474990673|FG000|Overall Study|Data collected under different amendment|2|||
131874237|NCT02564900|474820155|FG009|Dose Expansion|Clinical progression|3|||
131874238|NCT02564900|474820156|FG010|Dose Expansion|Clinical progression|2|||
131874239|NCT02564900|474820157|FG011|Dose Expansion|Clinical progression|0|||
131874240|NCT02564900|474820158|FG012|Dose Expansion|Clinical progression|1|||
131874241|NCT02564900|474820159|FG013|Dose Expansion|Clinical progression|3|||
131920040|NCT00640289|474990673|FG000|Overall Study|Transferred to another center|1|||
131920041|NCT00640289|474990673|FG000|Overall Study|Missing status|5|||
131874242|NCT02564900|474820160|FG014|Dose Expansion|Clinical progression|1|||
131874243|NCT02564900|474820146|FG000|Dose Expansion|Adverse Event|0|||
131874244|NCT02564900|474820147|FG001|Dose Expansion|Adverse Event|0|||
131874245|NCT02564900|474820148|FG002|Dose Expansion|Adverse Event|0|||
131874246|NCT02564900|474820149|FG003|Dose Expansion|Adverse Event|0|||
131874247|NCT02564900|474820150|FG004|Dose Expansion|Adverse Event|0|||
131874248|NCT02564900|474820151|FG005|Dose Expansion|Adverse Event|0|||
131874249|NCT02564900|474820152|FG006|Dose Expansion|Adverse Event|9|||
131874250|NCT02564900|474820153|FG007|Dose Expansion|Adverse Event|22|||
131874251|NCT02564900|474820154|FG008|Dose Expansion|Adverse Event|0|||
131874252|NCT02564900|474820155|FG009|Dose Expansion|Adverse Event|11|||
131874253|NCT02564900|474820156|FG010|Dose Expansion|Adverse Event|0|||
131874254|NCT02564900|474820157|FG011|Dose Expansion|Adverse Event|5|||
131920042|NCT02207608|474990674|FG000|Overall Study|Adverse Event|1|||
131920043|NCT02207608|474990675|FG001|Overall Study|Adverse Event|0|||
131920044|NCT03043573|474990676|FG000|Overall Study|Lost to Follow-up|3|||
131920045|NCT03043573|474990677|FG001|Overall Study|Lost to Follow-up|3|||
131920046|NCT03043573|474990676|FG000|Overall Study|Physician Decision|0|||
131920047|NCT03043573|474990677|FG001|Overall Study|Physician Decision|5|||
131920048|NCT03043573|474990676|FG000|Overall Study|Withdrawal by Subject|0|||
131920049|NCT03043573|474990677|FG001|Overall Study|Withdrawal by Subject|4|||
131920050|NCT00980460|474990680|FG000|Overall Study|Death|0|||
131920051|NCT00980460|474990681|FG001|Overall Study|Death|0|||
131920052|NCT00980460|474990682|FG002|Overall Study|Death|1|||
131920053|NCT00980460|474990683|FG003|Overall Study|Death|2|||
131920054|NCT00980460|474990684|FG004|Overall Study|Death|1|||
131920055|NCT00980460|474990680|FG000|Overall Study|Lack of Efficacy|0|||
131920056|NCT00980460|474990681|FG001|Overall Study|Lack of Efficacy|0|||
131920057|NCT00980460|474990682|FG002|Overall Study|Lack of Efficacy|10|||
131920058|NCT00980460|474990683|FG003|Overall Study|Lack of Efficacy|6|||
131920059|NCT00980460|474990684|FG004|Overall Study|Lack of Efficacy|8|||
131920060|NCT00980460|474990680|FG000|Overall Study|Lost to Follow-up|0|||
131408346|NCT01133405|473118260|FG006|Period 2|Adverse Event|0|||
131408347|NCT01133405|473118261|FG007|Period 2|Adverse Event|0|||
131874255|NCT02564900|474820158|FG012|Dose Expansion|Adverse Event|2|||
131874256|NCT02564900|474820159|FG013|Dose Expansion|Adverse Event|2|||
131874257|NCT02564900|474820160|FG014|Dose Expansion|Adverse Event|1|||
131874258|NCT02564900|474820146|FG000|Dose Expansion|Ongoing|0|||
131874259|NCT02564900|474820147|FG001|Dose Expansion|Ongoing|0|||
131874260|NCT02564900|474820148|FG002|Dose Expansion|Ongoing|0|||
131874261|NCT02564900|474820149|FG003|Dose Expansion|Ongoing|0|||
131874262|NCT02564900|474820150|FG004|Dose Expansion|Ongoing|0|||
131874263|NCT02564900|474820151|FG005|Dose Expansion|Ongoing|0|||
131874264|NCT02564900|474820152|FG006|Dose Expansion|Ongoing|9|||
131874265|NCT02564900|474820153|FG007|Dose Expansion|Ongoing|10|||
131874266|NCT02564900|474820154|FG008|Dose Expansion|Ongoing|11|||
131874267|NCT02564900|474820155|FG009|Dose Expansion|Ongoing|3|||
131874268|NCT02564900|474820156|FG010|Dose Expansion|Ongoing|0|||
131408348|NCT01133405|473118262|FG008|Period 2|Adverse Event|0|||
131408349|NCT01133405|473118263|FG009|Period 2|Adverse Event|0|||
131408350|NCT01133405|473118254|FG000|Period 2|Withdrawal by Subject|0|||
131408351|NCT01133405|473118255|FG001|Period 2|Withdrawal by Subject|0|||
131408352|NCT01133405|473118256|FG002|Period 2|Withdrawal by Subject|0|||
131408353|NCT01133405|473118257|FG003|Period 2|Withdrawal by Subject|1|||
131874269|NCT02564900|474820157|FG011|Dose Expansion|Ongoing|0|||
131874270|NCT02564900|474820158|FG012|Dose Expansion|Ongoing|4|||
131874271|NCT02564900|474820159|FG013|Dose Expansion|Ongoing|0|||
131874272|NCT02564900|474820160|FG014|Dose Expansion|Ongoing|6|||
131874273|NCT02564900|474820146|FG000|Dose Expansion|Death|0|||
131874274|NCT02564900|474820147|FG001|Dose Expansion|Death|0|||
131408354|NCT01133405|473118258|FG004|Period 2|Withdrawal by Subject|0|||
131408355|NCT01133405|473118259|FG005|Period 2|Withdrawal by Subject|1|||
131408356|NCT01133405|473118260|FG006|Period 2|Withdrawal by Subject|0|||
131874275|NCT02564900|474820148|FG002|Dose Expansion|Death|0|||
131874276|NCT02564900|474820149|FG003|Dose Expansion|Death|0|||
131874277|NCT02564900|474820150|FG004|Dose Expansion|Death|0|||
131874278|NCT02564900|474820151|FG005|Dose Expansion|Death|0|||
131874279|NCT02564900|474820152|FG006|Dose Expansion|Death|1|||
131874280|NCT02564900|474820153|FG007|Dose Expansion|Death|0|||
131874281|NCT02564900|474820154|FG008|Dose Expansion|Death|0|||
131920061|NCT00980460|474990681|FG001|Overall Study|Lost to Follow-up|0|||
131920062|NCT00980460|474990682|FG002|Overall Study|Lost to Follow-up|0|||
131920063|NCT00980460|474990683|FG003|Overall Study|Lost to Follow-up|1|||
131920064|NCT00980460|474990684|FG004|Overall Study|Lost to Follow-up|0|||
131874282|NCT02564900|474820155|FG009|Dose Expansion|Death|0|||
131874283|NCT02564900|474820156|FG010|Dose Expansion|Death|1|||
131874284|NCT02564900|474820157|FG011|Dose Expansion|Death|0|||
131874285|NCT02564900|474820158|FG012|Dose Expansion|Death|1|||
131874286|NCT02564900|474820159|FG013|Dose Expansion|Death|1|||
131874287|NCT02564900|474820160|FG014|Dose Expansion|Death|0|||
131874288|NCT02564900|474820146|FG000|Dose Expansion|Withdrawal by Subject|0|||
131874289|NCT02564900|474820147|FG001|Dose Expansion|Withdrawal by Subject|0|||
131874290|NCT02564900|474820148|FG002|Dose Expansion|Withdrawal by Subject|0|||
131874291|NCT02564900|474820149|FG003|Dose Expansion|Withdrawal by Subject|0|||
131874292|NCT02564900|474820150|FG004|Dose Expansion|Withdrawal by Subject|0|||
131874293|NCT02564900|474820151|FG005|Dose Expansion|Withdrawal by Subject|0|||
131874294|NCT02564900|474820152|FG006|Dose Expansion|Withdrawal by Subject|4|||
131874295|NCT02564900|474820153|FG007|Dose Expansion|Withdrawal by Subject|0|||
131874296|NCT02564900|474820154|FG008|Dose Expansion|Withdrawal by Subject|0|||
131874297|NCT02564900|474820155|FG009|Dose Expansion|Withdrawal by Subject|0|||
131874298|NCT02564900|474820156|FG010|Dose Expansion|Withdrawal by Subject|1|||
131874299|NCT02564900|474820157|FG011|Dose Expansion|Withdrawal by Subject|0|||
131874300|NCT02564900|474820158|FG012|Dose Expansion|Withdrawal by Subject|0|||
131874301|NCT02564900|474820159|FG013|Dose Expansion|Withdrawal by Subject|1|||
131874302|NCT02564900|474820160|FG014|Dose Expansion|Withdrawal by Subject|1|||
131874303|NCT02564900|474820146|FG000|Dose Expansion|Other|0|||
131874304|NCT02564900|474820147|FG001|Dose Expansion|Other|0|||
131874305|NCT02564900|474820148|FG002|Dose Expansion|Other|0|||
131874306|NCT02564900|474820149|FG003|Dose Expansion|Other|0|||
131874307|NCT02564900|474820150|FG004|Dose Expansion|Other|0|||
131874308|NCT02564900|474820151|FG005|Dose Expansion|Other|0|||
131874309|NCT02564900|474820152|FG006|Dose Expansion|Other|1|||
131874310|NCT02564900|474820153|FG007|Dose Expansion|Other|0|||
131874311|NCT02564900|474820154|FG008|Dose Expansion|Other|1|||
131874312|NCT02564900|474820155|FG009|Dose Expansion|Other|0|||
131874313|NCT02564900|474820156|FG010|Dose Expansion|Other|0|||
131874314|NCT02564900|474820157|FG011|Dose Expansion|Other|0|||
131874315|NCT02564900|474820158|FG012|Dose Expansion|Other|0|||
131874316|NCT02564900|474820159|FG013|Dose Expansion|Other|0|||
131874317|NCT02564900|474820160|FG014|Dose Expansion|Other|1|||
131874318|NCT02564900|474820146|FG000|Dose Expansion|Did not receive treatment|0|||
131874319|NCT02564900|474820147|FG001|Dose Expansion|Did not receive treatment|0|||
131874320|NCT02564900|474820148|FG002|Dose Expansion|Did not receive treatment|0|||
131874321|NCT02564900|474820149|FG003|Dose Expansion|Did not receive treatment|0|||
131874322|NCT02564900|474820150|FG004|Dose Expansion|Did not receive treatment|0|||
131874323|NCT02564900|474820151|FG005|Dose Expansion|Did not receive treatment|0|||
131874324|NCT02564900|474820152|FG006|Dose Expansion|Did not receive treatment|1|||
131874325|NCT02564900|474820153|FG007|Dose Expansion|Did not receive treatment|1|||
131874326|NCT02564900|474820154|FG008|Dose Expansion|Did not receive treatment|0|||
131874327|NCT02564900|474820155|FG009|Dose Expansion|Did not receive treatment|0|||
131874328|NCT02564900|474820156|FG010|Dose Expansion|Did not receive treatment|0|||
131874329|NCT02564900|474820157|FG011|Dose Expansion|Did not receive treatment|0|||
131874330|NCT02564900|474820158|FG012|Dose Expansion|Did not receive treatment|0|||
131874331|NCT02564900|474820159|FG013|Dose Expansion|Did not receive treatment|0|||
131874332|NCT02564900|474820160|FG014|Dose Expansion|Did not receive treatment|1|||
131874333|NCT00892151|474820161|FG000|Overall Study|Protocol Violation|1|||
131874334|NCT04075682|474820164|FG000|Overall Study|Lost to Follow-up|5|||
131874335|NCT04075682|474820165|FG001|Overall Study|Lost to Follow-up|5|||
131874336|NCT04075682|474820166|FG002|Overall Study|Lost to Follow-up|2|||
131874337|NCT04075682|474820167|FG003|Overall Study|Lost to Follow-up|2|||
131874338|NCT04075682|474820164|FG000|Overall Study|Withdrawal by Subject|1|||
131874339|NCT04075682|474820165|FG001|Overall Study|Withdrawal by Subject|0|||
131874340|NCT04075682|474820166|FG002|Overall Study|Withdrawal by Subject|1|||
131874341|NCT04075682|474820167|FG003|Overall Study|Withdrawal by Subject|0|||
131874342|NCT04075682|474820164|FG000|Overall Study|Protocol Violation|0|||
131874343|NCT04075682|474820165|FG001|Overall Study|Protocol Violation|1|||
131920065|NCT00980460|474990680|FG000|Overall Study|Physician Decision|0|||
131920066|NCT00980460|474990681|FG001|Overall Study|Physician Decision|0|||
131874344|NCT04075682|474820166|FG002|Overall Study|Protocol Violation|1|||
131874345|NCT04075682|474820167|FG003|Overall Study|Protocol Violation|0|||
131874346|NCT04075682|474820164|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
131874347|NCT04075682|474820165|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
131874348|NCT04075682|474820166|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
131874349|NCT04075682|474820167|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
131874350|NCT04075682|474820164|FG000|Overall Study|Lost study phone the first day of study participation|0|||
131874351|NCT04075682|474820165|FG001|Overall Study|Lost study phone the first day of study participation|1|||
131874352|NCT04075682|474820166|FG002|Overall Study|Lost study phone the first day of study participation|0|||
131874353|NCT04075682|474820167|FG003|Overall Study|Lost study phone the first day of study participation|0|||
131920067|NCT00980460|474990682|FG002|Overall Study|Physician Decision|11|||
131874354|NCT01289639|474820171|FG000|Overall Study|Lost to Follow-up|1|||
131920068|NCT00980460|474990683|FG003|Overall Study|Physician Decision|5|||
131920069|NCT00980460|474990684|FG004|Overall Study|Physician Decision|3|||
131920070|NCT00980460|474990680|FG000|Overall Study|Withdrawal by Subject|0|||
131920071|NCT00980460|474990681|FG001|Overall Study|Withdrawal by Subject|0|||
131920072|NCT00980460|474990682|FG002|Overall Study|Withdrawal by Subject|1|||
131920073|NCT00980460|474990683|FG003|Overall Study|Withdrawal by Subject|0|||
131920074|NCT00980460|474990684|FG004|Overall Study|Withdrawal by Subject|0|||
131920075|NCT00980460|474990680|FG000|Overall Study|Ineligible|0|||
131920076|NCT00980460|474990681|FG001|Overall Study|Ineligible|2|||
131920077|NCT00980460|474990682|FG002|Overall Study|Ineligible|3|||
131920078|NCT00980460|474990683|FG003|Overall Study|Ineligible|1|||
131920079|NCT00980460|474990684|FG004|Overall Study|Ineligible|4|||
131920080|NCT00980460|474990680|FG000|Overall Study|Refusal of further therapy|0|||
131920081|NCT00980460|474990681|FG001|Overall Study|Refusal of further therapy|2|||
131920082|NCT00980460|474990682|FG002|Overall Study|Refusal of further therapy|3|||
131920083|NCT00980460|474990683|FG003|Overall Study|Refusal of further therapy|2|||
131920084|NCT00980460|474990684|FG004|Overall Study|Refusal of further therapy|0|||
131920085|NCT00980460|474990680|FG000|Overall Study|No therapy within 42 days of resection|0|||
131920086|NCT00980460|474990681|FG001|Overall Study|No therapy within 42 days of resection|0|||
131920087|NCT00980460|474990682|FG002|Overall Study|No therapy within 42 days of resection|3|||
131920088|NCT00980460|474990683|FG003|Overall Study|No therapy within 42 days of resection|1|||
131920089|NCT00980460|474990684|FG004|Overall Study|No therapy within 42 days of resection|0|||
131920090|NCT00980460|474990680|FG000|Overall Study|No transplant by protocol timepoints|0|||
131920091|NCT00980460|474990681|FG001|Overall Study|No transplant by protocol timepoints|0|||
131920092|NCT00980460|474990682|FG002|Overall Study|No transplant by protocol timepoints|3|||
131920093|NCT00980460|474990683|FG003|Overall Study|No transplant by protocol timepoints|0|||
131920094|NCT00980460|474990684|FG004|Overall Study|No transplant by protocol timepoints|0|||
131920095|NCT03599713|474990685|FG000|Overall Study|Death|38|||
131920096|NCT03599713|474990686|FG001|Overall Study|Death|3|||
131920097|NCT03599713|474990685|FG000|Overall Study|Withdrawal by Subject|17|||
131920098|NCT03599713|474990686|FG001|Overall Study|Withdrawal by Subject|0|||
131920099|NCT03599713|474990685|FG000|Overall Study|Lost to Follow-up|4|||
131920100|NCT03599713|474990686|FG001|Overall Study|Lost to Follow-up|0|||
131920101|NCT03599713|474990685|FG000|Overall Study|Discontinued Due to End of Study|42|||
131920102|NCT03599713|474990686|FG001|Overall Study|Discontinued Due to End of Study|3|||
131920103|NCT05800145|474990687|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
131920104|NCT05800145|474990688|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131920105|NCT05800145|474990689|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131920106|NCT05800145|474990690|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
131920107|NCT05800145|474990691|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131920108|NCT05800145|474990692|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131920109|NCT05800145|474990687|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
131920110|NCT05800145|474990688|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
131920111|NCT05800145|474990689|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
131920112|NCT05800145|474990690|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
131920113|NCT05800145|474990691|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
131920114|NCT05800145|474990692|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
131920115|NCT05800145|474990687|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
131920116|NCT05800145|474990688|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
131920117|NCT05800145|474990689|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
131920118|NCT05800145|474990690|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
131920119|NCT05800145|474990691|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
131920120|NCT05800145|474990692|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
131920121|NCT02850406|474990693|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920122|NCT02850406|474990694|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920123|NCT02850406|474990695|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920124|NCT02850406|474990696|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
131920125|NCT02850406|474990697|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920126|NCT02850406|474990698|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920127|NCT02850406|474990699|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920128|NCT02850406|474990700|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
131920129|NCT02850406|474990693|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
131920130|NCT02850406|474990694|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
131920131|NCT02850406|474990695|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
131408357|NCT01133405|473118261|FG007|Period 2|Withdrawal by Subject|0|||
131920132|NCT02850406|474990696|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
131920133|NCT02850406|474990697|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
131920134|NCT02850406|474990698|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
131920135|NCT02850406|474990699|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
131920136|NCT02850406|474990700|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
131920137|NCT02850406|474990693|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131920138|NCT02850406|474990694|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131920139|NCT02850406|474990695|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
131874355|NCT01289639|474820172|FG001|Overall Study|Lost to Follow-up|0|||
131874356|NCT01289639|474820173|FG002|Overall Study|Lost to Follow-up|0|||
131874357|NCT02780713|474820174|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
131874358|NCT02780713|474820175|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
131874359|NCT02780713|474820176|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
131874360|NCT02780713|474820177|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
131874361|NCT02780713|474820178|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
131874362|NCT01931475|474820181|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
131874363|NCT01931475|474820182|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
131874364|NCT01931475|474820181|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
131874365|NCT01931475|474820182|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
131874366|NCT01931475|474820181|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
131874367|NCT01931475|474820182|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
131874368|NCT01931475|474820181|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
131874369|NCT01931475|474820182|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
131874370|NCT01931475|474820181|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
131874371|NCT01931475|474820182|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
131874372|NCT01931475|474820181|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
131874373|NCT01931475|474820182|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
131874374|NCT01931475|474820181|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
131874375|NCT01931475|474820182|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
131874376|NCT01931475|474820181|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
131874377|NCT01931475|474820182|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
131874378|NCT01931475|474820181|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
131874379|NCT01931475|474820182|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
131874380|NCT01931475|474820181|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
131874381|NCT01931475|474820182|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
131874382|NCT01931475|474820181|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
131874383|NCT01931475|474820182|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
131874384|NCT04292912|474820183|FG000|Overall Study|Physician Decision|1|||
131874385|NCT04292912|474820183|FG000|Overall Study|Protocol Violation|6|||
131874386|NCT02278939|474820189|FG000|Overall Study|lack of time|1|||
131874387|NCT02278939|474820190|FG001|Overall Study|lack of time|0|||
131874388|NCT02278939|474820189|FG000|Overall Study|Lost to Follow-up|1|||
131874389|NCT02278939|474820190|FG001|Overall Study|Lost to Follow-up|1|||
131874390|NCT02278939|474820189|FG000|Overall Study|death in family|1|||
131874391|NCT02278939|474820190|FG001|Overall Study|death in family|0|||
131874392|NCT02278939|474820189|FG000|Overall Study|family emergency unable to commit|2|||
131874393|NCT02278939|474820190|FG001|Overall Study|family emergency unable to commit|0|||
131874394|NCT03436693|474820191|FG000|Overall Study|Adverse Event|22|||
131874395|NCT03436693|474820192|FG001|Overall Study|Adverse Event|10|||
131874396|NCT03436693|474820191|FG000|Overall Study|Physician Decision|3|||
131874397|NCT03436693|474820192|FG001|Overall Study|Physician Decision|3|||
131874398|NCT03436693|474820191|FG000|Overall Study|Withdrawal by Subject|4|||
131874399|NCT03436693|474820192|FG001|Overall Study|Withdrawal by Subject|13|||
131874400|NCT03436693|474820191|FG000|Overall Study|Progressive Disease|1|||
131874401|NCT03436693|474820192|FG001|Overall Study|Progressive Disease|1|||
131874402|NCT01680861|474820193|FG000|Early Post-transplant Period|Protocol Violation|1|||
131874403|NCT01680861|474820194|FG001|Early Post-transplant Period|Protocol Violation|1|||
131874404|NCT02111577|474820195|FG000|Overall Study|Protocol Violation|2|||
131874405|NCT02111577|474820196|FG001|Overall Study|Protocol Violation|0|||
131874406|NCT02111577|474820195|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
131874407|NCT02111577|474820196|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
131874408|NCT02111577|474820195|FG000|Overall Study|Failure to produce study treatment|6|||
131874409|NCT02111577|474820196|FG001|Overall Study|Failure to produce study treatment|0|||
131874410|NCT02111577|474820195|FG000|Overall Study|Death|518|||
131874411|NCT02111577|474820196|FG001|Overall Study|Death|254|||
131874412|NCT02111577|474820195|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
131874413|NCT02111577|474820196|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
131874414|NCT02111577|474820195|FG000|Overall Study|Adverse Event|1|||
131874415|NCT02111577|474820196|FG001|Overall Study|Adverse Event|1|||
131874416|NCT02111577|474820195|FG000|Overall Study|Withdrawal by Subject|51|||
131874417|NCT02111577|474820196|FG001|Overall Study|Withdrawal by Subject|23|||
131874418|NCT02111577|474820195|FG000|Overall Study|Disease progression|0|||
131874419|NCT02111577|474820196|FG001|Overall Study|Disease progression|1|||
131874420|NCT02111577|474820195|FG000|Overall Study|Lost to Follow-up|19|||
131874421|NCT02111577|474820196|FG001|Overall Study|Lost to Follow-up|10|||
131874422|NCT00654875|474820197|FG000|Overall Study|Adverse Event|5|||
131874423|NCT00654875|474820198|FG001|Overall Study|Adverse Event|5|||
131874424|NCT00654875|474820197|FG000|Overall Study|Withdrawal by Subject|4|||
131874425|NCT00654875|474820198|FG001|Overall Study|Withdrawal by Subject|4|||
131874426|NCT00654875|474820197|FG000|Overall Study|Protocol Violation|3|||
131874427|NCT00654875|474820198|FG001|Overall Study|Protocol Violation|3|||
131920140|NCT02850406|474990696|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131920141|NCT02850406|474990697|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131920142|NCT02850406|474990698|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131874428|NCT00654875|474820197|FG000|Overall Study|Lack of Efficacy|2|||
131874429|NCT00654875|474820198|FG001|Overall Study|Lack of Efficacy|2|||
131874430|NCT00654875|474820197|FG000|Overall Study|Lost to Follow-up|1|||
131874431|NCT00654875|474820198|FG001|Overall Study|Lost to Follow-up|3|||
131874432|NCT00654875|474820197|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
131874433|NCT00654875|474820198|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
131874434|NCT00654875|474820197|FG000|Overall Study|Administrative Problems|1|||
131874435|NCT00654875|474820198|FG001|Overall Study|Administrative Problems|0|||
131874436|NCT04967885|474820199|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
131874437|NCT04967885|474820200|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
131874438|NCT04967885|474820199|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
131874439|NCT04967885|474820200|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
131874440|NCT04967885|474820199|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
131874441|NCT04967885|474820200|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
131874442|NCT04967885|474820199|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
131874443|NCT04967885|474820200|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
131874444|NCT04967885|474820199|FG000|EMI-II Intervention|Lost to Follow-up|14|||
131874445|NCT04967885|474820200|FG001|EMI-II Intervention|Lost to Follow-up|10|||
131874446|NCT02042950|474820201|FG000|Overall Study|Progressive Disease|4|||
131874447|NCT01940887|474820204|FG000|Year 1|Protocol Violation|0|||
131874448|NCT01940887|474820205|FG001|Year 1|Protocol Violation|1|||
131874449|NCT01940887|474820204|FG000|Year 1|Physician Decision|7|||
131874450|NCT01940887|474820205|FG001|Year 1|Physician Decision|3|||
131874451|NCT01940887|474820204|FG000|Year 1|Death|5|||
131874452|NCT01940887|474820205|FG001|Year 1|Death|3|||
131874453|NCT01940887|474820204|FG000|Year 1|Adverse Event|7|||
131874454|NCT01940887|474820205|FG001|Year 1|Adverse Event|6|||
131874455|NCT01940887|474820204|FG000|Year 1|Withdrawal by Subject|18|||
131874456|NCT01940887|474820205|FG001|Year 1|Withdrawal by Subject|9|||
131874457|NCT01940887|474820204|FG000|Year 1|Lost to Follow-up|2|||
131874458|NCT01940887|474820205|FG001|Year 1|Lost to Follow-up|1|||
131874459|NCT01940887|474820204|FG000|Year 2|Physician Decision|8|||
131874460|NCT01940887|474820205|FG001|Year 2|Physician Decision|1|||
131874461|NCT01940887|474820204|FG000|Year 2|Death|0|||
131874462|NCT01940887|474820205|FG001|Year 2|Death|2|||
131874463|NCT01940887|474820204|FG000|Year 2|Sponsor Decision, early termination|192|||
131874464|NCT01940887|474820205|FG001|Year 2|Sponsor Decision, early termination|203|||
131874465|NCT01940887|474820204|FG000|Year 2|Adverse Event|8|||
131874466|NCT01940887|474820205|FG001|Year 2|Adverse Event|2|||
131874467|NCT01940887|474820204|FG000|Year 2|Withdrawal by Subject|8|||
131874468|NCT01940887|474820205|FG001|Year 2|Withdrawal by Subject|8|||
131874469|NCT01940887|474820204|FG000|Year 2|Lost to Follow-up|1|||
131874470|NCT01940887|474820205|FG001|Year 2|Lost to Follow-up|6|||
131874471|NCT02429778|474820206|FG000|Overall Study|Lost to Follow-up|2|||
131874472|NCT02429778|474820207|FG001|Overall Study|Lost to Follow-up|0|||
131874473|NCT02429778|474820206|FG000|Overall Study|Withdrawal by Subject|5|||
131874474|NCT02429778|474820207|FG001|Overall Study|Withdrawal by Subject|0|||
131874475|NCT02475265|474820209|FG000|Overall Study|Physician Decision|1|||
131874476|NCT02475265|474820209|FG000|Overall Study|Withdrawal by Subject|2|||
131874477|NCT04791319|474820210|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
131874478|NCT04791319|474820211|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
131874479|NCT04791319|474820212|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
131874480|NCT04791319|474820213|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
131874481|NCT04791319|474820214|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131874482|NCT04791319|474820215|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131874483|NCT04791319|474820216|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131920143|NCT02850406|474990699|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131920144|NCT02850406|474990700|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
131453938|NCT01301027|473291842|FG000|Overall Study|Withdrawal by Subject|2|||
131453939|NCT01301027|473291843|FG001|Overall Study|Withdrawal by Subject|3|||
131453940|NCT01301027|473291842|FG000|Overall Study|Adverse Event|0|||
131874484|NCT04791319|474820217|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131874485|NCT04791319|474820218|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131874486|NCT04791319|474820219|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131874487|NCT04791319|474820220|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
131874488|NCT04791319|474820210|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
131874489|NCT04791319|474820211|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874490|NCT04791319|474820212|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
131874491|NCT04791319|474820213|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
131874492|NCT04791319|474820214|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874493|NCT04791319|474820215|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131920145|NCT02850406|474990693|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
131874494|NCT04791319|474820216|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874495|NCT04791319|474820217|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874496|NCT04791319|474820218|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874497|NCT04791319|474820219|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874498|NCT04791319|474820220|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
131874499|NCT04791319|474820210|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
131874500|NCT04791319|474820211|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
131874501|NCT04791319|474820212|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
131874502|NCT04791319|474820213|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
131874503|NCT04791319|474820214|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874504|NCT04791319|474820215|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874505|NCT04791319|474820216|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874506|NCT04791319|474820217|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874507|NCT04791319|474820218|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874508|NCT04791319|474820219|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874509|NCT04791319|474820220|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
131874510|NCT04791319|474820210|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
131874511|NCT04791319|474820211|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
131874512|NCT04791319|474820212|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
131874513|NCT04791319|474820213|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
131874514|NCT04791319|474820214|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874515|NCT04791319|474820215|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874516|NCT04791319|474820216|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874517|NCT04791319|474820217|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874518|NCT04791319|474820218|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874519|NCT04791319|474820219|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874520|NCT04791319|474820220|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
131874521|NCT04791319|474820210|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874522|NCT04791319|474820211|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874523|NCT04791319|474820212|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874524|NCT04791319|474820213|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
131874525|NCT04791319|474820214|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874526|NCT04791319|474820215|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874527|NCT04791319|474820216|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874528|NCT04791319|474820217|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874529|NCT04791319|474820218|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874530|NCT04791319|474820219|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874531|NCT04791319|474820220|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
131874532|NCT04791319|474820210|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874533|NCT04791319|474820211|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874534|NCT04791319|474820212|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874535|NCT04791319|474820213|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874536|NCT04791319|474820214|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
131874537|NCT04791319|474820215|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
131874538|NCT04791319|474820216|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
131874539|NCT04791319|474820217|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874540|NCT04791319|474820218|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874541|NCT04791319|474820219|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
131874542|NCT04791319|474820220|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
131874543|NCT04791319|474820210|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874544|NCT04791319|474820211|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874545|NCT04791319|474820212|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874546|NCT04791319|474820213|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874547|NCT04791319|474820214|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874548|NCT04791319|474820215|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874549|NCT04791319|474820216|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874550|NCT04791319|474820217|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874551|NCT04791319|474820218|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131874552|NCT04791319|474820219|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
131874553|NCT04791319|474820220|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
131920146|NCT02850406|474990694|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
131920147|NCT02850406|474990695|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
131408358|NCT01133405|473118262|FG008|Period 2|Withdrawal by Subject|0|||
131408359|NCT01133405|473118263|FG009|Period 2|Withdrawal by Subject|0|||
131874554|NCT04791319|474820210|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
131874555|NCT04791319|474820211|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
131874556|NCT04791319|474820212|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
131874557|NCT04791319|474820213|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
131874558|NCT04791319|474820214|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
131874559|NCT04791319|474820215|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
131874560|NCT04791319|474820216|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
131874561|NCT04791319|474820217|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
131874562|NCT04791319|474820218|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
131874563|NCT04791319|474820219|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
131874564|NCT04791319|474820220|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
131874565|NCT04791319|474820210|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
131874566|NCT04791319|474820211|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
131874567|NCT04791319|474820212|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
131874568|NCT04791319|474820213|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
131874569|NCT04791319|474820214|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
131874570|NCT04791319|474820215|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
131874571|NCT04791319|474820216|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
131874572|NCT04791319|474820217|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
131874573|NCT04791319|474820218|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
131874574|NCT04791319|474820219|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
131874575|NCT04791319|474820220|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
131874576|NCT00355147|474820223|FG000|Overall Study|Lost to Follow-up|10|||
131874577|NCT00355147|474820224|FG001|Overall Study|Lost to Follow-up|8|||
131874578|NCT00355147|474820223|FG000|Overall Study|Withdrawal by Subject|8|||
131874579|NCT00355147|474820224|FG001|Overall Study|Withdrawal by Subject|12|||
131874580|NCT02828124|474820225|FG000|Overall Study|Disease Progression|1|||
131874581|NCT02828124|474820226|FG001|Overall Study|Disease Progression|2|||
131874582|NCT02828124|474820227|FG002|Overall Study|Disease Progression|1|||
131874583|NCT02828124|474820228|FG003|Overall Study|Disease Progression|4|||
131874584|NCT02828124|474820225|FG000|Overall Study|AE Unrelated to Study Drug|0|||
131874585|NCT02828124|474820226|FG001|Overall Study|AE Unrelated to Study Drug|0|||
131874586|NCT02828124|474820227|FG002|Overall Study|AE Unrelated to Study Drug|0|||
131874587|NCT02828124|474820228|FG003|Overall Study|AE Unrelated to Study Drug|1|||
131874588|NCT02828124|474820225|FG000|Overall Study|Subject Withdrew Consent|0|||
131874589|NCT02828124|474820226|FG001|Overall Study|Subject Withdrew Consent|0|||
131874590|NCT02828124|474820227|FG002|Overall Study|Subject Withdrew Consent|0|||
131874591|NCT02828124|474820228|FG003|Overall Study|Subject Withdrew Consent|1|||
131874592|NCT01726270|474820233|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
131874593|NCT01726270|474820233|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
131874594|NCT01726270|474820233|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
131874595|NCT01726270|474820233|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
131874596|NCT01726270|474820233|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
131874597|NCT01726270|474820233|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
131874598|NCT00582608|474820234|FG000|Overall Study|Not Treated|7|||
131874599|NCT00582608|474820234|FG000|Overall Study|Patient Ineligible|1|||
131874600|NCT00582608|474820234|FG000|Overall Study|Lack of accrual|4|||
131874601|NCT02073929|474820235|FG000|Overall Study|Lost to Follow-up|2|||
131874602|NCT02073929|474820236|FG001|Overall Study|Lost to Follow-up|1|||
131874603|NCT02073929|474820235|FG000|Overall Study|Adverse Event|2|||
131874604|NCT02073929|474820236|FG001|Overall Study|Adverse Event|1|||
131874605|NCT02073929|474820235|FG000|Overall Study|Withdrawal by Subject|0|||
131874606|NCT02073929|474820236|FG001|Overall Study|Withdrawal by Subject|1|||
131874607|NCT00430573|474820237|FG000|Overall Study|Withdrawal by Subject|5|||
131874608|NCT04463251|474820238|FG000|Overall Study|Death|1|||
131874609|NCT04463251|474820239|FG001|Overall Study|Death|0|||
131874610|NCT04463251|474820240|FG002|Overall Study|Death|1|||
131874611|NCT04463251|474820238|FG000|Overall Study|Adverse Event|0|||
131874612|NCT04463251|474820239|FG001|Overall Study|Adverse Event|1|||
131874613|NCT04463251|474820240|FG002|Overall Study|Adverse Event|0|||
131874614|NCT04463251|474820238|FG000|Overall Study|Lost to Follow-up|0|||
131874615|NCT04463251|474820239|FG001|Overall Study|Lost to Follow-up|1|||
131874616|NCT04463251|474820240|FG002|Overall Study|Lost to Follow-up|0|||
131874617|NCT04463251|474820238|FG000|Overall Study|Withdrawal by Subject|0|||
131874618|NCT04463251|474820239|FG001|Overall Study|Withdrawal by Subject|2|||
131874619|NCT04463251|474820240|FG002|Overall Study|Withdrawal by Subject|2|||
131874620|NCT05020665|474820243|FG000|Overall Study|Study terminated by Sponsor|5|||
131874621|NCT05020665|474820244|FG001|Overall Study|Study terminated by Sponsor|4|||
131874622|NCT05020665|474820243|FG000|Overall Study|Death|2|||
131874623|NCT05020665|474820244|FG001|Overall Study|Death|1|||
131874624|NCT05020665|474820243|FG000|Overall Study|Physician Decision|0|||
131874625|NCT05020665|474820244|FG001|Overall Study|Physician Decision|1|||
131874626|NCT05020665|474820243|FG000|Overall Study|Withdrawal by Subject|0|||
131874627|NCT05020665|474820244|FG001|Overall Study|Withdrawal by Subject|1|||
131874628|NCT05020665|474820243|FG000|Overall Study|Reason not specified|1|||
131874629|NCT05020665|474820244|FG001|Overall Study|Reason not specified|0|||
131874630|NCT00072280|474820245|FG000|Treatment|Found ineligible|1|||
131874631|NCT00072280|474820246|FG001|Treatment|Found ineligible|2|||
131874632|NCT00072280|474820245|FG000|Follow-up|Early termination of study|2|||
131874633|NCT00072280|474820246|FG001|Follow-up|Early termination of study|2|||
131874634|NCT00022698|474820247|FG000|Overall Study|Adverse Event|5|||
131874635|NCT00022698|474820248|FG001|Overall Study|Adverse Event|9|||
131874636|NCT00022698|474820247|FG000|Overall Study|Death|0|||
131874637|NCT00022698|474820248|FG001|Overall Study|Death|2|||
131874638|NCT00022698|474820247|FG000|Overall Study|Failure to return|0|||
131874639|NCT00022698|474820248|FG001|Overall Study|Failure to return|1|||
131874640|NCT00022698|474820247|FG000|Overall Study|Refused treatment|0|||
131874641|NCT00022698|474820248|FG001|Overall Study|Refused treatment|2|||
131874642|NCT00022698|474820247|FG000|Overall Study|Insufficient therapeutic response|2|||
131874643|NCT00022698|474820248|FG001|Overall Study|Insufficient therapeutic response|14|||
131874644|NCT00022698|474820247|FG000|Overall Study|Administrative /other|1|||
131874645|NCT00022698|474820248|FG001|Overall Study|Administrative /other|7|||
131874646|NCT02504827|474820252|FG000|Overall Study|Could not produce sputum|1|||
131874647|NCT01732640|474820259|FG000|Overall Study|Adverse Event|0|||
131874648|NCT01732640|474820260|FG001|Overall Study|Adverse Event|1|||
131874649|NCT01732640|474820259|FG000|Overall Study|Death|0|||
131874650|NCT01732640|474820260|FG001|Overall Study|Death|1|||
131874651|NCT00877487|474820263|FG000|Open-label Treatment Phase|Adverse Event|1|||
131874652|NCT00877487|474820264|FG001|Open-label Treatment Phase|Adverse Event|0|||
131874653|NCT00877487|474820263|FG000|Open-label Treatment Phase|Protocol Violation|3|||
131874654|NCT00877487|474820264|FG001|Open-label Treatment Phase|Protocol Violation|0|||
131874655|NCT00877487|474820263|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
131874656|NCT00877487|474820264|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
131874657|NCT00877487|474820263|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
131874658|NCT00877487|474820264|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
131874659|NCT00877487|474820263|FG000|Open-label Treatment Phase|Out of country for business|1|||
131874660|NCT00877487|474820264|FG001|Open-label Treatment Phase|Out of country for business|0|||
131874661|NCT00877487|474820263|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
131874662|NCT00877487|474820264|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
131874663|NCT00877487|474820263|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
131874664|NCT00877487|474820264|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
131874665|NCT00877487|474820263|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
131874666|NCT00877487|474820264|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
131874667|NCT00877487|474820263|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
131874668|NCT00877487|474820264|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
131874669|NCT03070002|474820265|FG000|Follow up for 2 Years|Death|1|||
131874670|NCT00712543|474820268|FG000|Day 8-14|Lost to Follow-up|0|||
131874671|NCT00712543|474820269|FG001|Day 8-14|Lost to Follow-up|2|||
131874672|NCT02729051|474820272|FG000|Overall Study|Adverse Event|21|||
131874673|NCT02729051|474820273|FG001|Overall Study|Adverse Event|11|||
131874674|NCT02729051|474820272|FG000|Overall Study|Lack of Efficacy|1|||
131874675|NCT02729051|474820273|FG001|Overall Study|Lack of Efficacy|1|||
131874676|NCT02729051|474820272|FG000|Overall Study|Lost to Follow-up|1|||
131874677|NCT02729051|474820273|FG001|Overall Study|Lost to Follow-up|2|||
131874678|NCT02729051|474820272|FG000|Overall Study|Physician Decision|1|||
131874679|NCT02729051|474820273|FG001|Overall Study|Physician Decision|1|||
131874680|NCT02729051|474820272|FG000|Overall Study|Withdrawal by Subject|6|||
131874681|NCT02729051|474820273|FG001|Overall Study|Withdrawal by Subject|17|||
131874682|NCT02702388|474820274|FG000|Overall Study|Disease Progression|18|||
131874683|NCT02702388|474820275|FG001|Overall Study|Disease Progression|25|||
131874684|NCT02702388|474820274|FG000|Overall Study|Withdrawal by Subject|9|||
131874685|NCT02702388|474820275|FG001|Overall Study|Withdrawal by Subject|7|||
131874686|NCT02702388|474820274|FG000|Overall Study|Adverse Event|11|||
131874687|NCT02702388|474820275|FG001|Overall Study|Adverse Event|15|||
131874688|NCT02702388|474820274|FG000|Overall Study|Other|2|||
131874689|NCT02702388|474820275|FG001|Overall Study|Other|4|||
131874690|NCT04520997|474820290|FG000|Overall Study|Lost to Follow-up|1|||
131874691|NCT04520997|474820291|FG001|Overall Study|Lost to Follow-up|1|||
131874692|NCT04520997|474820290|FG000|Overall Study|Withdrawal by Subject|1|||
131874693|NCT04520997|474820291|FG001|Overall Study|Withdrawal by Subject|0|||
131874694|NCT04520997|474820290|FG000|Overall Study|Not Treated|0|||
131874695|NCT04520997|474820291|FG001|Overall Study|Not Treated|1|||
131874696|NCT02981082|474820292|FG000|Overall Study|Withdrawal by Subject|2|||
131920148|NCT02850406|474990696|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
131920149|NCT02850406|474990697|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
131920150|NCT02850406|474990698|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
131920151|NCT02850406|474990699|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
131920152|NCT02850406|474990700|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
131920153|NCT02850406|474990693|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
131920154|NCT02850406|474990694|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
131920155|NCT02850406|474990695|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
131920156|NCT02850406|474990696|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
131920157|NCT02850406|474990697|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
131920158|NCT02850406|474990698|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
131920159|NCT02850406|474990699|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
131920160|NCT02850406|474990700|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
131920161|NCT02850406|474990693|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920162|NCT02850406|474990694|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920163|NCT02850406|474990695|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920164|NCT02850406|474990696|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920165|NCT02850406|474990697|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
131920166|NCT02850406|474990698|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
131920167|NCT02850406|474990699|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920168|NCT02850406|474990700|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920169|NCT02850406|474990693|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920170|NCT02850406|474990694|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920171|NCT02850406|474990695|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920172|NCT02850406|474990696|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920173|NCT02850406|474990697|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
131920174|NCT02850406|474990698|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920175|NCT02850406|474990699|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920176|NCT02850406|474990700|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
131920177|NCT02850406|474990693|FG000|Part C (Up to 52 Weeks)|Other|0|||
131920178|NCT02850406|474990694|FG001|Part C (Up to 52 Weeks)|Other|0|||
131920179|NCT02850406|474990695|FG002|Part C (Up to 52 Weeks)|Other|0|||
131920180|NCT02850406|474990696|FG003|Part C (Up to 52 Weeks)|Other|0|||
131920181|NCT02850406|474990697|FG004|Part C (Up to 52 Weeks)|Other|1|||
131920182|NCT02850406|474990698|FG005|Part C (Up to 52 Weeks)|Other|3|||
131920183|NCT02850406|474990699|FG006|Part C (Up to 52 Weeks)|Other|0|||
131920184|NCT02850406|474990700|FG007|Part C (Up to 52 Weeks)|Other|0|||
131920185|NCT02850406|474990693|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920186|NCT02850406|474990694|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920187|NCT02850406|474990695|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920188|NCT02850406|474990696|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920189|NCT02850406|474990697|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920190|NCT02850406|474990698|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920191|NCT02850406|474990699|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
131920192|NCT02850406|474990700|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
131920193|NCT02850406|474990693|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920194|NCT02850406|474990694|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920195|NCT02850406|474990695|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920196|NCT02850406|474990696|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920197|NCT02850406|474990697|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920198|NCT02850406|474990698|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920199|NCT02850406|474990699|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
131920200|NCT02850406|474990700|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
131920201|NCT02850406|474990693|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
131920202|NCT02850406|474990694|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
131920203|NCT02850406|474990695|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
131920204|NCT02850406|474990696|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
131920205|NCT02850406|474990697|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
131920206|NCT02850406|474990698|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
131920207|NCT02850406|474990699|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
131920208|NCT02850406|474990700|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
131920209|NCT02850406|474990693|FG000|Part D (Up to 52 Weeks)|Other|0|||
131920210|NCT02850406|474990694|FG001|Part D (Up to 52 Weeks)|Other|0|||
131453941|NCT01301027|473291843|FG001|Overall Study|Adverse Event|2|||
131920211|NCT02850406|474990695|FG002|Part D (Up to 52 Weeks)|Other|0|||
131920212|NCT02850406|474990696|FG003|Part D (Up to 52 Weeks)|Other|0|||
131920213|NCT02850406|474990697|FG004|Part D (Up to 52 Weeks)|Other|0|||
131920214|NCT02850406|474990698|FG005|Part D (Up to 52 Weeks)|Other|0|||
131920215|NCT02850406|474990699|FG006|Part D (Up to 52 Weeks)|Other|0|||
131920216|NCT02850406|474990700|FG007|Part D (Up to 52 Weeks)|Other|1|||
131920217|NCT05643794|474991679|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
131920218|NCT05643794|474991680|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
131920219|NCT05643794|474991681|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131920220|NCT05643794|474991679|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131920221|NCT05643794|474991680|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131920222|NCT05643794|474991681|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131920223|NCT05643794|474991679|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
131920224|NCT05643794|474991680|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
131920225|NCT05643794|474991681|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
131920226|NCT05643794|474991679|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131920227|NCT05643794|474991680|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131920228|NCT05643794|474991681|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131920229|NCT05643794|474991679|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
131920230|NCT05643794|474991680|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
131920231|NCT05643794|474991681|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
131920232|NCT05643794|474991679|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
131920233|NCT05643794|474991680|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
131920234|NCT05643794|474991681|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
131920235|NCT01127061|474991684|FG000|Overall Study|Lost to Follow-up|7|||
131920236|NCT01127061|474991685|FG001|Overall Study|Lost to Follow-up|10|||
131920237|NCT01127061|474991684|FG000|Overall Study|Physician Decision|3|||
131920238|NCT01127061|474991685|FG001|Overall Study|Physician Decision|3|||
131920239|NCT04827446|474991686|FG000|Overall Study|Lost to Follow-up|1|||
131920240|NCT04827446|474991687|FG001|Overall Study|Lost to Follow-up|1|||
131920241|NCT04827446|474991686|FG000|Overall Study|Death|2|||
131920242|NCT04827446|474991687|FG001|Overall Study|Death|0|||
131920243|NCT04827446|474991686|FG000|Overall Study|Withdrawal by Subject|2|||
131920244|NCT04827446|474991687|FG001|Overall Study|Withdrawal by Subject|2|||
131920245|NCT00003456|474991690|FG000|Overall Study|Not evaluable|8|||
131920246|NCT00479232|474991691|FG000|Overall Study|Adverse Event|0|||
131920247|NCT00479232|474991692|FG001|Overall Study|Adverse Event|0|||
131920248|NCT00479232|474991693|FG002|Overall Study|Adverse Event|5|||
131920249|NCT00479232|474991694|FG003|Overall Study|Adverse Event|0|||
131920250|NCT00479232|474991695|FG004|Overall Study|Adverse Event|0|||
131920251|NCT00479232|474991696|FG005|Overall Study|Adverse Event|10|||
131920252|NCT00479232|474991691|FG000|Overall Study|Deviation from Protocol|0|||
131920253|NCT00479232|474991692|FG001|Overall Study|Deviation from Protocol|0|||
131920254|NCT00479232|474991693|FG002|Overall Study|Deviation from Protocol|1|||
131920255|NCT00479232|474991694|FG003|Overall Study|Deviation from Protocol|0|||
131920256|NCT00479232|474991695|FG004|Overall Study|Deviation from Protocol|0|||
131920257|NCT00479232|474991696|FG005|Overall Study|Deviation from Protocol|0|||
131920258|NCT00479232|474991691|FG000|Overall Study|Lack of Efficacy|0|||
131920259|NCT00479232|474991692|FG001|Overall Study|Lack of Efficacy|0|||
131920260|NCT00479232|474991693|FG002|Overall Study|Lack of Efficacy|2|||
131920261|NCT00479232|474991694|FG003|Overall Study|Lack of Efficacy|0|||
131920262|NCT00479232|474991695|FG004|Overall Study|Lack of Efficacy|0|||
131920263|NCT00479232|474991696|FG005|Overall Study|Lack of Efficacy|4|||
131920264|NCT00479232|474991691|FG000|Overall Study|Physician Decision|0|||
131920265|NCT00479232|474991692|FG001|Overall Study|Physician Decision|0|||
131920266|NCT00479232|474991693|FG002|Overall Study|Physician Decision|2|||
131920267|NCT00479232|474991694|FG003|Overall Study|Physician Decision|0|||
131920268|NCT00479232|474991695|FG004|Overall Study|Physician Decision|0|||
131920269|NCT00479232|474991696|FG005|Overall Study|Physician Decision|1|||
131920270|NCT00479232|474991691|FG000|Overall Study|Progressive Disease|3|||
131920271|NCT00479232|474991692|FG001|Overall Study|Progressive Disease|1|||
131920272|NCT00479232|474991693|FG002|Overall Study|Progressive Disease|12|||
131920273|NCT00479232|474991694|FG003|Overall Study|Progressive Disease|3|||
131920274|NCT00479232|474991695|FG004|Overall Study|Progressive Disease|3|||
131920275|NCT00479232|474991696|FG005|Overall Study|Progressive Disease|12|||
131920276|NCT00479232|474991691|FG000|Overall Study|Withdrew Consent|0|||
131920277|NCT00479232|474991692|FG001|Overall Study|Withdrew Consent|2|||
131920278|NCT00479232|474991693|FG002|Overall Study|Withdrew Consent|6|||
131920279|NCT00479232|474991694|FG003|Overall Study|Withdrew Consent|0|||
131920280|NCT00479232|474991695|FG004|Overall Study|Withdrew Consent|1|||
131920281|NCT00479232|474991696|FG005|Overall Study|Withdrew Consent|3|||
131920282|NCT03720847|474991697|FG000|Washout|Physician Decision|1|||
131920283|NCT03720847|474991698|FG001|Washout|Physician Decision|2|||
131920284|NCT03033901|474991699|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
131920285|NCT03033901|474991699|FG000|Overall Study|Refused PSG|23|||
131920286|NCT03033901|474991699|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
131920287|NCT03033901|474991699|FG000|Overall Study|Missing Oximetry Data|3|||
131920288|NCT02513199|474991702|FG000|Treatment|Death|1|||
131920289|NCT02513199|474991702|FG000|Treatment|Lost to Follow-up|1|||
131920290|NCT02513199|474991702|FG000|Follow-Up|Death|11|||
131920291|NCT04307394|474991706|FG000|Overall Study|Lost to Follow-up|3|||
131920292|NCT04307394|474991706|FG000|Overall Study|Withdrawal by Subject|2|||
131920293|NCT04900272|474991713|FG000|Overall Study|Lost to Follow-up|2|||
131920294|NCT04900272|474991713|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
131920295|NCT04900272|474991713|FG000|Overall Study|Withdrawal by Subject|1|||
131874697|NCT02981082|474820293|FG001|Overall Study|Withdrawal by Subject|0|||
131874698|NCT02981082|474820292|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
131874699|NCT02981082|474820293|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
131874700|NCT02981082|474820292|FG000|Overall Study|Adverse Event|0|||
131874701|NCT02981082|474820293|FG001|Overall Study|Adverse Event|1|||
131874702|NCT00504725|474822339|FG000|Overall Study|Protocol Violation|1|||
131874703|NCT00504725|474822340|FG001|Overall Study|Protocol Violation|0|||
131874704|NCT01435018|474822342|FG000|Overall Study|Death|37|||
131874705|NCT01435018|474822343|FG001|Overall Study|Death|18|||
131874706|NCT01435018|474822344|FG002|Overall Study|Death|25|||
131874707|NCT01435018|474822342|FG000|Overall Study|Site is closing|4|||
131874708|NCT01435018|474822343|FG001|Overall Study|Site is closing|9|||
131874709|NCT01435018|474822344|FG002|Overall Study|Site is closing|7|||
131874710|NCT01435018|474822342|FG000|Overall Study|Withdrew consent|0|||
131874711|NCT01435018|474822343|FG001|Overall Study|Withdrew consent|3|||
131874712|NCT01435018|474822344|FG002|Overall Study|Withdrew consent|1|||
131874713|NCT01435018|474822342|FG000|Overall Study|Not willing to adhere to requirements|0|||
131874714|NCT01435018|474822343|FG001|Overall Study|Not willing to adhere to requirements|2|||
131874715|NCT01435018|474822344|FG002|Overall Study|Not willing to adhere to requirements|3|||
131874716|NCT01435018|474822342|FG000|Overall Study|Not able to get to clinic|2|||
131874717|NCT01435018|474822343|FG001|Overall Study|Not able to get to clinic|0|||
131874718|NCT01435018|474822344|FG002|Overall Study|Not able to get to clinic|2|||
131874719|NCT01435018|474822342|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131874720|NCT01435018|474822343|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131874721|NCT01435018|474822344|FG002|Overall Study|Severe debilitation, unable to continue|1|||
131874722|NCT01435018|474822342|FG000|Overall Study|Unable to contact participant/parent|1|||
131874723|NCT01435018|474822343|FG001|Overall Study|Unable to contact participant/parent|1|||
131874724|NCT01435018|474822344|FG002|Overall Study|Unable to contact participant/parent|1|||
131874725|NCT01435018|474822342|FG000|Overall Study|Enrollment Violation|0|||
131874726|NCT01435018|474822343|FG001|Overall Study|Enrollment Violation|1|||
131874727|NCT01435018|474822344|FG002|Overall Study|Enrollment Violation|0|||
131874728|NCT01435018|474822342|FG000|Overall Study|Never started chemotherapy|3|||
131874729|NCT01435018|474822343|FG001|Overall Study|Never started chemotherapy|0|||
131874730|NCT01435018|474822344|FG002|Overall Study|Never started chemotherapy|1|||
131874731|NCT00769067|474822345|FG000|Overall Study|Death|89|||
131874732|NCT00769067|474822346|FG001|Overall Study|Death|86|||
131874733|NCT00769067|474822345|FG000|Overall Study|Lost to Follow-up|3|||
131874734|NCT00769067|474822346|FG001|Overall Study|Lost to Follow-up|1|||
131874735|NCT00769067|474822345|FG000|Overall Study|Study terminated by sponsor|1|||
131874736|NCT00769067|474822346|FG001|Overall Study|Study terminated by sponsor|3|||
131874737|NCT00769067|474822345|FG000|Overall Study|Other|1|||
131874738|NCT00769067|474822346|FG001|Overall Study|Other|3|||
131874739|NCT00769067|474822345|FG000|Overall Study|Withdrawal by Subject|0|||
131874740|NCT00769067|474822346|FG001|Overall Study|Withdrawal by Subject|1|||
131874741|NCT03806933|474822347|FG000|Main Period|Physician Decision|0|||
131874742|NCT03806933|474822348|FG001|Main Period|Physician Decision|0|||
131874743|NCT03806933|474822349|FG002|Main Period|Physician Decision|0|||
131874744|NCT03806933|474822350|FG003|Main Period|Physician Decision|1|||
131874745|NCT03806933|474822347|FG000|Main Period|Pregnancy|0|||
131874746|NCT03806933|474822348|FG001|Main Period|Pregnancy|0|||
131874747|NCT03806933|474822349|FG002|Main Period|Pregnancy|1|||
131874748|NCT03806933|474822350|FG003|Main Period|Pregnancy|0|||
131874749|NCT03806933|474822347|FG000|Main Period|Withdrawal by Subject|2|||
131874750|NCT03806933|474822348|FG001|Main Period|Withdrawal by Subject|1|||
131874751|NCT03806933|474822349|FG002|Main Period|Withdrawal by Subject|1|||
131874752|NCT03806933|474822350|FG003|Main Period|Withdrawal by Subject|2|||
131874753|NCT03806933|474822347|FG000|Main Period|Lost to Follow-up|2|||
131874754|NCT03806933|474822348|FG001|Main Period|Lost to Follow-up|2|||
131874755|NCT03806933|474822349|FG002|Main Period|Lost to Follow-up|0|||
131874756|NCT03806933|474822350|FG003|Main Period|Lost to Follow-up|0|||
131874757|NCT03806933|474822347|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
131874758|NCT03806933|474822348|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
131874759|NCT03806933|474822349|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
131874760|NCT03806933|474822350|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
131874761|NCT03625466|474822351|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
131874762|NCT03625466|474822352|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
131874763|NCT03625466|474822353|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
131874764|NCT03625466|474822351|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
131874765|NCT03625466|474822352|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
131874766|NCT03625466|474822353|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
131874767|NCT03625466|474822351|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
131874768|NCT03625466|474822352|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
131874769|NCT03625466|474822353|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
131874770|NCT00809471|474822356|FG000|Overall Study|Protocol non-compliance|15|||
131874771|NCT00809471|474822357|FG001|Overall Study|Protocol non-compliance|15|||
131874772|NCT00809471|474822358|FG002|Overall Study|Protocol non-compliance|6|||
131874773|NCT00809471|474822356|FG000|Overall Study|Lost to Follow-up|4|||
131874774|NCT00809471|474822357|FG001|Overall Study|Lost to Follow-up|2|||
131874775|NCT00809471|474822358|FG002|Overall Study|Lost to Follow-up|9|||
131874776|NCT00809471|474822356|FG000|Overall Study|Adverse Event|0|||
131874777|NCT00809471|474822357|FG001|Overall Study|Adverse Event|2|||
131874778|NCT00809471|474822358|FG002|Overall Study|Adverse Event|2|||
131874779|NCT00809471|474822356|FG000|Overall Study|Requirement for restricted medication|1|||
131874780|NCT00809471|474822357|FG001|Overall Study|Requirement for restricted medication|1|||
131874781|NCT00809471|474822358|FG002|Overall Study|Requirement for restricted medication|0|||
131874782|NCT00831311|474822359|FG000|Overall Study|Definitive Contraindication|3|||
131874783|NCT00831311|474822360|FG001|Overall Study|Definitive Contraindication|3|||
131874784|NCT00831311|474822359|FG000|Overall Study|Lost to Follow-up|3|||
131874785|NCT00831311|474822360|FG001|Overall Study|Lost to Follow-up|0|||
131874786|NCT00831311|474822359|FG000|Overall Study|Physician Decision|0|||
131874787|NCT00831311|474822360|FG001|Overall Study|Physician Decision|1|||
131874788|NCT00831311|474822359|FG000|Overall Study|Withdrawal by Subject|6|||
131874789|NCT00831311|474822360|FG001|Overall Study|Withdrawal by Subject|4|||
131874790|NCT01868438|474822361|FG000|First Intervention|Withdrawal by Subject|5|||
131874791|NCT01868438|474822362|FG001|First Intervention|Withdrawal by Subject|1|||
131874792|NCT01868438|474822361|FG000|First Intervention|Lost to Follow-up|2|||
131874793|NCT01868438|474822362|FG001|First Intervention|Lost to Follow-up|3|||
131874794|NCT01868438|474822361|FG000|First Intervention|Meeting the non-redosing criteria|0|||
131874795|NCT01868438|474822362|FG001|First Intervention|Meeting the non-redosing criteria|1|||
131874796|NCT01868438|474822361|FG000|Second Intervention|Adverse Event|3|||
131874797|NCT01868438|474822362|FG001|Second Intervention|Adverse Event|3|||
131874798|NCT00956592|474822366|FG000|Overall Study|Protocol Violation|1|||
131874799|NCT00956592|474822367|FG001|Overall Study|Protocol Violation|3|||
131874800|NCT00076752|474822370|FG000|Overall Study|Death|2|||
131874801|NCT00076752|474822370|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
131874802|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
131874803|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
131874804|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
131874805|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
131874806|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
131874807|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
131874808|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
131874809|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
131874810|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Death|0|||
131874811|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Death|1|||
131874812|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
131874813|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
131874814|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
131874815|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
131874816|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
131874817|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
131874818|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
131874819|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
131874820|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
131874821|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
131874822|NCT00394836|474822373|FG000|Teatment or Follow-up Phase|Non compliance|0|||
131874823|NCT00394836|474822374|FG001|Teatment or Follow-up Phase|Non compliance|1|||
131874824|NCT00394836|474822373|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
131874825|NCT00394836|474822374|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
131874826|NCT00394836|474822373|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
131874827|NCT00394836|474822374|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
131874828|NCT00394836|474822373|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
131874829|NCT00394836|474822374|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
131874830|NCT00394836|474822373|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
131874831|NCT00394836|474822374|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
131874832|NCT02028767|474822375|FG000|Treatment Period 2|Non compliant with protocol|1|||
131874833|NCT02028767|474822376|FG001|Treatment Period 2|Non compliant with protocol|0|||
131874834|NCT02028767|474822375|FG000|Treatment Period 2|Reason other than those specified above|1|||
131874835|NCT02028767|474822376|FG001|Treatment Period 2|Reason other than those specified above|0|||
131874836|NCT05338502|474822379|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
131874837|NCT05338502|474822380|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
131874838|NCT05338502|474822381|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
131874839|NCT05338502|474822379|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
131874840|NCT05338502|474822380|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
131874841|NCT05338502|474822381|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
131874842|NCT03575793|474822382|FG000|Overall Study|Withdrawal by Subject|0|||
131874843|NCT03575793|474822383|FG001|Overall Study|Withdrawal by Subject|1|||
131874844|NCT03575793|474822382|FG000|Overall Study|Never Treated|0|||
131874845|NCT03575793|474822383|FG001|Overall Study|Never Treated|2|||
131874846|NCT01250873|474822384|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
131874847|NCT01250873|474822384|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
131874848|NCT00886743|474822387|FG000|Overall Study|Adverse Event|3|||
131874849|NCT00886743|474822387|FG000|Overall Study|Other|1|||
131874850|NCT03521115|474822388|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
131874851|NCT03521115|474822389|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
131874852|NCT03521115|474822388|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
131874853|NCT03521115|474822389|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
131874854|NCT03063086|474822390|FG000|Overall Study|technical problems|1|||
131874855|NCT03063086|474822391|FG001|Overall Study|technical problems|0|||
131874856|NCT03063086|474822392|FG002|Overall Study|technical problems|0|||
131874857|NCT03063086|474822393|FG003|Overall Study|technical problems|0|||
131874858|NCT03063086|474822394|FG004|Overall Study|technical problems|0|||
131874859|NCT03063086|474822395|FG005|Overall Study|technical problems|0|||
131874860|NCT03063086|474822390|FG000|Overall Study|Adverse Event|1|||
131874861|NCT03063086|474822391|FG001|Overall Study|Adverse Event|1|||
131874862|NCT03063086|474822392|FG002|Overall Study|Adverse Event|1|||
131874863|NCT03063086|474822393|FG003|Overall Study|Adverse Event|1|||
131874864|NCT03063086|474822394|FG004|Overall Study|Adverse Event|0|||
131874865|NCT03063086|474822395|FG005|Overall Study|Adverse Event|0|||
131874866|NCT03063086|474822390|FG000|Overall Study|subject/guardian decision|1|||
131874867|NCT03063086|474822391|FG001|Overall Study|subject/guardian decision|0|||
131874868|NCT03063086|474822392|FG002|Overall Study|subject/guardian decision|0|||
131874869|NCT03063086|474822393|FG003|Overall Study|subject/guardian decision|0|||
131874870|NCT03063086|474822394|FG004|Overall Study|subject/guardian decision|0|||
131874871|NCT03063086|474822395|FG005|Overall Study|subject/guardian decision|0|||
131874872|NCT03063086|474822390|FG000|Overall Study|Non-compliance with study treatment|0|||
131874873|NCT03063086|474822391|FG001|Overall Study|Non-compliance with study treatment|0|||
131874874|NCT03063086|474822392|FG002|Overall Study|Non-compliance with study treatment|0|||
131874875|NCT03063086|474822393|FG003|Overall Study|Non-compliance with study treatment|1|||
131874876|NCT03063086|474822394|FG004|Overall Study|Non-compliance with study treatment|0|||
131874877|NCT03063086|474822395|FG005|Overall Study|Non-compliance with study treatment|1|||
131874878|NCT03063086|474822390|FG000|Overall Study|Physician Decision|0|||
131874879|NCT03063086|474822391|FG001|Overall Study|Physician Decision|0|||
131874880|NCT03063086|474822392|FG002|Overall Study|Physician Decision|0|||
131874881|NCT03063086|474822393|FG003|Overall Study|Physician Decision|1|||
131874882|NCT03063086|474822394|FG004|Overall Study|Physician Decision|0|||
131874883|NCT03063086|474822395|FG005|Overall Study|Physician Decision|0|||
131874884|NCT01893281|474822396|FG000|Overall Study|Adverse Event|1|||
131874885|NCT01893281|474822396|FG000|Overall Study|Protocol Violation|1|||
131874886|NCT01893281|474822396|FG000|Overall Study|Withdrawal by Subject|1|||
131874887|NCT02244463|474822397|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
131874888|NCT02244463|474822398|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
131874889|NCT02244463|474822399|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
131874890|NCT02244463|474822400|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
131874891|NCT02244463|474822401|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
131874892|NCT02244463|474822402|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
131874893|NCT02244463|474822397|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
131874894|NCT02244463|474822398|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
131874895|NCT02244463|474822399|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
131874896|NCT02244463|474822400|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
131874897|NCT02244463|474822401|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
131874898|NCT02244463|474822402|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
131874899|NCT02244463|474822397|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
131874900|NCT02244463|474822398|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
131874901|NCT02244463|474822399|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
131874902|NCT02244463|474822400|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
131874903|NCT02244463|474822401|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
131874904|NCT02244463|474822402|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
131874905|NCT02244463|474822397|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
131874906|NCT02244463|474822398|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
131874907|NCT02244463|474822399|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
131453942|NCT01301027|473291842|FG000|Overall Study|Fracture|1|||
131874908|NCT02244463|474822400|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
131874909|NCT02244463|474822401|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
131874910|NCT02244463|474822402|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
131874911|NCT02244463|474822397|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
131920296|NCT00741611|474991714|FG000|Overall Study|Death|0|||
131920297|NCT00741611|474991715|FG001|Overall Study|Death|0|||
131920298|NCT00741611|474991716|FG002|Overall Study|Death|1|||
131920299|NCT00741611|474991714|FG000|Overall Study|Withdrawal by Subject|0|||
131920300|NCT00741611|474991715|FG001|Overall Study|Withdrawal by Subject|2|||
131920301|NCT00741611|474991716|FG002|Overall Study|Withdrawal by Subject|2|||
131920302|NCT05607043|474991717|FG000|Overall Study|Lost to Follow-up|2|||
131874912|NCT02244463|474822398|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
131874913|NCT02244463|474822399|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
131874914|NCT02244463|474822400|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
131874915|NCT02244463|474822401|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
131874916|NCT02244463|474822402|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
131874917|NCT02244463|474822397|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
131874918|NCT02244463|474822398|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
131874919|NCT02244463|474822399|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
131874920|NCT02244463|474822400|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
131874921|NCT02244463|474822401|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
131874922|NCT02244463|474822402|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
131874923|NCT02244463|474822397|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
131874924|NCT02244463|474822398|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
131874925|NCT02244463|474822399|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
131874926|NCT02244463|474822400|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
131874927|NCT02244463|474822401|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
131874928|NCT02244463|474822402|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
131874929|NCT02244463|474822397|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
131874930|NCT02244463|474822398|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
131874931|NCT02244463|474822399|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
131874932|NCT02244463|474822400|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
131874933|NCT02244463|474822401|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
131874934|NCT02244463|474822402|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
131874935|NCT02244463|474822397|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
131874936|NCT02244463|474822398|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
131874937|NCT02244463|474822399|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
131874938|NCT02244463|474822400|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
131874939|NCT02244463|474822401|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
131874940|NCT02244463|474822402|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
131874941|NCT02244463|474822397|FG000|Period 5: Phase II|Disease Progression|0|||
131874942|NCT02244463|474822398|FG001|Period 5: Phase II|Disease Progression|0|||
131874943|NCT02244463|474822399|FG002|Period 5: Phase II|Disease Progression|0|||
131874944|NCT02244463|474822400|FG003|Period 5: Phase II|Disease Progression|0|||
131874945|NCT02244463|474822401|FG004|Period 5: Phase II|Disease Progression|10|||
131874946|NCT02244463|474822402|FG005|Period 5: Phase II|Disease Progression|11|||
131874947|NCT02244463|474822397|FG000|Period 5: Phase II|Physician Decision|0|||
131874948|NCT02244463|474822398|FG001|Period 5: Phase II|Physician Decision|0|||
131874949|NCT02244463|474822399|FG002|Period 5: Phase II|Physician Decision|0|||
131874950|NCT02244463|474822400|FG003|Period 5: Phase II|Physician Decision|0|||
131874951|NCT02244463|474822401|FG004|Period 5: Phase II|Physician Decision|3|||
131874952|NCT02244463|474822402|FG005|Period 5: Phase II|Physician Decision|2|||
131874953|NCT02244463|474822397|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
131874954|NCT02244463|474822398|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
131874955|NCT02244463|474822399|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
131874956|NCT02244463|474822400|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
131874957|NCT02244463|474822401|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
131874958|NCT02244463|474822402|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
131874959|NCT02244463|474822397|FG000|Period 5: Phase II|Intercurrent Illness|0|||
131874960|NCT02244463|474822398|FG001|Period 5: Phase II|Intercurrent Illness|0|||
131874961|NCT02244463|474822399|FG002|Period 5: Phase II|Intercurrent Illness|0|||
131874962|NCT02244463|474822400|FG003|Period 5: Phase II|Intercurrent Illness|0|||
131874963|NCT02244463|474822401|FG004|Period 5: Phase II|Intercurrent Illness|2|||
131874964|NCT02244463|474822402|FG005|Period 5: Phase II|Intercurrent Illness|0|||
131874965|NCT02244463|474822397|FG000|Period 5: Phase II|Adverse Event|0|||
131874966|NCT02244463|474822398|FG001|Period 5: Phase II|Adverse Event|0|||
131874967|NCT02244463|474822399|FG002|Period 5: Phase II|Adverse Event|0|||
131874968|NCT02244463|474822400|FG003|Period 5: Phase II|Adverse Event|0|||
131874969|NCT02244463|474822401|FG004|Period 5: Phase II|Adverse Event|0|||
131874970|NCT02244463|474822402|FG005|Period 5: Phase II|Adverse Event|2|||
131874971|NCT02244463|474822397|FG000|Period 5: Phase II|Still On treatment|0|||
131874972|NCT02244463|474822398|FG001|Period 5: Phase II|Still On treatment|0|||
131874973|NCT02244463|474822399|FG002|Period 5: Phase II|Still On treatment|0|||
131874974|NCT02244463|474822400|FG003|Period 5: Phase II|Still On treatment|0|||
131874975|NCT02244463|474822401|FG004|Period 5: Phase II|Still On treatment|0|||
131874976|NCT02244463|474822402|FG005|Period 5: Phase II|Still On treatment|3|||
131920303|NCT02447029|474991723|FG000|Overall Study|Withdrawal by Subject|3|||
131920304|NCT02447029|474991724|FG001|Overall Study|Withdrawal by Subject|2|||
131920305|NCT03384966|474991728|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
131920306|NCT03384966|474991729|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
131920307|NCT03384966|474991730|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
131920308|NCT03384966|474991728|FG000|Follow-up Period|Adverse Event|1|||
131920309|NCT03384966|474991729|FG001|Follow-up Period|Adverse Event|0|||
131920310|NCT03384966|474991730|FG002|Follow-up Period|Adverse Event|0|||
131920311|NCT03637374|474991731|FG000|Overall Study|Death|2|||
131920312|NCT03637374|474991732|FG001|Overall Study|Death|0|||
131920313|NCT01479530|474991735|FG000|Overall Study|Adverse Event|5|||
131920314|NCT01479530|474991736|FG001|Overall Study|Adverse Event|6|||
131920315|NCT01479530|474991735|FG000|Overall Study|Lack of Efficacy|0|||
131920316|NCT01479530|474991736|FG001|Overall Study|Lack of Efficacy|1|||
131920317|NCT01479530|474991735|FG000|Overall Study|Protocol Violation|2|||
131920318|NCT01479530|474991736|FG001|Overall Study|Protocol Violation|3|||
131920319|NCT01479530|474991735|FG000|Overall Study|Withdrawal of Consent|3|||
131920320|NCT01479530|474991736|FG001|Overall Study|Withdrawal of Consent|2|||
131920321|NCT00303628|474991737|FG000|Overall Study|Disease progression|0|||
131920322|NCT00303628|474991738|FG001|Overall Study|Disease progression|1|||
131920323|NCT00303628|474991737|FG000|Overall Study|Adverse Event|26|||
131920324|NCT00303628|474991738|FG001|Overall Study|Adverse Event|36|||
131920325|NCT00303628|474991737|FG000|Overall Study|Death|0|||
131920326|NCT00303628|474991738|FG001|Overall Study|Death|1|||
131920327|NCT00303628|474991737|FG000|Overall Study|Withdrawal by Subject|11|||
131920328|NCT00303628|474991738|FG001|Overall Study|Withdrawal by Subject|20|||
131920329|NCT00303628|474991737|FG000|Overall Study|Alternative therapy|2|||
131920330|NCT00303628|474991738|FG001|Overall Study|Alternative therapy|0|||
131920331|NCT00303628|474991737|FG000|Overall Study|Other complicating disease|0|||
131920332|NCT00303628|474991738|FG001|Overall Study|Other complicating disease|1|||
131920333|NCT00303628|474991737|FG000|Overall Study|Not start protocol therapy|3|||
131920334|NCT00303628|474991738|FG001|Overall Study|Not start protocol therapy|5|||
131920335|NCT00303628|474991737|FG000|Overall Study|Other|8|||
131920336|NCT00303628|474991738|FG001|Overall Study|Other|9|||
131874977|NCT05481125|474822403|FG000|Overall Study|Adverse Event|1|||
131874978|NCT05481125|474822404|FG001|Overall Study|Adverse Event|0|||
131874979|NCT05481125|474822403|FG000|Overall Study|Lost to Follow-up|0|||
131874980|NCT05481125|474822404|FG001|Overall Study|Lost to Follow-up|1|||
131874981|NCT05481125|474822403|FG000|Overall Study|Withdrawal by Subject|0|||
131874982|NCT05481125|474822404|FG001|Overall Study|Withdrawal by Subject|1|||
131874983|NCT01769508|474822405|FG000|Overall Study|Death|3|||
131874984|NCT01769508|474822405|FG000|Overall Study|Withdrawal by Subject|1|||
131874985|NCT01769508|474822405|FG000|Overall Study|Adverse Event|1|||
131874986|NCT01769508|474822405|FG000|Overall Study|Lost to Follow-up|1|||
131874987|NCT01598090|474822409|FG000|Treatment Period|Poor/non-compliance|0|||
131874988|NCT01598090|474822410|FG001|Treatment Period|Poor/non-compliance|2|||
131874989|NCT01598090|474822411|FG002|Treatment Period|Poor/non-compliance|0|||
131874990|NCT01598090|474822409|FG000|Treatment Period|No longer meet study criteria|0|||
131874991|NCT01598090|474822410|FG001|Treatment Period|No longer meet study criteria|1|||
131874992|NCT01598090|474822411|FG002|Treatment Period|No longer meet study criteria|0|||
131874993|NCT01598090|474822409|FG000|Treatment Period|Lack of Efficacy|5|||
131874994|NCT01598090|474822410|FG001|Treatment Period|Lack of Efficacy|14|||
131874995|NCT01598090|474822411|FG002|Treatment Period|Lack of Efficacy|6|||
131874996|NCT01598090|474822409|FG000|Treatment Period|Adverse Event|2|||
131874997|NCT01598090|474822410|FG001|Treatment Period|Adverse Event|33|||
131874998|NCT01598090|474822411|FG002|Treatment Period|Adverse Event|17|||
131874999|NCT01598090|474822409|FG000|Treatment Period|Other reasons|0|||
131875000|NCT01598090|474822410|FG001|Treatment Period|Other reasons|4|||
131875001|NCT01598090|474822411|FG002|Treatment Period|Other reasons|1|||
131875002|NCT01598090|474822409|FG000|Treatment Period|Withdrawal by Subject|3|||
131875003|NCT01598090|474822410|FG001|Treatment Period|Withdrawal by Subject|13|||
131875004|NCT01598090|474822411|FG002|Treatment Period|Withdrawal by Subject|10|||
131920337|NCT00376506|474991739|FG000|Overall Study|Death|0|||
131920338|NCT00376506|474991740|FG001|Overall Study|Death|2|||
131920339|NCT00776997|474991741|FG000|Overall Study|Adverse Event|2|||
131875005|NCT01598090|474822409|FG000|Treatment Period|Lost to Follow-up|1|||
131875006|NCT01598090|474822410|FG001|Treatment Period|Lost to Follow-up|5|||
131875007|NCT01598090|474822411|FG002|Treatment Period|Lost to Follow-up|1|||
131875008|NCT01598090|474822409|FG000|Follow-up Period|Death|0|||
131875009|NCT01598090|474822410|FG001|Follow-up Period|Death|1|||
131920340|NCT02948400|474991742|FG000|Overall Study|Withdrawal by Subject|17|||
131920341|NCT02948400|474991743|FG001|Overall Study|Withdrawal by Subject|10|||
131920342|NCT02948400|474991742|FG000|Overall Study|failed to attend appointments|47|||
131920343|NCT02948400|474991743|FG001|Overall Study|failed to attend appointments|34|||
131920344|NCT02948400|474991742|FG000|Overall Study|COVID-related closure|6|||
131920345|NCT02948400|474991743|FG001|Overall Study|COVID-related closure|2|||
131920346|NCT02948400|474991742|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
131920347|NCT02948400|474991743|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
131920348|NCT02948400|474991742|FG000|Overall Study|motion sickness in virtual reality|2|||
131920349|NCT02948400|474991743|FG001|Overall Study|motion sickness in virtual reality|0|||
131920350|NCT02403271|474991744|FG000|Period 1|Other varied reasons|1|||
131920351|NCT02403271|474991745|FG001|Period 1|Other varied reasons|0|||
131920352|NCT02403271|474991744|FG000|Period 2|Withdrawal by Subject|0|||
131920353|NCT02403271|474991745|FG001|Period 2|Withdrawal by Subject|14|||
131920354|NCT02403271|474991744|FG000|Period 2|Death|0|||
131920355|NCT02403271|474991745|FG001|Period 2|Death|84|||
131920356|NCT02403271|474991744|FG000|Period 2|Lost to Follow-up|0|||
131920357|NCT02403271|474991745|FG001|Period 2|Lost to Follow-up|2|||
131920358|NCT02403271|474991744|FG000|Period 2|Study Terminated by Sponsor|0|||
131920359|NCT02403271|474991745|FG001|Period 2|Study Terminated by Sponsor|14|||
131920360|NCT02403271|474991744|FG000|Period 2|Other varied reasons|0|||
131920361|NCT02403271|474991745|FG001|Period 2|Other varied reasons|10|||
131920362|NCT03487445|474991750|FG000|Randomization|Not treated for administrative reasons|1|||
131920363|NCT03487445|474991751|FG001|Randomization|Not treated for administrative reasons|0|||
131920364|NCT00221104|474991752|FG000|Overall Study|Adverse Event|1|||
131920365|NCT00221104|474991753|FG001|Overall Study|Adverse Event|0|||
131920366|NCT00221104|474991752|FG000|Overall Study|Physician Decision|1|||
131920367|NCT00221104|474991753|FG001|Overall Study|Physician Decision|0|||
131920368|NCT00221104|474991752|FG000|Overall Study|Protocol Violation|2|||
131920369|NCT00221104|474991753|FG001|Overall Study|Protocol Violation|0|||
131920370|NCT00221104|474991752|FG000|Overall Study|Withdrawal by Subject|42|||
131920371|NCT00221104|474991753|FG001|Overall Study|Withdrawal by Subject|29|||
131920372|NCT00221104|474991752|FG000|Overall Study|Others|37|||
131920373|NCT00221104|474991753|FG001|Overall Study|Others|47|||
131920374|NCT02989389|474991754|FG000|Period 1|Lost to Follow-up|0|||
131920375|NCT02989389|474991755|FG001|Period 1|Lost to Follow-up|1|||
131920376|NCT02989389|474991756|FG002|Period 1|Lost to Follow-up|0|||
131920377|NCT02989389|474991757|FG003|Period 1|Lost to Follow-up|0|||
131920378|NCT02989389|474991758|FG004|Period 1|Lost to Follow-up|0|||
131920379|NCT02989389|474991759|FG005|Period 1|Lost to Follow-up|0|||
131920380|NCT02989389|474991760|FG006|Period 1|Lost to Follow-up|0|||
131920381|NCT02989389|474991761|FG007|Period 1|Lost to Follow-up|0|||
131920382|NCT02989389|474991762|FG008|Period 1|Lost to Follow-up|0|||
131920383|NCT02989389|474991763|FG009|Period 1|Lost to Follow-up|0|||
131920384|NCT02989389|474991754|FG000|Period 1|Physician Decision|0|||
131920385|NCT02989389|474991755|FG001|Period 1|Physician Decision|0|||
131920386|NCT02989389|474991756|FG002|Period 1|Physician Decision|0|||
131920387|NCT02989389|474991757|FG003|Period 1|Physician Decision|0|||
131920388|NCT02989389|474991758|FG004|Period 1|Physician Decision|0|||
131920389|NCT02989389|474991759|FG005|Period 1|Physician Decision|0|||
131920390|NCT02989389|474991760|FG006|Period 1|Physician Decision|0|||
131920391|NCT02989389|474991761|FG007|Period 1|Physician Decision|0|||
131920392|NCT02989389|474991762|FG008|Period 1|Physician Decision|1|||
131920393|NCT02989389|474991763|FG009|Period 1|Physician Decision|0|||
131920394|NCT01666652|474991764|FG000|Overall Study|Serious Adverse Event|0|||
131920395|NCT01666652|474991765|FG001|Overall Study|Serious Adverse Event|0|||
131920396|NCT01666652|474991766|FG002|Overall Study|Serious Adverse Event|0|||
131920397|NCT01666652|474991767|FG003|Overall Study|Serious Adverse Event|1|||
131920398|NCT01666652|474991768|FG004|Overall Study|Serious Adverse Event|0|||
131920399|NCT01666652|474991764|FG000|Overall Study|Withdrawal by Subject|0|||
131920400|NCT01666652|474991765|FG001|Overall Study|Withdrawal by Subject|0|||
131920401|NCT01666652|474991766|FG002|Overall Study|Withdrawal by Subject|0|||
131920402|NCT01666652|474991767|FG003|Overall Study|Withdrawal by Subject|0|||
131920403|NCT01666652|474991768|FG004|Overall Study|Withdrawal by Subject|1|||
131920404|NCT01666652|474991764|FG000|Overall Study|Moved from study area|1|||
131920405|NCT01666652|474991765|FG001|Overall Study|Moved from study area|0|||
131920406|NCT01666652|474991766|FG002|Overall Study|Moved from study area|0|||
131920407|NCT01666652|474991767|FG003|Overall Study|Moved from study area|2|||
131920408|NCT01666652|474991768|FG004|Overall Study|Moved from study area|0|||
131920409|NCT01666652|474991764|FG000|Overall Study|Lost to Follow-up|1|||
131920410|NCT01666652|474991765|FG001|Overall Study|Lost to Follow-up|1|||
131920411|NCT01666652|474991766|FG002|Overall Study|Lost to Follow-up|1|||
131408360|NCT01133405|473118254|FG000|Period 2|Entry Criteria Not Met|0|||
131408361|NCT01133405|473118255|FG001|Period 2|Entry Criteria Not Met|1|||
131920412|NCT01666652|474991767|FG003|Overall Study|Lost to Follow-up|1|||
131920413|NCT01666652|474991768|FG004|Overall Study|Lost to Follow-up|0|||
131920414|NCT04470427|474991769|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
131920415|NCT04470427|474991770|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
131920416|NCT04470427|474991771|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
131920417|NCT04470427|474991772|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
131920418|NCT04470427|474991773|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
131920419|NCT04470427|474991774|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
131920420|NCT04470427|474991769|FG000|Part B :Open-label|Other than specified|0|||
131920421|NCT04470427|474991770|FG001|Part B :Open-label|Other than specified|0|||
131920422|NCT04470427|474991771|FG002|Part B :Open-label|Other than specified|788|||
131920423|NCT04470427|474991772|FG003|Part B :Open-label|Other than specified|0|||
131453943|NCT01301027|473291843|FG001|Overall Study|Fracture|3|||
131875010|NCT01598090|474822411|FG002|Follow-up Period|Death|0|||
131875011|NCT01598090|474822409|FG000|Follow-up Period|No longer required per protocol|1|||
131875012|NCT01598090|474822410|FG001|Follow-up Period|No longer required per protocol|3|||
131875013|NCT01598090|474822411|FG002|Follow-up Period|No longer required per protocol|2|||
131875014|NCT01598090|474822409|FG000|Follow-up Period|Not reported|0|||
131875015|NCT01598090|474822410|FG001|Follow-up Period|Not reported|10|||
131875016|NCT01598090|474822411|FG002|Follow-up Period|Not reported|4|||
131875017|NCT01598090|474822409|FG000|Follow-up Period|Withdrawal by Subject|0|||
131875018|NCT01598090|474822410|FG001|Follow-up Period|Withdrawal by Subject|3|||
131875019|NCT01598090|474822411|FG002|Follow-up Period|Withdrawal by Subject|2|||
131875020|NCT01598090|474822409|FG000|Follow-up Period|Other reasons|2|||
131875021|NCT01598090|474822410|FG001|Follow-up Period|Other reasons|8|||
131875022|NCT01598090|474822411|FG002|Follow-up Period|Other reasons|8|||
131875023|NCT01598090|474822409|FG000|Follow-up Period|Lost to Follow-up|2|||
131875024|NCT01598090|474822410|FG001|Follow-up Period|Lost to Follow-up|10|||
131875025|NCT01598090|474822411|FG002|Follow-up Period|Lost to Follow-up|12|||
131875026|NCT03615144|474822412|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
131875027|NCT03615144|474822413|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
131875028|NCT02587598|474822416|FG000|Overall Study|Death|4|||
131875029|NCT02587598|474822417|FG001|Overall Study|Death|8|||
131875030|NCT02587598|474822418|FG002|Overall Study|Death|4|||
131875031|NCT02587598|474822419|FG003|Overall Study|Death|16|||
131875032|NCT02587598|474822420|FG004|Overall Study|Death|9|||
131875033|NCT02587598|474822421|FG005|Overall Study|Death|4|||
131875034|NCT02587598|474822422|FG006|Overall Study|Death|6|||
131875035|NCT02587598|474822423|FG007|Overall Study|Death|7|||
131875036|NCT02587598|474822424|FG008|Overall Study|Death|9|||
131875037|NCT02587598|474822425|FG009|Overall Study|Death|1|||
131875038|NCT02587598|474822426|FG010|Overall Study|Death|3|||
131875039|NCT02587598|474822416|FG000|Overall Study|Study Terminated by the Sponsor|0|||
131875040|NCT02587598|474822417|FG001|Overall Study|Study Terminated by the Sponsor|1|||
131875041|NCT02587598|474822418|FG002|Overall Study|Study Terminated by the Sponsor|0|||
131875042|NCT02587598|474822419|FG003|Overall Study|Study Terminated by the Sponsor|3|||
131875043|NCT02587598|474822420|FG004|Overall Study|Study Terminated by the Sponsor|0|||
131875044|NCT02587598|474822421|FG005|Overall Study|Study Terminated by the Sponsor|1|||
131875045|NCT02587598|474822422|FG006|Overall Study|Study Terminated by the Sponsor|0|||
131875046|NCT02587598|474822423|FG007|Overall Study|Study Terminated by the Sponsor|0|||
131875047|NCT02587598|474822424|FG008|Overall Study|Study Terminated by the Sponsor|0|||
131875048|NCT02587598|474822425|FG009|Overall Study|Study Terminated by the Sponsor|1|||
131875049|NCT02587598|474822426|FG010|Overall Study|Study Terminated by the Sponsor|6|||
131875050|NCT02587598|474822416|FG000|Overall Study|Reason for study withdrawal not specified|0|||
131875051|NCT02587598|474822417|FG001|Overall Study|Reason for study withdrawal not specified|1|||
131875052|NCT02587598|474822418|FG002|Overall Study|Reason for study withdrawal not specified|0|||
131875053|NCT02587598|474822419|FG003|Overall Study|Reason for study withdrawal not specified|0|||
131875054|NCT02587598|474822420|FG004|Overall Study|Reason for study withdrawal not specified|0|||
131875055|NCT02587598|474822421|FG005|Overall Study|Reason for study withdrawal not specified|0|||
131875056|NCT02587598|474822422|FG006|Overall Study|Reason for study withdrawal not specified|0|||
131875057|NCT02587598|474822423|FG007|Overall Study|Reason for study withdrawal not specified|0|||
131875058|NCT02587598|474822424|FG008|Overall Study|Reason for study withdrawal not specified|0|||
131875059|NCT02587598|474822425|FG009|Overall Study|Reason for study withdrawal not specified|0|||
131875060|NCT02587598|474822426|FG010|Overall Study|Reason for study withdrawal not specified|0|||
131875061|NCT02587598|474822416|FG000|Overall Study|Withdrawal by Subject|0|||
131875062|NCT02587598|474822417|FG001|Overall Study|Withdrawal by Subject|1|||
131875063|NCT02587598|474822418|FG002|Overall Study|Withdrawal by Subject|0|||
131875064|NCT02587598|474822419|FG003|Overall Study|Withdrawal by Subject|2|||
131875065|NCT02587598|474822420|FG004|Overall Study|Withdrawal by Subject|3|||
131875066|NCT02587598|474822421|FG005|Overall Study|Withdrawal by Subject|1|||
131875067|NCT02587598|474822422|FG006|Overall Study|Withdrawal by Subject|0|||
131875068|NCT02587598|474822423|FG007|Overall Study|Withdrawal by Subject|0|||
131875069|NCT02587598|474822424|FG008|Overall Study|Withdrawal by Subject|0|||
131875070|NCT02587598|474822425|FG009|Overall Study|Withdrawal by Subject|1|||
131875071|NCT02587598|474822426|FG010|Overall Study|Withdrawal by Subject|2|||
131875072|NCT02587598|474822416|FG000|Overall Study|Physician Decision|0|||
131875073|NCT02587598|474822417|FG001|Overall Study|Physician Decision|0|||
131875074|NCT02587598|474822418|FG002|Overall Study|Physician Decision|0|||
131875075|NCT02587598|474822419|FG003|Overall Study|Physician Decision|0|||
131875076|NCT02587598|474822420|FG004|Overall Study|Physician Decision|0|||
131875077|NCT02587598|474822421|FG005|Overall Study|Physician Decision|0|||
131875078|NCT02587598|474822422|FG006|Overall Study|Physician Decision|0|||
131875079|NCT02587598|474822423|FG007|Overall Study|Physician Decision|0|||
131875080|NCT02587598|474822424|FG008|Overall Study|Physician Decision|0|||
131875081|NCT02587598|474822425|FG009|Overall Study|Physician Decision|0|||
131875082|NCT02587598|474822426|FG010|Overall Study|Physician Decision|3|||
131875083|NCT02394340|474822433|FG000|Overall Study|Failed drug screen test|1|||
131920424|NCT04470427|474991773|FG004|Part B :Open-label|Other than specified|523|||
131920425|NCT04470427|474991774|FG005|Part B :Open-label|Other than specified|0|||
131920426|NCT04470427|474991769|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
131920427|NCT04470427|474991770|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
131920428|NCT04470427|474991771|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
131920429|NCT04470427|474991772|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
131920430|NCT04470427|474991773|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
131920431|NCT04470427|474991774|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
131920432|NCT04470427|474991769|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
131920433|NCT04470427|474991770|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
131920434|NCT04470427|474991771|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
131920435|NCT04470427|474991772|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
131920436|NCT04470427|474991773|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
131920437|NCT04470427|474991774|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
131920438|NCT01018979|474991775|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
131920439|NCT01018979|474991776|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
131920440|NCT01018979|474991775|FG000|Overall Study|Not received at least one dose|0|||
131920441|NCT01018979|474991776|FG001|Overall Study|Not received at least one dose|1|||
131920442|NCT03301714|474991777|FG000|Overall Study|Lost to Follow-up|10|||
131920443|NCT03301714|474991778|FG001|Overall Study|Lost to Follow-up|4|||
131920444|NCT03301714|474991779|FG002|Overall Study|Lost to Follow-up|4|||
131920445|NCT03301714|474991777|FG000|Overall Study|Did not receive allocated intervention|0|||
131920446|NCT03301714|474991778|FG001|Overall Study|Did not receive allocated intervention|2|||
131920447|NCT03301714|474991779|FG002|Overall Study|Did not receive allocated intervention|3|||
131920448|NCT00544882|474991786|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
131920449|NCT00544882|474991787|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
131920450|NCT00544882|474991788|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
131920451|NCT00544882|474991786|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
131920452|NCT00544882|474991787|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
131920453|NCT00544882|474991788|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
131920454|NCT00544882|474991786|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
131920455|NCT00544882|474991787|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
131920456|NCT00544882|474991788|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
131920457|NCT00544882|474991786|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
131920458|NCT00544882|474991787|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
131920459|NCT00544882|474991788|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
131920460|NCT00544882|474991786|FG000|Cycle 3: Follow-up|Noncompliance|0|||
131920461|NCT00544882|474991787|FG001|Cycle 3: Follow-up|Noncompliance|1|||
131920462|NCT00544882|474991788|FG002|Cycle 3: Follow-up|Noncompliance|0|||
131920463|NCT00544882|474991786|FG000|Cycle 3: Follow-up|Pregnancy|0|||
131920464|NCT00544882|474991787|FG001|Cycle 3: Follow-up|Pregnancy|1|||
131920465|NCT00544882|474991788|FG002|Cycle 3: Follow-up|Pregnancy|0|||
131920466|NCT01251861|474991789|FG000|Overall Study|Disease progression|6|||
131920467|NCT01251861|474991790|FG001|Overall Study|Disease progression|6|||
131920468|NCT01251861|474991789|FG000|Overall Study|Adverse Event|2|||
131920469|NCT01251861|474991790|FG001|Overall Study|Adverse Event|17|||
131920470|NCT01251861|474991789|FG000|Overall Study|Withdrawal by Subject|2|||
131875084|NCT02394340|474822433|FG000|Overall Study|Adverse Event|1|||
131875085|NCT00256854|474822434|FG000|Overall Study|Withdrawal by Subject|2|||
131875086|NCT00256854|474822435|FG001|Overall Study|Withdrawal by Subject|3|||
131875087|NCT00256854|474822436|FG002|Overall Study|Withdrawal by Subject|0|||
131875088|NCT00256854|474822437|FG003|Overall Study|Withdrawal by Subject|0|||
131875089|NCT00256854|474822438|FG004|Overall Study|Withdrawal by Subject|0|||
131875090|NCT00256854|474822439|FG005|Overall Study|Withdrawal by Subject|0|||
131875091|NCT00256854|474822434|FG000|Overall Study|Lack of Efficacy|1|||
131875092|NCT00256854|474822435|FG001|Overall Study|Lack of Efficacy|0|||
131875093|NCT00256854|474822436|FG002|Overall Study|Lack of Efficacy|0|||
131875094|NCT00256854|474822437|FG003|Overall Study|Lack of Efficacy|0|||
131875095|NCT00256854|474822438|FG004|Overall Study|Lack of Efficacy|0|||
131875096|NCT00256854|474822439|FG005|Overall Study|Lack of Efficacy|0|||
131875097|NCT00256854|474822434|FG000|Overall Study|Protocol Violation|0|||
131875098|NCT00256854|474822435|FG001|Overall Study|Protocol Violation|1|||
131875099|NCT00256854|474822436|FG002|Overall Study|Protocol Violation|1|||
131920471|NCT01251861|474991790|FG001|Overall Study|Withdrawal by Subject|2|||
131920472|NCT01251861|474991789|FG000|Overall Study|Alternative therapy|1|||
131408362|NCT01133405|473118256|FG002|Period 2|Entry Criteria Not Met|0|||
131875100|NCT00256854|474822437|FG003|Overall Study|Protocol Violation|1|||
131920473|NCT01251861|474991790|FG001|Overall Study|Alternative therapy|0|||
131920474|NCT01251861|474991789|FG000|Overall Study|Other complicating disease|0|||
131920475|NCT01251861|474991790|FG001|Overall Study|Other complicating disease|1|||
131920476|NCT01251861|474991789|FG000|Overall Study|Physician Decision|1|||
131920477|NCT01251861|474991790|FG001|Overall Study|Physician Decision|0|||
131920478|NCT01251861|474991789|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
131920479|NCT01251861|474991790|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
131920480|NCT01251861|474991789|FG000|Overall Study|Other|1|||
131920481|NCT01251861|474991790|FG001|Overall Study|Other|0|||
131920482|NCT01251861|474991789|FG000|Overall Study|Never started therapy|4|||
131920483|NCT01251861|474991790|FG001|Overall Study|Never started therapy|1|||
131920484|NCT01251861|474991789|FG000|Overall Study|Potential interaction of drugs|0|||
131920485|NCT01251861|474991790|FG001|Overall Study|Potential interaction of drugs|1|||
131920486|NCT03580928|474991793|FG000|Overall Study|Death|0|||
131920487|NCT03580928|474991794|FG001|Overall Study|Death|3|||
131920488|NCT03580928|474991793|FG000|Overall Study|Withdrawal by Subject|2|||
131920489|NCT03580928|474991794|FG001|Overall Study|Withdrawal by Subject|1|||
131920490|NCT03580928|474991793|FG000|Overall Study|Lost to Follow-up|2|||
131920491|NCT03580928|474991794|FG001|Overall Study|Lost to Follow-up|0|||
131920492|NCT03580928|474991793|FG000|Overall Study|Progressive Disease|0|||
131920493|NCT03580928|474991794|FG001|Overall Study|Progressive Disease|1|||
131920494|NCT04167670|474992727|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
131920495|NCT04167670|474992728|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
131920496|NCT04167670|474992729|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
131920497|NCT04167670|474992727|FG000|Overall Study|Significant protocol deviation|3|||
131920498|NCT04167670|474992728|FG001|Overall Study|Significant protocol deviation|1|||
131920499|NCT04167670|474992729|FG002|Overall Study|Significant protocol deviation|0|||
131920500|NCT04167670|474992727|FG000|Overall Study|Lost to Follow-up|0|||
131920501|NCT04167670|474992728|FG001|Overall Study|Lost to Follow-up|3|||
131920502|NCT04167670|474992729|FG002|Overall Study|Lost to Follow-up|3|||
131920503|NCT04167670|474992727|FG000|Overall Study|Voluntary Withdrawal|0|||
131920504|NCT04167670|474992728|FG001|Overall Study|Voluntary Withdrawal|1|||
131920505|NCT04167670|474992729|FG002|Overall Study|Voluntary Withdrawal|1|||
131920506|NCT04167670|474992727|FG000|Overall Study|Withdrawal of Consent|4|||
131920507|NCT04167670|474992728|FG001|Overall Study|Withdrawal of Consent|1|||
131920508|NCT04167670|474992729|FG002|Overall Study|Withdrawal of Consent|3|||
131920509|NCT04167670|474992727|FG000|Overall Study|Miscellaneous|7|||
131920510|NCT04167670|474992728|FG001|Overall Study|Miscellaneous|5|||
131408363|NCT01133405|473118257|FG003|Period 2|Entry Criteria Not Met|0|||
131408364|NCT01133405|473118258|FG004|Period 2|Entry Criteria Not Met|0|||
131408365|NCT01133405|473118259|FG005|Period 2|Entry Criteria Not Met|0|||
131408366|NCT01133405|473118260|FG006|Period 2|Entry Criteria Not Met|0|||
131408367|NCT01133405|473118261|FG007|Period 2|Entry Criteria Not Met|0|||
131408368|NCT01133405|473118262|FG008|Period 2|Entry Criteria Not Met|0|||
131408369|NCT01133405|473118263|FG009|Period 2|Entry Criteria Not Met|0|||
131408370|NCT01133405|473118254|FG000|Period 2|Physician Decision|0|||
131875101|NCT00256854|474822438|FG004|Overall Study|Protocol Violation|0|||
131875102|NCT00256854|474822439|FG005|Overall Study|Protocol Violation|0|||
131875103|NCT00256854|474822434|FG000|Overall Study|Adverse Event|0|||
131875104|NCT00256854|474822435|FG001|Overall Study|Adverse Event|0|||
131875105|NCT00256854|474822436|FG002|Overall Study|Adverse Event|2|||
131875106|NCT00256854|474822437|FG003|Overall Study|Adverse Event|2|||
131875107|NCT00256854|474822438|FG004|Overall Study|Adverse Event|0|||
131875108|NCT00256854|474822439|FG005|Overall Study|Adverse Event|1|||
131875109|NCT00256854|474822434|FG000|Overall Study|Not compliant with the study drug|0|||
131875110|NCT00256854|474822435|FG001|Overall Study|Not compliant with the study drug|0|||
131875111|NCT00256854|474822436|FG002|Overall Study|Not compliant with the study drug|0|||
131875112|NCT00256854|474822437|FG003|Overall Study|Not compliant with the study drug|0|||
131875113|NCT00256854|474822438|FG004|Overall Study|Not compliant with the study drug|1|||
131875114|NCT00256854|474822439|FG005|Overall Study|Not compliant with the study drug|0|||
131875115|NCT02353442|474822440|FG000|Overall Study|Withdrawal by Subject|3|||
131875116|NCT02353442|474822441|FG001|Overall Study|Withdrawal by Subject|4|||
131875117|NCT03514485|474822442|FG000|Overall Study|Lost to Follow-up|5|||
131875118|NCT03514485|474822443|FG001|Overall Study|Lost to Follow-up|3|||
131875119|NCT03514485|474822444|FG002|Overall Study|Lost to Follow-up|2|||
131875120|NCT03514485|474822445|FG003|Overall Study|Lost to Follow-up|0|||
131875121|NCT03514485|474822446|FG004|Overall Study|Lost to Follow-up|1|||
131875122|NCT03514485|474822447|FG005|Overall Study|Lost to Follow-up|4|||
131875123|NCT03514485|474822442|FG000|Overall Study|Withdrawal by Subject|0|||
131875124|NCT03514485|474822443|FG001|Overall Study|Withdrawal by Subject|1|||
131875125|NCT03514485|474822444|FG002|Overall Study|Withdrawal by Subject|3|||
131875126|NCT03514485|474822445|FG003|Overall Study|Withdrawal by Subject|1|||
131875127|NCT03514485|474822446|FG004|Overall Study|Withdrawal by Subject|2|||
131875128|NCT03514485|474822447|FG005|Overall Study|Withdrawal by Subject|1|||
131875129|NCT00791661|474822449|FG000|7 Day Wash-out|Adverse Event|0|||
131875130|NCT00791661|474822450|FG001|7 Day Wash-out|Adverse Event|0|||
131875131|NCT00791661|474822451|FG002|7 Day Wash-out|Adverse Event|1|||
131875132|NCT00791661|474822449|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
131920511|NCT04167670|474992729|FG002|Overall Study|Miscellaneous|3|||
131920512|NCT00484159|474992732|FG000|Overall Study|Lost to Follow-up|1|||
131920513|NCT00484159|474992733|FG001|Overall Study|Lost to Follow-up|1|||
131920514|NCT00484159|474992734|FG002|Overall Study|Lost to Follow-up|0|||
131920515|NCT01239680|474992735|FG000|Overall Study|Withdrawal by Subject|2|||
131920516|NCT01239680|474992736|FG001|Overall Study|Withdrawal by Subject|0|||
131875133|NCT00791661|474822450|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
131875134|NCT00791661|474822451|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
131875135|NCT01355575|474822456|FG000|Overall Study|Withdrawal by Subject|2|||
131875136|NCT02294396|474822457|FG000|Overall Study|Adverse Event|26|||
131875137|NCT02294396|474822458|FG001|Overall Study|Adverse Event|25|||
131875138|NCT02294396|474822459|FG002|Overall Study|Adverse Event|21|||
131875139|NCT02294396|474822460|FG003|Overall Study|Adverse Event|24|||
131875140|NCT02294396|474822457|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
131875141|NCT02294396|474822458|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
131875142|NCT02294396|474822459|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
131875143|NCT02294396|474822460|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
131875144|NCT02294396|474822457|FG000|Overall Study|Withdrawal by Subject|8|||
131875145|NCT02294396|474822458|FG001|Overall Study|Withdrawal by Subject|6|||
131875146|NCT02294396|474822459|FG002|Overall Study|Withdrawal by Subject|6|||
131875147|NCT02294396|474822460|FG003|Overall Study|Withdrawal by Subject|8|||
131875148|NCT02294396|474822457|FG000|Overall Study|Lost to Follow-up|0|||
131875149|NCT02294396|474822458|FG001|Overall Study|Lost to Follow-up|0|||
131875150|NCT02294396|474822459|FG002|Overall Study|Lost to Follow-up|1|||
131875151|NCT02294396|474822460|FG003|Overall Study|Lost to Follow-up|1|||
131875152|NCT02294396|474822457|FG000|Overall Study|Protocol Deviation|3|||
131875153|NCT02294396|474822458|FG001|Overall Study|Protocol Deviation|2|||
131875154|NCT02294396|474822459|FG002|Overall Study|Protocol Deviation|2|||
131875155|NCT02294396|474822460|FG003|Overall Study|Protocol Deviation|1|||
131875156|NCT02294396|474822457|FG000|Overall Study|Miscellaneous|2|||
131875157|NCT02294396|474822458|FG001|Overall Study|Miscellaneous|0|||
131875158|NCT02294396|474822459|FG002|Overall Study|Miscellaneous|5|||
131875159|NCT02294396|474822460|FG003|Overall Study|Miscellaneous|2|||
131875160|NCT02120833|474822461|FG000|Overall Study|Adverse Event|1|||
131875161|NCT02120833|474822462|FG001|Overall Study|Adverse Event|0|||
131875162|NCT02120833|474822461|FG000|Overall Study|Withdrawal by Subject|2|||
131875163|NCT02120833|474822462|FG001|Overall Study|Withdrawal by Subject|0|||
131875164|NCT02120833|474822461|FG000|Overall Study|Lost to Follow-up|1|||
131875165|NCT02120833|474822462|FG001|Overall Study|Lost to Follow-up|1|||
131875166|NCT02438826|474822465|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
131875167|NCT02438826|474822466|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
131875168|NCT02438826|474822467|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
131875169|NCT02438826|474822468|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131875170|NCT02438826|474822465|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
131875171|NCT02438826|474822466|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131875172|NCT02438826|474822467|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131875173|NCT02438826|474822468|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131875174|NCT02438826|474822465|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
131875175|NCT02438826|474822466|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
131875176|NCT02438826|474822467|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131875177|NCT02438826|474822468|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131875178|NCT02438826|474822465|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
131875179|NCT02438826|474822466|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
131875180|NCT02438826|474822467|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
131875181|NCT02438826|474822468|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
131875182|NCT02438826|474822465|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
131875183|NCT02438826|474822466|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
131875184|NCT02438826|474822467|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
131875185|NCT02438826|474822468|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
131875186|NCT02438826|474822465|FG000|Open-Label Treatment Phase|Adverse Event|11|||
131875187|NCT02438826|474822466|FG001|Open-Label Treatment Phase|Adverse Event|6|||
131875188|NCT02438826|474822467|FG002|Open-Label Treatment Phase|Adverse Event|0|||
131875189|NCT02438826|474822468|FG003|Open-Label Treatment Phase|Adverse Event|0|||
131875190|NCT02438826|474822465|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
131875191|NCT02438826|474822466|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
131875192|NCT02438826|474822467|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
131875193|NCT02438826|474822468|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
131875194|NCT02438826|474822465|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
131875195|NCT02438826|474822466|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
131875196|NCT02438826|474822467|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
131875197|NCT02438826|474822468|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
131875198|NCT02438826|474822465|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
131875199|NCT02438826|474822466|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
131875200|NCT02438826|474822467|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
131875201|NCT02438826|474822468|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
131875202|NCT02438826|474822465|FG000|Post-Treatment Phase|Adverse Event|3|||
131875203|NCT02438826|474822466|FG001|Post-Treatment Phase|Adverse Event|0|||
131875204|NCT02438826|474822467|FG002|Post-Treatment Phase|Adverse Event|0|||
131875205|NCT02438826|474822468|FG003|Post-Treatment Phase|Adverse Event|0|||
131920517|NCT01410604|474992740|FG000|Overall Study|Adverse Event|2|||
131920518|NCT01410604|474992741|FG001|Overall Study|Adverse Event|1|||
131920519|NCT01410604|474992740|FG000|Overall Study|Lost to Follow-up|1|||
131920520|NCT01410604|474992741|FG001|Overall Study|Lost to Follow-up|0|||
131920521|NCT01410604|474992740|FG000|Overall Study|Physician Decision|0|||
131920522|NCT01410604|474992741|FG001|Overall Study|Physician Decision|1|||
131920523|NCT05059080|474992743|FG000|Overall Study|Withdrawal by Subject|3|||
131920524|NCT05059080|474992743|FG000|Overall Study|Study Terminated by Sponsor|64|||
131920525|NCT00429299|474992746|FG000|Overall Study|Disease Progression|1|||
131920526|NCT00429299|474992747|FG001|Overall Study|Disease Progression|1|||
131920527|NCT00429299|474992748|FG002|Overall Study|Disease Progression|0|||
131920528|NCT00429299|474992746|FG000|Overall Study|Adverse Event|2|||
131920529|NCT00429299|474992747|FG001|Overall Study|Adverse Event|5|||
131920530|NCT00429299|474992748|FG002|Overall Study|Adverse Event|1|||
131920531|NCT00429299|474992746|FG000|Overall Study|Protocol Violation|1|||
131920532|NCT00429299|474992747|FG001|Overall Study|Protocol Violation|0|||
131920533|NCT00429299|474992748|FG002|Overall Study|Protocol Violation|0|||
131920534|NCT00429299|474992746|FG000|Overall Study|Withdrawal by Subject|0|||
131920535|NCT00429299|474992747|FG001|Overall Study|Withdrawal by Subject|1|||
131920536|NCT00429299|474992748|FG002|Overall Study|Withdrawal by Subject|3|||
131920537|NCT01510756|474992749|FG000|Overall Study|Death|1|||
131920538|NCT01510756|474992749|FG000|Overall Study|Lack of Efficacy|2|||
131920539|NCT01510756|474992749|FG000|Overall Study|Physician Decision|1|||
131920540|NCT03927157|474992750|FG000|Overall Study|Adverse Event|1|||
131920541|NCT03927157|474992751|FG001|Overall Study|Adverse Event|3|||
131920542|NCT03927157|474992750|FG000|Overall Study|Protocol Violation|1|||
131920543|NCT03927157|474992751|FG001|Overall Study|Protocol Violation|2|||
131920544|NCT03927157|474992750|FG000|Overall Study|Withdrawal by Subject|8|||
131920545|NCT03927157|474992751|FG001|Overall Study|Withdrawal by Subject|21|||
131920546|NCT03927157|474992750|FG000|Overall Study|Due to COVID-19 pandemic|5|||
131920547|NCT03927157|474992751|FG001|Overall Study|Due to COVID-19 pandemic|2|||
131920548|NCT03927157|474992750|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
131920549|NCT03927157|474992751|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
131920550|NCT03927157|474992750|FG000|Overall Study|Other than above|0|||
131920551|NCT03927157|474992751|FG001|Overall Study|Other than above|1|||
131920552|NCT04871113|474992752|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920553|NCT04871113|474992753|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920554|NCT04871113|474992754|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920555|NCT04871113|474992755|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920556|NCT04871113|474992756|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920557|NCT04871113|474992757|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
131920558|NCT04871113|474992758|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920559|NCT04871113|474992759|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920560|NCT04871113|474992760|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920561|NCT04871113|474992761|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
131920562|NCT04871113|474992752|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920563|NCT04871113|474992753|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920564|NCT04871113|474992754|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920565|NCT04871113|474992755|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920566|NCT04871113|474992756|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920567|NCT04871113|474992757|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920568|NCT04871113|474992758|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
131920569|NCT04871113|474992759|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
131920570|NCT04871113|474992760|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920571|NCT04871113|474992761|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
131920572|NCT01239745|474992762|FG000|Overall Study|Study terminated by sponsor|45|||
131920573|NCT01239745|474992762|FG000|Overall Study|Adverse Event|1|||
131920574|NCT00726557|474992763|FG000|Overall Study|Screening failure|4|||
131920575|NCT00726557|474992763|FG000|Overall Study|No end of treatment documentation|37|||
131920576|NCT00726557|474992763|FG000|Overall Study|No follow-up documentation available|55|||
131920577|NCT00726557|474992763|FG000|Overall Study|Treatment less than 3 months|17|||
131920578|NCT00726557|474992763|FG000|Overall Study|Inclusion criteria not met|15|||
131920579|NCT01257542|474992766|FG000|Overall Study|Protocol Violation|3|||
131920580|NCT01257542|474992767|FG001|Overall Study|Protocol Violation|5|||
131920581|NCT01257542|474992766|FG000|Overall Study|Withdrawal by Subject|0|||
131920582|NCT01257542|474992767|FG001|Overall Study|Withdrawal by Subject|2|||
131920583|NCT00081458|474992769|FG000|Overall Study|Adverse Event|1|||
131920584|NCT00081458|474992770|FG001|Overall Study|Adverse Event|5|||
131920585|NCT00081458|474992771|FG002|Overall Study|Adverse Event|2|||
131920586|NCT00081458|474992769|FG000|Overall Study|Withdrawal by Subject|0|||
131920587|NCT00081458|474992770|FG001|Overall Study|Withdrawal by Subject|3|||
131920588|NCT00081458|474992771|FG002|Overall Study|Withdrawal by Subject|1|||
131920589|NCT00081458|474992769|FG000|Overall Study|Randomized but not dosed|0|||
131920590|NCT00081458|474992770|FG001|Overall Study|Randomized but not dosed|0|||
131920591|NCT00081458|474992771|FG002|Overall Study|Randomized but not dosed|1|||
131920592|NCT00549328|474992774|FG000|Overall Study|Adverse Event|2|||
131920593|NCT00549328|474992774|FG000|Overall Study|Disease Progression|10|||
131920594|NCT00549328|474992774|FG000|Overall Study|Death|1|||
131920595|NCT00549328|474992774|FG000|Overall Study|Use of Prohibited Medication|1|||
131920596|NCT00770484|474992775|FG000|Overall Study|Withdrawal by Subject|1|||
131920597|NCT00770484|474992776|FG001|Overall Study|Withdrawal by Subject|0|||
131920598|NCT03097315|474992781|FG000|Overall Study|Withdrawal by Subject|1|||
131920599|NCT01946802|474992782|FG000|Overall Study|Death|1|||
131920600|NCT01946802|474992782|FG000|Overall Study|Withdrawal by Subject|2|||
131920601|NCT01946802|474992782|FG000|Overall Study|Combined septic shock|1|||
131920602|NCT01946802|474992782|FG000|Overall Study|Protocol Violation|1|||
131920603|NCT02836769|474992788|FG000|Overall Study|Lost to Follow-up|10|||
131920604|NCT02836769|474992788|FG000|Overall Study|Medical withdrawal|2|||
131920605|NCT02836769|474992788|FG000|Overall Study|Withdrawal by Subject|3|||
131920606|NCT02691663|474992797|FG000|Overall Study|Screen failure after baseline|2|||
131920607|NCT02691663|474992798|FG001|Overall Study|Screen failure after baseline|2|||
131920608|NCT02691663|474992797|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
131920609|NCT02691663|474992798|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
131920610|NCT02691663|474992797|FG000|Overall Study|Withdrawn after Follow up 2|1|||
131920611|NCT02691663|474992798|FG001|Overall Study|Withdrawn after Follow up 2|1|||
131920612|NCT02691663|474992797|FG000|Overall Study|Lost to Follow-up|3|||
131920613|NCT02691663|474992798|FG001|Overall Study|Lost to Follow-up|2|||
131920614|NCT03158688|474992799|FG000|Overall Study|Withdrawal by Subject|14|||
131920615|NCT03158688|474992800|FG001|Overall Study|Withdrawal by Subject|28|||
131920616|NCT03158688|474992799|FG000|Overall Study|Decision by sponsor|13|||
131920617|NCT03158688|474992800|FG001|Overall Study|Decision by sponsor|37|||
131920618|NCT03158688|474992799|FG000|Overall Study|Lost to Follow-up|4|||
131920619|NCT03158688|474992800|FG001|Overall Study|Lost to Follow-up|3|||
131920620|NCT03158688|474992799|FG000|Overall Study|Death|74|||
131920621|NCT03158688|474992800|FG001|Overall Study|Death|142|||
131920622|NCT02942407|474992803|FG000|Overall Study|Lost to Follow-up|3|||
131920623|NCT02942407|474992804|FG001|Overall Study|Lost to Follow-up|2|||
131920624|NCT02942407|474992803|FG000|Overall Study|Withdrawal by Subject|7|||
131920625|NCT02942407|474992804|FG001|Overall Study|Withdrawal by Subject|9|||
131920626|NCT02942407|474992803|FG000|Overall Study|Death|16|||
131920627|NCT02942407|474992804|FG001|Overall Study|Death|13|||
131920628|NCT03412890|474992812|FG000|Overall Study|Adverse Event|5|||
131920629|NCT03412890|474992813|FG001|Overall Study|Adverse Event|5|||
131920630|NCT03412890|474992814|FG002|Overall Study|Adverse Event|9|||
131920631|NCT03412890|474992812|FG000|Overall Study|Protocol deviation|2|||
131920632|NCT03412890|474992813|FG001|Overall Study|Protocol deviation|1|||
131920633|NCT03412890|474992814|FG002|Overall Study|Protocol deviation|2|||
131920634|NCT03412890|474992812|FG000|Overall Study|Lost to Follow-up|7|||
131920635|NCT03412890|474992813|FG001|Overall Study|Lost to Follow-up|10|||
131920636|NCT03412890|474992814|FG002|Overall Study|Lost to Follow-up|10|||
131920637|NCT03412890|474992812|FG000|Overall Study|Withdrawal by Subject|9|||
131920638|NCT03412890|474992813|FG001|Overall Study|Withdrawal by Subject|12|||
131920639|NCT03412890|474992814|FG002|Overall Study|Withdrawal by Subject|11|||
131920640|NCT03412890|474992812|FG000|Overall Study|Lack of Efficacy|2|||
131920641|NCT03412890|474992813|FG001|Overall Study|Lack of Efficacy|7|||
131920642|NCT03412890|474992814|FG002|Overall Study|Lack of Efficacy|5|||
131920643|NCT03412890|474992812|FG000|Overall Study|Other|5|||
131920644|NCT03412890|474992813|FG001|Overall Study|Other|6|||
131920645|NCT03412890|474992814|FG002|Overall Study|Other|5|||
131920646|NCT03412890|474992812|FG000|Overall Study|Participants who did not receive any study drug|0|||
131920647|NCT03412890|474992813|FG001|Overall Study|Participants who did not receive any study drug|1|||
131920648|NCT03412890|474992814|FG002|Overall Study|Participants who did not receive any study drug|0|||
131920649|NCT00021255|474992815|FG000|Overall Study|Death|1|||
131920650|NCT00021255|474992816|FG001|Overall Study|Death|0|||
131920651|NCT00021255|474992817|FG002|Overall Study|Death|2|||
131408371|NCT01133405|473118255|FG001|Period 2|Physician Decision|0|||
131920652|NCT00021255|474992815|FG000|Overall Study|Breast cancer relapse|5|||
131920653|NCT00021255|474992816|FG001|Overall Study|Breast cancer relapse|18|||
131920654|NCT00021255|474992817|FG002|Overall Study|Breast cancer relapse|11|||
131920655|NCT00021255|474992815|FG000|Overall Study|Second primary malignancy|0|||
131920656|NCT00021255|474992816|FG001|Overall Study|Second primary malignancy|4|||
131920657|NCT00021255|474992817|FG002|Overall Study|Second primary malignancy|1|||
131920658|NCT00021255|474992815|FG000|Overall Study|Withdrawal by Subject|41|||
131920659|NCT00021255|474992816|FG001|Overall Study|Withdrawal by Subject|64|||
131920660|NCT00021255|474992817|FG002|Overall Study|Withdrawal by Subject|26|||
131920661|NCT00021255|474992815|FG000|Overall Study|Lost to Follow-up|0|||
131920662|NCT00021255|474992816|FG001|Overall Study|Lost to Follow-up|2|||
131920663|NCT00021255|474992817|FG002|Overall Study|Lost to Follow-up|3|||
131920664|NCT00021255|474992815|FG000|Overall Study|Cardiac toxicity|0|||
131920665|NCT00021255|474992816|FG001|Overall Study|Cardiac toxicity|61|||
131920666|NCT00021255|474992817|FG002|Overall Study|Cardiac toxicity|32|||
131875206|NCT02438826|474822465|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
131875207|NCT02438826|474822466|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
131875208|NCT02438826|474822467|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
131875209|NCT02438826|474822468|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
131875210|NCT02438826|474822465|FG000|Post-Treatment Phase|Physician Decision|1|||
131875211|NCT02438826|474822466|FG001|Post-Treatment Phase|Physician Decision|0|||
131875212|NCT02438826|474822467|FG002|Post-Treatment Phase|Physician Decision|0|||
131875213|NCT02438826|474822468|FG003|Post-Treatment Phase|Physician Decision|0|||
131875214|NCT02438826|474822465|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
131875215|NCT02438826|474822466|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
131875216|NCT02438826|474822467|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
131875217|NCT02438826|474822468|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
131875218|NCT04105218|474822474|FG000|Overall Study|Withdrawal by Subject|3|||
131875219|NCT04105218|474822475|FG001|Overall Study|Withdrawal by Subject|2|||
131875220|NCT04105218|474822474|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
131875221|NCT04105218|474822475|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
131875222|NCT04105218|474822474|FG000|Overall Study|Failed screening tests|2|||
131875223|NCT04105218|474822475|FG001|Overall Study|Failed screening tests|1|||
131875224|NCT01706939|474822476|FG000|Pre Randomization|Screen Failure|1|||
131875225|NCT01706939|474822477|FG001|Pre Randomization|Screen Failure|0|||
131875226|NCT01706939|474822478|FG002|Pre Randomization|Screen Failure|0|||
131875227|NCT01706939|474822476|FG000|Pre Randomization|Ineligible for Randomization|1|||
131875228|NCT01706939|474822477|FG001|Pre Randomization|Ineligible for Randomization|0|||
131875229|NCT01706939|474822478|FG002|Pre Randomization|Ineligible for Randomization|0|||
131875230|NCT01706939|474822476|FG000|Pre Randomization|Withdrawal by Subject|1|||
131875231|NCT01706939|474822477|FG001|Pre Randomization|Withdrawal by Subject|0|||
131875232|NCT01706939|474822478|FG002|Pre Randomization|Withdrawal by Subject|0|||
131875233|NCT01706939|474822476|FG000|Randomization|Insufficient QoL survey compliance|0|||
131875234|NCT01706939|474822477|FG001|Randomization|Insufficient QoL survey compliance|1|||
131875235|NCT01706939|474822478|FG002|Randomization|Insufficient QoL survey compliance|1|||
131875236|NCT01706939|474822476|FG000|Randomization|Progression of disease|0|||
131875237|NCT01706939|474822477|FG001|Randomization|Progression of disease|2|||
131875238|NCT01706939|474822478|FG002|Randomization|Progression of disease|1|||
131875239|NCT00101166|474822489|FG000|Overall Study|progressive disease|10|||
131875240|NCT00686829|474822490|FG000|Overall Study|Adverse Event|5|||
131875241|NCT00686829|474822490|FG000|Overall Study|Lack of Efficacy|6|||
131875242|NCT00686829|474822490|FG000|Overall Study|Lost to Follow-up|4|||
131875243|NCT00686829|474822490|FG000|Overall Study|Withdrawal by Subject|14|||
131875244|NCT00686829|474822490|FG000|Overall Study|Protocol Violation|3|||
131875245|NCT00686829|474822490|FG000|Overall Study|Sponsor discontinued VCV|47|||
131875246|NCT04740827|474822491|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
131875247|NCT04740827|474822492|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
131875248|NCT04740827|474822491|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
131875249|NCT04740827|474822492|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
131875250|NCT04740827|474822491|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
131875251|NCT04740827|474822492|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
131875252|NCT04740827|474822491|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
131875253|NCT04740827|474822492|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
131875254|NCT04740827|474822491|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
131875255|NCT04740827|474822492|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
131875256|NCT04740827|474822491|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
131875257|NCT04740827|474822492|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
131875258|NCT02147158|474822493|FG000|Treatment Course 1|Adverse Event|1|||
131875259|NCT02147158|474822494|FG001|Treatment Course 1|Adverse Event|4|||
131875260|NCT02147158|474822495|FG002|Treatment Course 1|Adverse Event|3|||
131875261|NCT02147158|474822496|FG003|Treatment Course 1|Adverse Event|4|||
131875262|NCT02147158|474822497|FG004|Treatment Course 1|Adverse Event|1|||
131875263|NCT02147158|474822498|FG005|Treatment Course 1|Adverse Event|2|||
131875264|NCT02147158|474822493|FG000|Treatment Course 1|Lost to Follow-up|2|||
131875265|NCT02147158|474822494|FG001|Treatment Course 1|Lost to Follow-up|4|||
131875266|NCT02147158|474822495|FG002|Treatment Course 1|Lost to Follow-up|3|||
131875267|NCT02147158|474822496|FG003|Treatment Course 1|Lost to Follow-up|3|||
131875268|NCT02147158|474822497|FG004|Treatment Course 1|Lost to Follow-up|2|||
131875269|NCT02147158|474822498|FG005|Treatment Course 1|Lost to Follow-up|4|||
131875270|NCT02147158|474822493|FG000|Treatment Course 1|Protocol Violation|0|||
131408372|NCT01133405|473118256|FG002|Period 2|Physician Decision|0|||
131875271|NCT02147158|474822494|FG001|Treatment Course 1|Protocol Violation|0|||
131875272|NCT02147158|474822495|FG002|Treatment Course 1|Protocol Violation|1|||
131875273|NCT02147158|474822496|FG003|Treatment Course 1|Protocol Violation|1|||
131875274|NCT02147158|474822497|FG004|Treatment Course 1|Protocol Violation|0|||
131875275|NCT02147158|474822498|FG005|Treatment Course 1|Protocol Violation|0|||
131875276|NCT02147158|474822493|FG000|Treatment Course 1|Withdrawal of Consent|1|||
131875277|NCT02147158|474822494|FG001|Treatment Course 1|Withdrawal of Consent|1|||
131875278|NCT02147158|474822495|FG002|Treatment Course 1|Withdrawal of Consent|1|||
131875279|NCT02147158|474822496|FG003|Treatment Course 1|Withdrawal of Consent|5|||
131408373|NCT01133405|473118257|FG003|Period 2|Physician Decision|0|||
131408374|NCT01133405|473118258|FG004|Period 2|Physician Decision|0|||
131408375|NCT01133405|473118259|FG005|Period 2|Physician Decision|1|||
131408376|NCT01133405|473118260|FG006|Period 2|Physician Decision|0|||
131408377|NCT01133405|473118261|FG007|Period 2|Physician Decision|0|||
131408378|NCT01133405|473118262|FG008|Period 2|Physician Decision|0|||
131408379|NCT01133405|473118263|FG009|Period 2|Physician Decision|0|||
131875280|NCT02147158|474822497|FG004|Treatment Course 1|Withdrawal of Consent|3|||
131875281|NCT02147158|474822498|FG005|Treatment Course 1|Withdrawal of Consent|2|||
131875282|NCT02147158|474822493|FG000|Off-Treatment Interval 1|Adverse Event|1|||
131875283|NCT02147158|474822494|FG001|Off-Treatment Interval 1|Adverse Event|0|||
131875284|NCT02147158|474822495|FG002|Off-Treatment Interval 1|Adverse Event|0|||
131875285|NCT02147158|474822496|FG003|Off-Treatment Interval 1|Adverse Event|1|||
131875286|NCT02147158|474822497|FG004|Off-Treatment Interval 1|Adverse Event|0|||
131875287|NCT02147158|474822498|FG005|Off-Treatment Interval 1|Adverse Event|0|||
131875288|NCT02147158|474822493|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
131875289|NCT02147158|474822494|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
131875290|NCT02147158|474822495|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
131875291|NCT02147158|474822496|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
131875292|NCT02147158|474822497|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
131875293|NCT02147158|474822498|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
131875294|NCT02147158|474822493|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
131875295|NCT02147158|474822494|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
131875296|NCT02147158|474822495|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
131875297|NCT02147158|474822496|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
131875298|NCT02147158|474822497|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
131875299|NCT02147158|474822498|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
131875300|NCT02147158|474822493|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
131875301|NCT02147158|474822494|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
131875302|NCT02147158|474822495|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
131875303|NCT02147158|474822496|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
131875304|NCT02147158|474822497|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
131875305|NCT02147158|474822498|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
131875306|NCT02147158|474822493|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
131875307|NCT02147158|474822494|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
131875308|NCT02147158|474822495|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
131875309|NCT02147158|474822496|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
131875310|NCT02147158|474822497|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
131875311|NCT02147158|474822498|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
131875312|NCT02147158|474822493|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
131875313|NCT02147158|474822494|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
131875314|NCT02147158|474822495|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
131875315|NCT02147158|474822496|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
131875316|NCT02147158|474822497|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
131875317|NCT02147158|474822498|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
131875318|NCT02147158|474822493|FG000|Treatment Course 2|Adverse Event|0|||
131875319|NCT02147158|474822494|FG001|Treatment Course 2|Adverse Event|4|||
131875320|NCT02147158|474822495|FG002|Treatment Course 2|Adverse Event|2|||
131875321|NCT02147158|474822496|FG003|Treatment Course 2|Adverse Event|1|||
131875322|NCT02147158|474822497|FG004|Treatment Course 2|Adverse Event|0|||
131875323|NCT02147158|474822498|FG005|Treatment Course 2|Adverse Event|1|||
131875324|NCT02147158|474822493|FG000|Treatment Course 2|Withdrawal of Consent|0|||
131875325|NCT02147158|474822494|FG001|Treatment Course 2|Withdrawal of Consent|1|||
131875326|NCT02147158|474822495|FG002|Treatment Course 2|Withdrawal of Consent|2|||
131875327|NCT02147158|474822496|FG003|Treatment Course 2|Withdrawal of Consent|3|||
131875328|NCT02147158|474822497|FG004|Treatment Course 2|Withdrawal of Consent|0|||
131875329|NCT02147158|474822498|FG005|Treatment Course 2|Withdrawal of Consent|0|||
131875330|NCT02147158|474822493|FG000|Treatment Course 2|Lost to Follow-up|1|||
131875331|NCT02147158|474822494|FG001|Treatment Course 2|Lost to Follow-up|0|||
131875332|NCT02147158|474822495|FG002|Treatment Course 2|Lost to Follow-up|1|||
131875333|NCT02147158|474822496|FG003|Treatment Course 2|Lost to Follow-up|1|||
131875334|NCT02147158|474822497|FG004|Treatment Course 2|Lost to Follow-up|0|||
131875335|NCT02147158|474822498|FG005|Treatment Course 2|Lost to Follow-up|1|||
131875336|NCT02147158|474822493|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
131875337|NCT02147158|474822494|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
131875338|NCT02147158|474822495|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
131875339|NCT02147158|474822496|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
131875340|NCT02147158|474822497|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
131875341|NCT02147158|474822498|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
131875342|NCT02147158|474822493|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
131408380|NCT01238835|473118264|FG000|Overall Study|Death|124|||
131408381|NCT01238835|473118264|FG000|Overall Study|Withdrawal by Subject|9|||
131920667|NCT00021255|474992815|FG000|Overall Study|Herceptin toxicity|0|||
131920668|NCT00021255|474992816|FG001|Overall Study|Herceptin toxicity|22|||
131920669|NCT00021255|474992817|FG002|Overall Study|Herceptin toxicity|6|||
131920670|NCT00021255|474992815|FG000|Overall Study|Adverse Event|46|||
131920671|NCT00021255|474992816|FG001|Overall Study|Adverse Event|30|||
131920672|NCT00021255|474992817|FG002|Overall Study|Adverse Event|18|||
131920673|NCT00021255|474992815|FG000|Overall Study|Protocol Violation|0|||
131920674|NCT00021255|474992816|FG001|Overall Study|Protocol Violation|2|||
131920675|NCT00021255|474992817|FG002|Overall Study|Protocol Violation|0|||
131920676|NCT00021255|474992815|FG000|Overall Study|Other than specified above|0|||
131920677|NCT00021255|474992816|FG001|Overall Study|Other than specified above|38|||
131920678|NCT00021255|474992817|FG002|Overall Study|Other than specified above|19|||
131920679|NCT00021255|474992815|FG000|Overall Study|Missing|0|||
131920680|NCT00021255|474992816|FG001|Overall Study|Missing|27|||
131920681|NCT00021255|474992817|FG002|Overall Study|Missing|13|||
131920682|NCT00021255|474992815|FG000|Overall Study|Randomized but not treated|28|||
131920683|NCT00021255|474992816|FG001|Overall Study|Randomized but not treated|2|||
131920684|NCT00021255|474992817|FG002|Overall Study|Randomized but not treated|18|||
131920685|NCT01132755|474992820|FG000|Overall Study|Procedure not done due to medical reason|23|||
131920686|NCT01132755|474992820|FG000|Overall Study|Protocol Violation|15|||
131920687|NCT01132755|474992820|FG000|Overall Study|Withdrawal by Subject|4|||
131920688|NCT02232698|474992821|FG000|Overall Study|Pregnancy|1|||
131920689|NCT02232698|474992822|FG001|Overall Study|Pregnancy|1|||
131920690|NCT02232698|474992821|FG000|Overall Study|Met exclusion criteria|1|||
131920691|NCT02232698|474992822|FG001|Overall Study|Met exclusion criteria|1|||
131920692|NCT02232698|474992821|FG000|Overall Study|Had device-associated symptoms|7|||
131920693|NCT02232698|474992822|FG001|Overall Study|Had device-associated symptoms|0|||
131920694|NCT02232698|474992821|FG000|Overall Study|Non-compliance with study device|1|||
131920695|NCT02232698|474992822|FG001|Overall Study|Non-compliance with study device|4|||
131920696|NCT02232698|474992821|FG000|Overall Study|Allocated to control group|0|||
131920697|NCT02232698|474992822|FG001|Overall Study|Allocated to control group|3|||
131920698|NCT02232698|474992821|FG000|Overall Study|Withdrawal by Subject|0|||
131920699|NCT02232698|474992822|FG001|Overall Study|Withdrawal by Subject|11|||
131920700|NCT02393755|474992823|FG000|Overall Study|Withdrawal by Subject|0|||
131920701|NCT02393755|474992824|FG001|Overall Study|Withdrawal by Subject|3|||
131920702|NCT02393755|474992823|FG000|Overall Study|Adverse Event|0|||
131920703|NCT02393755|474992824|FG001|Overall Study|Adverse Event|2|||
131920704|NCT02393755|474992823|FG000|Overall Study|Physician Decision|0|||
131920705|NCT02393755|474992824|FG001|Overall Study|Physician Decision|2|||
131920706|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
131920707|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
131920708|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
131920709|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
131920710|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
131920711|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
131920712|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
131920713|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
131920714|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
131920715|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
131920716|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
131920717|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
131920718|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
131920719|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
131920720|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
131920721|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
131920722|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
131920723|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
131920724|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
131920725|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
131920726|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
131920727|NCT02337946|474992825|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
131920728|NCT02337946|474992826|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
131920729|NCT02337946|474992827|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
131920730|NCT02337946|474992825|FG000|In-between Period|Without Informed Consent|1|||
131920731|NCT02337946|474992826|FG001|In-between Period|Without Informed Consent|0|||
131920732|NCT02337946|474992827|FG002|In-between Period|Without Informed Consent|0|||
131920733|NCT02337946|474992825|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
131920734|NCT02337946|474992826|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
131920735|NCT02337946|474992827|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
131920736|NCT02337946|474992825|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
131920737|NCT02337946|474992826|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
131920738|NCT02337946|474992827|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
131408382|NCT01238835|473118264|FG000|Overall Study|Lost to Follow-up|1|||
131920739|NCT02337946|474992825|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
131920740|NCT02337946|474992826|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
131920741|NCT02337946|474992827|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
131920742|NCT02337946|474992825|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
131920743|NCT02337946|474992826|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
131920744|NCT02337946|474992827|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
131920745|NCT02337946|474992825|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
131920746|NCT02337946|474992826|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
131920747|NCT02337946|474992827|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
131920748|NCT02337946|474992825|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
131920749|NCT02337946|474992826|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
131920750|NCT02337946|474992827|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
131920751|NCT05324371|474992829|FG000|Overall Study|Withdrawal by Subject|1|||
131920752|NCT05324371|474992829|FG000|Overall Study|Death|1|||
131920753|NCT02949934|474992831|FG000|Natural Drinking Period|Adverse Event|1|||
131920754|NCT02949934|474992832|FG001|Natural Drinking Period|Adverse Event|0|||
131920755|NCT02949934|474992833|FG002|Natural Drinking Period|Adverse Event|0|||
131920756|NCT02949934|474992834|FG003|Natural Drinking Period|Adverse Event|1|||
131920757|NCT02949934|474992835|FG004|Natural Drinking Period|Adverse Event|0|||
131920758|NCT02949934|474992836|FG005|Natural Drinking Period|Adverse Event|0|||
131920759|NCT02949934|474992831|FG000|Natural Drinking Period|Lost to Follow-up|0|||
131920760|NCT02949934|474992832|FG001|Natural Drinking Period|Lost to Follow-up|0|||
131875343|NCT02147158|474822494|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
131920761|NCT02949934|474992833|FG002|Natural Drinking Period|Lost to Follow-up|0|||
131920762|NCT02949934|474992834|FG003|Natural Drinking Period|Lost to Follow-up|0|||
131920763|NCT02949934|474992835|FG004|Natural Drinking Period|Lost to Follow-up|1|||
131920764|NCT02949934|474992836|FG005|Natural Drinking Period|Lost to Follow-up|0|||
131875344|NCT02147158|474822495|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
131875345|NCT02147158|474822496|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
131875346|NCT02147158|474822497|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
131875347|NCT02147158|474822498|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
131875348|NCT02147158|474822493|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
131875349|NCT02147158|474822494|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
131875350|NCT02147158|474822495|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
131875351|NCT02147158|474822496|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
131875352|NCT02147158|474822497|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
131875353|NCT02147158|474822498|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
131875354|NCT02147158|474822493|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
131875355|NCT02147158|474822494|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
131875356|NCT02147158|474822495|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
131875357|NCT02147158|474822496|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
131875358|NCT02147158|474822497|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
131875359|NCT02147158|474822498|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
131875360|NCT02147158|474822493|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
131875361|NCT02147158|474822494|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
131875362|NCT02147158|474822495|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
131875363|NCT02147158|474822496|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
131875364|NCT02147158|474822497|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
131875365|NCT02147158|474822498|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
131875366|NCT03425396|474822499|FG000|Overall Study|Lost to Follow-up|2|||
131875367|NCT03425396|474822500|FG001|Overall Study|Lost to Follow-up|5|||
131875368|NCT03425396|474822501|FG002|Overall Study|Lost to Follow-up|2|||
131875369|NCT03425396|474822502|FG003|Overall Study|Lost to Follow-up|0|||
131875370|NCT03425396|474822503|FG004|Overall Study|Lost to Follow-up|0|||
131875371|NCT03425396|474822499|FG000|Overall Study|Withdrawal by Subject|0|||
131875372|NCT03425396|474822500|FG001|Overall Study|Withdrawal by Subject|1|||
131875373|NCT03425396|474822501|FG002|Overall Study|Withdrawal by Subject|0|||
131875374|NCT03425396|474822502|FG003|Overall Study|Withdrawal by Subject|1|||
131875375|NCT03425396|474822503|FG004|Overall Study|Withdrawal by Subject|0|||
131875376|NCT03425396|474822499|FG000|Overall Study|Other|0|||
131875377|NCT03425396|474822500|FG001|Overall Study|Other|1|||
131875378|NCT03425396|474822501|FG002|Overall Study|Other|1|||
131875379|NCT03425396|474822502|FG003|Overall Study|Other|0|||
131875380|NCT03425396|474822503|FG004|Overall Study|Other|1|||
131875381|NCT01441765|474822504|FG000|Overall Study|Death|1|||
131875382|NCT01441765|474822505|FG001|Overall Study|Death|0|||
131875383|NCT03689374|474822506|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
131875384|NCT03689374|474822507|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
131875385|NCT03689374|474822508|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
131875386|NCT03689374|474822506|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
131875387|NCT03689374|474822507|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
131920765|NCT02949934|474992831|FG000|Neuroimaging|Protocol Violation|2|||
131920766|NCT02949934|474992832|FG001|Neuroimaging|Protocol Violation|0|||
131875388|NCT03689374|474822508|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
131875389|NCT03689374|474822506|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
131875390|NCT03689374|474822507|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
131875391|NCT03689374|474822508|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
131875392|NCT03689374|474822506|FG000|Treatment Period (Week 0 to 52)|Death|0|||
131875393|NCT03689374|474822507|FG001|Treatment Period (Week 0 to 52)|Death|11|||
131875394|NCT03689374|474822508|FG002|Treatment Period (Week 0 to 52)|Death|1|||
131875395|NCT05367973|474822509|FG000|Overall Study|Adverse Event|0|||
131875396|NCT05367973|474822510|FG001|Overall Study|Adverse Event|2|||
131875397|NCT04445714|474822511|FG000|Overall Study|Discontinuation of the study|14|||
131875398|NCT04445714|474822511|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
131875399|NCT04445714|474822511|FG000|Overall Study|Withdrawal of Informed Consent|8|||
131875400|NCT02805660|474822512|FG000|Overall Study|Death|5|||
131875401|NCT02805660|474822513|FG001|Overall Study|Death|2|||
131875402|NCT02805660|474822514|FG002|Overall Study|Death|9|||
131875403|NCT02805660|474822515|FG003|Overall Study|Death|5|||
131875404|NCT02805660|474822516|FG004|Overall Study|Death|0|||
131875405|NCT02805660|474822517|FG005|Overall Study|Death|14|||
131875406|NCT02805660|474822518|FG006|Overall Study|Death|12|||
131875407|NCT02805660|474822512|FG000|Overall Study|Lost to Follow-up|0|||
131875408|NCT02805660|474822513|FG001|Overall Study|Lost to Follow-up|1|||
131875409|NCT02805660|474822514|FG002|Overall Study|Lost to Follow-up|1|||
131875410|NCT02805660|474822515|FG003|Overall Study|Lost to Follow-up|2|||
131875411|NCT02805660|474822516|FG004|Overall Study|Lost to Follow-up|0|||
131875412|NCT02805660|474822517|FG005|Overall Study|Lost to Follow-up|0|||
131875413|NCT02805660|474822518|FG006|Overall Study|Lost to Follow-up|0|||
131875414|NCT02805660|474822512|FG000|Overall Study|Withdrawal by Subject|0|||
131875415|NCT02805660|474822513|FG001|Overall Study|Withdrawal by Subject|0|||
131875416|NCT02805660|474822514|FG002|Overall Study|Withdrawal by Subject|0|||
131875417|NCT02805660|474822515|FG003|Overall Study|Withdrawal by Subject|3|||
131875418|NCT02805660|474822516|FG004|Overall Study|Withdrawal by Subject|1|||
131875419|NCT02805660|474822517|FG005|Overall Study|Withdrawal by Subject|0|||
131875420|NCT02805660|474822518|FG006|Overall Study|Withdrawal by Subject|2|||
131875421|NCT02805660|474822512|FG000|Overall Study|Study terminated by Sponsor|0|||
131875422|NCT02805660|474822513|FG001|Overall Study|Study terminated by Sponsor|0|||
131875423|NCT02805660|474822514|FG002|Overall Study|Study terminated by Sponsor|1|||
131875424|NCT02805660|474822515|FG003|Overall Study|Study terminated by Sponsor|4|||
131875425|NCT02805660|474822516|FG004|Overall Study|Study terminated by Sponsor|2|||
131875426|NCT02805660|474822517|FG005|Overall Study|Study terminated by Sponsor|3|||
131875427|NCT02805660|474822518|FG006|Overall Study|Study terminated by Sponsor|1|||
131875428|NCT02805660|474822512|FG000|Overall Study|Miscellaneous|0|||
131875429|NCT02805660|474822513|FG001|Overall Study|Miscellaneous|1|||
131875430|NCT02805660|474822514|FG002|Overall Study|Miscellaneous|0|||
131875431|NCT02805660|474822515|FG003|Overall Study|Miscellaneous|4|||
131875432|NCT02805660|474822516|FG004|Overall Study|Miscellaneous|0|||
131875433|NCT02805660|474822517|FG005|Overall Study|Miscellaneous|6|||
131875434|NCT02805660|474822518|FG006|Overall Study|Miscellaneous|4|||
131875435|NCT01190410|474824343|FG000|Overall Study|Adverse Event|0|||
131875436|NCT01190410|474824344|FG001|Overall Study|Adverse Event|3|||
131875437|NCT01190410|474824343|FG000|Overall Study|Lack of Efficacy|0|||
131875438|NCT01190410|474824344|FG001|Overall Study|Lack of Efficacy|2|||
131875439|NCT01190410|474824343|FG000|Overall Study|Withdrawal by Subject|0|||
131875440|NCT01190410|474824344|FG001|Overall Study|Withdrawal by Subject|2|||
131875441|NCT01190410|474824343|FG000|Overall Study|Administrative decision|1|||
131875442|NCT01190410|474824344|FG001|Overall Study|Administrative decision|0|||
131875443|NCT01190410|474824343|FG000|Overall Study|PI discretion|0|||
131875444|NCT01190410|474824344|FG001|Overall Study|PI discretion|2|||
131875445|NCT01399047|474824345|FG000|Overall Study|Withdrawal by Subject|0|||
131875446|NCT01399047|474824346|FG001|Overall Study|Withdrawal by Subject|1|||
131875447|NCT03652636|474824350|FG000|Overall Study|Withdrawal by Subject|7|||
131875448|NCT01177293|474824356|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
131875449|NCT01177293|474824357|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
131875450|NCT00160706|474824359|FG000|Overall Study|Adverse Event|53|||
131875451|NCT00160706|474824359|FG000|Overall Study|Adverse Event and Other Reason|105|||
131920767|NCT02949934|474992833|FG002|Neuroimaging|Protocol Violation|0|||
131920768|NCT02949934|474992834|FG003|Neuroimaging|Protocol Violation|0|||
131875452|NCT00160706|474824359|FG000|Overall Study|Protocol Violation|3|||
131875453|NCT00160706|474824359|FG000|Overall Study|Withdrawal by Subject|41|||
131875454|NCT00160706|474824359|FG000|Overall Study|Withdrawal by Subject and Other|12|||
131875455|NCT00160706|474824359|FG000|Overall Study|Physician Decision|10|||
131920769|NCT02949934|474992835|FG004|Neuroimaging|Protocol Violation|1|||
131875456|NCT00160706|474824359|FG000|Overall Study|Physician Decision and Other|3|||
131875457|NCT00160706|474824359|FG000|Overall Study|Lost to Follow-up|4|||
131875458|NCT00160706|474824359|FG000|Overall Study|Lost to Follow-up and Other|1|||
131875459|NCT00160706|474824359|FG000|Overall Study|Lack of Efficacy|42|||
131875460|NCT00160706|474824359|FG000|Overall Study|Lack of Efficacy and Other|1|||
131875461|NCT00160706|474824359|FG000|Overall Study|Other Reason|11|||
131875462|NCT03214380|474824360|FG000|Lead-in|Adverse Event|3|||
131875463|NCT03214380|474824361|FG001|Lead-in|Adverse Event|0|||
131875464|NCT03214380|474824362|FG002|Lead-in|Adverse Event|0|||
131875465|NCT03214380|474824363|FG003|Lead-in|Adverse Event|1|||
131875466|NCT03214380|474824364|FG004|Lead-in|Adverse Event|0|||
131875467|NCT03214380|474824365|FG005|Lead-in|Adverse Event|0|||
131875468|NCT03214380|474824360|FG000|Lead-in|Lost to Follow-up|4|||
131875469|NCT03214380|474824361|FG001|Lead-in|Lost to Follow-up|0|||
131875470|NCT03214380|474824362|FG002|Lead-in|Lost to Follow-up|0|||
131875471|NCT03214380|474824363|FG003|Lead-in|Lost to Follow-up|1|||
131875472|NCT03214380|474824364|FG004|Lead-in|Lost to Follow-up|0|||
131875473|NCT03214380|474824365|FG005|Lead-in|Lost to Follow-up|0|||
131875474|NCT03214380|474824360|FG000|Lead-in|Eligibility Criteria|3|||
131875475|NCT03214380|474824361|FG001|Lead-in|Eligibility Criteria|0|||
131875476|NCT03214380|474824362|FG002|Lead-in|Eligibility Criteria|0|||
131875477|NCT03214380|474824363|FG003|Lead-in|Eligibility Criteria|0|||
131875478|NCT03214380|474824364|FG004|Lead-in|Eligibility Criteria|0|||
131875479|NCT03214380|474824365|FG005|Lead-in|Eligibility Criteria|0|||
131875480|NCT03214380|474824360|FG000|Lead-in|Physician Decision|6|||
131875481|NCT03214380|474824361|FG001|Lead-in|Physician Decision|0|||
131875482|NCT03214380|474824362|FG002|Lead-in|Physician Decision|0|||
131875483|NCT03214380|474824363|FG003|Lead-in|Physician Decision|0|||
131875484|NCT03214380|474824364|FG004|Lead-in|Physician Decision|0|||
131875485|NCT03214380|474824365|FG005|Lead-in|Physician Decision|0|||
131875486|NCT03214380|474824360|FG000|Lead-in|Protocol Deviation|7|||
131875487|NCT03214380|474824361|FG001|Lead-in|Protocol Deviation|0|||
131875488|NCT03214380|474824362|FG002|Lead-in|Protocol Deviation|0|||
131875489|NCT03214380|474824363|FG003|Lead-in|Protocol Deviation|3|||
131875490|NCT03214380|474824364|FG004|Lead-in|Protocol Deviation|0|||
131875491|NCT03214380|474824365|FG005|Lead-in|Protocol Deviation|0|||
131875492|NCT03214380|474824360|FG000|Lead-in|Withdrawal by Subject|41|||
131875493|NCT03214380|474824361|FG001|Lead-in|Withdrawal by Subject|0|||
131875494|NCT03214380|474824362|FG002|Lead-in|Withdrawal by Subject|0|||
131875495|NCT03214380|474824363|FG003|Lead-in|Withdrawal by Subject|14|||
131875496|NCT03214380|474824364|FG004|Lead-in|Withdrawal by Subject|0|||
131875497|NCT03214380|474824365|FG005|Lead-in|Withdrawal by Subject|0|||
131875498|NCT03214380|474824360|FG000|Lead-in|Family Emergency|1|||
131875499|NCT03214380|474824361|FG001|Lead-in|Family Emergency|0|||
131875500|NCT03214380|474824362|FG002|Lead-in|Family Emergency|0|||
131875501|NCT03214380|474824363|FG003|Lead-in|Family Emergency|0|||
131875502|NCT03214380|474824364|FG004|Lead-in|Family Emergency|0|||
131875503|NCT03214380|474824365|FG005|Lead-in|Family Emergency|0|||
131875504|NCT03214380|474824360|FG000|Lead-in|Natural Disaster|9|||
131875505|NCT03214380|474824361|FG001|Lead-in|Natural Disaster|0|||
131875506|NCT03214380|474824362|FG002|Lead-in|Natural Disaster|0|||
131875507|NCT03214380|474824363|FG003|Lead-in|Natural Disaster|0|||
131875508|NCT03214380|474824364|FG004|Lead-in|Natural Disaster|0|||
131875509|NCT03214380|474824365|FG005|Lead-in|Natural Disaster|0|||
131875510|NCT03214380|474824360|FG000|Lead-in|Non Compliance|1|||
131875511|NCT03214380|474824361|FG001|Lead-in|Non Compliance|0|||
131875512|NCT03214380|474824362|FG002|Lead-in|Non Compliance|0|||
131875513|NCT03214380|474824363|FG003|Lead-in|Non Compliance|0|||
131875514|NCT03214380|474824364|FG004|Lead-in|Non Compliance|0|||
131875515|NCT03214380|474824365|FG005|Lead-in|Non Compliance|0|||
131875516|NCT03214380|474824360|FG000|Lead-in|Participant Schedule|2|||
131875517|NCT03214380|474824361|FG001|Lead-in|Participant Schedule|0|||
131875518|NCT03214380|474824362|FG002|Lead-in|Participant Schedule|0|||
131875519|NCT03214380|474824363|FG003|Lead-in|Participant Schedule|0|||
131875520|NCT03214380|474824364|FG004|Lead-in|Participant Schedule|0|||
131875521|NCT03214380|474824365|FG005|Lead-in|Participant Schedule|0|||
131875522|NCT03214380|474824360|FG000|Treatment Period|Adverse Event|0|||
131875523|NCT03214380|474824361|FG001|Treatment Period|Adverse Event|1|||
131875524|NCT03214380|474824362|FG002|Treatment Period|Adverse Event|1|||
131875525|NCT03214380|474824363|FG003|Treatment Period|Adverse Event|0|||
131875526|NCT03214380|474824364|FG004|Treatment Period|Adverse Event|1|||
131875527|NCT03214380|474824365|FG005|Treatment Period|Adverse Event|0|||
131875528|NCT03214380|474824360|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
131875529|NCT03214380|474824361|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
131875530|NCT03214380|474824362|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
131875531|NCT03214380|474824363|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
131875532|NCT03214380|474824364|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
131875533|NCT03214380|474824365|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
131875534|NCT03214380|474824360|FG000|Treatment Period|Withdrawal by Subject|0|||
131875535|NCT03214380|474824361|FG001|Treatment Period|Withdrawal by Subject|10|||
131875536|NCT03214380|474824362|FG002|Treatment Period|Withdrawal by Subject|8|||
131875537|NCT03214380|474824363|FG003|Treatment Period|Withdrawal by Subject|0|||
131875538|NCT03214380|474824364|FG004|Treatment Period|Withdrawal by Subject|7|||
131875539|NCT03214380|474824365|FG005|Treatment Period|Withdrawal by Subject|11|||
131875540|NCT03214380|474824360|FG000|Treatment Period|Death|0|||
131875541|NCT03214380|474824361|FG001|Treatment Period|Death|1|||
131875542|NCT03214380|474824362|FG002|Treatment Period|Death|2|||
131875543|NCT03214380|474824363|FG003|Treatment Period|Death|0|||
131875544|NCT03214380|474824364|FG004|Treatment Period|Death|0|||
131920770|NCT02949934|474992836|FG005|Neuroimaging|Protocol Violation|0|||
131920771|NCT02949934|474992831|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
131920772|NCT02949934|474992832|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
131920773|NCT02949934|474992833|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
131920774|NCT02949934|474992834|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
131920775|NCT02949934|474992835|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
131920776|NCT02949934|474992836|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
131920777|NCT02949934|474992831|FG000|Neuroimaging|Not scanned|0|||
131920778|NCT02949934|474992832|FG001|Neuroimaging|Not scanned|0|||
131920779|NCT02949934|474992833|FG002|Neuroimaging|Not scanned|1|||
131920780|NCT02949934|474992834|FG003|Neuroimaging|Not scanned|0|||
131920781|NCT02949934|474992835|FG004|Neuroimaging|Not scanned|0|||
131920782|NCT02949934|474992836|FG005|Neuroimaging|Not scanned|2|||
131920783|NCT02949934|474992831|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
131920784|NCT02949934|474992832|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
131920785|NCT02949934|474992833|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
131920786|NCT02949934|474992834|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
131920787|NCT02949934|474992835|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
131920788|NCT02949934|474992836|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
131920789|NCT02949934|474992831|FG000|Bar Laboratory|Adverse Event|1|||
131920790|NCT02949934|474992832|FG001|Bar Laboratory|Adverse Event|0|||
131920791|NCT02949934|474992833|FG002|Bar Laboratory|Adverse Event|2|||
131920792|NCT02949934|474992834|FG003|Bar Laboratory|Adverse Event|0|||
131920793|NCT02949934|474992835|FG004|Bar Laboratory|Adverse Event|1|||
131920794|NCT02949934|474992836|FG005|Bar Laboratory|Adverse Event|0|||
131920795|NCT02949934|474992831|FG000|Bar Laboratory|Protocol Violation|0|||
131920796|NCT02949934|474992832|FG001|Bar Laboratory|Protocol Violation|0|||
131920797|NCT02949934|474992833|FG002|Bar Laboratory|Protocol Violation|0|||
131920798|NCT02949934|474992834|FG003|Bar Laboratory|Protocol Violation|1|||
131920799|NCT02949934|474992835|FG004|Bar Laboratory|Protocol Violation|0|||
131920800|NCT02949934|474992836|FG005|Bar Laboratory|Protocol Violation|0|||
131920801|NCT04822194|474992837|FG000|Overall Study|Withdrawal by Subject|5|||
131920802|NCT04822194|474992838|FG001|Overall Study|Withdrawal by Subject|4|||
131920803|NCT04822194|474992837|FG000|Overall Study|Technical issues with MR scanner|1|||
131920804|NCT04822194|474992838|FG001|Overall Study|Technical issues with MR scanner|0|||
131920805|NCT04822194|474992837|FG000|Overall Study|Lost to Follow-up|5|||
131920806|NCT04822194|474992838|FG001|Overall Study|Lost to Follow-up|7|||
131920807|NCT01363076|474993625|FG000|Overall Study|Withdrawal by Subject|0|||
131920808|NCT01363076|474993626|FG001|Overall Study|Withdrawal by Subject|1|||
131920809|NCT04706403|474993627|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
131920810|NCT04706403|474993628|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
131920811|NCT04706403|474993629|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
131920812|NCT04706403|474993630|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
131920813|NCT04706403|474993631|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
131920814|NCT00182637|474993632|FG000|Overall Study|Adverse Event|2|||
131920815|NCT00182637|474993632|FG000|Overall Study|Disease Progression|1|||
131920816|NCT05399771|474993633|FG000|Overall Study|Physician Decision|3|||
131920817|NCT05399771|474993633|FG000|Overall Study|Adverse Event|1|||
131920818|NCT04766333|474993636|FG000|Overall Study|Lost to Follow-up|40|||
131920819|NCT04766333|474993637|FG001|Overall Study|Lost to Follow-up|826|||
131920820|NCT00639379|474993638|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
131920821|NCT00639379|474993639|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
131920822|NCT00639379|474993638|FG000|Period 1 - 2 Weeks|lens issue|3|||
131920823|NCT00639379|474993639|FG001|Period 1 - 2 Weeks|lens issue|0|||
131920824|NCT02636283|474993640|FG000|Overall Study|Adverse Event|2|||
131920825|NCT02636283|474993641|FG001|Overall Study|Adverse Event|0|||
131920826|NCT02636283|474993640|FG000|Overall Study|Trial Terminated Prematurely|0|||
131920827|NCT02636283|474993641|FG001|Overall Study|Trial Terminated Prematurely|3|||
131920828|NCT02541903|474993645|FG000|Overall Study|Death|1|||
131920829|NCT00367458|474993646|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
131920830|NCT00367458|474993647|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
131408383|NCT01238835|473118264|FG000|Overall Study|Site early discontinuation|2|||
131920831|NCT04795323|474993650|FG000|Overall Study|Did not interact with TARA|1|||
131408384|NCT00907803|473118266|FG000|Overall Study|Withdrawal of consent - long commute|1|||
131920832|NCT04795323|474993651|FG001|Overall Study|Did not interact with TARA|0|||
131920833|NCT04339972|474993652|FG000|Overall Study|Scheduling Issues|3|||
131920834|NCT04339972|474993653|FG001|Overall Study|Scheduling Issues|3|||
131920835|NCT04339972|474993652|FG000|Overall Study|dropout|1|||
131920836|NCT04339972|474993653|FG001|Overall Study|dropout|1|||
131920837|NCT04339972|474993652|FG000|Overall Study|Technical issues|1|||
131920838|NCT04339972|474993653|FG001|Overall Study|Technical issues|0|||
131920839|NCT04339972|474993652|FG000|Overall Study|Claustraphobia|0|||
131920840|NCT04339972|474993653|FG001|Overall Study|Claustraphobia|1|||
131920841|NCT03142750|474993655|FG000|Overall Study|Lost to Follow-up|4|||
131920842|NCT03142750|474993656|FG001|Overall Study|Lost to Follow-up|1|||
131920843|NCT04925934|474993659|FG000|Overall Study|Adverse Event|1|||
131920844|NCT04925934|474993660|FG001|Overall Study|Adverse Event|0|||
131920845|NCT04925934|474993661|FG002|Overall Study|Adverse Event|0|||
131920846|NCT04925934|474993659|FG000|Overall Study|Lost to Follow-up|2|||
131920847|NCT04925934|474993660|FG001|Overall Study|Lost to Follow-up|0|||
131920848|NCT04925934|474993661|FG002|Overall Study|Lost to Follow-up|1|||
131920849|NCT04925934|474993659|FG000|Overall Study|Death|0|||
131920850|NCT04925934|474993660|FG001|Overall Study|Death|1|||
131920851|NCT04925934|474993661|FG002|Overall Study|Death|0|||
131920852|NCT04925934|474993659|FG000|Overall Study|Withdrawal by Subject|8|||
131920853|NCT04925934|474993660|FG001|Overall Study|Withdrawal by Subject|5|||
131920854|NCT04925934|474993661|FG002|Overall Study|Withdrawal by Subject|9|||
131920855|NCT04925934|474993659|FG000|Overall Study|Other|2|||
131920856|NCT04925934|474993660|FG001|Overall Study|Other|2|||
131920857|NCT04925934|474993661|FG002|Overall Study|Other|2|||
131920858|NCT04925934|474993659|FG000|Overall Study|Eastern European Conflict|7|||
131920859|NCT04925934|474993660|FG001|Overall Study|Eastern European Conflict|3|||
131920860|NCT04925934|474993661|FG002|Overall Study|Eastern European Conflict|2|||
131920861|NCT01716156|474993666|FG000|Overall Study|Protocol Violation|1|||
131920862|NCT01716156|474993667|FG001|Overall Study|Protocol Violation|0|||
131920863|NCT01716156|474993668|FG002|Overall Study|Protocol Violation|0|||
131920864|NCT01716156|474993666|FG000|Overall Study|Withdrawal by Subject|0|||
131920865|NCT01716156|474993667|FG001|Overall Study|Withdrawal by Subject|1|||
131920866|NCT01716156|474993668|FG002|Overall Study|Withdrawal by Subject|2|||
131920867|NCT01716156|474993666|FG000|Overall Study|Lost to Follow-up|1|||
131920868|NCT01716156|474993667|FG001|Overall Study|Lost to Follow-up|0|||
131920869|NCT01716156|474993668|FG002|Overall Study|Lost to Follow-up|0|||
131920870|NCT05221866|474993669|FG000|Overall Study|Withdrawal by Subject|5|||
131920871|NCT05221866|474993670|FG001|Overall Study|Withdrawal by Subject|7|||
131920872|NCT05221866|474993671|FG002|Overall Study|Withdrawal by Subject|6|||
131920873|NCT05221866|474993672|FG003|Overall Study|Withdrawal by Subject|4|||
131920874|NCT05221866|474993669|FG000|Overall Study|Physician Decision|3|||
131920875|NCT05221866|474993670|FG001|Overall Study|Physician Decision|2|||
131920876|NCT05221866|474993671|FG002|Overall Study|Physician Decision|1|||
131920877|NCT05221866|474993672|FG003|Overall Study|Physician Decision|4|||
131920878|NCT05221866|474993669|FG000|Overall Study|Lost to Follow-up|12|||
131920879|NCT05221866|474993670|FG001|Overall Study|Lost to Follow-up|17|||
131920880|NCT05221866|474993671|FG002|Overall Study|Lost to Follow-up|14|||
131920881|NCT05221866|474993672|FG003|Overall Study|Lost to Follow-up|14|||
131920882|NCT05221866|474993669|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
131920883|NCT05221866|474993670|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
131920884|NCT05221866|474993671|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
131920885|NCT05221866|474993672|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
131920886|NCT05561140|474993673|FG000|Randomized Treatment Period|Adverse Event|1|||
131920887|NCT05561140|474993674|FG001|Randomized Treatment Period|Adverse Event|0|||
131920888|NCT05561140|474993673|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
131920889|NCT05561140|474993674|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
131920890|NCT05561140|474993673|FG000|Open Label Treatment Period|Adverse Event|6|||
131920891|NCT05561140|474993674|FG001|Open Label Treatment Period|Adverse Event|4|||
131920892|NCT05561140|474993673|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
131920893|NCT05561140|474993674|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
131920894|NCT05561140|474993673|FG000|Open Label Treatment Period|Physician Decision|0|||
131920895|NCT05561140|474993674|FG001|Open Label Treatment Period|Physician Decision|1|||
131920896|NCT05561140|474993673|FG000|Open Label Treatment Period|Pregnancy|1|||
131920897|NCT05561140|474993674|FG001|Open Label Treatment Period|Pregnancy|0|||
131920898|NCT05561140|474993673|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
131920899|NCT05561140|474993674|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
131920900|NCT05561140|474993673|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
131920901|NCT05561140|474993674|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
131920902|NCT05561140|474993673|FG000|Open Label Treatment Period|Other|1|||
131408385|NCT00907803|473118267|FG001|Overall Study|Withdrawal of consent - long commute|0|||
131408386|NCT00907803|473118268|FG002|Overall Study|Withdrawal of consent - long commute|0|||
131408387|NCT00907803|473118266|FG000|Overall Study|Adverse Event|2|||
131920903|NCT05561140|474993674|FG001|Open Label Treatment Period|Other|0|||
131920904|NCT01944774|474993675|FG000|Overall Study|Withdrawal by Subject|2|||
131920905|NCT01944774|474993676|FG001|Overall Study|Withdrawal by Subject|3|||
131920906|NCT01944774|474993677|FG002|Overall Study|Withdrawal by Subject|3|||
131408388|NCT00907803|473118267|FG001|Overall Study|Adverse Event|0|||
131920907|NCT01944774|474993675|FG000|Overall Study|Adverse Event|3|||
131920908|NCT01944774|474993676|FG001|Overall Study|Adverse Event|2|||
131920909|NCT01944774|474993677|FG002|Overall Study|Adverse Event|3|||
131920910|NCT01944774|474993675|FG000|Overall Study|Lack of Efficacy|1|||
131920911|NCT01944774|474993676|FG001|Overall Study|Lack of Efficacy|2|||
131920912|NCT01944774|474993677|FG002|Overall Study|Lack of Efficacy|2|||
131920913|NCT01944774|474993675|FG000|Overall Study|Lost to Follow-up|0|||
131920914|NCT01944774|474993676|FG001|Overall Study|Lost to Follow-up|1|||
131920915|NCT01944774|474993677|FG002|Overall Study|Lost to Follow-up|0|||
131920916|NCT00374868|474993682|FG000|Overall Study|Adverse Event|12|||
131920917|NCT00374868|474993682|FG000|Overall Study|Progressive Disease|7|||
131920918|NCT00374868|474993682|FG000|Overall Study|Physician Decision|13|||
131920919|NCT00374868|474993682|FG000|Overall Study|Lost to Follow-up|1|||
131920920|NCT00374868|474993682|FG000|Overall Study|Death|2|||
131920921|NCT00374868|474993682|FG000|Overall Study|Other - Not Specified|1|||
131920922|NCT03188185|474993683|FG000|Stage 1|Adverse Event|4|||
131920923|NCT03188185|474993684|FG001|Stage 1|Adverse Event|12|||
131920924|NCT03188185|474993685|FG002|Stage 1|Adverse Event|0|||
131920925|NCT03188185|474993686|FG003|Stage 1|Adverse Event|0|||
131920926|NCT03188185|474993683|FG000|Stage 1|Lack of Efficacy|0|||
131920927|NCT03188185|474993684|FG001|Stage 1|Lack of Efficacy|2|||
131920928|NCT03188185|474993685|FG002|Stage 1|Lack of Efficacy|0|||
131920929|NCT03188185|474993686|FG003|Stage 1|Lack of Efficacy|0|||
131920930|NCT03188185|474993683|FG000|Stage 1|Lost to Follow-up|6|||
131920931|NCT03188185|474993684|FG001|Stage 1|Lost to Follow-up|1|||
131920932|NCT03188185|474993685|FG002|Stage 1|Lost to Follow-up|0|||
131920933|NCT03188185|474993686|FG003|Stage 1|Lost to Follow-up|0|||
131920934|NCT03188185|474993683|FG000|Stage 1|Withdrawal by Subject|9|||
131920935|NCT03188185|474993684|FG001|Stage 1|Withdrawal by Subject|0|||
131920936|NCT03188185|474993685|FG002|Stage 1|Withdrawal by Subject|0|||
131920937|NCT03188185|474993686|FG003|Stage 1|Withdrawal by Subject|0|||
131920938|NCT03188185|474993683|FG000|Stage 1|Identified as a professional patient|0|||
131920939|NCT03188185|474993684|FG001|Stage 1|Identified as a professional patient|1|||
131920940|NCT03188185|474993685|FG002|Stage 1|Identified as a professional patient|0|||
131920941|NCT03188185|474993686|FG003|Stage 1|Identified as a professional patient|0|||
131920942|NCT03188185|474993683|FG000|Stage 2|Adverse Event|0|||
131920943|NCT03188185|474993684|FG001|Stage 2|Adverse Event|0|||
131920944|NCT03188185|474993685|FG002|Stage 2|Adverse Event|2|||
131920945|NCT03188185|474993686|FG003|Stage 2|Adverse Event|4|||
131920946|NCT03188185|474993683|FG000|Stage 2|Lack of Efficacy|0|||
131920947|NCT03188185|474993684|FG001|Stage 2|Lack of Efficacy|0|||
131920948|NCT03188185|474993685|FG002|Stage 2|Lack of Efficacy|3|||
131920949|NCT03188185|474993686|FG003|Stage 2|Lack of Efficacy|0|||
131920950|NCT03188185|474993683|FG000|Stage 2|Lost to Follow-up|0|||
131920951|NCT03188185|474993684|FG001|Stage 2|Lost to Follow-up|0|||
131920952|NCT03188185|474993685|FG002|Stage 2|Lost to Follow-up|1|||
131920953|NCT03188185|474993686|FG003|Stage 2|Lost to Follow-up|0|||
131920954|NCT03188185|474993683|FG000|Stage 2|Physician Decision|0|||
131920955|NCT03188185|474993684|FG001|Stage 2|Physician Decision|0|||
131920956|NCT03188185|474993685|FG002|Stage 2|Physician Decision|0|||
131920957|NCT03188185|474993686|FG003|Stage 2|Physician Decision|1|||
131920958|NCT03188185|474993683|FG000|Stage 2|Withdrawal by Subject|0|||
131920959|NCT03188185|474993684|FG001|Stage 2|Withdrawal by Subject|0|||
131920960|NCT03188185|474993685|FG002|Stage 2|Withdrawal by Subject|3|||
131920961|NCT03188185|474993686|FG003|Stage 2|Withdrawal by Subject|1|||
131920962|NCT03349515|474993689|FG000|Overall Study|Lack of Efficacy|2|||
131920963|NCT03349515|474993690|FG001|Overall Study|Lack of Efficacy|0|||
131920964|NCT03349515|474993689|FG000|Overall Study|Physician Decision|3|||
131920965|NCT03349515|474993690|FG001|Overall Study|Physician Decision|1|||
131920966|NCT02315625|474993691|FG000|First Intervention|Disease Progression|1|||
131920967|NCT02315625|474993692|FG001|First Intervention|Disease Progression|0|||
131920968|NCT02315625|474993691|FG000|Second Intervention|Physician Decision|2|||
131920969|NCT02315625|474993692|FG001|Second Intervention|Physician Decision|1|||
131920970|NCT02315625|474993691|FG000|Second Intervention|Study closure|1|||
131408389|NCT00907803|473118268|FG002|Overall Study|Adverse Event|0|||
131408390|NCT00907803|473118266|FG000|Overall Study|Withdrawal by Subject|0|||
131408391|NCT00907803|473118267|FG001|Overall Study|Withdrawal by Subject|1|||
131408392|NCT00907803|473118268|FG002|Overall Study|Withdrawal by Subject|0|||
131408393|NCT00907803|473118266|FG000|Overall Study|Lost to Follow-up|0|||
131408394|NCT00907803|473118267|FG001|Overall Study|Lost to Follow-up|1|||
131408395|NCT00907803|473118268|FG002|Overall Study|Lost to Follow-up|0|||
131920971|NCT02315625|474993692|FG001|Second Intervention|Study closure|0|||
131920972|NCT02315625|474993691|FG000|Second Intervention|Disease Progression|1|||
131920973|NCT02315625|474993692|FG001|Second Intervention|Disease Progression|0|||
131920974|NCT04069520|474993695|FG000|Overall Study|Lost to Follow-up|0|||
131920975|NCT04069520|474993696|FG001|Overall Study|Lost to Follow-up|2|||
131920976|NCT04069520|474993695|FG000|Overall Study|Withdrawal by Subject|0|||
131920977|NCT04069520|474993696|FG001|Overall Study|Withdrawal by Subject|1|||
131920978|NCT04069520|474993695|FG000|Overall Study|Prior Injury|1|||
131920979|NCT04069520|474993696|FG001|Overall Study|Prior Injury|0|||
131920980|NCT04069520|474993695|FG000|Overall Study|Orthodontia|1|||
131920981|NCT04069520|474993696|FG001|Overall Study|Orthodontia|0|||
131920982|NCT04069520|474993695|FG000|Overall Study|Cut from team|0|||
131920983|NCT04069520|474993696|FG001|Overall Study|Cut from team|2|||
131920984|NCT01068912|474993697|FG000|Overall Study|Adverse Event|2|||
131920985|NCT01068912|474993698|FG001|Overall Study|Adverse Event|3|||
131920986|NCT01068912|474993699|FG002|Overall Study|Adverse Event|2|||
131920987|NCT01068912|474993697|FG000|Overall Study|Withdrawal by Subject|5|||
131920988|NCT01068912|474993698|FG001|Overall Study|Withdrawal by Subject|6|||
131920989|NCT01068912|474993699|FG002|Overall Study|Withdrawal by Subject|6|||
131920990|NCT01068912|474993697|FG000|Overall Study|Lost to Follow-up|3|||
131920991|NCT01068912|474993698|FG001|Overall Study|Lost to Follow-up|7|||
131920992|NCT01068912|474993699|FG002|Overall Study|Lost to Follow-up|3|||
131920993|NCT01068912|474993697|FG000|Overall Study|Protocol Violation|0|||
131920994|NCT01068912|474993698|FG001|Overall Study|Protocol Violation|2|||
131920995|NCT01068912|474993699|FG002|Overall Study|Protocol Violation|0|||
131920996|NCT01068912|474993697|FG000|Overall Study|aggravation influenza|1|||
131920997|NCT01068912|474993698|FG001|Overall Study|aggravation influenza|1|||
131920998|NCT01068912|474993699|FG002|Overall Study|aggravation influenza|1|||
131920999|NCT01068912|474993697|FG000|Overall Study|other underlying illness|0|||
131921000|NCT01068912|474993698|FG001|Overall Study|other underlying illness|3|||
131921001|NCT01068912|474993699|FG002|Overall Study|other underlying illness|3|||
131921002|NCT01947933|474993701|FG000|Overall Study|Withdrawal by Subject|0|||
131921003|NCT01947933|474993702|FG001|Overall Study|Withdrawal by Subject|0|||
131921004|NCT01947933|474993703|FG002|Overall Study|Withdrawal by Subject|1|||
131921005|NCT01947933|474993704|FG003|Overall Study|Withdrawal by Subject|0|||
131921006|NCT01947933|474993705|FG004|Overall Study|Withdrawal by Subject|0|||
131921007|NCT01947933|474993706|FG005|Overall Study|Withdrawal by Subject|0|||
131921008|NCT01947933|474993707|FG006|Overall Study|Withdrawal by Subject|0|||
131921009|NCT01947933|474993708|FG007|Overall Study|Withdrawal by Subject|0|||
131921010|NCT01947933|474993709|FG008|Overall Study|Withdrawal by Subject|0|||
131921011|NCT01947933|474993701|FG000|Overall Study|Lost to Follow-up|0|||
131921012|NCT01947933|474993702|FG001|Overall Study|Lost to Follow-up|0|||
131921013|NCT01947933|474993703|FG002|Overall Study|Lost to Follow-up|0|||
131921014|NCT01947933|474993704|FG003|Overall Study|Lost to Follow-up|0|||
131921015|NCT01947933|474993705|FG004|Overall Study|Lost to Follow-up|0|||
131921016|NCT01947933|474993706|FG005|Overall Study|Lost to Follow-up|0|||
131921017|NCT01947933|474993707|FG006|Overall Study|Lost to Follow-up|0|||
131921018|NCT01947933|474993708|FG007|Overall Study|Lost to Follow-up|0|||
131921019|NCT01947933|474993709|FG008|Overall Study|Lost to Follow-up|1|||
131921020|NCT02965833|474993712|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
131921021|NCT02965833|474993713|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
131921022|NCT02965833|474993712|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
131921023|NCT02965833|474993713|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
131921024|NCT02965833|474993712|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
131921025|NCT02965833|474993713|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
131921026|NCT02965833|474993712|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
131921027|NCT02965833|474993713|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
131921028|NCT02965833|474993712|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
131921029|NCT02965833|474993713|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
131921030|NCT00118287|474993714|FG000|Overall Study|Intracranial haemorrhage|1|||
131921031|NCT00118287|474993714|FG000|Overall Study|Muscle pain|1|||
131921032|NCT03442569|474993715|FG000|Overall Study|Subject was ineligible after enrollment|1|||
131408396|NCT00907803|473118266|FG000|Overall Study|Protocol Violation|0|||
131408397|NCT00907803|473118267|FG001|Overall Study|Protocol Violation|1|||
131408398|NCT00907803|473118268|FG002|Overall Study|Protocol Violation|0|||
131408399|NCT03510468|473118269|FG000|Overall Study|Lost to Follow-up|1|||
131921033|NCT03770455|474993732|FG000|Overall Study|Screen failures|3|||
131921034|NCT01039675|474993735|FG000|Overall Study|Adverse Event|0|||
131921035|NCT01039675|474993736|FG001|Overall Study|Adverse Event|2|||
131921036|NCT01039675|474993735|FG000|Overall Study|Lack of Efficacy|0|||
131921037|NCT01039675|474993736|FG001|Overall Study|Lack of Efficacy|2|||
131921038|NCT01039675|474993735|FG000|Overall Study|Withdrawal by Subject|0|||
131921039|NCT01039675|474993736|FG001|Overall Study|Withdrawal by Subject|1|||
131921040|NCT01039675|474993735|FG000|Overall Study|Lost to Follow-up|0|||
131921041|NCT01039675|474993736|FG001|Overall Study|Lost to Follow-up|1|||
131921042|NCT01039675|474993735|FG000|Overall Study|Physician Decision|0|||
131408400|NCT03510468|473118269|FG000|Overall Study|Adverse Event|5|||
131408401|NCT03510468|473118269|FG000|Overall Study|Physician Decision|1|||
131408402|NCT03510468|473118269|FG000|Overall Study|non-compliant with treatment|2|||
131921043|NCT01039675|474993736|FG001|Overall Study|Physician Decision|1|||
131921044|NCT01112267|474994953|FG000|Overall Study|Adverse Event|24|||
131921045|NCT01112267|474994954|FG001|Overall Study|Adverse Event|6|||
131921046|NCT01112267|474994953|FG000|Overall Study|Withdrawal by Subject|3|||
131408403|NCT03510468|473118269|FG000|Overall Study|Missed visit|1|||
131921047|NCT01112267|474994954|FG001|Overall Study|Withdrawal by Subject|5|||
131921048|NCT01112267|474994953|FG000|Overall Study|Protocol Violation|5|||
131921049|NCT01112267|474994954|FG001|Overall Study|Protocol Violation|3|||
131921050|NCT01112267|474994953|FG000|Overall Study|Participants not compliant|1|||
131921051|NCT01112267|474994954|FG001|Overall Study|Participants not compliant|2|||
131921052|NCT01112267|474994953|FG000|Overall Study|Participants not receive any study drug|1|||
131921053|NCT01112267|474994954|FG001|Overall Study|Participants not receive any study drug|2|||
131408404|NCT04612842|473118270|FG000|Overall Study|Lost to Follow-up|20|||
131921054|NCT00420407|474994956|FG000|Overall Study|Lost to Follow-up|0|||
131921055|NCT00420407|474994957|FG001|Overall Study|Lost to Follow-up|3|||
131921056|NCT00420407|474994956|FG000|Overall Study|Physician Decision|2|||
131921057|NCT00420407|474994957|FG001|Overall Study|Physician Decision|1|||
131921058|NCT00420407|474994956|FG000|Overall Study|subject identified as detainee|1|||
131921059|NCT00420407|474994957|FG001|Overall Study|subject identified as detainee|0|||
131921060|NCT00420407|474994956|FG000|Overall Study|subject identified as Jehovah's witness|1|||
131921061|NCT00420407|474994957|FG001|Overall Study|subject identified as Jehovah's witness|0|||
131921062|NCT00420407|474994956|FG000|Overall Study|Withdrawal by Subject|0|||
131921063|NCT00420407|474994957|FG001|Overall Study|Withdrawal by Subject|2|||
131921064|NCT01807520|474994958|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
131921065|NCT01807520|474994959|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
131921066|NCT01807520|474994960|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
131921067|NCT01807520|474994961|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
131921068|NCT01807520|474994962|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
131921069|NCT01807520|474994963|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
131921070|NCT01807520|474994964|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
131921071|NCT01807520|474994958|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
131921072|NCT01807520|474994959|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
131921073|NCT01807520|474994960|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
131921074|NCT01807520|474994961|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
131921075|NCT01807520|474994962|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
131921076|NCT01807520|474994963|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
131921077|NCT01807520|474994964|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
131921078|NCT01807520|474994958|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
131921079|NCT01807520|474994959|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
131921080|NCT01807520|474994960|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
131921081|NCT01807520|474994961|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
131921082|NCT01807520|474994962|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
131921083|NCT01807520|474994963|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
131921084|NCT01807520|474994964|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
131921085|NCT01807520|474994958|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
131921086|NCT01807520|474994959|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
131921087|NCT01807520|474994960|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
131921088|NCT01807520|474994961|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
131921089|NCT01807520|474994962|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
131921090|NCT01807520|474994963|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
131921091|NCT01807520|474994964|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
131921092|NCT01807520|474994958|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
131921093|NCT01807520|474994959|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
131921094|NCT01807520|474994960|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
131921095|NCT01807520|474994961|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
131921096|NCT01807520|474994962|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
131921097|NCT01807520|474994963|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
131921098|NCT01807520|474994964|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
131921099|NCT01807520|474994958|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
131921100|NCT01807520|474994959|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
131921101|NCT01807520|474994960|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
131921102|NCT01807520|474994961|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
131921103|NCT01807520|474994962|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
131921104|NCT01807520|474994963|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
131921105|NCT01807520|474994964|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
131408405|NCT04612842|473118271|FG001|Overall Study|Lost to Follow-up|11|||
131921106|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
131921107|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
131921108|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
131921109|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
131921110|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
131921111|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
131921112|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
131921113|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
131921114|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
131921115|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
131921116|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
131408406|NCT04612842|473118270|FG000|Overall Study|Withdrawal by Subject|26|||
131408407|NCT04612842|473118271|FG001|Overall Study|Withdrawal by Subject|15|||
131408408|NCT04612842|473118270|FG000|Overall Study|Death|2|||
131921117|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
131921118|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
131408409|NCT04612842|473118271|FG001|Overall Study|Death|2|||
131408410|NCT02419131|473118272|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
131875545|NCT03214380|474824365|FG005|Treatment Period|Death|0|||
131875546|NCT03214380|474824360|FG000|Treatment Period|Lost to Follow-up|0|||
131875547|NCT03214380|474824361|FG001|Treatment Period|Lost to Follow-up|6|||
131875548|NCT03214380|474824362|FG002|Treatment Period|Lost to Follow-up|3|||
131875549|NCT03214380|474824363|FG003|Treatment Period|Lost to Follow-up|0|||
131875550|NCT03214380|474824364|FG004|Treatment Period|Lost to Follow-up|0|||
131875551|NCT03214380|474824365|FG005|Treatment Period|Lost to Follow-up|0|||
131875552|NCT03214380|474824360|FG000|Treatment Period|Participant schedule|0|||
131875553|NCT03214380|474824361|FG001|Treatment Period|Participant schedule|0|||
131875554|NCT03214380|474824362|FG002|Treatment Period|Participant schedule|1|||
131875555|NCT03214380|474824363|FG003|Treatment Period|Participant schedule|0|||
131875556|NCT03214380|474824364|FG004|Treatment Period|Participant schedule|0|||
131875557|NCT03214380|474824365|FG005|Treatment Period|Participant schedule|0|||
131875558|NCT03214380|474824360|FG000|Treatment Period|Treatment Interruption|0|||
131875559|NCT03214380|474824361|FG001|Treatment Period|Treatment Interruption|0|||
131875560|NCT03214380|474824362|FG002|Treatment Period|Treatment Interruption|1|||
131875561|NCT03214380|474824363|FG003|Treatment Period|Treatment Interruption|0|||
131875562|NCT03214380|474824364|FG004|Treatment Period|Treatment Interruption|0|||
131875563|NCT03214380|474824365|FG005|Treatment Period|Treatment Interruption|0|||
131875564|NCT01905553|474824372|FG000|Period 2|Adverse Event|1|||
131875565|NCT01905553|474824373|FG001|Period 2|Adverse Event|0|||
131875566|NCT01014988|474824386|FG000|Overall Study|Adverse Event|20|||
131875567|NCT01014988|474824387|FG001|Overall Study|Adverse Event|0|||
131875568|NCT01014988|474824388|FG002|Overall Study|Adverse Event|1|||
131875569|NCT01014988|474824389|FG003|Overall Study|Adverse Event|0|||
131875570|NCT01014988|474824390|FG004|Overall Study|Adverse Event|1|||
131875571|NCT01014988|474824391|FG005|Overall Study|Adverse Event|3|||
131875572|NCT01014988|474824386|FG000|Overall Study|Lost to Follow-up|1|||
131875573|NCT01014988|474824387|FG001|Overall Study|Lost to Follow-up|0|||
131875574|NCT01014988|474824388|FG002|Overall Study|Lost to Follow-up|1|||
131875575|NCT01014988|474824389|FG003|Overall Study|Lost to Follow-up|0|||
131875576|NCT01014988|474824390|FG004|Overall Study|Lost to Follow-up|0|||
131875577|NCT01014988|474824391|FG005|Overall Study|Lost to Follow-up|0|||
131875578|NCT01014988|474824386|FG000|Overall Study|Physician Decision|1|||
131875579|NCT01014988|474824387|FG001|Overall Study|Physician Decision|0|||
131875580|NCT01014988|474824388|FG002|Overall Study|Physician Decision|0|||
131875581|NCT01014988|474824389|FG003|Overall Study|Physician Decision|0|||
131875582|NCT01014988|474824390|FG004|Overall Study|Physician Decision|0|||
131875583|NCT01014988|474824391|FG005|Overall Study|Physician Decision|0|||
131875584|NCT01014988|474824386|FG000|Overall Study|Withdrawal by Subject|1|||
131875585|NCT01014988|474824387|FG001|Overall Study|Withdrawal by Subject|0|||
131875586|NCT01014988|474824388|FG002|Overall Study|Withdrawal by Subject|0|||
131875587|NCT01014988|474824389|FG003|Overall Study|Withdrawal by Subject|0|||
131875588|NCT01014988|474824390|FG004|Overall Study|Withdrawal by Subject|0|||
131875589|NCT01014988|474824391|FG005|Overall Study|Withdrawal by Subject|0|||
131875590|NCT01683266|474824394|FG000|Overall Study|Adverse Event|5|||
131875591|NCT01683266|474824395|FG001|Overall Study|Adverse Event|4|||
131875592|NCT01683266|474824394|FG000|Overall Study|Lack of Efficacy|5|||
131875593|NCT01683266|474824395|FG001|Overall Study|Lack of Efficacy|2|||
131875594|NCT01683266|474824394|FG000|Overall Study|Protocol Violation|13|||
131875595|NCT01683266|474824395|FG001|Overall Study|Protocol Violation|6|||
131875596|NCT01683266|474824394|FG000|Overall Study|Personal Reason|17|||
131875597|NCT01683266|474824395|FG001|Overall Study|Personal Reason|25|||
131875598|NCT01683266|474824394|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
131875599|NCT01683266|474824395|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
131875600|NCT01683266|474824394|FG000|Overall Study|Lost to Follow-up|5|||
131875601|NCT01683266|474824395|FG001|Overall Study|Lost to Follow-up|0|||
131875602|NCT01683266|474824394|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
131875603|NCT01683266|474824395|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
131875604|NCT01683266|474824394|FG000|Overall Study|Nonserious Hypoglycemia|0|||
131875605|NCT01683266|474824395|FG001|Overall Study|Nonserious Hypoglycemia|3|||
131875606|NCT01683266|474824394|FG000|Overall Study|Perceived Lack of Efficacy|1|||
131875607|NCT01683266|474824395|FG001|Overall Study|Perceived Lack of Efficacy|1|||
131453944|NCT01301027|473291842|FG000|Overall Study|Transplant|0|||
131875608|NCT01683266|474824394|FG000|Overall Study|Possibly Hypoglycemia|1|||
131875609|NCT01683266|474824395|FG001|Overall Study|Possibly Hypoglycemia|0|||
131875610|NCT01683266|474824394|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
131875611|NCT01683266|474824395|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
131875612|NCT00626821|474824403|FG000|Overall Study|Adverse Event|44|||
131875613|NCT00626821|474824403|FG000|Overall Study|Protocol Violation|33|||
131875614|NCT00626821|474824403|FG000|Overall Study|Withdrawal by Subject|10|||
131875615|NCT00626821|474824403|FG000|Overall Study|Physician Decision|9|||
131875616|NCT00626821|474824403|FG000|Overall Study|Product dysfunction|21|||
131875617|NCT00626821|474824403|FG000|Overall Study|other/unknown reason|104|||
131875618|NCT01867710|474824405|FG000|Overall Study|Death|25|||
131875619|NCT01867710|474824406|FG001|Overall Study|Death|15|||
131408411|NCT02419131|473118273|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
131408412|NCT02419131|473118274|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
131408413|NCT02419131|473118272|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
131408414|NCT02419131|473118273|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
131408415|NCT02419131|473118274|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
131408416|NCT05426031|473118275|FG000|Overall Study|Circulatory Arrest|3|||
131875620|NCT01867710|474824407|FG002|Overall Study|Death|27|||
131875621|NCT01867710|474824408|FG003|Overall Study|Death|20|||
131875622|NCT01867710|474824405|FG000|Overall Study|Lost to Follow-up|3|||
131875623|NCT01867710|474824406|FG001|Overall Study|Lost to Follow-up|4|||
131875624|NCT01867710|474824407|FG002|Overall Study|Lost to Follow-up|3|||
131875625|NCT01867710|474824408|FG003|Overall Study|Lost to Follow-up|2|||
131875626|NCT01867710|474824405|FG000|Overall Study|Withdrawal of consent|2|||
131875627|NCT01867710|474824406|FG001|Overall Study|Withdrawal of consent|5|||
131875628|NCT01867710|474824407|FG002|Overall Study|Withdrawal of consent|1|||
131875629|NCT01867710|474824408|FG003|Overall Study|Withdrawal of consent|2|||
131875630|NCT01867710|474824405|FG000|Overall Study|Study Terminated by Sponsor|9|||
131875631|NCT01867710|474824406|FG001|Overall Study|Study Terminated by Sponsor|13|||
131875632|NCT01867710|474824407|FG002|Overall Study|Study Terminated by Sponsor|8|||
131875633|NCT01867710|474824408|FG003|Overall Study|Study Terminated by Sponsor|16|||
131875634|NCT01867710|474824405|FG000|Overall Study|Biochemical progression|0|||
131875635|NCT01867710|474824406|FG001|Overall Study|Biochemical progression|1|||
131875636|NCT01867710|474824407|FG002|Overall Study|Biochemical progression|0|||
131875637|NCT01867710|474824408|FG003|Overall Study|Biochemical progression|0|||
131875638|NCT01867710|474824405|FG000|Overall Study|Clinical progression|0|||
131875639|NCT01867710|474824406|FG001|Overall Study|Clinical progression|0|||
131875640|NCT01867710|474824407|FG002|Overall Study|Clinical progression|1|||
131875641|NCT01867710|474824408|FG003|Overall Study|Clinical progression|0|||
131875642|NCT01867710|474824405|FG000|Overall Study|Disease progression|1|||
131875643|NCT01867710|474824406|FG001|Overall Study|Disease progression|0|||
131875644|NCT01867710|474824407|FG002|Overall Study|Disease progression|0|||
131875645|NCT01867710|474824408|FG003|Overall Study|Disease progression|0|||
131875646|NCT01867710|474824405|FG000|Overall Study|Patient decision|0|||
131875647|NCT01867710|474824406|FG001|Overall Study|Patient decision|0|||
131875648|NCT01867710|474824407|FG002|Overall Study|Patient decision|0|||
131875649|NCT01867710|474824408|FG003|Overall Study|Patient decision|1|||
131875650|NCT01867710|474824405|FG000|Overall Study|Patient to follow subsequent treatment|0|||
131875651|NCT01867710|474824406|FG001|Overall Study|Patient to follow subsequent treatment|1|||
131875652|NCT01867710|474824407|FG002|Overall Study|Patient to follow subsequent treatment|0|||
131875653|NCT01867710|474824408|FG003|Overall Study|Patient to follow subsequent treatment|0|||
131875654|NCT01867710|474824405|FG000|Overall Study|Progressive disease|1|||
131875655|NCT01867710|474824406|FG001|Overall Study|Progressive disease|0|||
131875656|NCT01867710|474824407|FG002|Overall Study|Progressive disease|0|||
131875657|NCT01867710|474824408|FG003|Overall Study|Progressive disease|0|||
131875658|NCT01867710|474824405|FG000|Overall Study|Protocol Violation|0|||
131875659|NCT01867710|474824406|FG001|Overall Study|Protocol Violation|0|||
131875660|NCT01867710|474824407|FG002|Overall Study|Protocol Violation|0|||
131875661|NCT01867710|474824408|FG003|Overall Study|Protocol Violation|1|||
131875662|NCT01867710|474824405|FG000|Overall Study|PSA-progression|0|||
131875663|NCT01867710|474824406|FG001|Overall Study|PSA-progression|1|||
131875664|NCT01867710|474824407|FG002|Overall Study|PSA-progression|0|||
131875665|NCT01867710|474824408|FG003|Overall Study|PSA-progression|0|||
131875666|NCT01867710|474824405|FG000|Overall Study|Study medication no longer effective|0|||
131875667|NCT01867710|474824406|FG001|Overall Study|Study medication no longer effective|1|||
131875668|NCT01867710|474824407|FG002|Overall Study|Study medication no longer effective|0|||
131875669|NCT01867710|474824408|FG003|Overall Study|Study medication no longer effective|0|||
131875670|NCT01062113|474824409|FG000|Overall Study|Adverse Event|1|||
131875671|NCT01062113|474824410|FG001|Overall Study|Adverse Event|0|||
131875672|NCT01062113|474824411|FG002|Overall Study|Adverse Event|0|||
131875673|NCT01062113|474824409|FG000|Overall Study|Lack of Efficacy|38|||
131875674|NCT01062113|474824410|FG001|Overall Study|Lack of Efficacy|22|||
131875675|NCT01062113|474824411|FG002|Overall Study|Lack of Efficacy|31|||
131875676|NCT01062113|474824409|FG000|Overall Study|Withdrawal by Subject|1|||
131875677|NCT01062113|474824410|FG001|Overall Study|Withdrawal by Subject|0|||
131875678|NCT01062113|474824411|FG002|Overall Study|Withdrawal by Subject|0|||
131875679|NCT01471340|474824412|FG000|Overall Study|Death|5|||
131875680|NCT01471340|474824413|FG001|Overall Study|Death|4|||
131875681|NCT01471340|474824412|FG000|Overall Study|Lost to Follow-up|0|||
131875682|NCT01471340|474824413|FG001|Overall Study|Lost to Follow-up|1|||
131875683|NCT01471340|474824412|FG000|Overall Study|Investigational site closure|0|||
131875684|NCT01471340|474824413|FG001|Overall Study|Investigational site closure|1|||
131875685|NCT01471340|474824412|FG000|Overall Study|Invalid informed consent|1|||
131875686|NCT01471340|474824413|FG001|Overall Study|Invalid informed consent|0|||
131875687|NCT00526669|474824416|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
131875688|NCT00526669|474824417|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
131875689|NCT00526669|474824416|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
131875690|NCT00526669|474824417|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
131875691|NCT00526669|474824416|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
131875692|NCT00526669|474824417|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
131875693|NCT00526669|474824416|FG000|Combined Treatment Phase|Death|0|||
131875694|NCT00526669|474824417|FG001|Combined Treatment Phase|Death|2|||
131875695|NCT03499899|474824420|FG000|Overall Study|Adverse Event|2|||
131875696|NCT03499899|474824421|FG001|Overall Study|Adverse Event|3|||
131875697|NCT03499899|474824422|FG002|Overall Study|Adverse Event|3|||
131875698|NCT03499899|474824420|FG000|Overall Study|Death|0|||
131875699|NCT03499899|474824421|FG001|Overall Study|Death|0|||
131875700|NCT03499899|474824422|FG002|Overall Study|Death|1|||
131875701|NCT03499899|474824420|FG000|Overall Study|Physician Decision|3|||
131875702|NCT03499899|474824421|FG001|Overall Study|Physician Decision|6|||
131875703|NCT03499899|474824422|FG002|Overall Study|Physician Decision|6|||
131875704|NCT03499899|474824420|FG000|Overall Study|Progressive disease|15|||
131875705|NCT03499899|474824421|FG001|Overall Study|Progressive disease|23|||
131875706|NCT03499899|474824422|FG002|Overall Study|Progressive disease|23|||
131875707|NCT03499899|474824420|FG000|Overall Study|Patient decision|0|||
131875708|NCT03499899|474824421|FG001|Overall Study|Patient decision|1|||
131875709|NCT03499899|474824422|FG002|Overall Study|Patient decision|1|||
131875710|NCT03499899|474824420|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
131875711|NCT03499899|474824421|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
131875712|NCT03499899|474824422|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
131875713|NCT01981954|474824427|FG000|Titration Period|Protocol Deviation|1|||
131875714|NCT01981954|474824427|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
131875715|NCT03655470|474824428|FG000|Overall Study|Lost to Follow-up|6|||
131875716|NCT03655470|474824429|FG001|Overall Study|Lost to Follow-up|7|||
131875717|NCT04590586|474824432|FG000|Overall Study|Death|7|||
131875718|NCT04590586|474824433|FG001|Overall Study|Death|1|||
131875719|NCT04590586|474824434|FG002|Overall Study|Death|37|||
131875720|NCT04590586|474824435|FG003|Overall Study|Death|34|||
131875721|NCT04590586|474824436|FG004|Overall Study|Death|19|||
131875722|NCT04590586|474824437|FG005|Overall Study|Death|3|||
131875723|NCT04590586|474824432|FG000|Overall Study|Lost to Follow-up|3|||
131875724|NCT04590586|474824433|FG001|Overall Study|Lost to Follow-up|0|||
131875725|NCT04590586|474824434|FG002|Overall Study|Lost to Follow-up|11|||
131875726|NCT04590586|474824435|FG003|Overall Study|Lost to Follow-up|11|||
131875727|NCT04590586|474824436|FG004|Overall Study|Lost to Follow-up|6|||
131875728|NCT04590586|474824437|FG005|Overall Study|Lost to Follow-up|0|||
131875729|NCT04590586|474824432|FG000|Overall Study|Withdrawal by Subject|0|||
131875730|NCT04590586|474824433|FG001|Overall Study|Withdrawal by Subject|0|||
131875731|NCT04590586|474824434|FG002|Overall Study|Withdrawal by Subject|6|||
131875732|NCT04590586|474824435|FG003|Overall Study|Withdrawal by Subject|0|||
131875733|NCT04590586|474824436|FG004|Overall Study|Withdrawal by Subject|3|||
131875734|NCT04590586|474824437|FG005|Overall Study|Withdrawal by Subject|0|||
131875735|NCT04590586|474824432|FG000|Overall Study|Other|3|||
131875736|NCT04590586|474824433|FG001|Overall Study|Other|0|||
131875737|NCT04590586|474824434|FG002|Overall Study|Other|1|||
131875738|NCT04590586|474824435|FG003|Overall Study|Other|1|||
131875739|NCT04590586|474824436|FG004|Overall Study|Other|2|||
131875740|NCT04590586|474824437|FG005|Overall Study|Other|1|||
131875741|NCT02218736|474824440|FG000|Overall Study|Withdrawal by Subject|10|||
131875742|NCT02218736|474824441|FG001|Overall Study|Withdrawal by Subject|9|||
131875743|NCT02218736|474824440|FG000|Overall Study|Protocol Violation|2|||
131875744|NCT02218736|474824441|FG001|Overall Study|Protocol Violation|0|||
131875745|NCT01082211|474824442|FG000|Overall Study|Protocol Violation|4|||
131875746|NCT01082211|474824442|FG000|Overall Study|No protocol treatment received|3|||
131875747|NCT04016779|474824457|FG000|Overall Study|Adverse Event|9|||
131875748|NCT04016779|474824458|FG001|Overall Study|Adverse Event|17|||
131875749|NCT04016779|474824457|FG000|Overall Study|Lack of Efficacy|4|||
131875750|NCT04016779|474824458|FG001|Overall Study|Lack of Efficacy|1|||
131875751|NCT04016779|474824457|FG000|Overall Study|Lost to Follow-up|5|||
131875752|NCT04016779|474824458|FG001|Overall Study|Lost to Follow-up|14|||
131875753|NCT04016779|474824457|FG000|Overall Study|Physician Decision|1|||
131875754|NCT04016779|474824458|FG001|Overall Study|Physician Decision|3|||
131875755|NCT04016779|474824457|FG000|Overall Study|Withdrawal by Subject|6|||
131875756|NCT04016779|474824458|FG001|Overall Study|Withdrawal by Subject|8|||
131875757|NCT04016779|474824457|FG000|Overall Study|Non-compliance with Study Drug|2|||
131875758|NCT04016779|474824458|FG001|Overall Study|Non-compliance with Study Drug|3|||
131875759|NCT04016779|474824457|FG000|Overall Study|Other, Multiple categories|17|||
131875760|NCT04016779|474824458|FG001|Overall Study|Other, Multiple categories|17|||
131875761|NCT02295020|474824459|FG000|Overall Study|Adverse Event|0|||
131875762|NCT02295020|474824460|FG001|Overall Study|Adverse Event|1|||
131875763|NCT02295020|474824459|FG000|Overall Study|Withdrawal by Subject|3|||
131875764|NCT02295020|474824460|FG001|Overall Study|Withdrawal by Subject|2|||
131875765|NCT06586788|474824463|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
131875766|NCT00679289|474824464|FG000|Overall Study|Progressive disease|4|||
131408417|NCT05426031|473118276|FG001|Overall Study|Circulatory Arrest|2|||
131408418|NCT04677660|473118277|FG000|Overall Study|Lost to Follow-up|0|||
131408419|NCT04677660|473118278|FG001|Overall Study|Lost to Follow-up|2|||
131408420|NCT04677660|473118277|FG000|Overall Study|Withdrawal by Subject|0|||
131408421|NCT04677660|473118278|FG001|Overall Study|Withdrawal by Subject|1|||
131408422|NCT04677660|473118277|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
131408423|NCT04677660|473118278|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
131408424|NCT03242772|473118279|FG000|Overall Study|Lost to Follow-up|2|||
131875767|NCT00679289|474824465|FG001|Overall Study|Progressive disease|5|||
131921119|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
131921120|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
131921121|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
131921122|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
131921123|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
131921124|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
131921125|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
131921126|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
131921127|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
131921128|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
131921129|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
131921130|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
131921131|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
131921132|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
131921133|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
131921134|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
131921135|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
131875768|NCT00679289|474824466|FG002|Overall Study|Progressive disease|18|||
131875769|NCT00679289|474824464|FG000|Overall Study|Withdrawal by Subject|0|||
131875770|NCT00679289|474824465|FG001|Overall Study|Withdrawal by Subject|1|||
131875771|NCT00679289|474824466|FG002|Overall Study|Withdrawal by Subject|1|||
131875772|NCT00679289|474824464|FG000|Overall Study|Adverse Event|0|||
131875773|NCT00679289|474824465|FG001|Overall Study|Adverse Event|0|||
131875774|NCT00679289|474824466|FG002|Overall Study|Adverse Event|3|||
131875775|NCT00679289|474824464|FG000|Overall Study|Physician Decision|1|||
131875776|NCT00679289|474824465|FG001|Overall Study|Physician Decision|0|||
131875777|NCT00679289|474824466|FG002|Overall Study|Physician Decision|1|||
131875778|NCT01053962|474824467|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
131875779|NCT01053962|474824468|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
131875780|NCT01053962|474824469|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
131875781|NCT01053962|474824470|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
131875782|NCT01053962|474824471|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
131875783|NCT01053962|474824467|FG000|Pretreatment Period|Venipuncture Failure|0|||
131875784|NCT01053962|474824468|FG001|Pretreatment Period|Venipuncture Failure|0|||
131875785|NCT01053962|474824469|FG002|Pretreatment Period|Venipuncture Failure|1|||
131875786|NCT01053962|474824470|FG003|Pretreatment Period|Venipuncture Failure|0|||
131875787|NCT01053962|474824471|FG004|Pretreatment Period|Venipuncture Failure|0|||
131875788|NCT01053962|474824467|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
131875789|NCT01053962|474824468|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
131875790|NCT01053962|474824469|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
131875791|NCT01053962|474824470|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
131875792|NCT01053962|474824471|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
131875793|NCT01053962|474824467|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
131875794|NCT01053962|474824468|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
131875795|NCT01053962|474824469|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
131875796|NCT01053962|474824470|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
131875797|NCT01053962|474824471|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
131875798|NCT01053962|474824467|FG000|Treatment Period|Lack of Efficacy|0|||
131875799|NCT01053962|474824468|FG001|Treatment Period|Lack of Efficacy|0|||
131875800|NCT01053962|474824469|FG002|Treatment Period|Lack of Efficacy|0|||
131408425|NCT03242772|473118280|FG001|Overall Study|Lost to Follow-up|0|||
131875801|NCT01053962|474824470|FG003|Treatment Period|Lack of Efficacy|0|||
131875802|NCT01053962|474824471|FG004|Treatment Period|Lack of Efficacy|1|||
131875803|NCT01053962|474824467|FG000|Treatment Period|Adverse Event|0|||
131875804|NCT01053962|474824468|FG001|Treatment Period|Adverse Event|0|||
131408426|NCT03242772|473118279|FG000|Overall Study|Physician Decision|0|||
131408427|NCT03242772|473118280|FG001|Overall Study|Physician Decision|1|||
131875805|NCT01053962|474824469|FG002|Treatment Period|Adverse Event|0|||
131875806|NCT01053962|474824470|FG003|Treatment Period|Adverse Event|0|||
131875807|NCT01053962|474824471|FG004|Treatment Period|Adverse Event|1|||
131875808|NCT01053962|474824467|FG000|Treatment Period|Withdrawal by Subject|0|||
131875809|NCT01053962|474824468|FG001|Treatment Period|Withdrawal by Subject|0|||
131875810|NCT01053962|474824469|FG002|Treatment Period|Withdrawal by Subject|0|||
131921136|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
131921137|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
131921138|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
131921139|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
131921140|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
131921141|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
131921142|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
131921143|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
131921144|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
131921145|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
131921146|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
131921147|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
131921148|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
131921149|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
131921150|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
131921151|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
131921152|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
131921153|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
131921154|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
131921155|NCT01807520|474994958|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
131921156|NCT01807520|474994959|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
131921157|NCT01807520|474994960|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
131921158|NCT01807520|474994961|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
131921159|NCT01807520|474994962|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
131921160|NCT01807520|474994963|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
131921161|NCT01807520|474994964|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
131921162|NCT01807520|474994958|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
131921163|NCT01807520|474994959|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
131921164|NCT01807520|474994960|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
131921165|NCT01807520|474994961|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
131921166|NCT01807520|474994962|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
131921167|NCT01807520|474994963|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
131921168|NCT01807520|474994964|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
131921169|NCT01807520|474994958|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
131921170|NCT01807520|474994959|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
131921171|NCT01807520|474994960|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
131921172|NCT01807520|474994961|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
131921173|NCT01807520|474994962|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
131921174|NCT01807520|474994963|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
131921175|NCT01807520|474994964|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
131921176|NCT01807520|474994958|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
131921177|NCT01807520|474994959|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
131921178|NCT01807520|474994960|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
131921179|NCT01807520|474994961|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
131921180|NCT01807520|474994962|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
131921181|NCT01807520|474994963|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
131921182|NCT01807520|474994964|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
131921183|NCT01797185|474994967|FG000|Overall Study|Adverse Event|5|||
131875811|NCT01053962|474824470|FG003|Treatment Period|Withdrawal by Subject|0|||
131875812|NCT01053962|474824471|FG004|Treatment Period|Withdrawal by Subject|1|||
131875813|NCT01053962|474824467|FG000|Treatment Period|Noncompliance with protocol|1|||
131875814|NCT01053962|474824468|FG001|Treatment Period|Noncompliance with protocol|0|||
131875815|NCT01053962|474824469|FG002|Treatment Period|Noncompliance with protocol|0|||
131875816|NCT01053962|474824470|FG003|Treatment Period|Noncompliance with protocol|0|||
131875817|NCT01053962|474824471|FG004|Treatment Period|Noncompliance with protocol|0|||
131875818|NCT00937040|474824472|FG000|Overall Study|Adverse Event|5|||
131875819|NCT00937040|474824473|FG001|Overall Study|Adverse Event|8|||
131875820|NCT00937040|474824472|FG000|Overall Study|Lost to Follow-up|12|||
131875821|NCT00937040|474824473|FG001|Overall Study|Lost to Follow-up|12|||
131921184|NCT01797185|474994968|FG001|Overall Study|Adverse Event|15|||
131921185|NCT01797185|474994969|FG002|Overall Study|Adverse Event|6|||
131921186|NCT01797185|474994967|FG000|Overall Study|Withdrawal by Subject|6|||
131921187|NCT01797185|474994968|FG001|Overall Study|Withdrawal by Subject|9|||
131921188|NCT01797185|474994969|FG002|Overall Study|Withdrawal by Subject|5|||
131875822|NCT00937040|474824472|FG000|Overall Study|Protocol Violation|3|||
131921189|NCT01797185|474994967|FG000|Overall Study|Site terminated|8|||
131875823|NCT00937040|474824473|FG001|Overall Study|Protocol Violation|0|||
131875824|NCT00937040|474824472|FG000|Overall Study|Withdrawal by Subject|13|||
131875825|NCT00937040|474824473|FG001|Overall Study|Withdrawal by Subject|7|||
131875826|NCT00937040|474824472|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
131921190|NCT01797185|474994968|FG001|Overall Study|Site terminated|4|||
131921191|NCT01797185|474994969|FG002|Overall Study|Site terminated|0|||
131921192|NCT01797185|474994967|FG000|Overall Study|Lost to Follow-up|2|||
131921193|NCT01797185|474994968|FG001|Overall Study|Lost to Follow-up|6|||
131921194|NCT01797185|474994969|FG002|Overall Study|Lost to Follow-up|1|||
131921195|NCT01797185|474994967|FG000|Overall Study|Withdrawn per sponsor|5|||
131921196|NCT01797185|474994968|FG001|Overall Study|Withdrawn per sponsor|0|||
131921197|NCT01797185|474994969|FG002|Overall Study|Withdrawn per sponsor|0|||
131921198|NCT01797185|474994967|FG000|Overall Study|Physician Decision|1|||
131921199|NCT01797185|474994968|FG001|Overall Study|Physician Decision|3|||
131921200|NCT01797185|474994969|FG002|Overall Study|Physician Decision|0|||
131408428|NCT03242772|473118279|FG000|Overall Study|Withdrawal by Subject|1|||
131408429|NCT03242772|473118280|FG001|Overall Study|Withdrawal by Subject|0|||
131408430|NCT00413920|473118301|FG000|Overall Study|Adverse Event|9|||
131408431|NCT00413920|473118302|FG001|Overall Study|Adverse Event|11|||
131408432|NCT00413920|473118301|FG000|Overall Study|Lack of Efficacy|11|||
131408433|NCT00413920|473118302|FG001|Overall Study|Lack of Efficacy|9|||
131408434|NCT00413920|473118301|FG000|Overall Study|Death|3|||
131408435|NCT00413920|473118302|FG001|Overall Study|Death|5|||
131408436|NCT00413920|473118301|FG000|Overall Study|Graft Loss|5|||
131408437|NCT00413920|473118302|FG001|Overall Study|Graft Loss|3|||
131408438|NCT01071200|473118303|FG000|Overall Study|Lack of ovarian response|1|||
131408439|NCT01071200|473118304|FG001|Overall Study|Lack of ovarian response|1|||
131408440|NCT01071200|473118303|FG000|Overall Study|No fertilization|4|||
131921201|NCT01797185|474994967|FG000|Overall Study|Protocol Violation|1|||
131921202|NCT01797185|474994968|FG001|Overall Study|Protocol Violation|1|||
131921203|NCT01797185|474994969|FG002|Overall Study|Protocol Violation|0|||
131921204|NCT02582632|474994975|FG000|Overall Study|Other|1|||
131921205|NCT03298061|474994976|FG000|Overall Study|Adverse Event|3|||
131921206|NCT03298061|474994976|FG000|Overall Study|Lack of Efficacy|6|||
131921207|NCT03298061|474994976|FG000|Overall Study|Protocol Violation|1|||
131921208|NCT03298061|474994976|FG000|Overall Study|Physician Decision|7|||
131921209|NCT03298061|474994976|FG000|Overall Study|Withdrawal by Subject|10|||
131921210|NCT01771913|474994979|FG000|Overall Study|Withdrawal by Subject|1|||
131921211|NCT01771913|474994980|FG001|Overall Study|Withdrawal by Subject|0|||
131921212|NCT00992836|474994984|FG000|Overall Study|Lost to Follow-up|1|||
131921213|NCT00992836|474994984|FG000|Overall Study|Withdrawal by Subject|2|||
131921214|NCT00992836|474994984|FG000|Overall Study|Protocol Violation|2|||
131921215|NCT01617967|474994985|FG000|Overall Study|Protocol Violation|0|||
131921216|NCT01617967|474994986|FG001|Overall Study|Protocol Violation|0|||
131921217|NCT01617967|474994987|FG002|Overall Study|Protocol Violation|0|||
131921218|NCT01617967|474994988|FG003|Overall Study|Protocol Violation|1|||
131921219|NCT01617967|474994989|FG004|Overall Study|Protocol Violation|0|||
131921220|NCT01617967|474994990|FG005|Overall Study|Protocol Violation|0|||
131921221|NCT01617967|474994985|FG000|Overall Study|Withdrawal by Subject|0|||
131921222|NCT01617967|474994986|FG001|Overall Study|Withdrawal by Subject|0|||
131921223|NCT01617967|474994987|FG002|Overall Study|Withdrawal by Subject|0|||
131921224|NCT01617967|474994988|FG003|Overall Study|Withdrawal by Subject|0|||
131921225|NCT01617967|474994989|FG004|Overall Study|Withdrawal by Subject|0|||
131921226|NCT01617967|474994990|FG005|Overall Study|Withdrawal by Subject|1|||
131921227|NCT01617967|474994985|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
131921228|NCT01617967|474994986|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
131921229|NCT01617967|474994987|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
131921230|NCT01617967|474994988|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
131921231|NCT01617967|474994989|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
131921232|NCT01617967|474994990|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
131921233|NCT05276804|474994997|FG000|Overall Study|screen failure|23|||
131921234|NCT05276804|474994998|FG001|Overall Study|screen failure|0|||
131921235|NCT02827708|474994999|FG000|Overall Study|Lost to Follow-up|3|||
131921236|NCT02827708|474995000|FG001|Overall Study|Lost to Follow-up|1|||
131921237|NCT02827708|474994999|FG000|Overall Study|Withdrawal by Subject|1|||
131408441|NCT01071200|473118304|FG001|Overall Study|No fertilization|0|||
131921238|NCT02827708|474995000|FG001|Overall Study|Withdrawal by Subject|2|||
131921239|NCT02827708|474994999|FG000|Overall Study|Death|1|||
131921240|NCT02827708|474995000|FG001|Overall Study|Death|2|||
131408442|NCT01071200|473118303|FG000|Overall Study|No oocytes retrieved|1|||
131921241|NCT00407511|474995001|FG000|Overall Study|Adverse Event|9|||
131921242|NCT00407511|474995001|FG000|Overall Study|Lost to Follow-up|4|||
131921243|NCT00407511|474995001|FG000|Overall Study|Other|5|||
131921244|NCT00407511|474995001|FG000|Overall Study|Withdrawal by Subject|4|||
131921245|NCT01137812|474995002|FG000|Overall Study|Adverse Event|21|||
131921246|NCT01137812|474995003|FG001|Overall Study|Adverse Event|14|||
131408443|NCT01071200|473118304|FG001|Overall Study|No oocytes retrieved|1|||
131408444|NCT01071200|473118303|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
131408445|NCT01071200|473118304|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
131921247|NCT01137812|474995002|FG000|Overall Study|Lost to Follow-up|6|||
131921248|NCT01137812|474995003|FG001|Overall Study|Lost to Follow-up|8|||
131408446|NCT01071200|473118303|FG000|Overall Study|No viable embryos|0|||
131921249|NCT01137812|474995002|FG000|Overall Study|Physician Decision|25|||
131921250|NCT01137812|474995003|FG001|Overall Study|Physician Decision|17|||
131921251|NCT01137812|474995002|FG000|Overall Study|Protocol Violation|5|||
131921252|NCT01137812|474995003|FG001|Overall Study|Protocol Violation|4|||
131921253|NCT01137812|474995002|FG000|Overall Study|Withdrawal by Subject|5|||
131921254|NCT01137812|474995003|FG001|Overall Study|Withdrawal by Subject|13|||
131921255|NCT01137812|474995002|FG000|Overall Study|Death|2|||
131921256|NCT01137812|474995003|FG001|Overall Study|Death|0|||
131921257|NCT01137812|474995002|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
131921258|NCT01137812|474995003|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
131921259|NCT01137812|474995002|FG000|Overall Study|Other|19|||
131921260|NCT01137812|474995003|FG001|Overall Study|Other|27|||
131921261|NCT02383173|474995007|FG000|Overall Study|Palliative Care Team withdrew|0|||
131921262|NCT02383173|474995008|FG001|Overall Study|Palliative Care Team withdrew|2|||
131921263|NCT04621760|474995009|FG000|Overall Study|Lost to Follow-up|2|||
131921264|NCT04621760|474995010|FG001|Overall Study|Lost to Follow-up|4|||
131921265|NCT04621760|474995009|FG000|Overall Study|Withdrawal by Subject|1|||
131921266|NCT04621760|474995010|FG001|Overall Study|Withdrawal by Subject|0|||
131921267|NCT01297244|474995011|FG000|Overall Study|Progressive disease|22|||
131921268|NCT01297244|474995012|FG001|Overall Study|Progressive disease|3|||
131921269|NCT01297244|474995011|FG000|Overall Study|Adverse Event|9|||
131921270|NCT01297244|474995012|FG001|Overall Study|Adverse Event|1|||
131921271|NCT01297244|474995011|FG000|Overall Study|Death|1|||
131921272|NCT01297244|474995012|FG001|Overall Study|Death|1|||
131921273|NCT01297244|474995011|FG000|Overall Study|Clinical progression|1|||
131921274|NCT01297244|474995012|FG001|Overall Study|Clinical progression|1|||
131921275|NCT01297244|474995011|FG000|Overall Study|Withdrawal by Subject|2|||
131921276|NCT01297244|474995012|FG001|Overall Study|Withdrawal by Subject|0|||
131921277|NCT01913470|474995016|FG000|Overall Study|Lost to Follow-up|0|||
131921278|NCT01913470|474995017|FG001|Overall Study|Lost to Follow-up|1|||
131921279|NCT01913470|474995016|FG000|Overall Study|Physician Decision|0|||
131921280|NCT01913470|474995017|FG001|Overall Study|Physician Decision|1|||
131921281|NCT01913470|474995016|FG000|Overall Study|Withdrawal by Subject|0|||
131921282|NCT01913470|474995017|FG001|Overall Study|Withdrawal by Subject|1|||
131921283|NCT02573467|474995018|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
131921284|NCT02573467|474995019|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
131921285|NCT02573467|474995020|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
131921286|NCT02573467|474995021|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
131921287|NCT02573467|474995018|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
131921288|NCT02573467|474995019|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
131921289|NCT02573467|474995020|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
131921290|NCT02573467|474995021|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
131921291|NCT02573467|474995018|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
131921292|NCT02573467|474995019|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
131921293|NCT02573467|474995020|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
131921294|NCT02573467|474995021|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
131921295|NCT02573467|474995018|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
131921296|NCT02573467|474995019|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
131921297|NCT02573467|474995020|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
131921298|NCT02573467|474995021|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
131921299|NCT02573467|474995018|FG000|Post-treatment Follow up Epoch|Death|1|||
131921300|NCT02573467|474995019|FG001|Post-treatment Follow up Epoch|Death|1|||
131921301|NCT02573467|474995020|FG002|Post-treatment Follow up Epoch|Death|0|||
131921302|NCT02573467|474995021|FG003|Post-treatment Follow up Epoch|Death|1|||
131921303|NCT02573467|474995018|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
131921304|NCT02573467|474995019|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
131921305|NCT02573467|474995020|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
131921306|NCT02573467|474995021|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
131921307|NCT02573467|474995018|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
131921308|NCT02573467|474995019|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
131921309|NCT02573467|474995020|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
131921310|NCT02573467|474995021|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
131921311|NCT00923702|474995023|FG000|Overall Study|Ongoing enrollment|0|||
131921312|NCT00923702|474995024|FG001|Overall Study|Ongoing enrollment|0|||
131921313|NCT00923702|474995025|FG002|Overall Study|Ongoing enrollment|0|||
131921314|NCT00923702|474995026|FG003|Overall Study|Ongoing enrollment|0|||
131921315|NCT00923702|474995027|FG004|Overall Study|Ongoing enrollment|354|||
131921316|NCT00195429|474995028|FG000|Overall Study|Adverse Event|2|||
131921317|NCT00195429|474995029|FG001|Overall Study|Adverse Event|4|||
131921318|NCT00195429|474995028|FG000|Overall Study|Lack of Efficacy|2|||
131921319|NCT00195429|474995029|FG001|Overall Study|Lack of Efficacy|1|||
131921320|NCT00195429|474995028|FG000|Overall Study|Lost to Follow-up|1|||
131408447|NCT01071200|473118304|FG001|Overall Study|No viable embryos|1|||
131921321|NCT00195429|474995029|FG001|Overall Study|Lost to Follow-up|0|||
131921322|NCT03925220|474995030|FG000|Overall Study|Withdrawal by Subject|4|||
131921323|NCT03925220|474995031|FG001|Overall Study|Withdrawal by Subject|4|||
131921324|NCT03925220|474995032|FG002|Overall Study|Withdrawal by Subject|4|||
131921325|NCT03925220|474995033|FG003|Overall Study|Withdrawal by Subject|4|||
131921326|NCT03925220|474995030|FG000|Overall Study|Lost to Follow-up|40|||
131921327|NCT03925220|474995031|FG001|Overall Study|Lost to Follow-up|46|||
131921328|NCT03925220|474995032|FG002|Overall Study|Lost to Follow-up|37|||
131921329|NCT03925220|474995033|FG003|Overall Study|Lost to Follow-up|38|||
131921330|NCT03325439|474995035|FG000|Overall Study|Ineligibility|3|||
131921331|NCT02112552|474995038|FG000|Overall Study|Withdrawal by Subject|1|||
131921332|NCT02112552|474995038|FG000|Overall Study|Adverse Event|1|||
131921333|NCT00774748|474995039|FG000|Overall Study|Lost to Follow-up|3|||
131921334|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
131921335|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
131921336|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
131921337|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Death|1|||
131921338|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Death|0|||
131921339|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Death|0|||
131921340|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
131921341|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
131921342|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
131921343|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
131921344|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
131921345|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
131921346|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
131921347|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
131921348|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
131921349|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
131921350|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
131921351|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
131921352|NCT05073315|474995041|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
131921353|NCT05073315|474995042|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
131921354|NCT05073315|474995043|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
131921355|NCT05073315|474995041|FG000|Period 2|Adverse Event|0|||
131921356|NCT05073315|474995042|FG001|Period 2|Adverse Event|3|||
131921357|NCT05073315|474995043|FG002|Period 2|Adverse Event|6|||
131921358|NCT05073315|474995041|FG000|Period 2|Lost to Follow-up|0|||
131921359|NCT05073315|474995042|FG001|Period 2|Lost to Follow-up|5|||
131921360|NCT05073315|474995043|FG002|Period 2|Lost to Follow-up|5|||
131921361|NCT05073315|474995041|FG000|Period 2|Withdrawal by Subject|0|||
131921362|NCT05073315|474995042|FG001|Period 2|Withdrawal by Subject|4|||
131921363|NCT05073315|474995043|FG002|Period 2|Withdrawal by Subject|9|||
131921364|NCT05073315|474995041|FG000|Period 2|Protocol Violation|0|||
131921365|NCT05073315|474995042|FG001|Period 2|Protocol Violation|0|||
131921366|NCT05073315|474995043|FG002|Period 2|Protocol Violation|1|||
131408448|NCT03730961|473118305|FG000|Overall Study|Adverse Event|0|||
131408449|NCT03730961|473118306|FG001|Overall Study|Adverse Event|1|||
131408450|NCT03158012|473118310|FG000|Overall Study|Withdrawal by Subject|0|||
131408451|NCT03158012|473118311|FG001|Overall Study|Withdrawal by Subject|1|||
131921367|NCT01529268|474995044|FG000|Overall Study|Lost to Follow-up|9|||
131921368|NCT01529268|474995045|FG001|Overall Study|Lost to Follow-up|3|||
131921369|NCT01529268|474995044|FG000|Overall Study|Moved|3|||
131921370|NCT01529268|474995045|FG001|Overall Study|Moved|0|||
131921371|NCT04465955|474995046|FG000|Overall Study|Withdrew consent|6|||
131921372|NCT04465955|474995047|FG001|Overall Study|Withdrew consent|10|||
131921373|NCT04465955|474995048|FG002|Overall Study|Withdrew consent|7|||
131921374|NCT04465955|474995046|FG000|Overall Study|Adverse Event|6|||
131921375|NCT04465955|474995047|FG001|Overall Study|Adverse Event|5|||
131921376|NCT04465955|474995048|FG002|Overall Study|Adverse Event|1|||
131921377|NCT04465955|474995046|FG000|Overall Study|Lost to Follow-up|2|||
131921378|NCT04465955|474995047|FG001|Overall Study|Lost to Follow-up|0|||
131921379|NCT04465955|474995048|FG002|Overall Study|Lost to Follow-up|3|||
131408452|NCT01338610|473118312|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
131408453|NCT01338610|473118313|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
131408454|NCT01338610|473118314|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
131921380|NCT04465955|474995046|FG000|Overall Study|Other|1|||
131921381|NCT04465955|474995047|FG001|Overall Study|Other|1|||
131921382|NCT04465955|474995048|FG002|Overall Study|Other|3|||
131921383|NCT00294398|474995054|FG000|Overall Study|Lost to Follow-up|21|||
131921384|NCT00294398|474995055|FG001|Overall Study|Lost to Follow-up|26|||
131921385|NCT03407482|474995059|FG000|Overall Study|Adverse Event|12|||
131408455|NCT01338610|473118312|FG000|Overall Study|Protocol Violation|1|||
131921386|NCT03407482|474995059|FG000|Overall Study|Disease Relapse|1|||
131408456|NCT01338610|473118313|FG001|Overall Study|Protocol Violation|0|||
131921387|NCT03407482|474995059|FG000|Overall Study|Lost to Follow-up|1|||
131921388|NCT03407482|474995059|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131921389|NCT03407482|474995059|FG000|Overall Study|Pregnancy|2|||
131921390|NCT03407482|474995059|FG000|Overall Study|Protocol Violation|1|||
131921391|NCT03407482|474995059|FG000|Overall Study|Study Terminated By Sponsor|106|||
131921392|NCT03407482|474995059|FG000|Overall Study|Withdrawal by Subject|6|||
131921393|NCT03407482|474995059|FG000|Overall Study|Data Entry Error|1|||
131921394|NCT05089357|474995062|FG000|Overall Study|Withdrawal by Subject|23|||
131921395|NCT05089357|474995062|FG000|Overall Study|Lost to Follow-up|6|||
131921396|NCT05089357|474995062|FG000|Overall Study|Medical reason|1|||
131921397|NCT05089357|474995062|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
131921398|NCT05089357|474995062|FG000|Overall Study|Pregnancy|2|||
131921399|NCT05537571|474995063|FG000|Overall Study|Withdrawal by Subject|1|||
131921400|NCT05537571|474995064|FG001|Overall Study|Withdrawal by Subject|1|||
131921401|NCT05537571|474995065|FG002|Overall Study|Withdrawal by Subject|0|||
131921402|NCT05537571|474995066|FG003|Overall Study|Withdrawal by Subject|0|||
131921403|NCT05537571|474995067|FG004|Overall Study|Withdrawal by Subject|0|||
131921404|NCT05537571|474995063|FG000|Overall Study|Adverse Event|2|||
131921405|NCT05537571|474995064|FG001|Overall Study|Adverse Event|0|||
131921406|NCT05537571|474995065|FG002|Overall Study|Adverse Event|0|||
131921407|NCT05537571|474995066|FG003|Overall Study|Adverse Event|0|||
131921408|NCT05537571|474995067|FG004|Overall Study|Adverse Event|0|||
131921409|NCT05537571|474995063|FG000|Overall Study|Hepatitis A screening result|2|||
131921410|NCT05537571|474995064|FG001|Overall Study|Hepatitis A screening result|0|||
131921411|NCT05537571|474995065|FG002|Overall Study|Hepatitis A screening result|0|||
131921412|NCT05537571|474995066|FG003|Overall Study|Hepatitis A screening result|0|||
131921413|NCT05537571|474995067|FG004|Overall Study|Hepatitis A screening result|0|||
131921414|NCT05537571|474995063|FG000|Overall Study|Lost to Follow-up|0|||
131921415|NCT05537571|474995064|FG001|Overall Study|Lost to Follow-up|0|||
131921416|NCT05537571|474995065|FG002|Overall Study|Lost to Follow-up|1|||
131921417|NCT05537571|474995066|FG003|Overall Study|Lost to Follow-up|0|||
131921418|NCT05537571|474995067|FG004|Overall Study|Lost to Follow-up|1|||
131921419|NCT05752487|474995068|FG000|Overall Study|Enrolled, not treated|9|||
131921420|NCT05752487|474995068|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
131921421|NCT05752487|474995068|FG000|Overall Study|Withdrawal by Subject|2|||
131921422|NCT03091439|474995069|FG000|Overall Study|Study Terminated by the Sponsor|1|||
131921423|NCT03091439|474995070|FG001|Overall Study|Study Terminated by the Sponsor|0|||
131921424|NCT01685437|474995072|FG000|Overall Study|Withdrawal by Subject|22|||
131921425|NCT01685437|474995072|FG000|Overall Study|Lost to Follow-up|3|||
131921426|NCT01685437|474995072|FG000|Overall Study|Adverse Event|1|||
131921427|NCT01685437|474995072|FG000|Overall Study|Protocol Violation|4|||
131921428|NCT01685437|474995072|FG000|Overall Study|Unable to make visits due to work|1|||
131921429|NCT01214720|474995073|FG000|Overall Study|Alive and still on treatment|34|||
131921430|NCT01214720|474995074|FG001|Overall Study|Alive and still on treatment|18|||
131921431|NCT01214720|474995073|FG000|Overall Study|Alive and in follow-up|45|||
131921432|NCT01214720|474995074|FG001|Overall Study|Alive and in follow-up|48|||
131921433|NCT01214720|474995073|FG000|Overall Study|Lost to Follow-up|6|||
131921434|NCT01214720|474995074|FG001|Overall Study|Lost to Follow-up|2|||
131921435|NCT02347787|474995075|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
131921436|NCT02347787|474995076|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
131921437|NCT02347787|474995075|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
131921438|NCT02347787|474995076|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
131921439|NCT02347787|474995075|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
131921440|NCT02347787|474995076|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
131921441|NCT02347787|474995075|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
131921442|NCT02347787|474995076|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
131921443|NCT03921541|474996963|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
131921444|NCT03921541|474996964|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
131921445|NCT02642679|474996965|FG000|Overall Study|Withdrawal by Subject|1|||
131921446|NCT02642679|474996965|FG000|Overall Study|Physician Decision|1|||
131408457|NCT01338610|473118314|FG002|Overall Study|Protocol Violation|1|||
131408458|NCT01338610|473118312|FG000|Overall Study|Adverse Event|3|||
131408459|NCT01338610|473118313|FG001|Overall Study|Adverse Event|0|||
131408460|NCT01338610|473118314|FG002|Overall Study|Adverse Event|0|||
131408461|NCT01414205|473118315|FG000|Overall Study|Death|5|||
131408462|NCT01414205|473118316|FG001|Overall Study|Death|1|||
131408463|NCT01414205|473118315|FG000|Overall Study|Lost to Follow-up|1|||
131408464|NCT01414205|473118316|FG001|Overall Study|Lost to Follow-up|4|||
131921447|NCT02642679|474996965|FG000|Overall Study|Physician Decision|1|||
131921448|NCT01653262|474996966|FG000|Overall Study|Lack of Efficacy|1|||
131921449|NCT01653262|474996966|FG000|Overall Study|SAE, non-fatal|1|||
131921450|NCT01653262|474996966|FG000|Overall Study|AE, non-serious non-fatal|1|||
131921451|NCT05638737|474996970|FG000|Overall Study|Withdrawal by Subject|4|||
131921452|NCT05638737|474996971|FG001|Overall Study|Withdrawal by Subject|7|||
131921453|NCT04633447|474996974|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
131921454|NCT04633447|474996975|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
131921455|NCT04633447|474996974|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
131921456|NCT04633447|474996975|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
131921457|NCT04633447|474996974|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
131408465|NCT01414205|473118315|FG000|Overall Study|Physician Decision|0|||
131408466|NCT01414205|473118316|FG001|Overall Study|Physician Decision|1|||
131921458|NCT04633447|474996975|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
131921459|NCT04633447|474996974|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
131921460|NCT04633447|474996975|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
131921461|NCT04633447|474996974|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
131921462|NCT04633447|474996975|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
131921463|NCT04633447|474996974|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
131921464|NCT04633447|474996975|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
131921465|NCT03641924|474996976|FG000|Overall Study|Withdrawal by Subject|26|||
131921466|NCT03641924|474996976|FG000|Overall Study|Lost to Follow-up|16|||
131921467|NCT03641924|474996976|FG000|Overall Study|Protocol Violation|10|||
131921468|NCT04333498|474996977|FG000|Overall Study|Lost to Follow-up|1|||
131921469|NCT04333498|474996978|FG001|Overall Study|Lost to Follow-up|0|||
131921470|NCT04333498|474996977|FG000|Overall Study|Lost to Follow-up|0|||
131921471|NCT04333498|474996978|FG001|Overall Study|Lost to Follow-up|1|||
131921472|NCT01565694|474996979|FG000|Dose-Titration Period|Adverse Event|4|||
131921473|NCT01565694|474996979|FG000|Dose-Titration Period|Protocol Violation|10|||
131921474|NCT01565694|474996979|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
131921475|NCT00134719|474996986|FG000|Primary Vaccination Phase|Adverse Event|4|||
131921476|NCT00134719|474996987|FG001|Primary Vaccination Phase|Adverse Event|0|||
131921477|NCT00134719|474996988|FG002|Primary Vaccination Phase|Adverse Event|0|||
131921478|NCT00134719|474996986|FG000|Primary Vaccination Phase|Protocol Violation|1|||
131921479|NCT00134719|474996987|FG001|Primary Vaccination Phase|Protocol Violation|0|||
131921480|NCT00134719|474996988|FG002|Primary Vaccination Phase|Protocol Violation|0|||
131921481|NCT00134719|474996986|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
131921482|NCT00134719|474996987|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
131921483|NCT00134719|474996988|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
131921484|NCT00134719|474996986|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
131921485|NCT00134719|474996987|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
131921486|NCT00134719|474996988|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
131921487|NCT00134719|474996986|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
131921488|NCT00134719|474996987|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
131921489|NCT00134719|474996988|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
131921490|NCT00134719|474996986|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
131921491|NCT00134719|474996987|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
131921492|NCT00134719|474996988|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
131921493|NCT00541229|474996989|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
131921494|NCT00541229|474996990|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
131921495|NCT00541229|474996991|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
131921496|NCT00541229|474996992|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
131921497|NCT00541229|474996993|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
131921498|NCT00541229|474996994|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
131921499|NCT00541229|474996989|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
131921500|NCT00541229|474996990|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
131921501|NCT00541229|474996991|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
131921502|NCT00541229|474996992|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
131921503|NCT00541229|474996993|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
131921504|NCT00541229|474996994|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
131921505|NCT00541229|474996989|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
131921506|NCT00541229|474996990|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
131921507|NCT00541229|474996991|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
131921508|NCT00541229|474996992|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
131453945|NCT01301027|473291843|FG001|Overall Study|Transplant|2|||
131453946|NCT01301027|473291842|FG000|Overall Study|Volume Overload|3|||
131921509|NCT00541229|474996993|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
131921510|NCT00541229|474996994|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
131921511|NCT00541229|474996989|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
131921512|NCT00541229|474996990|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
131921513|NCT00541229|474996991|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
131921514|NCT00541229|474996992|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
131921515|NCT00541229|474996993|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
131921516|NCT00541229|474996994|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
131921517|NCT00541229|474996989|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
131921518|NCT00541229|474996990|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
131921519|NCT00541229|474996991|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
131921520|NCT00541229|474996992|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
131921521|NCT00541229|474996993|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
131921522|NCT00541229|474996994|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
131921523|NCT00541229|474996989|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
131921524|NCT00541229|474996990|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
131453947|NCT01301027|473291843|FG001|Overall Study|Volume Overload|0|||
131921525|NCT00541229|474996991|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
131921526|NCT00541229|474996992|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
131921527|NCT00541229|474996993|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
131921528|NCT00541229|474996994|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
131921529|NCT00541229|474996989|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
131921530|NCT00541229|474996990|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
131921531|NCT00541229|474996991|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
131921532|NCT00541229|474996992|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
131921533|NCT00541229|474996993|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
131921534|NCT00541229|474996994|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
131921535|NCT00541229|474996989|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
131921536|NCT00541229|474996990|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
131921537|NCT00541229|474996991|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
131921538|NCT00541229|474996992|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
131921539|NCT00541229|474996993|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
131921540|NCT00541229|474996994|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
131921541|NCT00541229|474996989|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
131921542|NCT00541229|474996990|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
131921543|NCT00541229|474996991|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
131921544|NCT00541229|474996992|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
131921545|NCT00541229|474996993|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
131921546|NCT00541229|474996994|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
131921547|NCT00541229|474996989|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
131921548|NCT00541229|474996990|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
131921549|NCT00541229|474996991|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
131921550|NCT00541229|474996992|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
131921551|NCT00541229|474996993|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
131921552|NCT00541229|474996994|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
131921553|NCT00541229|474996989|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
131921554|NCT00541229|474996990|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
131921555|NCT00541229|474996991|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
131921556|NCT00541229|474996992|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
131921557|NCT00541229|474996993|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
131921558|NCT00541229|474996994|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
131921559|NCT00541229|474996989|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
131921560|NCT00541229|474996990|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
131921561|NCT00541229|474996991|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
131921562|NCT00541229|474996992|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
131921563|NCT00541229|474996993|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
131921564|NCT00541229|474996994|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
131921565|NCT00541229|474996989|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
131921566|NCT00541229|474996990|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
131921567|NCT00541229|474996991|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
131921568|NCT00541229|474996992|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
131921569|NCT00541229|474996993|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
131921570|NCT00541229|474996994|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
131921571|NCT00541229|474996989|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
131921572|NCT00541229|474996990|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
131921573|NCT00541229|474996991|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
131921574|NCT00541229|474996992|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
131921575|NCT00541229|474996993|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
131921576|NCT00541229|474996994|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
131921577|NCT00541229|474996989|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
131921578|NCT00541229|474996990|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
131921579|NCT00541229|474996991|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
131921580|NCT00541229|474996992|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
131921581|NCT00541229|474996993|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
131921582|NCT00541229|474996994|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
131921583|NCT00541229|474996989|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
131921584|NCT00541229|474996990|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
131921585|NCT00541229|474996991|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
131921586|NCT00541229|474996992|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
131921587|NCT00541229|474996993|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
131921588|NCT00541229|474996994|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
131921589|NCT03439839|474996995|FG000|Overall Study|Death|3|||
131921590|NCT03439839|474996996|FG001|Overall Study|Death|0|||
131921591|NCT00723944|474997002|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
131875827|NCT00937040|474824473|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
131875828|NCT00937040|474824472|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
131875829|NCT00937040|474824473|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
131875830|NCT00638443|474824474|FG000|First Intervention|Adverse Event|2|||
131875831|NCT00638443|474824475|FG001|First Intervention|Adverse Event|1|||
131875832|NCT00179673|474824477|FG000|Overall Study|Adverse Event|7|||
131875833|NCT00179673|474824477|FG000|Overall Study|Lack of Efficacy|15|||
131875834|NCT00179673|474824477|FG000|Overall Study|Withdrawal by Subject|3|||
131875835|NCT00179673|474824477|FG000|Overall Study|Death|4|||
131875836|NCT00179673|474824477|FG000|Overall Study|Other Observations and options|14|||
131875837|NCT01435460|474824478|FG000|Overall Study|Adverse Event|2|||
131875838|NCT01435460|474824479|FG001|Overall Study|Adverse Event|1|||
131875839|NCT01435460|474824478|FG000|Overall Study|Lost to Follow-up|6|||
131875840|NCT01435460|474824479|FG001|Overall Study|Lost to Follow-up|1|||
131875841|NCT01435460|474824478|FG000|Overall Study|Withdrawal by Subject|1|||
131875842|NCT01435460|474824479|FG001|Overall Study|Withdrawal by Subject|3|||
131875843|NCT01435460|474824478|FG000|Overall Study|Protocol Violation|0|||
131875844|NCT01435460|474824479|FG001|Overall Study|Protocol Violation|1|||
131875845|NCT01435460|474824478|FG000|Overall Study|Did not meet eligibility criteria|2|||
131875846|NCT01435460|474824479|FG001|Overall Study|Did not meet eligibility criteria|0|||
131875847|NCT04152837|474824482|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
131875848|NCT04152837|474824482|FG000|Maintenance Period|Adverse Event|1|||
131875849|NCT04152837|474824482|FG000|Maintenance Period|Withdrawal by Subject|1|||
131875850|NCT04152837|474824482|FG000|Maintenance Period|Sponsor Termination of Study|2|||
131875851|NCT01217476|474824483|FG000|Overall Study|Adverse Event|6|||
131875852|NCT01217476|474824484|FG001|Overall Study|Adverse Event|1|||
131875853|NCT01217476|474824483|FG000|Overall Study|Physician Decision|0|||
131875854|NCT01217476|474824484|FG001|Overall Study|Physician Decision|1|||
131875855|NCT01217476|474824483|FG000|Overall Study|Withdrawal by Subject|3|||
131875856|NCT01217476|474824484|FG001|Overall Study|Withdrawal by Subject|3|||
131875857|NCT01217476|474824483|FG000|Overall Study|Surgery on the Target Limb|0|||
131875858|NCT01217476|474824484|FG001|Overall Study|Surgery on the Target Limb|2|||
131875859|NCT01217476|474824483|FG000|Overall Study|Protocol Deviation|1|||
131875860|NCT01217476|474824484|FG001|Overall Study|Protocol Deviation|0|||
131875861|NCT01217476|474824483|FG000|Overall Study|Other|2|||
131875862|NCT01217476|474824484|FG001|Overall Study|Other|0|||
131875863|NCT03033602|474824485|FG000|Overall Study|Withdrawal by Subject|11|||
131875864|NCT03033602|474824486|FG001|Overall Study|Withdrawal by Subject|21|||
131875865|NCT03033602|474824485|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
131875866|NCT03033602|474824486|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
131875867|NCT01283334|474826419|FG000|Overall Study|Withdrawal by Subject|1|||
131875868|NCT01283334|474826419|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
131875869|NCT01283334|474826419|FG000|Overall Study|Adverse Event|4|||
131875870|NCT01283334|474826419|FG000|Overall Study|Physician Decision|1|||
131875871|NCT03467217|474826420|FG000|Overall Study|Trial stopped early|5|||
131875872|NCT03467217|474826421|FG001|Overall Study|Trial stopped early|2|||
131875873|NCT03467217|474826420|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
131875874|NCT03467217|474826421|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
131875875|NCT03467217|474826420|FG000|Overall Study|Lost to Follow-up|0|||
131875876|NCT03467217|474826421|FG001|Overall Study|Lost to Follow-up|2|||
131875877|NCT00972816|474826422|FG000|Overall Study|Adverse Event|0|||
131875878|NCT00972816|474826423|FG001|Overall Study|Adverse Event|0|||
131875879|NCT00972816|474826424|FG002|Overall Study|Adverse Event|1|||
131875880|NCT00972816|474826425|FG003|Overall Study|Adverse Event|0|||
131875881|NCT00972816|474826426|FG004|Overall Study|Adverse Event|0|||
131875882|NCT00972816|474826427|FG005|Overall Study|Adverse Event|0|||
131875883|NCT00972816|474826428|FG006|Overall Study|Adverse Event|0|||
131875884|NCT00972816|474826429|FG007|Overall Study|Adverse Event|0|||
131875885|NCT00972816|474826422|FG000|Overall Study|Withdrawal by Subject|4|||
131875886|NCT00972816|474826423|FG001|Overall Study|Withdrawal by Subject|2|||
131875887|NCT00972816|474826424|FG002|Overall Study|Withdrawal by Subject|1|||
131875888|NCT00972816|474826425|FG003|Overall Study|Withdrawal by Subject|3|||
131875889|NCT00972816|474826426|FG004|Overall Study|Withdrawal by Subject|0|||
131453948|NCT02023697|473291844|FG000|Treatment Period|Radiological progression|13|||
131875890|NCT00972816|474826427|FG005|Overall Study|Withdrawal by Subject|1|||
131875891|NCT00972816|474826428|FG006|Overall Study|Withdrawal by Subject|1|||
131875892|NCT00972816|474826429|FG007|Overall Study|Withdrawal by Subject|2|||
131875893|NCT00972816|474826422|FG000|Overall Study|Lost to Follow-up|11|||
131875894|NCT00972816|474826423|FG001|Overall Study|Lost to Follow-up|9|||
131875895|NCT00972816|474826424|FG002|Overall Study|Lost to Follow-up|7|||
131875896|NCT00972816|474826425|FG003|Overall Study|Lost to Follow-up|5|||
131875897|NCT00972816|474826426|FG004|Overall Study|Lost to Follow-up|11|||
131875898|NCT00972816|474826427|FG005|Overall Study|Lost to Follow-up|10|||
131875899|NCT00972816|474826428|FG006|Overall Study|Lost to Follow-up|7|||
131875900|NCT00972816|474826429|FG007|Overall Study|Lost to Follow-up|7|||
131875901|NCT00972816|474826422|FG000|Overall Study|Inappropriate enrolment|0|||
131875902|NCT00972816|474826423|FG001|Overall Study|Inappropriate enrolment|0|||
131921592|NCT00723944|474997003|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
131921593|NCT00723944|474997002|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
131921594|NCT00723944|474997003|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
131921595|NCT00723944|474997002|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
131921596|NCT00723944|474997003|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
131921597|NCT05177094|474997004|FG000|Overall Study|Adverse Event|5|||
131921598|NCT05177094|474997005|FG001|Overall Study|Adverse Event|5|||
131921599|NCT05177094|474997004|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
131921600|NCT05177094|474997005|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
131408467|NCT01414205|473118315|FG000|Overall Study|Randomized but not Treated|1|||
131408468|NCT01414205|473118316|FG001|Overall Study|Randomized but not Treated|1|||
131408469|NCT01095653|473118317|FG000|Overall Study|Lack of Efficacy|3|||
131408470|NCT01095653|473118318|FG001|Overall Study|Lack of Efficacy|0|||
131408471|NCT01095653|473118319|FG002|Overall Study|Lack of Efficacy|0|||
131408472|NCT01095653|473118317|FG000|Overall Study|Adverse Event|1|||
131408473|NCT01095653|473118318|FG001|Overall Study|Adverse Event|4|||
131408474|NCT01095653|473118319|FG002|Overall Study|Adverse Event|4|||
131921601|NCT05177094|474997004|FG000|Overall Study|Protocol Deviation|3|||
131921602|NCT05177094|474997005|FG001|Overall Study|Protocol Deviation|0|||
131921603|NCT05177094|474997004|FG000|Overall Study|Withdrawal by Subject|6|||
131921604|NCT05177094|474997005|FG001|Overall Study|Withdrawal by Subject|3|||
131921605|NCT05177094|474997004|FG000|Overall Study|Participant could not tolerate long study visits|1|||
131921606|NCT05177094|474997005|FG001|Overall Study|Participant could not tolerate long study visits|0|||
131921607|NCT03520569|474997006|FG000|Overall Study|Withdrawal by Subject|1|||
131921608|NCT03677401|474997007|FG000|Overall Study|Adverse Event|4|||
131921609|NCT03677401|474997008|FG001|Overall Study|Adverse Event|14|||
131921610|NCT03677401|474997007|FG000|Overall Study|Lack of Efficacy|3|||
131921611|NCT03677401|474997008|FG001|Overall Study|Lack of Efficacy|1|||
131921612|NCT03677401|474997007|FG000|Overall Study|Withdrawal by Subject|2|||
131921613|NCT03677401|474997008|FG001|Overall Study|Withdrawal by Subject|2|||
131921614|NCT03677401|474997007|FG000|Overall Study|Sponsor decision|0|||
131921615|NCT03677401|474997008|FG001|Overall Study|Sponsor decision|1|||
131921616|NCT03677401|474997007|FG000|Overall Study|Reason Unspecified|1|||
131921617|NCT03677401|474997008|FG001|Overall Study|Reason Unspecified|0|||
131921618|NCT04602000|474997009|FG000|Overall Study|Withdrawal by Subject|3|||
131921619|NCT04602000|474997010|FG001|Overall Study|Withdrawal by Subject|6|||
131921620|NCT04602000|474997011|FG002|Overall Study|Withdrawal by Subject|3|||
131921621|NCT04602000|474997012|FG003|Overall Study|Withdrawal by Subject|27|||
131921622|NCT04602000|474997013|FG004|Overall Study|Withdrawal by Subject|39|||
131921623|NCT04602000|474997009|FG000|Overall Study|Physician Decision|1|||
131921624|NCT04602000|474997010|FG001|Overall Study|Physician Decision|0|||
131921625|NCT04602000|474997011|FG002|Overall Study|Physician Decision|0|||
131921626|NCT04602000|474997012|FG003|Overall Study|Physician Decision|2|||
131921627|NCT04602000|474997013|FG004|Overall Study|Physician Decision|2|||
131921628|NCT04602000|474997009|FG000|Overall Study|Death|0|||
131921629|NCT04602000|474997010|FG001|Overall Study|Death|1|||
131921630|NCT04602000|474997011|FG002|Overall Study|Death|0|||
131921631|NCT04602000|474997012|FG003|Overall Study|Death|1|||
131921632|NCT04602000|474997013|FG004|Overall Study|Death|2|||
131921633|NCT04602000|474997009|FG000|Overall Study|Lost to Follow-up|0|||
131921634|NCT04602000|474997010|FG001|Overall Study|Lost to Follow-up|0|||
131921635|NCT04602000|474997011|FG002|Overall Study|Lost to Follow-up|0|||
131921636|NCT04602000|474997012|FG003|Overall Study|Lost to Follow-up|3|||
131921637|NCT04602000|474997013|FG004|Overall Study|Lost to Follow-up|4|||
131921638|NCT04602000|474997009|FG000|Overall Study|Other|4|||
131921639|NCT04602000|474997010|FG001|Overall Study|Other|1|||
131921640|NCT04602000|474997011|FG002|Overall Study|Other|2|||
131921641|NCT04602000|474997012|FG003|Overall Study|Other|5|||
131921642|NCT04602000|474997013|FG004|Overall Study|Other|4|||
131921643|NCT04602000|474997009|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
131921644|NCT04602000|474997010|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
131921645|NCT04602000|474997011|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
131921646|NCT04602000|474997012|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
131921647|NCT04602000|474997013|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
131921648|NCT01177410|474997014|FG000|Overall Study|Adverse Event|0|||
131921649|NCT01177410|474997015|FG001|Overall Study|Adverse Event|2|||
131921650|NCT01177410|474997016|FG002|Overall Study|Adverse Event|2|||
131921651|NCT01177410|474997014|FG000|Overall Study|Withdrawal by Subject|1|||
131921652|NCT01177410|474997015|FG001|Overall Study|Withdrawal by Subject|4|||
131408475|NCT01095653|473118317|FG000|Overall Study|Lost to Follow-up|1|||
131453949|NCT02023697|473291845|FG001|Treatment Period|Radiological progression|17|||
131453950|NCT02023697|473291846|FG002|Treatment Period|Radiological progression|26|||
131408476|NCT01095653|473118318|FG001|Overall Study|Lost to Follow-up|0|||
131453951|NCT02023697|473291844|FG000|Treatment Period|Never Treated|5|||
131921653|NCT01177410|474997016|FG002|Overall Study|Withdrawal by Subject|3|||
131921654|NCT01177410|474997014|FG000|Overall Study|Lost to Follow-up|0|||
131921655|NCT01177410|474997015|FG001|Overall Study|Lost to Follow-up|1|||
131921656|NCT01177410|474997016|FG002|Overall Study|Lost to Follow-up|0|||
131921657|NCT00471354|474997017|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
131921658|NCT00471354|474997017|FG000|Overall Study|Adverse Event|13|||
131408477|NCT01095653|473118319|FG002|Overall Study|Lost to Follow-up|4|||
131408478|NCT01095653|473118317|FG000|Overall Study|Withdrawal by Subject|4|||
131875903|NCT00972816|474826424|FG002|Overall Study|Inappropriate enrolment|0|||
131875904|NCT00972816|474826425|FG003|Overall Study|Inappropriate enrolment|0|||
131875905|NCT00972816|474826426|FG004|Overall Study|Inappropriate enrolment|0|||
131875906|NCT00972816|474826427|FG005|Overall Study|Inappropriate enrolment|0|||
131875907|NCT00972816|474826428|FG006|Overall Study|Inappropriate enrolment|2|||
131875908|NCT00972816|474826429|FG007|Overall Study|Inappropriate enrolment|0|||
131875909|NCT00972816|474826422|FG000|Overall Study|Unable to classify|2|||
131875910|NCT00972816|474826423|FG001|Overall Study|Unable to classify|0|||
131875911|NCT00972816|474826424|FG002|Overall Study|Unable to classify|0|||
131875912|NCT00972816|474826425|FG003|Overall Study|Unable to classify|0|||
131875913|NCT00972816|474826426|FG004|Overall Study|Unable to classify|1|||
131875914|NCT00972816|474826427|FG005|Overall Study|Unable to classify|0|||
131875915|NCT00972816|474826428|FG006|Overall Study|Unable to classify|0|||
131875916|NCT00972816|474826429|FG007|Overall Study|Unable to classify|0|||
131875917|NCT03233529|474826433|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
131875918|NCT03233529|474826433|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
131875919|NCT03854370|474826436|FG000|Overall Study|samples not collected|1|||
131875920|NCT03854370|474826437|FG001|Overall Study|samples not collected|1|||
131875921|NCT03854370|474826438|FG002|Overall Study|samples not collected|1|||
131875922|NCT03854370|474826439|FG003|Overall Study|samples not collected|1|||
131875923|NCT01608087|474826440|FG000|Overall Study|Lost to Follow-up|0|||
131875924|NCT01608087|474826441|FG001|Overall Study|Lost to Follow-up|1|||
131875925|NCT01608087|474826442|FG002|Overall Study|Lost to Follow-up|0|||
131875926|NCT01608087|474826440|FG000|Overall Study|Other Reason|0|||
131875927|NCT01608087|474826441|FG001|Overall Study|Other Reason|1|||
131875928|NCT01608087|474826442|FG002|Overall Study|Other Reason|0|||
131875929|NCT00348595|474826443|FG000|Overall Study|Adverse Event|5|||
131875930|NCT00348595|474826444|FG001|Overall Study|Adverse Event|8|||
131875931|NCT01942486|474826445|FG000|Overall Study|Lost to Follow-up|27|||
131875932|NCT00231114|474826447|FG000|Randomized|Withdrawal by Subject|6|||
131875933|NCT00231114|474826448|FG001|Randomized|Withdrawal by Subject|3|||
131875934|NCT00231114|474826447|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
131875935|NCT00231114|474826448|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
131875936|NCT00231114|474826447|FG000|Post-Treatment Period|Lost to Follow-up|6|||
131875937|NCT00231114|474826448|FG001|Post-Treatment Period|Lost to Follow-up|1|||
131875938|NCT00231114|474826447|FG000|Post-Treatment Period|Physician Decision|1|||
131875939|NCT00231114|474826448|FG001|Post-Treatment Period|Physician Decision|0|||
131875940|NCT00231114|474826447|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
131875941|NCT00231114|474826448|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
131875942|NCT04470544|474826449|FG000|Overall Study|Withdrawal by Subject|4|||
131875943|NCT04470544|474826450|FG001|Overall Study|Withdrawal by Subject|6|||
131875944|NCT03702010|474826463|FG000|Follow-up (30days)|Lack of Efficacy|2|||
131875945|NCT03702010|474826464|FG001|Follow-up (30days)|Lack of Efficacy|2|||
131875946|NCT01137110|474826465|FG000|Overall Study|Protocol Violation|1|||
131875947|NCT01137110|474826466|FG001|Overall Study|Protocol Violation|0|||
131875948|NCT03557931|474826467|FG000|Overall Study|Adverse Event|4|||
131875949|NCT03557931|474826468|FG001|Overall Study|Adverse Event|6|||
131875950|NCT03557931|474826469|FG002|Overall Study|Adverse Event|1|||
131875951|NCT03557931|474826467|FG000|Overall Study|Lost to Follow-up|4|||
131875952|NCT03557931|474826468|FG001|Overall Study|Lost to Follow-up|4|||
131875953|NCT03557931|474826469|FG002|Overall Study|Lost to Follow-up|1|||
131875954|NCT03557931|474826467|FG000|Overall Study|Protocol Violation|1|||
131875955|NCT03557931|474826468|FG001|Overall Study|Protocol Violation|4|||
131875956|NCT03557931|474826469|FG002|Overall Study|Protocol Violation|1|||
131875957|NCT03557931|474826467|FG000|Overall Study|Withdrawal by Subject|14|||
131875958|NCT03557931|474826468|FG001|Overall Study|Withdrawal by Subject|0|||
131875959|NCT03557931|474826469|FG002|Overall Study|Withdrawal by Subject|7|||
131875960|NCT03557931|474826467|FG000|Overall Study|Miscellaneous|8|||
131875961|NCT03557931|474826468|FG001|Overall Study|Miscellaneous|5|||
131921659|NCT00471354|474997017|FG000|Overall Study|Protocol Violation|12|||
131875962|NCT03557931|474826469|FG002|Overall Study|Miscellaneous|3|||
131875963|NCT02829723|474826470|FG000|Overall Study|Adverse Event|0|||
131875964|NCT02829723|474826471|FG001|Overall Study|Adverse Event|0|||
131875965|NCT02829723|474826472|FG002|Overall Study|Adverse Event|1|||
131875966|NCT02829723|474826473|FG003|Overall Study|Adverse Event|1|||
131875967|NCT02829723|474826474|FG004|Overall Study|Adverse Event|0|||
131875968|NCT02829723|474826475|FG005|Overall Study|Adverse Event|0|||
131875969|NCT02829723|474826476|FG006|Overall Study|Adverse Event|0|||
131875970|NCT02829723|474826477|FG007|Overall Study|Adverse Event|1|||
131875971|NCT02829723|474826478|FG008|Overall Study|Adverse Event|0|||
131875972|NCT02829723|474826479|FG009|Overall Study|Adverse Event|0|||
131875973|NCT02829723|474826480|FG010|Overall Study|Adverse Event|0|||
131408479|NCT01095653|473118318|FG001|Overall Study|Withdrawal by Subject|5|||
131408480|NCT01095653|473118319|FG002|Overall Study|Withdrawal by Subject|3|||
131408481|NCT01095653|473118317|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
131408482|NCT01095653|473118318|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
131408483|NCT01095653|473118319|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
131408484|NCT02046226|473118320|FG000|Overall Study|Lost to Follow-up|7|||
131408485|NCT00171925|473118321|FG000|Overall Study|Adverse Event|10|||
131408486|NCT00171925|473118322|FG001|Overall Study|Adverse Event|6|||
131408487|NCT00171925|473118321|FG000|Overall Study|Protocol Violation|1|||
131408488|NCT00171925|473118322|FG001|Overall Study|Protocol Violation|1|||
131408489|NCT00171925|473118321|FG000|Overall Study|Withdrawal by Subject|6|||
131408490|NCT00171925|473118322|FG001|Overall Study|Withdrawal by Subject|9|||
131875974|NCT02829723|474826481|FG011|Overall Study|Adverse Event|0|||
131875975|NCT02829723|474826482|FG012|Overall Study|Adverse Event|0|||
131875976|NCT02829723|474826483|FG013|Overall Study|Adverse Event|0|||
131875977|NCT02829723|474826484|FG014|Overall Study|Adverse Event|1|||
131875978|NCT02829723|474826485|FG015|Overall Study|Adverse Event|1|||
131875979|NCT02829723|474826486|FG016|Overall Study|Adverse Event|1|||
131875980|NCT02829723|474826487|FG017|Overall Study|Adverse Event|2|||
131875981|NCT02829723|474826488|FG018|Overall Study|Adverse Event|1|||
131875982|NCT02829723|474826489|FG019|Overall Study|Adverse Event|1|||
131875983|NCT02829723|474826490|FG020|Overall Study|Adverse Event|3|||
131875984|NCT02829723|474826491|FG021|Overall Study|Adverse Event|0|||
131875985|NCT02829723|474826492|FG022|Overall Study|Adverse Event|0|||
131875986|NCT02829723|474826493|FG023|Overall Study|Adverse Event|1|||
131875987|NCT02829723|474826494|FG024|Overall Study|Adverse Event|1|||
131875988|NCT02829723|474826495|FG025|Overall Study|Adverse Event|3|||
131875989|NCT02829723|474826496|FG026|Overall Study|Adverse Event|5|||
131875990|NCT02829723|474826470|FG000|Overall Study|Death|1|||
131875991|NCT02829723|474826471|FG001|Overall Study|Death|0|||
131875992|NCT02829723|474826472|FG002|Overall Study|Death|1|||
131875993|NCT02829723|474826473|FG003|Overall Study|Death|1|||
131875994|NCT02829723|474826474|FG004|Overall Study|Death|0|||
131875995|NCT02829723|474826475|FG005|Overall Study|Death|0|||
131875996|NCT02829723|474826476|FG006|Overall Study|Death|2|||
131875997|NCT02829723|474826477|FG007|Overall Study|Death|0|||
131875998|NCT02829723|474826478|FG008|Overall Study|Death|1|||
131875999|NCT02829723|474826479|FG009|Overall Study|Death|0|||
131876000|NCT02829723|474826480|FG010|Overall Study|Death|0|||
131876001|NCT02829723|474826481|FG011|Overall Study|Death|0|||
131876002|NCT02829723|474826482|FG012|Overall Study|Death|2|||
131876003|NCT02829723|474826483|FG013|Overall Study|Death|1|||
131876004|NCT02829723|474826484|FG014|Overall Study|Death|0|||
131876005|NCT02829723|474826485|FG015|Overall Study|Death|0|||
131876006|NCT02829723|474826486|FG016|Overall Study|Death|0|||
131876007|NCT02829723|474826487|FG017|Overall Study|Death|0|||
131876008|NCT02829723|474826488|FG018|Overall Study|Death|0|||
131876009|NCT02829723|474826489|FG019|Overall Study|Death|0|||
131876010|NCT02829723|474826490|FG020|Overall Study|Death|0|||
131876011|NCT02829723|474826491|FG021|Overall Study|Death|2|||
131876012|NCT02829723|474826492|FG022|Overall Study|Death|0|||
131876013|NCT02829723|474826493|FG023|Overall Study|Death|0|||
131876014|NCT02829723|474826494|FG024|Overall Study|Death|0|||
131876015|NCT02829723|474826495|FG025|Overall Study|Death|1|||
131876016|NCT02829723|474826496|FG026|Overall Study|Death|2|||
131876017|NCT02829723|474826470|FG000|Overall Study|Physician Decision|0|||
131876018|NCT02829723|474826471|FG001|Overall Study|Physician Decision|0|||
131876019|NCT02829723|474826472|FG002|Overall Study|Physician Decision|0|||
131921660|NCT00471354|474997017|FG000|Overall Study|Withdrawal by Subject|1|||
131408491|NCT00171925|473118321|FG000|Overall Study|Lost to Follow-up|2|||
131408492|NCT00171925|473118322|FG001|Overall Study|Lost to Follow-up|2|||
131408493|NCT00171925|473118321|FG000|Overall Study|Administrative problems|10|||
131876020|NCT02829723|474826473|FG003|Overall Study|Physician Decision|0|||
131876021|NCT02829723|474826474|FG004|Overall Study|Physician Decision|0|||
131408494|NCT00171925|473118322|FG001|Overall Study|Administrative problems|11|||
131408495|NCT00171925|473118321|FG000|Overall Study|Death|1|||
131876022|NCT02829723|474826475|FG005|Overall Study|Physician Decision|0|||
131876023|NCT02829723|474826476|FG006|Overall Study|Physician Decision|0|||
131876024|NCT02829723|474826477|FG007|Overall Study|Physician Decision|0|||
131876025|NCT02829723|474826478|FG008|Overall Study|Physician Decision|0|||
131876026|NCT02829723|474826479|FG009|Overall Study|Physician Decision|1|||
131876027|NCT02829723|474826480|FG010|Overall Study|Physician Decision|1|||
131876028|NCT02829723|474826481|FG011|Overall Study|Physician Decision|0|||
131876029|NCT02829723|474826482|FG012|Overall Study|Physician Decision|0|||
131876030|NCT02829723|474826483|FG013|Overall Study|Physician Decision|1|||
131876031|NCT02829723|474826484|FG014|Overall Study|Physician Decision|0|||
131876032|NCT02829723|474826485|FG015|Overall Study|Physician Decision|0|||
131876033|NCT02829723|474826486|FG016|Overall Study|Physician Decision|2|||
131876034|NCT02829723|474826487|FG017|Overall Study|Physician Decision|0|||
131876035|NCT02829723|474826488|FG018|Overall Study|Physician Decision|0|||
131876036|NCT02829723|474826489|FG019|Overall Study|Physician Decision|0|||
131876037|NCT02829723|474826490|FG020|Overall Study|Physician Decision|0|||
131921661|NCT00471354|474997017|FG000|Overall Study|Physician Decision|4|||
131921662|NCT00471354|474997017|FG000|Overall Study|Sponsor Decision|1|||
131921663|NCT00471354|474997017|FG000|Overall Study|Lost to Follow-up|3|||
131921664|NCT00471354|474997017|FG000|Overall Study|Lack of Efficacy|5|||
131921665|NCT00471354|474997017|FG000|Overall Study|Patient/Caregiver Decision|12|||
131921666|NCT00875667|474997019|FG000|Overall Study|Adverse Event|29|||
131921667|NCT00875667|474997020|FG001|Overall Study|Adverse Event|10|||
131921668|NCT00875667|474997019|FG000|Overall Study|Withdrawal by Subject|17|||
131921669|NCT00875667|474997020|FG001|Overall Study|Withdrawal by Subject|5|||
131921670|NCT00875667|474997019|FG000|Overall Study|Death|7|||
131921671|NCT00875667|474997020|FG001|Overall Study|Death|2|||
131921672|NCT00875667|474997019|FG000|Overall Study|Protocol Violation|2|||
131921673|NCT00875667|474997020|FG001|Overall Study|Protocol Violation|0|||
131921674|NCT00875667|474997019|FG000|Overall Study|Disease Progression|100|||
131921675|NCT00875667|474997020|FG001|Overall Study|Disease Progression|49|||
131921676|NCT00875667|474997019|FG000|Overall Study|Miscellaneous|12|||
131921677|NCT00875667|474997020|FG001|Overall Study|Miscellaneous|6|||
131921678|NCT00875667|474997019|FG000|Overall Study|Randomized but no Study Drug Given|3|||
131921679|NCT00875667|474997020|FG001|Overall Study|Randomized but no Study Drug Given|1|||
131921680|NCT00894647|474997021|FG000|Overall Study|Adverse Event|5|||
131921681|NCT00894647|474997022|FG001|Overall Study|Adverse Event|4|||
131921682|NCT00894647|474997021|FG000|Overall Study|Withdrawal by Subject|4|||
131921683|NCT00894647|474997022|FG001|Overall Study|Withdrawal by Subject|4|||
131921684|NCT00894647|474997021|FG000|Overall Study|Lost to Follow-up|0|||
131921685|NCT00894647|474997022|FG001|Overall Study|Lost to Follow-up|2|||
131921686|NCT00894647|474997021|FG000|Overall Study|Non-compliance with study procedures|0|||
131921687|NCT00894647|474997022|FG001|Overall Study|Non-compliance with study procedures|2|||
131921688|NCT00894647|474997021|FG000|Overall Study|Other, not due to AE|1|||
131921689|NCT00894647|474997022|FG001|Overall Study|Other, not due to AE|2|||
131921690|NCT02153827|474997030|FG000|Overall Study|Lost to Follow-up|3|||
131921691|NCT02153827|474997031|FG001|Overall Study|Lost to Follow-up|9|||
131408496|NCT00171925|473118322|FG001|Overall Study|Death|2|||
131408497|NCT02692040|473118323|FG000|Overall Study|Protocol Violation|0|||
131921692|NCT01158404|474997032|FG000|Overall Study|Withdrawal by Subject|0|||
131921693|NCT01158404|474997033|FG001|Overall Study|Withdrawal by Subject|1|||
131921694|NCT01158404|474997034|FG002|Overall Study|Withdrawal by Subject|0|||
131921695|NCT01158404|474997035|FG003|Overall Study|Withdrawal by Subject|0|||
131921696|NCT01158404|474997036|FG004|Overall Study|Withdrawal by Subject|3|||
131921697|NCT01158404|474997037|FG005|Overall Study|Withdrawal by Subject|1|||
131921698|NCT01158404|474997038|FG006|Overall Study|Withdrawal by Subject|0|||
131921699|NCT01158404|474997039|FG007|Overall Study|Withdrawal by Subject|1|||
131921700|NCT01158404|474997032|FG000|Overall Study|Physician Decision|0|||
131921701|NCT01158404|474997033|FG001|Overall Study|Physician Decision|0|||
131921702|NCT01158404|474997034|FG002|Overall Study|Physician Decision|0|||
131921703|NCT01158404|474997035|FG003|Overall Study|Physician Decision|0|||
131921704|NCT01158404|474997036|FG004|Overall Study|Physician Decision|0|||
131921705|NCT01158404|474997037|FG005|Overall Study|Physician Decision|0|||
131921706|NCT01158404|474997038|FG006|Overall Study|Physician Decision|0|||
131921707|NCT01158404|474997039|FG007|Overall Study|Physician Decision|1|||
131921708|NCT01158404|474997032|FG000|Overall Study|Progressive Disease|0|||
131921709|NCT01158404|474997033|FG001|Overall Study|Progressive Disease|0|||
131921710|NCT01158404|474997034|FG002|Overall Study|Progressive Disease|0|||
131921711|NCT01158404|474997035|FG003|Overall Study|Progressive Disease|0|||
131921712|NCT01158404|474997036|FG004|Overall Study|Progressive Disease|0|||
131921713|NCT01158404|474997037|FG005|Overall Study|Progressive Disease|0|||
131921714|NCT01158404|474997038|FG006|Overall Study|Progressive Disease|1|||
131921715|NCT01158404|474997039|FG007|Overall Study|Progressive Disease|0|||
131921716|NCT02143778|474997041|FG000|Overall Study|Withdrawal by Subject|2|||
131921717|NCT02143778|474997041|FG000|Overall Study|Device malfunction|1|||
131921718|NCT00625378|474997043|FG000|Overall Study|Adverse Event|22|||
131921719|NCT00625378|474997044|FG001|Overall Study|Adverse Event|0|||
131921720|NCT00625378|474997043|FG000|Overall Study|Withdrawal by Subject|16|||
131921721|NCT00625378|474997044|FG001|Overall Study|Withdrawal by Subject|0|||
131921722|NCT00625378|474997043|FG000|Overall Study|Death|38|||
131921723|NCT00625378|474997044|FG001|Overall Study|Death|0|||
131921724|NCT00625378|474997043|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
131921725|NCT00625378|474997044|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
131408498|NCT02692040|473118324|FG001|Overall Study|Protocol Violation|0|||
131921726|NCT00625378|474997043|FG000|Overall Study|Lost to Follow-up|17|||
131921727|NCT00625378|474997044|FG001|Overall Study|Lost to Follow-up|0|||
131921728|NCT00625378|474997043|FG000|Overall Study|Non-compliant with study medication|3|||
131921729|NCT00625378|474997044|FG001|Overall Study|Non-compliant with study medication|0|||
131921730|NCT00625378|474997043|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
131921731|NCT00625378|474997044|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
131921732|NCT00625378|474997043|FG000|Overall Study|Medical decision|1|||
131408499|NCT02692040|473118325|FG002|Overall Study|Protocol Violation|0|||
131921733|NCT00625378|474997044|FG001|Overall Study|Medical decision|0|||
131921734|NCT00625378|474997043|FG000|Overall Study|Multiple toxicities|1|||
131921735|NCT00625378|474997044|FG001|Overall Study|Multiple toxicities|0|||
131921736|NCT00625378|474997043|FG000|Overall Study|New cancer|1|||
131921737|NCT00625378|474997044|FG001|Overall Study|New cancer|0|||
131921738|NCT00625378|474997043|FG000|Overall Study|PTA program|2|||
131921739|NCT00625378|474997044|FG001|Overall Study|PTA program|0|||
131921740|NCT00625378|474997043|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
131921741|NCT00625378|474997044|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
131921742|NCT00625378|474997043|FG000|Overall Study|Sponsor decision|1|||
131921743|NCT00625378|474997044|FG001|Overall Study|Sponsor decision|0|||
131921744|NCT00625378|474997043|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
131921745|NCT00625378|474997044|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
131921746|NCT00625378|474997043|FG000|Overall Study|Switch to commercial drug|6|||
131921747|NCT00625378|474997044|FG001|Overall Study|Switch to commercial drug|1|||
131921748|NCT00625378|474997043|FG000|Overall Study|Missing|2|||
131921749|NCT00625378|474997044|FG001|Overall Study|Missing|0|||
131921750|NCT00625378|474997043|FG000|Overall Study|End of treatment not available|2|||
131921751|NCT00625378|474997044|FG001|Overall Study|End of treatment not available|0|||
131921752|NCT00625378|474997043|FG000|Overall Study|Never treated|2|||
131921753|NCT00625378|474997044|FG001|Overall Study|Never treated|0|||
131921754|NCT02639559|474997046|FG000|Overall Study|Mobilization failure|0|||
131921755|NCT02639559|474997047|FG001|Overall Study|Mobilization failure|3|||
131921756|NCT02639559|474997046|FG000|Overall Study|Issues with vascular acess|1|||
131921757|NCT02639559|474997047|FG001|Overall Study|Issues with vascular acess|0|||
131921758|NCT03880565|474997052|FG000|Overall Study|Withdrawal by Subject|1|||
131921759|NCT03880565|474997053|FG001|Overall Study|Withdrawal by Subject|0|||
131921760|NCT02969018|474997054|FG000|Overall Study|Adverse Event|2|||
131921761|NCT02969018|474997055|FG001|Overall Study|Adverse Event|4|||
131921762|NCT02969018|474997056|FG002|Overall Study|Adverse Event|1|||
131921763|NCT02969018|474997057|FG003|Overall Study|Adverse Event|2|||
131921764|NCT02969018|474997058|FG004|Overall Study|Adverse Event|0|||
131921765|NCT02969018|474997059|FG005|Overall Study|Adverse Event|1|||
131921766|NCT02969018|474997060|FG006|Overall Study|Adverse Event|2|||
131921767|NCT02969018|474997061|FG007|Overall Study|Adverse Event|0|||
131921768|NCT02969018|474997054|FG000|Overall Study|Lack of Efficacy|0|||
131921769|NCT02969018|474997055|FG001|Overall Study|Lack of Efficacy|1|||
131921770|NCT02969018|474997056|FG002|Overall Study|Lack of Efficacy|0|||
131921771|NCT02969018|474997057|FG003|Overall Study|Lack of Efficacy|0|||
131921772|NCT02969018|474997058|FG004|Overall Study|Lack of Efficacy|1|||
131921773|NCT02969018|474997059|FG005|Overall Study|Lack of Efficacy|1|||
131921774|NCT02969018|474997060|FG006|Overall Study|Lack of Efficacy|1|||
131921775|NCT02969018|474997061|FG007|Overall Study|Lack of Efficacy|1|||
131921776|NCT02969018|474997054|FG000|Overall Study|Lost to Follow-up|1|||
131921777|NCT02969018|474997055|FG001|Overall Study|Lost to Follow-up|2|||
131921778|NCT02969018|474997056|FG002|Overall Study|Lost to Follow-up|2|||
131921779|NCT02969018|474997057|FG003|Overall Study|Lost to Follow-up|0|||
131921780|NCT02969018|474997058|FG004|Overall Study|Lost to Follow-up|1|||
131921781|NCT02969018|474997059|FG005|Overall Study|Lost to Follow-up|1|||
131921782|NCT02969018|474997060|FG006|Overall Study|Lost to Follow-up|0|||
131921783|NCT02969018|474997061|FG007|Overall Study|Lost to Follow-up|1|||
131921784|NCT02969018|474997054|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921785|NCT02969018|474997055|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921786|NCT02969018|474997056|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921787|NCT02969018|474997057|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921788|NCT02969018|474997058|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921789|NCT02969018|474997059|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921790|NCT02969018|474997060|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
131921791|NCT02969018|474997061|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
131921792|NCT02969018|474997054|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131921793|NCT02969018|474997055|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131921794|NCT02969018|474997056|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131921795|NCT02969018|474997057|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131921796|NCT02969018|474997058|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131921797|NCT02969018|474997059|FG005|Overall Study|Non-Compliance With Study Drug|0|||
131921798|NCT02969018|474997060|FG006|Overall Study|Non-Compliance With Study Drug|0|||
131921799|NCT02969018|474997061|FG007|Overall Study|Non-Compliance With Study Drug|0|||
131921800|NCT02969018|474997054|FG000|Overall Study|Other|0|||
131921801|NCT02969018|474997055|FG001|Overall Study|Other|0|||
131921802|NCT02969018|474997056|FG002|Overall Study|Other|0|||
131921803|NCT02969018|474997057|FG003|Overall Study|Other|1|||
131453952|NCT02023697|473291845|FG001|Treatment Period|Never Treated|6|||
131921804|NCT02969018|474997058|FG004|Overall Study|Other|0|||
131921805|NCT02969018|474997059|FG005|Overall Study|Other|0|||
131921806|NCT02969018|474997060|FG006|Overall Study|Other|0|||
131921807|NCT02969018|474997061|FG007|Overall Study|Other|2|||
131921808|NCT02969018|474997054|FG000|Overall Study|Pregnancy|0|||
131921809|NCT02969018|474997055|FG001|Overall Study|Pregnancy|0|||
131453953|NCT02023697|473291846|FG002|Treatment Period|Never Treated|10|||
131921810|NCT02969018|474997056|FG002|Overall Study|Pregnancy|0|||
131921811|NCT02969018|474997057|FG003|Overall Study|Pregnancy|0|||
131921812|NCT02969018|474997058|FG004|Overall Study|Pregnancy|0|||
131921813|NCT02969018|474997059|FG005|Overall Study|Pregnancy|1|||
131921814|NCT02969018|474997060|FG006|Overall Study|Pregnancy|0|||
131921815|NCT02969018|474997061|FG007|Overall Study|Pregnancy|0|||
131921816|NCT02969018|474997054|FG000|Overall Study|Protocol Violation|0|||
131921817|NCT02969018|474997055|FG001|Overall Study|Protocol Violation|0|||
131921818|NCT02969018|474997056|FG002|Overall Study|Protocol Violation|1|||
131921819|NCT02969018|474997057|FG003|Overall Study|Protocol Violation|1|||
131921820|NCT02969018|474997058|FG004|Overall Study|Protocol Violation|0|||
131921821|NCT02969018|474997059|FG005|Overall Study|Protocol Violation|0|||
131921822|NCT02969018|474997060|FG006|Overall Study|Protocol Violation|0|||
131921823|NCT02969018|474997061|FG007|Overall Study|Protocol Violation|0|||
131921824|NCT02969018|474997054|FG000|Overall Study|Withdrawal by Subject|0|||
131921825|NCT02969018|474997055|FG001|Overall Study|Withdrawal by Subject|1|||
131921826|NCT02969018|474997056|FG002|Overall Study|Withdrawal by Subject|2|||
131921827|NCT02969018|474997057|FG003|Overall Study|Withdrawal by Subject|1|||
131921828|NCT02969018|474997058|FG004|Overall Study|Withdrawal by Subject|0|||
131921829|NCT02969018|474997059|FG005|Overall Study|Withdrawal by Subject|4|||
131921830|NCT02969018|474997060|FG006|Overall Study|Withdrawal by Subject|4|||
131921831|NCT02969018|474997061|FG007|Overall Study|Withdrawal by Subject|3|||
131921832|NCT04790201|474997065|FG000|Overall Study|Lost to Follow-up|0|||
131921833|NCT04790201|474997066|FG001|Overall Study|Lost to Follow-up|0|||
131921834|NCT04790201|474997067|FG002|Overall Study|Lost to Follow-up|2|||
131921835|NCT04790201|474997065|FG000|Overall Study|Death|0|||
131921836|NCT04790201|474997066|FG001|Overall Study|Death|1|||
131921837|NCT04790201|474997067|FG002|Overall Study|Death|0|||
131921838|NCT04790201|474997065|FG000|Overall Study|Protocol Violation|1|||
131921839|NCT04790201|474997066|FG001|Overall Study|Protocol Violation|0|||
131921840|NCT04790201|474997067|FG002|Overall Study|Protocol Violation|1|||
131921841|NCT05762679|474997070|FG000|Overall Study|Withdrawal by Subject|1|||
131921842|NCT05762679|474997070|FG000|Overall Study|No analyzable imaging data|1|||
131921843|NCT03670628|474997071|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
131921844|NCT03670628|474997072|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
131921845|NCT03670628|474997071|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
131921846|NCT03670628|474997072|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
131921847|NCT06377488|474997073|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
131921848|NCT06377488|474997073|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
131921849|NCT06377488|474997073|FG000|Overall Study|Protocol Violation|1|||
131921850|NCT06377488|474997073|FG000|Overall Study|Lost to Follow-up|1|||
131921851|NCT06377488|474997073|FG000|Overall Study|Incorrect Lens Dispensed|2|||
131921852|NCT01179516|474997074|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
131921853|NCT01179516|474997075|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
131921854|NCT01179516|474997076|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
131921855|NCT01179516|474997074|FG000|Overall Study|Lack of Efficacy|4|||
131921856|NCT01179516|474997075|FG001|Overall Study|Lack of Efficacy|2|||
131921857|NCT01179516|474997076|FG002|Overall Study|Lack of Efficacy|0|||
131921858|NCT01179516|474997074|FG000|Overall Study|Noncompliance with Study Drug|2|||
131921859|NCT01179516|474997075|FG001|Overall Study|Noncompliance with Study Drug|0|||
131921860|NCT01179516|474997076|FG002|Overall Study|Noncompliance with Study Drug|1|||
131921861|NCT01179516|474997074|FG000|Overall Study|Protocol Deviations|4|||
131921862|NCT01179516|474997075|FG001|Overall Study|Protocol Deviations|3|||
131921863|NCT01179516|474997076|FG002|Overall Study|Protocol Deviations|3|||
131921864|NCT01179516|474997074|FG000|Overall Study|Withdrawal of Consent|2|||
131921865|NCT01179516|474997075|FG001|Overall Study|Withdrawal of Consent|6|||
131921866|NCT01179516|474997076|FG002|Overall Study|Withdrawal of Consent|10|||
131921867|NCT01179516|474997074|FG000|Overall Study|Lost to Follow-up|7|||
131921868|NCT01179516|474997075|FG001|Overall Study|Lost to Follow-up|7|||
131921869|NCT01179516|474997076|FG002|Overall Study|Lost to Follow-up|3|||
131921870|NCT01179516|474997074|FG000|Overall Study|Other|2|||
131921871|NCT01179516|474997075|FG001|Overall Study|Other|0|||
131921872|NCT01179516|474997076|FG002|Overall Study|Other|2|||
131921873|NCT00866320|474997077|FG000|Overall Study|Withdrawal by Subject|4|||
131921874|NCT00866320|474997077|FG000|Overall Study|Death|2|||
131921875|NCT02503865|474997078|FG000|Overall Study|Moved out of area|1|||
131921876|NCT02503865|474997079|FG001|Overall Study|Moved out of area|8|||
131921877|NCT02503865|474997080|FG002|Overall Study|Moved out of area|0|||
131921878|NCT02503865|474997078|FG000|Overall Study|Refused treatment|4|||
131921879|NCT02503865|474997079|FG001|Overall Study|Refused treatment|39|||
131921880|NCT02503865|474997080|FG002|Overall Study|Refused treatment|2|||
131921881|NCT02965456|474997081|FG000|Overall Study|Lost to Follow-up|40|||
131921882|NCT02965456|474997082|FG001|Overall Study|Lost to Follow-up|18|||
131921883|NCT02965456|474997081|FG000|Overall Study|Subject Request|22|||
131921884|NCT02965456|474997082|FG001|Overall Study|Subject Request|13|||
131921885|NCT02965456|474997081|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
131921886|NCT02965456|474997082|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
131921887|NCT02965456|474997081|FG000|Overall Study|Adverse Event|3|||
131921888|NCT02965456|474997082|FG001|Overall Study|Adverse Event|0|||
131921889|NCT02965456|474997081|FG000|Overall Study|Noncompliance with Study Drug|1|||
131921890|NCT02965456|474997082|FG001|Overall Study|Noncompliance with Study Drug|1|||
131921891|NCT02965456|474997081|FG000|Overall Study|Worsening Condition|0|||
131921892|NCT02965456|474997082|FG001|Overall Study|Worsening Condition|2|||
131921893|NCT02965456|474997081|FG000|Overall Study|Lack of Efficacy|1|||
131921894|NCT02965456|474997082|FG001|Overall Study|Lack of Efficacy|0|||
131921895|NCT02965456|474997081|FG000|Overall Study|Physician Decision|0|||
131921896|NCT02965456|474997082|FG001|Overall Study|Physician Decision|1|||
131921897|NCT02965456|474997081|FG000|Overall Study|Pregnancy|1|||
131921898|NCT02965456|474997082|FG001|Overall Study|Pregnancy|0|||
131921899|NCT02965456|474997081|FG000|Overall Study|Protocol Violation|0|||
131921900|NCT02965456|474997082|FG001|Overall Study|Protocol Violation|1|||
131921901|NCT02965456|474997081|FG000|Overall Study|Participant ran out of study drug|0|||
131921902|NCT02965456|474997082|FG001|Overall Study|Participant ran out of study drug|1|||
131921903|NCT00303953|474997083|FG000|Overall Study|Ineligible|1|||
131921904|NCT00303953|474997083|FG000|Overall Study|Death|1|||
131921905|NCT00303953|474997083|FG000|Overall Study|Adverse Event|4|||
131921906|NCT00303953|474997083|FG000|Overall Study|Lack of Efficacy|12|||
131921907|NCT00303953|474997083|FG000|Overall Study|Physician Decision|1|||
131921908|NCT00387127|474997086|FG000|Overall Study|Lost to Follow-up|0|||
131921909|NCT00387127|474997087|FG001|Overall Study|Lost to Follow-up|4|||
131921910|NCT00387127|474997086|FG000|Overall Study|Death|16|||
131921911|NCT00387127|474997087|FG001|Overall Study|Death|16|||
131921912|NCT00387127|474997086|FG000|Overall Study|Physician Decision|0|||
131921913|NCT00387127|474997087|FG001|Overall Study|Physician Decision|1|||
131921914|NCT00387127|474997086|FG000|Overall Study|Withdrawal by Subject|3|||
131921915|NCT00387127|474997087|FG001|Overall Study|Withdrawal by Subject|2|||
131921916|NCT00387127|474997086|FG000|Overall Study|Required by Protocol Amendment #4|12|||
131921917|NCT00387127|474997087|FG001|Overall Study|Required by Protocol Amendment #4|10|||
131921918|NCT00387127|474997086|FG000|Overall Study|Serious Adverse Event|1|||
131921919|NCT00387127|474997087|FG001|Overall Study|Serious Adverse Event|1|||
131921920|NCT00387127|474997086|FG000|Overall Study|Sponsor Unblinded|1|||
131921921|NCT00387127|474997087|FG001|Overall Study|Sponsor Unblinded|0|||
131921922|NCT00812097|474997088|FG000|Overall Study|Death|3|||
131921923|NCT00812097|474997089|FG001|Overall Study|Death|10|||
131921924|NCT00812097|474997090|FG002|Overall Study|Death|3|||
131921925|NCT00812097|474997091|FG003|Overall Study|Death|3|||
131921926|NCT00812097|474997088|FG000|Overall Study|Withdrawal by Subject|14|||
131921927|NCT00812097|474997089|FG001|Overall Study|Withdrawal by Subject|12|||
131921928|NCT00812097|474997090|FG002|Overall Study|Withdrawal by Subject|8|||
131921929|NCT00812097|474997091|FG003|Overall Study|Withdrawal by Subject|2|||
131921930|NCT00812097|474997088|FG000|Overall Study|Lost to Follow-up|90|||
131921931|NCT00812097|474997089|FG001|Overall Study|Lost to Follow-up|14|||
131921932|NCT00812097|474997090|FG002|Overall Study|Lost to Follow-up|17|||
131921933|NCT00812097|474997091|FG003|Overall Study|Lost to Follow-up|5|||
131921934|NCT00812097|474997088|FG000|Overall Study|Explantation of study device(s)|27|||
131921935|NCT00812097|474997089|FG001|Overall Study|Explantation of study device(s)|29|||
131921936|NCT00812097|474997090|FG002|Overall Study|Explantation of study device(s)|14|||
131921937|NCT00812097|474997091|FG003|Overall Study|Explantation of study device(s)|20|||
131921938|NCT00812097|474997088|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
131921939|NCT00812097|474997089|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
131921940|NCT00812097|474997090|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
131921941|NCT00812097|474997091|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
131921942|NCT01786109|474997092|FG000|Overall Study|fail manometry barostat tube placement|1|||
131921943|NCT01786109|474997093|FG001|Overall Study|fail manometry barostat tube placement|0|||
131921944|NCT01786109|474997094|FG002|Overall Study|fail manometry barostat tube placement|0|||
131921945|NCT01786109|474997092|FG000|Overall Study|unrelated illness|0|||
131921946|NCT01786109|474997093|FG001|Overall Study|unrelated illness|0|||
131921947|NCT01786109|474997094|FG002|Overall Study|unrelated illness|1|||
131921948|NCT01786109|474997092|FG000|Overall Study|adverse effects colon preparation|0|||
131921949|NCT01786109|474997093|FG001|Overall Study|adverse effects colon preparation|0|||
131921950|NCT01786109|474997094|FG002|Overall Study|adverse effects colon preparation|1|||
131921951|NCT00317369|474997095|FG000|Overall Study|Adverse Event|2|||
131921952|NCT00317369|474997096|FG001|Overall Study|Adverse Event|1|||
131921953|NCT00317369|474997097|FG002|Overall Study|Adverse Event|0|||
131921954|NCT00317369|474997095|FG000|Overall Study|Lack of Efficacy|0|||
131921955|NCT00317369|474997096|FG001|Overall Study|Lack of Efficacy|1|||
131921956|NCT00317369|474997097|FG002|Overall Study|Lack of Efficacy|1|||
131921957|NCT00317369|474997095|FG000|Overall Study|Withdrawal by Subject|0|||
131921958|NCT00317369|474997096|FG001|Overall Study|Withdrawal by Subject|0|||
131921959|NCT00317369|474997097|FG002|Overall Study|Withdrawal by Subject|1|||
131921960|NCT00825175|474997100|FG000|Overall Study|Withdrawal by Subject|0|||
131921961|NCT00825175|474997101|FG001|Overall Study|Withdrawal by Subject|5|||
131921962|NCT02762604|474997102|FG000|Overall Study|Lost to Follow-up|2|||
131408500|NCT02692040|473118326|FG003|Overall Study|Protocol Violation|0|||
131408501|NCT02692040|473118327|FG004|Overall Study|Protocol Violation|0|||
131408502|NCT02692040|473118328|FG005|Overall Study|Protocol Violation|0|||
131408503|NCT02692040|473118329|FG006|Overall Study|Protocol Violation|0|||
131408504|NCT02692040|473118330|FG007|Overall Study|Protocol Violation|0|||
131408505|NCT02692040|473118331|FG008|Overall Study|Protocol Violation|0|||
131408506|NCT02692040|473118332|FG009|Overall Study|Protocol Violation|0|||
131408507|NCT02692040|473118333|FG010|Overall Study|Protocol Violation|0|||
131408508|NCT02692040|473118334|FG011|Overall Study|Protocol Violation|0|||
131408509|NCT02692040|473118335|FG012|Overall Study|Protocol Violation|1|||
131453954|NCT02023697|473291844|FG000|Treatment Period|Adverse Event|13|||
131876038|NCT02829723|474826491|FG021|Overall Study|Physician Decision|0|||
131876039|NCT02829723|474826492|FG022|Overall Study|Physician Decision|1|||
131876040|NCT02829723|474826493|FG023|Overall Study|Physician Decision|1|||
131876041|NCT02829723|474826494|FG024|Overall Study|Physician Decision|1|||
131876042|NCT02829723|474826495|FG025|Overall Study|Physician Decision|1|||
131876043|NCT02829723|474826496|FG026|Overall Study|Physician Decision|3|||
131876044|NCT02829723|474826470|FG000|Overall Study|Progressive disease|4|||
131876045|NCT02829723|474826471|FG001|Overall Study|Progressive disease|6|||
131876046|NCT02829723|474826472|FG002|Overall Study|Progressive disease|3|||
131876047|NCT02829723|474826473|FG003|Overall Study|Progressive disease|3|||
131876048|NCT02829723|474826474|FG004|Overall Study|Progressive disease|3|||
131876049|NCT02829723|474826475|FG005|Overall Study|Progressive disease|5|||
131876050|NCT02829723|474826476|FG006|Overall Study|Progressive disease|4|||
131876051|NCT02829723|474826477|FG007|Overall Study|Progressive disease|6|||
131876052|NCT02829723|474826478|FG008|Overall Study|Progressive disease|8|||
131876053|NCT02829723|474826479|FG009|Overall Study|Progressive disease|4|||
131876054|NCT02829723|474826480|FG010|Overall Study|Progressive disease|9|||
131876055|NCT02829723|474826481|FG011|Overall Study|Progressive disease|0|||
131876056|NCT02829723|474826482|FG012|Overall Study|Progressive disease|3|||
131876057|NCT02829723|474826483|FG013|Overall Study|Progressive disease|4|||
131876058|NCT02829723|474826484|FG014|Overall Study|Progressive disease|2|||
131876059|NCT02829723|474826485|FG015|Overall Study|Progressive disease|4|||
131876060|NCT02829723|474826486|FG016|Overall Study|Progressive disease|5|||
131876061|NCT02829723|474826487|FG017|Overall Study|Progressive disease|3|||
131876062|NCT02829723|474826488|FG018|Overall Study|Progressive disease|4|||
131876063|NCT02829723|474826489|FG019|Overall Study|Progressive disease|4|||
131876064|NCT02829723|474826490|FG020|Overall Study|Progressive disease|7|||
131876065|NCT02829723|474826491|FG021|Overall Study|Progressive disease|6|||
131876066|NCT02829723|474826492|FG022|Overall Study|Progressive disease|3|||
131876067|NCT02829723|474826493|FG023|Overall Study|Progressive disease|3|||
131876068|NCT02829723|474826494|FG024|Overall Study|Progressive disease|3|||
131876069|NCT02829723|474826495|FG025|Overall Study|Progressive disease|16|||
131876070|NCT02829723|474826496|FG026|Overall Study|Progressive disease|10|||
131876071|NCT02829723|474826470|FG000|Overall Study|Subject/guardian decision|0|||
131876072|NCT02829723|474826471|FG001|Overall Study|Subject/guardian decision|1|||
131876073|NCT02829723|474826472|FG002|Overall Study|Subject/guardian decision|0|||
131876074|NCT02829723|474826473|FG003|Overall Study|Subject/guardian decision|1|||
131876075|NCT02829723|474826474|FG004|Overall Study|Subject/guardian decision|0|||
131876076|NCT02829723|474826475|FG005|Overall Study|Subject/guardian decision|0|||
131876077|NCT02829723|474826476|FG006|Overall Study|Subject/guardian decision|0|||
131876078|NCT02829723|474826477|FG007|Overall Study|Subject/guardian decision|1|||
131876079|NCT02829723|474826478|FG008|Overall Study|Subject/guardian decision|0|||
131876080|NCT02829723|474826479|FG009|Overall Study|Subject/guardian decision|0|||
131876081|NCT02829723|474826480|FG010|Overall Study|Subject/guardian decision|0|||
131876082|NCT02829723|474826481|FG011|Overall Study|Subject/guardian decision|0|||
131876083|NCT02829723|474826482|FG012|Overall Study|Subject/guardian decision|0|||
131876084|NCT02829723|474826483|FG013|Overall Study|Subject/guardian decision|0|||
131876085|NCT02829723|474826484|FG014|Overall Study|Subject/guardian decision|1|||
131876086|NCT02829723|474826485|FG015|Overall Study|Subject/guardian decision|0|||
131876087|NCT02829723|474826486|FG016|Overall Study|Subject/guardian decision|1|||
131876088|NCT02829723|474826487|FG017|Overall Study|Subject/guardian decision|0|||
131876089|NCT02829723|474826488|FG018|Overall Study|Subject/guardian decision|1|||
131876090|NCT02829723|474826489|FG019|Overall Study|Subject/guardian decision|0|||
131408510|NCT02692040|473118336|FG013|Overall Study|Protocol Violation|0|||
131408511|NCT02692040|473118337|FG014|Overall Study|Protocol Violation|0|||
131876091|NCT02829723|474826490|FG020|Overall Study|Subject/guardian decision|1|||
131876092|NCT02829723|474826491|FG021|Overall Study|Subject/guardian decision|0|||
131876093|NCT02829723|474826492|FG022|Overall Study|Subject/guardian decision|0|||
131876094|NCT02829723|474826493|FG023|Overall Study|Subject/guardian decision|1|||
131876095|NCT02829723|474826494|FG024|Overall Study|Subject/guardian decision|0|||
131408512|NCT02692040|473118338|FG015|Overall Study|Protocol Violation|0|||
131876096|NCT02829723|474826495|FG025|Overall Study|Subject/guardian decision|1|||
131876097|NCT02829723|474826496|FG026|Overall Study|Subject/guardian decision|1|||
131876098|NCT02829723|474826470|FG000|Overall Study|Study terminated by sponsor|0|||
131876099|NCT02829723|474826471|FG001|Overall Study|Study terminated by sponsor|0|||
131876100|NCT02829723|474826472|FG002|Overall Study|Study terminated by sponsor|0|||
131876101|NCT02829723|474826473|FG003|Overall Study|Study terminated by sponsor|0|||
131876102|NCT02829723|474826474|FG004|Overall Study|Study terminated by sponsor|0|||
131408513|NCT02692040|473118339|FG016|Overall Study|Protocol Violation|0|||
131408514|NCT02692040|473118323|FG000|Overall Study|Adverse Event|0|||
131408515|NCT02692040|473118324|FG001|Overall Study|Adverse Event|0|||
131408516|NCT02692040|473118325|FG002|Overall Study|Adverse Event|0|||
131408517|NCT02692040|473118326|FG003|Overall Study|Adverse Event|0|||
131408518|NCT02692040|473118327|FG004|Overall Study|Adverse Event|0|||
131921963|NCT02762604|474997103|FG001|Overall Study|Lost to Follow-up|7|||
131921964|NCT02762604|474997102|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
131921965|NCT02762604|474997103|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
131921966|NCT06038643|474997106|FG000|Overall Study|Withdrawal by Subject|9|||
131921967|NCT06038643|474997107|FG001|Overall Study|Withdrawal by Subject|4|||
131921968|NCT06038643|474997106|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
131921969|NCT06038643|474997107|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
131921970|NCT02691572|474997111|FG000|Overall Study|Withdrawal by Subject|1|||
131921971|NCT02691572|474997112|FG001|Overall Study|Withdrawal by Subject|0|||
131921972|NCT02691572|474997111|FG000|Overall Study|Protocol Violation|0|||
131921973|NCT02691572|474997112|FG001|Overall Study|Protocol Violation|1|||
131921974|NCT00699751|474997113|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
131921975|NCT00699751|474997114|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
131921976|NCT00699751|474997113|FG000|Period 1: Without/Before Drug Switch|Death|28|||
131921977|NCT00699751|474997114|FG001|Period 1: Without/Before Drug Switch|Death|29|||
131921978|NCT00699751|474997113|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
131921979|NCT00699751|474997114|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
131921980|NCT00699751|474997113|FG000|Period 1: Without/Before Drug Switch|Other|30|||
131921981|NCT00699751|474997114|FG001|Period 1: Without/Before Drug Switch|Other|20|||
131921982|NCT00699751|474997113|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
131921983|NCT00699751|474997114|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
131921984|NCT00699751|474997113|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
131921985|NCT00699751|474997114|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
131921986|NCT00699751|474997113|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
131921987|NCT00699751|474997114|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
131921988|NCT00699751|474997113|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
131921989|NCT00699751|474997114|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
131921990|NCT03370302|474997118|FG000|Dose Escalation Phase|Other|0|||
131921991|NCT03370302|474997119|FG001|Dose Escalation Phase|Other|1|||
131921992|NCT03370302|474997120|FG002|Dose Escalation Phase|Other|1|||
131921993|NCT03370302|474997121|FG003|Dose Escalation Phase|Other|0|||
131921994|NCT03370302|474997122|FG004|Dose Escalation Phase|Other|0|||
131921995|NCT03370302|474997123|FG005|Dose Escalation Phase|Other|0|||
131921996|NCT03370302|474997118|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131921997|NCT03370302|474997119|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
131921998|NCT03370302|474997120|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
131921999|NCT03370302|474997121|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131922000|NCT03370302|474997122|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
131922001|NCT03370302|474997123|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
131922002|NCT03370302|474997118|FG000|Dose Escalation Phase|Adverse Event|1|||
131922003|NCT03370302|474997119|FG001|Dose Escalation Phase|Adverse Event|0|||
131922004|NCT03370302|474997120|FG002|Dose Escalation Phase|Adverse Event|2|||
131922005|NCT03370302|474997121|FG003|Dose Escalation Phase|Adverse Event|0|||
131922006|NCT03370302|474997122|FG004|Dose Escalation Phase|Adverse Event|0|||
131922007|NCT03370302|474997123|FG005|Dose Escalation Phase|Adverse Event|0|||
131922008|NCT03370302|474997118|FG000|Dose Escalation Phase|Progressive Disease|2|||
131922009|NCT03370302|474997119|FG001|Dose Escalation Phase|Progressive Disease|4|||
131922010|NCT03370302|474997120|FG002|Dose Escalation Phase|Progressive Disease|2|||
131922011|NCT03370302|474997121|FG003|Dose Escalation Phase|Progressive Disease|0|||
131408519|NCT02692040|473118328|FG005|Overall Study|Adverse Event|0|||
131922012|NCT03370302|474997122|FG004|Dose Escalation Phase|Progressive Disease|3|||
131922013|NCT03370302|474997123|FG005|Dose Escalation Phase|Progressive Disease|1|||
131922014|NCT03370302|474997118|FG000|Dose Expansion Phase|Progressive Disease|0|||
131922015|NCT03370302|474997119|FG001|Dose Expansion Phase|Progressive Disease|0|||
131922016|NCT03370302|474997120|FG002|Dose Expansion Phase|Progressive Disease|0|||
131408520|NCT02692040|473118329|FG006|Overall Study|Adverse Event|0|||
131408521|NCT02692040|473118330|FG007|Overall Study|Adverse Event|0|||
131408522|NCT02692040|473118331|FG008|Overall Study|Adverse Event|0|||
131922017|NCT03370302|474997121|FG003|Dose Expansion Phase|Progressive Disease|6|||
131922018|NCT03370302|474997122|FG004|Dose Expansion Phase|Progressive Disease|0|||
131922019|NCT03370302|474997123|FG005|Dose Expansion Phase|Progressive Disease|0|||
131922020|NCT01428128|474997124|FG000|Overall Study|Withdrawal by Subject|4|||
131922021|NCT01428128|474997124|FG000|Overall Study|Screen failure by p53|10|||
131408523|NCT02692040|473118332|FG009|Overall Study|Adverse Event|0|||
131408524|NCT02692040|473118333|FG010|Overall Study|Adverse Event|0|||
131408525|NCT02692040|473118334|FG011|Overall Study|Adverse Event|0|||
131408526|NCT02692040|473118335|FG012|Overall Study|Adverse Event|0|||
131408527|NCT02692040|473118336|FG013|Overall Study|Adverse Event|3|||
131408528|NCT02692040|473118337|FG014|Overall Study|Adverse Event|1|||
131408529|NCT02692040|473118338|FG015|Overall Study|Adverse Event|1|||
131408530|NCT02692040|473118339|FG016|Overall Study|Adverse Event|0|||
131408531|NCT02826421|473118349|FG000|Overall Study|Adverse Event|1|||
131408532|NCT02826421|473118350|FG001|Overall Study|Adverse Event|0|||
131408533|NCT02826421|473118351|FG002|Overall Study|Adverse Event|0|||
131408534|NCT02826421|473118352|FG003|Overall Study|Adverse Event|1|||
131408535|NCT02826421|473118349|FG000|Overall Study|Withdrawal by Subject|1|||
131408536|NCT02826421|473118350|FG001|Overall Study|Withdrawal by Subject|3|||
131408537|NCT02826421|473118351|FG002|Overall Study|Withdrawal by Subject|1|||
131408538|NCT02826421|473118352|FG003|Overall Study|Withdrawal by Subject|1|||
131408539|NCT02826421|473118349|FG000|Overall Study|Reason not given|1|||
131408540|NCT02826421|473118350|FG001|Overall Study|Reason not given|0|||
131408541|NCT02826421|473118351|FG002|Overall Study|Reason not given|1|||
131408542|NCT02826421|473118352|FG003|Overall Study|Reason not given|0|||
131408543|NCT02210221|473118357|FG000|Overall Study|Lack of Efficacy|7|||
131408544|NCT02210221|473118357|FG000|Overall Study|Withdrawal by Subject|43|||
131408545|NCT02141490|473118358|FG000|Overall Study|Screening failures|4|||
131408546|NCT02141490|473118359|FG001|Overall Study|Screening failures|0|||
131408547|NCT02141490|473118360|FG002|Overall Study|Screening failures|0|||
131408548|NCT02305849|473118365|FG000|Overall Study|Adverse Event|10|||
131408549|NCT02305849|473118366|FG001|Overall Study|Adverse Event|12|||
131408550|NCT02305849|473118367|FG002|Overall Study|Adverse Event|7|||
131408551|NCT02305849|473118368|FG003|Overall Study|Adverse Event|3|||
131408552|NCT02305849|473118365|FG000|Overall Study|Lack of Efficacy|10|||
131408553|NCT02305849|473118366|FG001|Overall Study|Lack of Efficacy|6|||
131408554|NCT02305849|473118367|FG002|Overall Study|Lack of Efficacy|3|||
131408555|NCT02305849|473118368|FG003|Overall Study|Lack of Efficacy|9|||
131408556|NCT02305849|473118365|FG000|Overall Study|Withdrawal by Subject|2|||
131408557|NCT02305849|473118366|FG001|Overall Study|Withdrawal by Subject|2|||
131408558|NCT02305849|473118367|FG002|Overall Study|Withdrawal by Subject|1|||
131408559|NCT02305849|473118368|FG003|Overall Study|Withdrawal by Subject|4|||
131408560|NCT02305849|473118365|FG000|Overall Study|Lost to Follow-up|0|||
131408561|NCT02305849|473118366|FG001|Overall Study|Lost to Follow-up|2|||
131408562|NCT02305849|473118367|FG002|Overall Study|Lost to Follow-up|0|||
131408563|NCT02305849|473118368|FG003|Overall Study|Lost to Follow-up|0|||
131408564|NCT02305849|473118365|FG000|Overall Study|Protocol Violation|3|||
131408565|NCT02305849|473118366|FG001|Overall Study|Protocol Violation|2|||
131408566|NCT02305849|473118367|FG002|Overall Study|Protocol Violation|1|||
131922022|NCT01428128|474997124|FG000|Overall Study|Received Neulasta in one cycle|2|||
131922023|NCT01428128|474997124|FG000|Overall Study|Adverse Event|1|||
131922024|NCT01860989|474997127|FG000|Overall Study|Unsatisfactory therapeutic|5|||
131922025|NCT05417113|474998950|FG000|Overall Study|Lost to Follow-up|2|||
131922026|NCT05417113|474998951|FG001|Overall Study|Lost to Follow-up|2|||
131922027|NCT01022580|474998952|FG000|Overall Study|Death|18|||
131922028|NCT01022580|474998953|FG001|Overall Study|Death|22|||
131922029|NCT01500096|474998956|FG000|Overall Study|Lost to Follow-up|1|||
131922030|NCT01500096|474998957|FG001|Overall Study|Lost to Follow-up|0|||
131922031|NCT01500096|474998958|FG002|Overall Study|Lost to Follow-up|0|||
131922032|NCT01500096|474998959|FG003|Overall Study|Lost to Follow-up|2|||
131408567|NCT02305849|473118368|FG003|Overall Study|Protocol Violation|1|||
131408568|NCT02305849|473118365|FG000|Overall Study|Lab data met discontinuation criteria|0|||
131408569|NCT02305849|473118366|FG001|Overall Study|Lab data met discontinuation criteria|1|||
131408570|NCT02305849|473118367|FG002|Overall Study|Lab data met discontinuation criteria|2|||
131408571|NCT02305849|473118368|FG003|Overall Study|Lab data met discontinuation criteria|1|||
131408572|NCT02305849|473118365|FG000|Overall Study|Miscellaneous|1|||
131408573|NCT02305849|473118366|FG001|Overall Study|Miscellaneous|2|||
131408574|NCT02305849|473118367|FG002|Overall Study|Miscellaneous|4|||
131408575|NCT02305849|473118368|FG003|Overall Study|Miscellaneous|1|||
131408576|NCT02305849|473118365|FG000|Overall Study|Not fulfill eligibility criteria|1|||
131408577|NCT02305849|473118366|FG001|Overall Study|Not fulfill eligibility criteria|1|||
131408578|NCT02305849|473118367|FG002|Overall Study|Not fulfill eligibility criteria|0|||
131408579|NCT02305849|473118368|FG003|Overall Study|Not fulfill eligibility criteria|0|||
131408580|NCT00355342|473118369|FG000|Overall Study|Adverse Event|13|||
131408581|NCT00355342|473118370|FG001|Overall Study|Adverse Event|15|||
131408582|NCT00355342|473118369|FG000|Overall Study|Lost to Follow-up|4|||
131922033|NCT03418675|474998960|FG000|Overall Study|Lost to Follow-up|13|||
131408583|NCT00355342|473118370|FG001|Overall Study|Lost to Follow-up|2|||
131408584|NCT00355342|473118369|FG000|Overall Study|Withdrawal by Subject|14|||
131408585|NCT00355342|473118370|FG001|Overall Study|Withdrawal by Subject|11|||
131408586|NCT00355342|473118369|FG000|Overall Study|Sponsor terminated study|2|||
131408587|NCT00355342|473118370|FG001|Overall Study|Sponsor terminated study|2|||
131408588|NCT00355342|473118369|FG000|Overall Study|Overcompliant-PI discretion|1|||
131408589|NCT00355342|473118370|FG001|Overall Study|Overcompliant-PI discretion|0|||
131408590|NCT00355342|473118369|FG000|Overall Study|Use of prohibited medication|1|||
131408591|NCT00355342|473118370|FG001|Overall Study|Use of prohibited medication|0|||
131922034|NCT03418675|474998961|FG001|Overall Study|Lost to Follow-up|10|||
131922035|NCT03418675|474998960|FG000|Overall Study|Adverse Event|2|||
131922036|NCT03418675|474998961|FG001|Overall Study|Adverse Event|0|||
131922037|NCT01178411|474998962|FG000|Overall Study|Adverse Event|5|||
131922038|NCT01178411|474998962|FG000|Overall Study|Withdrawal by Subject|4|||
131922039|NCT01178411|474998962|FG000|Overall Study|Protocol Violation|1|||
131922040|NCT01178411|474998962|FG000|Overall Study|Progressive disease per RECIST|32|||
131922041|NCT01178411|474998962|FG000|Overall Study|Progressive disease per clinician|9|||
131922042|NCT01178411|474998962|FG000|Overall Study|Physician Decision|6|||
131922043|NCT01178411|474998962|FG000|Overall Study|Death|1|||
131922044|NCT01178411|474998962|FG000|Overall Study|No reason provided|1|||
131922045|NCT01178411|474998962|FG000|Overall Study|Drug manufacturing ended|1|||
131922046|NCT00845182|474998963|FG000|Overall Study|Lost to Follow-up|3|||
131922047|NCT00845182|474998964|FG001|Overall Study|Lost to Follow-up|3|||
131922048|NCT00845182|474998965|FG002|Overall Study|Lost to Follow-up|4|||
131922049|NCT00845182|474998963|FG000|Overall Study|Adverse Event|0|||
131922050|NCT00845182|474998964|FG001|Overall Study|Adverse Event|1|||
131922051|NCT00845182|474998965|FG002|Overall Study|Adverse Event|1|||
131922052|NCT00845182|474998963|FG000|Overall Study|Physician Decision|0|||
131922053|NCT00845182|474998964|FG001|Overall Study|Physician Decision|0|||
131922054|NCT00845182|474998965|FG002|Overall Study|Physician Decision|1|||
131922055|NCT01625182|474998966|FG000|Overall Study|Administrative problems|1|||
131922056|NCT01625182|474998967|FG001|Overall Study|Administrative problems|0|||
131922057|NCT01625182|474998966|FG000|Overall Study|Protocol deviation|0|||
131922058|NCT01625182|474998967|FG001|Overall Study|Protocol deviation|2|||
131922059|NCT01625182|474998966|FG000|Overall Study|Adverse Event|2|||
131922060|NCT01625182|474998967|FG001|Overall Study|Adverse Event|0|||
131922061|NCT01625182|474998966|FG000|Overall Study|Withdrawal by Subject|5|||
131922062|NCT01625182|474998967|FG001|Overall Study|Withdrawal by Subject|1|||
131922063|NCT01625182|474998966|FG000|Overall Study|Lack of Efficacy|12|||
131922064|NCT01625182|474998967|FG001|Overall Study|Lack of Efficacy|8|||
131922065|NCT00263562|474998970|FG000|Overall Study|Protocol Violation|3|||
131922066|NCT00263562|474998971|FG001|Overall Study|Protocol Violation|0|||
131922067|NCT05427916|474998972|FG000|Overall Study|Adverse Event|3|||
131922068|NCT05427916|474998973|FG001|Overall Study|Adverse Event|0|||
131922069|NCT05427916|474998972|FG000|Overall Study|Lack of Efficacy|6|||
131922070|NCT05427916|474998973|FG001|Overall Study|Lack of Efficacy|0|||
131922071|NCT05427916|474998972|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
131922072|NCT05427916|474998973|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
131922073|NCT05558410|474998974|FG000|Overall Study|Adverse Event|1|||
131922074|NCT05558410|474998975|FG001|Overall Study|Adverse Event|2|||
131922075|NCT05558410|474998976|FG002|Overall Study|Adverse Event|0|||
131922076|NCT05558410|474998974|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
131922077|NCT05558410|474998975|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
131922078|NCT05558410|474998976|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
131922079|NCT05558410|474998974|FG000|Overall Study|Lost to Follow-up|10|||
131922080|NCT05558410|474998975|FG001|Overall Study|Lost to Follow-up|17|||
131922081|NCT05558410|474998976|FG002|Overall Study|Lost to Follow-up|19|||
131922082|NCT05558410|474998974|FG000|Overall Study|Death|1|||
131922083|NCT05558410|474998975|FG001|Overall Study|Death|0|||
131922084|NCT05558410|474998976|FG002|Overall Study|Death|0|||
131922085|NCT05558410|474998974|FG000|Overall Study|Other non-compliance|0|||
131922086|NCT05558410|474998975|FG001|Overall Study|Other non-compliance|1|||
131922087|NCT05558410|474998976|FG002|Overall Study|Other non-compliance|2|||
131922088|NCT05558410|474998974|FG000|Overall Study|Sponsor Decision|1|||
131408592|NCT00355342|473118369|FG000|Overall Study|COPD exacerbation|1|||
131408593|NCT00355342|473118370|FG001|Overall Study|COPD exacerbation|1|||
131408594|NCT00355342|473118369|FG000|Overall Study|Dispensed wrong study drug kit|1|||
131408595|NCT00355342|473118370|FG001|Overall Study|Dispensed wrong study drug kit|0|||
131408596|NCT00355342|473118369|FG000|Overall Study|Non-compliance with Dexa scans|1|||
131922089|NCT05558410|474998975|FG001|Overall Study|Sponsor Decision|0|||
131922090|NCT05558410|474998976|FG002|Overall Study|Sponsor Decision|0|||
131922091|NCT05558410|474998974|FG000|Overall Study|Other|1|||
131922092|NCT05558410|474998975|FG001|Overall Study|Other|0|||
131922093|NCT05558410|474998976|FG002|Overall Study|Other|1|||
131922094|NCT02265744|474998981|FG000|Overall Study|Poor/Non-compliance|1|||
131922095|NCT02265744|474998982|FG001|Overall Study|Poor/Non-compliance|1|||
131922096|NCT02265744|474998983|FG002|Overall Study|Poor/Non-compliance|0|||
131922097|NCT02265744|474998984|FG003|Overall Study|Poor/Non-compliance|0|||
131922098|NCT02265744|474998985|FG004|Overall Study|Poor/Non-compliance|2|||
131922099|NCT02265744|474998981|FG000|Overall Study|Lost to Follow-up|0|||
131922100|NCT02265744|474998982|FG001|Overall Study|Lost to Follow-up|0|||
131922101|NCT02265744|474998983|FG002|Overall Study|Lost to Follow-up|0|||
131922102|NCT02265744|474998984|FG003|Overall Study|Lost to Follow-up|1|||
131408597|NCT00355342|473118370|FG001|Overall Study|Non-compliance with Dexa scans|0|||
131408598|NCT00355342|473118369|FG000|Overall Study|Withdrawal by participant and physician|1|||
131922103|NCT02265744|474998985|FG004|Overall Study|Lost to Follow-up|0|||
131922104|NCT02265744|474998981|FG000|Overall Study|Death|0|||
131922105|NCT02265744|474998982|FG001|Overall Study|Death|0|||
131922106|NCT02265744|474998983|FG002|Overall Study|Death|0|||
131876103|NCT02829723|474826475|FG005|Overall Study|Study terminated by sponsor|0|||
131876104|NCT02829723|474826476|FG006|Overall Study|Study terminated by sponsor|0|||
131876105|NCT02829723|474826477|FG007|Overall Study|Study terminated by sponsor|0|||
131876106|NCT02829723|474826478|FG008|Overall Study|Study terminated by sponsor|0|||
131876107|NCT02829723|474826479|FG009|Overall Study|Study terminated by sponsor|0|||
131876108|NCT02829723|474826480|FG010|Overall Study|Study terminated by sponsor|0|||
131876109|NCT02829723|474826481|FG011|Overall Study|Study terminated by sponsor|0|||
131876110|NCT02829723|474826482|FG012|Overall Study|Study terminated by sponsor|0|||
131876111|NCT02829723|474826483|FG013|Overall Study|Study terminated by sponsor|0|||
131876112|NCT02829723|474826484|FG014|Overall Study|Study terminated by sponsor|0|||
131876113|NCT02829723|474826485|FG015|Overall Study|Study terminated by sponsor|0|||
131876114|NCT02829723|474826486|FG016|Overall Study|Study terminated by sponsor|0|||
131876115|NCT02829723|474826487|FG017|Overall Study|Study terminated by sponsor|0|||
131876116|NCT02829723|474826488|FG018|Overall Study|Study terminated by sponsor|0|||
131876117|NCT02829723|474826489|FG019|Overall Study|Study terminated by sponsor|0|||
131876118|NCT02829723|474826490|FG020|Overall Study|Study terminated by sponsor|0|||
131876119|NCT02829723|474826491|FG021|Overall Study|Study terminated by sponsor|1|||
131876120|NCT02829723|474826492|FG022|Overall Study|Study terminated by sponsor|0|||
131876121|NCT02829723|474826493|FG023|Overall Study|Study terminated by sponsor|0|||
131876122|NCT02829723|474826494|FG024|Overall Study|Study terminated by sponsor|0|||
131876123|NCT02829723|474826495|FG025|Overall Study|Study terminated by sponsor|0|||
131876124|NCT02829723|474826496|FG026|Overall Study|Study terminated by sponsor|0|||
131876125|NCT02989649|474826497|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
131876126|NCT02989649|474826497|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
131876127|NCT02989649|474826497|FG000|Overall Study|Lost For Observation During Study|3|||
131876128|NCT02989649|474826497|FG000|Overall Study|Reason Not Specified|13|||
131876129|NCT02004886|474826498|FG000|Overall Study|Adverse Event|0|||
131876130|NCT02004886|474826499|FG001|Overall Study|Adverse Event|1|||
131876131|NCT02004886|474826500|FG002|Overall Study|Adverse Event|0|||
131876132|NCT02004886|474826501|FG003|Overall Study|Adverse Event|0|||
131876133|NCT02004886|474826498|FG000|Overall Study|Unable to attend future visits|1|||
131876134|NCT02004886|474826499|FG001|Overall Study|Unable to attend future visits|0|||
131876135|NCT02004886|474826500|FG002|Overall Study|Unable to attend future visits|0|||
131876136|NCT02004886|474826501|FG003|Overall Study|Unable to attend future visits|0|||
131876137|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
131876138|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
131876139|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
131876140|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
131876141|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
131876142|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
131876143|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
131876144|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
131876145|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
131876146|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
131876147|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Death|1|||
131876148|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Death|0|||
131876149|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
131876150|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
131876151|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
131876152|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
131876153|NCT01876784|474826504|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
131876154|NCT01876784|474826505|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
131876155|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
131876156|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
131876157|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Adverse Event|2|||
131876158|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Adverse Event|6|||
131876159|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
131876160|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
131876161|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Progressive disease|4|||
131876162|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Progressive disease|35|||
131876163|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
131876164|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
131876165|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
131922107|NCT02265744|474998984|FG003|Overall Study|Death|2|||
131876166|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
131876167|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Death|0|||
131876168|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Death|1|||
131876169|NCT01876784|474826504|FG000|Open-label Period (31 Months)|Other than specified above|9|||
131876170|NCT01876784|474826505|FG001|Open-label Period (31 Months)|Other than specified above|18|||
131922108|NCT02265744|474998985|FG004|Overall Study|Death|0|||
131922109|NCT02265744|474998981|FG000|Overall Study|Withdrawal by Subject|2|||
131922110|NCT02265744|474998982|FG001|Overall Study|Withdrawal by Subject|0|||
131922111|NCT02265744|474998983|FG002|Overall Study|Withdrawal by Subject|0|||
131922112|NCT02265744|474998984|FG003|Overall Study|Withdrawal by Subject|2|||
131922113|NCT02265744|474998985|FG004|Overall Study|Withdrawal by Subject|0|||
131922114|NCT02265744|474998981|FG000|Overall Study|Participant request to discontinue|2|||
131922115|NCT02265744|474998982|FG001|Overall Study|Participant request to discontinue|2|||
131922116|NCT02265744|474998983|FG002|Overall Study|Participant request to discontinue|2|||
131922117|NCT02265744|474998984|FG003|Overall Study|Participant request to discontinue|0|||
131922118|NCT02265744|474998985|FG004|Overall Study|Participant request to discontinue|0|||
131922119|NCT02265744|474998981|FG000|Overall Study|Adverse Event|8|||
131922120|NCT02265744|474998982|FG001|Overall Study|Adverse Event|4|||
131922121|NCT02265744|474998983|FG002|Overall Study|Adverse Event|9|||
131922122|NCT02265744|474998984|FG003|Overall Study|Adverse Event|8|||
131922123|NCT02265744|474998985|FG004|Overall Study|Adverse Event|2|||
131922124|NCT02265744|474998981|FG000|Overall Study|Lack of Efficacy|2|||
131922125|NCT02265744|474998982|FG001|Overall Study|Lack of Efficacy|4|||
131922126|NCT02265744|474998983|FG002|Overall Study|Lack of Efficacy|3|||
131922127|NCT02265744|474998984|FG003|Overall Study|Lack of Efficacy|4|||
131922128|NCT02265744|474998985|FG004|Overall Study|Lack of Efficacy|5|||
131922129|NCT02265744|474998981|FG000|Overall Study|Reason not provided by Investigator|1|||
131922130|NCT02265744|474998982|FG001|Overall Study|Reason not provided by Investigator|0|||
131922131|NCT02265744|474998983|FG002|Overall Study|Reason not provided by Investigator|0|||
131922132|NCT02265744|474998984|FG003|Overall Study|Reason not provided by Investigator|2|||
131408599|NCT00355342|473118370|FG001|Overall Study|Withdrawal by participant and physician|0|||
131408600|NCT00355342|473118369|FG000|Overall Study|Participant relocated|0|||
131408601|NCT00355342|473118370|FG001|Overall Study|Participant relocated|1|||
131408602|NCT00355342|473118369|FG000|Overall Study|Participant discontinued study drug|0|||
131408603|NCT00355342|473118370|FG001|Overall Study|Participant discontinued study drug|1|||
131408604|NCT00355342|473118369|FG000|Overall Study|Study management|0|||
131876171|NCT03605862|474826506|FG000|Overall Study|Withdrawal by Subject|12|||
131876172|NCT03605862|474826507|FG001|Overall Study|Withdrawal by Subject|9|||
131876173|NCT03605862|474826506|FG000|Overall Study|Adverse Event|2|||
131876174|NCT03605862|474826507|FG001|Overall Study|Adverse Event|1|||
131876175|NCT03605862|474826506|FG000|Overall Study|Physician Decision|3|||
131876176|NCT03605862|474826507|FG001|Overall Study|Physician Decision|1|||
131876177|NCT03605862|474826506|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
131876178|NCT03605862|474826507|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
131876179|NCT03891862|474826508|FG000|Open-label Period|Adverse Event|2|||
131876180|NCT03891862|474826509|FG001|Open-label Period|Adverse Event|0|||
131876181|NCT03891862|474826510|FG002|Open-label Period|Adverse Event|0|||
131876182|NCT03891862|474826508|FG000|Open-label Period|Protocol Violation|5|||
131876183|NCT03891862|474826509|FG001|Open-label Period|Protocol Violation|0|||
131876184|NCT03891862|474826510|FG002|Open-label Period|Protocol Violation|0|||
131876185|NCT03891862|474826508|FG000|Open-label Period|Withdrawal by Subject|6|||
131876186|NCT03891862|474826509|FG001|Open-label Period|Withdrawal by Subject|0|||
131876187|NCT03891862|474826510|FG002|Open-label Period|Withdrawal by Subject|0|||
131876188|NCT03891862|474826508|FG000|Open-label Period|Death|1|||
131876189|NCT03891862|474826509|FG001|Open-label Period|Death|0|||
131876190|NCT03891862|474826510|FG002|Open-label Period|Death|0|||
131876191|NCT03891862|474826508|FG000|Open-label Period|Lost to Follow-up|2|||
131876192|NCT03891862|474826509|FG001|Open-label Period|Lost to Follow-up|0|||
131876193|NCT03891862|474826510|FG002|Open-label Period|Lost to Follow-up|0|||
131876194|NCT03891862|474826508|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
131876195|NCT03891862|474826509|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
131876196|NCT03891862|474826510|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
131876197|NCT03891862|474826508|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
131876198|NCT03891862|474826509|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
131876199|NCT03891862|474826510|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
131876200|NCT03891862|474826508|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
131876201|NCT03891862|474826509|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
131876202|NCT03891862|474826510|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
131876203|NCT03891862|474826508|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
131876204|NCT03891862|474826509|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
131922133|NCT02265744|474998985|FG004|Overall Study|Reason not provided by Investigator|0|||
131922134|NCT02265744|474998981|FG000|Overall Study|Administrative reason by sponsor|3|||
131922135|NCT02265744|474998982|FG001|Overall Study|Administrative reason by sponsor|2|||
131408605|NCT00355342|473118370|FG001|Overall Study|Study management|1|||
131876205|NCT03891862|474826510|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
131876206|NCT05239494|474826511|FG000|Overall Study|Lost to Follow-up|1|||
131922136|NCT02265744|474998983|FG002|Overall Study|Administrative reason by sponsor|2|||
131922137|NCT02265744|474998984|FG003|Overall Study|Administrative reason by sponsor|3|||
131922138|NCT02265744|474998985|FG004|Overall Study|Administrative reason by sponsor|3|||
131922139|NCT02265744|474998981|FG000|Overall Study|Subject no longer meets study criteria|0|||
131922140|NCT02265744|474998982|FG001|Overall Study|Subject no longer meets study criteria|0|||
131922141|NCT02265744|474998983|FG002|Overall Study|Subject no longer meets study criteria|0|||
131922142|NCT02265744|474998984|FG003|Overall Study|Subject no longer meets study criteria|0|||
131922143|NCT02265744|474998985|FG004|Overall Study|Subject no longer meets study criteria|1|||
131922144|NCT02265744|474998981|FG000|Overall Study|Pregnancy|1|||
131922145|NCT02265744|474998982|FG001|Overall Study|Pregnancy|2|||
131922146|NCT02265744|474998983|FG002|Overall Study|Pregnancy|1|||
131922147|NCT02265744|474998984|FG003|Overall Study|Pregnancy|1|||
131922148|NCT02265744|474998985|FG004|Overall Study|Pregnancy|0|||
131922149|NCT02384460|474998990|FG000|Overall Study|Protocol Violation|0|||
131922150|NCT02384460|474998991|FG001|Overall Study|Protocol Violation|1|||
131922151|NCT02384460|474998990|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
131922152|NCT02384460|474998991|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
131922153|NCT02384460|474998990|FG000|Overall Study|Adverse Event|5|||
131922154|NCT02384460|474998991|FG001|Overall Study|Adverse Event|2|||
131922155|NCT02384460|474998990|FG000|Overall Study|Withdrawal by Subject|0|||
131922156|NCT02384460|474998991|FG001|Overall Study|Withdrawal by Subject|3|||
131922157|NCT02384460|474998990|FG000|Overall Study|Elective medical treatment|1|||
131922158|NCT02384460|474998991|FG001|Overall Study|Elective medical treatment|0|||
131922159|NCT02384460|474998990|FG000|Overall Study|Non-compliance|1|||
131922160|NCT02384460|474998991|FG001|Overall Study|Non-compliance|0|||
131922161|NCT01060111|474998992|FG000|Overall Study|Adverse Event|9|||
131922162|NCT01060111|474998993|FG001|Overall Study|Adverse Event|5|||
131922163|NCT01060111|474998994|FG002|Overall Study|Adverse Event|18|||
131922164|NCT01060111|474998992|FG000|Overall Study|Lack of Efficacy|2|||
131922165|NCT01060111|474998993|FG001|Overall Study|Lack of Efficacy|1|||
131922166|NCT01060111|474998994|FG002|Overall Study|Lack of Efficacy|0|||
131922167|NCT01060111|474998992|FG000|Overall Study|Inappropriate participant|5|||
131876207|NCT01194531|474826512|FG000|Overall Study|Withdrawal by Subject|1|||
131876208|NCT01194531|474826513|FG001|Overall Study|Withdrawal by Subject|0|||
131876209|NCT01194531|474826512|FG000|Overall Study|Protocol Violation|4|||
131876210|NCT01194531|474826513|FG001|Overall Study|Protocol Violation|1|||
131876211|NCT01194531|474826512|FG000|Overall Study|Physician Decision|0|||
131876212|NCT01194531|474826513|FG001|Overall Study|Physician Decision|2|||
131876213|NCT04603482|474826514|FG000|Overall Study|Lost to Follow-up|15|||
131876214|NCT04603482|474826515|FG001|Overall Study|Lost to Follow-up|15|||
131876215|NCT04603482|474826516|FG002|Overall Study|Lost to Follow-up|15|||
131876216|NCT03502070|474826520|FG000|Overall Study|Withdrawal by Subject|1|||
131876217|NCT03502070|474826520|FG000|Overall Study|Screen Failure|1|||
131876218|NCT00595517|474826523|FG000|Overall Study|Adverse Event|6|||
131876219|NCT00595517|474826523|FG000|Overall Study|Withdrawal by Subject|4|||
131876220|NCT00595517|474826523|FG000|Overall Study|Protocol Violation|2|||
131876221|NCT00595517|474826523|FG000|Overall Study|Recurrence of ulcer|5|||
131876222|NCT00595517|474826523|FG000|Overall Study|usage of prohibited treatment|1|||
131876223|NCT00595517|474826523|FG000|Overall Study|No intention to attend regularly|1|||
131876224|NCT01167881|474826526|FG000|Overall Study|Adverse Event|47|||
131876225|NCT01167881|474826527|FG001|Overall Study|Adverse Event|51|||
131876226|NCT01167881|474826526|FG000|Overall Study|Lack of Efficacy|4|||
131876227|NCT01167881|474826527|FG001|Overall Study|Lack of Efficacy|7|||
131876228|NCT01167881|474826526|FG000|Overall Study|Non compliant with protocol|9|||
131876229|NCT01167881|474826527|FG001|Overall Study|Non compliant with protocol|18|||
131922168|NCT01060111|474998993|FG001|Overall Study|Inappropriate participant|4|||
131922169|NCT01060111|474998994|FG002|Overall Study|Inappropriate participant|5|||
131922170|NCT01060111|474998992|FG000|Overall Study|Participants' evasion for hospital visit|0|||
131922171|NCT01060111|474998993|FG001|Overall Study|Participants' evasion for hospital visit|3|||
131922172|NCT01060111|474998994|FG002|Overall Study|Participants' evasion for hospital visit|2|||
131922173|NCT01060111|474998992|FG000|Overall Study|Participants' non-cooperation|8|||
131922174|NCT01060111|474998993|FG001|Overall Study|Participants' non-cooperation|6|||
131922175|NCT01060111|474998994|FG002|Overall Study|Participants' non-cooperation|6|||
131922176|NCT01060111|474998992|FG000|Overall Study|Adverse event and insufficient effect|0|||
131922177|NCT01060111|474998993|FG001|Overall Study|Adverse event and insufficient effect|1|||
131922178|NCT01060111|474998994|FG002|Overall Study|Adverse event and insufficient effect|0|||
131922179|NCT01060111|474998992|FG000|Overall Study|Participants' non-cooperation|1|||
131876230|NCT01167881|474826526|FG000|Overall Study|Lost to Follow-up|19|||
131922180|NCT01060111|474998993|FG001|Overall Study|Participants' non-cooperation|0|||
131922181|NCT01060111|474998994|FG002|Overall Study|Participants' non-cooperation|0|||
131922182|NCT01060111|474998992|FG000|Overall Study|Other|2|||
131922183|NCT01060111|474998993|FG001|Overall Study|Other|3|||
131922184|NCT01060111|474998994|FG002|Overall Study|Other|4|||
131876231|NCT01167881|474826527|FG001|Overall Study|Lost to Follow-up|20|||
131876232|NCT01167881|474826526|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
131876233|NCT01167881|474826527|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
131876234|NCT01167881|474826526|FG000|Overall Study|Not treated|4|||
131922185|NCT04999020|474998996|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
131922186|NCT04999020|474998997|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
131922187|NCT04999020|474998998|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
131922188|NCT04999020|474998999|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
131922189|NCT04999020|474998996|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
131922190|NCT04999020|474998997|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
131922191|NCT04999020|474998998|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
131922192|NCT04999020|474998999|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
131922193|NCT04999020|474998996|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
131922194|NCT04999020|474998997|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
131922195|NCT04999020|474998998|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
131922196|NCT04999020|474998999|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
131922197|NCT04999020|474998996|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131922198|NCT04999020|474998997|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131922199|NCT04999020|474998998|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
131922200|NCT04999020|474998999|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
131922201|NCT04999020|474998996|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
131922202|NCT04999020|474998997|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
131922203|NCT04999020|474998998|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
131922204|NCT04999020|474998999|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
131922205|NCT04999020|474998996|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
131922206|NCT04999020|474998997|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
131922207|NCT04999020|474998998|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
131922208|NCT04999020|474998999|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
131922209|NCT04999020|474998996|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
131922210|NCT04999020|474998997|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
131922211|NCT04999020|474998998|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
131922212|NCT04999020|474998999|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
131922213|NCT04999020|474998996|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
131922214|NCT04999020|474998997|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
131922215|NCT04999020|474998998|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
131922216|NCT04999020|474998999|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
131922217|NCT02448043|474999000|FG000|Overall Study|Withdrawal by Subject|2|||
131922218|NCT02448043|474999001|FG001|Overall Study|Withdrawal by Subject|2|||
131922219|NCT02448043|474999000|FG000|Overall Study|Protocol Violation|1|||
131922220|NCT02448043|474999001|FG001|Overall Study|Protocol Violation|2|||
131922221|NCT00997126|474999002|FG000|Overall Study|Physician Decision|7|||
131922222|NCT00997126|474999003|FG001|Overall Study|Physician Decision|11|||
131922223|NCT01327703|474999008|FG000|Second Treatment Period|Adverse Event|1|||
131922224|NCT01327703|474999009|FG001|Second Treatment Period|Adverse Event|1|||
131922225|NCT01327703|474999008|FG000|Second Treatment Period|Protocol Violation|0|||
131922226|NCT01327703|474999009|FG001|Second Treatment Period|Protocol Violation|1|||
131922227|NCT01131585|474999010|FG000|Overall Study|Adverse Event|0|||
131922228|NCT01131585|474999011|FG001|Overall Study|Adverse Event|2|||
131922229|NCT01131585|474999010|FG000|Overall Study|Abnormal laboratory value|1|||
131922230|NCT01131585|474999011|FG001|Overall Study|Abnormal laboratory value|0|||
131922231|NCT01131585|474999010|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131922232|NCT01131585|474999011|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131922233|NCT01131585|474999010|FG000|Overall Study|Protocol Violation|2|||
131922234|NCT01131585|474999011|FG001|Overall Study|Protocol Violation|1|||
131922235|NCT01131585|474999010|FG000|Overall Study|Withdrawal by Subject|3|||
131922236|NCT01131585|474999011|FG001|Overall Study|Withdrawal by Subject|3|||
131922237|NCT01131585|474999010|FG000|Overall Study|Lost to Follow-up|0|||
131922238|NCT01131585|474999011|FG001|Overall Study|Lost to Follow-up|1|||
131922239|NCT01131585|474999010|FG000|Overall Study|Administrative problems|1|||
131922240|NCT01131585|474999011|FG001|Overall Study|Administrative problems|1|||
131922241|NCT01131585|474999010|FG000|Overall Study|Study termination|78|||
131922242|NCT01131585|474999011|FG001|Overall Study|Study termination|32|||
131922243|NCT01860404|474999013|FG000|Overall Study|Lost to Follow-up|3|||
131922244|NCT01860404|474999014|FG001|Overall Study|Lost to Follow-up|4|||
131922245|NCT01860404|474999015|FG002|Overall Study|Lost to Follow-up|1|||
131922246|NCT01860404|474999016|FG003|Overall Study|Lost to Follow-up|6|||
131922247|NCT01860404|474999017|FG004|Overall Study|Lost to Follow-up|4|||
131922248|NCT01860404|474999013|FG000|Overall Study|Withdrawal by Subject|0|||
131922249|NCT01860404|474999014|FG001|Overall Study|Withdrawal by Subject|0|||
131922250|NCT01860404|474999015|FG002|Overall Study|Withdrawal by Subject|4|||
131922251|NCT01860404|474999016|FG003|Overall Study|Withdrawal by Subject|0|||
131922252|NCT01860404|474999017|FG004|Overall Study|Withdrawal by Subject|0|||
131922253|NCT00985790|474999019|FG000|Overall Study|Withdrawal by Subject|1|||
131922254|NCT00985790|474999020|FG001|Overall Study|Withdrawal by Subject|1|||
131922255|NCT00985790|474999019|FG000|Overall Study|Lost to Follow-up|6|||
131922256|NCT00985790|474999020|FG001|Overall Study|Lost to Follow-up|7|||
131922257|NCT04180696|474999028|FG000|Overall Study|Death|5|||
131922258|NCT04180696|474999029|FG001|Overall Study|Death|6|||
131922259|NCT04180696|474999028|FG000|Overall Study|Lost to Follow-up|1|||
131922260|NCT04180696|474999029|FG001|Overall Study|Lost to Follow-up|0|||
131922261|NCT04180696|474999028|FG000|Overall Study|Withdrawal by Subject|0|||
131922262|NCT04180696|474999029|FG001|Overall Study|Withdrawal by Subject|1|||
131922263|NCT04210375|474999030|FG000|Overall Study|Death|0|||
131922264|NCT04210375|474999031|FG001|Overall Study|Death|1|||
131922265|NCT04210375|474999032|FG002|Overall Study|Death|0|||
131922266|NCT04210375|474999033|FG003|Overall Study|Death|0|||
131922267|NCT00424008|474999034|FG000|Overall Study|Adverse Event|8|||
131922268|NCT00424008|474999035|FG001|Overall Study|Adverse Event|6|||
131922269|NCT00424008|474999034|FG000|Overall Study|Lack of Efficacy|40|||
131922270|NCT00424008|474999035|FG001|Overall Study|Lack of Efficacy|34|||
131922271|NCT00424008|474999034|FG000|Overall Study|Lost to Follow-up|1|||
131922272|NCT00424008|474999035|FG001|Overall Study|Lost to Follow-up|2|||
131922273|NCT00424008|474999034|FG000|Overall Study|Withdrawal by Subject|5|||
131922274|NCT00424008|474999035|FG001|Overall Study|Withdrawal by Subject|8|||
131922275|NCT00424008|474999034|FG000|Overall Study|Noncompliance with protocol|13|||
131922276|NCT00424008|474999035|FG001|Overall Study|Noncompliance with protocol|7|||
131922277|NCT00424008|474999034|FG000|Overall Study|Did not meet protocol eligibility|16|||
131922278|NCT00424008|474999035|FG001|Overall Study|Did not meet protocol eligibility|21|||
131922279|NCT00424008|474999034|FG000|Overall Study|Administrative|266|||
131922280|NCT00424008|474999035|FG001|Overall Study|Administrative|257|||
131922281|NCT02593864|474999038|FG000|Overall Study|Withdrawal by Subject|3|||
131922282|NCT02593864|474999038|FG000|Overall Study|Lost to Follow-up|3|||
131922283|NCT01405911|474999039|FG000|Overall Study|Pre-treatment lab AE|0|||
131922284|NCT01405911|474999040|FG001|Overall Study|Pre-treatment lab AE|1|||
131922285|NCT01405911|474999041|FG002|Overall Study|Pre-treatment lab AE|0|||
131922286|NCT01405911|474999039|FG000|Overall Study|Lost to Follow-up|0|||
131922287|NCT01405911|474999040|FG001|Overall Study|Lost to Follow-up|1|||
131922288|NCT01405911|474999041|FG002|Overall Study|Lost to Follow-up|0|||
131922289|NCT01405911|474999039|FG000|Overall Study|Protocol Violation|1|||
131922290|NCT01405911|474999040|FG001|Overall Study|Protocol Violation|0|||
131922291|NCT01405911|474999041|FG002|Overall Study|Protocol Violation|0|||
131922292|NCT01405911|474999039|FG000|Overall Study|Withdrawal by Subject|3|||
131922293|NCT01405911|474999040|FG001|Overall Study|Withdrawal by Subject|1|||
131922294|NCT01405911|474999041|FG002|Overall Study|Withdrawal by Subject|1|||
131922295|NCT04739709|474999042|FG000|Overall Study|Physician Decision|1|||
131922296|NCT04739709|474999043|FG001|Overall Study|Physician Decision|0|||
131922297|NCT04124965|474999047|FG000|Overall Study|Adverse event, non-fatal|3|||
131922298|NCT04124965|474999048|FG001|Overall Study|Adverse event, non-fatal|1|||
131922299|NCT04124965|474999047|FG000|Overall Study|Withdrawal by Subject|1|||
131922300|NCT04124965|474999048|FG001|Overall Study|Withdrawal by Subject|1|||
131922301|NCT04124965|474999047|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
131922302|NCT04124965|474999048|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
131922303|NCT04124965|474999047|FG000|Overall Study|Pregnancy|1|||
131922304|NCT04124965|474999048|FG001|Overall Study|Pregnancy|0|||
131922305|NCT04124965|474999047|FG000|Overall Study|Sponsor and participant decision|0|||
131922306|NCT04124965|474999048|FG001|Overall Study|Sponsor and participant decision|1|||
131922307|NCT04124965|474999047|FG000|Overall Study|Personal surgery|0|||
131922308|NCT04124965|474999048|FG001|Overall Study|Personal surgery|1|||
131922309|NCT04124965|474999047|FG000|Overall Study|Physician Decision|0|||
131922310|NCT04124965|474999048|FG001|Overall Study|Physician Decision|1|||
131922311|NCT02184156|474999049|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
131922312|NCT02184156|474999050|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
131922313|NCT02184156|474999049|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
131922314|NCT02184156|474999050|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
131922315|NCT00002874|474999055|FG000|Overall Study|Withdrawal by Subject|1|||
131922316|NCT00002874|474999056|FG001|Overall Study|Withdrawal by Subject|1|||
131922317|NCT00002874|474999055|FG000|Overall Study|Protocol Violation|44|||
131922318|NCT00002874|474999056|FG001|Overall Study|Protocol Violation|34|||
131922319|NCT02530242|474999064|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
131453955|NCT02023697|473291845|FG001|Treatment Period|Adverse Event|25|||
131922320|NCT02530242|474999065|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
131922321|NCT00283959|474999066|FG000|Extension Period|Low Compliance|1|||
131453956|NCT02023697|473291846|FG002|Treatment Period|Adverse Event|23|||
131453957|NCT02023697|473291844|FG000|Treatment Period|Logistical difficulties|1|||
131922322|NCT05591755|474999067|FG000|Overall Study|Screen Failure|1|||
131922323|NCT05591755|474999068|FG001|Overall Study|Screen Failure|0|||
131922324|NCT05591755|474999069|FG002|Overall Study|Screen Failure|0|||
131922325|NCT05591755|474999070|FG003|Overall Study|Screen Failure|0|||
131922326|NCT05591755|474999067|FG000|Overall Study|Protocol Violation|0|||
131922327|NCT05591755|474999068|FG001|Overall Study|Protocol Violation|0|||
131922328|NCT05591755|474999069|FG002|Overall Study|Protocol Violation|2|||
131453958|NCT02023697|473291845|FG001|Treatment Period|Logistical difficulties|1|||
131922329|NCT05591755|474999070|FG003|Overall Study|Protocol Violation|0|||
131922330|NCT05591755|474999067|FG000|Overall Study|Withdrawal by Subject|0|||
131408606|NCT00355342|473118369|FG000|Overall Study|Protocol Violation|0|||
131408607|NCT00355342|473118370|FG001|Overall Study|Protocol Violation|1|||
131408608|NCT00355342|473118369|FG000|Overall Study|Use of protocol excluded medication|0|||
131408609|NCT00355342|473118370|FG001|Overall Study|Use of protocol excluded medication|1|||
131408610|NCT00434759|473118371|FG000|Overall Study|Lack of Efficacy|5|||
131408611|NCT00434759|473118372|FG001|Overall Study|Lack of Efficacy|4|||
131408612|NCT00434759|473118371|FG000|Overall Study|Withdrawal by Subject|17|||
131408613|NCT00434759|473118372|FG001|Overall Study|Withdrawal by Subject|1|||
131408614|NCT00434759|473118371|FG000|Overall Study|family affairs|2|||
131408615|NCT00434759|473118372|FG001|Overall Study|family affairs|0|||
131408616|NCT00495521|473118378|FG000|Overall Study|Physician Decision|0|||
131408617|NCT00495521|473118379|FG001|Overall Study|Physician Decision|1|||
131408618|NCT01300819|473118380|FG000|Overall Study|Adverse Event|9|||
131408619|NCT01300819|473118381|FG001|Overall Study|Adverse Event|27|||
131408620|NCT01300819|473118380|FG000|Overall Study|Lack of Efficacy|2|||
131408621|NCT01300819|473118381|FG001|Overall Study|Lack of Efficacy|1|||
131408622|NCT01300819|473118380|FG000|Overall Study|Withdrawal by Subject|10|||
131408623|NCT01300819|473118381|FG001|Overall Study|Withdrawal by Subject|12|||
131408624|NCT01300819|473118380|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
131408625|NCT01300819|473118381|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
131408626|NCT01300819|473118380|FG000|Overall Study|Refusal to down titrate study drug|0|||
131408627|NCT01300819|473118381|FG001|Overall Study|Refusal to down titrate study drug|1|||
131408628|NCT01300819|473118380|FG000|Overall Study|Administrative reason|0|||
131408629|NCT01300819|473118381|FG001|Overall Study|Administrative reason|1|||
131408630|NCT01300819|473118380|FG000|Overall Study|Safety follow up not done by mistake|0|||
131408631|NCT01300819|473118381|FG001|Overall Study|Safety follow up not done by mistake|1|||
131408632|NCT01300819|473118380|FG000|Overall Study|Follow up call was not done|1|||
131408633|NCT01300819|473118381|FG001|Overall Study|Follow up call was not done|0|||
131408634|NCT01038713|473118382|FG000|Overall Study|Patient to hospice|1|||
131408635|NCT01038713|473118383|FG001|Overall Study|Patient to hospice|1|||
131408636|NCT01038713|473118384|FG002|Overall Study|Patient to hospice|1|||
131408637|NCT01038713|473118382|FG000|Overall Study|Lost to Follow-up|3|||
131408638|NCT01038713|473118383|FG001|Overall Study|Lost to Follow-up|0|||
131408639|NCT01038713|473118384|FG002|Overall Study|Lost to Follow-up|0|||
131408640|NCT01038713|473118382|FG000|Overall Study|Neuroendocrine Tumor|0|||
131408641|NCT01038713|473118383|FG001|Overall Study|Neuroendocrine Tumor|1|||
131408642|NCT01038713|473118384|FG002|Overall Study|Neuroendocrine Tumor|0|||
131408643|NCT01038713|473118382|FG000|Overall Study|died from PEP|0|||
131408644|NCT01038713|473118383|FG001|Overall Study|died from PEP|1|||
131408645|NCT01038713|473118384|FG002|Overall Study|died from PEP|0|||
131408646|NCT01038713|473118382|FG000|Overall Study|Autoimmune Pancreatitis|1|||
131408647|NCT01038713|473118383|FG001|Overall Study|Autoimmune Pancreatitis|0|||
131408648|NCT01038713|473118384|FG002|Overall Study|Autoimmune Pancreatitis|0|||
131408649|NCT02818036|473118385|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
131408650|NCT02818036|473118386|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
131408651|NCT02818036|473118385|FG000|Overall Study|Withdrawal by Subject|1|||
131408652|NCT02818036|473118386|FG001|Overall Study|Withdrawal by Subject|0|||
131876235|NCT01167881|474826527|FG001|Overall Study|Not treated|0|||
131876236|NCT01167881|474826526|FG000|Overall Study|Other not defined above|31|||
131876237|NCT01167881|474826527|FG001|Overall Study|Other not defined above|55|||
131876238|NCT01046903|474826528|FG000|Overall Study|Lost to Follow-up|16|||
131876239|NCT01046903|474826528|FG000|Overall Study|Adverse Event|4|||
131876240|NCT01046903|474826528|FG000|Overall Study|Withdrawal by Subject|3|||
131876241|NCT01046903|474826528|FG000|Overall Study|Other|5|||
131876242|NCT00977314|474826529|FG000|Overall Study|Withdrawal by Subject|1|||
131876243|NCT00977314|474826530|FG001|Overall Study|Withdrawal by Subject|0|||
131876244|NCT00977314|474826529|FG000|Overall Study|Physician Decision|1|||
131876245|NCT00977314|474826530|FG001|Overall Study|Physician Decision|0|||
131876246|NCT02107859|474826531|FG000|Overall Study|Withdrawal by Subject|14|||
131876247|NCT02107859|474826531|FG000|Overall Study|Adverse Event|3|||
131876248|NCT02107859|474826531|FG000|Overall Study|Study closure|41|||
131876249|NCT02107859|474826531|FG000|Overall Study|Other than specified|3|||
131876250|NCT01894100|474826534|FG000|Overall Study|Lost to Follow-up|0|||
131876251|NCT01894100|474826535|FG001|Overall Study|Lost to Follow-up|1|||
131876252|NCT01894100|474826534|FG000|Overall Study|Withdrawal by Subject|3|||
131876253|NCT01894100|474826535|FG001|Overall Study|Withdrawal by Subject|0|||
131876254|NCT00135512|474826536|FG000|Overall Study|Adverse Event|56|||
131876255|NCT00135512|474826536|FG000|Overall Study|Lack of Efficacy|25|||
131876256|NCT00135512|474826536|FG000|Overall Study|Other|42|||
131876257|NCT01094301|474826537|FG000|Trial Stage|Withdrawal by Subject|1|||
131876258|NCT01094301|474826537|FG000|Implant Stage|Adverse Event|1|||
131876259|NCT01094301|474826537|FG000|Implant Stage|Protocol Violation|1|||
131876260|NCT01094301|474826537|FG000|Implant Stage|Withdrawal by Subject|2|||
131876261|NCT01094301|474826537|FG000|Implant Stage|No return of pain|4|||
131876262|NCT02235077|474826538|FG000|Overall Study|Death|5|||
131876263|NCT02235077|474826539|FG001|Overall Study|Death|7|||
131876264|NCT02235077|474826538|FG000|Overall Study|Lost to Follow-up|5|||
131408653|NCT03777917|473118392|FG000|Overall Study|Withdrawal by Subject|1|||
131408654|NCT03777917|473118393|FG001|Overall Study|Withdrawal by Subject|0|||
131408655|NCT03777917|473118392|FG000|Overall Study|Physician Decision|1|||
131408656|NCT03777917|473118393|FG001|Overall Study|Physician Decision|0|||
131408657|NCT03777917|473118392|FG000|Overall Study|Lost to Follow-up|6|||
131408658|NCT03777917|473118393|FG001|Overall Study|Lost to Follow-up|2|||
131408659|NCT03777917|473118392|FG000|Overall Study|Other|1|||
131408660|NCT03777917|473118393|FG001|Overall Study|Other|0|||
131408661|NCT01154283|473118394|FG000|0-6 Weeks|Withdrawal by Subject|7|||
131408662|NCT01154283|473118395|FG001|0-6 Weeks|Withdrawal by Subject|2|||
131408663|NCT01154283|473118394|FG000|0-6 Weeks|Death|0|||
131408664|NCT01154283|473118395|FG001|0-6 Weeks|Death|1|||
131408665|NCT01154283|473118394|FG000|7-12 Weeks|Death|1|||
131408666|NCT01154283|473118395|FG001|7-12 Weeks|Death|0|||
131408667|NCT01154283|473118394|FG000|7-12 Weeks|Withdrawal by Subject|0|||
131408668|NCT01154283|473118395|FG001|7-12 Weeks|Withdrawal by Subject|1|||
131408669|NCT00042432|473118396|FG000|Overall Study|Adverse Event|4|||
131408670|NCT00042432|473118397|FG001|Overall Study|Adverse Event|1|||
131408671|NCT00042432|473118396|FG000|Overall Study|Withdrawal by Subject|1|||
131408672|NCT00042432|473118397|FG001|Overall Study|Withdrawal by Subject|3|||
131408673|NCT00042432|473118396|FG000|Overall Study|Death|0|||
131408674|NCT00042432|473118397|FG001|Overall Study|Death|2|||
131408675|NCT00042432|473118396|FG000|Overall Study|Ineligibility determined|1|||
131408676|NCT00042432|473118397|FG001|Overall Study|Ineligibility determined|0|||
131408677|NCT00042432|473118396|FG000|Overall Study|Initiation of maintenance dialysis|1|||
131408678|NCT00042432|473118397|FG001|Overall Study|Initiation of maintenance dialysis|1|||
131408679|NCT00042432|473118396|FG000|Overall Study|Other|2|||
131408680|NCT00042432|473118397|FG001|Overall Study|Other|0|||
131408681|NCT02966795|473118398|FG000|Overall Study|Patient Left the Country|0|||
131408682|NCT02966795|473118399|FG001|Overall Study|Patient Left the Country|1|||
131408683|NCT00432744|473118400|FG000|Months 0-6|Withdrawal by Subject|4|||
131408684|NCT00432744|473118401|FG001|Months 0-6|Withdrawal by Subject|4|||
131408685|NCT00432744|473118400|FG000|Months 0-6|Too disabled to score|1|||
131408686|NCT00432744|473118401|FG001|Months 0-6|Too disabled to score|0|||
131408687|NCT00432744|473118400|FG000|Months 7 - 12|Withdrawal by Subject|1|||
131408688|NCT00432744|473118401|FG001|Months 7 - 12|Withdrawal by Subject|0|||
131408689|NCT00432744|473118400|FG000|Months 7 - 12|Too disabled to score|0|||
131408690|NCT00432744|473118401|FG001|Months 7 - 12|Too disabled to score|1|||
131408691|NCT00468845|473118404|FG000|Overall Study|Adverse Event|9|||
131408692|NCT00468845|473118405|FG001|Overall Study|Adverse Event|14|||
131408693|NCT00468845|473118406|FG002|Overall Study|Adverse Event|11|||
131408694|NCT00468845|473118404|FG000|Overall Study|Lost to Follow-up|2|||
131408695|NCT00468845|473118405|FG001|Overall Study|Lost to Follow-up|1|||
131876265|NCT02235077|474826539|FG001|Overall Study|Lost to Follow-up|6|||
131876266|NCT02235077|474826538|FG000|Overall Study|Withdrawal by Subject|8|||
131876267|NCT02235077|474826539|FG001|Overall Study|Withdrawal by Subject|5|||
131876268|NCT02235077|474826538|FG000|Overall Study|Physician Decision|0|||
131876269|NCT02235077|474826539|FG001|Overall Study|Physician Decision|1|||
131876270|NCT04013672|474826540|FG000|Overall Study|Withdrawal by Subject|3|||
131876271|NCT04013672|474826541|FG001|Overall Study|Withdrawal by Subject|0|||
131876272|NCT04013672|474826540|FG000|Overall Study|Death|1|||
131408696|NCT00468845|473118406|FG002|Overall Study|Lost to Follow-up|2|||
131408697|NCT00468845|473118404|FG000|Overall Study|Other|4|||
131408698|NCT00468845|473118405|FG001|Overall Study|Other|9|||
131408699|NCT00468845|473118406|FG002|Overall Study|Other|5|||
131408700|NCT00468845|473118404|FG000|Overall Study|No longer willing to participate|5|||
131408701|NCT00468845|473118405|FG001|Overall Study|No longer willing to participate|6|||
131453959|NCT02023697|473291846|FG002|Treatment Period|Logistical difficulties|1|||
131876273|NCT04013672|474826541|FG001|Overall Study|Death|0|||
131876274|NCT04013672|474826540|FG000|Overall Study|Physician Decision|5|||
131876275|NCT04013672|474826541|FG001|Overall Study|Physician Decision|0|||
131876276|NCT01628198|474826544|FG000|Overall Study|Lost to Follow-up|7|||
131408702|NCT00468845|473118406|FG002|Overall Study|No longer willing to participate|10|||
131408703|NCT00468845|473118404|FG000|Overall Study|Randomized, not treated|1|||
131408704|NCT00468845|473118405|FG001|Overall Study|Randomized, not treated|4|||
131408705|NCT00468845|473118406|FG002|Overall Study|Randomized, not treated|2|||
131408706|NCT00461305|473118407|FG000|Treatment|Adverse Event|26|||
131408707|NCT00461305|473118408|FG001|Treatment|Adverse Event|3|||
131408708|NCT00461305|473118407|FG000|Treatment|Lost to Follow-up|4|||
131408709|NCT00461305|473118408|FG001|Treatment|Lost to Follow-up|2|||
131408710|NCT00461305|473118407|FG000|Treatment|Protocol Violation|13|||
131408711|NCT00461305|473118408|FG001|Treatment|Protocol Violation|2|||
131876277|NCT01628198|474826544|FG000|Overall Study|Withdrawal by Subject|10|||
131408712|NCT00461305|473118407|FG000|Treatment|Withdrawal by Subject|48|||
131453960|NCT02023697|473291844|FG000|Treatment Period|Clinical progression|10|||
131408713|NCT00461305|473118408|FG001|Treatment|Withdrawal by Subject|2|||
131408714|NCT00461305|473118407|FG000|Treatment|Never dispensed|5|||
131408715|NCT00461305|473118408|FG001|Treatment|Never dispensed|0|||
131408716|NCT00461305|473118407|FG000|Treatment|Study drug not taken|1|||
131408717|NCT00461305|473118408|FG001|Treatment|Study drug not taken|0|||
131876278|NCT01628198|474826544|FG000|Overall Study|Screen failure|1|||
131876279|NCT01827267|474826545|FG000|Overall Study|Did not receive study drug|1|||
131876280|NCT01827267|474826546|FG001|Overall Study|Did not receive study drug|1|||
131876281|NCT01827267|474826545|FG000|Overall Study|Physician Decision|1|||
131876282|NCT01827267|474826546|FG001|Overall Study|Physician Decision|0|||
131876283|NCT01827267|474826545|FG000|Overall Study|Disease Progression|1|||
131876284|NCT01827267|474826546|FG001|Overall Study|Disease Progression|1|||
131876285|NCT01827267|474826545|FG000|Overall Study|Sponsor Discontinued Study|2|||
131876286|NCT01827267|474826546|FG001|Overall Study|Sponsor Discontinued Study|8|||
131876287|NCT01827267|474826545|FG000|Overall Study|Still on study|0|||
131876288|NCT01827267|474826546|FG001|Overall Study|Still on study|2|||
131876289|NCT00813813|474826553|FG000|Overall Study|Withdrawal by Subject|1|||
131876290|NCT00813813|474826554|FG001|Overall Study|Withdrawal by Subject|1|||
131876291|NCT00813813|474826553|FG000|Overall Study|Lost to Follow-up|2|||
131876292|NCT00813813|474826554|FG001|Overall Study|Lost to Follow-up|7|||
131876293|NCT00813813|474826553|FG000|Overall Study|Other|0|||
131876294|NCT00813813|474826554|FG001|Overall Study|Other|1|||
131876295|NCT00986921|474826555|FG000|Overall Study|Physician Decision|1|||
131876296|NCT00986921|474826556|FG001|Overall Study|Physician Decision|0|||
131876297|NCT02778074|474826557|FG000|Overall Study|Lost to Follow-up|7|||
131876298|NCT02778074|474826558|FG001|Overall Study|Lost to Follow-up|10|||
131876299|NCT01684943|474826559|FG000|Overall Study|Inadequate Venous Access|3|||
131876300|NCT01684943|474826560|FG001|Overall Study|Inadequate Venous Access|0|||
131876301|NCT01684943|474826561|FG002|Overall Study|Inadequate Venous Access|0|||
131876302|NCT01684943|474826559|FG000|Overall Study|Principal Investigator Determination|1|||
131876303|NCT01684943|474826560|FG001|Overall Study|Principal Investigator Determination|0|||
131876304|NCT01684943|474826561|FG002|Overall Study|Principal Investigator Determination|0|||
131876305|NCT01684943|474826559|FG000|Overall Study|Excluded from Analysis|1|||
131876306|NCT01684943|474826560|FG001|Overall Study|Excluded from Analysis|1|||
131876307|NCT01684943|474826561|FG002|Overall Study|Excluded from Analysis|1|||
131876308|NCT01684943|474826559|FG000|Overall Study|Lost to Follow-up|3|||
131876309|NCT01684943|474826560|FG001|Overall Study|Lost to Follow-up|0|||
131876310|NCT01684943|474826561|FG002|Overall Study|Lost to Follow-up|0|||
131876311|NCT01684943|474826559|FG000|Overall Study|Planning Pregnancy|1|||
131876312|NCT01684943|474826560|FG001|Overall Study|Planning Pregnancy|0|||
131876313|NCT01684943|474826561|FG002|Overall Study|Planning Pregnancy|0|||
131876314|NCT01672710|474826564|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
131876315|NCT01672710|474826565|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
131876316|NCT01672710|474826564|FG000|3 Month Follow up|Lost to Follow-up|2|||
131876317|NCT01672710|474826565|FG001|3 Month Follow up|Lost to Follow-up|3|||
131876318|NCT01672710|474826564|FG000|3 Month Follow up|follow up due after termination date|4|||
131876319|NCT01672710|474826565|FG001|3 Month Follow up|follow up due after termination date|1|||
131876320|NCT04999163|474826566|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
131876321|NCT04999163|474826567|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
131876322|NCT04999163|474826566|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
131876323|NCT04999163|474826567|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
131876324|NCT04999163|474826566|FG000|Overall Study|Withdrawal by Subject|1|||
131876325|NCT04999163|474826567|FG001|Overall Study|Withdrawal by Subject|0|||
131876326|NCT03917472|474828987|FG000|Overall Study|Physician Decision|4|||
131876327|NCT03917472|474828988|FG001|Overall Study|Physician Decision|0|||
131876328|NCT03917472|474828987|FG000|Overall Study|Adverse Event|3|||
131876329|NCT03917472|474828988|FG001|Overall Study|Adverse Event|1|||
131876330|NCT03917472|474828987|FG000|Overall Study|Death|7|||
131876331|NCT03917472|474828988|FG001|Overall Study|Death|5|||
131876332|NCT03917472|474828987|FG000|Overall Study|Withdrawal by Subject|11|||
131876333|NCT03917472|474828988|FG001|Overall Study|Withdrawal by Subject|4|||
131876334|NCT03917472|474828987|FG000|Overall Study|Lost to Follow-up|10|||
131876335|NCT03917472|474828988|FG001|Overall Study|Lost to Follow-up|5|||
131876336|NCT01953601|474828992|FG000|Part 1 (Base Study)|Adverse Event|24|||
131876337|NCT01953601|474828993|FG001|Part 1 (Base Study)|Adverse Event|37|||
131876338|NCT01953601|474828994|FG002|Part 1 (Base Study)|Adverse Event|15|||
131876339|NCT01953601|474828992|FG000|Part 1 (Base Study)|Death|2|||
131876340|NCT01953601|474828993|FG001|Part 1 (Base Study)|Death|0|||
131876341|NCT01953601|474828994|FG002|Part 1 (Base Study)|Death|3|||
131876342|NCT01953601|474828992|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
131876343|NCT01953601|474828993|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
131876344|NCT01953601|474828994|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
131876345|NCT01953601|474828992|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
131876346|NCT01953601|474828993|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
131876347|NCT01953601|474828994|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
131876348|NCT01953601|474828992|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
131876349|NCT01953601|474828993|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
131876350|NCT01953601|474828994|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
131876351|NCT01953601|474828992|FG000|Part 1 (Base Study)|Physician Decision|3|||
131876352|NCT01953601|474828993|FG001|Part 1 (Base Study)|Physician Decision|7|||
131876353|NCT01953601|474828994|FG002|Part 1 (Base Study)|Physician Decision|4|||
131876354|NCT01953601|474828992|FG000|Part 1 (Base Study)|Screen failure|1|||
131876355|NCT01953601|474828993|FG001|Part 1 (Base Study)|Screen failure|0|||
131876356|NCT01953601|474828994|FG002|Part 1 (Base Study)|Screen failure|1|||
131876357|NCT01953601|474828992|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
131876358|NCT01953601|474828993|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
131876359|NCT01953601|474828994|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
131876360|NCT01953601|474828992|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
131876361|NCT01953601|474828993|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
131876362|NCT01953601|474828994|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
131876363|NCT01953601|474828992|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
131876364|NCT01953601|474828993|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
131876365|NCT01953601|474828994|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
131876366|NCT01953601|474828992|FG000|Part 1 (Base Study)|Subject moved|2|||
131876367|NCT01953601|474828993|FG001|Part 1 (Base Study)|Subject moved|2|||
131876368|NCT01953601|474828994|FG002|Part 1 (Base Study)|Subject moved|1|||
131876369|NCT01953601|474828992|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
131876370|NCT01953601|474828993|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
131876371|NCT01953601|474828994|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
131876372|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Adverse Event|1|||
131876373|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Adverse Event|1|||
131876374|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Adverse Event|10|||
131876375|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Death|0|||
131876376|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Death|3|||
131876377|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Death|0|||
131876378|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
131876379|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
131876380|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
131876381|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
131876382|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
131876383|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
131876384|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Physician Decision|2|||
131876385|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Physician Decision|0|||
131876386|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Physician Decision|2|||
131876387|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
131876388|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
131876389|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
131876390|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
131876391|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
131876392|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
131876393|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
131876394|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
131876395|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
131876396|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Subject moved|0|||
131876397|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Subject moved|0|||
131876398|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Subject moved|1|||
131876399|NCT01953601|474828992|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
131876400|NCT01953601|474828993|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
131876401|NCT01953601|474828994|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
131876402|NCT00452673|474828998|FG000|Dose Escalation Period|Disease Progression|6|||
131876403|NCT00452673|474828999|FG001|Dose Escalation Period|Disease Progression|6|||
131876404|NCT00452673|474829000|FG002|Dose Escalation Period|Disease Progression|2|||
131876405|NCT00452673|474829001|FG003|Dose Escalation Period|Disease Progression|6|||
131876406|NCT00452673|474829002|FG004|Dose Escalation Period|Disease Progression|0|||
131876407|NCT00452673|474828998|FG000|Dose Escalation Period|study drug toxicity|1|||
131876408|NCT00452673|474828999|FG001|Dose Escalation Period|study drug toxicity|3|||
131876409|NCT00452673|474829000|FG002|Dose Escalation Period|study drug toxicity|3|||
131876410|NCT00452673|474829001|FG003|Dose Escalation Period|study drug toxicity|1|||
131876411|NCT00452673|474829002|FG004|Dose Escalation Period|study drug toxicity|0|||
131876412|NCT00452673|474828998|FG000|Dose Escalation Period|Other|0|||
131876413|NCT00452673|474828999|FG001|Dose Escalation Period|Other|0|||
131876414|NCT00452673|474829000|FG002|Dose Escalation Period|Other|1|||
131876415|NCT00452673|474829001|FG003|Dose Escalation Period|Other|0|||
131876416|NCT00452673|474829002|FG004|Dose Escalation Period|Other|0|||
131876417|NCT00452673|474828998|FG000|Dose Escalation Period|Adverse Event|0|||
131876418|NCT00452673|474828999|FG001|Dose Escalation Period|Adverse Event|0|||
131876419|NCT00452673|474829000|FG002|Dose Escalation Period|Adverse Event|0|||
131876420|NCT00452673|474829001|FG003|Dose Escalation Period|Adverse Event|1|||
131876421|NCT00452673|474829002|FG004|Dose Escalation Period|Adverse Event|0|||
131876422|NCT00452673|474828998|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
131876423|NCT00452673|474828999|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
131876424|NCT00452673|474829000|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
131876425|NCT00452673|474829001|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
131876426|NCT00452673|474829002|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
131876427|NCT00452673|474828998|FG000|Dose Expansion Period|Disease Progression|0|||
131876428|NCT00452673|474828999|FG001|Dose Expansion Period|Disease Progression|0|||
131876429|NCT00452673|474829000|FG002|Dose Expansion Period|Disease Progression|0|||
131876430|NCT00452673|474829001|FG003|Dose Expansion Period|Disease Progression|0|||
131876431|NCT00452673|474829002|FG004|Dose Expansion Period|Disease Progression|19|||
131876432|NCT00452673|474828998|FG000|Dose Expansion Period|Other|0|||
131876433|NCT00452673|474828999|FG001|Dose Expansion Period|Other|0|||
131876434|NCT00452673|474829000|FG002|Dose Expansion Period|Other|0|||
131876435|NCT00452673|474829001|FG003|Dose Expansion Period|Other|0|||
131876436|NCT00452673|474829002|FG004|Dose Expansion Period|Other|2|||
131876437|NCT02656290|474829003|FG000|Overall Study|Lost to Follow-up|1|||
131876438|NCT02656290|474829003|FG000|Overall Study|Reintervention|3|||
131876439|NCT01943851|474829007|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876440|NCT01943851|474829008|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876441|NCT01943851|474829009|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876442|NCT01943851|474829010|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
131876443|NCT01943851|474829011|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876444|NCT01943851|474829012|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876445|NCT01943851|474829013|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
131876446|NCT01943851|474829014|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
131876447|NCT01943851|474829015|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
131876448|NCT01943851|474829016|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876449|NCT01943851|474829017|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876450|NCT01943851|474829018|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876451|NCT01943851|474829019|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876452|NCT01943851|474829020|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876453|NCT01943851|474829021|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876454|NCT01943851|474829022|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876455|NCT01943851|474829023|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876456|NCT01943851|474829024|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
131876457|NCT01943851|474829007|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876458|NCT01943851|474829008|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876459|NCT01943851|474829009|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876460|NCT01943851|474829010|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876461|NCT01943851|474829011|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
131876462|NCT01943851|474829012|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876463|NCT01943851|474829013|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876464|NCT01943851|474829014|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
131876465|NCT01943851|474829015|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876466|NCT01943851|474829016|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876467|NCT01943851|474829017|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876468|NCT01943851|474829018|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876469|NCT01943851|474829019|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876470|NCT01943851|474829020|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876471|NCT01943851|474829021|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876472|NCT01943851|474829022|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876473|NCT01943851|474829023|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876474|NCT01943851|474829024|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
131876475|NCT01943851|474829007|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876476|NCT01943851|474829008|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876477|NCT01943851|474829009|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876478|NCT01943851|474829010|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876479|NCT01943851|474829011|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876480|NCT01943851|474829012|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876481|NCT01943851|474829013|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876482|NCT01943851|474829014|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876483|NCT01943851|474829015|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876484|NCT01943851|474829016|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876485|NCT01943851|474829017|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876486|NCT01943851|474829018|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876487|NCT01943851|474829019|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876488|NCT01943851|474829020|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
131876489|NCT01943851|474829021|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876490|NCT01943851|474829022|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876491|NCT01943851|474829023|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876492|NCT01943851|474829024|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
131876493|NCT01943851|474829007|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876494|NCT01943851|474829008|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131408718|NCT00461305|473118407|FG000|Treatment|Partially missing diary|2|||
131876495|NCT01943851|474829009|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876496|NCT01943851|474829010|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876497|NCT01943851|474829011|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876498|NCT01943851|474829012|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876499|NCT01943851|474829013|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876500|NCT01943851|474829014|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876501|NCT01943851|474829015|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876502|NCT01943851|474829016|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876503|NCT01943851|474829017|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876504|NCT01943851|474829018|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876505|NCT01943851|474829019|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876506|NCT01943851|474829020|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876507|NCT01943851|474829021|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876508|NCT01943851|474829022|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
131876509|NCT01943851|474829023|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876510|NCT01943851|474829024|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
131876511|NCT01943851|474829007|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876512|NCT01943851|474829008|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876513|NCT01943851|474829009|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876514|NCT01943851|474829010|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876515|NCT01943851|474829011|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876516|NCT01943851|474829012|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876517|NCT01943851|474829013|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876518|NCT01943851|474829014|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876519|NCT01943851|474829015|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876520|NCT01943851|474829016|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876521|NCT01943851|474829017|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876522|NCT01943851|474829018|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876523|NCT01943851|474829019|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876524|NCT01943851|474829020|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876525|NCT01943851|474829021|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
131876526|NCT01943851|474829022|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
131876527|NCT01943851|474829023|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
131876528|NCT01943851|474829024|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
131876529|NCT03320850|474829025|FG000|Overall Study|Lost to Follow-up|0|||
131876530|NCT03320850|474829026|FG001|Overall Study|Lost to Follow-up|0|||
131876531|NCT03320850|474829027|FG002|Overall Study|Lost to Follow-up|0|||
131876532|NCT03320850|474829028|FG003|Overall Study|Lost to Follow-up|0|||
131876533|NCT03320850|474829029|FG004|Overall Study|Lost to Follow-up|1|||
131876534|NCT03320850|474829030|FG005|Overall Study|Lost to Follow-up|2|||
131876535|NCT03320850|474829031|FG006|Overall Study|Lost to Follow-up|2|||
131876536|NCT03320850|474829032|FG007|Overall Study|Lost to Follow-up|0|||
131876537|NCT03320850|474829033|FG008|Overall Study|Lost to Follow-up|6|||
131876538|NCT03320850|474829034|FG009|Overall Study|Lost to Follow-up|4|||
131876539|NCT03320850|474829025|FG000|Overall Study|Withdrawal by Subject|0|||
131876540|NCT03320850|474829026|FG001|Overall Study|Withdrawal by Subject|0|||
131876541|NCT03320850|474829027|FG002|Overall Study|Withdrawal by Subject|0|||
131876542|NCT03320850|474829028|FG003|Overall Study|Withdrawal by Subject|0|||
131876543|NCT03320850|474829029|FG004|Overall Study|Withdrawal by Subject|1|||
131876544|NCT03320850|474829030|FG005|Overall Study|Withdrawal by Subject|2|||
131876545|NCT03320850|474829031|FG006|Overall Study|Withdrawal by Subject|4|||
131876546|NCT03320850|474829032|FG007|Overall Study|Withdrawal by Subject|5|||
131876547|NCT03320850|474829033|FG008|Overall Study|Withdrawal by Subject|2|||
131876548|NCT03320850|474829034|FG009|Overall Study|Withdrawal by Subject|1|||
131876549|NCT03320850|474829025|FG000|Overall Study|Lack of Efficacy|0|||
131876550|NCT03320850|474829026|FG001|Overall Study|Lack of Efficacy|0|||
131876551|NCT03320850|474829027|FG002|Overall Study|Lack of Efficacy|0|||
131876552|NCT03320850|474829028|FG003|Overall Study|Lack of Efficacy|1|||
131876553|NCT03320850|474829029|FG004|Overall Study|Lack of Efficacy|0|||
131876554|NCT03320850|474829030|FG005|Overall Study|Lack of Efficacy|1|||
131876555|NCT03320850|474829031|FG006|Overall Study|Lack of Efficacy|0|||
131876556|NCT03320850|474829032|FG007|Overall Study|Lack of Efficacy|2|||
131876557|NCT03320850|474829033|FG008|Overall Study|Lack of Efficacy|0|||
131876558|NCT03320850|474829034|FG009|Overall Study|Lack of Efficacy|3|||
131876559|NCT03320850|474829025|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
131876560|NCT03320850|474829026|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131876561|NCT03320850|474829027|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
131876562|NCT03320850|474829028|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
131876563|NCT03320850|474829029|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
131876564|NCT03320850|474829030|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
131922331|NCT05591755|474999068|FG001|Overall Study|Withdrawal by Subject|1|||
131876565|NCT03320850|474829031|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
131922332|NCT05591755|474999069|FG002|Overall Study|Withdrawal by Subject|0|||
131922333|NCT05591755|474999070|FG003|Overall Study|Withdrawal by Subject|0|||
131922334|NCT00433290|474999071|FG000|Overall Study|Adverse Event|24|||
131408719|NCT00461305|473118408|FG001|Treatment|Partially missing diary|0|||
131408720|NCT00461305|473118407|FG000|Treatment|Other (missing drug etc)|2|||
131408721|NCT00461305|473118408|FG001|Treatment|Other (missing drug etc)|0|||
131408722|NCT00461305|473118407|FG000|Continued Treatment|Adverse Event|26|||
131408723|NCT00461305|473118408|FG001|Continued Treatment|Adverse Event|0|||
131408724|NCT00461305|473118407|FG000|Continued Treatment|Lost to Follow-up|4|||
131408725|NCT00461305|473118408|FG001|Continued Treatment|Lost to Follow-up|0|||
131408726|NCT00461305|473118407|FG000|Continued Treatment|Protocol Violation|13|||
131453961|NCT02023697|473291845|FG001|Treatment Period|Clinical progression|8|||
131876566|NCT03320850|474829032|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
131876567|NCT03320850|474829033|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
131876568|NCT03320850|474829034|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
131876569|NCT03320850|474829025|FG000|Overall Study|Adverse Event|0|||
131876570|NCT03320850|474829026|FG001|Overall Study|Adverse Event|0|||
131876571|NCT03320850|474829027|FG002|Overall Study|Adverse Event|0|||
131876572|NCT03320850|474829028|FG003|Overall Study|Adverse Event|0|||
131876573|NCT03320850|474829029|FG004|Overall Study|Adverse Event|0|||
131876574|NCT03320850|474829030|FG005|Overall Study|Adverse Event|2|||
131876575|NCT03320850|474829031|FG006|Overall Study|Adverse Event|1|||
131876576|NCT03320850|474829032|FG007|Overall Study|Adverse Event|0|||
131876577|NCT03320850|474829033|FG008|Overall Study|Adverse Event|2|||
131876578|NCT03320850|474829034|FG009|Overall Study|Adverse Event|0|||
131876579|NCT03320850|474829025|FG000|Overall Study|Reason Not Specified|0|||
131876580|NCT03320850|474829026|FG001|Overall Study|Reason Not Specified|0|||
131876581|NCT03320850|474829027|FG002|Overall Study|Reason Not Specified|0|||
131876582|NCT03320850|474829028|FG003|Overall Study|Reason Not Specified|0|||
131876583|NCT03320850|474829029|FG004|Overall Study|Reason Not Specified|0|||
131876584|NCT03320850|474829030|FG005|Overall Study|Reason Not Specified|1|||
131876585|NCT03320850|474829031|FG006|Overall Study|Reason Not Specified|0|||
131876586|NCT03320850|474829032|FG007|Overall Study|Reason Not Specified|0|||
131876587|NCT03320850|474829033|FG008|Overall Study|Reason Not Specified|0|||
131876588|NCT03320850|474829034|FG009|Overall Study|Reason Not Specified|1|||
131876589|NCT03991299|474829035|FG000|Overall Study|Study closed, sponsor decision|3|||
131876590|NCT03991299|474829035|FG000|Overall Study|Withdrawal by Subject|1|||
131876591|NCT03728426|474829042|FG000|Overall Study|Death|3|||
131876592|NCT02048826|474829044|FG000|Overall Study|Withdrawal by Subject|1|||
131876593|NCT02048826|474829045|FG001|Overall Study|Withdrawal by Subject|0|||
131876594|NCT00712881|474829046|FG000|Overall Study|Adverse Event|3|||
131876595|NCT00712881|474829047|FG001|Overall Study|Adverse Event|3|||
131876596|NCT00712881|474829046|FG000|Overall Study|Withdrawal by Subject|1|||
131876597|NCT00712881|474829047|FG001|Overall Study|Withdrawal by Subject|1|||
131876598|NCT00712881|474829046|FG000|Overall Study|Disease Progression|2|||
131876599|NCT00712881|474829047|FG001|Overall Study|Disease Progression|1|||
131876600|NCT00712881|474829046|FG000|Overall Study|Lost to Follow-up|1|||
131876601|NCT00712881|474829047|FG001|Overall Study|Lost to Follow-up|1|||
131876602|NCT00712881|474829046|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
131876603|NCT00712881|474829047|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
131876604|NCT00712881|474829046|FG000|Overall Study|Protocol Violation|1|||
131876605|NCT00712881|474829047|FG001|Overall Study|Protocol Violation|1|||
131876606|NCT00712881|474829046|FG000|Overall Study|Randomized but not treated|1|||
131876607|NCT00712881|474829047|FG001|Overall Study|Randomized but not treated|0|||
131876608|NCT01194999|474829049|FG000|Overall Study|Lost to Follow-up|17|||
131876609|NCT01011465|474829050|FG000|Overall Study|Withdrawal by Subject|2|||
131876610|NCT01011465|474829051|FG001|Overall Study|Withdrawal by Subject|1|||
131876611|NCT01011465|474829052|FG002|Overall Study|Withdrawal by Subject|0|||
131876612|NCT01011465|474829053|FG003|Overall Study|Withdrawal by Subject|0|||
131876613|NCT01011465|474829054|FG004|Overall Study|Withdrawal by Subject|1|||
131876614|NCT01011465|474829055|FG005|Overall Study|Withdrawal by Subject|0|||
131876615|NCT01011465|474829056|FG006|Overall Study|Withdrawal by Subject|1|||
131876616|NCT01011465|474829057|FG007|Overall Study|Withdrawal by Subject|0|||
131876617|NCT00723008|474829059|FG000|Enrollment|Lost to Follow-up|1|||
131876618|NCT00723008|474829060|FG001|Enrollment|Lost to Follow-up|0|||
131876619|NCT00723008|474829059|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
131876620|NCT00723008|474829060|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
131876621|NCT00723008|474829059|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
131876622|NCT00723008|474829060|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
131876623|NCT00723008|474829059|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
131876624|NCT00723008|474829060|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
131876625|NCT00723008|474829059|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
131922335|NCT00433290|474999072|FG001|Overall Study|Adverse Event|7|||
131408727|NCT00461305|473118408|FG001|Continued Treatment|Protocol Violation|0|||
131408728|NCT00461305|473118407|FG000|Continued Treatment|Withdrawal by Subject|48|||
131408729|NCT00461305|473118408|FG001|Continued Treatment|Withdrawal by Subject|0|||
131408730|NCT00461305|473118407|FG000|Continued Treatment|Partially missing diary|2|||
131876626|NCT00723008|474829060|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
131876627|NCT00723008|474829059|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
131876628|NCT00723008|474829060|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
131876629|NCT05835011|474829062|FG000|Overall Study|Study Terminated by the Sponsor|1|||
131876630|NCT05835011|474829062|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
131876631|NCT00968981|474829066|FG000|Overall Study|Adverse Event|2|||
131876632|NCT00968981|474829067|FG001|Overall Study|Adverse Event|0|||
131876633|NCT00968981|474829068|FG002|Overall Study|Adverse Event|0|||
131876634|NCT00968981|474829066|FG000|Overall Study|Disease Progression|14|||
131876635|NCT00968981|474829067|FG001|Overall Study|Disease Progression|16|||
131876636|NCT00968981|474829068|FG002|Overall Study|Disease Progression|13|||
131876637|NCT00968981|474829066|FG000|Overall Study|Lost to Follow-up|0|||
131876638|NCT00968981|474829067|FG001|Overall Study|Lost to Follow-up|0|||
131876639|NCT00968981|474829068|FG002|Overall Study|Lost to Follow-up|1|||
131876640|NCT00968981|474829066|FG000|Overall Study|Physician Decision|5|||
131876641|NCT00968981|474829067|FG001|Overall Study|Physician Decision|3|||
131876642|NCT00968981|474829068|FG002|Overall Study|Physician Decision|5|||
131876643|NCT00968981|474829066|FG000|Overall Study|Withdrawal by Subject|1|||
131876644|NCT00968981|474829067|FG001|Overall Study|Withdrawal by Subject|3|||
131876645|NCT00968981|474829068|FG002|Overall Study|Withdrawal by Subject|3|||
131876646|NCT00492648|474829074|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
131876647|NCT00492648|474829075|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
131876648|NCT00282113|474829076|FG000|Overall Study|Removed at parents request|1|||
131876649|NCT00282113|474829077|FG001|Overall Study|Removed at parents request|0|||
131876650|NCT00282113|474829078|FG002|Overall Study|Removed at parents request|0|||
131876651|NCT02949843|474829079|FG000|Overall Study|Withdrawal by Subject|0|||
131876652|NCT02949843|474829080|FG001|Overall Study|Withdrawal by Subject|1|||
131876653|NCT02949843|474829081|FG002|Overall Study|Withdrawal by Subject|1|||
131876654|NCT01500187|474829082|FG000|Overall Study|Lost to Follow-up|6|||
131876655|NCT01500187|474829083|FG001|Overall Study|Lost to Follow-up|0|||
131876656|NCT01343277|474829095|FG000|Overall Study|Other|3|||
131876657|NCT01343277|474829096|FG001|Overall Study|Other|3|||
131876658|NCT01343277|474829095|FG000|Overall Study|Withdrawal by Subject|18|||
131876659|NCT01343277|474829096|FG001|Overall Study|Withdrawal by Subject|13|||
131876660|NCT01343277|474829095|FG000|Overall Study|Physician Decision|1|||
131876661|NCT01343277|474829096|FG001|Overall Study|Physician Decision|2|||
131876662|NCT01343277|474829095|FG000|Overall Study|Death|10|||
131876663|NCT01343277|474829096|FG001|Overall Study|Death|1|||
131876664|NCT01343277|474829095|FG000|Overall Study|Adverse Event|67|||
131876665|NCT01343277|474829096|FG001|Overall Study|Adverse Event|13|||
131876666|NCT01343277|474829095|FG000|Overall Study|Disease progression|270|||
131876667|NCT01343277|474829096|FG001|Overall Study|Disease progression|138|||
131876668|NCT01343277|474829095|FG000|Overall Study|Randomized not treated|6|||
131876669|NCT01343277|474829096|FG001|Overall Study|Randomized not treated|21|||
131876670|NCT01343277|474829095|FG000|Overall Study|Treatment ongoing|8|||
131876671|NCT01343277|474829096|FG001|Overall Study|Treatment ongoing|2|||
131876672|NCT01343277|474829095|FG000|Overall Study|Subsequent anticancer therapy|1|||
131876673|NCT01343277|474829096|FG001|Overall Study|Subsequent anticancer therapy|0|||
131876674|NCT01582178|474829097|FG000|Overall Study|Physician Decision|6|||
131876675|NCT01582178|474829098|FG001|Overall Study|Physician Decision|5|||
131876676|NCT03852628|474829099|FG000|Overall Study|Lost to Follow-up|7|||
131876677|NCT03852628|474829100|FG001|Overall Study|Lost to Follow-up|6|||
131876678|NCT03852628|474829099|FG000|Overall Study|Lack of Efficacy|6|||
131876679|NCT03852628|474829100|FG001|Overall Study|Lack of Efficacy|6|||
131876680|NCT00586820|474829105|FG000|Overall Study|Unsuccessful PCI|1|||
131876681|NCT00586820|474829106|FG001|Overall Study|Unsuccessful PCI|0|||
131876682|NCT00556933|474829111|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
131876683|NCT00556933|474829112|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
131876684|NCT00556933|474829113|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
131876685|NCT00556933|474829114|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
131876686|NCT00556933|474829111|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
131876687|NCT00556933|474829112|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
131876688|NCT00556933|474829113|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
131876689|NCT00556933|474829114|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
131876690|NCT00556933|474829111|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
131876691|NCT00556933|474829112|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
131876692|NCT00556933|474829113|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
131876693|NCT00556933|474829114|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
131876694|NCT00556933|474829111|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
131876695|NCT00556933|474829112|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
131876696|NCT00556933|474829113|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
131876697|NCT00556933|474829114|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
131876698|NCT00556933|474829111|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
131876699|NCT00556933|474829112|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
131876700|NCT00556933|474829113|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
131876701|NCT00556933|474829114|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
131876702|NCT00556933|474829111|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
131876703|NCT00556933|474829112|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
131876704|NCT00556933|474829113|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
131876705|NCT00556933|474829114|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
131876706|NCT00556933|474829111|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
131876707|NCT00556933|474829112|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
131876708|NCT00556933|474829113|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
131876709|NCT00556933|474829114|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
131876710|NCT00556933|474829111|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
131876711|NCT00556933|474829112|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
131876712|NCT00556933|474829113|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
131876713|NCT00556933|474829114|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
131876714|NCT00556933|474829111|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
131876715|NCT00556933|474829112|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
131876716|NCT00556933|474829113|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
131876717|NCT00556933|474829114|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
131876718|NCT00556933|474829111|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
131876719|NCT00556933|474829112|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
131876720|NCT00556933|474829113|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
131876721|NCT00556933|474829114|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
131876722|NCT00556933|474829111|FG000|CNI Withdrawal vs. Minimization|Death|0|||
131876723|NCT00556933|474829112|FG001|CNI Withdrawal vs. Minimization|Death|0|||
131876724|NCT00556933|474829113|FG002|CNI Withdrawal vs. Minimization|Death|0|||
131876725|NCT00556933|474829114|FG003|CNI Withdrawal vs. Minimization|Death|1|||
131876726|NCT03887442|474829115|FG000|Overall Study|Adverse Event|1|||
131876727|NCT03887442|474829116|FG001|Overall Study|Adverse Event|0|||
131876728|NCT01295827|474829119|FG000|Overall Study|Adverse Event|1|||
131876729|NCT01295827|474829120|FG001|Overall Study|Adverse Event|2|||
131876730|NCT01295827|474829121|FG002|Overall Study|Adverse Event|2|||
131876731|NCT01295827|474829122|FG003|Overall Study|Adverse Event|1|||
131876732|NCT01295827|474829123|FG004|Overall Study|Adverse Event|1|||
131876733|NCT01295827|474829124|FG005|Overall Study|Adverse Event|4|||
131876734|NCT01295827|474829125|FG006|Overall Study|Adverse Event|15|||
131876735|NCT01295827|474829126|FG007|Overall Study|Adverse Event|49|||
131876736|NCT01295827|474829127|FG008|Overall Study|Adverse Event|22|||
131876737|NCT01295827|474829128|FG009|Overall Study|Adverse Event|7|||
131876738|NCT01295827|474829129|FG010|Overall Study|Adverse Event|50|||
131876739|NCT01295827|474829130|FG011|Overall Study|Adverse Event|21|||
131876740|NCT01295827|474829131|FG012|Overall Study|Adverse Event|0|||
131876741|NCT01295827|474829132|FG013|Overall Study|Adverse Event|0|||
131876742|NCT01295827|474829133|FG014|Overall Study|Adverse Event|0|||
131876743|NCT01295827|474829119|FG000|Overall Study|Lost to Follow-up|0|||
131876744|NCT01295827|474829120|FG001|Overall Study|Lost to Follow-up|0|||
131876745|NCT01295827|474829121|FG002|Overall Study|Lost to Follow-up|3|||
131876746|NCT01295827|474829122|FG003|Overall Study|Lost to Follow-up|0|||
131876747|NCT01295827|474829123|FG004|Overall Study|Lost to Follow-up|1|||
131876748|NCT01295827|474829124|FG005|Overall Study|Lost to Follow-up|0|||
131876749|NCT01295827|474829125|FG006|Overall Study|Lost to Follow-up|4|||
131876750|NCT01295827|474829126|FG007|Overall Study|Lost to Follow-up|8|||
131876751|NCT01295827|474829127|FG008|Overall Study|Lost to Follow-up|7|||
131876752|NCT01295827|474829128|FG009|Overall Study|Lost to Follow-up|4|||
131876753|NCT01295827|474829129|FG010|Overall Study|Lost to Follow-up|7|||
131876754|NCT01295827|474829130|FG011|Overall Study|Lost to Follow-up|3|||
131876755|NCT01295827|474829131|FG012|Overall Study|Lost to Follow-up|0|||
131876756|NCT01295827|474829132|FG013|Overall Study|Lost to Follow-up|0|||
131876757|NCT01295827|474829133|FG014|Overall Study|Lost to Follow-up|0|||
131876758|NCT01295827|474829119|FG000|Overall Study|Not Reported|0|||
131876759|NCT01295827|474829120|FG001|Overall Study|Not Reported|0|||
131876760|NCT01295827|474829121|FG002|Overall Study|Not Reported|0|||
131876761|NCT01295827|474829122|FG003|Overall Study|Not Reported|1|||
131876762|NCT01295827|474829123|FG004|Overall Study|Not Reported|0|||
131876763|NCT01295827|474829124|FG005|Overall Study|Not Reported|0|||
131876764|NCT01295827|474829125|FG006|Overall Study|Not Reported|24|||
131876765|NCT01295827|474829126|FG007|Overall Study|Not Reported|58|||
131876766|NCT01295827|474829127|FG008|Overall Study|Not Reported|41|||
131876767|NCT01295827|474829128|FG009|Overall Study|Not Reported|2|||
131922336|NCT00433290|474999071|FG000|Overall Study|Lack of Efficacy|1|||
131922337|NCT00433290|474999072|FG001|Overall Study|Lack of Efficacy|5|||
131453962|NCT02023697|473291846|FG002|Treatment Period|Clinical progression|28|||
131876768|NCT01295827|474829129|FG010|Overall Study|Not Reported|23|||
131876769|NCT01295827|474829130|FG011|Overall Study|Not Reported|13|||
131876770|NCT01295827|474829131|FG012|Overall Study|Not Reported|0|||
131876771|NCT01295827|474829132|FG013|Overall Study|Not Reported|0|||
131922338|NCT00433290|474999071|FG000|Overall Study|Withdrawal by Subject|4|||
131922339|NCT00433290|474999072|FG001|Overall Study|Withdrawal by Subject|2|||
131922340|NCT00433290|474999071|FG000|Overall Study|Protocol Violation|3|||
131922341|NCT00433290|474999072|FG001|Overall Study|Protocol Violation|2|||
131922342|NCT00433290|474999071|FG000|Overall Study|Physician Decision|2|||
131922343|NCT00433290|474999072|FG001|Overall Study|Physician Decision|0|||
131922344|NCT00433290|474999071|FG000|Overall Study|Entry Criteria Not Met|0|||
131922345|NCT00433290|474999072|FG001|Overall Study|Entry Criteria Not Met|1|||
131922346|NCT00433290|474999071|FG000|Overall Study|Lost to Follow-up|1|||
131922347|NCT00433290|474999072|FG001|Overall Study|Lost to Follow-up|0|||
131922348|NCT01397747|474999077|FG000|Overall Study|Multitarget DNA test excluded|689|||
131922349|NCT01397747|474999077|FG000|Overall Study|Colonoscopy excluded|304|||
131922350|NCT01397747|474999077|FG000|Overall Study|FIT excluded|34|||
131922351|NCT03828383|474999083|FG000|Overall Study|Lost to Follow-up|3|||
131922352|NCT03828383|474999084|FG001|Overall Study|Lost to Follow-up|2|||
131922353|NCT03828383|474999083|FG000|Overall Study|Withdrawal by Subject|4|||
131922354|NCT03828383|474999084|FG001|Overall Study|Withdrawal by Subject|5|||
131922355|NCT00504309|474999085|FG000|Overall Study|Death|0|||
131922356|NCT00504309|474999086|FG001|Overall Study|Death|0|||
131922357|NCT00504309|474999087|FG002|Overall Study|Death|0|||
131922358|NCT00504309|474999088|FG003|Overall Study|Death|0|||
131922359|NCT00504309|474999089|FG004|Overall Study|Death|1|||
131922360|NCT00504309|474999090|FG005|Overall Study|Death|0|||
131922361|NCT00504309|474999085|FG000|Overall Study|Withdrawal by Subject|0|||
131922362|NCT00504309|474999086|FG001|Overall Study|Withdrawal by Subject|0|||
131922363|NCT00504309|474999087|FG002|Overall Study|Withdrawal by Subject|1|||
131922364|NCT00504309|474999088|FG003|Overall Study|Withdrawal by Subject|0|||
131922365|NCT00504309|474999089|FG004|Overall Study|Withdrawal by Subject|0|||
131922366|NCT00504309|474999090|FG005|Overall Study|Withdrawal by Subject|0|||
131922367|NCT00308685|474999092|FG000|Overall Study|Lost to Follow-up|1|||
131922368|NCT00308685|474999093|FG001|Overall Study|Lost to Follow-up|0|||
131922369|NCT00308685|474999092|FG000|Overall Study|Need to administer prohibited medication|1|||
131922370|NCT00308685|474999093|FG001|Overall Study|Need to administer prohibited medication|2|||
131922371|NCT00308685|474999092|FG000|Overall Study|Other than specified|1|||
131922372|NCT00308685|474999093|FG001|Overall Study|Other than specified|3|||
131922373|NCT03345095|474999094|FG000|Overall Study|Lack of Efficacy|184|||
131922374|NCT03345095|474999095|FG001|Overall Study|Lack of Efficacy|156|||
131922375|NCT03345095|474999094|FG000|Overall Study|Adverse Event|36|||
131922376|NCT03345095|474999095|FG001|Overall Study|Adverse Event|118|||
131922377|NCT03345095|474999094|FG000|Overall Study|Withdrawal by Subject|22|||
131922378|NCT03345095|474999095|FG001|Overall Study|Withdrawal by Subject|59|||
131922379|NCT03345095|474999094|FG000|Overall Study|Physician Decision|3|||
131922380|NCT03345095|474999095|FG001|Overall Study|Physician Decision|18|||
131922381|NCT03345095|474999094|FG000|Overall Study|Death|2|||
131922382|NCT03345095|474999095|FG001|Overall Study|Death|4|||
131922383|NCT03345095|474999094|FG000|Overall Study|Other reasons|2|||
131922384|NCT03345095|474999095|FG001|Overall Study|Other reasons|11|||
131922385|NCT03345095|474999094|FG000|Overall Study|Protocol Violation|0|||
131922386|NCT03345095|474999095|FG001|Overall Study|Protocol Violation|1|||
131922387|NCT01121575|474999096|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
131922388|NCT01121575|474999097|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
131922389|NCT01121575|474999098|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
131922390|NCT01121575|474999099|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
131922391|NCT01121575|474999100|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
131922392|NCT01121575|474999101|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
131922393|NCT01121575|474999096|FG000|Overall Study|Unspecified Reasons|8|||
131922394|NCT01121575|474999097|FG001|Overall Study|Unspecified Reasons|6|||
131922395|NCT01121575|474999098|FG002|Overall Study|Unspecified Reasons|7|||
131922396|NCT01121575|474999099|FG003|Overall Study|Unspecified Reasons|5|||
131922397|NCT01121575|474999100|FG004|Overall Study|Unspecified Reasons|13|||
131922398|NCT01121575|474999101|FG005|Overall Study|Unspecified Reasons|10|||
131922399|NCT01121575|474999096|FG000|Overall Study|Death|6|||
131922400|NCT01121575|474999097|FG001|Overall Study|Death|0|||
131922401|NCT01121575|474999098|FG002|Overall Study|Death|0|||
131922402|NCT01121575|474999099|FG003|Overall Study|Death|1|||
131922403|NCT01121575|474999100|FG004|Overall Study|Death|7|||
131922404|NCT01121575|474999101|FG005|Overall Study|Death|1|||
131922405|NCT03158311|474999104|FG000|Overall Study|Subject/Guardian Decision|10|||
131922406|NCT03158311|474999105|FG001|Overall Study|Subject/Guardian Decision|6|||
131922407|NCT03158311|474999106|FG002|Overall Study|Subject/Guardian Decision|11|||
131922408|NCT03158311|474999104|FG000|Overall Study|Adverse Event|5|||
131922409|NCT03158311|474999105|FG001|Overall Study|Adverse Event|3|||
131922410|NCT03158311|474999106|FG002|Overall Study|Adverse Event|3|||
131922411|NCT03158311|474999104|FG000|Overall Study|Techinical Problems|3|||
131922412|NCT03158311|474999105|FG001|Overall Study|Techinical Problems|1|||
131922413|NCT03158311|474999106|FG002|Overall Study|Techinical Problems|5|||
131922414|NCT03158311|474999104|FG000|Overall Study|Physician Decision|2|||
131922415|NCT03158311|474999105|FG001|Overall Study|Physician Decision|3|||
131922416|NCT03158311|474999106|FG002|Overall Study|Physician Decision|7|||
131876772|NCT01295827|474829133|FG014|Overall Study|Not Reported|0|||
131876773|NCT01295827|474829119|FG000|Overall Study|Progressive Disease|2|||
131876774|NCT01295827|474829120|FG001|Overall Study|Progressive Disease|1|||
131408731|NCT00461305|473118408|FG001|Continued Treatment|Partially missing diary|0|||
131408732|NCT00461305|473118407|FG000|Continued Treatment|Other (missing drug etc)|2|||
131408733|NCT00461305|473118408|FG001|Continued Treatment|Other (missing drug etc)|0|||
131408734|NCT00787930|473118413|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
131408735|NCT01896271|473118414|FG000|Overall Study|Physician Decision|10|||
131408736|NCT00969761|473118418|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
131408737|NCT00969761|473118419|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408738|NCT00969761|473118420|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408739|NCT00969761|473118421|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
131408740|NCT00969761|473118422|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408741|NCT00969761|473118423|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408742|NCT00969761|473118424|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408743|NCT00969761|473118425|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408744|NCT00969761|473118426|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
131408745|NCT00969761|473118427|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
131408746|NCT00969761|473118428|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408747|NCT00969761|473118429|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
131408748|NCT00969761|473118418|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408749|NCT00969761|473118419|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408750|NCT00969761|473118420|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
131408751|NCT00969761|473118421|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408752|NCT00969761|473118422|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408753|NCT00969761|473118423|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408754|NCT00969761|473118424|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408755|NCT00969761|473118425|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408756|NCT00969761|473118426|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408757|NCT00969761|473118427|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408758|NCT00969761|473118428|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408759|NCT00969761|473118429|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
131408760|NCT00969761|473118418|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408761|NCT00969761|473118419|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408762|NCT00969761|473118420|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
131408763|NCT00969761|473118421|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408764|NCT00969761|473118422|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408765|NCT00969761|473118423|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408766|NCT00969761|473118424|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408767|NCT00969761|473118425|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408768|NCT00969761|473118426|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408769|NCT00969761|473118427|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408770|NCT00969761|473118428|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408771|NCT00969761|473118429|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
131408772|NCT00969761|473118418|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408773|NCT00969761|473118419|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408774|NCT00969761|473118420|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408775|NCT00969761|473118421|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408776|NCT00969761|473118422|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408777|NCT00969761|473118423|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408778|NCT00969761|473118424|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408779|NCT00969761|473118425|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408780|NCT00969761|473118426|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
131408781|NCT00969761|473118427|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408782|NCT00969761|473118428|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408783|NCT00969761|473118429|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
131408784|NCT00969761|473118418|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
131408785|NCT00969761|473118419|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
131408786|NCT00969761|473118420|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
131408787|NCT00969761|473118421|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
131876775|NCT01295827|474829121|FG002|Overall Study|Progressive Disease|5|||
131876776|NCT01295827|474829122|FG003|Overall Study|Progressive Disease|2|||
131876777|NCT01295827|474829123|FG004|Overall Study|Progressive Disease|0|||
131922417|NCT03158311|474999104|FG000|Overall Study|Lost to Follow-up|1|||
131922418|NCT03158311|474999105|FG001|Overall Study|Lost to Follow-up|1|||
131922419|NCT03158311|474999106|FG002|Overall Study|Lost to Follow-up|1|||
131922420|NCT03158311|474999104|FG000|Overall Study|Sponsor decision|1|||
131922421|NCT03158311|474999105|FG001|Overall Study|Sponsor decision|0|||
131922422|NCT03158311|474999106|FG002|Overall Study|Sponsor decision|0|||
131922423|NCT03158311|474999104|FG000|Overall Study|Pregnancy|0|||
131922424|NCT03158311|474999105|FG001|Overall Study|Pregnancy|2|||
131922425|NCT03158311|474999106|FG002|Overall Study|Pregnancy|0|||
131922426|NCT03158311|474999104|FG000|Overall Study|Randomized in error|0|||
131922427|NCT03158311|474999105|FG001|Overall Study|Randomized in error|0|||
131922428|NCT03158311|474999106|FG002|Overall Study|Randomized in error|1|||
131922429|NCT01018953|474999107|FG000|Overall Study|Adverse Event|2|||
131922430|NCT01018953|474999107|FG000|Overall Study|Withdrawal by Subject|1|||
131922431|NCT01018953|474999107|FG000|Overall Study|Study termination by sponsor|5|||
131922432|NCT02665455|474999108|FG000|Overall Study|Withdrawal by Subject|6|||
131922433|NCT02665455|474999108|FG000|Overall Study|Lost to Follow-up|1|||
131922434|NCT02665455|474999108|FG000|Overall Study|Adverse Event|1|||
131922435|NCT02665455|474999108|FG000|Overall Study|Protocol Violation|1|||
131922436|NCT01928771|474999110|FG000|Overall Study|Adverse Event|6|||
131922437|NCT01928771|474999111|FG001|Overall Study|Adverse Event|5|||
131922438|NCT01928771|474999112|FG002|Overall Study|Adverse Event|1|||
131922439|NCT01928771|474999110|FG000|Overall Study|Death|2|||
131922440|NCT01928771|474999111|FG001|Overall Study|Death|2|||
131922441|NCT01928771|474999112|FG002|Overall Study|Death|2|||
131922442|NCT01928771|474999110|FG000|Overall Study|Lost to Follow-up|5|||
131922443|NCT01928771|474999111|FG001|Overall Study|Lost to Follow-up|6|||
131922444|NCT01928771|474999112|FG002|Overall Study|Lost to Follow-up|3|||
131922445|NCT01928771|474999110|FG000|Overall Study|Withdrawal by Subject|20|||
131922446|NCT01928771|474999111|FG001|Overall Study|Withdrawal by Subject|15|||
131922447|NCT01928771|474999112|FG002|Overall Study|Withdrawal by Subject|17|||
131922448|NCT01928771|474999110|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
131922449|NCT01928771|474999111|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
131922450|NCT01928771|474999112|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
131922451|NCT01928771|474999110|FG000|Overall Study|Other Reasons|9|||
131922452|NCT01928771|474999111|FG001|Overall Study|Other Reasons|9|||
131922453|NCT01928771|474999112|FG002|Overall Study|Other Reasons|14|||
131922454|NCT01928771|474999110|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
131922455|NCT01928771|474999111|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
131922456|NCT01928771|474999112|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
131922457|NCT03932331|474999113|FG000|Overall Study|Death|0|||
131922458|NCT03932331|474999114|FG001|Overall Study|Death|7|||
131922459|NCT03932331|474999115|FG002|Overall Study|Death|2|||
131922460|NCT03932331|474999113|FG000|Overall Study|Withdrawal by Subject|0|||
131922461|NCT03932331|474999114|FG001|Overall Study|Withdrawal by Subject|3|||
131922462|NCT03932331|474999115|FG002|Overall Study|Withdrawal by Subject|0|||
131922463|NCT03932331|474999113|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
131922464|NCT03932331|474999114|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
131922465|NCT03932331|474999115|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
131922466|NCT03932331|474999113|FG000|Overall Study|Progressive disease|3|||
131922467|NCT03932331|474999114|FG001|Overall Study|Progressive disease|0|||
131922468|NCT03932331|474999115|FG002|Overall Study|Progressive disease|0|||
131922469|NCT03932331|474999113|FG000|Overall Study|Lung infection|1|||
131922470|NCT03932331|474999114|FG001|Overall Study|Lung infection|0|||
131922471|NCT03932331|474999115|FG002|Overall Study|Lung infection|0|||
131922472|NCT03932331|474999113|FG000|Overall Study|Other|0|||
131922473|NCT03932331|474999114|FG001|Overall Study|Other|0|||
131922474|NCT03932331|474999115|FG002|Overall Study|Other|58|||
131922475|NCT01937117|474999116|FG000|Overall Study|Disease Progression|7|||
131922476|NCT01937117|474999116|FG000|Overall Study|Physician Decision|4|||
131922477|NCT01937117|474999116|FG000|Overall Study|Adverse Event|2|||
131922478|NCT01407367|474999121|FG000|Overall Study|Death|24|||
131922479|NCT01407367|474999122|FG001|Overall Study|Death|32|||
131922480|NCT01407367|474999121|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
131922481|NCT01407367|474999122|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
131922482|NCT01407367|474999121|FG000|Overall Study|Withdrawal by Subject|4|||
131922483|NCT01407367|474999122|FG001|Overall Study|Withdrawal by Subject|15|||
131922484|NCT01407367|474999121|FG000|Overall Study|Lost to Follow-up|0|||
131922485|NCT01407367|474999122|FG001|Overall Study|Lost to Follow-up|2|||
131922486|NCT01452347|474999123|FG000|Overall Study|Adverse Event|2|||
131922487|NCT01452347|474999124|FG001|Overall Study|Adverse Event|1|||
131922488|NCT01452347|474999123|FG000|Overall Study|Non compliance protocol|2|||
131922489|NCT01452347|474999124|FG001|Overall Study|Non compliance protocol|0|||
131922490|NCT01452347|474999123|FG000|Overall Study|Lost to Follow-up|2|||
131922491|NCT01452347|474999124|FG001|Overall Study|Lost to Follow-up|0|||
131922492|NCT01452347|474999123|FG000|Overall Study|Withdrawal by Subject|3|||
131922493|NCT01452347|474999124|FG001|Overall Study|Withdrawal by Subject|3|||
131922494|NCT01452347|474999123|FG000|Overall Study|Not treated|6|||
131922495|NCT01452347|474999124|FG001|Overall Study|Not treated|3|||
131408788|NCT00969761|473118422|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
131408789|NCT00969761|473118423|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
131408790|NCT00969761|473118424|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
131408791|NCT00969761|473118425|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
131408792|NCT00969761|473118426|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
131408793|NCT00969761|473118427|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
131408794|NCT00969761|473118428|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
131408795|NCT00969761|473118429|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
131408796|NCT00969761|473118418|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408797|NCT00969761|473118419|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408798|NCT00969761|473118420|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131876778|NCT01295827|474829124|FG005|Overall Study|Progressive Disease|1|||
131876779|NCT01295827|474829125|FG006|Overall Study|Progressive Disease|87|||
131876780|NCT01295827|474829126|FG007|Overall Study|Progressive Disease|144|||
131876781|NCT01295827|474829127|FG008|Overall Study|Progressive Disease|85|||
131876782|NCT01295827|474829128|FG009|Overall Study|Progressive Disease|40|||
131876783|NCT01295827|474829129|FG010|Overall Study|Progressive Disease|175|||
131876784|NCT01295827|474829130|FG011|Overall Study|Progressive Disease|136|||
131876785|NCT01295827|474829131|FG012|Overall Study|Progressive Disease|0|||
131876786|NCT01295827|474829132|FG013|Overall Study|Progressive Disease|0|||
131876787|NCT01295827|474829133|FG014|Overall Study|Progressive Disease|0|||
131876788|NCT01295827|474829119|FG000|Overall Study|Screen Failure|0|||
131876789|NCT01295827|474829120|FG001|Overall Study|Screen Failure|0|||
131876790|NCT01295827|474829121|FG002|Overall Study|Screen Failure|0|||
131876791|NCT01295827|474829122|FG003|Overall Study|Screen Failure|0|||
131876792|NCT01295827|474829123|FG004|Overall Study|Screen Failure|0|||
131876793|NCT01295827|474829124|FG005|Overall Study|Screen Failure|0|||
131876794|NCT01295827|474829125|FG006|Overall Study|Screen Failure|2|||
131876795|NCT01295827|474829126|FG007|Overall Study|Screen Failure|2|||
131876796|NCT01295827|474829127|FG008|Overall Study|Screen Failure|2|||
131876797|NCT01295827|474829128|FG009|Overall Study|Screen Failure|0|||
131876798|NCT01295827|474829129|FG010|Overall Study|Screen Failure|1|||
131876799|NCT01295827|474829130|FG011|Overall Study|Screen Failure|0|||
131876800|NCT01295827|474829131|FG012|Overall Study|Screen Failure|0|||
131876801|NCT01295827|474829132|FG013|Overall Study|Screen Failure|0|||
131876802|NCT01295827|474829133|FG014|Overall Study|Screen Failure|0|||
131876803|NCT01295827|474829119|FG000|Overall Study|Withdrawal by Subject|1|||
131876804|NCT01295827|474829120|FG001|Overall Study|Withdrawal by Subject|0|||
131876805|NCT01295827|474829121|FG002|Overall Study|Withdrawal by Subject|2|||
131876806|NCT01295827|474829122|FG003|Overall Study|Withdrawal by Subject|0|||
131876807|NCT01295827|474829123|FG004|Overall Study|Withdrawal by Subject|0|||
131876808|NCT01295827|474829124|FG005|Overall Study|Withdrawal by Subject|1|||
131876809|NCT01295827|474829125|FG006|Overall Study|Withdrawal by Subject|13|||
131876810|NCT01295827|474829126|FG007|Overall Study|Withdrawal by Subject|35|||
131876811|NCT01295827|474829127|FG008|Overall Study|Withdrawal by Subject|11|||
131876812|NCT01295827|474829128|FG009|Overall Study|Withdrawal by Subject|2|||
131876813|NCT01295827|474829129|FG010|Overall Study|Withdrawal by Subject|18|||
131876814|NCT01295827|474829130|FG011|Overall Study|Withdrawal by Subject|13|||
131876815|NCT01295827|474829131|FG012|Overall Study|Withdrawal by Subject|0|||
131876816|NCT01295827|474829132|FG013|Overall Study|Withdrawal by Subject|0|||
131876817|NCT01295827|474829133|FG014|Overall Study|Withdrawal by Subject|0|||
131876818|NCT01295827|474829119|FG000|Overall Study|Other|0|||
131876819|NCT01295827|474829120|FG001|Overall Study|Other|0|||
131876820|NCT01295827|474829121|FG002|Overall Study|Other|0|||
131876821|NCT01295827|474829122|FG003|Overall Study|Other|0|||
131876822|NCT01295827|474829123|FG004|Overall Study|Other|0|||
131876823|NCT01295827|474829124|FG005|Overall Study|Other|0|||
131876824|NCT01295827|474829125|FG006|Overall Study|Other|1|||
131876825|NCT01295827|474829126|FG007|Overall Study|Other|1|||
131876826|NCT01295827|474829127|FG008|Overall Study|Other|1|||
131876827|NCT01295827|474829128|FG009|Overall Study|Other|0|||
131876828|NCT01295827|474829129|FG010|Overall Study|Other|2|||
131876829|NCT01295827|474829130|FG011|Overall Study|Other|0|||
131876830|NCT01295827|474829131|FG012|Overall Study|Other|0|||
131876831|NCT01295827|474829132|FG013|Overall Study|Other|0|||
131876832|NCT01295827|474829133|FG014|Overall Study|Other|0|||
131876833|NCT01668173|474829136|FG000|Overall Study|Adverse Event|3|||
131876834|NCT01668173|474829136|FG000|Overall Study|Trial suspension|4|||
131876835|NCT01868022|474829137|FG000|Overall Study|Withdrawal by Subject|0|||
131876836|NCT01868022|474829138|FG001|Overall Study|Withdrawal by Subject|0|||
131876837|NCT01868022|474829139|FG002|Overall Study|Withdrawal by Subject|1|||
131876838|NCT01868022|474829140|FG003|Overall Study|Withdrawal by Subject|1|||
131876839|NCT01868022|474829141|FG004|Overall Study|Withdrawal by Subject|0|||
131876840|NCT01868022|474829142|FG005|Overall Study|Withdrawal by Subject|0|||
131876841|NCT01868022|474829143|FG006|Overall Study|Withdrawal by Subject|0|||
131876842|NCT01868022|474829144|FG007|Overall Study|Withdrawal by Subject|1|||
131876843|NCT01868022|474829145|FG008|Overall Study|Withdrawal by Subject|0|||
131876844|NCT01868022|474829137|FG000|Overall Study|Adverse Event|0|||
131922496|NCT01452347|474999123|FG000|Overall Study|Other reason not defined above|2|||
131922497|NCT01452347|474999124|FG001|Overall Study|Other reason not defined above|0|||
131922498|NCT00884949|475000876|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
131922499|NCT00884949|475000876|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
131922500|NCT03022630|475000877|FG000|Overall Study|Death|9|||
131922501|NCT03022630|475000878|FG001|Overall Study|Death|7|||
131922502|NCT03022630|475000877|FG000|Overall Study|Withdrawal by Subject|0|||
131922503|NCT03022630|475000878|FG001|Overall Study|Withdrawal by Subject|5|||
131922504|NCT01734928|475000879|FG000|Randomization|Physician Decision|0|||
131922505|NCT01734928|475000880|FG001|Randomization|Physician Decision|1|||
131922506|NCT01734928|475000879|FG000|Randomization|clinical progression|0|||
131922507|NCT01734928|475000880|FG001|Randomization|clinical progression|1|||
131922508|NCT01734928|475000879|FG000|Randomization|progressive disease|0|||
131922509|NCT01734928|475000880|FG001|Randomization|progressive disease|2|||
131922510|NCT01734928|475000879|FG000|Randomization|Withdrew informed consent|0|||
131922511|NCT01734928|475000880|FG001|Randomization|Withdrew informed consent|4|||
131922512|NCT01734928|475000879|FG000|Randomization|Death|1|||
131922513|NCT01734928|475000880|FG001|Randomization|Death|0|||
131922514|NCT01734928|475000879|FG000|Randomization|Randomization error|1|||
131922515|NCT01734928|475000880|FG001|Randomization|Randomization error|0|||
131922516|NCT01734928|475000879|FG000|Randomization|Lost to Follow-up|1|||
131922517|NCT01734928|475000880|FG001|Randomization|Lost to Follow-up|0|||
131922518|NCT01734928|475000879|FG000|Treatment Period|Lost to Follow-up|0|||
131922519|NCT01734928|475000880|FG001|Treatment Period|Lost to Follow-up|2|||
131922520|NCT01734928|475000879|FG000|Treatment Period|Progressive Disease|167|||
131922521|NCT01734928|475000880|FG001|Treatment Period|Progressive Disease|165|||
131922522|NCT01734928|475000879|FG000|Treatment Period|Adverse Event|39|||
131922523|NCT01734928|475000880|FG001|Treatment Period|Adverse Event|52|||
131922524|NCT01734928|475000879|FG000|Treatment Period|Withdrawal of Consent|25|||
131922525|NCT01734928|475000880|FG001|Treatment Period|Withdrawal of Consent|22|||
131922526|NCT01734928|475000879|FG000|Treatment Period|Death|20|||
131922527|NCT01734928|475000880|FG001|Treatment Period|Death|9|||
131922528|NCT01734928|475000879|FG000|Treatment Period|Other Reasons|27|||
131922529|NCT01734928|475000880|FG001|Treatment Period|Other Reasons|19|||
131922530|NCT01734928|475000879|FG000|Treatment Period|Pregnancy|0|||
131922531|NCT01734928|475000880|FG001|Treatment Period|Pregnancy|1|||
131922532|NCT01778985|475000881|FG000|Overall Study|Lost to Follow-up|1|||
131922533|NCT01778985|475000882|FG001|Overall Study|Lost to Follow-up|0|||
131922534|NCT01778985|475000881|FG000|Overall Study|Physician Decision|2|||
131922535|NCT01778985|475000882|FG001|Overall Study|Physician Decision|2|||
131922536|NCT01778985|475000881|FG000|Overall Study|Protocol Violation|4|||
131922537|NCT01778985|475000882|FG001|Overall Study|Protocol Violation|1|||
131922538|NCT00504231|475000883|FG000|Overall Study|Discrepant chart documentation re route|0|||
131922539|NCT00504231|475000884|FG001|Overall Study|Discrepant chart documentation re route|0|||
131922540|NCT00504231|475000885|FG002|Overall Study|Discrepant chart documentation re route|1|||
131922541|NCT00504231|475000886|FG003|Overall Study|Discrepant chart documentation re route|0|||
131922542|NCT00088881|475000888|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
131922543|NCT00088881|475000888|FG000|Step 1 - R-CHOP|Adverse Event|1|||
131922544|NCT00088881|475000888|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
131922545|NCT00088881|475000888|FG000|Step 1 - R-CHOP|Physician Decision|1|||
131922546|NCT00088881|475000888|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
131922547|NCT00088881|475000888|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
131922548|NCT00088881|475000888|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
131922549|NCT01631188|475000894|FG000|Overall Study|Physician Decision|75|||
131922550|NCT03600350|475000895|FG000|Overall Study|Death|1|||
131922551|NCT03600350|475000895|FG000|Overall Study|On Follow Up|18|||
131922552|NCT00835978|475000896|FG000|Overall Study|Death|33|||
131922553|NCT00835978|475000897|FG001|Overall Study|Death|40|||
131922554|NCT00835978|475000898|FG002|Overall Study|Death|49|||
131922555|NCT00835978|475000899|FG003|Overall Study|Death|4|||
131922556|NCT00835978|475000896|FG000|Overall Study|Lost to Follow-up|3|||
131408799|NCT00969761|473118421|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
131408800|NCT00969761|473118422|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
131408801|NCT00969761|473118423|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131922557|NCT00835978|475000897|FG001|Overall Study|Lost to Follow-up|4|||
131922558|NCT00835978|475000898|FG002|Overall Study|Lost to Follow-up|2|||
131922559|NCT00835978|475000899|FG003|Overall Study|Lost to Follow-up|1|||
131922560|NCT00835978|475000896|FG000|Overall Study|Other|5|||
131922561|NCT00835978|475000897|FG001|Overall Study|Other|1|||
131922562|NCT00835978|475000898|FG002|Overall Study|Other|8|||
131922563|NCT00835978|475000899|FG003|Overall Study|Other|0|||
131922564|NCT00835978|475000896|FG000|Overall Study|Objective progression or relapse|2|||
131922565|NCT00835978|475000897|FG001|Overall Study|Objective progression or relapse|0|||
131922566|NCT00835978|475000898|FG002|Overall Study|Objective progression or relapse|1|||
131922567|NCT00835978|475000899|FG003|Overall Study|Objective progression or relapse|0|||
131922568|NCT00835978|475000896|FG000|Overall Study|Adverse Event|1|||
131922569|NCT00835978|475000897|FG001|Overall Study|Adverse Event|0|||
131922570|NCT00835978|475000898|FG002|Overall Study|Adverse Event|1|||
131408802|NCT00969761|473118424|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408803|NCT00969761|473118425|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408804|NCT00969761|473118426|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
131408805|NCT00969761|473118427|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408806|NCT00969761|473118428|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408807|NCT00969761|473118429|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
131408808|NCT04030247|473120676|FG000|Overall Study|Withdrawal by Subject|4|||
131408809|NCT04030247|473120676|FG000|Overall Study|Lost to Follow-up|13|||
131408810|NCT00320255|473120677|FG000|Overall Study|Lack of Efficacy|1|||
131408811|NCT00320255|473120678|FG001|Overall Study|Lack of Efficacy|0|||
131408812|NCT00320255|473120679|FG002|Overall Study|Lack of Efficacy|0|||
131408813|NCT00320255|473120680|FG003|Overall Study|Lack of Efficacy|0|||
131408814|NCT00320255|473120681|FG004|Overall Study|Lack of Efficacy|0|||
131408815|NCT00320255|473120682|FG005|Overall Study|Lack of Efficacy|0|||
131408816|NCT00320255|473120677|FG000|Overall Study|Adverse Event|5|||
131408817|NCT00320255|473120678|FG001|Overall Study|Adverse Event|2|||
131408818|NCT00320255|473120679|FG002|Overall Study|Adverse Event|3|||
131408819|NCT00320255|473120680|FG003|Overall Study|Adverse Event|2|||
131408820|NCT00320255|473120681|FG004|Overall Study|Adverse Event|0|||
131408821|NCT00320255|473120682|FG005|Overall Study|Adverse Event|0|||
131408822|NCT00320255|473120677|FG000|Overall Study|Withdrawal by Subject|1|||
131408823|NCT00320255|473120678|FG001|Overall Study|Withdrawal by Subject|2|||
131408824|NCT00320255|473120679|FG002|Overall Study|Withdrawal by Subject|2|||
131408825|NCT00320255|473120680|FG003|Overall Study|Withdrawal by Subject|4|||
131408826|NCT00320255|473120681|FG004|Overall Study|Withdrawal by Subject|0|||
131408827|NCT00320255|473120682|FG005|Overall Study|Withdrawal by Subject|0|||
131408828|NCT00320255|473120677|FG000|Overall Study|Poor compliance/noncompliance|1|||
131408829|NCT00320255|473120678|FG001|Overall Study|Poor compliance/noncompliance|1|||
131408830|NCT00320255|473120679|FG002|Overall Study|Poor compliance/noncompliance|0|||
131408831|NCT00320255|473120680|FG003|Overall Study|Poor compliance/noncompliance|1|||
131408832|NCT00320255|473120681|FG004|Overall Study|Poor compliance/noncompliance|0|||
131408833|NCT00320255|473120682|FG005|Overall Study|Poor compliance/noncompliance|0|||
131408834|NCT00320255|473120677|FG000|Overall Study|No longer meets study criteria|0|||
131408835|NCT00320255|473120678|FG001|Overall Study|No longer meets study criteria|0|||
131408836|NCT00320255|473120679|FG002|Overall Study|No longer meets study criteria|0|||
131408837|NCT00320255|473120680|FG003|Overall Study|No longer meets study criteria|1|||
131408838|NCT00320255|473120681|FG004|Overall Study|No longer meets study criteria|0|||
131408839|NCT00320255|473120682|FG005|Overall Study|No longer meets study criteria|0|||
131408840|NCT00320255|473120677|FG000|Overall Study|Other|3|||
131408841|NCT00320255|473120678|FG001|Overall Study|Other|2|||
131408842|NCT00320255|473120679|FG002|Overall Study|Other|1|||
131408843|NCT00320255|473120680|FG003|Overall Study|Other|0|||
131408844|NCT00320255|473120681|FG004|Overall Study|Other|0|||
131408845|NCT00320255|473120682|FG005|Overall Study|Other|0|||
131408846|NCT03383783|473120689|FG000|Overall Study|Withdrawal by Subject|2|||
131408847|NCT02781792|473120690|FG000|Overall Study|Adverse Event|1|||
131408848|NCT02781792|473120691|FG001|Overall Study|Adverse Event|2|||
131408849|NCT02781792|473120690|FG000|Overall Study|Withdrawal by Subject|3|||
131408850|NCT02781792|473120691|FG001|Overall Study|Withdrawal by Subject|1|||
131408851|NCT02781792|473120690|FG000|Overall Study|Lack of Efficacy|1|||
131408852|NCT02781792|473120691|FG001|Overall Study|Lack of Efficacy|1|||
131408853|NCT02781792|473120690|FG000|Overall Study|Hospice|0|||
131876845|NCT01868022|474829138|FG001|Overall Study|Adverse Event|0|||
131876846|NCT01868022|474829139|FG002|Overall Study|Adverse Event|0|||
131876847|NCT01868022|474829140|FG003|Overall Study|Adverse Event|0|||
131876848|NCT01868022|474829141|FG004|Overall Study|Adverse Event|2|||
131408854|NCT02781792|473120691|FG001|Overall Study|Hospice|1|||
131408855|NCT01703117|473120692|FG000|Overall Study|Adverse Event|4|||
131408856|NCT01703117|473120693|FG001|Overall Study|Adverse Event|3|||
131408857|NCT01703117|473120692|FG000|Overall Study|Withdrawal by Subject|0|||
131408858|NCT01703117|473120693|FG001|Overall Study|Withdrawal by Subject|1|||
131408859|NCT00937404|473120705|FG000|Overall Study|Protocol Violation|1|||
131408860|NCT00937404|473120705|FG000|Overall Study|Withdrawal by Subject|1|||
131408861|NCT04644237|473120706|FG000|Overall Study|Death|3|||
131408862|NCT04644237|473120707|FG001|Overall Study|Death|2|||
131408863|NCT04644237|473120706|FG000|Overall Study|Adverse Event|15|||
131408864|NCT04644237|473120707|FG001|Overall Study|Adverse Event|12|||
131408865|NCT04644237|473120706|FG000|Overall Study|Progressive Disease|47|||
131408866|NCT04644237|473120707|FG001|Overall Study|Progressive Disease|19|||
131408867|NCT04644237|473120706|FG000|Overall Study|Clinical Progression|4|||
131408868|NCT04644237|473120707|FG001|Overall Study|Clinical Progression|1|||
131408869|NCT04644237|473120706|FG000|Overall Study|Withdrawal by Subject|1|||
131408870|NCT04644237|473120707|FG001|Overall Study|Withdrawal by Subject|2|||
131408871|NCT04644237|473120706|FG000|Overall Study|Physician Decision|3|||
131408872|NCT04644237|473120707|FG001|Overall Study|Physician Decision|0|||
131408873|NCT04644237|473120706|FG000|Overall Study|Other|1|||
131408874|NCT04644237|473120707|FG001|Overall Study|Other|0|||
131922571|NCT00835978|475000899|FG003|Overall Study|Adverse Event|0|||
131922572|NCT00835978|475000896|FG000|Overall Study|Withdrawal by Subject|0|||
131922573|NCT00835978|475000897|FG001|Overall Study|Withdrawal by Subject|3|||
131922574|NCT00835978|475000898|FG002|Overall Study|Withdrawal by Subject|0|||
131922575|NCT00835978|475000899|FG003|Overall Study|Withdrawal by Subject|5|||
131922576|NCT00835978|475000896|FG000|Overall Study|Study terminated by sponsor|12|||
131922577|NCT00835978|475000897|FG001|Overall Study|Study terminated by sponsor|8|||
131922578|NCT00835978|475000898|FG002|Overall Study|Study terminated by sponsor|30|||
131922579|NCT00835978|475000899|FG003|Overall Study|Study terminated by sponsor|0|||
131922580|NCT04575324|475000902|FG000|Overall Study|Lost to Follow-up|29|||
131922581|NCT04575324|475000903|FG001|Overall Study|Lost to Follow-up|25|||
131922582|NCT04575324|475000902|FG000|Overall Study|Death|1|||
131922583|NCT04575324|475000903|FG001|Overall Study|Death|2|||
131922584|NCT04575324|475000902|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
131922585|NCT04575324|475000903|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
131922586|NCT02400736|475000904|FG000|Overall Study|Lost to Follow-up|6|||
131922587|NCT02400736|475000905|FG001|Overall Study|Lost to Follow-up|6|||
131922588|NCT02400736|475000904|FG000|Overall Study|Withdrawal by Subject|2|||
131922589|NCT02400736|475000905|FG001|Overall Study|Withdrawal by Subject|1|||
131922590|NCT02400736|475000904|FG000|Overall Study|Moved from the area|3|||
131922591|NCT02400736|475000905|FG001|Overall Study|Moved from the area|1|||
131922592|NCT03684057|475000906|FG000|Overall Study|Withdrawal by Subject|4|||
131922593|NCT03684057|475000907|FG001|Overall Study|Withdrawal by Subject|5|||
131922594|NCT01105130|475000908|FG000|Overall Study|Withdrawal by Subject|4|||
131922595|NCT01105130|475000909|FG001|Overall Study|Withdrawal by Subject|6|||
131922596|NCT01105130|475000910|FG002|Overall Study|Withdrawal by Subject|2|||
131922597|NCT01105130|475000908|FG000|Overall Study|Never Started|2|||
131922598|NCT01105130|475000909|FG001|Overall Study|Never Started|2|||
131922599|NCT01105130|475000910|FG002|Overall Study|Never Started|4|||
131922600|NCT01105130|475000908|FG000|Overall Study|Toxicity|1|||
131922601|NCT01105130|475000909|FG001|Overall Study|Toxicity|3|||
131922602|NCT01105130|475000910|FG002|Overall Study|Toxicity|2|||
131922603|NCT01105130|475000908|FG000|Overall Study|Multiple Reasons|3|||
131922604|NCT01105130|475000909|FG001|Overall Study|Multiple Reasons|0|||
131922605|NCT01105130|475000910|FG002|Overall Study|Multiple Reasons|2|||
131922606|NCT02927145|475000912|FG000|Initial Recruitment|Withdrawal by Subject|0|||
131922607|NCT02927145|475000913|FG001|Initial Recruitment|Withdrawal by Subject|1|||
131922608|NCT02927145|475000914|FG002|Initial Recruitment|Withdrawal by Subject|1|||
131922609|NCT02927145|475000915|FG003|Initial Recruitment|Withdrawal by Subject|4|||
131922610|NCT02927145|475000916|FG004|Initial Recruitment|Withdrawal by Subject|1|||
131922611|NCT02927145|475000917|FG005|Initial Recruitment|Withdrawal by Subject|1|||
131922612|NCT02927145|475000918|FG006|Initial Recruitment|Withdrawal by Subject|0|||
131922613|NCT02927145|475000919|FG007|Initial Recruitment|Withdrawal by Subject|0|||
131922614|NCT02927145|475000920|FG008|Initial Recruitment|Withdrawal by Subject|2|||
131922615|NCT02927145|475000912|FG000|Initial Recruitment|Adverse Event|0|||
131922616|NCT02927145|475000913|FG001|Initial Recruitment|Adverse Event|0|||
131922617|NCT02927145|475000914|FG002|Initial Recruitment|Adverse Event|0|||
131922618|NCT02927145|475000915|FG003|Initial Recruitment|Adverse Event|0|||
131922619|NCT02927145|475000916|FG004|Initial Recruitment|Adverse Event|2|||
131922620|NCT02927145|475000917|FG005|Initial Recruitment|Adverse Event|0|||
131922621|NCT02927145|475000918|FG006|Initial Recruitment|Adverse Event|0|||
131922622|NCT02927145|475000919|FG007|Initial Recruitment|Adverse Event|0|||
131922623|NCT02927145|475000920|FG008|Initial Recruitment|Adverse Event|0|||
131922624|NCT02927145|475000912|FG000|Invitation for Additional Challenge|Pregnancy|0|||
131922625|NCT02927145|475000913|FG001|Invitation for Additional Challenge|Pregnancy|0|||
131922626|NCT02927145|475000914|FG002|Invitation for Additional Challenge|Pregnancy|0|||
131922627|NCT02927145|475000915|FG003|Invitation for Additional Challenge|Pregnancy|0|||
131922628|NCT02927145|475000916|FG004|Invitation for Additional Challenge|Pregnancy|0|||
131922629|NCT02927145|475000917|FG005|Invitation for Additional Challenge|Pregnancy|0|||
131922630|NCT02927145|475000918|FG006|Invitation for Additional Challenge|Pregnancy|1|||
131922631|NCT02927145|475000919|FG007|Invitation for Additional Challenge|Pregnancy|0|||
131922632|NCT02927145|475000920|FG008|Invitation for Additional Challenge|Pregnancy|0|||
131922633|NCT01002105|475000921|FG000|Overall Study|Lost to Follow-up|10|||
131922634|NCT01002105|475000922|FG001|Overall Study|Lost to Follow-up|16|||
131922635|NCT01002105|475000921|FG000|Overall Study|non compliance|5|||
131922636|NCT01002105|475000922|FG001|Overall Study|non compliance|3|||
131922637|NCT01002105|475000921|FG000|Overall Study|condition worsened|4|||
131922638|NCT01002105|475000922|FG001|Overall Study|condition worsened|2|||
131922639|NCT01363440|475000924|FG000|Overall Study|Adverse Event|5|||
131922640|NCT01363440|475000925|FG001|Overall Study|Adverse Event|4|||
131922641|NCT01363440|475000926|FG002|Overall Study|Adverse Event|4|||
131922642|NCT01363440|475000924|FG000|Overall Study|Death|3|||
131922643|NCT01363440|475000925|FG001|Overall Study|Death|7|||
131922644|NCT01363440|475000926|FG002|Overall Study|Death|5|||
131922645|NCT01363440|475000924|FG000|Overall Study|Withdrawal by Subject|9|||
131922646|NCT01363440|475000925|FG001|Overall Study|Withdrawal by Subject|11|||
131922647|NCT01363440|475000926|FG002|Overall Study|Withdrawal by Subject|11|||
131922648|NCT01363440|475000924|FG000|Overall Study|Lost to Follow-up|2|||
131922649|NCT01363440|475000925|FG001|Overall Study|Lost to Follow-up|4|||
131922650|NCT01363440|475000926|FG002|Overall Study|Lost to Follow-up|5|||
131922651|NCT01363440|475000924|FG000|Overall Study|Other|4|||
131922652|NCT01363440|475000925|FG001|Overall Study|Other|5|||
131922653|NCT01363440|475000926|FG002|Overall Study|Other|2|||
131922654|NCT03695094|475000928|FG000|Overall Study|Adverse Event|1|||
131922655|NCT03695094|475000929|FG001|Overall Study|Adverse Event|1|||
131922656|NCT03695094|475000928|FG000|Overall Study|Withdrawal by Subject|1|||
131922657|NCT03695094|475000929|FG001|Overall Study|Withdrawal by Subject|0|||
131922658|NCT02323334|475000930|FG000|Period 3|Lost to Follow-up|0|||
131922659|NCT02323334|475000931|FG001|Period 3|Lost to Follow-up|0|||
131922660|NCT02323334|475000932|FG002|Period 3|Lost to Follow-up|1|||
131922661|NCT02323334|475000933|FG003|Period 3|Lost to Follow-up|0|||
131922662|NCT02323334|475000934|FG004|Period 3|Lost to Follow-up|0|||
131922663|NCT02323334|475000935|FG005|Period 3|Lost to Follow-up|0|||
131922664|NCT02323334|475000936|FG006|Period 3|Lost to Follow-up|0|||
131922665|NCT02323334|475000937|FG007|Period 3|Lost to Follow-up|0|||
131922666|NCT02323334|475000938|FG008|Period 3|Lost to Follow-up|0|||
131922667|NCT02323334|475000939|FG009|Period 3|Lost to Follow-up|0|||
131922668|NCT02323334|475000940|FG010|Period 3|Lost to Follow-up|0|||
131922669|NCT02323334|475000941|FG011|Period 3|Lost to Follow-up|0|||
131922670|NCT02323334|475000942|FG012|Period 3|Lost to Follow-up|0|||
131922671|NCT02323334|475000943|FG013|Period 3|Lost to Follow-up|0|||
131922672|NCT02323334|475000944|FG014|Period 3|Lost to Follow-up|0|||
131922673|NCT02323334|475000945|FG015|Period 3|Lost to Follow-up|0|||
131922674|NCT02323334|475000946|FG016|Period 3|Lost to Follow-up|0|||
131922675|NCT02323334|475000930|FG000|Period 3|Withdrawal by Subject|1|||
131922676|NCT02323334|475000931|FG001|Period 3|Withdrawal by Subject|0|||
131922677|NCT02323334|475000932|FG002|Period 3|Withdrawal by Subject|0|||
131922678|NCT02323334|475000933|FG003|Period 3|Withdrawal by Subject|0|||
131922679|NCT02323334|475000934|FG004|Period 3|Withdrawal by Subject|0|||
131922680|NCT02323334|475000935|FG005|Period 3|Withdrawal by Subject|0|||
131922681|NCT02323334|475000936|FG006|Period 3|Withdrawal by Subject|0|||
131922682|NCT02323334|475000937|FG007|Period 3|Withdrawal by Subject|0|||
131922683|NCT02323334|475000938|FG008|Period 3|Withdrawal by Subject|0|||
131922684|NCT02323334|475000939|FG009|Period 3|Withdrawal by Subject|0|||
131922685|NCT02323334|475000940|FG010|Period 3|Withdrawal by Subject|0|||
131922686|NCT02323334|475000941|FG011|Period 3|Withdrawal by Subject|0|||
131922687|NCT02323334|475000942|FG012|Period 3|Withdrawal by Subject|0|||
131922688|NCT02323334|475000943|FG013|Period 3|Withdrawal by Subject|0|||
131922689|NCT02323334|475000944|FG014|Period 3|Withdrawal by Subject|0|||
131922690|NCT02323334|475000945|FG015|Period 3|Withdrawal by Subject|0|||
131922691|NCT02323334|475000946|FG016|Period 3|Withdrawal by Subject|0|||
131922692|NCT00266812|475000947|FG000|Overall Study|Disease Progression|9|||
131922693|NCT00266812|475000948|FG001|Overall Study|Disease Progression|3|||
131922694|NCT00266812|475000947|FG000|Overall Study|Death|5|||
131922695|NCT00266812|475000948|FG001|Overall Study|Death|4|||
131922696|NCT00266812|475000947|FG000|Overall Study|Adverse Event|3|||
131922697|NCT00266812|475000948|FG001|Overall Study|Adverse Event|1|||
131922698|NCT00266812|475000947|FG000|Overall Study|Protocol Violation|0|||
131922699|NCT00266812|475000948|FG001|Overall Study|Protocol Violation|1|||
131922700|NCT00266812|475000947|FG000|Overall Study|Withdrawal by Subject|0|||
131922701|NCT00266812|475000948|FG001|Overall Study|Withdrawal by Subject|2|||
131922702|NCT00266812|475000947|FG000|Overall Study|Discontinued before starting study drug|4|||
131922703|NCT00266812|475000948|FG001|Overall Study|Discontinued before starting study drug|0|||
131922704|NCT00456612|475000950|FG000|Overall Study|Withdrawal by Subject|3|||
131922705|NCT02506036|475000951|FG000|First Intervention (4-6 Weeks)|Death|1|||
131922706|NCT02506036|475000952|FG001|First Intervention (4-6 Weeks)|Death|0|||
131922707|NCT02506036|475000951|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
131922708|NCT02506036|475000952|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
131922709|NCT02506036|475000951|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
131922710|NCT02506036|475000952|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
131922711|NCT00530075|475000955|FG000|Overall Study|Adverse Event|1|||
131922712|NCT00530075|475000955|FG000|Overall Study|Death|1|||
131922713|NCT00530075|475000955|FG000|Overall Study|Lack of Efficacy|3|||
131922714|NCT00530075|475000955|FG000|Overall Study|Protocol Violation|1|||
131922715|NCT00530075|475000955|FG000|Overall Study|Withdrawal by Subject|1|||
131922716|NCT02316613|475000956|FG000|Overall Study|Death|63|||
131922717|NCT02316613|475000956|FG000|Overall Study|Lost to Follow-up|9|||
131922718|NCT02316613|475000956|FG000|Overall Study|Lymphoma transformation|2|||
131922719|NCT02316613|475000956|FG000|Overall Study|Participant moved/changed medical team|11|||
131922720|NCT02316613|475000956|FG000|Overall Study|No data and duplicate cases|5|||
131922721|NCT02316613|475000956|FG000|Overall Study|Did not met selection criteria|14|||
131922722|NCT01166945|475000957|FG000|Randomized|diagnosed with Group A strep|4|||
131922723|NCT01166945|475000958|FG001|Randomized|diagnosed with Group A strep|4|||
131922724|NCT01166945|475000957|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
131922725|NCT01166945|475000958|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
131922726|NCT01166945|475000957|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
131922727|NCT01166945|475000958|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
131922728|NCT01166945|475000957|FG000|Day 30|Lost to Follow-up|4|||
131922729|NCT01166945|475000958|FG001|Day 30|Lost to Follow-up|3|||
131922730|NCT00758043|475000962|FG000|Overall Study|Adverse Event|1|||
131922731|NCT00758043|475000963|FG001|Overall Study|Adverse Event|20|||
131922732|NCT00758043|475000964|FG002|Overall Study|Adverse Event|12|||
131922733|NCT00758043|475000965|FG003|Overall Study|Adverse Event|62|||
131922734|NCT00758043|475000962|FG000|Overall Study|Lack of Efficacy|0|||
131922735|NCT00758043|475000963|FG001|Overall Study|Lack of Efficacy|6|||
131922736|NCT00758043|475000964|FG002|Overall Study|Lack of Efficacy|18|||
131922737|NCT00758043|475000965|FG003|Overall Study|Lack of Efficacy|12|||
131922738|NCT00758043|475000962|FG000|Overall Study|Refused Further Treatment|0|||
131922739|NCT00758043|475000963|FG001|Overall Study|Refused Further Treatment|11|||
131922740|NCT00758043|475000964|FG002|Overall Study|Refused Further Treatment|5|||
131922741|NCT00758043|475000965|FG003|Overall Study|Refused Further Treatment|8|||
131922742|NCT00758043|475000962|FG000|Overall Study|Lost to Follow-up|0|||
131922743|NCT00758043|475000963|FG001|Overall Study|Lost to Follow-up|2|||
131922744|NCT00758043|475000964|FG002|Overall Study|Lost to Follow-up|2|||
131922745|NCT00758043|475000965|FG003|Overall Study|Lost to Follow-up|5|||
131922746|NCT00758043|475000962|FG000|Overall Study|Withdrawal by Subject|0|||
131922747|NCT00758043|475000963|FG001|Overall Study|Withdrawal by Subject|1|||
131922748|NCT00758043|475000964|FG002|Overall Study|Withdrawal by Subject|1|||
131922749|NCT00758043|475000965|FG003|Overall Study|Withdrawal by Subject|4|||
131922750|NCT00758043|475000962|FG000|Overall Study|Required Prohibited Medication|0|||
131922751|NCT00758043|475000963|FG001|Overall Study|Required Prohibited Medication|0|||
131922752|NCT00758043|475000964|FG002|Overall Study|Required Prohibited Medication|1|||
131922753|NCT00758043|475000965|FG003|Overall Study|Required Prohibited Medication|3|||
131922754|NCT00758043|475000962|FG000|Overall Study|Non-Compliant With study Drug|0|||
131922755|NCT00758043|475000963|FG001|Overall Study|Non-Compliant With study Drug|0|||
131922756|NCT00758043|475000964|FG002|Overall Study|Non-Compliant With study Drug|0|||
131922757|NCT00758043|475000965|FG003|Overall Study|Non-Compliant With study Drug|1|||
131922758|NCT00758043|475000962|FG000|Overall Study|Other Reasons|0|||
131922759|NCT00758043|475000963|FG001|Overall Study|Other Reasons|1|||
131922760|NCT00758043|475000964|FG002|Overall Study|Other Reasons|0|||
131922761|NCT00758043|475000965|FG003|Overall Study|Other Reasons|5|||
131922762|NCT03422718|475000972|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
131922763|NCT03422718|475000973|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
131922764|NCT03422718|475000974|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
131922765|NCT03422718|475000975|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
131922766|NCT03422718|475000976|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
131922767|NCT03422718|475000977|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
131922768|NCT03422718|475000978|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
131922769|NCT03422718|475000979|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
131922770|NCT03422718|475000972|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
131922771|NCT03422718|475000973|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
131876849|NCT01868022|474829142|FG005|Overall Study|Adverse Event|0|||
131876850|NCT01868022|474829143|FG006|Overall Study|Adverse Event|0|||
131876851|NCT01868022|474829144|FG007|Overall Study|Adverse Event|2|||
131876852|NCT01868022|474829145|FG008|Overall Study|Adverse Event|2|||
131876853|NCT01868022|474829137|FG000|Overall Study|Physician Decision|0|||
131876854|NCT01868022|474829138|FG001|Overall Study|Physician Decision|0|||
131876855|NCT01868022|474829139|FG002|Overall Study|Physician Decision|0|||
131876856|NCT01868022|474829140|FG003|Overall Study|Physician Decision|0|||
131876857|NCT01868022|474829141|FG004|Overall Study|Physician Decision|0|||
131876858|NCT01868022|474829142|FG005|Overall Study|Physician Decision|1|||
131876859|NCT01868022|474829143|FG006|Overall Study|Physician Decision|0|||
131876860|NCT01868022|474829144|FG007|Overall Study|Physician Decision|2|||
131876861|NCT01868022|474829145|FG008|Overall Study|Physician Decision|0|||
131876862|NCT01868022|474829137|FG000|Overall Study|Study closed/terminated|0|||
131876863|NCT01868022|474829138|FG001|Overall Study|Study closed/terminated|0|||
131876864|NCT01868022|474829139|FG002|Overall Study|Study closed/terminated|0|||
131876865|NCT01868022|474829140|FG003|Overall Study|Study closed/terminated|0|||
131876866|NCT01868022|474829141|FG004|Overall Study|Study closed/terminated|0|||
131922772|NCT03422718|475000974|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
131876867|NCT01868022|474829142|FG005|Overall Study|Study closed/terminated|0|||
131876868|NCT01868022|474829143|FG006|Overall Study|Study closed/terminated|0|||
131876869|NCT01868022|474829144|FG007|Overall Study|Study closed/terminated|1|||
131876870|NCT01868022|474829145|FG008|Overall Study|Study closed/terminated|0|||
131876871|NCT01868022|474829137|FG000|Overall Study|Ongoing|0|||
131922773|NCT03422718|475000975|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
131922774|NCT03422718|475000976|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
131922775|NCT03422718|475000977|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
131922776|NCT03422718|475000978|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
131876872|NCT01868022|474829138|FG001|Overall Study|Ongoing|0|||
131876873|NCT01868022|474829139|FG002|Overall Study|Ongoing|0|||
131876874|NCT01868022|474829140|FG003|Overall Study|Ongoing|0|||
131876875|NCT01868022|474829141|FG004|Overall Study|Ongoing|0|||
131876876|NCT01868022|474829142|FG005|Overall Study|Ongoing|0|||
131876877|NCT01868022|474829143|FG006|Overall Study|Ongoing|0|||
131876878|NCT01868022|474829144|FG007|Overall Study|Ongoing|3|||
131876879|NCT01868022|474829145|FG008|Overall Study|Ongoing|0|||
131876880|NCT00746564|474829146|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
131876881|NCT02640677|474829150|FG000|Overall Study|Lost to Follow-up|1|||
131876882|NCT02640677|474829150|FG000|Overall Study|Withdrawal by Subject|1|||
131876883|NCT01516008|474829157|FG000|Overall Study|Adverse Event|0|||
131876884|NCT01516008|474829158|FG001|Overall Study|Adverse Event|2|||
131876885|NCT01516008|474829159|FG002|Overall Study|Adverse Event|7|||
131876886|NCT01516008|474829157|FG000|Overall Study|Lack of Efficacy|44|||
131876887|NCT01516008|474829158|FG001|Overall Study|Lack of Efficacy|14|||
131876888|NCT01516008|474829159|FG002|Overall Study|Lack of Efficacy|10|||
131876889|NCT01516008|474829157|FG000|Overall Study|Protocol Violation|1|||
131876890|NCT01516008|474829158|FG001|Overall Study|Protocol Violation|0|||
131876891|NCT01516008|474829159|FG002|Overall Study|Protocol Violation|0|||
131876892|NCT01516008|474829157|FG000|Overall Study|Reason not specified|0|||
131876893|NCT01516008|474829158|FG001|Overall Study|Reason not specified|0|||
131876894|NCT01516008|474829159|FG002|Overall Study|Reason not specified|1|||
131876895|NCT00833482|474829163|FG000|Days 11-20|Adverse Event|0|||
131876896|NCT00833482|474829164|FG001|Days 11-20|Adverse Event|2|||
131876897|NCT00833482|474829165|FG002|Days 11-20|Adverse Event|0|||
131876898|NCT00833482|474829166|FG003|Days 11-20|Adverse Event|0|||
131876899|NCT00833482|474829167|FG004|Days 11-20|Adverse Event|0|||
131876900|NCT00833482|474829168|FG005|Days 11-20|Adverse Event|0|||
131876901|NCT00833482|474829163|FG000|Days 11-20|Withdrawal by Subject|0|||
131876902|NCT00833482|474829164|FG001|Days 11-20|Withdrawal by Subject|1|||
131876903|NCT00833482|474829165|FG002|Days 11-20|Withdrawal by Subject|0|||
131876904|NCT00833482|474829166|FG003|Days 11-20|Withdrawal by Subject|0|||
131876905|NCT00833482|474829167|FG004|Days 11-20|Withdrawal by Subject|0|||
131876906|NCT00833482|474829168|FG005|Days 11-20|Withdrawal by Subject|0|||
131876907|NCT00833482|474829163|FG000|Days 21-30|Adverse Event|0|||
131876908|NCT00833482|474829164|FG001|Days 21-30|Adverse Event|0|||
131876909|NCT00833482|474829165|FG002|Days 21-30|Adverse Event|1|||
131876910|NCT00833482|474829166|FG003|Days 21-30|Adverse Event|0|||
131876911|NCT00833482|474829167|FG004|Days 21-30|Adverse Event|0|||
131876912|NCT00833482|474829168|FG005|Days 21-30|Adverse Event|0|||
131876913|NCT00833482|474829163|FG000|Days 21-30|Withdrawal by Subject|0|||
131876914|NCT00833482|474829164|FG001|Days 21-30|Withdrawal by Subject|0|||
131876915|NCT00833482|474829165|FG002|Days 21-30|Withdrawal by Subject|0|||
131876916|NCT00833482|474829166|FG003|Days 21-30|Withdrawal by Subject|0|||
131876917|NCT00833482|474829167|FG004|Days 21-30|Withdrawal by Subject|1|||
131876918|NCT00833482|474829168|FG005|Days 21-30|Withdrawal by Subject|0|||
131876919|NCT03489707|474829171|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
131876920|NCT03489707|474829172|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
131876921|NCT03489707|474829171|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
131876922|NCT03489707|474829172|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
131876923|NCT01817582|474829173|FG000|Overall Study|Withdrawal by Subject|0|||
131876924|NCT01817582|474829174|FG001|Overall Study|Withdrawal by Subject|1|||
131876925|NCT01817582|474829175|FG002|Overall Study|Withdrawal by Subject|0|||
131876926|NCT01817582|474829173|FG000|Overall Study|Participant revealed masked treatment|1|||
131876927|NCT01817582|474829174|FG001|Overall Study|Participant revealed masked treatment|0|||
131876928|NCT01817582|474829175|FG002|Overall Study|Participant revealed masked treatment|0|||
131876929|NCT01817582|474829173|FG000|Overall Study|Randomized but exclusion criteria met|1|||
131876930|NCT01817582|474829174|FG001|Overall Study|Randomized but exclusion criteria met|0|||
131876931|NCT01817582|474829175|FG002|Overall Study|Randomized but exclusion criteria met|0|||
131876932|NCT02836236|474831314|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
131876933|NCT02836236|474831315|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
131876934|NCT02836236|474831316|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
131876935|NCT02836236|474831317|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
131876936|NCT02836236|474831314|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
131876937|NCT02836236|474831315|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
131876938|NCT02836236|474831316|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
131876939|NCT02836236|474831317|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
131876940|NCT02836236|474831314|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131876941|NCT02836236|474831315|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
131876942|NCT02836236|474831316|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
131876943|NCT02836236|474831317|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131876944|NCT02836236|474831314|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
131876945|NCT02836236|474831315|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
131876946|NCT02836236|474831316|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
131876947|NCT02836236|474831317|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
131876948|NCT02836236|474831314|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
131922777|NCT03422718|475000979|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
131922778|NCT03422718|475000972|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
131922779|NCT03422718|475000973|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
131922780|NCT03422718|475000974|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
131922781|NCT03422718|475000975|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
131922782|NCT03422718|475000976|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
131922783|NCT03422718|475000977|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
131922784|NCT03422718|475000978|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
131922785|NCT03422718|475000979|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
131922786|NCT03422718|475000972|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
131922787|NCT03422718|475000973|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
131922788|NCT03422718|475000974|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
131922789|NCT03422718|475000975|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
131922790|NCT03422718|475000976|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
131922791|NCT03422718|475000977|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
131922792|NCT03422718|475000978|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
131922793|NCT03422718|475000979|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
131922794|NCT03422718|475000972|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
131922795|NCT03422718|475000973|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
131922796|NCT03422718|475000974|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
131922797|NCT03422718|475000975|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
131922798|NCT03422718|475000976|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
131922799|NCT03422718|475000977|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
131922800|NCT03422718|475000978|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
131922801|NCT03422718|475000979|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
131922802|NCT03422718|475000972|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
131922803|NCT03422718|475000973|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
131922804|NCT03422718|475000974|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
131922805|NCT03422718|475000975|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
131922806|NCT03422718|475000976|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
131922807|NCT03422718|475000977|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
131922808|NCT03422718|475000978|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
131922809|NCT03422718|475000979|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
131922810|NCT01129284|475000980|FG000|Overall Study|Adverse Event|2|||
131922811|NCT01129284|475000981|FG001|Overall Study|Adverse Event|0|||
131922812|NCT01129284|475000982|FG002|Overall Study|Adverse Event|1|||
131922813|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
131922814|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
131922815|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
131922816|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
131922817|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
131922818|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
131922819|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
131922820|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
131922821|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
131922822|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
131922823|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
131922824|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
131922825|NCT00447278|475000992|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
131922826|NCT00447278|475000993|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
131922827|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
131408875|NCT04644237|473120706|FG000|Overall Study|Randomized but not Treated|1|||
131408876|NCT04644237|473120707|FG001|Overall Study|Randomized but not Treated|0|||
131408877|NCT00090233|473120708|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
131408878|NCT00090233|473120709|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
131408879|NCT00090233|473120708|FG000|Overall Study|Adverse Event|214|||
131408880|NCT00090233|473120709|FG001|Overall Study|Adverse Event|198|||
131408881|NCT00090233|473120708|FG000|Overall Study|Lost to Follow-up|68|||
131408882|NCT00090233|473120709|FG001|Overall Study|Lost to Follow-up|95|||
131408883|NCT00090233|473120708|FG000|Overall Study|Protocol Violation|960|||
131408884|NCT00090233|473120709|FG001|Overall Study|Protocol Violation|1022|||
131408885|NCT00090233|473120708|FG000|Overall Study|Withdrawal by Subject|182|||
131408886|NCT00090233|473120709|FG001|Overall Study|Withdrawal by Subject|211|||
131408887|NCT00090233|473120708|FG000|Overall Study|Moved|203|||
131408888|NCT00090233|473120709|FG001|Overall Study|Moved|189|||
131408889|NCT00090233|473120708|FG000|Overall Study|Other|1211|||
131408890|NCT00090233|473120709|FG001|Overall Study|Other|1160|||
131408891|NCT00090233|473120708|FG000|Overall Study|Data not available at data cut-off point|1552|||
131408892|NCT00090233|473120709|FG001|Overall Study|Data not available at data cut-off point|1563|||
131876949|NCT02836236|474831315|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
131876950|NCT02836236|474831316|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
131876951|NCT02836236|474831317|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
131876952|NCT02836236|474831314|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
131876953|NCT02836236|474831315|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
131876954|NCT02836236|474831316|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
131876955|NCT02836236|474831317|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
131408893|NCT04863248|473120710|FG000|Overall Study|Sponsor Terminated|4|||
131408894|NCT04863248|473120711|FG001|Overall Study|Sponsor Terminated|1|||
131876956|NCT02836236|474831314|FG000|Open-Label TAF Treatment Phase|Death|0|||
131876957|NCT02836236|474831315|FG001|Open-Label TAF Treatment Phase|Death|0|||
131876958|NCT02836236|474831316|FG002|Open-Label TAF Treatment Phase|Death|1|||
131876959|NCT02836236|474831317|FG003|Open-Label TAF Treatment Phase|Death|1|||
131876960|NCT02836236|474831314|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
131876961|NCT02836236|474831315|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
131876962|NCT02836236|474831316|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
131876963|NCT02836236|474831317|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
131876964|NCT01806961|474831318|FG000|Overall Study|sponsor decision|16|||
131876965|NCT00378508|474831320|FG000|Overall Study|Withdrawal by Subject|1|||
131876966|NCT00378508|474831321|FG001|Overall Study|Withdrawal by Subject|3|||
131876967|NCT00378508|474831320|FG000|Overall Study|Lost to Follow-up|1|||
131876968|NCT00378508|474831321|FG001|Overall Study|Lost to Follow-up|0|||
131876969|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
131876970|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
131876971|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
131876972|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
131876973|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Death|0|||
131876974|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Death|0|||
131876975|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Death|1|||
131876976|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Death|0|||
131876977|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
131876978|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
131876979|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
131876980|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
131876981|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
131876982|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
131876983|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
131876984|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
131876985|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
131876986|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
131876987|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
131876988|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
131876989|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
131876990|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
131876991|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
131876992|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
131876993|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
131876994|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
131876995|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
131876996|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
131876997|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
131876998|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
131876999|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
131877000|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
131877001|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131877002|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
131877003|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131877004|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131877005|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
131877006|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
131877007|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
131877008|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
131877009|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
131877010|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
131877011|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
131877012|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
131877013|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Other|8|||
131877014|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Other|14|||
131408895|NCT04863248|473120710|FG000|Overall Study|Death|0|||
131408896|NCT04863248|473120711|FG001|Overall Study|Death|1|||
131408897|NCT04863248|473120710|FG000|Overall Study|Withdrawal by Subject|0|||
131408898|NCT04863248|473120711|FG001|Overall Study|Withdrawal by Subject|1|||
131408899|NCT02536300|473120712|FG000|Overall Study|Investigator's Discretion|17|||
131408900|NCT02536300|473120713|FG001|Overall Study|Investigator's Discretion|11|||
131408901|NCT02536300|473120714|FG002|Overall Study|Investigator's Discretion|2|||
131408902|NCT02536300|473120712|FG000|Overall Study|Progressive Disease|11|||
131408903|NCT02536300|473120713|FG001|Overall Study|Progressive Disease|7|||
131408904|NCT02536300|473120714|FG002|Overall Study|Progressive Disease|6|||
131408905|NCT02536300|473120712|FG000|Overall Study|Study Terminated by Sponsor|6|||
131408906|NCT02536300|473120713|FG001|Overall Study|Study Terminated by Sponsor|4|||
131408907|NCT02536300|473120714|FG002|Overall Study|Study Terminated by Sponsor|7|||
131408908|NCT02536300|473120712|FG000|Overall Study|Death|7|||
131408909|NCT02536300|473120713|FG001|Overall Study|Death|0|||
131408910|NCT02536300|473120714|FG002|Overall Study|Death|5|||
131408911|NCT02536300|473120712|FG000|Overall Study|Withdrew Consent|4|||
131408912|NCT02536300|473120713|FG001|Overall Study|Withdrew Consent|2|||
131408913|NCT02536300|473120714|FG002|Overall Study|Withdrew Consent|0|||
131408914|NCT02536300|473120712|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
131408915|NCT02536300|473120713|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
131408916|NCT02536300|473120714|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
131408917|NCT02536300|473120712|FG000|Overall Study|Enrolled but Never Treated|0|||
131408918|NCT02536300|473120713|FG001|Overall Study|Enrolled but Never Treated|0|||
131408919|NCT02536300|473120714|FG002|Overall Study|Enrolled but Never Treated|1|||
131408920|NCT02536300|473120712|FG000|Overall Study|Non-compliance With Study Drug|1|||
131922828|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
131922829|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
131922830|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
131922831|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
131922832|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
131922833|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
131922834|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
131922835|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
131922836|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
131922837|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
131922838|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
131922839|NCT00447278|475000992|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
131922840|NCT00447278|475000993|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
131922841|NCT01348698|475000994|FG000|Overall Study|Does not meet lesion size criteria|1|||
131922842|NCT01348698|475000994|FG000|Overall Study|Death|3|||
131922843|NCT01348698|475000994|FG000|Overall Study|PI decision to close study|68|||
131922844|NCT02595749|475000995|FG000|Overall Study|Withdrawal by Subject|12|||
131922845|NCT02595749|475000996|FG001|Overall Study|Withdrawal by Subject|7|||
131922846|NCT01875237|475001002|FG000|Overall Study|GVDH before DLI|1|||
131922847|NCT01875237|475001003|FG001|Overall Study|GVDH before DLI|0|||
131922848|NCT01875237|475001002|FG000|Overall Study|DLI cells could not be produced|1|||
131922849|NCT01875237|475001003|FG001|Overall Study|DLI cells could not be produced|0|||
131922850|NCT03558672|475001004|FG000|Overall Study|Study Early Termination|10|||
131922851|NCT00421733|475001006|FG000|Overall Study|Adverse Event|4|||
131922852|NCT00421733|475001007|FG001|Overall Study|Adverse Event|9|||
131922853|NCT00421733|475001008|FG002|Overall Study|Adverse Event|2|||
131922854|NCT00421733|475001006|FG000|Overall Study|Lost to Follow-up|1|||
131922855|NCT00421733|475001007|FG001|Overall Study|Lost to Follow-up|2|||
131408921|NCT02536300|473120713|FG001|Overall Study|Non-compliance With Study Drug|0|||
131408922|NCT02536300|473120714|FG002|Overall Study|Non-compliance With Study Drug|0|||
131922856|NCT00421733|475001008|FG002|Overall Study|Lost to Follow-up|4|||
131922857|NCT00421733|475001006|FG000|Overall Study|Withdrawal by Subject|1|||
131922858|NCT00421733|475001007|FG001|Overall Study|Withdrawal by Subject|2|||
131922859|NCT00421733|475001008|FG002|Overall Study|Withdrawal by Subject|7|||
131922860|NCT00421733|475001006|FG000|Overall Study|Death|0|||
131408923|NCT02536300|473120712|FG000|Overall Study|Protocol Violation|0|||
131408924|NCT02536300|473120713|FG001|Overall Study|Protocol Violation|1|||
131408925|NCT02536300|473120714|FG002|Overall Study|Protocol Violation|0|||
131408926|NCT01691105|473120721|FG000|1 Month Follow-up|Lost to Follow-up|41|||
131408927|NCT01691105|473120722|FG001|1 Month Follow-up|Lost to Follow-up|38|||
131408928|NCT01691105|473120721|FG000|1 Month Follow-up|Death|2|||
131453963|NCT02023697|473291844|FG000|Treatment Period|Withdrawal by Subject|4|||
131922861|NCT00421733|475001007|FG001|Overall Study|Death|3|||
131922862|NCT00421733|475001008|FG002|Overall Study|Death|0|||
131922863|NCT00421733|475001006|FG000|Overall Study|Required dialysis|1|||
131922864|NCT00421733|475001007|FG001|Overall Study|Required dialysis|0|||
131408929|NCT01691105|473120722|FG001|1 Month Follow-up|Death|3|||
131408930|NCT01691105|473120721|FG000|6 Month Follow-up|Lost to Follow-up|39|||
131408931|NCT01691105|473120722|FG001|6 Month Follow-up|Lost to Follow-up|58|||
131408932|NCT01691105|473120721|FG000|6 Month Follow-up|Death|13|||
131408933|NCT01691105|473120722|FG001|6 Month Follow-up|Death|13|||
131408934|NCT01691105|473120721|FG000|12 Month Follow-up|Lost to Follow-up|50|||
131408935|NCT01691105|473120722|FG001|12 Month Follow-up|Lost to Follow-up|71|||
131408936|NCT01691105|473120721|FG000|12 Month Follow-up|Death|22|||
131408937|NCT01691105|473120722|FG001|12 Month Follow-up|Death|30|||
131408938|NCT01691105|473120721|FG000|12 Month Biochemical Verification|Death|22|||
131408939|NCT01691105|473120722|FG001|12 Month Biochemical Verification|Death|30|||
131408940|NCT01691105|473120721|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
131408941|NCT01691105|473120722|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
131408942|NCT01691105|473120721|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
131408943|NCT01691105|473120722|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
131408944|NCT02233738|473120723|FG000|Overall Study|Lost to Follow-up|5|||
131408945|NCT02233738|473120724|FG001|Overall Study|Lost to Follow-up|12|||
131408946|NCT02233738|473120723|FG000|Overall Study|Death|0|||
131408947|NCT02233738|473120724|FG001|Overall Study|Death|1|||
131408948|NCT02233738|473120723|FG000|Overall Study|Withdrawal by Subject|0|||
131408949|NCT02233738|473120724|FG001|Overall Study|Withdrawal by Subject|1|||
131408950|NCT02233738|473120723|FG000|Overall Study|Did not return after Baseline|3|||
131408951|NCT02233738|473120724|FG001|Overall Study|Did not return after Baseline|2|||
131408952|NCT00096174|473120728|FG000|Overall Study|Lack of Efficacy|9|||
131408953|NCT00096174|473120728|FG000|Overall Study|Adverse Event|15|||
131408954|NCT00096174|473120728|FG000|Overall Study|Death|6|||
131408955|NCT00096174|473120728|FG000|Overall Study|Withdrawal by Subject|15|||
131408956|NCT00096174|473120728|FG000|Overall Study|Not started protocol therapy|3|||
131408957|NCT00096174|473120728|FG000|Overall Study|Ineligible|6|||
131408958|NCT00096174|473120728|FG000|Overall Study|other reason|8|||
131408959|NCT02279719|473120731|FG000|Overall Study|Patients randomized but never treated|0|||
131408960|NCT02279719|473120732|FG001|Overall Study|Patients randomized but never treated|0|||
131408961|NCT02279719|473120733|FG002|Overall Study|Patients randomized but never treated|0|||
131408962|NCT02279719|473120734|FG003|Overall Study|Patients randomized but never treated|0|||
131408963|NCT02279719|473120735|FG004|Overall Study|Patients randomized but never treated|3|||
131408964|NCT02279719|473120736|FG005|Overall Study|Patients randomized but never treated|0|||
131408965|NCT02279719|473120737|FG006|Overall Study|Patients randomized but never treated|3|||
131408966|NCT03541187|473120738|FG000|Overall Study|Lost to Follow-up|2|||
131408967|NCT03541187|473120739|FG001|Overall Study|Lost to Follow-up|6|||
131408968|NCT03541187|473120738|FG000|Overall Study|Pregnancy|0|||
131408969|NCT03541187|473120739|FG001|Overall Study|Pregnancy|1|||
131408970|NCT03541187|473120738|FG000|Overall Study|Withdrawal by Subject|6|||
131408971|NCT03541187|473120739|FG001|Overall Study|Withdrawal by Subject|2|||
131408972|NCT03541187|473120738|FG000|Overall Study|Moved out of town|1|||
131408973|NCT03541187|473120739|FG001|Overall Study|Moved out of town|0|||
131408974|NCT03541187|473120738|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
131408975|NCT03541187|473120739|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
131408976|NCT03541187|473120738|FG000|Overall Study|Did not meet randomization criteria|1|||
131408977|NCT03541187|473120739|FG001|Overall Study|Did not meet randomization criteria|1|||
131408978|NCT03541187|473120738|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
131922865|NCT00421733|475001008|FG002|Overall Study|Required dialysis|0|||
131922866|NCT00421733|475001006|FG000|Overall Study|Administrative|2|||
131922867|NCT00421733|475001007|FG001|Overall Study|Administrative|0|||
131922868|NCT00421733|475001008|FG002|Overall Study|Administrative|0|||
131922869|NCT00421733|475001006|FG000|Overall Study|Did not satisfy entry criteria|1|||
131922870|NCT00421733|475001007|FG001|Overall Study|Did not satisfy entry criteria|3|||
131922871|NCT00421733|475001008|FG002|Overall Study|Did not satisfy entry criteria|2|||
131922872|NCT00421733|475001006|FG000|Overall Study|Sponsor request|1|||
131922873|NCT00421733|475001007|FG001|Overall Study|Sponsor request|0|||
131922874|NCT00421733|475001008|FG002|Overall Study|Sponsor request|3|||
131922875|NCT00421733|475001006|FG000|Overall Study|Protocol deviation|4|||
131922876|NCT00421733|475001007|FG001|Overall Study|Protocol deviation|7|||
131408979|NCT03541187|473120739|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
131408980|NCT03541187|473120738|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
131408981|NCT03541187|473120739|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
131408982|NCT02585830|473120740|FG000|Overall Study|Withdrawal by Subject|3|||
131408983|NCT01323270|473120741|FG000|Overall Study|Withdrawal by Subject|19|||
131408984|NCT01323270|473120742|FG001|Overall Study|Withdrawal by Subject|10|||
131408985|NCT01323270|473120741|FG000|Overall Study|Protocol Violation|9|||
131408986|NCT01323270|473120742|FG001|Overall Study|Protocol Violation|7|||
131408987|NCT01323270|473120741|FG000|Overall Study|Lost to Follow-up|4|||
131922877|NCT00421733|475001008|FG002|Overall Study|Protocol deviation|2|||
131922878|NCT05161936|475001011|FG000|Overall Study|Study terminated by Sponsor|1|||
131922879|NCT05161936|475001012|FG001|Overall Study|Study terminated by Sponsor|0|||
131922880|NCT05161936|475001013|FG002|Overall Study|Study terminated by Sponsor|0|||
131922881|NCT05161936|475001011|FG000|Overall Study|Withdrawal by Subject|0|||
131408988|NCT01323270|473120742|FG001|Overall Study|Lost to Follow-up|6|||
131408989|NCT01323270|473120741|FG000|Overall Study|Adverse Event|8|||
131408990|NCT01323270|473120742|FG001|Overall Study|Adverse Event|0|||
131408991|NCT01323270|473120741|FG000|Overall Study|Other|0|||
131408992|NCT01323270|473120742|FG001|Overall Study|Other|3|||
131408993|NCT01323270|473120741|FG000|Overall Study|Physician Decision|0|||
131408994|NCT01323270|473120742|FG001|Overall Study|Physician Decision|2|||
131408995|NCT01323270|473120741|FG000|Overall Study|Not eligible|1|||
131877015|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Other|8|||
131877016|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Other|23|||
131877017|NCT01106677|474831322|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
131877018|NCT01106677|474831323|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
131877019|NCT01106677|474831324|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
131877020|NCT01106677|474831325|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
131877021|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
131877022|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
131877023|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
131877024|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
131877025|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Death|0|||
131877026|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Death|0|||
131877027|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Death|0|||
131877028|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Death|1|||
131877029|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
131877030|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
131877031|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
131877032|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
131877033|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
131877034|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
131877035|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
131877036|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
131877037|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
131877038|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
131877039|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
131877040|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
131877041|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131877042|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131877043|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131877044|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131877045|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131877046|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
131877047|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
131877048|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131877049|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
131877050|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
131877051|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
131877052|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
131877053|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131877054|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131877055|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
131877056|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
131877057|NCT01106677|474831322|FG000|Extension Period: Week 26 to Week 52|Other|6|||
131877058|NCT01106677|474831323|FG001|Extension Period: Week 26 to Week 52|Other|5|||
131877059|NCT01106677|474831324|FG002|Extension Period: Week 26 to Week 52|Other|8|||
131877060|NCT01106677|474831325|FG003|Extension Period: Week 26 to Week 52|Other|5|||
131877061|NCT00784238|474831326|FG000|Overall Study|Adverse Event|14|||
131877062|NCT00784238|474831326|FG000|Overall Study|Death|2|||
131877063|NCT00784238|474831326|FG000|Overall Study|Lack of Efficacy|33|||
131877064|NCT00784238|474831326|FG000|Overall Study|Lost to Follow-up|29|||
131877065|NCT00784238|474831326|FG000|Overall Study|Pregnancy|1|||
131877066|NCT00784238|474831326|FG000|Overall Study|Withdrawal by Subject|26|||
131877067|NCT00784238|474831326|FG000|Overall Study|Other|14|||
131877068|NCT04434469|474831327|FG000|Overall Study|Death|2|||
131877069|NCT04434469|474831328|FG001|Overall Study|Death|3|||
131877070|NCT04434469|474831329|FG002|Overall Study|Death|2|||
131408996|NCT01323270|473120742|FG001|Overall Study|Not eligible|1|||
131877071|NCT04434469|474831330|FG003|Overall Study|Death|2|||
131877072|NCT04434469|474831331|FG004|Overall Study|Death|2|||
131877073|NCT04434469|474831332|FG005|Overall Study|Death|0|||
131408997|NCT01323270|473120741|FG000|Overall Study|Death|1|||
131408998|NCT01323270|473120742|FG001|Overall Study|Death|0|||
131922882|NCT05161936|475001012|FG001|Overall Study|Withdrawal by Subject|0|||
131922883|NCT05161936|475001013|FG002|Overall Study|Withdrawal by Subject|1|||
131922884|NCT00965094|475001018|FG000|Overall Study|Adverse Event|5|||
131922885|NCT00965094|475001019|FG001|Overall Study|Adverse Event|0|||
131922886|NCT00965094|475001018|FG000|Overall Study|Lost to Follow-up|0|||
131922887|NCT00965094|475001019|FG001|Overall Study|Lost to Follow-up|1|||
131922888|NCT01336972|475001024|FG000|Overall Study|Adverse Event|1|||
131922889|NCT01336972|475001025|FG001|Overall Study|Adverse Event|1|||
131922890|NCT01336972|475001026|FG002|Overall Study|Adverse Event|0|||
131922891|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
131922892|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
131922893|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
131922894|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
131922895|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
131922896|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
131922897|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
131922898|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
131922899|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
131922900|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
131922901|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
131922902|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
131922903|NCT03446573|475001027|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
131922904|NCT03446573|475001028|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
131922905|NCT03446573|475001027|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
131922906|NCT03446573|475001028|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
131922907|NCT03446573|475001027|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
131922908|NCT03446573|475001028|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
131922909|NCT03446573|475001027|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
131922910|NCT03446573|475001028|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
131922911|NCT03446573|475001027|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
131922912|NCT03446573|475001028|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
131922913|NCT03446573|475001027|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
131922914|NCT03446573|475001028|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
131922915|NCT03446573|475001027|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
131922916|NCT03446573|475001028|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
131922917|NCT02583477|475001033|FG000|Overall Study|Adverse Event|0|||
131922918|NCT02583477|475001034|FG001|Overall Study|Adverse Event|2|||
131922919|NCT02583477|475001033|FG000|Overall Study|Death|1|||
131922920|NCT02583477|475001034|FG001|Overall Study|Death|16|||
131922921|NCT02583477|475001033|FG000|Overall Study|Study terminated|2|||
131922922|NCT02583477|475001034|FG001|Overall Study|Study terminated|2|||
131922923|NCT03501277|475001037|FG000|Intervention Period 1 (4 Days)|Other|0|||
131922924|NCT03501277|475001038|FG001|Intervention Period 1 (4 Days)|Other|0|||
131922925|NCT03501277|475001039|FG002|Intervention Period 1 (4 Days)|Other|1|||
131922926|NCT03501277|475001040|FG003|Intervention Period 1 (4 Days)|Other|0|||
131922927|NCT03501277|475001037|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
131922928|NCT03501277|475001038|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
131922929|NCT03501277|475001039|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
131922930|NCT03501277|475001040|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
131922931|NCT03501277|475001037|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
131922932|NCT03501277|475001038|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
131922933|NCT03501277|475001039|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
131922934|NCT03501277|475001040|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
131922935|NCT03501277|475001037|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
131922936|NCT03501277|475001038|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
131922937|NCT03501277|475001039|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
131922938|NCT03501277|475001040|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
131922939|NCT00927082|475001041|FG000|Overall Study|Lost to Follow-up|9|||
131922940|NCT00927082|475001042|FG001|Overall Study|Lost to Follow-up|8|||
131922941|NCT00927082|475001043|FG002|Overall Study|Lost to Follow-up|12|||
131922942|NCT00927082|475001044|FG003|Overall Study|Lost to Follow-up|16|||
131922943|NCT00927082|475001041|FG000|Overall Study|Withdrawal by Subject|3|||
131922944|NCT00927082|475001042|FG001|Overall Study|Withdrawal by Subject|2|||
131922945|NCT00927082|475001043|FG002|Overall Study|Withdrawal by Subject|7|||
131922946|NCT00927082|475001044|FG003|Overall Study|Withdrawal by Subject|2|||
131922947|NCT00927082|475001041|FG000|Overall Study|Death|0|||
131922948|NCT00927082|475001042|FG001|Overall Study|Death|0|||
131922949|NCT00927082|475001043|FG002|Overall Study|Death|1|||
131922950|NCT00927082|475001044|FG003|Overall Study|Death|0|||
131922951|NCT00927082|475001041|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
131922952|NCT00927082|475001042|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
131922953|NCT00927082|475001043|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
131922954|NCT00927082|475001044|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
131922955|NCT00849472|475001048|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
131922956|NCT00849472|475001048|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
131922957|NCT00849472|475001048|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
131922958|NCT00849472|475001048|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
131922959|NCT00849472|475001048|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
131922960|NCT00849472|475001048|FG000|Weekly Paclitaxel|Disease Progression|1|||
131922961|NCT00849472|475001048|FG000|Weekly Paclitaxel|Adverse Event|11|||
131922962|NCT00849472|475001048|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
131922963|NCT00849472|475001048|FG000|Weekly Paclitaxel|Physician Decision|3|||
131922964|NCT00849472|475001048|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
131922965|NCT00849472|475001048|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
131922966|NCT00849472|475001048|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
131922967|NCT00849472|475001048|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
131922968|NCT00849472|475001048|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
131922969|NCT00849472|475001048|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
131922970|NCT00849472|475001048|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
131922971|NCT00849472|475001048|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
131922972|NCT05259033|475001052|FG000|Overall Study|Withdrawal by Subject|10|||
131922973|NCT05259033|475001053|FG001|Overall Study|Withdrawal by Subject|5|||
131922974|NCT05259033|475001052|FG000|Overall Study|Lost to Follow-up|1|||
131922975|NCT05259033|475001053|FG001|Overall Study|Lost to Follow-up|0|||
131922976|NCT05259033|475001052|FG000|Overall Study|Death|2|||
131922977|NCT05259033|475001053|FG001|Overall Study|Death|0|||
131922978|NCT00724503|475001056|FG000|Overall Study|Lost to Follow-up|4|||
131922979|NCT00724503|475001057|FG001|Overall Study|Lost to Follow-up|8|||
131922980|NCT00724503|475001056|FG000|Overall Study|Withdrawal by Subject|11|||
131922981|NCT00724503|475001057|FG001|Overall Study|Withdrawal by Subject|23|||
131922982|NCT00724503|475001056|FG000|Overall Study|Death|190|||
131922983|NCT00724503|475001057|FG001|Overall Study|Death|182|||
131922984|NCT00724503|475001056|FG000|Overall Study|Adverse Event|1|||
131922985|NCT00724503|475001057|FG001|Overall Study|Adverse Event|0|||
131922986|NCT00724503|475001056|FG000|Overall Study|Not otherwise specified|4|||
131922987|NCT00724503|475001057|FG001|Overall Study|Not otherwise specified|7|||
131922988|NCT01186419|475001060|FG000|Overall Study|Withdrawal by Subject|5|||
131922989|NCT01186419|475001061|FG001|Overall Study|Withdrawal by Subject|3|||
131922990|NCT01186419|475001060|FG000|Overall Study|Adverse Event|1|||
131922991|NCT01186419|475001061|FG001|Overall Study|Adverse Event|2|||
131922992|NCT01186419|475001060|FG000|Overall Study|Physician Decision|0|||
131922993|NCT01186419|475001061|FG001|Overall Study|Physician Decision|3|||
131922994|NCT01186419|475001060|FG000|Overall Study|Other|1|||
131922995|NCT01186419|475001061|FG001|Overall Study|Other|1|||
131922996|NCT01560416|475001062|FG000|Randomized Phase|Crossover Participants|7|||
131922997|NCT01560416|475001063|FG001|Randomized Phase|Crossover Participants|0|||
131922998|NCT00004859|475001064|FG000|Overall Study|Lack of Efficacy|43|||
131922999|NCT00004859|475001065|FG001|Overall Study|Lack of Efficacy|113|||
131923000|NCT00004859|475001064|FG000|Overall Study|Adverse Event|31|||
131923001|NCT00004859|475001065|FG001|Overall Study|Adverse Event|93|||
131923002|NCT00004859|475001064|FG000|Overall Study|Death|5|||
131923003|NCT00004859|475001065|FG001|Overall Study|Death|5|||
131923004|NCT00004859|475001064|FG000|Overall Study|Withdrawal by Subject|7|||
131923005|NCT00004859|475001065|FG001|Overall Study|Withdrawal by Subject|33|||
131923006|NCT00004859|475001064|FG000|Overall Study|Protocol Violation|2|||
131923007|NCT00004859|475001065|FG001|Overall Study|Protocol Violation|2|||
131923008|NCT00004859|475001064|FG000|Overall Study|other disease|0|||
131923009|NCT00004859|475001065|FG001|Overall Study|other disease|3|||
131923010|NCT00004859|475001064|FG000|Overall Study|error|3|||
131923011|NCT00004859|475001065|FG001|Overall Study|error|1|||
131923012|NCT00004859|475001064|FG000|Overall Study|missing data|14|||
131923013|NCT00004859|475001065|FG001|Overall Study|missing data|11|||
131923014|NCT00004859|475001064|FG000|Overall Study|Other|13|||
131923015|NCT00004859|475001065|FG001|Overall Study|Other|21|||
131923016|NCT00552058|475003220|FG000|Overall Study|Adverse Event|8|||
131923017|NCT00552058|475003221|FG001|Overall Study|Adverse Event|7|||
131923018|NCT00552058|475003220|FG000|Overall Study|Lack of Efficacy|1|||
131923019|NCT00552058|475003221|FG001|Overall Study|Lack of Efficacy|5|||
131923020|NCT00552058|475003220|FG000|Overall Study|Lost to Follow-up|1|||
131923021|NCT00552058|475003221|FG001|Overall Study|Lost to Follow-up|0|||
131923022|NCT00552058|475003220|FG000|Overall Study|Withdrawal by Subject|4|||
131923023|NCT00552058|475003221|FG001|Overall Study|Withdrawal by Subject|4|||
131923024|NCT00552058|475003220|FG000|Overall Study|Other: Protocol Violation|0|||
131923025|NCT00552058|475003221|FG001|Overall Study|Other: Protocol Violation|1|||
131923026|NCT00552058|475003220|FG000|Overall Study|Other: Non Compliance|1|||
131923027|NCT00552058|475003221|FG001|Overall Study|Other: Non Compliance|2|||
131923028|NCT00552058|475003220|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
131408999|NCT01323270|473120741|FG000|Overall Study|Randomized, but not vaccinated|1|||
131409000|NCT01323270|473120742|FG001|Overall Study|Randomized, but not vaccinated|0|||
131409001|NCT03761394|473120743|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
131409002|NCT03761394|473120744|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
131409003|NCT03761394|473120745|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
131923029|NCT00552058|475003221|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
131923030|NCT00552058|475003220|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
131923031|NCT00552058|475003221|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
131923032|NCT00552058|475003220|FG000|Overall Study|Other: Positive Stool Result|0|||
131923033|NCT00552058|475003221|FG001|Overall Study|Other: Positive Stool Result|1|||
131923034|NCT00552058|475003220|FG000|Overall Study|Other: Randomized in error|0|||
131923035|NCT00552058|475003221|FG001|Overall Study|Other: Randomized in error|1|||
131923036|NCT00552058|475003220|FG000|Overall Study|Other: Sponsors Decision|0|||
131923037|NCT00552058|475003221|FG001|Overall Study|Other: Sponsors Decision|1|||
131923038|NCT00552058|475003220|FG000|Overall Study|Other: Early Roll Over|1|||
131923039|NCT00552058|475003221|FG001|Overall Study|Other: Early Roll Over|0|||
131923040|NCT03309605|475003222|FG000|Overall Study|Adverse Event|0|||
131923041|NCT03309605|475003223|FG001|Overall Study|Adverse Event|0|||
131923042|NCT03309605|475003224|FG002|Overall Study|Adverse Event|0|||
131923043|NCT03309605|475003225|FG003|Overall Study|Adverse Event|1|||
131923044|NCT03309605|475003226|FG004|Overall Study|Adverse Event|0|||
131923045|NCT03309605|475003227|FG005|Overall Study|Adverse Event|0|||
131923046|NCT03309605|475003228|FG006|Overall Study|Adverse Event|2|||
131923047|NCT03309605|475003229|FG007|Overall Study|Adverse Event|1|||
131923048|NCT03309605|475003222|FG000|Overall Study|Withdrawal by Subject|0|||
131923049|NCT03309605|475003223|FG001|Overall Study|Withdrawal by Subject|0|||
131923050|NCT03309605|475003224|FG002|Overall Study|Withdrawal by Subject|0|||
131923051|NCT03309605|475003225|FG003|Overall Study|Withdrawal by Subject|0|||
131923052|NCT03309605|475003226|FG004|Overall Study|Withdrawal by Subject|1|||
131923053|NCT03309605|475003227|FG005|Overall Study|Withdrawal by Subject|0|||
131923054|NCT03309605|475003228|FG006|Overall Study|Withdrawal by Subject|1|||
131923055|NCT03309605|475003229|FG007|Overall Study|Withdrawal by Subject|1|||
131923056|NCT03197935|475003232|FG000|Overall Study|Death due to any cause|26|||
131923057|NCT03197935|475003233|FG001|Overall Study|Death due to any cause|15|||
131923058|NCT03197935|475003232|FG000|Overall Study|Lost to Follow-up|3|||
131923059|NCT03197935|475003233|FG001|Overall Study|Lost to Follow-up|5|||
131923060|NCT03197935|475003232|FG000|Overall Study|Physician Decision|2|||
131923061|NCT03197935|475003233|FG001|Overall Study|Physician Decision|1|||
131923062|NCT03197935|475003232|FG000|Overall Study|Withdrawal by Subject|16|||
131923063|NCT03197935|475003233|FG001|Overall Study|Withdrawal by Subject|8|||
131923064|NCT00784927|475003234|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
131923065|NCT00784927|475003234|FG000|Overall Study|Protocol Violation|1|||
131923066|NCT00784927|475003234|FG000|Overall Study|Ineligible|1|||
131923067|NCT02082483|475003235|FG000|Overall Study|Lost to Follow-up|1|||
131923068|NCT02082483|475003236|FG001|Overall Study|Lost to Follow-up|1|||
131923069|NCT02082483|475003235|FG000|Overall Study|Withdrawal by Subject|2|||
131923070|NCT02082483|475003236|FG001|Overall Study|Withdrawal by Subject|1|||
131923071|NCT02082483|475003235|FG000|Overall Study|Physician Decision|1|||
131923072|NCT02082483|475003236|FG001|Overall Study|Physician Decision|1|||
131923073|NCT02082483|475003235|FG000|Overall Study|Death|2|||
131923074|NCT02082483|475003236|FG001|Overall Study|Death|3|||
131923075|NCT00422461|475003239|FG000|Overall Study|Adverse Event|1|||
131923076|NCT00422461|475003240|FG001|Overall Study|Adverse Event|2|||
131923077|NCT00422461|475003241|FG002|Overall Study|Adverse Event|1|||
131923078|NCT00422461|475003242|FG003|Overall Study|Adverse Event|1|||
131923079|NCT00422461|475003239|FG000|Overall Study|Other|0|||
131923080|NCT00422461|475003240|FG001|Overall Study|Other|0|||
131923081|NCT00422461|475003241|FG002|Overall Study|Other|0|||
131923082|NCT00422461|475003242|FG003|Overall Study|Other|2|||
131409004|NCT03761394|473120746|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
131409005|NCT03761394|473120743|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
131409006|NCT03761394|473120744|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
131923083|NCT00422461|475003239|FG000|Overall Study|Participants no longer willing to participate in study|1|||
131923084|NCT00422461|475003240|FG001|Overall Study|Participants no longer willing to participate in study|0|||
131409007|NCT03761394|473120745|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
131453964|NCT02023697|473291845|FG001|Treatment Period|Withdrawal by Subject|5|||
131923085|NCT00422461|475003241|FG002|Overall Study|Participants no longer willing to participate in study|0|||
131923086|NCT00422461|475003242|FG003|Overall Study|Participants no longer willing to participate in study|0|||
131923087|NCT00422461|475003239|FG000|Overall Study|Randomized but not treated|1|||
131923088|NCT00422461|475003240|FG001|Overall Study|Randomized but not treated|1|||
131923089|NCT00422461|475003241|FG002|Overall Study|Randomized but not treated|0|||
131923090|NCT00422461|475003242|FG003|Overall Study|Randomized but not treated|0|||
131923091|NCT01471574|475003244|FG000|Treatment Period|Lack of Efficacy|12|||
131923092|NCT01471574|475003245|FG001|Treatment Period|Lack of Efficacy|4|||
131923093|NCT01471574|475003246|FG002|Treatment Period|Lack of Efficacy|14|||
131923094|NCT01471574|475003247|FG003|Treatment Period|Lack of Efficacy|1|||
131923095|NCT01471574|475003244|FG000|Treatment Period|Adverse Event|7|||
131923096|NCT01471574|475003245|FG001|Treatment Period|Adverse Event|3|||
131923097|NCT01471574|475003246|FG002|Treatment Period|Adverse Event|6|||
131923098|NCT01471574|475003247|FG003|Treatment Period|Adverse Event|1|||
131923099|NCT01471574|475003244|FG000|Treatment Period|Withdrawal by Subject|5|||
131923100|NCT01471574|475003245|FG001|Treatment Period|Withdrawal by Subject|1|||
131923101|NCT01471574|475003246|FG002|Treatment Period|Withdrawal by Subject|1|||
131923102|NCT01471574|475003247|FG003|Treatment Period|Withdrawal by Subject|0|||
131923103|NCT01471574|475003244|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
131923104|NCT01471574|475003245|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
131923105|NCT01471574|475003246|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
131923106|NCT01471574|475003247|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
131923107|NCT01471574|475003244|FG000|Treatment Period|Lost to Follow-up|1|||
131923108|NCT01471574|475003245|FG001|Treatment Period|Lost to Follow-up|2|||
131409008|NCT03761394|473120746|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
131409009|NCT03761394|473120743|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
131409010|NCT03761394|473120744|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
131409011|NCT03761394|473120745|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
131877074|NCT04434469|474831327|FG000|Overall Study|Lost to Follow-up|0|||
131877075|NCT04434469|474831328|FG001|Overall Study|Lost to Follow-up|0|||
131877076|NCT04434469|474831329|FG002|Overall Study|Lost to Follow-up|0|||
131877077|NCT04434469|474831330|FG003|Overall Study|Lost to Follow-up|1|||
131877078|NCT04434469|474831331|FG004|Overall Study|Lost to Follow-up|1|||
131877079|NCT04434469|474831332|FG005|Overall Study|Lost to Follow-up|0|||
131877080|NCT04434469|474831327|FG000|Overall Study|Study terminated by sponsor|1|||
131877081|NCT04434469|474831328|FG001|Overall Study|Study terminated by sponsor|1|||
131877082|NCT04434469|474831329|FG002|Overall Study|Study terminated by sponsor|1|||
131877083|NCT04434469|474831330|FG003|Overall Study|Study terminated by sponsor|2|||
131877084|NCT04434469|474831331|FG004|Overall Study|Study terminated by sponsor|3|||
131877085|NCT04434469|474831332|FG005|Overall Study|Study terminated by sponsor|3|||
131877086|NCT04434469|474831327|FG000|Overall Study|Withdrawal by Subject|0|||
131877087|NCT04434469|474831328|FG001|Overall Study|Withdrawal by Subject|0|||
131877088|NCT04434469|474831329|FG002|Overall Study|Withdrawal by Subject|1|||
131877089|NCT04434469|474831330|FG003|Overall Study|Withdrawal by Subject|0|||
131877090|NCT04434469|474831331|FG004|Overall Study|Withdrawal by Subject|0|||
131877091|NCT04434469|474831332|FG005|Overall Study|Withdrawal by Subject|0|||
131877092|NCT03692325|474831341|FG000|Overall Study|Adverse Event|2|||
131877093|NCT03692325|474831341|FG000|Overall Study|Progression/Recurrence|2|||
131877094|NCT02817516|474831346|FG000|Overall Study|Other|0|||
131877095|NCT02817516|474831347|FG001|Overall Study|Other|0|||
131877096|NCT02817516|474831348|FG002|Overall Study|Other|1|||
131877097|NCT02817516|474831349|FG003|Overall Study|Other|0|||
131877098|NCT00664859|474831350|FG000|Overall Study|Adverse Event|2|||
131877099|NCT00664859|474831351|FG001|Overall Study|Adverse Event|1|||
131877100|NCT00664859|474831352|FG002|Overall Study|Adverse Event|3|||
131877101|NCT00664859|474831350|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
131877102|NCT00664859|474831351|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
131877103|NCT00664859|474831352|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
131877104|NCT00664859|474831350|FG000|Overall Study|Noncompliance with protocol|1|||
131877105|NCT00664859|474831351|FG001|Overall Study|Noncompliance with protocol|0|||
131877106|NCT00664859|474831352|FG002|Overall Study|Noncompliance with protocol|4|||
131877107|NCT00664859|474831350|FG000|Overall Study|Laboratory abnormality|2|||
131877108|NCT00664859|474831351|FG001|Overall Study|Laboratory abnormality|1|||
131877109|NCT00664859|474831352|FG002|Overall Study|Laboratory abnormality|4|||
131877110|NCT00664859|474831350|FG000|Overall Study|Withdrawal by Subject|4|||
131877111|NCT00664859|474831351|FG001|Overall Study|Withdrawal by Subject|1|||
131877112|NCT00664859|474831352|FG002|Overall Study|Withdrawal by Subject|3|||
131877113|NCT00664859|474831350|FG000|Overall Study|Lost to Follow-up|2|||
131877114|NCT00664859|474831351|FG001|Overall Study|Lost to Follow-up|2|||
131877115|NCT00664859|474831352|FG002|Overall Study|Lost to Follow-up|1|||
131877116|NCT00664859|474831350|FG000|Overall Study|Other|0|||
131877117|NCT00664859|474831351|FG001|Overall Study|Other|1|||
131877118|NCT00664859|474831352|FG002|Overall Study|Other|2|||
131877119|NCT00900757|474831353|FG000|Overall Study|screen failure|19|||
131877120|NCT00748189|474831354|FG000|Overall Study|Death|99|||
131877121|NCT00748189|474831355|FG001|Overall Study|Death|84|||
131877122|NCT00748189|474831354|FG000|Overall Study|Withdrawal by Subject|23|||
131877123|NCT00748189|474831355|FG001|Overall Study|Withdrawal by Subject|29|||
131877124|NCT00748189|474831354|FG000|Overall Study|Physician Decision|16|||
131877125|NCT00748189|474831355|FG001|Overall Study|Physician Decision|5|||
131877126|NCT00748189|474831354|FG000|Overall Study|Lost to Follow-up|8|||
131877127|NCT00748189|474831355|FG001|Overall Study|Lost to Follow-up|15|||
131877128|NCT00748189|474831354|FG000|Overall Study|Study terminated by Sponsor|70|||
131877129|NCT00748189|474831355|FG001|Overall Study|Study terminated by Sponsor|79|||
131877130|NCT04481191|474831356|FG000|Overall Study|Withdrawn by parent/guardian|15|||
131877131|NCT04481191|474831357|FG001|Overall Study|Withdrawn by parent/guardian|10|||
131877132|NCT00546117|474831358|FG000|Overall Study|Withdrawal by Subject|3|||
131877133|NCT00546117|474831359|FG001|Overall Study|Withdrawal by Subject|0|||
131877134|NCT00546117|474831358|FG000|Overall Study|Inability to schedule follow-up visit|1|||
131877135|NCT00546117|474831359|FG001|Overall Study|Inability to schedule follow-up visit|0|||
131877136|NCT01424514|474831360|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
131877137|NCT01424514|474831361|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
131877138|NCT01424514|474831360|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
131877139|NCT01424514|474831361|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
131877140|NCT02487771|474831364|FG000|Overall Study|Lost to Follow-up|2|||
131877141|NCT02487771|474831365|FG001|Overall Study|Lost to Follow-up|3|||
131877142|NCT02487771|474831364|FG000|Overall Study|Moved out of area|5|||
131877143|NCT02487771|474831365|FG001|Overall Study|Moved out of area|6|||
131877144|NCT02487771|474831364|FG000|Overall Study|Withdrawal by Subject|3|||
131877145|NCT02487771|474831365|FG001|Overall Study|Withdrawal by Subject|5|||
131877146|NCT02653170|474831366|FG000|Overall Study|Withdrawal by Subject|3|||
131877147|NCT02653170|474831367|FG001|Overall Study|Withdrawal by Subject|8|||
131877148|NCT02653170|474831368|FG002|Overall Study|Withdrawal by Subject|3|||
131877149|NCT02653170|474831366|FG000|Overall Study|withdrawn by study team|2|||
131877150|NCT02653170|474831367|FG001|Overall Study|withdrawn by study team|4|||
131877151|NCT02653170|474831368|FG002|Overall Study|withdrawn by study team|5|||
131877152|NCT02653170|474831366|FG000|Overall Study|Lost to Follow-up|12|||
131877153|NCT02653170|474831367|FG001|Overall Study|Lost to Follow-up|4|||
131877154|NCT02653170|474831368|FG002|Overall Study|Lost to Follow-up|10|||
131877155|NCT04304235|474831369|FG000|Overall Study|incomplete triage data|0|||
131877156|NCT04304235|474831370|FG001|Overall Study|incomplete triage data|69|||
131877157|NCT04304235|474831371|FG002|Overall Study|incomplete triage data|0|||
131877158|NCT04304235|474831372|FG003|Overall Study|incomplete triage data|0|||
131877159|NCT04304235|474831373|FG004|Overall Study|incomplete triage data|289|||
131877160|NCT04304235|474831374|FG005|Overall Study|incomplete triage data|123|||
131877161|NCT04304235|474831375|FG006|Overall Study|incomplete triage data|65|||
131877162|NCT04429555|474831376|FG000|Overall Study|Death|0|||
131877163|NCT04429555|474831377|FG001|Overall Study|Death|2|||
131877164|NCT04429555|474831376|FG000|Overall Study|Other|2|||
131877165|NCT04429555|474831377|FG001|Overall Study|Other|0|||
131877166|NCT00425061|474831378|FG000|Overall Study|Adverse Event|1|||
131877167|NCT00425061|474831379|FG001|Overall Study|Adverse Event|0|||
131877168|NCT00425061|474831380|FG002|Overall Study|Adverse Event|0|||
131877169|NCT00425061|474831381|FG003|Overall Study|Adverse Event|2|||
131877170|NCT00425061|474831382|FG004|Overall Study|Adverse Event|2|||
131877171|NCT00425061|474831383|FG005|Overall Study|Adverse Event|0|||
131877172|NCT00425061|474831384|FG006|Overall Study|Adverse Event|0|||
131877173|NCT00425061|474831378|FG000|Overall Study|Lost to Follow-up|0|||
131877174|NCT00425061|474831379|FG001|Overall Study|Lost to Follow-up|1|||
131877175|NCT00425061|474831380|FG002|Overall Study|Lost to Follow-up|0|||
131877176|NCT00425061|474831381|FG003|Overall Study|Lost to Follow-up|0|||
131877177|NCT00425061|474831382|FG004|Overall Study|Lost to Follow-up|0|||
131877178|NCT00425061|474831383|FG005|Overall Study|Lost to Follow-up|0|||
131877179|NCT00425061|474831384|FG006|Overall Study|Lost to Follow-up|0|||
131877180|NCT00425061|474831378|FG000|Overall Study|Protocol Violation|1|||
131877181|NCT00425061|474831379|FG001|Overall Study|Protocol Violation|0|||
131877182|NCT00425061|474831380|FG002|Overall Study|Protocol Violation|0|||
131877183|NCT00425061|474831381|FG003|Overall Study|Protocol Violation|0|||
131877184|NCT00425061|474831382|FG004|Overall Study|Protocol Violation|0|||
131877185|NCT00425061|474831383|FG005|Overall Study|Protocol Violation|0|||
131877186|NCT00425061|474831384|FG006|Overall Study|Protocol Violation|0|||
131877187|NCT00425061|474831378|FG000|Overall Study|Withdrawal by Subject|0|||
131877188|NCT00425061|474831379|FG001|Overall Study|Withdrawal by Subject|1|||
131877189|NCT00425061|474831380|FG002|Overall Study|Withdrawal by Subject|0|||
131877190|NCT00425061|474831381|FG003|Overall Study|Withdrawal by Subject|0|||
131877191|NCT00425061|474831382|FG004|Overall Study|Withdrawal by Subject|1|||
131877192|NCT00425061|474831383|FG005|Overall Study|Withdrawal by Subject|0|||
131409012|NCT03761394|473120746|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
131409013|NCT03761394|473120743|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
131877193|NCT00425061|474831384|FG006|Overall Study|Withdrawal by Subject|3|||
131877194|NCT00425061|474831378|FG000|Overall Study|Sponsor's request|0|||
131877195|NCT00425061|474831379|FG001|Overall Study|Sponsor's request|0|||
131409014|NCT03761394|473120744|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
131877196|NCT00425061|474831380|FG002|Overall Study|Sponsor's request|0|||
131877197|NCT00425061|474831381|FG003|Overall Study|Sponsor's request|0|||
131877198|NCT00425061|474831382|FG004|Overall Study|Sponsor's request|19|||
131877199|NCT00425061|474831383|FG005|Overall Study|Sponsor's request|4|||
131877200|NCT00425061|474831384|FG006|Overall Study|Sponsor's request|15|||
131877201|NCT00425061|474831378|FG000|Overall Study|Physician Decision|0|||
131877202|NCT00425061|474831379|FG001|Overall Study|Physician Decision|0|||
131877203|NCT00425061|474831380|FG002|Overall Study|Physician Decision|0|||
131923109|NCT01471574|475003246|FG002|Treatment Period|Lost to Follow-up|2|||
131923110|NCT01471574|475003247|FG003|Treatment Period|Lost to Follow-up|0|||
131923111|NCT01471574|475003244|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
131923112|NCT01471574|475003245|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
131923113|NCT01471574|475003246|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
131923114|NCT01471574|475003247|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
131923115|NCT01471574|475003244|FG000|Treatment Period|Other|1|||
131923116|NCT01471574|475003245|FG001|Treatment Period|Other|0|||
131923117|NCT01471574|475003246|FG002|Treatment Period|Other|0|||
131923118|NCT01471574|475003247|FG003|Treatment Period|Other|0|||
131923119|NCT01471574|475003244|FG000|Follow-up Period|Withdrawal by Subject|3|||
131923120|NCT01471574|475003245|FG001|Follow-up Period|Withdrawal by Subject|0|||
131923121|NCT01471574|475003246|FG002|Follow-up Period|Withdrawal by Subject|3|||
131923122|NCT01471574|475003247|FG003|Follow-up Period|Withdrawal by Subject|1|||
131923123|NCT01471574|475003244|FG000|Follow-up Period|Lost to Follow-up|4|||
131923124|NCT01471574|475003245|FG001|Follow-up Period|Lost to Follow-up|1|||
131923125|NCT01471574|475003246|FG002|Follow-up Period|Lost to Follow-up|3|||
131923126|NCT01471574|475003247|FG003|Follow-up Period|Lost to Follow-up|2|||
131923127|NCT01471574|475003244|FG000|Follow-up Period|Death|0|||
131923128|NCT01471574|475003245|FG001|Follow-up Period|Death|0|||
131923129|NCT01471574|475003246|FG002|Follow-up Period|Death|1|||
131923130|NCT01471574|475003247|FG003|Follow-up Period|Death|0|||
131923131|NCT01471574|475003244|FG000|Follow-up Period|Follow-up no longer required|0|||
131923132|NCT01471574|475003245|FG001|Follow-up Period|Follow-up no longer required|1|||
131923133|NCT01471574|475003246|FG002|Follow-up Period|Follow-up no longer required|0|||
131923134|NCT01471574|475003247|FG003|Follow-up Period|Follow-up no longer required|0|||
131923135|NCT01795937|475003248|FG000|Overall Study|Withdrawal by Subject|1|||
131923136|NCT01795937|475003249|FG001|Overall Study|Withdrawal by Subject|0|||
131923137|NCT01795937|475003250|FG002|Overall Study|Withdrawal by Subject|0|||
131923138|NCT01795937|475003248|FG000|Overall Study|Physician Decision|0|||
131923139|NCT01795937|475003249|FG001|Overall Study|Physician Decision|1|||
131923140|NCT01795937|475003250|FG002|Overall Study|Physician Decision|0|||
131923141|NCT01028053|475003255|FG000|Overall Study|Screen Failure|113|||
131923142|NCT01028053|475003255|FG000|Overall Study|Patient Request|11|||
131923143|NCT01028053|475003255|FG000|Overall Study|Protocol Violation|1|||
131923144|NCT01028053|475003255|FG000|Overall Study|Physician Decision|2|||
131923145|NCT01028053|475003255|FG000|Overall Study|Technical Problem|1|||
131923146|NCT01028053|475003255|FG000|Overall Study|Terminated by Sponsor|1|||
131923147|NCT01028053|475003255|FG000|Overall Study|Various reasons|4|||
131923148|NCT04027946|475003256|FG000|Overall Study|Screen failures|3|||
131923149|NCT00864513|475003258|FG000|Overall Study|Withdrawal by Subject|3|||
131923150|NCT03073109|475003259|FG000|Overall Study|Adverse Event|0|||
131923151|NCT03073109|475003260|FG001|Overall Study|Adverse Event|1|||
131923152|NCT03073109|475003259|FG000|Overall Study|Other|2|||
131923153|NCT03073109|475003260|FG001|Overall Study|Other|0|||
131923154|NCT03073109|475003259|FG000|Overall Study|Lost to Follow-up|8|||
131923155|NCT03073109|475003260|FG001|Overall Study|Lost to Follow-up|1|||
131923156|NCT00790933|475003263|FG000|Overall Study|Adverse Event|94|||
131923157|NCT00790933|475003264|FG001|Overall Study|Adverse Event|119|||
131923158|NCT00790933|475003265|FG002|Overall Study|Adverse Event|65|||
131923159|NCT00790933|475003266|FG003|Overall Study|Adverse Event|5|||
131923160|NCT00790933|475003267|FG004|Overall Study|Adverse Event|69|||
131923161|NCT00790933|475003263|FG000|Overall Study|Protocol Violation(s)|8|||
131923162|NCT00790933|475003264|FG001|Overall Study|Protocol Violation(s)|18|||
131923163|NCT00790933|475003265|FG002|Overall Study|Protocol Violation(s)|7|||
131923164|NCT00790933|475003266|FG003|Overall Study|Protocol Violation(s)|0|||
131923165|NCT00790933|475003267|FG004|Overall Study|Protocol Violation(s)|12|||
131923166|NCT00790933|475003263|FG000|Overall Study|Lack of Efficacy|192|||
131923167|NCT00790933|475003264|FG001|Overall Study|Lack of Efficacy|176|||
131923168|NCT00790933|475003265|FG002|Overall Study|Lack of Efficacy|130|||
131923169|NCT00790933|475003266|FG003|Overall Study|Lack of Efficacy|1|||
131923170|NCT00790933|475003267|FG004|Overall Study|Lack of Efficacy|121|||
131923171|NCT00790933|475003263|FG000|Overall Study|Study Terminated by Sponsor|0|||
131923172|NCT00790933|475003264|FG001|Overall Study|Study Terminated by Sponsor|0|||
131923173|NCT00790933|475003265|FG002|Overall Study|Study Terminated by Sponsor|1|||
131923174|NCT00790933|475003266|FG003|Overall Study|Study Terminated by Sponsor|0|||
131923175|NCT00790933|475003267|FG004|Overall Study|Study Terminated by Sponsor|0|||
131923176|NCT00790933|475003263|FG000|Overall Study|Withdrawal by Subject|123|||
131923177|NCT00790933|475003264|FG001|Overall Study|Withdrawal by Subject|120|||
131923178|NCT00790933|475003265|FG002|Overall Study|Withdrawal by Subject|52|||
131923179|NCT00790933|475003266|FG003|Overall Study|Withdrawal by Subject|6|||
131923180|NCT00790933|475003267|FG004|Overall Study|Withdrawal by Subject|50|||
131923181|NCT00790933|475003263|FG000|Overall Study|Lost to Follow-up|13|||
131923182|NCT00790933|475003264|FG001|Overall Study|Lost to Follow-up|31|||
131923183|NCT00790933|475003265|FG002|Overall Study|Lost to Follow-up|10|||
131923184|NCT00790933|475003266|FG003|Overall Study|Lost to Follow-up|1|||
131923185|NCT00790933|475003267|FG004|Overall Study|Lost to Follow-up|15|||
131923186|NCT00790933|475003263|FG000|Overall Study|Reason Not Specified|8|||
131409015|NCT03761394|473120745|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
131409016|NCT03761394|473120746|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
131409017|NCT00089986|473120754|FG000|Overall Study|Adverse Event|6|||
131409018|NCT00089986|473120755|FG001|Overall Study|Adverse Event|9|||
131409019|NCT00089986|473120756|FG002|Overall Study|Adverse Event|6|||
131409020|NCT00089986|473120754|FG000|Overall Study|Lost to Follow-up|3|||
131409021|NCT00089986|473120755|FG001|Overall Study|Lost to Follow-up|1|||
131409022|NCT00089986|473120756|FG002|Overall Study|Lost to Follow-up|1|||
131877204|NCT00425061|474831381|FG003|Overall Study|Physician Decision|0|||
131877205|NCT00425061|474831382|FG004|Overall Study|Physician Decision|1|||
131877206|NCT00425061|474831383|FG005|Overall Study|Physician Decision|0|||
131877207|NCT00425061|474831384|FG006|Overall Study|Physician Decision|0|||
131877208|NCT00425061|474831378|FG000|Overall Study|Other|0|||
131877209|NCT00425061|474831379|FG001|Overall Study|Other|0|||
131877210|NCT00425061|474831380|FG002|Overall Study|Other|0|||
131877211|NCT00425061|474831381|FG003|Overall Study|Other|0|||
131877212|NCT00425061|474831382|FG004|Overall Study|Other|3|||
131877213|NCT00425061|474831383|FG005|Overall Study|Other|0|||
131877214|NCT00425061|474831384|FG006|Overall Study|Other|1|||
131877215|NCT04720911|474831389|FG000|Overall Study|Withdrawal by Subject|0|||
131877216|NCT04720911|474831390|FG001|Overall Study|Withdrawal by Subject|1|||
131877217|NCT04720911|474831391|FG002|Overall Study|Withdrawal by Subject|0|||
131877218|NCT00090220|474831392|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
131877219|NCT00090220|474831393|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
131877220|NCT00090220|474831394|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131877221|NCT00090220|474831395|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131877222|NCT00090220|474831396|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131877223|NCT00090220|474831397|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131877224|NCT00090220|474831392|FG000|Base Study Vaccination Period|Adverse Event|6|||
131877225|NCT00090220|474831393|FG001|Base Study Vaccination Period|Adverse Event|1|||
131877226|NCT00090220|474831394|FG002|Base Study Vaccination Period|Adverse Event|0|||
131877227|NCT00090220|474831395|FG003|Base Study Vaccination Period|Adverse Event|0|||
131877228|NCT00090220|474831396|FG004|Base Study Vaccination Period|Adverse Event|0|||
131877229|NCT00090220|474831397|FG005|Base Study Vaccination Period|Adverse Event|0|||
131877230|NCT00090220|474831392|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
131877231|NCT00090220|474831393|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
131877232|NCT00090220|474831394|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
131877233|NCT00090220|474831395|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
131877234|NCT00090220|474831396|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131877235|NCT00090220|474831397|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
131877236|NCT00090220|474831392|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
131877237|NCT00090220|474831393|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
131877238|NCT00090220|474831394|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
131877239|NCT00090220|474831395|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
131877240|NCT00090220|474831396|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131877241|NCT00090220|474831397|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
131877242|NCT00090220|474831392|FG000|Base Study Vaccination Period|Patient Moved|6|||
131877243|NCT00090220|474831393|FG001|Base Study Vaccination Period|Patient Moved|2|||
131877244|NCT00090220|474831394|FG002|Base Study Vaccination Period|Patient Moved|0|||
131877245|NCT00090220|474831395|FG003|Base Study Vaccination Period|Patient Moved|0|||
131877246|NCT00090220|474831396|FG004|Base Study Vaccination Period|Patient Moved|0|||
131877247|NCT00090220|474831397|FG005|Base Study Vaccination Period|Patient Moved|0|||
131877248|NCT00090220|474831392|FG000|Base Study Vaccination Period|Other|4|||
131877249|NCT00090220|474831393|FG001|Base Study Vaccination Period|Other|4|||
131877250|NCT00090220|474831394|FG002|Base Study Vaccination Period|Other|0|||
131877251|NCT00090220|474831395|FG003|Base Study Vaccination Period|Other|0|||
131877252|NCT00090220|474831396|FG004|Base Study Vaccination Period|Other|0|||
131877253|NCT00090220|474831397|FG005|Base Study Vaccination Period|Other|0|||
131877254|NCT00090220|474831392|FG000|Base Study Follow-up Period|Adverse Event|6|||
131409023|NCT00089986|473120754|FG000|Overall Study|Protocol Violation|0|||
131877255|NCT00090220|474831393|FG001|Base Study Follow-up Period|Adverse Event|1|||
131877256|NCT00090220|474831394|FG002|Base Study Follow-up Period|Adverse Event|0|||
131877257|NCT00090220|474831395|FG003|Base Study Follow-up Period|Adverse Event|0|||
131877258|NCT00090220|474831396|FG004|Base Study Follow-up Period|Adverse Event|0|||
131877259|NCT00090220|474831397|FG005|Base Study Follow-up Period|Adverse Event|0|||
131409024|NCT00089986|473120755|FG001|Overall Study|Protocol Violation|1|||
131409025|NCT00089986|473120756|FG002|Overall Study|Protocol Violation|0|||
131409026|NCT00089986|473120754|FG000|Overall Study|Patient transferred to another hospital|2|||
131877260|NCT00090220|474831392|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
131877261|NCT00090220|474831393|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
131877262|NCT00090220|474831394|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
131877263|NCT00090220|474831395|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
131409027|NCT00089986|473120755|FG001|Overall Study|Patient transferred to another hospital|1|||
131409028|NCT00089986|473120756|FG002|Overall Study|Patient transferred to another hospital|0|||
131877264|NCT00090220|474831396|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
131877265|NCT00090220|474831397|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
131877266|NCT00090220|474831392|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
131877267|NCT00090220|474831393|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
131877268|NCT00090220|474831394|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
131877269|NCT00090220|474831395|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
131877270|NCT00090220|474831396|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
131877271|NCT00090220|474831397|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
131877272|NCT00090220|474831392|FG000|Base Study Follow-up Period|Patient Moved|20|||
131877273|NCT00090220|474831393|FG001|Base Study Follow-up Period|Patient Moved|28|||
131877274|NCT00090220|474831394|FG002|Base Study Follow-up Period|Patient Moved|0|||
131877275|NCT00090220|474831395|FG003|Base Study Follow-up Period|Patient Moved|0|||
131877276|NCT00090220|474831396|FG004|Base Study Follow-up Period|Patient Moved|0|||
131877277|NCT00090220|474831397|FG005|Base Study Follow-up Period|Patient Moved|0|||
131877278|NCT00090220|474831392|FG000|Base Study Follow-up Period|Other|19|||
131877279|NCT00090220|474831393|FG001|Base Study Follow-up Period|Other|21|||
131877280|NCT00090220|474831394|FG002|Base Study Follow-up Period|Other|0|||
131877281|NCT00090220|474831395|FG003|Base Study Follow-up Period|Other|0|||
131877282|NCT00090220|474831396|FG004|Base Study Follow-up Period|Other|0|||
131877283|NCT00090220|474831397|FG005|Base Study Follow-up Period|Other|0|||
131877284|NCT00090220|474831392|FG000|Extension 1 (EXT1)|Adverse Event|0|||
131877285|NCT00090220|474831393|FG001|Extension 1 (EXT1)|Adverse Event|0|||
131877286|NCT00090220|474831394|FG002|Extension 1 (EXT1)|Adverse Event|4|||
131877287|NCT00090220|474831395|FG003|Extension 1 (EXT1)|Adverse Event|0|||
131877288|NCT00090220|474831396|FG004|Extension 1 (EXT1)|Adverse Event|0|||
131877289|NCT00090220|474831397|FG005|Extension 1 (EXT1)|Adverse Event|0|||
131877290|NCT00090220|474831392|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
131877291|NCT00090220|474831393|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
131877292|NCT00090220|474831394|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
131877293|NCT00090220|474831395|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
131877294|NCT00090220|474831396|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
131877295|NCT00090220|474831397|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
131877296|NCT00090220|474831392|FG000|Extension 1 (EXT1)|Moved|0|||
131877297|NCT00090220|474831393|FG001|Extension 1 (EXT1)|Moved|0|||
131877298|NCT00090220|474831394|FG002|Extension 1 (EXT1)|Moved|2|||
131877299|NCT00090220|474831395|FG003|Extension 1 (EXT1)|Moved|1|||
131877300|NCT00090220|474831396|FG004|Extension 1 (EXT1)|Moved|0|||
131877301|NCT00090220|474831397|FG005|Extension 1 (EXT1)|Moved|0|||
131877302|NCT00090220|474831392|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
131877303|NCT00090220|474831393|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
131877304|NCT00090220|474831394|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
131877305|NCT00090220|474831395|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
131877306|NCT00090220|474831396|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
131877307|NCT00090220|474831397|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
131877308|NCT00090220|474831392|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
131877309|NCT00090220|474831393|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
131877310|NCT00090220|474831394|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
131877311|NCT00090220|474831395|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
131877312|NCT00090220|474831396|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
131877313|NCT00090220|474831397|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
131877314|NCT00090220|474831392|FG000|Extension 1 (EXT1)|Other reason|0|||
131877315|NCT00090220|474831393|FG001|Extension 1 (EXT1)|Other reason|0|||
131877316|NCT00090220|474831394|FG002|Extension 1 (EXT1)|Other reason|2|||
131877317|NCT00090220|474831395|FG003|Extension 1 (EXT1)|Other reason|0|||
131877318|NCT00090220|474831396|FG004|Extension 1 (EXT1)|Other reason|0|||
131877319|NCT00090220|474831397|FG005|Extension 1 (EXT1)|Other reason|0|||
131877320|NCT00090220|474831392|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131877321|NCT00090220|474831393|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131877322|NCT00090220|474831394|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131877323|NCT00090220|474831395|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131877324|NCT00090220|474831396|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
131877325|NCT00090220|474831397|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
131877326|NCT00090220|474831392|FG000|Long-term Follow-up (EXT2)|Death|0|||
131877327|NCT00090220|474831393|FG001|Long-term Follow-up (EXT2)|Death|0|||
131877328|NCT00090220|474831394|FG002|Long-term Follow-up (EXT2)|Death|0|||
131877329|NCT00090220|474831395|FG003|Long-term Follow-up (EXT2)|Death|0|||
131877330|NCT00090220|474831396|FG004|Long-term Follow-up (EXT2)|Death|1|||
131877331|NCT00090220|474831397|FG005|Long-term Follow-up (EXT2)|Death|1|||
131409029|NCT00089986|473120754|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
131877332|NCT00090220|474831392|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131877333|NCT00090220|474831393|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131877334|NCT00090220|474831394|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131877335|NCT00090220|474831395|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131409030|NCT00089986|473120755|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
131877336|NCT00090220|474831396|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
131923187|NCT00790933|475003264|FG001|Overall Study|Reason Not Specified|16|||
131923188|NCT00790933|475003265|FG002|Overall Study|Reason Not Specified|4|||
131923189|NCT00790933|475003266|FG003|Overall Study|Reason Not Specified|1|||
131923190|NCT00790933|475003267|FG004|Overall Study|Reason Not Specified|9|||
131923191|NCT00574951|475003268|FG000|Overall Study|Ineligible - improper prior treatment|1|||
131923192|NCT02400580|475003284|FG000|Overall Study|Withdrawal by Subject|1|||
131923193|NCT02400580|475003285|FG001|Overall Study|Withdrawal by Subject|1|||
131923194|NCT02400580|475003284|FG000|Overall Study|Adverse Event|1|||
131923195|NCT02400580|475003285|FG001|Overall Study|Adverse Event|0|||
131923196|NCT02441114|475003286|FG000|Washout2|Withdrawal by Subject|4|||
131923197|NCT01371565|475003290|FG000|Overall Study|Withdrawal by Subject|1|||
131923198|NCT01371565|475003290|FG000|Overall Study|Death|1|||
131923199|NCT01371565|475003290|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
131923200|NCT04270760|475003291|FG000|Overall Study|Withdrawal by Subject|0|||
131923201|NCT04270760|475003292|FG001|Overall Study|Withdrawal by Subject|1|||
131923202|NCT04270760|475003293|FG002|Overall Study|Withdrawal by Subject|3|||
131923203|NCT04270760|475003294|FG003|Overall Study|Withdrawal by Subject|0|||
131923204|NCT04270760|475003295|FG004|Overall Study|Withdrawal by Subject|0|||
131923205|NCT04270760|475003291|FG000|Overall Study|Lost to Follow-up|1|||
131923206|NCT04270760|475003292|FG001|Overall Study|Lost to Follow-up|2|||
131923207|NCT04270760|475003293|FG002|Overall Study|Lost to Follow-up|1|||
131923208|NCT04270760|475003294|FG003|Overall Study|Lost to Follow-up|0|||
131923209|NCT04270760|475003295|FG004|Overall Study|Lost to Follow-up|0|||
131923210|NCT04270760|475003291|FG000|Overall Study|Death|0|||
131923211|NCT04270760|475003292|FG001|Overall Study|Death|0|||
131923212|NCT04270760|475003293|FG002|Overall Study|Death|0|||
131923213|NCT04270760|475003294|FG003|Overall Study|Death|0|||
131923214|NCT04270760|475003295|FG004|Overall Study|Death|1|||
131923215|NCT02070991|475003296|FG000|Overall Study|Death|2|||
131923216|NCT02070991|475003297|FG001|Overall Study|Death|0|||
131923217|NCT02070991|475003296|FG000|Overall Study|Withdrawal by Subject|1|||
131923218|NCT02070991|475003297|FG001|Overall Study|Withdrawal by Subject|0|||
131923219|NCT00827242|475003298|FG000|Overall Study|Withdrawal by Subject|2|||
131923220|NCT00827242|475003299|FG001|Overall Study|Withdrawal by Subject|4|||
131923221|NCT00827242|475003298|FG000|Overall Study|Protocol Violation|1|||
131923222|NCT00827242|475003299|FG001|Overall Study|Protocol Violation|3|||
131923223|NCT00827242|475003298|FG000|Overall Study|Lost to Follow-up|0|||
131923224|NCT00827242|475003299|FG001|Overall Study|Lost to Follow-up|3|||
131923225|NCT00827242|475003298|FG000|Overall Study|Adverse Event Excluding Death|2|||
131923226|NCT00827242|475003299|FG001|Overall Study|Adverse Event Excluding Death|1|||
131923227|NCT00827242|475003298|FG000|Overall Study|Entry Criteria Not Met|4|||
131923228|NCT00827242|475003299|FG001|Overall Study|Entry Criteria Not Met|1|||
131923229|NCT00827242|475003298|FG000|Overall Study|Physician Decision|2|||
131923230|NCT00827242|475003299|FG001|Overall Study|Physician Decision|0|||
131923231|NCT00827242|475003298|FG000|Overall Study|Death|1|||
131923232|NCT00827242|475003299|FG001|Overall Study|Death|0|||
131923233|NCT00827242|475003298|FG000|Overall Study|Lack of Efficacy|1|||
131923234|NCT00827242|475003299|FG001|Overall Study|Lack of Efficacy|0|||
131923235|NCT02609633|475003304|FG000|Overall Study|Consent Withdrawn|0|||
131923236|NCT02609633|475003305|FG001|Overall Study|Consent Withdrawn|1|||
131923237|NCT02609633|475003304|FG000|Overall Study|Protocol Deviation|1|||
131923238|NCT02609633|475003305|FG001|Overall Study|Protocol Deviation|0|||
131923239|NCT02609633|475003304|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
131923240|NCT02609633|475003305|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
131923241|NCT02609633|475003304|FG000|Overall Study|Reason not Specified|2|||
131923242|NCT02609633|475003305|FG001|Overall Study|Reason not Specified|1|||
131923243|NCT05987540|475003306|FG000|Overall Study|Withdrawal by Subject|2|||
131923244|NCT05987540|475003306|FG000|Overall Study|Death|1|||
131923245|NCT05987540|475003306|FG000|Overall Study|Study Termination|1|||
131923246|NCT05987540|475003306|FG000|Overall Study|Adverse Event|2|||
131923247|NCT00471107|475003307|FG000|Overall Study|Technical problems/data loss|3|||
131923248|NCT00471107|475003308|FG001|Overall Study|Technical problems/data loss|1|||
131923249|NCT00471107|475003309|FG002|Overall Study|Technical problems/data loss|3|||
131923250|NCT01769443|475003310|FG000|Overall Study|Study closure|1|||
131923251|NCT01769443|475003311|FG001|Overall Study|Study closure|0|||
131923252|NCT00933166|475003312|FG000|Overall Study|Lost to Follow-up|4|||
131923253|NCT00933166|475003312|FG000|Overall Study|Lack of Efficacy|9|||
131923254|NCT00933166|475003312|FG000|Overall Study|Unavailable|4|||
131923255|NCT00933166|475003312|FG000|Overall Study|Withdrawal by Subject|1|||
131923256|NCT04996264|475003313|FG000|Overall Study|Lost to Follow-up|0|||
131923257|NCT04996264|475003314|FG001|Overall Study|Lost to Follow-up|1|||
131923258|NCT04996264|475003313|FG000|Overall Study|Withdrawal by Subject|4|||
131923259|NCT04996264|475003314|FG001|Overall Study|Withdrawal by Subject|3|||
131923260|NCT04996264|475003313|FG000|Overall Study|1 left AMA|0|||
131923261|NCT04996264|475003314|FG001|Overall Study|1 left AMA|1|||
131923262|NCT04996264|475003313|FG000|Overall Study|Subject changed hospitals|0|||
131923263|NCT04996264|475003314|FG001|Overall Study|Subject changed hospitals|1|||
131923264|NCT04996264|475003313|FG000|Overall Study|unable to complete due to work|0|||
131877337|NCT00090220|474831397|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
131877338|NCT00090220|474831392|FG000|Long-term Follow-up (EXT2)|Other|0|||
131877339|NCT00090220|474831393|FG001|Long-term Follow-up (EXT2)|Other|0|||
131877340|NCT00090220|474831394|FG002|Long-term Follow-up (EXT2)|Other|0|||
131877341|NCT00090220|474831395|FG003|Long-term Follow-up (EXT2)|Other|0|||
131877342|NCT00090220|474831396|FG004|Long-term Follow-up (EXT2)|Other|1|||
131877343|NCT00090220|474831397|FG005|Long-term Follow-up (EXT2)|Other|0|||
131877344|NCT00941863|474831398|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
131877345|NCT00941863|474831399|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
131877346|NCT00941863|474831400|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
131877347|NCT00941863|474831401|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
131877348|NCT00941863|474831402|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
131877349|NCT00941863|474831398|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
131877350|NCT00941863|474831399|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
131877351|NCT00941863|474831400|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
131877352|NCT00941863|474831401|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
131877353|NCT00941863|474831402|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
131877354|NCT00941863|474831398|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
131877355|NCT00941863|474831399|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
131877356|NCT00941863|474831400|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
131877357|NCT00941863|474831401|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
131877358|NCT00941863|474831402|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
131877359|NCT00941863|474831398|FG000|Until Primary Completion Date (PCD)|Death|0|||
131877360|NCT00941863|474831399|FG001|Until Primary Completion Date (PCD)|Death|0|||
131877361|NCT00941863|474831400|FG002|Until Primary Completion Date (PCD)|Death|1|||
131877362|NCT00941863|474831401|FG003|Until Primary Completion Date (PCD)|Death|2|||
131877363|NCT00941863|474831402|FG004|Until Primary Completion Date (PCD)|Death|7|||
131877364|NCT00941863|474831398|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
131877365|NCT00941863|474831399|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
131877366|NCT00941863|474831400|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
131877367|NCT00941863|474831401|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
131877368|NCT00941863|474831402|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
131877369|NCT00941863|474831398|FG000|Continued After PCD|Withdrawal by Subject|0|||
131877370|NCT00941863|474831399|FG001|Continued After PCD|Withdrawal by Subject|0|||
131877371|NCT00941863|474831400|FG002|Continued After PCD|Withdrawal by Subject|0|||
131877372|NCT00941863|474831401|FG003|Continued After PCD|Withdrawal by Subject|0|||
131877373|NCT00941863|474831402|FG004|Continued After PCD|Withdrawal by Subject|1|||
131877374|NCT00941863|474831398|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
131877375|NCT00941863|474831399|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
131877376|NCT00941863|474831400|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
131877377|NCT00941863|474831401|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
131877378|NCT00941863|474831402|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
131877379|NCT00537316|474831403|FG000|Part 1|Adverse Event|7|||
131877380|NCT00537316|474831404|FG001|Part 1|Adverse Event|11|||
131877381|NCT00537316|474831405|FG002|Part 1|Adverse Event|8|||
131877382|NCT00537316|474831406|FG003|Part 1|Adverse Event|0|||
131877383|NCT00537316|474831407|FG004|Part 1|Adverse Event|0|||
131877384|NCT00537316|474831408|FG005|Part 1|Adverse Event|0|||
131877385|NCT00537316|474831409|FG006|Part 1|Adverse Event|0|||
131877386|NCT00537316|474831403|FG000|Part 1|Protocol defined clinical event|1|||
131877387|NCT00537316|474831404|FG001|Part 1|Protocol defined clinical event|0|||
131877388|NCT00537316|474831405|FG002|Part 1|Protocol defined clinical event|0|||
131877389|NCT00537316|474831406|FG003|Part 1|Protocol defined clinical event|0|||
131877390|NCT00537316|474831407|FG004|Part 1|Protocol defined clinical event|0|||
131877391|NCT00537316|474831408|FG005|Part 1|Protocol defined clinical event|0|||
131877392|NCT00537316|474831409|FG006|Part 1|Protocol defined clinical event|0|||
131877393|NCT00537316|474831403|FG000|Part 1|Lost to Follow-up|1|||
131877394|NCT00537316|474831404|FG001|Part 1|Lost to Follow-up|0|||
131877395|NCT00537316|474831405|FG002|Part 1|Lost to Follow-up|0|||
131877396|NCT00537316|474831406|FG003|Part 1|Lost to Follow-up|0|||
131877397|NCT00537316|474831407|FG004|Part 1|Lost to Follow-up|0|||
131877398|NCT00537316|474831408|FG005|Part 1|Lost to Follow-up|0|||
131877399|NCT00537316|474831409|FG006|Part 1|Lost to Follow-up|0|||
131877400|NCT00537316|474831403|FG000|Part 1|Withdrawal by Subject|3|||
131877401|NCT00537316|474831404|FG001|Part 1|Withdrawal by Subject|8|||
131877402|NCT00537316|474831405|FG002|Part 1|Withdrawal by Subject|4|||
131877403|NCT00537316|474831406|FG003|Part 1|Withdrawal by Subject|0|||
131877404|NCT00537316|474831407|FG004|Part 1|Withdrawal by Subject|0|||
131877405|NCT00537316|474831408|FG005|Part 1|Withdrawal by Subject|0|||
131877406|NCT00537316|474831409|FG006|Part 1|Withdrawal by Subject|0|||
131877407|NCT00537316|474831403|FG000|Part 1|Protocol Violation|1|||
131877408|NCT00537316|474831404|FG001|Part 1|Protocol Violation|5|||
131877409|NCT00537316|474831405|FG002|Part 1|Protocol Violation|1|||
131877410|NCT00537316|474831406|FG003|Part 1|Protocol Violation|0|||
131877411|NCT00537316|474831407|FG004|Part 1|Protocol Violation|0|||
131923265|NCT04996264|475003314|FG001|Overall Study|unable to complete due to work|1|||
131923266|NCT04433975|475003315|FG000|1-month Follow Up|Withdrawal by Subject|1|||
131923267|NCT04433975|475003316|FG001|1-month Follow Up|Withdrawal by Subject|1|||
131923268|NCT04433975|475003315|FG000|1-month Follow Up|Lost to Follow-up|21|||
131923269|NCT04433975|475003316|FG001|1-month Follow Up|Lost to Follow-up|25|||
131923270|NCT04433975|475003315|FG000|3-month Follow Up|Lost to Follow-up|20|||
131923271|NCT04433975|475003316|FG001|3-month Follow Up|Lost to Follow-up|24|||
131923272|NCT04433975|475003315|FG000|3-month Follow Up|Death|1|||
131923273|NCT04433975|475003316|FG001|3-month Follow Up|Death|0|||
131923274|NCT04433975|475003315|FG000|3-month Follow Up|Withdrawal by Subject|2|||
131923275|NCT04433975|475003316|FG001|3-month Follow Up|Withdrawal by Subject|0|||
131923276|NCT04433975|475003315|FG000|6-month Follow Up|Lost to Follow-up|23|||
131923277|NCT04433975|475003316|FG001|6-month Follow Up|Lost to Follow-up|28|||
131923278|NCT04433975|475003315|FG000|6-month Follow Up|Withdrawal by Subject|1|||
131923279|NCT04433975|475003316|FG001|6-month Follow Up|Withdrawal by Subject|1|||
131923280|NCT04433975|475003315|FG000|9-month Follow Up|Lost to Follow-up|27|||
131923281|NCT04433975|475003316|FG001|9-month Follow Up|Lost to Follow-up|36|||
131923282|NCT04433975|475003315|FG000|9-month Follow Up|Death|0|||
131923283|NCT04433975|475003316|FG001|9-month Follow Up|Death|1|||
131923284|NCT04433975|475003315|FG000|12-month Follow Up|Lost to Follow-up|27|||
131923285|NCT04433975|475003316|FG001|12-month Follow Up|Lost to Follow-up|31|||
131923286|NCT04606771|475003317|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
131923287|NCT04606771|475003318|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
131923288|NCT04606771|475003317|FG000|Overall Study|Death|5|||
131923289|NCT04606771|475003318|FG001|Overall Study|Death|6|||
131923290|NCT04606771|475003317|FG000|Overall Study|Wrong randomisation|0|||
131923291|NCT04606771|475003318|FG001|Overall Study|Wrong randomisation|1|||
131923292|NCT04392635|475003319|FG000|Overall Study|Lost to Follow-up|0|||
131923293|NCT04392635|475003320|FG001|Overall Study|Lost to Follow-up|1|||
131923294|NCT02030418|475003321|FG000|Overall Study|Death|78|||
131923295|NCT02030418|475003321|FG000|Overall Study|Missed 12-Month Visit|9|||
131923296|NCT02030418|475003321|FG000|Overall Study|Withdrawn|57|||
131923297|NCT01149538|475003325|FG000|Overall Study|Lost to Follow-up|0|||
131923298|NCT01149538|475003326|FG001|Overall Study|Lost to Follow-up|1|||
131923299|NCT01149538|475003325|FG000|Overall Study|Withdrawal by Subject|5|||
131923300|NCT01149538|475003326|FG001|Overall Study|Withdrawal by Subject|3|||
131923301|NCT00250718|475003327|FG000|Overall Study|Death|1|||
131923302|NCT00250718|475003327|FG000|Overall Study|Adverse Event|1|||
131923303|NCT00250718|475003327|FG000|Overall Study|Withdrawal by Subject|1|||
131923304|NCT06100250|475003328|FG000|Overall Study|Lost to Follow-up|5|||
131923305|NCT02021318|475003329|FG000|Overall Study|Adverse Event|2|||
131923306|NCT02021318|475003330|FG001|Overall Study|Adverse Event|1|||
131923307|NCT02021318|475003329|FG000|Overall Study|Death|33|||
131923308|NCT02021318|475003330|FG001|Overall Study|Death|34|||
131923309|NCT02021318|475003329|FG000|Overall Study|Lost to Follow-up|3|||
131923310|NCT02021318|475003330|FG001|Overall Study|Lost to Follow-up|3|||
131923311|NCT02021318|475003329|FG000|Overall Study|Progressive Disease|0|||
131923312|NCT02021318|475003330|FG001|Overall Study|Progressive Disease|1|||
131923313|NCT02021318|475003329|FG000|Overall Study|Withdrawal by Subject|30|||
131923314|NCT02021318|475003330|FG001|Overall Study|Withdrawal by Subject|18|||
131923315|NCT02021318|475003329|FG000|Overall Study|Physician Decision|3|||
131923316|NCT02021318|475003330|FG001|Overall Study|Physician Decision|3|||
131923317|NCT02021318|475003329|FG000|Overall Study|Miscellaneous|2|||
131923318|NCT02021318|475003330|FG001|Overall Study|Miscellaneous|3|||
131923319|NCT00421993|475003334|FG000|Overall Study|Withdrawal by Subject|22|||
131923320|NCT00421993|475003335|FG001|Overall Study|Withdrawal by Subject|23|||
131923321|NCT00421993|475003336|FG002|Overall Study|Withdrawal by Subject|23|||
131923322|NCT00421993|475003337|FG003|Overall Study|Withdrawal by Subject|24|||
131923323|NCT00421993|475003334|FG000|Overall Study|Lost to Follow-up|18|||
131923324|NCT00421993|475003335|FG001|Overall Study|Lost to Follow-up|19|||
131923325|NCT00421993|475003336|FG002|Overall Study|Lost to Follow-up|22|||
131923326|NCT00421993|475003337|FG003|Overall Study|Lost to Follow-up|20|||
131923327|NCT00421993|475003334|FG000|Overall Study|Adverse Event|11|||
131923328|NCT00421993|475003335|FG001|Overall Study|Adverse Event|1|||
131923329|NCT00421993|475003336|FG002|Overall Study|Adverse Event|6|||
131923330|NCT00421993|475003337|FG003|Overall Study|Adverse Event|4|||
131923331|NCT00421993|475003334|FG000|Overall Study|Protocol Violation|2|||
131923332|NCT00421993|475003335|FG001|Overall Study|Protocol Violation|2|||
131923333|NCT00421993|475003336|FG002|Overall Study|Protocol Violation|0|||
131923334|NCT00421993|475003337|FG003|Overall Study|Protocol Violation|1|||
131923335|NCT00421993|475003334|FG000|Overall Study|Lack of Efficacy|0|||
131923336|NCT00421993|475003335|FG001|Overall Study|Lack of Efficacy|3|||
131923337|NCT00421993|475003336|FG002|Overall Study|Lack of Efficacy|0|||
131923338|NCT00421993|475003337|FG003|Overall Study|Lack of Efficacy|5|||
131923339|NCT00421993|475003334|FG000|Overall Study|Pregnancy|0|||
131923340|NCT00421993|475003335|FG001|Overall Study|Pregnancy|1|||
131923341|NCT00421993|475003336|FG002|Overall Study|Pregnancy|1|||
131923342|NCT00421993|475003337|FG003|Overall Study|Pregnancy|2|||
131923343|NCT00421993|475003334|FG000|Overall Study|Subject transportation issues|0|||
131923344|NCT00421993|475003335|FG001|Overall Study|Subject transportation issues|0|||
131923345|NCT00421993|475003336|FG002|Overall Study|Subject transportation issues|0|||
131923346|NCT00421993|475003337|FG003|Overall Study|Subject transportation issues|1|||
131923347|NCT01980888|475003338|FG000|Overall Study|Study Terminated by Sponsor|116|||
131923348|NCT01980888|475003339|FG001|Overall Study|Study Terminated by Sponsor|122|||
131923349|NCT01980888|475003338|FG000|Overall Study|Withdrew Consent|17|||
131923350|NCT01980888|475003339|FG001|Overall Study|Withdrew Consent|6|||
131923351|NCT01980888|475003338|FG000|Overall Study|Investigator's Discretion|8|||
131923352|NCT01980888|475003339|FG001|Overall Study|Investigator's Discretion|3|||
131923353|NCT01980888|475003338|FG000|Overall Study|Non-Compliance with Study Drug|3|||
131453965|NCT02023697|473291846|FG002|Treatment Period|Withdrawal by Subject|13|||
131453966|NCT02023697|473291844|FG000|Treatment Period|Safety outcome reached|0|||
131453967|NCT02023697|473291845|FG001|Treatment Period|Safety outcome reached|1|||
131453968|NCT02023697|473291846|FG002|Treatment Period|Safety outcome reached|0|||
131453969|NCT02023697|473291844|FG000|Treatment Period|Physician Decision|0|||
131877412|NCT00537316|474831408|FG005|Part 1|Protocol Violation|0|||
131877413|NCT00537316|474831409|FG006|Part 1|Protocol Violation|0|||
131923354|NCT01980888|475003339|FG001|Overall Study|Non-Compliance with Study Drug|2|||
131923355|NCT01483651|475003345|FG000|Overall Study|Withdrawal by Subject|0|||
131923356|NCT01483651|475003346|FG001|Overall Study|Withdrawal by Subject|1|||
131923357|NCT01483651|475003347|FG002|Overall Study|Withdrawal by Subject|1|||
131923358|NCT01483651|475003348|FG003|Overall Study|Withdrawal by Subject|0|||
131923359|NCT01483651|475003349|FG004|Overall Study|Withdrawal by Subject|0|||
131923360|NCT01483651|475003350|FG005|Overall Study|Withdrawal by Subject|1|||
131923361|NCT01301092|475003355|FG000|Overall Study|Lost to Follow-up|0|||
131923362|NCT01301092|475003356|FG001|Overall Study|Lost to Follow-up|0|||
131923363|NCT01301092|475003357|FG002|Overall Study|Lost to Follow-up|1|||
131877414|NCT00537316|474831403|FG000|Part 1|Did not meet protocol eligibility|1|||
131877415|NCT00537316|474831404|FG001|Part 1|Did not meet protocol eligibility|3|||
131877416|NCT00537316|474831405|FG002|Part 1|Did not meet protocol eligibility|2|||
131877417|NCT00537316|474831406|FG003|Part 1|Did not meet protocol eligibility|0|||
131877418|NCT00537316|474831407|FG004|Part 1|Did not meet protocol eligibility|0|||
131877419|NCT00537316|474831408|FG005|Part 1|Did not meet protocol eligibility|0|||
131877420|NCT00537316|474831409|FG006|Part 1|Did not meet protocol eligibility|0|||
131877421|NCT00537316|474831403|FG000|Part 1|Administrative|0|||
131877422|NCT00537316|474831404|FG001|Part 1|Administrative|0|||
131877423|NCT00537316|474831405|FG002|Part 1|Administrative|2|||
131877424|NCT00537316|474831406|FG003|Part 1|Administrative|0|||
131877425|NCT00537316|474831407|FG004|Part 1|Administrative|0|||
131877426|NCT00537316|474831408|FG005|Part 1|Administrative|0|||
131877427|NCT00537316|474831409|FG006|Part 1|Administrative|0|||
131877428|NCT00537316|474831403|FG000|Part 2|Never entered follow-up|0|||
131877429|NCT00537316|474831404|FG001|Part 2|Never entered follow-up|0|||
131877430|NCT00537316|474831405|FG002|Part 2|Never entered follow-up|0|||
131877431|NCT00537316|474831406|FG003|Part 2|Never entered follow-up|0|||
131877432|NCT00537316|474831407|FG004|Part 2|Never entered follow-up|0|||
131877433|NCT00537316|474831408|FG005|Part 2|Never entered follow-up|0|||
131877434|NCT00537316|474831409|FG006|Part 2|Never entered follow-up|1|||
131877435|NCT00537316|474831403|FG000|Part 2|Adverse Event|4|||
131877436|NCT00537316|474831404|FG001|Part 2|Adverse Event|0|||
131877437|NCT00537316|474831405|FG002|Part 2|Adverse Event|2|||
131877438|NCT00537316|474831406|FG003|Part 2|Adverse Event|0|||
131877439|NCT00537316|474831407|FG004|Part 2|Adverse Event|0|||
131877440|NCT00537316|474831408|FG005|Part 2|Adverse Event|0|||
131877441|NCT00537316|474831409|FG006|Part 2|Adverse Event|0|||
131877442|NCT00537316|474831403|FG000|Part 2|Lost to Follow-up|1|||
131877443|NCT00537316|474831404|FG001|Part 2|Lost to Follow-up|0|||
131877444|NCT00537316|474831405|FG002|Part 2|Lost to Follow-up|2|||
131877445|NCT00537316|474831406|FG003|Part 2|Lost to Follow-up|0|||
131923364|NCT03334175|475003358|FG000|Overall Study|Lost to Follow-up|0|||
131923365|NCT03334175|475003359|FG001|Overall Study|Lost to Follow-up|1|||
131923366|NCT01350973|475003360|FG000|Overall Study|Adverse Event|4|||
131923367|NCT01350973|475003361|FG001|Overall Study|Adverse Event|7|||
131923368|NCT01350973|475003362|FG002|Overall Study|Adverse Event|7|||
131923369|NCT01350973|475003360|FG000|Overall Study|Voluntary Withdrawal|2|||
131877446|NCT00537316|474831407|FG004|Part 2|Lost to Follow-up|0|||
131877447|NCT00537316|474831408|FG005|Part 2|Lost to Follow-up|0|||
131877448|NCT00537316|474831409|FG006|Part 2|Lost to Follow-up|0|||
131877449|NCT00537316|474831403|FG000|Part 2|Withdrawal by Subject|5|||
131877450|NCT00537316|474831404|FG001|Part 2|Withdrawal by Subject|1|||
131923370|NCT01350973|475003361|FG001|Overall Study|Voluntary Withdrawal|1|||
131923371|NCT01350973|475003362|FG002|Overall Study|Voluntary Withdrawal|1|||
131877451|NCT00537316|474831405|FG002|Part 2|Withdrawal by Subject|4|||
131877452|NCT00537316|474831406|FG003|Part 2|Withdrawal by Subject|0|||
131923372|NCT03738215|475003366|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
131453970|NCT02023697|473291845|FG001|Treatment Period|Physician Decision|0|||
131877453|NCT00537316|474831407|FG004|Part 2|Withdrawal by Subject|0|||
131877454|NCT00537316|474831408|FG005|Part 2|Withdrawal by Subject|0|||
131877455|NCT00537316|474831409|FG006|Part 2|Withdrawal by Subject|0|||
131877456|NCT00537316|474831403|FG000|Part 2|Administrative|16|||
131923373|NCT03738215|475003367|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
131923374|NCT03738215|475003368|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
131923375|NCT03738215|475003366|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
131877457|NCT00537316|474831404|FG001|Part 2|Administrative|8|||
131923376|NCT03738215|475003367|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
131923377|NCT03738215|475003368|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131923378|NCT03738215|475003366|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
131923379|NCT03738215|475003367|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
131923380|NCT03738215|475003368|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
131923381|NCT03738215|475003366|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
131923382|NCT03738215|475003367|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
131923383|NCT03738215|475003368|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
131923384|NCT03738215|475003366|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
131923385|NCT03738215|475003367|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
131923386|NCT03738215|475003368|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
131923387|NCT03738215|475003366|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
131923388|NCT03738215|475003367|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
131923389|NCT03738215|475003368|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
131923390|NCT03738215|475003366|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
131923391|NCT03738215|475003367|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
131923392|NCT03738215|475003368|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
131923393|NCT03738215|475003366|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
131923394|NCT03738215|475003367|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
131923395|NCT03738215|475003368|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
131923396|NCT03738215|475003366|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
131923397|NCT03738215|475003367|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
131923398|NCT03738215|475003368|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
131923399|NCT03738215|475003366|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
131923400|NCT03738215|475003367|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
131877458|NCT00537316|474831405|FG002|Part 2|Administrative|24|||
131877459|NCT00537316|474831406|FG003|Part 2|Administrative|3|||
131877460|NCT00537316|474831407|FG004|Part 2|Administrative|1|||
131877461|NCT00537316|474831408|FG005|Part 2|Administrative|4|||
131877462|NCT00537316|474831409|FG006|Part 2|Administrative|1|||
131877463|NCT02651155|474831410|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131877464|NCT02651155|474831411|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
131877465|NCT02651155|474831410|FG000|Overall Study|Voluntary Withdrawal|5|||
131877466|NCT02651155|474831411|FG001|Overall Study|Voluntary Withdrawal|0|||
131877467|NCT04533412|474831412|FG000|Overall Study|Withdrawal by Subject|1|||
131877468|NCT04533412|474831413|FG001|Overall Study|Withdrawal by Subject|1|||
131877469|NCT04533412|474831412|FG000|Overall Study|Lost to Follow-up|1|||
131877470|NCT04533412|474831413|FG001|Overall Study|Lost to Follow-up|4|||
131877471|NCT05113979|474831416|FG000|Overall Study|Death|2|||
131877472|NCT05113979|474831416|FG000|Overall Study|Lost to Follow-up|1|||
131877473|NCT01489254|474831421|FG000|Double-blind Part|Adverse Event|7|||
131877474|NCT01489254|474831422|FG001|Double-blind Part|Adverse Event|2|||
131877475|NCT01489254|474831423|FG002|Double-blind Part|Adverse Event|2|||
131877476|NCT01489254|474831424|FG003|Double-blind Part|Adverse Event|0|||
131877477|NCT01489254|474831421|FG000|Double-blind Part|Pregnancy|1|||
131877478|NCT01489254|474831422|FG001|Double-blind Part|Pregnancy|3|||
131877479|NCT01489254|474831423|FG002|Double-blind Part|Pregnancy|0|||
131877480|NCT01489254|474831424|FG003|Double-blind Part|Pregnancy|0|||
131877481|NCT01489254|474831421|FG000|Double-blind Part|Withdrawal by Subject|12|||
131877482|NCT01489254|474831422|FG001|Double-blind Part|Withdrawal by Subject|20|||
131877483|NCT01489254|474831423|FG002|Double-blind Part|Withdrawal by Subject|1|||
131877484|NCT01489254|474831424|FG003|Double-blind Part|Withdrawal by Subject|0|||
131877485|NCT01489254|474831421|FG000|Double-blind Part|Lost to Follow-up|1|||
131877486|NCT01489254|474831422|FG001|Double-blind Part|Lost to Follow-up|2|||
131877487|NCT01489254|474831423|FG002|Double-blind Part|Lost to Follow-up|0|||
131877488|NCT01489254|474831424|FG003|Double-blind Part|Lost to Follow-up|0|||
131877489|NCT01489254|474831421|FG000|Double-blind Part|Other reasons for not completing study|4|||
131877490|NCT01489254|474831422|FG001|Double-blind Part|Other reasons for not completing study|6|||
131877491|NCT01489254|474831423|FG002|Double-blind Part|Other reasons for not completing study|0|||
131877492|NCT01489254|474831424|FG003|Double-blind Part|Other reasons for not completing study|0|||
131877493|NCT01489254|474831421|FG000|Open-label Extension Part|Adverse Event|0|||
131877494|NCT01489254|474831422|FG001|Open-label Extension Part|Adverse Event|0|||
131877495|NCT01489254|474831423|FG002|Open-label Extension Part|Adverse Event|0|||
131877496|NCT01489254|474831424|FG003|Open-label Extension Part|Adverse Event|10|||
131877497|NCT01489254|474831421|FG000|Open-label Extension Part|Pregnancy|0|||
131877498|NCT01489254|474831422|FG001|Open-label Extension Part|Pregnancy|0|||
131877499|NCT01489254|474831423|FG002|Open-label Extension Part|Pregnancy|0|||
131877500|NCT01489254|474831424|FG003|Open-label Extension Part|Pregnancy|3|||
131877501|NCT01489254|474831421|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
131877502|NCT01489254|474831422|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
131877503|NCT01489254|474831423|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
131877504|NCT01489254|474831424|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
131877505|NCT01489254|474831421|FG000|Open-label Extension Part|Protocol Violation|0|||
131877506|NCT01489254|474831422|FG001|Open-label Extension Part|Protocol Violation|0|||
131877507|NCT01489254|474831423|FG002|Open-label Extension Part|Protocol Violation|0|||
131877508|NCT01489254|474831424|FG003|Open-label Extension Part|Protocol Violation|1|||
131409031|NCT00089986|473120756|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
131409032|NCT00089986|473120754|FG000|Overall Study|Hemohlobin stopping rule|0|||
131409033|NCT00089986|473120755|FG001|Overall Study|Hemohlobin stopping rule|1|||
131877509|NCT01489254|474831421|FG000|Open-label Extension Part|Lost to Follow-up|0|||
131877510|NCT01489254|474831422|FG001|Open-label Extension Part|Lost to Follow-up|0|||
131877511|NCT01489254|474831423|FG002|Open-label Extension Part|Lost to Follow-up|0|||
131877512|NCT01489254|474831424|FG003|Open-label Extension Part|Lost to Follow-up|9|||
131877513|NCT01489254|474831421|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
131877514|NCT01489254|474831422|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
131877515|NCT01489254|474831423|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
131877516|NCT01489254|474831424|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
131877517|NCT01609543|474831425|FG000|Overall Study|Disease Progression|28|||
131877518|NCT01609543|474831425|FG000|Overall Study|Adverse Event|5|||
131877519|NCT01609543|474831425|FG000|Overall Study|Withdrawal by Subject|1|||
131877520|NCT01609543|474831425|FG000|Overall Study|Protocol Violation|1|||
131877521|NCT01609543|474831425|FG000|Overall Study|Death|7|||
131877522|NCT00507819|474831426|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
131877523|NCT00507819|474831427|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
131877524|NCT03452488|474831431|FG000|Overall Study|Adverse Event|4|||
131877525|NCT03452488|474831432|FG001|Overall Study|Adverse Event|6|||
131877526|NCT03452488|474831433|FG002|Overall Study|Adverse Event|1|||
131877527|NCT03452488|474831431|FG000|Overall Study|Death|0|||
131877528|NCT03452488|474831432|FG001|Overall Study|Death|0|||
131877529|NCT03452488|474831433|FG002|Overall Study|Death|1|||
131877530|NCT03452488|474831431|FG000|Overall Study|Lost to Follow-up|1|||
131877531|NCT03452488|474831432|FG001|Overall Study|Lost to Follow-up|2|||
131877532|NCT03452488|474831433|FG002|Overall Study|Lost to Follow-up|0|||
131877533|NCT03452488|474831431|FG000|Overall Study|PI Decision|1|||
131877534|NCT03452488|474831432|FG001|Overall Study|PI Decision|0|||
131877535|NCT03452488|474831433|FG002|Overall Study|PI Decision|0|||
131877536|NCT03452488|474831431|FG000|Overall Study|Withdrew consent|4|||
131877537|NCT03452488|474831432|FG001|Overall Study|Withdrew consent|2|||
131877538|NCT03452488|474831433|FG002|Overall Study|Withdrew consent|2|||
131877539|NCT03452488|474831431|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
131877540|NCT03452488|474831432|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
131877541|NCT03452488|474831433|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
131877542|NCT03452488|474831431|FG000|Overall Study|Other|0|||
131877543|NCT03452488|474831432|FG001|Overall Study|Other|2|||
131877544|NCT03452488|474831433|FG002|Overall Study|Other|2|||
131877545|NCT01254318|474831436|FG000|Overall Study|Lost to Follow-up|5|||
131877546|NCT01254318|474831436|FG000|Overall Study|Death|47|||
131877547|NCT00330343|474831441|FG000|Overall Study|Lost to Follow-up|5|||
131877548|NCT00281632|474831442|FG000|Overall Study|Adverse Event|7|||
131877549|NCT00281632|474831442|FG000|Overall Study|Withdrawal by Subject|2|||
131877550|NCT00281632|474831442|FG000|Overall Study|Disease Progression|22|||
131877551|NCT00281632|474831442|FG000|Overall Study|Death|1|||
131877552|NCT00281632|474831442|FG000|Overall Study|Physician Decision|1|||
131877553|NCT00281632|474831442|FG000|Overall Study|Ongoing|3|||
131877554|NCT03990571|474831443|FG000|Overall Study|Withdrawal by Subject|1|||
131877555|NCT03990571|474831443|FG000|Overall Study|Insurance Issues|3|||
131877556|NCT03990571|474831443|FG000|Overall Study|Covid Restrictions|2|||
131877557|NCT00782184|474831450|FG000|Overall Study|Adverse Event|1|||
131409034|NCT00089986|473120756|FG002|Overall Study|Hemohlobin stopping rule|0|||
131877558|NCT00782184|474831451|FG001|Overall Study|Adverse Event|2|||
131877559|NCT00782184|474831450|FG000|Overall Study|Protocol Violation|0|||
131877560|NCT00782184|474831451|FG001|Overall Study|Protocol Violation|1|||
131877561|NCT00782184|474831450|FG000|Overall Study|Withdrawal by Subject|3|||
131877562|NCT00782184|474831451|FG001|Overall Study|Withdrawal by Subject|2|||
131877563|NCT03614078|474831452|FG000|Overall Study|Withdrawal by Subject|2|||
131877564|NCT03614078|474831453|FG001|Overall Study|Withdrawal by Subject|2|||
131409035|NCT00089986|473120754|FG000|Overall Study|Investigator decision to withdrew|0|||
131877565|NCT03614078|474831454|FG002|Overall Study|Withdrawal by Subject|3|||
131877566|NCT03614078|474831452|FG000|Overall Study|Participant Did Not Return for Visit|0|||
131877567|NCT03614078|474831453|FG001|Overall Study|Participant Did Not Return for Visit|1|||
131877568|NCT03614078|474831454|FG002|Overall Study|Participant Did Not Return for Visit|0|||
131877569|NCT03614078|474831452|FG000|Overall Study|High Neutrophils|0|||
131877570|NCT03614078|474831453|FG001|Overall Study|High Neutrophils|0|||
131409036|NCT00089986|473120755|FG001|Overall Study|Investigator decision to withdrew|1|||
131409037|NCT00089986|473120756|FG002|Overall Study|Investigator decision to withdrew|0|||
131409038|NCT00089986|473120754|FG000|Overall Study|Enrollment in another study|0|||
131409039|NCT00089986|473120755|FG001|Overall Study|Enrollment in another study|1|||
131409040|NCT00089986|473120756|FG002|Overall Study|Enrollment in another study|0|||
131877571|NCT03614078|474831454|FG002|Overall Study|High Neutrophils|2|||
131877572|NCT03614078|474831452|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
131409041|NCT00089986|473120754|FG000|Overall Study|Family decision|0|||
131409042|NCT00089986|473120755|FG001|Overall Study|Family decision|1|||
131409043|NCT00089986|473120756|FG002|Overall Study|Family decision|0|||
131453971|NCT02023697|473291846|FG002|Treatment Period|Physician Decision|1|||
131877573|NCT03614078|474831453|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
131877574|NCT03614078|474831454|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
131877575|NCT03614078|474831452|FG000|Overall Study|Exacerbation of Psoriasis|0|||
131877576|NCT03614078|474831453|FG001|Overall Study|Exacerbation of Psoriasis|1|||
131877577|NCT03614078|474831454|FG002|Overall Study|Exacerbation of Psoriasis|0|||
131877578|NCT03614078|474831452|FG000|Overall Study|Adverse Event|0|||
131877579|NCT03614078|474831453|FG001|Overall Study|Adverse Event|2|||
131877580|NCT03614078|474831454|FG002|Overall Study|Adverse Event|0|||
131877581|NCT03614078|474831452|FG000|Overall Study|Dizziness and Rash|0|||
131877582|NCT03614078|474831453|FG001|Overall Study|Dizziness and Rash|1|||
131877583|NCT03614078|474831454|FG002|Overall Study|Dizziness and Rash|0|||
131877584|NCT04143594|474831457|FG000|Overall Study|Withdrew consent|3|||
131877585|NCT04143594|474831458|FG001|Overall Study|Withdrew consent|10|||
131877586|NCT04143594|474831459|FG002|Overall Study|Withdrew consent|3|||
131877587|NCT04143594|474831460|FG003|Overall Study|Withdrew consent|1|||
131877588|NCT04143594|474831457|FG000|Overall Study|Lost to Follow-up|3|||
131877589|NCT04143594|474831458|FG001|Overall Study|Lost to Follow-up|5|||
131877590|NCT04143594|474831459|FG002|Overall Study|Lost to Follow-up|11|||
131877591|NCT04143594|474831460|FG003|Overall Study|Lost to Follow-up|0|||
131877592|NCT04143594|474831457|FG000|Overall Study|Investigator's discretion|2|||
131877593|NCT04143594|474831458|FG001|Overall Study|Investigator's discretion|2|||
131877594|NCT04143594|474831459|FG002|Overall Study|Investigator's discretion|0|||
131877595|NCT04143594|474831460|FG003|Overall Study|Investigator's discretion|0|||
131877596|NCT04143594|474831457|FG000|Overall Study|Randomized but never treated|0|||
131877597|NCT04143594|474831458|FG001|Overall Study|Randomized but never treated|0|||
131877598|NCT04143594|474831459|FG002|Overall Study|Randomized but never treated|0|||
131877599|NCT04143594|474831460|FG003|Overall Study|Randomized but never treated|1|||
131877600|NCT04143594|474831457|FG000|Overall Study|Death|1|||
131877601|NCT04143594|474831458|FG001|Overall Study|Death|0|||
131877602|NCT04143594|474831459|FG002|Overall Study|Death|1|||
131877603|NCT04143594|474831460|FG003|Overall Study|Death|0|||
131877604|NCT04143594|474831457|FG000|Overall Study|Adverse Event|1|||
131877605|NCT04143594|474831458|FG001|Overall Study|Adverse Event|0|||
131877606|NCT04143594|474831459|FG002|Overall Study|Adverse Event|0|||
131877607|NCT04143594|474831460|FG003|Overall Study|Adverse Event|0|||
131877608|NCT04143594|474831457|FG000|Overall Study|Pregnancy|0|||
131877609|NCT04143594|474831458|FG001|Overall Study|Pregnancy|0|||
131877610|NCT04143594|474831459|FG002|Overall Study|Pregnancy|1|||
131877611|NCT04143594|474831460|FG003|Overall Study|Pregnancy|0|||
131877612|NCT04143594|474831457|FG000|Overall Study|Lack of Efficacy|1|||
131877613|NCT04143594|474831458|FG001|Overall Study|Lack of Efficacy|1|||
131877614|NCT04143594|474831459|FG002|Overall Study|Lack of Efficacy|0|||
131877615|NCT04143594|474831460|FG003|Overall Study|Lack of Efficacy|0|||
131877616|NCT01054196|474831461|FG000|Overall Study|Physician Decision|0|||
131877617|NCT01054196|474831462|FG001|Overall Study|Physician Decision|0|||
131877618|NCT01054196|474831463|FG002|Overall Study|Physician Decision|0|||
131877619|NCT01054196|474831464|FG003|Overall Study|Physician Decision|1|||
131877620|NCT01054196|474831465|FG004|Overall Study|Physician Decision|0|||
131877621|NCT01054196|474831466|FG005|Overall Study|Physician Decision|0|||
131877622|NCT01054196|474831467|FG006|Overall Study|Physician Decision|1|||
131877623|NCT01992653|474831474|FG000|Overall Study|Death|0|||
131877624|NCT01992653|474831475|FG001|Overall Study|Death|0|||
131877625|NCT01992653|474831476|FG002|Overall Study|Death|1|||
131877626|NCT01992653|474831477|FG003|Overall Study|Death|0|||
131877627|NCT01992653|474831478|FG004|Overall Study|Death|1|||
131877628|NCT01992653|474831479|FG005|Overall Study|Death|0|||
131877629|NCT01992653|474831480|FG006|Overall Study|Death|4|||
131877630|NCT01992653|474831481|FG007|Overall Study|Death|2|||
131877631|NCT01992653|474831474|FG000|Overall Study|Lost to Follow-up|0|||
131877632|NCT01992653|474831475|FG001|Overall Study|Lost to Follow-up|0|||
131877633|NCT01992653|474831476|FG002|Overall Study|Lost to Follow-up|0|||
131877634|NCT01992653|474831477|FG003|Overall Study|Lost to Follow-up|0|||
131877635|NCT01992653|474831478|FG004|Overall Study|Lost to Follow-up|0|||
131877636|NCT01992653|474831479|FG005|Overall Study|Lost to Follow-up|0|||
131877637|NCT01992653|474831480|FG006|Overall Study|Lost to Follow-up|0|||
131877638|NCT01992653|474831481|FG007|Overall Study|Lost to Follow-up|1|||
131877639|NCT01992653|474831474|FG000|Overall Study|Study Completed|0|||
131877640|NCT01992653|474831475|FG001|Overall Study|Study Completed|0|||
131877641|NCT01992653|474831476|FG002|Overall Study|Study Completed|0|||
131923401|NCT03738215|475003368|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
131923402|NCT00853047|475003369|FG000|Core Phase|Participant Request|0|||
131923403|NCT00853047|475003370|FG001|Core Phase|Participant Request|0|||
131923404|NCT00853047|475003371|FG002|Core Phase|Participant Request|0|||
131923405|NCT00853047|475003372|FG003|Core Phase|Participant Request|1|||
131923406|NCT00853047|475003373|FG004|Core Phase|Participant Request|0|||
131923407|NCT00853047|475003374|FG005|Core Phase|Participant Request|0|||
131923408|NCT00853047|475003369|FG000|Open-Label Extension Phase|Participant Request|0|||
131923409|NCT00853047|475003370|FG001|Open-Label Extension Phase|Participant Request|0|||
131923410|NCT00853047|475003371|FG002|Open-Label Extension Phase|Participant Request|0|||
131923411|NCT00853047|475003372|FG003|Open-Label Extension Phase|Participant Request|0|||
131923412|NCT00853047|475003373|FG004|Open-Label Extension Phase|Participant Request|0|||
131923413|NCT00853047|475003374|FG005|Open-Label Extension Phase|Participant Request|7|||
131923414|NCT00853047|475003369|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
131923415|NCT00853047|475003370|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
131923416|NCT00853047|475003371|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
131923417|NCT00853047|475003372|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
131923418|NCT00853047|475003373|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
131923419|NCT00853047|475003374|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
131923420|NCT00853047|475003369|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
131923421|NCT00853047|475003370|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
131923422|NCT00853047|475003371|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
131923423|NCT00853047|475003372|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
131923424|NCT00853047|475003373|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
131923425|NCT00853047|475003374|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
131923426|NCT00853047|475003369|FG000|Open-Label Extension Phase|Investigator Decision|0|||
131923427|NCT00853047|475003370|FG001|Open-Label Extension Phase|Investigator Decision|0|||
131923428|NCT00853047|475003371|FG002|Open-Label Extension Phase|Investigator Decision|0|||
131923429|NCT00853047|475003372|FG003|Open-Label Extension Phase|Investigator Decision|0|||
131923430|NCT00853047|475003373|FG004|Open-Label Extension Phase|Investigator Decision|0|||
131923431|NCT00853047|475003374|FG005|Open-Label Extension Phase|Investigator Decision|1|||
131923432|NCT00853047|475003369|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
131923433|NCT00853047|475003370|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
131923434|NCT00853047|475003371|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
131923435|NCT00853047|475003372|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
131923436|NCT00853047|475003373|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
131923437|NCT00853047|475003374|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
131923438|NCT02638493|475003375|FG000|Overall Study|Inability to provide semen samples|2|||
131923439|NCT02638493|475003376|FG001|Overall Study|Inability to provide semen samples|0|||
131923440|NCT02638493|475003377|FG002|Overall Study|Inability to provide semen samples|0|||
131923441|NCT01033071|475003378|FG000|Overall Study|Adverse Event|28|||
131923442|NCT01033071|475003379|FG001|Overall Study|Adverse Event|51|||
131923443|NCT01033071|475003380|FG002|Overall Study|Adverse Event|26|||
131923444|NCT01033071|475003378|FG000|Overall Study|Protocol Violation|0|||
131923445|NCT01033071|475003379|FG001|Overall Study|Protocol Violation|2|||
131923446|NCT01033071|475003380|FG002|Overall Study|Protocol Violation|1|||
131923447|NCT01033071|475003378|FG000|Overall Study|Lost to Follow-up|4|||
131923448|NCT01033071|475003379|FG001|Overall Study|Lost to Follow-up|5|||
131923449|NCT01033071|475003380|FG002|Overall Study|Lost to Follow-up|5|||
131923450|NCT01033071|475003378|FG000|Overall Study|Withdrawal by Subject|17|||
131923451|NCT01033071|475003379|FG001|Overall Study|Withdrawal by Subject|14|||
131923452|NCT01033071|475003380|FG002|Overall Study|Withdrawal by Subject|11|||
131923453|NCT01033071|475003378|FG000|Overall Study|Lack of Efficacy|0|||
131923454|NCT01033071|475003379|FG001|Overall Study|Lack of Efficacy|1|||
131923455|NCT01033071|475003380|FG002|Overall Study|Lack of Efficacy|1|||
131923456|NCT01033071|475003378|FG000|Overall Study|Other|6|||
131923457|NCT01033071|475003379|FG001|Overall Study|Other|4|||
131923458|NCT01033071|475003380|FG002|Overall Study|Other|3|||
131923459|NCT01695772|475003382|FG000|Overall Study|Withdrawal by Subject|18|||
131923460|NCT01695772|475003382|FG000|Overall Study|Progressive Disease|8|||
131923461|NCT01695772|475003382|FG000|Overall Study|Investigator Decision|5|||
131923462|NCT01695772|475003382|FG000|Overall Study|Lost to Follow-up|4|||
131923463|NCT01695772|475003382|FG000|Overall Study|Protocol Violation|2|||
131923464|NCT01695772|475003382|FG000|Overall Study|Unspecified Reason|1|||
131923465|NCT04073407|475003390|FG000|Part 1|Withdrawal by Subject|1|||
131923466|NCT04073407|475003391|FG001|Part 1|Withdrawal by Subject|0|||
131923467|NCT04073407|475003390|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
131923468|NCT04073407|475003391|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
131923469|NCT04073407|475003390|FG000|Part 2|Withdrawal by Subject|0|||
131923470|NCT04073407|475003391|FG001|Part 2|Withdrawal by Subject|1|||
131923471|NCT04941898|475005027|FG000|Overall Study|Protocol Violation|1|||
131923472|NCT02724644|475005028|FG000|Overall Study|Adverse Event|7|||
131923473|NCT02724644|475005029|FG001|Overall Study|Adverse Event|1|||
131409044|NCT00089986|473120754|FG000|Overall Study|Do not resuscitate (DNR)|0|||
131409045|NCT00089986|473120755|FG001|Overall Study|Do not resuscitate (DNR)|0|||
131409046|NCT00089986|473120756|FG002|Overall Study|Do not resuscitate (DNR)|1|||
131409047|NCT00089986|473120754|FG000|Overall Study|Withdrawal by Subject|3|||
131409048|NCT00089986|473120755|FG001|Overall Study|Withdrawal by Subject|6|||
131409049|NCT00089986|473120756|FG002|Overall Study|Withdrawal by Subject|2|||
131409050|NCT02334683|473120764|FG000|First 12 Week Period|Lost to Follow-up|1|||
131409051|NCT02334683|473120765|FG001|First 12 Week Period|Lost to Follow-up|0|||
131409052|NCT02334683|473120764|FG000|Second 12 Week Period|Adverse Event|0|||
131409053|NCT02334683|473120765|FG001|Second 12 Week Period|Adverse Event|1|||
131409054|NCT01062841|473120766|FG000|Overall Study|Indwelling Device Removed|41|||
131409055|NCT01062841|473120767|FG001|Overall Study|Indwelling Device Removed|48|||
131409056|NCT01062841|473120766|FG000|Overall Study|Death|3|||
131409057|NCT01062841|473120767|FG001|Overall Study|Death|5|||
131409058|NCT01062841|473120766|FG000|Overall Study|Withdrawal by Subject|2|||
131409059|NCT01062841|473120767|FG001|Overall Study|Withdrawal by Subject|0|||
131409060|NCT01062841|473120766|FG000|Overall Study|Withdrawal by Study|3|||
131409061|NCT01062841|473120767|FG001|Overall Study|Withdrawal by Study|0|||
131409062|NCT01218100|473120768|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
131409063|NCT01218100|473120769|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
131409064|NCT01218100|473120770|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
131409065|NCT01218100|473120771|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
131409066|NCT01218100|473120768|FG000|Overall Study|Adverse Event|4|||
131409067|NCT01218100|473120769|FG001|Overall Study|Adverse Event|6|||
131409068|NCT01218100|473120770|FG002|Overall Study|Adverse Event|6|||
131409069|NCT01218100|473120771|FG003|Overall Study|Adverse Event|7|||
131409070|NCT01218100|473120768|FG000|Overall Study|Lack of Efficacy|9|||
131409071|NCT01218100|473120769|FG001|Overall Study|Lack of Efficacy|6|||
131409072|NCT01218100|473120770|FG002|Overall Study|Lack of Efficacy|5|||
131409073|NCT01218100|473120771|FG003|Overall Study|Lack of Efficacy|12|||
131409074|NCT01218100|473120768|FG000|Overall Study|Protocol Violation|0|||
131409075|NCT01218100|473120769|FG001|Overall Study|Protocol Violation|0|||
131409076|NCT01218100|473120770|FG002|Overall Study|Protocol Violation|1|||
131409077|NCT01218100|473120771|FG003|Overall Study|Protocol Violation|1|||
131409078|NCT01218100|473120768|FG000|Overall Study|Withdrawal by Subject|5|||
131409079|NCT01218100|473120769|FG001|Overall Study|Withdrawal by Subject|2|||
131409080|NCT01218100|473120770|FG002|Overall Study|Withdrawal by Subject|6|||
131409081|NCT01218100|473120771|FG003|Overall Study|Withdrawal by Subject|7|||
131409082|NCT01218100|473120768|FG000|Overall Study|Lost to Follow-up|3|||
131409083|NCT01218100|473120769|FG001|Overall Study|Lost to Follow-up|8|||
131409084|NCT01218100|473120770|FG002|Overall Study|Lost to Follow-up|2|||
131409085|NCT01218100|473120771|FG003|Overall Study|Lost to Follow-up|1|||
131409086|NCT01218100|473120768|FG000|Overall Study|Other Reason|2|||
131453972|NCT02023697|473291844|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
131877642|NCT01992653|474831477|FG003|Overall Study|Study Completed|0|||
131877643|NCT01992653|474831478|FG004|Overall Study|Study Completed|0|||
131877644|NCT01992653|474831479|FG005|Overall Study|Study Completed|0|||
131877645|NCT01992653|474831480|FG006|Overall Study|Study Completed|0|||
131877646|NCT01992653|474831481|FG007|Overall Study|Study Completed|1|||
131877647|NCT01992653|474831474|FG000|Overall Study|Disease Progression|0|||
131877648|NCT01992653|474831475|FG001|Overall Study|Disease Progression|0|||
131877649|NCT01992653|474831476|FG002|Overall Study|Disease Progression|0|||
131877650|NCT01992653|474831477|FG003|Overall Study|Disease Progression|0|||
131877651|NCT01992653|474831478|FG004|Overall Study|Disease Progression|0|||
131877652|NCT01992653|474831479|FG005|Overall Study|Disease Progression|0|||
131877653|NCT01992653|474831480|FG006|Overall Study|Disease Progression|4|||
131877654|NCT01992653|474831481|FG007|Overall Study|Disease Progression|0|||
131877655|NCT03617770|474831486|FG000|Overall Study|Lost to Follow-up|1|||
131877656|NCT03617770|474831487|FG001|Overall Study|Lost to Follow-up|0|||
131409087|NCT01218100|473120769|FG001|Overall Study|Other Reason|2|||
131409088|NCT01218100|473120770|FG002|Overall Study|Other Reason|6|||
131409089|NCT01218100|473120771|FG003|Overall Study|Other Reason|4|||
131409090|NCT01118520|473120774|FG000|Overall Study|AAA repair|9|||
131409091|NCT01118520|473120775|FG001|Overall Study|AAA repair|7|||
131409092|NCT01118520|473120776|FG002|Overall Study|AAA repair|9|||
131409093|NCT01118520|473120774|FG000|Overall Study|Adverse Event|3|||
131409094|NCT01118520|473120775|FG001|Overall Study|Adverse Event|3|||
131409095|NCT01118520|473120776|FG002|Overall Study|Adverse Event|3|||
131409096|NCT01118520|473120774|FG000|Overall Study|Withdrawal by Subject|8|||
131409097|NCT01118520|473120775|FG001|Overall Study|Withdrawal by Subject|13|||
131409098|NCT01118520|473120776|FG002|Overall Study|Withdrawal by Subject|8|||
131409099|NCT01089023|473120782|FG000|Overall Study|Lost to Follow-up|3|||
131877657|NCT03963232|474831488|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131877658|NCT03963232|474831489|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
131409100|NCT01089023|473120782|FG000|Overall Study|Adverse Event|1|||
131409101|NCT01089023|473120782|FG000|Overall Study|Withdrawal by Subject|1|||
131409102|NCT01089023|473120782|FG000|Overall Study|Protocol Violation|1|||
131409103|NCT01089023|473120782|FG000|Overall Study|Lack of Efficacy|1|||
131409104|NCT02434354|473120785|FG000|Overall Study|screen fail|3|||
131923474|NCT02724644|475005028|FG000|Overall Study|Lost to Follow-up|6|||
131923475|NCT02724644|475005029|FG001|Overall Study|Lost to Follow-up|2|||
131923476|NCT02724644|475005028|FG000|Overall Study|Withdrawal by Subject|7|||
131923477|NCT02724644|475005029|FG001|Overall Study|Withdrawal by Subject|1|||
131923478|NCT02724644|475005028|FG000|Overall Study|Administrative|1|||
131923479|NCT02724644|475005029|FG001|Overall Study|Administrative|0|||
131923480|NCT01567085|475005032|FG000|Overall Study|Death|6|||
131923481|NCT01567085|475005032|FG000|Overall Study|Adverse Event|6|||
131923482|NCT01567085|475005032|FG000|Overall Study|Lost to Follow-up|3|||
131923483|NCT01567085|475005032|FG000|Overall Study|Graft loss|2|||
131923484|NCT01567085|475005032|FG000|Overall Study|Renal transplantectomy|1|||
131923485|NCT01567085|475005032|FG000|Overall Study|Returned to chronic dialysis|1|||
131923486|NCT01567085|475005032|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
131923487|NCT03928704|475005038|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
131923488|NCT03928704|475005039|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
131923489|NCT03928704|475005040|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
131923490|NCT03928704|475005041|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
131923491|NCT03928704|475005042|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
131923492|NCT03928704|475005043|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
131923493|NCT03928704|475005038|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
131923494|NCT03928704|475005039|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
131923495|NCT03928704|475005040|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
131923496|NCT03928704|475005041|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
131923497|NCT03928704|475005042|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
131923498|NCT03928704|475005043|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
131923499|NCT03928704|475005038|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
131923500|NCT03928704|475005039|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
131923501|NCT03928704|475005040|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
131923502|NCT03928704|475005041|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
131923503|NCT03928704|475005042|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
131923504|NCT03928704|475005043|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
131923505|NCT03928704|475005038|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
131923506|NCT03928704|475005039|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
131923507|NCT03928704|475005040|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
131923508|NCT03928704|475005041|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
131923509|NCT03928704|475005042|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
131923510|NCT03928704|475005043|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
131923511|NCT03928704|475005038|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
131409105|NCT00919867|473120786|FG000|First Intervention|Withdrawal by Subject|0|||
131409106|NCT00919867|473120787|FG001|First Intervention|Withdrawal by Subject|0|||
131409107|NCT00919867|473120788|FG002|First Intervention|Withdrawal by Subject|1|||
131409108|NCT00919867|473120789|FG003|First Intervention|Withdrawal by Subject|0|||
131409109|NCT00919867|473120790|FG004|First Intervention|Withdrawal by Subject|0|||
131409110|NCT00919867|473120791|FG005|First Intervention|Withdrawal by Subject|0|||
131409111|NCT00919867|473120786|FG000|First Intervention|Physician Decision|0|||
131409112|NCT00919867|473120787|FG001|First Intervention|Physician Decision|0|||
131409113|NCT00919867|473120788|FG002|First Intervention|Physician Decision|0|||
131409114|NCT00919867|473120789|FG003|First Intervention|Physician Decision|0|||
131409115|NCT00919867|473120790|FG004|First Intervention|Physician Decision|0|||
131409116|NCT00919867|473120791|FG005|First Intervention|Physician Decision|1|||
131409117|NCT02446418|473120792|FG000|Overall Study|Adverse Event|4|||
131409118|NCT02446418|473120793|FG001|Overall Study|Adverse Event|8|||
131409119|NCT02446418|473120792|FG000|Overall Study|Physician Decision|5|||
131409120|NCT02446418|473120793|FG001|Overall Study|Physician Decision|1|||
131409121|NCT02446418|473120792|FG000|Overall Study|Withdrawal by Subject|3|||
131923512|NCT03928704|475005039|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
131923513|NCT03928704|475005040|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
131923514|NCT03928704|475005041|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
131409122|NCT02446418|473120793|FG001|Overall Study|Withdrawal by Subject|3|||
131923515|NCT03928704|475005042|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
131923516|NCT03928704|475005043|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
131923517|NCT03928704|475005038|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
131409123|NCT02446418|473120792|FG000|Overall Study|Lost to Follow-up|2|||
131409124|NCT02446418|473120793|FG001|Overall Study|Lost to Follow-up|2|||
131409125|NCT02446418|473120792|FG000|Overall Study|Protocol Violation|1|||
131409126|NCT02446418|473120793|FG001|Overall Study|Protocol Violation|2|||
131409127|NCT02446418|473120792|FG000|Overall Study|Lack of Efficacy|2|||
131409128|NCT02446418|473120793|FG001|Overall Study|Lack of Efficacy|0|||
131409129|NCT02446418|473120792|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
131923518|NCT03928704|475005039|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
131923519|NCT03928704|475005040|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
131923520|NCT03928704|475005041|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
131923521|NCT03928704|475005042|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
131923522|NCT03928704|475005043|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
131923523|NCT03928704|475005038|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
131923524|NCT03928704|475005039|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
131923525|NCT03928704|475005040|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
131923526|NCT03928704|475005041|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
131923527|NCT03928704|475005042|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
131923528|NCT03928704|475005043|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
131923529|NCT03928704|475005038|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
131923530|NCT03928704|475005039|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
131923531|NCT03928704|475005040|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
131923532|NCT03928704|475005041|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
131923533|NCT03928704|475005042|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
131923534|NCT03928704|475005043|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
131923535|NCT03928704|475005038|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
131923536|NCT03928704|475005039|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
131923537|NCT03928704|475005040|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
131923538|NCT03928704|475005041|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
131923539|NCT03928704|475005042|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
131923540|NCT03928704|475005043|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
131923541|NCT03928704|475005038|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
131923542|NCT03928704|475005039|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
131923543|NCT03928704|475005040|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
131923544|NCT03928704|475005041|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
131923545|NCT03928704|475005042|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
131923546|NCT03928704|475005043|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
131923547|NCT03954938|475005044|FG000|Overall Study|Withdrawal by Subject|2|||
131923548|NCT03954938|475005044|FG000|Overall Study|Adverse Event|1|||
131923549|NCT00899847|475005046|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
131923550|NCT03338023|475005047|FG000|Overall Study|Withdrawal by Subject|3|||
131923551|NCT03338023|475005048|FG001|Overall Study|Withdrawal by Subject|4|||
131923552|NCT03338023|475005047|FG000|Overall Study|Protocol Violation|3|||
131923553|NCT03338023|475005048|FG001|Overall Study|Protocol Violation|3|||
131923554|NCT03338023|475005047|FG000|Overall Study|Lost to Follow-up|2|||
131923555|NCT03338023|475005048|FG001|Overall Study|Lost to Follow-up|1|||
131923556|NCT03338023|475005047|FG000|Overall Study|Physician Decision|1|||
131923557|NCT03338023|475005048|FG001|Overall Study|Physician Decision|2|||
131923558|NCT00685698|475005049|FG000|Overall Study|Withdrawal by Subject|1|||
131409130|NCT02446418|473120793|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
131409131|NCT02014480|473120794|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
131409132|NCT02014480|473120795|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
131409133|NCT02014480|473120796|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
131409134|NCT02014480|473120797|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
131409135|NCT02014480|473120798|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
131409136|NCT02014480|473120799|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
131409137|NCT02014480|473120794|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131409138|NCT02014480|473120795|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131409139|NCT02014480|473120796|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131409140|NCT02014480|473120797|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
131409141|NCT02014480|473120798|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131409142|NCT02014480|473120799|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131409143|NCT02014480|473120794|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131409144|NCT02014480|473120795|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131409145|NCT02014480|473120796|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
131409146|NCT02014480|473120797|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131409147|NCT02014480|473120798|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131409148|NCT02014480|473120799|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
131409149|NCT02014480|473120794|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
131409150|NCT02014480|473120795|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
131923559|NCT00685698|475005049|FG000|Overall Study|Protocol Violation|6|||
131923560|NCT00685698|475005049|FG000|Overall Study|Adverse Event|3|||
131409151|NCT02014480|473120796|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
131409152|NCT02014480|473120797|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
131409153|NCT02014480|473120798|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131409154|NCT02014480|473120799|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131409155|NCT02014480|473120794|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131409156|NCT02014480|473120795|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
131409157|NCT02014480|473120796|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131923561|NCT00685698|475005049|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
131923562|NCT00685698|475005049|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
131923563|NCT00685698|475005049|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
131923564|NCT00724893|475005051|FG000|Overall Study|Adverse Event|76|||
131923565|NCT00724893|475005052|FG001|Overall Study|Adverse Event|142|||
131923566|NCT00724893|475005051|FG000|Overall Study|Withdrawal by Subject|0|||
131923567|NCT00724893|475005052|FG001|Overall Study|Withdrawal by Subject|1|||
131923568|NCT00724893|475005051|FG000|Overall Study|Lack of virologic response|94|||
131923569|NCT00724893|475005052|FG001|Overall Study|Lack of virologic response|202|||
131923570|NCT00724893|475005051|FG000|Overall Study|Reason not specified|193|||
131923571|NCT00724893|475005052|FG001|Overall Study|Reason not specified|7|||
131923572|NCT00724893|475005051|FG000|Overall Study|Patient choice|0|||
131923573|NCT00724893|475005052|FG001|Overall Study|Patient choice|26|||
131923574|NCT00724893|475005051|FG000|Overall Study|Geographic reasons|0|||
131923575|NCT00724893|475005052|FG001|Overall Study|Geographic reasons|11|||
131923576|NCT00724893|475005051|FG000|Overall Study|Incarceration|0|||
131923577|NCT00724893|475005052|FG001|Overall Study|Incarceration|9|||
131923578|NCT00724893|475005051|FG000|Overall Study|Substance abuse|0|||
131923579|NCT00724893|475005052|FG001|Overall Study|Substance abuse|3|||
131923580|NCT00724893|475005051|FG000|Overall Study|Financial reasons|0|||
131923581|NCT00724893|475005052|FG001|Overall Study|Financial reasons|2|||
131923582|NCT00724893|475005051|FG000|Overall Study|Assigned shorter treatment|0|||
131923583|NCT00724893|475005052|FG001|Overall Study|Assigned shorter treatment|2|||
131923584|NCT00724893|475005051|FG000|Overall Study|Lost to Follow-up|0|||
131923585|NCT00724893|475005052|FG001|Overall Study|Lost to Follow-up|52|||
131923586|NCT00724893|475005051|FG000|Overall Study|Unknown, missing data|1|||
131923587|NCT00724893|475005052|FG001|Overall Study|Unknown, missing data|1|||
131923588|NCT00888849|475005057|FG000|Overall Study|Death|4|||
131923589|NCT00888849|475005058|FG001|Overall Study|Death|7|||
131923590|NCT00888849|475005057|FG000|Overall Study|Lost to Follow-up|1|||
131923591|NCT00888849|475005058|FG001|Overall Study|Lost to Follow-up|2|||
131923592|NCT00896233|475005063|FG000|Overall Study|Claustrophobia during MRI|1|||
131923593|NCT04280562|475005064|FG000|Study|Adverse Event|2|||
131923594|NCT04280562|475005065|FG001|Study|Adverse Event|0|||
131923595|NCT04280562|475005064|FG000|Study|Lost to Follow-up|3|||
131923596|NCT04280562|475005065|FG001|Study|Lost to Follow-up|3|||
131923597|NCT05507450|475005069|FG000|Overall Study|Death|0|||
131923598|NCT05507450|475005070|FG001|Overall Study|Death|0|||
131923599|NCT05507450|475005071|FG002|Overall Study|Death|1|||
131923600|NCT05507450|475005072|FG003|Overall Study|Death|0|||
131923601|NCT05507450|475005069|FG000|Overall Study|Lost to Follow-up|22|||
131923602|NCT05507450|475005070|FG001|Overall Study|Lost to Follow-up|20|||
131923603|NCT05507450|475005071|FG002|Overall Study|Lost to Follow-up|20|||
131923604|NCT05507450|475005072|FG003|Overall Study|Lost to Follow-up|7|||
131923605|NCT05507450|475005069|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131923606|NCT05507450|475005070|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
131923607|NCT05507450|475005071|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131923608|NCT05507450|475005072|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131923609|NCT05507450|475005069|FG000|Overall Study|Withdrawal by Subject|4|||
131923610|NCT05507450|475005070|FG001|Overall Study|Withdrawal by Subject|11|||
131923611|NCT05507450|475005071|FG002|Overall Study|Withdrawal by Subject|7|||
131923612|NCT05507450|475005072|FG003|Overall Study|Withdrawal by Subject|3|||
131923613|NCT05507450|475005069|FG000|Overall Study|Participant left the country|0|||
131923614|NCT05507450|475005070|FG001|Overall Study|Participant left the country|0|||
131923615|NCT05507450|475005071|FG002|Overall Study|Participant left the country|1|||
131923616|NCT05507450|475005072|FG003|Overall Study|Participant left the country|0|||
131923617|NCT00514917|475005076|FG000|Overall Study|Death|4|||
131923618|NCT00514917|475005077|FG001|Overall Study|Death|10|||
131923619|NCT00514917|475005076|FG000|Overall Study|Protocol Violation|1|||
131923620|NCT00514917|475005077|FG001|Overall Study|Protocol Violation|0|||
131923621|NCT00514917|475005076|FG000|Overall Study|Lost to Follow-up|4|||
131923622|NCT00514917|475005077|FG001|Overall Study|Lost to Follow-up|3|||
131923623|NCT00514917|475005076|FG000|Overall Study|Withdrawal by Subject|18|||
131923624|NCT00514917|475005077|FG001|Overall Study|Withdrawal by Subject|16|||
131923625|NCT00514917|475005076|FG000|Overall Study|Discontinued due to study closure|88|||
131923626|NCT00514917|475005077|FG001|Overall Study|Discontinued due to study closure|81|||
131923627|NCT00514917|475005076|FG000|Overall Study|Undefined|11|||
131923628|NCT00514917|475005077|FG001|Overall Study|Undefined|5|||
131923629|NCT02697422|475005078|FG000|Overall Study|Declined exit survey|9|||
131923630|NCT02697422|475005079|FG001|Overall Study|Declined exit survey|2|||
131923631|NCT02697422|475005078|FG000|Overall Study|Lost to Follow-up|13|||
131923632|NCT02697422|475005079|FG001|Overall Study|Lost to Follow-up|8|||
131923633|NCT02697422|475005078|FG000|Overall Study|Death|2|||
131923634|NCT02697422|475005079|FG001|Overall Study|Death|1|||
131923635|NCT02697422|475005078|FG000|Overall Study|Withdrawal by Subject|0|||
131923636|NCT02697422|475005079|FG001|Overall Study|Withdrawal by Subject|1|||
131923637|NCT02697422|475005078|FG000|Overall Study|Physician Decision|1|||
131923638|NCT02697422|475005079|FG001|Overall Study|Physician Decision|1|||
131877659|NCT03963232|474831488|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
131877660|NCT03963232|474831489|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
131877661|NCT03963232|474831488|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
131877662|NCT03963232|474831489|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
131877663|NCT03963232|474831488|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
131877664|NCT03963232|474831489|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131877665|NCT03963232|474831488|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
131877666|NCT03963232|474831489|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
131877667|NCT03963232|474831488|FG000|Open-Label Treatment Phase|Adverse Event|1|||
131877668|NCT03963232|474831489|FG001|Open-Label Treatment Phase|Adverse Event|2|||
131877669|NCT03963232|474831488|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
131877670|NCT03963232|474831489|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
131877671|NCT03963232|474831488|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
131877672|NCT03963232|474831489|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
131877673|NCT03963232|474831488|FG000|Open-Label Treatment Phase|Pregnancy|1|||
131877674|NCT03963232|474831489|FG001|Open-Label Treatment Phase|Pregnancy|0|||
131877675|NCT03963232|474831488|FG000|Follow-up Phase|Withdrawal by Subject|7|||
131877676|NCT03963232|474831489|FG001|Follow-up Phase|Withdrawal by Subject|5|||
131877677|NCT03963232|474831488|FG000|Follow-up Phase|Protocol Violation|0|||
131877678|NCT03963232|474831489|FG001|Follow-up Phase|Protocol Violation|2|||
131877679|NCT03963232|474831488|FG000|Follow-up Phase|Adverse Event|0|||
131877680|NCT03963232|474831489|FG001|Follow-up Phase|Adverse Event|1|||
131877681|NCT03963232|474831488|FG000|Follow-up Phase|Lost to Follow-up|0|||
131877682|NCT03963232|474831489|FG001|Follow-up Phase|Lost to Follow-up|1|||
131877683|NCT00356135|474831490|FG000|Overall Study|Protocol Violation|1|||
131877684|NCT00356135|474831491|FG001|Overall Study|Protocol Violation|0|||
131877685|NCT00356135|474831492|FG002|Overall Study|Protocol Violation|0|||
131877686|NCT00356135|474831490|FG000|Overall Study|Adverse Event|1|||
131877687|NCT00356135|474831491|FG001|Overall Study|Adverse Event|0|||
131877688|NCT00356135|474831492|FG002|Overall Study|Adverse Event|0|||
131877689|NCT00356135|474831490|FG000|Overall Study|Lost to Follow-up|0|||
131877690|NCT00356135|474831491|FG001|Overall Study|Lost to Follow-up|0|||
131877691|NCT00356135|474831492|FG002|Overall Study|Lost to Follow-up|1|||
131877692|NCT00356135|474831490|FG000|Overall Study|Physician Decision|1|||
131877693|NCT00356135|474831491|FG001|Overall Study|Physician Decision|1|||
131877694|NCT00356135|474831492|FG002|Overall Study|Physician Decision|1|||
131877695|NCT00356135|474831490|FG000|Overall Study|Subject non-compliance|1|||
131877696|NCT00356135|474831491|FG001|Overall Study|Subject non-compliance|1|||
131877697|NCT00356135|474831492|FG002|Overall Study|Subject non-compliance|3|||
131877698|NCT03512210|474831493|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
131877699|NCT03512210|474831493|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
131877700|NCT03512210|474831493|FG000|Step 2:Post-MINMON|Death|2|||
131877701|NCT03512210|474831493|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
131877702|NCT03512210|474831493|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
131877703|NCT02122887|474831494|FG000|Overall Study|Withdrawal by Subject|20|||
131877704|NCT02122887|474831495|FG001|Overall Study|Withdrawal by Subject|2|||
131877705|NCT03725761|474831500|FG000|Overall Study|still on study|1|||
131877706|NCT03937908|474833222|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
131877707|NCT03937908|474833223|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
131877708|NCT03875092|474833224|FG000|Overall Study|Adverse Event|2|||
131877709|NCT03875092|474833225|FG001|Overall Study|Adverse Event|5|||
131877710|NCT03875092|474833224|FG000|Overall Study|Death|44|||
131877711|NCT03875092|474833225|FG001|Overall Study|Death|51|||
131877712|NCT03875092|474833224|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
131877713|NCT03875092|474833225|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
131877714|NCT03558152|474833226|FG000|Overall Study|Adverse Event|0|||
131877715|NCT03558152|474833227|FG001|Overall Study|Adverse Event|0|||
131877716|NCT03558152|474833228|FG002|Overall Study|Adverse Event|1|||
131877717|NCT03558152|474833229|FG003|Overall Study|Adverse Event|1|||
131877718|NCT03558152|474833230|FG004|Overall Study|Adverse Event|2|||
131877719|NCT03558152|474833231|FG005|Overall Study|Adverse Event|1|||
131877720|NCT03558152|474833232|FG006|Overall Study|Adverse Event|1|||
131877721|NCT03558152|474833233|FG007|Overall Study|Adverse Event|0|||
131877722|NCT03558152|474833226|FG000|Overall Study|Death|0|||
131877723|NCT03558152|474833227|FG001|Overall Study|Death|0|||
131877724|NCT03558152|474833228|FG002|Overall Study|Death|0|||
131877725|NCT03558152|474833229|FG003|Overall Study|Death|0|||
131877726|NCT03558152|474833230|FG004|Overall Study|Death|1|||
131877727|NCT03558152|474833231|FG005|Overall Study|Death|0|||
131877728|NCT03558152|474833232|FG006|Overall Study|Death|0|||
131877729|NCT03558152|474833233|FG007|Overall Study|Death|0|||
131877730|NCT03558152|474833226|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
131877731|NCT03558152|474833227|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131877732|NCT03558152|474833228|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131877733|NCT03558152|474833229|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131877734|NCT03558152|474833230|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131923639|NCT02697422|475005078|FG000|Overall Study|Exit survey data lost|1|||
131923640|NCT02697422|475005079|FG001|Overall Study|Exit survey data lost|0|||
131923641|NCT01873833|475005083|FG000|Overall Study|Withdrawal by Subject|1|||
131923642|NCT03983109|475005086|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
131923643|NCT03983109|475005087|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
131923644|NCT04149353|475005093|FG000|Overall Study|Study terminated|1|||
131923645|NCT02068599|475005094|FG000|Overall Study|Adverse Event|4|||
131923646|NCT02068599|475005095|FG001|Overall Study|Adverse Event|1|||
131923647|NCT02068599|475005096|FG002|Overall Study|Adverse Event|1|||
131923648|NCT02068599|475005094|FG000|Overall Study|Withdrawal by Subject|2|||
131923649|NCT02068599|475005095|FG001|Overall Study|Withdrawal by Subject|7|||
131923650|NCT02068599|475005096|FG002|Overall Study|Withdrawal by Subject|5|||
131923651|NCT02068599|475005094|FG000|Overall Study|Protocol Violation|4|||
131923652|NCT02068599|475005095|FG001|Overall Study|Protocol Violation|2|||
131923653|NCT02068599|475005096|FG002|Overall Study|Protocol Violation|3|||
131923654|NCT02068599|475005094|FG000|Overall Study|Lost to Follow-up|1|||
131923655|NCT02068599|475005095|FG001|Overall Study|Lost to Follow-up|0|||
131923656|NCT02068599|475005096|FG002|Overall Study|Lost to Follow-up|0|||
131923657|NCT02068599|475005094|FG000|Overall Study|Lack of Efficacy|0|||
131923658|NCT02068599|475005095|FG001|Overall Study|Lack of Efficacy|0|||
131923659|NCT02068599|475005096|FG002|Overall Study|Lack of Efficacy|3|||
131923660|NCT02068599|475005094|FG000|Overall Study|Noncompliance|0|||
131923661|NCT02068599|475005095|FG001|Overall Study|Noncompliance|0|||
131923662|NCT02068599|475005096|FG002|Overall Study|Noncompliance|1|||
131923663|NCT01871727|475005099|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
131923664|NCT01871727|475005100|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
131923665|NCT01871727|475005101|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
131923666|NCT01871727|475005102|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
131923667|NCT01871727|475005103|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
131923668|NCT01871727|475005099|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
131923669|NCT01871727|475005100|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
131923670|NCT01871727|475005101|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
131923671|NCT01871727|475005102|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
131923672|NCT01871727|475005103|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
131923673|NCT01871727|475005099|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
131923674|NCT01871727|475005100|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
131923675|NCT01871727|475005101|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
131923676|NCT01871727|475005102|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
131923677|NCT01871727|475005103|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
131923678|NCT01871727|475005099|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
131923679|NCT01871727|475005100|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
131923680|NCT01871727|475005101|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
131923681|NCT01871727|475005102|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
131923682|NCT01871727|475005103|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
131923683|NCT01871727|475005099|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
131923684|NCT01871727|475005100|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
131409158|NCT02014480|473120797|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131409159|NCT02014480|473120798|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131409160|NCT02014480|473120799|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
131409161|NCT02014480|473120794|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
131409162|NCT02014480|473120795|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
131409163|NCT02014480|473120796|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
131409164|NCT02014480|473120797|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
131409165|NCT02014480|473120798|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
131409166|NCT02014480|473120799|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
131409167|NCT02014480|473120794|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131409168|NCT02014480|473120795|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131409169|NCT02014480|473120796|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131409170|NCT02014480|473120797|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131409171|NCT02014480|473120798|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131409172|NCT02014480|473120799|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
131923685|NCT01871727|475005101|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
131923686|NCT01871727|475005102|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
131923687|NCT01871727|475005103|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
131409173|NCT03421743|473120807|FG000|Overall Study|Lack of Efficacy|1|||
131923688|NCT01871727|475005099|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
131923689|NCT01871727|475005100|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
131409174|NCT03421743|473120808|FG001|Overall Study|Lack of Efficacy|0|||
131409175|NCT03421743|473120807|FG000|Overall Study|Adverse Event|2|||
131923690|NCT01871727|475005101|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
131923691|NCT01871727|475005102|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
131923692|NCT01871727|475005103|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
131923693|NCT01871727|475005099|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
131923694|NCT01871727|475005100|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
131923695|NCT01871727|475005101|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
131923696|NCT01871727|475005102|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
131923697|NCT01871727|475005103|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
131923698|NCT01263028|475005104|FG000|Overall Study|Withdrawal by Subject|1|||
131923699|NCT01263028|475005104|FG000|Overall Study|Adverse Event|1|||
131923700|NCT01263028|475005104|FG000|Overall Study|Study terminated due to low enrollment.|4|||
131453973|NCT02023697|473291845|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
131453974|NCT02023697|473291846|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
131453975|NCT02023697|473291844|FG000|Active Follow-up Period|Lost to Follow-up|1|||
131453976|NCT02023697|473291845|FG001|Active Follow-up Period|Lost to Follow-up|1|||
131453977|NCT02023697|473291846|FG002|Active Follow-up Period|Lost to Follow-up|1|||
131453978|NCT02023697|473291844|FG000|Active Follow-up Period|Deterioration of general condition|1|||
131453979|NCT02023697|473291845|FG001|Active Follow-up Period|Deterioration of general condition|1|||
131453980|NCT02023697|473291846|FG002|Active Follow-up Period|Deterioration of general condition|1|||
131453981|NCT02023697|473291844|FG000|Active Follow-up Period|Other unspecified|2|||
131453982|NCT02023697|473291845|FG001|Active Follow-up Period|Other unspecified|0|||
131453983|NCT02023697|473291846|FG002|Active Follow-up Period|Other unspecified|1|||
131453984|NCT02023697|473291844|FG000|Active Follow-up Period|Clinical progression|0|||
131453985|NCT02023697|473291845|FG001|Active Follow-up Period|Clinical progression|2|||
131453986|NCT02023697|473291846|FG002|Active Follow-up Period|Clinical progression|1|||
131453987|NCT02023697|473291844|FG000|Active Follow-up Period|Radiological progression|0|||
131453988|NCT02023697|473291845|FG001|Active Follow-up Period|Radiological progression|0|||
131453989|NCT02023697|473291846|FG002|Active Follow-up Period|Radiological progression|1|||
131453990|NCT02023697|473291844|FG000|Active Follow-up Period|Death|83|||
131453991|NCT02023697|473291845|FG001|Active Follow-up Period|Death|82|||
131453992|NCT02023697|473291846|FG002|Active Follow-up Period|Death|87|||
131453993|NCT02023697|473291844|FG000|Long-term Follow-up Period|Death|9|||
131453994|NCT02023697|473291845|FG001|Long-term Follow-up Period|Death|6|||
131453995|NCT02023697|473291846|FG002|Long-term Follow-up Period|Death|4|||
131453996|NCT02023697|473291844|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
131453997|NCT02023697|473291845|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
131453998|NCT02023697|473291846|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
131453999|NCT02023697|473291844|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
131454000|NCT02023697|473291845|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
131454001|NCT02023697|473291846|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
131454002|NCT02023697|473291844|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
131877735|NCT03558152|474833231|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131877736|NCT03558152|474833232|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131877737|NCT03558152|474833233|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
131877738|NCT03558152|474833226|FG000|Overall Study|Miscalculation in mmcs|0|||
131877739|NCT03558152|474833227|FG001|Overall Study|Miscalculation in mmcs|0|||
131877740|NCT03558152|474833228|FG002|Overall Study|Miscalculation in mmcs|0|||
131877741|NCT03558152|474833229|FG003|Overall Study|Miscalculation in mmcs|0|||
131877742|NCT03558152|474833230|FG004|Overall Study|Miscalculation in mmcs|0|||
131877743|NCT03558152|474833231|FG005|Overall Study|Miscalculation in mmcs|0|||
131877744|NCT03558152|474833232|FG006|Overall Study|Miscalculation in mmcs|1|||
131877745|NCT03558152|474833233|FG007|Overall Study|Miscalculation in mmcs|0|||
131877746|NCT03558152|474833226|FG000|Overall Study|Mistake in calculation|0|||
131877747|NCT03558152|474833227|FG001|Overall Study|Mistake in calculation|0|||
131877748|NCT03558152|474833228|FG002|Overall Study|Mistake in calculation|0|||
131877749|NCT03558152|474833229|FG003|Overall Study|Mistake in calculation|1|||
131877750|NCT03558152|474833230|FG004|Overall Study|Mistake in calculation|0|||
131877751|NCT03558152|474833231|FG005|Overall Study|Mistake in calculation|0|||
131877752|NCT03558152|474833232|FG006|Overall Study|Mistake in calculation|0|||
131877753|NCT03558152|474833233|FG007|Overall Study|Mistake in calculation|0|||
131877754|NCT03558152|474833226|FG000|Overall Study|Mistake in evaluation of disease status|0|||
131877755|NCT03558152|474833227|FG001|Overall Study|Mistake in evaluation of disease status|0|||
131877756|NCT03558152|474833228|FG002|Overall Study|Mistake in evaluation of disease status|0|||
131877757|NCT03558152|474833229|FG003|Overall Study|Mistake in evaluation of disease status|0|||
131877758|NCT03558152|474833230|FG004|Overall Study|Mistake in evaluation of disease status|0|||
131877759|NCT03558152|474833231|FG005|Overall Study|Mistake in evaluation of disease status|0|||
131454003|NCT02023697|473291845|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
131877760|NCT03558152|474833232|FG006|Overall Study|Mistake in evaluation of disease status|0|||
131877761|NCT03558152|474833233|FG007|Overall Study|Mistake in evaluation of disease status|1|||
131923701|NCT00309244|475005105|FG000|Overall Study|Adverse Event|29|||
131877762|NCT03558152|474833226|FG000|Overall Study|Physician Decision|0|||
131877763|NCT03558152|474833227|FG001|Overall Study|Physician Decision|0|||
131877764|NCT03558152|474833228|FG002|Overall Study|Physician Decision|0|||
131409176|NCT03421743|473120808|FG001|Overall Study|Adverse Event|1|||
131409177|NCT03421743|473120807|FG000|Overall Study|Withdrawal by Subject|0|||
131409178|NCT03421743|473120808|FG001|Overall Study|Withdrawal by Subject|1|||
131409179|NCT01765426|473120811|FG000|Overall Study|Lost to Follow-up|0|||
131409180|NCT01765426|473120812|FG001|Overall Study|Lost to Follow-up|1|||
131409181|NCT01765426|473120813|FG002|Overall Study|Lost to Follow-up|0|||
131409182|NCT01765426|473120814|FG003|Overall Study|Lost to Follow-up|0|||
131409183|NCT01819129|473120815|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
131409184|NCT01819129|473120816|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
131409185|NCT01819129|473120815|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
131409186|NCT01819129|473120816|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
131409187|NCT01819129|473120815|FG000|Overall Study|Other, Subject moved out of the country|0|||
131409188|NCT01819129|473120816|FG001|Overall Study|Other, Subject moved out of the country|1|||
131409189|NCT01819129|473120815|FG000|Overall Study|Withdrawal by Subject|15|||
131409190|NCT01819129|473120816|FG001|Overall Study|Withdrawal by Subject|15|||
131409191|NCT01819129|473120815|FG000|Overall Study|Lost to Follow-up|5|||
131409192|NCT01819129|473120816|FG001|Overall Study|Lost to Follow-up|2|||
131409193|NCT01819129|473120815|FG000|Overall Study|Lack of Efficacy|0|||
131409194|NCT01819129|473120816|FG001|Overall Study|Lack of Efficacy|1|||
131409195|NCT01819129|473120815|FG000|Overall Study|Adverse Event|1|||
131877765|NCT03558152|474833229|FG003|Overall Study|Physician Decision|0|||
131877766|NCT03558152|474833230|FG004|Overall Study|Physician Decision|0|||
131877767|NCT03558152|474833231|FG005|Overall Study|Physician Decision|0|||
131877768|NCT03558152|474833232|FG006|Overall Study|Physician Decision|1|||
131877769|NCT03558152|474833233|FG007|Overall Study|Physician Decision|0|||
131877770|NCT03558152|474833226|FG000|Overall Study|Withdrawal by Subject|2|||
131877771|NCT03558152|474833227|FG001|Overall Study|Withdrawal by Subject|3|||
131877772|NCT03558152|474833228|FG002|Overall Study|Withdrawal by Subject|2|||
131877773|NCT03558152|474833229|FG003|Overall Study|Withdrawal by Subject|1|||
131877774|NCT03558152|474833230|FG004|Overall Study|Withdrawal by Subject|1|||
131877775|NCT03558152|474833231|FG005|Overall Study|Withdrawal by Subject|1|||
131877776|NCT03558152|474833232|FG006|Overall Study|Withdrawal by Subject|3|||
131877777|NCT03558152|474833233|FG007|Overall Study|Withdrawal by Subject|2|||
131877778|NCT03558152|474833226|FG000|Overall Study|Lack of Efficacy|11|||
131877779|NCT03558152|474833227|FG001|Overall Study|Lack of Efficacy|11|||
131877780|NCT03558152|474833228|FG002|Overall Study|Lack of Efficacy|10|||
131877781|NCT03558152|474833229|FG003|Overall Study|Lack of Efficacy|11|||
131877782|NCT03558152|474833230|FG004|Overall Study|Lack of Efficacy|14|||
131877783|NCT03558152|474833231|FG005|Overall Study|Lack of Efficacy|12|||
131877784|NCT03558152|474833232|FG006|Overall Study|Lack of Efficacy|14|||
131877785|NCT03558152|474833233|FG007|Overall Study|Lack of Efficacy|13|||
131877786|NCT03558152|474833226|FG000|Overall Study|Protocol Violation|1|||
131877787|NCT03558152|474833227|FG001|Overall Study|Protocol Violation|1|||
131877788|NCT03558152|474833228|FG002|Overall Study|Protocol Violation|0|||
131877789|NCT03558152|474833229|FG003|Overall Study|Protocol Violation|1|||
131877790|NCT03558152|474833230|FG004|Overall Study|Protocol Violation|1|||
131877791|NCT03558152|474833231|FG005|Overall Study|Protocol Violation|0|||
131877792|NCT03558152|474833232|FG006|Overall Study|Protocol Violation|2|||
131877793|NCT03558152|474833233|FG007|Overall Study|Protocol Violation|0|||
131877794|NCT03693612|474833234|FG000|Overall Study|Lost to Follow-up|0|||
131877795|NCT03693612|474833235|FG001|Overall Study|Lost to Follow-up|0|||
131877796|NCT03693612|474833236|FG002|Overall Study|Lost to Follow-up|0|||
131877797|NCT03693612|474833237|FG003|Overall Study|Lost to Follow-up|0|||
131877798|NCT03693612|474833238|FG004|Overall Study|Lost to Follow-up|1|||
131877799|NCT03693612|474833239|FG005|Overall Study|Lost to Follow-up|0|||
131877800|NCT03693612|474833240|FG006|Overall Study|Lost to Follow-up|0|||
131877801|NCT03693612|474833234|FG000|Overall Study|Withdrawal by Subject|0|||
131877802|NCT03693612|474833235|FG001|Overall Study|Withdrawal by Subject|0|||
131877803|NCT03693612|474833236|FG002|Overall Study|Withdrawal by Subject|1|||
131877804|NCT03693612|474833237|FG003|Overall Study|Withdrawal by Subject|0|||
131877805|NCT03693612|474833238|FG004|Overall Study|Withdrawal by Subject|2|||
131877806|NCT03693612|474833239|FG005|Overall Study|Withdrawal by Subject|0|||
131877807|NCT03693612|474833240|FG006|Overall Study|Withdrawal by Subject|0|||
131877808|NCT03693612|474833234|FG000|Overall Study|Study Terminated by Sponsor|0|||
131877809|NCT03693612|474833235|FG001|Overall Study|Study Terminated by Sponsor|1|||
131877810|NCT03693612|474833236|FG002|Overall Study|Study Terminated by Sponsor|0|||
131877811|NCT03693612|474833237|FG003|Overall Study|Study Terminated by Sponsor|0|||
131877812|NCT03693612|474833238|FG004|Overall Study|Study Terminated by Sponsor|3|||
131877813|NCT03693612|474833239|FG005|Overall Study|Study Terminated by Sponsor|0|||
131877814|NCT03693612|474833240|FG006|Overall Study|Study Terminated by Sponsor|0|||
131877815|NCT05318092|474833241|FG000|Overall Study|Lost to Follow-up|3|||
131877816|NCT05318092|474833241|FG000|Overall Study|Withdrawal by Subject|1|||
131877817|NCT01669174|474833245|FG000|Overall Study|Subject withdrew consent|2|||
131877818|NCT01669174|474833246|FG001|Overall Study|Subject withdrew consent|2|||
131877819|NCT01669174|474833245|FG000|Overall Study|Lost to Follow-up|1|||
131409196|NCT01819129|473120816|FG001|Overall Study|Adverse Event|4|||
131409197|NCT01819129|473120815|FG000|Overall Study|Death|1|||
131877820|NCT01669174|474833246|FG001|Overall Study|Lost to Follow-up|0|||
131877821|NCT01669174|474833245|FG000|Overall Study|Adverse Event|2|||
131877822|NCT01669174|474833246|FG001|Overall Study|Adverse Event|2|||
131877823|NCT01669174|474833245|FG000|Overall Study|Administrative problems|1|||
131877824|NCT01669174|474833246|FG001|Overall Study|Administrative problems|2|||
131877825|NCT01154296|474833249|FG000|Randomization and Intervention|Decided to decline|1|||
131877826|NCT01154296|474833250|FG001|Randomization and Intervention|Decided to decline|1|||
131877827|NCT01154296|474833249|FG000|Randomization and Intervention|Declined by staff|1|||
131877828|NCT01154296|474833250|FG001|Randomization and Intervention|Declined by staff|0|||
131877829|NCT01154296|474833249|FG000|Randomization and Intervention|Did not return|1|||
131877830|NCT01154296|474833250|FG001|Randomization and Intervention|Did not return|0|||
131877831|NCT01154296|474833249|FG000|Randomization and Intervention|Left before test|0|||
131877832|NCT01154296|474833250|FG001|Randomization and Intervention|Left before test|1|||
131877833|NCT01154296|474833249|FG000|Randomization and Intervention|Left clinic early|2|||
131877834|NCT01154296|474833250|FG001|Randomization and Intervention|Left clinic early|0|||
131877835|NCT01154296|474833249|FG000|6-month Follow-up|Lost contact|269|||
131877836|NCT01154296|474833250|FG001|6-month Follow-up|Lost contact|275|||
131877837|NCT01154296|474833249|FG000|6-month Follow-up|Incarcerated|37|||
131877838|NCT01154296|474833250|FG001|6-month Follow-up|Incarcerated|32|||
131877839|NCT01154296|474833249|FG000|6-month Follow-up|Withdrew consent|14|||
131877840|NCT01154296|474833250|FG001|6-month Follow-up|Withdrew consent|15|||
131877841|NCT01154296|474833249|FG000|6-month Follow-up|Death|3|||
131877842|NCT01154296|474833250|FG001|6-month Follow-up|Death|2|||
131877843|NCT01154296|474833249|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
131877844|NCT01154296|474833250|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
131877845|NCT04310397|474833251|FG000|Overall Study|Lack of Efficacy|3|||
131877846|NCT04310397|474833251|FG000|Overall Study|Withdrawal by Subject|1|||
131877847|NCT02759055|474833252|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
131877848|NCT02759055|474833253|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
131877849|NCT01300338|474833259|FG000|Overall Study|Lost to Follow-up|5|||
131877850|NCT01300338|474833260|FG001|Overall Study|Lost to Follow-up|0|||
131877851|NCT02461524|474833261|FG000|Overall Study|Death|16|||
131877852|NCT02461524|474833261|FG000|Overall Study|Withdrawal by Subject|4|||
131877853|NCT02461524|474833261|FG000|Overall Study|Device Explanted|5|||
131877854|NCT02461524|474833261|FG000|Overall Study|Missed Visit|6|||
131877855|NCT01936181|474833264|FG000|Randomised, Double-blind|Adverse Event|27|||
131877856|NCT01936181|474833265|FG001|Randomised, Double-blind|Adverse Event|21|||
131877857|NCT01936181|474833266|FG002|Randomised, Double-blind|Adverse Event|0|||
131877858|NCT01936181|474833267|FG003|Randomised, Double-blind|Adverse Event|0|||
131877859|NCT01936181|474833264|FG000|Randomised, Double-blind|Protocol Violation|1|||
131877860|NCT01936181|474833265|FG001|Randomised, Double-blind|Protocol Violation|5|||
131877861|NCT01936181|474833266|FG002|Randomised, Double-blind|Protocol Violation|0|||
131877862|NCT01936181|474833267|FG003|Randomised, Double-blind|Protocol Violation|0|||
131877863|NCT01936181|474833264|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
131877864|NCT01936181|474833265|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
131877865|NCT01936181|474833266|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
131877866|NCT01936181|474833267|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
131877867|NCT01936181|474833264|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
131877868|NCT01936181|474833265|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
131877869|NCT01936181|474833266|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
131877870|NCT01936181|474833267|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
131877871|NCT01936181|474833264|FG000|Randomised, Double-blind|Pregnancy|0|||
131877872|NCT01936181|474833265|FG001|Randomised, Double-blind|Pregnancy|1|||
131877873|NCT01936181|474833266|FG002|Randomised, Double-blind|Pregnancy|0|||
131877874|NCT01936181|474833267|FG003|Randomised, Double-blind|Pregnancy|0|||
131877875|NCT01936181|474833264|FG000|Randomised, Double-blind|Physician Decision|4|||
131877876|NCT01936181|474833265|FG001|Randomised, Double-blind|Physician Decision|4|||
131877877|NCT01936181|474833266|FG002|Randomised, Double-blind|Physician Decision|0|||
131877878|NCT01936181|474833267|FG003|Randomised, Double-blind|Physician Decision|0|||
131877879|NCT01936181|474833264|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
131877880|NCT01936181|474833265|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
131877881|NCT01936181|474833266|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
131877882|NCT01936181|474833267|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
131877883|NCT01936181|474833264|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
131877884|NCT01936181|474833265|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
131877885|NCT01936181|474833266|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
131877886|NCT01936181|474833267|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
131877887|NCT01936181|474833264|FG000|Transition-extension|Adverse Event|3|||
131877888|NCT01936181|474833265|FG001|Transition-extension|Adverse Event|0|||
131877889|NCT01936181|474833266|FG002|Transition-extension|Adverse Event|3|||
131877890|NCT01936181|474833267|FG003|Transition-extension|Adverse Event|1|||
131877891|NCT01936181|474833264|FG000|Transition-extension|Lost to Follow-up|3|||
131923702|NCT00309244|475005106|FG001|Overall Study|Adverse Event|12|||
131877892|NCT01936181|474833265|FG001|Transition-extension|Lost to Follow-up|0|||
131877893|NCT01936181|474833266|FG002|Transition-extension|Lost to Follow-up|1|||
131877894|NCT01936181|474833267|FG003|Transition-extension|Lost to Follow-up|2|||
131877895|NCT01936181|474833264|FG000|Transition-extension|Physician Decision|2|||
131877896|NCT01936181|474833265|FG001|Transition-extension|Physician Decision|0|||
131877897|NCT01936181|474833266|FG002|Transition-extension|Physician Decision|0|||
131877898|NCT01936181|474833267|FG003|Transition-extension|Physician Decision|1|||
131877899|NCT01936181|474833264|FG000|Transition-extension|Withdrawal by Subject|7|||
131877900|NCT01936181|474833265|FG001|Transition-extension|Withdrawal by Subject|0|||
131877901|NCT01936181|474833266|FG002|Transition-extension|Withdrawal by Subject|2|||
131877902|NCT01936181|474833267|FG003|Transition-extension|Withdrawal by Subject|1|||
131877903|NCT00970632|474833268|FG000|Overall Study|Adverse Event|2|||
131877904|NCT00970632|474833269|FG001|Overall Study|Adverse Event|2|||
131877905|NCT00970632|474833270|FG002|Overall Study|Adverse Event|1|||
131877906|NCT00970632|474833268|FG000|Overall Study|Lack of Efficacy|3|||
131877907|NCT00970632|474833269|FG001|Overall Study|Lack of Efficacy|0|||
131877908|NCT00970632|474833270|FG002|Overall Study|Lack of Efficacy|0|||
131877909|NCT00970632|474833268|FG000|Overall Study|Lost to Follow-up|3|||
131877910|NCT00970632|474833269|FG001|Overall Study|Lost to Follow-up|0|||
131877911|NCT00970632|474833270|FG002|Overall Study|Lost to Follow-up|2|||
131877912|NCT00970632|474833268|FG000|Overall Study|Protocol Violation|8|||
131877913|NCT00970632|474833269|FG001|Overall Study|Protocol Violation|5|||
131877914|NCT00970632|474833270|FG002|Overall Study|Protocol Violation|8|||
131877915|NCT00970632|474833268|FG000|Overall Study|Withdrawal by Subject|7|||
131877916|NCT00970632|474833269|FG001|Overall Study|Withdrawal by Subject|6|||
131877917|NCT00970632|474833270|FG002|Overall Study|Withdrawal by Subject|4|||
131877918|NCT00970632|474833268|FG000|Overall Study|Entry criteria not met|0|||
131877919|NCT00970632|474833269|FG001|Overall Study|Entry criteria not met|2|||
131877920|NCT00970632|474833270|FG002|Overall Study|Entry criteria not met|2|||
131877921|NCT00970632|474833268|FG000|Overall Study|Sponsor decision|1|||
131877922|NCT00970632|474833269|FG001|Overall Study|Sponsor decision|0|||
131877923|NCT00970632|474833270|FG002|Overall Study|Sponsor decision|1|||
131877924|NCT02002533|474833277|FG000|Overall Study|Withdrawal by Subject|6|||
131877925|NCT02002533|474833278|FG001|Overall Study|Withdrawal by Subject|13|||
131877926|NCT02002533|474833277|FG000|Overall Study|Protocol Violation|0|||
131877927|NCT02002533|474833278|FG001|Overall Study|Protocol Violation|1|||
131877928|NCT02002533|474833277|FG000|Overall Study|Adverse Event|0|||
131877929|NCT02002533|474833278|FG001|Overall Study|Adverse Event|3|||
131877930|NCT02002533|474833277|FG000|Overall Study|Lost to Follow-up|0|||
131877931|NCT02002533|474833278|FG001|Overall Study|Lost to Follow-up|1|||
131877932|NCT04984278|474833291|FG000|Period 1|Withdrawal by Subject|1|||
131877933|NCT04984278|474833292|FG001|Period 1|Withdrawal by Subject|0|||
131877934|NCT04984278|474833291|FG000|Period 1|Other|0|||
131877935|NCT04984278|474833292|FG001|Period 1|Other|1|||
131877936|NCT04984278|474833291|FG000|Period 2|Adverse Event|1|||
131877937|NCT04984278|474833292|FG001|Period 2|Adverse Event|0|||
131877938|NCT04984278|474833291|FG000|Period 2|Other|0|||
131877939|NCT04984278|474833292|FG001|Period 2|Other|1|||
131877940|NCT00890084|474833297|FG000|Overall Study|Adverse Event|16|||
131877941|NCT00890084|474833297|FG000|Overall Study|Lost to Follow-up|126|||
131877942|NCT02691936|474833303|FG000|Overall Study|Withdrawal by Subject|2|||
131877943|NCT02691936|474833304|FG001|Overall Study|Withdrawal by Subject|5|||
131877944|NCT01878084|474833305|FG000|Overall Study|Physician Decision|2|||
131877945|NCT03155178|474833308|FG000|Overall Study|Did not meet treatment day baseline|7|||
131877946|NCT03155178|474833309|FG001|Overall Study|Did not meet treatment day baseline|7|||
131877947|NCT03155178|474833310|FG002|Overall Study|Did not meet treatment day baseline|7|||
131877948|NCT03155178|474833311|FG003|Overall Study|Did not meet treatment day baseline|7|||
131877949|NCT03089697|474833312|FG000|Overall Study|Adverse Event|1|||
131877950|NCT03089697|474833313|FG001|Overall Study|Adverse Event|2|||
131877951|NCT03089697|474833312|FG000|Overall Study|Withdrawal by Subject|1|||
131877952|NCT03089697|474833313|FG001|Overall Study|Withdrawal by Subject|0|||
131877953|NCT04323306|474833314|FG000|Overall Study|Physician Decision|1|||
131877954|NCT04323306|474833315|FG001|Overall Study|Physician Decision|0|||
131877955|NCT04323306|474833316|FG002|Overall Study|Physician Decision|0|||
131877956|NCT04323306|474833317|FG003|Overall Study|Physician Decision|0|||
131877957|NCT04323306|474833318|FG004|Overall Study|Physician Decision|0|||
131877958|NCT04323306|474833319|FG005|Overall Study|Physician Decision|0|||
131877959|NCT04323306|474833320|FG006|Overall Study|Physician Decision|0|||
131877960|NCT04323306|474833321|FG007|Overall Study|Physician Decision|0|||
131877961|NCT04323306|474833322|FG008|Overall Study|Physician Decision|0|||
131877962|NCT04323306|474833314|FG000|Overall Study|Withdrawal by Subject|0|||
131877963|NCT04323306|474833315|FG001|Overall Study|Withdrawal by Subject|0|||
131877964|NCT04323306|474833316|FG002|Overall Study|Withdrawal by Subject|0|||
131877965|NCT04323306|474833317|FG003|Overall Study|Withdrawal by Subject|0|||
131877966|NCT04323306|474833318|FG004|Overall Study|Withdrawal by Subject|0|||
131877967|NCT04323306|474833319|FG005|Overall Study|Withdrawal by Subject|1|||
131409198|NCT01819129|473120816|FG001|Overall Study|Death|1|||
131877968|NCT04323306|474833320|FG006|Overall Study|Withdrawal by Subject|3|||
131877969|NCT04323306|474833321|FG007|Overall Study|Withdrawal by Subject|0|||
131877970|NCT04323306|474833322|FG008|Overall Study|Withdrawal by Subject|1|||
131877971|NCT00834639|474833323|FG000|Second Intervention|Physician Decision|0|||
131877972|NCT00834639|474833324|FG001|Second Intervention|Physician Decision|2|||
131877973|NCT05129137|474833325|FG000|Second Period|Adverse Event|1|||
131877974|NCT05129137|474833326|FG001|Second Period|Adverse Event|0|||
131877975|NCT05129137|474833327|FG002|Second Period|Adverse Event|0|||
131877976|NCT05129137|474833328|FG003|Second Period|Adverse Event|0|||
131877977|NCT05129137|474833325|FG000|Second Period|Protocol Violation|0|||
131877978|NCT05129137|474833326|FG001|Second Period|Protocol Violation|0|||
131877979|NCT05129137|474833327|FG002|Second Period|Protocol Violation|0|||
131877980|NCT05129137|474833328|FG003|Second Period|Protocol Violation|1|||
131877981|NCT05129137|474833325|FG000|Third Period|Protocol Violation|0|||
131877982|NCT05129137|474833326|FG001|Third Period|Protocol Violation|0|||
131877983|NCT05129137|474833327|FG002|Third Period|Protocol Violation|0|||
131877984|NCT05129137|474833328|FG003|Third Period|Protocol Violation|1|||
131877985|NCT05129137|474833325|FG000|Forth Period|Protocol Violation|0|||
131877986|NCT05129137|474833326|FG001|Forth Period|Protocol Violation|1|||
131877987|NCT05129137|474833327|FG002|Forth Period|Protocol Violation|0|||
131877988|NCT05129137|474833328|FG003|Forth Period|Protocol Violation|0|||
131877989|NCT05129137|474833325|FG000|Forth Period|Withdrawal by Subject|0|||
131877990|NCT05129137|474833326|FG001|Forth Period|Withdrawal by Subject|0|||
131877991|NCT05129137|474833327|FG002|Forth Period|Withdrawal by Subject|1|||
131877992|NCT05129137|474833328|FG003|Forth Period|Withdrawal by Subject|0|||
131877993|NCT03382834|474833340|FG000|Step 1|Lost to Follow-up|0|||
131877994|NCT03382834|474833341|FG001|Step 1|Lost to Follow-up|1|||
131877995|NCT03382834|474833340|FG000|Step 2|Death|1|||
131923703|NCT00309244|475005105|FG000|Overall Study|Lost to Follow-up|6|||
131923704|NCT00309244|475005106|FG001|Overall Study|Lost to Follow-up|22|||
131923705|NCT00309244|475005105|FG000|Overall Study|Physician Decision|5|||
131409199|NCT01819129|473120815|FG000|Overall Study|Withdrawal Criteria|20|||
131409200|NCT01819129|473120816|FG001|Overall Study|Withdrawal Criteria|15|||
131409201|NCT01166373|473120817|FG000|Overall Study|Lost to Follow-up|3|||
131409202|NCT01166373|473120818|FG001|Overall Study|Lost to Follow-up|2|||
131409203|NCT01166373|473120819|FG002|Overall Study|Lost to Follow-up|2|||
131409204|NCT01166373|473120820|FG003|Overall Study|Lost to Follow-up|2|||
131409205|NCT01166373|473120817|FG000|Overall Study|Withdrawal by Subject|1|||
131409206|NCT01166373|473120818|FG001|Overall Study|Withdrawal by Subject|2|||
131409207|NCT01166373|473120819|FG002|Overall Study|Withdrawal by Subject|2|||
131409208|NCT01166373|473120820|FG003|Overall Study|Withdrawal by Subject|3|||
131409209|NCT01166373|473120817|FG000|Overall Study|Physician Decision|1|||
131409210|NCT01166373|473120818|FG001|Overall Study|Physician Decision|0|||
131409211|NCT01166373|473120819|FG002|Overall Study|Physician Decision|0|||
131409212|NCT01166373|473120820|FG003|Overall Study|Physician Decision|0|||
131409213|NCT01510184|473120821|FG000|Overall Study|Sponsor discretion|28|||
131409214|NCT01510184|473120822|FG001|Overall Study|Sponsor discretion|28|||
131409215|NCT01510184|473120821|FG000|Overall Study|Death|1|||
131409216|NCT01510184|473120822|FG001|Overall Study|Death|2|||
131409217|NCT01510184|473120821|FG000|Overall Study|Withdrawal by Subject|1|||
131409218|NCT01510184|473120822|FG001|Overall Study|Withdrawal by Subject|4|||
131409219|NCT01510184|473120821|FG000|Overall Study|Other|0|||
131409220|NCT01510184|473120822|FG001|Overall Study|Other|1|||
131409221|NCT02836873|473120830|FG000|Overall Study|Protocol Violation|0|||
131409222|NCT02836873|473120831|FG001|Overall Study|Protocol Violation|1|||
131409223|NCT02836873|473120830|FG000|Overall Study|Adverse Event|1|||
131409224|NCT02836873|473120831|FG001|Overall Study|Adverse Event|4|||
131409225|NCT02836873|473120830|FG000|Overall Study|Withdrawal by Subject|2|||
131409226|NCT02836873|473120831|FG001|Overall Study|Withdrawal by Subject|2|||
131409227|NCT02836873|473120830|FG000|Overall Study|Lost to Follow-up|1|||
131409228|NCT02836873|473120831|FG001|Overall Study|Lost to Follow-up|3|||
131409229|NCT02836873|473120830|FG000|Overall Study|Physician Decision|0|||
131409230|NCT02836873|473120831|FG001|Overall Study|Physician Decision|1|||
131409231|NCT02836873|473120830|FG000|Overall Study|Other|1|||
131409232|NCT02836873|473120831|FG001|Overall Study|Other|0|||
131409233|NCT00694096|473120832|FG000|Overall Study|Withdrawal by Subject|5|||
131409234|NCT02914548|473120835|FG000|Overall Study|Adverse Event|15|||
131877996|NCT03382834|474833341|FG001|Step 2|Death|0|||
131877997|NCT03382834|474833340|FG000|Step 2|Lost to Follow-up|2|||
131877998|NCT03382834|474833341|FG001|Step 2|Lost to Follow-up|2|||
131877999|NCT03382834|474833340|FG000|Step 2|Site Terminated by Sponsor|1|||
131878000|NCT03382834|474833341|FG001|Step 2|Site Terminated by Sponsor|0|||
131878001|NCT02387957|474833342|FG000|Overall Study|The study was discontinued|21|||
131923706|NCT00309244|475005106|FG001|Overall Study|Physician Decision|8|||
131409235|NCT02914548|473120836|FG001|Overall Study|Adverse Event|7|||
131409236|NCT02914548|473120837|FG002|Overall Study|Adverse Event|15|||
131409237|NCT02914548|473120835|FG000|Overall Study|Physician Decision|2|||
131409238|NCT02914548|473120836|FG001|Overall Study|Physician Decision|2|||
131409239|NCT02914548|473120837|FG002|Overall Study|Physician Decision|0|||
131409240|NCT02914548|473120835|FG000|Overall Study|Protocol Violation|1|||
131878002|NCT02387957|474833343|FG001|Overall Study|The study was discontinued|21|||
131878003|NCT02387957|474833344|FG002|Overall Study|The study was discontinued|20|||
131923707|NCT00309244|475005105|FG000|Overall Study|Protocol Violation|6|||
131409241|NCT02914548|473120836|FG001|Overall Study|Protocol Violation|0|||
131409242|NCT02914548|473120837|FG002|Overall Study|Protocol Violation|0|||
131409243|NCT02914548|473120835|FG000|Overall Study|Withdrawal by Subject|3|||
131409244|NCT02914548|473120836|FG001|Overall Study|Withdrawal by Subject|4|||
131409245|NCT02914548|473120837|FG002|Overall Study|Withdrawal by Subject|4|||
131409246|NCT02914548|473120835|FG000|Overall Study|>40% of body surface area|0|||
131409247|NCT02914548|473120836|FG001|Overall Study|>40% of body surface area|1|||
131409248|NCT02914548|473120837|FG002|Overall Study|>40% of body surface area|1|||
131454004|NCT02023697|473291846|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
131878004|NCT03613649|474833345|FG000|Second Treatment|Lost to Follow-up|0|||
131878005|NCT03613649|474833346|FG001|Second Treatment|Lost to Follow-up|0|||
131878006|NCT03613649|474833347|FG002|Second Treatment|Lost to Follow-up|1|||
131878007|NCT03613649|474833348|FG003|Second Treatment|Lost to Follow-up|0|||
131878008|NCT03613649|474833349|FG004|Second Treatment|Lost to Follow-up|0|||
131878009|NCT03613649|474833350|FG005|Second Treatment|Lost to Follow-up|0|||
131878010|NCT03613649|474833351|FG006|Second Treatment|Lost to Follow-up|0|||
131878011|NCT03613649|474833352|FG007|Second Treatment|Lost to Follow-up|0|||
131878012|NCT03613649|474833353|FG008|Second Treatment|Lost to Follow-up|0|||
131878013|NCT03613649|474833354|FG009|Second Treatment|Lost to Follow-up|0|||
131878014|NCT03613649|474833355|FG010|Second Treatment|Lost to Follow-up|0|||
131878015|NCT03613649|474833356|FG011|Second Treatment|Lost to Follow-up|0|||
131878016|NCT03613649|474833345|FG000|Second Treatment|Withdrawal by Subject|0|||
131878017|NCT03613649|474833346|FG001|Second Treatment|Withdrawal by Subject|0|||
131878018|NCT03613649|474833347|FG002|Second Treatment|Withdrawal by Subject|0|||
131878019|NCT03613649|474833348|FG003|Second Treatment|Withdrawal by Subject|0|||
131878020|NCT03613649|474833349|FG004|Second Treatment|Withdrawal by Subject|1|||
131878021|NCT03613649|474833350|FG005|Second Treatment|Withdrawal by Subject|0|||
131878022|NCT03613649|474833351|FG006|Second Treatment|Withdrawal by Subject|0|||
131878023|NCT03613649|474833352|FG007|Second Treatment|Withdrawal by Subject|0|||
131878024|NCT03613649|474833353|FG008|Second Treatment|Withdrawal by Subject|0|||
131878025|NCT03613649|474833354|FG009|Second Treatment|Withdrawal by Subject|0|||
131878026|NCT03613649|474833355|FG010|Second Treatment|Withdrawal by Subject|0|||
131878027|NCT03613649|474833356|FG011|Second Treatment|Withdrawal by Subject|0|||
131878028|NCT03613649|474833345|FG000|Third Treatment|Lost to Follow-up|0|||
131878029|NCT03613649|474833346|FG001|Third Treatment|Lost to Follow-up|0|||
131878030|NCT03613649|474833347|FG002|Third Treatment|Lost to Follow-up|0|||
131878031|NCT03613649|474833348|FG003|Third Treatment|Lost to Follow-up|0|||
131878032|NCT03613649|474833349|FG004|Third Treatment|Lost to Follow-up|1|||
131878033|NCT03613649|474833350|FG005|Third Treatment|Lost to Follow-up|0|||
131878034|NCT03613649|474833351|FG006|Third Treatment|Lost to Follow-up|0|||
131878035|NCT03613649|474833352|FG007|Third Treatment|Lost to Follow-up|0|||
131878036|NCT03613649|474833353|FG008|Third Treatment|Lost to Follow-up|0|||
131878037|NCT03613649|474833354|FG009|Third Treatment|Lost to Follow-up|0|||
131878038|NCT03613649|474833355|FG010|Third Treatment|Lost to Follow-up|0|||
131878039|NCT03613649|474833356|FG011|Third Treatment|Lost to Follow-up|1|||
131878040|NCT03613649|474833345|FG000|Third Treatment|Protocol Violation|0|||
131878041|NCT03613649|474833346|FG001|Third Treatment|Protocol Violation|0|||
131878042|NCT03613649|474833347|FG002|Third Treatment|Protocol Violation|0|||
131878043|NCT03613649|474833348|FG003|Third Treatment|Protocol Violation|0|||
131878044|NCT03613649|474833349|FG004|Third Treatment|Protocol Violation|0|||
131878045|NCT03613649|474833350|FG005|Third Treatment|Protocol Violation|0|||
131878046|NCT03613649|474833351|FG006|Third Treatment|Protocol Violation|1|||
131878047|NCT03613649|474833352|FG007|Third Treatment|Protocol Violation|0|||
131878048|NCT03613649|474833353|FG008|Third Treatment|Protocol Violation|0|||
131878049|NCT03613649|474833354|FG009|Third Treatment|Protocol Violation|0|||
131878050|NCT03613649|474833355|FG010|Third Treatment|Protocol Violation|0|||
131878051|NCT03613649|474833356|FG011|Third Treatment|Protocol Violation|1|||
131878052|NCT03613649|474833345|FG000|Fourth Treatment|Protocol Violation|1|||
131878053|NCT03613649|474833346|FG001|Fourth Treatment|Protocol Violation|0|||
131878054|NCT03613649|474833347|FG002|Fourth Treatment|Protocol Violation|0|||
131878055|NCT03613649|474833348|FG003|Fourth Treatment|Protocol Violation|0|||
131878056|NCT03613649|474833349|FG004|Fourth Treatment|Protocol Violation|1|||
131878057|NCT03613649|474833350|FG005|Fourth Treatment|Protocol Violation|0|||
131878058|NCT03613649|474833351|FG006|Fourth Treatment|Protocol Violation|0|||
131878059|NCT03613649|474833352|FG007|Fourth Treatment|Protocol Violation|0|||
131878060|NCT03613649|474833353|FG008|Fourth Treatment|Protocol Violation|0|||
131878061|NCT03613649|474833354|FG009|Fourth Treatment|Protocol Violation|0|||
131878062|NCT03613649|474833355|FG010|Fourth Treatment|Protocol Violation|0|||
131454005|NCT02023697|473291844|FG000|Long-term Follow-up Period|Technical problems|0|||
131878063|NCT03613649|474833356|FG011|Fourth Treatment|Protocol Violation|0|||
131878064|NCT03613649|474833345|FG000|Fourth Treatment|Physician Decision|0|||
131878065|NCT03613649|474833346|FG001|Fourth Treatment|Physician Decision|0|||
131878066|NCT03613649|474833347|FG002|Fourth Treatment|Physician Decision|0|||
131878067|NCT03613649|474833348|FG003|Fourth Treatment|Physician Decision|0|||
131409249|NCT00747344|473120838|FG000|Controlled Period|Adverse Event|3|||
131409250|NCT00747344|473120839|FG001|Controlled Period|Adverse Event|0|||
131923708|NCT00309244|475005106|FG001|Overall Study|Protocol Violation|3|||
131923709|NCT00309244|475005105|FG000|Overall Study|Withdrawal by Subject|50|||
131923710|NCT00309244|475005106|FG001|Overall Study|Withdrawal by Subject|32|||
131923711|NCT00309244|475005105|FG000|Overall Study|Various|7|||
131923712|NCT00309244|475005106|FG001|Overall Study|Various|7|||
131923713|NCT00309244|475005105|FG000|Overall Study|Randomized but not dosed|11|||
131923714|NCT00309244|475005106|FG001|Overall Study|Randomized but not dosed|12|||
131923715|NCT00309244|475005105|FG000|Overall Study|Death|4|||
131923716|NCT00309244|475005106|FG001|Overall Study|Death|1|||
131923717|NCT03019588|475005107|FG000|Overall Study|Death|44|||
131923718|NCT03019588|475005108|FG001|Overall Study|Death|46|||
131923719|NCT03019588|475005107|FG000|Overall Study|Study terminated by Sponsor|3|||
131923720|NCT03019588|475005108|FG001|Overall Study|Study terminated by Sponsor|1|||
131923721|NCT00887588|475005109|FG000|Core Period|Death|1|||
131923722|NCT00887588|475005110|FG001|Core Period|Death|1|||
131923723|NCT00887588|475005109|FG000|Core Period|Lost to Follow-up|3|||
131923724|NCT00887588|475005110|FG001|Core Period|Lost to Follow-up|1|||
131923725|NCT00887588|475005109|FG000|Core Period|Withdrawal by Subject|6|||
131923726|NCT00887588|475005110|FG001|Core Period|Withdrawal by Subject|8|||
131923727|NCT00887588|475005109|FG000|Core Period|Adverse Event|9|||
131923728|NCT00887588|475005110|FG001|Core Period|Adverse Event|11|||
131923729|NCT00887588|475005109|FG000|Extension Period|Adverse Event|4|||
131923730|NCT00887588|475005110|FG001|Extension Period|Adverse Event|4|||
131923731|NCT00887588|475005109|FG000|Extension Period|Death|0|||
131923732|NCT00887588|475005110|FG001|Extension Period|Death|1|||
131923733|NCT00887588|475005109|FG000|Extension Period|Protocol deviation|1|||
131923734|NCT00887588|475005110|FG001|Extension Period|Protocol deviation|0|||
131923735|NCT00887588|475005109|FG000|Extension Period|Lost to Follow-up|1|||
131923736|NCT00887588|475005110|FG001|Extension Period|Lost to Follow-up|0|||
131923737|NCT00366535|475005111|FG000|First Phase: 12 Weeks|Adverse Event|1|||
131923738|NCT00366535|475005112|FG001|First Phase: 12 Weeks|Adverse Event|3|||
131923739|NCT00366535|475005111|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
131923740|NCT00366535|475005112|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
131923741|NCT00366535|475005111|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
131923742|NCT00366535|475005112|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
131923743|NCT00366535|475005111|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
131923744|NCT00366535|475005112|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
131923745|NCT02958527|475005117|FG000|Overall Study|Not collected CRFs|12|||
131923746|NCT03753542|475005118|FG000|Overall Study|Lost to Follow-up|9|||
131923747|NCT03753542|475005119|FG001|Overall Study|Lost to Follow-up|14|||
131923748|NCT05762744|475005122|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
131923749|NCT05762744|475005123|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
131923750|NCT05762744|475005122|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
131923751|NCT05762744|475005123|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
131923752|NCT01671059|475005124|FG000|Overall Study|Adverse Event|4|||
131923753|NCT01671059|475005124|FG000|Overall Study|Lack of Efficacy|1|||
131923754|NCT01030900|475005131|FG000|Overall Study|Not treated due to congestive heart failure|1|||
131923755|NCT01030900|475005131|FG000|Overall Study|Not treated due to rapid disease|1|||
131923756|NCT01179399|475005134|FG000|Overall Study|Adverse Event|1|||
131923757|NCT01179399|475005134|FG000|Overall Study|Lack of Efficacy|30|||
131923758|NCT01179399|475005134|FG000|Overall Study|Withdrawal by Subject|1|||
131923759|NCT00441896|475005135|FG000|Overall Study|Withdrawal by Subject|0|||
131923760|NCT00441896|475005136|FG001|Overall Study|Withdrawal by Subject|0|||
131923761|NCT00441896|475005137|FG002|Overall Study|Withdrawal by Subject|0|||
131923762|NCT00441896|475005138|FG003|Overall Study|Withdrawal by Subject|1|||
131923763|NCT00441896|475005139|FG004|Overall Study|Withdrawal by Subject|0|||
131923764|NCT00441896|475005140|FG005|Overall Study|Withdrawal by Subject|0|||
131923765|NCT00441896|475005141|FG006|Overall Study|Withdrawal by Subject|0|||
131923766|NCT00441896|475005142|FG007|Overall Study|Withdrawal by Subject|0|||
131923767|NCT00441896|475005143|FG008|Overall Study|Withdrawal by Subject|0|||
131923768|NCT00441896|475005144|FG009|Overall Study|Withdrawal by Subject|0|||
131923769|NCT00441896|475005135|FG000|Overall Study|Other|0|||
131923770|NCT00441896|475005136|FG001|Overall Study|Other|0|||
131923771|NCT00441896|475005137|FG002|Overall Study|Other|0|||
131923772|NCT00441896|475005138|FG003|Overall Study|Other|0|||
131923773|NCT00441896|475005139|FG004|Overall Study|Other|1|||
131923774|NCT00441896|475005140|FG005|Overall Study|Other|0|||
131923775|NCT00441896|475005141|FG006|Overall Study|Other|0|||
131923776|NCT00441896|475005142|FG007|Overall Study|Other|0|||
131923777|NCT00441896|475005143|FG008|Overall Study|Other|0|||
131923778|NCT00441896|475005144|FG009|Overall Study|Other|0|||
131923779|NCT03554473|475007118|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
131923780|NCT03554473|475007119|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
131923781|NCT03554473|475007120|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
131923782|NCT03554473|475007118|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
131923783|NCT03554473|475007119|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
131878068|NCT03613649|474833349|FG004|Fourth Treatment|Physician Decision|0|||
131878069|NCT03613649|474833350|FG005|Fourth Treatment|Physician Decision|0|||
131878070|NCT03613649|474833351|FG006|Fourth Treatment|Physician Decision|1|||
131878071|NCT03613649|474833352|FG007|Fourth Treatment|Physician Decision|0|||
131878072|NCT03613649|474833353|FG008|Fourth Treatment|Physician Decision|0|||
131878073|NCT03613649|474833354|FG009|Fourth Treatment|Physician Decision|0|||
131878074|NCT03613649|474833355|FG010|Fourth Treatment|Physician Decision|0|||
131878075|NCT03613649|474833356|FG011|Fourth Treatment|Physician Decision|0|||
131878076|NCT00675428|474833357|FG000|Overall Study|Disease Progression|2|||
131878077|NCT00675428|474833358|FG001|Overall Study|Disease Progression|2|||
131878078|NCT00675428|474833357|FG000|Overall Study|No Disease Response After Cycle 6|0|||
131878079|NCT00675428|474833358|FG001|Overall Study|No Disease Response After Cycle 6|1|||
131878080|NCT00675428|474833357|FG000|Overall Study|Physician Decision|1|||
131878081|NCT00675428|474833358|FG001|Overall Study|Physician Decision|0|||
131878082|NCT00750139|474833361|FG000|Overall Study|Adverse Event|1|||
131878083|NCT00750139|474833362|FG001|Overall Study|Adverse Event|2|||
131878084|NCT00750139|474833363|FG002|Overall Study|Adverse Event|0|||
131878085|NCT00750139|474833364|FG003|Overall Study|Adverse Event|1|||
131878086|NCT00750139|474833361|FG000|Overall Study|Lost to Follow-up|17|||
131878087|NCT00750139|474833362|FG001|Overall Study|Lost to Follow-up|12|||
131878088|NCT00750139|474833363|FG002|Overall Study|Lost to Follow-up|15|||
131878089|NCT00750139|474833364|FG003|Overall Study|Lost to Follow-up|6|||
131878090|NCT00750139|474833361|FG000|Overall Study|Withdrawal by Subject|3|||
131878091|NCT00750139|474833362|FG001|Overall Study|Withdrawal by Subject|2|||
131878092|NCT00750139|474833363|FG002|Overall Study|Withdrawal by Subject|6|||
131878093|NCT00750139|474833364|FG003|Overall Study|Withdrawal by Subject|2|||
131878094|NCT00750139|474833361|FG000|Overall Study|Physician Decision|1|||
131878095|NCT00750139|474833362|FG001|Overall Study|Physician Decision|1|||
131878096|NCT00750139|474833363|FG002|Overall Study|Physician Decision|0|||
131878097|NCT00750139|474833364|FG003|Overall Study|Physician Decision|0|||
131878098|NCT00750139|474833361|FG000|Overall Study|Non-compliance|1|||
131878099|NCT00750139|474833362|FG001|Overall Study|Non-compliance|0|||
131878100|NCT00750139|474833363|FG002|Overall Study|Non-compliance|1|||
131878101|NCT00750139|474833364|FG003|Overall Study|Non-compliance|3|||
131878102|NCT00750139|474833361|FG000|Overall Study|Termination by sponsor|4|||
131878103|NCT00750139|474833362|FG001|Overall Study|Termination by sponsor|0|||
131878104|NCT00750139|474833363|FG002|Overall Study|Termination by sponsor|0|||
131878105|NCT00750139|474833364|FG003|Overall Study|Termination by sponsor|1|||
131878106|NCT00750139|474833361|FG000|Overall Study|Non-specific|62|||
131878107|NCT00750139|474833362|FG001|Overall Study|Non-specific|42|||
131878108|NCT00750139|474833363|FG002|Overall Study|Non-specific|79|||
131878109|NCT00750139|474833364|FG003|Overall Study|Non-specific|33|||
131878110|NCT04439214|474833368|FG000|Overall Study|Adverse Event|13|||
131878111|NCT04439214|474833368|FG000|Overall Study|Disease progression|16|||
131878112|NCT04439214|474833368|FG000|Overall Study|Death|1|||
131878113|NCT04439214|474833368|FG000|Overall Study|Withdrawal by Subject|2|||
131878114|NCT04439214|474833368|FG000|Overall Study|Declining health|1|||
131878115|NCT04439214|474833368|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
131878116|NCT04439214|474833368|FG000|Overall Study|Ineligible|5|||
131878117|NCT02964208|474833369|FG000|Overall Study|Death|103|||
131878118|NCT02964208|474833369|FG000|Overall Study|Withdrawal by Subject|6|||
131878119|NCT02964208|474833369|FG000|Overall Study|Lost to Follow-up|6|||
131878120|NCT02964208|474833369|FG000|Overall Study|Unsuccessful Procedure|5|||
131878121|NCT02964208|474833369|FG000|Overall Study|Device Explant|1|||
131878122|NCT02964208|474833369|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
131878123|NCT01743560|474833370|FG000|Overall Study|Disease progression|26|||
131878124|NCT01743560|474833370|FG000|Overall Study|Adverse Event|8|||
131878125|NCT01743560|474833370|FG000|Overall Study|Death|3|||
131878126|NCT01743560|474833370|FG000|Overall Study|Withdrawal by Subject|2|||
131878127|NCT01743560|474833370|FG000|Overall Study|Protocol Violation|1|||
131878128|NCT01743560|474833370|FG000|Overall Study|>1 dose of study drug|3|||
131878129|NCT03226769|474833371|FG000|Overall Study|Withdrawal by Subject|0|||
131878130|NCT03226769|474833372|FG001|Overall Study|Withdrawal by Subject|1|||
131878131|NCT04553471|474833373|FG000|Overall Study|Did not start treatment on protocol|3|||
131878132|NCT04553471|474833373|FG000|Overall Study|Death|1|||
131878133|NCT00940823|474833374|FG000|Overall Study|Death|8|||
131878134|NCT00940823|474833375|FG001|Overall Study|Death|12|||
131878135|NCT00940823|474833374|FG000|Overall Study|Lost to Follow-up|27|||
131878136|NCT00940823|474833375|FG001|Overall Study|Lost to Follow-up|20|||
131878137|NCT01758731|474833376|FG000|Overall Study|Physician Decision|1|||
131878138|NCT05270395|474833388|FG000|Overall Study|Lost to Follow-up|2|||
131878139|NCT05270395|474833389|FG001|Overall Study|Lost to Follow-up|2|||
131878140|NCT05270395|474833388|FG000|Overall Study|Death|1|||
131878141|NCT05270395|474833389|FG001|Overall Study|Death|2|||
131878142|NCT05270395|474833388|FG000|Overall Study|Study Team Withdrew|1|||
131878143|NCT05270395|474833389|FG001|Overall Study|Study Team Withdrew|0|||
131878144|NCT00199797|474835111|FG000|Overall Study|Progressive Disease|1|||
131878145|NCT00199797|474835111|FG000|Overall Study|Adverse Event|1|||
131923784|NCT03554473|475007120|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
131923785|NCT03554473|475007118|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
131923786|NCT03554473|475007119|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
131923787|NCT03554473|475007120|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
131923788|NCT04971837|475007124|FG000|Overall Study|Long Term Illness|1|||
131923789|NCT04971837|475007124|FG000|Overall Study|BMI too low|9|||
131923790|NCT04971837|475007124|FG000|Overall Study|geographic location|1|||
131923791|NCT04971837|475007124|FG000|Overall Study|Discontinued scheduling conflict|1|||
131923792|NCT00160615|475007125|FG000|Overall Study|Adverse Event|5|||
131923793|NCT00160615|475007126|FG001|Overall Study|Adverse Event|12|||
131923794|NCT00160615|475007125|FG000|Overall Study|Withdrawal by Subject|0|||
131923795|NCT00160615|475007126|FG001|Overall Study|Withdrawal by Subject|2|||
131923796|NCT00160615|475007125|FG000|Overall Study|Lack of Efficacy|11|||
131923797|NCT00160615|475007126|FG001|Overall Study|Lack of Efficacy|23|||
131923798|NCT00160615|475007125|FG000|Overall Study|Patient decision|1|||
131923799|NCT00160615|475007126|FG001|Overall Study|Patient decision|2|||
131923800|NCT00160615|475007125|FG000|Overall Study|Investigator decision|1|||
131923801|NCT00160615|475007126|FG001|Overall Study|Investigator decision|1|||
131923802|NCT00160615|475007125|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
131923803|NCT00160615|475007126|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
131923804|NCT00160615|475007125|FG000|Overall Study|Switch to surgical treatment|0|||
131923805|NCT00160615|475007126|FG001|Overall Study|Switch to surgical treatment|2|||
131923806|NCT00160615|475007125|FG000|Overall Study|Non-compliance was suspected|0|||
131923807|NCT00160615|475007126|FG001|Overall Study|Non-compliance was suspected|1|||
131923808|NCT00160615|475007125|FG000|Overall Study|Poor compliance|0|||
131923809|NCT00160615|475007126|FG001|Overall Study|Poor compliance|1|||
131923810|NCT03166631|475007127|FG000|Overall Study|Progressive disease|2|||
131923811|NCT03166631|475007128|FG001|Overall Study|Progressive disease|1|||
131923812|NCT03166631|475007129|FG002|Overall Study|Progressive disease|3|||
131923813|NCT03166631|475007130|FG003|Overall Study|Progressive disease|4|||
131923814|NCT03166631|475007131|FG004|Overall Study|Progressive disease|2|||
131923815|NCT03166631|475007132|FG005|Overall Study|Progressive disease|2|||
131923816|NCT03166631|475007133|FG006|Overall Study|Progressive disease|5|||
131923817|NCT03166631|475007134|FG007|Overall Study|Progressive disease|6|||
131923818|NCT03166631|475007135|FG008|Overall Study|Progressive disease|11|||
131923819|NCT03166631|475007136|FG009|Overall Study|Progressive disease|5|||
131923820|NCT03166631|475007137|FG010|Overall Study|Progressive disease|7|||
131923821|NCT03166631|475007127|FG000|Overall Study|Physician Decision|0|||
131923822|NCT03166631|475007128|FG001|Overall Study|Physician Decision|0|||
131923823|NCT03166631|475007129|FG002|Overall Study|Physician Decision|0|||
131923824|NCT03166631|475007130|FG003|Overall Study|Physician Decision|0|||
131923825|NCT03166631|475007131|FG004|Overall Study|Physician Decision|0|||
131923826|NCT03166631|475007132|FG005|Overall Study|Physician Decision|0|||
131923827|NCT03166631|475007133|FG006|Overall Study|Physician Decision|1|||
131923828|NCT03166631|475007134|FG007|Overall Study|Physician Decision|0|||
131923829|NCT03166631|475007135|FG008|Overall Study|Physician Decision|1|||
131923830|NCT03166631|475007136|FG009|Overall Study|Physician Decision|0|||
131923831|NCT03166631|475007137|FG010|Overall Study|Physician Decision|1|||
131923832|NCT03166631|475007127|FG000|Overall Study|Death|0|||
131923833|NCT03166631|475007128|FG001|Overall Study|Death|0|||
131923834|NCT03166631|475007129|FG002|Overall Study|Death|0|||
131923835|NCT03166631|475007130|FG003|Overall Study|Death|0|||
131923836|NCT03166631|475007131|FG004|Overall Study|Death|1|||
131923837|NCT03166631|475007132|FG005|Overall Study|Death|0|||
131923838|NCT03166631|475007133|FG006|Overall Study|Death|1|||
131923839|NCT03166631|475007134|FG007|Overall Study|Death|0|||
131923840|NCT03166631|475007135|FG008|Overall Study|Death|0|||
131923841|NCT03166631|475007136|FG009|Overall Study|Death|0|||
131923842|NCT03166631|475007137|FG010|Overall Study|Death|0|||
131923843|NCT03166631|475007127|FG000|Overall Study|Adverse Event|1|||
131923844|NCT03166631|475007128|FG001|Overall Study|Adverse Event|0|||
131409251|NCT00747344|473120840|FG002|Controlled Period|Adverse Event|0|||
131409252|NCT00747344|473120841|FG003|Controlled Period|Adverse Event|0|||
131409253|NCT00747344|473120838|FG000|Controlled Period|Lack of Efficacy|2|||
131923845|NCT03166631|475007129|FG002|Overall Study|Adverse Event|0|||
131923846|NCT03166631|475007130|FG003|Overall Study|Adverse Event|0|||
131923847|NCT03166631|475007131|FG004|Overall Study|Adverse Event|0|||
131923848|NCT03166631|475007132|FG005|Overall Study|Adverse Event|1|||
131923849|NCT03166631|475007133|FG006|Overall Study|Adverse Event|1|||
131409254|NCT00747344|473120839|FG001|Controlled Period|Lack of Efficacy|1|||
131409255|NCT00747344|473120840|FG002|Controlled Period|Lack of Efficacy|0|||
131409256|NCT00747344|473120841|FG003|Controlled Period|Lack of Efficacy|0|||
131923850|NCT03166631|475007134|FG007|Overall Study|Adverse Event|0|||
131923851|NCT03166631|475007135|FG008|Overall Study|Adverse Event|1|||
131923852|NCT03166631|475007136|FG009|Overall Study|Adverse Event|2|||
131409257|NCT00747344|473120838|FG000|Controlled Period|Other|0|||
131409258|NCT00747344|473120839|FG001|Controlled Period|Other|3|||
131409259|NCT00747344|473120840|FG002|Controlled Period|Other|0|||
131409260|NCT00747344|473120841|FG003|Controlled Period|Other|0|||
131409261|NCT00747344|473120838|FG000|After Controlled Period|Adverse Event|0|||
131409262|NCT00747344|473120839|FG001|After Controlled Period|Adverse Event|0|||
131409263|NCT00747344|473120840|FG002|After Controlled Period|Adverse Event|0|||
131409264|NCT00747344|473120841|FG003|After Controlled Period|Adverse Event|1|||
131409265|NCT03754582|473120842|FG000|Treatment Phase|Adverse Event|0|||
131409266|NCT03754582|473120843|FG001|Treatment Phase|Adverse Event|1|||
131409267|NCT03754582|473120844|FG002|Treatment Phase|Adverse Event|0|||
131878146|NCT00199797|474835111|FG000|Overall Study|Physician Decision|1|||
131878147|NCT04250350|474835120|FG000|Overall Study|Withdrawal by Subject|13|||
131878148|NCT04250350|474835120|FG000|Overall Study|Lost to Follow-up|8|||
131878149|NCT04250350|474835120|FG000|Overall Study|Adverse Event|5|||
131878150|NCT04250350|474835120|FG000|Overall Study|Lack of Efficacy|4|||
131878151|NCT04250350|474835120|FG000|Overall Study|Physician Decision|1|||
131878152|NCT04250350|474835120|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
131878153|NCT00784550|474835121|FG000|Overall Study|Adverse Event|12|||
131878154|NCT00784550|474835122|FG001|Overall Study|Adverse Event|10|||
131878155|NCT00784550|474835121|FG000|Overall Study|Lack of Efficacy|0|||
131878156|NCT00784550|474835122|FG001|Overall Study|Lack of Efficacy|1|||
131878157|NCT00784550|474835121|FG000|Overall Study|Protocol Violation|10|||
131878158|NCT00784550|474835122|FG001|Overall Study|Protocol Violation|10|||
131878159|NCT00784550|474835121|FG000|Overall Study|Lost to Follow-up|8|||
131878160|NCT00784550|474835122|FG001|Overall Study|Lost to Follow-up|5|||
131878161|NCT00784550|474835121|FG000|Overall Study|Physician Decision|2|||
131878162|NCT00784550|474835122|FG001|Overall Study|Physician Decision|3|||
131878163|NCT00784550|474835121|FG000|Overall Study|Withdrawal by Subject|4|||
131878164|NCT00784550|474835122|FG001|Overall Study|Withdrawal by Subject|13|||
131878165|NCT00688701|474835123|FG000|Overall Study|Adverse Event|1|||
131878166|NCT00688701|474835124|FG001|Overall Study|Adverse Event|0|||
131878167|NCT00688701|474835125|FG002|Overall Study|Adverse Event|5|||
131878168|NCT00688701|474835126|FG003|Overall Study|Adverse Event|3|||
131878169|NCT00688701|474835123|FG000|Overall Study|Lack of Efficacy|0|||
131878170|NCT00688701|474835124|FG001|Overall Study|Lack of Efficacy|1|||
131878171|NCT00688701|474835125|FG002|Overall Study|Lack of Efficacy|0|||
131878172|NCT00688701|474835126|FG003|Overall Study|Lack of Efficacy|0|||
131878173|NCT00688701|474835123|FG000|Overall Study|Withdrawal by Subject|3|||
131878174|NCT00688701|474835124|FG001|Overall Study|Withdrawal by Subject|3|||
131878175|NCT00688701|474835125|FG002|Overall Study|Withdrawal by Subject|4|||
131878176|NCT00688701|474835126|FG003|Overall Study|Withdrawal by Subject|8|||
131878177|NCT00688701|474835123|FG000|Overall Study|Poor compliance to protocol|0|||
131878178|NCT00688701|474835124|FG001|Overall Study|Poor compliance to protocol|1|||
131878179|NCT00688701|474835125|FG002|Overall Study|Poor compliance to protocol|1|||
131878180|NCT00688701|474835126|FG003|Overall Study|Poor compliance to protocol|0|||
131878181|NCT03205761|474835138|FG000|Overall Study|Withdrawal by Subject|1|||
131878182|NCT03205761|474835138|FG000|Overall Study|Progressive Disease|10|||
131878183|NCT04420585|474835140|FG000|Overall Study|Adverse Event|1|||
131878184|NCT04420585|474835140|FG000|Overall Study|Never initiated medication|2|||
131878185|NCT04114357|474835141|FG000|Baseline-Randomization|Adverse Event|2|||
131878186|NCT04114357|474835142|FG001|Baseline-Randomization|Adverse Event|1|||
131878187|NCT04114357|474835141|FG000|Baseline-Randomization|Lost to Follow-up|1|||
131878188|NCT04114357|474835142|FG001|Baseline-Randomization|Lost to Follow-up|1|||
131878189|NCT04114357|474835141|FG000|Cross-over|Adverse Event|0|||
131878190|NCT04114357|474835142|FG001|Cross-over|Adverse Event|1|||
131878191|NCT02163226|474835143|FG000|Overall Study|Death|2|||
131878192|NCT02163226|474835144|FG001|Overall Study|Death|1|||
131878193|NCT02163226|474835143|FG000|Overall Study|Withdrawal by Subject|5|||
131878194|NCT02163226|474835144|FG001|Overall Study|Withdrawal by Subject|2|||
131878195|NCT02163226|474835143|FG000|Overall Study|Returned home, local radiotherapy|3|||
131878196|NCT02163226|474835144|FG001|Overall Study|Returned home, local radiotherapy|0|||
131923853|NCT03166631|475007137|FG010|Overall Study|Adverse Event|1|||
131923854|NCT03166631|475007127|FG000|Overall Study|Withdrawal by Subject|0|||
131409268|NCT03754582|473120842|FG000|Follow-up Phase|Other|0|||
131409269|NCT03754582|473120843|FG001|Follow-up Phase|Other|0|||
131878197|NCT02163226|474835143|FG000|Overall Study|Repeat imaging showed no disease|2|||
131878198|NCT02163226|474835144|FG001|Overall Study|Repeat imaging showed no disease|0|||
131878199|NCT02163226|474835143|FG000|Overall Study|Incomplete radiotherapy|3|||
131878200|NCT02163226|474835144|FG001|Overall Study|Incomplete radiotherapy|0|||
131409270|NCT03754582|473120844|FG002|Follow-up Phase|Other|1|||
131409271|NCT02847858|473120845|FG000|Overall Study|Lost to Follow-up|401|||
131409272|NCT02847858|473120846|FG001|Overall Study|Lost to Follow-up|269|||
131409273|NCT00681564|473120847|FG000|Overall Study|Lost to Follow-up|6|||
131409274|NCT00681564|473120848|FG001|Overall Study|Lost to Follow-up|6|||
131878201|NCT02163226|474835143|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
131878202|NCT02163226|474835144|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
131878203|NCT02163226|474835143|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
131878204|NCT02163226|474835144|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
131923855|NCT03166631|475007128|FG001|Overall Study|Withdrawal by Subject|0|||
131923856|NCT03166631|475007129|FG002|Overall Study|Withdrawal by Subject|0|||
131923857|NCT03166631|475007130|FG003|Overall Study|Withdrawal by Subject|0|||
131923858|NCT03166631|475007131|FG004|Overall Study|Withdrawal by Subject|0|||
131923859|NCT03166631|475007132|FG005|Overall Study|Withdrawal by Subject|0|||
131923860|NCT03166631|475007133|FG006|Overall Study|Withdrawal by Subject|0|||
131923861|NCT03166631|475007134|FG007|Overall Study|Withdrawal by Subject|0|||
131923862|NCT03166631|475007135|FG008|Overall Study|Withdrawal by Subject|1|||
131923863|NCT03166631|475007136|FG009|Overall Study|Withdrawal by Subject|1|||
131923864|NCT03166631|475007137|FG010|Overall Study|Withdrawal by Subject|0|||
131923865|NCT00567580|475007140|FG000|Overall Study|Protocol Violation|28|||
131923866|NCT00567580|475007141|FG001|Overall Study|Protocol Violation|24|||
131923867|NCT00567580|475007142|FG002|Overall Study|Protocol Violation|24|||
131923868|NCT00382070|475007143|FG000|Overall Study|No follow up data mapped to Other|17|||
131923869|NCT00382070|475007144|FG001|Overall Study|No follow up data mapped to Other|19|||
131923870|NCT00382070|475007143|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
131923871|NCT00382070|475007144|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
131923872|NCT00382070|475007143|FG000|Overall Study|No clinical assessment|9|||
131923873|NCT00382070|475007144|FG001|Overall Study|No clinical assessment|11|||
131923874|NCT00327171|475007153|FG000|Overall Study|Did not receive study medication|3|||
131923875|NCT00327171|475007154|FG001|Overall Study|Did not receive study medication|0|||
131923876|NCT00327171|475007153|FG000|Overall Study|Adverse Event|23|||
131923877|NCT00327171|475007154|FG001|Overall Study|Adverse Event|23|||
131923878|NCT00327171|475007153|FG000|Overall Study|Disease progression/lack of efficacy|68|||
131923879|NCT00327171|475007154|FG001|Overall Study|Disease progression/lack of efficacy|69|||
131923880|NCT00327171|475007153|FG000|Overall Study|Investigator/participant request|1|||
131923881|NCT00327171|475007154|FG001|Overall Study|Investigator/participant request|8|||
131923882|NCT00327171|475007153|FG000|Overall Study|Clinical progression|12|||
131923883|NCT00327171|475007154|FG001|Overall Study|Clinical progression|8|||
131923884|NCT00327171|475007153|FG000|Overall Study|Undisclosed history of ischemia|0|||
131923885|NCT00327171|475007154|FG001|Overall Study|Undisclosed history of ischemia|1|||
131923886|NCT00327171|475007153|FG000|Overall Study|Other|1|||
131923887|NCT00327171|475007154|FG001|Overall Study|Other|0|||
131923888|NCT00284934|475007155|FG000|Overall Study|Adverse Event|1|||
131923889|NCT00284934|475007156|FG001|Overall Study|Adverse Event|2|||
131923890|NCT00284934|475007155|FG000|Overall Study|Other reasons|3|||
131923891|NCT00284934|475007156|FG001|Overall Study|Other reasons|1|||
131923892|NCT05788328|475007162|FG000|Treatment Period 4 (5 Days)|Other|1|||
131923893|NCT05788328|475007162|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
131923894|NCT00145327|475007163|FG000|Overall Study|Withdrawal by Subject|77|||
131923895|NCT00145327|475007164|FG001|Overall Study|Withdrawal by Subject|72|||
131923896|NCT00145327|475007165|FG002|Overall Study|Withdrawal by Subject|164|||
131923897|NCT00145327|475007163|FG000|Overall Study|Death|26|||
131923898|NCT00145327|475007164|FG001|Overall Study|Death|18|||
131923899|NCT00145327|475007165|FG002|Overall Study|Death|30|||
131923900|NCT00145327|475007163|FG000|Overall Study|Adverse Event|14|||
131923901|NCT00145327|475007164|FG001|Overall Study|Adverse Event|11|||
131923902|NCT00145327|475007165|FG002|Overall Study|Adverse Event|22|||
131923903|NCT00145327|475007163|FG000|Overall Study|Lost to Follow-up|9|||
131923904|NCT00145327|475007164|FG001|Overall Study|Lost to Follow-up|14|||
131923905|NCT00145327|475007165|FG002|Overall Study|Lost to Follow-up|14|||
131923906|NCT00145327|475007163|FG000|Overall Study|Administrative problems|12|||
131923907|NCT00145327|475007164|FG001|Overall Study|Administrative problems|9|||
131923908|NCT00145327|475007165|FG002|Overall Study|Administrative problems|13|||
131923909|NCT00145327|475007163|FG000|Overall Study|Protocol Violation|2|||
131923910|NCT00145327|475007164|FG001|Overall Study|Protocol Violation|0|||
131923911|NCT00145327|475007165|FG002|Overall Study|Protocol Violation|2|||
131923912|NCT00145327|475007163|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131923913|NCT00145327|475007164|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131923914|NCT00145327|475007165|FG002|Overall Study|Abnormal laboratory value(s)|2|||
131923915|NCT00145327|475007163|FG000|Overall Study|Missing - not stated|1|||
131923916|NCT00145327|475007164|FG001|Overall Study|Missing - not stated|0|||
131923917|NCT00145327|475007165|FG002|Overall Study|Missing - not stated|1|||
131923918|NCT03315689|475007166|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
131923919|NCT03315689|475007167|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
131923920|NCT03315689|475007166|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
131923921|NCT03315689|475007167|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
131923922|NCT03315689|475007166|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
131454006|NCT02023697|473291845|FG001|Long-term Follow-up Period|Technical problems|0|||
131454007|NCT02023697|473291846|FG002|Long-term Follow-up Period|Technical problems|1|||
131923923|NCT03315689|475007167|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
131923924|NCT00762788|475007168|FG000|Overall Study|Lost to Follow-up|26|||
131923925|NCT00762788|475007169|FG001|Overall Study|Lost to Follow-up|37|||
131923926|NCT00762788|475007170|FG002|Overall Study|Lost to Follow-up|21|||
131923927|NCT00762788|475007171|FG003|Overall Study|Lost to Follow-up|26|||
131878205|NCT02163226|474835143|FG000|Overall Study|ineligible|0|||
131878206|NCT02163226|474835144|FG001|Overall Study|ineligible|3|||
131878207|NCT00477750|474835145|FG000|Overall Study|Currently Receiving Treatment|11|||
131878208|NCT00601172|474835146|FG000|Overall Study|Adverse Event|43|||
131878209|NCT00601172|474835147|FG001|Overall Study|Adverse Event|32|||
131878210|NCT00601172|474835146|FG000|Overall Study|Lack of Efficacy|11|||
131878211|NCT00601172|474835147|FG001|Overall Study|Lack of Efficacy|12|||
131878212|NCT00601172|474835146|FG000|Overall Study|Protocol Violation|2|||
131878213|NCT00601172|474835147|FG001|Overall Study|Protocol Violation|5|||
131878214|NCT00601172|474835146|FG000|Overall Study|Lost to Follow-up|4|||
131878215|NCT00601172|474835147|FG001|Overall Study|Lost to Follow-up|3|||
131878216|NCT00601172|474835146|FG000|Overall Study|Physician Decision|27|||
131878217|NCT00601172|474835147|FG001|Overall Study|Physician Decision|28|||
131878218|NCT00601172|474835146|FG000|Overall Study|Withdrawal by Subject|35|||
131878219|NCT00601172|474835147|FG001|Overall Study|Withdrawal by Subject|27|||
131878220|NCT00601172|474835146|FG000|Overall Study|Did not meet continuation criteria|19|||
131878221|NCT00601172|474835147|FG001|Overall Study|Did not meet continuation criteria|20|||
131878222|NCT02706886|474835148|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
131878223|NCT02706886|474835149|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
131878224|NCT02706886|474835150|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
131878225|NCT02706886|474835151|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
131878226|NCT02706886|474835152|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
131878227|NCT02706886|474835153|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
131878228|NCT02706886|474835154|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
131878229|NCT02706886|474835155|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
131878230|NCT02706886|474835156|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
131878231|NCT00614523|474835159|FG000|Overall Study|Adverse Event|4|||
131878232|NCT00614523|474835160|FG001|Overall Study|Adverse Event|20|||
131878233|NCT00614523|474835159|FG000|Overall Study|Death|5|||
131878234|NCT00614523|474835160|FG001|Overall Study|Death|8|||
131878235|NCT00614523|474835159|FG000|Overall Study|Lack of Efficacy|9|||
131878236|NCT00614523|474835160|FG001|Overall Study|Lack of Efficacy|11|||
131878237|NCT00614523|474835159|FG000|Overall Study|Lost to Follow-up|0|||
131878238|NCT00614523|474835160|FG001|Overall Study|Lost to Follow-up|1|||
131878239|NCT00614523|474835159|FG000|Overall Study|Protocol Violation|3|||
131878240|NCT00614523|474835160|FG001|Overall Study|Protocol Violation|2|||
131878241|NCT00614523|474835159|FG000|Overall Study|Withdrawal by Subject|12|||
131878242|NCT00614523|474835160|FG001|Overall Study|Withdrawal by Subject|22|||
131878243|NCT00614523|474835159|FG000|Overall Study|Other|6|||
131878244|NCT00614523|474835160|FG001|Overall Study|Other|11|||
131878245|NCT00614523|474835159|FG000|Overall Study|Ineligibility Determined|1|||
131878246|NCT00614523|474835160|FG001|Overall Study|Ineligibility Determined|2|||
131878247|NCT00614523|474835159|FG000|Overall Study|Disease Progression|0|||
131878248|NCT00614523|474835160|FG001|Overall Study|Disease Progression|8|||
131878249|NCT00614523|474835159|FG000|Overall Study|Administrative Decision|23|||
131878250|NCT00614523|474835160|FG001|Overall Study|Administrative Decision|46|||
131878251|NCT04598451|474835165|FG000|Overall Study|Adverse Event|3|||
131878252|NCT04598451|474835166|FG001|Overall Study|Adverse Event|2|||
131878253|NCT04598451|474835165|FG000|Overall Study|Withdrawal by Subject|3|||
131878254|NCT04598451|474835166|FG001|Overall Study|Withdrawal by Subject|7|||
131878255|NCT04598451|474835165|FG000|Overall Study|Lost to Follow-up|2|||
131878256|NCT04598451|474835166|FG001|Overall Study|Lost to Follow-up|0|||
131878257|NCT04598451|474835165|FG000|Overall Study|Physician Decision|4|||
131878258|NCT04598451|474835166|FG001|Overall Study|Physician Decision|1|||
131878259|NCT04598451|474835165|FG000|Overall Study|Requires Prohibited Medication|1|||
131878260|NCT04598451|474835166|FG001|Overall Study|Requires Prohibited Medication|0|||
131878261|NCT04598451|474835165|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
131878262|NCT04598451|474835166|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
131878263|NCT01482065|474835171|FG000|Overall Study|Withdrawal by Subject|0|||
131878264|NCT01482065|474835172|FG001|Overall Study|Withdrawal by Subject|1|||
131878265|NCT00976820|474835173|FG000|Overall Study|Lost to Follow-up|5|||
131878266|NCT00976820|474835174|FG001|Overall Study|Lost to Follow-up|16|||
131878267|NCT00976820|474835175|FG002|Overall Study|Lost to Follow-up|2|||
131878268|NCT00976820|474835176|FG003|Overall Study|Lost to Follow-up|3|||
131878269|NCT00976820|474835173|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
131878270|NCT00976820|474835174|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
131878271|NCT00976820|474835175|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
131878272|NCT00976820|474835176|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
131878273|NCT00976820|474835173|FG000|Overall Study|Withdrawal by Subject|2|||
131878274|NCT00976820|474835174|FG001|Overall Study|Withdrawal by Subject|4|||
131878275|NCT00976820|474835175|FG002|Overall Study|Withdrawal by Subject|1|||
131878276|NCT00976820|474835176|FG003|Overall Study|Withdrawal by Subject|4|||
131878277|NCT03261674|474835177|FG000|Overall Study|Lost to Follow-up|6|||
131878278|NCT03261674|474835178|FG001|Overall Study|Lost to Follow-up|7|||
131878279|NCT03261674|474835177|FG000|Overall Study|Protocol Violation|1|||
131878280|NCT03261674|474835178|FG001|Overall Study|Protocol Violation|4|||
131923928|NCT00762788|475007172|FG004|Overall Study|Lost to Follow-up|13|||
131923929|NCT00762788|475007173|FG005|Overall Study|Lost to Follow-up|21|||
131923930|NCT05938010|475007175|FG000|Overall Study|Lost to Follow-up|2|||
131923931|NCT00669331|475007178|FG000|Randomisation to First Dose|Adverse Event|1|||
131923932|NCT00669331|475007179|FG001|Randomisation to First Dose|Adverse Event|0|||
131923933|NCT00669331|475007178|FG000|Randomisation to First Dose|Protocol Violation|1|||
131923934|NCT00669331|475007179|FG001|Randomisation to First Dose|Protocol Violation|0|||
131923935|NCT00669331|475007178|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
131923936|NCT00669331|475007179|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
131923937|NCT00669331|475007178|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
131923938|NCT00669331|475007179|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
131923939|NCT00669331|475007178|FG000|Randomisation to First Dose|Death|1|||
131923940|NCT00669331|475007179|FG001|Randomisation to First Dose|Death|0|||
131923941|NCT00669331|475007178|FG000|Randomisation to First Dose|Sponsor decision|0|||
131923942|NCT00669331|475007179|FG001|Randomisation to First Dose|Sponsor decision|1|||
131923943|NCT00669331|475007178|FG000|Randomisation to First Dose|Randomised in error|3|||
131923944|NCT00669331|475007179|FG001|Randomisation to First Dose|Randomised in error|10|||
131923945|NCT00669331|475007178|FG000|Blinded Treatment Period|Adverse Event|16|||
131923946|NCT00669331|475007179|FG001|Blinded Treatment Period|Adverse Event|10|||
131923947|NCT00669331|475007178|FG000|Blinded Treatment Period|Protocol Violation|1|||
131923948|NCT00669331|475007179|FG001|Blinded Treatment Period|Protocol Violation|1|||
131923949|NCT00669331|475007178|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
131923950|NCT00669331|475007179|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
131923951|NCT00669331|475007178|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
131923952|NCT00669331|475007179|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
131923953|NCT00669331|475007178|FG000|Blinded Treatment Period|Death|0|||
131923954|NCT00669331|475007179|FG001|Blinded Treatment Period|Death|2|||
131923955|NCT00669331|475007178|FG000|Blinded Treatment Period|Physician Decision|3|||
131923956|NCT00669331|475007179|FG001|Blinded Treatment Period|Physician Decision|3|||
131923957|NCT00669331|475007178|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
131923958|NCT00669331|475007179|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
131923959|NCT01454063|475007180|FG000|Randomized|Adverse Event|1|||
131923960|NCT01454063|475007181|FG001|Randomized|Adverse Event|1|||
131923961|NCT01454063|475007180|FG000|Randomized|Protocol Violation|0|||
131923962|NCT01454063|475007181|FG001|Randomized|Protocol Violation|1|||
131923963|NCT01562444|475007183|FG000|Overall Study|Did not meet entry criteria|2|||
131923964|NCT01562444|475007184|FG001|Overall Study|Did not meet entry criteria|0|||
131923965|NCT01562444|475007185|FG002|Overall Study|Did not meet entry criteria|3|||
131923966|NCT01562444|475007183|FG000|Overall Study|Did not comply with blood draw schedule|1|||
131923967|NCT01562444|475007184|FG001|Overall Study|Did not comply with blood draw schedule|0|||
131923968|NCT01562444|475007185|FG002|Overall Study|Did not comply with blood draw schedule|1|||
131923969|NCT01562444|475007183|FG000|Overall Study|Unavailable serological results|0|||
131923970|NCT01562444|475007184|FG001|Overall Study|Unavailable serological results|2|||
131923971|NCT01562444|475007185|FG002|Overall Study|Unavailable serological results|2|||
131923972|NCT01562444|475007183|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
131923973|NCT01562444|475007184|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
131923974|NCT01562444|475007185|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
131923975|NCT01562444|475007183|FG000|Overall Study|Protocol forbidden medication|1|||
131923976|NCT01562444|475007184|FG001|Overall Study|Protocol forbidden medication|0|||
131923977|NCT01562444|475007185|FG002|Overall Study|Protocol forbidden medication|0|||
131923978|NCT00983957|475007192|FG000|Overall Study|Adverse Event|1|||
131923979|NCT00983957|475007192|FG000|Overall Study|Personal Reasons|1|||
131923980|NCT03055195|475007193|FG000|Overall Study|Lack of Efficacy|1|||
131923981|NCT03055195|475007194|FG001|Overall Study|Lack of Efficacy|0|||
131923982|NCT03055195|475007193|FG000|Overall Study|Withdrawal by Subject|6|||
131923983|NCT03055195|475007194|FG001|Overall Study|Withdrawal by Subject|7|||
131923984|NCT03055195|475007193|FG000|Overall Study|Study Terminated by Sponsor|2|||
131923985|NCT03055195|475007194|FG001|Overall Study|Study Terminated by Sponsor|6|||
131409275|NCT00681564|473120847|FG000|Overall Study|Withdrawal by Subject|0|||
131409276|NCT00681564|473120848|FG001|Overall Study|Withdrawal by Subject|1|||
131409277|NCT00681564|473120847|FG000|Overall Study|Death|0|||
131409278|NCT00681564|473120848|FG001|Overall Study|Death|1|||
131923986|NCT03055195|475007193|FG000|Overall Study|Protocol Violation|2|||
131923987|NCT03055195|475007194|FG001|Overall Study|Protocol Violation|1|||
131923988|NCT03055195|475007193|FG000|Overall Study|Physician Decision|1|||
131923989|NCT03055195|475007194|FG001|Overall Study|Physician Decision|0|||
131923990|NCT00986232|475007195|FG000|Overall Study|Adverse Event|1|||
131923991|NCT00986232|475007196|FG001|Overall Study|Adverse Event|2|||
131923992|NCT00986232|475007197|FG002|Overall Study|Adverse Event|3|||
131923993|NCT00986232|475007198|FG003|Overall Study|Adverse Event|0|||
131409279|NCT01253265|473120853|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
131923994|NCT00986232|475007195|FG000|Overall Study|Lost to Follow-up|19|||
131923995|NCT00986232|475007196|FG001|Overall Study|Lost to Follow-up|12|||
131923996|NCT00986232|475007197|FG002|Overall Study|Lost to Follow-up|12|||
131878281|NCT03261674|474835177|FG000|Overall Study|Withdrawal by Subject|1|||
131878282|NCT03261674|474835178|FG001|Overall Study|Withdrawal by Subject|4|||
131878283|NCT03261674|474835177|FG000|Overall Study|Physician Decision|1|||
131923997|NCT00986232|475007198|FG003|Overall Study|Lost to Follow-up|7|||
131923998|NCT00986232|475007195|FG000|Overall Study|Protocol Violation|2|||
131923999|NCT00986232|475007196|FG001|Overall Study|Protocol Violation|3|||
131924000|NCT00986232|475007197|FG002|Overall Study|Protocol Violation|0|||
131924001|NCT00986232|475007198|FG003|Overall Study|Protocol Violation|1|||
131924002|NCT00986232|475007195|FG000|Overall Study|Withdrawal by Subject|13|||
131924003|NCT00986232|475007196|FG001|Overall Study|Withdrawal by Subject|16|||
131924004|NCT00986232|475007197|FG002|Overall Study|Withdrawal by Subject|12|||
131924005|NCT00986232|475007198|FG003|Overall Study|Withdrawal by Subject|3|||
131924006|NCT00986232|475007195|FG000|Overall Study|Missed one or more bleeds|13|||
131924007|NCT00986232|475007196|FG001|Overall Study|Missed one or more bleeds|10|||
131924008|NCT00986232|475007197|FG002|Overall Study|Missed one or more bleeds|6|||
131924009|NCT00986232|475007198|FG003|Overall Study|Missed one or more bleeds|7|||
131924010|NCT00986232|475007195|FG000|Overall Study|Incomplete safety follow-up|3|||
131924011|NCT00986232|475007196|FG001|Overall Study|Incomplete safety follow-up|7|||
131924012|NCT00986232|475007197|FG002|Overall Study|Incomplete safety follow-up|2|||
131924013|NCT00986232|475007198|FG003|Overall Study|Incomplete safety follow-up|2|||
131924014|NCT02568423|475007199|FG000|Overall Study|Lost to Follow-up|0|||
131924015|NCT02568423|475007200|FG001|Overall Study|Lost to Follow-up|2|||
131924016|NCT02568423|475007201|FG002|Overall Study|Lost to Follow-up|0|||
131924017|NCT02568423|475007202|FG003|Overall Study|Lost to Follow-up|0|||
131924018|NCT02568423|475007203|FG004|Overall Study|Lost to Follow-up|0|||
131924019|NCT02568423|475007204|FG005|Overall Study|Lost to Follow-up|0|||
131924020|NCT02568423|475007205|FG006|Overall Study|Lost to Follow-up|0|||
131924021|NCT02568423|475007206|FG007|Overall Study|Lost to Follow-up|0|||
131924022|NCT02568423|475007199|FG000|Overall Study|Physician Decision|0|||
131924023|NCT02568423|475007200|FG001|Overall Study|Physician Decision|0|||
131924024|NCT02568423|475007201|FG002|Overall Study|Physician Decision|0|||
131924025|NCT02568423|475007202|FG003|Overall Study|Physician Decision|0|||
131924026|NCT02568423|475007203|FG004|Overall Study|Physician Decision|0|||
131924027|NCT02568423|475007204|FG005|Overall Study|Physician Decision|1|||
131924028|NCT02568423|475007205|FG006|Overall Study|Physician Decision|0|||
131924029|NCT02568423|475007206|FG007|Overall Study|Physician Decision|0|||
131924030|NCT01027416|475007209|FG000|Overall Study|Withdrawal by Subject|0|||
131924031|NCT01027416|475007210|FG001|Overall Study|Withdrawal by Subject|1|||
131924032|NCT01027416|475007209|FG000|Overall Study|Physician Decision|1|||
131924033|NCT01027416|475007210|FG001|Overall Study|Physician Decision|4|||
131924034|NCT00245570|475007213|FG000|Washout Between Periods III and IV|Adverse Event|0|||
131924035|NCT00245570|475007214|FG001|Washout Between Periods III and IV|Adverse Event|1|||
131924036|NCT00245570|475007215|FG002|Washout Between Periods III and IV|Adverse Event|0|||
131924037|NCT00245570|475007216|FG003|Washout Between Periods III and IV|Adverse Event|0|||
131924038|NCT00245570|475007217|FG004|Washout Between Periods III and IV|Adverse Event|0|||
131924039|NCT00245570|475007218|FG005|Washout Between Periods III and IV|Adverse Event|0|||
131924040|NCT01829165|475007219|FG000|Overall Study|Did not complete intervention|2|||
131924041|NCT01829165|475007220|FG001|Overall Study|Did not complete intervention|0|||
131924042|NCT02391584|475007227|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
131924043|NCT02391584|475007228|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
131924044|NCT02391584|475007227|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
131924045|NCT02391584|475007228|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
131924046|NCT02391584|475007227|FG000|3 Month|Lost to Follow-up|1|||
131924047|NCT02391584|475007228|FG001|3 Month|Lost to Follow-up|0|||
131924048|NCT02391584|475007227|FG000|6 Month|Withdrawal by Subject|1|||
131924049|NCT02391584|475007228|FG001|6 Month|Withdrawal by Subject|0|||
131924050|NCT02391584|475007227|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
131924051|NCT02391584|475007228|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
131924052|NCT01160744|475007236|FG000|Overall Study|Withdrawal by Subject|11|||
131878284|NCT03261674|474835178|FG001|Overall Study|Physician Decision|0|||
131878285|NCT00623935|474835181|FG000|Overall Study|Death|1|||
131878286|NCT00623935|474835181|FG000|Overall Study|Patient Declined Transplant|1|||
131878287|NCT00747474|474835184|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878288|NCT00747474|474835185|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131924053|NCT01160744|475007237|FG001|Overall Study|Withdrawal by Subject|5|||
131924054|NCT01160744|475007238|FG002|Overall Study|Withdrawal by Subject|6|||
131924055|NCT01160744|475007239|FG003|Overall Study|Withdrawal by Subject|4|||
131924056|NCT01160744|475007236|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
131924057|NCT01160744|475007237|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
131924058|NCT01160744|475007238|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
131924059|NCT01160744|475007239|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
131924060|NCT02301429|475007248|FG000|Overall Study|not acceptable vascular anatomy|3|||
131924061|NCT04233580|475007249|FG000|Overall Study|Adverse Event|3|||
131924062|NCT04233580|475007250|FG001|Overall Study|Adverse Event|3|||
131924063|NCT04233580|475007249|FG000|Overall Study|Withdrawal by Subject|2|||
131924064|NCT04233580|475007250|FG001|Overall Study|Withdrawal by Subject|1|||
131878289|NCT00747474|474835186|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878290|NCT00747474|474835187|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878291|NCT00747474|474835188|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878292|NCT00747474|474835189|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878293|NCT00747474|474835190|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878294|NCT00747474|474835191|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
131878295|NCT00747474|474835192|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878296|NCT00747474|474835193|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878297|NCT00747474|474835194|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878298|NCT00747474|474835195|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
131878299|NCT04507256|474835196|FG000|Overall Study|Withdrawal by Subject|1|||
131878300|NCT04507256|474835197|FG001|Overall Study|Withdrawal by Subject|0|||
131878301|NCT04507256|474835198|FG002|Overall Study|Withdrawal by Subject|0|||
131878302|NCT04507256|474835199|FG003|Overall Study|Withdrawal by Subject|1|||
131878303|NCT04507256|474835200|FG004|Overall Study|Withdrawal by Subject|0|||
131878304|NCT04507256|474835201|FG005|Overall Study|Withdrawal by Subject|0|||
131878305|NCT00631410|474835202|FG000|Overall Study|Adverse Event|1|||
131878306|NCT00631410|474835203|FG001|Overall Study|Adverse Event|3|||
131878307|NCT00631410|474835202|FG000|Overall Study|Objective Progression or Relapse|4|||
131878308|NCT00631410|474835203|FG001|Overall Study|Objective Progression or Relapse|3|||
131878309|NCT00631410|474835202|FG000|Overall Study|Surgery|1|||
131878310|NCT00631410|474835203|FG001|Overall Study|Surgery|0|||
131878311|NCT02980341|474835208|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
131878312|NCT02980341|474835209|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
131878313|NCT02980341|474835210|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
131878314|NCT02980341|474835211|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
131878315|NCT02980341|474835212|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
131878316|NCT02980341|474835213|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
131878317|NCT02980341|474835214|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
131878318|NCT02980341|474835215|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
131878319|NCT02980341|474835216|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
131878320|NCT02980341|474835217|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
131878321|NCT02980341|474835218|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
131878322|NCT02980341|474835208|FG000|Dose Escalation|Clinical progression|0|||
131878323|NCT02980341|474835209|FG001|Dose Escalation|Clinical progression|0|||
131878324|NCT02980341|474835210|FG002|Dose Escalation|Clinical progression|2|||
131878325|NCT02980341|474835211|FG003|Dose Escalation|Clinical progression|1|||
131878326|NCT02980341|474835212|FG004|Dose Escalation|Clinical progression|0|||
131878327|NCT02980341|474835213|FG005|Dose Escalation|Clinical progression|0|||
131878328|NCT02980341|474835214|FG006|Dose Escalation|Clinical progression|0|||
131878329|NCT02980341|474835215|FG007|Dose Escalation|Clinical progression|0|||
131878330|NCT02980341|474835216|FG008|Dose Escalation|Clinical progression|0|||
131878331|NCT02980341|474835217|FG009|Dose Escalation|Clinical progression|0|||
131878332|NCT02980341|474835218|FG010|Dose Escalation|Clinical progression|0|||
131878333|NCT02980341|474835208|FG000|Dose Escalation|Adverse Event|0|||
131878334|NCT02980341|474835209|FG001|Dose Escalation|Adverse Event|0|||
131878335|NCT02980341|474835210|FG002|Dose Escalation|Adverse Event|1|||
131878336|NCT02980341|474835211|FG003|Dose Escalation|Adverse Event|2|||
131878337|NCT02980341|474835212|FG004|Dose Escalation|Adverse Event|2|||
131878338|NCT02980341|474835213|FG005|Dose Escalation|Adverse Event|0|||
131878339|NCT02980341|474835214|FG006|Dose Escalation|Adverse Event|0|||
131878340|NCT02980341|474835215|FG007|Dose Escalation|Adverse Event|0|||
131878341|NCT02980341|474835216|FG008|Dose Escalation|Adverse Event|0|||
131878342|NCT02980341|474835217|FG009|Dose Escalation|Adverse Event|0|||
131878343|NCT02980341|474835218|FG010|Dose Escalation|Adverse Event|0|||
131878344|NCT02980341|474835208|FG000|Dose Escalation|Withdrawal by Subject|0|||
131878345|NCT02980341|474835209|FG001|Dose Escalation|Withdrawal by Subject|0|||
131878346|NCT02980341|474835210|FG002|Dose Escalation|Withdrawal by Subject|1|||
131878347|NCT02980341|474835211|FG003|Dose Escalation|Withdrawal by Subject|0|||
131878348|NCT02980341|474835212|FG004|Dose Escalation|Withdrawal by Subject|0|||
131878349|NCT02980341|474835213|FG005|Dose Escalation|Withdrawal by Subject|0|||
131878350|NCT02980341|474835214|FG006|Dose Escalation|Withdrawal by Subject|0|||
131878351|NCT02980341|474835215|FG007|Dose Escalation|Withdrawal by Subject|0|||
131878352|NCT02980341|474835216|FG008|Dose Escalation|Withdrawal by Subject|0|||
131878353|NCT02980341|474835217|FG009|Dose Escalation|Withdrawal by Subject|0|||
131878354|NCT02980341|474835218|FG010|Dose Escalation|Withdrawal by Subject|0|||
131878355|NCT02980341|474835208|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878356|NCT02980341|474835209|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878357|NCT02980341|474835210|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878358|NCT02980341|474835211|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
131454008|NCT02023697|473291844|FG000|Long-term Follow-up Period|Other unspecified|6|||
131878359|NCT02980341|474835212|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878360|NCT02980341|474835213|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878361|NCT02980341|474835214|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878362|NCT02980341|474835215|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878363|NCT02980341|474835216|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878364|NCT02980341|474835217|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878365|NCT02980341|474835218|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
131878366|NCT02980341|474835208|FG000|Dose Escalation|Due to investigator's decision|0|||
131878367|NCT02980341|474835209|FG001|Dose Escalation|Due to investigator's decision|0|||
131878368|NCT02980341|474835210|FG002|Dose Escalation|Due to investigator's decision|0|||
131878369|NCT02980341|474835211|FG003|Dose Escalation|Due to investigator's decision|0|||
131878370|NCT02980341|474835212|FG004|Dose Escalation|Due to investigator's decision|1|||
131878371|NCT02980341|474835213|FG005|Dose Escalation|Due to investigator's decision|0|||
131878372|NCT02980341|474835214|FG006|Dose Escalation|Due to investigator's decision|0|||
131878373|NCT02980341|474835215|FG007|Dose Escalation|Due to investigator's decision|0|||
131924065|NCT02217982|475007251|FG000|Overall Study|Trial discontinued|1|||
131924066|NCT02217982|475007252|FG001|Overall Study|Trial discontinued|0|||
131924067|NCT02217982|475007251|FG000|Overall Study|Adverse Event|0|||
131924068|NCT02217982|475007252|FG001|Overall Study|Adverse Event|1|||
131924069|NCT02421510|475007253|FG000|Overall Study|Other|4|||
131924070|NCT02421510|475007254|FG001|Overall Study|Other|2|||
131924071|NCT02421510|475007255|FG002|Overall Study|Other|3|||
131924072|NCT02421510|475007253|FG000|Overall Study|Protocol Violation|1|||
131924073|NCT02421510|475007254|FG001|Overall Study|Protocol Violation|2|||
131924074|NCT02421510|475007255|FG002|Overall Study|Protocol Violation|0|||
131878374|NCT02980341|474835216|FG008|Dose Escalation|Due to investigator's decision|0|||
131878375|NCT02980341|474835217|FG009|Dose Escalation|Due to investigator's decision|0|||
131878376|NCT02980341|474835218|FG010|Dose Escalation|Due to investigator's decision|0|||
131878377|NCT02980341|474835208|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878378|NCT02980341|474835209|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878379|NCT02980341|474835210|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878380|NCT02980341|474835211|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878381|NCT02980341|474835212|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878382|NCT02980341|474835213|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
131878383|NCT02980341|474835214|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
131878384|NCT02980341|474835215|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878385|NCT02980341|474835216|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878386|NCT02980341|474835217|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878387|NCT02980341|474835218|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
131878388|NCT02980341|474835208|FG000|Dose Finding|Adverse Event|0|||
131878389|NCT02980341|474835209|FG001|Dose Finding|Adverse Event|0|||
131878390|NCT02980341|474835210|FG002|Dose Finding|Adverse Event|0|||
131878391|NCT02980341|474835211|FG003|Dose Finding|Adverse Event|0|||
131878392|NCT02980341|474835212|FG004|Dose Finding|Adverse Event|0|||
131878393|NCT02980341|474835213|FG005|Dose Finding|Adverse Event|3|||
131878394|NCT02980341|474835214|FG006|Dose Finding|Adverse Event|0|||
131878395|NCT02980341|474835215|FG007|Dose Finding|Adverse Event|0|||
131878396|NCT02980341|474835216|FG008|Dose Finding|Adverse Event|0|||
131878397|NCT02980341|474835217|FG009|Dose Finding|Adverse Event|0|||
131878398|NCT02980341|474835218|FG010|Dose Finding|Adverse Event|0|||
131878399|NCT02980341|474835208|FG000|Dose Finding|Withdrawal by Subject|0|||
131878400|NCT02980341|474835209|FG001|Dose Finding|Withdrawal by Subject|0|||
131878401|NCT02980341|474835210|FG002|Dose Finding|Withdrawal by Subject|0|||
131878402|NCT02980341|474835211|FG003|Dose Finding|Withdrawal by Subject|0|||
131878403|NCT02980341|474835212|FG004|Dose Finding|Withdrawal by Subject|0|||
131878404|NCT02980341|474835213|FG005|Dose Finding|Withdrawal by Subject|1|||
131878405|NCT02980341|474835214|FG006|Dose Finding|Withdrawal by Subject|1|||
131878406|NCT02980341|474835215|FG007|Dose Finding|Withdrawal by Subject|0|||
131878407|NCT02980341|474835216|FG008|Dose Finding|Withdrawal by Subject|0|||
131878408|NCT02980341|474835217|FG009|Dose Finding|Withdrawal by Subject|0|||
131878409|NCT02980341|474835218|FG010|Dose Finding|Withdrawal by Subject|0|||
131878410|NCT02980341|474835208|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131878411|NCT02980341|474835209|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131924075|NCT02421510|475007253|FG000|Overall Study|Death|1|||
131924076|NCT02421510|475007254|FG001|Overall Study|Death|0|||
131924077|NCT02421510|475007255|FG002|Overall Study|Death|0|||
131878412|NCT02980341|474835210|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131878413|NCT02980341|474835211|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131924078|NCT02421510|475007253|FG000|Overall Study|Noncompliance with study drug|1|||
131924079|NCT02421510|475007254|FG001|Overall Study|Noncompliance with study drug|0|||
131924080|NCT02421510|475007255|FG002|Overall Study|Noncompliance with study drug|0|||
131924081|NCT02421510|475007253|FG000|Overall Study|Physician Decision|1|||
131924082|NCT02421510|475007254|FG001|Overall Study|Physician Decision|1|||
131924083|NCT02421510|475007255|FG002|Overall Study|Physician Decision|3|||
131878414|NCT02980341|474835212|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131878415|NCT02980341|474835213|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131878416|NCT02980341|474835214|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
131878417|NCT02980341|474835215|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
131878418|NCT02980341|474835216|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
131878419|NCT02980341|474835217|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
131878420|NCT02980341|474835218|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
131878421|NCT02980341|474835208|FG000|Dose Expansion|Clinical progression|0|||
131878422|NCT02980341|474835209|FG001|Dose Expansion|Clinical progression|0|||
131878423|NCT02980341|474835210|FG002|Dose Expansion|Clinical progression|0|||
131878424|NCT02980341|474835211|FG003|Dose Expansion|Clinical progression|0|||
131878425|NCT02980341|474835212|FG004|Dose Expansion|Clinical progression|0|||
131878426|NCT02980341|474835213|FG005|Dose Expansion|Clinical progression|0|||
131878427|NCT02980341|474835214|FG006|Dose Expansion|Clinical progression|0|||
131878428|NCT02980341|474835215|FG007|Dose Expansion|Clinical progression|4|||
131878429|NCT02980341|474835216|FG008|Dose Expansion|Clinical progression|3|||
131878430|NCT02980341|474835217|FG009|Dose Expansion|Clinical progression|1|||
131878431|NCT02980341|474835218|FG010|Dose Expansion|Clinical progression|4|||
131878432|NCT02980341|474835208|FG000|Dose Expansion|Adverse Event|0|||
131878433|NCT02980341|474835209|FG001|Dose Expansion|Adverse Event|0|||
131878434|NCT02980341|474835210|FG002|Dose Expansion|Adverse Event|0|||
131878435|NCT02980341|474835211|FG003|Dose Expansion|Adverse Event|0|||
131878436|NCT02980341|474835212|FG004|Dose Expansion|Adverse Event|0|||
131878437|NCT02980341|474835213|FG005|Dose Expansion|Adverse Event|0|||
131878438|NCT02980341|474835214|FG006|Dose Expansion|Adverse Event|0|||
131878439|NCT02980341|474835215|FG007|Dose Expansion|Adverse Event|3|||
131878440|NCT02980341|474835216|FG008|Dose Expansion|Adverse Event|0|||
131878441|NCT02980341|474835217|FG009|Dose Expansion|Adverse Event|1|||
131878442|NCT02980341|474835218|FG010|Dose Expansion|Adverse Event|3|||
131878443|NCT02980341|474835208|FG000|Dose Expansion|Death|0|||
131878444|NCT02980341|474835209|FG001|Dose Expansion|Death|0|||
131878445|NCT02980341|474835210|FG002|Dose Expansion|Death|0|||
131878446|NCT02980341|474835211|FG003|Dose Expansion|Death|0|||
131878447|NCT02980341|474835212|FG004|Dose Expansion|Death|0|||
131878448|NCT02980341|474835213|FG005|Dose Expansion|Death|0|||
131878449|NCT02980341|474835214|FG006|Dose Expansion|Death|0|||
131878450|NCT02980341|474835215|FG007|Dose Expansion|Death|0|||
131878451|NCT02980341|474835216|FG008|Dose Expansion|Death|2|||
131878452|NCT02980341|474835217|FG009|Dose Expansion|Death|1|||
131878453|NCT02980341|474835218|FG010|Dose Expansion|Death|0|||
131878454|NCT02980341|474835208|FG000|Dose Expansion|Withdrawal by Subject|0|||
131878455|NCT02980341|474835209|FG001|Dose Expansion|Withdrawal by Subject|0|||
131878456|NCT02980341|474835210|FG002|Dose Expansion|Withdrawal by Subject|0|||
131878457|NCT02980341|474835211|FG003|Dose Expansion|Withdrawal by Subject|0|||
131878458|NCT02980341|474835212|FG004|Dose Expansion|Withdrawal by Subject|0|||
131878459|NCT02980341|474835213|FG005|Dose Expansion|Withdrawal by Subject|0|||
131878460|NCT02980341|474835214|FG006|Dose Expansion|Withdrawal by Subject|0|||
131878461|NCT02980341|474835215|FG007|Dose Expansion|Withdrawal by Subject|2|||
131878462|NCT02980341|474835216|FG008|Dose Expansion|Withdrawal by Subject|0|||
131878463|NCT02980341|474835217|FG009|Dose Expansion|Withdrawal by Subject|1|||
131878464|NCT02980341|474835218|FG010|Dose Expansion|Withdrawal by Subject|0|||
131878465|NCT02980341|474835208|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878466|NCT02980341|474835209|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878467|NCT02980341|474835210|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878468|NCT02980341|474835211|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878469|NCT02980341|474835212|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878470|NCT02980341|474835213|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878471|NCT02980341|474835214|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878472|NCT02980341|474835215|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
131878473|NCT02980341|474835216|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878474|NCT02980341|474835217|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878475|NCT02980341|474835218|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
131878476|NCT02980341|474835208|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878477|NCT02980341|474835209|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878478|NCT02980341|474835210|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878479|NCT02980341|474835211|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878480|NCT02980341|474835212|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878481|NCT02980341|474835213|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878482|NCT02980341|474835214|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131924084|NCT02421510|475007253|FG000|Overall Study|Adverse Event|9|||
131924085|NCT02421510|475007254|FG001|Overall Study|Adverse Event|10|||
131924086|NCT02421510|475007255|FG002|Overall Study|Adverse Event|18|||
131924087|NCT02421510|475007253|FG000|Overall Study|Pregnancy|1|||
131924088|NCT02421510|475007254|FG001|Overall Study|Pregnancy|1|||
131924089|NCT02421510|475007255|FG002|Overall Study|Pregnancy|0|||
131924090|NCT02421510|475007253|FG000|Overall Study|Withdrawal by Subject|14|||
131924091|NCT02421510|475007254|FG001|Overall Study|Withdrawal by Subject|18|||
131924092|NCT02421510|475007255|FG002|Overall Study|Withdrawal by Subject|12|||
131924093|NCT02421510|475007253|FG000|Overall Study|Lost to Follow-up|1|||
131924094|NCT02421510|475007254|FG001|Overall Study|Lost to Follow-up|1|||
131924095|NCT02421510|475007255|FG002|Overall Study|Lost to Follow-up|0|||
131924096|NCT01755637|475007258|FG000|Period 1|Adverse Event|0|||
131924097|NCT01755637|475007259|FG001|Period 1|Adverse Event|1|||
131924098|NCT01814332|475007260|FG000|Overall Study|Adverse Event|8|||
131924099|NCT01814332|475007261|FG001|Overall Study|Adverse Event|3|||
131924100|NCT01814332|475007260|FG000|Overall Study|Withdrawal by Subject|3|||
131924101|NCT01814332|475007261|FG001|Overall Study|Withdrawal by Subject|8|||
131924102|NCT01814332|475007260|FG000|Overall Study|Protocol Violation|0|||
131924103|NCT01814332|475007261|FG001|Overall Study|Protocol Violation|4|||
131924104|NCT01814332|475007260|FG000|Overall Study|Lost to Follow-up|5|||
131924105|NCT01814332|475007261|FG001|Overall Study|Lost to Follow-up|1|||
131924106|NCT00122187|475007266|FG000|Overall Study|Withdrew because of resource limitations|2|||
131924107|NCT00122187|475007267|FG001|Overall Study|Withdrew because of resource limitations|2|||
131924108|NCT02061592|475007268|FG000|Period 1|Withdrawal by Subject|1|||
131924109|NCT02061592|475007269|FG001|Period 1|Withdrawal by Subject|0|||
131924110|NCT02061592|475007268|FG000|Period 1|Protocol Violation|1|||
131924111|NCT02061592|475007269|FG001|Period 1|Protocol Violation|0|||
131924112|NCT02061592|475007268|FG000|Period 2|Lost to Follow-up|0|||
131924113|NCT02061592|475007269|FG001|Period 2|Lost to Follow-up|1|||
131924114|NCT05061706|475007272|FG000|Overall Study|Adverse Event|29|||
131924115|NCT05061706|475007273|FG001|Overall Study|Adverse Event|1|||
131924116|NCT05061706|475007272|FG000|Overall Study|Lack of Efficacy|0|||
131924117|NCT05061706|475007273|FG001|Overall Study|Lack of Efficacy|1|||
131924118|NCT05061706|475007272|FG000|Overall Study|Lost to Follow-up|2|||
131924119|NCT05061706|475007273|FG001|Overall Study|Lost to Follow-up|2|||
131924120|NCT05061706|475007272|FG000|Overall Study|Protocol Violation|3|||
131924121|NCT05061706|475007273|FG001|Overall Study|Protocol Violation|1|||
131924122|NCT05061706|475007272|FG000|Overall Study|Withdrawal by Subject|3|||
131924123|NCT05061706|475007273|FG001|Overall Study|Withdrawal by Subject|9|||
131924124|NCT01279200|475007274|FG000|Overall Study|Withdrawal by Subject|1|||
131924125|NCT01279200|475007275|FG001|Overall Study|Withdrawal by Subject|3|||
131924126|NCT01279200|475007274|FG000|Overall Study|Patient withdrawal due to high cost|0|||
131924127|NCT01279200|475007275|FG001|Overall Study|Patient withdrawal due to high cost|1|||
131924128|NCT01279200|475007274|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
131924129|NCT01279200|475007275|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
131924130|NCT01279200|475007274|FG000|Overall Study|ultrasound screening failure|0|||
131924131|NCT01279200|475007275|FG001|Overall Study|ultrasound screening failure|1|||
131924132|NCT01279200|475007274|FG000|Overall Study|Lost to Follow-up|0|||
131924133|NCT01279200|475007275|FG001|Overall Study|Lost to Follow-up|1|||
131924134|NCT01279200|475007274|FG000|Overall Study|Adverse Event|1|||
131924135|NCT01279200|475007275|FG001|Overall Study|Adverse Event|0|||
131924136|NCT00541775|475007281|FG000|Overall Study|Adverse Event|3|||
131924137|NCT00541775|475007282|FG001|Overall Study|Adverse Event|2|||
131924138|NCT00541775|475007283|FG002|Overall Study|Adverse Event|1|||
131924139|NCT00541775|475007281|FG000|Overall Study|Lack of Efficacy|0|||
131924140|NCT00541775|475007282|FG001|Overall Study|Lack of Efficacy|0|||
131924141|NCT00541775|475007283|FG002|Overall Study|Lack of Efficacy|3|||
131878483|NCT02980341|474835215|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878484|NCT02980341|474835216|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
131878485|NCT02980341|474835217|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878486|NCT02980341|474835218|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
131878487|NCT02980341|474835208|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878488|NCT02980341|474835209|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878489|NCT02980341|474835210|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131924142|NCT00541775|475007281|FG000|Overall Study|Lost to Follow-up|0|||
131924143|NCT00541775|475007282|FG001|Overall Study|Lost to Follow-up|0|||
131924144|NCT00541775|475007283|FG002|Overall Study|Lost to Follow-up|2|||
131924145|NCT00541775|475007281|FG000|Overall Study|Protocol Violation|1|||
131924146|NCT00541775|475007282|FG001|Overall Study|Protocol Violation|0|||
131924147|NCT00541775|475007283|FG002|Overall Study|Protocol Violation|0|||
131924148|NCT00541775|475007281|FG000|Overall Study|Withdrawal by Subject and Other|5|||
131924149|NCT00541775|475007282|FG001|Overall Study|Withdrawal by Subject and Other|0|||
131924150|NCT00541775|475007283|FG002|Overall Study|Withdrawal by Subject and Other|2|||
131924151|NCT02939781|475007284|FG000|Overall Study|Protocol Violation|8|||
131924152|NCT02939781|475007284|FG000|Overall Study|Withdrawal by Subject|1|||
131924153|NCT01666314|475007285|FG000|Overall Study|Adverse Event|3|||
131924154|NCT01666314|475007286|FG001|Overall Study|Adverse Event|13|||
131924155|NCT01666314|475007287|FG002|Overall Study|Adverse Event|7|||
131924156|NCT01666314|475007288|FG003|Overall Study|Adverse Event|7|||
131924157|NCT01666314|475007285|FG000|Overall Study|Progressive Disease|11|||
131924158|NCT01666314|475007286|FG001|Overall Study|Progressive Disease|9|||
131924159|NCT01666314|475007287|FG002|Overall Study|Progressive Disease|19|||
131924160|NCT01666314|475007288|FG003|Overall Study|Progressive Disease|20|||
131924161|NCT01666314|475007285|FG000|Overall Study|Symptomatic Deterioration|1|||
131924162|NCT01666314|475007286|FG001|Overall Study|Symptomatic Deterioration|0|||
131924163|NCT01666314|475007287|FG002|Overall Study|Symptomatic Deterioration|2|||
131924164|NCT01666314|475007288|FG003|Overall Study|Symptomatic Deterioration|0|||
131924165|NCT01666314|475007285|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
131924166|NCT01666314|475007286|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
131924167|NCT01666314|475007287|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
131924168|NCT01666314|475007288|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
131409280|NCT01253265|473120854|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
131409281|NCT01253265|473120855|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
131409282|NCT01253265|473120856|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
131409283|NCT01253265|473120857|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
131878490|NCT02980341|474835211|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878491|NCT02980341|474835212|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878492|NCT02980341|474835213|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878493|NCT02980341|474835214|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878494|NCT02980341|474835215|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878495|NCT02980341|474835216|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
131878496|NCT02980341|474835217|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878497|NCT02980341|474835218|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
131878498|NCT02980341|474835208|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878499|NCT02980341|474835209|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878500|NCT02980341|474835210|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878501|NCT02980341|474835211|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878502|NCT02980341|474835212|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878503|NCT02980341|474835213|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878504|NCT02980341|474835214|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878505|NCT02980341|474835215|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878506|NCT02980341|474835216|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878507|NCT02980341|474835217|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
131878508|NCT02980341|474835218|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
131878509|NCT01647516|474835219|FG000|Induction Period (IP)|Physician Decision|2|||
131878510|NCT01647516|474835220|FG001|Induction Period (IP)|Physician Decision|0|||
131878511|NCT01647516|474835221|FG002|Induction Period (IP)|Physician Decision|0|||
131878512|NCT01647516|474835222|FG003|Induction Period (IP)|Physician Decision|0|||
131878513|NCT01647516|474835223|FG004|Induction Period (IP)|Physician Decision|0|||
131878514|NCT01647516|474835224|FG005|Induction Period (IP)|Physician Decision|0|||
131878515|NCT01647516|474835219|FG000|Induction Period (IP)|Adverse Event|1|||
131878516|NCT01647516|474835220|FG001|Induction Period (IP)|Adverse Event|2|||
131878517|NCT01647516|474835221|FG002|Induction Period (IP)|Adverse Event|0|||
131878518|NCT01647516|474835222|FG003|Induction Period (IP)|Adverse Event|0|||
131878519|NCT01647516|474835223|FG004|Induction Period (IP)|Adverse Event|0|||
131878520|NCT01647516|474835224|FG005|Induction Period (IP)|Adverse Event|0|||
131878521|NCT01647516|474835219|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
131878522|NCT01647516|474835220|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
131878523|NCT01647516|474835221|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
131878524|NCT01647516|474835222|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
131878525|NCT01647516|474835223|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
131878526|NCT01647516|474835224|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
131878527|NCT01647516|474835219|FG000|Induction Period (IP)|Participant Choice|0|||
131878528|NCT01647516|474835220|FG001|Induction Period (IP)|Participant Choice|0|||
131878529|NCT01647516|474835221|FG002|Induction Period (IP)|Participant Choice|1|||
131878530|NCT01647516|474835222|FG003|Induction Period (IP)|Participant Choice|0|||
131878531|NCT01647516|474835223|FG004|Induction Period (IP)|Participant Choice|0|||
131878532|NCT01647516|474835224|FG005|Induction Period (IP)|Participant Choice|0|||
131878533|NCT01647516|474835219|FG000|Induction Period (IP)|Lack of Efficacy|1|||
131878534|NCT01647516|474835220|FG001|Induction Period (IP)|Lack of Efficacy|0|||
131878535|NCT01647516|474835221|FG002|Induction Period (IP)|Lack of Efficacy|0|||
131924169|NCT01666314|475007285|FG000|Overall Study|Withdrawal by Subject|1|||
131409284|NCT01253265|473120853|FG000|Overall Study|Withdrawal by Subject|0|||
131878536|NCT01647516|474835222|FG003|Induction Period (IP)|Lack of Efficacy|0|||
131878537|NCT01647516|474835223|FG004|Induction Period (IP)|Lack of Efficacy|0|||
131878538|NCT01647516|474835224|FG005|Induction Period (IP)|Lack of Efficacy|0|||
131878539|NCT01647516|474835219|FG000|Induction Period (IP)|No study drug received|1|||
131878540|NCT01647516|474835220|FG001|Induction Period (IP)|No study drug received|1|||
131878541|NCT01647516|474835221|FG002|Induction Period (IP)|No study drug received|0|||
131878542|NCT01647516|474835222|FG003|Induction Period (IP)|No study drug received|0|||
131878543|NCT01647516|474835223|FG004|Induction Period (IP)|No study drug received|0|||
131878544|NCT01647516|474835224|FG005|Induction Period (IP)|No study drug received|0|||
131878545|NCT01647516|474835219|FG000|Maintenance Period (MP)|Adverse Event|2|||
131878546|NCT01647516|474835220|FG001|Maintenance Period (MP)|Adverse Event|1|||
131878547|NCT01647516|474835221|FG002|Maintenance Period (MP)|Adverse Event|0|||
131878548|NCT01647516|474835222|FG003|Maintenance Period (MP)|Adverse Event|0|||
131878549|NCT01647516|474835223|FG004|Maintenance Period (MP)|Adverse Event|0|||
131878550|NCT01647516|474835224|FG005|Maintenance Period (MP)|Adverse Event|0|||
131878551|NCT01647516|474835219|FG000|Maintenance Period (MP)|Non-compliance|1|||
131878552|NCT01647516|474835220|FG001|Maintenance Period (MP)|Non-compliance|0|||
131878553|NCT01647516|474835221|FG002|Maintenance Period (MP)|Non-compliance|0|||
131878554|NCT01647516|474835222|FG003|Maintenance Period (MP)|Non-compliance|0|||
131878555|NCT01647516|474835223|FG004|Maintenance Period (MP)|Non-compliance|0|||
131878556|NCT01647516|474835224|FG005|Maintenance Period (MP)|Non-compliance|0|||
131878557|NCT01647516|474835219|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
131878558|NCT01647516|474835220|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
131878559|NCT01647516|474835221|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
131878560|NCT01647516|474835222|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
131878561|NCT01647516|474835223|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
131878562|NCT01647516|474835224|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
131878563|NCT01647516|474835219|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
131878564|NCT01647516|474835220|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
131878565|NCT01647516|474835221|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
131878566|NCT01647516|474835222|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
131878567|NCT01647516|474835223|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
131878568|NCT01647516|474835224|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
131878569|NCT01647516|474835219|FG000|Open-Label Period|Adverse Event|0|||
131878570|NCT01647516|474835220|FG001|Open-Label Period|Adverse Event|0|||
131878571|NCT01647516|474835221|FG002|Open-Label Period|Adverse Event|0|||
131878572|NCT01647516|474835222|FG003|Open-Label Period|Adverse Event|5|||
131878573|NCT01647516|474835223|FG004|Open-Label Period|Adverse Event|6|||
131878574|NCT01647516|474835224|FG005|Open-Label Period|Adverse Event|3|||
131878575|NCT01647516|474835219|FG000|Open-Label Period|Pregnancy|0|||
131878576|NCT01647516|474835220|FG001|Open-Label Period|Pregnancy|0|||
131878577|NCT01647516|474835221|FG002|Open-Label Period|Pregnancy|0|||
131878578|NCT01647516|474835222|FG003|Open-Label Period|Pregnancy|0|||
131878579|NCT01647516|474835223|FG004|Open-Label Period|Pregnancy|0|||
131878580|NCT01647516|474835224|FG005|Open-Label Period|Pregnancy|1|||
131878581|NCT01647516|474835219|FG000|Open-Label Period|Non-compliance|0|||
131878582|NCT01647516|474835220|FG001|Open-Label Period|Non-compliance|0|||
131878583|NCT01647516|474835221|FG002|Open-Label Period|Non-compliance|0|||
131878584|NCT01647516|474835222|FG003|Open-Label Period|Non-compliance|1|||
131878585|NCT01647516|474835223|FG004|Open-Label Period|Non-compliance|0|||
131878586|NCT01647516|474835224|FG005|Open-Label Period|Non-compliance|1|||
131878587|NCT01647516|474835219|FG000|Open-Label Period|Physician Decision|0|||
131878588|NCT01647516|474835220|FG001|Open-Label Period|Physician Decision|0|||
131878589|NCT01647516|474835221|FG002|Open-Label Period|Physician Decision|0|||
131878590|NCT01647516|474835222|FG003|Open-Label Period|Physician Decision|1|||
131878591|NCT01647516|474835223|FG004|Open-Label Period|Physician Decision|1|||
131878592|NCT01647516|474835224|FG005|Open-Label Period|Physician Decision|0|||
131878593|NCT01647516|474835219|FG000|Open-Label Period|Withdrawal by Subject|0|||
131878594|NCT01647516|474835220|FG001|Open-Label Period|Withdrawal by Subject|0|||
131878595|NCT01647516|474835221|FG002|Open-Label Period|Withdrawal by Subject|0|||
131878596|NCT01647516|474835222|FG003|Open-Label Period|Withdrawal by Subject|9|||
131878597|NCT01647516|474835223|FG004|Open-Label Period|Withdrawal by Subject|11|||
131878598|NCT01647516|474835224|FG005|Open-Label Period|Withdrawal by Subject|6|||
131878599|NCT01647516|474835219|FG000|Open-Label Period|Lost to Follow-up|0|||
131878600|NCT01647516|474835220|FG001|Open-Label Period|Lost to Follow-up|0|||
131878601|NCT01647516|474835221|FG002|Open-Label Period|Lost to Follow-up|0|||
131878602|NCT01647516|474835222|FG003|Open-Label Period|Lost to Follow-up|1|||
131878603|NCT01647516|474835223|FG004|Open-Label Period|Lost to Follow-up|0|||
131878604|NCT01647516|474835224|FG005|Open-Label Period|Lost to Follow-up|1|||
131878605|NCT01647516|474835219|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
131878606|NCT01647516|474835220|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
131878607|NCT01647516|474835221|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
131878608|NCT01647516|474835222|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
131409285|NCT01253265|473120854|FG001|Overall Study|Withdrawal by Subject|0|||
131409286|NCT01253265|473120855|FG002|Overall Study|Withdrawal by Subject|0|||
131409287|NCT01253265|473120856|FG003|Overall Study|Withdrawal by Subject|0|||
131409288|NCT01253265|473120857|FG004|Overall Study|Withdrawal by Subject|1|||
131878609|NCT01647516|474835223|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
131878610|NCT01647516|474835224|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
131878611|NCT01647516|474835219|FG000|Open-Label Period|Lack of Efficacy|0|||
131878612|NCT01647516|474835220|FG001|Open-Label Period|Lack of Efficacy|0|||
131878613|NCT01647516|474835221|FG002|Open-Label Period|Lack of Efficacy|0|||
131878614|NCT01647516|474835222|FG003|Open-Label Period|Lack of Efficacy|7|||
131878615|NCT01647516|474835223|FG004|Open-Label Period|Lack of Efficacy|9|||
131878616|NCT01647516|474835224|FG005|Open-Label Period|Lack of Efficacy|10|||
131878617|NCT01647516|474835219|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
131878618|NCT01647516|474835220|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
131878619|NCT01647516|474835221|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
131878620|NCT01647516|474835222|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
131878621|NCT01647516|474835223|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
131878622|NCT01647516|474835224|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
131878623|NCT01647516|474835219|FG000|Open-Label Period|No completion / discontinuation visit|0|||
131878624|NCT01647516|474835220|FG001|Open-Label Period|No completion / discontinuation visit|0|||
131878625|NCT01647516|474835221|FG002|Open-Label Period|No completion / discontinuation visit|0|||
131878626|NCT01647516|474835222|FG003|Open-Label Period|No completion / discontinuation visit|0|||
131878627|NCT01647516|474835223|FG004|Open-Label Period|No completion / discontinuation visit|2|||
131878628|NCT01647516|474835224|FG005|Open-Label Period|No completion / discontinuation visit|1|||
131878629|NCT03193801|474835225|FG000|Overall Study|Physician Decision|2|||
131878630|NCT03193801|474835225|FG000|Overall Study|Withdrawal by Subject|1|||
131878631|NCT04964544|474835226|FG000|Overall Study|Screen failure or other uncategorised|10|||
131878632|NCT04964544|474835226|FG000|Overall Study|Physician Decision|4|||
131878633|NCT04964544|474835226|FG000|Overall Study|Lost to Follow-up|9|||
131878634|NCT04964544|474835226|FG000|Overall Study|Withdrawal by Subject|18|||
131878635|NCT04964544|474835226|FG000|Overall Study|Death|1|||
131878636|NCT01613222|474835229|FG000|Overall Study|Physician Decision|1|||
131878637|NCT01613222|474835229|FG000|Overall Study|Unable to place arterial line|1|||
131878638|NCT01613222|474835229|FG000|Overall Study|Reused disposable sensors|10|||
131878639|NCT00749684|474835230|FG000|Overall Study|Death|1|||
131878640|NCT00749684|474835230|FG000|Overall Study|Adverse Event|27|||
131878641|NCT00749684|474835230|FG000|Overall Study|Participant's Wish|10|||
131878642|NCT00749684|474835230|FG000|Overall Study|Not Documented|1|||
131878643|NCT00749684|474835230|FG000|Overall Study|Progressive Desease|31|||
131878644|NCT00749684|474835230|FG000|Overall Study|Therapy according to protocol + AE|2|||
131878645|NCT00749684|474835230|FG000|Overall Study|AE+discontinuation on participants wish|1|||
131878646|NCT00749684|474835230|FG000|Overall Study|Missing|9|||
131878647|NCT03696108|474835231|FG000|Overall Study|Physician Decision|1|||
131878648|NCT03696108|474835232|FG001|Overall Study|Physician Decision|0|||
131878649|NCT03696108|474835231|FG000|Overall Study|Withdrawal by Subject|3|||
131878650|NCT03696108|474835232|FG001|Overall Study|Withdrawal by Subject|6|||
131878651|NCT03505593|474835233|FG000|Overall Study|Withdrawal by Subject|1|||
131878652|NCT03505593|474835233|FG000|Overall Study|Died before procedure|1|||
131878653|NCT03505593|474835233|FG000|Overall Study|Anatomical abnormality|1|||
131878654|NCT03505593|474835233|FG000|Overall Study|Unable to pass through esophagus|1|||
131878655|NCT03505593|474835233|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
131878656|NCT02892422|474835236|FG000|Overall Study|Enrolled not treated|4|||
131878657|NCT02892422|474835236|FG000|Overall Study|Adverse Event|38|||
131878658|NCT02892422|474835236|FG000|Overall Study|Lack of Efficacy|32|||
131878659|NCT02892422|474835236|FG000|Overall Study|Non-compliance with study drug|11|||
131878660|NCT02892422|474835236|FG000|Overall Study|Protocol Violation|4|||
131878661|NCT02892422|474835236|FG000|Overall Study|Withdrawal by Subject|56|||
131878662|NCT02892422|474835236|FG000|Overall Study|Lost to Follow-up|5|||
131878663|NCT02892422|474835236|FG000|Overall Study|sponsor information 16159A results|21|||
131878664|NCT02892422|474835236|FG000|Overall Study|withdrawal of consent|13|||
131878665|NCT02892422|474835236|FG000|Overall Study|exclusion criteria met|3|||
131878666|NCT02892422|474835236|FG000|Overall Study|moving elsewhere|4|||
131878667|NCT02892422|474835236|FG000|Overall Study|non-compliance|10|||
131878668|NCT02892422|474835236|FG000|Overall Study|patient legally incapable|1|||
131878669|NCT02892422|474835236|FG000|Overall Study|patient decision|7|||
131878670|NCT02892422|474835236|FG000|Overall Study|Investigator decision|1|||
131878671|NCT01023256|474835237|FG000|Overall Study|Protocol Violation|2|||
131878672|NCT01023256|474835238|FG001|Overall Study|Protocol Violation|3|||
131878673|NCT01023256|474835239|FG002|Overall Study|Protocol Violation|0|||
131878674|NCT01023256|474835240|FG003|Overall Study|Protocol Violation|0|||
131878675|NCT01023256|474835237|FG000|Overall Study|Randomized but not treated|1|||
131878676|NCT01023256|474835238|FG001|Overall Study|Randomized but not treated|0|||
131878677|NCT01023256|474835239|FG002|Overall Study|Randomized but not treated|1|||
131878678|NCT01023256|474835240|FG003|Overall Study|Randomized but not treated|0|||
131924170|NCT01666314|475007286|FG001|Overall Study|Withdrawal by Subject|1|||
131878679|NCT01023256|474835237|FG000|Overall Study|Other|1|||
131878680|NCT01023256|474835238|FG001|Overall Study|Other|0|||
131878681|NCT01023256|474835239|FG002|Overall Study|Other|0|||
131878682|NCT01023256|474835240|FG003|Overall Study|Other|2|||
131878683|NCT01023256|474835237|FG000|Overall Study|Adverse Event|0|||
131878684|NCT01023256|474835238|FG001|Overall Study|Adverse Event|0|||
131878685|NCT01023256|474835239|FG002|Overall Study|Adverse Event|0|||
131878686|NCT01023256|474835240|FG003|Overall Study|Adverse Event|1|||
131878687|NCT01023256|474835237|FG000|Overall Study|Withdrawal by Subject|0|||
131878688|NCT01023256|474835238|FG001|Overall Study|Withdrawal by Subject|0|||
131878689|NCT01023256|474835239|FG002|Overall Study|Withdrawal by Subject|0|||
131878690|NCT01023256|474835240|FG003|Overall Study|Withdrawal by Subject|2|||
131878691|NCT00089778|474835241|FG000|Overall Study|Protocol Violation|0|||
131878692|NCT00089778|474835242|FG001|Overall Study|Protocol Violation|0|||
131878693|NCT00089778|474835243|FG002|Overall Study|Protocol Violation|1|||
131878694|NCT01475851|474835244|FG000|Overall Study|Protocol defined stopping criteria|1|||
131878695|NCT01475851|474835245|FG001|Overall Study|Protocol defined stopping criteria|0|||
131878696|NCT01867294|474835246|FG000|Overall Study|Withdrawal by Subject|1|||
131878697|NCT01867294|474835247|FG001|Overall Study|Withdrawal by Subject|1|||
131878698|NCT01867294|474835248|FG002|Overall Study|Withdrawal by Subject|0|||
131878699|NCT01867294|474835249|FG003|Overall Study|Withdrawal by Subject|0|||
131878700|NCT02447497|474835250|FG000|Overall Study|Did not meet treatment day baseline.|6|||
131878701|NCT02447497|474835251|FG001|Overall Study|Did not meet treatment day baseline.|5|||
131878702|NCT02447497|474835252|FG002|Overall Study|Did not meet treatment day baseline.|2|||
131878703|NCT02447497|474835253|FG003|Overall Study|Did not meet treatment day baseline.|2|||
131878704|NCT02447497|474835250|FG000|Overall Study|Dressing was compromised|0|||
131878705|NCT02447497|474835251|FG001|Overall Study|Dressing was compromised|1|||
131878706|NCT02447497|474835252|FG002|Overall Study|Dressing was compromised|0|||
131878707|NCT02447497|474835253|FG003|Overall Study|Dressing was compromised|0|||
131878708|NCT02017912|474835254|FG000|Overall Study|Withdrawal by Subject|2|||
131878709|NCT02017912|474835255|FG001|Overall Study|Withdrawal by Subject|1|||
131878710|NCT02017912|474835254|FG000|Overall Study|miscellaneous|1|||
131878711|NCT02017912|474835255|FG001|Overall Study|miscellaneous|1|||
131878712|NCT01322035|474835256|FG000|Overall Study|Lost to Follow-up|8|||
131878713|NCT01322035|474835257|FG001|Overall Study|Lost to Follow-up|3|||
131878714|NCT00319592|474835259|FG000|Overall Study|Protocol Violation|1|||
131878715|NCT00319592|474835260|FG001|Overall Study|Protocol Violation|0|||
131878716|NCT00319592|474835259|FG000|Overall Study|Physician Decision|0|||
131878717|NCT00319592|474835260|FG001|Overall Study|Physician Decision|1|||
131878718|NCT05033262|474835263|FG000|Overall Study|Lost to Follow-up|1|||
131878719|NCT05033262|474835264|FG001|Overall Study|Lost to Follow-up|0|||
131878720|NCT05033262|474835265|FG002|Overall Study|Lost to Follow-up|0|||
131878721|NCT05033262|474835266|FG003|Overall Study|Lost to Follow-up|1|||
131878722|NCT02396420|474835267|FG000|Overall Study|Death|1|||
131878723|NCT01273623|474835268|FG000|Overall Study|did not meet IVUS criteria|29|||
131878724|NCT01493284|474835270|FG000|Overall Study|Death|29|||
131878725|NCT01493284|474835270|FG000|Overall Study|Withdrawal by Subject|32|||
131878726|NCT00325156|474835273|FG000|Overall Study|Protocol Violation|8|||
131878727|NCT00325156|474835273|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
131878728|NCT00325156|474835273|FG000|Overall Study|Migrated/moved from study area|12|||
131878729|NCT00325156|474835273|FG000|Overall Study|Adverse event, non-fatal|3|||
131878730|NCT00325156|474835273|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
131878731|NCT00325156|474835273|FG000|Overall Study|Other|1|||
131878732|NCT00325156|474835273|FG000|Overall Study|Withdrawal by Subject|31|||
131878733|NCT00519428|474835274|FG000|Overall Study|Adverse Event|5|||
131878734|NCT00519428|474835275|FG001|Overall Study|Adverse Event|2|||
131878735|NCT00519428|474835276|FG002|Overall Study|Adverse Event|10|||
131878736|NCT00519428|474835274|FG000|Overall Study|Lost to Follow-up|7|||
131878737|NCT00519428|474835275|FG001|Overall Study|Lost to Follow-up|7|||
131878738|NCT00519428|474835276|FG002|Overall Study|Lost to Follow-up|6|||
131878739|NCT00519428|474835274|FG000|Overall Study|Withdrawal by Subject|8|||
131878740|NCT00519428|474835275|FG001|Overall Study|Withdrawal by Subject|3|||
131878741|NCT00519428|474835276|FG002|Overall Study|Withdrawal by Subject|7|||
131878742|NCT00519428|474835274|FG000|Overall Study|unstated|1|||
131878743|NCT00519428|474835275|FG001|Overall Study|unstated|3|||
131878744|NCT00519428|474835276|FG002|Overall Study|unstated|2|||
131878745|NCT04064411|474835277|FG000|Overall Study|Adverse Event|29|||
131878746|NCT04064411|474835278|FG001|Overall Study|Adverse Event|19|||
131878747|NCT04064411|474835277|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
131878748|NCT04064411|474835278|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
131878749|NCT04064411|474835277|FG000|Overall Study|Protocol Deviation|0|||
131878750|NCT04064411|474835278|FG001|Overall Study|Protocol Deviation|2|||
131878751|NCT04064411|474835277|FG000|Overall Study|Withdrawal by Subject|25|||
131878752|NCT04064411|474835278|FG001|Overall Study|Withdrawal by Subject|29|||
131878753|NCT04064411|474835277|FG000|Overall Study|Lost to Follow-up|5|||
131878754|NCT04064411|474835278|FG001|Overall Study|Lost to Follow-up|2|||
131878755|NCT04064411|474835277|FG000|Overall Study|Other than Specified|4|||
131409289|NCT00541099|473120858|FG000|Overall Study|Ineligible|3|||
131878756|NCT04064411|474835278|FG001|Overall Study|Other than Specified|1|||
131878757|NCT04064411|474835277|FG000|Overall Study|Death|1|||
131878758|NCT04064411|474835278|FG001|Overall Study|Death|0|||
131878759|NCT03395184|474835281|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
131878760|NCT03395184|474835282|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
131878761|NCT03395184|474835283|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
131878762|NCT03395184|474835284|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
131878763|NCT03395184|474835285|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
131878764|NCT03395184|474835286|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
131878765|NCT03395184|474835287|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
131878766|NCT03395184|474835281|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
131878767|NCT03395184|474835282|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
131878768|NCT03395184|474835283|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
131878769|NCT03395184|474835284|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
131878770|NCT03395184|474835285|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
131878771|NCT03395184|474835286|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
131878772|NCT03395184|474835287|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
131878773|NCT03395184|474835281|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
131878774|NCT03395184|474835282|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
131878775|NCT03395184|474835283|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131878776|NCT03395184|474835284|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131878777|NCT03395184|474835285|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131878778|NCT03395184|474835286|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131878779|NCT03395184|474835287|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131878780|NCT03395184|474835281|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
131878781|NCT03395184|474835282|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
131878782|NCT03395184|474835283|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
131878783|NCT03395184|474835284|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
131878784|NCT03395184|474835285|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
131878785|NCT03395184|474835286|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
131878786|NCT03395184|474835287|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
131878787|NCT03395184|474835281|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
131878788|NCT03395184|474835282|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131878789|NCT03395184|474835283|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
131878790|NCT03395184|474835284|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131878791|NCT03395184|474835285|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131878792|NCT03395184|474835286|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131878793|NCT03395184|474835287|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131878794|NCT03395184|474835281|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
131878795|NCT03395184|474835282|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
131878796|NCT03395184|474835283|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
131878797|NCT03395184|474835284|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
131878798|NCT03395184|474835285|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
131878799|NCT03395184|474835286|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
131878800|NCT03395184|474835287|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
131878801|NCT03395184|474835281|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
131878802|NCT03395184|474835282|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
131878803|NCT03395184|474835283|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
131878804|NCT03395184|474835284|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
131878805|NCT03395184|474835285|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
131878806|NCT03395184|474835286|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
131878807|NCT03395184|474835287|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
131878808|NCT03395184|474835281|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
131878809|NCT03395184|474835282|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
131878810|NCT03395184|474835283|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
131878811|NCT03395184|474835284|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
131878812|NCT03395184|474835285|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
131878813|NCT03395184|474835286|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
131878814|NCT03395184|474835287|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
131878815|NCT03395184|474835281|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
131878816|NCT03395184|474835282|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
131878817|NCT03395184|474835283|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
131878818|NCT03395184|474835284|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
131409290|NCT00066469|473120860|FG000|Overall Study|Death|3|||
131409291|NCT00066469|473120860|FG000|Overall Study|Lack of Efficacy|9|||
131878819|NCT03395184|474835285|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
131878820|NCT03395184|474835286|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
131409292|NCT00066469|473120860|FG000|Overall Study|Lost to Follow-up|1|||
131924171|NCT01666314|475007287|FG002|Overall Study|Withdrawal by Subject|2|||
131924172|NCT01666314|475007288|FG003|Overall Study|Withdrawal by Subject|3|||
131924173|NCT01666314|475007285|FG000|Overall Study|Reason not Specified|10|||
131924174|NCT01666314|475007286|FG001|Overall Study|Reason not Specified|7|||
131924175|NCT01666314|475007287|FG002|Overall Study|Reason not Specified|5|||
131924176|NCT01666314|475007288|FG003|Overall Study|Reason not Specified|5|||
131924177|NCT02114684|475007292|FG000|Overall Study|Death|6|||
131924178|NCT02114684|475007293|FG001|Overall Study|Death|4|||
131924179|NCT02114684|475007292|FG000|Overall Study|Lost to Follow-up|1|||
131924180|NCT02114684|475007293|FG001|Overall Study|Lost to Follow-up|2|||
131924181|NCT02114684|475007292|FG000|Overall Study|Withdrawal by Subject|1|||
131924182|NCT02114684|475007293|FG001|Overall Study|Withdrawal by Subject|2|||
131924183|NCT02114684|475007292|FG000|Overall Study|Relocation|3|||
131924184|NCT02114684|475007293|FG001|Overall Study|Relocation|1|||
131924185|NCT02114684|475007292|FG000|Overall Study|Rifampicin resistant on culture|0|||
131924186|NCT02114684|475007293|FG001|Overall Study|Rifampicin resistant on culture|1|||
131924187|NCT02114684|475007292|FG000|Overall Study|Patient Incarcerated|1|||
131924188|NCT02114684|475007293|FG001|Overall Study|Patient Incarcerated|0|||
131924189|NCT01245062|475007294|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
131924190|NCT01245062|475007295|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
131924191|NCT01245062|475007296|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
131924192|NCT01245062|475007294|FG000|Randomization and Crossover Phase|Physician Decision|2|||
131924193|NCT01245062|475007295|FG001|Randomization and Crossover Phase|Physician Decision|4|||
131924194|NCT01245062|475007296|FG002|Randomization and Crossover Phase|Physician Decision|0|||
131924195|NCT01245062|475007294|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
131924196|NCT01245062|475007295|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
131924197|NCT01245062|475007296|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
131924198|NCT01245062|475007294|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
131924199|NCT01245062|475007295|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
131924200|NCT01245062|475007296|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
131924201|NCT01245062|475007294|FG000|Cross-over Phase|Lost to Follow-up|0|||
131924202|NCT01245062|475007295|FG001|Cross-over Phase|Lost to Follow-up|0|||
131924203|NCT01245062|475007296|FG002|Cross-over Phase|Lost to Follow-up|1|||
131924204|NCT01245062|475007294|FG000|Cross-over Phase|Physician Decision|0|||
131924205|NCT01245062|475007295|FG001|Cross-over Phase|Physician Decision|0|||
131924206|NCT01245062|475007296|FG002|Cross-over Phase|Physician Decision|1|||
131924207|NCT01245062|475007294|FG000|Cross-over Phase|Withdrew Consent|0|||
131924208|NCT01245062|475007295|FG001|Cross-over Phase|Withdrew Consent|0|||
131924209|NCT01245062|475007296|FG002|Cross-over Phase|Withdrew Consent|4|||
131924210|NCT01245062|475007294|FG000|Cross-over Phase|Study closed/ terminated|0|||
131924211|NCT01245062|475007295|FG001|Cross-over Phase|Study closed/ terminated|0|||
131924212|NCT01245062|475007296|FG002|Cross-over Phase|Study closed/ terminated|11|||
131924213|NCT02015104|475007297|FG000|Overall Study|Withdrew consent after first dose drug|1|||
131924214|NCT02015104|475007298|FG001|Overall Study|Withdrew consent after first dose drug|0|||
131924215|NCT02015104|475007297|FG000|Overall Study|Withdrew consent prior to treatment|0|||
131924216|NCT02015104|475007298|FG001|Overall Study|Withdrew consent prior to treatment|1|||
131924217|NCT05206604|475009043|FG000|Overall Study|Non-compliance with study drug|0|||
131924218|NCT05206604|475009044|FG001|Overall Study|Non-compliance with study drug|0|||
131924219|NCT05206604|475009045|FG002|Overall Study|Non-compliance with study drug|0|||
131924220|NCT05206604|475009046|FG003|Overall Study|Non-compliance with study drug|0|||
131924221|NCT05206604|475009047|FG004|Overall Study|Non-compliance with study drug|0|||
131924222|NCT05206604|475009048|FG005|Overall Study|Non-compliance with study drug|1|||
131924223|NCT05206604|475009049|FG006|Overall Study|Non-compliance with study drug|0|||
131924224|NCT05206604|475009050|FG007|Overall Study|Non-compliance with study drug|0|||
131924225|NCT03735498|475009051|FG000|Overall Study|Withdrawal by Subject|3|||
131924226|NCT03735498|475009051|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
131924227|NCT02014103|475009053|FG000|Overall Study|Protocol Violation|7|||
131924228|NCT02014103|475009054|FG001|Overall Study|Protocol Violation|7|||
131924229|NCT02014103|475009053|FG000|Overall Study|Adverse Event|1|||
131924230|NCT02014103|475009054|FG001|Overall Study|Adverse Event|0|||
131924231|NCT02014103|475009053|FG000|Overall Study|Lost venous access|1|||
131924232|NCT02014103|475009054|FG001|Overall Study|Lost venous access|0|||
131924233|NCT02014103|475009053|FG000|Overall Study|Withdrawal by Subject|0|||
131924234|NCT02014103|475009054|FG001|Overall Study|Withdrawal by Subject|2|||
131924235|NCT04289298|475009056|FG000|Overall Study|Lost to Follow-up|5|||
131924236|NCT04289298|475009057|FG001|Overall Study|Lost to Follow-up|0|||
131924237|NCT04289298|475009056|FG000|Overall Study|Withdrawal by Subject|2|||
131924238|NCT04289298|475009057|FG001|Overall Study|Withdrawal by Subject|0|||
131924239|NCT00620035|475009058|FG000|Overall Study|Adverse Event|106|||
131409293|NCT00066469|473120860|FG000|Overall Study|Physician Decision|1|||
131409294|NCT00066469|473120860|FG000|Overall Study|Withdrawal by Subject|1|||
131409295|NCT00066469|473120860|FG000|Overall Study|ineligible|1|||
131409296|NCT03271047|473120861|FG000|Phase 1b: Dose Finding Period|Death|8|||
131409297|NCT03271047|473120862|FG001|Phase 1b: Dose Finding Period|Death|8|||
131409298|NCT03271047|473120863|FG002|Phase 1b: Dose Finding Period|Death|0|||
131409299|NCT03271047|473120864|FG003|Phase 1b: Dose Finding Period|Death|0|||
131409300|NCT03271047|473120861|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
131409301|NCT03271047|473120862|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
131409302|NCT03271047|473120863|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
131409303|NCT03271047|473120864|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
131409304|NCT03271047|473120861|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
131409305|NCT03271047|473120862|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
131409306|NCT03271047|473120863|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
131409307|NCT03271047|473120864|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
131409308|NCT03271047|473120861|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
131409309|NCT03271047|473120862|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
131409310|NCT03271047|473120863|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
131409311|NCT03271047|473120864|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
131409312|NCT03271047|473120861|FG000|Randomized Phase 2 Period|Other|0|||
131409313|NCT03271047|473120862|FG001|Randomized Phase 2 Period|Other|0|||
131409314|NCT03271047|473120863|FG002|Randomized Phase 2 Period|Other|0|||
131409315|NCT03271047|473120864|FG003|Randomized Phase 2 Period|Other|1|||
131409316|NCT03271047|473120861|FG000|Randomized Phase 2 Period|Death|0|||
131878821|NCT03395184|474835287|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
131878822|NCT03395184|474835281|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
131878823|NCT03395184|474835282|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
131878824|NCT03395184|474835283|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
131878825|NCT03395184|474835284|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
131878826|NCT03395184|474835285|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
131878827|NCT03395184|474835286|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
131878828|NCT03395184|474835287|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
131878829|NCT03395184|474835281|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
131878830|NCT03395184|474835282|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
131878831|NCT03395184|474835283|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
131878832|NCT03395184|474835284|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
131878833|NCT03395184|474835285|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
131878834|NCT03395184|474835286|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
131878835|NCT03395184|474835287|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
131878836|NCT03395184|474835281|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
131878837|NCT03395184|474835282|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
131878838|NCT03395184|474835283|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
131878839|NCT03395184|474835284|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
131878840|NCT03395184|474835285|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
131878841|NCT03395184|474835286|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
131878842|NCT03395184|474835287|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
131409317|NCT03271047|473120862|FG001|Randomized Phase 2 Period|Death|0|||
131409318|NCT03271047|473120863|FG002|Randomized Phase 2 Period|Death|20|||
131409319|NCT03271047|473120864|FG003|Randomized Phase 2 Period|Death|21|||
131409320|NCT03271047|473120861|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
131878843|NCT01397786|474837808|FG000|Phase A|Lost to Follow-up|0|||
131878844|NCT01397786|474837809|FG001|Phase A|Lost to Follow-up|0|||
131878845|NCT01397786|474837810|FG002|Phase A|Lost to Follow-up|6|||
131878846|NCT01397786|474837808|FG000|Phase A|Adverse Event|0|||
131878847|NCT01397786|474837809|FG001|Phase A|Adverse Event|0|||
131878848|NCT01397786|474837810|FG002|Phase A|Adverse Event|8|||
131878849|NCT01397786|474837808|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
131878850|NCT01397786|474837809|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
131878851|NCT01397786|474837810|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
131878852|NCT01397786|474837808|FG000|Phase A|Physician Decision|0|||
131878853|NCT01397786|474837809|FG001|Phase A|Physician Decision|0|||
131878854|NCT01397786|474837810|FG002|Phase A|Physician Decision|1|||
131878855|NCT01397786|474837808|FG000|Phase A|Withdrawal by Subject|0|||
131878856|NCT01397786|474837809|FG001|Phase A|Withdrawal by Subject|0|||
131878857|NCT01397786|474837810|FG002|Phase A|Withdrawal by Subject|5|||
131878858|NCT01397786|474837808|FG000|Phase A|Lack of Efficacy|0|||
131878859|NCT01397786|474837809|FG001|Phase A|Lack of Efficacy|0|||
131878860|NCT01397786|474837810|FG002|Phase A|Lack of Efficacy|1|||
131878861|NCT01397786|474837808|FG000|Phase B|Lost to Follow-up|22|||
131878862|NCT01397786|474837809|FG001|Phase B|Lost to Follow-up|12|||
131878863|NCT01397786|474837810|FG002|Phase B|Lost to Follow-up|22|||
131878864|NCT01397786|474837808|FG000|Phase B|Adverse Event|109|||
131878865|NCT01397786|474837809|FG001|Phase B|Adverse Event|23|||
131878866|NCT01397786|474837810|FG002|Phase B|Adverse Event|27|||
131878867|NCT01397786|474837808|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
131878868|NCT01397786|474837809|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
131878869|NCT01397786|474837810|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
131878870|NCT01397786|474837808|FG000|Phase B|Physician Decision|9|||
131924240|NCT00620035|475009058|FG000|Overall Study|Withdrawal of Informed Consent|1|||
131924241|NCT00620035|475009058|FG000|Overall Study|Other Reason|38|||
131924242|NCT01960842|475009065|FG000|Overall Study|Adverse Event|1|||
131924243|NCT01960842|475009065|FG000|Overall Study|Withdrawal by Subject|2|||
131924244|NCT00397930|475009066|FG000|Overall Study|Personal reasons|14|||
131924245|NCT00397930|475009067|FG001|Overall Study|Personal reasons|8|||
131924246|NCT00397930|475009066|FG000|Overall Study|Other medical|9|||
131924247|NCT00397930|475009067|FG001|Overall Study|Other medical|4|||
131409321|NCT03271047|473120862|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
131409322|NCT03271047|473120863|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
131409323|NCT03271047|473120864|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
131878871|NCT01397786|474837809|FG001|Phase B|Physician Decision|1|||
131878872|NCT01397786|474837810|FG002|Phase B|Physician Decision|3|||
131878873|NCT01397786|474837808|FG000|Phase B|Withdrawal by Subject|102|||
131878874|NCT01397786|474837809|FG001|Phase B|Withdrawal by Subject|45|||
131878875|NCT01397786|474837810|FG002|Phase B|Withdrawal by Subject|30|||
131878876|NCT01397786|474837808|FG000|Phase B|Protocol Deviation|1|||
131878877|NCT01397786|474837809|FG001|Phase B|Protocol Deviation|2|||
131878878|NCT01397786|474837810|FG002|Phase B|Protocol Deviation|4|||
131878879|NCT01397786|474837808|FG000|Phase B|Lack of Efficacy|22|||
131878880|NCT01397786|474837809|FG001|Phase B|Lack of Efficacy|7|||
131878881|NCT01397786|474837810|FG002|Phase B|Lack of Efficacy|14|||
131878882|NCT03339726|474837813|FG000|Overall Study|Withdrawal by Subject|1|||
131878883|NCT03339726|474837814|FG001|Overall Study|Withdrawal by Subject|0|||
131878884|NCT03339726|474837815|FG002|Overall Study|Withdrawal by Subject|0|||
131878885|NCT03339726|474837813|FG000|Overall Study|Lost to Follow-up|0|||
131878886|NCT03339726|474837814|FG001|Overall Study|Lost to Follow-up|1|||
131878887|NCT03339726|474837815|FG002|Overall Study|Lost to Follow-up|0|||
131878888|NCT01275755|474837816|FG000|Double-blind Treatment Period|Adverse Event|0|||
131878889|NCT01275755|474837817|FG001|Double-blind Treatment Period|Adverse Event|2|||
131878890|NCT01275755|474837816|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
131878891|NCT01275755|474837817|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
131878892|NCT01275755|474837816|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131878893|NCT01275755|474837817|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131878894|NCT01275755|474837816|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
131878895|NCT01275755|474837817|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
131878896|NCT00636194|474837818|FG000|Overall Study|Study related symptoms and complaints|1|||
131878897|NCT00636194|474837819|FG001|Overall Study|Study related symptoms and complaints|0|||
131878898|NCT00636194|474837818|FG000|Overall Study|Protocol Violation|2|||
131878899|NCT00636194|474837819|FG001|Overall Study|Protocol Violation|0|||
131878900|NCT03030989|474837820|FG000|Overall Study|Fever|2|||
131878901|NCT03030989|474837821|FG001|Overall Study|Fever|2|||
131878902|NCT03030989|474837820|FG000|Overall Study|Rash|2|||
131878903|NCT03030989|474837821|FG001|Overall Study|Rash|1|||
131878904|NCT03030989|474837820|FG000|Overall Study|Fatigue/Overwhelmed|1|||
131878905|NCT03030989|474837821|FG001|Overall Study|Fatigue/Overwhelmed|5|||
131878906|NCT03030989|474837820|FG000|Overall Study|Positive Blood Cultures|2|||
131878907|NCT03030989|474837821|FG001|Overall Study|Positive Blood Cultures|1|||
131878908|NCT03030989|474837820|FG000|Overall Study|Line Removed|0|||
131878909|NCT03030989|474837821|FG001|Overall Study|Line Removed|2|||
131878910|NCT03030989|474837820|FG000|Overall Study|No longer interested|5|||
131878911|NCT03030989|474837821|FG001|Overall Study|No longer interested|3|||
131878912|NCT00723255|474837831|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
131878913|NCT00723255|474837831|FG000|Overall Study|Ineligible: Second primary|1|||
131878914|NCT00723255|474837831|FG000|Overall Study|Ineligible: Wrong Primary|2|||
131878915|NCT03962790|474837832|FG000|Period 1|Adverse Event|0|||
131878916|NCT03962790|474837833|FG001|Period 1|Adverse Event|1|||
131878917|NCT03962790|474837832|FG000|Period 1|Failed to meet all eligibility criteria|1|||
131878918|NCT03962790|474837833|FG001|Period 1|Failed to meet all eligibility criteria|1|||
131878919|NCT03962790|474837832|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
131878920|NCT03962790|474837833|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
131878921|NCT03962790|474837832|FG000|Period 1|Withdrawal by Subject|1|||
131878922|NCT03962790|474837833|FG001|Period 1|Withdrawal by Subject|0|||
131878923|NCT00381238|474837837|FG000|Overall Study|Adverse Event|3|||
131878924|NCT00381238|474837837|FG000|Overall Study|Protocol Violation|1|||
131878925|NCT00381238|474837837|FG000|Overall Study|Withdrawal by Subject|4|||
131878926|NCT00381238|474837837|FG000|Overall Study|Lack of Efficacy|2|||
131878927|NCT00381238|474837837|FG000|Overall Study|Withdrew by physician|1|||
131878928|NCT00381238|474837837|FG000|Overall Study|Disease progression|1|||
131878929|NCT02086448|474837840|FG000|Overall Study|Withdrawal by Subject|1|||
131878930|NCT02086448|474837841|FG001|Overall Study|Withdrawal by Subject|0|||
131878931|NCT02086448|474837842|FG002|Overall Study|Withdrawal by Subject|0|||
131878932|NCT02086448|474837843|FG003|Overall Study|Withdrawal by Subject|2|||
131878933|NCT03535194|474837844|FG000|Induction Period|Adverse Event|2|||
131878934|NCT03535194|474837845|FG001|Induction Period|Adverse Event|2|||
131924248|NCT00397930|475009066|FG000|Overall Study|Unknown reasons|9|||
131924249|NCT00397930|475009067|FG001|Overall Study|Unknown reasons|14|||
131924250|NCT00397930|475009066|FG000|Overall Study|Noncompliant|3|||
131924251|NCT00397930|475009067|FG001|Overall Study|Noncompliant|2|||
131924252|NCT00397930|475009066|FG000|Overall Study|Too time-consuming|2|||
131924253|NCT00397930|475009067|FG001|Overall Study|Too time-consuming|9|||
131924254|NCT00397930|475009066|FG000|Overall Study|Started own yoga program|1|||
131924255|NCT00397930|475009067|FG001|Overall Study|Started own yoga program|1|||
131924256|NCT00397930|475009066|FG000|Overall Study|Did not want to be in control group|0|||
131924257|NCT00397930|475009067|FG001|Overall Study|Did not want to be in control group|1|||
131924258|NCT00397930|475009066|FG000|Overall Study|Withdrawal by Subject|0|||
131924259|NCT00397930|475009067|FG001|Overall Study|Withdrawal by Subject|8|||
131924260|NCT00397930|475009066|FG000|Overall Study|Missing data|0|||
131924261|NCT00397930|475009067|FG001|Overall Study|Missing data|4|||
131924262|NCT02056288|475009068|FG000|In-Hospital Data|Surgery cancelled|1|||
131924263|NCT02056288|475009069|FG001|In-Hospital Data|Surgery cancelled|0|||
131924264|NCT02056288|475009068|FG000|In-Hospital Data|Protocol Violation|3|||
131924265|NCT02056288|475009069|FG001|In-Hospital Data|Protocol Violation|0|||
131924266|NCT02056288|475009068|FG000|In-Hospital Data|Physician Decision|1|||
131924267|NCT02056288|475009069|FG001|In-Hospital Data|Physician Decision|0|||
131924268|NCT02056288|475009068|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
131924269|NCT02056288|475009069|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
131924270|NCT01433978|475009070|FG000|Core Study|Adverse Event, Non-Fatal|0|||
131924271|NCT01433978|475009071|FG001|Core Study|Adverse Event, Non-Fatal|1|||
131924272|NCT01433978|475009072|FG002|Core Study|Adverse Event, Non-Fatal|0|||
131924273|NCT01433978|475009070|FG000|Core Study|Lack of Efficacy|5|||
131924274|NCT01433978|475009071|FG001|Core Study|Lack of Efficacy|1|||
131924275|NCT01433978|475009072|FG002|Core Study|Lack of Efficacy|0|||
131924276|NCT01433978|475009070|FG000|Core Study|Study Terminated by Sponsor|6|||
131924277|NCT01433978|475009071|FG001|Core Study|Study Terminated by Sponsor|9|||
131924278|NCT01433978|475009072|FG002|Core Study|Study Terminated by Sponsor|0|||
131924279|NCT01433978|475009070|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
131924280|NCT01433978|475009071|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
131924281|NCT01433978|475009072|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
131924282|NCT01433978|475009070|FG000|Extension Phase|Lack of Efficacy|0|||
131924283|NCT01433978|475009071|FG001|Extension Phase|Lack of Efficacy|0|||
131924284|NCT01433978|475009072|FG002|Extension Phase|Lack of Efficacy|1|||
131924285|NCT01433978|475009070|FG000|Extension Phase|Study Terminated by Sponsor|0|||
131924286|NCT01433978|475009071|FG001|Extension Phase|Study Terminated by Sponsor|0|||
131924287|NCT01433978|475009072|FG002|Extension Phase|Study Terminated by Sponsor|4|||
131924288|NCT01441414|475009073|FG000|Overall Study|Participant died|9|||
131924289|NCT01441414|475009073|FG000|Overall Study|Other reasons|3|||
131924290|NCT01441414|475009073|FG000|Overall Study|Study terminated by sponsor|2|||
131924291|NCT01441414|475009073|FG000|Overall Study|Subject refused further follow-up|1|||
131924292|NCT01773889|475009074|FG000|Overall Study|lack of funding|2|||
131454009|NCT02023697|473291845|FG001|Long-term Follow-up Period|Other unspecified|3|||
131454010|NCT02023697|473291846|FG002|Long-term Follow-up Period|Other unspecified|5|||
131454011|NCT00845897|473291852|FG000|Overall Study|Lost to Follow-up|1|||
131454012|NCT00845897|473291853|FG001|Overall Study|Lost to Follow-up|1|||
131454013|NCT00845897|473291854|FG002|Overall Study|Lost to Follow-up|0|||
131454014|NCT00845897|473291852|FG000|Overall Study|Withdrawal by Subject|0|||
131454015|NCT00845897|473291853|FG001|Overall Study|Withdrawal by Subject|3|||
131454016|NCT00845897|473291854|FG002|Overall Study|Withdrawal by Subject|2|||
131454017|NCT00845897|473291852|FG000|Overall Study|Ulcer did not heal|1|||
131454018|NCT00845897|473291853|FG001|Overall Study|Ulcer did not heal|0|||
131454019|NCT00845897|473291854|FG002|Overall Study|Ulcer did not heal|1|||
131454020|NCT00845897|473291852|FG000|Overall Study|Too ill to participate|0|||
131454021|NCT00845897|473291853|FG001|Overall Study|Too ill to participate|1|||
131454022|NCT00845897|473291854|FG002|Overall Study|Too ill to participate|0|||
131454023|NCT00369265|473291855|FG000|Overall Study|Study terminated|4|||
131454024|NCT00369265|473291856|FG001|Overall Study|Study terminated|7|||
131454025|NCT00068419|473291857|FG000|Overall Study|Adverse Event|3|||
131454026|NCT00068419|473291857|FG000|Overall Study|Lack of Efficacy|24|||
131454027|NCT00068419|473291857|FG000|Overall Study|Lost to Follow-up|1|||
131454028|NCT00068419|473291857|FG000|Overall Study|Physician Decision|7|||
131454029|NCT00068419|473291857|FG000|Overall Study|Withdrawal by Subject|14|||
131454030|NCT00068419|473291857|FG000|Overall Study|Ineligible|11|||
131454031|NCT01032889|473291866|FG000|Overall Study|Adverse Event|2|||
131454032|NCT01032889|473291867|FG001|Overall Study|Adverse Event|2|||
131454033|NCT01032889|473291868|FG002|Overall Study|Adverse Event|0|||
131924293|NCT01502072|475009075|FG000|Overall Study|Withdrawal by Subject|1|||
131924294|NCT01502072|475009076|FG001|Overall Study|Withdrawal by Subject|0|||
131924295|NCT01502072|475009077|FG002|Overall Study|Withdrawal by Subject|0|||
131924296|NCT01502072|475009075|FG000|Overall Study|Death|0|||
131924297|NCT01502072|475009076|FG001|Overall Study|Death|1|||
131924298|NCT01502072|475009077|FG002|Overall Study|Death|0|||
131924299|NCT00500110|475009078|FG000|Overall Study|Withdrawal by Subject|3|||
131924300|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
131924301|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
131924302|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
131924303|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
131924304|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
131924305|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
131924306|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
131924307|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
131924308|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
131924309|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
131924310|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
131924311|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
131924312|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
131924313|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
131924314|NCT00976391|475009084|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
131924315|NCT00976391|475009085|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
131924316|NCT00976391|475009084|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
131924317|NCT00976391|475009085|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
131924318|NCT00976391|475009084|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
131924319|NCT00976391|475009085|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
131924320|NCT00976391|475009084|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
131924321|NCT00976391|475009085|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
131924322|NCT00976391|475009084|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
131924323|NCT00976391|475009085|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
131924324|NCT00976391|475009084|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
131924325|NCT00976391|475009085|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
131924326|NCT00976391|475009084|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
131924327|NCT00976391|475009085|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
131924328|NCT02565186|475009086|FG000|Overall Study|Adverse Event|113|||
131924329|NCT02565186|475009087|FG001|Overall Study|Adverse Event|148|||
131924330|NCT02565186|475009086|FG000|Overall Study|Lost to Follow-up|102|||
131924331|NCT02565186|475009087|FG001|Overall Study|Lost to Follow-up|93|||
131924332|NCT02565186|475009086|FG000|Overall Study|Non-Compliance|57|||
131924333|NCT02565186|475009087|FG001|Overall Study|Non-Compliance|55|||
131924334|NCT02565186|475009086|FG000|Overall Study|Withdrawal by Subject|229|||
131924335|NCT02565186|475009087|FG001|Overall Study|Withdrawal by Subject|214|||
131924336|NCT02565186|475009086|FG000|Overall Study|Physician Decision|18|||
131924337|NCT02565186|475009087|FG001|Overall Study|Physician Decision|16|||
131924338|NCT02565186|475009086|FG000|Overall Study|Sponsor Request|5|||
131878935|NCT03535194|474837846|FG002|Induction Period|Adverse Event|1|||
131878936|NCT03535194|474837847|FG003|Induction Period|Adverse Event|3|||
131878937|NCT03535194|474837848|FG004|Induction Period|Adverse Event|0|||
131878938|NCT03535194|474837844|FG000|Induction Period|Death|0|||
131878939|NCT03535194|474837845|FG001|Induction Period|Death|1|||
131878940|NCT03535194|474837846|FG002|Induction Period|Death|0|||
131878941|NCT03535194|474837847|FG003|Induction Period|Death|0|||
131878942|NCT03535194|474837848|FG004|Induction Period|Death|0|||
131878943|NCT03535194|474837844|FG000|Induction Period|Lack of Efficacy|1|||
131878944|NCT03535194|474837845|FG001|Induction Period|Lack of Efficacy|3|||
131878945|NCT03535194|474837846|FG002|Induction Period|Lack of Efficacy|2|||
131878946|NCT03535194|474837847|FG003|Induction Period|Lack of Efficacy|2|||
131878947|NCT03535194|474837848|FG004|Induction Period|Lack of Efficacy|0|||
131878948|NCT03535194|474837844|FG000|Induction Period|Lost to Follow-up|3|||
131878949|NCT03535194|474837845|FG001|Induction Period|Lost to Follow-up|5|||
131878950|NCT03535194|474837846|FG002|Induction Period|Lost to Follow-up|2|||
131878951|NCT03535194|474837847|FG003|Induction Period|Lost to Follow-up|3|||
131878952|NCT03535194|474837848|FG004|Induction Period|Lost to Follow-up|0|||
131878953|NCT03535194|474837844|FG000|Induction Period|Physician Decision|1|||
131878954|NCT03535194|474837845|FG001|Induction Period|Physician Decision|1|||
131878955|NCT03535194|474837846|FG002|Induction Period|Physician Decision|0|||
131878956|NCT03535194|474837847|FG003|Induction Period|Physician Decision|0|||
131878957|NCT03535194|474837848|FG004|Induction Period|Physician Decision|0|||
131878958|NCT03535194|474837844|FG000|Induction Period|Protocol Violation|1|||
131878959|NCT03535194|474837845|FG001|Induction Period|Protocol Violation|0|||
131878960|NCT03535194|474837846|FG002|Induction Period|Protocol Violation|0|||
131878961|NCT03535194|474837847|FG003|Induction Period|Protocol Violation|1|||
131878962|NCT03535194|474837848|FG004|Induction Period|Protocol Violation|0|||
131878963|NCT03535194|474837844|FG000|Induction Period|Screen Failure|0|||
131878964|NCT03535194|474837845|FG001|Induction Period|Screen Failure|1|||
131878965|NCT03535194|474837846|FG002|Induction Period|Screen Failure|0|||
131878966|NCT03535194|474837847|FG003|Induction Period|Screen Failure|0|||
131924339|NCT02565186|475009087|FG001|Overall Study|Sponsor Request|9|||
131924340|NCT02565186|475009086|FG000|Overall Study|Missing|1|||
131924341|NCT02565186|475009087|FG001|Overall Study|Missing|0|||
131924342|NCT02565186|475009086|FG000|Overall Study|Did Not Receive Study Drug|55|||
131924343|NCT02565186|475009087|FG001|Overall Study|Did Not Receive Study Drug|86|||
131924344|NCT00617903|475009088|FG000|Overall Study|Withdrawal by Subject|2|||
131924345|NCT00617903|475009089|FG001|Overall Study|Withdrawal by Subject|3|||
131924346|NCT00617903|475009088|FG000|Overall Study|Lost to Follow-up|1|||
131924347|NCT00617903|475009089|FG001|Overall Study|Lost to Follow-up|1|||
131924348|NCT00617903|475009088|FG000|Overall Study|Lack of Efficacy|0|||
131924349|NCT00617903|475009089|FG001|Overall Study|Lack of Efficacy|1|||
131924350|NCT00617903|475009088|FG000|Overall Study|Adverse Event|0|||
131924351|NCT00617903|475009089|FG001|Overall Study|Adverse Event|1|||
131924352|NCT00617903|475009088|FG000|Overall Study|noncompliance|0|||
131924353|NCT00617903|475009089|FG001|Overall Study|noncompliance|1|||
131924354|NCT04676646|475009090|FG000|Open-label Run-in Phase|Adverse Event|3|||
131924355|NCT04676646|475009091|FG001|Open-label Run-in Phase|Adverse Event|0|||
131924356|NCT04676646|475009092|FG002|Open-label Run-in Phase|Adverse Event|0|||
131924357|NCT04676646|475009090|FG000|Open-label Run-in Phase|Death|3|||
131924358|NCT04676646|475009091|FG001|Open-label Run-in Phase|Death|0|||
131924359|NCT04676646|475009092|FG002|Open-label Run-in Phase|Death|0|||
131924360|NCT04676646|475009090|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
131924361|NCT04676646|475009091|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
131924362|NCT04676646|475009092|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
131924363|NCT04676646|475009090|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
131924364|NCT04676646|475009091|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
131924365|NCT04676646|475009092|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
131924366|NCT04676646|475009090|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
131924367|NCT04676646|475009091|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
131924368|NCT04676646|475009092|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
131924369|NCT04676646|475009090|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
131924370|NCT04676646|475009091|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
131924371|NCT04676646|475009092|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
131924372|NCT04676646|475009090|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
131409324|NCT03271047|473120861|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
131409325|NCT03271047|473120862|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
131878967|NCT03535194|474837848|FG004|Induction Period|Screen Failure|0|||
131878968|NCT03535194|474837844|FG000|Induction Period|Withdrawal by Subject|3|||
131878969|NCT03535194|474837845|FG001|Induction Period|Withdrawal by Subject|4|||
131878970|NCT03535194|474837846|FG002|Induction Period|Withdrawal by Subject|3|||
131878971|NCT03535194|474837847|FG003|Induction Period|Withdrawal by Subject|2|||
131878972|NCT03535194|474837848|FG004|Induction Period|Withdrawal by Subject|0|||
131878973|NCT03535194|474837844|FG000|Maintenance Period|Adverse Event|6|||
131878974|NCT03535194|474837845|FG001|Maintenance Period|Adverse Event|5|||
131878975|NCT03535194|474837846|FG002|Maintenance Period|Adverse Event|1|||
131878976|NCT03535194|474837847|FG003|Maintenance Period|Adverse Event|11|||
131878977|NCT03535194|474837848|FG004|Maintenance Period|Adverse Event|4|||
131878978|NCT03535194|474837844|FG000|Maintenance Period|Lack of Efficacy|3|||
131878979|NCT03535194|474837845|FG001|Maintenance Period|Lack of Efficacy|2|||
131878980|NCT03535194|474837846|FG002|Maintenance Period|Lack of Efficacy|5|||
131878981|NCT03535194|474837847|FG003|Maintenance Period|Lack of Efficacy|9|||
131878982|NCT03535194|474837848|FG004|Maintenance Period|Lack of Efficacy|0|||
131878983|NCT03535194|474837844|FG000|Maintenance Period|Lost to Follow-up|4|||
131878984|NCT03535194|474837845|FG001|Maintenance Period|Lost to Follow-up|2|||
131878985|NCT03535194|474837846|FG002|Maintenance Period|Lost to Follow-up|1|||
131878986|NCT03535194|474837847|FG003|Maintenance Period|Lost to Follow-up|5|||
131878987|NCT03535194|474837848|FG004|Maintenance Period|Lost to Follow-up|2|||
131878988|NCT03535194|474837844|FG000|Maintenance Period|Other|1|||
131878989|NCT03535194|474837845|FG001|Maintenance Period|Other|2|||
131878990|NCT03535194|474837846|FG002|Maintenance Period|Other|0|||
131878991|NCT03535194|474837847|FG003|Maintenance Period|Other|0|||
131878992|NCT03535194|474837848|FG004|Maintenance Period|Other|0|||
131878993|NCT03535194|474837844|FG000|Maintenance Period|Physician Decision|1|||
131878994|NCT03535194|474837845|FG001|Maintenance Period|Physician Decision|2|||
131878995|NCT03535194|474837846|FG002|Maintenance Period|Physician Decision|0|||
131878996|NCT03535194|474837847|FG003|Maintenance Period|Physician Decision|2|||
131878997|NCT03535194|474837848|FG004|Maintenance Period|Physician Decision|0|||
131878998|NCT03535194|474837844|FG000|Maintenance Period|Pregnancy|0|||
131878999|NCT03535194|474837845|FG001|Maintenance Period|Pregnancy|0|||
131879000|NCT03535194|474837846|FG002|Maintenance Period|Pregnancy|0|||
131879001|NCT03535194|474837847|FG003|Maintenance Period|Pregnancy|2|||
131879002|NCT03535194|474837848|FG004|Maintenance Period|Pregnancy|0|||
131879003|NCT03535194|474837844|FG000|Maintenance Period|Protocol Violation|0|||
131879004|NCT03535194|474837845|FG001|Maintenance Period|Protocol Violation|1|||
131879005|NCT03535194|474837846|FG002|Maintenance Period|Protocol Violation|0|||
131879006|NCT03535194|474837847|FG003|Maintenance Period|Protocol Violation|0|||
131879007|NCT03535194|474837848|FG004|Maintenance Period|Protocol Violation|0|||
131879008|NCT03535194|474837844|FG000|Maintenance Period|Withdrawal by Subject|7|||
131879009|NCT03535194|474837845|FG001|Maintenance Period|Withdrawal by Subject|2|||
131879010|NCT03535194|474837846|FG002|Maintenance Period|Withdrawal by Subject|1|||
131879011|NCT03535194|474837847|FG003|Maintenance Period|Withdrawal by Subject|8|||
131409326|NCT03271047|473120863|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
131409327|NCT03271047|473120864|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
131879012|NCT03535194|474837848|FG004|Maintenance Period|Withdrawal by Subject|0|||
131879013|NCT03535194|474837844|FG000|Post-Treatment Followup Period|Adverse Event|4|||
131879014|NCT03535194|474837845|FG001|Post-Treatment Followup Period|Adverse Event|5|||
131879015|NCT03535194|474837846|FG002|Post-Treatment Followup Period|Adverse Event|1|||
131879016|NCT03535194|474837847|FG003|Post-Treatment Followup Period|Adverse Event|8|||
131879017|NCT03535194|474837848|FG004|Post-Treatment Followup Period|Adverse Event|0|||
131879018|NCT03535194|474837844|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
131879019|NCT03535194|474837845|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
131879020|NCT03535194|474837846|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
131879021|NCT03535194|474837847|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
131879022|NCT03535194|474837848|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
131879023|NCT03535194|474837844|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
131879024|NCT03535194|474837845|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
131879025|NCT03535194|474837846|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
131879026|NCT03535194|474837847|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
131879027|NCT03535194|474837848|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
131879028|NCT03535194|474837844|FG000|Post-Treatment Followup Period|Other|1|||
131879029|NCT03535194|474837845|FG001|Post-Treatment Followup Period|Other|0|||
131879030|NCT03535194|474837846|FG002|Post-Treatment Followup Period|Other|0|||
131879031|NCT03535194|474837847|FG003|Post-Treatment Followup Period|Other|5|||
131879032|NCT03535194|474837848|FG004|Post-Treatment Followup Period|Other|0|||
131879033|NCT03535194|474837844|FG000|Post-Treatment Followup Period|Physician Decision|0|||
131879034|NCT03535194|474837845|FG001|Post-Treatment Followup Period|Physician Decision|2|||
131879035|NCT03535194|474837846|FG002|Post-Treatment Followup Period|Physician Decision|1|||
131879036|NCT03535194|474837847|FG003|Post-Treatment Followup Period|Physician Decision|1|||
131879037|NCT03535194|474837848|FG004|Post-Treatment Followup Period|Physician Decision|0|||
131879038|NCT03535194|474837844|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
131879039|NCT03535194|474837845|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
131879040|NCT03535194|474837846|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
131879041|NCT03535194|474837847|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
131879042|NCT03535194|474837848|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131879043|NCT02005692|474837855|FG000|Overall Study|Protocol Violation|1|||
131879044|NCT02005692|474837855|FG000|Overall Study|Withdrawal by Subject|1|||
131879045|NCT02005692|474837855|FG000|Overall Study|Discharged earlier than anticipated|5|||
131879046|NCT01895270|474837856|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
131879047|NCT01895270|474837857|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
131879048|NCT01895270|474837856|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
131879049|NCT01895270|474837857|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
131879050|NCT01895270|474837856|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
131879051|NCT01895270|474837857|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
131879052|NCT01895270|474837856|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
131879053|NCT01895270|474837857|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
131879054|NCT01895270|474837856|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
131879055|NCT01895270|474837857|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
131879056|NCT01895270|474837856|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
131879057|NCT01895270|474837857|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
131879058|NCT01895270|474837856|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
131879059|NCT01895270|474837857|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
131879060|NCT02091375|474837859|FG000|Overall Study|Adverse Event|8|||
131879061|NCT02091375|474837860|FG001|Overall Study|Adverse Event|1|||
131879062|NCT02091375|474837859|FG000|Overall Study|Lost to Follow-up|0|||
131879063|NCT02091375|474837860|FG001|Overall Study|Lost to Follow-up|1|||
131879064|NCT02091375|474837859|FG000|Overall Study|Withdrawal by Subject|0|||
131879065|NCT02091375|474837860|FG001|Overall Study|Withdrawal by Subject|1|||
131879066|NCT02091375|474837859|FG000|Overall Study|Withdrawn by the investigator|1|||
131879067|NCT02091375|474837860|FG001|Overall Study|Withdrawn by the investigator|0|||
131879068|NCT02682823|474837861|FG000|Overall Study|Withdrawal by Subject|0|||
131879069|NCT02682823|474837862|FG001|Overall Study|Withdrawal by Subject|0|||
131879070|NCT02682823|474837863|FG002|Overall Study|Withdrawal by Subject|1|||
131879071|NCT02682823|474837864|FG003|Overall Study|Withdrawal by Subject|0|||
131879072|NCT02682823|474837865|FG004|Overall Study|Withdrawal by Subject|1|||
131879073|NCT02682823|474837861|FG000|Overall Study|Protocol Deviation|0|||
131879074|NCT02682823|474837862|FG001|Overall Study|Protocol Deviation|1|||
131879075|NCT02682823|474837863|FG002|Overall Study|Protocol Deviation|0|||
131879076|NCT02682823|474837864|FG003|Overall Study|Protocol Deviation|0|||
131879077|NCT02682823|474837865|FG004|Overall Study|Protocol Deviation|0|||
131879078|NCT02682823|474837861|FG000|Overall Study|Adverse Event|0|||
131879079|NCT02682823|474837862|FG001|Overall Study|Adverse Event|0|||
131924373|NCT04676646|475009091|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
131924374|NCT04676646|475009092|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
131924375|NCT04676646|475009090|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
131924376|NCT04676646|475009091|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
131924377|NCT04676646|475009092|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
131924378|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
131924379|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
131924380|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
131924381|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Death|0|||
131924382|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Death|1|||
131924383|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Death|2|||
131924384|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
131924385|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
131924386|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
131924387|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
131924388|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
131924389|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
131924390|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
131924391|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
131924392|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
131924393|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
131924394|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
131924395|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
131924396|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
131924397|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
131924398|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
131924399|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
131924400|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
131924401|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
131924402|NCT04676646|475009090|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
131924403|NCT04676646|475009091|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
131924404|NCT04676646|475009092|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
131924405|NCT05156125|475009093|FG000|Overall Study|Lack of Efficacy|1|||
131924406|NCT05156125|475009094|FG001|Overall Study|Lack of Efficacy|1|||
131924407|NCT05156125|475009095|FG002|Overall Study|Lack of Efficacy|1|||
131924408|NCT05156125|475009093|FG000|Overall Study|Physician Decision|0|||
131924409|NCT05156125|475009094|FG001|Overall Study|Physician Decision|0|||
131924410|NCT05156125|475009095|FG002|Overall Study|Physician Decision|1|||
131924411|NCT05156125|475009093|FG000|Overall Study|Non-compliance|0|||
131924412|NCT05156125|475009094|FG001|Overall Study|Non-compliance|1|||
131924413|NCT05156125|475009095|FG002|Overall Study|Non-compliance|1|||
131924414|NCT05156125|475009093|FG000|Overall Study|Withdrawal by Subject|0|||
131924415|NCT05156125|475009094|FG001|Overall Study|Withdrawal by Subject|0|||
131924416|NCT05156125|475009095|FG002|Overall Study|Withdrawal by Subject|1|||
131924417|NCT05156125|475009093|FG000|Overall Study|Adverse Event|2|||
131924418|NCT05156125|475009094|FG001|Overall Study|Adverse Event|1|||
131924419|NCT05156125|475009095|FG002|Overall Study|Adverse Event|0|||
131924420|NCT03123588|475009103|FG000|Overall Study|Study Terminated by Sponsor|2|||
131924421|NCT03123588|475009104|FG001|Overall Study|Study Terminated by Sponsor|5|||
131924422|NCT03123588|475009103|FG000|Overall Study|Withdrawal by Subject|1|||
131924423|NCT03123588|475009104|FG001|Overall Study|Withdrawal by Subject|0|||
131924424|NCT03123588|475009103|FG000|Overall Study|Adverse Event|1|||
131924425|NCT03123588|475009104|FG001|Overall Study|Adverse Event|0|||
131924426|NCT03123588|475009103|FG000|Overall Study|Physician Decision|2|||
131924427|NCT03123588|475009104|FG001|Overall Study|Physician Decision|1|||
131924428|NCT01058005|475009105|FG000|Overall Study|Adverse Event|0|||
131924429|NCT01058005|475009106|FG001|Overall Study|Adverse Event|2|||
131924430|NCT01058005|475009107|FG002|Overall Study|Adverse Event|1|||
131924431|NCT01058005|475009105|FG000|Overall Study|Physician Decision|2|||
131924432|NCT01058005|475009106|FG001|Overall Study|Physician Decision|2|||
131924433|NCT01058005|475009107|FG002|Overall Study|Physician Decision|0|||
131924434|NCT01058005|475009105|FG000|Overall Study|Withdrawal by Subject|4|||
131924435|NCT01058005|475009106|FG001|Overall Study|Withdrawal by Subject|5|||
131924436|NCT01058005|475009107|FG002|Overall Study|Withdrawal by Subject|11|||
131924437|NCT01058005|475009105|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
131879080|NCT02682823|474837863|FG002|Overall Study|Adverse Event|0|||
131879081|NCT02682823|474837864|FG003|Overall Study|Adverse Event|1|||
131879082|NCT02682823|474837865|FG004|Overall Study|Adverse Event|0|||
131879083|NCT01741792|474837866|FG000|Overall Study|Death|6|||
131879084|NCT01741792|474837867|FG001|Overall Study|Death|1|||
131879085|NCT01741792|474837868|FG002|Overall Study|Death|12|||
131879086|NCT01938430|474837869|FG000|Overall Study|Randomized but Not Treated|0|||
131879087|NCT01938430|474837870|FG001|Overall Study|Randomized but Not Treated|0|||
131879088|NCT01938430|474837871|FG002|Overall Study|Randomized but Not Treated|0|||
131879089|NCT01938430|474837872|FG003|Overall Study|Randomized but Not Treated|0|||
131879090|NCT01938430|474837873|FG004|Overall Study|Randomized but Not Treated|0|||
131879091|NCT01938430|474837874|FG005|Overall Study|Randomized but Not Treated|0|||
131879092|NCT01938430|474837875|FG006|Overall Study|Randomized but Not Treated|0|||
131879093|NCT01938430|474837876|FG007|Overall Study|Randomized but Not Treated|0|||
131879094|NCT01938430|474837877|FG008|Overall Study|Randomized but Not Treated|0|||
131879095|NCT01938430|474837878|FG009|Overall Study|Randomized but Not Treated|0|||
131879096|NCT01938430|474837879|FG010|Overall Study|Randomized but Not Treated|1|||
131879097|NCT01938430|474837880|FG011|Overall Study|Randomized but Not Treated|0|||
131879098|NCT01938430|474837881|FG012|Overall Study|Randomized but Not Treated|0|||
131879099|NCT01938430|474837882|FG013|Overall Study|Randomized but Not Treated|1|||
131879100|NCT01938430|474837869|FG000|Overall Study|Adverse Event|0|||
131879101|NCT01938430|474837870|FG001|Overall Study|Adverse Event|0|||
131879102|NCT01938430|474837871|FG002|Overall Study|Adverse Event|0|||
131879103|NCT01938430|474837872|FG003|Overall Study|Adverse Event|0|||
131879104|NCT01938430|474837873|FG004|Overall Study|Adverse Event|0|||
131879105|NCT01938430|474837874|FG005|Overall Study|Adverse Event|0|||
131879106|NCT01938430|474837875|FG006|Overall Study|Adverse Event|1|||
131879107|NCT01938430|474837876|FG007|Overall Study|Adverse Event|0|||
131879108|NCT01938430|474837877|FG008|Overall Study|Adverse Event|0|||
131879109|NCT01938430|474837878|FG009|Overall Study|Adverse Event|0|||
131879110|NCT01938430|474837879|FG010|Overall Study|Adverse Event|0|||
131879111|NCT01938430|474837880|FG011|Overall Study|Adverse Event|0|||
131879112|NCT01938430|474837881|FG012|Overall Study|Adverse Event|0|||
131879113|NCT01938430|474837882|FG013|Overall Study|Adverse Event|0|||
131879114|NCT01938430|474837869|FG000|Overall Study|Death|1|||
131879115|NCT01938430|474837870|FG001|Overall Study|Death|2|||
131879116|NCT01938430|474837871|FG002|Overall Study|Death|2|||
131879117|NCT01938430|474837872|FG003|Overall Study|Death|1|||
131879118|NCT01938430|474837873|FG004|Overall Study|Death|0|||
131879119|NCT01938430|474837874|FG005|Overall Study|Death|0|||
131879120|NCT01938430|474837875|FG006|Overall Study|Death|1|||
131879121|NCT01938430|474837876|FG007|Overall Study|Death|1|||
131879122|NCT01938430|474837877|FG008|Overall Study|Death|2|||
131879123|NCT01938430|474837878|FG009|Overall Study|Death|3|||
131879124|NCT01938430|474837879|FG010|Overall Study|Death|0|||
131879125|NCT01938430|474837880|FG011|Overall Study|Death|0|||
131879126|NCT01938430|474837881|FG012|Overall Study|Death|0|||
131879127|NCT01938430|474837882|FG013|Overall Study|Death|0|||
131879128|NCT01938430|474837869|FG000|Overall Study|Investigator's Discretion|0|||
131879129|NCT01938430|474837870|FG001|Overall Study|Investigator's Discretion|0|||
131879130|NCT01938430|474837871|FG002|Overall Study|Investigator's Discretion|1|||
131879131|NCT01938430|474837872|FG003|Overall Study|Investigator's Discretion|0|||
131879132|NCT01938430|474837873|FG004|Overall Study|Investigator's Discretion|0|||
131879133|NCT01938430|474837874|FG005|Overall Study|Investigator's Discretion|0|||
131879134|NCT01938430|474837875|FG006|Overall Study|Investigator's Discretion|0|||
131879135|NCT01938430|474837876|FG007|Overall Study|Investigator's Discretion|0|||
131879136|NCT01938430|474837877|FG008|Overall Study|Investigator's Discretion|0|||
131879137|NCT01938430|474837878|FG009|Overall Study|Investigator's Discretion|0|||
131879138|NCT01938430|474837879|FG010|Overall Study|Investigator's Discretion|0|||
131879139|NCT01938430|474837880|FG011|Overall Study|Investigator's Discretion|0|||
131879140|NCT01938430|474837881|FG012|Overall Study|Investigator's Discretion|0|||
131879141|NCT01938430|474837882|FG013|Overall Study|Investigator's Discretion|0|||
131879142|NCT01938430|474837869|FG000|Overall Study|Lack of Efficacy|3|||
131879143|NCT01938430|474837870|FG001|Overall Study|Lack of Efficacy|1|||
131879144|NCT01938430|474837871|FG002|Overall Study|Lack of Efficacy|1|||
131879145|NCT01938430|474837872|FG003|Overall Study|Lack of Efficacy|1|||
131879146|NCT01938430|474837873|FG004|Overall Study|Lack of Efficacy|0|||
131879147|NCT01938430|474837874|FG005|Overall Study|Lack of Efficacy|0|||
131879148|NCT01938430|474837875|FG006|Overall Study|Lack of Efficacy|0|||
131879149|NCT01938430|474837876|FG007|Overall Study|Lack of Efficacy|0|||
131879150|NCT01938430|474837877|FG008|Overall Study|Lack of Efficacy|1|||
131879151|NCT01938430|474837878|FG009|Overall Study|Lack of Efficacy|0|||
131879152|NCT01938430|474837879|FG010|Overall Study|Lack of Efficacy|2|||
131879153|NCT01938430|474837880|FG011|Overall Study|Lack of Efficacy|1|||
131879154|NCT01938430|474837881|FG012|Overall Study|Lack of Efficacy|0|||
131879155|NCT01938430|474837882|FG013|Overall Study|Lack of Efficacy|0|||
131879156|NCT01938430|474837869|FG000|Overall Study|Lost to Follow-up|0|||
131879157|NCT01938430|474837870|FG001|Overall Study|Lost to Follow-up|0|||
131879158|NCT01938430|474837871|FG002|Overall Study|Lost to Follow-up|1|||
131879159|NCT01938430|474837872|FG003|Overall Study|Lost to Follow-up|0|||
131924438|NCT01058005|475009106|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
131879160|NCT01938430|474837873|FG004|Overall Study|Lost to Follow-up|0|||
131879161|NCT01938430|474837874|FG005|Overall Study|Lost to Follow-up|1|||
131879162|NCT01938430|474837875|FG006|Overall Study|Lost to Follow-up|0|||
131879163|NCT01938430|474837876|FG007|Overall Study|Lost to Follow-up|0|||
131879164|NCT01938430|474837877|FG008|Overall Study|Lost to Follow-up|0|||
131879165|NCT01938430|474837878|FG009|Overall Study|Lost to Follow-up|0|||
131879166|NCT01938430|474837879|FG010|Overall Study|Lost to Follow-up|0|||
131924439|NCT01058005|475009107|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
131924440|NCT01058005|475009105|FG000|Overall Study|Reason Missing|5|||
131924441|NCT01058005|475009106|FG001|Overall Study|Reason Missing|3|||
131924442|NCT01058005|475009107|FG002|Overall Study|Reason Missing|1|||
131879167|NCT01938430|474837880|FG011|Overall Study|Lost to Follow-up|0|||
131879168|NCT01938430|474837881|FG012|Overall Study|Lost to Follow-up|0|||
131879169|NCT01938430|474837882|FG013|Overall Study|Lost to Follow-up|0|||
131879170|NCT01938430|474837869|FG000|Overall Study|Withdrew Consent|0|||
131879171|NCT01938430|474837870|FG001|Overall Study|Withdrew Consent|0|||
131879172|NCT01938430|474837871|FG002|Overall Study|Withdrew Consent|0|||
131879173|NCT01938430|474837872|FG003|Overall Study|Withdrew Consent|0|||
131879174|NCT01938430|474837873|FG004|Overall Study|Withdrew Consent|0|||
131879175|NCT01938430|474837874|FG005|Overall Study|Withdrew Consent|0|||
131879176|NCT01938430|474837875|FG006|Overall Study|Withdrew Consent|0|||
131879177|NCT01938430|474837876|FG007|Overall Study|Withdrew Consent|0|||
131879178|NCT01938430|474837877|FG008|Overall Study|Withdrew Consent|1|||
131879179|NCT01938430|474837878|FG009|Overall Study|Withdrew Consent|0|||
131879180|NCT01938430|474837879|FG010|Overall Study|Withdrew Consent|0|||
131879181|NCT01938430|474837880|FG011|Overall Study|Withdrew Consent|0|||
131879182|NCT01938430|474837881|FG012|Overall Study|Withdrew Consent|0|||
131879183|NCT01938430|474837882|FG013|Overall Study|Withdrew Consent|0|||
131879184|NCT01899742|474837890|FG000|Overall Study|Adverse Event|5|||
131879185|NCT01899742|474837891|FG001|Overall Study|Adverse Event|4|||
131879186|NCT01899742|474837890|FG000|Overall Study|Lack of Efficacy|1|||
131879187|NCT01899742|474837891|FG001|Overall Study|Lack of Efficacy|5|||
131879188|NCT01899742|474837890|FG000|Overall Study|Protocol Violation|2|||
131879189|NCT01899742|474837891|FG001|Overall Study|Protocol Violation|2|||
131879190|NCT01899742|474837890|FG000|Overall Study|Withdrawal by Subject|9|||
131879191|NCT01899742|474837891|FG001|Overall Study|Withdrawal by Subject|5|||
131879192|NCT01154088|474837894|FG000|Overall Study|Lost to Follow-up|4|||
131879193|NCT01154088|474837895|FG001|Overall Study|Lost to Follow-up|6|||
131879194|NCT01154088|474837896|FG002|Overall Study|Lost to Follow-up|7|||
131879195|NCT01104246|474837897|FG000|Overall Study|Withdrawal by Subject|1|||
131879196|NCT01104246|474837897|FG000|Overall Study|did not meet inclusion criteria|4|||
131879197|NCT01931956|474837902|FG000|Overall Study|Death|42|||
131879198|NCT01931956|474837903|FG001|Overall Study|Death|7|||
131879199|NCT01931956|474837904|FG002|Overall Study|Death|379|||
131879200|NCT01931956|474837905|FG003|Overall Study|Death|96|||
131879201|NCT01931956|474837902|FG000|Overall Study|Withdrawal by Subject|5|||
131879202|NCT01931956|474837903|FG001|Overall Study|Withdrawal by Subject|0|||
131879203|NCT01931956|474837904|FG002|Overall Study|Withdrawal by Subject|70|||
131879204|NCT01931956|474837905|FG003|Overall Study|Withdrawal by Subject|30|||
131879205|NCT01931956|474837902|FG000|Overall Study|Lost to Follow-up|2|||
131879206|NCT01931956|474837903|FG001|Overall Study|Lost to Follow-up|0|||
131879207|NCT01931956|474837904|FG002|Overall Study|Lost to Follow-up|11|||
131879208|NCT01931956|474837905|FG003|Overall Study|Lost to Follow-up|7|||
131924443|NCT02287025|475009110|FG000|Overall Study|Not treated|2|||
131924444|NCT02287025|475009111|FG001|Overall Study|Not treated|0|||
131924445|NCT02287025|475009110|FG000|Overall Study|Progression of disease|3|||
131924446|NCT02287025|475009111|FG001|Overall Study|Progression of disease|2|||
131924447|NCT02287025|475009110|FG000|Overall Study|Adverse Event|2|||
131924448|NCT02287025|475009111|FG001|Overall Study|Adverse Event|4|||
131924449|NCT02287025|475009110|FG000|Overall Study|Withdrawal by Subject|2|||
131924450|NCT02287025|475009111|FG001|Overall Study|Withdrawal by Subject|2|||
131924451|NCT02287025|475009110|FG000|Overall Study|Screening failed|1|||
131924452|NCT02287025|475009111|FG001|Overall Study|Screening failed|1|||
131879209|NCT01931956|474837902|FG000|Overall Study|Expected|2|||
131879210|NCT01931956|474837903|FG001|Overall Study|Expected|0|||
131879211|NCT01931956|474837904|FG002|Overall Study|Expected|6|||
131879212|NCT01931956|474837905|FG003|Overall Study|Expected|0|||
131879213|NCT01931956|474837902|FG000|Overall Study|Not due|0|||
131879214|NCT01931956|474837903|FG001|Overall Study|Not due|0|||
131879215|NCT01931956|474837904|FG002|Overall Study|Not due|21|||
131879216|NCT01931956|474837905|FG003|Overall Study|Not due|0|||
131879217|NCT02847494|474837910|FG000|Overall Study|Lost to Follow-up|8|||
131879218|NCT02847494|474837911|FG001|Overall Study|Lost to Follow-up|5|||
131879219|NCT01901653|474837912|FG000|Overall Study|Death|2|||
131879220|NCT01901653|474837913|FG001|Overall Study|Death|1|||
131879221|NCT01901653|474837914|FG002|Overall Study|Death|8|||
131879222|NCT01901653|474837915|FG003|Overall Study|Death|3|||
131879223|NCT01901653|474837916|FG004|Overall Study|Death|2|||
131879224|NCT01901653|474837917|FG005|Overall Study|Death|2|||
131879225|NCT01901653|474837918|FG006|Overall Study|Death|6|||
131409328|NCT03271047|473120861|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
131409329|NCT03271047|473120862|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
131409330|NCT03271047|473120863|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
131879226|NCT01901653|474837919|FG007|Overall Study|Death|9|||
131409331|NCT03271047|473120864|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
131409332|NCT02410824|473120865|FG000|First Intervention (One Week)|Headache|0|||
131409333|NCT02410824|473120866|FG001|First Intervention (One Week)|Headache|1|||
131409334|NCT02761694|473120871|FG000|Overall Study|Lack of Efficacy|0|||
131409335|NCT02761694|473120872|FG001|Overall Study|Lack of Efficacy|0|||
131409336|NCT02761694|473120873|FG002|Overall Study|Lack of Efficacy|0|||
131409337|NCT02761694|473120874|FG003|Overall Study|Lack of Efficacy|0|||
131409338|NCT02761694|473120875|FG004|Overall Study|Lack of Efficacy|0|||
131409339|NCT02761694|473120876|FG005|Overall Study|Lack of Efficacy|0|||
131409340|NCT02761694|473120877|FG006|Overall Study|Lack of Efficacy|6|||
131409341|NCT02761694|473120878|FG007|Overall Study|Lack of Efficacy|0|||
131409342|NCT02761694|473120879|FG008|Overall Study|Lack of Efficacy|0|||
131409343|NCT02761694|473120880|FG009|Overall Study|Lack of Efficacy|1|||
131409344|NCT02761694|473120881|FG010|Overall Study|Lack of Efficacy|1|||
131409345|NCT02761694|473120882|FG011|Overall Study|Lack of Efficacy|4|||
131409346|NCT02761694|473120871|FG000|Overall Study|Death|0|||
131409347|NCT02761694|473120872|FG001|Overall Study|Death|0|||
131409348|NCT02761694|473120873|FG002|Overall Study|Death|0|||
131409349|NCT02761694|473120874|FG003|Overall Study|Death|0|||
131409350|NCT02761694|473120875|FG004|Overall Study|Death|0|||
131409351|NCT02761694|473120876|FG005|Overall Study|Death|0|||
131409352|NCT02761694|473120877|FG006|Overall Study|Death|2|||
131409353|NCT02761694|473120878|FG007|Overall Study|Death|0|||
131409354|NCT02761694|473120879|FG008|Overall Study|Death|2|||
131409355|NCT02761694|473120880|FG009|Overall Study|Death|2|||
131409356|NCT02761694|473120881|FG010|Overall Study|Death|1|||
131409357|NCT02761694|473120882|FG011|Overall Study|Death|0|||
131409358|NCT02761694|473120871|FG000|Overall Study|Physician Decision|0|||
131409359|NCT02761694|473120872|FG001|Overall Study|Physician Decision|0|||
131409360|NCT02761694|473120873|FG002|Overall Study|Physician Decision|0|||
131409361|NCT02761694|473120874|FG003|Overall Study|Physician Decision|0|||
131409362|NCT02761694|473120875|FG004|Overall Study|Physician Decision|0|||
131409363|NCT02761694|473120876|FG005|Overall Study|Physician Decision|0|||
131409364|NCT02761694|473120877|FG006|Overall Study|Physician Decision|1|||
131409365|NCT02761694|473120878|FG007|Overall Study|Physician Decision|0|||
131409366|NCT02761694|473120879|FG008|Overall Study|Physician Decision|0|||
131409367|NCT02761694|473120880|FG009|Overall Study|Physician Decision|0|||
131409368|NCT02761694|473120881|FG010|Overall Study|Physician Decision|0|||
131409369|NCT02761694|473120882|FG011|Overall Study|Physician Decision|0|||
131454034|NCT01032889|473291866|FG000|Overall Study|Withdrawal of Consent|1|||
131454035|NCT01032889|473291867|FG001|Overall Study|Withdrawal of Consent|2|||
131879227|NCT01901653|474837920|FG008|Overall Study|Death|1|||
131879228|NCT01901653|474837921|FG009|Overall Study|Death|16|||
131879229|NCT01901653|474837922|FG010|Overall Study|Death|2|||
131879230|NCT01901653|474837923|FG011|Overall Study|Death|15|||
131879231|NCT01901653|474837924|FG012|Overall Study|Death|4|||
131879232|NCT01901653|474837912|FG000|Overall Study|Lost to Follow-up|1|||
131879233|NCT01901653|474837913|FG001|Overall Study|Lost to Follow-up|0|||
131879234|NCT01901653|474837914|FG002|Overall Study|Lost to Follow-up|2|||
131879235|NCT01901653|474837915|FG003|Overall Study|Lost to Follow-up|0|||
131879236|NCT01901653|474837916|FG004|Overall Study|Lost to Follow-up|0|||
131879237|NCT01901653|474837917|FG005|Overall Study|Lost to Follow-up|1|||
131879238|NCT01901653|474837918|FG006|Overall Study|Lost to Follow-up|0|||
131879239|NCT01901653|474837919|FG007|Overall Study|Lost to Follow-up|1|||
131879240|NCT01901653|474837920|FG008|Overall Study|Lost to Follow-up|0|||
131879241|NCT01901653|474837921|FG009|Overall Study|Lost to Follow-up|0|||
131879242|NCT01901653|474837922|FG010|Overall Study|Lost to Follow-up|0|||
131879243|NCT01901653|474837923|FG011|Overall Study|Lost to Follow-up|0|||
131879244|NCT01901653|474837924|FG012|Overall Study|Lost to Follow-up|0|||
131879245|NCT01901653|474837912|FG000|Overall Study|Withdrawal by Subject|0|||
131879246|NCT01901653|474837913|FG001|Overall Study|Withdrawal by Subject|0|||
131409370|NCT02761694|473120871|FG000|Overall Study|Withdrawal by Subject|0|||
131454036|NCT01032889|473291868|FG002|Overall Study|Withdrawal of Consent|1|||
131454037|NCT01032889|473291866|FG000|Overall Study|Patient Request|0|||
131409371|NCT02761694|473120872|FG001|Overall Study|Withdrawal by Subject|0|||
131409372|NCT02761694|473120873|FG002|Overall Study|Withdrawal by Subject|0|||
131409373|NCT02761694|473120874|FG003|Overall Study|Withdrawal by Subject|1|||
131454038|NCT01032889|473291867|FG001|Overall Study|Patient Request|1|||
131409374|NCT02761694|473120875|FG004|Overall Study|Withdrawal by Subject|0|||
131409375|NCT02761694|473120876|FG005|Overall Study|Withdrawal by Subject|0|||
131409376|NCT02761694|473120877|FG006|Overall Study|Withdrawal by Subject|4|||
131409377|NCT02761694|473120878|FG007|Overall Study|Withdrawal by Subject|0|||
131454039|NCT01032889|473291868|FG002|Overall Study|Patient Request|0|||
131409378|NCT02761694|473120879|FG008|Overall Study|Withdrawal by Subject|2|||
131879247|NCT01901653|474837914|FG002|Overall Study|Withdrawal by Subject|0|||
131879248|NCT01901653|474837915|FG003|Overall Study|Withdrawal by Subject|0|||
131924453|NCT01096186|475009112|FG000|Overall Study|Adverse Event|16|||
131924454|NCT01096186|475009112|FG000|Overall Study|Death|4|||
131924455|NCT01096186|475009112|FG000|Overall Study|Lack of Efficacy|4|||
131924456|NCT01096186|475009112|FG000|Overall Study|Lost to Follow-up|2|||
131879249|NCT01901653|474837916|FG004|Overall Study|Withdrawal by Subject|0|||
131879250|NCT01901653|474837917|FG005|Overall Study|Withdrawal by Subject|0|||
131924457|NCT01096186|475009112|FG000|Overall Study|Withdrawal by Subject|22|||
131924458|NCT01096186|475009112|FG000|Overall Study|Physician Decision|1|||
131924459|NCT01096186|475009112|FG000|Overall Study|Noncompliance with study drug|1|||
131924460|NCT04053452|475009113|FG000|Overall Study|Withdrawal by Subject|1|||
131924461|NCT04053452|475009114|FG001|Overall Study|Withdrawal by Subject|0|||
131924462|NCT04053452|475009113|FG000|Overall Study|Time restraint due to inpatient needs|1|||
131924463|NCT04053452|475009114|FG001|Overall Study|Time restraint due to inpatient needs|2|||
131924464|NCT01421134|475009115|FG000|Overall Study|Adverse Event|3|||
131924465|NCT01421134|475009116|FG001|Overall Study|Adverse Event|5|||
131924466|NCT01421134|475009115|FG000|Overall Study|Lack of Efficacy|2|||
131924467|NCT01421134|475009116|FG001|Overall Study|Lack of Efficacy|4|||
131924468|NCT01421134|475009115|FG000|Overall Study|Protocol Violation|0|||
131924469|NCT01421134|475009116|FG001|Overall Study|Protocol Violation|3|||
131924470|NCT01421134|475009115|FG000|Overall Study|Withdrawal by Subject|1|||
131924471|NCT01421134|475009116|FG001|Overall Study|Withdrawal by Subject|1|||
131924472|NCT01421134|475009115|FG000|Overall Study|Administrative|0|||
131924473|NCT01421134|475009116|FG001|Overall Study|Administrative|1|||
131924474|NCT01421134|475009115|FG000|Overall Study|Lost to Follow-up|1|||
131924475|NCT01421134|475009116|FG001|Overall Study|Lost to Follow-up|1|||
131924476|NCT02959892|475009117|FG000|Overall Study|PET tracer synthesis failure|1|||
131924477|NCT02959892|475009118|FG001|Overall Study|PET tracer synthesis failure|0|||
131924478|NCT02959892|475009117|FG000|Overall Study|Study termination|0|||
131879251|NCT01901653|474837918|FG006|Overall Study|Withdrawal by Subject|1|||
131879252|NCT01901653|474837919|FG007|Overall Study|Withdrawal by Subject|0|||
131879253|NCT01901653|474837920|FG008|Overall Study|Withdrawal by Subject|0|||
131879254|NCT01901653|474837921|FG009|Overall Study|Withdrawal by Subject|0|||
131879255|NCT01901653|474837922|FG010|Overall Study|Withdrawal by Subject|0|||
131879256|NCT01901653|474837923|FG011|Overall Study|Withdrawal by Subject|0|||
131879257|NCT01901653|474837924|FG012|Overall Study|Withdrawal by Subject|0|||
131879258|NCT01901653|474837912|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
131879259|NCT01901653|474837913|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
131879260|NCT01901653|474837914|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
131879261|NCT01901653|474837915|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
131879262|NCT01901653|474837916|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
131879263|NCT01901653|474837917|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
131879264|NCT01901653|474837918|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
131879265|NCT01901653|474837919|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
131879266|NCT01901653|474837920|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
131879267|NCT01901653|474837921|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
131879268|NCT01901653|474837922|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
131879269|NCT01901653|474837923|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
131879270|NCT01901653|474837924|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
131879271|NCT02841280|474837927|FG000|Overall Study|Adverse Event|2|||
131879272|NCT02841280|474837928|FG001|Overall Study|Adverse Event|1|||
131879273|NCT02841280|474837927|FG000|Overall Study|Death|1|||
131879274|NCT02841280|474837928|FG001|Overall Study|Death|0|||
131879275|NCT02841280|474837927|FG000|Overall Study|Lost to Follow-up|2|||
131879276|NCT02841280|474837928|FG001|Overall Study|Lost to Follow-up|2|||
131879277|NCT02841280|474837927|FG000|Overall Study|Withdrawal by Subject|7|||
131879278|NCT02841280|474837928|FG001|Overall Study|Withdrawal by Subject|3|||
131879279|NCT02841280|474837927|FG000|Overall Study|Stop Point: BP above threshold|2|||
131879280|NCT02841280|474837928|FG001|Overall Study|Stop Point: BP above threshold|0|||
131879281|NCT02727777|474837929|FG000|Overall Study|Screen Failure|2|||
131879282|NCT02727777|474837930|FG001|Overall Study|Screen Failure|0|||
131879283|NCT02727777|474837931|FG002|Overall Study|Screen Failure|0|||
131879284|NCT02727777|474837929|FG000|Overall Study|Progressive disease|2|||
131879285|NCT02727777|474837930|FG001|Overall Study|Progressive disease|0|||
131924479|NCT02959892|475009118|FG001|Overall Study|Study termination|1|||
131879286|NCT02727777|474837931|FG002|Overall Study|Progressive disease|0|||
131879287|NCT00957268|474837932|FG000|Overall Study|Voluntary Withdrawal|0|||
131924480|NCT00799864|475009122|FG000|Overall Study|Participant reached a virologic endpoint|9|||
131924481|NCT00799864|475009123|FG001|Overall Study|Participant reached a virologic endpoint|2|||
131924482|NCT00799864|475009124|FG002|Overall Study|Participant reached a virologic endpoint|2|||
131879288|NCT00957268|474837933|FG001|Overall Study|Voluntary Withdrawal|0|||
131924483|NCT00799864|475009125|FG003|Overall Study|Participant reached a virologic endpoint|0|||
131879289|NCT00957268|474837934|FG002|Overall Study|Voluntary Withdrawal|1|||
131879290|NCT00957268|474837935|FG003|Overall Study|Voluntary Withdrawal|0|||
131879291|NCT00957268|474837936|FG004|Overall Study|Voluntary Withdrawal|0|||
131879292|NCT01738503|474837937|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
131879293|NCT01738503|474837938|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
131879294|NCT01738503|474837939|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
131879295|NCT01738503|474837940|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
131879296|NCT01738503|474837941|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
131879297|NCT01738503|474837942|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
131879298|NCT01738503|474837943|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
131879299|NCT01738503|474837937|FG000|Treatment Period|Adverse Event|0|||
131879300|NCT01738503|474837938|FG001|Treatment Period|Adverse Event|1|||
131879301|NCT01738503|474837939|FG002|Treatment Period|Adverse Event|0|||
131879302|NCT01738503|474837940|FG003|Treatment Period|Adverse Event|1|||
131879303|NCT01738503|474837941|FG004|Treatment Period|Adverse Event|2|||
131879304|NCT01738503|474837942|FG005|Treatment Period|Adverse Event|2|||
131879305|NCT01738503|474837943|FG006|Treatment Period|Adverse Event|2|||
131879306|NCT01738503|474837937|FG000|Treatment Period|Lost to Follow-up|0|||
131879307|NCT01738503|474837938|FG001|Treatment Period|Lost to Follow-up|0|||
131879308|NCT01738503|474837939|FG002|Treatment Period|Lost to Follow-up|3|||
131879309|NCT01738503|474837940|FG003|Treatment Period|Lost to Follow-up|4|||
131879310|NCT01738503|474837941|FG004|Treatment Period|Lost to Follow-up|1|||
131879311|NCT01738503|474837942|FG005|Treatment Period|Lost to Follow-up|1|||
131879312|NCT01738503|474837943|FG006|Treatment Period|Lost to Follow-up|5|||
131879313|NCT01738503|474837937|FG000|Treatment Period|Withdrawal by Subject|0|||
131879314|NCT01738503|474837938|FG001|Treatment Period|Withdrawal by Subject|1|||
131879315|NCT01738503|474837939|FG002|Treatment Period|Withdrawal by Subject|0|||
131879316|NCT01738503|474837940|FG003|Treatment Period|Withdrawal by Subject|1|||
131879317|NCT01738503|474837941|FG004|Treatment Period|Withdrawal by Subject|1|||
131879318|NCT01738503|474837942|FG005|Treatment Period|Withdrawal by Subject|1|||
131879319|NCT01738503|474837943|FG006|Treatment Period|Withdrawal by Subject|1|||
131879320|NCT01738503|474837937|FG000|Treatment Period|Protocol Violation|0|||
131879321|NCT01738503|474837938|FG001|Treatment Period|Protocol Violation|3|||
131879322|NCT01738503|474837939|FG002|Treatment Period|Protocol Violation|1|||
131879323|NCT01738503|474837940|FG003|Treatment Period|Protocol Violation|0|||
131879324|NCT01738503|474837941|FG004|Treatment Period|Protocol Violation|4|||
131879325|NCT01738503|474837942|FG005|Treatment Period|Protocol Violation|2|||
131879326|NCT01738503|474837943|FG006|Treatment Period|Protocol Violation|0|||
131879327|NCT01738503|474837937|FG000|Treatment Period|Other|0|||
131879328|NCT01738503|474837938|FG001|Treatment Period|Other|0|||
131879329|NCT01738503|474837939|FG002|Treatment Period|Other|1|||
131879330|NCT01738503|474837940|FG003|Treatment Period|Other|0|||
131879331|NCT01738503|474837941|FG004|Treatment Period|Other|0|||
131879332|NCT01738503|474837942|FG005|Treatment Period|Other|0|||
131879333|NCT01738503|474837943|FG006|Treatment Period|Other|0|||
131879334|NCT01738503|474837937|FG000|PET Imaging Sub-study|Adverse Event|0|||
131879335|NCT01738503|474837938|FG001|PET Imaging Sub-study|Adverse Event|0|||
131879336|NCT01738503|474837939|FG002|PET Imaging Sub-study|Adverse Event|0|||
131879337|NCT01738503|474837940|FG003|PET Imaging Sub-study|Adverse Event|0|||
131879338|NCT01738503|474837941|FG004|PET Imaging Sub-study|Adverse Event|0|||
131879339|NCT01738503|474837942|FG005|PET Imaging Sub-study|Adverse Event|1|||
131879340|NCT01738503|474837943|FG006|PET Imaging Sub-study|Adverse Event|0|||
131879341|NCT01738503|474837937|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
131879342|NCT01738503|474837938|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
131879343|NCT01738503|474837939|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
131879344|NCT01738503|474837940|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
131879345|NCT01738503|474837941|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
131879346|NCT01738503|474837942|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
131879347|NCT01738503|474837943|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
131879348|NCT03005327|474837945|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
131879349|NCT03005327|474837946|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
131879350|NCT03005327|474837947|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
131879351|NCT03005327|474837948|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
131879352|NCT03005327|474837945|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131879353|NCT03005327|474837946|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131879354|NCT03005327|474837947|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131879355|NCT03005327|474837948|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131879356|NCT01340027|474837949|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
131879357|NCT01340027|474837950|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
131879358|NCT01340027|474837951|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
131879359|NCT01340027|474837952|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
131879360|NCT01340027|474837953|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
131879361|NCT01340027|474837954|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
131879362|NCT01340027|474837955|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
131879363|NCT01340027|474837956|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
131879364|NCT01340027|474837957|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
131879365|NCT01340027|474837958|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
131879366|NCT01340027|474837959|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
131879367|NCT01340027|474837960|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
131879368|NCT01340027|474837949|FG000|Overall Study|Adverse Event|0|||
131879369|NCT01340027|474837950|FG001|Overall Study|Adverse Event|1|||
131879370|NCT01340027|474837951|FG002|Overall Study|Adverse Event|2|||
131879371|NCT01340027|474837952|FG003|Overall Study|Adverse Event|0|||
131879372|NCT01340027|474837953|FG004|Overall Study|Adverse Event|1|||
131879373|NCT01340027|474837954|FG005|Overall Study|Adverse Event|2|||
131879374|NCT01340027|474837955|FG006|Overall Study|Adverse Event|2|||
131879375|NCT01340027|474837956|FG007|Overall Study|Adverse Event|1|||
131879376|NCT01340027|474837957|FG008|Overall Study|Adverse Event|4|||
131879377|NCT01340027|474837958|FG009|Overall Study|Adverse Event|1|||
131879378|NCT01340027|474837959|FG010|Overall Study|Adverse Event|1|||
131879379|NCT01340027|474837960|FG011|Overall Study|Adverse Event|3|||
131879380|NCT01340027|474837949|FG000|Overall Study|Lack of Efficacy|0|||
131879381|NCT01340027|474837950|FG001|Overall Study|Lack of Efficacy|0|||
131879382|NCT01340027|474837951|FG002|Overall Study|Lack of Efficacy|0|||
131879383|NCT01340027|474837952|FG003|Overall Study|Lack of Efficacy|0|||
131879384|NCT01340027|474837953|FG004|Overall Study|Lack of Efficacy|0|||
131879385|NCT01340027|474837954|FG005|Overall Study|Lack of Efficacy|0|||
131879386|NCT01340027|474837955|FG006|Overall Study|Lack of Efficacy|1|||
131879387|NCT01340027|474837956|FG007|Overall Study|Lack of Efficacy|1|||
131879388|NCT01340027|474837957|FG008|Overall Study|Lack of Efficacy|1|||
131879389|NCT01340027|474837958|FG009|Overall Study|Lack of Efficacy|0|||
131879390|NCT01340027|474837959|FG010|Overall Study|Lack of Efficacy|0|||
131879391|NCT01340027|474837960|FG011|Overall Study|Lack of Efficacy|0|||
131879392|NCT01340027|474837949|FG000|Overall Study|Lost to Follow-up|0|||
131879393|NCT01340027|474837950|FG001|Overall Study|Lost to Follow-up|1|||
131879394|NCT01340027|474837951|FG002|Overall Study|Lost to Follow-up|0|||
131879395|NCT01340027|474837952|FG003|Overall Study|Lost to Follow-up|0|||
131879396|NCT01340027|474837953|FG004|Overall Study|Lost to Follow-up|0|||
131879397|NCT01340027|474837954|FG005|Overall Study|Lost to Follow-up|0|||
131879398|NCT01340027|474837955|FG006|Overall Study|Lost to Follow-up|1|||
131879399|NCT01340027|474837956|FG007|Overall Study|Lost to Follow-up|0|||
131879400|NCT01340027|474837957|FG008|Overall Study|Lost to Follow-up|0|||
131879401|NCT01340027|474837958|FG009|Overall Study|Lost to Follow-up|1|||
131879402|NCT01340027|474837959|FG010|Overall Study|Lost to Follow-up|0|||
131879403|NCT01340027|474837960|FG011|Overall Study|Lost to Follow-up|0|||
131879404|NCT01340027|474837949|FG000|Overall Study|Protocol Violation|1|||
131879405|NCT01340027|474837950|FG001|Overall Study|Protocol Violation|2|||
131879406|NCT01340027|474837951|FG002|Overall Study|Protocol Violation|0|||
131879407|NCT01340027|474837952|FG003|Overall Study|Protocol Violation|0|||
131879408|NCT01340027|474837953|FG004|Overall Study|Protocol Violation|6|||
131879409|NCT01340027|474837954|FG005|Overall Study|Protocol Violation|0|||
131879410|NCT01340027|474837955|FG006|Overall Study|Protocol Violation|0|||
131879411|NCT01340027|474837956|FG007|Overall Study|Protocol Violation|1|||
131879412|NCT01340027|474837957|FG008|Overall Study|Protocol Violation|2|||
131879413|NCT01340027|474837958|FG009|Overall Study|Protocol Violation|2|||
131879414|NCT01340027|474837959|FG010|Overall Study|Protocol Violation|0|||
131879415|NCT01340027|474837960|FG011|Overall Study|Protocol Violation|0|||
131879416|NCT01340027|474837949|FG000|Overall Study|Withdrawal by Subject|4|||
131879417|NCT01340027|474837950|FG001|Overall Study|Withdrawal by Subject|3|||
131879418|NCT01340027|474837951|FG002|Overall Study|Withdrawal by Subject|1|||
131879419|NCT01340027|474837952|FG003|Overall Study|Withdrawal by Subject|3|||
131879420|NCT01340027|474837953|FG004|Overall Study|Withdrawal by Subject|3|||
131879421|NCT01340027|474837954|FG005|Overall Study|Withdrawal by Subject|2|||
131879422|NCT01340027|474837955|FG006|Overall Study|Withdrawal by Subject|3|||
131879423|NCT01340027|474837956|FG007|Overall Study|Withdrawal by Subject|4|||
131879424|NCT01340027|474837957|FG008|Overall Study|Withdrawal by Subject|1|||
131879425|NCT01340027|474837958|FG009|Overall Study|Withdrawal by Subject|2|||
131879426|NCT01340027|474837959|FG010|Overall Study|Withdrawal by Subject|0|||
131879427|NCT01340027|474837960|FG011|Overall Study|Withdrawal by Subject|1|||
131879428|NCT01340027|474837949|FG000|Overall Study|Miscellaneous|0|||
131879429|NCT01340027|474837950|FG001|Overall Study|Miscellaneous|0|||
131879430|NCT01340027|474837951|FG002|Overall Study|Miscellaneous|0|||
131879431|NCT01340027|474837952|FG003|Overall Study|Miscellaneous|1|||
131879432|NCT01340027|474837953|FG004|Overall Study|Miscellaneous|0|||
131879433|NCT01340027|474837954|FG005|Overall Study|Miscellaneous|0|||
131879434|NCT01340027|474837955|FG006|Overall Study|Miscellaneous|0|||
131879435|NCT01340027|474837956|FG007|Overall Study|Miscellaneous|0|||
131879436|NCT01340027|474837957|FG008|Overall Study|Miscellaneous|0|||
131879437|NCT01340027|474837958|FG009|Overall Study|Miscellaneous|0|||
131879438|NCT01340027|474837959|FG010|Overall Study|Miscellaneous|1|||
131879439|NCT01340027|474837960|FG011|Overall Study|Miscellaneous|0|||
131879440|NCT04687072|474837961|FG000|Overall Study|Adverse Event|2|||
131879441|NCT04687072|474837962|FG001|Overall Study|Adverse Event|0|||
131879442|NCT04687072|474837961|FG000|Overall Study|Death|1|||
131409379|NCT02761694|473120880|FG009|Overall Study|Withdrawal by Subject|1|||
131409380|NCT02761694|473120881|FG010|Overall Study|Withdrawal by Subject|0|||
131409381|NCT02761694|473120882|FG011|Overall Study|Withdrawal by Subject|0|||
131409382|NCT02761694|473120871|FG000|Overall Study|Lost to Follow-up|0|||
131879443|NCT04687072|474837962|FG001|Overall Study|Death|0|||
131879444|NCT04687072|474837961|FG000|Overall Study|Lack of Efficacy|2|||
131879445|NCT04687072|474837962|FG001|Overall Study|Lack of Efficacy|1|||
131879446|NCT04687072|474837961|FG000|Overall Study|Physician Decision|1|||
131879447|NCT04687072|474837962|FG001|Overall Study|Physician Decision|0|||
131879448|NCT04687072|474837961|FG000|Overall Study|Pregnancy|1|||
131879449|NCT04687072|474837962|FG001|Overall Study|Pregnancy|0|||
131879450|NCT04687072|474837961|FG000|Overall Study|Requires Prohibited Medication|2|||
131879451|NCT04687072|474837962|FG001|Overall Study|Requires Prohibited Medication|0|||
131879452|NCT04687072|474837961|FG000|Overall Study|Withdrawal of Consent|11|||
131879453|NCT04687072|474837962|FG001|Overall Study|Withdrawal of Consent|6|||
131879454|NCT04687072|474837961|FG000|Overall Study|Miscellaneous|4|||
131879455|NCT04687072|474837962|FG001|Overall Study|Miscellaneous|1|||
131879456|NCT00915876|474837963|FG000|Overall Study|Adverse Event|0|||
131879457|NCT00915876|474837964|FG001|Overall Study|Adverse Event|1|||
131879458|NCT02572076|474837971|FG000|Overall Study|Protocol Violation|1|||
131879459|NCT02496091|474837972|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131879460|NCT02272842|474837973|FG000|Overall Study|Lost to Follow-up|8|||
131879461|NCT02272842|474837974|FG001|Overall Study|Lost to Follow-up|8|||
131879462|NCT02272842|474837973|FG000|Overall Study|Withdrawal by Subject|8|||
131879463|NCT02272842|474837974|FG001|Overall Study|Withdrawal by Subject|2|||
131879464|NCT03053063|474837981|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
131879465|NCT03053063|474837982|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
131879466|NCT03053063|474837983|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
131879467|NCT03053063|474837984|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
131879468|NCT03053063|474837981|FG000|Randomized Phase|Withdrew consent|8|||
131879469|NCT03053063|474837982|FG001|Randomized Phase|Withdrew consent|11|||
131879470|NCT03053063|474837983|FG002|Randomized Phase|Withdrew consent|5|||
131879471|NCT03053063|474837984|FG003|Randomized Phase|Withdrew consent|0|||
131879472|NCT03053063|474837981|FG000|Randomized Phase|Investigator's Discretion|8|||
131879473|NCT03053063|474837982|FG001|Randomized Phase|Investigator's Discretion|6|||
131879474|NCT03053063|474837983|FG002|Randomized Phase|Investigator's Discretion|2|||
131879475|NCT03053063|474837984|FG003|Randomized Phase|Investigator's Discretion|0|||
131879476|NCT03053063|474837981|FG000|Randomized Phase|Lost to Follow-up|3|||
131879477|NCT03053063|474837982|FG001|Randomized Phase|Lost to Follow-up|5|||
131879478|NCT03053063|474837983|FG002|Randomized Phase|Lost to Follow-up|1|||
131879479|NCT03053063|474837984|FG003|Randomized Phase|Lost to Follow-up|0|||
131879480|NCT03053063|474837981|FG000|Randomized Phase|Adverse Event|0|||
131879481|NCT03053063|474837982|FG001|Randomized Phase|Adverse Event|1|||
131879482|NCT03053063|474837983|FG002|Randomized Phase|Adverse Event|0|||
131879483|NCT03053063|474837984|FG003|Randomized Phase|Adverse Event|0|||
131879484|NCT03053063|474837981|FG000|Randomized Phase|Randomized but Never Treated|1|||
131879485|NCT03053063|474837982|FG001|Randomized Phase|Randomized but Never Treated|3|||
131879486|NCT03053063|474837983|FG002|Randomized Phase|Randomized but Never Treated|2|||
131879487|NCT03053063|474837984|FG003|Randomized Phase|Randomized but Never Treated|0|||
131879488|NCT03053063|474837981|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
131879489|NCT03053063|474837982|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
131879490|NCT03053063|474837983|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
131879491|NCT03053063|474837984|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
131879492|NCT03053063|474837981|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
131879493|NCT03053063|474837982|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
131879494|NCT03053063|474837983|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
131879495|NCT03053063|474837984|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
131879496|NCT03053063|474837981|FG000|Open-Label Phase|Death|0|||
131879497|NCT03053063|474837982|FG001|Open-Label Phase|Death|0|||
131879498|NCT03053063|474837983|FG002|Open-Label Phase|Death|0|||
131879499|NCT03053063|474837984|FG003|Open-Label Phase|Death|2|||
131879500|NCT03053063|474837981|FG000|Open-Label Phase|Investigator's discretion|0|||
131879501|NCT03053063|474837982|FG001|Open-Label Phase|Investigator's discretion|0|||
131879502|NCT03053063|474837983|FG002|Open-Label Phase|Investigator's discretion|0|||
131879503|NCT03053063|474837984|FG003|Open-Label Phase|Investigator's discretion|2|||
131879504|NCT01970475|474837986|FG000|Overall Study|Withdrawal by Subject|11|||
131879505|NCT01970475|474837987|FG001|Overall Study|Withdrawal by Subject|6|||
131879506|NCT01970475|474837986|FG000|Overall Study|Adverse Event|7|||
131409383|NCT02761694|473120872|FG001|Overall Study|Lost to Follow-up|0|||
131409384|NCT02761694|473120873|FG002|Overall Study|Lost to Follow-up|0|||
131879507|NCT01970475|474837987|FG001|Overall Study|Adverse Event|3|||
131879508|NCT01970475|474837986|FG000|Overall Study|Lost to Follow-up|2|||
131879509|NCT01970475|474837987|FG001|Overall Study|Lost to Follow-up|2|||
131879510|NCT01970475|474837986|FG000|Overall Study|Protocol Violation|1|||
131879511|NCT01970475|474837987|FG001|Overall Study|Protocol Violation|0|||
131879512|NCT06366087|474839643|FG000|Overall Study|Withdrawal by Subject|0|||
131924484|NCT00799864|475009126|FG004|Overall Study|Participant reached a virologic endpoint|0|||
131924485|NCT00799864|475009122|FG000|Overall Study|Other|2|||
131924486|NCT00799864|475009123|FG001|Overall Study|Other|1|||
131924487|NCT00799864|475009124|FG002|Overall Study|Other|0|||
131924488|NCT00799864|475009125|FG003|Overall Study|Other|0|||
131924489|NCT00799864|475009126|FG004|Overall Study|Other|0|||
131924490|NCT03528577|475009129|FG000|Sequence 1|Failed Spirometry|1|||
131924491|NCT03528577|475009129|FG000|Sequence 1|Restricted medication|1|||
131409385|NCT02761694|473120874|FG003|Overall Study|Lost to Follow-up|0|||
131409386|NCT02761694|473120875|FG004|Overall Study|Lost to Follow-up|0|||
131409387|NCT02761694|473120876|FG005|Overall Study|Lost to Follow-up|0|||
131409388|NCT02761694|473120877|FG006|Overall Study|Lost to Follow-up|1|||
131409389|NCT02761694|473120878|FG007|Overall Study|Lost to Follow-up|0|||
131409390|NCT02761694|473120879|FG008|Overall Study|Lost to Follow-up|0|||
131409391|NCT02761694|473120880|FG009|Overall Study|Lost to Follow-up|0|||
131409392|NCT02761694|473120881|FG010|Overall Study|Lost to Follow-up|0|||
131879513|NCT06366087|474839644|FG001|Overall Study|Withdrawal by Subject|1|||
131879514|NCT00860249|474839646|FG000|Overall Study|trial was terminated prior to completion|21|||
131879515|NCT00860249|474839647|FG001|Overall Study|trial was terminated prior to completion|18|||
131879516|NCT00860249|474839648|FG002|Overall Study|trial was terminated prior to completion|21|||
131879517|NCT00174967|474839655|FG000|Overall Study|Adverse Event|1|||
131879518|NCT00174967|474839656|FG001|Overall Study|Adverse Event|2|||
131879519|NCT00174967|474839657|FG002|Overall Study|Adverse Event|2|||
131879520|NCT00174967|474839658|FG003|Overall Study|Adverse Event|1|||
131879521|NCT00174967|474839655|FG000|Overall Study|Gout Flare|0|||
131879522|NCT00174967|474839656|FG001|Overall Study|Gout Flare|0|||
131879523|NCT00174967|474839657|FG002|Overall Study|Gout Flare|0|||
131879524|NCT00174967|474839658|FG003|Overall Study|Gout Flare|1|||
131879525|NCT00174967|474839655|FG000|Overall Study|Other|0|||
131879526|NCT00174967|474839656|FG001|Overall Study|Other|1|||
131879527|NCT00174967|474839657|FG002|Overall Study|Other|0|||
131879528|NCT00174967|474839658|FG003|Overall Study|Other|0|||
131879529|NCT04934189|474839659|FG000|Overall Study|Lost to Follow-up|4|||
131879530|NCT04934189|474839659|FG000|Overall Study|Withdrawal by Subject|17|||
131879531|NCT01286168|474839668|FG000|Overall Study|Withdrawal by Subject|1|||
131879532|NCT01286168|474839668|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
131879533|NCT00843037|474839673|FG000|Overall Study|Lost to Follow-up|1|||
131879534|NCT02091960|474839676|FG000|Overall Study|Death|7|||
131879535|NCT02091960|474839676|FG000|Overall Study|Withdrawal by Subject|1|||
131879536|NCT02091960|474839676|FG000|Overall Study|Miscellaneous Reasons|37|||
131879537|NCT02662764|474839687|FG000|Overall Study|Adverse Event|6|||
131879538|NCT02662764|474839687|FG000|Overall Study|Lack of Efficacy|8|||
131879539|NCT02662764|474839687|FG000|Overall Study|Protocol Violation|1|||
131879540|NCT02662764|474839687|FG000|Overall Study|Withdrawal by Subject|5|||
131879541|NCT02662764|474839687|FG000|Overall Study|Device failure|4|||
131879542|NCT02662764|474839687|FG000|Overall Study|Patient changed treatment|1|||
131879543|NCT02662764|474839687|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
131879544|NCT05178641|474839688|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
131879545|NCT05178641|474839689|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
131879546|NCT05178641|474839688|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
131879547|NCT05178641|474839689|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
131879548|NCT01869699|474839690|FG000|Overall Study|Withdrawal by Subject|1|||
131879549|NCT01869699|474839691|FG001|Overall Study|Withdrawal by Subject|0|||
131879550|NCT00189306|474839697|FG000|Treatment Period|Withdrawal by Subject|2|||
131879551|NCT00189306|474839697|FG000|Treatment Period|Adverse Event|2|||
131879552|NCT00189306|474839697|FG000|Treatment Period|Protocol Violation|1|||
131879553|NCT00189306|474839697|FG000|Posttreatment Period|Death|1|||
131924492|NCT03528577|475009129|FG000|Sequence 2|Adverse Event|1|||
131879554|NCT00189306|474839697|FG000|Posttreatment Period|Withdrawal by Subject|2|||
131879555|NCT00189306|474839697|FG000|Posttreatment Period|Noncompliance|1|||
131924493|NCT03528577|475009129|FG000|Sequence 2|Withdrawal by Subject|1|||
131924494|NCT03528577|475009129|FG000|Sequence 2|Failed Spirometry|1|||
131924495|NCT03528577|475009129|FG000|Sequence 3|Failed Spirometry|1|||
131879556|NCT00189306|474839697|FG000|Posttreatment Period|Target lesion excised|1|||
131879557|NCT00189306|474839697|FG000|Posttreatment Period|Protocol Violation|1|||
131879558|NCT00189306|474839697|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
131879559|NCT00189306|474839697|FG000|Posttreatment Period|Local skin reaction/sign|1|||
131879560|NCT00189306|474839697|FG000|Long-Term Follow-up|Adverse Event|2|||
131879561|NCT00189306|474839697|FG000|Long-Term Follow-up|Death|4|||
131924496|NCT03528577|475009129|FG000|Sequence 4|Failed Spirometry|2|||
131409393|NCT02761694|473120882|FG011|Overall Study|Lost to Follow-up|1|||
131879562|NCT00189306|474839697|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
131409394|NCT02761694|473120871|FG000|Overall Study|Adverse Event|0|||
131409395|NCT02761694|473120872|FG001|Overall Study|Adverse Event|0|||
131409396|NCT02761694|473120873|FG002|Overall Study|Adverse Event|0|||
131879563|NCT00189306|474839697|FG000|Long-Term Follow-up|Intercurrent disease|2|||
131879564|NCT00189306|474839697|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
131924497|NCT03528577|475009129|FG000|Sequence 4|Adverse Event|1|||
131924498|NCT04882215|475009130|FG000|Overall Study|Withdrawal by Subject|5|||
131879565|NCT00189306|474839697|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
131879566|NCT00459706|474839698|FG000|Overall Study|Adverse Event|19|||
131879567|NCT00459706|474839699|FG001|Overall Study|Adverse Event|13|||
131879568|NCT00459706|474839698|FG000|Overall Study|Withdrawal by Subject|1|||
131879569|NCT00459706|474839699|FG001|Overall Study|Withdrawal by Subject|6|||
131879570|NCT00459706|474839698|FG000|Overall Study|Physician Decision|2|||
131879571|NCT00459706|474839699|FG001|Overall Study|Physician Decision|0|||
131879572|NCT00459706|474839698|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
131879573|NCT00459706|474839699|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131879574|NCT00459706|474839698|FG000|Overall Study|Protocol Violation|2|||
131879575|NCT00459706|474839699|FG001|Overall Study|Protocol Violation|1|||
131879576|NCT00459706|474839698|FG000|Overall Study|Failed to Return|1|||
131879577|NCT00459706|474839699|FG001|Overall Study|Failed to Return|0|||
131879578|NCT00459706|474839698|FG000|Overall Study|Other|0|||
131879579|NCT00459706|474839699|FG001|Overall Study|Other|1|||
131879580|NCT03640481|474839700|FG000|Overall Study|Death|14|||
131879581|NCT03640481|474839701|FG001|Overall Study|Death|14|||
131879582|NCT03640481|474839702|FG002|Overall Study|Death|0|||
131879583|NCT03640481|474839703|FG003|Overall Study|Death|0|||
131879584|NCT03640481|474839700|FG000|Overall Study|Lost to Follow-up|2|||
131879585|NCT03640481|474839701|FG001|Overall Study|Lost to Follow-up|0|||
131879586|NCT03640481|474839702|FG002|Overall Study|Lost to Follow-up|0|||
131879587|NCT03640481|474839703|FG003|Overall Study|Lost to Follow-up|0|||
131879588|NCT03640481|474839700|FG000|Overall Study|Site terminated by sponsor|1|||
131879589|NCT03640481|474839701|FG001|Overall Study|Site terminated by sponsor|3|||
131879590|NCT03640481|474839702|FG002|Overall Study|Site terminated by sponsor|0|||
131879591|NCT03640481|474839703|FG003|Overall Study|Site terminated by sponsor|0|||
131879592|NCT03640481|474839700|FG000|Overall Study|Study terminated by sponsor|29|||
131879593|NCT03640481|474839701|FG001|Overall Study|Study terminated by sponsor|42|||
131879594|NCT03640481|474839702|FG002|Overall Study|Study terminated by sponsor|1|||
131879595|NCT03640481|474839703|FG003|Overall Study|Study terminated by sponsor|0|||
131879596|NCT03640481|474839700|FG000|Overall Study|Withdrawal by Subject|5|||
131879597|NCT03640481|474839701|FG001|Overall Study|Withdrawal by Subject|4|||
131879598|NCT03640481|474839702|FG002|Overall Study|Withdrawal by Subject|0|||
131879599|NCT03640481|474839703|FG003|Overall Study|Withdrawal by Subject|1|||
131879600|NCT03640481|474839700|FG000|Overall Study|Other|26|||
131879601|NCT03640481|474839701|FG001|Overall Study|Other|12|||
131879602|NCT03640481|474839702|FG002|Overall Study|Other|1|||
131879603|NCT03640481|474839703|FG003|Overall Study|Other|0|||
131879604|NCT03640481|474839700|FG000|Overall Study|Randomized, but not treated|1|||
131879605|NCT03640481|474839701|FG001|Overall Study|Randomized, but not treated|3|||
131879606|NCT03640481|474839702|FG002|Overall Study|Randomized, but not treated|0|||
131879607|NCT03640481|474839703|FG003|Overall Study|Randomized, but not treated|0|||
131879608|NCT00727844|474839704|FG000|Initial Randomization|Physician Decision|2|||
131879609|NCT00727844|474839705|FG001|Initial Randomization|Physician Decision|0|||
131879610|NCT00727844|474839706|FG002|Initial Randomization|Physician Decision|0|||
131879611|NCT00727844|474839707|FG003|Initial Randomization|Physician Decision|0|||
131879612|NCT00732758|474839708|FG000|Overall Study|Lost to Follow-up|8|||
131879613|NCT00732758|474839709|FG001|Overall Study|Lost to Follow-up|16|||
131879614|NCT00373958|474839710|FG000|Infant Series|Withdrawal by Subject|13|||
131879615|NCT00373958|474839711|FG001|Infant Series|Withdrawal by Subject|15|||
131879616|NCT00373958|474839710|FG000|Infant Series|Failed to return|8|||
131879617|NCT00373958|474839711|FG001|Infant Series|Failed to return|13|||
131879618|NCT00373958|474839710|FG000|Infant Series|Lost to Follow-up|6|||
131879619|NCT00373958|474839711|FG001|Infant Series|Lost to Follow-up|5|||
131879620|NCT00373958|474839710|FG000|Infant Series|Protocol Violation|3|||
131879621|NCT00373958|474839711|FG001|Infant Series|Protocol Violation|7|||
131879622|NCT00373958|474839710|FG000|Infant Series|Lost Kaiser coverage|4|||
131879623|NCT00373958|474839711|FG001|Infant Series|Lost Kaiser coverage|0|||
131924499|NCT04882215|475009131|FG001|Overall Study|Withdrawal by Subject|0|||
131924500|NCT04263532|475009132|FG000|Overall Study|Withdrawal by Subject|2|||
131409397|NCT02761694|473120874|FG003|Overall Study|Adverse Event|0|||
131409398|NCT02761694|473120875|FG004|Overall Study|Adverse Event|0|||
131409399|NCT02761694|473120876|FG005|Overall Study|Adverse Event|0|||
131879624|NCT00373958|474839710|FG000|Infant Series|Child relocated|1|||
131879625|NCT00373958|474839711|FG001|Infant Series|Child relocated|0|||
131879626|NCT00373958|474839710|FG000|Infant Series|Consent was not received|1|||
131879627|NCT00373958|474839711|FG001|Infant Series|Consent was not received|0|||
131409400|NCT02761694|473120877|FG006|Overall Study|Adverse Event|1|||
131879628|NCT00373958|474839710|FG000|Infant Series|Adverse Event|3|||
131879629|NCT00373958|474839711|FG001|Infant Series|Adverse Event|1|||
131879630|NCT00373958|474839710|FG000|Infant Series|Physician Decision|1|||
131879631|NCT00373958|474839711|FG001|Infant Series|Physician Decision|1|||
131879632|NCT00373958|474839710|FG000|Toddler Dose|Lost to Follow-up|5|||
131879633|NCT00373958|474839711|FG001|Toddler Dose|Lost to Follow-up|8|||
131879634|NCT00373958|474839710|FG000|Toddler Dose|Withdrawal by Subject|2|||
131879635|NCT00373958|474839711|FG001|Toddler Dose|Withdrawal by Subject|2|||
131879636|NCT00373958|474839710|FG000|Toddler Dose|Failed to return|1|||
131879637|NCT00373958|474839711|FG001|Toddler Dose|Failed to return|2|||
131879638|NCT00373958|474839710|FG000|Toddler Dose|Protocol Violation|0|||
131879639|NCT00373958|474839711|FG001|Toddler Dose|Protocol Violation|1|||
131879640|NCT00373958|474839710|FG000|Toddler Dose|Withdrawn after infant series|22|||
131879641|NCT00373958|474839711|FG001|Toddler Dose|Withdrawn after infant series|25|||
131879642|NCT04240457|474839716|FG000|Overall Study|Lost to Follow-up|5|||
131879643|NCT04240457|474839717|FG001|Overall Study|Lost to Follow-up|1|||
131879644|NCT01508130|474839721|FG000|Overall Study|Adverse Event|81|||
131879645|NCT01508130|474839722|FG001|Overall Study|Adverse Event|28|||
131879646|NCT01508130|474839721|FG000|Overall Study|Death|3|||
131879647|NCT01508130|474839722|FG001|Overall Study|Death|1|||
131879648|NCT01508130|474839721|FG000|Overall Study|Protocol Violation|2|||
131879649|NCT01508130|474839722|FG001|Overall Study|Protocol Violation|0|||
131879650|NCT01508130|474839721|FG000|Overall Study|Lost to Follow-up|25|||
131879651|NCT01508130|474839722|FG001|Overall Study|Lost to Follow-up|2|||
131879652|NCT01508130|474839721|FG000|Overall Study|Withdrawal by Subject|3|||
131879653|NCT01508130|474839722|FG001|Overall Study|Withdrawal by Subject|3|||
131879654|NCT01508130|474839721|FG000|Overall Study|Subject's substantial non-compliance|25|||
131879655|NCT01508130|474839722|FG001|Overall Study|Subject's substantial non-compliance|9|||
131879656|NCT01508130|474839721|FG000|Overall Study|Insufficient therapeutic response|74|||
131879657|NCT01508130|474839722|FG001|Overall Study|Insufficient therapeutic response|23|||
131879658|NCT01508130|474839721|FG000|Overall Study|Administrative|14|||
131879659|NCT01508130|474839722|FG001|Overall Study|Administrative|3|||
131879660|NCT01680159|474839723|FG000|Screening Period|Not meet criteria for dose-up period|7|||
131879661|NCT01680159|474839723|FG000|Increased Dose Period|Adverse Event|6|||
131879662|NCT01680159|474839723|FG000|Increased Dose Period|Withdrawal by Subject|2|||
131879663|NCT01252563|474839729|FG000|Overall Study|Contract Deviation|41|||
131879664|NCT01252563|474839729|FG000|Overall Study|Centralized Registration Deviation|30|||
131879665|NCT01252563|474839729|FG000|Overall Study|Lost to Follow-up|161|||
131879666|NCT01252563|474839729|FG000|Overall Study|No visit after first day of treatment|194|||
131879667|NCT01252563|474839729|FG000|Overall Study|No drug administration|6|||
131879668|NCT03429244|474839730|FG000|Overall Study|Withdrawal by Subject|2|||
131879669|NCT03429244|474839731|FG001|Overall Study|Withdrawal by Subject|1|||
131879670|NCT03429244|474839732|FG002|Overall Study|Withdrawal by Subject|1|||
131879671|NCT03843632|474839742|FG000|Overall Study|Withdrawal by Subject|1|||
131879672|NCT03843632|474839743|FG001|Overall Study|Withdrawal by Subject|0|||
131879673|NCT03843632|474839744|FG002|Overall Study|Withdrawal by Subject|0|||
131879674|NCT03843632|474839745|FG003|Overall Study|Withdrawal by Subject|0|||
131879675|NCT03403751|474839746|FG000|Overall Study|Death|5|||
131879676|NCT03403751|474839747|FG001|Overall Study|Death|6|||
131879677|NCT03403751|474839746|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
131879678|NCT03403751|474839747|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
131924501|NCT04263532|475009133|FG001|Overall Study|Withdrawal by Subject|0|||
131924502|NCT04098302|475009136|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
131924503|NCT04098302|475009137|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
131924504|NCT04098302|475009138|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
131924505|NCT04098302|475009139|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
131924506|NCT04098302|475009136|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
131924507|NCT04098302|475009137|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
131924508|NCT04098302|475009138|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
131924509|NCT04098302|475009139|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
131924510|NCT04098302|475009136|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
131924511|NCT04098302|475009137|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
131924512|NCT04098302|475009138|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
131924513|NCT04098302|475009139|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
131924514|NCT04098302|475009136|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
131924515|NCT04098302|475009137|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
131409401|NCT02761694|473120878|FG007|Overall Study|Adverse Event|0|||
131879679|NCT01820572|474839748|FG000|Randomization|Not Treated|2|||
131879680|NCT01820572|474839749|FG001|Randomization|Not Treated|1|||
131879681|NCT01820572|474839748|FG000|Treatment Period|Adverse Event|12|||
131879682|NCT01820572|474839749|FG001|Treatment Period|Adverse Event|7|||
131879683|NCT01820572|474839748|FG000|Treatment Period|Death|3|||
131879684|NCT01820572|474839749|FG001|Treatment Period|Death|3|||
131879685|NCT01820572|474839748|FG000|Treatment Period|Lack of Efficacy|1|||
131879686|NCT01820572|474839749|FG001|Treatment Period|Lack of Efficacy|0|||
131409402|NCT02761694|473120879|FG008|Overall Study|Adverse Event|1|||
131879687|NCT01820572|474839748|FG000|Treatment Period|poor/non compliance|0|||
131879688|NCT01820572|474839749|FG001|Treatment Period|poor/non compliance|3|||
131879689|NCT01820572|474839748|FG000|Treatment Period|request to discontinue|6|||
131879690|NCT01820572|474839749|FG001|Treatment Period|request to discontinue|11|||
131879691|NCT01820572|474839748|FG000|Treatment Period|No longer meets study criteria|3|||
131879692|NCT01820572|474839749|FG001|Treatment Period|No longer meets study criteria|10|||
131879693|NCT01820572|474839748|FG000|Treatment Period|withdrew consent|1|||
131924516|NCT04098302|475009138|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
131924517|NCT04098302|475009139|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
131924518|NCT04098302|475009136|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
131924519|NCT04098302|475009137|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
131924520|NCT04098302|475009138|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
131924521|NCT04098302|475009139|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
131924522|NCT04098302|475009136|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
131924523|NCT04098302|475009137|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
131924524|NCT04098302|475009138|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
131924525|NCT04098302|475009139|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
131924526|NCT04098302|475009136|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
131924527|NCT04098302|475009137|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
131924528|NCT04098302|475009138|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
131924529|NCT04098302|475009139|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
131924530|NCT04098302|475009136|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
131924531|NCT04098302|475009137|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
131924532|NCT04098302|475009138|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
131924533|NCT04098302|475009139|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
131924534|NCT01290731|475009142|FG000|Overall Study|Withdrawal by Subject|1|||
131924535|NCT04477486|475009143|FG000|Overall Study|Death|2|||
131924536|NCT04477486|475009143|FG000|Overall Study|Ongoing at Time of Analysis|11|||
131924537|NCT01936974|475009144|FG000|Overall Study|Physician Decision|2|||
131924538|NCT01936974|475009145|FG001|Overall Study|Physician Decision|5|||
131924539|NCT04584554|475009146|FG000|Overall Study|Withdrawal by Subject|2|||
131924540|NCT04584554|475009147|FG001|Overall Study|Withdrawal by Subject|2|||
131924541|NCT02497755|475009150|FG000|Overall Study|Protocol Violation|1|||
131924542|NCT02497755|475009151|FG001|Overall Study|Protocol Violation|0|||
131924543|NCT01774370|475009152|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
131924544|NCT01774370|475009152|FG000|Overall Study|Administered prior to the contract date|4|||
131924545|NCT01774370|475009152|FG000|Overall Study|Subjects of contraindications|34|||
131924546|NCT01774370|475009152|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
131924547|NCT01774370|475009152|FG000|Overall Study|Follow-up failure|34|||
131924548|NCT05436288|475009153|FG000|Overall Study|Lost to Follow-up|1|||
131924549|NCT05436288|475009153|FG000|Overall Study|Adverse Event|1|||
131924550|NCT00356421|475009159|FG000|Overall Study|Lack of Efficacy|3|||
131924551|NCT00356421|475009160|FG001|Overall Study|Lack of Efficacy|0|||
131924552|NCT00356421|475009159|FG000|Overall Study|Withdrawal by Subject|9|||
131924553|NCT00356421|475009160|FG001|Overall Study|Withdrawal by Subject|2|||
131924554|NCT00356421|475009159|FG000|Overall Study|Related to study drug|15|||
131924555|NCT00356421|475009160|FG001|Overall Study|Related to study drug|12|||
131924556|NCT00356421|475009159|FG000|Overall Study|Not related to study drug|5|||
131924557|NCT00356421|475009160|FG001|Overall Study|Not related to study drug|3|||
131924558|NCT00501085|475009161|FG000|Overall Study|Lost to Follow-up|195|||
131924559|NCT00501085|475009161|FG000|Overall Study|Withdrawal by Subject|34|||
131924560|NCT00501085|475009161|FG000|Overall Study|Subject Decision|1|||
131924561|NCT00501085|475009161|FG000|Overall Study|Revision Surgery|7|||
131924562|NCT00501085|475009161|FG000|Overall Study|Explantation Surgery|26|||
131924563|NCT00501085|475009161|FG000|Overall Study|Adverse Event|4|||
131924564|NCT00501085|475009161|FG000|Overall Study|Non-Compliance|24|||
131924565|NCT00501085|475009161|FG000|Overall Study|Study closed by sponsor|109|||
131924566|NCT00501085|475009161|FG000|Overall Study|Other loss to follow-up|32|||
131924567|NCT01487161|475009162|FG000|Overall Study|Adverse Event|1|||
131924568|NCT01487161|475009163|FG001|Overall Study|Adverse Event|0|||
131924569|NCT01487161|475009164|FG002|Overall Study|Adverse Event|0|||
131924570|NCT01487161|475009165|FG003|Overall Study|Adverse Event|0|||
131924571|NCT01487161|475009162|FG000|Overall Study|Withdrawal by Subject|1|||
131924572|NCT01487161|475009163|FG001|Overall Study|Withdrawal by Subject|1|||
131924573|NCT01487161|475009164|FG002|Overall Study|Withdrawal by Subject|1|||
131409403|NCT02761694|473120880|FG009|Overall Study|Adverse Event|0|||
131409404|NCT02761694|473120881|FG010|Overall Study|Adverse Event|0|||
131409405|NCT02761694|473120882|FG011|Overall Study|Adverse Event|1|||
131924574|NCT01487161|475009165|FG003|Overall Study|Withdrawal by Subject|2|||
131924575|NCT01487161|475009162|FG000|Overall Study|missing data|0|||
131924576|NCT01487161|475009163|FG001|Overall Study|missing data|1|||
131409406|NCT02761694|473120871|FG000|Overall Study|Other|4|||
131409407|NCT02761694|473120872|FG001|Overall Study|Other|4|||
131409408|NCT02761694|473120873|FG002|Overall Study|Other|1|||
131409409|NCT02761694|473120874|FG003|Overall Study|Other|2|||
131409410|NCT02761694|473120875|FG004|Overall Study|Other|3|||
131409411|NCT02761694|473120876|FG005|Overall Study|Other|3|||
131409412|NCT02761694|473120877|FG006|Overall Study|Other|18|||
131409413|NCT02761694|473120878|FG007|Overall Study|Other|8|||
131409414|NCT02761694|473120879|FG008|Overall Study|Other|0|||
131924577|NCT01487161|475009164|FG002|Overall Study|missing data|0|||
131924578|NCT01487161|475009165|FG003|Overall Study|missing data|0|||
131924579|NCT02945046|475009166|FG000|Overall Study|Adverse Event|1|||
131924580|NCT02945046|475009167|FG001|Overall Study|Adverse Event|0|||
131924581|NCT02945046|475009168|FG002|Overall Study|Adverse Event|2|||
131924582|NCT02945046|475009166|FG000|Overall Study|Withdrawal by Subject|3|||
131924583|NCT02945046|475009167|FG001|Overall Study|Withdrawal by Subject|3|||
131924584|NCT02945046|475009168|FG002|Overall Study|Withdrawal by Subject|3|||
131924585|NCT02945046|475009166|FG000|Overall Study|Protocol Violation|2|||
131924586|NCT02945046|475009167|FG001|Overall Study|Protocol Violation|3|||
131924587|NCT02945046|475009168|FG002|Overall Study|Protocol Violation|2|||
131924588|NCT02945046|475009166|FG000|Overall Study|Lost to Follow-up|1|||
131924589|NCT02945046|475009167|FG001|Overall Study|Lost to Follow-up|1|||
131924590|NCT02945046|475009168|FG002|Overall Study|Lost to Follow-up|0|||
131924591|NCT02945046|475009166|FG000|Overall Study|Lack of Efficacy|1|||
131924592|NCT02945046|475009167|FG001|Overall Study|Lack of Efficacy|2|||
131924593|NCT02945046|475009168|FG002|Overall Study|Lack of Efficacy|1|||
131924594|NCT02945046|475009166|FG000|Overall Study|Other than specified|5|||
131924595|NCT02945046|475009167|FG001|Overall Study|Other than specified|4|||
131924596|NCT02945046|475009168|FG002|Overall Study|Other than specified|7|||
131924597|NCT03113136|475009169|FG000|Overall Study|Lost to Follow-up|22|||
131924598|NCT03113136|475009170|FG001|Overall Study|Lost to Follow-up|47|||
131924599|NCT03113136|475009171|FG002|Overall Study|Lost to Follow-up|54|||
131924600|NCT03113136|475009169|FG000|Overall Study|Withdrawal by Subject|4|||
131924601|NCT03113136|475009170|FG001|Overall Study|Withdrawal by Subject|13|||
131924602|NCT03113136|475009171|FG002|Overall Study|Withdrawal by Subject|14|||
131924603|NCT03113136|475009169|FG000|Overall Study|Ineligible|0|||
131924604|NCT03113136|475009170|FG001|Overall Study|Ineligible|2|||
131924605|NCT03113136|475009171|FG002|Overall Study|Ineligible|1|||
131924606|NCT03113136|475009169|FG000|Overall Study|Study Team Decision|1|||
131924607|NCT03113136|475009170|FG001|Overall Study|Study Team Decision|4|||
131924608|NCT03113136|475009171|FG002|Overall Study|Study Team Decision|0|||
131924609|NCT02675452|475009175|FG000|Overall Study|Sponsor decision|0|||
131924610|NCT02675452|475009176|FG001|Overall Study|Sponsor decision|0|||
131924611|NCT02675452|475009177|FG002|Overall Study|Sponsor decision|0|||
131924612|NCT02675452|475009178|FG003|Overall Study|Sponsor decision|0|||
131924613|NCT02675452|475009179|FG004|Overall Study|Sponsor decision|0|||
131924614|NCT02675452|475009180|FG005|Overall Study|Sponsor decision|0|||
131924615|NCT02675452|475009181|FG006|Overall Study|Sponsor decision|0|||
131924616|NCT02675452|475009182|FG007|Overall Study|Sponsor decision|0|||
131924617|NCT02675452|475009183|FG008|Overall Study|Sponsor decision|0|||
131924618|NCT02675452|475009184|FG009|Overall Study|Sponsor decision|1|||
131924619|NCT02675452|475009185|FG010|Overall Study|Sponsor decision|0|||
131924620|NCT02675452|475009186|FG011|Overall Study|Sponsor decision|0|||
131924621|NCT02675452|475009187|FG012|Overall Study|Sponsor decision|0|||
131924622|NCT02675452|475009188|FG013|Overall Study|Sponsor decision|2|||
131924623|NCT02675452|475009189|FG014|Overall Study|Sponsor decision|1|||
131924624|NCT02675452|475009190|FG015|Overall Study|Sponsor decision|0|||
131924625|NCT02675452|475009191|FG016|Overall Study|Sponsor decision|1|||
131924626|NCT02675452|475009192|FG017|Overall Study|Sponsor decision|0|||
131924627|NCT02675452|475009193|FG018|Overall Study|Sponsor decision|0|||
131924628|NCT02675452|475009194|FG019|Overall Study|Sponsor decision|0|||
131924629|NCT02675452|475009195|FG020|Overall Study|Sponsor decision|0|||
131924630|NCT02675452|475009196|FG021|Overall Study|Sponsor decision|0|||
131924631|NCT02675452|475009197|FG022|Overall Study|Sponsor decision|0|||
131924632|NCT02675452|475009198|FG023|Overall Study|Sponsor decision|0|||
131924633|NCT02675452|475009199|FG024|Overall Study|Sponsor decision|0|||
131924634|NCT02675452|475009200|FG025|Overall Study|Sponsor decision|0|||
131924635|NCT02675452|475009201|FG026|Overall Study|Sponsor decision|2|||
131924636|NCT02675452|475009202|FG027|Overall Study|Sponsor decision|0|||
131924637|NCT02675452|475009203|FG028|Overall Study|Sponsor decision|0|||
131924638|NCT02675452|475009175|FG000|Overall Study|Withdrawal by Subject|0|||
131924639|NCT02675452|475009176|FG001|Overall Study|Withdrawal by Subject|0|||
131924640|NCT02675452|475009177|FG002|Overall Study|Withdrawal by Subject|0|||
131924641|NCT02675452|475009178|FG003|Overall Study|Withdrawal by Subject|0|||
131409415|NCT02761694|473120880|FG009|Overall Study|Other|1|||
131409416|NCT02761694|473120881|FG010|Overall Study|Other|1|||
131924642|NCT02675452|475009179|FG004|Overall Study|Withdrawal by Subject|0|||
131924643|NCT02675452|475009180|FG005|Overall Study|Withdrawal by Subject|0|||
131924644|NCT02675452|475009181|FG006|Overall Study|Withdrawal by Subject|0|||
131924645|NCT02675452|475009182|FG007|Overall Study|Withdrawal by Subject|0|||
131409417|NCT02761694|473120882|FG011|Overall Study|Other|0|||
131924646|NCT02675452|475009183|FG008|Overall Study|Withdrawal by Subject|0|||
131924647|NCT02675452|475009184|FG009|Overall Study|Withdrawal by Subject|1|||
131924648|NCT02675452|475009185|FG010|Overall Study|Withdrawal by Subject|0|||
131924649|NCT02675452|475009186|FG011|Overall Study|Withdrawal by Subject|1|||
131924650|NCT02675452|475009187|FG012|Overall Study|Withdrawal by Subject|0|||
131924651|NCT02675452|475009188|FG013|Overall Study|Withdrawal by Subject|1|||
131924652|NCT02675452|475009189|FG014|Overall Study|Withdrawal by Subject|1|||
131924653|NCT02675452|475009190|FG015|Overall Study|Withdrawal by Subject|0|||
131924654|NCT02675452|475009191|FG016|Overall Study|Withdrawal by Subject|2|||
131924655|NCT02675452|475009192|FG017|Overall Study|Withdrawal by Subject|0|||
131879694|NCT01820572|474839749|FG001|Treatment Period|withdrew consent|2|||
131879695|NCT05036668|474839750|FG000|Overall Study|lost to follow Up|0|||
131879696|NCT05036668|474839751|FG001|Overall Study|lost to follow Up|0|||
131879697|NCT05036668|474839752|FG002|Overall Study|lost to follow Up|1|||
131879698|NCT00658775|474839755|FG000|Overall Study|Adverse Event|4|||
131879699|NCT00658775|474839756|FG001|Overall Study|Adverse Event|6|||
131879700|NCT00658775|474839755|FG000|Overall Study|Lost to Follow-up|17|||
131879701|NCT00658775|474839756|FG001|Overall Study|Lost to Follow-up|18|||
131879702|NCT00658775|474839755|FG000|Overall Study|Withdrawal by Subject|6|||
131879703|NCT00658775|474839756|FG001|Overall Study|Withdrawal by Subject|4|||
131879704|NCT00658775|474839755|FG000|Overall Study|Withdrawal of consent|8|||
131879705|NCT00658775|474839756|FG001|Overall Study|Withdrawal of consent|7|||
131879706|NCT00658775|474839755|FG000|Overall Study|Other|7|||
131879707|NCT00658775|474839756|FG001|Overall Study|Other|8|||
131879708|NCT00387010|474839757|FG000|Dose Titration Period|Adverse Event|12|||
131879709|NCT00387010|474839757|FG000|Dose Titration Period|Lack of Efficacy|5|||
131879710|NCT00387010|474839757|FG000|Dose Titration Period|Withdrawal by Subject|3|||
131879711|NCT00387010|474839757|FG000|Dose Titration Period|Protocol Violation|1|||
131879712|NCT00387010|474839757|FG000|Dose Titration Period|Lost to Follow-up|2|||
131879713|NCT00387010|474839757|FG000|Dose Titration Period|Noncompliance with study medication|8|||
131879714|NCT00387010|474839757|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
131879715|NCT00387010|474839757|FG000|Treatment Period|Adverse Event|4|||
131879716|NCT00387010|474839757|FG000|Treatment Period|Withdrawal by Subject|1|||
131879717|NCT00387010|474839757|FG000|Treatment Period|Noncompliance with study medication|2|||
131879718|NCT00387010|474839757|FG000|Treatment Period|Noncompliance with study procedures|3|||
131879719|NCT00387010|474839757|FG000|Treatment Period|Participant reported study drug stolen|1|||
131879720|NCT02537431|474839760|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
131879721|NCT00794040|474839761|FG000|Overall Study|Withdrawal by Subject|3|||
131879722|NCT00794040|474839762|FG001|Overall Study|Withdrawal by Subject|4|||
131879723|NCT00794040|474839761|FG000|Overall Study|Physician Decision|0|||
131879724|NCT00794040|474839762|FG001|Overall Study|Physician Decision|1|||
131879725|NCT03626363|474839765|FG000|Overall Study|Protocol Violation|4|||
131879726|NCT03626363|474839766|FG001|Overall Study|Protocol Violation|0|||
131879727|NCT03626363|474839765|FG000|Overall Study|Lost to Follow-up|5|||
131879728|NCT03626363|474839766|FG001|Overall Study|Lost to Follow-up|7|||
131879729|NCT00533702|474839767|FG000|Overall Study|Withdrawal by Subject|3|||
131879730|NCT00533702|474839768|FG001|Overall Study|Withdrawal by Subject|1|||
131879731|NCT00533702|474839767|FG000|Overall Study|Found ineligible after randomization|2|||
131879732|NCT00533702|474839768|FG001|Overall Study|Found ineligible after randomization|1|||
131879733|NCT04413552|474839774|FG000|Overall Study|Adverse Event|0|||
131879734|NCT04413552|474839775|FG001|Overall Study|Adverse Event|0|||
131879735|NCT04413552|474839776|FG002|Overall Study|Adverse Event|0|||
131879736|NCT04413552|474839777|FG003|Overall Study|Adverse Event|0|||
131879737|NCT04413552|474839778|FG004|Overall Study|Adverse Event|0|||
131879738|NCT04413552|474839779|FG005|Overall Study|Adverse Event|0|||
131879739|NCT04413552|474839780|FG006|Overall Study|Adverse Event|1|||
131879740|NCT04413552|474839781|FG007|Overall Study|Adverse Event|0|||
131879741|NCT04413552|474839782|FG008|Overall Study|Adverse Event|0|||
131879742|NCT04413552|474839783|FG009|Overall Study|Adverse Event|0|||
131879743|NCT02703272|474841476|FG000|Overall Study|Death|4|||
131879744|NCT02703272|474841477|FG001|Overall Study|Death|9|||
131879745|NCT02703272|474841478|FG002|Overall Study|Death|19|||
131879746|NCT02703272|474841479|FG003|Overall Study|Death|10|||
131879747|NCT02703272|474841476|FG000|Overall Study|Withdrawal by Subject|0|||
131879748|NCT02703272|474841477|FG001|Overall Study|Withdrawal by Subject|0|||
131879749|NCT02703272|474841478|FG002|Overall Study|Withdrawal by Subject|4|||
131879750|NCT02703272|474841479|FG003|Overall Study|Withdrawal by Subject|2|||
131879751|NCT02703272|474841476|FG000|Overall Study|Study Terminated by Sponsor|6|||
131879752|NCT02703272|474841477|FG001|Overall Study|Study Terminated by Sponsor|1|||
131879753|NCT02703272|474841478|FG002|Overall Study|Study Terminated by Sponsor|12|||
131879754|NCT02703272|474841479|FG003|Overall Study|Study Terminated by Sponsor|4|||
131879755|NCT02703272|474841476|FG000|Overall Study|Other|1|||
131879756|NCT02703272|474841477|FG001|Overall Study|Other|0|||
131879757|NCT02703272|474841478|FG002|Overall Study|Other|0|||
131879758|NCT02703272|474841479|FG003|Overall Study|Other|0|||
131879759|NCT05139303|474841480|FG000|Overall Study|Lost to Follow-up|3|||
131879760|NCT05139303|474841481|FG001|Overall Study|Lost to Follow-up|0|||
131879761|NCT05139303|474841480|FG000|Overall Study|Adverse Event|1|||
131879762|NCT05139303|474841481|FG001|Overall Study|Adverse Event|0|||
131879763|NCT02222545|474841482|FG000|Overall Study|Adverse Event|1|||
131879764|NCT02222545|474841483|FG001|Overall Study|Adverse Event|0|||
131879765|NCT02222545|474841484|FG002|Overall Study|Adverse Event|2|||
131879766|NCT02222545|474841482|FG000|Overall Study|Death|0|||
131454040|NCT01032889|473291866|FG000|Overall Study|Lost to Follow-up|1|||
131879767|NCT02222545|474841483|FG001|Overall Study|Death|0|||
131879768|NCT02222545|474841484|FG002|Overall Study|Death|9|||
131879769|NCT02222545|474841482|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
131879770|NCT02222545|474841483|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
131879771|NCT02222545|474841484|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
131879772|NCT02222545|474841482|FG000|Overall Study|Withdrawal by Subject|0|||
131879773|NCT02222545|474841483|FG001|Overall Study|Withdrawal by Subject|0|||
131879774|NCT02222545|474841484|FG002|Overall Study|Withdrawal by Subject|3|||
131879775|NCT02222545|474841482|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
131879776|NCT02222545|474841483|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
131879777|NCT02222545|474841484|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
131879778|NCT02045862|474841485|FG000|Overall Study|Death|0|||
131879779|NCT02045862|474841486|FG001|Overall Study|Death|0|||
131879780|NCT02045862|474841487|FG002|Overall Study|Death|1|||
131879781|NCT02045862|474841485|FG000|Overall Study|Miscellaneous|5|||
131879782|NCT02045862|474841486|FG001|Overall Study|Miscellaneous|0|||
131879783|NCT02045862|474841487|FG002|Overall Study|Miscellaneous|8|||
131879784|NCT02045862|474841485|FG000|Overall Study|Withdrawal by Patient|18|||
131879785|NCT02045862|474841486|FG001|Overall Study|Withdrawal by Patient|27|||
131879786|NCT02045862|474841487|FG002|Overall Study|Withdrawal by Patient|57|||
131879787|NCT02045862|474841485|FG000|Overall Study|Protocol Violation|0|||
131879788|NCT02045862|474841486|FG001|Overall Study|Protocol Violation|0|||
131879789|NCT02045862|474841487|FG002|Overall Study|Protocol Violation|6|||
131879790|NCT02045862|474841485|FG000|Overall Study|Lack of Efficacy|8|||
131879791|NCT02045862|474841486|FG001|Overall Study|Lack of Efficacy|4|||
131879792|NCT02045862|474841487|FG002|Overall Study|Lack of Efficacy|13|||
131879793|NCT02045862|474841485|FG000|Overall Study|Randomized but not Received Study Drug|0|||
131879794|NCT02045862|474841486|FG001|Overall Study|Randomized but not Received Study Drug|2|||
131879795|NCT02045862|474841487|FG002|Overall Study|Randomized but not Received Study Drug|8|||
131879796|NCT02045862|474841485|FG000|Overall Study|Adverse Event|7|||
131879797|NCT02045862|474841486|FG001|Overall Study|Adverse Event|5|||
131879798|NCT02045862|474841487|FG002|Overall Study|Adverse Event|27|||
131879799|NCT02045862|474841485|FG000|Overall Study|Lost to Follow-up|1|||
131879800|NCT02045862|474841486|FG001|Overall Study|Lost to Follow-up|2|||
131879801|NCT02045862|474841487|FG002|Overall Study|Lost to Follow-up|6|||
131879802|NCT02738879|474841488|FG000|Overall Study|Adverse Event|1|||
131879803|NCT02738879|474841489|FG001|Overall Study|Adverse Event|1|||
131879804|NCT02738879|474841488|FG000|Overall Study|Death|0|||
131879805|NCT02738879|474841489|FG001|Overall Study|Death|2|||
131879806|NCT02738879|474841488|FG000|Overall Study|Lost to Follow-up|1|||
131879807|NCT02738879|474841489|FG001|Overall Study|Lost to Follow-up|5|||
131879808|NCT02738879|474841488|FG000|Overall Study|Protocol Violation|1|||
131879809|NCT02738879|474841489|FG001|Overall Study|Protocol Violation|3|||
131879810|NCT02738879|474841488|FG000|Overall Study|Physician Decision|3|||
131879811|NCT02738879|474841489|FG001|Overall Study|Physician Decision|4|||
131879812|NCT02738879|474841488|FG000|Overall Study|Pregnancy|0|||
131879813|NCT02738879|474841489|FG001|Overall Study|Pregnancy|1|||
131879814|NCT02738879|474841488|FG000|Overall Study|Screen Failure|1|||
131879815|NCT02738879|474841489|FG001|Overall Study|Screen Failure|2|||
131879816|NCT02738879|474841488|FG000|Overall Study|Site Discontinued Study Participation|1|||
131879817|NCT02738879|474841489|FG001|Overall Study|Site Discontinued Study Participation|0|||
131879818|NCT02738879|474841488|FG000|Overall Study|Withdrawal by Subject|5|||
131879819|NCT02738879|474841489|FG001|Overall Study|Withdrawal by Subject|7|||
131879820|NCT01438294|474841490|FG000|Overall Study|Lost to Follow-up|3|||
131879821|NCT01438294|474841491|FG001|Overall Study|Lost to Follow-up|7|||
131879822|NCT01346189|474841494|FG000|Overall Study|Withdrawal by Subject|7|||
131879823|NCT01346189|474841495|FG001|Overall Study|Withdrawal by Subject|5|||
131879824|NCT01346189|474841496|FG002|Overall Study|Withdrawal by Subject|3|||
131879825|NCT01346189|474841497|FG003|Overall Study|Withdrawal by Subject|5|||
131879826|NCT01346189|474841494|FG000|Overall Study|Physician Decision|4|||
131879827|NCT01346189|474841495|FG001|Overall Study|Physician Decision|0|||
131879828|NCT01346189|474841496|FG002|Overall Study|Physician Decision|0|||
131879829|NCT01346189|474841497|FG003|Overall Study|Physician Decision|0|||
131879830|NCT01346189|474841494|FG000|Overall Study|Moved|3|||
131879831|NCT01346189|474841495|FG001|Overall Study|Moved|0|||
131879832|NCT01346189|474841496|FG002|Overall Study|Moved|4|||
131879833|NCT01346189|474841497|FG003|Overall Study|Moved|0|||
131879834|NCT01346189|474841494|FG000|Overall Study|Other|2|||
131879835|NCT01346189|474841495|FG001|Overall Study|Other|4|||
131879836|NCT01346189|474841496|FG002|Overall Study|Other|7|||
131454041|NCT01032889|473291867|FG001|Overall Study|Lost to Follow-up|1|||
131879837|NCT01346189|474841497|FG003|Overall Study|Other|3|||
131879838|NCT01346189|474841494|FG000|Overall Study|Death|0|||
131879839|NCT01346189|474841495|FG001|Overall Study|Death|3|||
131879840|NCT01346189|474841496|FG002|Overall Study|Death|0|||
131879841|NCT01346189|474841497|FG003|Overall Study|Death|0|||
131879842|NCT01346189|474841494|FG000|Overall Study|Non-health system primary care physician|0|||
131879843|NCT01346189|474841495|FG001|Overall Study|Non-health system primary care physician|5|||
131879844|NCT01346189|474841496|FG002|Overall Study|Non-health system primary care physician|0|||
131879845|NCT01346189|474841497|FG003|Overall Study|Non-health system primary care physician|0|||
131879846|NCT01346189|474841494|FG000|Overall Study|Travel|0|||
131879847|NCT01346189|474841495|FG001|Overall Study|Travel|0|||
131879848|NCT01346189|474841496|FG002|Overall Study|Travel|0|||
131879849|NCT01346189|474841497|FG003|Overall Study|Travel|3|||
131879850|NCT01075646|474841500|FG000|Overall Study|Lost to Follow-up|4|||
131879851|NCT01075646|474841501|FG001|Overall Study|Lost to Follow-up|3|||
131879852|NCT01075646|474841502|FG002|Overall Study|Lost to Follow-up|1|||
131879853|NCT01075646|474841503|FG003|Overall Study|Lost to Follow-up|2|||
131879854|NCT01730534|474841504|FG000|Overall Study|Withdrawal by Subject|97|||
131879855|NCT01730534|474841505|FG001|Overall Study|Withdrawal by Subject|127|||
131879856|NCT01730534|474841504|FG000|Overall Study|Lost to Follow-up|12|||
131879857|NCT01730534|474841505|FG001|Overall Study|Lost to Follow-up|18|||
131879858|NCT01676896|474841509|FG000|Overall Study|Withdrawal by Subject|12|||
131879859|NCT01676896|474841510|FG001|Overall Study|Withdrawal by Subject|7|||
131879860|NCT01676896|474841511|FG002|Overall Study|Withdrawal by Subject|19|||
131879861|NCT02256982|474841512|FG000|Overall Study|Disease Progression|0|||
131879862|NCT02256982|474841513|FG001|Overall Study|Disease Progression|1|||
131879863|NCT01895608|474841514|FG000|Overall Study|change in health status|0|||
131879864|NCT01895608|474841515|FG001|Overall Study|change in health status|1|||
131879865|NCT01895608|474841516|FG002|Overall Study|change in health status|1|||
131879866|NCT01895608|474841517|FG003|Overall Study|change in health status|0|||
131879867|NCT01895608|474841514|FG000|Overall Study|Withdrawal by Subject|0|||
131879868|NCT01895608|474841515|FG001|Overall Study|Withdrawal by Subject|0|||
131879869|NCT01895608|474841516|FG002|Overall Study|Withdrawal by Subject|2|||
131879870|NCT01895608|474841517|FG003|Overall Study|Withdrawal by Subject|0|||
131879871|NCT02822573|474841518|FG000|Overall Study|Lost to Follow-up|5|||
131879872|NCT02822573|474841519|FG001|Overall Study|Lost to Follow-up|3|||
131879873|NCT02822573|474841518|FG000|Overall Study|Physician Decision|1|||
131879874|NCT02822573|474841519|FG001|Overall Study|Physician Decision|1|||
131879875|NCT02822573|474841518|FG000|Overall Study|Withdrawal by Subject|9|||
131879876|NCT02822573|474841519|FG001|Overall Study|Withdrawal by Subject|5|||
131879877|NCT02822573|474841518|FG000|Overall Study|Protocol Violation|6|||
131879878|NCT02822573|474841519|FG001|Overall Study|Protocol Violation|4|||
131879879|NCT02822573|474841518|FG000|Overall Study|Too sick or ill|2|||
131879880|NCT02822573|474841519|FG001|Overall Study|Too sick or ill|1|||
131879881|NCT02822573|474841518|FG000|Overall Study|Disease Progression|1|||
131879882|NCT02822573|474841519|FG001|Overall Study|Disease Progression|1|||
131879883|NCT02822573|474841518|FG000|Overall Study|No reason given|6|||
131879884|NCT02822573|474841519|FG001|Overall Study|No reason given|4|||
131879885|NCT02855359|474841522|FG000|Overall Study|Death|2|||
131879886|NCT02855359|474841523|FG001|Overall Study|Death|2|||
131879887|NCT02855359|474841524|FG002|Overall Study|Death|0|||
131879888|NCT02855359|474841525|FG003|Overall Study|Death|0|||
131879889|NCT02855359|474841522|FG000|Overall Study|Study Termination by Sponsor|9|||
131879890|NCT02855359|474841523|FG001|Overall Study|Study Termination by Sponsor|11|||
131879891|NCT02855359|474841524|FG002|Overall Study|Study Termination by Sponsor|0|||
131879892|NCT02855359|474841525|FG003|Overall Study|Study Termination by Sponsor|0|||
131879893|NCT02833844|474841526|FG000|Double-Blind Period|Withdrawal by Subject|2|||
131879894|NCT02833844|474841527|FG001|Double-Blind Period|Withdrawal by Subject|3|||
131879895|NCT02833844|474841526|FG000|Double-Blind Period|Protocol Violation|0|||
131879896|NCT02833844|474841527|FG001|Double-Blind Period|Protocol Violation|4|||
131879897|NCT02833844|474841526|FG000|Open-Label Period|Death|0|||
131879898|NCT02833844|474841527|FG001|Open-Label Period|Death|2|||
131879899|NCT02833844|474841526|FG000|Open-Label Period|Lost to Follow-up|1|||
131879900|NCT02833844|474841527|FG001|Open-Label Period|Lost to Follow-up|0|||
131879901|NCT02833844|474841526|FG000|Open-Label Period|Withdrawal by Subject|1|||
131879902|NCT02833844|474841527|FG001|Open-Label Period|Withdrawal by Subject|0|||
131879903|NCT01044290|474841530|FG000|Follow-up 1|Death|3|||
131879904|NCT01044290|474841531|FG001|Follow-up 1|Death|3|||
131879905|NCT01044290|474841532|FG002|Follow-up 1|Death|1|||
131879906|NCT01044290|474841530|FG000|Follow-up 1|Withdrawal by Subject|2|||
131879907|NCT01044290|474841531|FG001|Follow-up 1|Withdrawal by Subject|2|||
131879908|NCT01044290|474841532|FG002|Follow-up 1|Withdrawal by Subject|0|||
131879909|NCT01044290|474841530|FG000|Follow-Up 2|Death|0|||
131879910|NCT01044290|474841531|FG001|Follow-Up 2|Death|1|||
131879911|NCT01044290|474841532|FG002|Follow-Up 2|Death|1|||
131924656|NCT02675452|475009193|FG018|Overall Study|Withdrawal by Subject|0|||
131879912|NCT01044290|474841530|FG000|Follow-Up 2|Withdrawal by Subject|0|||
131879913|NCT01044290|474841531|FG001|Follow-Up 2|Withdrawal by Subject|1|||
131924657|NCT02675452|475009194|FG019|Overall Study|Withdrawal by Subject|0|||
131879914|NCT01044290|474841532|FG002|Follow-Up 2|Withdrawal by Subject|1|||
131879915|NCT00759785|474841538|FG000|Overall Study|Participant sample not evaluable|11|||
131879916|NCT00759785|474841539|FG001|Overall Study|Participant sample not evaluable|2|||
131879917|NCT00759785|474841538|FG000|Overall Study|Participant sample lost|0|||
131879918|NCT00759785|474841539|FG001|Overall Study|Participant sample lost|1|||
131879919|NCT00759785|474841538|FG000|Overall Study|Protocol Violation|1|||
131879920|NCT00759785|474841539|FG001|Overall Study|Protocol Violation|0|||
131879921|NCT00759785|474841538|FG000|Overall Study|Physician Decision|0|||
131879922|NCT00759785|474841539|FG001|Overall Study|Physician Decision|1|||
131879923|NCT00759785|474841538|FG000|Overall Study|Withdrawal by Subject|0|||
131879924|NCT00759785|474841539|FG001|Overall Study|Withdrawal by Subject|1|||
131879925|NCT01646021|474841540|FG000|Overall Study|Death|77|||
131879926|NCT01646021|474841541|FG001|Overall Study|Death|83|||
131879927|NCT01646021|474841540|FG000|Overall Study|Study Terminated by Sponsor|50|||
131879928|NCT01646021|474841541|FG001|Overall Study|Study Terminated by Sponsor|41|||
131879929|NCT01646021|474841540|FG000|Overall Study|Lost to Follow-up|2|||
131879930|NCT01646021|474841541|FG001|Overall Study|Lost to Follow-up|2|||
131879931|NCT01646021|474841540|FG000|Overall Study|Withdrawal by Subject|10|||
131879932|NCT01646021|474841541|FG001|Overall Study|Withdrawal by Subject|15|||
131879933|NCT02777970|474841547|FG000|Overall Study|Lost to Follow-up|0|||
131879934|NCT02777970|474841548|FG001|Overall Study|Lost to Follow-up|1|||
131879935|NCT02777970|474841549|FG002|Overall Study|Lost to Follow-up|0|||
131879936|NCT02777970|474841547|FG000|Overall Study|Protocol Violation|1|||
131879937|NCT02777970|474841548|FG001|Overall Study|Protocol Violation|0|||
131879938|NCT02777970|474841549|FG002|Overall Study|Protocol Violation|0|||
131879939|NCT01967706|474841550|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
131879940|NCT01967706|474841551|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
131879941|NCT01967706|474841552|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131879942|NCT01967706|474841553|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
131879943|NCT02347891|474841554|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
131879944|NCT02347891|474841555|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
131879945|NCT02347891|474841554|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
131879946|NCT02347891|474841555|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
131879947|NCT02541669|474841559|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
131879948|NCT02541669|474841560|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
131879949|NCT02541669|474841561|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
131879950|NCT02541669|474841562|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
131879951|NCT02541669|474841563|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
131879952|NCT01084668|474841565|FG000|Overall Study|Lack of Efficacy|5|||
131879953|NCT01084668|474841565|FG000|Overall Study|Withdrawal by Subject|2|||
131879954|NCT01084668|474841565|FG000|Overall Study|Pregnancy|1|||
131879955|NCT01084668|474841565|FG000|Overall Study|Non-compliance|1|||
131879956|NCT01083186|474841568|FG000|Overall Study|Lost to Follow-up|48|||
131879957|NCT01083186|474841568|FG000|Overall Study|Consent Withdrawal|7|||
131879958|NCT01083186|474841568|FG000|Overall Study|Death|3|||
131879959|NCT01083186|474841568|FG000|Overall Study|Adverse Event|3|||
131879960|NCT01083186|474841568|FG000|Overall Study|Lack of Efficacy|2|||
131879961|NCT01083186|474841568|FG000|Overall Study|Hemodialysis Initiation|28|||
131879962|NCT01083186|474841568|FG000|Overall Study|Administrative Reasons|2|||
131879963|NCT01083186|474841568|FG000|Overall Study|Non-compliance to Study Treatment|1|||
131879964|NCT00655733|474841569|FG000|Overall Study|Lost to Follow-up|2|||
131879965|NCT00655733|474841570|FG001|Overall Study|Lost to Follow-up|2|||
131879966|NCT00655733|474841569|FG000|Overall Study|Adverse Event|2|||
131879967|NCT00655733|474841570|FG001|Overall Study|Adverse Event|2|||
131879968|NCT00655733|474841569|FG000|Overall Study|Withdrawal by Subject|3|||
131879969|NCT00655733|474841570|FG001|Overall Study|Withdrawal by Subject|3|||
131879970|NCT00655733|474841569|FG000|Overall Study|Physician Decision|0|||
131879971|NCT00655733|474841570|FG001|Overall Study|Physician Decision|1|||
131879972|NCT02122770|474841571|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
131879973|NCT02122770|474841572|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
131879974|NCT02122770|474841573|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
131879975|NCT02122770|474841574|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
131879976|NCT02122770|474841575|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
131879977|NCT02122770|474841576|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
131879978|NCT02122770|474841571|FG000|Part A: Drug-drug Interaction 2|Other|0|||
131879979|NCT02122770|474841572|FG001|Part A: Drug-drug Interaction 2|Other|0|||
131879980|NCT02122770|474841573|FG002|Part A: Drug-drug Interaction 2|Other|1|||
131879981|NCT02122770|474841574|FG003|Part A: Drug-drug Interaction 2|Other|0|||
131879982|NCT02122770|474841575|FG004|Part A: Drug-drug Interaction 2|Other|0|||
131879983|NCT02122770|474841576|FG005|Part A: Drug-drug Interaction 2|Other|0|||
131879984|NCT02122770|474841571|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
131879985|NCT02122770|474841572|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
131879986|NCT02122770|474841573|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
131879987|NCT02122770|474841574|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
131879988|NCT02122770|474841575|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
131879989|NCT02122770|474841576|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
131879990|NCT02122770|474841571|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
131879991|NCT02122770|474841572|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
131879992|NCT02122770|474841573|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
131879993|NCT02122770|474841574|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
131879994|NCT02122770|474841575|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
131879995|NCT02122770|474841576|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
131879996|NCT02122770|474841571|FG000|Part B: Standard of Care|Adverse Event|0|||
131879997|NCT02122770|474841572|FG001|Part B: Standard of Care|Adverse Event|0|||
131879998|NCT02122770|474841573|FG002|Part B: Standard of Care|Adverse Event|0|||
131879999|NCT02122770|474841574|FG003|Part B: Standard of Care|Adverse Event|0|||
131880000|NCT02122770|474841575|FG004|Part B: Standard of Care|Adverse Event|4|||
131880001|NCT02122770|474841576|FG005|Part B: Standard of Care|Adverse Event|1|||
131880002|NCT02122770|474841571|FG000|Part B: Standard of Care|Other|0|||
131880003|NCT02122770|474841572|FG001|Part B: Standard of Care|Other|0|||
131880004|NCT02122770|474841573|FG002|Part B: Standard of Care|Other|0|||
131880005|NCT02122770|474841574|FG003|Part B: Standard of Care|Other|0|||
131880006|NCT02122770|474841575|FG004|Part B: Standard of Care|Other|0|||
131880007|NCT02122770|474841576|FG005|Part B: Standard of Care|Other|2|||
131880008|NCT02122770|474841571|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
131880009|NCT02122770|474841572|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
131880010|NCT02122770|474841573|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
131880011|NCT02122770|474841574|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
131880012|NCT02122770|474841575|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
131880013|NCT02122770|474841576|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
131880014|NCT02122770|474841571|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
131880015|NCT02122770|474841572|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
131924658|NCT02675452|475009195|FG020|Overall Study|Withdrawal by Subject|0|||
131924659|NCT02675452|475009196|FG021|Overall Study|Withdrawal by Subject|0|||
131924660|NCT02675452|475009197|FG022|Overall Study|Withdrawal by Subject|3|||
131924661|NCT02675452|475009198|FG023|Overall Study|Withdrawal by Subject|0|||
131924662|NCT02675452|475009199|FG024|Overall Study|Withdrawal by Subject|1|||
131924663|NCT02675452|475009200|FG025|Overall Study|Withdrawal by Subject|0|||
131924664|NCT02675452|475009201|FG026|Overall Study|Withdrawal by Subject|1|||
131924665|NCT02675452|475009202|FG027|Overall Study|Withdrawal by Subject|3|||
131924666|NCT02675452|475009203|FG028|Overall Study|Withdrawal by Subject|4|||
131924667|NCT02675452|475009175|FG000|Overall Study|Death|0|||
131924668|NCT02675452|475009176|FG001|Overall Study|Death|0|||
131924669|NCT02675452|475009177|FG002|Overall Study|Death|1|||
131924670|NCT02675452|475009178|FG003|Overall Study|Death|0|||
131924671|NCT02675452|475009179|FG004|Overall Study|Death|0|||
131924672|NCT02675452|475009180|FG005|Overall Study|Death|1|||
131924673|NCT02675452|475009181|FG006|Overall Study|Death|0|||
131924674|NCT02675452|475009182|FG007|Overall Study|Death|0|||
131924675|NCT02675452|475009183|FG008|Overall Study|Death|1|||
131924676|NCT02675452|475009184|FG009|Overall Study|Death|0|||
131924677|NCT02675452|475009185|FG010|Overall Study|Death|0|||
131924678|NCT02675452|475009186|FG011|Overall Study|Death|0|||
131924679|NCT02675452|475009187|FG012|Overall Study|Death|1|||
131924680|NCT02675452|475009188|FG013|Overall Study|Death|0|||
131924681|NCT02675452|475009189|FG014|Overall Study|Death|0|||
131924682|NCT02675452|475009190|FG015|Overall Study|Death|2|||
131924683|NCT02675452|475009191|FG016|Overall Study|Death|0|||
131924684|NCT02675452|475009192|FG017|Overall Study|Death|0|||
131924685|NCT02675452|475009193|FG018|Overall Study|Death|4|||
131924686|NCT02675452|475009194|FG019|Overall Study|Death|3|||
131924687|NCT02675452|475009195|FG020|Overall Study|Death|3|||
131924688|NCT02675452|475009196|FG021|Overall Study|Death|3|||
131924689|NCT02675452|475009197|FG022|Overall Study|Death|7|||
131924690|NCT02675452|475009198|FG023|Overall Study|Death|5|||
131924691|NCT02675452|475009199|FG024|Overall Study|Death|3|||
131924692|NCT02675452|475009200|FG025|Overall Study|Death|4|||
131924693|NCT02675452|475009201|FG026|Overall Study|Death|7|||
131880016|NCT02122770|474841573|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
131880017|NCT02122770|474841574|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
131409418|NCT02395055|473120883|FG000|Overall Study|Withdrawal by Subject|7|||
131880018|NCT02122770|474841575|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
131880019|NCT02122770|474841576|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
131880020|NCT02122770|474841571|FG000|Part B: Standard of Care|Progressive Disease|0|||
131880021|NCT02122770|474841572|FG001|Part B: Standard of Care|Progressive Disease|0|||
131924694|NCT02675452|475009202|FG027|Overall Study|Death|6|||
131924695|NCT02675452|475009203|FG028|Overall Study|Death|9|||
131924696|NCT02675452|475009175|FG000|Overall Study|Lost to Follow-up|0|||
131924697|NCT02675452|475009176|FG001|Overall Study|Lost to Follow-up|1|||
131409419|NCT02395055|473120884|FG001|Overall Study|Withdrawal by Subject|3|||
131409420|NCT00526110|473120889|FG000|Overall Study|Adverse Event|2|||
131924698|NCT02675452|475009177|FG002|Overall Study|Lost to Follow-up|0|||
131924699|NCT02675452|475009178|FG003|Overall Study|Lost to Follow-up|0|||
131924700|NCT02675452|475009179|FG004|Overall Study|Lost to Follow-up|0|||
131924701|NCT02675452|475009180|FG005|Overall Study|Lost to Follow-up|0|||
131924702|NCT02675452|475009181|FG006|Overall Study|Lost to Follow-up|0|||
131924703|NCT02675452|475009182|FG007|Overall Study|Lost to Follow-up|0|||
131924704|NCT02675452|475009183|FG008|Overall Study|Lost to Follow-up|0|||
131924705|NCT02675452|475009184|FG009|Overall Study|Lost to Follow-up|0|||
131924706|NCT02675452|475009185|FG010|Overall Study|Lost to Follow-up|0|||
131924707|NCT02675452|475009186|FG011|Overall Study|Lost to Follow-up|0|||
131924708|NCT02675452|475009187|FG012|Overall Study|Lost to Follow-up|1|||
131924709|NCT02675452|475009188|FG013|Overall Study|Lost to Follow-up|0|||
131924710|NCT02675452|475009189|FG014|Overall Study|Lost to Follow-up|0|||
131924711|NCT02675452|475009190|FG015|Overall Study|Lost to Follow-up|0|||
131924712|NCT02675452|475009191|FG016|Overall Study|Lost to Follow-up|0|||
131924713|NCT02675452|475009192|FG017|Overall Study|Lost to Follow-up|0|||
131924714|NCT02675452|475009193|FG018|Overall Study|Lost to Follow-up|0|||
131924715|NCT02675452|475009194|FG019|Overall Study|Lost to Follow-up|0|||
131924716|NCT02675452|475009195|FG020|Overall Study|Lost to Follow-up|0|||
131924717|NCT02675452|475009196|FG021|Overall Study|Lost to Follow-up|0|||
131924718|NCT02675452|475009197|FG022|Overall Study|Lost to Follow-up|0|||
131924719|NCT02675452|475009198|FG023|Overall Study|Lost to Follow-up|0|||
131924720|NCT02675452|475009199|FG024|Overall Study|Lost to Follow-up|0|||
131924721|NCT02675452|475009200|FG025|Overall Study|Lost to Follow-up|0|||
131924722|NCT02675452|475009201|FG026|Overall Study|Lost to Follow-up|1|||
131924723|NCT02675452|475009202|FG027|Overall Study|Lost to Follow-up|0|||
131924724|NCT02675452|475009203|FG028|Overall Study|Lost to Follow-up|0|||
131924725|NCT02675452|475009175|FG000|Overall Study|Other|0|||
131924726|NCT02675452|475009176|FG001|Overall Study|Other|0|||
131924727|NCT02675452|475009177|FG002|Overall Study|Other|0|||
131924728|NCT02675452|475009178|FG003|Overall Study|Other|0|||
131924729|NCT02675452|475009179|FG004|Overall Study|Other|0|||
131924730|NCT02675452|475009180|FG005|Overall Study|Other|0|||
131409421|NCT00526110|473120890|FG001|Overall Study|Adverse Event|9|||
131409422|NCT00526110|473120889|FG000|Overall Study|Disease Progression|0|||
131409423|NCT00526110|473120890|FG001|Overall Study|Disease Progression|19|||
131880022|NCT02122770|474841573|FG002|Part B: Standard of Care|Progressive Disease|0|||
131880023|NCT02122770|474841574|FG003|Part B: Standard of Care|Progressive Disease|0|||
131880024|NCT02122770|474841575|FG004|Part B: Standard of Care|Progressive Disease|10|||
131880025|NCT02122770|474841576|FG005|Part B: Standard of Care|Progressive Disease|8|||
131880026|NCT02474589|474841577|FG000|Overall Study|Adverse Event|6|||
131880027|NCT02474589|474841578|FG001|Overall Study|Adverse Event|2|||
131880028|NCT02474589|474841577|FG000|Overall Study|Lost to Follow-up|6|||
131880029|NCT02474589|474841578|FG001|Overall Study|Lost to Follow-up|1|||
131880030|NCT02474589|474841577|FG000|Overall Study|Protocol Violation|4|||
131880031|NCT02474589|474841578|FG001|Overall Study|Protocol Violation|1|||
131880032|NCT02474589|474841577|FG000|Overall Study|Withdrawal by Subject|4|||
131880033|NCT02474589|474841578|FG001|Overall Study|Withdrawal by Subject|0|||
131880034|NCT02474589|474841577|FG000|Overall Study|Inability to complete study procedures|5|||
131880035|NCT02474589|474841578|FG001|Overall Study|Inability to complete study procedures|1|||
131880036|NCT01740128|474841579|FG000|Overall Study|Pregnancy|0|||
131880037|NCT01740128|474841580|FG001|Overall Study|Pregnancy|1|||
131880038|NCT01740128|474841579|FG000|Overall Study|Protocol Violation|1|||
131880039|NCT01740128|474841580|FG001|Overall Study|Protocol Violation|2|||
131880040|NCT01740128|474841579|FG000|Overall Study|Lost to Follow-up|2|||
131880041|NCT01740128|474841580|FG001|Overall Study|Lost to Follow-up|2|||
131880042|NCT01740128|474841579|FG000|Overall Study|Withdrawal by Subject|1|||
131880043|NCT01740128|474841580|FG001|Overall Study|Withdrawal by Subject|0|||
131880044|NCT01740128|474841579|FG000|Overall Study|Insufficient protocol compliance|2|||
131880045|NCT01740128|474841580|FG001|Overall Study|Insufficient protocol compliance|2|||
131880046|NCT02658734|474841583|FG000|Overall Study|Adverse Event|2|||
131880047|NCT02658734|474841583|FG000|Overall Study|Death|4|||
131880048|NCT02658734|474841583|FG000|Overall Study|Lost to Follow-up|7|||
131880049|NCT02658734|474841583|FG000|Overall Study|Withdrawal of Consent|16|||
131880050|NCT02658734|474841583|FG000|Overall Study|Disease Progression|28|||
131880051|NCT01552915|474841584|FG000|Overall Study|Adverse Event|3|||
131880052|NCT01552915|474841585|FG001|Overall Study|Adverse Event|14|||
131880053|NCT01552915|474841586|FG002|Overall Study|Adverse Event|3|||
131880054|NCT01552915|474841584|FG000|Overall Study|Lost to Follow-up|4|||
131880055|NCT01552915|474841585|FG001|Overall Study|Lost to Follow-up|6|||
131880056|NCT01552915|474841586|FG002|Overall Study|Lost to Follow-up|5|||
131880057|NCT01552915|474841584|FG000|Overall Study|Withdrawal by Subject|6|||
131880058|NCT01552915|474841585|FG001|Overall Study|Withdrawal by Subject|4|||
131880059|NCT01552915|474841586|FG002|Overall Study|Withdrawal by Subject|5|||
131880060|NCT01552915|474841584|FG000|Overall Study|Protocol Violation|0|||
131880061|NCT01552915|474841585|FG001|Overall Study|Protocol Violation|4|||
131880062|NCT01552915|474841586|FG002|Overall Study|Protocol Violation|4|||
131880063|NCT01552915|474841584|FG000|Overall Study|Lack of Efficacy|8|||
131880064|NCT01552915|474841585|FG001|Overall Study|Lack of Efficacy|1|||
131880065|NCT01552915|474841586|FG002|Overall Study|Lack of Efficacy|4|||
131880066|NCT01552915|474841584|FG000|Overall Study|Other|2|||
131880067|NCT01552915|474841585|FG001|Overall Study|Other|0|||
131880068|NCT01552915|474841586|FG002|Overall Study|Other|6|||
131880069|NCT00976209|474841587|FG000|Treatment Period 1|Protocol Violation|1|||
131880070|NCT00976209|474841588|FG001|Treatment Period 1|Protocol Violation|0|||
131880071|NCT00976209|474841587|FG000|Treatment Period 1|Lost to Follow-up|2|||
131880072|NCT00976209|474841588|FG001|Treatment Period 1|Lost to Follow-up|0|||
131880073|NCT00976209|474841587|FG000|Treatment Period 1|Other|0|||
131924731|NCT02675452|475009181|FG006|Overall Study|Other|0|||
131924732|NCT02675452|475009182|FG007|Overall Study|Other|0|||
131924733|NCT02675452|475009183|FG008|Overall Study|Other|0|||
131924734|NCT02675452|475009184|FG009|Overall Study|Other|0|||
131924735|NCT02675452|475009185|FG010|Overall Study|Other|0|||
131924736|NCT02675452|475009186|FG011|Overall Study|Other|0|||
131880074|NCT00976209|474841588|FG001|Treatment Period 1|Other|1|||
131880075|NCT00976209|474841587|FG000|Wash-out Period|Adverse Event|1|||
131880076|NCT00976209|474841588|FG001|Wash-out Period|Adverse Event|2|||
131880077|NCT00976209|474841587|FG000|Wash-out Period|Lost to Follow-up|1|||
131880078|NCT00976209|474841588|FG001|Wash-out Period|Lost to Follow-up|0|||
131880079|NCT00976209|474841587|FG000|Wash-out Period|Protocol Violation|1|||
131880080|NCT00976209|474841588|FG001|Wash-out Period|Protocol Violation|0|||
131880081|NCT00976209|474841587|FG000|Wash-out Period|Other|1|||
131880082|NCT00976209|474841588|FG001|Wash-out Period|Other|0|||
131880083|NCT00976209|474841587|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131880084|NCT00976209|474841588|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131880085|NCT00976209|474841587|FG000|Treatment Period 2|Lost to Follow-up|0|||
131880086|NCT00976209|474841588|FG001|Treatment Period 2|Lost to Follow-up|1|||
131880087|NCT00176644|474841589|FG000|Overall Study|Withdrawal by Subject|1|||
131880088|NCT03973918|474841594|FG000|Overall Study|Adverse Event|0|||
131880089|NCT03973918|474841595|FG001|Overall Study|Adverse Event|0|||
131880090|NCT03973918|474841596|FG002|Overall Study|Adverse Event|0|||
131880091|NCT03973918|474841597|FG003|Overall Study|Adverse Event|1|||
131880092|NCT03973918|474841594|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
131880093|NCT03973918|474841595|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
131880094|NCT03973918|474841596|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
131880095|NCT03973918|474841597|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
131880096|NCT00978250|474841598|FG000|Overall Study|Late determination of ineligibility|0|||
131880097|NCT00978250|474841599|FG001|Overall Study|Late determination of ineligibility|1|||
131880098|NCT00978250|474841600|FG002|Overall Study|Late determination of ineligibility|0|||
131880099|NCT00978250|474841601|FG003|Overall Study|Late determination of ineligibility|1|||
131880100|NCT04351373|474841604|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
131880101|NCT00520481|474841610|FG000|Overall Study|Adverse Event|4|||
131880102|NCT00520481|474841611|FG001|Overall Study|Adverse Event|1|||
131880103|NCT00520481|474841610|FG000|Overall Study|Withdrawal by Subject|3|||
131880104|NCT00520481|474841611|FG001|Overall Study|Withdrawal by Subject|0|||
131880105|NCT00742508|474841621|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
131880106|NCT00742508|474841622|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
131880107|NCT00742508|474841621|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
131880108|NCT00742508|474841622|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
131880109|NCT00742508|474841621|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
131880110|NCT00742508|474841622|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
131880111|NCT00742508|474841621|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
131880112|NCT00742508|474841622|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
131880113|NCT00742508|474841621|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
131880114|NCT00742508|474841622|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
131880115|NCT02091986|474841625|FG000|Overall Study|7 rand in error 1 patient decision|2|||
131880116|NCT02091986|474841626|FG001|Overall Study|7 rand in error 1 patient decision|3|||
131880117|NCT02091986|474841627|FG002|Overall Study|7 rand in error 1 patient decision|3|||
131880118|NCT02091986|474841625|FG000|Overall Study|Lost to Follow-up|1|||
131880119|NCT02091986|474841626|FG001|Overall Study|Lost to Follow-up|0|||
131880120|NCT02091986|474841627|FG002|Overall Study|Lost to Follow-up|0|||
131880121|NCT02091986|474841625|FG000|Overall Study|Withdrawal by Subject|4|||
131880122|NCT02091986|474841626|FG001|Overall Study|Withdrawal by Subject|8|||
131880123|NCT02091986|474841627|FG002|Overall Study|Withdrawal by Subject|3|||
131880124|NCT02091986|474841625|FG000|Overall Study|Adverse Event|0|||
131880125|NCT02091986|474841626|FG001|Overall Study|Adverse Event|0|||
131880126|NCT02091986|474841627|FG002|Overall Study|Adverse Event|2|||
131880127|NCT04696354|474841631|FG000|Overall Study|Study termination|6|||
131880128|NCT04696354|474841632|FG001|Overall Study|Study termination|6|||
131880129|NCT02600845|474841633|FG000|Overall Study|Reason Not Specified|3|||
131880130|NCT02600845|474841633|FG000|Overall Study|Non-compliance with Study Procedures|10|||
131880131|NCT02600845|474841633|FG000|Overall Study|Consent Withdrawal|5|||
131880132|NCT04852679|474841634|FG000|Main Intervention Period|Withdrawal by Subject|3|||
131880133|NCT04852679|474841634|FG000|Main Intervention Period|Adverse Event|1|||
131880134|NCT04852679|474841634|FG000|Main Intervention Period|Progressive Disease|16|||
131880135|NCT04852679|474841634|FG000|Main Intervention Period|Refused study visit|1|||
131880136|NCT04852679|474841634|FG000|Independent Injection Period|Missed study visit|1|||
131880137|NCT01294696|474841635|FG000|Overall Study|Screening failures|7|||
131880138|NCT01294696|474841635|FG000|Overall Study|Protocol Violation|8|||
131880139|NCT01294696|474841635|FG000|Overall Study|Missing BPI Response|7|||
131880140|NCT01294696|474841635|FG000|Overall Study|Site closure|52|||
131880141|NCT02730377|474843665|FG000|Overall Study|Other|5|||
131880142|NCT02730377|474843666|FG001|Overall Study|Other|4|||
131880143|NCT02730377|474843665|FG000|Overall Study|Death|1|||
131880144|NCT02730377|474843666|FG001|Overall Study|Death|8|||
131880145|NCT02730377|474843665|FG000|Overall Study|Inadequate glycaemic control|368|||
131880146|NCT02730377|474843666|FG001|Overall Study|Inadequate glycaemic control|473|||
131880147|NCT02730377|474843665|FG000|Overall Study|Adverse Event|79|||
131880148|NCT02730377|474843666|FG001|Overall Study|Adverse Event|41|||
131880149|NCT02730377|474843665|FG000|Overall Study|Protocol Violation|23|||
131880150|NCT02730377|474843666|FG001|Overall Study|Protocol Violation|30|||
131880151|NCT02730377|474843665|FG000|Overall Study|Lack of Efficacy|4|||
131880152|NCT02730377|474843666|FG001|Overall Study|Lack of Efficacy|13|||
131880153|NCT02730377|474843665|FG000|Overall Study|Pregnancy|0|||
131880154|NCT02730377|474843666|FG001|Overall Study|Pregnancy|1|||
131880155|NCT02730377|474843665|FG000|Overall Study|Withdrawal by Subject|45|||
131880156|NCT02730377|474843666|FG001|Overall Study|Withdrawal by Subject|42|||
131880157|NCT02730377|474843665|FG000|Overall Study|Lost to Follow-up|25|||
131880158|NCT02730377|474843666|FG001|Overall Study|Lost to Follow-up|21|||
131880159|NCT04045132|474843669|FG000|Overall Study|Lost to Follow-up|3|||
131880160|NCT04045132|474843670|FG001|Overall Study|Lost to Follow-up|6|||
131880161|NCT00401544|474843673|FG000|Overall Study|Adverse Event|5|||
131880162|NCT00401544|474843674|FG001|Overall Study|Adverse Event|1|||
131880163|NCT00401544|474843675|FG002|Overall Study|Adverse Event|1|||
131880164|NCT00401544|474843676|FG003|Overall Study|Adverse Event|1|||
131880165|NCT00401544|474843673|FG000|Overall Study|Death|3|||
131880166|NCT00401544|474843674|FG001|Overall Study|Death|6|||
131880167|NCT00401544|474843675|FG002|Overall Study|Death|2|||
131880168|NCT00401544|474843676|FG003|Overall Study|Death|5|||
131880169|NCT00401544|474843673|FG000|Overall Study|Lost to Follow-up|2|||
131880170|NCT00401544|474843674|FG001|Overall Study|Lost to Follow-up|0|||
131880171|NCT00401544|474843675|FG002|Overall Study|Lost to Follow-up|1|||
131880172|NCT00401544|474843676|FG003|Overall Study|Lost to Follow-up|1|||
131880173|NCT00401544|474843673|FG000|Overall Study|Withdrawal by Subject|7|||
131880174|NCT00401544|474843674|FG001|Overall Study|Withdrawal by Subject|6|||
131880175|NCT00401544|474843675|FG002|Overall Study|Withdrawal by Subject|6|||
131880176|NCT00401544|474843676|FG003|Overall Study|Withdrawal by Subject|5|||
131880177|NCT00401544|474843673|FG000|Overall Study|Physician Decision|1|||
131880178|NCT00401544|474843674|FG001|Overall Study|Physician Decision|3|||
131880179|NCT00401544|474843675|FG002|Overall Study|Physician Decision|0|||
131880180|NCT00401544|474843676|FG003|Overall Study|Physician Decision|0|||
131880181|NCT00401544|474843673|FG000|Overall Study|Ineligibility determined|0|||
131880182|NCT00401544|474843674|FG001|Overall Study|Ineligibility determined|1|||
131880183|NCT00401544|474843675|FG002|Overall Study|Ineligibility determined|0|||
131880184|NCT00401544|474843676|FG003|Overall Study|Ineligibility determined|2|||
131880185|NCT00401544|474843673|FG000|Overall Study|Disease progression|0|||
131880186|NCT00401544|474843674|FG001|Overall Study|Disease progression|1|||
131880187|NCT00401544|474843675|FG002|Overall Study|Disease progression|0|||
131880188|NCT00401544|474843676|FG003|Overall Study|Disease progression|0|||
131880189|NCT00401544|474843673|FG000|Overall Study|Other|0|||
131880190|NCT00401544|474843674|FG001|Overall Study|Other|0|||
131880191|NCT00401544|474843675|FG002|Overall Study|Other|2|||
131880192|NCT00401544|474843676|FG003|Overall Study|Other|2|||
131880193|NCT01871402|474843681|FG000|Overall Study|Lost to Follow-up|1|||
131880194|NCT01871402|474843682|FG001|Overall Study|Lost to Follow-up|0|||
131880195|NCT01871402|474843681|FG000|Overall Study|Withdrawal by Subject|0|||
131880196|NCT01871402|474843682|FG001|Overall Study|Withdrawal by Subject|2|||
131880197|NCT01871402|474843681|FG000|Overall Study|Non-compliance|0|||
131880198|NCT01871402|474843682|FG001|Overall Study|Non-compliance|1|||
131880199|NCT04594941|474843683|FG000|Overall Study|Other|0|||
131880200|NCT04594941|474843684|FG001|Overall Study|Other|3|||
131880201|NCT04594941|474843685|FG002|Overall Study|Other|1|||
131880202|NCT04594941|474843686|FG003|Overall Study|Other|0|||
131880203|NCT02424630|474843687|FG000|Overall Study|No rotator cuff tear|1|||
131880204|NCT02424630|474843688|FG001|Overall Study|No rotator cuff tear|2|||
131880205|NCT02424630|474843687|FG000|Overall Study|Open procedure|0|||
131880206|NCT02424630|474843688|FG001|Overall Study|Open procedure|1|||
131880207|NCT02637895|474843689|FG000|Overall Study|Lost to Follow-up|4|||
131880208|NCT02637895|474843690|FG001|Overall Study|Lost to Follow-up|0|||
131880209|NCT02637895|474843689|FG000|Overall Study|Protocol Violation|0|||
131880210|NCT02637895|474843690|FG001|Overall Study|Protocol Violation|1|||
131880211|NCT02637895|474843689|FG000|Overall Study|Lack of Efficacy|1|||
131880212|NCT02637895|474843690|FG001|Overall Study|Lack of Efficacy|0|||
131880213|NCT02637895|474843689|FG000|Overall Study|Withdrawal by Subject|1|||
131880214|NCT02637895|474843690|FG001|Overall Study|Withdrawal by Subject|1|||
131880215|NCT02637895|474843689|FG000|Overall Study|Abnormal baseline lab|0|||
131880216|NCT02637895|474843690|FG001|Overall Study|Abnormal baseline lab|1|||
131880217|NCT02031640|474843691|FG000|Screening Period|Adverse Event|1|||
131880218|NCT02031640|474843692|FG001|Screening Period|Adverse Event|0|||
131880219|NCT02031640|474843693|FG002|Screening Period|Adverse Event|0|||
131880220|NCT02031640|474843694|FG003|Screening Period|Adverse Event|0|||
131880221|NCT02031640|474843695|FG004|Screening Period|Adverse Event|0|||
131880222|NCT02031640|474843696|FG005|Screening Period|Adverse Event|0|||
131880223|NCT02031640|474843691|FG000|Screening Period|Withdrawal by Subject|29|||
131880224|NCT02031640|474843692|FG001|Screening Period|Withdrawal by Subject|0|||
131880225|NCT02031640|474843693|FG002|Screening Period|Withdrawal by Subject|0|||
131880226|NCT02031640|474843694|FG003|Screening Period|Withdrawal by Subject|0|||
131880227|NCT02031640|474843695|FG004|Screening Period|Withdrawal by Subject|0|||
131880228|NCT02031640|474843696|FG005|Screening Period|Withdrawal by Subject|0|||
131880229|NCT02031640|474843691|FG000|Screening Period|Inclusion criteria not met|312|||
131880230|NCT02031640|474843692|FG001|Screening Period|Inclusion criteria not met|0|||
131880231|NCT02031640|474843693|FG002|Screening Period|Inclusion criteria not met|0|||
131880232|NCT02031640|474843694|FG003|Screening Period|Inclusion criteria not met|0|||
131880233|NCT02031640|474843695|FG004|Screening Period|Inclusion criteria not met|0|||
131880234|NCT02031640|474843696|FG005|Screening Period|Inclusion criteria not met|0|||
131880235|NCT02031640|474843691|FG000|Screening Period|Exclusion criteria met|30|||
131880236|NCT02031640|474843692|FG001|Screening Period|Exclusion criteria met|0|||
131880237|NCT02031640|474843693|FG002|Screening Period|Exclusion criteria met|0|||
131880238|NCT02031640|474843694|FG003|Screening Period|Exclusion criteria met|0|||
131880239|NCT02031640|474843695|FG004|Screening Period|Exclusion criteria met|0|||
131880240|NCT02031640|474843696|FG005|Screening Period|Exclusion criteria met|0|||
131880241|NCT02031640|474843691|FG000|Screening Period|Lost to Follow-up|14|||
131880242|NCT02031640|474843692|FG001|Screening Period|Lost to Follow-up|0|||
131880243|NCT02031640|474843693|FG002|Screening Period|Lost to Follow-up|0|||
131880244|NCT02031640|474843694|FG003|Screening Period|Lost to Follow-up|0|||
131880245|NCT02031640|474843695|FG004|Screening Period|Lost to Follow-up|0|||
131880246|NCT02031640|474843696|FG005|Screening Period|Lost to Follow-up|0|||
131880247|NCT02031640|474843691|FG000|Screening Period|Enrollment closed|26|||
131880248|NCT02031640|474843692|FG001|Screening Period|Enrollment closed|0|||
131880249|NCT02031640|474843693|FG002|Screening Period|Enrollment closed|0|||
131880250|NCT02031640|474843694|FG003|Screening Period|Enrollment closed|0|||
131880251|NCT02031640|474843695|FG004|Screening Period|Enrollment closed|0|||
131880252|NCT02031640|474843696|FG005|Screening Period|Enrollment closed|0|||
131880253|NCT02031640|474843691|FG000|Run-In Period|Adverse Event|4|||
131880254|NCT02031640|474843692|FG001|Run-In Period|Adverse Event|0|||
131880255|NCT02031640|474843693|FG002|Run-In Period|Adverse Event|0|||
131880256|NCT02031640|474843694|FG003|Run-In Period|Adverse Event|0|||
131880257|NCT02031640|474843695|FG004|Run-In Period|Adverse Event|0|||
131880258|NCT02031640|474843696|FG005|Run-In Period|Adverse Event|0|||
131880259|NCT02031640|474843691|FG000|Run-In Period|Withdrawal by Subject|17|||
131880260|NCT02031640|474843692|FG001|Run-In Period|Withdrawal by Subject|0|||
131880261|NCT02031640|474843693|FG002|Run-In Period|Withdrawal by Subject|0|||
131880262|NCT02031640|474843694|FG003|Run-In Period|Withdrawal by Subject|0|||
131880263|NCT02031640|474843695|FG004|Run-In Period|Withdrawal by Subject|0|||
131880264|NCT02031640|474843696|FG005|Run-In Period|Withdrawal by Subject|0|||
131880265|NCT02031640|474843691|FG000|Run-In Period|Inclusion criteria not met|38|||
131880266|NCT02031640|474843692|FG001|Run-In Period|Inclusion criteria not met|0|||
131880267|NCT02031640|474843693|FG002|Run-In Period|Inclusion criteria not met|0|||
131880268|NCT02031640|474843694|FG003|Run-In Period|Inclusion criteria not met|0|||
131880269|NCT02031640|474843695|FG004|Run-In Period|Inclusion criteria not met|0|||
131880270|NCT02031640|474843696|FG005|Run-In Period|Inclusion criteria not met|0|||
131880271|NCT02031640|474843691|FG000|Run-In Period|Exclusion criteria met|8|||
131880272|NCT02031640|474843692|FG001|Run-In Period|Exclusion criteria met|0|||
131880273|NCT02031640|474843693|FG002|Run-In Period|Exclusion criteria met|0|||
131880274|NCT02031640|474843694|FG003|Run-In Period|Exclusion criteria met|0|||
131880275|NCT02031640|474843695|FG004|Run-In Period|Exclusion criteria met|0|||
131880276|NCT02031640|474843696|FG005|Run-In Period|Exclusion criteria met|0|||
131880277|NCT02031640|474843691|FG000|Run-In Period|Randomization criteria not met|85|||
131880278|NCT02031640|474843692|FG001|Run-In Period|Randomization criteria not met|0|||
131880279|NCT02031640|474843693|FG002|Run-In Period|Randomization criteria not met|0|||
131880280|NCT02031640|474843694|FG003|Run-In Period|Randomization criteria not met|0|||
131880281|NCT02031640|474843695|FG004|Run-In Period|Randomization criteria not met|0|||
131880282|NCT02031640|474843696|FG005|Run-In Period|Randomization criteria not met|0|||
131880283|NCT02031640|474843691|FG000|Run-In Period|Various administrative reasons|17|||
131880284|NCT02031640|474843692|FG001|Run-In Period|Various administrative reasons|0|||
131880285|NCT02031640|474843693|FG002|Run-In Period|Various administrative reasons|0|||
131880286|NCT02031640|474843694|FG003|Run-In Period|Various administrative reasons|0|||
131880287|NCT02031640|474843695|FG004|Run-In Period|Various administrative reasons|0|||
131880288|NCT02031640|474843696|FG005|Run-In Period|Various administrative reasons|0|||
131880289|NCT02031640|474843691|FG000|Double-blind Treatment Period|Protocol deviation|0|||
131880290|NCT02031640|474843692|FG001|Double-blind Treatment Period|Protocol deviation|2|||
131880291|NCT02031640|474843693|FG002|Double-blind Treatment Period|Protocol deviation|0|||
131880292|NCT02031640|474843694|FG003|Double-blind Treatment Period|Protocol deviation|1|||
131880293|NCT02031640|474843695|FG004|Double-blind Treatment Period|Protocol deviation|3|||
131880294|NCT02031640|474843696|FG005|Double-blind Treatment Period|Protocol deviation|1|||
131880295|NCT02031640|474843691|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
131880296|NCT02031640|474843692|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
131880297|NCT02031640|474843693|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
131880298|NCT02031640|474843694|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
131924737|NCT02675452|475009187|FG012|Overall Study|Other|0|||
131924738|NCT02675452|475009188|FG013|Overall Study|Other|0|||
131924739|NCT02675452|475009189|FG014|Overall Study|Other|0|||
131924740|NCT02675452|475009190|FG015|Overall Study|Other|0|||
131924741|NCT02675452|475009191|FG016|Overall Study|Other|0|||
131924742|NCT02675452|475009192|FG017|Overall Study|Other|0|||
131924743|NCT02675452|475009193|FG018|Overall Study|Other|0|||
131924744|NCT02675452|475009194|FG019|Overall Study|Other|0|||
131924745|NCT02675452|475009195|FG020|Overall Study|Other|0|||
131924746|NCT02675452|475009196|FG021|Overall Study|Other|0|||
131924747|NCT02675452|475009197|FG022|Overall Study|Other|0|||
131924748|NCT02675452|475009198|FG023|Overall Study|Other|0|||
131924749|NCT02675452|475009199|FG024|Overall Study|Other|0|||
131924750|NCT02675452|475009200|FG025|Overall Study|Other|0|||
131924751|NCT02675452|475009201|FG026|Overall Study|Other|1|||
131924752|NCT02675452|475009202|FG027|Overall Study|Other|0|||
131924753|NCT02675452|475009203|FG028|Overall Study|Other|0|||
131924754|NCT00032487|475009204|FG000|Overall Study|Withdrawal by Subject|67|||
131924755|NCT00032487|475009205|FG001|Overall Study|Withdrawal by Subject|43|||
131924756|NCT00032487|475009204|FG000|Overall Study|Adverse Event|3|||
131924757|NCT00032487|475009205|FG001|Overall Study|Adverse Event|7|||
131924758|NCT00032487|475009204|FG000|Overall Study|Lost to Follow-up|57|||
131924759|NCT00032487|475009205|FG001|Overall Study|Lost to Follow-up|58|||
131924760|NCT00032487|475009204|FG000|Overall Study|Had other reason|12|||
131924761|NCT00032487|475009205|FG001|Overall Study|Had other reason|12|||
131924762|NCT02569242|475009206|FG000|Overall Study|Death|1|||
131924763|NCT02569242|475009207|FG001|Overall Study|Death|0|||
131924764|NCT02569242|475009206|FG000|Overall Study|Withdrawal by Subject|0|||
131924765|NCT02569242|475009207|FG001|Overall Study|Withdrawal by Subject|1|||
131924766|NCT00689052|475009208|FG000|Overall Study|Adverse Event|4|||
131924767|NCT00689052|475009209|FG001|Overall Study|Adverse Event|6|||
131924768|NCT00689052|475009208|FG000|Overall Study|Protocol Violation|1|||
131924769|NCT00689052|475009209|FG001|Overall Study|Protocol Violation|0|||
131924770|NCT00689052|475009208|FG000|Overall Study|Lost to Follow-up|2|||
131924771|NCT00689052|475009209|FG001|Overall Study|Lost to Follow-up|0|||
131924772|NCT00689052|475009208|FG000|Overall Study|Withdrawal by Subject|2|||
131924773|NCT00689052|475009209|FG001|Overall Study|Withdrawal by Subject|0|||
131924774|NCT00689052|475009208|FG000|Overall Study|Early termination of the trial|22|||
131924775|NCT00689052|475009209|FG001|Overall Study|Early termination of the trial|24|||
131924776|NCT03003468|475009210|FG000|Overall Study|Withdrawal by Subject|0|||
131924777|NCT03003468|475009211|FG001|Overall Study|Withdrawal by Subject|0|||
131924778|NCT03003468|475009212|FG002|Overall Study|Withdrawal by Subject|1|||
131924779|NCT03003468|475009210|FG000|Overall Study|No measurable lesions|0|||
131924780|NCT03003468|475009211|FG001|Overall Study|No measurable lesions|0|||
131924781|NCT03003468|475009212|FG002|Overall Study|No measurable lesions|1|||
131924782|NCT04625972|475009213|FG000|Overall Study|Death|3|||
131924783|NCT04625972|475009214|FG001|Overall Study|Death|2|||
131924784|NCT04625972|475009213|FG000|Overall Study|Lost to Follow-up|82|||
131924785|NCT04625972|475009214|FG001|Overall Study|Lost to Follow-up|38|||
131924786|NCT04625972|475009213|FG000|Overall Study|Physician Decision|2|||
131924787|NCT04625972|475009214|FG001|Overall Study|Physician Decision|0|||
131924788|NCT04625972|475009213|FG000|Overall Study|Protocol Violation|0|||
131924789|NCT04625972|475009214|FG001|Overall Study|Protocol Violation|1|||
131924790|NCT04625972|475009213|FG000|Overall Study|Withdrawal by Subject|37|||
131924791|NCT04625972|475009214|FG001|Overall Study|Withdrawal by Subject|24|||
131924792|NCT04625972|475009213|FG000|Overall Study|Not specified elsewhere|8|||
131924793|NCT04625972|475009214|FG001|Overall Study|Not specified elsewhere|6|||
131924794|NCT03259308|475009222|FG000|Overall Study|Adverse Event|5|||
131924795|NCT03259308|475009223|FG001|Overall Study|Adverse Event|4|||
131924796|NCT03259308|475009224|FG002|Overall Study|Adverse Event|1|||
131924797|NCT03259308|475009222|FG000|Overall Study|Withdrawal by Subject|2|||
131924798|NCT03259308|475009223|FG001|Overall Study|Withdrawal by Subject|1|||
131924799|NCT03259308|475009224|FG002|Overall Study|Withdrawal by Subject|3|||
131924800|NCT03259308|475009222|FG000|Overall Study|Lost to Follow-up|0|||
131924801|NCT03259308|475009223|FG001|Overall Study|Lost to Follow-up|0|||
131924802|NCT03259308|475009224|FG002|Overall Study|Lost to Follow-up|1|||
131924803|NCT03259308|475009222|FG000|Overall Study|Pregnancy|0|||
131924804|NCT03259308|475009223|FG001|Overall Study|Pregnancy|0|||
131924805|NCT03259308|475009224|FG002|Overall Study|Pregnancy|1|||
131924806|NCT03259308|475009222|FG000|Overall Study|Protocol Deviation|0|||
131924807|NCT03259308|475009223|FG001|Overall Study|Protocol Deviation|3|||
131924808|NCT03259308|475009224|FG002|Overall Study|Protocol Deviation|0|||
131924809|NCT03259308|475009222|FG000|Overall Study|Lack of Efficacy|0|||
131924810|NCT03259308|475009223|FG001|Overall Study|Lack of Efficacy|0|||
131924811|NCT03259308|475009224|FG002|Overall Study|Lack of Efficacy|1|||
131924812|NCT00694122|475009225|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
131924813|NCT00694122|475009226|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
131924814|NCT00694122|475009225|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
131924815|NCT00694122|475009226|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
131924816|NCT00694122|475009225|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
131924817|NCT00694122|475009226|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
131924818|NCT01727154|475009229|FG000|Overall Study|Death|17|||
131924819|NCT01727154|475009229|FG000|Overall Study|Withdrawal by Subject|14|||
131924820|NCT01727154|475009229|FG000|Overall Study|Subject Withdrew Consent|18|||
131924821|NCT01727154|475009229|FG000|Overall Study|Study Terminated|6|||
131924822|NCT01727154|475009229|FG000|Overall Study|No Discontinuation Documentation|4|||
131924823|NCT00003474|475009230|FG000|Overall Study|Not Evaluable|14|||
131924824|NCT03020888|475009233|FG000|Overall Study|Physician Decision|4|||
131924825|NCT03020888|475009233|FG000|Overall Study|Withdrawal by Subject|6|||
131924826|NCT03020888|475009233|FG000|Overall Study|Insurance coverage|2|||
131924827|NCT03020888|475009233|FG000|Overall Study|Lost to Follow-up|1|||
131924828|NCT01198548|475009240|FG000|Overall Study|Disease Progression|9|||
131924829|NCT01198548|475009240|FG000|Overall Study|Administrative Decision|1|||
131924830|NCT06025695|475009242|FG000|Overall Study|Adverse Event|5|||
131924831|NCT06025695|475009243|FG001|Overall Study|Adverse Event|6|||
131924832|NCT06025695|475009242|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
131924833|NCT06025695|475009243|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
131924834|NCT06025695|475009242|FG000|Overall Study|Other|23|||
131924835|NCT06025695|475009243|FG001|Overall Study|Other|19|||
131924836|NCT06025695|475009242|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
131409424|NCT00526110|473120889|FG000|Overall Study|Maximal Response|0|||
131409425|NCT00526110|473120890|FG001|Overall Study|Maximal Response|6|||
131409426|NCT00526110|473120889|FG000|Overall Study|Withdrawal by Subject|0|||
131409427|NCT00526110|473120890|FG001|Overall Study|Withdrawal by Subject|2|||
131409428|NCT00526110|473120889|FG000|Overall Study|Poor Tolerance|0|||
131409429|NCT00526110|473120890|FG001|Overall Study|Poor Tolerance|5|||
131409430|NCT03959982|473123138|FG000|Overall Study|Withdrawal by Subject|1|||
131409431|NCT03959982|473123139|FG001|Overall Study|Withdrawal by Subject|0|||
131409432|NCT03959982|473123138|FG000|Overall Study|Physician Decision|2|||
131409433|NCT03959982|473123139|FG001|Overall Study|Physician Decision|0|||
131409434|NCT03959982|473123138|FG000|Overall Study|Lost to Follow-up|1|||
131409435|NCT03959982|473123139|FG001|Overall Study|Lost to Follow-up|0|||
131409436|NCT00758589|473123140|FG000|Overall Study|Adverse Event|3|||
131409437|NCT00758589|473123141|FG001|Overall Study|Adverse Event|2|||
131409438|NCT00758589|473123142|FG002|Overall Study|Adverse Event|5|||
131409439|NCT00758589|473123143|FG003|Overall Study|Adverse Event|4|||
131409440|NCT00758589|473123140|FG000|Overall Study|Withdrawal by Subject|0|||
131409441|NCT00758589|473123141|FG001|Overall Study|Withdrawal by Subject|1|||
131409442|NCT00758589|473123142|FG002|Overall Study|Withdrawal by Subject|1|||
131409443|NCT00758589|473123143|FG003|Overall Study|Withdrawal by Subject|1|||
131409444|NCT00758589|473123140|FG000|Overall Study|Palm stopped to work|0|||
131409445|NCT00758589|473123141|FG001|Overall Study|Palm stopped to work|0|||
131409446|NCT00758589|473123142|FG002|Overall Study|Palm stopped to work|0|||
131409447|NCT00758589|473123143|FG003|Overall Study|Palm stopped to work|1|||
131409448|NCT05320393|473123144|FG000|Overall Study|Withdrawal by Subject|1|||
131409449|NCT05320393|473123145|FG001|Overall Study|Withdrawal by Subject|0|||
131409450|NCT05320393|473123146|FG002|Overall Study|Withdrawal by Subject|2|||
131409451|NCT05320393|473123144|FG000|Overall Study|Lost to Follow-up|1|||
131409452|NCT05320393|473123145|FG001|Overall Study|Lost to Follow-up|2|||
131409453|NCT05320393|473123146|FG002|Overall Study|Lost to Follow-up|1|||
131409454|NCT05320393|473123144|FG000|Overall Study|Moved; too much driving|0|||
131409455|NCT05320393|473123145|FG001|Overall Study|Moved; too much driving|0|||
131409456|NCT05320393|473123146|FG002|Overall Study|Moved; too much driving|2|||
131409457|NCT05320393|473123144|FG000|Overall Study|Did not receive treatment|0|||
131409458|NCT05320393|473123145|FG001|Overall Study|Did not receive treatment|0|||
131409459|NCT05320393|473123146|FG002|Overall Study|Did not receive treatment|1|||
131409460|NCT03559699|473123150|FG000|Overall Study|Withdrawal by Subject|6|||
131409461|NCT03559699|473123150|FG000|Overall Study|Lost to Follow-up|1|||
131409462|NCT05438602|473123157|FG000|Treatment (15 Days)|Adverse Event|2|||
131409463|NCT05438602|473123158|FG001|Treatment (15 Days)|Adverse Event|1|||
131409464|NCT05438602|473123159|FG002|Treatment (15 Days)|Adverse Event|3|||
131409465|NCT05438602|473123157|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
131409466|NCT05438602|473123158|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
131409467|NCT05438602|473123159|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
131924837|NCT06025695|475009243|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
131924838|NCT03834883|475009244|FG000|Second Treatment|Withdrawal by Subject|1|||
131924839|NCT03834883|475009245|FG001|Second Treatment|Withdrawal by Subject|0|||
131409468|NCT05438602|473123157|FG000|Treatment (15 Days)|Other|0|||
131409469|NCT05438602|473123158|FG001|Treatment (15 Days)|Other|0|||
131409470|NCT05438602|473123159|FG002|Treatment (15 Days)|Other|1|||
131409471|NCT05438602|473123157|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
131409472|NCT05438602|473123158|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
131409473|NCT05438602|473123159|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
131409474|NCT05438602|473123157|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
131924840|NCT03834883|475009246|FG002|Second Treatment|Withdrawal by Subject|0|||
131924841|NCT03834883|475009247|FG003|Second Treatment|Withdrawal by Subject|0|||
131924842|NCT03834883|475009244|FG000|Second Treatment|COVID-19 pandemic|1|||
131924843|NCT03834883|475009245|FG001|Second Treatment|COVID-19 pandemic|0|||
131880299|NCT02031640|474843695|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
131880300|NCT02031640|474843696|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
131880301|NCT02031640|474843691|FG000|Double-blind Treatment Period|Non-compliance|0|||
131880302|NCT02031640|474843692|FG001|Double-blind Treatment Period|Non-compliance|1|||
131880303|NCT02031640|474843693|FG002|Double-blind Treatment Period|Non-compliance|0|||
131880304|NCT02031640|474843694|FG003|Double-blind Treatment Period|Non-compliance|1|||
131880305|NCT02031640|474843695|FG004|Double-blind Treatment Period|Non-compliance|1|||
131880306|NCT02031640|474843696|FG005|Double-blind Treatment Period|Non-compliance|0|||
131880307|NCT02031640|474843691|FG000|Double-blind Treatment Period|Adverse Event|0|||
131880308|NCT02031640|474843692|FG001|Double-blind Treatment Period|Adverse Event|0|||
131880309|NCT02031640|474843693|FG002|Double-blind Treatment Period|Adverse Event|0|||
131880310|NCT02031640|474843694|FG003|Double-blind Treatment Period|Adverse Event|2|||
131880311|NCT02031640|474843695|FG004|Double-blind Treatment Period|Adverse Event|0|||
131880312|NCT02031640|474843696|FG005|Double-blind Treatment Period|Adverse Event|0|||
131880313|NCT02031640|474843691|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131880314|NCT02031640|474843692|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131880315|NCT02031640|474843693|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
131880316|NCT02031640|474843694|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
131880317|NCT02031640|474843695|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
131880318|NCT02031640|474843696|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
131880319|NCT02031640|474843691|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131880320|NCT02031640|474843692|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
131880321|NCT02031640|474843693|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131880322|NCT02031640|474843694|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131880323|NCT02031640|474843695|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
131880324|NCT02031640|474843696|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
131880325|NCT05896527|474843701|FG000|Overall Study|Withdrawal by Subject|11|||
131880326|NCT05896527|474843702|FG001|Overall Study|Withdrawal by Subject|10|||
131880327|NCT05896527|474843703|FG002|Overall Study|Withdrawal by Subject|4|||
131880328|NCT05896527|474843704|FG003|Overall Study|Withdrawal by Subject|3|||
131880329|NCT05896527|474843705|FG004|Overall Study|Withdrawal by Subject|2|||
131880330|NCT05896527|474843701|FG000|Overall Study|Lost to Follow-up|0|||
131880331|NCT05896527|474843702|FG001|Overall Study|Lost to Follow-up|2|||
131880332|NCT05896527|474843703|FG002|Overall Study|Lost to Follow-up|2|||
131880333|NCT05896527|474843704|FG003|Overall Study|Lost to Follow-up|2|||
131880334|NCT05896527|474843705|FG004|Overall Study|Lost to Follow-up|1|||
131880335|NCT05896527|474843701|FG000|Overall Study|Significant protocol noncompliance|0|||
131880336|NCT05896527|474843702|FG001|Overall Study|Significant protocol noncompliance|1|||
131880337|NCT05896527|474843703|FG002|Overall Study|Significant protocol noncompliance|0|||
131880338|NCT05896527|474843704|FG003|Overall Study|Significant protocol noncompliance|0|||
131880339|NCT05896527|474843705|FG004|Overall Study|Significant protocol noncompliance|0|||
131880340|NCT05896527|474843701|FG000|Overall Study|Eligibility criteria not met|1|||
131880341|NCT05896527|474843702|FG001|Overall Study|Eligibility criteria not met|0|||
131880342|NCT05896527|474843703|FG002|Overall Study|Eligibility criteria not met|0|||
131880343|NCT05896527|474843704|FG003|Overall Study|Eligibility criteria not met|0|||
131880344|NCT05896527|474843705|FG004|Overall Study|Eligibility criteria not met|0|||
131880345|NCT05896527|474843701|FG000|Overall Study|Sponsor's decision|0|||
131880346|NCT05896527|474843702|FG001|Overall Study|Sponsor's decision|0|||
131880347|NCT05896527|474843703|FG002|Overall Study|Sponsor's decision|0|||
131880348|NCT05896527|474843704|FG003|Overall Study|Sponsor's decision|1|||
131880349|NCT05896527|474843705|FG004|Overall Study|Sponsor's decision|0|||
131880350|NCT05896527|474843701|FG000|Overall Study|Investigator's decision|0|||
131880351|NCT05896527|474843702|FG001|Overall Study|Investigator's decision|1|||
131880352|NCT05896527|474843703|FG002|Overall Study|Investigator's decision|0|||
131880353|NCT05896527|474843704|FG003|Overall Study|Investigator's decision|0|||
131880354|NCT05896527|474843705|FG004|Overall Study|Investigator's decision|0|||
131880355|NCT05896527|474843701|FG000|Overall Study|Pregnancy of his partner|0|||
131880356|NCT05896527|474843702|FG001|Overall Study|Pregnancy of his partner|0|||
131880357|NCT05896527|474843703|FG002|Overall Study|Pregnancy of his partner|0|||
131880358|NCT05896527|474843704|FG003|Overall Study|Pregnancy of his partner|1|||
131880359|NCT05896527|474843705|FG004|Overall Study|Pregnancy of his partner|0|||
131880360|NCT03085238|474843706|FG000|Overall Study|Adverse Event|2|||
131880361|NCT03085238|474843706|FG000|Overall Study|Death|2|||
131880362|NCT01279070|474843707|FG000|Overall Study|Withdrawal by Subject|2|||
131880363|NCT01279070|474843708|FG001|Overall Study|Withdrawal by Subject|3|||
131880364|NCT01279070|474843707|FG000|Overall Study|Acute exacerbation|3|||
131880365|NCT01279070|474843708|FG001|Overall Study|Acute exacerbation|1|||
131880366|NCT03781583|474843709|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
131880367|NCT03781583|474843710|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
131880368|NCT03781583|474843711|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
131880369|NCT03781583|474843712|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
131880370|NCT03781583|474843709|FG000|Overall Study|Technology did not work for that person in that environment|1|||
131924844|NCT03834883|475009246|FG002|Second Treatment|COVID-19 pandemic|1|||
131924845|NCT03834883|475009247|FG003|Second Treatment|COVID-19 pandemic|1|||
131924846|NCT03787212|475010712|FG000|Period 1|Study Termination|2|||
131924847|NCT03787212|475010713|FG001|Period 1|Study Termination|2|||
131924848|NCT04193176|475010715|FG000|Overall Study|Withdrawal by Subject|6|||
131924849|NCT04193176|475010716|FG001|Overall Study|Withdrawal by Subject|10|||
131924850|NCT01629563|475010717|FG000|Overall Study|Adverse Event|16|||
131924851|NCT01629563|475010718|FG001|Overall Study|Adverse Event|16|||
131924852|NCT01629563|475010717|FG000|Overall Study|Death|2|||
131924853|NCT01629563|475010718|FG001|Overall Study|Death|0|||
131924854|NCT01629563|475010717|FG000|Overall Study|Lack of Efficacy|2|||
131924855|NCT01629563|475010718|FG001|Overall Study|Lack of Efficacy|3|||
131924856|NCT01629563|475010717|FG000|Overall Study|Lost to Follow-up|1|||
131924857|NCT01629563|475010718|FG001|Overall Study|Lost to Follow-up|0|||
131924858|NCT01629563|475010717|FG000|Overall Study|Pregnancy|1|||
131924859|NCT01629563|475010718|FG001|Overall Study|Pregnancy|2|||
131924860|NCT01629563|475010717|FG000|Overall Study|Protocol Violation|0|||
131924861|NCT01629563|475010718|FG001|Overall Study|Protocol Violation|1|||
131924862|NCT01629563|475010717|FG000|Overall Study|Withdrawal by Subject|27|||
131924863|NCT01629563|475010718|FG001|Overall Study|Withdrawal by Subject|20|||
131924864|NCT01629563|475010717|FG000|Overall Study|surgery|0|||
131924865|NCT01629563|475010718|FG001|Overall Study|surgery|3|||
131924866|NCT01629563|475010717|FG000|Overall Study|Lack of return of menses|12|||
131924867|NCT01629563|475010718|FG001|Overall Study|Lack of return of menses|7|||
131924868|NCT01629563|475010717|FG000|Overall Study|Protocol Violation|0|||
131924869|NCT01629563|475010718|FG001|Overall Study|Protocol Violation|1|||
131924870|NCT02370394|475010720|FG000|Overall Study|Lost to Follow-up|2|||
131924871|NCT02370394|475010721|FG001|Overall Study|Lost to Follow-up|1|||
131924872|NCT02370394|475010720|FG000|Overall Study|Withdrawal by Subject|0|||
131924873|NCT02370394|475010721|FG001|Overall Study|Withdrawal by Subject|1|||
131924874|NCT02545127|475010724|FG000|Overall Study|Lost to Follow-up|1|||
131924875|NCT02545127|475010725|FG001|Overall Study|Lost to Follow-up|0|||
131924876|NCT01245751|475010726|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
131924877|NCT01245751|475010727|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
131924878|NCT01245751|475010728|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
131924879|NCT01245751|475010729|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
131924880|NCT01245751|475010726|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
131924881|NCT01245751|475010727|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
131924882|NCT01245751|475010728|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
131924883|NCT01245751|475010729|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
131924884|NCT01245751|475010726|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
131924885|NCT01245751|475010727|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
131924886|NCT01245751|475010728|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
131924887|NCT01245751|475010729|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
131924888|NCT00985192|475010730|FG000|Overall Study|Withdrawal by Subject|1|||
131924889|NCT00985192|475010730|FG000|Overall Study|Disease Progression|1|||
131924890|NCT00985192|475010730|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
131924891|NCT02930941|475010732|FG000|Overall Study|Lost to Follow-up|1|||
131924892|NCT02930941|475010733|FG001|Overall Study|Lost to Follow-up|2|||
131924893|NCT01967277|475010734|FG000|Overall Study|Lost to Follow-up|1|||
131924894|NCT01967277|475010735|FG001|Overall Study|Lost to Follow-up|2|||
131924895|NCT01967277|475010734|FG000|Overall Study|Unrelated illness|0|||
131924896|NCT01967277|475010735|FG001|Overall Study|Unrelated illness|1|||
131924897|NCT00103506|475010736|FG000|Overall Study|Study closed by sponsor|34|||
131924898|NCT00103506|475010737|FG001|Overall Study|Study closed by sponsor|37|||
131924899|NCT00103506|475010736|FG000|Overall Study|Death|257|||
131924900|NCT00103506|475010737|FG001|Overall Study|Death|253|||
131924901|NCT00103506|475010736|FG000|Overall Study|Lost to Follow-up|13|||
131924902|NCT00103506|475010737|FG001|Overall Study|Lost to Follow-up|13|||
131924903|NCT00103506|475010736|FG000|Overall Study|Withdrawal by Subject|18|||
131924904|NCT00103506|475010737|FG001|Overall Study|Withdrawal by Subject|21|||
131924905|NCT00585585|475010738|FG000|Overall Study|Adverse Event|1|||
131924906|NCT00710554|475010746|FG000|Overall Study|Adverse Event|24|||
131924907|NCT00710554|475010747|FG001|Overall Study|Adverse Event|7|||
131924908|NCT00710554|475010746|FG000|Overall Study|Withdrawal by Subject|7|||
131924909|NCT00710554|475010747|FG001|Overall Study|Withdrawal by Subject|3|||
131924910|NCT00710554|475010746|FG000|Overall Study|Lost to Follow-up|7|||
131924911|NCT00710554|475010747|FG001|Overall Study|Lost to Follow-up|1|||
131924912|NCT00710554|475010746|FG000|Overall Study|Lack of Efficacy|11|||
131924913|NCT00710554|475010747|FG001|Overall Study|Lack of Efficacy|12|||
131924914|NCT00710554|475010746|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
131924915|NCT00710554|475010747|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
131924916|NCT01301001|475010752|FG000|First Intervention|Lost to Follow-up|4|||
131924917|NCT01301001|475010753|FG001|First Intervention|Lost to Follow-up|4|||
131924918|NCT01301001|475010752|FG000|First Intervention|Withdrawal by Subject|1|||
131924919|NCT01301001|475010753|FG001|First Intervention|Withdrawal by Subject|4|||
131924920|NCT01301001|475010752|FG000|First Intervention|Adverse Event|5|||
131880371|NCT03781583|474843710|FG001|Overall Study|Technology did not work for that person in that environment|0|||
131880372|NCT03781583|474843711|FG002|Overall Study|Technology did not work for that person in that environment|0|||
131880373|NCT03781583|474843712|FG003|Overall Study|Technology did not work for that person in that environment|0|||
131880374|NCT03781583|474843709|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
131880375|NCT03781583|474843710|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
131880376|NCT03781583|474843711|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
131880377|NCT03781583|474843712|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
131880378|NCT03781583|474843709|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
131880379|NCT03781583|474843710|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
131880380|NCT03781583|474843711|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
131880381|NCT03781583|474843712|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
131880382|NCT00761280|474843713|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
131880383|NCT00761280|474843714|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
131880384|NCT00761280|474843713|FG000|Randomization to First Dose|Sponsor decision|1|||
131880385|NCT00761280|474843714|FG001|Randomization to First Dose|Sponsor decision|0|||
131880386|NCT00761280|474843713|FG000|Randomization to First Dose|Other|1|||
131880387|NCT00761280|474843714|FG001|Randomization to First Dose|Other|0|||
131880388|NCT00761280|474843713|FG000|First Dose to End of Study|End of trial|5|||
131880389|NCT00761280|474843714|FG001|First Dose to End of Study|End of trial|5|||
131880390|NCT00761280|474843713|FG000|First Dose to End of Study|Progressive disease|5|||
131880391|NCT00761280|474843714|FG001|First Dose to End of Study|Progressive disease|3|||
131880392|NCT00761280|474843713|FG000|First Dose to End of Study|Sponsor decision|1|||
131880393|NCT00761280|474843714|FG001|First Dose to End of Study|Sponsor decision|2|||
131880394|NCT00761280|474843713|FG000|First Dose to End of Study|Death|1|||
131880395|NCT00761280|474843714|FG001|First Dose to End of Study|Death|0|||
131880396|NCT00761280|474843713|FG000|First Dose to End of Study|Lost to Follow-up|0|||
131880397|NCT00761280|474843714|FG001|First Dose to End of Study|Lost to Follow-up|1|||
131880398|NCT03875482|474843715|FG000|Overall Study|Adverse Event|0|||
131880399|NCT03875482|474843716|FG001|Overall Study|Adverse Event|1|||
131880400|NCT03875482|474843715|FG000|Overall Study|Withdrew consent|5|||
131880401|NCT03875482|474843716|FG001|Overall Study|Withdrew consent|6|||
131880402|NCT03875482|474843715|FG000|Overall Study|Lost to Follow-up|8|||
131880403|NCT03875482|474843716|FG001|Overall Study|Lost to Follow-up|2|||
131880404|NCT03875482|474843715|FG000|Overall Study|Lack of Efficacy|0|||
131880405|NCT03875482|474843716|FG001|Overall Study|Lack of Efficacy|11|||
131880406|NCT02691013|474843718|FG000|Overall Study|Withdrawal by Subject|3|||
131880407|NCT02691013|474843719|FG001|Overall Study|Withdrawal by Subject|0|||
131880408|NCT02111785|474843723|FG000|Overall Study|Death|0|||
131880409|NCT02111785|474843724|FG001|Overall Study|Death|1|||
131880410|NCT02111785|474843725|FG002|Overall Study|Death|0|||
131880411|NCT02111785|474843726|FG003|Overall Study|Death|0|||
131880412|NCT00348790|474843733|FG000|Completed Treatment|Withdrawal by Subject|4|||
131880413|NCT00348790|474843733|FG000|Completed Treatment|Disease progression|14|||
131880414|NCT00348790|474843733|FG000|Completed Treatment|Adverse Event|4|||
131880415|NCT00348790|474843733|FG000|Completed Treatment|Required surgery|2|||
131880416|NCT00348790|474843733|FG000|Completed Treatment|Unable to travel to study site|1|||
131880417|NCT04712019|474843734|FG000|Overall Study|Withdrawal by Subject|2|||
131880418|NCT04712019|474843735|FG001|Overall Study|Withdrawal by Subject|2|||
131880419|NCT04712019|474843734|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
131880420|NCT04712019|474843735|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
131880421|NCT03419598|474843751|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
131880422|NCT04569968|474843752|FG000|Overall Study|Lost to Follow-up|2|||
131880423|NCT04569968|474843753|FG001|Overall Study|Lost to Follow-up|5|||
131880424|NCT04569968|474843752|FG000|Overall Study|Story of head and/or neck surgery|2|||
131880425|NCT04569968|474843753|FG001|Overall Study|Story of head and/or neck surgery|2|||
131880426|NCT04569968|474843752|FG000|Overall Study|Time of stroke onset|8|||
131880427|NCT04569968|474843753|FG001|Overall Study|Time of stroke onset|7|||
131880428|NCT04569968|474843752|FG000|Overall Study|Type of strokr|12|||
131880429|NCT04569968|474843753|FG001|Overall Study|Type of strokr|8|||
131880430|NCT04569968|474843752|FG000|Overall Study|Cooperation|8|||
131880431|NCT04569968|474843753|FG001|Overall Study|Cooperation|8|||
131880432|NCT04569968|474843752|FG000|Overall Study|Age interval|17|||
131880433|NCT04569968|474843753|FG001|Overall Study|Age interval|6|||
131880434|NCT04569968|474843752|FG000|Overall Study|Denial of participation to the study|0|||
131880435|NCT04569968|474843753|FG001|Overall Study|Denial of participation to the study|3|||
131880436|NCT04569968|474843752|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
131880437|NCT04569968|474843753|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
131880438|NCT04569968|474843752|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
131880439|NCT04569968|474843753|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
131880440|NCT04569968|474843752|FG000|Overall Study|Quarantine|1|||
131924921|NCT01301001|475010753|FG001|First Intervention|Adverse Event|0|||
131924922|NCT01301001|475010752|FG000|First Intervention|Protocol Violation|0|||
131924923|NCT01301001|475010753|FG001|First Intervention|Protocol Violation|1|||
131924924|NCT01301001|475010752|FG000|Second Intervention|Adverse Event|2|||
131924925|NCT01301001|475010753|FG001|Second Intervention|Adverse Event|0|||
131924926|NCT01301001|475010752|FG000|Second Intervention|Withdrawal by Subject|2|||
131924927|NCT01301001|475010753|FG001|Second Intervention|Withdrawal by Subject|0|||
131924928|NCT02852434|475010754|FG000|Overall Study|Withdrawal by Subject|0|||
131924929|NCT02852434|475010755|FG001|Overall Study|Withdrawal by Subject|1|||
131924930|NCT02852434|475010754|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
131924931|NCT02852434|475010755|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
131924932|NCT00927186|475010756|FG000|12 Months Primary Study|Adverse Event|5|||
131924933|NCT00927186|475010757|FG001|12 Months Primary Study|Adverse Event|2|||
131924934|NCT00927186|475010756|FG000|12 Months Primary Study|Lost to Follow-up|1|||
131924935|NCT00927186|475010757|FG001|12 Months Primary Study|Lost to Follow-up|0|||
131924936|NCT00927186|475010756|FG000|12 Months Primary Study|Protocol Violation|0|||
131924937|NCT00927186|475010757|FG001|12 Months Primary Study|Protocol Violation|1|||
131924938|NCT00927186|475010756|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
131924939|NCT00927186|475010757|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
131924940|NCT01145222|475010758|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
131454042|NCT01032889|473291868|FG002|Overall Study|Lost to Follow-up|0|||
131880441|NCT04569968|474843753|FG001|Overall Study|Quarantine|0|||
131880442|NCT04569968|474843752|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
131880443|NCT04569968|474843753|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
131880444|NCT04569968|474843752|FG000|Overall Study|Repetitive stroke|8|||
131880445|NCT04569968|474843753|FG001|Overall Study|Repetitive stroke|0|||
131880446|NCT04569968|474843752|FG000|Overall Study|Insufficient mastication|1|||
131880447|NCT04569968|474843753|FG001|Overall Study|Insufficient mastication|0|||
131880448|NCT04569968|474843752|FG000|Overall Study|Infection|1|||
131880449|NCT04569968|474843753|FG001|Overall Study|Infection|0|||
131880450|NCT02370667|474843754|FG000|Overall Study|Lost to Follow-up|0|||
131880451|NCT02370667|474843755|FG001|Overall Study|Lost to Follow-up|1|||
131880452|NCT02370667|474843756|FG002|Overall Study|Lost to Follow-up|0|||
131880453|NCT00423189|474843757|FG000|Overall Study|Death|0|||
131880454|NCT00423189|474843758|FG001|Overall Study|Death|1|||
131880455|NCT00423189|474843759|FG002|Overall Study|Death|0|||
131880456|NCT01459718|474843762|FG000|Overall Study|Physician Decision|1|||
131880457|NCT01459718|474843762|FG000|Overall Study|Lost to Follow-up|1|||
131880458|NCT01459718|474843762|FG000|Overall Study|Adverse Event|1|||
131880459|NCT01258075|474843768|FG000|Overall Study|Adverse Event|8|||
131880460|NCT01258075|474843769|FG001|Overall Study|Adverse Event|3|||
131880461|NCT01258075|474843768|FG000|Overall Study|Lost to Follow-up|11|||
131880462|NCT01258075|474843769|FG001|Overall Study|Lost to Follow-up|6|||
131880463|NCT01258075|474843768|FG000|Overall Study|Withdrawal by Subject|10|||
131880464|NCT01258075|474843769|FG001|Overall Study|Withdrawal by Subject|7|||
131880465|NCT01258075|474843768|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
131880466|NCT01258075|474843769|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
131880467|NCT01258075|474843768|FG000|Overall Study|Other|12|||
131880468|NCT01258075|474843769|FG001|Overall Study|Other|5|||
131880469|NCT03197870|474843775|FG000|Overall Study|Adverse Event|9|||
131880470|NCT03197870|474843776|FG001|Overall Study|Adverse Event|4|||
131880471|NCT03197870|474843777|FG002|Overall Study|Adverse Event|6|||
131880472|NCT03197870|474843775|FG000|Overall Study|Withdrawal by Subject|2|||
131880473|NCT03197870|474843776|FG001|Overall Study|Withdrawal by Subject|3|||
131880474|NCT03197870|474843777|FG002|Overall Study|Withdrawal by Subject|0|||
131880475|NCT03197870|474843775|FG000|Overall Study|Lost to Follow-up|2|||
131880476|NCT03197870|474843776|FG001|Overall Study|Lost to Follow-up|2|||
131880477|NCT03197870|474843777|FG002|Overall Study|Lost to Follow-up|0|||
131880478|NCT03197870|474843775|FG000|Overall Study|data not available|1|||
131880479|NCT03197870|474843776|FG001|Overall Study|data not available|1|||
131880480|NCT03197870|474843777|FG002|Overall Study|data not available|0|||
131880481|NCT01618019|474843779|FG000|Overall Study|Withdrawal by Subject|14|||
131880482|NCT01618019|474843780|FG001|Overall Study|Withdrawal by Subject|14|||
131924941|NCT01145222|475010759|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
131924942|NCT01145222|475010760|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
131924943|NCT01145222|475010761|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
131924944|NCT01145222|475010758|FG000|Overall Study|Poor bowel preparation|0|||
131924945|NCT01145222|475010759|FG001|Overall Study|Poor bowel preparation|0|||
131924946|NCT01145222|475010760|FG002|Overall Study|Poor bowel preparation|0|||
131924947|NCT01145222|475010761|FG003|Overall Study|Poor bowel preparation|1|||
131924948|NCT01698008|475010762|FG000|Overall Study|Withdrawal by Subject|1|||
131924949|NCT01698008|475010763|FG001|Overall Study|Withdrawal by Subject|2|||
131924950|NCT01011283|475010765|FG000|Overall Study|Adverse Event|4|||
131924951|NCT01011283|475010766|FG001|Overall Study|Adverse Event|2|||
131880483|NCT01542034|474843781|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
131880484|NCT01542034|474843782|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
131880485|NCT01542034|474843781|FG000|Overall Study|Administrative decision|0|||
131880486|NCT01542034|474843782|FG001|Overall Study|Administrative decision|3|||
131880487|NCT01542034|474843781|FG000|Overall Study|Subject Noncompliance|1|||
131880488|NCT01542034|474843782|FG001|Overall Study|Subject Noncompliance|0|||
131880489|NCT01542034|474843781|FG000|Overall Study|Adverse Event|2|||
131880490|NCT01542034|474843782|FG001|Overall Study|Adverse Event|2|||
131880491|NCT01542034|474843781|FG000|Overall Study|Lost to Follow-up|7|||
131880492|NCT01542034|474843782|FG001|Overall Study|Lost to Follow-up|6|||
131880493|NCT02612610|474843783|FG000|Overall Study|Withdrawal by Subject|1|||
131880494|NCT02612610|474843784|FG001|Overall Study|Withdrawal by Subject|1|||
131880495|NCT02612610|474843785|FG002|Overall Study|Withdrawal by Subject|0|||
131880496|NCT02612610|474843786|FG003|Overall Study|Withdrawal by Subject|2|||
131880497|NCT02612610|474843783|FG000|Overall Study|Adverse Event|2|||
131880498|NCT02612610|474843784|FG001|Overall Study|Adverse Event|2|||
131880499|NCT02612610|474843785|FG002|Overall Study|Adverse Event|3|||
131880500|NCT02612610|474843786|FG003|Overall Study|Adverse Event|10|||
131880501|NCT02612610|474843783|FG000|Overall Study|Lost to Follow-up|0|||
131880502|NCT02612610|474843784|FG001|Overall Study|Lost to Follow-up|1|||
131880503|NCT02612610|474843785|FG002|Overall Study|Lost to Follow-up|0|||
131880504|NCT02612610|474843786|FG003|Overall Study|Lost to Follow-up|0|||
131880505|NCT02612610|474843783|FG000|Overall Study|Protocol Violation|0|||
131880506|NCT02612610|474843784|FG001|Overall Study|Protocol Violation|1|||
131880507|NCT02612610|474843785|FG002|Overall Study|Protocol Violation|1|||
131880508|NCT02612610|474843786|FG003|Overall Study|Protocol Violation|0|||
131880509|NCT02612610|474843783|FG000|Overall Study|Lack of Efficacy|1|||
131880510|NCT02612610|474843784|FG001|Overall Study|Lack of Efficacy|2|||
131880511|NCT02612610|474843785|FG002|Overall Study|Lack of Efficacy|0|||
131880512|NCT02612610|474843786|FG003|Overall Study|Lack of Efficacy|1|||
131880513|NCT02612610|474843783|FG000|Overall Study|Physician Decision|0|||
131880514|NCT02612610|474843784|FG001|Overall Study|Physician Decision|1|||
131880515|NCT02612610|474843785|FG002|Overall Study|Physician Decision|0|||
131880516|NCT02612610|474843786|FG003|Overall Study|Physician Decision|0|||
131880517|NCT02612610|474843783|FG000|Overall Study|Noncompliance|1|||
131880518|NCT02612610|474843784|FG001|Overall Study|Noncompliance|0|||
131880519|NCT02612610|474843785|FG002|Overall Study|Noncompliance|0|||
131880520|NCT02612610|474843786|FG003|Overall Study|Noncompliance|0|||
131880521|NCT02612610|474843783|FG000|Overall Study|Cough Improvement|0|||
131880522|NCT02612610|474843784|FG001|Overall Study|Cough Improvement|0|||
131880523|NCT02612610|474843785|FG002|Overall Study|Cough Improvement|1|||
131880524|NCT02612610|474843786|FG003|Overall Study|Cough Improvement|0|||
131880525|NCT01801280|474843787|FG000|Period 1|Withdrawal by Subject|0|||
131880526|NCT01801280|474843788|FG001|Period 1|Withdrawal by Subject|1|||
131880527|NCT01801280|474843789|FG002|Period 1|Withdrawal by Subject|0|||
131880528|NCT01801280|474843790|FG003|Period 1|Withdrawal by Subject|0|||
131880529|NCT01801280|474843787|FG000|Period 2|Withdrawal by Subject|1|||
131880530|NCT01801280|474843788|FG001|Period 2|Withdrawal by Subject|0|||
131880531|NCT01801280|474843789|FG002|Period 2|Withdrawal by Subject|0|||
131880532|NCT01801280|474843790|FG003|Period 2|Withdrawal by Subject|0|||
131880533|NCT01801280|474843787|FG000|Period 4|Protocol Violation|0|||
131880534|NCT01801280|474843788|FG001|Period 4|Protocol Violation|0|||
131880535|NCT01801280|474843789|FG002|Period 4|Protocol Violation|1|||
131880536|NCT01801280|474843790|FG003|Period 4|Protocol Violation|0|||
131880537|NCT02783729|474843791|FG000|Overall Study|Lack of Efficacy|1|||
131880538|NCT02783729|474843792|FG001|Overall Study|Lack of Efficacy|0|||
131880539|NCT02783729|474843793|FG002|Overall Study|Lack of Efficacy|0|||
131880540|NCT02783729|474843794|FG003|Overall Study|Lack of Efficacy|0|||
131880541|NCT02783729|474843791|FG000|Overall Study|Adverse Event|2|||
131880542|NCT02783729|474843792|FG001|Overall Study|Adverse Event|6|||
131880543|NCT02783729|474843793|FG002|Overall Study|Adverse Event|2|||
131880544|NCT02783729|474843794|FG003|Overall Study|Adverse Event|3|||
131880545|NCT02783729|474843791|FG000|Overall Study|Other|1|||
131880546|NCT02783729|474843792|FG001|Overall Study|Other|6|||
131880547|NCT02783729|474843793|FG002|Overall Study|Other|2|||
131880548|NCT02783729|474843794|FG003|Overall Study|Other|3|||
131880549|NCT02783729|474843791|FG000|Overall Study|Withdrawal by Subject|2|||
131880550|NCT02783729|474843792|FG001|Overall Study|Withdrawal by Subject|3|||
131880551|NCT02783729|474843793|FG002|Overall Study|Withdrawal by Subject|1|||
131880552|NCT02783729|474843794|FG003|Overall Study|Withdrawal by Subject|2|||
131880553|NCT02783729|474843791|FG000|Overall Study|Participant's choice|2|||
131880554|NCT02783729|474843792|FG001|Overall Study|Participant's choice|1|||
131880555|NCT02783729|474843793|FG002|Overall Study|Participant's choice|2|||
131880556|NCT02783729|474843794|FG003|Overall Study|Participant's choice|1|||
131880557|NCT02783729|474843791|FG000|Overall Study|Lost to Follow-up|2|||
131880558|NCT02783729|474843792|FG001|Overall Study|Lost to Follow-up|1|||
131880559|NCT02783729|474843793|FG002|Overall Study|Lost to Follow-up|1|||
131880560|NCT02783729|474843794|FG003|Overall Study|Lost to Follow-up|0|||
131880561|NCT02693171|474843795|FG000|Overall Study|Adverse Event|1|||
131880562|NCT02693171|474843795|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
131880563|NCT01866657|474843803|FG000|Overall Study|Surgery canceled|2|||
131880564|NCT01866657|474843804|FG001|Overall Study|Surgery canceled|0|||
131924952|NCT01011283|475010765|FG000|Overall Study|Progressive Disease|0|||
131924953|NCT01011283|475010766|FG001|Overall Study|Progressive Disease|2|||
131924954|NCT01011283|475010765|FG000|Overall Study|Terminated by Sponsor|5|||
131924955|NCT01011283|475010766|FG001|Overall Study|Terminated by Sponsor|5|||
131924956|NCT01011283|475010765|FG000|Overall Study|Other|2|||
131924957|NCT01011283|475010766|FG001|Overall Study|Other|2|||
131924958|NCT02346370|475010770|FG000|Overall Study|Not treated|1|||
131924959|NCT02346370|475010771|FG001|Overall Study|Not treated|0|||
131924960|NCT02346370|475010772|FG002|Overall Study|Not treated|0|||
131924961|NCT02346370|475010770|FG000|Overall Study|Withdrawal of consent|1|||
131924962|NCT02346370|475010771|FG001|Overall Study|Withdrawal of consent|0|||
131924963|NCT02346370|475010772|FG002|Overall Study|Withdrawal of consent|0|||
131924964|NCT02346370|475010770|FG000|Overall Study|Death|1|||
131924965|NCT02346370|475010771|FG001|Overall Study|Death|3|||
131924966|NCT02346370|475010772|FG002|Overall Study|Death|1|||
131924967|NCT02346370|475010770|FG000|Overall Study|Sponsor discontinued study|5|||
131924968|NCT02346370|475010771|FG001|Overall Study|Sponsor discontinued study|0|||
131924969|NCT02346370|475010772|FG002|Overall Study|Sponsor discontinued study|2|||
131924970|NCT02346370|475010770|FG000|Overall Study|Radiologic progression|0|||
131924971|NCT02346370|475010771|FG001|Overall Study|Radiologic progression|0|||
131924972|NCT02346370|475010772|FG002|Overall Study|Radiologic progression|1|||
131924973|NCT02346370|475010770|FG000|Overall Study|Physician Decision|0|||
131924974|NCT02346370|475010771|FG001|Overall Study|Physician Decision|1|||
131924975|NCT02346370|475010772|FG002|Overall Study|Physician Decision|0|||
131924976|NCT01399099|475010773|FG000|Overall Study|Lost to Follow-up|14|||
131924977|NCT01399099|475010773|FG000|Overall Study|Physician Decision|1|||
131924978|NCT01399099|475010773|FG000|Overall Study|Protocol Violation|1|||
131924979|NCT01399099|475010773|FG000|Overall Study|Skin Irritation|13|||
131924980|NCT01399099|475010773|FG000|Overall Study|Infection|1|||
131924981|NCT01399099|475010773|FG000|Overall Study|Miscellaneous|4|||
131924982|NCT01668537|475010775|FG000|Overall Study|Request to Discontinue Prematurely|1|||
131924983|NCT01668537|475010776|FG001|Overall Study|Request to Discontinue Prematurely|1|||
131924984|NCT01668537|475010775|FG000|Overall Study|Subject unwilling/unable to comply|5|||
131924985|NCT01668537|475010776|FG001|Overall Study|Subject unwilling/unable to comply|0|||
131924986|NCT01668537|475010775|FG000|Overall Study|Reason Precludes Participation|1|||
131924987|NCT01668537|475010776|FG001|Overall Study|Reason Precludes Participation|0|||
131924988|NCT01668537|475010775|FG000|Overall Study|Lost to Follow-up|13|||
131924989|NCT01668537|475010776|FG001|Overall Study|Lost to Follow-up|6|||
131924990|NCT01668537|475010775|FG000|Overall Study|Other|2|||
131924991|NCT01668537|475010776|FG001|Overall Study|Other|3|||
131924992|NCT05064800|475010777|FG000|Period 3|Withdrawal by Subject|0|||
131924993|NCT05064800|475010778|FG001|Period 3|Withdrawal by Subject|0|||
131924994|NCT05064800|475010779|FG002|Period 3|Withdrawal by Subject|0|||
131924995|NCT05064800|475010780|FG003|Period 3|Withdrawal by Subject|0|||
131924996|NCT05064800|475010781|FG004|Period 3|Withdrawal by Subject|1|||
131924997|NCT05064800|475010782|FG005|Period 3|Withdrawal by Subject|0|||
131924998|NCT03364686|475010783|FG000|Overall Study|Physician Decision|2|||
131924999|NCT01210443|475010787|FG000|Overall Study|Study terminated by sponsor|2|||
131925000|NCT02807181|475010790|FG000|Overall Study|Death|28|||
131925001|NCT02807181|475010791|FG001|Overall Study|Death|24|||
131925002|NCT02807181|475010790|FG000|Overall Study|Withdrawal by Subject|1|||
131925003|NCT02807181|475010791|FG001|Overall Study|Withdrawal by Subject|1|||
131925004|NCT02807181|475010790|FG000|Overall Study|Lost to Follow-up|0|||
131925005|NCT02807181|475010791|FG001|Overall Study|Lost to Follow-up|2|||
131925006|NCT02807181|475010790|FG000|Overall Study|Subject decision|1|||
131925007|NCT02807181|475010791|FG001|Overall Study|Subject decision|0|||
131925008|NCT02807181|475010790|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
131925009|NCT02807181|475010791|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
131925010|NCT02807181|475010790|FG000|Overall Study|In Study|3|||
131925011|NCT02807181|475010791|FG001|Overall Study|In Study|3|||
131925012|NCT02807181|475010790|FG000|Overall Study|Post Progression|3|||
131925013|NCT02807181|475010791|FG001|Overall Study|Post Progression|2|||
131925014|NCT00063999|475010792|FG000|Overall Study|Withdrawal by Subject|1|||
131925015|NCT00063999|475010793|FG001|Overall Study|Withdrawal by Subject|0|||
131925016|NCT00063999|475010792|FG000|Overall Study|Ineligible|44|||
131925017|NCT00063999|475010793|FG001|Overall Study|Ineligible|24|||
131925018|NCT01078545|475010794|FG000|Overall Study|Lost to Follow-up|13|||
131925019|NCT01078545|475010794|FG000|Overall Study|Physician Decision|6|||
131925020|NCT01078545|475010794|FG000|Overall Study|Withdrawal by Subject|3|||
131925021|NCT01078545|475010794|FG000|Overall Study|Death|3|||
131925022|NCT01078545|475010794|FG000|Overall Study|Participant moved to another physician|1|||
131925023|NCT03767894|475010795|FG000|Overall Study|Withdrawal by Subject|1|||
131925024|NCT04243837|475010799|FG000|Overall Study|Adverse Event|2|||
131925025|NCT04243837|475010800|FG001|Overall Study|Adverse Event|1|||
131925026|NCT04243837|475010799|FG000|Overall Study|Withdrawal by Subject|4|||
131925027|NCT04243837|475010800|FG001|Overall Study|Withdrawal by Subject|2|||
131925028|NCT04243837|475010799|FG000|Overall Study|Covid-19 lock down|1|||
131925029|NCT04243837|475010800|FG001|Overall Study|Covid-19 lock down|0|||
131925030|NCT04243837|475010799|FG000|Overall Study|Study Terminated by Sponsor|11|||
131880565|NCT01880086|474843805|FG000|Overall Study|Lost to Follow-up|1|||
131880566|NCT01880086|474843806|FG001|Overall Study|Lost to Follow-up|1|||
131880567|NCT04021121|474843813|FG000|Overall Study|Death|3|||
131880568|NCT04021121|474843814|FG001|Overall Study|Death|3|||
131880569|NCT04021121|474843815|FG002|Overall Study|Death|5|||
131880570|NCT04021121|474843816|FG003|Overall Study|Death|4|||
131880571|NCT02288091|474843817|FG000|Overall Study|Lost to Follow-up|1|||
131880572|NCT02288091|474843817|FG000|Overall Study|Screen fail|7|||
131880573|NCT05174949|474843821|FG000|Overall Study|Physician Decision|1|||
131880574|NCT05174949|474843822|FG001|Overall Study|Physician Decision|2|||
131880575|NCT05174949|474843823|FG002|Overall Study|Physician Decision|0|||
131880576|NCT05174949|474843824|FG003|Overall Study|Physician Decision|1|||
131880577|NCT05174949|474843825|FG004|Overall Study|Physician Decision|0|||
131880578|NCT05174949|474843826|FG005|Overall Study|Physician Decision|0|||
131880579|NCT05174949|474843821|FG000|Overall Study|Withdrawal by Subject|0|||
131880580|NCT05174949|474843822|FG001|Overall Study|Withdrawal by Subject|1|||
131925031|NCT04243837|475010800|FG001|Overall Study|Study Terminated by Sponsor|12|||
131925032|NCT02280499|475010804|FG000|Overall Study|Death|14|||
131925033|NCT02280499|475010804|FG000|Overall Study|Lost to Follow-up|42|||
131925034|NCT02280499|475010804|FG000|Overall Study|Adverse Event|5|||
131925035|NCT01436500|475010805|FG000|Overall Study|Death|1|||
131925036|NCT01436500|475010806|FG001|Overall Study|Death|0|||
131925037|NCT01436500|475010807|FG002|Overall Study|Death|0|||
131925038|NCT01436500|475010808|FG003|Overall Study|Death|0|||
131925039|NCT01436500|475010809|FG004|Overall Study|Death|0|||
131925040|NCT01436500|475010805|FG000|Overall Study|Adverse Event|0|||
131925041|NCT01436500|475010806|FG001|Overall Study|Adverse Event|2|||
131925042|NCT01436500|475010807|FG002|Overall Study|Adverse Event|2|||
131925043|NCT01436500|475010808|FG003|Overall Study|Adverse Event|0|||
131925044|NCT01436500|475010809|FG004|Overall Study|Adverse Event|1|||
131925045|NCT01436500|475010805|FG000|Overall Study|Withdrawal by Subject|0|||
131925046|NCT01436500|475010806|FG001|Overall Study|Withdrawal by Subject|0|||
131925047|NCT01436500|475010807|FG002|Overall Study|Withdrawal by Subject|2|||
131925048|NCT01436500|475010808|FG003|Overall Study|Withdrawal by Subject|0|||
131925049|NCT01436500|475010809|FG004|Overall Study|Withdrawal by Subject|2|||
131925050|NCT01436500|475010805|FG000|Overall Study|Physician Decision|0|||
131925051|NCT01436500|475010806|FG001|Overall Study|Physician Decision|0|||
131409475|NCT05438602|473123158|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
131409476|NCT05438602|473123159|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
131409477|NCT05438602|473123157|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
131409478|NCT05438602|473123158|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
131409479|NCT05438602|473123159|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
131409480|NCT05438602|473123157|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
131409481|NCT05438602|473123158|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
131409482|NCT05438602|473123159|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
131409483|NCT05438602|473123157|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
131409484|NCT05438602|473123158|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
131409485|NCT05438602|473123159|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
131409486|NCT05438602|473123157|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
131409487|NCT05438602|473123158|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
131409488|NCT05438602|473123159|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
131409489|NCT05438602|473123157|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
131880581|NCT05174949|474843823|FG002|Overall Study|Withdrawal by Subject|0|||
131880582|NCT05174949|474843824|FG003|Overall Study|Withdrawal by Subject|0|||
131925052|NCT01436500|475010807|FG002|Overall Study|Physician Decision|1|||
131925053|NCT01436500|475010808|FG003|Overall Study|Physician Decision|0|||
131925054|NCT01436500|475010809|FG004|Overall Study|Physician Decision|0|||
131925055|NCT01436500|475010805|FG000|Overall Study|liver transplant|1|||
131925056|NCT01436500|475010806|FG001|Overall Study|liver transplant|0|||
131409490|NCT05438602|473123158|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
131409491|NCT05438602|473123159|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
131454043|NCT01032889|473291866|FG000|Overall Study|Lack of Submental Fat|2|||
131454044|NCT01032889|473291867|FG001|Overall Study|Lack of Submental Fat|8|||
131880583|NCT05174949|474843825|FG004|Overall Study|Withdrawal by Subject|0|||
131880584|NCT05174949|474843826|FG005|Overall Study|Withdrawal by Subject|0|||
131880585|NCT05174949|474843821|FG000|Overall Study|Lost to Follow-up|0|||
131925057|NCT01436500|475010807|FG002|Overall Study|liver transplant|0|||
131925058|NCT01436500|475010808|FG003|Overall Study|liver transplant|0|||
131925059|NCT01436500|475010809|FG004|Overall Study|liver transplant|0|||
131925060|NCT01436500|475010805|FG000|Overall Study|initiation of dialysis|0|||
131925061|NCT01436500|475010806|FG001|Overall Study|initiation of dialysis|0|||
131925062|NCT01436500|475010807|FG002|Overall Study|initiation of dialysis|0|||
131925063|NCT01436500|475010808|FG003|Overall Study|initiation of dialysis|0|||
131925064|NCT01436500|475010809|FG004|Overall Study|initiation of dialysis|1|||
131880586|NCT05174949|474843822|FG001|Overall Study|Lost to Follow-up|0|||
131925065|NCT01436500|475010805|FG000|Overall Study|discontinued study drug|1|||
131925066|NCT01436500|475010806|FG001|Overall Study|discontinued study drug|0|||
131880587|NCT05174949|474843823|FG002|Overall Study|Lost to Follow-up|0|||
131880588|NCT05174949|474843824|FG003|Overall Study|Lost to Follow-up|1|||
131880589|NCT05174949|474843825|FG004|Overall Study|Lost to Follow-up|0|||
131880590|NCT05174949|474843826|FG005|Overall Study|Lost to Follow-up|0|||
131880591|NCT02951533|474843827|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
131880592|NCT02951533|474843828|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
131880593|NCT02951533|474843829|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
131880594|NCT02951533|474843827|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
131880595|NCT02951533|474843828|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
131880596|NCT02951533|474843829|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
131880597|NCT02951533|474843827|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
131880598|NCT02951533|474843828|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
131880599|NCT02951533|474843829|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
131880600|NCT02951533|474843827|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
131880601|NCT02951533|474843828|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
131880602|NCT02951533|474843829|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
131880603|NCT02951533|474843827|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
131880604|NCT02951533|474843828|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
131880605|NCT02951533|474843829|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
131880606|NCT02951533|474843827|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
131880607|NCT02951533|474843828|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
131880608|NCT02951533|474843829|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
131880609|NCT02951533|474843827|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
131409492|NCT01930890|473123160|FG000|Overall Study|Study Termination|14|||
131409493|NCT01930890|473123161|FG001|Overall Study|Study Termination|28|||
131409494|NCT01930890|473123162|FG002|Overall Study|Study Termination|13|||
131409495|NCT01930890|473123163|FG003|Overall Study|Study Termination|25|||
131409496|NCT01930890|473123160|FG000|Overall Study|Death|0|||
131409497|NCT01930890|473123161|FG001|Overall Study|Death|0|||
131409498|NCT01930890|473123162|FG002|Overall Study|Death|0|||
131409499|NCT01930890|473123163|FG003|Overall Study|Death|1|||
131409500|NCT01930890|473123160|FG000|Overall Study|Investigator Decision|0|||
131409501|NCT01930890|473123161|FG001|Overall Study|Investigator Decision|1|||
131409502|NCT01930890|473123162|FG002|Overall Study|Investigator Decision|0|||
131409503|NCT01930890|473123163|FG003|Overall Study|Investigator Decision|0|||
131409504|NCT01930890|473123160|FG000|Overall Study|Consent Withdrawn|0|||
131409505|NCT01930890|473123161|FG001|Overall Study|Consent Withdrawn|3|||
131409506|NCT01930890|473123162|FG002|Overall Study|Consent Withdrawn|0|||
131409507|NCT01930890|473123163|FG003|Overall Study|Consent Withdrawn|1|||
131409508|NCT01930890|473123160|FG000|Overall Study|Adverse Event|0|||
131409509|NCT01930890|473123161|FG001|Overall Study|Adverse Event|1|||
131409510|NCT01930890|473123162|FG002|Overall Study|Adverse Event|0|||
131409511|NCT01930890|473123163|FG003|Overall Study|Adverse Event|0|||
131409512|NCT02091284|473123164|FG000|Overall Study|Withdrawal by Subject|2|||
131880610|NCT02951533|474843828|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
131880611|NCT02951533|474843829|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
131880612|NCT02951533|474843827|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
131880613|NCT02951533|474843828|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
131880614|NCT02951533|474843829|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
131880615|NCT02951533|474843827|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
131880616|NCT02951533|474843828|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
131880617|NCT02951533|474843829|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
131880618|NCT02951533|474843827|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
131880619|NCT02951533|474843828|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
131409513|NCT02091284|473123165|FG001|Overall Study|Withdrawal by Subject|1|||
131880620|NCT02951533|474843829|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
131880621|NCT02951533|474843827|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
131880622|NCT02951533|474843828|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
131880623|NCT02951533|474843829|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
131880624|NCT02029989|474843830|FG000|Overall Study|Withdrawal by Subject|1|||
131880625|NCT02029989|474843831|FG001|Overall Study|Withdrawal by Subject|0|||
131880626|NCT02029989|474843830|FG000|Overall Study|Withdrawal: Fear of needles|1|||
131880627|NCT02029989|474843831|FG001|Overall Study|Withdrawal: Fear of needles|0|||
131409514|NCT02091284|473123164|FG000|Overall Study|unreliable data|1|||
131409515|NCT02091284|473123165|FG001|Overall Study|unreliable data|0|||
131880628|NCT02029989|474843830|FG000|Overall Study|Change of location|2|||
131880629|NCT02029989|474843831|FG001|Overall Study|Change of location|3|||
131880630|NCT02029989|474843830|FG000|Overall Study|Physician Decision|2|||
131409516|NCT01278407|473123166|FG000|Confirmatory Phase|Adverse Event|5|||
131409517|NCT01278407|473123167|FG001|Confirmatory Phase|Adverse Event|10|||
131409518|NCT01278407|473123168|FG002|Confirmatory Phase|Adverse Event|1|||
131409519|NCT01278407|473123169|FG003|Confirmatory Phase|Adverse Event|0|||
131409520|NCT01278407|473123170|FG004|Confirmatory Phase|Adverse Event|0|||
131409521|NCT01278407|473123166|FG000|Confirmatory Phase|Participant's Choice|3|||
131409522|NCT01278407|473123167|FG001|Confirmatory Phase|Participant's Choice|5|||
131880631|NCT02029989|474843831|FG001|Overall Study|Physician Decision|0|||
131880632|NCT02029989|474843830|FG000|Overall Study|Lost to Follow-up|9|||
131880633|NCT02029989|474843831|FG001|Overall Study|Lost to Follow-up|7|||
131880634|NCT02029989|474843830|FG000|Overall Study|Death|0|||
131880635|NCT02029989|474843831|FG001|Overall Study|Death|1|||
131880636|NCT02029989|474843830|FG000|Overall Study|Protocol Violation|1|||
131880637|NCT02029989|474843831|FG001|Overall Study|Protocol Violation|0|||
131880638|NCT03099694|474843839|FG000|Overall Study|Withdrawal by Subject|11|||
131880639|NCT03099694|474843840|FG001|Overall Study|Withdrawal by Subject|13|||
131880640|NCT03099694|474843839|FG000|Overall Study|Lost to Follow-up|9|||
131880641|NCT03099694|474843840|FG001|Overall Study|Lost to Follow-up|5|||
131880642|NCT00471718|474843841|FG000|Overall Study|Adverse Event|3|||
131880643|NCT00471718|474843841|FG000|Overall Study|other complicating disease|1|||
131880644|NCT00471718|474843841|FG000|Overall Study|disease progression|22|||
131880645|NCT00471718|474843841|FG000|Overall Study|Withdrawal by Subject|1|||
131880646|NCT02880865|474843847|FG000|Overall Study|Adverse Event|1|||
131880647|NCT02880865|474843848|FG001|Overall Study|Adverse Event|0|||
131880648|NCT02880865|474843847|FG000|Overall Study|Withdrawal by Subject|0|||
131880649|NCT02880865|474843848|FG001|Overall Study|Withdrawal by Subject|2|||
131880650|NCT02880865|474843847|FG000|Overall Study|Physician Decision|0|||
131880651|NCT02880865|474843848|FG001|Overall Study|Physician Decision|1|||
131880652|NCT01446237|474843850|FG000|Overall Study|Adverse Event|1|||
131880653|NCT01446237|474843850|FG000|Overall Study|Lost to Follow-up|2|||
131880654|NCT01446237|474843850|FG000|Overall Study|Withdrawal by Subject|7|||
131880655|NCT01190267|474843853|FG000|Overall Study|Adverse Event|10|||
131880656|NCT01190267|474843854|FG001|Overall Study|Adverse Event|0|||
131880657|NCT01190267|474843853|FG000|Overall Study|Treatment Failure|8|||
131880658|NCT01190267|474843854|FG001|Overall Study|Treatment Failure|2|||
131880659|NCT01190267|474843853|FG000|Overall Study|Lost to Follow-up|2|||
131880660|NCT01190267|474843854|FG001|Overall Study|Lost to Follow-up|0|||
131880661|NCT01190267|474843853|FG000|Overall Study|Withdrawal by Subject|13|||
131880662|NCT01190267|474843854|FG001|Overall Study|Withdrawal by Subject|1|||
131880663|NCT01190267|474843853|FG000|Overall Study|Protocol Violation|8|||
131880664|NCT01190267|474843854|FG001|Overall Study|Protocol Violation|1|||
131880665|NCT03634033|474845621|FG000|Overall Study|Did not have a post-assessment|384|||
131880666|NCT03634033|474845622|FG001|Overall Study|Did not have a post-assessment|291|||
131880667|NCT03634033|474845623|FG002|Overall Study|Did not have a post-assessment|114|||
131880668|NCT03634033|474845624|FG003|Overall Study|Did not have a post-assessment|161|||
131880669|NCT03634033|474845625|FG004|Overall Study|Did not have a post-assessment|5|||
131880670|NCT03634033|474845626|FG005|Overall Study|Did not have a post-assessment|0|||
131880671|NCT03634033|474845627|FG006|Overall Study|Did not have a post-assessment|0|||
131880672|NCT03634033|474845621|FG000|Overall Study|Death|0|||
131880673|NCT03634033|474845622|FG001|Overall Study|Death|0|||
131880674|NCT03634033|474845623|FG002|Overall Study|Death|0|||
131880675|NCT03634033|474845624|FG003|Overall Study|Death|0|||
131880676|NCT03634033|474845625|FG004|Overall Study|Death|0|||
131880677|NCT03634033|474845626|FG005|Overall Study|Death|7|||
131880678|NCT03634033|474845627|FG006|Overall Study|Death|7|||
131880679|NCT03634033|474845621|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
131880680|NCT03634033|474845622|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
131880681|NCT03634033|474845623|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
131880682|NCT03634033|474845624|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
131880683|NCT03634033|474845625|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
131880684|NCT03634033|474845626|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
131880685|NCT03634033|474845627|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
131880686|NCT03634033|474845621|FG000|Overall Study|Lost to Follow-up|0|||
131880687|NCT03634033|474845622|FG001|Overall Study|Lost to Follow-up|0|||
131880688|NCT03634033|474845623|FG002|Overall Study|Lost to Follow-up|0|||
131880689|NCT03634033|474845624|FG003|Overall Study|Lost to Follow-up|0|||
131880690|NCT03634033|474845625|FG004|Overall Study|Lost to Follow-up|0|||
131880691|NCT03634033|474845626|FG005|Overall Study|Lost to Follow-up|1|||
131880692|NCT03634033|474845627|FG006|Overall Study|Lost to Follow-up|2|||
131409523|NCT01278407|473123168|FG002|Confirmatory Phase|Participant's Choice|3|||
131880693|NCT03634033|474845621|FG000|Overall Study|Withdrawal by Subject|0|||
131880694|NCT03634033|474845622|FG001|Overall Study|Withdrawal by Subject|0|||
131880695|NCT03634033|474845623|FG002|Overall Study|Withdrawal by Subject|0|||
131880696|NCT03634033|474845624|FG003|Overall Study|Withdrawal by Subject|0|||
131880697|NCT03634033|474845625|FG004|Overall Study|Withdrawal by Subject|0|||
131880698|NCT03634033|474845626|FG005|Overall Study|Withdrawal by Subject|0|||
131880699|NCT03634033|474845627|FG006|Overall Study|Withdrawal by Subject|1|||
131880700|NCT00743288|474845628|FG000|Overall Study|Adverse Event|1|||
131409524|NCT01278407|473123169|FG003|Confirmatory Phase|Participant's Choice|0|||
131880701|NCT00743288|474845629|FG001|Overall Study|Adverse Event|1|||
131880702|NCT00743288|474845630|FG002|Overall Study|Adverse Event|2|||
131880703|NCT00743288|474845631|FG003|Overall Study|Adverse Event|2|||
131880704|NCT00743288|474845632|FG004|Overall Study|Adverse Event|1|||
131925067|NCT01436500|475010807|FG002|Overall Study|discontinued study drug|0|||
131925068|NCT01436500|475010808|FG003|Overall Study|discontinued study drug|0|||
131925069|NCT01436500|475010809|FG004|Overall Study|discontinued study drug|0|||
131925070|NCT01436500|475010805|FG000|Overall Study|Other|0|||
131925071|NCT01436500|475010806|FG001|Overall Study|Other|1|||
131925072|NCT01436500|475010807|FG002|Overall Study|Other|0|||
131925073|NCT01436500|475010808|FG003|Overall Study|Other|1|||
131925074|NCT01436500|475010809|FG004|Overall Study|Other|0|||
131925075|NCT00977561|475010815|FG000|Overall Study|Death|3|||
131925076|NCT00977561|475010816|FG001|Overall Study|Death|2|||
131925077|NCT00977561|475010815|FG000|Overall Study|Study terminated|0|||
131925078|NCT00977561|475010816|FG001|Overall Study|Study terminated|2|||
131925079|NCT00977561|475010815|FG000|Overall Study|Other|2|||
131925080|NCT00977561|475010816|FG001|Overall Study|Other|0|||
131925081|NCT04689009|475010821|FG000|Overall Study|Adverse Event|1|||
131925082|NCT04689009|475010822|FG001|Overall Study|Adverse Event|0|||
131925083|NCT04689009|475010821|FG000|Overall Study|Lost to Follow-up|1|||
131409525|NCT01278407|473123170|FG004|Confirmatory Phase|Participant's Choice|0|||
131880705|NCT00743288|474845633|FG005|Overall Study|Adverse Event|1|||
131880706|NCT00743288|474845634|FG006|Overall Study|Adverse Event|2|||
131880707|NCT00743288|474845628|FG000|Overall Study|Withdrawal by Subject|0|||
131880708|NCT00743288|474845629|FG001|Overall Study|Withdrawal by Subject|0|||
131880709|NCT00743288|474845630|FG002|Overall Study|Withdrawal by Subject|1|||
131880710|NCT00743288|474845631|FG003|Overall Study|Withdrawal by Subject|0|||
131880711|NCT00743288|474845632|FG004|Overall Study|Withdrawal by Subject|0|||
131880712|NCT00743288|474845633|FG005|Overall Study|Withdrawal by Subject|1|||
131880713|NCT00743288|474845634|FG006|Overall Study|Withdrawal by Subject|1|||
131880714|NCT00743288|474845628|FG000|Overall Study|Progressive disease (PD)|2|||
131880715|NCT00743288|474845629|FG001|Overall Study|Progressive disease (PD)|0|||
131880716|NCT00743288|474845630|FG002|Overall Study|Progressive disease (PD)|1|||
131880717|NCT00743288|474845631|FG003|Overall Study|Progressive disease (PD)|4|||
131880718|NCT00743288|474845632|FG004|Overall Study|Progressive disease (PD)|5|||
131880719|NCT00743288|474845633|FG005|Overall Study|Progressive disease (PD)|3|||
131880720|NCT00743288|474845634|FG006|Overall Study|Progressive disease (PD)|6|||
131880721|NCT00743288|474845628|FG000|Overall Study|Worsening of condition (Not PD)|0|||
131880722|NCT00743288|474845629|FG001|Overall Study|Worsening of condition (Not PD)|2|||
131880723|NCT00743288|474845630|FG002|Overall Study|Worsening of condition (Not PD)|1|||
131880724|NCT00743288|474845631|FG003|Overall Study|Worsening of condition (Not PD)|1|||
131880725|NCT00743288|474845632|FG004|Overall Study|Worsening of condition (Not PD)|0|||
131880726|NCT00743288|474845633|FG005|Overall Study|Worsening of condition (Not PD)|0|||
131880727|NCT00743288|474845634|FG006|Overall Study|Worsening of condition (Not PD)|0|||
131880728|NCT05903924|474845635|FG000|Overall Study|Lost to Follow-up|1|||
131880729|NCT05903924|474845636|FG001|Overall Study|Lost to Follow-up|0|||
131880730|NCT05903924|474845637|FG002|Overall Study|Lost to Follow-up|0|||
131880731|NCT02677038|474845641|FG000|Overall Study|Physician Decision|1|||
131880732|NCT02677038|474845641|FG000|Overall Study|Withdrawal by Subject|1|||
131880733|NCT03671564|474845643|FG000|Overall Study|Progressive Disease|3|||
131880734|NCT03671564|474845644|FG001|Overall Study|Progressive Disease|5|||
131880735|NCT03671564|474845645|FG002|Overall Study|Progressive Disease|3|||
131880736|NCT03671564|474845643|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
131880737|NCT03671564|474845644|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
131880738|NCT03671564|474845645|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
131880739|NCT03671564|474845643|FG000|Overall Study|Withdrawal by Subject|1|||
131880740|NCT03671564|474845644|FG001|Overall Study|Withdrawal by Subject|1|||
131880741|NCT03671564|474845645|FG002|Overall Study|Withdrawal by Subject|0|||
131880742|NCT00725608|474845646|FG000|Overall Study|Lost to Follow-up|60|||
131880743|NCT00725608|474845646|FG000|Overall Study|Adverse Event|14|||
131880744|NCT00725608|474845646|FG000|Overall Study|Individual reasons|86|||
131925084|NCT04689009|475010822|FG001|Overall Study|Lost to Follow-up|2|||
131925085|NCT04689009|475010821|FG000|Overall Study|Withdrawal by Subject|4|||
131925086|NCT04689009|475010822|FG001|Overall Study|Withdrawal by Subject|3|||
131925087|NCT04689009|475010821|FG000|Overall Study|Protocol Violation|1|||
131409526|NCT01278407|473123166|FG000|Confirmatory Phase|Other|1|||
131925088|NCT04689009|475010822|FG001|Overall Study|Protocol Violation|0|||
131409527|NCT01278407|473123167|FG001|Confirmatory Phase|Other|1|||
131880745|NCT00725608|474845646|FG000|Overall Study|Other|7|||
131880746|NCT00380081|474845647|FG000|Overall Study|Withdrawal by Subject|0|||
131880747|NCT00380081|474845648|FG001|Overall Study|Withdrawal by Subject|0|||
131880748|NCT00380081|474845649|FG002|Overall Study|Withdrawal by Subject|0|||
131880749|NCT00380081|474845650|FG003|Overall Study|Withdrawal by Subject|0|||
131880750|NCT00380081|474845651|FG004|Overall Study|Withdrawal by Subject|1|||
131880751|NCT00380081|474845652|FG005|Overall Study|Withdrawal by Subject|0|||
131880752|NCT00380081|474845647|FG000|Overall Study|Family Emergency|0|||
131880753|NCT00380081|474845648|FG001|Overall Study|Family Emergency|0|||
131925089|NCT02187055|475010823|FG000|Overall Study|Lack of Efficacy|10|||
131925090|NCT02187055|475010824|FG001|Overall Study|Lack of Efficacy|3|||
131925091|NCT02187055|475010825|FG002|Overall Study|Lack of Efficacy|7|||
131925092|NCT02187055|475010823|FG000|Overall Study|Lost to Follow-up|2|||
131925093|NCT02187055|475010824|FG001|Overall Study|Lost to Follow-up|7|||
131925094|NCT02187055|475010825|FG002|Overall Study|Lost to Follow-up|3|||
131925095|NCT02187055|475010823|FG000|Overall Study|No longer meets eligibility criteria|0|||
131925096|NCT02187055|475010824|FG001|Overall Study|No longer meets eligibility criteria|2|||
131925097|NCT02187055|475010825|FG002|Overall Study|No longer meets eligibility criteria|0|||
131925098|NCT02187055|475010823|FG000|Overall Study|No longer willing to participate|6|||
131925099|NCT02187055|475010824|FG001|Overall Study|No longer willing to participate|8|||
131925100|NCT02187055|475010825|FG002|Overall Study|No longer willing to participate|10|||
131925101|NCT02187055|475010823|FG000|Overall Study|Other|5|||
131925102|NCT02187055|475010824|FG001|Overall Study|Other|6|||
131925103|NCT02187055|475010825|FG002|Overall Study|Other|3|||
131925104|NCT02187055|475010823|FG000|Overall Study|Protocol Violation|9|||
131925105|NCT02187055|475010824|FG001|Overall Study|Protocol Violation|9|||
131925106|NCT02187055|475010825|FG002|Overall Study|Protocol Violation|4|||
131925107|NCT02187055|475010823|FG000|Overall Study|Pregnancy|3|||
131925108|NCT02187055|475010824|FG001|Overall Study|Pregnancy|1|||
131925109|NCT02187055|475010825|FG002|Overall Study|Pregnancy|0|||
131925110|NCT02187055|475010823|FG000|Overall Study|Withdrawal by Subject|11|||
131925111|NCT02187055|475010824|FG001|Overall Study|Withdrawal by Subject|11|||
131925112|NCT02187055|475010825|FG002|Overall Study|Withdrawal by Subject|11|||
131925113|NCT02187055|475010823|FG000|Overall Study|Adverse Event|21|||
131925114|NCT02187055|475010824|FG001|Overall Study|Adverse Event|26|||
131925115|NCT02187055|475010825|FG002|Overall Study|Adverse Event|36|||
131925116|NCT02187055|475010823|FG000|Overall Study|Death|2|||
131925117|NCT02187055|475010824|FG001|Overall Study|Death|0|||
131925118|NCT02187055|475010825|FG002|Overall Study|Death|0|||
131925119|NCT05737745|475010826|FG000|Overall Study|Withdrawal by Subject|0|||
131925120|NCT05737745|475010827|FG001|Overall Study|Withdrawal by Subject|6|||
131925121|NCT05737745|475010828|FG002|Overall Study|Withdrawal by Subject|1|||
131925122|NCT00165698|475010829|FG000|Overall Study|Adverse Event|2|||
131925123|NCT00165698|475010830|FG001|Overall Study|Adverse Event|10|||
131925124|NCT00165698|475010829|FG000|Overall Study|Lost to Follow-up|2|||
131925125|NCT00165698|475010830|FG001|Overall Study|Lost to Follow-up|2|||
131925126|NCT00165698|475010829|FG000|Overall Study|Withdrawal by Subject|2|||
131925127|NCT00165698|475010830|FG001|Overall Study|Withdrawal by Subject|1|||
131925128|NCT00165698|475010829|FG000|Overall Study|Protocol Violation|1|||
131925129|NCT00165698|475010830|FG001|Overall Study|Protocol Violation|0|||
131925130|NCT00165698|475010829|FG000|Overall Study|Not Taken/Lost the medicine|1|||
131925131|NCT00165698|475010830|FG001|Overall Study|Not Taken/Lost the medicine|2|||
131925132|NCT03679884|475010831|FG000|Overall Study|Other|12|||
131925133|NCT03679884|475010832|FG001|Overall Study|Other|12|||
131925134|NCT03679884|475010833|FG002|Overall Study|Other|12|||
131925135|NCT03679884|475010834|FG003|Overall Study|Other|7|||
131925136|NCT03679884|475010835|FG004|Overall Study|Other|8|||
131925137|NCT03679884|475010831|FG000|Overall Study|Lack of Efficacy|15|||
131925138|NCT03679884|475010832|FG001|Overall Study|Lack of Efficacy|29|||
131925139|NCT03679884|475010833|FG002|Overall Study|Lack of Efficacy|13|||
131925140|NCT03679884|475010834|FG003|Overall Study|Lack of Efficacy|29|||
131925141|NCT03679884|475010835|FG004|Overall Study|Lack of Efficacy|10|||
131925142|NCT03679884|475010831|FG000|Overall Study|Death|1|||
131925143|NCT03679884|475010832|FG001|Overall Study|Death|0|||
131925144|NCT03679884|475010833|FG002|Overall Study|Death|0|||
131925145|NCT03679884|475010834|FG003|Overall Study|Death|0|||
131925146|NCT03679884|475010835|FG004|Overall Study|Death|0|||
131925147|NCT03679884|475010831|FG000|Overall Study|Adverse Event|2|||
131925148|NCT03679884|475010832|FG001|Overall Study|Adverse Event|10|||
131925149|NCT03679884|475010833|FG002|Overall Study|Adverse Event|9|||
131925150|NCT03679884|475010834|FG003|Overall Study|Adverse Event|6|||
131409528|NCT01278407|473123168|FG002|Confirmatory Phase|Other|2|||
131409529|NCT01278407|473123169|FG003|Confirmatory Phase|Other|0|||
131925151|NCT03679884|475010835|FG004|Overall Study|Adverse Event|6|||
131925152|NCT03679884|475010831|FG000|Overall Study|Withdrawal by Subject|12|||
131925153|NCT03679884|475010832|FG001|Overall Study|Withdrawal by Subject|23|||
131925154|NCT03679884|475010833|FG002|Overall Study|Withdrawal by Subject|8|||
131925155|NCT03679884|475010834|FG003|Overall Study|Withdrawal by Subject|8|||
131925156|NCT03679884|475010835|FG004|Overall Study|Withdrawal by Subject|9|||
131925157|NCT03679884|475010831|FG000|Overall Study|Lost to Follow-up|1|||
131925158|NCT03679884|475010832|FG001|Overall Study|Lost to Follow-up|4|||
131409530|NCT01278407|473123170|FG004|Confirmatory Phase|Other|0|||
131409531|NCT01278407|473123166|FG000|Extension Phase|Adverse Event|0|||
131925159|NCT03679884|475010833|FG002|Overall Study|Lost to Follow-up|2|||
131925160|NCT03679884|475010834|FG003|Overall Study|Lost to Follow-up|0|||
131925161|NCT03679884|475010835|FG004|Overall Study|Lost to Follow-up|3|||
131925162|NCT01107457|475010836|FG000|Part A|Adverse Event|1|||
131925163|NCT01107457|475010837|FG001|Part A|Adverse Event|2|||
131925164|NCT01107457|475010838|FG002|Part A|Adverse Event|1|||
131925165|NCT01107457|475010839|FG003|Part A|Adverse Event|0|||
131925166|NCT01107457|475010840|FG004|Part A|Adverse Event|0|||
131925167|NCT01107457|475010841|FG005|Part A|Adverse Event|0|||
131925168|NCT01107457|475010836|FG000|Part A|Withdrawal by Subject|3|||
131880754|NCT00380081|474845649|FG002|Overall Study|Family Emergency|0|||
131880755|NCT00380081|474845650|FG003|Overall Study|Family Emergency|0|||
131880756|NCT00380081|474845651|FG004|Overall Study|Family Emergency|0|||
131880757|NCT00380081|474845652|FG005|Overall Study|Family Emergency|1|||
131880758|NCT00535847|474845653|FG000|Overall Study|Adverse Event|5|||
131880759|NCT00535847|474845654|FG001|Overall Study|Adverse Event|3|||
131880760|NCT00535847|474845655|FG002|Overall Study|Adverse Event|2|||
131880761|NCT00535847|474845653|FG000|Overall Study|Non compliance|1|||
131880762|NCT00535847|474845654|FG001|Overall Study|Non compliance|1|||
131880763|NCT00535847|474845655|FG002|Overall Study|Non compliance|0|||
131880764|NCT00535847|474845653|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
131880765|NCT00535847|474845654|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
131880766|NCT00535847|474845655|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
131880767|NCT05007041|474845656|FG000|Overall Study|Missing Diary Entries|0|||
131880768|NCT05007041|474845657|FG001|Overall Study|Missing Diary Entries|1|||
131880769|NCT01546168|474845660|FG000|Overall Study|Lost to Follow-up|1|||
131880770|NCT01546168|474845661|FG001|Overall Study|Lost to Follow-up|0|||
131880771|NCT01546168|474845660|FG000|Overall Study|Withdrawal by Subject|1|||
131880772|NCT01546168|474845661|FG001|Overall Study|Withdrawal by Subject|0|||
131880773|NCT01546168|474845660|FG000|Overall Study|ineligible after signing consent|2|||
131880774|NCT01546168|474845661|FG001|Overall Study|ineligible after signing consent|0|||
131880775|NCT02850016|474845662|FG000|Overall Study|Withdrawal by Subject|1|||
131880776|NCT02850016|474845663|FG001|Overall Study|Withdrawal by Subject|2|||
131880777|NCT02954653|474845664|FG000|Overall Study|Death|3|||
131880778|NCT02954653|474845665|FG001|Overall Study|Death|1|||
131880779|NCT02954653|474845666|FG002|Overall Study|Death|0|||
131880780|NCT02954653|474845667|FG003|Overall Study|Death|0|||
131880781|NCT02954653|474845668|FG004|Overall Study|Death|0|||
131880782|NCT02954653|474845669|FG005|Overall Study|Death|0|||
131880783|NCT02954653|474845670|FG006|Overall Study|Death|0|||
131880784|NCT02954653|474845671|FG007|Overall Study|Death|0|||
131880785|NCT02954653|474845672|FG008|Overall Study|Death|0|||
131880786|NCT02954653|474845664|FG000|Overall Study|Randomized but did not receive treatment|1|||
131880787|NCT02954653|474845665|FG001|Overall Study|Randomized but did not receive treatment|0|||
131880788|NCT02954653|474845666|FG002|Overall Study|Randomized but did not receive treatment|0|||
131880789|NCT02954653|474845667|FG003|Overall Study|Randomized but did not receive treatment|0|||
131880790|NCT02954653|474845668|FG004|Overall Study|Randomized but did not receive treatment|0|||
131880791|NCT02954653|474845669|FG005|Overall Study|Randomized but did not receive treatment|0|||
131880792|NCT02954653|474845670|FG006|Overall Study|Randomized but did not receive treatment|0|||
131880793|NCT02954653|474845671|FG007|Overall Study|Randomized but did not receive treatment|0|||
131880794|NCT02954653|474845672|FG008|Overall Study|Randomized but did not receive treatment|0|||
131880795|NCT02954653|474845664|FG000|Overall Study|Started another anti-cancer therapy|0|||
131880796|NCT02954653|474845665|FG001|Overall Study|Started another anti-cancer therapy|1|||
131880797|NCT02954653|474845666|FG002|Overall Study|Started another anti-cancer therapy|0|||
131880798|NCT02954653|474845667|FG003|Overall Study|Started another anti-cancer therapy|0|||
131880799|NCT02954653|474845668|FG004|Overall Study|Started another anti-cancer therapy|0|||
131880800|NCT02954653|474845669|FG005|Overall Study|Started another anti-cancer therapy|0|||
131880801|NCT02954653|474845670|FG006|Overall Study|Started another anti-cancer therapy|0|||
131880802|NCT02954653|474845671|FG007|Overall Study|Started another anti-cancer therapy|0|||
131880803|NCT02954653|474845672|FG008|Overall Study|Started another anti-cancer therapy|0|||
131880804|NCT02954653|474845664|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
131880805|NCT02954653|474845665|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
131880806|NCT02954653|474845666|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
131880807|NCT02954653|474845667|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
131880808|NCT02954653|474845668|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
131880809|NCT02954653|474845669|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
131880810|NCT02954653|474845670|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
131880811|NCT02954653|474845671|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
131880812|NCT02954653|474845672|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
131880813|NCT00070018|474845674|FG000|Overall Study|Adverse Event|2|||
131880814|NCT00070018|474845674|FG000|Overall Study|Lack of Efficacy|1|||
131880815|NCT00070018|474845674|FG000|Overall Study|Withdrawal by Subject|1|||
131880816|NCT00985959|474845681|FG000|Overall Study|Adverse Event|0|||
131880817|NCT00985959|474845682|FG001|Overall Study|Adverse Event|0|||
131880818|NCT00985959|474845683|FG002|Overall Study|Adverse Event|19|||
131880819|NCT00985959|474845681|FG000|Overall Study|Withdrawal by Subject|0|||
131880820|NCT00985959|474845682|FG001|Overall Study|Withdrawal by Subject|0|||
131880821|NCT00985959|474845683|FG002|Overall Study|Withdrawal by Subject|8|||
131880822|NCT00985959|474845681|FG000|Overall Study|Progressive disease|1|||
131880823|NCT00985959|474845682|FG001|Overall Study|Progressive disease|2|||
131925169|NCT01107457|475010837|FG001|Part A|Withdrawal by Subject|3|||
131409532|NCT01278407|473123167|FG001|Extension Phase|Adverse Event|0|||
131880824|NCT00985959|474845683|FG002|Overall Study|Progressive disease|8|||
131880825|NCT00985959|474845681|FG000|Overall Study|Unrecovered toxicity|0|||
131880826|NCT00985959|474845682|FG001|Overall Study|Unrecovered toxicity|0|||
131880827|NCT00985959|474845683|FG002|Overall Study|Unrecovered toxicity|7|||
131880828|NCT00985959|474845681|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
131880829|NCT00985959|474845682|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
131880830|NCT00985959|474845683|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
131880831|NCT00985959|474845681|FG000|Overall Study|Complete response observed over 2 cycles|0|||
131880832|NCT00985959|474845682|FG001|Overall Study|Complete response observed over 2 cycles|1|||
131880833|NCT00985959|474845683|FG002|Overall Study|Complete response observed over 2 cycles|4|||
131880834|NCT00985959|474845681|FG000|Overall Study|Other|0|||
131880835|NCT00985959|474845682|FG001|Overall Study|Other|0|||
131880836|NCT00985959|474845683|FG002|Overall Study|Other|11|||
131880837|NCT00844480|474845690|FG000|Overall Study|Withdrawal by Subject|2|||
131880838|NCT00844480|474845691|FG001|Overall Study|Withdrawal by Subject|3|||
131880839|NCT02858180|474845692|FG000|Overall Study|Lost to Follow-up|0|||
131880840|NCT02858180|474845693|FG001|Overall Study|Lost to Follow-up|2|||
131880841|NCT00979420|474845694|FG000|Overall Study|Adverse Event|1|||
131880842|NCT00979420|474845695|FG001|Overall Study|Adverse Event|0|||
131880843|NCT00979420|474845696|FG002|Overall Study|Adverse Event|0|||
131880844|NCT00979420|474845697|FG003|Overall Study|Adverse Event|0|||
131880845|NCT00979420|474845694|FG000|Overall Study|Lack of Efficacy|3|||
131880846|NCT00979420|474845695|FG001|Overall Study|Lack of Efficacy|0|||
131880847|NCT00979420|474845696|FG002|Overall Study|Lack of Efficacy|1|||
131880848|NCT00979420|474845697|FG003|Overall Study|Lack of Efficacy|1|||
131880849|NCT00979420|474845694|FG000|Overall Study|Other reasons not related to Viramune|3|||
131880850|NCT00979420|474845695|FG001|Overall Study|Other reasons not related to Viramune|0|||
131880851|NCT00979420|474845696|FG002|Overall Study|Other reasons not related to Viramune|0|||
131880852|NCT00979420|474845697|FG003|Overall Study|Other reasons not related to Viramune|1|||
131880853|NCT00526331|474845698|FG000|Overall Study|Sponsor Termination|55|||
131880854|NCT00574249|474845700|FG000|Overall Study|Adverse Event|6|||
131880855|NCT00574249|474845701|FG001|Overall Study|Adverse Event|18|||
131880856|NCT00574249|474845700|FG000|Overall Study|Lack of Efficacy|5|||
131880857|NCT00574249|474845701|FG001|Overall Study|Lack of Efficacy|3|||
131880858|NCT00574249|474845700|FG000|Overall Study|Lost to Follow-up|4|||
131880859|NCT00574249|474845701|FG001|Overall Study|Lost to Follow-up|3|||
131880860|NCT00574249|474845700|FG000|Overall Study|Protocol Violation|5|||
131880861|NCT00574249|474845701|FG001|Overall Study|Protocol Violation|2|||
131880862|NCT00574249|474845700|FG000|Overall Study|History of carcinoma|1|||
131880863|NCT00574249|474845701|FG001|Overall Study|History of carcinoma|0|||
131880864|NCT00574249|474845700|FG000|Overall Study|Withdrawal by Subject|3|||
131880865|NCT00574249|474845701|FG001|Overall Study|Withdrawal by Subject|0|||
131880866|NCT00574249|474845700|FG000|Overall Study|Physician Decision|1|||
131880867|NCT00574249|474845701|FG001|Overall Study|Physician Decision|0|||
131880868|NCT00574249|474845700|FG000|Overall Study|Pregnancy|1|||
131880869|NCT00574249|474845701|FG001|Overall Study|Pregnancy|0|||
131880870|NCT00574249|474845700|FG000|Overall Study|Excluded by company|0|||
131880871|NCT00574249|474845701|FG001|Overall Study|Excluded by company|1|||
131880872|NCT00574249|474845700|FG000|Overall Study|PPD test taken twice|0|||
131880873|NCT00574249|474845701|FG001|Overall Study|PPD test taken twice|1|||
131880874|NCT00347919|474845703|FG000|Overall Study|Lost to Follow-up|11|||
131880875|NCT00347919|474845704|FG001|Overall Study|Lost to Follow-up|13|||
131880876|NCT00347919|474845705|FG002|Overall Study|Lost to Follow-up|0|||
131880877|NCT00347919|474845703|FG000|Overall Study|Withdrawal by Subject|6|||
131880878|NCT00347919|474845704|FG001|Overall Study|Withdrawal by Subject|8|||
131880879|NCT00347919|474845705|FG002|Overall Study|Withdrawal by Subject|0|||
131880880|NCT00347919|474845703|FG000|Overall Study|Physician Decision|1|||
131880881|NCT00347919|474845704|FG001|Overall Study|Physician Decision|1|||
131880882|NCT00347919|474845705|FG002|Overall Study|Physician Decision|0|||
131880883|NCT00347919|474845703|FG000|Overall Study|Sponsor terminated study|15|||
131880884|NCT00347919|474845704|FG001|Overall Study|Sponsor terminated study|10|||
131880885|NCT00347919|474845705|FG002|Overall Study|Sponsor terminated study|16|||
131880886|NCT00347919|474845703|FG000|Overall Study|Death|35|||
131880887|NCT00347919|474845704|FG001|Overall Study|Death|42|||
131409533|NCT01278407|473123168|FG002|Extension Phase|Adverse Event|0|||
131880888|NCT00347919|474845705|FG002|Overall Study|Death|19|||
131880889|NCT00347919|474845703|FG000|Overall Study|Par. Started Other Treatment|1|||
131880890|NCT00347919|474845704|FG001|Overall Study|Par. Started Other Treatment|1|||
131880891|NCT00347919|474845705|FG002|Overall Study|Par. Started Other Treatment|1|||
131880892|NCT00347919|474845703|FG000|Overall Study|Missing|2|||
131880893|NCT00347919|474845704|FG001|Overall Study|Missing|1|||
131880894|NCT00347919|474845705|FG002|Overall Study|Missing|2|||
131880895|NCT04017832|474845717|FG000|Overall Study|Withdrawal by Subject|13|||
131880896|NCT04017832|474845718|FG001|Overall Study|Withdrawal by Subject|12|||
131880897|NCT04017832|474845719|FG002|Overall Study|Withdrawal by Subject|21|||
131880898|NCT04017832|474845720|FG003|Overall Study|Withdrawal by Subject|7|||
131880899|NCT04017832|474845717|FG000|Overall Study|Lost to Follow-up|0|||
131880900|NCT04017832|474845718|FG001|Overall Study|Lost to Follow-up|3|||
131880901|NCT04017832|474845719|FG002|Overall Study|Lost to Follow-up|3|||
131880902|NCT04017832|474845720|FG003|Overall Study|Lost to Follow-up|1|||
131409534|NCT01278407|473123169|FG003|Extension Phase|Adverse Event|7|||
131409535|NCT01278407|473123170|FG004|Extension Phase|Adverse Event|16|||
131409536|NCT01278407|473123166|FG000|Extension Phase|Participant's Choice|0|||
131409537|NCT01278407|473123167|FG001|Extension Phase|Participant's Choice|0|||
131409538|NCT01278407|473123168|FG002|Extension Phase|Participant's Choice|0|||
131409539|NCT01278407|473123169|FG003|Extension Phase|Participant's Choice|4|||
131409540|NCT01278407|473123170|FG004|Extension Phase|Participant's Choice|11|||
131409541|NCT01278407|473123166|FG000|Extension Phase|Other|0|||
131409542|NCT01278407|473123167|FG001|Extension Phase|Other|0|||
131409543|NCT01278407|473123168|FG002|Extension Phase|Other|0|||
131409544|NCT01278407|473123169|FG003|Extension Phase|Other|1|||
131409545|NCT01278407|473123170|FG004|Extension Phase|Other|3|||
131409546|NCT02534935|473123171|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
131409547|NCT02534935|473123172|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
131409548|NCT02534935|473123173|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
131409549|NCT02534935|473123171|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
131409550|NCT02534935|473123172|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
131409551|NCT02534935|473123173|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
131409552|NCT02534935|473123171|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
131409553|NCT02534935|473123172|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
131409554|NCT02534935|473123173|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
131409555|NCT02534935|473123171|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
131409556|NCT02534935|473123172|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
131409557|NCT02534935|473123173|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
131409558|NCT02534935|473123171|FG000|Stage 1: 24 Months|Adverse Event|0|||
131409559|NCT02534935|473123172|FG001|Stage 1: 24 Months|Adverse Event|2|||
131880903|NCT04017832|474845717|FG000|Overall Study|Physician Decision|1|||
131880904|NCT04017832|474845718|FG001|Overall Study|Physician Decision|1|||
131880905|NCT04017832|474845719|FG002|Overall Study|Physician Decision|1|||
131880906|NCT04017832|474845720|FG003|Overall Study|Physician Decision|1|||
131880907|NCT04017832|474845717|FG000|Overall Study|Death|2|||
131880908|NCT04017832|474845718|FG001|Overall Study|Death|2|||
131880909|NCT04017832|474845719|FG002|Overall Study|Death|1|||
131880910|NCT04017832|474845720|FG003|Overall Study|Death|0|||
131880911|NCT01382225|474845721|FG000|Overall Study|Adverse Event|3|||
131880912|NCT01382225|474845722|FG001|Overall Study|Adverse Event|2|||
131880913|NCT01382225|474845721|FG000|Overall Study|Protocol Violation|2|||
131880914|NCT01382225|474845722|FG001|Overall Study|Protocol Violation|1|||
131880915|NCT01382225|474845721|FG000|Overall Study|Subject Withdrew Consent|5|||
131880916|NCT01382225|474845722|FG001|Overall Study|Subject Withdrew Consent|2|||
131880917|NCT01382225|474845721|FG000|Overall Study|Other|4|||
131880918|NCT01382225|474845722|FG001|Overall Study|Other|2|||
131880919|NCT02294175|474845738|FG000|Overall Study|Withdrawal by Subject|1|||
131880920|NCT02294175|474845739|FG001|Overall Study|Withdrawal by Subject|2|||
131880921|NCT02294175|474845738|FG000|Overall Study|pt taking excluded medication|3|||
131880922|NCT02294175|474845739|FG001|Overall Study|pt taking excluded medication|1|||
131880923|NCT02294175|474845738|FG000|Overall Study|Protocol Violation|1|||
131880924|NCT02294175|474845739|FG001|Overall Study|Protocol Violation|0|||
131880925|NCT02294175|474845738|FG000|Overall Study|Lost to Follow-up|0|||
131880926|NCT02294175|474845739|FG001|Overall Study|Lost to Follow-up|1|||
131880927|NCT02294175|474845738|FG000|Overall Study|wound healed|0|||
131880928|NCT02294175|474845739|FG001|Overall Study|wound healed|2|||
131880929|NCT02548351|474845740|FG000|Overall Study|Withdrawal by Subject|149|||
131880930|NCT02548351|474845741|FG001|Overall Study|Withdrawal by Subject|154|||
131880931|NCT02548351|474845742|FG002|Overall Study|Withdrawal by Subject|152|||
131880932|NCT02548351|474845740|FG000|Overall Study|Death|11|||
131880933|NCT02548351|474845741|FG001|Overall Study|Death|15|||
131880934|NCT02548351|474845742|FG002|Overall Study|Death|12|||
131880935|NCT02548351|474845740|FG000|Overall Study|Adverse Event|22|||
131880936|NCT02548351|474845741|FG001|Overall Study|Adverse Event|56|||
131880937|NCT02548351|474845742|FG002|Overall Study|Adverse Event|36|||
131880938|NCT02548351|474845740|FG000|Overall Study|Study Terminated by Sponsor|549|||
131880939|NCT02548351|474845741|FG001|Overall Study|Study Terminated by Sponsor|509|||
131880940|NCT02548351|474845742|FG002|Overall Study|Study Terminated by Sponsor|528|||
131409560|NCT02534935|473123173|FG002|Stage 1: 24 Months|Adverse Event|0|||
131409561|NCT02534935|473123171|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
131409562|NCT02534935|473123172|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
131409563|NCT02534935|473123173|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
131409564|NCT02534935|473123171|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
131409565|NCT02534935|473123172|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
131880941|NCT02548351|474845740|FG000|Overall Study|Site Closure|14|||
131880942|NCT02548351|474845741|FG001|Overall Study|Site Closure|5|||
131880943|NCT02548351|474845742|FG002|Overall Study|Site Closure|7|||
131409566|NCT02534935|473123173|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
131409567|NCT01460719|473123174|FG000|Overall Study|Adverse Event|1|||
131880944|NCT02548351|474845740|FG000|Overall Study|Non-compliance with Study Drug|4|||
131925170|NCT01107457|475010838|FG002|Part A|Withdrawal by Subject|0|||
131925171|NCT01107457|475010839|FG003|Part A|Withdrawal by Subject|3|||
131925172|NCT01107457|475010840|FG004|Part A|Withdrawal by Subject|1|||
131925173|NCT01107457|475010841|FG005|Part A|Withdrawal by Subject|0|||
131925174|NCT01107457|475010836|FG000|Part A|Lost to Follow-up|0|||
131925175|NCT01107457|475010837|FG001|Part A|Lost to Follow-up|1|||
131925176|NCT01107457|475010838|FG002|Part A|Lost to Follow-up|0|||
131925177|NCT01107457|475010839|FG003|Part A|Lost to Follow-up|0|||
131925178|NCT01107457|475010840|FG004|Part A|Lost to Follow-up|0|||
131925179|NCT01107457|475010841|FG005|Part A|Lost to Follow-up|0|||
131925180|NCT01107457|475010836|FG000|Part A|Lack of Efficacy|1|||
131925181|NCT01107457|475010837|FG001|Part A|Lack of Efficacy|0|||
131925182|NCT01107457|475010838|FG002|Part A|Lack of Efficacy|0|||
131925183|NCT01107457|475010839|FG003|Part A|Lack of Efficacy|0|||
131925184|NCT01107457|475010840|FG004|Part A|Lack of Efficacy|0|||
131925185|NCT01107457|475010841|FG005|Part A|Lack of Efficacy|0|||
131925186|NCT01107457|475010836|FG000|Part A|Protocol Violation|0|||
131925187|NCT01107457|475010837|FG001|Part A|Protocol Violation|1|||
131925188|NCT01107457|475010838|FG002|Part A|Protocol Violation|0|||
131925189|NCT01107457|475010839|FG003|Part A|Protocol Violation|0|||
131925190|NCT01107457|475010840|FG004|Part A|Protocol Violation|0|||
131925191|NCT01107457|475010841|FG005|Part A|Protocol Violation|0|||
131925192|NCT01107457|475010836|FG000|Part B and C|Adverse Event|0|||
131925193|NCT01107457|475010837|FG001|Part B and C|Adverse Event|0|||
131925194|NCT01107457|475010838|FG002|Part B and C|Adverse Event|0|||
131925195|NCT01107457|475010839|FG003|Part B and C|Adverse Event|0|||
131925196|NCT01107457|475010840|FG004|Part B and C|Adverse Event|0|||
131925197|NCT01107457|475010841|FG005|Part B and C|Adverse Event|12|||
131925198|NCT01107457|475010836|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
131925199|NCT01107457|475010837|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
131925200|NCT01107457|475010838|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
131925201|NCT01107457|475010839|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
131925202|NCT01107457|475010840|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
131925203|NCT01107457|475010841|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
131925204|NCT01107457|475010836|FG000|Part B and C|Physician Decision|0|||
131925205|NCT01107457|475010837|FG001|Part B and C|Physician Decision|0|||
131925206|NCT01107457|475010838|FG002|Part B and C|Physician Decision|0|||
131925207|NCT01107457|475010839|FG003|Part B and C|Physician Decision|0|||
131925208|NCT01107457|475010840|FG004|Part B and C|Physician Decision|0|||
131925209|NCT01107457|475010841|FG005|Part B and C|Physician Decision|3|||
131925210|NCT01107457|475010836|FG000|Part B and C|Lack of Efficacy|0|||
131925211|NCT01107457|475010837|FG001|Part B and C|Lack of Efficacy|0|||
131925212|NCT01107457|475010838|FG002|Part B and C|Lack of Efficacy|0|||
131925213|NCT01107457|475010839|FG003|Part B and C|Lack of Efficacy|0|||
131925214|NCT01107457|475010840|FG004|Part B and C|Lack of Efficacy|0|||
131925215|NCT01107457|475010841|FG005|Part B and C|Lack of Efficacy|7|||
131925216|NCT01107457|475010836|FG000|Part B and C|Lost to Follow-up|0|||
131925217|NCT01107457|475010837|FG001|Part B and C|Lost to Follow-up|0|||
131925218|NCT01107457|475010838|FG002|Part B and C|Lost to Follow-up|0|||
131925219|NCT01107457|475010839|FG003|Part B and C|Lost to Follow-up|0|||
131925220|NCT01107457|475010840|FG004|Part B and C|Lost to Follow-up|0|||
131925221|NCT01107457|475010841|FG005|Part B and C|Lost to Follow-up|10|||
131925222|NCT01107457|475010836|FG000|Part B and C|Protocol Violation|0|||
131925223|NCT01107457|475010837|FG001|Part B and C|Protocol Violation|0|||
131925224|NCT01107457|475010838|FG002|Part B and C|Protocol Violation|0|||
131925225|NCT01107457|475010839|FG003|Part B and C|Protocol Violation|0|||
131925226|NCT01107457|475010840|FG004|Part B and C|Protocol Violation|0|||
131925227|NCT01107457|475010841|FG005|Part B and C|Protocol Violation|1|||
131925228|NCT01107457|475010836|FG000|Part B and C|Sponsor Decision|0|||
131925229|NCT01107457|475010837|FG001|Part B and C|Sponsor Decision|0|||
131925230|NCT01107457|475010838|FG002|Part B and C|Sponsor Decision|0|||
131925231|NCT01107457|475010839|FG003|Part B and C|Sponsor Decision|0|||
131925232|NCT01107457|475010840|FG004|Part B and C|Sponsor Decision|0|||
131925233|NCT01107457|475010841|FG005|Part B and C|Sponsor Decision|66|||
131925234|NCT01107457|475010836|FG000|Part B and C|Withdrawal by Subject|0|||
131925235|NCT01107457|475010837|FG001|Part B and C|Withdrawal by Subject|0|||
131925236|NCT01107457|475010838|FG002|Part B and C|Withdrawal by Subject|0|||
131925237|NCT01107457|475010839|FG003|Part B and C|Withdrawal by Subject|0|||
131925238|NCT01107457|475010840|FG004|Part B and C|Withdrawal by Subject|0|||
131925239|NCT01107457|475010841|FG005|Part B and C|Withdrawal by Subject|16|||
131925240|NCT01107457|475010836|FG000|Part B and C|Clinical Relapse|0|||
131925241|NCT01107457|475010837|FG001|Part B and C|Clinical Relapse|0|||
131925242|NCT01107457|475010838|FG002|Part B and C|Clinical Relapse|0|||
131925243|NCT01107457|475010839|FG003|Part B and C|Clinical Relapse|0|||
131925244|NCT01107457|475010840|FG004|Part B and C|Clinical Relapse|0|||
131925245|NCT01107457|475010841|FG005|Part B and C|Clinical Relapse|4|||
131925246|NCT02547935|475010842|FG000|Overall Study|Other|0|||
131925247|NCT02547935|475010843|FG001|Overall Study|Other|1|||
131925248|NCT02547935|475010844|FG002|Overall Study|Other|0|||
131925249|NCT02547935|475010842|FG000|Overall Study|Withdrawal by Subject|2|||
131925250|NCT02547935|475010843|FG001|Overall Study|Withdrawal by Subject|3|||
131925251|NCT02547935|475010844|FG002|Overall Study|Withdrawal by Subject|4|||
131409568|NCT01460719|473123174|FG000|Overall Study|Withdrawal by Subject|1|||
131880945|NCT02548351|474845741|FG001|Overall Study|Non-compliance with Study Drug|2|||
131880946|NCT02548351|474845742|FG002|Overall Study|Non-compliance with Study Drug|0|||
131880947|NCT02548351|474845740|FG000|Overall Study|Protocol Violation|2|||
131880948|NCT02548351|474845741|FG001|Overall Study|Protocol Violation|1|||
131880949|NCT02548351|474845742|FG002|Overall Study|Protocol Violation|2|||
131880950|NCT02548351|474845740|FG000|Overall Study|Physician Decision|11|||
131880951|NCT02548351|474845741|FG001|Overall Study|Physician Decision|18|||
131880952|NCT02548351|474845742|FG002|Overall Study|Physician Decision|11|||
131880953|NCT02548351|474845740|FG000|Overall Study|Lost to Follow-up|43|||
131880954|NCT02548351|474845741|FG001|Overall Study|Lost to Follow-up|50|||
131880955|NCT02548351|474845742|FG002|Overall Study|Lost to Follow-up|57|||
131880956|NCT02548351|474845740|FG000|Overall Study|Other|19|||
131880957|NCT02548351|474845741|FG001|Overall Study|Other|16|||
131880958|NCT02548351|474845742|FG002|Overall Study|Other|20|||
131880959|NCT02548351|474845740|FG000|Overall Study|Missing|1|||
131880960|NCT02548351|474845741|FG001|Overall Study|Missing|1|||
131880961|NCT02548351|474845742|FG002|Overall Study|Missing|0|||
131880962|NCT00125242|474845746|FG000|Overall Study|did not qualify|7|||
131880963|NCT00125242|474845747|FG001|Overall Study|did not qualify|2|||
131880964|NCT01664949|474845750|FG000|Overall Study|Adverse Event|11|||
131880965|NCT01664949|474845751|FG001|Overall Study|Adverse Event|12|||
131880966|NCT01664949|474845750|FG000|Overall Study|Lack of Efficacy|1|||
131880967|NCT01664949|474845751|FG001|Overall Study|Lack of Efficacy|1|||
131880968|NCT01664949|474845750|FG000|Overall Study|Lost to Follow-up|1|||
131880969|NCT01664949|474845751|FG001|Overall Study|Lost to Follow-up|2|||
131880970|NCT01664949|474845750|FG000|Overall Study|Personal Reasons|3|||
131880971|NCT01664949|474845751|FG001|Overall Study|Personal Reasons|4|||
131880972|NCT01664949|474845750|FG000|Overall Study|Protocol Violation|5|||
131880973|NCT01664949|474845751|FG001|Overall Study|Protocol Violation|5|||
131880974|NCT01664949|474845750|FG000|Overall Study|Other Miscellaneous Reasons|3|||
131880975|NCT01664949|474845751|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131880976|NCT03003494|474845753|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
131880977|NCT05238025|474845756|FG000|Overall Study|Adverse Event|2|||
131880978|NCT05238025|474845757|FG001|Overall Study|Adverse Event|2|||
131880979|NCT05238025|474845756|FG000|Overall Study|Lost to Follow-up|334|||
131880980|NCT05238025|474845757|FG001|Overall Study|Lost to Follow-up|339|||
131880981|NCT05238025|474845756|FG000|Overall Study|Withdrawal by Subject|203|||
131880982|NCT05238025|474845757|FG001|Overall Study|Withdrawal by Subject|222|||
131880983|NCT05238025|474845756|FG000|Overall Study|Physician Decision|20|||
131880984|NCT05238025|474845757|FG001|Overall Study|Physician Decision|8|||
131880985|NCT05238025|474845756|FG000|Overall Study|Protocol Violation|6|||
131880986|NCT05238025|474845757|FG001|Overall Study|Protocol Violation|2|||
131880987|NCT05238025|474845756|FG000|Overall Study|Death|38|||
131880988|NCT05238025|474845757|FG001|Overall Study|Death|32|||
131880989|NCT05238025|474845756|FG000|Overall Study|Study terminated by Sponsor|6358|||
131880990|NCT05238025|474845757|FG001|Overall Study|Study terminated by Sponsor|6358|||
131880991|NCT05238025|474845756|FG000|Overall Study|Other Reason|669|||
131880992|NCT05238025|474845757|FG001|Overall Study|Other Reason|690|||
131880993|NCT01263782|474845759|FG000|Overall Study|Death|0|||
131880994|NCT01263782|474845760|FG001|Overall Study|Death|0|||
131880995|NCT01263782|474845761|FG002|Overall Study|Death|1|||
131880996|NCT01263782|474845762|FG003|Overall Study|Death|0|||
131880997|NCT01263782|474845759|FG000|Overall Study|Progressive disease|0|||
131880998|NCT01263782|474845760|FG001|Overall Study|Progressive disease|0|||
131880999|NCT01263782|474845761|FG002|Overall Study|Progressive disease|0|||
131881000|NCT01263782|474845762|FG003|Overall Study|Progressive disease|1|||
131881001|NCT01263782|474845759|FG000|Overall Study|Too early|0|||
131881002|NCT01263782|474845760|FG001|Overall Study|Too early|0|||
131881003|NCT01263782|474845761|FG002|Overall Study|Too early|1|||
131881004|NCT01263782|474845762|FG003|Overall Study|Too early|0|||
131881005|NCT01263782|474845759|FG000|Overall Study|Inevaluable|0|||
131881006|NCT01263782|474845760|FG001|Overall Study|Inevaluable|0|||
131881007|NCT01263782|474845761|FG002|Overall Study|Inevaluable|1|||
131881008|NCT01263782|474845762|FG003|Overall Study|Inevaluable|0|||
131409569|NCT00076336|473123184|FG000|Overall Study|Death|13|||
131881009|NCT04545567|474845763|FG000|Overall Study|tested positive for SARS-co-V2|1|||
131881010|NCT04545567|474845764|FG001|Overall Study|tested positive for SARS-co-V2|1|||
131881011|NCT04545567|474845763|FG000|Overall Study|Withdrawal by Subject|0|||
131881012|NCT04545567|474845764|FG001|Overall Study|Withdrawal by Subject|1|||
131881013|NCT00965341|474845765|FG000|Overall Study|Withdrew consent|1|||
131409570|NCT00076336|473123185|FG001|Overall Study|Death|17|||
131409571|NCT00076336|473123184|FG000|Overall Study|Adverse Event|4|||
131409572|NCT00076336|473123185|FG001|Overall Study|Adverse Event|4|||
131881014|NCT00965341|474845766|FG001|Overall Study|Withdrew consent|5|||
131881015|NCT00965341|474845765|FG000|Overall Study|Lost to Follow-up|1|||
131881016|NCT00965341|474845766|FG001|Overall Study|Lost to Follow-up|0|||
131881017|NCT00965341|474845765|FG000|Overall Study|Transportation issues|4|||
131881018|NCT00965341|474845766|FG001|Overall Study|Transportation issues|3|||
131881019|NCT00960986|474845772|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
131881020|NCT00960986|474845773|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
131881021|NCT00960986|474845774|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
131881022|NCT00960986|474845775|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
131881023|NCT00960986|474845772|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
131881024|NCT00960986|474845773|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
131881025|NCT00960986|474845774|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
131881026|NCT00960986|474845775|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
131881027|NCT00960986|474845772|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
131881028|NCT00960986|474845773|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
131881029|NCT00960986|474845774|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
131881030|NCT00960986|474845775|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
131881031|NCT00960986|474845772|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
131881032|NCT00960986|474845773|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
131881033|NCT00960986|474845774|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
131881034|NCT00960986|474845775|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
131881035|NCT00960986|474845772|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
131881036|NCT00960986|474845773|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
131881037|NCT00960986|474845774|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
131881038|NCT00960986|474845775|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
131881039|NCT00960986|474845772|FG000|Period 3 (7-week Therapy Period)|Death|0|||
131881040|NCT00960986|474845773|FG001|Period 3 (7-week Therapy Period)|Death|0|||
131881041|NCT00960986|474845774|FG002|Period 3 (7-week Therapy Period)|Death|1|||
131881042|NCT00960986|474845775|FG003|Period 3 (7-week Therapy Period)|Death|0|||
131881043|NCT00960986|474845772|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
131881044|NCT00960986|474845773|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
131881045|NCT00960986|474845774|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
131881046|NCT00960986|474845775|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
131881047|NCT00960986|474845772|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
131881048|NCT00960986|474845773|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
131881049|NCT00960986|474845774|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
131881050|NCT00960986|474845775|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
131881051|NCT00960986|474845772|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
131881052|NCT00960986|474845773|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
131881053|NCT00960986|474845774|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
131881054|NCT00960986|474845775|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
131881055|NCT00960986|474845772|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
131881056|NCT00960986|474845773|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
131881057|NCT00960986|474845774|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
131881058|NCT00960986|474845775|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
131881059|NCT01077739|474845776|FG000|Overall Study|Premature withdrawal|1|||
131881060|NCT01077739|474845777|FG001|Overall Study|Premature withdrawal|3|||
131881061|NCT01077739|474845776|FG000|Overall Study|Withdrawal by Subject|1|||
131881062|NCT01077739|474845777|FG001|Overall Study|Withdrawal by Subject|0|||
131881063|NCT01077739|474845776|FG000|Overall Study|Death|0|||
131881064|NCT01077739|474845777|FG001|Overall Study|Death|3|||
131881065|NCT01077739|474845776|FG000|Overall Study|Unacceptable toxicity|1|||
131881066|NCT01077739|474845777|FG001|Overall Study|Unacceptable toxicity|2|||
131881067|NCT01077739|474845776|FG000|Overall Study|Other|2|||
131881068|NCT01077739|474845777|FG001|Overall Study|Other|2|||
131881069|NCT00877071|474845778|FG000|Overall Study|disease progression|2|||
131925252|NCT02547935|475010842|FG000|Overall Study|Screen Failure|2|||
131925253|NCT02547935|475010843|FG001|Overall Study|Screen Failure|0|||
131925254|NCT02547935|475010844|FG002|Overall Study|Screen Failure|0|||
131925255|NCT02547935|475010842|FG000|Overall Study|Physician Decision|0|||
131925256|NCT02547935|475010843|FG001|Overall Study|Physician Decision|1|||
131925257|NCT02547935|475010844|FG002|Overall Study|Physician Decision|0|||
131925258|NCT02547935|475010842|FG000|Overall Study|Lost to Follow-up|0|||
131925259|NCT02547935|475010843|FG001|Overall Study|Lost to Follow-up|2|||
131925260|NCT02547935|475010844|FG002|Overall Study|Lost to Follow-up|1|||
131881070|NCT01984892|474845779|FG000|Overall Study|Progressive disease|7|||
131881071|NCT04464720|474845780|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
131881072|NCT00954512|474845787|FG000|Overall Study|Withdrawal by Subject|0|||
131925261|NCT02547935|475010842|FG000|Overall Study|Death|1|||
131925262|NCT02547935|475010843|FG001|Overall Study|Death|1|||
131409573|NCT00076336|473123184|FG000|Overall Study|Lost to Follow-up|4|||
131409574|NCT00076336|473123185|FG001|Overall Study|Lost to Follow-up|4|||
131409575|NCT00076336|473123184|FG000|Overall Study|Non-Compliance|2|||
131409576|NCT00076336|473123185|FG001|Overall Study|Non-Compliance|0|||
131881073|NCT00954512|474845788|FG001|Overall Study|Withdrawal by Subject|0|||
131881074|NCT00954512|474845789|FG002|Overall Study|Withdrawal by Subject|0|||
131925263|NCT02547935|475010844|FG002|Overall Study|Death|0|||
131925264|NCT00086307|475010845|FG000|Overall Study|Lack of Efficacy|1|||
131925265|NCT00086307|475010846|FG001|Overall Study|Lack of Efficacy|1|||
131925266|NCT00086307|475010847|FG002|Overall Study|Lack of Efficacy|2|||
131409577|NCT00076336|473123184|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
131409578|NCT00076336|473123185|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
131409579|NCT00076336|473123184|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
131409580|NCT00076336|473123185|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
131409581|NCT00076336|473123184|FG000|Overall Study|Liver Transplantation|3|||
131409582|NCT00076336|473123185|FG001|Overall Study|Liver Transplantation|3|||
131409583|NCT00076336|473123184|FG000|Overall Study|Virologic Breakthrough|14|||
131409584|NCT00076336|473123185|FG001|Overall Study|Virologic Breakthrough|16|||
131409585|NCT00076336|473123184|FG000|Overall Study|Treatment failure|4|||
131409586|NCT00076336|473123185|FG001|Overall Study|Treatment failure|5|||
131409587|NCT02838901|473123186|FG000|Overall Study|Withdrawal by Subject|1|||
131409588|NCT02838901|473123187|FG001|Overall Study|Withdrawal by Subject|1|||
131409589|NCT02838901|473123186|FG000|Overall Study|Lost to Follow-up|1|||
131409590|NCT02838901|473123187|FG001|Overall Study|Lost to Follow-up|1|||
131409591|NCT04431713|473123190|FG000|Overall Study|Withdrawal by Subject|2|||
131409592|NCT04431713|473123191|FG001|Overall Study|Withdrawal by Subject|0|||
131409593|NCT04431713|473123190|FG000|Overall Study|Death|2|||
131409594|NCT04431713|473123191|FG001|Overall Study|Death|2|||
131409595|NCT02285114|473123193|FG000|Main Phase|Investigator's Discretion|0|||
131409596|NCT02285114|473123194|FG001|Main Phase|Investigator's Discretion|2|||
131409597|NCT02285114|473123195|FG002|Main Phase|Investigator's Discretion|0|||
131409598|NCT02285114|473123196|FG003|Main Phase|Investigator's Discretion|0|||
131409599|NCT02285114|473123197|FG004|Main Phase|Investigator's Discretion|0|||
131409600|NCT02285114|473123198|FG005|Main Phase|Investigator's Discretion|0|||
131409601|NCT02285114|473123193|FG000|Main Phase|Enrolled but Never Treated|1|||
131409602|NCT02285114|473123194|FG001|Main Phase|Enrolled but Never Treated|0|||
131409603|NCT02285114|473123195|FG002|Main Phase|Enrolled but Never Treated|0|||
131409604|NCT02285114|473123196|FG003|Main Phase|Enrolled but Never Treated|0|||
131409605|NCT02285114|473123197|FG004|Main Phase|Enrolled but Never Treated|0|||
131409606|NCT02285114|473123198|FG005|Main Phase|Enrolled but Never Treated|0|||
131409607|NCT02285114|473123193|FG000|Main Phase|Withdrew Consent|0|||
131409608|NCT02285114|473123194|FG001|Main Phase|Withdrew Consent|0|||
131409609|NCT02285114|473123195|FG002|Main Phase|Withdrew Consent|1|||
131409610|NCT02285114|473123196|FG003|Main Phase|Withdrew Consent|0|||
131409611|NCT02285114|473123197|FG004|Main Phase|Withdrew Consent|0|||
131409612|NCT02285114|473123198|FG005|Main Phase|Withdrew Consent|0|||
131409613|NCT02285114|473123193|FG000|Extension Phase|Investigator's Discretion|0|||
131409614|NCT02285114|473123194|FG001|Extension Phase|Investigator's Discretion|0|||
131409615|NCT02285114|473123195|FG002|Extension Phase|Investigator's Discretion|0|||
131409616|NCT02285114|473123196|FG003|Extension Phase|Investigator's Discretion|14|||
131409617|NCT02285114|473123197|FG004|Extension Phase|Investigator's Discretion|1|||
131409618|NCT02285114|473123198|FG005|Extension Phase|Investigator's Discretion|0|||
131409619|NCT02285114|473123193|FG000|Extension Phase|Lost to Follow-up|0|||
131409620|NCT02285114|473123194|FG001|Extension Phase|Lost to Follow-up|0|||
131409621|NCT02285114|473123195|FG002|Extension Phase|Lost to Follow-up|0|||
131881075|NCT00954512|474845790|FG003|Overall Study|Withdrawal by Subject|0|||
131881076|NCT00954512|474845791|FG004|Overall Study|Withdrawal by Subject|0|||
131881077|NCT00954512|474845792|FG005|Overall Study|Withdrawal by Subject|1|||
131881078|NCT00954512|474845787|FG000|Overall Study|Adverse Event|0|||
131881079|NCT00954512|474845788|FG001|Overall Study|Adverse Event|0|||
131881080|NCT00954512|474845789|FG002|Overall Study|Adverse Event|0|||
131881081|NCT00954512|474845790|FG003|Overall Study|Adverse Event|0|||
131881082|NCT00954512|474845791|FG004|Overall Study|Adverse Event|1|||
131881083|NCT00954512|474845792|FG005|Overall Study|Adverse Event|2|||
131881084|NCT00954512|474845787|FG000|Overall Study|Physician Decision|0|||
131881085|NCT00954512|474845788|FG001|Overall Study|Physician Decision|1|||
131881086|NCT00954512|474845789|FG002|Overall Study|Physician Decision|0|||
131881087|NCT00954512|474845790|FG003|Overall Study|Physician Decision|1|||
131881088|NCT00954512|474845791|FG004|Overall Study|Physician Decision|0|||
131881089|NCT00954512|474845792|FG005|Overall Study|Physician Decision|0|||
131881090|NCT00954512|474845787|FG000|Overall Study|Symptomatic Deterioration|0|||
131409622|NCT02285114|473123196|FG003|Extension Phase|Lost to Follow-up|1|||
131409623|NCT02285114|473123197|FG004|Extension Phase|Lost to Follow-up|1|||
131409624|NCT02285114|473123198|FG005|Extension Phase|Lost to Follow-up|0|||
131409625|NCT02285114|473123193|FG000|Extension Phase|Non-compliance with Study Drug|0|||
131409626|NCT02285114|473123194|FG001|Extension Phase|Non-compliance with Study Drug|0|||
131409627|NCT02285114|473123195|FG002|Extension Phase|Non-compliance with Study Drug|0|||
131409628|NCT02285114|473123196|FG003|Extension Phase|Non-compliance with Study Drug|2|||
131409629|NCT02285114|473123197|FG004|Extension Phase|Non-compliance with Study Drug|0|||
131409630|NCT02285114|473123198|FG005|Extension Phase|Non-compliance with Study Drug|0|||
131409631|NCT02285114|473123193|FG000|Extension Phase|Pregnancy|0|||
131409632|NCT02285114|473123194|FG001|Extension Phase|Pregnancy|0|||
131409633|NCT02285114|473123195|FG002|Extension Phase|Pregnancy|0|||
131881091|NCT00954512|474845788|FG001|Overall Study|Symptomatic Deterioration|1|||
131881092|NCT00954512|474845789|FG002|Overall Study|Symptomatic Deterioration|0|||
131881093|NCT00954512|474845790|FG003|Overall Study|Symptomatic Deterioration|0|||
131881094|NCT00954512|474845791|FG004|Overall Study|Symptomatic Deterioration|2|||
131881095|NCT00954512|474845792|FG005|Overall Study|Symptomatic Deterioration|0|||
131925267|NCT00086307|475010845|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
131925268|NCT00086307|475010846|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
131925269|NCT00086307|475010847|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
131925270|NCT00086307|475010845|FG000|Overall Study|Nausea and headaches|0|||
131925271|NCT00086307|475010846|FG001|Overall Study|Nausea and headaches|0|||
131925272|NCT00086307|475010847|FG002|Overall Study|Nausea and headaches|1|||
131925273|NCT00086307|475010845|FG000|Overall Study|Constipation and sleepiness|0|||
131925274|NCT00086307|475010846|FG001|Overall Study|Constipation and sleepiness|0|||
131925275|NCT00086307|475010847|FG002|Overall Study|Constipation and sleepiness|1|||
131925276|NCT00086307|475010845|FG000|Overall Study|Suicidal ideation|0|||
131925277|NCT00086307|475010846|FG001|Overall Study|Suicidal ideation|0|||
131925278|NCT00086307|475010847|FG002|Overall Study|Suicidal ideation|1|||
131925279|NCT00086307|475010845|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
131925280|NCT00086307|475010846|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
131925281|NCT00086307|475010847|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
131925282|NCT00086307|475010845|FG000|Overall Study|Withdrawal by Subject|0|||
131925283|NCT00086307|475010846|FG001|Overall Study|Withdrawal by Subject|0|||
131925284|NCT00086307|475010847|FG002|Overall Study|Withdrawal by Subject|2|||
131925285|NCT00362609|475010848|FG000|Overall Study|Withdrawal by Subject|0|||
131925286|NCT00362609|475010849|FG001|Overall Study|Withdrawal by Subject|1|||
131925287|NCT00362609|475010848|FG000|Overall Study|Protocol Violation|0|||
131925288|NCT00362609|475010849|FG001|Overall Study|Protocol Violation|1|||
131925289|NCT02487199|475010852|FG000|Overall Study|Withdrew Consent|0|||
131925290|NCT02487199|475010853|FG001|Overall Study|Withdrew Consent|1|||
131925291|NCT01108796|475012510|FG000|Overall Study|Adverse Event|0|||
131925292|NCT01108796|475012511|FG001|Overall Study|Adverse Event|1|||
131925293|NCT01108796|475012510|FG000|Overall Study|Lost to Follow-up|7|||
131925294|NCT01108796|475012511|FG001|Overall Study|Lost to Follow-up|6|||
131925295|NCT00454142|475012512|FG000|Overall Study|Withdrawal by Subject|1|||
131925296|NCT00520572|475012514|FG000|Overall Study|Adverse Event|9|||
131925297|NCT00520572|475012515|FG001|Overall Study|Adverse Event|3|||
131925298|NCT00520572|475012516|FG002|Overall Study|Adverse Event|6|||
131925299|NCT00520572|475012517|FG003|Overall Study|Adverse Event|9|||
131925300|NCT00520572|475012518|FG004|Overall Study|Adverse Event|7|||
131925301|NCT00520572|475012519|FG005|Overall Study|Adverse Event|2|||
131925302|NCT00520572|475012514|FG000|Overall Study|Withdrawal by Subject|0|||
131925303|NCT00520572|475012515|FG001|Overall Study|Withdrawal by Subject|9|||
131925304|NCT00520572|475012516|FG002|Overall Study|Withdrawal by Subject|5|||
131409634|NCT02285114|473123196|FG003|Extension Phase|Pregnancy|1|||
131409635|NCT02285114|473123197|FG004|Extension Phase|Pregnancy|0|||
131409636|NCT02285114|473123198|FG005|Extension Phase|Pregnancy|0|||
131409637|NCT01156389|473123205|FG000|Overall Study|Elevated liver enzymes|4|||
131881096|NCT00954512|474845787|FG000|Overall Study|Progression of Disease|2|||
131881097|NCT00954512|474845788|FG001|Overall Study|Progression of Disease|1|||
131881098|NCT00954512|474845789|FG002|Overall Study|Progression of Disease|0|||
131881099|NCT00954512|474845790|FG003|Overall Study|Progression of Disease|1|||
131881100|NCT00954512|474845791|FG004|Overall Study|Progression of Disease|1|||
131881101|NCT00954512|474845792|FG005|Overall Study|Progression of Disease|1|||
131881102|NCT01794793|474845794|FG000|Treatment Period|Withdrawal by Subject|24|||
131881103|NCT01794793|474845794|FG000|Treatment Period|Lack of Efficacy|22|||
131881104|NCT01794793|474845794|FG000|Treatment Period|Adverse Event|17|||
131881105|NCT01794793|474845794|FG000|Treatment Period|Physician Decision|14|||
131881106|NCT01794793|474845794|FG000|Treatment Period|Lost to Follow-up|7|||
131881107|NCT01794793|474845794|FG000|Treatment Period|Death|6|||
131881108|NCT01794793|474845794|FG000|Treatment Period|Protocol Violation|5|||
131881109|NCT01794793|474845794|FG000|Treatment Period|administrative problem|3|||
131881110|NCT01794793|474845794|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
131881111|NCT01794793|474845794|FG000|Post-treatment Follow-up|Adverse Event|8|||
131881112|NCT01794793|474845794|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
131881113|NCT01794793|474845794|FG000|Post-treatment Follow-up|administrative problem|5|||
131881114|NCT01794793|474845794|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
131881115|NCT01794793|474845794|FG000|Post-treatment Follow-up|Protocol Violation|3|||
131409638|NCT01156389|473123206|FG001|Overall Study|Elevated liver enzymes|0|||
131881116|NCT03495154|474845795|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
131881117|NCT03495154|474845795|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
131881118|NCT03495154|474845795|FG000|Overall Study|Screen Failures During Surgery|6|||
131881119|NCT03495154|474845795|FG000|Overall Study|Death|2|||
131925305|NCT00520572|475012517|FG003|Overall Study|Withdrawal by Subject|2|||
131925306|NCT00520572|475012518|FG004|Overall Study|Withdrawal by Subject|2|||
131925307|NCT00520572|475012519|FG005|Overall Study|Withdrawal by Subject|0|||
131925308|NCT00520572|475012514|FG000|Overall Study|Protocol Violation|0|||
131925309|NCT00520572|475012515|FG001|Overall Study|Protocol Violation|0|||
131925310|NCT00520572|475012516|FG002|Overall Study|Protocol Violation|1|||
131925311|NCT00520572|475012517|FG003|Overall Study|Protocol Violation|0|||
131925312|NCT00520572|475012518|FG004|Overall Study|Protocol Violation|0|||
131881120|NCT03495154|474845795|FG000|Overall Study|Lost to Follow-up|16|||
131881121|NCT03495154|474845795|FG000|Overall Study|Withdrawal by Subject|2|||
131881122|NCT03495154|474845795|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
131881123|NCT05685732|474845796|FG000|Overall Study|Withdrawal by Subject|2|||
131881124|NCT05685732|474845797|FG001|Overall Study|Withdrawal by Subject|0|||
131881125|NCT05685732|474845798|FG002|Overall Study|Withdrawal by Subject|2|||
131881126|NCT05685732|474845799|FG003|Overall Study|Withdrawal by Subject|3|||
131881127|NCT05685732|474845796|FG000|Overall Study|Protocol Violation|1|||
131881128|NCT05685732|474845797|FG001|Overall Study|Protocol Violation|2|||
131881129|NCT05685732|474845798|FG002|Overall Study|Protocol Violation|4|||
131881130|NCT05685732|474845799|FG003|Overall Study|Protocol Violation|1|||
131881131|NCT05685732|474845796|FG000|Overall Study|Lost to Follow-up|5|||
131881132|NCT05685732|474845797|FG001|Overall Study|Lost to Follow-up|1|||
131881133|NCT05685732|474845798|FG002|Overall Study|Lost to Follow-up|3|||
131881134|NCT05685732|474845799|FG003|Overall Study|Lost to Follow-up|1|||
131881135|NCT05685732|474845796|FG000|Overall Study|Adverse Event|2|||
131881136|NCT05685732|474845797|FG001|Overall Study|Adverse Event|1|||
131881137|NCT05685732|474845798|FG002|Overall Study|Adverse Event|0|||
131881138|NCT05685732|474845799|FG003|Overall Study|Adverse Event|0|||
131881139|NCT05685732|474845796|FG000|Overall Study|Physician Decision|1|||
131881140|NCT05685732|474845797|FG001|Overall Study|Physician Decision|0|||
131881141|NCT05685732|474845798|FG002|Overall Study|Physician Decision|0|||
131881142|NCT05685732|474845799|FG003|Overall Study|Physician Decision|0|||
131881143|NCT02640404|474845800|FG000|Overall Study|Protocol Violation|1|||
131881144|NCT02640404|474845801|FG001|Overall Study|Protocol Violation|0|||
131881145|NCT02640404|474845800|FG000|Overall Study|Withdrawal by Subject|1|||
131881146|NCT02640404|474845801|FG001|Overall Study|Withdrawal by Subject|0|||
131881147|NCT05397171|474845803|FG000|Overall Study|Death|2|||
131881148|NCT05397171|474845804|FG001|Overall Study|Death|3|||
131881149|NCT05397171|474845805|FG002|Overall Study|Death|3|||
131881150|NCT05397171|474845803|FG000|Overall Study|Study Terminated By Sponsor|1|||
131881151|NCT05397171|474845804|FG001|Overall Study|Study Terminated By Sponsor|2|||
131881152|NCT05397171|474845805|FG002|Overall Study|Study Terminated By Sponsor|3|||
131881153|NCT05397171|474845803|FG000|Overall Study|Withdrawal by Subject|0|||
131881154|NCT05397171|474845804|FG001|Overall Study|Withdrawal by Subject|1|||
131881155|NCT05397171|474845805|FG002|Overall Study|Withdrawal by Subject|1|||
131881156|NCT02100670|474845806|FG000|Overall Study|Adverse Event|10|||
131881157|NCT02100670|474845807|FG001|Overall Study|Adverse Event|3|||
131881158|NCT02100670|474845808|FG002|Overall Study|Adverse Event|3|||
131881159|NCT02100670|474845809|FG003|Overall Study|Adverse Event|0|||
131881160|NCT02100670|474845806|FG000|Overall Study|Lost to Follow-up|1|||
131881161|NCT02100670|474845807|FG001|Overall Study|Lost to Follow-up|0|||
131881162|NCT02100670|474845808|FG002|Overall Study|Lost to Follow-up|0|||
131881163|NCT02100670|474845809|FG003|Overall Study|Lost to Follow-up|0|||
131881164|NCT02100670|474845806|FG000|Overall Study|Protocol Violation|0|||
131881165|NCT02100670|474845807|FG001|Overall Study|Protocol Violation|1|||
131881166|NCT02100670|474845808|FG002|Overall Study|Protocol Violation|0|||
131881167|NCT02100670|474845809|FG003|Overall Study|Protocol Violation|1|||
131881168|NCT02100670|474845806|FG000|Overall Study|Withdrawal of Consent|0|||
131881169|NCT02100670|474845807|FG001|Overall Study|Withdrawal of Consent|1|||
131881170|NCT02100670|474845808|FG002|Overall Study|Withdrawal of Consent|1|||
131881171|NCT02100670|474845809|FG003|Overall Study|Withdrawal of Consent|0|||
131881172|NCT02100670|474845806|FG000|Overall Study|No swelling no pain|1|||
131881173|NCT02100670|474845807|FG001|Overall Study|No swelling no pain|0|||
131881174|NCT02100670|474845808|FG002|Overall Study|No swelling no pain|0|||
131881175|NCT02100670|474845809|FG003|Overall Study|No swelling no pain|0|||
131881176|NCT02100670|474845806|FG000|Overall Study|Poor Efficacy|0|||
131881177|NCT02100670|474845807|FG001|Overall Study|Poor Efficacy|1|||
131881178|NCT02100670|474845808|FG002|Overall Study|Poor Efficacy|0|||
131881179|NCT02100670|474845809|FG003|Overall Study|Poor Efficacy|0|||
131881180|NCT02100670|474845806|FG000|Overall Study|Physician Decision|0|||
131881181|NCT02100670|474845807|FG001|Overall Study|Physician Decision|1|||
131881182|NCT02100670|474845808|FG002|Overall Study|Physician Decision|0|||
131881183|NCT02100670|474845809|FG003|Overall Study|Physician Decision|0|||
131881184|NCT02100670|474845806|FG000|Overall Study|Withdrawal by Subject|1|||
131881185|NCT02100670|474845807|FG001|Overall Study|Withdrawal by Subject|0|||
131881186|NCT02100670|474845808|FG002|Overall Study|Withdrawal by Subject|0|||
131881187|NCT02100670|474845809|FG003|Overall Study|Withdrawal by Subject|0|||
131881188|NCT02234596|474845810|FG000|Overall Study|Participant not treated|2|||
131881189|NCT03055494|474847717|FG000|Overall Study|Lost to Follow-up|6|||
131881190|NCT03055494|474847718|FG001|Overall Study|Lost to Follow-up|0|||
131409639|NCT01156389|473123205|FG000|Overall Study|Vomiting|0|||
131881191|NCT03055494|474847717|FG000|Overall Study|Physician Decision|2|||
131881192|NCT03055494|474847718|FG001|Overall Study|Physician Decision|0|||
131881193|NCT03055494|474847717|FG000|Overall Study|Withdrawal by Subject|1|||
131881194|NCT03055494|474847718|FG001|Overall Study|Withdrawal by Subject|0|||
131881195|NCT03055494|474847717|FG000|Overall Study|Adverse Event|0|||
131881196|NCT03055494|474847718|FG001|Overall Study|Adverse Event|1|||
131881197|NCT03055494|474847717|FG000|Overall Study|Non-compliance with study treatment|1|||
131409640|NCT01156389|473123206|FG001|Overall Study|Vomiting|1|||
131881198|NCT03055494|474847718|FG001|Overall Study|Non-compliance with study treatment|0|||
131881199|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
131881200|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
131881201|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
131881202|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
131881203|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
131881204|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
131881205|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
131881206|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
131881207|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
131881208|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
131881209|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
131881210|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
131881211|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
131881212|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
131881213|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
131881214|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
131881215|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
131881216|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
131881217|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
131881218|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
131881219|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
131881220|NCT04488419|474847723|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
131881221|NCT04488419|474847724|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
131881222|NCT04488419|474847725|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
131881223|NCT04488419|474847723|FG000|Primary Analysis Population|Adverse Event|6|||
131881224|NCT04488419|474847724|FG001|Primary Analysis Population|Adverse Event|9|||
131881225|NCT04488419|474847725|FG002|Primary Analysis Population|Adverse Event|0|||
131881226|NCT04488419|474847723|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
131881227|NCT04488419|474847724|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
131881228|NCT04488419|474847725|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
131881229|NCT04488419|474847723|FG000|Primary Analysis Population|Protocol Violation|1|||
131881230|NCT04488419|474847724|FG001|Primary Analysis Population|Protocol Violation|1|||
131881231|NCT04488419|474847725|FG002|Primary Analysis Population|Protocol Violation|0|||
131881232|NCT04488419|474847723|FG000|Primary Analysis Population|Undetermined|7|||
131881233|NCT04488419|474847724|FG001|Primary Analysis Population|Undetermined|3|||
131881234|NCT04488419|474847725|FG002|Primary Analysis Population|Undetermined|0|||
131881235|NCT04488419|474847723|FG000|Primary Analysis Population|>1 Reason|2|||
131881236|NCT04488419|474847724|FG001|Primary Analysis Population|>1 Reason|4|||
131881237|NCT04488419|474847725|FG002|Primary Analysis Population|>1 Reason|0|||
131881238|NCT01944670|474847728|FG000|Overall Study|Lost to Follow-up|2|||
131881239|NCT04338269|474847729|FG000|Overall Study|Death|86|||
131881240|NCT04338269|474847730|FG001|Overall Study|Death|89|||
131881241|NCT04338269|474847729|FG000|Overall Study|Lost to Follow-up|1|||
131881242|NCT04338269|474847730|FG001|Overall Study|Lost to Follow-up|2|||
131881243|NCT04338269|474847729|FG000|Overall Study|Physician Decision|1|||
131881244|NCT04338269|474847730|FG001|Overall Study|Physician Decision|0|||
131881245|NCT04338269|474847729|FG000|Overall Study|Withdrawal by Subject|14|||
131881246|NCT04338269|474847730|FG001|Overall Study|Withdrawal by Subject|11|||
131881247|NCT04166591|474847734|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
131881248|NCT04166591|474847735|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
131881249|NCT04166591|474847736|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131881250|NCT04166591|474847737|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131881251|NCT04166591|474847734|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
131881252|NCT04166591|474847735|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
131881253|NCT04166591|474847736|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131881254|NCT04166591|474847737|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131881255|NCT02203851|474847740|FG000|Overall Study|Lost to Follow-up|4|||
131881256|NCT02203851|474847740|FG000|Overall Study|Withdrawal by Subject|6|||
131881257|NCT02203851|474847740|FG000|Overall Study|Other|1|||
131881258|NCT04161079|474847741|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
131881259|NCT02515994|474847742|FG000|Overall Study|Protocol Violation|3|||
131881260|NCT02515994|474847743|FG001|Overall Study|Protocol Violation|5|||
131409641|NCT01224821|473123210|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
131409642|NCT01224821|473123210|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
131881261|NCT02515994|474847742|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
131881262|NCT02515994|474847743|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
131881263|NCT02515994|474847742|FG000|Overall Study|Adverse Event|3|||
131881264|NCT02515994|474847743|FG001|Overall Study|Adverse Event|1|||
131925313|NCT00520572|475012519|FG005|Overall Study|Protocol Violation|0|||
131925314|NCT00520572|475012514|FG000|Overall Study|Lack of Efficacy|1|||
131925315|NCT00520572|475012515|FG001|Overall Study|Lack of Efficacy|1|||
131925316|NCT00520572|475012516|FG002|Overall Study|Lack of Efficacy|1|||
131925317|NCT00520572|475012517|FG003|Overall Study|Lack of Efficacy|2|||
131925318|NCT00520572|475012518|FG004|Overall Study|Lack of Efficacy|1|||
131925319|NCT00520572|475012519|FG005|Overall Study|Lack of Efficacy|0|||
131925320|NCT00520572|475012514|FG000|Overall Study|Lost to Follow-up|0|||
131925321|NCT00520572|475012515|FG001|Overall Study|Lost to Follow-up|0|||
131925322|NCT00520572|475012516|FG002|Overall Study|Lost to Follow-up|0|||
131925323|NCT00520572|475012517|FG003|Overall Study|Lost to Follow-up|0|||
131925324|NCT00520572|475012518|FG004|Overall Study|Lost to Follow-up|1|||
131925325|NCT00520572|475012519|FG005|Overall Study|Lost to Follow-up|0|||
131925326|NCT00520572|475012514|FG000|Overall Study|Incorrect enrollment|1|||
131925327|NCT00520572|475012515|FG001|Overall Study|Incorrect enrollment|0|||
131925328|NCT00520572|475012516|FG002|Overall Study|Incorrect enrollment|1|||
131925329|NCT00520572|475012517|FG003|Overall Study|Incorrect enrollment|0|||
131925330|NCT00520572|475012518|FG004|Overall Study|Incorrect enrollment|1|||
131925331|NCT00520572|475012519|FG005|Overall Study|Incorrect enrollment|0|||
131925332|NCT00520572|475012514|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
131925333|NCT00520572|475012515|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
131925334|NCT00520572|475012516|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
131925335|NCT00520572|475012517|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
131925336|NCT00520572|475012518|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
131925337|NCT00520572|475012519|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
131925338|NCT00520572|475012514|FG000|Overall Study|Long break in taking Medication|0|||
131925339|NCT00520572|475012515|FG001|Overall Study|Long break in taking Medication|0|||
131925340|NCT00520572|475012516|FG002|Overall Study|Long break in taking Medication|0|||
131925341|NCT00520572|475012517|FG003|Overall Study|Long break in taking Medication|1|||
131925342|NCT00520572|475012518|FG004|Overall Study|Long break in taking Medication|0|||
131925343|NCT00520572|475012519|FG005|Overall Study|Long break in taking Medication|0|||
131925344|NCT00520572|475012514|FG000|Overall Study|Did not receive Treatment|1|||
131925345|NCT00520572|475012515|FG001|Overall Study|Did not receive Treatment|0|||
131925346|NCT00520572|475012516|FG002|Overall Study|Did not receive Treatment|1|||
131768856|NCT01724021|474431887|FG001|Overall Study|Participant request/ Withdrew consent|14|||
131768857|NCT01724021|474431886|FG000|Overall Study|Lost to Follow-up|15|||
131768858|NCT01724021|474431887|FG001|Overall Study|Lost to Follow-up|15|||
131768859|NCT01724021|474431886|FG000|Overall Study|Reason Not Specified|36|||
131768860|NCT01724021|474431887|FG001|Overall Study|Reason Not Specified|39|||
131768861|NCT01724021|474431886|FG000|Overall Study|Missing|1|||
131768862|NCT01724021|474431887|FG001|Overall Study|Missing|1|||
131768863|NCT02041533|474431889|FG000|Pre-Treatment Period|Disease Progression|1|||
131768864|NCT02041533|474431890|FG001|Pre-Treatment Period|Disease Progression|1|||
131925347|NCT00520572|475012517|FG003|Overall Study|Did not receive Treatment|0|||
131409643|NCT01224821|473123210|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
131409644|NCT01224821|473123210|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
131409645|NCT01224821|473123210|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
131881265|NCT02515994|474847742|FG000|Overall Study|Withdrawal by Subject|2|||
131881266|NCT02515994|474847743|FG001|Overall Study|Withdrawal by Subject|0|||
131881267|NCT01632150|474847746|FG000|Overall Study|Disease progression|27|||
131881268|NCT01632150|474847746|FG000|Overall Study|Study drug toxicity|1|||
131881269|NCT01632150|474847746|FG000|Overall Study|Unrelated adverse event|7|||
131881270|NCT01632150|474847746|FG000|Overall Study|Withdrawal by Subject|2|||
131881271|NCT01632150|474847746|FG000|Overall Study|Patient underwent autologous transplant|1|||
131881272|NCT01632150|474847746|FG000|Overall Study|Moved to compassionate program|2|||
131881273|NCT02143791|474847747|FG000|Enrolled|Withdrawal by Subject|4|||
131881274|NCT02143791|474847747|FG000|Trial Stimulation|Lack of Efficacy|21|||
131881275|NCT02143791|474847747|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
131881276|NCT02143791|474847747|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
131881277|NCT02143791|474847747|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
131881278|NCT02143791|474847747|FG000|Any Programming (3-6 Months)|Missing Data|1|||
131881279|NCT02143791|474847747|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
131881280|NCT03391232|474847750|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
131925348|NCT00520572|475012518|FG004|Overall Study|Did not receive Treatment|0|||
131925349|NCT00520572|475012519|FG005|Overall Study|Did not receive Treatment|0|||
131925350|NCT02181621|475012520|FG000|Overall Study|Adverse Event|1|||
131925351|NCT02181621|475012521|FG001|Overall Study|Adverse Event|0|||
131925352|NCT02181621|475012520|FG000|Overall Study|Previously Enrolled|0|||
131881281|NCT03391232|474847751|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
131925353|NCT02181621|475012521|FG001|Overall Study|Previously Enrolled|1|||
131925354|NCT02181621|475012520|FG000|Overall Study|Enrollment Hold|1|||
131925355|NCT02181621|475012521|FG001|Overall Study|Enrollment Hold|1|||
131925356|NCT00960856|475012522|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131925357|NCT00960856|475012523|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
131881282|NCT03391232|474847750|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
131881283|NCT03391232|474847751|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
131881284|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Adverse Event|6|||
131881285|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Adverse Event|14|||
131881286|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Death|3|||
131881287|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Death|1|||
131881288|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
131881289|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
131881290|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
131881291|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
131881292|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
131881293|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
131881294|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
131881295|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
131881296|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
131881297|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
131881298|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Physician Decision|2|||
131881299|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Physician Decision|4|||
131881300|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Pregnancy|2|||
131881301|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Pregnancy|1|||
131881302|NCT02275780|474847763|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
131881303|NCT02275780|474847764|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
131881304|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
131881305|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
131881306|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
131881307|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
131881308|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
131881309|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
131881310|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
131881311|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
131881312|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
131881313|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
131881314|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
131881315|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
131881316|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
131881317|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
131881318|NCT02275780|474847763|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
131881319|NCT02275780|474847764|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
131881320|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
131881321|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
131881322|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
131881323|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
131881324|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
131881325|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
131881326|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
131881327|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
131881328|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
131881329|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
131881330|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
131881331|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
131881332|NCT02275780|474847763|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
131881333|NCT02275780|474847764|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
131881334|NCT02275780|474847763|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
131881335|NCT02275780|474847764|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
131881336|NCT02275780|474847763|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
131881337|NCT02275780|474847764|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
131881338|NCT02275780|474847763|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
131881339|NCT02275780|474847764|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
131881340|NCT02275780|474847763|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
131881341|NCT02275780|474847764|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
131881342|NCT02275780|474847763|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
131881343|NCT02275780|474847764|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
131881344|NCT02275780|474847763|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
131881345|NCT02275780|474847764|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
131881346|NCT01054300|474847765|FG000|Period 1|Adverse Event|1|||
131881347|NCT01054300|474847766|FG001|Period 1|Adverse Event|0|||
131925358|NCT00960856|475012524|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
131925359|NCT00960856|475012525|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
131925360|NCT00960856|475012522|FG000|Washout Period of 7 Days|Adverse Event|0|||
131925361|NCT00960856|475012523|FG001|Washout Period of 7 Days|Adverse Event|0|||
131925362|NCT00960856|475012524|FG002|Washout Period of 7 Days|Adverse Event|1|||
131925363|NCT00960856|475012525|FG003|Washout Period of 7 Days|Adverse Event|0|||
131925364|NCT02802865|475012527|FG000|Overall Study|Pregnancy|1|||
131925365|NCT02802865|475012528|FG001|Overall Study|Pregnancy|1|||
131925366|NCT02802865|475012527|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
131925367|NCT02802865|475012528|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
131925368|NCT01783015|475012529|FG000|Blinded Treatment|Adverse Event|0|||
131925369|NCT01783015|475012530|FG001|Blinded Treatment|Adverse Event|1|||
131925370|NCT01783015|475012531|FG002|Blinded Treatment|Adverse Event|0|||
131925371|NCT01783015|475012529|FG000|Blinded Treatment|Protocol Violation|0|||
131925372|NCT01783015|475012530|FG001|Blinded Treatment|Protocol Violation|1|||
131925373|NCT01783015|475012531|FG002|Blinded Treatment|Protocol Violation|0|||
131925374|NCT01783015|475012529|FG000|Blinded Treatment|Withdrawal by Subject|0|||
131925375|NCT01783015|475012530|FG001|Blinded Treatment|Withdrawal by Subject|1|||
131925376|NCT01783015|475012531|FG002|Blinded Treatment|Withdrawal by Subject|0|||
131925377|NCT01783015|475012529|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
131925378|NCT01783015|475012530|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
131925379|NCT01783015|475012531|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
131925380|NCT01783015|475012529|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
131925381|NCT01783015|475012530|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
131925382|NCT01783015|475012531|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
131925383|NCT03387046|475012534|FG000|Overall Study|Adverse Event|1|||
131925384|NCT03387046|475012535|FG001|Overall Study|Adverse Event|1|||
131925385|NCT00509600|475012536|FG000|Overall Study|Adverse Event|1|||
131925386|NCT03794544|475012538|FG000|Overall Study|Withdrawal by Subject|1|||
131925387|NCT03794544|475012539|FG001|Overall Study|Withdrawal by Subject|1|||
131925388|NCT03794544|475012540|FG002|Overall Study|Withdrawal by Subject|0|||
131925389|NCT03794544|475012541|FG003|Overall Study|Withdrawal by Subject|0|||
131925390|NCT03794544|475012538|FG000|Overall Study|Death|0|||
131925391|NCT03794544|475012539|FG001|Overall Study|Death|0|||
131925392|NCT03794544|475012540|FG002|Overall Study|Death|0|||
131925393|NCT03794544|475012541|FG003|Overall Study|Death|1|||
131925394|NCT03794544|475012538|FG000|Overall Study|Lost to Follow-up|0|||
131925395|NCT03794544|475012539|FG001|Overall Study|Lost to Follow-up|1|||
131925396|NCT03794544|475012540|FG002|Overall Study|Lost to Follow-up|1|||
131925397|NCT03794544|475012541|FG003|Overall Study|Lost to Follow-up|0|||
131925398|NCT03794544|475012538|FG000|Overall Study|Other|0|||
131925399|NCT03794544|475012539|FG001|Overall Study|Other|1|||
131925400|NCT03794544|475012540|FG002|Overall Study|Other|0|||
131925401|NCT03794544|475012541|FG003|Overall Study|Other|0|||
131925402|NCT00676052|475012544|FG000|Overall Study|Adverse Event|0|||
131409646|NCT01224821|473123210|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
131925403|NCT00676052|475012545|FG001|Overall Study|Adverse Event|1|||
131925404|NCT00676052|475012546|FG002|Overall Study|Adverse Event|1|||
131925405|NCT00676052|475012547|FG003|Overall Study|Adverse Event|2|||
131925406|NCT00676052|475012548|FG004|Overall Study|Adverse Event|2|||
131925407|NCT00676052|475012549|FG005|Overall Study|Adverse Event|2|||
131925408|NCT00676052|475012544|FG000|Overall Study|Lack of Efficacy|2|||
131925409|NCT00676052|475012545|FG001|Overall Study|Lack of Efficacy|2|||
131925410|NCT00676052|475012546|FG002|Overall Study|Lack of Efficacy|1|||
131409647|NCT01224821|473123210|FG000|Long-Term Follow-Up|Death|2|||
131409648|NCT01224821|473123210|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
131409649|NCT01340937|473123211|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
131409650|NCT01340937|473123212|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
131409651|NCT01340937|473123213|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
131409652|NCT01340937|473123214|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
131409653|NCT01340937|473123211|FG000|Period 1: Infant Series|Adverse Event|0|||
131454045|NCT01032889|473291868|FG002|Overall Study|Lack of Submental Fat|1|||
131925411|NCT00676052|475012547|FG003|Overall Study|Lack of Efficacy|1|||
131925412|NCT00676052|475012548|FG004|Overall Study|Lack of Efficacy|2|||
131925413|NCT00676052|475012549|FG005|Overall Study|Lack of Efficacy|1|||
131925414|NCT00676052|475012544|FG000|Overall Study|Protocol Violation|5|||
131454046|NCT01032889|473291866|FG000|Overall Study|Miscellaneous Reasons|2|||
131925415|NCT00676052|475012545|FG001|Overall Study|Protocol Violation|3|||
131925416|NCT00676052|475012546|FG002|Overall Study|Protocol Violation|2|||
131925417|NCT00676052|475012547|FG003|Overall Study|Protocol Violation|2|||
131925418|NCT00676052|475012548|FG004|Overall Study|Protocol Violation|1|||
131925419|NCT00676052|475012549|FG005|Overall Study|Protocol Violation|2|||
131925420|NCT00676052|475012544|FG000|Overall Study|Lost to Follow-up|0|||
131925421|NCT00676052|475012545|FG001|Overall Study|Lost to Follow-up|0|||
131925422|NCT00676052|475012546|FG002|Overall Study|Lost to Follow-up|0|||
131925423|NCT00676052|475012547|FG003|Overall Study|Lost to Follow-up|0|||
131925424|NCT00676052|475012548|FG004|Overall Study|Lost to Follow-up|1|||
131925425|NCT00676052|475012549|FG005|Overall Study|Lost to Follow-up|0|||
131881348|NCT01054300|474847767|FG002|Period 1|Adverse Event|0|||
131881349|NCT01054300|474847768|FG003|Period 1|Adverse Event|0|||
131881350|NCT01054300|474847765|FG000|Period 2|Withdrawal by Subject|0|||
131881351|NCT01054300|474847766|FG001|Period 2|Withdrawal by Subject|0|||
131881352|NCT01054300|474847767|FG002|Period 2|Withdrawal by Subject|1|||
131881353|NCT01054300|474847768|FG003|Period 2|Withdrawal by Subject|0|||
131881354|NCT00308087|474847771|FG000|Overall Study|Progressive Disease|19|||
131881355|NCT00308087|474847772|FG001|Overall Study|Progressive Disease|21|||
131881356|NCT00308087|474847771|FG000|Overall Study|Study Closure|11|||
131881357|NCT00308087|474847772|FG001|Overall Study|Study Closure|12|||
131881358|NCT00308087|474847771|FG000|Overall Study|Withdrawal by Subject|2|||
131881359|NCT00308087|474847772|FG001|Overall Study|Withdrawal by Subject|1|||
131881360|NCT00308087|474847771|FG000|Overall Study|Other|4|||
131881361|NCT00308087|474847772|FG001|Overall Study|Other|3|||
131881362|NCT00738881|474847778|FG000|Overall Study|Withdrawal by Subject|0|||
131881363|NCT00738881|474847779|FG001|Overall Study|Withdrawal by Subject|2|||
131881364|NCT04186806|474847780|FG000|Period 1: 7 Days|Adverse Event|1|||
131881365|NCT04186806|474847781|FG001|Period 1: 7 Days|Adverse Event|0|||
131881366|NCT00177307|474847782|FG000|Overall Study|Withdrawal by Subject|1|||
131881367|NCT04521621|474847785|FG000|Overall Study|Death|17|||
131881368|NCT04521621|474847786|FG001|Overall Study|Death|8|||
131881369|NCT04521621|474847787|FG002|Overall Study|Death|8|||
131881370|NCT04521621|474847788|FG003|Overall Study|Death|5|||
131881371|NCT04521621|474847789|FG004|Overall Study|Death|2|||
131881372|NCT04521621|474847790|FG005|Overall Study|Death|7|||
131881373|NCT04521621|474847791|FG006|Overall Study|Death|0|||
131881374|NCT04521621|474847792|FG007|Overall Study|Death|0|||
131881375|NCT04521621|474847785|FG000|Overall Study|Study Terminated by Sponsor|4|||
131881376|NCT04521621|474847786|FG001|Overall Study|Study Terminated by Sponsor|6|||
131881377|NCT04521621|474847787|FG002|Overall Study|Study Terminated by Sponsor|8|||
131881378|NCT04521621|474847788|FG003|Overall Study|Study Terminated by Sponsor|0|||
131881379|NCT04521621|474847789|FG004|Overall Study|Study Terminated by Sponsor|1|||
131881380|NCT04521621|474847790|FG005|Overall Study|Study Terminated by Sponsor|7|||
131881381|NCT04521621|474847791|FG006|Overall Study|Study Terminated by Sponsor|0|||
131881382|NCT04521621|474847792|FG007|Overall Study|Study Terminated by Sponsor|0|||
131881383|NCT04521621|474847785|FG000|Overall Study|Withdrawal by Subject|0|||
131881384|NCT04521621|474847786|FG001|Overall Study|Withdrawal by Subject|0|||
131881385|NCT04521621|474847787|FG002|Overall Study|Withdrawal by Subject|1|||
131881386|NCT04521621|474847788|FG003|Overall Study|Withdrawal by Subject|1|||
131881387|NCT04521621|474847789|FG004|Overall Study|Withdrawal by Subject|0|||
131881388|NCT04521621|474847790|FG005|Overall Study|Withdrawal by Subject|0|||
131881389|NCT04521621|474847791|FG006|Overall Study|Withdrawal by Subject|0|||
131881390|NCT04521621|474847792|FG007|Overall Study|Withdrawal by Subject|0|||
131881391|NCT04521621|474847785|FG000|Overall Study|Allocated in error without study intervention|1|||
131881392|NCT04521621|474847786|FG001|Overall Study|Allocated in error without study intervention|0|||
131881393|NCT04521621|474847787|FG002|Overall Study|Allocated in error without study intervention|0|||
131881394|NCT04521621|474847788|FG003|Overall Study|Allocated in error without study intervention|0|||
131881395|NCT04521621|474847789|FG004|Overall Study|Allocated in error without study intervention|0|||
131881396|NCT04521621|474847790|FG005|Overall Study|Allocated in error without study intervention|0|||
131881397|NCT04521621|474847791|FG006|Overall Study|Allocated in error without study intervention|0|||
131881398|NCT04521621|474847792|FG007|Overall Study|Allocated in error without study intervention|0|||
131881399|NCT01282164|474847793|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
131881400|NCT01282164|474847794|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
131881401|NCT05845567|474847799|FG000|Overall Study|Withdrawal by Subject|1|||
131881402|NCT04739722|474847803|FG000|Overall Study|Lost to Follow-up|5301|||
131881403|NCT04739722|474847803|FG000|Overall Study|Withdrawal by Subject|42|||
131881404|NCT04739722|474847803|FG000|Overall Study|Non Average-risk|1157|||
131881405|NCT03047720|474847807|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
131881406|NCT03047720|474847808|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
131881407|NCT00614120|474847809|FG000|Overall Study|Adverse Event|9|||
131881408|NCT00614120|474847810|FG001|Overall Study|Adverse Event|22|||
131881409|NCT00614120|474847811|FG002|Overall Study|Adverse Event|30|||
131881410|NCT00614120|474847812|FG003|Overall Study|Adverse Event|3|||
131881411|NCT00614120|474847809|FG000|Overall Study|Lack of Efficacy|3|||
131881412|NCT00614120|474847810|FG001|Overall Study|Lack of Efficacy|3|||
131881413|NCT00614120|474847811|FG002|Overall Study|Lack of Efficacy|2|||
131881414|NCT00614120|474847812|FG003|Overall Study|Lack of Efficacy|2|||
131881415|NCT00614120|474847809|FG000|Overall Study|Protocol Violation|2|||
131881416|NCT00614120|474847810|FG001|Overall Study|Protocol Violation|5|||
131881417|NCT00614120|474847811|FG002|Overall Study|Protocol Violation|3|||
131881418|NCT00614120|474847812|FG003|Overall Study|Protocol Violation|1|||
131881419|NCT00614120|474847809|FG000|Overall Study|Withdrawal criteria|1|||
131881420|NCT00614120|474847810|FG001|Overall Study|Withdrawal criteria|0|||
131881421|NCT00614120|474847811|FG002|Overall Study|Withdrawal criteria|0|||
131881422|NCT00614120|474847812|FG003|Overall Study|Withdrawal criteria|0|||
131881423|NCT00614120|474847809|FG000|Overall Study|Withdrawal by Subject|9|||
131881424|NCT00614120|474847810|FG001|Overall Study|Withdrawal by Subject|10|||
131925426|NCT00676052|475012544|FG000|Overall Study|Physician Decision|1|||
131925427|NCT00676052|475012545|FG001|Overall Study|Physician Decision|1|||
131925428|NCT00676052|475012546|FG002|Overall Study|Physician Decision|1|||
131925429|NCT00676052|475012547|FG003|Overall Study|Physician Decision|0|||
131925430|NCT00676052|475012548|FG004|Overall Study|Physician Decision|0|||
131925431|NCT00676052|475012549|FG005|Overall Study|Physician Decision|1|||
131925432|NCT00676052|475012544|FG000|Overall Study|Withdrawal by Subject|1|||
131925433|NCT00676052|475012545|FG001|Overall Study|Withdrawal by Subject|0|||
131925434|NCT00676052|475012546|FG002|Overall Study|Withdrawal by Subject|1|||
131925435|NCT00676052|475012547|FG003|Overall Study|Withdrawal by Subject|0|||
131925436|NCT00676052|475012548|FG004|Overall Study|Withdrawal by Subject|0|||
131925437|NCT00676052|475012549|FG005|Overall Study|Withdrawal by Subject|0|||
131925438|NCT00289978|475012552|FG000|Overall Study|Withdrawal by Subject|31|||
131925439|NCT00289978|475012553|FG001|Overall Study|Withdrawal by Subject|17|||
131925440|NCT00289978|475012554|FG002|Overall Study|Withdrawal by Subject|28|||
131925441|NCT00289978|475012552|FG000|Overall Study|Adverse Event|22|||
131925442|NCT00289978|475012553|FG001|Overall Study|Adverse Event|13|||
131925443|NCT00289978|475012554|FG002|Overall Study|Adverse Event|18|||
131925444|NCT00289978|475012552|FG000|Overall Study|Lack of Efficacy|13|||
131925445|NCT00289978|475012553|FG001|Overall Study|Lack of Efficacy|6|||
131409654|NCT01340937|473123212|FG001|Period 1: Infant Series|Adverse Event|1|||
131409655|NCT01340937|473123213|FG002|Period 1: Infant Series|Adverse Event|4|||
131409656|NCT01340937|473123214|FG003|Period 1: Infant Series|Adverse Event|0|||
131409657|NCT01340937|473123211|FG000|Period 1: Infant Series|Death|2|||
131409658|NCT01340937|473123212|FG001|Period 1: Infant Series|Death|0|||
131409659|NCT01340937|473123213|FG002|Period 1: Infant Series|Death|2|||
131409660|NCT01340937|473123214|FG003|Period 1: Infant Series|Death|0|||
131925446|NCT00289978|475012554|FG002|Overall Study|Lack of Efficacy|25|||
131925447|NCT00289978|475012552|FG000|Overall Study|Abnormal laboratory value(s)|20|||
131925448|NCT00289978|475012553|FG001|Overall Study|Abnormal laboratory value(s)|9|||
131925449|NCT00289978|475012554|FG002|Overall Study|Abnormal laboratory value(s)|1|||
131925450|NCT00289978|475012552|FG000|Overall Study|Lost to Follow-up|3|||
131925451|NCT00289978|475012553|FG001|Overall Study|Lost to Follow-up|5|||
131925452|NCT00289978|475012554|FG002|Overall Study|Lost to Follow-up|7|||
131925453|NCT00289978|475012552|FG000|Overall Study|Protocol Violation|5|||
131925454|NCT00289978|475012553|FG001|Overall Study|Protocol Violation|5|||
131925455|NCT00289978|475012554|FG002|Overall Study|Protocol Violation|4|||
131925456|NCT00289978|475012552|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131925457|NCT00289978|475012553|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131925458|NCT00289978|475012554|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131925459|NCT00289978|475012552|FG000|Overall Study|Death|1|||
131925460|NCT00289978|475012553|FG001|Overall Study|Death|0|||
131409661|NCT01340937|473123211|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
131409662|NCT01340937|473123212|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
131409663|NCT01340937|473123213|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
131409664|NCT01340937|473123214|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
131409665|NCT01340937|473123211|FG000|Period 1: Infant Series|Physician Decision|2|||
131409666|NCT01340937|473123212|FG001|Period 1: Infant Series|Physician Decision|3|||
131409667|NCT01340937|473123213|FG002|Period 1: Infant Series|Physician Decision|1|||
131409668|NCT01340937|473123214|FG003|Period 1: Infant Series|Physician Decision|0|||
131409669|NCT01340937|473123211|FG000|Period 1: Infant Series|Protocol Violation|1|||
131409670|NCT01340937|473123212|FG001|Period 1: Infant Series|Protocol Violation|4|||
131409671|NCT01340937|473123213|FG002|Period 1: Infant Series|Protocol Violation|4|||
131409672|NCT01340937|473123214|FG003|Period 1: Infant Series|Protocol Violation|3|||
131409673|NCT01340937|473123211|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
131409674|NCT01340937|473123212|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
131409675|NCT01340937|473123213|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
131409676|NCT01340937|473123214|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
131409677|NCT01340937|473123211|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
131409678|NCT01340937|473123212|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
131409679|NCT01340937|473123213|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
131409680|NCT01340937|473123214|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
131409681|NCT01340937|473123211|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
131409682|NCT01340937|473123212|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
131409683|NCT01340937|473123213|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
131925461|NCT00289978|475012554|FG002|Overall Study|Death|2|||
131409684|NCT01340937|473123214|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
131925462|NCT00120250|475012555|FG000|Overall Study|Lost to Follow-up|1|||
131925463|NCT00120250|475012556|FG001|Overall Study|Lost to Follow-up|1|||
131925464|NCT00120250|475012555|FG000|Overall Study|Protocol Violation|0|||
131925465|NCT00120250|475012556|FG001|Overall Study|Protocol Violation|1|||
131925466|NCT00720083|475012557|FG000|Overall Study|Ineligible|1|||
131925467|NCT00720083|475012558|FG001|Overall Study|Ineligible|2|||
131925468|NCT00585169|475012562|FG000|Overall Study|Withdrawal by Subject|1|||
131925469|NCT00710970|475012567|FG000|Overall Study|Never took drug|3|||
131925470|NCT01028560|475012568|FG000|Overall Study|Lack of Efficacy|3|||
131409685|NCT01340937|473123211|FG000|Period 2: Interim Period|Adverse Event|1|||
131409686|NCT01340937|473123212|FG001|Period 2: Interim Period|Adverse Event|0|||
131409687|NCT01340937|473123213|FG002|Period 2: Interim Period|Adverse Event|1|||
131409688|NCT01340937|473123214|FG003|Period 2: Interim Period|Adverse Event|0|||
131409689|NCT01340937|473123211|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
131409690|NCT01340937|473123212|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
131409691|NCT01340937|473123213|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
131409692|NCT01340937|473123214|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
131409693|NCT01340937|473123211|FG000|Period 2: Interim Period|Physician Decision|0|||
131409694|NCT01340937|473123212|FG001|Period 2: Interim Period|Physician Decision|1|||
131409695|NCT01340937|473123213|FG002|Period 2: Interim Period|Physician Decision|1|||
131409696|NCT01340937|473123214|FG003|Period 2: Interim Period|Physician Decision|0|||
131409697|NCT01340937|473123211|FG000|Period 2: Interim Period|Protocol Violation|5|||
131409698|NCT01340937|473123212|FG001|Period 2: Interim Period|Protocol Violation|3|||
131409699|NCT01340937|473123213|FG002|Period 2: Interim Period|Protocol Violation|6|||
131409700|NCT01340937|473123214|FG003|Period 2: Interim Period|Protocol Violation|3|||
131409701|NCT01340937|473123211|FG000|Period 2: Interim Period|Technical problems|4|||
131409702|NCT01340937|473123212|FG001|Period 2: Interim Period|Technical problems|4|||
131409703|NCT01340937|473123213|FG002|Period 2: Interim Period|Technical problems|6|||
131409704|NCT01340937|473123214|FG003|Period 2: Interim Period|Technical problems|3|||
131409705|NCT01340937|473123211|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
131409706|NCT01340937|473123212|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
131409707|NCT01340937|473123213|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
131409708|NCT01340937|473123214|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
131409709|NCT01340937|473123211|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
131409710|NCT01340937|473123212|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
131409711|NCT01340937|473123213|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
131409712|NCT01340937|473123214|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
131881425|NCT00614120|474847811|FG002|Overall Study|Withdrawal by Subject|16|||
131881426|NCT00614120|474847812|FG003|Overall Study|Withdrawal by Subject|3|||
131881427|NCT00614120|474847809|FG000|Overall Study|Did not meet trial criteria|0|||
131881428|NCT00614120|474847810|FG001|Overall Study|Did not meet trial criteria|1|||
131881429|NCT00614120|474847811|FG002|Overall Study|Did not meet trial criteria|1|||
131881430|NCT00614120|474847812|FG003|Overall Study|Did not meet trial criteria|1|||
131881431|NCT00614120|474847809|FG000|Overall Study|hCG positive (not pregnant)|0|||
131881432|NCT00614120|474847810|FG001|Overall Study|hCG positive (not pregnant)|0|||
131881433|NCT00614120|474847811|FG002|Overall Study|hCG positive (not pregnant)|1|||
131881434|NCT00614120|474847812|FG003|Overall Study|hCG positive (not pregnant)|0|||
131881435|NCT00614120|474847809|FG000|Overall Study|Hypoglycaemia|0|||
131881436|NCT00614120|474847810|FG001|Overall Study|Hypoglycaemia|0|||
131881437|NCT00614120|474847811|FG002|Overall Study|Hypoglycaemia|0|||
131881438|NCT00614120|474847812|FG003|Overall Study|Hypoglycaemia|1|||
131881439|NCT00614120|474847809|FG000|Overall Study|Lack of trial product|3|||
131881440|NCT00614120|474847810|FG001|Overall Study|Lack of trial product|3|||
131881441|NCT00614120|474847811|FG002|Overall Study|Lack of trial product|2|||
131881442|NCT00614120|474847812|FG003|Overall Study|Lack of trial product|0|||
131881443|NCT00614120|474847809|FG000|Overall Study|Late syphilis, latent|1|||
131881444|NCT00614120|474847810|FG001|Overall Study|Late syphilis, latent|0|||
131881445|NCT00614120|474847811|FG002|Overall Study|Late syphilis, latent|0|||
131881446|NCT00614120|474847812|FG003|Overall Study|Late syphilis, latent|0|||
131881447|NCT00614120|474847809|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
131881448|NCT00614120|474847810|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
131881449|NCT00614120|474847811|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
131881450|NCT00614120|474847812|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
131881451|NCT00614120|474847809|FG000|Overall Study|Lost to Follow-up|1|||
131409713|NCT01340937|473123211|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
131409714|NCT01340937|473123212|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
131409715|NCT01340937|473123213|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
131881452|NCT00614120|474847810|FG001|Overall Study|Lost to Follow-up|2|||
131881453|NCT00614120|474847811|FG002|Overall Study|Lost to Follow-up|3|||
131881454|NCT00614120|474847812|FG003|Overall Study|Lost to Follow-up|4|||
131881455|NCT03409107|474847813|FG000|Overall Study|Withdrawal by Subject|4|||
131881456|NCT03409107|474847814|FG001|Overall Study|Withdrawal by Subject|2|||
131881457|NCT03409107|474847813|FG000|Overall Study|Physician Decision|1|||
131881458|NCT03409107|474847814|FG001|Overall Study|Physician Decision|0|||
131881459|NCT03409107|474847813|FG000|Overall Study|Lost to Follow-up|7|||
131881460|NCT03409107|474847814|FG001|Overall Study|Lost to Follow-up|2|||
131881461|NCT03409107|474847813|FG000|Overall Study|Adverse Event|5|||
131881462|NCT03409107|474847814|FG001|Overall Study|Adverse Event|3|||
131881463|NCT01185509|474847815|FG000|Overall Study|Progression/Relapse|9|||
131881464|NCT01185509|474847816|FG001|Overall Study|Progression/Relapse|15|||
131881465|NCT01185509|474847815|FG000|Overall Study|Physician Decision|2|||
131881466|NCT01185509|474847816|FG001|Overall Study|Physician Decision|2|||
131925471|NCT01028560|475012569|FG001|Overall Study|Lack of Efficacy|6|||
131881467|NCT01185509|474847815|FG000|Overall Study|Withdrawal by Subject|0|||
131409716|NCT01340937|473123214|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
131409717|NCT01340937|473123211|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
131409718|NCT01340937|473123212|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
131409719|NCT01340937|473123213|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
131409720|NCT01340937|473123214|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
131409721|NCT02119156|473123215|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
131409722|NCT02119156|473123216|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
131409723|NCT02119156|473123217|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
131409724|NCT02119156|473123215|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
131409725|NCT02119156|473123216|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
131409726|NCT02119156|473123217|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
131409727|NCT02119156|473123215|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
131409728|NCT02119156|473123216|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
131409729|NCT02119156|473123217|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
131409730|NCT02119156|473123215|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
131409731|NCT02119156|473123216|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
131409732|NCT02119156|473123217|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
131881468|NCT01185509|474847816|FG001|Overall Study|Withdrawal by Subject|1|||
131881469|NCT01185509|474847815|FG000|Overall Study|Death|0|||
131881470|NCT01185509|474847816|FG001|Overall Study|Death|1|||
131881471|NCT01185509|474847815|FG000|Overall Study|Intercurrent Illness|0|||
131881472|NCT01185509|474847816|FG001|Overall Study|Intercurrent Illness|1|||
131881473|NCT03687372|474847817|FG000|Overall Study|Lost to Follow-up|12|||
131881474|NCT03687372|474847818|FG001|Overall Study|Lost to Follow-up|21|||
131881475|NCT03687372|474847817|FG000|Overall Study|Withdrawal by Subject|4|||
131881476|NCT03687372|474847818|FG001|Overall Study|Withdrawal by Subject|17|||
131881477|NCT03687372|474847817|FG000|Overall Study|Investigator Decision|1|||
131881478|NCT03687372|474847818|FG001|Overall Study|Investigator Decision|1|||
131881479|NCT00108485|474847821|FG000|Overall Study|Withdrawal by Subject|3|||
131881480|NCT00108485|474847822|FG001|Overall Study|Withdrawal by Subject|0|||
131881481|NCT00108485|474847821|FG000|Overall Study|Lost to Follow-up|0|||
131881482|NCT00108485|474847822|FG001|Overall Study|Lost to Follow-up|2|||
131881483|NCT00878969|474847825|FG000|Overall Study|Physician Decision|5|||
131881484|NCT00878969|474847826|FG001|Overall Study|Physician Decision|3|||
131881485|NCT00878969|474847827|FG002|Overall Study|Physician Decision|2|||
131881486|NCT00878969|474847825|FG000|Overall Study|Withdrawal by Subject|1|||
131881487|NCT00878969|474847826|FG001|Overall Study|Withdrawal by Subject|6|||
131881488|NCT00878969|474847827|FG002|Overall Study|Withdrawal by Subject|3|||
131881489|NCT00878969|474847825|FG000|Overall Study|kidney transplant|2|||
131881490|NCT00878969|474847826|FG001|Overall Study|kidney transplant|3|||
131881491|NCT00878969|474847827|FG002|Overall Study|kidney transplant|2|||
131881492|NCT00878969|474847825|FG000|Overall Study|Adverse Event|3|||
131881493|NCT00878969|474847826|FG001|Overall Study|Adverse Event|1|||
131881494|NCT00878969|474847827|FG002|Overall Study|Adverse Event|2|||
131881495|NCT00878969|474847825|FG000|Overall Study|Lost to Follow-up|2|||
131881496|NCT00878969|474847826|FG001|Overall Study|Lost to Follow-up|1|||
131881497|NCT00878969|474847827|FG002|Overall Study|Lost to Follow-up|0|||
131881498|NCT00878969|474847825|FG000|Overall Study|Protocol Violation|2|||
131881499|NCT00878969|474847826|FG001|Overall Study|Protocol Violation|0|||
131881500|NCT00878969|474847827|FG002|Overall Study|Protocol Violation|0|||
131881501|NCT00878969|474847825|FG000|Overall Study|Death|0|||
131881502|NCT00878969|474847826|FG001|Overall Study|Death|0|||
131881503|NCT00878969|474847827|FG002|Overall Study|Death|2|||
131881504|NCT00878969|474847825|FG000|Overall Study|Pregnancy|0|||
131881505|NCT00878969|474847826|FG001|Overall Study|Pregnancy|1|||
131881506|NCT00878969|474847827|FG002|Overall Study|Pregnancy|0|||
131881507|NCT03729570|474847828|FG000|Overall Study|Lost to Follow-up|16|||
131881508|NCT03729570|474847829|FG001|Overall Study|Lost to Follow-up|20|||
131881509|NCT03729570|474847828|FG000|Overall Study|Seroconversion|5|||
131925472|NCT01028560|475012568|FG000|Overall Study|Withdrawal by Subject|7|||
131409733|NCT02119156|473123215|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
131881510|NCT03729570|474847829|FG001|Overall Study|Seroconversion|0|||
131881511|NCT03729570|474847828|FG000|Overall Study|Moved out of the city|1|||
131881512|NCT03729570|474847829|FG001|Overall Study|Moved out of the city|0|||
131881513|NCT03729570|474847828|FG000|Overall Study|Time Conflict|1|||
131881514|NCT03729570|474847829|FG001|Overall Study|Time Conflict|0|||
131881515|NCT03729570|474847828|FG000|Overall Study|Time Commitment|2|||
131881516|NCT03729570|474847829|FG001|Overall Study|Time Commitment|0|||
131881517|NCT03729570|474847828|FG000|Overall Study|Bad Experience|0|||
131881518|NCT03729570|474847829|FG001|Overall Study|Bad Experience|1|||
131881519|NCT03729570|474847828|FG000|Overall Study|No reason provided|2|||
131881520|NCT03729570|474847829|FG001|Overall Study|No reason provided|1|||
131881521|NCT03729570|474847828|FG000|Overall Study|Family Conflict|0|||
131881522|NCT03729570|474847829|FG001|Overall Study|Family Conflict|1|||
131881523|NCT03729570|474847828|FG000|Overall Study|Did not want to continue taking medications|0|||
131925473|NCT01028560|475012569|FG001|Overall Study|Withdrawal by Subject|12|||
131925474|NCT03055221|475012570|FG000|Overall Study|Adverse Event|2|||
131925475|NCT03055221|475012570|FG000|Overall Study|Withdrawal by Subject|4|||
131925476|NCT03055221|475012570|FG000|Overall Study|Death|6|||
131925477|NCT03055221|475012570|FG000|Overall Study|Physician Decision|1|||
131925478|NCT03055221|475012570|FG000|Overall Study|Study terminated by Sponsor|3|||
131925479|NCT03055221|475012570|FG000|Overall Study|Lost to Follow-up|4|||
131925480|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
131925481|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
131925482|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
131925483|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
131925484|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
131925485|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
131925486|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
131925487|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
131925488|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
131925489|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
131925490|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
131925491|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
131925492|NCT01243424|475012571|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
131925493|NCT01243424|475012572|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
131925494|NCT01243424|475012571|FG000|Discontinuation From Treatment|Not treated|5|||
131925495|NCT01243424|475012572|FG001|Discontinuation From Treatment|Not treated|4|||
131925496|NCT01243424|475012571|FG000|Discontinuation From Treatment|Adverse Event|457|||
131925497|NCT01243424|475012572|FG001|Discontinuation From Treatment|Adverse Event|523|||
131925498|NCT01243424|475012571|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
131925499|NCT01243424|475012572|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
131925500|NCT01243424|475012571|FG000|Discontinuation From Treatment|Protocol Violation|46|||
131925501|NCT01243424|475012572|FG001|Discontinuation From Treatment|Protocol Violation|47|||
131925502|NCT01243424|475012571|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
131925503|NCT01243424|475012572|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
131925504|NCT01243424|475012571|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
131925505|NCT01243424|475012572|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
131925506|NCT01243424|475012571|FG000|Discontinuation From Treatment|Other than listed above|230|||
131925507|NCT01243424|475012572|FG001|Discontinuation From Treatment|Other than listed above|211|||
131925508|NCT01964560|475012575|FG000|Overall Study|Adverse Event|23|||
131925509|NCT01964560|475012575|FG000|Overall Study|Lack of Efficacy|46|||
131925510|NCT01964560|475012575|FG000|Overall Study|Protocol deviation|2|||
131925511|NCT01964560|475012575|FG000|Overall Study|Lost to Follow-up|4|||
131925512|NCT01964560|475012575|FG000|Overall Study|Withdrawal by Subject|64|||
131925513|NCT01964560|475012575|FG000|Overall Study|Surgery-hemispherotomy|1|||
131925514|NCT01964560|475012575|FG000|Overall Study|Surgery|1|||
131925515|NCT01964560|475012575|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
131925516|NCT01964560|475012575|FG000|Overall Study|Patient and Investigator choice|1|||
131925517|NCT01964560|475012575|FG000|Overall Study|Patient was prescribed CBD|1|||
131925518|NCT01964560|475012575|FG000|Overall Study|Participant moved to another country|1|||
131925519|NCT00378560|475012576|FG000|Overall Study|Adverse Event|1|||
131925520|NCT00378560|475012577|FG001|Overall Study|Adverse Event|0|||
131925521|NCT00378560|475012576|FG000|Overall Study|Lost to Follow-up|24|||
131925522|NCT00378560|475012577|FG001|Overall Study|Lost to Follow-up|29|||
131925523|NCT00378560|475012576|FG000|Overall Study|Protocol Violation|2|||
131925524|NCT00378560|475012577|FG001|Overall Study|Protocol Violation|0|||
131925525|NCT00378560|475012576|FG000|Overall Study|Withdrawal by Subject|17|||
131409734|NCT02119156|473123216|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
131409735|NCT02119156|473123217|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
131409736|NCT02469415|473123218|FG000|Overall Study|Withdrawal by Subject|1|||
131409737|NCT02469415|473123218|FG000|Overall Study|Investigational agent placed on hold|2|||
131409738|NCT00350623|473123221|FG000|Overall Study|Lost to Follow-up|8|||
131409739|NCT00350623|473123222|FG001|Overall Study|Lost to Follow-up|3|||
131409740|NCT00350623|473123223|FG002|Overall Study|Lost to Follow-up|4|||
131409741|NCT00350623|473123221|FG000|Overall Study|Withdrawal by Subject|0|||
131409742|NCT00350623|473123222|FG001|Overall Study|Withdrawal by Subject|1|||
131409743|NCT00350623|473123223|FG002|Overall Study|Withdrawal by Subject|1|||
131409744|NCT00350623|473123221|FG000|Overall Study|patient traveling outside the country|0|||
131409745|NCT00350623|473123222|FG001|Overall Study|patient traveling outside the country|0|||
131925526|NCT00378560|475012577|FG001|Overall Study|Withdrawal by Subject|21|||
131409746|NCT00350623|473123223|FG002|Overall Study|patient traveling outside the country|1|||
131409747|NCT00623545|473123224|FG000|Overall Study|Adverse Event|6|||
131454047|NCT01032889|473291867|FG001|Overall Study|Miscellaneous Reasons|1|||
131925527|NCT00378560|475012576|FG000|Overall Study|Moved|4|||
131881524|NCT03729570|474847829|FG001|Overall Study|Did not want to continue taking medications|1|||
131881525|NCT03729570|474847828|FG000|Overall Study|Found another PrEP provider|1|||
131881526|NCT03729570|474847829|FG001|Overall Study|Found another PrEP provider|0|||
131881527|NCT03729570|474847828|FG000|Overall Study|Did not enjoy being in the control group|0|||
131881528|NCT03729570|474847829|FG001|Overall Study|Did not enjoy being in the control group|1|||
131881529|NCT01701193|474847832|FG000|Overall Study|Withdrawal by Subject|2|||
131881530|NCT01701193|474847833|FG001|Overall Study|Withdrawal by Subject|2|||
131881531|NCT01701193|474847834|FG002|Overall Study|Withdrawal by Subject|1|||
131881532|NCT01701193|474847835|FG003|Overall Study|Withdrawal by Subject|2|||
131881533|NCT01701193|474847832|FG000|Overall Study|Adverse Event|1|||
131881534|NCT01701193|474847833|FG001|Overall Study|Adverse Event|0|||
131881535|NCT01701193|474847834|FG002|Overall Study|Adverse Event|0|||
131881536|NCT01701193|474847835|FG003|Overall Study|Adverse Event|0|||
131881537|NCT00278148|474847836|FG000|Phase II - Expansion Phase|Disease progression|0|||
131409748|NCT00623545|473123224|FG000|Overall Study|Withdrawal by Subject|4|||
131409749|NCT02685748|473123225|FG000|Overall Study|Withdrawal by Subject|3|||
131409750|NCT02685748|473123226|FG001|Overall Study|Withdrawal by Subject|2|||
131409751|NCT04126564|473123227|FG000|Overall Study|Withdrawal by Subject|0|||
131409752|NCT04126564|473123228|FG001|Overall Study|Withdrawal by Subject|2|||
131409753|NCT04126564|473123227|FG000|Overall Study|Lost to Follow-up|0|||
131409754|NCT04126564|473123228|FG001|Overall Study|Lost to Follow-up|1|||
131409755|NCT03500172|473123229|FG000|Period 1: Baseline Randomization|Death|0|||
131409756|NCT03500172|473123230|FG001|Period 1: Baseline Randomization|Death|0|||
131409757|NCT03500172|473123231|FG002|Period 1: Baseline Randomization|Death|0|||
131409758|NCT03500172|473123232|FG003|Period 1: Baseline Randomization|Death|0|||
131409759|NCT03500172|473123233|FG004|Period 1: Baseline Randomization|Death|0|||
131409760|NCT03500172|473123234|FG005|Period 1: Baseline Randomization|Death|0|||
131409761|NCT03500172|473123235|FG006|Period 1: Baseline Randomization|Death|0|||
131409762|NCT03500172|473123236|FG007|Period 1: Baseline Randomization|Death|0|||
131409763|NCT03500172|473123237|FG008|Period 1: Baseline Randomization|Death|0|||
131409764|NCT03500172|473123238|FG009|Period 1: Baseline Randomization|Death|2|||
131409765|NCT03500172|473123239|FG010|Period 1: Baseline Randomization|Death|0|||
131409766|NCT03500172|473123229|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
131409767|NCT03500172|473123230|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
131409768|NCT03500172|473123231|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
131409769|NCT03500172|473123232|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
131409770|NCT03500172|473123233|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
131409771|NCT03500172|473123234|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
131409772|NCT03500172|473123235|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
131409773|NCT03500172|473123236|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
131409774|NCT03500172|473123237|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
131409775|NCT03500172|473123238|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
131409776|NCT03500172|473123239|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
131409777|NCT03500172|473123229|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
131409778|NCT03500172|473123230|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
131409779|NCT03500172|473123231|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
131409780|NCT03500172|473123232|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
131409781|NCT03500172|473123233|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
131409782|NCT03500172|473123234|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
131409783|NCT03500172|473123235|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
131409784|NCT03500172|473123236|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
131409785|NCT03500172|473123237|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
131409786|NCT03500172|473123238|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
131881538|NCT00278148|474847837|FG001|Phase II - Expansion Phase|Disease progression|0|||
131881539|NCT00278148|474847838|FG002|Phase II - Expansion Phase|Disease progression|4|||
131881540|NCT00278148|474847836|FG000|Phase II - Expansion Phase|Adverse Event|0|||
131881541|NCT00278148|474847837|FG001|Phase II - Expansion Phase|Adverse Event|0|||
131881542|NCT00278148|474847838|FG002|Phase II - Expansion Phase|Adverse Event|2|||
131881543|NCT02407457|474847839|FG000|1 Month|Death|3|||
131881544|NCT02407457|474847840|FG001|1 Month|Death|0|||
131881545|NCT02407457|474847839|FG000|1 Month|Lost to Follow-up|1|||
131881546|NCT02407457|474847840|FG001|1 Month|Lost to Follow-up|1|||
131881547|NCT02407457|474847839|FG000|1 Month|missed visit|2|||
131881548|NCT02407457|474847840|FG001|1 Month|missed visit|5|||
131881549|NCT02407457|474847839|FG000|6-Month|Death|2|||
131409787|NCT03500172|473123239|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
131409788|NCT03500172|473123229|FG000|Period 2: Re-Randomization|Death|0|||
131409789|NCT03500172|473123230|FG001|Period 2: Re-Randomization|Death|0|||
131409790|NCT03500172|473123231|FG002|Period 2: Re-Randomization|Death|0|||
131881550|NCT02407457|474847840|FG001|6-Month|Death|8|||
131881551|NCT02407457|474847839|FG000|6-Month|Lost to Follow-up|2|||
131881552|NCT02407457|474847840|FG001|6-Month|Lost to Follow-up|2|||
131881553|NCT02407457|474847839|FG000|6-Month|missed visit|16|||
131881554|NCT02407457|474847840|FG001|6-Month|missed visit|14|||
131881555|NCT02407457|474847839|FG000|6-Month|Open Repair|0|||
131409791|NCT03500172|473123232|FG003|Period 2: Re-Randomization|Death|4|||
131409792|NCT03500172|473123233|FG004|Period 2: Re-Randomization|Death|2|||
131881556|NCT02407457|474847840|FG001|6-Month|Open Repair|1|||
131881557|NCT02407457|474847839|FG000|1 Year|Death|6|||
131881558|NCT02407457|474847840|FG001|1 Year|Death|11|||
131881559|NCT02407457|474847839|FG000|1 Year|Lost to Follow-up|3|||
131881560|NCT02407457|474847840|FG001|1 Year|Lost to Follow-up|2|||
131881561|NCT02407457|474847839|FG000|1 Year|Missed Visit|24|||
131881562|NCT02407457|474847840|FG001|1 Year|Missed Visit|14|||
131881563|NCT02407457|474847839|FG000|1 Year|Open Repair|0|||
131881564|NCT02407457|474847840|FG001|1 Year|Open Repair|1|||
131881565|NCT02407457|474847839|FG000|2-year|Death|14|||
131881566|NCT02407457|474847840|FG001|2-year|Death|8|||
131881567|NCT02407457|474847839|FG000|2-year|Lost to Follow-up|7|||
131881568|NCT02407457|474847840|FG001|2-year|Lost to Follow-up|10|||
131881569|NCT02407457|474847839|FG000|2-year|Missed Visit|13|||
131881570|NCT02407457|474847840|FG001|2-year|Missed Visit|15|||
131881571|NCT02407457|474847839|FG000|2-year|Open Repair|0|||
131881572|NCT02407457|474847840|FG001|2-year|Open Repair|2|||
131881573|NCT02407457|474847839|FG000|3-year|Death|11|||
131881574|NCT02407457|474847840|FG001|3-year|Death|10|||
131881575|NCT02407457|474847839|FG000|3-year|Lost to Follow-up|9|||
131881576|NCT02407457|474847840|FG001|3-year|Lost to Follow-up|10|||
131881577|NCT02407457|474847839|FG000|3-year|Missed Visit|19|||
131881578|NCT02407457|474847840|FG001|3-year|Missed Visit|16|||
131881579|NCT02407457|474847839|FG000|4-year|Death|18|||
131881580|NCT02407457|474847840|FG001|4-year|Death|10|||
131881581|NCT02407457|474847839|FG000|4-year|Lost to Follow-up|10|||
131881582|NCT02407457|474847840|FG001|4-year|Lost to Follow-up|12|||
131881583|NCT02407457|474847839|FG000|4-year|Missed Visit|18|||
131881584|NCT02407457|474847840|FG001|4-year|Missed Visit|16|||
131881585|NCT02407457|474847839|FG000|5-year|Death|10|||
131881586|NCT02407457|474847840|FG001|5-year|Death|3|||
131881587|NCT02407457|474847839|FG000|5-year|Lost to Follow-up|22|||
131881588|NCT02407457|474847840|FG001|5-year|Lost to Follow-up|13|||
131881589|NCT02407457|474847839|FG000|5-year|Missed Visit|9|||
131881590|NCT02407457|474847840|FG001|5-year|Missed Visit|1|||
131881591|NCT02083185|474847842|FG000|Overall Study|Lost to Follow-up|0|||
131881592|NCT02083185|474847843|FG001|Overall Study|Lost to Follow-up|3|||
131881593|NCT02083185|474847844|FG002|Overall Study|Lost to Follow-up|0|||
131881594|NCT02083185|474847842|FG000|Overall Study|Withdrawal by Subject|9|||
131881595|NCT02083185|474847843|FG001|Overall Study|Withdrawal by Subject|15|||
131881596|NCT02083185|474847844|FG002|Overall Study|Withdrawal by Subject|1|||
131881597|NCT02083185|474847842|FG000|Overall Study|Death|2|||
131881598|NCT02083185|474847843|FG001|Overall Study|Death|2|||
131881599|NCT02083185|474847844|FG002|Overall Study|Death|1|||
131881600|NCT02083185|474847842|FG000|Overall Study|Reason not Specified|9|||
131881601|NCT02083185|474847843|FG001|Overall Study|Reason not Specified|6|||
131881602|NCT02083185|474847844|FG002|Overall Study|Reason not Specified|5|||
131881603|NCT02083185|474847842|FG000|Overall Study|Study Terminated by Sponsor|0|||
131881604|NCT02083185|474847843|FG001|Overall Study|Study Terminated by Sponsor|1|||
131881605|NCT02083185|474847844|FG002|Overall Study|Study Terminated by Sponsor|0|||
131881606|NCT02083185|474847842|FG000|Overall Study|Did not Receive Study Drug|0|||
131881607|NCT02083185|474847843|FG001|Overall Study|Did not Receive Study Drug|2|||
131881608|NCT02083185|474847844|FG002|Overall Study|Did not Receive Study Drug|0|||
131881609|NCT01041976|474847845|FG000|Overall Study|Withdrawal by Subject|3|||
131881610|NCT01041976|474847846|FG001|Overall Study|Withdrawal by Subject|0|||
131881611|NCT01041976|474847845|FG000|Overall Study|Incarceration|2|||
131881612|NCT01041976|474847846|FG001|Overall Study|Incarceration|0|||
131881613|NCT01041976|474847845|FG000|Overall Study|Death|0|||
131881614|NCT01041976|474847846|FG001|Overall Study|Death|4|||
131881615|NCT03054064|474847847|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
131881616|NCT03054064|474847847|FG000|Overall Study|Investigator Decision|2|||
131881617|NCT03054064|474847847|FG000|Overall Study|Bladder Issue|1|||
131881618|NCT03054064|474847847|FG000|Overall Study|High Blood Pressure|1|||
131881619|NCT03054064|474847847|FG000|Overall Study|Change in Status|1|||
131881620|NCT03787303|474847850|FG000|Overall Study|Death|1|||
131881621|NCT03787303|474847850|FG000|Overall Study|Premature Termination of Study|1|||
131881622|NCT01210495|474847851|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
131881623|NCT01210495|474847852|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
131881624|NCT01210495|474847853|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
131409793|NCT03500172|473123234|FG005|Period 2: Re-Randomization|Death|0|||
131881625|NCT01210495|474847854|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
131881626|NCT01210495|474847851|FG000|Overall Study|Death|14|||
131409794|NCT03500172|473123235|FG006|Period 2: Re-Randomization|Death|5|||
131881627|NCT01210495|474847852|FG001|Overall Study|Death|7|||
131881628|NCT01210495|474847853|FG002|Overall Study|Death|112|||
131881629|NCT01210495|474847854|FG003|Overall Study|Death|54|||
131409795|NCT03500172|473123236|FG007|Period 2: Re-Randomization|Death|2|||
131881630|NCT01210495|474847851|FG000|Overall Study|Study Terminated by Sponsor|0|||
131881631|NCT01210495|474847852|FG001|Overall Study|Study Terminated by Sponsor|0|||
131881632|NCT01210495|474847853|FG002|Overall Study|Study Terminated by Sponsor|4|||
131881633|NCT01210495|474847854|FG003|Overall Study|Study Terminated by Sponsor|11|||
131925528|NCT00378560|475012577|FG001|Overall Study|Moved|3|||
131925529|NCT00378560|475012576|FG000|Overall Study|Pregnancy|7|||
131925530|NCT00378560|475012577|FG001|Overall Study|Pregnancy|5|||
131925531|NCT00378560|475012576|FG000|Overall Study|Laboratory test values abnormal|1|||
131925532|NCT00378560|475012577|FG001|Overall Study|Laboratory test values abnormal|0|||
131925533|NCT02018887|475012580|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
131925534|NCT02018887|475012581|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925535|NCT02018887|475012582|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925536|NCT02018887|475012583|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925537|NCT02018887|475012584|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925538|NCT02018887|475012585|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925539|NCT02018887|475012586|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925540|NCT02018887|475012587|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925541|NCT02018887|475012588|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925542|NCT02018887|475012589|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925543|NCT02018887|475012590|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
131925544|NCT02018887|475012580|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925545|NCT02018887|475012581|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925546|NCT02018887|475012582|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925547|NCT02018887|475012583|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925548|NCT02018887|475012584|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
131925549|NCT02018887|475012585|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925550|NCT02018887|475012586|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
131925551|NCT02018887|475012587|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
131925552|NCT02018887|475012588|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925553|NCT02018887|475012589|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925554|NCT02018887|475012590|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
131925555|NCT02018887|475012580|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
131925556|NCT02018887|475012581|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
131925557|NCT02018887|475012582|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
131925558|NCT02018887|475012583|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
131925559|NCT02018887|475012584|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
131925560|NCT02018887|475012585|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
131925561|NCT02018887|475012586|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
131925562|NCT02018887|475012587|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
131925563|NCT02018887|475012588|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
131925564|NCT02018887|475012589|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
131925565|NCT02018887|475012590|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
131925566|NCT02018887|475012580|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
131925567|NCT02018887|475012581|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
131925568|NCT02018887|475012582|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
131925569|NCT02018887|475012583|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
131925570|NCT02018887|475012584|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
131925571|NCT02018887|475012585|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
131925572|NCT02018887|475012586|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
131925573|NCT02018887|475012587|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
131925574|NCT02018887|475012588|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
131925575|NCT02018887|475012589|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
131925576|NCT02018887|475012590|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
131925577|NCT01717859|475012592|FG000|Overall Study|Adverse Event|5|||
131925578|NCT01717859|475012592|FG000|Overall Study|Moved out of state|1|||
131925579|NCT01717859|475012592|FG000|Overall Study|Patient concerned about mental health|1|||
131925580|NCT01717859|475012592|FG000|Overall Study|Lost to Follow-up|1|||
131925581|NCT01717859|475012592|FG000|Overall Study|Withdrawal by Subject|2|||
131925582|NCT01623752|475012593|FG000|Phase 1 (78 Weeks)|No Data|249|||
131925583|NCT01623752|475012594|FG001|Phase 1 (78 Weeks)|No Data|66|||
131925584|NCT01623752|475012595|FG002|Phase 1 (78 Weeks)|No Data|2|||
131925585|NCT01623752|475012593|FG000|Phase 1 (78 Weeks)|Other|33|||
131925586|NCT01623752|475012594|FG001|Phase 1 (78 Weeks)|Other|20|||
131925587|NCT01623752|475012595|FG002|Phase 1 (78 Weeks)|Other|0|||
131925588|NCT01623752|475012593|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
131925589|NCT01623752|475012594|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
131925590|NCT01623752|475012595|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
131925591|NCT01623752|475012593|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
131925592|NCT01623752|475012594|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
131925593|NCT01623752|475012595|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
131925594|NCT01623752|475012593|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
131925595|NCT01623752|475012594|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
131409796|NCT03500172|473123237|FG008|Period 2: Re-Randomization|Death|0|||
131409797|NCT03500172|473123238|FG009|Period 2: Re-Randomization|Death|0|||
131925596|NCT01623752|475012595|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
131925597|NCT01623752|475012593|FG000|Phase 2 (78 Weeks)|Other|5|||
131925598|NCT01623752|475012594|FG001|Phase 2 (78 Weeks)|Other|1|||
131925599|NCT01623752|475012595|FG002|Phase 2 (78 Weeks)|Other|0|||
131925600|NCT01623752|475012593|FG000|Phase 2 (78 Weeks)|No Data|43|||
131925601|NCT01623752|475012594|FG001|Phase 2 (78 Weeks)|No Data|11|||
131925602|NCT01623752|475012595|FG002|Phase 2 (78 Weeks)|No Data|0|||
131925603|NCT01623752|475012593|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
131925604|NCT01623752|475012594|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
131925605|NCT01623752|475012595|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
131925606|NCT04389671|475012596|FG000|Overall Study|Death|7|||
131925607|NCT04865978|475012597|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
131925608|NCT04865978|475012598|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
131925609|NCT03835117|475012599|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
131925610|NCT03835117|475012600|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
131925611|NCT00629239|475012602|FG000|Overall Study|Adverse Event|7|||
131925612|NCT00629239|475012603|FG001|Overall Study|Adverse Event|4|||
131925613|NCT00629239|475012602|FG000|Overall Study|Physician Decision|1|||
131925614|NCT00629239|475012603|FG001|Overall Study|Physician Decision|0|||
131925615|NCT00183391|475012604|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
131925616|NCT00183391|475012605|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
131925617|NCT00183391|475012604|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
131925618|NCT00183391|475012605|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
131925619|NCT01543503|475012607|FG000|Overall Study|Lost to Follow-up|32|||
131925620|NCT01543503|475012608|FG001|Overall Study|Lost to Follow-up|36|||
131409798|NCT03500172|473123239|FG010|Period 2: Re-Randomization|Death|0|||
131409799|NCT04599166|473123247|FG000|Overall Study|Technological failure connecting to study app|80|||
131409800|NCT01974752|473123250|FG000|Overall Study|Death|33|||
131881634|NCT01210495|474847851|FG000|Overall Study|Lost to Follow-up|0|||
131881635|NCT01210495|474847852|FG001|Overall Study|Lost to Follow-up|0|||
131881636|NCT01210495|474847853|FG002|Overall Study|Lost to Follow-up|1|||
131881637|NCT01210495|474847854|FG003|Overall Study|Lost to Follow-up|1|||
131881638|NCT01210495|474847851|FG000|Overall Study|Other unspecified|0|||
131881639|NCT01210495|474847852|FG001|Overall Study|Other unspecified|0|||
131881640|NCT01210495|474847853|FG002|Overall Study|Other unspecified|6|||
131881641|NCT01210495|474847854|FG003|Overall Study|Other unspecified|0|||
131881642|NCT01384019|474847857|FG000|Overall Study|Withdrawal by Subject|3|||
131881643|NCT01384019|474847858|FG001|Overall Study|Withdrawal by Subject|0|||
131881644|NCT01384019|474847857|FG000|Overall Study|Death|1|||
131881645|NCT01384019|474847858|FG001|Overall Study|Death|0|||
131881646|NCT01384019|474847857|FG000|Overall Study|MRI refusal|6|||
131881647|NCT01384019|474847858|FG001|Overall Study|MRI refusal|6|||
131881648|NCT00767039|474847861|FG000|Overall Study|Death|5|||
131881649|NCT00767039|474847862|FG001|Overall Study|Death|2|||
131881650|NCT01826370|474847863|FG000|Overall Study|Protocol Violation|6|||
131881651|NCT01826370|474847863|FG000|Overall Study|Lost to Follow-up|12|||
131881652|NCT01826370|474847863|FG000|Overall Study|Other reason not defined above|2|||
131881653|NCT04416737|474847865|FG000|Week 1 (First Injection)|Physician Decision|0|||
131881654|NCT04416737|474847866|FG001|Week 1 (First Injection)|Physician Decision|1|||
131881655|NCT03332628|474847867|FG000|Overall Study|Physician Decision|2|||
131881656|NCT01472757|474847868|FG000|Overall Study|Withdrawal by Subject|1|||
131881657|NCT01472757|474847869|FG001|Overall Study|Withdrawal by Subject|2|||
131881658|NCT01472757|474847870|FG002|Overall Study|Withdrawal by Subject|2|||
131881659|NCT01472757|474847871|FG003|Overall Study|Withdrawal by Subject|0|||
131881660|NCT01472757|474847868|FG000|Overall Study|Asthma exacerbation|4|||
131881661|NCT01472757|474847869|FG001|Overall Study|Asthma exacerbation|1|||
131881662|NCT01472757|474847870|FG002|Overall Study|Asthma exacerbation|2|||
131881663|NCT01472757|474847871|FG003|Overall Study|Asthma exacerbation|1|||
131881664|NCT01472757|474847868|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
131881665|NCT01472757|474847869|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
131881666|NCT01472757|474847870|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
131881667|NCT01472757|474847871|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
131881668|NCT01472757|474847868|FG000|Overall Study|Protocol Violation|3|||
131881669|NCT01472757|474847869|FG001|Overall Study|Protocol Violation|2|||
131881670|NCT01472757|474847870|FG002|Overall Study|Protocol Violation|4|||
131881671|NCT01472757|474847871|FG003|Overall Study|Protocol Violation|4|||
131881672|NCT01472757|474847868|FG000|Overall Study|Other reasons|1|||
131881673|NCT01472757|474847869|FG001|Overall Study|Other reasons|0|||
131881674|NCT01472757|474847870|FG002|Overall Study|Other reasons|2|||
131925621|NCT01543503|475012607|FG000|Overall Study|Adverse Event|9|||
131925622|NCT01543503|475012608|FG001|Overall Study|Adverse Event|13|||
131925623|NCT01543503|475012607|FG000|Overall Study|Lack of Efficacy|4|||
131925624|NCT01543503|475012608|FG001|Overall Study|Lack of Efficacy|16|||
131409801|NCT01974752|473123251|FG001|Overall Study|Death|11|||
131409802|NCT01974752|473123250|FG000|Overall Study|Lost to Follow-up|2|||
131409803|NCT01974752|473123251|FG001|Overall Study|Lost to Follow-up|0|||
131881675|NCT01472757|474847871|FG003|Overall Study|Other reasons|2|||
131881676|NCT04489381|474847876|FG000|Overall Study|Lost to Follow-up|2|||
131881677|NCT04489381|474847877|FG001|Overall Study|Lost to Follow-up|3|||
131881678|NCT04489381|474847876|FG000|Overall Study|Withdrawal by Subject|1|||
131881679|NCT04489381|474847877|FG001|Overall Study|Withdrawal by Subject|0|||
131881680|NCT02939716|474847882|FG000|Overall Study|scanner failure|0|||
131881681|NCT02939716|474847883|FG001|Overall Study|scanner failure|0|||
131925625|NCT01543503|475012607|FG000|Overall Study|Participant withdrew informed consent|8|||
131925626|NCT01543503|475012608|FG001|Overall Study|Participant withdrew informed consent|10|||
131925627|NCT01543503|475012607|FG000|Overall Study|Change of jobs|0|||
131925628|NCT01543503|475012608|FG001|Overall Study|Change of jobs|1|||
131925629|NCT01543503|475012607|FG000|Overall Study|Intolerance to the biologic treatment|0|||
131925630|NCT01543503|475012608|FG001|Overall Study|Intolerance to the biologic treatment|1|||
131925631|NCT01543503|475012607|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
131925632|NCT01543503|475012608|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
131925633|NCT01543503|475012607|FG000|Overall Study|Participant did not complete last visit|0|||
131925634|NCT01543503|475012608|FG001|Overall Study|Participant did not complete last visit|2|||
131925635|NCT01543503|475012607|FG000|Overall Study|Refused to continue treatment|7|||
131925636|NCT01543503|475012608|FG001|Overall Study|Refused to continue treatment|0|||
131925637|NCT01543503|475012607|FG000|Overall Study|Incorrect medication received|1|||
131925638|NCT01543503|475012608|FG001|Overall Study|Incorrect medication received|0|||
131925639|NCT01543503|475012607|FG000|Overall Study|Participant moved to another city|2|||
131925640|NCT01543503|475012608|FG001|Overall Study|Participant moved to another city|0|||
131925641|NCT01543503|475012607|FG000|Overall Study|Participant will not return for visits|0|||
131925642|NCT01543503|475012608|FG001|Overall Study|Participant will not return for visits|2|||
131925643|NCT01543503|475012607|FG000|Overall Study|Participant transferred to another city|1|||
131925644|NCT01543503|475012608|FG001|Overall Study|Participant transferred to another city|0|||
131925645|NCT01543503|475012607|FG000|Overall Study|Participant moved to Scotland|1|||
131925646|NCT01543503|475012608|FG001|Overall Study|Participant moved to Scotland|0|||
131925647|NCT01543503|475012607|FG000|Overall Study|Participant decision to stop treatment|1|||
131925648|NCT01543503|475012608|FG001|Overall Study|Participant decision to stop treatment|0|||
131925649|NCT01543503|475012607|FG000|Overall Study|Investigator did not wish to participate|1|||
131925650|NCT01543503|475012608|FG001|Overall Study|Investigator did not wish to participate|1|||
131925651|NCT01543503|475012607|FG000|Overall Study|Participant recruited after closing date|0|||
131925652|NCT01543503|475012608|FG001|Overall Study|Participant recruited after closing date|1|||
131925653|NCT01543503|475012607|FG000|Overall Study|Site stopped participation|5|||
131925654|NCT01543503|475012608|FG001|Overall Study|Site stopped participation|1|||
131925655|NCT01543503|475012607|FG000|Overall Study|Participant did not attend a visit|1|||
131925656|NCT01543503|475012608|FG001|Overall Study|Participant did not attend a visit|0|||
131925657|NCT01543503|475012607|FG000|Overall Study|Moved to other rheumatologic site|0|||
131925658|NCT01543503|475012608|FG001|Overall Study|Moved to other rheumatologic site|1|||
131925659|NCT01543503|475012607|FG000|Overall Study|Participant consented to another study|0|||
131925660|NCT01543503|475012608|FG001|Overall Study|Participant consented to another study|2|||
131925661|NCT01543503|475012607|FG000|Overall Study|Participant went to United States|1|||
131925662|NCT01543503|475012608|FG001|Overall Study|Participant went to United States|0|||
131925663|NCT01543503|475012607|FG000|Overall Study|Screen failure|1|||
131925664|NCT01543503|475012608|FG001|Overall Study|Screen failure|0|||
131925665|NCT01478087|475012609|FG000|Overall Study|due to sponsor closing study|1|||
131925666|NCT03566550|475012610|FG000|Overall Study|Withdrawal by Subject|0|||
131925667|NCT03566550|475012611|FG001|Overall Study|Withdrawal by Subject|1|||
131925668|NCT04576949|475012613|FG000|Overall Study|Adverse Event|1|||
131925669|NCT04576949|475012614|FG001|Overall Study|Adverse Event|3|||
131925670|NCT04576949|475012615|FG002|Overall Study|Adverse Event|2|||
131925671|NCT04576949|475012613|FG000|Overall Study|Withdrawal by Subject|41|||
131925672|NCT04576949|475012614|FG001|Overall Study|Withdrawal by Subject|26|||
131925673|NCT04576949|475012615|FG002|Overall Study|Withdrawal by Subject|18|||
131925674|NCT04576949|475012613|FG000|Overall Study|Physician Decision|3|||
131925675|NCT04576949|475012614|FG001|Overall Study|Physician Decision|0|||
131925676|NCT04576949|475012615|FG002|Overall Study|Physician Decision|0|||
131881682|NCT02939716|474847884|FG002|Overall Study|scanner failure|0|||
131881683|NCT02939716|474847885|FG003|Overall Study|scanner failure|1|||
131881684|NCT02939716|474847886|FG004|Overall Study|scanner failure|1|||
131881685|NCT02939716|474847887|FG005|Overall Study|scanner failure|1|||
131881686|NCT02543892|474847888|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
131881687|NCT02543892|474847889|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
131881688|NCT02543892|474847890|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
131925677|NCT04576949|475012613|FG000|Overall Study|Death|0|||
131925678|NCT04576949|475012614|FG001|Overall Study|Death|1|||
131925679|NCT04576949|475012615|FG002|Overall Study|Death|0|||
131925680|NCT04576949|475012613|FG000|Overall Study|Lost to Follow-up|29|||
131925681|NCT04576949|475012614|FG001|Overall Study|Lost to Follow-up|37|||
131925682|NCT04576949|475012615|FG002|Overall Study|Lost to Follow-up|24|||
131925683|NCT04576949|475012613|FG000|Overall Study|Other, Not Specified|2|||
131925684|NCT04576949|475012614|FG001|Overall Study|Other, Not Specified|3|||
131925685|NCT04576949|475012615|FG002|Overall Study|Other, Not Specified|1|||
131925686|NCT04576949|475012613|FG000|Overall Study|Other|1|||
131925687|NCT04576949|475012614|FG001|Overall Study|Other|0|||
131925688|NCT04576949|475012615|FG002|Overall Study|Other|0|||
131409804|NCT01974752|473123250|FG000|Overall Study|Withdrawal by Subject|2|||
131881689|NCT02543892|474847891|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
131925689|NCT00052715|475012616|FG000|Overall Study|wrong histology|1|||
131925690|NCT01063881|475012617|FG000|Overall Study|Adverse Event|12|||
131925691|NCT01063881|475012618|FG001|Overall Study|Adverse Event|2|||
131925692|NCT01063881|475012619|FG002|Overall Study|Adverse Event|0|||
131925693|NCT01063881|475012617|FG000|Overall Study|Lost to Follow-up|13|||
131925694|NCT01063881|475012618|FG001|Overall Study|Lost to Follow-up|7|||
131925695|NCT01063881|475012619|FG002|Overall Study|Lost to Follow-up|1|||
131925696|NCT01063881|475012617|FG000|Overall Study|Withdrawal by Subject|25|||
131925697|NCT01063881|475012618|FG001|Overall Study|Withdrawal by Subject|1|||
131925698|NCT01063881|475012619|FG002|Overall Study|Withdrawal by Subject|0|||
131925699|NCT01063881|475012617|FG000|Overall Study|Reason for not completed not specified|5|||
131925700|NCT01063881|475012618|FG001|Overall Study|Reason for not completed not specified|1|||
131925701|NCT01063881|475012619|FG002|Overall Study|Reason for not completed not specified|0|||
131925702|NCT01968785|475012620|FG000|Overall Study|Withdrawal by Subject|1|||
131925703|NCT01968785|475012621|FG001|Overall Study|Withdrawal by Subject|0|||
131925704|NCT03518203|475012626|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
131925705|NCT03518203|475012626|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
131925706|NCT05085405|475012628|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
131925707|NCT05085405|475012629|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
131925708|NCT05085405|475012630|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
131925709|NCT05085405|475012631|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
131925710|NCT05085405|475012632|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
131925711|NCT05085405|475012633|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
131925712|NCT05085405|475012628|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
131925713|NCT05085405|475012629|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
131925714|NCT05085405|475012630|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
131925715|NCT05085405|475012631|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
131925716|NCT05085405|475012632|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
131925717|NCT05085405|475012633|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
131925718|NCT01663987|475012635|FG000|Overall Study|Adverse Event|7|||
131925719|NCT01663987|475012636|FG001|Overall Study|Adverse Event|2|||
131925720|NCT01663987|475012635|FG000|Overall Study|Lost to Follow-up|1|||
131925721|NCT01663987|475012636|FG001|Overall Study|Lost to Follow-up|1|||
131925722|NCT01663987|475012635|FG000|Overall Study|Withdrawal by Subject|2|||
131925723|NCT01663987|475012636|FG001|Overall Study|Withdrawal by Subject|3|||
131925724|NCT01663987|475012635|FG000|Overall Study|Other reason not defined above|3|||
131925725|NCT01663987|475012636|FG001|Overall Study|Other reason not defined above|0|||
131925726|NCT00455455|475012641|FG000|Washout|Withdrawal by Subject|0|||
131925727|NCT00455455|475012642|FG001|Washout|Withdrawal by Subject|1|||
131925728|NCT00455455|475012641|FG000|Washout|Withdrawal by Subject|1|||
131925729|NCT00455455|475012642|FG001|Washout|Withdrawal by Subject|0|||
131925730|NCT03808909|475012643|FG000|Overall Study|Lost to Follow-up|3|||
131925731|NCT03808909|475012644|FG001|Overall Study|Lost to Follow-up|0|||
131925732|NCT01827943|475012645|FG000|Overall Study|Protocol Violation|8|||
131925733|NCT01827943|475012645|FG000|Overall Study|Never treated because of an rapid progression|1|||
131925734|NCT01084135|475012646|FG000|20 Week|Physician Decision|0|||
131925735|NCT01084135|475012647|FG001|20 Week|Physician Decision|1|||
131925736|NCT03335566|475012648|FG000|Overall Study|Adverse Event|0|||
131925737|NCT03335566|475012649|FG001|Overall Study|Adverse Event|1|||
131925738|NCT03335566|475012648|FG000|Overall Study|Lost to Follow-up|1|||
131925739|NCT03335566|475012649|FG001|Overall Study|Lost to Follow-up|0|||
131925740|NCT03335566|475012648|FG000|Overall Study|Technical Problems|1|||
131925741|NCT03335566|475012649|FG001|Overall Study|Technical Problems|0|||
131925742|NCT03335566|475012648|FG000|Overall Study|Protocol Violation|1|||
131925743|NCT03335566|475012649|FG001|Overall Study|Protocol Violation|0|||
131925744|NCT03335566|475012648|FG000|Overall Study|Other than specified above|1|||
131925745|NCT03335566|475012649|FG001|Overall Study|Other than specified above|2|||
131925746|NCT00663351|475012650|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
131409805|NCT01974752|473123251|FG001|Overall Study|Withdrawal by Subject|3|||
131409806|NCT01974752|473123250|FG000|Overall Study|Other Eligibility Criteria|0|||
131409807|NCT01974752|473123251|FG001|Overall Study|Other Eligibility Criteria|1|||
131409808|NCT02435680|473123253|FG000|Overall Study|Physician Decision|3|||
131925747|NCT00663351|475012651|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
131925748|NCT00663351|475012650|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
131925749|NCT00663351|475012651|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
131925750|NCT00663351|475012650|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
131925751|NCT00663351|475012651|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
131409809|NCT02435680|473123254|FG001|Overall Study|Physician Decision|0|||
131409810|NCT02435680|473123255|FG002|Overall Study|Physician Decision|0|||
131925752|NCT00663351|475012650|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
131925753|NCT00663351|475012651|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
131409811|NCT02435680|473123253|FG000|Overall Study|subject / guardian decision|0|||
131409812|NCT02435680|473123254|FG001|Overall Study|subject / guardian decision|3|||
131409813|NCT02435680|473123255|FG002|Overall Study|subject / guardian decision|2|||
131409814|NCT02435680|473123253|FG000|Overall Study|Adverse Event|8|||
131409815|NCT02435680|473123254|FG001|Overall Study|Adverse Event|3|||
131409816|NCT02435680|473123255|FG002|Overall Study|Adverse Event|2|||
131409817|NCT02435680|473123253|FG000|Overall Study|progressive disease|10|||
131409818|NCT02435680|473123254|FG001|Overall Study|progressive disease|7|||
131409819|NCT02435680|473123255|FG002|Overall Study|progressive disease|11|||
131409820|NCT02435680|473123253|FG000|Overall Study|not treated|0|||
131409821|NCT02435680|473123254|FG001|Overall Study|not treated|0|||
131881690|NCT02543892|474847892|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
131881691|NCT02543892|474847893|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
131881692|NCT02543892|474847894|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
131881693|NCT02543892|474847895|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
131881694|NCT02543892|474847888|FG000|Received Vaccination 2|Physician Decision|0|||
131881695|NCT02543892|474847889|FG001|Received Vaccination 2|Physician Decision|0|||
131881696|NCT02543892|474847890|FG002|Received Vaccination 2|Physician Decision|0|||
131881697|NCT02543892|474847891|FG003|Received Vaccination 2|Physician Decision|0|||
131881698|NCT02543892|474847892|FG004|Received Vaccination 2|Physician Decision|0|||
131881699|NCT02543892|474847893|FG005|Received Vaccination 2|Physician Decision|1|||
131881700|NCT02543892|474847894|FG006|Received Vaccination 2|Physician Decision|0|||
131881701|NCT02543892|474847895|FG007|Received Vaccination 2|Physician Decision|0|||
131881702|NCT02543892|474847888|FG000|Received Vaccination 2|Adverse Event|0|||
131881703|NCT02543892|474847889|FG001|Received Vaccination 2|Adverse Event|1|||
131881704|NCT02543892|474847890|FG002|Received Vaccination 2|Adverse Event|0|||
131881705|NCT02543892|474847891|FG003|Received Vaccination 2|Adverse Event|0|||
131881706|NCT02543892|474847892|FG004|Received Vaccination 2|Adverse Event|0|||
131881707|NCT02543892|474847893|FG005|Received Vaccination 2|Adverse Event|0|||
131881708|NCT02543892|474847894|FG006|Received Vaccination 2|Adverse Event|0|||
131881709|NCT02543892|474847895|FG007|Received Vaccination 2|Adverse Event|0|||
131881710|NCT02543892|474847888|FG000|Had Immunology Data|Withdrawal by Subject|0|||
131881711|NCT02543892|474847889|FG001|Had Immunology Data|Withdrawal by Subject|0|||
131881712|NCT02543892|474847890|FG002|Had Immunology Data|Withdrawal by Subject|0|||
131881713|NCT02543892|474847891|FG003|Had Immunology Data|Withdrawal by Subject|0|||
131881714|NCT02543892|474847892|FG004|Had Immunology Data|Withdrawal by Subject|0|||
131881715|NCT02543892|474847893|FG005|Had Immunology Data|Withdrawal by Subject|0|||
131881716|NCT02543892|474847894|FG006|Had Immunology Data|Withdrawal by Subject|1|||
131881717|NCT02543892|474847895|FG007|Had Immunology Data|Withdrawal by Subject|0|||
131881718|NCT01500213|474847896|FG000|Overall Study|Adverse Event|35|||
131881719|NCT01500213|474847897|FG001|Overall Study|Adverse Event|35|||
131881720|NCT01500213|474847896|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
131881721|NCT01500213|474847897|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
131881722|NCT01500213|474847896|FG000|Overall Study|Withdrawal by Subject|28|||
131881723|NCT01500213|474847897|FG001|Overall Study|Withdrawal by Subject|37|||
131881724|NCT01500213|474847896|FG000|Overall Study|Death|7|||
131881725|NCT01500213|474847897|FG001|Overall Study|Death|3|||
131881726|NCT01500213|474847896|FG000|Overall Study|Disease Progression|13|||
131881727|NCT01500213|474847897|FG001|Overall Study|Disease Progression|21|||
131881728|NCT01500213|474847896|FG000|Overall Study|Protocol Violation|19|||
131881729|NCT01500213|474847897|FG001|Overall Study|Protocol Violation|19|||
131881730|NCT01500213|474847896|FG000|Overall Study|Physician Decision|12|||
131881731|NCT01500213|474847897|FG001|Overall Study|Physician Decision|10|||
131881732|NCT01500213|474847896|FG000|Overall Study|Lack of Efficacy|9|||
131881733|NCT01500213|474847897|FG001|Overall Study|Lack of Efficacy|7|||
131881734|NCT01500213|474847896|FG000|Overall Study|Lost to Follow-up|3|||
131881735|NCT01500213|474847897|FG001|Overall Study|Lost to Follow-up|6|||
131881736|NCT01500213|474847896|FG000|Overall Study|Other Reasons|7|||
131881737|NCT01500213|474847897|FG001|Overall Study|Other Reasons|5|||
131881738|NCT00785213|474847898|FG000|Quinine Sulfate Alone|Adverse Event|4|||
131881739|NCT00785213|474847898|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
131881740|NCT00525902|474847899|FG000|Overall Study|Lack of Efficacy|1|||
131881741|NCT01259375|474847900|FG000|Overall Study|Adverse Event|1|||
131881742|NCT03814720|474847905|FG000|Overall Study|Lost to Follow-up|0|||
131881743|NCT03814720|474847906|FG001|Overall Study|Lost to Follow-up|1|||
131881744|NCT03814720|474847907|FG002|Overall Study|Lost to Follow-up|0|||
131881745|NCT03814720|474847908|FG003|Overall Study|Lost to Follow-up|0|||
131409822|NCT02435680|473123255|FG002|Overall Study|not treated|1|||
131409823|NCT00330928|473123258|FG000|Overall Study|Lost to Follow-up|6|||
131409824|NCT00330928|473123258|FG000|Overall Study|Physician Decision|9|||
131409825|NCT00330928|473123258|FG000|Overall Study|Death|1|||
131881746|NCT03814720|474847909|FG004|Overall Study|Lost to Follow-up|0|||
131881747|NCT02135107|474847910|FG000|Treatment Period|Withdrawal by Subject|11|||
131881748|NCT02135107|474847911|FG001|Treatment Period|Withdrawal by Subject|0|||
131881749|NCT02135107|474847912|FG002|Treatment Period|Withdrawal by Subject|0|||
131881750|NCT02135107|474847913|FG003|Treatment Period|Withdrawal by Subject|0|||
131881751|NCT02135107|474847910|FG000|Treatment Period|Adverse Event|5|||
131881752|NCT02135107|474847911|FG001|Treatment Period|Adverse Event|2|||
131454048|NCT01032889|473291868|FG002|Overall Study|Miscellaneous Reasons|1|||
131881753|NCT02135107|474847912|FG002|Treatment Period|Adverse Event|0|||
131881754|NCT02135107|474847913|FG003|Treatment Period|Adverse Event|0|||
131881755|NCT02135107|474847910|FG000|Treatment Period|Pregnancy|1|||
131881756|NCT02135107|474847911|FG001|Treatment Period|Pregnancy|0|||
131881757|NCT02135107|474847912|FG002|Treatment Period|Pregnancy|0|||
131881758|NCT02135107|474847913|FG003|Treatment Period|Pregnancy|0|||
131881759|NCT02135107|474847910|FG000|Treatment Period|Other|115|||
131881760|NCT02135107|474847911|FG001|Treatment Period|Other|24|||
131881761|NCT02135107|474847912|FG002|Treatment Period|Other|0|||
131881762|NCT02135107|474847913|FG003|Treatment Period|Other|0|||
131881763|NCT02135107|474847910|FG000|Maintenance Therapy Period|Adverse Event|0|||
131881764|NCT02135107|474847911|FG001|Maintenance Therapy Period|Adverse Event|0|||
131881765|NCT02135107|474847912|FG002|Maintenance Therapy Period|Adverse Event|3|||
131881766|NCT02135107|474847913|FG003|Maintenance Therapy Period|Adverse Event|7|||
131881767|NCT02135107|474847910|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
131881768|NCT02135107|474847911|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
131881769|NCT02135107|474847912|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
131881770|NCT02135107|474847913|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
131881771|NCT02135107|474847910|FG000|Maintenance Therapy Period|Pregnancy|0|||
131881772|NCT02135107|474847911|FG001|Maintenance Therapy Period|Pregnancy|0|||
131881773|NCT02135107|474847912|FG002|Maintenance Therapy Period|Pregnancy|0|||
131881774|NCT02135107|474847913|FG003|Maintenance Therapy Period|Pregnancy|1|||
131881775|NCT02135107|474847910|FG000|Maintenance Therapy Period|Other|0|||
131881776|NCT02135107|474847911|FG001|Maintenance Therapy Period|Other|0|||
131881777|NCT02135107|474847912|FG002|Maintenance Therapy Period|Other|7|||
131881778|NCT02135107|474847913|FG003|Maintenance Therapy Period|Other|8|||
131881779|NCT03197324|474847914|FG000|Overall Study|Adverse Event|0|||
131881780|NCT03197324|474847915|FG001|Overall Study|Adverse Event|1|||
131881781|NCT05723328|474847917|FG000|Overall Study|Investigator's Decision|5|||
131881782|NCT05723328|474847918|FG001|Overall Study|Investigator's Decision|2|||
131881783|NCT00197002|474849235|FG000|Overall Study|Adverse Event|0|||
131881784|NCT00197002|474849236|FG001|Overall Study|Adverse Event|1|||
131881785|NCT00197002|474849237|FG002|Overall Study|Adverse Event|0|||
131881786|NCT00197002|474849235|FG000|Overall Study|Protocol Violation|1|||
131881787|NCT00197002|474849236|FG001|Overall Study|Protocol Violation|0|||
131881788|NCT00197002|474849237|FG002|Overall Study|Protocol Violation|2|||
131881789|NCT00197002|474849235|FG000|Overall Study|Withdrawal by Subject|9|||
131881790|NCT00197002|474849236|FG001|Overall Study|Withdrawal by Subject|5|||
131881791|NCT00197002|474849237|FG002|Overall Study|Withdrawal by Subject|7|||
131881792|NCT00197002|474849235|FG000|Overall Study|Migrated/moved from study area|3|||
131881793|NCT00197002|474849236|FG001|Overall Study|Migrated/moved from study area|5|||
131881794|NCT00197002|474849237|FG002|Overall Study|Migrated/moved from study area|1|||
131881795|NCT00197002|474849235|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
131881796|NCT00197002|474849236|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
131881797|NCT00197002|474849237|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
131881798|NCT00197002|474849235|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
131881799|NCT00197002|474849236|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
131881800|NCT00197002|474849237|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
131881801|NCT00197002|474849235|FG000|Overall Study|Others|3|||
131881802|NCT00197002|474849236|FG001|Overall Study|Others|1|||
131881803|NCT00197002|474849237|FG002|Overall Study|Others|1|||
131881804|NCT02017717|474849238|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881805|NCT02017717|474849239|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881806|NCT02017717|474849240|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881807|NCT02017717|474849241|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881808|NCT02017717|474849242|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881809|NCT02017717|474849243|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881810|NCT02017717|474849244|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881811|NCT02017717|474849245|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
131881812|NCT02017717|474849246|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
131881813|NCT02017717|474849238|FG000|Before Treatment Period|Participant request to stop therapy|0|||
131881814|NCT02017717|474849239|FG001|Before Treatment Period|Participant request to stop therapy|0|||
131881815|NCT02017717|474849240|FG002|Before Treatment Period|Participant request to stop therapy|0|||
131881816|NCT02017717|474849241|FG003|Before Treatment Period|Participant request to stop therapy|0|||
131881817|NCT02017717|474849242|FG004|Before Treatment Period|Participant request to stop therapy|0|||
131881818|NCT02017717|474849243|FG005|Before Treatment Period|Participant request to stop therapy|0|||
131881819|NCT02017717|474849244|FG006|Before Treatment Period|Participant request to stop therapy|0|||
131881820|NCT02017717|474849245|FG007|Before Treatment Period|Participant request to stop therapy|0|||
131881821|NCT02017717|474849246|FG008|Before Treatment Period|Participant request to stop therapy|5|||
131881822|NCT02017717|474849238|FG000|Before Treatment Period|Participant withdrew consent|0|||
131925754|NCT00663351|475012650|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
131881823|NCT02017717|474849239|FG001|Before Treatment Period|Participant withdrew consent|0|||
131881824|NCT02017717|474849240|FG002|Before Treatment Period|Participant withdrew consent|0|||
131881825|NCT02017717|474849241|FG003|Before Treatment Period|Participant withdrew consent|0|||
131881826|NCT02017717|474849242|FG004|Before Treatment Period|Participant withdrew consent|0|||
131881827|NCT02017717|474849243|FG005|Before Treatment Period|Participant withdrew consent|0|||
131881828|NCT02017717|474849244|FG006|Before Treatment Period|Participant withdrew consent|2|||
131881829|NCT02017717|474849245|FG007|Before Treatment Period|Participant withdrew consent|0|||
131881830|NCT02017717|474849246|FG008|Before Treatment Period|Participant withdrew consent|11|||
131881831|NCT02017717|474849238|FG000|Before Treatment Period|Lost to Follow-up|0|||
131881832|NCT02017717|474849239|FG001|Before Treatment Period|Lost to Follow-up|0|||
131881833|NCT02017717|474849240|FG002|Before Treatment Period|Lost to Follow-up|0|||
131881834|NCT02017717|474849241|FG003|Before Treatment Period|Lost to Follow-up|0|||
131881835|NCT02017717|474849242|FG004|Before Treatment Period|Lost to Follow-up|0|||
131881836|NCT02017717|474849243|FG005|Before Treatment Period|Lost to Follow-up|0|||
131881837|NCT02017717|474849244|FG006|Before Treatment Period|Lost to Follow-up|0|||
131881838|NCT02017717|474849245|FG007|Before Treatment Period|Lost to Follow-up|0|||
131881839|NCT02017717|474849246|FG008|Before Treatment Period|Lost to Follow-up|1|||
131881840|NCT02017717|474849238|FG000|Before Treatment Period|Participant no longer met criteria|0|||
131881841|NCT02017717|474849239|FG001|Before Treatment Period|Participant no longer met criteria|0|||
131881842|NCT02017717|474849240|FG002|Before Treatment Period|Participant no longer met criteria|0|||
131925755|NCT00663351|475012651|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
131925756|NCT00663351|475012650|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
131925757|NCT00663351|475012651|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
131925758|NCT03467945|475012653|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131925759|NCT03467945|475012654|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131925760|NCT03467945|475012655|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131925761|NCT03467945|475012656|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131925762|NCT03467945|475012653|FG000|Treatment Period 3|Withdrawal by Subject|1|||
131925763|NCT03467945|475012654|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131925764|NCT03467945|475012655|FG002|Treatment Period 3|Withdrawal by Subject|2|||
131925765|NCT03467945|475012656|FG003|Treatment Period 3|Withdrawal by Subject|1|||
131925766|NCT01740427|475012667|FG000|Overall Study|Objective Progression or Relapse|286|||
131925767|NCT01740427|475012668|FG001|Overall Study|Objective Progression or Relapse|172|||
131925768|NCT01740427|475012667|FG000|Overall Study|Adverse Event|32|||
131925769|NCT01740427|475012668|FG001|Overall Study|Adverse Event|9|||
131925770|NCT01740427|475012667|FG000|Overall Study|Global Deterioration of Health Status|28|||
131925771|NCT01740427|475012668|FG001|Overall Study|Global Deterioration of Health Status|12|||
131925772|NCT01740427|475012667|FG000|Overall Study|Participant Refused Continued Treatment|27|||
131925773|NCT01740427|475012668|FG001|Overall Study|Participant Refused Continued Treatment|15|||
131925774|NCT01740427|475012667|FG000|Overall Study|Unspecified reasons|52|||
131925775|NCT01740427|475012668|FG001|Overall Study|Unspecified reasons|8|||
131925776|NCT01740427|475012667|FG000|Overall Study|Death|10|||
131925777|NCT01740427|475012668|FG001|Overall Study|Death|3|||
131925778|NCT01740427|475012667|FG000|Overall Study|Protocol Violation|5|||
131925779|NCT01740427|475012668|FG001|Overall Study|Protocol Violation|3|||
131925780|NCT01740427|475012667|FG000|Overall Study|Lost to Follow-up|3|||
131925781|NCT01740427|475012668|FG001|Overall Study|Lost to Follow-up|0|||
131925782|NCT01740427|475012667|FG000|Overall Study|Site Terminated by Sponsor|1|||
131925783|NCT01740427|475012668|FG001|Overall Study|Site Terminated by Sponsor|0|||
131925784|NCT04796207|475012671|FG000|Overall Study|Lost to Follow-up|7|||
131925785|NCT04796207|475012672|FG001|Overall Study|Lost to Follow-up|2|||
131925786|NCT02405962|475012675|FG000|Overall Study|Lost to Follow-up|1|||
131925787|NCT02405962|475012676|FG001|Overall Study|Lost to Follow-up|4|||
131925788|NCT02405962|475012675|FG000|Overall Study|A participant has moved to another place|0|||
131925789|NCT02405962|475012676|FG001|Overall Study|A participant has moved to another place|1|||
131925790|NCT00105508|475012681|FG000|Overall Study|Prephase Dropout|1|||
131925791|NCT00105508|475012682|FG001|Overall Study|Prephase Dropout|0|||
131925792|NCT00105508|475012681|FG000|Overall Study|Adverse Event|16|||
131925793|NCT00105508|475012682|FG001|Overall Study|Adverse Event|19|||
131925794|NCT00105508|475012681|FG000|Overall Study|Insufficient Efficacy|1|||
131925795|NCT00105508|475012682|FG001|Overall Study|Insufficient Efficacy|0|||
131925796|NCT00105508|475012681|FG000|Overall Study|Withdrawal by Subject|10|||
131925797|NCT00105508|475012682|FG001|Overall Study|Withdrawal by Subject|6|||
131925798|NCT00105508|475012681|FG000|Overall Study|Lost to Follow-up|3|||
131925799|NCT00105508|475012682|FG001|Overall Study|Lost to Follow-up|0|||
131409826|NCT00330928|473123258|FG000|Overall Study|IVUS could not be performed.|1|||
131925800|NCT00105508|475012681|FG000|Overall Study|Protocol Violation|1|||
131925801|NCT00105508|475012682|FG001|Overall Study|Protocol Violation|2|||
131925802|NCT00105508|475012681|FG000|Overall Study|Other|8|||
131925803|NCT00105508|475012682|FG001|Overall Study|Other|9|||
131925804|NCT01800058|475012684|FG000|Overall Study|Lost to Follow-up|1|||
131925805|NCT00337194|475015247|FG000|Overall Study|Adverse Event|5|||
131409827|NCT03028480|473123259|FG000|Overall Study|No revisit after the first prescription date|2|||
131925806|NCT00337194|475015248|FG001|Overall Study|Adverse Event|1|||
131925807|NCT00337194|475015247|FG000|Overall Study|Death|2|||
131925808|NCT00337194|475015248|FG001|Overall Study|Death|0|||
131925809|NCT00337194|475015247|FG000|Overall Study|Withdrawal by Subject|1|||
131925810|NCT00337194|475015248|FG001|Overall Study|Withdrawal by Subject|0|||
131925811|NCT00337194|475015247|FG000|Overall Study|Disease progression|1|||
131925812|NCT00337194|475015248|FG001|Overall Study|Disease progression|2|||
131925813|NCT00337194|475015247|FG000|Overall Study|Subsequent non-protocol therapy|3|||
131925814|NCT00337194|475015248|FG001|Overall Study|Subsequent non-protocol therapy|1|||
131925815|NCT03188705|475015249|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
131925816|NCT03188705|475015249|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
131925817|NCT01174459|475015250|FG000|Overall Study|case report form (CRF) not collected|5|||
131925818|NCT00609973|475015257|FG000|Overall Study|Adverse Event|2|||
131925819|NCT00609973|475015258|FG001|Overall Study|Adverse Event|1|||
131925820|NCT00609973|475015257|FG000|Overall Study|Protocol Violation|4|||
131925821|NCT00609973|475015258|FG001|Overall Study|Protocol Violation|3|||
131925822|NCT00609973|475015257|FG000|Overall Study|Lost to Follow-up|2|||
131925823|NCT00609973|475015258|FG001|Overall Study|Lost to Follow-up|1|||
131925824|NCT00609973|475015257|FG000|Overall Study|Withdrawal by Subject|0|||
131925825|NCT00609973|475015258|FG001|Overall Study|Withdrawal by Subject|1|||
131925826|NCT00191152|475015259|FG000|Initial Treatment|Adverse Event|43|||
131925827|NCT00191152|475015260|FG001|Initial Treatment|Adverse Event|67|||
131925828|NCT00191152|475015259|FG000|Initial Treatment|Physician Decision|40|||
131925829|NCT00191152|475015260|FG001|Initial Treatment|Physician Decision|31|||
131925830|NCT00191152|475015259|FG000|Initial Treatment|Withdrawal by Subject|40|||
131925831|NCT00191152|475015260|FG001|Initial Treatment|Withdrawal by Subject|28|||
131925832|NCT00191152|475015259|FG000|Initial Treatment|Lost to Follow-up|0|||
131925833|NCT00191152|475015260|FG001|Initial Treatment|Lost to Follow-up|6|||
131925834|NCT00191152|475015259|FG000|Initial Treatment|Other|18|||
131925835|NCT00191152|475015260|FG001|Initial Treatment|Other|21|||
131925836|NCT00191152|475015259|FG000|Crossover Treatment|Adverse Event|8|||
131925837|NCT00191152|475015260|FG001|Crossover Treatment|Adverse Event|8|||
131925838|NCT00191152|475015259|FG000|Crossover Treatment|Physician Decision|7|||
131925839|NCT00191152|475015260|FG001|Crossover Treatment|Physician Decision|7|||
131925840|NCT00191152|475015259|FG000|Crossover Treatment|Withdrawal by Subject|6|||
131925841|NCT00191152|475015260|FG001|Crossover Treatment|Withdrawal by Subject|9|||
131925842|NCT00191152|475015259|FG000|Crossover Treatment|Lost to Follow-up|2|||
131925843|NCT00191152|475015260|FG001|Crossover Treatment|Lost to Follow-up|1|||
131925844|NCT00191152|475015259|FG000|Crossover Treatment|Other|4|||
131925845|NCT00191152|475015260|FG001|Crossover Treatment|Other|3|||
131925846|NCT02336503|475015262|FG000|Overall Study|Lost to Follow-up|0|||
131925847|NCT02336503|475015263|FG001|Overall Study|Lost to Follow-up|3|||
131925848|NCT02336503|475015264|FG002|Overall Study|Lost to Follow-up|0|||
131925849|NCT02336503|475015265|FG003|Overall Study|Lost to Follow-up|2|||
131925850|NCT02336503|475015262|FG000|Overall Study|Withdrawal by Subject|2|||
131925851|NCT02336503|475015263|FG001|Overall Study|Withdrawal by Subject|0|||
131925852|NCT02336503|475015264|FG002|Overall Study|Withdrawal by Subject|0|||
131925853|NCT02336503|475015265|FG003|Overall Study|Withdrawal by Subject|4|||
131925854|NCT02336503|475015262|FG000|Overall Study|Adverse Event|0|||
131925855|NCT02336503|475015263|FG001|Overall Study|Adverse Event|0|||
131925856|NCT02336503|475015264|FG002|Overall Study|Adverse Event|1|||
131925857|NCT02336503|475015265|FG003|Overall Study|Adverse Event|0|||
131925858|NCT02460380|475015266|FG000|Overall Study|Withdrawal by Subject|10|||
131925859|NCT02460380|475015267|FG001|Overall Study|Withdrawal by Subject|5|||
131925860|NCT00395512|475015268|FG000|Overall Study|Adverse Event|3|||
131925861|NCT00395512|475015269|FG001|Overall Study|Adverse Event|8|||
131925862|NCT00395512|475015270|FG002|Overall Study|Adverse Event|6|||
131925863|NCT00395512|475015271|FG003|Overall Study|Adverse Event|6|||
131925864|NCT00395512|475015268|FG000|Overall Study|Protocol Violation|2|||
131925865|NCT00395512|475015269|FG001|Overall Study|Protocol Violation|3|||
131925866|NCT00395512|475015270|FG002|Overall Study|Protocol Violation|6|||
131925867|NCT00395512|475015271|FG003|Overall Study|Protocol Violation|7|||
131925868|NCT00395512|475015268|FG000|Overall Study|Lost to Follow-up|2|||
131925869|NCT00395512|475015269|FG001|Overall Study|Lost to Follow-up|6|||
131925870|NCT00395512|475015270|FG002|Overall Study|Lost to Follow-up|5|||
131925871|NCT00395512|475015271|FG003|Overall Study|Lost to Follow-up|5|||
131925872|NCT00395512|475015268|FG000|Overall Study|Withdrawal by Subject|6|||
131925873|NCT00395512|475015269|FG001|Overall Study|Withdrawal by Subject|5|||
131925874|NCT00395512|475015270|FG002|Overall Study|Withdrawal by Subject|5|||
131925875|NCT00395512|475015271|FG003|Overall Study|Withdrawal by Subject|12|||
131925876|NCT00395512|475015268|FG000|Overall Study|Physician Decision|6|||
131925877|NCT00395512|475015269|FG001|Overall Study|Physician Decision|4|||
131925878|NCT00395512|475015270|FG002|Overall Study|Physician Decision|2|||
131925879|NCT00395512|475015271|FG003|Overall Study|Physician Decision|2|||
131925880|NCT00395512|475015268|FG000|Overall Study|Other|1|||
131925881|NCT00395512|475015269|FG001|Overall Study|Other|1|||
131925882|NCT00395512|475015270|FG002|Overall Study|Other|0|||
131925883|NCT00395512|475015271|FG003|Overall Study|Other|0|||
131925884|NCT00395512|475015268|FG000|Overall Study|Hyperglycemic Rescue|18|||
131925885|NCT00395512|475015269|FG001|Overall Study|Hyperglycemic Rescue|10|||
131925886|NCT00395512|475015270|FG002|Overall Study|Hyperglycemic Rescue|4|||
131925887|NCT00395512|475015271|FG003|Overall Study|Hyperglycemic Rescue|6|||
131925888|NCT01986751|475015276|FG000|Overall Study|improperly consented|10|||
131925889|NCT01986751|475015277|FG001|Overall Study|improperly consented|2|||
131925890|NCT01309100|475015283|FG000|Overall Study|Protocol Violation|1|||
131925891|NCT01309100|475015283|FG000|Overall Study|Positive Slit lamp finding|1|||
131925892|NCT01489358|475015284|FG000|Overall Study|Lost to Follow-up|0|||
131925893|NCT01489358|475015285|FG001|Overall Study|Lost to Follow-up|0|||
131925894|NCT01489358|475015286|FG002|Overall Study|Lost to Follow-up|2|||
131925895|NCT00736476|475015289|FG000|Overall Study|Adverse Event|1|||
131925896|NCT00736476|475015290|FG001|Overall Study|Adverse Event|0|||
131925897|NCT03511066|475015294|FG000|Overall Study|Withdrawal by Subject|1|||
131925898|NCT03511066|475015295|FG001|Overall Study|Withdrawal by Subject|2|||
131925899|NCT03511066|475015296|FG002|Overall Study|Withdrawal by Subject|3|||
131925900|NCT03511066|475015294|FG000|Overall Study|Lost to Follow-up|2|||
131925901|NCT03511066|475015295|FG001|Overall Study|Lost to Follow-up|3|||
131925902|NCT03511066|475015296|FG002|Overall Study|Lost to Follow-up|0|||
131925903|NCT04560309|475015298|FG000|Overall Study|Meet drop out criteria|1|||
131925904|NCT04560309|475015299|FG001|Overall Study|Meet drop out criteria|1|||
131925905|NCT04146909|475015300|FG000|Overall Study|Withdrawal by Subject|3|||
131925906|NCT04146909|475015300|FG000|Overall Study|Did not qualify after consented|1|||
131925907|NCT00754559|475015301|FG000|Overall Study|Adverse Event|15|||
131925908|NCT00754559|475015301|FG000|Overall Study|Protocol Violation|11|||
131925909|NCT00754559|475015301|FG000|Overall Study|Lack of Efficacy|10|||
131925910|NCT00754559|475015301|FG000|Overall Study|Lost to Follow-up|2|||
131925911|NCT00754559|475015301|FG000|Overall Study|Administrative reason|1|||
131925912|NCT00754559|475015301|FG000|Overall Study|Other|5|||
131925913|NCT00754559|475015301|FG000|Overall Study|Withdrawal by Subject|3|||
131925914|NCT04000724|475015305|FG000|Overall Study|Withdrawal by Subject|5|||
131925915|NCT04000724|475015306|FG001|Overall Study|Withdrawal by Subject|3|||
131925916|NCT04000724|475015307|FG002|Overall Study|Withdrawal by Subject|4|||
131925917|NCT04000724|475015305|FG000|Overall Study|Lost to Follow-up|11|||
131925918|NCT04000724|475015306|FG001|Overall Study|Lost to Follow-up|7|||
131925919|NCT04000724|475015307|FG002|Overall Study|Lost to Follow-up|13|||
131925920|NCT01370538|475015308|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
131925921|NCT01370538|475015309|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
131925922|NCT01370538|475015308|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131925923|NCT01370538|475015309|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131925924|NCT01370538|475015308|FG000|Overall Study|Adverse Event|1|||
131925925|NCT01370538|475015309|FG001|Overall Study|Adverse Event|0|||
131925926|NCT01370538|475015308|FG000|Overall Study|Protocol Violation|8|||
131925927|NCT01370538|475015309|FG001|Overall Study|Protocol Violation|5|||
131925928|NCT01370538|475015308|FG000|Overall Study|Development of study specific withdrawal|1|||
131925929|NCT01370538|475015309|FG001|Overall Study|Development of study specific withdrawal|1|||
131925930|NCT01370538|475015308|FG000|Overall Study|Lost to follow up|6|||
131925931|NCT01370538|475015309|FG001|Overall Study|Lost to follow up|10|||
131925932|NCT04193527|475015310|FG000|Overall Study|Other|1|||
131925933|NCT04193527|475015311|FG001|Overall Study|Other|1|||
131925934|NCT04193527|475015312|FG002|Overall Study|Other|0|||
131925935|NCT00676689|475015313|FG000|Overall Study|Screen Failure|2|||
131925936|NCT00676689|475015313|FG000|Overall Study|Death|2|||
131925937|NCT00676689|475015313|FG000|Overall Study|Lost to Follow-up|4|||
131925938|NCT00676689|475015313|FG000|Overall Study|Physician Decision|1|||
131925939|NCT00676689|475015313|FG000|Overall Study|Withdrawal by Subject|3|||
131925940|NCT00676689|475015313|FG000|Overall Study|Continuing FU|49|||
131925941|NCT00567112|475015314|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
131925942|NCT00567112|475015315|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
131925943|NCT00567112|475015316|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
131925944|NCT00567112|475015314|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
131925945|NCT00567112|475015315|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
131925946|NCT00567112|475015316|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
131925947|NCT00567112|475015314|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
131925948|NCT00567112|475015315|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
131925949|NCT00567112|475015316|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
131409828|NCT03028480|473123259|FG000|Overall Study|Did not use the drug|1|||
131925950|NCT02362412|475015317|FG000|Treatment Period III|Lost to Follow-up|0|||
131925951|NCT02362412|475015318|FG001|Treatment Period III|Lost to Follow-up|1|||
131925952|NCT00545948|475015320|FG000|Overall Study|Not Treated|1|||
131925953|NCT00545948|475015321|FG001|Overall Study|Not Treated|1|||
131409829|NCT03028480|473123259|FG000|Overall Study|Violation of the enrollment deadline|10|||
131925954|NCT00545948|475015322|FG002|Overall Study|Not Treated|7|||
131925955|NCT03520387|475015327|FG000|Pre-Randomization|Withdrawal by Subject|1|||
131925956|NCT03520387|475015328|FG001|Pre-Randomization|Withdrawal by Subject|0|||
131925957|NCT03520387|475015329|FG002|Pre-Randomization|Withdrawal by Subject|0|||
131925958|NCT03520387|475015330|FG003|Pre-Randomization|Withdrawal by Subject|0|||
131925959|NCT03520387|475015331|FG004|Pre-Randomization|Withdrawal by Subject|0|||
131925960|NCT03520387|475015327|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
131925961|NCT03520387|475015328|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
131925962|NCT03520387|475015329|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
131925963|NCT03520387|475015330|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
131925964|NCT03520387|475015331|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
131925965|NCT03336866|475015332|FG000|Overall Study|Lost to Follow-up|2|||
131925966|NCT03336866|475015333|FG001|Overall Study|Lost to Follow-up|0|||
131925967|NCT03336866|475015334|FG002|Overall Study|Lost to Follow-up|3|||
131925968|NCT03336866|475015332|FG000|Overall Study|Withdrawal by Subject|1|||
131925969|NCT03336866|475015333|FG001|Overall Study|Withdrawal by Subject|1|||
131925970|NCT03336866|475015334|FG002|Overall Study|Withdrawal by Subject|0|||
131925971|NCT03336866|475015332|FG000|Overall Study|Noncompliance with clinic house rules|0|||
131925972|NCT03336866|475015333|FG001|Overall Study|Noncompliance with clinic house rules|0|||
131925973|NCT03336866|475015334|FG002|Overall Study|Noncompliance with clinic house rules|1|||
131925974|NCT04913675|475015335|FG000|Main Study (Up to Week 36)|Death|0|||
131925975|NCT04913675|475015336|FG001|Main Study (Up to Week 36)|Death|2|||
131925976|NCT04913675|475015337|FG002|Main Study (Up to Week 36)|Death|2|||
131925977|NCT04913675|475015338|FG003|Main Study (Up to Week 36)|Death|0|||
131925978|NCT04913675|475015335|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
131925979|NCT04913675|475015336|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
131925980|NCT04913675|475015337|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
131925981|NCT04913675|475015338|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
131925982|NCT04913675|475015335|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
131925983|NCT04913675|475015336|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
131925984|NCT04913675|475015337|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
131925985|NCT04913675|475015338|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
131925986|NCT04913675|475015335|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
131925987|NCT04913675|475015336|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
131925988|NCT04913675|475015337|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
131925989|NCT04913675|475015338|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
131925990|NCT04913675|475015335|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
131925991|NCT04913675|475015336|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
131925992|NCT04913675|475015337|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
131925993|NCT04913675|475015338|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
131925994|NCT02975700|475015339|FG000|Overall Study|Adverse Event|1|||
131925995|NCT02975700|475015339|FG000|Overall Study|Progressive disease|3|||
131925996|NCT02975700|475015339|FG000|Overall Study|Failed screening criteria|2|||
131925997|NCT01541254|475015341|FG000|Overall Study|Withdrawal by Subject|1|||
131925998|NCT01541254|475015341|FG000|Overall Study|excluded - metal allergy|1|||
131925999|NCT01541254|475015341|FG000|Overall Study|enrolled after study closed|1|||
131926000|NCT01541254|475015341|FG000|Overall Study|GI bleed prior to procedure|1|||
131926001|NCT01541254|475015341|FG000|Overall Study|stent not required|1|||
131926002|NCT01541254|475015341|FG000|Overall Study|alternate stent used|1|||
131926003|NCT05660538|475015342|FG000|Overall Study|Adverse Event|0|||
131926004|NCT05660538|475015343|FG001|Overall Study|Adverse Event|0|||
131926005|NCT05660538|475015344|FG002|Overall Study|Adverse Event|1|||
131926006|NCT05660538|475015345|FG003|Overall Study|Adverse Event|0|||
131926007|NCT05660538|475015342|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
131926008|NCT05660538|475015343|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
131926009|NCT05660538|475015344|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
131926010|NCT05660538|475015345|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
131926011|NCT05660538|475015342|FG000|Overall Study|Lost to Follow-up|0|||
131926012|NCT05660538|475015343|FG001|Overall Study|Lost to Follow-up|0|||
131926013|NCT05660538|475015344|FG002|Overall Study|Lost to Follow-up|1|||
131926014|NCT05660538|475015345|FG003|Overall Study|Lost to Follow-up|1|||
131926015|NCT05660538|475015342|FG000|Overall Study|Death|0|||
131926016|NCT05660538|475015343|FG001|Overall Study|Death|0|||
131926017|NCT05660538|475015344|FG002|Overall Study|Death|1|||
131926018|NCT05660538|475015345|FG003|Overall Study|Death|0|||
131926019|NCT05660538|475015342|FG000|Overall Study|Physician Decision|0|||
131926020|NCT05660538|475015343|FG001|Overall Study|Physician Decision|0|||
131926021|NCT05660538|475015344|FG002|Overall Study|Physician Decision|0|||
131926022|NCT05660538|475015345|FG003|Overall Study|Physician Decision|1|||
131926023|NCT05660538|475015342|FG000|Overall Study|Sponsor Decision|1|||
131926024|NCT05660538|475015343|FG001|Overall Study|Sponsor Decision|0|||
131926025|NCT05660538|475015344|FG002|Overall Study|Sponsor Decision|0|||
131926026|NCT05660538|475015345|FG003|Overall Study|Sponsor Decision|0|||
131926027|NCT05660538|475015342|FG000|Overall Study|Other|1|||
131926028|NCT05660538|475015343|FG001|Overall Study|Other|0|||
131926029|NCT05660538|475015344|FG002|Overall Study|Other|0|||
131926030|NCT05660538|475015345|FG003|Overall Study|Other|1|||
131926031|NCT05660538|475015342|FG000|Overall Study|Randomized but did not receive study drug|1|||
131926032|NCT05660538|475015343|FG001|Overall Study|Randomized but did not receive study drug|0|||
131926033|NCT05660538|475015344|FG002|Overall Study|Randomized but did not receive study drug|0|||
131926034|NCT05660538|475015345|FG003|Overall Study|Randomized but did not receive study drug|1|||
131926035|NCT05660538|475015342|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
131926036|NCT05660538|475015343|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
131926037|NCT05660538|475015344|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
131926038|NCT05660538|475015345|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
131926039|NCT04518410|475015349|FG000|Overall Study|Lost to Follow-up|1|||
131926040|NCT04518410|475015350|FG001|Overall Study|Lost to Follow-up|1|||
131926041|NCT04518410|475015351|FG002|Overall Study|Lost to Follow-up|8|||
131926042|NCT04518410|475015352|FG003|Overall Study|Lost to Follow-up|5|||
131926043|NCT04518410|475015353|FG004|Overall Study|Lost to Follow-up|92|||
131926044|NCT04518410|475015354|FG005|Overall Study|Lost to Follow-up|25|||
131926045|NCT04518410|475015355|FG006|Overall Study|Lost to Follow-up|25|||
131926046|NCT04518410|475015356|FG007|Overall Study|Lost to Follow-up|3|||
131926047|NCT04518410|475015357|FG008|Overall Study|Lost to Follow-up|2|||
131926048|NCT04518410|475015358|FG009|Overall Study|Lost to Follow-up|13|||
131926049|NCT04518410|475015359|FG010|Overall Study|Lost to Follow-up|9|||
131926050|NCT04518410|475015360|FG011|Overall Study|Lost to Follow-up|13|||
131926051|NCT04518410|475015361|FG012|Overall Study|Lost to Follow-up|9|||
131926052|NCT04518410|475015362|FG013|Overall Study|Lost to Follow-up|13|||
131926053|NCT04518410|475015363|FG014|Overall Study|Lost to Follow-up|8|||
131926054|NCT04518410|475015364|FG015|Overall Study|Lost to Follow-up|10|||
131926055|NCT04518410|475015365|FG016|Overall Study|Lost to Follow-up|6|||
131926056|NCT04518410|475015366|FG017|Overall Study|Lost to Follow-up|13|||
131926057|NCT04518410|475015367|FG018|Overall Study|Lost to Follow-up|21|||
131926058|NCT04518410|475015368|FG019|Overall Study|Lost to Follow-up|6|||
131926059|NCT04518410|475015369|FG020|Overall Study|Lost to Follow-up|7|||
131926060|NCT04518410|475015370|FG021|Overall Study|Lost to Follow-up|21|||
131926061|NCT04518410|475015371|FG022|Overall Study|Lost to Follow-up|1|||
131926062|NCT04518410|475015372|FG023|Overall Study|Lost to Follow-up|7|||
131926063|NCT04518410|475015373|FG024|Overall Study|Lost to Follow-up|6|||
131926064|NCT04518410|475015349|FG000|Overall Study|Withdrawal by Subject|1|||
131926065|NCT04518410|475015350|FG001|Overall Study|Withdrawal by Subject|2|||
131926066|NCT04518410|475015351|FG002|Overall Study|Withdrawal by Subject|2|||
131926067|NCT04518410|475015352|FG003|Overall Study|Withdrawal by Subject|3|||
131926068|NCT04518410|475015353|FG004|Overall Study|Withdrawal by Subject|20|||
131926069|NCT04518410|475015354|FG005|Overall Study|Withdrawal by Subject|20|||
131926070|NCT04518410|475015355|FG006|Overall Study|Withdrawal by Subject|25|||
131926071|NCT04518410|475015356|FG007|Overall Study|Withdrawal by Subject|6|||
131926072|NCT04518410|475015357|FG008|Overall Study|Withdrawal by Subject|1|||
131926073|NCT04518410|475015358|FG009|Overall Study|Withdrawal by Subject|12|||
131926074|NCT04518410|475015359|FG010|Overall Study|Withdrawal by Subject|5|||
131926075|NCT04518410|475015360|FG011|Overall Study|Withdrawal by Subject|7|||
131926076|NCT04518410|475015361|FG012|Overall Study|Withdrawal by Subject|2|||
131926077|NCT04518410|475015362|FG013|Overall Study|Withdrawal by Subject|13|||
131926078|NCT04518410|475015363|FG014|Overall Study|Withdrawal by Subject|4|||
131926079|NCT04518410|475015364|FG015|Overall Study|Withdrawal by Subject|9|||
131926080|NCT04518410|475015365|FG016|Overall Study|Withdrawal by Subject|0|||
131926081|NCT04518410|475015366|FG017|Overall Study|Withdrawal by Subject|15|||
131926082|NCT04518410|475015367|FG018|Overall Study|Withdrawal by Subject|12|||
131926083|NCT04518410|475015368|FG019|Overall Study|Withdrawal by Subject|9|||
131926084|NCT04518410|475015369|FG020|Overall Study|Withdrawal by Subject|14|||
131926085|NCT04518410|475015370|FG021|Overall Study|Withdrawal by Subject|3|||
131926086|NCT04518410|475015371|FG022|Overall Study|Withdrawal by Subject|2|||
131926087|NCT04518410|475015372|FG023|Overall Study|Withdrawal by Subject|9|||
131926088|NCT04518410|475015373|FG024|Overall Study|Withdrawal by Subject|8|||
131926089|NCT04518410|475015349|FG000|Overall Study|Other|1|||
131926090|NCT04518410|475015350|FG001|Overall Study|Other|0|||
131926091|NCT04518410|475015351|FG002|Overall Study|Other|0|||
131454049|NCT00092443|473291869|FG000|Overall Study|Adverse Event|9|||
131926092|NCT04518410|475015352|FG003|Overall Study|Other|1|||
131926093|NCT04518410|475015353|FG004|Overall Study|Other|6|||
131926094|NCT04518410|475015354|FG005|Overall Study|Other|6|||
131926095|NCT04518410|475015355|FG006|Overall Study|Other|5|||
131926096|NCT04518410|475015356|FG007|Overall Study|Other|2|||
131926097|NCT04518410|475015357|FG008|Overall Study|Other|0|||
131926098|NCT04518410|475015358|FG009|Overall Study|Other|1|||
131926099|NCT04518410|475015359|FG010|Overall Study|Other|0|||
131926100|NCT04518410|475015360|FG011|Overall Study|Other|2|||
131926101|NCT04518410|475015361|FG012|Overall Study|Other|0|||
131926102|NCT04518410|475015362|FG013|Overall Study|Other|0|||
131926103|NCT04518410|475015363|FG014|Overall Study|Other|0|||
131926104|NCT04518410|475015364|FG015|Overall Study|Other|3|||
131926105|NCT04518410|475015365|FG016|Overall Study|Other|1|||
131926106|NCT04518410|475015366|FG017|Overall Study|Other|1|||
131926107|NCT04518410|475015367|FG018|Overall Study|Other|1|||
131926108|NCT04518410|475015368|FG019|Overall Study|Other|0|||
131926109|NCT04518410|475015369|FG020|Overall Study|Other|1|||
131926110|NCT04518410|475015370|FG021|Overall Study|Other|0|||
131926111|NCT04518410|475015371|FG022|Overall Study|Other|1|||
131926112|NCT04518410|475015372|FG023|Overall Study|Other|2|||
131926113|NCT04518410|475015373|FG024|Overall Study|Other|2|||
131926114|NCT04518410|475015349|FG000|Overall Study|Protocol Violation|0|||
131926115|NCT04518410|475015350|FG001|Overall Study|Protocol Violation|0|||
131926116|NCT04518410|475015351|FG002|Overall Study|Protocol Violation|0|||
131409830|NCT03028480|473123259|FG000|Overall Study|Case report forms were not collected|21|||
131409831|NCT01777542|473123262|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
131409832|NCT01777542|473123263|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
131409833|NCT00435162|473123265|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
131409834|NCT00435162|473123266|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
131409835|NCT00435162|473123267|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
131409836|NCT00435162|473123268|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
131409837|NCT00435162|473123269|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
131409838|NCT00435162|473123270|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
131409839|NCT01484834|473123281|FG000|Overall Study|Lost to Follow-up|5|||
131409840|NCT01484834|473123282|FG001|Overall Study|Lost to Follow-up|8|||
131926117|NCT04518410|475015352|FG003|Overall Study|Protocol Violation|2|||
131926118|NCT04518410|475015353|FG004|Overall Study|Protocol Violation|17|||
131926119|NCT04518410|475015354|FG005|Overall Study|Protocol Violation|1|||
131926120|NCT04518410|475015355|FG006|Overall Study|Protocol Violation|2|||
131926121|NCT04518410|475015356|FG007|Overall Study|Protocol Violation|1|||
131926122|NCT04518410|475015357|FG008|Overall Study|Protocol Violation|0|||
131926123|NCT04518410|475015358|FG009|Overall Study|Protocol Violation|0|||
131926124|NCT04518410|475015359|FG010|Overall Study|Protocol Violation|0|||
131926125|NCT04518410|475015360|FG011|Overall Study|Protocol Violation|0|||
131926126|NCT04518410|475015361|FG012|Overall Study|Protocol Violation|0|||
131926127|NCT04518410|475015362|FG013|Overall Study|Protocol Violation|0|||
131926128|NCT04518410|475015363|FG014|Overall Study|Protocol Violation|0|||
131926129|NCT04518410|475015364|FG015|Overall Study|Protocol Violation|0|||
131926130|NCT04518410|475015365|FG016|Overall Study|Protocol Violation|1|||
131926131|NCT04518410|475015366|FG017|Overall Study|Protocol Violation|1|||
131926132|NCT04518410|475015367|FG018|Overall Study|Protocol Violation|0|||
131926133|NCT04518410|475015368|FG019|Overall Study|Protocol Violation|0|||
131926134|NCT04518410|475015369|FG020|Overall Study|Protocol Violation|1|||
131926135|NCT04518410|475015370|FG021|Overall Study|Protocol Violation|2|||
131926136|NCT04518410|475015371|FG022|Overall Study|Protocol Violation|0|||
131926137|NCT04518410|475015372|FG023|Overall Study|Protocol Violation|3|||
131926138|NCT04518410|475015373|FG024|Overall Study|Protocol Violation|0|||
131926139|NCT04518410|475015349|FG000|Overall Study|Death|0|||
131926140|NCT04518410|475015350|FG001|Overall Study|Death|0|||
131926141|NCT04518410|475015351|FG002|Overall Study|Death|0|||
131926142|NCT04518410|475015352|FG003|Overall Study|Death|0|||
131926143|NCT04518410|475015353|FG004|Overall Study|Death|12|||
131926144|NCT04518410|475015354|FG005|Overall Study|Death|2|||
131926145|NCT04518410|475015355|FG006|Overall Study|Death|11|||
131926146|NCT04518410|475015356|FG007|Overall Study|Death|0|||
131926147|NCT04518410|475015357|FG008|Overall Study|Death|1|||
131926148|NCT04518410|475015358|FG009|Overall Study|Death|0|||
131926149|NCT04518410|475015359|FG010|Overall Study|Death|0|||
131926150|NCT04518410|475015360|FG011|Overall Study|Death|0|||
131926151|NCT04518410|475015361|FG012|Overall Study|Death|0|||
131926152|NCT04518410|475015362|FG013|Overall Study|Death|1|||
131926153|NCT04518410|475015363|FG014|Overall Study|Death|1|||
131926154|NCT04518410|475015364|FG015|Overall Study|Death|0|||
131926155|NCT04518410|475015365|FG016|Overall Study|Death|0|||
131926156|NCT04518410|475015366|FG017|Overall Study|Death|1|||
131926157|NCT04518410|475015367|FG018|Overall Study|Death|4|||
131926158|NCT04518410|475015368|FG019|Overall Study|Death|4|||
131926159|NCT04518410|475015369|FG020|Overall Study|Death|1|||
131926160|NCT04518410|475015370|FG021|Overall Study|Death|0|||
131926161|NCT04518410|475015371|FG022|Overall Study|Death|0|||
131926162|NCT04518410|475015372|FG023|Overall Study|Death|0|||
131926163|NCT04518410|475015373|FG024|Overall Study|Death|0|||
131926164|NCT04518410|475015349|FG000|Overall Study|Requirement to start alternative therapy|0|||
131926165|NCT04518410|475015350|FG001|Overall Study|Requirement to start alternative therapy|0|||
131926166|NCT04518410|475015351|FG002|Overall Study|Requirement to start alternative therapy|1|||
131926167|NCT04518410|475015352|FG003|Overall Study|Requirement to start alternative therapy|0|||
131926168|NCT04518410|475015353|FG004|Overall Study|Requirement to start alternative therapy|0|||
131926169|NCT04518410|475015354|FG005|Overall Study|Requirement to start alternative therapy|0|||
131926170|NCT04518410|475015355|FG006|Overall Study|Requirement to start alternative therapy|0|||
131926171|NCT04518410|475015356|FG007|Overall Study|Requirement to start alternative therapy|0|||
131926172|NCT04518410|475015357|FG008|Overall Study|Requirement to start alternative therapy|0|||
131926173|NCT04518410|475015358|FG009|Overall Study|Requirement to start alternative therapy|0|||
131926174|NCT04518410|475015359|FG010|Overall Study|Requirement to start alternative therapy|0|||
131926175|NCT04518410|475015360|FG011|Overall Study|Requirement to start alternative therapy|0|||
131926176|NCT04518410|475015361|FG012|Overall Study|Requirement to start alternative therapy|0|||
131926177|NCT04518410|475015362|FG013|Overall Study|Requirement to start alternative therapy|0|||
131926178|NCT04518410|475015363|FG014|Overall Study|Requirement to start alternative therapy|0|||
131926179|NCT04518410|475015364|FG015|Overall Study|Requirement to start alternative therapy|0|||
131926180|NCT04518410|475015365|FG016|Overall Study|Requirement to start alternative therapy|0|||
131926181|NCT04518410|475015366|FG017|Overall Study|Requirement to start alternative therapy|0|||
131926182|NCT04518410|475015367|FG018|Overall Study|Requirement to start alternative therapy|0|||
131926183|NCT04518410|475015368|FG019|Overall Study|Requirement to start alternative therapy|0|||
131926184|NCT04518410|475015369|FG020|Overall Study|Requirement to start alternative therapy|0|||
131926185|NCT04518410|475015370|FG021|Overall Study|Requirement to start alternative therapy|0|||
131926186|NCT04518410|475015371|FG022|Overall Study|Requirement to start alternative therapy|0|||
131926187|NCT04518410|475015372|FG023|Overall Study|Requirement to start alternative therapy|0|||
131926188|NCT04518410|475015373|FG024|Overall Study|Requirement to start alternative therapy|0|||
131926189|NCT04518410|475015349|FG000|Overall Study|Randomized but not treated|0|||
131926190|NCT04518410|475015350|FG001|Overall Study|Randomized but not treated|0|||
131926191|NCT04518410|475015351|FG002|Overall Study|Randomized but not treated|0|||
131409841|NCT01484834|473123283|FG002|Overall Study|Lost to Follow-up|1|||
131409842|NCT01484834|473123284|FG003|Overall Study|Lost to Follow-up|4|||
131409843|NCT00765882|473123285|FG000|Overall Study|Adverse Event|10|||
131409844|NCT00765882|473123286|FG001|Overall Study|Adverse Event|21|||
131409845|NCT00765882|473123287|FG002|Overall Study|Adverse Event|20|||
131881843|NCT02017717|474849241|FG003|Before Treatment Period|Participant no longer met criteria|0|||
131881844|NCT02017717|474849242|FG004|Before Treatment Period|Participant no longer met criteria|0|||
131881845|NCT02017717|474849243|FG005|Before Treatment Period|Participant no longer met criteria|1|||
131409846|NCT00765882|473123285|FG000|Overall Study|Lack of Efficacy|4|||
131409847|NCT00765882|473123286|FG001|Overall Study|Lack of Efficacy|0|||
131409848|NCT00765882|473123287|FG002|Overall Study|Lack of Efficacy|1|||
131881846|NCT02017717|474849244|FG006|Before Treatment Period|Participant no longer met criteria|0|||
131881847|NCT02017717|474849245|FG007|Before Treatment Period|Participant no longer met criteria|1|||
131881848|NCT02017717|474849246|FG008|Before Treatment Period|Participant no longer met criteria|2|||
131881849|NCT02017717|474849238|FG000|Before Treatment Period|other reason|0|||
131881850|NCT02017717|474849239|FG001|Before Treatment Period|other reason|0|||
131881851|NCT02017717|474849240|FG002|Before Treatment Period|other reason|0|||
131881852|NCT02017717|474849241|FG003|Before Treatment Period|other reason|0|||
131881853|NCT02017717|474849242|FG004|Before Treatment Period|other reason|0|||
131881854|NCT02017717|474849243|FG005|Before Treatment Period|other reason|0|||
131881855|NCT02017717|474849244|FG006|Before Treatment Period|other reason|0|||
131881856|NCT02017717|474849245|FG007|Before Treatment Period|other reason|0|||
131881857|NCT02017717|474849246|FG008|Before Treatment Period|other reason|1|||
131881858|NCT02017717|474849238|FG000|Treatment Period|Disease progression|7|||
131881859|NCT02017717|474849239|FG001|Treatment Period|Disease progression|9|||
131881860|NCT02017717|474849240|FG002|Treatment Period|Disease progression|12|||
131881861|NCT02017717|474849241|FG003|Treatment Period|Disease progression|20|||
131881862|NCT02017717|474849242|FG004|Treatment Period|Disease progression|26|||
131881863|NCT02017717|474849243|FG005|Treatment Period|Disease progression|16|||
131881864|NCT02017717|474849244|FG006|Treatment Period|Disease progression|22|||
131881865|NCT02017717|474849245|FG007|Treatment Period|Disease progression|165|||
131881866|NCT02017717|474849246|FG008|Treatment Period|Disease progression|135|||
131881867|NCT02017717|474849238|FG000|Treatment Period|Study drug toxicity|3|||
131881868|NCT02017717|474849239|FG001|Treatment Period|Study drug toxicity|0|||
131881869|NCT02017717|474849240|FG002|Treatment Period|Study drug toxicity|1|||
131881870|NCT02017717|474849241|FG003|Treatment Period|Study drug toxicity|4|||
131881871|NCT02017717|474849242|FG004|Treatment Period|Study drug toxicity|4|||
131881872|NCT02017717|474849243|FG005|Treatment Period|Study drug toxicity|5|||
131881873|NCT02017717|474849244|FG006|Treatment Period|Study drug toxicity|3|||
131881874|NCT02017717|474849245|FG007|Treatment Period|Study drug toxicity|7|||
131881875|NCT02017717|474849246|FG008|Treatment Period|Study drug toxicity|11|||
131881876|NCT02017717|474849238|FG000|Treatment Period|Death|0|||
131881877|NCT02017717|474849239|FG001|Treatment Period|Death|0|||
131881878|NCT02017717|474849240|FG002|Treatment Period|Death|1|||
131881879|NCT02017717|474849241|FG003|Treatment Period|Death|0|||
131881880|NCT02017717|474849242|FG004|Treatment Period|Death|0|||
131881881|NCT02017717|474849243|FG005|Treatment Period|Death|2|||
131881882|NCT02017717|474849244|FG006|Treatment Period|Death|0|||
131881883|NCT02017717|474849245|FG007|Treatment Period|Death|0|||
131881884|NCT02017717|474849246|FG008|Treatment Period|Death|0|||
131881885|NCT02017717|474849238|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
131881886|NCT02017717|474849239|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
131881887|NCT02017717|474849240|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
131881888|NCT02017717|474849241|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
131881889|NCT02017717|474849242|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
131881890|NCT02017717|474849243|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
131881891|NCT02017717|474849244|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
131881892|NCT02017717|474849245|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
131926192|NCT04518410|475015352|FG003|Overall Study|Randomized but not treated|2|||
131926193|NCT04518410|475015353|FG004|Overall Study|Randomized but not treated|6|||
131926194|NCT04518410|475015354|FG005|Overall Study|Randomized but not treated|4|||
131926195|NCT04518410|475015355|FG006|Overall Study|Randomized but not treated|3|||
131926196|NCT04518410|475015356|FG007|Overall Study|Randomized but not treated|3|||
131926197|NCT04518410|475015357|FG008|Overall Study|Randomized but not treated|0|||
131926198|NCT04518410|475015358|FG009|Overall Study|Randomized but not treated|4|||
131926199|NCT04518410|475015359|FG010|Overall Study|Randomized but not treated|0|||
131926200|NCT04518410|475015360|FG011|Overall Study|Randomized but not treated|0|||
131926201|NCT04518410|475015361|FG012|Overall Study|Randomized but not treated|1|||
131926202|NCT04518410|475015362|FG013|Overall Study|Randomized but not treated|3|||
131926203|NCT04518410|475015363|FG014|Overall Study|Randomized but not treated|3|||
131926204|NCT04518410|475015364|FG015|Overall Study|Randomized but not treated|3|||
131926205|NCT04518410|475015365|FG016|Overall Study|Randomized but not treated|4|||
131409849|NCT00765882|473123285|FG000|Overall Study|Protocol Violation|4|||
131409850|NCT00765882|473123286|FG001|Overall Study|Protocol Violation|3|||
131409851|NCT00765882|473123287|FG002|Overall Study|Protocol Violation|1|||
131409852|NCT00765882|473123285|FG000|Overall Study|Withdrawal by Subject|2|||
131409853|NCT00765882|473123286|FG001|Overall Study|Withdrawal by Subject|6|||
131409854|NCT00765882|473123287|FG002|Overall Study|Withdrawal by Subject|6|||
131409855|NCT00765882|473123285|FG000|Overall Study|Lost to Follow-up|1|||
131409856|NCT00765882|473123286|FG001|Overall Study|Lost to Follow-up|9|||
131409857|NCT00765882|473123287|FG002|Overall Study|Lost to Follow-up|6|||
131409858|NCT00765882|473123285|FG000|Overall Study|Other Reason|3|||
131926206|NCT04518410|475015366|FG017|Overall Study|Randomized but not treated|5|||
131926207|NCT04518410|475015367|FG018|Overall Study|Randomized but not treated|4|||
131926208|NCT04518410|475015368|FG019|Overall Study|Randomized but not treated|0|||
131926209|NCT04518410|475015369|FG020|Overall Study|Randomized but not treated|0|||
131926210|NCT04518410|475015370|FG021|Overall Study|Randomized but not treated|5|||
131926211|NCT04518410|475015371|FG022|Overall Study|Randomized but not treated|0|||
131926212|NCT04518410|475015372|FG023|Overall Study|Randomized but not treated|3|||
131926213|NCT04518410|475015373|FG024|Overall Study|Randomized but not treated|1|||
131926214|NCT04518410|475015349|FG000|Overall Study|Screen Fail but Randomized|0|||
131926215|NCT04518410|475015350|FG001|Overall Study|Screen Fail but Randomized|0|||
131926216|NCT04518410|475015351|FG002|Overall Study|Screen Fail but Randomized|0|||
131926217|NCT04518410|475015352|FG003|Overall Study|Screen Fail but Randomized|0|||
131926218|NCT04518410|475015353|FG004|Overall Study|Screen Fail but Randomized|2|||
131926219|NCT04518410|475015354|FG005|Overall Study|Screen Fail but Randomized|0|||
131926220|NCT04518410|475015355|FG006|Overall Study|Screen Fail but Randomized|0|||
131926221|NCT04518410|475015356|FG007|Overall Study|Screen Fail but Randomized|0|||
131926222|NCT04518410|475015357|FG008|Overall Study|Screen Fail but Randomized|0|||
131926223|NCT04518410|475015358|FG009|Overall Study|Screen Fail but Randomized|0|||
131926224|NCT04518410|475015359|FG010|Overall Study|Screen Fail but Randomized|0|||
131926225|NCT04518410|475015360|FG011|Overall Study|Screen Fail but Randomized|0|||
131926226|NCT04518410|475015361|FG012|Overall Study|Screen Fail but Randomized|0|||
131926227|NCT04518410|475015362|FG013|Overall Study|Screen Fail but Randomized|0|||
131926228|NCT04518410|475015363|FG014|Overall Study|Screen Fail but Randomized|0|||
131926229|NCT04518410|475015364|FG015|Overall Study|Screen Fail but Randomized|0|||
131926230|NCT04518410|475015365|FG016|Overall Study|Screen Fail but Randomized|0|||
131926231|NCT04518410|475015366|FG017|Overall Study|Screen Fail but Randomized|0|||
131926232|NCT04518410|475015367|FG018|Overall Study|Screen Fail but Randomized|0|||
131881893|NCT02017717|474849246|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
131881894|NCT02017717|474849238|FG000|Treatment Period|Participant request to stop therapy|0|||
131881895|NCT02017717|474849239|FG001|Treatment Period|Participant request to stop therapy|0|||
131881896|NCT02017717|474849240|FG002|Treatment Period|Participant request to stop therapy|3|||
131881897|NCT02017717|474849241|FG003|Treatment Period|Participant request to stop therapy|6|||
131881898|NCT02017717|474849242|FG004|Treatment Period|Participant request to stop therapy|0|||
131881899|NCT02017717|474849243|FG005|Treatment Period|Participant request to stop therapy|2|||
131881900|NCT02017717|474849244|FG006|Treatment Period|Participant request to stop therapy|1|||
131881901|NCT02017717|474849245|FG007|Treatment Period|Participant request to stop therapy|4|||
131881902|NCT02017717|474849246|FG008|Treatment Period|Participant request to stop therapy|7|||
131881903|NCT02017717|474849238|FG000|Treatment Period|Participant withdrew consent|0|||
131881904|NCT02017717|474849239|FG001|Treatment Period|Participant withdrew consent|0|||
131881905|NCT02017717|474849240|FG002|Treatment Period|Participant withdrew consent|1|||
131881906|NCT02017717|474849241|FG003|Treatment Period|Participant withdrew consent|0|||
131881907|NCT02017717|474849242|FG004|Treatment Period|Participant withdrew consent|0|||
131881908|NCT02017717|474849243|FG005|Treatment Period|Participant withdrew consent|2|||
131881909|NCT02017717|474849244|FG006|Treatment Period|Participant withdrew consent|0|||
131926233|NCT04518410|475015368|FG019|Overall Study|Screen Fail but Randomized|0|||
131926234|NCT04518410|475015369|FG020|Overall Study|Screen Fail but Randomized|0|||
131926235|NCT04518410|475015370|FG021|Overall Study|Screen Fail but Randomized|0|||
131926236|NCT04518410|475015371|FG022|Overall Study|Screen Fail but Randomized|0|||
131926237|NCT04518410|475015372|FG023|Overall Study|Screen Fail but Randomized|0|||
131926238|NCT04518410|475015373|FG024|Overall Study|Screen Fail but Randomized|0|||
131881910|NCT02017717|474849245|FG007|Treatment Period|Participant withdrew consent|1|||
131881911|NCT02017717|474849246|FG008|Treatment Period|Participant withdrew consent|4|||
131881912|NCT02017717|474849238|FG000|Treatment Period|Participant no longer met criteria|0|||
131881913|NCT02017717|474849239|FG001|Treatment Period|Participant no longer met criteria|0|||
131881914|NCT02017717|474849240|FG002|Treatment Period|Participant no longer met criteria|0|||
131881915|NCT02017717|474849241|FG003|Treatment Period|Participant no longer met criteria|0|||
131881916|NCT02017717|474849242|FG004|Treatment Period|Participant no longer met criteria|0|||
131881917|NCT02017717|474849243|FG005|Treatment Period|Participant no longer met criteria|0|||
131881918|NCT02017717|474849244|FG006|Treatment Period|Participant no longer met criteria|0|||
131881919|NCT02017717|474849245|FG007|Treatment Period|Participant no longer met criteria|0|||
131881920|NCT02017717|474849246|FG008|Treatment Period|Participant no longer met criteria|1|||
131881921|NCT02017717|474849238|FG000|Treatment Period|Other reasons|0|||
131881922|NCT02017717|474849239|FG001|Treatment Period|Other reasons|0|||
131881923|NCT02017717|474849240|FG002|Treatment Period|Other reasons|0|||
131881924|NCT02017717|474849241|FG003|Treatment Period|Other reasons|1|||
131881925|NCT02017717|474849242|FG004|Treatment Period|Other reasons|0|||
131881926|NCT02017717|474849243|FG005|Treatment Period|Other reasons|1|||
131881927|NCT02017717|474849244|FG006|Treatment Period|Other reasons|1|||
131881928|NCT02017717|474849245|FG007|Treatment Period|Other reasons|1|||
131881929|NCT02017717|474849246|FG008|Treatment Period|Other reasons|1|||
131881930|NCT02017717|474849238|FG000|Treatment Period|Maximum clinical benefit|0|||
131881931|NCT02017717|474849239|FG001|Treatment Period|Maximum clinical benefit|0|||
131881932|NCT02017717|474849240|FG002|Treatment Period|Maximum clinical benefit|0|||
131881933|NCT02017717|474849241|FG003|Treatment Period|Maximum clinical benefit|0|||
131881934|NCT02017717|474849242|FG004|Treatment Period|Maximum clinical benefit|0|||
131881935|NCT02017717|474849243|FG005|Treatment Period|Maximum clinical benefit|0|||
131881936|NCT02017717|474849244|FG006|Treatment Period|Maximum clinical benefit|0|||
131881937|NCT02017717|474849245|FG007|Treatment Period|Maximum clinical benefit|0|||
131881938|NCT02017717|474849246|FG008|Treatment Period|Maximum clinical benefit|1|||
131881939|NCT02017717|474849238|FG000|Treatment Period|Not reported|0|||
131881940|NCT02017717|474849239|FG001|Treatment Period|Not reported|1|||
131881941|NCT02017717|474849240|FG002|Treatment Period|Not reported|0|||
131881942|NCT02017717|474849241|FG003|Treatment Period|Not reported|0|||
131881943|NCT02017717|474849242|FG004|Treatment Period|Not reported|0|||
131881944|NCT02017717|474849243|FG005|Treatment Period|Not reported|0|||
131881945|NCT02017717|474849244|FG006|Treatment Period|Not reported|0|||
131881946|NCT02017717|474849245|FG007|Treatment Period|Not reported|0|||
131881947|NCT02017717|474849246|FG008|Treatment Period|Not reported|0|||
131881948|NCT00623597|474849247|FG000|Overall Study|Failed to return|1|||
131881949|NCT00623597|474849248|FG001|Overall Study|Failed to return|0|||
131881950|NCT02339155|474849252|FG000|Overall Study|Adverse Event|0|||
131881951|NCT02339155|474849253|FG001|Overall Study|Adverse Event|6|||
131881952|NCT02339155|474849252|FG000|Overall Study|Death|1|||
131881953|NCT02339155|474849253|FG001|Overall Study|Death|1|||
131881954|NCT02339155|474849252|FG000|Overall Study|Lost to Follow-up|8|||
131881955|NCT02339155|474849253|FG001|Overall Study|Lost to Follow-up|9|||
131881956|NCT02339155|474849252|FG000|Overall Study|Physician Decision|2|||
131881957|NCT02339155|474849253|FG001|Overall Study|Physician Decision|1|||
131881958|NCT02339155|474849252|FG000|Overall Study|Withdrawal by Subject|4|||
131881959|NCT02339155|474849253|FG001|Overall Study|Withdrawal by Subject|4|||
131881960|NCT01214252|474849256|FG000|Overall Study|Not eligible per protocol|82|||
131881961|NCT04327661|474849260|FG000|Overall Study|Withdrawal by Subject|1|||
131881962|NCT04327661|474849261|FG001|Overall Study|Withdrawal by Subject|0|||
131881963|NCT04327661|474849262|FG002|Overall Study|Withdrawal by Subject|0|||
131881964|NCT03427268|474849263|FG000|Overall Study|Progressive disease|25|||
131881965|NCT03427268|474849263|FG000|Overall Study|Never treated|2|||
131881966|NCT03427268|474849263|FG000|Overall Study|Compassionate use|1|||
131881967|NCT03427268|474849263|FG000|Overall Study|Withdrawal by Subject|1|||
131881968|NCT03427268|474849263|FG000|Overall Study|Adverse Event|3|||
131881969|NCT00345878|474849265|FG000|Overall Study|Adverse Event|1|||
131881970|NCT00345878|474849266|FG001|Overall Study|Adverse Event|0|||
131881971|NCT00345878|474849265|FG000|Overall Study|Lost to Follow-up|2|||
131926239|NCT04518410|475015349|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131926240|NCT04518410|475015350|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131881972|NCT00345878|474849266|FG001|Overall Study|Lost to Follow-up|1|||
131881973|NCT00345878|474849265|FG000|Overall Study|Other|1|||
131881974|NCT00345878|474849266|FG001|Overall Study|Other|0|||
131881975|NCT01995175|474849268|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
131926241|NCT04518410|475015351|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131881976|NCT01995175|474849268|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
131881977|NCT01995175|474849268|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
131926242|NCT04518410|475015352|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131926243|NCT04518410|475015353|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
131926244|NCT04518410|475015354|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
131926245|NCT04518410|475015355|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
131926246|NCT04518410|475015356|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
131926247|NCT04518410|475015357|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
131926248|NCT04518410|475015358|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
131926249|NCT04518410|475015359|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
131926250|NCT04518410|475015360|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131926251|NCT04518410|475015361|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131926252|NCT04518410|475015362|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
131926253|NCT04518410|475015363|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
131926254|NCT04518410|475015364|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
131926255|NCT04518410|475015365|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
131926256|NCT04518410|475015366|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
131926257|NCT04518410|475015367|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
131926258|NCT04518410|475015368|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
131926259|NCT04518410|475015369|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
131926260|NCT04518410|475015370|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
131926261|NCT04518410|475015371|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
131926262|NCT04518410|475015372|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
131926263|NCT04518410|475015373|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
131926264|NCT04518410|475015349|FG000|Overall Study|Dual Enrolled Subject|0|||
131926265|NCT04518410|475015350|FG001|Overall Study|Dual Enrolled Subject|0|||
131926266|NCT04518410|475015351|FG002|Overall Study|Dual Enrolled Subject|0|||
131926267|NCT04518410|475015352|FG003|Overall Study|Dual Enrolled Subject|0|||
131926268|NCT04518410|475015353|FG004|Overall Study|Dual Enrolled Subject|0|||
131926269|NCT04518410|475015354|FG005|Overall Study|Dual Enrolled Subject|0|||
131926270|NCT04518410|475015355|FG006|Overall Study|Dual Enrolled Subject|0|||
131926271|NCT04518410|475015356|FG007|Overall Study|Dual Enrolled Subject|0|||
131926272|NCT04518410|475015357|FG008|Overall Study|Dual Enrolled Subject|0|||
131926273|NCT04518410|475015358|FG009|Overall Study|Dual Enrolled Subject|0|||
131926274|NCT04518410|475015359|FG010|Overall Study|Dual Enrolled Subject|0|||
131926275|NCT04518410|475015360|FG011|Overall Study|Dual Enrolled Subject|0|||
131926276|NCT04518410|475015361|FG012|Overall Study|Dual Enrolled Subject|0|||
131926277|NCT04518410|475015362|FG013|Overall Study|Dual Enrolled Subject|0|||
131926278|NCT04518410|475015363|FG014|Overall Study|Dual Enrolled Subject|0|||
131926279|NCT04518410|475015364|FG015|Overall Study|Dual Enrolled Subject|0|||
131926280|NCT04518410|475015365|FG016|Overall Study|Dual Enrolled Subject|0|||
131926281|NCT04518410|475015366|FG017|Overall Study|Dual Enrolled Subject|1|||
131926282|NCT04518410|475015367|FG018|Overall Study|Dual Enrolled Subject|0|||
131926283|NCT04518410|475015368|FG019|Overall Study|Dual Enrolled Subject|0|||
131926284|NCT04518410|475015369|FG020|Overall Study|Dual Enrolled Subject|0|||
131926285|NCT04518410|475015370|FG021|Overall Study|Dual Enrolled Subject|0|||
131926286|NCT04518410|475015371|FG022|Overall Study|Dual Enrolled Subject|0|||
131926287|NCT04518410|475015372|FG023|Overall Study|Dual Enrolled Subject|0|||
131926288|NCT04518410|475015373|FG024|Overall Study|Dual Enrolled Subject|0|||
131926289|NCT03462563|475015374|FG000|Overall Study|Death|1|||
131926290|NCT03462563|475015375|FG001|Overall Study|Death|1|||
131926291|NCT03462563|475015374|FG000|Overall Study|Termination of study|2|||
131926292|NCT03462563|475015375|FG001|Overall Study|Termination of study|1|||
131926293|NCT03462563|475015374|FG000|Overall Study|Adverse Event|1|||
131926294|NCT03462563|475015375|FG001|Overall Study|Adverse Event|3|||
131926295|NCT03462563|475015374|FG000|Overall Study|Unspecified reason|10|||
131926296|NCT03462563|475015375|FG001|Overall Study|Unspecified reason|12|||
131926297|NCT03462563|475015374|FG000|Overall Study|Physician Decision|1|||
131409859|NCT00765882|473123286|FG001|Overall Study|Other Reason|1|||
131926298|NCT03462563|475015375|FG001|Overall Study|Physician Decision|0|||
131926299|NCT05103332|475015376|FG000|Overall Study|Lost to Follow-up|0|||
131926300|NCT05103332|475015377|FG001|Overall Study|Lost to Follow-up|2|||
131926301|NCT05103332|475015378|FG002|Overall Study|Lost to Follow-up|1|||
131926302|NCT05103332|475015379|FG003|Overall Study|Lost to Follow-up|0|||
131926303|NCT05103332|475015380|FG004|Overall Study|Lost to Follow-up|0|||
131926304|NCT05103332|475015381|FG005|Overall Study|Lost to Follow-up|2|||
131926305|NCT05103332|475015376|FG000|Overall Study|Physician Decision|0|||
131926306|NCT05103332|475015377|FG001|Overall Study|Physician Decision|1|||
131926307|NCT05103332|475015378|FG002|Overall Study|Physician Decision|0|||
131926308|NCT05103332|475015379|FG003|Overall Study|Physician Decision|1|||
131926309|NCT05103332|475015380|FG004|Overall Study|Physician Decision|0|||
131926310|NCT05103332|475015381|FG005|Overall Study|Physician Decision|0|||
131926311|NCT05103332|475015376|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
131926312|NCT05103332|475015377|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
131926313|NCT05103332|475015378|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
131926314|NCT05103332|475015379|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
131926315|NCT05103332|475015380|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
131926316|NCT05103332|475015381|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
131926317|NCT05103332|475015376|FG000|Overall Study|Unspeccified|0|||
131926318|NCT05103332|475015377|FG001|Overall Study|Unspeccified|0|||
131926319|NCT05103332|475015378|FG002|Overall Study|Unspeccified|0|||
131926320|NCT05103332|475015379|FG003|Overall Study|Unspeccified|1|||
131926321|NCT05103332|475015380|FG004|Overall Study|Unspeccified|0|||
131926322|NCT05103332|475015381|FG005|Overall Study|Unspeccified|0|||
131926323|NCT02218268|475015382|FG000|24 Hour Washout|Physician Decision|11|||
131926324|NCT02218268|475015383|FG001|24 Hour Washout|Physician Decision|9|||
131926325|NCT03651336|475015384|FG000|Overall Study|Withdrawal by Subject|4|||
131926326|NCT01125748|475015385|FG000|Overall Study|Adverse Event|0|||
131926327|NCT01125748|475015386|FG001|Overall Study|Adverse Event|2|||
131926328|NCT01125748|475015385|FG000|Overall Study|Lost to Follow-up|0|||
131926329|NCT01125748|475015386|FG001|Overall Study|Lost to Follow-up|1|||
131926330|NCT01125748|475015385|FG000|Overall Study|Physician Decision|8|||
131926331|NCT01125748|475015386|FG001|Overall Study|Physician Decision|7|||
131926332|NCT01125748|475015385|FG000|Overall Study|Patient Decision to Withdraw|2|||
131926333|NCT01125748|475015386|FG001|Overall Study|Patient Decision to Withdraw|4|||
131926334|NCT01028391|475015387|FG000|Overall Study|Adverse Event|4|||
131926335|NCT01028391|475015388|FG001|Overall Study|Adverse Event|0|||
131926336|NCT01028391|475015387|FG000|Overall Study|Lack of Efficacy|0|||
131926337|NCT01028391|475015388|FG001|Overall Study|Lack of Efficacy|2|||
131926338|NCT01028391|475015387|FG000|Overall Study|Lost to Follow-up|3|||
131926339|NCT01028391|475015388|FG001|Overall Study|Lost to Follow-up|4|||
131926340|NCT01028391|475015387|FG000|Overall Study|Physician Decision|0|||
131926341|NCT01028391|475015388|FG001|Overall Study|Physician Decision|1|||
131926342|NCT01028391|475015387|FG000|Overall Study|Withdrawal by Subject|6|||
131926343|NCT01028391|475015388|FG001|Overall Study|Withdrawal by Subject|3|||
131926344|NCT01028391|475015387|FG000|Overall Study|Needed excluded medication|1|||
131926345|NCT01028391|475015388|FG001|Overall Study|Needed excluded medication|1|||
131926346|NCT01026038|475015389|FG000|Overall Study|Lost to Follow-up|1|||
131926347|NCT01026038|475015390|FG001|Overall Study|Lost to Follow-up|1|||
131926348|NCT01026038|475015391|FG002|Overall Study|Lost to Follow-up|0|||
131926349|NCT03601052|475015392|FG000|Overall Study|Lost to Follow-up|2|||
131926350|NCT01227395|475015393|FG000|Overall Study|Protocol Violation|0|||
131926351|NCT01227395|475015394|FG001|Overall Study|Protocol Violation|1|||
131926352|NCT00683384|475015395|FG000|Overall Study|Death|1|||
131926353|NCT00683384|475015395|FG000|Overall Study|Adverse Event|1|||
131926354|NCT00120874|475015397|FG000|Overall Study|Death|0|||
131926355|NCT00120874|475015398|FG001|Overall Study|Death|1|||
131926356|NCT01049828|475015413|FG000|Overall Study|Claustrophibia and Frustration|2|||
131926357|NCT00290238|475015414|FG000|Overall Study|Study terminated|27|||
131926358|NCT00290238|475015415|FG001|Overall Study|Study terminated|27|||
131926359|NCT00290238|475015414|FG000|Overall Study|Lost to Follow-up|0|||
131926360|NCT00290238|475015415|FG001|Overall Study|Lost to Follow-up|1|||
131926361|NCT00290238|475015414|FG000|Overall Study|Withdrawal by Subject|15|||
131926362|NCT00290238|475015415|FG001|Overall Study|Withdrawal by Subject|13|||
131926363|NCT02186171|475015416|FG000|Overall Study|Withdrawal by Subject|1|||
131926364|NCT02186171|475015417|FG001|Overall Study|Withdrawal by Subject|9|||
131926365|NCT02186171|475015416|FG000|Overall Study|Lost to Follow-up|2|||
131926366|NCT02186171|475015417|FG001|Overall Study|Lost to Follow-up|2|||
131926367|NCT02186171|475015416|FG000|Overall Study|Death|1|||
131926368|NCT02186171|475015417|FG001|Overall Study|Death|2|||
131926369|NCT02186171|475015416|FG000|Overall Study|Protocol-specified Criteria|0|||
131409860|NCT00765882|473123287|FG002|Overall Study|Other Reason|2|||
131926370|NCT02186171|475015417|FG001|Overall Study|Protocol-specified Criteria|2|||
131926371|NCT02946996|475015419|FG000|Overall Study|non-evaluable|3|||
131926372|NCT02946996|475015420|FG001|Overall Study|non-evaluable|6|||
131926373|NCT02946996|475015421|FG002|Overall Study|non-evaluable|5|||
131926374|NCT06868667|475015425|FG000|Overall Study|Death|0|||
131926375|NCT06868667|475015426|FG001|Overall Study|Death|4|||
131926376|NCT06868667|475015425|FG000|Overall Study|Lost to Follow-up|0|||
131926377|NCT06868667|475015426|FG001|Overall Study|Lost to Follow-up|1|||
131926378|NCT06868667|475015425|FG000|Overall Study|Withdrawal by Subject|1|||
131926379|NCT06868667|475015426|FG001|Overall Study|Withdrawal by Subject|0|||
131926380|NCT06868667|475015425|FG000|Overall Study|Ongoing|9|||
131926381|NCT06868667|475015426|FG001|Overall Study|Ongoing|9|||
131926382|NCT05330429|475015429|FG000|Overall Study|Study Terminated by Sponsor|4|||
131926383|NCT05330429|475015430|FG001|Overall Study|Study Terminated by Sponsor|33|||
131926384|NCT05330429|475015431|FG002|Overall Study|Study Terminated by Sponsor|12|||
131926385|NCT05330429|475015429|FG000|Overall Study|Death|5|||
131926386|NCT05330429|475015430|FG001|Overall Study|Death|2|||
131926387|NCT05330429|475015431|FG002|Overall Study|Death|4|||
131926388|NCT05330429|475015429|FG000|Overall Study|Withdrew Consent|0|||
131926389|NCT05330429|475015430|FG001|Overall Study|Withdrew Consent|5|||
131926390|NCT05330429|475015431|FG002|Overall Study|Withdrew Consent|4|||
131926391|NCT05330429|475015429|FG000|Overall Study|Investigator's Discretion|0|||
131926392|NCT05330429|475015430|FG001|Overall Study|Investigator's Discretion|1|||
131926393|NCT05330429|475015431|FG002|Overall Study|Investigator's Discretion|3|||
131926394|NCT05330429|475015429|FG000|Overall Study|Subject Decision|1|||
131926395|NCT05330429|475015430|FG001|Overall Study|Subject Decision|2|||
131926396|NCT05330429|475015431|FG002|Overall Study|Subject Decision|0|||
131926397|NCT05330429|475015429|FG000|Overall Study|Lost to Follow-up|0|||
131926398|NCT05330429|475015430|FG001|Overall Study|Lost to Follow-up|1|||
131926399|NCT05330429|475015431|FG002|Overall Study|Lost to Follow-up|0|||
131926400|NCT03572218|475015433|FG000|Overall Study|Lost to Follow-up|3|||
131926401|NCT03572218|475015434|FG001|Overall Study|Lost to Follow-up|2|||
131926402|NCT03572218|475015433|FG000|Overall Study|No longer available for study visits|2|||
131926403|NCT03572218|475015434|FG001|Overall Study|No longer available for study visits|1|||
131926404|NCT03572218|475015433|FG000|Overall Study|No longer interested|1|||
131926405|NCT03572218|475015434|FG001|Overall Study|No longer interested|2|||
131926406|NCT00286455|475015435|FG000|Overall Study|Hyperglycemia rescue|19|||
131926407|NCT00286455|475015436|FG001|Overall Study|Hyperglycemia rescue|13|||
131926408|NCT00286455|475015437|FG002|Overall Study|Hyperglycemia rescue|10|||
131926409|NCT00286455|475015435|FG000|Overall Study|Adverse Event|1|||
131926410|NCT00286455|475015436|FG001|Overall Study|Adverse Event|3|||
131926411|NCT00286455|475015437|FG002|Overall Study|Adverse Event|2|||
131926412|NCT00286455|475015435|FG000|Overall Study|Lost to Follow-up|0|||
131926413|NCT00286455|475015436|FG001|Overall Study|Lost to Follow-up|3|||
131926414|NCT00286455|475015437|FG002|Overall Study|Lost to Follow-up|3|||
131926415|NCT00286455|475015435|FG000|Overall Study|Physician Decision|3|||
131926416|NCT00286455|475015436|FG001|Overall Study|Physician Decision|0|||
131926417|NCT00286455|475015437|FG002|Overall Study|Physician Decision|2|||
131926418|NCT00286455|475015435|FG000|Overall Study|Protocol Violation|1|||
131926419|NCT00286455|475015436|FG001|Overall Study|Protocol Violation|1|||
131926420|NCT00286455|475015437|FG002|Overall Study|Protocol Violation|0|||
131926421|NCT00286455|475015435|FG000|Overall Study|Participant Non-compliance|1|||
131926422|NCT00286455|475015436|FG001|Overall Study|Participant Non-compliance|0|||
131926423|NCT00286455|475015437|FG002|Overall Study|Participant Non-compliance|0|||
131926424|NCT00286455|475015435|FG000|Overall Study|Withdrawal by Subject|0|||
131926425|NCT00286455|475015436|FG001|Overall Study|Withdrawal by Subject|8|||
131926426|NCT00286455|475015437|FG002|Overall Study|Withdrawal by Subject|7|||
131926427|NCT00450749|475015440|FG000|Overall Study|Withdrawal by Subject|0|||
131926428|NCT00450749|475015441|FG001|Overall Study|Withdrawal by Subject|0|||
131926429|NCT00450749|475015442|FG002|Overall Study|Withdrawal by Subject|2|||
131926430|NCT00450749|475015440|FG000|Overall Study|Noncompliant|0|||
131926431|NCT00450749|475015441|FG001|Overall Study|Noncompliant|1|||
131926432|NCT00450749|475015442|FG002|Overall Study|Noncompliant|0|||
131926433|NCT01245049|475015443|FG000|Overall Study|Migrated/moved from study area|0|||
131926434|NCT01245049|475015444|FG001|Overall Study|Migrated/moved from study area|1|||
131926435|NCT01245049|475015443|FG000|Overall Study|Withdrawal by Subject|0|||
131926436|NCT01245049|475015444|FG001|Overall Study|Withdrawal by Subject|1|||
131926437|NCT01245049|475015443|FG000|Overall Study|Lost to Follow-up|1|||
131926438|NCT01245049|475015444|FG001|Overall Study|Lost to Follow-up|2|||
131926439|NCT06097273|475015447|FG000|Overall Study|Death|2|||
131926440|NCT06097273|475015448|FG001|Overall Study|Death|1|||
131926441|NCT06097273|475015449|FG002|Overall Study|Death|2|||
131926442|NCT06097273|475015450|FG003|Overall Study|Death|2|||
131926443|NCT06097273|475015447|FG000|Overall Study|Lost to Follow-up|27|||
131926444|NCT06097273|475015448|FG001|Overall Study|Lost to Follow-up|18|||
131926445|NCT06097273|475015449|FG002|Overall Study|Lost to Follow-up|36|||
131926446|NCT06097273|475015450|FG003|Overall Study|Lost to Follow-up|31|||
131926447|NCT06097273|475015447|FG000|Overall Study|Physician Decision|0|||
131926448|NCT06097273|475015448|FG001|Overall Study|Physician Decision|1|||
131926449|NCT06097273|475015449|FG002|Overall Study|Physician Decision|0|||
131926450|NCT06097273|475015450|FG003|Overall Study|Physician Decision|3|||
131926451|NCT06097273|475015447|FG000|Overall Study|Protocol Violation|1|||
131926452|NCT06097273|475015448|FG001|Overall Study|Protocol Violation|1|||
131926453|NCT06097273|475015449|FG002|Overall Study|Protocol Violation|2|||
131926454|NCT06097273|475015450|FG003|Overall Study|Protocol Violation|1|||
131926455|NCT06097273|475015447|FG000|Overall Study|Withdrawal by Subject|14|||
131926456|NCT06097273|475015448|FG001|Overall Study|Withdrawal by Subject|11|||
131926457|NCT06097273|475015449|FG002|Overall Study|Withdrawal by Subject|14|||
131926458|NCT06097273|475015450|FG003|Overall Study|Withdrawal by Subject|15|||
131926459|NCT06097273|475015447|FG000|Overall Study|Other Than Specified|7|||
131926460|NCT06097273|475015448|FG001|Overall Study|Other Than Specified|3|||
131926461|NCT06097273|475015449|FG002|Overall Study|Other Than Specified|11|||
131926462|NCT06097273|475015450|FG003|Overall Study|Other Than Specified|6|||
131926463|NCT03882801|475017028|FG000|Period 1|Adverse Event|0|||
131926464|NCT03882801|475017029|FG001|Period 1|Adverse Event|1|||
131926465|NCT03882801|475017028|FG000|Period 1|Non-compliance with study drug|1|||
131926466|NCT03882801|475017029|FG001|Period 1|Non-compliance with study drug|1|||
131926467|NCT03882801|475017028|FG000|Period 1|Never treated with study drug|1|||
131926468|NCT03882801|475017029|FG001|Period 1|Never treated with study drug|0|||
131926469|NCT03882801|475017028|FG000|Washout Period|Physician Decision|0|||
131926470|NCT03882801|475017029|FG001|Washout Period|Physician Decision|1|||
131926471|NCT03882801|475017028|FG000|Period 2|Non-compliance with study drug|0|||
131926472|NCT03882801|475017029|FG001|Period 2|Non-compliance with study drug|1|||
131926473|NCT03548415|475017036|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
131926474|NCT03548415|475017037|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
131926475|NCT03548415|475017038|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
131926476|NCT03548415|475017039|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
131926477|NCT03548415|475017040|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
131926478|NCT04605588|475017041|FG000|Overall Study|Withdrawal by Subject|1|||
131926479|NCT04605588|475017042|FG001|Overall Study|Withdrawal by Subject|0|||
131926480|NCT01230814|475017043|FG000|Overall Study|Lost to Follow-up|11|||
131926481|NCT01230814|475017044|FG001|Overall Study|Lost to Follow-up|3|||
131926482|NCT01230814|475017043|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
131926483|NCT01230814|475017044|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
131926484|NCT01803737|475017047|FG000|Overall Study|Lack of Time|1|||
131926485|NCT01803737|475017048|FG001|Overall Study|Lack of Time|0|||
131926486|NCT01803737|475017047|FG000|Overall Study|Medical Reason|0|||
131926487|NCT01803737|475017048|FG001|Overall Study|Medical Reason|1|||
131926488|NCT01803737|475017047|FG000|Overall Study|Lost to Follow-up|0|||
131926489|NCT01803737|475017048|FG001|Overall Study|Lost to Follow-up|2|||
131926490|NCT01529112|475017049|FG000|Overall Study|Adverse Event|2|||
131926491|NCT01529112|475017050|FG001|Overall Study|Adverse Event|0|||
131926492|NCT01529112|475017049|FG000|Overall Study|Death|59|||
131926493|NCT01529112|475017050|FG001|Overall Study|Death|38|||
131926494|NCT01529112|475017049|FG000|Overall Study|Protocol Violation|1|||
131926495|NCT01529112|475017050|FG001|Overall Study|Protocol Violation|0|||
131926496|NCT01529112|475017049|FG000|Overall Study|Withdrawal by Subject|7|||
131926497|NCT01529112|475017050|FG001|Overall Study|Withdrawal by Subject|3|||
131926498|NCT03607695|475017051|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
131926499|NCT03607695|475017051|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
131926500|NCT01524705|475017052|FG000|Overall Study|Adverse Event|2|||
131926501|NCT01524705|475017053|FG001|Overall Study|Adverse Event|0|||
131926502|NCT01524705|475017052|FG000|Overall Study|Death|1|||
131926503|NCT01524705|475017053|FG001|Overall Study|Death|0|||
131926504|NCT01524705|475017052|FG000|Overall Study|Lost to Follow-up|0|||
131926505|NCT01524705|475017053|FG001|Overall Study|Lost to Follow-up|1|||
131926506|NCT01524705|475017052|FG000|Overall Study|Withdrawal by Subject|0|||
131926507|NCT01524705|475017053|FG001|Overall Study|Withdrawal by Subject|1|||
131926508|NCT01524705|475017052|FG000|Overall Study|Pancreatic Cancer|0|||
131926509|NCT01524705|475017053|FG001|Overall Study|Pancreatic Cancer|1|||
131926510|NCT03994120|475017058|FG000|Overall Study|Lost to Follow-up|3|||
131926511|NCT03994120|475017059|FG001|Overall Study|Lost to Follow-up|1|||
131926512|NCT01111292|475017060|FG000|Treatment|Physician Decision|1|||
131926513|NCT01111292|475017061|FG001|Treatment|Physician Decision|1|||
131926514|NCT00225758|475017064|FG000|Overall Study|Adverse Event|4|||
131926515|NCT00756444|475017065|FG000|Overall Study|Adverse Event|1|||
131926516|NCT00756444|475017066|FG001|Overall Study|Adverse Event|1|||
131926517|NCT00756444|475017065|FG000|Overall Study|Withdrawal by Subject|6|||
131926518|NCT00756444|475017066|FG001|Overall Study|Withdrawal by Subject|8|||
131926519|NCT00756444|475017065|FG000|Overall Study|Lost to Follow-up|0|||
131926520|NCT00756444|475017066|FG001|Overall Study|Lost to Follow-up|1|||
131926521|NCT00756444|475017065|FG000|Overall Study|Death|5|||
131926522|NCT00756444|475017066|FG001|Overall Study|Death|4|||
131926523|NCT00756444|475017065|FG000|Overall Study|Disease Progression|2|||
131926524|NCT00756444|475017066|FG001|Overall Study|Disease Progression|7|||
131926525|NCT00756444|475017065|FG000|Overall Study|Ineligibility Determined|1|||
131409861|NCT02231762|473123288|FG000|Combination Phase|Adverse Event|10|||
131926526|NCT00756444|475017066|FG001|Overall Study|Ineligibility Determined|0|||
131926527|NCT00564070|475017067|FG000|Overall Study|Lost to Follow-up|9|||
131926528|NCT00564070|475017068|FG001|Overall Study|Lost to Follow-up|7|||
131926529|NCT00564070|475017067|FG000|Overall Study|Worsening depression, referred to care|3|||
131926530|NCT00564070|475017068|FG001|Overall Study|Worsening depression, referred to care|0|||
131926531|NCT03142334|475017072|FG000|Overall Study|Death|18|||
131926532|NCT03142334|475017073|FG001|Overall Study|Death|33|||
131926533|NCT03142334|475017072|FG000|Overall Study|Withdrawal by Subject|15|||
131926534|NCT03142334|475017073|FG001|Overall Study|Withdrawal by Subject|11|||
131926535|NCT03142334|475017072|FG000|Overall Study|Ongoing on trial follow up|463|||
131926536|NCT03142334|475017073|FG001|Overall Study|Ongoing on trial follow up|454|||
131926537|NCT01217047|475017074|FG000|Overall Study|Lost to Follow-up|0|||
131926538|NCT01217047|475017075|FG001|Overall Study|Lost to Follow-up|1|||
131926539|NCT01217047|475017076|FG002|Overall Study|Lost to Follow-up|0|||
131926540|NCT05529173|475017077|FG000|Overall Study|Physician Decision|3|||
131926541|NCT05529173|475017078|FG001|Overall Study|Physician Decision|6|||
131926542|NCT05529173|475017077|FG000|Overall Study|Sample shipment delay more than one day|4|||
131926543|NCT05529173|475017078|FG001|Overall Study|Sample shipment delay more than one day|0|||
131926544|NCT05587998|475017079|FG000|Overall Study|Withdrawal by Subject|1|||
131926545|NCT05587998|475017080|FG001|Overall Study|Withdrawal by Subject|1|||
131926546|NCT05587998|475017079|FG000|Overall Study|Not treated|3|||
131926547|NCT05587998|475017080|FG001|Overall Study|Not treated|1|||
131926548|NCT05587998|475017079|FG000|Overall Study|Non-compliance with study procedures|0|||
131926549|NCT05587998|475017080|FG001|Overall Study|Non-compliance with study procedures|1|||
131926550|NCT01530997|475017084|FG000|Overall Study|Physician Decision|1|||
131926551|NCT01530997|475017084|FG000|Overall Study|Withdrawal by Subject|1|||
131926552|NCT03892915|475017088|FG000|Overall Study|Lost to Follow-up|6|||
131926553|NCT03892915|475017089|FG001|Overall Study|Lost to Follow-up|12|||
131926554|NCT03892915|475017088|FG000|Overall Study|Death|0|||
131926555|NCT03892915|475017089|FG001|Overall Study|Death|2|||
131926556|NCT03892915|475017088|FG000|Overall Study|Withdrawal by Subject|1|||
131926557|NCT03892915|475017089|FG001|Overall Study|Withdrawal by Subject|1|||
131926558|NCT03892915|475017088|FG000|Overall Study|unsuccessful delivery|13|||
131926559|NCT03892915|475017089|FG001|Overall Study|unsuccessful delivery|18|||
131926560|NCT02181738|475017090|FG000|Overall Study|Participant Withdrew Consent|2|||
131926561|NCT02181738|475017091|FG001|Overall Study|Participant Withdrew Consent|1|||
131926562|NCT02181738|475017092|FG002|Overall Study|Participant Withdrew Consent|1|||
131926563|NCT02181738|475017093|FG003|Overall Study|Participant Withdrew Consent|1|||
131926564|NCT02181738|475017090|FG000|Overall Study|Lost to Follow-up|1|||
131926565|NCT02181738|475017091|FG001|Overall Study|Lost to Follow-up|2|||
131926566|NCT02181738|475017092|FG002|Overall Study|Lost to Follow-up|1|||
131881978|NCT01995175|474849268|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
131881979|NCT01995175|474849268|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
131881980|NCT01995175|474849268|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
131881981|NCT01995175|474849268|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
131881982|NCT01995175|474849268|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
131881983|NCT01995175|474849268|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
131409862|NCT02231762|473123289|FG001|Combination Phase|Adverse Event|0|||
131409863|NCT02231762|473123290|FG002|Combination Phase|Adverse Event|0|||
131409864|NCT02231762|473123291|FG003|Combination Phase|Adverse Event|0|||
131881984|NCT01877551|474849269|FG000|Overall Study|Physician Decision|0|||
131881985|NCT01877551|474849270|FG001|Overall Study|Physician Decision|1|||
131881986|NCT00984061|474849271|FG000|Clarithromycin Alone|Protocol Violation|1|||
131881987|NCT02659514|474849274|FG000|Overall Study|Adverse Event|3|||
131881988|NCT02659514|474849275|FG001|Overall Study|Adverse Event|12|||
131926567|NCT02181738|475017093|FG003|Overall Study|Lost to Follow-up|1|||
131926568|NCT02181738|475017090|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
131926569|NCT02181738|475017091|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
131926570|NCT02181738|475017092|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
131926571|NCT02181738|475017093|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
131926572|NCT02181738|475017090|FG000|Overall Study|Poor/Non-Compliance|1|||
131926573|NCT02181738|475017091|FG001|Overall Study|Poor/Non-Compliance|0|||
131926574|NCT02181738|475017092|FG002|Overall Study|Poor/Non-Compliance|2|||
131926575|NCT02181738|475017093|FG003|Overall Study|Poor/Non-Compliance|1|||
131926576|NCT02181738|475017090|FG000|Overall Study|Disease Progression|28|||
131926577|NCT02181738|475017091|FG001|Overall Study|Disease Progression|35|||
131926578|NCT02181738|475017092|FG002|Overall Study|Disease Progression|40|||
131926579|NCT02181738|475017093|FG003|Overall Study|Disease Progression|0|||
131926580|NCT02181738|475017090|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
131926581|NCT02181738|475017091|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
131926582|NCT02181738|475017092|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
131926583|NCT02181738|475017093|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
131926584|NCT02181738|475017090|FG000|Overall Study|Study Drug Toxicity|6|||
131926585|NCT02181738|475017091|FG001|Overall Study|Study Drug Toxicity|11|||
131409865|NCT02231762|473123288|FG000|Combination Phase|Withdrawal by Subject|2|||
131409866|NCT02231762|473123289|FG001|Combination Phase|Withdrawal by Subject|0|||
131926586|NCT02181738|475017092|FG002|Overall Study|Study Drug Toxicity|8|||
131926587|NCT02181738|475017093|FG003|Overall Study|Study Drug Toxicity|1|||
131926588|NCT02181738|475017090|FG000|Overall Study|Other Reasons|14|||
131926589|NCT02181738|475017091|FG001|Overall Study|Other Reasons|16|||
131926590|NCT02181738|475017092|FG002|Overall Study|Other Reasons|28|||
131926591|NCT02181738|475017093|FG003|Overall Study|Other Reasons|0|||
131926592|NCT02181738|475017090|FG000|Overall Study|Maximum Clinical Benefit|3|||
131926593|NCT02181738|475017091|FG001|Overall Study|Maximum Clinical Benefit|0|||
131926594|NCT02181738|475017092|FG002|Overall Study|Maximum Clinical Benefit|1|||
131454050|NCT00092443|473291870|FG001|Overall Study|Adverse Event|13|||
131926595|NCT02181738|475017093|FG003|Overall Study|Maximum Clinical Benefit|0|||
131926596|NCT02181738|475017090|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
131926597|NCT02181738|475017091|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
131926598|NCT02181738|475017092|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
131926599|NCT02181738|475017093|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131926600|NCT00114777|475017097|FG000|Randomization to Month 36|Death|10|||
131926601|NCT00114777|475017098|FG001|Randomization to Month 36|Death|4|||
131926602|NCT00114777|475017099|FG002|Randomization to Month 36|Death|3|||
131926603|NCT00114777|475017097|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
131926604|NCT00114777|475017098|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
131926605|NCT00114777|475017099|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
131926606|NCT00114777|475017097|FG000|Randomization to Month 36|Lack of Efficacy|19|||
131926607|NCT00114777|475017098|FG001|Randomization to Month 36|Lack of Efficacy|15|||
131926608|NCT00114777|475017099|FG002|Randomization to Month 36|Lack of Efficacy|17|||
131926609|NCT00114777|475017097|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
131926610|NCT00114777|475017098|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
131926611|NCT00114777|475017099|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
131926612|NCT00114777|475017097|FG000|Randomization to Month 36|Adverse Event|34|||
131926613|NCT00114777|475017098|FG001|Randomization to Month 36|Adverse Event|35|||
131926614|NCT00114777|475017099|FG002|Randomization to Month 36|Adverse Event|44|||
131926615|NCT00114777|475017097|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
131926616|NCT00114777|475017098|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
131926617|NCT00114777|475017099|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
131926618|NCT00114777|475017097|FG000|Randomization to Month 36|Other|9|||
131926619|NCT00114777|475017098|FG001|Randomization to Month 36|Other|3|||
131926620|NCT00114777|475017099|FG002|Randomization to Month 36|Other|12|||
131926621|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Death|8|||
131926622|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Death|13|||
131926623|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Death|7|||
131926624|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
131926625|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
131926626|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
131926627|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
131926628|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
131926629|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
131926630|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
131926631|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
131926632|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
131926633|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
131926634|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
131926635|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
131926636|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
131926637|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
131926638|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
131926639|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
131926640|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
131926641|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
131926642|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
131926643|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
131926644|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
131926645|NCT00114777|475017097|FG000|Long-Term Extension to Month 84|Other|2|||
131926646|NCT00114777|475017098|FG001|Long-Term Extension to Month 84|Other|0|||
131926647|NCT00114777|475017099|FG002|Long-Term Extension to Month 84|Other|2|||
131409867|NCT02231762|473123290|FG002|Combination Phase|Withdrawal by Subject|0|||
131926648|NCT01851369|475017101|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926649|NCT01851369|475017102|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926650|NCT01851369|475017103|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926651|NCT01851369|475017104|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926652|NCT01851369|475017105|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926653|NCT01851369|475017106|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
131926654|NCT01851369|475017107|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926655|NCT01851369|475017108|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926656|NCT01851369|475017109|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926657|NCT01851369|475017110|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131409868|NCT02231762|473123291|FG003|Combination Phase|Withdrawal by Subject|0|||
131926658|NCT01851369|475017111|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926659|NCT01851369|475017112|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926660|NCT01851369|475017113|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
131926661|NCT02318277|475017114|FG000|Overall Study|Physician Decision|0|||
131926662|NCT02318277|475017115|FG001|Overall Study|Physician Decision|0|||
131926663|NCT02318277|475017116|FG002|Overall Study|Physician Decision|0|||
131926664|NCT02318277|475017117|FG003|Overall Study|Physician Decision|0|||
131926665|NCT02318277|475017118|FG004|Overall Study|Physician Decision|0|||
131926666|NCT02318277|475017119|FG005|Overall Study|Physician Decision|0|||
131926667|NCT02318277|475017120|FG006|Overall Study|Physician Decision|0|||
131926668|NCT02318277|475017121|FG007|Overall Study|Physician Decision|1|||
131926669|NCT02318277|475017114|FG000|Overall Study|Other|0|||
131926670|NCT02318277|475017115|FG001|Overall Study|Other|0|||
131926671|NCT02318277|475017116|FG002|Overall Study|Other|0|||
131926672|NCT02318277|475017117|FG003|Overall Study|Other|0|||
131926673|NCT02318277|475017118|FG004|Overall Study|Other|0|||
131926674|NCT02318277|475017119|FG005|Overall Study|Other|0|||
131926675|NCT02318277|475017120|FG006|Overall Study|Other|1|||
131926676|NCT02318277|475017121|FG007|Overall Study|Other|0|||
131926677|NCT02318277|475017114|FG000|Overall Study|Withdrawal by Subject|0|||
131926678|NCT02318277|475017115|FG001|Overall Study|Withdrawal by Subject|0|||
131926679|NCT02318277|475017116|FG002|Overall Study|Withdrawal by Subject|1|||
131926680|NCT02318277|475017117|FG003|Overall Study|Withdrawal by Subject|0|||
131926681|NCT02318277|475017118|FG004|Overall Study|Withdrawal by Subject|1|||
131926682|NCT02318277|475017119|FG005|Overall Study|Withdrawal by Subject|1|||
131926683|NCT02318277|475017120|FG006|Overall Study|Withdrawal by Subject|6|||
131926684|NCT02318277|475017121|FG007|Overall Study|Withdrawal by Subject|14|||
131926685|NCT02318277|475017114|FG000|Overall Study|Participant trial terminated by sponsor|0|||
131926686|NCT02318277|475017115|FG001|Overall Study|Participant trial terminated by sponsor|0|||
131926687|NCT02318277|475017116|FG002|Overall Study|Participant trial terminated by sponsor|1|||
131926688|NCT02318277|475017117|FG003|Overall Study|Participant trial terminated by sponsor|0|||
131926689|NCT02318277|475017118|FG004|Overall Study|Participant trial terminated by sponsor|1|||
131926690|NCT02318277|475017119|FG005|Overall Study|Participant trial terminated by sponsor|2|||
131926691|NCT02318277|475017120|FG006|Overall Study|Participant trial terminated by sponsor|5|||
131926692|NCT02318277|475017121|FG007|Overall Study|Participant trial terminated by sponsor|16|||
131926693|NCT02318277|475017114|FG000|Overall Study|Lost to Follow-up|1|||
131926694|NCT02318277|475017115|FG001|Overall Study|Lost to Follow-up|0|||
131926695|NCT02318277|475017116|FG002|Overall Study|Lost to Follow-up|1|||
131926696|NCT02318277|475017117|FG003|Overall Study|Lost to Follow-up|0|||
131926697|NCT02318277|475017118|FG004|Overall Study|Lost to Follow-up|0|||
131926698|NCT02318277|475017119|FG005|Overall Study|Lost to Follow-up|0|||
131926699|NCT02318277|475017120|FG006|Overall Study|Lost to Follow-up|3|||
131926700|NCT02318277|475017121|FG007|Overall Study|Lost to Follow-up|4|||
131926701|NCT02318277|475017114|FG000|Overall Study|Death|5|||
131926702|NCT02318277|475017115|FG001|Overall Study|Death|3|||
131926703|NCT02318277|475017116|FG002|Overall Study|Death|1|||
131926704|NCT02318277|475017117|FG003|Overall Study|Death|4|||
131926705|NCT02318277|475017118|FG004|Overall Study|Death|6|||
131926706|NCT02318277|475017119|FG005|Overall Study|Death|5|||
131926707|NCT02318277|475017120|FG006|Overall Study|Death|34|||
131926708|NCT02318277|475017121|FG007|Overall Study|Death|58|||
131926709|NCT02318277|475017114|FG000|Overall Study|Transitioned to Hospice|0|||
131926710|NCT02318277|475017115|FG001|Overall Study|Transitioned to Hospice|0|||
131926711|NCT02318277|475017116|FG002|Overall Study|Transitioned to Hospice|0|||
131926712|NCT02318277|475017117|FG003|Overall Study|Transitioned to Hospice|0|||
131926713|NCT02318277|475017118|FG004|Overall Study|Transitioned to Hospice|0|||
131926714|NCT02318277|475017119|FG005|Overall Study|Transitioned to Hospice|1|||
131926715|NCT02318277|475017120|FG006|Overall Study|Transitioned to Hospice|0|||
131926716|NCT02318277|475017121|FG007|Overall Study|Transitioned to Hospice|0|||
131926717|NCT02453191|475017124|FG000|Overall Study|Withdrawal by Subject|1|||
131926718|NCT01520714|475017125|FG000|Overall Study|Protocol Violation|0|||
131926719|NCT01520714|475017126|FG001|Overall Study|Protocol Violation|3|||
131926720|NCT01520714|475017125|FG000|Overall Study|Adverse Event|0|||
131926721|NCT01520714|475017126|FG001|Overall Study|Adverse Event|2|||
131926722|NCT01520714|475017125|FG000|Overall Study|Lack of Efficacy|0|||
131926723|NCT01520714|475017126|FG001|Overall Study|Lack of Efficacy|1|||
131926724|NCT01691482|475017127|FG000|Treatment Period 2|Adverse Event|0|||
131926725|NCT01691482|475017128|FG001|Treatment Period 2|Adverse Event|1|||
131926726|NCT01691482|475017127|FG000|Treatment Period 2|Protocol Violation|1|||
131926727|NCT01691482|475017128|FG001|Treatment Period 2|Protocol Violation|1|||
131926728|NCT02829957|475017130|FG000|Overall Study|Lost to Follow-up|2|||
131926729|NCT02829957|475017131|FG001|Overall Study|Lost to Follow-up|1|||
131926730|NCT02366130|475017132|FG000|Overall Study|Withdrawal by Subject|3|||
131926731|NCT02366130|475017132|FG000|Overall Study|Ineligible|6|||
131926732|NCT04595370|475017133|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
131926733|NCT04595370|475017134|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
131926734|NCT04595370|475017135|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
131926735|NCT04595370|475017136|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
131926736|NCT04595370|475017137|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
131926737|NCT04595370|475017138|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
131926738|NCT04595370|475017133|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
131926739|NCT04595370|475017134|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
131926740|NCT04595370|475017135|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
131926741|NCT04595370|475017136|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
131926742|NCT04595370|475017137|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
131926743|NCT04595370|475017138|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
131926744|NCT04595370|475017133|FG000|Overall Study|Adverse Event|0|||
131926745|NCT04595370|475017134|FG001|Overall Study|Adverse Event|4|||
131926746|NCT04595370|475017135|FG002|Overall Study|Adverse Event|3|||
131926747|NCT04595370|475017136|FG003|Overall Study|Adverse Event|1|||
131926748|NCT04595370|475017137|FG004|Overall Study|Adverse Event|1|||
131926749|NCT04595370|475017138|FG005|Overall Study|Adverse Event|1|||
131926750|NCT04595370|475017133|FG000|Overall Study|Withdrawal of Consent|1|||
131926751|NCT04595370|475017134|FG001|Overall Study|Withdrawal of Consent|1|||
131926752|NCT04595370|475017135|FG002|Overall Study|Withdrawal of Consent|1|||
131926753|NCT04595370|475017136|FG003|Overall Study|Withdrawal of Consent|0|||
131926754|NCT04595370|475017137|FG004|Overall Study|Withdrawal of Consent|0|||
131926755|NCT04595370|475017138|FG005|Overall Study|Withdrawal of Consent|0|||
131926756|NCT04595370|475017133|FG000|Overall Study|Death|0|||
131926757|NCT04595370|475017134|FG001|Overall Study|Death|1|||
131926758|NCT04595370|475017135|FG002|Overall Study|Death|0|||
131926759|NCT04595370|475017136|FG003|Overall Study|Death|0|||
131926760|NCT04595370|475017137|FG004|Overall Study|Death|1|||
131926761|NCT04595370|475017138|FG005|Overall Study|Death|0|||
131926762|NCT04595370|475017133|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131926763|NCT04595370|475017134|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131926764|NCT04595370|475017135|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131926765|NCT04595370|475017136|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131926766|NCT04595370|475017137|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131926767|NCT04595370|475017138|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131926768|NCT04595370|475017133|FG000|Overall Study|Withdrawal by Subject|0|||
131926769|NCT04595370|475017134|FG001|Overall Study|Withdrawal by Subject|0|||
131926770|NCT04595370|475017135|FG002|Overall Study|Withdrawal by Subject|1|||
131926771|NCT04595370|475017136|FG003|Overall Study|Withdrawal by Subject|0|||
131926772|NCT04595370|475017137|FG004|Overall Study|Withdrawal by Subject|2|||
131926773|NCT04595370|475017138|FG005|Overall Study|Withdrawal by Subject|0|||
131926774|NCT04595370|475017133|FG000|Overall Study|Lost to Follow-up|0|||
131926775|NCT04595370|475017134|FG001|Overall Study|Lost to Follow-up|0|||
131926776|NCT04595370|475017135|FG002|Overall Study|Lost to Follow-up|0|||
131926777|NCT04595370|475017136|FG003|Overall Study|Lost to Follow-up|0|||
131926778|NCT04595370|475017137|FG004|Overall Study|Lost to Follow-up|1|||
131926779|NCT04595370|475017138|FG005|Overall Study|Lost to Follow-up|0|||
131926780|NCT04595370|475017133|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
131926781|NCT04595370|475017134|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
131926782|NCT04595370|475017135|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
131926783|NCT04595370|475017136|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
131926784|NCT04595370|475017137|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
131926785|NCT04595370|475017138|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
131926786|NCT01945242|475017139|FG000|Overall Study|Physician Decision|3|||
131926787|NCT01945242|475017140|FG001|Overall Study|Physician Decision|3|||
131926788|NCT05661734|475017141|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
131926789|NCT05661734|475017141|FG000|Overall Study|Lost to Follow-up|13|||
131926790|NCT05661734|475017141|FG000|Overall Study|Enrolled but not dosed|2|||
131926791|NCT01341990|475017142|FG000|Overall Study|Adverse Event|0|||
131926792|NCT01341990|475017143|FG001|Overall Study|Adverse Event|1|||
131926793|NCT01341990|475017142|FG000|Overall Study|Torn Study Lens|1|||
131926794|NCT01341990|475017143|FG001|Overall Study|Torn Study Lens|0|||
131926795|NCT01341990|475017142|FG000|Overall Study|Withdrawal by Subject|2|||
131926796|NCT01341990|475017143|FG001|Overall Study|Withdrawal by Subject|0|||
131926797|NCT04401293|475017145|FG000|Overall Study|Withdrawal by Subject|1|||
131926798|NCT04401293|475017146|FG001|Overall Study|Withdrawal by Subject|3|||
131926799|NCT00694161|475017147|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
131926800|NCT00694161|475017147|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
131926801|NCT00694161|475017147|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
131926802|NCT00837330|475017148|FG000|Overall Study|Lost to Follow-up|1|||
131926803|NCT00837330|475017149|FG001|Overall Study|Lost to Follow-up|3|||
131409869|NCT02231762|473123288|FG000|Combination Phase|Disease Progression|6|||
131926804|NCT01348490|475017154|FG000|Overall Study|Death|1|||
131926805|NCT01348490|475017154|FG000|Overall Study|Adverse Event|3|||
131926806|NCT01348490|475017154|FG000|Overall Study|Consent withdrawn|7|||
131926807|NCT01348490|475017154|FG000|Overall Study|Disease progression|3|||
131409870|NCT02231762|473123289|FG001|Combination Phase|Disease Progression|0|||
131409871|NCT02231762|473123290|FG002|Combination Phase|Disease Progression|0|||
131409872|NCT02231762|473123291|FG003|Combination Phase|Disease Progression|0|||
131409873|NCT02231762|473123288|FG000|Combination Phase|Did not meet inclusion criteria|1|||
131409874|NCT02231762|473123289|FG001|Combination Phase|Did not meet inclusion criteria|0|||
131409875|NCT02231762|473123290|FG002|Combination Phase|Did not meet inclusion criteria|0|||
131409876|NCT02231762|473123291|FG003|Combination Phase|Did not meet inclusion criteria|0|||
131409877|NCT02231762|473123288|FG000|Combination Phase|Protocol Violation|1|||
131409878|NCT02231762|473123289|FG001|Combination Phase|Protocol Violation|0|||
131409879|NCT02231762|473123290|FG002|Combination Phase|Protocol Violation|0|||
131409880|NCT02231762|473123291|FG003|Combination Phase|Protocol Violation|0|||
131926808|NCT01348490|475017154|FG000|Overall Study|Lost to Follow-up|1|||
131926809|NCT01348490|475017154|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
131926810|NCT01348490|475017154|FG000|Overall Study|Other Unspecified|8|||
131926811|NCT00300495|475017155|FG000|Overall Study|Protocol Violation|4|||
131926812|NCT00300495|475017156|FG001|Overall Study|Protocol Violation|1|||
131926813|NCT01184118|475017157|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
131926814|NCT01184118|475017157|FG000|Overall Study|No physiologic confirmation of asthma|8|||
131926815|NCT01184118|475017157|FG000|Overall Study|FEV1 <60% predicted|2|||
131926816|NCT01184118|475017157|FG000|Overall Study|Exclusionary medical condition|2|||
131926817|NCT01184118|475017157|FG000|Overall Study|Withdrawal by Subject|5|||
131926818|NCT03632720|475017159|FG000|Overall Study|Adverse Event|2|||
131926819|NCT03632720|475017160|FG001|Overall Study|Adverse Event|0|||
131926820|NCT03632720|475017161|FG002|Overall Study|Adverse Event|0|||
131926821|NCT03632720|475017159|FG000|Overall Study|Lost to Follow-up|0|||
131926822|NCT03632720|475017160|FG001|Overall Study|Lost to Follow-up|1|||
131926823|NCT03632720|475017161|FG002|Overall Study|Lost to Follow-up|0|||
131926824|NCT03632720|475017159|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
131926825|NCT03632720|475017160|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
131926826|NCT03632720|475017161|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
131926827|NCT03632720|475017159|FG000|Overall Study|Screen failure|0|||
131926828|NCT03632720|475017160|FG001|Overall Study|Screen failure|1|||
131926829|NCT03632720|475017161|FG002|Overall Study|Screen failure|0|||
131926830|NCT00682435|475017164|FG000|Overall Study|Insufficient data|5|||
131926831|NCT00682435|475017164|FG000|Overall Study|Erroneously enrolled twice|2|||
131926832|NCT01117350|475017165|FG000|Comparative Period|Not Treated|5|||
131926833|NCT01117350|475017166|FG001|Comparative Period|Not Treated|8|||
131926834|NCT01117350|475017165|FG000|Comparative Period|Adverse Event|6|||
131926835|NCT01117350|475017166|FG001|Comparative Period|Adverse Event|33|||
131926836|NCT01117350|475017165|FG000|Comparative Period|Lost to Follow-up|11|||
131926837|NCT01117350|475017166|FG001|Comparative Period|Lost to Follow-up|7|||
131926838|NCT01117350|475017165|FG000|Comparative Period|Withdrawal by Subject|9|||
131926839|NCT01117350|475017166|FG001|Comparative Period|Withdrawal by Subject|13|||
131926840|NCT01117350|475017165|FG000|Comparative Period|Protocol Violation|8|||
131926841|NCT01117350|475017166|FG001|Comparative Period|Protocol Violation|12|||
131926842|NCT01117350|475017165|FG000|Comparative Period|Lack of Efficacy|1|||
131926843|NCT01117350|475017166|FG001|Comparative Period|Lack of Efficacy|0|||
131926844|NCT01117350|475017165|FG000|Comparative Period|Physician Decision|0|||
131926845|NCT01117350|475017166|FG001|Comparative Period|Physician Decision|1|||
131926846|NCT01117350|475017165|FG000|Comparative Period|Move to another city/country|2|||
131926847|NCT01117350|475017166|FG001|Comparative Period|Move to another city/country|1|||
131926848|NCT01117350|475017165|FG000|Extension Period|Not included in extension, not treated|0|||
131926849|NCT01117350|475017166|FG001|Extension Period|Not included in extension, not treated|50|||
131926850|NCT01117350|475017165|FG000|Extension Period|Adverse Event|0|||
131926851|NCT01117350|475017166|FG001|Extension Period|Adverse Event|2|||
131926852|NCT01117350|475017165|FG000|Extension Period|Protocol Violation|0|||
131926853|NCT01117350|475017166|FG001|Extension Period|Protocol Violation|2|||
131926854|NCT01117350|475017165|FG000|Extension Period|Lost to Follow-up|0|||
131926855|NCT01117350|475017166|FG001|Extension Period|Lost to Follow-up|2|||
131926856|NCT01117350|475017165|FG000|Extension Period|Withdrawal by Subject|0|||
131926857|NCT01117350|475017166|FG001|Extension Period|Withdrawal by Subject|3|||
131926858|NCT01117350|475017165|FG000|Extension Period|Lack of Efficacy|0|||
131926859|NCT01117350|475017166|FG001|Extension Period|Lack of Efficacy|2|||
131926860|NCT01117350|475017165|FG000|Extension Period|Inclusion criteria not respected|0|||
131409881|NCT02231762|473123288|FG000|Maintenance Phase|Disease progression|0|||
131409882|NCT02231762|473123289|FG001|Maintenance Phase|Disease progression|3|||
131409883|NCT02231762|473123290|FG002|Maintenance Phase|Disease progression|4|||
131409884|NCT02231762|473123291|FG003|Maintenance Phase|Disease progression|3|||
131409885|NCT02231762|473123288|FG000|Maintenance Phase|Adverse Event|0|||
131926861|NCT01117350|475017166|FG001|Extension Period|Inclusion criteria not respected|1|||
131926862|NCT01117350|475017165|FG000|Extension Period|Prohibited medication|0|||
131926863|NCT01117350|475017166|FG001|Extension Period|Prohibited medication|1|||
131926864|NCT01862029|475018332|FG000|Overall Study|Physician Decision|1|||
131926865|NCT03931785|475018333|FG000|Overall Study|Lost to Follow-up|4|||
131926866|NCT03931785|475018334|FG001|Overall Study|Lost to Follow-up|1|||
131926867|NCT03931785|475018335|FG002|Overall Study|Lost to Follow-up|4|||
131926868|NCT03931785|475018336|FG003|Overall Study|Lost to Follow-up|3|||
131926869|NCT03931785|475018333|FG000|Overall Study|Adverse Event|1|||
131926870|NCT03931785|475018334|FG001|Overall Study|Adverse Event|0|||
131926871|NCT03931785|475018335|FG002|Overall Study|Adverse Event|3|||
131926872|NCT03931785|475018336|FG003|Overall Study|Adverse Event|4|||
131926873|NCT03931785|475018333|FG000|Overall Study|Protocol Violation|0|||
131926874|NCT03931785|475018334|FG001|Overall Study|Protocol Violation|1|||
131926875|NCT03931785|475018335|FG002|Overall Study|Protocol Violation|0|||
131926876|NCT03931785|475018336|FG003|Overall Study|Protocol Violation|0|||
131926877|NCT03931785|475018333|FG000|Overall Study|Noncompliance With Study drug|0|||
131926878|NCT03931785|475018334|FG001|Overall Study|Noncompliance With Study drug|1|||
131926879|NCT03931785|475018335|FG002|Overall Study|Noncompliance With Study drug|0|||
131926880|NCT03931785|475018336|FG003|Overall Study|Noncompliance With Study drug|0|||
131926881|NCT03931785|475018333|FG000|Overall Study|Other Not specified|0|||
131926882|NCT03931785|475018334|FG001|Overall Study|Other Not specified|2|||
131926883|NCT03931785|475018335|FG002|Overall Study|Other Not specified|2|||
131926884|NCT03931785|475018336|FG003|Overall Study|Other Not specified|2|||
131926885|NCT03931785|475018333|FG000|Overall Study|Withdrawal by Subject|0|||
131926886|NCT03931785|475018334|FG001|Overall Study|Withdrawal by Subject|2|||
131926887|NCT03931785|475018335|FG002|Overall Study|Withdrawal by Subject|4|||
131926888|NCT03931785|475018336|FG003|Overall Study|Withdrawal by Subject|1|||
131926889|NCT03931785|475018333|FG000|Overall Study|Pregnancy|0|||
131926890|NCT03931785|475018334|FG001|Overall Study|Pregnancy|0|||
131926891|NCT03931785|475018335|FG002|Overall Study|Pregnancy|0|||
131926892|NCT03931785|475018336|FG003|Overall Study|Pregnancy|1|||
131926893|NCT00504556|475018337|FG000|Overall Study|Adverse Event|11|||
131926894|NCT00504556|475018338|FG001|Overall Study|Adverse Event|11|||
131926895|NCT00504556|475018339|FG002|Overall Study|Adverse Event|14|||
131926896|NCT00504556|475018340|FG003|Overall Study|Adverse Event|13|||
131926897|NCT00504556|475018341|FG004|Overall Study|Adverse Event|5|||
131926898|NCT00504556|475018337|FG000|Overall Study|Death|3|||
131926899|NCT00504556|475018338|FG001|Overall Study|Death|3|||
131926900|NCT00504556|475018339|FG002|Overall Study|Death|1|||
131926901|NCT00504556|475018340|FG003|Overall Study|Death|0|||
131926902|NCT00504556|475018341|FG004|Overall Study|Death|2|||
131926903|NCT00504556|475018337|FG000|Overall Study|Protocol Violation|1|||
131926904|NCT00504556|475018338|FG001|Overall Study|Protocol Violation|3|||
131926905|NCT00504556|475018339|FG002|Overall Study|Protocol Violation|2|||
131926906|NCT00504556|475018340|FG003|Overall Study|Protocol Violation|1|||
131926907|NCT00504556|475018341|FG004|Overall Study|Protocol Violation|2|||
131926908|NCT00504556|475018337|FG000|Overall Study|Lost to Follow-up|0|||
131926909|NCT00504556|475018338|FG001|Overall Study|Lost to Follow-up|0|||
131926910|NCT00504556|475018339|FG002|Overall Study|Lost to Follow-up|1|||
131926911|NCT00504556|475018340|FG003|Overall Study|Lost to Follow-up|1|||
131926912|NCT00504556|475018341|FG004|Overall Study|Lost to Follow-up|1|||
131926913|NCT00504556|475018337|FG000|Overall Study|Withdrawal by Subject|16|||
131926914|NCT00504556|475018338|FG001|Overall Study|Withdrawal by Subject|16|||
131926915|NCT00504556|475018339|FG002|Overall Study|Withdrawal by Subject|7|||
131926916|NCT00504556|475018340|FG003|Overall Study|Withdrawal by Subject|8|||
131926917|NCT00504556|475018341|FG004|Overall Study|Withdrawal by Subject|12|||
131926918|NCT00504556|475018337|FG000|Overall Study|administrative reasons|0|||
131926919|NCT00504556|475018338|FG001|Overall Study|administrative reasons|2|||
131926920|NCT00504556|475018339|FG002|Overall Study|administrative reasons|2|||
131926921|NCT00504556|475018340|FG003|Overall Study|administrative reasons|1|||
131926922|NCT00504556|475018341|FG004|Overall Study|administrative reasons|2|||
131926923|NCT00504556|475018337|FG000|Overall Study|did not meet entry criteria|2|||
131926924|NCT00504556|475018338|FG001|Overall Study|did not meet entry criteria|0|||
131926925|NCT00504556|475018339|FG002|Overall Study|did not meet entry criteria|1|||
131926926|NCT00504556|475018340|FG003|Overall Study|did not meet entry criteria|1|||
131926927|NCT00504556|475018341|FG004|Overall Study|did not meet entry criteria|0|||
131926928|NCT00504556|475018337|FG000|Overall Study|data monitor committee decision|0|||
131926929|NCT00504556|475018338|FG001|Overall Study|data monitor committee decision|0|||
131926930|NCT00504556|475018339|FG002|Overall Study|data monitor committee decision|0|||
131926931|NCT00504556|475018340|FG003|Overall Study|data monitor committee decision|100|||
131926932|NCT00504556|475018341|FG004|Overall Study|data monitor committee decision|0|||
131926933|NCT00504556|475018337|FG000|Overall Study|Other|2|||
131926934|NCT00504556|475018338|FG001|Overall Study|Other|2|||
131926935|NCT00504556|475018339|FG002|Overall Study|Other|2|||
131926936|NCT00504556|475018340|FG003|Overall Study|Other|3|||
131926937|NCT00504556|475018341|FG004|Overall Study|Other|0|||
131926938|NCT00504556|475018337|FG000|Overall Study|not in safety analysis set|0|||
131409886|NCT02231762|473123289|FG001|Maintenance Phase|Adverse Event|0|||
131926939|NCT00504556|475018338|FG001|Overall Study|not in safety analysis set|1|||
131926940|NCT00504556|475018339|FG002|Overall Study|not in safety analysis set|1|||
131926941|NCT00504556|475018340|FG003|Overall Study|not in safety analysis set|0|||
131926942|NCT00504556|475018341|FG004|Overall Study|not in safety analysis set|1|||
131926943|NCT02741193|475018344|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
131409887|NCT02231762|473123290|FG002|Maintenance Phase|Adverse Event|1|||
131409888|NCT02231762|473123291|FG003|Maintenance Phase|Adverse Event|2|||
131409889|NCT02214225|473123292|FG000|Overall Study|Lost to Follow-up|46|||
131409890|NCT02214225|473123293|FG001|Overall Study|Lost to Follow-up|18|||
131409891|NCT02214225|473123294|FG002|Overall Study|Lost to Follow-up|18|||
131409892|NCT02214225|473123292|FG000|Overall Study|Withdrawal by Subject|2|||
131409893|NCT02214225|473123293|FG001|Overall Study|Withdrawal by Subject|0|||
131409894|NCT02214225|473123294|FG002|Overall Study|Withdrawal by Subject|2|||
131409895|NCT02214225|473123292|FG000|Overall Study|Death|5|||
131409896|NCT02214225|473123293|FG001|Overall Study|Death|0|||
131409897|NCT02214225|473123294|FG002|Overall Study|Death|1|||
131409898|NCT02214225|473123292|FG000|Overall Study|randomized in error, not vaccinated|2|||
131454051|NCT00092443|473291869|FG000|Overall Study|Lost to Follow-up|7|||
131454052|NCT00092443|473291870|FG001|Overall Study|Lost to Follow-up|3|||
131926944|NCT02741193|475018344|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
131926945|NCT02502383|475018345|FG000|Overall Study|Lost to Follow-up|130|||
131926946|NCT02502383|475018346|FG001|Overall Study|Lost to Follow-up|131|||
131926947|NCT02502383|475018345|FG000|Overall Study|Withdrawal by Subject|31|||
131926948|NCT02502383|475018346|FG001|Overall Study|Withdrawal by Subject|24|||
131926949|NCT00363467|475018347|FG000|Overall Study|Physician Decision|1|||
131926950|NCT00903344|475018348|FG000|Overall Study|Pregnancy|2|||
131926951|NCT00903344|475018349|FG001|Overall Study|Pregnancy|3|||
131926952|NCT00903344|475018348|FG000|Overall Study|Lost to Follow-up|3|||
131926953|NCT00903344|475018349|FG001|Overall Study|Lost to Follow-up|0|||
131926954|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
131926955|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
131926956|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
131926957|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
131926958|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
131926959|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
131926960|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
131926961|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
131926962|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
131926963|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
131926964|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
131926965|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
131926966|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
131926967|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
131926968|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
131926969|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
131926970|NCT01755156|475018350|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
131926971|NCT01755156|475018351|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
131926972|NCT01755156|475018350|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
131926973|NCT01755156|475018351|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
131926974|NCT01755156|475018350|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
131926975|NCT01755156|475018351|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
131926976|NCT01530256|475018354|FG000|Overall Study|Death|2|||
131926977|NCT00527748|475018355|FG000|Overall Study|Other|3|||
131926978|NCT02004275|475018357|FG000|Phase 1|Ineligible|0|||
131926979|NCT02004275|475018358|FG001|Phase 1|Ineligible|0|||
131926980|NCT02004275|475018359|FG002|Phase 1|Ineligible|0|||
131926981|NCT02004275|475018360|FG003|Phase 1|Ineligible|1|||
131926982|NCT02004275|475018361|FG004|Phase 1|Ineligible|1|||
131926983|NCT02004275|475018362|FG005|Phase 1|Ineligible|0|||
131926984|NCT02004275|475018357|FG000|Phase 1|Protocol Violation|0|||
131926985|NCT02004275|475018358|FG001|Phase 1|Protocol Violation|0|||
131926986|NCT02004275|475018359|FG002|Phase 1|Protocol Violation|0|||
131926987|NCT02004275|475018360|FG003|Phase 1|Protocol Violation|1|||
131926988|NCT02004275|475018361|FG004|Phase 1|Protocol Violation|0|||
131926989|NCT02004275|475018362|FG005|Phase 1|Protocol Violation|5|||
131926990|NCT02004275|475018357|FG000|Phase 2 Part 1|Ineligible|6|||
131926991|NCT02004275|475018358|FG001|Phase 2 Part 1|Ineligible|9|||
131926992|NCT02004275|475018359|FG002|Phase 2 Part 1|Ineligible|0|||
131926993|NCT02004275|475018360|FG003|Phase 2 Part 1|Ineligible|0|||
131926994|NCT02004275|475018361|FG004|Phase 2 Part 1|Ineligible|0|||
131926995|NCT02004275|475018362|FG005|Phase 2 Part 1|Ineligible|0|||
131926996|NCT02004275|475018357|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
131926997|NCT02004275|475018358|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
131926998|NCT02004275|475018359|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
131926999|NCT02004275|475018360|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
131927000|NCT02004275|475018361|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
131409899|NCT02214225|473123293|FG001|Overall Study|randomized in error, not vaccinated|1|||
131409900|NCT02214225|473123294|FG002|Overall Study|randomized in error, not vaccinated|1|||
131927001|NCT02004275|475018362|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
131927002|NCT01093885|475018363|FG000|Overall Study|Adverse Event|4|||
131927003|NCT01093885|475018363|FG000|Overall Study|Lost to Follow-up|1|||
131927004|NCT00292370|475018364|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
131927005|NCT00292370|475018365|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
131927006|NCT00292370|475018366|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
131927007|NCT00292370|475018364|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
131927008|NCT00292370|475018365|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
131927009|NCT00292370|475018366|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
131927010|NCT00292370|475018364|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
131927011|NCT00292370|475018365|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
131927012|NCT00292370|475018366|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
131927013|NCT00292370|475018364|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
131927014|NCT00292370|475018365|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
131927015|NCT00292370|475018366|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
131927016|NCT00292370|475018364|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
131927017|NCT00292370|475018365|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
131927018|NCT00292370|475018366|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
131409901|NCT02680574|473123295|FG000|Overall Study|Death|137|||
131409902|NCT02680574|473123296|FG001|Overall Study|Death|137|||
131409903|NCT02680574|473123295|FG000|Overall Study|Withdrawal by Subject|17|||
131409904|NCT02680574|473123296|FG001|Overall Study|Withdrawal by Subject|9|||
131409905|NCT02680574|473123295|FG000|Overall Study|Lost to Follow-up|4|||
131409906|NCT02680574|473123296|FG001|Overall Study|Lost to Follow-up|6|||
131409907|NCT01009346|473123297|FG000|Overall Study|Adverse Event|4|||
131409908|NCT00711802|473123299|FG000|Overall Study|Not treated (no further detail)|2|||
131409909|NCT00711802|473123300|FG001|Overall Study|Not treated (no further detail)|1|||
131409910|NCT00711802|473123301|FG002|Overall Study|Not treated (no further detail)|2|||
131409911|NCT00711802|473123302|FG003|Overall Study|Not treated (no further detail)|0|||
131409912|NCT00711802|473123303|FG004|Overall Study|Not treated (no further detail)|2|||
131409913|NCT00711802|473123304|FG005|Overall Study|Not treated (no further detail)|0|||
131409914|NCT00711802|473123305|FG006|Overall Study|Not treated (no further detail)|0|||
131409915|NCT00711802|473123306|FG007|Overall Study|Not treated (no further detail)|0|||
131409916|NCT00711802|473123299|FG000|Overall Study|Adverse Event|0|||
131409917|NCT00711802|473123300|FG001|Overall Study|Adverse Event|0|||
131409918|NCT00711802|473123301|FG002|Overall Study|Adverse Event|0|||
131409919|NCT00711802|473123302|FG003|Overall Study|Adverse Event|0|||
131409920|NCT00711802|473123303|FG004|Overall Study|Adverse Event|1|||
131409921|NCT00711802|473123304|FG005|Overall Study|Adverse Event|1|||
131409922|NCT00711802|473123305|FG006|Overall Study|Adverse Event|0|||
131409923|NCT00711802|473123306|FG007|Overall Study|Adverse Event|0|||
131409924|NCT00711802|473123299|FG000|Overall Study|Microbiological failure|0|||
131409925|NCT00711802|473123300|FG001|Overall Study|Microbiological failure|1|||
131409926|NCT00711802|473123301|FG002|Overall Study|Microbiological failure|0|||
131409927|NCT00711802|473123302|FG003|Overall Study|Microbiological failure|0|||
131409928|NCT00711802|473123303|FG004|Overall Study|Microbiological failure|0|||
131454053|NCT00092443|473291869|FG000|Overall Study|Protocol Violation|11|||
131927019|NCT00292370|475018364|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
131927020|NCT00292370|475018365|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
131927021|NCT00292370|475018366|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
131927022|NCT02533674|475018367|FG000|Dose Level I|Progressive disease|1|||
131927023|NCT02533674|475018368|FG001|Dose Level I|Progressive disease|0|||
131927024|NCT02533674|475018369|FG002|Dose Level I|Progressive disease|0|||
131927025|NCT02533674|475018370|FG003|Dose Level I|Progressive disease|0|||
131927026|NCT02533674|475018371|FG004|Dose Level I|Progressive disease|0|||
131927027|NCT02533674|475018372|FG005|Dose Level I|Progressive disease|0|||
131927028|NCT02533674|475018373|FG006|Dose Level I|Progressive disease|0|||
131927029|NCT02533674|475018374|FG007|Dose Level I|Progressive disease|0|||
131927030|NCT02533674|475018367|FG000|Dose Level I|Withdrawal by Subject|1|||
131927031|NCT02533674|475018368|FG001|Dose Level I|Withdrawal by Subject|0|||
131927032|NCT02533674|475018369|FG002|Dose Level I|Withdrawal by Subject|0|||
131927033|NCT02533674|475018370|FG003|Dose Level I|Withdrawal by Subject|0|||
131927034|NCT02533674|475018371|FG004|Dose Level I|Withdrawal by Subject|0|||
131927035|NCT02533674|475018372|FG005|Dose Level I|Withdrawal by Subject|0|||
131927036|NCT02533674|475018373|FG006|Dose Level I|Withdrawal by Subject|0|||
131927037|NCT02533674|475018374|FG007|Dose Level I|Withdrawal by Subject|0|||
131927038|NCT02533674|475018367|FG000|Dose Level I|Physician Decision|1|||
131927039|NCT02533674|475018368|FG001|Dose Level I|Physician Decision|0|||
131927040|NCT02533674|475018369|FG002|Dose Level I|Physician Decision|0|||
131927041|NCT02533674|475018370|FG003|Dose Level I|Physician Decision|0|||
131927042|NCT02533674|475018371|FG004|Dose Level I|Physician Decision|0|||
131927043|NCT02533674|475018372|FG005|Dose Level I|Physician Decision|0|||
131927044|NCT02533674|475018373|FG006|Dose Level I|Physician Decision|0|||
131409929|NCT00711802|473123304|FG005|Overall Study|Microbiological failure|1|||
131409930|NCT00711802|473123305|FG006|Overall Study|Microbiological failure|0|||
131409931|NCT00711802|473123306|FG007|Overall Study|Microbiological failure|0|||
131927045|NCT02533674|475018374|FG007|Dose Level I|Physician Decision|0|||
131927046|NCT02533674|475018367|FG000|Dose Level I|Death|1|||
131409932|NCT00711802|473123299|FG000|Overall Study|Protocol Violation|0|||
131409933|NCT00711802|473123300|FG001|Overall Study|Protocol Violation|0|||
131409934|NCT00711802|473123301|FG002|Overall Study|Protocol Violation|0|||
131409935|NCT00711802|473123302|FG003|Overall Study|Protocol Violation|1|||
131409936|NCT00711802|473123303|FG004|Overall Study|Protocol Violation|0|||
131409937|NCT00711802|473123304|FG005|Overall Study|Protocol Violation|0|||
131409938|NCT00711802|473123305|FG006|Overall Study|Protocol Violation|0|||
131409939|NCT00711802|473123306|FG007|Overall Study|Protocol Violation|0|||
131409940|NCT00711802|473123299|FG000|Overall Study|Physician Decision|0|||
131409941|NCT00711802|473123300|FG001|Overall Study|Physician Decision|2|||
131409942|NCT00711802|473123301|FG002|Overall Study|Physician Decision|0|||
131409943|NCT00711802|473123302|FG003|Overall Study|Physician Decision|0|||
131409944|NCT00711802|473123303|FG004|Overall Study|Physician Decision|0|||
131409945|NCT00711802|473123304|FG005|Overall Study|Physician Decision|0|||
131409946|NCT00711802|473123305|FG006|Overall Study|Physician Decision|0|||
131409947|NCT00711802|473123306|FG007|Overall Study|Physician Decision|0|||
131409948|NCT00711802|473123299|FG000|Overall Study|Withdrawal by Subject|0|||
131409949|NCT00711802|473123300|FG001|Overall Study|Withdrawal by Subject|1|||
131409950|NCT00711802|473123301|FG002|Overall Study|Withdrawal by Subject|0|||
131409951|NCT00711802|473123302|FG003|Overall Study|Withdrawal by Subject|1|||
131409952|NCT00711802|473123303|FG004|Overall Study|Withdrawal by Subject|0|||
131409953|NCT00711802|473123304|FG005|Overall Study|Withdrawal by Subject|0|||
131409954|NCT00711802|473123305|FG006|Overall Study|Withdrawal by Subject|0|||
131409955|NCT00711802|473123306|FG007|Overall Study|Withdrawal by Subject|0|||
131409956|NCT00711802|473123299|FG000|Overall Study|Lost to Follow-up|0|||
131454054|NCT00092443|473291870|FG001|Overall Study|Protocol Violation|9|||
131454055|NCT00092443|473291869|FG000|Overall Study|Withdrawal by Subject|9|||
131454056|NCT00092443|473291870|FG001|Overall Study|Withdrawal by Subject|11|||
131454057|NCT00092443|473291869|FG000|Overall Study|Moved|5|||
131927047|NCT02533674|475018368|FG001|Dose Level I|Death|0|||
131927048|NCT02533674|475018369|FG002|Dose Level I|Death|0|||
131927049|NCT02533674|475018370|FG003|Dose Level I|Death|0|||
131927050|NCT02533674|475018371|FG004|Dose Level I|Death|0|||
131927051|NCT02533674|475018372|FG005|Dose Level I|Death|0|||
131927052|NCT02533674|475018373|FG006|Dose Level I|Death|0|||
131927053|NCT02533674|475018374|FG007|Dose Level I|Death|0|||
131927054|NCT02533674|475018367|FG000|Dose Level I|Never Treated|1|||
131927055|NCT02533674|475018368|FG001|Dose Level I|Never Treated|0|||
131927056|NCT02533674|475018369|FG002|Dose Level I|Never Treated|0|||
131927057|NCT02533674|475018370|FG003|Dose Level I|Never Treated|0|||
131927058|NCT02533674|475018371|FG004|Dose Level I|Never Treated|0|||
131927059|NCT02533674|475018372|FG005|Dose Level I|Never Treated|0|||
131927060|NCT02533674|475018373|FG006|Dose Level I|Never Treated|0|||
131927061|NCT02533674|475018374|FG007|Dose Level I|Never Treated|0|||
131927062|NCT02533674|475018367|FG000|Dose Level II|Progressive disease|0|||
131927063|NCT02533674|475018368|FG001|Dose Level II|Progressive disease|3|||
131927064|NCT02533674|475018369|FG002|Dose Level II|Progressive disease|0|||
131927065|NCT02533674|475018370|FG003|Dose Level II|Progressive disease|0|||
131927066|NCT02533674|475018371|FG004|Dose Level II|Progressive disease|0|||
131927067|NCT02533674|475018372|FG005|Dose Level II|Progressive disease|0|||
131927068|NCT02533674|475018373|FG006|Dose Level II|Progressive disease|0|||
131927069|NCT02533674|475018374|FG007|Dose Level II|Progressive disease|0|||
131927070|NCT02533674|475018367|FG000|Dose Level II|Withdrawal by Subject|0|||
131927071|NCT02533674|475018368|FG001|Dose Level II|Withdrawal by Subject|1|||
131927072|NCT02533674|475018369|FG002|Dose Level II|Withdrawal by Subject|0|||
131927073|NCT02533674|475018370|FG003|Dose Level II|Withdrawal by Subject|0|||
131927074|NCT02533674|475018371|FG004|Dose Level II|Withdrawal by Subject|0|||
131927075|NCT02533674|475018372|FG005|Dose Level II|Withdrawal by Subject|0|||
131927076|NCT02533674|475018373|FG006|Dose Level II|Withdrawal by Subject|0|||
131927077|NCT02533674|475018374|FG007|Dose Level II|Withdrawal by Subject|0|||
131927078|NCT02533674|475018367|FG000|Dose Level II|Treatment-related AE|0|||
131927079|NCT02533674|475018368|FG001|Dose Level II|Treatment-related AE|1|||
131927080|NCT02533674|475018369|FG002|Dose Level II|Treatment-related AE|0|||
131927081|NCT02533674|475018370|FG003|Dose Level II|Treatment-related AE|0|||
131927082|NCT02533674|475018371|FG004|Dose Level II|Treatment-related AE|0|||
131927083|NCT02533674|475018372|FG005|Dose Level II|Treatment-related AE|0|||
131927084|NCT02533674|475018373|FG006|Dose Level II|Treatment-related AE|0|||
131927085|NCT02533674|475018374|FG007|Dose Level II|Treatment-related AE|0|||
131927086|NCT02533674|475018367|FG000|Dose Level II|Physician Decision|0|||
131927087|NCT02533674|475018368|FG001|Dose Level II|Physician Decision|1|||
131409957|NCT00711802|473123300|FG001|Overall Study|Lost to Follow-up|0|||
131409958|NCT00711802|473123301|FG002|Overall Study|Lost to Follow-up|3|||
131409959|NCT00711802|473123302|FG003|Overall Study|Lost to Follow-up|1|||
131409960|NCT00711802|473123303|FG004|Overall Study|Lost to Follow-up|10|||
131409961|NCT00711802|473123304|FG005|Overall Study|Lost to Follow-up|6|||
131409962|NCT00711802|473123305|FG006|Overall Study|Lost to Follow-up|4|||
131927088|NCT02533674|475018369|FG002|Dose Level II|Physician Decision|0|||
131927089|NCT02533674|475018370|FG003|Dose Level II|Physician Decision|0|||
131927090|NCT02533674|475018371|FG004|Dose Level II|Physician Decision|0|||
131927091|NCT02533674|475018372|FG005|Dose Level II|Physician Decision|0|||
131409963|NCT00711802|473123306|FG007|Overall Study|Lost to Follow-up|2|||
131409964|NCT00711802|473123299|FG000|Overall Study|Reason not reported|0|||
131409965|NCT00711802|473123300|FG001|Overall Study|Reason not reported|1|||
131409966|NCT00711802|473123301|FG002|Overall Study|Reason not reported|1|||
131409967|NCT00711802|473123302|FG003|Overall Study|Reason not reported|0|||
131409968|NCT00711802|473123303|FG004|Overall Study|Reason not reported|1|||
131409969|NCT00711802|473123304|FG005|Overall Study|Reason not reported|0|||
131409970|NCT00711802|473123305|FG006|Overall Study|Reason not reported|1|||
131409971|NCT00711802|473123306|FG007|Overall Study|Reason not reported|0|||
131409972|NCT02436408|473123307|FG000|Overall Study|Death|1|||
131409973|NCT00392808|473123308|FG000|Overall Study|Lost to Follow-up|3|||
131409974|NCT00392808|473123309|FG001|Overall Study|Lost to Follow-up|2|||
131409975|NCT00392808|473123310|FG002|Overall Study|Lost to Follow-up|1|||
131409976|NCT00392808|473123311|FG003|Overall Study|Lost to Follow-up|2|||
131409977|NCT00392808|473123308|FG000|Overall Study|Unable to withdraw blood|3|||
131409978|NCT00392808|473123309|FG001|Overall Study|Unable to withdraw blood|1|||
131409979|NCT00392808|473123310|FG002|Overall Study|Unable to withdraw blood|1|||
131409980|NCT00392808|473123311|FG003|Overall Study|Unable to withdraw blood|2|||
131409981|NCT02649855|473123312|FG000|Overall Study|Refused further treatment|2|||
131409982|NCT02649855|473123313|FG001|Overall Study|Refused further treatment|1|||
131409983|NCT02649855|473123314|FG002|Overall Study|Refused further treatment|1|||
131409984|NCT02649855|473123312|FG000|Overall Study|Withdrew consent|0|||
131409985|NCT02649855|473123313|FG001|Overall Study|Withdrew consent|1|||
131409986|NCT02649855|473123314|FG002|Overall Study|Withdrew consent|0|||
131409987|NCT02649855|473123312|FG000|Overall Study|Switched to alternative treatment|0|||
131409988|NCT02649855|473123313|FG001|Overall Study|Switched to alternative treatment|1|||
131409989|NCT02649855|473123314|FG002|Overall Study|Switched to alternative treatment|1|||
131409990|NCT02649855|473123312|FG000|Overall Study|Principal investigator discretion|0|||
131409991|NCT02649855|473123313|FG001|Overall Study|Principal investigator discretion|1|||
131409992|NCT02649855|473123314|FG002|Overall Study|Principal investigator discretion|1|||
131409993|NCT02649855|473123312|FG000|Overall Study|No treatment, per protocol|1|||
131409994|NCT02649855|473123313|FG001|Overall Study|No treatment, per protocol|0|||
131409995|NCT02649855|473123314|FG002|Overall Study|No treatment, per protocol|0|||
131409996|NCT02649855|473123312|FG000|Overall Study|Initiate new treatment|1|||
131409997|NCT02649855|473123313|FG001|Overall Study|Initiate new treatment|0|||
131409998|NCT02649855|473123314|FG002|Overall Study|Initiate new treatment|0|||
131409999|NCT02782325|473123315|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
131410000|NCT02782325|473123316|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
131410001|NCT02782325|473123317|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
131410002|NCT02782325|473123315|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
131410003|NCT02782325|473123316|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
131410004|NCT02782325|473123317|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
131410005|NCT00657150|473123318|FG000|Overall Study|Adverse Event|19|||
131410006|NCT00657150|473123319|FG001|Overall Study|Adverse Event|10|||
131410007|NCT00657150|473123318|FG000|Overall Study|Non-compliant with protocol|5|||
131410008|NCT00657150|473123319|FG001|Overall Study|Non-compliant with protocol|9|||
131410009|NCT00657150|473123318|FG000|Overall Study|Lost to Follow-up|2|||
131410010|NCT00657150|473123319|FG001|Overall Study|Lost to Follow-up|0|||
131927092|NCT02533674|475018373|FG006|Dose Level II|Physician Decision|0|||
131927093|NCT02533674|475018374|FG007|Dose Level II|Physician Decision|0|||
131927094|NCT02533674|475018367|FG000|Dose Level II|Non-treatment-related AE|0|||
131927095|NCT02533674|475018368|FG001|Dose Level II|Non-treatment-related AE|1|||
131927096|NCT02533674|475018369|FG002|Dose Level II|Non-treatment-related AE|0|||
131927097|NCT02533674|475018370|FG003|Dose Level II|Non-treatment-related AE|0|||
131927098|NCT02533674|475018371|FG004|Dose Level II|Non-treatment-related AE|0|||
131927099|NCT02533674|475018372|FG005|Dose Level II|Non-treatment-related AE|0|||
131927100|NCT02533674|475018373|FG006|Dose Level II|Non-treatment-related AE|0|||
131927101|NCT02533674|475018374|FG007|Dose Level II|Non-treatment-related AE|0|||
131927102|NCT02533674|475018367|FG000|Dose Level III|Progressive disease|0|||
131927103|NCT02533674|475018368|FG001|Dose Level III|Progressive disease|0|||
131410011|NCT00657150|473123318|FG000|Overall Study|Withdrawal by Subject|51|||
131410012|NCT00657150|473123319|FG001|Overall Study|Withdrawal by Subject|36|||
131410013|NCT00657150|473123318|FG000|Overall Study|Other|38|||
131410014|NCT00657150|473123319|FG001|Overall Study|Other|38|||
131927104|NCT02533674|475018369|FG002|Dose Level III|Progressive disease|2|||
131927105|NCT02533674|475018370|FG003|Dose Level III|Progressive disease|0|||
131927106|NCT02533674|475018371|FG004|Dose Level III|Progressive disease|0|||
131927107|NCT02533674|475018372|FG005|Dose Level III|Progressive disease|0|||
131410015|NCT00657150|473123318|FG000|Treatment|Adverse Event|60|||
131410016|NCT00657150|473123319|FG001|Treatment|Adverse Event|53|||
131410017|NCT00657150|473123318|FG000|Treatment|Non-compliant with protocol|10|||
131410018|NCT00657150|473123319|FG001|Treatment|Non-compliant with protocol|9|||
131410019|NCT00657150|473123318|FG000|Treatment|Lost to Follow-up|1|||
131410020|NCT00657150|473123319|FG001|Treatment|Lost to Follow-up|0|||
131410021|NCT00657150|473123318|FG000|Treatment|Withdrawal by Subject|23|||
131410022|NCT00657150|473123319|FG001|Treatment|Withdrawal by Subject|20|||
131410023|NCT00657150|473123318|FG000|Treatment|Other|13|||
131927108|NCT02533674|475018373|FG006|Dose Level III|Progressive disease|0|||
131927109|NCT02533674|475018374|FG007|Dose Level III|Progressive disease|0|||
131927110|NCT02533674|475018367|FG000|Dose Level III|Withdrawal by Subject|0|||
131927111|NCT02533674|475018368|FG001|Dose Level III|Withdrawal by Subject|0|||
131927112|NCT02533674|475018369|FG002|Dose Level III|Withdrawal by Subject|1|||
131927113|NCT02533674|475018370|FG003|Dose Level III|Withdrawal by Subject|0|||
131927114|NCT02533674|475018371|FG004|Dose Level III|Withdrawal by Subject|0|||
131927115|NCT02533674|475018372|FG005|Dose Level III|Withdrawal by Subject|0|||
131927116|NCT02533674|475018373|FG006|Dose Level III|Withdrawal by Subject|0|||
131927117|NCT02533674|475018374|FG007|Dose Level III|Withdrawal by Subject|0|||
131927118|NCT02533674|475018367|FG000|Dose Level III|Treatment-related AE|0|||
131927119|NCT02533674|475018368|FG001|Dose Level III|Treatment-related AE|0|||
131927120|NCT02533674|475018369|FG002|Dose Level III|Treatment-related AE|1|||
131927121|NCT02533674|475018370|FG003|Dose Level III|Treatment-related AE|0|||
131927122|NCT02533674|475018371|FG004|Dose Level III|Treatment-related AE|0|||
131927123|NCT02533674|475018372|FG005|Dose Level III|Treatment-related AE|0|||
131927124|NCT02533674|475018373|FG006|Dose Level III|Treatment-related AE|0|||
131927125|NCT02533674|475018374|FG007|Dose Level III|Treatment-related AE|0|||
131927126|NCT02533674|475018367|FG000|Dose Level IV|Progressive disease|0|||
131927127|NCT02533674|475018368|FG001|Dose Level IV|Progressive disease|0|||
131927128|NCT02533674|475018369|FG002|Dose Level IV|Progressive disease|0|||
131927129|NCT02533674|475018370|FG003|Dose Level IV|Progressive disease|3|||
131927130|NCT02533674|475018371|FG004|Dose Level IV|Progressive disease|0|||
131927131|NCT02533674|475018372|FG005|Dose Level IV|Progressive disease|0|||
131927132|NCT02533674|475018373|FG006|Dose Level IV|Progressive disease|0|||
131927133|NCT02533674|475018374|FG007|Dose Level IV|Progressive disease|0|||
131927134|NCT02533674|475018367|FG000|Dose Level IV|Withdrawal by Subject|0|||
131927135|NCT02533674|475018368|FG001|Dose Level IV|Withdrawal by Subject|0|||
131927136|NCT02533674|475018369|FG002|Dose Level IV|Withdrawal by Subject|0|||
131927137|NCT02533674|475018370|FG003|Dose Level IV|Withdrawal by Subject|1|||
131927138|NCT02533674|475018371|FG004|Dose Level IV|Withdrawal by Subject|0|||
131927139|NCT02533674|475018372|FG005|Dose Level IV|Withdrawal by Subject|0|||
131927140|NCT02533674|475018373|FG006|Dose Level IV|Withdrawal by Subject|0|||
131927141|NCT02533674|475018374|FG007|Dose Level IV|Withdrawal by Subject|0|||
131927142|NCT02533674|475018367|FG000|Dose Level IV|Physician Decision|0|||
131927143|NCT02533674|475018368|FG001|Dose Level IV|Physician Decision|0|||
131927144|NCT02533674|475018369|FG002|Dose Level IV|Physician Decision|0|||
131927145|NCT02533674|475018370|FG003|Dose Level IV|Physician Decision|1|||
131927146|NCT02533674|475018371|FG004|Dose Level IV|Physician Decision|0|||
131927147|NCT02533674|475018372|FG005|Dose Level IV|Physician Decision|0|||
131927148|NCT02533674|475018373|FG006|Dose Level IV|Physician Decision|0|||
131927149|NCT02533674|475018374|FG007|Dose Level IV|Physician Decision|0|||
131927150|NCT02533674|475018367|FG000|Dose Level V|Progressive disease|0|||
131927151|NCT02533674|475018368|FG001|Dose Level V|Progressive disease|0|||
131927152|NCT02533674|475018369|FG002|Dose Level V|Progressive disease|0|||
131927153|NCT02533674|475018370|FG003|Dose Level V|Progressive disease|0|||
131927154|NCT02533674|475018371|FG004|Dose Level V|Progressive disease|3|||
131927155|NCT02533674|475018372|FG005|Dose Level V|Progressive disease|0|||
131927156|NCT02533674|475018373|FG006|Dose Level V|Progressive disease|0|||
131927157|NCT02533674|475018374|FG007|Dose Level V|Progressive disease|0|||
131927158|NCT02533674|475018367|FG000|Dose Level V|Withdrawal by Subject|0|||
131927159|NCT02533674|475018368|FG001|Dose Level V|Withdrawal by Subject|0|||
131927160|NCT02533674|475018369|FG002|Dose Level V|Withdrawal by Subject|0|||
131927161|NCT02533674|475018370|FG003|Dose Level V|Withdrawal by Subject|0|||
131927162|NCT02533674|475018371|FG004|Dose Level V|Withdrawal by Subject|1|||
131927163|NCT02533674|475018372|FG005|Dose Level V|Withdrawal by Subject|0|||
131927164|NCT02533674|475018373|FG006|Dose Level V|Withdrawal by Subject|0|||
131927165|NCT02533674|475018374|FG007|Dose Level V|Withdrawal by Subject|0|||
131927166|NCT02533674|475018367|FG000|Dose Level V|Physician Decision|0|||
131927167|NCT02533674|475018368|FG001|Dose Level V|Physician Decision|0|||
131927168|NCT02533674|475018369|FG002|Dose Level V|Physician Decision|0|||
131927169|NCT02533674|475018370|FG003|Dose Level V|Physician Decision|0|||
131927170|NCT02533674|475018371|FG004|Dose Level V|Physician Decision|1|||
131927171|NCT02533674|475018372|FG005|Dose Level V|Physician Decision|0|||
131927172|NCT02533674|475018373|FG006|Dose Level V|Physician Decision|0|||
131927173|NCT02533674|475018374|FG007|Dose Level V|Physician Decision|0|||
131927174|NCT02533674|475018367|FG000|Dose Level VI|Progressive disease|0|||
131927175|NCT02533674|475018368|FG001|Dose Level VI|Progressive disease|0|||
131454058|NCT00092443|473291870|FG001|Overall Study|Moved|5|||
131454059|NCT00092443|473291869|FG000|Overall Study|Other|17|||
131927176|NCT02533674|475018369|FG002|Dose Level VI|Progressive disease|0|||
131927177|NCT02533674|475018370|FG003|Dose Level VI|Progressive disease|0|||
131454060|NCT00092443|473291870|FG001|Overall Study|Other|13|||
131927178|NCT02533674|475018371|FG004|Dose Level VI|Progressive disease|0|||
131927179|NCT02533674|475018372|FG005|Dose Level VI|Progressive disease|7|||
131927180|NCT02533674|475018373|FG006|Dose Level VI|Progressive disease|0|||
131927181|NCT02533674|475018374|FG007|Dose Level VI|Progressive disease|0|||
131927182|NCT02533674|475018367|FG000|Dose Level VI|Withdrawal by Subject|0|||
131927183|NCT02533674|475018368|FG001|Dose Level VI|Withdrawal by Subject|0|||
131410024|NCT00657150|473123319|FG001|Treatment|Other|15|||
131410025|NCT02513823|473123330|FG000|Overall Study|Lost to Follow-up|4|||
131410026|NCT02513823|473123330|FG000|Overall Study|Physician Decision|1|||
131410027|NCT01294462|473123335|FG000|Overall Study|Lost to Follow-up|1|||
131410028|NCT01294462|473123336|FG001|Overall Study|Lost to Follow-up|0|||
131410029|NCT01294462|473123335|FG000|Overall Study|Withdrawal by Subject|65|||
131410030|NCT01294462|473123336|FG001|Overall Study|Withdrawal by Subject|63|||
131410031|NCT02743780|473123337|FG000|Part 3 (7 Days)|Adverse Event|0|||
131927184|NCT02533674|475018369|FG002|Dose Level VI|Withdrawal by Subject|0|||
131927185|NCT02533674|475018370|FG003|Dose Level VI|Withdrawal by Subject|0|||
131927186|NCT02533674|475018371|FG004|Dose Level VI|Withdrawal by Subject|0|||
131927187|NCT02533674|475018372|FG005|Dose Level VI|Withdrawal by Subject|1|||
131927188|NCT02533674|475018373|FG006|Dose Level VI|Withdrawal by Subject|0|||
131927189|NCT02533674|475018374|FG007|Dose Level VI|Withdrawal by Subject|0|||
131927190|NCT02533674|475018367|FG000|Dose Level VI|Treatment-related AE|0|||
131927191|NCT02533674|475018368|FG001|Dose Level VI|Treatment-related AE|0|||
131927192|NCT02533674|475018369|FG002|Dose Level VI|Treatment-related AE|0|||
131927193|NCT02533674|475018370|FG003|Dose Level VI|Treatment-related AE|0|||
131927194|NCT02533674|475018371|FG004|Dose Level VI|Treatment-related AE|0|||
131927195|NCT02533674|475018372|FG005|Dose Level VI|Treatment-related AE|1|||
131927196|NCT02533674|475018373|FG006|Dose Level VI|Treatment-related AE|0|||
131927197|NCT02533674|475018374|FG007|Dose Level VI|Treatment-related AE|0|||
131927198|NCT02533674|475018367|FG000|Dose Level VII|Progressive disease|0|||
131927199|NCT02533674|475018368|FG001|Dose Level VII|Progressive disease|0|||
131927200|NCT02533674|475018369|FG002|Dose Level VII|Progressive disease|0|||
131927201|NCT02533674|475018370|FG003|Dose Level VII|Progressive disease|0|||
131927202|NCT02533674|475018371|FG004|Dose Level VII|Progressive disease|0|||
131927203|NCT02533674|475018372|FG005|Dose Level VII|Progressive disease|0|||
131927204|NCT02533674|475018373|FG006|Dose Level VII|Progressive disease|10|||
131927205|NCT02533674|475018374|FG007|Dose Level VII|Progressive disease|0|||
131927206|NCT02533674|475018367|FG000|Dose Level VII|Withdrawal by Subject|0|||
131927207|NCT02533674|475018368|FG001|Dose Level VII|Withdrawal by Subject|0|||
131927208|NCT02533674|475018369|FG002|Dose Level VII|Withdrawal by Subject|0|||
131927209|NCT02533674|475018370|FG003|Dose Level VII|Withdrawal by Subject|0|||
131927210|NCT02533674|475018371|FG004|Dose Level VII|Withdrawal by Subject|0|||
131927211|NCT02533674|475018372|FG005|Dose Level VII|Withdrawal by Subject|0|||
131927212|NCT02533674|475018373|FG006|Dose Level VII|Withdrawal by Subject|3|||
131927213|NCT02533674|475018374|FG007|Dose Level VII|Withdrawal by Subject|0|||
131927214|NCT02533674|475018367|FG000|Dose Level VII|Treatment-related AE|0|||
131927215|NCT02533674|475018368|FG001|Dose Level VII|Treatment-related AE|0|||
131927216|NCT02533674|475018369|FG002|Dose Level VII|Treatment-related AE|0|||
131927217|NCT02533674|475018370|FG003|Dose Level VII|Treatment-related AE|0|||
131927218|NCT02533674|475018371|FG004|Dose Level VII|Treatment-related AE|0|||
131927219|NCT02533674|475018372|FG005|Dose Level VII|Treatment-related AE|0|||
131927220|NCT02533674|475018373|FG006|Dose Level VII|Treatment-related AE|1|||
131927221|NCT02533674|475018374|FG007|Dose Level VII|Treatment-related AE|0|||
131927222|NCT02533674|475018367|FG000|Dose Level VII|Death|0|||
131927223|NCT02533674|475018368|FG001|Dose Level VII|Death|0|||
131927224|NCT02533674|475018369|FG002|Dose Level VII|Death|0|||
131927225|NCT02533674|475018370|FG003|Dose Level VII|Death|0|||
131927226|NCT02533674|475018371|FG004|Dose Level VII|Death|0|||
131927227|NCT02533674|475018372|FG005|Dose Level VII|Death|0|||
131927228|NCT02533674|475018373|FG006|Dose Level VII|Death|2|||
131927229|NCT02533674|475018374|FG007|Dose Level VII|Death|0|||
131927230|NCT02533674|475018367|FG000|Dose Level VIII|Progressive disease|0|||
131927231|NCT02533674|475018368|FG001|Dose Level VIII|Progressive disease|0|||
131927232|NCT02533674|475018369|FG002|Dose Level VIII|Progressive disease|0|||
131927233|NCT02533674|475018370|FG003|Dose Level VIII|Progressive disease|0|||
131927234|NCT02533674|475018371|FG004|Dose Level VIII|Progressive disease|0|||
131927235|NCT02533674|475018372|FG005|Dose Level VIII|Progressive disease|0|||
131927236|NCT02533674|475018373|FG006|Dose Level VIII|Progressive disease|0|||
131927237|NCT02533674|475018374|FG007|Dose Level VIII|Progressive disease|3|||
131927238|NCT02533674|475018367|FG000|Dose Level VIII|Withdrawal by Subject|0|||
131927239|NCT02533674|475018368|FG001|Dose Level VIII|Withdrawal by Subject|0|||
131927240|NCT02533674|475018369|FG002|Dose Level VIII|Withdrawal by Subject|0|||
131410032|NCT02743780|473123338|FG001|Part 3 (7 Days)|Adverse Event|0|||
131927241|NCT02533674|475018370|FG003|Dose Level VIII|Withdrawal by Subject|0|||
131927242|NCT02533674|475018371|FG004|Dose Level VIII|Withdrawal by Subject|0|||
131927243|NCT02533674|475018372|FG005|Dose Level VIII|Withdrawal by Subject|0|||
131927244|NCT02533674|475018373|FG006|Dose Level VIII|Withdrawal by Subject|0|||
131927245|NCT02533674|475018374|FG007|Dose Level VIII|Withdrawal by Subject|1|||
131927246|NCT02533674|475018367|FG000|Dose Level VIII|Treatment-related AE|0|||
131927247|NCT02533674|475018368|FG001|Dose Level VIII|Treatment-related AE|0|||
131927248|NCT02533674|475018369|FG002|Dose Level VIII|Treatment-related AE|0|||
131927249|NCT02533674|475018370|FG003|Dose Level VIII|Treatment-related AE|0|||
131410033|NCT02743780|473123339|FG002|Part 3 (7 Days)|Adverse Event|1|||
131410034|NCT02743780|473123340|FG003|Part 3 (7 Days)|Adverse Event|0|||
131410035|NCT02743780|473123341|FG004|Part 3 (7 Days)|Adverse Event|0|||
131410036|NCT04342689|473123347|FG000|Overall Study|Withdrawal by Subject|32|||
131410037|NCT04342689|473123348|FG001|Overall Study|Withdrawal by Subject|33|||
131410038|NCT04342689|473123347|FG000|Overall Study|Lost to Follow-up|10|||
131410039|NCT04342689|473123348|FG001|Overall Study|Lost to Follow-up|12|||
131410040|NCT01460407|473123353|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
131410041|NCT01460407|473123354|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
131410042|NCT04070326|473123357|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
131410043|NCT04070326|473123358|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
131410044|NCT01367704|473123359|FG000|Overall Study|Lost to Follow-up|47|||
131410045|NCT01367704|473123360|FG001|Overall Study|Lost to Follow-up|161|||
131410046|NCT01400243|473123361|FG000|Overall Study|Protocol Violation|8|||
131410047|NCT01400243|473123362|FG001|Overall Study|Protocol Violation|11|||
131454061|NCT04717336|473291874|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
131927250|NCT02533674|475018371|FG004|Dose Level VIII|Treatment-related AE|0|||
131927251|NCT02533674|475018372|FG005|Dose Level VIII|Treatment-related AE|0|||
131927252|NCT02533674|475018373|FG006|Dose Level VIII|Treatment-related AE|0|||
131927253|NCT02533674|475018374|FG007|Dose Level VIII|Treatment-related AE|1|||
131927254|NCT02533674|475018367|FG000|Dose Level VIII|Never treated|0|||
131927255|NCT02533674|475018368|FG001|Dose Level VIII|Never treated|0|||
131927256|NCT02533674|475018369|FG002|Dose Level VIII|Never treated|0|||
131927257|NCT02533674|475018370|FG003|Dose Level VIII|Never treated|0|||
131927258|NCT02533674|475018371|FG004|Dose Level VIII|Never treated|0|||
131927259|NCT02533674|475018372|FG005|Dose Level VIII|Never treated|0|||
131927260|NCT02533674|475018373|FG006|Dose Level VIII|Never treated|0|||
131927261|NCT02533674|475018374|FG007|Dose Level VIII|Never treated|1|||
131927262|NCT01560988|475018375|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
131927263|NCT01560988|475018376|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
131927264|NCT01560988|475018375|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
131927265|NCT01560988|475018376|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
131927266|NCT01560988|475018375|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
131927267|NCT01560988|475018376|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
131927268|NCT01346709|475018377|FG000|Overall Study|Protocol Violation|35|||
131927269|NCT01346709|475018377|FG000|Overall Study|Lost to Follow-up|31|||
131927270|NCT01346709|475018377|FG000|Overall Study|Missing data in candidate risk factor|285|||
131927271|NCT01292473|475018381|FG000|Overall Study|Adverse Event|1|||
131927272|NCT01292473|475018382|FG001|Overall Study|Adverse Event|0|||
131927273|NCT01292473|475018383|FG002|Overall Study|Adverse Event|1|||
131927274|NCT01292473|475018384|FG003|Overall Study|Adverse Event|1|||
131927275|NCT01292473|475018381|FG000|Overall Study|Lost to Follow-up|1|||
131927276|NCT01292473|475018382|FG001|Overall Study|Lost to Follow-up|1|||
131927277|NCT01292473|475018383|FG002|Overall Study|Lost to Follow-up|2|||
131927278|NCT01292473|475018384|FG003|Overall Study|Lost to Follow-up|2|||
131927279|NCT01292473|475018381|FG000|Overall Study|Withdrawal by Subject|3|||
131927280|NCT01292473|475018382|FG001|Overall Study|Withdrawal by Subject|4|||
131927281|NCT01292473|475018383|FG002|Overall Study|Withdrawal by Subject|3|||
131927282|NCT01292473|475018384|FG003|Overall Study|Withdrawal by Subject|3|||
131927283|NCT01292473|475018381|FG000|Overall Study|Physician Decision|0|||
131927284|NCT01292473|475018382|FG001|Overall Study|Physician Decision|1|||
131927285|NCT01292473|475018383|FG002|Overall Study|Physician Decision|0|||
131927286|NCT01292473|475018384|FG003|Overall Study|Physician Decision|0|||
131927287|NCT01292473|475018381|FG000|Overall Study|Disease Progression|0|||
131927288|NCT01292473|475018382|FG001|Overall Study|Disease Progression|1|||
131927289|NCT01292473|475018383|FG002|Overall Study|Disease Progression|3|||
131927290|NCT01292473|475018384|FG003|Overall Study|Disease Progression|6|||
131927291|NCT04821245|475018390|FG000|Overall Study|Withdrawal by Subject|3|||
131927292|NCT04821245|475018390|FG000|Overall Study|Physician Decision|1|||
131927293|NCT04821245|475018390|FG000|Overall Study|Protocol Violation|5|||
131927294|NCT02123511|475018391|FG000|Overall Study|Cancelled treatment|1|||
131927295|NCT02123511|475018392|FG001|Overall Study|Cancelled treatment|0|||
131927296|NCT02123511|475018391|FG000|Overall Study|Incomplete data|1|||
131927297|NCT02123511|475018392|FG001|Overall Study|Incomplete data|3|||
131927298|NCT02123511|475018391|FG000|Overall Study|Ineligible|0|||
131927299|NCT02123511|475018392|FG001|Overall Study|Ineligible|1|||
131927300|NCT02595437|475018393|FG000|Triferic Via IV|Withdrawal by Subject|1|||
131410048|NCT02193087|473123364|FG000|Overall Study|Adverse Event|2|||
131410049|NCT02193087|473123365|FG001|Overall Study|Adverse Event|0|||
131410050|NCT02193087|473123366|FG002|Overall Study|Adverse Event|0|||
131927301|NCT00458705|475018394|FG000|Overall Study|Adverse Event|4|||
131927302|NCT00458705|475018394|FG000|Overall Study|Not Treated|1|||
131927303|NCT01975285|475018410|FG000|Overall Study|Failed Block and follow up|2|||
131927304|NCT01975285|475018411|FG001|Overall Study|Failed Block and follow up|2|||
131927305|NCT00604383|475018416|FG000|Overall Study|Withdrawal by Subject|33|||
131927306|NCT00604383|475018417|FG001|Overall Study|Withdrawal by Subject|31|||
131927307|NCT00604383|475018416|FG000|Overall Study|Lost to Follow-up|24|||
131927308|NCT00604383|475018417|FG001|Overall Study|Lost to Follow-up|19|||
131927309|NCT00604383|475018416|FG000|Overall Study|Death|14|||
131927310|NCT00604383|475018417|FG001|Overall Study|Death|22|||
131410051|NCT02193087|473123367|FG003|Overall Study|Adverse Event|11|||
131410052|NCT02193087|473123364|FG000|Overall Study|Lost to Follow-up|14|||
131410053|NCT02193087|473123365|FG001|Overall Study|Lost to Follow-up|6|||
131410054|NCT02193087|473123366|FG002|Overall Study|Lost to Follow-up|4|||
131927311|NCT00604383|475018416|FG000|Overall Study|Adverse Event|16|||
131927312|NCT00604383|475018417|FG001|Overall Study|Adverse Event|9|||
131927313|NCT00604383|475018416|FG000|Overall Study|Physician Decision|0|||
131927314|NCT00604383|475018417|FG001|Overall Study|Physician Decision|3|||
131927315|NCT04914000|475018418|FG000|Overall Study|Lost to Follow-up|8|||
131927316|NCT04914000|475018418|FG000|Overall Study|Withdrawal by Subject|1|||
131927317|NCT01429623|475018419|FG000|Overall Study|Death|1|||
131927318|NCT01429623|475018420|FG001|Overall Study|Death|0|||
131927319|NCT01429623|475018419|FG000|Overall Study|Adverse Event|7|||
131927320|NCT01429623|475018420|FG001|Overall Study|Adverse Event|14|||
131927321|NCT01429623|475018419|FG000|Overall Study|Withdrawal by Subject|19|||
131927322|NCT01429623|475018420|FG001|Overall Study|Withdrawal by Subject|13|||
131927323|NCT01429623|475018419|FG000|Overall Study|Physician Decision|2|||
131927324|NCT01429623|475018420|FG001|Overall Study|Physician Decision|3|||
131927325|NCT01429623|475018419|FG000|Overall Study|Protocol Violation|3|||
131927326|NCT01429623|475018420|FG001|Overall Study|Protocol Violation|2|||
131927327|NCT01429623|475018419|FG000|Overall Study|Assorted|1|||
131927328|NCT01429623|475018420|FG001|Overall Study|Assorted|2|||
131927329|NCT01429623|475018419|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
131927330|NCT01429623|475018420|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
131927331|NCT01429623|475018419|FG000|Overall Study|No post baseline data|4|||
131927332|NCT01429623|475018420|FG001|Overall Study|No post baseline data|4|||
131927333|NCT01122680|475018427|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
131927334|NCT01122680|475018428|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
131927335|NCT01122680|475018429|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
131927336|NCT01122680|475018430|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
131927337|NCT01122680|475018427|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
131927338|NCT01122680|475018428|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
131927339|NCT01122680|475018429|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
131927340|NCT01122680|475018430|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
131927341|NCT01122680|475018427|FG000|Period 1 (4 Weeks)|Other|1|||
131927342|NCT01122680|475018428|FG001|Period 1 (4 Weeks)|Other|1|||
131927343|NCT01122680|475018429|FG002|Period 1 (4 Weeks)|Other|0|||
131927344|NCT01122680|475018430|FG003|Period 1 (4 Weeks)|Other|0|||
131927345|NCT01122680|475018427|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
131927346|NCT01122680|475018428|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
131927347|NCT01122680|475018429|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
131927348|NCT01122680|475018430|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
131927349|NCT01122680|475018427|FG000|Period 2 (4 Weeks)|Other|1|||
131927350|NCT01122680|475018428|FG001|Period 2 (4 Weeks)|Other|0|||
131927351|NCT01122680|475018429|FG002|Period 2 (4 Weeks)|Other|0|||
131927352|NCT01122680|475018430|FG003|Period 2 (4 Weeks)|Other|0|||
131927353|NCT01122680|475018427|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
131927354|NCT01122680|475018428|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
131927355|NCT01122680|475018429|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
131927356|NCT01122680|475018430|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
131927357|NCT01122680|475018427|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131927358|NCT01122680|475018428|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
131927359|NCT01122680|475018429|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131927360|NCT01122680|475018430|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131927361|NCT00576407|475018431|FG000|Overall Study|Death|7|||
131927362|NCT00576407|475018431|FG000|Overall Study|Physician Decision|1|||
131927363|NCT03071965|475018432|FG000|Overall Study|Adverse Event|0|||
131927364|NCT03071965|475018433|FG001|Overall Study|Adverse Event|0|||
131927365|NCT03071965|475018434|FG002|Overall Study|Adverse Event|1|||
131927366|NCT03071965|475018435|FG003|Overall Study|Adverse Event|0|||
131927367|NCT03071965|475018432|FG000|Overall Study|Death|0|||
131927368|NCT03071965|475018433|FG001|Overall Study|Death|0|||
131927369|NCT03071965|475018434|FG002|Overall Study|Death|1|||
131927370|NCT03071965|475018435|FG003|Overall Study|Death|1|||
131410055|NCT02193087|473123367|FG003|Overall Study|Lost to Follow-up|37|||
131410056|NCT02193087|473123364|FG000|Overall Study|Protocol Violation|2|||
131410057|NCT02193087|473123365|FG001|Overall Study|Protocol Violation|0|||
131927371|NCT03071965|475018432|FG000|Overall Study|COVID-19|0|||
131927372|NCT03071965|475018433|FG001|Overall Study|COVID-19|1|||
131927373|NCT03071965|475018434|FG002|Overall Study|COVID-19|0|||
131927374|NCT03071965|475018435|FG003|Overall Study|COVID-19|1|||
131927375|NCT03071965|475018432|FG000|Overall Study|Other Health Reason|0|||
131927376|NCT03071965|475018433|FG001|Overall Study|Other Health Reason|0|||
131927377|NCT03071965|475018434|FG002|Overall Study|Other Health Reason|0|||
131927378|NCT03071965|475018435|FG003|Overall Study|Other Health Reason|1|||
131927379|NCT06399471|475018436|FG000|Overall Study|Withdrawal by Subject|1|||
131927380|NCT06083493|475018437|FG000|Overall Study|Technical issues with the interventional device|2|||
131410058|NCT02193087|473123366|FG002|Overall Study|Protocol Violation|1|||
131927381|NCT06083493|475018438|FG001|Overall Study|Technical issues with the interventional device|2|||
131927382|NCT06083493|475018437|FG000|Overall Study|Performed incorrect visual task|1|||
131410059|NCT02193087|473123367|FG003|Overall Study|Protocol Violation|2|||
131410060|NCT02193087|473123364|FG000|Overall Study|Withdrawal by Subject|10|||
131410061|NCT02193087|473123365|FG001|Overall Study|Withdrawal by Subject|3|||
131410062|NCT02193087|473123366|FG002|Overall Study|Withdrawal by Subject|1|||
131410063|NCT02193087|473123367|FG003|Overall Study|Withdrawal by Subject|19|||
131410064|NCT02193087|473123364|FG000|Overall Study|Other Reason Not Specified|7|||
131410065|NCT02193087|473123365|FG001|Overall Study|Other Reason Not Specified|2|||
131410066|NCT02193087|473123366|FG002|Overall Study|Other Reason Not Specified|1|||
131410067|NCT02193087|473123367|FG003|Overall Study|Other Reason Not Specified|9|||
131410068|NCT02193087|473123364|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
131410069|NCT02193087|473123365|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
131410070|NCT02193087|473123366|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
131410071|NCT02193087|473123367|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
131410072|NCT04096820|473123368|FG000|Overall Study|Did not return for intervention|2|||
131410073|NCT04096820|473123368|FG000|Overall Study|Death|1|||
131410074|NCT00475865|473123369|FG000|Overall Study|Adverse Event|0|||
131410075|NCT00475865|473123370|FG001|Overall Study|Adverse Event|3|||
131410076|NCT00475865|473123371|FG002|Overall Study|Adverse Event|4|||
131410077|NCT00475865|473123369|FG000|Overall Study|Lack of Efficacy|1|||
131410078|NCT00475865|473123370|FG001|Overall Study|Lack of Efficacy|0|||
131410079|NCT00475865|473123371|FG002|Overall Study|Lack of Efficacy|0|||
131410080|NCT00475865|473123369|FG000|Overall Study|Progressive disease|0|||
131410081|NCT00475865|473123370|FG001|Overall Study|Progressive disease|1|||
131410082|NCT00475865|473123371|FG002|Overall Study|Progressive disease|2|||
131410083|NCT00475865|473123369|FG000|Overall Study|Participant did not wish to continue|1|||
131410084|NCT00475865|473123370|FG001|Overall Study|Participant did not wish to continue|0|||
131410085|NCT00475865|473123371|FG002|Overall Study|Participant did not wish to continue|0|||
131410086|NCT00475865|473123369|FG000|Overall Study|Other than above|0|||
131410087|NCT00475865|473123370|FG001|Overall Study|Other than above|1|||
131410088|NCT00475865|473123371|FG002|Overall Study|Other than above|0|||
131410089|NCT00953524|473124727|FG000|Overall Study|Adverse Event|2|||
131410090|NCT00953524|473124728|FG001|Overall Study|Adverse Event|0|||
131410091|NCT00953524|473124729|FG002|Overall Study|Adverse Event|1|||
131410092|NCT00953524|473124730|FG003|Overall Study|Adverse Event|2|||
131927383|NCT06083493|475018438|FG001|Overall Study|Performed incorrect visual task|0|||
131927384|NCT06083493|475018437|FG000|Overall Study|Insufficient baseline performance|0|||
131927385|NCT06083493|475018438|FG001|Overall Study|Insufficient baseline performance|1|||
131927386|NCT03225989|475018439|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
131927387|NCT03225989|475018440|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
131927388|NCT03225989|475018441|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
131927389|NCT03225989|475018439|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
131927390|NCT03225989|475018440|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
131927391|NCT03225989|475018441|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
131927392|NCT03225989|475018439|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
131927393|NCT03225989|475018440|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
131927394|NCT03225989|475018441|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
131927395|NCT03225989|475018439|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
131927396|NCT03225989|475018440|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
131927397|NCT03225989|475018441|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
131927398|NCT03225989|475018439|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
131927399|NCT03225989|475018440|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
131927400|NCT03225989|475018441|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
131927401|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
131927402|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
131927403|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
131927404|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
131927405|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
131927406|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
131927407|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
131927408|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
131927409|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
131927410|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
131927411|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
131927412|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
131410093|NCT00953524|473124727|FG000|Overall Study|Protocol Violation|18|||
131410094|NCT00953524|473124728|FG001|Overall Study|Protocol Violation|10|||
131410095|NCT00953524|473124729|FG002|Overall Study|Protocol Violation|11|||
131410096|NCT00953524|473124730|FG003|Overall Study|Protocol Violation|6|||
131410097|NCT00953524|473124727|FG000|Overall Study|Lost to Follow-up|0|||
131410098|NCT00953524|473124728|FG001|Overall Study|Lost to Follow-up|1|||
131410099|NCT00953524|473124729|FG002|Overall Study|Lost to Follow-up|1|||
131410100|NCT00953524|473124730|FG003|Overall Study|Lost to Follow-up|0|||
131927413|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
131927414|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
131927415|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
131927416|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
131927417|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
131927418|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
131927419|NCT03225989|475018439|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
131927420|NCT03225989|475018440|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
131927421|NCT03225989|475018441|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
131927422|NCT00601107|475018442|FG000|Overall Study|Adverse Event|0|||
131927423|NCT00601107|475018443|FG001|Overall Study|Adverse Event|1|||
131927424|NCT00601107|475018444|FG002|Overall Study|Adverse Event|3|||
131927425|NCT00601107|475018445|FG003|Overall Study|Adverse Event|0|||
131927426|NCT00601107|475018442|FG000|Overall Study|Withdrawal by Subject|5|||
131927427|NCT00601107|475018443|FG001|Overall Study|Withdrawal by Subject|4|||
131927428|NCT00601107|475018444|FG002|Overall Study|Withdrawal by Subject|7|||
131927429|NCT00601107|475018445|FG003|Overall Study|Withdrawal by Subject|4|||
131927430|NCT00601107|475018442|FG000|Overall Study|Lost to Follow-up|3|||
131927431|NCT00601107|475018443|FG001|Overall Study|Lost to Follow-up|3|||
131927432|NCT00601107|475018444|FG002|Overall Study|Lost to Follow-up|0|||
131927433|NCT00601107|475018445|FG003|Overall Study|Lost to Follow-up|3|||
131927434|NCT00601107|475018442|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
131927435|NCT00601107|475018443|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
131927436|NCT00601107|475018444|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
131927437|NCT00601107|475018445|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
131927438|NCT00601107|475018442|FG000|Overall Study|Worsening of Psoriasis|4|||
131927439|NCT00601107|475018443|FG001|Overall Study|Worsening of Psoriasis|1|||
131927440|NCT00601107|475018444|FG002|Overall Study|Worsening of Psoriasis|1|||
131927441|NCT00601107|475018445|FG003|Overall Study|Worsening of Psoriasis|4|||
131927442|NCT00601107|475018442|FG000|Overall Study|Undefined|1|||
131927443|NCT00601107|475018443|FG001|Overall Study|Undefined|0|||
131927444|NCT00601107|475018444|FG002|Overall Study|Undefined|1|||
131927445|NCT00601107|475018445|FG003|Overall Study|Undefined|0|||
131927446|NCT01181128|475018448|FG000|Overall Study|Withdrawal by Subject|2|||
131927447|NCT01181128|475018449|FG001|Overall Study|Withdrawal by Subject|2|||
131927448|NCT01181128|475018450|FG002|Overall Study|Withdrawal by Subject|0|||
131927449|NCT01181128|475018448|FG000|Overall Study|Death|1|||
131927450|NCT01181128|475018449|FG001|Overall Study|Death|0|||
131927451|NCT01181128|475018450|FG002|Overall Study|Death|0|||
131927452|NCT01181128|475018448|FG000|Overall Study|Physician Decision|2|||
131927453|NCT01181128|475018449|FG001|Overall Study|Physician Decision|0|||
131927454|NCT01181128|475018450|FG002|Overall Study|Physician Decision|0|||
131927455|NCT01181128|475018448|FG000|Overall Study|Adverse Event|0|||
131927456|NCT01181128|475018449|FG001|Overall Study|Adverse Event|2|||
131927457|NCT01181128|475018450|FG002|Overall Study|Adverse Event|0|||
131927458|NCT01181128|475018448|FG000|Overall Study|Other|1|||
131927459|NCT01181128|475018449|FG001|Overall Study|Other|1|||
131927460|NCT01181128|475018450|FG002|Overall Study|Other|1|||
131927461|NCT01362270|475018453|FG000|Overall Study|Withdrawal by Subject|1|||
131927462|NCT01362270|475018454|FG001|Overall Study|Withdrawal by Subject|0|||
131927463|NCT01362270|475018453|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
131927464|NCT01362270|475018454|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
131927465|NCT01362270|475018453|FG000|Overall Study|Met excl. criteria before 1st session|1|||
131927466|NCT01362270|475018454|FG001|Overall Study|Met excl. criteria before 1st session|1|||
131927467|NCT00407030|475018457|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
131927468|NCT00407030|475018458|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
131927469|NCT00407030|475018459|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
131927470|NCT00407030|475018457|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
131927471|NCT00407030|475018458|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
131927472|NCT00407030|475018459|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
131927473|NCT00407030|475018457|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
131927474|NCT00407030|475018458|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
131927475|NCT00407030|475018459|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
131927476|NCT00407030|475018457|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
131927477|NCT00407030|475018458|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
131927478|NCT00407030|475018459|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
131927479|NCT00407030|475018457|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
131927480|NCT00407030|475018458|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
131927481|NCT00407030|475018459|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
131927482|NCT00407030|475018457|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
131927483|NCT00407030|475018458|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
131927484|NCT00407030|475018459|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
131927485|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
131927486|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
131927487|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
131927488|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
131927489|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
131927490|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
131927491|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
131927492|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
131927493|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
131927494|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
131927495|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
131927496|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
131927497|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
131927498|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
131927499|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
131927500|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
131927501|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
131927502|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
131927503|NCT00407030|475018457|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
131927504|NCT00407030|475018458|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
131927505|NCT00407030|475018459|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
131927506|NCT01751685|475018460|FG000|6-mo Followup|Missed study visit|1|||
131927507|NCT01751685|475018461|FG001|6-mo Followup|Missed study visit|0|||
131927508|NCT01751685|475018460|FG000|6-mo Followup|Withdrawal by Subject|2|||
131927509|NCT01751685|475018461|FG001|6-mo Followup|Withdrawal by Subject|2|||
131927510|NCT01751685|475018460|FG000|6-mo Followup|Lost to Follow-up|0|||
131927511|NCT01751685|475018461|FG001|6-mo Followup|Lost to Follow-up|1|||
131927512|NCT01751685|475018460|FG000|12-mo Followup|Lost to Follow-up|5|||
131927513|NCT01751685|475018461|FG001|12-mo Followup|Lost to Follow-up|0|||
131927514|NCT01108055|475018464|FG000|Overall Study|Ineligible|11|||
131927515|NCT01108055|475018464|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
131927516|NCT03339453|475018466|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
131927517|NCT03339453|475018467|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
131927518|NCT01027754|475020661|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
131927519|NCT01027754|475020662|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
131927520|NCT01027754|475020661|FG000|Overall Study|Withdrawal by Subject|0|||
131927521|NCT01027754|475020662|FG001|Overall Study|Withdrawal by Subject|5|||
131927522|NCT01213251|475020663|FG000|Overall Study|Death|2|||
131927523|NCT01213251|475020664|FG001|Overall Study|Death|1|||
131927524|NCT01213251|475020665|FG002|Overall Study|Death|2|||
131927525|NCT01213251|475020663|FG000|Overall Study|Exit|3|||
131927526|NCT01213251|475020664|FG001|Overall Study|Exit|2|||
131927527|NCT01213251|475020665|FG002|Overall Study|Exit|8|||
131927528|NCT01213251|475020663|FG000|Overall Study|Protocol Violation|1|||
131927529|NCT01213251|475020664|FG001|Overall Study|Protocol Violation|1|||
131927530|NCT01213251|475020665|FG002|Overall Study|Protocol Violation|0|||
131927531|NCT01213251|475020663|FG000|Overall Study|Missed 18-Month Follow-up|0|||
131927532|NCT01213251|475020664|FG001|Overall Study|Missed 18-Month Follow-up|0|||
131927533|NCT01213251|475020665|FG002|Overall Study|Missed 18-Month Follow-up|1|||
131927534|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
131927535|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
131927536|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
131927537|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
131927538|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
131927539|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
131927540|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
131927541|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
131927542|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
131927543|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
131927544|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
131927545|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
131927546|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
131927547|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
131927548|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
131927549|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
131927550|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
131927551|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
131927552|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
131927553|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
131927554|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
131927555|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
131927556|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
131927557|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
131927558|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
131927559|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
131927560|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
131927561|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
131927562|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
131927563|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
131927564|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
131927565|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
131927566|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
131927567|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
131927568|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
131927569|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
131927570|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
131927571|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
131927572|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
131927573|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
131927574|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
131927575|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
131927576|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
131927577|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
131927578|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
131927579|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
131927580|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
131927581|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
131927582|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
131927583|NCT01557244|475020666|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
131927584|NCT01557244|475020667|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
131927585|NCT01557244|475020668|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
131927586|NCT01557244|475020669|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
131927587|NCT01557244|475020670|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
131927588|NCT01557244|475020671|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
131927589|NCT01557244|475020672|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
131927590|NCT01557244|475020666|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
131927591|NCT01557244|475020667|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
131927592|NCT01557244|475020668|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
131927593|NCT01557244|475020669|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
131927594|NCT01557244|475020670|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
131927595|NCT01557244|475020671|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
131927596|NCT01557244|475020672|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
131927597|NCT01557244|475020666|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
131927598|NCT01557244|475020667|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
131927599|NCT01557244|475020668|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
131927600|NCT01557244|475020669|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
131927601|NCT01557244|475020670|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
131927602|NCT01557244|475020671|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
131927603|NCT01557244|475020672|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
131927604|NCT01557244|475020666|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
131927605|NCT01557244|475020667|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
131927606|NCT01557244|475020668|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
131927607|NCT01557244|475020669|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
131927608|NCT01557244|475020670|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
131927609|NCT01557244|475020671|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
131927610|NCT01557244|475020672|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
131927611|NCT01557244|475020666|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
131927612|NCT01557244|475020667|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
131927613|NCT01557244|475020668|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
131927614|NCT01557244|475020669|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
131927615|NCT01557244|475020670|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
131927616|NCT01557244|475020671|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
131927617|NCT01557244|475020672|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
131927618|NCT03312114|475020673|FG000|Overall Study|All the five enrolled dropped out of the|5|||
131927619|NCT01313676|475020674|FG000|Overall Study|Adverse Event|395|||
131927620|NCT01313676|475020675|FG001|Overall Study|Adverse Event|365|||
131927621|NCT01313676|475020676|FG002|Overall Study|Adverse Event|372|||
131927622|NCT01313676|475020677|FG003|Overall Study|Adverse Event|333|||
131927623|NCT01313676|475020674|FG000|Overall Study|Lack of Efficacy|98|||
131927624|NCT01313676|475020675|FG001|Overall Study|Lack of Efficacy|90|||
131927625|NCT01313676|475020676|FG002|Overall Study|Lack of Efficacy|65|||
131927626|NCT01313676|475020677|FG003|Overall Study|Lack of Efficacy|46|||
131927627|NCT01313676|475020674|FG000|Overall Study|Protocol Violation|37|||
131927628|NCT01313676|475020675|FG001|Overall Study|Protocol Violation|44|||
131927629|NCT01313676|475020676|FG002|Overall Study|Protocol Violation|46|||
131927630|NCT01313676|475020677|FG003|Overall Study|Protocol Violation|44|||
131927631|NCT01313676|475020674|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
131927632|NCT01313676|475020675|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
131927633|NCT01313676|475020676|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
131927634|NCT01313676|475020677|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
131927635|NCT01313676|475020674|FG000|Overall Study|Study Closed/terminated|7|||
131927636|NCT01313676|475020675|FG001|Overall Study|Study Closed/terminated|6|||
131927637|NCT01313676|475020676|FG002|Overall Study|Study Closed/terminated|9|||
131927638|NCT01313676|475020677|FG003|Overall Study|Study Closed/terminated|9|||
131927639|NCT01313676|475020674|FG000|Overall Study|Lost to Follow-up|0|||
131927640|NCT01313676|475020675|FG001|Overall Study|Lost to Follow-up|0|||
131927641|NCT01313676|475020676|FG002|Overall Study|Lost to Follow-up|1|||
131927642|NCT01313676|475020677|FG003|Overall Study|Lost to Follow-up|0|||
131927643|NCT01313676|475020674|FG000|Overall Study|Physician Decision|53|||
131927644|NCT01313676|475020675|FG001|Overall Study|Physician Decision|64|||
131927645|NCT01313676|475020676|FG002|Overall Study|Physician Decision|62|||
131927646|NCT01313676|475020677|FG003|Overall Study|Physician Decision|48|||
131927647|NCT01313676|475020674|FG000|Overall Study|Decision by Participant or Proxy|643|||
131927648|NCT01313676|475020675|FG001|Overall Study|Decision by Participant or Proxy|527|||
131927649|NCT01313676|475020676|FG002|Overall Study|Decision by Participant or Proxy|515|||
131927650|NCT01313676|475020677|FG003|Overall Study|Decision by Participant or Proxy|492|||
131927651|NCT01313676|475020674|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
131927652|NCT01313676|475020675|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
131927653|NCT01313676|475020676|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
131927654|NCT01313676|475020677|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
131927655|NCT01313676|475020674|FG000|Overall Study|Investigator Site Closed|12|||
131927656|NCT01313676|475020675|FG001|Overall Study|Investigator Site Closed|11|||
131927657|NCT01313676|475020676|FG002|Overall Study|Investigator Site Closed|15|||
131927658|NCT01313676|475020677|FG003|Overall Study|Investigator Site Closed|10|||
131927659|NCT01313676|475020674|FG000|Overall Study|Missing|1|||
131927660|NCT01313676|475020675|FG001|Overall Study|Missing|1|||
131927661|NCT01313676|475020676|FG002|Overall Study|Missing|1|||
131927662|NCT01313676|475020677|FG003|Overall Study|Missing|0|||
131927663|NCT00944645|475020678|FG000|Period 2|Adverse Event|1|||
131927664|NCT00944645|475020679|FG001|Period 2|Adverse Event|0|||
131927665|NCT00944645|475020678|FG000|Period 2|Lost to Follow-up|0|||
131927666|NCT00944645|475020679|FG001|Period 2|Lost to Follow-up|3|||
131927667|NCT00944645|475020678|FG000|Period 2|Withdrawal by Subject|7|||
131927668|NCT00944645|475020679|FG001|Period 2|Withdrawal by Subject|6|||
131927669|NCT03537729|475020680|FG000|Overall Study|Death|2|||
131927670|NCT03537729|475020681|FG001|Overall Study|Death|2|||
131927671|NCT03537729|475020682|FG002|Overall Study|Death|7|||
131927672|NCT03537729|475020680|FG000|Overall Study|Withdrawal by Subject|3|||
131927673|NCT03537729|475020681|FG001|Overall Study|Withdrawal by Subject|3|||
131927674|NCT03537729|475020682|FG002|Overall Study|Withdrawal by Subject|0|||
131927675|NCT03537729|475020680|FG000|Overall Study|Subject Moved|8|||
131927676|NCT03537729|475020681|FG001|Overall Study|Subject Moved|5|||
131927677|NCT03537729|475020682|FG002|Overall Study|Subject Moved|4|||
131927678|NCT03537729|475020680|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
131927679|NCT03537729|475020681|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
131927680|NCT03537729|475020682|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
131927681|NCT03537729|475020680|FG000|Overall Study|COVID-19 Site Restrictions|11|||
131927682|NCT03537729|475020681|FG001|Overall Study|COVID-19 Site Restrictions|15|||
131927683|NCT03537729|475020682|FG002|Overall Study|COVID-19 Site Restrictions|18|||
131927684|NCT03537729|475020680|FG000|Overall Study|Decline in Health|5|||
131927685|NCT03537729|475020681|FG001|Overall Study|Decline in Health|9|||
131927686|NCT03537729|475020682|FG002|Overall Study|Decline in Health|4|||
131927687|NCT03537729|475020680|FG000|Overall Study|Determined Ineligible|0|||
131927688|NCT03537729|475020681|FG001|Overall Study|Determined Ineligible|0|||
131927689|NCT03537729|475020682|FG002|Overall Study|Determined Ineligible|1|||
131927690|NCT00394472|475020686|FG000|Overall Study|Protocol Violation|1|||
131927691|NCT00394472|475020687|FG001|Overall Study|Protocol Violation|3|||
131927692|NCT00394472|475020686|FG000|Overall Study|incorrect enrolment|4|||
131927693|NCT00394472|475020687|FG001|Overall Study|incorrect enrolment|2|||
131927694|NCT00394472|475020686|FG000|Overall Study|Adverse Event|4|||
131927695|NCT00394472|475020687|FG001|Overall Study|Adverse Event|2|||
131927696|NCT00394472|475020686|FG000|Overall Study|Withdrawal by Subject|0|||
131927697|NCT00394472|475020687|FG001|Overall Study|Withdrawal by Subject|2|||
131927698|NCT00394472|475020686|FG000|Overall Study|Physician Decision|0|||
131927699|NCT00394472|475020687|FG001|Overall Study|Physician Decision|1|||
131927700|NCT00394472|475020686|FG000|Overall Study|Lost to Follow-up|0|||
131927701|NCT00394472|475020687|FG001|Overall Study|Lost to Follow-up|1|||
131927702|NCT04359680|475020688|FG000|Overall Study|Withdrawal by Subject|29|||
131927703|NCT04359680|475020689|FG001|Overall Study|Withdrawal by Subject|24|||
131927704|NCT04359680|475020688|FG000|Overall Study|Adverse Event|6|||
131927705|NCT04359680|475020689|FG001|Overall Study|Adverse Event|2|||
131927706|NCT04359680|475020688|FG000|Overall Study|Lost to Follow-up|56|||
131927707|NCT04359680|475020689|FG001|Overall Study|Lost to Follow-up|59|||
131927708|NCT04359680|475020688|FG000|Overall Study|Protocol Violation|3|||
131927709|NCT04359680|475020689|FG001|Overall Study|Protocol Violation|5|||
131927710|NCT04359680|475020688|FG000|Overall Study|Physician Decision|1|||
131927711|NCT04359680|475020689|FG001|Overall Study|Physician Decision|1|||
131927712|NCT04359680|475020688|FG000|Overall Study|Sponsor Decision|0|||
131927713|NCT04359680|475020689|FG001|Overall Study|Sponsor Decision|1|||
131927714|NCT01654250|475020690|FG000|Overall Study|Lost to Follow-up|1|||
131927715|NCT01654250|475020691|FG001|Overall Study|Lost to Follow-up|0|||
131927716|NCT01748552|475020696|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
131927717|NCT01748552|475020697|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
131927718|NCT01748552|475020698|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
131927719|NCT01748552|475020699|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
131927720|NCT01748552|475020700|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
131927721|NCT01748552|475020701|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
131927722|NCT01748552|475020702|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
131927723|NCT01748552|475020703|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
131927724|NCT01748552|475020704|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
131927725|NCT01748552|475020705|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
131927726|NCT01748552|475020706|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
131927727|NCT01748552|475020707|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
131927728|NCT01748552|475020696|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927729|NCT01748552|475020697|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927730|NCT01748552|475020698|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927731|NCT01748552|475020699|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927732|NCT01748552|475020700|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927733|NCT01748552|475020701|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927734|NCT01748552|475020702|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
131927735|NCT01748552|475020703|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
131927736|NCT01748552|475020704|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
131927737|NCT01748552|475020705|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927738|NCT01748552|475020706|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927739|NCT01748552|475020707|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
131927740|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
131927741|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
131927742|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
131927743|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
131927744|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
131927745|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
131927746|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
131927747|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
131927748|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
131927749|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
131927750|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
131927751|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
131927752|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
131927753|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
131410101|NCT00953524|473124727|FG000|Overall Study|Withdrawal by Subject|2|||
131410102|NCT00953524|473124728|FG001|Overall Study|Withdrawal by Subject|4|||
131410103|NCT00953524|473124729|FG002|Overall Study|Withdrawal by Subject|1|||
131410104|NCT00953524|473124730|FG003|Overall Study|Withdrawal by Subject|0|||
131927754|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
131410105|NCT00869050|473124739|FG000|Overall Study|Screen Failure|3|||
131927755|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
131927756|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
131927757|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
131927758|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
131927759|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
131927760|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
131927761|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
131927762|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
131927763|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
131927764|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
131927765|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
131927766|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
131927767|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
131927768|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
131927769|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
131927770|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
131927771|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
131927772|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
131927773|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
131927774|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
131927775|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
131927776|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
131927777|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
131927778|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
131927779|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
131927780|NCT02596893|475020710|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
131927781|NCT02596893|475020711|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
131927782|NCT02596893|475020712|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
131927783|NCT02596893|475020713|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
131927784|NCT03280615|475020714|FG000|Overall Study|Lost to Follow-up|1|||
131927785|NCT03280615|475020715|FG001|Overall Study|Lost to Follow-up|2|||
131927786|NCT03280615|475020714|FG000|Overall Study|Adverse Event|1|||
131927787|NCT03280615|475020715|FG001|Overall Study|Adverse Event|1|||
131927788|NCT03280615|475020714|FG000|Overall Study|Withdrawal by Subject|2|||
131927789|NCT03280615|475020715|FG001|Overall Study|Withdrawal by Subject|2|||
131927790|NCT00004228|475020720|FG000|Overall Study|Adverse Event|0|||
131927791|NCT00004228|475020721|FG001|Overall Study|Adverse Event|1|||
131927792|NCT00004228|475020722|FG002|Overall Study|Adverse Event|0|||
131927793|NCT00004228|475020723|FG003|Overall Study|Adverse Event|0|||
131927794|NCT00004228|475020724|FG004|Overall Study|Adverse Event|1|||
131927795|NCT00004228|475020725|FG005|Overall Study|Adverse Event|0|||
131927796|NCT00004228|475020726|FG006|Overall Study|Adverse Event|0|||
131927797|NCT00004228|475020720|FG000|Overall Study|Death|0|||
131927798|NCT00004228|475020721|FG001|Overall Study|Death|1|||
131927799|NCT00004228|475020722|FG002|Overall Study|Death|2|||
131927800|NCT00004228|475020723|FG003|Overall Study|Death|0|||
131927801|NCT00004228|475020724|FG004|Overall Study|Death|1|||
131927802|NCT00004228|475020725|FG005|Overall Study|Death|0|||
131927803|NCT00004228|475020726|FG006|Overall Study|Death|0|||
131927804|NCT00004228|475020720|FG000|Overall Study|Lack of Efficacy|1|||
131927805|NCT00004228|475020721|FG001|Overall Study|Lack of Efficacy|6|||
131927806|NCT00004228|475020722|FG002|Overall Study|Lack of Efficacy|5|||
131927807|NCT00004228|475020723|FG003|Overall Study|Lack of Efficacy|3|||
131927808|NCT00004228|475020724|FG004|Overall Study|Lack of Efficacy|9|||
131927809|NCT00004228|475020725|FG005|Overall Study|Lack of Efficacy|8|||
131927810|NCT00004228|475020726|FG006|Overall Study|Lack of Efficacy|4|||
131927811|NCT00004228|475020720|FG000|Overall Study|Lost to Follow-up|0|||
131927812|NCT00004228|475020721|FG001|Overall Study|Lost to Follow-up|0|||
131927813|NCT00004228|475020722|FG002|Overall Study|Lost to Follow-up|1|||
131927814|NCT00004228|475020723|FG003|Overall Study|Lost to Follow-up|0|||
131927815|NCT00004228|475020724|FG004|Overall Study|Lost to Follow-up|0|||
131927816|NCT00004228|475020725|FG005|Overall Study|Lost to Follow-up|0|||
131927817|NCT00004228|475020726|FG006|Overall Study|Lost to Follow-up|0|||
131927818|NCT00004228|475020720|FG000|Overall Study|Physician Decision|1|||
131927819|NCT00004228|475020721|FG001|Overall Study|Physician Decision|0|||
131927820|NCT00004228|475020722|FG002|Overall Study|Physician Decision|3|||
131927821|NCT00004228|475020723|FG003|Overall Study|Physician Decision|2|||
131927822|NCT00004228|475020724|FG004|Overall Study|Physician Decision|1|||
131927823|NCT00004228|475020725|FG005|Overall Study|Physician Decision|1|||
131927824|NCT00004228|475020726|FG006|Overall Study|Physician Decision|1|||
131927825|NCT00004228|475020720|FG000|Overall Study|Protocol Violation|0|||
131927826|NCT00004228|475020721|FG001|Overall Study|Protocol Violation|5|||
131927827|NCT00004228|475020722|FG002|Overall Study|Protocol Violation|2|||
131927828|NCT00004228|475020723|FG003|Overall Study|Protocol Violation|1|||
131927829|NCT00004228|475020724|FG004|Overall Study|Protocol Violation|1|||
131927830|NCT00004228|475020725|FG005|Overall Study|Protocol Violation|2|||
131927831|NCT00004228|475020726|FG006|Overall Study|Protocol Violation|0|||
131927832|NCT00004228|475020720|FG000|Overall Study|Withdrawal by Subject|3|||
131927833|NCT00004228|475020721|FG001|Overall Study|Withdrawal by Subject|0|||
131927834|NCT00004228|475020722|FG002|Overall Study|Withdrawal by Subject|1|||
131927835|NCT00004228|475020723|FG003|Overall Study|Withdrawal by Subject|0|||
131927836|NCT00004228|475020724|FG004|Overall Study|Withdrawal by Subject|2|||
131927837|NCT00004228|475020725|FG005|Overall Study|Withdrawal by Subject|1|||
131927838|NCT00004228|475020726|FG006|Overall Study|Withdrawal by Subject|2|||
131927839|NCT00004228|475020720|FG000|Overall Study|Other|0|||
131927840|NCT00004228|475020721|FG001|Overall Study|Other|0|||
131927841|NCT00004228|475020722|FG002|Overall Study|Other|1|||
131927842|NCT00004228|475020723|FG003|Overall Study|Other|0|||
131927843|NCT00004228|475020724|FG004|Overall Study|Other|0|||
131927844|NCT00004228|475020725|FG005|Overall Study|Other|0|||
131927845|NCT00004228|475020726|FG006|Overall Study|Other|0|||
131927846|NCT00004228|475020720|FG000|Overall Study|ineligible|4|||
131927847|NCT00004228|475020721|FG001|Overall Study|ineligible|2|||
131927848|NCT00004228|475020722|FG002|Overall Study|ineligible|4|||
131927849|NCT00004228|475020723|FG003|Overall Study|ineligible|1|||
131927850|NCT00004228|475020724|FG004|Overall Study|ineligible|1|||
131768865|NCT02041533|474431889|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
131768866|NCT02041533|474431890|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
131768867|NCT02041533|474431889|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
131768868|NCT02041533|474431890|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
131768869|NCT02041533|474431889|FG000|Treatment Period|Disease progression|189|||
131768870|NCT02041533|474431890|FG001|Treatment Period|Disease progression|146|||
131768871|NCT02041533|474431889|FG000|Treatment Period|Study drug toxicity|30|||
131768872|NCT02041533|474431890|FG001|Treatment Period|Study drug toxicity|34|||
131768873|NCT02041533|474431889|FG000|Treatment Period|Death|1|||
131768874|NCT02041533|474431890|FG001|Treatment Period|Death|0|||
131881989|NCT02659514|474849274|FG000|Overall Study|Disease Progression|23|||
131881990|NCT02659514|474849275|FG001|Overall Study|Disease Progression|13|||
131927851|NCT00004228|475020725|FG005|Overall Study|ineligible|2|||
131927852|NCT00004228|475020726|FG006|Overall Study|ineligible|5|||
131927853|NCT02255279|475020727|FG000|Overall Study|Lost to Follow-up|2|||
131927854|NCT02255279|475020728|FG001|Overall Study|Lost to Follow-up|2|||
131927855|NCT02255279|475020727|FG000|Overall Study|Protocol Violation|0|||
131927856|NCT02255279|475020728|FG001|Overall Study|Protocol Violation|1|||
131927857|NCT02255279|475020727|FG000|Overall Study|Withdrawal by Subject|3|||
131927858|NCT02255279|475020728|FG001|Overall Study|Withdrawal by Subject|6|||
131927859|NCT01013870|475020729|FG000|Overall Study|Lost to Follow-up|1|||
131927860|NCT01013870|475020730|FG001|Overall Study|Lost to Follow-up|3|||
131927861|NCT01386645|475020731|FG000|Overall Study|Physician Decision|0|||
131927862|NCT01386645|475020732|FG001|Overall Study|Physician Decision|0|||
131927863|NCT01386645|475020733|FG002|Overall Study|Physician Decision|1|||
131927864|NCT01386645|475020731|FG000|Overall Study|Withdrawal by Subject|0|||
131927865|NCT01386645|475020732|FG001|Overall Study|Withdrawal by Subject|1|||
131927866|NCT01386645|475020733|FG002|Overall Study|Withdrawal by Subject|1|||
131927867|NCT04432298|475020737|FG000|Overall Study|Other than specified|1|||
131927868|NCT04432298|475020738|FG001|Overall Study|Other than specified|0|||
131927869|NCT04432298|475020737|FG000|Overall Study|Lost to Follow-up|0|||
131927870|NCT04432298|475020738|FG001|Overall Study|Lost to Follow-up|1|||
131927871|NCT04432298|475020737|FG000|Overall Study|Death|3|||
131927872|NCT04432298|475020738|FG001|Overall Study|Death|2|||
131927873|NCT04432298|475020737|FG000|Overall Study|Withdrawal by Subject|2|||
131927874|NCT04432298|475020738|FG001|Overall Study|Withdrawal by Subject|0|||
131927875|NCT02365064|475020739|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
131927876|NCT02365064|475020740|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
131881991|NCT02659514|474849274|FG000|Overall Study|Withdrawal by Subject|0|||
131881992|NCT02659514|474849275|FG001|Overall Study|Withdrawal by Subject|4|||
131881993|NCT02659514|474849274|FG000|Overall Study|Lost to Follow-up|0|||
131881994|NCT02659514|474849275|FG001|Overall Study|Lost to Follow-up|1|||
131881995|NCT02659514|474849274|FG000|Overall Study|Death|6|||
131881996|NCT02659514|474849275|FG001|Overall Study|Death|1|||
131881997|NCT02659514|474849274|FG000|Overall Study|Reason Unspecified|0|||
131881998|NCT02659514|474849275|FG001|Overall Study|Reason Unspecified|3|||
131881999|NCT01968707|474849278|FG000|Overall Study|Did not meet treatment day baseline|49|||
131882000|NCT01968707|474849279|FG001|Overall Study|Did not meet treatment day baseline|12|||
131882001|NCT01968707|474849280|FG002|Overall Study|Did not meet treatment day baseline|41|||
131882002|NCT01968707|474849281|FG003|Overall Study|Did not meet treatment day baseline|44|||
131882003|NCT01968707|474849282|FG004|Overall Study|Did not meet treatment day baseline|36|||
131882004|NCT01968707|474849283|FG005|Overall Study|Did not meet treatment day baseline|11|||
131882005|NCT01968707|474849284|FG006|Overall Study|Did not meet treatment day baseline|34|||
131882006|NCT01968707|474849285|FG007|Overall Study|Did not meet treatment day baseline|35|||
131882007|NCT00916344|474849286|FG000|Overall Study|Death|2|||
131882008|NCT00916344|474849286|FG000|Overall Study|ICD upgrade|1|||
131927877|NCT02365064|475020739|FG000|Overall Study|Withdrawal by Subject|6|||
131927878|NCT02365064|475020740|FG001|Overall Study|Withdrawal by Subject|9|||
131927879|NCT02365064|475020739|FG000|Overall Study|Treatment intolerance|2|||
131927880|NCT02365064|475020740|FG001|Overall Study|Treatment intolerance|4|||
131927881|NCT02451007|475020743|FG000|Overall Study|Withdrawal by Subject|4|||
131927882|NCT02451007|475020743|FG000|Overall Study|Adverse Event|1|||
131927883|NCT02451007|475020743|FG000|Overall Study|Disease Progression|2|||
131927884|NCT01716559|475020744|FG000|Overall Study|Adverse Event|11|||
131927885|NCT01716559|475020744|FG000|Overall Study|Death|21|||
131927886|NCT01716559|475020744|FG000|Overall Study|Withdrawal by Subject|4|||
131927887|NCT01716559|475020744|FG000|Overall Study|Other withdrawal reason|75|||
131927888|NCT01133977|475020747|FG000|Overall Study|Adverse Event|0|||
131927889|NCT01133977|475020748|FG001|Overall Study|Adverse Event|0|||
131927890|NCT01133977|475020749|FG002|Overall Study|Adverse Event|1|||
131927891|NCT01133977|475020750|FG003|Overall Study|Adverse Event|0|||
131927892|NCT01133977|475020751|FG004|Overall Study|Adverse Event|0|||
131927893|NCT01133977|475020747|FG000|Overall Study|Death|1|||
131927894|NCT01133977|475020748|FG001|Overall Study|Death|1|||
131927895|NCT01133977|475020749|FG002|Overall Study|Death|1|||
131927896|NCT01133977|475020750|FG003|Overall Study|Death|7|||
131927897|NCT01133977|475020751|FG004|Overall Study|Death|3|||
131927898|NCT01133977|475020747|FG000|Overall Study|Started a New Line of Therapy|2|||
131927899|NCT01133977|475020748|FG001|Overall Study|Started a New Line of Therapy|6|||
131927900|NCT01133977|475020749|FG002|Overall Study|Started a New Line of Therapy|4|||
131927901|NCT01133977|475020750|FG003|Overall Study|Started a New Line of Therapy|25|||
131927902|NCT01133977|475020751|FG004|Overall Study|Started a New Line of Therapy|33|||
131927903|NCT01133977|475020747|FG000|Overall Study|Lost to Follow-up|0|||
131927904|NCT01133977|475020748|FG001|Overall Study|Lost to Follow-up|0|||
131927905|NCT01133977|475020749|FG002|Overall Study|Lost to Follow-up|0|||
131927906|NCT01133977|475020750|FG003|Overall Study|Lost to Follow-up|2|||
131927907|NCT01133977|475020751|FG004|Overall Study|Lost to Follow-up|1|||
131927908|NCT01133977|475020747|FG000|Overall Study|Withdrawal by Subject|0|||
131927909|NCT01133977|475020748|FG001|Overall Study|Withdrawal by Subject|0|||
131927910|NCT01133977|475020749|FG002|Overall Study|Withdrawal by Subject|0|||
131927911|NCT01133977|475020750|FG003|Overall Study|Withdrawal by Subject|5|||
131927912|NCT01133977|475020751|FG004|Overall Study|Withdrawal by Subject|1|||
131927913|NCT02773537|475020752|FG000|Overall Study|Lost to Follow-up|0|||
131927914|NCT02773537|475020753|FG001|Overall Study|Lost to Follow-up|1|||
131927915|NCT02773537|475020754|FG002|Overall Study|Lost to Follow-up|4|||
131927916|NCT01840163|475020755|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
131927917|NCT01840163|475020756|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
131927918|NCT01840163|475020755|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
131927919|NCT01840163|475020756|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
131927920|NCT01840163|475020755|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
131927921|NCT01840163|475020756|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
131927922|NCT00662038|475020757|FG000|Overall Study|Reason not specified|3|||
131927923|NCT00662038|475020757|FG000|Overall Study|Withdrawn consent|22|||
131927924|NCT00662038|475020757|FG000|Overall Study|Withdrawal by Subject|83|||
131927925|NCT00662038|475020757|FG000|Overall Study|Sponsor decision|1|||
131927926|NCT00662038|475020757|FG000|Overall Study|Physician Decision|19|||
131927927|NCT00662038|475020757|FG000|Overall Study|Lung transplantation|44|||
131927928|NCT00662038|475020757|FG000|Overall Study|Lost to Follow-up|1|||
131927929|NCT00662038|475020757|FG000|Overall Study|Death|95|||
131927930|NCT00662038|475020757|FG000|Overall Study|Adverse Event|358|||
131927931|NCT00662038|475020757|FG000|Overall Study|Continued treatment|5|||
131927932|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
131927933|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
131927934|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
131927935|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
131927936|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
131927937|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
131927938|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
131927939|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
131927940|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
131927941|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
131927942|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
131927943|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
131927944|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Other|6|||
131927945|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Other|3|||
131927946|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Other|0|||
131927947|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
131927948|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131927949|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131927950|NCT03636269|475020758|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
131927951|NCT03636269|475020759|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
131927952|NCT03636269|475020760|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
131927953|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Adverse Event|0|||
131927954|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Adverse Event|0|||
131927955|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Adverse Event|21|||
131927956|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
131927957|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
131927958|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
131927959|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
131927960|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
131927961|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
131927962|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
131927963|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
131927964|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
131927965|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Administrative|0|||
131927966|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Administrative|0|||
131927967|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Administrative|36|||
131927968|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Other|0|||
131927969|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Other|0|||
131927970|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Other|9|||
131927971|NCT03636269|475020758|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
131927972|NCT03636269|475020759|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
131927973|NCT03636269|475020760|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
131927974|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
131927975|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
131927976|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
131927977|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
131927978|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
131927979|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
131927980|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
131927981|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
131927982|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
131927983|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
131927984|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
131927985|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
131927986|NCT00290758|475020772|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
131927987|NCT00290758|475020773|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
131927988|NCT00290758|475020772|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
131927989|NCT00290758|475020773|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
131927990|NCT01896986|475020774|FG000|Overall Study|samples lost|14|||
131927991|NCT01896986|475020775|FG001|Overall Study|samples lost|23|||
131927992|NCT01750281|475020776|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
131927993|NCT01750281|475020777|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
131927994|NCT01750281|475020778|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
131927995|NCT01750281|475020776|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
131927996|NCT01750281|475020777|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
131927997|NCT01750281|475020778|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
131927998|NCT01750281|475020776|FG000|Overall Study|Did not receive treatment|0|||
131927999|NCT01750281|475020777|FG001|Overall Study|Did not receive treatment|1|||
131928000|NCT01750281|475020778|FG002|Overall Study|Did not receive treatment|0|||
131928001|NCT01061710|475020779|FG000|Overall Study|Protocol Violation|14|||
131928002|NCT03757715|475020780|FG000|Overall Study|Lost to Follow-up|4|||
131928003|NCT03757715|475020781|FG001|Overall Study|Lost to Follow-up|9|||
131928004|NCT03757715|475020780|FG000|Overall Study|Withdrawal by Subject|1|||
131928005|NCT03757715|475020781|FG001|Overall Study|Withdrawal by Subject|1|||
131928006|NCT00281580|475020782|FG000|Overall Study|Adverse Event|2|||
131928007|NCT00281580|475020783|FG001|Overall Study|Adverse Event|0|||
131928008|NCT00281580|475020784|FG002|Overall Study|Adverse Event|2|||
131928009|NCT00281580|475020785|FG003|Overall Study|Adverse Event|4|||
131928010|NCT00281580|475020786|FG004|Overall Study|Adverse Event|1|||
131928011|NCT00281580|475020787|FG005|Overall Study|Adverse Event|0|||
131928012|NCT00281580|475020788|FG006|Overall Study|Adverse Event|1|||
131928013|NCT00281580|475020789|FG007|Overall Study|Adverse Event|0|||
131928014|NCT00281580|475020790|FG008|Overall Study|Adverse Event|1|||
131928015|NCT00281580|475020791|FG009|Overall Study|Adverse Event|6|||
131928016|NCT00281580|475020792|FG010|Overall Study|Adverse Event|0|||
131928017|NCT00281580|475020793|FG011|Overall Study|Adverse Event|5|||
131928018|NCT00281580|475020794|FG012|Overall Study|Adverse Event|8|||
131928019|NCT00281580|475020795|FG013|Overall Study|Adverse Event|2|||
131928020|NCT00281580|475020796|FG014|Overall Study|Adverse Event|3|||
131928021|NCT00281580|475020797|FG015|Overall Study|Adverse Event|3|||
131928022|NCT00281580|475020782|FG000|Overall Study|Protocol Violation|0|||
131928023|NCT00281580|475020783|FG001|Overall Study|Protocol Violation|0|||
131928024|NCT00281580|475020784|FG002|Overall Study|Protocol Violation|1|||
131928025|NCT00281580|475020785|FG003|Overall Study|Protocol Violation|1|||
131928026|NCT00281580|475020786|FG004|Overall Study|Protocol Violation|0|||
131928027|NCT00281580|475020787|FG005|Overall Study|Protocol Violation|0|||
131928028|NCT00281580|475020788|FG006|Overall Study|Protocol Violation|1|||
131928029|NCT00281580|475020789|FG007|Overall Study|Protocol Violation|0|||
131928030|NCT00281580|475020790|FG008|Overall Study|Protocol Violation|2|||
131928031|NCT00281580|475020791|FG009|Overall Study|Protocol Violation|0|||
131928032|NCT00281580|475020792|FG010|Overall Study|Protocol Violation|1|||
131928033|NCT00281580|475020793|FG011|Overall Study|Protocol Violation|2|||
131928034|NCT00281580|475020794|FG012|Overall Study|Protocol Violation|0|||
131928035|NCT00281580|475020795|FG013|Overall Study|Protocol Violation|1|||
131928036|NCT00281580|475020796|FG014|Overall Study|Protocol Violation|1|||
131928037|NCT00281580|475020797|FG015|Overall Study|Protocol Violation|3|||
131928038|NCT00281580|475020782|FG000|Overall Study|Withdrawal by Subject|3|||
131928039|NCT00281580|475020783|FG001|Overall Study|Withdrawal by Subject|0|||
131928040|NCT00281580|475020784|FG002|Overall Study|Withdrawal by Subject|1|||
131928041|NCT00281580|475020785|FG003|Overall Study|Withdrawal by Subject|1|||
131928042|NCT00281580|475020786|FG004|Overall Study|Withdrawal by Subject|1|||
131928043|NCT00281580|475020787|FG005|Overall Study|Withdrawal by Subject|2|||
131928044|NCT00281580|475020788|FG006|Overall Study|Withdrawal by Subject|2|||
131928045|NCT00281580|475020789|FG007|Overall Study|Withdrawal by Subject|0|||
131928046|NCT00281580|475020790|FG008|Overall Study|Withdrawal by Subject|1|||
131928047|NCT00281580|475020791|FG009|Overall Study|Withdrawal by Subject|4|||
131928048|NCT00281580|475020792|FG010|Overall Study|Withdrawal by Subject|1|||
131928049|NCT00281580|475020793|FG011|Overall Study|Withdrawal by Subject|1|||
131928050|NCT00281580|475020794|FG012|Overall Study|Withdrawal by Subject|2|||
131928051|NCT00281580|475020795|FG013|Overall Study|Withdrawal by Subject|2|||
131928052|NCT00281580|475020796|FG014|Overall Study|Withdrawal by Subject|1|||
131928053|NCT00281580|475020797|FG015|Overall Study|Withdrawal by Subject|5|||
131928054|NCT00281580|475020782|FG000|Overall Study|Lack of Efficacy|2|||
131928055|NCT00281580|475020783|FG001|Overall Study|Lack of Efficacy|1|||
131928056|NCT00281580|475020784|FG002|Overall Study|Lack of Efficacy|1|||
131928057|NCT00281580|475020785|FG003|Overall Study|Lack of Efficacy|6|||
131928058|NCT00281580|475020786|FG004|Overall Study|Lack of Efficacy|2|||
131928059|NCT00281580|475020787|FG005|Overall Study|Lack of Efficacy|0|||
131928060|NCT00281580|475020788|FG006|Overall Study|Lack of Efficacy|0|||
131928061|NCT00281580|475020789|FG007|Overall Study|Lack of Efficacy|0|||
131928062|NCT00281580|475020790|FG008|Overall Study|Lack of Efficacy|0|||
131928063|NCT00281580|475020791|FG009|Overall Study|Lack of Efficacy|0|||
131928064|NCT00281580|475020792|FG010|Overall Study|Lack of Efficacy|0|||
131928065|NCT00281580|475020793|FG011|Overall Study|Lack of Efficacy|1|||
131928066|NCT00281580|475020794|FG012|Overall Study|Lack of Efficacy|0|||
131928067|NCT00281580|475020795|FG013|Overall Study|Lack of Efficacy|2|||
131928068|NCT00281580|475020796|FG014|Overall Study|Lack of Efficacy|1|||
131928069|NCT00281580|475020797|FG015|Overall Study|Lack of Efficacy|0|||
131928070|NCT00281580|475020782|FG000|Overall Study|Lost to Follow-up|0|||
131928071|NCT00281580|475020783|FG001|Overall Study|Lost to Follow-up|0|||
131928072|NCT00281580|475020784|FG002|Overall Study|Lost to Follow-up|0|||
131928073|NCT00281580|475020785|FG003|Overall Study|Lost to Follow-up|3|||
131928074|NCT00281580|475020786|FG004|Overall Study|Lost to Follow-up|0|||
131928075|NCT00281580|475020787|FG005|Overall Study|Lost to Follow-up|1|||
131928076|NCT00281580|475020788|FG006|Overall Study|Lost to Follow-up|0|||
131928077|NCT00281580|475020789|FG007|Overall Study|Lost to Follow-up|1|||
131928078|NCT00281580|475020790|FG008|Overall Study|Lost to Follow-up|2|||
131928079|NCT00281580|475020791|FG009|Overall Study|Lost to Follow-up|1|||
131928080|NCT00281580|475020792|FG010|Overall Study|Lost to Follow-up|1|||
131928081|NCT00281580|475020793|FG011|Overall Study|Lost to Follow-up|0|||
131928082|NCT00281580|475020794|FG012|Overall Study|Lost to Follow-up|1|||
131928083|NCT00281580|475020795|FG013|Overall Study|Lost to Follow-up|0|||
131928084|NCT00281580|475020796|FG014|Overall Study|Lost to Follow-up|0|||
131928085|NCT00281580|475020797|FG015|Overall Study|Lost to Follow-up|0|||
131928086|NCT00281580|475020782|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
131410106|NCT03554772|473124749|FG000|Overall Study|Lost to Follow-up|0|||
131410107|NCT03554772|473124750|FG001|Overall Study|Lost to Follow-up|0|||
131928087|NCT00281580|475020783|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
131928088|NCT00281580|475020784|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
131928089|NCT00281580|475020785|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
131928090|NCT00281580|475020786|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
131928091|NCT00281580|475020787|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
131410108|NCT03554772|473124751|FG002|Overall Study|Lost to Follow-up|0|||
131928092|NCT00281580|475020788|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
131928093|NCT00281580|475020789|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
131928094|NCT00281580|475020790|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
131928095|NCT00281580|475020791|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
131928096|NCT00281580|475020792|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
131410109|NCT03554772|473124752|FG003|Overall Study|Lost to Follow-up|2|||
131410110|NCT03276052|473124754|FG000|Overall Study|Withdrawal by Subject|5|||
131410111|NCT03276052|473124754|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
131410112|NCT01994863|473124755|FG000|Period 1|Adverse Event|4|||
131410113|NCT01994863|473124756|FG001|Period 1|Adverse Event|0|||
131410114|NCT01994863|473124755|FG000|Period 1|Withdrawal by Subject|1|||
131410115|NCT01994863|473124756|FG001|Period 1|Withdrawal by Subject|0|||
131410116|NCT01994863|473124755|FG000|Period 1|Trial stopped by sponsor|1|||
131410117|NCT01994863|473124756|FG001|Period 1|Trial stopped by sponsor|3|||
131410118|NCT01994863|473124755|FG000|Period 1|Lack of Efficacy|1|||
131410119|NCT01994863|473124756|FG001|Period 1|Lack of Efficacy|0|||
131410120|NCT01994863|473124755|FG000|Period 2|Adverse Event|0|||
131410121|NCT01994863|473124756|FG001|Period 2|Adverse Event|1|||
131410122|NCT01994863|473124755|FG000|Period 2|Lack of Efficacy|0|||
131410123|NCT01994863|473124756|FG001|Period 2|Lack of Efficacy|2|||
131410124|NCT01994863|473124755|FG000|Period 2|Withdrawal by Subject|1|||
131410125|NCT01994863|473124756|FG001|Period 2|Withdrawal by Subject|1|||
131410126|NCT05136898|473124757|FG000|Overall Study|Adverse Event|2|||
131410127|NCT01145053|473124758|FG000|Overall Study|Adverse Event|22|||
131410128|NCT01145053|473124758|FG000|Overall Study|Lost to Follow-up|28|||
131410129|NCT01145053|473124758|FG000|Overall Study|Withdrawal by Subject|25|||
131410130|NCT01145053|473124758|FG000|Overall Study|Other|18|||
131410131|NCT03060512|473124759|FG000|Overall Study|Adverse Event|4|||
131410132|NCT03060512|473124760|FG001|Overall Study|Adverse Event|6|||
131410133|NCT03060512|473124759|FG000|Overall Study|Lost to Follow-up|1|||
131410134|NCT03060512|473124760|FG001|Overall Study|Lost to Follow-up|1|||
131410135|NCT03060512|473124759|FG000|Overall Study|Withdrawal by Subject|1|||
131410136|NCT03060512|473124760|FG001|Overall Study|Withdrawal by Subject|0|||
131410137|NCT03060512|473124759|FG000|Overall Study|Non-compliance with study medication|1|||
131410138|NCT03060512|473124760|FG001|Overall Study|Non-compliance with study medication|2|||
131410139|NCT03946124|473124761|FG000|Overall Study|Withdrawal by Subject|19|||
131410140|NCT00241631|473124763|FG000|Run in (2 Weeks)|Physician Decision|3|||
131410141|NCT00241631|473124764|FG001|Run in (2 Weeks)|Physician Decision|3|||
131410142|NCT00241631|473124763|FG000|Phase 1 (4 Weeks)|sore throat|1|||
131410143|NCT00241631|473124764|FG001|Phase 1 (4 Weeks)|sore throat|0|||
131410144|NCT00241631|473124763|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
131410145|NCT00241631|473124764|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
131410146|NCT00241631|473124763|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
131410147|NCT00241631|473124764|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
131410148|NCT00241631|473124763|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
131410149|NCT00241631|473124764|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
131410150|NCT03220581|473124766|FG000|Overall Study|Withdrawal by Subject|0|||
131410151|NCT03220581|473124767|FG001|Overall Study|Withdrawal by Subject|1|||
131410152|NCT03220581|473124766|FG000|Overall Study|Lost to Follow-up|3|||
131410153|NCT03220581|473124767|FG001|Overall Study|Lost to Follow-up|6|||
131410154|NCT01457950|473124769|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
131410155|NCT01457950|473124770|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
131410156|NCT01457950|473124771|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
131410157|NCT01457950|473124772|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
131410158|NCT01457950|473124769|FG000|Double-Blind Phase|Protocol Violation|2|||
131410159|NCT01457950|473124770|FG001|Double-Blind Phase|Protocol Violation|1|||
131410160|NCT01457950|473124771|FG002|Double-Blind Phase|Protocol Violation|0|||
131410161|NCT01457950|473124772|FG003|Double-Blind Phase|Protocol Violation|0|||
131410162|NCT01457950|473124769|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
131410163|NCT01457950|473124770|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
131410164|NCT01457950|473124771|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131410165|NCT01457950|473124772|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131410166|NCT01457950|473124769|FG000|Open-Label Phase|Adverse Event|0|||
131410167|NCT01457950|473124770|FG001|Open-Label Phase|Adverse Event|0|||
131410168|NCT01457950|473124771|FG002|Open-Label Phase|Adverse Event|0|||
131410169|NCT01457950|473124772|FG003|Open-Label Phase|Adverse Event|1|||
131410170|NCT01457950|473124769|FG000|Open-Label Phase|Protocol Violation|0|||
131410171|NCT01457950|473124770|FG001|Open-Label Phase|Protocol Violation|0|||
131410172|NCT01457950|473124771|FG002|Open-Label Phase|Protocol Violation|0|||
131410173|NCT01457950|473124772|FG003|Open-Label Phase|Protocol Violation|1|||
131410174|NCT01457950|473124769|FG000|Open-Label Phase|Withdrawal by Subject|0|||
131410175|NCT01457950|473124770|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131410176|NCT01457950|473124771|FG002|Open-Label Phase|Withdrawal by Subject|2|||
131410177|NCT01457950|473124772|FG003|Open-Label Phase|Withdrawal by Subject|0|||
131410178|NCT00054691|473124773|FG000|Overall Study|Unmeasurable Disease|2|||
131410179|NCT00054691|473124773|FG000|Overall Study|Noncompliant|1|||
131410180|NCT03987932|473124778|FG000|Overall Study|Lost to Follow-up|2|||
131410181|NCT03987932|473124779|FG001|Overall Study|Lost to Follow-up|1|||
131410182|NCT03987932|473124780|FG002|Overall Study|Lost to Follow-up|1|||
131410183|NCT03987932|473124778|FG000|Overall Study|Non-study related elective surgery|0|||
131410184|NCT03987932|473124779|FG001|Overall Study|Non-study related elective surgery|0|||
131882009|NCT00916344|474849286|FG000|Overall Study|Drop-out|5|||
131410185|NCT03987932|473124780|FG002|Overall Study|Non-study related elective surgery|1|||
131410186|NCT01799239|473124781|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
131410187|NCT01799239|473124782|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
131410188|NCT01799239|473124781|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
131410189|NCT01799239|473124782|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
131410190|NCT01799239|473124781|FG000|Period 1 (7 Days)|Protocol Violation|0|||
131410191|NCT01799239|473124782|FG001|Period 1 (7 Days)|Protocol Violation|1|||
131410192|NCT01799239|473124781|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
131410193|NCT01799239|473124782|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
131410194|NCT01799239|473124781|FG000|Period 2 (7 Days)|Protocol Violation|1|||
131410195|NCT01799239|473124782|FG001|Period 2 (7 Days)|Protocol Violation|0|||
131410196|NCT01561755|473124785|FG000|Overall Study|Lost to Follow-up|0|||
131410197|NCT01561755|473124786|FG001|Overall Study|Lost to Follow-up|1|||
131410198|NCT01286987|473124791|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
131410199|NCT01286987|473124792|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
131410200|NCT01286987|473124793|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
131410201|NCT01286987|473124794|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
131928097|NCT00281580|475020793|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
131928098|NCT00281580|475020794|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
131928099|NCT00281580|475020795|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
131928100|NCT00281580|475020796|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
131928101|NCT00281580|475020797|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
131928102|NCT03302936|475020798|FG000|Overall Study|Protocol Violation|3|||
131928103|NCT03302936|475020799|FG001|Overall Study|Protocol Violation|4|||
131928104|NCT01550965|475020800|FG000|Overall Study|Adverse Event|26|||
131928105|NCT01550965|475020800|FG000|Overall Study|Withdrawal by Subject|10|||
131410202|NCT01286987|473124795|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
131410203|NCT01286987|473124796|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
131410204|NCT01286987|473124797|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
131410205|NCT01286987|473124798|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
131410206|NCT01286987|473124799|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
131928106|NCT01550965|475020800|FG000|Overall Study|Lost to Follow-up|2|||
131928107|NCT01550965|475020800|FG000|Overall Study|Lack of Efficacy|59|||
131928108|NCT01550965|475020800|FG000|Overall Study|Other|13|||
131928109|NCT03016403|475020803|FG000|Baseline|Death|5|||
131928110|NCT03016403|475020804|FG001|Baseline|Death|8|||
131928111|NCT03016403|475020805|FG002|Baseline|Death|1|||
131928112|NCT03016403|475020806|FG003|Baseline|Death|0|||
131928113|NCT03016403|475020803|FG000|Baseline|Withdrawal by Subject|2|||
131928114|NCT03016403|475020804|FG001|Baseline|Withdrawal by Subject|8|||
131928115|NCT03016403|475020805|FG002|Baseline|Withdrawal by Subject|4|||
131928116|NCT03016403|475020806|FG003|Baseline|Withdrawal by Subject|10|||
131928117|NCT03016403|475020803|FG000|Baseline|Lost to Follow-up|9|||
131928118|NCT03016403|475020804|FG001|Baseline|Lost to Follow-up|11|||
131928119|NCT03016403|475020805|FG002|Baseline|Lost to Follow-up|6|||
131928120|NCT03016403|475020806|FG003|Baseline|Lost to Follow-up|24|||
131928121|NCT03016403|475020803|FG000|6-week Follow-up|Death|1|||
131928122|NCT03016403|475020804|FG001|6-week Follow-up|Death|4|||
131928123|NCT03016403|475020805|FG002|6-week Follow-up|Death|0|||
131928124|NCT03016403|475020806|FG003|6-week Follow-up|Death|0|||
131928125|NCT03016403|475020803|FG000|6-week Follow-up|Lost to Follow-up|2|||
131928126|NCT03016403|475020804|FG001|6-week Follow-up|Lost to Follow-up|7|||
131928127|NCT03016403|475020805|FG002|6-week Follow-up|Lost to Follow-up|4|||
131928128|NCT03016403|475020806|FG003|6-week Follow-up|Lost to Follow-up|8|||
131928129|NCT03016403|475020803|FG000|6-week Follow-up|Withdrawal by Subject|0|||
131928130|NCT03016403|475020804|FG001|6-week Follow-up|Withdrawal by Subject|2|||
131928131|NCT03016403|475020805|FG002|6-week Follow-up|Withdrawal by Subject|0|||
131928132|NCT03016403|475020806|FG003|6-week Follow-up|Withdrawal by Subject|1|||
131928133|NCT03016403|475020803|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
131928134|NCT03016403|475020804|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
131928135|NCT03016403|475020805|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
131928136|NCT03016403|475020806|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
131928137|NCT03016403|475020803|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
131928138|NCT03016403|475020804|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
131410207|NCT01286987|473124800|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
131410208|NCT01286987|473124801|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
131410209|NCT01286987|473124802|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
131410210|NCT01286987|473124803|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
131928139|NCT03016403|475020805|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
131928140|NCT03016403|475020806|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
131928141|NCT03016403|475020803|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
131928142|NCT03016403|475020804|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
131928143|NCT03016403|475020805|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
131410211|NCT01286987|473124804|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
131928144|NCT03016403|475020806|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
131928145|NCT05463705|475020807|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
131928146|NCT05463705|475020808|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
131928147|NCT05463705|475020809|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
131928148|NCT05463705|475020810|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
131928149|NCT05463705|475020811|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
131928150|NCT05463705|475020812|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
131928151|NCT00621322|475020813|FG000|Overall Study|Lost to Follow-up|0|||
131928152|NCT00621322|475020814|FG001|Overall Study|Lost to Follow-up|0|||
131928153|NCT00621322|475020815|FG002|Overall Study|Lost to Follow-up|0|||
131928154|NCT00621322|475020816|FG003|Overall Study|Lost to Follow-up|0|||
131928155|NCT00621322|475020817|FG004|Overall Study|Lost to Follow-up|1|||
131928156|NCT00621322|475020818|FG005|Overall Study|Lost to Follow-up|0|||
131928157|NCT00621322|475020813|FG000|Overall Study|Physician Decision|0|||
131928158|NCT00621322|475020814|FG001|Overall Study|Physician Decision|0|||
131928159|NCT00621322|475020815|FG002|Overall Study|Physician Decision|1|||
131928160|NCT00621322|475020816|FG003|Overall Study|Physician Decision|1|||
131928161|NCT00621322|475020817|FG004|Overall Study|Physician Decision|0|||
131928162|NCT00621322|475020818|FG005|Overall Study|Physician Decision|0|||
131928163|NCT00621322|475020813|FG000|Overall Study|Withdrawal by Subject|0|||
131928164|NCT00621322|475020814|FG001|Overall Study|Withdrawal by Subject|0|||
131928165|NCT00621322|475020815|FG002|Overall Study|Withdrawal by Subject|0|||
131928166|NCT00621322|475020816|FG003|Overall Study|Withdrawal by Subject|1|||
131928167|NCT00621322|475020817|FG004|Overall Study|Withdrawal by Subject|0|||
131928168|NCT00621322|475020818|FG005|Overall Study|Withdrawal by Subject|2|||
131928169|NCT00621322|475020813|FG000|Overall Study|Migrated/moved from study area|1|||
131928170|NCT00621322|475020814|FG001|Overall Study|Migrated/moved from study area|0|||
131928171|NCT00621322|475020815|FG002|Overall Study|Migrated/moved from study area|1|||
131928172|NCT00621322|475020816|FG003|Overall Study|Migrated/moved from study area|1|||
131928173|NCT00621322|475020817|FG004|Overall Study|Migrated/moved from study area|0|||
131928174|NCT00621322|475020818|FG005|Overall Study|Migrated/moved from study area|2|||
131928175|NCT01655069|475020827|FG000|Overall Study|Physician Decision|0|||
131928176|NCT01655069|475020828|FG001|Overall Study|Physician Decision|0|||
131928177|NCT01655069|475020829|FG002|Overall Study|Physician Decision|0|||
131928178|NCT01655069|475020830|FG003|Overall Study|Physician Decision|1|||
131928179|NCT01655069|475020827|FG000|Overall Study|Adverse Event|6|||
131928180|NCT01655069|475020828|FG001|Overall Study|Adverse Event|7|||
131928181|NCT01655069|475020829|FG002|Overall Study|Adverse Event|2|||
131928182|NCT01655069|475020830|FG003|Overall Study|Adverse Event|3|||
131928183|NCT01655069|475020827|FG000|Overall Study|Lack of Efficacy|0|||
131928184|NCT01655069|475020828|FG001|Overall Study|Lack of Efficacy|1|||
131928185|NCT01655069|475020829|FG002|Overall Study|Lack of Efficacy|0|||
131928186|NCT01655069|475020830|FG003|Overall Study|Lack of Efficacy|0|||
131928187|NCT01655069|475020827|FG000|Overall Study|No Treatment Needed|0|||
131928188|NCT01655069|475020828|FG001|Overall Study|No Treatment Needed|1|||
131928189|NCT01655069|475020829|FG002|Overall Study|No Treatment Needed|0|||
131928190|NCT01655069|475020830|FG003|Overall Study|No Treatment Needed|0|||
131928191|NCT01655069|475020827|FG000|Overall Study|Withdrawal by Subject|2|||
131928192|NCT01655069|475020828|FG001|Overall Study|Withdrawal by Subject|3|||
131928193|NCT01655069|475020829|FG002|Overall Study|Withdrawal by Subject|0|||
131928194|NCT01655069|475020830|FG003|Overall Study|Withdrawal by Subject|0|||
131928195|NCT00986102|475020831|FG000|Overall Study|Lost to Follow-up|0|||
131928196|NCT00986102|475020832|FG001|Overall Study|Lost to Follow-up|1|||
131928197|NCT00986102|475020833|FG002|Overall Study|Lost to Follow-up|0|||
131928198|NCT00986102|475020834|FG003|Overall Study|Lost to Follow-up|1|||
131928199|NCT00986102|475020831|FG000|Overall Study|Withdrawal by Subject|1|||
131928200|NCT00986102|475020832|FG001|Overall Study|Withdrawal by Subject|1|||
131928201|NCT00986102|475020833|FG002|Overall Study|Withdrawal by Subject|0|||
131410212|NCT01286987|473124805|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
131410213|NCT01286987|473124791|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
131410214|NCT01286987|473124792|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
131410215|NCT01286987|473124793|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
131410216|NCT01286987|473124794|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
131410217|NCT01286987|473124795|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
131410218|NCT01286987|473124796|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
131410219|NCT01286987|473124797|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
131928202|NCT00986102|475020834|FG003|Overall Study|Withdrawal by Subject|0|||
131928203|NCT00147537|475020838|FG000|Phase 1b|Death|0|||
131928204|NCT00147537|475020839|FG001|Phase 1b|Death|1|||
131928205|NCT00147537|475020840|FG002|Phase 1b|Death|2|||
131928206|NCT00147537|475020841|FG003|Phase 1b|Death|1|||
131928207|NCT00147537|475020842|FG004|Phase 1b|Death|2|||
131928208|NCT00147537|475020843|FG005|Phase 1b|Death|2|||
131928209|NCT00147537|475020844|FG006|Phase 1b|Death|1|||
131928210|NCT00147537|475020845|FG007|Phase 1b|Death|3|||
131928211|NCT00147537|475020846|FG008|Phase 1b|Death|9|||
131928212|NCT00147537|475020847|FG009|Phase 1b|Death|0|||
131928213|NCT00147537|475020848|FG010|Phase 1b|Death|0|||
131928214|NCT00147537|475020838|FG000|Phase 1b|Lost to Follow-up|2|||
131928215|NCT00147537|475020839|FG001|Phase 1b|Lost to Follow-up|1|||
131928216|NCT00147537|475020840|FG002|Phase 1b|Lost to Follow-up|0|||
131928217|NCT00147537|475020841|FG003|Phase 1b|Lost to Follow-up|0|||
131928218|NCT00147537|475020842|FG004|Phase 1b|Lost to Follow-up|0|||
131928219|NCT00147537|475020843|FG005|Phase 1b|Lost to Follow-up|0|||
131928220|NCT00147537|475020844|FG006|Phase 1b|Lost to Follow-up|2|||
131928221|NCT00147537|475020845|FG007|Phase 1b|Lost to Follow-up|0|||
131928222|NCT00147537|475020846|FG008|Phase 1b|Lost to Follow-up|1|||
131928223|NCT00147537|475020847|FG009|Phase 1b|Lost to Follow-up|0|||
131928224|NCT00147537|475020848|FG010|Phase 1b|Lost to Follow-up|0|||
131928225|NCT00147537|475020838|FG000|Phase 1b|Other|0|||
131928226|NCT00147537|475020839|FG001|Phase 1b|Other|0|||
131928227|NCT00147537|475020840|FG002|Phase 1b|Other|2|||
131928228|NCT00147537|475020841|FG003|Phase 1b|Other|1|||
131928229|NCT00147537|475020842|FG004|Phase 1b|Other|1|||
131928230|NCT00147537|475020843|FG005|Phase 1b|Other|1|||
131928231|NCT00147537|475020844|FG006|Phase 1b|Other|14|||
131928232|NCT00147537|475020845|FG007|Phase 1b|Other|4|||
131928233|NCT00147537|475020846|FG008|Phase 1b|Other|4|||
131928234|NCT00147537|475020847|FG009|Phase 1b|Other|0|||
131928235|NCT00147537|475020848|FG010|Phase 1b|Other|0|||
131928236|NCT00147537|475020838|FG000|Phase 1b|Withdrawal by Subject|0|||
131928237|NCT00147537|475020839|FG001|Phase 1b|Withdrawal by Subject|0|||
131928238|NCT00147537|475020840|FG002|Phase 1b|Withdrawal by Subject|0|||
131928239|NCT00147537|475020841|FG003|Phase 1b|Withdrawal by Subject|0|||
131928240|NCT00147537|475020842|FG004|Phase 1b|Withdrawal by Subject|0|||
131928241|NCT00147537|475020843|FG005|Phase 1b|Withdrawal by Subject|0|||
131928242|NCT00147537|475020844|FG006|Phase 1b|Withdrawal by Subject|0|||
131928243|NCT00147537|475020845|FG007|Phase 1b|Withdrawal by Subject|0|||
131928244|NCT00147537|475020846|FG008|Phase 1b|Withdrawal by Subject|2|||
131928245|NCT00147537|475020847|FG009|Phase 1b|Withdrawal by Subject|0|||
131928246|NCT00147537|475020848|FG010|Phase 1b|Withdrawal by Subject|0|||
131928247|NCT00147537|475020838|FG000|Phase 1b|Randomized but not treated|0|||
131928248|NCT00147537|475020839|FG001|Phase 1b|Randomized but not treated|0|||
131928249|NCT00147537|475020840|FG002|Phase 1b|Randomized but not treated|0|||
131928250|NCT00147537|475020841|FG003|Phase 1b|Randomized but not treated|0|||
131928251|NCT00147537|475020842|FG004|Phase 1b|Randomized but not treated|0|||
131928252|NCT00147537|475020843|FG005|Phase 1b|Randomized but not treated|0|||
131928253|NCT00147537|475020844|FG006|Phase 1b|Randomized but not treated|1|||
131928254|NCT00147537|475020845|FG007|Phase 1b|Randomized but not treated|0|||
131928255|NCT00147537|475020846|FG008|Phase 1b|Randomized but not treated|1|||
131928256|NCT00147537|475020847|FG009|Phase 1b|Randomized but not treated|0|||
131928257|NCT00147537|475020848|FG010|Phase 1b|Randomized but not treated|0|||
131928258|NCT00147537|475020838|FG000|Phase 2|Death|0|||
131928259|NCT00147537|475020839|FG001|Phase 2|Death|0|||
131928260|NCT00147537|475020840|FG002|Phase 2|Death|0|||
131928261|NCT00147537|475020841|FG003|Phase 2|Death|0|||
131928262|NCT00147537|475020842|FG004|Phase 2|Death|0|||
131928263|NCT00147537|475020843|FG005|Phase 2|Death|0|||
131928264|NCT00147537|475020844|FG006|Phase 2|Death|0|||
131928265|NCT00147537|475020845|FG007|Phase 2|Death|0|||
131928266|NCT00147537|475020846|FG008|Phase 2|Death|0|||
131928267|NCT00147537|475020847|FG009|Phase 2|Death|85|||
131928268|NCT00147537|475020848|FG010|Phase 2|Death|31|||
131928269|NCT00147537|475020838|FG000|Phase 2|Lost to Follow-up|0|||
131928270|NCT00147537|475020839|FG001|Phase 2|Lost to Follow-up|0|||
131928271|NCT00147537|475020840|FG002|Phase 2|Lost to Follow-up|0|||
131928272|NCT00147537|475020841|FG003|Phase 2|Lost to Follow-up|0|||
131928273|NCT00147537|475020842|FG004|Phase 2|Lost to Follow-up|0|||
131928274|NCT00147537|475020843|FG005|Phase 2|Lost to Follow-up|0|||
131928275|NCT00147537|475020844|FG006|Phase 2|Lost to Follow-up|0|||
131928276|NCT00147537|475020845|FG007|Phase 2|Lost to Follow-up|0|||
131928277|NCT00147537|475020846|FG008|Phase 2|Lost to Follow-up|0|||
131928278|NCT00147537|475020847|FG009|Phase 2|Lost to Follow-up|12|||
131928279|NCT00147537|475020848|FG010|Phase 2|Lost to Follow-up|4|||
131928280|NCT00147537|475020838|FG000|Phase 2|Other|0|||
131928281|NCT00147537|475020839|FG001|Phase 2|Other|0|||
131410220|NCT01286987|473124798|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
131410221|NCT01286987|473124799|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
131928282|NCT00147537|475020840|FG002|Phase 2|Other|0|||
131928283|NCT00147537|475020841|FG003|Phase 2|Other|0|||
131928284|NCT00147537|475020842|FG004|Phase 2|Other|0|||
131928285|NCT00147537|475020843|FG005|Phase 2|Other|0|||
131928286|NCT00147537|475020844|FG006|Phase 2|Other|0|||
131928287|NCT00147537|475020845|FG007|Phase 2|Other|0|||
131928288|NCT00147537|475020846|FG008|Phase 2|Other|0|||
131928289|NCT00147537|475020847|FG009|Phase 2|Other|47|||
131928290|NCT00147537|475020848|FG010|Phase 2|Other|12|||
131928291|NCT00147537|475020838|FG000|Phase 2|Withdrawal by Subject|0|||
131928292|NCT00147537|475020839|FG001|Phase 2|Withdrawal by Subject|0|||
131928293|NCT00147537|475020840|FG002|Phase 2|Withdrawal by Subject|0|||
131928294|NCT00147537|475020841|FG003|Phase 2|Withdrawal by Subject|0|||
131928295|NCT00147537|475020842|FG004|Phase 2|Withdrawal by Subject|0|||
131928296|NCT00147537|475020843|FG005|Phase 2|Withdrawal by Subject|0|||
131928297|NCT00147537|475020844|FG006|Phase 2|Withdrawal by Subject|0|||
131928298|NCT00147537|475020845|FG007|Phase 2|Withdrawal by Subject|0|||
131928299|NCT00147537|475020846|FG008|Phase 2|Withdrawal by Subject|0|||
131928300|NCT00147537|475020847|FG009|Phase 2|Withdrawal by Subject|16|||
131928301|NCT00147537|475020848|FG010|Phase 2|Withdrawal by Subject|4|||
131928302|NCT00147537|475020838|FG000|Phase 2|Randomized but not treated|0|||
131928303|NCT00147537|475020839|FG001|Phase 2|Randomized but not treated|0|||
131928304|NCT00147537|475020840|FG002|Phase 2|Randomized but not treated|0|||
131928305|NCT00147537|475020841|FG003|Phase 2|Randomized but not treated|0|||
131928306|NCT00147537|475020842|FG004|Phase 2|Randomized but not treated|0|||
131928307|NCT00147537|475020843|FG005|Phase 2|Randomized but not treated|0|||
131928308|NCT00147537|475020844|FG006|Phase 2|Randomized but not treated|0|||
131928309|NCT00147537|475020845|FG007|Phase 2|Randomized but not treated|0|||
131928310|NCT00147537|475020846|FG008|Phase 2|Randomized but not treated|0|||
131928311|NCT00147537|475020847|FG009|Phase 2|Randomized but not treated|1|||
131928312|NCT00147537|475020848|FG010|Phase 2|Randomized but not treated|1|||
131928313|NCT00345592|475020849|FG000|Overall Study|Death|14|||
131928314|NCT00345592|475020850|FG001|Overall Study|Death|16|||
131928315|NCT00345592|475020849|FG000|Overall Study|Withdrawal by Subject|11|||
131928316|NCT00345592|475020850|FG001|Overall Study|Withdrawal by Subject|8|||
131928317|NCT02006654|475020852|FG000|Overall Study|Withdrawal before treatment|4|||
131928318|NCT02006654|475020853|FG001|Overall Study|Withdrawal before treatment|2|||
131928319|NCT02006654|475020852|FG000|Overall Study|Adverse Event|16|||
131928320|NCT02006654|475020853|FG001|Overall Study|Adverse Event|17|||
131928321|NCT02006654|475020852|FG000|Overall Study|Death|1|||
131928322|NCT02006654|475020853|FG001|Overall Study|Death|0|||
131928323|NCT02006654|475020852|FG000|Overall Study|Withdrawal by Subject|14|||
131928324|NCT02006654|475020853|FG001|Overall Study|Withdrawal by Subject|12|||
131928325|NCT02006654|475020852|FG000|Overall Study|Protocol Violation|5|||
131928326|NCT02006654|475020853|FG001|Overall Study|Protocol Violation|8|||
131928327|NCT02006654|475020852|FG000|Overall Study|Lost to Follow-up|1|||
131928328|NCT02006654|475020853|FG001|Overall Study|Lost to Follow-up|0|||
131928329|NCT02006654|475020852|FG000|Overall Study|patient's will|2|||
131928330|NCT02006654|475020853|FG001|Overall Study|patient's will|1|||
131928331|NCT02006654|475020852|FG000|Overall Study|insufficient compliance|1|||
131928332|NCT02006654|475020853|FG001|Overall Study|insufficient compliance|0|||
131928333|NCT02006654|475020852|FG000|Overall Study|worsening cognitive condition|0|||
131928334|NCT02006654|475020853|FG001|Overall Study|worsening cognitive condition|1|||
131928335|NCT02006654|475020852|FG000|Overall Study|faecal incontinence|0|||
131928336|NCT02006654|475020853|FG001|Overall Study|faecal incontinence|1|||
131928337|NCT02006654|475020852|FG000|Overall Study|mood disorder|0|||
131928338|NCT02006654|475020853|FG001|Overall Study|mood disorder|1|||
131928339|NCT02006654|475020852|FG000|Overall Study|disallowed medication|1|||
131928340|NCT02006654|475020853|FG001|Overall Study|disallowed medication|0|||
131928341|NCT02006654|475020852|FG000|Overall Study|moving out of state|0|||
131928342|NCT02006654|475020853|FG001|Overall Study|moving out of state|1|||
131928343|NCT00478140|475020854|FG000|Overall Study|Clinical Disease Progression|1|||
131928344|NCT03438656|475020855|FG000|Overall Study|Lost to Follow-up|2|||
131928345|NCT03721965|475020856|FG000|Overall Study|Death|1|||
131928346|NCT03721965|475020856|FG000|Overall Study|Study Terminated by Sponsor|1|||
131928347|NCT00563316|475020857|FG000|Overall Study|Adverse Event|2|||
131928348|NCT00563316|475020857|FG000|Overall Study|Physician Decision|1|||
131928349|NCT00563316|475020857|FG000|Overall Study|Lost to Follow-up|2|||
131928350|NCT00563316|475020857|FG000|Overall Study|Death|1|||
131928351|NCT00563316|475020857|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
131410222|NCT01286987|473124800|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
131410223|NCT01286987|473124801|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
131928352|NCT00563316|475020857|FG000|Overall Study|Other|1|||
131928353|NCT01793129|475022371|FG000|Overall Study|Lost to Follow-up|3|||
131928354|NCT01793129|475022372|FG001|Overall Study|Lost to Follow-up|7|||
131928355|NCT01793129|475022371|FG000|Overall Study|Withdrawal by Subject|0|||
131928356|NCT01793129|475022372|FG001|Overall Study|Withdrawal by Subject|2|||
131928357|NCT03004183|475022375|FG000|Overall Study|Adverse Event|7|||
131928358|NCT03004183|475022375|FG000|Overall Study|Lost to Follow-up|1|||
131928359|NCT03004183|475022375|FG000|Overall Study|Physician Decision|40|||
131928360|NCT03004183|475022375|FG000|Overall Study|Withdrawal by Subject|1|||
131410224|NCT01286987|473124802|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
131928361|NCT03004183|475022375|FG000|Overall Study|COVID-19|1|||
131928362|NCT02529488|475022376|FG000|Overall Study|Adverse Event|1|||
131928363|NCT02529488|475022376|FG000|Overall Study|Death|3|||
131928364|NCT02698787|475022377|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
131928365|NCT02698787|475022378|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
131928366|NCT02562040|475022388|FG000|Overall Study|Lost to Follow-up|20|||
131928367|NCT02562040|475022389|FG001|Overall Study|Lost to Follow-up|28|||
131928368|NCT02562040|475022388|FG000|Overall Study|Withdrawal by Subject|8|||
131928369|NCT02562040|475022389|FG001|Overall Study|Withdrawal by Subject|7|||
131928370|NCT02562040|475022388|FG000|Overall Study|Adverse Event|1|||
131928371|NCT02562040|475022389|FG001|Overall Study|Adverse Event|0|||
131928372|NCT01902303|475022390|FG000|Overall Study|Adverse Event|0|||
131928373|NCT01902303|475022391|FG001|Overall Study|Adverse Event|1|||
131928374|NCT01902303|475022390|FG000|Overall Study|Lost to Follow-up|0|||
131928375|NCT01902303|475022391|FG001|Overall Study|Lost to Follow-up|1|||
131928376|NCT01902303|475022390|FG000|Overall Study|Protocol Violation|2|||
131928377|NCT01902303|475022391|FG001|Overall Study|Protocol Violation|2|||
131928378|NCT01902303|475022390|FG000|Overall Study|subject lost investigational product|0|||
131928379|NCT01902303|475022391|FG001|Overall Study|subject lost investigational product|1|||
131928380|NCT01902303|475022390|FG000|Overall Study|Did not develop a cold sore|21|||
131928381|NCT01902303|475022391|FG001|Overall Study|Did not develop a cold sore|19|||
131928382|NCT02821000|475022392|FG000|Overall Study|Death|89|||
131928383|NCT02821000|475022392|FG000|Overall Study|Sponsor Decision|12|||
131928384|NCT02821000|475022392|FG000|Overall Study|Withdrawal by Subject|2|||
131928385|NCT00326495|475022393|FG000|Overall Study|Switched to alternative treatment|1|||
131928386|NCT00326495|475022393|FG000|Overall Study|Disease progression before treatment|1|||
131928387|NCT00326495|475022393|FG000|Overall Study|Refused further treatment|2|||
131928388|NCT00326495|475022393|FG000|Overall Study|Subject off study before assessment|1|||
131928389|NCT02933151|475022394|FG000|Overall Study|Lost to Follow-up|19|||
131928390|NCT02933151|475022395|FG001|Overall Study|Lost to Follow-up|18|||
131928391|NCT02933151|475022394|FG000|Overall Study|Death|1732|||
131928392|NCT02933151|475022395|FG001|Overall Study|Death|1827|||
131928393|NCT02933151|475022394|FG000|Overall Study|Transplant|210|||
131928394|NCT02933151|475022395|FG001|Overall Study|Transplant|278|||
131928395|NCT02933151|475022394|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
131928396|NCT02933151|475022395|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
131928397|NCT02933151|475022394|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
131928398|NCT02933151|475022395|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
131928399|NCT02933151|475022394|FG000|Overall Study|Recovered Kidney Function|47|||
131928400|NCT02933151|475022395|FG001|Overall Study|Recovered Kidney Function|29|||
131928401|NCT01428713|475022396|FG000|Overall Study|Non-compliance|2|||
131928402|NCT01428713|475022397|FG001|Overall Study|Non-compliance|2|||
131928403|NCT01428713|475022396|FG000|Overall Study|Withdrawal by Subject|1|||
131928404|NCT01428713|475022397|FG001|Overall Study|Withdrawal by Subject|1|||
131928405|NCT01428713|475022396|FG000|Overall Study|Adverse Event|0|||
131928406|NCT01428713|475022397|FG001|Overall Study|Adverse Event|2|||
131928407|NCT00432991|475022398|FG000|Overall Study|Protocol Violation|7|||
131928408|NCT00432991|475022399|FG001|Overall Study|Protocol Violation|12|||
131928409|NCT03142451|475022409|FG000|Overall Study|Adverse Event|5|||
131928410|NCT03142451|475022410|FG001|Overall Study|Adverse Event|2|||
131928411|NCT03142451|475022409|FG000|Overall Study|Lost to Follow-up|25|||
131928412|NCT03142451|475022410|FG001|Overall Study|Lost to Follow-up|8|||
131928413|NCT03142451|475022409|FG000|Overall Study|Participant request|24|||
131928414|NCT03142451|475022410|FG001|Overall Study|Participant request|12|||
131928415|NCT03142451|475022409|FG000|Overall Study|Protocol Violation|3|||
131928416|NCT03142451|475022410|FG001|Overall Study|Protocol Violation|1|||
131928417|NCT03142451|475022409|FG000|Overall Study|Other|1|||
131928418|NCT03142451|475022410|FG001|Overall Study|Other|1|||
131928419|NCT00090402|475022411|FG000|Overall Study|Death|1|||
131928420|NCT00090402|475022412|FG001|Overall Study|Death|1|||
131928421|NCT00090402|475022413|FG002|Overall Study|Death|0|||
131928422|NCT00090402|475022411|FG000|Overall Study|subject moved|0|||
131928423|NCT00090402|475022412|FG001|Overall Study|subject moved|1|||
131928424|NCT00090402|475022413|FG002|Overall Study|subject moved|0|||
131928425|NCT00090402|475022411|FG000|Overall Study|stopped taking study medication|1|||
131928426|NCT00090402|475022412|FG001|Overall Study|stopped taking study medication|0|||
131928427|NCT00090402|475022413|FG002|Overall Study|stopped taking study medication|1|||
131928428|NCT04621786|475022426|FG000|Overall Study|Lost to Follow-up|9|||
131928429|NCT04621786|475022426|FG000|Overall Study|Protocol Violation|3|||
131928430|NCT00397046|475022427|FG000|Overall Study|Disease Progression|3|||
131928431|NCT00397046|475022428|FG001|Overall Study|Disease Progression|3|||
131928432|NCT00397046|475022429|FG002|Overall Study|Disease Progression|10|||
131928433|NCT00397046|475022430|FG003|Overall Study|Disease Progression|5|||
131928434|NCT00493285|475022436|FG000|Overall Study|Lost to Follow-up|0|||
131928435|NCT00493285|475022437|FG001|Overall Study|Lost to Follow-up|0|||
131928436|NCT00493285|475022438|FG002|Overall Study|Lost to Follow-up|0|||
131928437|NCT00493285|475022439|FG003|Overall Study|Lost to Follow-up|0|||
131928438|NCT00493285|475022440|FG004|Overall Study|Lost to Follow-up|1|||
131928439|NCT00493285|475022441|FG005|Overall Study|Lost to Follow-up|0|||
131928440|NCT04535362|475022442|FG000|Overall Study|Lost to Follow-up|3|||
131928441|NCT04535362|475022443|FG001|Overall Study|Lost to Follow-up|1|||
131928442|NCT03791060|475022444|FG000|Overall Study|Withdrawal by Subject|1|||
131928443|NCT03774810|475022445|FG000|Phase 1|Lack of Efficacy|21|||
131928444|NCT03774810|475022446|FG001|Phase 1|Lack of Efficacy|0|||
131928445|NCT03774810|475022447|FG002|Phase 1|Lack of Efficacy|0|||
131928446|NCT03774810|475022448|FG003|Phase 1|Lack of Efficacy|0|||
131928447|NCT03774810|475022449|FG004|Phase 1|Lack of Efficacy|0|||
131928448|NCT03774810|475022445|FG000|Phase 1|Withdrawal by Subject|9|||
131928449|NCT03774810|475022446|FG001|Phase 1|Withdrawal by Subject|0|||
131928450|NCT03774810|475022447|FG002|Phase 1|Withdrawal by Subject|0|||
131410225|NCT01286987|473124803|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
131410226|NCT01286987|473124804|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
131410227|NCT01286987|473124805|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
131410228|NCT01286987|473124791|FG000|Part 1: Dose Escalation|Physician Decision|0|||
131410229|NCT01286987|473124792|FG001|Part 1: Dose Escalation|Physician Decision|0|||
131410230|NCT01286987|473124793|FG002|Part 1: Dose Escalation|Physician Decision|0|||
131410231|NCT01286987|473124794|FG003|Part 1: Dose Escalation|Physician Decision|0|||
131410232|NCT01286987|473124795|FG004|Part 1: Dose Escalation|Physician Decision|1|||
131410233|NCT01286987|473124796|FG005|Part 1: Dose Escalation|Physician Decision|0|||
131410234|NCT01286987|473124797|FG006|Part 1: Dose Escalation|Physician Decision|0|||
131410235|NCT01286987|473124798|FG007|Part 1: Dose Escalation|Physician Decision|0|||
131410236|NCT01286987|473124799|FG008|Part 1: Dose Escalation|Physician Decision|0|||
131410237|NCT01286987|473124800|FG009|Part 1: Dose Escalation|Physician Decision|0|||
131410238|NCT01286987|473124801|FG010|Part 1: Dose Escalation|Physician Decision|0|||
131410239|NCT01286987|473124802|FG011|Part 1: Dose Escalation|Physician Decision|0|||
131410240|NCT01286987|473124803|FG012|Part 1: Dose Escalation|Physician Decision|0|||
131410241|NCT01286987|473124804|FG013|Part 1: Dose Escalation|Physician Decision|0|||
131410242|NCT01286987|473124805|FG014|Part 1: Dose Escalation|Physician Decision|0|||
131410243|NCT01286987|473124791|FG000|Part 2: Dose Expansion|Death|0|||
131410244|NCT01286987|473124792|FG001|Part 2: Dose Expansion|Death|0|||
131410245|NCT01286987|473124793|FG002|Part 2: Dose Expansion|Death|0|||
131928451|NCT03774810|475022448|FG003|Phase 1|Withdrawal by Subject|0|||
131928452|NCT03774810|475022449|FG004|Phase 1|Withdrawal by Subject|0|||
131928453|NCT03774810|475022445|FG000|Phase 1|Lost to Follow-up|2|||
131928454|NCT03774810|475022446|FG001|Phase 1|Lost to Follow-up|0|||
131928455|NCT03774810|475022447|FG002|Phase 1|Lost to Follow-up|0|||
131928456|NCT03774810|475022448|FG003|Phase 1|Lost to Follow-up|0|||
131928457|NCT03774810|475022449|FG004|Phase 1|Lost to Follow-up|0|||
131928458|NCT03774810|475022445|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
131928459|NCT03774810|475022446|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
131928460|NCT03774810|475022447|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
131928461|NCT03774810|475022448|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
131928462|NCT03774810|475022449|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
131928463|NCT03774810|475022445|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
131928464|NCT03774810|475022446|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
131928465|NCT03774810|475022447|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
131928466|NCT03774810|475022448|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
131928467|NCT03774810|475022449|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
131928468|NCT03774810|475022445|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
131928469|NCT03774810|475022446|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
131928470|NCT03774810|475022447|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
131928471|NCT03774810|475022448|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
131928472|NCT03774810|475022449|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
131928473|NCT03774810|475022445|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
131928474|NCT03774810|475022446|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
131928475|NCT03774810|475022447|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
131928476|NCT03774810|475022448|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
131928477|NCT03774810|475022449|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
131928478|NCT03774810|475022445|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
131928479|NCT03774810|475022446|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
131928480|NCT03774810|475022447|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
131928481|NCT03774810|475022448|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
131928482|NCT03774810|475022449|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
131928483|NCT03774810|475022445|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
131928484|NCT03774810|475022446|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
131928485|NCT03774810|475022447|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
131928486|NCT03774810|475022448|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
131928487|NCT03774810|475022449|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
131928488|NCT00474968|475022455|FG000|Overall Study|Withdrawal by Subject|8|||
131410246|NCT01286987|473124794|FG003|Part 2: Dose Expansion|Death|0|||
131410247|NCT01286987|473124795|FG004|Part 2: Dose Expansion|Death|0|||
131410248|NCT01286987|473124796|FG005|Part 2: Dose Expansion|Death|0|||
131410249|NCT01286987|473124797|FG006|Part 2: Dose Expansion|Death|0|||
131410250|NCT01286987|473124798|FG007|Part 2: Dose Expansion|Death|0|||
131928489|NCT00474968|475022456|FG001|Overall Study|Withdrawal by Subject|7|||
131928490|NCT00474968|475022455|FG000|Overall Study|Protocol Violation|9|||
131928491|NCT00474968|475022456|FG001|Overall Study|Protocol Violation|8|||
131928492|NCT00474968|475022455|FG000|Overall Study|Sample not collected|1|||
131928493|NCT00474968|475022456|FG001|Overall Study|Sample not collected|1|||
131928494|NCT00981175|475022457|FG000|Primary Dose Vaccination|Adverse Event|1|||
131410251|NCT01286987|473124799|FG008|Part 2: Dose Expansion|Death|0|||
131410252|NCT01286987|473124800|FG009|Part 2: Dose Expansion|Death|0|||
131410253|NCT01286987|473124801|FG010|Part 2: Dose Expansion|Death|0|||
131410254|NCT01286987|473124802|FG011|Part 2: Dose Expansion|Death|0|||
131928495|NCT00981175|475022458|FG001|Primary Dose Vaccination|Adverse Event|0|||
131928496|NCT00981175|475022457|FG000|Primary Dose Vaccination|Protocol Violation|0|||
131928497|NCT00981175|475022458|FG001|Primary Dose Vaccination|Protocol Violation|1|||
131928498|NCT00981175|475022457|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
131928499|NCT00981175|475022458|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
131928500|NCT00981175|475022457|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
131928501|NCT00981175|475022458|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
131928502|NCT02619812|475022459|FG000|Overall Study|Withdrawal by Subject|0|||
131928503|NCT02619812|475022460|FG001|Overall Study|Withdrawal by Subject|0|||
131928504|NCT02619812|475022461|FG002|Overall Study|Withdrawal by Subject|1|||
131928505|NCT02619812|475022462|FG003|Overall Study|Withdrawal by Subject|2|||
131928506|NCT04189588|475022464|FG000|Overall Study|Death|0|||
131928507|NCT04189588|475022465|FG001|Overall Study|Death|1|||
131928508|NCT04189588|475022464|FG000|Overall Study|Lost to Follow-up|0|||
131928509|NCT04189588|475022465|FG001|Overall Study|Lost to Follow-up|1|||
131928510|NCT01658735|475022466|FG000|Overall Study|Lack of Efficacy|1|||
131928511|NCT01658735|475022467|FG001|Overall Study|Lack of Efficacy|0|||
131928512|NCT01658735|475022468|FG002|Overall Study|Lack of Efficacy|1|||
131928513|NCT01658735|475022466|FG000|Overall Study|Lost to Follow-up|1|||
131928514|NCT01658735|475022467|FG001|Overall Study|Lost to Follow-up|1|||
131928515|NCT01658735|475022468|FG002|Overall Study|Lost to Follow-up|0|||
131928516|NCT01658735|475022466|FG000|Overall Study|Protocol Violation|0|||
131928517|NCT01658735|475022467|FG001|Overall Study|Protocol Violation|1|||
131928518|NCT01658735|475022468|FG002|Overall Study|Protocol Violation|0|||
131928519|NCT01658735|475022466|FG000|Overall Study|Withdrawal by Subject|3|||
131928520|NCT01658735|475022467|FG001|Overall Study|Withdrawal by Subject|5|||
131928521|NCT01658735|475022468|FG002|Overall Study|Withdrawal by Subject|3|||
131928522|NCT03156621|475022469|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
131928523|NCT03156621|475022470|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
131928524|NCT03156621|475022469|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
131928525|NCT03156621|475022470|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
131928526|NCT01379937|475022471|FG000|Overall Study|Protocol Violation|0|||
131928527|NCT01379937|475022472|FG001|Overall Study|Protocol Violation|0|||
131928528|NCT01379937|475022473|FG002|Overall Study|Protocol Violation|0|||
131928529|NCT01379937|475022474|FG003|Overall Study|Protocol Violation|1|||
131928530|NCT01379937|475022471|FG000|Overall Study|Consent withdrawal|0|||
131928531|NCT01379937|475022472|FG001|Overall Study|Consent withdrawal|1|||
131928532|NCT01379937|475022473|FG002|Overall Study|Consent withdrawal|0|||
131928533|NCT01379937|475022474|FG003|Overall Study|Consent withdrawal|0|||
131928534|NCT01379937|475022471|FG000|Overall Study|Lost to Follow-up|1|||
131928535|NCT01379937|475022472|FG001|Overall Study|Lost to Follow-up|2|||
131928536|NCT01379937|475022473|FG002|Overall Study|Lost to Follow-up|2|||
131928537|NCT01379937|475022474|FG003|Overall Study|Lost to Follow-up|0|||
131928538|NCT04985682|475022475|FG000|Overall Study|Withdrawal by Subject|1|||
131928539|NCT00079781|475022487|FG000|Pre-implant Period|Withdrawal by Subject|2|||
131928540|NCT00079781|475022488|FG001|Pre-implant Period|Withdrawal by Subject|0|||
131928541|NCT00079781|475022489|FG002|Pre-implant Period|Withdrawal by Subject|0|||
131928542|NCT00079781|475022487|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
131928543|NCT00079781|475022488|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
131928544|NCT00079781|475022489|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
131928545|NCT00079781|475022487|FG000|Follow-up Period|Withdrawal by Subject|3|||
131928546|NCT00079781|475022488|FG001|Follow-up Period|Withdrawal by Subject|0|||
131928547|NCT00079781|475022489|FG002|Follow-up Period|Withdrawal by Subject|1|||
131928548|NCT00079781|475022487|FG000|Follow-up Period|Lost to Follow-up|1|||
131928549|NCT00079781|475022488|FG001|Follow-up Period|Lost to Follow-up|0|||
131928550|NCT00079781|475022489|FG002|Follow-up Period|Lost to Follow-up|0|||
131928551|NCT00079781|475022487|FG000|Follow-up Period|Death|0|||
131928552|NCT00079781|475022488|FG001|Follow-up Period|Death|0|||
131928553|NCT00079781|475022489|FG002|Follow-up Period|Death|1|||
131928554|NCT04641975|475022490|FG000|Overall Study|Protocol Violation|1|||
131928555|NCT04641975|475022491|FG001|Overall Study|Protocol Violation|2|||
131928556|NCT04641975|475022492|FG002|Overall Study|Protocol Violation|0|||
131928557|NCT04641975|475022493|FG003|Overall Study|Protocol Violation|0|||
131928558|NCT04641975|475022490|FG000|Overall Study|Adverse Event|0|||
131928559|NCT04641975|475022491|FG001|Overall Study|Adverse Event|0|||
131928560|NCT04641975|475022492|FG002|Overall Study|Adverse Event|1|||
131928561|NCT04641975|475022493|FG003|Overall Study|Adverse Event|1|||
131928562|NCT04641975|475022490|FG000|Overall Study|Withdrawal by Subject|1|||
131928563|NCT04641975|475022491|FG001|Overall Study|Withdrawal by Subject|0|||
131928564|NCT04641975|475022492|FG002|Overall Study|Withdrawal by Subject|0|||
131928565|NCT04641975|475022493|FG003|Overall Study|Withdrawal by Subject|0|||
131928566|NCT01259024|475022496|FG000|Overall Study|Physician Decision|1|||
131410255|NCT01286987|473124803|FG012|Part 2: Dose Expansion|Death|1|||
131928567|NCT01657500|475022497|FG000|Overall Study|set impropperly matched|3|||
131928568|NCT01657500|475022498|FG001|Overall Study|set impropperly matched|3|||
131928569|NCT01657500|475022497|FG000|Overall Study|Lost to Follow-up|2|||
131928570|NCT01657500|475022498|FG001|Overall Study|Lost to Follow-up|2|||
131928571|NCT04034056|475022500|FG000|Overall Study|Withdrawal by Subject|2|||
131928572|NCT04034056|475022500|FG000|Overall Study|Reason Not Specified|13|||
131928573|NCT04034056|475022500|FG000|Overall Study|Adverse Event|56|||
131928574|NCT01248468|475022508|FG000|Overall Study|Administrative problem|1|||
131928575|NCT01248468|475022509|FG001|Overall Study|Administrative problem|0|||
131928576|NCT01248468|475022510|FG002|Overall Study|Administrative problem|0|||
131928577|NCT01248468|475022508|FG000|Overall Study|Lost to Follow-up|9|||
131928578|NCT01248468|475022509|FG001|Overall Study|Lost to Follow-up|12|||
131928579|NCT01248468|475022510|FG002|Overall Study|Lost to Follow-up|4|||
131928580|NCT01248468|475022508|FG000|Overall Study|Pregnancy|1|||
131928581|NCT01248468|475022509|FG001|Overall Study|Pregnancy|0|||
131928582|NCT01248468|475022510|FG002|Overall Study|Pregnancy|0|||
131928583|NCT01248468|475022508|FG000|Overall Study|Withdrawal by Subject|4|||
131928584|NCT01248468|475022509|FG001|Overall Study|Withdrawal by Subject|2|||
131928585|NCT01248468|475022510|FG002|Overall Study|Withdrawal by Subject|0|||
131928586|NCT00472641|475022511|FG000|Overall Study|Lack of Efficacy|3|||
131928587|NCT00472641|475022511|FG000|Overall Study|Adverse Event|3|||
131928588|NCT00472641|475022511|FG000|Overall Study|Lost to Follow-up|1|||
131928589|NCT03111732|475022514|FG000|Overall Study|Enrolled in different study|1|||
131928590|NCT03111732|475022514|FG000|Overall Study|Progressive disease|3|||
131928591|NCT03111732|475022514|FG000|Overall Study|Withdrawal by Subject|1|||
131928592|NCT00800384|475022517|FG000|Overall Study|Withdrawal by Subject|24|||
131928593|NCT00800384|475022518|FG001|Overall Study|Withdrawal by Subject|17|||
131928594|NCT00800384|475022517|FG000|Overall Study|Lost to Follow-up|17|||
131928595|NCT00800384|475022518|FG001|Overall Study|Lost to Follow-up|26|||
131928596|NCT02151604|475022521|FG000|Overall Study|Lost to Follow-up|3|||
131928597|NCT02151604|475022521|FG000|Overall Study|Withdrawal by Subject|2|||
131928598|NCT02151604|475022521|FG000|Overall Study|Physician Decision|3|||
131928599|NCT02151604|475022521|FG000|Overall Study|Death|1|||
131928600|NCT03048019|475024409|FG000|Overall Study|Adverse Event|1|||
131928601|NCT03048019|475024410|FG001|Overall Study|Adverse Event|0|||
131454062|NCT04717336|473291875|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
131928602|NCT00862277|475024411|FG000|Overall Study|Protocol Violation|1|||
131928603|NCT00862277|475024412|FG001|Overall Study|Protocol Violation|2|||
131928604|NCT00862277|475024413|FG002|Overall Study|Protocol Violation|5|||
131928605|NCT00871000|475024414|FG000|Overall Study|Withdrawal by Subject|1|||
131928606|NCT00871000|475024415|FG001|Overall Study|Withdrawal by Subject|0|||
131928607|NCT01052428|475024416|FG000|Overall Study|Death|1|||
131928608|NCT01052428|475024417|FG001|Overall Study|Death|0|||
131928609|NCT01052428|475024416|FG000|Overall Study|Withdrawal by Subject|0|||
131928610|NCT01052428|475024417|FG001|Overall Study|Withdrawal by Subject|1|||
131928611|NCT00348374|475024418|FG000|Overall Study|Adverse Event|1|||
131928612|NCT00348374|475024419|FG001|Overall Study|Adverse Event|4|||
131928613|NCT00348374|475024418|FG000|Overall Study|Lost to Follow-up|1|||
131928614|NCT00348374|475024419|FG001|Overall Study|Lost to Follow-up|3|||
131928615|NCT00348374|475024418|FG000|Overall Study|Withdrawal by Subject|5|||
131928616|NCT00348374|475024419|FG001|Overall Study|Withdrawal by Subject|5|||
131928617|NCT00348374|475024418|FG000|Overall Study|Other|11|||
131928618|NCT00348374|475024419|FG001|Overall Study|Other|12|||
131928619|NCT00348374|475024418|FG000|Overall Study|ongoing at date of cutoff|1|||
131928620|NCT00348374|475024419|FG001|Overall Study|ongoing at date of cutoff|1|||
131928621|NCT00348374|475024418|FG000|Overall Study|randomized but did not receive treatment|0|||
131928622|NCT00348374|475024419|FG001|Overall Study|randomized but did not receive treatment|7|||
131928623|NCT00605657|475024428|FG000|Overall Study|Adverse Event|1|||
131928624|NCT00605657|475024428|FG000|Overall Study|Protocol Violation|1|||
131928625|NCT01104870|475024444|FG000|Overall Study|Adverse Event|1|||
131928626|NCT01104870|475024445|FG001|Overall Study|Adverse Event|1|||
131928627|NCT01104870|475024446|FG002|Overall Study|Adverse Event|0|||
131928628|NCT01104870|475024444|FG000|Overall Study|Death|0|||
131928629|NCT01104870|475024445|FG001|Overall Study|Death|0|||
131928630|NCT01104870|475024446|FG002|Overall Study|Death|1|||
131928631|NCT01104870|475024444|FG000|Overall Study|Withdrawal by Subject|0|||
131928632|NCT01104870|475024445|FG001|Overall Study|Withdrawal by Subject|0|||
131928633|NCT01104870|475024446|FG002|Overall Study|Withdrawal by Subject|1|||
131928634|NCT02067156|475024449|FG000|Overall Study|Lost to Follow-up|4|||
131928635|NCT03596983|475024450|FG000|Overall Study|Withdrawal by Subject|3|||
131928636|NCT04135352|475024451|FG000|Overall Study|Not treated-randomization error|0|||
131928637|NCT04135352|475024452|FG001|Overall Study|Not treated-randomization error|0|||
131928638|NCT04135352|475024453|FG002|Overall Study|Not treated-randomization error|1|||
131928639|NCT04135352|475024454|FG003|Overall Study|Not treated-randomization error|0|||
131928640|NCT04135352|475024455|FG004|Overall Study|Not treated-randomization error|0|||
131928641|NCT04135352|475024456|FG005|Overall Study|Not treated-randomization error|0|||
131928642|NCT04135352|475024457|FG006|Overall Study|Not treated-randomization error|0|||
131928643|NCT04135352|475024458|FG007|Overall Study|Not treated-randomization error|0|||
131928644|NCT04135352|475024451|FG000|Overall Study|Withdrawal by Subject|0|||
131928645|NCT04135352|475024452|FG001|Overall Study|Withdrawal by Subject|0|||
131410256|NCT01286987|473124804|FG013|Part 2: Dose Expansion|Death|1|||
131410257|NCT01286987|473124805|FG014|Part 2: Dose Expansion|Death|0|||
131410258|NCT01286987|473124791|FG000|Part 2: Dose Expansion|Physician Decision|0|||
131410259|NCT01286987|473124792|FG001|Part 2: Dose Expansion|Physician Decision|0|||
131410260|NCT01286987|473124793|FG002|Part 2: Dose Expansion|Physician Decision|0|||
131410261|NCT01286987|473124794|FG003|Part 2: Dose Expansion|Physician Decision|0|||
131410262|NCT01286987|473124795|FG004|Part 2: Dose Expansion|Physician Decision|0|||
131410263|NCT01286987|473124796|FG005|Part 2: Dose Expansion|Physician Decision|0|||
131410264|NCT01286987|473124797|FG006|Part 2: Dose Expansion|Physician Decision|0|||
131410265|NCT01286987|473124798|FG007|Part 2: Dose Expansion|Physician Decision|0|||
131410266|NCT01286987|473124799|FG008|Part 2: Dose Expansion|Physician Decision|0|||
131410267|NCT01286987|473124800|FG009|Part 2: Dose Expansion|Physician Decision|0|||
131410268|NCT01286987|473124801|FG010|Part 2: Dose Expansion|Physician Decision|1|||
131410269|NCT01286987|473124802|FG011|Part 2: Dose Expansion|Physician Decision|1|||
131410270|NCT01286987|473124803|FG012|Part 2: Dose Expansion|Physician Decision|0|||
131410271|NCT01286987|473124804|FG013|Part 2: Dose Expansion|Physician Decision|1|||
131410272|NCT01286987|473124805|FG014|Part 2: Dose Expansion|Physician Decision|0|||
131410273|NCT01286987|473124791|FG000|Part 2: Dose Expansion|Other|0|||
131410274|NCT01286987|473124792|FG001|Part 2: Dose Expansion|Other|0|||
131410275|NCT01286987|473124793|FG002|Part 2: Dose Expansion|Other|0|||
131410276|NCT01286987|473124794|FG003|Part 2: Dose Expansion|Other|0|||
131410277|NCT01286987|473124795|FG004|Part 2: Dose Expansion|Other|0|||
131410278|NCT01286987|473124796|FG005|Part 2: Dose Expansion|Other|0|||
131410279|NCT01286987|473124797|FG006|Part 2: Dose Expansion|Other|0|||
131410280|NCT01286987|473124798|FG007|Part 2: Dose Expansion|Other|0|||
131410281|NCT01286987|473124799|FG008|Part 2: Dose Expansion|Other|0|||
131410282|NCT01286987|473124800|FG009|Part 2: Dose Expansion|Other|0|||
131410283|NCT01286987|473124801|FG010|Part 2: Dose Expansion|Other|0|||
131410284|NCT01286987|473124802|FG011|Part 2: Dose Expansion|Other|0|||
131410285|NCT01286987|473124803|FG012|Part 2: Dose Expansion|Other|0|||
131410286|NCT01286987|473124804|FG013|Part 2: Dose Expansion|Other|1|||
131410287|NCT01286987|473124805|FG014|Part 2: Dose Expansion|Other|0|||
131410288|NCT01286987|473124791|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
131410289|NCT01286987|473124792|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
131410290|NCT01286987|473124793|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
131410291|NCT01286987|473124794|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
131410292|NCT01286987|473124795|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
131410293|NCT01286987|473124796|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
131410294|NCT01286987|473124797|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
131410295|NCT01286987|473124798|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
131410296|NCT01286987|473124799|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
131410297|NCT01286987|473124800|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
131410298|NCT01286987|473124801|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
131410299|NCT01286987|473124802|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
131410300|NCT01286987|473124803|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
131410301|NCT01286987|473124804|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
131410302|NCT01286987|473124805|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
131410303|NCT01286987|473124791|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
131410304|NCT01286987|473124792|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
131410305|NCT01286987|473124793|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
131410306|NCT01286987|473124794|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
131410307|NCT01286987|473124795|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
131410308|NCT01286987|473124796|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
131410309|NCT01286987|473124797|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
131410310|NCT01286987|473124798|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
131928646|NCT04135352|475024453|FG002|Overall Study|Withdrawal by Subject|2|||
131928647|NCT04135352|475024454|FG003|Overall Study|Withdrawal by Subject|0|||
131928648|NCT04135352|475024455|FG004|Overall Study|Withdrawal by Subject|0|||
131928649|NCT04135352|475024456|FG005|Overall Study|Withdrawal by Subject|0|||
131928650|NCT04135352|475024457|FG006|Overall Study|Withdrawal by Subject|0|||
131410311|NCT01286987|473124799|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
131410312|NCT01286987|473124800|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
131410313|NCT01286987|473124801|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
131410314|NCT01286987|473124802|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
131410315|NCT01286987|473124803|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
131410316|NCT01286987|473124804|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
131410317|NCT01286987|473124805|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
131410318|NCT01286987|473124791|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410319|NCT01286987|473124792|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410320|NCT01286987|473124793|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410321|NCT01286987|473124794|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410322|NCT01286987|473124795|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410323|NCT01286987|473124796|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131928651|NCT04135352|475024458|FG007|Overall Study|Withdrawal by Subject|0|||
131928652|NCT04135352|475024451|FG000|Overall Study|Sponsor Decision|0|||
131928653|NCT04135352|475024452|FG001|Overall Study|Sponsor Decision|0|||
131928654|NCT04135352|475024453|FG002|Overall Study|Sponsor Decision|2|||
131928655|NCT04135352|475024454|FG003|Overall Study|Sponsor Decision|5|||
131928656|NCT04135352|475024455|FG004|Overall Study|Sponsor Decision|1|||
131928657|NCT04135352|475024456|FG005|Overall Study|Sponsor Decision|4|||
131928658|NCT04135352|475024457|FG006|Overall Study|Sponsor Decision|0|||
131928659|NCT04135352|475024458|FG007|Overall Study|Sponsor Decision|0|||
131928660|NCT04135352|475024451|FG000|Overall Study|Physician Decision|0|||
131928661|NCT04135352|475024452|FG001|Overall Study|Physician Decision|0|||
131928662|NCT04135352|475024453|FG002|Overall Study|Physician Decision|1|||
131928663|NCT04135352|475024454|FG003|Overall Study|Physician Decision|0|||
131928664|NCT04135352|475024455|FG004|Overall Study|Physician Decision|1|||
131928665|NCT04135352|475024456|FG005|Overall Study|Physician Decision|0|||
131928666|NCT04135352|475024457|FG006|Overall Study|Physician Decision|0|||
131928667|NCT04135352|475024458|FG007|Overall Study|Physician Decision|0|||
131928668|NCT04135352|475024451|FG000|Overall Study|Death|3|||
131928669|NCT04135352|475024452|FG001|Overall Study|Death|4|||
131928670|NCT04135352|475024453|FG002|Overall Study|Death|7|||
131928671|NCT04135352|475024454|FG003|Overall Study|Death|0|||
131928672|NCT04135352|475024455|FG004|Overall Study|Death|3|||
131928673|NCT04135352|475024456|FG005|Overall Study|Death|1|||
131928674|NCT04135352|475024457|FG006|Overall Study|Death|0|||
131928675|NCT04135352|475024458|FG007|Overall Study|Death|0|||
131928676|NCT04008069|475024459|FG000|Open-Label Period|Adverse Event|1|||
131928677|NCT04008069|475024460|FG001|Open-Label Period|Adverse Event|0|||
131928678|NCT04008069|475024461|FG002|Open-Label Period|Adverse Event|0|||
131928679|NCT04008069|475024459|FG000|Open-Label Period|Lack of Efficacy|4|||
131928680|NCT04008069|475024460|FG001|Open-Label Period|Lack of Efficacy|0|||
131928681|NCT04008069|475024461|FG002|Open-Label Period|Lack of Efficacy|0|||
131928682|NCT04008069|475024459|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
131928683|NCT04008069|475024460|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
131928684|NCT04008069|475024461|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
131928685|NCT04008069|475024459|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
131928686|NCT04008069|475024460|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
131928687|NCT04008069|475024461|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
131928688|NCT02134028|475024463|FG000|Overall Study|Lack of Efficacy|1|||
131928689|NCT02134028|475024464|FG001|Overall Study|Lack of Efficacy|0|||
131928690|NCT02134028|475024465|FG002|Overall Study|Lack of Efficacy|3|||
131928691|NCT02134028|475024466|FG003|Overall Study|Lack of Efficacy|2|||
131928692|NCT02134028|475024467|FG004|Overall Study|Lack of Efficacy|1|||
131928693|NCT02134028|475024468|FG005|Overall Study|Lack of Efficacy|2|||
131928694|NCT02134028|475024469|FG006|Overall Study|Lack of Efficacy|1|||
131928695|NCT02134028|475024470|FG007|Overall Study|Lack of Efficacy|0|||
131928696|NCT02134028|475024463|FG000|Overall Study|Poor compliance to protocol|1|||
131928697|NCT02134028|475024464|FG001|Overall Study|Poor compliance to protocol|1|||
131928698|NCT02134028|475024465|FG002|Overall Study|Poor compliance to protocol|3|||
131928699|NCT02134028|475024466|FG003|Overall Study|Poor compliance to protocol|7|||
131928700|NCT02134028|475024467|FG004|Overall Study|Poor compliance to protocol|1|||
131928701|NCT02134028|475024468|FG005|Overall Study|Poor compliance to protocol|1|||
131928702|NCT02134028|475024469|FG006|Overall Study|Poor compliance to protocol|0|||
131928703|NCT02134028|475024470|FG007|Overall Study|Poor compliance to protocol|0|||
131928704|NCT02134028|475024463|FG000|Overall Study|Other unspecified|4|||
131928705|NCT02134028|475024464|FG001|Overall Study|Other unspecified|22|||
131928706|NCT02134028|475024465|FG002|Overall Study|Other unspecified|33|||
131928707|NCT02134028|475024466|FG003|Overall Study|Other unspecified|64|||
131928708|NCT02134028|475024467|FG004|Overall Study|Other unspecified|8|||
131928709|NCT02134028|475024468|FG005|Overall Study|Other unspecified|6|||
131928710|NCT02134028|475024469|FG006|Overall Study|Other unspecified|2|||
131928711|NCT02134028|475024470|FG007|Overall Study|Other unspecified|1|||
131928712|NCT02134028|475024463|FG000|Overall Study|Adverse Event|3|||
131928713|NCT02134028|475024464|FG001|Overall Study|Adverse Event|19|||
131928714|NCT02134028|475024465|FG002|Overall Study|Adverse Event|13|||
131928715|NCT02134028|475024466|FG003|Overall Study|Adverse Event|32|||
131928716|NCT02134028|475024467|FG004|Overall Study|Adverse Event|4|||
131928717|NCT02134028|475024468|FG005|Overall Study|Adverse Event|5|||
131928718|NCT02134028|475024469|FG006|Overall Study|Adverse Event|1|||
131928719|NCT02134028|475024470|FG007|Overall Study|Adverse Event|2|||
131928720|NCT00819832|475024473|FG000|Overall Study|Sponsor Termination of Study|3|||
131928721|NCT00819832|475024474|FG001|Overall Study|Sponsor Termination of Study|0|||
131928722|NCT00819832|475024475|FG002|Overall Study|Sponsor Termination of Study|0|||
131410324|NCT01286987|473124797|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131928723|NCT00819832|475024476|FG003|Overall Study|Sponsor Termination of Study|0|||
131928724|NCT00819832|475024477|FG004|Overall Study|Sponsor Termination of Study|0|||
131928725|NCT00819832|475024478|FG005|Overall Study|Sponsor Termination of Study|0|||
131928726|NCT01260311|475024482|FG000|Overall Study|Adverse Event|11|||
131928727|NCT01260311|475024482|FG000|Overall Study|Lack of Efficacy|4|||
131928728|NCT01260311|475024482|FG000|Overall Study|Lost to Follow-up|25|||
131928729|NCT01260311|475024482|FG000|Overall Study|Withdrawal by Subject|6|||
131410325|NCT01286987|473124798|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410326|NCT01286987|473124799|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410327|NCT01286987|473124800|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410328|NCT01286987|473124801|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131410329|NCT01286987|473124802|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410330|NCT01286987|473124803|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410331|NCT01286987|473124804|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131928730|NCT01260311|475024482|FG000|Overall Study|Financial Constraints|77|||
131928731|NCT01260311|475024482|FG000|Overall Study|Gone to Province|2|||
131928732|NCT01260311|475024482|FG000|Overall Study|Medication Stopped|1|||
131928733|NCT01260311|475024482|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
131928734|NCT01452789|475024489|FG000|Overall Study|Withdrawal by Subject|3|||
131928735|NCT01452789|475024490|FG001|Overall Study|Withdrawal by Subject|2|||
131928736|NCT01340170|475024491|FG000|Overall Study|Lost to Follow-up|2|||
131928737|NCT01340170|475024492|FG001|Overall Study|Lost to Follow-up|4|||
131928738|NCT01340170|475024493|FG002|Overall Study|Lost to Follow-up|0|||
131928739|NCT01340170|475024491|FG000|Overall Study|Implant failure|1|||
131928740|NCT01340170|475024492|FG001|Overall Study|Implant failure|3|||
131410332|NCT01286987|473124805|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131410333|NCT02594098|473124806|FG000|Overall Study|Lack of Efficacy|17|||
131928741|NCT01340170|475024493|FG002|Overall Study|Implant failure|0|||
131928742|NCT03878602|475024494|FG000|Overall Study|cord blood donation|7|||
131928743|NCT03878602|475024495|FG001|Overall Study|cord blood donation|1|||
131928744|NCT03878602|475024494|FG000|Overall Study|incomplete data collection|2|||
131928745|NCT03878602|475024495|FG001|Overall Study|incomplete data collection|0|||
131928746|NCT00066170|475024496|FG000|Overall Study|Adverse Event|2|||
131928747|NCT00066170|475024497|FG001|Overall Study|Adverse Event|4|||
131928748|NCT00066170|475024498|FG002|Overall Study|Adverse Event|1|||
131928749|NCT00066170|475024499|FG003|Overall Study|Adverse Event|7|||
131928750|NCT00066170|475024496|FG000|Overall Study|Serious Adverse Event|0|||
131928751|NCT00066170|475024497|FG001|Overall Study|Serious Adverse Event|0|||
131928752|NCT00066170|475024498|FG002|Overall Study|Serious Adverse Event|1|||
131928753|NCT00066170|475024499|FG003|Overall Study|Serious Adverse Event|1|||
131928754|NCT00066170|475024496|FG000|Overall Study|Lost to Follow-up|0|||
131928755|NCT00066170|475024497|FG001|Overall Study|Lost to Follow-up|1|||
131928756|NCT00066170|475024498|FG002|Overall Study|Lost to Follow-up|0|||
131928757|NCT00066170|475024499|FG003|Overall Study|Lost to Follow-up|0|||
131928758|NCT00066170|475024496|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
131928759|NCT00066170|475024497|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
131928760|NCT00066170|475024498|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
131928761|NCT00066170|475024499|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
131928762|NCT00066170|475024496|FG000|Overall Study|Protocol Violation|3|||
131928763|NCT00066170|475024497|FG001|Overall Study|Protocol Violation|0|||
131928764|NCT00066170|475024498|FG002|Overall Study|Protocol Violation|0|||
131928765|NCT00066170|475024499|FG003|Overall Study|Protocol Violation|0|||
131928766|NCT00066170|475024496|FG000|Overall Study|Other|1|||
131928767|NCT00066170|475024497|FG001|Overall Study|Other|5|||
131928768|NCT00066170|475024498|FG002|Overall Study|Other|2|||
131928769|NCT00066170|475024499|FG003|Overall Study|Other|0|||
131928770|NCT03722030|475024500|FG000|Overall Study|Withdrawal by Subject|1|||
131928771|NCT03722030|475024501|FG001|Overall Study|Withdrawal by Subject|0|||
131928772|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Adverse Event|14|||
131928773|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Adverse Event|27|||
131928774|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Adverse Event|60|||
131928775|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Adverse Event|0|||
131928776|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Adverse Event|0|||
131928777|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Pregnancy|0|||
131928778|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Pregnancy|7|||
131928779|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Pregnancy|9|||
131928780|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Pregnancy|0|||
131928781|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Pregnancy|0|||
131928782|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
131928783|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
131410334|NCT02594098|473124807|FG001|Overall Study|Lack of Efficacy|6|||
131410335|NCT02594098|473124806|FG000|Overall Study|Withdrawal by Subject|1|||
131928784|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
131928785|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
131928786|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
131410336|NCT02594098|473124807|FG001|Overall Study|Withdrawal by Subject|3|||
131928787|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
131928788|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
131928789|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
131928790|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
131928791|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
131928792|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Death|1|||
131928793|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Death|2|||
131928794|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Death|2|||
131928795|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Death|0|||
131928796|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Death|0|||
131928797|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
131928798|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
131928799|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
131928800|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
131928801|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
131928802|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
131928803|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
131928804|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
131928805|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
131928806|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
131928807|NCT00098293|475024502|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
131928808|NCT00098293|475024503|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
131928809|NCT00098293|475024504|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
131928810|NCT00098293|475024505|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
131928811|NCT00098293|475024506|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
131928812|NCT00098293|475024502|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
131928813|NCT00098293|475024503|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
131928814|NCT00098293|475024504|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
131928815|NCT00098293|475024505|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
131928816|NCT00098293|475024506|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
131928817|NCT00098293|475024502|FG000|Open-label (OL) Phase|Adverse Event|0|||
131928818|NCT00098293|475024503|FG001|Open-label (OL) Phase|Adverse Event|3|||
131928819|NCT00098293|475024504|FG002|Open-label (OL) Phase|Adverse Event|7|||
131928820|NCT00098293|475024505|FG003|Open-label (OL) Phase|Adverse Event|6|||
131928821|NCT00098293|475024506|FG004|Open-label (OL) Phase|Adverse Event|0|||
131928822|NCT00098293|475024502|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
131928823|NCT00098293|475024503|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
131928824|NCT00098293|475024504|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
131928825|NCT00098293|475024505|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
131928826|NCT00098293|475024506|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
131928827|NCT00098293|475024502|FG000|Open-label (OL) Phase|Pregnancy|0|||
131928828|NCT00098293|475024503|FG001|Open-label (OL) Phase|Pregnancy|1|||
131928829|NCT00098293|475024504|FG002|Open-label (OL) Phase|Pregnancy|0|||
131928830|NCT00098293|475024505|FG003|Open-label (OL) Phase|Pregnancy|3|||
131928831|NCT00098293|475024506|FG004|Open-label (OL) Phase|Pregnancy|0|||
131928832|NCT00098293|475024502|FG000|Open-label (OL) Phase|Protocol Violation|0|||
131928833|NCT00098293|475024503|FG001|Open-label (OL) Phase|Protocol Violation|6|||
131928834|NCT00098293|475024504|FG002|Open-label (OL) Phase|Protocol Violation|13|||
131928835|NCT00098293|475024505|FG003|Open-label (OL) Phase|Protocol Violation|16|||
131928836|NCT00098293|475024506|FG004|Open-label (OL) Phase|Protocol Violation|0|||
131928837|NCT00098293|475024502|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
131928838|NCT00098293|475024503|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
131928839|NCT00098293|475024504|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
131928840|NCT00098293|475024505|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
131928841|NCT00098293|475024506|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
131928842|NCT00098293|475024502|FG000|Open-label (OL) Phase|Death|0|||
131928843|NCT00098293|475024503|FG001|Open-label (OL) Phase|Death|2|||
131928844|NCT00098293|475024504|FG002|Open-label (OL) Phase|Death|3|||
131928845|NCT00098293|475024505|FG003|Open-label (OL) Phase|Death|0|||
131928846|NCT00098293|475024506|FG004|Open-label (OL) Phase|Death|0|||
131928847|NCT00098293|475024502|FG000|Supplemental Phase (SP)|Death|0|||
131928848|NCT00098293|475024503|FG001|Supplemental Phase (SP)|Death|0|||
131928849|NCT00098293|475024504|FG002|Supplemental Phase (SP)|Death|0|||
131928850|NCT00098293|475024505|FG003|Supplemental Phase (SP)|Death|0|||
131928851|NCT00098293|475024506|FG004|Supplemental Phase (SP)|Death|1|||
131928852|NCT00098293|475024502|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
131928853|NCT00098293|475024503|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
131928854|NCT00098293|475024504|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
131928855|NCT00098293|475024505|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
131928856|NCT00098293|475024506|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
131928857|NCT00098293|475024502|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
131928858|NCT00098293|475024503|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
131928859|NCT00098293|475024504|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
131928860|NCT00098293|475024505|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
131928861|NCT00098293|475024506|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
131928862|NCT00098293|475024502|FG000|Supplemental Phase (SP)|Other|0|||
131928863|NCT00098293|475024503|FG001|Supplemental Phase (SP)|Other|0|||
131928864|NCT00098293|475024504|FG002|Supplemental Phase (SP)|Other|0|||
131928865|NCT00098293|475024505|FG003|Supplemental Phase (SP)|Other|0|||
131410337|NCT02594098|473124806|FG000|Overall Study|Terminated participation|6|||
131410338|NCT02594098|473124807|FG001|Overall Study|Terminated participation|2|||
131928866|NCT00098293|475024506|FG004|Supplemental Phase (SP)|Other|22|||
131928867|NCT01927861|475024507|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
131928868|NCT01927861|475024508|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
131928869|NCT01927861|475024507|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
131928870|NCT01927861|475024508|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
131928871|NCT00987935|475024509|FG000|Overall Study|Progressive disease|3|||
131928872|NCT00987935|475024510|FG001|Overall Study|Progressive disease|2|||
131928873|NCT00987935|475024511|FG002|Overall Study|Progressive disease|3|||
131928874|NCT00987935|475024512|FG003|Overall Study|Progressive disease|2|||
131928875|NCT00987935|475024513|FG004|Overall Study|Progressive disease|5|||
131928876|NCT00987935|475024514|FG005|Overall Study|Progressive disease|3|||
131928877|NCT00987935|475024515|FG006|Overall Study|Progressive disease|9|||
131928878|NCT00987935|475024516|FG007|Overall Study|Progressive disease|48|||
131928879|NCT00987935|475024517|FG008|Overall Study|Progressive disease|23|||
131928880|NCT00987935|475024509|FG000|Overall Study|Adverse Event|0|||
131928881|NCT00987935|475024510|FG001|Overall Study|Adverse Event|1|||
131928882|NCT00987935|475024511|FG002|Overall Study|Adverse Event|0|||
131928883|NCT00987935|475024512|FG003|Overall Study|Adverse Event|1|||
131928884|NCT00987935|475024513|FG004|Overall Study|Adverse Event|1|||
131928885|NCT00987935|475024514|FG005|Overall Study|Adverse Event|0|||
131928886|NCT00987935|475024515|FG006|Overall Study|Adverse Event|2|||
131928887|NCT00987935|475024516|FG007|Overall Study|Adverse Event|10|||
131928888|NCT00987935|475024517|FG008|Overall Study|Adverse Event|6|||
131928889|NCT00987935|475024509|FG000|Overall Study|Refused to continue taking trial med.|1|||
131928890|NCT00987935|475024510|FG001|Overall Study|Refused to continue taking trial med.|0|||
131928891|NCT00987935|475024511|FG002|Overall Study|Refused to continue taking trial med.|0|||
131928892|NCT00987935|475024512|FG003|Overall Study|Refused to continue taking trial med.|0|||
131928893|NCT00987935|475024513|FG004|Overall Study|Refused to continue taking trial med.|1|||
131928894|NCT00987935|475024514|FG005|Overall Study|Refused to continue taking trial med.|0|||
131928895|NCT00987935|475024515|FG006|Overall Study|Refused to continue taking trial med.|4|||
131928896|NCT00987935|475024516|FG007|Overall Study|Refused to continue taking trial med.|4|||
131928897|NCT00987935|475024517|FG008|Overall Study|Refused to continue taking trial med.|2|||
131928898|NCT00987935|475024509|FG000|Overall Study|Reason other than those specified above|0|||
131928899|NCT00987935|475024510|FG001|Overall Study|Reason other than those specified above|0|||
131928900|NCT00987935|475024511|FG002|Overall Study|Reason other than those specified above|0|||
131928901|NCT00987935|475024512|FG003|Overall Study|Reason other than those specified above|0|||
131928902|NCT00987935|475024513|FG004|Overall Study|Reason other than those specified above|0|||
131928903|NCT00987935|475024514|FG005|Overall Study|Reason other than those specified above|0|||
131928904|NCT00987935|475024515|FG006|Overall Study|Reason other than those specified above|0|||
131928905|NCT00987935|475024516|FG007|Overall Study|Reason other than those specified above|0|||
131928906|NCT00987935|475024517|FG008|Overall Study|Reason other than those specified above|1|||
131928907|NCT01089543|475024518|FG000|Overall Study|Withdrawal by Subject|2|||
131928908|NCT01089543|475024519|FG001|Overall Study|Withdrawal by Subject|3|||
131928909|NCT01089543|475024520|FG002|Overall Study|Withdrawal by Subject|3|||
131928910|NCT01089543|475024521|FG003|Overall Study|Withdrawal by Subject|1|||
131928911|NCT01089543|475024518|FG000|Overall Study|Physician Decision|1|||
131928912|NCT01089543|475024519|FG001|Overall Study|Physician Decision|0|||
131928913|NCT01089543|475024520|FG002|Overall Study|Physician Decision|0|||
131928914|NCT01089543|475024521|FG003|Overall Study|Physician Decision|1|||
131928915|NCT01089543|475024518|FG000|Overall Study|Adverse Event|0|||
131928916|NCT01089543|475024519|FG001|Overall Study|Adverse Event|1|||
131928917|NCT01089543|475024520|FG002|Overall Study|Adverse Event|0|||
131928918|NCT01089543|475024521|FG003|Overall Study|Adverse Event|0|||
131928919|NCT00468546|475024523|FG000|Week 24 Analysis|Lack of Efficacy|83|||
131928920|NCT00468546|475024524|FG001|Week 24 Analysis|Lack of Efficacy|37|||
131928921|NCT00468546|475024523|FG000|Week 24 Analysis|Refused treatment|5|||
131928922|NCT00468546|475024524|FG001|Week 24 Analysis|Refused treatment|5|||
131928923|NCT00468546|475024523|FG000|Week 24 Analysis|Adverse Event|1|||
131928924|NCT00468546|475024524|FG001|Week 24 Analysis|Adverse Event|8|||
131928925|NCT00468546|475024523|FG000|Week 24 Analysis|Failure to return|3|||
131928926|NCT00468546|475024524|FG001|Week 24 Analysis|Failure to return|4|||
131928927|NCT00468546|475024523|FG000|Week 24 Analysis|Rescue therapy|2|||
131928928|NCT00468546|475024524|FG001|Week 24 Analysis|Rescue therapy|0|||
131928929|NCT00468546|475024523|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
131928930|NCT00468546|475024524|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
131928931|NCT00468546|475024523|FG000|Week 24 Analysis|Due to clinical hold|1|||
131928932|NCT00468546|475024524|FG001|Week 24 Analysis|Due to clinical hold|0|||
131928933|NCT00468546|475024523|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
131928934|NCT00468546|475024524|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
131928935|NCT00468546|475024523|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
131928936|NCT00468546|475024524|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
131928937|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
131928938|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
131928939|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Death|1|||
131928940|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Death|0|||
131928941|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
131928942|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
131928943|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
131928944|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
131928945|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
131928946|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
131928947|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
131928948|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
131928949|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
131928950|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
131928951|NCT00468546|475024523|FG000|Week 24 to Week 104 Analysis|Other|17|||
131928952|NCT00468546|475024524|FG001|Week 24 to Week 104 Analysis|Other|14|||
131928953|NCT01189227|475024527|FG000|Overall Study|Study terminated due to low accrual|6|||
131928954|NCT01189227|475024528|FG001|Overall Study|Study terminated due to low accrual|3|||
131928955|NCT03211832|475024529|FG000|Overall Study|No longer with agency|32|||
131928956|NCT03211832|475024530|FG001|Overall Study|No longer with agency|49|||
131928957|NCT03211832|475024531|FG002|Overall Study|No longer with agency|30|||
131928958|NCT03211832|475024529|FG000|Overall Study|Declined survey|3|||
131928959|NCT03211832|475024530|FG001|Overall Study|Declined survey|3|||
131928960|NCT03211832|475024531|FG002|Overall Study|Declined survey|2|||
131928961|NCT03211832|475024529|FG000|Overall Study|Not available during data collection|1|||
131928962|NCT03211832|475024530|FG001|Overall Study|Not available during data collection|0|||
131928963|NCT03211832|475024531|FG002|Overall Study|Not available during data collection|2|||
131928964|NCT02991859|475024534|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928965|NCT02991859|475024535|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
131928966|NCT02991859|475024536|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928967|NCT02991859|475024537|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928968|NCT02991859|475024538|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
131928969|NCT02991859|475024539|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928970|NCT02991859|475024540|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928971|NCT02991859|475024541|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928972|NCT02991859|475024542|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928973|NCT02991859|475024543|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928974|NCT02991859|475024544|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928975|NCT02991859|475024545|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928976|NCT02991859|475024546|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928977|NCT02991859|475024547|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928978|NCT02991859|475024548|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928979|NCT02991859|475024549|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928980|NCT02991859|475024550|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
131928981|NCT02991859|475024534|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928982|NCT02991859|475024535|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928983|NCT02991859|475024536|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928984|NCT02991859|475024537|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928985|NCT02991859|475024538|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928986|NCT02991859|475024539|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928987|NCT02991859|475024540|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928988|NCT02991859|475024541|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928989|NCT02991859|475024542|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928990|NCT02991859|475024543|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928991|NCT02991859|475024544|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928992|NCT02991859|475024545|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928993|NCT02991859|475024546|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
131410339|NCT02594098|473124806|FG000|Overall Study|Seek alternative treatment|2|||
131410340|NCT02594098|473124807|FG001|Overall Study|Seek alternative treatment|1|||
131410341|NCT02594098|473124806|FG000|Overall Study|Other|0|||
131410342|NCT02594098|473124807|FG001|Overall Study|Other|1|||
131410343|NCT00033540|473124808|FG000|Overall Study|Adverse Event|14|||
131410344|NCT00033540|473124808|FG000|Overall Study|Death|1|||
131928994|NCT02991859|475024547|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
131928995|NCT02991859|475024548|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131410345|NCT00033540|473124808|FG000|Overall Study|Progression|26|||
131410346|NCT00033540|473124808|FG000|Overall Study|Withdrawal by Subject|6|||
131410347|NCT00033540|473124808|FG000|Overall Study|Other|5|||
131410348|NCT00033540|473124808|FG000|Overall Study|Ineligible|3|||
131928996|NCT02991859|475024549|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131410349|NCT00033540|473124808|FG000|Overall Study|Never received treatment|2|||
131410350|NCT03366103|473124809|FG000|Overall Study|Disease Progression|3|||
131928997|NCT02991859|475024550|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
131928998|NCT02991859|475024534|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131928999|NCT02991859|475024535|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929000|NCT02991859|475024536|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929001|NCT02991859|475024537|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929002|NCT02991859|475024538|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929003|NCT02991859|475024539|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
131929004|NCT02991859|475024540|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929005|NCT02991859|475024541|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929006|NCT02991859|475024542|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929007|NCT02991859|475024543|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929008|NCT02991859|475024544|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929009|NCT02991859|475024545|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929010|NCT02991859|475024546|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929011|NCT02991859|475024547|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929012|NCT02991859|475024548|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929013|NCT02991859|475024549|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929014|NCT02991859|475024550|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
131929015|NCT02991859|475024534|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929016|NCT02991859|475024535|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929017|NCT02991859|475024536|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929018|NCT02991859|475024537|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929019|NCT02991859|475024538|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929020|NCT02991859|475024539|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929021|NCT02991859|475024540|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929022|NCT02991859|475024541|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929023|NCT02991859|475024542|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929024|NCT02991859|475024543|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
131929025|NCT02991859|475024544|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929026|NCT02991859|475024545|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929027|NCT02991859|475024546|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929028|NCT02991859|475024547|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929029|NCT02991859|475024548|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929030|NCT02991859|475024549|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929031|NCT02991859|475024550|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
131929032|NCT02991859|475024534|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929033|NCT02991859|475024535|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929034|NCT02991859|475024536|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929035|NCT02991859|475024537|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929036|NCT02991859|475024538|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929037|NCT02991859|475024539|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929038|NCT02991859|475024540|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929039|NCT02991859|475024541|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929040|NCT02991859|475024542|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
131929041|NCT02991859|475024543|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929042|NCT02991859|475024544|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929043|NCT02991859|475024545|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929044|NCT02991859|475024546|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929045|NCT02991859|475024547|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929046|NCT02991859|475024548|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929047|NCT02991859|475024549|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929048|NCT02991859|475024550|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
131929049|NCT04223687|475024557|FG000|Overall Study|Missing primary outcome|1|||
131929050|NCT04223687|475024558|FG001|Overall Study|Missing primary outcome|0|||
131410351|NCT03366103|473124810|FG001|Overall Study|Disease Progression|1|||
131410352|NCT03366103|473124811|FG002|Overall Study|Disease Progression|0|||
131929051|NCT00425854|475024559|FG000|Overall Study|Progressive Disease|19|||
131929052|NCT00425854|475024560|FG001|Overall Study|Progressive Disease|12|||
131929053|NCT00425854|475024559|FG000|Overall Study|Dose reduction toxicity AE|8|||
131929054|NCT00425854|475024560|FG001|Overall Study|Dose reduction toxicity AE|7|||
131929055|NCT00425854|475024559|FG000|Overall Study|Other Adverse Event|2|||
131929056|NCT00425854|475024560|FG001|Overall Study|Other Adverse Event|2|||
131929057|NCT01608308|475024563|FG000|Overall Study|pretreatment medical and billing reasons|0|||
131929058|NCT01608308|475024564|FG001|Overall Study|pretreatment medical and billing reasons|2|||
131929059|NCT05652140|475024566|FG000|Overall Study|Lost to Follow-up|7|||
131929060|NCT05652140|475024567|FG001|Overall Study|Lost to Follow-up|16|||
131410353|NCT03366103|473124809|FG000|Overall Study|Adverse Event|0|||
131929061|NCT05652140|475024568|FG002|Overall Study|Lost to Follow-up|22|||
131410354|NCT03366103|473124810|FG001|Overall Study|Adverse Event|1|||
131410355|NCT03366103|473124811|FG002|Overall Study|Adverse Event|0|||
131410356|NCT01036529|473124812|FG000|Overall Study|Adverse Event|0|||
131410357|NCT01036529|473124813|FG001|Overall Study|Adverse Event|1|||
131410358|NCT01036529|473124812|FG000|Overall Study|Lost to Follow-up|0|||
131410359|NCT01036529|473124813|FG001|Overall Study|Lost to Follow-up|1|||
131410360|NCT01036529|473124812|FG000|Overall Study|Physician Decision|1|||
131410361|NCT01036529|473124813|FG001|Overall Study|Physician Decision|0|||
131410362|NCT01036529|473124812|FG000|Overall Study|Withdrawal by Subject|1|||
131410363|NCT01036529|473124813|FG001|Overall Study|Withdrawal by Subject|1|||
131410364|NCT01036529|473124812|FG000|Overall Study|Sponsor study termination|11|||
131410365|NCT01036529|473124813|FG001|Overall Study|Sponsor study termination|12|||
131410366|NCT01853072|473124814|FG000|Overall Study|Adverse event prior to treatment|0|||
131410367|NCT01853072|473124815|FG001|Overall Study|Adverse event prior to treatment|1|||
131454063|NCT04717336|473291874|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
131454064|NCT04717336|473291875|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
131454065|NCT02039843|473291876|FG000|Randomization and Observation Period|Adverse Event|2|||
131454066|NCT02039843|473291877|FG001|Randomization and Observation Period|Adverse Event|0|||
131454067|NCT02039843|473291876|FG000|Randomization and Observation Period|Death|1|||
131454068|NCT02039843|473291877|FG001|Randomization and Observation Period|Death|0|||
131454069|NCT02039843|473291876|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
131454070|NCT02039843|473291877|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
131454071|NCT02039843|473291876|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
131454072|NCT02039843|473291877|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
131454073|NCT02039843|473291876|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
131454074|NCT02039843|473291877|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
131454075|NCT02039843|473291876|FG000|Pairing With a Study Dog|Death|1|||
131454076|NCT02039843|473291877|FG001|Pairing With a Study Dog|Death|0|||
131454077|NCT02039843|473291876|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
131454078|NCT02039843|473291877|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
131454079|NCT02039843|473291876|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
131454080|NCT02039843|473291877|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
131454081|NCT02039843|473291876|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
131454082|NCT02039843|473291877|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
131454083|NCT01500720|473291887|FG000|Overall Study|Randomized But Not Treated|1|||
131454084|NCT01500720|473291888|FG001|Overall Study|Randomized But Not Treated|1|||
131454085|NCT01500720|473291887|FG000|Overall Study|Other|4|||
131454086|NCT01500720|473291888|FG001|Overall Study|Other|8|||
131454087|NCT01326104|473291889|FG000|Overall Study|progressed prior to vaccine|0|||
131454088|NCT01326104|473291890|FG001|Overall Study|progressed prior to vaccine|2|||
131454089|NCT01326104|473291889|FG000|Overall Study|unable to make vaccine|0|||
131454090|NCT01326104|473291890|FG001|Overall Study|unable to make vaccine|2|||
131454091|NCT04421027|473291891|FG000|Treatment Period|Adverse Event|5|||
131454092|NCT04421027|473291892|FG001|Treatment Period|Adverse Event|3|||
131454093|NCT04421027|473291893|FG002|Treatment Period|Adverse Event|0|||
131454094|NCT04421027|473291894|FG003|Treatment Period|Adverse Event|0|||
131454095|NCT04421027|473291891|FG000|Treatment Period|Death|98|||
131454096|NCT04421027|473291892|FG001|Treatment Period|Death|61|||
131454097|NCT04421027|473291893|FG002|Treatment Period|Death|0|||
131454098|NCT04421027|473291894|FG003|Treatment Period|Death|0|||
131454099|NCT04421027|473291891|FG000|Treatment Period|Lost to Follow-up|22|||
131454100|NCT04421027|473291892|FG001|Treatment Period|Lost to Follow-up|20|||
131454101|NCT04421027|473291893|FG002|Treatment Period|Lost to Follow-up|0|||
131454102|NCT04421027|473291894|FG003|Treatment Period|Lost to Follow-up|0|||
131454103|NCT04421027|473291891|FG000|Treatment Period|Other-Unknown|15|||
131454104|NCT04421027|473291892|FG001|Treatment Period|Other-Unknown|9|||
131454105|NCT04421027|473291893|FG002|Treatment Period|Other-Unknown|0|||
131454106|NCT04421027|473291894|FG003|Treatment Period|Other-Unknown|0|||
131454107|NCT04421027|473291891|FG000|Treatment Period|Physician Decision|1|||
131454108|NCT04421027|473291892|FG001|Treatment Period|Physician Decision|1|||
131454109|NCT04421027|473291893|FG002|Treatment Period|Physician Decision|0|||
131454110|NCT04421027|473291894|FG003|Treatment Period|Physician Decision|0|||
131454111|NCT04421027|473291891|FG000|Treatment Period|Withdrawal by Subject|7|||
131454112|NCT04421027|473291892|FG001|Treatment Period|Withdrawal by Subject|12|||
131454113|NCT04421027|473291893|FG002|Treatment Period|Withdrawal by Subject|0|||
131454114|NCT04421027|473291894|FG003|Treatment Period|Withdrawal by Subject|0|||
131454115|NCT04421027|473291891|FG000|Treatment Period|Randomized Not Dosed|9|||
131454116|NCT04421027|473291892|FG001|Treatment Period|Randomized Not Dosed|14|||
131454117|NCT04421027|473291893|FG002|Treatment Period|Randomized Not Dosed|0|||
131454118|NCT04421027|473291894|FG003|Treatment Period|Randomized Not Dosed|0|||
131454119|NCT04421027|473291891|FG000|Follow-Up Period|Adverse Event|0|||
131454120|NCT04421027|473291892|FG001|Follow-Up Period|Adverse Event|0|||
131454121|NCT04421027|473291893|FG002|Follow-Up Period|Adverse Event|0|||
131454122|NCT04421027|473291894|FG003|Follow-Up Period|Adverse Event|3|||
131454123|NCT04421027|473291891|FG000|Follow-Up Period|Death|0|||
131454124|NCT04421027|473291892|FG001|Follow-Up Period|Death|0|||
131929062|NCT05652140|475024569|FG003|Overall Study|Lost to Follow-up|31|||
131929063|NCT06048705|475024573|FG000|Overall Study|Physician Decision|1|||
131929064|NCT06048705|475024574|FG001|Overall Study|Physician Decision|0|||
131929065|NCT06048705|475024575|FG002|Overall Study|Physician Decision|0|||
131929066|NCT06048705|475024573|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
131929067|NCT06048705|475024574|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
131929068|NCT06048705|475024575|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
131929069|NCT06048705|475024573|FG000|Overall Study|Death prior to lymphodepletion|0|||
131929070|NCT06048705|475024574|FG001|Overall Study|Death prior to lymphodepletion|0|||
131929071|NCT06048705|475024575|FG002|Overall Study|Death prior to lymphodepletion|1|||
131929072|NCT01016015|475024576|FG000|Overall Study|Not Treated|3|||
131929073|NCT01016015|475024576|FG000|Overall Study|Withdrawal by Subject|1|||
131929074|NCT01016015|475024576|FG000|Overall Study|Adverse Event|15|||
131929075|NCT03163264|475024577|FG000|Overall Study|Withdrawal by Subject|13|||
131929076|NCT03163264|475024578|FG001|Overall Study|Withdrawal by Subject|3|||
131929077|NCT03163264|475024579|FG002|Overall Study|Withdrawal by Subject|4|||
131929078|NCT03163264|475024580|FG003|Overall Study|Withdrawal by Subject|2|||
131929079|NCT03163264|475024577|FG000|Overall Study|Lost to Follow-up|17|||
131929080|NCT03163264|475024578|FG001|Overall Study|Lost to Follow-up|20|||
131929081|NCT03163264|475024579|FG002|Overall Study|Lost to Follow-up|0|||
131929082|NCT03163264|475024580|FG003|Overall Study|Lost to Follow-up|0|||
131929083|NCT03163264|475024577|FG000|Overall Study|Death|0|||
131929084|NCT03163264|475024578|FG001|Overall Study|Death|2|||
131929085|NCT03163264|475024579|FG002|Overall Study|Death|0|||
131929086|NCT03163264|475024580|FG003|Overall Study|Death|0|||
131929087|NCT04648241|475024581|FG000|Overall Study|Lost to Follow-up|1|||
131929088|NCT04648241|475024582|FG001|Overall Study|Lost to Follow-up|0|||
131929089|NCT02057666|475024583|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
131929090|NCT02057666|475024584|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
131929091|NCT02057666|475024583|FG000|Double Blind Treatment Period|Poor tolerability|7|||
131929092|NCT02057666|475024584|FG001|Double Blind Treatment Period|Poor tolerability|2|||
131929093|NCT02057666|475024583|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
131929094|NCT02057666|475024584|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
131929095|NCT02057666|475024583|FG000|Double Blind Treatment Period|Physician Decision|1|||
131929096|NCT02057666|475024584|FG001|Double Blind Treatment Period|Physician Decision|0|||
131929097|NCT02057666|475024583|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
131929098|NCT02057666|475024584|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
131929099|NCT02057666|475024583|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
131929100|NCT02057666|475024584|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
131929101|NCT02057666|475024583|FG000|Double Blind Treatment Period|Sponsor's request|70|||
131929102|NCT02057666|475024584|FG001|Double Blind Treatment Period|Sponsor's request|34|||
131929103|NCT02057666|475024583|FG000|Open-Label Treatment Period|Poor tolerability|0|||
131929104|NCT02057666|475024584|FG001|Open-Label Treatment Period|Poor tolerability|1|||
131929105|NCT02057666|475024583|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
131929106|NCT02057666|475024584|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
131929107|NCT02057666|475024583|FG000|Open-Label Treatment Period|Sponsor's request|0|||
131929108|NCT02057666|475024584|FG001|Open-Label Treatment Period|Sponsor's request|4|||
131929109|NCT02489045|475024585|FG000|Overall Study|unable to collect usable data|53|||
131929110|NCT02489045|475024585|FG000|Follow-up|Lost to Follow-up|10|||
131929111|NCT02614066|475024588|FG000|Overall Study|Death|6|||
131929112|NCT02614066|475024589|FG001|Overall Study|Death|14|||
131929113|NCT02614066|475024590|FG002|Overall Study|Death|11|||
131929114|NCT02614066|475024591|FG003|Overall Study|Death|29|||
131929115|NCT02614066|475024588|FG000|Overall Study|Full consent withdrawn|0|||
131929116|NCT02614066|475024589|FG001|Overall Study|Full consent withdrawn|1|||
131929117|NCT02614066|475024590|FG002|Overall Study|Full consent withdrawn|0|||
131929118|NCT02614066|475024591|FG003|Overall Study|Full consent withdrawn|8|||
131929119|NCT02614066|475024588|FG000|Overall Study|Lost to Follow-up|0|||
131929120|NCT02614066|475024589|FG001|Overall Study|Lost to Follow-up|2|||
131929121|NCT02614066|475024590|FG002|Overall Study|Lost to Follow-up|2|||
131929122|NCT02614066|475024591|FG003|Overall Study|Lost to Follow-up|2|||
131929123|NCT02614066|475024588|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
131929124|NCT02614066|475024589|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
131929125|NCT02614066|475024590|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
131929126|NCT02614066|475024591|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
131929127|NCT02614066|475024588|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
131929128|NCT02614066|475024589|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
131929129|NCT02614066|475024590|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
131929130|NCT02614066|475024591|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
131929131|NCT02614066|475024588|FG000|Overall Study|Reason not specified|0|||
131929132|NCT02614066|475024589|FG001|Overall Study|Reason not specified|2|||
131929133|NCT02614066|475024590|FG002|Overall Study|Reason not specified|1|||
131410368|NCT01853072|473124814|FG000|Overall Study|Adverse Event|0|||
131410369|NCT01853072|473124815|FG001|Overall Study|Adverse Event|3|||
131410370|NCT01853072|473124814|FG000|Overall Study|Death|1|||
131410371|NCT01853072|473124815|FG001|Overall Study|Death|4|||
131410372|NCT01853072|473124814|FG000|Overall Study|Lost to Follow-up|0|||
131410373|NCT01853072|473124815|FG001|Overall Study|Lost to Follow-up|3|||
131410374|NCT01853072|473124814|FG000|Overall Study|Non-compliance with study drug|0|||
131410375|NCT01853072|473124815|FG001|Overall Study|Non-compliance with study drug|1|||
131410376|NCT01853072|473124814|FG000|Overall Study|Physician Decision|1|||
131410377|NCT01853072|473124815|FG001|Overall Study|Physician Decision|1|||
131410378|NCT01853072|473124814|FG000|Overall Study|Withdrawal by Subject|1|||
131410379|NCT01853072|473124815|FG001|Overall Study|Withdrawal by Subject|2|||
131410380|NCT01853072|473124814|FG000|Overall Study|Reason not specified|9|||
131410381|NCT01853072|473124815|FG001|Overall Study|Reason not specified|6|||
131410382|NCT01816906|473124816|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
131410383|NCT01816906|473124817|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
131410384|NCT01816906|473124816|FG000|Six Months|Lost to Follow-up|14|||
131410385|NCT01816906|473124817|FG001|Six Months|Lost to Follow-up|16|||
131410386|NCT01816906|473124816|FG000|12 Months|Adverse Event|2|||
131410387|NCT01816906|473124817|FG001|12 Months|Adverse Event|2|||
131410388|NCT01816906|473124816|FG000|12 Months|Death|0|||
131410389|NCT01816906|473124817|FG001|12 Months|Death|2|||
131410390|NCT01816906|473124816|FG000|12 Months|Lost to Follow-up|2|||
131410391|NCT01816906|473124817|FG001|12 Months|Lost to Follow-up|1|||
131410392|NCT01527383|473124818|FG000|Overall Study|Adverse Event|5|||
131410393|NCT01527383|473124819|FG001|Overall Study|Adverse Event|0|||
131410394|NCT01527383|473124818|FG000|Overall Study|Lost to Follow-up|3|||
131410395|NCT01527383|473124819|FG001|Overall Study|Lost to Follow-up|0|||
131410396|NCT01527383|473124818|FG000|Overall Study|Physician Decision|2|||
131410397|NCT01527383|473124819|FG001|Overall Study|Physician Decision|0|||
131410398|NCT01527383|473124818|FG000|Overall Study|Pregnancy|1|||
131410399|NCT01527383|473124819|FG001|Overall Study|Pregnancy|0|||
131410400|NCT01527383|473124818|FG000|Overall Study|Protocol Violation|1|||
131410401|NCT01527383|473124819|FG001|Overall Study|Protocol Violation|0|||
131410402|NCT01527383|473124818|FG000|Overall Study|Screen failure|1|||
131410403|NCT01527383|473124819|FG001|Overall Study|Screen failure|0|||
131410404|NCT01527383|473124818|FG000|Overall Study|Participant moved|0|||
131410405|NCT01527383|473124819|FG001|Overall Study|Participant moved|1|||
131410406|NCT01527383|473124818|FG000|Overall Study|Withdrawal by Subject|2|||
131410407|NCT01527383|473124819|FG001|Overall Study|Withdrawal by Subject|3|||
131410408|NCT00746733|473124820|FG000|Second Intervention|Adverse Event|1|||
131410409|NCT00746733|473124821|FG001|Second Intervention|Adverse Event|0|||
131410410|NCT00746733|473124820|FG000|Third Intervention|Withdrawal by Subject|1|||
131410411|NCT00746733|473124821|FG001|Third Intervention|Withdrawal by Subject|1|||
131410412|NCT03412604|473124822|FG000|Overall Study|Withdrawal by Subject|1|||
131410413|NCT01287221|473124824|FG000|Overall Study|Lack of Perceived Benefit|1|||
131410414|NCT01287221|473124825|FG001|Overall Study|Lack of Perceived Benefit|1|||
131410415|NCT01287221|473124824|FG000|Overall Study|Adverse Event|3|||
131410416|NCT01287221|473124825|FG001|Overall Study|Adverse Event|3|||
131410417|NCT01287221|473124824|FG000|Overall Study|Withdrawal by Subject|0|||
131410418|NCT01287221|473124825|FG001|Overall Study|Withdrawal by Subject|1|||
131410419|NCT00930969|473124826|FG000|Overall Study|Death|5|||
131410420|NCT00930969|473124826|FG000|Overall Study|Lost to Follow-up|1|||
131410421|NCT00930969|473124826|FG000|Overall Study|Physician Decision|13|||
131410422|NCT00930969|473124826|FG000|Overall Study|Withdrawal by Subject|19|||
131410423|NCT00787137|473124828|FG000|Overall Study|Study Termination|0|||
131410424|NCT00787137|473124829|FG001|Overall Study|Study Termination|0|||
131410425|NCT00787137|473124830|FG002|Overall Study|Study Termination|1|||
131410426|NCT00946322|473124834|FG000|Pre-treatment|participant failure to follow up|1|||
131410427|NCT00946322|473124834|FG000|Post-treatment|participant failure to follow up|2|||
131410428|NCT01453946|473124835|FG000|Overall Study|Did not receive drug for the taper phase|1|||
131410429|NCT01453946|473124835|FG000|Overall Study|Protocol Violation|2|||
131410430|NCT01453946|473124835|FG000|Overall Study|Lack of Efficacy|3|||
131410431|NCT01453946|473124835|FG000|Overall Study|Adverse Event|3|||
131454125|NCT04421027|473291893|FG002|Follow-Up Period|Death|16|||
131410432|NCT00846040|473124836|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
131410433|NCT00846040|473124837|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
131410434|NCT00846040|473124838|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
131410435|NCT00846040|473124836|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
131410436|NCT00846040|473124837|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
131410437|NCT00846040|473124838|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
131410438|NCT03158272|473124841|FG000|Overall Study|Disease progression|3|||
131410439|NCT03158272|473124842|FG001|Overall Study|Disease progression|3|||
131410440|NCT03158272|473124843|FG002|Overall Study|Disease progression|4|||
131410441|NCT03158272|473124844|FG003|Overall Study|Disease progression|6|||
131410442|NCT03158272|473124841|FG000|Overall Study|Death|0|||
131454126|NCT04421027|473291894|FG003|Follow-Up Period|Death|17|||
131410443|NCT03158272|473124842|FG001|Overall Study|Death|0|||
131410444|NCT03158272|473124843|FG002|Overall Study|Death|1|||
131410445|NCT03158272|473124844|FG003|Overall Study|Death|0|||
131410446|NCT03158272|473124841|FG000|Overall Study|Other reasons|0|||
131410447|NCT03158272|473124842|FG001|Overall Study|Other reasons|0|||
131410448|NCT03158272|473124843|FG002|Overall Study|Other reasons|1|||
131410449|NCT03158272|473124844|FG003|Overall Study|Other reasons|0|||
131410450|NCT03158272|473124841|FG000|Overall Study|Adverse event unrelated to the drug|0|||
131410451|NCT03158272|473124842|FG001|Overall Study|Adverse event unrelated to the drug|1|||
131410452|NCT03158272|473124843|FG002|Overall Study|Adverse event unrelated to the drug|0|||
131410453|NCT03158272|473124844|FG003|Overall Study|Adverse event unrelated to the drug|0|||
131410454|NCT01822535|473124845|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
131410455|NCT01822535|473124846|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
131410456|NCT01822535|473124845|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
131410457|NCT01822535|473124846|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
131410458|NCT01822535|473124845|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
131410459|NCT01822535|473124846|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
131410460|NCT02278614|473124847|FG000|Overall Study|Withdrawal by Subject|3|||
131410461|NCT02278614|473124848|FG001|Overall Study|Withdrawal by Subject|5|||
131929134|NCT02614066|475024591|FG003|Overall Study|Reason not specified|1|||
131929135|NCT00236197|475024597|FG000|Overall Study|Withdrawal by Subject|3|||
131929136|NCT00236197|475024598|FG001|Overall Study|Withdrawal by Subject|2|||
131929137|NCT00236197|475024597|FG000|Overall Study|Lost to Follow-up|1|||
131929138|NCT00236197|475024598|FG001|Overall Study|Lost to Follow-up|5|||
131929139|NCT00236197|475024597|FG000|Overall Study|Protocol Violation|0|||
131929140|NCT00236197|475024598|FG001|Overall Study|Protocol Violation|3|||
131929141|NCT00236197|475024597|FG000|Overall Study|Medication non-compliance|1|||
131929142|NCT00236197|475024598|FG001|Overall Study|Medication non-compliance|2|||
131929143|NCT00236197|475024597|FG000|Overall Study|Other|0|||
131929144|NCT00236197|475024598|FG001|Overall Study|Other|2|||
131929145|NCT04495478|475024603|FG000|Overall Study|Withdrawal by Subject|0|||
131929146|NCT04495478|475024604|FG001|Overall Study|Withdrawal by Subject|0|||
131929147|NCT04495478|475024605|FG002|Overall Study|Withdrawal by Subject|0|||
131929148|NCT04495478|475024606|FG003|Overall Study|Withdrawal by Subject|1|||
131929149|NCT04495478|475024607|FG004|Overall Study|Withdrawal by Subject|0|||
131929150|NCT04495478|475024608|FG005|Overall Study|Withdrawal by Subject|0|||
131929151|NCT04495478|475024609|FG006|Overall Study|Withdrawal by Subject|0|||
131929152|NCT04495478|475024603|FG000|Overall Study|Physician Decision|0|||
131929153|NCT04495478|475024604|FG001|Overall Study|Physician Decision|1|||
131929154|NCT04495478|475024605|FG002|Overall Study|Physician Decision|0|||
131929155|NCT04495478|475024606|FG003|Overall Study|Physician Decision|0|||
131929156|NCT04495478|475024607|FG004|Overall Study|Physician Decision|1|||
131929157|NCT04495478|475024608|FG005|Overall Study|Physician Decision|0|||
131929158|NCT04495478|475024609|FG006|Overall Study|Physician Decision|0|||
131929159|NCT05058456|475026855|FG000|Overall Study|Death|1|||
131929160|NCT05058456|475026855|FG000|Overall Study|End of Study data not yet due for release|34|||
131929161|NCT03400787|475026856|FG000|Overall Study|Lost to Follow-up|1|||
131929162|NCT03400787|475026857|FG001|Overall Study|Lost to Follow-up|0|||
131929163|NCT03400787|475026856|FG000|Overall Study|Death|1|||
131929164|NCT03400787|475026857|FG001|Overall Study|Death|0|||
131929165|NCT03400787|475026856|FG000|Overall Study|Protocol Violation|0|||
131929166|NCT03400787|475026857|FG001|Overall Study|Protocol Violation|2|||
131929167|NCT03400787|475026856|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
131929168|NCT03400787|475026857|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
131929169|NCT02168439|475026858|FG000|Overall Study|Protocol Violation|0|||
131929170|NCT02168439|475026859|FG001|Overall Study|Protocol Violation|2|||
131929171|NCT02180672|475026864|FG000|Overall Study|Lost to Follow-up|5|||
131929172|NCT02180672|475026865|FG001|Overall Study|Lost to Follow-up|7|||
131929173|NCT02070380|475026867|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
131929174|NCT02070380|475026868|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
131929175|NCT02070380|475026869|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
131929176|NCT02070380|475026870|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
131929177|NCT02070380|475026867|FG000|Second Injection|Image sets missing or technically inadeq|0|||
131929178|NCT02070380|475026868|FG001|Second Injection|Image sets missing or technically inadeq|1|||
131929179|NCT02070380|475026869|FG002|Second Injection|Image sets missing or technically inadeq|0|||
131929180|NCT02070380|475026870|FG003|Second Injection|Image sets missing or technically inadeq|0|||
131929181|NCT02070380|475026867|FG000|Second Injection|Protocol Violation|0|||
131410462|NCT02278614|473124847|FG000|Overall Study|Adverse Event|1|||
131929182|NCT02070380|475026868|FG001|Second Injection|Protocol Violation|1|||
131929183|NCT02070380|475026869|FG002|Second Injection|Protocol Violation|1|||
131929184|NCT02070380|475026870|FG003|Second Injection|Protocol Violation|5|||
131929185|NCT02837952|475026871|FG000|Overall Study|Adverse Event|0|||
131929186|NCT02837952|475026872|FG001|Overall Study|Adverse Event|1|||
131929187|NCT02837952|475026871|FG000|Overall Study|Withdrawal by Subject|4|||
131410463|NCT02278614|473124848|FG001|Overall Study|Adverse Event|0|||
131410464|NCT02278614|473124847|FG000|Overall Study|left eye was not eligible|1|||
131929188|NCT02837952|475026872|FG001|Overall Study|Withdrawal by Subject|5|||
131410465|NCT02278614|473124848|FG001|Overall Study|left eye was not eligible|0|||
131410466|NCT02279498|473124851|FG000|Overall Study|Adverse Event|3|||
131410467|NCT02279498|473124852|FG001|Overall Study|Adverse Event|0|||
131410468|NCT02279498|473124851|FG000|Overall Study|Lack of Efficacy|4|||
131410469|NCT02279498|473124852|FG001|Overall Study|Lack of Efficacy|0|||
131410470|NCT02279498|473124851|FG000|Overall Study|Lost to Follow-up|0|||
131410471|NCT02279498|473124852|FG001|Overall Study|Lost to Follow-up|1|||
131410472|NCT02279498|473124851|FG000|Overall Study|Withdrawal by Subject|9|||
131410473|NCT02279498|473124852|FG001|Overall Study|Withdrawal by Subject|2|||
131410474|NCT02279498|473124851|FG000|Overall Study|Undefined|2|||
131410475|NCT02279498|473124852|FG001|Overall Study|Undefined|1|||
131410476|NCT03582813|473124853|FG000|Overall Study|Lost to Follow-up|18|||
131410477|NCT03582813|473124854|FG001|Overall Study|Lost to Follow-up|21|||
131410478|NCT03582813|473124853|FG000|Overall Study|Withdrawal by Subject|1|||
131929189|NCT02837952|475026871|FG000|Overall Study|Medication Error|1|||
131929190|NCT02837952|475026872|FG001|Overall Study|Medication Error|0|||
131929191|NCT01362530|475026873|FG000|Base Study (Cycle 1)|Adverse Event|2|||
131929192|NCT01362530|475026874|FG001|Base Study (Cycle 1)|Adverse Event|0|||
131929193|NCT01362530|475026873|FG000|Base Study (Cycle 1)|Physician Decision|0|||
131929194|NCT01362530|475026874|FG001|Base Study (Cycle 1)|Physician Decision|1|||
131929195|NCT01362530|475026873|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
131929196|NCT01362530|475026874|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
131929197|NCT01362530|475026873|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
131929198|NCT01362530|475026874|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
131929199|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
131929200|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
131929201|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
131929202|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
131929203|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
131929204|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
131929205|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
131929206|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
131929207|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
131929208|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
131929209|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
131929210|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
131929211|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
131929212|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
131929213|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
131929214|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
131929215|NCT01362530|475026873|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
131929216|NCT01362530|475026874|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
131929217|NCT01034657|475026875|FG000|Core Phase|Withdrawal by Subject|1|||
131929218|NCT01034657|475026876|FG001|Core Phase|Withdrawal by Subject|0|||
131929219|NCT01034657|475026877|FG002|Core Phase|Withdrawal by Subject|0|||
131929220|NCT01034657|475026875|FG000|Core Phase|Lack of Efficacy|2|||
131929221|NCT01034657|475026876|FG001|Core Phase|Lack of Efficacy|0|||
131929222|NCT01034657|475026877|FG002|Core Phase|Lack of Efficacy|0|||
131929223|NCT01034657|475026875|FG000|Core Phase|Abnormal laboratory value|1|||
131929224|NCT01034657|475026876|FG001|Core Phase|Abnormal laboratory value|0|||
131929225|NCT01034657|475026877|FG002|Core Phase|Abnormal laboratory value|0|||
131929226|NCT01034657|475026875|FG000|Core Phase|Adverse Event|8|||
131929227|NCT01034657|475026876|FG001|Core Phase|Adverse Event|0|||
131929228|NCT01034657|475026877|FG002|Core Phase|Adverse Event|0|||
131929229|NCT01034657|475026875|FG000|Core Phase|Protocol Violation|2|||
131929230|NCT01034657|475026876|FG001|Core Phase|Protocol Violation|0|||
131929231|NCT01034657|475026877|FG002|Core Phase|Protocol Violation|0|||
131929232|NCT01034657|475026875|FG000|Randomized Phase|Withdrawal by Subject|0|||
131929233|NCT01034657|475026876|FG001|Randomized Phase|Withdrawal by Subject|2|||
131929234|NCT01034657|475026877|FG002|Randomized Phase|Withdrawal by Subject|0|||
131929235|NCT01034657|475026875|FG000|Randomized Phase|Lack of Efficacy|5|||
131929236|NCT01034657|475026876|FG001|Randomized Phase|Lack of Efficacy|1|||
131929237|NCT01034657|475026877|FG002|Randomized Phase|Lack of Efficacy|0|||
131929238|NCT01034657|475026875|FG000|Randomized Phase|Abnormal laboratory value|0|||
131929239|NCT01034657|475026876|FG001|Randomized Phase|Abnormal laboratory value|1|||
131929240|NCT01034657|475026877|FG002|Randomized Phase|Abnormal laboratory value|0|||
131929241|NCT01034657|475026875|FG000|Randomized Phase|Adverse Event|0|||
131410479|NCT03582813|473124854|FG001|Overall Study|Withdrawal by Subject|0|||
131410480|NCT01048866|473124855|FG000|Overall Study|Adverse Event|1|||
131410481|NCT01048866|473124856|FG001|Overall Study|Adverse Event|0|||
131410482|NCT01048866|473124855|FG000|Overall Study|Protocol Violation|1|||
131410483|NCT01048866|473124856|FG001|Overall Study|Protocol Violation|0|||
131929242|NCT01034657|475026876|FG001|Randomized Phase|Adverse Event|2|||
131929243|NCT01034657|475026877|FG002|Randomized Phase|Adverse Event|1|||
131929244|NCT01791205|475026889|FG000|Phase II|Lack of Efficacy|6|||
131410484|NCT01048866|473124855|FG000|Overall Study|Physician Decision|1|||
131410485|NCT01048866|473124856|FG001|Overall Study|Physician Decision|0|||
131410486|NCT01048866|473124855|FG000|Overall Study|Withdrawal by Subject|0|||
131410487|NCT01048866|473124856|FG001|Overall Study|Withdrawal by Subject|2|||
131410488|NCT01048866|473124855|FG000|Overall Study|Lost to Follow-up|0|||
131410489|NCT01048866|473124856|FG001|Overall Study|Lost to Follow-up|2|||
131410490|NCT01048866|473124855|FG000|Overall Study|Other|1|||
131410491|NCT01048866|473124856|FG001|Overall Study|Other|1|||
131410492|NCT02366767|473124859|FG000|Overall Study|left for home after 1 day at camp|1|||
131410493|NCT02366767|473124860|FG001|Overall Study|left for home after 1 day at camp|0|||
131410494|NCT02558400|473124863|FG000|Overall Study|Adverse Event|47|||
131410495|NCT02558400|473124864|FG001|Overall Study|Adverse Event|53|||
131410496|NCT02558400|473124865|FG002|Overall Study|Adverse Event|4|||
131410497|NCT02558400|473124863|FG000|Overall Study|Withdrawal by Subject|13|||
131410498|NCT02558400|473124864|FG001|Overall Study|Withdrawal by Subject|9|||
131410499|NCT02558400|473124865|FG002|Overall Study|Withdrawal by Subject|8|||
131410500|NCT02558400|473124863|FG000|Overall Study|Non-Compliant|0|||
131410501|NCT02558400|473124864|FG001|Overall Study|Non-Compliant|1|||
131410502|NCT02558400|473124865|FG002|Overall Study|Non-Compliant|3|||
131410503|NCT02558400|473124863|FG000|Overall Study|Lost to Follow-up|5|||
131410504|NCT02558400|473124864|FG001|Overall Study|Lost to Follow-up|5|||
131410505|NCT02558400|473124865|FG002|Overall Study|Lost to Follow-up|4|||
131410506|NCT02558400|473124863|FG000|Overall Study|Lack of Efficacy|0|||
131410507|NCT02558400|473124864|FG001|Overall Study|Lack of Efficacy|13|||
131410508|NCT02558400|473124865|FG002|Overall Study|Lack of Efficacy|1|||
131410509|NCT02558400|473124863|FG000|Overall Study|Disallowed Concurrent Medication|6|||
131410510|NCT02558400|473124864|FG001|Overall Study|Disallowed Concurrent Medication|7|||
131410511|NCT02558400|473124865|FG002|Overall Study|Disallowed Concurrent Medication|5|||
131410512|NCT02558400|473124863|FG000|Overall Study|Physician Decision|2|||
131410513|NCT02558400|473124864|FG001|Overall Study|Physician Decision|2|||
131410514|NCT02558400|473124865|FG002|Overall Study|Physician Decision|0|||
131410515|NCT02558400|473124863|FG000|Overall Study|Protocol Violation|6|||
131410516|NCT02558400|473124864|FG001|Overall Study|Protocol Violation|3|||
131410517|NCT02558400|473124865|FG002|Overall Study|Protocol Violation|8|||
131410518|NCT02558400|473124863|FG000|Overall Study|Death|0|||
131410519|NCT02558400|473124864|FG001|Overall Study|Death|1|||
131410520|NCT02558400|473124865|FG002|Overall Study|Death|0|||
131410521|NCT02558400|473124863|FG000|Overall Study|Ineligible for the study|0|||
131410522|NCT02558400|473124864|FG001|Overall Study|Ineligible for the study|2|||
131410523|NCT02558400|473124865|FG002|Overall Study|Ineligible for the study|0|||
131410524|NCT02230683|473124866|FG000|Overall Study|Adverse Event|1|||
131410525|NCT00260065|473124867|FG000|Overall Study|Progressive Disease|22|||
131410526|NCT00260065|473124867|FG000|Overall Study|Adverse Event|17|||
131410527|NCT00260065|473124867|FG000|Overall Study|Death|13|||
131410528|NCT00260065|473124867|FG000|Overall Study|Withdrawal by Subject|13|||
131410529|NCT00260065|473124867|FG000|Overall Study|Physician Decision|19|||
131410530|NCT00260065|473124867|FG000|Overall Study|Not otherwise specified|8|||
131410531|NCT00260065|473124867|FG000|Overall Study|Medication Noncompliance|1|||
131929245|NCT01791205|475026890|FG001|Phase II|Lack of Efficacy|0|||
131929246|NCT01791205|475026889|FG000|Phase II|Adverse Event|2|||
131929247|NCT01791205|475026890|FG001|Phase II|Adverse Event|0|||
131929248|NCT01791205|475026889|FG000|Phase II|Safety|1|||
131929249|NCT01791205|475026890|FG001|Phase II|Safety|0|||
131929250|NCT01791205|475026889|FG000|Phase II|Lost to Follow-up|1|||
131929251|NCT01791205|475026890|FG001|Phase II|Lost to Follow-up|0|||
131929252|NCT01791205|475026889|FG000|Phase II|Remission of disease|1|||
131929253|NCT01791205|475026890|FG001|Phase II|Remission of disease|0|||
131929254|NCT01791205|475026889|FG000|Phase II|Physician's decision|1|||
131929255|NCT01791205|475026890|FG001|Phase II|Physician's decision|0|||
131929256|NCT02242903|475026891|FG000|Overall Study|Withdrawal by Subject|1|||
131929257|NCT02242903|475026892|FG001|Overall Study|Withdrawal by Subject|0|||
131410532|NCT04068519|473124870|FG000|Dose Verification|Death|15|||
131410533|NCT04068519|473124870|FG000|Dose Verification|Withdrawal by Subject|1|||
131410534|NCT04068519|473124870|FG000|Pharmacokinetic Sub-study|Death|35|||
131410535|NCT04068519|473124870|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
131410536|NCT04068519|473124870|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
131410537|NCT04068519|473124870|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
131410538|NCT04068519|473124870|FG000|Indication Expansion|Death|152|||
131410539|NCT04068519|473124870|FG000|Indication Expansion|Withdrawal by Subject|10|||
131410540|NCT04068519|473124870|FG000|Indication Expansion|Lost to Follow-up|7|||
131410541|NCT03081858|473126553|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
131410542|NCT03081858|473126554|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
131410543|NCT03081858|473126555|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
131410544|NCT03081858|473126556|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
131410545|NCT00262847|473126559|FG000|Overall Study|Disease Progression|309|||
131410546|NCT00262847|473126560|FG001|Overall Study|Disease Progression|274|||
131410547|NCT00262847|473126561|FG002|Overall Study|Disease Progression|195|||
131410548|NCT00262847|473126559|FG000|Overall Study|Patient Refusal|41|||
131410549|NCT00262847|473126560|FG001|Overall Study|Patient Refusal|52|||
131410550|NCT00262847|473126561|FG002|Overall Study|Patient Refusal|47|||
131410551|NCT00262847|473126559|FG000|Overall Study|Adverse Event|74|||
131410552|NCT00262847|473126560|FG001|Overall Study|Adverse Event|88|||
131410553|NCT00262847|473126561|FG002|Overall Study|Adverse Event|108|||
131410554|NCT00262847|473126559|FG000|Overall Study|Death|8|||
131410555|NCT00262847|473126560|FG001|Overall Study|Death|8|||
131929258|NCT02242903|475026893|FG002|Overall Study|Withdrawal by Subject|0|||
131929259|NCT02242903|475026894|FG003|Overall Study|Withdrawal by Subject|0|||
131929260|NCT02242903|475026895|FG004|Overall Study|Withdrawal by Subject|0|||
131929261|NCT02242903|475026896|FG005|Overall Study|Withdrawal by Subject|0|||
131929262|NCT02242903|475026897|FG006|Overall Study|Withdrawal by Subject|0|||
131929263|NCT02105012|475026898|FG000|Overall Study|Withdrawal by Subject|11|||
131929264|NCT02105012|475026898|FG000|Overall Study|Protocol Specified Criteria|9|||
131929265|NCT02105012|475026898|FG000|Overall Study|Lost to Follow-up|4|||
131929266|NCT02105012|475026898|FG000|Overall Study|Protocol Violation|4|||
131929267|NCT02105012|475026898|FG000|Overall Study|Physician Decision|3|||
131929268|NCT02105012|475026898|FG000|Overall Study|Adverse Event|1|||
131929269|NCT02105012|475026898|FG000|Overall Study|Lack of Efficacy|1|||
131929270|NCT03021005|475026899|FG000|Overall Study|Lost to Follow-up|39|||
131929271|NCT03021005|475026900|FG001|Overall Study|Lost to Follow-up|26|||
131929272|NCT03436420|475026907|FG000|Overall Study|Lack of Efficacy|3|||
131929273|NCT00215553|475026908|FG000|Overall Study|Adverse Event|0|||
131929274|NCT00215553|475026909|FG001|Overall Study|Adverse Event|1|||
131929275|NCT00215553|475026910|FG002|Overall Study|Adverse Event|2|||
131929276|NCT00215553|475026911|FG003|Overall Study|Adverse Event|1|||
131929277|NCT00215553|475026912|FG004|Overall Study|Adverse Event|2|||
131929278|NCT00215553|475026913|FG005|Overall Study|Adverse Event|6|||
131929279|NCT00215553|475026914|FG006|Overall Study|Adverse Event|0|||
131929280|NCT00276380|475026920|FG000|Overall Study|Adverse Event|5|||
131929281|NCT00276380|475026921|FG001|Overall Study|Adverse Event|3|||
131929282|NCT00276380|475026920|FG000|Overall Study|Lost to Follow-up|1|||
131929283|NCT00276380|475026921|FG001|Overall Study|Lost to Follow-up|1|||
131929284|NCT00276380|475026920|FG000|Overall Study|Withdrawal by Subject|3|||
131929285|NCT00276380|475026921|FG001|Overall Study|Withdrawal by Subject|6|||
131929286|NCT00276380|475026920|FG000|Overall Study|Death|5|||
131929287|NCT00276380|475026921|FG001|Overall Study|Death|3|||
131929288|NCT00276380|475026920|FG000|Overall Study|Abnormal aPPT Levels|0|||
131929289|NCT00276380|475026921|FG001|Overall Study|Abnormal aPPT Levels|1|||
131929290|NCT02264821|475026922|FG000|Overall Study|Protocol Violation|1|||
131929291|NCT02264821|475026923|FG001|Overall Study|Protocol Violation|3|||
131929292|NCT02264821|475026924|FG002|Overall Study|Protocol Violation|6|||
131929293|NCT00552279|475026925|FG000|Overall Study|Adverse Event|0|||
131929294|NCT00552279|475026926|FG001|Overall Study|Adverse Event|1|||
131929295|NCT00552279|475026925|FG000|Overall Study|Withdrawal by Subject|12|||
131929296|NCT00552279|475026926|FG001|Overall Study|Withdrawal by Subject|1|||
131929297|NCT00552279|475026925|FG000|Overall Study|Lost to Follow-up|1|||
131929298|NCT00552279|475026926|FG001|Overall Study|Lost to Follow-up|0|||
131929299|NCT00552279|475026925|FG000|Overall Study|Other|1|||
131929300|NCT00552279|475026926|FG001|Overall Study|Other|1|||
131929301|NCT03473301|475026928|FG000|Overall Study|Protocol Violation|4|||
131929302|NCT03473301|475026929|FG001|Overall Study|Protocol Violation|0|||
131929303|NCT03473301|475026930|FG002|Overall Study|Protocol Violation|0|||
131929304|NCT03473301|475026928|FG000|Overall Study|Withdrawal by Subject|0|||
131929305|NCT03473301|475026929|FG001|Overall Study|Withdrawal by Subject|1|||
131929306|NCT03473301|475026930|FG002|Overall Study|Withdrawal by Subject|0|||
131929307|NCT03473301|475026928|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
131929308|NCT03473301|475026929|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
131929309|NCT03473301|475026930|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
131929310|NCT05287685|475026931|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
131929311|NCT05287685|475026932|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
131929312|NCT05287685|475026931|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
131929313|NCT05287685|475026932|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
131929314|NCT03093870|475026933|FG000|Overall Study|Withdrawal by Subject|2|||
131929315|NCT03093870|475026934|FG001|Overall Study|Withdrawal by Subject|6|||
131929316|NCT03093870|475026935|FG002|Overall Study|Withdrawal by Subject|5|||
131929317|NCT03093870|475026933|FG000|Overall Study|Death|1|||
131929318|NCT03093870|475026934|FG001|Overall Study|Death|35|||
131929319|NCT03093870|475026935|FG002|Overall Study|Death|35|||
131929320|NCT03093870|475026933|FG000|Overall Study|Radiographic disease progression|10|||
131929321|NCT03093870|475026934|FG001|Overall Study|Radiographic disease progression|0|||
131929322|NCT03093870|475026935|FG002|Overall Study|Radiographic disease progression|0|||
131410556|NCT00262847|473126561|FG002|Overall Study|Death|11|||
131410557|NCT00262847|473126559|FG000|Overall Study|Concomitant disease|3|||
131454127|NCT04421027|473291891|FG000|Follow-Up Period|Lost to Follow-up|0|||
131454128|NCT04421027|473291892|FG001|Follow-Up Period|Lost to Follow-up|0|||
131929323|NCT03093870|475026933|FG000|Overall Study|Clinical disease progression|1|||
131410558|NCT00262847|473126560|FG001|Overall Study|Concomitant disease|2|||
131410559|NCT00262847|473126561|FG002|Overall Study|Concomitant disease|4|||
131410560|NCT00262847|473126559|FG000|Overall Study|Other Reasons|79|||
131410561|NCT00262847|473126560|FG001|Overall Study|Other Reasons|88|||
131410562|NCT00262847|473126561|FG002|Overall Study|Other Reasons|27|||
131410563|NCT00262847|473126559|FG000|Overall Study|Did not receive study treatment|4|||
131410564|NCT00262847|473126560|FG001|Overall Study|Did not receive study treatment|1|||
131410565|NCT00262847|473126561|FG002|Overall Study|Did not receive study treatment|4|||
131410566|NCT03966885|473126562|FG000|Overall Study|Death|1|||
131410567|NCT03966885|473126563|FG001|Overall Study|Death|0|||
131410568|NCT03966885|473126562|FG000|Overall Study|Lost to Follow-up|1|||
131410569|NCT03966885|473126563|FG001|Overall Study|Lost to Follow-up|2|||
131410570|NCT03966885|473126562|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
131410571|NCT03966885|473126563|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
131929324|NCT03093870|475026934|FG001|Overall Study|Clinical disease progression|0|||
131929325|NCT03093870|475026935|FG002|Overall Study|Clinical disease progression|0|||
131410572|NCT03966885|473126562|FG000|Overall Study|Moved from study area.|0|||
131929326|NCT03093870|475026933|FG000|Overall Study|Physician Decision|2|||
131929327|NCT03093870|475026934|FG001|Overall Study|Physician Decision|0|||
131929328|NCT03093870|475026935|FG002|Overall Study|Physician Decision|0|||
131929329|NCT03093870|475026933|FG000|Overall Study|Adverse Event|7|||
131929330|NCT03093870|475026934|FG001|Overall Study|Adverse Event|0|||
131929331|NCT03093870|475026935|FG002|Overall Study|Adverse Event|0|||
131929332|NCT03093870|475026933|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
131929333|NCT03093870|475026934|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
131929334|NCT03093870|475026935|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
131929335|NCT03093870|475026933|FG000|Overall Study|Lost to Follow-up|0|||
131929336|NCT03093870|475026934|FG001|Overall Study|Lost to Follow-up|0|||
131929337|NCT03093870|475026935|FG002|Overall Study|Lost to Follow-up|1|||
131929338|NCT01370642|475026941|FG000|Overall Study|Adverse Event|2|||
131929339|NCT01370642|475026942|FG001|Overall Study|Adverse Event|1|||
131929340|NCT01370642|475026943|FG002|Overall Study|Adverse Event|1|||
131410573|NCT03966885|473126563|FG001|Overall Study|Moved from study area.|2|||
131410574|NCT05013424|473126582|FG000|Overall Study|Lost to Follow-up|1|||
131929341|NCT01370642|475026941|FG000|Overall Study|Detectable HCV RNA|0|||
131929342|NCT01370642|475026942|FG001|Overall Study|Detectable HCV RNA|0|||
131929343|NCT01370642|475026943|FG002|Overall Study|Detectable HCV RNA|22|||
131929344|NCT01370642|475026941|FG000|Overall Study|Lost to Follow-up|0|||
131929345|NCT01370642|475026942|FG001|Overall Study|Lost to Follow-up|0|||
131929346|NCT01370642|475026943|FG002|Overall Study|Lost to Follow-up|1|||
131929347|NCT01370642|475026941|FG000|Overall Study|Physician Decision|4|||
131929348|NCT01370642|475026942|FG001|Overall Study|Physician Decision|1|||
131929349|NCT01370642|475026943|FG002|Overall Study|Physician Decision|2|||
131929350|NCT01370642|475026941|FG000|Overall Study|Withdrawal by Subject|2|||
131929351|NCT01370642|475026942|FG001|Overall Study|Withdrawal by Subject|4|||
131929352|NCT01370642|475026943|FG002|Overall Study|Withdrawal by Subject|3|||
131929353|NCT01796470|475026944|FG000|Overall Study|Adverse Event|4|||
131929354|NCT01796470|475026945|FG001|Overall Study|Adverse Event|2|||
131929355|NCT01796470|475026946|FG002|Overall Study|Adverse Event|2|||
131929356|NCT01796470|475026947|FG003|Overall Study|Adverse Event|1|||
131929357|NCT01796470|475026948|FG004|Overall Study|Adverse Event|3|||
131929358|NCT01796470|475026944|FG000|Overall Study|Death|2|||
131929359|NCT01796470|475026945|FG001|Overall Study|Death|0|||
131929360|NCT01796470|475026946|FG002|Overall Study|Death|0|||
131929361|NCT01796470|475026947|FG003|Overall Study|Death|0|||
131929362|NCT01796470|475026948|FG004|Overall Study|Death|1|||
131929363|NCT01796470|475026944|FG000|Overall Study|Initiated New Therapy|9|||
131929364|NCT01796470|475026945|FG001|Overall Study|Initiated New Therapy|0|||
131929365|NCT01796470|475026946|FG002|Overall Study|Initiated New Therapy|0|||
131929366|NCT01796470|475026947|FG003|Overall Study|Initiated New Therapy|0|||
131929367|NCT01796470|475026948|FG004|Overall Study|Initiated New Therapy|2|||
131929368|NCT01796470|475026944|FG000|Overall Study|Lost to Follow-up|0|||
131929369|NCT01796470|475026945|FG001|Overall Study|Lost to Follow-up|1|||
131929370|NCT01796470|475026946|FG002|Overall Study|Lost to Follow-up|0|||
131929371|NCT01796470|475026947|FG003|Overall Study|Lost to Follow-up|0|||
131410575|NCT05013424|473126583|FG001|Overall Study|Lost to Follow-up|1|||
131410576|NCT05013424|473126584|FG002|Overall Study|Lost to Follow-up|1|||
131929372|NCT01796470|475026948|FG004|Overall Study|Lost to Follow-up|0|||
131410577|NCT05013424|473126582|FG000|Overall Study|Withdrawal by Subject|0|||
131410578|NCT05013424|473126583|FG001|Overall Study|Withdrawal by Subject|1|||
131410579|NCT05013424|473126584|FG002|Overall Study|Withdrawal by Subject|0|||
131929373|NCT01796470|475026944|FG000|Overall Study|Physician Decision|5|||
131929374|NCT01796470|475026945|FG001|Overall Study|Physician Decision|4|||
131929375|NCT01796470|475026946|FG002|Overall Study|Physician Decision|1|||
131929376|NCT01796470|475026947|FG003|Overall Study|Physician Decision|0|||
131929377|NCT01796470|475026948|FG004|Overall Study|Physician Decision|1|||
131929378|NCT01796470|475026944|FG000|Overall Study|Progressive Disease|7|||
131410580|NCT03654885|473126585|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
131410581|NCT03654885|473126586|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
131410582|NCT03654885|473126585|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
131410583|NCT03654885|473126586|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
131410584|NCT03654885|473126585|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
131410585|NCT03654885|473126586|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
131410586|NCT03654885|473126585|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
131410587|NCT03654885|473126586|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
131410588|NCT03654885|473126585|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
131410589|NCT03654885|473126586|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
131410590|NCT03654885|473126585|FG000|Overall Study|Adverse Event in Study Eye|3|||
131410591|NCT03654885|473126586|FG001|Overall Study|Adverse Event in Study Eye|0|||
131410592|NCT03654885|473126585|FG000|Overall Study|Consent Withdrawn|1|||
131410593|NCT03654885|473126586|FG001|Overall Study|Consent Withdrawn|0|||
131410594|NCT03654885|473126585|FG000|Overall Study|Death|3|||
131410595|NCT03654885|473126586|FG001|Overall Study|Death|1|||
131410596|NCT03654885|473126585|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
131410597|NCT03654885|473126586|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
131410598|NCT03654885|473126585|FG000|Overall Study|Lost to Follow-up|3|||
131410599|NCT03654885|473126586|FG001|Overall Study|Lost to Follow-up|3|||
131410600|NCT05275582|473126587|FG000|Overall Study|Lost to Follow-up|1|||
131410601|NCT05275582|473126588|FG001|Overall Study|Lost to Follow-up|0|||
131410602|NCT05275582|473126587|FG000|Overall Study|Withdrawal by Subject|0|||
131410603|NCT05275582|473126588|FG001|Overall Study|Withdrawal by Subject|2|||
131410604|NCT05275582|473126587|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
131410605|NCT05275582|473126588|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
131410606|NCT05275582|473126587|FG000|Overall Study|Death|1|||
131410607|NCT05275582|473126588|FG001|Overall Study|Death|0|||
131929379|NCT01796470|475026945|FG001|Overall Study|Progressive Disease|7|||
131929380|NCT01796470|475026946|FG002|Overall Study|Progressive Disease|3|||
131929381|NCT01796470|475026947|FG003|Overall Study|Progressive Disease|2|||
131929382|NCT01796470|475026948|FG004|Overall Study|Progressive Disease|0|||
131929383|NCT01796470|475026944|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
131929384|NCT01796470|475026945|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
131929385|NCT01796470|475026946|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
131929386|NCT01796470|475026947|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
131929387|NCT01796470|475026948|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
131929388|NCT01796470|475026944|FG000|Overall Study|Withdrawal by Subject|7|||
131929389|NCT01796470|475026945|FG001|Overall Study|Withdrawal by Subject|0|||
131929390|NCT01796470|475026946|FG002|Overall Study|Withdrawal by Subject|0|||
131929391|NCT01796470|475026947|FG003|Overall Study|Withdrawal by Subject|0|||
131929392|NCT01796470|475026948|FG004|Overall Study|Withdrawal by Subject|1|||
131929393|NCT02176525|475026949|FG000|Overall Study|Adverse Event|0|||
131929394|NCT02176525|475026950|FG001|Overall Study|Adverse Event|0|||
131929395|NCT02176525|475026951|FG002|Overall Study|Adverse Event|0|||
131929396|NCT02176525|475026952|FG003|Overall Study|Adverse Event|1|||
131929397|NCT02176525|475026953|FG004|Overall Study|Adverse Event|1|||
131929398|NCT02176525|475026954|FG005|Overall Study|Adverse Event|0|||
131929399|NCT02176525|475026955|FG006|Overall Study|Adverse Event|1|||
131929400|NCT02176525|475026956|FG007|Overall Study|Adverse Event|0|||
131929401|NCT02176525|475026949|FG000|Overall Study|not treated|1|||
131929402|NCT02176525|475026950|FG001|Overall Study|not treated|0|||
131929403|NCT02176525|475026951|FG002|Overall Study|not treated|0|||
131929404|NCT02176525|475026952|FG003|Overall Study|not treated|0|||
131929405|NCT02176525|475026953|FG004|Overall Study|not treated|0|||
131929406|NCT02176525|475026954|FG005|Overall Study|not treated|1|||
131929407|NCT02176525|475026955|FG006|Overall Study|not treated|0|||
131929408|NCT02176525|475026956|FG007|Overall Study|not treated|0|||
131929409|NCT01905267|475026957|FG000|Overall Study|Physician Decision|2|||
131929410|NCT01905267|475026958|FG001|Overall Study|Physician Decision|2|||
131929411|NCT03888482|475026959|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
131929412|NCT03888482|475026960|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
131929413|NCT03888482|475026959|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
131929414|NCT03888482|475026960|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
131929415|NCT02554474|475026961|FG000|Overall Study|Protocol Violation|1|||
131929416|NCT02554474|475026962|FG001|Overall Study|Protocol Violation|1|||
131929417|NCT02554474|475026961|FG000|Overall Study|Health issue not related to the study|1|||
131929418|NCT02554474|475026962|FG001|Overall Study|Health issue not related to the study|0|||
131410608|NCT05275582|473126587|FG000|Overall Study|Protocol Violation|1|||
131410609|NCT05275582|473126588|FG001|Overall Study|Protocol Violation|0|||
131410610|NCT03899064|473126589|FG000|Overall Study|Lost to Follow-up|1|||
131929419|NCT02554474|475026961|FG000|Overall Study|Withdrawal by Subject|1|||
131929420|NCT02554474|475026962|FG001|Overall Study|Withdrawal by Subject|1|||
131410611|NCT03899064|473126589|FG000|Overall Study|Protocol Violation|2|||
131410612|NCT03899064|473126589|FG000|Overall Study|Withdrawal by Subject|2|||
131410613|NCT03899064|473126589|FG000|Overall Study|Other|2|||
131410614|NCT00031460|473126592|FG000|Overall Study|Lost to Follow-up|0|||
131410615|NCT00031460|473126593|FG001|Overall Study|Lost to Follow-up|1|||
131410616|NCT00031460|473126592|FG000|Overall Study|Withdrawal by Subject|1|||
131929421|NCT00215657|475026965|FG000|Overall Study|Adverse Event|5|||
131929422|NCT00215657|475026966|FG001|Overall Study|Adverse Event|1|||
131929423|NCT00215657|475026967|FG002|Overall Study|Adverse Event|3|||
131929424|NCT00215657|475026968|FG003|Overall Study|Adverse Event|0|||
131929425|NCT00215657|475026969|FG004|Overall Study|Adverse Event|3|||
131929426|NCT00215657|475026970|FG005|Overall Study|Adverse Event|1|||
131929427|NCT00215657|475026971|FG006|Overall Study|Adverse Event|0|||
131929428|NCT00215657|475026972|FG007|Overall Study|Adverse Event|3|||
131929429|NCT00215657|475026965|FG000|Overall Study|Withdrawal by Subject|6|||
131929430|NCT00215657|475026966|FG001|Overall Study|Withdrawal by Subject|3|||
131929431|NCT00215657|475026967|FG002|Overall Study|Withdrawal by Subject|3|||
131929432|NCT00215657|475026968|FG003|Overall Study|Withdrawal by Subject|1|||
131929433|NCT00215657|475026969|FG004|Overall Study|Withdrawal by Subject|6|||
131929434|NCT00215657|475026970|FG005|Overall Study|Withdrawal by Subject|1|||
131929435|NCT00215657|475026971|FG006|Overall Study|Withdrawal by Subject|10|||
131929436|NCT00215657|475026972|FG007|Overall Study|Withdrawal by Subject|3|||
131929437|NCT00215657|475026965|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
131929438|NCT00215657|475026966|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
131929439|NCT00215657|475026967|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
131929440|NCT00215657|475026968|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
131929441|NCT00215657|475026969|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
131929442|NCT00215657|475026970|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
131929443|NCT00215657|475026971|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
131929444|NCT00215657|475026972|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
131929445|NCT00215657|475026965|FG000|Overall Study|Insufficient testosterone response|5|||
131929446|NCT00215657|475026966|FG001|Overall Study|Insufficient testosterone response|4|||
131929447|NCT00215657|475026967|FG002|Overall Study|Insufficient testosterone response|1|||
131929448|NCT00215657|475026968|FG003|Overall Study|Insufficient testosterone response|12|||
131929449|NCT00215657|475026969|FG004|Overall Study|Insufficient testosterone response|8|||
131929450|NCT00215657|475026970|FG005|Overall Study|Insufficient testosterone response|12|||
131929451|NCT00215657|475026971|FG006|Overall Study|Insufficient testosterone response|4|||
131929452|NCT00215657|475026972|FG007|Overall Study|Insufficient testosterone response|7|||
131929453|NCT00215657|475026965|FG000|Overall Study|Other|3|||
131929454|NCT00215657|475026966|FG001|Overall Study|Other|1|||
131929455|NCT00215657|475026967|FG002|Overall Study|Other|2|||
131929456|NCT00215657|475026968|FG003|Overall Study|Other|3|||
131929457|NCT00215657|475026969|FG004|Overall Study|Other|5|||
131929458|NCT00215657|475026970|FG005|Overall Study|Other|4|||
131929459|NCT00215657|475026971|FG006|Overall Study|Other|6|||
131929460|NCT00215657|475026972|FG007|Overall Study|Other|1|||
131929461|NCT03769467|475026973|FG000|Overall Study|Adverse Event|1|||
131929462|NCT03769467|475026974|FG001|Overall Study|Adverse Event|1|||
131929463|NCT03769467|475026975|FG002|Overall Study|Adverse Event|0|||
131929464|NCT03769467|475026973|FG000|Overall Study|Death|3|||
131929465|NCT03769467|475026974|FG001|Overall Study|Death|3|||
131929466|NCT03769467|475026975|FG002|Overall Study|Death|0|||
131929467|NCT03769467|475026973|FG000|Overall Study|Study Terminated By Sponsor|2|||
131929468|NCT03769467|475026974|FG001|Overall Study|Study Terminated By Sponsor|1|||
131929469|NCT03769467|475026975|FG002|Overall Study|Study Terminated By Sponsor|0|||
131929470|NCT03769467|475026973|FG000|Overall Study|Withdrawal by Subject|0|||
131929471|NCT03769467|475026974|FG001|Overall Study|Withdrawal by Subject|1|||
131929472|NCT03769467|475026975|FG002|Overall Study|Withdrawal by Subject|0|||
131410617|NCT00031460|473126593|FG001|Overall Study|Withdrawal by Subject|1|||
131410618|NCT00031460|473126592|FG000|Overall Study|Non-Compliant|1|||
131410619|NCT00031460|473126593|FG001|Overall Study|Non-Compliant|1|||
131410620|NCT00031460|473126592|FG000|Overall Study|Death|0|||
131410621|NCT00031460|473126593|FG001|Overall Study|Death|1|||
131410622|NCT00031460|473126592|FG000|Overall Study|Reactivation of Disease|5|||
131410623|NCT00031460|473126593|FG001|Overall Study|Reactivation of Disease|9|||
131410624|NCT00031460|473126592|FG000|Overall Study|Disruption of blinded drug supply|2|||
131410625|NCT00031460|473126593|FG001|Overall Study|Disruption of blinded drug supply|0|||
131410626|NCT00031460|473126592|FG000|Overall Study|Confirmed unevaluable|0|||
131410627|NCT00031460|473126593|FG001|Overall Study|Confirmed unevaluable|1|||
131410628|NCT02210832|473126594|FG000|Overall Study|Pregnancy termination .|3|||
131410629|NCT02210832|473126595|FG001|Overall Study|Pregnancy termination .|4|||
131454129|NCT04421027|473291893|FG002|Follow-Up Period|Lost to Follow-up|7|||
131929473|NCT01185366|475026976|FG000|First Line Therapy|Insurance Coverage Denied|1|||
131929474|NCT01185366|475026977|FG001|First Line Therapy|Insurance Coverage Denied|1|||
131929475|NCT01185366|475026976|FG000|First Line Therapy|Withdrawal by Subject|1|||
131929476|NCT01185366|475026977|FG001|First Line Therapy|Withdrawal by Subject|0|||
131410630|NCT02210832|473126596|FG002|Overall Study|Pregnancy termination .|1|||
131410631|NCT02210832|473126594|FG000|Overall Study|Lost to Follow-up|26|||
131882010|NCT01097421|474849301|FG000|Overall Study|Adverse Event|8|||
131882011|NCT01097421|474849301|FG000|Overall Study|Protocol Violation|2|||
131882012|NCT01097421|474849301|FG000|Overall Study|Lost to Follow-up|1|||
131882013|NCT01097421|474849301|FG000|Overall Study|Withdrawal by Subject|3|||
131882014|NCT02062944|474849307|FG000|Overall Study|Lost to Follow-up|1|||
131882015|NCT02062944|474849307|FG000|Overall Study|New hemotological disorder identified|1|||
131882016|NCT02062944|474849307|FG000|Overall Study|Uncontrolled Hypertension|1|||
131882017|NCT02062944|474849307|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
131882018|NCT01088243|474849309|FG000|Overall Study|Adverse Event|1|||
131882019|NCT01088243|474849310|FG001|Overall Study|Adverse Event|0|||
131882020|NCT00478699|474849315|FG000|Overall Study|Inclusion Error|1|||
131882021|NCT00478699|474849316|FG001|Overall Study|Inclusion Error|7|||
131882022|NCT00478699|474849315|FG000|Overall Study|Not receive study treatment|6|||
131882023|NCT00478699|474849316|FG001|Overall Study|Not receive study treatment|30|||
131882024|NCT01043705|474849319|FG000|Overall Study|Death|28|||
131882025|NCT01043705|474849320|FG001|Overall Study|Death|60|||
131882026|NCT01043705|474849321|FG002|Overall Study|Death|26|||
131882027|NCT01043705|474849319|FG000|Overall Study|Lost to Follow-up|27|||
131882028|NCT01043705|474849320|FG001|Overall Study|Lost to Follow-up|12|||
131882029|NCT01043705|474849321|FG002|Overall Study|Lost to Follow-up|0|||
131882030|NCT01043705|474849319|FG000|Overall Study|Multiple Reasons|4|||
131882031|NCT01043705|474849320|FG001|Overall Study|Multiple Reasons|7|||
131882032|NCT01043705|474849321|FG002|Overall Study|Multiple Reasons|0|||
131882033|NCT01043705|474849319|FG000|Overall Study|Protocol Violation|2|||
131882034|NCT01043705|474849320|FG001|Overall Study|Protocol Violation|1|||
131882035|NCT01043705|474849321|FG002|Overall Study|Protocol Violation|0|||
131882036|NCT01043705|474849319|FG000|Overall Study|Withdrawal by Subject|8|||
131882037|NCT01043705|474849320|FG001|Overall Study|Withdrawal by Subject|6|||
131882038|NCT01043705|474849321|FG002|Overall Study|Withdrawal by Subject|0|||
131882039|NCT01043705|474849319|FG000|Overall Study|Site Closure|8|||
131882040|NCT01043705|474849320|FG001|Overall Study|Site Closure|0|||
131882041|NCT01043705|474849321|FG002|Overall Study|Site Closure|0|||
131882042|NCT01043705|474849319|FG000|Overall Study|Subsequent Procedure|9|||
131882043|NCT01043705|474849320|FG001|Overall Study|Subsequent Procedure|24|||
131882044|NCT01043705|474849321|FG002|Overall Study|Subsequent Procedure|29|||
131882045|NCT01043705|474849319|FG000|Overall Study|Adverse Event|0|||
131882046|NCT01043705|474849320|FG001|Overall Study|Adverse Event|2|||
131882047|NCT01043705|474849321|FG002|Overall Study|Adverse Event|0|||
131882048|NCT01043705|474849319|FG000|Overall Study|Screen Fail|21|||
131882049|NCT01043705|474849320|FG001|Overall Study|Screen Fail|0|||
131882050|NCT01043705|474849321|FG002|Overall Study|Screen Fail|0|||
131882051|NCT01043705|474849319|FG000|Overall Study|Other|0|||
131882052|NCT01043705|474849320|FG001|Overall Study|Other|19|||
131882053|NCT01043705|474849321|FG002|Overall Study|Other|25|||
131882054|NCT01123941|474849324|FG000|Overall Study|Lost to Follow-up|2|||
131882055|NCT01123941|474849325|FG001|Overall Study|Lost to Follow-up|1|||
131882056|NCT04601103|474849326|FG000|Overall Study|Needed crown & cleaning|0|||
131882057|NCT04601103|474849327|FG001|Overall Study|Needed crown & cleaning|0|||
131882058|NCT04601103|474849328|FG002|Overall Study|Needed crown & cleaning|1|||
131882059|NCT04601103|474849326|FG000|Overall Study|study was terminated|18|||
131882060|NCT04601103|474849327|FG001|Overall Study|study was terminated|18|||
131882061|NCT04601103|474849328|FG002|Overall Study|study was terminated|16|||
131882062|NCT06011161|474849329|FG000|Overall Study|Withdrawal by Subject|2|||
131882063|NCT06011161|474849329|FG000|Overall Study|Lost to Follow-up|5|||
131882064|NCT00381043|474849330|FG000|Overall Study|Lost to Follow-up|8|||
131882065|NCT00381043|474849331|FG001|Overall Study|Lost to Follow-up|6|||
131882066|NCT00381043|474849330|FG000|Overall Study|Withdrawal by Subject|3|||
131882067|NCT00381043|474849331|FG001|Overall Study|Withdrawal by Subject|1|||
131882068|NCT00381043|474849330|FG000|Overall Study|wanted more care|0|||
131882069|NCT00381043|474849331|FG001|Overall Study|wanted more care|1|||
131882070|NCT00381043|474849330|FG000|Overall Study|incarcerated|1|||
131882071|NCT00381043|474849331|FG001|Overall Study|incarcerated|0|||
131882072|NCT03045276|474849334|FG000|Intervention Phase|Withdrawal by Subject|7|||
131882073|NCT03045276|474849335|FG001|Intervention Phase|Withdrawal by Subject|2|||
131882074|NCT03045276|474849336|FG002|Intervention Phase|Withdrawal by Subject|3|||
131882075|NCT03045276|474849337|FG003|Intervention Phase|Withdrawal by Subject|7|||
131882076|NCT03045276|474849334|FG000|Intervention Phase|Developed exclusionary criteria|3|||
131882077|NCT03045276|474849335|FG001|Intervention Phase|Developed exclusionary criteria|3|||
131882078|NCT03045276|474849336|FG002|Intervention Phase|Developed exclusionary criteria|0|||
131882079|NCT03045276|474849337|FG003|Intervention Phase|Developed exclusionary criteria|0|||
131882080|NCT03045276|474849334|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
131882081|NCT03045276|474849335|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
131882082|NCT03045276|474849336|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
131929477|NCT01185366|475026976|FG000|First Line Therapy|Lack of Metastatic Site|1|||
131929478|NCT01185366|475026977|FG001|First Line Therapy|Lack of Metastatic Site|0|||
131410632|NCT02210832|473126595|FG001|Overall Study|Lost to Follow-up|32|||
131410633|NCT02210832|473126596|FG002|Overall Study|Lost to Follow-up|17|||
131410634|NCT02080260|473126598|FG000|Overall Study|Death|18|||
131410635|NCT02080260|473126598|FG000|Overall Study|Withdrawal by Subject|1|||
131410636|NCT00471887|473126604|FG000|Overall Study|Adverse Event|9|||
131410637|NCT03710876|473126605|FG000|Overall Study|Death|0|||
131410638|NCT03710876|473126606|FG001|Overall Study|Death|2|||
131410639|NCT03710876|473126605|FG000|Overall Study|Withdrawal by Subject|0|||
131410640|NCT03710876|473126606|FG001|Overall Study|Withdrawal by Subject|2|||
131410641|NCT03602885|473126618|FG000|Overall Study|Lost to Follow-up|3|||
131410642|NCT03602885|473126619|FG001|Overall Study|Lost to Follow-up|0|||
131410643|NCT01998893|473126620|FG000|Overall Study|Adverse Event|2|||
131410644|NCT01998893|473126620|FG000|Overall Study|Death|1|||
131454130|NCT04421027|473291894|FG003|Follow-Up Period|Lost to Follow-up|7|||
131454131|NCT04421027|473291891|FG000|Follow-Up Period|Protocol Deviation|0|||
131454132|NCT04421027|473291892|FG001|Follow-Up Period|Protocol Deviation|0|||
131454133|NCT04421027|473291893|FG002|Follow-Up Period|Protocol Deviation|1|||
131454134|NCT04421027|473291894|FG003|Follow-Up Period|Protocol Deviation|0|||
131454135|NCT04421027|473291891|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
131454136|NCT04421027|473291892|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
131454137|NCT04421027|473291893|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
131454138|NCT04421027|473291894|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
131454139|NCT04421027|473291891|FG000|Follow-Up Period|Left message, participant did not call back|0|||
131454140|NCT04421027|473291892|FG001|Follow-Up Period|Left message, participant did not call back|0|||
131454141|NCT04421027|473291893|FG002|Follow-Up Period|Left message, participant did not call back|0|||
131454142|NCT04421027|473291894|FG003|Follow-Up Period|Left message, participant did not call back|1|||
131454143|NCT04421027|473291891|FG000|Follow-Up Period|Participant died|0|||
131454144|NCT04421027|473291892|FG001|Follow-Up Period|Participant died|0|||
131454145|NCT04421027|473291893|FG002|Follow-Up Period|Participant died|0|||
131454146|NCT04421027|473291894|FG003|Follow-Up Period|Participant died|1|||
131454147|NCT04421027|473291891|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
131454148|NCT04421027|473291892|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
131454149|NCT04421027|473291893|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
131454150|NCT04421027|473291894|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
131454151|NCT02003924|473291905|FG000|Double-blind Phase|Lost to Follow-up|2|||
131929479|NCT01185366|475026976|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
131929480|NCT01185366|475026977|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
131929481|NCT01185366|475026976|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
131929482|NCT01185366|475026977|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
131929483|NCT01185366|475026976|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
131929484|NCT01185366|475026977|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
131929485|NCT01185366|475026976|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
131929486|NCT01185366|475026977|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
131929487|NCT01783938|475026979|FG000|Overall Study|Disease Progression|18|||
131929488|NCT01783938|475026980|FG001|Overall Study|Disease Progression|41|||
131929489|NCT01783938|475026979|FG000|Overall Study|Study Drug Toxicity|27|||
131929490|NCT01783938|475026980|FG001|Overall Study|Study Drug Toxicity|14|||
131929491|NCT01783938|475026979|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
131929492|NCT01783938|475026980|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
131929493|NCT01783938|475026979|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
131929494|NCT01783938|475026980|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
131929495|NCT01783938|475026979|FG000|Overall Study|Participant Withdrew Consent|2|||
131929496|NCT01783938|475026980|FG001|Overall Study|Participant Withdrew Consent|0|||
131929497|NCT01783938|475026979|FG000|Overall Study|Maximum Clinical Benefit|1|||
131929498|NCT01783938|475026980|FG001|Overall Study|Maximum Clinical Benefit|0|||
131929499|NCT01783938|475026979|FG000|Overall Study|Other Reasons|3|||
131929500|NCT01783938|475026980|FG001|Overall Study|Other Reasons|1|||
131929501|NCT03072875|475026981|FG000|Overall Study|Lost to Follow-up|1|||
131929502|NCT03478787|475026982|FG000|Overall Study|Adverse Event|5|||
131929503|NCT03478787|475026983|FG001|Overall Study|Adverse Event|1|||
131929504|NCT03478787|475026982|FG000|Overall Study|Protocol Violation|3|||
131929505|NCT03478787|475026983|FG001|Overall Study|Protocol Violation|0|||
131929506|NCT03478787|475026982|FG000|Overall Study|Lack of Efficacy|7|||
131929507|NCT03478787|475026983|FG001|Overall Study|Lack of Efficacy|1|||
131410645|NCT01998893|473126620|FG000|Overall Study|Lost to Follow-up|8|||
131410646|NCT01998893|473126620|FG000|Overall Study|Physician Decision|2|||
131410647|NCT01998893|473126620|FG000|Overall Study|Protocol Violation|2|||
131410648|NCT01998893|473126620|FG000|Overall Study|Withdrawal by Subject|1|||
131410649|NCT01998893|473126620|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
131410650|NCT03784846|473126621|FG000|Pre-COVID Study|Lost to Follow-up|3|||
131929508|NCT03478787|475026982|FG000|Overall Study|Lost to Follow-up|9|||
131929509|NCT03478787|475026983|FG001|Overall Study|Lost to Follow-up|5|||
131929510|NCT03478787|475026982|FG000|Overall Study|Withdrawal by Subject|2|||
131929511|NCT03478787|475026983|FG001|Overall Study|Withdrawal by Subject|6|||
131929512|NCT03478787|475026982|FG000|Overall Study|Other, Not Specified|3|||
131929513|NCT03478787|475026983|FG001|Overall Study|Other, Not Specified|0|||
131929514|NCT01539525|475026985|FG000|Overall Study|Lost to Follow-up|19|||
131929515|NCT01539525|475026986|FG001|Overall Study|Lost to Follow-up|12|||
131929516|NCT01539525|475026987|FG002|Overall Study|Lost to Follow-up|11|||
131929517|NCT01539525|475026985|FG000|Overall Study|Withdrawal by Subject|0|||
131929518|NCT01539525|475026986|FG001|Overall Study|Withdrawal by Subject|3|||
131929519|NCT01539525|475026987|FG002|Overall Study|Withdrawal by Subject|2|||
131929520|NCT01539525|475026985|FG000|Overall Study|Protocol Violation|1|||
131929521|NCT01539525|475026986|FG001|Overall Study|Protocol Violation|1|||
131929522|NCT01539525|475026987|FG002|Overall Study|Protocol Violation|4|||
131929523|NCT01712074|475026988|FG000|Placebo Run-in Period|Adverse Event|2|||
131929524|NCT01712074|475026989|FG001|Placebo Run-in Period|Adverse Event|0|||
131929525|NCT01712074|475026990|FG002|Placebo Run-in Period|Adverse Event|0|||
131929526|NCT01712074|475026988|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
131929527|NCT01712074|475026989|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
131929528|NCT01712074|475026990|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
131929529|NCT01712074|475026988|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
131929530|NCT01712074|475026989|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
131929531|NCT01712074|475026990|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
131929532|NCT01712074|475026988|FG000|Placebo Run-in Period|Other|1|||
131929533|NCT01712074|475026989|FG001|Placebo Run-in Period|Other|0|||
131929534|NCT01712074|475026990|FG002|Placebo Run-in Period|Other|0|||
131929535|NCT01712074|475026988|FG000|Placebo Run-in Period|No longer willing to participate|1|||
131929536|NCT01712074|475026989|FG001|Placebo Run-in Period|No longer willing to participate|0|||
131929537|NCT01712074|475026990|FG002|Placebo Run-in Period|No longer willing to participate|0|||
131929538|NCT01712074|475026988|FG000|Double Blind Period|Adverse Event|0|||
131929539|NCT01712074|475026989|FG001|Double Blind Period|Adverse Event|2|||
131929540|NCT01712074|475026990|FG002|Double Blind Period|Adverse Event|1|||
131929541|NCT01712074|475026988|FG000|Double Blind Period|No longer willing to participate|0|||
131929542|NCT01712074|475026989|FG001|Double Blind Period|No longer willing to participate|2|||
131929543|NCT01712074|475026990|FG002|Double Blind Period|No longer willing to participate|4|||
131929544|NCT01712074|475026988|FG000|Double Blind Period|Death|0|||
131929545|NCT01712074|475026989|FG001|Double Blind Period|Death|1|||
131929546|NCT01712074|475026990|FG002|Double Blind Period|Death|0|||
131929547|NCT01712074|475026988|FG000|Double Blind Period|Lost to Follow-up|0|||
131929548|NCT01712074|475026989|FG001|Double Blind Period|Lost to Follow-up|2|||
131929549|NCT01712074|475026990|FG002|Double Blind Period|Lost to Follow-up|1|||
131929550|NCT01712074|475026988|FG000|Double Blind Period|Other|0|||
131929551|NCT01712074|475026989|FG001|Double Blind Period|Other|4|||
131929552|NCT01712074|475026990|FG002|Double Blind Period|Other|1|||
131929553|NCT01712074|475026988|FG000|Double Blind Period|Protocol Violation|0|||
131929554|NCT01712074|475026989|FG001|Double Blind Period|Protocol Violation|0|||
131929555|NCT01712074|475026990|FG002|Double Blind Period|Protocol Violation|1|||
131929556|NCT01712074|475026988|FG000|Double Blind Period|No longer met eligibility criteria|0|||
131929557|NCT01712074|475026989|FG001|Double Blind Period|No longer met eligibility criteria|3|||
131929558|NCT01712074|475026990|FG002|Double Blind Period|No longer met eligibility criteria|0|||
131929559|NCT02268851|475026991|FG000|Overall Study|Death|0|||
131929560|NCT02268851|475026992|FG001|Overall Study|Death|0|||
131929561|NCT02268851|475026993|FG002|Overall Study|Death|0|||
131929562|NCT02268851|475026994|FG003|Overall Study|Death|1|||
131929563|NCT02268851|475026995|FG004|Overall Study|Death|2|||
131929564|NCT02268851|475026996|FG005|Overall Study|Death|1|||
131929565|NCT02268851|475026991|FG000|Overall Study|Adverse Event|0|||
131929566|NCT02268851|475026992|FG001|Overall Study|Adverse Event|0|||
131929567|NCT02268851|475026993|FG002|Overall Study|Adverse Event|0|||
131929568|NCT02268851|475026994|FG003|Overall Study|Adverse Event|0|||
131929569|NCT02268851|475026995|FG004|Overall Study|Adverse Event|2|||
131929570|NCT02268851|475026996|FG005|Overall Study|Adverse Event|2|||
131929571|NCT02268851|475026991|FG000|Overall Study|Withdrawal by Subject|0|||
131929572|NCT02268851|475026992|FG001|Overall Study|Withdrawal by Subject|0|||
131929573|NCT02268851|475026993|FG002|Overall Study|Withdrawal by Subject|0|||
131929574|NCT02268851|475026994|FG003|Overall Study|Withdrawal by Subject|2|||
131929575|NCT02268851|475026995|FG004|Overall Study|Withdrawal by Subject|0|||
131929576|NCT02268851|475026996|FG005|Overall Study|Withdrawal by Subject|1|||
131929577|NCT02268851|475026991|FG000|Overall Study|Progressive Disease|1|||
131929578|NCT02268851|475026992|FG001|Overall Study|Progressive Disease|3|||
131929579|NCT02268851|475026993|FG002|Overall Study|Progressive Disease|0|||
131929580|NCT02268851|475026994|FG003|Overall Study|Progressive Disease|0|||
131929581|NCT02268851|475026995|FG004|Overall Study|Progressive Disease|1|||
131929582|NCT02268851|475026996|FG005|Overall Study|Progressive Disease|4|||
131929583|NCT02268851|475026991|FG000|Overall Study|Physician Decision|0|||
131929584|NCT02268851|475026992|FG001|Overall Study|Physician Decision|0|||
131410651|NCT03784846|473126622|FG001|Pre-COVID Study|Lost to Follow-up|3|||
131410652|NCT03784846|473126623|FG002|Pre-COVID Study|Lost to Follow-up|2|||
131410653|NCT03784846|473126621|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
131410654|NCT03784846|473126622|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
131410655|NCT03784846|473126623|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
131410656|NCT03784846|473126621|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
131410657|NCT03784846|473126622|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
131410658|NCT03784846|473126623|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
131410659|NCT03784846|473126621|FG000|Post-COVID Study|Lost to Follow-up|3|||
131410660|NCT03784846|473126622|FG001|Post-COVID Study|Lost to Follow-up|5|||
131410661|NCT03784846|473126623|FG002|Post-COVID Study|Lost to Follow-up|1|||
131410662|NCT03784846|473126621|FG000|Post-COVID Study|Withdrawal by Subject|1|||
131410663|NCT03784846|473126622|FG001|Post-COVID Study|Withdrawal by Subject|2|||
131410664|NCT03784846|473126623|FG002|Post-COVID Study|Withdrawal by Subject|0|||
131410665|NCT00867087|473126624|FG000|Overall Study|Other|1|||
131410666|NCT00867087|473126624|FG000|Overall Study|Withdrawal by Subject|4|||
131410667|NCT00867087|473126624|FG000|Overall Study|Death|37|||
131410668|NCT03883113|473126626|FG000|Overall Study|Physician Decision|4|||
131410669|NCT03883113|473126627|FG001|Overall Study|Physician Decision|2|||
131410670|NCT03883113|473126626|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
131410671|NCT03883113|473126627|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
131410672|NCT03883113|473126626|FG000|Overall Study|Pregnancy|1|||
131454152|NCT02003924|473291906|FG001|Double-blind Phase|Lost to Follow-up|1|||
131929585|NCT02268851|475026993|FG002|Overall Study|Physician Decision|1|||
131929586|NCT02268851|475026994|FG003|Overall Study|Physician Decision|0|||
131929587|NCT02268851|475026995|FG004|Overall Study|Physician Decision|0|||
131929588|NCT02268851|475026996|FG005|Overall Study|Physician Decision|1|||
131929589|NCT02268851|475026991|FG000|Overall Study|Patient Compliance|0|||
131929590|NCT02268851|475026992|FG001|Overall Study|Patient Compliance|0|||
131929591|NCT02268851|475026993|FG002|Overall Study|Patient Compliance|0|||
131929592|NCT02268851|475026994|FG003|Overall Study|Patient Compliance|0|||
131929593|NCT02268851|475026995|FG004|Overall Study|Patient Compliance|1|||
131929594|NCT02268851|475026996|FG005|Overall Study|Patient Compliance|1|||
131929595|NCT02268851|475026991|FG000|Overall Study|Co-Morbid Condition|0|||
131929596|NCT02268851|475026992|FG001|Overall Study|Co-Morbid Condition|0|||
131929597|NCT02268851|475026993|FG002|Overall Study|Co-Morbid Condition|0|||
131929598|NCT02268851|475026994|FG003|Overall Study|Co-Morbid Condition|0|||
131929599|NCT02268851|475026995|FG004|Overall Study|Co-Morbid Condition|1|||
131929600|NCT02268851|475026996|FG005|Overall Study|Co-Morbid Condition|1|||
131929601|NCT01472835|475026999|FG000|Overall Study|Lost to Follow-up|2|||
131929602|NCT01472835|475027000|FG001|Overall Study|Lost to Follow-up|0|||
131929603|NCT02539394|475027001|FG000|Overall Study|Protocol Violation|1|||
131929604|NCT02539394|475027002|FG001|Overall Study|Protocol Violation|3|||
131929605|NCT02539394|475027001|FG000|Overall Study|Lost to Follow-up|1|||
131929606|NCT02539394|475027002|FG001|Overall Study|Lost to Follow-up|2|||
131929607|NCT02539394|475027001|FG000|Overall Study|Incomplete dataset|6|||
131929608|NCT02539394|475027002|FG001|Overall Study|Incomplete dataset|6|||
131929609|NCT02413346|475027003|FG000|Overall Study|Adverse Event|6|||
131929610|NCT02413346|475027004|FG001|Overall Study|Adverse Event|6|||
131929611|NCT02413346|475027003|FG000|Overall Study|Withdrawal by Subject|30|||
131929612|NCT02413346|475027004|FG001|Overall Study|Withdrawal by Subject|40|||
131929613|NCT02413346|475027003|FG000|Overall Study|Lost to Follow-up|17|||
131929614|NCT02413346|475027004|FG001|Overall Study|Lost to Follow-up|21|||
131929615|NCT02413346|475027003|FG000|Overall Study|Protocol Violation|2|||
131929616|NCT02413346|475027004|FG001|Overall Study|Protocol Violation|0|||
131929617|NCT02413346|475027003|FG000|Overall Study|Other Miscellaneous Reasons|4|||
131929618|NCT02413346|475027004|FG001|Overall Study|Other Miscellaneous Reasons|3|||
131929619|NCT02205359|475027022|FG000|Overall Study|Death|293|||
131929620|NCT02205359|475027023|FG001|Overall Study|Death|327|||
131929621|NCT02205359|475027022|FG000|Overall Study|Lost to Follow-up|182|||
131454153|NCT02003924|473291907|FG002|Double-blind Phase|Lost to Follow-up|0|||
131929622|NCT02205359|475027023|FG001|Overall Study|Lost to Follow-up|162|||
131929623|NCT02205359|475027022|FG000|Overall Study|Physician Decision|51|||
131929624|NCT02205359|475027023|FG001|Overall Study|Physician Decision|53|||
131929625|NCT02205359|475027022|FG000|Overall Study|Withdrawal by Subject|167|||
131929626|NCT02205359|475027023|FG001|Overall Study|Withdrawal by Subject|169|||
131929627|NCT02792257|475027032|FG000|Overall Study|Lost to Follow-up|3|||
131929628|NCT02792257|475027033|FG001|Overall Study|Lost to Follow-up|4|||
131929629|NCT02792257|475027032|FG000|Overall Study|Allergy|0|||
131929630|NCT02792257|475027033|FG001|Overall Study|Allergy|1|||
131929631|NCT02792257|475027032|FG000|Overall Study|Protocol Violation|2|||
131410673|NCT03883113|473126627|FG001|Overall Study|Pregnancy|0|||
131929632|NCT02792257|475027033|FG001|Overall Study|Protocol Violation|0|||
131929633|NCT02792257|475027032|FG000|Overall Study|Excessive Agitation|0|||
131410674|NCT03883113|473126626|FG000|Overall Study|Adverse Event|0|||
131410675|NCT03883113|473126627|FG001|Overall Study|Adverse Event|1|||
131410676|NCT03883113|473126626|FG000|Overall Study|Withdrawal by Subject|1|||
131410677|NCT03883113|473126627|FG001|Overall Study|Withdrawal by Subject|2|||
131929634|NCT02792257|475027033|FG001|Overall Study|Excessive Agitation|1|||
131929635|NCT02792257|475027032|FG000|Overall Study|Not Feeling Well|0|||
131929636|NCT02792257|475027033|FG001|Overall Study|Not Feeling Well|1|||
131929637|NCT00553475|475027034|FG000|Overall Study|Adverse Event|7|||
131929638|NCT00553475|475027035|FG001|Overall Study|Adverse Event|17|||
131929639|NCT00553475|475027036|FG002|Overall Study|Adverse Event|13|||
131929640|NCT00553475|475027034|FG000|Overall Study|Lack of Efficacy|7|||
131929641|NCT00553475|475027035|FG001|Overall Study|Lack of Efficacy|1|||
131929642|NCT00553475|475027036|FG002|Overall Study|Lack of Efficacy|0|||
131929643|NCT00553475|475027034|FG000|Overall Study|Withdrawal by Subject|1|||
131929644|NCT00553475|475027035|FG001|Overall Study|Withdrawal by Subject|1|||
131929645|NCT00553475|475027036|FG002|Overall Study|Withdrawal by Subject|0|||
131929646|NCT00553475|475027034|FG000|Overall Study|Physician Decision|1|||
131929647|NCT00553475|475027035|FG001|Overall Study|Physician Decision|0|||
131929648|NCT00553475|475027036|FG002|Overall Study|Physician Decision|0|||
131929649|NCT00553475|475027034|FG000|Overall Study|Due to moving|0|||
131929650|NCT00553475|475027035|FG001|Overall Study|Due to moving|1|||
131929651|NCT00553475|475027036|FG002|Overall Study|Due to moving|0|||
131929652|NCT00954538|475027037|FG000|Part III|Withdrawal by Subject|0|||
131929653|NCT00954538|475027038|FG001|Part III|Withdrawal by Subject|0|||
131929654|NCT00954538|475027039|FG002|Part III|Withdrawal by Subject|0|||
131929655|NCT00954538|475027040|FG003|Part III|Withdrawal by Subject|0|||
131929656|NCT00954538|475027041|FG004|Part III|Withdrawal by Subject|1|||
131929657|NCT00954538|475027042|FG005|Part III|Withdrawal by Subject|0|||
131929658|NCT00992394|475027045|FG000|Overall Study|Lack of Efficacy|6|||
131929659|NCT00992394|475027046|FG001|Overall Study|Lack of Efficacy|3|||
131929660|NCT00992394|475027045|FG000|Overall Study|Adverse Event|4|||
131929661|NCT00992394|475027046|FG001|Overall Study|Adverse Event|5|||
131929662|NCT00992394|475027045|FG000|Overall Study|Withdrawal by Subject|8|||
131929663|NCT00992394|475027046|FG001|Overall Study|Withdrawal by Subject|2|||
131929664|NCT00992394|475027045|FG000|Overall Study|Physician Decision|1|||
131929665|NCT00992394|475027046|FG001|Overall Study|Physician Decision|0|||
131929666|NCT00992394|475027045|FG000|Overall Study|Protocol Violation|2|||
131929667|NCT00992394|475027046|FG001|Overall Study|Protocol Violation|4|||
131929668|NCT00992394|475027045|FG000|Overall Study|Lost to Follow-up|2|||
131929669|NCT00992394|475027046|FG001|Overall Study|Lost to Follow-up|0|||
131929670|NCT00992394|475027045|FG000|Overall Study|Other event|1|||
131929671|NCT00992394|475027046|FG001|Overall Study|Other event|0|||
131929672|NCT01905683|475027047|FG000|Overall Study|Protocol Violation|1|||
131929673|NCT01905683|475027047|FG000|Overall Study|Re-injection criteria not met; others|13|||
131929674|NCT01905683|475027047|FG000|Overall Study|Physician Decision|1|||
131929675|NCT01905683|475027047|FG000|Overall Study|Lack of Efficacy|8|||
131929676|NCT01905683|475027047|FG000|Overall Study|Withdrawal by Subject|20|||
131929677|NCT01905683|475027047|FG000|Overall Study|Adverse Event|4|||
131929678|NCT01905683|475027047|FG000|Overall Study|Lost to Follow-up|4|||
131929679|NCT00537082|475027051|FG000|Overall Study|Adverse Event|6|||
131929680|NCT00537082|475027052|FG001|Overall Study|Adverse Event|6|||
131929681|NCT00537082|475027053|FG002|Overall Study|Adverse Event|3|||
131929682|NCT00537082|475027051|FG000|Overall Study|Protocol Violation|0|||
131929683|NCT00537082|475027052|FG001|Overall Study|Protocol Violation|2|||
131929684|NCT00537082|475027053|FG002|Overall Study|Protocol Violation|1|||
131929685|NCT00537082|475027051|FG000|Overall Study|Lack of Efficacy|0|||
131929686|NCT00537082|475027052|FG001|Overall Study|Lack of Efficacy|0|||
131929687|NCT00537082|475027053|FG002|Overall Study|Lack of Efficacy|2|||
131929688|NCT00537082|475027051|FG000|Overall Study|Withdrawal by Subject|0|||
131929689|NCT00537082|475027052|FG001|Overall Study|Withdrawal by Subject|1|||
131929690|NCT00537082|475027053|FG002|Overall Study|Withdrawal by Subject|0|||
131929691|NCT00537082|475027051|FG000|Overall Study|Discontinued before initiating treatment|3|||
131929692|NCT00537082|475027052|FG001|Overall Study|Discontinued before initiating treatment|0|||
131929693|NCT00537082|475027053|FG002|Overall Study|Discontinued before initiating treatment|0|||
131929694|NCT02568254|475027054|FG000|Period 2|Adverse Event|0|||
131929695|NCT02568254|475027055|FG001|Period 2|Adverse Event|0|||
131929696|NCT02568254|475027056|FG002|Period 2|Adverse Event|1|||
131929697|NCT02568254|475027057|FG003|Period 2|Adverse Event|0|||
131929698|NCT02568254|475027058|FG004|Period 2|Adverse Event|0|||
131929699|NCT02568254|475027059|FG005|Period 2|Adverse Event|0|||
131929700|NCT02568254|475027054|FG000|Period 3|Unstatisfactory Lens fitting|0|||
131929701|NCT02568254|475027055|FG001|Period 3|Unstatisfactory Lens fitting|0|||
131929702|NCT02568254|475027056|FG002|Period 3|Unstatisfactory Lens fitting|0|||
131929703|NCT02568254|475027057|FG003|Period 3|Unstatisfactory Lens fitting|0|||
131929704|NCT02568254|475027058|FG004|Period 3|Unstatisfactory Lens fitting|1|||
131929705|NCT02568254|475027059|FG005|Period 3|Unstatisfactory Lens fitting|0|||
131929706|NCT00655746|475027060|FG000|Overall Study|Withdrawal by Subject|1|||
131929707|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
131929708|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
131929709|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
131929710|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Adverse Event|5|||
131929711|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Adverse Event|1|||
131929712|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Adverse Event|0|||
131929713|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
131410678|NCT03883113|473126626|FG000|Overall Study|Lost to Follow-up|1|||
131410679|NCT03883113|473126627|FG001|Overall Study|Lost to Follow-up|0|||
131410680|NCT02498067|473126628|FG000|Overall Study|Lost to Follow-up|22|||
131410681|NCT02498067|473126628|FG000|Overall Study|Did not meet inclusion criteria|11|||
131410682|NCT03351114|473126632|FG000|Overall Study|Withdrawal by Subject|1|||
131410683|NCT01371643|473126633|FG000|Overall Study|Withdrawal by Subject|3|||
131410684|NCT01371643|473126634|FG001|Overall Study|Withdrawal by Subject|0|||
131929714|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
131929715|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
131929716|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Death|8|||
131929717|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Death|24|||
131929718|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Death|0|||
131929719|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
131929720|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
131929721|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
131929722|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
131929723|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
131929724|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
131929725|NCT02931539|475027061|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
131929726|NCT02931539|475027062|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
131929727|NCT02931539|475027063|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
131929728|NCT02931539|475027061|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
131929729|NCT02931539|475027062|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
131929730|NCT02931539|475027063|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
131929731|NCT03178942|475027066|FG000|Overall Study|Withdrawal by Subject|2|||
131929732|NCT03178942|475027067|FG001|Overall Study|Withdrawal by Subject|0|||
131929733|NCT03178942|475027066|FG000|Overall Study|Lost to Follow-up|1|||
131929734|NCT03178942|475027067|FG001|Overall Study|Lost to Follow-up|2|||
131929735|NCT03061214|475027072|FG000|Overall Study|Withdrawal by Subject|21|||
131929736|NCT03061214|475027073|FG001|Overall Study|Withdrawal by Subject|26|||
131929737|NCT03061214|475027074|FG002|Overall Study|Withdrawal by Subject|9|||
131929738|NCT03061214|475027072|FG000|Overall Study|Lost to Follow-up|3|||
131929739|NCT03061214|475027073|FG001|Overall Study|Lost to Follow-up|1|||
131929740|NCT03061214|475027074|FG002|Overall Study|Lost to Follow-up|1|||
131929741|NCT03061214|475027072|FG000|Overall Study|Death|1|||
131929742|NCT03061214|475027073|FG001|Overall Study|Death|1|||
131929743|NCT03061214|475027074|FG002|Overall Study|Death|0|||
131929744|NCT01926509|475028662|FG000|Overall Study|vital sign met discontinuation criteria|1|||
131929745|NCT01926509|475028663|FG001|Overall Study|vital sign met discontinuation criteria|0|||
131929746|NCT01926509|475028664|FG002|Overall Study|vital sign met discontinuation criteria|0|||
131929747|NCT01926509|475028665|FG003|Overall Study|vital sign met discontinuation criteria|0|||
131929748|NCT03681093|475028666|FG000|Overall Study|Subject decision|0|||
131929749|NCT03681093|475028667|FG001|Overall Study|Subject decision|2|||
131929750|NCT03681093|475028668|FG002|Overall Study|Subject decision|1|||
131929751|NCT01882829|475028672|FG000|Overall Study|Adverse Event|4|||
131929752|NCT01882829|475028672|FG000|Overall Study|Protocol Violation|1|||
131929753|NCT01882829|475028672|FG000|Overall Study|Withdrawal by Subject|1|||
131929754|NCT02469961|475028674|FG000|Overall Study|Physician Decision|4|||
131929755|NCT02469961|475028675|FG001|Overall Study|Physician Decision|1|||
131929756|NCT05130281|475028679|FG000|Overall Study|Withdrawal by Subject|0|||
131929757|NCT05130281|475028680|FG001|Overall Study|Withdrawal by Subject|0|||
131929758|NCT05130281|475028681|FG002|Overall Study|Withdrawal by Subject|1|||
131929759|NCT06844812|475028682|FG000|Overall Study|Lost to Follow-up|5|||
131929760|NCT06844812|475028682|FG000|Overall Study|stigmatization concerns|2|||
131929761|NCT06844812|475028682|FG000|Overall Study|medication refusal|2|||
131929762|NCT06844812|475028682|FG000|Overall Study|concerns about possible side effects|2|||
131929763|NCT06844812|475028682|FG000|Overall Study|wanting to seek another specialist opinion|2|||
131929764|NCT06844812|475028682|FG000|Overall Study|side effects (dizziness)|1|||
131929765|NCT00368849|475028683|FG000|Overall Study|Withdrawal by Subject|0|||
131929766|NCT00368849|475028684|FG001|Overall Study|Withdrawal by Subject|1|||
131929767|NCT00368849|475028683|FG000|Overall Study|Physician Decision|0|||
131929768|NCT00368849|475028684|FG001|Overall Study|Physician Decision|1|||
131929769|NCT01699685|475028688|FG000|Period 1|Adverse Event|1|||
131929770|NCT01699685|475028689|FG001|Period 1|Adverse Event|1|||
131929771|NCT01699685|475028688|FG000|Period 1|Medical or ethical, noncompliance|2|||
131929772|NCT01699685|475028689|FG001|Period 1|Medical or ethical, noncompliance|0|||
131929773|NCT01699685|475028688|FG000|Period 1|Other|0|||
131929774|NCT01699685|475028689|FG001|Period 1|Other|1|||
131929775|NCT01699685|475028688|FG000|Period 1|Patient request|0|||
131929776|NCT01699685|475028689|FG001|Period 1|Patient request|1|||
131929777|NCT01699685|475028688|FG000|Period 2|Lost to Follow-up|1|||
131929778|NCT01699685|475028689|FG001|Period 2|Lost to Follow-up|0|||
131929779|NCT03635996|475028690|FG000|Overall Study|Study terminated by Sponsor|94|||
131929780|NCT03635996|475028690|FG000|Overall Study|Withdrawal by Subject|20|||
131410685|NCT02813668|473126640|FG000|Overall Study|Death|4|||
131929781|NCT03635996|475028690|FG000|Overall Study|Ablation|26|||
131929782|NCT03635996|475028690|FG000|Overall Study|Adverse Event|7|||
131929783|NCT03635996|475028690|FG000|Overall Study|Physician Decision|3|||
131929784|NCT03635996|475028690|FG000|Overall Study|Prohibited medication|5|||
131929785|NCT03635996|475028690|FG000|Overall Study|Did not meet eligibility criteria|5|||
131929786|NCT03635996|475028690|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
131929787|NCT03635996|475028690|FG000|Overall Study|Protocol Violation|1|||
131929788|NCT03635996|475028690|FG000|Overall Study|Lost to Follow-up|1|||
131929789|NCT01832038|475028691|FG000|Overall Study|Death|5|||
131929790|NCT01832038|475028691|FG000|Overall Study|Adverse Event|50|||
131929791|NCT01832038|475028691|FG000|Overall Study|Lack of Efficacy|81|||
131929792|NCT01832038|475028691|FG000|Overall Study|Protocol Violation|7|||
131929793|NCT01832038|475028691|FG000|Overall Study|Lost to Follow-up|10|||
131929794|NCT01832038|475028691|FG000|Overall Study|Withdrawal by Subject|49|||
131410686|NCT02813668|473126640|FG000|Overall Study|Lost to Follow-up|509|||
131929795|NCT01832038|475028691|FG000|Overall Study|Visit non-compliance|2|||
131929796|NCT01832038|475028691|FG000|Overall Study|Subject refused to return visit|2|||
131929797|NCT01832038|475028691|FG000|Overall Study|Not convenient to come back to site|2|||
131929798|NCT01832038|475028691|FG000|Overall Study|Participant was asked to quit|5|||
131929799|NCT01832038|475028691|FG000|Overall Study|Back home|1|||
131929800|NCT01832038|475028691|FG000|Overall Study|Pregnancy|1|||
131929801|NCT01832038|475028691|FG000|Overall Study|Low compliance|3|||
131929802|NCT01832038|475028691|FG000|Overall Study|Prohibit procedure|2|||
131929803|NCT01832038|475028691|FG000|Overall Study|Not possible to visit the hospital|1|||
131929804|NCT01832038|475028691|FG000|Overall Study|Changes of implementation system|3|||
131929805|NCT01832038|475028691|FG000|Overall Study|Plan to pregnancy|7|||
131929806|NCT01832038|475028691|FG000|Overall Study|Bad mood and has suicidal thought|1|||
131929807|NCT01832038|475028691|FG000|Overall Study|Prohibited concomitant medication|1|||
131929808|NCT01832038|475028691|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
131410687|NCT02813668|473126640|FG000|Overall Study|Withdrawal by Subject|148|||
131410688|NCT02813668|473126640|FG000|Overall Study|No longer at worksite|85|||
131410689|NCT02813668|473126640|FG000|Overall Study|Medical reasons not related to the study|4|||
131410690|NCT04662073|473126641|FG000|Overall Study|Withdrawal by Subject|1|||
131410691|NCT04662073|473126642|FG001|Overall Study|Withdrawal by Subject|0|||
131410692|NCT02185014|473126643|FG000|Overall Study|Adverse Event|18|||
131410693|NCT02185014|473126643|FG000|Overall Study|Withdrew Consent|8|||
131410694|NCT02185014|473126643|FG000|Overall Study|Lost to Follow-up|4|||
131410695|NCT02185014|473126643|FG000|Overall Study|Lack of Efficacy|14|||
131410696|NCT02185014|473126643|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
131410697|NCT02185014|473126643|FG000|Overall Study|Subject Noncompliance|1|||
131410698|NCT02185014|473126643|FG000|Overall Study|Other|4|||
131410699|NCT02370641|473126648|FG000|Overall Study|dropped study|4|||
131410700|NCT02370641|473126649|FG001|Overall Study|dropped study|2|||
131410701|NCT00810901|473126653|FG000|Overall Study|Lost to Follow-up|88|||
131410702|NCT00810901|473126654|FG001|Overall Study|Lost to Follow-up|58|||
131410703|NCT02133664|473126655|FG000|Overall Study|Lost to Follow-up|2|||
131410704|NCT02133664|473126656|FG001|Overall Study|Lost to Follow-up|1|||
131410705|NCT02133664|473126655|FG000|Overall Study|Adverse Event|3|||
131410706|NCT02133664|473126656|FG001|Overall Study|Adverse Event|6|||
131410707|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
131410708|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
131410709|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
131410710|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
131410711|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
131410712|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
131410713|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
131929809|NCT01832038|475028691|FG000|Overall Study|Subject considered the efficacy was poor|1|||
131929810|NCT00107614|475028697|FG000|Overall Study|Physician Decision|10|||
131929811|NCT00107614|475028697|FG000|Overall Study|Death|2|||
131929812|NCT00101400|475028704|FG000|Survival Follow-Up|Alive|7|||
131929813|NCT05333965|475028725|FG000|First Intervention|Adverse Event|0|||
131454154|NCT02003924|473291905|FG000|Double-blind Phase|Protocol Violation|1|||
131929814|NCT05333965|475028726|FG001|First Intervention|Adverse Event|1|||
131410714|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
131410715|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
131410716|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
131410717|NCT03906656|473126659|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
131454155|NCT02003924|473291906|FG001|Double-blind Phase|Protocol Violation|2|||
131929815|NCT05333965|475028725|FG000|First Intervention|Withdrawal by Subject|0|||
131929816|NCT05333965|475028726|FG001|First Intervention|Withdrawal by Subject|1|||
131929817|NCT00382863|475028727|FG000|Overall Study|Death|9|||
131929818|NCT00382863|475028728|FG001|Overall Study|Death|9|||
131929819|NCT00382863|475028727|FG000|Overall Study|Lost to Follow-up|1|||
131410718|NCT03906656|473126660|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
131929820|NCT00382863|475028728|FG001|Overall Study|Lost to Follow-up|2|||
131929821|NCT00382863|475028727|FG000|Overall Study|Withdrawal by Subject|5|||
131929822|NCT00382863|475028728|FG001|Overall Study|Withdrawal by Subject|25|||
131410719|NCT03906656|473126659|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
131410720|NCT03906656|473126660|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
131410721|NCT03906656|473126659|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
131410722|NCT03906656|473126660|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
131410723|NCT03906656|473126659|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
131410724|NCT03906656|473126660|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
131410725|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
131410726|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
131410727|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
131410728|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
131410729|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
131410730|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
131410731|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
131410732|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
131410733|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
131410734|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
131410735|NCT03906656|473126659|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
131410736|NCT03906656|473126660|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
131410737|NCT03906656|473126659|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
131410738|NCT03906656|473126660|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
131410739|NCT03906656|473126659|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
131410740|NCT03906656|473126660|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
131410741|NCT03906656|473126659|FG000|Home Use 2 (3 Months)|Death|2|||
131410742|NCT03906656|473126660|FG001|Home Use 2 (3 Months)|Death|0|||
131410743|NCT03906656|473126659|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
131410744|NCT03906656|473126660|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
131410745|NCT03906656|473126659|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
131410746|NCT03906656|473126660|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
131410747|NCT01945775|473126667|FG000|Overall Study|Death|214|||
131410748|NCT01945775|473126668|FG001|Overall Study|Death|98|||
131410749|NCT01945775|473126667|FG000|Overall Study|Lost to Follow-up|12|||
131410750|NCT01945775|473126668|FG001|Overall Study|Lost to Follow-up|7|||
131410751|NCT01945775|473126667|FG000|Overall Study|Withdrawal by Subject|11|||
131410752|NCT01945775|473126668|FG001|Overall Study|Withdrawal by Subject|21|||
131410753|NCT01945775|473126667|FG000|Overall Study|Other|50|||
131410754|NCT01945775|473126668|FG001|Overall Study|Other|18|||
131410755|NCT02876328|473126669|FG000|Overall Study|Death|2|||
131410756|NCT02876328|473126670|FG001|Overall Study|Death|1|||
131410757|NCT02876328|473126671|FG002|Overall Study|Death|3|||
131410758|NCT02876328|473126672|FG003|Overall Study|Death|0|||
131410759|NCT02876328|473126673|FG004|Overall Study|Death|0|||
131410760|NCT02876328|473126674|FG005|Overall Study|Death|0|||
131410761|NCT02876328|473126675|FG006|Overall Study|Death|1|||
131410762|NCT02876328|473126676|FG007|Overall Study|Death|3|||
131410763|NCT02876328|473126677|FG008|Overall Study|Death|0|||
131410764|NCT02876328|473126678|FG009|Overall Study|Death|1|||
131410765|NCT02876328|473126679|FG010|Overall Study|Death|1|||
131410766|NCT02876328|473126680|FG011|Overall Study|Death|0|||
131410767|NCT02876328|473126681|FG012|Overall Study|Death|0|||
131410768|NCT02876328|473126682|FG013|Overall Study|Death|0|||
131410769|NCT02876328|473126683|FG014|Overall Study|Death|0|||
131410770|NCT02876328|473126684|FG015|Overall Study|Death|0|||
131410771|NCT02876328|473126685|FG016|Overall Study|Death|1|||
131410772|NCT02876328|473126686|FG017|Overall Study|Death|1|||
131929823|NCT01423084|475028729|FG000|Overall Study|Adverse Event|0|||
131929824|NCT01423084|475028730|FG001|Overall Study|Adverse Event|1|||
131929825|NCT01423084|475028729|FG000|Overall Study|Withdrawal by Subject|2|||
131929826|NCT01423084|475028730|FG001|Overall Study|Withdrawal by Subject|3|||
131929827|NCT00661687|475028734|FG000|Overall Study|Study related symptoms and complaints|5|||
131929828|NCT00661687|475028734|FG000|Overall Study|Positive slit lamp findings|4|||
131929829|NCT00661687|475028734|FG000|Overall Study|Inability to maintain wearing schedule|3|||
131410773|NCT02876328|473126687|FG018|Overall Study|Death|0|||
131410774|NCT02876328|473126688|FG019|Overall Study|Death|0|||
131410775|NCT02876328|473126689|FG020|Overall Study|Death|0|||
131410776|NCT02876328|473126690|FG021|Overall Study|Death|1|||
131410777|NCT02876328|473126691|FG022|Overall Study|Death|0|||
131410778|NCT02876328|473126692|FG023|Overall Study|Death|0|||
131410779|NCT02876328|473126669|FG000|Overall Study|Withdrawal by Subject|0|||
131410780|NCT02876328|473126670|FG001|Overall Study|Withdrawal by Subject|2|||
131410781|NCT02876328|473126671|FG002|Overall Study|Withdrawal by Subject|3|||
131410782|NCT02876328|473126672|FG003|Overall Study|Withdrawal by Subject|3|||
131410783|NCT02876328|473126673|FG004|Overall Study|Withdrawal by Subject|0|||
131410784|NCT02876328|473126674|FG005|Overall Study|Withdrawal by Subject|1|||
131410785|NCT02876328|473126675|FG006|Overall Study|Withdrawal by Subject|0|||
131410786|NCT02876328|473126676|FG007|Overall Study|Withdrawal by Subject|1|||
131410787|NCT02876328|473126677|FG008|Overall Study|Withdrawal by Subject|1|||
131410788|NCT02876328|473126678|FG009|Overall Study|Withdrawal by Subject|2|||
131410789|NCT02876328|473126679|FG010|Overall Study|Withdrawal by Subject|0|||
131410790|NCT02876328|473126680|FG011|Overall Study|Withdrawal by Subject|0|||
131410791|NCT02876328|473126681|FG012|Overall Study|Withdrawal by Subject|0|||
131410792|NCT02876328|473126682|FG013|Overall Study|Withdrawal by Subject|0|||
131410793|NCT02876328|473126683|FG014|Overall Study|Withdrawal by Subject|0|||
131410794|NCT02876328|473126684|FG015|Overall Study|Withdrawal by Subject|0|||
131410795|NCT02876328|473126685|FG016|Overall Study|Withdrawal by Subject|1|||
131410796|NCT02876328|473126686|FG017|Overall Study|Withdrawal by Subject|3|||
131410797|NCT02876328|473126687|FG018|Overall Study|Withdrawal by Subject|0|||
131410798|NCT02876328|473126688|FG019|Overall Study|Withdrawal by Subject|0|||
131410799|NCT02876328|473126689|FG020|Overall Study|Withdrawal by Subject|1|||
131410800|NCT02876328|473126690|FG021|Overall Study|Withdrawal by Subject|0|||
131410801|NCT02876328|473126691|FG022|Overall Study|Withdrawal by Subject|0|||
131410802|NCT02876328|473126692|FG023|Overall Study|Withdrawal by Subject|0|||
131410803|NCT02876328|473126669|FG000|Overall Study|Missed 12 Month Visit|15|||
131410804|NCT02876328|473126670|FG001|Overall Study|Missed 12 Month Visit|10|||
131410805|NCT02876328|473126671|FG002|Overall Study|Missed 12 Month Visit|11|||
131410806|NCT02876328|473126672|FG003|Overall Study|Missed 12 Month Visit|6|||
131410807|NCT02876328|473126673|FG004|Overall Study|Missed 12 Month Visit|10|||
131410808|NCT02876328|473126674|FG005|Overall Study|Missed 12 Month Visit|14|||
131410809|NCT02876328|473126675|FG006|Overall Study|Missed 12 Month Visit|3|||
131410810|NCT02876328|473126676|FG007|Overall Study|Missed 12 Month Visit|8|||
131410811|NCT02876328|473126677|FG008|Overall Study|Missed 12 Month Visit|9|||
131410812|NCT02876328|473126678|FG009|Overall Study|Missed 12 Month Visit|5|||
131410813|NCT02876328|473126679|FG010|Overall Study|Missed 12 Month Visit|4|||
131410814|NCT02876328|473126680|FG011|Overall Study|Missed 12 Month Visit|1|||
131410815|NCT02876328|473126681|FG012|Overall Study|Missed 12 Month Visit|5|||
131929830|NCT00661687|475028734|FG000|Overall Study|Physician Decision|1|||
131929831|NCT00661687|475028734|FG000|Overall Study|Adverse Event|2|||
131410816|NCT02876328|473126682|FG013|Overall Study|Missed 12 Month Visit|4|||
131410817|NCT02876328|473126683|FG014|Overall Study|Missed 12 Month Visit|4|||
131410818|NCT02876328|473126684|FG015|Overall Study|Missed 12 Month Visit|4|||
131410819|NCT02876328|473126685|FG016|Overall Study|Missed 12 Month Visit|3|||
131410820|NCT02876328|473126686|FG017|Overall Study|Missed 12 Month Visit|6|||
131410821|NCT02876328|473126687|FG018|Overall Study|Missed 12 Month Visit|2|||
131410822|NCT02876328|473126688|FG019|Overall Study|Missed 12 Month Visit|2|||
131410823|NCT02876328|473126689|FG020|Overall Study|Missed 12 Month Visit|11|||
131410824|NCT02876328|473126690|FG021|Overall Study|Missed 12 Month Visit|7|||
131410825|NCT02876328|473126691|FG022|Overall Study|Missed 12 Month Visit|1|||
131410826|NCT02876328|473126692|FG023|Overall Study|Missed 12 Month Visit|0|||
131410827|NCT03515941|473126695|FG000|Overall Study|Adverse Event|1|||
131410828|NCT03515941|473126696|FG001|Overall Study|Adverse Event|0|||
131410829|NCT00334282|473126699|FG000|Overall Study|Lost to Follow-up|11|||
131410830|NCT00334282|473126700|FG001|Overall Study|Lost to Follow-up|5|||
131410831|NCT00334282|473126699|FG000|Overall Study|Withdrawal by Subject|17|||
131410832|NCT00334282|473126700|FG001|Overall Study|Withdrawal by Subject|3|||
131410833|NCT00334282|473126699|FG000|Overall Study|Death|194|||
131410834|NCT00334282|473126700|FG001|Overall Study|Death|100|||
131410835|NCT02759315|473126701|FG000|Overall Study|Adverse Event|0|||
131410836|NCT02759315|473126702|FG001|Overall Study|Adverse Event|0|||
131410837|NCT02759315|473126703|FG002|Overall Study|Adverse Event|0|||
131410838|NCT02759315|473126704|FG003|Overall Study|Adverse Event|1|||
131929832|NCT02771145|475028735|FG000|Overall Study|Adverse Event|3|||
131929833|NCT02771145|475028735|FG000|Overall Study|Lost to Follow-up|1|||
131929834|NCT02191397|475028736|FG000|Overall Study|Adverse Event|28|||
131929835|NCT02191397|475028737|FG001|Overall Study|Adverse Event|17|||
131929836|NCT02191397|475028736|FG000|Overall Study|Lack of Efficacy|10|||
131929837|NCT02191397|475028737|FG001|Overall Study|Lack of Efficacy|5|||
131929838|NCT02191397|475028736|FG000|Overall Study|Protocol Violation|0|||
131929839|NCT02191397|475028737|FG001|Overall Study|Protocol Violation|3|||
131410839|NCT02759315|473126705|FG004|Overall Study|Adverse Event|0|||
131410840|NCT02759315|473126701|FG000|Overall Study|Death|0|||
131929840|NCT02191397|475028736|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
131929841|NCT02191397|475028737|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
131929842|NCT02191397|475028736|FG000|Overall Study|Lost to Follow-up|10|||
131410841|NCT02759315|473126702|FG001|Overall Study|Death|0|||
131410842|NCT02759315|473126703|FG002|Overall Study|Death|1|||
131410843|NCT02759315|473126704|FG003|Overall Study|Death|0|||
131410844|NCT02759315|473126705|FG004|Overall Study|Death|0|||
131410845|NCT02759315|473126701|FG000|Overall Study|Lost to Follow-up|2|||
131410846|NCT02759315|473126702|FG001|Overall Study|Lost to Follow-up|0|||
131410847|NCT02759315|473126703|FG002|Overall Study|Lost to Follow-up|4|||
131410848|NCT02759315|473126704|FG003|Overall Study|Lost to Follow-up|0|||
131410849|NCT02759315|473126705|FG004|Overall Study|Lost to Follow-up|0|||
131929843|NCT02191397|475028737|FG001|Overall Study|Lost to Follow-up|11|||
131410850|NCT02759315|473126701|FG000|Overall Study|Protocol Violation|0|||
131410851|NCT02759315|473126702|FG001|Overall Study|Protocol Violation|1|||
131410852|NCT02759315|473126703|FG002|Overall Study|Protocol Violation|0|||
131410853|NCT02759315|473126704|FG003|Overall Study|Protocol Violation|0|||
131410854|NCT02759315|473126705|FG004|Overall Study|Protocol Violation|0|||
131410855|NCT02759315|473126701|FG000|Overall Study|Study terminated prior to completion|2|||
131410856|NCT02759315|473126702|FG001|Overall Study|Study terminated prior to completion|0|||
131410857|NCT02759315|473126703|FG002|Overall Study|Study terminated prior to completion|5|||
131410858|NCT02759315|473126704|FG003|Overall Study|Study terminated prior to completion|0|||
131410859|NCT02759315|473126705|FG004|Overall Study|Study terminated prior to completion|1|||
131410860|NCT03464422|473126715|FG000|Overall Study|Lost to Follow-up|2|||
131410861|NCT03464422|473126715|FG000|Overall Study|Withdrawal by Subject|2|||
131410862|NCT01628367|473126720|FG000|Overall Study|Adverse Event|1|||
131410863|NCT01628367|473126721|FG001|Overall Study|Adverse Event|0|||
131410864|NCT03353922|473126722|FG000|Overall Study|Withdrawal by Subject|1|||
131410865|NCT03353922|473126723|FG001|Overall Study|Withdrawal by Subject|0|||
131410866|NCT03353922|473126724|FG002|Overall Study|Withdrawal by Subject|1|||
131410867|NCT03353922|473126725|FG003|Overall Study|Withdrawal by Subject|1|||
131410868|NCT03353922|473126726|FG004|Overall Study|Withdrawal by Subject|0|||
131410869|NCT03353922|473126727|FG005|Overall Study|Withdrawal by Subject|0|||
131410870|NCT03353922|473126722|FG000|Overall Study|Adverse Event|0|||
131410871|NCT03353922|473126723|FG001|Overall Study|Adverse Event|1|||
131410872|NCT03353922|473126724|FG002|Overall Study|Adverse Event|0|||
131410873|NCT03353922|473126725|FG003|Overall Study|Adverse Event|0|||
131410874|NCT03353922|473126726|FG004|Overall Study|Adverse Event|0|||
131410875|NCT03353922|473126727|FG005|Overall Study|Adverse Event|0|||
131410876|NCT00740714|473126728|FG000|Overall Study|Withdrawal by Subject|17|||
131410877|NCT00740714|473126729|FG001|Overall Study|Withdrawal by Subject|19|||
131410878|NCT00740714|473126730|FG002|Overall Study|Withdrawal by Subject|29|||
131410879|NCT03688555|473126731|FG000|Treatment Period|Adverse Event|0|||
131410880|NCT03688555|473126732|FG001|Treatment Period|Adverse Event|0|||
131410881|NCT03688555|473126733|FG002|Treatment Period|Adverse Event|1|||
131410882|NCT00886119|473126734|FG000|Period 1|Did not meet inclusion criteria|1|||
131410883|NCT00886119|473126735|FG001|Period 1|Did not meet inclusion criteria|0|||
131410884|NCT01352741|473126740|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
131410885|NCT01352741|473126741|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
131410886|NCT01352741|473126740|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
131410887|NCT01352741|473126741|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
131410888|NCT01352741|473126740|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
131410889|NCT01352741|473126741|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
131410890|NCT01352741|473126740|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
131410891|NCT01352741|473126741|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
131410892|NCT01352741|473126740|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
131410893|NCT01352741|473126741|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
131410894|NCT01352741|473126740|FG000|Open-label Tapentadol Titration Period|Other|4|||
131410895|NCT01352741|473126741|FG001|Open-label Tapentadol Titration Period|Other|0|||
131410896|NCT01352741|473126740|FG000|Double-blind Comparative Period|Protocol Violation|2|||
131929844|NCT02191397|475028736|FG000|Overall Study|Physician Decision|8|||
131929845|NCT02191397|475028737|FG001|Overall Study|Physician Decision|3|||
131929846|NCT02191397|475028736|FG000|Overall Study|Withdrawal by Subject|22|||
131929847|NCT02191397|475028737|FG001|Overall Study|Withdrawal by Subject|27|||
131929848|NCT00728182|475028738|FG000|Overall Study|Adverse Event|1|||
131929849|NCT00728182|475028739|FG001|Overall Study|Adverse Event|0|||
131929850|NCT00728182|475028738|FG000|Overall Study|Lost to Follow-up|2|||
131929851|NCT00728182|475028739|FG001|Overall Study|Lost to Follow-up|0|||
131929852|NCT00728182|475028738|FG000|Overall Study|Death|0|||
131929853|NCT00728182|475028739|FG001|Overall Study|Death|2|||
131410897|NCT01352741|473126741|FG001|Double-blind Comparative Period|Protocol Violation|0|||
131410898|NCT01352741|473126740|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
131410899|NCT01352741|473126741|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
131410900|NCT01352741|473126740|FG000|Double-blind Comparative Period|Adverse Event|16|||
131410901|NCT01352741|473126741|FG001|Double-blind Comparative Period|Adverse Event|17|||
131410902|NCT01352741|473126740|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
131410903|NCT01352741|473126741|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
131410904|NCT01352741|473126740|FG000|Double-blind Comparative Period|Death|0|||
131410905|NCT01352741|473126741|FG001|Double-blind Comparative Period|Death|1|||
131410906|NCT01352741|473126740|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
131410907|NCT01352741|473126741|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
131929854|NCT00728182|475028738|FG000|Overall Study|Protocol Noncompliance|0|||
131929855|NCT00728182|475028739|FG001|Overall Study|Protocol Noncompliance|1|||
131929856|NCT03721107|475028740|FG000|Overall Study|Adverse Event|1|||
131929857|NCT03721107|475028741|FG001|Overall Study|Adverse Event|1|||
131929858|NCT03721107|475028742|FG002|Overall Study|Adverse Event|6|||
131929859|NCT03721107|475028743|FG003|Overall Study|Adverse Event|5|||
131929860|NCT03721107|475028740|FG000|Overall Study|Lost to Follow-up|2|||
131929861|NCT03721107|475028741|FG001|Overall Study|Lost to Follow-up|0|||
131929862|NCT03721107|475028742|FG002|Overall Study|Lost to Follow-up|3|||
131929863|NCT03721107|475028743|FG003|Overall Study|Lost to Follow-up|0|||
131929864|NCT03721107|475028740|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
131929865|NCT03721107|475028741|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
131929866|NCT03721107|475028742|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
131929867|NCT03721107|475028743|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
131929868|NCT03721107|475028740|FG000|Overall Study|Physician Decision|0|||
131929869|NCT03721107|475028741|FG001|Overall Study|Physician Decision|1|||
131929870|NCT03721107|475028742|FG002|Overall Study|Physician Decision|0|||
131929871|NCT03721107|475028743|FG003|Overall Study|Physician Decision|0|||
131929872|NCT03721107|475028740|FG000|Overall Study|Pregnancy|0|||
131929873|NCT03721107|475028741|FG001|Overall Study|Pregnancy|0|||
131929874|NCT03721107|475028742|FG002|Overall Study|Pregnancy|1|||
131929875|NCT03721107|475028743|FG003|Overall Study|Pregnancy|0|||
131929876|NCT03721107|475028740|FG000|Overall Study|Withdrawal by Subject|1|||
131929877|NCT03721107|475028741|FG001|Overall Study|Withdrawal by Subject|1|||
131929878|NCT03721107|475028742|FG002|Overall Study|Withdrawal by Subject|5|||
131929879|NCT03721107|475028743|FG003|Overall Study|Withdrawal by Subject|5|||
131929880|NCT03721107|475028740|FG000|Overall Study|Other|1|||
131929881|NCT03721107|475028741|FG001|Overall Study|Other|0|||
131929882|NCT03721107|475028742|FG002|Overall Study|Other|0|||
131929883|NCT03721107|475028743|FG003|Overall Study|Other|1|||
131929884|NCT01065766|475028744|FG000|Overall Study|Assessed before the contracted date|1|||
131929885|NCT01065766|475028744|FG000|Overall Study|Contraindication to administration|6|||
131929886|NCT01065766|475028744|FG000|Overall Study|Violated dosage/administration|25|||
131929887|NCT01630811|475028749|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
131929888|NCT01630811|475028750|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
131929889|NCT04818086|475028751|FG000|Overall Study|Physician Decision|1|||
131929890|NCT04818086|475028752|FG001|Overall Study|Physician Decision|0|||
131929891|NCT04818086|475028751|FG000|Overall Study|Withdrawal by Subject|0|||
131929892|NCT04818086|475028752|FG001|Overall Study|Withdrawal by Subject|1|||
131929893|NCT01725308|475028754|FG000|Treatment Period I|Did Not Receive Drug|1|||
131929894|NCT01725308|475028755|FG001|Treatment Period I|Did Not Receive Drug|0|||
131929895|NCT01725308|475028756|FG002|Treatment Period I|Did Not Receive Drug|0|||
131929896|NCT01725308|475028754|FG000|Treatment Period I|Adverse Event|5|||
131929897|NCT01725308|475028755|FG001|Treatment Period I|Adverse Event|4|||
131929898|NCT01725308|475028756|FG002|Treatment Period I|Adverse Event|21|||
131929899|NCT01725308|475028754|FG000|Treatment Period I|Insufficient Response|7|||
131929900|NCT01725308|475028755|FG001|Treatment Period I|Insufficient Response|0|||
131929901|NCT01725308|475028756|FG002|Treatment Period I|Insufficient Response|5|||
131929902|NCT01725308|475028754|FG000|Treatment Period I|Worsening of the Target Disease|8|||
131929903|NCT01725308|475028755|FG001|Treatment Period I|Worsening of the Target Disease|0|||
131929904|NCT01725308|475028756|FG002|Treatment Period I|Worsening of the Target Disease|2|||
131929905|NCT01725308|475028754|FG000|Treatment Period I|Changes in the Episodes|3|||
131929906|NCT01725308|475028755|FG001|Treatment Period I|Changes in the Episodes|0|||
131929907|NCT01725308|475028756|FG002|Treatment Period I|Changes in the Episodes|2|||
131929908|NCT01725308|475028754|FG000|Treatment Period I|Withdrawal of Consent|12|||
131929909|NCT01725308|475028755|FG001|Treatment Period I|Withdrawal of Consent|7|||
131929910|NCT01725308|475028756|FG002|Treatment Period I|Withdrawal of Consent|5|||
131929911|NCT01725308|475028754|FG000|Treatment Period I|Lost to Follow-up|3|||
131929912|NCT01725308|475028755|FG001|Treatment Period I|Lost to Follow-up|2|||
131929913|NCT01725308|475028756|FG002|Treatment Period I|Lost to Follow-up|2|||
131929914|NCT01725308|475028754|FG000|Treatment Period I|Protocol Deviations|3|||
131929915|NCT01725308|475028755|FG001|Treatment Period I|Protocol Deviations|1|||
131929916|NCT01725308|475028756|FG002|Treatment Period I|Protocol Deviations|1|||
131929917|NCT01725308|475028754|FG000|Treatment Period I|Miscellaneous|2|||
131929918|NCT01725308|475028755|FG001|Treatment Period I|Miscellaneous|0|||
131929919|NCT01725308|475028756|FG002|Treatment Period I|Miscellaneous|3|||
131929920|NCT01725308|475028754|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
131929921|NCT01725308|475028755|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
131929922|NCT01725308|475028756|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
131929923|NCT01725308|475028754|FG000|Treatment Period II|Did Not Receive Drug|4|||
131929924|NCT01725308|475028755|FG001|Treatment Period II|Did Not Receive Drug|0|||
131929925|NCT01725308|475028756|FG002|Treatment Period II|Did Not Receive Drug|0|||
131929926|NCT01725308|475028754|FG000|Treatment Period II|Adverse Event|13|||
131929927|NCT01725308|475028755|FG001|Treatment Period II|Adverse Event|8|||
131929928|NCT01725308|475028756|FG002|Treatment Period II|Adverse Event|20|||
131929929|NCT01725308|475028754|FG000|Treatment Period II|Insufficient Response|2|||
131929930|NCT01725308|475028755|FG001|Treatment Period II|Insufficient Response|4|||
131929931|NCT01725308|475028756|FG002|Treatment Period II|Insufficient Response|6|||
131929932|NCT01725308|475028754|FG000|Treatment Period II|Worsening of the Target Disease|1|||
131929933|NCT01725308|475028755|FG001|Treatment Period II|Worsening of the Target Disease|4|||
131410908|NCT01352741|473126740|FG000|Double-blind Comparative Period|Other|1|||
131410909|NCT01352741|473126741|FG001|Double-blind Comparative Period|Other|2|||
131410910|NCT01352741|473126740|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
131410911|NCT01352741|473126741|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
131410912|NCT01352741|473126740|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
131410913|NCT01352741|473126741|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
131410914|NCT01352741|473126740|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
131410915|NCT01352741|473126741|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
131410916|NCT01352741|473126740|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
131410917|NCT01352741|473126741|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
131410918|NCT00259298|473126742|FG000|Overall Study|Withdrawal by Subject|1|||
131410919|NCT00259298|473126742|FG000|Overall Study|Physician Decision|2|||
131410920|NCT00645528|473126743|FG000|Overall Study|Did not show up for Visit 2|7|||
131410921|NCT01886690|473126744|FG000|Overall Study|Protocol Violation|0|||
131410922|NCT01886690|473126745|FG001|Overall Study|Protocol Violation|1|||
131410923|NCT01886690|473126744|FG000|Overall Study|Personal Reasons|0|||
131410924|NCT01886690|473126745|FG001|Overall Study|Personal Reasons|1|||
131410925|NCT01140568|473126746|FG000|Overall Study|disease progression|31|||
131410926|NCT01140568|473126746|FG000|Overall Study|Withdrawal by Subject|1|||
131410927|NCT01140568|473126746|FG000|Overall Study|Screen Fail|4|||
131410928|NCT03618628|473126747|FG000|Overall Study|Death|1|||
131410929|NCT03618628|473126747|FG000|Overall Study|Lost to Follow-up|1|||
131410930|NCT01741532|473126749|FG000|Overall Study|Adverse Event|4|||
131410931|NCT01741532|473126750|FG001|Overall Study|Adverse Event|0|||
131410932|NCT01741532|473126749|FG000|Overall Study|Withdrawal by Subject|1|||
131410933|NCT01741532|473126750|FG001|Overall Study|Withdrawal by Subject|1|||
131410934|NCT01741532|473126749|FG000|Overall Study|Protocol Violation|0|||
131410935|NCT01741532|473126750|FG001|Overall Study|Protocol Violation|1|||
131410936|NCT01741532|473126749|FG000|Overall Study|Worsening of the disease|3|||
131410937|NCT01741532|473126750|FG001|Overall Study|Worsening of the disease|1|||
131410938|NCT01741532|473126749|FG000|Overall Study|Sponsor decision|1|||
131410939|NCT01741532|473126750|FG001|Overall Study|Sponsor decision|0|||
131410940|NCT01741532|473126749|FG000|Overall Study|Medical event|1|||
131410941|NCT01741532|473126750|FG001|Overall Study|Medical event|0|||
131410942|NCT01510145|473126751|FG000|Overall Study|Adverse Event|6|||
131410943|NCT01510145|473126751|FG000|Overall Study|Lost to Follow-up|5|||
131410944|NCT01510145|473126751|FG000|Overall Study|Withdrawal by Subject|6|||
131410945|NCT01510145|473126751|FG000|Overall Study|Relative reported subject withdrew|1|||
131410946|NCT02153346|473126752|FG000|Overall Study|Lost to Follow-up|11|||
131410947|NCT00387647|473128498|FG000|Overall Study|Death|18|||
131410948|NCT01309269|473128501|FG000|Overall Study|Adverse Event|56|||
131410949|NCT01309269|473128501|FG000|Overall Study|Withdrawal by Subject|25|||
131410950|NCT01309269|473128501|FG000|Overall Study|Lack of Acceptance|15|||
131410951|NCT01309269|473128501|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
131410952|NCT01309269|473128501|FG000|Overall Study|Kidney Transplant|25|||
131410953|NCT01309269|473128501|FG000|Overall Study|Administrative Problems|141|||
131410954|NCT01309269|473128501|FG000|Overall Study|Other|256|||
131410955|NCT01309269|473128501|FG000|Overall Study|Other|1|||
131410956|NCT01309269|473128501|FG000|Overall Study|Study Completion Data Not Recorded|95|||
131410957|NCT01309269|473128501|FG000|Overall Study|Enrolled but not Treated|107|||
131410958|NCT03131596|473128504|FG000|Overall Study|Protocol Violation|3|||
131410959|NCT03131596|473128505|FG001|Overall Study|Protocol Violation|3|||
131410960|NCT03131596|473128504|FG000|Overall Study|Lost to Follow-up|3|||
131410961|NCT03131596|473128505|FG001|Overall Study|Lost to Follow-up|0|||
131410962|NCT04411420|473128506|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
131410963|NCT04411420|473128507|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
131410964|NCT04411420|473128506|FG000|Survey Subset|Lost to Follow-up|134|||
131410965|NCT04411420|473128507|FG001|Survey Subset|Lost to Follow-up|120|||
131410966|NCT03769311|473128510|FG000|Overall Study|Withdrawal by Subject|1|||
131410967|NCT01596335|473128511|FG000|Overall Study|exacerbation of primary disease|5|||
131410968|NCT01596335|473128512|FG001|Overall Study|exacerbation of primary disease|9|||
131410969|NCT03627065|473128513|FG000|Overall Study|Study Terminated by sponsor|1|||
131410970|NCT03627065|473128513|FG000|Overall Study|Withdrawal by Subject|2|||
131410971|NCT04524455|473128514|FG000|Overall Study|Death|3|||
131410972|NCT04524455|473128515|FG001|Overall Study|Death|3|||
131410973|NCT04524455|473128514|FG000|Overall Study|Decision by Sponsor|0|||
131410974|NCT04524455|473128515|FG001|Overall Study|Decision by Sponsor|2|||
131410975|NCT04524455|473128514|FG000|Overall Study|Withdrawal of Consent From Study|1|||
131410976|NCT04524455|473128515|FG001|Overall Study|Withdrawal of Consent From Study|0|||
131410977|NCT04524455|473128514|FG000|Overall Study|Lost to Follow-up|0|||
131410978|NCT04524455|473128515|FG001|Overall Study|Lost to Follow-up|1|||
131410979|NCT00289198|473128520|FG000|Overall Study|Adverse Event|0|||
131410980|NCT00289198|473128521|FG001|Overall Study|Adverse Event|2|||
131410981|NCT00289198|473128520|FG000|Overall Study|Protocol Violation|2|||
131410982|NCT00289198|473128521|FG001|Overall Study|Protocol Violation|1|||
131410983|NCT00289198|473128520|FG000|Overall Study|Withdrawal by Subject|4|||
131410984|NCT00289198|473128521|FG001|Overall Study|Withdrawal by Subject|1|||
131410985|NCT00289198|473128520|FG000|Overall Study|Lack of Efficacy|2|||
131410986|NCT00289198|473128521|FG001|Overall Study|Lack of Efficacy|0|||
131410987|NCT00289198|473128520|FG000|Overall Study|Other: Low compliance|0|||
131410988|NCT00289198|473128521|FG001|Overall Study|Other: Low compliance|1|||
131410989|NCT00289198|473128520|FG000|Overall Study|Other: Physician's decision|0|||
131410990|NCT00289198|473128521|FG001|Overall Study|Other: Physician's decision|1|||
131410991|NCT00289198|473128520|FG000|Overall Study|Other: Unable to attend on schedule|2|||
131410992|NCT00289198|473128521|FG001|Overall Study|Other: Unable to attend on schedule|1|||
131410993|NCT00289198|473128520|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
131410994|NCT00289198|473128521|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
131410995|NCT00289198|473128520|FG000|Overall Study|Other: Impossible to come on visit|0|||
131410996|NCT00289198|473128521|FG001|Overall Study|Other: Impossible to come on visit|1|||
131410997|NCT01176565|473128522|FG000|Overall Study|Lost to Follow-up|12|||
131410998|NCT01176565|473128523|FG001|Overall Study|Lost to Follow-up|16|||
131410999|NCT01176565|473128522|FG000|Overall Study|Withdrawal by Subject|7|||
131411000|NCT01176565|473128523|FG001|Overall Study|Withdrawal by Subject|1|||
131411001|NCT01176565|473128522|FG000|Overall Study|Not Analyzed (any other reason)|1|||
131411002|NCT01176565|473128523|FG001|Overall Study|Not Analyzed (any other reason)|2|||
131411003|NCT01062061|473128526|FG000|Overall Study|Enrolled more than once|2|||
131411004|NCT01062061|473128526|FG000|Overall Study|Investigated before study start|13|||
131411005|NCT01062061|473128526|FG000|Overall Study|Outside chief indications|10|||
131411006|NCT01062061|473128526|FG000|Overall Study|Failed to meet inclusion criteria|2|||
131411007|NCT00524589|473128527|FG000|Overall Study|Withdrawal by Subject|2|||
131411008|NCT00524589|473128527|FG000|Overall Study|Disease Progression|16|||
131411009|NCT00098722|473128531|FG000|Double Blind Phase|Adverse Event|7|||
131411010|NCT00098722|473128532|FG001|Double Blind Phase|Adverse Event|7|||
131411011|NCT00098722|473128533|FG002|Double Blind Phase|Adverse Event|3|||
131411012|NCT00098722|473128534|FG003|Double Blind Phase|Adverse Event|0|||
131411013|NCT00098722|473128535|FG004|Double Blind Phase|Adverse Event|0|||
131411014|NCT00098722|473128536|FG005|Double Blind Phase|Adverse Event|0|||
131411015|NCT00098722|473128537|FG006|Double Blind Phase|Adverse Event|0|||
131411016|NCT00098722|473128531|FG000|Double Blind Phase|Death|2|||
131411017|NCT00098722|473128532|FG001|Double Blind Phase|Death|5|||
131411018|NCT00098722|473128533|FG002|Double Blind Phase|Death|0|||
131411019|NCT00098722|473128534|FG003|Double Blind Phase|Death|0|||
131411020|NCT00098722|473128535|FG004|Double Blind Phase|Death|0|||
131411021|NCT00098722|473128536|FG005|Double Blind Phase|Death|0|||
131411022|NCT00098722|473128537|FG006|Double Blind Phase|Death|0|||
131411023|NCT00098722|473128531|FG000|Double Blind Phase|Lack of Efficacy|21|||
131411024|NCT00098722|473128532|FG001|Double Blind Phase|Lack of Efficacy|23|||
131411025|NCT00098722|473128533|FG002|Double Blind Phase|Lack of Efficacy|15|||
131411026|NCT00098722|473128534|FG003|Double Blind Phase|Lack of Efficacy|0|||
131411027|NCT00098722|473128535|FG004|Double Blind Phase|Lack of Efficacy|0|||
131411028|NCT00098722|473128536|FG005|Double Blind Phase|Lack of Efficacy|0|||
131411029|NCT00098722|473128537|FG006|Double Blind Phase|Lack of Efficacy|0|||
131411030|NCT00098722|473128531|FG000|Double Blind Phase|Participant defaulted|16|||
131411031|NCT00098722|473128532|FG001|Double Blind Phase|Participant defaulted|11|||
131411032|NCT00098722|473128533|FG002|Double Blind Phase|Participant defaulted|9|||
131411033|NCT00098722|473128534|FG003|Double Blind Phase|Participant defaulted|0|||
131411034|NCT00098722|473128535|FG004|Double Blind Phase|Participant defaulted|0|||
131411035|NCT00098722|473128536|FG005|Double Blind Phase|Participant defaulted|0|||
131411036|NCT00098722|473128537|FG006|Double Blind Phase|Participant defaulted|0|||
131411037|NCT00098722|473128531|FG000|Double Blind Phase|Pregnancy|1|||
131411038|NCT00098722|473128532|FG001|Double Blind Phase|Pregnancy|0|||
131411039|NCT00098722|473128533|FG002|Double Blind Phase|Pregnancy|0|||
131411040|NCT00098722|473128534|FG003|Double Blind Phase|Pregnancy|0|||
131411041|NCT00098722|473128535|FG004|Double Blind Phase|Pregnancy|0|||
131411042|NCT00098722|473128536|FG005|Double Blind Phase|Pregnancy|0|||
131411043|NCT00098722|473128537|FG006|Double Blind Phase|Pregnancy|0|||
131411044|NCT00098722|473128531|FG000|Double Blind Phase|Randomized, not treated|4|||
131411045|NCT00098722|473128532|FG001|Double Blind Phase|Randomized, not treated|3|||
131411046|NCT00098722|473128533|FG002|Double Blind Phase|Randomized, not treated|3|||
131411047|NCT00098722|473128534|FG003|Double Blind Phase|Randomized, not treated|0|||
131411048|NCT00098722|473128535|FG004|Double Blind Phase|Randomized, not treated|0|||
131411049|NCT00098722|473128536|FG005|Double Blind Phase|Randomized, not treated|0|||
131411050|NCT00098722|473128537|FG006|Double Blind Phase|Randomized, not treated|0|||
131411051|NCT00098722|473128531|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
131411052|NCT00098722|473128532|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
131411053|NCT00098722|473128533|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
131411054|NCT00098722|473128534|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
131411055|NCT00098722|473128535|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
131411056|NCT00098722|473128536|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
131411057|NCT00098722|473128537|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
131411058|NCT00098722|473128531|FG000|Double Blind Phase|Other|7|||
131411059|NCT00098722|473128532|FG001|Double Blind Phase|Other|8|||
131411060|NCT00098722|473128533|FG002|Double Blind Phase|Other|7|||
131411061|NCT00098722|473128534|FG003|Double Blind Phase|Other|0|||
131411062|NCT00098722|473128535|FG004|Double Blind Phase|Other|0|||
131411063|NCT00098722|473128536|FG005|Double Blind Phase|Other|0|||
131411064|NCT00098722|473128537|FG006|Double Blind Phase|Other|0|||
131411065|NCT00098722|473128531|FG000|Open Label Phase|Adverse Event|0|||
131411066|NCT00098722|473128532|FG001|Open Label Phase|Adverse Event|0|||
131411067|NCT00098722|473128533|FG002|Open Label Phase|Adverse Event|0|||
131411068|NCT00098722|473128534|FG003|Open Label Phase|Adverse Event|5|||
131411069|NCT00098722|473128535|FG004|Open Label Phase|Adverse Event|0|||
131411070|NCT00098722|473128536|FG005|Open Label Phase|Adverse Event|0|||
131411071|NCT00098722|473128537|FG006|Open Label Phase|Adverse Event|0|||
131411072|NCT00098722|473128531|FG000|Open Label Phase|Death|0|||
131411073|NCT00098722|473128532|FG001|Open Label Phase|Death|0|||
131411074|NCT00098722|473128533|FG002|Open Label Phase|Death|0|||
131411075|NCT00098722|473128534|FG003|Open Label Phase|Death|2|||
131411076|NCT00098722|473128535|FG004|Open Label Phase|Death|0|||
131411077|NCT00098722|473128536|FG005|Open Label Phase|Death|0|||
131411078|NCT00098722|473128537|FG006|Open Label Phase|Death|0|||
131929934|NCT01725308|475028756|FG002|Treatment Period II|Worsening of the Target Disease|2|||
131929935|NCT01725308|475028754|FG000|Treatment Period II|Changes in the Episodes|1|||
131929936|NCT01725308|475028755|FG001|Treatment Period II|Changes in the Episodes|0|||
131929937|NCT01725308|475028756|FG002|Treatment Period II|Changes in the Episodes|5|||
131929938|NCT01725308|475028754|FG000|Treatment Period II|Withdrawal of Consent|28|||
131929939|NCT01725308|475028755|FG001|Treatment Period II|Withdrawal of Consent|2|||
131929940|NCT01725308|475028756|FG002|Treatment Period II|Withdrawal of Consent|16|||
131929941|NCT01725308|475028754|FG000|Treatment Period II|Lost to Follow-up|1|||
131929942|NCT01725308|475028755|FG001|Treatment Period II|Lost to Follow-up|5|||
131929943|NCT01725308|475028756|FG002|Treatment Period II|Lost to Follow-up|3|||
131929944|NCT01725308|475028754|FG000|Treatment Period II|Protocol Deviations|0|||
131929945|NCT01725308|475028755|FG001|Treatment Period II|Protocol Deviations|0|||
131929946|NCT01725308|475028756|FG002|Treatment Period II|Protocol Deviations|1|||
131929947|NCT01725308|475028754|FG000|Treatment Period II|Miscellaneous|5|||
131929948|NCT01725308|475028755|FG001|Treatment Period II|Miscellaneous|3|||
131929949|NCT01725308|475028756|FG002|Treatment Period II|Miscellaneous|7|||
131929950|NCT04128228|475028760|FG000|Overall Study|Withdrawal by Subject|3|||
131929951|NCT04128228|475028761|FG001|Overall Study|Withdrawal by Subject|3|||
131929952|NCT04128228|475028762|FG002|Overall Study|Withdrawal by Subject|0|||
131929953|NCT04128228|475028763|FG003|Overall Study|Withdrawal by Subject|0|||
131929954|NCT04128228|475028760|FG000|Overall Study|noncompliance|2|||
131929955|NCT04128228|475028761|FG001|Overall Study|noncompliance|2|||
131929956|NCT04128228|475028762|FG002|Overall Study|noncompliance|0|||
131929957|NCT04128228|475028763|FG003|Overall Study|noncompliance|0|||
131929958|NCT03511209|475028764|FG000|Overall Study|Withdrawal by Subject|2|||
131929959|NCT03511209|475028765|FG001|Overall Study|Withdrawal by Subject|4|||
131929960|NCT03511209|475028764|FG000|Overall Study|Death|1|||
131929961|NCT03511209|475028765|FG001|Overall Study|Death|0|||
131929962|NCT03511209|475028764|FG000|Overall Study|Lost to Follow-up|0|||
131929963|NCT03511209|475028765|FG001|Overall Study|Lost to Follow-up|2|||
131929964|NCT01602666|475028766|FG000|Induction Chemotherapy|Death|2|||
131929965|NCT01602666|475028767|FG001|Induction Chemotherapy|Death|1|||
131929966|NCT01602666|475028766|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
131929967|NCT01602666|475028767|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
131929968|NCT01602666|475028766|FG000|Induction Chemotherapy|Physician Decision|12|||
131929969|NCT01602666|475028767|FG001|Induction Chemotherapy|Physician Decision|5|||
131929970|NCT01602666|475028766|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
131929971|NCT01602666|475028767|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
131929972|NCT01602666|475028766|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
131929973|NCT01602666|475028767|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
131411079|NCT00098722|473128531|FG000|Open Label Phase|Lack of Efficacy|0|||
131411080|NCT00098722|473128532|FG001|Open Label Phase|Lack of Efficacy|0|||
131411081|NCT00098722|473128533|FG002|Open Label Phase|Lack of Efficacy|0|||
131411082|NCT00098722|473128534|FG003|Open Label Phase|Lack of Efficacy|8|||
131411083|NCT00098722|473128535|FG004|Open Label Phase|Lack of Efficacy|0|||
131411084|NCT00098722|473128536|FG005|Open Label Phase|Lack of Efficacy|0|||
131454156|NCT02003924|473291907|FG002|Double-blind Phase|Protocol Violation|0|||
131929974|NCT01602666|475028766|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
131929975|NCT01602666|475028767|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
131929976|NCT01602666|475028766|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
131929977|NCT01602666|475028767|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
131929978|NCT01602666|475028766|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
131411085|NCT00098722|473128537|FG006|Open Label Phase|Lack of Efficacy|0|||
131411086|NCT00098722|473128531|FG000|Open Label Phase|Pregnancy|0|||
131411087|NCT00098722|473128532|FG001|Open Label Phase|Pregnancy|0|||
131411088|NCT00098722|473128533|FG002|Open Label Phase|Pregnancy|0|||
131411089|NCT00098722|473128534|FG003|Open Label Phase|Pregnancy|1|||
131411090|NCT00098722|473128535|FG004|Open Label Phase|Pregnancy|0|||
131929979|NCT01602666|475028767|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
131929980|NCT01602666|475028766|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
131929981|NCT01602666|475028767|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
131929982|NCT01602666|475028766|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
131929983|NCT01602666|475028767|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
131929984|NCT01602666|475028766|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
131929985|NCT01602666|475028767|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
131929986|NCT04754399|475028772|FG000|Overall Study|Adverse Event|5|||
131929987|NCT04754399|475028772|FG000|Overall Study|Withdrawal by Subject|6|||
131929988|NCT04565756|475028773|FG000|Overall Study|Withdrawal by Subject|0|||
131929989|NCT04565756|475028774|FG001|Overall Study|Withdrawal by Subject|0|||
131929990|NCT04565756|475028775|FG002|Overall Study|Withdrawal by Subject|0|||
131929991|NCT04565756|475028776|FG003|Overall Study|Withdrawal by Subject|0|||
131929992|NCT04565756|475028777|FG004|Overall Study|Withdrawal by Subject|1|||
131929993|NCT04565756|475028778|FG005|Overall Study|Withdrawal by Subject|0|||
131929994|NCT04565756|475028773|FG000|Overall Study|Protocol Violation|0|||
131929995|NCT04565756|475028774|FG001|Overall Study|Protocol Violation|0|||
131929996|NCT04565756|475028775|FG002|Overall Study|Protocol Violation|0|||
131929997|NCT04565756|475028776|FG003|Overall Study|Protocol Violation|0|||
131929998|NCT04565756|475028777|FG004|Overall Study|Protocol Violation|0|||
131929999|NCT04565756|475028778|FG005|Overall Study|Protocol Violation|1|||
131930000|NCT05259722|475028787|FG000|Overall Study|Adverse Event|2|||
131930001|NCT05259722|475028788|FG001|Overall Study|Adverse Event|24|||
131930002|NCT05259722|475028787|FG000|Overall Study|Lost to Follow-up|5|||
131930003|NCT05259722|475028788|FG001|Overall Study|Lost to Follow-up|1|||
131930004|NCT05259722|475028787|FG000|Overall Study|Lack of Efficacy|8|||
131930005|NCT05259722|475028788|FG001|Overall Study|Lack of Efficacy|26|||
131930006|NCT05259722|475028787|FG000|Overall Study|Withdrawal by Subject|15|||
131930007|NCT05259722|475028788|FG001|Overall Study|Withdrawal by Subject|33|||
131930008|NCT05259722|475028787|FG000|Overall Study|Various reasons|3|||
131930009|NCT05259722|475028788|FG001|Overall Study|Various reasons|9|||
131930010|NCT05259722|475028787|FG000|Overall Study|Not exposed to IMP|1|||
131930011|NCT05259722|475028788|FG001|Overall Study|Not exposed to IMP|12|||
131930012|NCT05259722|475028787|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
131930013|NCT05259722|475028788|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
131930014|NCT00962650|475028789|FG000|Overall Study|Transgastric DP was not completed|2|||
131930015|NCT00231465|475028791|FG000|Overall Study|Completed only one cycle|1|||
131930016|NCT00231465|475028791|FG000|Overall Study|Did not have follow up CT scans|1|||
131930017|NCT00968968|475028792|FG000|Overall Study|Study closed/terminated|10|||
131930018|NCT00968968|475028793|FG001|Overall Study|Study closed/terminated|10|||
131930019|NCT00968968|475028792|FG000|Overall Study|Protocol defined stopping criteria|3|||
131930020|NCT00968968|475028793|FG001|Overall Study|Protocol defined stopping criteria|1|||
131930021|NCT00968968|475028792|FG000|Overall Study|Withdrawal by Subject|2|||
131930022|NCT00968968|475028793|FG001|Overall Study|Withdrawal by Subject|0|||
131930023|NCT00968968|475028792|FG000|Overall Study|Physician Decision|1|||
131930024|NCT00968968|475028793|FG001|Overall Study|Physician Decision|2|||
131930025|NCT00968968|475028792|FG000|Overall Study|Lost to Follow-up|0|||
131930026|NCT00968968|475028793|FG001|Overall Study|Lost to Follow-up|1|||
131930027|NCT03624036|475028794|FG000|Overall Study|Death|2|||
131930028|NCT03624036|475028795|FG001|Overall Study|Death|3|||
131930029|NCT03624036|475028796|FG002|Overall Study|Death|0|||
131930030|NCT03624036|475028797|FG003|Overall Study|Death|1|||
131930031|NCT03624036|475028794|FG000|Overall Study|Withdrawal by Subject|1|||
131930032|NCT03624036|475028795|FG001|Overall Study|Withdrawal by Subject|0|||
131930033|NCT03624036|475028796|FG002|Overall Study|Withdrawal by Subject|1|||
131930034|NCT03624036|475028797|FG003|Overall Study|Withdrawal by Subject|0|||
131930035|NCT03624036|475028794|FG000|Overall Study|Enrolled but Never Treated|1|||
131930036|NCT03624036|475028795|FG001|Overall Study|Enrolled but Never Treated|0|||
131930037|NCT03624036|475028796|FG002|Overall Study|Enrolled but Never Treated|0|||
131930038|NCT03624036|475028797|FG003|Overall Study|Enrolled but Never Treated|0|||
131930039|NCT03624036|475028794|FG000|Overall Study|Reason not Specified|3|||
131930040|NCT03624036|475028795|FG001|Overall Study|Reason not Specified|0|||
131930041|NCT03624036|475028796|FG002|Overall Study|Reason not Specified|2|||
131930042|NCT03624036|475028797|FG003|Overall Study|Reason not Specified|2|||
131930043|NCT02774278|475028802|FG000|Overall Study|Lack of Efficacy|199|||
131930044|NCT02774278|475028802|FG000|Overall Study|Death|29|||
131930045|NCT02774278|475028802|FG000|Overall Study|Adverse event/intercurrent illness|16|||
131930046|NCT02774278|475028802|FG000|Overall Study|Refused treatment/did not cooperate|9|||
131930047|NCT02774278|475028802|FG000|Overall Study|Administrative reasons|6|||
131930048|NCT02774278|475028802|FG000|Overall Study|Withdrawal by Subject|3|||
131930049|NCT02774278|475028802|FG000|Overall Study|Protocol Violation|2|||
131930050|NCT00127933|475028805|FG000|Overall Study|Randomized but not dosed|1|||
131930051|NCT00127933|475028806|FG001|Overall Study|Randomized but not dosed|0|||
131930052|NCT00498485|475028811|FG000|Overall Study|Adverse Event|1|||
131930053|NCT00498485|475028812|FG001|Overall Study|Adverse Event|5|||
131930054|NCT00930176|475028814|FG000|Overall Study|Death|1|||
131930055|NCT00401830|475028818|FG000|Overall Study|Adverse Event|10|||
131930056|NCT00401830|475028819|FG001|Overall Study|Adverse Event|18|||
131930057|NCT00401830|475028818|FG000|Overall Study|Lack of Efficacy|11|||
131930058|NCT00401830|475028819|FG001|Overall Study|Lack of Efficacy|5|||
131930059|NCT00401830|475028818|FG000|Overall Study|Withdrawal by Subject|4|||
131930060|NCT00401830|475028819|FG001|Overall Study|Withdrawal by Subject|3|||
131930061|NCT00401830|475028818|FG000|Overall Study|Protocol Violation|3|||
131930062|NCT00401830|475028819|FG001|Overall Study|Protocol Violation|3|||
131930063|NCT00401830|475028818|FG000|Overall Study|Non-compliance with drug study|1|||
131930064|NCT00401830|475028819|FG001|Overall Study|Non-compliance with drug study|0|||
131930065|NCT00401830|475028818|FG000|Overall Study|Lost to Follow-up|1|||
131930066|NCT00401830|475028819|FG001|Overall Study|Lost to Follow-up|3|||
131930067|NCT00401830|475028818|FG000|Overall Study|Other: Personal / Family problems|1|||
131930068|NCT00401830|475028819|FG001|Overall Study|Other: Personal / Family problems|0|||
131930069|NCT03378635|475028822|FG000|Overall Study|Adverse Event|1|||
131930070|NCT03378635|475028823|FG001|Overall Study|Adverse Event|0|||
131930071|NCT03378635|475028824|FG002|Overall Study|Adverse Event|0|||
131930072|NCT03378635|475028822|FG000|Overall Study|Withdrawal by Subject|1|||
131930073|NCT03378635|475028823|FG001|Overall Study|Withdrawal by Subject|0|||
131930074|NCT03378635|475028824|FG002|Overall Study|Withdrawal by Subject|0|||
131930075|NCT01316900|475028828|FG000|Overall Study|Adverse Event|10|||
131930076|NCT01316900|475028829|FG001|Overall Study|Adverse Event|10|||
131930077|NCT01316900|475028830|FG002|Overall Study|Adverse Event|15|||
131930078|NCT01316900|475028831|FG003|Overall Study|Adverse Event|9|||
131930079|NCT01316900|475028828|FG000|Overall Study|Lack of Efficacy|17|||
131930080|NCT01316900|475028829|FG001|Overall Study|Lack of Efficacy|9|||
131930081|NCT01316900|475028830|FG002|Overall Study|Lack of Efficacy|5|||
131930082|NCT01316900|475028831|FG003|Overall Study|Lack of Efficacy|7|||
131930083|NCT01316900|475028828|FG000|Overall Study|Protocol Violation|7|||
131930084|NCT01316900|475028829|FG001|Overall Study|Protocol Violation|1|||
131930085|NCT01316900|475028830|FG002|Overall Study|Protocol Violation|4|||
131930086|NCT01316900|475028831|FG003|Overall Study|Protocol Violation|0|||
131930087|NCT01316900|475028828|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
131930088|NCT01316900|475028829|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
131930089|NCT01316900|475028830|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
131930090|NCT01316900|475028831|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
131930091|NCT01316900|475028828|FG000|Overall Study|Lost to Follow-up|1|||
131930092|NCT01316900|475028829|FG001|Overall Study|Lost to Follow-up|0|||
131930093|NCT01316900|475028830|FG002|Overall Study|Lost to Follow-up|1|||
131930094|NCT01316900|475028831|FG003|Overall Study|Lost to Follow-up|1|||
131930095|NCT01316900|475028828|FG000|Overall Study|Withdrawal by Subject|7|||
131930096|NCT01316900|475028829|FG001|Overall Study|Withdrawal by Subject|8|||
131930097|NCT01316900|475028830|FG002|Overall Study|Withdrawal by Subject|6|||
131930098|NCT01316900|475028831|FG003|Overall Study|Withdrawal by Subject|9|||
131930099|NCT01684033|475028832|FG000|Period 1, First 30 Days|Adverse Event|1|||
131930100|NCT01684033|475028833|FG001|Period 1, First 30 Days|Adverse Event|1|||
131930101|NCT01684033|475028832|FG000|Period 1, First 30 Days|Noncompliance|1|||
131930102|NCT01684033|475028833|FG001|Period 1, First 30 Days|Noncompliance|0|||
131930103|NCT01684033|475028832|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
131930104|NCT01684033|475028833|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
131930105|NCT01684033|475028832|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
131930106|NCT01684033|475028833|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
131930107|NCT01684033|475028832|FG000|Period 2, Second 30 Days|Adverse Event|1|||
131930108|NCT01684033|475028833|FG001|Period 2, Second 30 Days|Adverse Event|0|||
131930109|NCT01569763|475030461|FG000|Overall Study|Lack of Efficacy|2|||
131930110|NCT01569763|475030462|FG001|Overall Study|Lack of Efficacy|7|||
131930111|NCT01569763|475030461|FG000|Overall Study|Adverse Event|1|||
131930112|NCT01569763|475030462|FG001|Overall Study|Adverse Event|0|||
131930113|NCT02730169|475030463|FG000|Overall Study|Protocol Violation|1|||
131411091|NCT00098722|473128536|FG005|Open Label Phase|Pregnancy|0|||
131411092|NCT00098722|473128537|FG006|Open Label Phase|Pregnancy|0|||
131930114|NCT02730169|475030464|FG001|Overall Study|Protocol Violation|0|||
131930115|NCT02730169|475030465|FG002|Overall Study|Protocol Violation|0|||
131930116|NCT02730169|475030466|FG003|Overall Study|Protocol Violation|1|||
131930117|NCT02730169|475030463|FG000|Overall Study|Adverse Event|2|||
131930118|NCT02730169|475030464|FG001|Overall Study|Adverse Event|3|||
131930119|NCT02730169|475030465|FG002|Overall Study|Adverse Event|3|||
131930120|NCT02730169|475030466|FG003|Overall Study|Adverse Event|0|||
131930121|NCT02730169|475030463|FG000|Overall Study|Adverse Event of Special Interest|0|||
131930122|NCT02730169|475030464|FG001|Overall Study|Adverse Event of Special Interest|1|||
131930123|NCT02730169|475030465|FG002|Overall Study|Adverse Event of Special Interest|2|||
131930124|NCT02730169|475030466|FG003|Overall Study|Adverse Event of Special Interest|0|||
131930125|NCT02730169|475030463|FG000|Overall Study|Withdrawal by Subject|6|||
131930126|NCT02730169|475030464|FG001|Overall Study|Withdrawal by Subject|11|||
131930127|NCT02730169|475030465|FG002|Overall Study|Withdrawal by Subject|6|||
131930128|NCT02730169|475030466|FG003|Overall Study|Withdrawal by Subject|8|||
131930129|NCT02730169|475030463|FG000|Overall Study|Lost to Follow-up|5|||
131930130|NCT02730169|475030464|FG001|Overall Study|Lost to Follow-up|6|||
131930131|NCT02730169|475030465|FG002|Overall Study|Lost to Follow-up|5|||
131930132|NCT02730169|475030466|FG003|Overall Study|Lost to Follow-up|6|||
131930133|NCT02730169|475030463|FG000|Overall Study|Other|0|||
131930134|NCT02730169|475030464|FG001|Overall Study|Other|0|||
131930135|NCT02730169|475030465|FG002|Overall Study|Other|1|||
131930136|NCT02730169|475030466|FG003|Overall Study|Other|1|||
131930137|NCT03211858|475030474|FG000|Overall Study|Adverse Event|8|||
131930138|NCT03211858|475030475|FG001|Overall Study|Adverse Event|6|||
131930139|NCT03211858|475030474|FG000|Overall Study|Lack of Efficacy|0|||
131930140|NCT03211858|475030475|FG001|Overall Study|Lack of Efficacy|4|||
131930141|NCT03211858|475030474|FG000|Overall Study|Poor compliance to protocol|6|||
131930142|NCT03211858|475030475|FG001|Overall Study|Poor compliance to protocol|2|||
131930143|NCT03211858|475030474|FG000|Overall Study|Non-serious Hypoglycemia|1|||
131930144|NCT03211858|475030475|FG001|Overall Study|Non-serious Hypoglycemia|0|||
131930145|NCT03211858|475030474|FG000|Overall Study|Other than specified above|22|||
131930146|NCT03211858|475030475|FG001|Overall Study|Other than specified above|21|||
131930147|NCT03810365|475030476|FG000|Overall Study|Lost to Follow-up|2|||
131930148|NCT03810365|475030477|FG001|Overall Study|Lost to Follow-up|2|||
131930149|NCT03810365|475030476|FG000|Overall Study|Withdrawal by Subject|4|||
131930150|NCT03810365|475030477|FG001|Overall Study|Withdrawal by Subject|5|||
131930151|NCT03160573|475030482|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
131930152|NCT03160573|475030483|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
131930153|NCT03160573|475030484|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
131930154|NCT03160573|475030485|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
131930155|NCT02144337|475030490|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
131930156|NCT02144337|475030491|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
131930157|NCT02144337|475030490|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
131930158|NCT02144337|475030491|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
131930159|NCT02144337|475030490|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
131930160|NCT02144337|475030491|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
131930161|NCT02144337|475030490|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
131930162|NCT02144337|475030491|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
131411093|NCT00098722|473128531|FG000|Open Label Phase|Participant defaulted|0|||
131411094|NCT00098722|473128532|FG001|Open Label Phase|Participant defaulted|0|||
131411095|NCT00098722|473128533|FG002|Open Label Phase|Participant defaulted|0|||
131411096|NCT00098722|473128534|FG003|Open Label Phase|Participant defaulted|18|||
131411097|NCT00098722|473128535|FG004|Open Label Phase|Participant defaulted|0|||
131411098|NCT00098722|473128536|FG005|Open Label Phase|Participant defaulted|0|||
131411099|NCT00098722|473128537|FG006|Open Label Phase|Participant defaulted|0|||
131411100|NCT00098722|473128531|FG000|Open Label Phase|Ongoing at cut-off date|0|||
131411101|NCT00098722|473128532|FG001|Open Label Phase|Ongoing at cut-off date|0|||
131411102|NCT00098722|473128533|FG002|Open Label Phase|Ongoing at cut-off date|0|||
131411103|NCT00098722|473128534|FG003|Open Label Phase|Ongoing at cut-off date|220|||
131411104|NCT00098722|473128535|FG004|Open Label Phase|Ongoing at cut-off date|50|||
131411105|NCT00098722|473128536|FG005|Open Label Phase|Ongoing at cut-off date|0|||
131411106|NCT00098722|473128537|FG006|Open Label Phase|Ongoing at cut-off date|0|||
131411107|NCT00098722|473128531|FG000|Open Label Phase|Other|0|||
131411108|NCT00098722|473128532|FG001|Open Label Phase|Other|0|||
131411109|NCT00098722|473128533|FG002|Open Label Phase|Other|0|||
131411110|NCT00098722|473128534|FG003|Open Label Phase|Other|18|||
131411111|NCT00098722|473128535|FG004|Open Label Phase|Other|0|||
131411112|NCT00098722|473128536|FG005|Open Label Phase|Other|0|||
131930163|NCT02144337|475030490|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
131930164|NCT02144337|475030491|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
131930165|NCT01730729|475030494|FG000|Overall Study|Adverse Event|1|||
131930166|NCT01730729|475030494|FG000|Overall Study|Death|1|||
131930167|NCT01730729|475030494|FG000|Overall Study|Progressive Disease|12|||
131930168|NCT02402907|475030495|FG000|Overall Study|Delivered vaginally|9|||
131930169|NCT02402907|475030496|FG001|Overall Study|Delivered vaginally|3|||
131930170|NCT02402907|475030495|FG000|Overall Study|Delivered outside of Sinai|1|||
131930171|NCT02402907|475030496|FG001|Overall Study|Delivered outside of Sinai|1|||
131411113|NCT00098722|473128537|FG006|Open Label Phase|Other|0|||
131930172|NCT02402907|475030495|FG000|Overall Study|Lost to follow up after C-Section|10|||
131930173|NCT02402907|475030496|FG001|Overall Study|Lost to follow up after C-Section|23|||
131930174|NCT00449787|475030497|FG000|Overall Study|Lost to Follow-up|10|||
131930175|NCT00449787|475030498|FG001|Overall Study|Lost to Follow-up|8|||
131411114|NCT00098722|473128531|FG000|Observation Phase|Death|0|||
131411115|NCT00098722|473128532|FG001|Observation Phase|Death|0|||
131411116|NCT00098722|473128533|FG002|Observation Phase|Death|0|||
131930176|NCT00449787|475030497|FG000|Overall Study|Did not require medication|95|||
131930177|NCT00449787|475030498|FG001|Overall Study|Did not require medication|92|||
131930178|NCT03701074|475030499|FG000|Overall Study|Physician Decision|1|||
131930179|NCT03701074|475030500|FG001|Overall Study|Physician Decision|0|||
131411117|NCT00098722|473128534|FG003|Observation Phase|Death|0|||
131930180|NCT01661595|475030501|FG000|Phase 1: Week 0-4|Adverse Event|1|||
131930181|NCT01661595|475030502|FG001|Phase 1: Week 0-4|Adverse Event|0|||
131411118|NCT00098722|473128535|FG004|Observation Phase|Death|0|||
131411119|NCT00098722|473128536|FG005|Observation Phase|Death|5|||
131411120|NCT00098722|473128537|FG006|Observation Phase|Death|3|||
131411121|NCT00098722|473128531|FG000|Observation Phase|Lack of Efficacy|0|||
131411122|NCT00098722|473128532|FG001|Observation Phase|Lack of Efficacy|0|||
131411123|NCT00098722|473128533|FG002|Observation Phase|Lack of Efficacy|0|||
131411124|NCT00098722|473128534|FG003|Observation Phase|Lack of Efficacy|0|||
131411125|NCT00098722|473128535|FG004|Observation Phase|Lack of Efficacy|0|||
131411126|NCT00098722|473128536|FG005|Observation Phase|Lack of Efficacy|2|||
131411127|NCT00098722|473128537|FG006|Observation Phase|Lack of Efficacy|0|||
131411128|NCT00098722|473128531|FG000|Observation Phase|Participant defaulted|0|||
131411129|NCT00098722|473128532|FG001|Observation Phase|Participant defaulted|0|||
131411130|NCT00098722|473128533|FG002|Observation Phase|Participant defaulted|0|||
131454157|NCT02003924|473291905|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
131454158|NCT02003924|473291906|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
131930182|NCT01661595|475030503|FG002|Phase 1: Week 0-4|Adverse Event|0|||
131930183|NCT01661595|475030504|FG003|Phase 1: Week 0-4|Adverse Event|0|||
131930184|NCT01661595|475030501|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
131930185|NCT01661595|475030502|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
131930186|NCT01661595|475030503|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
131930187|NCT01661595|475030504|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
131930188|NCT03574389|475030505|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
131930189|NCT03574389|475030506|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
131930190|NCT03574389|475030507|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
131930191|NCT03574389|475030508|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
131930192|NCT03574389|475030509|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
131930193|NCT03574389|475030510|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
131930194|NCT03574389|475030511|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
131930195|NCT03574389|475030505|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
131930196|NCT03574389|475030506|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
131930197|NCT03574389|475030507|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
131930198|NCT03574389|475030508|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
131930199|NCT03574389|475030509|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
131930200|NCT03574389|475030510|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
131930201|NCT03574389|475030511|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
131930202|NCT03574389|475030505|FG000|Vaccination Period|Other|6|||
131930203|NCT03574389|475030506|FG001|Vaccination Period|Other|0|||
131930204|NCT03574389|475030507|FG002|Vaccination Period|Other|0|||
131930205|NCT03574389|475030508|FG003|Vaccination Period|Other|0|||
131930206|NCT03574389|475030509|FG004|Vaccination Period|Other|0|||
131930207|NCT03574389|475030510|FG005|Vaccination Period|Other|0|||
131930208|NCT03574389|475030511|FG006|Vaccination Period|Other|0|||
131930209|NCT03574389|475030505|FG000|Vaccination Period|Adverse Event|0|||
131930210|NCT03574389|475030506|FG001|Vaccination Period|Adverse Event|1|||
131930211|NCT03574389|475030507|FG002|Vaccination Period|Adverse Event|0|||
131930212|NCT03574389|475030508|FG003|Vaccination Period|Adverse Event|0|||
131930213|NCT03574389|475030509|FG004|Vaccination Period|Adverse Event|0|||
131930214|NCT03574389|475030510|FG005|Vaccination Period|Adverse Event|0|||
131930215|NCT03574389|475030511|FG006|Vaccination Period|Adverse Event|0|||
131930216|NCT03574389|475030505|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
131930217|NCT03574389|475030506|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
131930218|NCT03574389|475030507|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
131930219|NCT03574389|475030508|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
131930220|NCT03574389|475030509|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
131930221|NCT03574389|475030510|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
131930222|NCT03574389|475030511|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
131930223|NCT01682603|475030512|FG000|Overall Study|Lost to Follow-up|3|||
131930224|NCT01959919|475030513|FG000|Overall Study|Did not meet the eligibility criteria|2|||
131930225|NCT00159874|475030516|FG000|Overall Study|Adverse Event|2|||
131930226|NCT00159874|475030517|FG001|Overall Study|Adverse Event|2|||
131930227|NCT00159874|475030518|FG002|Overall Study|Adverse Event|5|||
131930228|NCT00159874|475030519|FG003|Overall Study|Adverse Event|1|||
131930229|NCT00159874|475030520|FG004|Overall Study|Adverse Event|1|||
131930230|NCT00159874|475030521|FG005|Overall Study|Adverse Event|2|||
131930231|NCT00159874|475030522|FG006|Overall Study|Adverse Event|0|||
131930232|NCT00159874|475030516|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
131930233|NCT00159874|475030517|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
131411131|NCT00098722|473128534|FG003|Observation Phase|Participant defaulted|0|||
131930234|NCT00159874|475030518|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
131930235|NCT00159874|475030519|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
131930236|NCT00159874|475030520|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
131930237|NCT00159874|475030521|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
131930238|NCT00159874|475030522|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
131930239|NCT00159874|475030516|FG000|Overall Study|Lack of Efficacy|2|||
131930240|NCT00159874|475030517|FG001|Overall Study|Lack of Efficacy|0|||
131930241|NCT00159874|475030518|FG002|Overall Study|Lack of Efficacy|1|||
131930242|NCT00159874|475030519|FG003|Overall Study|Lack of Efficacy|1|||
131930243|NCT00159874|475030520|FG004|Overall Study|Lack of Efficacy|0|||
131930244|NCT00159874|475030521|FG005|Overall Study|Lack of Efficacy|3|||
131930245|NCT00159874|475030522|FG006|Overall Study|Lack of Efficacy|0|||
131930246|NCT00159874|475030516|FG000|Overall Study|Lost to Follow-up|1|||
131930247|NCT00159874|475030517|FG001|Overall Study|Lost to Follow-up|0|||
131930248|NCT00159874|475030518|FG002|Overall Study|Lost to Follow-up|3|||
131930249|NCT00159874|475030519|FG003|Overall Study|Lost to Follow-up|0|||
131930250|NCT00159874|475030520|FG004|Overall Study|Lost to Follow-up|1|||
131930251|NCT00159874|475030521|FG005|Overall Study|Lost to Follow-up|2|||
131930252|NCT00159874|475030522|FG006|Overall Study|Lost to Follow-up|1|||
131930253|NCT00159874|475030516|FG000|Overall Study|Other|8|||
131930254|NCT00159874|475030517|FG001|Overall Study|Other|8|||
131930255|NCT00159874|475030518|FG002|Overall Study|Other|8|||
131930256|NCT00159874|475030519|FG003|Overall Study|Other|0|||
131930257|NCT00159874|475030520|FG004|Overall Study|Other|2|||
131930258|NCT00159874|475030521|FG005|Overall Study|Other|1|||
131930259|NCT00159874|475030522|FG006|Overall Study|Other|3|||
131930260|NCT00159874|475030516|FG000|Overall Study|Protocol Violation|0|||
131930261|NCT00159874|475030517|FG001|Overall Study|Protocol Violation|5|||
131930262|NCT00159874|475030518|FG002|Overall Study|Protocol Violation|2|||
131930263|NCT00159874|475030519|FG003|Overall Study|Protocol Violation|0|||
131930264|NCT00159874|475030520|FG004|Overall Study|Protocol Violation|0|||
131930265|NCT00159874|475030521|FG005|Overall Study|Protocol Violation|0|||
131930266|NCT00159874|475030522|FG006|Overall Study|Protocol Violation|0|||
131930267|NCT00159874|475030516|FG000|Overall Study|Death|3|||
131930268|NCT00159874|475030517|FG001|Overall Study|Death|8|||
131930269|NCT00159874|475030518|FG002|Overall Study|Death|15|||
131930270|NCT00159874|475030519|FG003|Overall Study|Death|0|||
131930271|NCT00159874|475030520|FG004|Overall Study|Death|1|||
131930272|NCT00159874|475030521|FG005|Overall Study|Death|2|||
131930273|NCT00159874|475030522|FG006|Overall Study|Death|0|||
131930274|NCT00159874|475030516|FG000|Overall Study|Withdrawal by Subject|2|||
131930275|NCT00159874|475030517|FG001|Overall Study|Withdrawal by Subject|6|||
131930276|NCT00159874|475030518|FG002|Overall Study|Withdrawal by Subject|8|||
131930277|NCT00159874|475030519|FG003|Overall Study|Withdrawal by Subject|4|||
131930278|NCT00159874|475030520|FG004|Overall Study|Withdrawal by Subject|3|||
131930279|NCT00159874|475030521|FG005|Overall Study|Withdrawal by Subject|2|||
131930280|NCT00159874|475030522|FG006|Overall Study|Withdrawal by Subject|1|||
131930281|NCT00159874|475030516|FG000|Overall Study|Pregnancy|1|||
131930282|NCT00159874|475030517|FG001|Overall Study|Pregnancy|1|||
131930283|NCT00159874|475030518|FG002|Overall Study|Pregnancy|0|||
131930284|NCT00159874|475030519|FG003|Overall Study|Pregnancy|0|||
131930285|NCT00159874|475030520|FG004|Overall Study|Pregnancy|0|||
131930286|NCT00159874|475030521|FG005|Overall Study|Pregnancy|0|||
131930287|NCT00159874|475030522|FG006|Overall Study|Pregnancy|0|||
131930288|NCT05122143|475030525|FG000|Overall Study|Adverse Event|1|||
131930289|NCT05122143|475030526|FG001|Overall Study|Adverse Event|0|||
131930290|NCT05122143|475030527|FG002|Overall Study|Adverse Event|0|||
131930291|NCT05122143|475030528|FG003|Overall Study|Adverse Event|0|||
131930292|NCT05122143|475030529|FG004|Overall Study|Adverse Event|1|||
131930293|NCT05122143|475030530|FG005|Overall Study|Adverse Event|0|||
131930294|NCT05122143|475030525|FG000|Overall Study|Protocol non-compliance|0|||
131930295|NCT05122143|475030526|FG001|Overall Study|Protocol non-compliance|0|||
131930296|NCT05122143|475030527|FG002|Overall Study|Protocol non-compliance|1|||
131930297|NCT05122143|475030528|FG003|Overall Study|Protocol non-compliance|0|||
131930298|NCT05122143|475030529|FG004|Overall Study|Protocol non-compliance|0|||
131930299|NCT05122143|475030530|FG005|Overall Study|Protocol non-compliance|0|||
131930300|NCT05122143|475030525|FG000|Overall Study|Covid contact|0|||
131930301|NCT05122143|475030526|FG001|Overall Study|Covid contact|0|||
131930302|NCT05122143|475030527|FG002|Overall Study|Covid contact|0|||
131930303|NCT05122143|475030528|FG003|Overall Study|Covid contact|0|||
131930304|NCT05122143|475030529|FG004|Overall Study|Covid contact|1|||
131930305|NCT05122143|475030530|FG005|Overall Study|Covid contact|0|||
131411132|NCT00098722|473128535|FG004|Observation Phase|Participant defaulted|0|||
131930306|NCT04829214|475030531|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
131930307|NCT04829214|475030532|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
131930308|NCT04829214|475030531|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
131930309|NCT04829214|475030532|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
131930310|NCT02739828|475030534|FG000|Overall Study|Adverse Event|1|||
131930311|NCT02739828|475030534|FG000|Overall Study|Lost to Follow-up|4|||
131930312|NCT01392495|475030535|FG000|Overall Study|Death|3|||
131930313|NCT01392495|475030535|FG000|Overall Study|Administrative problems|8|||
131930314|NCT01392495|475030535|FG000|Overall Study|Withdrawal by Subject|2|||
131930315|NCT01392495|475030535|FG000|Overall Study|Adverse Event|3|||
131930316|NCT02571244|475030536|FG000|Overall Study|Lost to Follow-up|0|||
131930317|NCT02571244|475030537|FG001|Overall Study|Lost to Follow-up|1|||
131930318|NCT02571244|475030536|FG000|Overall Study|Unable to reach out post discharge|3|||
131930319|NCT02571244|475030537|FG001|Overall Study|Unable to reach out post discharge|0|||
131930320|NCT01696214|475030538|FG000|Overall Study|Lost to Follow-up|1|||
131930321|NCT01696214|475030539|FG001|Overall Study|Lost to Follow-up|0|||
131930322|NCT01696214|475030540|FG002|Overall Study|Lost to Follow-up|0|||
131930323|NCT01696214|475030541|FG003|Overall Study|Lost to Follow-up|0|||
131930324|NCT01570192|475030542|FG000|Overall Study|no qualifying organism|6|||
131930325|NCT01570192|475030543|FG001|Overall Study|no qualifying organism|12|||
131930326|NCT01570192|475030542|FG000|Overall Study|changed to palliative care|1|||
131930327|NCT01570192|475030543|FG001|Overall Study|changed to palliative care|0|||
131930328|NCT01570192|475030542|FG000|Overall Study|Physician Decision|0|||
131930329|NCT01570192|475030543|FG001|Overall Study|Physician Decision|1|||
131930330|NCT01714063|475030544|FG000|Overall Study|Equipment malfunction|2|||
131930331|NCT00452530|475030545|FG000|Overall Study|Death|1|||
131930332|NCT00452530|475030546|FG001|Overall Study|Death|0|||
131930333|NCT00452530|475030545|FG000|Overall Study|Adverse Event|40|||
131930334|NCT00452530|475030546|FG001|Overall Study|Adverse Event|44|||
131930335|NCT00452530|475030545|FG000|Overall Study|Withdrawal by Subject|68|||
131930336|NCT00452530|475030546|FG001|Overall Study|Withdrawal by Subject|57|||
131930337|NCT00452530|475030545|FG000|Overall Study|Lost to Follow-up|1|||
131930338|NCT00452530|475030546|FG001|Overall Study|Lost to Follow-up|0|||
131930339|NCT00452530|475030545|FG000|Overall Study|Poor compliance/noncompliance|1|||
131930340|NCT00452530|475030546|FG001|Overall Study|Poor compliance/noncompliance|2|||
131930341|NCT00452530|475030545|FG000|Overall Study|No longer met study criteria|18|||
131930342|NCT00452530|475030546|FG001|Overall Study|No longer met study criteria|22|||
131930343|NCT00452530|475030545|FG000|Overall Study|Other|7|||
131930344|NCT00452530|475030546|FG001|Overall Study|Other|11|||
131930345|NCT02100644|475030547|FG000|LTG Escalation Phase|Adverse Event|9|||
131930346|NCT02100644|475030548|FG001|LTG Escalation Phase|Adverse Event|0|||
131930347|NCT02100644|475030549|FG002|LTG Escalation Phase|Adverse Event|0|||
131930348|NCT02100644|475030547|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
131930349|NCT02100644|475030548|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
131930350|NCT02100644|475030549|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
131930351|NCT02100644|475030547|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
131930352|NCT02100644|475030548|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
131930353|NCT02100644|475030549|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
131930354|NCT04629521|475030550|FG000|Overall Study|Death|1|||
131930355|NCT04629521|475030550|FG000|Overall Study|Lost to Follow-up|3|||
131930356|NCT04629521|475030550|FG000|Overall Study|Subject withdrew consent|3|||
131930357|NCT04629521|475030550|FG000|Overall Study|Enrolled in error|1|||
131930358|NCT01898091|475030552|FG000|Overall Study|Lost to Follow-up|1|||
131930359|NCT01898091|475030553|FG001|Overall Study|Lost to Follow-up|1|||
131930360|NCT01898091|475030552|FG000|Overall Study|Withdrawal by Subject|1|||
131930361|NCT01898091|475030553|FG001|Overall Study|Withdrawal by Subject|5|||
131930362|NCT01618708|475030554|FG000|Overall Study|Adverse Event|10|||
131930363|NCT01618708|475030555|FG001|Overall Study|Adverse Event|10|||
131930364|NCT01618708|475030554|FG000|Overall Study|Lost to Follow-up|3|||
131930365|NCT01618708|475030555|FG001|Overall Study|Lost to Follow-up|3|||
131930366|NCT01618708|475030554|FG000|Overall Study|Withdrawal by Subject|17|||
131930367|NCT01618708|475030555|FG001|Overall Study|Withdrawal by Subject|22|||
131930368|NCT01618708|475030554|FG000|Overall Study|Lack of Efficacy|8|||
131930369|NCT01618708|475030555|FG001|Overall Study|Lack of Efficacy|8|||
131930370|NCT01618708|475030554|FG000|Overall Study|Technical problems|2|||
131930371|NCT01618708|475030555|FG001|Overall Study|Technical problems|0|||
131930372|NCT01618708|475030554|FG000|Overall Study|Other than specified above|1|||
131930373|NCT01618708|475030555|FG001|Overall Study|Other than specified above|1|||
131930374|NCT01618708|475030554|FG000|Overall Study|Randomized but not treated|3|||
131930375|NCT01618708|475030555|FG001|Overall Study|Randomized but not treated|2|||
131930376|NCT02496156|475030564|FG000|Overall Study|Lost to Follow-up|5|||
131454159|NCT02003924|473291907|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
131454160|NCT02003924|473291905|FG000|Double-blind Phase|Disease Progression|229|||
131454161|NCT02003924|473291906|FG001|Double-blind Phase|Disease Progression|247|||
131454162|NCT02003924|473291907|FG002|Double-blind Phase|Disease Progression|0|||
131930377|NCT02496156|475030565|FG001|Overall Study|Lost to Follow-up|0|||
131930378|NCT02496156|475030564|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
131930379|NCT02496156|475030565|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
131930380|NCT00089583|475030566|FG000|Overall Study|Adverse Event|0|||
131930381|NCT00089583|475030567|FG001|Overall Study|Adverse Event|3|||
131930382|NCT00089583|475030566|FG000|Overall Study|Insufficient Viral Load Response|5|||
131454163|NCT02003924|473291905|FG000|Double-blind Phase|Adverse Event|120|||
131930383|NCT00089583|475030567|FG001|Overall Study|Insufficient Viral Load Response|5|||
131930384|NCT00089583|475030566|FG000|Overall Study|Withdrawal by Subject|0|||
131930385|NCT00089583|475030567|FG001|Overall Study|Withdrawal by Subject|4|||
131930386|NCT00089583|475030566|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
131930387|NCT00089583|475030567|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
131930388|NCT00089583|475030566|FG000|Overall Study|Participant Refused Study Medication|0|||
131930389|NCT00089583|475030567|FG001|Overall Study|Participant Refused Study Medication|2|||
131930390|NCT00089583|475030566|FG000|Overall Study|Non-Compliance|0|||
131930391|NCT00089583|475030567|FG001|Overall Study|Non-Compliance|4|||
131930392|NCT00089583|475030566|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
131930393|NCT00089583|475030567|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
131930394|NCT00089583|475030566|FG000|Overall Study|Participant Management Criteria Met|0|||
131930395|NCT00089583|475030567|FG001|Overall Study|Participant Management Criteria Met|1|||
131930396|NCT00089583|475030566|FG000|Overall Study|Reason Not Provided|0|||
131930397|NCT00089583|475030567|FG001|Overall Study|Reason Not Provided|1|||
131930398|NCT00089583|475030566|FG000|Overall Study|Protocol Violation|0|||
131930399|NCT00089583|475030567|FG001|Overall Study|Protocol Violation|3|||
131930400|NCT00089583|475030566|FG000|Overall Study|Principal Investigator Decision|0|||
131930401|NCT00089583|475030567|FG001|Overall Study|Principal Investigator Decision|10|||
131930402|NCT00089583|475030566|FG000|Overall Study|Start of Disallowed Medication|0|||
131930403|NCT00089583|475030567|FG001|Overall Study|Start of Disallowed Medication|1|||
131930404|NCT00089583|475030566|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
131930405|NCT00089583|475030567|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
131930406|NCT00089583|475030566|FG000|Overall Study|Participant Incarcerated|0|||
131411133|NCT00098722|473128536|FG005|Observation Phase|Participant defaulted|17|||
131411134|NCT00098722|473128537|FG006|Observation Phase|Participant defaulted|4|||
131411135|NCT00098722|473128531|FG000|Observation Phase|Other|0|||
131411136|NCT00098722|473128532|FG001|Observation Phase|Other|0|||
131411137|NCT00098722|473128533|FG002|Observation Phase|Other|0|||
131411138|NCT00098722|473128534|FG003|Observation Phase|Other|0|||
131411139|NCT00098722|473128535|FG004|Observation Phase|Other|0|||
131411140|NCT00098722|473128536|FG005|Observation Phase|Other|21|||
131411141|NCT00098722|473128537|FG006|Observation Phase|Other|10|||
131930407|NCT00089583|475030567|FG001|Overall Study|Participant Incarcerated|1|||
131930408|NCT00507507|475030568|FG000|Treatment Period|Lost to Follow-up|0|||
131930409|NCT00507507|475030569|FG001|Treatment Period|Lost to Follow-up|2|||
131930410|NCT00507507|475030568|FG000|Treatment Period|Physician Decision|4|||
131930411|NCT00507507|475030569|FG001|Treatment Period|Physician Decision|1|||
131930412|NCT00507507|475030568|FG000|Treatment Period|Protocol Violation|1|||
131930413|NCT00507507|475030569|FG001|Treatment Period|Protocol Violation|2|||
131930414|NCT00507507|475030568|FG000|Treatment Period|Adverse Event|1|||
131930415|NCT00507507|475030569|FG001|Treatment Period|Adverse Event|1|||
131930416|NCT00507507|475030568|FG000|Treatment Period|Withdrawal by Subject|46|||
131930417|NCT00507507|475030569|FG001|Treatment Period|Withdrawal by Subject|47|||
131930418|NCT00507507|475030568|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
131930419|NCT00507507|475030569|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
131930420|NCT00507507|475030568|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
131930421|NCT00507507|475030569|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
131930422|NCT00507507|475030568|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
131930423|NCT00507507|475030569|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
131930424|NCT02916433|475030570|FG000|Overall Study|Withdrawal by Subject|1|||
131930425|NCT02916433|475030571|FG001|Overall Study|Withdrawal by Subject|0|||
131930426|NCT02916433|475030570|FG000|Overall Study|Physician Decision|1|||
131930427|NCT02916433|475030571|FG001|Overall Study|Physician Decision|0|||
131930428|NCT03760666|475030572|FG000|Overall Study|Adverse Event|2|||
131930429|NCT03760666|475030573|FG001|Overall Study|Adverse Event|4|||
131930430|NCT03760666|475030574|FG002|Overall Study|Adverse Event|1|||
131930431|NCT03760666|475030572|FG000|Overall Study|AML Disease Progression|3|||
131930432|NCT03760666|475030573|FG001|Overall Study|AML Disease Progression|3|||
131930433|NCT03760666|475030574|FG002|Overall Study|AML Disease Progression|0|||
131930434|NCT03760666|475030572|FG000|Overall Study|Physician Decision|0|||
131930435|NCT03760666|475030573|FG001|Overall Study|Physician Decision|3|||
131411142|NCT02351349|473128538|FG000|Overall Study|Withdrawal by Subject|2|||
131411143|NCT02351349|473128539|FG001|Overall Study|Withdrawal by Subject|3|||
131930436|NCT03760666|475030574|FG002|Overall Study|Physician Decision|0|||
131930437|NCT03760666|475030572|FG000|Overall Study|Withdrawal by Subject|0|||
131930438|NCT03760666|475030573|FG001|Overall Study|Withdrawal by Subject|1|||
131930439|NCT03760666|475030574|FG002|Overall Study|Withdrawal by Subject|0|||
131930440|NCT01623154|475030575|FG000|Overall Study|Did not drink Pranactin Citric|4|||
131411144|NCT00440310|473128540|FG000|Overall Study|Lost to Follow-up|4|||
131411145|NCT00440310|473128541|FG001|Overall Study|Lost to Follow-up|5|||
131411146|NCT00440310|473128540|FG000|Overall Study|Protocol Violation|0|||
131411147|NCT00440310|473128541|FG001|Overall Study|Protocol Violation|1|||
131411148|NCT00440310|473128540|FG000|Overall Study|Withdrawal by Subject|15|||
131411149|NCT00440310|473128541|FG001|Overall Study|Withdrawal by Subject|14|||
131411150|NCT00440310|473128540|FG000|Overall Study|No Reply at EOS|7|||
131930441|NCT00890097|475030576|FG000|Overall Study|Adverse Event|21|||
131930442|NCT00890097|475030577|FG001|Overall Study|Adverse Event|32|||
131930443|NCT00890097|475030578|FG002|Overall Study|Adverse Event|28|||
131930444|NCT00890097|475030576|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
131930445|NCT00890097|475030577|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
131930446|NCT00890097|475030578|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
131930447|NCT00890097|475030576|FG000|Overall Study|Withdrew Consent|9|||
131930448|NCT00890097|475030577|FG001|Overall Study|Withdrew Consent|6|||
131930449|NCT00890097|475030578|FG002|Overall Study|Withdrew Consent|9|||
131930450|NCT00890097|475030576|FG000|Overall Study|Lost to Follow-up|5|||
131930451|NCT00890097|475030577|FG001|Overall Study|Lost to Follow-up|5|||
131930452|NCT00890097|475030578|FG002|Overall Study|Lost to Follow-up|5|||
131930453|NCT00890097|475030576|FG000|Overall Study|Noncompliance|0|||
131930454|NCT00890097|475030577|FG001|Overall Study|Noncompliance|4|||
131930455|NCT00890097|475030578|FG002|Overall Study|Noncompliance|4|||
131930456|NCT00890097|475030576|FG000|Overall Study|Sponsor Decision|7|||
131930457|NCT00890097|475030577|FG001|Overall Study|Sponsor Decision|11|||
131930458|NCT00890097|475030578|FG002|Overall Study|Sponsor Decision|7|||
131930459|NCT00890097|475030576|FG000|Overall Study|Did not attend final visit|2|||
131930460|NCT00890097|475030577|FG001|Overall Study|Did not attend final visit|3|||
131930461|NCT00890097|475030578|FG002|Overall Study|Did not attend final visit|0|||
131930462|NCT00890097|475030576|FG000|Overall Study|Subject Decision|3|||
131930463|NCT00890097|475030577|FG001|Overall Study|Subject Decision|2|||
131930464|NCT00890097|475030578|FG002|Overall Study|Subject Decision|6|||
131930465|NCT00890097|475030576|FG000|Overall Study|Randomization Error|2|||
131930466|NCT00890097|475030577|FG001|Overall Study|Randomization Error|0|||
131930467|NCT00890097|475030578|FG002|Overall Study|Randomization Error|0|||
131930468|NCT00890097|475030576|FG000|Overall Study|Failed inclusion criteria|3|||
131930469|NCT00890097|475030577|FG001|Overall Study|Failed inclusion criteria|4|||
131930470|NCT00890097|475030578|FG002|Overall Study|Failed inclusion criteria|0|||
131930471|NCT00890097|475030576|FG000|Overall Study|Transportation|0|||
131930472|NCT00890097|475030577|FG001|Overall Study|Transportation|2|||
131930473|NCT00890097|475030578|FG002|Overall Study|Transportation|0|||
131930474|NCT00890097|475030576|FG000|Overall Study|Subject Moved|0|||
131930475|NCT00890097|475030577|FG001|Overall Study|Subject Moved|4|||
131930476|NCT00890097|475030578|FG002|Overall Study|Subject Moved|0|||
131930477|NCT00890097|475030576|FG000|Overall Study|Protocol Deviation|1|||
131930478|NCT00890097|475030577|FG001|Overall Study|Protocol Deviation|1|||
131930479|NCT00890097|475030578|FG002|Overall Study|Protocol Deviation|1|||
131930480|NCT01694771|475030579|FG000|Overall Study|Adverse Event|18|||
131930481|NCT01694771|475030580|FG001|Overall Study|Adverse Event|16|||
131930482|NCT01694771|475030579|FG000|Overall Study|Lack of Efficacy|1|||
131930483|NCT01694771|475030580|FG001|Overall Study|Lack of Efficacy|0|||
131930484|NCT01694771|475030579|FG000|Overall Study|Non compliance protocol|7|||
131930485|NCT01694771|475030580|FG001|Overall Study|Non compliance protocol|6|||
131930486|NCT01694771|475030579|FG000|Overall Study|Lost to Follow-up|2|||
131930487|NCT01694771|475030580|FG001|Overall Study|Lost to Follow-up|3|||
131930488|NCT01694771|475030579|FG000|Overall Study|Consent withdrawn|7|||
131930489|NCT01694771|475030580|FG001|Overall Study|Consent withdrawn|9|||
131930490|NCT01694771|475030579|FG000|Overall Study|Other reasons|5|||
131930491|NCT01694771|475030580|FG001|Overall Study|Other reasons|6|||
131930492|NCT05486065|475030584|FG000|Overall Study|Withdrawal by Subject|1|||
131930493|NCT05486065|475030585|FG001|Overall Study|Withdrawal by Subject|5|||
131930494|NCT05486065|475030586|FG002|Overall Study|Withdrawal by Subject|4|||
131930495|NCT05486065|475030587|FG003|Overall Study|Withdrawal by Subject|3|||
131930496|NCT05486065|475030584|FG000|Overall Study|Lost to Follow-up|4|||
131930497|NCT05486065|475030585|FG001|Overall Study|Lost to Follow-up|2|||
131930498|NCT05486065|475030586|FG002|Overall Study|Lost to Follow-up|2|||
131930499|NCT05486065|475030587|FG003|Overall Study|Lost to Follow-up|2|||
131930500|NCT05486065|475030584|FG000|Overall Study|Physician Decision|0|||
131930501|NCT05486065|475030585|FG001|Overall Study|Physician Decision|1|||
131930502|NCT05486065|475030586|FG002|Overall Study|Physician Decision|1|||
131930503|NCT05486065|475030587|FG003|Overall Study|Physician Decision|0|||
131930504|NCT05486065|475030584|FG000|Overall Study|Failure to meet randomization criteria|0|||
131930505|NCT05486065|475030585|FG001|Overall Study|Failure to meet randomization criteria|0|||
131930506|NCT05486065|475030586|FG002|Overall Study|Failure to meet randomization criteria|0|||
131930507|NCT05486065|475030587|FG003|Overall Study|Failure to meet randomization criteria|1|||
131930508|NCT02656173|475030588|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
131411151|NCT00440310|473128541|FG001|Overall Study|No Reply at EOS|7|||
131411152|NCT00440310|473128540|FG000|Overall Study|Other|1|||
131411153|NCT00440310|473128541|FG001|Overall Study|Other|0|||
131930509|NCT02656173|475030589|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
131930510|NCT02656173|475030588|FG000|Overall Study|Adverse Event|7|||
131930511|NCT02656173|475030589|FG001|Overall Study|Adverse Event|5|||
131930512|NCT02656173|475030588|FG000|Overall Study|Withdrawal by Subject|1|||
131930513|NCT02656173|475030589|FG001|Overall Study|Withdrawal by Subject|3|||
131930514|NCT02656173|475030588|FG000|Overall Study|Protocol Violation|0|||
131930515|NCT02656173|475030589|FG001|Overall Study|Protocol Violation|1|||
131930516|NCT02656173|475030588|FG000|Overall Study|Miscellaneous|2|||
131930517|NCT02656173|475030589|FG001|Overall Study|Miscellaneous|0|||
131930518|NCT01064622|475030590|FG000|Randomized Phase II|Withdrawal by Subject|2|||
131930519|NCT01064622|475030591|FG001|Randomized Phase II|Withdrawal by Subject|2|||
131930520|NCT01064622|475030590|FG000|Randomized Phase II|Protocol Violation|0|||
131930521|NCT01064622|475030591|FG001|Randomized Phase II|Protocol Violation|1|||
131930522|NCT03810495|475030592|FG000|Overall Study|Lost to Follow-up|2|||
131930523|NCT03810495|475030592|FG000|Overall Study|Withdrawal by Subject|1|||
131930524|NCT03289741|475030593|FG000|Overall Study|Adverse Event|1|||
131930525|NCT03289741|475030594|FG001|Overall Study|Adverse Event|1|||
131930526|NCT03289741|475030593|FG000|Overall Study|Physician Decision|2|||
131930527|NCT03289741|475030594|FG001|Overall Study|Physician Decision|2|||
131930528|NCT03289741|475030593|FG000|Overall Study|Withdrawal by Subject|1|||
131930529|NCT03289741|475030594|FG001|Overall Study|Withdrawal by Subject|0|||
131930530|NCT03449147|475030595|FG000|52-week Treatment Period|Death|0|||
131930531|NCT03449147|475030596|FG001|52-week Treatment Period|Death|1|||
131930532|NCT03449147|475030597|FG002|52-week Treatment Period|Death|0|||
131930533|NCT03449147|475030595|FG000|52-week Treatment Period|Lost to Follow-up|6|||
131930534|NCT03449147|475030596|FG001|52-week Treatment Period|Lost to Follow-up|2|||
131930535|NCT03449147|475030597|FG002|52-week Treatment Period|Lost to Follow-up|5|||
131930536|NCT03449147|475030595|FG000|52-week Treatment Period|Other|0|||
131930537|NCT03449147|475030596|FG001|52-week Treatment Period|Other|1|||
131930538|NCT03449147|475030597|FG002|52-week Treatment Period|Other|2|||
131930539|NCT03449147|475030595|FG000|52-week Treatment Period|Physician Decision|1|||
131930540|NCT03449147|475030596|FG001|52-week Treatment Period|Physician Decision|0|||
131930541|NCT03449147|475030597|FG002|52-week Treatment Period|Physician Decision|3|||
131930542|NCT03449147|475030595|FG000|52-week Treatment Period|Screen Failure|1|||
131930543|NCT03449147|475030596|FG001|52-week Treatment Period|Screen Failure|2|||
131930544|NCT03449147|475030597|FG002|52-week Treatment Period|Screen Failure|0|||
131930545|NCT03449147|475030595|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
131930546|NCT03449147|475030596|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
131930547|NCT03449147|475030597|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
131930548|NCT03449147|475030595|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
131930549|NCT03449147|475030596|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
131930550|NCT03449147|475030597|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
131930551|NCT03449147|475030595|FG000|12-Week Off-Treatment Durability Period|Other|0|||
131930552|NCT03449147|475030596|FG001|12-Week Off-Treatment Durability Period|Other|1|||
131930553|NCT03449147|475030597|FG002|12-Week Off-Treatment Durability Period|Other|0|||
131930554|NCT00974233|475030601|FG000|Induction Chemoimmunotherapy|Death|2|||
131930555|NCT00974233|475030601|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
131930556|NCT00974233|475030601|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
131930557|NCT00974233|475030601|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
131930558|NCT00974233|475030601|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
131930559|NCT00974233|475030601|FG000|Maintenance Lenalidomide|Adverse Event|8|||
131930560|NCT01691092|475030602|FG000|Overall Study|Lost to Follow-up|10|||
131930561|NCT01691092|475030602|FG000|Overall Study|Physician Decision|4|||
131930562|NCT01691092|475030602|FG000|Overall Study|Withdrawal by Subject|3|||
131930563|NCT01691092|475030602|FG000|Overall Study|non-compliance|3|||
131930564|NCT01691092|475030602|FG000|Overall Study|used for different study|2|||
131930565|NCT01691092|475030602|FG000|Overall Study|screen fail|19|||
131930566|NCT01657942|475030603|FG000|Overall Study|Alternative Treatment|7|||
131930567|NCT01657942|475030603|FG000|Overall Study|Lost to Follow-up|1|||
131930568|NCT02457546|475032599|FG000|Overall Study|Other reasons|4|||
131930569|NCT02457546|475032600|FG001|Overall Study|Other reasons|1|||
131930570|NCT02457546|475032599|FG000|Overall Study|Refused to complete study/procedures|1|||
131930571|NCT02457546|475032600|FG001|Overall Study|Refused to complete study/procedures|1|||
131930572|NCT02457546|475032599|FG000|Overall Study|Lost to Follow-up|4|||
131930573|NCT02457546|475032600|FG001|Overall Study|Lost to Follow-up|1|||
131930574|NCT02457546|475032599|FG000|Overall Study|Adverse Event|0|||
131930575|NCT02457546|475032600|FG001|Overall Study|Adverse Event|1|||
131930576|NCT02462057|475032601|FG000|Overall Study|Left Vitality|32|||
131930577|NCT02462057|475032602|FG001|Overall Study|Left Vitality|27|||
131930578|NCT02462057|475032603|FG002|Overall Study|Left Vitality|23|||
131930579|NCT02462057|475032604|FG003|Overall Study|Left Vitality|35|||
131930580|NCT02462057|475032605|FG004|Overall Study|Left Vitality|33|||
131930581|NCT02462057|475032601|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
131930582|NCT02462057|475032602|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
131930583|NCT02462057|475032603|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
131930584|NCT02462057|475032604|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
131930585|NCT02462057|475032605|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
131930586|NCT02336555|475032606|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131930587|NCT02336555|475032607|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131930588|NCT02336555|475032606|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
131930589|NCT02336555|475032607|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
131930590|NCT02336555|475032606|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
131930591|NCT02336555|475032607|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
131930592|NCT00993473|475032608|FG000|Overall Study|Adverse Event|0|||
131930593|NCT00993473|475032609|FG001|Overall Study|Adverse Event|2|||
131930594|NCT00993473|475032608|FG000|Overall Study|Protocol Violation|1|||
131930595|NCT00993473|475032609|FG001|Overall Study|Protocol Violation|2|||
131930596|NCT00993473|475032608|FG000|Overall Study|Lost to Follow-up|1|||
131930597|NCT00993473|475032609|FG001|Overall Study|Lost to Follow-up|0|||
131930598|NCT00993473|475032608|FG000|Overall Study|Withdrawal by Subject|1|||
131930599|NCT00993473|475032609|FG001|Overall Study|Withdrawal by Subject|5|||
131930600|NCT00993473|475032608|FG000|Overall Study|Technical problem with CGM device|0|||
131930601|NCT00993473|475032609|FG001|Overall Study|Technical problem with CGM device|1|||
131930602|NCT00993473|475032608|FG000|Overall Study|Family event|1|||
131930603|NCT00993473|475032609|FG001|Overall Study|Family event|0|||
131930604|NCT01633112|475032610|FG000|Overall Study|Lack of Efficacy|1|||
131930605|NCT01633112|475032611|FG001|Overall Study|Lack of Efficacy|6|||
131930606|NCT01633112|475032612|FG002|Overall Study|Lack of Efficacy|13|||
131930607|NCT01633112|475032610|FG000|Overall Study|Abnormal laboratory value(s)|3|||
131930608|NCT01633112|475032611|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131930609|NCT01633112|475032612|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131930610|NCT01633112|475032610|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131930611|NCT01633112|475032611|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131930612|NCT01633112|475032612|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131930613|NCT01633112|475032610|FG000|Overall Study|Administrative problems|1|||
131930614|NCT01633112|475032611|FG001|Overall Study|Administrative problems|2|||
131930615|NCT01633112|475032612|FG002|Overall Study|Administrative problems|5|||
131930616|NCT01633112|475032610|FG000|Overall Study|Adverse Event|16|||
131930617|NCT01633112|475032611|FG001|Overall Study|Adverse Event|18|||
131930618|NCT01633112|475032612|FG002|Overall Study|Adverse Event|20|||
131930619|NCT01633112|475032610|FG000|Overall Study|Lost to Follow-up|7|||
131930620|NCT01633112|475032611|FG001|Overall Study|Lost to Follow-up|19|||
131930621|NCT01633112|475032612|FG002|Overall Study|Lost to Follow-up|6|||
131930622|NCT01633112|475032610|FG000|Overall Study|Protocol Violation|4|||
131930623|NCT01633112|475032611|FG001|Overall Study|Protocol Violation|0|||
131930624|NCT01633112|475032612|FG002|Overall Study|Protocol Violation|2|||
131930625|NCT01633112|475032610|FG000|Overall Study|Subject no longer requires study drug|0|||
131930626|NCT01633112|475032611|FG001|Overall Study|Subject no longer requires study drug|0|||
131930627|NCT01633112|475032612|FG002|Overall Study|Subject no longer requires study drug|1|||
131930628|NCT01633112|475032610|FG000|Overall Study|Withdrawal by Subject|20|||
131930629|NCT01633112|475032611|FG001|Overall Study|Withdrawal by Subject|12|||
131930630|NCT01633112|475032612|FG002|Overall Study|Withdrawal by Subject|41|||
131930631|NCT01633112|475032610|FG000|Overall Study|missing Study Completion CRF|1|||
131930632|NCT01633112|475032611|FG001|Overall Study|missing Study Completion CRF|1|||
131930633|NCT01633112|475032612|FG002|Overall Study|missing Study Completion CRF|4|||
131930634|NCT01908699|475032613|FG000|Overall Study|Adverse Event|8|||
131930635|NCT01908699|475032614|FG001|Overall Study|Adverse Event|12|||
131930636|NCT01908699|475032613|FG000|Overall Study|Lack of Efficacy|2|||
131930637|NCT01908699|475032614|FG001|Overall Study|Lack of Efficacy|2|||
131930638|NCT01908699|475032613|FG000|Overall Study|Lost to Follow-up|2|||
131930639|NCT01908699|475032614|FG001|Overall Study|Lost to Follow-up|4|||
131930640|NCT01908699|475032613|FG000|Overall Study|Physician Decision|8|||
131930641|NCT01908699|475032614|FG001|Overall Study|Physician Decision|8|||
131930642|NCT01908699|475032613|FG000|Overall Study|Withdrawal by Subject|15|||
131930643|NCT01908699|475032614|FG001|Overall Study|Withdrawal by Subject|10|||
131930644|NCT01908699|475032613|FG000|Overall Study|Pregnancy|0|||
131930645|NCT01908699|475032614|FG001|Overall Study|Pregnancy|1|||
131930646|NCT01908699|475032613|FG000|Overall Study|Randomized in Error|1|||
131930647|NCT01908699|475032614|FG001|Overall Study|Randomized in Error|0|||
131930648|NCT01908699|475032613|FG000|Overall Study|Death|9|||
131930649|NCT01908699|475032614|FG001|Overall Study|Death|12|||
131930650|NCT01908699|475032613|FG000|Overall Study|Progressive Disease|30|||
131930651|NCT01908699|475032614|FG001|Overall Study|Progressive Disease|29|||
131930652|NCT01697501|475032615|FG000|Overall Study|Protocol Violation|2|||
131930653|NCT02094885|475032619|FG000|Overall Study|Death|1|||
131930654|NCT02094885|475032620|FG001|Overall Study|Death|5|||
131930655|NCT02094885|475032619|FG000|Overall Study|Withdrawn due to age|1|||
131930656|NCT02094885|475032620|FG001|Overall Study|Withdrawn due to age|0|||
131930657|NCT01537432|475032623|FG000|Overall Study|Lost to Follow-up|3|||
131930658|NCT01537432|475032624|FG001|Overall Study|Lost to Follow-up|1|||
131411154|NCT00440310|473128540|FG000|Overall Study|Status Unknown|1|||
131930659|NCT01537432|475032623|FG000|Overall Study|Withdrawal by Subject|0|||
131411155|NCT00440310|473128541|FG001|Overall Study|Status Unknown|3|||
131411156|NCT01519674|473128542|FG000|Overall Study|Adverse Event|3|||
131930660|NCT01537432|475032624|FG001|Overall Study|Withdrawal by Subject|1|||
131930661|NCT01537432|475032623|FG000|Overall Study|Administrative problems|1|||
131930662|NCT01537432|475032624|FG001|Overall Study|Administrative problems|0|||
131930663|NCT01537432|475032623|FG000|Overall Study|Adverse Event|1|||
131930664|NCT01537432|475032624|FG001|Overall Study|Adverse Event|0|||
131930665|NCT01537432|475032623|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131930666|NCT01537432|475032624|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131930667|NCT03707821|475032625|FG000|Overall Study|Protocol Violation|0|||
131930668|NCT03707821|475032626|FG001|Overall Study|Protocol Violation|1|||
131930669|NCT03707821|475032625|FG000|Overall Study|Unsatisfactory Visual Response|1|||
131930670|NCT03707821|475032626|FG001|Overall Study|Unsatisfactory Visual Response|0|||
131930671|NCT03707821|475032625|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
131930672|NCT03707821|475032626|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
131930673|NCT00889005|475032627|FG000|Overall Study|Lost to Follow-up|4|||
131930674|NCT00889005|475032628|FG001|Overall Study|Lost to Follow-up|2|||
131930675|NCT00889005|475032627|FG000|Overall Study|Withdrawal by Subject|4|||
131930676|NCT00889005|475032628|FG001|Overall Study|Withdrawal by Subject|0|||
131930677|NCT05166902|475032629|FG000|First Intervention|Lost to Follow-up|0|||
131930678|NCT05166902|475032630|FG001|First Intervention|Lost to Follow-up|1|||
131930679|NCT01998477|475032631|FG000|Overall Study|Lost to Follow-up|4|||
131930680|NCT01998477|475032632|FG001|Overall Study|Lost to Follow-up|5|||
131930681|NCT01998477|475032631|FG000|Overall Study|Withdrawal by Subject|6|||
131930682|NCT01998477|475032632|FG001|Overall Study|Withdrawal by Subject|0|||
131930683|NCT00779909|475032633|FG000|Overall Study|Lost to Follow-up|1|||
131930684|NCT00779909|475032634|FG001|Overall Study|Lost to Follow-up|0|||
131930685|NCT00779909|475032635|FG002|Overall Study|Lost to Follow-up|0|||
131930686|NCT00779909|475032636|FG003|Overall Study|Lost to Follow-up|1|||
131930687|NCT00779909|475032633|FG000|Overall Study|Withdrawal by Subject|0|||
131930688|NCT00779909|475032634|FG001|Overall Study|Withdrawal by Subject|1|||
131930689|NCT00779909|475032635|FG002|Overall Study|Withdrawal by Subject|0|||
131930690|NCT00779909|475032636|FG003|Overall Study|Withdrawal by Subject|0|||
131930691|NCT03523585|475032637|FG000|Overall Study|Progressive Disease|174|||
131930692|NCT03523585|475032638|FG001|Overall Study|Progressive Disease|64|||
131930693|NCT03523585|475032639|FG002|Overall Study|Progressive Disease|77|||
131930694|NCT03523585|475032637|FG000|Overall Study|Adverse Event|74|||
131930695|NCT03523585|475032638|FG001|Overall Study|Adverse Event|5|||
131930696|NCT03523585|475032639|FG002|Overall Study|Adverse Event|9|||
131930697|NCT03523585|475032637|FG000|Overall Study|Withdrawal by Subject|30|||
131930698|NCT03523585|475032638|FG001|Overall Study|Withdrawal by Subject|11|||
131930699|NCT03523585|475032639|FG002|Overall Study|Withdrawal by Subject|6|||
131930700|NCT03523585|475032637|FG000|Overall Study|Clinical Progression|23|||
131930701|NCT03523585|475032638|FG001|Overall Study|Clinical Progression|5|||
131930702|NCT03523585|475032639|FG002|Overall Study|Clinical Progression|10|||
131930703|NCT03523585|475032637|FG000|Overall Study|Death|4|||
131930704|NCT03523585|475032638|FG001|Overall Study|Death|0|||
131930705|NCT03523585|475032639|FG002|Overall Study|Death|1|||
131930706|NCT03523585|475032637|FG000|Overall Study|Physician Decision|2|||
131930707|NCT03523585|475032638|FG001|Overall Study|Physician Decision|1|||
131930708|NCT03523585|475032639|FG002|Overall Study|Physician Decision|0|||
131930709|NCT03523585|475032637|FG000|Overall Study|Lost to Follow-up|1|||
131930710|NCT03523585|475032638|FG001|Overall Study|Lost to Follow-up|0|||
131930711|NCT03523585|475032639|FG002|Overall Study|Lost to Follow-up|0|||
131930712|NCT03523585|475032637|FG000|Overall Study|Miscellaneous|1|||
131411157|NCT01519674|473128543|FG001|Overall Study|Adverse Event|3|||
131411158|NCT01519674|473128544|FG002|Overall Study|Adverse Event|0|||
131411159|NCT01519674|473128542|FG000|Overall Study|Lack of Efficacy|1|||
131930713|NCT03523585|475032638|FG001|Overall Study|Miscellaneous|0|||
131930714|NCT03523585|475032639|FG002|Overall Study|Miscellaneous|0|||
131930715|NCT03523585|475032637|FG000|Overall Study|Protocol Deviation|1|||
131930716|NCT03523585|475032638|FG001|Overall Study|Protocol Deviation|0|||
131930717|NCT03523585|475032639|FG002|Overall Study|Protocol Deviation|1|||
131930718|NCT03523585|475032637|FG000|Overall Study|Randomized But Not Treated|2|||
131930719|NCT03523585|475032638|FG001|Overall Study|Randomized But Not Treated|4|||
131930720|NCT03523585|475032639|FG002|Overall Study|Randomized But Not Treated|3|||
131930721|NCT00128492|475032640|FG000|Overall Study|AE unrelated to study|2|||
131930722|NCT00128492|475032641|FG001|Overall Study|AE unrelated to study|9|||
131930723|NCT00128492|475032640|FG000|Overall Study|Study drug intolerance (AE)|2|||
131930724|NCT00128492|475032641|FG001|Overall Study|Study drug intolerance (AE)|8|||
131930725|NCT00128492|475032640|FG000|Overall Study|AE related to study|1|||
131930726|NCT00128492|475032641|FG001|Overall Study|AE related to study|4|||
131930727|NCT00128492|475032640|FG000|Overall Study|Death|1|||
131930728|NCT00128492|475032641|FG001|Overall Study|Death|0|||
131930729|NCT00128492|475032640|FG000|Overall Study|Lost to Follow-up|1|||
131930730|NCT00128492|475032641|FG001|Overall Study|Lost to Follow-up|5|||
131930731|NCT00128492|475032640|FG000|Overall Study|Noncompliance|0|||
131411160|NCT01519674|473128543|FG001|Overall Study|Lack of Efficacy|1|||
131930732|NCT00128492|475032641|FG001|Overall Study|Noncompliance|5|||
131930733|NCT00128492|475032640|FG000|Overall Study|Personal or administrative|10|||
131930734|NCT00128492|475032641|FG001|Overall Study|Personal or administrative|22|||
131930735|NCT00128492|475032640|FG000|Overall Study|Withdrawal by Subject|3|||
131930736|NCT00128492|475032641|FG001|Overall Study|Withdrawal by Subject|5|||
131930737|NCT00128492|475032640|FG000|Overall Study|Pregnancy|0|||
131930738|NCT00128492|475032641|FG001|Overall Study|Pregnancy|1|||
131930739|NCT00756314|475032647|FG000|Overall Study|Lost to Follow-up|2|||
131930740|NCT00756314|475032648|FG001|Overall Study|Lost to Follow-up|59|||
131930741|NCT02872142|475032650|FG000|Overall Study|Adverse Event|2|||
131930742|NCT02872142|475032650|FG000|Overall Study|Death|1|||
131411161|NCT01519674|473128544|FG002|Overall Study|Lack of Efficacy|1|||
131930743|NCT02872142|475032650|FG000|Overall Study|Participant Decision|3|||
131454164|NCT02003924|473291906|FG001|Double-blind Phase|Adverse Event|31|||
131454165|NCT02003924|473291907|FG002|Double-blind Phase|Adverse Event|0|||
131454166|NCT02003924|473291905|FG000|Double-blind Phase|Randomized But not Treated|3|||
131454167|NCT02003924|473291906|FG001|Double-blind Phase|Randomized But not Treated|3|||
131454168|NCT02003924|473291907|FG002|Double-blind Phase|Randomized But not Treated|0|||
131454169|NCT02003924|473291905|FG000|Double-blind Phase|Other|29|||
131454170|NCT02003924|473291906|FG001|Double-blind Phase|Other|50|||
131454171|NCT02003924|473291907|FG002|Double-blind Phase|Other|0|||
131454172|NCT02003924|473291905|FG000|Open-label Phase|Lost to Follow-up|0|||
131454173|NCT02003924|473291906|FG001|Open-label Phase|Lost to Follow-up|0|||
131454174|NCT02003924|473291907|FG002|Open-label Phase|Lost to Follow-up|1|||
131454175|NCT02003924|473291905|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
131454176|NCT02003924|473291906|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
131454177|NCT02003924|473291907|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
131454178|NCT02003924|473291905|FG000|Open-label Phase|Disease Progression|59|||
131454179|NCT02003924|473291906|FG001|Open-label Phase|Disease Progression|0|||
131454180|NCT02003924|473291907|FG002|Open-label Phase|Disease Progression|5|||
131411162|NCT01519674|473128542|FG000|Overall Study|Protocol Violation|0|||
131411163|NCT01519674|473128543|FG001|Overall Study|Protocol Violation|3|||
131411164|NCT01519674|473128544|FG002|Overall Study|Protocol Violation|1|||
131411165|NCT01519674|473128542|FG000|Overall Study|Withdrawal Criteria|7|||
131411166|NCT01519674|473128543|FG001|Overall Study|Withdrawal Criteria|2|||
131411167|NCT01519674|473128544|FG002|Overall Study|Withdrawal Criteria|7|||
131411168|NCT01519674|473128542|FG000|Overall Study|Unsclassified|10|||
131411169|NCT01519674|473128543|FG001|Overall Study|Unsclassified|4|||
131411170|NCT01519674|473128544|FG002|Overall Study|Unsclassified|3|||
131411171|NCT01610596|473128551|FG000|Overall Study|Lost to Follow-up|0|||
131411172|NCT01610596|473128552|FG001|Overall Study|Lost to Follow-up|1|||
131411173|NCT00799591|473128553|FG000|Overall Study|De-escalation of doses|20|||
131411174|NCT00799591|473128553|FG000|Overall Study|Death|14|||
131411175|NCT00799591|473128553|FG000|Overall Study|Technical failure|12|||
131411176|NCT00799591|473128553|FG000|Overall Study|Resistant germ|11|||
131411177|NCT00799591|473128553|FG000|Overall Study|New infection|4|||
131411178|NCT00799591|473128553|FG000|Overall Study|Resistance germ and technical failure|2|||
131411179|NCT00799591|473128553|FG000|Overall Study|Persistance of fever undetermined origin|1|||
131411180|NCT00799591|473128553|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
131411181|NCT00799591|473128553|FG000|Overall Study|Infectious origin not probable|1|||
131930744|NCT02605967|475032651|FG000|Overall Study|subject / guardian decision|1|||
131930745|NCT02605967|475032652|FG001|Overall Study|subject / guardian decision|2|||
131930746|NCT02605967|475032651|FG000|Overall Study|Physician Decision|10|||
131930747|NCT02605967|475032652|FG001|Overall Study|Physician Decision|1|||
131930748|NCT02605967|475032651|FG000|Overall Study|Death|4|||
131930749|NCT02605967|475032652|FG001|Overall Study|Death|2|||
131930750|NCT02605967|475032651|FG000|Overall Study|Adverse Event|1|||
131930751|NCT02605967|475032652|FG001|Overall Study|Adverse Event|0|||
131930752|NCT02605967|475032651|FG000|Overall Study|progressive disease|66|||
131930753|NCT02605967|475032652|FG001|Overall Study|progressive disease|35|||
131930754|NCT01903720|475032657|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
131930755|NCT01903720|475032657|FG000|Overall Study|Adverse Event|1|||
131930756|NCT01903720|475032657|FG000|Overall Study|Rescinding of informed consent|2|||
131411182|NCT02317809|473128554|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
131411183|NCT02317809|473128555|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
131411184|NCT02317809|473128554|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
131411185|NCT02317809|473128555|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
131411186|NCT01030874|473128556|FG000|Overall Study|Withdrawal by Subject|1|||
131411187|NCT01030874|473128557|FG001|Overall Study|Withdrawal by Subject|0|||
131411188|NCT01030874|473128556|FG000|Overall Study|Discharged in first 2 weeks|17|||
131411189|NCT01030874|473128557|FG001|Overall Study|Discharged in first 2 weeks|16|||
131411190|NCT03106415|473128558|FG000|Phase 1|Withdrawal by Subject|1|||
131411191|NCT03106415|473128559|FG001|Phase 1|Withdrawal by Subject|0|||
131411192|NCT03106415|473128560|FG002|Phase 1|Withdrawal by Subject|0|||
131411193|NCT03106415|473128558|FG000|Phase 1|Adverse Event|1|||
131411194|NCT03106415|473128559|FG001|Phase 1|Adverse Event|1|||
131454181|NCT02003924|473291905|FG000|Open-label Phase|Adverse Event|25|||
131454182|NCT02003924|473291906|FG001|Open-label Phase|Adverse Event|0|||
131454183|NCT02003924|473291907|FG002|Open-label Phase|Adverse Event|10|||
131454184|NCT02003924|473291905|FG000|Open-label Phase|Other|7|||
131454185|NCT02003924|473291906|FG001|Open-label Phase|Other|0|||
131930757|NCT01903720|475032657|FG000|Overall Study|Lost to Follow-up|2|||
131930758|NCT01903720|475032657|FG000|Overall Study|Treatment with alternative drug|1|||
131930759|NCT00692237|475032658|FG000|Overall Study|Withdrawal by Subject|1|||
131930760|NCT00692237|475032659|FG001|Overall Study|Withdrawal by Subject|3|||
131454186|NCT02003924|473291907|FG002|Open-label Phase|Other|0|||
131454187|NCT02003924|473291905|FG000|Long-term Follow-up Phase|Death|288|||
131930761|NCT00692237|475032658|FG000|Overall Study|Adverse Event|0|||
131930762|NCT00692237|475032659|FG001|Overall Study|Adverse Event|1|||
131930763|NCT01475825|475032660|FG000|Overall Study|Adverse Event|41|||
131411195|NCT03106415|473128560|FG002|Phase 1|Adverse Event|0|||
131411196|NCT03106415|473128558|FG000|Phase 1|Protocol Violation|0|||
131411197|NCT03106415|473128559|FG001|Phase 1|Protocol Violation|1|||
131411198|NCT03106415|473128560|FG002|Phase 1|Protocol Violation|0|||
131411199|NCT02046174|473128561|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
131411200|NCT02046174|473128562|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
131930764|NCT01475825|475032661|FG001|Overall Study|Adverse Event|15|||
131930765|NCT01475825|475032662|FG002|Overall Study|Adverse Event|27|||
131930766|NCT01475825|475032663|FG003|Overall Study|Adverse Event|11|||
131930767|NCT01475825|475032660|FG000|Overall Study|Death|1|||
131930768|NCT01475825|475032661|FG001|Overall Study|Death|0|||
131930769|NCT01475825|475032662|FG002|Overall Study|Death|1|||
131930770|NCT01475825|475032663|FG003|Overall Study|Death|0|||
131930771|NCT01475825|475032660|FG000|Overall Study|Lack of Efficacy|0|||
131930772|NCT01475825|475032661|FG001|Overall Study|Lack of Efficacy|0|||
131930773|NCT01475825|475032662|FG002|Overall Study|Lack of Efficacy|1|||
131930774|NCT01475825|475032663|FG003|Overall Study|Lack of Efficacy|0|||
131930775|NCT01475825|475032660|FG000|Overall Study|Lost to Follow-up|0|||
131930776|NCT01475825|475032661|FG001|Overall Study|Lost to Follow-up|0|||
131930777|NCT01475825|475032662|FG002|Overall Study|Lost to Follow-up|3|||
131930778|NCT01475825|475032663|FG003|Overall Study|Lost to Follow-up|1|||
131930779|NCT01475825|475032660|FG000|Overall Study|Non-compliance with Study Drug|1|||
131930780|NCT01475825|475032661|FG001|Overall Study|Non-compliance with Study Drug|2|||
131930781|NCT01475825|475032662|FG002|Overall Study|Non-compliance with Study Drug|4|||
131930782|NCT01475825|475032663|FG003|Overall Study|Non-compliance with Study Drug|0|||
131930783|NCT01475825|475032660|FG000|Overall Study|Other: Not available|0|||
131930784|NCT01475825|475032661|FG001|Overall Study|Other: Not available|0|||
131930785|NCT01475825|475032662|FG002|Overall Study|Other: Not available|2|||
131930786|NCT01475825|475032663|FG003|Overall Study|Other: Not available|0|||
131930787|NCT01475825|475032660|FG000|Overall Study|Protocol Violation|1|||
131930788|NCT01475825|475032661|FG001|Overall Study|Protocol Violation|0|||
131930789|NCT01475825|475032662|FG002|Overall Study|Protocol Violation|0|||
131930790|NCT01475825|475032663|FG003|Overall Study|Protocol Violation|0|||
131930791|NCT01475825|475032660|FG000|Overall Study|Physician Decision|0|||
131930792|NCT01475825|475032661|FG001|Overall Study|Physician Decision|1|||
131930793|NCT01475825|475032662|FG002|Overall Study|Physician Decision|0|||
131930794|NCT01475825|475032663|FG003|Overall Study|Physician Decision|0|||
131930795|NCT01475825|475032660|FG000|Overall Study|Withdrawal by Subject|8|||
131930796|NCT01475825|475032661|FG001|Overall Study|Withdrawal by Subject|3|||
131930797|NCT01475825|475032662|FG002|Overall Study|Withdrawal by Subject|11|||
131930798|NCT01475825|475032663|FG003|Overall Study|Withdrawal by Subject|7|||
131930799|NCT01475825|475032660|FG000|Overall Study|Did not enter OLC|15|||
131930800|NCT01475825|475032661|FG001|Overall Study|Did not enter OLC|11|||
131930801|NCT01475825|475032662|FG002|Overall Study|Did not enter OLC|15|||
131930802|NCT01475825|475032663|FG003|Overall Study|Did not enter OLC|11|||
131930803|NCT00309946|475032666|FG000|Overall Study|Withdrawal by Subject|1|||
131930804|NCT02244957|475032667|FG000|Overall Study|Lack of Efficacy|1|||
131930805|NCT02244957|475032668|FG001|Overall Study|Lack of Efficacy|0|||
131930806|NCT01347086|475032672|FG000|Overall Study|failed screening visit|0|||
131930807|NCT01347086|475032673|FG001|Overall Study|failed screening visit|0|||
131930808|NCT01347086|475032674|FG002|Overall Study|failed screening visit|1|||
131930809|NCT01347086|475032675|FG003|Overall Study|failed screening visit|0|||
131930810|NCT01347086|475032676|FG004|Overall Study|failed screening visit|0|||
131930811|NCT01347086|475032677|FG005|Overall Study|failed screening visit|0|||
131930812|NCT01347086|475032678|FG006|Overall Study|failed screening visit|1|||
131930813|NCT01347086|475032679|FG007|Overall Study|failed screening visit|1|||
131930814|NCT01347086|475032680|FG008|Overall Study|failed screening visit|0|||
131930815|NCT01347086|475032681|FG009|Overall Study|failed screening visit|1|||
131930816|NCT00395447|475032682|FG000|Overall Study|Death|37|||
131930817|NCT00395447|475032683|FG001|Overall Study|Death|32|||
131930818|NCT00395447|475032682|FG000|Overall Study|Lost to Follow-up|52|||
131930819|NCT00395447|475032683|FG001|Overall Study|Lost to Follow-up|43|||
131930820|NCT00395447|475032682|FG000|Overall Study|Withdrawal by Subject|24|||
131930821|NCT00395447|475032683|FG001|Overall Study|Withdrawal by Subject|19|||
131930822|NCT00395447|475032682|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
131411201|NCT02118597|473128563|FG000|Overall Study|Sponsor terminated the study|14|||
131411202|NCT02118597|473128563|FG000|Overall Study|Serious Adverse Event|1|||
131930823|NCT00395447|475032683|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
131930824|NCT02624687|475032685|FG000|Overall Study|Withdrawal by Subject|1|||
131930825|NCT02624687|475032686|FG001|Overall Study|Withdrawal by Subject|1|||
131930826|NCT02624687|475032685|FG000|Overall Study|medical leave from work|0|||
131930827|NCT02624687|475032686|FG001|Overall Study|medical leave from work|1|||
131930828|NCT03111108|475032687|FG000|Overall Study|Death|0|||
131930829|NCT03111108|475032688|FG001|Overall Study|Death|1|||
131930830|NCT03111108|475032687|FG000|Overall Study|Withdrawal by Subject|1|||
131930831|NCT03111108|475032688|FG001|Overall Study|Withdrawal by Subject|0|||
131930832|NCT00104884|475032689|FG000|Overall Study|Disease progression|4|||
131930833|NCT02662582|475032690|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
131411203|NCT02118597|473128563|FG000|Overall Study|Investigator's decision|1|||
131411204|NCT01891344|473128564|FG000|Overall Study|Ongoing|6|||
131411205|NCT01891344|473128565|FG001|Overall Study|Ongoing|2|||
131411206|NCT01891344|473128566|FG002|Overall Study|Ongoing|0|||
131411207|NCT01891344|473128567|FG003|Overall Study|Ongoing|1|||
131411208|NCT01891344|473128568|FG004|Overall Study|Ongoing|4|||
131411209|NCT01891344|473128569|FG005|Overall Study|Ongoing|1|||
131411210|NCT01891344|473128570|FG006|Overall Study|Ongoing|0|||
131411211|NCT01891344|473128571|FG007|Overall Study|Ongoing|0|||
131411212|NCT00186537|473128572|FG000|Overall Study|Withdrawal by Subject|4|||
131411213|NCT00186537|473128573|FG001|Overall Study|Withdrawal by Subject|0|||
131411214|NCT00186537|473128574|FG002|Overall Study|Withdrawal by Subject|3|||
131411215|NCT00186537|473128572|FG000|Overall Study|ALT > 1.5 x ULN|3|||
131411216|NCT00186537|473128573|FG001|Overall Study|ALT > 1.5 x ULN|0|||
131411217|NCT00186537|473128574|FG002|Overall Study|ALT > 1.5 x ULN|0|||
131411218|NCT03294135|473128575|FG000|Overall Study|Serious Adverse Event|1|||
131411219|NCT03294135|473128576|FG001|Overall Study|Serious Adverse Event|0|||
131411220|NCT03294135|473128577|FG002|Overall Study|Serious Adverse Event|0|||
131411221|NCT03294135|473128575|FG000|Overall Study|Lost to Follow-up|1|||
131411222|NCT03294135|473128576|FG001|Overall Study|Lost to Follow-up|0|||
131411223|NCT03294135|473128577|FG002|Overall Study|Lost to Follow-up|1|||
131411224|NCT03294135|473128575|FG000|Overall Study|Withdrawal by Subject|0|||
131411225|NCT03294135|473128576|FG001|Overall Study|Withdrawal by Subject|0|||
131411226|NCT03294135|473128577|FG002|Overall Study|Withdrawal by Subject|1|||
131930834|NCT02662582|475032691|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
131930835|NCT02662582|475032690|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
131930836|NCT02662582|475032691|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
131930837|NCT02662582|475032690|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
131930838|NCT02662582|475032691|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
131930839|NCT02662582|475032690|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131930840|NCT02662582|475032691|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131930841|NCT00511199|475032692|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
131930842|NCT00511199|475032693|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
131930843|NCT00511199|475032692|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
131930844|NCT00511199|475032693|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
131930845|NCT00511199|475032692|FG000|Overall Study|Withdrawal of Informed Consent|19|||
131930846|NCT00511199|475032693|FG001|Overall Study|Withdrawal of Informed Consent|4|||
131930847|NCT00511199|475032692|FG000|Overall Study|Pregnancy|6|||
131930848|NCT00511199|475032693|FG001|Overall Study|Pregnancy|3|||
131930849|NCT00511199|475032692|FG000|Overall Study|Pregnancy Wish|16|||
131930850|NCT00511199|475032693|FG001|Overall Study|Pregnancy Wish|8|||
131930851|NCT00511199|475032692|FG000|Overall Study|Lost to Follow-up|40|||
131930852|NCT00511199|475032693|FG001|Overall Study|Lost to Follow-up|17|||
131930853|NCT00511199|475032692|FG000|Overall Study|Other Reason|78|||
131930854|NCT00511199|475032693|FG001|Overall Study|Other Reason|37|||
131930855|NCT02314247|475032699|FG000|Overall Study|Adverse Event|2|||
131930856|NCT02314247|475032700|FG001|Overall Study|Adverse Event|1|||
131930857|NCT02314247|475032701|FG002|Overall Study|Adverse Event|0|||
131930858|NCT02314247|475032699|FG000|Overall Study|Withdrawal by Subject|1|||
131930859|NCT02314247|475032700|FG001|Overall Study|Withdrawal by Subject|3|||
131930860|NCT02314247|475032701|FG002|Overall Study|Withdrawal by Subject|1|||
131930861|NCT02314247|475032699|FG000|Overall Study|Progression of Disease|6|||
131930862|NCT02314247|475032700|FG001|Overall Study|Progression of Disease|2|||
131930863|NCT02314247|475032701|FG002|Overall Study|Progression of Disease|0|||
131930864|NCT01953354|475032702|FG000|Overall Study|Withdrawal by Subject|0|||
131930865|NCT01953354|475032703|FG001|Overall Study|Withdrawal by Subject|1|||
131930866|NCT01953354|475032702|FG000|Overall Study|Decision of Sponsor|0|||
131930867|NCT01953354|475032703|FG001|Overall Study|Decision of Sponsor|1|||
131930868|NCT01953354|475032702|FG000|Overall Study|Disease Exacerbation|1|||
131930869|NCT01953354|475032703|FG001|Overall Study|Disease Exacerbation|0|||
131930870|NCT00806026|475032704|FG000|Overall Study|Death|0|||
131930871|NCT00806026|475032705|FG001|Overall Study|Death|0|||
131930872|NCT00806026|475032706|FG002|Overall Study|Death|0|||
131930873|NCT00806026|475032707|FG003|Overall Study|Death|1|||
131411227|NCT03294135|473128575|FG000|Overall Study|Other|2|||
131411228|NCT03294135|473128576|FG001|Overall Study|Other|0|||
131930874|NCT00806026|475032708|FG004|Overall Study|Death|0|||
131930875|NCT00806026|475032709|FG005|Overall Study|Death|0|||
131930876|NCT00806026|475032704|FG000|Overall Study|Did not meet entrance criteria|4|||
131930877|NCT00806026|475032705|FG001|Overall Study|Did not meet entrance criteria|1|||
131411229|NCT03294135|473128577|FG002|Overall Study|Other|0|||
131411230|NCT02763254|473128578|FG000|Overall Study|Adverse Event|1|||
131411231|NCT03684304|473128579|FG000|Overall Study|Lost to Follow-up|19|||
131411232|NCT03684304|473128580|FG001|Overall Study|Lost to Follow-up|17|||
131930878|NCT00806026|475032706|FG002|Overall Study|Did not meet entrance criteria|2|||
131930879|NCT00806026|475032707|FG003|Overall Study|Did not meet entrance criteria|1|||
131930880|NCT00806026|475032708|FG004|Overall Study|Did not meet entrance criteria|0|||
131930881|NCT00806026|475032709|FG005|Overall Study|Did not meet entrance criteria|0|||
131930882|NCT00806026|475032704|FG000|Overall Study|Lack of Efficacy|5|||
131930883|NCT00806026|475032705|FG001|Overall Study|Lack of Efficacy|18|||
131930884|NCT00806026|475032706|FG002|Overall Study|Lack of Efficacy|13|||
131930885|NCT00806026|475032707|FG003|Overall Study|Lack of Efficacy|4|||
131930886|NCT00806026|475032708|FG004|Overall Study|Lack of Efficacy|8|||
131930887|NCT00806026|475032709|FG005|Overall Study|Lack of Efficacy|7|||
131930888|NCT00806026|475032704|FG000|Overall Study|Lost to Follow-up|8|||
131930889|NCT00806026|475032705|FG001|Overall Study|Lost to Follow-up|15|||
131930890|NCT00806026|475032706|FG002|Overall Study|Lost to Follow-up|8|||
131930891|NCT00806026|475032707|FG003|Overall Study|Lost to Follow-up|2|||
131930892|NCT00806026|475032708|FG004|Overall Study|Lost to Follow-up|6|||
131930893|NCT00806026|475032709|FG005|Overall Study|Lost to Follow-up|6|||
131930894|NCT00806026|475032704|FG000|Overall Study|Withdrawal by Subject|14|||
131930895|NCT00806026|475032705|FG001|Overall Study|Withdrawal by Subject|17|||
131930896|NCT00806026|475032706|FG002|Overall Study|Withdrawal by Subject|9|||
131930897|NCT00806026|475032707|FG003|Overall Study|Withdrawal by Subject|2|||
131930898|NCT00806026|475032708|FG004|Overall Study|Withdrawal by Subject|5|||
131930899|NCT00806026|475032709|FG005|Overall Study|Withdrawal by Subject|3|||
131930900|NCT00806026|475032704|FG000|Overall Study|Other|3|||
131930901|NCT00806026|475032705|FG001|Overall Study|Other|6|||
131930902|NCT00806026|475032706|FG002|Overall Study|Other|8|||
131930903|NCT00806026|475032707|FG003|Overall Study|Other|2|||
131930904|NCT00806026|475032708|FG004|Overall Study|Other|0|||
131930905|NCT00806026|475032709|FG005|Overall Study|Other|4|||
131930906|NCT00806026|475032704|FG000|Overall Study|Protocol Violation|6|||
131930907|NCT00806026|475032705|FG001|Overall Study|Protocol Violation|9|||
131930908|NCT00806026|475032706|FG002|Overall Study|Protocol Violation|9|||
131930909|NCT00806026|475032707|FG003|Overall Study|Protocol Violation|0|||
131930910|NCT00806026|475032708|FG004|Overall Study|Protocol Violation|2|||
131930911|NCT00806026|475032709|FG005|Overall Study|Protocol Violation|3|||
131930912|NCT00806026|475032704|FG000|Overall Study|Adverse Event|52|||
131930913|NCT00806026|475032705|FG001|Overall Study|Adverse Event|35|||
131930914|NCT00806026|475032706|FG002|Overall Study|Adverse Event|44|||
131930915|NCT00806026|475032707|FG003|Overall Study|Adverse Event|17|||
131930916|NCT00806026|475032708|FG004|Overall Study|Adverse Event|9|||
131930917|NCT00806026|475032709|FG005|Overall Study|Adverse Event|9|||
131930918|NCT00489359|475032710|FG000|Overall Study|Death|0|||
131930919|NCT00489359|475032711|FG001|Overall Study|Death|2|||
131930920|NCT00489359|475032710|FG000|Overall Study|Progressive Disease|5|||
131930921|NCT00489359|475032711|FG001|Overall Study|Progressive Disease|6|||
131930922|NCT00489359|475032710|FG000|Overall Study|Lost to Follow-up|1|||
131930923|NCT00489359|475032711|FG001|Overall Study|Lost to Follow-up|0|||
131930924|NCT00489359|475032710|FG000|Overall Study|Withdrawal by Subject|1|||
131930925|NCT00489359|475032711|FG001|Overall Study|Withdrawal by Subject|5|||
131930926|NCT00489359|475032710|FG000|Overall Study|Adverse Event|0|||
131930927|NCT00489359|475032711|FG001|Overall Study|Adverse Event|16|||
131930928|NCT03180138|475032712|FG000|Overall Study|Mobile-phone could not be verified|2|||
131930929|NCT03180138|475032713|FG001|Overall Study|Mobile-phone could not be verified|13|||
131930930|NCT03180138|475032714|FG002|Overall Study|Mobile-phone could not be verified|15|||
131930931|NCT03180138|475032712|FG000|Overall Study|No prior immunization records|17|||
131930932|NCT03180138|475032713|FG001|Overall Study|No prior immunization records|0|||
131930933|NCT03180138|475032714|FG002|Overall Study|No prior immunization records|6|||
131930934|NCT03180138|475032712|FG000|Overall Study|Found to be >24 mon after randomization|3|||
131930935|NCT03180138|475032713|FG001|Overall Study|Found to be >24 mon after randomization|0|||
131930936|NCT03180138|475032714|FG002|Overall Study|Found to be >24 mon after randomization|3|||
131930937|NCT04191733|475032715|FG000|Overall Study|Withdrawn due to study closure|13|||
131930938|NCT04191733|475032716|FG001|Overall Study|Withdrawn due to study closure|14|||
131930939|NCT04191733|475032715|FG000|Overall Study|Withdrawal by Subject|2|||
131930940|NCT04191733|475032716|FG001|Overall Study|Withdrawal by Subject|4|||
131930941|NCT04191733|475032715|FG000|Overall Study|Physician Decision|1|||
131930942|NCT04191733|475032716|FG001|Overall Study|Physician Decision|1|||
131930943|NCT04191733|475032715|FG000|Overall Study|Lost to Follow-up|5|||
131930944|NCT04191733|475032716|FG001|Overall Study|Lost to Follow-up|6|||
131930945|NCT04191733|475032715|FG000|Overall Study|Death|0|||
131930946|NCT04191733|475032716|FG001|Overall Study|Death|1|||
131930947|NCT01903733|475032720|FG000|Overall Study|Death|23|||
131930948|NCT01903733|475032721|FG001|Overall Study|Death|54|||
131930949|NCT01903733|475032722|FG002|Overall Study|Death|30|||
131930950|NCT01903733|475032723|FG003|Overall Study|Death|98|||
131930951|NCT01903733|475032720|FG000|Overall Study|Participant refused further follow-up|35|||
131930952|NCT01903733|475032721|FG001|Overall Study|Participant refused further follow-up|38|||
131930953|NCT01903733|475032722|FG002|Overall Study|Participant refused further follow-up|13|||
131930954|NCT01903733|475032723|FG003|Overall Study|Participant refused further follow-up|9|||
131930955|NCT01903733|475032720|FG000|Overall Study|Lost to Follow-up|18|||
131930956|NCT01903733|475032721|FG001|Overall Study|Lost to Follow-up|19|||
131930957|NCT01903733|475032722|FG002|Overall Study|Lost to Follow-up|6|||
131930958|NCT01903733|475032723|FG003|Overall Study|Lost to Follow-up|9|||
131930959|NCT01903733|475032720|FG000|Overall Study|Other|10|||
131930960|NCT01903733|475032721|FG001|Overall Study|Other|15|||
131930961|NCT01903733|475032722|FG002|Overall Study|Other|12|||
131930962|NCT01903733|475032723|FG003|Overall Study|Other|3|||
131930963|NCT01903733|475032720|FG000|Overall Study|Missing|2|||
131930964|NCT01903733|475032721|FG001|Overall Study|Missing|0|||
131930965|NCT01903733|475032722|FG002|Overall Study|Missing|0|||
131930966|NCT01903733|475032723|FG003|Overall Study|Missing|0|||
131930967|NCT01903733|475032720|FG000|Overall Study|Investigator request|18|||
131930968|NCT01903733|475032721|FG001|Overall Study|Investigator request|0|||
131930969|NCT01903733|475032722|FG002|Overall Study|Investigator request|0|||
131930970|NCT01903733|475032723|FG003|Overall Study|Investigator request|0|||
131930971|NCT01887600|475032732|FG000|Overall Study|Death|39|||
131930972|NCT01887600|475032733|FG001|Overall Study|Death|16|||
131930973|NCT01887600|475032732|FG000|Overall Study|Lack of Efficacy|3|||
131930974|NCT01887600|475032733|FG001|Overall Study|Lack of Efficacy|26|||
131930975|NCT01887600|475032732|FG000|Overall Study|Lost to Follow-up|5|||
131930976|NCT01887600|475032733|FG001|Overall Study|Lost to Follow-up|1|||
131930977|NCT01887600|475032732|FG000|Overall Study|Physician Decision|7|||
131930978|NCT01887600|475032733|FG001|Overall Study|Physician Decision|8|||
131930979|NCT01887600|475032732|FG000|Overall Study|Protocol Deviation|3|||
131930980|NCT01887600|475032733|FG001|Overall Study|Protocol Deviation|0|||
131930981|NCT01887600|475032732|FG000|Overall Study|Withdrawal by Subject|58|||
131930982|NCT01887600|475032733|FG001|Overall Study|Withdrawal by Subject|52|||
131930983|NCT01887600|475032732|FG000|Overall Study|Adverse Event|21|||
131930984|NCT01887600|475032733|FG001|Overall Study|Adverse Event|9|||
131930985|NCT01887600|475032732|FG000|Overall Study|Non-compliance with study drug|3|||
131930986|NCT01887600|475032733|FG001|Overall Study|Non-compliance with study drug|0|||
131930987|NCT01887600|475032732|FG000|Overall Study|Miscellaneous|6|||
131930988|NCT01887600|475032733|FG001|Overall Study|Miscellaneous|2|||
131930989|NCT01887600|475032732|FG000|Overall Study|Progressive Disease|1|||
131930990|NCT01887600|475032733|FG001|Overall Study|Progressive Disease|0|||
131930991|NCT03688139|475032734|FG000|Overall Study|Lost to Follow-up|2|||
131930992|NCT03688139|475032735|FG001|Overall Study|Lost to Follow-up|0|||
131930993|NCT03688139|475032734|FG000|Overall Study|Physician Decision|0|||
131930994|NCT03688139|475032735|FG001|Overall Study|Physician Decision|1|||
131930995|NCT03688139|475032734|FG000|Overall Study|Withdrawal by Subject|2|||
131930996|NCT03688139|475032735|FG001|Overall Study|Withdrawal by Subject|3|||
131930997|NCT00420056|475032736|FG000|Overall Study|Objective progression or relapse|17|||
131930998|NCT00025233|475032740|FG000|Overall Study|Ineligible: wrong cell type|1|||
131930999|NCT00025233|475032740|FG000|Overall Study|Ineligible: wrong primary|1|||
131931000|NCT00025233|475032740|FG000|Overall Study|Ineligible: improper prior treatment|1|||
131931001|NCT00025233|475032740|FG000|Overall Study|Never treated|1|||
131931002|NCT03425188|475032741|FG000|Overall Study|Withdrawal by Subject|1|||
131931003|NCT00655356|475032742|FG000|Overall Study|Withdrawal by Subject|3|||
131931004|NCT00655356|475032743|FG001|Overall Study|Withdrawal by Subject|4|||
131931005|NCT00655356|475032742|FG000|Overall Study|Sponsor Request|10|||
131931006|NCT00655356|475032743|FG001|Overall Study|Sponsor Request|4|||
131931007|NCT00655356|475032742|FG000|Overall Study|Adverse Event|1|||
131931008|NCT00655356|475032743|FG001|Overall Study|Adverse Event|1|||
131931009|NCT00655356|475032742|FG000|Overall Study|Protocol Violation|2|||
131931010|NCT00655356|475032743|FG001|Overall Study|Protocol Violation|1|||
131931011|NCT00655356|475032742|FG000|Overall Study|Other Reason|1|||
131931012|NCT00655356|475032743|FG001|Overall Study|Other Reason|0|||
131931013|NCT01412983|475032744|FG000|1st Period|Ineligible|0|||
131931014|NCT01412983|475032745|FG001|1st Period|Ineligible|1|||
131931015|NCT01412983|475032744|FG000|1st Period|Positive slit lamp finding|0|||
131931016|NCT01412983|475032745|FG001|1st Period|Positive slit lamp finding|1|||
131931017|NCT01412983|475032744|FG000|1st Period|Unacceptable lens movement|0|||
131931018|NCT01412983|475032745|FG001|1st Period|Unacceptable lens movement|1|||
131931019|NCT01412983|475032744|FG000|1st Period|Inability to maintain wear|0|||
131411233|NCT01143051|473128581|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
131411234|NCT01143051|473128582|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
131411235|NCT01143051|473128583|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
131931020|NCT01412983|475032745|FG001|1st Period|Inability to maintain wear|1|||
131931021|NCT04349098|475032746|FG000|Overall Study|Death|16|||
131931022|NCT04349098|475032747|FG001|Overall Study|Death|8|||
131931023|NCT04349098|475032746|FG000|Overall Study|Lost to Follow-up|11|||
131931024|NCT04349098|475032747|FG001|Overall Study|Lost to Follow-up|8|||
131931025|NCT04349098|475032746|FG000|Overall Study|Withdrawal by Subject|8|||
131931026|NCT04349098|475032747|FG001|Overall Study|Withdrawal by Subject|5|||
131931027|NCT04349098|475032746|FG000|Overall Study|Other|3|||
131931028|NCT04349098|475032747|FG001|Overall Study|Other|5|||
131931029|NCT00289900|475032748|FG000|Overall Study|Adverse Event|28|||
131931030|NCT00289900|475032749|FG001|Overall Study|Adverse Event|40|||
131931031|NCT00289900|475032750|FG002|Overall Study|Adverse Event|13|||
131931032|NCT00289900|475032751|FG003|Overall Study|Adverse Event|19|||
131931033|NCT00289900|475032752|FG004|Overall Study|Adverse Event|20|||
131931034|NCT00289900|475032753|FG005|Overall Study|Adverse Event|33|||
131931035|NCT00289900|475032748|FG000|Overall Study|Lost to Follow-up|7|||
131931036|NCT00289900|475032749|FG001|Overall Study|Lost to Follow-up|7|||
131931037|NCT00289900|475032750|FG002|Overall Study|Lost to Follow-up|8|||
131931038|NCT00289900|475032751|FG003|Overall Study|Lost to Follow-up|8|||
131931039|NCT00289900|475032752|FG004|Overall Study|Lost to Follow-up|4|||
131931040|NCT00289900|475032753|FG005|Overall Study|Lost to Follow-up|8|||
131931041|NCT00289900|475032748|FG000|Overall Study|Participant had flushing|18|||
131931042|NCT00289900|475032749|FG001|Overall Study|Participant had flushing|42|||
131931043|NCT00289900|475032750|FG002|Overall Study|Participant had flushing|1|||
131931044|NCT00289900|475032751|FG003|Overall Study|Participant had flushing|2|||
131931045|NCT00289900|475032752|FG004|Overall Study|Participant had flushing|0|||
131931046|NCT00289900|475032753|FG005|Overall Study|Participant had flushing|4|||
131931047|NCT00289900|475032748|FG000|Overall Study|Other|0|||
131931048|NCT00289900|475032749|FG001|Overall Study|Other|0|||
131931049|NCT00289900|475032750|FG002|Overall Study|Other|0|||
131931050|NCT00289900|475032751|FG003|Overall Study|Other|5|||
131931051|NCT00289900|475032752|FG004|Overall Study|Other|1|||
131931052|NCT00289900|475032753|FG005|Overall Study|Other|0|||
131931053|NCT00289900|475032748|FG000|Overall Study|Participant moved|1|||
131931054|NCT00289900|475032749|FG001|Overall Study|Participant moved|0|||
131931055|NCT00289900|475032750|FG002|Overall Study|Participant moved|0|||
131931056|NCT00289900|475032751|FG003|Overall Study|Participant moved|1|||
131931057|NCT00289900|475032752|FG004|Overall Study|Participant moved|1|||
131931058|NCT00289900|475032753|FG005|Overall Study|Participant moved|1|||
131931059|NCT00289900|475032748|FG000|Overall Study|Withdrawal by Subject|10|||
131931060|NCT00289900|475032749|FG001|Overall Study|Withdrawal by Subject|21|||
131931061|NCT00289900|475032750|FG002|Overall Study|Withdrawal by Subject|8|||
131931062|NCT00289900|475032751|FG003|Overall Study|Withdrawal by Subject|18|||
131931063|NCT00289900|475032752|FG004|Overall Study|Withdrawal by Subject|12|||
131931064|NCT00289900|475032753|FG005|Overall Study|Withdrawal by Subject|11|||
131931065|NCT00289900|475032748|FG000|Overall Study|Protocol Violation|3|||
131931066|NCT00289900|475032749|FG001|Overall Study|Protocol Violation|9|||
131931067|NCT00289900|475032750|FG002|Overall Study|Protocol Violation|2|||
131931068|NCT00289900|475032751|FG003|Overall Study|Protocol Violation|6|||
131931069|NCT00289900|475032752|FG004|Overall Study|Protocol Violation|7|||
131931070|NCT00289900|475032753|FG005|Overall Study|Protocol Violation|4|||
131931071|NCT00289900|475032748|FG000|Overall Study|site terminated|1|||
131931072|NCT00289900|475032749|FG001|Overall Study|site terminated|0|||
131931073|NCT00289900|475032750|FG002|Overall Study|site terminated|1|||
131931074|NCT00289900|475032751|FG003|Overall Study|site terminated|0|||
131931075|NCT00289900|475032752|FG004|Overall Study|site terminated|0|||
131931076|NCT00289900|475032753|FG005|Overall Study|site terminated|0|||
131931077|NCT00289900|475032748|FG000|Overall Study|Not treated|0|||
131931078|NCT00289900|475032749|FG001|Overall Study|Not treated|1|||
131931079|NCT00289900|475032750|FG002|Overall Study|Not treated|0|||
131931080|NCT00289900|475032751|FG003|Overall Study|Not treated|0|||
131931081|NCT00289900|475032752|FG004|Overall Study|Not treated|0|||
131931082|NCT00289900|475032753|FG005|Overall Study|Not treated|0|||
131931083|NCT01703221|475032754|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
131931084|NCT01703221|475032755|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
131931085|NCT01703221|475032756|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131931086|NCT01703221|475032754|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
131931087|NCT01703221|475032755|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
131931088|NCT01703221|475032756|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
131931089|NCT01703221|475032754|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
131931090|NCT01703221|475032755|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131931091|NCT01703221|475032756|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131931092|NCT01703221|475032754|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
131931093|NCT01703221|475032755|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131931094|NCT01703221|475032756|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131931095|NCT01703221|475032754|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131931096|NCT01703221|475032755|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131931097|NCT01703221|475032756|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
131931098|NCT01703221|475032754|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
131931099|NCT01703221|475032755|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
131931100|NCT01703221|475032756|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
131931101|NCT01703221|475032754|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
131931102|NCT01703221|475032755|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
131931103|NCT01703221|475032756|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
131931104|NCT01703221|475032754|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
131931105|NCT01703221|475032755|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
131931106|NCT01703221|475032756|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
131931107|NCT01152385|475032757|FG000|Overall Study|Withdrawal by Subject|3|||
131931108|NCT01152385|475032758|FG001|Overall Study|Withdrawal by Subject|1|||
131454188|NCT02003924|473291906|FG001|Long-term Follow-up Phase|Death|174|||
131931109|NCT01152385|475032759|FG002|Overall Study|Withdrawal by Subject|1|||
131931110|NCT01152385|475032760|FG003|Overall Study|Withdrawal by Subject|1|||
131931111|NCT01152385|475032757|FG000|Overall Study|Protocol Violation|0|||
131931112|NCT01152385|475032758|FG001|Overall Study|Protocol Violation|0|||
131931113|NCT01152385|475032759|FG002|Overall Study|Protocol Violation|0|||
131931114|NCT01152385|475032760|FG003|Overall Study|Protocol Violation|1|||
131931115|NCT01152385|475032757|FG000|Overall Study|Adverse Event|1|||
131931116|NCT01152385|475032758|FG001|Overall Study|Adverse Event|1|||
131931117|NCT01152385|475032759|FG002|Overall Study|Adverse Event|0|||
131931118|NCT01152385|475032760|FG003|Overall Study|Adverse Event|0|||
131931119|NCT01152385|475032757|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131411236|NCT01143051|473128584|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
131411237|NCT01143051|473128585|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
131411238|NCT01143051|473128586|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
131411239|NCT01143051|473128581|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
131411240|NCT01143051|473128582|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
131411241|NCT01143051|473128583|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
131411242|NCT01143051|473128584|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
131411243|NCT01143051|473128585|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
131411244|NCT01143051|473128586|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
131411245|NCT01665430|473128587|FG000|Overall Study|Adverse Event|1|||
131411246|NCT01665430|473128587|FG000|Overall Study|Withdrawal by Subject|6|||
131411247|NCT01665430|473128587|FG000|Overall Study|Other Unspecified|2|||
131411248|NCT02310230|473128588|FG000|Overall Study|Physician Decision|1|||
131411249|NCT02310230|473128589|FG001|Overall Study|Physician Decision|3|||
131411250|NCT02310230|473128588|FG000|Overall Study|monitor baseline taken after induction|2|||
131411251|NCT02310230|473128589|FG001|Overall Study|monitor baseline taken after induction|7|||
131411252|NCT02310230|473128588|FG000|Overall Study|Poor signal quality|5|||
131411253|NCT02310230|473128589|FG001|Overall Study|Poor signal quality|8|||
131411254|NCT02310230|473128588|FG000|Overall Study|Case cancelled|1|||
131411255|NCT02310230|473128589|FG001|Overall Study|Case cancelled|0|||
131411256|NCT03249935|473128590|FG000|Overall Study|Discharged from facility early|36|||
131411257|NCT03249935|473128590|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
131411258|NCT03249935|473128590|FG000|Overall Study|Protocol Violation|5|||
131411259|NCT03593681|473128591|FG000|Overall Study|Inadequate sample collected|12|||
131411260|NCT03593681|473128591|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
131411261|NCT03593681|473128591|FG000|Overall Study|Protocol Violation|3|||
131411262|NCT03593681|473128591|FG000|Overall Study|Withdrawal by Subject|3|||
131411263|NCT03593681|473128591|FG000|Overall Study|Procedure not attempted|3|||
131411264|NCT03593681|473128591|FG000|Overall Study|Adverse Event|2|||
131411265|NCT03593681|473128591|FG000|Overall Study|Physician Decision|1|||
131931120|NCT01152385|475032758|FG001|Overall Study|Study-specific withdrawal criteria|1|||
131931121|NCT01152385|475032759|FG002|Overall Study|Study-specific withdrawal criteria|2|||
131931122|NCT01152385|475032760|FG003|Overall Study|Study-specific withdrawal criteria|0|||
131931123|NCT01152385|475032757|FG000|Overall Study|Other|4|||
131931124|NCT01152385|475032758|FG001|Overall Study|Other|3|||
131931125|NCT01152385|475032759|FG002|Overall Study|Other|2|||
131931126|NCT01152385|475032760|FG003|Overall Study|Other|3|||
131931127|NCT03878069|475032766|FG000|Overall Study|Death|0|||
131931128|NCT03878069|475032767|FG001|Overall Study|Death|1|||
131931129|NCT03878069|475032768|FG002|Overall Study|Death|0|||
131931130|NCT00834587|475032769|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131931131|NCT00834587|475032770|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
131931132|NCT02536339|475032772|FG000|Overall Study|Death|20|||
131931133|NCT02536339|475032772|FG000|Overall Study|Withdrawal by Subject|3|||
131931134|NCT02536339|475032772|FG000|Overall Study|Lost to Follow-up|2|||
131931135|NCT02536339|475032772|FG000|Overall Study|Treatment discontinued|2|||
131931136|NCT02536339|475032772|FG000|Overall Study|Physician Decision|1|||
131931137|NCT02037984|475032773|FG000|Overall Study|Lack of Efficacy|0|||
131931138|NCT02037984|475032774|FG001|Overall Study|Lack of Efficacy|0|||
131931139|NCT02037984|475032775|FG002|Overall Study|Lack of Efficacy|3|||
131931140|NCT02037984|475032776|FG003|Overall Study|Lack of Efficacy|10|||
131931141|NCT02037984|475032777|FG004|Overall Study|Lack of Efficacy|2|||
131931142|NCT02037984|475032778|FG005|Overall Study|Lack of Efficacy|2|||
131931143|NCT02037984|475032779|FG006|Overall Study|Lack of Efficacy|4|||
131931144|NCT02037984|475032780|FG007|Overall Study|Lack of Efficacy|3|||
131931145|NCT02037984|475032773|FG000|Overall Study|Lost to Follow-up|1|||
131931146|NCT02037984|475032774|FG001|Overall Study|Lost to Follow-up|0|||
131931147|NCT02037984|475032775|FG002|Overall Study|Lost to Follow-up|3|||
131931148|NCT02037984|475032776|FG003|Overall Study|Lost to Follow-up|5|||
131931149|NCT02037984|475032777|FG004|Overall Study|Lost to Follow-up|2|||
131931150|NCT02037984|475032778|FG005|Overall Study|Lost to Follow-up|2|||
131931151|NCT02037984|475032779|FG006|Overall Study|Lost to Follow-up|2|||
131931152|NCT02037984|475032780|FG007|Overall Study|Lost to Follow-up|4|||
131931153|NCT02037984|475032773|FG000|Overall Study|Physician Decision|0|||
131931154|NCT02037984|475032774|FG001|Overall Study|Physician Decision|0|||
131411266|NCT01669421|473128595|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
131411267|NCT01669421|473128595|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
131931155|NCT02037984|475032775|FG002|Overall Study|Physician Decision|0|||
131931156|NCT02037984|475032776|FG003|Overall Study|Physician Decision|0|||
131931157|NCT02037984|475032777|FG004|Overall Study|Physician Decision|0|||
131931158|NCT02037984|475032778|FG005|Overall Study|Physician Decision|0|||
131931159|NCT02037984|475032779|FG006|Overall Study|Physician Decision|1|||
131931160|NCT02037984|475032780|FG007|Overall Study|Physician Decision|0|||
131411268|NCT01605227|473128599|FG000|Overall Study|Did not receive study treatment|2|||
131411269|NCT01605227|473128600|FG001|Overall Study|Did not receive study treatment|3|||
131411270|NCT01605227|473128599|FG000|Overall Study|Adverse Event|228|||
131411271|NCT01605227|473128600|FG001|Overall Study|Adverse Event|42|||
131411272|NCT01605227|473128599|FG000|Overall Study|Progressive Disease|132|||
131411273|NCT01605227|473128600|FG001|Overall Study|Progressive Disease|128|||
131411274|NCT01605227|473128599|FG000|Overall Study|Clinical Deterioration|227|||
131411275|NCT01605227|473128600|FG001|Overall Study|Clinical Deterioration|133|||
131411276|NCT01605227|473128599|FG000|Overall Study|Lost to Follow-up|1|||
131411277|NCT01605227|473128600|FG001|Overall Study|Lost to Follow-up|0|||
131411278|NCT01605227|473128599|FG000|Overall Study|Protocol Violation|1|||
131411279|NCT01605227|473128600|FG001|Overall Study|Protocol Violation|0|||
131411280|NCT01605227|473128599|FG000|Overall Study|Physician Decision|9|||
131411281|NCT01605227|473128600|FG001|Overall Study|Physician Decision|7|||
131411282|NCT01605227|473128599|FG000|Overall Study|Withdrawal by Subject|18|||
131411283|NCT01605227|473128600|FG001|Overall Study|Withdrawal by Subject|14|||
131411284|NCT01605227|473128599|FG000|Overall Study|Sponsor Decision|2|||
131411285|NCT01605227|473128600|FG001|Overall Study|Sponsor Decision|0|||
131411286|NCT01605227|473128599|FG000|Overall Study|Started New Therapy|1|||
131411287|NCT01605227|473128600|FG001|Overall Study|Started New Therapy|0|||
131411288|NCT01605227|473128599|FG000|Overall Study|Subject Decision|0|||
131411289|NCT01605227|473128600|FG001|Overall Study|Subject Decision|1|||
131411290|NCT01605227|473128599|FG000|Overall Study|Dose Held >6 weeks|0|||
131411291|NCT01605227|473128600|FG001|Overall Study|Dose Held >6 weeks|1|||
131411292|NCT02961790|473128601|FG000|Overall Study|Canceled|4|||
131411293|NCT02961790|473128602|FG001|Overall Study|Canceled|5|||
131411294|NCT02961790|473128603|FG002|Overall Study|Canceled|1|||
131411295|NCT02961790|473128604|FG003|Overall Study|Canceled|4|||
131411296|NCT02961790|473128601|FG000|Overall Study|without baseline data|4|||
131411297|NCT02961790|473128602|FG001|Overall Study|without baseline data|0|||
131411298|NCT02961790|473128603|FG002|Overall Study|without baseline data|1|||
131411299|NCT02961790|473128604|FG003|Overall Study|without baseline data|0|||
131411300|NCT02961790|473128601|FG000|Overall Study|without post baseline data|7|||
131411301|NCT02961790|473128602|FG001|Overall Study|without post baseline data|6|||
131411302|NCT02961790|473128603|FG002|Overall Study|without post baseline data|4|||
131411303|NCT02961790|473128604|FG003|Overall Study|without post baseline data|1|||
131411304|NCT02078102|473128605|FG000|Overall Study|Adverse Event|1|||
131411305|NCT02078102|473128606|FG001|Overall Study|Adverse Event|0|||
131411306|NCT02078102|473128605|FG000|Overall Study|Withdrawal by Subject|1|||
131411307|NCT02078102|473128606|FG001|Overall Study|Withdrawal by Subject|0|||
131411308|NCT02078102|473128605|FG000|Overall Study|Physician Decision|0|||
131411309|NCT02078102|473128606|FG001|Overall Study|Physician Decision|1|||
131411310|NCT03093974|473128611|FG000|Overall Study|Withdrawal by Subject|32|||
131411311|NCT03093974|473128612|FG001|Overall Study|Withdrawal by Subject|27|||
131411312|NCT03093974|473128611|FG000|Overall Study|Adverse Event|17|||
131411313|NCT03093974|473128612|FG001|Overall Study|Adverse Event|24|||
131411314|NCT03093974|473128611|FG000|Overall Study|Death|0|||
131411315|NCT03093974|473128612|FG001|Overall Study|Death|1|||
131411316|NCT03093974|473128611|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131411317|NCT03093974|473128612|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131411318|NCT03093974|473128611|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
131411319|NCT03093974|473128612|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
131411320|NCT03093974|473128611|FG000|Overall Study|Lost to Follow-up|0|||
131411321|NCT03093974|473128612|FG001|Overall Study|Lost to Follow-up|1|||
131411322|NCT03093974|473128611|FG000|Overall Study|Other|1|||
131931161|NCT02037984|475032773|FG000|Overall Study|Protocol Violation|0|||
131931162|NCT02037984|475032774|FG001|Overall Study|Protocol Violation|0|||
131931163|NCT02037984|475032775|FG002|Overall Study|Protocol Violation|0|||
131931164|NCT02037984|475032776|FG003|Overall Study|Protocol Violation|0|||
131931165|NCT02037984|475032777|FG004|Overall Study|Protocol Violation|0|||
131931166|NCT02037984|475032778|FG005|Overall Study|Protocol Violation|1|||
131931167|NCT02037984|475032779|FG006|Overall Study|Protocol Violation|2|||
131931168|NCT02037984|475032780|FG007|Overall Study|Protocol Violation|0|||
131931169|NCT02037984|475032773|FG000|Overall Study|Technical Problems|0|||
131931170|NCT02037984|475032774|FG001|Overall Study|Technical Problems|0|||
131931171|NCT02037984|475032775|FG002|Overall Study|Technical Problems|3|||
131411323|NCT03093974|473128612|FG001|Overall Study|Other|2|||
131411324|NCT01866423|473128613|FG000|Overall Study|Lack of Efficacy|3|||
131411325|NCT01866423|473128613|FG000|Overall Study|Sponsor Decision|1|||
131411326|NCT01813721|473128614|FG000|Overall Study|Ineligibility determined|63|||
131411327|NCT01813721|473128614|FG000|Overall Study|Withdrawal by Subject|1|||
131411328|NCT02387164|473128615|FG000|Overall Study|Lost to Follow-up|2|||
131411329|NCT02387164|473128616|FG001|Overall Study|Lost to Follow-up|0|||
131931172|NCT02037984|475032776|FG003|Overall Study|Technical Problems|3|||
131411330|NCT02387164|473128615|FG000|Overall Study|Diagnosed|1|||
131411331|NCT02387164|473128616|FG001|Overall Study|Diagnosed|2|||
131411332|NCT00343915|473128617|FG000|Primary Study|Withdrawal by Subject|1|||
131411333|NCT00343915|473128618|FG001|Primary Study|Withdrawal by Subject|0|||
131931173|NCT02037984|475032777|FG004|Overall Study|Technical Problems|2|||
131454189|NCT02003924|473291907|FG002|Long-term Follow-up Phase|Death|4|||
131931174|NCT02037984|475032778|FG005|Overall Study|Technical Problems|3|||
131931175|NCT02037984|475032779|FG006|Overall Study|Technical Problems|4|||
131931176|NCT02037984|475032780|FG007|Overall Study|Technical Problems|2|||
131931177|NCT02037984|475032773|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131931178|NCT02037984|475032774|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131931179|NCT02037984|475032775|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
131931180|NCT02037984|475032776|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
131931181|NCT02037984|475032777|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
131931182|NCT02037984|475032778|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
131931183|NCT02037984|475032779|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
131931184|NCT02037984|475032780|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
131931185|NCT02037984|475032773|FG000|Overall Study|Withdrawal by Subject|0|||
131931186|NCT02037984|475032774|FG001|Overall Study|Withdrawal by Subject|0|||
131931187|NCT02037984|475032775|FG002|Overall Study|Withdrawal by Subject|0|||
131931188|NCT02037984|475032776|FG003|Overall Study|Withdrawal by Subject|1|||
131931189|NCT02037984|475032777|FG004|Overall Study|Withdrawal by Subject|1|||
131931190|NCT02037984|475032778|FG005|Overall Study|Withdrawal by Subject|3|||
131931191|NCT02037984|475032779|FG006|Overall Study|Withdrawal by Subject|0|||
131931192|NCT02037984|475032780|FG007|Overall Study|Withdrawal by Subject|1|||
131931193|NCT05520333|475034378|FG000|Overall Study|Lost to Follow-up|3|||
131931194|NCT05520333|475034379|FG001|Overall Study|Lost to Follow-up|6|||
131931195|NCT00185614|475034380|FG000|Inter-treatment Period|Physician Decision|1|||
131931196|NCT00185614|475034380|FG000|Inter-treatment Period|Relapse|2|||
131931197|NCT00185614|475034380|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
131931198|NCT01897896|475034381|FG000|Overall Study|Death|1|||
131931199|NCT01897896|475034382|FG001|Overall Study|Death|0|||
131931200|NCT01897896|475034381|FG000|Overall Study|Adverse Event|11|||
131931201|NCT01897896|475034382|FG001|Overall Study|Adverse Event|1|||
131931202|NCT01897896|475034381|FG000|Overall Study|Lost to Follow-up|1|||
131931203|NCT01897896|475034382|FG001|Overall Study|Lost to Follow-up|0|||
131931204|NCT01897896|475034381|FG000|Overall Study|Non-compliance with study drug dosing|1|||
131931205|NCT01897896|475034382|FG001|Overall Study|Non-compliance with study drug dosing|1|||
131931206|NCT01897896|475034381|FG000|Overall Study|Withdrawal by Subject|7|||
131931207|NCT01897896|475034382|FG001|Overall Study|Withdrawal by Subject|1|||
131931208|NCT01897896|475034381|FG000|Overall Study|Require drug that interfere with study|1|||
131931209|NCT01897896|475034382|FG001|Overall Study|Require drug that interfere with study|4|||
131931210|NCT01897896|475034381|FG000|Overall Study|Protocol Violation|1|||
131931211|NCT01897896|475034382|FG001|Overall Study|Protocol Violation|1|||
131931212|NCT01897896|475034381|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
131931213|NCT01897896|475034382|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
131931214|NCT01897896|475034381|FG000|Overall Study|Caregiver can no longer participate|0|||
131931215|NCT01897896|475034382|FG001|Overall Study|Caregiver can no longer participate|2|||
131931216|NCT01897896|475034381|FG000|Overall Study|Other than specified|2|||
131931217|NCT01897896|475034382|FG001|Overall Study|Other than specified|1|||
131931218|NCT05069415|475034383|FG000|Overall Study|Withdrawal by Subject|2|||
131931219|NCT05069415|475034384|FG001|Overall Study|Withdrawal by Subject|0|||
131931220|NCT05069415|475034383|FG000|Overall Study|Adverse Event|2|||
131931221|NCT05069415|475034384|FG001|Overall Study|Adverse Event|0|||
131931222|NCT00203242|475034385|FG000|Overall Study|Lost to Follow-up|1|||
131931223|NCT01500135|475034386|FG000|Overall Study|Withdrawal of Consent|4|||
131931224|NCT01500135|475034387|FG001|Overall Study|Withdrawal of Consent|0|||
131931225|NCT01500135|475034386|FG000|Overall Study|Lost to Follow-up|6|||
131931226|NCT01500135|475034387|FG001|Overall Study|Lost to Follow-up|4|||
131931227|NCT01500135|475034386|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
131931228|NCT01500135|475034387|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
131931229|NCT01500135|475034386|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
131931230|NCT01500135|475034387|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
131931231|NCT01500135|475034386|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
131931232|NCT01500135|475034387|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
131931233|NCT01500135|475034386|FG000|Overall Study|Participant was a Safety Concern|1|||
131931234|NCT01500135|475034387|FG001|Overall Study|Participant was a Safety Concern|0|||
131931235|NCT01500135|475034386|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
131931236|NCT01500135|475034387|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
131931237|NCT00912509|475034388|FG000|Overall Study|Lost to Follow-up|1|||
131931238|NCT00912509|475034389|FG001|Overall Study|Lost to Follow-up|0|||
131931239|NCT00912509|475034388|FG000|Overall Study|Lack of Efficacy|4|||
131931240|NCT00912509|475034389|FG001|Overall Study|Lack of Efficacy|3|||
131931241|NCT02715856|475034390|FG000|Overall Study|Software Issues|12|||
131931242|NCT02715856|475034391|FG001|Overall Study|Software Issues|7|||
131931243|NCT02715856|475034390|FG000|Overall Study|Death|6|||
131931244|NCT02715856|475034391|FG001|Overall Study|Death|5|||
131931245|NCT02715856|475034390|FG000|Overall Study|Non- Compliant|0|||
131931246|NCT02715856|475034391|FG001|Overall Study|Non- Compliant|40|||
131931247|NCT01772693|475034392|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
131931248|NCT01772693|475034393|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
131931249|NCT01772693|475034392|FG000|Overall Study|Withdrawal by Subject|2|||
131931250|NCT01772693|475034393|FG001|Overall Study|Withdrawal by Subject|0|||
131931251|NCT01772693|475034392|FG000|Overall Study|Alternative Treatment|2|||
131931252|NCT01772693|475034393|FG001|Overall Study|Alternative Treatment|0|||
131931253|NCT03439072|475034398|FG000|Overall Study|Withdrawal by Subject|2|||
131931254|NCT03439072|475034399|FG001|Overall Study|Withdrawal by Subject|3|||
131931255|NCT03439072|475034398|FG000|Overall Study|Physician Decision|0|||
131931256|NCT03439072|475034399|FG001|Overall Study|Physician Decision|1|||
131931257|NCT02003898|475034400|FG000|Overall Study|Death|3|||
131931258|NCT02003898|475034400|FG000|Overall Study|Lost to Follow-up|12|||
131931259|NCT02003898|475034400|FG000|Overall Study|Withdrawal by Subject|52|||
131931260|NCT05345405|475034403|FG000|Overall Study|Withdrawal by Subject|2|||
131931261|NCT05345405|475034404|FG001|Overall Study|Withdrawal by Subject|0|||
131931262|NCT05345405|475034405|FG002|Overall Study|Withdrawal by Subject|0|||
131931263|NCT05345405|475034403|FG000|Overall Study|Did not meet eligibility criteria|0|||
131931264|NCT05345405|475034404|FG001|Overall Study|Did not meet eligibility criteria|2|||
131931265|NCT05345405|475034405|FG002|Overall Study|Did not meet eligibility criteria|0|||
131931266|NCT05345405|475034403|FG000|Overall Study|Lost to Follow-up|0|||
131931267|NCT05345405|475034404|FG001|Overall Study|Lost to Follow-up|0|||
131931268|NCT05345405|475034405|FG002|Overall Study|Lost to Follow-up|1|||
131931269|NCT02150863|475034406|FG000|Overall Study|Lost to Follow-up|0|||
131931270|NCT02150863|475034407|FG001|Overall Study|Lost to Follow-up|1|||
131931271|NCT02150863|475034408|FG002|Overall Study|Lost to Follow-up|0|||
131931272|NCT01651208|475034409|FG000|Overall Study|Lost to Follow-up|14|||
131931273|NCT01651208|475034410|FG001|Overall Study|Lost to Follow-up|16|||
131931274|NCT05071027|475034418|FG000|Overall Study|Lost to Follow-up|1|||
131931275|NCT05071027|475034419|FG001|Overall Study|Lost to Follow-up|4|||
131931276|NCT02965976|475034424|FG000|Overall Study|Withdrawal by Subject|2|||
131931277|NCT02965976|475034425|FG001|Overall Study|Withdrawal by Subject|0|||
131931278|NCT01687595|475034426|FG000|Overall Study|Withdrawal by Subject|8|||
131931279|NCT01687595|475034427|FG001|Overall Study|Withdrawal by Subject|0|||
131931280|NCT01687595|475034426|FG000|Overall Study|Lost to Follow-up|3|||
131931281|NCT01687595|475034427|FG001|Overall Study|Lost to Follow-up|1|||
131931282|NCT01687595|475034426|FG000|Overall Study|Investigator's decision|1|||
131931283|NCT01687595|475034427|FG001|Overall Study|Investigator's decision|0|||
131931284|NCT01687595|475034426|FG000|Overall Study|Sponsor's decision|1|||
131931285|NCT01687595|475034427|FG001|Overall Study|Sponsor's decision|0|||
131931286|NCT01687595|475034426|FG000|Overall Study|Noncompliance|1|||
131931287|NCT01687595|475034427|FG001|Overall Study|Noncompliance|2|||
131931288|NCT01687595|475034426|FG000|Overall Study|Other than specified|56|||
131931289|NCT01687595|475034427|FG001|Overall Study|Other than specified|7|||
131931290|NCT02633527|475034431|FG000|Overall Study|Failed to meet eligibility|0|||
131931291|NCT02633527|475034432|FG001|Overall Study|Failed to meet eligibility|1|||
131931292|NCT02633527|475034433|FG002|Overall Study|Failed to meet eligibility|1|||
131931293|NCT02633527|475034434|FG003|Overall Study|Failed to meet eligibility|0|||
131931294|NCT02633527|475034435|FG004|Overall Study|Failed to meet eligibility|1|||
131931295|NCT02633527|475034431|FG000|Overall Study|Adverse Event|0|||
131931296|NCT02633527|475034432|FG001|Overall Study|Adverse Event|4|||
131931297|NCT02633527|475034433|FG002|Overall Study|Adverse Event|3|||
131931298|NCT02633527|475034434|FG003|Overall Study|Adverse Event|1|||
131931299|NCT02633527|475034435|FG004|Overall Study|Adverse Event|5|||
131931300|NCT02633527|475034431|FG000|Overall Study|Lost to Follow-up|1|||
131931301|NCT02633527|475034432|FG001|Overall Study|Lost to Follow-up|2|||
131931302|NCT02633527|475034433|FG002|Overall Study|Lost to Follow-up|5|||
131931303|NCT02633527|475034434|FG003|Overall Study|Lost to Follow-up|5|||
131931304|NCT02633527|475034435|FG004|Overall Study|Lost to Follow-up|4|||
131931305|NCT02633527|475034431|FG000|Overall Study|Withdrawal by Subject|0|||
131931306|NCT02633527|475034432|FG001|Overall Study|Withdrawal by Subject|3|||
131931307|NCT02633527|475034433|FG002|Overall Study|Withdrawal by Subject|5|||
131931308|NCT02633527|475034434|FG003|Overall Study|Withdrawal by Subject|4|||
131931309|NCT02633527|475034435|FG004|Overall Study|Withdrawal by Subject|4|||
131931310|NCT02633527|475034431|FG000|Overall Study|Protocol Violation|0|||
131931311|NCT02633527|475034432|FG001|Overall Study|Protocol Violation|1|||
131931312|NCT02633527|475034433|FG002|Overall Study|Protocol Violation|1|||
131931313|NCT02633527|475034434|FG003|Overall Study|Protocol Violation|1|||
131931314|NCT02633527|475034435|FG004|Overall Study|Protocol Violation|1|||
131931315|NCT02633527|475034431|FG000|Overall Study|Physician Decision|0|||
131931316|NCT02633527|475034432|FG001|Overall Study|Physician Decision|0|||
131931317|NCT02633527|475034433|FG002|Overall Study|Physician Decision|0|||
131931318|NCT02633527|475034434|FG003|Overall Study|Physician Decision|0|||
131931319|NCT02633527|475034435|FG004|Overall Study|Physician Decision|1|||
131931320|NCT02633527|475034431|FG000|Overall Study|Administrative reason|1|||
131931321|NCT02633527|475034432|FG001|Overall Study|Administrative reason|0|||
131931322|NCT02633527|475034433|FG002|Overall Study|Administrative reason|0|||
131931323|NCT02633527|475034434|FG003|Overall Study|Administrative reason|1|||
131931324|NCT02633527|475034435|FG004|Overall Study|Administrative reason|0|||
131931325|NCT02633527|475034431|FG000|Overall Study|Multiple reasons|1|||
131411334|NCT00343915|473128617|FG000|Primary Study|Lost to Follow-up|2|||
131411335|NCT00343915|473128618|FG001|Primary Study|Lost to Follow-up|3|||
131411336|NCT00343915|473128617|FG000|Primary Study|Other|1|||
131411337|NCT00343915|473128618|FG001|Primary Study|Other|0|||
131411338|NCT00882908|473128619|FG000|Overall Study|Adverse Event|0|||
131411339|NCT00882908|473128620|FG001|Overall Study|Adverse Event|0|||
131411340|NCT00882908|473128621|FG002|Overall Study|Adverse Event|1|||
131411341|NCT00882908|473128622|FG003|Overall Study|Adverse Event|0|||
131411342|NCT00882908|473128623|FG004|Overall Study|Adverse Event|1|||
131411343|NCT00882908|473128619|FG000|Overall Study|Lost to Follow-up|3|||
131411344|NCT00882908|473128620|FG001|Overall Study|Lost to Follow-up|5|||
131411345|NCT00882908|473128621|FG002|Overall Study|Lost to Follow-up|3|||
131411346|NCT00882908|473128622|FG003|Overall Study|Lost to Follow-up|1|||
131411347|NCT00882908|473128623|FG004|Overall Study|Lost to Follow-up|2|||
131411348|NCT00882908|473128619|FG000|Overall Study|Protocol Violation|0|||
131411349|NCT00882908|473128620|FG001|Overall Study|Protocol Violation|1|||
131411350|NCT00882908|473128621|FG002|Overall Study|Protocol Violation|0|||
131411351|NCT00882908|473128622|FG003|Overall Study|Protocol Violation|0|||
131931326|NCT02633527|475034432|FG001|Overall Study|Multiple reasons|0|||
131931327|NCT02633527|475034433|FG002|Overall Study|Multiple reasons|2|||
131931328|NCT02633527|475034434|FG003|Overall Study|Multiple reasons|2|||
131931329|NCT02633527|475034435|FG004|Overall Study|Multiple reasons|1|||
131931330|NCT01681849|475034437|FG000|Overall Study|Protocol Violation|2|||
131931331|NCT01681849|475034438|FG001|Overall Study|Protocol Violation|0|||
131931332|NCT01681849|475034439|FG002|Overall Study|Protocol Violation|0|||
131931333|NCT01681849|475034437|FG000|Overall Study|Withdrawal by Subject|3|||
131931334|NCT01681849|475034438|FG001|Overall Study|Withdrawal by Subject|5|||
131931335|NCT01681849|475034439|FG002|Overall Study|Withdrawal by Subject|33|||
131931336|NCT01681849|475034437|FG000|Overall Study|Lost to Follow-up|3|||
131931337|NCT01681849|475034438|FG001|Overall Study|Lost to Follow-up|2|||
131931338|NCT01681849|475034439|FG002|Overall Study|Lost to Follow-up|6|||
131931339|NCT02852005|475034442|FG000|Overall Study|Lost to Follow-up|0|||
131931340|NCT02852005|475034443|FG001|Overall Study|Lost to Follow-up|0|||
131931341|NCT02852005|475034444|FG002|Overall Study|Lost to Follow-up|0|||
131931342|NCT02852005|475034445|FG003|Overall Study|Lost to Follow-up|0|||
131931343|NCT02852005|475034446|FG004|Overall Study|Lost to Follow-up|1|||
131931344|NCT02852005|475034442|FG000|Overall Study|Withdrawal by Subject|1|||
131931345|NCT02852005|475034443|FG001|Overall Study|Withdrawal by Subject|0|||
131931346|NCT02852005|475034444|FG002|Overall Study|Withdrawal by Subject|0|||
131931347|NCT02852005|475034445|FG003|Overall Study|Withdrawal by Subject|0|||
131931348|NCT02852005|475034446|FG004|Overall Study|Withdrawal by Subject|0|||
131931349|NCT02420314|475034449|FG000|Overall Study|Withdrawal by Subject|1|||
131931350|NCT02420314|475034449|FG000|Overall Study|Protocol Violation|1|||
131931351|NCT03760068|475034451|FG000|Overall Study|Withdrawal by Subject|7|||
131931352|NCT03760068|475034452|FG001|Overall Study|Withdrawal by Subject|8|||
131931353|NCT03760068|475034451|FG000|Overall Study|Adverse Event|1|||
131931354|NCT03760068|475034452|FG001|Overall Study|Adverse Event|2|||
131931355|NCT03760068|475034451|FG000|Overall Study|Administrative Decision by Sponsor|0|||
131931356|NCT03760068|475034452|FG001|Overall Study|Administrative Decision by Sponsor|2|||
131931357|NCT03760068|475034451|FG000|Overall Study|Physician Decision|1|||
131931358|NCT03760068|475034452|FG001|Overall Study|Physician Decision|2|||
131931359|NCT03760068|475034451|FG000|Overall Study|Lost to Follow-up|4|||
131931360|NCT03760068|475034452|FG001|Overall Study|Lost to Follow-up|9|||
131931361|NCT03760068|475034451|FG000|Overall Study|Subject Moved Out of State|1|||
131931362|NCT03760068|475034452|FG001|Overall Study|Subject Moved Out of State|0|||
131931363|NCT02294019|475034455|FG000|Overall Study|Adverse Event|2|||
131931364|NCT02294019|475034455|FG000|Overall Study|Protocol Violation|68|||
131931365|NCT02294019|475034455|FG000|Overall Study|Lost to Follow-up|31|||
131931366|NCT02294019|475034455|FG000|Overall Study|Other|1|||
131931367|NCT02294019|475034455|FG000|Overall Study|Withdrawal by Subject|1|||
131931368|NCT02369159|475034457|FG000|Overall Study|Adverse Event|0|||
131931369|NCT02369159|475034458|FG001|Overall Study|Adverse Event|1|||
131931370|NCT02369159|475034457|FG000|Overall Study|Lost to Follow-up|1|||
131931371|NCT02369159|475034458|FG001|Overall Study|Lost to Follow-up|1|||
131931372|NCT02369159|475034457|FG000|Overall Study|Withdrawal by Subject|7|||
131931373|NCT02369159|475034458|FG001|Overall Study|Withdrawal by Subject|0|||
131411352|NCT00882908|473128623|FG004|Overall Study|Protocol Violation|0|||
131931374|NCT03460704|475034459|FG000|Overall Study|Withdrawal by Subject|11|||
131931375|NCT03460704|475034460|FG001|Overall Study|Withdrawal by Subject|14|||
131411353|NCT00882908|473128619|FG000|Overall Study|Withdrawal by Subject|0|||
131411354|NCT00882908|473128620|FG001|Overall Study|Withdrawal by Subject|0|||
131411355|NCT00882908|473128621|FG002|Overall Study|Withdrawal by Subject|3|||
131411356|NCT00882908|473128622|FG003|Overall Study|Withdrawal by Subject|5|||
131931376|NCT03460704|475034459|FG000|Overall Study|Study terminated by the Sponsor|29|||
131931377|NCT03460704|475034460|FG001|Overall Study|Study terminated by the Sponsor|19|||
131931378|NCT03460704|475034459|FG000|Overall Study|Adverse Event|10|||
131931379|NCT03460704|475034460|FG001|Overall Study|Adverse Event|5|||
131931380|NCT03460704|475034459|FG000|Overall Study|Death|3|||
131931381|NCT03460704|475034460|FG001|Overall Study|Death|2|||
131931382|NCT03460704|475034459|FG000|Overall Study|Non-Compliance with Study Drug|3|||
131931383|NCT03460704|475034460|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131931384|NCT03460704|475034459|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131931385|NCT03460704|475034460|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
131931386|NCT03460704|475034459|FG000|Overall Study|Other|2|||
131931387|NCT03460704|475034460|FG001|Overall Study|Other|1|||
131931388|NCT02913326|475034465|FG000|Overall Study|Reason not listed|0|||
131931389|NCT02913326|475034466|FG001|Overall Study|Reason not listed|1|||
131931390|NCT02913326|475034465|FG000|Overall Study|Lost to Follow-up|0|||
131931391|NCT02913326|475034466|FG001|Overall Study|Lost to Follow-up|1|||
131931392|NCT02913326|475034465|FG000|Overall Study|Adverse Event|1|||
131931393|NCT02913326|475034466|FG001|Overall Study|Adverse Event|0|||
131411357|NCT00882908|473128623|FG004|Overall Study|Withdrawal by Subject|2|||
131411358|NCT00882908|473128619|FG000|Overall Study|Subject reached a virologic endpoint|0|||
131411359|NCT00882908|473128620|FG001|Overall Study|Subject reached a virologic endpoint|0|||
131411360|NCT00882908|473128621|FG002|Overall Study|Subject reached a virologic endpoint|0|||
131411361|NCT00882908|473128622|FG003|Overall Study|Subject reached a virologic endpoint|0|||
131411362|NCT00882908|473128623|FG004|Overall Study|Subject reached a virologic endpoint|1|||
131411363|NCT00882908|473128619|FG000|Overall Study|Study terminated in error|0|||
131411364|NCT00882908|473128620|FG001|Overall Study|Study terminated in error|0|||
131411365|NCT00882908|473128621|FG002|Overall Study|Study terminated in error|0|||
131411366|NCT00882908|473128622|FG003|Overall Study|Study terminated in error|1|||
131411367|NCT00882908|473128623|FG004|Overall Study|Study terminated in error|0|||
131411368|NCT05291936|473128624|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
131411369|NCT05291936|473128625|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
131411370|NCT05291936|473128624|FG000|Period 1|Withdrew Consent during study|1|||
131411371|NCT05291936|473128625|FG001|Period 1|Withdrew Consent during study|0|||
131411372|NCT05291936|473128624|FG000|Period 2|Adverse Event|0|||
131411373|NCT05291936|473128625|FG001|Period 2|Adverse Event|1|||
131411374|NCT05291936|473128624|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
131411375|NCT05291936|473128625|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131411376|NCT02370095|473128626|FG000|Overall Study|Withdrawal by Subject|0|||
131411377|NCT02370095|473128627|FG001|Overall Study|Withdrawal by Subject|1|||
131411378|NCT00581828|473128628|FG000|Overall Study|Protocol Violation|1|||
131931394|NCT01767857|475034467|FG000|Overall Study|Adverse Event|27|||
131931395|NCT01767857|475034468|FG001|Overall Study|Adverse Event|7|||
131931396|NCT01767857|475034467|FG000|Overall Study|Death|28|||
131931397|NCT01767857|475034468|FG001|Overall Study|Death|13|||
131931398|NCT01767857|475034467|FG000|Overall Study|Lack of Efficacy|299|||
131931399|NCT01767857|475034468|FG001|Overall Study|Lack of Efficacy|151|||
131931400|NCT01767857|475034467|FG000|Overall Study|Lost to Follow-up|1|||
131931401|NCT01767857|475034468|FG001|Overall Study|Lost to Follow-up|1|||
131931402|NCT01767857|475034467|FG000|Overall Study|Withdrawal by Subject|38|||
131931403|NCT01767857|475034468|FG001|Overall Study|Withdrawal by Subject|18|||
131931404|NCT01767857|475034467|FG000|Overall Study|Physician Decision|17|||
131931405|NCT01767857|475034468|FG001|Overall Study|Physician Decision|10|||
131931406|NCT01767857|475034467|FG000|Overall Study|Protocol Terminated|1|||
131931407|NCT01767857|475034468|FG001|Overall Study|Protocol Terminated|0|||
131931408|NCT01767857|475034467|FG000|Overall Study|Randomized But Never Treated|19|||
131931409|NCT01767857|475034468|FG001|Overall Study|Randomized But Never Treated|13|||
131931410|NCT03769116|475034473|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
131931411|NCT03769116|475034474|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
131931412|NCT03769116|475034473|FG000|Part 3 - Open Label|Physician Decision|1|||
131931413|NCT03769116|475034474|FG001|Part 3 - Open Label|Physician Decision|0|||
131931414|NCT03769116|475034473|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
131931415|NCT03769116|475034474|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
131931416|NCT01390584|475034486|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
131931417|NCT01390584|475034487|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
131931418|NCT01390584|475034488|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
131931419|NCT00452400|475034489|FG000|Overall Study|Adverse Event|1|||
131931420|NCT00452400|475034490|FG001|Overall Study|Adverse Event|1|||
131931421|NCT00452400|475034491|FG002|Overall Study|Adverse Event|5|||
131931422|NCT00452400|475034492|FG003|Overall Study|Adverse Event|0|||
131931423|NCT00452400|475034493|FG004|Overall Study|Adverse Event|2|||
131931424|NCT00452400|475034489|FG000|Overall Study|Protocol Violation|0|||
131931425|NCT00452400|475034490|FG001|Overall Study|Protocol Violation|0|||
131931426|NCT00452400|475034491|FG002|Overall Study|Protocol Violation|1|||
131931427|NCT00452400|475034492|FG003|Overall Study|Protocol Violation|0|||
131931428|NCT00452400|475034493|FG004|Overall Study|Protocol Violation|0|||
131931429|NCT00452400|475034489|FG000|Overall Study|Lost to Follow-up|1|||
131931430|NCT00452400|475034490|FG001|Overall Study|Lost to Follow-up|0|||
131931431|NCT00452400|475034491|FG002|Overall Study|Lost to Follow-up|0|||
131931432|NCT00452400|475034492|FG003|Overall Study|Lost to Follow-up|0|||
131931433|NCT00452400|475034493|FG004|Overall Study|Lost to Follow-up|0|||
131931434|NCT00452400|475034489|FG000|Overall Study|Withdrawal by Subject|1|||
131931435|NCT00452400|475034490|FG001|Overall Study|Withdrawal by Subject|0|||
131411379|NCT01667562|473128629|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
131411380|NCT01667562|473128630|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
131411381|NCT01667562|473128629|FG000|Erlotinib Phase|Lost to Follow-up|0|||
131411382|NCT01667562|473128630|FG001|Erlotinib Phase|Lost to Follow-up|1|||
131411383|NCT01667562|473128629|FG000|Erlotinib Phase|Adverse Event|0|||
131411384|NCT01667562|473128630|FG001|Erlotinib Phase|Adverse Event|1|||
131411385|NCT01667562|473128629|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
131411386|NCT01667562|473128630|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
131411387|NCT02130986|473128634|FG000|Overall Study|Withdrawal by Subject|4|||
131454190|NCT02003924|473291905|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
131454191|NCT02003924|473291906|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
131454192|NCT02003924|473291907|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
131454193|NCT02003924|473291905|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
131454194|NCT02003924|473291906|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
131454195|NCT02003924|473291907|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
131454196|NCT02003924|473291905|FG000|Long-term Follow-up Phase|Other|5|||
131454197|NCT02003924|473291906|FG001|Long-term Follow-up Phase|Other|2|||
131454198|NCT02003924|473291907|FG002|Long-term Follow-up Phase|Other|1|||
131454199|NCT02930018|473291910|FG000|Overall Study|Lost to Follow-up|1|||
131454200|NCT02930018|473291911|FG001|Overall Study|Lost to Follow-up|1|||
131454201|NCT02930018|473291910|FG000|Overall Study|Withdrawal by Subject|5|||
131454202|NCT02930018|473291911|FG001|Overall Study|Withdrawal by Subject|2|||
131454203|NCT00560352|473291912|FG000|Overall Study|Adverse event unrelated to study drug|2|||
131454204|NCT00560352|473291913|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131454205|NCT00560352|473291914|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131454206|NCT00560352|473291912|FG000|Overall Study|Study drug toxicity|3|||
131454207|NCT00560352|473291913|FG001|Overall Study|Study drug toxicity|0|||
131454208|NCT00560352|473291914|FG002|Overall Study|Study drug toxicity|1|||
131454209|NCT00560352|473291912|FG000|Overall Study|Disease progression|0|||
131454210|NCT00560352|473291913|FG001|Overall Study|Disease progression|1|||
131454211|NCT00560352|473291914|FG002|Overall Study|Disease progression|1|||
131454212|NCT00560352|473291912|FG000|Overall Study|Withdrawal by Subject|1|||
131454213|NCT00560352|473291913|FG001|Overall Study|Withdrawal by Subject|1|||
131454214|NCT00560352|473291914|FG002|Overall Study|Withdrawal by Subject|1|||
131454215|NCT00560352|473291912|FG000|Overall Study|Maximum clinical benefit|1|||
131454216|NCT00560352|473291913|FG001|Overall Study|Maximum clinical benefit|0|||
131454217|NCT00560352|473291914|FG002|Overall Study|Maximum clinical benefit|0|||
131454218|NCT04434937|473291918|FG000|Overall Study|Death|4|||
131454219|NCT04434937|473291918|FG000|Overall Study|Withdrawal by Subject|1|||
131454220|NCT04434937|473291918|FG000|Overall Study|Transitioned to Rollover Study|19|||
131454221|NCT04434937|473291918|FG000|Overall Study|Progressive Disease|18|||
131454222|NCT04695977|473291923|FG000|Overall Study|Sponsor Decision|9|||
131454223|NCT04695977|473291924|FG001|Overall Study|Sponsor Decision|4|||
131454224|NCT04695977|473291923|FG000|Overall Study|Death|2|||
131454225|NCT04695977|473291924|FG001|Overall Study|Death|5|||
131454226|NCT02269267|473293240|FG000|Overall Study|Death|5|||
131454227|NCT00796419|473293241|FG000|Overall Study|Death|0|||
131454228|NCT00796419|473293242|FG001|Overall Study|Death|1|||
131454229|NCT01193257|473293246|FG000|Overall Study|Death|202|||
131454230|NCT01193257|473293247|FG001|Overall Study|Death|391|||
131454231|NCT01193257|473293246|FG000|Overall Study|Study termination by sponsor|0|||
131454232|NCT01193257|473293247|FG001|Overall Study|Study termination by sponsor|3|||
131454233|NCT01193257|473293246|FG000|Overall Study|Withdrawal by Subject|26|||
131454234|NCT01193257|473293247|FG001|Overall Study|Withdrawal by Subject|86|||
131454235|NCT01193257|473293246|FG000|Overall Study|Lost to Follow-up|2|||
131454236|NCT01193257|473293247|FG001|Overall Study|Lost to Follow-up|3|||
131454237|NCT01193257|473293246|FG000|Overall Study|Unblinded due to futility|135|||
131454238|NCT01193257|473293247|FG001|Overall Study|Unblinded due to futility|251|||
131454239|NCT01027273|473293250|FG000|Overall Study|Lost to Follow-up|57|||
131454240|NCT01027273|473293251|FG001|Overall Study|Lost to Follow-up|31|||
131454241|NCT01027273|473293250|FG000|Overall Study|Death|2|||
131454242|NCT01027273|473293251|FG001|Overall Study|Death|2|||
131454243|NCT03656562|473293253|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
131931436|NCT00452400|475034491|FG002|Overall Study|Withdrawal by Subject|1|||
131931437|NCT00452400|475034492|FG003|Overall Study|Withdrawal by Subject|0|||
131411388|NCT02130986|473128635|FG001|Overall Study|Withdrawal by Subject|4|||
131454244|NCT03656562|473293254|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
131454245|NCT03656562|473293255|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
131411389|NCT02130986|473128634|FG000|Overall Study|Lost to Follow-up|151|||
131454246|NCT03656562|473293256|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
131454247|NCT03656562|473293253|FG000|Overall Study|Physician Decision|1|||
131454248|NCT03656562|473293254|FG001|Overall Study|Physician Decision|2|||
131454249|NCT03656562|473293255|FG002|Overall Study|Physician Decision|0|||
131454250|NCT03656562|473293256|FG003|Overall Study|Physician Decision|0|||
131454251|NCT03656562|473293253|FG000|Overall Study|Subject Decision|3|||
131454252|NCT03656562|473293254|FG001|Overall Study|Subject Decision|5|||
131411390|NCT02130986|473128635|FG001|Overall Study|Lost to Follow-up|160|||
131411391|NCT01129882|473128636|FG000|Overall Study|Adverse Event|39|||
131411392|NCT01129882|473128636|FG000|Overall Study|Death|6|||
131411393|NCT01129882|473128636|FG000|Overall Study|Lack of Efficacy|5|||
131411394|NCT01129882|473128636|FG000|Overall Study|Lost to Follow-up|13|||
131411395|NCT01129882|473128636|FG000|Overall Study|Physician Decision|27|||
131411396|NCT01129882|473128636|FG000|Overall Study|Protocol Deviation|3|||
131411397|NCT01129882|473128636|FG000|Overall Study|Withdrawal Criteria Met|19|||
131411398|NCT01129882|473128636|FG000|Overall Study|Trial Termination by Sponsor|6|||
131411399|NCT01129882|473128636|FG000|Overall Study|Withdrawal by Subject|160|||
131411400|NCT05590000|473128637|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
131411401|NCT00762996|473128638|FG000|Period One|Protocol Violation|0|||
131411402|NCT00762996|473128639|FG001|Period One|Protocol Violation|0|||
131931438|NCT00452400|475034493|FG004|Overall Study|Withdrawal by Subject|0|||
131931439|NCT00452400|475034489|FG000|Overall Study|Lack of Efficacy|2|||
131931440|NCT00452400|475034490|FG001|Overall Study|Lack of Efficacy|0|||
131931441|NCT00452400|475034491|FG002|Overall Study|Lack of Efficacy|0|||
131931442|NCT00452400|475034492|FG003|Overall Study|Lack of Efficacy|0|||
131931443|NCT00452400|475034493|FG004|Overall Study|Lack of Efficacy|0|||
131931444|NCT00452400|475034489|FG000|Overall Study|Other reasons not listed above|0|||
131931445|NCT00452400|475034490|FG001|Overall Study|Other reasons not listed above|0|||
131931446|NCT00452400|475034491|FG002|Overall Study|Other reasons not listed above|0|||
131931447|NCT00452400|475034492|FG003|Overall Study|Other reasons not listed above|1|||
131931448|NCT00452400|475034493|FG004|Overall Study|Other reasons not listed above|1|||
131931449|NCT01720602|475034498|FG000|Overall Study|Adverse Event|3|||
131931450|NCT01720602|475034498|FG000|Overall Study|Progressive disease on therapy|2|||
131931451|NCT01943825|475034499|FG000|Overall Study|Lost to Follow-up|9|||
131931452|NCT01943825|475034500|FG001|Overall Study|Lost to Follow-up|3|||
131931453|NCT01943825|475034501|FG002|Overall Study|Lost to Follow-up|12|||
131931454|NCT01943825|475034502|FG003|Overall Study|Lost to Follow-up|8|||
131931455|NCT01943825|475034499|FG000|Overall Study|Withdrawal by Subject|1|||
131931456|NCT01943825|475034500|FG001|Overall Study|Withdrawal by Subject|0|||
131931457|NCT01943825|475034501|FG002|Overall Study|Withdrawal by Subject|3|||
131931458|NCT01943825|475034502|FG003|Overall Study|Withdrawal by Subject|2|||
131931459|NCT01943825|475034499|FG000|Overall Study|Other than specified above|0|||
131931460|NCT01943825|475034500|FG001|Overall Study|Other than specified above|1|||
131931461|NCT01943825|475034501|FG002|Overall Study|Other than specified above|0|||
131931462|NCT01943825|475034502|FG003|Overall Study|Other than specified above|1|||
131931463|NCT01835431|475034505|FG000|Overall Study|Adverse Event|1|||
131931464|NCT01835431|475034506|FG001|Overall Study|Adverse Event|0|||
131931465|NCT01835431|475034505|FG000|Overall Study|other|0|||
131931466|NCT01835431|475034506|FG001|Overall Study|other|2|||
131931467|NCT01835431|475034505|FG000|Overall Study|Withdrawal by Subject|6|||
131931468|NCT01835431|475034506|FG001|Overall Study|Withdrawal by Subject|10|||
131931469|NCT01835431|475034505|FG000|Overall Study|Protocol Violation|1|||
131931470|NCT01835431|475034506|FG001|Overall Study|Protocol Violation|0|||
131931471|NCT00562861|475034511|FG000|Overall Study|Adverse Event|1|||
131931472|NCT00562861|475034512|FG001|Overall Study|Adverse Event|1|||
131931473|NCT00562861|475034511|FG000|Overall Study|Lack of Efficacy|5|||
131931474|NCT00562861|475034512|FG001|Overall Study|Lack of Efficacy|5|||
131931475|NCT00562861|475034511|FG000|Overall Study|noncompliance, moved|7|||
131931476|NCT00562861|475034512|FG001|Overall Study|noncompliance, moved|2|||
131931477|NCT00562861|475034511|FG000|Overall Study|Lost to Follow-up|7|||
131931478|NCT00562861|475034512|FG001|Overall Study|Lost to Follow-up|3|||
131931479|NCT03927846|475034513|FG000|Overall Study|Lost to Follow-up|10|||
131931480|NCT03927846|475034514|FG001|Overall Study|Lost to Follow-up|11|||
131931481|NCT02113878|475036113|FG000|Overall Study|Adverse Event|1|||
131931482|NCT02113878|475036114|FG001|Overall Study|Adverse Event|0|||
131931483|NCT02113878|475036113|FG000|Overall Study|Withdrawal by Subject|1|||
131931484|NCT02113878|475036114|FG001|Overall Study|Withdrawal by Subject|0|||
131931485|NCT02113878|475036113|FG000|Overall Study|patient non-compliance|1|||
131931486|NCT02113878|475036114|FG001|Overall Study|patient non-compliance|0|||
131931487|NCT04744831|475036115|FG000|Overall Study|Progressive Disease|31|||
131931488|NCT04744831|475036116|FG001|Overall Study|Progressive Disease|27|||
131931489|NCT04744831|475036117|FG002|Overall Study|Progressive Disease|25|||
131931490|NCT04744831|475036115|FG000|Overall Study|Adverse Event|3|||
131411403|NCT00762996|473128640|FG002|Period One|Protocol Violation|1|||
131411404|NCT00762996|473128641|FG003|Period One|Protocol Violation|0|||
131931491|NCT04744831|475036116|FG001|Overall Study|Adverse Event|3|||
131931492|NCT04744831|475036117|FG002|Overall Study|Adverse Event|3|||
131931493|NCT04744831|475036115|FG000|Overall Study|Clinical Progression|3|||
131931494|NCT04744831|475036116|FG001|Overall Study|Clinical Progression|2|||
131931495|NCT04744831|475036117|FG002|Overall Study|Clinical Progression|5|||
131931496|NCT04744831|475036115|FG000|Overall Study|Other|0|||
131931497|NCT04744831|475036116|FG001|Overall Study|Other|2|||
131931498|NCT04744831|475036117|FG002|Overall Study|Other|1|||
131931499|NCT04744831|475036115|FG000|Overall Study|Death|0|||
131931500|NCT04744831|475036116|FG001|Overall Study|Death|2|||
131931501|NCT04744831|475036117|FG002|Overall Study|Death|1|||
131411405|NCT00762996|473128638|FG000|Period One|ineligible|0|||
131931502|NCT00530257|475036123|FG000|Overall Study|Lost to Follow-up|1|||
131931503|NCT00866775|475036126|FG000|Overall Study|Adverse Event|5|||
131931504|NCT00866775|475036127|FG001|Overall Study|Adverse Event|19|||
131931505|NCT00866775|475036126|FG000|Overall Study|Death|1|||
131931506|NCT00866775|475036127|FG001|Overall Study|Death|0|||
131931507|NCT00866775|475036126|FG000|Overall Study|Lost to Follow-up|0|||
131931508|NCT00866775|475036127|FG001|Overall Study|Lost to Follow-up|4|||
131931509|NCT00866775|475036126|FG000|Overall Study|Physician Decision|0|||
131931510|NCT00866775|475036127|FG001|Overall Study|Physician Decision|3|||
131931511|NCT00866775|475036126|FG000|Overall Study|Protocol Violation|3|||
131931512|NCT00866775|475036127|FG001|Overall Study|Protocol Violation|4|||
131931513|NCT00866775|475036126|FG000|Overall Study|Withdrawal by Subject|4|||
131931514|NCT00866775|475036127|FG001|Overall Study|Withdrawal by Subject|4|||
131931515|NCT00866775|475036126|FG000|Overall Study|met exit criteria|23|||
131931516|NCT00866775|475036127|FG001|Overall Study|met exit criteria|17|||
131931517|NCT00866775|475036126|FG000|Overall Study|discontinued due to communication error|0|||
131931518|NCT00866775|475036127|FG001|Overall Study|discontinued due to communication error|1|||
131931519|NCT00129974|475036128|FG000|Overall Study|Other|1|||
131931520|NCT00414609|475036129|FG000|Core Study|Adverse Event|9|||
131931521|NCT00414609|475036130|FG001|Core Study|Adverse Event|11|||
131931522|NCT00414609|475036131|FG002|Core Study|Adverse Event|0|||
131931523|NCT00414609|475036129|FG000|Core Study|Abnormal laboratory values|0|||
131931524|NCT00414609|475036130|FG001|Core Study|Abnormal laboratory values|1|||
131931525|NCT00414609|475036131|FG002|Core Study|Abnormal laboratory values|0|||
131931526|NCT00414609|475036129|FG000|Core Study|Abnormal test procedure results|1|||
131931527|NCT00414609|475036130|FG001|Core Study|Abnormal test procedure results|1|||
131931528|NCT00414609|475036131|FG002|Core Study|Abnormal test procedure results|0|||
131931529|NCT00414609|475036129|FG000|Core Study|Protocol deviation|0|||
131931530|NCT00414609|475036130|FG001|Core Study|Protocol deviation|1|||
131931531|NCT00414609|475036131|FG002|Core Study|Protocol deviation|0|||
131931532|NCT00414609|475036129|FG000|Core Study|Patient withdrew consent|10|||
131931533|NCT00414609|475036130|FG001|Core Study|Patient withdrew consent|11|||
131931534|NCT00414609|475036131|FG002|Core Study|Patient withdrew consent|0|||
131931535|NCT00414609|475036129|FG000|Core Study|Lost to Follow-up|7|||
131931536|NCT00414609|475036130|FG001|Core Study|Lost to Follow-up|4|||
131931537|NCT00414609|475036131|FG002|Core Study|Lost to Follow-up|0|||
131931538|NCT00414609|475036129|FG000|Core Study|Administrative problems|0|||
131931539|NCT00414609|475036130|FG001|Core Study|Administrative problems|2|||
131931540|NCT00414609|475036131|FG002|Core Study|Administrative problems|0|||
131931541|NCT00414609|475036129|FG000|Core Study|Death|7|||
131931542|NCT00414609|475036130|FG001|Core Study|Death|14|||
131931543|NCT00414609|475036131|FG002|Core Study|Death|0|||
131931544|NCT00414609|475036129|FG000|Extension Study|Adverse Event|0|||
131931545|NCT00414609|475036130|FG001|Extension Study|Adverse Event|0|||
131931546|NCT00414609|475036131|FG002|Extension Study|Adverse Event|14|||
131931547|NCT00414609|475036129|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
131931548|NCT00414609|475036130|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
131931549|NCT00414609|475036131|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
131931550|NCT00414609|475036129|FG000|Extension Study|Withdrawal by Subject|0|||
131931551|NCT00414609|475036130|FG001|Extension Study|Withdrawal by Subject|0|||
131931552|NCT00414609|475036131|FG002|Extension Study|Withdrawal by Subject|13|||
131931553|NCT00414609|475036129|FG000|Extension Study|Lost to Follow-up|0|||
131931554|NCT00414609|475036130|FG001|Extension Study|Lost to Follow-up|0|||
131931555|NCT00414609|475036131|FG002|Extension Study|Lost to Follow-up|10|||
131931556|NCT00414609|475036129|FG000|Extension Study|Administrative problems|0|||
131931557|NCT00414609|475036130|FG001|Extension Study|Administrative problems|0|||
131931558|NCT00414609|475036131|FG002|Extension Study|Administrative problems|1|||
131931559|NCT00414609|475036129|FG000|Extension Study|Death|0|||
131931560|NCT00414609|475036130|FG001|Extension Study|Death|0|||
131931561|NCT00414609|475036131|FG002|Extension Study|Death|17|||
131931562|NCT03766906|475036135|FG000|Overall Study|Withdrawal by Subject|6|||
131931563|NCT00836901|475036136|FG000|First Intervention|Withdrawal by Subject|1|||
131931564|NCT00836901|475036137|FG001|First Intervention|Withdrawal by Subject|0|||
131931565|NCT00830336|475036138|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
131931566|NCT00830336|475036139|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
131931567|NCT01853280|475036142|FG000|Overall Study|Lack of Efficacy|2|||
131931568|NCT01853280|475036143|FG001|Overall Study|Lack of Efficacy|2|||
131411406|NCT00762996|473128639|FG001|Period One|ineligible|0|||
131931569|NCT01853280|475036142|FG000|Overall Study|Lost to Follow-up|0|||
131931570|NCT01853280|475036143|FG001|Overall Study|Lost to Follow-up|1|||
131931571|NCT01853280|475036142|FG000|Overall Study|Physician Decision|0|||
131931572|NCT01853280|475036143|FG001|Overall Study|Physician Decision|1|||
131931573|NCT01853280|475036142|FG000|Overall Study|Withdrawal by Subject|0|||
131931574|NCT01853280|475036143|FG001|Overall Study|Withdrawal by Subject|1|||
131931575|NCT01853280|475036142|FG000|Overall Study|Ineligible|0|||
131931576|NCT01853280|475036143|FG001|Overall Study|Ineligible|1|||
131931577|NCT03032484|475036144|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
131931578|NCT03032484|475036145|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
131931579|NCT03032484|475036144|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
131931580|NCT03032484|475036145|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
131931581|NCT03268499|475036148|FG000|Overall Study|Withdrawal by Subject|2|||
131931582|NCT03268499|475036149|FG001|Overall Study|Withdrawal by Subject|1|||
131931583|NCT03760081|475036150|FG000|Overall Study|Miscellaneous|0|||
131931584|NCT03760081|475036151|FG001|Overall Study|Miscellaneous|1|||
131931585|NCT03760081|475036150|FG000|Overall Study|Progressive Disease|5|||
131931586|NCT03760081|475036151|FG001|Overall Study|Progressive Disease|10|||
131931587|NCT03760081|475036150|FG000|Overall Study|Death|1|||
131931588|NCT03760081|475036151|FG001|Overall Study|Death|1|||
131931589|NCT03533491|475036152|FG000|Overall Study|Lost to Follow-up|2|||
131931590|NCT01725282|475036157|FG000|Overall Study|Adverse Event|1|||
131931591|NCT01725282|475036158|FG001|Overall Study|Adverse Event|3|||
131931592|NCT01725282|475036159|FG002|Overall Study|Adverse Event|6|||
131931593|NCT01725282|475036160|FG003|Overall Study|Adverse Event|4|||
131931594|NCT01725282|475036157|FG000|Overall Study|Exacerbation of Target Disease|1|||
131931595|NCT01725282|475036158|FG001|Overall Study|Exacerbation of Target Disease|0|||
131931596|NCT01725282|475036159|FG002|Overall Study|Exacerbation of Target Disease|0|||
131931597|NCT01725282|475036160|FG003|Overall Study|Exacerbation of Target Disease|1|||
131931598|NCT01725282|475036157|FG000|Overall Study|Met Exclusion Criteria|0|||
131931599|NCT01725282|475036158|FG001|Overall Study|Met Exclusion Criteria|0|||
131931600|NCT01725282|475036159|FG002|Overall Study|Met Exclusion Criteria|1|||
131931601|NCT01725282|475036160|FG003|Overall Study|Met Exclusion Criteria|0|||
131931602|NCT01725282|475036157|FG000|Overall Study|Study Site Withdrawal|0|||
131931603|NCT01725282|475036158|FG001|Overall Study|Study Site Withdrawal|1|||
131931604|NCT01725282|475036159|FG002|Overall Study|Study Site Withdrawal|0|||
131931605|NCT01725282|475036160|FG003|Overall Study|Study Site Withdrawal|0|||
131931606|NCT01725282|475036157|FG000|Overall Study|Withdrawal by Subject|0|||
131931607|NCT01725282|475036158|FG001|Overall Study|Withdrawal by Subject|0|||
131931608|NCT01725282|475036159|FG002|Overall Study|Withdrawal by Subject|1|||
131931609|NCT01725282|475036160|FG003|Overall Study|Withdrawal by Subject|1|||
131931610|NCT01725282|475036157|FG000|Overall Study|Lack of Efficacy|0|||
131931611|NCT01725282|475036158|FG001|Overall Study|Lack of Efficacy|1|||
131931612|NCT01725282|475036159|FG002|Overall Study|Lack of Efficacy|0|||
131931613|NCT01725282|475036160|FG003|Overall Study|Lack of Efficacy|1|||
131931614|NCT04064567|475036161|FG000|Overall Study|Lost to Follow-up|23|||
131931615|NCT04064567|475036162|FG001|Overall Study|Lost to Follow-up|22|||
131931616|NCT04064567|475036161|FG000|Overall Study|Withdrawal by Subject|0|||
131931617|NCT04064567|475036162|FG001|Overall Study|Withdrawal by Subject|1|||
131931618|NCT04064567|475036161|FG000|Overall Study|Reincarcerated|7|||
131931619|NCT04064567|475036162|FG001|Overall Study|Reincarcerated|10|||
131931620|NCT04064567|475036161|FG000|Overall Study|Moved out of U.S.|0|||
131931621|NCT04064567|475036162|FG001|Overall Study|Moved out of U.S.|1|||
131931622|NCT04576481|475036164|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
131931623|NCT04576481|475036165|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
131931624|NCT04576481|475036166|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
131931625|NCT04576481|475036167|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
131931626|NCT02758626|475036173|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
131931627|NCT02758626|475036174|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
131931628|NCT02758626|475036173|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
131931629|NCT02758626|475036174|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
131931630|NCT02758626|475036173|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
131931631|NCT02758626|475036174|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
131931632|NCT02758626|475036173|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
131931633|NCT02758626|475036174|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
131931634|NCT05261490|475036176|FG000|Overall Study|Other|1|||
131931635|NCT05261490|475036177|FG001|Overall Study|Other|0|||
131931636|NCT05261490|475036178|FG002|Overall Study|Other|0|||
131931637|NCT05261490|475036176|FG000|Overall Study|Study Terminated by Sponsor|1|||
131931638|NCT05261490|475036177|FG001|Overall Study|Study Terminated by Sponsor|1|||
131931639|NCT05261490|475036178|FG002|Overall Study|Study Terminated by Sponsor|4|||
131931640|NCT05261490|475036176|FG000|Overall Study|Death|1|||
131931641|NCT05261490|475036177|FG001|Overall Study|Death|2|||
131931642|NCT05261490|475036178|FG002|Overall Study|Death|0|||
131931643|NCT01682720|475036187|FG000|Overall Study|Randomized but Not Treated|0|||
131931644|NCT01682720|475036188|FG001|Overall Study|Randomized but Not Treated|1|||
131931645|NCT01682720|475036189|FG002|Overall Study|Randomized but Not Treated|1|||
131931646|NCT01682720|475036190|FG003|Overall Study|Randomized but Not Treated|0|||
131931647|NCT01682720|475036187|FG000|Overall Study|Terminated by Sponsor|83|||
131931648|NCT01682720|475036188|FG001|Overall Study|Terminated by Sponsor|0|||
131931649|NCT01682720|475036189|FG002|Overall Study|Terminated by Sponsor|0|||
131931650|NCT01682720|475036190|FG003|Overall Study|Terminated by Sponsor|0|||
131931651|NCT01682720|475036187|FG000|Overall Study|Efficacy Failure|0|||
131931652|NCT01682720|475036188|FG001|Overall Study|Efficacy Failure|3|||
131931653|NCT01682720|475036189|FG002|Overall Study|Efficacy Failure|3|||
131931654|NCT01682720|475036190|FG003|Overall Study|Efficacy Failure|30|||
131931655|NCT01682720|475036187|FG000|Overall Study|Lost to Follow-up|1|||
131931656|NCT01682720|475036188|FG001|Overall Study|Lost to Follow-up|1|||
131931657|NCT01682720|475036189|FG002|Overall Study|Lost to Follow-up|0|||
131931658|NCT01682720|475036190|FG003|Overall Study|Lost to Follow-up|6|||
131931659|NCT01682720|475036187|FG000|Overall Study|Subject Withdrew Consent|0|||
131931660|NCT01682720|475036188|FG001|Overall Study|Subject Withdrew Consent|0|||
131931661|NCT01682720|475036189|FG002|Overall Study|Subject Withdrew Consent|2|||
131931662|NCT01682720|475036190|FG003|Overall Study|Subject Withdrew Consent|2|||
131931663|NCT01682720|475036187|FG000|Overall Study|Adverse Event|1|||
131931664|NCT01682720|475036188|FG001|Overall Study|Adverse Event|0|||
131931665|NCT01682720|475036189|FG002|Overall Study|Adverse Event|1|||
131931666|NCT01682720|475036190|FG003|Overall Study|Adverse Event|1|||
131931667|NCT01646216|475036196|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
131931668|NCT01646216|475036197|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
131931669|NCT01646216|475036196|FG000|Overall Study|Did not complete training|0|||
131931670|NCT01646216|475036197|FG001|Overall Study|Did not complete training|2|||
131931671|NCT01646216|475036196|FG000|Overall Study|Investigator decision|1|||
131931672|NCT01646216|475036197|FG001|Overall Study|Investigator decision|1|||
131931673|NCT02395627|475036198|FG000|Overall Study|Withdrawal by Subject|0|||
131931674|NCT02395627|475036199|FG001|Overall Study|Withdrawal by Subject|2|||
131931675|NCT02395627|475036200|FG002|Overall Study|Withdrawal by Subject|0|||
131931676|NCT02395627|475036198|FG000|Overall Study|Did not receive pembrolizumab|3|||
131931677|NCT02395627|475036199|FG001|Overall Study|Did not receive pembrolizumab|1|||
131931678|NCT02395627|475036200|FG002|Overall Study|Did not receive pembrolizumab|0|||
131931679|NCT01335685|475036204|FG000|Overall Study|Study Terminated by Sponsor|2|||
131931680|NCT01335685|475036205|FG001|Overall Study|Study Terminated by Sponsor|1|||
131931681|NCT01335685|475036206|FG002|Overall Study|Study Terminated by Sponsor|1|||
131931682|NCT01335685|475036207|FG003|Overall Study|Study Terminated by Sponsor|10|||
131931683|NCT01335685|475036208|FG004|Overall Study|Study Terminated by Sponsor|0|||
131931684|NCT01335685|475036209|FG005|Overall Study|Study Terminated by Sponsor|4|||
131931685|NCT01335685|475036210|FG006|Overall Study|Study Terminated by Sponsor|2|||
131931686|NCT01335685|475036211|FG007|Overall Study|Study Terminated by Sponsor|3|||
131931687|NCT01335685|475036204|FG000|Overall Study|Withdrawal by Subject|1|||
131931688|NCT01335685|475036205|FG001|Overall Study|Withdrawal by Subject|0|||
131931689|NCT01335685|475036206|FG002|Overall Study|Withdrawal by Subject|0|||
131931690|NCT01335685|475036207|FG003|Overall Study|Withdrawal by Subject|1|||
131931691|NCT01335685|475036208|FG004|Overall Study|Withdrawal by Subject|0|||
131931692|NCT01335685|475036209|FG005|Overall Study|Withdrawal by Subject|0|||
131931693|NCT01335685|475036210|FG006|Overall Study|Withdrawal by Subject|0|||
131931694|NCT01335685|475036211|FG007|Overall Study|Withdrawal by Subject|0|||
131931695|NCT01335685|475036204|FG000|Overall Study|Reason not Specified|0|||
131931696|NCT01335685|475036205|FG001|Overall Study|Reason not Specified|0|||
131931697|NCT01335685|475036206|FG002|Overall Study|Reason not Specified|1|||
131931698|NCT01335685|475036207|FG003|Overall Study|Reason not Specified|0|||
131931699|NCT01335685|475036208|FG004|Overall Study|Reason not Specified|0|||
131931700|NCT01335685|475036209|FG005|Overall Study|Reason not Specified|1|||
131931701|NCT01335685|475036210|FG006|Overall Study|Reason not Specified|0|||
131931702|NCT01335685|475036211|FG007|Overall Study|Reason not Specified|0|||
131931703|NCT03777020|475036216|FG000|Overall Study|Withdrawal by Subject|4|||
131931704|NCT03777020|475036217|FG001|Overall Study|Withdrawal by Subject|4|||
131931705|NCT03777020|475036216|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
131931706|NCT03777020|475036217|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
131931707|NCT00489476|475036218|FG000|Overall Study|Lost to Follow-up|0|||
131931708|NCT00489476|475036219|FG001|Overall Study|Lost to Follow-up|1|||
131931709|NCT00489476|475036220|FG002|Overall Study|Lost to Follow-up|0|||
131931710|NCT00489476|475036221|FG003|Overall Study|Lost to Follow-up|0|||
131931711|NCT00803049|475036222|FG000|Overall Study|Adverse Event|21|||
131931712|NCT00803049|475036223|FG001|Overall Study|Adverse Event|33|||
131931713|NCT00803049|475036224|FG002|Overall Study|Adverse Event|13|||
131931714|NCT00803049|475036225|FG003|Overall Study|Adverse Event|27|||
131931715|NCT00803049|475036222|FG000|Overall Study|Lack of Efficacy|10|||
131931716|NCT00803049|475036223|FG001|Overall Study|Lack of Efficacy|19|||
131931717|NCT00803049|475036224|FG002|Overall Study|Lack of Efficacy|6|||
131931718|NCT00803049|475036225|FG003|Overall Study|Lack of Efficacy|13|||
131931719|NCT00803049|475036222|FG000|Overall Study|Lost to Follow-up|0|||
131931720|NCT00803049|475036223|FG001|Overall Study|Lost to Follow-up|2|||
131931721|NCT00803049|475036224|FG002|Overall Study|Lost to Follow-up|0|||
131931722|NCT00803049|475036225|FG003|Overall Study|Lost to Follow-up|3|||
131931723|NCT00803049|475036222|FG000|Overall Study|Death|2|||
131931724|NCT00803049|475036223|FG001|Overall Study|Death|1|||
131931725|NCT00803049|475036224|FG002|Overall Study|Death|0|||
131931726|NCT00803049|475036225|FG003|Overall Study|Death|2|||
131931727|NCT00803049|475036222|FG000|Overall Study|Progressive Disease|6|||
131931728|NCT00803049|475036223|FG001|Overall Study|Progressive Disease|10|||
131931729|NCT00803049|475036224|FG002|Overall Study|Progressive Disease|6|||
131931730|NCT00803049|475036225|FG003|Overall Study|Progressive Disease|6|||
131411407|NCT00762996|473128640|FG002|Period One|ineligible|1|||
131411408|NCT00762996|473128641|FG003|Period One|ineligible|1|||
131411409|NCT00762996|473128638|FG000|Period One|Adverse Event|0|||
131411410|NCT00762996|473128639|FG001|Period One|Adverse Event|0|||
131931731|NCT00803049|475036222|FG000|Overall Study|Withdrawal by Subject|19|||
131931732|NCT00803049|475036223|FG001|Overall Study|Withdrawal by Subject|43|||
131931733|NCT00803049|475036224|FG002|Overall Study|Withdrawal by Subject|16|||
131931734|NCT00803049|475036225|FG003|Overall Study|Withdrawal by Subject|44|||
131931735|NCT00803049|475036222|FG000|Overall Study|Protocol Violation|0|||
131931736|NCT00803049|475036223|FG001|Overall Study|Protocol Violation|1|||
131931737|NCT00803049|475036224|FG002|Overall Study|Protocol Violation|1|||
131931738|NCT00803049|475036225|FG003|Overall Study|Protocol Violation|0|||
131931739|NCT00803049|475036222|FG000|Overall Study|Randomized and Not Treated|0|||
131931740|NCT00803049|475036223|FG001|Overall Study|Randomized and Not Treated|0|||
131931741|NCT00803049|475036224|FG002|Overall Study|Randomized and Not Treated|0|||
131931742|NCT00803049|475036225|FG003|Overall Study|Randomized and Not Treated|2|||
131931743|NCT00803049|475036222|FG000|Overall Study|Other than Specified Above|3|||
131931744|NCT00803049|475036223|FG001|Overall Study|Other than Specified Above|9|||
131931745|NCT00803049|475036224|FG002|Overall Study|Other than Specified Above|2|||
131931746|NCT00803049|475036225|FG003|Overall Study|Other than Specified Above|5|||
131931747|NCT01421459|475036226|FG000|Overall Study|Adverse Event|6|||
131931748|NCT01421459|475036227|FG001|Overall Study|Adverse Event|10|||
131931749|NCT01421459|475036226|FG000|Overall Study|Death|1|||
131931750|NCT01421459|475036227|FG001|Overall Study|Death|1|||
131931751|NCT01421459|475036226|FG000|Overall Study|Lack of Efficacy|1|||
131931752|NCT01421459|475036227|FG001|Overall Study|Lack of Efficacy|2|||
131931753|NCT01421459|475036226|FG000|Overall Study|Lost to Follow-up|8|||
131931754|NCT01421459|475036227|FG001|Overall Study|Lost to Follow-up|9|||
131931755|NCT01421459|475036226|FG000|Overall Study|Physician Decision|9|||
131931756|NCT01421459|475036227|FG001|Overall Study|Physician Decision|9|||
131931757|NCT01421459|475036226|FG000|Overall Study|Protocol Violation|8|||
131931758|NCT01421459|475036227|FG001|Overall Study|Protocol Violation|5|||
131931759|NCT01421459|475036226|FG000|Overall Study|Withdrawal by Subject|12|||
131931760|NCT01421459|475036227|FG001|Overall Study|Withdrawal by Subject|16|||
131931761|NCT04126174|475036228|FG000|Overall Study|Lost to Follow-up|3|||
131931762|NCT04126174|475036229|FG001|Overall Study|Lost to Follow-up|3|||
131931763|NCT01514422|475036230|FG000|Overall Study|Lost to Follow-up|1|||
131931764|NCT04439903|475036243|FG000|Overall Study|Withdrawal by Subject|2|||
131931765|NCT04439903|475036243|FG000|Overall Study|Screen Failure|1|||
131931766|NCT02899754|475036244|FG000|Overall Study|Lost to Follow-up|7|||
131931767|NCT02899754|475036245|FG001|Overall Study|Lost to Follow-up|9|||
131931768|NCT04003142|475036246|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
131931769|NCT04003142|475036247|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
131931770|NCT04003142|475036248|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
131931771|NCT04003142|475036249|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
131931772|NCT04003142|475036250|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
131931773|NCT04003142|475036246|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
131931774|NCT04003142|475036247|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
131931775|NCT04003142|475036248|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
131931776|NCT04003142|475036249|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
131931777|NCT04003142|475036250|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
131931778|NCT04003142|475036246|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
131931779|NCT04003142|475036247|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
131931780|NCT04003142|475036248|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
131931781|NCT04003142|475036249|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
131931782|NCT04003142|475036250|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
131931783|NCT04003142|475036246|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
131931784|NCT04003142|475036247|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
131931785|NCT04003142|475036248|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
131931786|NCT04003142|475036249|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
131931787|NCT04003142|475036250|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
131931788|NCT04003142|475036246|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
131931789|NCT04003142|475036247|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
131931790|NCT04003142|475036248|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
131931791|NCT04003142|475036249|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
131931792|NCT04003142|475036250|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
131931793|NCT04003142|475036246|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
131931794|NCT04003142|475036247|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
131931795|NCT04003142|475036248|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
131931796|NCT04003142|475036249|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
131411411|NCT00762996|473128640|FG002|Period One|Adverse Event|1|||
131411412|NCT00762996|473128641|FG003|Period One|Adverse Event|0|||
131931797|NCT04003142|475036250|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
131931798|NCT04003142|475036246|FG000|Extension Period (40 Weeks)|Death|0|||
131931799|NCT04003142|475036247|FG001|Extension Period (40 Weeks)|Death|0|||
131931800|NCT04003142|475036248|FG002|Extension Period (40 Weeks)|Death|0|||
131931801|NCT04003142|475036249|FG003|Extension Period (40 Weeks)|Death|0|||
131931802|NCT04003142|475036250|FG004|Extension Period (40 Weeks)|Death|1|||
131931803|NCT04003142|475036246|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
131931804|NCT04003142|475036247|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
131931805|NCT04003142|475036248|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
131931806|NCT04003142|475036249|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
131931807|NCT04003142|475036250|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
131931808|NCT04003142|475036246|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
131931809|NCT04003142|475036247|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
131931810|NCT04003142|475036248|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
131931811|NCT04003142|475036249|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
131931812|NCT04003142|475036250|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
131931813|NCT04003142|475036246|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
131931814|NCT04003142|475036247|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
131931815|NCT04003142|475036248|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
131931816|NCT04003142|475036249|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
131931817|NCT04003142|475036250|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
131931818|NCT04003142|475036246|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
131931819|NCT04003142|475036247|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
131931820|NCT04003142|475036248|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
131931821|NCT04003142|475036249|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
131931822|NCT04003142|475036250|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
131931823|NCT04042311|475036251|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
131931824|NCT04042311|475036251|FG000|Overall Study|Unable to tolerate|4|||
131931825|NCT04042311|475036251|FG000|Overall Study|Concurrent illness|2|||
131931826|NCT04042311|475036251|FG000|Overall Study|Adverse Event|2|||
131931827|NCT04042311|475036251|FG000|Overall Study|No longer meeting inclusion criteria|2|||
131931828|NCT04042311|475036251|FG000|Overall Study|No reason given|1|||
131931829|NCT04042311|475036251|FG000|Overall Study|Withdrawal by Subject|4|||
131931830|NCT03382873|475036252|FG000|Overall Study|Lost to Follow-up|9|||
131931831|NCT03382873|475036253|FG001|Overall Study|Lost to Follow-up|10|||
131931832|NCT03382873|475036252|FG000|Overall Study|Withdrawal by Subject|6|||
131931833|NCT03382873|475036253|FG001|Overall Study|Withdrawal by Subject|11|||
131931834|NCT03382873|475036252|FG000|Overall Study|Visit not completed due to pandemic|16|||
131931835|NCT03382873|475036253|FG001|Overall Study|Visit not completed due to pandemic|41|||
131931836|NCT02971137|475036258|FG000|Overall Study|Lost to Follow-up|44|||
131931837|NCT02971137|475036259|FG001|Overall Study|Lost to Follow-up|56|||
131931838|NCT02757963|475036260|FG000|Overall Study|Adverse Event|3|||
131931839|NCT02757963|475036260|FG000|Overall Study|Reached Stopping Criteria|1054|||
131931840|NCT02757963|475036260|FG000|Overall Study|Lost to Follow-up|5|||
131931841|NCT02757963|475036260|FG000|Overall Study|Physician Decision|1|||
131931842|NCT02757963|475036260|FG000|Overall Study|Withdrawal by Subject|34|||
131931843|NCT04755231|475036261|FG000|Overall Study|Lost to Follow-up|5|||
131931844|NCT04755231|475036261|FG000|Overall Study|Withdrawal by Subject|5|||
131931845|NCT00911157|475036262|FG000|Overall Study|Adverse Event|4|||
131931846|NCT00911157|475036263|FG001|Overall Study|Adverse Event|1|||
131931847|NCT00911157|475036262|FG000|Overall Study|Withdrawal by Subject|1|||
131931848|NCT00911157|475036263|FG001|Overall Study|Withdrawal by Subject|1|||
131931849|NCT00911157|475036262|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
131931850|NCT00911157|475036263|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
131931851|NCT00911157|475036262|FG000|Overall Study|Need to treat for lung cancer|1|||
131931852|NCT00911157|475036263|FG001|Overall Study|Need to treat for lung cancer|0|||
131931853|NCT01044459|475036267|FG000|Overall Study|Withdrawal by Subject|21|||
131931854|NCT01044459|475036268|FG001|Overall Study|Withdrawal by Subject|28|||
131931855|NCT01044459|475036267|FG000|Overall Study|Terminated by Sponsor|22|||
131931856|NCT01044459|475036268|FG001|Overall Study|Terminated by Sponsor|21|||
131931857|NCT01044459|475036267|FG000|Overall Study|Adverse Event|22|||
131931858|NCT01044459|475036268|FG001|Overall Study|Adverse Event|20|||
131931859|NCT01044459|475036267|FG000|Overall Study|Lack of Efficacy|23|||
131931860|NCT01044459|475036268|FG001|Overall Study|Lack of Efficacy|12|||
131931861|NCT01044459|475036267|FG000|Overall Study|Protocol Violation|11|||
131931862|NCT01044459|475036268|FG001|Overall Study|Protocol Violation|16|||
131931863|NCT01044459|475036267|FG000|Overall Study|Other Reason|7|||
131931864|NCT01044459|475036268|FG001|Overall Study|Other Reason|14|||
131931865|NCT01044459|475036267|FG000|Overall Study|COPD exacerbation|9|||
131931866|NCT01044459|475036268|FG001|Overall Study|COPD exacerbation|8|||
131931867|NCT01044459|475036267|FG000|Overall Study|Lost to Follow-up|18|||
131931868|NCT01044459|475036268|FG001|Overall Study|Lost to Follow-up|12|||
131931869|NCT04105725|475036269|FG000|Primary Intervention|Lost to Follow-up|0|||
131931870|NCT04105725|475036270|FG001|Primary Intervention|Lost to Follow-up|2|||
131931871|NCT04105725|475036269|FG000|Primary Intervention|Withdrawal by Subject|0|||
131931872|NCT04105725|475036270|FG001|Primary Intervention|Withdrawal by Subject|1|||
131931873|NCT05346640|475036271|FG000|Overall Study|Lack of Efficacy|2|||
131931874|NCT05346640|475036271|FG000|Overall Study|Lost to Follow-up|14|||
131931875|NCT05346640|475036271|FG000|Overall Study|Protocol Violation|4|||
131931876|NCT05346640|475036271|FG000|Overall Study|Withdrawal by Subject|2|||
131931877|NCT05346640|475036271|FG000|Overall Study|Physiological Complications|3|||
131931878|NCT05346640|475036271|FG000|Overall Study|Other Reason|3|||
131931879|NCT00480025|475036272|FG000|Overall Study|Protocol Violation|12|||
131931880|NCT00480025|475036273|FG001|Overall Study|Protocol Violation|7|||
131931881|NCT00480025|475036272|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
131931882|NCT00480025|475036273|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
131931883|NCT00480025|475036272|FG000|Overall Study|Disease Progression / Recurrence|449|||
131931884|NCT00480025|475036273|FG001|Overall Study|Disease Progression / Recurrence|224|||
131931885|NCT00480025|475036272|FG000|Overall Study|Adverse Event|44|||
131931886|NCT00480025|475036273|FG001|Overall Study|Adverse Event|12|||
131931887|NCT00480025|475036272|FG000|Overall Study|Other|70|||
131931888|NCT00480025|475036273|FG001|Overall Study|Other|29|||
131931889|NCT00480025|475036272|FG000|Overall Study|SAE including intercurrent illness|76|||
131931890|NCT00480025|475036273|FG001|Overall Study|SAE including intercurrent illness|42|||
131931891|NCT04634331|475036278|FG000|Overall Study|Withdrawal by Subject|2|||
131931892|NCT04634331|475036279|FG001|Overall Study|Withdrawal by Subject|2|||
131931893|NCT03726879|475036280|FG000|Overall Study|Death|11|||
131931894|NCT03726879|475036281|FG001|Overall Study|Death|13|||
131931895|NCT03726879|475036280|FG000|Overall Study|Physician Decision|0|||
131931896|NCT03726879|475036281|FG001|Overall Study|Physician Decision|2|||
131931897|NCT03726879|475036280|FG000|Overall Study|Protocol Violation|0|||
131931898|NCT03726879|475036281|FG001|Overall Study|Protocol Violation|1|||
131931899|NCT03726879|475036280|FG000|Overall Study|Withdrawal by Subject|5|||
131931900|NCT03726879|475036281|FG001|Overall Study|Withdrawal by Subject|6|||
131931901|NCT03726879|475036280|FG000|Overall Study|TSH result is unstable|0|||
131931902|NCT03726879|475036281|FG001|Overall Study|TSH result is unstable|1|||
131931903|NCT03726879|475036280|FG000|Overall Study|Disease relapse|1|||
131931904|NCT03726879|475036281|FG001|Overall Study|Disease relapse|0|||
131931905|NCT03726879|475036280|FG000|Overall Study|Lost to Follow-up|3|||
131931906|NCT03726879|475036281|FG001|Overall Study|Lost to Follow-up|0|||
131931907|NCT02766478|475036282|FG000|Overall Study|Withdrawal by Subject|1|||
131931908|NCT02766478|475036283|FG001|Overall Study|Withdrawal by Subject|1|||
131931909|NCT01093573|475036284|FG000|Overall Study|Physician Decision|0|||
131931910|NCT01093573|475036285|FG001|Overall Study|Physician Decision|0|||
131931911|NCT01093573|475036286|FG002|Overall Study|Physician Decision|1|||
131931912|NCT01093573|475036284|FG000|Overall Study|Insurance Denied|0|||
131931913|NCT01093573|475036285|FG001|Overall Study|Insurance Denied|0|||
131931914|NCT01093573|475036286|FG002|Overall Study|Insurance Denied|1|||
131931915|NCT05626686|475036287|FG000|Overall Study|Protocol Violation|3|||
131931916|NCT05626686|475036287|FG000|Overall Study|Withdrawal by Subject|3|||
131931917|NCT00581100|475038023|FG000|Overall Study|Death|1|||
131931918|NCT00581100|475038024|FG001|Overall Study|Death|0|||
131931919|NCT00581100|475038023|FG000|Overall Study|Adverse Event|2|||
131931920|NCT00581100|475038024|FG001|Overall Study|Adverse Event|1|||
131931921|NCT00581100|475038023|FG000|Overall Study|Withdrawal by Subject|1|||
131931922|NCT00581100|475038024|FG001|Overall Study|Withdrawal by Subject|4|||
131931923|NCT00581100|475038023|FG000|Overall Study|Other|3|||
131931924|NCT00581100|475038024|FG001|Overall Study|Other|0|||
131931925|NCT00590317|475038025|FG000|Overall Study|Lack of Efficacy|1|||
131931926|NCT00590317|475038026|FG001|Overall Study|Lack of Efficacy|5|||
131931927|NCT03837509|475038027|FG000|Phase 1|Death|5|||
131931928|NCT03837509|475038028|FG001|Phase 1|Death|2|||
131931929|NCT03837509|475038029|FG002|Phase 1|Death|0|||
131931930|NCT03837509|475038030|FG003|Phase 1|Death|0|||
131931931|NCT03837509|475038031|FG004|Phase 1|Death|0|||
131931932|NCT03837509|475038027|FG000|Phase 2|Death|0|||
131931933|NCT03837509|475038028|FG001|Phase 2|Death|0|||
131931934|NCT03837509|475038029|FG002|Phase 2|Death|0|||
131931935|NCT03837509|475038030|FG003|Phase 2|Death|1|||
131931936|NCT03837509|475038031|FG004|Phase 2|Death|1|||
131931937|NCT01251965|475038032|FG000|Overall Study|Participant/physician decision|1|||
131931938|NCT01251965|475038033|FG001|Overall Study|Participant/physician decision|2|||
131931939|NCT01251965|475038034|FG002|Overall Study|Participant/physician decision|0|||
131931940|NCT01251965|475038032|FG000|Overall Study|Death|0|||
131931941|NCT01251965|475038033|FG001|Overall Study|Death|0|||
131931942|NCT01251965|475038034|FG002|Overall Study|Death|11|||
131931943|NCT04616196|475038035|FG000|Overall Study|Progressive Disease|3|||
131931944|NCT04616196|475038036|FG001|Overall Study|Progressive Disease|0|||
131411413|NCT00762996|473128638|FG000|Period One|Withdrawal by Subject|0|||
131931945|NCT04616196|475038037|FG002|Overall Study|Progressive Disease|4|||
131931946|NCT04616196|475038038|FG003|Overall Study|Progressive Disease|1|||
131931947|NCT04616196|475038035|FG000|Overall Study|Death|2|||
131931948|NCT04616196|475038036|FG001|Overall Study|Death|4|||
131931949|NCT04616196|475038037|FG002|Overall Study|Death|1|||
131931950|NCT04616196|475038038|FG003|Overall Study|Death|0|||
131931951|NCT04616196|475038035|FG000|Overall Study|Withdrawal by Subject|0|||
131931952|NCT04616196|475038036|FG001|Overall Study|Withdrawal by Subject|2|||
131931953|NCT04616196|475038037|FG002|Overall Study|Withdrawal by Subject|0|||
131931954|NCT04616196|475038038|FG003|Overall Study|Withdrawal by Subject|0|||
131931955|NCT04616196|475038035|FG000|Overall Study|Lost to Follow-up|1|||
131931956|NCT04616196|475038036|FG001|Overall Study|Lost to Follow-up|0|||
131931957|NCT04616196|475038037|FG002|Overall Study|Lost to Follow-up|0|||
131931958|NCT04616196|475038038|FG003|Overall Study|Lost to Follow-up|0|||
131931959|NCT04616196|475038035|FG000|Overall Study|Sponsor request|2|||
131931960|NCT04616196|475038036|FG001|Overall Study|Sponsor request|1|||
131931961|NCT04616196|475038037|FG002|Overall Study|Sponsor request|1|||
131931962|NCT04616196|475038038|FG003|Overall Study|Sponsor request|2|||
131931963|NCT05401409|475038039|FG000|Overall Study|Lost to Follow-up|1|||
131931964|NCT05401409|475038040|FG001|Overall Study|Lost to Follow-up|0|||
131931965|NCT02371889|475038041|FG000|Overall Study|Adverse medication effect|11|||
131931966|NCT02371889|475038042|FG001|Overall Study|Adverse medication effect|2|||
131931967|NCT02371889|475038041|FG000|Overall Study|Lost to Follow-up|6|||
131931968|NCT02371889|475038042|FG001|Overall Study|Lost to Follow-up|5|||
131931969|NCT02371889|475038041|FG000|Overall Study|Personal time constraints|2|||
131931970|NCT02371889|475038042|FG001|Overall Study|Personal time constraints|4|||
131931971|NCT02371889|475038041|FG000|Overall Study|Lack of Efficacy|0|||
131931972|NCT02371889|475038042|FG001|Overall Study|Lack of Efficacy|2|||
131931973|NCT02371889|475038041|FG000|Overall Study|Relapse|0|||
131931974|NCT02371889|475038042|FG001|Overall Study|Relapse|1|||
131931975|NCT02410200|475038043|FG000|Overall Study|Adverse Event|2|||
131931976|NCT01149460|475038044|FG000|Overall Study|Withdrawal by Subject|0|||
131931977|NCT01149460|475038045|FG001|Overall Study|Withdrawal by Subject|2|||
131931978|NCT03682367|475038053|FG000|Overall Study|Protocol Violation|2|||
131931979|NCT03682367|475038054|FG001|Overall Study|Protocol Violation|1|||
131931980|NCT03682367|475038053|FG000|Overall Study|Closed Study Early|0|||
131931981|NCT03682367|475038054|FG001|Overall Study|Closed Study Early|3|||
131931982|NCT00770679|475038055|FG000|Overall Study|Lost to Follow-up|3|||
131931983|NCT00770679|475038055|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
131931984|NCT01047540|475038066|FG000|Overall Study|Protocol Violation|1|||
131931985|NCT01047540|475038067|FG001|Overall Study|Protocol Violation|0|||
131931986|NCT01047540|475038068|FG002|Overall Study|Protocol Violation|0|||
131931987|NCT01047540|475038069|FG003|Overall Study|Protocol Violation|0|||
131931988|NCT01047540|475038070|FG004|Overall Study|Protocol Violation|0|||
131931989|NCT01047540|475038066|FG000|Overall Study|Lost to Follow-up|1|||
131931990|NCT01047540|475038067|FG001|Overall Study|Lost to Follow-up|0|||
131931991|NCT01047540|475038068|FG002|Overall Study|Lost to Follow-up|0|||
131931992|NCT01047540|475038069|FG003|Overall Study|Lost to Follow-up|0|||
131931993|NCT01047540|475038070|FG004|Overall Study|Lost to Follow-up|0|||
131931994|NCT01047540|475038066|FG000|Overall Study|Withdrawal by Subject|1|||
131931995|NCT01047540|475038067|FG001|Overall Study|Withdrawal by Subject|0|||
131931996|NCT01047540|475038068|FG002|Overall Study|Withdrawal by Subject|3|||
131931997|NCT01047540|475038069|FG003|Overall Study|Withdrawal by Subject|0|||
131931998|NCT01047540|475038070|FG004|Overall Study|Withdrawal by Subject|1|||
131931999|NCT01047540|475038066|FG000|Overall Study|Pregnancy|1|||
131932000|NCT01047540|475038067|FG001|Overall Study|Pregnancy|0|||
131932001|NCT01047540|475038068|FG002|Overall Study|Pregnancy|0|||
131932002|NCT01047540|475038069|FG003|Overall Study|Pregnancy|0|||
131932003|NCT01047540|475038070|FG004|Overall Study|Pregnancy|0|||
131932004|NCT01047540|475038066|FG000|Overall Study|Adverse Event|1|||
131932005|NCT01047540|475038067|FG001|Overall Study|Adverse Event|0|||
131932006|NCT01047540|475038068|FG002|Overall Study|Adverse Event|0|||
131932007|NCT01047540|475038069|FG003|Overall Study|Adverse Event|0|||
131932008|NCT01047540|475038070|FG004|Overall Study|Adverse Event|0|||
131932009|NCT01229111|475038071|FG000|Overall Study|Death|1|||
131932010|NCT00835549|475038072|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
131932011|NCT00835549|475038073|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131932012|NCT04893811|475038074|FG000|Vaccination Phase|Death|1|||
131932013|NCT04893811|475038075|FG001|Vaccination Phase|Death|0|||
131932014|NCT04893811|475038074|FG000|Vaccination Phase|Lost to Follow-up|1|||
131932015|NCT04893811|475038075|FG001|Vaccination Phase|Lost to Follow-up|1|||
131932016|NCT04893811|475038074|FG000|Vaccination Phase|Protocol Violation|2|||
131932017|NCT04893811|475038075|FG001|Vaccination Phase|Protocol Violation|0|||
131932018|NCT04893811|475038074|FG000|Vaccination Phase|Withdrawal by Subject|2|||
131932019|NCT04893811|475038075|FG001|Vaccination Phase|Withdrawal by Subject|1|||
131932020|NCT04893811|475038074|FG000|Vaccination Phase|Other|0|||
131932021|NCT04893811|475038075|FG001|Vaccination Phase|Other|1|||
131932022|NCT04893811|475038074|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
131932023|NCT04893811|475038075|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
131932024|NCT04893811|475038074|FG000|Follow-up Phase|Lost to Follow-up|0|||
131932025|NCT04893811|475038075|FG001|Follow-up Phase|Lost to Follow-up|1|||
131932026|NCT00835042|475038076|FG000|First Intervention|Withdrawal by Subject|3|||
131932027|NCT00835042|475038077|FG001|First Intervention|Withdrawal by Subject|0|||
131932028|NCT00835042|475038076|FG000|First Intervention|Adverse Event|1|||
131932029|NCT00835042|475038077|FG001|First Intervention|Adverse Event|2|||
131932030|NCT00835042|475038076|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
131932031|NCT00835042|475038077|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
131932032|NCT05524948|475038100|FG000|Overall Study|Withdrawal by Subject|1|||
131932033|NCT05524948|475038101|FG001|Overall Study|Withdrawal by Subject|0|||
131932034|NCT05524948|475038100|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
131932035|NCT05524948|475038101|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
131932036|NCT05463952|475038104|FG000|Treatment|Progressive disease|4|||
131932037|NCT05463952|475038104|FG000|Treatment|Ongoing|2|||
131932038|NCT00595075|475038105|FG000|Overall Study|Withdrawal by Subject|1|||
131932039|NCT00595075|475038106|FG001|Overall Study|Withdrawal by Subject|0|||
131932040|NCT01946880|475038107|FG000|Overall Study|Lost to Follow-up|1|||
131932041|NCT01946880|475038108|FG001|Overall Study|Lost to Follow-up|0|||
131932042|NCT01946880|475038107|FG000|Overall Study|Physician Decision|1|||
131932043|NCT01946880|475038108|FG001|Overall Study|Physician Decision|1|||
131932044|NCT01946880|475038107|FG000|Overall Study|Withdrawal by Subject|3|||
131932045|NCT01946880|475038108|FG001|Overall Study|Withdrawal by Subject|2|||
131932046|NCT01946880|475038107|FG000|Overall Study|Met Primary Endpoint|1|||
131932047|NCT01946880|475038108|FG001|Overall Study|Met Primary Endpoint|0|||
131932048|NCT01946880|475038107|FG000|Overall Study|Personal and Family Issues|1|||
131932049|NCT01946880|475038108|FG001|Overall Study|Personal and Family Issues|0|||
131932050|NCT04204902|475038111|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
131932051|NCT04204902|475038112|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
131932052|NCT00456365|475038113|FG000|Overall Study|Lost to Follow-up|1|||
131932053|NCT00456365|475038114|FG001|Overall Study|Lost to Follow-up|3|||
131932054|NCT00456365|475038113|FG000|Overall Study|Withdrawal by Subject|4|||
131932055|NCT00456365|475038114|FG001|Overall Study|Withdrawal by Subject|7|||
131932056|NCT00456365|475038113|FG000|Overall Study|Pregnancy|1|||
131932057|NCT00456365|475038114|FG001|Overall Study|Pregnancy|1|||
131932058|NCT00456365|475038113|FG000|Overall Study|oncologic diagnosis|1|||
131932059|NCT00456365|475038114|FG001|Overall Study|oncologic diagnosis|1|||
131932060|NCT05451329|475038115|FG000|Overall Study|Adverse Event|1|||
131932061|NCT05451329|475038116|FG001|Overall Study|Adverse Event|1|||
131932062|NCT05451329|475038117|FG002|Overall Study|Adverse Event|0|||
131932063|NCT05451329|475038115|FG000|Overall Study|Withdrawal by Subject|1|||
131932064|NCT05451329|475038116|FG001|Overall Study|Withdrawal by Subject|0|||
131932065|NCT05451329|475038117|FG002|Overall Study|Withdrawal by Subject|0|||
131932066|NCT05451329|475038115|FG000|Overall Study|Investigational Product Lot exchange|1|||
131932067|NCT05451329|475038116|FG001|Overall Study|Investigational Product Lot exchange|1|||
131932068|NCT05451329|475038117|FG002|Overall Study|Investigational Product Lot exchange|0|||
131932069|NCT02202577|475038118|FG000|Overall Study|Lost to Follow-up|6|||
131932070|NCT02202577|475038119|FG001|Overall Study|Lost to Follow-up|16|||
131932071|NCT02202577|475038118|FG000|Overall Study|Protocol Violation|7|||
131411414|NCT00762996|473128639|FG001|Period One|Withdrawal by Subject|0|||
131411415|NCT00762996|473128640|FG002|Period One|Withdrawal by Subject|1|||
131411416|NCT00762996|473128641|FG003|Period One|Withdrawal by Subject|0|||
131411417|NCT00536874|473128642|FG000|Overall Study|Adverse Event|1|||
131932072|NCT02202577|475038119|FG001|Overall Study|Protocol Violation|3|||
131932073|NCT00069953|475038120|FG000|Overall Study|Protocol Violation|2|||
131932074|NCT02034565|475038121|FG000|Overall Study|Adverse Event|1|||
131932075|NCT02034565|475038122|FG001|Overall Study|Adverse Event|0|||
131932076|NCT00113373|475038123|FG000|Overall Study|Ineligible: wrong primary|1|||
131932077|NCT00113373|475038123|FG000|Overall Study|Ineligible: second primary|1|||
131932078|NCT00113373|475038123|FG000|Overall Study|Never Treated|1|||
131932079|NCT00829868|475038124|FG000|Washout|Physician Decision|1|||
131932080|NCT00829868|475038125|FG001|Washout|Physician Decision|0|||
131932081|NCT02799043|475038127|FG000|Overall Study|Adverse Event|0|||
131932082|NCT02799043|475038128|FG001|Overall Study|Adverse Event|1|||
131932083|NCT02799043|475038127|FG000|Overall Study|Death|1|||
131932084|NCT02799043|475038128|FG001|Overall Study|Death|1|||
131932085|NCT02799043|475038127|FG000|Overall Study|Lost to Follow-up|3|||
131932086|NCT02799043|475038128|FG001|Overall Study|Lost to Follow-up|6|||
131932087|NCT02799043|475038127|FG000|Overall Study|Withdrawal by Subject|4|||
131932088|NCT02799043|475038128|FG001|Overall Study|Withdrawal by Subject|4|||
131932089|NCT02799043|475038127|FG000|Overall Study|Moved to different country|0|||
131932090|NCT02799043|475038128|FG001|Overall Study|Moved to different country|1|||
131932091|NCT02799043|475038127|FG000|Overall Study|Trial Screen Failure|1|||
131932092|NCT02799043|475038128|FG001|Overall Study|Trial Screen Failure|0|||
131411418|NCT00536874|473128642|FG000|Overall Study|Death|2|||
131411419|NCT00536874|473128642|FG000|Overall Study|Withdrawal by Subject|1|||
131411420|NCT02689076|473128644|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
131411421|NCT02689076|473128645|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
131411422|NCT02689076|473128646|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
131411423|NCT02689076|473128644|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
131411424|NCT02689076|473128645|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
131411425|NCT02689076|473128646|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
131411426|NCT02689076|473128644|FG000|Overall Study|Did not have an HIE match|2|||
131411427|NCT02689076|473128645|FG001|Overall Study|Did not have an HIE match|0|||
131411428|NCT02689076|473128646|FG002|Overall Study|Did not have an HIE match|0|||
131932093|NCT02799043|475038127|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
131932094|NCT02799043|475038128|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
131932095|NCT06091956|475038129|FG000|Overall Study|Withdrawal by Subject|1|||
131932096|NCT06091956|475038129|FG000|Overall Study|Complicating Disease|1|||
131932097|NCT04525183|475038140|FG000|Overall Study|Withdrawal by Subject|0|||
131932098|NCT04525183|475038141|FG001|Overall Study|Withdrawal by Subject|0|||
131932099|NCT04525183|475038142|FG002|Overall Study|Withdrawal by Subject|3|||
131932100|NCT04525183|475038140|FG000|Overall Study|Study non-compliance|0|||
131932101|NCT04525183|475038141|FG001|Overall Study|Study non-compliance|0|||
131932102|NCT04525183|475038142|FG002|Overall Study|Study non-compliance|1|||
131932103|NCT04525183|475038140|FG000|Overall Study|Recurrent disease before starting on study|0|||
131932104|NCT04525183|475038141|FG001|Overall Study|Recurrent disease before starting on study|0|||
131932105|NCT04525183|475038142|FG002|Overall Study|Recurrent disease before starting on study|1|||
131932106|NCT00979407|475038143|FG000|Overall Study|Withdrawal by Subject|3|||
131932107|NCT00979407|475038144|FG001|Overall Study|Withdrawal by Subject|4|||
131932108|NCT00979407|475038143|FG000|Overall Study|Lost to Follow-up|3|||
131932109|NCT00979407|475038144|FG001|Overall Study|Lost to Follow-up|3|||
131932110|NCT01166646|475038145|FG000|Overall Study|Protocol Violation|0|||
131932111|NCT01166646|475038146|FG001|Overall Study|Protocol Violation|1|||
131932112|NCT01166646|475038145|FG000|Overall Study|Adverse Event|1|||
131932113|NCT01166646|475038146|FG001|Overall Study|Adverse Event|0|||
131932114|NCT04818229|475038149|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
131932115|NCT04818229|475038150|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
131932116|NCT04818229|475038151|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
131932117|NCT04818229|475038149|FG000|Overall Study|Adverse Event|3|||
131932118|NCT04818229|475038150|FG001|Overall Study|Adverse Event|1|||
131932119|NCT04818229|475038151|FG002|Overall Study|Adverse Event|1|||
131932120|NCT04818229|475038149|FG000|Overall Study|Withdrawal by Subject|0|||
131932121|NCT04818229|475038150|FG001|Overall Study|Withdrawal by Subject|0|||
131932122|NCT04818229|475038151|FG002|Overall Study|Withdrawal by Subject|2|||
131932123|NCT04818229|475038149|FG000|Overall Study|Lost to Follow-up|0|||
131932124|NCT04818229|475038150|FG001|Overall Study|Lost to Follow-up|0|||
131932125|NCT04818229|475038151|FG002|Overall Study|Lost to Follow-up|1|||
131932126|NCT03186378|475038152|FG000|Overall Study|Lost to Follow-up|1|||
131932127|NCT03186378|475038153|FG001|Overall Study|Lost to Follow-up|0|||
131932128|NCT02181413|475038156|FG000|Overall Study|Withdrawal by Subject|45|||
131932129|NCT02181413|475038157|FG001|Overall Study|Withdrawal by Subject|61|||
131932130|NCT02181413|475038156|FG000|Overall Study|Reason Not Specified|2|||
131932131|NCT02181413|475038157|FG001|Overall Study|Reason Not Specified|5|||
131932132|NCT02181413|475038156|FG000|Overall Study|Lost to Follow-up|8|||
131932133|NCT02181413|475038157|FG001|Overall Study|Lost to Follow-up|7|||
131932134|NCT02514746|475038158|FG000|Overall Study|Chronically Ill|1|||
131932135|NCT02514746|475038159|FG001|Overall Study|Chronically Ill|2|||
131932136|NCT02514746|475038158|FG000|Overall Study|Physician Decision|4|||
131932137|NCT02514746|475038159|FG001|Overall Study|Physician Decision|2|||
131932138|NCT02514746|475038158|FG000|Overall Study|Withdrawal by Subject|12|||
131932139|NCT02514746|475038159|FG001|Overall Study|Withdrawal by Subject|10|||
131932140|NCT02514746|475038158|FG000|Overall Study|Other|5|||
131932141|NCT02514746|475038159|FG001|Overall Study|Other|1|||
131932142|NCT03996395|475038161|FG000|Overall Study|Lost to Follow-up|4|||
131932143|NCT03996395|475038161|FG000|Overall Study|Withdrawal by Subject|1|||
131932144|NCT03996395|475038161|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
131932145|NCT03301415|475038164|FG000|Overall Study|Lost to Follow-up|2|||
131932146|NCT03301415|475038164|FG000|Overall Study|Unable to comply with visit schedule|2|||
131932147|NCT03247673|475038165|FG000|Overall Study|Withdrawal by Subject|1|||
131932148|NCT03247673|475038166|FG001|Overall Study|Withdrawal by Subject|0|||
131932149|NCT03247673|475038167|FG002|Overall Study|Withdrawal by Subject|3|||
131932150|NCT03247673|475038165|FG000|Overall Study|Lost to Follow-up|0|||
131932151|NCT03247673|475038166|FG001|Overall Study|Lost to Follow-up|0|||
131932152|NCT03247673|475038167|FG002|Overall Study|Lost to Follow-up|1|||
131932153|NCT00392288|475038168|FG000|Overall Study|Adverse Event|17|||
131932154|NCT00392288|475038169|FG001|Overall Study|Adverse Event|7|||
131932155|NCT00392288|475038170|FG002|Overall Study|Adverse Event|8|||
131932156|NCT00392288|475038168|FG000|Overall Study|Lack of Efficacy|8|||
131932157|NCT00392288|475038169|FG001|Overall Study|Lack of Efficacy|5|||
131932158|NCT00392288|475038170|FG002|Overall Study|Lack of Efficacy|3|||
131932159|NCT00392288|475038168|FG000|Overall Study|Protocol Violation|1|||
131932160|NCT00392288|475038169|FG001|Overall Study|Protocol Violation|3|||
131932161|NCT00392288|475038170|FG002|Overall Study|Protocol Violation|1|||
131411429|NCT02689076|473128644|FG000|Overall Study|Death during non-VA encounter|2|||
131932162|NCT00392288|475038168|FG000|Overall Study|Lost to Follow-up|1|||
131932163|NCT00392288|475038169|FG001|Overall Study|Lost to Follow-up|1|||
131932164|NCT00392288|475038170|FG002|Overall Study|Lost to Follow-up|1|||
131411430|NCT02689076|473128645|FG001|Overall Study|Death during non-VA encounter|5|||
131932165|NCT00392288|475038168|FG000|Overall Study|Withdrawal by Subject|1|||
131932166|NCT00392288|475038169|FG001|Overall Study|Withdrawal by Subject|0|||
131932167|NCT00392288|475038170|FG002|Overall Study|Withdrawal by Subject|2|||
131932168|NCT00392288|475038168|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
131932169|NCT00392288|475038169|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
131932170|NCT00392288|475038170|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
131932171|NCT00392288|475038168|FG000|Overall Study|Other|3|||
131932172|NCT00392288|475038169|FG001|Overall Study|Other|4|||
131932173|NCT00392288|475038170|FG002|Overall Study|Other|1|||
131932174|NCT02544763|475038171|FG000|Overall Study|Adverse Event|8|||
131932175|NCT02544763|475038172|FG001|Overall Study|Adverse Event|8|||
131932176|NCT02544763|475038173|FG002|Overall Study|Adverse Event|0|||
131932177|NCT02544763|475038171|FG000|Overall Study|Withdrawn by parent/guardian|1|||
131932178|NCT02544763|475038172|FG001|Overall Study|Withdrawn by parent/guardian|1|||
131932179|NCT02544763|475038173|FG002|Overall Study|Withdrawn by parent/guardian|1|||
131932180|NCT02544763|475038171|FG000|Overall Study|Met withdrawal criteria|0|||
131932181|NCT02544763|475038172|FG001|Overall Study|Met withdrawal criteria|2|||
131932182|NCT02544763|475038173|FG002|Overall Study|Met withdrawal criteria|0|||
131932183|NCT02544763|475038171|FG000|Overall Study|Physician Decision|0|||
131932184|NCT02544763|475038172|FG001|Overall Study|Physician Decision|1|||
131932185|NCT02544763|475038173|FG002|Overall Study|Physician Decision|0|||
131932186|NCT02544763|475038171|FG000|Overall Study|Difficulties taking IMP|1|||
131932187|NCT02544763|475038172|FG001|Overall Study|Difficulties taking IMP|0|||
131932188|NCT02544763|475038173|FG002|Overall Study|Difficulties taking IMP|0|||
131932189|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
131932190|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131932191|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131932192|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131932193|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131932194|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
131932195|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131932196|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131932197|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131932198|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131932199|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
131932200|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131932201|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131932202|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131932203|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131932204|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
131932205|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
131932206|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
131932207|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
131932208|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
131932209|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
131932210|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
131932211|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
131932212|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
131932213|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
131932214|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
131932215|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
131932216|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
131932217|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
131932218|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
131932219|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
131932220|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131932221|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131932222|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131932223|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131932224|NCT01111552|475038174|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
131932225|NCT01111552|475038175|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
131932226|NCT01111552|475038176|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
131932227|NCT01111552|475038177|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
131932228|NCT01111552|475038178|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
131932229|NCT01111552|475038174|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131932230|NCT01111552|475038175|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131932231|NCT01111552|475038176|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131932232|NCT01111552|475038177|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
131932233|NCT01111552|475038178|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131411431|NCT02689076|473128646|FG002|Overall Study|Death during non-VA encounter|0|||
131411432|NCT02689076|473128644|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
131932234|NCT01111552|475038174|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
131932235|NCT01111552|475038175|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
131932236|NCT01111552|475038176|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
131932237|NCT01111552|475038177|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
131932238|NCT01111552|475038178|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
131932239|NCT01111552|475038174|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
131932240|NCT01111552|475038175|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
131932241|NCT01111552|475038176|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
131932242|NCT01111552|475038177|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
131932243|NCT01111552|475038178|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
131932244|NCT01111552|475038174|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
131932245|NCT01111552|475038175|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
131932246|NCT01111552|475038176|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
131932247|NCT01111552|475038177|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
131932248|NCT01111552|475038178|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
131932249|NCT01111552|475038174|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
131932250|NCT01111552|475038175|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
131932251|NCT01111552|475038176|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
131932252|NCT01111552|475038177|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
131932253|NCT01111552|475038178|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
131932254|NCT01111552|475038174|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131932255|NCT01111552|475038175|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131932256|NCT01111552|475038176|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
131932257|NCT01111552|475038177|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131932258|NCT01111552|475038178|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131932259|NCT02097225|475038179|FG000|Dose Level 4|Adverse Event|0|||
131932260|NCT02097225|475038180|FG001|Dose Level 4|Adverse Event|0|||
131932261|NCT02097225|475038181|FG002|Dose Level 4|Adverse Event|0|||
131932262|NCT02097225|475038182|FG003|Dose Level 4|Adverse Event|0|||
131932263|NCT02097225|475038183|FG004|Dose Level 4|Adverse Event|1|||
131932264|NCT01027351|475038185|FG000|Overall Study|Withdrawal by Subject|1|||
131932265|NCT01027351|475038186|FG001|Overall Study|Withdrawal by Subject|0|||
131932266|NCT01027351|475038187|FG002|Overall Study|Withdrawal by Subject|1|||
131932267|NCT01027351|475038188|FG003|Overall Study|Withdrawal by Subject|0|||
131932268|NCT01027351|475038189|FG004|Overall Study|Withdrawal by Subject|3|||
131932269|NCT01027351|475038190|FG005|Overall Study|Withdrawal by Subject|5|||
131932270|NCT01027351|475038185|FG000|Overall Study|Lost to Follow-up|1|||
131932271|NCT01027351|475038186|FG001|Overall Study|Lost to Follow-up|1|||
131932272|NCT01027351|475038187|FG002|Overall Study|Lost to Follow-up|0|||
131932273|NCT01027351|475038188|FG003|Overall Study|Lost to Follow-up|1|||
131932274|NCT01027351|475038189|FG004|Overall Study|Lost to Follow-up|6|||
131932275|NCT01027351|475038190|FG005|Overall Study|Lost to Follow-up|0|||
131932276|NCT01027351|475038185|FG000|Overall Study|Inappropriate enrollment|0|||
131932277|NCT01027351|475038186|FG001|Overall Study|Inappropriate enrollment|0|||
131932278|NCT01027351|475038187|FG002|Overall Study|Inappropriate enrollment|0|||
131932279|NCT01027351|475038188|FG003|Overall Study|Inappropriate enrollment|0|||
131932280|NCT01027351|475038189|FG004|Overall Study|Inappropriate enrollment|1|||
131932281|NCT01027351|475038190|FG005|Overall Study|Inappropriate enrollment|0|||
131932282|NCT01027351|475038185|FG000|Overall Study|Protocol Violation|1|||
131932283|NCT01027351|475038186|FG001|Overall Study|Protocol Violation|0|||
131932284|NCT01027351|475038187|FG002|Overall Study|Protocol Violation|0|||
131932285|NCT01027351|475038188|FG003|Overall Study|Protocol Violation|1|||
131932286|NCT01027351|475038189|FG004|Overall Study|Protocol Violation|1|||
131932287|NCT01027351|475038190|FG005|Overall Study|Protocol Violation|0|||
131932288|NCT04650893|475038191|FG000|Overall Study|Lost to Follow-up|11|||
131932289|NCT04650893|475038192|FG001|Overall Study|Lost to Follow-up|10|||
131932290|NCT04650893|475038193|FG002|Overall Study|Lost to Follow-up|11|||
131932291|NCT00176254|475038206|FG000|Overall Study|Lost to Follow-up|1|||
131932292|NCT01197300|475039973|FG000|Overall Study|Lost to Follow-up|0|||
131932293|NCT01197300|475039974|FG001|Overall Study|Lost to Follow-up|1|||
131932294|NCT01197300|475039973|FG000|Overall Study|Protocol Violation|0|||
131932295|NCT01197300|475039974|FG001|Overall Study|Protocol Violation|1|||
131932296|NCT03058952|475039977|FG000|Overall Study|Adverse Event|1|||
131932297|NCT03058952|475039978|FG001|Overall Study|Adverse Event|0|||
131932298|NCT03058952|475039977|FG000|Overall Study|Lost to Follow-up|15|||
131932299|NCT03058952|475039978|FG001|Overall Study|Lost to Follow-up|15|||
131932300|NCT03058952|475039977|FG000|Overall Study|Withdrawal by Subject|7|||
131932301|NCT03058952|475039978|FG001|Overall Study|Withdrawal by Subject|11|||
131932302|NCT02579759|475039985|FG000|Overall Study|Protocol Violation|2|||
131932303|NCT02579759|475039986|FG001|Overall Study|Protocol Violation|0|||
131932304|NCT02579759|475039987|FG002|Overall Study|Protocol Violation|0|||
131932305|NCT02579759|475039985|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
131932306|NCT02579759|475039986|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
131932307|NCT02579759|475039987|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
131932308|NCT02579759|475039985|FG000|Overall Study|BfArM hold|13|||
131932309|NCT02579759|475039986|FG001|Overall Study|BfArM hold|12|||
131932310|NCT02579759|475039987|FG002|Overall Study|BfArM hold|12|||
131932311|NCT02579759|475039985|FG000|Overall Study|Sponsor stopped Dose 2|0|||
131932312|NCT02579759|475039986|FG001|Overall Study|Sponsor stopped Dose 2|41|||
131932313|NCT02579759|475039987|FG002|Overall Study|Sponsor stopped Dose 2|0|||
131932314|NCT02579759|475039985|FG000|Overall Study|Non compliance|0|||
131932315|NCT02579759|475039986|FG001|Overall Study|Non compliance|1|||
131932316|NCT02579759|475039987|FG002|Overall Study|Non compliance|0|||
131932317|NCT02579759|475039985|FG000|Overall Study|Pregnancy|0|||
131932318|NCT02579759|475039986|FG001|Overall Study|Pregnancy|1|||
131932319|NCT02579759|475039987|FG002|Overall Study|Pregnancy|0|||
131932320|NCT02579759|475039985|FG000|Overall Study|Inclusion/exclusion criteria|0|||
131932321|NCT02579759|475039986|FG001|Overall Study|Inclusion/exclusion criteria|0|||
131932322|NCT02579759|475039987|FG002|Overall Study|Inclusion/exclusion criteria|1|||
131932323|NCT02579759|475039985|FG000|Overall Study|Adverse Event|4|||
131932324|NCT02579759|475039986|FG001|Overall Study|Adverse Event|3|||
131932325|NCT02579759|475039987|FG002|Overall Study|Adverse Event|1|||
131932326|NCT02579759|475039985|FG000|Overall Study|Withdrawal by Subject|3|||
131932327|NCT02579759|475039986|FG001|Overall Study|Withdrawal by Subject|3|||
131932328|NCT02579759|475039987|FG002|Overall Study|Withdrawal by Subject|5|||
131932329|NCT02579759|475039985|FG000|Overall Study|Lost to Follow-up|2|||
131932330|NCT02579759|475039986|FG001|Overall Study|Lost to Follow-up|2|||
131932331|NCT02579759|475039987|FG002|Overall Study|Lost to Follow-up|2|||
131932332|NCT01050218|475039994|FG000|Overall Study|Adverse Event|37|||
131932333|NCT01050218|475039994|FG000|Overall Study|Lack of Efficacy|8|||
131932334|NCT01050218|475039994|FG000|Overall Study|Protocol Violation|3|||
131932335|NCT01050218|475039994|FG000|Overall Study|Withdrawal by Subject|18|||
131932336|NCT01050218|475039994|FG000|Overall Study|Discontinued by sponsor|18|||
131932337|NCT01050218|475039994|FG000|Overall Study|Compliance|2|||
131932338|NCT01050218|475039994|FG000|Overall Study|Failed to return|7|||
131932339|NCT01050218|475039994|FG000|Overall Study|Serious Adverse Event|1|||
131932340|NCT01050218|475039994|FG000|Overall Study|Family emergency|1|||
131932341|NCT02801578|475039997|FG000|Overall Study|Adverse Event|2|||
131932342|NCT00668642|475039998|FG000|First Off-cycle|Cancer progression|1|||
131932343|NCT00668642|475039999|FG001|First Off-cycle|Cancer progression|0|||
131932344|NCT00668642|475039998|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
131932345|NCT00668642|475039999|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
131932346|NCT00266032|475040000|FG000|Treatment|Adverse Event|42|||
131932347|NCT00266032|475040001|FG001|Treatment|Adverse Event|26|||
131932348|NCT00266032|475040002|FG002|Treatment|Adverse Event|10|||
131932349|NCT00266032|475040000|FG000|Treatment|Lost to Follow-up|19|||
131932350|NCT00266032|475040001|FG001|Treatment|Lost to Follow-up|4|||
131932351|NCT00266032|475040002|FG002|Treatment|Lost to Follow-up|2|||
131932352|NCT00266032|475040000|FG000|Treatment|Pregnancy|3|||
131932353|NCT00266032|475040001|FG001|Treatment|Pregnancy|2|||
131932354|NCT00266032|475040002|FG002|Treatment|Pregnancy|2|||
131932355|NCT00266032|475040000|FG000|Treatment|Protocol Violation|6|||
131932356|NCT00266032|475040001|FG001|Treatment|Protocol Violation|14|||
131932357|NCT00266032|475040002|FG002|Treatment|Protocol Violation|13|||
131932358|NCT00266032|475040000|FG000|Treatment|Withdrawal by Subject|28|||
131932359|NCT00266032|475040001|FG001|Treatment|Withdrawal by Subject|13|||
131932360|NCT00266032|475040002|FG002|Treatment|Withdrawal by Subject|12|||
131932361|NCT00266032|475040000|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
131932362|NCT00266032|475040001|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
131932363|NCT00266032|475040002|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
131932364|NCT00266032|475040000|FG000|Open-label Safety Extension|Adverse Event|5|||
131932365|NCT00266032|475040001|FG001|Open-label Safety Extension|Adverse Event|0|||
131932366|NCT00266032|475040002|FG002|Open-label Safety Extension|Adverse Event|4|||
131932367|NCT00266032|475040000|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
131932368|NCT00266032|475040001|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
131932369|NCT00266032|475040002|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
131932370|NCT00266032|475040000|FG000|Open-label Safety Extension|Pregnancy|4|||
131932371|NCT00266032|475040001|FG001|Open-label Safety Extension|Pregnancy|1|||
131932372|NCT00266032|475040002|FG002|Open-label Safety Extension|Pregnancy|2|||
131932373|NCT00266032|475040000|FG000|Open-label Safety Extension|Protocol Violation|1|||
131932374|NCT00266032|475040001|FG001|Open-label Safety Extension|Protocol Violation|3|||
131932375|NCT00266032|475040002|FG002|Open-label Safety Extension|Protocol Violation|2|||
131932376|NCT00266032|475040000|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
131932377|NCT00266032|475040001|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
131932378|NCT00266032|475040002|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
131932379|NCT00266032|475040000|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
131932380|NCT00266032|475040001|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
131932381|NCT00266032|475040002|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
131411433|NCT02689076|473128645|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
131411434|NCT02689076|473128646|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
131411435|NCT02689076|473128644|FG000|Overall Study|Participant no longer active in VA system|1|||
131411436|NCT02689076|473128645|FG001|Overall Study|Participant no longer active in VA system|0|||
131411437|NCT02689076|473128646|FG002|Overall Study|Participant no longer active in VA system|0|||
131411438|NCT02689076|473128644|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
131932382|NCT00814983|475040005|FG000|Overall Study|Screen failure|1|||
131932383|NCT00814983|475040006|FG001|Overall Study|Screen failure|0|||
131932384|NCT00814983|475040005|FG000|Overall Study|Withdrawal by Subject|1|||
131932385|NCT00814983|475040006|FG001|Overall Study|Withdrawal by Subject|0|||
131932386|NCT00814983|475040005|FG000|Overall Study|Graft failure|1|||
131932387|NCT00814983|475040006|FG001|Overall Study|Graft failure|0|||
131932388|NCT03627468|475040007|FG000|Overall Study|Adverse Event|5|||
131932389|NCT03627468|475040008|FG001|Overall Study|Adverse Event|33|||
131932390|NCT03627468|475040007|FG000|Overall Study|Withdrawal by Subject|13|||
131932391|NCT03627468|475040008|FG001|Overall Study|Withdrawal by Subject|23|||
131932392|NCT03627468|475040007|FG000|Overall Study|Physician Decision|1|||
131932393|NCT03627468|475040008|FG001|Overall Study|Physician Decision|0|||
131932394|NCT03627468|475040007|FG000|Overall Study|Protocol Violation|0|||
131932395|NCT03627468|475040008|FG001|Overall Study|Protocol Violation|2|||
131932396|NCT03627468|475040007|FG000|Overall Study|Lost to Follow-up|10|||
131932397|NCT03627468|475040008|FG001|Overall Study|Lost to Follow-up|16|||
131932398|NCT03627468|475040007|FG000|Overall Study|Death|1|||
131932399|NCT03627468|475040008|FG001|Overall Study|Death|0|||
131932400|NCT03627468|475040007|FG000|Overall Study|Pregnancy|1|||
131932401|NCT03627468|475040008|FG001|Overall Study|Pregnancy|1|||
131932402|NCT03627468|475040007|FG000|Overall Study|Lack of Efficacy|0|||
131932403|NCT03627468|475040008|FG001|Overall Study|Lack of Efficacy|2|||
131932404|NCT03627468|475040007|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
131932405|NCT03627468|475040008|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
131932406|NCT04157738|475040009|FG000|Overall Study|Moved out of state|0|||
131932407|NCT04157738|475040010|FG001|Overall Study|Moved out of state|2|||
131932408|NCT04157738|475040009|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
131932409|NCT04157738|475040010|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
131932410|NCT00160563|475040011|FG000|Overall Study|Adverse Event|1|||
131932411|NCT00160563|475040012|FG001|Overall Study|Adverse Event|1|||
131932412|NCT00160563|475040013|FG002|Overall Study|Adverse Event|1|||
131932413|NCT00160563|475040011|FG000|Overall Study|Lost to Follow-up|1|||
131932414|NCT00160563|475040012|FG001|Overall Study|Lost to Follow-up|1|||
131932415|NCT00160563|475040013|FG002|Overall Study|Lost to Follow-up|2|||
131932416|NCT00160563|475040011|FG000|Overall Study|Protocol Violation|0|||
131932417|NCT00160563|475040012|FG001|Overall Study|Protocol Violation|0|||
131932418|NCT00160563|475040013|FG002|Overall Study|Protocol Violation|3|||
131932419|NCT00160563|475040011|FG000|Overall Study|Withdrawal by Subject|1|||
131932420|NCT00160563|475040012|FG001|Overall Study|Withdrawal by Subject|2|||
131932421|NCT00160563|475040013|FG002|Overall Study|Withdrawal by Subject|3|||
131932422|NCT00160563|475040011|FG000|Overall Study|Other (listed in the study report)|48|||
131932423|NCT00160563|475040012|FG001|Overall Study|Other (listed in the study report)|40|||
131932424|NCT00160563|475040013|FG002|Overall Study|Other (listed in the study report)|81|||
131932425|NCT00160563|475040011|FG000|Overall Study|Missing reason|0|||
131932426|NCT00160563|475040012|FG001|Overall Study|Missing reason|1|||
131932427|NCT00160563|475040013|FG002|Overall Study|Missing reason|0|||
131932428|NCT01514357|475040017|FG000|Overall Study|Screen failure|2|||
131932429|NCT01514357|475040018|FG001|Overall Study|Screen failure|0|||
131932430|NCT01514357|475040017|FG000|Overall Study|Withdrawal by Subject|2|||
131932431|NCT01514357|475040018|FG001|Overall Study|Withdrawal by Subject|0|||
131932432|NCT00752219|475040019|FG000|Overall Study|Clinical failure|0|||
131932433|NCT00752219|475040020|FG001|Overall Study|Clinical failure|1|||
131932434|NCT00752219|475040019|FG000|Overall Study|Adverse Event|5|||
131932435|NCT00752219|475040020|FG001|Overall Study|Adverse Event|3|||
131932436|NCT00752219|475040019|FG000|Overall Study|Protocol deviation|1|||
131932437|NCT00752219|475040020|FG001|Overall Study|Protocol deviation|0|||
131932438|NCT00752219|475040019|FG000|Overall Study|Lost to Follow-up|1|||
131932439|NCT00752219|475040020|FG001|Overall Study|Lost to Follow-up|2|||
131932440|NCT00752219|475040019|FG000|Overall Study|Randomized but not treated|1|||
131932441|NCT00752219|475040020|FG001|Overall Study|Randomized but not treated|0|||
131932442|NCT00752219|475040019|FG000|Overall Study|Other|3|||
131932443|NCT00752219|475040020|FG001|Overall Study|Other|0|||
131932444|NCT04691115|475040025|FG000|Overall Study|Withdrawal by Subject|0|||
131932445|NCT04691115|475040026|FG001|Overall Study|Withdrawal by Subject|0|||
131932446|NCT04691115|475040027|FG002|Overall Study|Withdrawal by Subject|0|||
131932447|NCT04691115|475040028|FG003|Overall Study|Withdrawal by Subject|0|||
131932448|NCT04691115|475040029|FG004|Overall Study|Withdrawal by Subject|0|||
131932449|NCT04691115|475040030|FG005|Overall Study|Withdrawal by Subject|1|||
131932450|NCT04691115|475040031|FG006|Overall Study|Withdrawal by Subject|0|||
131932451|NCT04691115|475040032|FG007|Overall Study|Withdrawal by Subject|0|||
131932452|NCT04691115|475040033|FG008|Overall Study|Withdrawal by Subject|0|||
131411439|NCT02689076|473128645|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
131411440|NCT02689076|473128646|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
131411441|NCT02084238|473128647|FG000|Overall Study|Lost to Follow-up|2|||
131411442|NCT01304329|473128648|FG000|Third Intervention (3 Days)|Adverse Event|0|||
131411443|NCT01304329|473128649|FG001|Third Intervention (3 Days)|Adverse Event|1|||
131411444|NCT01304329|473128650|FG002|Third Intervention (3 Days)|Adverse Event|0|||
131932453|NCT04691115|475040034|FG009|Overall Study|Withdrawal by Subject|0|||
131932454|NCT04691115|475040035|FG010|Overall Study|Withdrawal by Subject|0|||
131932455|NCT04691115|475040036|FG011|Overall Study|Withdrawal by Subject|0|||
131932456|NCT04691115|475040037|FG012|Overall Study|Withdrawal by Subject|0|||
131932457|NCT04691115|475040038|FG013|Overall Study|Withdrawal by Subject|0|||
131932458|NCT01437189|475040044|FG000|Overall Study|Adverse Event|3|||
131932459|NCT01437189|475040044|FG000|Overall Study|Lack of Efficacy|4|||
131932460|NCT01437189|475040044|FG000|Overall Study|Withdrawal by Subject|8|||
131932461|NCT00347269|475040045|FG000|Overall Study|Lost to Follow-up|74|||
131932462|NCT00347269|475040046|FG001|Overall Study|Lost to Follow-up|65|||
131932463|NCT00347269|475040045|FG000|Overall Study|Withdrawal by Subject|18|||
131932464|NCT00347269|475040046|FG001|Overall Study|Withdrawal by Subject|38|||
131932465|NCT00347269|475040045|FG000|Overall Study|Death|2|||
131932466|NCT00347269|475040046|FG001|Overall Study|Death|3|||
131932467|NCT03654326|475040047|FG000|Overall Study|Withdrawal by Subject|5|||
131932468|NCT03654326|475040048|FG001|Overall Study|Withdrawal by Subject|3|||
131932469|NCT03654326|475040047|FG000|Overall Study|Physician Decision|0|||
131932470|NCT03654326|475040048|FG001|Overall Study|Physician Decision|1|||
131932471|NCT03654326|475040047|FG000|Overall Study|Unable to adhere to study schedule|0|||
131932472|NCT03654326|475040048|FG001|Overall Study|Unable to adhere to study schedule|1|||
131932473|NCT03654326|475040047|FG000|Overall Study|Lost to Follow-up|1|||
131932474|NCT03654326|475040048|FG001|Overall Study|Lost to Follow-up|1|||
131932475|NCT04102514|475040049|FG000|Overall Study|Death|3|||
131932476|NCT04102514|475040050|FG001|Overall Study|Death|0|||
131932477|NCT04102514|475040051|FG002|Overall Study|Death|0|||
131932478|NCT04102514|475040052|FG003|Overall Study|Death|0|||
131932479|NCT04102514|475040049|FG000|Overall Study|Lost to Follow-up|0|||
131932480|NCT04102514|475040050|FG001|Overall Study|Lost to Follow-up|0|||
131932481|NCT04102514|475040051|FG002|Overall Study|Lost to Follow-up|3|||
131932482|NCT04102514|475040052|FG003|Overall Study|Lost to Follow-up|0|||
131932483|NCT04102514|475040049|FG000|Overall Study|Physician Decision|0|||
131932484|NCT04102514|475040050|FG001|Overall Study|Physician Decision|0|||
131932485|NCT04102514|475040051|FG002|Overall Study|Physician Decision|1|||
131932486|NCT04102514|475040052|FG003|Overall Study|Physician Decision|0|||
131932487|NCT04102514|475040049|FG000|Overall Study|Withdrawal by Subject|7|||
131932488|NCT04102514|475040050|FG001|Overall Study|Withdrawal by Subject|13|||
131932489|NCT04102514|475040051|FG002|Overall Study|Withdrawal by Subject|7|||
131932490|NCT04102514|475040052|FG003|Overall Study|Withdrawal by Subject|14|||
131932491|NCT04102514|475040049|FG000|Overall Study|Moved to longterm care facility|6|||
131932492|NCT04102514|475040050|FG001|Overall Study|Moved to longterm care facility|0|||
131932493|NCT04102514|475040051|FG002|Overall Study|Moved to longterm care facility|4|||
131932494|NCT04102514|475040052|FG003|Overall Study|Moved to longterm care facility|0|||
131932495|NCT01689649|475040053|FG000|Overall Study|Lack of Efficacy|3|||
131932496|NCT01689649|475040053|FG000|Overall Study|Non-compliance|11|||
131932497|NCT01689649|475040053|FG000|Overall Study|Protocol Violation|3|||
131932498|NCT01689649|475040053|FG000|Overall Study|Lost to Follow-up|5|||
131932499|NCT00619918|475040054|FG000|Overall Study|Withdrawal by Subject|4|||
131932500|NCT00619918|475040055|FG001|Overall Study|Withdrawal by Subject|3|||
131932501|NCT00619918|475040054|FG000|Overall Study|Physician Decision|2|||
131932502|NCT00619918|475040055|FG001|Overall Study|Physician Decision|4|||
131932503|NCT00619918|475040054|FG000|Overall Study|Transfer to outside facility|3|||
131932504|NCT00619918|475040055|FG001|Overall Study|Transfer to outside facility|3|||
131932505|NCT00619918|475040054|FG000|Overall Study|Left before receiving first dose|7|||
131932506|NCT00619918|475040055|FG001|Overall Study|Left before receiving first dose|6|||
131932507|NCT00619918|475040054|FG000|Overall Study|ICU admission|4|||
131411445|NCT01304329|473128651|FG003|Third Intervention (3 Days)|Adverse Event|0|||
131932508|NCT00619918|475040055|FG001|Overall Study|ICU admission|6|||
131932509|NCT02096354|475040064|FG000|Overall Study|Physician Decision|4|||
131932510|NCT02096354|475040065|FG001|Overall Study|Physician Decision|5|||
131932511|NCT02096354|475040066|FG002|Overall Study|Physician Decision|0|||
131932512|NCT02096354|475040064|FG000|Overall Study|Withdrawal by Subject|3|||
131932513|NCT02096354|475040065|FG001|Overall Study|Withdrawal by Subject|1|||
131932514|NCT02096354|475040066|FG002|Overall Study|Withdrawal by Subject|0|||
131932515|NCT02096354|475040064|FG000|Overall Study|Adverse Event|7|||
131932516|NCT02096354|475040065|FG001|Overall Study|Adverse Event|4|||
131932517|NCT02096354|475040066|FG002|Overall Study|Adverse Event|0|||
131932518|NCT02096354|475040064|FG000|Overall Study|Ineligible|0|||
131932519|NCT02096354|475040065|FG001|Overall Study|Ineligible|0|||
131932520|NCT02096354|475040066|FG002|Overall Study|Ineligible|11|||
131932521|NCT03715829|475040067|FG000|Dose Ranging Period|Adverse Event|2|||
131932522|NCT03715829|475040068|FG001|Dose Ranging Period|Adverse Event|4|||
131932523|NCT03715829|475040069|FG002|Dose Ranging Period|Adverse Event|5|||
131932524|NCT03715829|475040070|FG003|Dose Ranging Period|Adverse Event|2|||
131932525|NCT03715829|475040071|FG004|Dose Ranging Period|Adverse Event|3|||
131932526|NCT03715829|475040072|FG005|Dose Ranging Period|Adverse Event|3|||
131932527|NCT03715829|475040073|FG006|Dose Ranging Period|Adverse Event|0|||
131932528|NCT03715829|475040074|FG007|Dose Ranging Period|Adverse Event|0|||
131932529|NCT03715829|475040075|FG008|Dose Ranging Period|Adverse Event|0|||
131932530|NCT03715829|475040076|FG009|Dose Ranging Period|Adverse Event|0|||
131932531|NCT03715829|475040077|FG010|Dose Ranging Period|Adverse Event|0|||
131932532|NCT03715829|475040067|FG000|Dose Ranging Period|Lack of Efficacy|0|||
131932533|NCT03715829|475040068|FG001|Dose Ranging Period|Lack of Efficacy|1|||
131932534|NCT03715829|475040069|FG002|Dose Ranging Period|Lack of Efficacy|0|||
131932535|NCT03715829|475040070|FG003|Dose Ranging Period|Lack of Efficacy|1|||
131932536|NCT03715829|475040071|FG004|Dose Ranging Period|Lack of Efficacy|0|||
131932537|NCT03715829|475040072|FG005|Dose Ranging Period|Lack of Efficacy|0|||
131932538|NCT03715829|475040073|FG006|Dose Ranging Period|Lack of Efficacy|0|||
131932539|NCT03715829|475040074|FG007|Dose Ranging Period|Lack of Efficacy|0|||
131932540|NCT03715829|475040075|FG008|Dose Ranging Period|Lack of Efficacy|0|||
131932541|NCT03715829|475040076|FG009|Dose Ranging Period|Lack of Efficacy|0|||
131932542|NCT03715829|475040077|FG010|Dose Ranging Period|Lack of Efficacy|0|||
131932543|NCT03715829|475040067|FG000|Dose Ranging Period|Lost to Follow-up|2|||
131932544|NCT03715829|475040068|FG001|Dose Ranging Period|Lost to Follow-up|0|||
131932545|NCT03715829|475040069|FG002|Dose Ranging Period|Lost to Follow-up|1|||
131932546|NCT03715829|475040070|FG003|Dose Ranging Period|Lost to Follow-up|1|||
131932547|NCT03715829|475040071|FG004|Dose Ranging Period|Lost to Follow-up|1|||
131932548|NCT03715829|475040072|FG005|Dose Ranging Period|Lost to Follow-up|2|||
131932549|NCT03715829|475040073|FG006|Dose Ranging Period|Lost to Follow-up|0|||
131932550|NCT03715829|475040074|FG007|Dose Ranging Period|Lost to Follow-up|0|||
131932551|NCT03715829|475040075|FG008|Dose Ranging Period|Lost to Follow-up|0|||
131932552|NCT03715829|475040076|FG009|Dose Ranging Period|Lost to Follow-up|0|||
131932553|NCT03715829|475040077|FG010|Dose Ranging Period|Lost to Follow-up|0|||
131932554|NCT03715829|475040067|FG000|Dose Ranging Period|Protocol Violation|0|||
131932555|NCT03715829|475040068|FG001|Dose Ranging Period|Protocol Violation|0|||
131932556|NCT03715829|475040069|FG002|Dose Ranging Period|Protocol Violation|0|||
131932557|NCT03715829|475040070|FG003|Dose Ranging Period|Protocol Violation|1|||
131932558|NCT03715829|475040071|FG004|Dose Ranging Period|Protocol Violation|0|||
131932559|NCT03715829|475040072|FG005|Dose Ranging Period|Protocol Violation|0|||
131932560|NCT03715829|475040073|FG006|Dose Ranging Period|Protocol Violation|0|||
131932561|NCT03715829|475040074|FG007|Dose Ranging Period|Protocol Violation|0|||
131932562|NCT03715829|475040075|FG008|Dose Ranging Period|Protocol Violation|0|||
131932563|NCT03715829|475040076|FG009|Dose Ranging Period|Protocol Violation|0|||
131932564|NCT03715829|475040077|FG010|Dose Ranging Period|Protocol Violation|0|||
131932565|NCT03715829|475040067|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
131932566|NCT03715829|475040068|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
131932567|NCT03715829|475040069|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
131932568|NCT03715829|475040070|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
131932569|NCT03715829|475040071|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
131932570|NCT03715829|475040072|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
131932571|NCT03715829|475040073|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
131932572|NCT03715829|475040074|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
131932573|NCT03715829|475040075|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
131932574|NCT03715829|475040076|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
131932575|NCT03715829|475040077|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
131932576|NCT03715829|475040067|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932577|NCT03715829|475040068|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932578|NCT03715829|475040069|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
131932579|NCT03715829|475040070|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932580|NCT03715829|475040071|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932581|NCT03715829|475040072|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932582|NCT03715829|475040073|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932583|NCT03715829|475040074|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932584|NCT03715829|475040075|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932585|NCT03715829|475040076|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932586|NCT03715829|475040077|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
131932587|NCT03715829|475040067|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932588|NCT03715829|475040068|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932589|NCT03715829|475040069|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
131932590|NCT03715829|475040070|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932591|NCT03715829|475040071|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
131932592|NCT03715829|475040072|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932593|NCT03715829|475040073|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131411446|NCT01304329|473128652|FG004|Third Intervention (3 Days)|Adverse Event|0|||
131411447|NCT01304329|473128653|FG005|Third Intervention (3 Days)|Adverse Event|0|||
131411448|NCT00993499|473128660|FG000|Run-in Period (8 Days)|Adverse Event|0|||
131411449|NCT00993499|473128661|FG001|Run-in Period (8 Days)|Adverse Event|1|||
131411450|NCT00993499|473128662|FG002|Run-in Period (8 Days)|Adverse Event|0|||
131411451|NCT00993499|473128663|FG003|Run-in Period (8 Days)|Adverse Event|0|||
131411452|NCT00993499|473128664|FG004|Run-in Period (8 Days)|Adverse Event|0|||
131411453|NCT00993499|473128665|FG005|Run-in Period (8 Days)|Adverse Event|0|||
131411454|NCT00993499|473128660|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
131411455|NCT00993499|473128661|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
131411456|NCT00993499|473128662|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
131411457|NCT00993499|473128663|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
131411458|NCT00993499|473128664|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
131411459|NCT00993499|473128665|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
131411460|NCT00993499|473128660|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
131411461|NCT00993499|473128661|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
131411462|NCT00993499|473128662|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
131411463|NCT00993499|473128663|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
131411464|NCT00993499|473128664|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
131411465|NCT00993499|473128665|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
131411466|NCT00993499|473128660|FG000|Run-in Period (8 Days)|Progressive disease|0|||
131411467|NCT00993499|473128661|FG001|Run-in Period (8 Days)|Progressive disease|1|||
131411468|NCT00993499|473128662|FG002|Run-in Period (8 Days)|Progressive disease|1|||
131411469|NCT00993499|473128663|FG003|Run-in Period (8 Days)|Progressive disease|0|||
131411470|NCT00993499|473128664|FG004|Run-in Period (8 Days)|Progressive disease|0|||
131411471|NCT00993499|473128665|FG005|Run-in Period (8 Days)|Progressive disease|0|||
131411472|NCT00993499|473128660|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
131411473|NCT00993499|473128661|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
131411474|NCT00993499|473128662|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
131411475|NCT00993499|473128663|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
131411476|NCT00993499|473128664|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
131411477|NCT00993499|473128665|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
131411478|NCT00993499|473128660|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
131411479|NCT00993499|473128661|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
131411480|NCT00993499|473128662|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
131411481|NCT00993499|473128663|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
131411482|NCT00993499|473128664|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
131411483|NCT00993499|473128665|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
131411484|NCT00993499|473128660|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
131411485|NCT00993499|473128661|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
131411486|NCT00993499|473128662|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
131411487|NCT00993499|473128663|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
131411488|NCT00993499|473128664|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
131411489|NCT00993499|473128665|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
131411490|NCT00993499|473128660|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
131411491|NCT00993499|473128661|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
131411492|NCT00993499|473128662|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
131411493|NCT00993499|473128663|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
131411494|NCT00993499|473128664|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
131411495|NCT00993499|473128665|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
131411496|NCT00993499|473128660|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
131932594|NCT03715829|475040074|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131411497|NCT00993499|473128661|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
131411498|NCT00993499|473128662|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
131411499|NCT00993499|473128663|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
131411500|NCT00993499|473128664|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
131411501|NCT00993499|473128665|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
131411502|NCT00993499|473128660|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
131411503|NCT00993499|473128661|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
131411504|NCT00993499|473128662|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
131411505|NCT00993499|473128663|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
131411506|NCT00993499|473128664|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
131932595|NCT03715829|475040075|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932596|NCT03715829|475040076|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932597|NCT03715829|475040077|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
131932598|NCT03715829|475040067|FG000|Dose Ranging Period|Other|0|||
131932599|NCT03715829|475040068|FG001|Dose Ranging Period|Other|0|||
131932600|NCT03715829|475040069|FG002|Dose Ranging Period|Other|2|||
131932601|NCT03715829|475040070|FG003|Dose Ranging Period|Other|0|||
131932602|NCT03715829|475040071|FG004|Dose Ranging Period|Other|0|||
131932603|NCT03715829|475040072|FG005|Dose Ranging Period|Other|3|||
131932604|NCT03715829|475040073|FG006|Dose Ranging Period|Other|0|||
131932605|NCT03715829|475040074|FG007|Dose Ranging Period|Other|0|||
131932606|NCT03715829|475040075|FG008|Dose Ranging Period|Other|0|||
131932607|NCT03715829|475040076|FG009|Dose Ranging Period|Other|0|||
131932608|NCT03715829|475040077|FG010|Dose Ranging Period|Other|0|||
131932609|NCT03715829|475040067|FG000|Extension Period|Adverse Event|0|||
131932610|NCT03715829|475040068|FG001|Extension Period|Adverse Event|0|||
131932611|NCT03715829|475040069|FG002|Extension Period|Adverse Event|0|||
131932612|NCT03715829|475040070|FG003|Extension Period|Adverse Event|0|||
131932613|NCT03715829|475040071|FG004|Extension Period|Adverse Event|0|||
131932614|NCT03715829|475040072|FG005|Extension Period|Adverse Event|0|||
131411507|NCT00993499|473128665|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
131411508|NCT00993499|473128660|FG000|Discontinued After Starting Course 3|DLT|1|||
131411509|NCT00993499|473128661|FG001|Discontinued After Starting Course 3|DLT|0|||
131932615|NCT03715829|475040073|FG006|Extension Period|Adverse Event|3|||
131932616|NCT03715829|475040074|FG007|Extension Period|Adverse Event|1|||
131932617|NCT03715829|475040075|FG008|Extension Period|Adverse Event|6|||
131932618|NCT03715829|475040076|FG009|Extension Period|Adverse Event|0|||
131932619|NCT03715829|475040077|FG010|Extension Period|Adverse Event|0|||
131932620|NCT03715829|475040067|FG000|Extension Period|Lack of Efficacy|0|||
131932621|NCT03715829|475040068|FG001|Extension Period|Lack of Efficacy|0|||
131932622|NCT03715829|475040069|FG002|Extension Period|Lack of Efficacy|0|||
131932623|NCT03715829|475040070|FG003|Extension Period|Lack of Efficacy|0|||
131932624|NCT03715829|475040071|FG004|Extension Period|Lack of Efficacy|0|||
131932625|NCT03715829|475040072|FG005|Extension Period|Lack of Efficacy|0|||
131932626|NCT03715829|475040073|FG006|Extension Period|Lack of Efficacy|1|||
131932627|NCT03715829|475040074|FG007|Extension Period|Lack of Efficacy|9|||
131932628|NCT03715829|475040075|FG008|Extension Period|Lack of Efficacy|2|||
131932629|NCT03715829|475040076|FG009|Extension Period|Lack of Efficacy|0|||
131932630|NCT03715829|475040077|FG010|Extension Period|Lack of Efficacy|0|||
131932631|NCT03715829|475040067|FG000|Extension Period|Lost to Follow-up|0|||
131932632|NCT03715829|475040068|FG001|Extension Period|Lost to Follow-up|0|||
131932633|NCT03715829|475040069|FG002|Extension Period|Lost to Follow-up|0|||
131932634|NCT03715829|475040070|FG003|Extension Period|Lost to Follow-up|0|||
131932635|NCT03715829|475040071|FG004|Extension Period|Lost to Follow-up|0|||
131932636|NCT03715829|475040072|FG005|Extension Period|Lost to Follow-up|0|||
131932637|NCT03715829|475040073|FG006|Extension Period|Lost to Follow-up|0|||
131932638|NCT03715829|475040074|FG007|Extension Period|Lost to Follow-up|0|||
131932639|NCT03715829|475040075|FG008|Extension Period|Lost to Follow-up|2|||
131932640|NCT03715829|475040076|FG009|Extension Period|Lost to Follow-up|0|||
131932641|NCT03715829|475040077|FG010|Extension Period|Lost to Follow-up|0|||
131932642|NCT03715829|475040067|FG000|Extension Period|Protocol Violation|0|||
131932643|NCT03715829|475040068|FG001|Extension Period|Protocol Violation|0|||
131932644|NCT03715829|475040069|FG002|Extension Period|Protocol Violation|0|||
131932645|NCT03715829|475040070|FG003|Extension Period|Protocol Violation|0|||
131932646|NCT03715829|475040071|FG004|Extension Period|Protocol Violation|0|||
131932647|NCT03715829|475040072|FG005|Extension Period|Protocol Violation|0|||
131932648|NCT03715829|475040073|FG006|Extension Period|Protocol Violation|0|||
131932649|NCT03715829|475040074|FG007|Extension Period|Protocol Violation|0|||
131932650|NCT03715829|475040075|FG008|Extension Period|Protocol Violation|1|||
131932651|NCT03715829|475040076|FG009|Extension Period|Protocol Violation|0|||
131932652|NCT03715829|475040077|FG010|Extension Period|Protocol Violation|0|||
131932653|NCT03715829|475040067|FG000|Extension Period|Withdrawal by Subject|0|||
131932654|NCT03715829|475040068|FG001|Extension Period|Withdrawal by Subject|0|||
131411510|NCT00993499|473128662|FG002|Discontinued After Starting Course 3|DLT|2|||
131411511|NCT00993499|473128663|FG003|Discontinued After Starting Course 3|DLT|1|||
131411512|NCT00993499|473128664|FG004|Discontinued After Starting Course 3|DLT|0|||
131932655|NCT03715829|475040069|FG002|Extension Period|Withdrawal by Subject|0|||
131932656|NCT03715829|475040070|FG003|Extension Period|Withdrawal by Subject|0|||
131932657|NCT03715829|475040071|FG004|Extension Period|Withdrawal by Subject|0|||
131932658|NCT03715829|475040072|FG005|Extension Period|Withdrawal by Subject|0|||
131932659|NCT03715829|475040073|FG006|Extension Period|Withdrawal by Subject|3|||
131932660|NCT03715829|475040074|FG007|Extension Period|Withdrawal by Subject|3|||
131932661|NCT03715829|475040075|FG008|Extension Period|Withdrawal by Subject|12|||
131932662|NCT03715829|475040076|FG009|Extension Period|Withdrawal by Subject|3|||
131932663|NCT03715829|475040077|FG010|Extension Period|Withdrawal by Subject|0|||
131411513|NCT00993499|473128665|FG005|Discontinued After Starting Course 3|DLT|0|||
131932664|NCT03715829|475040067|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932665|NCT03715829|475040068|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932666|NCT03715829|475040069|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932667|NCT03715829|475040070|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932668|NCT03715829|475040071|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932669|NCT03715829|475040072|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932670|NCT03715829|475040073|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932671|NCT03715829|475040074|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
131932672|NCT03715829|475040075|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
131932673|NCT03715829|475040076|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932674|NCT03715829|475040077|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
131932675|NCT03715829|475040067|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932676|NCT03715829|475040068|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932677|NCT03715829|475040069|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932678|NCT03715829|475040070|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932679|NCT03715829|475040071|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932680|NCT03715829|475040072|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932681|NCT03715829|475040073|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932682|NCT03715829|475040074|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932683|NCT03715829|475040075|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
131932684|NCT03715829|475040076|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932685|NCT03715829|475040077|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
131932686|NCT03715829|475040067|FG000|Extension Period|Other|0|||
131932687|NCT03715829|475040068|FG001|Extension Period|Other|0|||
131932688|NCT03715829|475040069|FG002|Extension Period|Other|0|||
131932689|NCT03715829|475040070|FG003|Extension Period|Other|0|||
131932690|NCT03715829|475040071|FG004|Extension Period|Other|0|||
131932691|NCT03715829|475040072|FG005|Extension Period|Other|0|||
131932692|NCT03715829|475040073|FG006|Extension Period|Other|1|||
131932693|NCT03715829|475040074|FG007|Extension Period|Other|2|||
131932694|NCT03715829|475040075|FG008|Extension Period|Other|4|||
131932695|NCT03715829|475040076|FG009|Extension Period|Other|0|||
131932696|NCT03715829|475040077|FG010|Extension Period|Other|0|||
131932697|NCT03579719|475040078|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
131411514|NCT00993499|473128660|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
131411515|NCT00993499|473128661|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
131411516|NCT00993499|473128662|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
131411517|NCT00993499|473128663|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
131411518|NCT00993499|473128664|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
131411519|NCT00993499|473128665|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
131411520|NCT01406015|473128674|FG000|Overall Study|Withdrawal by Subject|3|||
131411521|NCT01406015|473128675|FG001|Overall Study|Withdrawal by Subject|3|||
131411522|NCT00844805|473128676|FG000|Treatment Phase|Adverse Event|5|||
131411523|NCT00844805|473128677|FG001|Treatment Phase|Adverse Event|1|||
131411524|NCT00844805|473128678|FG002|Treatment Phase|Adverse Event|0|||
131411525|NCT00844805|473128679|FG003|Treatment Phase|Adverse Event|0|||
131411526|NCT00844805|473128676|FG000|Treatment Phase|Withdrawal by Subject|3|||
131411527|NCT00844805|473128677|FG001|Treatment Phase|Withdrawal by Subject|4|||
131411528|NCT00844805|473128678|FG002|Treatment Phase|Withdrawal by Subject|0|||
131411529|NCT00844805|473128679|FG003|Treatment Phase|Withdrawal by Subject|0|||
131411530|NCT00844805|473128676|FG000|Treatment Phase|Noncompliance With Protocol|1|||
131411531|NCT00844805|473128677|FG001|Treatment Phase|Noncompliance With Protocol|0|||
131411532|NCT00844805|473128678|FG002|Treatment Phase|Noncompliance With Protocol|0|||
131411533|NCT00844805|473128679|FG003|Treatment Phase|Noncompliance With Protocol|0|||
131411534|NCT00844805|473128676|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
131411535|NCT00844805|473128677|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
131411536|NCT00844805|473128678|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
131411537|NCT00844805|473128679|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
131411538|NCT00844805|473128676|FG000|Follow-Up Phase|Adverse Event|0|||
131411539|NCT00844805|473128677|FG001|Follow-Up Phase|Adverse Event|0|||
131411540|NCT00844805|473128678|FG002|Follow-Up Phase|Adverse Event|1|||
131411541|NCT00844805|473128679|FG003|Follow-Up Phase|Adverse Event|0|||
131411542|NCT00844805|473128676|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
131411543|NCT00844805|473128677|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
131411544|NCT00844805|473128678|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
131411545|NCT00844805|473128679|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
131411546|NCT00844805|473128676|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
131411547|NCT00844805|473128677|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
131454253|NCT03656562|473293255|FG002|Overall Study|Subject Decision|0|||
131411548|NCT00844805|473128678|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
131411549|NCT00844805|473128679|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
131454254|NCT03656562|473293256|FG003|Overall Study|Subject Decision|2|||
131932700|NCT01916226|475040081|FG000|Overall Study|Adverse Event|1|||
131932701|NCT01916226|475040082|FG001|Overall Study|Adverse Event|0|||
131932702|NCT01916226|475040083|FG002|Overall Study|Adverse Event|1|||
131932703|NCT01916226|475040084|FG003|Overall Study|Adverse Event|1|||
131932704|NCT01916226|475040081|FG000|Overall Study|Lack of Efficacy|0|||
131932705|NCT01916226|475040082|FG001|Overall Study|Lack of Efficacy|0|||
131932706|NCT01916226|475040083|FG002|Overall Study|Lack of Efficacy|2|||
131932707|NCT01916226|475040084|FG003|Overall Study|Lack of Efficacy|1|||
131932708|NCT01916226|475040081|FG000|Overall Study|Protocol Violation|0|||
131932709|NCT01916226|475040082|FG001|Overall Study|Protocol Violation|1|||
131932710|NCT01916226|475040083|FG002|Overall Study|Protocol Violation|0|||
131932711|NCT01916226|475040084|FG003|Overall Study|Protocol Violation|1|||
131932712|NCT01916226|475040081|FG000|Overall Study|Physician Decision|0|||
131932713|NCT01916226|475040082|FG001|Overall Study|Physician Decision|0|||
131932714|NCT01916226|475040083|FG002|Overall Study|Physician Decision|0|||
131932715|NCT01916226|475040084|FG003|Overall Study|Physician Decision|1|||
131932716|NCT03163667|475040085|FG000|Overall Study|Death|15|||
131932717|NCT03163667|475040086|FG001|Overall Study|Death|27|||
131932718|NCT03163667|475040085|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
131932719|NCT03163667|475040086|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
131932720|NCT05430919|475040087|FG000|Overall Study|Protocol Violation|0|||
131932721|NCT05430919|475040088|FG001|Overall Study|Protocol Violation|0|||
131932722|NCT05430919|475040089|FG002|Overall Study|Protocol Violation|1|||
131932723|NCT05430919|475040090|FG003|Overall Study|Protocol Violation|0|||
131932724|NCT05430919|475040087|FG000|Overall Study|Lost to Follow-up|0|||
131932725|NCT05430919|475040088|FG001|Overall Study|Lost to Follow-up|1|||
131932726|NCT05430919|475040089|FG002|Overall Study|Lost to Follow-up|0|||
131932727|NCT05430919|475040090|FG003|Overall Study|Lost to Follow-up|0|||
131932728|NCT05430919|475040087|FG000|Overall Study|Withdrawal by Subject|3|||
131932729|NCT05430919|475040088|FG001|Overall Study|Withdrawal by Subject|0|||
131932730|NCT05430919|475040089|FG002|Overall Study|Withdrawal by Subject|0|||
131932731|NCT05430919|475040090|FG003|Overall Study|Withdrawal by Subject|1|||
131932732|NCT00855166|475040091|FG000|Overall Study|Adverse Event|0|||
131932733|NCT00855166|475040092|FG001|Overall Study|Adverse Event|2|||
131932734|NCT00855166|475040091|FG000|Overall Study|Death|0|||
131932735|NCT00855166|475040092|FG001|Overall Study|Death|1|||
131932736|NCT00855166|475040091|FG000|Overall Study|Withdrawal by Subject|1|||
131932737|NCT00855166|475040092|FG001|Overall Study|Withdrawal by Subject|4|||
131932738|NCT00855166|475040091|FG000|Overall Study|Poor/non-compliance|2|||
131932739|NCT00855166|475040092|FG001|Overall Study|Poor/non-compliance|0|||
131932740|NCT00855166|475040091|FG000|Overall Study|Administrative reasons by sponsor|1|||
131932741|NCT00855166|475040092|FG001|Overall Study|Administrative reasons by sponsor|0|||
131932742|NCT00855166|475040091|FG000|Overall Study|Subject no longer meets study criteria|1|||
131932743|NCT00855166|475040092|FG001|Overall Study|Subject no longer meets study criteria|1|||
131932744|NCT01422382|475040093|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
131932745|NCT04082364|475040094|FG000|Overall Study|Death|23|||
131932746|NCT04082364|475040095|FG001|Overall Study|Death|1|||
131932747|NCT04082364|475040096|FG002|Overall Study|Death|1|||
131932748|NCT04082364|475040097|FG003|Overall Study|Death|2|||
131932749|NCT04082364|475040098|FG004|Overall Study|Death|1|||
131932750|NCT04082364|475040094|FG000|Overall Study|Lost to Follow-up|1|||
131932751|NCT04082364|475040095|FG001|Overall Study|Lost to Follow-up|0|||
131932752|NCT04082364|475040096|FG002|Overall Study|Lost to Follow-up|0|||
131932753|NCT04082364|475040097|FG003|Overall Study|Lost to Follow-up|0|||
131932754|NCT04082364|475040098|FG004|Overall Study|Lost to Follow-up|1|||
131932755|NCT04082364|475040094|FG000|Overall Study|Physician Decision|1|||
131932756|NCT04082364|475040095|FG001|Overall Study|Physician Decision|1|||
131932757|NCT04082364|475040096|FG002|Overall Study|Physician Decision|0|||
131932758|NCT04082364|475040097|FG003|Overall Study|Physician Decision|2|||
131932759|NCT04082364|475040098|FG004|Overall Study|Physician Decision|1|||
131932760|NCT04082364|475040094|FG000|Overall Study|Withdrawal by Subject|1|||
131932761|NCT04082364|475040095|FG001|Overall Study|Withdrawal by Subject|1|||
131932762|NCT04082364|475040096|FG002|Overall Study|Withdrawal by Subject|0|||
131411550|NCT00844805|473128676|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
131411551|NCT00844805|473128677|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
131411552|NCT00844805|473128678|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
131932763|NCT04082364|475040097|FG003|Overall Study|Withdrawal by Subject|0|||
131932764|NCT04082364|475040098|FG004|Overall Study|Withdrawal by Subject|1|||
131932765|NCT04082364|475040094|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
131932766|NCT04082364|475040095|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
131932767|NCT04082364|475040096|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
131932768|NCT04082364|475040097|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
131932769|NCT04082364|475040098|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
131411553|NCT00844805|473128679|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
131932770|NCT04082364|475040094|FG000|Overall Study|Disease progression|0|||
131411554|NCT00844805|473128676|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
131932771|NCT04082364|475040095|FG001|Overall Study|Disease progression|0|||
131932772|NCT04082364|475040096|FG002|Overall Study|Disease progression|0|||
131932773|NCT04082364|475040097|FG003|Overall Study|Disease progression|1|||
131932774|NCT04082364|475040098|FG004|Overall Study|Disease progression|0|||
131932775|NCT05021224|475040101|FG000|Overall Study|Did not complete all survey items|4|||
131411555|NCT00844805|473128677|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
131411556|NCT00844805|473128678|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
131411557|NCT00844805|473128679|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
131411558|NCT00293709|473130241|FG000|Overall Study|Other|47|||
131411559|NCT02088073|473130242|FG000|Acute Phase|Withdrawal by Subject|5|||
131411560|NCT02088073|473130243|FG001|Acute Phase|Withdrawal by Subject|0|||
131411561|NCT02088073|473130244|FG002|Acute Phase|Withdrawal by Subject|0|||
131411562|NCT02088073|473130245|FG003|Acute Phase|Withdrawal by Subject|0|||
131411563|NCT02088073|473130246|FG004|Acute Phase|Withdrawal by Subject|0|||
131411564|NCT02088073|473130242|FG000|Acute Phase|Hyperkalemia|2|||
131411565|NCT02088073|473130243|FG001|Acute Phase|Hyperkalemia|0|||
131411566|NCT02088073|473130244|FG002|Acute Phase|Hyperkalemia|0|||
131411567|NCT02088073|473130245|FG003|Acute Phase|Hyperkalemia|0|||
131411568|NCT02088073|473130246|FG004|Acute Phase|Hyperkalemia|0|||
131411569|NCT02088073|473130242|FG000|Maintanance Phase|Withdrawal by Subject|0|||
131411570|NCT02088073|473130243|FG001|Maintanance Phase|Withdrawal by Subject|2|||
131411571|NCT02088073|473130244|FG002|Maintanance Phase|Withdrawal by Subject|0|||
131411572|NCT02088073|473130245|FG003|Maintanance Phase|Withdrawal by Subject|0|||
131411573|NCT02088073|473130246|FG004|Maintanance Phase|Withdrawal by Subject|0|||
131411574|NCT02088073|473130242|FG000|Maintanance Phase|Adverse Event|0|||
131411575|NCT02088073|473130243|FG001|Maintanance Phase|Adverse Event|0|||
131411576|NCT02088073|473130244|FG002|Maintanance Phase|Adverse Event|3|||
131411577|NCT02088073|473130245|FG003|Maintanance Phase|Adverse Event|0|||
131411578|NCT02088073|473130246|FG004|Maintanance Phase|Adverse Event|1|||
131411579|NCT02088073|473130242|FG000|Maintanance Phase|Physician Decision|0|||
131411580|NCT02088073|473130243|FG001|Maintanance Phase|Physician Decision|0|||
131411581|NCT02088073|473130244|FG002|Maintanance Phase|Physician Decision|0|||
131411582|NCT02088073|473130245|FG003|Maintanance Phase|Physician Decision|0|||
131411583|NCT02088073|473130246|FG004|Maintanance Phase|Physician Decision|1|||
131411584|NCT02088073|473130242|FG000|Maintanance Phase|Sponsor's decision|0|||
131411585|NCT02088073|473130243|FG001|Maintanance Phase|Sponsor's decision|2|||
131411586|NCT02088073|473130244|FG002|Maintanance Phase|Sponsor's decision|0|||
131411587|NCT02088073|473130245|FG003|Maintanance Phase|Sponsor's decision|2|||
131411588|NCT02088073|473130246|FG004|Maintanance Phase|Sponsor's decision|1|||
131411589|NCT02088073|473130242|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
131411590|NCT02088073|473130243|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
131411591|NCT02088073|473130244|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
131411592|NCT02088073|473130245|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
131411593|NCT02088073|473130246|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
131411594|NCT02088073|473130242|FG000|Maintanance Phase|Miscellaneous|0|||
131411595|NCT02088073|473130243|FG001|Maintanance Phase|Miscellaneous|2|||
131411596|NCT02088073|473130244|FG002|Maintanance Phase|Miscellaneous|1|||
131411597|NCT02088073|473130245|FG003|Maintanance Phase|Miscellaneous|2|||
131411598|NCT02088073|473130246|FG004|Maintanance Phase|Miscellaneous|1|||
131411599|NCT02088073|473130242|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
131411600|NCT02088073|473130243|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
131411601|NCT02088073|473130244|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
131411602|NCT02088073|473130245|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
131411603|NCT02088073|473130246|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
131411604|NCT02088073|473130242|FG000|Maintanance Phase|Subject compliance|0|||
131411605|NCT02088073|473130243|FG001|Maintanance Phase|Subject compliance|1|||
131411606|NCT02088073|473130244|FG002|Maintanance Phase|Subject compliance|0|||
131411607|NCT02088073|473130245|FG003|Maintanance Phase|Subject compliance|0|||
131411608|NCT02088073|473130246|FG004|Maintanance Phase|Subject compliance|0|||
131411609|NCT01804582|473130247|FG000|Overall Study|Lost to Follow-up|47|||
131411610|NCT01804582|473130248|FG001|Overall Study|Lost to Follow-up|56|||
131411611|NCT01804582|473130247|FG000|Overall Study|Physician Decision|2|||
131411612|NCT01804582|473130248|FG001|Overall Study|Physician Decision|0|||
131411613|NCT02969590|473130252|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
131411614|NCT02969590|473130253|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
131411615|NCT02969590|473130254|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
131411616|NCT02590562|473130259|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
131411617|NCT01149486|473130261|FG000|First Intervention|Adverse Event|0|||
131411618|NCT01149486|473130262|FG001|First Intervention|Adverse Event|1|||
131411619|NCT01135914|473130263|FG000|Overall Study|Withdrawal by Subject|1|||
131411620|NCT01135914|473130264|FG001|Overall Study|Withdrawal by Subject|3|||
131411621|NCT01135914|473130265|FG002|Overall Study|Withdrawal by Subject|6|||
131411622|NCT01135914|473130263|FG000|Overall Study|Lost to Follow-up|1|||
131411623|NCT01135914|473130264|FG001|Overall Study|Lost to Follow-up|0|||
131411624|NCT01135914|473130265|FG002|Overall Study|Lost to Follow-up|1|||
131411625|NCT01135914|473130263|FG000|Overall Study|Protocol Violation|0|||
131411626|NCT01135914|473130264|FG001|Overall Study|Protocol Violation|0|||
131411627|NCT01135914|473130265|FG002|Overall Study|Protocol Violation|3|||
131411628|NCT01135914|473130263|FG000|Overall Study|Lack of Efficacy|2|||
131411629|NCT01135914|473130264|FG001|Overall Study|Lack of Efficacy|1|||
131411630|NCT01135914|473130265|FG002|Overall Study|Lack of Efficacy|10|||
131411631|NCT01135914|473130263|FG000|Overall Study|Adverse Event|0|||
131932776|NCT05021224|475040102|FG001|Overall Study|Did not complete all survey items|1|||
131932777|NCT05021224|475040103|FG002|Overall Study|Did not complete all survey items|0|||
131932778|NCT05021224|475040104|FG003|Overall Study|Did not complete all survey items|2|||
131932779|NCT02061085|475040105|FG000|Overall Study|Adverse Event|8|||
131932780|NCT03973489|475040111|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
131932781|NCT03973489|475040112|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
131932782|NCT03973489|475040113|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
131932783|NCT03973489|475040114|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
131932784|NCT03973489|475040115|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
131932785|NCT03973489|475040116|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
131932786|NCT03973489|475040117|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
131932787|NCT03973489|475040118|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
131932788|NCT03973489|475040111|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
131932789|NCT03973489|475040112|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
131932790|NCT03973489|475040113|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
131932791|NCT03973489|475040114|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
131932792|NCT03973489|475040115|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
131932793|NCT03973489|475040116|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
131932794|NCT03973489|475040117|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
131932795|NCT03973489|475040118|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
131932796|NCT03973489|475040111|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
131932797|NCT03973489|475040112|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
131932798|NCT03973489|475040113|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
131932799|NCT03973489|475040114|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
131932800|NCT03973489|475040115|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
131932801|NCT03973489|475040116|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
131932802|NCT03973489|475040117|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
131932803|NCT03973489|475040118|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
131932804|NCT03973489|475040111|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
131932805|NCT03973489|475040112|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
131932806|NCT03973489|475040113|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
131932807|NCT03973489|475040114|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
131932808|NCT03973489|475040115|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
131932809|NCT03973489|475040116|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
131932810|NCT03973489|475040117|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
131932811|NCT03973489|475040118|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
131932812|NCT03973489|475040111|FG000|Second Intervention (1 Day)|Adverse Event|0|||
131932813|NCT03973489|475040112|FG001|Second Intervention (1 Day)|Adverse Event|0|||
131932814|NCT03973489|475040113|FG002|Second Intervention (1 Day)|Adverse Event|0|||
131932815|NCT03973489|475040114|FG003|Second Intervention (1 Day)|Adverse Event|1|||
131932816|NCT03973489|475040115|FG004|Second Intervention (1 Day)|Adverse Event|0|||
131932817|NCT03973489|475040116|FG005|Second Intervention (1 Day)|Adverse Event|0|||
131932818|NCT03973489|475040117|FG006|Second Intervention (1 Day)|Adverse Event|0|||
131932819|NCT03973489|475040118|FG007|Second Intervention (1 Day)|Adverse Event|0|||
131932820|NCT02691494|475040119|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
131932821|NCT02691494|475040120|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
131932822|NCT02691494|475040121|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
131932823|NCT02691494|475040119|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
131932824|NCT02691494|475040120|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
131454255|NCT00337675|473293257|FG000|Overall Study|Adverse Event|10|||
131454256|NCT00337675|473293258|FG001|Overall Study|Adverse Event|9|||
131454257|NCT00337675|473293259|FG002|Overall Study|Adverse Event|19|||
131454258|NCT00337675|473293257|FG000|Overall Study|Lack of Efficacy|10|||
131454259|NCT00337675|473293258|FG001|Overall Study|Lack of Efficacy|7|||
131454260|NCT00337675|473293259|FG002|Overall Study|Lack of Efficacy|9|||
131454261|NCT00337675|473293257|FG000|Overall Study|Lost to Follow-up|22|||
131454262|NCT00337675|473293258|FG001|Overall Study|Lost to Follow-up|19|||
131454263|NCT00337675|473293259|FG002|Overall Study|Lost to Follow-up|17|||
131454264|NCT00337675|473293257|FG000|Overall Study|Physician Decision|9|||
131454265|NCT00337675|473293258|FG001|Overall Study|Physician Decision|17|||
131454266|NCT00337675|473293259|FG002|Overall Study|Physician Decision|14|||
131454267|NCT00337675|473293257|FG000|Overall Study|Protocol Violation|21|||
131454268|NCT00337675|473293258|FG001|Overall Study|Protocol Violation|24|||
131454269|NCT00337675|473293259|FG002|Overall Study|Protocol Violation|19|||
131454270|NCT00337675|473293257|FG000|Overall Study|Withdrawal by Subject|25|||
131454271|NCT00337675|473293258|FG001|Overall Study|Withdrawal by Subject|25|||
131932825|NCT02691494|475040121|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
131932826|NCT02691494|475040119|FG000|Post-Treatment Follow-Up Period|Other|2|||
131454272|NCT00337675|473293259|FG002|Overall Study|Withdrawal by Subject|19|||
131454273|NCT00337675|473293257|FG000|Overall Study|Progressive Disease|0|||
131932827|NCT02691494|475040120|FG001|Post-Treatment Follow-Up Period|Other|1|||
131932828|NCT02691494|475040121|FG002|Post-Treatment Follow-Up Period|Other|1|||
131932829|NCT02691494|475040119|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
131932830|NCT02691494|475040120|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
131932831|NCT02691494|475040121|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
131932832|NCT02691494|475040119|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
131932833|NCT02691494|475040120|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
131932834|NCT02691494|475040121|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
131932835|NCT00773461|475040124|FG000|Overall Study|Adverse Event|1|||
131932836|NCT00773461|475040125|FG001|Overall Study|Adverse Event|3|||
131932837|NCT00773461|475040124|FG000|Overall Study|Withdrawal by Subject|4|||
131932838|NCT00773461|475040125|FG001|Overall Study|Withdrawal by Subject|1|||
131932839|NCT00913835|475040126|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
131932840|NCT00913835|475040127|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
131932841|NCT00913835|475040126|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
131932842|NCT00913835|475040127|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
131932843|NCT00913835|475040126|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
131932844|NCT00913835|475040127|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
131932845|NCT00913835|475040126|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
131932846|NCT00913835|475040127|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
131932847|NCT00913835|475040126|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
131932848|NCT00913835|475040127|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
131932849|NCT00637156|475040128|FG000|Overall Study|Withdrawal by Subject|0|||
131932850|NCT00637156|475040129|FG001|Overall Study|Withdrawal by Subject|7|||
131932851|NCT00637156|475040128|FG000|Overall Study|Death|0|||
131932852|NCT00637156|475040129|FG001|Overall Study|Death|1|||
131932853|NCT00637156|475040128|FG000|Overall Study|Lost to Follow-up|10|||
131932854|NCT00637156|475040129|FG001|Overall Study|Lost to Follow-up|16|||
131932855|NCT00561821|475040130|FG000|Overall Study|Not treated|0|||
131932856|NCT00561821|475040131|FG001|Overall Study|Not treated|0|||
131932857|NCT00561821|475040132|FG002|Overall Study|Not treated|1|||
131932858|NCT00561821|475040133|FG003|Overall Study|Not treated|0|||
131932859|NCT00561821|475040130|FG000|Overall Study|Withdrawal by Subject|0|||
131932860|NCT00561821|475040131|FG001|Overall Study|Withdrawal by Subject|1|||
131932861|NCT00561821|475040132|FG002|Overall Study|Withdrawal by Subject|0|||
131932862|NCT00561821|475040133|FG003|Overall Study|Withdrawal by Subject|2|||
131932863|NCT00561821|475040130|FG000|Overall Study|Reasons not related to trial|2|||
131932864|NCT00561821|475040131|FG001|Overall Study|Reasons not related to trial|1|||
131932865|NCT00561821|475040132|FG002|Overall Study|Reasons not related to trial|0|||
131932866|NCT00561821|475040133|FG003|Overall Study|Reasons not related to trial|0|||
131932867|NCT00561821|475040130|FG000|Overall Study|Other (reason not specified)|1|||
131932868|NCT00561821|475040131|FG001|Overall Study|Other (reason not specified)|1|||
131932869|NCT00561821|475040132|FG002|Overall Study|Other (reason not specified)|0|||
131932870|NCT00561821|475040133|FG003|Overall Study|Other (reason not specified)|0|||
131932871|NCT00561821|475040130|FG000|Overall Study|Adverse Event|2|||
131932872|NCT00561821|475040131|FG001|Overall Study|Adverse Event|3|||
131932873|NCT00561821|475040132|FG002|Overall Study|Adverse Event|1|||
131932874|NCT00561821|475040133|FG003|Overall Study|Adverse Event|1|||
131932875|NCT04129398|475041348|FG000|Overall Study|Physician Decision|2|||
131932876|NCT02363283|475041353|FG000|Overall Study|Withdrawal by Subject|1|||
131932877|NCT02363283|475041353|FG000|Overall Study|Not eligible due to transaminitis|1|||
131932878|NCT01394185|475041354|FG000|Overall Study|Withdrawal by Subject|2|||
131932879|NCT01394185|475041355|FG001|Overall Study|Withdrawal by Subject|0|||
131932880|NCT01394185|475041356|FG002|Overall Study|Withdrawal by Subject|0|||
131932881|NCT01394185|475041357|FG003|Overall Study|Withdrawal by Subject|0|||
131932882|NCT01394185|475041358|FG004|Overall Study|Withdrawal by Subject|1|||
131932883|NCT01394185|475041359|FG005|Overall Study|Withdrawal by Subject|0|||
131932884|NCT01394185|475041354|FG000|Overall Study|Change in protocol|3|||
131932885|NCT01394185|475041355|FG001|Overall Study|Change in protocol|0|||
131932886|NCT01394185|475041356|FG002|Overall Study|Change in protocol|0|||
131932887|NCT01394185|475041357|FG003|Overall Study|Change in protocol|0|||
131932888|NCT01394185|475041358|FG004|Overall Study|Change in protocol|3|||
131932889|NCT01394185|475041359|FG005|Overall Study|Change in protocol|0|||
131932890|NCT01394185|475041354|FG000|Overall Study|Protocol Violation|1|||
131932891|NCT01394185|475041355|FG001|Overall Study|Protocol Violation|0|||
131932892|NCT01394185|475041356|FG002|Overall Study|Protocol Violation|0|||
131932893|NCT01394185|475041357|FG003|Overall Study|Protocol Violation|1|||
131932894|NCT01394185|475041358|FG004|Overall Study|Protocol Violation|0|||
131932895|NCT01394185|475041359|FG005|Overall Study|Protocol Violation|1|||
131932896|NCT00003907|475041372|FG000|Overall Study|Adverse Event|2|||
131932897|NCT00003907|475041373|FG001|Overall Study|Adverse Event|11|||
131932898|NCT00003907|475041372|FG000|Overall Study|Death|2|||
131932899|NCT00003907|475041373|FG001|Overall Study|Death|0|||
131932900|NCT00003907|475041372|FG000|Overall Study|Withdrawal by Subject|1|||
131932901|NCT00003907|475041373|FG001|Overall Study|Withdrawal by Subject|3|||
131932902|NCT00003907|475041372|FG000|Overall Study|Progressive disease|4|||
131932903|NCT00003907|475041373|FG001|Overall Study|Progressive disease|4|||
131932904|NCT00003907|475041372|FG000|Overall Study|Complicating disease|1|||
131932905|NCT00003907|475041373|FG001|Overall Study|Complicating disease|0|||
131932906|NCT00003907|475041372|FG000|Overall Study|Other|1|||
131932907|NCT00003907|475041373|FG001|Overall Study|Other|3|||
131932908|NCT00003907|475041372|FG000|Overall Study|ineligible or not treated|2|||
131932909|NCT00003907|475041373|FG001|Overall Study|ineligible or not treated|2|||
131932910|NCT01517178|475041374|FG000|Period 1|Adverse Event|1|||
131932911|NCT01517178|475041375|FG001|Period 1|Adverse Event|2|||
131932912|NCT01517178|475041374|FG000|Period 1|Lack of Efficacy|0|||
131932913|NCT01517178|475041375|FG001|Period 1|Lack of Efficacy|1|||
131932914|NCT01517178|475041374|FG000|Period 1|E.g. study termination|3|||
131932915|NCT01517178|475041375|FG001|Period 1|E.g. study termination|1|||
131932916|NCT01517178|475041374|FG000|Period 1|Withdrawal by Subject|0|||
131932917|NCT01517178|475041375|FG001|Period 1|Withdrawal by Subject|1|||
131932918|NCT01517178|475041374|FG000|Period 2|Adverse Event|1|||
131932919|NCT01517178|475041375|FG001|Period 2|Adverse Event|0|||
131932920|NCT01517178|475041374|FG000|Period 2|Withdrawal by Subject|3|||
131932921|NCT01517178|475041375|FG001|Period 2|Withdrawal by Subject|0|||
131932922|NCT01517178|475041374|FG000|Period 2|E.g. study termination|2|||
131932923|NCT01517178|475041375|FG001|Period 2|E.g. study termination|2|||
131932924|NCT00267488|475041378|FG000|Overall Study|Sponsor Terminated Study|9|||
131932925|NCT00267488|475041378|FG000|Overall Study|Protocol Violation|1|||
131932926|NCT00267488|475041378|FG000|Overall Study|Other (Disease Progression)|1|||
131932927|NCT01557569|475041379|FG000|Overall Study|Adverse Event|2|||
131932928|NCT01557569|475041380|FG001|Overall Study|Adverse Event|0|||
131932929|NCT01557569|475041379|FG000|Overall Study|high blood pressure|0|||
131932930|NCT01557569|475041380|FG001|Overall Study|high blood pressure|1|||
131932931|NCT01557569|475041379|FG000|Overall Study|Withdrawal by Subject|3|||
131932932|NCT01557569|475041380|FG001|Overall Study|Withdrawal by Subject|5|||
131932933|NCT01557569|475041379|FG000|Overall Study|noncompliance with rules of residential|0|||
131932934|NCT01557569|475041380|FG001|Overall Study|noncompliance with rules of residential|1|||
131932935|NCT03412591|475041386|FG000|Overall Study|Withdrawal by Subject|1|||
131932936|NCT03412591|475041387|FG001|Overall Study|Withdrawal by Subject|8|||
131932937|NCT03412591|475041386|FG000|Overall Study|Adverse Event|0|||
131932938|NCT03412591|475041387|FG001|Overall Study|Adverse Event|1|||
131932939|NCT02272985|475041388|FG000|Overall Study|Withdrawal by Subject|1|||
131932940|NCT02272985|475041388|FG000|Overall Study|hip fracture|1|||
131932941|NCT02272985|475041388|FG000|Overall Study|kidney transplantation|1|||
131932942|NCT00831389|475041389|FG000|Overall Study|Withdrawal by Subject|0|||
131932943|NCT00831389|475041390|FG001|Overall Study|Withdrawal by Subject|1|||
131932944|NCT00278161|475041391|FG000|Overall Study|Death|11|||
131932945|NCT01592747|475041392|FG000|Overall Study|Loss of Therapeutic Response|107|||
131932946|NCT01592747|475041393|FG001|Overall Study|Loss of Therapeutic Response|108|||
131932947|NCT01592747|475041394|FG002|Overall Study|Loss of Therapeutic Response|100|||
131932948|NCT01592747|475041392|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
131932949|NCT01592747|475041393|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
131932950|NCT01592747|475041394|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
131932951|NCT01592747|475041392|FG000|Overall Study|Adverse Event|1|||
131932952|NCT01592747|475041393|FG001|Overall Study|Adverse Event|0|||
131932953|NCT01592747|475041394|FG002|Overall Study|Adverse Event|0|||
131932954|NCT01592747|475041392|FG000|Overall Study|Protocol Violation|4|||
131932955|NCT01592747|475041393|FG001|Overall Study|Protocol Violation|0|||
131932956|NCT01592747|475041394|FG002|Overall Study|Protocol Violation|4|||
131932957|NCT01592747|475041392|FG000|Overall Study|Lack of Efficacy|0|||
131932958|NCT01592747|475041393|FG001|Overall Study|Lack of Efficacy|1|||
131932959|NCT01592747|475041394|FG002|Overall Study|Lack of Efficacy|0|||
131932960|NCT01592747|475041392|FG000|Overall Study|Withdrawal by Subject|2|||
131932961|NCT01592747|475041393|FG001|Overall Study|Withdrawal by Subject|0|||
131932962|NCT01592747|475041394|FG002|Overall Study|Withdrawal by Subject|2|||
131932963|NCT01592747|475041392|FG000|Overall Study|Lost to Follow-up|1|||
131932964|NCT01592747|475041393|FG001|Overall Study|Lost to Follow-up|0|||
131932965|NCT01592747|475041394|FG002|Overall Study|Lost to Follow-up|1|||
131932966|NCT01592747|475041392|FG000|Overall Study|Other Reasons|1|||
131932967|NCT01592747|475041393|FG001|Overall Study|Other Reasons|1|||
131932968|NCT01592747|475041394|FG002|Overall Study|Other Reasons|0|||
131932969|NCT00124657|475041395|FG000|Overall Study|Toxicity|0|||
131932970|NCT00124657|475041396|FG001|Overall Study|Toxicity|0|||
131932971|NCT00124657|475041397|FG002|Overall Study|Toxicity|1|||
131932972|NCT00124657|475041395|FG000|Overall Study|Non-compliance|1|||
131932973|NCT00124657|475041396|FG001|Overall Study|Non-compliance|0|||
131932974|NCT00124657|475041397|FG002|Overall Study|Non-compliance|4|||
131932975|NCT00124657|475041395|FG000|Overall Study|Progressive disease|14|||
131932976|NCT00124657|475041396|FG001|Overall Study|Progressive disease|5|||
131932977|NCT00124657|475041397|FG002|Overall Study|Progressive disease|27|||
131932978|NCT00124657|475041395|FG000|Overall Study|Intercurrent illness|1|||
131932979|NCT00124657|475041396|FG001|Overall Study|Intercurrent illness|0|||
131932980|NCT00124657|475041397|FG002|Overall Study|Intercurrent illness|0|||
131932981|NCT01935947|475041398|FG000|Overall Study|Adverse Event|0|||
131932982|NCT01935947|475041399|FG001|Overall Study|Adverse Event|2|||
131932983|NCT01935947|475041400|FG002|Overall Study|Adverse Event|0|||
131932984|NCT01935947|475041398|FG000|Overall Study|Diease Progression|2|||
131932985|NCT01935947|475041399|FG001|Overall Study|Diease Progression|2|||
131932986|NCT01935947|475041400|FG002|Overall Study|Diease Progression|2|||
131932987|NCT01935947|475041398|FG000|Overall Study|Death|1|||
131932988|NCT01935947|475041399|FG001|Overall Study|Death|0|||
131932989|NCT01935947|475041400|FG002|Overall Study|Death|0|||
131932990|NCT04661839|475041401|FG000|Overall Study|Not Treated|0|||
131932991|NCT04661839|475041402|FG001|Overall Study|Not Treated|0|||
131932992|NCT04661839|475041403|FG002|Overall Study|Not Treated|1|||
131932993|NCT04661839|475041404|FG003|Overall Study|Not Treated|0|||
131932994|NCT04661839|475041401|FG000|Overall Study|Lost to Follow-up|1|||
131932995|NCT04661839|475041402|FG001|Overall Study|Lost to Follow-up|0|||
131932996|NCT04661839|475041403|FG002|Overall Study|Lost to Follow-up|0|||
131932997|NCT04661839|475041404|FG003|Overall Study|Lost to Follow-up|1|||
131932998|NCT02951819|475041409|FG000|Overall Study|Death|9|||
131932999|NCT02951819|475041410|FG001|Overall Study|Death|7|||
131933000|NCT02951819|475041409|FG000|Overall Study|Withdrawal by Subject|3|||
131933001|NCT02951819|475041410|FG001|Overall Study|Withdrawal by Subject|0|||
131933002|NCT02951819|475041409|FG000|Overall Study|Adverse Event|1|||
131933003|NCT02951819|475041410|FG001|Overall Study|Adverse Event|0|||
131933004|NCT02951819|475041409|FG000|Overall Study|Lack of Efficacy|4|||
131933005|NCT02951819|475041410|FG001|Overall Study|Lack of Efficacy|0|||
131933006|NCT02951819|475041409|FG000|Overall Study|Lost to Follow-up|1|||
131933007|NCT02951819|475041410|FG001|Overall Study|Lost to Follow-up|0|||
131933008|NCT02951819|475041409|FG000|Overall Study|Progressive Disease|1|||
131933009|NCT02951819|475041410|FG001|Overall Study|Progressive Disease|0|||
131933010|NCT02951819|475041409|FG000|Overall Study|Other|9|||
131933011|NCT02951819|475041410|FG001|Overall Study|Other|0|||
131933012|NCT03647137|475041412|FG000|Overall Study|Scan Limitation|2|||
131933013|NCT03647137|475041413|FG001|Overall Study|Scan Limitation|1|||
131933014|NCT03647137|475041414|FG002|Overall Study|Scan Limitation|1|||
131933015|NCT03647137|475041415|FG003|Overall Study|Scan Limitation|2|||
131933016|NCT01443026|475041417|FG000|Overall Study|Physician Decision|1|||
131933017|NCT01443026|475041418|FG001|Overall Study|Physician Decision|0|||
131933018|NCT01443026|475041417|FG000|Overall Study|Death|0|||
131933019|NCT01443026|475041418|FG001|Overall Study|Death|1|||
131933020|NCT01443026|475041417|FG000|Overall Study|Withdrawal by Subject|0|||
131933021|NCT01443026|475041418|FG001|Overall Study|Withdrawal by Subject|3|||
131933022|NCT01443026|475041417|FG000|Overall Study|Lost to Follow-up|2|||
131933023|NCT01443026|475041418|FG001|Overall Study|Lost to Follow-up|1|||
131933024|NCT02655601|475041421|FG000|Overall Study|Adverse Event|0|||
131933025|NCT02655601|475041422|FG001|Overall Study|Adverse Event|0|||
131933026|NCT02655601|475041423|FG002|Overall Study|Adverse Event|0|||
131933027|NCT02655601|475041424|FG003|Overall Study|Adverse Event|1|||
131933028|NCT02655601|475041425|FG004|Overall Study|Adverse Event|1|||
131933029|NCT02655601|475041426|FG005|Overall Study|Adverse Event|0|||
131933030|NCT02655601|475041421|FG000|Overall Study|Physician Decision|0|||
131933031|NCT02655601|475041422|FG001|Overall Study|Physician Decision|0|||
131933032|NCT02655601|475041423|FG002|Overall Study|Physician Decision|0|||
131933033|NCT02655601|475041424|FG003|Overall Study|Physician Decision|0|||
131933034|NCT02655601|475041425|FG004|Overall Study|Physician Decision|1|||
131933035|NCT02655601|475041426|FG005|Overall Study|Physician Decision|1|||
131933036|NCT02655601|475041421|FG000|Overall Study|Withdrawal by Subject|0|||
131933037|NCT02655601|475041422|FG001|Overall Study|Withdrawal by Subject|0|||
131933038|NCT02655601|475041423|FG002|Overall Study|Withdrawal by Subject|0|||
131933039|NCT02655601|475041424|FG003|Overall Study|Withdrawal by Subject|0|||
131933040|NCT02655601|475041425|FG004|Overall Study|Withdrawal by Subject|4|||
131933041|NCT02655601|475041426|FG005|Overall Study|Withdrawal by Subject|8|||
131933042|NCT02655601|475041421|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
131933043|NCT02655601|475041422|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
131933044|NCT02655601|475041423|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
131933045|NCT02655601|475041424|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
131933046|NCT02655601|475041425|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
131933047|NCT02655601|475041426|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
131933048|NCT03253627|475041427|FG000|Overall Study|Lost to Follow-up|1|||
131933049|NCT03253627|475041428|FG001|Overall Study|Lost to Follow-up|2|||
131933050|NCT03253627|475041427|FG000|Overall Study|Withdrawal by Subject|0|||
131933051|NCT03253627|475041428|FG001|Overall Study|Withdrawal by Subject|2|||
131933052|NCT03253627|475041427|FG000|Overall Study|Inability to complete MRI|1|||
131933053|NCT03253627|475041428|FG001|Overall Study|Inability to complete MRI|0|||
131933054|NCT03829683|475041431|FG000|Overall Study|Lost to Follow-up|1|||
131933055|NCT03829683|475041432|FG001|Overall Study|Lost to Follow-up|0|||
131933056|NCT03829683|475041431|FG000|Overall Study|Physician Decision|3|||
131933057|NCT03829683|475041432|FG001|Overall Study|Physician Decision|1|||
131933058|NCT03829683|475041431|FG000|Overall Study|Withdrawal by Subject|0|||
131933059|NCT03829683|475041432|FG001|Overall Study|Withdrawal by Subject|1|||
131933060|NCT03829683|475041431|FG000|Overall Study|Discharge from hospital|1|||
131933061|NCT03829683|475041432|FG001|Overall Study|Discharge from hospital|0|||
131933062|NCT02940223|475041438|FG000|Overall Study|Failed Requirement|2|||
131933063|NCT02940223|475041439|FG001|Overall Study|Failed Requirement|0|||
131933064|NCT01813357|475041442|FG000|Overall Study|Lost to Follow-up|5|||
131933065|NCT01813357|475041443|FG001|Overall Study|Lost to Follow-up|6|||
131933066|NCT01272219|475041444|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
131933067|NCT01272219|475041445|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
131933068|NCT01272219|475041446|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
131933069|NCT01272219|475041447|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
131933070|NCT01272219|475041448|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
131933071|NCT01272219|475041449|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
131933072|NCT01272219|475041444|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
131933073|NCT01272219|475041445|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
131933074|NCT01272219|475041446|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
131933075|NCT01272219|475041447|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
131933076|NCT01272219|475041448|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
131933077|NCT01272219|475041449|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
131933078|NCT01272219|475041444|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
131933079|NCT01272219|475041445|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
131933080|NCT01272219|475041446|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
131933081|NCT01272219|475041447|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
131933082|NCT01272219|475041448|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
131933083|NCT01272219|475041449|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
131933084|NCT01272219|475041444|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
131933085|NCT01272219|475041445|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
131933086|NCT01272219|475041446|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
131933087|NCT01272219|475041447|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
131933088|NCT01272219|475041448|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
131933089|NCT01272219|475041449|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
131933090|NCT01272219|475041444|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
131933091|NCT01272219|475041445|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
131933092|NCT01272219|475041446|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
131933093|NCT01272219|475041447|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
131933094|NCT01272219|475041448|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
131933095|NCT01272219|475041449|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
131933096|NCT01272219|475041444|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
131933097|NCT01272219|475041445|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
131933098|NCT01272219|475041446|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
131933099|NCT01272219|475041447|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
131933100|NCT01272219|475041448|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
131933101|NCT01272219|475041449|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
131933102|NCT01272219|475041444|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
131933103|NCT01272219|475041445|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
131933104|NCT01272219|475041446|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
131933105|NCT01272219|475041447|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
131933106|NCT01272219|475041448|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
131933107|NCT01272219|475041449|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
131933108|NCT01272219|475041444|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
131933109|NCT01272219|475041445|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
131933110|NCT01272219|475041446|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
131933111|NCT01272219|475041447|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
131933112|NCT01272219|475041448|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
131933113|NCT01272219|475041449|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
131933114|NCT01272219|475041444|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
131933115|NCT01272219|475041445|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
131933116|NCT01272219|475041446|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
131933117|NCT01272219|475041447|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
131933118|NCT01272219|475041448|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
131411632|NCT01135914|473130264|FG001|Overall Study|Adverse Event|1|||
131411633|NCT01135914|473130265|FG002|Overall Study|Adverse Event|2|||
131411634|NCT00598078|473130270|FG000|Period 2 (Day 2)|Adverse Event|1|||
131411635|NCT00598078|473130271|FG001|Period 2 (Day 2)|Adverse Event|0|||
131933119|NCT01272219|475041449|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
131411636|NCT01479595|473130275|FG000|Overall Study|Protocol deviation|0|||
131411637|NCT01479595|473130276|FG001|Overall Study|Protocol deviation|1|||
131411638|NCT01479595|473130275|FG000|Overall Study|Adverse Event|2|||
131933120|NCT01272219|475041444|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
131933121|NCT01272219|475041445|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
131933122|NCT01272219|475041446|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
131933123|NCT01272219|475041447|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
131933124|NCT01272219|475041448|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
131933125|NCT01272219|475041449|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
131933126|NCT01272219|475041444|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
131933127|NCT01272219|475041445|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
131933128|NCT01272219|475041446|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
131933129|NCT01272219|475041447|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
131933130|NCT01272219|475041448|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
131933131|NCT01272219|475041449|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
131933132|NCT01272219|475041444|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
131933133|NCT01272219|475041445|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
131933134|NCT01272219|475041446|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
131933135|NCT01272219|475041447|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
131933136|NCT01272219|475041448|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
131933137|NCT01272219|475041449|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
131933138|NCT01272219|475041444|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
131933139|NCT01272219|475041445|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
131933140|NCT01272219|475041446|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
131933141|NCT01272219|475041447|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
131933142|NCT01272219|475041448|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
131933143|NCT01272219|475041449|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
131933144|NCT01272219|475041444|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
131933145|NCT01272219|475041445|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
131933146|NCT01272219|475041446|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
131933147|NCT01272219|475041447|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
131933148|NCT01272219|475041448|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
131933149|NCT01272219|475041449|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
131933150|NCT01272219|475041444|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
131411639|NCT01479595|473130276|FG001|Overall Study|Adverse Event|1|||
131411640|NCT02255565|473130278|FG000|Overall Study|Withdrawal by Subject|0|||
131933151|NCT01272219|475041445|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
131933152|NCT01272219|475041446|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
131933153|NCT01272219|475041447|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
131933154|NCT01272219|475041448|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
131933155|NCT01272219|475041449|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
131933156|NCT01272219|475041444|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
131933157|NCT01272219|475041445|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
131933158|NCT01272219|475041446|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
131933159|NCT01272219|475041447|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
131933160|NCT01272219|475041448|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
131933161|NCT01272219|475041449|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
131933162|NCT03131479|475041450|FG000|Overall Study|Adverse Event|0|||
131933163|NCT03131479|475041451|FG001|Overall Study|Adverse Event|0|||
131933164|NCT03131479|475041452|FG002|Overall Study|Adverse Event|1|||
131933165|NCT03131479|475041453|FG003|Overall Study|Adverse Event|1|||
131933166|NCT03131479|475041454|FG004|Overall Study|Adverse Event|0|||
131933167|NCT03131479|475041450|FG000|Overall Study|Subject/Guardian Decision|0|||
131933168|NCT03131479|475041451|FG001|Overall Study|Subject/Guardian Decision|0|||
131933169|NCT03131479|475041452|FG002|Overall Study|Subject/Guardian Decision|0|||
131933170|NCT03131479|475041453|FG003|Overall Study|Subject/Guardian Decision|1|||
131933171|NCT03131479|475041454|FG004|Overall Study|Subject/Guardian Decision|0|||
131933172|NCT00050011|475041455|FG000|Overall Study|Adverse Event|41|||
131933173|NCT00050011|475041456|FG001|Overall Study|Adverse Event|46|||
131933174|NCT00050011|475041455|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131933175|NCT00050011|475041456|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131933176|NCT00050011|475041455|FG000|Overall Study|Abnormal test procedure results|0|||
131933177|NCT00050011|475041456|FG001|Overall Study|Abnormal test procedure results|1|||
131933178|NCT00050011|475041455|FG000|Overall Study|Lack of Efficacy|16|||
131933179|NCT00050011|475041456|FG001|Overall Study|Lack of Efficacy|21|||
131933180|NCT00050011|475041455|FG000|Overall Study|Participant condition no longer required|1|||
131933181|NCT00050011|475041456|FG001|Overall Study|Participant condition no longer required|0|||
131933182|NCT00050011|475041455|FG000|Overall Study|Protocol Violation|4|||
131933183|NCT00050011|475041456|FG001|Overall Study|Protocol Violation|10|||
131933184|NCT00050011|475041455|FG000|Overall Study|Withdrawal by Subject|34|||
131933185|NCT00050011|475041456|FG001|Overall Study|Withdrawal by Subject|26|||
131933186|NCT00050011|475041455|FG000|Overall Study|Lost to Follow-up|7|||
131411641|NCT02255565|473130279|FG001|Overall Study|Withdrawal by Subject|1|||
131933187|NCT00050011|475041456|FG001|Overall Study|Lost to Follow-up|9|||
131933188|NCT00050011|475041455|FG000|Overall Study|Administrative problems|10|||
131933189|NCT00050011|475041456|FG001|Overall Study|Administrative problems|6|||
131933190|NCT00050011|475041455|FG000|Overall Study|Death|7|||
131933191|NCT00050011|475041456|FG001|Overall Study|Death|4|||
131933192|NCT00050011|475041455|FG000|Overall Study|Unknown - Reason is missing|0|||
131933193|NCT00050011|475041456|FG001|Overall Study|Unknown - Reason is missing|2|||
131933194|NCT04806373|475041457|FG000|Overall Study|Withdrawal by Subject|1|||
131933195|NCT04806373|475041458|FG001|Overall Study|Withdrawal by Subject|1|||
131933196|NCT05810597|475041459|FG000|Period 1|Adverse Event|2|||
131933197|NCT05810597|475041460|FG001|Period 1|Adverse Event|0|||
131933198|NCT05810597|475041459|FG000|Period 1|Physician Decision|1|||
131933199|NCT05810597|475041460|FG001|Period 1|Physician Decision|0|||
131933200|NCT04903093|475041467|FG000|Overall Study|Withdrawal by Subject|0|||
131933201|NCT04903093|475041468|FG001|Overall Study|Withdrawal by Subject|0|||
131933202|NCT04903093|475041469|FG002|Overall Study|Withdrawal by Subject|0|||
131933203|NCT04903093|475041470|FG003|Overall Study|Withdrawal by Subject|1|||
131933204|NCT04903093|475041471|FG004|Overall Study|Withdrawal by Subject|0|||
131933205|NCT04903093|475041472|FG005|Overall Study|Withdrawal by Subject|0|||
131933206|NCT02412436|475041473|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
131933207|NCT02412436|475041473|FG000|Overall Study|Lost to Follow-up|6|||
131933208|NCT02412436|475041473|FG000|Overall Study|Unable to get to clinic|3|||
131933209|NCT02412436|475041473|FG000|Overall Study|Death|1|||
131933210|NCT02412436|475041473|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
131933211|NCT04090749|475041479|FG000|Open Label Pilot|Lost to Follow-up|1|||
131933212|NCT04090749|475041480|FG001|Open Label Pilot|Lost to Follow-up|0|||
131933213|NCT04090749|475041481|FG002|Open Label Pilot|Lost to Follow-up|0|||
131933214|NCT04090749|475041479|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
131933215|NCT04090749|475041480|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
131933216|NCT04090749|475041481|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
131933217|NCT04090749|475041479|FG000|Pilot Trial|Lost to Follow-up|0|||
131933218|NCT04090749|475041480|FG001|Pilot Trial|Lost to Follow-up|1|||
131933219|NCT04090749|475041481|FG002|Pilot Trial|Lost to Follow-up|1|||
131933220|NCT02528305|475041482|FG000|Overall Study|Withdrawal by Subject|1|||
131933221|NCT02528305|475041482|FG000|Overall Study|Adverse Event|1|||
131933222|NCT02528305|475041482|FG000|Overall Study|Physician Decision|1|||
131933223|NCT02184442|475041483|FG000|Overall Study|Death|61|||
131933224|NCT02184442|475041484|FG001|Overall Study|Death|65|||
131933225|NCT02184442|475041483|FG000|Overall Study|Withdrawal by Subject|3|||
131933226|NCT02184442|475041484|FG001|Overall Study|Withdrawal by Subject|11|||
131933227|NCT03249558|475041489|FG000|Overall Study|Lost to Follow-up|2|||
131933228|NCT03249558|475041490|FG001|Overall Study|Lost to Follow-up|1|||
131933229|NCT03249558|475041491|FG002|Overall Study|Lost to Follow-up|4|||
131933230|NCT03249558|475041489|FG000|Overall Study|Physician Decision|1|||
131933231|NCT03249558|475041490|FG001|Overall Study|Physician Decision|0|||
131933232|NCT03249558|475041491|FG002|Overall Study|Physician Decision|0|||
131933233|NCT03249558|475041489|FG000|Overall Study|Withdrawal by Subject|6|||
131933234|NCT03249558|475041490|FG001|Overall Study|Withdrawal by Subject|5|||
131933235|NCT03249558|475041491|FG002|Overall Study|Withdrawal by Subject|7|||
131933236|NCT03249558|475041489|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
131933237|NCT03249558|475041490|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
131933238|NCT03249558|475041491|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
131933239|NCT03249558|475041489|FG000|Overall Study|Protocol Violation|1|||
131933240|NCT03249558|475041490|FG001|Overall Study|Protocol Violation|1|||
131933241|NCT03249558|475041491|FG002|Overall Study|Protocol Violation|2|||
131933242|NCT02657356|475042357|FG000|Overall Study|Death|1|||
131933243|NCT02657356|475042358|FG001|Overall Study|Death|0|||
131933244|NCT02657356|475042357|FG000|Overall Study|Withdrawal by Subject|5|||
131933245|NCT02657356|475042358|FG001|Overall Study|Withdrawal by Subject|6|||
131933246|NCT02657356|475042357|FG000|Overall Study|Terminated by Sponsor|8|||
131933247|NCT02657356|475042358|FG001|Overall Study|Terminated by Sponsor|5|||
131933248|NCT02657356|475042357|FG000|Overall Study|Rolled over to EAP study|6|||
131933249|NCT02657356|475042358|FG001|Overall Study|Rolled over to EAP study|4|||
131933250|NCT03379870|475042361|FG000|Overall Study|Lost to Follow-up|1|||
131933251|NCT03379870|475042362|FG001|Overall Study|Lost to Follow-up|0|||
131933252|NCT03379870|475042361|FG000|Overall Study|Protocol Violation|1|||
131933253|NCT03379870|475042362|FG001|Overall Study|Protocol Violation|1|||
131933254|NCT00980044|475042367|FG000|Overall Study|Withdrawal by Subject|5|||
131933255|NCT00980044|475042368|FG001|Overall Study|Withdrawal by Subject|7|||
131933256|NCT00980044|475042369|FG002|Overall Study|Withdrawal by Subject|3|||
131933257|NCT00980044|475042367|FG000|Overall Study|Protocol Violation|0|||
131933258|NCT00980044|475042368|FG001|Overall Study|Protocol Violation|0|||
131933259|NCT00980044|475042369|FG002|Overall Study|Protocol Violation|2|||
131933260|NCT02904265|475042370|FG000|Overall Study|Physician Decision|1|||
131933261|NCT02904265|475042371|FG001|Overall Study|Physician Decision|2|||
131933262|NCT05538728|475042373|FG000|Overall Study|Withdrawal by Subject|1|||
131933263|NCT05538728|475042374|FG001|Overall Study|Withdrawal by Subject|1|||
131933264|NCT02254460|475042375|FG000|Overall Study|Adverse Event|1|||
131933265|NCT02254460|475042376|FG001|Overall Study|Adverse Event|0|||
131933266|NCT01148771|475042380|FG000|Washout Period|Withdrawal by Subject|0|||
131933267|NCT01148771|475042381|FG001|Washout Period|Withdrawal by Subject|1|||
131933268|NCT05418426|475042383|FG000|Overall Study|Adverse Event|0|||
131933269|NCT05418426|475042384|FG001|Overall Study|Adverse Event|1|||
131933270|NCT05418426|475042385|FG002|Overall Study|Adverse Event|0|||
131933271|NCT05418426|475042383|FG000|Overall Study|Withdrawal by Subject|0|||
131933272|NCT05418426|475042384|FG001|Overall Study|Withdrawal by Subject|1|||
131933273|NCT05418426|475042385|FG002|Overall Study|Withdrawal by Subject|0|||
131933274|NCT05418426|475042383|FG000|Overall Study|Protocol Violation|0|||
131933275|NCT05418426|475042384|FG001|Overall Study|Protocol Violation|0|||
131933276|NCT05418426|475042385|FG002|Overall Study|Protocol Violation|1|||
131933277|NCT01674062|475042386|FG000|Overall Study|Insufficient Therapeutic Response|56|||
131933278|NCT01674062|475042387|FG001|Overall Study|Insufficient Therapeutic Response|26|||
131933279|NCT01674062|475042386|FG000|Overall Study|Other|8|||
131933280|NCT01674062|475042387|FG001|Overall Study|Other|1|||
131933281|NCT01674062|475042386|FG000|Overall Study|Adverse Event|1|||
131933282|NCT01674062|475042387|FG001|Overall Study|Adverse Event|1|||
131933283|NCT01674062|475042386|FG000|Overall Study|Death|0|||
131933284|NCT01674062|475042387|FG001|Overall Study|Death|1|||
131933285|NCT01674062|475042386|FG000|Overall Study|Programming Error|1|||
131933286|NCT01674062|475042387|FG001|Overall Study|Programming Error|0|||
131933287|NCT00581919|475042388|FG000|Overall Study|Adverse Event|8|||
131933288|NCT00581919|475042388|FG000|Overall Study|Death|1|||
131933289|NCT00581919|475042388|FG000|Overall Study|Disease Progression|10|||
131933290|NCT00581919|475042388|FG000|Overall Study|Physician Decision|1|||
131933291|NCT00581919|475042388|FG000|Overall Study|Other Complicating Disease|1|||
131933292|NCT00581919|475042388|FG000|Overall Study|Started Non-Protocol Therapy|2|||
131933293|NCT00581919|475042388|FG000|Overall Study|Withdrawal by Subject|1|||
131933294|NCT01922895|475042391|FG000|Overall Study|Death|0|||
131933295|NCT01922895|475042392|FG001|Overall Study|Death|1|||
131933296|NCT01922895|475042391|FG000|Overall Study|Withdrawal by Subject|1|||
131933297|NCT01922895|475042392|FG001|Overall Study|Withdrawal by Subject|2|||
131933298|NCT01922895|475042391|FG000|Overall Study|Lost to Follow-up|5|||
131933299|NCT01922895|475042392|FG001|Overall Study|Lost to Follow-up|11|||
131933300|NCT02971163|475042393|FG000|Overall Study|Lost to Follow-up|4|||
131933301|NCT02971163|475042394|FG001|Overall Study|Lost to Follow-up|2|||
131933302|NCT01848457|475042395|FG000|Overall Study|Death|1|||
131933303|NCT01848457|475042396|FG001|Overall Study|Death|0|||
131933304|NCT01848457|475042397|FG002|Overall Study|Death|0|||
131933305|NCT01848457|475042398|FG003|Overall Study|Death|0|||
131933306|NCT03773562|475042402|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
131933307|NCT03773562|475042402|FG000|Overall Study|Lost to Follow-up|10|||
131933308|NCT03773562|475042402|FG000|Overall Study|Withdrawal by Subject|1|||
131933309|NCT01852214|475042404|FG000|Period 1|Adverse Event|1|||
131933310|NCT01852214|475042405|FG001|Period 1|Adverse Event|2|||
131933311|NCT01852214|475042404|FG000|Period 1|Withdrawal by Subject|0|||
131933312|NCT01852214|475042405|FG001|Period 1|Withdrawal by Subject|1|||
131933313|NCT01852214|475042404|FG000|Washout Period|Withdrawal by Subject|0|||
131933314|NCT01852214|475042405|FG001|Washout Period|Withdrawal by Subject|1|||
131933315|NCT04091438|475042406|FG000|Treatment Period 1 (1 Day)|Other|1|||
131933316|NCT04091438|475042407|FG001|Treatment Period 1 (1 Day)|Other|0|||
131933317|NCT04091438|475042406|FG000|Washout Period (1 Day)|Protocol deviation|0|||
131933318|NCT04091438|475042407|FG001|Washout Period (1 Day)|Protocol deviation|1|||
131933319|NCT04091438|475042406|FG000|Washout Period (1 Day)|Other|0|||
131933320|NCT04091438|475042407|FG001|Washout Period (1 Day)|Other|1|||
131933321|NCT00421408|475042408|FG000|Overall Study|Lost to Follow-up|30|||
131933322|NCT00421408|475042409|FG001|Overall Study|Lost to Follow-up|20|||
131933323|NCT00421408|475042408|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
131933324|NCT00421408|475042409|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
131933325|NCT00787800|475042412|FG000|Overall Study|Withdrawal by Subject|3|||
131933326|NCT00787800|475042413|FG001|Overall Study|Withdrawal by Subject|5|||
131933327|NCT00787800|475042412|FG000|Overall Study|Death|0|||
131933328|NCT00787800|475042413|FG001|Overall Study|Death|2|||
131933329|NCT04309500|475042415|FG000|Overall Study|Lost to Follow-up|1|||
131933330|NCT04309500|475042416|FG001|Overall Study|Lost to Follow-up|0|||
131933331|NCT04309500|475042417|FG002|Overall Study|Lost to Follow-up|0|||
131933332|NCT04309500|475042418|FG003|Overall Study|Lost to Follow-up|0|||
131933333|NCT00461812|475042419|FG000|Overall Study|study terminated|10|||
131933334|NCT01308788|475042420|FG000|2-year Treatment|medication change by treating physician|4|||
131933335|NCT01308788|475042421|FG001|2-year Treatment|medication change by treating physician|11|||
131933336|NCT03193437|475042422|FG000|Overall Study|Adverse Event|4|||
131933337|NCT03193437|475042422|FG000|Overall Study|Withdrawal by Subject|2|||
131933338|NCT03193437|475042422|FG000|Overall Study|Disease Progression|2|||
131933339|NCT02414841|475042423|FG000|Overall Study|Withdrawal by Subject|7|||
131933340|NCT02414841|475042424|FG001|Overall Study|Withdrawal by Subject|5|||
131933341|NCT02414841|475042423|FG000|Overall Study|Lost to Follow-up|13|||
131933342|NCT02414841|475042424|FG001|Overall Study|Lost to Follow-up|6|||
131933343|NCT02414841|475042423|FG000|Overall Study|Death|17|||
131933344|NCT02414841|475042424|FG001|Overall Study|Death|14|||
131933345|NCT02414841|475042423|FG000|Overall Study|Received a Kidney Transplant|13|||
131933346|NCT02414841|475042424|FG001|Overall Study|Received a Kidney Transplant|4|||
131933347|NCT02414841|475042423|FG000|Overall Study|Randomized But Not Treated|6|||
131933348|NCT02414841|475042424|FG001|Overall Study|Randomized But Not Treated|4|||
131933349|NCT02613507|475042426|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
131933350|NCT02613507|475042427|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
131933351|NCT02613507|475042426|FG000|Pre-Treamtent|Participant withdrew consent|0|||
131933352|NCT02613507|475042427|FG001|Pre-Treamtent|Participant withdrew consent|4|||
131933353|NCT02613507|475042426|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
131933354|NCT02613507|475042427|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
131933355|NCT02613507|475042426|FG000|Treatment|Not reported|3|||
131933356|NCT02613507|475042427|FG001|Treatment|Not reported|0|||
131933357|NCT02613507|475042426|FG000|Treatment|Other reasons|8|||
131933358|NCT02613507|475042427|FG001|Treatment|Other reasons|0|||
131933359|NCT02613507|475042426|FG000|Treatment|Participant no longer meets criteria|3|||
131933360|NCT02613507|475042427|FG001|Treatment|Participant no longer meets criteria|0|||
131933361|NCT02613507|475042426|FG000|Treatment|Maximum clinical benefit|5|||
131933362|NCT02613507|475042427|FG001|Treatment|Maximum clinical benefit|10|||
131933363|NCT02613507|475042426|FG000|Treatment|Lost to Follow-up|1|||
131933364|NCT02613507|475042427|FG001|Treatment|Lost to Follow-up|0|||
131933365|NCT02613507|475042426|FG000|Treatment|Participant withdrew consent|0|||
131933366|NCT02613507|475042427|FG001|Treatment|Participant withdrew consent|2|||
131933367|NCT02613507|475042426|FG000|Treatment|Participant request to discontinue study treatment|13|||
131933368|NCT02613507|475042427|FG001|Treatment|Participant request to discontinue study treatment|17|||
131933369|NCT02613507|475042426|FG000|Treatment|Adverse event unrelated to study drug|20|||
131933370|NCT02613507|475042427|FG001|Treatment|Adverse event unrelated to study drug|3|||
131933371|NCT02613507|475042426|FG000|Treatment|Death|2|||
131933372|NCT02613507|475042427|FG001|Treatment|Death|0|||
131933373|NCT02613507|475042426|FG000|Treatment|Study drug toxicity|19|||
131933374|NCT02613507|475042427|FG001|Treatment|Study drug toxicity|14|||
131933375|NCT02613507|475042426|FG000|Treatment|Disease progression|263|||
131933376|NCT02613507|475042427|FG001|Treatment|Disease progression|110|||
131933377|NCT03941093|475042428|FG000|Overall Study|Protocol Violation|0|||
131933378|NCT03941093|475042429|FG001|Overall Study|Protocol Violation|1|||
131933379|NCT03941093|475042428|FG000|Overall Study|Withdrawal by Subject|9|||
131933380|NCT03941093|475042429|FG001|Overall Study|Withdrawal by Subject|6|||
131933381|NCT00964678|475042449|FG000|Overall Study|Physician Decision|4|||
131933382|NCT04280783|475043775|FG000|Overall Study|Family issues unrelated to the study.|1|||
131933383|NCT04280783|475043776|FG001|Overall Study|Family issues unrelated to the study.|0|||
131933384|NCT04280783|475043775|FG000|Overall Study|Withdrawal by Subject|0|||
131933385|NCT04280783|475043776|FG001|Overall Study|Withdrawal by Subject|1|||
131933386|NCT03443401|475043777|FG000|Overall Study|Lost to Follow-up|13|||
131933387|NCT03443401|475043777|FG000|Overall Study|Influential outlier|1|||
131933388|NCT00488293|475043780|FG000|Overall Study|Lost to Follow-up|28|||
131933389|NCT00488293|475043781|FG001|Overall Study|Lost to Follow-up|25|||
131933390|NCT00488293|475043780|FG000|Overall Study|Withdrawal by Subject|5|||
131933391|NCT00488293|475043781|FG001|Overall Study|Withdrawal by Subject|3|||
131933392|NCT00488293|475043780|FG000|Overall Study|Death|2|||
131933393|NCT00488293|475043781|FG001|Overall Study|Death|1|||
131933394|NCT00488293|475043780|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
131933395|NCT00488293|475043781|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
131933396|NCT00833703|475043782|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
131933397|NCT00833703|475043783|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
131933398|NCT00137449|475043786|FG000|Overall Study|Disease Progression|8|||
131933399|NCT00137449|475043787|FG001|Overall Study|Disease Progression|13|||
131933400|NCT00137449|475043786|FG000|Overall Study|Death|4|||
131933401|NCT00137449|475043787|FG001|Overall Study|Death|3|||
131933402|NCT00137449|475043786|FG000|Overall Study|Adverse Event|3|||
131933403|NCT00137449|475043787|FG001|Overall Study|Adverse Event|1|||
131933404|NCT00137449|475043786|FG000|Overall Study|Withdrawal by Subject|1|||
131933405|NCT00137449|475043787|FG001|Overall Study|Withdrawal by Subject|1|||
131933406|NCT01356940|475043788|FG000|First Intervention (28 Days)|Adverse Event|1|||
131933407|NCT01356940|475043789|FG001|First Intervention (28 Days)|Adverse Event|0|||
131933408|NCT01356940|475043788|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
131933409|NCT01356940|475043789|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
131933410|NCT01344356|475043792|FG000|Overall Study|Physician Decision|0|||
131933411|NCT01344356|475043793|FG001|Overall Study|Physician Decision|3|||
131933412|NCT01344356|475043792|FG000|Overall Study|Lost to Follow-up|0|||
131933413|NCT01344356|475043793|FG001|Overall Study|Lost to Follow-up|6|||
131933414|NCT00095576|475043794|FG000|Overall Study|Adverse Event|5|||
131933415|NCT00095576|475043795|FG001|Overall Study|Adverse Event|3|||
131933416|NCT00095576|475043794|FG000|Overall Study|Lost to Follow-up|233|||
131933417|NCT00095576|475043795|FG001|Overall Study|Lost to Follow-up|229|||
131933418|NCT00095576|475043794|FG000|Overall Study|Protocol Violation|1|||
131933419|NCT00095576|475043795|FG001|Overall Study|Protocol Violation|0|||
131933420|NCT00095576|475043794|FG000|Overall Study|Withdrawal by Subject|34|||
131933421|NCT00095576|475043795|FG001|Overall Study|Withdrawal by Subject|47|||
131933422|NCT00095576|475043794|FG000|Overall Study|Option to switch to a rollover study|1097|||
131933423|NCT00095576|475043795|FG001|Overall Study|Option to switch to a rollover study|1099|||
131933424|NCT00095576|475043794|FG000|Overall Study|Site terminated|75|||
131933425|NCT00095576|475043795|FG001|Overall Study|Site terminated|67|||
131411642|NCT02255565|473130280|FG002|Overall Study|Withdrawal by Subject|0|||
131411643|NCT02120365|473130283|FG000|Overall Study|Withdrawal by Subject|0|||
131411644|NCT02120365|473130284|FG001|Overall Study|Withdrawal by Subject|0|||
131411645|NCT02120365|473130285|FG002|Overall Study|Withdrawal by Subject|2|||
131411646|NCT02120365|473130286|FG003|Overall Study|Withdrawal by Subject|4|||
131411647|NCT02120365|473130287|FG004|Overall Study|Withdrawal by Subject|0|||
131411648|NCT02120365|473130288|FG005|Overall Study|Withdrawal by Subject|2|||
131411649|NCT01719003|473130294|FG000|Overall Study|Non compliant with protocol|1|||
131933426|NCT00095576|475043794|FG000|Overall Study|Subject moved|30|||
131933427|NCT00095576|475043795|FG001|Overall Study|Subject moved|36|||
131933428|NCT00505687|475043796|FG000|Overall Study|Important protocol violation|2|||
131933429|NCT00505687|475043796|FG000|Overall Study|Lack of Efficacy|15|||
131933430|NCT00505687|475043796|FG000|Overall Study|Adverse Event|48|||
131933431|NCT00505687|475043796|FG000|Overall Study|Subject withdrew consent|15|||
131933432|NCT00505687|475043796|FG000|Overall Study|Lost to Follow-up|1|||
131933433|NCT00505687|475043796|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
131933434|NCT00505687|475043796|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
131933435|NCT00505687|475043796|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
131933436|NCT00505687|475043796|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
131933437|NCT00505687|475043796|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
131933438|NCT00505687|475043796|FG000|Overall Study|Other: Disease Progression|1|||
131933439|NCT00505687|475043796|FG000|Overall Study|Other: As Per Sponsor|8|||
131933440|NCT00480532|475043799|FG000|Overall Study|Withdrawal by Subject|2|||
131933441|NCT00480532|475043800|FG001|Overall Study|Withdrawal by Subject|4|||
131933442|NCT00480532|475043801|FG002|Overall Study|Withdrawal by Subject|3|||
131933443|NCT00480532|475043802|FG003|Overall Study|Withdrawal by Subject|1|||
131933444|NCT00480532|475043799|FG000|Overall Study|Protocol Violation|0|||
131933445|NCT00480532|475043800|FG001|Overall Study|Protocol Violation|0|||
131933446|NCT00480532|475043801|FG002|Overall Study|Protocol Violation|1|||
131933447|NCT00480532|475043802|FG003|Overall Study|Protocol Violation|0|||
131933448|NCT01817777|475043803|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
131933449|NCT01817777|475043804|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
131933450|NCT01817777|475043805|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
131933451|NCT01817777|475043803|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
131933452|NCT01817777|475043804|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
131933453|NCT01817777|475043805|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
131933454|NCT01817777|475043803|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
131933455|NCT01817777|475043804|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
131933456|NCT01817777|475043805|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
131933457|NCT01817777|475043803|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
131933458|NCT01817777|475043804|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
131933459|NCT01817777|475043805|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
131933460|NCT01817777|475043803|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
131933461|NCT01817777|475043804|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
131933462|NCT01817777|475043805|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
131933463|NCT00443456|475043806|FG000|Overall Study|Adverse Event|16|||
131933464|NCT00443456|475043806|FG000|Overall Study|Move|1|||
131933465|NCT00443456|475043806|FG000|Overall Study|Withdrawal by Subject|1|||
131933466|NCT03242434|475043807|FG000|Overall Study|Death|0|||
131933467|NCT03242434|475043808|FG001|Overall Study|Death|2|||
131933468|NCT02157610|475043809|FG000|Overall Study|Death|4|||
131933469|NCT02157610|475043810|FG001|Overall Study|Death|4|||
131933470|NCT01378195|475043811|FG000|Overall Study|Lost to Follow-up|29|||
131933471|NCT01378195|475043812|FG001|Overall Study|Lost to Follow-up|18|||
131933472|NCT03427619|475043813|FG000|Overall Study|Physician Decision|3|||
131933473|NCT03427619|475043813|FG000|Overall Study|Withdrawal by Subject|4|||
131933474|NCT03427619|475043813|FG000|Overall Study|Lost to Follow-up|5|||
131933475|NCT03427619|475043813|FG000|Overall Study|Administrative|4|||
131933476|NCT03427619|475043813|FG000|Overall Study|Other|2|||
131933477|NCT03427619|475043813|FG000|Overall Study|Unknown or Missing Completion Status|48|||
131411650|NCT01719003|473130295|FG001|Overall Study|Non compliant with protocol|1|||
131411651|NCT01719003|473130296|FG002|Overall Study|Non compliant with protocol|0|||
131933478|NCT00425555|475043814|FG000|Overall Study|Withdrawal by Subject|11|||
131933479|NCT00425555|475043815|FG001|Overall Study|Withdrawal by Subject|8|||
131933480|NCT00425555|475043814|FG000|Overall Study|Lost to Follow-up|0|||
131933481|NCT00425555|475043815|FG001|Overall Study|Lost to Follow-up|1|||
131933482|NCT00425555|475043814|FG000|Overall Study|Administrative problems|3|||
131933483|NCT00425555|475043815|FG001|Overall Study|Administrative problems|0|||
131411652|NCT01719003|473130297|FG003|Overall Study|Non compliant with protocol|1|||
131411653|NCT01719003|473130298|FG004|Overall Study|Non compliant with protocol|2|||
131411654|NCT01719003|473130299|FG005|Overall Study|Non compliant with protocol|1|||
131411655|NCT01719003|473130300|FG006|Overall Study|Non compliant with protocol|2|||
131411656|NCT01719003|473130301|FG007|Overall Study|Non compliant with protocol|3|||
131411657|NCT01719003|473130302|FG008|Overall Study|Non compliant with protocol|0|||
131411658|NCT01719003|473130294|FG000|Overall Study|Adverse Event|6|||
131411659|NCT01719003|473130295|FG001|Overall Study|Adverse Event|5|||
131411660|NCT01719003|473130296|FG002|Overall Study|Adverse Event|4|||
131411661|NCT01719003|473130297|FG003|Overall Study|Adverse Event|3|||
131411662|NCT01719003|473130298|FG004|Overall Study|Adverse Event|4|||
131411663|NCT01719003|473130299|FG005|Overall Study|Adverse Event|3|||
131411664|NCT01719003|473130300|FG006|Overall Study|Adverse Event|6|||
131411665|NCT01719003|473130301|FG007|Overall Study|Adverse Event|5|||
131411666|NCT01719003|473130302|FG008|Overall Study|Adverse Event|0|||
131411667|NCT01719003|473130294|FG000|Overall Study|Lost to Follow-up|0|||
131411668|NCT01719003|473130295|FG001|Overall Study|Lost to Follow-up|6|||
131411669|NCT01719003|473130296|FG002|Overall Study|Lost to Follow-up|7|||
131411670|NCT01719003|473130297|FG003|Overall Study|Lost to Follow-up|2|||
131411671|NCT01719003|473130298|FG004|Overall Study|Lost to Follow-up|3|||
131411672|NCT01719003|473130299|FG005|Overall Study|Lost to Follow-up|4|||
131411673|NCT01719003|473130300|FG006|Overall Study|Lost to Follow-up|3|||
131411674|NCT01719003|473130301|FG007|Overall Study|Lost to Follow-up|2|||
131411675|NCT01719003|473130302|FG008|Overall Study|Lost to Follow-up|2|||
131411676|NCT01719003|473130294|FG000|Overall Study|Refusal to continue, not due to AE|2|||
131411677|NCT01719003|473130295|FG001|Overall Study|Refusal to continue, not due to AE|5|||
131411678|NCT01719003|473130296|FG002|Overall Study|Refusal to continue, not due to AE|4|||
131411679|NCT01719003|473130297|FG003|Overall Study|Refusal to continue, not due to AE|4|||
131411680|NCT01719003|473130298|FG004|Overall Study|Refusal to continue, not due to AE|4|||
131411681|NCT01719003|473130299|FG005|Overall Study|Refusal to continue, not due to AE|3|||
131411682|NCT01719003|473130300|FG006|Overall Study|Refusal to continue, not due to AE|8|||
131411683|NCT01719003|473130301|FG007|Overall Study|Refusal to continue, not due to AE|7|||
131411684|NCT01719003|473130302|FG008|Overall Study|Refusal to continue, not due to AE|1|||
131411685|NCT01719003|473130294|FG000|Overall Study|Reason other than those specified|0|||
131411686|NCT01719003|473130295|FG001|Overall Study|Reason other than those specified|0|||
131411687|NCT01719003|473130296|FG002|Overall Study|Reason other than those specified|2|||
131411688|NCT01719003|473130297|FG003|Overall Study|Reason other than those specified|3|||
131411689|NCT01719003|473130298|FG004|Overall Study|Reason other than those specified|4|||
131411690|NCT01719003|473130299|FG005|Overall Study|Reason other than those specified|1|||
131411691|NCT01719003|473130300|FG006|Overall Study|Reason other than those specified|0|||
131411692|NCT01719003|473130301|FG007|Overall Study|Reason other than those specified|3|||
131411693|NCT01719003|473130302|FG008|Overall Study|Reason other than those specified|1|||
131411694|NCT01719003|473130294|FG000|Overall Study|Lack of Efficacy|0|||
131411695|NCT01719003|473130295|FG001|Overall Study|Lack of Efficacy|0|||
131411696|NCT01719003|473130296|FG002|Overall Study|Lack of Efficacy|0|||
131411697|NCT01719003|473130297|FG003|Overall Study|Lack of Efficacy|0|||
131411698|NCT01719003|473130298|FG004|Overall Study|Lack of Efficacy|0|||
131411699|NCT01719003|473130299|FG005|Overall Study|Lack of Efficacy|0|||
131411700|NCT01719003|473130300|FG006|Overall Study|Lack of Efficacy|1|||
131411701|NCT01719003|473130301|FG007|Overall Study|Lack of Efficacy|0|||
131411702|NCT01719003|473130302|FG008|Overall Study|Lack of Efficacy|0|||
131411703|NCT01344629|473130304|FG000|Crossover Period 2|Withdrawal by Subject|0|||
131411704|NCT01344629|473130305|FG001|Crossover Period 2|Withdrawal by Subject|1|||
131411705|NCT01133275|473130306|FG000|Overall Study|Withdrawal by Subject|1|||
131411706|NCT01133275|473130306|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
131411707|NCT00900146|473130307|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
131411708|NCT00900146|473130308|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
131411709|NCT00900146|473130309|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
131411710|NCT00900146|473130310|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
131411711|NCT00900146|473130311|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
131411712|NCT00900146|473130307|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
131411713|NCT00900146|473130308|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
131411714|NCT00900146|473130309|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
131411715|NCT00900146|473130310|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
131411716|NCT00900146|473130311|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
131411717|NCT00900146|473130307|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
131933484|NCT00425555|475043814|FG000|Overall Study|Death|1|||
131411718|NCT00900146|473130308|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
131411719|NCT00900146|473130309|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
131411720|NCT00900146|473130310|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
131411721|NCT00900146|473130311|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
131411722|NCT00900146|473130307|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
131411723|NCT00900146|473130308|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
131933485|NCT00425555|475043815|FG001|Overall Study|Death|2|||
131933486|NCT00425555|475043814|FG000|Overall Study|New cancer therapy|2|||
131933487|NCT00425555|475043815|FG001|Overall Study|New cancer therapy|1|||
131933488|NCT00425555|475043814|FG000|Overall Study|Disease progression|36|||
131933489|NCT00425555|475043815|FG001|Overall Study|Disease progression|33|||
131933490|NCT00425555|475043814|FG000|Overall Study|Adverse Event|25|||
131933491|NCT00425555|475043815|FG001|Overall Study|Adverse Event|15|||
131933492|NCT00425555|475043814|FG000|Overall Study|Protocol Violation|1|||
131933493|NCT00425555|475043815|FG001|Overall Study|Protocol Violation|0|||
131933494|NCT02853136|475043816|FG000|Wash-out|Adverse Event|0|||
131933495|NCT02853136|475043817|FG001|Wash-out|Adverse Event|0|||
131933496|NCT02853136|475043818|FG002|Wash-out|Adverse Event|0|||
131933497|NCT02853136|475043819|FG003|Wash-out|Adverse Event|1|||
131933498|NCT00867334|475043821|FG000|Overall Study|Withdrawal by Subject|0|||
131933499|NCT00867334|475043822|FG001|Overall Study|Withdrawal by Subject|1|||
131933500|NCT00867334|475043821|FG000|Overall Study|Withdrawal by Subject|1|||
131933501|NCT00867334|475043822|FG001|Overall Study|Withdrawal by Subject|0|||
131933502|NCT00867334|475043821|FG000|Overall Study|Withdrawal by Subject|1|||
131933503|NCT00867334|475043822|FG001|Overall Study|Withdrawal by Subject|0|||
131933504|NCT03787615|475043823|FG000|Overall Study|Withdrawal by Subject|2|||
131933505|NCT03787615|475043823|FG000|Overall Study|Lost to Follow-up|2|||
131933506|NCT02697448|475043824|FG000|Overall Study|Protocol Violation|2|||
131933507|NCT02697448|475043825|FG001|Overall Study|Protocol Violation|4|||
131933508|NCT02697448|475043824|FG000|Overall Study|Clinical concerns during ablation|1|||
131933509|NCT02697448|475043825|FG001|Overall Study|Clinical concerns during ablation|1|||
131933510|NCT02697448|475043824|FG000|Overall Study|No data collected|2|||
131933511|NCT02697448|475043825|FG001|Overall Study|No data collected|0|||
131933512|NCT03464461|475043826|FG000|Overall Study|exclusionary medication given ,|1|||
131933513|NCT03464461|475043827|FG001|Overall Study|exclusionary medication given ,|2|||
131933514|NCT03464461|475043828|FG002|Overall Study|exclusionary medication given ,|0|||
131933515|NCT03464461|475043826|FG000|Overall Study|Physician Decision|0|||
131933516|NCT03464461|475043827|FG001|Overall Study|Physician Decision|1|||
131933517|NCT03464461|475043828|FG002|Overall Study|Physician Decision|0|||
131933518|NCT04620668|475043829|FG000|Overall Study|Withdrawal by Subject|2|||
131933519|NCT04620668|475043830|FG001|Overall Study|Withdrawal by Subject|0|||
131933520|NCT04620668|475043829|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
131933521|NCT04620668|475043830|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
131933522|NCT04620668|475043829|FG000|Overall Study|Removed before analysis: missing data|2|||
131933523|NCT04620668|475043830|FG001|Overall Study|Removed before analysis: missing data|0|||
131933524|NCT04620668|475043829|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
131933525|NCT04620668|475043830|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
131933526|NCT04620668|475043829|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
131933527|NCT04620668|475043830|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
131933528|NCT05014919|475043837|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
131933529|NCT05014919|475043838|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
131933530|NCT05014919|475043839|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
131933531|NCT05014919|475043837|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
131933532|NCT05014919|475043838|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
131933533|NCT05014919|475043839|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
131933534|NCT05014919|475043837|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
131933535|NCT05014919|475043838|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
131933536|NCT05014919|475043839|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
131933537|NCT05014919|475043837|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
131933538|NCT05014919|475043838|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
131933539|NCT05014919|475043839|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
131933540|NCT05014919|475043837|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
131933541|NCT05014919|475043838|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
131933542|NCT05014919|475043839|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
131933543|NCT05014919|475043837|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
131933544|NCT05014919|475043838|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
131933545|NCT05014919|475043839|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
131933546|NCT05014919|475043837|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
131933547|NCT05014919|475043838|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
131933548|NCT05014919|475043839|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
131933549|NCT05014919|475043837|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
131933550|NCT05014919|475043838|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
131933551|NCT05014919|475043839|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
131933552|NCT00680914|475043840|FG000|Overall Study|Consent withdrawal|6|||
131933553|NCT00680914|475043841|FG001|Overall Study|Consent withdrawal|3|||
131933554|NCT00680914|475043840|FG000|Overall Study|Lost to Follow-up|4|||
131933555|NCT00680914|475043841|FG001|Overall Study|Lost to Follow-up|0|||
131454274|NCT00337675|473293258|FG001|Overall Study|Progressive Disease|2|||
131933556|NCT00680914|475043840|FG000|Overall Study|serious adverse event (SAE)|0|||
131933557|NCT00680914|475043841|FG001|Overall Study|serious adverse event (SAE)|1|||
131933558|NCT00539500|475043842|FG000|Overall Study|Disease Progression|1|||
131933559|NCT00539500|475043842|FG000|Overall Study|Lost to Follow-up|2|||
131933560|NCT01491919|475043847|FG000|Overall Study|Insufficient PK sampling|1|||
131933561|NCT01491919|475043848|FG001|Overall Study|Insufficient PK sampling|2|||
131933562|NCT01491919|475043849|FG002|Overall Study|Insufficient PK sampling|1|||
131933563|NCT04003389|475043850|FG000|Overall Study|Adverse Event|27|||
131933564|NCT04003389|475043851|FG001|Overall Study|Adverse Event|34|||
131933565|NCT04003389|475043852|FG002|Overall Study|Adverse Event|28|||
131933566|NCT04003389|475043850|FG000|Overall Study|Lost to Follow-up|39|||
131933567|NCT04003389|475043851|FG001|Overall Study|Lost to Follow-up|30|||
131933568|NCT04003389|475043852|FG002|Overall Study|Lost to Follow-up|33|||
131933569|NCT04003389|475043850|FG000|Overall Study|Protocol Violation|1|||
131933570|NCT04003389|475043851|FG001|Overall Study|Protocol Violation|6|||
131933571|NCT04003389|475043852|FG002|Overall Study|Protocol Violation|5|||
131933572|NCT04003389|475043850|FG000|Overall Study|Withdrawal by Subject|119|||
131933573|NCT04003389|475043851|FG001|Overall Study|Withdrawal by Subject|79|||
131933574|NCT04003389|475043852|FG002|Overall Study|Withdrawal by Subject|85|||
131933575|NCT04003389|475043850|FG000|Overall Study|Miscellaneous|14|||
131933576|NCT04003389|475043851|FG001|Overall Study|Miscellaneous|11|||
131933577|NCT04003389|475043852|FG002|Overall Study|Miscellaneous|14|||
131933578|NCT04003389|475043850|FG000|Overall Study|Participant did not receive study drug|1|||
131933579|NCT04003389|475043851|FG001|Overall Study|Participant did not receive study drug|0|||
131933580|NCT04003389|475043852|FG002|Overall Study|Participant did not receive study drug|0|||
131933581|NCT02871219|475043853|FG000|Overall Study|Adverse Event|15|||
131933582|NCT02871219|475043853|FG000|Overall Study|Death|3|||
131933583|NCT02871219|475043853|FG000|Overall Study|Progression|3|||
131933584|NCT02871219|475043853|FG000|Overall Study|Infections|7|||
131933585|NCT02871219|475043853|FG000|Overall Study|Infusion Related|4|||
131933586|NCT05375929|475043860|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
131933587|NCT05375929|475043861|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
131933588|NCT05375929|475043862|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
131933589|NCT05375929|475043863|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
131933590|NCT05375929|475043860|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
131933591|NCT05375929|475043861|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
131933592|NCT05375929|475043862|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
131933593|NCT05375929|475043863|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
131933594|NCT05375929|475043860|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
131933595|NCT05375929|475043861|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
131933596|NCT05375929|475043862|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
131933597|NCT05375929|475043863|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
131933598|NCT05375929|475043860|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
131933599|NCT05375929|475043861|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
131933600|NCT05375929|475043862|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
131933601|NCT05375929|475043863|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
131933602|NCT05375929|475043860|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
131933603|NCT05375929|475043861|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
131933604|NCT05375929|475043862|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
131933605|NCT05375929|475043863|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
131933606|NCT05375929|475043860|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
131933607|NCT05375929|475043861|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
131933608|NCT05375929|475043862|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
131933609|NCT05375929|475043863|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
131933610|NCT05375929|475043860|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
131933611|NCT05375929|475043861|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
131933612|NCT05375929|475043862|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
131933613|NCT05375929|475043863|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
131933614|NCT05375929|475043860|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
131933615|NCT05375929|475043861|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
131933616|NCT05375929|475043862|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
131933617|NCT05375929|475043863|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
131933618|NCT05375929|475043860|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
131933619|NCT05375929|475043861|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
131933620|NCT05375929|475043862|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
131933621|NCT05375929|475043863|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
131933622|NCT05375929|475043860|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
131933623|NCT05375929|475043861|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
131933624|NCT05375929|475043862|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
131933625|NCT05375929|475043863|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
131411724|NCT00900146|473130309|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
131411725|NCT00900146|473130310|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
131411726|NCT00900146|473130311|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
131411727|NCT00900146|473130307|FG000|Intermediate: Period III|Lost to Follow-up|2|||
131411728|NCT00900146|473130308|FG001|Intermediate: Period III|Lost to Follow-up|0|||
131411729|NCT00900146|473130309|FG002|Intermediate: Period III|Lost to Follow-up|0|||
131411730|NCT00900146|473130310|FG003|Intermediate: Period III|Lost to Follow-up|0|||
131411731|NCT00900146|473130311|FG004|Intermediate: Period III|Lost to Follow-up|1|||
131411732|NCT00900146|473130307|FG000|Intermediate: Period III|Administrative problems|85|||
131411733|NCT00900146|473130308|FG001|Intermediate: Period III|Administrative problems|92|||
131411734|NCT00900146|473130309|FG002|Intermediate: Period III|Administrative problems|84|||
131411735|NCT00900146|473130310|FG003|Intermediate: Period III|Administrative problems|90|||
131411736|NCT00900146|473130311|FG004|Intermediate: Period III|Administrative problems|163|||
131411737|NCT00700102|473130312|FG000|Overall Study|Died|394|||
131411738|NCT00700102|473130313|FG001|Overall Study|Died|385|||
131411739|NCT00700102|473130312|FG000|Overall Study|Lost to Follow-up|8|||
131411740|NCT00700102|473130313|FG001|Overall Study|Lost to Follow-up|10|||
131411741|NCT02525939|473130318|FG000|Overall Study|Lost to Follow-up|27|||
131411742|NCT02525939|473130319|FG001|Overall Study|Lost to Follow-up|24|||
131411743|NCT02525939|473130318|FG000|Overall Study|Physician Decision|0|||
131411744|NCT02525939|473130319|FG001|Overall Study|Physician Decision|1|||
131411745|NCT02525939|473130318|FG000|Overall Study|Withdrawal by Subject|24|||
131411746|NCT02525939|473130319|FG001|Overall Study|Withdrawal by Subject|39|||
131411747|NCT02525939|473130318|FG000|Overall Study|Death|180|||
131411748|NCT02525939|473130319|FG001|Overall Study|Death|179|||
131411749|NCT01028716|473130320|FG000|Overall Study|Physician Decision|1|||
131411750|NCT01143896|473130325|FG000|Overall Study|Did not complete Baseline Interview|5|||
131933626|NCT00322218|475043870|FG000|Overall Study|Death|3|||
131933627|NCT00322218|475043871|FG001|Overall Study|Death|6|||
131411751|NCT01143896|473130326|FG001|Overall Study|Did not complete Baseline Interview|4|||
131411752|NCT01143896|473130325|FG000|Overall Study|Lost to Follow-up|18|||
131411753|NCT01143896|473130326|FG001|Overall Study|Lost to Follow-up|13|||
131411754|NCT01143896|473130325|FG000|Overall Study|Withdrawal by Subject|13|||
131411755|NCT01143896|473130326|FG001|Overall Study|Withdrawal by Subject|5|||
131411756|NCT01143896|473130325|FG000|Overall Study|Death|6|||
131411757|NCT01143896|473130326|FG001|Overall Study|Death|3|||
131411758|NCT00391391|473130327|FG000|Overall Study|Adverse Event|0|||
131411759|NCT00391391|473130328|FG001|Overall Study|Adverse Event|0|||
131411760|NCT00391391|473130329|FG002|Overall Study|Adverse Event|0|||
131411761|NCT00391391|473130330|FG003|Overall Study|Adverse Event|1|||
131411762|NCT00391391|473130327|FG000|Overall Study|Lost to Follow-up|1|||
131411763|NCT00391391|473130328|FG001|Overall Study|Lost to Follow-up|3|||
131411764|NCT00391391|473130329|FG002|Overall Study|Lost to Follow-up|7|||
131411765|NCT00391391|473130330|FG003|Overall Study|Lost to Follow-up|4|||
131411766|NCT00391391|473130327|FG000|Overall Study|Protocol Violation|2|||
131411767|NCT00391391|473130328|FG001|Overall Study|Protocol Violation|3|||
131411768|NCT00391391|473130329|FG002|Overall Study|Protocol Violation|6|||
131411769|NCT00391391|473130330|FG003|Overall Study|Protocol Violation|7|||
131411770|NCT00391391|473130327|FG000|Overall Study|Withdrawal by Subject|6|||
131411771|NCT00391391|473130328|FG001|Overall Study|Withdrawal by Subject|4|||
131411772|NCT00391391|473130329|FG002|Overall Study|Withdrawal by Subject|10|||
131411773|NCT00391391|473130330|FG003|Overall Study|Withdrawal by Subject|7|||
131411774|NCT00693472|473130331|FG000|Part 1|Adverse Event|1|||
131411775|NCT00693472|473130332|FG001|Part 1|Adverse Event|1|||
131411776|NCT00693472|473130333|FG002|Part 1|Adverse Event|0|||
131411777|NCT00693472|473130334|FG003|Part 1|Adverse Event|0|||
131411778|NCT00693472|473130331|FG000|Part 1|Lost to Follow-up|0|||
131411779|NCT00693472|473130332|FG001|Part 1|Lost to Follow-up|1|||
131411780|NCT00693472|473130333|FG002|Part 1|Lost to Follow-up|0|||
131411781|NCT00693472|473130334|FG003|Part 1|Lost to Follow-up|0|||
131411782|NCT00693472|473130331|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
131411783|NCT00693472|473130332|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
131411784|NCT00693472|473130333|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
131411785|NCT00693472|473130334|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
131411786|NCT00693472|473130331|FG000|Part 2|Adverse Event|0|||
131411787|NCT00693472|473130332|FG001|Part 2|Adverse Event|0|||
131411788|NCT00693472|473130333|FG002|Part 2|Adverse Event|1|||
131411789|NCT00693472|473130334|FG003|Part 2|Adverse Event|0|||
131411790|NCT00693472|473130331|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
131411791|NCT00693472|473130332|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
131933628|NCT05487378|475043872|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
131411792|NCT00693472|473130333|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
131411793|NCT00693472|473130334|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
131411794|NCT00320372|473130337|FG000|Overall Study|Physician Decision|4|||
131933629|NCT05487378|475043873|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
131933630|NCT05487378|475043872|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
131411795|NCT00320372|473130338|FG001|Overall Study|Physician Decision|7|||
131411796|NCT00320372|473130337|FG000|Overall Study|Death|7|||
131933631|NCT05487378|475043873|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
131933632|NCT03359395|475043879|FG000|First Intervention A / B|Withdrawal by Subject|1|||
131933633|NCT03359395|475043880|FG001|First Intervention A / B|Withdrawal by Subject|0|||
131933634|NCT03359395|475043879|FG000|First Intervention A / B|Lost to Follow-up|2|||
131933635|NCT03359395|475043880|FG001|First Intervention A / B|Lost to Follow-up|3|||
131933636|NCT03359395|475043879|FG000|Second Intervention B/A|Exclusion criteria|0|||
131933637|NCT03359395|475043880|FG001|Second Intervention B/A|Exclusion criteria|1|||
131933638|NCT03359395|475043879|FG000|Second Intervention B/A|Lost to Follow-up|3|||
131933639|NCT03359395|475043880|FG001|Second Intervention B/A|Lost to Follow-up|2|||
131933640|NCT03164356|475043881|FG000|Overall Study|Lost to Follow-up|1|||
131933641|NCT03164356|475043882|FG001|Overall Study|Lost to Follow-up|1|||
131933642|NCT03164356|475043883|FG002|Overall Study|Lost to Follow-up|2|||
131933643|NCT03164356|475043884|FG003|Overall Study|Lost to Follow-up|1|||
131933644|NCT03164356|475043881|FG000|Overall Study|Physician Decision|0|||
131933645|NCT03164356|475043882|FG001|Overall Study|Physician Decision|0|||
131933646|NCT03164356|475043883|FG002|Overall Study|Physician Decision|3|||
131933647|NCT03164356|475043884|FG003|Overall Study|Physician Decision|0|||
131933648|NCT03164356|475043881|FG000|Overall Study|Protocol Violation|2|||
131933649|NCT03164356|475043882|FG001|Overall Study|Protocol Violation|1|||
131933650|NCT03164356|475043883|FG002|Overall Study|Protocol Violation|0|||
131933651|NCT03164356|475043884|FG003|Overall Study|Protocol Violation|0|||
131933652|NCT03164356|475043881|FG000|Overall Study|Withdrawal by Subject|1|||
131933653|NCT03164356|475043882|FG001|Overall Study|Withdrawal by Subject|0|||
131933654|NCT03164356|475043883|FG002|Overall Study|Withdrawal by Subject|0|||
131933655|NCT03164356|475043884|FG003|Overall Study|Withdrawal by Subject|0|||
131933656|NCT03164356|475043881|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
131933657|NCT03164356|475043882|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
131933658|NCT03164356|475043883|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
131411797|NCT00320372|473130338|FG001|Overall Study|Death|8|||
131411798|NCT00320372|473130337|FG000|Overall Study|Withdrawal by Subject|55|||
131411799|NCT00320372|473130338|FG001|Overall Study|Withdrawal by Subject|37|||
131411800|NCT00320372|473130337|FG000|Overall Study|Non-Compliance|40|||
131411801|NCT00320372|473130338|FG001|Overall Study|Non-Compliance|39|||
131411802|NCT00320372|473130337|FG000|Overall Study|Did not Meet (I/E)|3|||
131411803|NCT00320372|473130338|FG001|Overall Study|Did not Meet (I/E)|1|||
131411804|NCT00320372|473130337|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
131411805|NCT00320372|473130338|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
131411806|NCT00849875|473130339|FG000|Overall Study|Death|28|||
131411807|NCT00849875|473130339|FG000|Overall Study|Ongoing (unknown completion status)|11|||
131411808|NCT00849875|473130339|FG000|Overall Study|Others|6|||
131411809|NCT00849875|473130339|FG000|Overall Study|Lost to Follow-up|2|||
131411810|NCT00086502|473130340|FG000|Overall Study|Adverse Event|11|||
131411811|NCT00086502|473130341|FG001|Overall Study|Adverse Event|2|||
131411812|NCT00086502|473130340|FG000|Overall Study|Lack of Efficacy|0|||
131933659|NCT03164356|475043884|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
131933660|NCT03164356|475043881|FG000|Overall Study|Subject Incarcerated|0|||
131933661|NCT03164356|475043882|FG001|Overall Study|Subject Incarcerated|1|||
131933662|NCT03164356|475043883|FG002|Overall Study|Subject Incarcerated|0|||
131933663|NCT03164356|475043884|FG003|Overall Study|Subject Incarcerated|0|||
131933664|NCT03164356|475043881|FG000|Overall Study|Prosthetist unable to participate|0|||
131933665|NCT03164356|475043882|FG001|Overall Study|Prosthetist unable to participate|2|||
131933666|NCT03164356|475043883|FG002|Overall Study|Prosthetist unable to participate|1|||
131933667|NCT03164356|475043884|FG003|Overall Study|Prosthetist unable to participate|0|||
131933668|NCT00908141|475043885|FG000|Overall Study|Withdrawal by Subject|0|||
131933669|NCT00908141|475043886|FG001|Overall Study|Withdrawal by Subject|1|||
131933670|NCT02520154|475043887|FG000|Overall Study|Death|1|||
131933671|NCT02520154|475043887|FG000|Overall Study|Withdrawal by Subject|2|||
131933672|NCT02520154|475043887|FG000|Overall Study|Physician Decision|2|||
131933673|NCT03648372|475043888|FG000|Overall Study|Withdrawal by Subject|2|||
131933674|NCT03648372|475043889|FG001|Overall Study|Withdrawal by Subject|0|||
131933675|NCT03648372|475043890|FG002|Overall Study|Withdrawal by Subject|0|||
131933676|NCT03648372|475043891|FG003|Overall Study|Withdrawal by Subject|0|||
131933677|NCT03648372|475043892|FG004|Overall Study|Withdrawal by Subject|0|||
131933678|NCT03648372|475043893|FG005|Overall Study|Withdrawal by Subject|1|||
131933679|NCT03648372|475043894|FG006|Overall Study|Withdrawal by Subject|2|||
131933680|NCT03648372|475043895|FG007|Overall Study|Withdrawal by Subject|0|||
131933681|NCT03648372|475043896|FG008|Overall Study|Withdrawal by Subject|0|||
131933682|NCT03648372|475043897|FG009|Overall Study|Withdrawal by Subject|0|||
131933683|NCT03648372|475043898|FG010|Overall Study|Withdrawal by Subject|2|||
131933684|NCT03648372|475043899|FG011|Overall Study|Withdrawal by Subject|0|||
131933685|NCT03648372|475043900|FG012|Overall Study|Withdrawal by Subject|2|||
131411813|NCT00086502|473130341|FG001|Overall Study|Lack of Efficacy|2|||
131933686|NCT03648372|475043901|FG013|Overall Study|Withdrawal by Subject|0|||
131933687|NCT03648372|475043902|FG014|Overall Study|Withdrawal by Subject|0|||
131411814|NCT00086502|473130340|FG000|Overall Study|Lost to Follow-up|3|||
131933688|NCT03648372|475043903|FG015|Overall Study|Withdrawal by Subject|0|||
131933689|NCT03648372|475043904|FG016|Overall Study|Withdrawal by Subject|1|||
131933690|NCT03648372|475043905|FG017|Overall Study|Withdrawal by Subject|0|||
131933691|NCT03648372|475043906|FG018|Overall Study|Withdrawal by Subject|0|||
131933692|NCT03648372|475043907|FG019|Overall Study|Withdrawal by Subject|0|||
131933693|NCT03648372|475043908|FG020|Overall Study|Withdrawal by Subject|0|||
131933694|NCT03648372|475043888|FG000|Overall Study|Progressive Disease|2|||
131933695|NCT03648372|475043889|FG001|Overall Study|Progressive Disease|3|||
131933696|NCT03648372|475043890|FG002|Overall Study|Progressive Disease|4|||
131933697|NCT03648372|475043891|FG003|Overall Study|Progressive Disease|3|||
131933698|NCT03648372|475043892|FG004|Overall Study|Progressive Disease|2|||
131933699|NCT03648372|475043893|FG005|Overall Study|Progressive Disease|2|||
131933700|NCT03648372|475043894|FG006|Overall Study|Progressive Disease|3|||
131933701|NCT03648372|475043895|FG007|Overall Study|Progressive Disease|3|||
131933702|NCT03648372|475043896|FG008|Overall Study|Progressive Disease|5|||
131933703|NCT03648372|475043897|FG009|Overall Study|Progressive Disease|5|||
131933704|NCT03648372|475043898|FG010|Overall Study|Progressive Disease|2|||
131933705|NCT03648372|475043899|FG011|Overall Study|Progressive Disease|3|||
131933706|NCT03648372|475043900|FG012|Overall Study|Progressive Disease|3|||
131933707|NCT03648372|475043901|FG013|Overall Study|Progressive Disease|3|||
131933708|NCT03648372|475043902|FG014|Overall Study|Progressive Disease|6|||
131933709|NCT03648372|475043903|FG015|Overall Study|Progressive Disease|0|||
131933710|NCT03648372|475043904|FG016|Overall Study|Progressive Disease|0|||
131933711|NCT03648372|475043905|FG017|Overall Study|Progressive Disease|0|||
131933712|NCT03648372|475043906|FG018|Overall Study|Progressive Disease|0|||
131933713|NCT03648372|475043907|FG019|Overall Study|Progressive Disease|0|||
131933714|NCT03648372|475043908|FG020|Overall Study|Progressive Disease|0|||
131933715|NCT03648372|475043888|FG000|Overall Study|Other|0|||
131933716|NCT03648372|475043889|FG001|Overall Study|Other|0|||
131933717|NCT03648372|475043890|FG002|Overall Study|Other|0|||
131933718|NCT03648372|475043891|FG003|Overall Study|Other|0|||
131933719|NCT03648372|475043892|FG004|Overall Study|Other|1|||
131933720|NCT03648372|475043893|FG005|Overall Study|Other|0|||
131933721|NCT03648372|475043894|FG006|Overall Study|Other|0|||
131933722|NCT03648372|475043895|FG007|Overall Study|Other|0|||
131933723|NCT03648372|475043896|FG008|Overall Study|Other|0|||
131933724|NCT03648372|475043897|FG009|Overall Study|Other|0|||
131933725|NCT03648372|475043898|FG010|Overall Study|Other|1|||
131933726|NCT03648372|475043899|FG011|Overall Study|Other|2|||
131933727|NCT03648372|475043900|FG012|Overall Study|Other|1|||
131933728|NCT03648372|475043901|FG013|Overall Study|Other|3|||
131933729|NCT03648372|475043902|FG014|Overall Study|Other|0|||
131933730|NCT03648372|475043903|FG015|Overall Study|Other|5|||
131933731|NCT03648372|475043904|FG016|Overall Study|Other|1|||
131933732|NCT03648372|475043905|FG017|Overall Study|Other|5|||
131933733|NCT03648372|475043906|FG018|Overall Study|Other|0|||
131933734|NCT03648372|475043907|FG019|Overall Study|Other|1|||
131933735|NCT03648372|475043908|FG020|Overall Study|Other|0|||
131933736|NCT03648372|475043888|FG000|Overall Study|Lost to Follow-up|0|||
131933737|NCT03648372|475043889|FG001|Overall Study|Lost to Follow-up|0|||
131933738|NCT03648372|475043890|FG002|Overall Study|Lost to Follow-up|0|||
131933739|NCT03648372|475043891|FG003|Overall Study|Lost to Follow-up|0|||
131933740|NCT03648372|475043892|FG004|Overall Study|Lost to Follow-up|0|||
131933741|NCT03648372|475043893|FG005|Overall Study|Lost to Follow-up|0|||
131933742|NCT03648372|475043894|FG006|Overall Study|Lost to Follow-up|0|||
131933743|NCT03648372|475043895|FG007|Overall Study|Lost to Follow-up|0|||
131933744|NCT03648372|475043896|FG008|Overall Study|Lost to Follow-up|0|||
131933745|NCT03648372|475043897|FG009|Overall Study|Lost to Follow-up|0|||
131933746|NCT03648372|475043898|FG010|Overall Study|Lost to Follow-up|0|||
131933747|NCT03648372|475043899|FG011|Overall Study|Lost to Follow-up|0|||
131933748|NCT03648372|475043900|FG012|Overall Study|Lost to Follow-up|0|||
131933749|NCT03648372|475043901|FG013|Overall Study|Lost to Follow-up|1|||
131933750|NCT03648372|475043902|FG014|Overall Study|Lost to Follow-up|0|||
131933751|NCT03648372|475043903|FG015|Overall Study|Lost to Follow-up|1|||
131933752|NCT03648372|475043904|FG016|Overall Study|Lost to Follow-up|0|||
131411815|NCT00086502|473130341|FG001|Overall Study|Lost to Follow-up|1|||
131411816|NCT00086502|473130340|FG000|Overall Study|Physician Decision|1|||
131411817|NCT00086502|473130341|FG001|Overall Study|Physician Decision|1|||
131411818|NCT00086502|473130340|FG000|Overall Study|Pregnancy|0|||
131933753|NCT03648372|475043905|FG017|Overall Study|Lost to Follow-up|1|||
131933754|NCT03648372|475043906|FG018|Overall Study|Lost to Follow-up|0|||
131933755|NCT03648372|475043907|FG019|Overall Study|Lost to Follow-up|0|||
131933756|NCT03648372|475043908|FG020|Overall Study|Lost to Follow-up|0|||
131933757|NCT03648372|475043888|FG000|Overall Study|Start of a New Systemic Treatment|0|||
131933758|NCT03648372|475043889|FG001|Overall Study|Start of a New Systemic Treatment|0|||
131933759|NCT03648372|475043890|FG002|Overall Study|Start of a New Systemic Treatment|0|||
131933760|NCT03648372|475043891|FG003|Overall Study|Start of a New Systemic Treatment|0|||
131933761|NCT03648372|475043892|FG004|Overall Study|Start of a New Systemic Treatment|0|||
131933762|NCT03648372|475043893|FG005|Overall Study|Start of a New Systemic Treatment|0|||
131411819|NCT00086502|473130341|FG001|Overall Study|Pregnancy|1|||
131933763|NCT03648372|475043894|FG006|Overall Study|Start of a New Systemic Treatment|0|||
131933764|NCT03648372|475043895|FG007|Overall Study|Start of a New Systemic Treatment|2|||
131933765|NCT03648372|475043896|FG008|Overall Study|Start of a New Systemic Treatment|0|||
131411820|NCT00086502|473130340|FG000|Overall Study|Protocol Violation|3|||
131411821|NCT00086502|473130341|FG001|Overall Study|Protocol Violation|3|||
131411822|NCT00086502|473130340|FG000|Overall Study|Withdrawal by Subject|5|||
131411823|NCT00086502|473130341|FG001|Overall Study|Withdrawal by Subject|6|||
131411824|NCT00086502|473130340|FG000|Overall Study|Patient Moved|1|||
131411825|NCT00086502|473130341|FG001|Overall Study|Patient Moved|1|||
131411826|NCT00086502|473130340|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
131411827|NCT00086502|473130341|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
131411828|NCT00086502|473130340|FG000|Overall Study|Patient Accidentally Unblinded|1|||
131411829|NCT00086502|473130341|FG001|Overall Study|Patient Accidentally Unblinded|0|||
131411830|NCT02068118|473130346|FG000|18-month Comparative Study Period|Death|90|||
131411831|NCT02068118|473130347|FG001|18-month Comparative Study Period|Death|97|||
131411832|NCT02068118|473130346|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
131411833|NCT02068118|473130347|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
131411834|NCT02068118|473130346|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
131411835|NCT02068118|473130347|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
131411836|NCT02068118|473130346|FG000|18-month Comparative Study Period|Heart transplant|9|||
131411837|NCT02068118|473130347|FG001|18-month Comparative Study Period|Heart transplant|15|||
131411838|NCT02068118|473130346|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
131411839|NCT02068118|473130347|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
131411840|NCT02068118|473130346|FG000|18-month Comparative Study Period|Hemiplegia|0|||
131411841|NCT02068118|473130347|FG001|18-month Comparative Study Period|Hemiplegia|1|||
131411842|NCT02068118|473130346|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
131411843|NCT02068118|473130347|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
131411844|NCT02068118|473130346|FG000|18-month Comparative Study Period|Move|0|||
131411845|NCT02068118|473130347|FG001|18-month Comparative Study Period|Move|1|||
131411846|NCT02068118|473130346|FG000|18-month Comparative Study Period|Hearing loss|0|||
131411847|NCT02068118|473130347|FG001|18-month Comparative Study Period|Hearing loss|1|||
131411848|NCT02068118|473130346|FG000|Extension Period|Death|0|||
131411849|NCT02068118|473130347|FG001|Extension Period|Death|2|||
131411850|NCT02068118|473130346|FG000|Extension Period|Withdrawal by Subject|1|||
131411851|NCT02068118|473130347|FG001|Extension Period|Withdrawal by Subject|0|||
131411852|NCT02068118|473130346|FG000|Extension Period|Heart transplant|1|||
131411853|NCT02068118|473130347|FG001|Extension Period|Heart transplant|0|||
131411854|NCT02068118|473130346|FG000|Extension Period|Wrong device use|0|||
131411855|NCT02068118|473130347|FG001|Extension Period|Wrong device use|1|||
131411856|NCT00283868|473130348|FG000|Overall Study|Lost to Follow-up|7|||
131411857|NCT00283868|473130349|FG001|Overall Study|Lost to Follow-up|8|||
131411858|NCT01420627|473130350|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
131411859|NCT00276094|473130352|FG000|Overall Study|Adverse Event|15|||
131411860|NCT00276094|473130353|FG001|Overall Study|Adverse Event|13|||
131411861|NCT00276094|473130354|FG002|Overall Study|Adverse Event|11|||
131411862|NCT00276094|473130352|FG000|Overall Study|Withdrawal by Subject|14|||
131411863|NCT00276094|473130353|FG001|Overall Study|Withdrawal by Subject|14|||
131411864|NCT00276094|473130354|FG002|Overall Study|Withdrawal by Subject|12|||
131411865|NCT00276094|473130352|FG000|Overall Study|Protocol Violation|16|||
131411866|NCT00276094|473130353|FG001|Overall Study|Protocol Violation|7|||
131411867|NCT00276094|473130354|FG002|Overall Study|Protocol Violation|10|||
131411868|NCT00276094|473130352|FG000|Overall Study|Lost to Follow-up|8|||
131411869|NCT00276094|473130353|FG001|Overall Study|Lost to Follow-up|6|||
131411870|NCT00276094|473130354|FG002|Overall Study|Lost to Follow-up|4|||
131411871|NCT00276094|473130352|FG000|Overall Study|Other-Subject moved out of country|1|||
131411872|NCT00276094|473130353|FG001|Overall Study|Other-Subject moved out of country|0|||
131411873|NCT00276094|473130354|FG002|Overall Study|Other-Subject moved out of country|0|||
131411874|NCT00276094|473130352|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
131411875|NCT00276094|473130353|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
131411876|NCT00276094|473130354|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
131411877|NCT00276094|473130352|FG000|Overall Study|Other-Lack of efficacy|1|||
131411878|NCT00276094|473130353|FG001|Overall Study|Other-Lack of efficacy|0|||
131411879|NCT00276094|473130354|FG002|Overall Study|Other-Lack of efficacy|0|||
131411880|NCT00276094|473130352|FG000|Overall Study|Other-Refused follow-up visit|1|||
131411881|NCT00276094|473130353|FG001|Overall Study|Other-Refused follow-up visit|0|||
131411882|NCT00276094|473130354|FG002|Overall Study|Other-Refused follow-up visit|0|||
131411883|NCT00276094|473130352|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
131411884|NCT00276094|473130353|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
131411885|NCT00276094|473130354|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
131411886|NCT00276094|473130352|FG000|Overall Study|Other-Relocation|0|||
131411887|NCT00276094|473130353|FG001|Overall Study|Other-Relocation|1|||
131411888|NCT00276094|473130354|FG002|Overall Study|Other-Relocation|0|||
131411889|NCT00276094|473130352|FG000|Overall Study|Other-Study medication lost|0|||
131411890|NCT00276094|473130353|FG001|Overall Study|Other-Study medication lost|0|||
131411891|NCT00276094|473130354|FG002|Overall Study|Other-Study medication lost|1|||
131933766|NCT03648372|475043897|FG009|Overall Study|Start of a New Systemic Treatment|0|||
131933767|NCT03648372|475043898|FG010|Overall Study|Start of a New Systemic Treatment|1|||
131933768|NCT03648372|475043899|FG011|Overall Study|Start of a New Systemic Treatment|0|||
131933769|NCT03648372|475043900|FG012|Overall Study|Start of a New Systemic Treatment|0|||
131933770|NCT03648372|475043901|FG013|Overall Study|Start of a New Systemic Treatment|0|||
131933771|NCT03648372|475043902|FG014|Overall Study|Start of a New Systemic Treatment|0|||
131933772|NCT03648372|475043903|FG015|Overall Study|Start of a New Systemic Treatment|0|||
131933773|NCT03648372|475043904|FG016|Overall Study|Start of a New Systemic Treatment|0|||
131933774|NCT03648372|475043905|FG017|Overall Study|Start of a New Systemic Treatment|0|||
131933775|NCT03648372|475043906|FG018|Overall Study|Start of a New Systemic Treatment|0|||
131933776|NCT03648372|475043907|FG019|Overall Study|Start of a New Systemic Treatment|0|||
131933777|NCT03648372|475043908|FG020|Overall Study|Start of a New Systemic Treatment|0|||
131933778|NCT05943990|475043909|FG000|Overall Study|Study Terminated by Sponsor|0|||
131933779|NCT05943990|475043910|FG001|Overall Study|Study Terminated by Sponsor|0|||
131933780|NCT05943990|475043911|FG002|Overall Study|Study Terminated by Sponsor|1|||
131933781|NCT03514134|475045299|FG000|Overall Study|Lost to Follow-up|0|||
131933782|NCT03514134|475045300|FG001|Overall Study|Lost to Follow-up|1|||
131933783|NCT02471144|475045301|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
131933784|NCT02471144|475045302|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
131933785|NCT02471144|475045303|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
131933786|NCT02471144|475045304|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
131933787|NCT02471144|475045305|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
131933788|NCT02471144|475045306|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
131933789|NCT02471144|475045307|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
131933790|NCT02471144|475045308|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
131933791|NCT02471144|475045309|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
131933792|NCT02471144|475045310|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
131933793|NCT02471144|475045311|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
131933794|NCT02471144|475045301|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933795|NCT02471144|475045302|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933796|NCT02471144|475045303|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131411892|NCT01996592|473130355|FG000|Overall Study|no response to text/no diary entry|32|||
131411893|NCT01996592|473130355|FG000|Overall Study|change in surgical date|4|||
131411894|NCT01996592|473130355|FG000|Overall Study|Withdrawal by Subject|5|||
131411895|NCT01996592|473130355|FG000|Overall Study|change in mode of delivery|4|||
131411896|NCT02075632|473130358|FG000|Overall Study|Adverse Event|1|||
131411897|NCT02075632|473130359|FG001|Overall Study|Adverse Event|1|||
131411898|NCT02075632|473130358|FG000|Overall Study|Lost to Follow-up|0|||
131411899|NCT02075632|473130359|FG001|Overall Study|Lost to Follow-up|3|||
131411900|NCT02075632|473130358|FG000|Overall Study|Withdrawal by Subject|0|||
131411901|NCT02075632|473130359|FG001|Overall Study|Withdrawal by Subject|1|||
131411902|NCT00394901|473130360|FG000|Baseline Phase|Protocol Violation|0|||
131411903|NCT00394901|473130361|FG001|Baseline Phase|Protocol Violation|0|||
131411904|NCT00394901|473130362|FG002|Baseline Phase|Protocol Violation|1|||
131411905|NCT00394901|473130363|FG003|Baseline Phase|Protocol Violation|0|||
131411906|NCT00394901|473130360|FG000|Double-blind Phase|Adverse Event|5|||
131933797|NCT02471144|475045304|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
131933798|NCT02471144|475045305|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933799|NCT02471144|475045306|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933800|NCT02471144|475045307|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933801|NCT02471144|475045308|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933802|NCT02471144|475045309|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933803|NCT02471144|475045310|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933804|NCT02471144|475045311|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
131933805|NCT02471144|475045301|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933806|NCT02471144|475045302|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933807|NCT02471144|475045303|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
131933808|NCT02471144|475045304|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933809|NCT02471144|475045305|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933810|NCT02471144|475045306|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933811|NCT02471144|475045307|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933812|NCT02471144|475045308|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933813|NCT02471144|475045309|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933814|NCT02471144|475045310|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933815|NCT02471144|475045311|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
131933816|NCT02471144|475045301|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
131933817|NCT02471144|475045302|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
131411907|NCT00394901|473130361|FG001|Double-blind Phase|Adverse Event|7|||
131411908|NCT00394901|473130362|FG002|Double-blind Phase|Adverse Event|16|||
131411909|NCT00394901|473130363|FG003|Double-blind Phase|Adverse Event|20|||
131411910|NCT00394901|473130360|FG000|Double-blind Phase|Lack of Efficacy|6|||
131933818|NCT02471144|475045303|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933819|NCT02471144|475045304|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933820|NCT02471144|475045305|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933821|NCT02471144|475045306|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933822|NCT02471144|475045307|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933823|NCT02471144|475045308|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933824|NCT02471144|475045309|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933825|NCT02471144|475045310|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933826|NCT02471144|475045311|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
131933827|NCT02471144|475045301|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933828|NCT02471144|475045302|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933829|NCT02471144|475045303|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933830|NCT02471144|475045304|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933831|NCT02471144|475045305|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
131933832|NCT02471144|475045306|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933833|NCT02471144|475045307|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
131933834|NCT02471144|475045308|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933835|NCT02471144|475045309|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
131933836|NCT02471144|475045310|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933837|NCT02471144|475045311|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
131933838|NCT02471144|475045301|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933839|NCT02471144|475045302|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933840|NCT02471144|475045303|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933841|NCT02471144|475045304|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933842|NCT02471144|475045305|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933843|NCT02471144|475045306|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
131933844|NCT02471144|475045307|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933845|NCT02471144|475045308|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933846|NCT02471144|475045309|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
131933847|NCT02471144|475045310|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933848|NCT02471144|475045311|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
131933849|NCT02471144|475045301|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933850|NCT02471144|475045302|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933851|NCT02471144|475045303|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933852|NCT02471144|475045304|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933853|NCT02471144|475045305|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933854|NCT02471144|475045306|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933855|NCT02471144|475045307|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933856|NCT02471144|475045308|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933857|NCT02471144|475045309|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
131933858|NCT02471144|475045310|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933859|NCT02471144|475045311|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
131933860|NCT02471144|475045301|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933861|NCT02471144|475045302|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933862|NCT02471144|475045303|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933863|NCT02471144|475045304|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933864|NCT02471144|475045305|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933865|NCT02471144|475045306|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933866|NCT02471144|475045307|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933867|NCT02471144|475045308|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
131933868|NCT02471144|475045309|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
131933869|NCT02471144|475045310|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933870|NCT02471144|475045311|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
131933871|NCT02471144|475045301|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933872|NCT02471144|475045302|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933873|NCT02471144|475045303|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933874|NCT02471144|475045304|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933875|NCT02471144|475045305|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933876|NCT02471144|475045306|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933877|NCT02471144|475045307|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933878|NCT02471144|475045308|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933879|NCT02471144|475045309|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
131933880|NCT02471144|475045310|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
131454275|NCT00337675|473293259|FG002|Overall Study|Progressive Disease|0|||
131454276|NCT00337675|473293257|FG000|Overall Study|Trial Terminated|0|||
131933881|NCT02471144|475045311|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
131933882|NCT02471144|475045301|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933883|NCT02471144|475045302|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933884|NCT02471144|475045303|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933885|NCT02471144|475045304|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933886|NCT02471144|475045305|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933887|NCT02471144|475045306|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933888|NCT02471144|475045307|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933889|NCT02471144|475045308|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933890|NCT02471144|475045309|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933891|NCT02471144|475045310|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
131933892|NCT02471144|475045311|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
131933893|NCT02471144|475045301|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933894|NCT02471144|475045302|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933895|NCT02471144|475045303|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933896|NCT02471144|475045304|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933897|NCT02471144|475045305|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933898|NCT02471144|475045306|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933899|NCT02471144|475045307|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933900|NCT02471144|475045308|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933901|NCT02471144|475045309|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933902|NCT02471144|475045310|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
131933903|NCT02471144|475045311|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
131933904|NCT02471144|475045301|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933905|NCT02471144|475045302|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933906|NCT02471144|475045303|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933907|NCT02471144|475045304|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933908|NCT02471144|475045305|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933909|NCT02471144|475045306|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933910|NCT02471144|475045307|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933911|NCT02471144|475045308|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933912|NCT02471144|475045309|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
131933913|NCT02471144|475045310|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
131933914|NCT02471144|475045311|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
131933915|NCT02471144|475045301|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933916|NCT02471144|475045302|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933917|NCT02471144|475045303|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933918|NCT02471144|475045304|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933919|NCT02471144|475045305|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933920|NCT02471144|475045306|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933921|NCT02471144|475045307|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933922|NCT02471144|475045308|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933923|NCT02471144|475045309|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933924|NCT02471144|475045310|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
131933925|NCT02471144|475045311|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
131933926|NCT02471144|475045301|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933927|NCT02471144|475045302|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933928|NCT02471144|475045303|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933929|NCT02471144|475045304|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933930|NCT02471144|475045305|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933931|NCT02471144|475045306|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933932|NCT02471144|475045307|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933933|NCT02471144|475045308|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933934|NCT02471144|475045309|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
131933935|NCT02471144|475045310|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
131933936|NCT02471144|475045311|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
131933937|NCT04101331|475045312|FG000|Overall Study|Adverse Event|9|||
131933938|NCT04101331|475045312|FG000|Overall Study|Disease progression|82|||
131933939|NCT04101331|475045312|FG000|Overall Study|Withdrawal by Subject|1|||
131933940|NCT04101331|475045312|FG000|Overall Study|Investigator decision|6|||
131933941|NCT04101331|475045312|FG000|Overall Study|Death|6|||
131933942|NCT04101331|475045312|FG000|Overall Study|Allogenic transplant|1|||
131933943|NCT04110145|475045314|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
131933944|NCT04110145|475045315|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
131933945|NCT04110145|475045316|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
131933946|NCT04110145|475045317|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
131933947|NCT04110145|475045318|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
131933948|NCT02254291|475045319|FG000|Overall Study|Withdrawal by Subject|0|||
131933949|NCT02254291|475045320|FG001|Overall Study|Withdrawal by Subject|3|||
131933950|NCT02254291|475045321|FG002|Overall Study|Withdrawal by Subject|1|||
131933951|NCT02254291|475045319|FG000|Overall Study|Missing follow-up information|0|||
131933952|NCT02254291|475045320|FG001|Overall Study|Missing follow-up information|0|||
131933953|NCT02254291|475045321|FG002|Overall Study|Missing follow-up information|1|||
131933954|NCT00500331|475045326|FG000|Overall Study|Adverse Event|0|||
131933955|NCT00500331|475045327|FG001|Overall Study|Adverse Event|2|||
131933956|NCT00500331|475045328|FG002|Overall Study|Adverse Event|0|||
131933957|NCT00500331|475045329|FG003|Overall Study|Adverse Event|1|||
131933958|NCT00500331|475045330|FG004|Overall Study|Adverse Event|2|||
131933959|NCT00500331|475045331|FG005|Overall Study|Adverse Event|2|||
131933960|NCT00500331|475045332|FG006|Overall Study|Adverse Event|0|||
131933961|NCT00500331|475045326|FG000|Overall Study|Lost to Follow-up|1|||
131933962|NCT00500331|475045327|FG001|Overall Study|Lost to Follow-up|1|||
131933963|NCT00500331|475045328|FG002|Overall Study|Lost to Follow-up|1|||
131933964|NCT00500331|475045329|FG003|Overall Study|Lost to Follow-up|2|||
131933965|NCT00500331|475045330|FG004|Overall Study|Lost to Follow-up|1|||
131933966|NCT00500331|475045331|FG005|Overall Study|Lost to Follow-up|0|||
131933967|NCT00500331|475045332|FG006|Overall Study|Lost to Follow-up|0|||
131933968|NCT00500331|475045326|FG000|Overall Study|Protocol Violation|3|||
131933969|NCT00500331|475045327|FG001|Overall Study|Protocol Violation|1|||
131933970|NCT00500331|475045328|FG002|Overall Study|Protocol Violation|1|||
131933971|NCT00500331|475045329|FG003|Overall Study|Protocol Violation|0|||
131933972|NCT00500331|475045330|FG004|Overall Study|Protocol Violation|1|||
131933973|NCT00500331|475045331|FG005|Overall Study|Protocol Violation|1|||
131933974|NCT00500331|475045332|FG006|Overall Study|Protocol Violation|1|||
131933975|NCT00500331|475045326|FG000|Overall Study|Withdrawal by Subject|4|||
131933976|NCT00500331|475045327|FG001|Overall Study|Withdrawal by Subject|0|||
131933977|NCT00500331|475045328|FG002|Overall Study|Withdrawal by Subject|1|||
131933978|NCT00500331|475045329|FG003|Overall Study|Withdrawal by Subject|5|||
131933979|NCT00500331|475045330|FG004|Overall Study|Withdrawal by Subject|0|||
131933980|NCT00500331|475045331|FG005|Overall Study|Withdrawal by Subject|1|||
131933981|NCT00500331|475045332|FG006|Overall Study|Withdrawal by Subject|1|||
131933982|NCT00500331|475045326|FG000|Overall Study|Lack of Efficacy|3|||
131933983|NCT00500331|475045327|FG001|Overall Study|Lack of Efficacy|1|||
131933984|NCT00500331|475045328|FG002|Overall Study|Lack of Efficacy|0|||
131933985|NCT00500331|475045329|FG003|Overall Study|Lack of Efficacy|0|||
131933986|NCT00500331|475045330|FG004|Overall Study|Lack of Efficacy|0|||
131933987|NCT00500331|475045331|FG005|Overall Study|Lack of Efficacy|0|||
131933988|NCT00500331|475045332|FG006|Overall Study|Lack of Efficacy|0|||
131933989|NCT00500331|475045326|FG000|Overall Study|Liver function test abnormality|0|||
131933990|NCT00500331|475045327|FG001|Overall Study|Liver function test abnormality|0|||
131933991|NCT00500331|475045328|FG002|Overall Study|Liver function test abnormality|1|||
131933992|NCT00500331|475045329|FG003|Overall Study|Liver function test abnormality|0|||
131933993|NCT00500331|475045330|FG004|Overall Study|Liver function test abnormality|0|||
131933994|NCT00500331|475045331|FG005|Overall Study|Liver function test abnormality|0|||
131933995|NCT00500331|475045332|FG006|Overall Study|Liver function test abnormality|0|||
131933996|NCT00500331|475045326|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
131933997|NCT00500331|475045327|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
131933998|NCT00500331|475045328|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
131933999|NCT00500331|475045329|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
131934000|NCT00500331|475045330|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
131934001|NCT00500331|475045331|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
131934002|NCT00500331|475045332|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
131934003|NCT00500331|475045326|FG000|Overall Study|Didn't return for continuation of study|1|||
131934004|NCT00500331|475045327|FG001|Overall Study|Didn't return for continuation of study|0|||
131934005|NCT00500331|475045328|FG002|Overall Study|Didn't return for continuation of study|0|||
131934006|NCT00500331|475045329|FG003|Overall Study|Didn't return for continuation of study|0|||
131934007|NCT00500331|475045330|FG004|Overall Study|Didn't return for continuation of study|0|||
131934008|NCT00500331|475045331|FG005|Overall Study|Didn't return for continuation of study|0|||
131934009|NCT00500331|475045332|FG006|Overall Study|Didn't return for continuation of study|0|||
131934010|NCT00500331|475045326|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
131411911|NCT00394901|473130361|FG001|Double-blind Phase|Lack of Efficacy|4|||
131411912|NCT00394901|473130362|FG002|Double-blind Phase|Lack of Efficacy|1|||
131411913|NCT00394901|473130363|FG003|Double-blind Phase|Lack of Efficacy|3|||
131411914|NCT00394901|473130360|FG000|Double-blind Phase|Withdrawal by Subject|2|||
131411915|NCT00394901|473130361|FG001|Double-blind Phase|Withdrawal by Subject|0|||
131411916|NCT00394901|473130362|FG002|Double-blind Phase|Withdrawal by Subject|0|||
131934011|NCT00500331|475045327|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
131934012|NCT00500331|475045328|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
131934013|NCT00500331|475045329|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
131934014|NCT00500331|475045330|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
131934015|NCT00500331|475045331|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
131934016|NCT00500331|475045332|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
131934017|NCT00500331|475045326|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
131934018|NCT00500331|475045327|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
131934019|NCT00500331|475045328|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
131934020|NCT00500331|475045329|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
131934021|NCT00500331|475045330|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
131934022|NCT00500331|475045331|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
131934023|NCT00500331|475045332|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
131934024|NCT00500331|475045326|FG000|Overall Study|Participant was randomized by mistake|1|||
131934025|NCT00500331|475045327|FG001|Overall Study|Participant was randomized by mistake|0|||
131934026|NCT00500331|475045328|FG002|Overall Study|Participant was randomized by mistake|0|||
131934027|NCT00500331|475045329|FG003|Overall Study|Participant was randomized by mistake|0|||
131934028|NCT00500331|475045330|FG004|Overall Study|Participant was randomized by mistake|0|||
131934029|NCT00500331|475045331|FG005|Overall Study|Participant was randomized by mistake|0|||
131934030|NCT00500331|475045332|FG006|Overall Study|Participant was randomized by mistake|0|||
131934031|NCT00500331|475045326|FG000|Overall Study|Diabetologist nurse in the study|0|||
131934032|NCT00500331|475045327|FG001|Overall Study|Diabetologist nurse in the study|0|||
131934033|NCT00500331|475045328|FG002|Overall Study|Diabetologist nurse in the study|1|||
131934034|NCT00500331|475045329|FG003|Overall Study|Diabetologist nurse in the study|0|||
131934035|NCT00500331|475045330|FG004|Overall Study|Diabetologist nurse in the study|0|||
131934036|NCT00500331|475045331|FG005|Overall Study|Diabetologist nurse in the study|0|||
131934037|NCT00500331|475045332|FG006|Overall Study|Diabetologist nurse in the study|0|||
131934038|NCT00500331|475045326|FG000|Overall Study|State ban of biological samples export|0|||
131934039|NCT00500331|475045327|FG001|Overall Study|State ban of biological samples export|0|||
131934040|NCT00500331|475045328|FG002|Overall Study|State ban of biological samples export|0|||
131934041|NCT00500331|475045329|FG003|Overall Study|State ban of biological samples export|1|||
131934042|NCT00500331|475045330|FG004|Overall Study|State ban of biological samples export|0|||
131934043|NCT00500331|475045331|FG005|Overall Study|State ban of biological samples export|0|||
131934044|NCT00500331|475045332|FG006|Overall Study|State ban of biological samples export|0|||
131934045|NCT00500331|475045326|FG000|Overall Study|Protocol violated|0|||
131934046|NCT00500331|475045327|FG001|Overall Study|Protocol violated|0|||
131934047|NCT00500331|475045328|FG002|Overall Study|Protocol violated|0|||
131934048|NCT00500331|475045329|FG003|Overall Study|Protocol violated|1|||
131934049|NCT00500331|475045330|FG004|Overall Study|Protocol violated|0|||
131934050|NCT00500331|475045331|FG005|Overall Study|Protocol violated|0|||
131934051|NCT00500331|475045332|FG006|Overall Study|Protocol violated|0|||
131934052|NCT03436732|475045333|FG000|Overall Study|Not treated-enrolled in different study|1|||
131934053|NCT03436732|475045334|FG001|Overall Study|Not treated-enrolled in different study|0|||
131934054|NCT03436732|475045333|FG000|Overall Study|Off study after cycle 1|1|||
131934055|NCT03436732|475045334|FG001|Overall Study|Off study after cycle 1|0|||
131934056|NCT03436732|475045333|FG000|Overall Study|Adverse Event|2|||
131934057|NCT03436732|475045334|FG001|Overall Study|Adverse Event|0|||
131934058|NCT03436732|475045333|FG000|Overall Study|Death|0|||
131934059|NCT03436732|475045334|FG001|Overall Study|Death|1|||
131934060|NCT00321932|475045336|FG000|Overall Study|Death|3|||
131934061|NCT00321932|475045337|FG001|Overall Study|Death|6|||
131934062|NCT00321932|475045336|FG000|Overall Study|Withdrawal by Subject|3|||
131934063|NCT00321932|475045337|FG001|Overall Study|Withdrawal by Subject|6|||
131934064|NCT00321932|475045336|FG000|Overall Study|Early relapse|2|||
131934065|NCT00321932|475045337|FG001|Overall Study|Early relapse|8|||
131934066|NCT00321932|475045336|FG000|Overall Study|Missing data|2|||
131934067|NCT00321932|475045337|FG001|Overall Study|Missing data|1|||
131934068|NCT01904279|475045339|FG000|Overall Study|Lack of Efficacy|2|||
131934069|NCT01904279|475045340|FG001|Overall Study|Lack of Efficacy|3|||
131934070|NCT01904279|475045339|FG000|Overall Study|Withdrawal by Subject|1|||
131934071|NCT01904279|475045340|FG001|Overall Study|Withdrawal by Subject|0|||
131934072|NCT03257657|475045341|FG000|Overall Study|Lost to Follow-up|0|||
131934073|NCT03257657|475045342|FG001|Overall Study|Lost to Follow-up|3|||
131934074|NCT03257657|475045341|FG000|Overall Study|Withdrawn|0|||
131934075|NCT03257657|475045342|FG001|Overall Study|Withdrawn|1|||
131934076|NCT03257657|475045341|FG000|Overall Study|Noted not eligible right after enrolled|0|||
131934077|NCT03257657|475045342|FG001|Overall Study|Noted not eligible right after enrolled|1|||
131934078|NCT02489279|475045351|FG000|Overall Study|Lost to Follow-up|12|||
131934079|NCT02489279|475045352|FG001|Overall Study|Lost to Follow-up|10|||
131934080|NCT02263547|475045353|FG000|Overall Study|Adverse Event|1|||
131934081|NCT02263547|475045353|FG000|Overall Study|Lost to Follow-up|2|||
131934082|NCT00586157|475045354|FG000|First Intervention|Worsening behavior|1|||
131934083|NCT00586157|475045355|FG001|First Intervention|Worsening behavior|0|||
131934084|NCT00586157|475045354|FG000|Second Intervention|Withdrawal by Subject|1|||
131934085|NCT00586157|475045355|FG001|Second Intervention|Withdrawal by Subject|0|||
131934086|NCT00586157|475045354|FG000|Second Intervention|Worsening behavior|1|||
131454277|NCT00337675|473293258|FG001|Overall Study|Trial Terminated|0|||
131454278|NCT00337675|473293259|FG002|Overall Study|Trial Terminated|2|||
131454279|NCT04269265|473293260|FG000|Overall Study|Physician Decision|1|||
131454280|NCT04269265|473293260|FG000|Overall Study|Withdrawal by Subject|1|||
131454281|NCT04269265|473293260|FG000|Overall Study|Overenrolled (sample size reached)|4|||
131454282|NCT04838626|473293261|FG000|Overall Study|Adverse Event|2|||
131454283|NCT04838626|473293261|FG000|Overall Study|Physician Decision|6|||
131454284|NCT04838626|473293261|FG000|Overall Study|Protocol Violation|3|||
131454285|NCT04838626|473293261|FG000|Overall Study|Withdrawal by Subject|9|||
131454286|NCT04838626|473293261|FG000|Overall Study|Technical Problems|2|||
131454287|NCT02867384|473293262|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
131454288|NCT02867384|473293263|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
131454289|NCT02867384|473293264|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
131454290|NCT02867384|473293262|FG000|Overall Study|Progression/ Relapse|15|||
131454291|NCT02867384|473293263|FG001|Overall Study|Progression/ Relapse|19|||
131454292|NCT02867384|473293264|FG002|Overall Study|Progression/ Relapse|0|||
131454293|NCT02867384|473293262|FG000|Overall Study|Adverse Event|13|||
131454294|NCT02867384|473293263|FG001|Overall Study|Adverse Event|1|||
131454295|NCT02867384|473293264|FG002|Overall Study|Adverse Event|0|||
131454296|NCT02867384|473293262|FG000|Overall Study|Withdrawal by Subject|6|||
131454297|NCT02867384|473293263|FG001|Overall Study|Withdrawal by Subject|5|||
131454298|NCT02867384|473293264|FG002|Overall Study|Withdrawal by Subject|0|||
131454299|NCT02867384|473293262|FG000|Overall Study|Physician Decision|1|||
131454300|NCT02867384|473293263|FG001|Overall Study|Physician Decision|2|||
131454301|NCT02867384|473293264|FG002|Overall Study|Physician Decision|0|||
131454302|NCT02867384|473293262|FG000|Overall Study|Patient compliance|1|||
131454303|NCT02867384|473293263|FG001|Overall Study|Patient compliance|0|||
131454304|NCT02867384|473293264|FG002|Overall Study|Patient compliance|0|||
131454305|NCT02867384|473293262|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
131454306|NCT02867384|473293263|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
131454307|NCT02867384|473293264|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
131454308|NCT02867384|473293262|FG000|Overall Study|Never start treatment|3|||
131454309|NCT02867384|473293263|FG001|Overall Study|Never start treatment|0|||
131454310|NCT02867384|473293264|FG002|Overall Study|Never start treatment|0|||
131454311|NCT03901469|473293268|FG000|Overall Study|Radiographic Progression|4|||
131454312|NCT03901469|473293269|FG001|Overall Study|Radiographic Progression|6|||
131454313|NCT03901469|473293270|FG002|Overall Study|Radiographic Progression|3|||
131454314|NCT03901469|473293271|FG003|Overall Study|Radiographic Progression|30|||
131934087|NCT00586157|475045355|FG001|Second Intervention|Worsening behavior|0|||
131934088|NCT00586157|475045354|FG000|Second Intervention|Adverse Event|0|||
131934089|NCT00586157|475045355|FG001|Second Intervention|Adverse Event|1|||
131934090|NCT02378480|475045357|FG000|Overall Study|Physician Decision|1|||
131934091|NCT02378480|475045358|FG001|Overall Study|Physician Decision|1|||
131934092|NCT02378480|475045357|FG000|Overall Study|Death|1|||
131934093|NCT02378480|475045358|FG001|Overall Study|Death|2|||
131934094|NCT02378480|475045357|FG000|Overall Study|Randomized, but Not Treated|6|||
131934095|NCT02378480|475045358|FG001|Overall Study|Randomized, but Not Treated|4|||
131934096|NCT02378480|475045357|FG000|Overall Study|Adverse Event|0|||
131934097|NCT02378480|475045358|FG001|Overall Study|Adverse Event|1|||
131934098|NCT02378480|475045357|FG000|Overall Study|Missed EOT/PTE Visit|1|||
131934099|NCT02378480|475045358|FG001|Overall Study|Missed EOT/PTE Visit|2|||
131934100|NCT02378480|475045357|FG000|Overall Study|Withdrawal by Subject|9|||
131934101|NCT02378480|475045358|FG001|Overall Study|Withdrawal by Subject|4|||
131934102|NCT02378480|475045357|FG000|Overall Study|Lost to Follow-up|10|||
131934103|NCT02378480|475045358|FG001|Overall Study|Lost to Follow-up|18|||
131934104|NCT02014467|475045362|FG000|Overall Study|Adverse Event|4|||
131934105|NCT02014467|475045363|FG001|Overall Study|Adverse Event|0|||
131934106|NCT02014467|475045362|FG000|Overall Study|Protocol Violation|3|||
131934107|NCT02014467|475045363|FG001|Overall Study|Protocol Violation|0|||
131934108|NCT02014467|475045362|FG000|Overall Study|Physician Decision|2|||
131934109|NCT02014467|475045363|FG001|Overall Study|Physician Decision|3|||
131934110|NCT02014467|475045362|FG000|Overall Study|Withdrawal by Subject|16|||
131454315|NCT03901469|473293272|FG004|Overall Study|Radiographic Progression|7|||
131454316|NCT03901469|473293273|FG005|Overall Study|Radiographic Progression|2|||
131454317|NCT03901469|473293274|FG006|Overall Study|Radiographic Progression|11|||
131454318|NCT03901469|473293268|FG000|Overall Study|Clinical Progression|0|||
131454319|NCT03901469|473293269|FG001|Overall Study|Clinical Progression|2|||
131454320|NCT03901469|473293270|FG002|Overall Study|Clinical Progression|0|||
131454321|NCT03901469|473293271|FG003|Overall Study|Clinical Progression|7|||
131454322|NCT03901469|473293272|FG004|Overall Study|Clinical Progression|6|||
131454323|NCT03901469|473293273|FG005|Overall Study|Clinical Progression|0|||
131934111|NCT02014467|475045363|FG001|Overall Study|Withdrawal by Subject|4|||
131934112|NCT00557440|475045364|FG000|Treatment Period 1|Adverse Event|0|||
131934113|NCT00557440|475045365|FG001|Treatment Period 1|Adverse Event|0|||
131934114|NCT00557440|475045366|FG002|Treatment Period 1|Adverse Event|1|||
131934115|NCT03524157|475045367|FG000|Overall Study|cytology not readable|0|||
131411917|NCT00394901|473130363|FG003|Double-blind Phase|Withdrawal by Subject|0|||
131411918|NCT00394901|473130360|FG000|Double-blind Phase|Lost to Follow-up|0|||
131411919|NCT00394901|473130361|FG001|Double-blind Phase|Lost to Follow-up|0|||
131411920|NCT00394901|473130362|FG002|Double-blind Phase|Lost to Follow-up|0|||
131411921|NCT00394901|473130363|FG003|Double-blind Phase|Lost to Follow-up|1|||
131411922|NCT00394901|473130360|FG000|Double-blind Phase|Protocol Violation|0|||
131411923|NCT00394901|473130361|FG001|Double-blind Phase|Protocol Violation|0|||
131411924|NCT00394901|473130362|FG002|Double-blind Phase|Protocol Violation|0|||
131411925|NCT00394901|473130363|FG003|Double-blind Phase|Protocol Violation|1|||
131411926|NCT00394901|473130360|FG000|Double-blind Phase|Death|1|||
131411927|NCT00394901|473130361|FG001|Double-blind Phase|Death|0|||
131411928|NCT00394901|473130362|FG002|Double-blind Phase|Death|0|||
131411929|NCT00394901|473130363|FG003|Double-blind Phase|Death|0|||
131411930|NCT00394901|473130360|FG000|Double-blind Phase|Subject's Personal Reason|1|||
131411931|NCT00394901|473130361|FG001|Double-blind Phase|Subject's Personal Reason|0|||
131411932|NCT00394901|473130362|FG002|Double-blind Phase|Subject's Personal Reason|0|||
131411933|NCT00394901|473130363|FG003|Double-blind Phase|Subject's Personal Reason|1|||
131411934|NCT00394901|473130360|FG000|Double-blind Phase|Lack of Compliance|0|||
131411935|NCT00394901|473130361|FG001|Double-blind Phase|Lack of Compliance|3|||
131411936|NCT00394901|473130362|FG002|Double-blind Phase|Lack of Compliance|0|||
131411937|NCT00394901|473130363|FG003|Double-blind Phase|Lack of Compliance|0|||
131411938|NCT00394901|473130360|FG000|Double-blind Phase|Entry into another study was found|0|||
131411939|NCT00394901|473130361|FG001|Double-blind Phase|Entry into another study was found|0|||
131411940|NCT00394901|473130362|FG002|Double-blind Phase|Entry into another study was found|1|||
131411941|NCT00394901|473130363|FG003|Double-blind Phase|Entry into another study was found|0|||
131411942|NCT00394901|473130360|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
131411943|NCT00394901|473130361|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
131411944|NCT00394901|473130362|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
131411945|NCT00394901|473130363|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
131411946|NCT05028517|473130364|FG000|Overall Study|Lost to Follow-up|13|||
131411947|NCT05028517|473130365|FG001|Overall Study|Lost to Follow-up|20|||
131411948|NCT05028517|473130366|FG002|Overall Study|Lost to Follow-up|12|||
131411949|NCT05028517|473130364|FG000|Overall Study|Withdrawal by Subject|0|||
131411950|NCT05028517|473130365|FG001|Overall Study|Withdrawal by Subject|0|||
131411951|NCT05028517|473130366|FG002|Overall Study|Withdrawal by Subject|1|||
131411952|NCT02256267|473130367|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
131934116|NCT03524157|475045368|FG001|Overall Study|cytology not readable|0|||
131934117|NCT03524157|475045369|FG002|Overall Study|cytology not readable|1|||
131934118|NCT05763381|475045370|FG000|Overall Study|Lost to Follow-up|2|||
131934119|NCT05763381|475045371|FG001|Overall Study|Lost to Follow-up|3|||
131934120|NCT05763381|475045370|FG000|Overall Study|Withdrawal by Subject|1|||
131934121|NCT05763381|475045371|FG001|Overall Study|Withdrawal by Subject|2|||
131934122|NCT00841815|475045372|FG000|Washout|Withdrawal by Subject|0|||
131934123|NCT00841815|475045373|FG001|Washout|Withdrawal by Subject|1|||
131934124|NCT03685149|475045375|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
131934125|NCT03685149|475045376|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
131934126|NCT03685149|475045375|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131934127|NCT03685149|475045376|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131934128|NCT03685149|475045375|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
131934129|NCT03685149|475045376|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
131934130|NCT00209131|475045383|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
131934131|NCT00209131|475045384|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
131934132|NCT02796651|475045385|FG000|Overall Study|Adverse Event|6|||
131934133|NCT02796651|475045385|FG000|Overall Study|Lost to Follow-up|1|||
131934134|NCT02796651|475045385|FG000|Overall Study|Withdrawal by Subject|4|||
131934135|NCT02796651|475045385|FG000|Overall Study|Protocol Violation|4|||
131934136|NCT02796651|475045385|FG000|Overall Study|Lack of Efficacy|1|||
131934137|NCT02796651|475045385|FG000|Overall Study|Other|10|||
131934138|NCT05360784|475045386|FG000|Overall Study|Discontinued|25|||
131934139|NCT05360784|475045387|FG001|Overall Study|Discontinued|11|||
131934140|NCT05142306|475045391|FG000|Overall Study|Withdrawal by Subject|0|||
131934141|NCT05142306|475045392|FG001|Overall Study|Withdrawal by Subject|0|||
131934142|NCT05142306|475045393|FG002|Overall Study|Withdrawal by Subject|1|||
131934143|NCT02251041|475045394|FG000|Overall Study|Did not receive intervention|15|||
131934144|NCT02251041|475045395|FG001|Overall Study|Did not receive intervention|4|||
131934145|NCT04079920|475045396|FG000|Overall Study|Adverse event, not related to study drug|2|||
131934146|NCT04079920|475045396|FG000|Overall Study|Adverse event related to study drug|10|||
131934147|NCT04079920|475045396|FG000|Overall Study|Death|2|||
131934148|NCT04079920|475045396|FG000|Overall Study|Lost to Follow-up|22|||
131934149|NCT04079920|475045396|FG000|Overall Study|Physician Decision|1|||
131934150|NCT04079920|475045396|FG000|Overall Study|Withdrawal by Subject|11|||
131411953|NCT02256267|473130367|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
131411954|NCT01066780|473130371|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
131411955|NCT01066780|473130372|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
131934151|NCT04918771|475045397|FG000|Overall Study|Withdrawal by Subject|4|||
131934152|NCT04918771|475045398|FG001|Overall Study|Withdrawal by Subject|5|||
131934153|NCT04918771|475045397|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
131934154|NCT04918771|475045398|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
131934155|NCT02298946|475045406|FG000|Overall Study|Did not receive treatment|2|||
131934156|NCT02298946|475045407|FG001|Overall Study|Did not receive treatment|0|||
131934157|NCT02298946|475045406|FG000|Overall Study|Unevaluable|2|||
131934158|NCT02298946|475045407|FG001|Overall Study|Unevaluable|1|||
131934159|NCT05535972|475045408|FG000|Overall Study|Withdrawal by Subject|31|||
131934160|NCT05535972|475045408|FG000|Overall Study|Lost to Follow-up|5|||
131934161|NCT05535972|475045408|FG000|Overall Study|Adverse Event|6|||
131934162|NCT05535972|475045408|FG000|Overall Study|Protocol Deviation|2|||
131934163|NCT04629196|475045412|FG000|Overall Study|Subject discontinued study drug|1|||
131934164|NCT04629196|475045413|FG001|Overall Study|Subject discontinued study drug|0|||
131934165|NCT04629196|475045412|FG000|Overall Study|Subject study drug dosing increased|1|||
131934166|NCT04629196|475045413|FG001|Overall Study|Subject study drug dosing increased|1|||
131934167|NCT04629196|475045412|FG000|Overall Study|Withdrawal by Subject|1|||
131934168|NCT04629196|475045413|FG001|Overall Study|Withdrawal by Subject|2|||
131934169|NCT01450631|475045417|FG000|Overall Study|Lost to Follow-up|2|||
131934170|NCT01450631|475045418|FG001|Overall Study|Lost to Follow-up|4|||
131934171|NCT01450631|475045417|FG000|Overall Study|Withdrawal by Subject|1|||
131934172|NCT01450631|475045418|FG001|Overall Study|Withdrawal by Subject|0|||
131934173|NCT00835354|475045419|FG000|First Intervention|Adverse Event|0|||
131934174|NCT00835354|475045420|FG001|First Intervention|Adverse Event|1|||
131934175|NCT03204812|475045421|FG000|Overall Study|Adverse Event|3|||
131934176|NCT01385995|475045422|FG000|Period 1, 2 Months|Physician Decision|1|||
131934177|NCT01385995|475045423|FG001|Period 1, 2 Months|Physician Decision|0|||
131934178|NCT00112385|475045424|FG000|Overall Study|Lost to Follow-up|1|||
131934179|NCT00112385|475045425|FG001|Overall Study|Lost to Follow-up|0|||
131934180|NCT00112385|475045424|FG000|Overall Study|Withdrawal by Subject|0|||
131934181|NCT00112385|475045425|FG001|Overall Study|Withdrawal by Subject|1|||
131934182|NCT00003645|475046585|FG000|Overall Study|Death|4|||
131934183|NCT00003645|475046586|FG001|Overall Study|Death|1|||
131934184|NCT00003645|475046585|FG000|Overall Study|Lost to Follow-up|7|||
131934185|NCT00003645|475046586|FG001|Overall Study|Lost to Follow-up|8|||
131934186|NCT00003645|475046585|FG000|Overall Study|Withdrawal by Subject|1|||
131934187|NCT00003645|475046586|FG001|Overall Study|Withdrawal by Subject|3|||
131934188|NCT03768336|475046589|FG000|Overall Study|Lost to Follow-up|3|||
131934189|NCT03768336|475046590|FG001|Overall Study|Lost to Follow-up|2|||
131934190|NCT03768336|475046589|FG000|Overall Study|Became Ineligible|2|||
131934191|NCT03768336|475046590|FG001|Overall Study|Became Ineligible|0|||
131934192|NCT03768336|475046589|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
131934193|NCT03768336|475046590|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
131934194|NCT03768336|475046589|FG000|Overall Study|Missed final survey (post-treatment|0|||
131934195|NCT03768336|475046590|FG001|Overall Study|Missed final survey (post-treatment|1|||
131934196|NCT05654181|475046591|FG000|Overall Study|Adverse Event|1|||
131934197|NCT05654181|475046592|FG001|Overall Study|Adverse Event|0|||
131934198|NCT05654181|475046593|FG002|Overall Study|Adverse Event|0|||
131934199|NCT05654181|475046594|FG003|Overall Study|Adverse Event|0|||
131934200|NCT05654181|475046595|FG004|Overall Study|Adverse Event|0|||
131934201|NCT05654181|475046596|FG005|Overall Study|Adverse Event|0|||
131934202|NCT05654181|475046597|FG006|Overall Study|Adverse Event|0|||
131934203|NCT05654181|475046598|FG007|Overall Study|Adverse Event|1|||
131934204|NCT05654181|475046599|FG008|Overall Study|Adverse Event|0|||
131934205|NCT05654181|475046600|FG009|Overall Study|Adverse Event|0|||
131934206|NCT05654181|475046591|FG000|Overall Study|Withdrawal by Subject|0|||
131411956|NCT02360293|473130373|FG000|Overall Study|Lost to Follow-up|73|||
131411957|NCT02360293|473130374|FG001|Overall Study|Lost to Follow-up|95|||
131411958|NCT02360293|473130373|FG000|Overall Study|Withdrawal by Subject|2|||
131411959|NCT02360293|473130374|FG001|Overall Study|Withdrawal by Subject|1|||
131411960|NCT02360293|473130373|FG000|Overall Study|Excluded|1|||
131411961|NCT02360293|473130374|FG001|Overall Study|Excluded|0|||
131411962|NCT04316741|473130375|FG000|Baseline Enrollment|Lost to Follow-up|1|||
131934207|NCT05654181|475046592|FG001|Overall Study|Withdrawal by Subject|0|||
131934208|NCT05654181|475046593|FG002|Overall Study|Withdrawal by Subject|0|||
131934209|NCT05654181|475046594|FG003|Overall Study|Withdrawal by Subject|0|||
131934210|NCT05654181|475046595|FG004|Overall Study|Withdrawal by Subject|0|||
131934211|NCT05654181|475046596|FG005|Overall Study|Withdrawal by Subject|0|||
131934212|NCT05654181|475046597|FG006|Overall Study|Withdrawal by Subject|0|||
131934213|NCT05654181|475046598|FG007|Overall Study|Withdrawal by Subject|1|||
131934214|NCT05654181|475046599|FG008|Overall Study|Withdrawal by Subject|0|||
131411963|NCT04316741|473130376|FG001|Baseline Enrollment|Lost to Follow-up|1|||
131934215|NCT05654181|475046600|FG009|Overall Study|Withdrawal by Subject|0|||
131934216|NCT05654181|475046591|FG000|Overall Study|Other|0|||
131934217|NCT05654181|475046592|FG001|Overall Study|Other|0|||
131934218|NCT05654181|475046593|FG002|Overall Study|Other|0|||
131934219|NCT05654181|475046594|FG003|Overall Study|Other|0|||
131934220|NCT05654181|475046595|FG004|Overall Study|Other|1|||
131934221|NCT05654181|475046596|FG005|Overall Study|Other|1|||
131934222|NCT05654181|475046597|FG006|Overall Study|Other|0|||
131934223|NCT05654181|475046598|FG007|Overall Study|Other|0|||
131934224|NCT05654181|475046599|FG008|Overall Study|Other|0|||
131934225|NCT05654181|475046600|FG009|Overall Study|Other|0|||
131934226|NCT03977155|475046601|FG000|Overall Study|Adverse Event|3|||
131934227|NCT03977155|475046602|FG001|Overall Study|Adverse Event|0|||
131934228|NCT03977155|475046603|FG002|Overall Study|Adverse Event|0|||
131934229|NCT03977155|475046601|FG000|Overall Study|Lost to Follow-up|0|||
131934230|NCT03977155|475046602|FG001|Overall Study|Lost to Follow-up|1|||
131934231|NCT03977155|475046603|FG002|Overall Study|Lost to Follow-up|0|||
131934232|NCT03977155|475046601|FG000|Overall Study|Withdrawal by Subject|1|||
131934233|NCT03977155|475046602|FG001|Overall Study|Withdrawal by Subject|1|||
131934234|NCT03977155|475046603|FG002|Overall Study|Withdrawal by Subject|2|||
131934235|NCT03977155|475046601|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
131934236|NCT03977155|475046602|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
131934237|NCT03977155|475046603|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
131934238|NCT03502681|475046606|FG000|Overall Study|Adverse Event|1|||
131934239|NCT03502681|475046607|FG001|Overall Study|Adverse Event|1|||
131934240|NCT03502681|475046606|FG000|Overall Study|Disease Progression|2|||
131934241|NCT03502681|475046607|FG001|Overall Study|Disease Progression|1|||
131934242|NCT01444781|475046608|FG000|Overall Study|Lost to Follow-up|0|||
131934243|NCT01444781|475046609|FG001|Overall Study|Lost to Follow-up|3|||
131934244|NCT01444781|475046610|FG002|Overall Study|Lost to Follow-up|1|||
131934245|NCT01444781|475046608|FG000|Overall Study|Withdrawal by Subject|3|||
131934246|NCT01444781|475046609|FG001|Overall Study|Withdrawal by Subject|1|||
131934247|NCT01444781|475046610|FG002|Overall Study|Withdrawal by Subject|2|||
131934248|NCT06790303|475046611|FG000|Overall Study|Study Terminated by sponsor|4|||
131934249|NCT06790303|475046611|FG000|Overall Study|Death|4|||
131934250|NCT03345550|475046620|FG000|Overall Study|Withdrawal by Subject|1|||
131934251|NCT03345550|475046621|FG001|Overall Study|Withdrawal by Subject|0|||
131934252|NCT03345550|475046620|FG000|Overall Study|Lost to Follow-up|4|||
131934253|NCT03345550|475046621|FG001|Overall Study|Lost to Follow-up|5|||
131934254|NCT03360344|475046624|FG000|Overall Study|Withdrawal by Subject|0|||
131934255|NCT03360344|475046625|FG001|Overall Study|Withdrawal by Subject|1|||
131934256|NCT03360344|475046626|FG002|Overall Study|Withdrawal by Subject|1|||
131934257|NCT00959049|475046631|FG000|Overall Study|Adverse Event|1|||
131934258|NCT00959049|475046632|FG001|Overall Study|Adverse Event|0|||
131934259|NCT00959049|475046633|FG002|Overall Study|Adverse Event|0|||
131934260|NCT00959049|475046634|FG003|Overall Study|Adverse Event|0|||
131934261|NCT00959049|475046635|FG004|Overall Study|Adverse Event|0|||
131934262|NCT00959049|475046636|FG005|Overall Study|Adverse Event|0|||
131934263|NCT00959049|475046631|FG000|Overall Study|Lost to Follow-up|17|||
131934264|NCT00959049|475046632|FG001|Overall Study|Lost to Follow-up|5|||
131934265|NCT00959049|475046633|FG002|Overall Study|Lost to Follow-up|1|||
131934266|NCT00959049|475046634|FG003|Overall Study|Lost to Follow-up|10|||
131934267|NCT00959049|475046635|FG004|Overall Study|Lost to Follow-up|9|||
131934268|NCT00959049|475046636|FG005|Overall Study|Lost to Follow-up|1|||
131934269|NCT00959049|475046631|FG000|Overall Study|Contraindicated medication|0|||
131934270|NCT00959049|475046632|FG001|Overall Study|Contraindicated medication|0|||
131411964|NCT04316741|473130375|FG000|Immediate Post-Test|Lost to Follow-up|5|||
131934271|NCT00959049|475046633|FG002|Overall Study|Contraindicated medication|0|||
131934272|NCT00959049|475046634|FG003|Overall Study|Contraindicated medication|1|||
131934273|NCT00959049|475046635|FG004|Overall Study|Contraindicated medication|0|||
131934274|NCT00959049|475046636|FG005|Overall Study|Contraindicated medication|0|||
131934275|NCT00959049|475046631|FG000|Overall Study|Withdrawal by Subject|0|||
131934276|NCT00959049|475046632|FG001|Overall Study|Withdrawal by Subject|2|||
131934277|NCT00959049|475046633|FG002|Overall Study|Withdrawal by Subject|0|||
131934278|NCT00959049|475046634|FG003|Overall Study|Withdrawal by Subject|0|||
131934279|NCT00959049|475046635|FG004|Overall Study|Withdrawal by Subject|0|||
131934280|NCT00959049|475046636|FG005|Overall Study|Withdrawal by Subject|0|||
131934281|NCT01230060|475046641|FG000|Overall Study|Withdrawal by Subject|1|||
131934282|NCT01217892|475046643|FG000|Overall Study|Adverse Event|1|||
131934283|NCT01217892|475046644|FG001|Overall Study|Adverse Event|1|||
131934284|NCT01217892|475046645|FG002|Overall Study|Adverse Event|1|||
131934285|NCT01217892|475046646|FG003|Overall Study|Adverse Event|0|||
131934286|NCT01217892|475046643|FG000|Overall Study|Withdrawal by Subject|0|||
131934287|NCT01217892|475046644|FG001|Overall Study|Withdrawal by Subject|2|||
131411965|NCT04316741|473130376|FG001|Immediate Post-Test|Lost to Follow-up|1|||
131934288|NCT01217892|475046645|FG002|Overall Study|Withdrawal by Subject|1|||
131934289|NCT01217892|475046646|FG003|Overall Study|Withdrawal by Subject|0|||
131934290|NCT01217892|475046643|FG000|Overall Study|Lab value|1|||
131934291|NCT01217892|475046644|FG001|Overall Study|Lab value|0|||
131411966|NCT04316741|473130375|FG000|1-month Post-test|Lost to Follow-up|7|||
131411967|NCT04316741|473130376|FG001|1-month Post-test|Lost to Follow-up|2|||
131411968|NCT04316741|473130375|FG000|3-month Follow-up|Lost to Follow-up|10|||
131411969|NCT04316741|473130376|FG001|3-month Follow-up|Lost to Follow-up|2|||
131934292|NCT01217892|475046645|FG002|Overall Study|Lab value|1|||
131934293|NCT01217892|475046646|FG003|Overall Study|Lab value|0|||
131934294|NCT01217892|475046643|FG000|Overall Study|Subject no longer meets study criteria|5|||
131934295|NCT01217892|475046644|FG001|Overall Study|Subject no longer meets study criteria|2|||
131934296|NCT01217892|475046645|FG002|Overall Study|Subject no longer meets study criteria|4|||
131934297|NCT01217892|475046646|FG003|Overall Study|Subject no longer meets study criteria|8|||
131934298|NCT01217892|475046643|FG000|Overall Study|Incorrect enrollment|0|||
131934299|NCT01217892|475046644|FG001|Overall Study|Incorrect enrollment|1|||
131934300|NCT01217892|475046645|FG002|Overall Study|Incorrect enrollment|1|||
131934301|NCT01217892|475046646|FG003|Overall Study|Incorrect enrollment|0|||
131934302|NCT01217892|475046643|FG000|Overall Study|Poor/Non-Compliance|0|||
131934303|NCT01217892|475046644|FG001|Overall Study|Poor/Non-Compliance|0|||
131934304|NCT01217892|475046645|FG002|Overall Study|Poor/Non-Compliance|1|||
131934305|NCT01217892|475046646|FG003|Overall Study|Poor/Non-Compliance|0|||
131934306|NCT01052779|475046647|FG000|Overall Study|Adverse Event|1|||
131934307|NCT01052779|475046648|FG001|Overall Study|Adverse Event|4|||
131934308|NCT01052779|475046647|FG000|Overall Study|Withdrawal by Subject|1|||
131934309|NCT01052779|475046648|FG001|Overall Study|Withdrawal by Subject|2|||
131934310|NCT01052779|475046647|FG000|Overall Study|Other-Protocol Violation|1|||
131934311|NCT01052779|475046648|FG001|Overall Study|Other-Protocol Violation|1|||
131934312|NCT01052779|475046647|FG000|Overall Study|Other-Surgery|0|||
131934313|NCT01052779|475046648|FG001|Overall Study|Other-Surgery|2|||
131934314|NCT01052779|475046647|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
131934315|NCT01052779|475046648|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
131934316|NCT03802916|475046649|FG000|Overall Study|Adverse Event|0|||
131934317|NCT03802916|475046650|FG001|Overall Study|Adverse Event|1|||
131934318|NCT03802916|475046649|FG000|Overall Study|Withdrawal by Subject|0|||
131934319|NCT03802916|475046650|FG001|Overall Study|Withdrawal by Subject|1|||
131934320|NCT03663582|475046651|FG000|Overall Study|Physician Decision|1|||
131934321|NCT04507763|475046654|FG000|Overall Study|Participants did not meet entrance criteria|201|||
131934322|NCT01905540|475046655|FG000|Period 3|Other|1|||
131934323|NCT01905540|475046656|FG001|Period 3|Other|0|||
131934324|NCT01905540|475046657|FG002|Period 3|Other|1|||
131934325|NCT01905540|475046658|FG003|Period 3|Other|1|||
131934326|NCT02367885|475046659|FG000|Overall Study|Lost to Follow-up|1|||
131934327|NCT02367885|475046660|FG001|Overall Study|Lost to Follow-up|0|||
131934328|NCT02367885|475046661|FG002|Overall Study|Lost to Follow-up|0|||
131934329|NCT02367885|475046659|FG000|Overall Study|Withdrawal by Subject|1|||
131934330|NCT02367885|475046660|FG001|Overall Study|Withdrawal by Subject|0|||
131934331|NCT02367885|475046661|FG002|Overall Study|Withdrawal by Subject|0|||
131934332|NCT03729609|475046668|FG000|Overall Study|Protocol Violation|1|||
131934333|NCT00605189|475046677|FG000|Overall Study|Adverse Event|1|||
131934334|NCT00605189|475046678|FG001|Overall Study|Adverse Event|0|||
131934335|NCT00605189|475046679|FG002|Overall Study|Adverse Event|0|||
131934336|NCT00605189|475046677|FG000|Overall Study|Other|2|||
131934337|NCT00605189|475046678|FG001|Overall Study|Other|2|||
131934338|NCT00605189|475046679|FG002|Overall Study|Other|0|||
131934339|NCT05473715|475046680|FG000|Overall Study|Trial terminate|2|||
131934340|NCT05473715|475046681|FG001|Overall Study|Trial terminate|1|||
131934341|NCT02919618|475046682|FG000|Overall Study|Death|1|||
131934342|NCT02592863|475046683|FG000|Overall Study|Withdrawal by Subject|2|||
131934343|NCT02592863|475046684|FG001|Overall Study|Withdrawal by Subject|2|||
131934344|NCT02592863|475046683|FG000|Overall Study|Lost to Follow-up|1|||
131934345|NCT02592863|475046684|FG001|Overall Study|Lost to Follow-up|1|||
131934346|NCT02743221|475046685|FG000|Overall Study|Progressive disease|29|||
131934347|NCT02743221|475046686|FG001|Overall Study|Progressive disease|38|||
131934348|NCT02743221|475046685|FG000|Overall Study|Adverse Event|17|||
131934349|NCT02743221|475046686|FG001|Overall Study|Adverse Event|14|||
131934350|NCT02743221|475046685|FG000|Overall Study|non medical reason|8|||
131934351|NCT02743221|475046686|FG001|Overall Study|non medical reason|2|||
131934352|NCT02743221|475046685|FG000|Overall Study|Physician Decision|2|||
131934353|NCT02743221|475046686|FG001|Overall Study|Physician Decision|5|||
131934354|NCT02743221|475046685|FG000|Overall Study|Patient not eligible, not treated|0|||
131934355|NCT02743221|475046686|FG001|Overall Study|Patient not eligible, not treated|1|||
131934356|NCT03411044|475046688|FG000|Overall Study|Death|30|||
131934357|NCT03411044|475046688|FG000|Overall Study|Withdrawal by Subject|48|||
131934358|NCT03411044|475046688|FG000|Overall Study|Lost to Follow-up|78|||
131934359|NCT03411044|475046688|FG000|Overall Study|Adverse Event|30|||
131934360|NCT03411044|475046688|FG000|Overall Study|Missing status|4|||
131934361|NCT01969409|475046689|FG000|Overall Study|Death|2|||
131934362|NCT01969409|475046690|FG001|Overall Study|Death|2|||
131934363|NCT01969409|475046689|FG000|Overall Study|Transplant|1|||
131934364|NCT01969409|475046690|FG001|Overall Study|Transplant|1|||
131934365|NCT01969409|475046689|FG000|Overall Study|Withdrawal by Subject|0|||
131934366|NCT01969409|475046690|FG001|Overall Study|Withdrawal by Subject|1|||
131934367|NCT02226653|475046693|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
131934368|NCT02226653|475046694|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
131934369|NCT02226653|475046693|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
131934370|NCT02226653|475046694|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
131934371|NCT03078868|475046695|FG000|Overall Study|Physician Decision|3|||
131934372|NCT01299961|475046696|FG000|Overall Study|Adverse Event|3|||
131934373|NCT01299961|475046696|FG000|Overall Study|Lack of Efficacy|2|||
131934374|NCT01299961|475046696|FG000|Overall Study|Lost to Follow-up|1|||
131934375|NCT02904096|475046697|FG000|Overall Study|Adverse Event|1|||
131934376|NCT02904096|475046698|FG001|Overall Study|Adverse Event|0|||
131934377|NCT02904096|475046697|FG000|Overall Study|Withdrawal by Subject|4|||
131934378|NCT02904096|475046698|FG001|Overall Study|Withdrawal by Subject|3|||
131934379|NCT02904096|475046697|FG000|Overall Study|Lost to Follow-up|10|||
131934380|NCT02904096|475046698|FG001|Overall Study|Lost to Follow-up|17|||
131934381|NCT02904096|475046697|FG000|Overall Study|Non-compliant|3|||
131934382|NCT02904096|475046698|FG001|Overall Study|Non-compliant|1|||
131934383|NCT02904096|475046697|FG000|Overall Study|Sponsor instructed|1|||
131411970|NCT01498185|473130378|FG000|Overall Study|Adverse Event|0|||
131934384|NCT02904096|475046698|FG001|Overall Study|Sponsor instructed|0|||
131934385|NCT05305651|475046699|FG000|Overall Study|Death|1|||
131934386|NCT05305651|475046699|FG000|Overall Study|Withdrawal by Subject|4|||
131934387|NCT05305651|475046699|FG000|Overall Study|Lost to Follow-up|4|||
131934388|NCT00526799|475046700|FG000|Overall Study|Withdrawal by Subject|1|||
131934389|NCT00526799|475046701|FG001|Overall Study|Withdrawal by Subject|0|||
131934390|NCT00526799|475046700|FG000|Overall Study|Intercurrent Complicating Disease|0|||
131934391|NCT00526799|475046701|FG001|Overall Study|Intercurrent Complicating Disease|1|||
131934392|NCT00967499|475046702|FG000|Overall Study|Adverse Event|0|||
131934393|NCT00967499|475046703|FG001|Overall Study|Adverse Event|1|||
131934394|NCT00967499|475046702|FG000|Overall Study|Protocol Violation|1|||
131934395|NCT00967499|475046703|FG001|Overall Study|Protocol Violation|0|||
131934396|NCT00967499|475046702|FG000|Overall Study|Sponsor Decision|1|||
131934397|NCT00967499|475046703|FG001|Overall Study|Sponsor Decision|0|||
131934398|NCT00967499|475046702|FG000|Overall Study|Randomized but not treated|63|||
131934399|NCT00967499|475046703|FG001|Overall Study|Randomized but not treated|59|||
131934400|NCT00323622|475046707|FG000|Overall Study|Other|30|||
131934401|NCT00323622|475046708|FG001|Overall Study|Other|91|||
131934402|NCT00323622|475046709|FG002|Overall Study|Other|4|||
131934403|NCT00323622|475046710|FG003|Overall Study|Other|12|||
131934404|NCT00323622|475046711|FG004|Overall Study|Other|32|||
131934405|NCT00323622|475046712|FG005|Overall Study|Other|74|||
131934406|NCT00323622|475046713|FG006|Overall Study|Other|5|||
131934407|NCT00323622|475046714|FG007|Overall Study|Other|13|||
131934408|NCT00323622|475046707|FG000|Overall Study|Death|1|||
131934409|NCT00323622|475046708|FG001|Overall Study|Death|1|||
131934410|NCT00323622|475046709|FG002|Overall Study|Death|0|||
131934411|NCT00323622|475046710|FG003|Overall Study|Death|0|||
131934412|NCT00323622|475046711|FG004|Overall Study|Death|7|||
131934413|NCT00323622|475046712|FG005|Overall Study|Death|0|||
131934414|NCT00323622|475046713|FG006|Overall Study|Death|0|||
131934415|NCT00323622|475046714|FG007|Overall Study|Death|2|||
131934416|NCT04191135|475046726|FG000|Induction Treatment|Not Treated|2|||
131934417|NCT04191135|475046727|FG001|Induction Treatment|Not Treated|0|||
131934418|NCT04191135|475046728|FG002|Induction Treatment|Not Treated|0|||
131934419|NCT04191135|475046726|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
131934420|NCT04191135|475046727|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
131934421|NCT04191135|475046728|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
131934422|NCT04191135|475046726|FG000|Induction Treatment|Adverse Event|25|||
131934423|NCT04191135|475046727|FG001|Induction Treatment|Adverse Event|0|||
131934424|NCT04191135|475046728|FG002|Induction Treatment|Adverse Event|0|||
131934425|NCT04191135|475046726|FG000|Induction Treatment|Clinical Progression|8|||
131934426|NCT04191135|475046727|FG001|Induction Treatment|Clinical Progression|0|||
131934427|NCT04191135|475046728|FG002|Induction Treatment|Clinical Progression|0|||
131934428|NCT04191135|475046726|FG000|Induction Treatment|Excluded Medication|1|||
131934429|NCT04191135|475046727|FG001|Induction Treatment|Excluded Medication|0|||
131934430|NCT04191135|475046728|FG002|Induction Treatment|Excluded Medication|0|||
131411971|NCT01498185|473130379|FG001|Overall Study|Adverse Event|0|||
131411972|NCT01498185|473130380|FG002|Overall Study|Adverse Event|0|||
131934431|NCT04191135|475046726|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
131934432|NCT04191135|475046727|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
131934433|NCT04191135|475046728|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
131934434|NCT04191135|475046726|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
131934435|NCT04191135|475046727|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
131934436|NCT04191135|475046728|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
131934437|NCT04191135|475046726|FG000|Induction Treatment|Physician Decision|2|||
131934438|NCT04191135|475046727|FG001|Induction Treatment|Physician Decision|0|||
131934439|NCT04191135|475046728|FG002|Induction Treatment|Physician Decision|0|||
131934440|NCT04191135|475046726|FG000|Induction Treatment|Progressive Disease|135|||
131934441|NCT04191135|475046727|FG001|Induction Treatment|Progressive Disease|0|||
131934442|NCT04191135|475046728|FG002|Induction Treatment|Progressive Disease|0|||
131411973|NCT01498185|473130381|FG003|Overall Study|Adverse Event|1|||
131411974|NCT01498185|473130382|FG004|Overall Study|Adverse Event|0|||
131934443|NCT04191135|475046726|FG000|Induction Treatment|Protocol Violation|10|||
131934444|NCT04191135|475046727|FG001|Induction Treatment|Protocol Violation|0|||
131934445|NCT04191135|475046728|FG002|Induction Treatment|Protocol Violation|0|||
131934446|NCT04191135|475046726|FG000|Induction Treatment|Withdrawal by Subject|4|||
131934447|NCT04191135|475046727|FG001|Induction Treatment|Withdrawal by Subject|0|||
131934448|NCT04191135|475046728|FG002|Induction Treatment|Withdrawal by Subject|0|||
131934449|NCT04191135|475046726|FG000|Randomized Treatment|Death|0|||
131934450|NCT04191135|475046727|FG001|Randomized Treatment|Death|50|||
131934451|NCT04191135|475046728|FG002|Randomized Treatment|Death|54|||
131934452|NCT04191135|475046726|FG000|Randomized Treatment|Lost to Follow-up|0|||
131934453|NCT04191135|475046727|FG001|Randomized Treatment|Lost to Follow-up|0|||
131934454|NCT04191135|475046728|FG002|Randomized Treatment|Lost to Follow-up|1|||
131934455|NCT04191135|475046726|FG000|Randomized Treatment|Withdrawal by Subject|0|||
131934456|NCT04191135|475046727|FG001|Randomized Treatment|Withdrawal by Subject|2|||
131934457|NCT04191135|475046728|FG002|Randomized Treatment|Withdrawal by Subject|0|||
131934458|NCT04191135|475046726|FG000|Randomized Treatment|Ongoing in Trial|0|||
131934459|NCT04191135|475046727|FG001|Randomized Treatment|Ongoing in Trial|83|||
131934460|NCT04191135|475046728|FG002|Randomized Treatment|Ongoing in Trial|81|||
131934461|NCT02374255|475048136|FG000|Overall Study|Withdrawal by Subject|2|||
131934462|NCT02374255|475048137|FG001|Overall Study|Withdrawal by Subject|0|||
131934463|NCT02374255|475048138|FG002|Overall Study|Withdrawal by Subject|0|||
131934464|NCT02374255|475048139|FG003|Overall Study|Withdrawal by Subject|0|||
131934465|NCT00688740|475048141|FG000|Overall Study|Adverse Event|45|||
131934466|NCT00688740|475048142|FG001|Overall Study|Adverse Event|8|||
131934467|NCT00688740|475048141|FG000|Overall Study|Death|2|||
131934468|NCT00688740|475048142|FG001|Overall Study|Death|2|||
131934469|NCT00688740|475048141|FG000|Overall Study|Lost to Follow-up|0|||
131934470|NCT00688740|475048142|FG001|Overall Study|Lost to Follow-up|1|||
131934471|NCT00688740|475048141|FG000|Overall Study|Consent Withdrawn|17|||
131934472|NCT00688740|475048142|FG001|Overall Study|Consent Withdrawn|17|||
131934473|NCT00688740|475048141|FG000|Overall Study|Breast Cancer Relapse|1|||
131934474|NCT00688740|475048142|FG001|Overall Study|Breast Cancer Relapse|4|||
131934475|NCT00688740|475048141|FG000|Overall Study|Violation of Inclusion Criteria|1|||
131934476|NCT00688740|475048142|FG001|Overall Study|Violation of Inclusion Criteria|3|||
131934477|NCT00567502|475048145|FG000|Overall Study|Lost to Follow-up|91|||
131934478|NCT00567502|475048146|FG001|Overall Study|Lost to Follow-up|14|||
131934479|NCT00567502|475048147|FG002|Overall Study|Lost to Follow-up|351|||
131934480|NCT00567502|475048148|FG003|Overall Study|Lost to Follow-up|2|||
131934481|NCT00567502|475048145|FG000|Overall Study|Death|65|||
131934482|NCT00567502|475048146|FG001|Overall Study|Death|16|||
131934483|NCT00567502|475048147|FG002|Overall Study|Death|360|||
131934484|NCT00567502|475048148|FG003|Overall Study|Death|5|||
131934485|NCT00567502|475048145|FG000|Overall Study|Other|64|||
131934486|NCT00567502|475048146|FG001|Overall Study|Other|2|||
131934487|NCT00567502|475048147|FG002|Overall Study|Other|134|||
131934488|NCT00567502|475048148|FG003|Overall Study|Other|6|||
131934489|NCT00567502|475048145|FG000|Overall Study|Participant request|12|||
131934490|NCT00567502|475048146|FG001|Overall Study|Participant request|1|||
131934491|NCT00567502|475048147|FG002|Overall Study|Participant request|33|||
131934492|NCT00567502|475048148|FG003|Overall Study|Participant request|1|||
131934493|NCT00567502|475048145|FG000|Overall Study|Sponsor request|9|||
131934494|NCT00567502|475048146|FG001|Overall Study|Sponsor request|0|||
131934495|NCT00567502|475048147|FG002|Overall Study|Sponsor request|30|||
131934496|NCT00567502|475048148|FG003|Overall Study|Sponsor request|1|||
131934497|NCT00567502|475048145|FG000|Overall Study|Never Initiated Treatment|0|||
131934498|NCT00567502|475048146|FG001|Overall Study|Never Initiated Treatment|0|||
131934499|NCT00567502|475048147|FG002|Overall Study|Never Initiated Treatment|0|||
131934500|NCT00567502|475048148|FG003|Overall Study|Never Initiated Treatment|72|||
131934501|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
131934502|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
131934503|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
131934504|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
131934505|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
131934506|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
131934507|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
131934508|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
131934509|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
131934510|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
131934511|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
131934512|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
131934513|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
131934514|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
131934515|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
131934516|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
131934517|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
131934518|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
131934519|NCT01432444|475048149|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
131934520|NCT01432444|475048150|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
131934521|NCT01432444|475048151|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
131934522|NCT01432444|475048149|FG000|Treatment Phase|Lost to Follow-up|0|||
131934523|NCT01432444|475048150|FG001|Treatment Phase|Lost to Follow-up|33|||
131934524|NCT01432444|475048151|FG002|Treatment Phase|Lost to Follow-up|0|||
131934525|NCT01432444|475048149|FG000|Treatment Phase|Adverse Event|0|||
131934526|NCT01432444|475048150|FG001|Treatment Phase|Adverse Event|37|||
131934527|NCT01432444|475048151|FG002|Treatment Phase|Adverse Event|0|||
131934528|NCT01432444|475048149|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
131934529|NCT01432444|475048150|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
131934530|NCT01432444|475048151|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
131934531|NCT01432444|475048149|FG000|Treatment Phase|Physician Decision|0|||
131934532|NCT01432444|475048150|FG001|Treatment Phase|Physician Decision|5|||
131934533|NCT01432444|475048151|FG002|Treatment Phase|Physician Decision|0|||
131934534|NCT01432444|475048149|FG000|Treatment Phase|Withdrawal by Subject|0|||
131934535|NCT01432444|475048150|FG001|Treatment Phase|Withdrawal by Subject|41|||
131934536|NCT01432444|475048151|FG002|Treatment Phase|Withdrawal by Subject|0|||
131934537|NCT01432444|475048149|FG000|Treatment Phase|Protocol Deviation|0|||
131934538|NCT01432444|475048150|FG001|Treatment Phase|Protocol Deviation|3|||
131934539|NCT01432444|475048151|FG002|Treatment Phase|Protocol Deviation|0|||
131934540|NCT01432444|475048149|FG000|Treatment Phase|Lack of Efficacy|0|||
131934541|NCT01432444|475048150|FG001|Treatment Phase|Lack of Efficacy|10|||
131934542|NCT01432444|475048151|FG002|Treatment Phase|Lack of Efficacy|0|||
131934543|NCT01432444|475048149|FG000|Extension Phase|Lost to Follow-up|0|||
131934544|NCT01432444|475048150|FG001|Extension Phase|Lost to Follow-up|0|||
131934545|NCT01432444|475048151|FG002|Extension Phase|Lost to Follow-up|17|||
131934546|NCT01432444|475048149|FG000|Extension Phase|Adverse Event|0|||
131934547|NCT01432444|475048150|FG001|Extension Phase|Adverse Event|0|||
131934548|NCT01432444|475048151|FG002|Extension Phase|Adverse Event|10|||
131934549|NCT01432444|475048149|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
131934550|NCT01432444|475048150|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
131934551|NCT01432444|475048151|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
131934552|NCT01432444|475048149|FG000|Extension Phase|Met Withdrawal Criteria|0|||
131934553|NCT01432444|475048150|FG001|Extension Phase|Met Withdrawal Criteria|0|||
131934554|NCT01432444|475048151|FG002|Extension Phase|Met Withdrawal Criteria|144|||
131934555|NCT01432444|475048149|FG000|Extension Phase|Physician Decision|0|||
131934556|NCT01432444|475048150|FG001|Extension Phase|Physician Decision|0|||
131934557|NCT01432444|475048151|FG002|Extension Phase|Physician Decision|1|||
131934558|NCT01432444|475048149|FG000|Extension Phase|Withdrawal by Subject|0|||
131934559|NCT01432444|475048150|FG001|Extension Phase|Withdrawal by Subject|0|||
131934560|NCT01432444|475048151|FG002|Extension Phase|Withdrawal by Subject|13|||
131934561|NCT02301897|475048152|FG000|Treatment Course 1|Non-Compliance|0|||
131934562|NCT02301897|475048153|FG001|Treatment Course 1|Non-Compliance|0|||
131934563|NCT02301897|475048154|FG002|Treatment Course 1|Non-Compliance|1|||
131934564|NCT02301897|475048152|FG000|Treatment Course 1|Adverse Event|1|||
131934565|NCT02301897|475048153|FG001|Treatment Course 1|Adverse Event|1|||
131934566|NCT02301897|475048154|FG002|Treatment Course 1|Adverse Event|0|||
131934567|NCT02301897|475048152|FG000|Treatment Course 1|Lost to Follow-up|1|||
131934568|NCT02301897|475048153|FG001|Treatment Course 1|Lost to Follow-up|2|||
131934569|NCT02301897|475048154|FG002|Treatment Course 1|Lost to Follow-up|1|||
131934570|NCT02301897|475048152|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
131934571|NCT02301897|475048153|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
131934572|NCT02301897|475048154|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
131934573|NCT02301897|475048152|FG000|Treatment Course 1|Withdrawal by Subject|0|||
131934574|NCT02301897|475048153|FG001|Treatment Course 1|Withdrawal by Subject|0|||
131934575|NCT02301897|475048154|FG002|Treatment Course 1|Withdrawal by Subject|2|||
131934576|NCT02301897|475048152|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
131934577|NCT02301897|475048153|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
131934578|NCT02301897|475048154|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
131934579|NCT02301897|475048152|FG000|Treatment Course 2|Lost to Follow-up|0|||
131934580|NCT02301897|475048153|FG001|Treatment Course 2|Lost to Follow-up|2|||
131934581|NCT02301897|475048154|FG002|Treatment Course 2|Lost to Follow-up|0|||
131934582|NCT02301897|475048152|FG000|Treatment Course 2|Pregnancy|0|||
131934583|NCT02301897|475048153|FG001|Treatment Course 2|Pregnancy|1|||
131934584|NCT02301897|475048154|FG002|Treatment Course 2|Pregnancy|1|||
131934585|NCT02301897|475048152|FG000|Treatment Course 2|Withdrawal by Subject|0|||
131934586|NCT02301897|475048153|FG001|Treatment Course 2|Withdrawal by Subject|2|||
131934587|NCT02301897|475048154|FG002|Treatment Course 2|Withdrawal by Subject|0|||
131934588|NCT02301897|475048152|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
131934589|NCT02301897|475048153|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
131934590|NCT02301897|475048154|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
131934591|NCT03673176|475048155|FG000|Overall Study|Death prior to intervention|1|||
131934592|NCT03673176|475048155|FG000|Overall Study|Death following intervention|3|||
131934593|NCT03673176|475048155|FG000|Overall Study|Withdrawal by Subject|1|||
131934594|NCT00337168|475048156|FG000|Overall Study|Death|5|||
131934595|NCT00337168|475048156|FG000|Overall Study|Not protocol specified|2|||
131934596|NCT00337168|475048156|FG000|Overall Study|Did not start therapy|1|||
131934597|NCT03283241|475048157|FG000|Overall Study|Adverse Event|4|||
131934598|NCT03283241|475048158|FG001|Overall Study|Adverse Event|1|||
131934599|NCT03283241|475048157|FG000|Overall Study|Withdrawal by Subject|0|||
131934600|NCT03283241|475048158|FG001|Overall Study|Withdrawal by Subject|1|||
131934601|NCT03283241|475048157|FG000|Overall Study|Subject relocated to Finland|0|||
131934602|NCT03283241|475048158|FG001|Overall Study|Subject relocated to Finland|1|||
131934603|NCT00666263|475048161|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
131934604|NCT00666263|475048162|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
131934605|NCT00666263|475048161|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
131934606|NCT00666263|475048162|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
131934607|NCT00666263|475048161|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
131934608|NCT00666263|475048162|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
131934609|NCT01225952|475048163|FG000|Overall Study|Lost to Follow-up|1|||
131934610|NCT01225952|475048164|FG001|Overall Study|Lost to Follow-up|0|||
131934611|NCT01225952|475048165|FG002|Overall Study|Lost to Follow-up|0|||
131934612|NCT01225952|475048163|FG000|Overall Study|Study Eye Explanted|0|||
131934613|NCT01225952|475048164|FG001|Overall Study|Study Eye Explanted|0|||
131934614|NCT01225952|475048165|FG002|Overall Study|Study Eye Explanted|1|||
131934615|NCT01225952|475048163|FG000|Overall Study|Withdrawal by Subject|4|||
131934616|NCT01225952|475048164|FG001|Overall Study|Withdrawal by Subject|4|||
131934617|NCT01225952|475048165|FG002|Overall Study|Withdrawal by Subject|5|||
131934618|NCT01225952|475048163|FG000|Overall Study|Surgical complications|1|||
131934619|NCT01225952|475048164|FG001|Overall Study|Surgical complications|0|||
131934620|NCT01225952|475048165|FG002|Overall Study|Surgical complications|0|||
131934621|NCT01285102|475048167|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
131934622|NCT01602484|475048177|FG000|Overall Study|Airway issues unrelated to study|0|||
131934623|NCT01602484|475048178|FG001|Overall Study|Airway issues unrelated to study|1|||
131934624|NCT02743962|475048181|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
131934625|NCT02743962|475048182|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
131934626|NCT02609503|475048186|FG000|Overall Study|Adverse Event|1|||
131934627|NCT02609503|475048186|FG000|Overall Study|Death|1|||
131934628|NCT02609503|475048186|FG000|Overall Study|Withdrawal by Subject|1|||
131934629|NCT02609503|475048186|FG000|Overall Study|Disease progression|1|||
131934630|NCT03900650|475048187|FG000|Overall Study|Withdrawal by Subject|1|||
131934631|NCT03900650|475048188|FG001|Overall Study|Withdrawal by Subject|1|||
131934632|NCT03900650|475048189|FG002|Overall Study|Withdrawal by Subject|0|||
131934633|NCT03900650|475048190|FG003|Overall Study|Withdrawal by Subject|0|||
131934634|NCT03900650|475048187|FG000|Overall Study|Withdrawn by staff|1|||
131934635|NCT03900650|475048188|FG001|Overall Study|Withdrawn by staff|0|||
131934636|NCT03900650|475048189|FG002|Overall Study|Withdrawn by staff|0|||
131934637|NCT03900650|475048190|FG003|Overall Study|Withdrawn by staff|0|||
131934638|NCT00427700|475048193|FG000|Overall Study|Lost to Follow-up|2|||
131934639|NCT00427700|475048194|FG001|Overall Study|Lost to Follow-up|5|||
131934640|NCT00427700|475048193|FG000|Overall Study|no induction of menses|1|||
131934641|NCT00427700|475048194|FG001|Overall Study|no induction of menses|4|||
131934642|NCT00427700|475048193|FG000|Overall Study|Pregnancy|0|||
131934643|NCT00427700|475048194|FG001|Overall Study|Pregnancy|2|||
131934644|NCT02014376|475048195|FG000|Overall Study|Adverse Event|1|||
131934645|NCT02014376|475048196|FG001|Overall Study|Adverse Event|1|||
131934646|NCT02014376|475048197|FG002|Overall Study|Adverse Event|0|||
131934647|NCT02014376|475048195|FG000|Overall Study|Lost to Follow-up|2|||
131934648|NCT02014376|475048196|FG001|Overall Study|Lost to Follow-up|0|||
131934649|NCT02014376|475048197|FG002|Overall Study|Lost to Follow-up|0|||
131934650|NCT01051661|475048205|FG000|Overall Study|Adverse Event|1|||
131934651|NCT01051661|475048206|FG001|Overall Study|Adverse Event|1|||
131934652|NCT01051661|475048207|FG002|Overall Study|Adverse Event|1|||
131934653|NCT01051661|475048208|FG003|Overall Study|Adverse Event|1|||
131934654|NCT01051661|475048209|FG004|Overall Study|Adverse Event|0|||
131934655|NCT01051661|475048210|FG005|Overall Study|Adverse Event|0|||
131934656|NCT01051661|475048205|FG000|Overall Study|Lost to Follow-up|13|||
131934657|NCT01051661|475048206|FG001|Overall Study|Lost to Follow-up|22|||
131934658|NCT01051661|475048207|FG002|Overall Study|Lost to Follow-up|15|||
131934659|NCT01051661|475048208|FG003|Overall Study|Lost to Follow-up|17|||
131934660|NCT01051661|475048209|FG004|Overall Study|Lost to Follow-up|10|||
131934661|NCT01051661|475048210|FG005|Overall Study|Lost to Follow-up|24|||
131934662|NCT01051661|475048205|FG000|Overall Study|Migrated/moved from study area|1|||
131934663|NCT01051661|475048206|FG001|Overall Study|Migrated/moved from study area|6|||
131934664|NCT01051661|475048207|FG002|Overall Study|Migrated/moved from study area|6|||
131934665|NCT01051661|475048208|FG003|Overall Study|Migrated/moved from study area|8|||
131934666|NCT01051661|475048209|FG004|Overall Study|Migrated/moved from study area|7|||
131934667|NCT01051661|475048210|FG005|Overall Study|Migrated/moved from study area|3|||
131934668|NCT01051661|475048205|FG000|Overall Study|Refused blood sampling|0|||
131934669|NCT01051661|475048206|FG001|Overall Study|Refused blood sampling|0|||
131934670|NCT01051661|475048207|FG002|Overall Study|Refused blood sampling|0|||
131934671|NCT01051661|475048208|FG003|Overall Study|Refused blood sampling|0|||
131934672|NCT01051661|475048209|FG004|Overall Study|Refused blood sampling|0|||
131934673|NCT01051661|475048210|FG005|Overall Study|Refused blood sampling|1|||
131934674|NCT01051661|475048205|FG000|Overall Study|Data not reliable|1|||
131934675|NCT01051661|475048206|FG001|Overall Study|Data not reliable|0|||
131934676|NCT01051661|475048207|FG002|Overall Study|Data not reliable|0|||
131934677|NCT01051661|475048208|FG003|Overall Study|Data not reliable|0|||
131934678|NCT01051661|475048209|FG004|Overall Study|Data not reliable|0|||
131934679|NCT01051661|475048210|FG005|Overall Study|Data not reliable|1|||
131934680|NCT01051661|475048205|FG000|Overall Study|Unable to attend visit(s)|2|||
131934681|NCT01051661|475048206|FG001|Overall Study|Unable to attend visit(s)|4|||
131934682|NCT01051661|475048207|FG002|Overall Study|Unable to attend visit(s)|2|||
131934683|NCT01051661|475048208|FG003|Overall Study|Unable to attend visit(s)|1|||
131934684|NCT01051661|475048209|FG004|Overall Study|Unable to attend visit(s)|3|||
131934685|NCT01051661|475048210|FG005|Overall Study|Unable to attend visit(s)|2|||
131934686|NCT01051661|475048205|FG000|Overall Study|Consent not received from both parents|0|||
131934687|NCT01051661|475048206|FG001|Overall Study|Consent not received from both parents|0|||
131934688|NCT01051661|475048207|FG002|Overall Study|Consent not received from both parents|0|||
131934689|NCT01051661|475048208|FG003|Overall Study|Consent not received from both parents|0|||
131934690|NCT01051661|475048209|FG004|Overall Study|Consent not received from both parents|0|||
131934691|NCT01051661|475048210|FG005|Overall Study|Consent not received from both parents|1|||
131934692|NCT01051661|475048205|FG000|Overall Study|Failure to comply with protocol|0|||
131934693|NCT01051661|475048206|FG001|Overall Study|Failure to comply with protocol|0|||
131934694|NCT01051661|475048207|FG002|Overall Study|Failure to comply with protocol|2|||
131934695|NCT01051661|475048208|FG003|Overall Study|Failure to comply with protocol|0|||
131934696|NCT01051661|475048209|FG004|Overall Study|Failure to comply with protocol|0|||
131934697|NCT01051661|475048210|FG005|Overall Study|Failure to comply with protocol|0|||
131934698|NCT01051661|475048205|FG000|Overall Study|Subject lost legal representation|0|||
131934699|NCT01051661|475048206|FG001|Overall Study|Subject lost legal representation|0|||
131934700|NCT01051661|475048207|FG002|Overall Study|Subject lost legal representation|0|||
131934701|NCT01051661|475048208|FG003|Overall Study|Subject lost legal representation|0|||
131934702|NCT01051661|475048209|FG004|Overall Study|Subject lost legal representation|1|||
131934703|NCT01051661|475048210|FG005|Overall Study|Subject lost legal representation|0|||
131934704|NCT01051661|475048205|FG000|Overall Study|Protocol Violation|0|||
131934705|NCT01051661|475048206|FG001|Overall Study|Protocol Violation|0|||
131934706|NCT01051661|475048207|FG002|Overall Study|Protocol Violation|0|||
131934707|NCT01051661|475048208|FG003|Overall Study|Protocol Violation|1|||
131934708|NCT01051661|475048209|FG004|Overall Study|Protocol Violation|2|||
131934709|NCT01051661|475048210|FG005|Overall Study|Protocol Violation|1|||
131934710|NCT01051661|475048205|FG000|Overall Study|Withdrawal by Subject|16|||
131934711|NCT01051661|475048206|FG001|Overall Study|Withdrawal by Subject|30|||
131934712|NCT01051661|475048207|FG002|Overall Study|Withdrawal by Subject|13|||
131934713|NCT01051661|475048208|FG003|Overall Study|Withdrawal by Subject|28|||
131934714|NCT01051661|475048209|FG004|Overall Study|Withdrawal by Subject|12|||
131934715|NCT01051661|475048210|FG005|Overall Study|Withdrawal by Subject|34|||
131934716|NCT04642079|475048211|FG000|Overall Study|Lost to Follow-up|2|||
131934717|NCT04642079|475048212|FG001|Overall Study|Lost to Follow-up|5|||
131934718|NCT04642079|475048213|FG002|Overall Study|Lost to Follow-up|2|||
131934719|NCT04642079|475048214|FG003|Overall Study|Lost to Follow-up|0|||
131934720|NCT04642079|475048211|FG000|Overall Study|Withdrawal by Subject|0|||
131934721|NCT04642079|475048212|FG001|Overall Study|Withdrawal by Subject|4|||
131934722|NCT04642079|475048213|FG002|Overall Study|Withdrawal by Subject|1|||
131934723|NCT04642079|475048214|FG003|Overall Study|Withdrawal by Subject|2|||
131934724|NCT04642079|475048211|FG000|Overall Study|Other|0|||
131934725|NCT04642079|475048212|FG001|Overall Study|Other|0|||
131934726|NCT04642079|475048213|FG002|Overall Study|Other|0|||
131934727|NCT04642079|475048214|FG003|Overall Study|Other|1|||
131934728|NCT04642079|475048211|FG000|Overall Study|No longer met eligibility criteria|1|||
131934729|NCT04642079|475048212|FG001|Overall Study|No longer met eligibility criteria|0|||
131934730|NCT04642079|475048213|FG002|Overall Study|No longer met eligibility criteria|1|||
131934731|NCT04642079|475048214|FG003|Overall Study|No longer met eligibility criteria|1|||
131934732|NCT03038620|475048218|FG000|Overall Study|Lost to Follow-up|18|||
131411975|NCT01498185|473130378|FG000|Overall Study|Withdrawal by Subject|1|||
131934733|NCT03038620|475048219|FG001|Overall Study|Lost to Follow-up|23|||
131934734|NCT03038620|475048218|FG000|Overall Study|Withdrawal by Subject|0|||
131934735|NCT03038620|475048219|FG001|Overall Study|Withdrawal by Subject|15|||
131411976|NCT01498185|473130379|FG001|Overall Study|Withdrawal by Subject|1|||
131934736|NCT03038620|475048218|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
131934737|NCT03038620|475048219|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
131934738|NCT00759395|475048221|FG000|Overall Study|Adverse Event|1|||
131934739|NCT00759395|475048222|FG001|Overall Study|Adverse Event|0|||
131934740|NCT00759395|475048221|FG000|Overall Study|Withdrawal by Subject|1|||
131934741|NCT00759395|475048222|FG001|Overall Study|Withdrawal by Subject|0|||
131934742|NCT00759395|475048221|FG000|Overall Study|Lack of Efficacy|0|||
131934743|NCT00759395|475048222|FG001|Overall Study|Lack of Efficacy|2|||
131934744|NCT01435356|475048227|FG000|Overall Study|Adverse Event|2|||
131411977|NCT01498185|473130380|FG002|Overall Study|Withdrawal by Subject|0|||
131411978|NCT01498185|473130381|FG003|Overall Study|Withdrawal by Subject|2|||
131411979|NCT01498185|473130382|FG004|Overall Study|Withdrawal by Subject|1|||
131411980|NCT01498185|473130378|FG000|Overall Study|No longer met criteria, etc|0|||
131411981|NCT01498185|473130379|FG001|Overall Study|No longer met criteria, etc|0|||
131411982|NCT01498185|473130380|FG002|Overall Study|No longer met criteria, etc|0|||
131411983|NCT01498185|473130381|FG003|Overall Study|No longer met criteria, etc|0|||
131411984|NCT01498185|473130382|FG004|Overall Study|No longer met criteria, etc|2|||
131934745|NCT01435356|475048228|FG001|Overall Study|Adverse Event|0|||
131934746|NCT01435356|475048227|FG000|Overall Study|Disease progression/recurrence|17|||
131934747|NCT01435356|475048228|FG001|Overall Study|Disease progression/recurrence|10|||
131934748|NCT01435356|475048227|FG000|Overall Study|Protocol Violation|0|||
131934749|NCT01435356|475048228|FG001|Overall Study|Protocol Violation|1|||
131934750|NCT01435356|475048227|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
131934751|NCT01435356|475048228|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
131934752|NCT01435356|475048227|FG000|Overall Study|Withdrawal by Subject|1|||
131934753|NCT01435356|475048228|FG001|Overall Study|Withdrawal by Subject|1|||
131934754|NCT01435356|475048227|FG000|Overall Study|Facial palsy|1|||
131934755|NCT01435356|475048228|FG001|Overall Study|Facial palsy|0|||
131934756|NCT01435356|475048227|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
131934757|NCT01435356|475048228|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
131934758|NCT01435356|475048227|FG000|Overall Study|Physician Decision|1|||
131934759|NCT01435356|475048228|FG001|Overall Study|Physician Decision|0|||
131934760|NCT01435356|475048227|FG000|Overall Study|Patient decision|3|||
131934761|NCT01435356|475048228|FG001|Overall Study|Patient decision|0|||
131934762|NCT01435356|475048227|FG000|Overall Study|Patient moved to another city|1|||
131934763|NCT01435356|475048228|FG001|Overall Study|Patient moved to another city|1|||
131934764|NCT00437073|475048229|FG000|Overall Study|Sponsor Terminated Study|1|||
131934765|NCT00437073|475048230|FG001|Overall Study|Sponsor Terminated Study|0|||
131934766|NCT00437073|475048229|FG000|Overall Study|Physician Decision|0|||
131934767|NCT00437073|475048230|FG001|Overall Study|Physician Decision|1|||
131934768|NCT03485157|475048231|FG000|Double Blind Phase|Lost to Follow-up|4|||
131934769|NCT03485157|475048232|FG001|Double Blind Phase|Lost to Follow-up|4|||
131934770|NCT03485157|475048231|FG000|Double Blind Phase|Adverse Event|2|||
131934771|NCT03485157|475048232|FG001|Double Blind Phase|Adverse Event|1|||
131934772|NCT03485157|475048231|FG000|Double Blind Phase|Withdrawal by Subject|6|||
131934773|NCT03485157|475048232|FG001|Double Blind Phase|Withdrawal by Subject|9|||
131934774|NCT03485157|475048231|FG000|Double Blind Phase|Removal by PI|3|||
131934775|NCT03485157|475048232|FG001|Double Blind Phase|Removal by PI|7|||
131934776|NCT03485157|475048231|FG000|Open Label Phase|Lost to Follow-up|1|||
131934777|NCT03485157|475048232|FG001|Open Label Phase|Lost to Follow-up|2|||
131934778|NCT03485157|475048231|FG000|Open Label Phase|Adverse Event|0|||
131934779|NCT03485157|475048232|FG001|Open Label Phase|Adverse Event|1|||
131934780|NCT03485157|475048231|FG000|Open Label Phase|Withdrawal by Subject|1|||
131934781|NCT03485157|475048232|FG001|Open Label Phase|Withdrawal by Subject|2|||
131934782|NCT03485157|475048231|FG000|Open Label Phase|Removal by PI|2|||
131934783|NCT03485157|475048232|FG001|Open Label Phase|Removal by PI|0|||
131934784|NCT04875533|475048233|FG000|Overall Study|Adverse Event|6|||
131934785|NCT04875533|475048234|FG001|Overall Study|Adverse Event|4|||
131934786|NCT04875533|475048233|FG000|Overall Study|Protocol Violation|4|||
131934787|NCT04875533|475048234|FG001|Overall Study|Protocol Violation|0|||
131934788|NCT04875533|475048233|FG000|Overall Study|Withdrawal by Subject|8|||
131934789|NCT04875533|475048234|FG001|Overall Study|Withdrawal by Subject|5|||
131934790|NCT04875533|475048233|FG000|Overall Study|No longer meets eligibility criteria|1|||
131934791|NCT04875533|475048234|FG001|Overall Study|No longer meets eligibility criteria|0|||
131934792|NCT04875533|475048233|FG000|Overall Study|Other|0|||
131934793|NCT04875533|475048234|FG001|Overall Study|Other|2|||
131934794|NCT02657343|475048237|FG000|Overall Study|Death|0|||
131934795|NCT02657343|475048238|FG001|Overall Study|Death|2|||
131934796|NCT02657343|475048239|FG002|Overall Study|Death|0|||
131934797|NCT02657343|475048240|FG003|Overall Study|Death|0|||
131934798|NCT02657343|475048241|FG004|Overall Study|Death|0|||
131411985|NCT01827332|473130383|FG000|Overall Study|Lost to Follow-up|2|||
131411986|NCT01827332|473130384|FG001|Overall Study|Lost to Follow-up|1|||
131411987|NCT02725593|473130385|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
131411988|NCT02725593|473130386|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
131411989|NCT02725593|473130385|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
131411990|NCT02725593|473130386|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
131411991|NCT02725593|473130385|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
131934799|NCT02657343|475048242|FG005|Overall Study|Death|0|||
131934800|NCT02657343|475048237|FG000|Overall Study|Patient went to hospice|1|||
131934801|NCT02657343|475048238|FG001|Overall Study|Patient went to hospice|0|||
131934802|NCT02657343|475048239|FG002|Overall Study|Patient went to hospice|0|||
131934803|NCT02657343|475048240|FG003|Overall Study|Patient went to hospice|0|||
131934804|NCT02657343|475048241|FG004|Overall Study|Patient went to hospice|0|||
131934805|NCT02657343|475048242|FG005|Overall Study|Patient went to hospice|0|||
131934806|NCT02657343|475048237|FG000|Overall Study|Withdrawal by Subject|0|||
131934807|NCT02657343|475048238|FG001|Overall Study|Withdrawal by Subject|0|||
131934808|NCT02657343|475048239|FG002|Overall Study|Withdrawal by Subject|0|||
131934809|NCT02657343|475048240|FG003|Overall Study|Withdrawal by Subject|0|||
131934810|NCT02657343|475048241|FG004|Overall Study|Withdrawal by Subject|1|||
131934811|NCT02657343|475048242|FG005|Overall Study|Withdrawal by Subject|0|||
131934812|NCT02011542|475048244|FG000|Overall Study|Physician Decision|1|||
131934813|NCT00980798|475048245|FG000|Overall Study|Adverse Event|7|||
131934814|NCT00980798|475048246|FG001|Overall Study|Adverse Event|36|||
131934815|NCT00980798|475048245|FG000|Overall Study|Lack of Efficacy|16|||
131934816|NCT00980798|475048246|FG001|Overall Study|Lack of Efficacy|5|||
131934817|NCT00980798|475048245|FG000|Overall Study|Lost to Follow-up|0|||
131934818|NCT00980798|475048246|FG001|Overall Study|Lost to Follow-up|1|||
131934819|NCT00980798|475048245|FG000|Overall Study|Physician Decision|2|||
131934820|NCT00980798|475048246|FG001|Overall Study|Physician Decision|1|||
131934821|NCT00980798|475048245|FG000|Overall Study|Withdrawal by Subject|8|||
131934822|NCT00980798|475048246|FG001|Overall Study|Withdrawal by Subject|11|||
131934823|NCT00980798|475048245|FG000|Overall Study|Other|0|||
131934824|NCT00980798|475048246|FG001|Overall Study|Other|1|||
131934825|NCT03034044|475048251|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
131934826|NCT02402647|475048252|FG000|Overall Study|Lost to Follow-up|13|||
131934827|NCT02402647|475048253|FG001|Overall Study|Lost to Follow-up|7|||
131934828|NCT02402647|475048252|FG000|Overall Study|Protocol Violation|1|||
131934829|NCT02402647|475048253|FG001|Overall Study|Protocol Violation|1|||
131934830|NCT02402647|475048252|FG000|Overall Study|scheduled and timed out|2|||
131934831|NCT02402647|475048253|FG001|Overall Study|scheduled and timed out|1|||
131934832|NCT02402647|475048252|FG000|Overall Study|medical illness|2|||
131934833|NCT02402647|475048253|FG001|Overall Study|medical illness|4|||
131934834|NCT02402647|475048252|FG000|Overall Study|Moved|2|||
131934835|NCT02402647|475048253|FG001|Overall Study|Moved|0|||
131934836|NCT02402647|475048252|FG000|Overall Study|loved one illness|1|||
131934837|NCT02402647|475048253|FG001|Overall Study|loved one illness|0|||
131934838|NCT02402647|475048252|FG000|Overall Study|deceased preexisting condition|2|||
131934839|NCT02402647|475048253|FG001|Overall Study|deceased preexisting condition|0|||
131934840|NCT02402647|475048252|FG000|Overall Study|Other|2|||
131934841|NCT02402647|475048253|FG001|Overall Study|Other|1|||
131934842|NCT04197583|475048254|FG000|Overall Study|Study Stent Replacement|34|||
131934843|NCT04197583|475048255|FG001|Overall Study|Study Stent Replacement|8|||
131934844|NCT04197583|475048254|FG000|Overall Study|Lost to Follow-up|14|||
131934845|NCT04197583|475048255|FG001|Overall Study|Lost to Follow-up|3|||
131934846|NCT04197583|475048254|FG000|Overall Study|Death|3|||
131934847|NCT04197583|475048255|FG001|Overall Study|Death|0|||
131934848|NCT04197583|475048254|FG000|Overall Study|Physician Decision|1|||
131934849|NCT04197583|475048255|FG001|Overall Study|Physician Decision|0|||
131934850|NCT04197583|475048254|FG000|Overall Study|Withdrawal by Subject|1|||
131934851|NCT04197583|475048255|FG001|Overall Study|Withdrawal by Subject|1|||
131934852|NCT04197583|475048254|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
131934853|NCT04197583|475048255|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
131934854|NCT04197583|475048254|FG000|Overall Study|Screen Failure|0|||
131934855|NCT04197583|475048255|FG001|Overall Study|Screen Failure|20|||
131934856|NCT01373281|475050053|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
131934857|NCT01373281|475050054|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
131934858|NCT01373281|475050053|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
131934859|NCT01373281|475050054|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
131934860|NCT01373281|475050053|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
131934861|NCT01373281|475050054|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
131934862|NCT01373281|475050053|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
131934863|NCT01373281|475050054|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
131934864|NCT01373281|475050053|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
131934865|NCT01373281|475050054|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
131934866|NCT01373281|475050053|FG000|Surveillance Expansion Period|Protocol Violation|9|||
131934867|NCT01373281|475050054|FG001|Surveillance Expansion Period|Protocol Violation|1|||
131934868|NCT01373281|475050053|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
131934869|NCT01373281|475050054|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
131934870|NCT01373281|475050053|FG000|Surveillance Expansion Period|Serious adverse event|3|||
131934871|NCT01373281|475050054|FG001|Surveillance Expansion Period|Serious adverse event|4|||
131934872|NCT03033784|475050058|FG000|Overall Study|Anxiety related to MRI scanner|0|||
131934873|NCT03033784|475050059|FG001|Overall Study|Anxiety related to MRI scanner|1|||
131934874|NCT03033784|475050060|FG002|Overall Study|Anxiety related to MRI scanner|0|||
131934875|NCT03033784|475050061|FG003|Overall Study|Anxiety related to MRI scanner|0|||
131934876|NCT03033784|475050062|FG004|Overall Study|Anxiety related to MRI scanner|0|||
131934877|NCT03033784|475050063|FG005|Overall Study|Anxiety related to MRI scanner|0|||
131934878|NCT03033784|475050064|FG006|Overall Study|Anxiety related to MRI scanner|0|||
131934879|NCT03033784|475050065|FG007|Overall Study|Anxiety related to MRI scanner|0|||
131934880|NCT03033784|475050066|FG008|Overall Study|Anxiety related to MRI scanner|0|||
131934881|NCT03033784|475050067|FG009|Overall Study|Anxiety related to MRI scanner|0|||
131934882|NCT03033784|475050068|FG010|Overall Study|Anxiety related to MRI scanner|0|||
131934883|NCT03033784|475050069|FG011|Overall Study|Anxiety related to MRI scanner|0|||
131934884|NCT03033784|475050070|FG012|Overall Study|Anxiety related to MRI scanner|0|||
131934885|NCT03033784|475050058|FG000|Overall Study|Withdrawal by Subject|0|||
131934886|NCT03033784|475050059|FG001|Overall Study|Withdrawal by Subject|0|||
131934887|NCT03033784|475050060|FG002|Overall Study|Withdrawal by Subject|0|||
131934888|NCT03033784|475050061|FG003|Overall Study|Withdrawal by Subject|0|||
131934889|NCT03033784|475050062|FG004|Overall Study|Withdrawal by Subject|0|||
131934890|NCT03033784|475050063|FG005|Overall Study|Withdrawal by Subject|0|||
131934891|NCT03033784|475050064|FG006|Overall Study|Withdrawal by Subject|0|||
131934892|NCT03033784|475050065|FG007|Overall Study|Withdrawal by Subject|0|||
131934893|NCT03033784|475050066|FG008|Overall Study|Withdrawal by Subject|0|||
131934894|NCT03033784|475050067|FG009|Overall Study|Withdrawal by Subject|0|||
131934895|NCT03033784|475050068|FG010|Overall Study|Withdrawal by Subject|0|||
131934896|NCT03033784|475050069|FG011|Overall Study|Withdrawal by Subject|0|||
131934897|NCT03033784|475050070|FG012|Overall Study|Withdrawal by Subject|2|||
131934898|NCT03332056|475050072|FG000|Overall Study|Incomplete questionnaires|8|||
131934899|NCT03332056|475050073|FG001|Overall Study|Incomplete questionnaires|9|||
131934900|NCT03332056|475050072|FG000|Overall Study|Passed stone prior to surgery date|1|||
131934901|NCT03332056|475050073|FG001|Overall Study|Passed stone prior to surgery date|0|||
131934902|NCT03332056|475050072|FG000|Overall Study|Did not require a ureteral stent|0|||
131934903|NCT03332056|475050073|FG001|Overall Study|Did not require a ureteral stent|1|||
131934904|NCT02093520|475050074|FG000|Overall Study|Not treated|6|||
131934905|NCT02093520|475050075|FG001|Overall Study|Not treated|22|||
131934906|NCT03014089|475050076|FG000|Overall Study|Withdrawal by Subject|0|||
131934907|NCT03014089|475050077|FG001|Overall Study|Withdrawal by Subject|1|||
131934908|NCT03014089|475050078|FG002|Overall Study|Withdrawal by Subject|1|||
131934909|NCT03014089|475050079|FG003|Overall Study|Withdrawal by Subject|1|||
131934910|NCT03014089|475050076|FG000|Overall Study|Lost to Follow-up|1|||
131934911|NCT03014089|475050077|FG001|Overall Study|Lost to Follow-up|0|||
131934912|NCT03014089|475050078|FG002|Overall Study|Lost to Follow-up|0|||
131934913|NCT03014089|475050079|FG003|Overall Study|Lost to Follow-up|0|||
131934914|NCT03014089|475050076|FG000|Overall Study|Adverse Event|1|||
131934915|NCT03014089|475050077|FG001|Overall Study|Adverse Event|0|||
131934916|NCT03014089|475050078|FG002|Overall Study|Adverse Event|1|||
131934917|NCT03014089|475050079|FG003|Overall Study|Adverse Event|0|||
131934918|NCT00851084|475050080|FG000|Overall Study|Randomized but not treated|1|||
131934919|NCT00851084|475050081|FG001|Overall Study|Randomized but not treated|0|||
131934920|NCT00851084|475050080|FG000|Overall Study|Adverse Event|26|||
131934921|NCT00851084|475050081|FG001|Overall Study|Adverse Event|36|||
131934922|NCT00851084|475050080|FG000|Overall Study|Disease progression|52|||
131934923|NCT00851084|475050081|FG001|Overall Study|Disease progression|47|||
131934924|NCT00851084|475050080|FG000|Overall Study|Poor compliance to protocol|1|||
131934925|NCT00851084|475050081|FG001|Overall Study|Poor compliance to protocol|1|||
131934926|NCT00851084|475050080|FG000|Overall Study|Physician Decision|13|||
131934927|NCT00851084|475050081|FG001|Overall Study|Physician Decision|14|||
131934928|NCT00851084|475050080|FG000|Overall Study|Consent withdrawn|0|||
131934929|NCT00851084|475050081|FG001|Overall Study|Consent withdrawn|2|||
131934930|NCT00851084|475050080|FG000|Overall Study|Withdrawal by Subject|11|||
131934931|NCT00851084|475050081|FG001|Overall Study|Withdrawal by Subject|12|||
131934932|NCT00851084|475050080|FG000|Overall Study|Metastatic surgery|6|||
131934933|NCT00851084|475050081|FG001|Overall Study|Metastatic surgery|6|||
131934934|NCT00851084|475050080|FG000|Overall Study|Other|7|||
131934935|NCT00851084|475050081|FG001|Overall Study|Other|1|||
131934936|NCT03440411|475050091|FG000|Overall Study|Adverse Event|0|||
131934937|NCT03440411|475050092|FG001|Overall Study|Adverse Event|0|||
131934938|NCT03440411|475050093|FG002|Overall Study|Adverse Event|1|||
131934939|NCT03440411|475050094|FG003|Overall Study|Adverse Event|0|||
131934940|NCT03440411|475050091|FG000|Overall Study|PD|2|||
131934941|NCT03440411|475050092|FG001|Overall Study|PD|1|||
131934942|NCT03440411|475050093|FG002|Overall Study|PD|1|||
131934943|NCT03440411|475050094|FG003|Overall Study|PD|1|||
131934944|NCT03440411|475050091|FG000|Overall Study|Withdrawal by Subject|1|||
131934945|NCT03440411|475050092|FG001|Overall Study|Withdrawal by Subject|0|||
131934946|NCT03440411|475050093|FG002|Overall Study|Withdrawal by Subject|0|||
131934947|NCT03440411|475050094|FG003|Overall Study|Withdrawal by Subject|0|||
131934948|NCT03440411|475050091|FG000|Overall Study|Closed study by sponsor|0|||
131934949|NCT03440411|475050092|FG001|Overall Study|Closed study by sponsor|0|||
131934950|NCT03440411|475050093|FG002|Overall Study|Closed study by sponsor|0|||
131934951|NCT03440411|475050094|FG003|Overall Study|Closed study by sponsor|1|||
131934952|NCT02439957|475050095|FG000|Overall Study|Study Terminated|3|||
131934953|NCT02439957|475050096|FG001|Overall Study|Study Terminated|3|||
131934954|NCT00863304|475050097|FG000|Overall Study|Adverse Event|10|||
131934955|NCT00863304|475050098|FG001|Overall Study|Adverse Event|4|||
131934956|NCT00863304|475050099|FG002|Overall Study|Adverse Event|14|||
131934957|NCT00863304|475050100|FG003|Overall Study|Adverse Event|16|||
131934958|NCT00863304|475050097|FG000|Overall Study|Lost to Follow-up|1|||
131934959|NCT00863304|475050098|FG001|Overall Study|Lost to Follow-up|5|||
131934960|NCT00863304|475050099|FG002|Overall Study|Lost to Follow-up|4|||
131934961|NCT00863304|475050100|FG003|Overall Study|Lost to Follow-up|2|||
131934962|NCT00863304|475050097|FG000|Overall Study|Lack of Efficacy|57|||
131934963|NCT00863304|475050098|FG001|Overall Study|Lack of Efficacy|26|||
131934964|NCT00863304|475050099|FG002|Overall Study|Lack of Efficacy|30|||
131934965|NCT00863304|475050100|FG003|Overall Study|Lack of Efficacy|28|||
131934966|NCT00863304|475050097|FG000|Overall Study|Withdrawal by Subject|19|||
131934967|NCT00863304|475050098|FG001|Overall Study|Withdrawal by Subject|14|||
131934968|NCT00863304|475050099|FG002|Overall Study|Withdrawal by Subject|20|||
131934969|NCT00863304|475050100|FG003|Overall Study|Withdrawal by Subject|18|||
131934970|NCT00863304|475050097|FG000|Overall Study|Other|1|||
131934971|NCT00863304|475050098|FG001|Overall Study|Other|0|||
131934972|NCT00863304|475050099|FG002|Overall Study|Other|0|||
131934973|NCT00863304|475050100|FG003|Overall Study|Other|1|||
131934974|NCT00863304|475050097|FG000|Overall Study|Protocol Violation|2|||
131934975|NCT00863304|475050098|FG001|Overall Study|Protocol Violation|6|||
131934976|NCT00863304|475050099|FG002|Overall Study|Protocol Violation|2|||
131934977|NCT00863304|475050100|FG003|Overall Study|Protocol Violation|0|||
131934978|NCT00863304|475050097|FG000|Overall Study|Randomized, but not Treated|3|||
131934979|NCT00863304|475050098|FG001|Overall Study|Randomized, but not Treated|1|||
131934980|NCT00863304|475050099|FG002|Overall Study|Randomized, but not Treated|4|||
131934981|NCT00863304|475050100|FG003|Overall Study|Randomized, but not Treated|1|||
131934982|NCT00863304|475050097|FG000|Overall Study|Entered extension study|101|||
131934983|NCT00863304|475050098|FG001|Overall Study|Entered extension study|129|||
131934984|NCT00863304|475050099|FG002|Overall Study|Entered extension study|113|||
131934985|NCT00863304|475050100|FG003|Overall Study|Entered extension study|125|||
131934986|NCT02327169|475050102|FG000|Overall Study|Progressive Disease|1|||
131934987|NCT02327169|475050103|FG001|Overall Study|Progressive Disease|3|||
131934988|NCT02327169|475050104|FG002|Overall Study|Progressive Disease|4|||
131934989|NCT02327169|475050105|FG003|Overall Study|Progressive Disease|3|||
131934990|NCT02327169|475050106|FG004|Overall Study|Progressive Disease|4|||
131934991|NCT02327169|475050107|FG005|Overall Study|Progressive Disease|3|||
131934992|NCT02327169|475050108|FG006|Overall Study|Progressive Disease|3|||
131934993|NCT02327169|475050109|FG007|Overall Study|Progressive Disease|3|||
131934994|NCT02327169|475050110|FG008|Overall Study|Progressive Disease|4|||
131934995|NCT02327169|475050111|FG009|Overall Study|Progressive Disease|4|||
131934996|NCT02327169|475050112|FG010|Overall Study|Progressive Disease|4|||
131934997|NCT02327169|475050113|FG011|Overall Study|Progressive Disease|3|||
131934998|NCT02327169|475050114|FG012|Overall Study|Progressive Disease|1|||
131934999|NCT02327169|475050115|FG013|Overall Study|Progressive Disease|3|||
131935000|NCT02327169|475050116|FG014|Overall Study|Progressive Disease|3|||
131935001|NCT02327169|475050102|FG000|Overall Study|Adverse Event|2|||
131935002|NCT02327169|475050103|FG001|Overall Study|Adverse Event|0|||
131935003|NCT02327169|475050104|FG002|Overall Study|Adverse Event|1|||
131935004|NCT02327169|475050105|FG003|Overall Study|Adverse Event|0|||
131935005|NCT02327169|475050106|FG004|Overall Study|Adverse Event|1|||
131935006|NCT02327169|475050107|FG005|Overall Study|Adverse Event|0|||
131935007|NCT02327169|475050108|FG006|Overall Study|Adverse Event|0|||
131935008|NCT02327169|475050109|FG007|Overall Study|Adverse Event|0|||
131935009|NCT02327169|475050110|FG008|Overall Study|Adverse Event|0|||
131935010|NCT02327169|475050111|FG009|Overall Study|Adverse Event|2|||
131935011|NCT02327169|475050112|FG010|Overall Study|Adverse Event|0|||
131935012|NCT02327169|475050113|FG011|Overall Study|Adverse Event|3|||
131935013|NCT02327169|475050114|FG012|Overall Study|Adverse Event|0|||
131935014|NCT02327169|475050115|FG013|Overall Study|Adverse Event|2|||
131935015|NCT02327169|475050116|FG014|Overall Study|Adverse Event|1|||
131935016|NCT02327169|475050102|FG000|Overall Study|Symptomatic Deterioration|0|||
131935017|NCT02327169|475050103|FG001|Overall Study|Symptomatic Deterioration|0|||
131935018|NCT02327169|475050104|FG002|Overall Study|Symptomatic Deterioration|1|||
131935019|NCT02327169|475050105|FG003|Overall Study|Symptomatic Deterioration|0|||
131935020|NCT02327169|475050106|FG004|Overall Study|Symptomatic Deterioration|1|||
131411992|NCT02725593|473130386|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
131411993|NCT02725593|473130385|FG000|Long Term Extension|Withdrawal by Subject|1|||
131935021|NCT02327169|475050107|FG005|Overall Study|Symptomatic Deterioration|1|||
131935022|NCT02327169|475050108|FG006|Overall Study|Symptomatic Deterioration|0|||
131935023|NCT02327169|475050109|FG007|Overall Study|Symptomatic Deterioration|0|||
131935024|NCT02327169|475050110|FG008|Overall Study|Symptomatic Deterioration|2|||
131935025|NCT02327169|475050111|FG009|Overall Study|Symptomatic Deterioration|1|||
131411994|NCT02725593|473130386|FG001|Long Term Extension|Withdrawal by Subject|3|||
131411995|NCT00664326|473131946|FG000|Overall Study|Adverse Event|14|||
131411996|NCT00664326|473131946|FG000|Overall Study|Noncompliance with study medication|3|||
131411997|NCT00664326|473131946|FG000|Overall Study|Withdrawal by Subject|1|||
131411998|NCT00664326|473131946|FG000|Overall Study|Physician Decision|1|||
131411999|NCT00664326|473131946|FG000|Overall Study|Other Reasons|3|||
131412000|NCT00664326|473131946|FG000|Overall Study|Death|2|||
131412001|NCT00664326|473131946|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
131935026|NCT02327169|475050112|FG010|Overall Study|Symptomatic Deterioration|0|||
131935027|NCT02327169|475050113|FG011|Overall Study|Symptomatic Deterioration|0|||
131454324|NCT03901469|473293274|FG006|Overall Study|Clinical Progression|2|||
131454325|NCT03901469|473293268|FG000|Overall Study|Adverse Event|1|||
131454326|NCT03901469|473293269|FG001|Overall Study|Adverse Event|0|||
131454327|NCT03901469|473293270|FG002|Overall Study|Adverse Event|0|||
131454328|NCT03901469|473293271|FG003|Overall Study|Adverse Event|0|||
131454329|NCT03901469|473293272|FG004|Overall Study|Adverse Event|0|||
131454330|NCT03901469|473293273|FG005|Overall Study|Adverse Event|0|||
131454331|NCT03901469|473293274|FG006|Overall Study|Adverse Event|9|||
131454332|NCT03901469|473293268|FG000|Overall Study|Physician Decision|0|||
131454333|NCT03901469|473293269|FG001|Overall Study|Physician Decision|0|||
131454334|NCT03901469|473293270|FG002|Overall Study|Physician Decision|0|||
131454335|NCT03901469|473293271|FG003|Overall Study|Physician Decision|1|||
131454336|NCT03901469|473293272|FG004|Overall Study|Physician Decision|0|||
131454337|NCT03901469|473293273|FG005|Overall Study|Physician Decision|0|||
131454338|NCT03901469|473293274|FG006|Overall Study|Physician Decision|0|||
131454339|NCT03901469|473293268|FG000|Overall Study|Withdrawal by Subject|0|||
131454340|NCT03901469|473293269|FG001|Overall Study|Withdrawal by Subject|0|||
131454341|NCT03901469|473293270|FG002|Overall Study|Withdrawal by Subject|0|||
131454342|NCT03901469|473293271|FG003|Overall Study|Withdrawal by Subject|0|||
131454343|NCT03901469|473293272|FG004|Overall Study|Withdrawal by Subject|2|||
131454344|NCT03901469|473293273|FG005|Overall Study|Withdrawal by Subject|0|||
131454345|NCT03901469|473293274|FG006|Overall Study|Withdrawal by Subject|8|||
131454346|NCT03901469|473293268|FG000|Overall Study|Death|0|||
131454347|NCT03901469|473293269|FG001|Overall Study|Death|0|||
131454348|NCT03901469|473293270|FG002|Overall Study|Death|0|||
131454349|NCT03901469|473293271|FG003|Overall Study|Death|3|||
131454350|NCT03901469|473293272|FG004|Overall Study|Death|5|||
131454351|NCT03901469|473293273|FG005|Overall Study|Death|0|||
131454352|NCT03901469|473293274|FG006|Overall Study|Death|1|||
131454353|NCT03901469|473293268|FG000|Overall Study|Termination of study by sponsor|0|||
131454354|NCT03901469|473293269|FG001|Overall Study|Termination of study by sponsor|0|||
131454355|NCT03901469|473293270|FG002|Overall Study|Termination of study by sponsor|0|||
131454356|NCT03901469|473293271|FG003|Overall Study|Termination of study by sponsor|0|||
131454357|NCT03901469|473293272|FG004|Overall Study|Termination of study by sponsor|1|||
131454358|NCT03901469|473293273|FG005|Overall Study|Termination of study by sponsor|1|||
131454359|NCT03901469|473293274|FG006|Overall Study|Termination of study by sponsor|0|||
131454360|NCT03901469|473293268|FG000|Overall Study|Not Reported|1|||
131454361|NCT03901469|473293269|FG001|Overall Study|Not Reported|0|||
131454362|NCT03901469|473293270|FG002|Overall Study|Not Reported|0|||
131454363|NCT03901469|473293271|FG003|Overall Study|Not Reported|1|||
131454364|NCT03901469|473293272|FG004|Overall Study|Not Reported|0|||
131454365|NCT03901469|473293273|FG005|Overall Study|Not Reported|0|||
131454366|NCT03901469|473293274|FG006|Overall Study|Not Reported|1|||
131454367|NCT03738228|473293278|FG000|Overall Study|Never received study treatment|2|||
131935028|NCT02327169|475050114|FG012|Overall Study|Symptomatic Deterioration|0|||
131935029|NCT02327169|475050115|FG013|Overall Study|Symptomatic Deterioration|2|||
131935030|NCT02327169|475050116|FG014|Overall Study|Symptomatic Deterioration|1|||
131935031|NCT02327169|475050102|FG000|Overall Study|Reason Not Specified|0|||
131935032|NCT02327169|475050103|FG001|Overall Study|Reason Not Specified|0|||
131935033|NCT02327169|475050104|FG002|Overall Study|Reason Not Specified|1|||
131935034|NCT02327169|475050105|FG003|Overall Study|Reason Not Specified|0|||
131935035|NCT02327169|475050106|FG004|Overall Study|Reason Not Specified|0|||
131935036|NCT02327169|475050107|FG005|Overall Study|Reason Not Specified|0|||
131935037|NCT02327169|475050108|FG006|Overall Study|Reason Not Specified|0|||
131935038|NCT02327169|475050109|FG007|Overall Study|Reason Not Specified|0|||
131935039|NCT02327169|475050110|FG008|Overall Study|Reason Not Specified|0|||
131935040|NCT02327169|475050111|FG009|Overall Study|Reason Not Specified|1|||
131935041|NCT02327169|475050112|FG010|Overall Study|Reason Not Specified|2|||
131935042|NCT02327169|475050113|FG011|Overall Study|Reason Not Specified|1|||
131935043|NCT02327169|475050114|FG012|Overall Study|Reason Not Specified|0|||
131935044|NCT02327169|475050115|FG013|Overall Study|Reason Not Specified|0|||
131935045|NCT02327169|475050116|FG014|Overall Study|Reason Not Specified|2|||
131935046|NCT02327169|475050102|FG000|Overall Study|Withdrawal by Subject|1|||
131935047|NCT02327169|475050103|FG001|Overall Study|Withdrawal by Subject|0|||
131935048|NCT02327169|475050104|FG002|Overall Study|Withdrawal by Subject|0|||
131454368|NCT03738228|473293279|FG001|Overall Study|Never received study treatment|2|||
131454369|NCT06170242|473293280|FG000|Overall Study|Lost to Follow-up|0|||
131454370|NCT06170242|473293281|FG001|Overall Study|Lost to Follow-up|0|||
131454371|NCT06170242|473293282|FG002|Overall Study|Lost to Follow-up|1|||
131935049|NCT02327169|475050105|FG003|Overall Study|Withdrawal by Subject|0|||
131935050|NCT02327169|475050106|FG004|Overall Study|Withdrawal by Subject|1|||
131454372|NCT06170242|473293283|FG003|Overall Study|Lost to Follow-up|1|||
131454373|NCT02586207|473293291|FG000|Overall Study|Physician Decision|1|||
131454374|NCT02586207|473293291|FG000|Overall Study|Withdrawal by Subject|1|||
131935051|NCT02327169|475050107|FG005|Overall Study|Withdrawal by Subject|0|||
131935052|NCT02327169|475050108|FG006|Overall Study|Withdrawal by Subject|0|||
131935053|NCT02327169|475050109|FG007|Overall Study|Withdrawal by Subject|1|||
131935054|NCT02327169|475050110|FG008|Overall Study|Withdrawal by Subject|0|||
131935055|NCT02327169|475050111|FG009|Overall Study|Withdrawal by Subject|0|||
131412002|NCT01266317|473131947|FG000|Overall Study|Withdrawal by Subject|2|||
131412003|NCT00490776|473131948|FG000|Overall Study|Withdrawal by Subject|1|||
131412004|NCT00490776|473131948|FG000|Overall Study|Administrative Problems|1|||
131412005|NCT00490776|473131948|FG000|Overall Study|Death|1|||
131412006|NCT00490776|473131948|FG000|Overall Study|New Cancer Therapy|1|||
131412007|NCT00490776|473131948|FG000|Overall Study|Disease Progression|5|||
131412008|NCT00046930|473131956|FG000|Overall Study|Ineligible|12|||
131412009|NCT00046930|473131957|FG001|Overall Study|Ineligible|4|||
131412010|NCT04912895|473131958|FG000|Overall Study|Unable to provide specimen|2|||
131412011|NCT04912895|473131959|FG001|Overall Study|Unable to provide specimen|0|||
131412012|NCT04912895|473131960|FG002|Overall Study|Unable to provide specimen|0|||
131412013|NCT00520013|473131961|FG000|Overall Study|Withdrawal by Subject|0|||
131412014|NCT00520013|473131962|FG001|Overall Study|Withdrawal by Subject|0|||
131412015|NCT00520013|473131963|FG002|Overall Study|Withdrawal by Subject|1|||
131412016|NCT00520013|473131961|FG000|Overall Study|Adverse Event|2|||
131412017|NCT00520013|473131962|FG001|Overall Study|Adverse Event|10|||
131412018|NCT00520013|473131963|FG002|Overall Study|Adverse Event|7|||
131412019|NCT00520013|473131961|FG000|Overall Study|Progressive Disease|7|||
131412020|NCT00520013|473131962|FG001|Overall Study|Progressive Disease|3|||
131412021|NCT00520013|473131963|FG002|Overall Study|Progressive Disease|0|||
131412022|NCT00520013|473131961|FG000|Overall Study|Clinical Progression|3|||
131412023|NCT00520013|473131962|FG001|Overall Study|Clinical Progression|1|||
131412024|NCT00520013|473131963|FG002|Overall Study|Clinical Progression|0|||
131412025|NCT00520013|473131961|FG000|Overall Study|Death|0|||
131412026|NCT00520013|473131962|FG001|Overall Study|Death|1|||
131412027|NCT00520013|473131963|FG002|Overall Study|Death|0|||
131412028|NCT00520013|473131961|FG000|Overall Study|Physician Decision|0|||
131412029|NCT00520013|473131962|FG001|Overall Study|Physician Decision|0|||
131412030|NCT00520013|473131963|FG002|Overall Study|Physician Decision|3|||
131412031|NCT02677844|473131964|FG000|Period 3|Withdrawal by Subject|0|||
131412032|NCT02677844|473131965|FG001|Period 3|Withdrawal by Subject|0|||
131412033|NCT02677844|473131966|FG002|Period 3|Withdrawal by Subject|0|||
131412034|NCT02677844|473131967|FG003|Period 3|Withdrawal by Subject|1|||
131412035|NCT02677844|473131968|FG004|Period 3|Withdrawal by Subject|0|||
131412036|NCT02677844|473131969|FG005|Period 3|Withdrawal by Subject|0|||
131412037|NCT02677844|473131970|FG006|Period 3|Withdrawal by Subject|0|||
131412038|NCT03532932|473131976|FG000|Overall Study|Protocol Deviation|33|||
131412039|NCT03532932|473131977|FG001|Overall Study|Protocol Deviation|31|||
131412040|NCT03532932|473131976|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
131412041|NCT03532932|473131977|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
131412042|NCT03532932|473131976|FG000|Overall Study|Withdrawal by Subject|2|||
131935056|NCT02327169|475050112|FG010|Overall Study|Withdrawal by Subject|0|||
131935057|NCT02327169|475050113|FG011|Overall Study|Withdrawal by Subject|0|||
131935058|NCT02327169|475050114|FG012|Overall Study|Withdrawal by Subject|0|||
131935059|NCT02327169|475050115|FG013|Overall Study|Withdrawal by Subject|0|||
131935060|NCT02327169|475050116|FG014|Overall Study|Withdrawal by Subject|3|||
131935061|NCT02327169|475050102|FG000|Overall Study|Lost to Follow-up|0|||
131935062|NCT02327169|475050103|FG001|Overall Study|Lost to Follow-up|0|||
131935063|NCT02327169|475050104|FG002|Overall Study|Lost to Follow-up|0|||
131935064|NCT02327169|475050105|FG003|Overall Study|Lost to Follow-up|0|||
131935065|NCT02327169|475050106|FG004|Overall Study|Lost to Follow-up|1|||
131935066|NCT02327169|475050107|FG005|Overall Study|Lost to Follow-up|0|||
131935067|NCT02327169|475050108|FG006|Overall Study|Lost to Follow-up|0|||
131935068|NCT02327169|475050109|FG007|Overall Study|Lost to Follow-up|0|||
131935069|NCT02327169|475050110|FG008|Overall Study|Lost to Follow-up|0|||
131412043|NCT03532932|473131977|FG001|Overall Study|Withdrawal by Subject|0|||
131412044|NCT03532932|473131976|FG000|Overall Study|Lost to Follow-up|15|||
131412045|NCT03532932|473131977|FG001|Overall Study|Lost to Follow-up|9|||
131935070|NCT02327169|475050111|FG009|Overall Study|Lost to Follow-up|0|||
131412046|NCT03532932|473131976|FG000|Overall Study|Adverse Event|4|||
131412047|NCT03532932|473131977|FG001|Overall Study|Adverse Event|3|||
131412048|NCT03532932|473131976|FG000|Overall Study|Death|0|||
131412049|NCT03532932|473131977|FG001|Overall Study|Death|2|||
131412050|NCT03532932|473131976|FG000|Overall Study|Other|11|||
131935071|NCT02327169|475050112|FG010|Overall Study|Lost to Follow-up|0|||
131935072|NCT02327169|475050113|FG011|Overall Study|Lost to Follow-up|0|||
131412051|NCT03532932|473131977|FG001|Overall Study|Other|16|||
131412052|NCT02699450|473131978|FG000|Overall Study|Death|2|||
131412053|NCT02699450|473131979|FG001|Overall Study|Death|1|||
131935073|NCT02327169|475050114|FG012|Overall Study|Lost to Follow-up|0|||
131935074|NCT02327169|475050115|FG013|Overall Study|Lost to Follow-up|0|||
131412054|NCT02699450|473131980|FG002|Overall Study|Death|2|||
131412055|NCT02699450|473131978|FG000|Overall Study|Met Criteria for Study Exit|0|||
131412056|NCT02699450|473131979|FG001|Overall Study|Met Criteria for Study Exit|0|||
131412057|NCT02699450|473131980|FG002|Overall Study|Met Criteria for Study Exit|1|||
131412058|NCT02699450|473131978|FG000|Overall Study|Protocol Violation|4|||
131412059|NCT02699450|473131979|FG001|Overall Study|Protocol Violation|3|||
131935075|NCT02327169|475050116|FG014|Overall Study|Lost to Follow-up|0|||
131935076|NCT00478257|475050117|FG000|Overall Study|Withdrawal by Subject|8|||
131935077|NCT00478257|475050118|FG001|Overall Study|Withdrawal by Subject|3|||
131935078|NCT03931330|475050120|FG000|Overall Study|Physician Decision|1|||
131935079|NCT03412929|475050121|FG000|Overall Study|Protocol Violation|3|||
131935080|NCT01381679|475050124|FG000|Overall Study|Adverse Event|3|||
131935081|NCT01381679|475050124|FG000|Overall Study|Lost to Follow-up|885|||
131935082|NCT04023487|475050125|FG000|Overall Study|Lost to Follow-up|5|||
131935083|NCT04023487|475050126|FG001|Overall Study|Lost to Follow-up|4|||
131935084|NCT04023487|475050125|FG000|Overall Study|Pregnancy|1|||
131935085|NCT04023487|475050126|FG001|Overall Study|Pregnancy|2|||
131935086|NCT04023487|475050125|FG000|Overall Study|Withdrawal by Subject|4|||
131935087|NCT04023487|475050126|FG001|Overall Study|Withdrawal by Subject|5|||
131935088|NCT04023487|475050125|FG000|Overall Study|Partially completed testing|8|||
131935089|NCT04023487|475050126|FG001|Overall Study|Partially completed testing|4|||
131935090|NCT03528902|475050133|FG000|Overall Study|Adverse Event|1|||
131935091|NCT03528902|475050134|FG001|Overall Study|Adverse Event|0|||
131935092|NCT05030766|475050135|FG000|Phase 1 Participants|Lost to Follow-up|12|||
131935093|NCT05030766|475050136|FG001|Phase 1 Participants|Lost to Follow-up|22|||
131935094|NCT05030766|475050137|FG002|Phase 1 Participants|Lost to Follow-up|0|||
131935095|NCT05030766|475050138|FG003|Phase 1 Participants|Lost to Follow-up|0|||
131935096|NCT05030766|475050135|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
131935097|NCT05030766|475050136|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
131935098|NCT05030766|475050137|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
131935099|NCT05030766|475050138|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
131935100|NCT05030766|475050135|FG000|Phase 2 Participants|Lost to Follow-up|0|||
131935101|NCT05030766|475050136|FG001|Phase 2 Participants|Lost to Follow-up|0|||
131935102|NCT05030766|475050137|FG002|Phase 2 Participants|Lost to Follow-up|6|||
131935103|NCT05030766|475050138|FG003|Phase 2 Participants|Lost to Follow-up|2|||
131935104|NCT00645658|475050139|FG000|Overall Study|Withdrawal by Subject|1|||
131935105|NCT00645658|475050140|FG001|Overall Study|Withdrawal by Subject|0|||
131935106|NCT00645658|475050139|FG000|Overall Study|Did not complete all assesments|0|||
131935107|NCT00645658|475050140|FG001|Overall Study|Did not complete all assesments|2|||
131935108|NCT05889468|475050141|FG000|Overall Study|Lost to Follow-up|9|||
131935109|NCT05889468|475050142|FG001|Overall Study|Lost to Follow-up|2|||
131935110|NCT05889468|475050141|FG000|Overall Study|Withdrawal by Subject|2|||
131935111|NCT05889468|475050142|FG001|Overall Study|Withdrawal by Subject|2|||
131935112|NCT01309230|475050143|FG000|Overall Study|Withdrawal by Subject|0|||
131935113|NCT01309230|475050144|FG001|Overall Study|Withdrawal by Subject|2|||
131935114|NCT01309230|475050143|FG000|Overall Study|Observation arm closed|0|||
131935115|NCT01309230|475050144|FG001|Overall Study|Observation arm closed|2|||
131935116|NCT00635050|475050151|FG000|Overall Study|Withdrawal by Subject|1|||
131935117|NCT02082977|475050152|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
131935118|NCT02082977|475050153|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
131935119|NCT02082977|475050154|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
131935120|NCT02082977|475050155|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
131935121|NCT02082977|475050156|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
131935122|NCT02082977|475050157|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
131935123|NCT02082977|475050158|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
131935124|NCT02082977|475050159|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
131935125|NCT02082977|475050160|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
131935126|NCT02082977|475050161|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
131935127|NCT02082977|475050152|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935128|NCT02082977|475050153|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935129|NCT02082977|475050154|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935130|NCT02082977|475050155|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935131|NCT02082977|475050156|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935132|NCT02082977|475050157|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935133|NCT02082977|475050158|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935134|NCT02082977|475050159|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
131935135|NCT02082977|475050160|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935136|NCT02082977|475050161|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
131935137|NCT02082977|475050152|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935138|NCT02082977|475050153|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935139|NCT02082977|475050154|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935140|NCT02082977|475050155|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935141|NCT02082977|475050156|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935142|NCT02082977|475050157|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
131935143|NCT02082977|475050158|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935144|NCT02082977|475050159|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935145|NCT02082977|475050160|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935146|NCT02082977|475050161|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
131935147|NCT02082977|475050152|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
131935148|NCT02082977|475050153|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
131935149|NCT02082977|475050154|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
131454375|NCT04896073|473293292|FG000|Overall Study|Screen failure|0|||
131454376|NCT04896073|473293293|FG001|Overall Study|Screen failure|2|||
131454377|NCT04896073|473293292|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
131454378|NCT04896073|473293293|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
131454379|NCT01385176|473293294|FG000|Randomization Phase|Death|1|||
131454380|NCT01385176|473293295|FG001|Randomization Phase|Death|2|||
131454381|NCT01385176|473293294|FG000|6-18 Month All VNS Active|Death|1|||
131454382|NCT01385176|473293295|FG001|6-18 Month All VNS Active|Death|2|||
131454383|NCT01385176|473293294|FG000|6-18 Month All VNS Active|Physician Decision|0|||
131454384|NCT01385176|473293295|FG001|6-18 Month All VNS Active|Physician Decision|1|||
131454385|NCT01385176|473293294|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
131454386|NCT01385176|473293295|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
131454387|NCT01385176|473293294|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
131454388|NCT01385176|473293295|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
131454389|NCT02306161|473293296|FG000|Overall Study|Death|1|||
131454390|NCT02306161|473293297|FG001|Overall Study|Death|3|||
131454391|NCT02306161|473293296|FG000|Overall Study|Lack of Efficacy|20|||
131454392|NCT02306161|473293297|FG001|Overall Study|Lack of Efficacy|43|||
131454393|NCT02306161|473293296|FG000|Overall Study|Physician Decision|30|||
131454394|NCT02306161|473293297|FG001|Overall Study|Physician Decision|18|||
131454395|NCT02306161|473293296|FG000|Overall Study|Withdrawal by Subject|4|||
131454396|NCT02306161|473293297|FG001|Overall Study|Withdrawal by Subject|0|||
131454397|NCT02306161|473293296|FG000|Overall Study|Ineligible|9|||
131454398|NCT02306161|473293297|FG001|Overall Study|Ineligible|5|||
131454399|NCT04995419|473293298|FG000|Overall Study|Withdrawal by Subject|3|||
131454400|NCT04995419|473293298|FG000|Overall Study|Progressive Disease|19|||
131454401|NCT04995419|473293298|FG000|Overall Study|Adverse Event|2|||
131454402|NCT04995419|473293298|FG000|Overall Study|Ongoing|16|||
131454403|NCT03306173|473293299|FG000|Overall Study|Lost to Follow-up|16|||
131454404|NCT03306173|473293300|FG001|Overall Study|Lost to Follow-up|23|||
131454405|NCT03306173|473293299|FG000|Overall Study|Withdrawal by Subject|4|||
131454406|NCT03306173|473293300|FG001|Overall Study|Withdrawal by Subject|3|||
131454407|NCT03306173|473293299|FG000|Overall Study|Discontinued|4|||
131454408|NCT03306173|473293300|FG001|Overall Study|Discontinued|4|||
131454409|NCT00441064|473293301|FG000|Overall Study|Adverse Event|1|||
131454410|NCT00441064|473293302|FG001|Overall Study|Adverse Event|0|||
131454411|NCT00441064|473293301|FG000|Overall Study|Abnormal laboratory values|0|||
131454412|NCT00441064|473293302|FG001|Overall Study|Abnormal laboratory values|2|||
131454413|NCT00441064|473293301|FG000|Overall Study|Abnormal test procedure results|0|||
131454414|NCT00441064|473293302|FG001|Overall Study|Abnormal test procedure results|1|||
131454415|NCT00441064|473293301|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131454416|NCT00441064|473293302|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131454417|NCT00441064|473293301|FG000|Overall Study|Protocol Deviation|3|||
131454418|NCT00441064|473293302|FG001|Overall Study|Protocol Deviation|2|||
131454419|NCT00441064|473293301|FG000|Overall Study|Patient withdrew consent|5|||
131454420|NCT00441064|473293302|FG001|Overall Study|Patient withdrew consent|2|||
131454421|NCT03962504|473293303|FG000|Overall Study|Other|11|||
131454422|NCT03962504|473293304|FG001|Overall Study|Other|32|||
131454423|NCT03776812|473293305|FG000|Overall Study|Death|53|||
131454424|NCT03776812|473293306|FG001|Overall Study|Death|49|||
131454425|NCT03776812|473293307|FG002|Overall Study|Death|56|||
131454426|NCT03776812|473293305|FG000|Overall Study|Withdrawal by Subject|1|||
131454427|NCT03776812|473293306|FG001|Overall Study|Withdrawal by Subject|7|||
131454428|NCT03776812|473293307|FG002|Overall Study|Withdrawal by Subject|2|||
131454429|NCT03776812|473293305|FG000|Overall Study|Lost to Follow-up|1|||
131454430|NCT03776812|473293306|FG001|Overall Study|Lost to Follow-up|1|||
131454431|NCT03776812|473293307|FG002|Overall Study|Lost to Follow-up|0|||
131454432|NCT03776812|473293305|FG000|Overall Study|Did not enter long-term follow-up|3|||
131454433|NCT03776812|473293306|FG001|Overall Study|Did not enter long-term follow-up|3|||
131454434|NCT03776812|473293307|FG002|Overall Study|Did not enter long-term follow-up|2|||
131454435|NCT04758637|473293308|FG000|Overall Study|Lost to Follow-up|0|||
131454436|NCT04758637|473293309|FG001|Overall Study|Lost to Follow-up|1|||
131935150|NCT02082977|475050155|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
131935151|NCT02082977|475050156|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
131935152|NCT02082977|475050157|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
131935153|NCT02082977|475050158|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
131935154|NCT02082977|475050159|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
131454437|NCT04758637|473293310|FG002|Overall Study|Lost to Follow-up|0|||
131454438|NCT04758637|473293311|FG003|Overall Study|Lost to Follow-up|0|||
131454439|NCT00048074|473293316|FG000|Overall Study|Adverse Event|46|||
131935155|NCT02082977|475050160|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
131454440|NCT00048074|473293317|FG001|Overall Study|Adverse Event|41|||
131454441|NCT00048074|473293318|FG002|Overall Study|Adverse Event|53|||
131454442|NCT00048074|473293316|FG000|Overall Study|Death|3|||
131454443|NCT00048074|473293317|FG001|Overall Study|Death|3|||
131454444|NCT00048074|473293318|FG002|Overall Study|Death|2|||
131454445|NCT00048074|473293316|FG000|Overall Study|Lost to Follow-up|2|||
131412060|NCT02699450|473131980|FG002|Overall Study|Protocol Violation|5|||
131412061|NCT02699450|473131978|FG000|Overall Study|Lost to Follow-up|3|||
131412062|NCT02699450|473131979|FG001|Overall Study|Lost to Follow-up|0|||
131412063|NCT02699450|473131980|FG002|Overall Study|Lost to Follow-up|5|||
131412064|NCT02699450|473131978|FG000|Overall Study|Physician Decision|2|||
131412065|NCT02699450|473131979|FG001|Overall Study|Physician Decision|0|||
131412066|NCT02699450|473131980|FG002|Overall Study|Physician Decision|0|||
131412067|NCT02699450|473131978|FG000|Overall Study|Withdrawal by Subject|3|||
131412068|NCT02699450|473131979|FG001|Overall Study|Withdrawal by Subject|1|||
131412069|NCT02699450|473131980|FG002|Overall Study|Withdrawal by Subject|2|||
131412070|NCT02699450|473131978|FG000|Overall Study|Adverse Event|1|||
131412071|NCT02699450|473131979|FG001|Overall Study|Adverse Event|0|||
131412072|NCT02699450|473131980|FG002|Overall Study|Adverse Event|0|||
131412073|NCT01635764|473131981|FG000|Overall Study|Adverse Event|46|||
131412074|NCT01635764|473131981|FG000|Overall Study|Lack of Efficacy|76|||
131412075|NCT01635764|473131981|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
131412076|NCT01635764|473131981|FG000|Overall Study|Protocol Deviation|1|||
131412077|NCT01635764|473131981|FG000|Overall Study|Withdrew Consent|67|||
131412078|NCT01635764|473131981|FG000|Overall Study|Lost to Follow-up|53|||
131412079|NCT01635764|473131981|FG000|Overall Study|Other|28|||
131412080|NCT01174004|473131982|FG000|Overall Study|Adverse Event|2|||
131412081|NCT01174004|473131983|FG001|Overall Study|Adverse Event|10|||
131412082|NCT01174004|473131982|FG000|Overall Study|Withdrawal by Subject|2|||
131412083|NCT01174004|473131983|FG001|Overall Study|Withdrawal by Subject|3|||
131412084|NCT01174004|473131982|FG000|Overall Study|At Discretion of Sponsor|2|||
131412085|NCT01174004|473131983|FG001|Overall Study|At Discretion of Sponsor|2|||
131412086|NCT01174004|473131982|FG000|Overall Study|Protocol Violation|0|||
131412087|NCT01174004|473131983|FG001|Overall Study|Protocol Violation|1|||
131412088|NCT01174004|473131982|FG000|Overall Study|Physician Decision|1|||
131412089|NCT01174004|473131983|FG001|Overall Study|Physician Decision|0|||
131412090|NCT04063787|473131985|FG000|Overall Study|Inadequate Doppler data|4|||
131412091|NCT04063787|473131985|FG000|Overall Study|Lost to Follow-up|2|||
131412092|NCT04063787|473131985|FG000|Overall Study|Death|3|||
131412093|NCT01515475|473131988|FG000|Overall Study|Lost to Follow-up|20|||
131412094|NCT01515475|473131989|FG001|Overall Study|Lost to Follow-up|15|||
131412095|NCT01515475|473131990|FG002|Overall Study|Lost to Follow-up|12|||
131412096|NCT01515475|473131991|FG003|Overall Study|Lost to Follow-up|12|||
131412097|NCT00837876|473131992|FG000|Overall Study|Death|2|||
131412098|NCT00837876|473131992|FG000|Overall Study|Adverse Event|7|||
131412099|NCT00837876|473131992|FG000|Overall Study|Physician Decision|1|||
131412100|NCT00837876|473131992|FG000|Overall Study|Withdrawal by Subject|3|||
131412101|NCT00837876|473131992|FG000|Overall Study|disease progression|24|||
131412102|NCT00453973|473131993|FG000|Overall Study|Adverse Event|4|||
131412103|NCT00453973|473131994|FG001|Overall Study|Adverse Event|9|||
131412104|NCT00453973|473131993|FG000|Overall Study|Withdrawal by Subject|7|||
131412105|NCT00453973|473131994|FG001|Overall Study|Withdrawal by Subject|6|||
131412106|NCT00453973|473131993|FG000|Overall Study|PI Decision|0|||
131412107|NCT00453973|473131994|FG001|Overall Study|PI Decision|2|||
131412108|NCT00453973|473131993|FG000|Overall Study|Relocation|1|||
131412109|NCT00453973|473131994|FG001|Overall Study|Relocation|0|||
131412110|NCT00453973|473131993|FG000|Overall Study|Renal transplant|1|||
131412111|NCT00453973|473131994|FG001|Overall Study|Renal transplant|1|||
131412112|NCT00453973|473131993|FG000|Overall Study|Site closed by sponsor|3|||
131412113|NCT00453973|473131994|FG001|Overall Study|Site closed by sponsor|0|||
131412114|NCT00453973|473131993|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
131412115|NCT00453973|473131994|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
131412116|NCT01011933|473132006|FG000|Overall Study|Wrong cell type|1|||
131412117|NCT01011933|473132006|FG000|Overall Study|Improper pre-protocol Rx|1|||
131412118|NCT01011933|473132006|FG000|Overall Study|Inadequate pathology|1|||
131412119|NCT01011933|473132006|FG000|Overall Study|Never treated|1|||
131412120|NCT01969500|473132007|FG000|Overall Study|Death|0|||
131412121|NCT01969500|473132008|FG001|Overall Study|Death|1|||
131412122|NCT01969500|473132007|FG000|Overall Study|extended hospitalization|1|||
131412123|NCT01969500|473132008|FG001|Overall Study|extended hospitalization|1|||
131412124|NCT02639338|473132009|FG000|Overall Study|Lost to Follow-up|2|||
131412125|NCT02639338|473132010|FG001|Overall Study|Lost to Follow-up|2|||
131412126|NCT02639338|473132009|FG000|Overall Study|Withdrew Consent|1|||
131412127|NCT02639338|473132010|FG001|Overall Study|Withdrew Consent|2|||
131412128|NCT02639338|473132009|FG000|Overall Study|Death|1|||
131412129|NCT02639338|473132010|FG001|Overall Study|Death|0|||
131412130|NCT02639338|473132009|FG000|Overall Study|Randomized but Not Treated|0|||
131412131|NCT02639338|473132010|FG001|Overall Study|Randomized but Not Treated|1|||
131412132|NCT00493636|473132011|FG000|Overall Study|Withdrawal by Subject|1|||
131412133|NCT00493636|473132012|FG001|Overall Study|Withdrawal by Subject|0|||
131412134|NCT00493636|473132011|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
131412135|NCT00493636|473132012|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
131412136|NCT00493636|473132011|FG000|Overall Study|Mis-randomization|1|||
131412137|NCT00493636|473132012|FG001|Overall Study|Mis-randomization|1|||
131412138|NCT01873729|473132016|FG000|Overall Study|Withdrawal by Subject|1|||
131412139|NCT02463032|473132017|FG000|Overall Study|Lack of Efficacy|61|||
131412140|NCT02463032|473132018|FG001|Overall Study|Lack of Efficacy|50|||
131412141|NCT02463032|473132017|FG000|Overall Study|Death|8|||
131412142|NCT02463032|473132018|FG001|Overall Study|Death|8|||
131412143|NCT02463032|473132017|FG000|Overall Study|Adverse Event|2|||
131412144|NCT02463032|473132018|FG001|Overall Study|Adverse Event|6|||
131412145|NCT00613080|473132019|FG000|Overall Study|Ineligible / no protocol treatment|11|||
131412146|NCT03757130|473132020|FG000|Overall Study|Lost to Follow-up|0|||
131412147|NCT03757130|473132021|FG001|Overall Study|Lost to Follow-up|0|||
131412148|NCT03757130|473132022|FG002|Overall Study|Lost to Follow-up|0|||
131412149|NCT03757130|473132023|FG003|Overall Study|Lost to Follow-up|1|||
131412150|NCT03757130|473132024|FG004|Overall Study|Lost to Follow-up|0|||
131412151|NCT03757130|473132025|FG005|Overall Study|Lost to Follow-up|0|||
131412152|NCT03757130|473132026|FG006|Overall Study|Lost to Follow-up|0|||
131412153|NCT03757130|473132027|FG007|Overall Study|Lost to Follow-up|1|||
131412154|NCT03757130|473132020|FG000|Overall Study|Withdrawal by Subject|0|||
131412155|NCT03757130|473132021|FG001|Overall Study|Withdrawal by Subject|0|||
131412156|NCT03757130|473132022|FG002|Overall Study|Withdrawal by Subject|0|||
131412157|NCT03757130|473132023|FG003|Overall Study|Withdrawal by Subject|0|||
131412158|NCT03757130|473132024|FG004|Overall Study|Withdrawal by Subject|0|||
131412159|NCT03757130|473132025|FG005|Overall Study|Withdrawal by Subject|0|||
131412160|NCT03757130|473132026|FG006|Overall Study|Withdrawal by Subject|1|||
131412161|NCT03757130|473132027|FG007|Overall Study|Withdrawal by Subject|0|||
131412162|NCT02226549|473132028|FG000|Overall Study|Randomized but Never Treated|1|||
131412163|NCT02226549|473132029|FG001|Overall Study|Randomized but Never Treated|0|||
131412164|NCT02226549|473132028|FG000|Overall Study|Lost to Follow-up|0|||
131412165|NCT02226549|473132029|FG001|Overall Study|Lost to Follow-up|1|||
131412166|NCT02726880|473132031|FG000|Overall Study|Withdrawal by Subject|2|||
131412167|NCT02726880|473132032|FG001|Overall Study|Withdrawal by Subject|0|||
131412168|NCT02726880|473132031|FG000|Overall Study|Lost to Follow-up|1|||
131412169|NCT02726880|473132032|FG001|Overall Study|Lost to Follow-up|3|||
131412170|NCT02012686|473132033|FG000|Overall Study|muscle contraction|0|||
131412171|NCT02012686|473132034|FG001|Overall Study|muscle contraction|1|||
131412172|NCT02012686|473132033|FG000|Overall Study|electrocardiography monitoring noise|0|||
131412173|NCT02012686|473132034|FG001|Overall Study|electrocardiography monitoring noise|1|||
131412174|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
131412175|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
131412176|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
131412177|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
131412178|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
131412179|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
131412180|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
131412181|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
131412182|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
131412183|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
131412184|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
131412185|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
131412186|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
131412187|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
131412188|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
131412189|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
131412190|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
131412191|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
131412192|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
131412193|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
131412194|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
131412195|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
131412196|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
131412197|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
131412198|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
131412199|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
131412200|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
131412201|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
131412202|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
131412203|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
131412204|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
131412205|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
131412206|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
131935156|NCT02082977|475050161|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
131935157|NCT02082977|475050152|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935158|NCT02082977|475050153|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935159|NCT02082977|475050154|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935160|NCT02082977|475050155|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935161|NCT02082977|475050156|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935162|NCT02082977|475050157|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935163|NCT02082977|475050158|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935164|NCT02082977|475050159|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
131935165|NCT02082977|475050160|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935166|NCT02082977|475050161|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
131935167|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
131935168|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
131935169|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
131935170|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
131935171|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
131935172|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
131935173|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
131935174|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
131935175|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
131935176|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
131935177|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
131935178|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
131935179|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
131935180|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
131935181|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
131935182|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
131935183|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
131935184|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
131935185|NCT00086515|475050162|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
131935186|NCT00086515|475050163|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
131935187|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
131935188|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
131935189|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
131935190|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
131935191|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
131935192|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
131935193|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
131935194|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
131935195|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
131935196|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
131935197|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
131935198|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
131935199|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
131935200|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
131935201|NCT00086515|475050162|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
131935202|NCT00086515|475050163|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
131935203|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
131935204|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
131935205|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
131935206|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
131935207|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
131935208|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
131935209|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
131935210|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
131935211|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
131935212|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
131935213|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
131935214|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
131935215|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
131935216|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
131935217|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
131935218|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
131935219|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
131935220|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
131935221|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
131935222|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
131935223|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
131454446|NCT00048074|473293317|FG001|Overall Study|Lost to Follow-up|6|||
131935224|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
131935225|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
131935226|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
131935227|NCT00086515|475050162|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
131935228|NCT00086515|475050163|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
131935229|NCT00049543|475050167|FG000|Overall Study|still on treatment|2|||
131935230|NCT00049543|475050168|FG001|Overall Study|still on treatment|9|||
131935231|NCT02106832|475050169|FG000|Overall Study|Adverse Event|1|||
131935232|NCT02106832|475050170|FG001|Overall Study|Adverse Event|2|||
131935233|NCT02106832|475050171|FG002|Overall Study|Adverse Event|3|||
131935234|NCT02106832|475050172|FG003|Overall Study|Adverse Event|0|||
131935235|NCT02106832|475050169|FG000|Overall Study|Death|4|||
131935236|NCT02106832|475050170|FG001|Overall Study|Death|4|||
131935237|NCT02106832|475050171|FG002|Overall Study|Death|1|||
131935238|NCT02106832|475050172|FG003|Overall Study|Death|4|||
131935239|NCT02106832|475050169|FG000|Overall Study|Deterioration of general conditions|0|||
131935240|NCT02106832|475050170|FG001|Overall Study|Deterioration of general conditions|0|||
131935241|NCT02106832|475050171|FG002|Overall Study|Deterioration of general conditions|1|||
131935242|NCT02106832|475050172|FG003|Overall Study|Deterioration of general conditions|0|||
131935243|NCT02106832|475050169|FG000|Overall Study|Lost to Follow-up|0|||
131935244|NCT02106832|475050170|FG001|Overall Study|Lost to Follow-up|1|||
131935245|NCT02106832|475050171|FG002|Overall Study|Lost to Follow-up|1|||
131935246|NCT02106832|475050172|FG003|Overall Study|Lost to Follow-up|3|||
131935247|NCT02106832|475050169|FG000|Overall Study|Physician Decision|1|||
131935248|NCT02106832|475050170|FG001|Overall Study|Physician Decision|0|||
131935249|NCT02106832|475050171|FG002|Overall Study|Physician Decision|0|||
131935250|NCT02106832|475050172|FG003|Overall Study|Physician Decision|0|||
131935251|NCT02106832|475050169|FG000|Overall Study|Protocol Violation|0|||
131935252|NCT02106832|475050170|FG001|Overall Study|Protocol Violation|0|||
131935253|NCT02106832|475050171|FG002|Overall Study|Protocol Violation|0|||
131935254|NCT02106832|475050172|FG003|Overall Study|Protocol Violation|1|||
131935255|NCT02106832|475050169|FG000|Overall Study|Withdrawal by Subject|17|||
131935256|NCT02106832|475050170|FG001|Overall Study|Withdrawal by Subject|17|||
131935257|NCT02106832|475050171|FG002|Overall Study|Withdrawal by Subject|10|||
131935258|NCT02106832|475050172|FG003|Overall Study|Withdrawal by Subject|7|||
131935259|NCT02106832|475050169|FG000|Overall Study|Technical problems|0|||
131935260|NCT02106832|475050170|FG001|Overall Study|Technical problems|1|||
131935261|NCT02106832|475050171|FG002|Overall Study|Technical problems|0|||
131935262|NCT02106832|475050172|FG003|Overall Study|Technical problems|0|||
131935263|NCT00982280|475050176|FG000|Observation Period|Not eligible to be dosed|19|||
131935264|NCT00982280|475050176|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
131935265|NCT00982280|475050176|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
131935266|NCT00982280|475050176|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
131935267|NCT00982280|475050176|FG000|Maintenance Period|Adverse Event|1|||
131935268|NCT01979185|475050177|FG000|Period 2|Other|0|||
131935269|NCT01979185|475050178|FG001|Period 2|Other|1|||
131935270|NCT02231580|475050179|FG000|Overall Study|Adverse Event|5|||
131935271|NCT02231580|475050180|FG001|Overall Study|Adverse Event|0|||
131935272|NCT04221438|475050181|FG000|Overall Study|Adverse Event|1|||
131935273|NCT04221438|475050181|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
131935274|NCT04724837|475050184|FG000|Overall Study|Other|4|||
131935275|NCT04724837|475050185|FG001|Overall Study|Other|16|||
131935276|NCT04724837|475050186|FG002|Overall Study|Other|0|||
131935277|NCT04724837|475050184|FG000|Overall Study|Withdrawal by Subject|2|||
131935278|NCT04724837|475050185|FG001|Overall Study|Withdrawal by Subject|9|||
131935279|NCT04724837|475050186|FG002|Overall Study|Withdrawal by Subject|9|||
131935280|NCT04724837|475050184|FG000|Overall Study|Adverse Event|2|||
131935281|NCT04724837|475050185|FG001|Overall Study|Adverse Event|7|||
131935282|NCT04724837|475050186|FG002|Overall Study|Adverse Event|4|||
131935283|NCT04724837|475050184|FG000|Overall Study|Lost to Follow-up|0|||
131935284|NCT04724837|475050185|FG001|Overall Study|Lost to Follow-up|1|||
131935285|NCT04724837|475050186|FG002|Overall Study|Lost to Follow-up|3|||
131935286|NCT04724837|475050184|FG000|Overall Study|Physician Decision|1|||
131935287|NCT04724837|475050185|FG001|Overall Study|Physician Decision|2|||
131935288|NCT04724837|475050186|FG002|Overall Study|Physician Decision|0|||
131935289|NCT04724837|475050184|FG000|Overall Study|Death|0|||
131935290|NCT04724837|475050185|FG001|Overall Study|Death|0|||
131935291|NCT04724837|475050186|FG002|Overall Study|Death|1|||
131935292|NCT04724837|475050184|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
131935293|NCT04724837|475050185|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
131935294|NCT04724837|475050186|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
131935295|NCT04724837|475050184|FG000|Overall Study|Study Terminated by Sponsor|0|||
131935296|NCT04724837|475050185|FG001|Overall Study|Study Terminated by Sponsor|1|||
131935297|NCT04724837|475050186|FG002|Overall Study|Study Terminated by Sponsor|0|||
131935298|NCT00522379|475050187|FG000|Overall Study|Adverse Event|12|||
131935299|NCT00522379|475050188|FG001|Overall Study|Adverse Event|15|||
131935300|NCT00522379|475050189|FG002|Overall Study|Adverse Event|12|||
131935301|NCT00522379|475050190|FG003|Overall Study|Adverse Event|5|||
131935302|NCT00522379|475050191|FG004|Overall Study|Adverse Event|17|||
131935303|NCT00522379|475050187|FG000|Overall Study|Lack of Efficacy|3|||
131935304|NCT00522379|475050188|FG001|Overall Study|Lack of Efficacy|0|||
131935305|NCT00522379|475050189|FG002|Overall Study|Lack of Efficacy|2|||
131935306|NCT00522379|475050190|FG003|Overall Study|Lack of Efficacy|2|||
131935307|NCT00522379|475050191|FG004|Overall Study|Lack of Efficacy|7|||
131935308|NCT00522379|475050187|FG000|Overall Study|Withdrawal by Subject|2|||
131935309|NCT00522379|475050188|FG001|Overall Study|Withdrawal by Subject|3|||
131935310|NCT00522379|475050189|FG002|Overall Study|Withdrawal by Subject|1|||
131935311|NCT00522379|475050190|FG003|Overall Study|Withdrawal by Subject|2|||
131935312|NCT00522379|475050191|FG004|Overall Study|Withdrawal by Subject|0|||
131935313|NCT00522379|475050187|FG000|Overall Study|Protocol Violation|1|||
131935314|NCT00522379|475050188|FG001|Overall Study|Protocol Violation|1|||
131935315|NCT00522379|475050189|FG002|Overall Study|Protocol Violation|2|||
131935316|NCT00522379|475050190|FG003|Overall Study|Protocol Violation|0|||
131935317|NCT00522379|475050191|FG004|Overall Study|Protocol Violation|0|||
131935318|NCT00522379|475050187|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
131935319|NCT00522379|475050188|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
131935320|NCT00522379|475050189|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
131935321|NCT00522379|475050190|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
131935322|NCT00522379|475050191|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
131935323|NCT00522379|475050187|FG000|Overall Study|Lost to Follow-up|1|||
131935324|NCT00522379|475050188|FG001|Overall Study|Lost to Follow-up|0|||
131935325|NCT00522379|475050189|FG002|Overall Study|Lost to Follow-up|4|||
131935326|NCT00522379|475050190|FG003|Overall Study|Lost to Follow-up|2|||
131935327|NCT00522379|475050191|FG004|Overall Study|Lost to Follow-up|2|||
131935328|NCT00522379|475050187|FG000|Overall Study|Randomization error|0|||
131935329|NCT00522379|475050188|FG001|Overall Study|Randomization error|0|||
131935330|NCT00522379|475050189|FG002|Overall Study|Randomization error|0|||
131935331|NCT00522379|475050190|FG003|Overall Study|Randomization error|0|||
131935332|NCT00522379|475050191|FG004|Overall Study|Randomization error|1|||
131935333|NCT00522379|475050187|FG000|Overall Study|Dispensing error|1|||
131935334|NCT00522379|475050188|FG001|Overall Study|Dispensing error|0|||
131935335|NCT00522379|475050189|FG002|Overall Study|Dispensing error|0|||
131935336|NCT00522379|475050190|FG003|Overall Study|Dispensing error|1|||
131935337|NCT00522379|475050191|FG004|Overall Study|Dispensing error|0|||
131935338|NCT00522379|475050187|FG000|Overall Study|Subject Moved|1|||
131935339|NCT00522379|475050188|FG001|Overall Study|Subject Moved|1|||
131935340|NCT00522379|475050189|FG002|Overall Study|Subject Moved|0|||
131935341|NCT00522379|475050190|FG003|Overall Study|Subject Moved|0|||
131935342|NCT00522379|475050191|FG004|Overall Study|Subject Moved|0|||
131935343|NCT00522379|475050187|FG000|Overall Study|Sponsor Request|0|||
131935344|NCT00522379|475050188|FG001|Overall Study|Sponsor Request|1|||
131935345|NCT00522379|475050189|FG002|Overall Study|Sponsor Request|0|||
131935346|NCT00522379|475050190|FG003|Overall Study|Sponsor Request|0|||
131935347|NCT00522379|475050191|FG004|Overall Study|Sponsor Request|0|||
131935348|NCT00522379|475050187|FG000|Overall Study|Family Problem|0|||
131935349|NCT00522379|475050188|FG001|Overall Study|Family Problem|0|||
131935350|NCT00522379|475050189|FG002|Overall Study|Family Problem|1|||
131935351|NCT00522379|475050190|FG003|Overall Study|Family Problem|0|||
131935352|NCT00522379|475050191|FG004|Overall Study|Family Problem|0|||
131935353|NCT00522379|475050187|FG000|Overall Study|Site Closed|0|||
131935354|NCT00522379|475050188|FG001|Overall Study|Site Closed|0|||
131935355|NCT00522379|475050189|FG002|Overall Study|Site Closed|0|||
131935356|NCT00522379|475050190|FG003|Overall Study|Site Closed|1|||
131935357|NCT00522379|475050191|FG004|Overall Study|Site Closed|0|||
131935358|NCT00522379|475050187|FG000|Overall Study|Subject Withdrawal|0|||
131935359|NCT00522379|475050188|FG001|Overall Study|Subject Withdrawal|0|||
131935360|NCT00522379|475050189|FG002|Overall Study|Subject Withdrawal|0|||
131935361|NCT00522379|475050190|FG003|Overall Study|Subject Withdrawal|1|||
131935362|NCT00522379|475050191|FG004|Overall Study|Subject Withdrawal|0|||
131935363|NCT03238196|475050192|FG000|Overall Study|Adverse Event|3|||
131935364|NCT03238196|475050193|FG001|Overall Study|Adverse Event|0|||
131935365|NCT03238196|475050194|FG002|Overall Study|Adverse Event|2|||
131935366|NCT03238196|475050195|FG003|Overall Study|Adverse Event|2|||
131935367|NCT03238196|475050192|FG000|Overall Study|Withdrawal by Subject|4|||
131935368|NCT03238196|475050193|FG001|Overall Study|Withdrawal by Subject|1|||
131935369|NCT03238196|475050194|FG002|Overall Study|Withdrawal by Subject|1|||
131935370|NCT03238196|475050195|FG003|Overall Study|Withdrawal by Subject|0|||
131935371|NCT03238196|475050192|FG000|Overall Study|Disease progression|14|||
131935372|NCT03238196|475050193|FG001|Overall Study|Disease progression|2|||
131935373|NCT03238196|475050194|FG002|Overall Study|Disease progression|3|||
131935374|NCT03238196|475050195|FG003|Overall Study|Disease progression|2|||
131935375|NCT03238196|475050192|FG000|Overall Study|Still on treatment|1|||
131935376|NCT03238196|475050193|FG001|Overall Study|Still on treatment|0|||
131935377|NCT03238196|475050194|FG002|Overall Study|Still on treatment|0|||
131935378|NCT03238196|475050195|FG003|Overall Study|Still on treatment|0|||
131935379|NCT04562090|475050196|FG000|Overall Study|Withdrawal by Subject|3|||
131935380|NCT04562090|475050197|FG001|Overall Study|Withdrawal by Subject|4|||
131935381|NCT04562090|475050196|FG000|Overall Study|Protocol Violation|2|||
131454447|NCT00048074|473293318|FG002|Overall Study|Lost to Follow-up|6|||
131454448|NCT00048074|473293316|FG000|Overall Study|Withdrawal by Subject|28|||
131454449|NCT00048074|473293317|FG001|Overall Study|Withdrawal by Subject|30|||
131454450|NCT00048074|473293318|FG002|Overall Study|Withdrawal by Subject|35|||
131454451|NCT00048074|473293316|FG000|Overall Study|Protocol Violation|1|||
131454452|NCT00048074|473293317|FG001|Overall Study|Protocol Violation|3|||
131454453|NCT00048074|473293318|FG002|Overall Study|Protocol Violation|0|||
131454454|NCT00048074|473293316|FG000|Overall Study|Study participation was terminated|0|||
131454455|NCT00048074|473293317|FG001|Overall Study|Study participation was terminated|1|||
131454456|NCT00048074|473293318|FG002|Overall Study|Study participation was terminated|0|||
131454457|NCT00048074|473293316|FG000|Overall Study|Husband ill|0|||
131454458|NCT00048074|473293317|FG001|Overall Study|Husband ill|1|||
131935382|NCT04562090|475050197|FG001|Overall Study|Protocol Violation|0|||
131935383|NCT04562090|475050196|FG000|Overall Study|Lack of Efficacy|0|||
131935384|NCT04562090|475050197|FG001|Overall Study|Lack of Efficacy|1|||
131935385|NCT04562090|475050196|FG000|Overall Study|Adverse Event|1|||
131454459|NCT00048074|473293318|FG002|Overall Study|Husband ill|0|||
131454460|NCT00048074|473293316|FG000|Overall Study|Poor compliance|0|||
131454461|NCT00048074|473293317|FG001|Overall Study|Poor compliance|1|||
131454462|NCT00048074|473293318|FG002|Overall Study|Poor compliance|0|||
131454463|NCT00048074|473293316|FG000|Overall Study|Out of station|0|||
131454464|NCT00048074|473293317|FG001|Overall Study|Out of station|1|||
131454465|NCT00048074|473293318|FG002|Overall Study|Out of station|1|||
131454466|NCT00048074|473293316|FG000|Overall Study|Social reasons|1|||
131454467|NCT00048074|473293317|FG001|Overall Study|Social reasons|0|||
131454468|NCT00048074|473293318|FG002|Overall Study|Social reasons|0|||
131454469|NCT02873377|473293319|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
131454470|NCT02873377|473293320|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
131454471|NCT02873377|473293319|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
131454472|NCT02873377|473293320|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
131454473|NCT02624986|473293322|FG000|Overall Study|Death|0|||
131454474|NCT02624986|473293323|FG001|Overall Study|Death|1|||
131454475|NCT02624986|473293324|FG002|Overall Study|Death|2|||
131454476|NCT02624986|473293325|FG003|Overall Study|Death|2|||
131454477|NCT02624986|473293326|FG004|Overall Study|Death|2|||
131454478|NCT02624986|473293327|FG005|Overall Study|Death|0|||
131454479|NCT02624986|473293328|FG006|Overall Study|Death|0|||
131454480|NCT02624986|473293329|FG007|Overall Study|Death|1|||
131454481|NCT02624986|473293322|FG000|Overall Study|Study Terminated by Sponsor|1|||
131454482|NCT02624986|473293323|FG001|Overall Study|Study Terminated by Sponsor|1|||
131454483|NCT02624986|473293324|FG002|Overall Study|Study Terminated by Sponsor|0|||
131454484|NCT02624986|473293325|FG003|Overall Study|Study Terminated by Sponsor|1|||
131454485|NCT02624986|473293326|FG004|Overall Study|Study Terminated by Sponsor|2|||
131454486|NCT02624986|473293327|FG005|Overall Study|Study Terminated by Sponsor|2|||
131454487|NCT02624986|473293328|FG006|Overall Study|Study Terminated by Sponsor|4|||
131454488|NCT02624986|473293329|FG007|Overall Study|Study Terminated by Sponsor|3|||
131454489|NCT02624986|473293322|FG000|Overall Study|Progressive Disease|0|||
131454490|NCT02624986|473293323|FG001|Overall Study|Progressive Disease|1|||
131454491|NCT02624986|473293324|FG002|Overall Study|Progressive Disease|0|||
131454492|NCT02624986|473293325|FG003|Overall Study|Progressive Disease|0|||
131454493|NCT02624986|473293326|FG004|Overall Study|Progressive Disease|0|||
131454494|NCT02624986|473293327|FG005|Overall Study|Progressive Disease|0|||
131454495|NCT02624986|473293328|FG006|Overall Study|Progressive Disease|0|||
131454496|NCT02624986|473293329|FG007|Overall Study|Progressive Disease|0|||
131454497|NCT02624986|473293322|FG000|Overall Study|Protocol Violation|1|||
131454498|NCT02624986|473293323|FG001|Overall Study|Protocol Violation|0|||
131454499|NCT02624986|473293324|FG002|Overall Study|Protocol Violation|0|||
131454500|NCT02624986|473293325|FG003|Overall Study|Protocol Violation|0|||
131454501|NCT02624986|473293326|FG004|Overall Study|Protocol Violation|0|||
131454502|NCT02624986|473293327|FG005|Overall Study|Protocol Violation|0|||
131454503|NCT02624986|473293328|FG006|Overall Study|Protocol Violation|0|||
131454504|NCT02624986|473293329|FG007|Overall Study|Protocol Violation|0|||
131454505|NCT02624986|473293322|FG000|Overall Study|Withdrawal by Subject|0|||
131454506|NCT02624986|473293323|FG001|Overall Study|Withdrawal by Subject|0|||
131935386|NCT04562090|475050197|FG001|Overall Study|Adverse Event|4|||
131454507|NCT02624986|473293324|FG002|Overall Study|Withdrawal by Subject|0|||
131454508|NCT02624986|473293325|FG003|Overall Study|Withdrawal by Subject|0|||
131454509|NCT02624986|473293326|FG004|Overall Study|Withdrawal by Subject|0|||
131454510|NCT02624986|473293327|FG005|Overall Study|Withdrawal by Subject|0|||
131935387|NCT04562090|475050196|FG000|Overall Study|Miscellaneous|0|||
131454511|NCT02624986|473293328|FG006|Overall Study|Withdrawal by Subject|0|||
131454512|NCT02624986|473293329|FG007|Overall Study|Withdrawal by Subject|1|||
131454513|NCT00740857|473293330|FG000|Overall Study|Withdrawal by Subject|1|||
131454514|NCT00740857|473293331|FG001|Overall Study|Withdrawal by Subject|0|||
131454515|NCT00740857|473293332|FG002|Overall Study|Withdrawal by Subject|0|||
131454516|NCT03532451|473293336|FG000|Overall Study|Withdrawal by Subject|0|||
131454517|NCT03532451|473293337|FG001|Overall Study|Withdrawal by Subject|1|||
131454518|NCT03532451|473293336|FG000|Overall Study|Did not undergo surgery|1|||
131454519|NCT03532451|473293337|FG001|Overall Study|Did not undergo surgery|1|||
131412207|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
131412208|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
131412209|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
131412210|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
131412211|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
131412212|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
131412213|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
131412214|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
131935388|NCT04562090|475050197|FG001|Overall Study|Miscellaneous|3|||
131935389|NCT03633058|475050198|FG000|Overall Study|Adverse Event|0|||
131935390|NCT03633058|475050199|FG001|Overall Study|Adverse Event|0|||
131935391|NCT03633058|475050200|FG002|Overall Study|Adverse Event|1|||
131935392|NCT03633058|475050201|FG003|Overall Study|Adverse Event|0|||
131412215|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
131412216|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
131412217|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
131412218|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
131412219|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
131412220|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
131412221|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
131412222|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
131412223|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
131412224|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
131412225|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
131412226|NCT02008357|473132035|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
131412227|NCT02008357|473132036|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
131412228|NCT02008357|473132035|FG000|Open-label Extension Period|Adverse Event|8|||
131412229|NCT02008357|473132036|FG001|Open-label Extension Period|Adverse Event|7|||
131412230|NCT02008357|473132035|FG000|Open-label Extension Period|Death|7|||
131412231|NCT02008357|473132036|FG001|Open-label Extension Period|Death|4|||
131412232|NCT02008357|473132035|FG000|Open-label Extension Period|Lack of Efficacy|9|||
131412233|NCT02008357|473132036|FG001|Open-label Extension Period|Lack of Efficacy|5|||
131412234|NCT02008357|473132035|FG000|Open-label Extension Period|Lost to Follow-up|2|||
131412235|NCT02008357|473132036|FG001|Open-label Extension Period|Lost to Follow-up|2|||
131412236|NCT02008357|473132035|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
131412237|NCT02008357|473132036|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
131412238|NCT02008357|473132035|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
131412239|NCT02008357|473132036|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
131412240|NCT02008357|473132035|FG000|Open-label Extension Period|Safety Risk|2|||
131412241|NCT02008357|473132036|FG001|Open-label Extension Period|Safety Risk|1|||
131412242|NCT02008357|473132035|FG000|Open-label Extension Period|Non-Compliance|0|||
131412243|NCT02008357|473132036|FG001|Open-label Extension Period|Non-Compliance|1|||
131412244|NCT02008357|473132035|FG000|Open-label Extension Period|Investigator Recommendation|0|||
131412245|NCT02008357|473132036|FG001|Open-label Extension Period|Investigator Recommendation|1|||
131412246|NCT02008357|473132035|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
131412247|NCT02008357|473132036|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
131412248|NCT02008357|473132035|FG000|Open-label Extension Period|Coordinating Center Request|2|||
131412249|NCT02008357|473132036|FG001|Open-label Extension Period|Coordinating Center Request|4|||
131412250|NCT02008357|473132035|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
131454520|NCT00806819|473293338|FG000|Overall Study|progressive disease (modified RECIST )|217|||
131454521|NCT00806819|473293339|FG001|Overall Study|progressive disease (modified RECIST )|216|||
131454522|NCT00806819|473293338|FG000|Overall Study|Worsening or AE of underlying disease|18|||
131935393|NCT03312543|475050202|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
131935394|NCT03312543|475050203|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
131935395|NCT03312543|475050202|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
131935396|NCT03312543|475050203|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
131935397|NCT03312543|475050202|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
131935398|NCT03312543|475050203|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
131935399|NCT03312543|475050202|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
131935400|NCT03312543|475050203|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
131935401|NCT03312543|475050202|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
131935402|NCT03312543|475050203|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
131935403|NCT03312543|475050202|FG000|Regression (Week 12 to Week 24)|Death|0|||
131935404|NCT03312543|475050203|FG001|Regression (Week 12 to Week 24)|Death|1|||
131935405|NCT04134936|475050204|FG000|Overall Study|Adverse Event|3|||
131935406|NCT04134936|475050205|FG001|Overall Study|Adverse Event|2|||
131935407|NCT04134936|475050204|FG000|Overall Study|Withdrawal by Subject|2|||
131935408|NCT04134936|475050205|FG001|Overall Study|Withdrawal by Subject|3|||
131935409|NCT04134936|475050204|FG000|Overall Study|Physician Decision|0|||
131935410|NCT04134936|475050205|FG001|Overall Study|Physician Decision|1|||
131935411|NCT04134936|475050204|FG000|Overall Study|Progressive disease, joined another trial|1|||
131935412|NCT04134936|475050205|FG001|Overall Study|Progressive disease, joined another trial|0|||
131935413|NCT04134936|475050204|FG000|Overall Study|Progressive disease|1|||
131935414|NCT04134936|475050205|FG001|Overall Study|Progressive disease|0|||
131935415|NCT02420717|475050206|FG000|Overall Study|Did not receive all study medication|2|||
131935416|NCT02420717|475050207|FG001|Overall Study|Did not receive all study medication|0|||
131935417|NCT02420717|475050208|FG002|Overall Study|Did not receive all study medication|0|||
131935418|NCT04144517|475050211|FG000|Overall Study|Physician Decision|0|||
131935419|NCT04144517|475050212|FG001|Overall Study|Physician Decision|1|||
131935420|NCT04144517|475050211|FG000|Overall Study|Other|2|||
131935421|NCT04144517|475050212|FG001|Overall Study|Other|2|||
131935422|NCT04144517|475050211|FG000|Overall Study|Death|6|||
131935423|NCT04144517|475050212|FG001|Overall Study|Death|3|||
131935424|NCT00835367|475050218|FG000|Washout|Adverse Event|2|||
131935425|NCT00835367|475050219|FG001|Washout|Adverse Event|0|||
131935426|NCT00835367|475050218|FG000|Washout|Withdrawal by Subject|1|||
131935427|NCT00835367|475050219|FG001|Washout|Withdrawal by Subject|0|||
131935428|NCT00835367|475050218|FG000|Second Intervention|Adverse Event|1|||
131935429|NCT00835367|475050219|FG001|Second Intervention|Adverse Event|1|||
131935430|NCT02495883|475050220|FG000|Overall Study|Excessive head motion|1|||
131935431|NCT02495883|475050221|FG001|Overall Study|Excessive head motion|0|||
131935432|NCT00936936|475052575|FG000|Overall Study|Adverse Event|7|||
131935433|NCT00936936|475052576|FG001|Overall Study|Adverse Event|1|||
131935434|NCT00936936|475052575|FG000|Overall Study|Disease Progression|2|||
131935435|NCT00936936|475052576|FG001|Overall Study|Disease Progression|2|||
131935436|NCT00936936|475052575|FG000|Overall Study|Unrelated|3|||
131935437|NCT00936936|475052576|FG001|Overall Study|Unrelated|1|||
131935438|NCT00734032|475052577|FG000|Overall Study|Adverse Event|0|||
131935439|NCT00734032|475052578|FG001|Overall Study|Adverse Event|1|||
131935440|NCT00734032|475052579|FG002|Overall Study|Adverse Event|0|||
131935441|NCT00734032|475052580|FG003|Overall Study|Adverse Event|0|||
131935442|NCT00133705|475052581|FG000|Overall Study|Withdrawal by Subject|2|||
131935443|NCT00133705|475052582|FG001|Overall Study|Withdrawal by Subject|3|||
131935444|NCT01992757|475052584|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
131935445|NCT00856557|475052585|FG000|Overall Study|No patients with contextual flags|12|||
131935446|NCT00856557|475052586|FG001|Overall Study|No patients with contextual flags|16|||
131935447|NCT04770285|475052591|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
131935448|NCT04770285|475052592|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
131935449|NCT04770285|475052591|FG000|Overall Study|Lack of Efficacy|0|||
131935450|NCT04770285|475052592|FG001|Overall Study|Lack of Efficacy|1|||
131935451|NCT04770285|475052591|FG000|Overall Study|Lost to Follow-up|11|||
131935452|NCT04770285|475052592|FG001|Overall Study|Lost to Follow-up|8|||
131935453|NCT04770285|475052591|FG000|Overall Study|Protocol Deviation|6|||
131935454|NCT04770285|475052592|FG001|Overall Study|Protocol Deviation|6|||
131935455|NCT04770285|475052591|FG000|Overall Study|Technical Problem|0|||
131935456|NCT04770285|475052592|FG001|Overall Study|Technical Problem|1|||
131935457|NCT04770285|475052591|FG000|Overall Study|Withdrawal by Subject|9|||
131935458|NCT04770285|475052592|FG001|Overall Study|Withdrawal by Subject|8|||
131935459|NCT04770285|475052591|FG000|Overall Study|Reason Not Specified|0|||
131935460|NCT04770285|475052592|FG001|Overall Study|Reason Not Specified|1|||
131935461|NCT03766399|475052593|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935462|NCT03766399|475052594|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935463|NCT03766399|475052595|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935464|NCT03766399|475052596|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935465|NCT03766399|475052597|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935466|NCT03766399|475052598|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935467|NCT03766399|475052599|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935468|NCT03766399|475052600|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935469|NCT03766399|475052601|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935470|NCT03766399|475052602|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935471|NCT03766399|475052603|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935472|NCT03766399|475052604|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935473|NCT03766399|475052605|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935474|NCT03766399|475052606|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
131935475|NCT03766399|475052607|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935476|NCT03766399|475052608|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935477|NCT03766399|475052609|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131935478|NCT03766399|475052610|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
131454523|NCT00806819|473293339|FG001|Overall Study|Worsening or AE of underlying disease|25|||
131454524|NCT00806819|473293338|FG000|Overall Study|Other AE|38|||
131412251|NCT02008357|473132036|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
131412252|NCT02008357|473132035|FG000|Open-label Extension Period|Study Ended|20|||
131412253|NCT02008357|473132036|FG001|Open-label Extension Period|Study Ended|25|||
131412254|NCT02008357|473132035|FG000|Open-label Extension Period|Personal Reasons|0|||
131412255|NCT02008357|473132036|FG001|Open-label Extension Period|Personal Reasons|1|||
131412256|NCT02008357|473132035|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
131412257|NCT02008357|473132036|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
131412258|NCT02008357|473132035|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
131412259|NCT02008357|473132036|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
131412260|NCT02008357|473132035|FG000|Open-label Extension Period|Other|2|||
131412261|NCT02008357|473132036|FG001|Open-label Extension Period|Other|0|||
131412262|NCT00787202|473132037|FG000|Overall Study|Adverse Event|3|||
131412263|NCT00787202|473132038|FG001|Overall Study|Adverse Event|2|||
131412264|NCT00787202|473132039|FG002|Overall Study|Adverse Event|0|||
131412265|NCT00787202|473132040|FG003|Overall Study|Adverse Event|0|||
131412266|NCT00787202|473132041|FG004|Overall Study|Adverse Event|2|||
131412267|NCT00787202|473132037|FG000|Overall Study|Lack of Efficacy|5|||
131412268|NCT00787202|473132038|FG001|Overall Study|Lack of Efficacy|6|||
131412269|NCT00787202|473132039|FG002|Overall Study|Lack of Efficacy|5|||
131412270|NCT00787202|473132040|FG003|Overall Study|Lack of Efficacy|2|||
131412271|NCT00787202|473132041|FG004|Overall Study|Lack of Efficacy|1|||
131412272|NCT00787202|473132037|FG000|Overall Study|Lost to Follow-up|1|||
131412273|NCT00787202|473132038|FG001|Overall Study|Lost to Follow-up|0|||
131412274|NCT00787202|473132039|FG002|Overall Study|Lost to Follow-up|0|||
131412275|NCT00787202|473132040|FG003|Overall Study|Lost to Follow-up|0|||
131412276|NCT00787202|473132041|FG004|Overall Study|Lost to Follow-up|0|||
131412277|NCT00787202|473132037|FG000|Overall Study|Withdrawal by Subject|2|||
131412278|NCT00787202|473132038|FG001|Overall Study|Withdrawal by Subject|2|||
131412279|NCT00787202|473132039|FG002|Overall Study|Withdrawal by Subject|2|||
131412280|NCT00787202|473132040|FG003|Overall Study|Withdrawal by Subject|0|||
131412281|NCT00787202|473132041|FG004|Overall Study|Withdrawal by Subject|0|||
131412282|NCT00787202|473132037|FG000|Overall Study|Protocol Violation|2|||
131412283|NCT00787202|473132038|FG001|Overall Study|Protocol Violation|1|||
131412284|NCT00787202|473132039|FG002|Overall Study|Protocol Violation|0|||
131412285|NCT00787202|473132040|FG003|Overall Study|Protocol Violation|0|||
131412286|NCT00787202|473132041|FG004|Overall Study|Protocol Violation|1|||
131412287|NCT00787202|473132037|FG000|Overall Study|Randomized, not treated|1|||
131412288|NCT00787202|473132038|FG001|Overall Study|Randomized, not treated|0|||
131412289|NCT00787202|473132039|FG002|Overall Study|Randomized, not treated|0|||
131412290|NCT00787202|473132040|FG003|Overall Study|Randomized, not treated|0|||
131412291|NCT00787202|473132041|FG004|Overall Study|Randomized, not treated|0|||
131412292|NCT01442064|473132042|FG000|Overall Study|Adverse Event|2|||
131412293|NCT01442064|473132043|FG001|Overall Study|Adverse Event|2|||
131412294|NCT01442064|473132044|FG002|Overall Study|Adverse Event|2|||
131412295|NCT01442064|473132045|FG003|Overall Study|Adverse Event|1|||
131412296|NCT01442064|473132046|FG004|Overall Study|Adverse Event|2|||
131412297|NCT01442064|473132047|FG005|Overall Study|Adverse Event|0|||
131412298|NCT01442064|473132042|FG000|Overall Study|Death|0|||
131412299|NCT01442064|473132043|FG001|Overall Study|Death|1|||
131412300|NCT01442064|473132044|FG002|Overall Study|Death|3|||
131412301|NCT01442064|473132045|FG003|Overall Study|Death|3|||
131412302|NCT01442064|473132046|FG004|Overall Study|Death|1|||
131412303|NCT01442064|473132047|FG005|Overall Study|Death|3|||
131412304|NCT01442064|473132042|FG000|Overall Study|Lost to Follow-up|5|||
131412305|NCT01442064|473132043|FG001|Overall Study|Lost to Follow-up|5|||
131412306|NCT01442064|473132044|FG002|Overall Study|Lost to Follow-up|1|||
131412307|NCT01442064|473132045|FG003|Overall Study|Lost to Follow-up|1|||
131454525|NCT00806819|473293339|FG001|Overall Study|Other AE|40|||
131935479|NCT03895372|475052613|FG000|Investigational Treatment Period|Adverse Event|1|||
131412308|NCT01442064|473132046|FG004|Overall Study|Lost to Follow-up|3|||
131454526|NCT00806819|473293338|FG000|Overall Study|Protocol Violation|9|||
131454527|NCT00806819|473293339|FG001|Overall Study|Protocol Violation|4|||
131935480|NCT03895372|475052614|FG001|Investigational Treatment Period|Adverse Event|0|||
131412309|NCT01442064|473132047|FG005|Overall Study|Lost to Follow-up|3|||
131412310|NCT01442064|473132042|FG000|Overall Study|Physician Decision|1|||
131412311|NCT01442064|473132043|FG001|Overall Study|Physician Decision|1|||
131412312|NCT01442064|473132044|FG002|Overall Study|Physician Decision|2|||
131412313|NCT01442064|473132045|FG003|Overall Study|Physician Decision|3|||
131412314|NCT01442064|473132046|FG004|Overall Study|Physician Decision|3|||
131412315|NCT01442064|473132047|FG005|Overall Study|Physician Decision|1|||
131412316|NCT01442064|473132042|FG000|Overall Study|Withdrawal by Subject|6|||
131412317|NCT01442064|473132043|FG001|Overall Study|Withdrawal by Subject|3|||
131412318|NCT01442064|473132044|FG002|Overall Study|Withdrawal by Subject|2|||
131412319|NCT01442064|473132045|FG003|Overall Study|Withdrawal by Subject|2|||
131412320|NCT01442064|473132046|FG004|Overall Study|Withdrawal by Subject|2|||
131454528|NCT00806819|473293338|FG000|Overall Study|Lost to Follow-up|1|||
131935481|NCT03895372|475052615|FG002|Investigational Treatment Period|Adverse Event|0|||
131935482|NCT03895372|475052616|FG003|Investigational Treatment Period|Adverse Event|0|||
131935483|NCT03895372|475052617|FG004|Investigational Treatment Period|Adverse Event|0|||
131935484|NCT03895372|475052618|FG005|Investigational Treatment Period|Adverse Event|0|||
131935485|NCT03895372|475052619|FG006|Investigational Treatment Period|Adverse Event|4|||
131935486|NCT03895372|475052620|FG007|Investigational Treatment Period|Adverse Event|3|||
131935487|NCT03895372|475052613|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
131935488|NCT03895372|475052614|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
131935489|NCT03895372|475052615|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
131935490|NCT03895372|475052616|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
131935491|NCT03895372|475052617|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
131935492|NCT03895372|475052618|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
131935493|NCT03895372|475052619|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
131935494|NCT03895372|475052620|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
131935495|NCT03895372|475052613|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
131935496|NCT03895372|475052614|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
131935497|NCT03895372|475052615|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
131935498|NCT03895372|475052616|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
131935499|NCT03895372|475052617|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
131935500|NCT03895372|475052618|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
131935501|NCT03895372|475052619|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
131935502|NCT03895372|475052620|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
131935503|NCT03895372|475052613|FG000|Investigational Treatment Period|Other|0|||
131935504|NCT03895372|475052614|FG001|Investigational Treatment Period|Other|0|||
131935505|NCT03895372|475052615|FG002|Investigational Treatment Period|Other|0|||
131935506|NCT03895372|475052616|FG003|Investigational Treatment Period|Other|0|||
131935507|NCT03895372|475052617|FG004|Investigational Treatment Period|Other|0|||
131935508|NCT03895372|475052618|FG005|Investigational Treatment Period|Other|1|||
131935509|NCT03895372|475052619|FG006|Investigational Treatment Period|Other|0|||
131935510|NCT03895372|475052620|FG007|Investigational Treatment Period|Other|2|||
131935511|NCT03895372|475052613|FG000|Investigational Treatment Period|Protocol Violation|0|||
131935512|NCT03895372|475052614|FG001|Investigational Treatment Period|Protocol Violation|0|||
131935513|NCT03895372|475052615|FG002|Investigational Treatment Period|Protocol Violation|0|||
131935514|NCT03895372|475052616|FG003|Investigational Treatment Period|Protocol Violation|1|||
131935515|NCT03895372|475052617|FG004|Investigational Treatment Period|Protocol Violation|0|||
131935516|NCT03895372|475052618|FG005|Investigational Treatment Period|Protocol Violation|0|||
131935517|NCT03895372|475052619|FG006|Investigational Treatment Period|Protocol Violation|0|||
131935518|NCT03895372|475052620|FG007|Investigational Treatment Period|Protocol Violation|0|||
131935519|NCT03895372|475052613|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
131935520|NCT03895372|475052614|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
131935521|NCT03895372|475052615|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
131935522|NCT03895372|475052616|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
131935523|NCT03895372|475052617|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
131935524|NCT03895372|475052618|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
131935525|NCT03895372|475052619|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
131935526|NCT03895372|475052620|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
131935527|NCT03895372|475052613|FG000|Extension Treatment Period|Adverse Event|0|||
131935528|NCT03895372|475052614|FG001|Extension Treatment Period|Adverse Event|1|||
131935529|NCT03895372|475052615|FG002|Extension Treatment Period|Adverse Event|0|||
131935530|NCT03895372|475052616|FG003|Extension Treatment Period|Adverse Event|1|||
131935531|NCT03895372|475052617|FG004|Extension Treatment Period|Adverse Event|0|||
131935532|NCT03895372|475052618|FG005|Extension Treatment Period|Adverse Event|0|||
131935533|NCT03895372|475052619|FG006|Extension Treatment Period|Adverse Event|3|||
131935534|NCT03895372|475052620|FG007|Extension Treatment Period|Adverse Event|3|||
131935535|NCT03895372|475052613|FG000|Extension Treatment Period|Other|1|||
131935536|NCT03895372|475052614|FG001|Extension Treatment Period|Other|3|||
131935537|NCT03895372|475052615|FG002|Extension Treatment Period|Other|0|||
131935538|NCT03895372|475052616|FG003|Extension Treatment Period|Other|0|||
131935539|NCT03895372|475052617|FG004|Extension Treatment Period|Other|1|||
131935540|NCT03895372|475052618|FG005|Extension Treatment Period|Other|0|||
131935541|NCT03895372|475052619|FG006|Extension Treatment Period|Other|0|||
131935542|NCT03895372|475052620|FG007|Extension Treatment Period|Other|2|||
131935543|NCT03895372|475052613|FG000|Extension Treatment Period|Pregnancy|0|||
131935544|NCT03895372|475052614|FG001|Extension Treatment Period|Pregnancy|0|||
131454529|NCT00806819|473293339|FG001|Overall Study|Lost to Follow-up|0|||
131935545|NCT03895372|475052615|FG002|Extension Treatment Period|Pregnancy|0|||
131935546|NCT03895372|475052616|FG003|Extension Treatment Period|Pregnancy|0|||
131935547|NCT03895372|475052617|FG004|Extension Treatment Period|Pregnancy|1|||
131935548|NCT03895372|475052618|FG005|Extension Treatment Period|Pregnancy|0|||
131935549|NCT03895372|475052619|FG006|Extension Treatment Period|Pregnancy|0|||
131935550|NCT03895372|475052620|FG007|Extension Treatment Period|Pregnancy|0|||
131412321|NCT01442064|473132047|FG005|Overall Study|Withdrawal by Subject|1|||
131412322|NCT01442064|473132042|FG000|Overall Study|Sponsor decision|82|||
131412323|NCT01442064|473132043|FG001|Overall Study|Sponsor decision|88|||
131412324|NCT01442064|473132044|FG002|Overall Study|Sponsor decision|92|||
131412325|NCT01442064|473132045|FG003|Overall Study|Sponsor decision|88|||
131412326|NCT01442064|473132046|FG004|Overall Study|Sponsor decision|95|||
131412327|NCT01442064|473132047|FG005|Overall Study|Sponsor decision|87|||
131412328|NCT01442064|473132042|FG000|Overall Study|Subject non-compliance|0|||
131412329|NCT01442064|473132043|FG001|Overall Study|Subject non-compliance|0|||
131412330|NCT01442064|473132044|FG002|Overall Study|Subject non-compliance|0|||
131412331|NCT01442064|473132045|FG003|Overall Study|Subject non-compliance|0|||
131412332|NCT01442064|473132046|FG004|Overall Study|Subject non-compliance|0|||
131412333|NCT01442064|473132047|FG005|Overall Study|Subject non-compliance|2|||
131412334|NCT01442064|473132042|FG000|Overall Study|Condition mandated other intervention|1|||
131412335|NCT01442064|473132043|FG001|Overall Study|Condition mandated other intervention|1|||
131412336|NCT01442064|473132044|FG002|Overall Study|Condition mandated other intervention|2|||
131412337|NCT01442064|473132045|FG003|Overall Study|Condition mandated other intervention|0|||
131412338|NCT01442064|473132046|FG004|Overall Study|Condition mandated other intervention|0|||
131412339|NCT01442064|473132047|FG005|Overall Study|Condition mandated other intervention|2|||
131412340|NCT02312219|473132048|FG000|Overall Study|Withdrawal by Subject|1|||
131412341|NCT02312219|473132049|FG001|Overall Study|Withdrawal by Subject|2|||
131412342|NCT02312219|473132048|FG000|Overall Study|could not schedule imaging in time|0|||
131412343|NCT02312219|473132049|FG001|Overall Study|could not schedule imaging in time|2|||
131412344|NCT02312219|473132048|FG000|Overall Study|Other|0|||
131412345|NCT02312219|473132049|FG001|Overall Study|Other|1|||
131412346|NCT02312219|473132048|FG000|Overall Study|Not randomized. Ineligible|0|||
131412347|NCT02312219|473132049|FG001|Overall Study|Not randomized. Ineligible|1|||
131412348|NCT01269385|473132050|FG000|Overall Study|Adverse Event|1|||
131412349|NCT01269385|473132051|FG001|Overall Study|Adverse Event|1|||
131412350|NCT01269385|473132052|FG002|Overall Study|Adverse Event|0|||
131412351|NCT01269385|473132053|FG003|Overall Study|Adverse Event|0|||
131412352|NCT04941807|473132056|FG000|Overall Study|Lost to Follow-up|1|||
131412353|NCT04941807|473132057|FG001|Overall Study|Lost to Follow-up|1|||
131412354|NCT03553498|473132058|FG000|Overall Study|Missing primary outcome|1|||
131412355|NCT03553498|473132059|FG001|Overall Study|Missing primary outcome|2|||
131412356|NCT01100567|473132060|FG000|Overall Study|Withdrawal by Subject|5|||
131412357|NCT01100567|473132061|FG001|Overall Study|Withdrawal by Subject|8|||
131412358|NCT01100567|473132060|FG000|Overall Study|Early Hospital Discharge|6|||
131412359|NCT01100567|473132061|FG001|Overall Study|Early Hospital Discharge|4|||
131412360|NCT01100567|473132060|FG000|Overall Study|Lost to Follow-up|1|||
131412361|NCT01100567|473132061|FG001|Overall Study|Lost to Follow-up|2|||
131412362|NCT01100567|473132060|FG000|Overall Study|Physician Decision|0|||
131412363|NCT01100567|473132061|FG001|Overall Study|Physician Decision|1|||
131412364|NCT01100567|473132060|FG000|Overall Study|Deemed ineligible after consent|0|||
131412365|NCT01100567|473132061|FG001|Overall Study|Deemed ineligible after consent|1|||
131412366|NCT02741570|473132062|FG000|Pre-Treatment Period|Other reasons|0|||
131412367|NCT02741570|473132063|FG001|Pre-Treatment Period|Other reasons|3|||
131412368|NCT02741570|473132062|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
131412369|NCT02741570|473132063|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
131412370|NCT02741570|473132062|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
131412371|NCT02741570|473132063|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
131412372|NCT02741570|473132062|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
131412373|NCT02741570|473132063|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
131412374|NCT02741570|473132062|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
131412375|NCT02741570|473132063|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
131412376|NCT02741570|473132062|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
131412377|NCT02741570|473132063|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
131412378|NCT02741570|473132062|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
131412379|NCT02741570|473132063|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131412380|NCT02741570|473132062|FG000|Pre-Treatment Period|Death|0|||
131412381|NCT02741570|473132063|FG001|Pre-Treatment Period|Death|1|||
131412382|NCT02741570|473132062|FG000|Pre-Treatment Period|Disease progression|0|||
131412383|NCT02741570|473132063|FG001|Pre-Treatment Period|Disease progression|1|||
131412384|NCT02741570|473132062|FG000|Treatment Period|Other reasons|47|||
131412385|NCT02741570|473132063|FG001|Treatment Period|Other reasons|12|||
131412386|NCT02741570|473132062|FG000|Treatment Period|Poor/non-compliance|0|||
131412387|NCT02741570|473132063|FG001|Treatment Period|Poor/non-compliance|2|||
131412388|NCT02741570|473132062|FG000|Treatment Period|Maximum clinical benefit|4|||
131412389|NCT02741570|473132063|FG001|Treatment Period|Maximum clinical benefit|6|||
131412390|NCT02741570|473132062|FG000|Treatment Period|Lost to Follow-up|1|||
131412391|NCT02741570|473132063|FG001|Treatment Period|Lost to Follow-up|3|||
131412392|NCT02741570|473132062|FG000|Treatment Period|Participant withdrew consent|9|||
131412393|NCT02741570|473132063|FG001|Treatment Period|Participant withdrew consent|13|||
131412394|NCT02741570|473132062|FG000|Treatment Period|Participant request to discontinue treatment|8|||
131935551|NCT03895372|475052613|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
131935552|NCT03895372|475052614|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
131935553|NCT03895372|475052615|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
131935554|NCT03895372|475052616|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
131935555|NCT03895372|475052617|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
131935556|NCT03895372|475052618|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
131935557|NCT03895372|475052619|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
131935558|NCT03895372|475052620|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
131935559|NCT00023595|475052625|FG000|5 Year Follow up|Lost to Follow-up|2|||
131935560|NCT00023595|475052626|FG001|5 Year Follow up|Lost to Follow-up|2|||
131935561|NCT00023595|475052627|FG002|5 Year Follow up|Lost to Follow-up|1|||
131935562|NCT00023595|475052628|FG003|5 Year Follow up|Lost to Follow-up|7|||
131935563|NCT00023595|475052629|FG004|5 Year Follow up|Lost to Follow-up|3|||
131935564|NCT00023595|475052625|FG000|10 Year Follow up|Lost to Follow-up|12|||
131935565|NCT00023595|475052626|FG001|10 Year Follow up|Lost to Follow-up|10|||
131935566|NCT00023595|475052627|FG002|10 Year Follow up|Lost to Follow-up|3|||
131935567|NCT00023595|475052628|FG003|10 Year Follow up|Lost to Follow-up|0|||
131935568|NCT00023595|475052629|FG004|10 Year Follow up|Lost to Follow-up|0|||
131935569|NCT01472185|475052630|FG000|Overall Study|Randomized but Not Treated|0|||
131935570|NCT01472185|475052631|FG001|Overall Study|Randomized but Not Treated|1|||
131935571|NCT01472185|475052630|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
131935572|NCT01472185|475052631|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
131935573|NCT01472185|475052630|FG000|Overall Study|Hyperglycemia|5|||
131935574|NCT01472185|475052631|FG001|Overall Study|Hyperglycemia|2|||
131935575|NCT01472185|475052630|FG000|Overall Study|Investigator's Discretion|3|||
131935576|NCT01472185|475052631|FG001|Overall Study|Investigator's Discretion|1|||
131935577|NCT01472185|475052630|FG000|Overall Study|Lost to Follow-up|4|||
131935578|NCT01472185|475052631|FG001|Overall Study|Lost to Follow-up|1|||
131935579|NCT01472185|475052630|FG000|Overall Study|Protocol Violation|5|||
131935580|NCT01472185|475052631|FG001|Overall Study|Protocol Violation|1|||
131935581|NCT01472185|475052630|FG000|Overall Study|Subject Noncompliance|8|||
131935582|NCT01472185|475052631|FG001|Overall Study|Subject Noncompliance|15|||
131935583|NCT01472185|475052630|FG000|Overall Study|Subject Withdrew Consent|6|||
131935584|NCT01472185|475052631|FG001|Overall Study|Subject Withdrew Consent|3|||
131935585|NCT02457065|475052632|FG000|Overall Study|Lost to Follow-up|9|||
131935586|NCT02457065|475052633|FG001|Overall Study|Lost to Follow-up|11|||
131935587|NCT01554904|475052634|FG000|Overall Study|Withdrawal by Subject|3|||
131935588|NCT01554904|475052634|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
131935589|NCT01605097|475052636|FG000|Overall Study|Protocol Violation|1|||
131935590|NCT02038647|475052637|FG000|Overall Study|Progressive Disease|50|||
131935591|NCT02038647|475052638|FG001|Overall Study|Progressive Disease|59|||
131935592|NCT02038647|475052637|FG000|Overall Study|Adverse Event|18|||
131935593|NCT02038647|475052638|FG001|Overall Study|Adverse Event|10|||
131935594|NCT02038647|475052637|FG000|Overall Study|Symptomatic Deterioration|7|||
131935595|NCT02038647|475052638|FG001|Overall Study|Symptomatic Deterioration|7|||
131935596|NCT02038647|475052637|FG000|Overall Study|Withdrawal by Subject|5|||
131935597|NCT02038647|475052638|FG001|Overall Study|Withdrawal by Subject|2|||
131935598|NCT02038647|475052637|FG000|Overall Study|Not Reported|0|||
131935599|NCT02038647|475052638|FG001|Overall Study|Not Reported|1|||
131935600|NCT02038647|475052637|FG000|Overall Study|Ongoing at Datacut|9|||
131935601|NCT02038647|475052638|FG001|Overall Study|Ongoing at Datacut|10|||
131935602|NCT05205616|475052639|FG000|Overall Study|Lost to Follow-up|4|||
131935603|NCT05205616|475052640|FG001|Overall Study|Lost to Follow-up|4|||
131935604|NCT00663260|475052648|FG000|Overall Study|Lack of Efficacy|2|||
131935605|NCT00663260|475052649|FG001|Overall Study|Lack of Efficacy|0|||
131935606|NCT00663260|475052650|FG002|Overall Study|Lack of Efficacy|0|||
131935607|NCT00663260|475052648|FG000|Overall Study|Adverse Event|12|||
131935608|NCT00663260|475052649|FG001|Overall Study|Adverse Event|7|||
131935609|NCT00663260|475052650|FG002|Overall Study|Adverse Event|6|||
131935610|NCT00663260|475052648|FG000|Overall Study|Withdrawal by Subject|3|||
131935611|NCT00663260|475052649|FG001|Overall Study|Withdrawal by Subject|1|||
131935612|NCT00663260|475052650|FG002|Overall Study|Withdrawal by Subject|6|||
131935613|NCT00663260|475052648|FG000|Overall Study|Death|1|||
131935614|NCT00663260|475052649|FG001|Overall Study|Death|0|||
131935615|NCT00663260|475052650|FG002|Overall Study|Death|1|||
131935616|NCT00663260|475052648|FG000|Overall Study|Lost to Follow-up|0|||
131935617|NCT00663260|475052649|FG001|Overall Study|Lost to Follow-up|1|||
131935618|NCT00663260|475052650|FG002|Overall Study|Lost to Follow-up|0|||
131935619|NCT00663260|475052648|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
131935620|NCT00663260|475052649|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
131935621|NCT00663260|475052650|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
131935622|NCT03620981|475052662|FG000|Overall Study|Adverse Event|14|||
131935623|NCT03620981|475052663|FG001|Overall Study|Adverse Event|38|||
131935624|NCT03620981|475052664|FG002|Overall Study|Adverse Event|25|||
131935625|NCT03620981|475052662|FG000|Overall Study|Lack of Efficacy|2|||
131935626|NCT03620981|475052663|FG001|Overall Study|Lack of Efficacy|1|||
131935627|NCT03620981|475052664|FG002|Overall Study|Lack of Efficacy|1|||
131454530|NCT00806819|473293338|FG000|Overall Study|Withdrawal by Subject|32|||
131454531|NCT00806819|473293339|FG001|Overall Study|Withdrawal by Subject|29|||
131454532|NCT00806819|473293338|FG000|Overall Study|Not treated|6|||
131935628|NCT03620981|475052662|FG000|Overall Study|Physician Decision|7|||
131935629|NCT03620981|475052663|FG001|Overall Study|Physician Decision|4|||
131935630|NCT03620981|475052664|FG002|Overall Study|Physician Decision|4|||
131935631|NCT03620981|475052662|FG000|Overall Study|Protocol Violation|1|||
131935632|NCT03620981|475052663|FG001|Overall Study|Protocol Violation|2|||
131935633|NCT03620981|475052664|FG002|Overall Study|Protocol Violation|1|||
131935634|NCT03620981|475052662|FG000|Overall Study|Withdrawal by Legal Representative|2|||
131935635|NCT03620981|475052663|FG001|Overall Study|Withdrawal by Legal Representative|1|||
131935636|NCT03620981|475052664|FG002|Overall Study|Withdrawal by Legal Representative|1|||
131935637|NCT03620981|475052662|FG000|Overall Study|Withdrawal by Care Giver|2|||
131935638|NCT03620981|475052663|FG001|Overall Study|Withdrawal by Care Giver|0|||
131935639|NCT03620981|475052664|FG002|Overall Study|Withdrawal by Care Giver|1|||
131935640|NCT03620981|475052662|FG000|Overall Study|Non-compliance with Study Drug|1|||
131935641|NCT03620981|475052663|FG001|Overall Study|Non-compliance with Study Drug|1|||
131935642|NCT03620981|475052664|FG002|Overall Study|Non-compliance with Study Drug|0|||
131935643|NCT02607722|475052667|FG000|Overall Study|No data reliability|1|||
131935644|NCT02607722|475052667|FG000|Overall Study|no patient visit|18|||
131935645|NCT02607722|475052667|FG000|Overall Study|missing info in CRF|13|||
131935646|NCT02607722|475052667|FG000|Overall Study|Withdrawal by Subject|616|||
131935647|NCT02607722|475052667|FG000|Overall Study|Lost to Follow-up|312|||
131935648|NCT02607722|475052667|FG000|Overall Study|Improved|22|||
131935649|NCT02607722|475052667|FG000|Overall Study|Lack of Efficacy|316|||
131935650|NCT02607722|475052667|FG000|Overall Study|Adverse Event|2553|||
131935651|NCT02607722|475052667|FG000|Overall Study|Not treated|1|||
131935652|NCT02607722|475052667|FG000|Overall Study|No CRF collected|138|||
131935653|NCT02607722|475052667|FG000|Overall Study|without CRF|4225|||
131935654|NCT02607722|475052667|FG000|Overall Study|Physician Decision|367|||
131935655|NCT04347538|475052668|FG000|Overall Study|Lost to Follow-up|4|||
131935656|NCT04347538|475052669|FG001|Overall Study|Lost to Follow-up|5|||
131935657|NCT04347538|475052670|FG002|Overall Study|Lost to Follow-up|7|||
131935658|NCT02135133|475052671|FG000|Overall Study|Adverse Event|10|||
131935659|NCT02135133|475052671|FG000|Overall Study|regulatory mandate|5|||
131935660|NCT05081843|475052672|FG000|Overall Study|Lost to Follow-up|135|||
131935661|NCT05081843|475052673|FG001|Overall Study|Lost to Follow-up|145|||
131935662|NCT02303821|475052674|FG000|Overall Study|Withdrawal by Subject|0|||
131935663|NCT02303821|475052675|FG001|Overall Study|Withdrawal by Subject|0|||
131935664|NCT02303821|475052676|FG002|Overall Study|Withdrawal by Subject|0|||
131935665|NCT02303821|475052677|FG003|Overall Study|Withdrawal by Subject|0|||
131935666|NCT02303821|475052678|FG004|Overall Study|Withdrawal by Subject|0|||
131935667|NCT02303821|475052679|FG005|Overall Study|Withdrawal by Subject|0|||
131935668|NCT02303821|475052680|FG006|Overall Study|Withdrawal by Subject|0|||
131935669|NCT02303821|475052681|FG007|Overall Study|Withdrawal by Subject|2|||
131935670|NCT02303821|475052674|FG000|Overall Study|Death|0|||
131935671|NCT02303821|475052675|FG001|Overall Study|Death|2|||
131935672|NCT02303821|475052676|FG002|Overall Study|Death|0|||
131935673|NCT02303821|475052677|FG003|Overall Study|Death|0|||
131935674|NCT02303821|475052678|FG004|Overall Study|Death|0|||
131935675|NCT02303821|475052679|FG005|Overall Study|Death|3|||
131935676|NCT02303821|475052680|FG006|Overall Study|Death|41|||
131935677|NCT02303821|475052681|FG007|Overall Study|Death|29|||
131935678|NCT02303821|475052674|FG000|Overall Study|Lost to Follow-up|0|||
131935679|NCT02303821|475052675|FG001|Overall Study|Lost to Follow-up|0|||
131935680|NCT02303821|475052676|FG002|Overall Study|Lost to Follow-up|0|||
131935681|NCT02303821|475052677|FG003|Overall Study|Lost to Follow-up|0|||
131935682|NCT02303821|475052678|FG004|Overall Study|Lost to Follow-up|0|||
131935683|NCT02303821|475052679|FG005|Overall Study|Lost to Follow-up|0|||
131935684|NCT02303821|475052680|FG006|Overall Study|Lost to Follow-up|1|||
131454533|NCT00806819|473293339|FG001|Overall Study|Not treated|3|||
131454534|NCT00806819|473293338|FG000|Overall Study|Reasons other than stated above|25|||
131935685|NCT02303821|475052681|FG007|Overall Study|Lost to Follow-up|0|||
131935686|NCT02303821|475052674|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935687|NCT02303821|475052675|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935688|NCT02303821|475052676|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935689|NCT02303821|475052677|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935690|NCT02303821|475052678|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935691|NCT02303821|475052679|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935692|NCT02303821|475052680|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
131935693|NCT02303821|475052681|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
131935694|NCT02303821|475052674|FG000|Overall Study|Decision by sponsor|0|||
131935695|NCT02303821|475052675|FG001|Overall Study|Decision by sponsor|0|||
131454535|NCT00806819|473293339|FG001|Overall Study|Reasons other than stated above|41|||
131935696|NCT02303821|475052676|FG002|Overall Study|Decision by sponsor|0|||
131935697|NCT02303821|475052677|FG003|Overall Study|Decision by sponsor|0|||
131935698|NCT02303821|475052678|FG004|Overall Study|Decision by sponsor|0|||
131935699|NCT02303821|475052679|FG005|Overall Study|Decision by sponsor|1|||
131935700|NCT02303821|475052680|FG006|Overall Study|Decision by sponsor|0|||
131935701|NCT02303821|475052681|FG007|Overall Study|Decision by sponsor|0|||
131935702|NCT02303821|475052674|FG000|Overall Study|Protocol-specified criteria|0|||
131935703|NCT02303821|475052675|FG001|Overall Study|Protocol-specified criteria|1|||
131935704|NCT02303821|475052676|FG002|Overall Study|Protocol-specified criteria|0|||
131935705|NCT02303821|475052677|FG003|Overall Study|Protocol-specified criteria|0|||
131935706|NCT02303821|475052678|FG004|Overall Study|Protocol-specified criteria|0|||
131935707|NCT02303821|475052679|FG005|Overall Study|Protocol-specified criteria|1|||
131935708|NCT02303821|475052680|FG006|Overall Study|Protocol-specified criteria|0|||
131935709|NCT02303821|475052681|FG007|Overall Study|Protocol-specified criteria|0|||
131935710|NCT04938427|475052684|FG000|Overall Study|Adverse Event|5|||
131935711|NCT04938427|475052685|FG001|Overall Study|Adverse Event|19|||
131935712|NCT04938427|475052684|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131935713|NCT04938427|475052685|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131935714|NCT04938427|475052684|FG000|Overall Study|Withdrawal by Subject|1|||
131935715|NCT04938427|475052685|FG001|Overall Study|Withdrawal by Subject|0|||
131935716|NCT04938427|475052684|FG000|Overall Study|Reason Not Specified|2|||
131935717|NCT04938427|475052685|FG001|Overall Study|Reason Not Specified|1|||
131935718|NCT04507269|475052694|FG000|Overall Study|Withdrawal by Subject|1|||
131935719|NCT04507269|475052695|FG001|Overall Study|Withdrawal by Subject|1|||
131935720|NCT04507269|475052696|FG002|Overall Study|Withdrawal by Subject|0|||
131935721|NCT04507269|475052697|FG003|Overall Study|Withdrawal by Subject|0|||
131935722|NCT04507269|475052698|FG004|Overall Study|Withdrawal by Subject|0|||
131935723|NCT04507269|475052699|FG005|Overall Study|Withdrawal by Subject|0|||
131935724|NCT04507269|475052694|FG000|Overall Study|Lost to Follow-up|0|||
131935725|NCT04507269|475052695|FG001|Overall Study|Lost to Follow-up|0|||
131935726|NCT04507269|475052696|FG002|Overall Study|Lost to Follow-up|0|||
131935727|NCT04507269|475052697|FG003|Overall Study|Lost to Follow-up|0|||
131935728|NCT04507269|475052698|FG004|Overall Study|Lost to Follow-up|1|||
131935729|NCT04507269|475052699|FG005|Overall Study|Lost to Follow-up|0|||
131935730|NCT05852340|475052700|FG000|Period 5|Not completing the meal|0|||
131935731|NCT05852340|475052701|FG001|Period 5|Not completing the meal|1|||
131935732|NCT05852340|475052702|FG002|Period 5|Not completing the meal|0|||
131935733|NCT05852340|475052703|FG003|Period 5|Not completing the meal|0|||
131935734|NCT05852340|475052700|FG000|Period 5|Adverse Event|0|||
131935735|NCT05852340|475052701|FG001|Period 5|Adverse Event|0|||
131935736|NCT05852340|475052702|FG002|Period 5|Adverse Event|0|||
131935737|NCT05852340|475052703|FG003|Period 5|Adverse Event|1|||
131935738|NCT00071032|475052707|FG000|Overall Study|Lost to Follow-up|1|||
131935739|NCT00071032|475052708|FG001|Overall Study|Lost to Follow-up|1|||
131935740|NCT00071032|475052707|FG000|Overall Study|Withdrawal by Subject|8|||
131935741|NCT00071032|475052708|FG001|Overall Study|Withdrawal by Subject|6|||
131935742|NCT00071032|475052707|FG000|Overall Study|Missing Primary Outcome|0|||
131935743|NCT00071032|475052708|FG001|Overall Study|Missing Primary Outcome|1|||
131935744|NCT05852470|475052709|FG000|Overall Study|Withdrawal by Subject|0|||
131935745|NCT05852470|475052710|FG001|Overall Study|Withdrawal by Subject|1|||
131935746|NCT06071104|475052711|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
131935747|NCT03518060|475052712|FG000|Overall Study|Death|1|||
131935748|NCT03518060|475052712|FG000|Overall Study|Poor adherence|1|||
131935749|NCT03518060|475052712|FG000|Overall Study|Withdrawal of informed consent|2|||
131935750|NCT03518060|475052712|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
131935751|NCT03518060|475052712|FG000|Overall Study|Physician Decision|7|||
131935752|NCT03518060|475052712|FG000|Overall Study|Adverse drug reactions|23|||
131935753|NCT03518060|475052712|FG000|Overall Study|Withdrawal by Subject|25|||
131935754|NCT03518060|475052712|FG000|Overall Study|Lost to Follow-up|13|||
131412395|NCT02741570|473132063|FG001|Treatment Period|Participant request to discontinue treatment|23|||
131412396|NCT02741570|473132062|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
131412397|NCT02741570|473132063|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
131412398|NCT02741570|473132062|FG000|Treatment Period|Death|9|||
131935755|NCT01903863|475052714|FG000|Overall Study|Physician Decision|2|||
131935756|NCT01903863|475052715|FG001|Overall Study|Physician Decision|0|||
131935757|NCT04727151|475052724|FG000|Overall Study|Death|0|||
131935758|NCT04727151|475052725|FG001|Overall Study|Death|0|||
131935759|NCT04727151|475052726|FG002|Overall Study|Death|0|||
131935760|NCT04727151|475052727|FG003|Overall Study|Death|0|||
131935761|NCT04727151|475052728|FG004|Overall Study|Death|3|||
131935762|NCT04727151|475052724|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
131935763|NCT04727151|475052725|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
131412399|NCT02741570|473132063|FG001|Treatment Period|Death|7|||
131935764|NCT04727151|475052726|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
131935765|NCT04727151|475052727|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
131935766|NCT04727151|475052728|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
131935767|NCT01969058|475052729|FG000|Overall Study|Withdrawal by Subject|2|||
131935768|NCT01969058|475052730|FG001|Overall Study|Withdrawal by Subject|0|||
131412400|NCT02741570|473132062|FG000|Treatment Period|Study drug toxicity|55|||
131935769|NCT01969058|475052729|FG000|Overall Study|Adverse Event|1|||
131935770|NCT01969058|475052730|FG001|Overall Study|Adverse Event|0|||
131935771|NCT01346592|475052732|FG000|Overall Study|Lost to Follow-up|62|||
131935772|NCT01346592|475052733|FG001|Overall Study|Lost to Follow-up|29|||
131935773|NCT01346592|475052734|FG002|Overall Study|Lost to Follow-up|29|||
131935774|NCT01346592|475052732|FG000|Overall Study|Protocol Violation|2|||
131935775|NCT01346592|475052733|FG001|Overall Study|Protocol Violation|1|||
131935776|NCT01346592|475052734|FG002|Overall Study|Protocol Violation|0|||
131935777|NCT01346592|475052732|FG000|Overall Study|Death|1|||
131935778|NCT01346592|475052733|FG001|Overall Study|Death|3|||
131935779|NCT01346592|475052734|FG002|Overall Study|Death|4|||
131935780|NCT01346592|475052732|FG000|Overall Study|Adverse Event|0|||
131935781|NCT01346592|475052733|FG001|Overall Study|Adverse Event|1|||
131935782|NCT01346592|475052734|FG002|Overall Study|Adverse Event|0|||
131935783|NCT01346592|475052732|FG000|Overall Study|Withdrawal by Subject|77|||
131935784|NCT01346592|475052733|FG001|Overall Study|Withdrawal by Subject|51|||
131935785|NCT01346592|475052734|FG002|Overall Study|Withdrawal by Subject|38|||
131935786|NCT01346592|475052732|FG000|Overall Study|Inappropriate enrollment|3|||
131935787|NCT01346592|475052733|FG001|Overall Study|Inappropriate enrollment|1|||
131935788|NCT01346592|475052734|FG002|Overall Study|Inappropriate enrollment|1|||
131935789|NCT01346592|475052732|FG000|Overall Study|Administrative reason|1|||
131935790|NCT01346592|475052733|FG001|Overall Study|Administrative reason|0|||
131935791|NCT01346592|475052734|FG002|Overall Study|Administrative reason|0|||
131935792|NCT01346592|475052732|FG000|Overall Study|Unable to Classify|7|||
131935793|NCT01346592|475052733|FG001|Overall Study|Unable to Classify|3|||
131935794|NCT01346592|475052734|FG002|Overall Study|Unable to Classify|6|||
131935795|NCT02679274|475052735|FG000|Overall Study|Withdrawal by Subject|1|||
131935796|NCT02679274|475052736|FG001|Overall Study|Withdrawal by Subject|0|||
131935797|NCT03537508|475052741|FG000|Overall Study|Adverse Event|2|||
131935798|NCT03537508|475052742|FG001|Overall Study|Adverse Event|1|||
131935799|NCT03537508|475052741|FG000|Overall Study|Protocol Violation|65|||
131935800|NCT03537508|475052742|FG001|Overall Study|Protocol Violation|48|||
131935801|NCT03537508|475052741|FG000|Overall Study|Lost to Follow-up|86|||
131935802|NCT03537508|475052742|FG001|Overall Study|Lost to Follow-up|60|||
131935803|NCT03537508|475052741|FG000|Overall Study|Withdrawal by parent/guardian|263|||
131935804|NCT03537508|475052742|FG001|Overall Study|Withdrawal by parent/guardian|149|||
131935805|NCT01972659|475052755|FG000|Overall Study|Protocol Violation|2|||
131935806|NCT01972659|475052756|FG001|Overall Study|Protocol Violation|2|||
131935807|NCT01972659|475052755|FG000|Overall Study|problems realted to acceleromyograph|2|||
131935808|NCT01972659|475052756|FG001|Overall Study|problems realted to acceleromyograph|1|||
131935809|NCT00835172|475052778|FG000|Washout|Protocol Violation|0|||
131935810|NCT00835172|475052779|FG001|Washout|Protocol Violation|1|||
131935811|NCT02776735|475052782|FG000|Overall Study|Adverse Event|0|||
131935812|NCT02776735|475052783|FG001|Overall Study|Adverse Event|0|||
131935813|NCT02776735|475052784|FG002|Overall Study|Adverse Event|0|||
131935814|NCT02776735|475052785|FG003|Overall Study|Adverse Event|1|||
131935815|NCT02776735|475052786|FG004|Overall Study|Adverse Event|0|||
131935816|NCT02776735|475052787|FG005|Overall Study|Adverse Event|1|||
131935817|NCT02776735|475052782|FG000|Overall Study|Lost to Follow-up|0|||
131935818|NCT02776735|475052783|FG001|Overall Study|Lost to Follow-up|0|||
131935819|NCT02776735|475052784|FG002|Overall Study|Lost to Follow-up|0|||
131935820|NCT02776735|475052785|FG003|Overall Study|Lost to Follow-up|1|||
131935821|NCT02776735|475052786|FG004|Overall Study|Lost to Follow-up|0|||
131935822|NCT02776735|475052787|FG005|Overall Study|Lost to Follow-up|0|||
131935823|NCT02776735|475052782|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131935824|NCT02776735|475052783|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131935825|NCT02776735|475052784|FG002|Overall Study|Withdrawal by parent/guardian|2|||
131935826|NCT02776735|475052785|FG003|Overall Study|Withdrawal by parent/guardian|2|||
131935827|NCT02776735|475052786|FG004|Overall Study|Withdrawal by parent/guardian|0|||
131935828|NCT02776735|475052787|FG005|Overall Study|Withdrawal by parent/guardian|0|||
131935829|NCT02776735|475052782|FG000|Overall Study|Withdrawal by Subject|1|||
131935830|NCT02776735|475052783|FG001|Overall Study|Withdrawal by Subject|0|||
131935831|NCT02776735|475052784|FG002|Overall Study|Withdrawal by Subject|0|||
131935832|NCT02776735|475052785|FG003|Overall Study|Withdrawal by Subject|0|||
131935833|NCT02776735|475052786|FG004|Overall Study|Withdrawal by Subject|0|||
131935834|NCT02776735|475052787|FG005|Overall Study|Withdrawal by Subject|1|||
131935835|NCT02776735|475052782|FG000|Overall Study|Other|0|||
131935836|NCT02776735|475052783|FG001|Overall Study|Other|0|||
131935837|NCT02776735|475052784|FG002|Overall Study|Other|3|||
131935838|NCT02776735|475052785|FG003|Overall Study|Other|0|||
131935839|NCT02776735|475052786|FG004|Overall Study|Other|0|||
131935840|NCT02776735|475052787|FG005|Overall Study|Other|0|||
131935841|NCT00791648|475054072|FG000|Overall Study|Physician Decision|0|||
131935842|NCT00791648|475054073|FG001|Overall Study|Physician Decision|1|||
131935843|NCT00791648|475054072|FG000|Overall Study|Withdrawal by Subject|0|||
131935844|NCT00791648|475054073|FG001|Overall Study|Withdrawal by Subject|1|||
131935845|NCT00462826|475054074|FG000|Overall Study|Ineligible - second primary|1|||
131935846|NCT00462826|475054074|FG000|Overall Study|Ineligible - wrong cell type|1|||
131935847|NCT00462826|475054074|FG000|Overall Study|Ineligible - wrong primary|2|||
131935848|NCT00462826|475054074|FG000|Overall Study|Never treated|1|||
131935849|NCT04976777|475054075|FG000|Overall Study|COVID-19 Infection|1|||
131935850|NCT04976777|475054076|FG001|Overall Study|COVID-19 Infection|0|||
131935851|NCT01397253|475054077|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
131935852|NCT01397253|475054078|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
131935853|NCT00363298|475054081|FG000|First Study Week|Lack of Efficacy|6|||
131935854|NCT00363298|475054082|FG001|First Study Week|Lack of Efficacy|5|||
131935855|NCT00363298|475054081|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
131935856|NCT00363298|475054082|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
131935857|NCT01892189|475054083|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
131935858|NCT01892189|475054084|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
131935859|NCT01892189|475054085|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
131935860|NCT01892189|475054086|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
131935861|NCT01892189|475054087|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
131935862|NCT01892189|475054088|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
131935863|NCT01892189|475054089|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
131935864|NCT01892189|475054090|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
131935865|NCT01892189|475054091|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
131935866|NCT01892189|475054083|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131412401|NCT02741570|473132063|FG001|Treatment Period|Study drug toxicity|47|||
131412402|NCT02741570|473132062|FG000|Treatment Period|Disease progression|294|||
131412403|NCT02741570|473132063|FG001|Treatment Period|Disease progression|301|||
131412404|NCT02741570|473132062|FG000|Treatment Period|Administrative reason by sponsor|0|||
131412405|NCT02741570|473132063|FG001|Treatment Period|Administrative reason by sponsor|1|||
131412406|NCT00160199|473132066|FG000|Overall Study|Adverse Event|5|||
131412407|NCT00160199|473132067|FG001|Overall Study|Adverse Event|14|||
131412408|NCT00160199|473132066|FG000|Overall Study|Lack of Efficacy|0|||
131412409|NCT00160199|473132067|FG001|Overall Study|Lack of Efficacy|1|||
131412410|NCT00160199|473132066|FG000|Overall Study|Lost to Follow-up|7|||
131412411|NCT00160199|473132067|FG001|Overall Study|Lost to Follow-up|7|||
131412412|NCT00160199|473132066|FG000|Overall Study|Withdrawal by Subject|4|||
131412413|NCT00160199|473132067|FG001|Overall Study|Withdrawal by Subject|6|||
131412414|NCT00160199|473132066|FG000|Overall Study|Administrative|0|||
131412415|NCT00160199|473132067|FG001|Overall Study|Administrative|1|||
131412416|NCT00160199|473132066|FG000|Overall Study|Protocol Violation|8|||
131412417|NCT00160199|473132067|FG001|Overall Study|Protocol Violation|8|||
131412418|NCT03352453|473132068|FG000|Overall Study|Miscellaneous Reasons|1|||
131412419|NCT03352453|473132069|FG001|Overall Study|Miscellaneous Reasons|2|||
131412420|NCT03352453|473132068|FG000|Overall Study|Lack of Efficacy|1|||
131412421|NCT03352453|473132069|FG001|Overall Study|Lack of Efficacy|0|||
131412422|NCT03352453|473132068|FG000|Overall Study|Withdrawal by Subject|8|||
131412423|NCT03352453|473132069|FG001|Overall Study|Withdrawal by Subject|14|||
131412424|NCT03352453|473132068|FG000|Overall Study|Study Terminated by Sponsor|2|||
131412425|NCT03352453|473132069|FG001|Overall Study|Study Terminated by Sponsor|1|||
131412426|NCT03352453|473132068|FG000|Overall Study|Protocol Deviation|1|||
131412427|NCT03352453|473132069|FG001|Overall Study|Protocol Deviation|0|||
131412428|NCT03352453|473132068|FG000|Overall Study|Lost to Follow-up|7|||
131412429|NCT03352453|473132069|FG001|Overall Study|Lost to Follow-up|6|||
131412430|NCT03352453|473132068|FG000|Overall Study|Adverse Event|2|||
131412431|NCT03352453|473132069|FG001|Overall Study|Adverse Event|9|||
131412432|NCT00546260|473132072|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
131412433|NCT00546260|473132073|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
131412434|NCT01241760|473132076|FG000|Overall Study|Adverse Event|1|||
131412435|NCT01241760|473132077|FG001|Overall Study|Adverse Event|0|||
131412436|NCT01241760|473132076|FG000|Overall Study|Lost to Follow-up|18|||
131412437|NCT01241760|473132077|FG001|Overall Study|Lost to Follow-up|22|||
131412438|NCT01241760|473132076|FG000|Overall Study|Withdrawal by Subject|13|||
131412439|NCT01241760|473132077|FG001|Overall Study|Withdrawal by Subject|13|||
131412440|NCT01241760|473132076|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
131412441|NCT01241760|473132077|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
131412442|NCT01241760|473132076|FG000|Overall Study|Other|1|||
131412443|NCT01241760|473132077|FG001|Overall Study|Other|1|||
131412444|NCT00514020|473132078|FG000|Overall Study|Adverse Event|6|||
131412445|NCT00514020|473132078|FG000|Overall Study|Withdrawal by Subject|3|||
131412446|NCT00514020|473132078|FG000|Overall Study|Physician Decision|1|||
131412447|NCT00514020|473132078|FG000|Overall Study|disease progression|9|||
131412448|NCT00514020|473132078|FG000|Overall Study|other complicating disease|2|||
131412449|NCT00514020|473132078|FG000|Overall Study|patient went to radiation treatment|1|||
131412450|NCT00514020|473132078|FG000|Overall Study|"patients moved to the no tx group"|6|||
131412451|NCT03089944|473132079|FG000|Overall Study|Lost to Follow-up|8|||
131412452|NCT03089944|473132079|FG000|Overall Study|Withdrew Consent|2|||
131412453|NCT03089944|473132079|FG000|Overall Study|Adverse Event|1|||
131412454|NCT03089944|473132079|FG000|Overall Study|Other|1|||
131412455|NCT01636713|473132080|FG000|Overall Study|Adverse Event|16|||
131935867|NCT01892189|475054084|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131935868|NCT01892189|475054085|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
131935869|NCT01892189|475054086|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131454536|NCT00912197|473293344|FG000|Overall Study|Withdrawal by Subject|3|||
131454537|NCT00912197|473293345|FG001|Overall Study|Withdrawal by Subject|3|||
131454538|NCT01287741|473293352|FG000|Overall Study|Withdrawal by Subject|35|||
131935870|NCT01892189|475054087|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131935871|NCT01892189|475054088|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131935872|NCT01892189|475054089|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131935873|NCT01892189|475054090|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131935874|NCT01892189|475054091|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131935875|NCT01892189|475054083|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935876|NCT01892189|475054084|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935877|NCT01892189|475054085|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935878|NCT01892189|475054086|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935879|NCT01892189|475054087|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935880|NCT01892189|475054088|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
131935881|NCT01892189|475054089|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935882|NCT01892189|475054090|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935883|NCT01892189|475054091|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
131935884|NCT00633126|475054094|FG000|Overall Study|Did not receive full dose|1|||
131935885|NCT04484857|475054100|FG000|Overall Study|Adverse Event|2|||
131935886|NCT04484857|475054100|FG000|Overall Study|Death|10|||
131935887|NCT04484857|475054100|FG000|Overall Study|Withdrawal by Subject|3|||
131935888|NCT04484857|475054100|FG000|Overall Study|Transferred/Relocation|5|||
131935889|NCT04484857|475054100|FG000|Overall Study|Kidney Transplant|7|||
131935890|NCT04484857|475054100|FG000|Overall Study|Other than specified|4|||
131935891|NCT04484857|475054100|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
131935892|NCT03847519|475054103|FG000|Overall Study|Death|5|||
131935893|NCT03847519|475054104|FG001|Overall Study|Death|8|||
131935894|NCT03847519|475054105|FG002|Overall Study|Death|1|||
131935895|NCT03847519|475054103|FG000|Overall Study|Lost to Follow-up|1|||
131935896|NCT03847519|475054104|FG001|Overall Study|Lost to Follow-up|2|||
131935897|NCT03847519|475054105|FG002|Overall Study|Lost to Follow-up|0|||
131935898|NCT03847519|475054103|FG000|Overall Study|Study Terminated by Sponsor|0|||
131935899|NCT03847519|475054104|FG001|Overall Study|Study Terminated by Sponsor|3|||
131935900|NCT03847519|475054105|FG002|Overall Study|Study Terminated by Sponsor|2|||
131935901|NCT00725985|475054108|FG000|ITP- Treatment Disposition|Adverse Event|20|||
131935902|NCT00725985|475054109|FG001|ITP- Treatment Disposition|Adverse Event|10|||
131935903|NCT00725985|475054110|FG002|ITP- Treatment Disposition|Adverse Event|5|||
131935904|NCT00725985|475054111|FG003|ITP- Treatment Disposition|Adverse Event|0|||
131935905|NCT00725985|475054112|FG004|ITP- Treatment Disposition|Adverse Event|0|||
131935906|NCT00725985|475054113|FG005|ITP- Treatment Disposition|Adverse Event|0|||
131935907|NCT00725985|475054114|FG006|ITP- Treatment Disposition|Adverse Event|0|||
131935908|NCT00725985|475054115|FG007|ITP- Treatment Disposition|Adverse Event|0|||
131935909|NCT00725985|475054116|FG008|ITP- Treatment Disposition|Adverse Event|0|||
131935910|NCT00725985|475054117|FG009|ITP- Treatment Disposition|Adverse Event|0|||
131935911|NCT00725985|475054118|FG010|ITP- Treatment Disposition|Adverse Event|0|||
131935912|NCT00725985|475054119|FG011|ITP- Treatment Disposition|Adverse Event|0|||
131935913|NCT00725985|475054108|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935914|NCT00725985|475054109|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935915|NCT00725985|475054110|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
131935916|NCT00725985|475054111|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935917|NCT00725985|475054112|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935918|NCT00725985|475054113|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935919|NCT00725985|475054114|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935920|NCT00725985|475054115|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935921|NCT00725985|475054116|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935922|NCT00725985|475054117|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935923|NCT00725985|475054118|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935924|NCT00725985|475054119|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
131935925|NCT00725985|475054108|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
131935926|NCT00725985|475054109|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
131935927|NCT00725985|475054110|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
131935928|NCT00725985|475054111|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
131935929|NCT00725985|475054112|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
131935930|NCT00725985|475054113|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
131935931|NCT00725985|475054114|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
131935932|NCT00725985|475054115|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
131935933|NCT00725985|475054116|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
131935934|NCT00725985|475054117|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
131935935|NCT00725985|475054118|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
131935936|NCT00725985|475054119|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
131935937|NCT00725985|475054108|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
131454539|NCT01287741|473293353|FG001|Overall Study|Withdrawal by Subject|38|||
131454540|NCT01287741|473293352|FG000|Overall Study|Protocol Violation|2|||
131454541|NCT01287741|473293353|FG001|Overall Study|Protocol Violation|0|||
131454542|NCT01287741|473293352|FG000|Overall Study|Physician Decision|15|||
131454543|NCT01287741|473293353|FG001|Overall Study|Physician Decision|23|||
131454544|NCT01287741|473293352|FG000|Overall Study|Non-compliance|8|||
131454545|NCT01287741|473293353|FG001|Overall Study|Non-compliance|6|||
131454546|NCT01287741|473293352|FG000|Overall Study|Lost to Follow-up|10|||
131454547|NCT01287741|473293353|FG001|Overall Study|Lost to Follow-up|8|||
131454548|NCT01287741|473293352|FG000|Overall Study|Death|32|||
131454549|NCT01287741|473293353|FG001|Overall Study|Death|44|||
131454550|NCT01287741|473293352|FG000|Overall Study|Adverse Event|4|||
131935938|NCT00725985|475054109|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
131935939|NCT00725985|475054110|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
131935940|NCT00725985|475054111|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
131935941|NCT00725985|475054112|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
131935942|NCT00725985|475054113|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
131935943|NCT00725985|475054114|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
131935944|NCT00725985|475054115|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
131935945|NCT00725985|475054116|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
131935946|NCT00725985|475054117|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
131935947|NCT00725985|475054118|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
131935948|NCT00725985|475054119|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
131935949|NCT00725985|475054108|FG000|ITP- Treatment Disposition|Other|50|||
131935950|NCT00725985|475054109|FG001|ITP- Treatment Disposition|Other|38|||
131935951|NCT00725985|475054110|FG002|ITP- Treatment Disposition|Other|24|||
131935952|NCT00725985|475054111|FG003|ITP- Treatment Disposition|Other|0|||
131935953|NCT00725985|475054112|FG004|ITP- Treatment Disposition|Other|0|||
131935954|NCT00725985|475054113|FG005|ITP- Treatment Disposition|Other|0|||
131935955|NCT00725985|475054114|FG006|ITP- Treatment Disposition|Other|0|||
131935956|NCT00725985|475054115|FG007|ITP- Treatment Disposition|Other|0|||
131935957|NCT00725985|475054116|FG008|ITP- Treatment Disposition|Other|0|||
131935958|NCT00725985|475054117|FG009|ITP- Treatment Disposition|Other|0|||
131935959|NCT00725985|475054118|FG010|ITP- Treatment Disposition|Other|0|||
131935960|NCT00725985|475054119|FG011|ITP- Treatment Disposition|Other|0|||
131935961|NCT00725985|475054108|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935962|NCT00725985|475054109|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935963|NCT00725985|475054110|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935964|NCT00725985|475054111|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
131935965|NCT00725985|475054112|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
131935966|NCT00725985|475054113|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
131935967|NCT00725985|475054114|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935968|NCT00725985|475054115|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935969|NCT00725985|475054116|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935970|NCT00725985|475054117|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935971|NCT00725985|475054118|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935972|NCT00725985|475054119|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
131935973|NCT00725985|475054108|FG000|OLMP (Up to 96 Weeks)|Death|0|||
131935974|NCT00725985|475054109|FG001|OLMP (Up to 96 Weeks)|Death|0|||
131935975|NCT00725985|475054110|FG002|OLMP (Up to 96 Weeks)|Death|0|||
131935976|NCT00725985|475054111|FG003|OLMP (Up to 96 Weeks)|Death|0|||
131935977|NCT00725985|475054112|FG004|OLMP (Up to 96 Weeks)|Death|1|||
131935978|NCT00725985|475054113|FG005|OLMP (Up to 96 Weeks)|Death|0|||
131935979|NCT00725985|475054114|FG006|OLMP (Up to 96 Weeks)|Death|0|||
131935980|NCT00725985|475054115|FG007|OLMP (Up to 96 Weeks)|Death|0|||
131935981|NCT00725985|475054116|FG008|OLMP (Up to 96 Weeks)|Death|0|||
131935982|NCT00725985|475054117|FG009|OLMP (Up to 96 Weeks)|Death|0|||
131935983|NCT00725985|475054118|FG010|OLMP (Up to 96 Weeks)|Death|0|||
131935984|NCT00725985|475054119|FG011|OLMP (Up to 96 Weeks)|Death|0|||
131935985|NCT00725985|475054108|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935986|NCT00725985|475054109|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131454551|NCT01287741|473293353|FG001|Overall Study|Adverse Event|6|||
131454552|NCT01287741|473293352|FG000|Overall Study|Study terminated by Sponsor|307|||
131454553|NCT01287741|473293353|FG001|Overall Study|Study terminated by Sponsor|315|||
131454554|NCT01287741|473293352|FG000|Overall Study|Progressive disease|190|||
131454555|NCT01287741|473293353|FG001|Overall Study|Progressive disease|166|||
131454556|NCT01287741|473293352|FG000|Overall Study|Reason not specified|23|||
131935987|NCT00725985|475054110|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935988|NCT00725985|475054111|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
131935989|NCT00725985|475054112|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935990|NCT00725985|475054113|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935991|NCT00725985|475054114|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935992|NCT00725985|475054115|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935993|NCT00725985|475054116|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935994|NCT00725985|475054117|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935995|NCT00725985|475054118|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935996|NCT00725985|475054119|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
131935997|NCT00725985|475054108|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
131935998|NCT00725985|475054109|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
131935999|NCT00725985|475054110|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936000|NCT00725985|475054111|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936001|NCT00725985|475054112|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936002|NCT00725985|475054113|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
131936003|NCT00725985|475054114|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936004|NCT00725985|475054115|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936005|NCT00725985|475054116|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936006|NCT00725985|475054117|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936007|NCT00725985|475054118|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936008|NCT00725985|475054119|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
131936009|NCT00725985|475054108|FG000|OLMP (Up to 96 Weeks)|Other|0|||
131936010|NCT00725985|475054109|FG001|OLMP (Up to 96 Weeks)|Other|0|||
131936011|NCT00725985|475054110|FG002|OLMP (Up to 96 Weeks)|Other|0|||
131936012|NCT00725985|475054111|FG003|OLMP (Up to 96 Weeks)|Other|15|||
131936013|NCT00725985|475054112|FG004|OLMP (Up to 96 Weeks)|Other|20|||
131936014|NCT00725985|475054113|FG005|OLMP (Up to 96 Weeks)|Other|44|||
131936015|NCT00725985|475054114|FG006|OLMP (Up to 96 Weeks)|Other|0|||
131936016|NCT00725985|475054115|FG007|OLMP (Up to 96 Weeks)|Other|0|||
131936017|NCT00725985|475054116|FG008|OLMP (Up to 96 Weeks)|Other|0|||
131936018|NCT00725985|475054117|FG009|OLMP (Up to 96 Weeks)|Other|0|||
131936019|NCT00725985|475054118|FG010|OLMP (Up to 96 Weeks)|Other|0|||
131936020|NCT00725985|475054119|FG011|OLMP (Up to 96 Weeks)|Other|0|||
131936021|NCT00725985|475054108|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936022|NCT00725985|475054109|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936023|NCT00725985|475054110|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936024|NCT00725985|475054111|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936025|NCT00725985|475054112|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936026|NCT00725985|475054113|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936027|NCT00725985|475054114|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936028|NCT00725985|475054115|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
131936029|NCT00725985|475054116|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936030|NCT00725985|475054117|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936031|NCT00725985|475054118|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936032|NCT00725985|475054119|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
131936033|NCT00725985|475054108|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936034|NCT00725985|475054109|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936035|NCT00725985|475054110|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936036|NCT00725985|475054111|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936037|NCT00725985|475054112|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936038|NCT00725985|475054113|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936039|NCT00725985|475054114|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936040|NCT00725985|475054115|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936041|NCT00725985|475054116|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
131936042|NCT00725985|475054117|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936043|NCT00725985|475054118|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936044|NCT00725985|475054119|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
131936045|NCT00725985|475054108|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936046|NCT00725985|475054109|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936047|NCT00725985|475054110|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131412456|NCT01636713|473132081|FG001|Overall Study|Adverse Event|16|||
131412457|NCT01636713|473132082|FG002|Overall Study|Adverse Event|7|||
131412458|NCT01636713|473132080|FG000|Overall Study|Lack of Efficacy|6|||
131412459|NCT01636713|473132081|FG001|Overall Study|Lack of Efficacy|6|||
131412460|NCT01636713|473132082|FG002|Overall Study|Lack of Efficacy|2|||
131412461|NCT01636713|473132080|FG000|Overall Study|Protocol Violation|3|||
131412462|NCT01636713|473132081|FG001|Overall Study|Protocol Violation|0|||
131412463|NCT01636713|473132082|FG002|Overall Study|Protocol Violation|1|||
131412464|NCT01636713|473132080|FG000|Overall Study|Lost to Follow-up|0|||
131412465|NCT01636713|473132081|FG001|Overall Study|Lost to Follow-up|0|||
131412466|NCT01636713|473132082|FG002|Overall Study|Lost to Follow-up|1|||
131412467|NCT01636713|473132080|FG000|Overall Study|Withdrawal by Subject|5|||
131412468|NCT01636713|473132081|FG001|Overall Study|Withdrawal by Subject|4|||
131412469|NCT01636713|473132082|FG002|Overall Study|Withdrawal by Subject|8|||
131412470|NCT01636713|473132080|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
131412471|NCT01636713|473132081|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
131412472|NCT01636713|473132082|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
131412473|NCT03780959|473132083|FG000|Part 1|Adverse Event|1|||
131412474|NCT03780959|473132084|FG001|Part 1|Adverse Event|0|||
131412475|NCT03780959|473132085|FG002|Part 1|Adverse Event|0|||
131412476|NCT03780959|473132083|FG000|Part 1|Withdrawal by Subject|1|||
131412477|NCT03780959|473132084|FG001|Part 1|Withdrawal by Subject|0|||
131936048|NCT00725985|475054111|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936049|NCT00725985|475054112|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936050|NCT00725985|475054113|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936051|NCT00725985|475054114|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
131936052|NCT00725985|475054115|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
131936053|NCT00725985|475054116|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
131936054|NCT00725985|475054117|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936055|NCT00725985|475054118|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936056|NCT00725985|475054119|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
131936057|NCT00725985|475054108|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936058|NCT00725985|475054109|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936059|NCT00725985|475054110|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936060|NCT00725985|475054111|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936061|NCT00725985|475054112|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936062|NCT00725985|475054113|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936063|NCT00725985|475054114|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936064|NCT00725985|475054115|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936065|NCT00725985|475054116|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
131936066|NCT00725985|475054117|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
131936067|NCT00725985|475054118|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
131936068|NCT00725985|475054119|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
131936069|NCT06582732|475054120|FG000|Initial Study Period|Adverse Event|0|||
131936070|NCT06582732|475054121|FG001|Initial Study Period|Adverse Event|0|||
131936071|NCT06582732|475054122|FG002|Initial Study Period|Adverse Event|0|||
131936072|NCT06582732|475054123|FG003|Initial Study Period|Adverse Event|2|||
131936073|NCT06582732|475054124|FG004|Initial Study Period|Adverse Event|0|||
131936074|NCT06582732|475054125|FG005|Initial Study Period|Adverse Event|0|||
131936075|NCT06582732|475054126|FG006|Initial Study Period|Adverse Event|0|||
131936076|NCT06582732|475054120|FG000|Initial Study Period|Death|1|||
131936077|NCT06582732|475054121|FG001|Initial Study Period|Death|0|||
131936078|NCT06582732|475054122|FG002|Initial Study Period|Death|0|||
131936079|NCT06582732|475054123|FG003|Initial Study Period|Death|0|||
131936080|NCT06582732|475054124|FG004|Initial Study Period|Death|1|||
131936081|NCT06582732|475054125|FG005|Initial Study Period|Death|0|||
131936082|NCT06582732|475054126|FG006|Initial Study Period|Death|0|||
131936083|NCT06582732|475054120|FG000|Initial Study Period|Lost to Follow-up|0|||
131936084|NCT06582732|475054121|FG001|Initial Study Period|Lost to Follow-up|0|||
131936085|NCT06582732|475054122|FG002|Initial Study Period|Lost to Follow-up|2|||
131936086|NCT06582732|475054123|FG003|Initial Study Period|Lost to Follow-up|0|||
131936087|NCT06582732|475054124|FG004|Initial Study Period|Lost to Follow-up|0|||
131936088|NCT06582732|475054125|FG005|Initial Study Period|Lost to Follow-up|0|||
131936089|NCT06582732|475054126|FG006|Initial Study Period|Lost to Follow-up|0|||
131936090|NCT06582732|475054120|FG000|Initial Study Period|Withdrawal by Subject|0|||
131936091|NCT06582732|475054121|FG001|Initial Study Period|Withdrawal by Subject|1|||
131936092|NCT06582732|475054122|FG002|Initial Study Period|Withdrawal by Subject|0|||
131936093|NCT06582732|475054123|FG003|Initial Study Period|Withdrawal by Subject|1|||
131936094|NCT06582732|475054124|FG004|Initial Study Period|Withdrawal by Subject|3|||
131936095|NCT06582732|475054125|FG005|Initial Study Period|Withdrawal by Subject|1|||
131936096|NCT06582732|475054126|FG006|Initial Study Period|Withdrawal by Subject|2|||
131936097|NCT06582732|475054120|FG000|Initial Study Period|Moved Away|0|||
131936098|NCT06582732|475054121|FG001|Initial Study Period|Moved Away|0|||
131936099|NCT06582732|475054122|FG002|Initial Study Period|Moved Away|0|||
131936100|NCT06582732|475054123|FG003|Initial Study Period|Moved Away|0|||
131936101|NCT06582732|475054124|FG004|Initial Study Period|Moved Away|1|||
131936102|NCT06582732|475054125|FG005|Initial Study Period|Moved Away|0|||
131936103|NCT06582732|475054126|FG006|Initial Study Period|Moved Away|0|||
131936104|NCT01182350|475054127|FG000|Overall Study|Adverse Event|5|||
131936105|NCT01182350|475054128|FG001|Overall Study|Adverse Event|0|||
131936106|NCT01182350|475054129|FG002|Overall Study|Adverse Event|0|||
131936107|NCT01182350|475054130|FG003|Overall Study|Adverse Event|0|||
131936108|NCT01182350|475054131|FG004|Overall Study|Adverse Event|0|||
131412478|NCT03780959|473132085|FG002|Part 1|Withdrawal by Subject|0|||
131412479|NCT03780959|473132083|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
131936109|NCT01182350|475054127|FG000|Overall Study|Disease Progression|15|||
131936110|NCT01182350|475054128|FG001|Overall Study|Disease Progression|12|||
131936111|NCT01182350|475054129|FG002|Overall Study|Disease Progression|0|||
131936112|NCT01182350|475054130|FG003|Overall Study|Disease Progression|1|||
131936113|NCT01182350|475054131|FG004|Overall Study|Disease Progression|0|||
131936114|NCT01182350|475054127|FG000|Overall Study|Death|0|||
131936115|NCT01182350|475054128|FG001|Overall Study|Death|1|||
131936116|NCT01182350|475054129|FG002|Overall Study|Death|1|||
131936117|NCT01182350|475054130|FG003|Overall Study|Death|0|||
131936118|NCT01182350|475054131|FG004|Overall Study|Death|0|||
131936119|NCT01182350|475054127|FG000|Overall Study|Withdrawal by Subject|3|||
131936120|NCT01182350|475054128|FG001|Overall Study|Withdrawal by Subject|1|||
131936121|NCT01182350|475054129|FG002|Overall Study|Withdrawal by Subject|0|||
131936122|NCT01182350|475054130|FG003|Overall Study|Withdrawal by Subject|1|||
131454557|NCT01287741|473293353|FG001|Overall Study|Reason not specified|9|||
131454558|NCT03892967|473293354|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
131454559|NCT03892967|473293355|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
131454560|NCT03892967|473293356|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
131454561|NCT03892967|473293357|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
131454562|NCT03892967|473293358|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
131454563|NCT03892967|473293354|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
131454564|NCT03892967|473293355|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
131454565|NCT03892967|473293356|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
131454566|NCT03892967|473293357|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
131454567|NCT03892967|473293358|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
131454568|NCT03892967|473293354|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
131454569|NCT03892967|473293355|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
131454570|NCT03892967|473293356|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
131454571|NCT03892967|473293357|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
131454572|NCT03892967|473293358|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
131454573|NCT03892967|473293354|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
131454574|NCT03892967|473293355|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
131454575|NCT03892967|473293356|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
131454576|NCT03892967|473293357|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
131454577|NCT03892967|473293358|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
131454578|NCT03892967|473293354|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
131454579|NCT03892967|473293355|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
131454580|NCT03892967|473293356|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
131454581|NCT03892967|473293357|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
131454582|NCT03892967|473293358|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
131454583|NCT03892967|473293354|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
131454584|NCT03892967|473293355|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
131454585|NCT03892967|473293356|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
131454586|NCT03892967|473293357|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
131454587|NCT03892967|473293358|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
131454588|NCT00114517|473293362|FG000|Overall Study|Adverse Event|6|||
131454589|NCT00114517|473293363|FG001|Overall Study|Adverse Event|1|||
131454590|NCT00114517|473293364|FG002|Overall Study|Adverse Event|6|||
131454591|NCT00114517|473293365|FG003|Overall Study|Adverse Event|3|||
131454592|NCT00114517|473293362|FG000|Overall Study|Lost to Follow-up|2|||
131454593|NCT00114517|473293363|FG001|Overall Study|Lost to Follow-up|2|||
131454594|NCT00114517|473293364|FG002|Overall Study|Lost to Follow-up|2|||
131454595|NCT00114517|473293365|FG003|Overall Study|Lost to Follow-up|1|||
131454596|NCT00114517|473293362|FG000|Overall Study|Too busy|3|||
131454597|NCT00114517|473293363|FG001|Overall Study|Too busy|1|||
131454598|NCT00114517|473293364|FG002|Overall Study|Too busy|1|||
131454599|NCT00114517|473293365|FG003|Overall Study|Too busy|2|||
131454600|NCT00114517|473293362|FG000|Overall Study|Moved from area|0|||
131454601|NCT00114517|473293363|FG001|Overall Study|Moved from area|3|||
131454602|NCT00114517|473293364|FG002|Overall Study|Moved from area|2|||
131454603|NCT00114517|473293365|FG003|Overall Study|Moved from area|1|||
131454604|NCT00114517|473293362|FG000|Overall Study|Did not want estradiol|1|||
131454605|NCT00114517|473293363|FG001|Overall Study|Did not want estradiol|1|||
131454606|NCT00114517|473293364|FG002|Overall Study|Did not want estradiol|0|||
131454607|NCT00114517|473293365|FG003|Overall Study|Did not want estradiol|0|||
131454608|NCT00114517|473293362|FG000|Overall Study|Armed-services duty|0|||
131454609|NCT00114517|473293363|FG001|Overall Study|Armed-services duty|1|||
131454610|NCT00114517|473293364|FG002|Overall Study|Armed-services duty|0|||
131454611|NCT00114517|473293365|FG003|Overall Study|Armed-services duty|1|||
131936123|NCT01182350|475054131|FG004|Overall Study|Withdrawal by Subject|0|||
131936124|NCT01182350|475054127|FG000|Overall Study|Alternative Therapy|2|||
131936125|NCT01182350|475054128|FG001|Overall Study|Alternative Therapy|0|||
131936126|NCT01182350|475054129|FG002|Overall Study|Alternative Therapy|1|||
131936127|NCT01182350|475054130|FG003|Overall Study|Alternative Therapy|0|||
131936128|NCT01182350|475054131|FG004|Overall Study|Alternative Therapy|0|||
131936129|NCT01182350|475054127|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
131936130|NCT01182350|475054128|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
131936131|NCT01182350|475054129|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
131936132|NCT01182350|475054130|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
131936133|NCT01182350|475054131|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
131936134|NCT01182350|475054127|FG000|Overall Study|Unevaluable for Biopsy|0|||
131936135|NCT01182350|475054128|FG001|Overall Study|Unevaluable for Biopsy|0|||
131936136|NCT01182350|475054129|FG002|Overall Study|Unevaluable for Biopsy|0|||
131936137|NCT01182350|475054130|FG003|Overall Study|Unevaluable for Biopsy|0|||
131936138|NCT01182350|475054131|FG004|Overall Study|Unevaluable for Biopsy|3|||
131936139|NCT03898180|475054132|FG000|Overall Study|Death|178|||
131936140|NCT03898180|475054133|FG001|Overall Study|Death|173|||
131936141|NCT03898180|475054132|FG000|Overall Study|Physician Decision|1|||
131936142|NCT03898180|475054133|FG001|Overall Study|Physician Decision|0|||
131936143|NCT03898180|475054132|FG000|Overall Study|Sponsor Decision|3|||
131936144|NCT03898180|475054133|FG001|Overall Study|Sponsor Decision|0|||
131936145|NCT03898180|475054132|FG000|Overall Study|Lost to Follow-up|1|||
131936146|NCT03898180|475054133|FG001|Overall Study|Lost to Follow-up|0|||
131936147|NCT03898180|475054132|FG000|Overall Study|Withdrawal by Subject|5|||
131936148|NCT03898180|475054133|FG001|Overall Study|Withdrawal by Subject|4|||
131936149|NCT02507934|475054134|FG000|Overall Study|Lost to Follow-up|2|||
131936150|NCT02507934|475054135|FG001|Overall Study|Lost to Follow-up|0|||
131936151|NCT02507934|475054134|FG000|Overall Study|Withdrawal by Subject|2|||
131936152|NCT02507934|475054135|FG001|Overall Study|Withdrawal by Subject|0|||
131936153|NCT03605693|475054142|FG000|Overall Study|Lost to Follow-up|4|||
131936154|NCT03605693|475054143|FG001|Overall Study|Lost to Follow-up|0|||
131936155|NCT03605693|475054142|FG000|Overall Study|Physician Decision|1|||
131936156|NCT03605693|475054143|FG001|Overall Study|Physician Decision|0|||
131936157|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
131936158|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
131936159|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
131936160|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
131936161|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
131936162|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
131936163|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
131936164|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
131936165|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
131936166|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
131936167|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
131936168|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
131936169|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
131936170|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
131936171|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
131936172|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
131936173|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
131936174|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
131936175|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
131936176|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
131936177|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
131936178|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
131936179|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
131936180|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
131936181|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
131936182|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
131936183|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
131936184|NCT03093415|475054144|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
131936185|NCT03093415|475054145|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
131936186|NCT03093415|475054146|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
131936187|NCT03093415|475054144|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
131936188|NCT03093415|475054145|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
131936189|NCT03093415|475054146|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
131936190|NCT03559530|475054147|FG000|Overall Study|non-location of medical records|44|||
131936191|NCT03559530|475054148|FG001|Overall Study|non-location of medical records|0|||
131936192|NCT03559530|475054147|FG000|Overall Study|culture results not considered for treat|29|||
131936193|NCT03559530|475054148|FG001|Overall Study|culture results not considered for treat|0|||
131936194|NCT03559530|475054147|FG000|Overall Study|duplicate cases|8|||
131936195|NCT03559530|475054148|FG001|Overall Study|duplicate cases|0|||
131936196|NCT03559530|475054147|FG000|Overall Study|other species of Acinetobacte|7|||
131936197|NCT03559530|475054148|FG001|Overall Study|other species of Acinetobacte|0|||
131936198|NCT03559530|475054147|FG000|Overall Study|contamination / colonization|3|||
131936199|NCT03559530|475054148|FG001|Overall Study|contamination / colonization|0|||
131936200|NCT03331354|475054149|FG000|Overall Study|Withdrawal by Subject|1|||
131936201|NCT03331354|475054150|FG001|Overall Study|Withdrawal by Subject|3|||
131936202|NCT03331354|475054149|FG000|Overall Study|Lost to Follow-up|3|||
131936203|NCT03331354|475054150|FG001|Overall Study|Lost to Follow-up|3|||
131936204|NCT03331354|475054149|FG000|Overall Study|Found employment before initiated active intervention|0|||
131936205|NCT03331354|475054150|FG001|Overall Study|Found employment before initiated active intervention|4|||
131936206|NCT01646827|475054153|FG000|Overall Study|Lost to Follow-up|0|||
131936207|NCT01646827|475054154|FG001|Overall Study|Lost to Follow-up|3|||
131936208|NCT01646827|475054153|FG000|Overall Study|Physician Decision|1|||
131936209|NCT01646827|475054154|FG001|Overall Study|Physician Decision|2|||
131936210|NCT01646827|475054153|FG000|Overall Study|Withdrawal by Subject|1|||
131936211|NCT01646827|475054154|FG001|Overall Study|Withdrawal by Subject|0|||
131936212|NCT00815633|475054157|FG000|Overall Study|study terminated|1|||
131936213|NCT00721110|475054158|FG000|Overall Study|Ultram use|1|||
131936214|NCT00721110|475054159|FG001|Overall Study|Ultram use|0|||
131936215|NCT00721110|475054160|FG002|Overall Study|Ultram use|0|||
131936216|NCT00721110|475054161|FG003|Overall Study|Ultram use|0|||
131936217|NCT00721110|475054158|FG000|Overall Study|vertical incision|0|||
131936218|NCT00721110|475054159|FG001|Overall Study|vertical incision|0|||
131936219|NCT00721110|475054160|FG002|Overall Study|vertical incision|1|||
131936220|NCT00721110|475054161|FG003|Overall Study|vertical incision|0|||
131936221|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
131936222|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
131936223|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
131936224|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
131936225|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
131936226|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
131936227|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
131936228|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
131936229|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
131936230|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
131936231|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
131936232|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
131936233|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
131936234|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
131936235|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
131936236|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
131936237|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
131936238|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
131936239|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
131936240|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
131936241|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
131936242|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
131936243|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
131936244|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
131936245|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
131936246|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
131936247|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
131936248|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
131936249|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
131936250|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
131936251|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
131936252|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
131936253|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
131936254|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
131936255|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
131936256|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
131936257|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
131936258|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
131936259|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
131936260|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
131936261|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
131936262|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
131454612|NCT00114517|473293362|FG000|Overall Study|Competing family issue|0|||
131454613|NCT00114517|473293363|FG001|Overall Study|Competing family issue|1|||
131454614|NCT00114517|473293364|FG002|Overall Study|Competing family issue|0|||
131936263|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
131936264|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
131936265|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
131936266|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
131936267|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
131936268|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
131936269|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
131936270|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
131936271|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
131936272|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
131936273|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
131936274|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
131936275|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
131936276|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
131936277|NCT01362790|475054162|FG000|Pilot Phase & Phase 2|Death on study|0|||
131936278|NCT01362790|475054163|FG001|Pilot Phase & Phase 2|Death on study|0|||
131936279|NCT01362790|475054164|FG002|Pilot Phase & Phase 2|Death on study|0|||
131936280|NCT01362790|475054165|FG003|Pilot Phase & Phase 2|Death on study|1|||
131936281|NCT01362790|475054166|FG004|Pilot Phase & Phase 2|Death on study|0|||
131936282|NCT01362790|475054167|FG005|Pilot Phase & Phase 2|Death on study|0|||
131936283|NCT01362790|475054168|FG006|Pilot Phase & Phase 2|Death on study|0|||
131936284|NCT01362790|475054162|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
131936285|NCT01362790|475054163|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
131936286|NCT01362790|475054164|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
131936287|NCT01362790|475054165|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
131936288|NCT01362790|475054166|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
131936289|NCT01362790|475054167|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
131936290|NCT01362790|475054168|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
131936291|NCT01362790|475054162|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
131936292|NCT01362790|475054163|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
131936293|NCT01362790|475054164|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
131936294|NCT01362790|475054165|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
131936295|NCT01362790|475054166|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
131936296|NCT01362790|475054167|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
131936297|NCT01362790|475054168|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
131936298|NCT01362790|475054162|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
131936299|NCT01362790|475054163|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
131936300|NCT01362790|475054164|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
131936301|NCT01362790|475054165|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
131936302|NCT01362790|475054166|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
131936303|NCT01362790|475054167|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
131936304|NCT01362790|475054168|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
131936305|NCT02757430|475054169|FG000|Overall Study|Physician Decision|6|||
131936306|NCT02757430|475054169|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
131936307|NCT02757430|475054169|FG000|Overall Study|No informed consent|1|||
131936308|NCT02757430|475054169|FG000|Overall Study|No procedure performed|2|||
131936309|NCT00265122|475054188|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
131936310|NCT00265122|475054189|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
131936311|NCT00265122|475054190|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
131936312|NCT00265122|475054191|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
131936313|NCT00265122|475054192|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
131936314|NCT00265122|475054193|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
131936315|NCT00265122|475054188|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
131936316|NCT00265122|475054189|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
131936317|NCT00265122|475054190|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
131936318|NCT00265122|475054191|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
131936319|NCT00265122|475054192|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
131936320|NCT00265122|475054193|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
131936321|NCT00265122|475054188|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
131936322|NCT00265122|475054189|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
131936323|NCT00265122|475054190|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
131936324|NCT00265122|475054191|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
131936325|NCT00265122|475054192|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
131936326|NCT00265122|475054193|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
131454615|NCT00114517|473293365|FG003|Overall Study|Competing family issue|1|||
131936327|NCT00265122|475054188|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
131936328|NCT00265122|475054189|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
131936329|NCT00265122|475054190|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
131936330|NCT00265122|475054191|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
131936331|NCT00265122|475054192|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
131936332|NCT00265122|475054193|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
131936333|NCT00265122|475054188|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
131936334|NCT00265122|475054189|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
131936335|NCT00265122|475054190|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
131936336|NCT00265122|475054191|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
131936337|NCT00265122|475054192|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
131936338|NCT00265122|475054193|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
131936339|NCT00265122|475054188|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
131936340|NCT00265122|475054189|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
131936341|NCT00265122|475054190|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
131936342|NCT00265122|475054191|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
131936343|NCT00265122|475054192|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
131936344|NCT00265122|475054193|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
131936345|NCT04716894|475054194|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
131936346|NCT04716894|475054194|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
131936347|NCT04976855|475054203|FG000|Part I|Withdrawal by Subject|0|||
131936348|NCT04976855|475054204|FG001|Part I|Withdrawal by Subject|1|||
131936349|NCT04976855|475054205|FG002|Part I|Withdrawal by Subject|0|||
131936350|NCT04976855|475054206|FG003|Part I|Withdrawal by Subject|0|||
131936351|NCT04976855|475054207|FG004|Part I|Withdrawal by Subject|0|||
131936352|NCT04976855|475054208|FG005|Part I|Withdrawal by Subject|0|||
131936353|NCT04976855|475054209|FG006|Part I|Withdrawal by Subject|0|||
131936354|NCT04976855|475054203|FG000|Part II|Adverse Event|0|||
131936355|NCT04976855|475054204|FG001|Part II|Adverse Event|0|||
131936356|NCT04976855|475054205|FG002|Part II|Adverse Event|0|||
131936357|NCT04976855|475054206|FG003|Part II|Adverse Event|1|||
131936358|NCT04976855|475054207|FG004|Part II|Adverse Event|0|||
131936359|NCT04976855|475054208|FG005|Part II|Adverse Event|0|||
131936360|NCT04976855|475054209|FG006|Part II|Adverse Event|0|||
131936361|NCT04976855|475054203|FG000|Part II|Withdrawal by Subject|0|||
131936362|NCT04976855|475054204|FG001|Part II|Withdrawal by Subject|0|||
131936363|NCT04976855|475054205|FG002|Part II|Withdrawal by Subject|0|||
131936364|NCT04976855|475054206|FG003|Part II|Withdrawal by Subject|0|||
131936365|NCT04976855|475054207|FG004|Part II|Withdrawal by Subject|1|||
131936366|NCT04976855|475054208|FG005|Part II|Withdrawal by Subject|0|||
131936367|NCT04976855|475054209|FG006|Part II|Withdrawal by Subject|0|||
131936368|NCT04976855|475054203|FG000|Part II|Lost to Follow-up|0|||
131936369|NCT04976855|475054204|FG001|Part II|Lost to Follow-up|0|||
131936370|NCT04976855|475054205|FG002|Part II|Lost to Follow-up|0|||
131936371|NCT04976855|475054206|FG003|Part II|Lost to Follow-up|0|||
131936372|NCT04976855|475054207|FG004|Part II|Lost to Follow-up|0|||
131936373|NCT04976855|475054208|FG005|Part II|Lost to Follow-up|1|||
131936374|NCT04976855|475054209|FG006|Part II|Lost to Follow-up|0|||
131936375|NCT02038036|475054217|FG000|Core Study|Adverse Event|7|||
131936376|NCT02038036|475054218|FG001|Core Study|Adverse Event|7|||
131936377|NCT02038036|475054217|FG000|Core Study|Death|1|||
131936378|NCT02038036|475054218|FG001|Core Study|Death|1|||
131936379|NCT02038036|475054217|FG000|Core Study|Disease progression|2|||
131936380|NCT02038036|475054218|FG001|Core Study|Disease progression|2|||
131936381|NCT02038036|475054217|FG000|Core Study|Lost to Follow-up|0|||
131936382|NCT02038036|475054218|FG001|Core Study|Lost to Follow-up|1|||
131936383|NCT02038036|475054217|FG000|Core Study|Physician Decision|2|||
131936384|NCT02038036|475054218|FG001|Core Study|Physician Decision|1|||
131936385|NCT02038036|475054217|FG000|Core Study|Subject/guardian decision|0|||
131936386|NCT02038036|475054218|FG001|Core Study|Subject/guardian decision|1|||
131936387|NCT02038036|475054217|FG000|Core Study|Withdrawal by Subject|3|||
131936388|NCT02038036|475054218|FG001|Core Study|Withdrawal by Subject|1|||
131936389|NCT02038036|475054217|FG000|Crossover Period|Withdrawal by Subject|0|||
131936390|NCT02038036|475054218|FG001|Crossover Period|Withdrawal by Subject|3|||
131936391|NCT02038036|475054217|FG000|Crossover Period|Adverse Event|0|||
131936392|NCT02038036|475054218|FG001|Crossover Period|Adverse Event|9|||
131936393|NCT02038036|475054217|FG000|Crossover Period|Death|0|||
131936394|NCT02038036|475054218|FG001|Crossover Period|Death|2|||
131936395|NCT02038036|475054217|FG000|Crossover Period|Disease progression|0|||
131936396|NCT02038036|475054218|FG001|Crossover Period|Disease progression|3|||
131936397|NCT02038036|475054217|FG000|Crossover Period|Lost to Follow-up|0|||
131936398|NCT02038036|475054218|FG001|Crossover Period|Lost to Follow-up|1|||
131936399|NCT02038036|475054217|FG000|Crossover Period|Physician Decision|0|||
131936400|NCT02038036|475054218|FG001|Crossover Period|Physician Decision|2|||
131936401|NCT05318287|475054224|FG000|Overall Study|Lost to Follow-up|8|||
131936402|NCT05185453|475054225|FG000|Overall Study|Lost to Follow-up|13|||
131936403|NCT05185453|475054226|FG001|Overall Study|Lost to Follow-up|3|||
131936404|NCT02757768|475054232|FG000|Overall Study|Randomized Never Received Study Drug|3|||
131936405|NCT02757768|475054233|FG001|Overall Study|Randomized Never Received Study Drug|4|||
131936406|NCT02757768|475054232|FG000|Overall Study|Adverse Event|5|||
131936407|NCT02757768|475054233|FG001|Overall Study|Adverse Event|3|||
131936408|NCT02757768|475054232|FG000|Overall Study|Lack of Efficacy|2|||
131936409|NCT02757768|475054233|FG001|Overall Study|Lack of Efficacy|1|||
131936410|NCT02757768|475054232|FG000|Overall Study|Lost to Follow-up|1|||
131936411|NCT02757768|475054233|FG001|Overall Study|Lost to Follow-up|0|||
131936412|NCT02757768|475054232|FG000|Overall Study|Protocol Deviation|2|||
131936413|NCT02757768|475054233|FG001|Overall Study|Protocol Deviation|9|||
131936414|NCT02757768|475054232|FG000|Overall Study|Withdrawal by Subject|16|||
131936415|NCT02757768|475054233|FG001|Overall Study|Withdrawal by Subject|9|||
131936416|NCT02757768|475054232|FG000|Overall Study|Miscellaneous|4|||
131936417|NCT02757768|475054233|FG001|Overall Study|Miscellaneous|2|||
131936418|NCT02278003|475055595|FG000|Overall Study|Withdrawal by Subject|11|||
131936419|NCT02278003|475055596|FG001|Overall Study|Withdrawal by Subject|0|||
131936420|NCT02278003|475055595|FG000|Overall Study|Not Treated|1|||
131936421|NCT02278003|475055596|FG001|Overall Study|Not Treated|0|||
131936422|NCT02278003|475055595|FG000|Overall Study|Recognition task improperly completed|7|||
131936423|NCT02278003|475055596|FG001|Overall Study|Recognition task improperly completed|0|||
131936424|NCT04123704|475055599|FG000|Overall Study|Disease progression|2|||
131936425|NCT00939185|475055600|FG000|Overall Study|Adverse Event|3|||
131936426|NCT00939185|475055600|FG000|Overall Study|Lack of Efficacy|1|||
131936427|NCT00939185|475055600|FG000|Overall Study|Lost to Follow-up|6|||
131936428|NCT00939185|475055600|FG000|Overall Study|Other|3|||
131936429|NCT00939185|475055600|FG000|Overall Study|Withdrawal by Subject|2|||
131936430|NCT00939185|475055600|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
131936431|NCT03552029|475055604|FG000|Overall Study|Death|3|||
131936432|NCT03552029|475055605|FG001|Overall Study|Death|0|||
131936433|NCT03552029|475055604|FG000|Overall Study|Adverse Event|1|||
131936434|NCT03552029|475055605|FG001|Overall Study|Adverse Event|0|||
131936435|NCT03552029|475055604|FG000|Overall Study|Lack of Efficacy|0|||
131936436|NCT03552029|475055605|FG001|Overall Study|Lack of Efficacy|2|||
131936437|NCT03552029|475055604|FG000|Overall Study|Physician Decision|0|||
131936438|NCT03552029|475055605|FG001|Overall Study|Physician Decision|1|||
131936439|NCT03552029|475055604|FG000|Overall Study|Study terminated by Sponsor|0|||
131936440|NCT03552029|475055605|FG001|Overall Study|Study terminated by Sponsor|1|||
131936441|NCT03552029|475055604|FG000|Overall Study|Other|0|||
131936442|NCT03552029|475055605|FG001|Overall Study|Other|2|||
131936443|NCT03468998|475055608|FG000|Overall Study|Withdrawal by Subject|1|||
131936444|NCT03468998|475055609|FG001|Overall Study|Withdrawal by Subject|1|||
131936445|NCT03468998|475055610|FG002|Overall Study|Withdrawal by Subject|0|||
131936446|NCT03468998|475055611|FG003|Overall Study|Withdrawal by Subject|4|||
131936447|NCT03468998|475055612|FG004|Overall Study|Withdrawal by Subject|1|||
131936448|NCT03468998|475055613|FG005|Overall Study|Withdrawal by Subject|0|||
131936449|NCT02989857|475055616|FG000|Randomization Phase|Not Treated|3|||
131936450|NCT02989857|475055617|FG001|Randomization Phase|Not Treated|2|||
131936451|NCT02989857|475055618|FG002|Randomization Phase|Not Treated|0|||
131936452|NCT02538614|475055629|FG000|Overall Study|Progressive Disease|2|||
131936453|NCT02332928|475055631|FG000|Overall Study|Withdrawal by Subject|0|||
131936454|NCT02332928|475055632|FG001|Overall Study|Withdrawal by Subject|2|||
131936455|NCT02332928|475055631|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
131936456|NCT02332928|475055632|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
131936457|NCT02684461|475055636|FG000|Overall Study|Adverse Event|1|||
131936458|NCT02684461|475055637|FG001|Overall Study|Adverse Event|0|||
131936459|NCT02684461|475055638|FG002|Overall Study|Adverse Event|0|||
131936460|NCT02684461|475055636|FG000|Overall Study|Lack of Efficacy|1|||
131936461|NCT02684461|475055637|FG001|Overall Study|Lack of Efficacy|2|||
131936462|NCT02684461|475055638|FG002|Overall Study|Lack of Efficacy|0|||
131936463|NCT01358734|475055644|FG000|Overall Study|Adverse Event|4|||
131936464|NCT01358734|475055645|FG001|Overall Study|Adverse Event|7|||
131936465|NCT01358734|475055646|FG002|Overall Study|Adverse Event|3|||
131936466|NCT01358734|475055644|FG000|Overall Study|Lack of Efficacy|0|||
131936467|NCT01358734|475055645|FG001|Overall Study|Lack of Efficacy|1|||
131936468|NCT01358734|475055646|FG002|Overall Study|Lack of Efficacy|3|||
131936469|NCT01358734|475055644|FG000|Overall Study|Withdrawal by Subject|1|||
131936470|NCT01358734|475055645|FG001|Overall Study|Withdrawal by Subject|6|||
131936471|NCT01358734|475055646|FG002|Overall Study|Withdrawal by Subject|3|||
131936472|NCT01358734|475055644|FG000|Overall Study|Death|3|||
131936473|NCT01358734|475055645|FG001|Overall Study|Death|7|||
131936474|NCT01358734|475055646|FG002|Overall Study|Death|2|||
131936475|NCT01358734|475055644|FG000|Overall Study|Progressive Disease|5|||
131936476|NCT01358734|475055645|FG001|Overall Study|Progressive Disease|13|||
131936477|NCT01358734|475055646|FG002|Overall Study|Progressive Disease|16|||
131936478|NCT01358734|475055644|FG000|Overall Study|Non-compliance with study drug|0|||
131936479|NCT01358734|475055645|FG001|Overall Study|Non-compliance with study drug|0|||
131936480|NCT01358734|475055646|FG002|Overall Study|Non-compliance with study drug|1|||
131936481|NCT01358734|475055644|FG000|Overall Study|Other|2|||
131936482|NCT01358734|475055645|FG001|Overall Study|Other|5|||
131936483|NCT01358734|475055646|FG002|Overall Study|Other|4|||
131936484|NCT01358734|475055644|FG000|Overall Study|Protocol Violation|0|||
131936485|NCT01358734|475055645|FG001|Overall Study|Protocol Violation|0|||
131936486|NCT01358734|475055646|FG002|Overall Study|Protocol Violation|2|||
131936487|NCT01822925|475055647|FG000|Overall Study|Adverse Event|1|||
131936488|NCT01822925|475055648|FG001|Overall Study|Adverse Event|1|||
131936489|NCT01822925|475055649|FG002|Overall Study|Adverse Event|1|||
131936490|NCT01822925|475055650|FG003|Overall Study|Adverse Event|1|||
131936491|NCT01822925|475055647|FG000|Overall Study|Lost to Follow-up|0|||
131936492|NCT01822925|475055648|FG001|Overall Study|Lost to Follow-up|1|||
131936493|NCT01822925|475055649|FG002|Overall Study|Lost to Follow-up|0|||
131936494|NCT01822925|475055650|FG003|Overall Study|Lost to Follow-up|0|||
131936495|NCT01822925|475055647|FG000|Overall Study|Protocol Violation|1|||
131936496|NCT01822925|475055648|FG001|Overall Study|Protocol Violation|0|||
131936497|NCT01822925|475055649|FG002|Overall Study|Protocol Violation|0|||
131936498|NCT01822925|475055650|FG003|Overall Study|Protocol Violation|1|||
131936499|NCT01822925|475055647|FG000|Overall Study|Withdrawal by Subject|2|||
131936500|NCT01822925|475055648|FG001|Overall Study|Withdrawal by Subject|0|||
131936501|NCT01822925|475055649|FG002|Overall Study|Withdrawal by Subject|2|||
131936502|NCT01822925|475055650|FG003|Overall Study|Withdrawal by Subject|2|||
131936503|NCT01822925|475055647|FG000|Overall Study|Taking prohibited medication|2|||
131936504|NCT01822925|475055648|FG001|Overall Study|Taking prohibited medication|0|||
131936505|NCT01822925|475055649|FG002|Overall Study|Taking prohibited medication|0|||
131936506|NCT01822925|475055650|FG003|Overall Study|Taking prohibited medication|1|||
131936507|NCT03243084|475055658|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
131936508|NCT03243084|475055659|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
131936509|NCT03322566|475055660|FG000|Overall Study|Death|34|||
131936510|NCT03322566|475055661|FG001|Overall Study|Death|35|||
131936511|NCT03322566|475055662|FG002|Overall Study|Death|23|||
131936512|NCT03322566|475055660|FG000|Overall Study|Physician Decision|6|||
131936513|NCT03322566|475055661|FG001|Overall Study|Physician Decision|7|||
131936514|NCT03322566|475055662|FG002|Overall Study|Physician Decision|2|||
131936515|NCT03322566|475055660|FG000|Overall Study|Withdrawal by Subject|4|||
131936516|NCT03322566|475055661|FG001|Overall Study|Withdrawal by Subject|3|||
131936517|NCT03322566|475055662|FG002|Overall Study|Withdrawal by Subject|6|||
131936518|NCT03322566|475055660|FG000|Overall Study|Lost to Follow-up|0|||
131936519|NCT03322566|475055661|FG001|Overall Study|Lost to Follow-up|0|||
131936520|NCT03322566|475055662|FG002|Overall Study|Lost to Follow-up|1|||
131936521|NCT03322566|475055660|FG000|Overall Study|Study terminated by sponsor|1|||
131936522|NCT03322566|475055661|FG001|Overall Study|Study terminated by sponsor|0|||
131936523|NCT03322566|475055662|FG002|Overall Study|Study terminated by sponsor|1|||
131936524|NCT02095106|475055663|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
131936525|NCT02095106|475055664|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
131936526|NCT02314923|475055667|FG000|Overall Study|Death|0|||
131936527|NCT02314923|475055668|FG001|Overall Study|Death|0|||
131936528|NCT02314923|475055669|FG002|Overall Study|Death|0|||
131936529|NCT02314923|475055670|FG003|Overall Study|Death|1|||
131936530|NCT02314923|475055671|FG004|Overall Study|Death|0|||
131936531|NCT02314923|475055672|FG005|Overall Study|Death|0|||
131936532|NCT02314923|475055673|FG006|Overall Study|Death|0|||
131936533|NCT02314923|475055674|FG007|Overall Study|Death|0|||
131936534|NCT02314923|475055675|FG008|Overall Study|Death|0|||
131936535|NCT02314923|475055676|FG009|Overall Study|Death|0|||
131936536|NCT02314923|475055667|FG000|Overall Study|Lost to Follow-up|2|||
131936537|NCT02314923|475055668|FG001|Overall Study|Lost to Follow-up|3|||
131936538|NCT02314923|475055669|FG002|Overall Study|Lost to Follow-up|1|||
131936539|NCT02314923|475055670|FG003|Overall Study|Lost to Follow-up|0|||
131936540|NCT02314923|475055671|FG004|Overall Study|Lost to Follow-up|0|||
131936541|NCT02314923|475055672|FG005|Overall Study|Lost to Follow-up|0|||
131936542|NCT02314923|475055673|FG006|Overall Study|Lost to Follow-up|3|||
131936543|NCT02314923|475055674|FG007|Overall Study|Lost to Follow-up|4|||
131936544|NCT02314923|475055675|FG008|Overall Study|Lost to Follow-up|2|||
131936545|NCT02314923|475055676|FG009|Overall Study|Lost to Follow-up|0|||
131936546|NCT02314923|475055667|FG000|Overall Study|Withdrawal by Subject|0|||
131936547|NCT02314923|475055668|FG001|Overall Study|Withdrawal by Subject|0|||
131936548|NCT02314923|475055669|FG002|Overall Study|Withdrawal by Subject|1|||
131936549|NCT02314923|475055670|FG003|Overall Study|Withdrawal by Subject|0|||
131936550|NCT02314923|475055671|FG004|Overall Study|Withdrawal by Subject|1|||
131936551|NCT02314923|475055672|FG005|Overall Study|Withdrawal by Subject|0|||
131936552|NCT02314923|475055673|FG006|Overall Study|Withdrawal by Subject|1|||
131936553|NCT02314923|475055674|FG007|Overall Study|Withdrawal by Subject|0|||
131936554|NCT02314923|475055675|FG008|Overall Study|Withdrawal by Subject|0|||
131936555|NCT02314923|475055676|FG009|Overall Study|Withdrawal by Subject|0|||
131936556|NCT02314923|475055667|FG000|Overall Study|Physician Decision|0|||
131454616|NCT00114517|473293362|FG000|Overall Study|Physician Decision|0|||
131936557|NCT02314923|475055668|FG001|Overall Study|Physician Decision|1|||
131936558|NCT02314923|475055669|FG002|Overall Study|Physician Decision|0|||
131936559|NCT02314923|475055670|FG003|Overall Study|Physician Decision|0|||
131936560|NCT02314923|475055671|FG004|Overall Study|Physician Decision|0|||
131936561|NCT02314923|475055672|FG005|Overall Study|Physician Decision|0|||
131936562|NCT02314923|475055673|FG006|Overall Study|Physician Decision|0|||
131936563|NCT02314923|475055674|FG007|Overall Study|Physician Decision|0|||
131936564|NCT02314923|475055675|FG008|Overall Study|Physician Decision|0|||
131936565|NCT02314923|475055676|FG009|Overall Study|Physician Decision|0|||
131936566|NCT02314923|475055667|FG000|Overall Study|Participant unavailable|0|||
131936567|NCT02314923|475055668|FG001|Overall Study|Participant unavailable|0|||
131936568|NCT02314923|475055669|FG002|Overall Study|Participant unavailable|0|||
131936569|NCT02314923|475055670|FG003|Overall Study|Participant unavailable|0|||
131936570|NCT02314923|475055671|FG004|Overall Study|Participant unavailable|0|||
131936571|NCT02314923|475055672|FG005|Overall Study|Participant unavailable|1|||
131412480|NCT03780959|473132084|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
131412481|NCT03780959|473132085|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
131412482|NCT03780959|473132083|FG000|Part 1|Response Status|2|||
131412483|NCT03780959|473132084|FG001|Part 1|Response Status|0|||
131412484|NCT03780959|473132085|FG002|Part 1|Response Status|0|||
131412485|NCT03780959|473132083|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
131412486|NCT03780959|473132084|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
131412487|NCT03780959|473132085|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
131412488|NCT03780959|473132083|FG000|Part 2|Response Status|0|||
131412489|NCT03780959|473132084|FG001|Part 2|Response Status|18|||
131412490|NCT03780959|473132085|FG002|Part 2|Response Status|6|||
131412491|NCT03689244|473132090|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
131412492|NCT03689244|473132091|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
131412493|NCT03689244|473132092|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
131412494|NCT03689244|473132093|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
131412495|NCT03689244|473132090|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
131412496|NCT03689244|473132091|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
131412497|NCT03689244|473132092|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
131412498|NCT03689244|473132093|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
131412499|NCT03689244|473132090|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
131412500|NCT03689244|473132091|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
131412501|NCT03689244|473132092|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
131412502|NCT03689244|473132093|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
131412503|NCT03689244|473132090|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
131412504|NCT03689244|473132091|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
131412505|NCT03689244|473132092|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
131412506|NCT03689244|473132093|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
131412507|NCT03689244|473132090|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
131412508|NCT03689244|473132091|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
131412509|NCT03689244|473132092|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
131412510|NCT03689244|473132093|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
131412511|NCT03689244|473132090|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
131412512|NCT03689244|473132091|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
131412513|NCT03689244|473132092|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
131412514|NCT03689244|473132093|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
131412515|NCT03689244|473132090|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
131412516|NCT03689244|473132091|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
131412517|NCT03689244|473132092|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
131412518|NCT03689244|473132093|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
131412519|NCT03689244|473132090|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
131412520|NCT03689244|473132091|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
131412521|NCT03689244|473132092|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
131412522|NCT03689244|473132093|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
131412523|NCT03759041|473132097|FG000|Overall Study|Withdrawal by Subject|4|||
131412524|NCT03759041|473132098|FG001|Overall Study|Withdrawal by Subject|10|||
131936572|NCT02314923|475055673|FG006|Overall Study|Participant unavailable|0|||
131936573|NCT02314923|475055674|FG007|Overall Study|Participant unavailable|0|||
131936574|NCT02314923|475055675|FG008|Overall Study|Participant unavailable|0|||
131936575|NCT02314923|475055676|FG009|Overall Study|Participant unavailable|0|||
131936576|NCT02314923|475055667|FG000|Overall Study|Screen failure|0|||
131936577|NCT02314923|475055668|FG001|Overall Study|Screen failure|0|||
131936578|NCT02314923|475055669|FG002|Overall Study|Screen failure|0|||
131936579|NCT02314923|475055670|FG003|Overall Study|Screen failure|0|||
131936580|NCT02314923|475055671|FG004|Overall Study|Screen failure|0|||
131936581|NCT02314923|475055672|FG005|Overall Study|Screen failure|0|||
131936582|NCT02314923|475055673|FG006|Overall Study|Screen failure|1|||
131412525|NCT03759041|473132099|FG002|Overall Study|Withdrawal by Subject|10|||
131412526|NCT03759041|473132097|FG000|Overall Study|Adverse Event|1|||
131412527|NCT03759041|473132098|FG001|Overall Study|Adverse Event|3|||
131936583|NCT02314923|475055674|FG007|Overall Study|Screen failure|0|||
131936584|NCT02314923|475055675|FG008|Overall Study|Screen failure|0|||
131412528|NCT03759041|473132099|FG002|Overall Study|Adverse Event|4|||
131412529|NCT03759041|473132097|FG000|Overall Study|Lack of Efficacy|0|||
131412530|NCT03759041|473132098|FG001|Overall Study|Lack of Efficacy|0|||
131412531|NCT03759041|473132099|FG002|Overall Study|Lack of Efficacy|1|||
131412532|NCT03759041|473132097|FG000|Overall Study|Study Terminated by Sponsor|15|||
131412533|NCT03759041|473132098|FG001|Overall Study|Study Terminated by Sponsor|16|||
131412534|NCT03759041|473132099|FG002|Overall Study|Study Terminated by Sponsor|10|||
131412535|NCT03759041|473132097|FG000|Overall Study|Other reason for discontinuation|0|||
131412536|NCT03759041|473132098|FG001|Overall Study|Other reason for discontinuation|2|||
131412537|NCT03759041|473132099|FG002|Overall Study|Other reason for discontinuation|1|||
131412538|NCT03759041|473132097|FG000|Overall Study|Lost to Follow-up|7|||
131412539|NCT03759041|473132098|FG001|Overall Study|Lost to Follow-up|2|||
131412540|NCT03759041|473132099|FG002|Overall Study|Lost to Follow-up|2|||
131412541|NCT03759041|473132097|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
131412542|NCT03759041|473132098|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
131412543|NCT03759041|473132099|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
131412544|NCT04384107|473132100|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
131412545|NCT04384107|473132101|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
131412546|NCT04384107|473132100|FG000|Overall Study|Lost to Follow-up|1|||
131412547|NCT04384107|473132101|FG001|Overall Study|Lost to Follow-up|0|||
131412548|NCT00276614|473132102|FG000|Overall Study|Progression of disease under study|3|||
131412549|NCT01522404|473132105|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
131412550|NCT01522404|473132106|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
131412551|NCT01522404|473132105|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
131412552|NCT01522404|473132106|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
131412553|NCT01522404|473132105|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
131412554|NCT01522404|473132106|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
131412555|NCT01591863|473132111|FG000|Overall Study|Adverse Event|3|||
131412556|NCT01591863|473132111|FG000|Overall Study|Withdrawal by Subject|1|||
131412557|NCT01591863|473132111|FG000|Overall Study|recurrence|9|||
131412558|NCT01591863|473132111|FG000|Overall Study|Lack of Efficacy|1|||
131936585|NCT02314923|475055676|FG009|Overall Study|Screen failure|0|||
131936586|NCT02314923|475055667|FG000|Overall Study|Participant relocation|1|||
131936587|NCT02314923|475055668|FG001|Overall Study|Participant relocation|0|||
131936588|NCT02314923|475055669|FG002|Overall Study|Participant relocation|0|||
131936589|NCT02314923|475055670|FG003|Overall Study|Participant relocation|0|||
131936590|NCT02314923|475055671|FG004|Overall Study|Participant relocation|0|||
131936591|NCT02314923|475055672|FG005|Overall Study|Participant relocation|0|||
131936592|NCT02314923|475055673|FG006|Overall Study|Participant relocation|0|||
131936593|NCT02314923|475055674|FG007|Overall Study|Participant relocation|1|||
131936594|NCT02314923|475055675|FG008|Overall Study|Participant relocation|0|||
131936595|NCT02314923|475055676|FG009|Overall Study|Participant relocation|0|||
131936596|NCT02546323|475055677|FG000|Overall Study|Withdrawal by Subject|36|||
131936597|NCT02546323|475055678|FG001|Overall Study|Withdrawal by Subject|33|||
131936598|NCT02546323|475055677|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
131936599|NCT02546323|475055678|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
131936600|NCT02546323|475055677|FG000|Overall Study|Adverse Event|17|||
131936601|NCT02546323|475055678|FG001|Overall Study|Adverse Event|11|||
131936602|NCT02546323|475055677|FG000|Overall Study|Patient Specific Reasons|1|||
131936603|NCT02546323|475055678|FG001|Overall Study|Patient Specific Reasons|2|||
131936604|NCT02546323|475055677|FG000|Overall Study|Lost to Follow-up|2|||
131936605|NCT02546323|475055678|FG001|Overall Study|Lost to Follow-up|3|||
131936606|NCT02546323|475055677|FG000|Overall Study|Non-compliance with Study Drug|2|||
131936607|NCT02546323|475055678|FG001|Overall Study|Non-compliance with Study Drug|2|||
131936608|NCT02546323|475055677|FG000|Overall Study|Met Withdrawal Criteria|2|||
131936609|NCT02546323|475055678|FG001|Overall Study|Met Withdrawal Criteria|14|||
131936610|NCT04476784|475055679|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
131936611|NCT04476784|475055680|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
131936612|NCT04617860|475055681|FG000|Overall Study|Adverse Event|0|||
131936613|NCT04617860|475055682|FG001|Overall Study|Adverse Event|2|||
131936614|NCT04617860|475055683|FG002|Overall Study|Adverse Event|2|||
131936615|NCT04617860|475055681|FG000|Overall Study|Withdrawal by Subject|0|||
131936616|NCT04617860|475055682|FG001|Overall Study|Withdrawal by Subject|0|||
131936617|NCT04617860|475055683|FG002|Overall Study|Withdrawal by Subject|2|||
131936618|NCT04617860|475055681|FG000|Overall Study|Physician Decision|0|||
131936619|NCT04617860|475055682|FG001|Overall Study|Physician Decision|1|||
131936620|NCT04617860|475055683|FG002|Overall Study|Physician Decision|0|||
131936621|NCT04617860|475055681|FG000|Overall Study|Sponsor Decision|0|||
131936622|NCT04617860|475055682|FG001|Overall Study|Sponsor Decision|3|||
131936623|NCT04617860|475055683|FG002|Overall Study|Sponsor Decision|1|||
131412559|NCT02032407|473133657|FG000|Overall Study|Lost to Follow-up|2|||
131412560|NCT02032407|473133657|FG000|Overall Study|Pregnancy|1|||
131936624|NCT04617860|475055681|FG000|Overall Study|Termination of Study by Sponsor|8|||
131936625|NCT04617860|475055682|FG001|Overall Study|Termination of Study by Sponsor|4|||
131936626|NCT04617860|475055683|FG002|Overall Study|Termination of Study by Sponsor|13|||
131936627|NCT01055028|475055684|FG000|Screening|Screen Failure|1|||
131936628|NCT01055028|475055685|FG001|Screening|Screen Failure|1|||
131936629|NCT01055028|475055684|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
131936630|NCT01055028|475055685|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
131936631|NCT01055028|475055684|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
131936632|NCT01055028|475055685|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
131936633|NCT01055028|475055684|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
131936634|NCT01055028|475055685|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
131936635|NCT00928668|475055688|FG000|Overall Study|Adverse Event|1|||
131936636|NCT00928668|475055689|FG001|Overall Study|Adverse Event|0|||
131936637|NCT00928668|475055690|FG002|Overall Study|Adverse Event|0|||
131936638|NCT00928668|475055691|FG003|Overall Study|Adverse Event|0|||
131936639|NCT00928668|475055692|FG004|Overall Study|Adverse Event|0|||
131936640|NCT00928668|475055688|FG000|Overall Study|Protocol Violation|0|||
131936641|NCT00928668|475055689|FG001|Overall Study|Protocol Violation|0|||
131936642|NCT00928668|475055690|FG002|Overall Study|Protocol Violation|0|||
131936643|NCT00928668|475055691|FG003|Overall Study|Protocol Violation|0|||
131936644|NCT00928668|475055692|FG004|Overall Study|Protocol Violation|1|||
131936645|NCT00928668|475055688|FG000|Overall Study|Withdrawal by Subject|0|||
131936646|NCT00928668|475055689|FG001|Overall Study|Withdrawal by Subject|1|||
131936647|NCT00928668|475055690|FG002|Overall Study|Withdrawal by Subject|1|||
131936648|NCT00928668|475055691|FG003|Overall Study|Withdrawal by Subject|0|||
131936649|NCT00928668|475055692|FG004|Overall Study|Withdrawal by Subject|0|||
131936650|NCT00928668|475055688|FG000|Overall Study|Other reasons not listed above|0|||
131936651|NCT00928668|475055689|FG001|Overall Study|Other reasons not listed above|0|||
131936652|NCT00928668|475055690|FG002|Overall Study|Other reasons not listed above|0|||
131936653|NCT00928668|475055691|FG003|Overall Study|Other reasons not listed above|1|||
131936654|NCT00928668|475055692|FG004|Overall Study|Other reasons not listed above|0|||
131936655|NCT01767987|475055696|FG000|Overall Study|Physician Decision|4|||
131936656|NCT01767987|475055697|FG001|Overall Study|Physician Decision|1|||
131936657|NCT04581395|475055698|FG000|Overall Study|Protocol Violation|4|||
131936658|NCT04581395|475055699|FG001|Overall Study|Protocol Violation|3|||
131936659|NCT04581395|475055700|FG002|Overall Study|Protocol Violation|2|||
131936660|NCT04581395|475055698|FG000|Overall Study|Physician Decision|0|||
131936661|NCT04581395|475055699|FG001|Overall Study|Physician Decision|1|||
131936662|NCT04581395|475055700|FG002|Overall Study|Physician Decision|0|||
131936663|NCT03038087|475055707|FG000|Overall Study|lost data|1|||
131936664|NCT00654355|475055708|FG000|Overall Study|Lost to Follow-up|2|||
131936665|NCT00654355|475055709|FG001|Overall Study|Lost to Follow-up|2|||
131936666|NCT02259231|475055722|FG000|Overall Study|Adverse Event|1|||
131936667|NCT02259231|475055723|FG001|Overall Study|Adverse Event|1|||
131936668|NCT02259231|475055724|FG002|Overall Study|Adverse Event|2|||
131936669|NCT02259231|475055725|FG003|Overall Study|Adverse Event|0|||
131936670|NCT02259231|475055726|FG004|Overall Study|Adverse Event|0|||
131936671|NCT02259231|475055727|FG005|Overall Study|Adverse Event|0|||
131936672|NCT02259231|475055728|FG006|Overall Study|Adverse Event|0|||
131936673|NCT02259231|475055722|FG000|Overall Study|Progressive Disease|4|||
131936674|NCT02259231|475055723|FG001|Overall Study|Progressive Disease|5|||
131936675|NCT02259231|475055724|FG002|Overall Study|Progressive Disease|4|||
131936676|NCT02259231|475055725|FG003|Overall Study|Progressive Disease|5|||
131936677|NCT02259231|475055726|FG004|Overall Study|Progressive Disease|4|||
131936678|NCT02259231|475055727|FG005|Overall Study|Progressive Disease|5|||
131936679|NCT02259231|475055728|FG006|Overall Study|Progressive Disease|4|||
131936680|NCT02259231|475055722|FG000|Overall Study|Sponsor termination of study|1|||
131936681|NCT02259231|475055723|FG001|Overall Study|Sponsor termination of study|0|||
131936682|NCT02259231|475055724|FG002|Overall Study|Sponsor termination of study|0|||
131936683|NCT02259231|475055725|FG003|Overall Study|Sponsor termination of study|1|||
131936684|NCT02259231|475055726|FG004|Overall Study|Sponsor termination of study|2|||
131936685|NCT02259231|475055727|FG005|Overall Study|Sponsor termination of study|1|||
131936686|NCT02259231|475055728|FG006|Overall Study|Sponsor termination of study|1|||
131454617|NCT00114517|473293363|FG001|Overall Study|Physician Decision|1|||
131936687|NCT00847730|475055729|FG000|Overall Study|Multiple interruptions in therapy|8|||
131936688|NCT04116489|475055733|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
131936689|NCT04116489|475055733|FG000|Overall Study|Withdrawal by Subject|1|||
131454618|NCT00114517|473293364|FG002|Overall Study|Physician Decision|0|||
131454619|NCT00114517|473293365|FG003|Overall Study|Physician Decision|0|||
131936690|NCT02255656|475055738|FG000|Overall Study|Adverse Event|11|||
131936691|NCT02255656|475055738|FG000|Overall Study|Poor compliance to protocol|3|||
131936692|NCT02255656|475055738|FG000|Overall Study|Lost to Follow-up|30|||
131936693|NCT02255656|475055738|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
131936694|NCT02255656|475055738|FG000|Overall Study|Other|126|||
131936695|NCT02457793|475055739|FG000|Overall Study|Reason not specified|0|||
131936696|NCT02457793|475055740|FG001|Overall Study|Reason not specified|0|||
131936697|NCT02457793|475055741|FG002|Overall Study|Reason not specified|0|||
131936698|NCT02457793|475055742|FG003|Overall Study|Reason not specified|1|||
131936699|NCT02457793|475055743|FG004|Overall Study|Reason not specified|1|||
131936700|NCT02457793|475055744|FG005|Overall Study|Reason not specified|1|||
131936701|NCT02457793|475055739|FG000|Overall Study|Withdrawal by Subject|0|||
131936702|NCT02457793|475055740|FG001|Overall Study|Withdrawal by Subject|4|||
131936703|NCT02457793|475055741|FG002|Overall Study|Withdrawal by Subject|2|||
131936704|NCT02457793|475055742|FG003|Overall Study|Withdrawal by Subject|2|||
131936705|NCT02457793|475055743|FG004|Overall Study|Withdrawal by Subject|2|||
131936706|NCT02457793|475055744|FG005|Overall Study|Withdrawal by Subject|2|||
131936707|NCT02457793|475055739|FG000|Overall Study|Adverse Event|0|||
131936708|NCT02457793|475055740|FG001|Overall Study|Adverse Event|0|||
131936709|NCT02457793|475055741|FG002|Overall Study|Adverse Event|0|||
131936710|NCT02457793|475055742|FG003|Overall Study|Adverse Event|1|||
131936711|NCT02457793|475055743|FG004|Overall Study|Adverse Event|0|||
131936712|NCT02457793|475055744|FG005|Overall Study|Adverse Event|0|||
131936713|NCT02457793|475055739|FG000|Overall Study|Physician Decision|1|||
131936714|NCT02457793|475055740|FG001|Overall Study|Physician Decision|0|||
131936715|NCT02457793|475055741|FG002|Overall Study|Physician Decision|1|||
131936716|NCT02457793|475055742|FG003|Overall Study|Physician Decision|1|||
131936717|NCT02457793|475055743|FG004|Overall Study|Physician Decision|1|||
131936718|NCT02457793|475055744|FG005|Overall Study|Physician Decision|3|||
131936719|NCT05929326|475055745|FG000|Overall Study|unqualified sample|2|||
131936720|NCT05929326|475055746|FG001|Overall Study|unqualified sample|3|||
131936721|NCT05929326|475055747|FG002|Overall Study|unqualified sample|7|||
131936722|NCT01657370|475057767|FG000|Overall Study|Withdrawal by Subject|0|||
131936723|NCT01657370|475057768|FG001|Overall Study|Withdrawal by Subject|0|||
131936724|NCT01657370|475057769|FG002|Overall Study|Withdrawal by Subject|1|||
131936725|NCT01657370|475057770|FG003|Overall Study|Withdrawal by Subject|0|||
131936726|NCT01657370|475057771|FG004|Overall Study|Withdrawal by Subject|0|||
131936727|NCT01657370|475057772|FG005|Overall Study|Withdrawal by Subject|1|||
131936728|NCT01657370|475057767|FG000|Overall Study|Physician Decision|2|||
131936729|NCT01657370|475057768|FG001|Overall Study|Physician Decision|3|||
131936730|NCT01657370|475057769|FG002|Overall Study|Physician Decision|1|||
131936731|NCT01657370|475057770|FG003|Overall Study|Physician Decision|2|||
131936732|NCT01657370|475057771|FG004|Overall Study|Physician Decision|5|||
131936733|NCT01657370|475057772|FG005|Overall Study|Physician Decision|0|||
131936734|NCT01657370|475057767|FG000|Overall Study|Lack of Qualifying Event|1|||
131936735|NCT01657370|475057768|FG001|Overall Study|Lack of Qualifying Event|0|||
131936736|NCT01657370|475057769|FG002|Overall Study|Lack of Qualifying Event|3|||
131936737|NCT01657370|475057770|FG003|Overall Study|Lack of Qualifying Event|2|||
131936738|NCT01657370|475057771|FG004|Overall Study|Lack of Qualifying Event|1|||
131936739|NCT01657370|475057772|FG005|Overall Study|Lack of Qualifying Event|2|||
131936740|NCT01657370|475057767|FG000|Overall Study|Adverse Event|0|||
131936741|NCT01657370|475057768|FG001|Overall Study|Adverse Event|0|||
131936742|NCT01657370|475057769|FG002|Overall Study|Adverse Event|0|||
131936743|NCT01657370|475057770|FG003|Overall Study|Adverse Event|0|||
131936744|NCT01657370|475057771|FG004|Overall Study|Adverse Event|1|||
131936745|NCT01657370|475057772|FG005|Overall Study|Adverse Event|0|||
131936746|NCT01657370|475057767|FG000|Overall Study|Protocol Violation|1|||
131936747|NCT01657370|475057768|FG001|Overall Study|Protocol Violation|1|||
131936748|NCT01657370|475057769|FG002|Overall Study|Protocol Violation|1|||
131936749|NCT01657370|475057770|FG003|Overall Study|Protocol Violation|1|||
131936750|NCT01657370|475057771|FG004|Overall Study|Protocol Violation|0|||
131936751|NCT01657370|475057772|FG005|Overall Study|Protocol Violation|0|||
131936752|NCT01657370|475057767|FG000|Overall Study|Lost to Follow-up|2|||
131936753|NCT01657370|475057768|FG001|Overall Study|Lost to Follow-up|0|||
131936754|NCT01657370|475057769|FG002|Overall Study|Lost to Follow-up|1|||
131936755|NCT01657370|475057770|FG003|Overall Study|Lost to Follow-up|0|||
131936756|NCT01657370|475057771|FG004|Overall Study|Lost to Follow-up|0|||
131936757|NCT01657370|475057772|FG005|Overall Study|Lost to Follow-up|1|||
131936758|NCT03440385|475057783|FG000|Overall Study|Other Reason|4|||
131936759|NCT03440385|475057784|FG001|Overall Study|Other Reason|1|||
131936760|NCT03440385|475057783|FG000|Overall Study|Site Closed|1|||
131936761|NCT03440385|475057784|FG001|Overall Study|Site Closed|0|||
131936762|NCT03440385|475057783|FG000|Overall Study|Lost to Follow-up|2|||
131936763|NCT03440385|475057784|FG001|Overall Study|Lost to Follow-up|0|||
131936764|NCT03440385|475057783|FG000|Overall Study|Withdrawal by Subject|12|||
131936765|NCT03440385|475057784|FG001|Overall Study|Withdrawal by Subject|6|||
131412561|NCT02032407|473133657|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131412562|NCT02191605|473133658|FG000|Overall Study|Lost to Follow-up|9|||
131936766|NCT03440385|475057783|FG000|Overall Study|Lack of Efficacy|9|||
131936767|NCT03440385|475057784|FG001|Overall Study|Lack of Efficacy|2|||
131936768|NCT03440385|475057783|FG000|Overall Study|Adverse Event|15|||
131936769|NCT03440385|475057784|FG001|Overall Study|Adverse Event|11|||
131936770|NCT00836706|475057785|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
131936771|NCT00836706|475057786|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
131936772|NCT01168596|475057792|FG000|Overall Study|Withdrawal by Subject|3|||
131412563|NCT02191605|473133659|FG001|Overall Study|Lost to Follow-up|4|||
131936773|NCT01168596|475057793|FG001|Overall Study|Withdrawal by Subject|1|||
131936774|NCT00876447|475057796|FG000|Overall Study|Other miscellaneous reasons|3|||
131936775|NCT00876447|475057797|FG001|Overall Study|Other miscellaneous reasons|8|||
131936776|NCT00876447|475057796|FG000|Overall Study|Site closure|19|||
131936777|NCT00876447|475057797|FG001|Overall Study|Site closure|14|||
131936778|NCT00876447|475057796|FG000|Overall Study|Protocol Violation|9|||
131936779|NCT00876447|475057797|FG001|Overall Study|Protocol Violation|3|||
131936780|NCT00876447|475057796|FG000|Overall Study|Personal reasons|30|||
131936781|NCT00876447|475057797|FG001|Overall Study|Personal reasons|28|||
131936782|NCT00876447|475057796|FG000|Overall Study|Lost to Follow-up|6|||
131936783|NCT00876447|475057797|FG001|Overall Study|Lost to Follow-up|15|||
131936784|NCT00876447|475057796|FG000|Overall Study|Pregnancy|4|||
131936785|NCT00876447|475057797|FG001|Overall Study|Pregnancy|2|||
131936786|NCT00876447|475057796|FG000|Overall Study|Lack of Efficacy|5|||
131936787|NCT00876447|475057797|FG001|Overall Study|Lack of Efficacy|3|||
131936788|NCT00876447|475057796|FG000|Overall Study|Adverse Event|4|||
131936789|NCT00876447|475057797|FG001|Overall Study|Adverse Event|8|||
131936790|NCT01497197|475057805|FG000|Overall Study|Lost to Follow-up|1|||
131936791|NCT01497197|475057806|FG001|Overall Study|Lost to Follow-up|0|||
131936792|NCT01497197|475057805|FG000|Overall Study|Protocol Violation|0|||
131936793|NCT01497197|475057806|FG001|Overall Study|Protocol Violation|2|||
131936794|NCT01497197|475057805|FG000|Overall Study|Withdrawal by Subject|2|||
131936795|NCT01497197|475057806|FG001|Overall Study|Withdrawal by Subject|1|||
131936796|NCT01497197|475057805|FG000|Overall Study|Excessive/lack of response to treatment|1|||
131936797|NCT01497197|475057806|FG001|Overall Study|Excessive/lack of response to treatment|0|||
131936798|NCT01497197|475057805|FG000|Overall Study|Risk of OHSS|1|||
131936799|NCT01497197|475057806|FG001|Overall Study|Risk of OHSS|0|||
131936800|NCT01497197|475057805|FG000|Overall Study|No oocytes retrieved|3|||
131936801|NCT01497197|475057806|FG001|Overall Study|No oocytes retrieved|2|||
131936802|NCT01497197|475057805|FG000|Overall Study|No fertilisation|6|||
131936803|NCT01497197|475057806|FG001|Overall Study|No fertilisation|5|||
131936804|NCT01497197|475057805|FG000|Overall Study|Intention to freeze all embryos|0|||
131936805|NCT01497197|475057806|FG001|Overall Study|Intention to freeze all embryos|1|||
131936806|NCT01497197|475057805|FG000|Overall Study|All embryos discarded|0|||
131936807|NCT01497197|475057806|FG001|Overall Study|All embryos discarded|3|||
131936808|NCT01497197|475057805|FG000|Overall Study|Other|3|||
131936809|NCT01497197|475057806|FG001|Overall Study|Other|1|||
131936810|NCT01425814|475057808|FG000|Period 1|Stability criteria not fulfilled|0|||
131936811|NCT01425814|475057809|FG001|Period 1|Stability criteria not fulfilled|1|||
131936812|NCT01425814|475057810|FG002|Period 1|Stability criteria not fulfilled|0|||
131936813|NCT01425814|475057811|FG003|Period 1|Stability criteria not fulfilled|0|||
131936814|NCT01425814|475057812|FG004|Period 1|Stability criteria not fulfilled|0|||
131936815|NCT01425814|475057813|FG005|Period 1|Stability criteria not fulfilled|0|||
131936816|NCT01425814|475057808|FG000|Period 2|Stability criteria not fulfilled|0|||
131936817|NCT01425814|475057809|FG001|Period 2|Stability criteria not fulfilled|1|||
131936818|NCT01425814|475057810|FG002|Period 2|Stability criteria not fulfilled|0|||
131936819|NCT01425814|475057811|FG003|Period 2|Stability criteria not fulfilled|0|||
131936820|NCT01425814|475057812|FG004|Period 2|Stability criteria not fulfilled|0|||
131936821|NCT01425814|475057813|FG005|Period 2|Stability criteria not fulfilled|0|||
131936822|NCT01425814|475057808|FG000|Period 3|Adverse Event|0|||
131936823|NCT01425814|475057809|FG001|Period 3|Adverse Event|0|||
131936824|NCT01425814|475057810|FG002|Period 3|Adverse Event|0|||
131936825|NCT01425814|475057811|FG003|Period 3|Adverse Event|0|||
131936826|NCT01425814|475057812|FG004|Period 3|Adverse Event|0|||
131936827|NCT01425814|475057813|FG005|Period 3|Adverse Event|1|||
131936828|NCT01425814|475057808|FG000|Period 4|Adverse Event|1|||
131936829|NCT01425814|475057809|FG001|Period 4|Adverse Event|0|||
131936830|NCT01425814|475057810|FG002|Period 4|Adverse Event|1|||
131936831|NCT01425814|475057811|FG003|Period 4|Adverse Event|0|||
131936832|NCT01425814|475057812|FG004|Period 4|Adverse Event|0|||
131936833|NCT01425814|475057813|FG005|Period 4|Adverse Event|0|||
131936834|NCT01425814|475057808|FG000|Period 5|Stability criteria not fulfilled|0|||
131936835|NCT01425814|475057809|FG001|Period 5|Stability criteria not fulfilled|0|||
131936836|NCT01425814|475057810|FG002|Period 5|Stability criteria not fulfilled|1|||
131936837|NCT01425814|475057811|FG003|Period 5|Stability criteria not fulfilled|0|||
131936838|NCT01425814|475057812|FG004|Period 5|Stability criteria not fulfilled|0|||
131936839|NCT01425814|475057813|FG005|Period 5|Stability criteria not fulfilled|1|||
131936840|NCT00565747|475057821|FG000|Overall Study|No embryo transfer|67|||
131936841|NCT00565747|475057822|FG001|Overall Study|No embryo transfer|73|||
131936842|NCT00183248|475057823|FG000|Overall Study|Lost to Follow-up|0|||
131936843|NCT00183248|475057824|FG001|Overall Study|Lost to Follow-up|1|||
131936844|NCT00183248|475057823|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
131936845|NCT00183248|475057824|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
131936846|NCT02390076|475057825|FG000|Overall Study|Lost to Follow-up|2|||
131936847|NCT02390076|475057826|FG001|Overall Study|Lost to Follow-up|1|||
131936848|NCT02390076|475057827|FG002|Overall Study|Lost to Follow-up|4|||
131936849|NCT00553254|475057828|FG000|Overall Study|Death|3|||
131936850|NCT00553254|475057829|FG001|Overall Study|Death|6|||
131936851|NCT00553254|475057830|FG002|Overall Study|Death|25|||
131936852|NCT00553254|475057828|FG000|Overall Study|Lost to Follow-up|0|||
131936853|NCT00553254|475057829|FG001|Overall Study|Lost to Follow-up|0|||
131936854|NCT00553254|475057830|FG002|Overall Study|Lost to Follow-up|2|||
131936855|NCT00553254|475057828|FG000|Overall Study|Withdrawal by Subject|2|||
131936856|NCT00553254|475057829|FG001|Overall Study|Withdrawal by Subject|0|||
131936857|NCT00553254|475057830|FG002|Overall Study|Withdrawal by Subject|2|||
131936858|NCT00553254|475057828|FG000|Overall Study|Study terminated by Sponsor|0|||
131936859|NCT00553254|475057829|FG001|Overall Study|Study terminated by Sponsor|0|||
131936860|NCT00553254|475057830|FG002|Overall Study|Study terminated by Sponsor|1|||
131936861|NCT00553254|475057828|FG000|Overall Study|Other|1|||
131936862|NCT00553254|475057829|FG001|Overall Study|Other|0|||
131936863|NCT00553254|475057830|FG002|Overall Study|Other|13|||
131936864|NCT02300233|475057838|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
131936865|NCT02300233|475057839|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
131936866|NCT02300233|475057840|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
131936867|NCT02300233|475057838|FG000|Overall Study|Withdrawal by Subject|1|||
131936868|NCT02300233|475057839|FG001|Overall Study|Withdrawal by Subject|0|||
131936869|NCT02300233|475057840|FG002|Overall Study|Withdrawal by Subject|3|||
131936870|NCT02300233|475057838|FG000|Overall Study|Investigator Judgement|0|||
131936871|NCT02300233|475057839|FG001|Overall Study|Investigator Judgement|0|||
131936872|NCT02300233|475057840|FG002|Overall Study|Investigator Judgement|1|||
131936873|NCT02300233|475057838|FG000|Overall Study|Reason Not Specified|0|||
131936874|NCT02300233|475057839|FG001|Overall Study|Reason Not Specified|0|||
131936875|NCT02300233|475057840|FG002|Overall Study|Reason Not Specified|5|||
131936876|NCT00833690|475057841|FG000|Overall Study|Withdrawal by Subject|1|||
131936877|NCT00833690|475057842|FG001|Overall Study|Withdrawal by Subject|0|||
131936878|NCT00833690|475057843|FG002|Overall Study|Withdrawal by Subject|0|||
131936879|NCT00833690|475057841|FG000|Overall Study|Discontinued study drug|3|||
131936880|NCT00833690|475057842|FG001|Overall Study|Discontinued study drug|2|||
131936881|NCT00833690|475057843|FG002|Overall Study|Discontinued study drug|0|||
131936882|NCT03232567|475057844|FG000|Overall Study|Withdrawal by Subject|0|||
131936883|NCT03232567|475057845|FG001|Overall Study|Withdrawal by Subject|1|||
131936884|NCT03232567|475057846|FG002|Overall Study|Withdrawal by Subject|0|||
131936885|NCT03232567|475057847|FG003|Overall Study|Withdrawal by Subject|0|||
131936886|NCT05837481|475057849|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
131936887|NCT05837481|475057850|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
131936888|NCT05805150|475057861|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
131936889|NCT05805150|475057862|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
131936890|NCT02284893|475057865|FG000|26 Week (Short Term)|Adverse Event|1|||
131936891|NCT02284893|475057866|FG001|26 Week (Short Term)|Adverse Event|9|||
131936892|NCT02284893|475057865|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
131936893|NCT02284893|475057866|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
131936894|NCT02284893|475057865|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
131936895|NCT02284893|475057866|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
131936896|NCT02284893|475057865|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
131936897|NCT02284893|475057866|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
131936898|NCT02284893|475057865|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
131936899|NCT02284893|475057866|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
131936900|NCT02284893|475057865|FG000|26 Week (Short Term)|Other|1|||
131936901|NCT02284893|475057866|FG001|26 Week (Short Term)|Other|1|||
131936902|NCT02284893|475057865|FG000|52 Week (Long Term)|Adverse Event|3|||
131936903|NCT02284893|475057866|FG001|52 Week (Long Term)|Adverse Event|1|||
131936904|NCT02284893|475057865|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
131936905|NCT02284893|475057866|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
131936906|NCT02284893|475057865|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
131936907|NCT02284893|475057866|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
131936908|NCT02284893|475057865|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
131936909|NCT02284893|475057866|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
131936910|NCT02284893|475057865|FG000|52 Week (Long Term)|Non-Compliance|2|||
131936911|NCT02284893|475057866|FG001|52 Week (Long Term)|Non-Compliance|3|||
131936912|NCT00105066|475057869|FG000|Overall Study|Adverse Event|2|||
131936913|NCT00105066|475057870|FG001|Overall Study|Adverse Event|5|||
131936914|NCT04380142|475057871|FG000|LD/CD Stabilization Period|Adverse Event|3|||
131412564|NCT02191605|473133660|FG002|Overall Study|Lost to Follow-up|7|||
131412565|NCT02191605|473133661|FG003|Overall Study|Lost to Follow-up|3|||
131412566|NCT02191605|473133662|FG004|Overall Study|Lost to Follow-up|4|||
131412567|NCT00734071|473133663|FG000|Overall Study|Adverse Event|4|||
131412568|NCT00734071|473133664|FG001|Overall Study|Adverse Event|3|||
131412569|NCT00734071|473133663|FG000|Overall Study|Lack of Efficacy|3|||
131936915|NCT04380142|475057872|FG001|LD/CD Stabilization Period|Adverse Event|0|||
131936916|NCT04380142|475057873|FG002|LD/CD Stabilization Period|Adverse Event|0|||
131936917|NCT04380142|475057871|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
131936918|NCT04380142|475057872|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
131936919|NCT04380142|475057873|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
131412570|NCT00734071|473133664|FG001|Overall Study|Lack of Efficacy|1|||
131936920|NCT04380142|475057871|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
131936921|NCT04380142|475057872|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
131936922|NCT04380142|475057873|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
131936923|NCT04380142|475057871|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
131936924|NCT04380142|475057872|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
131936925|NCT04380142|475057873|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
131936926|NCT04380142|475057871|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
131936927|NCT04380142|475057872|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
131936928|NCT04380142|475057873|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
131936929|NCT04380142|475057871|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
131936930|NCT04380142|475057872|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
131936931|NCT04380142|475057873|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
131936932|NCT04380142|475057871|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131936933|NCT04380142|475057872|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131936934|NCT04380142|475057873|FG002|Double-Blind Treatment Period|Adverse Event|14|||
131936935|NCT04380142|475057871|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
131936936|NCT04380142|475057872|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
131936937|NCT04380142|475057873|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
131936938|NCT04380142|475057871|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
131936939|NCT04380142|475057872|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
131936940|NCT04380142|475057873|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
131936941|NCT04380142|475057871|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
131936942|NCT04380142|475057872|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
131936943|NCT04380142|475057873|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
131936944|NCT04380142|475057871|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
131936945|NCT04380142|475057872|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
131936946|NCT04380142|475057873|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
131936947|NCT04380142|475057871|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
131936948|NCT04380142|475057872|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
131936949|NCT04380142|475057873|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
131936950|NCT00787150|475057882|FG000|Overall Study|Adverse Event|4|||
131936951|NCT00787150|475057883|FG001|Overall Study|Adverse Event|4|||
131936952|NCT00787150|475057884|FG002|Overall Study|Adverse Event|4|||
131936953|NCT00787150|475057882|FG000|Overall Study|Physician Decision|1|||
131936954|NCT00787150|475057883|FG001|Overall Study|Physician Decision|2|||
131936955|NCT00787150|475057884|FG002|Overall Study|Physician Decision|1|||
131936956|NCT00787150|475057882|FG000|Overall Study|Withdrawal by Subject|2|||
131936957|NCT00787150|475057883|FG001|Overall Study|Withdrawal by Subject|1|||
131936958|NCT00787150|475057884|FG002|Overall Study|Withdrawal by Subject|0|||
131936959|NCT00787150|475057882|FG000|Overall Study|Dosing incorrect study durg|2|||
131936960|NCT00787150|475057883|FG001|Overall Study|Dosing incorrect study durg|0|||
131936961|NCT00787150|475057884|FG002|Overall Study|Dosing incorrect study durg|0|||
131936962|NCT01849276|475057887|FG000|Followed for Survival for 5 Years|Death|1|||
131936963|NCT01849276|475057887|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
131936964|NCT01506726|475057896|FG000|Overall Study|Adverse Event|1|||
131936965|NCT01506726|475057897|FG001|Overall Study|Adverse Event|2|||
131936966|NCT03773484|475057898|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
131936967|NCT01380080|475057899|FG000|Overall Study|Death|36|||
131936968|NCT01380080|475057900|FG001|Overall Study|Death|44|||
131936969|NCT01380080|475057899|FG000|Overall Study|Site is closing|28|||
131936970|NCT01380080|475057900|FG001|Overall Study|Site is closing|31|||
131936971|NCT01380080|475057899|FG000|Overall Study|Not able to get to clinic|7|||
131936972|NCT01380080|475057900|FG001|Overall Study|Not able to get to clinic|1|||
131936973|NCT01380080|475057899|FG000|Overall Study|Not willing to adhere to requirements|6|||
131936974|NCT01380080|475057900|FG001|Overall Study|Not willing to adhere to requirements|2|||
131936975|NCT01380080|475057899|FG000|Overall Study|Withdrawal by Subject|5|||
131936976|NCT01380080|475057900|FG001|Overall Study|Withdrawal by Subject|2|||
131936977|NCT01380080|475057899|FG000|Overall Study|Lost to Follow-up|3|||
131454620|NCT00114517|473293362|FG000|Overall Study|Lost interest|0|||
131936978|NCT01380080|475057900|FG001|Overall Study|Lost to Follow-up|3|||
131936979|NCT01722669|475057905|FG000|Overall Study|Withdrawal by Subject|0|||
131936980|NCT01722669|475057906|FG001|Overall Study|Withdrawal by Subject|0|||
131936981|NCT01722669|475057907|FG002|Overall Study|Withdrawal by Subject|0|||
131936982|NCT01722669|475057908|FG003|Overall Study|Withdrawal by Subject|0|||
131936983|NCT01722669|475057909|FG004|Overall Study|Withdrawal by Subject|0|||
131936984|NCT01722669|475057910|FG005|Overall Study|Withdrawal by Subject|2|||
131936985|NCT01344226|475057913|FG000|Overall Study|Protocol Violation|2|||
131936986|NCT01344226|475057913|FG000|Overall Study|Withdrawal by Subject|3|||
131936987|NCT01344226|475057913|FG000|Overall Study|Lack of Efficacy|3|||
131936988|NCT03211416|475057915|FG000|Overall Study|Adverse Event|7|||
131454621|NCT00114517|473293363|FG001|Overall Study|Lost interest|0|||
131936989|NCT03211416|475057915|FG000|Overall Study|Lack of Efficacy|2|||
131936990|NCT03211416|475057915|FG000|Overall Study|Physician Decision|1|||
131936991|NCT02302222|475057917|FG000|Overall Study|Physician Decision|0|||
131936992|NCT02302222|475057918|FG001|Overall Study|Physician Decision|4|||
131936993|NCT02302222|475057917|FG000|Overall Study|Lost to Follow-up|1|||
131936994|NCT02302222|475057918|FG001|Overall Study|Lost to Follow-up|0|||
131936995|NCT02302222|475057917|FG000|Overall Study|Treatment discontinued before day 5|0|||
131936996|NCT02302222|475057918|FG001|Overall Study|Treatment discontinued before day 5|1|||
131936997|NCT02302222|475057917|FG000|Overall Study|Withdrawn prior to any treatment|0|||
131936998|NCT02302222|475057918|FG001|Overall Study|Withdrawn prior to any treatment|1|||
131936999|NCT03781570|475057924|FG000|Overall Study|Technical Issues (equipment failure)|31|||
131937000|NCT03781570|475057924|FG000|Overall Study|Withdrawal by Subject|7|||
131937001|NCT03781570|475057924|FG000|Overall Study|Physical Constraints|11|||
131937002|NCT01107496|475057925|FG000|Overall Study|Adverse Event|1|||
131937003|NCT01107496|475057926|FG001|Overall Study|Adverse Event|0|||
131937004|NCT01107496|475057925|FG000|Overall Study|Lack of Efficacy|1|||
131937005|NCT01107496|475057926|FG001|Overall Study|Lack of Efficacy|0|||
131937006|NCT01107496|475057925|FG000|Overall Study|Protocol Violation|0|||
131937007|NCT01107496|475057926|FG001|Overall Study|Protocol Violation|1|||
131937008|NCT01107496|475057925|FG000|Overall Study|Lost to Follow-up|0|||
131937009|NCT01107496|475057926|FG001|Overall Study|Lost to Follow-up|1|||
131937010|NCT03709472|475057927|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
131937011|NCT03709472|475057928|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
131937012|NCT03709472|475057927|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
131937013|NCT03709472|475057928|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
131937014|NCT03559556|475057929|FG000|Overall Study|Withdrawal by Subject|1|||
131937015|NCT02496000|475057931|FG000|Overall Study|Withdrawal by Subject|1|||
131937016|NCT02496000|475057932|FG001|Overall Study|Withdrawal by Subject|2|||
131937017|NCT02496000|475057933|FG002|Overall Study|Withdrawal by Subject|0|||
131937018|NCT02496000|475057931|FG000|Overall Study|Lost to Follow-up|1|||
131937019|NCT02496000|475057932|FG001|Overall Study|Lost to Follow-up|0|||
131937020|NCT02496000|475057933|FG002|Overall Study|Lost to Follow-up|1|||
131937021|NCT02496000|475057931|FG000|Overall Study|Protocol Violation|0|||
131937022|NCT02496000|475057932|FG001|Overall Study|Protocol Violation|0|||
131937023|NCT02496000|475057933|FG002|Overall Study|Protocol Violation|1|||
131937024|NCT02496000|475057931|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
131937025|NCT02496000|475057932|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
131937026|NCT02496000|475057933|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
131937027|NCT02496000|475057931|FG000|Overall Study|undetermined|0|||
131937028|NCT02496000|475057932|FG001|Overall Study|undetermined|1|||
131937029|NCT02496000|475057933|FG002|Overall Study|undetermined|0|||
131937030|NCT03734536|475057934|FG000|Overall Study|Withdrew Consent|1|||
131937031|NCT03734536|475057935|FG001|Overall Study|Withdrew Consent|5|||
131937032|NCT03734536|475057934|FG000|Overall Study|Lost to Follow-up|10|||
131937033|NCT03734536|475057935|FG001|Overall Study|Lost to Follow-up|7|||
131937034|NCT01877278|475057936|FG000|Overall Study|Lost to Follow-up|3|||
131937035|NCT01877278|475057937|FG001|Overall Study|Lost to Follow-up|3|||
131937036|NCT04890509|475057938|FG000|Overall Study|Death|4|||
131937037|NCT04890509|475057939|FG001|Overall Study|Death|4|||
131937038|NCT03274466|475057940|FG000|Overall Study|Withdrawal by Subject|7|||
131937039|NCT03274466|475057941|FG001|Overall Study|Withdrawal by Subject|3|||
131937040|NCT03274466|475057940|FG000|Overall Study|Protocol Specified Withdrawal|5|||
131937041|NCT03274466|475057941|FG001|Overall Study|Protocol Specified Withdrawal|11|||
131937042|NCT03274466|475057940|FG000|Overall Study|Lost to Follow-up|5|||
131937043|NCT03274466|475057941|FG001|Overall Study|Lost to Follow-up|7|||
131937044|NCT03274466|475057940|FG000|Overall Study|Subject Non-compliance|0|||
131937045|NCT03274466|475057941|FG001|Overall Study|Subject Non-compliance|1|||
131937046|NCT03274466|475057940|FG000|Overall Study|Adverse Event|3|||
131937047|NCT03274466|475057941|FG001|Overall Study|Adverse Event|3|||
131937048|NCT03274466|475057940|FG000|Overall Study|Physician Decision|0|||
131937049|NCT03274466|475057941|FG001|Overall Study|Physician Decision|1|||
131937050|NCT03274466|475057940|FG000|Overall Study|Protocol Violation|3|||
131937051|NCT03274466|475057941|FG001|Overall Study|Protocol Violation|3|||
131937052|NCT00618787|475057942|FG000|Overall Study|Adverse Event|0|||
131937053|NCT00618787|475057943|FG001|Overall Study|Adverse Event|1|||
131937054|NCT00618787|475057942|FG000|Overall Study|Withdrawal by Subject|2|||
131937055|NCT00618787|475057943|FG001|Overall Study|Withdrawal by Subject|1|||
131937056|NCT00618787|475057942|FG000|Overall Study|Lost to Follow-up|1|||
131937057|NCT00618787|475057943|FG001|Overall Study|Lost to Follow-up|0|||
131937058|NCT01107886|475057944|FG000|Overall Study|Lost to Follow-up|15|||
131937059|NCT01107886|475057945|FG001|Overall Study|Lost to Follow-up|13|||
131937060|NCT01107886|475057944|FG000|Overall Study|Withdrawal by Subject|180|||
131937061|NCT01107886|475057945|FG001|Overall Study|Withdrawal by Subject|196|||
131937062|NCT01107886|475057944|FG000|Overall Study|Administrative withdrawal of consent|7|||
131937063|NCT01107886|475057945|FG001|Overall Study|Administrative withdrawal of consent|5|||
131412571|NCT00734071|473133663|FG000|Overall Study|Noncompliance|2|||
131412572|NCT00734071|473133664|FG001|Overall Study|Noncompliance|2|||
131937064|NCT02333799|475060062|FG000|Treatment Period|Withdrawal by Subject|1|||
131937065|NCT02333799|475060062|FG000|Treatment Period|Death|6|||
131937066|NCT02333799|475060062|FG000|6 Month Follow Up Period|Physician Decision|1|||
131937067|NCT02333799|475060062|FG000|6 Month Follow Up Period|Death|1|||
131937068|NCT02333799|475060062|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
131937069|NCT02333799|475060062|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
131937070|NCT02296476|475060063|FG000|Overall Study|Disease Progression|6|||
131937071|NCT02296476|475060064|FG001|Overall Study|Disease Progression|4|||
131937072|NCT02296476|475060065|FG002|Overall Study|Disease Progression|2|||
131937073|NCT00442702|475060066|FG000|Titration Period|Adverse Event|2|||
131937074|NCT00442702|475060067|FG001|Titration Period|Adverse Event|0|||
131937075|NCT00442702|475060066|FG000|Titration Period|Death|3|||
131937076|NCT00442702|475060067|FG001|Titration Period|Death|2|||
131937077|NCT00442702|475060066|FG000|Titration Period|Insufficient Therapeutic Response|1|||
131937078|NCT00442702|475060067|FG001|Titration Period|Insufficient Therapeutic Response|0|||
131937079|NCT00442702|475060066|FG000|Titration Period|Refused Treatment|4|||
131937080|NCT00442702|475060067|FG001|Titration Period|Refused Treatment|1|||
131937081|NCT00442702|475060066|FG000|Titration Period|Failure to return|1|||
131937082|NCT00442702|475060067|FG001|Titration Period|Failure to return|0|||
131937083|NCT00442702|475060066|FG000|Titration Period|Hospitalized in another hospital|1|||
131937084|NCT00442702|475060067|FG001|Titration Period|Hospitalized in another hospital|0|||
131937085|NCT00442702|475060066|FG000|Evaluation Period|Adverse Event|1|||
131937086|NCT00442702|475060067|FG001|Evaluation Period|Adverse Event|0|||
131937087|NCT00442702|475060066|FG000|Evaluation Period|Death|1|||
131937088|NCT00442702|475060067|FG001|Evaluation Period|Death|1|||
131937089|NCT00442702|475060066|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
131937090|NCT00442702|475060067|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
131937091|NCT00442702|475060066|FG000|Evaluation Period|Refused treatment|1|||
131937092|NCT00442702|475060067|FG001|Evaluation Period|Refused treatment|1|||
131937093|NCT00442702|475060066|FG000|Evaluation Period|Renal transplant|0|||
131937094|NCT00442702|475060067|FG001|Evaluation Period|Renal transplant|1|||
131937095|NCT00442702|475060066|FG000|Evaluation Period|Failure to return|1|||
131937096|NCT00442702|475060067|FG001|Evaluation Period|Failure to return|0|||
131937097|NCT00442702|475060066|FG000|Evaluation Period|Site closure|0|||
131937098|NCT00442702|475060067|FG001|Evaluation Period|Site closure|1|||
131937099|NCT02552225|475060074|FG000|Overall Study|Withdrawal by Subject|1|||
131937100|NCT02552225|475060075|FG001|Overall Study|Withdrawal by Subject|0|||
131937101|NCT02297516|475060076|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
131937102|NCT02297516|475060077|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
131937103|NCT02297516|475060076|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
131937104|NCT02297516|475060077|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
131937105|NCT02297516|475060076|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
131937106|NCT02297516|475060077|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
131937107|NCT00189423|475060080|FG000|Overall Study|Death|746|||
131937108|NCT00189423|475060081|FG001|Overall Study|Death|747|||
131937109|NCT00189423|475060080|FG000|Overall Study|Withdrawal by Subject|9|||
131937110|NCT00189423|475060081|FG001|Overall Study|Withdrawal by Subject|9|||
131937111|NCT00189423|475060080|FG000|Overall Study|Lost to Follow-up|10|||
131937112|NCT00189423|475060081|FG001|Overall Study|Lost to Follow-up|10|||
131937113|NCT04622592|475060082|FG000|Overall Study|Death|0|||
131937114|NCT04622592|475060083|FG001|Overall Study|Death|0|||
131937115|NCT04622592|475060084|FG002|Overall Study|Death|1|||
131937116|NCT04622592|475060085|FG003|Overall Study|Death|0|||
131937117|NCT04622592|475060086|FG004|Overall Study|Death|0|||
131937118|NCT04622592|475060087|FG005|Overall Study|Death|0|||
131937119|NCT04622592|475060088|FG006|Overall Study|Death|0|||
131937120|NCT04622592|475060089|FG007|Overall Study|Death|1|||
131937121|NCT04622592|475060082|FG000|Overall Study|Lost to Follow-up|0|||
131937122|NCT04622592|475060083|FG001|Overall Study|Lost to Follow-up|0|||
131937123|NCT04622592|475060084|FG002|Overall Study|Lost to Follow-up|0|||
131937124|NCT04622592|475060085|FG003|Overall Study|Lost to Follow-up|3|||
131937125|NCT04622592|475060086|FG004|Overall Study|Lost to Follow-up|1|||
131937126|NCT04622592|475060087|FG005|Overall Study|Lost to Follow-up|0|||
131937127|NCT04622592|475060088|FG006|Overall Study|Lost to Follow-up|2|||
131937128|NCT04622592|475060089|FG007|Overall Study|Lost to Follow-up|2|||
131937129|NCT04622592|475060082|FG000|Overall Study|Physician Decision|0|||
131937130|NCT04622592|475060083|FG001|Overall Study|Physician Decision|0|||
131937131|NCT04622592|475060084|FG002|Overall Study|Physician Decision|0|||
131937132|NCT04622592|475060085|FG003|Overall Study|Physician Decision|0|||
131937133|NCT04622592|475060086|FG004|Overall Study|Physician Decision|1|||
131937134|NCT04622592|475060087|FG005|Overall Study|Physician Decision|0|||
131937135|NCT04622592|475060088|FG006|Overall Study|Physician Decision|0|||
131937136|NCT04622592|475060089|FG007|Overall Study|Physician Decision|0|||
131937137|NCT04622592|475060082|FG000|Overall Study|Withdrawal by Subject|1|||
131937138|NCT04622592|475060083|FG001|Overall Study|Withdrawal by Subject|0|||
131937139|NCT04622592|475060084|FG002|Overall Study|Withdrawal by Subject|2|||
131937140|NCT04622592|475060085|FG003|Overall Study|Withdrawal by Subject|0|||
131937141|NCT04622592|475060086|FG004|Overall Study|Withdrawal by Subject|0|||
131937142|NCT04622592|475060087|FG005|Overall Study|Withdrawal by Subject|0|||
131937143|NCT04622592|475060088|FG006|Overall Study|Withdrawal by Subject|1|||
131937144|NCT04622592|475060089|FG007|Overall Study|Withdrawal by Subject|4|||
131937145|NCT04622592|475060082|FG000|Overall Study|Other than specified above|0|||
131937146|NCT04622592|475060083|FG001|Overall Study|Other than specified above|0|||
131937147|NCT04622592|475060084|FG002|Overall Study|Other than specified above|1|||
131937148|NCT04622592|475060085|FG003|Overall Study|Other than specified above|0|||
131937149|NCT04622592|475060086|FG004|Overall Study|Other than specified above|0|||
131937150|NCT04622592|475060087|FG005|Overall Study|Other than specified above|0|||
131937151|NCT04622592|475060088|FG006|Overall Study|Other than specified above|0|||
131937152|NCT04622592|475060089|FG007|Overall Study|Other than specified above|0|||
131937153|NCT04734210|475060090|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
131937154|NCT04734210|475060091|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
131937155|NCT04734210|475060092|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
131937156|NCT04734210|475060090|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
131937157|NCT04734210|475060091|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
131937158|NCT04734210|475060092|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
131937159|NCT04734210|475060090|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
131937160|NCT04734210|475060091|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
131937161|NCT04734210|475060092|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
131937162|NCT04734210|475060090|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
131937163|NCT04734210|475060091|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
131937164|NCT04734210|475060092|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
131937165|NCT02138825|475060093|FG000|Main Study Treatment|Adverse Event|11|||
131937166|NCT02138825|475060094|FG001|Main Study Treatment|Adverse Event|3|||
131937167|NCT02138825|475060093|FG000|Main Study Treatment|Death|1|||
131937168|NCT02138825|475060094|FG001|Main Study Treatment|Death|2|||
131937169|NCT02138825|475060093|FG000|Main Study Treatment|Protocol Violation|2|||
131937170|NCT02138825|475060094|FG001|Main Study Treatment|Protocol Violation|2|||
131937171|NCT02138825|475060093|FG000|Main Study Treatment|Sponsor decision|12|||
131937172|NCT02138825|475060094|FG001|Main Study Treatment|Sponsor decision|18|||
131937173|NCT02138825|475060093|FG000|Main Study Treatment|Study terminated by sponsor|10|||
131937174|NCT02138825|475060094|FG001|Main Study Treatment|Study terminated by sponsor|9|||
131937175|NCT02138825|475060093|FG000|Main Study Treatment|Withdrawal by Subject|3|||
131937176|NCT02138825|475060094|FG001|Main Study Treatment|Withdrawal by Subject|1|||
131937177|NCT02138825|475060093|FG000|Main Study Treatment|Medical decision|1|||
131937178|NCT02138825|475060094|FG001|Main Study Treatment|Medical decision|0|||
131937179|NCT02138825|475060093|FG000|Long-term Extension|Study termination by sponsor|32|||
131937180|NCT02138825|475060094|FG001|Long-term Extension|Study termination by sponsor|38|||
131937181|NCT02138825|475060093|FG000|Safety Follow-up|Adverse Event|4|||
131937182|NCT02138825|475060094|FG001|Safety Follow-up|Adverse Event|3|||
131937183|NCT02138825|475060093|FG000|Safety Follow-up|Death|11|||
131937184|NCT02138825|475060094|FG001|Safety Follow-up|Death|5|||
131937185|NCT02138825|475060093|FG000|Safety Follow-up|Withdrawal by Subject|5|||
131937186|NCT02138825|475060094|FG001|Safety Follow-up|Withdrawal by Subject|3|||
131937187|NCT02138825|475060093|FG000|Safety Follow-up|clinic worsening|1|||
131937188|NCT02138825|475060094|FG001|Safety Follow-up|clinic worsening|0|||
131937189|NCT02138825|475060093|FG000|Safety Follow-up|withdrawal by PI|1|||
131937190|NCT02138825|475060094|FG001|Safety Follow-up|withdrawal by PI|0|||
131937191|NCT02138825|475060093|FG000|Safety Follow-up|logistical difficulties|0|||
131937192|NCT02138825|475060094|FG001|Safety Follow-up|logistical difficulties|1|||
131937193|NCT02138825|475060093|FG000|Safety Follow-up|progressive disease|0|||
131937194|NCT02138825|475060094|FG001|Safety Follow-up|progressive disease|2|||
131937195|NCT02138825|475060093|FG000|Safety Follow-up|too unwell to attend the visit|0|||
131937196|NCT02138825|475060094|FG001|Safety Follow-up|too unwell to attend the visit|1|||
131937197|NCT02138825|475060093|FG000|Safety Follow-up|treatment unblinded|0|||
131937198|NCT02138825|475060094|FG001|Safety Follow-up|treatment unblinded|1|||
131937199|NCT02138825|475060093|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
131937200|NCT02138825|475060094|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
131937201|NCT05201807|475060100|FG000|Overall Study|Adverse Event|1|||
131937202|NCT05201807|475060100|FG000|Overall Study|COVID-19 Related|1|||
131937203|NCT01209767|475060101|FG000|Overall Study|Withdrawal by Subject|1|||
131937204|NCT01209767|475060101|FG000|Overall Study|Lost to Follow-up|3|||
131937205|NCT04507204|475060102|FG000|Overall Study|Adverse Event|8|||
131937206|NCT04507204|475060103|FG001|Overall Study|Adverse Event|13|||
131937207|NCT04507204|475060102|FG000|Overall Study|Death|0|||
131937208|NCT04507204|475060103|FG001|Overall Study|Death|1|||
131937209|NCT04507204|475060102|FG000|Overall Study|Lost to Follow-up|15|||
131937210|NCT04507204|475060103|FG001|Overall Study|Lost to Follow-up|14|||
131937211|NCT04507204|475060102|FG000|Overall Study|Poor Compliance with Protocol|2|||
131937212|NCT04507204|475060103|FG001|Overall Study|Poor Compliance with Protocol|4|||
131412573|NCT00734071|473133663|FG000|Overall Study|Protocol Deviations|3|||
131412574|NCT00734071|473133664|FG001|Overall Study|Protocol Deviations|4|||
131412575|NCT00734071|473133663|FG000|Overall Study|Voluntary Withdrawal|9|||
131412576|NCT00734071|473133664|FG001|Overall Study|Voluntary Withdrawal|7|||
131412577|NCT00734071|473133663|FG000|Overall Study|Lost to Follow-up|16|||
131412578|NCT00734071|473133664|FG001|Overall Study|Lost to Follow-up|8|||
131412579|NCT00734071|473133663|FG000|Overall Study|Other|1|||
131412580|NCT00734071|473133664|FG001|Overall Study|Other|2|||
131412581|NCT00240110|473133668|FG000|Overall Study|Lost to Follow-up|6|||
131412582|NCT00240110|473133669|FG001|Overall Study|Lost to Follow-up|7|||
131412583|NCT00583791|473133670|FG000|Overall Study|Other|67|||
131412584|NCT00583791|473133670|FG000|Overall Study|Death|6|||
131412585|NCT03323736|473133671|FG000|Overall Study|Screen Failure|14|||
131412586|NCT03323736|473133672|FG001|Overall Study|Screen Failure|9|||
131412587|NCT03323736|473133673|FG002|Overall Study|Screen Failure|1|||
131412588|NCT03323736|473133671|FG000|Overall Study|Withdrawal Before Treatment|3|||
131412589|NCT03323736|473133672|FG001|Overall Study|Withdrawal Before Treatment|1|||
131412590|NCT03323736|473133673|FG002|Overall Study|Withdrawal Before Treatment|1|||
131412591|NCT03323736|473133671|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
131412592|NCT03323736|473133672|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
131412593|NCT03323736|473133673|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
131412594|NCT02654236|473133677|FG000|Overall Study|Withdrawal by Subject|0|||
131412595|NCT02654236|473133678|FG001|Overall Study|Withdrawal by Subject|0|||
131412596|NCT02654236|473133679|FG002|Overall Study|Withdrawal by Subject|2|||
131412597|NCT03204890|473133680|FG000|Overall Study|Withdrawal by Subject|1|||
131412598|NCT01549873|473133681|FG000|Overall Study|Physician Decision|0|||
131412599|NCT01549873|473133682|FG001|Overall Study|Physician Decision|1|||
131412600|NCT02785458|473133683|FG000|1 Month|Withdrawal by Subject|2|||
131412601|NCT02785458|473133684|FG001|1 Month|Withdrawal by Subject|1|||
131412602|NCT02785458|473133683|FG000|1 Month|Lost to Follow-up|38|||
131412603|NCT02785458|473133684|FG001|1 Month|Lost to Follow-up|31|||
131412604|NCT02785458|473133683|FG000|1 Month|Deemed Ineligible|1|||
131412605|NCT02785458|473133684|FG001|1 Month|Deemed Ineligible|0|||
131412606|NCT02785458|473133683|FG000|1 Month|Completed Evaluation by Baseline|42|||
131412607|NCT02785458|473133684|FG001|1 Month|Completed Evaluation by Baseline|39|||
131412608|NCT02785458|473133683|FG000|1 Month|Partial Interview|0|||
131412609|NCT02785458|473133684|FG001|1 Month|Partial Interview|4|||
131412610|NCT02785458|473133683|FG000|3 Months|Withdrawal by Subject|3|||
131412611|NCT02785458|473133684|FG001|3 Months|Withdrawal by Subject|1|||
131412612|NCT02785458|473133683|FG000|3 Months|Lost to Follow-up|25|||
131412613|NCT02785458|473133684|FG001|3 Months|Lost to Follow-up|21|||
131412614|NCT02785458|473133683|FG000|3 Months|Completed Evaluation at 1 Month|100|||
131412615|NCT02785458|473133684|FG001|3 Months|Completed Evaluation at 1 Month|89|||
131412616|NCT00824005|473133686|FG000|Overall Study|Death|0|||
131412617|NCT00824005|473133687|FG001|Overall Study|Death|1|||
131412618|NCT00824005|473133686|FG000|Overall Study|Lost to Follow-up|0|||
131412619|NCT00824005|473133687|FG001|Overall Study|Lost to Follow-up|1|||
131412620|NCT03458702|473133688|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
131412621|NCT03458702|473133689|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
131412622|NCT03458702|473133688|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
131412623|NCT03458702|473133689|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
131412624|NCT01390779|473133690|FG000|Overall Study|Physician Decision|1|||
131412625|NCT01874275|473133691|FG000|Overall Study|Lost to Follow-up|1|||
131412626|NCT01874275|473133692|FG001|Overall Study|Lost to Follow-up|0|||
131412627|NCT01697462|473133695|FG000|Overall Study|Disease Progression|1|||
131937213|NCT04507204|475060102|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
131937214|NCT04507204|475060103|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
131937215|NCT04507204|475060102|FG000|Overall Study|Withdrawal of Patient Consent|21|||
131937216|NCT04507204|475060103|FG001|Overall Study|Withdrawal of Patient Consent|13|||
131937217|NCT01702298|475060104|FG000|Overall Study|Withdrawal by Subject|1|||
131937218|NCT03580044|475060108|FG000|Overall Study|Death|2|||
131937219|NCT03580044|475060109|FG001|Overall Study|Death|1|||
131937220|NCT03580044|475060108|FG000|Overall Study|Withdrawal by Subject|1|||
131937221|NCT03580044|475060109|FG001|Overall Study|Withdrawal by Subject|1|||
131937222|NCT01664624|475060112|FG000|Overall Study|Adverse Event|0|||
131937223|NCT01664624|475060113|FG001|Overall Study|Adverse Event|1|||
131412628|NCT01697462|473133695|FG000|Overall Study|Adverse Event|6|||
131412629|NCT01697462|473133695|FG000|Overall Study|Lost to Follow-up|21|||
131412630|NCT01697462|473133695|FG000|Overall Study|Withdrawal by Subject|12|||
131937224|NCT01664624|475060114|FG002|Overall Study|Adverse Event|0|||
131412631|NCT01697462|473133695|FG000|Overall Study|Investigator Decision|21|||
131412632|NCT01697462|473133695|FG000|Overall Study|Death|1|||
131412633|NCT01697462|473133695|FG000|Overall Study|Other|10|||
131412634|NCT01697462|473133695|FG000|Overall Study|Missing|5|||
131412635|NCT00168103|473133696|FG000|Overall Study|Withdrawal by Subject|1|||
131937225|NCT01664624|475060115|FG003|Overall Study|Adverse Event|0|||
131937226|NCT01206517|475060116|FG000|Overall Study|Withdrawal by Subject|0|||
131412636|NCT00168103|473133697|FG001|Overall Study|Withdrawal by Subject|2|||
131937227|NCT01206517|475060117|FG001|Overall Study|Withdrawal by Subject|0|||
131937228|NCT01206517|475060118|FG002|Overall Study|Withdrawal by Subject|2|||
131937229|NCT01206517|475060119|FG003|Overall Study|Withdrawal by Subject|0|||
131937230|NCT01206517|475060120|FG004|Overall Study|Withdrawal by Subject|1|||
131937231|NCT01206517|475060121|FG005|Overall Study|Withdrawal by Subject|0|||
131937232|NCT03493958|475060122|FG000|Overall Study|Withdrawal by Subject|6|||
131937233|NCT03493958|475060122|FG000|Overall Study|Lost to Follow-up|7|||
131937234|NCT03493958|475060122|FG000|Overall Study|Did not complete all required study procedures|2|||
131937235|NCT01029535|475060123|FG000|Overall Study|Lost to Follow-up|24|||
131937236|NCT01029535|475060123|FG000|Overall Study|Protocol Violation|2|||
131937237|NCT01029535|475060123|FG000|Overall Study|Participant Withdrew Consent|2|||
131937238|NCT01029535|475060123|FG000|Overall Study|Adverse Event|1|||
131937239|NCT01029535|475060123|FG000|Overall Study|Use of Another Treatment|1|||
131937240|NCT01029535|475060123|FG000|Overall Study|Death|1|||
131937241|NCT00904371|475060126|FG000|Overall Study|Adverse Event|2|||
131937242|NCT00904371|475060126|FG000|Overall Study|Lost to Follow-up|4|||
131937243|NCT00904371|475060126|FG000|Overall Study|Discontinued at target blood pressure|2|||
131937244|NCT00904371|475060126|FG000|Overall Study|Continued with Tritace|1|||
131937245|NCT00583219|475060131|FG000|Phase 2|Withdrawal by Subject|1|||
131937246|NCT02090764|475060132|FG000|Overall Study|Adverse Event|1|||
131937247|NCT02090764|475060133|FG001|Overall Study|Adverse Event|3|||
131454622|NCT00114517|473293364|FG002|Overall Study|Lost interest|1|||
131454623|NCT00114517|473293365|FG003|Overall Study|Lost interest|0|||
131454624|NCT00114517|473293362|FG000|Overall Study|Weight increase|0|||
131454625|NCT00114517|473293363|FG001|Overall Study|Weight increase|0|||
131454626|NCT00114517|473293364|FG002|Overall Study|Weight increase|1|||
131454627|NCT00114517|473293365|FG003|Overall Study|Weight increase|0|||
131454628|NCT00114517|473293362|FG000|Overall Study|Concern about blood clots|0|||
131454629|NCT00114517|473293363|FG001|Overall Study|Concern about blood clots|0|||
131937248|NCT02090764|475060132|FG000|Overall Study|Lack of Efficacy|0|||
131937249|NCT02090764|475060133|FG001|Overall Study|Lack of Efficacy|13|||
131937250|NCT02090764|475060132|FG000|Overall Study|Withdrawal by Subject|2|||
131937251|NCT02090764|475060133|FG001|Overall Study|Withdrawal by Subject|1|||
131937252|NCT02090764|475060132|FG000|Overall Study|Intercurrent illness and other|1|||
131937253|NCT02090764|475060133|FG001|Overall Study|Intercurrent illness and other|1|||
131937254|NCT02090764|475060132|FG000|Overall Study|Lost to Follow-up|2|||
131937255|NCT02090764|475060133|FG001|Overall Study|Lost to Follow-up|2|||
131937256|NCT00754572|475060134|FG000|Overall Study|Adverse Event|19|||
131937257|NCT00754572|475060134|FG000|Overall Study|Other|39|||
131937258|NCT00754572|475060134|FG000|Overall Study|Protocol Violation|3|||
131937259|NCT00754572|475060134|FG000|Overall Study|Withdrawal by Subject|3|||
131937260|NCT00754572|475060134|FG000|Overall Study|Lack of Efficacy|2|||
131937261|NCT00754572|475060134|FG000|Overall Study|Death|1|||
131937262|NCT00754572|475060134|FG000|Overall Study|Administrative Reason|3|||
131937263|NCT00754572|475060134|FG000|Overall Study|Lost to Follow-up|1|||
131937264|NCT04067011|475060140|FG000|Overall Study|Not Treated|8|||
131937265|NCT04067011|475060141|FG001|Overall Study|Not Treated|7|||
131937266|NCT04067011|475060142|FG002|Overall Study|Not Treated|5|||
131937267|NCT04067011|475060140|FG000|Overall Study|Adverse Event|2|||
131937268|NCT04067011|475060141|FG001|Overall Study|Adverse Event|1|||
131412637|NCT00168103|473133698|FG002|Overall Study|Withdrawal by Subject|1|||
131412638|NCT00168103|473133699|FG003|Overall Study|Withdrawal by Subject|0|||
131412639|NCT00168103|473133696|FG000|Overall Study|Lost to Follow-up|1|||
131412640|NCT00168103|473133697|FG001|Overall Study|Lost to Follow-up|3|||
131412641|NCT00168103|473133698|FG002|Overall Study|Lost to Follow-up|0|||
131412642|NCT00168103|473133699|FG003|Overall Study|Lost to Follow-up|0|||
131412643|NCT00989235|473133700|FG000|Overall Study|Death|0|||
131412644|NCT00989235|473133701|FG001|Overall Study|Death|1|||
131412645|NCT00989235|473133700|FG000|Overall Study|Adverse Event|0|||
131412646|NCT00989235|473133701|FG001|Overall Study|Adverse Event|1|||
131412647|NCT00989235|473133700|FG000|Overall Study|Lack of Efficacy|1|||
131412648|NCT00989235|473133701|FG001|Overall Study|Lack of Efficacy|0|||
131412649|NCT00989235|473133700|FG000|Overall Study|Withdrawal of Consent|1|||
131412650|NCT00989235|473133701|FG001|Overall Study|Withdrawal of Consent|1|||
131412651|NCT00989235|473133700|FG000|Overall Study|Desire to Become Pregnant|1|||
131412652|NCT00989235|473133701|FG001|Overall Study|Desire to Become Pregnant|0|||
131412653|NCT00989235|473133700|FG000|Overall Study|Randomized by Mistake|0|||
131412654|NCT00989235|473133701|FG001|Overall Study|Randomized by Mistake|2|||
131937269|NCT04067011|475060142|FG002|Overall Study|Adverse Event|0|||
131937270|NCT04067011|475060140|FG000|Overall Study|Withdrawal by Subject|6|||
131937271|NCT04067011|475060141|FG001|Overall Study|Withdrawal by Subject|2|||
131937272|NCT04067011|475060142|FG002|Overall Study|Withdrawal by Subject|1|||
131937273|NCT04067011|475060140|FG000|Overall Study|Lost to Follow-up|0|||
131412655|NCT00989235|473133700|FG000|Overall Study|Lost to Follow-up|0|||
131454630|NCT00114517|473293364|FG002|Overall Study|Concern about blood clots|1|||
131937274|NCT04067011|475060141|FG001|Overall Study|Lost to Follow-up|0|||
131937275|NCT04067011|475060142|FG002|Overall Study|Lost to Follow-up|1|||
131937276|NCT04067011|475060140|FG000|Overall Study|Physician Decision|1|||
131937277|NCT04067011|475060141|FG001|Overall Study|Physician Decision|1|||
131937278|NCT04067011|475060142|FG002|Overall Study|Physician Decision|0|||
131937279|NCT04067011|475060140|FG000|Overall Study|Other Reasons|2|||
131937280|NCT04067011|475060141|FG001|Overall Study|Other Reasons|0|||
131937281|NCT04067011|475060142|FG002|Overall Study|Other Reasons|1|||
131937282|NCT04067011|475060140|FG000|Overall Study|Missing|0|||
131937283|NCT04067011|475060141|FG001|Overall Study|Missing|2|||
131937284|NCT04067011|475060142|FG002|Overall Study|Missing|0|||
131937285|NCT05448950|475060143|FG000|Overall Study|Death|2|||
131937286|NCT05448950|475060143|FG000|Overall Study|Withdrawal by Subject|1|||
131937287|NCT05448950|475060143|FG000|Overall Study|AVG abandoned|4|||
131937288|NCT05209386|475060144|FG000|Overall Study|Withdrawal by Subject|8|||
131937289|NCT05209386|475060144|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
131937290|NCT02836249|475060145|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
131937291|NCT02836249|475060146|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
131937292|NCT02836249|475060147|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
131937293|NCT02836249|475060148|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
131937294|NCT02836249|475060145|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
131937295|NCT02836249|475060146|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
131937296|NCT02836249|475060147|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
131937297|NCT02836249|475060148|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
131937298|NCT02836249|475060145|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
131937299|NCT02836249|475060146|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
131937300|NCT02836249|475060147|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
131937301|NCT02836249|475060148|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
131937302|NCT02836249|475060145|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131937303|NCT02836249|475060146|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131937304|NCT02836249|475060147|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131937305|NCT02836249|475060148|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131937306|NCT02836249|475060145|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
131937307|NCT02836249|475060146|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
131937308|NCT02836249|475060147|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
131937309|NCT02836249|475060148|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
131937310|NCT02836249|475060145|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
131937311|NCT02836249|475060146|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
131937312|NCT02836249|475060147|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
131937313|NCT02836249|475060148|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
131937314|NCT02836249|475060145|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
131937315|NCT02836249|475060146|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
131937316|NCT02836249|475060147|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
131937317|NCT02836249|475060148|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
131937318|NCT02836249|475060145|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
131937319|NCT02836249|475060146|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
131937320|NCT02836249|475060147|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
131937321|NCT02836249|475060148|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
131937322|NCT02836249|475060145|FG000|Open-Label TAF Treatment Phase|Death|0|||
131937323|NCT02836249|475060146|FG001|Open-Label TAF Treatment Phase|Death|0|||
131937324|NCT02836249|475060147|FG002|Open-Label TAF Treatment Phase|Death|1|||
131937325|NCT02836249|475060148|FG003|Open-Label TAF Treatment Phase|Death|0|||
131937326|NCT02836249|475060145|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
131937327|NCT02836249|475060146|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
131937328|NCT02836249|475060147|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
131937329|NCT02836249|475060148|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
131937330|NCT02836249|475060145|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
131937331|NCT02836249|475060146|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
131937332|NCT02836249|475060147|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
131937333|NCT02836249|475060148|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
131937334|NCT04752566|475060149|FG000|Overall Study|Protocol Violation|0|||
131937335|NCT04752566|475060150|FG001|Overall Study|Protocol Violation|1|||
131937336|NCT04752566|475060149|FG000|Overall Study|Death|1|||
131937337|NCT04752566|475060150|FG001|Overall Study|Death|0|||
131937338|NCT04752566|475060149|FG000|Overall Study|Adverse Event|1|||
131937339|NCT04752566|475060150|FG001|Overall Study|Adverse Event|0|||
131937340|NCT04752566|475060149|FG000|Overall Study|Withdrawal by Subject|2|||
131937341|NCT04752566|475060150|FG001|Overall Study|Withdrawal by Subject|0|||
131937342|NCT04752566|475060149|FG000|Overall Study|Physician Decision|1|||
131937343|NCT04752566|475060150|FG001|Overall Study|Physician Decision|1|||
131937344|NCT05134649|475060151|FG000|Overall Study|Lost to Follow-up|12|||
131454631|NCT00114517|473293365|FG003|Overall Study|Concern about blood clots|0|||
131454632|NCT00114517|473293362|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
131454633|NCT00114517|473293363|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
131937345|NCT05134649|475060151|FG000|Overall Study|Withdrawal by Subject|14|||
131937346|NCT05134649|475060151|FG000|Overall Study|Pregnancy|1|||
131937347|NCT05134649|475060151|FG000|Overall Study|Other, not specified|3|||
131937348|NCT01153516|475060152|FG000|Overall Study|Both subjects refused surgery|2|||
131937349|NCT01153516|475060153|FG001|Overall Study|Both subjects refused surgery|0|||
131937350|NCT01983111|475060154|FG000|Overall Study|Withdrawal by Subject|8|||
131937351|NCT01983111|475060155|FG001|Overall Study|Withdrawal by Subject|6|||
131937352|NCT01983111|475060154|FG000|Overall Study|Adverse Event|4|||
131937353|NCT01983111|475060155|FG001|Overall Study|Adverse Event|0|||
131937354|NCT01983111|475060154|FG000|Overall Study|Protocol Violation|0|||
131937355|NCT01983111|475060155|FG001|Overall Study|Protocol Violation|1|||
131937356|NCT00855335|475060156|FG000|Overall Study|Lost to Follow-up|0|||
131937357|NCT00855335|475060157|FG001|Overall Study|Lost to Follow-up|0|||
131937358|NCT00855335|475060158|FG002|Overall Study|Lost to Follow-up|3|||
131937359|NCT00855335|475060159|FG003|Overall Study|Lost to Follow-up|1|||
131937360|NCT00855335|475060160|FG004|Overall Study|Lost to Follow-up|0|||
131937361|NCT00855335|475060156|FG000|Overall Study|Withdrawal by Subject|0|||
131937362|NCT00855335|475060157|FG001|Overall Study|Withdrawal by Subject|0|||
131937363|NCT00855335|475060158|FG002|Overall Study|Withdrawal by Subject|0|||
131937364|NCT00855335|475060159|FG003|Overall Study|Withdrawal by Subject|1|||
131937365|NCT00855335|475060160|FG004|Overall Study|Withdrawal by Subject|0|||
131937366|NCT00855335|475060156|FG000|Overall Study|Adverse Event|2|||
131937367|NCT00855335|475060157|FG001|Overall Study|Adverse Event|0|||
131937368|NCT00855335|475060158|FG002|Overall Study|Adverse Event|0|||
131937369|NCT00855335|475060159|FG003|Overall Study|Adverse Event|0|||
131937370|NCT00855335|475060160|FG004|Overall Study|Adverse Event|0|||
131937371|NCT00855335|475060156|FG000|Overall Study|Physician Decision|1|||
131937372|NCT00855335|475060157|FG001|Overall Study|Physician Decision|1|||
131937373|NCT00855335|475060158|FG002|Overall Study|Physician Decision|0|||
131937374|NCT00855335|475060159|FG003|Overall Study|Physician Decision|0|||
131937375|NCT00855335|475060160|FG004|Overall Study|Physician Decision|0|||
131937376|NCT00855335|475060156|FG000|Overall Study|Other|2|||
131937377|NCT00855335|475060157|FG001|Overall Study|Other|1|||
131937378|NCT00855335|475060158|FG002|Overall Study|Other|2|||
131937379|NCT00855335|475060159|FG003|Overall Study|Other|5|||
131937380|NCT00855335|475060160|FG004|Overall Study|Other|1|||
131937381|NCT03502200|475060161|FG000|Overall Study|Adverse Event|1|||
131937382|NCT03502200|475060162|FG001|Overall Study|Adverse Event|0|||
131937383|NCT03502200|475060161|FG000|Overall Study|Lost to Follow-up|36|||
131937384|NCT03502200|475060162|FG001|Overall Study|Lost to Follow-up|38|||
131937385|NCT03502200|475060161|FG000|Overall Study|Study Team Decision|1|||
131937386|NCT03502200|475060162|FG001|Overall Study|Study Team Decision|1|||
131937387|NCT03502200|475060161|FG000|Overall Study|Withdrawal by Subject|5|||
131937388|NCT03502200|475060162|FG001|Overall Study|Withdrawal by Subject|7|||
131937389|NCT03502200|475060161|FG000|Overall Study|Death|0|||
131937390|NCT03502200|475060162|FG001|Overall Study|Death|2|||
131937391|NCT00210132|475060167|FG000|Overall Study|Protocol Violation|1|||
131937392|NCT00210132|475060168|FG001|Overall Study|Protocol Violation|4|||
131937393|NCT01889251|475060169|FG000|Overall Study|Adverse Event|1|||
131937394|NCT01889251|475060170|FG001|Overall Study|Adverse Event|0|||
131937395|NCT03448393|475060180|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937396|NCT03448393|475060181|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937397|NCT03448393|475060182|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
131937398|NCT03448393|475060183|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937399|NCT03448393|475060184|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937400|NCT03448393|475060185|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937401|NCT03448393|475060186|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937402|NCT03448393|475060187|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
131937403|NCT03448393|475060188|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
131937404|NCT03448393|475060180|FG000|Dose Expansion|Not treated - screen failure|0|||
131937405|NCT03448393|475060181|FG001|Dose Expansion|Not treated - screen failure|0|||
131937406|NCT03448393|475060182|FG002|Dose Expansion|Not treated - screen failure|0|||
131937407|NCT03448393|475060183|FG003|Dose Expansion|Not treated - screen failure|0|||
131937408|NCT03448393|475060184|FG004|Dose Expansion|Not treated - screen failure|0|||
131937409|NCT03448393|475060185|FG005|Dose Expansion|Not treated - screen failure|0|||
131937410|NCT03448393|475060186|FG006|Dose Expansion|Not treated - screen failure|0|||
131937411|NCT03448393|475060187|FG007|Dose Expansion|Not treated - screen failure|0|||
131937412|NCT03448393|475060188|FG008|Dose Expansion|Not treated - screen failure|7|||
131937413|NCT01587196|475060189|FG000|Overall Study|Lost to Follow-up|50|||
131937414|NCT01587196|475060189|FG000|Overall Study|Withdrawal by Subject|4|||
131937415|NCT00643279|475060195|FG000|Overall Study|Death|13|||
131937416|NCT00643279|475060196|FG001|Overall Study|Death|11|||
131937417|NCT00643279|475060195|FG000|Overall Study|Withdrawal by Subject|3|||
131937418|NCT00643279|475060196|FG001|Overall Study|Withdrawal by Subject|0|||
131937419|NCT00643279|475060195|FG000|Overall Study|Lost to Follow-up|0|||
131937420|NCT00643279|475060196|FG001|Overall Study|Lost to Follow-up|1|||
131937421|NCT00643279|475060195|FG000|Overall Study|Physician Decision|0|||
131937422|NCT00643279|475060196|FG001|Overall Study|Physician Decision|1|||
131937423|NCT05715827|475060199|FG000|Overall Study|Physician Decision|0|||
131937424|NCT05715827|475060200|FG001|Overall Study|Physician Decision|1|||
131937425|NCT05715827|475060199|FG000|Overall Study|console communication error|0|||
131937426|NCT05715827|475060200|FG001|Overall Study|console communication error|1|||
131937427|NCT03814044|475060201|FG000|Overall Study|Protocol deviation|1|||
131937428|NCT03557502|475060202|FG000|Protocol 2|Withdrawal by Subject|1|||
131937429|NCT03557502|475060203|FG001|Protocol 2|Withdrawal by Subject|1|||
131937430|NCT03557502|475060202|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
131937431|NCT03557502|475060203|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
131937432|NCT01994876|475060204|FG000|Test Period 1|Withdrawal by Subject|0|||
131937433|NCT01994876|475060205|FG001|Test Period 1|Withdrawal by Subject|1|||
131937434|NCT01994876|475060204|FG000|Test Period 1|Adverse Event|0|||
131937435|NCT01994876|475060205|FG001|Test Period 1|Adverse Event|1|||
131937436|NCT01994876|475060204|FG000|Test Period 2|Adverse Event|1|||
131937437|NCT01994876|475060205|FG001|Test Period 2|Adverse Event|0|||
131937438|NCT01994876|475060204|FG000|Test Period 2|Protocol Violation|0|||
131937439|NCT01994876|475060205|FG001|Test Period 2|Protocol Violation|1|||
131937440|NCT01346176|475060206|FG000|Recruited|Protocol Violation|1|||
131937441|NCT01346176|475060207|FG001|Recruited|Protocol Violation|0|||
131937442|NCT01346176|475060208|FG002|Recruited|Protocol Violation|0|||
131937443|NCT01346176|475060206|FG000|Completed Advance Directive|Death|3|||
131937444|NCT01346176|475060207|FG001|Completed Advance Directive|Death|2|||
131937445|NCT01346176|475060208|FG002|Completed Advance Directive|Death|2|||
131937446|NCT01346176|475060206|FG000|Completed Advance Directive|Became Ineligible|3|||
131937447|NCT01346176|475060207|FG001|Completed Advance Directive|Became Ineligible|0|||
131937448|NCT01346176|475060208|FG002|Completed Advance Directive|Became Ineligible|1|||
131937449|NCT01346176|475060206|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
131937450|NCT01346176|475060207|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
131937451|NCT01346176|475060208|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
131937452|NCT01346176|475060206|FG000|Completed Satisfaction Survey|Death|3|||
131937453|NCT01346176|475060207|FG001|Completed Satisfaction Survey|Death|0|||
131937454|NCT01346176|475060208|FG002|Completed Satisfaction Survey|Death|2|||
131937455|NCT01346176|475060206|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
131937456|NCT01346176|475060207|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
131937457|NCT01346176|475060208|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
131937458|NCT01649869|475060213|FG000|Overall Study|Family member illness|1|||
131937459|NCT01649869|475060214|FG001|Overall Study|Family member illness|0|||
131937460|NCT01649869|475060213|FG000|Overall Study|Required treatment outside protocol|1|||
131937461|NCT01649869|475060214|FG001|Overall Study|Required treatment outside protocol|0|||
131937462|NCT01649869|475060213|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
131937463|NCT01649869|475060214|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
131937464|NCT03021486|475061757|FG000|Overall Study|Withdrawal by Subject|1|||
131937465|NCT03021486|475061758|FG001|Overall Study|Withdrawal by Subject|1|||
131937466|NCT03021486|475061759|FG002|Overall Study|Withdrawal by Subject|3|||
131937467|NCT03021486|475061757|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
131937468|NCT03021486|475061758|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
131937469|NCT03021486|475061759|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
131937470|NCT04795531|475061760|FG000|Overall Study|Withdrawal by Subject|4|||
131937471|NCT04795531|475061761|FG001|Overall Study|Withdrawal by Subject|4|||
131937472|NCT04795531|475061760|FG000|Overall Study|Lost to Follow-up|0|||
131937473|NCT04795531|475061761|FG001|Overall Study|Lost to Follow-up|1|||
131937474|NCT04795531|475061760|FG000|Overall Study|Physician Decision|0|||
131937475|NCT04795531|475061761|FG001|Overall Study|Physician Decision|2|||
131937476|NCT04795531|475061760|FG000|Overall Study|Death|2|||
131937477|NCT04795531|475061761|FG001|Overall Study|Death|1|||
131937478|NCT04043286|475061762|FG000|Overall Study|Withdrawal by Subject|2|||
131937479|NCT04043286|475061763|FG001|Overall Study|Withdrawal by Subject|2|||
131937480|NCT00730327|475061764|FG000|Overall Study|Lost to Follow-up|14|||
131937481|NCT00730327|475061765|FG001|Overall Study|Lost to Follow-up|16|||
131937482|NCT00730327|475061764|FG000|Overall Study|Adverse Event|8|||
131937483|NCT00730327|475061765|FG001|Overall Study|Adverse Event|1|||
131937484|NCT00730327|475061764|FG000|Overall Study|Withdrawal by Subject|3|||
131937485|NCT00730327|475061765|FG001|Overall Study|Withdrawal by Subject|13|||
131937486|NCT00730327|475061764|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
131937487|NCT00730327|475061765|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
131937488|NCT03122184|475061766|FG000|Overall Study|Lost to Follow-up|4|||
131937489|NCT03122184|475061767|FG001|Overall Study|Lost to Follow-up|6|||
131937490|NCT03122184|475061766|FG000|Overall Study|Withdrawal by Subject|3|||
131937491|NCT03122184|475061767|FG001|Overall Study|Withdrawal by Subject|0|||
131937492|NCT03122184|475061766|FG000|Overall Study|Terminated due to cognitive problem|1|||
131937493|NCT03122184|475061767|FG001|Overall Study|Terminated due to cognitive problem|0|||
131937494|NCT03674281|475061768|FG000|Overall Study|screen failure|2|||
131937495|NCT03674281|475061769|FG001|Overall Study|screen failure|0|||
131937496|NCT03674281|475061770|FG002|Overall Study|screen failure|0|||
131937497|NCT03674281|475061768|FG000|Overall Study|Withdrawal by Subject|1|||
131937498|NCT03674281|475061769|FG001|Overall Study|Withdrawal by Subject|3|||
131937499|NCT03674281|475061770|FG002|Overall Study|Withdrawal by Subject|3|||
131937500|NCT04490278|475061771|FG000|Overall Study|Lost to Follow-up|6|||
131937501|NCT00366457|475061772|FG000|Overall Study|never began study therapy|2|||
131937502|NCT02829996|475061773|FG000|Overall Study|Withdrawal by Subject|1|||
131937503|NCT02829996|475061774|FG001|Overall Study|Withdrawal by Subject|0|||
131937504|NCT02829996|475061775|FG002|Overall Study|Withdrawal by Subject|0|||
131937505|NCT02829996|475061776|FG003|Overall Study|Withdrawal by Subject|0|||
131937506|NCT02829996|475061777|FG004|Overall Study|Withdrawal by Subject|0|||
131412656|NCT00989235|473133701|FG001|Overall Study|Lost to Follow-up|1|||
131937507|NCT03309202|475061779|FG000|Overall Study|Lost to Follow-up|1|||
131937508|NCT03309202|475061780|FG001|Overall Study|Lost to Follow-up|0|||
131937509|NCT03309202|475061781|FG002|Overall Study|Lost to Follow-up|0|||
131937510|NCT03309202|475061782|FG003|Overall Study|Lost to Follow-up|0|||
131937511|NCT00415636|475061783|FG000|Overall Study|Symptomatic deterioration|1|||
131937512|NCT00415636|475061784|FG001|Overall Study|Symptomatic deterioration|0|||
131937513|NCT00415636|475061785|FG002|Overall Study|Symptomatic deterioration|1|||
131937514|NCT00415636|475061786|FG003|Overall Study|Symptomatic deterioration|2|||
131937515|NCT00415636|475061787|FG004|Overall Study|Symptomatic deterioration|0|||
131937516|NCT00415636|475061788|FG005|Overall Study|Symptomatic deterioration|1|||
131937517|NCT00415636|475061783|FG000|Overall Study|Adverse Event|0|||
131937518|NCT00415636|475061784|FG001|Overall Study|Adverse Event|0|||
131937519|NCT00415636|475061785|FG002|Overall Study|Adverse Event|0|||
131937520|NCT00415636|475061786|FG003|Overall Study|Adverse Event|1|||
131937521|NCT00415636|475061787|FG004|Overall Study|Adverse Event|1|||
131937522|NCT00415636|475061788|FG005|Overall Study|Adverse Event|0|||
131937523|NCT00415636|475061783|FG000|Overall Study|Withdrawal by Subject|0|||
131937524|NCT00415636|475061784|FG001|Overall Study|Withdrawal by Subject|0|||
131937525|NCT00415636|475061785|FG002|Overall Study|Withdrawal by Subject|0|||
131937526|NCT00415636|475061786|FG003|Overall Study|Withdrawal by Subject|0|||
131937527|NCT00415636|475061787|FG004|Overall Study|Withdrawal by Subject|1|||
131937528|NCT00415636|475061788|FG005|Overall Study|Withdrawal by Subject|0|||
131937529|NCT00415636|475061783|FG000|Overall Study|Disease progression|0|||
131937530|NCT00415636|475061784|FG001|Overall Study|Disease progression|0|||
131937531|NCT00415636|475061785|FG002|Overall Study|Disease progression|0|||
131937532|NCT00415636|475061786|FG003|Overall Study|Disease progression|3|||
131937533|NCT00415636|475061787|FG004|Overall Study|Disease progression|0|||
131937534|NCT00415636|475061788|FG005|Overall Study|Disease progression|1|||
131937535|NCT01263119|475061789|FG000|Period 1|Protocol Violation|2|||
131937536|NCT01263119|475061789|FG000|Period 2|Adverse Event|2|||
131937537|NCT04573972|475061793|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
131937538|NCT04573972|475061794|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
131937539|NCT01198587|475061797|FG000|Overall Study|Lost to Follow-up|8|||
131937540|NCT01198587|475061798|FG001|Overall Study|Lost to Follow-up|0|||
131937541|NCT01198587|475061799|FG002|Overall Study|Lost to Follow-up|9|||
131937542|NCT01198587|475061800|FG003|Overall Study|Lost to Follow-up|0|||
131937543|NCT00573768|475061801|FG000|Overall Study|Adverse Event|1|||
131937544|NCT00573768|475061802|FG001|Overall Study|Adverse Event|1|||
131937545|NCT00573768|475061803|FG002|Overall Study|Adverse Event|2|||
131937546|NCT00573768|475061801|FG000|Overall Study|Protocol Violation|1|||
131937547|NCT00573768|475061802|FG001|Overall Study|Protocol Violation|0|||
131937548|NCT00573768|475061803|FG002|Overall Study|Protocol Violation|1|||
131937549|NCT00573768|475061801|FG000|Overall Study|Withdrawal by Subject|0|||
131937550|NCT00573768|475061802|FG001|Overall Study|Withdrawal by Subject|1|||
131937551|NCT00573768|475061803|FG002|Overall Study|Withdrawal by Subject|0|||
131937552|NCT00573768|475061801|FG000|Overall Study|Lost to Follow-up|0|||
131937553|NCT00573768|475061802|FG001|Overall Study|Lost to Follow-up|0|||
131937554|NCT00573768|475061803|FG002|Overall Study|Lost to Follow-up|1|||
131412657|NCT00545532|473133702|FG000|Overall Study|Withdrawal by Subject|1|||
131412658|NCT00545532|473133703|FG001|Overall Study|Withdrawal by Subject|3|||
131412659|NCT00545532|473133702|FG000|Overall Study|Lost to Follow-up|5|||
131412660|NCT00545532|473133703|FG001|Overall Study|Lost to Follow-up|6|||
131412661|NCT00545532|473133702|FG000|Overall Study|Death|0|||
131937555|NCT00335829|475061806|FG000|Overall Study|Withdrawal by Subject|1|||
131937556|NCT00335829|475061806|FG000|Overall Study|Lost to Follow-up|1|||
131937557|NCT00335829|475061806|FG000|Overall Study|Adverse Event|1|||
131937558|NCT03746015|475061807|FG000|Overall Study|Withdrawal of Consent|1|||
131937559|NCT03746015|475061808|FG001|Overall Study|Withdrawal of Consent|0|||
131937560|NCT03746015|475061809|FG002|Overall Study|Withdrawal of Consent|0|||
131937561|NCT01559935|475061810|FG000|Car Phase|Toxicity|4|||
131412662|NCT00545532|473133703|FG001|Overall Study|Death|1|||
131412663|NCT03630302|473133706|FG000|Surgery|hardware issue prevented LFP recordings|1|||
131412664|NCT03630302|473133706|FG000|3 Month Visit|Adverse Event|2|||
131412665|NCT03630302|473133706|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
131412666|NCT00931801|473133709|FG000|Overall Study|Adverse Event|0|||
131412667|NCT00931801|473133710|FG001|Overall Study|Adverse Event|0|||
131412668|NCT00931801|473133711|FG002|Overall Study|Adverse Event|1|||
131937562|NCT01559935|475061810|FG000|Car Phase|Death|1|||
131937563|NCT01559935|475061810|FG000|Car Phase|Lack of Efficacy|2|||
131937564|NCT01559935|475061810|FG000|Car Phase|Lost to Follow-up|1|||
131937565|NCT01559935|475061810|FG000|Car Phase|Physician Decision|1|||
131937566|NCT01559935|475061810|FG000|Car Phase|Withdrawal by Subject|2|||
131937567|NCT01559935|475061810|FG000|Car Phase|Per protocol|1|||
131937568|NCT01559935|475061810|FG000|Car Phase|Insurance|1|||
131937569|NCT01559935|475061810|FG000|Car Phase|non-compliance|1|||
131937570|NCT01559935|475061810|FG000|BiRD Phase|Toxicity|1|||
131937571|NCT01559935|475061810|FG000|BiRD Phase|Lack of Efficacy|1|||
131937572|NCT01559935|475061810|FG000|BiRD Phase|Withdrawal by Subject|2|||
131937573|NCT01559935|475061810|FG000|Maintenance Phase|Remains on study|28|||
131937574|NCT01559935|475061810|FG000|Maintenance Phase|Toxicity|1|||
131937575|NCT01559935|475061810|FG000|Maintenance Phase|Lack of Efficacy|18|||
131937576|NCT01559935|475061810|FG000|Maintenance Phase|Withdrawal by Subject|5|||
131937577|NCT01559935|475061810|FG000|Maintenance Phase|Non-compliance|2|||
131937578|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937579|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
131937580|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937581|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
131937582|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
131937583|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
131937584|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
131937585|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937586|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937587|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937588|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937589|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937590|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937591|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937592|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937593|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
131937594|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
131937595|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
131937596|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
131937597|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
131937598|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
131937599|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
131937600|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
131937601|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
131937602|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
131937603|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
131937604|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
131937605|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
131937606|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
131937607|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
131937608|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
131937609|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
131937610|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
131937611|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
131937612|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937613|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937614|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937615|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937616|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937617|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937618|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937619|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937620|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937621|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937622|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937623|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937624|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937625|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
131937626|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
131937627|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937628|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
131937629|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
131937630|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
131937631|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
131937632|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
131937633|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937634|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937635|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937636|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937637|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937638|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937639|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937640|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937641|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131937642|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937643|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937644|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937645|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
131937646|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937647|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937648|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
131937649|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937650|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937651|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937652|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937653|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937654|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937655|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937656|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937657|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
131937658|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937659|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937660|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
131937661|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937662|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937663|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937664|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937665|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937666|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937667|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937668|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937669|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937670|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937671|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937672|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937673|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
131937674|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
131937675|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
131937676|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
131937677|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937678|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937679|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937680|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937681|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937682|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937683|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937684|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937685|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937686|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937687|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937688|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937689|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131937690|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
131937691|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
131937692|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
131937693|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
131937694|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
131937695|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
131937696|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
131937697|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
131937698|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
131937699|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
131937700|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
131937701|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
131937702|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
131937703|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
131937704|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
131937705|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
131937706|NCT02958865|475061811|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937707|NCT02958865|475061812|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937708|NCT02958865|475061813|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937709|NCT02958865|475061814|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937710|NCT02958865|475061815|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
131937711|NCT02958865|475061816|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937712|NCT02958865|475061817|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937713|NCT02958865|475061818|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937714|NCT02958865|475061819|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937715|NCT02958865|475061820|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937716|NCT02958865|475061821|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937717|NCT02958865|475061822|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937718|NCT02958865|475061823|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937719|NCT02958865|475061824|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937720|NCT02958865|475061825|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937721|NCT02958865|475061826|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131937722|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937723|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937724|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937725|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937726|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937727|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937728|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937729|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
131937730|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
131937731|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
131937732|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
131937733|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
131937734|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
131937735|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
131937736|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
131937737|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
131937738|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937739|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937740|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937741|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937742|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937743|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937744|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937745|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937746|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
131937747|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
131937748|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937749|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
131937750|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937751|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
131937752|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
131937753|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
131937754|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937755|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937756|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937757|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937758|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937759|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937760|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937761|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937762|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937763|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
131937764|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937765|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937766|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131412669|NCT00931801|473133709|FG000|Overall Study|Lost to Follow-up|0|||
131937767|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937768|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
131937769|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
131937770|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937771|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937772|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937773|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937774|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937775|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937776|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937777|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937778|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937779|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937780|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
131937781|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
131937782|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
131937783|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
131937784|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
131937785|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
131937786|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
131937787|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
131937788|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
131937789|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
131937790|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
131937791|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
131937792|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
131937793|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
131937794|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
131937795|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
131937796|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
131937797|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
131937798|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
131937799|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
131937800|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
131937801|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
131937802|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937803|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937804|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937805|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937806|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937807|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937808|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937809|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937810|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937811|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937812|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937813|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937814|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937815|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
131937816|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937817|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
131937818|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937819|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937820|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937821|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937822|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937823|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937824|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937825|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937826|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937827|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937828|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937829|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937830|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937831|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
131937832|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937833|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
131937834|NCT02958865|475061811|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937835|NCT02958865|475061812|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937836|NCT02958865|475061813|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937837|NCT02958865|475061814|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937838|NCT02958865|475061815|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937839|NCT02958865|475061816|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937840|NCT02958865|475061817|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937841|NCT02958865|475061818|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937842|NCT02958865|475061819|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937843|NCT02958865|475061820|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
131937844|NCT02958865|475061821|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937845|NCT02958865|475061822|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937846|NCT02958865|475061823|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937847|NCT02958865|475061824|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937848|NCT02958865|475061825|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937849|NCT02958865|475061826|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
131937850|NCT02661815|475061827|FG000|Overall Study|Withdrawal by Subject|1|||
131937851|NCT02661815|475061828|FG001|Overall Study|Withdrawal by Subject|0|||
131937852|NCT02661815|475061829|FG002|Overall Study|Withdrawal by Subject|0|||
131937853|NCT02661815|475061830|FG003|Overall Study|Withdrawal by Subject|0|||
131937854|NCT01728246|475061835|FG000|Overall Study|Participant needed rescue medication|1|||
131937855|NCT01728246|475061836|FG001|Overall Study|Participant needed rescue medication|5|||
131937856|NCT01728246|475061835|FG000|Overall Study|Protocol Violation|1|||
131937857|NCT01728246|475061836|FG001|Overall Study|Protocol Violation|0|||
131937858|NCT01728246|475061835|FG000|Overall Study|Withdrawal by Subject|2|||
131937859|NCT01728246|475061836|FG001|Overall Study|Withdrawal by Subject|3|||
131937860|NCT01728246|475061835|FG000|Overall Study|Lost to Follow-up|23|||
131937861|NCT01728246|475061836|FG001|Overall Study|Lost to Follow-up|22|||
131937862|NCT01728246|475061835|FG000|Overall Study|Lack of Efficacy|1|||
131937863|NCT01728246|475061836|FG001|Overall Study|Lack of Efficacy|1|||
131937864|NCT01728246|475061835|FG000|Overall Study|Adverse Event|8|||
131937865|NCT01728246|475061836|FG001|Overall Study|Adverse Event|5|||
131937866|NCT01143402|475061837|FG000|Overall Study|Rapid clinical decline|1|||
131937867|NCT01143402|475061838|FG001|Overall Study|Rapid clinical decline|1|||
131937868|NCT01143402|475061839|FG002|Overall Study|Rapid clinical decline|0|||
131937869|NCT01143402|475061837|FG000|Overall Study|Not Treated|0|||
131937870|NCT01143402|475061838|FG001|Overall Study|Not Treated|0|||
131937871|NCT01143402|475061839|FG002|Overall Study|Not Treated|1|||
131937872|NCT02526290|475061840|FG000|Overall Study|Adverse Event|3|||
131937873|NCT02526290|475061840|FG000|Overall Study|Withdrawal by Subject|4|||
131937874|NCT02526290|475061840|FG000|Overall Study|Physician Decision|1|||
131937875|NCT02706392|475061841|FG000|Overall Study|Death|1|||
131937876|NCT02706392|475061842|FG001|Overall Study|Death|0|||
131937877|NCT02706392|475061843|FG002|Overall Study|Death|2|||
131937878|NCT02706392|475061844|FG003|Overall Study|Death|2|||
131937879|NCT02706392|475061845|FG004|Overall Study|Death|5|||
131937880|NCT02706392|475061846|FG005|Overall Study|Death|2|||
131937881|NCT00619866|475061849|FG000|Weeks 1 - 12|Adverse Event|0|||
131937882|NCT00619866|475061850|FG001|Weeks 1 - 12|Adverse Event|1|||
131937883|NCT00619866|475061851|FG002|Weeks 1 - 12|Adverse Event|2|||
131937884|NCT00619866|475061852|FG003|Weeks 1 - 12|Adverse Event|0|||
131937885|NCT00619866|475061853|FG004|Weeks 1 - 12|Adverse Event|0|||
131937886|NCT00619866|475061849|FG000|Weeks 1 - 12|Non-compliance|0|||
131937887|NCT00619866|475061850|FG001|Weeks 1 - 12|Non-compliance|0|||
131937888|NCT00619866|475061851|FG002|Weeks 1 - 12|Non-compliance|1|||
131937889|NCT00619866|475061852|FG003|Weeks 1 - 12|Non-compliance|0|||
131937890|NCT00619866|475061853|FG004|Weeks 1 - 12|Non-compliance|0|||
131937891|NCT00619866|475061849|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
131937892|NCT00619866|475061850|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
131937893|NCT00619866|475061851|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
131937894|NCT00619866|475061852|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
131937895|NCT00619866|475061853|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
131937896|NCT00619866|475061849|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
131937897|NCT00619866|475061850|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
131937898|NCT00619866|475061851|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
131937899|NCT00619866|475061852|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
131937900|NCT00619866|475061853|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
131937901|NCT00619866|475061849|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
131937902|NCT00619866|475061850|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
131937903|NCT00619866|475061851|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
131937904|NCT00619866|475061852|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
131937905|NCT00619866|475061853|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
131937906|NCT00619866|475061849|FG000|Weeks 1 - 12|Sponsor Decision|0|||
131937907|NCT00619866|475061850|FG001|Weeks 1 - 12|Sponsor Decision|1|||
131937908|NCT00619866|475061851|FG002|Weeks 1 - 12|Sponsor Decision|0|||
131937909|NCT00619866|475061852|FG003|Weeks 1 - 12|Sponsor Decision|0|||
131937910|NCT00619866|475061853|FG004|Weeks 1 - 12|Sponsor Decision|0|||
131937911|NCT00619866|475061849|FG000|Weeks 13 - 24|Adverse Event|0|||
131937912|NCT00619866|475061850|FG001|Weeks 13 - 24|Adverse Event|0|||
131937913|NCT00619866|475061851|FG002|Weeks 13 - 24|Adverse Event|2|||
131937914|NCT00619866|475061852|FG003|Weeks 13 - 24|Adverse Event|1|||
131937915|NCT00619866|475061853|FG004|Weeks 13 - 24|Adverse Event|0|||
131937916|NCT00619866|475061849|FG000|Weeks 13 - 24|Protocol Deviation|0|||
131937917|NCT00619866|475061850|FG001|Weeks 13 - 24|Protocol Deviation|0|||
131937918|NCT00619866|475061851|FG002|Weeks 13 - 24|Protocol Deviation|0|||
131937919|NCT00619866|475061852|FG003|Weeks 13 - 24|Protocol Deviation|1|||
131937920|NCT00619866|475061853|FG004|Weeks 13 - 24|Protocol Deviation|0|||
131937921|NCT00619866|475061849|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
131937922|NCT00619866|475061850|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
131937923|NCT00619866|475061851|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
131937924|NCT00619866|475061852|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
131937925|NCT00619866|475061853|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
131937926|NCT00619866|475061849|FG000|Weeks 13 - 24|Non-compliance|0|||
131937927|NCT00619866|475061850|FG001|Weeks 13 - 24|Non-compliance|1|||
131937928|NCT00619866|475061851|FG002|Weeks 13 - 24|Non-compliance|1|||
131937929|NCT00619866|475061852|FG003|Weeks 13 - 24|Non-compliance|0|||
131937930|NCT00619866|475061853|FG004|Weeks 13 - 24|Non-compliance|0|||
131937931|NCT00619866|475061849|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
131937932|NCT00619866|475061850|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
131937933|NCT00619866|475061851|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
131937934|NCT00619866|475061852|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
131937935|NCT00619866|475061853|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
131937936|NCT01968980|475061857|FG000|Overall Study|Death|0|||
131937937|NCT01968980|475061858|FG001|Overall Study|Death|1|||
131937938|NCT01968980|475061857|FG000|Overall Study|Adverse Event|1|||
131937939|NCT01968980|475061858|FG001|Overall Study|Adverse Event|3|||
131937940|NCT01968980|475061857|FG000|Overall Study|Does not meet entry criteria|1|||
131937941|NCT01968980|475061858|FG001|Overall Study|Does not meet entry criteria|3|||
131937942|NCT01968980|475061857|FG000|Overall Study|Withdrawal by Subject|13|||
131937943|NCT01968980|475061858|FG001|Overall Study|Withdrawal by Subject|5|||
131937944|NCT01968980|475061857|FG000|Overall Study|Other unspecified|1|||
131937945|NCT01968980|475061858|FG001|Overall Study|Other unspecified|2|||
131937946|NCT02589938|475061866|FG000|Overall Study|Withdrawal by Subject|11|||
131937947|NCT02589938|475061867|FG001|Overall Study|Withdrawal by Subject|5|||
131937948|NCT02589938|475061868|FG002|Overall Study|Withdrawal by Subject|6|||
131937949|NCT02589938|475061866|FG000|Overall Study|Lost to Follow-up|3|||
131937950|NCT02589938|475061867|FG001|Overall Study|Lost to Follow-up|3|||
131937951|NCT02589938|475061868|FG002|Overall Study|Lost to Follow-up|3|||
131937952|NCT02589938|475061866|FG000|Overall Study|Death|1|||
131937953|NCT02589938|475061867|FG001|Overall Study|Death|0|||
131937954|NCT02589938|475061868|FG002|Overall Study|Death|1|||
131937955|NCT02589938|475061866|FG000|Overall Study|Protocol Violation|6|||
131937956|NCT02589938|475061867|FG001|Overall Study|Protocol Violation|2|||
131937957|NCT02589938|475061868|FG002|Overall Study|Protocol Violation|3|||
131937958|NCT02589938|475061866|FG000|Overall Study|Physician Decision|1|||
131937959|NCT02589938|475061867|FG001|Overall Study|Physician Decision|0|||
131937960|NCT02589938|475061868|FG002|Overall Study|Physician Decision|0|||
131937961|NCT02589938|475061866|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
131937962|NCT02589938|475061867|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
131937963|NCT02589938|475061868|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
131937964|NCT01276106|475061869|FG000|Overall Study|Adverse Event|3|||
131937965|NCT01276106|475061870|FG001|Overall Study|Adverse Event|3|||
131937966|NCT01276106|475061871|FG002|Overall Study|Adverse Event|11|||
131937967|NCT01276106|475061872|FG003|Overall Study|Adverse Event|3|||
131937968|NCT01276106|475061869|FG000|Overall Study|Withdrawal by Subject|6|||
131937969|NCT01276106|475061870|FG001|Overall Study|Withdrawal by Subject|3|||
131937970|NCT01276106|475061871|FG002|Overall Study|Withdrawal by Subject|1|||
131937971|NCT01276106|475061872|FG003|Overall Study|Withdrawal by Subject|6|||
131937972|NCT01276106|475061869|FG000|Overall Study|Lack of Efficacy|0|||
131937973|NCT01276106|475061870|FG001|Overall Study|Lack of Efficacy|1|||
131937974|NCT01276106|475061871|FG002|Overall Study|Lack of Efficacy|0|||
131937975|NCT01276106|475061872|FG003|Overall Study|Lack of Efficacy|1|||
131937976|NCT01276106|475061869|FG000|Overall Study|Lost to Follow-up|2|||
131937977|NCT01276106|475061870|FG001|Overall Study|Lost to Follow-up|1|||
131937978|NCT01276106|475061871|FG002|Overall Study|Lost to Follow-up|1|||
131937979|NCT01276106|475061872|FG003|Overall Study|Lost to Follow-up|0|||
131937980|NCT01276106|475061869|FG000|Overall Study|Physician Decision|0|||
131937981|NCT01276106|475061870|FG001|Overall Study|Physician Decision|0|||
131937982|NCT01276106|475061871|FG002|Overall Study|Physician Decision|1|||
131937983|NCT01276106|475061872|FG003|Overall Study|Physician Decision|1|||
131937984|NCT01276106|475061869|FG000|Overall Study|Protocol Violation|1|||
131937985|NCT01276106|475061870|FG001|Overall Study|Protocol Violation|1|||
131937986|NCT01276106|475061871|FG002|Overall Study|Protocol Violation|0|||
131937987|NCT01276106|475061872|FG003|Overall Study|Protocol Violation|2|||
131937988|NCT01276106|475061869|FG000|Overall Study|Insufficient therapeutic effects|0|||
131937989|NCT01276106|475061870|FG001|Overall Study|Insufficient therapeutic effects|0|||
131937990|NCT01276106|475061871|FG002|Overall Study|Insufficient therapeutic effects|2|||
131937991|NCT01276106|475061872|FG003|Overall Study|Insufficient therapeutic effects|0|||
131937992|NCT00862940|475061876|FG000|Overall Study|Adverse Event|15|||
131937993|NCT00862940|475061877|FG001|Overall Study|Adverse Event|12|||
131937994|NCT00862940|475061876|FG000|Overall Study|Lack of Efficacy|1|||
131937995|NCT00862940|475061877|FG001|Overall Study|Lack of Efficacy|3|||
131937996|NCT00862940|475061876|FG000|Overall Study|Protocol Violation|2|||
131937997|NCT00862940|475061877|FG001|Overall Study|Protocol Violation|5|||
131937998|NCT00862940|475061876|FG000|Overall Study|Withdrawal by Subject|4|||
131937999|NCT00862940|475061877|FG001|Overall Study|Withdrawal by Subject|6|||
131938000|NCT00862940|475061876|FG000|Overall Study|Non-compliance|4|||
131938001|NCT00862940|475061877|FG001|Overall Study|Non-compliance|0|||
131938002|NCT00862940|475061876|FG000|Overall Study|Lost to Follow-up|0|||
131938003|NCT00862940|475061877|FG001|Overall Study|Lost to Follow-up|1|||
131938004|NCT00862940|475061876|FG000|Overall Study|Administrative or other reason(s)|4|||
131938005|NCT00862940|475061877|FG001|Overall Study|Administrative or other reason(s)|3|||
131938006|NCT02521285|475061878|FG000|Overall Study|Lost to Follow-up|1|||
131938007|NCT02521285|475061879|FG001|Overall Study|Lost to Follow-up|1|||
131938008|NCT02521285|475061878|FG000|Overall Study|Withdrawal by Subject|1|||
131938009|NCT02521285|475061879|FG001|Overall Study|Withdrawal by Subject|1|||
131938010|NCT02521285|475061878|FG000|Overall Study|Adverse Event|0|||
131938011|NCT02521285|475061879|FG001|Overall Study|Adverse Event|1|||
131938012|NCT00879398|475061880|FG000|Overall Study|Visit Stop|399|||
131938013|NCT00879398|475061880|FG000|Overall Study|Lack of Efficacy|64|||
131938014|NCT00879398|475061880|FG000|Overall Study|Adverse Event|41|||
131938015|NCT00879398|475061880|FG000|Overall Study|Other Reasons|171|||
131938016|NCT00432965|475061881|FG000|Overall Study|Lost to Follow-up|22|||
131938017|NCT00432965|475061882|FG001|Overall Study|Lost to Follow-up|19|||
131938018|NCT00432965|475061881|FG000|Overall Study|Withdrawal by Subject|13|||
131938019|NCT00432965|475061882|FG001|Overall Study|Withdrawal by Subject|13|||
131938020|NCT00432965|475061881|FG000|Overall Study|Physician Decision|14|||
131938021|NCT00432965|475061882|FG001|Overall Study|Physician Decision|13|||
131938022|NCT00432965|475061881|FG000|Overall Study|Lack of Efficacy|8|||
131938023|NCT00432965|475061882|FG001|Overall Study|Lack of Efficacy|13|||
131938024|NCT00432965|475061881|FG000|Overall Study|Non-compliance|7|||
131938025|NCT00432965|475061882|FG001|Overall Study|Non-compliance|0|||
131938026|NCT00432965|475061881|FG000|Overall Study|Adverse Event|22|||
131938027|NCT00432965|475061882|FG001|Overall Study|Adverse Event|19|||
131938028|NCT00432965|475061881|FG000|Overall Study|Death|3|||
131938029|NCT00432965|475061882|FG001|Overall Study|Death|4|||
131938030|NCT00432965|475061881|FG000|Overall Study|Exclusionary Methods|1|||
131938031|NCT00432965|475061882|FG001|Overall Study|Exclusionary Methods|2|||
131938032|NCT00432965|475061881|FG000|Overall Study|Incomplete Data|4|||
131938033|NCT00432965|475061882|FG001|Overall Study|Incomplete Data|3|||
131938034|NCT03189719|475061883|FG000|Overall Study|Death|325|||
131938035|NCT03189719|475061884|FG001|Overall Study|Death|361|||
131938036|NCT03189719|475061883|FG000|Overall Study|Physician Decision|1|||
131938037|NCT03189719|475061884|FG001|Overall Study|Physician Decision|0|||
131938038|NCT03189719|475061883|FG000|Overall Study|Sponsor Decision|40|||
131938039|NCT03189719|475061884|FG001|Overall Study|Sponsor Decision|12|||
131938040|NCT03189719|475061883|FG000|Overall Study|Withdrawal by Subject|7|||
131938041|NCT03189719|475061884|FG001|Overall Study|Withdrawal by Subject|3|||
131938042|NCT03012880|475061885|FG000|Overall Study|Withdrawal by Subject|1|||
131938043|NCT03012880|475061886|FG001|Overall Study|Withdrawal by Subject|0|||
131938044|NCT03012880|475061885|FG000|Overall Study|Ineligible|1|||
131938045|NCT03012880|475061886|FG001|Overall Study|Ineligible|0|||
131938046|NCT02769481|475061887|FG000|Overall Study|Protocol Violation|1|||
131938047|NCT02769481|475061888|FG001|Overall Study|Protocol Violation|0|||
131938048|NCT02769481|475061887|FG000|Overall Study|Adverse Event|3|||
131938049|NCT02769481|475061888|FG001|Overall Study|Adverse Event|6|||
131938050|NCT02769481|475061887|FG000|Overall Study|Entry Criteria Not Met|1|||
131938051|NCT02769481|475061888|FG001|Overall Study|Entry Criteria Not Met|2|||
131938052|NCT02769481|475061887|FG000|Overall Study|Withdrawal by Subject|14|||
131938053|NCT02769481|475061888|FG001|Overall Study|Withdrawal by Subject|16|||
131938054|NCT02769481|475061887|FG000|Overall Study|Lost to Follow-up|9|||
131938055|NCT02769481|475061888|FG001|Overall Study|Lost to Follow-up|9|||
131938056|NCT02769481|475061887|FG000|Overall Study|Physician Decision|0|||
131938057|NCT02769481|475061888|FG001|Overall Study|Physician Decision|1|||
131938058|NCT02769481|475061887|FG000|Overall Study|Terminated by Sponsor|1|||
131938059|NCT02769481|475061888|FG001|Overall Study|Terminated by Sponsor|0|||
131938060|NCT02769481|475061887|FG000|Overall Study|Death|0|||
131938061|NCT02769481|475061888|FG001|Overall Study|Death|1|||
131938062|NCT02769481|475061887|FG000|Overall Study|Undefined|4|||
131938063|NCT02769481|475061888|FG001|Overall Study|Undefined|1|||
131938064|NCT00642759|475061889|FG000|Overall Study|Protocol Violation|1|||
131938065|NCT03510715|475061890|FG000|Overall Study|Adverse Event|1|||
131938066|NCT03510715|475061891|FG001|Overall Study|Adverse Event|0|||
131938067|NCT03612570|475061896|FG000|Overall Study|Lost to Follow-up|1|||
131938068|NCT05643495|475061897|FG000|Overall Study|Adverse Event|0|||
131938069|NCT05643495|475061898|FG001|Overall Study|Adverse Event|1|||
131938070|NCT05643495|475061897|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
131938071|NCT05643495|475061898|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
131938072|NCT06272383|475061899|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
131938073|NCT06272383|475061900|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
131938074|NCT04887831|475063099|FG000|Overall Study|Death|26|||
131938075|NCT04887831|475063100|FG001|Overall Study|Death|26|||
131938076|NCT04887831|475063099|FG000|Overall Study|Lost to Follow-up|0|||
131938077|NCT04887831|475063100|FG001|Overall Study|Lost to Follow-up|1|||
131938078|NCT04887831|475063099|FG000|Overall Study|Withdrawal by Subject|2|||
131938079|NCT04887831|475063100|FG001|Overall Study|Withdrawal by Subject|1|||
131938080|NCT04887831|475063099|FG000|Overall Study|Study Terminated by Sponsor|18|||
131938081|NCT04887831|475063100|FG001|Overall Study|Study Terminated by Sponsor|17|||
131938082|NCT04887831|475063099|FG000|Overall Study|Other|1|||
131938083|NCT04887831|475063100|FG001|Overall Study|Other|0|||
131938084|NCT01323192|475063101|FG000|Overall Study|Adverse Event|6|||
131938085|NCT01323192|475063102|FG001|Overall Study|Adverse Event|1|||
131938086|NCT01323192|475063101|FG000|Overall Study|Withdrawal by Subject|3|||
131938087|NCT01323192|475063102|FG001|Overall Study|Withdrawal by Subject|1|||
131938088|NCT01323192|475063101|FG000|Overall Study|Noncompliance with study medication|0|||
131938089|NCT01323192|475063102|FG001|Overall Study|Noncompliance with study medication|3|||
131938090|NCT01323192|475063101|FG000|Overall Study|Nonmedical reasons|0|||
131938091|NCT01323192|475063102|FG001|Overall Study|Nonmedical reasons|1|||
131938092|NCT02835690|475063103|FG000|Overall Study|Death|12|||
131938093|NCT02835690|475063104|FG001|Overall Study|Death|11|||
131938094|NCT02835690|475063105|FG002|Overall Study|Death|13|||
131938095|NCT02835690|475063103|FG000|Overall Study|Transferred to Extension Study|2|||
131938096|NCT02835690|475063104|FG001|Overall Study|Transferred to Extension Study|2|||
131938097|NCT02835690|475063105|FG002|Overall Study|Transferred to Extension Study|1|||
131938098|NCT02835690|475063103|FG000|Overall Study|Did Not Continue on Extension Study|0|||
131938099|NCT02835690|475063104|FG001|Overall Study|Did Not Continue on Extension Study|0|||
131938100|NCT02835690|475063105|FG002|Overall Study|Did Not Continue on Extension Study|1|||
131938101|NCT02835690|475063103|FG000|Overall Study|Not Treated|0|||
131938102|NCT02835690|475063104|FG001|Overall Study|Not Treated|2|||
131454634|NCT00114517|473293364|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
131938103|NCT02835690|475063105|FG002|Overall Study|Not Treated|0|||
131938104|NCT00710593|475063106|FG000|Overall Study|Incarceration|1|||
131938105|NCT00710593|475063107|FG001|Overall Study|Incarceration|0|||
131938106|NCT00710593|475063106|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
131938107|NCT00710593|475063107|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
131938108|NCT00710593|475063106|FG000|Overall Study|Lost to Follow-up|3|||
131938109|NCT00710593|475063107|FG001|Overall Study|Lost to Follow-up|1|||
131938110|NCT00710593|475063106|FG000|Overall Study|Moved out of area|1|||
131938111|NCT00710593|475063107|FG001|Overall Study|Moved out of area|0|||
131938112|NCT00710593|475063106|FG000|Overall Study|Failure to adhere or complete study eval|1|||
131938113|NCT00710593|475063107|FG001|Overall Study|Failure to adhere or complete study eval|1|||
131938114|NCT00710593|475063106|FG000|Overall Study|Protocol Violation|1|||
131938115|NCT00710593|475063107|FG001|Overall Study|Protocol Violation|1|||
131938116|NCT00710593|475063106|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
131938117|NCT00710593|475063107|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
131938118|NCT01441960|475063108|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
131938119|NCT01441960|475063109|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
131938120|NCT01441960|475063108|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
131938121|NCT01441960|475063109|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
131938122|NCT01441960|475063108|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
131938123|NCT01441960|475063109|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
131938124|NCT03186638|475063110|FG000|Overall Study|Withdrawal by Subject|4|||
131938125|NCT03186638|475063111|FG001|Overall Study|Withdrawal by Subject|4|||
131938126|NCT03186638|475063110|FG000|Overall Study|Withdrawn due to medical problem|3|||
131938127|NCT03186638|475063111|FG001|Overall Study|Withdrawn due to medical problem|2|||
131938128|NCT03186638|475063110|FG000|Overall Study|Lost to Follow-up|1|||
131938129|NCT03186638|475063111|FG001|Overall Study|Lost to Follow-up|0|||
131454635|NCT00114517|473293365|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
131938130|NCT04047446|475063112|FG000|Overall Study|Physician Decision|1|||
131938131|NCT04047446|475063113|FG001|Overall Study|Physician Decision|0|||
131938132|NCT02367456|475063114|FG000|Overall Study|Death|8|||
131938133|NCT02367456|475063115|FG001|Overall Study|Death|24|||
131938134|NCT02367456|475063116|FG002|Overall Study|Death|17|||
131938135|NCT02367456|475063114|FG000|Overall Study|Lost to Follow-up|1|||
131938136|NCT02367456|475063115|FG001|Overall Study|Lost to Follow-up|3|||
131938137|NCT02367456|475063116|FG002|Overall Study|Lost to Follow-up|1|||
131938138|NCT02367456|475063114|FG000|Overall Study|Other reason|3|||
131938139|NCT02367456|475063115|FG001|Overall Study|Other reason|3|||
131938140|NCT02367456|475063116|FG002|Overall Study|Other reason|9|||
131938141|NCT02367456|475063114|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
131938142|NCT02367456|475063115|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
131938143|NCT02367456|475063116|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
131938144|NCT01517984|475063117|FG000|Overall Study|Lost to Follow-up|0|||
131938145|NCT01517984|475063118|FG001|Overall Study|Lost to Follow-up|1|||
131938146|NCT01517984|475063119|FG002|Overall Study|Lost to Follow-up|0|||
131938147|NCT01517984|475063120|FG003|Overall Study|Lost to Follow-up|0|||
131938148|NCT01517984|475063117|FG000|Overall Study|Withdrawal by Subject|1|||
131938149|NCT01517984|475063118|FG001|Overall Study|Withdrawal by Subject|8|||
131938150|NCT01517984|475063119|FG002|Overall Study|Withdrawal by Subject|4|||
131938151|NCT01517984|475063120|FG003|Overall Study|Withdrawal by Subject|1|||
131938152|NCT01517984|475063117|FG000|Overall Study|Screen Failure|4|||
131938153|NCT01517984|475063118|FG001|Overall Study|Screen Failure|0|||
131938154|NCT01517984|475063119|FG002|Overall Study|Screen Failure|0|||
131938155|NCT01517984|475063120|FG003|Overall Study|Screen Failure|0|||
131938156|NCT01517984|475063117|FG000|Overall Study|Ineligible for randomization|0|||
131938157|NCT01517984|475063118|FG001|Overall Study|Ineligible for randomization|14|||
131938158|NCT01517984|475063119|FG002|Overall Study|Ineligible for randomization|0|||
131938159|NCT01517984|475063120|FG003|Overall Study|Ineligible for randomization|0|||
131938160|NCT01500317|475063123|FG000|Overall Study|Withdrawal by Subject|3|||
131938161|NCT01500317|475063124|FG001|Overall Study|Withdrawal by Subject|2|||
131938162|NCT01500317|475063125|FG002|Overall Study|Withdrawal by Subject|0|||
131938163|NCT01170663|475063126|FG000|Overall Study|Lost to Follow-up|3|||
131938164|NCT01170663|475063127|FG001|Overall Study|Lost to Follow-up|9|||
131938165|NCT01170663|475063126|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
131938166|NCT01170663|475063127|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
131938167|NCT04138056|475063132|FG000|Primary Study|Lost to Follow-up|3|||
131938168|NCT04138056|475063133|FG001|Primary Study|Lost to Follow-up|4|||
131938169|NCT04138056|475063134|FG002|Primary Study|Lost to Follow-up|1|||
131938170|NCT04138056|475063135|FG003|Primary Study|Lost to Follow-up|1|||
131938171|NCT04138056|475063136|FG004|Primary Study|Lost to Follow-up|4|||
131938172|NCT04138056|475063132|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
131938173|NCT04138056|475063133|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
131938174|NCT04138056|475063134|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
131938175|NCT04138056|475063135|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
131938176|NCT04138056|475063136|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
131938177|NCT04138056|475063132|FG000|Extension Study|Lost to Follow-up|1|||
131938178|NCT04138056|475063133|FG001|Extension Study|Lost to Follow-up|2|||
131938179|NCT04138056|475063134|FG002|Extension Study|Lost to Follow-up|1|||
131938180|NCT04138056|475063135|FG003|Extension Study|Lost to Follow-up|0|||
131938181|NCT04138056|475063136|FG004|Extension Study|Lost to Follow-up|1|||
131938182|NCT01656161|475063137|FG000|Overall Study|Death|3|||
131938183|NCT01656161|475063137|FG000|Overall Study|Adverse Event|2|||
131938184|NCT01656161|475063137|FG000|Overall Study|Protocol Violation|1|||
131938185|NCT01656161|475063137|FG000|Overall Study|Withdrawal by Subject|1|||
131938186|NCT01215851|475063141|FG000|Treatment Period|Adverse Event|1|||
131938187|NCT01215851|475063142|FG001|Treatment Period|Adverse Event|1|||
131938188|NCT01215851|475063143|FG002|Treatment Period|Adverse Event|1|||
131938189|NCT01215851|475063144|FG003|Treatment Period|Adverse Event|3|||
131938190|NCT01215851|475063145|FG004|Treatment Period|Adverse Event|0|||
131938191|NCT01215851|475063146|FG005|Treatment Period|Adverse Event|1|||
131938192|NCT01215851|475063141|FG000|Follow up Period|Lost to Follow-up|0|||
131938193|NCT01215851|475063142|FG001|Follow up Period|Lost to Follow-up|0|||
131938194|NCT01215851|475063143|FG002|Follow up Period|Lost to Follow-up|0|||
131938195|NCT01215851|475063144|FG003|Follow up Period|Lost to Follow-up|0|||
131938196|NCT01215851|475063145|FG004|Follow up Period|Lost to Follow-up|0|||
131938197|NCT01215851|475063146|FG005|Follow up Period|Lost to Follow-up|1|||
131938198|NCT03510273|475063147|FG000|Overall Study|Withdrawal by Subject|2|||
131938199|NCT03510273|475063147|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
131938200|NCT03510273|475063147|FG000|Overall Study|Moved away from study area|4|||
131938201|NCT01242514|475063148|FG000|Overall Study|e.g., project closure|1042|||
131938202|NCT01242514|475063149|FG001|Overall Study|e.g., project closure|305|||
131938203|NCT01242514|475063150|FG002|Overall Study|e.g., project closure|171|||
131938204|NCT01242514|475063148|FG000|Overall Study|Subject decision|33|||
131938205|NCT01242514|475063149|FG001|Overall Study|Subject decision|8|||
131938206|NCT01242514|475063150|FG002|Overall Study|Subject decision|2|||
131938207|NCT01242514|475063148|FG000|Overall Study|Severe non-compliance to protocol|5|||
131938208|NCT01242514|475063149|FG001|Overall Study|Severe non-compliance to protocol|2|||
131938209|NCT01242514|475063150|FG002|Overall Study|Severe non-compliance to protocol|1|||
131938210|NCT01242514|475063148|FG000|Overall Study|Lack of therapeutic response|99|||
131938211|NCT01242514|475063149|FG001|Overall Study|Lack of therapeutic response|16|||
131938212|NCT01242514|475063150|FG002|Overall Study|Lack of therapeutic response|10|||
131938213|NCT01242514|475063148|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
131938214|NCT01242514|475063149|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
131938215|NCT01242514|475063150|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
131938216|NCT01242514|475063148|FG000|Overall Study|Lost to Follow-up|14|||
131938217|NCT01242514|475063149|FG001|Overall Study|Lost to Follow-up|5|||
131938218|NCT01242514|475063150|FG002|Overall Study|Lost to Follow-up|4|||
131938219|NCT01242514|475063148|FG000|Overall Study|Adverse Event|129|||
131938220|NCT01242514|475063149|FG001|Overall Study|Adverse Event|18|||
131938221|NCT01242514|475063150|FG002|Overall Study|Adverse Event|19|||
131938222|NCT01121757|475063153|FG000|First Drug|Death|1|||
131938223|NCT01121757|475063154|FG001|First Drug|Death|0|||
131938224|NCT01121757|475063153|FG000|First Drug|Disease Progression|0|||
131938225|NCT01121757|475063154|FG001|First Drug|Disease Progression|2|||
131938226|NCT01121757|475063153|FG000|Combination|Physician Decision|0|||
131938227|NCT01121757|475063154|FG001|Combination|Physician Decision|1|||
131938228|NCT01121757|475063153|FG000|Combination|Disease Progression|2|||
131938229|NCT01121757|475063154|FG001|Combination|Disease Progression|0|||
131938230|NCT05552859|475063155|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
131938231|NCT05552859|475063156|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
131938232|NCT05901636|475063157|FG000|Overall Study|Lost to Follow-up|0|||
131938233|NCT05901636|475063158|FG001|Overall Study|Lost to Follow-up|1|||
131938234|NCT05901636|475063159|FG002|Overall Study|Lost to Follow-up|0|||
131938235|NCT05901636|475063160|FG003|Overall Study|Lost to Follow-up|1|||
131938236|NCT05901636|475063161|FG004|Overall Study|Lost to Follow-up|1|||
131938237|NCT05901636|475063162|FG005|Overall Study|Lost to Follow-up|3|||
131938238|NCT05901636|475063163|FG006|Overall Study|Lost to Follow-up|1|||
131938239|NCT05901636|475063157|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
131938240|NCT05901636|475063158|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
131938241|NCT05901636|475063159|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
131938242|NCT05901636|475063160|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
131938243|NCT05901636|475063161|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
131938244|NCT05901636|475063162|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
131938245|NCT05901636|475063163|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
131938246|NCT05901636|475063157|FG000|Overall Study|Withdrawal by Subject|1|||
131938247|NCT05901636|475063158|FG001|Overall Study|Withdrawal by Subject|1|||
131938248|NCT05901636|475063159|FG002|Overall Study|Withdrawal by Subject|0|||
131938249|NCT05901636|475063160|FG003|Overall Study|Withdrawal by Subject|0|||
131938250|NCT05901636|475063161|FG004|Overall Study|Withdrawal by Subject|1|||
131938251|NCT05901636|475063162|FG005|Overall Study|Withdrawal by Subject|1|||
131938252|NCT05901636|475063163|FG006|Overall Study|Withdrawal by Subject|0|||
131938253|NCT05901636|475063157|FG000|Overall Study|Other|0|||
131938254|NCT05901636|475063158|FG001|Overall Study|Other|0|||
131938255|NCT05901636|475063159|FG002|Overall Study|Other|1|||
131938256|NCT05901636|475063160|FG003|Overall Study|Other|1|||
131938257|NCT05901636|475063161|FG004|Overall Study|Other|0|||
131938258|NCT05901636|475063162|FG005|Overall Study|Other|0|||
131938259|NCT05901636|475063163|FG006|Overall Study|Other|0|||
131938260|NCT04583618|475063164|FG000|Overall Study|Adverse Event|0|||
131938261|NCT04583618|475063165|FG001|Overall Study|Adverse Event|0|||
131938262|NCT04583618|475063166|FG002|Overall Study|Adverse Event|1|||
131938263|NCT04583618|475063167|FG003|Overall Study|Adverse Event|0|||
131938264|NCT04583618|475063168|FG004|Overall Study|Adverse Event|0|||
131938265|NCT04583618|475063164|FG000|Overall Study|Protocol deviation|1|||
131938266|NCT04583618|475063165|FG001|Overall Study|Protocol deviation|1|||
131938267|NCT04583618|475063166|FG002|Overall Study|Protocol deviation|1|||
131938268|NCT04583618|475063167|FG003|Overall Study|Protocol deviation|0|||
131938269|NCT04583618|475063168|FG004|Overall Study|Protocol deviation|0|||
131938270|NCT04583618|475063164|FG000|Overall Study|Withdrawal by Subject|2|||
131938271|NCT04583618|475063165|FG001|Overall Study|Withdrawal by Subject|1|||
131938272|NCT04583618|475063166|FG002|Overall Study|Withdrawal by Subject|3|||
131938273|NCT04583618|475063167|FG003|Overall Study|Withdrawal by Subject|1|||
131938274|NCT04583618|475063168|FG004|Overall Study|Withdrawal by Subject|1|||
131938275|NCT04583618|475063164|FG000|Overall Study|Lost to Follow-up|0|||
131938276|NCT04583618|475063165|FG001|Overall Study|Lost to Follow-up|1|||
131938277|NCT04583618|475063166|FG002|Overall Study|Lost to Follow-up|3|||
131938278|NCT04583618|475063167|FG003|Overall Study|Lost to Follow-up|1|||
131938279|NCT04583618|475063168|FG004|Overall Study|Lost to Follow-up|1|||
131938280|NCT02711202|475063169|FG000|Overall Study|Adverse Event|3|||
131938281|NCT02711202|475063170|FG001|Overall Study|Adverse Event|0|||
131938282|NCT02711202|475063169|FG000|Overall Study|graft loss|1|||
131938283|NCT02711202|475063170|FG001|Overall Study|graft loss|0|||
131938284|NCT03636022|475063173|FG000|Overall Study|Withdrawal by Subject|1|||
131938285|NCT03636022|475063174|FG001|Overall Study|Withdrawal by Subject|3|||
131938286|NCT04569084|475063175|FG000|Overall Study|Adverse Event|10|||
131938287|NCT04569084|475063176|FG001|Overall Study|Adverse Event|14|||
131938288|NCT04569084|475063175|FG000|Overall Study|Death|2|||
131938289|NCT04569084|475063176|FG001|Overall Study|Death|3|||
131938290|NCT04569084|475063175|FG000|Overall Study|Lost to Follow-up|1|||
131938291|NCT04569084|475063176|FG001|Overall Study|Lost to Follow-up|1|||
131938292|NCT04569084|475063175|FG000|Overall Study|Physician Decision|3|||
131938293|NCT04569084|475063176|FG001|Overall Study|Physician Decision|3|||
131938294|NCT04569084|475063175|FG000|Overall Study|Protocol Violation|2|||
131938295|NCT04569084|475063176|FG001|Overall Study|Protocol Violation|1|||
131938296|NCT04569084|475063175|FG000|Overall Study|Withdrawal by Subject|20|||
131938297|NCT04569084|475063176|FG001|Overall Study|Withdrawal by Subject|21|||
131938298|NCT04569084|475063175|FG000|Overall Study|Study terminated by sponsor|26|||
131938299|NCT04569084|475063176|FG001|Overall Study|Study terminated by sponsor|23|||
131938300|NCT04569084|475063175|FG000|Overall Study|Other|3|||
131938301|NCT04569084|475063176|FG001|Overall Study|Other|5|||
131938302|NCT01400412|475063177|FG000|Overall Study|Lost to Follow-up|4|||
131938303|NCT01400412|475063178|FG001|Overall Study|Lost to Follow-up|7|||
131938304|NCT01400412|475063177|FG000|Overall Study|Withdrawal by Subject|3|||
131938305|NCT01400412|475063178|FG001|Overall Study|Withdrawal by Subject|4|||
131938306|NCT01400412|475063177|FG000|Overall Study|Unable to complete|3|||
131938307|NCT01400412|475063178|FG001|Overall Study|Unable to complete|3|||
131938308|NCT01400412|475063177|FG000|Overall Study|Never started study treatment|0|||
131938309|NCT01400412|475063178|FG001|Overall Study|Never started study treatment|3|||
131938310|NCT04696146|475064853|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
131938311|NCT04696146|475064854|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
131938312|NCT04696146|475064853|FG000|Overall Study|Off hours issue with product|1|||
131938313|NCT04696146|475064854|FG001|Overall Study|Off hours issue with product|0|||
131938314|NCT00529633|475064859|FG000|Overall Study|Withdrawal by Subject|1|||
131938315|NCT00529633|475064860|FG001|Overall Study|Withdrawal by Subject|1|||
131938316|NCT02276040|475064864|FG000|Overall Study|Physician Decision|15|||
131938317|NCT00069641|475064869|FG000|Overall Study|Death|1|||
131938318|NCT00069641|475064870|FG001|Overall Study|Death|0|||
131938319|NCT00069641|475064871|FG002|Overall Study|Death|1|||
131938320|NCT01645176|475064874|FG000|Overall Study|Lack of Efficacy|4|||
131938321|NCT01645176|475064874|FG000|Overall Study|did not complete final MRI|1|||
131938322|NCT01948427|475064875|FG000|Overall Study|Serious Adverse Event|3|||
131938323|NCT01948427|475064876|FG001|Overall Study|Serious Adverse Event|0|||
131938324|NCT01948427|475064877|FG002|Overall Study|Serious Adverse Event|0|||
131938325|NCT01948427|475064878|FG003|Overall Study|Serious Adverse Event|0|||
131938326|NCT01948427|475064879|FG004|Overall Study|Serious Adverse Event|1|||
131938327|NCT01948427|475064875|FG000|Overall Study|Investigator Request|0|||
131938328|NCT01948427|475064876|FG001|Overall Study|Investigator Request|8|||
131938329|NCT01948427|475064877|FG002|Overall Study|Investigator Request|0|||
131938330|NCT01948427|475064878|FG003|Overall Study|Investigator Request|0|||
131938331|NCT01948427|475064879|FG004|Overall Study|Investigator Request|6|||
131938332|NCT01948427|475064875|FG000|Overall Study|Lost to Follow-up|1|||
131938333|NCT01948427|475064876|FG001|Overall Study|Lost to Follow-up|0|||
131938334|NCT01948427|475064877|FG002|Overall Study|Lost to Follow-up|0|||
131938335|NCT01948427|475064878|FG003|Overall Study|Lost to Follow-up|0|||
131938336|NCT01948427|475064879|FG004|Overall Study|Lost to Follow-up|4|||
131938337|NCT01948427|475064875|FG000|Overall Study|Withdrawal by Subject|2|||
131938338|NCT01948427|475064876|FG001|Overall Study|Withdrawal by Subject|0|||
131938339|NCT01948427|475064877|FG002|Overall Study|Withdrawal by Subject|0|||
131938340|NCT01948427|475064878|FG003|Overall Study|Withdrawal by Subject|0|||
131938341|NCT01948427|475064879|FG004|Overall Study|Withdrawal by Subject|1|||
131938342|NCT01948427|475064875|FG000|Overall Study|Other, Not Specified|1|||
131938343|NCT01948427|475064876|FG001|Overall Study|Other, Not Specified|9|||
131938344|NCT01948427|475064877|FG002|Overall Study|Other, Not Specified|0|||
131938345|NCT01948427|475064878|FG003|Overall Study|Other, Not Specified|0|||
131938346|NCT01948427|475064879|FG004|Overall Study|Other, Not Specified|2|||
131938347|NCT00402987|475064880|FG000|Overall Study|Lack of Efficacy|0|||
131938348|NCT00402987|475064881|FG001|Overall Study|Lack of Efficacy|0|||
131938349|NCT00402987|475064882|FG002|Overall Study|Lack of Efficacy|1|||
131938350|NCT00402987|475064883|FG003|Overall Study|Lack of Efficacy|0|||
131938351|NCT02448381|475064886|FG000|Overall Study|Adverse Event|2|||
131938352|NCT02448381|475064887|FG001|Overall Study|Adverse Event|0|||
131938353|NCT02448381|475064886|FG000|Overall Study|Lost to Follow-up|16|||
131938354|NCT02448381|475064887|FG001|Overall Study|Lost to Follow-up|9|||
131938355|NCT02448381|475064886|FG000|Overall Study|Physician Decision|1|||
131938356|NCT02448381|475064887|FG001|Overall Study|Physician Decision|1|||
131938357|NCT02448381|475064886|FG000|Overall Study|Pregnancy|1|||
131938358|NCT02448381|475064887|FG001|Overall Study|Pregnancy|0|||
131938359|NCT02448381|475064886|FG000|Overall Study|Withdrawal by Subject|13|||
131938360|NCT02448381|475064887|FG001|Overall Study|Withdrawal by Subject|9|||
131938361|NCT02448381|475064886|FG000|Overall Study|Noncompliance with Study Procedures|2|||
131938362|NCT02448381|475064887|FG001|Overall Study|Noncompliance with Study Procedures|0|||
131938363|NCT02006927|475064892|FG000|Overall Study|Adverse Event|2|||
131938364|NCT02006927|475064892|FG000|Overall Study|Withdrawal by Subject|1|||
131938365|NCT00673920|475064895|FG000|Baseline up to Week 48|Withdrew consent|1|||
131938366|NCT00673920|475064896|FG001|Baseline up to Week 48|Withdrew consent|0|||
131938367|NCT00673920|475064897|FG002|Baseline up to Week 48|Withdrew consent|2|||
131938368|NCT00673920|475064898|FG003|Baseline up to Week 48|Withdrew consent|0|||
131938369|NCT00673920|475064899|FG004|Baseline up to Week 48|Withdrew consent|0|||
131938370|NCT00673920|475064900|FG005|Baseline up to Week 48|Withdrew consent|0|||
131938371|NCT00673920|475064901|FG006|Baseline up to Week 48|Withdrew consent|0|||
131938372|NCT00673920|475064902|FG007|Baseline up to Week 48|Withdrew consent|0|||
131938373|NCT00673920|475064895|FG000|Baseline up to Week 48|Refused treatment|1|||
131938374|NCT00673920|475064896|FG001|Baseline up to Week 48|Refused treatment|0|||
131938375|NCT00673920|475064897|FG002|Baseline up to Week 48|Refused treatment|0|||
131938376|NCT00673920|475064898|FG003|Baseline up to Week 48|Refused treatment|0|||
131938377|NCT00673920|475064899|FG004|Baseline up to Week 48|Refused treatment|0|||
131938378|NCT00673920|475064900|FG005|Baseline up to Week 48|Refused treatment|0|||
131938379|NCT00673920|475064901|FG006|Baseline up to Week 48|Refused treatment|0|||
131938380|NCT00673920|475064902|FG007|Baseline up to Week 48|Refused treatment|0|||
131938381|NCT00673920|475064895|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
131938382|NCT00673920|475064896|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
131938383|NCT00673920|475064897|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
131938384|NCT00673920|475064898|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
131938385|NCT00673920|475064899|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
131938386|NCT00673920|475064900|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
131938387|NCT00673920|475064901|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
131938388|NCT00673920|475064902|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
131938389|NCT00673920|475064895|FG000|Baseline up to Week 48|Protocol Violation|0|||
131938390|NCT00673920|475064896|FG001|Baseline up to Week 48|Protocol Violation|0|||
131938391|NCT00673920|475064897|FG002|Baseline up to Week 48|Protocol Violation|1|||
131938392|NCT00673920|475064898|FG003|Baseline up to Week 48|Protocol Violation|0|||
131938393|NCT00673920|475064899|FG004|Baseline up to Week 48|Protocol Violation|0|||
131938394|NCT00673920|475064900|FG005|Baseline up to Week 48|Protocol Violation|0|||
131938395|NCT00673920|475064901|FG006|Baseline up to Week 48|Protocol Violation|0|||
131938396|NCT00673920|475064902|FG007|Baseline up to Week 48|Protocol Violation|0|||
131938397|NCT00673920|475064895|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938398|NCT00673920|475064896|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938399|NCT00673920|475064897|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
131938400|NCT00673920|475064898|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938401|NCT00673920|475064899|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938402|NCT00673920|475064900|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938403|NCT00673920|475064901|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938404|NCT00673920|475064902|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
131938405|NCT00673920|475064895|FG000|Baseline up to Week 48|Administrative/Other|0|||
131938406|NCT00673920|475064896|FG001|Baseline up to Week 48|Administrative/Other|1|||
131938407|NCT00673920|475064897|FG002|Baseline up to Week 48|Administrative/Other|2|||
131938408|NCT00673920|475064898|FG003|Baseline up to Week 48|Administrative/Other|0|||
131938409|NCT00673920|475064899|FG004|Baseline up to Week 48|Administrative/Other|0|||
131938410|NCT00673920|475064900|FG005|Baseline up to Week 48|Administrative/Other|0|||
131938411|NCT00673920|475064901|FG006|Baseline up to Week 48|Administrative/Other|0|||
131938412|NCT00673920|475064902|FG007|Baseline up to Week 48|Administrative/Other|0|||
131938413|NCT00673920|475064895|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
131938414|NCT00673920|475064896|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
131938415|NCT00673920|475064897|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
131938416|NCT00673920|475064898|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
131938417|NCT00673920|475064899|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
131938418|NCT00673920|475064900|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
131938419|NCT00673920|475064901|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
131938420|NCT00673920|475064902|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
131938421|NCT00673920|475064895|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938422|NCT00673920|475064896|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938423|NCT00673920|475064897|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938424|NCT00673920|475064898|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938425|NCT00673920|475064899|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938426|NCT00673920|475064900|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938427|NCT00673920|475064901|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
131938428|NCT00673920|475064902|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
131938429|NCT00673920|475064895|FG000|Week 24 to Week 48|Failure to return|0|||
131938430|NCT00673920|475064896|FG001|Week 24 to Week 48|Failure to return|0|||
131938431|NCT00673920|475064897|FG002|Week 24 to Week 48|Failure to return|0|||
131938432|NCT00673920|475064898|FG003|Week 24 to Week 48|Failure to return|0|||
131938433|NCT00673920|475064899|FG004|Week 24 to Week 48|Failure to return|0|||
131938434|NCT00673920|475064900|FG005|Week 24 to Week 48|Failure to return|1|||
131938435|NCT00673920|475064901|FG006|Week 24 to Week 48|Failure to return|0|||
131454636|NCT00539864|473294204|FG000|Overall Study|Lost to Follow-up|0|||
131454637|NCT00539864|473294205|FG001|Overall Study|Lost to Follow-up|1|||
131454638|NCT00539864|473294204|FG000|Overall Study|Withdrawal by Subject|1|||
131454639|NCT00539864|473294205|FG001|Overall Study|Withdrawal by Subject|1|||
131454640|NCT02255435|473294206|FG000|Overall Study|Patient's Limited Time Availability|0|||
131454641|NCT02255435|473294207|FG001|Overall Study|Patient's Limited Time Availability|0|||
131454642|NCT02255435|473294208|FG002|Overall Study|Patient's Limited Time Availability|0|||
131454643|NCT02255435|473294209|FG003|Overall Study|Patient's Limited Time Availability|0|||
131454644|NCT02255435|473294210|FG004|Overall Study|Patient's Limited Time Availability|0|||
131454645|NCT02255435|473294211|FG005|Overall Study|Patient's Limited Time Availability|0|||
131454646|NCT02255435|473294212|FG006|Overall Study|Patient's Limited Time Availability|0|||
131454647|NCT02255435|473294213|FG007|Overall Study|Patient's Limited Time Availability|1|||
131454648|NCT02255435|473294214|FG008|Overall Study|Patient's Limited Time Availability|0|||
131454649|NCT02255435|473294215|FG009|Overall Study|Patient's Limited Time Availability|0|||
131454650|NCT02255435|473294206|FG000|Overall Study|Withdrawal by Subject|0|||
131454651|NCT02255435|473294207|FG001|Overall Study|Withdrawal by Subject|0|||
131454652|NCT02255435|473294208|FG002|Overall Study|Withdrawal by Subject|0|||
131454653|NCT02255435|473294209|FG003|Overall Study|Withdrawal by Subject|0|||
131454654|NCT02255435|473294210|FG004|Overall Study|Withdrawal by Subject|0|||
131454655|NCT02255435|473294211|FG005|Overall Study|Withdrawal by Subject|0|||
131454656|NCT02255435|473294212|FG006|Overall Study|Withdrawal by Subject|0|||
131454657|NCT02255435|473294213|FG007|Overall Study|Withdrawal by Subject|0|||
131454658|NCT02255435|473294214|FG008|Overall Study|Withdrawal by Subject|1|||
131454659|NCT02255435|473294215|FG009|Overall Study|Withdrawal by Subject|4|||
131938436|NCT00673920|475064902|FG007|Week 24 to Week 48|Failure to return|0|||
131938437|NCT00673920|475064895|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938438|NCT00673920|475064896|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938439|NCT00673920|475064897|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938440|NCT00673920|475064898|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938441|NCT00673920|475064899|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938442|NCT00673920|475064900|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
131938443|NCT00673920|475064901|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938444|NCT00673920|475064902|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
131938445|NCT00673920|475064895|FG000|Week 24 to Week 48|Death|0|||
131938446|NCT00673920|475064896|FG001|Week 24 to Week 48|Death|0|||
131938447|NCT00673920|475064897|FG002|Week 24 to Week 48|Death|0|||
131938448|NCT00673920|475064898|FG003|Week 24 to Week 48|Death|0|||
131938449|NCT00673920|475064899|FG004|Week 24 to Week 48|Death|0|||
131938450|NCT00673920|475064900|FG005|Week 24 to Week 48|Death|1|||
131938451|NCT00673920|475064901|FG006|Week 24 to Week 48|Death|0|||
131938452|NCT00673920|475064902|FG007|Week 24 to Week 48|Death|0|||
131938453|NCT00673920|475064895|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
131938454|NCT00673920|475064896|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
131938455|NCT00673920|475064897|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
131938456|NCT00673920|475064898|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
131938457|NCT00673920|475064899|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
131938458|NCT00673920|475064900|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
131938459|NCT00673920|475064901|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
131938460|NCT00673920|475064902|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
131938461|NCT01164007|475064907|FG000|Overall Study|Adverse Event|5|||
131938462|NCT01164007|475064907|FG000|Overall Study|Progression of Disease|30|||
131938463|NCT01164007|475064907|FG000|Overall Study|Protocol Violation|1|||
131938464|NCT01164007|475064907|FG000|Overall Study|Withdrawal by Subject|1|||
131938465|NCT01164007|475064907|FG000|Overall Study|Medical Decision|3|||
131938466|NCT00894387|475064908|FG000|Overall Study|Adverse Event|44|||
131938467|NCT00894387|475064909|FG001|Overall Study|Adverse Event|45|||
131938468|NCT00894387|475064908|FG000|Overall Study|Abnormal Laboratory values|2|||
131938469|NCT00894387|475064909|FG001|Overall Study|Abnormal Laboratory values|2|||
131938470|NCT00894387|475064908|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131938471|NCT00894387|475064909|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131938472|NCT00894387|475064908|FG000|Overall Study|Lost to Follow-up|3|||
131938473|NCT00894387|475064909|FG001|Overall Study|Lost to Follow-up|5|||
131938474|NCT00894387|475064908|FG000|Overall Study|Administrative problems|2|||
131938475|NCT00894387|475064909|FG001|Overall Study|Administrative problems|2|||
131938476|NCT00894387|475064908|FG000|Overall Study|Death|77|||
131938477|NCT00894387|475064909|FG001|Overall Study|Death|76|||
131938478|NCT00894387|475064908|FG000|Overall Study|Protocol Deviation|4|||
131938479|NCT00894387|475064909|FG001|Overall Study|Protocol Deviation|0|||
131938480|NCT00894387|475064908|FG000|Overall Study|Patient's request|25|||
131938481|NCT00894387|475064909|FG001|Overall Study|Patient's request|30|||
131938482|NCT00894387|475064908|FG000|Overall Study|Other (Missing)|5|||
131938483|NCT00894387|475064909|FG001|Overall Study|Other (Missing)|3|||
131938484|NCT00894387|475064908|FG000|Overall Study|Mis-randomized|13|||
131938485|NCT00894387|475064909|FG001|Overall Study|Mis-randomized|9|||
131454660|NCT02255435|473294206|FG000|Overall Study|Administrative reasons|0|||
131454661|NCT02255435|473294207|FG001|Overall Study|Administrative reasons|0|||
131938486|NCT00894387|475064908|FG000|Overall Study|GCP non-compliance|0|||
131938487|NCT00894387|475064909|FG001|Overall Study|GCP non-compliance|2|||
131938488|NCT04856527|475064910|FG000|Overall Study|Unable to complete experimental task|2|||
131938489|NCT04856527|475064911|FG001|Overall Study|Unable to complete experimental task|0|||
131938490|NCT04165824|475064912|FG000|Overall Study|Adverse Event|23|||
131938491|NCT04165824|475064912|FG000|Overall Study|Physician Decision|1|||
131938492|NCT04165824|475064912|FG000|Overall Study|Withdrawal by Subject|17|||
131938493|NCT04165824|475064912|FG000|Overall Study|Other|5|||
131938494|NCT02303262|475064919|FG000|Overall Study|Withdrawal by Subject|2|||
131938495|NCT01038323|475064922|FG000|Overall Study|Withdrawal by Subject|3|||
131938496|NCT01038323|475064923|FG001|Overall Study|Withdrawal by Subject|2|||
131938497|NCT01038323|475064924|FG002|Overall Study|Withdrawal by Subject|4|||
131938498|NCT04462471|475064925|FG000|Overall Study|Adverse Event|0|||
131938499|NCT04462471|475064926|FG001|Overall Study|Adverse Event|1|||
131938500|NCT04462471|475064927|FG002|Overall Study|Adverse Event|0|||
131938501|NCT04462471|475064928|FG003|Overall Study|Adverse Event|0|||
131938502|NCT04462471|475064925|FG000|Overall Study|Disease progression|1|||
131938503|NCT04462471|475064926|FG001|Overall Study|Disease progression|0|||
131938504|NCT04462471|475064927|FG002|Overall Study|Disease progression|0|||
131938505|NCT04462471|475064928|FG003|Overall Study|Disease progression|0|||
131454662|NCT02255435|473294208|FG002|Overall Study|Administrative reasons|0|||
131454663|NCT02255435|473294209|FG003|Overall Study|Administrative reasons|0|||
131454664|NCT02255435|473294210|FG004|Overall Study|Administrative reasons|0|||
131454665|NCT02255435|473294211|FG005|Overall Study|Administrative reasons|0|||
131454666|NCT02255435|473294212|FG006|Overall Study|Administrative reasons|0|||
131454667|NCT02255435|473294213|FG007|Overall Study|Administrative reasons|0|||
131454668|NCT02255435|473294214|FG008|Overall Study|Administrative reasons|0|||
131454669|NCT02255435|473294215|FG009|Overall Study|Administrative reasons|2|||
131454670|NCT00943072|473294216|FG000|Overall Study|Adverse Event|0|||
131454671|NCT00943072|473294217|FG001|Overall Study|Adverse Event|3|||
131454672|NCT00943072|473294216|FG000|Overall Study|Death|0|||
131938506|NCT04079738|475064947|FG000|Study Treatment|Death|1|||
131938507|NCT04079738|475064948|FG001|Study Treatment|Death|0|||
131938508|NCT04079738|475064949|FG002|Study Treatment|Death|0|||
131938509|NCT04079738|475064950|FG003|Study Treatment|Death|0|||
131938510|NCT04079738|475064947|FG000|Study Treatment|Adverse Event|2|||
131938511|NCT04079738|475064948|FG001|Study Treatment|Adverse Event|0|||
131938512|NCT04079738|475064949|FG002|Study Treatment|Adverse Event|0|||
131938513|NCT04079738|475064950|FG003|Study Treatment|Adverse Event|0|||
131938514|NCT04079738|475064947|FG000|Study Treatment|withdrawal before treatment|1|||
131938515|NCT04079738|475064948|FG001|Study Treatment|withdrawal before treatment|0|||
131938516|NCT04079738|475064949|FG002|Study Treatment|withdrawal before treatment|0|||
131938517|NCT04079738|475064950|FG003|Study Treatment|withdrawal before treatment|0|||
131938518|NCT04079738|475064947|FG000|Study Treatment|symptomatic deterioration|2|||
131938519|NCT04079738|475064948|FG001|Study Treatment|symptomatic deterioration|0|||
131938520|NCT04079738|475064949|FG002|Study Treatment|symptomatic deterioration|0|||
131938521|NCT04079738|475064950|FG003|Study Treatment|symptomatic deterioration|0|||
131938522|NCT04079738|475064947|FG000|Study Treatment|Disease Progression|1|||
131938523|NCT04079738|475064948|FG001|Study Treatment|Disease Progression|0|||
131938524|NCT04079738|475064949|FG002|Study Treatment|Disease Progression|0|||
131938525|NCT04079738|475064950|FG003|Study Treatment|Disease Progression|0|||
131938526|NCT04079738|475064947|FG000|Study Treatment|withdrawal after treatment|1|||
131938527|NCT04079738|475064948|FG001|Study Treatment|withdrawal after treatment|0|||
131938528|NCT04079738|475064949|FG002|Study Treatment|withdrawal after treatment|0|||
131938529|NCT04079738|475064950|FG003|Study Treatment|withdrawal after treatment|0|||
131938530|NCT04079738|475064947|FG000|Follow up|Withdrawal by Subject|3|||
131938531|NCT04079738|475064948|FG001|Follow up|Withdrawal by Subject|0|||
131938532|NCT04079738|475064949|FG002|Follow up|Withdrawal by Subject|0|||
131938533|NCT04079738|475064950|FG003|Follow up|Withdrawal by Subject|0|||
131938534|NCT04079738|475064947|FG000|Follow up|Death|5|||
131938535|NCT04079738|475064948|FG001|Follow up|Death|0|||
131938536|NCT04079738|475064949|FG002|Follow up|Death|0|||
131938537|NCT04079738|475064950|FG003|Follow up|Death|0|||
131454673|NCT00943072|473294217|FG001|Overall Study|Death|2|||
131454674|NCT00943072|473294216|FG000|Overall Study|Withdrawal by Subject|3|||
131454675|NCT00943072|473294217|FG001|Overall Study|Withdrawal by Subject|1|||
131454676|NCT00943072|473294216|FG000|Overall Study|Protocol Violation|0|||
131454677|NCT00943072|473294217|FG001|Overall Study|Protocol Violation|1|||
131454678|NCT00943072|473294216|FG000|Overall Study|Lost to Follow-up|1|||
131454679|NCT00943072|473294217|FG001|Overall Study|Lost to Follow-up|2|||
131938538|NCT03330847|475064960|FG000|Overall Study|Patients ongoing study|62|||
131938539|NCT03330847|475064961|FG001|Overall Study|Patients ongoing study|65|||
131454680|NCT00943072|473294216|FG000|Overall Study|Lack of Efficacy|0|||
131938540|NCT03330847|475064962|FG002|Overall Study|Patients ongoing study|15|||
131938541|NCT01355627|475064963|FG000|Overall Study|Request By the Patient to Discontinue|5|||
131938542|NCT01355627|475064964|FG001|Overall Study|Request By the Patient to Discontinue|7|||
131938543|NCT01355627|475064963|FG000|Overall Study|Lost to Follow-up|8|||
131938544|NCT01355627|475064964|FG001|Overall Study|Lost to Follow-up|7|||
131938545|NCT01355627|475064963|FG000|Overall Study|Fatal Adverse Event|19|||
131938546|NCT01355627|475064964|FG001|Overall Study|Fatal Adverse Event|23|||
131938547|NCT01355627|475064963|FG000|Overall Study|Other|1|||
131938548|NCT01355627|475064964|FG001|Overall Study|Other|1|||
131938549|NCT02293551|475064967|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
131938550|NCT02293551|475064968|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
131938551|NCT02293551|475064969|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
131938552|NCT02293551|475064970|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
131938553|NCT02293551|475064971|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
131938554|NCT02293551|475064972|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
131938555|NCT02293551|475064967|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
131938556|NCT02293551|475064968|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
131938557|NCT02293551|475064969|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
131938558|NCT02293551|475064970|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
131938559|NCT02293551|475064971|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
131938560|NCT02293551|475064972|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
131938561|NCT02293551|475064967|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
131938562|NCT02293551|475064968|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
131938563|NCT02293551|475064969|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
131938564|NCT02293551|475064970|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
131938565|NCT02293551|475064971|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
131938566|NCT02293551|475064972|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
131938567|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
131938568|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
131938569|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
131938570|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
131938571|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
131412670|NCT00931801|473133710|FG001|Overall Study|Lost to Follow-up|1|||
131412671|NCT00931801|473133711|FG002|Overall Study|Lost to Follow-up|0|||
131412672|NCT00931801|473133709|FG000|Overall Study|Withdrawal by Subject|1|||
131412673|NCT00931801|473133710|FG001|Overall Study|Withdrawal by Subject|0|||
131412674|NCT00931801|473133711|FG002|Overall Study|Withdrawal by Subject|0|||
131412675|NCT00931801|473133709|FG000|Overall Study|Confirmed Virologic Failure|0|||
131412676|NCT00931801|473133710|FG001|Overall Study|Confirmed Virologic Failure|0|||
131412677|NCT00931801|473133711|FG002|Overall Study|Confirmed Virologic Failure|3|||
131412678|NCT00933244|473133712|FG000|Overall Study|Withdrawal by Subject|5|||
131412679|NCT00933244|473133713|FG001|Overall Study|Withdrawal by Subject|1|||
131412680|NCT00933244|473133714|FG002|Overall Study|Withdrawal by Subject|3|||
131412681|NCT02266875|473133715|FG000|Overall Study|Withdrawal by Subject|9|||
131412682|NCT02266875|473133716|FG001|Overall Study|Withdrawal by Subject|0|||
131412683|NCT02266875|473133715|FG000|Overall Study|Lost to Follow-up|2|||
131412684|NCT02266875|473133716|FG001|Overall Study|Lost to Follow-up|0|||
131412685|NCT01920152|473133718|FG000|Overall Study|Withdrawal by Subject|1|||
131412686|NCT01920152|473133719|FG001|Overall Study|Withdrawal by Subject|2|||
131412687|NCT04375397|473133720|FG000|Overall Study|Death|1|||
131412688|NCT04375397|473133721|FG001|Overall Study|Death|1|||
131412689|NCT04375397|473133720|FG000|Overall Study|Withdrew consent|2|||
131412690|NCT04375397|473133721|FG001|Overall Study|Withdrew consent|0|||
131412691|NCT04375397|473133720|FG000|Overall Study|Lost to Follow-up|6|||
131412692|NCT04375397|473133721|FG001|Overall Study|Lost to Follow-up|4|||
131412693|NCT04375397|473133720|FG000|Overall Study|Other, not specified|0|||
131412694|NCT04375397|473133721|FG001|Overall Study|Other, not specified|1|||
131412695|NCT05545644|473133725|FG000|Overall Study|Lost to Follow-up|4|||
131412696|NCT05545644|473133726|FG001|Overall Study|Lost to Follow-up|3|||
131412697|NCT00610441|473133727|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
131412698|NCT00610441|473133728|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
131412699|NCT00610441|473133729|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
131412700|NCT00610441|473133730|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
131412701|NCT00610441|473133727|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
131412702|NCT00610441|473133728|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
131412703|NCT00610441|473133729|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
131412704|NCT00610441|473133730|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
131412705|NCT00610441|473133727|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
131412706|NCT00610441|473133728|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
131412707|NCT00610441|473133729|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
131412708|NCT00610441|473133730|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
131412709|NCT00610441|473133727|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
131412710|NCT00610441|473133728|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
131412711|NCT00610441|473133729|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
131412712|NCT00610441|473133730|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
131412713|NCT00610441|473133727|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
131938572|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
131938573|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
131938574|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
131938575|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
131938576|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
131938577|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
131938578|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
131938579|NCT04532749|475064973|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
131938580|NCT04532749|475064974|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
131938581|NCT04532749|475064973|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
131938582|NCT04532749|475064974|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
131938583|NCT04532749|475064973|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
131938584|NCT04532749|475064974|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
131938585|NCT04532749|475064973|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
131938586|NCT04532749|475064974|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
131938587|NCT04756531|475064977|FG000|Overall Study|Adverse Event|0|||
131938588|NCT04756531|475064978|FG001|Overall Study|Adverse Event|0|||
131938589|NCT04756531|475064979|FG002|Overall Study|Adverse Event|0|||
131938590|NCT04756531|475064980|FG003|Overall Study|Adverse Event|0|||
131938591|NCT04756531|475064981|FG004|Overall Study|Adverse Event|1|||
131938592|NCT04756531|475064982|FG005|Overall Study|Adverse Event|0|||
131938593|NCT04756531|475064983|FG006|Overall Study|Adverse Event|0|||
131938594|NCT04756531|475064984|FG007|Overall Study|Adverse Event|0|||
131938595|NCT04756531|475064985|FG008|Overall Study|Adverse Event|0|||
131938596|NCT04756531|475064986|FG009|Overall Study|Adverse Event|0|||
131938597|NCT04756531|475064987|FG010|Overall Study|Adverse Event|0|||
131938598|NCT04756531|475064988|FG011|Overall Study|Adverse Event|0|||
131938599|NCT04756531|475064989|FG012|Overall Study|Adverse Event|0|||
131938600|NCT04756531|475064990|FG013|Overall Study|Adverse Event|0|||
131938601|NCT04756531|475064991|FG014|Overall Study|Adverse Event|0|||
131938602|NCT04756531|475064992|FG015|Overall Study|Adverse Event|0|||
131938603|NCT04756531|475064993|FG016|Overall Study|Adverse Event|0|||
131938604|NCT04756531|475064994|FG017|Overall Study|Adverse Event|0|||
131938605|NCT04756531|475064977|FG000|Overall Study|Withdrawal by Subject|0|||
131454681|NCT00943072|473294217|FG001|Overall Study|Lack of Efficacy|4|||
131454682|NCT00943072|473294216|FG000|Overall Study|Other|1|||
131454683|NCT00943072|473294217|FG001|Overall Study|Other|1|||
131454684|NCT03887702|473294218|FG000|Overall Study|Study terminated|0|||
131454685|NCT03887702|473294219|FG001|Overall Study|Study terminated|0|||
131454686|NCT03887702|473294220|FG002|Overall Study|Study terminated|2|||
131454687|NCT03887702|473294221|FG003|Overall Study|Study terminated|2|||
131454688|NCT05064358|473294229|FG000|Overall Study|Death|23|||
131454689|NCT05064358|473294230|FG001|Overall Study|Death|23|||
131454690|NCT05064358|473294231|FG002|Overall Study|Death|25|||
131454691|NCT05064358|473294232|FG003|Overall Study|Death|21|||
131454692|NCT05064358|473294233|FG004|Overall Study|Death|5|||
131454693|NCT05064358|473294229|FG000|Overall Study|Lost to Follow-up|1|||
131454694|NCT05064358|473294230|FG001|Overall Study|Lost to Follow-up|2|||
131454695|NCT05064358|473294231|FG002|Overall Study|Lost to Follow-up|0|||
131454696|NCT05064358|473294232|FG003|Overall Study|Lost to Follow-up|2|||
131454697|NCT05064358|473294233|FG004|Overall Study|Lost to Follow-up|0|||
131454698|NCT05064358|473294229|FG000|Overall Study|Physician Decision|1|||
131454699|NCT05064358|473294230|FG001|Overall Study|Physician Decision|1|||
131454700|NCT05064358|473294231|FG002|Overall Study|Physician Decision|2|||
131454701|NCT05064358|473294232|FG003|Overall Study|Physician Decision|0|||
131454702|NCT05064358|473294233|FG004|Overall Study|Physician Decision|0|||
131454703|NCT05064358|473294229|FG000|Overall Study|Withdrawal by Subject|4|||
131454704|NCT05064358|473294230|FG001|Overall Study|Withdrawal by Subject|5|||
131454705|NCT05064358|473294231|FG002|Overall Study|Withdrawal by Subject|3|||
131454706|NCT05064358|473294232|FG003|Overall Study|Withdrawal by Subject|6|||
131454707|NCT05064358|473294233|FG004|Overall Study|Withdrawal by Subject|3|||
131454708|NCT05064358|473294229|FG000|Overall Study|Ongoing at the time of analysis|1|||
131454709|NCT05064358|473294230|FG001|Overall Study|Ongoing at the time of analysis|2|||
131454710|NCT05064358|473294231|FG002|Overall Study|Ongoing at the time of analysis|2|||
131454711|NCT05064358|473294232|FG003|Overall Study|Ongoing at the time of analysis|2|||
131454712|NCT05064358|473294233|FG004|Overall Study|Ongoing at the time of analysis|2|||
131938606|NCT04756531|475064978|FG001|Overall Study|Withdrawal by Subject|0|||
131938607|NCT04756531|475064979|FG002|Overall Study|Withdrawal by Subject|0|||
131938608|NCT04756531|475064980|FG003|Overall Study|Withdrawal by Subject|0|||
131938609|NCT04756531|475064981|FG004|Overall Study|Withdrawal by Subject|0|||
131938610|NCT04756531|475064982|FG005|Overall Study|Withdrawal by Subject|0|||
131938611|NCT04756531|475064983|FG006|Overall Study|Withdrawal by Subject|1|||
131454713|NCT04976192|473294234|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454714|NCT04976192|473294235|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
131454715|NCT04976192|473294236|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454716|NCT04976192|473294237|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454717|NCT04976192|473294238|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454718|NCT04976192|473294239|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454719|NCT04976192|473294240|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454720|NCT04976192|473294241|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454721|NCT04976192|473294242|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454722|NCT04976192|473294243|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
131454723|NCT04976192|473294234|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
131454724|NCT04976192|473294235|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
131454725|NCT04976192|473294236|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
131454726|NCT04976192|473294237|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
131454727|NCT04976192|473294238|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454728|NCT04976192|473294239|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454729|NCT04976192|473294240|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454730|NCT04976192|473294241|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454731|NCT04976192|473294242|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454732|NCT04976192|473294243|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454733|NCT04976192|473294234|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
131938612|NCT04756531|475064984|FG007|Overall Study|Withdrawal by Subject|0|||
131938613|NCT04756531|475064985|FG008|Overall Study|Withdrawal by Subject|0|||
131938614|NCT04756531|475064986|FG009|Overall Study|Withdrawal by Subject|0|||
131938615|NCT04756531|475064987|FG010|Overall Study|Withdrawal by Subject|0|||
131938616|NCT04756531|475064988|FG011|Overall Study|Withdrawal by Subject|0|||
131938617|NCT04756531|475064989|FG012|Overall Study|Withdrawal by Subject|0|||
131938618|NCT04756531|475064990|FG013|Overall Study|Withdrawal by Subject|0|||
131938619|NCT04756531|475064991|FG014|Overall Study|Withdrawal by Subject|0|||
131938620|NCT04756531|475064992|FG015|Overall Study|Withdrawal by Subject|0|||
131938621|NCT04756531|475064993|FG016|Overall Study|Withdrawal by Subject|0|||
131938622|NCT04756531|475064994|FG017|Overall Study|Withdrawal by Subject|0|||
131938623|NCT02257528|475064995|FG000|Overall Study|Never received study treatment|1|||
131938624|NCT00789555|475064996|FG000|Overall Study|Protocol Amendment|78|||
131938625|NCT00789555|475064997|FG001|Overall Study|Protocol Amendment|76|||
131938626|NCT00789555|475064998|FG002|Overall Study|Protocol Amendment|80|||
131938627|NCT00789555|475064996|FG000|Overall Study|Adverse Event|17|||
131938628|NCT00789555|475064997|FG001|Overall Study|Adverse Event|7|||
131938629|NCT00789555|475064998|FG002|Overall Study|Adverse Event|10|||
131938630|NCT00789555|475064996|FG000|Overall Study|Lost to Follow-up|9|||
131938631|NCT00789555|475064997|FG001|Overall Study|Lost to Follow-up|10|||
131938632|NCT00789555|475064998|FG002|Overall Study|Lost to Follow-up|18|||
131938633|NCT00789555|475064996|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
131938634|NCT00789555|475064997|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
131938635|NCT00789555|475064998|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
131938636|NCT00789555|475064996|FG000|Overall Study|Treatment failure|11|||
131938637|NCT00789555|475064997|FG001|Overall Study|Treatment failure|8|||
131938638|NCT00789555|475064998|FG002|Overall Study|Treatment failure|12|||
131938639|NCT00789555|475064996|FG000|Overall Study|Protocol Violation|6|||
131938640|NCT00789555|475064997|FG001|Overall Study|Protocol Violation|9|||
131938641|NCT00789555|475064998|FG002|Overall Study|Protocol Violation|13|||
131938642|NCT00404248|475064999|FG000|Overall Study|pts declining status|0|||
131938643|NCT00404248|475065000|FG001|Overall Study|pts declining status|1|||
131938644|NCT00404248|475065001|FG002|Overall Study|pts declining status|0|||
131938645|NCT00404248|475065002|FG003|Overall Study|pts declining status|0|||
131938646|NCT00404248|475065003|FG004|Overall Study|pts declining status|0|||
131938647|NCT00404248|475065004|FG005|Overall Study|pts declining status|0|||
131938648|NCT00404248|475065005|FG006|Overall Study|pts declining status|0|||
131938649|NCT00404248|475065006|FG007|Overall Study|pts declining status|0|||
131938650|NCT00404248|475065007|FG008|Overall Study|pts declining status|0|||
131938651|NCT04646005|475065011|FG000|Overall Study|Adverse Event|1|||
131454734|NCT04976192|473294235|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131454735|NCT04976192|473294236|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
131454736|NCT04976192|473294237|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131938652|NCT04646005|475065011|FG000|Overall Study|Progressive Disease|71|||
131938653|NCT04646005|475065011|FG000|Overall Study|Death|20|||
131938654|NCT04646005|475065011|FG000|Overall Study|Withdrawal by Subject|12|||
131938655|NCT04646005|475065011|FG000|Overall Study|Sponsor Request|9|||
131938656|NCT04398706|475065012|FG000|Overall Study|Adverse Event|0|||
131938657|NCT04398706|475065013|FG001|Overall Study|Adverse Event|0|||
131938658|NCT04398706|475065014|FG002|Overall Study|Adverse Event|0|||
131938659|NCT04398706|475065015|FG003|Overall Study|Adverse Event|0|||
131938660|NCT04398706|475065016|FG004|Overall Study|Adverse Event|0|||
131938661|NCT04398706|475065017|FG005|Overall Study|Adverse Event|1|||
131938662|NCT04398706|475065018|FG006|Overall Study|Adverse Event|1|||
131938663|NCT04398706|475065019|FG007|Overall Study|Adverse Event|0|||
131938664|NCT04398706|475065012|FG000|Overall Study|Lost to Follow-up|0|||
131938665|NCT04398706|475065013|FG001|Overall Study|Lost to Follow-up|1|||
131938666|NCT04398706|475065014|FG002|Overall Study|Lost to Follow-up|2|||
131938667|NCT04398706|475065015|FG003|Overall Study|Lost to Follow-up|1|||
131938668|NCT04398706|475065016|FG004|Overall Study|Lost to Follow-up|6|||
131938669|NCT04398706|475065017|FG005|Overall Study|Lost to Follow-up|3|||
131938670|NCT04398706|475065018|FG006|Overall Study|Lost to Follow-up|8|||
131938671|NCT04398706|475065019|FG007|Overall Study|Lost to Follow-up|2|||
131938672|NCT04398706|475065012|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131938673|NCT04398706|475065013|FG001|Overall Study|Withdrawal by parent/guardian|2|||
131938674|NCT04398706|475065014|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131938675|NCT04398706|475065015|FG003|Overall Study|Withdrawal by parent/guardian|2|||
131938676|NCT04398706|475065016|FG004|Overall Study|Withdrawal by parent/guardian|19|||
131938677|NCT04398706|475065017|FG005|Overall Study|Withdrawal by parent/guardian|23|||
131938678|NCT04398706|475065018|FG006|Overall Study|Withdrawal by parent/guardian|13|||
131938679|NCT04398706|475065019|FG007|Overall Study|Withdrawal by parent/guardian|11|||
131938680|NCT04398706|475065012|FG000|Overall Study|Protocol deviation|0|||
131938681|NCT04398706|475065013|FG001|Overall Study|Protocol deviation|1|||
131938682|NCT04398706|475065014|FG002|Overall Study|Protocol deviation|0|||
131938683|NCT04398706|475065015|FG003|Overall Study|Protocol deviation|0|||
131938684|NCT04398706|475065016|FG004|Overall Study|Protocol deviation|6|||
131938685|NCT04398706|475065017|FG005|Overall Study|Protocol deviation|4|||
131938686|NCT04398706|475065018|FG006|Overall Study|Protocol deviation|6|||
131938687|NCT04398706|475065019|FG007|Overall Study|Protocol deviation|3|||
131938688|NCT04577404|475065020|FG000|Overall Study|Adverse Event|31|||
131938689|NCT04577404|475065020|FG000|Overall Study|Death|1|||
131938690|NCT04577404|475065020|FG000|Overall Study|Lack of Efficacy|3|||
131938691|NCT04577404|475065020|FG000|Overall Study|Physician Decision|7|||
131938692|NCT04577404|475065020|FG000|Overall Study|Withdrawal by Subject|21|||
131938693|NCT04577404|475065020|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
131938694|NCT04237584|475065021|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
131938695|NCT04237584|475065022|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
131938696|NCT04237584|475065023|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
131938697|NCT04237584|475065024|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
131938698|NCT04237584|475065021|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
131938699|NCT04237584|475065022|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
131938700|NCT04237584|475065023|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
131938701|NCT04237584|475065024|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
131938702|NCT04237584|475065021|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
131938703|NCT04237584|475065022|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
131938704|NCT04237584|475065023|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
131938705|NCT04237584|475065024|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
131938706|NCT04237584|475065021|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
131938707|NCT04237584|475065022|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
131938708|NCT04237584|475065023|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
131938709|NCT04237584|475065024|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
131938710|NCT04237584|475065021|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
131938711|NCT04237584|475065022|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
131938712|NCT04237584|475065023|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
131938713|NCT04237584|475065024|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
131938714|NCT05239221|475065025|FG000|Overall Study|Adverse Event|0|||
131938715|NCT05239221|475065026|FG001|Overall Study|Adverse Event|0|||
131938716|NCT05239221|475065027|FG002|Overall Study|Adverse Event|0|||
131938717|NCT05239221|475065028|FG003|Overall Study|Adverse Event|0|||
131938718|NCT05239221|475065029|FG004|Overall Study|Adverse Event|0|||
131938719|NCT05239221|475065030|FG005|Overall Study|Adverse Event|0|||
131938720|NCT05239221|475065031|FG006|Overall Study|Adverse Event|1|||
131938721|NCT05239221|475065032|FG007|Overall Study|Adverse Event|0|||
131938722|NCT05239221|475065033|FG008|Overall Study|Adverse Event|0|||
131938723|NCT05239221|475065034|FG009|Overall Study|Adverse Event|0|||
131938724|NCT05239221|475065035|FG010|Overall Study|Adverse Event|1|||
131938725|NCT05239221|475065036|FG011|Overall Study|Adverse Event|1|||
131938726|NCT05239221|475065037|FG012|Overall Study|Adverse Event|0|||
131938727|NCT05239221|475065038|FG013|Overall Study|Adverse Event|0|||
131938728|NCT05239221|475065039|FG014|Overall Study|Adverse Event|0|||
131938729|NCT05239221|475065040|FG015|Overall Study|Adverse Event|0|||
131938730|NCT05239221|475065025|FG000|Overall Study|Withdrawal by Subject|0|||
131938731|NCT05239221|475065026|FG001|Overall Study|Withdrawal by Subject|0|||
131938732|NCT05239221|475065027|FG002|Overall Study|Withdrawal by Subject|0|||
131938733|NCT05239221|475065028|FG003|Overall Study|Withdrawal by Subject|0|||
131938734|NCT05239221|475065029|FG004|Overall Study|Withdrawal by Subject|0|||
131938735|NCT05239221|475065030|FG005|Overall Study|Withdrawal by Subject|0|||
131938736|NCT05239221|475065031|FG006|Overall Study|Withdrawal by Subject|0|||
131938737|NCT05239221|475065032|FG007|Overall Study|Withdrawal by Subject|0|||
131938738|NCT05239221|475065033|FG008|Overall Study|Withdrawal by Subject|0|||
131938739|NCT05239221|475065034|FG009|Overall Study|Withdrawal by Subject|0|||
131938740|NCT05239221|475065035|FG010|Overall Study|Withdrawal by Subject|1|||
131938741|NCT05239221|475065036|FG011|Overall Study|Withdrawal by Subject|0|||
131938742|NCT05239221|475065037|FG012|Overall Study|Withdrawal by Subject|0|||
131938743|NCT05239221|475065038|FG013|Overall Study|Withdrawal by Subject|0|||
131938744|NCT05239221|475065039|FG014|Overall Study|Withdrawal by Subject|0|||
131412714|NCT00610441|473133728|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
131412715|NCT00610441|473133729|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
131938745|NCT05239221|475065040|FG015|Overall Study|Withdrawal by Subject|1|||
131938746|NCT02661672|475065041|FG000|Overall Study|Lost to Follow-up|1|||
131938747|NCT02661672|475065041|FG000|Overall Study|Death|4|||
131938748|NCT01576783|475066922|FG000|Overall Study|Change in Medical Care|1|||
131938749|NCT01576783|475066923|FG001|Overall Study|Change in Medical Care|0|||
131938750|NCT01576783|475066922|FG000|Overall Study|Lost to Follow-up|14|||
131938751|NCT01576783|475066923|FG001|Overall Study|Lost to Follow-up|16|||
131938752|NCT01576783|475066922|FG000|Overall Study|Withdrawal by Subject|5|||
131938753|NCT01576783|475066923|FG001|Overall Study|Withdrawal by Subject|1|||
131938754|NCT01897493|475066924|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
131938755|NCT05489328|475066925|FG000|Overall Study|Lost to Follow-up|0|||
131938756|NCT05489328|475066926|FG001|Overall Study|Lost to Follow-up|0|||
131938757|NCT05489328|475066927|FG002|Overall Study|Lost to Follow-up|1|||
131938758|NCT05489328|475066928|FG003|Overall Study|Lost to Follow-up|0|||
131938759|NCT05489328|475066929|FG004|Overall Study|Lost to Follow-up|2|||
131938760|NCT05489328|475066930|FG005|Overall Study|Lost to Follow-up|0|||
131938761|NCT05489328|475066931|FG006|Overall Study|Lost to Follow-up|0|||
131938762|NCT05489328|475066932|FG007|Overall Study|Lost to Follow-up|1|||
131938763|NCT05489328|475066933|FG008|Overall Study|Lost to Follow-up|0|||
131938764|NCT05489328|475066925|FG000|Overall Study|Withdrawal by Subject|0|||
131938765|NCT05489328|475066926|FG001|Overall Study|Withdrawal by Subject|0|||
131938766|NCT05489328|475066927|FG002|Overall Study|Withdrawal by Subject|0|||
131938767|NCT05489328|475066928|FG003|Overall Study|Withdrawal by Subject|0|||
131938768|NCT05489328|475066929|FG004|Overall Study|Withdrawal by Subject|0|||
131938769|NCT05489328|475066930|FG005|Overall Study|Withdrawal by Subject|0|||
131938770|NCT05489328|475066931|FG006|Overall Study|Withdrawal by Subject|1|||
131938771|NCT05489328|475066932|FG007|Overall Study|Withdrawal by Subject|1|||
131938772|NCT05489328|475066933|FG008|Overall Study|Withdrawal by Subject|0|||
131938773|NCT05489328|475066925|FG000|Overall Study|Other|0|||
131938774|NCT05489328|475066926|FG001|Overall Study|Other|0|||
131938775|NCT05489328|475066927|FG002|Overall Study|Other|0|||
131938776|NCT05489328|475066928|FG003|Overall Study|Other|0|||
131938777|NCT05489328|475066929|FG004|Overall Study|Other|0|||
131938778|NCT05489328|475066930|FG005|Overall Study|Other|0|||
131938779|NCT05489328|475066931|FG006|Overall Study|Other|0|||
131938780|NCT05489328|475066932|FG007|Overall Study|Other|1|||
131938781|NCT05489328|475066933|FG008|Overall Study|Other|1|||
131938782|NCT01083602|475066934|FG000|Overall Study|Adverse Event|11|||
131938783|NCT01083602|475066934|FG000|Overall Study|New Cancer Therapy|2|||
131938784|NCT01083602|475066934|FG000|Overall Study|Death|1|||
131938785|NCT01083602|475066934|FG000|Overall Study|Withdrawal by Subject|5|||
131938786|NCT01083602|475066934|FG000|Overall Study|Lack of Efficacy|36|||
131938787|NCT03698279|475066936|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131938788|NCT03698279|475066937|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131938789|NCT03698279|475066938|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131938790|NCT03698279|475066939|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131938791|NCT03698279|475066940|FG004|Overall Study|Withdrawal by parent/guardian|0|||
131938792|NCT03698279|475066941|FG005|Overall Study|Withdrawal by parent/guardian|0|||
131938793|NCT03698279|475066936|FG000|Overall Study|Protocol deviation|1|||
131938794|NCT03698279|475066937|FG001|Overall Study|Protocol deviation|0|||
131938795|NCT03698279|475066938|FG002|Overall Study|Protocol deviation|1|||
131938796|NCT03698279|475066939|FG003|Overall Study|Protocol deviation|0|||
131938797|NCT03698279|475066940|FG004|Overall Study|Protocol deviation|0|||
131938798|NCT03698279|475066941|FG005|Overall Study|Protocol deviation|0|||
131938799|NCT03698279|475066936|FG000|Overall Study|Withdrawal by Subject|0|||
131938800|NCT03698279|475066937|FG001|Overall Study|Withdrawal by Subject|0|||
131938801|NCT03698279|475066938|FG002|Overall Study|Withdrawal by Subject|1|||
131938802|NCT03698279|475066939|FG003|Overall Study|Withdrawal by Subject|0|||
131938803|NCT03698279|475066940|FG004|Overall Study|Withdrawal by Subject|0|||
131938804|NCT03698279|475066941|FG005|Overall Study|Withdrawal by Subject|0|||
131938805|NCT03698279|475066936|FG000|Overall Study|Lost to Follow-up|3|||
131938806|NCT03698279|475066937|FG001|Overall Study|Lost to Follow-up|1|||
131938807|NCT03698279|475066938|FG002|Overall Study|Lost to Follow-up|4|||
131938808|NCT03698279|475066939|FG003|Overall Study|Lost to Follow-up|5|||
131938809|NCT03698279|475066940|FG004|Overall Study|Lost to Follow-up|0|||
131938810|NCT03698279|475066941|FG005|Overall Study|Lost to Follow-up|0|||
131938811|NCT01276704|475066942|FG000|Overall Study|Lost to Follow-up|2|||
131938812|NCT01276704|475066943|FG001|Overall Study|Lost to Follow-up|3|||
131938813|NCT01276704|475066942|FG000|Overall Study|Non-compliant|2|||
131938814|NCT01276704|475066943|FG001|Overall Study|Non-compliant|2|||
131938815|NCT01276704|475066942|FG000|Overall Study|Withdrawal by Subject|7|||
131938816|NCT01276704|475066943|FG001|Overall Study|Withdrawal by Subject|1|||
131938817|NCT01276704|475066942|FG000|Overall Study|Physician Decision|3|||
131938818|NCT01276704|475066943|FG001|Overall Study|Physician Decision|5|||
131938819|NCT02986074|475066944|FG000|First Trial Period|Adverse Event|1|||
131938820|NCT02986074|475066945|FG001|First Trial Period|Adverse Event|0|||
131938821|NCT02986074|475066946|FG002|First Trial Period|Adverse Event|0|||
131938822|NCT02986074|475066947|FG003|First Trial Period|Adverse Event|0|||
131938823|NCT02986074|475066944|FG000|Follow up Period|system explant|0|||
131938824|NCT02986074|475066945|FG001|Follow up Period|system explant|0|||
131938825|NCT02986074|475066946|FG002|Follow up Period|system explant|1|||
131938826|NCT02986074|475066947|FG003|Follow up Period|system explant|2|||
131938827|NCT02986074|475066944|FG000|Follow up Period|Physician Decision|0|||
131938828|NCT02986074|475066945|FG001|Follow up Period|Physician Decision|0|||
131938829|NCT02986074|475066946|FG002|Follow up Period|Physician Decision|0|||
131938830|NCT02986074|475066947|FG003|Follow up Period|Physician Decision|1|||
131938831|NCT03801525|475066948|FG000|Overall Study|Adverse Event|17|||
131938832|NCT03801525|475066949|FG001|Overall Study|Adverse Event|1|||
131938833|NCT03801525|475066950|FG002|Overall Study|Adverse Event|0|||
131938834|NCT03801525|475066948|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
131938835|NCT03801525|475066949|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
131938836|NCT03801525|475066950|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
131938837|NCT03801525|475066948|FG000|Overall Study|Death|29|||
131938838|NCT03801525|475066949|FG001|Overall Study|Death|1|||
131938839|NCT03801525|475066950|FG002|Overall Study|Death|4|||
131938840|NCT03801525|475066948|FG000|Overall Study|Disease Progression|6|||
131938841|NCT03801525|475066949|FG001|Overall Study|Disease Progression|0|||
131938842|NCT03801525|475066950|FG002|Overall Study|Disease Progression|1|||
131938843|NCT03801525|475066948|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
131938844|NCT03801525|475066949|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
131938845|NCT03801525|475066950|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
131938846|NCT03801525|475066948|FG000|Overall Study|Investigator Decision|18|||
131938847|NCT03801525|475066949|FG001|Overall Study|Investigator Decision|1|||
131938848|NCT03801525|475066950|FG002|Overall Study|Investigator Decision|0|||
131938849|NCT03801525|475066948|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
131938850|NCT03801525|475066949|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
131938851|NCT03801525|475066950|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
131938852|NCT03801525|475066948|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
131938853|NCT03801525|475066949|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
131938854|NCT03801525|475066950|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
131938855|NCT03801525|475066948|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
131938856|NCT03801525|475066949|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
131938857|NCT03801525|475066950|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
131938858|NCT03801525|475066948|FG000|Overall Study|Withdrawal of Subject Consent|38|||
131938859|NCT03801525|475066949|FG001|Overall Study|Withdrawal of Subject Consent|2|||
131938860|NCT03801525|475066950|FG002|Overall Study|Withdrawal of Subject Consent|1|||
131938861|NCT03801525|475066948|FG000|Overall Study|Reason not Specified|4|||
131938862|NCT03801525|475066949|FG001|Overall Study|Reason not Specified|0|||
131938863|NCT03801525|475066950|FG002|Overall Study|Reason not Specified|4|||
131938864|NCT04388826|475066951|FG000|Overall Study|Lost to Follow-up|3|||
131938865|NCT04388826|475066952|FG001|Overall Study|Lost to Follow-up|2|||
131938866|NCT04388826|475066951|FG000|Overall Study|Adverse Event|1|||
131938867|NCT04388826|475066952|FG001|Overall Study|Adverse Event|0|||
131938868|NCT00329420|475066953|FG000|Re-induction Phase|Lack of Efficacy|0|||
131938869|NCT00329420|475066954|FG001|Re-induction Phase|Lack of Efficacy|1|||
131938870|NCT00329420|475066955|FG002|Re-induction Phase|Lack of Efficacy|0|||
131938871|NCT00329420|475066953|FG000|Re-induction Phase|Withdrawal of Consent|0|||
131938872|NCT00329420|475066954|FG001|Re-induction Phase|Withdrawal of Consent|0|||
131938873|NCT00329420|475066955|FG002|Re-induction Phase|Withdrawal of Consent|1|||
131938874|NCT00329420|475066953|FG000|Re-induction Phase|Did not respond to re-induction|6|||
131938875|NCT00329420|475066954|FG001|Re-induction Phase|Did not respond to re-induction|5|||
131938876|NCT00329420|475066955|FG002|Re-induction Phase|Did not respond to re-induction|7|||
131938877|NCT00329420|475066953|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
131938878|NCT00329420|475066954|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
131938879|NCT00329420|475066955|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
131938880|NCT00329420|475066953|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
131938881|NCT00329420|475066954|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
131938882|NCT00329420|475066955|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
131938883|NCT00329420|475066953|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
131938884|NCT00329420|475066954|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
131938885|NCT00329420|475066955|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
131938886|NCT02862574|475066956|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131938887|NCT02862574|475066957|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131938888|NCT02862574|475066958|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131938889|NCT02862574|475066956|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
131938890|NCT02862574|475066957|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
131938891|NCT02862574|475066958|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
131938892|NCT02862574|475066956|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
131412716|NCT00610441|473133730|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
131412717|NCT00610441|473133727|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
131412718|NCT00610441|473133728|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
131938893|NCT02862574|475066957|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
131938894|NCT02862574|475066958|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
131938895|NCT03386773|475066959|FG000|Overall Study|Lost to Follow-up|24|||
131938896|NCT03386773|475066960|FG001|Overall Study|Lost to Follow-up|33|||
131938897|NCT03386773|475066959|FG000|Overall Study|Withdrawal by Subject|3|||
131938898|NCT03386773|475066960|FG001|Overall Study|Withdrawal by Subject|2|||
131938899|NCT03983421|475066961|FG000|Overall Study|Lost to Follow-up|1|||
131938900|NCT03639610|475066962|FG000|Overall Study|Adverse Event|7|||
131938901|NCT03639610|475066963|FG001|Overall Study|Adverse Event|1|||
131938902|NCT03639610|475066964|FG002|Overall Study|Adverse Event|0|||
131938903|NCT03639610|475066962|FG000|Overall Study|Physician Decision|3|||
131938904|NCT03639610|475066963|FG001|Overall Study|Physician Decision|1|||
131938905|NCT03639610|475066964|FG002|Overall Study|Physician Decision|0|||
131938906|NCT03639610|475066962|FG000|Overall Study|Disease progression|8|||
131938907|NCT03639610|475066963|FG001|Overall Study|Disease progression|5|||
131938908|NCT03639610|475066964|FG002|Overall Study|Disease progression|3|||
131938909|NCT03639610|475066962|FG000|Overall Study|Study terminated by sponsor|2|||
131938910|NCT03639610|475066963|FG001|Overall Study|Study terminated by sponsor|1|||
131938911|NCT03639610|475066964|FG002|Overall Study|Study terminated by sponsor|1|||
131938912|NCT03639610|475066962|FG000|Overall Study|Patient request to stop treatment|1|||
131938913|NCT03639610|475066963|FG001|Overall Study|Patient request to stop treatment|2|||
131938914|NCT03639610|475066964|FG002|Overall Study|Patient request to stop treatment|0|||
131938915|NCT05067335|475066967|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
131938916|NCT05067335|475066968|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
131938917|NCT05067335|475066969|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
131938918|NCT05067335|475066970|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
131938919|NCT05067335|475066967|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
131938920|NCT05067335|475066968|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
131938921|NCT05067335|475066969|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
131938922|NCT05067335|475066970|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
131938923|NCT05067335|475066967|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
131938924|NCT05067335|475066968|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
131938925|NCT05067335|475066969|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
131938926|NCT05067335|475066970|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
131938927|NCT05067335|475066967|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
131938928|NCT05067335|475066968|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
131938929|NCT05067335|475066969|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
131938930|NCT05067335|475066970|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
131938931|NCT05067335|475066967|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
131938932|NCT05067335|475066968|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
131938933|NCT05067335|475066969|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
131938934|NCT05067335|475066970|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
131938935|NCT05067335|475066967|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
131938936|NCT05067335|475066968|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
131938937|NCT05067335|475066969|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
131938938|NCT05067335|475066970|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
131938939|NCT05067335|475066967|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
131938940|NCT05067335|475066968|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
131938941|NCT05067335|475066969|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
131938942|NCT05067335|475066970|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
131938943|NCT05067335|475066967|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
131938944|NCT05067335|475066968|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
131938945|NCT05067335|475066969|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
131938946|NCT05067335|475066970|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
131938947|NCT05067335|475066967|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
131938948|NCT05067335|475066968|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
131938949|NCT05067335|475066969|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
131938950|NCT05067335|475066970|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
131938951|NCT05067335|475066967|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
131938952|NCT05067335|475066968|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
131938953|NCT05067335|475066969|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
131938954|NCT05067335|475066970|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
131938955|NCT02724839|475066971|FG000|Overall Study|Withdrawal by Subject|1|||
131938956|NCT02724839|475066972|FG001|Overall Study|Withdrawal by Subject|1|||
131938957|NCT02724839|475066973|FG002|Overall Study|Withdrawal by Subject|0|||
131938958|NCT02724839|475066971|FG000|Overall Study|Lost to Follow-up|0|||
131938959|NCT02724839|475066972|FG001|Overall Study|Lost to Follow-up|3|||
131938960|NCT02724839|475066973|FG002|Overall Study|Lost to Follow-up|2|||
131938961|NCT02724839|475066971|FG000|Overall Study|Physician Decision|0|||
131938962|NCT02724839|475066972|FG001|Overall Study|Physician Decision|0|||
131938963|NCT02724839|475066973|FG002|Overall Study|Physician Decision|3|||
131938964|NCT00560417|475066974|FG000|Overall Study|Adverse Event|3|||
131938965|NCT00560417|475066975|FG001|Overall Study|Adverse Event|2|||
131938966|NCT00560417|475066974|FG000|Overall Study|Entry Criteria Not Met|1|||
131938967|NCT00560417|475066975|FG001|Overall Study|Entry Criteria Not Met|0|||
131938968|NCT00560417|475066974|FG000|Overall Study|Lost to Follow-up|0|||
131938969|NCT00560417|475066975|FG001|Overall Study|Lost to Follow-up|1|||
131938970|NCT00560417|475066974|FG000|Overall Study|Physician Decision|2|||
131938971|NCT00560417|475066975|FG001|Overall Study|Physician Decision|6|||
131938972|NCT00560417|475066974|FG000|Overall Study|Protocol Violation|6|||
131938973|NCT00560417|475066975|FG001|Overall Study|Protocol Violation|5|||
131938974|NCT00560417|475066974|FG000|Overall Study|Sponsor Decision|2|||
131938975|NCT00560417|475066975|FG001|Overall Study|Sponsor Decision|0|||
131938976|NCT00560417|475066974|FG000|Overall Study|Withdrawal by Subject|3|||
131938977|NCT00560417|475066975|FG001|Overall Study|Withdrawal by Subject|3|||
131938978|NCT02164864|475066978|FG000|Overall Study|Trial disease worsening|7|||
131938979|NCT02164864|475066979|FG001|Overall Study|Trial disease worsening|5|||
131938980|NCT02164864|475066980|FG002|Overall Study|Trial disease worsening|1|||
131938981|NCT02164864|475066978|FG000|Overall Study|Other pre-existing disease worsening|6|||
131938982|NCT02164864|475066979|FG001|Overall Study|Other pre-existing disease worsening|4|||
131938983|NCT02164864|475066980|FG002|Overall Study|Other pre-existing disease worsening|9|||
131938984|NCT02164864|475066978|FG000|Overall Study|Other Adverse Event (AE)|52|||
131938985|NCT02164864|475066979|FG001|Overall Study|Other Adverse Event (AE)|32|||
131938986|NCT02164864|475066980|FG002|Overall Study|Other Adverse Event (AE)|49|||
131938987|NCT02164864|475066978|FG000|Overall Study|Protocol Violation|2|||
131938988|NCT02164864|475066979|FG001|Overall Study|Protocol Violation|4|||
131938989|NCT02164864|475066980|FG002|Overall Study|Protocol Violation|1|||
131938990|NCT02164864|475066978|FG000|Overall Study|Lost to Follow-up|4|||
131938991|NCT02164864|475066979|FG001|Overall Study|Lost to Follow-up|3|||
131938992|NCT02164864|475066980|FG002|Overall Study|Lost to Follow-up|2|||
131938993|NCT02164864|475066978|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
131938994|NCT02164864|475066979|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
131938995|NCT02164864|475066980|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
131938996|NCT02164864|475066978|FG000|Overall Study|Other than stated|3|||
131938997|NCT02164864|475066979|FG001|Overall Study|Other than stated|4|||
131938998|NCT02164864|475066980|FG002|Overall Study|Other than stated|14|||
131938999|NCT02569853|475066981|FG000|Overall Study|Adverse Event|2|||
131939000|NCT02569853|475066982|FG001|Overall Study|Adverse Event|0|||
131939001|NCT02569853|475066981|FG000|Overall Study|Withdrawal by Subject|3|||
131939002|NCT02569853|475066982|FG001|Overall Study|Withdrawal by Subject|2|||
131939003|NCT02569853|475066981|FG000|Overall Study|Lost to Follow-up|3|||
131939004|NCT02569853|475066982|FG001|Overall Study|Lost to Follow-up|3|||
131939005|NCT02569853|475066981|FG000|Overall Study|Protocol Violation|1|||
131939006|NCT02569853|475066982|FG001|Overall Study|Protocol Violation|1|||
131939007|NCT02569853|475066981|FG000|Overall Study|Did not experience migraine attack|10|||
131939008|NCT02569853|475066982|FG001|Overall Study|Did not experience migraine attack|7|||
131939009|NCT02569853|475066981|FG000|Overall Study|Physician Decision|1|||
131939010|NCT02569853|475066982|FG001|Overall Study|Physician Decision|1|||
131939011|NCT00261833|475066983|FG000|Overall Study|Death|1|||
131939012|NCT00261833|475066984|FG001|Overall Study|Death|3|||
131939013|NCT00261833|475066983|FG000|Overall Study|Adverse Event|1|||
131939014|NCT00261833|475066984|FG001|Overall Study|Adverse Event|4|||
131939015|NCT00261833|475066983|FG000|Overall Study|Withdrawal by Subject|5|||
131939016|NCT00261833|475066984|FG001|Overall Study|Withdrawal by Subject|7|||
131939017|NCT00261833|475066983|FG000|Overall Study|Protocol Violation|0|||
131939018|NCT00261833|475066984|FG001|Overall Study|Protocol Violation|1|||
131939019|NCT00261833|475066983|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
131939020|NCT00261833|475066984|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
131939021|NCT00261833|475066983|FG000|Overall Study|Lung transplantation|1|||
131939022|NCT00261833|475066984|FG001|Overall Study|Lung transplantation|1|||
131939023|NCT00261833|475066983|FG000|Overall Study|Missing reason|1|||
131939024|NCT00261833|475066984|FG001|Overall Study|Missing reason|0|||
131939025|NCT00261833|475066983|FG000|Overall Study|Not interested in being participant|0|||
131939026|NCT00261833|475066984|FG001|Overall Study|Not interested in being participant|1|||
131939027|NCT00622726|475066985|FG000|March, 2008 to August, 2010|Death|5|||
131939028|NCT00622726|475066986|FG001|March, 2008 to August, 2010|Death|2|||
131939029|NCT00622726|475066985|FG000|August, 2010 to April, 2013|Death|1|||
131939030|NCT00622726|475066986|FG001|August, 2010 to April, 2013|Death|5|||
131939031|NCT02434081|475066989|FG000|Overall Study|Death (never started treatment)|2|||
131939032|NCT02434081|475066989|FG000|Overall Study|Death|2|||
131939033|NCT02434081|475066989|FG000|Overall Study|Progression|20|||
131939034|NCT02434081|475066989|FG000|Overall Study|Adverse Event|20|||
131939035|NCT02434081|475066989|FG000|Overall Study|Physician Decision|2|||
131939036|NCT02434081|475066989|FG000|Overall Study|Withdrawal by Subject|1|||
131939037|NCT02434081|475066989|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
131939038|NCT01668004|475066990|FG000|Overall Study|Adverse Event|7|||
131939039|NCT01668004|475066990|FG000|Overall Study|Withdrawal by Subject|2|||
131939040|NCT01668004|475066990|FG000|Overall Study|Lost to Follow-up|5|||
131939041|NCT01668004|475066990|FG000|Overall Study|Lack of Efficacy|9|||
131939042|NCT01668004|475066990|FG000|Overall Study|Non-compliance with treatment|2|||
131939043|NCT02037529|475066996|FG000|Overall Study|Withdrawal by Subject|1|||
131939044|NCT02037529|475066997|FG001|Overall Study|Withdrawal by Subject|3|||
131939045|NCT02037529|475066996|FG000|Overall Study|Adverse Event|0|||
131939046|NCT02037529|475066997|FG001|Overall Study|Adverse Event|1|||
131939047|NCT02131766|475066998|FG000|Overall Study|Withdrawal by Subject|4|||
131939048|NCT00718315|475066999|FG000|Overall Study|Adverse Event|1|||
131939049|NCT00718315|475067000|FG001|Overall Study|Adverse Event|2|||
131939050|NCT00718315|475067001|FG002|Overall Study|Adverse Event|3|||
131939051|NCT00718315|475066999|FG000|Overall Study|Death|6|||
131939052|NCT00718315|475067000|FG001|Overall Study|Death|6|||
131939053|NCT00718315|475067001|FG002|Overall Study|Death|5|||
131939054|NCT00718315|475066999|FG000|Overall Study|Lost to Follow-up|2|||
131939055|NCT00718315|475067000|FG001|Overall Study|Lost to Follow-up|3|||
131939056|NCT00718315|475067001|FG002|Overall Study|Lost to Follow-up|4|||
131939057|NCT00718315|475066999|FG000|Overall Study|Protocol Violation|5|||
131939058|NCT00718315|475067000|FG001|Overall Study|Protocol Violation|5|||
131939059|NCT00718315|475067001|FG002|Overall Study|Protocol Violation|3|||
131939060|NCT00718315|475066999|FG000|Overall Study|Erlotinib dose decreased|4|||
131939061|NCT00718315|475067000|FG001|Overall Study|Erlotinib dose decreased|3|||
131939062|NCT00718315|475067001|FG002|Overall Study|Erlotinib dose decreased|1|||
131939063|NCT00718315|475066999|FG000|Overall Study|Use of Minocyclin|1|||
131939064|NCT00718315|475067000|FG001|Overall Study|Use of Minocyclin|1|||
131939065|NCT00718315|475067001|FG002|Overall Study|Use of Minocyclin|1|||
131939066|NCT00718315|475066999|FG000|Overall Study|Disease progression|0|||
131939067|NCT00718315|475067000|FG001|Overall Study|Disease progression|1|||
131939068|NCT00718315|475067001|FG002|Overall Study|Disease progression|1|||
131939069|NCT00718315|475066999|FG000|Overall Study|Other|0|||
131939070|NCT00718315|475067000|FG001|Overall Study|Other|0|||
131939071|NCT00718315|475067001|FG002|Overall Study|Other|1|||
131939072|NCT00718315|475066999|FG000|Overall Study|Use of ATB and Corticoids|0|||
131939073|NCT00718315|475067000|FG001|Overall Study|Use of ATB and Corticoids|1|||
131939074|NCT00718315|475067001|FG002|Overall Study|Use of ATB and Corticoids|2|||
131939075|NCT02746809|475067004|FG000|Enrollment|Inclusion Exclusion not met|9|||
131939076|NCT02746809|475067004|FG000|Enrollment|Withdrawal by Subject|1|||
131939077|NCT02746809|475067004|FG000|Enrollment|Expected Enrollment Met|2|||
131939078|NCT02746809|475067004|FG000|Procedure|Death|1|||
131939079|NCT02746809|475067004|FG000|1-Month|Death|5|||
131939080|NCT02746809|475067004|FG000|6-Month|Death|2|||
131939081|NCT02746809|475067004|FG000|6-Month|Withdrawal by Subject|1|||
131939082|NCT02746809|475067004|FG000|12-Month|Death|3|||
131939083|NCT02746809|475067004|FG000|12-Month|Withdrawal by Subject|2|||
131939084|NCT02746809|475067004|FG000|24-Month|Death|1|||
131939085|NCT02746809|475067004|FG000|24-Month|Withdrawal by Subject|1|||
131939086|NCT02746809|475067004|FG000|36-Month|Death|8|||
131939087|NCT02746809|475067004|FG000|36-Month|Withdrawal by Subject|1|||
131939088|NCT02746809|475067004|FG000|48-Month|Death|7|||
131939089|NCT02746809|475067004|FG000|48-Month|Withdrawal by Subject|1|||
131939090|NCT02746809|475067004|FG000|60-Month|Death|1|||
131939091|NCT02746809|475067004|FG000|60-Month|Lost to Follow-up|2|||
131939092|NCT04846231|475067005|FG000|Overall Study|Lost to Follow-up|1|||
131939093|NCT04846231|475067006|FG001|Overall Study|Lost to Follow-up|0|||
131939094|NCT04846231|475067007|FG002|Overall Study|Lost to Follow-up|0|||
131939095|NCT04846231|475067008|FG003|Overall Study|Lost to Follow-up|0|||
131939096|NCT04846231|475067009|FG004|Overall Study|Lost to Follow-up|0|||
131939097|NCT04846231|475067010|FG005|Overall Study|Lost to Follow-up|0|||
131939098|NCT04846231|475067011|FG006|Overall Study|Lost to Follow-up|0|||
131939099|NCT04846231|475067012|FG007|Overall Study|Lost to Follow-up|1|||
131939100|NCT04846231|475067005|FG000|Overall Study|Withdrawal by Subject|0|||
131939101|NCT04846231|475067006|FG001|Overall Study|Withdrawal by Subject|1|||
131939102|NCT04846231|475067007|FG002|Overall Study|Withdrawal by Subject|2|||
131939103|NCT04846231|475067008|FG003|Overall Study|Withdrawal by Subject|1|||
131939104|NCT04846231|475067009|FG004|Overall Study|Withdrawal by Subject|0|||
131939105|NCT04846231|475067010|FG005|Overall Study|Withdrawal by Subject|0|||
131939106|NCT04846231|475067011|FG006|Overall Study|Withdrawal by Subject|0|||
131939107|NCT04846231|475067012|FG007|Overall Study|Withdrawal by Subject|0|||
131939108|NCT04846231|475067005|FG000|Overall Study|Protocol Violation|0|||
131939109|NCT04846231|475067006|FG001|Overall Study|Protocol Violation|1|||
131939110|NCT04846231|475067007|FG002|Overall Study|Protocol Violation|0|||
131939111|NCT04846231|475067008|FG003|Overall Study|Protocol Violation|0|||
131939112|NCT04846231|475067009|FG004|Overall Study|Protocol Violation|0|||
131939113|NCT04846231|475067010|FG005|Overall Study|Protocol Violation|0|||
131939114|NCT04846231|475067011|FG006|Overall Study|Protocol Violation|0|||
131939115|NCT04846231|475067012|FG007|Overall Study|Protocol Violation|0|||
131939116|NCT04846231|475067005|FG000|Overall Study|Adverse Event|0|||
131939117|NCT04846231|475067006|FG001|Overall Study|Adverse Event|0|||
131939118|NCT04846231|475067007|FG002|Overall Study|Adverse Event|0|||
131939119|NCT04846231|475067008|FG003|Overall Study|Adverse Event|0|||
131939120|NCT04846231|475067009|FG004|Overall Study|Adverse Event|0|||
131939121|NCT04846231|475067010|FG005|Overall Study|Adverse Event|0|||
131939122|NCT04846231|475067011|FG006|Overall Study|Adverse Event|1|||
131939123|NCT04846231|475067012|FG007|Overall Study|Adverse Event|1|||
131939124|NCT02980107|475067013|FG000|Overall Study|Withdrawal by Subject|51|||
131939125|NCT02980107|475067014|FG001|Overall Study|Withdrawal by Subject|62|||
131939126|NCT00945659|475067015|FG000|Overall Study|Lost to Follow-up|7|||
131939127|NCT00945659|475067016|FG001|Overall Study|Lost to Follow-up|20|||
131939128|NCT00945659|475067017|FG002|Overall Study|Lost to Follow-up|17|||
131939129|NCT04562116|475067018|FG000|Overall Study|Lost to Follow-up|1|||
131939130|NCT04562116|475067018|FG000|Overall Study|Withdrawal by Subject|3|||
131939131|NCT02921256|475067022|FG000|Arm 1a v. Arm II|Adverse Event|6|||
131939132|NCT02921256|475067023|FG001|Arm 1a v. Arm II|Adverse Event|15|||
131939133|NCT02921256|475067024|FG002|Arm 1a v. Arm II|Adverse Event|0|||
131939134|NCT02921256|475067022|FG000|Arm 1a v. Arm II|Death|0|||
131939135|NCT02921256|475067023|FG001|Arm 1a v. Arm II|Death|2|||
131939136|NCT02921256|475067024|FG002|Arm 1a v. Arm II|Death|0|||
131939137|NCT02921256|475067022|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
131939138|NCT02921256|475067023|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
131939139|NCT02921256|475067024|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
131939140|NCT02921256|475067022|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
131939141|NCT02921256|475067023|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
131939142|NCT02921256|475067024|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
131939143|NCT02921256|475067022|FG000|Arm 1a v. Arm II|Physician Decision|1|||
131939144|NCT02921256|475067023|FG001|Arm 1a v. Arm II|Physician Decision|1|||
131939145|NCT02921256|475067024|FG002|Arm 1a v. Arm II|Physician Decision|0|||
131939146|NCT02921256|475067022|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
131939147|NCT02921256|475067023|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
131939148|NCT02921256|475067024|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
131939149|NCT02921256|475067022|FG000|Arm Ib v Arm III|Adverse Event|9|||
131939150|NCT02921256|475067023|FG001|Arm Ib v Arm III|Adverse Event|0|||
131939151|NCT02921256|475067024|FG002|Arm Ib v Arm III|Adverse Event|4|||
131939152|NCT02921256|475067022|FG000|Arm Ib v Arm III|Death|1|||
131939153|NCT02921256|475067023|FG001|Arm Ib v Arm III|Death|0|||
131939154|NCT02921256|475067024|FG002|Arm Ib v Arm III|Death|1|||
131939155|NCT02921256|475067022|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
131939156|NCT02921256|475067023|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
131939157|NCT02921256|475067024|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
131939158|NCT02921256|475067022|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
131939159|NCT02921256|475067023|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
131939160|NCT02921256|475067024|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
131939161|NCT02921256|475067022|FG000|Arm Ib v Arm III|Physician Decision|4|||
131939162|NCT02921256|475067023|FG001|Arm Ib v Arm III|Physician Decision|0|||
131939163|NCT02921256|475067024|FG002|Arm Ib v Arm III|Physician Decision|1|||
131939164|NCT02921256|475067022|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
131939165|NCT02921256|475067023|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
131939166|NCT02921256|475067024|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
131939167|NCT02943473|475067025|FG000|Overall Study|enrolled but not dosed|1|||
131939168|NCT02943473|475067025|FG000|Overall Study|screen failure|1|||
131939169|NCT02943473|475067025|FG000|Overall Study|Physician Decision|4|||
131939170|NCT04211363|475067028|FG000|Overall Study|Adverse Event|5|||
131939171|NCT04211363|475067029|FG001|Overall Study|Adverse Event|2|||
131939172|NCT04211363|475067028|FG000|Overall Study|Physician Decision|0|||
131939173|NCT04211363|475067029|FG001|Overall Study|Physician Decision|1|||
131939174|NCT04211363|475067028|FG000|Overall Study|Protocol Violation|1|||
131939175|NCT04211363|475067029|FG001|Overall Study|Protocol Violation|0|||
131939176|NCT04211363|475067028|FG000|Overall Study|Pregnancy|1|||
131939177|NCT04211363|475067029|FG001|Overall Study|Pregnancy|0|||
131939178|NCT04211363|475067028|FG000|Overall Study|Lost to Follow-up|12|||
131939179|NCT04211363|475067029|FG001|Overall Study|Lost to Follow-up|4|||
131939180|NCT04211363|475067028|FG000|Overall Study|Withdrawal by Subject|11|||
131939181|NCT04211363|475067029|FG001|Overall Study|Withdrawal by Subject|11|||
131939182|NCT04211363|475067028|FG000|Overall Study|Other|1|||
131939183|NCT04211363|475067029|FG001|Overall Study|Other|2|||
131939184|NCT03097289|475067030|FG000|Overall Study|Adverse Event|1|||
131939185|NCT03097289|475067030|FG000|Overall Study|Equipment failure|2|||
131939186|NCT03097289|475067030|FG000|Overall Study|Collected platelet product unusable|3|||
131939187|NCT01823289|475067031|FG000|Overall Study|Lost to Follow-up|5|||
131939188|NCT01823289|475067031|FG000|Overall Study|Adverse Event|5|||
131939189|NCT01823289|475067031|FG000|Overall Study|Lack of Efficacy|1|||
131939190|NCT01823289|475067031|FG000|Overall Study|Physician Decision|9|||
131939191|NCT01823289|475067031|FG000|Overall Study|Administered contraindicated medicine|1|||
131939192|NCT01823289|475067031|FG000|Overall Study|Transaminase increased more than 3 times|1|||
131939193|NCT01823289|475067031|FG000|Overall Study|Drug affected efficacy and safety|1|||
131939194|NCT01823289|475067031|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
131939195|NCT01736917|475067036|FG000|Overall Study|Adverse Event|1|||
131939196|NCT01736917|475067036|FG000|Overall Study|Protocol Violation|10|||
131939197|NCT01911260|475067037|FG000|Supplementation Period|transference or evasion of school|7|||
131939198|NCT01911260|475067038|FG001|Supplementation Period|transference or evasion of school|9|||
131939199|NCT01911260|475067039|FG002|Supplementation Period|transference or evasion of school|7|||
131939200|NCT01911260|475067040|FG003|Supplementation Period|transference or evasion of school|6|||
131939201|NCT01911260|475067037|FG000|Supplementation Period|Adverse Event|2|||
131939202|NCT01911260|475067038|FG001|Supplementation Period|Adverse Event|0|||
131939203|NCT01911260|475067039|FG002|Supplementation Period|Adverse Event|1|||
131939204|NCT01911260|475067040|FG003|Supplementation Period|Adverse Event|0|||
131939205|NCT01911260|475067037|FG000|Supplementation Period|refused to receive supplement|1|||
131939206|NCT01911260|475067038|FG001|Supplementation Period|refused to receive supplement|0|||
131939207|NCT01911260|475067039|FG002|Supplementation Period|refused to receive supplement|1|||
131939208|NCT01911260|475067040|FG003|Supplementation Period|refused to receive supplement|0|||
131939209|NCT01911260|475067037|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
131939210|NCT01911260|475067038|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
131939211|NCT01911260|475067039|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
131939212|NCT01911260|475067040|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
131939213|NCT01911260|475067037|FG000|Follow-up Period|transference or evasion of school|13|||
131939214|NCT01911260|475067038|FG001|Follow-up Period|transference or evasion of school|20|||
131939215|NCT01911260|475067039|FG002|Follow-up Period|transference or evasion of school|15|||
131939216|NCT01911260|475067040|FG003|Follow-up Period|transference or evasion of school|12|||
131939217|NCT01734902|475067046|FG000|Overall Study|Other than listed|0|||
131939218|NCT01734902|475067047|FG001|Overall Study|Other than listed|2|||
131939219|NCT00060944|475067048|FG000|Overall Study|Adverse Event|12|||
131939220|NCT00060944|475067049|FG001|Overall Study|Adverse Event|10|||
131939221|NCT00060944|475067048|FG000|Overall Study|Death|2|||
131939222|NCT00060944|475067049|FG001|Overall Study|Death|3|||
131939223|NCT00060944|475067048|FG000|Overall Study|Withdrawal by Subject|18|||
131939224|NCT00060944|475067049|FG001|Overall Study|Withdrawal by Subject|5|||
131939225|NCT00060944|475067048|FG000|Overall Study|Disease Progression|93|||
131939226|NCT00060944|475067049|FG001|Overall Study|Disease Progression|94|||
131939227|NCT00060944|475067048|FG000|Overall Study|Lost to Follow-up|1|||
131939228|NCT00060944|475067049|FG001|Overall Study|Lost to Follow-up|0|||
131939229|NCT00060944|475067048|FG000|Overall Study|Subject Ineligible To Continue|2|||
131939230|NCT00060944|475067049|FG001|Overall Study|Subject Ineligible To Continue|1|||
131939231|NCT00060944|475067048|FG000|Overall Study|Treatment Switch|0|||
131939232|NCT00060944|475067049|FG001|Overall Study|Treatment Switch|13|||
131939233|NCT00060944|475067048|FG000|Overall Study|Other|2|||
131939234|NCT00060944|475067049|FG001|Overall Study|Other|4|||
131939235|NCT00060944|475067048|FG000|Overall Study|randomized but not treated|6|||
131939236|NCT00060944|475067049|FG001|Overall Study|randomized but not treated|4|||
131939237|NCT00776230|475067050|FG000|Overall Study|Lost to Follow-up|2|||
131939238|NCT00776230|475067051|FG001|Overall Study|Lost to Follow-up|1|||
131939239|NCT00776230|475067052|FG002|Overall Study|Lost to Follow-up|5|||
131939240|NCT00776230|475067050|FG000|Overall Study|Not vaccinated at Day 0|1|||
131939241|NCT00776230|475067051|FG001|Overall Study|Not vaccinated at Day 0|0|||
131939242|NCT00776230|475067052|FG002|Overall Study|Not vaccinated at Day 0|0|||
131939243|NCT00776230|475067050|FG000|Overall Study|Withdrawal by Subject|0|||
131939244|NCT00776230|475067051|FG001|Overall Study|Withdrawal by Subject|1|||
131939245|NCT00776230|475067052|FG002|Overall Study|Withdrawal by Subject|0|||
131939246|NCT00776230|475067050|FG000|Overall Study|Subject missed Visit 4|0|||
131939247|NCT00776230|475067051|FG001|Overall Study|Subject missed Visit 4|1|||
131939248|NCT00776230|475067052|FG002|Overall Study|Subject missed Visit 4|0|||
131939249|NCT00746811|475067054|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
131939250|NCT00746811|475067055|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
131939251|NCT03213509|475067056|FG000|Overall Study|Did not consent for verbal autopsy|4|||
131939252|NCT03213509|475067057|FG001|Overall Study|Did not consent for verbal autopsy|5|||
131939253|NCT00016354|475067058|FG000|Overall Study|Lack of Efficacy|0|||
131939254|NCT00016354|475067059|FG001|Overall Study|Lack of Efficacy|0|||
131939255|NCT00016354|475067060|FG002|Overall Study|Lack of Efficacy|0|||
131939256|NCT00016354|475067061|FG003|Overall Study|Lack of Efficacy|0|||
131939257|NCT00016354|475067062|FG004|Overall Study|Lack of Efficacy|0|||
131412719|NCT00610441|473133729|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
131939258|NCT00016354|475067063|FG005|Overall Study|Lack of Efficacy|0|||
131939259|NCT00016354|475067064|FG006|Overall Study|Lack of Efficacy|0|||
131939260|NCT00016354|475067065|FG007|Overall Study|Lack of Efficacy|1|||
131939261|NCT03110562|475067066|FG000|Initial Treatment Period|Disease Progression|1|||
131939262|NCT03110562|475067067|FG001|Initial Treatment Period|Disease Progression|1|||
131939263|NCT03110562|475067068|FG002|Initial Treatment Period|Disease Progression|0|||
131939264|NCT03110562|475067069|FG003|Initial Treatment Period|Disease Progression|0|||
131939265|NCT03110562|475067066|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
131939266|NCT03110562|475067067|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
131939267|NCT03110562|475067068|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
131939268|NCT03110562|475067069|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
131939269|NCT03110562|475067066|FG000|Initial Treatment Period|Adverse Event|1|||
131939270|NCT03110562|475067067|FG001|Initial Treatment Period|Adverse Event|0|||
131939271|NCT03110562|475067068|FG002|Initial Treatment Period|Adverse Event|0|||
131939272|NCT03110562|475067069|FG003|Initial Treatment Period|Adverse Event|0|||
131939273|NCT03110562|475067066|FG000|Initial Treatment Period|Death|74|||
131939274|NCT03110562|475067067|FG001|Initial Treatment Period|Death|82|||
131939275|NCT03110562|475067068|FG002|Initial Treatment Period|Death|0|||
131939276|NCT03110562|475067069|FG003|Initial Treatment Period|Death|0|||
131939277|NCT03110562|475067066|FG000|Initial Treatment Period|Lost to Follow-up|13|||
131939278|NCT03110562|475067067|FG001|Initial Treatment Period|Lost to Follow-up|8|||
131939279|NCT03110562|475067068|FG002|Initial Treatment Period|Lost to Follow-up|0|||
131939280|NCT03110562|475067069|FG003|Initial Treatment Period|Lost to Follow-up|0|||
131939281|NCT03110562|475067066|FG000|Initial Treatment Period|Protocol Deviation|1|||
131939282|NCT03110562|475067067|FG001|Initial Treatment Period|Protocol Deviation|0|||
131939283|NCT03110562|475067068|FG002|Initial Treatment Period|Protocol Deviation|0|||
131939284|NCT03110562|475067069|FG003|Initial Treatment Period|Protocol Deviation|0|||
131939285|NCT03110562|475067066|FG000|Initial Treatment Period|Physician Decision|2|||
131939286|NCT03110562|475067067|FG001|Initial Treatment Period|Physician Decision|1|||
131939287|NCT03110562|475067068|FG002|Initial Treatment Period|Physician Decision|0|||
131939288|NCT03110562|475067069|FG003|Initial Treatment Period|Physician Decision|0|||
131939289|NCT03110562|475067066|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
131939290|NCT03110562|475067067|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
131939291|NCT03110562|475067068|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
131939292|NCT03110562|475067069|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
131939293|NCT03110562|475067066|FG000|Initial Treatment Period|Other|5|||
131939294|NCT03110562|475067067|FG001|Initial Treatment Period|Other|4|||
131939295|NCT03110562|475067068|FG002|Initial Treatment Period|Other|0|||
131939296|NCT03110562|475067069|FG003|Initial Treatment Period|Other|0|||
131939297|NCT03110562|475067066|FG000|Initial Treatment Period|Randomized but never treated|0|||
131939298|NCT03110562|475067067|FG001|Initial Treatment Period|Randomized but never treated|3|||
131939299|NCT03110562|475067068|FG002|Initial Treatment Period|Randomized but never treated|0|||
131939300|NCT03110562|475067069|FG003|Initial Treatment Period|Randomized but never treated|0|||
131939301|NCT03110562|475067066|FG000|Crossover Period|Disease Progression|0|||
131939302|NCT03110562|475067067|FG001|Crossover Period|Disease Progression|0|||
131939303|NCT03110562|475067068|FG002|Crossover Period|Disease Progression|1|||
131939304|NCT03110562|475067069|FG003|Crossover Period|Disease Progression|0|||
131939305|NCT03110562|475067066|FG000|Crossover Period|Withdrawal by Subject|0|||
131939306|NCT03110562|475067067|FG001|Crossover Period|Withdrawal by Subject|0|||
131939307|NCT03110562|475067068|FG002|Crossover Period|Withdrawal by Subject|8|||
131939308|NCT03110562|475067069|FG003|Crossover Period|Withdrawal by Subject|6|||
131939309|NCT03110562|475067066|FG000|Crossover Period|Death|0|||
131939310|NCT03110562|475067067|FG001|Crossover Period|Death|0|||
131939311|NCT03110562|475067068|FG002|Crossover Period|Death|37|||
131939312|NCT03110562|475067069|FG003|Crossover Period|Death|3|||
131939313|NCT03110562|475067066|FG000|Crossover Period|Lost to Follow-up|0|||
131939314|NCT03110562|475067067|FG001|Crossover Period|Lost to Follow-up|0|||
131939315|NCT03110562|475067068|FG002|Crossover Period|Lost to Follow-up|0|||
131939316|NCT03110562|475067069|FG003|Crossover Period|Lost to Follow-up|1|||
131939317|NCT03110562|475067066|FG000|Crossover Period|Other|0|||
131939318|NCT03110562|475067067|FG001|Crossover Period|Other|0|||
131939319|NCT03110562|475067068|FG002|Crossover Period|Other|1|||
131939320|NCT03110562|475067069|FG003|Crossover Period|Other|1|||
131939321|NCT03110562|475067066|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
131939322|NCT03110562|475067067|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
131939323|NCT03110562|475067068|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
131939324|NCT03110562|475067069|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
131939325|NCT02936323|475067072|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
131939326|NCT02936323|475067073|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
131939327|NCT02936323|475067074|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
131939328|NCT02936323|475067075|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
131939329|NCT02936323|475067076|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
131939330|NCT02936323|475067077|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
131939331|NCT02936323|475067078|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
131939332|NCT02936323|475067079|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
131939333|NCT02936323|475067080|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
131939334|NCT02936323|475067081|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
131939335|NCT02936323|475067072|FG000|Phase 1 Dose Escalation|Death|2|||
131939336|NCT02936323|475067073|FG001|Phase 1 Dose Escalation|Death|1|||
131939337|NCT02936323|475067074|FG002|Phase 1 Dose Escalation|Death|3|||
131939338|NCT02936323|475067075|FG003|Phase 1 Dose Escalation|Death|1|||
131939339|NCT02936323|475067076|FG004|Phase 1 Dose Escalation|Death|2|||
131939340|NCT02936323|475067077|FG005|Phase 1 Dose Escalation|Death|3|||
131939341|NCT02936323|475067078|FG006|Phase 1 Dose Escalation|Death|3|||
131939342|NCT02936323|475067079|FG007|Phase 1 Dose Escalation|Death|0|||
131939343|NCT02936323|475067080|FG008|Phase 1 Dose Escalation|Death|0|||
131939344|NCT02936323|475067081|FG009|Phase 1 Dose Escalation|Death|0|||
131939345|NCT02936323|475067072|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939346|NCT02936323|475067073|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939347|NCT02936323|475067074|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939348|NCT02936323|475067075|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939349|NCT02936323|475067076|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939350|NCT02936323|475067077|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
131939351|NCT02936323|475067078|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939352|NCT02936323|475067079|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939353|NCT02936323|475067080|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939354|NCT02936323|475067081|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
131939355|NCT02936323|475067072|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939356|NCT02936323|475067073|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939357|NCT02936323|475067074|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939358|NCT02936323|475067075|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939359|NCT02936323|475067076|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939360|NCT02936323|475067077|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939361|NCT02936323|475067078|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
131939362|NCT02936323|475067079|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
131939363|NCT02936323|475067080|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
131939364|NCT02936323|475067081|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
131939365|NCT02936323|475067072|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
131939366|NCT02936323|475067073|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
131939367|NCT02936323|475067074|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
131939368|NCT02936323|475067075|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
131939369|NCT02936323|475067076|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
131939370|NCT02936323|475067077|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
131939371|NCT02936323|475067078|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
131939372|NCT02936323|475067079|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
131939373|NCT02936323|475067080|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
131939374|NCT02936323|475067081|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
131939375|NCT02936323|475067072|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939376|NCT02936323|475067073|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939377|NCT02936323|475067074|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939378|NCT02936323|475067075|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939379|NCT02936323|475067076|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939380|NCT02936323|475067077|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939381|NCT02936323|475067078|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939382|NCT02936323|475067079|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
131939383|NCT02936323|475067080|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
131939384|NCT02936323|475067081|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
131939385|NCT02936323|475067072|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939386|NCT02936323|475067073|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939387|NCT02936323|475067074|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939388|NCT02936323|475067075|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939389|NCT02936323|475067076|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939390|NCT02936323|475067077|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939391|NCT02936323|475067078|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939392|NCT02936323|475067079|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939393|NCT02936323|475067080|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
131939394|NCT02936323|475067081|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
131939395|NCT02936323|475067072|FG000|Phase 2a Dose Expansion|Death|0|||
131939396|NCT02936323|475067073|FG001|Phase 2a Dose Expansion|Death|0|||
131939397|NCT02936323|475067074|FG002|Phase 2a Dose Expansion|Death|0|||
131939398|NCT02936323|475067075|FG003|Phase 2a Dose Expansion|Death|0|||
131939399|NCT02936323|475067076|FG004|Phase 2a Dose Expansion|Death|0|||
131939400|NCT02936323|475067077|FG005|Phase 2a Dose Expansion|Death|0|||
131939401|NCT02936323|475067078|FG006|Phase 2a Dose Expansion|Death|0|||
131939402|NCT02936323|475067079|FG007|Phase 2a Dose Expansion|Death|4|||
131939403|NCT02936323|475067080|FG008|Phase 2a Dose Expansion|Death|8|||
131939404|NCT02936323|475067081|FG009|Phase 2a Dose Expansion|Death|10|||
131939405|NCT03586973|475067083|FG000|Overall Study|Death|15|||
131412720|NCT00610441|473133730|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
131939406|NCT03586973|475067084|FG001|Overall Study|Death|8|||
131939407|NCT03586973|475067083|FG000|Overall Study|Site Terminated by Sponsor|3|||
131939408|NCT03586973|475067084|FG001|Overall Study|Site Terminated by Sponsor|6|||
131939409|NCT03586973|475067083|FG000|Overall Study|Withdrawal by Subject|1|||
131939410|NCT03586973|475067084|FG001|Overall Study|Withdrawal by Subject|0|||
131939411|NCT03586973|475067083|FG000|Overall Study|Lost to Follow-up|1|||
131939412|NCT03586973|475067084|FG001|Overall Study|Lost to Follow-up|0|||
131939413|NCT03423979|475067090|FG000|Overall Study|Death|1|||
131939414|NCT02581930|475067091|FG000|Overall Study|Withdrawal by Subject|1|||
131939415|NCT02581930|475067091|FG000|Overall Study|patient declined further treatment|1|||
131939416|NCT00805389|475068690|FG000|Overall Study|Adverse Event|0|||
131939417|NCT00805389|475068691|FG001|Overall Study|Adverse Event|0|||
131939418|NCT00805389|475068692|FG002|Overall Study|Adverse Event|1|||
131939419|NCT00805389|475068693|FG003|Overall Study|Adverse Event|2|||
131939420|NCT00805389|475068694|FG004|Overall Study|Adverse Event|0|||
131939421|NCT00805389|475068690|FG000|Overall Study|Lost to Follow-up|4|||
131939422|NCT00805389|475068691|FG001|Overall Study|Lost to Follow-up|3|||
131939423|NCT00805389|475068692|FG002|Overall Study|Lost to Follow-up|6|||
131939424|NCT00805389|475068693|FG003|Overall Study|Lost to Follow-up|10|||
131939425|NCT00805389|475068694|FG004|Overall Study|Lost to Follow-up|9|||
131939426|NCT00805389|475068690|FG000|Overall Study|Protocol Violation|0|||
131939427|NCT00805389|475068691|FG001|Overall Study|Protocol Violation|0|||
131939428|NCT00805389|475068692|FG002|Overall Study|Protocol Violation|1|||
131939429|NCT00805389|475068693|FG003|Overall Study|Protocol Violation|0|||
131939430|NCT00805389|475068694|FG004|Overall Study|Protocol Violation|0|||
131939431|NCT00805389|475068690|FG000|Overall Study|Withdrawal by Subject|3|||
131939432|NCT00805389|475068691|FG001|Overall Study|Withdrawal by Subject|2|||
131939433|NCT00805389|475068692|FG002|Overall Study|Withdrawal by Subject|4|||
131939434|NCT00805389|475068693|FG003|Overall Study|Withdrawal by Subject|5|||
131939435|NCT00805389|475068694|FG004|Overall Study|Withdrawal by Subject|4|||
131939436|NCT01359956|475068700|FG000|Overall Study|Death|58|||
131939437|NCT01359956|475068701|FG001|Overall Study|Death|60|||
131939438|NCT01359956|475068702|FG002|Overall Study|Death|66|||
131939439|NCT01359956|475068703|FG003|Overall Study|Death|57|||
131939440|NCT01359956|475068700|FG000|Overall Study|Lost to Follow-up|3|||
131939441|NCT01359956|475068701|FG001|Overall Study|Lost to Follow-up|4|||
131939442|NCT01359956|475068702|FG002|Overall Study|Lost to Follow-up|1|||
131939443|NCT01359956|475068703|FG003|Overall Study|Lost to Follow-up|1|||
131939444|NCT00370292|475068704|FG000|Overall Study|Disease Progression|4|||
131939445|NCT00370292|475068704|FG000|Overall Study|Adverse Event|7|||
131939446|NCT00370292|475068704|FG000|Overall Study|Physician Decision|2|||
131939447|NCT02239926|475068705|FG000|Overall Study|Withdrawal by Subject|0|||
131939448|NCT02239926|475068706|FG001|Overall Study|Withdrawal by Subject|1|||
131939449|NCT02704208|475068707|FG000|Overall Study|Lost to Follow-up|42|||
131939450|NCT02704208|475068708|FG001|Overall Study|Lost to Follow-up|37|||
131939451|NCT01628913|475068709|FG000|Overall Study|Adverse Event|12|||
131939452|NCT01628913|475068710|FG001|Overall Study|Adverse Event|5|||
131939453|NCT01628913|475068709|FG000|Overall Study|Disease Progression|11|||
131939454|NCT01628913|475068710|FG001|Overall Study|Disease Progression|14|||
131939455|NCT01628913|475068709|FG000|Overall Study|Protocol Violation|1|||
131939456|NCT01628913|475068710|FG001|Overall Study|Protocol Violation|0|||
131939457|NCT01628913|475068709|FG000|Overall Study|Death|1|||
131939458|NCT01628913|475068710|FG001|Overall Study|Death|0|||
131939459|NCT01628913|475068709|FG000|Overall Study|study terminated by Sponsor|4|||
131939460|NCT01628913|475068710|FG001|Overall Study|study terminated by Sponsor|9|||
131939461|NCT01628913|475068709|FG000|Overall Study|Withdrawal by Subject|1|||
131939462|NCT01628913|475068710|FG001|Overall Study|Withdrawal by Subject|0|||
131939463|NCT01628913|475068709|FG000|Overall Study|Physician Decision|1|||
131939464|NCT01628913|475068710|FG001|Overall Study|Physician Decision|3|||
131939465|NCT02410772|475068712|FG000|Overall Study|Death|3|||
131939466|NCT02410772|475068713|FG001|Overall Study|Death|4|||
131939467|NCT02410772|475068714|FG002|Overall Study|Death|8|||
131939468|NCT02410772|475068712|FG000|Overall Study|Lost to Follow-up|31|||
131939469|NCT02410772|475068713|FG001|Overall Study|Lost to Follow-up|23|||
131939470|NCT02410772|475068714|FG002|Overall Study|Lost to Follow-up|22|||
131939471|NCT02410772|475068712|FG000|Overall Study|Pregnancy|8|||
131939472|NCT02410772|475068713|FG001|Overall Study|Pregnancy|4|||
131939473|NCT02410772|475068714|FG002|Overall Study|Pregnancy|5|||
131939474|NCT02410772|475068712|FG000|Overall Study|Protocol Violation|8|||
131939475|NCT02410772|475068713|FG001|Overall Study|Protocol Violation|8|||
131939476|NCT02410772|475068714|FG002|Overall Study|Protocol Violation|4|||
131939477|NCT02410772|475068712|FG000|Overall Study|Baseline Drug Resistance|49|||
131939478|NCT02410772|475068713|FG001|Overall Study|Baseline Drug Resistance|40|||
131939479|NCT02410772|475068714|FG002|Overall Study|Baseline Drug Resistance|51|||
131939480|NCT02410772|475068712|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
131939481|NCT02410772|475068713|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
131939482|NCT02410772|475068714|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
131939483|NCT02410772|475068712|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
131939484|NCT02410772|475068713|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
131939485|NCT02410772|475068714|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
131939486|NCT05878067|475068718|FG000|Overall Study|Lost to Follow-up|2|||
131939487|NCT00949533|475068719|FG000|Overall Study|Lost to Follow-up|0|||
131939488|NCT00949533|475068720|FG001|Overall Study|Lost to Follow-up|1|||
131939489|NCT02234362|475068721|FG000|Overall Study|Not eligible after first screening visit|17|||
131939490|NCT02234362|475068721|FG000|Overall Study|Lost to Follow-up|6|||
131939491|NCT02234362|475068721|FG000|Overall Study|Withdrawal by Subject|3|||
131939492|NCT01959529|475068722|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
131939493|NCT01959529|475068723|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
131939494|NCT01959529|475068722|FG000|Overall Study|Lost to Follow-up|4|||
131939495|NCT01959529|475068723|FG001|Overall Study|Lost to Follow-up|1|||
131939496|NCT01959529|475068722|FG000|Overall Study|Other|70|||
131939497|NCT01959529|475068723|FG001|Overall Study|Other|68|||
131939498|NCT01959529|475068722|FG000|Overall Study|Hypoglycaemia|1|||
131939499|NCT01959529|475068723|FG001|Overall Study|Hypoglycaemia|1|||
131939500|NCT01959529|475068722|FG000|Overall Study|Lack of glycaemic control|1|||
131939501|NCT01959529|475068723|FG001|Overall Study|Lack of glycaemic control|1|||
131939502|NCT00557193|475068731|FG000|Induction|Adverse Event|2|||
131939503|NCT00557193|475068732|FG001|Induction|Adverse Event|0|||
131939504|NCT00557193|475068733|FG002|Induction|Adverse Event|0|||
131939505|NCT00557193|475068734|FG003|Induction|Adverse Event|0|||
131939506|NCT00557193|475068735|FG004|Induction|Adverse Event|0|||
131939507|NCT00557193|475068736|FG005|Induction|Adverse Event|0|||
131939508|NCT00557193|475068731|FG000|Induction|Death|6|||
131939509|NCT00557193|475068732|FG001|Induction|Death|0|||
131939510|NCT00557193|475068733|FG002|Induction|Death|0|||
131939511|NCT00557193|475068734|FG003|Induction|Death|0|||
131939512|NCT00557193|475068735|FG004|Induction|Death|0|||
131939513|NCT00557193|475068736|FG005|Induction|Death|0|||
131939514|NCT00557193|475068731|FG000|Induction|Physician Decision|3|||
131939515|NCT00557193|475068732|FG001|Induction|Physician Decision|0|||
131939516|NCT00557193|475068733|FG002|Induction|Physician Decision|0|||
131939517|NCT00557193|475068734|FG003|Induction|Physician Decision|0|||
131939518|NCT00557193|475068735|FG004|Induction|Physician Decision|0|||
131939519|NCT00557193|475068736|FG005|Induction|Physician Decision|0|||
131939520|NCT00557193|475068731|FG000|Induction|Withdrawal by Subject|1|||
131939521|NCT00557193|475068732|FG001|Induction|Withdrawal by Subject|0|||
131939522|NCT00557193|475068733|FG002|Induction|Withdrawal by Subject|0|||
131939523|NCT00557193|475068734|FG003|Induction|Withdrawal by Subject|0|||
131939524|NCT00557193|475068735|FG004|Induction|Withdrawal by Subject|0|||
131939525|NCT00557193|475068736|FG005|Induction|Withdrawal by Subject|0|||
131939526|NCT00557193|475068731|FG000|Induction|Refusal of Further Protocol Therapy|2|||
131939527|NCT00557193|475068732|FG001|Induction|Refusal of Further Protocol Therapy|0|||
131939528|NCT00557193|475068733|FG002|Induction|Refusal of Further Protocol Therapy|0|||
131939529|NCT00557193|475068734|FG003|Induction|Refusal of Further Protocol Therapy|0|||
131939530|NCT00557193|475068735|FG004|Induction|Refusal of Further Protocol Therapy|0|||
131939531|NCT00557193|475068736|FG005|Induction|Refusal of Further Protocol Therapy|0|||
131939532|NCT00557193|475068731|FG000|Induction|Ineligible|8|||
131939533|NCT00557193|475068732|FG001|Induction|Ineligible|0|||
131939534|NCT00557193|475068733|FG002|Induction|Ineligible|0|||
131939535|NCT00557193|475068734|FG003|Induction|Ineligible|0|||
131939536|NCT00557193|475068735|FG004|Induction|Ineligible|0|||
131939537|NCT00557193|475068736|FG005|Induction|Ineligible|0|||
131939538|NCT00557193|475068731|FG000|Induction|Inevaluable for post Induction|2|||
131939539|NCT00557193|475068732|FG001|Induction|Inevaluable for post Induction|0|||
131939540|NCT00557193|475068733|FG002|Induction|Inevaluable for post Induction|0|||
131939541|NCT00557193|475068734|FG003|Induction|Inevaluable for post Induction|0|||
131939542|NCT00557193|475068735|FG004|Induction|Inevaluable for post Induction|0|||
131939543|NCT00557193|475068736|FG005|Induction|Inevaluable for post Induction|0|||
131939544|NCT00557193|475068731|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
131939545|NCT00557193|475068732|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
131939546|NCT00557193|475068733|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
131939547|NCT00557193|475068734|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
131939548|NCT00557193|475068735|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
131939549|NCT00557193|475068736|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
131939550|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131939551|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
131939552|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
131939553|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
131939554|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131939555|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
131939556|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
131939557|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
131939558|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
131939559|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
131939560|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
131939561|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
131939562|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
131939563|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
131939564|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
131939565|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
131939566|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
131939567|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
131939568|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
131939569|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
131939570|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
131939571|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
131939572|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
131939573|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
131939574|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
131939575|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
131939576|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
131939577|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
131939578|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
131939579|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
131939580|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
131939581|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
131939582|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
131939583|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
131939584|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
131939585|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
131939586|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
131939587|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
131939588|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
131939589|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
131939590|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
131939591|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
131939592|NCT00557193|475068731|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
131939593|NCT00557193|475068732|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
131939594|NCT00557193|475068733|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
131939595|NCT00557193|475068734|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
131939596|NCT00557193|475068735|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
131939597|NCT00557193|475068736|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
131939598|NCT03984825|475068737|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
131939599|NCT03984825|475068737|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
131939600|NCT03984825|475068737|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
131939601|NCT00419744|475068738|FG000|Overall Study|Adverse Event|39|||
131939602|NCT00419744|475068739|FG001|Overall Study|Adverse Event|40|||
131939603|NCT00419744|475068740|FG002|Overall Study|Adverse Event|50|||
131939604|NCT00419744|475068738|FG000|Overall Study|Withdrawal by Subject|45|||
131939605|NCT00419744|475068739|FG001|Overall Study|Withdrawal by Subject|49|||
131939606|NCT00419744|475068740|FG002|Overall Study|Withdrawal by Subject|52|||
131939607|NCT00419744|475068738|FG000|Overall Study|Lost to Follow-up|8|||
131939608|NCT00419744|475068739|FG001|Overall Study|Lost to Follow-up|10|||
131939609|NCT00419744|475068740|FG002|Overall Study|Lost to Follow-up|6|||
131939610|NCT00419744|475068738|FG000|Overall Study|Protocol Violation|4|||
131939611|NCT00419744|475068739|FG001|Overall Study|Protocol Violation|7|||
131939612|NCT00419744|475068740|FG002|Overall Study|Protocol Violation|8|||
131939613|NCT00419744|475068738|FG000|Overall Study|Randomized in error|9|||
131939614|NCT00419744|475068739|FG001|Overall Study|Randomized in error|6|||
131939615|NCT00419744|475068740|FG002|Overall Study|Randomized in error|7|||
131939616|NCT00419744|475068738|FG000|Overall Study|Moving out of state|2|||
131939617|NCT00419744|475068739|FG001|Overall Study|Moving out of state|0|||
131939618|NCT00419744|475068740|FG002|Overall Study|Moving out of state|1|||
131939619|NCT00419744|475068738|FG000|Overall Study|Physician Decision|10|||
131939620|NCT00419744|475068739|FG001|Overall Study|Physician Decision|5|||
131939621|NCT00419744|475068740|FG002|Overall Study|Physician Decision|6|||
131939622|NCT00419744|475068738|FG000|Overall Study|Spirometry mouthpiece issues|0|||
131939623|NCT00419744|475068739|FG001|Overall Study|Spirometry mouthpiece issues|1|||
131939624|NCT00419744|475068740|FG002|Overall Study|Spirometry mouthpiece issues|2|||
131939625|NCT00419744|475068738|FG000|Overall Study|Incorrect medication kit dispensed|0|||
131939626|NCT00419744|475068739|FG001|Overall Study|Incorrect medication kit dispensed|0|||
131939627|NCT00419744|475068740|FG002|Overall Study|Incorrect medication kit dispensed|1|||
131939628|NCT00399035|475068741|FG000|Overall Study|Death|289|||
131939629|NCT00399035|475068742|FG001|Overall Study|Death|141|||
131939630|NCT00399035|475068743|FG002|Overall Study|Death|234|||
131939631|NCT00399035|475068741|FG000|Overall Study|Lost to Follow-up|2|||
131939632|NCT00399035|475068742|FG001|Overall Study|Lost to Follow-up|1|||
131939633|NCT00399035|475068743|FG002|Overall Study|Lost to Follow-up|5|||
131939634|NCT00399035|475068741|FG000|Overall Study|Withdrawal by Subject|19|||
131939635|NCT00399035|475068742|FG001|Overall Study|Withdrawal by Subject|15|||
131939636|NCT00399035|475068743|FG002|Overall Study|Withdrawal by Subject|12|||
131939637|NCT00399035|475068741|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
131939638|NCT00399035|475068742|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
131939639|NCT00399035|475068743|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
131939640|NCT00399035|475068741|FG000|Overall Study|Severe non-compliance with protocol|2|||
131939641|NCT00399035|475068742|FG001|Overall Study|Severe non-compliance with protocol|1|||
131939642|NCT00399035|475068743|FG002|Overall Study|Severe non-compliance with protocol|0|||
131939643|NCT00976456|475068744|FG000|Overall Study|Adverse Event|17|||
131939644|NCT00976456|475068745|FG001|Overall Study|Adverse Event|22|||
131939645|NCT00976456|475068744|FG000|Overall Study|Death|7|||
131939646|NCT00976456|475068745|FG001|Overall Study|Death|9|||
131939647|NCT00976456|475068744|FG000|Overall Study|Lack of Efficacy|5|||
131939648|NCT00976456|475068745|FG001|Overall Study|Lack of Efficacy|2|||
131939649|NCT00976456|475068744|FG000|Overall Study|Withdrawal by Subject|3|||
131939650|NCT00976456|475068745|FG001|Overall Study|Withdrawal by Subject|1|||
131939651|NCT00976456|475068744|FG000|Overall Study|screening failure, unknown|11|||
131939652|NCT00976456|475068745|FG001|Overall Study|screening failure, unknown|4|||
131939653|NCT00854360|475068746|FG000|Overall Study|Adverse Event|0|||
131939654|NCT00854360|475068747|FG001|Overall Study|Adverse Event|1|||
131939655|NCT00854360|475068748|FG002|Overall Study|Adverse Event|2|||
131939656|NCT00854360|475068749|FG003|Overall Study|Adverse Event|6|||
131939657|NCT00854360|475068746|FG000|Overall Study|Withdrawal by Subject|0|||
131939658|NCT00854360|475068747|FG001|Overall Study|Withdrawal by Subject|0|||
131939659|NCT00854360|475068748|FG002|Overall Study|Withdrawal by Subject|0|||
131939660|NCT00854360|475068749|FG003|Overall Study|Withdrawal by Subject|1|||
131939661|NCT00854360|475068746|FG000|Overall Study|Pregnancy|0|||
131939662|NCT00854360|475068747|FG001|Overall Study|Pregnancy|1|||
131939663|NCT00854360|475068748|FG002|Overall Study|Pregnancy|0|||
131939664|NCT00854360|475068749|FG003|Overall Study|Pregnancy|0|||
131939665|NCT00854360|475068746|FG000|Overall Study|Lack of Efficacy|2|||
131939666|NCT00854360|475068747|FG001|Overall Study|Lack of Efficacy|1|||
131939667|NCT00854360|475068748|FG002|Overall Study|Lack of Efficacy|0|||
131939668|NCT00854360|475068749|FG003|Overall Study|Lack of Efficacy|0|||
131939669|NCT00854360|475068746|FG000|Overall Study|Other|0|||
131939670|NCT00854360|475068747|FG001|Overall Study|Other|0|||
131939671|NCT00854360|475068748|FG002|Overall Study|Other|0|||
131939672|NCT00854360|475068749|FG003|Overall Study|Other|3|||
131939673|NCT02493764|475068754|FG000|Overall Study|Adverse Event|2|||
131939674|NCT02493764|475068755|FG001|Overall Study|Adverse Event|2|||
131939675|NCT02493764|475068754|FG000|Overall Study|Death|44|||
131939676|NCT02493764|475068755|FG001|Overall Study|Death|58|||
131939677|NCT02493764|475068754|FG000|Overall Study|Lost to Follow-up|2|||
131939678|NCT02493764|475068755|FG001|Overall Study|Lost to Follow-up|1|||
131939679|NCT02493764|475068754|FG000|Overall Study|Protocol Violation|6|||
131939680|NCT02493764|475068755|FG001|Overall Study|Protocol Violation|7|||
131939681|NCT02493764|475068754|FG000|Overall Study|Physician Decision|1|||
131939682|NCT02493764|475068755|FG001|Overall Study|Physician Decision|1|||
131939683|NCT02493764|475068754|FG000|Overall Study|Participant moved|17|||
131939684|NCT02493764|475068755|FG001|Overall Study|Participant moved|5|||
131939685|NCT02493764|475068754|FG000|Overall Study|Withdrawal parent/guardian|0|||
131939686|NCT02493764|475068755|FG001|Overall Study|Withdrawal parent/guardian|1|||
131939687|NCT02493764|475068754|FG000|Overall Study|Withdrawal by Subject|11|||
131939688|NCT02493764|475068755|FG001|Overall Study|Withdrawal by Subject|7|||
131939689|NCT01561976|475068756|FG000|Period 1|Adverse Event|0|||
131939690|NCT01561976|475068757|FG001|Period 1|Adverse Event|0|||
131939691|NCT01561976|475068758|FG002|Period 1|Adverse Event|1|||
131939692|NCT01561976|475068759|FG003|Period 1|Adverse Event|0|||
131939693|NCT01561976|475068760|FG004|Period 1|Adverse Event|0|||
131939694|NCT01561976|475068761|FG005|Period 1|Adverse Event|0|||
131939695|NCT01561976|475068756|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
131939696|NCT01561976|475068757|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
131939697|NCT01561976|475068758|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
131939698|NCT01561976|475068759|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
131939699|NCT01561976|475068760|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
131939700|NCT01561976|475068761|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
131939701|NCT01561976|475068756|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131939702|NCT01561976|475068757|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131939703|NCT01561976|475068758|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131939704|NCT01561976|475068759|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131939705|NCT01561976|475068760|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131939706|NCT01561976|475068761|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131939707|NCT01561976|475068756|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
131939708|NCT01561976|475068757|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
131939709|NCT01561976|475068758|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
131939710|NCT01561976|475068759|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
131939711|NCT01561976|475068760|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
131939712|NCT01561976|475068761|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
131939713|NCT01463527|475068764|FG000|Overall Study|Protocol Violation|1|||
131939714|NCT01463527|475068765|FG001|Overall Study|Protocol Violation|1|||
131939715|NCT01463527|475068764|FG000|Overall Study|Crying >20% of sedation|5|||
131939716|NCT01463527|475068765|FG001|Overall Study|Crying >20% of sedation|6|||
131939717|NCT05136170|475068766|FG000|Overall Study|Withdrawal by Subject|2|||
131939718|NCT05136170|475068767|FG001|Overall Study|Withdrawal by Subject|2|||
131939719|NCT05136170|475068766|FG000|Overall Study|Can no longer make office visits|1|||
131939720|NCT05136170|475068767|FG001|Overall Study|Can no longer make office visits|0|||
131939721|NCT01493414|475068768|FG000|Overall Study|Adverse Event|405|||
131939722|NCT01493414|475068768|FG000|Overall Study|Disease progression|204|||
131939723|NCT01493414|475068768|FG000|Overall Study|Death|101|||
131939724|NCT01493414|475068768|FG000|Overall Study|Physician Decision|93|||
131939725|NCT01493414|475068768|FG000|Overall Study|Withdrawal by Subject|79|||
131939726|NCT01493414|475068768|FG000|Overall Study|Protocol deviation|27|||
131939727|NCT01493414|475068768|FG000|Overall Study|Administrative problems|25|||
131939728|NCT01493414|475068768|FG000|Overall Study|Lost to Follow-up|16|||
131939729|NCT01816295|475068773|FG000|Double Blind Phase|Adverse Event|11|||
131939730|NCT01816295|475068774|FG001|Double Blind Phase|Adverse Event|8|||
131939731|NCT01816295|475068773|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
131939732|NCT01816295|475068774|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
131939733|NCT01816295|475068773|FG000|Double Blind Phase|Lost to Follow-up|3|||
131939734|NCT01816295|475068774|FG001|Double Blind Phase|Lost to Follow-up|5|||
131939735|NCT01816295|475068773|FG000|Double Blind Phase|Physician Decision|2|||
131939736|NCT01816295|475068774|FG001|Double Blind Phase|Physician Decision|2|||
131939737|NCT01816295|475068773|FG000|Double Blind Phase|Protocol Violation|17|||
131939738|NCT01816295|475068774|FG001|Double Blind Phase|Protocol Violation|11|||
131939739|NCT01816295|475068773|FG000|Double Blind Phase|Sponsor Decision|8|||
131939740|NCT01816295|475068774|FG001|Double Blind Phase|Sponsor Decision|8|||
131939741|NCT01816295|475068773|FG000|Double Blind Phase|Withdrawal by Subject|22|||
131939742|NCT01816295|475068774|FG001|Double Blind Phase|Withdrawal by Subject|20|||
131939743|NCT01816295|475068773|FG000|OLE Phase|Adverse Event|17|||
131939744|NCT01816295|475068774|FG001|OLE Phase|Adverse Event|15|||
131939745|NCT01816295|475068773|FG000|OLE Phase|Death|1|||
131939746|NCT01816295|475068774|FG001|OLE Phase|Death|0|||
131939747|NCT01816295|475068773|FG000|OLE Phase|Entry Criteria Not Met|3|||
131939748|NCT01816295|475068774|FG001|OLE Phase|Entry Criteria Not Met|5|||
131939749|NCT01816295|475068773|FG000|OLE Phase|Lost to Follow-up|5|||
131939750|NCT01816295|475068774|FG001|OLE Phase|Lost to Follow-up|5|||
131939751|NCT01816295|475068773|FG000|OLE Phase|Physician Decision|3|||
131939752|NCT01816295|475068774|FG001|OLE Phase|Physician Decision|1|||
131939753|NCT01816295|475068773|FG000|OLE Phase|Protocol Violation|4|||
131939754|NCT01816295|475068774|FG001|OLE Phase|Protocol Violation|4|||
131939755|NCT01816295|475068773|FG000|OLE Phase|Sponsor Decision|7|||
131939756|NCT01816295|475068774|FG001|OLE Phase|Sponsor Decision|9|||
131939757|NCT01816295|475068773|FG000|OLE Phase|Withdrawal by Subject|10|||
131939758|NCT01816295|475068774|FG001|OLE Phase|Withdrawal by Subject|10|||
131939759|NCT01816295|475068773|FG000|OLE Phase|Lack of Efficacy|3|||
131939760|NCT01816295|475068774|FG001|OLE Phase|Lack of Efficacy|7|||
131939761|NCT01977222|475068775|FG000|Overall Study|Withdrawal by Subject|1|||
131939762|NCT04403919|475068778|FG000|Overall Study|Lost to Follow-up|0|||
131939763|NCT04403919|475068779|FG001|Overall Study|Lost to Follow-up|0|||
131939764|NCT04403919|475068780|FG002|Overall Study|Lost to Follow-up|0|||
131939765|NCT04403919|475068781|FG003|Overall Study|Lost to Follow-up|1|||
131939766|NCT01612676|475068782|FG000|Overall Study|Adverse Event|2|||
131939767|NCT01612676|475068783|FG001|Overall Study|Adverse Event|3|||
131939768|NCT01612676|475068784|FG002|Overall Study|Adverse Event|1|||
131939769|NCT01612676|475068785|FG003|Overall Study|Adverse Event|3|||
131939770|NCT01612676|475068782|FG000|Overall Study|Protocol Violation|0|||
131939771|NCT01612676|475068783|FG001|Overall Study|Protocol Violation|1|||
131939772|NCT01612676|475068784|FG002|Overall Study|Protocol Violation|0|||
131939773|NCT01612676|475068785|FG003|Overall Study|Protocol Violation|0|||
131939774|NCT01156844|475068788|FG000|Overall Study|Adverse Event|0|||
131939775|NCT01156844|475068789|FG001|Overall Study|Adverse Event|0|||
131939776|NCT01156844|475068790|FG002|Overall Study|Adverse Event|1|||
131939777|NCT01156844|475068791|FG003|Overall Study|Adverse Event|1|||
131939778|NCT01156844|475068788|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131939779|NCT01156844|475068789|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131939780|NCT01156844|475068790|FG002|Overall Study|Abnormal test procedure result(s)|2|||
131939781|NCT01156844|475068791|FG003|Overall Study|Abnormal test procedure result(s)|2|||
131939782|NCT01156844|475068788|FG000|Overall Study|Withdrawal by Subject|0|||
131939783|NCT01156844|475068789|FG001|Overall Study|Withdrawal by Subject|0|||
131939784|NCT01156844|475068790|FG002|Overall Study|Withdrawal by Subject|2|||
131939785|NCT01156844|475068791|FG003|Overall Study|Withdrawal by Subject|2|||
131939786|NCT01156844|475068788|FG000|Overall Study|Lost to Follow-up|0|||
131939787|NCT01156844|475068789|FG001|Overall Study|Lost to Follow-up|0|||
131939788|NCT01156844|475068790|FG002|Overall Study|Lost to Follow-up|1|||
131939789|NCT01156844|475068791|FG003|Overall Study|Lost to Follow-up|0|||
131939790|NCT01156844|475068788|FG000|Overall Study|Administrative problems|0|||
131939791|NCT01156844|475068789|FG001|Overall Study|Administrative problems|1|||
131939792|NCT01156844|475068790|FG002|Overall Study|Administrative problems|0|||
131939793|NCT01156844|475068791|FG003|Overall Study|Administrative problems|1|||
131939794|NCT01156844|475068788|FG000|Overall Study|Protocol deviation|2|||
131939795|NCT01156844|475068789|FG001|Overall Study|Protocol deviation|0|||
131939796|NCT01156844|475068790|FG002|Overall Study|Protocol deviation|0|||
131939797|NCT01156844|475068791|FG003|Overall Study|Protocol deviation|0|||
131939798|NCT00107276|475068795|FG000|Overall Study|Progression|46|||
131939799|NCT00107276|475068795|FG000|Overall Study|Adverse Event|6|||
131939800|NCT00107276|475068795|FG000|Overall Study|M.D. decision|2|||
131939801|NCT00107276|475068795|FG000|Overall Study|Patient refusal|1|||
131939802|NCT00107276|475068795|FG000|Overall Study|Death|1|||
131939803|NCT00107276|475068795|FG000|Overall Study|Ineligible|16|||
131939804|NCT05200845|475068796|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
131939805|NCT05200845|475068797|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
131939806|NCT05200845|475068798|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
131939807|NCT05200845|475068799|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
131939808|NCT05200845|475068796|FG000|Overall Study|Withdrawal by Subject|0|||
131939809|NCT05200845|475068797|FG001|Overall Study|Withdrawal by Subject|1|||
131939810|NCT05200845|475068798|FG002|Overall Study|Withdrawal by Subject|1|||
131939811|NCT05200845|475068799|FG003|Overall Study|Withdrawal by Subject|0|||
131939812|NCT02412670|475068800|FG000|Overall Study|Adverse Event|4|||
131939813|NCT02412670|475068801|FG001|Overall Study|Adverse Event|1|||
131939814|NCT02412670|475068800|FG000|Overall Study|Physician Decision|1|||
131939815|NCT02412670|475068801|FG001|Overall Study|Physician Decision|0|||
131939816|NCT02412670|475068800|FG000|Overall Study|Withdrawal by Subject|1|||
131939817|NCT02412670|475068801|FG001|Overall Study|Withdrawal by Subject|0|||
131939818|NCT02412670|475068800|FG000|Overall Study|Ineligible|1|||
131939819|NCT02412670|475068801|FG001|Overall Study|Ineligible|0|||
131939820|NCT04549454|475068806|FG000|T1 to T2|Lost to Follow-up|22|||
131939821|NCT04549454|475068807|FG001|T1 to T2|Lost to Follow-up|26|||
131939822|NCT04549454|475068806|FG000|T1 to T3|Lost to Follow-up|31|||
131939823|NCT04549454|475068807|FG001|T1 to T3|Lost to Follow-up|36|||
131939824|NCT00867035|475068808|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
131939825|NCT00867035|475068809|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
131939826|NCT00867035|475068808|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
131939827|NCT00867035|475068809|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
131939828|NCT00829998|475068810|FG000|Washout|Adverse Event|0|||
131939829|NCT00829998|475068811|FG001|Washout|Adverse Event|1|||
131939830|NCT04712669|475068812|FG000|Double Blind Phase|Adverse Event|4|||
131939831|NCT04712669|475068813|FG001|Double Blind Phase|Adverse Event|4|||
131939832|NCT04712669|475068814|FG002|Double Blind Phase|Adverse Event|3|||
131939833|NCT04712669|475068815|FG003|Double Blind Phase|Adverse Event|0|||
131939834|NCT04712669|475068816|FG004|Double Blind Phase|Adverse Event|0|||
131939835|NCT04712669|475068817|FG005|Double Blind Phase|Adverse Event|0|||
131939836|NCT04712669|475068818|FG006|Double Blind Phase|Adverse Event|0|||
131939837|NCT04712669|475068819|FG007|Double Blind Phase|Adverse Event|0|||
131939838|NCT04712669|475068812|FG000|Double Blind Phase|Physician Decision|1|||
131939839|NCT04712669|475068813|FG001|Double Blind Phase|Physician Decision|0|||
131939840|NCT04712669|475068814|FG002|Double Blind Phase|Physician Decision|0|||
131939841|NCT04712669|475068815|FG003|Double Blind Phase|Physician Decision|0|||
131939842|NCT04712669|475068816|FG004|Double Blind Phase|Physician Decision|0|||
131939843|NCT04712669|475068817|FG005|Double Blind Phase|Physician Decision|0|||
131939844|NCT04712669|475068818|FG006|Double Blind Phase|Physician Decision|0|||
131939845|NCT04712669|475068819|FG007|Double Blind Phase|Physician Decision|0|||
131939846|NCT04712669|475068812|FG000|Double Blind Phase|Withdrawal by Subject|3|||
131939847|NCT04712669|475068813|FG001|Double Blind Phase|Withdrawal by Subject|6|||
131939848|NCT04712669|475068814|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131939849|NCT04712669|475068815|FG003|Double Blind Phase|Withdrawal by Subject|0|||
131939850|NCT04712669|475068816|FG004|Double Blind Phase|Withdrawal by Subject|0|||
131939851|NCT04712669|475068817|FG005|Double Blind Phase|Withdrawal by Subject|0|||
131939852|NCT04712669|475068818|FG006|Double Blind Phase|Withdrawal by Subject|0|||
131939853|NCT04712669|475068819|FG007|Double Blind Phase|Withdrawal by Subject|0|||
131939854|NCT04712669|475068812|FG000|Double Blind Phase|Termination by Sponsor|0|||
131939855|NCT04712669|475068813|FG001|Double Blind Phase|Termination by Sponsor|0|||
131939856|NCT04712669|475068814|FG002|Double Blind Phase|Termination by Sponsor|1|||
131939857|NCT04712669|475068815|FG003|Double Blind Phase|Termination by Sponsor|0|||
131939858|NCT04712669|475068816|FG004|Double Blind Phase|Termination by Sponsor|0|||
131939859|NCT04712669|475068817|FG005|Double Blind Phase|Termination by Sponsor|0|||
131939860|NCT04712669|475068818|FG006|Double Blind Phase|Termination by Sponsor|0|||
131939861|NCT04712669|475068819|FG007|Double Blind Phase|Termination by Sponsor|0|||
131939862|NCT04712669|475068812|FG000|Open Label Phase|Adverse Event|0|||
131939863|NCT04712669|475068813|FG001|Open Label Phase|Adverse Event|0|||
131939864|NCT04712669|475068814|FG002|Open Label Phase|Adverse Event|0|||
131939865|NCT04712669|475068815|FG003|Open Label Phase|Adverse Event|1|||
131939866|NCT04712669|475068816|FG004|Open Label Phase|Adverse Event|1|||
131939867|NCT04712669|475068817|FG005|Open Label Phase|Adverse Event|3|||
131939868|NCT04712669|475068818|FG006|Open Label Phase|Adverse Event|1|||
131939869|NCT04712669|475068819|FG007|Open Label Phase|Adverse Event|2|||
131939870|NCT04712669|475068812|FG000|Open Label Phase|Death|0|||
131939871|NCT04712669|475068813|FG001|Open Label Phase|Death|0|||
131939872|NCT04712669|475068814|FG002|Open Label Phase|Death|0|||
131939873|NCT04712669|475068815|FG003|Open Label Phase|Death|1|||
131939874|NCT04712669|475068816|FG004|Open Label Phase|Death|0|||
131939875|NCT04712669|475068817|FG005|Open Label Phase|Death|0|||
131939876|NCT04712669|475068818|FG006|Open Label Phase|Death|0|||
131939877|NCT04712669|475068819|FG007|Open Label Phase|Death|0|||
131939878|NCT04712669|475068812|FG000|Open Label Phase|Lack of Efficacy|0|||
131939879|NCT04712669|475068813|FG001|Open Label Phase|Lack of Efficacy|0|||
131939880|NCT04712669|475068814|FG002|Open Label Phase|Lack of Efficacy|0|||
131939881|NCT04712669|475068815|FG003|Open Label Phase|Lack of Efficacy|0|||
131939882|NCT04712669|475068816|FG004|Open Label Phase|Lack of Efficacy|1|||
131939883|NCT04712669|475068817|FG005|Open Label Phase|Lack of Efficacy|0|||
131939884|NCT04712669|475068818|FG006|Open Label Phase|Lack of Efficacy|0|||
131939885|NCT04712669|475068819|FG007|Open Label Phase|Lack of Efficacy|0|||
131939886|NCT04712669|475068812|FG000|Open Label Phase|Lost to Follow-up|0|||
131939887|NCT04712669|475068813|FG001|Open Label Phase|Lost to Follow-up|0|||
131939888|NCT04712669|475068814|FG002|Open Label Phase|Lost to Follow-up|0|||
131939889|NCT04712669|475068815|FG003|Open Label Phase|Lost to Follow-up|0|||
131939890|NCT04712669|475068816|FG004|Open Label Phase|Lost to Follow-up|0|||
131939891|NCT04712669|475068817|FG005|Open Label Phase|Lost to Follow-up|0|||
131939892|NCT04712669|475068818|FG006|Open Label Phase|Lost to Follow-up|1|||
131939893|NCT04712669|475068819|FG007|Open Label Phase|Lost to Follow-up|1|||
131939894|NCT04712669|475068812|FG000|Open Label Phase|Physician Decision|0|||
131939895|NCT04712669|475068813|FG001|Open Label Phase|Physician Decision|0|||
131939896|NCT04712669|475068814|FG002|Open Label Phase|Physician Decision|0|||
131939897|NCT04712669|475068815|FG003|Open Label Phase|Physician Decision|1|||
131939898|NCT04712669|475068816|FG004|Open Label Phase|Physician Decision|0|||
131939899|NCT04712669|475068817|FG005|Open Label Phase|Physician Decision|0|||
131939900|NCT04712669|475068818|FG006|Open Label Phase|Physician Decision|0|||
131939901|NCT04712669|475068819|FG007|Open Label Phase|Physician Decision|0|||
131939902|NCT04712669|475068812|FG000|Open Label Phase|Withdrawal by Subject|0|||
131939903|NCT04712669|475068813|FG001|Open Label Phase|Withdrawal by Subject|0|||
131939904|NCT04712669|475068814|FG002|Open Label Phase|Withdrawal by Subject|0|||
131939905|NCT04712669|475068815|FG003|Open Label Phase|Withdrawal by Subject|1|||
131939906|NCT04712669|475068816|FG004|Open Label Phase|Withdrawal by Subject|5|||
131939907|NCT04712669|475068817|FG005|Open Label Phase|Withdrawal by Subject|5|||
131939908|NCT04712669|475068818|FG006|Open Label Phase|Withdrawal by Subject|0|||
131939909|NCT04712669|475068819|FG007|Open Label Phase|Withdrawal by Subject|4|||
131939910|NCT04712669|475068812|FG000|Open Label Phase|Termination by Sponsor|0|||
131939911|NCT04712669|475068813|FG001|Open Label Phase|Termination by Sponsor|0|||
131939912|NCT04712669|475068814|FG002|Open Label Phase|Termination by Sponsor|0|||
131939913|NCT04712669|475068815|FG003|Open Label Phase|Termination by Sponsor|11|||
131939914|NCT04712669|475068816|FG004|Open Label Phase|Termination by Sponsor|9|||
131939915|NCT04712669|475068817|FG005|Open Label Phase|Termination by Sponsor|14|||
131939916|NCT04712669|475068818|FG006|Open Label Phase|Termination by Sponsor|0|||
131939917|NCT04712669|475068819|FG007|Open Label Phase|Termination by Sponsor|14|||
131939918|NCT04464473|475068820|FG000|Overall Study|New piercing could not be removed for scanning|0|||
131939919|NCT04464473|475068821|FG001|Overall Study|New piercing could not be removed for scanning|0|||
131939920|NCT04464473|475068822|FG002|Overall Study|New piercing could not be removed for scanning|0|||
131939921|NCT04464473|475068823|FG003|Overall Study|New piercing could not be removed for scanning|1|||
131939922|NCT04464473|475068824|FG004|Overall Study|New piercing could not be removed for scanning|0|||
131939923|NCT04464473|475068825|FG005|Overall Study|New piercing could not be removed for scanning|0|||
131939924|NCT04464473|475068820|FG000|Overall Study|Adverse Event|0|||
131939925|NCT04464473|475068821|FG001|Overall Study|Adverse Event|0|||
131939926|NCT04464473|475068822|FG002|Overall Study|Adverse Event|0|||
131939927|NCT04464473|475068823|FG003|Overall Study|Adverse Event|1|||
131939928|NCT04464473|475068824|FG004|Overall Study|Adverse Event|0|||
131939929|NCT04464473|475068825|FG005|Overall Study|Adverse Event|0|||
131939930|NCT04464473|475068820|FG000|Overall Study|Lost to Follow-up|0|||
131939931|NCT04464473|475068821|FG001|Overall Study|Lost to Follow-up|0|||
131939932|NCT04464473|475068822|FG002|Overall Study|Lost to Follow-up|0|||
131939933|NCT04464473|475068823|FG003|Overall Study|Lost to Follow-up|1|||
131939934|NCT04464473|475068824|FG004|Overall Study|Lost to Follow-up|0|||
131939935|NCT04464473|475068825|FG005|Overall Study|Lost to Follow-up|0|||
131939936|NCT02561962|475068832|FG000|Overall Study|Withdrawal by Subject|1|||
131939937|NCT02561962|475068833|FG001|Overall Study|Withdrawal by Subject|0|||
131939938|NCT02561962|475068834|FG002|Overall Study|Withdrawal by Subject|0|||
131939939|NCT02561962|475068835|FG003|Overall Study|Withdrawal by Subject|0|||
131939940|NCT02561962|475068836|FG004|Overall Study|Withdrawal by Subject|1|||
131939941|NCT02561962|475068837|FG005|Overall Study|Withdrawal by Subject|1|||
131939942|NCT02561962|475068838|FG006|Overall Study|Withdrawal by Subject|2|||
131939943|NCT02561962|475068839|FG007|Overall Study|Withdrawal by Subject|1|||
131939944|NCT02561962|475068840|FG008|Overall Study|Withdrawal by Subject|0|||
131939945|NCT02561962|475068832|FG000|Overall Study|Decision by sponsor|0|||
131939946|NCT02561962|475068833|FG001|Overall Study|Decision by sponsor|0|||
131939947|NCT02561962|475068834|FG002|Overall Study|Decision by sponsor|0|||
131939948|NCT02561962|475068835|FG003|Overall Study|Decision by sponsor|0|||
131939949|NCT02561962|475068836|FG004|Overall Study|Decision by sponsor|1|||
131939950|NCT02561962|475068837|FG005|Overall Study|Decision by sponsor|1|||
131454737|NCT04976192|473294238|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131939951|NCT02561962|475068838|FG006|Overall Study|Decision by sponsor|0|||
131939952|NCT02561962|475068839|FG007|Overall Study|Decision by sponsor|3|||
131939953|NCT02561962|475068840|FG008|Overall Study|Decision by sponsor|0|||
131939954|NCT02561962|475068832|FG000|Overall Study|Lost to Follow-up|0|||
131939955|NCT02561962|475068833|FG001|Overall Study|Lost to Follow-up|0|||
131939956|NCT02561962|475068834|FG002|Overall Study|Lost to Follow-up|0|||
131939957|NCT02561962|475068835|FG003|Overall Study|Lost to Follow-up|0|||
131939958|NCT02561962|475068836|FG004|Overall Study|Lost to Follow-up|0|||
131939959|NCT02561962|475068837|FG005|Overall Study|Lost to Follow-up|1|||
131939960|NCT02561962|475068838|FG006|Overall Study|Lost to Follow-up|0|||
131939961|NCT02561962|475068839|FG007|Overall Study|Lost to Follow-up|0|||
131939962|NCT02561962|475068840|FG008|Overall Study|Lost to Follow-up|0|||
131939963|NCT01585025|475069958|FG000|Overall Study|Withdrawal by Subject|0|||
131939964|NCT01585025|475069959|FG001|Overall Study|Withdrawal by Subject|3|||
131939965|NCT01585025|475069960|FG002|Overall Study|Withdrawal by Subject|4|||
131939966|NCT00582907|475069961|FG000|1st Course|Withdrawal by Subject|1|||
131939967|NCT00582907|475069962|FG001|1st Course|Withdrawal by Subject|0|||
131939968|NCT00582907|475069963|FG002|1st Course|Withdrawal by Subject|0|||
131939969|NCT00582907|475069964|FG003|1st Course|Withdrawal by Subject|0|||
131939970|NCT00582907|475069961|FG000|1st Course|Lost to Follow-up|0|||
131939971|NCT00582907|475069962|FG001|1st Course|Lost to Follow-up|0|||
131939972|NCT00582907|475069963|FG002|1st Course|Lost to Follow-up|0|||
131939973|NCT00582907|475069964|FG003|1st Course|Lost to Follow-up|1|||
131939974|NCT00582907|475069961|FG000|2nd Course|Lack of Efficacy|1|||
131939975|NCT00582907|475069962|FG001|2nd Course|Lack of Efficacy|0|||
131939976|NCT00582907|475069963|FG002|2nd Course|Lack of Efficacy|0|||
131939977|NCT00582907|475069964|FG003|2nd Course|Lack of Efficacy|0|||
131939978|NCT00598650|475069965|FG000|Overall Study|Withdrawal by Subject|3|||
131939979|NCT00598650|475069965|FG000|Overall Study|Adverse Event|18|||
131939980|NCT00598650|475069965|FG000|Overall Study|No treatment for 3 weeks|1|||
131939981|NCT00598650|475069965|FG000|Overall Study|Not eligible|1|||
131939982|NCT00598650|475069965|FG000|Overall Study|Prohibited Concomitant Medication|2|||
131939983|NCT00598650|475069965|FG000|Overall Study|Physician Decision|2|||
131939984|NCT03545672|475069966|FG000|Overall Study|Uncertain diagnosis|2|||
131939985|NCT03545672|475069967|FG001|Overall Study|Uncertain diagnosis|1|||
131939986|NCT03545672|475069966|FG000|Overall Study|Protocol Violation|2|||
131939987|NCT03545672|475069967|FG001|Overall Study|Protocol Violation|2|||
131939988|NCT03610048|475069971|FG000|Overall Study|Study terminated by sponsor|84|||
131939989|NCT03610048|475069971|FG000|Overall Study|Adverse Event|32|||
131939990|NCT03610048|475069971|FG000|Overall Study|Withdrawal by Subject|31|||
131939991|NCT03610048|475069971|FG000|Overall Study|Lost to Follow-up|8|||
131939992|NCT03610048|475069971|FG000|Overall Study|Other|4|||
131939993|NCT03610048|475069971|FG000|Overall Study|Physician Decision|1|||
131939994|NCT03610048|475069971|FG000|Overall Study|Pregnancy|1|||
131939995|NCT01155050|475069972|FG000|Overall Study|Lost to Follow-up|15|||
131939996|NCT01155050|475069973|FG001|Overall Study|Lost to Follow-up|20|||
131939997|NCT01155050|475069974|FG002|Overall Study|Lost to Follow-up|19|||
131939998|NCT01155050|475069975|FG003|Overall Study|Lost to Follow-up|22|||
131939999|NCT01146613|475069976|FG000|Overall Study|Lost to Follow-up|3|||
131940000|NCT01146613|475069977|FG001|Overall Study|Lost to Follow-up|8|||
131940001|NCT01146613|475069976|FG000|Overall Study|Lack of Efficacy|0|||
131940002|NCT01146613|475069977|FG001|Overall Study|Lack of Efficacy|1|||
131940003|NCT01146613|475069976|FG000|Overall Study|Death|1|||
131454738|NCT04976192|473294239|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131940004|NCT01146613|475069977|FG001|Overall Study|Death|0|||
131454739|NCT04976192|473294240|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131940005|NCT01146613|475069976|FG000|Overall Study|Physician Decision|1|||
131940006|NCT01146613|475069977|FG001|Overall Study|Physician Decision|0|||
131940007|NCT01146613|475069976|FG000|Overall Study|Withdrawal by Subject|0|||
131940008|NCT01146613|475069977|FG001|Overall Study|Withdrawal by Subject|3|||
131940009|NCT01146613|475069976|FG000|Overall Study|schedule conflict|1|||
131940010|NCT01146613|475069977|FG001|Overall Study|schedule conflict|0|||
131940011|NCT01146613|475069976|FG000|Overall Study|Outpatient detox|1|||
131940012|NCT01146613|475069977|FG001|Overall Study|Outpatient detox|0|||
131454740|NCT04976192|473294241|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131454741|NCT04976192|473294242|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131940013|NCT02735200|475069978|FG000|Overall Study|Lost to Follow-up|0|||
131940014|NCT02735200|475069979|FG001|Overall Study|Lost to Follow-up|5|||
131940015|NCT02735200|475069978|FG000|Overall Study|Withdrawal by Subject|8|||
131940016|NCT02735200|475069979|FG001|Overall Study|Withdrawal by Subject|0|||
131940017|NCT01128569|475069983|FG000|Washout Period 1|Adverse Event|0|||
131940018|NCT01128569|475069984|FG001|Washout Period 1|Adverse Event|0|||
131940019|NCT01128569|475069985|FG002|Washout Period 1|Adverse Event|1|||
131940020|NCT01128569|475069986|FG003|Washout Period 1|Adverse Event|0|||
131940021|NCT01128569|475069987|FG004|Washout Period 1|Adverse Event|0|||
131940022|NCT01128569|475069988|FG005|Washout Period 1|Adverse Event|0|||
131940023|NCT01128569|475069983|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131940024|NCT01128569|475069984|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131940025|NCT01128569|475069985|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131940026|NCT01128569|475069986|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131940027|NCT01128569|475069987|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131940028|NCT01128569|475069988|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131940029|NCT00565409|475069994|FG000|Period 1 Open Label|Adverse Event|17|||
131940030|NCT00565409|475069995|FG001|Period 1 Open Label|Adverse Event|0|||
131940031|NCT00565409|475069996|FG002|Period 1 Open Label|Adverse Event|0|||
131940032|NCT00565409|475069997|FG003|Period 1 Open Label|Adverse Event|0|||
131940033|NCT00565409|475069994|FG000|Period 1 Open Label|Death|2|||
131940034|NCT00565409|475069995|FG001|Period 1 Open Label|Death|0|||
131940035|NCT00565409|475069996|FG002|Period 1 Open Label|Death|0|||
131940036|NCT00565409|475069997|FG003|Period 1 Open Label|Death|0|||
131940037|NCT00565409|475069994|FG000|Period 1 Open Label|Lost to Follow-up|1|||
131940038|NCT00565409|475069995|FG001|Period 1 Open Label|Lost to Follow-up|0|||
131940039|NCT00565409|475069996|FG002|Period 1 Open Label|Lost to Follow-up|0|||
131940040|NCT00565409|475069997|FG003|Period 1 Open Label|Lost to Follow-up|0|||
131940041|NCT00565409|475069994|FG000|Period 1 Open Label|Other|21|||
131940042|NCT00565409|475069995|FG001|Period 1 Open Label|Other|0|||
131940043|NCT00565409|475069996|FG002|Period 1 Open Label|Other|0|||
131940044|NCT00565409|475069997|FG003|Period 1 Open Label|Other|0|||
131940045|NCT00565409|475069994|FG000|Period 1 Open Label|Protocol Violation|14|||
131940046|NCT00565409|475069995|FG001|Period 1 Open Label|Protocol Violation|0|||
131940047|NCT00565409|475069996|FG002|Period 1 Open Label|Protocol Violation|0|||
131940048|NCT00565409|475069997|FG003|Period 1 Open Label|Protocol Violation|0|||
131940049|NCT00565409|475069994|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
131940050|NCT00565409|475069995|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
131940051|NCT00565409|475069996|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
131940052|NCT00565409|475069997|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
131940053|NCT00565409|475069994|FG000|Period 1 Open Label|no conclusion of participation record|1|||
131940054|NCT00565409|475069995|FG001|Period 1 Open Label|no conclusion of participation record|0|||
131940055|NCT00565409|475069996|FG002|Period 1 Open Label|no conclusion of participation record|0|||
131940056|NCT00565409|475069997|FG003|Period 1 Open Label|no conclusion of participation record|0|||
131940057|NCT00565409|475069994|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
131940058|NCT00565409|475069995|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
131940059|NCT00565409|475069996|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
131940060|NCT00565409|475069997|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
131940061|NCT00565409|475069994|FG000|Period 2 Double-Blind|Adverse Event|0|||
131940062|NCT00565409|475069995|FG001|Period 2 Double-Blind|Adverse Event|7|||
131940063|NCT00565409|475069996|FG002|Period 2 Double-Blind|Adverse Event|4|||
131940064|NCT00565409|475069997|FG003|Period 2 Double-Blind|Adverse Event|5|||
131940065|NCT00565409|475069994|FG000|Period 2 Double-Blind|Death|0|||
131940066|NCT00565409|475069995|FG001|Period 2 Double-Blind|Death|2|||
131940067|NCT00565409|475069996|FG002|Period 2 Double-Blind|Death|0|||
131940068|NCT00565409|475069997|FG003|Period 2 Double-Blind|Death|0|||
131940069|NCT00565409|475069994|FG000|Period 2 Double-Blind|Protocol Violation|0|||
131454742|NCT04976192|473294243|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131940070|NCT00565409|475069995|FG001|Period 2 Double-Blind|Protocol Violation|4|||
131940071|NCT00565409|475069996|FG002|Period 2 Double-Blind|Protocol Violation|6|||
131940072|NCT00565409|475069997|FG003|Period 2 Double-Blind|Protocol Violation|2|||
131940073|NCT00565409|475069994|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
131940074|NCT00565409|475069995|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
131940075|NCT00565409|475069996|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
131940076|NCT00565409|475069997|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
131940077|NCT00565409|475069994|FG000|Period 2 Double-Blind|Other|0|||
131940078|NCT00565409|475069995|FG001|Period 2 Double-Blind|Other|4|||
131940079|NCT00565409|475069996|FG002|Period 2 Double-Blind|Other|5|||
131940080|NCT00565409|475069997|FG003|Period 2 Double-Blind|Other|9|||
131940081|NCT00565409|475069994|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
131940082|NCT00565409|475069995|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
131940083|NCT00565409|475069996|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
131940084|NCT00565409|475069997|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
131940085|NCT01448616|475069999|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
131940086|NCT01448616|475070000|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
131940087|NCT01448616|475070001|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
131454743|NCT04976192|473294234|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131940088|NCT01448616|475070002|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
131940089|NCT01448616|475069999|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
131940090|NCT01448616|475070000|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
131940091|NCT01448616|475070001|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
131940092|NCT01448616|475070002|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
131940093|NCT01448616|475069999|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
131940094|NCT01448616|475070000|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
131940095|NCT01448616|475070001|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
131940096|NCT01448616|475070002|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
131940097|NCT01448616|475069999|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
131940098|NCT01448616|475070000|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
131940099|NCT01448616|475070001|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
131940100|NCT01448616|475070002|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
131940101|NCT01448616|475069999|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
131940102|NCT01448616|475070000|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
131940103|NCT01448616|475070001|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
131940104|NCT01448616|475070002|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
131940105|NCT02170064|475070005|FG000|Overall Study|Withdrawal by Subject|5|||
131940106|NCT02170064|475070006|FG001|Overall Study|Withdrawal by Subject|1|||
131940107|NCT02170064|475070007|FG002|Overall Study|Withdrawal by Subject|1|||
131940108|NCT02170064|475070005|FG000|Overall Study|Physician Decision|1|||
131940109|NCT02170064|475070006|FG001|Overall Study|Physician Decision|1|||
131940110|NCT02170064|475070007|FG002|Overall Study|Physician Decision|0|||
131940111|NCT03323164|475070008|FG000|Overall Study|Poor quality imaging/scans|2|||
131940112|NCT03323164|475070009|FG001|Overall Study|Poor quality imaging/scans|2|||
131940113|NCT00654732|475070010|FG000|Overall Study|Adverse Event|4|||
131940114|NCT00654732|475070011|FG001|Overall Study|Adverse Event|6|||
131940115|NCT01959932|475070012|FG000|Overall Study|Withdrawal by Subject|1|||
131940116|NCT01959932|475070013|FG001|Overall Study|Withdrawal by Subject|0|||
131940117|NCT01959932|475070014|FG002|Overall Study|Withdrawal by Subject|0|||
131940118|NCT00397540|475070015|FG000|Overall Study|short follow-up duration < 12 months|1|||
131940119|NCT00397540|475070016|FG001|Overall Study|short follow-up duration < 12 months|0|||
131940120|NCT03507127|475070021|FG000|Overall Study|Withdrawal by Subject|1|||
131940121|NCT03507127|475070022|FG001|Overall Study|Withdrawal by Subject|0|||
131940122|NCT03507127|475070021|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
131940123|NCT03507127|475070022|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
131940124|NCT03508050|475070023|FG000|Overall Study|Pleural adhesions|1|||
131940125|NCT03508050|475070024|FG001|Overall Study|Pleural adhesions|0|||
131940126|NCT03508050|475070023|FG000|Overall Study|Mucus plug|1|||
131940127|NCT03508050|475070024|FG001|Overall Study|Mucus plug|0|||
131940128|NCT03508050|475070023|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
131940129|NCT03508050|475070024|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
131940130|NCT03508050|475070023|FG000|Overall Study|Sustained desaturation|0|||
131940131|NCT03508050|475070024|FG001|Overall Study|Sustained desaturation|1|||
131940132|NCT01240863|475070025|FG000|Open-label Titration Period|Adverse Event|47|||
131940133|NCT01240863|475070026|FG001|Open-label Titration Period|Adverse Event|0|||
131940134|NCT01240863|475070027|FG002|Open-label Titration Period|Adverse Event|0|||
131940135|NCT01240863|475070025|FG000|Open-label Titration Period|Lack of Efficacy|19|||
131940136|NCT01240863|475070026|FG001|Open-label Titration Period|Lack of Efficacy|0|||
131940137|NCT01240863|475070027|FG002|Open-label Titration Period|Lack of Efficacy|0|||
131940138|NCT01240863|475070025|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
131940139|NCT01240863|475070026|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
131940140|NCT01240863|475070027|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
131940141|NCT01240863|475070025|FG000|Open-label Titration Period|Protocol Violation|7|||
131940142|NCT01240863|475070026|FG001|Open-label Titration Period|Protocol Violation|0|||
131940143|NCT01240863|475070027|FG002|Open-label Titration Period|Protocol Violation|0|||
131940144|NCT01240863|475070025|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
131940145|NCT01240863|475070026|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
131940146|NCT01240863|475070027|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
131940147|NCT01240863|475070025|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
131940148|NCT01240863|475070026|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
131940149|NCT01240863|475070027|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
131940150|NCT01240863|475070025|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
131940151|NCT01240863|475070026|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
131940152|NCT01240863|475070027|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
131940153|NCT01240863|475070025|FG000|Open-label Titration Period|Other|7|||
131940154|NCT01240863|475070026|FG001|Open-label Titration Period|Other|0|||
131940155|NCT01240863|475070027|FG002|Open-label Titration Period|Other|0|||
131940156|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
131940157|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
131940158|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
131412721|NCT00610441|473133727|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
131940159|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131940160|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
131940161|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
131940162|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131940163|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
131940164|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
131940165|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
131940166|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
131940167|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
131940168|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
131940169|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
131940170|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
131940171|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
131940172|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
131940173|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
131940174|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
131940175|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
131940176|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
131940177|NCT01240863|475070025|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
131940178|NCT01240863|475070026|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
131940179|NCT01240863|475070027|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
131940180|NCT00485173|475070030|FG000|Overall Study|Death|4|||
131940181|NCT00485173|475070031|FG001|Overall Study|Death|3|||
131940182|NCT00485173|475070030|FG000|Overall Study|Lost to Follow-up|32|||
131940183|NCT00485173|475070031|FG001|Overall Study|Lost to Follow-up|61|||
131940184|NCT00829244|475070032|FG000|Overall Study|Adverse Event|1|||
131940185|NCT00829244|475070033|FG001|Overall Study|Adverse Event|3|||
131940186|NCT00829244|475070032|FG000|Overall Study|Protocol Violation|1|||
131940187|NCT00829244|475070033|FG001|Overall Study|Protocol Violation|0|||
131940188|NCT00829244|475070032|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
131940189|NCT00829244|475070033|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
131940190|NCT00829244|475070032|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
131940191|NCT00829244|475070033|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
131940192|NCT00829244|475070032|FG000|Overall Study|No fertilization|2|||
131940193|NCT00829244|475070033|FG001|Overall Study|No fertilization|2|||
131940194|NCT00829244|475070032|FG000|Overall Study|All embryos discarded|0|||
131940195|NCT00829244|475070033|FG001|Overall Study|All embryos discarded|3|||
131940196|NCT00829244|475070032|FG000|Overall Study|No embryo cleavage|0|||
131940197|NCT00829244|475070033|FG001|Overall Study|No embryo cleavage|2|||
131940198|NCT02604511|475070034|FG000|Overall Study|Adverse Event|3|||
131940199|NCT02604511|475070034|FG000|Overall Study|Disease Progression|4|||
131940200|NCT02604511|475070034|FG000|Overall Study|Withdrawal by Subject|3|||
131940201|NCT02604511|475070034|FG000|Overall Study|Participant ineligible|1|||
131940202|NCT02604511|475070034|FG000|Overall Study|Intercurrent illness|1|||
131940203|NCT02297412|475070035|FG000|Overall Study|Canceled|1|||
131940204|NCT02297412|475070036|FG001|Overall Study|Canceled|1|||
131940205|NCT02993263|475070056|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
131940206|NCT00545779|475070057|FG000|Overall Study|Violation of selection criteria at entry|8|||
131940207|NCT00545779|475070057|FG000|Overall Study|Other protocol violation|1|||
131940208|NCT00545779|475070057|FG000|Overall Study|Did not cooperate|7|||
131940209|NCT00545779|475070057|FG000|Overall Study|Withdrawal by Subject|20|||
131940210|NCT00545779|475070057|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
131940211|NCT00545779|475070057|FG000|Overall Study|Failure to return|3|||
131940212|NCT01405196|475070058|FG000|Overall Study|Study Terminated by Sponsor|0|||
131940213|NCT01405196|475070059|FG001|Overall Study|Study Terminated by Sponsor|0|||
131940214|NCT01405196|475070060|FG002|Overall Study|Study Terminated by Sponsor|9|||
131940215|NCT01405196|475070061|FG003|Overall Study|Study Terminated by Sponsor|0|||
131940216|NCT01405196|475070058|FG000|Overall Study|Other|2|||
131940217|NCT01405196|475070059|FG001|Overall Study|Other|2|||
131940218|NCT01405196|475070060|FG002|Overall Study|Other|5|||
131940219|NCT01405196|475070061|FG003|Overall Study|Other|0|||
131940220|NCT01405196|475070058|FG000|Overall Study|Withdrawal by Subject|4|||
131940221|NCT01405196|475070059|FG001|Overall Study|Withdrawal by Subject|6|||
131940222|NCT01405196|475070060|FG002|Overall Study|Withdrawal by Subject|3|||
131940223|NCT01405196|475070061|FG003|Overall Study|Withdrawal by Subject|6|||
131940224|NCT01405196|475070058|FG000|Overall Study|Adverse Event|2|||
131940225|NCT01405196|475070059|FG001|Overall Study|Adverse Event|2|||
131940226|NCT01405196|475070060|FG002|Overall Study|Adverse Event|0|||
131940227|NCT01405196|475070061|FG003|Overall Study|Adverse Event|2|||
131940228|NCT01405196|475070058|FG000|Overall Study|Death|1|||
131940229|NCT01405196|475070059|FG001|Overall Study|Death|0|||
131940230|NCT01405196|475070060|FG002|Overall Study|Death|3|||
131940231|NCT01405196|475070061|FG003|Overall Study|Death|0|||
131940232|NCT01405196|475070058|FG000|Overall Study|Lost to Follow-up|2|||
131940233|NCT01405196|475070059|FG001|Overall Study|Lost to Follow-up|2|||
131940234|NCT01405196|475070060|FG002|Overall Study|Lost to Follow-up|3|||
131940235|NCT01405196|475070061|FG003|Overall Study|Lost to Follow-up|1|||
131940236|NCT01729039|475070064|FG000|Overall Study|disqualified|2|||
131940237|NCT01729039|475070065|FG001|Overall Study|disqualified|5|||
131940238|NCT01729039|475070064|FG000|Overall Study|Withdrawal by Subject|8|||
131940239|NCT01729039|475070065|FG001|Overall Study|Withdrawal by Subject|7|||
131940240|NCT00698841|475070066|FG000|Overall Study|Withdrawal by Subject|2|||
131940241|NCT00698841|475070066|FG000|Overall Study|Adverse Event|3|||
131940242|NCT00698841|475070066|FG000|Overall Study|Disease progression|7|||
131940243|NCT00698841|475070066|FG000|Overall Study|Failure to meet eligibility criteria|2|||
131940244|NCT00698841|475070066|FG000|Overall Study|Study drug toxicity|2|||
131940245|NCT00698841|475070066|FG000|Overall Study|Other|2|||
131940246|NCT02611037|475070067|FG000|Overall Study|Withdrawal prior to treatment|2|||
131940247|NCT02611037|475070068|FG001|Overall Study|Withdrawal prior to treatment|0|||
131940248|NCT05788991|475070071|FG000|Overall Study|Not treated with study medication|1|||
131940249|NCT05788991|475070072|FG001|Overall Study|Not treated with study medication|3|||
131940250|NCT05788991|475070071|FG000|Overall Study|Withdrawal by Subject|1|||
131940251|NCT05788991|475070072|FG001|Overall Study|Withdrawal by Subject|0|||
131940252|NCT05788991|475070071|FG000|Overall Study|Lack of Efficacy|0|||
131940253|NCT05788991|475070072|FG001|Overall Study|Lack of Efficacy|1|||
131940254|NCT05788991|475070071|FG000|Overall Study|Protocol Violation|1|||
131940255|NCT05788991|475070072|FG001|Overall Study|Protocol Violation|2|||
131940256|NCT05270863|475070073|FG000|Visit 2 First Intervention|Randomization error|0|||
131940257|NCT05270863|475070074|FG001|Visit 2 First Intervention|Randomization error|0|||
131940258|NCT05270863|475070075|FG002|Visit 2 First Intervention|Randomization error|0|||
131940259|NCT05270863|475070076|FG003|Visit 2 First Intervention|Randomization error|1|||
131940260|NCT05270863|475070077|FG004|Visit 2 First Intervention|Randomization error|0|||
131940261|NCT05270863|475070078|FG005|Visit 2 First Intervention|Randomization error|0|||
131940262|NCT05270863|475070073|FG000|First Washout|Withdrawal by Subject|0|||
131940263|NCT05270863|475070074|FG001|First Washout|Withdrawal by Subject|0|||
131940264|NCT05270863|475070075|FG002|First Washout|Withdrawal by Subject|0|||
131940265|NCT05270863|475070076|FG003|First Washout|Withdrawal by Subject|0|||
131940266|NCT05270863|475070077|FG004|First Washout|Withdrawal by Subject|1|||
131940267|NCT05270863|475070078|FG005|First Washout|Withdrawal by Subject|1|||
131940268|NCT05270863|475070073|FG000|First Washout|Lost to Follow-up|0|||
131940269|NCT05270863|475070074|FG001|First Washout|Lost to Follow-up|0|||
131940270|NCT05270863|475070075|FG002|First Washout|Lost to Follow-up|0|||
131940271|NCT05270863|475070076|FG003|First Washout|Lost to Follow-up|0|||
131940272|NCT05270863|475070077|FG004|First Washout|Lost to Follow-up|0|||
131940273|NCT05270863|475070078|FG005|First Washout|Lost to Follow-up|1|||
131940274|NCT05270863|475070073|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
131940275|NCT05270863|475070074|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
131940276|NCT05270863|475070075|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
131940277|NCT05270863|475070076|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
131940278|NCT05270863|475070077|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
131940279|NCT05270863|475070078|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
131940280|NCT05270863|475070073|FG000|Second Washout|Withdrawal by Subject|1|||
131940281|NCT05270863|475070074|FG001|Second Washout|Withdrawal by Subject|1|||
131940282|NCT05270863|475070075|FG002|Second Washout|Withdrawal by Subject|0|||
131940283|NCT05270863|475070076|FG003|Second Washout|Withdrawal by Subject|0|||
131940284|NCT05270863|475070077|FG004|Second Washout|Withdrawal by Subject|0|||
131940285|NCT05270863|475070078|FG005|Second Washout|Withdrawal by Subject|0|||
131940286|NCT05270863|475070073|FG000|Second Washout|Lost to Follow-up|0|||
131940287|NCT05270863|475070074|FG001|Second Washout|Lost to Follow-up|0|||
131940288|NCT05270863|475070075|FG002|Second Washout|Lost to Follow-up|0|||
131412722|NCT00610441|473133728|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
131412723|NCT00610441|473133729|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
131412724|NCT00610441|473133730|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
131412725|NCT00610441|473133727|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
131412726|NCT00610441|473133728|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
131412727|NCT00610441|473133729|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
131940289|NCT05270863|475070076|FG003|Second Washout|Lost to Follow-up|1|||
131940290|NCT05270863|475070077|FG004|Second Washout|Lost to Follow-up|0|||
131940291|NCT05270863|475070078|FG005|Second Washout|Lost to Follow-up|0|||
131940292|NCT03802396|475070079|FG000|Overall Study|Withdrawal by Subject|2|||
131940293|NCT03802396|475070080|FG001|Overall Study|Withdrawal by Subject|0|||
131940294|NCT03802396|475070079|FG000|Overall Study|Surgery Cancelled|1|||
131940295|NCT03802396|475070080|FG001|Overall Study|Surgery Cancelled|0|||
131940296|NCT01334918|475071878|FG000|Overall Study|Did not receive study drug|6|||
131940297|NCT01334918|475071879|FG001|Overall Study|Did not receive study drug|0|||
131412728|NCT00610441|473133730|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
131940298|NCT01334918|475071878|FG000|Overall Study|Adverse Event|2|||
131940299|NCT01334918|475071879|FG001|Overall Study|Adverse Event|0|||
131940300|NCT01334918|475071878|FG000|Overall Study|Withdrawal by Subject|0|||
131940301|NCT01334918|475071879|FG001|Overall Study|Withdrawal by Subject|1|||
131940302|NCT02114177|475071880|FG000|Overall Study|Lost to Follow-up|1|||
131940303|NCT02114177|475071881|FG001|Overall Study|Lost to Follow-up|2|||
131940304|NCT02114177|475071880|FG000|Overall Study|Withdrawal by Subject|6|||
131940305|NCT02114177|475071881|FG001|Overall Study|Withdrawal by Subject|1|||
131940306|NCT02114177|475071880|FG000|Overall Study|Other|2|||
131940307|NCT02114177|475071881|FG001|Overall Study|Other|1|||
131940308|NCT01819272|475071882|FG000|Overall Study|Adverse Event|1|||
131940309|NCT01819272|475071883|FG001|Overall Study|Adverse Event|0|||
131940310|NCT01819272|475071884|FG002|Overall Study|Adverse Event|0|||
131940311|NCT01819272|475071885|FG003|Overall Study|Adverse Event|2|||
131940312|NCT01819272|475071886|FG004|Overall Study|Adverse Event|0|||
131940313|NCT01819272|475071887|FG005|Overall Study|Adverse Event|0|||
131940314|NCT01819272|475071882|FG000|Overall Study|Lost to Follow-up|3|||
131940315|NCT01819272|475071883|FG001|Overall Study|Lost to Follow-up|0|||
131940316|NCT01819272|475071884|FG002|Overall Study|Lost to Follow-up|1|||
131940317|NCT01819272|475071885|FG003|Overall Study|Lost to Follow-up|0|||
131940318|NCT01819272|475071886|FG004|Overall Study|Lost to Follow-up|0|||
131940319|NCT01819272|475071887|FG005|Overall Study|Lost to Follow-up|3|||
131940320|NCT01819272|475071882|FG000|Overall Study|Protocol Violation|0|||
131940321|NCT01819272|475071883|FG001|Overall Study|Protocol Violation|0|||
131940322|NCT01819272|475071884|FG002|Overall Study|Protocol Violation|0|||
131940323|NCT01819272|475071885|FG003|Overall Study|Protocol Violation|1|||
131940324|NCT01819272|475071886|FG004|Overall Study|Protocol Violation|2|||
131940325|NCT01819272|475071887|FG005|Overall Study|Protocol Violation|3|||
131940326|NCT01819272|475071882|FG000|Overall Study|Physician Decision|0|||
131940327|NCT01819272|475071883|FG001|Overall Study|Physician Decision|1|||
131940328|NCT01819272|475071884|FG002|Overall Study|Physician Decision|0|||
131940329|NCT01819272|475071885|FG003|Overall Study|Physician Decision|0|||
131940330|NCT01819272|475071886|FG004|Overall Study|Physician Decision|0|||
131940331|NCT01819272|475071887|FG005|Overall Study|Physician Decision|0|||
131940332|NCT01819272|475071882|FG000|Overall Study|Withdrawal of Consent|0|||
131940333|NCT01819272|475071883|FG001|Overall Study|Withdrawal of Consent|1|||
131940334|NCT01819272|475071884|FG002|Overall Study|Withdrawal of Consent|2|||
131940335|NCT01819272|475071885|FG003|Overall Study|Withdrawal of Consent|1|||
131940336|NCT01819272|475071886|FG004|Overall Study|Withdrawal of Consent|0|||
131940337|NCT01819272|475071887|FG005|Overall Study|Withdrawal of Consent|1|||
131940338|NCT01819272|475071882|FG000|Overall Study|Loss of Glucose Control|2|||
131940339|NCT01819272|475071883|FG001|Overall Study|Loss of Glucose Control|1|||
131940340|NCT01819272|475071884|FG002|Overall Study|Loss of Glucose Control|0|||
131940341|NCT01819272|475071885|FG003|Overall Study|Loss of Glucose Control|1|||
131940342|NCT01819272|475071886|FG004|Overall Study|Loss of Glucose Control|2|||
131940343|NCT01819272|475071887|FG005|Overall Study|Loss of Glucose Control|0|||
131940344|NCT02777086|475071890|FG000|Overall Study|Lost to Follow-up|96|||
131940345|NCT02777086|475071891|FG001|Overall Study|Lost to Follow-up|99|||
131940346|NCT01133665|475071892|FG000|Overall Study|Physician Decision|2|||
131940347|NCT01732536|475071893|FG000|Overall Study|Withdrawal by Subject|1|||
131940348|NCT01732536|475071894|FG001|Overall Study|Withdrawal by Subject|1|||
131940349|NCT00503984|475071895|FG000|Overall Study|Protocol Violation|0|||
131940350|NCT00503984|475071896|FG001|Overall Study|Protocol Violation|1|||
131940351|NCT00503984|475071897|FG002|Overall Study|Protocol Violation|0|||
131940352|NCT00503984|475071898|FG003|Overall Study|Protocol Violation|0|||
131940353|NCT00503984|475071899|FG004|Overall Study|Protocol Violation|0|||
131940354|NCT00503984|475071900|FG005|Overall Study|Protocol Violation|0|||
131940355|NCT00503984|475071895|FG000|Overall Study|Adverse Event|0|||
131940356|NCT00503984|475071896|FG001|Overall Study|Adverse Event|1|||
131940357|NCT00503984|475071897|FG002|Overall Study|Adverse Event|0|||
131940358|NCT00503984|475071898|FG003|Overall Study|Adverse Event|0|||
131940359|NCT00503984|475071899|FG004|Overall Study|Adverse Event|0|||
131940360|NCT00503984|475071900|FG005|Overall Study|Adverse Event|0|||
131940361|NCT00503984|475071895|FG000|Overall Study|Death|0|||
131940362|NCT00503984|475071896|FG001|Overall Study|Death|0|||
131940363|NCT00503984|475071897|FG002|Overall Study|Death|0|||
131940364|NCT00503984|475071898|FG003|Overall Study|Death|0|||
131940365|NCT00503984|475071899|FG004|Overall Study|Death|1|||
131940366|NCT00503984|475071900|FG005|Overall Study|Death|0|||
131940367|NCT01246960|475071903|FG000|Overall Study|Lost to Follow-up|3|||
131940368|NCT01246960|475071904|FG001|Overall Study|Lost to Follow-up|1|||
131940369|NCT01246960|475071903|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
131940370|NCT01246960|475071904|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
131940371|NCT02122380|475071906|FG000|First Intervention (30 Days)|Adverse Event|1|||
131940372|NCT02122380|475071907|FG001|First Intervention (30 Days)|Adverse Event|0|||
131940373|NCT02122380|475071906|FG000|First Intervention (30 Days)|Physician Decision|0|||
131940374|NCT02122380|475071907|FG001|First Intervention (30 Days)|Physician Decision|1|||
131940375|NCT02122380|475071906|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
131940376|NCT02122380|475071907|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
131940377|NCT02122380|475071906|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
131940378|NCT02122380|475071907|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
131940379|NCT02122380|475071906|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
131940380|NCT02122380|475071907|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
131940381|NCT00140140|475071908|FG000|Overall Study|Unacceptable toxicity|1|||
131940382|NCT00140140|475071909|FG001|Overall Study|Unacceptable toxicity|1|||
131940383|NCT00140140|475071910|FG002|Overall Study|Unacceptable toxicity|2|||
131940384|NCT00140140|475071908|FG000|Overall Study|Physician Decision|1|||
131940385|NCT00140140|475071909|FG001|Overall Study|Physician Decision|1|||
131940386|NCT00140140|475071910|FG002|Overall Study|Physician Decision|0|||
131940387|NCT03376516|475071911|FG000|Overall Study|Not treated|1|||
131940388|NCT03376516|475071911|FG000|Overall Study|Consent withdrawn|1|||
131940389|NCT03728933|475071912|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131940390|NCT03728933|475071913|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131940391|NCT03728933|475071914|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131940392|NCT03728933|475071912|FG000|Overall Study|Withdrawal by Subject|0|||
131940393|NCT03728933|475071913|FG001|Overall Study|Withdrawal by Subject|0|||
131940394|NCT03728933|475071914|FG002|Overall Study|Withdrawal by Subject|1|||
131940395|NCT03728933|475071912|FG000|Overall Study|Lost to Follow-up|0|||
131940396|NCT03728933|475071913|FG001|Overall Study|Lost to Follow-up|1|||
131940397|NCT03728933|475071914|FG002|Overall Study|Lost to Follow-up|0|||
131940398|NCT03728933|475071912|FG000|Overall Study|Adverse Event|1|||
131940399|NCT03728933|475071913|FG001|Overall Study|Adverse Event|0|||
131940400|NCT03728933|475071914|FG002|Overall Study|Adverse Event|0|||
131940401|NCT01784029|475071915|FG000|Overall Study|Lost to Follow-up|19|||
131940402|NCT01784029|475071916|FG001|Overall Study|Lost to Follow-up|20|||
131940403|NCT01784029|475071917|FG002|Overall Study|Lost to Follow-up|22|||
131940404|NCT00639457|475071918|FG000|Overall Study|Withdrawal by Subject|2|||
131940405|NCT00639457|475071919|FG001|Overall Study|Withdrawal by Subject|3|||
131940406|NCT00276419|475071920|FG000|First Intervention|Adverse Event|1|||
131940407|NCT00276419|475071921|FG001|First Intervention|Adverse Event|0|||
131940408|NCT00276419|475071920|FG000|First Intervention|Withdrawal by Subject|0|||
131940409|NCT00276419|475071921|FG001|First Intervention|Withdrawal by Subject|2|||
131940410|NCT02415556|475071923|FG000|Overall Study|Adverse Event|3|||
131940411|NCT02415556|475071924|FG001|Overall Study|Adverse Event|4|||
131940412|NCT02415556|475071925|FG002|Overall Study|Adverse Event|2|||
131940413|NCT02415556|475071926|FG003|Overall Study|Adverse Event|4|||
131940414|NCT02415556|475071923|FG000|Overall Study|Lost to Follow-up|4|||
131940415|NCT02415556|475071924|FG001|Overall Study|Lost to Follow-up|5|||
131940416|NCT02415556|475071925|FG002|Overall Study|Lost to Follow-up|4|||
131940417|NCT02415556|475071926|FG003|Overall Study|Lost to Follow-up|1|||
131940418|NCT02415556|475071923|FG000|Overall Study|Withdrawal by Subject|13|||
131940419|NCT02415556|475071924|FG001|Overall Study|Withdrawal by Subject|4|||
131940420|NCT02415556|475071925|FG002|Overall Study|Withdrawal by Subject|14|||
131940421|NCT02415556|475071926|FG003|Overall Study|Withdrawal by Subject|12|||
131940422|NCT02415556|475071923|FG000|Overall Study|Physician Decision|1|||
131940423|NCT02415556|475071924|FG001|Overall Study|Physician Decision|3|||
131940424|NCT02415556|475071925|FG002|Overall Study|Physician Decision|1|||
131940425|NCT02415556|475071926|FG003|Overall Study|Physician Decision|2|||
131940426|NCT02415556|475071923|FG000|Overall Study|Censored - study completion|4|||
131940427|NCT02415556|475071924|FG001|Overall Study|Censored - study completion|5|||
131940428|NCT02415556|475071925|FG002|Overall Study|Censored - study completion|1|||
131940429|NCT02415556|475071926|FG003|Overall Study|Censored - study completion|0|||
131940430|NCT02415556|475071923|FG000|Overall Study|Family-related issues|0|||
131940431|NCT02415556|475071924|FG001|Overall Study|Family-related issues|0|||
131940432|NCT02415556|475071925|FG002|Overall Study|Family-related issues|0|||
131940433|NCT02415556|475071926|FG003|Overall Study|Family-related issues|1|||
131940434|NCT01621178|475071927|FG000|Overall Study|Adverse Event|5|||
131940435|NCT01621178|475071928|FG001|Overall Study|Adverse Event|2|||
131940436|NCT01621178|475071929|FG002|Overall Study|Adverse Event|8|||
131940437|NCT01621178|475071927|FG000|Overall Study|Death|6|||
131940438|NCT01621178|475071928|FG001|Overall Study|Death|7|||
131940439|NCT01621178|475071929|FG002|Overall Study|Death|2|||
131940440|NCT01621178|475071927|FG000|Overall Study|Lost to Follow-up|1|||
131940441|NCT01621178|475071928|FG001|Overall Study|Lost to Follow-up|2|||
131940442|NCT01621178|475071929|FG002|Overall Study|Lost to Follow-up|1|||
131940443|NCT01621178|475071927|FG000|Overall Study|Withdrawal by Subject|14|||
131940444|NCT01621178|475071928|FG001|Overall Study|Withdrawal by Subject|17|||
131940445|NCT01621178|475071929|FG002|Overall Study|Withdrawal by Subject|18|||
131940446|NCT01621178|475071927|FG000|Overall Study|Physician Decision|5|||
131940447|NCT01621178|475071928|FG001|Overall Study|Physician Decision|2|||
131940448|NCT01621178|475071929|FG002|Overall Study|Physician Decision|7|||
131940449|NCT02935192|475071930|FG000|Overall Study|Withdrawal by Subject|8|||
131940450|NCT02935192|475071931|FG001|Overall Study|Withdrawal by Subject|4|||
131940451|NCT00560508|475071933|FG000|12 Week Double-blind Period|Adverse Event|3|||
131940452|NCT00560508|475071934|FG001|12 Week Double-blind Period|Adverse Event|2|||
131940453|NCT00560508|475071933|FG000|12 Week Double-blind Period|Protocol Violation|1|||
131940454|NCT00560508|475071934|FG001|12 Week Double-blind Period|Protocol Violation|0|||
131940455|NCT00560508|475071933|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
131940456|NCT00560508|475071934|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
131940457|NCT00560508|475071933|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
131940458|NCT00560508|475071934|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
131940459|NCT00560508|475071933|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
131940460|NCT00560508|475071934|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
131940461|NCT00560508|475071933|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
131940462|NCT00560508|475071934|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
131940463|NCT00560508|475071933|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
131940464|NCT00560508|475071934|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
131940465|NCT04102007|475071935|FG000|Overall Study|Adverse Event|4|||
131940466|NCT04102007|475071935|FG000|Overall Study|Lost to Follow-up|3|||
131940467|NCT04102007|475071935|FG000|Overall Study|Withdrawal by Subject|12|||
131940468|NCT04102007|475071935|FG000|Overall Study|Eligibility Violation|5|||
131940469|NCT04102007|475071935|FG000|Overall Study|Lack of Efficacy|6|||
131940470|NCT04102007|475071935|FG000|Overall Study|Protocol Deviation|5|||
131940471|NCT04102007|475071935|FG000|Overall Study|Protocol Compliance|1|||
131940472|NCT04102007|475071935|FG000|Overall Study|Withdrew Treatment|2|||
131940473|NCT04102007|475071935|FG000|Overall Study|Pregnancy|1|||
131940474|NCT00892008|475071941|FG000|Overall Study|Death|5|||
131940475|NCT00892008|475071941|FG000|Overall Study|Lack of Efficacy|3|||
131940476|NCT00892008|475071941|FG000|Overall Study|Lost to Follow-up|142|||
131940477|NCT00892008|475071941|FG000|Overall Study|Other|378|||
131940478|NCT00892008|475071941|FG000|Overall Study|Adverse Event|37|||
131940479|NCT02271880|475071942|FG000|Overall Study|Premature discontinuation of study|3|||
131940480|NCT02271880|475071943|FG001|Overall Study|Premature discontinuation of study|4|||
131940481|NCT00806585|475071944|FG000|Overall Study|Study terminated by Sponsor|0|||
131940482|NCT00806585|475071945|FG001|Overall Study|Study terminated by Sponsor|0|||
131940483|NCT00806585|475071946|FG002|Overall Study|Study terminated by Sponsor|1|||
131940484|NCT00806585|475071947|FG003|Overall Study|Study terminated by Sponsor|2|||
131940485|NCT00806585|475071948|FG004|Overall Study|Study terminated by Sponsor|0|||
131940486|NCT00806585|475071944|FG000|Overall Study|Protocol Violation|3|||
131940487|NCT00806585|475071945|FG001|Overall Study|Protocol Violation|1|||
131940488|NCT00806585|475071946|FG002|Overall Study|Protocol Violation|2|||
131940489|NCT00806585|475071947|FG003|Overall Study|Protocol Violation|0|||
131940490|NCT00806585|475071948|FG004|Overall Study|Protocol Violation|0|||
131940491|NCT00806585|475071944|FG000|Overall Study|Physician Decision|0|||
131940492|NCT00806585|475071945|FG001|Overall Study|Physician Decision|2|||
131940493|NCT00806585|475071946|FG002|Overall Study|Physician Decision|3|||
131940494|NCT00806585|475071947|FG003|Overall Study|Physician Decision|0|||
131940495|NCT00806585|475071948|FG004|Overall Study|Physician Decision|1|||
131940496|NCT00806585|475071944|FG000|Overall Study|Lost to Follow-up|2|||
131940497|NCT00806585|475071945|FG001|Overall Study|Lost to Follow-up|1|||
131940498|NCT00806585|475071946|FG002|Overall Study|Lost to Follow-up|2|||
131940499|NCT00806585|475071947|FG003|Overall Study|Lost to Follow-up|2|||
131940500|NCT00806585|475071948|FG004|Overall Study|Lost to Follow-up|5|||
131940501|NCT00806585|475071944|FG000|Overall Study|Lack of Efficacy|1|||
131940502|NCT00806585|475071945|FG001|Overall Study|Lack of Efficacy|0|||
131940503|NCT00806585|475071946|FG002|Overall Study|Lack of Efficacy|0|||
131940504|NCT00806585|475071947|FG003|Overall Study|Lack of Efficacy|0|||
131940505|NCT00806585|475071948|FG004|Overall Study|Lack of Efficacy|0|||
131940506|NCT00806585|475071944|FG000|Overall Study|Adverse Event|1|||
131940507|NCT00806585|475071945|FG001|Overall Study|Adverse Event|5|||
131940508|NCT00806585|475071946|FG002|Overall Study|Adverse Event|3|||
131940509|NCT00806585|475071947|FG003|Overall Study|Adverse Event|4|||
131940510|NCT00806585|475071948|FG004|Overall Study|Adverse Event|2|||
131940511|NCT00806585|475071944|FG000|Overall Study|Withdrawal by Subject|10|||
131940512|NCT00806585|475071945|FG001|Overall Study|Withdrawal by Subject|8|||
131940513|NCT00806585|475071946|FG002|Overall Study|Withdrawal by Subject|9|||
131940514|NCT00806585|475071947|FG003|Overall Study|Withdrawal by Subject|3|||
131940515|NCT00806585|475071948|FG004|Overall Study|Withdrawal by Subject|11|||
131940516|NCT00806585|475071944|FG000|Overall Study|Completion status unknown|15|||
131940517|NCT00806585|475071945|FG001|Overall Study|Completion status unknown|14|||
131940518|NCT00806585|475071946|FG002|Overall Study|Completion status unknown|12|||
131940519|NCT00806585|475071947|FG003|Overall Study|Completion status unknown|4|||
131940520|NCT00806585|475071948|FG004|Overall Study|Completion status unknown|12|||
131940521|NCT00474903|475071949|FG000|Overall Study|Protocol Violation|1|||
131940522|NCT00474903|475071950|FG001|Overall Study|Protocol Violation|5|||
131940523|NCT00474903|475071951|FG002|Overall Study|Protocol Violation|2|||
131940524|NCT00399529|475071952|FG000|Overall Study|Off Study Prior to Treatment|2|||
131940525|NCT01936831|475071958|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940526|NCT01936831|475071959|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940527|NCT01936831|475071960|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940528|NCT01936831|475071961|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940529|NCT01936831|475071962|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940530|NCT01936831|475071963|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
131940531|NCT01936831|475071964|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940532|NCT01936831|475071965|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940533|NCT01936831|475071966|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
131940534|NCT03435380|475071967|FG000|Overall Study|Death|1|||
131940535|NCT03435380|475071968|FG001|Overall Study|Death|2|||
131940536|NCT03435380|475071969|FG002|Overall Study|Death|1|||
131940537|NCT03435380|475071967|FG000|Overall Study|Lost to Follow-up|12|||
131940538|NCT03435380|475071968|FG001|Overall Study|Lost to Follow-up|8|||
131940539|NCT03435380|475071969|FG002|Overall Study|Lost to Follow-up|6|||
131940540|NCT03435380|475071967|FG000|Overall Study|Physician Decision|1|||
131940541|NCT03435380|475071968|FG001|Overall Study|Physician Decision|0|||
131940542|NCT03435380|475071969|FG002|Overall Study|Physician Decision|0|||
131940543|NCT03435380|475071967|FG000|Overall Study|Withdrawal by Subject|0|||
131940544|NCT03435380|475071968|FG001|Overall Study|Withdrawal by Subject|1|||
131940545|NCT03435380|475071969|FG002|Overall Study|Withdrawal by Subject|1|||
131940546|NCT03435380|475071967|FG000|Overall Study|Ineligible|0|||
131940547|NCT03435380|475071968|FG001|Overall Study|Ineligible|1|||
131940548|NCT03435380|475071969|FG002|Overall Study|Ineligible|1|||
131940549|NCT02133573|475071970|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
131940550|NCT02133573|475071971|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
131940551|NCT02133573|475071970|FG000|Overall Study|Child Deaths|3|||
131940552|NCT02133573|475071971|FG001|Overall Study|Child Deaths|5|||
131940553|NCT02133573|475071970|FG000|Overall Study|Child Declined Follow Ups|2|||
131940554|NCT02133573|475071971|FG001|Overall Study|Child Declined Follow Ups|1|||
131940555|NCT02133573|475071970|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
131940556|NCT02133573|475071971|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
131940557|NCT02431325|475071972|FG000|Overall Study|Adverse Event|3|||
131940558|NCT02431325|475071973|FG001|Overall Study|Adverse Event|0|||
131940559|NCT02431325|475071972|FG000|Overall Study|Lost to Follow-up|0|||
131940560|NCT02431325|475071973|FG001|Overall Study|Lost to Follow-up|1|||
131940561|NCT02431325|475071972|FG000|Overall Study|Withdrawal by Subject|1|||
131940562|NCT02431325|475071973|FG001|Overall Study|Withdrawal by Subject|2|||
131940563|NCT02431325|475071972|FG000|Overall Study|Declined to take study medication|1|||
131940564|NCT02431325|475071973|FG001|Overall Study|Declined to take study medication|0|||
131940565|NCT02431325|475071972|FG000|Overall Study|Withdrew before starting study medication|1|||
131940566|NCT02431325|475071973|FG001|Overall Study|Withdrew before starting study medication|0|||
131940567|NCT02431325|475071972|FG000|Overall Study|Placebo shortage|2|||
131940568|NCT02431325|475071973|FG001|Overall Study|Placebo shortage|0|||
131940569|NCT02519842|475071974|FG000|Base Study: Cycle 1|Screening Failure|1|||
131940570|NCT02519842|475071975|FG001|Base Study: Cycle 1|Screening Failure|1|||
131940571|NCT02519842|475071976|FG002|Base Study: Cycle 1|Screening Failure|0|||
131940572|NCT02519842|475071974|FG000|Base Study: Cycle 1|Adverse Event|1|||
131940573|NCT02519842|475071975|FG001|Base Study: Cycle 1|Adverse Event|0|||
131940574|NCT02519842|475071976|FG002|Base Study: Cycle 1|Adverse Event|0|||
131940575|NCT02519842|475071974|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
131940576|NCT02519842|475071975|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
131940577|NCT02519842|475071976|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
131940578|NCT02519842|475071974|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
131940579|NCT02519842|475071975|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
131940580|NCT02519842|475071976|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
131940581|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
131940582|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
131940583|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
131940584|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
131940585|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
131940586|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
131940587|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131940588|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
131940589|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
131940590|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
131940591|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
131940592|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
131940593|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Death|0|||
131940594|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Death|0|||
131940595|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Death|1|||
131940596|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
131940597|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
131940598|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
131940599|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
131940600|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
131940601|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
131940602|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
131940603|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
131940604|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
131940605|NCT02519842|475071974|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
131940606|NCT02519842|475071975|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
131940607|NCT02519842|475071976|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
131940608|NCT02115321|475071979|FG000|Overall Study|Death|1|||
131940609|NCT02115321|475071980|FG001|Overall Study|Death|0|||
131940610|NCT01307449|475071981|FG000|Overall Study|Adverse Event|1|||
131940611|NCT01307449|475071982|FG001|Overall Study|Adverse Event|0|||
131940612|NCT01307449|475071983|FG002|Overall Study|Adverse Event|0|||
131940613|NCT01307449|475071984|FG003|Overall Study|Adverse Event|0|||
131940614|NCT03218917|475071985|FG000|Overall Study|Adverse Event|3|||
131940615|NCT03218917|475071986|FG001|Overall Study|Adverse Event|3|||
131940616|NCT03218917|475071987|FG002|Overall Study|Adverse Event|2|||
131940617|NCT03218917|475071985|FG000|Overall Study|Subject withdrew consent|2|||
131940618|NCT03218917|475071986|FG001|Overall Study|Subject withdrew consent|4|||
131940619|NCT03218917|475071987|FG002|Overall Study|Subject withdrew consent|10|||
131940620|NCT03218917|475071985|FG000|Overall Study|Physician Decision|0|||
131940621|NCT03218917|475071986|FG001|Overall Study|Physician Decision|1|||
131940622|NCT03218917|475071987|FG002|Overall Study|Physician Decision|1|||
131940623|NCT03218917|475071985|FG000|Overall Study|Lost to Follow-up|1|||
131940624|NCT03218917|475071986|FG001|Overall Study|Lost to Follow-up|0|||
131940625|NCT03218917|475071987|FG002|Overall Study|Lost to Follow-up|0|||
131940626|NCT03218917|475071985|FG000|Overall Study|Reason Missing|0|||
131940627|NCT03218917|475071986|FG001|Overall Study|Reason Missing|2|||
131940628|NCT03218917|475071987|FG002|Overall Study|Reason Missing|0|||
131940629|NCT03218917|475071985|FG000|Overall Study|Death|0|||
131940630|NCT03218917|475071986|FG001|Overall Study|Death|1|||
131940631|NCT03218917|475071987|FG002|Overall Study|Death|0|||
131940632|NCT03218917|475071985|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131940633|NCT03218917|475071986|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131940634|NCT03218917|475071987|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131940635|NCT01788943|475071990|FG000|Overall Study|Withdrawal by Subject|1|||
131940636|NCT01788943|475071991|FG001|Overall Study|Withdrawal by Subject|0|||
131940637|NCT01119287|475071992|FG000|Overall Study|Patient Decision, not related to AE|0|||
131940638|NCT01119287|475071993|FG001|Overall Study|Patient Decision, not related to AE|0|||
131940639|NCT01119287|475071994|FG002|Overall Study|Patient Decision, not related to AE|2|||
131940640|NCT01119287|475071995|FG003|Overall Study|Patient Decision, not related to AE|2|||
131940641|NCT01119287|475071996|FG004|Overall Study|Patient Decision, not related to AE|1|||
131940642|NCT01119287|475071997|FG005|Overall Study|Patient Decision, not related to AE|0|||
131940643|NCT04064905|475072005|FG000|Overall Study|Lost to Follow-up|0|||
131940644|NCT04064905|475072006|FG001|Overall Study|Lost to Follow-up|3|||
131940645|NCT04064905|475072007|FG002|Overall Study|Lost to Follow-up|1|||
131940646|NCT04064905|475072008|FG003|Overall Study|Lost to Follow-up|4|||
131940647|NCT04064905|475072009|FG004|Overall Study|Lost to Follow-up|2|||
131940648|NCT02257684|475072010|FG000|Overall Study|Adverse Event|2|||
131940649|NCT02257684|475072010|FG000|Overall Study|Lack of Efficacy|1|||
131940650|NCT02257684|475072010|FG000|Overall Study|Sponsor's Decision|1|||
131940651|NCT03434834|475072013|FG000|Overall Study|unable to swallow OCT probe|16|||
131940652|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
131940653|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
131940654|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
131940655|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Death|0|||
131940656|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Death|0|||
131940657|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Death|1|||
131940658|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
131940659|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
131940660|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
131940661|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
131940662|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
131940663|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
131940664|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
131940665|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
131940666|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
131940667|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Graft loss|0|||
131940668|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Graft loss|0|||
131940669|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Graft loss|7|||
131940670|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
131940671|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
131940672|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
131940673|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
131940674|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
131940675|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
131940676|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
131412729|NCT00610441|473133727|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
131412730|NCT00610441|473133728|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
131412731|NCT00610441|473133729|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
131412732|NCT00610441|473133730|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
131412733|NCT01995552|473133735|FG000|Overall Study|Protocol Violation|1|||
131412734|NCT01995552|473133735|FG000|Overall Study|Lack of Efficacy|15|||
131412735|NCT01995552|473133735|FG000|Overall Study|Death|1|||
131412736|NCT00554099|473133739|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
131412737|NCT00554099|473133740|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
131412738|NCT00554099|473133741|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
131412739|NCT00554099|473133739|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
131412740|NCT00554099|473133740|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
131412741|NCT00554099|473133741|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
131412742|NCT00554099|473133739|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131412743|NCT00554099|473133740|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131412744|NCT00554099|473133741|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
131412745|NCT00554099|473133739|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
131412746|NCT00554099|473133740|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
131412747|NCT00554099|473133741|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
131412748|NCT00554099|473133739|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
131412749|NCT00554099|473133740|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
131412750|NCT00554099|473133741|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
131412751|NCT00554099|473133739|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
131412752|NCT00554099|473133740|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
131412753|NCT00554099|473133741|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
131412754|NCT00554099|473133739|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
131412755|NCT00554099|473133740|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
131412756|NCT00554099|473133741|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
131412757|NCT00554099|473133739|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
131412758|NCT00554099|473133740|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
131412759|NCT00554099|473133741|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
131412760|NCT00554099|473133739|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
131412761|NCT00554099|473133740|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
131412762|NCT00554099|473133741|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
131412763|NCT03002623|473133742|FG000|Overall Study|Lost to Follow-up|1|||
131412764|NCT03002623|473133743|FG001|Overall Study|Lost to Follow-up|0|||
131412765|NCT03002623|473133742|FG000|Overall Study|Physician Decision|1|||
131412766|NCT03002623|473133743|FG001|Overall Study|Physician Decision|1|||
131412767|NCT01439074|473133744|FG000|Overall Study|Lost to Follow-up|3|||
131412768|NCT01439074|473133745|FG001|Overall Study|Lost to Follow-up|4|||
131412769|NCT01439074|473133744|FG000|Overall Study|Subject shedding|1|||
131412770|NCT01439074|473133745|FG001|Overall Study|Subject shedding|0|||
131412771|NCT01439074|473133744|FG000|Overall Study|Withdrawal by Subject|1|||
131412772|NCT01439074|473133745|FG001|Overall Study|Withdrawal by Subject|5|||
131412773|NCT01439074|473133744|FG000|Overall Study|Other|4|||
131412774|NCT01439074|473133745|FG001|Overall Study|Other|4|||
131412775|NCT00612508|473133749|FG000|Overall Study|Withdrawal by Subject|3|||
131412776|NCT00612508|473133750|FG001|Overall Study|Withdrawal by Subject|4|||
131412777|NCT03697993|473133760|FG000|Overall Study|Became Ineligible after Enrollment|1|||
131412778|NCT03697993|473133761|FG001|Overall Study|Became Ineligible after Enrollment|3|||
131412779|NCT03697993|473133760|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
131412780|NCT03697993|473133761|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
131412781|NCT03697993|473133760|FG000|Overall Study|Lost to Follow-up|3|||
131412782|NCT03697993|473133761|FG001|Overall Study|Lost to Follow-up|0|||
131412783|NCT03697993|473133760|FG000|Overall Study|Physician Decision|4|||
131412784|NCT03697993|473133761|FG001|Overall Study|Physician Decision|0|||
131412785|NCT03697993|473133760|FG000|Overall Study|Initial Urine Culture Negative|0|||
131412786|NCT03697993|473133761|FG001|Overall Study|Initial Urine Culture Negative|1|||
131412787|NCT01565564|473133762|FG000|Overall Study|Lost to Follow-up|5|||
131412788|NCT01565564|473133763|FG001|Overall Study|Lost to Follow-up|1|||
131412789|NCT02698371|473133768|FG000|All Participants Flow|Lost to Follow-up|3|||
131412790|NCT02698371|473133768|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
131412791|NCT02698371|473133768|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
131412792|NCT02698371|473133768|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
131412793|NCT02698371|473133768|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
131412794|NCT02698371|473133768|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
131412795|NCT02698371|473133768|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
131412796|NCT02525094|473133769|FG000|Overall Study|Lost to Follow-up|2|||
131412797|NCT02525094|473133770|FG001|Overall Study|Lost to Follow-up|1|||
131412798|NCT02525094|473133769|FG000|Overall Study|Withdrawal by Subject|5|||
131412799|NCT02525094|473133770|FG001|Overall Study|Withdrawal by Subject|6|||
131412800|NCT02525094|473133769|FG000|Overall Study|Not Treated|1|||
131412801|NCT02525094|473133770|FG001|Overall Study|Not Treated|1|||
131940677|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
131940678|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
131940679|NCT00956293|475072015|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
131940680|NCT00956293|475072016|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
131940681|NCT00956293|475072017|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
131940682|NCT00956293|475072015|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
131940683|NCT00956293|475072016|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
131940684|NCT00956293|475072017|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
131940685|NCT00956293|475072015|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
131940686|NCT00956293|475072016|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
131940687|NCT00956293|475072017|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
131940688|NCT00956293|475072015|FG000|Main Period (Randomization)|Adverse Event|0|||
131940689|NCT00956293|475072016|FG001|Main Period (Randomization)|Adverse Event|15|||
131940690|NCT00956293|475072017|FG002|Main Period (Randomization)|Adverse Event|0|||
131940691|NCT00956293|475072015|FG000|Follow-up Period|Follow-up period was terminated.|20|||
131940692|NCT00956293|475072016|FG001|Follow-up Period|Follow-up period was terminated.|32|||
131940693|NCT00956293|475072017|FG002|Follow-up Period|Follow-up period was terminated.|0|||
131940694|NCT00659425|475072018|FG000|Overall Study|Disease progression|1|||
131940695|NCT00659425|475072019|FG001|Overall Study|Disease progression|0|||
131940696|NCT00659425|475072020|FG002|Overall Study|Disease progression|0|||
131940697|NCT00659425|475072021|FG003|Overall Study|Disease progression|1|||
131940698|NCT00659425|475072022|FG004|Overall Study|Disease progression|0|||
131940699|NCT00659425|475072023|FG005|Overall Study|Disease progression|2|||
131940700|NCT00659425|475072024|FG006|Overall Study|Disease progression|4|||
131940701|NCT00659425|475072025|FG007|Overall Study|Disease progression|3|||
131940702|NCT00659425|475072026|FG008|Overall Study|Disease progression|5|||
131940703|NCT00659425|475072027|FG009|Overall Study|Disease progression|3|||
131940704|NCT00659425|475072018|FG000|Overall Study|Death|0|||
131940705|NCT00659425|475072019|FG001|Overall Study|Death|0|||
131940706|NCT00659425|475072020|FG002|Overall Study|Death|0|||
131940707|NCT00659425|475072021|FG003|Overall Study|Death|1|||
131940708|NCT00659425|475072022|FG004|Overall Study|Death|0|||
131940709|NCT00659425|475072023|FG005|Overall Study|Death|0|||
131940710|NCT00659425|475072024|FG006|Overall Study|Death|1|||
131940711|NCT00659425|475072025|FG007|Overall Study|Death|0|||
131940712|NCT00659425|475072026|FG008|Overall Study|Death|0|||
131940713|NCT00659425|475072027|FG009|Overall Study|Death|0|||
131940714|NCT00659425|475072018|FG000|Overall Study|Adverse Event|0|||
131940715|NCT00659425|475072019|FG001|Overall Study|Adverse Event|0|||
131940716|NCT00659425|475072020|FG002|Overall Study|Adverse Event|0|||
131940717|NCT00659425|475072021|FG003|Overall Study|Adverse Event|0|||
131940718|NCT00659425|475072022|FG004|Overall Study|Adverse Event|0|||
131940719|NCT00659425|475072023|FG005|Overall Study|Adverse Event|1|||
131940720|NCT00659425|475072024|FG006|Overall Study|Adverse Event|0|||
131940721|NCT00659425|475072025|FG007|Overall Study|Adverse Event|3|||
131940722|NCT00659425|475072026|FG008|Overall Study|Adverse Event|1|||
131940723|NCT00659425|475072027|FG009|Overall Study|Adverse Event|4|||
131940724|NCT00659425|475072018|FG000|Overall Study|Investigator Discretion|0|||
131940725|NCT00659425|475072019|FG001|Overall Study|Investigator Discretion|0|||
131940726|NCT00659425|475072020|FG002|Overall Study|Investigator Discretion|0|||
131940727|NCT00659425|475072021|FG003|Overall Study|Investigator Discretion|0|||
131940728|NCT00659425|475072022|FG004|Overall Study|Investigator Discretion|0|||
131940729|NCT00659425|475072023|FG005|Overall Study|Investigator Discretion|1|||
131940730|NCT00659425|475072024|FG006|Overall Study|Investigator Discretion|0|||
131940731|NCT00659425|475072025|FG007|Overall Study|Investigator Discretion|3|||
131940732|NCT00659425|475072026|FG008|Overall Study|Investigator Discretion|0|||
131940733|NCT00659425|475072027|FG009|Overall Study|Investigator Discretion|0|||
131940734|NCT00659425|475072018|FG000|Overall Study|Other|0|||
131940735|NCT00659425|475072019|FG001|Overall Study|Other|1|||
131940736|NCT00659425|475072020|FG002|Overall Study|Other|1|||
131940737|NCT00659425|475072021|FG003|Overall Study|Other|2|||
131940738|NCT00659425|475072022|FG004|Overall Study|Other|4|||
131940739|NCT00659425|475072023|FG005|Overall Study|Other|0|||
131940740|NCT00659425|475072024|FG006|Overall Study|Other|3|||
131940741|NCT00659425|475072025|FG007|Overall Study|Other|2|||
131940742|NCT00659425|475072026|FG008|Overall Study|Other|0|||
131940743|NCT00659425|475072027|FG009|Overall Study|Other|6|||
131940744|NCT03342560|475072028|FG000|Overall Study|Lost to Follow-up|2|||
131412802|NCT01751776|473133776|FG000|Overall Study|Adverse Event|0|||
131940745|NCT03770286|475072029|FG000|Overall Study|Lost to Follow-up|6|||
131940746|NCT03770286|475072030|FG001|Overall Study|Lost to Follow-up|4|||
131940747|NCT03770286|475072031|FG002|Overall Study|Lost to Follow-up|3|||
131940748|NCT03770286|475072029|FG000|Overall Study|Protocol Violation|1|||
131940749|NCT03770286|475072030|FG001|Overall Study|Protocol Violation|0|||
131940750|NCT03770286|475072031|FG002|Overall Study|Protocol Violation|2|||
131940751|NCT02505425|475072032|FG000|Overall Study|Lost to Follow-up|41|||
131940752|NCT02505425|475072033|FG001|Overall Study|Lost to Follow-up|61|||
131940753|NCT02505425|475072034|FG002|Overall Study|Lost to Follow-up|31|||
131940754|NCT02505425|475072035|FG003|Overall Study|Lost to Follow-up|19|||
131940755|NCT02505425|475072032|FG000|Overall Study|Withdrawal by Subject|39|||
131940756|NCT02505425|475072033|FG001|Overall Study|Withdrawal by Subject|9|||
131940757|NCT02505425|475072034|FG002|Overall Study|Withdrawal by Subject|19|||
131940758|NCT02505425|475072035|FG003|Overall Study|Withdrawal by Subject|7|||
131940759|NCT02505425|475072032|FG000|Overall Study|Death|8|||
131940760|NCT02505425|475072033|FG001|Overall Study|Death|12|||
131940761|NCT02505425|475072034|FG002|Overall Study|Death|0|||
131940762|NCT02505425|475072035|FG003|Overall Study|Death|0|||
131940763|NCT02031302|475072036|FG000|Overall Study|Death|115|||
131940764|NCT02031302|475072037|FG001|Overall Study|Death|0|||
131940765|NCT02031302|475072036|FG000|Overall Study|Not treated with study valve system|18|||
131940766|NCT02031302|475072037|FG001|Overall Study|Not treated with study valve system|0|||
131940767|NCT02031302|475072036|FG000|Overall Study|Missed Follow Up|27|||
131940768|NCT02031302|475072037|FG001|Overall Study|Missed Follow Up|0|||
131940769|NCT02031302|475072036|FG000|Overall Study|Lost to Follow-up|4|||
131940770|NCT02031302|475072037|FG001|Overall Study|Lost to Follow-up|0|||
131940771|NCT02781558|475072039|FG000|Overall Study|Lost to Follow-up|2|||
131940772|NCT02781558|475072040|FG001|Overall Study|Lost to Follow-up|2|||
131940773|NCT02781558|475072039|FG000|Overall Study|Adverse Event|1|||
131940774|NCT02781558|475072040|FG001|Overall Study|Adverse Event|0|||
131940775|NCT01150357|475072041|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
131940776|NCT01150357|475072042|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
131940777|NCT01150357|475072043|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
131940778|NCT01150357|475072041|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
131940779|NCT01150357|475072042|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
131940780|NCT01150357|475072043|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
131940781|NCT01150357|475072041|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
131940782|NCT01150357|475072042|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
131940783|NCT01150357|475072043|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
131940784|NCT01150357|475072041|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
131940785|NCT01150357|475072042|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
131940786|NCT01150357|475072043|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
131940787|NCT01150357|475072041|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
131940788|NCT01150357|475072042|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
131940789|NCT01150357|475072043|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
131940790|NCT01150357|475072041|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
131940791|NCT01150357|475072042|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
131940792|NCT01150357|475072043|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
131940793|NCT01150357|475072041|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
131940794|NCT01150357|475072042|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
131940795|NCT01150357|475072043|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
131940796|NCT01581684|475073441|FG000|Overall Study|Other reason not defined|0|||
131940797|NCT01581684|475073442|FG001|Overall Study|Other reason not defined|0|||
131940798|NCT01581684|475073443|FG002|Overall Study|Other reason not defined|0|||
131940799|NCT01581684|475073444|FG003|Overall Study|Other reason not defined|0|||
131940800|NCT01581684|475073445|FG004|Overall Study|Other reason not defined|0|||
131940801|NCT01581684|475073446|FG005|Overall Study|Other reason not defined|0|||
131940802|NCT01581684|475073447|FG006|Overall Study|Other reason not defined|0|||
131940803|NCT01581684|475073448|FG007|Overall Study|Other reason not defined|0|||
131940804|NCT01581684|475073449|FG008|Overall Study|Other reason not defined|1|||
131940805|NCT01581684|475073450|FG009|Overall Study|Other reason not defined|0|||
131940806|NCT03235050|475073451|FG000|Overall Study|Adverse Event|0|||
131940807|NCT03235050|475073452|FG001|Overall Study|Adverse Event|0|||
131940808|NCT03235050|475073453|FG002|Overall Study|Adverse Event|1|||
131940809|NCT03235050|475073454|FG003|Overall Study|Adverse Event|4|||
131940810|NCT03235050|475073455|FG004|Overall Study|Adverse Event|1|||
131940811|NCT03235050|475073451|FG000|Overall Study|Death|0|||
131940812|NCT03235050|475073452|FG001|Overall Study|Death|0|||
131940813|NCT03235050|475073453|FG002|Overall Study|Death|0|||
131940814|NCT03235050|475073454|FG003|Overall Study|Death|2|||
131940815|NCT03235050|475073455|FG004|Overall Study|Death|1|||
131940816|NCT03235050|475073451|FG000|Overall Study|Lost to Follow-up|1|||
131940817|NCT03235050|475073452|FG001|Overall Study|Lost to Follow-up|2|||
131940818|NCT03235050|475073453|FG002|Overall Study|Lost to Follow-up|1|||
131940819|NCT03235050|475073454|FG003|Overall Study|Lost to Follow-up|2|||
131940820|NCT03235050|475073455|FG004|Overall Study|Lost to Follow-up|0|||
131940821|NCT03235050|475073451|FG000|Overall Study|Withdrawal by Subject|3|||
131940822|NCT03235050|475073452|FG001|Overall Study|Withdrawal by Subject|2|||
131940823|NCT03235050|475073453|FG002|Overall Study|Withdrawal by Subject|2|||
131940824|NCT03235050|475073454|FG003|Overall Study|Withdrawal by Subject|5|||
131940825|NCT03235050|475073455|FG004|Overall Study|Withdrawal by Subject|7|||
131940826|NCT03235050|475073451|FG000|Overall Study|Other reasons|0|||
131940827|NCT03235050|475073452|FG001|Overall Study|Other reasons|1|||
131940828|NCT03235050|475073453|FG002|Overall Study|Other reasons|0|||
131940829|NCT03235050|475073454|FG003|Overall Study|Other reasons|1|||
131454744|NCT04976192|473294235|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454745|NCT04976192|473294236|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454746|NCT04976192|473294237|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131454747|NCT04976192|473294238|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
131454748|NCT04976192|473294239|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
131454749|NCT04976192|473294240|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
131454750|NCT04976192|473294241|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
131454751|NCT04976192|473294242|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
131454752|NCT04976192|473294243|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
131454753|NCT04976192|473294234|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454754|NCT04976192|473294235|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454755|NCT04976192|473294236|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454756|NCT04976192|473294237|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454757|NCT04976192|473294238|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
131454758|NCT04976192|473294239|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454759|NCT04976192|473294240|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454760|NCT04976192|473294241|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454761|NCT04976192|473294242|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454762|NCT04976192|473294243|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
131454763|NCT04976192|473294234|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454764|NCT04976192|473294235|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454765|NCT04976192|473294236|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454766|NCT04976192|473294237|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454767|NCT04976192|473294238|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454768|NCT04976192|473294239|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131454769|NCT04976192|473294240|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454770|NCT04976192|473294241|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454771|NCT04976192|473294242|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454772|NCT04976192|473294243|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131454773|NCT02621151|473294244|FG000|Overall Study|Not eligible for trial|6|||
131454774|NCT04073225|473294245|FG000|Overall Study|Lost to Follow-up|4|||
131454775|NCT04073225|473294246|FG001|Overall Study|Lost to Follow-up|3|||
131454776|NCT02253316|473294256|FG000|Consolidation|Progression|4|||
131454777|NCT02253316|473294257|FG001|Consolidation|Progression|0|||
131454778|NCT02253316|473294258|FG002|Consolidation|Progression|0|||
131454779|NCT02253316|473294256|FG000|Consolidation|Non-Compliance|1|||
131454780|NCT02253316|473294257|FG001|Consolidation|Non-Compliance|0|||
131454781|NCT02253316|473294258|FG002|Consolidation|Non-Compliance|0|||
131454782|NCT02253316|473294256|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
131454783|NCT02253316|473294257|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
131454784|NCT02253316|473294258|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
131454785|NCT02253316|473294256|FG000|Consolidation|Secondary Malignancy|2|||
131454786|NCT02253316|473294257|FG001|Consolidation|Secondary Malignancy|0|||
131454787|NCT02253316|473294258|FG002|Consolidation|Secondary Malignancy|0|||
131454788|NCT02253316|473294256|FG000|Consolidation|Adverse Event|7|||
131454789|NCT02253316|473294257|FG001|Consolidation|Adverse Event|0|||
131454790|NCT02253316|473294258|FG002|Consolidation|Adverse Event|0|||
131454791|NCT02253316|473294256|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
131454792|NCT02253316|473294257|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
131454793|NCT02253316|473294258|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
131454794|NCT02253316|473294256|FG000|Maintenance|Physician Decision|0|||
131454795|NCT02253316|473294257|FG001|Maintenance|Physician Decision|7|||
131454796|NCT02253316|473294258|FG002|Maintenance|Physician Decision|16|||
131454797|NCT02253316|473294256|FG000|Maintenance|Non-Compliance|0|||
131454798|NCT02253316|473294257|FG001|Maintenance|Non-Compliance|1|||
131940830|NCT03235050|475073455|FG004|Overall Study|Other reasons|2|||
131940831|NCT00492557|475073458|FG000|Overall Study|Subject request|12|||
131940832|NCT00492557|475073459|FG001|Overall Study|Subject request|11|||
131940833|NCT00492557|475073458|FG000|Overall Study|Protocol Violation|7|||
131940834|NCT00492557|475073459|FG001|Overall Study|Protocol Violation|8|||
131454799|NCT02253316|473294258|FG002|Maintenance|Non-Compliance|1|||
131454800|NCT02253316|473294256|FG000|Maintenance|Secondary Malignancy|0|||
131454801|NCT02253316|473294257|FG001|Maintenance|Secondary Malignancy|2|||
131454802|NCT02253316|473294258|FG002|Maintenance|Secondary Malignancy|6|||
131454803|NCT02253316|473294256|FG000|Maintenance|Adverse Event|0|||
131454804|NCT02253316|473294257|FG001|Maintenance|Adverse Event|8|||
131454805|NCT02253316|473294258|FG002|Maintenance|Adverse Event|12|||
131454806|NCT02253316|473294256|FG000|Maintenance|Still receiving active treatment|0|||
131454807|NCT02253316|473294257|FG001|Maintenance|Still receiving active treatment|4|||
131454808|NCT02253316|473294258|FG002|Maintenance|Still receiving active treatment|0|||
131454809|NCT00124306|473294262|FG000|Overall Study|Adverse Event|7|||
131940835|NCT00492557|475073458|FG000|Overall Study|Other|2|||
131940836|NCT00492557|475073459|FG001|Overall Study|Other|2|||
131940837|NCT00492557|475073458|FG000|Overall Study|Death|1|||
131940838|NCT00492557|475073459|FG001|Overall Study|Death|1|||
131940839|NCT00492557|475073458|FG000|Overall Study|Adverse Event|1|||
131940840|NCT00492557|475073459|FG001|Overall Study|Adverse Event|0|||
131940841|NCT00492557|475073458|FG000|Overall Study|Failed to return|1|||
131940842|NCT00492557|475073459|FG001|Overall Study|Failed to return|0|||
131940843|NCT00492557|475073458|FG000|Overall Study|Lost to Follow-up|0|||
131940844|NCT00492557|475073459|FG001|Overall Study|Lost to Follow-up|1|||
131940845|NCT03423602|475073464|FG000|Overall Study|Death|1|||
131940846|NCT03423602|475073464|FG000|Overall Study|Lost to Follow-up|6|||
131940847|NCT03423602|475073464|FG000|Overall Study|Protocol Violation|1|||
131940848|NCT03423602|475073464|FG000|Overall Study|Withdrawal by Subject|4|||
131940849|NCT04778592|475073465|FG000|Overall Study|Adverse Event|1|||
131940850|NCT04778592|475073466|FG001|Overall Study|Adverse Event|2|||
131940851|NCT04778592|475073465|FG000|Overall Study|Withdrawal by Subject|1|||
131940852|NCT04778592|475073466|FG001|Overall Study|Withdrawal by Subject|2|||
131940853|NCT03423121|475073467|FG000|Overall Study|Lost to Follow-up|2|||
131940854|NCT03423121|475073468|FG001|Overall Study|Lost to Follow-up|6|||
131940855|NCT03423121|475073467|FG000|Overall Study|Adverse Event|1|||
131940856|NCT03423121|475073468|FG001|Overall Study|Adverse Event|0|||
131940857|NCT01192126|475073469|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
131940858|NCT01192126|475073470|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
131940859|NCT01192126|475073469|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
131940860|NCT01192126|475073470|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
131940861|NCT02660229|475073474|FG000|Overall Study|Adverse Event|2|||
131940862|NCT02660229|475073475|FG001|Overall Study|Adverse Event|0|||
131940863|NCT02660229|475073474|FG000|Overall Study|Withdrawal by Subject|0|||
131940864|NCT02660229|475073475|FG001|Overall Study|Withdrawal by Subject|1|||
131940865|NCT00329030|475073476|FG000|Overall Study|Withdrawal by Subject|1|||
131940866|NCT00329030|475073477|FG001|Overall Study|Withdrawal by Subject|3|||
131940867|NCT00329030|475073476|FG000|Overall Study|Progressive Disease|6|||
131940868|NCT00329030|475073477|FG001|Overall Study|Progressive Disease|2|||
131940869|NCT00329030|475073476|FG000|Overall Study|Ineligible Pathology|1|||
131940870|NCT00329030|475073477|FG001|Overall Study|Ineligible Pathology|1|||
131940871|NCT03012334|475073478|FG000|Period 1|Withdrawal by Subject|0|||
131940872|NCT03012334|475073479|FG001|Period 1|Withdrawal by Subject|0|||
131940873|NCT03012334|475073480|FG002|Period 1|Withdrawal by Subject|0|||
131940874|NCT03012334|475073481|FG003|Period 1|Withdrawal by Subject|0|||
131940875|NCT03012334|475073482|FG004|Period 1|Withdrawal by Subject|0|||
131940876|NCT03012334|475073483|FG005|Period 1|Withdrawal by Subject|0|||
131940877|NCT03012334|475073484|FG006|Period 1|Withdrawal by Subject|0|||
131940878|NCT03012334|475073485|FG007|Period 1|Withdrawal by Subject|0|||
131940879|NCT03012334|475073486|FG008|Period 1|Withdrawal by Subject|0|||
131940880|NCT03012334|475073487|FG009|Period 1|Withdrawal by Subject|1|||
131940881|NCT03012334|475073478|FG000|Period 2|Withdrawal by Subject|0|||
131940882|NCT03012334|475073479|FG001|Period 2|Withdrawal by Subject|1|||
131940883|NCT03012334|475073480|FG002|Period 2|Withdrawal by Subject|0|||
131940884|NCT03012334|475073481|FG003|Period 2|Withdrawal by Subject|0|||
131940885|NCT03012334|475073482|FG004|Period 2|Withdrawal by Subject|0|||
131940886|NCT03012334|475073483|FG005|Period 2|Withdrawal by Subject|0|||
131940887|NCT03012334|475073484|FG006|Period 2|Withdrawal by Subject|0|||
131940888|NCT03012334|475073485|FG007|Period 2|Withdrawal by Subject|0|||
131940889|NCT03012334|475073486|FG008|Period 2|Withdrawal by Subject|0|||
131940890|NCT03012334|475073487|FG009|Period 2|Withdrawal by Subject|0|||
131940891|NCT03012334|475073478|FG000|Period 2|Protocol Violation|0|||
131940892|NCT03012334|475073479|FG001|Period 2|Protocol Violation|0|||
131940893|NCT03012334|475073480|FG002|Period 2|Protocol Violation|1|||
131940894|NCT03012334|475073481|FG003|Period 2|Protocol Violation|0|||
131940895|NCT03012334|475073482|FG004|Period 2|Protocol Violation|0|||
131940896|NCT03012334|475073483|FG005|Period 2|Protocol Violation|0|||
131940897|NCT03012334|475073484|FG006|Period 2|Protocol Violation|0|||
131940898|NCT03012334|475073485|FG007|Period 2|Protocol Violation|1|||
131940899|NCT03012334|475073486|FG008|Period 2|Protocol Violation|0|||
131940900|NCT03012334|475073487|FG009|Period 2|Protocol Violation|0|||
131940901|NCT03012334|475073478|FG000|Period 4|Non-Compliance|0|||
131940902|NCT03012334|475073479|FG001|Period 4|Non-Compliance|0|||
131940903|NCT03012334|475073480|FG002|Period 4|Non-Compliance|0|||
131940904|NCT03012334|475073481|FG003|Period 4|Non-Compliance|0|||
131940905|NCT03012334|475073482|FG004|Period 4|Non-Compliance|0|||
131940906|NCT03012334|475073483|FG005|Period 4|Non-Compliance|0|||
131940907|NCT03012334|475073484|FG006|Period 4|Non-Compliance|1|||
131940908|NCT03012334|475073485|FG007|Period 4|Non-Compliance|0|||
131940909|NCT03012334|475073486|FG008|Period 4|Non-Compliance|0|||
131940910|NCT03012334|475073487|FG009|Period 4|Non-Compliance|0|||
131940911|NCT03012334|475073478|FG000|Period 4|Adverse Event|0|||
131940912|NCT03012334|475073479|FG001|Period 4|Adverse Event|0|||
131940913|NCT03012334|475073480|FG002|Period 4|Adverse Event|0|||
131940914|NCT03012334|475073481|FG003|Period 4|Adverse Event|0|||
131940915|NCT03012334|475073482|FG004|Period 4|Adverse Event|0|||
131940916|NCT03012334|475073483|FG005|Period 4|Adverse Event|0|||
131940917|NCT03012334|475073484|FG006|Period 4|Adverse Event|0|||
131940918|NCT03012334|475073485|FG007|Period 4|Adverse Event|0|||
131940919|NCT03012334|475073486|FG008|Period 4|Adverse Event|1|||
131940920|NCT03012334|475073487|FG009|Period 4|Adverse Event|0|||
131940921|NCT00652834|475073488|FG000|Overall Study|Withdrawal by Subject|3|||
131940922|NCT00652834|475073488|FG000|Overall Study|Lost to Follow-up|2|||
131940923|NCT00320606|475073489|FG000|Overall Study|Adverse Event|1|||
131940924|NCT00320606|475073489|FG000|Overall Study|Protocol Violation|1|||
131940925|NCT00320606|475073489|FG000|Overall Study|Withdrawal by Subject|1|||
131940926|NCT01541371|475073498|FG000|Overall Study|Withdrawal by Subject|14|||
131940927|NCT01541371|475073498|FG000|Overall Study|Lost to Follow-up|21|||
131940928|NCT01541371|475073498|FG000|Overall Study|Adverse Event|15|||
131940929|NCT01541371|475073498|FG000|Overall Study|Lack of Efficacy|12|||
131940930|NCT01541371|475073498|FG000|Overall Study|Protocol Violation|6|||
131940931|NCT01541371|475073498|FG000|Overall Study|Study medication non-compliance|3|||
131940932|NCT01541371|475073498|FG000|Overall Study|Other|6|||
131940933|NCT02441218|475073499|FG000|Overall Study|Death|503|||
131940934|NCT02441218|475073500|FG001|Overall Study|Death|553|||
131940935|NCT02441218|475073499|FG000|Overall Study|Withdrawal by Subject|73|||
131940936|NCT02441218|475073500|FG001|Overall Study|Withdrawal by Subject|58|||
131940937|NCT02441218|475073499|FG000|Overall Study|Lost to Follow-up|2|||
131940938|NCT02441218|475073500|FG001|Overall Study|Lost to Follow-up|1|||
131940939|NCT00744861|475073503|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
131940940|NCT00744861|475073504|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
131940941|NCT00744861|475073505|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
131940942|NCT00744861|475073506|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
131940943|NCT00744861|475073503|FG000|Feasibility Stage 1|Pregnancy|0|||
131940944|NCT00744861|475073504|FG001|Feasibility Stage 1|Pregnancy|1|||
131940945|NCT00744861|475073505|FG002|Feasibility Stage 1|Pregnancy|0|||
131940946|NCT00744861|475073506|FG003|Feasibility Stage 1|Pregnancy|0|||
131940947|NCT00744861|475073503|FG000|Pivotal Stage 2|Adverse Event|0|||
131940948|NCT00744861|475073504|FG001|Pivotal Stage 2|Adverse Event|0|||
131940949|NCT00744861|475073505|FG002|Pivotal Stage 2|Adverse Event|6|||
131940950|NCT00744861|475073506|FG003|Pivotal Stage 2|Adverse Event|11|||
131940951|NCT00744861|475073503|FG000|Pivotal Stage 2|Death|0|||
131940952|NCT00744861|475073504|FG001|Pivotal Stage 2|Death|0|||
131940953|NCT00744861|475073505|FG002|Pivotal Stage 2|Death|0|||
131940954|NCT00744861|475073506|FG003|Pivotal Stage 2|Death|1|||
131940955|NCT00744861|475073503|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
131940956|NCT00744861|475073504|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
131940957|NCT00744861|475073505|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
131940958|NCT00744861|475073506|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
131940959|NCT00744861|475073503|FG000|Pivotal Stage 2|Physician Decision|0|||
131940960|NCT00744861|475073504|FG001|Pivotal Stage 2|Physician Decision|0|||
131940961|NCT00744861|475073505|FG002|Pivotal Stage 2|Physician Decision|3|||
131940962|NCT00744861|475073506|FG003|Pivotal Stage 2|Physician Decision|1|||
131940963|NCT00744861|475073503|FG000|Pivotal Stage 2|Protocol Violation|0|||
131940964|NCT00744861|475073504|FG001|Pivotal Stage 2|Protocol Violation|0|||
131940965|NCT00744861|475073505|FG002|Pivotal Stage 2|Protocol Violation|0|||
131940966|NCT00744861|475073506|FG003|Pivotal Stage 2|Protocol Violation|1|||
131940967|NCT00744861|475073503|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
131940968|NCT00744861|475073504|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
131940969|NCT00744861|475073505|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
131940970|NCT00744861|475073506|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
131940971|NCT00744861|475073503|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
131940972|NCT00744861|475073504|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
131940973|NCT00744861|475073505|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
131940974|NCT00744861|475073506|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
131940975|NCT00186628|475073511|FG000|Overall Study|Death|2|||
131940976|NCT00186628|475073511|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
131940977|NCT02927795|475073512|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
131940978|NCT02927795|475073512|FG000|Overall Study|Not Treated|4|||
131940979|NCT01076010|475073513|FG000|Overall Study|Death|15|||
131940980|NCT01076010|475073514|FG001|Overall Study|Death|1|||
131940981|NCT01076010|475073515|FG002|Overall Study|Death|0|||
131940982|NCT01076010|475073513|FG000|Overall Study|Adverse Event|7|||
131940983|NCT01076010|475073514|FG001|Overall Study|Adverse Event|2|||
131940984|NCT01076010|475073515|FG002|Overall Study|Adverse Event|0|||
131940985|NCT01076010|475073513|FG000|Overall Study|Progressive disease|90|||
131940986|NCT01076010|475073514|FG001|Overall Study|Progressive disease|30|||
131940987|NCT01076010|475073515|FG002|Overall Study|Progressive disease|1|||
131940988|NCT01076010|475073513|FG000|Overall Study|Lack of Efficacy|4|||
131940989|NCT01076010|475073514|FG001|Overall Study|Lack of Efficacy|0|||
131940990|NCT01076010|475073515|FG002|Overall Study|Lack of Efficacy|0|||
131940991|NCT01076010|475073513|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
131940992|NCT01076010|475073514|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
131940993|NCT01076010|475073515|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
131940994|NCT01076010|475073513|FG000|Overall Study|Significant Surgical Procedure|0|||
131940995|NCT01076010|475073514|FG001|Overall Study|Significant Surgical Procedure|1|||
131940996|NCT01076010|475073515|FG002|Overall Study|Significant Surgical Procedure|0|||
131940997|NCT01076010|475073513|FG000|Overall Study|Protocol Violation|0|||
131940998|NCT01076010|475073514|FG001|Overall Study|Protocol Violation|1|||
131940999|NCT01076010|475073515|FG002|Overall Study|Protocol Violation|0|||
131941000|NCT01076010|475073513|FG000|Overall Study|Noncompliance|1|||
131941001|NCT01076010|475073514|FG001|Overall Study|Noncompliance|1|||
131941002|NCT01076010|475073515|FG002|Overall Study|Noncompliance|0|||
131941003|NCT01076010|475073513|FG000|Overall Study|Withdrawal by Subject|3|||
131941004|NCT01076010|475073514|FG001|Overall Study|Withdrawal by Subject|0|||
131941005|NCT01076010|475073515|FG002|Overall Study|Withdrawal by Subject|1|||
131941006|NCT01076010|475073513|FG000|Overall Study|Other|5|||
131941007|NCT01076010|475073514|FG001|Overall Study|Other|2|||
131941008|NCT01076010|475073515|FG002|Overall Study|Other|0|||
131941009|NCT00181844|475073516|FG000|Signed Consent|Withdrawal by Subject|5|||
131941010|NCT00181844|475073516|FG000|Signed Consent|Did not meet entrance criteria|7|||
131941011|NCT00181844|475073516|FG000|Exposed to Study Medication|Adverse Event|10|||
131941012|NCT00181844|475073516|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
131941013|NCT00181844|475073516|FG000|Exposed to Study Medication|Non-compliance|2|||
131941014|NCT00181844|475073516|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
131941015|NCT00181844|475073516|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
131941016|NCT04661033|475073517|FG000|Overall Study|Adverse Event|0|||
131941017|NCT04661033|475073518|FG001|Overall Study|Adverse Event|0|||
131941018|NCT04661033|475073519|FG002|Overall Study|Adverse Event|1|||
131941019|NCT04661033|475073520|FG003|Overall Study|Adverse Event|0|||
131941020|NCT04661033|475073517|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
131941021|NCT04661033|475073518|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
131941022|NCT04661033|475073519|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
131941023|NCT04661033|475073520|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
131941024|NCT04661033|475073517|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
131941025|NCT04661033|475073518|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
131941026|NCT04661033|475073519|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
131941027|NCT04661033|475073520|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
131941028|NCT04661033|475073517|FG000|Overall Study|Early discontinuation as per PI|1|||
131941029|NCT04661033|475073518|FG001|Overall Study|Early discontinuation as per PI|0|||
131941030|NCT04661033|475073519|FG002|Overall Study|Early discontinuation as per PI|0|||
131941031|NCT04661033|475073520|FG003|Overall Study|Early discontinuation as per PI|0|||
131941032|NCT01570387|475073524|FG000|Overall Study|Adverse Event|1|||
131941033|NCT01570387|475073525|FG001|Overall Study|Adverse Event|0|||
131941034|NCT01570387|475073526|FG002|Overall Study|Adverse Event|0|||
131941035|NCT01570387|475073527|FG003|Overall Study|Adverse Event|0|||
131941036|NCT01570387|475073524|FG000|Overall Study|Death|0|||
131941037|NCT01570387|475073525|FG001|Overall Study|Death|0|||
131941038|NCT01570387|475073526|FG002|Overall Study|Death|0|||
131941039|NCT01570387|475073527|FG003|Overall Study|Death|1|||
131941040|NCT01570387|475073524|FG000|Overall Study|Withdrawal by Subject|0|||
131941041|NCT01570387|475073525|FG001|Overall Study|Withdrawal by Subject|0|||
131941042|NCT01570387|475073526|FG002|Overall Study|Withdrawal by Subject|0|||
131941043|NCT01570387|475073527|FG003|Overall Study|Withdrawal by Subject|1|||
131941044|NCT01987557|475073528|FG000|Overall Study|Protocol Violation|1|||
131941045|NCT01987557|475073529|FG001|Overall Study|Protocol Violation|0|||
131941046|NCT01987557|475073530|FG002|Overall Study|Protocol Violation|1|||
131941047|NCT01987557|475073528|FG000|Overall Study|Withdrawal by Subject|2|||
131941048|NCT01987557|475073529|FG001|Overall Study|Withdrawal by Subject|1|||
131941049|NCT01987557|475073530|FG002|Overall Study|Withdrawal by Subject|2|||
131941050|NCT01987557|475073528|FG000|Overall Study|Adverse Event|0|||
131941051|NCT01987557|475073529|FG001|Overall Study|Adverse Event|2|||
131941052|NCT01987557|475073530|FG002|Overall Study|Adverse Event|0|||
131941053|NCT01567722|475073537|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
131941054|NCT01567722|475073538|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
131941055|NCT01567722|475073539|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
131941056|NCT01567722|475073537|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
131941057|NCT01567722|475073538|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
131941058|NCT01567722|475073539|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
131941059|NCT01567722|475073537|FG000|Overall Study|Protocol closure by the OCG|2|||
131941060|NCT01567722|475073538|FG001|Overall Study|Protocol closure by the OCG|0|||
131941061|NCT01567722|475073539|FG002|Overall Study|Protocol closure by the OCG|0|||
131941062|NCT01567722|475073537|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
131941063|NCT01567722|475073538|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
131941064|NCT01567722|475073539|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
131941065|NCT00431964|475073540|FG000|Overall Study|Adverse Event|1|||
131941066|NCT00431964|475073541|FG001|Overall Study|Adverse Event|0|||
131941067|NCT00431964|475073540|FG000|Overall Study|Lost to Follow-up|1|||
131941068|NCT00431964|475073541|FG001|Overall Study|Lost to Follow-up|2|||
131941069|NCT00431964|475073540|FG000|Overall Study|Physician Decision|2|||
131412803|NCT01751776|473133777|FG001|Overall Study|Adverse Event|0|||
131412804|NCT01751776|473133778|FG002|Overall Study|Adverse Event|0|||
131412805|NCT01751776|473133779|FG003|Overall Study|Adverse Event|0|||
131412806|NCT01751776|473133780|FG004|Overall Study|Adverse Event|0|||
131412807|NCT01751776|473133781|FG005|Overall Study|Adverse Event|0|||
131412808|NCT01751776|473133782|FG006|Overall Study|Adverse Event|4|||
131412809|NCT01751776|473133783|FG007|Overall Study|Adverse Event|2|||
131412810|NCT01751776|473133776|FG000|Overall Study|Consent withdrawn|0|||
131412811|NCT01751776|473133777|FG001|Overall Study|Consent withdrawn|0|||
131412812|NCT01751776|473133778|FG002|Overall Study|Consent withdrawn|0|||
131412813|NCT01751776|473133779|FG003|Overall Study|Consent withdrawn|0|||
131412814|NCT01751776|473133780|FG004|Overall Study|Consent withdrawn|0|||
131412815|NCT01751776|473133781|FG005|Overall Study|Consent withdrawn|0|||
131412816|NCT01751776|473133782|FG006|Overall Study|Consent withdrawn|0|||
131412817|NCT01751776|473133783|FG007|Overall Study|Consent withdrawn|1|||
131412818|NCT01751776|473133776|FG000|Overall Study|Other reason not specified above|0|||
131412819|NCT01751776|473133777|FG001|Overall Study|Other reason not specified above|0|||
131412820|NCT01751776|473133778|FG002|Overall Study|Other reason not specified above|0|||
131412821|NCT01751776|473133779|FG003|Overall Study|Other reason not specified above|0|||
131412822|NCT01751776|473133780|FG004|Overall Study|Other reason not specified above|0|||
131412823|NCT01751776|473133781|FG005|Overall Study|Other reason not specified above|0|||
131412824|NCT01751776|473133782|FG006|Overall Study|Other reason not specified above|0|||
131412825|NCT01751776|473133783|FG007|Overall Study|Other reason not specified above|1|||
131412826|NCT00831701|473133788|FG000|Overall Study|Withdrawal by Subject|2|||
131412827|NCT00831701|473133789|FG001|Overall Study|Withdrawal by Subject|0|||
131412828|NCT00831701|473133788|FG000|Overall Study|Stone expulsion before first medication|2|||
131412829|NCT00831701|473133789|FG001|Overall Study|Stone expulsion before first medication|2|||
131412830|NCT00831701|473133788|FG000|Overall Study|Lost to Follow-up|1|||
131412831|NCT00831701|473133789|FG001|Overall Study|Lost to Follow-up|3|||
131412832|NCT02210091|473133790|FG000|Overall Study|Physician Decision|0|||
131412833|NCT02210091|473133791|FG001|Overall Study|Physician Decision|1|||
131412834|NCT02210091|473133790|FG000|Overall Study|Withdrawal by Sponsor|0|||
131412835|NCT02210091|473133791|FG001|Overall Study|Withdrawal by Sponsor|1|||
131412836|NCT02290938|473133795|FG000|Overall Study|Lost to Follow-up|14|||
131412837|NCT02290938|473133796|FG001|Overall Study|Lost to Follow-up|43|||
131412838|NCT00459537|473133797|FG000|Overall Study|Adverse Event|1|||
131412839|NCT00459537|473133798|FG001|Overall Study|Adverse Event|6|||
131412840|NCT00459537|473133797|FG000|Overall Study|Lack of Efficacy|10|||
131412841|NCT00459537|473133798|FG001|Overall Study|Lack of Efficacy|11|||
131412842|NCT00459537|473133797|FG000|Overall Study|Withdrawal by Subject|20|||
131412843|NCT00459537|473133798|FG001|Overall Study|Withdrawal by Subject|26|||
131412844|NCT00459537|473133797|FG000|Overall Study|Lost to Follow-up|27|||
131412845|NCT00459537|473133798|FG001|Overall Study|Lost to Follow-up|30|||
131412846|NCT00459537|473133797|FG000|Overall Study|Administrative problems|3|||
131412847|NCT00459537|473133798|FG001|Overall Study|Administrative problems|0|||
131412848|NCT00459537|473133797|FG000|Overall Study|Protocol Violation|4|||
131412849|NCT00459537|473133798|FG001|Overall Study|Protocol Violation|3|||
131412850|NCT00459537|473133797|FG000|Overall Study|Missing|1|||
131412851|NCT00459537|473133798|FG001|Overall Study|Missing|0|||
131412852|NCT03159104|473133799|FG000|Overall Study|Violation of inclusion criteria|1|||
131412853|NCT03159104|473133800|FG001|Overall Study|Violation of inclusion criteria|2|||
131412854|NCT00456599|473133801|FG000|Overall Study|Non-compliance|1|||
131412855|NCT00456599|473133801|FG000|Overall Study|Withdrawal by Subject|2|||
131412856|NCT01999218|473133802|FG000|Overall Study|Hyperglycemia|18|||
131412857|NCT01999218|473133803|FG001|Overall Study|Hyperglycemia|17|||
131412858|NCT01999218|473133804|FG002|Overall Study|Hyperglycemia|17|||
131412859|NCT01999218|473133802|FG000|Overall Study|Lack of Efficacy|1|||
131412860|NCT01999218|473133803|FG001|Overall Study|Lack of Efficacy|0|||
131412861|NCT01999218|473133804|FG002|Overall Study|Lack of Efficacy|1|||
131412862|NCT01999218|473133802|FG000|Overall Study|Lost to Follow-up|22|||
131412863|NCT01999218|473133803|FG001|Overall Study|Lost to Follow-up|17|||
131412864|NCT01999218|473133804|FG002|Overall Study|Lost to Follow-up|18|||
131412865|NCT01999218|473133802|FG000|Overall Study|Non-Compliance With Study Drug|6|||
131412866|NCT01999218|473133803|FG001|Overall Study|Non-Compliance With Study Drug|4|||
131412867|NCT01999218|473133804|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131412868|NCT01999218|473133802|FG000|Overall Study|Physician Decision|1|||
131412869|NCT01999218|473133803|FG001|Overall Study|Physician Decision|4|||
131412870|NCT01999218|473133804|FG002|Overall Study|Physician Decision|6|||
131412871|NCT01999218|473133802|FG000|Overall Study|Protocol Violation|4|||
131412872|NCT01999218|473133803|FG001|Overall Study|Protocol Violation|5|||
131412873|NCT01999218|473133804|FG002|Overall Study|Protocol Violation|4|||
131412874|NCT01999218|473133802|FG000|Overall Study|Screen failure|0|||
131941070|NCT00431964|475073541|FG001|Overall Study|Physician Decision|2|||
131412875|NCT01999218|473133803|FG001|Overall Study|Screen failure|1|||
131412876|NCT01999218|473133804|FG002|Overall Study|Screen failure|0|||
131941071|NCT00431964|475073540|FG000|Overall Study|Withdrawal by Subject|2|||
131941072|NCT00431964|475073541|FG001|Overall Study|Withdrawal by Subject|1|||
131941073|NCT00431964|475073540|FG000|Overall Study|Parental Consent Withdrawn|0|||
131941074|NCT00431964|475073541|FG001|Overall Study|Parental Consent Withdrawn|2|||
131941075|NCT00431964|475073540|FG000|Overall Study|Due to Unstable Health|0|||
131941076|NCT00431964|475073541|FG001|Overall Study|Due to Unstable Health|1|||
131941077|NCT00518180|475073549|FG000|Overall Study|Withdrawal by Subject|29|||
131941078|NCT00518180|475073550|FG001|Overall Study|Withdrawal by Subject|30|||
131941079|NCT00518180|475073551|FG002|Overall Study|Withdrawal by Subject|42|||
131941080|NCT00518180|475073549|FG000|Overall Study|Lost to Follow-up|30|||
131941081|NCT00518180|475073550|FG001|Overall Study|Lost to Follow-up|28|||
131941082|NCT00518180|475073551|FG002|Overall Study|Lost to Follow-up|34|||
131941083|NCT00518180|475073549|FG000|Overall Study|Administrative reason|0|||
131941084|NCT00518180|475073550|FG001|Overall Study|Administrative reason|2|||
131941085|NCT00518180|475073551|FG002|Overall Study|Administrative reason|2|||
131941086|NCT00518180|475073549|FG000|Overall Study|Protocol Violation|5|||
131941087|NCT00518180|475073550|FG001|Overall Study|Protocol Violation|7|||
131941088|NCT00518180|475073551|FG002|Overall Study|Protocol Violation|4|||
131941089|NCT00518180|475073549|FG000|Overall Study|Unable to classify|0|||
131941090|NCT00518180|475073550|FG001|Overall Study|Unable to classify|2|||
131941091|NCT00518180|475073551|FG002|Overall Study|Unable to classify|0|||
131941092|NCT00518180|475073549|FG000|Overall Study|Adverse Event|1|||
131941093|NCT00518180|475073550|FG001|Overall Study|Adverse Event|0|||
131941094|NCT00518180|475073551|FG002|Overall Study|Adverse Event|0|||
131941095|NCT03383666|475073552|FG000|Overall Study|Withdrawal by Subject|2|||
131941096|NCT03383666|475073552|FG000|Overall Study|Lost to Follow-up|2|||
131941097|NCT02536664|475073553|FG000|Overall Study|Inadequate completion of documentation|2|||
131941098|NCT02536664|475073554|FG001|Overall Study|Inadequate completion of documentation|4|||
131941099|NCT02536664|475073553|FG000|Overall Study|Progression|13|||
131941100|NCT02536664|475073554|FG001|Overall Study|Progression|18|||
131941101|NCT02536664|475073553|FG000|Overall Study|Death due to lymphoma|2|||
131941102|NCT02536664|475073554|FG001|Overall Study|Death due to lymphoma|1|||
131941103|NCT02536664|475073553|FG000|Overall Study|Death due to other reason|3|||
131941104|NCT02536664|475073554|FG001|Overall Study|Death due to other reason|2|||
131941105|NCT02536664|475073553|FG000|Overall Study|Intolerability|8|||
131941106|NCT02536664|475073554|FG001|Overall Study|Intolerability|6|||
131941107|NCT02536664|475073553|FG000|Overall Study|Withdrawal by Subject|8|||
131941108|NCT02536664|475073554|FG001|Overall Study|Withdrawal by Subject|5|||
131941109|NCT02536664|475073553|FG000|Overall Study|Other|18|||
131941110|NCT02536664|475073554|FG001|Overall Study|Other|24|||
131941111|NCT02536664|475073553|FG000|Overall Study|Missing|53|||
131941112|NCT02536664|475073554|FG001|Overall Study|Missing|20|||
131941113|NCT03961308|475073569|FG000|Overall Study|Withdrawal by Subject|1|||
131941114|NCT03961308|475073570|FG001|Overall Study|Withdrawal by Subject|0|||
131941115|NCT03961308|475073569|FG000|Overall Study|Other|1|||
131941116|NCT03961308|475073570|FG001|Overall Study|Other|0|||
131941117|NCT03961308|475073569|FG000|Overall Study|Lost to Follow-up|0|||
131941118|NCT03961308|475073570|FG001|Overall Study|Lost to Follow-up|1|||
131941119|NCT03961308|475073569|FG000|Overall Study|Adverse Event|0|||
131941120|NCT03961308|475073570|FG001|Overall Study|Adverse Event|1|||
131941121|NCT00570713|475073571|FG000|Overall Study|Adverse Event|16|||
131941122|NCT00570713|475073572|FG001|Overall Study|Adverse Event|9|||
131941123|NCT00570713|475073571|FG000|Overall Study|Death|7|||
131941124|NCT00570713|475073572|FG001|Overall Study|Death|7|||
131941125|NCT00570713|475073571|FG000|Overall Study|Lack of Efficacy|40|||
131941126|NCT00570713|475073572|FG001|Overall Study|Lack of Efficacy|49|||
131941127|NCT00570713|475073571|FG000|Overall Study|Physician Decision|2|||
131941128|NCT00570713|475073572|FG001|Overall Study|Physician Decision|2|||
131941129|NCT00570713|475073571|FG000|Overall Study|Withdrawal by Subject|3|||
131941130|NCT00570713|475073572|FG001|Overall Study|Withdrawal by Subject|3|||
131941131|NCT00570713|475073571|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
131941132|NCT00570713|475073572|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
131941133|NCT02081586|475073573|FG000|Overall Study|Lost to Follow-up|0|||
131941134|NCT02081586|475073574|FG001|Overall Study|Lost to Follow-up|1|||
131941135|NCT02081586|475073575|FG002|Overall Study|Lost to Follow-up|0|||
131412877|NCT01999218|473133802|FG000|Overall Study|Study Terminated By Sponsor|7|||
131412878|NCT01999218|473133803|FG001|Overall Study|Study Terminated By Sponsor|5|||
131412879|NCT01999218|473133804|FG002|Overall Study|Study Terminated By Sponsor|12|||
131941136|NCT02081586|475073576|FG003|Overall Study|Lost to Follow-up|1|||
131941137|NCT02081586|475073573|FG000|Overall Study|Head injury not related to study|0|||
131941138|NCT02081586|475073574|FG001|Overall Study|Head injury not related to study|0|||
131941139|NCT02081586|475073575|FG002|Overall Study|Head injury not related to study|1|||
131941140|NCT02081586|475073576|FG003|Overall Study|Head injury not related to study|0|||
131941141|NCT01677988|475073579|FG000|Overall Study|Lack of Efficacy|2|||
131941142|NCT00271544|475073583|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
131941143|NCT00271544|475073583|FG000|Overall Study|Model 4196 lead not attempted|9|||
131941144|NCT00271544|475073583|FG000|Overall Study|Implant not attempted|4|||
131941145|NCT03358030|475073584|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
131941146|NCT03358030|475073585|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
131941147|NCT03358030|475073586|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
131941148|NCT03358030|475073587|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
131941149|NCT03358030|475073584|FG000|Overall Study|Ineligibility|0|||
131941150|NCT03358030|475073585|FG001|Overall Study|Ineligibility|0|||
131941151|NCT03358030|475073586|FG002|Overall Study|Ineligibility|0|||
131941152|NCT03358030|475073587|FG003|Overall Study|Ineligibility|2|||
131941153|NCT03358030|475073584|FG000|Overall Study|Voluntary Withdrawal|1|||
131941154|NCT03358030|475073585|FG001|Overall Study|Voluntary Withdrawal|1|||
131941155|NCT03358030|475073586|FG002|Overall Study|Voluntary Withdrawal|3|||
131941156|NCT03358030|475073587|FG003|Overall Study|Voluntary Withdrawal|1|||
131941157|NCT03358030|475073584|FG000|Overall Study|Other|0|||
131941158|NCT03358030|475073585|FG001|Overall Study|Other|0|||
131941159|NCT03358030|475073586|FG002|Overall Study|Other|1|||
131941160|NCT03358030|475073587|FG003|Overall Study|Other|0|||
131941161|NCT05899829|475073588|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
131941162|NCT05899829|475073589|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
131941163|NCT05899829|475073588|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
131941164|NCT05899829|475073589|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
131941165|NCT00636181|475073592|FG000|Overall Study|Withdrawal by Subject|8|||
131941166|NCT00636181|475073593|FG001|Overall Study|Withdrawal by Subject|6|||
131941167|NCT00636181|475073594|FG002|Overall Study|Withdrawal by Subject|10|||
131941168|NCT05076045|475073597|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
131941169|NCT05076045|475073598|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
131941170|NCT03402841|475073605|FG000|Overall Study|Withdrawal by Subject|3|||
131941171|NCT03402841|475073605|FG000|Overall Study|Lost to Follow-up|2|||
131941172|NCT03402841|475073605|FG000|Overall Study|Death|146|||
131941173|NCT01280968|475073610|FG000|Overall Study|Lost to Follow-up|8|||
131941174|NCT01280968|475073611|FG001|Overall Study|Lost to Follow-up|2|||
131941175|NCT01280968|475073610|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
131941176|NCT01280968|475073611|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
131941177|NCT01280968|475073610|FG000|Overall Study|Commuting Problems|2|||
131941178|NCT01280968|475073611|FG001|Overall Study|Commuting Problems|0|||
131941179|NCT01280968|475073610|FG000|Overall Study|Anxiety|2|||
131941180|NCT01280968|475073611|FG001|Overall Study|Anxiety|0|||
131941181|NCT01280968|475073610|FG000|Overall Study|Adverse Event|1|||
131941182|NCT01280968|475073611|FG001|Overall Study|Adverse Event|0|||
131941183|NCT01280968|475073610|FG000|Overall Study|Scheduling Conflicts|1|||
131941184|NCT01280968|475073611|FG001|Overall Study|Scheduling Conflicts|1|||
131941185|NCT01280968|475073610|FG000|Overall Study|Pre-existing Neurological Condition|1|||
131941186|NCT01280968|475073611|FG001|Overall Study|Pre-existing Neurological Condition|0|||
131941187|NCT01280968|475073610|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
131941188|NCT01280968|475073611|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
131941189|NCT04704193|475073612|FG000|Overall Study|Withdrawal by Subject|1|||
131941190|NCT01173679|475075110|FG000|Overall Study|Death|1|||
131941191|NCT02336815|475075111|FG000|Overall Study|Disease Progression|45|||
131941192|NCT02336815|475075112|FG001|Overall Study|Disease Progression|70|||
131941193|NCT02336815|475075111|FG000|Overall Study|Adverse Event|18|||
131941194|NCT02336815|475075112|FG001|Overall Study|Adverse Event|39|||
131941195|NCT02336815|475075111|FG000|Overall Study|Physician Decision|11|||
131941196|NCT02336815|475075112|FG001|Overall Study|Physician Decision|4|||
131941197|NCT02336815|475075111|FG000|Overall Study|Withdrawal by Subject|3|||
131941198|NCT02336815|475075112|FG001|Overall Study|Withdrawal by Subject|2|||
131941199|NCT02336815|475075111|FG000|Overall Study|Lost to Follow-up|1|||
131941200|NCT02336815|475075112|FG001|Overall Study|Lost to Follow-up|3|||
131941201|NCT02336815|475075111|FG000|Overall Study|Other|1|||
131941202|NCT02336815|475075112|FG001|Overall Study|Other|5|||
131941203|NCT00105534|475075113|FG000|Overall Study|Adverse Event|2|||
131941204|NCT00105534|475075114|FG001|Overall Study|Adverse Event|5|||
131941205|NCT00105534|475075113|FG000|Overall Study|Protocol Violation|1|||
131941206|NCT00105534|475075114|FG001|Overall Study|Protocol Violation|4|||
131941207|NCT00105534|475075113|FG000|Overall Study|Withdrawal by Subject|6|||
131941208|NCT00105534|475075114|FG001|Overall Study|Withdrawal by Subject|6|||
131941209|NCT00105534|475075113|FG000|Overall Study|Lost to Follow-up|5|||
131941210|NCT00105534|475075114|FG001|Overall Study|Lost to Follow-up|1|||
131941211|NCT00105534|475075113|FG000|Overall Study|Lack of Efficacy|7|||
131941212|NCT00105534|475075114|FG001|Overall Study|Lack of Efficacy|15|||
131941213|NCT00105534|475075113|FG000|Overall Study|Treatment unmasked|1|||
131941214|NCT00105534|475075114|FG001|Overall Study|Treatment unmasked|0|||
131941215|NCT00105534|475075113|FG000|Overall Study|Other Reason|0|||
131941216|NCT00105534|475075114|FG001|Overall Study|Other Reason|2|||
131941217|NCT02896257|475075115|FG000|Providers|Without eligible patients|21|||
131941218|NCT02896257|475075116|FG001|Providers|Without eligible patients|28|||
131941219|NCT02896257|475075115|FG000|Patients|PFT entry criteria not met|43|||
131941220|NCT02896257|475075116|FG001|Patients|PFT entry criteria not met|50|||
131941221|NCT02896257|475075115|FG000|Patients|No capacity to review|8|||
131941222|NCT02896257|475075116|FG001|Patients|No capacity to review|11|||
131941223|NCT02896257|475075115|FG000|Patients|Appointment rescheduled/cancelled|5|||
131941224|NCT02896257|475075116|FG001|Patients|Appointment rescheduled/cancelled|7|||
131941225|NCT02896257|475075115|FG000|Patients|PCP not assigned a clinic|4|||
131941226|NCT02896257|475075116|FG001|Patients|PCP not assigned a clinic|0|||
131941227|NCT02896257|475075115|FG000|Patients|No history of COPD|0|||
131941228|NCT02896257|475075116|FG001|Patients|No history of COPD|1|||
131941229|NCT02896257|475075115|FG000|Patients|Deceased between review and index date|0|||
131941230|NCT02896257|475075116|FG001|Patients|Deceased between review and index date|1|||
131941231|NCT02896257|475075115|FG000|Patients|No ICS Rx upon review|1|||
131941232|NCT02896257|475075116|FG001|Patients|No ICS Rx upon review|1|||
131941233|NCT02896257|475075115|FG000|Patients|Protocol Violation|2|||
131941234|NCT02896257|475075116|FG001|Patients|Protocol Violation|1|||
131941235|NCT02896257|475075115|FG000|Patients|Hospice care|0|||
131941236|NCT02896257|475075116|FG001|Patients|Hospice care|1|||
131941237|NCT02465931|475075117|FG000|Overall Study|Lost to Follow-up|9|||
131941238|NCT02465931|475075118|FG001|Overall Study|Lost to Follow-up|11|||
131941239|NCT02465931|475075117|FG000|Overall Study|Protocol Violation|1|||
131941240|NCT02465931|475075118|FG001|Overall Study|Protocol Violation|0|||
131941241|NCT02465931|475075117|FG000|Overall Study|Withdrawal by Subject|1|||
131941242|NCT02465931|475075118|FG001|Overall Study|Withdrawal by Subject|0|||
131941243|NCT00948688|475075119|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
131941244|NCT00948688|475075120|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
131941245|NCT00948688|475075119|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
131941246|NCT00948688|475075120|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
131941247|NCT00948688|475075119|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
131941248|NCT00948688|475075120|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
131941249|NCT01135992|475075121|FG000|Overall Study|Adverse Event|1|||
131941250|NCT01135992|475075121|FG000|Overall Study|Lack of Efficacy|1|||
131941251|NCT01135992|475075121|FG000|Overall Study|Protocol Violation|2|||
131941252|NCT01135992|475075121|FG000|Overall Study|Withdrawal criteria|10|||
131454810|NCT00124306|473294263|FG001|Overall Study|Adverse Event|2|||
131941253|NCT01135992|475075121|FG000|Overall Study|Unclassified|7|||
131941254|NCT01693367|475075124|FG000|Overall Study|Withdrawal by Subject|1|||
131941255|NCT01693367|475075125|FG001|Overall Study|Withdrawal by Subject|1|||
131941256|NCT01693367|475075124|FG000|Overall Study|Physician Decision|0|||
131941257|NCT01693367|475075125|FG001|Overall Study|Physician Decision|1|||
131941258|NCT02136914|475075126|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
131941259|NCT02136914|475075127|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
131941260|NCT02136914|475075126|FG000|Overall Study|Withdrawal by Subject|3|||
131941261|NCT02136914|475075127|FG001|Overall Study|Withdrawal by Subject|10|||
131941262|NCT02136914|475075126|FG000|Overall Study|Subject Unwilling to Proceed|7|||
131941263|NCT02136914|475075127|FG001|Overall Study|Subject Unwilling to Proceed|2|||
131941264|NCT02136914|475075126|FG000|Overall Study|Lost to Follow-up|1|||
131941265|NCT02136914|475075127|FG001|Overall Study|Lost to Follow-up|1|||
131941266|NCT02136914|475075126|FG000|Overall Study|Did Not Receive Study Drug|2|||
131941267|NCT02136914|475075127|FG001|Overall Study|Did Not Receive Study Drug|0|||
131941268|NCT02136914|475075126|FG000|Overall Study|Lack of Efficacy|1|||
131941269|NCT02136914|475075127|FG001|Overall Study|Lack of Efficacy|0|||
131941270|NCT02136914|475075126|FG000|Overall Study|Death|0|||
131941271|NCT02136914|475075127|FG001|Overall Study|Death|1|||
131941272|NCT02808897|475075132|FG000|Overall Study|Lost to Follow-up|9|||
131941273|NCT02808897|475075133|FG001|Overall Study|Lost to Follow-up|11|||
131941274|NCT01493089|475075134|FG000|Overall Study|Protocol Violation|2|||
131941275|NCT01493089|475075135|FG001|Overall Study|Protocol Violation|2|||
131941276|NCT01493089|475075134|FG000|Overall Study|Withdrawal by Subject|1|||
131941277|NCT01493089|475075135|FG001|Overall Study|Withdrawal by Subject|0|||
131941278|NCT01493089|475075134|FG000|Overall Study|Physician Decision|0|||
131941279|NCT01493089|475075135|FG001|Overall Study|Physician Decision|1|||
131941280|NCT00325143|475075136|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
131941281|NCT00325143|475075136|FG000|Overall Study|Migrated/moved from study area|1|||
131941282|NCT00325143|475075136|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
131941283|NCT00325143|475075136|FG000|Overall Study|Withdrawal by Subject|8|||
131941284|NCT01870869|475075137|FG000|Overall Study|Implanted with nonstudy device|1|||
131941285|NCT01870869|475075138|FG001|Overall Study|Implanted with nonstudy device|3|||
131941286|NCT01870869|475075139|FG002|Overall Study|Implanted with nonstudy device|14|||
131941287|NCT01870869|475075140|FG003|Overall Study|Implanted with nonstudy device|4|||
131454811|NCT00124306|473294262|FG000|Overall Study|Lost to Follow-up|10|||
131941288|NCT01870869|475075137|FG000|Overall Study|Death|0|||
131941289|NCT01870869|475075138|FG001|Overall Study|Death|0|||
131941290|NCT01870869|475075139|FG002|Overall Study|Death|7|||
131941291|NCT01870869|475075140|FG003|Overall Study|Death|1|||
131941292|NCT01870869|475075137|FG000|Overall Study|Subject choice|6|||
131941293|NCT01870869|475075138|FG001|Overall Study|Subject choice|2|||
131941294|NCT01870869|475075139|FG002|Overall Study|Subject choice|22|||
131941295|NCT01870869|475075140|FG003|Overall Study|Subject choice|8|||
131454812|NCT00124306|473294263|FG001|Overall Study|Lost to Follow-up|6|||
131941296|NCT01870869|475075137|FG000|Overall Study|Lost to Follow-up|10|||
131941297|NCT01870869|475075138|FG001|Overall Study|Lost to Follow-up|2|||
131941298|NCT01870869|475075139|FG002|Overall Study|Lost to Follow-up|25|||
131941299|NCT01870869|475075140|FG003|Overall Study|Lost to Follow-up|3|||
131941300|NCT01870869|475075137|FG000|Overall Study|Reason not Specified|1|||
131941301|NCT01870869|475075138|FG001|Overall Study|Reason not Specified|2|||
131941302|NCT01870869|475075139|FG002|Overall Study|Reason not Specified|20|||
131941303|NCT01870869|475075140|FG003|Overall Study|Reason not Specified|4|||
131941304|NCT01870869|475075137|FG000|Overall Study|Not evaluable|10|||
131941305|NCT01870869|475075138|FG001|Overall Study|Not evaluable|5|||
131941306|NCT01870869|475075139|FG002|Overall Study|Not evaluable|42|||
131941307|NCT01870869|475075140|FG003|Overall Study|Not evaluable|10|||
131941308|NCT02286895|475075141|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
131941309|NCT02286895|475075142|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
131941310|NCT02286895|475075141|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
131941311|NCT02286895|475075142|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
131941312|NCT02286895|475075141|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
131941313|NCT02286895|475075142|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
131941314|NCT01073293|475075143|FG000|Overall Study|Lost to Follow-up|0|||
131941315|NCT01073293|475075144|FG001|Overall Study|Lost to Follow-up|1|||
131941316|NCT01073293|475075143|FG000|Overall Study|Withdrawal by Subject|5|||
131941317|NCT01073293|475075144|FG001|Overall Study|Withdrawal by Subject|10|||
131941318|NCT00256126|475075147|FG000|Overall Study|Adverse Event|1|||
131941319|NCT00256126|475075148|FG001|Overall Study|Adverse Event|0|||
131941320|NCT00256126|475075147|FG000|Overall Study|Other|1|||
131941321|NCT00256126|475075148|FG001|Overall Study|Other|2|||
131941322|NCT02949011|475075149|FG000|Overall Study|Adverse Event|6|||
131941323|NCT02949011|475075150|FG001|Overall Study|Adverse Event|7|||
131941324|NCT02949011|475075151|FG002|Overall Study|Adverse Event|3|||
131941325|NCT02949011|475075149|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
131941326|NCT02949011|475075150|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
131941327|NCT02949011|475075151|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
131941328|NCT02949011|475075149|FG000|Overall Study|Protocol Deviation|5|||
131941329|NCT02949011|475075150|FG001|Overall Study|Protocol Deviation|3|||
131941330|NCT02949011|475075151|FG002|Overall Study|Protocol Deviation|3|||
131941331|NCT02949011|475075149|FG000|Overall Study|Lack of Efficacy|0|||
131941332|NCT02949011|475075150|FG001|Overall Study|Lack of Efficacy|2|||
131941333|NCT02949011|475075151|FG002|Overall Study|Lack of Efficacy|0|||
131941334|NCT02949011|475075149|FG000|Overall Study|Withdrawal by Subject|13|||
131941335|NCT02949011|475075150|FG001|Overall Study|Withdrawal by Subject|13|||
131941336|NCT02949011|475075151|FG002|Overall Study|Withdrawal by Subject|21|||
131941337|NCT02949011|475075149|FG000|Overall Study|Lost to Follow-up|7|||
131941338|NCT02949011|475075150|FG001|Overall Study|Lost to Follow-up|5|||
131941339|NCT02949011|475075151|FG002|Overall Study|Lost to Follow-up|5|||
131941340|NCT02949011|475075149|FG000|Overall Study|Death|0|||
131941341|NCT02949011|475075150|FG001|Overall Study|Death|0|||
131941342|NCT02949011|475075151|FG002|Overall Study|Death|1|||
131941343|NCT02949011|475075149|FG000|Overall Study|Miscellaneous|2|||
131941344|NCT02949011|475075150|FG001|Overall Study|Miscellaneous|4|||
131941345|NCT02949011|475075151|FG002|Overall Study|Miscellaneous|6|||
131941346|NCT00506142|475075152|FG000|Overall Study|Adverse Event|8|||
131941347|NCT00506142|475075153|FG001|Overall Study|Adverse Event|7|||
131941348|NCT00506142|475075152|FG000|Overall Study|Lack of Efficacy|21|||
131941349|NCT00506142|475075153|FG001|Overall Study|Lack of Efficacy|7|||
131941350|NCT00506142|475075152|FG000|Overall Study|Withdrawal by Subject|4|||
131941351|NCT00506142|475075153|FG001|Overall Study|Withdrawal by Subject|5|||
131941352|NCT00506142|475075152|FG000|Overall Study|Physician Decision|1|||
131941353|NCT00506142|475075153|FG001|Overall Study|Physician Decision|0|||
131941354|NCT00506142|475075152|FG000|Overall Study|New health condition|1|||
131941355|NCT00506142|475075153|FG001|Overall Study|New health condition|0|||
131941356|NCT02154061|475075154|FG000|Overall Study|Pregnancy|1|||
131941357|NCT02154061|475075155|FG001|Overall Study|Pregnancy|0|||
131941358|NCT02154061|475075154|FG000|Overall Study|enrolled but not vaccinated|1|||
131941359|NCT02154061|475075155|FG001|Overall Study|enrolled but not vaccinated|0|||
131941360|NCT00454116|475075156|FG000|Overall Study|Adverse Event|5|||
131941361|NCT00454116|475075157|FG001|Overall Study|Adverse Event|11|||
131941362|NCT00454116|475075158|FG002|Overall Study|Adverse Event|9|||
131941363|NCT00454116|475075156|FG000|Overall Study|Condition under investigation worsened|17|||
131941364|NCT00454116|475075157|FG001|Overall Study|Condition under investigation worsened|13|||
131941365|NCT00454116|475075158|FG002|Overall Study|Condition under investigation worsened|18|||
131941366|NCT00454116|475075156|FG000|Overall Study|Withdrawal by Subject|3|||
131941367|NCT00454116|475075157|FG001|Overall Study|Withdrawal by Subject|3|||
131941368|NCT00454116|475075158|FG002|Overall Study|Withdrawal by Subject|1|||
131941369|NCT00454116|475075156|FG000|Overall Study|Other|2|||
131941370|NCT00454116|475075157|FG001|Overall Study|Other|2|||
131941371|NCT00454116|475075158|FG002|Overall Study|Other|0|||
131941372|NCT01008618|475075161|FG000|Period 1 (Titration Period)|Physician Decision|2|||
131941373|NCT01008618|475075162|FG001|Period 1 (Titration Period)|Physician Decision|0|||
131941374|NCT01008618|475075163|FG002|Period 1 (Titration Period)|Physician Decision|0|||
131941375|NCT01008618|475075161|FG000|Period 1 (Titration Period)|Adverse Event|33|||
131941376|NCT01008618|475075162|FG001|Period 1 (Titration Period)|Adverse Event|0|||
131941377|NCT01008618|475075163|FG002|Period 1 (Titration Period)|Adverse Event|0|||
131941378|NCT01008618|475075161|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
131941379|NCT01008618|475075162|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
131941380|NCT01008618|475075163|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
131941381|NCT01008618|475075161|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
131941382|NCT01008618|475075162|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
131941383|NCT01008618|475075163|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
131941384|NCT01008618|475075161|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
131941385|NCT01008618|475075162|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
131941386|NCT01008618|475075163|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
131941387|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
131941388|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
131941389|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
131941390|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
131941391|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
131941392|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
131941393|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
131941394|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
131941395|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
131941396|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
131941397|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
131941398|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
131941399|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
131941400|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
131941401|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
131941402|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
131941403|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
131941404|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
131941405|NCT01008618|475075161|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
131941406|NCT01008618|475075162|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
131941407|NCT01008618|475075163|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
131941408|NCT00742625|475075164|FG000|Remission Induction|Progression|6|||
131941409|NCT00742625|475075164|FG000|Remission Induction|Failed induction|8|||
131941410|NCT00742625|475075164|FG000|Remission Induction|Adverse Event|3|||
131941411|NCT00742625|475075164|FG000|Remission Induction|Death|10|||
131941412|NCT00742625|475075164|FG000|Remission Induction|Refusal|5|||
131941413|NCT00742625|475075164|FG000|Remission Induction|Non protocol treatment|17|||
131941414|NCT00742625|475075164|FG000|Remission Induction|Other, not specified|5|||
131941415|NCT00742625|475075164|FG000|Consolidation|Progression|5|||
131941416|NCT00742625|475075164|FG000|Consolidation|Adverse Event|1|||
131941417|NCT00742625|475075164|FG000|Consolidation|Death|1|||
131941418|NCT00742625|475075164|FG000|Consolidation|Refused|1|||
131941419|NCT00742625|475075164|FG000|Consolidation|Non protocol therapy|13|||
131941420|NCT03338400|475075165|FG000|Overall Study|Lost to Follow-up|1|||
131941421|NCT03338400|475075166|FG001|Overall Study|Lost to Follow-up|2|||
131941422|NCT01865487|475075167|FG000|Overall Study|Lost to Follow-up|0|||
131941423|NCT01865487|475075168|FG001|Overall Study|Lost to Follow-up|0|||
131941424|NCT01865487|475075169|FG002|Overall Study|Lost to Follow-up|0|||
131941425|NCT01865487|475075170|FG003|Overall Study|Lost to Follow-up|1|||
131941426|NCT01865487|475075171|FG004|Overall Study|Lost to Follow-up|0|||
131941427|NCT01865487|475075172|FG005|Overall Study|Lost to Follow-up|0|||
131941428|NCT01865487|475075173|FG006|Overall Study|Lost to Follow-up|1|||
131941429|NCT01865487|475075174|FG007|Overall Study|Lost to Follow-up|0|||
131941430|NCT01865487|475075175|FG008|Overall Study|Lost to Follow-up|0|||
131941431|NCT01865487|475075176|FG009|Overall Study|Lost to Follow-up|0|||
131941432|NCT01865487|475075167|FG000|Overall Study|Withdrawal by Subject|0|||
131941433|NCT01865487|475075168|FG001|Overall Study|Withdrawal by Subject|0|||
131941434|NCT01865487|475075169|FG002|Overall Study|Withdrawal by Subject|0|||
131454813|NCT00124306|473294262|FG000|Overall Study|Lack of Efficacy|3|||
131454814|NCT00124306|473294263|FG001|Overall Study|Lack of Efficacy|6|||
131941435|NCT01865487|475075170|FG003|Overall Study|Withdrawal by Subject|0|||
131941436|NCT01865487|475075171|FG004|Overall Study|Withdrawal by Subject|1|||
131941437|NCT01865487|475075172|FG005|Overall Study|Withdrawal by Subject|0|||
131941438|NCT01865487|475075173|FG006|Overall Study|Withdrawal by Subject|0|||
131941439|NCT01865487|475075174|FG007|Overall Study|Withdrawal by Subject|0|||
131941440|NCT01865487|475075175|FG008|Overall Study|Withdrawal by Subject|0|||
131454815|NCT00124306|473294262|FG000|Overall Study|Personal constraints|0|||
131454816|NCT00124306|473294263|FG001|Overall Study|Personal constraints|2|||
131941441|NCT01865487|475075176|FG009|Overall Study|Withdrawal by Subject|0|||
131941442|NCT01627691|475075177|FG000|Overall Study|Death|11|||
131941443|NCT01627691|475075177|FG000|Overall Study|Lost to Follow-up|3|||
131941444|NCT01627691|475075177|FG000|Overall Study|Withdrawal by Subject|1|||
131941445|NCT01627691|475075177|FG000|Overall Study|Missed the visit|3|||
131941446|NCT01908140|475075180|FG000|Overall Study|Other or Progressive Disease|5|||
131941447|NCT01908140|475075181|FG001|Overall Study|Other or Progressive Disease|12|||
131941448|NCT01908140|475075180|FG000|Overall Study|Lack of Efficacy|7|||
131941449|NCT01908140|475075181|FG001|Overall Study|Lack of Efficacy|5|||
131941450|NCT01908140|475075180|FG000|Overall Study|Withdrawal by Subject|23|||
131941451|NCT01908140|475075181|FG001|Overall Study|Withdrawal by Subject|24|||
131941452|NCT01908140|475075180|FG000|Overall Study|Lost to Follow-up|1|||
131941453|NCT01908140|475075181|FG001|Overall Study|Lost to Follow-up|6|||
131941454|NCT01908140|475075180|FG000|Overall Study|Protocol Violation|8|||
131941455|NCT01908140|475075181|FG001|Overall Study|Protocol Violation|9|||
131941456|NCT01908140|475075180|FG000|Overall Study|Adverse Event|22|||
131941457|NCT01908140|475075181|FG001|Overall Study|Adverse Event|23|||
131941458|NCT03440008|475075190|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
131941459|NCT03440008|475075191|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
131941460|NCT03440008|475075190|FG000|Overall Study|Withdrawal by Subject|1|||
131941461|NCT03440008|475075191|FG001|Overall Study|Withdrawal by Subject|0|||
131941462|NCT00760552|475075209|FG000|Overall Study|Death|2|||
131941463|NCT00760552|475075210|FG001|Overall Study|Death|0|||
131941464|NCT00760552|475075209|FG000|Overall Study|Lost to Follow-up|11|||
131941465|NCT00760552|475075210|FG001|Overall Study|Lost to Follow-up|10|||
131941466|NCT00382174|475075211|FG000|Overall Study|Lost to Follow-up|1|||
131941467|NCT00382174|475075212|FG001|Overall Study|Lost to Follow-up|4|||
131941468|NCT00382174|475075213|FG002|Overall Study|Lost to Follow-up|5|||
131941469|NCT00382174|475075211|FG000|Overall Study|Adverse Event|1|||
131941470|NCT00382174|475075212|FG001|Overall Study|Adverse Event|4|||
131941471|NCT00382174|475075213|FG002|Overall Study|Adverse Event|5|||
131941472|NCT00382174|475075211|FG000|Overall Study|Withdrawal by Subject|1|||
131941473|NCT00382174|475075212|FG001|Overall Study|Withdrawal by Subject|4|||
131941474|NCT00382174|475075213|FG002|Overall Study|Withdrawal by Subject|5|||
131941475|NCT00382174|475075211|FG000|Overall Study|Non compliance|1|||
131941476|NCT00382174|475075212|FG001|Overall Study|Non compliance|0|||
131941477|NCT00382174|475075213|FG002|Overall Study|Non compliance|1|||
131941478|NCT00382174|475075211|FG000|Overall Study|Physician Decision|0|||
131941479|NCT00382174|475075212|FG001|Overall Study|Physician Decision|2|||
131941480|NCT00382174|475075213|FG002|Overall Study|Physician Decision|2|||
131941481|NCT00382174|475075211|FG000|Overall Study|Failed to meet criteria|0|||
131941482|NCT00382174|475075212|FG001|Overall Study|Failed to meet criteria|1|||
131941483|NCT00382174|475075213|FG002|Overall Study|Failed to meet criteria|1|||
131941484|NCT00382174|475075211|FG000|Overall Study|Wounds merged|0|||
131941485|NCT00382174|475075212|FG001|Overall Study|Wounds merged|2|||
131941486|NCT00382174|475075213|FG002|Overall Study|Wounds merged|2|||
131941487|NCT01657305|475075223|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
131941488|NCT01657305|475075223|FG000|Overall Study|Withdrawal by Subject|4|||
131941489|NCT01657305|475075223|FG000|Overall Study|Adverse Event|1|||
131941490|NCT01657305|475075223|FG000|Overall Study|Lost to Follow-up|1|||
131941491|NCT01657305|475075223|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
131941492|NCT03710889|475075230|FG000|Overall Study|Adverse Event|2|||
131941493|NCT03710889|475075230|FG000|Overall Study|Protocol Deviation|1|||
131941494|NCT04881760|475075231|FG000|Overall Study|Adverse Event|0|||
131941495|NCT04881760|475075232|FG001|Overall Study|Adverse Event|1|||
131941496|NCT04881760|475075233|FG002|Overall Study|Adverse Event|1|||
131941497|NCT04881760|475075234|FG003|Overall Study|Adverse Event|0|||
131941498|NCT04881760|475075235|FG004|Overall Study|Adverse Event|1|||
131941499|NCT04881760|475075236|FG005|Overall Study|Adverse Event|1|||
131941500|NCT04881760|475075237|FG006|Overall Study|Adverse Event|2|||
131941501|NCT04881760|475075231|FG000|Overall Study|Death|0|||
131941502|NCT04881760|475075232|FG001|Overall Study|Death|0|||
131941503|NCT04881760|475075233|FG002|Overall Study|Death|0|||
131941504|NCT04881760|475075234|FG003|Overall Study|Death|1|||
131941505|NCT04881760|475075235|FG004|Overall Study|Death|0|||
131941506|NCT04881760|475075236|FG005|Overall Study|Death|0|||
131941507|NCT04881760|475075237|FG006|Overall Study|Death|0|||
131941508|NCT04881760|475075231|FG000|Overall Study|Lost to Follow-up|5|||
131941509|NCT04881760|475075232|FG001|Overall Study|Lost to Follow-up|7|||
131941510|NCT04881760|475075233|FG002|Overall Study|Lost to Follow-up|5|||
131941511|NCT04881760|475075234|FG003|Overall Study|Lost to Follow-up|1|||
131941512|NCT04881760|475075235|FG004|Overall Study|Lost to Follow-up|2|||
131941513|NCT04881760|475075236|FG005|Overall Study|Lost to Follow-up|4|||
131941514|NCT04881760|475075237|FG006|Overall Study|Lost to Follow-up|4|||
131941515|NCT04881760|475075231|FG000|Overall Study|Withdrawal by Subject|13|||
131941516|NCT04881760|475075232|FG001|Overall Study|Withdrawal by Subject|1|||
131941517|NCT04881760|475075233|FG002|Overall Study|Withdrawal by Subject|1|||
131941518|NCT04881760|475075234|FG003|Overall Study|Withdrawal by Subject|4|||
131941519|NCT04881760|475075235|FG004|Overall Study|Withdrawal by Subject|2|||
131941520|NCT04881760|475075236|FG005|Overall Study|Withdrawal by Subject|1|||
131941521|NCT04881760|475075237|FG006|Overall Study|Withdrawal by Subject|2|||
131941522|NCT04881760|475075231|FG000|Overall Study|Randomized but Never Treated|0|||
131941523|NCT04881760|475075232|FG001|Overall Study|Randomized but Never Treated|0|||
131941524|NCT04881760|475075233|FG002|Overall Study|Randomized but Never Treated|0|||
131941525|NCT04881760|475075234|FG003|Overall Study|Randomized but Never Treated|1|||
131941526|NCT04881760|475075235|FG004|Overall Study|Randomized but Never Treated|0|||
131941527|NCT04881760|475075236|FG005|Overall Study|Randomized but Never Treated|0|||
131941528|NCT04881760|475075237|FG006|Overall Study|Randomized but Never Treated|0|||
131941529|NCT04881760|475075231|FG000|Overall Study|Inadvertent Enrollment|2|||
131941530|NCT04881760|475075232|FG001|Overall Study|Inadvertent Enrollment|0|||
131941531|NCT04881760|475075233|FG002|Overall Study|Inadvertent Enrollment|0|||
131941532|NCT04881760|475075234|FG003|Overall Study|Inadvertent Enrollment|0|||
131941533|NCT04881760|475075235|FG004|Overall Study|Inadvertent Enrollment|0|||
131941534|NCT04881760|475075236|FG005|Overall Study|Inadvertent Enrollment|0|||
131941535|NCT04881760|475075237|FG006|Overall Study|Inadvertent Enrollment|0|||
131941536|NCT04881760|475075231|FG000|Overall Study|Site Closure|0|||
131941537|NCT04881760|475075232|FG001|Overall Study|Site Closure|0|||
131941538|NCT04881760|475075233|FG002|Overall Study|Site Closure|0|||
131941539|NCT04881760|475075234|FG003|Overall Study|Site Closure|1|||
131941540|NCT04881760|475075235|FG004|Overall Study|Site Closure|0|||
131941541|NCT04881760|475075236|FG005|Overall Study|Site Closure|0|||
131941542|NCT04881760|475075237|FG006|Overall Study|Site Closure|0|||
131941543|NCT01538199|475075241|FG000|Overall Study|Lost to Follow-up|1|||
131941544|NCT01538199|475075242|FG001|Overall Study|Lost to Follow-up|2|||
131941545|NCT01538199|475075243|FG002|Overall Study|Lost to Follow-up|1|||
131941546|NCT01538199|475075244|FG003|Overall Study|Lost to Follow-up|0|||
131941547|NCT01538199|475075241|FG000|Overall Study|participant did not have time|1|||
131941548|NCT01538199|475075242|FG001|Overall Study|participant did not have time|0|||
131941549|NCT01538199|475075243|FG002|Overall Study|participant did not have time|0|||
131941550|NCT01538199|475075244|FG003|Overall Study|participant did not have time|2|||
131941551|NCT01538199|475075241|FG000|Overall Study|Lack of Efficacy|0|||
131941552|NCT01538199|475075242|FG001|Overall Study|Lack of Efficacy|1|||
131941553|NCT01538199|475075243|FG002|Overall Study|Lack of Efficacy|0|||
131941554|NCT01538199|475075244|FG003|Overall Study|Lack of Efficacy|0|||
131941555|NCT00902330|475075245|FG000|Overall Study|Too overwhelmed by treatment|2|||
131941556|NCT00902330|475075246|FG001|Overall Study|Too overwhelmed by treatment|5|||
131941557|NCT00902330|475075245|FG000|Overall Study|Adverse Event|1|||
131941558|NCT00902330|475075246|FG001|Overall Study|Adverse Event|0|||
131941559|NCT00902330|475075245|FG000|Overall Study|No post baseline data|1|||
131941560|NCT00902330|475075246|FG001|Overall Study|No post baseline data|0|||
131941561|NCT03950856|475075247|FG000|Overall Study|Death|1|||
131941562|NCT03950856|475075248|FG001|Overall Study|Death|2|||
131941563|NCT03950856|475075249|FG002|Overall Study|Death|0|||
131941564|NCT03950856|475075250|FG003|Overall Study|Death|0|||
131941565|NCT03950856|475075247|FG000|Overall Study|Lost to Follow-up|5|||
131941566|NCT03950856|475075248|FG001|Overall Study|Lost to Follow-up|6|||
131941567|NCT03950856|475075249|FG002|Overall Study|Lost to Follow-up|8|||
131941568|NCT03950856|475075250|FG003|Overall Study|Lost to Follow-up|2|||
131941569|NCT03950856|475075247|FG000|Overall Study|Protocol Violation|2|||
131941570|NCT03950856|475075248|FG001|Overall Study|Protocol Violation|0|||
131941571|NCT03950856|475075249|FG002|Overall Study|Protocol Violation|0|||
131941572|NCT03950856|475075250|FG003|Overall Study|Protocol Violation|1|||
131941573|NCT03950856|475075247|FG000|Overall Study|Withdrawal by Subject|4|||
131941574|NCT03950856|475075248|FG001|Overall Study|Withdrawal by Subject|1|||
131941575|NCT03950856|475075249|FG002|Overall Study|Withdrawal by Subject|3|||
131941576|NCT03950856|475075250|FG003|Overall Study|Withdrawal by Subject|1|||
131941577|NCT03950856|475075247|FG000|Overall Study|Unable to phone|7|||
131941578|NCT03950856|475075248|FG001|Overall Study|Unable to phone|6|||
131941579|NCT03950856|475075249|FG002|Overall Study|Unable to phone|7|||
131941580|NCT03950856|475075250|FG003|Overall Study|Unable to phone|2|||
131941581|NCT01816984|475075251|FG000|Overall Study|declining health status|1|||
131941582|NCT00542178|475075254|FG000|Overall Study|did not complete year 4 follow-up|75|||
131941583|NCT00542178|475075255|FG001|Overall Study|did not complete year 4 follow-up|80|||
131941584|NCT00542178|475075256|FG002|Overall Study|did not complete year 4 follow-up|74|||
131941585|NCT00542178|475075257|FG003|Overall Study|did not complete year 4 follow-up|62|||
131941586|NCT00542178|475075258|FG004|Overall Study|did not complete year 4 follow-up|64|||
131941587|NCT00542178|475075259|FG005|Overall Study|did not complete year 4 follow-up|89|||
131941588|NCT00542178|475075260|FG006|Overall Study|did not complete year 4 follow-up|87|||
131941589|NCT00542178|475075261|FG007|Overall Study|did not complete year 4 follow-up|85|||
131941590|NCT01492426|475076969|FG000|Treatment|Death|0|||
131941591|NCT01492426|475076970|FG001|Treatment|Death|1|||
131941592|NCT01492426|475076969|FG000|Treatment|Other|1|||
131941593|NCT01492426|475076970|FG001|Treatment|Other|0|||
131941594|NCT01492426|475076969|FG000|Treatment|Adverse Event|25|||
131941595|NCT01492426|475076970|FG001|Treatment|Adverse Event|25|||
131941596|NCT01492426|475076969|FG000|Treatment|Lack of Efficacy|38|||
131941597|NCT01492426|475076970|FG001|Treatment|Lack of Efficacy|5|||
131941598|NCT01492426|475076969|FG000|Treatment|Participant withdrew consent|1|||
131941599|NCT01492426|475076970|FG001|Treatment|Participant withdrew consent|2|||
131941600|NCT01492426|475076969|FG000|Treatment|Poor compliance/noncompliance|1|||
131941601|NCT01492426|475076970|FG001|Treatment|Poor compliance/noncompliance|0|||
131941602|NCT01492426|475076969|FG000|Treatment|Subject requested discontinue study drug|7|||
131941603|NCT01492426|475076970|FG001|Treatment|Subject requested discontinue study drug|3|||
131941604|NCT01492426|475076969|FG000|Treatment|Lost to Follow-up|9|||
131941605|NCT01492426|475076970|FG001|Treatment|Lost to Follow-up|4|||
131941606|NCT01492426|475076969|FG000|Treatment|Participant does not meet study criteria|1|||
131941607|NCT01492426|475076970|FG001|Treatment|Participant does not meet study criteria|0|||
131941608|NCT01492426|475076969|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
131941609|NCT01492426|475076970|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
131941610|NCT01492426|475076969|FG000|Follow-Up|Death|1|||
131941611|NCT01492426|475076970|FG001|Follow-Up|Death|0|||
131941612|NCT01492426|475076969|FG000|Follow-Up|Other|4|||
131941613|NCT01492426|475076970|FG001|Follow-Up|Other|2|||
131941614|NCT01492426|475076969|FG000|Follow-Up|Participant Withdrew Consent|6|||
131941615|NCT01492426|475076970|FG001|Follow-Up|Participant Withdrew Consent|1|||
131941616|NCT01492426|475076969|FG000|Follow-Up|Lost to Follow-up|12|||
131941617|NCT01492426|475076970|FG001|Follow-Up|Lost to Follow-up|6|||
131941618|NCT00652743|475076971|FG000|Months 12-18|Lost to Follow-up|1|||
131941619|NCT00652743|475076972|FG001|Months 12-18|Lost to Follow-up|2|||
131941620|NCT00652743|475076973|FG002|Months 12-18|Lost to Follow-up|7|||
131941621|NCT00652743|475076971|FG000|Months 24-30|Other|5|||
131941622|NCT00652743|475076972|FG001|Months 24-30|Other|1|||
131941623|NCT00652743|475076973|FG002|Months 24-30|Other|11|||
131941624|NCT00652743|475076971|FG000|Months 36-42|Serious Adverse Events|0|||
131941625|NCT00652743|475076972|FG001|Months 36-42|Serious Adverse Events|1|||
131941626|NCT00652743|475076973|FG002|Months 36-42|Serious Adverse Events|1|||
131941627|NCT00652743|475076971|FG000|Months 36-42|Withdrawal by Subject|1|||
131941628|NCT00652743|475076972|FG001|Months 36-42|Withdrawal by Subject|1|||
131941629|NCT00652743|475076973|FG002|Months 36-42|Withdrawal by Subject|0|||
131941630|NCT00652743|475076971|FG000|Months 36-42|Lost to Follow-up|0|||
131941631|NCT00652743|475076972|FG001|Months 36-42|Lost to Follow-up|1|||
131941632|NCT00652743|475076973|FG002|Months 36-42|Lost to Follow-up|0|||
131941633|NCT00652743|475076971|FG000|Months 36-42|Migrated/moved from study area|1|||
131941634|NCT00652743|475076972|FG001|Months 36-42|Migrated/moved from study area|0|||
131941635|NCT00652743|475076973|FG002|Months 36-42|Migrated/moved from study area|0|||
131941636|NCT00652743|475076971|FG000|Months 36-42|Other|4|||
131941637|NCT00652743|475076972|FG001|Months 36-42|Other|2|||
131941638|NCT00652743|475076973|FG002|Months 36-42|Other|8|||
131941639|NCT01978145|475076974|FG000|Treatment Period 1|Adverse Event|1|||
131941640|NCT01978145|475076975|FG001|Treatment Period 1|Adverse Event|9|||
131941641|NCT01978145|475076974|FG000|Treatment Period 1|Physician Decision|1|||
131941642|NCT01978145|475076975|FG001|Treatment Period 1|Physician Decision|0|||
131941643|NCT01978145|475076974|FG000|Treatment Period 1|Withdrawal by Subject|5|||
131941644|NCT01978145|475076975|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131941645|NCT01978145|475076974|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
131941646|NCT01978145|475076975|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
131941647|NCT01978145|475076974|FG000|Washout Period 1|Adverse Event|0|||
131941648|NCT01978145|475076975|FG001|Washout Period 1|Adverse Event|1|||
131941649|NCT01978145|475076974|FG000|Washout Period 1|Withdrawal by Subject|1|||
131941650|NCT01978145|475076975|FG001|Washout Period 1|Withdrawal by Subject|1|||
131941651|NCT01978145|475076974|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
131941652|NCT01978145|475076975|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
131941653|NCT01978145|475076974|FG000|Treatment Period 2|Adverse Event|3|||
131941654|NCT01978145|475076975|FG001|Treatment Period 2|Adverse Event|3|||
131941655|NCT01978145|475076974|FG000|Treatment Period 2|Protocol Violation|0|||
131941656|NCT01978145|475076975|FG001|Treatment Period 2|Protocol Violation|1|||
131941657|NCT01978145|475076974|FG000|Treatment Period 2|Lost to Follow-up|1|||
131941658|NCT01978145|475076975|FG001|Treatment Period 2|Lost to Follow-up|1|||
131941659|NCT01978145|475076974|FG000|Treatment Period 2|Withdrawal by Subject|7|||
131941660|NCT01978145|475076975|FG001|Treatment Period 2|Withdrawal by Subject|4|||
131941661|NCT01978145|475076974|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
131941662|NCT01978145|475076975|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
131941663|NCT00322049|475076976|FG000|Overall Study|Moved out of area|0|||
131941664|NCT00322049|475076977|FG001|Overall Study|Moved out of area|0|||
131941665|NCT00322049|475076978|FG002|Overall Study|Moved out of area|0|||
131941666|NCT00322049|475076979|FG003|Overall Study|Moved out of area|1|||
131941667|NCT00322049|475076976|FG000|Overall Study|Infected with Dengue during study|0|||
131941668|NCT00322049|475076977|FG001|Overall Study|Infected with Dengue during study|1|||
131941669|NCT00322049|475076978|FG002|Overall Study|Infected with Dengue during study|0|||
131941670|NCT00322049|475076979|FG003|Overall Study|Infected with Dengue during study|0|||
131941671|NCT01250054|475076980|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
131941672|NCT01250054|475076981|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
131941673|NCT02026011|475076982|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
131941674|NCT02026011|475076983|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
131941675|NCT02026011|475076982|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
131941676|NCT02026011|475076983|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
131941677|NCT02026011|475076982|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
131941678|NCT02026011|475076983|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
131941679|NCT02026011|475076982|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
131941680|NCT02026011|475076983|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
131941681|NCT01770743|475076984|FG000|Overall Study|Adverse Event|1|||
131941682|NCT01770743|475076985|FG001|Overall Study|Adverse Event|0|||
131941683|NCT01770743|475076986|FG002|Overall Study|Adverse Event|0|||
131941684|NCT01770743|475076987|FG003|Overall Study|Adverse Event|0|||
131941685|NCT01770743|475076988|FG004|Overall Study|Adverse Event|0|||
131941686|NCT01770743|475076984|FG000|Overall Study|Withdrawal by Subject|0|||
131941687|NCT01770743|475076985|FG001|Overall Study|Withdrawal by Subject|0|||
131941688|NCT01770743|475076986|FG002|Overall Study|Withdrawal by Subject|1|||
131941689|NCT01770743|475076987|FG003|Overall Study|Withdrawal by Subject|1|||
131941690|NCT01770743|475076988|FG004|Overall Study|Withdrawal by Subject|1|||
131941691|NCT01770743|475076984|FG000|Overall Study|Lost to Follow-up|0|||
131941692|NCT01770743|475076985|FG001|Overall Study|Lost to Follow-up|2|||
131941693|NCT01770743|475076986|FG002|Overall Study|Lost to Follow-up|0|||
131941694|NCT01770743|475076987|FG003|Overall Study|Lost to Follow-up|0|||
131941695|NCT01770743|475076988|FG004|Overall Study|Lost to Follow-up|1|||
131941696|NCT01770743|475076984|FG000|Overall Study|Sponsor Terminated Subject|1|||
131941697|NCT01770743|475076985|FG001|Overall Study|Sponsor Terminated Subject|0|||
131941698|NCT01770743|475076986|FG002|Overall Study|Sponsor Terminated Subject|0|||
131941699|NCT01770743|475076987|FG003|Overall Study|Sponsor Terminated Subject|1|||
131941700|NCT01770743|475076988|FG004|Overall Study|Sponsor Terminated Subject|0|||
131941701|NCT01770743|475076984|FG000|Overall Study|Moving Out of State|0|||
131941702|NCT01770743|475076985|FG001|Overall Study|Moving Out of State|1|||
131941703|NCT01770743|475076986|FG002|Overall Study|Moving Out of State|0|||
131941704|NCT01770743|475076987|FG003|Overall Study|Moving Out of State|0|||
131941705|NCT01770743|475076988|FG004|Overall Study|Moving Out of State|0|||
131941706|NCT00755807|475076995|FG000|Acute Phase|Adverse Event|16|||
131941707|NCT00755807|475076996|FG001|Acute Phase|Adverse Event|5|||
131941708|NCT00755807|475076995|FG000|Acute Phase|Protocol Violation|1|||
131941709|NCT00755807|475076996|FG001|Acute Phase|Protocol Violation|3|||
131941710|NCT00755807|475076995|FG000|Acute Phase|Withdrawal by Subject|1|||
131941711|NCT00755807|475076996|FG001|Acute Phase|Withdrawal by Subject|2|||
131941712|NCT00755807|475076995|FG000|Acute Phase|Lack of Efficacy|0|||
131941713|NCT00755807|475076996|FG001|Acute Phase|Lack of Efficacy|1|||
131941714|NCT00755807|475076995|FG000|Acute Phase|Physician Decision|0|||
131941715|NCT00755807|475076996|FG001|Acute Phase|Physician Decision|1|||
131941716|NCT00755807|475076995|FG000|Open-label Extension Phase|Adverse Event|7|||
131941717|NCT00755807|475076996|FG001|Open-label Extension Phase|Adverse Event|7|||
131941718|NCT00755807|475076995|FG000|Open-label Extension Phase|Protocol Violation|5|||
131941719|NCT00755807|475076996|FG001|Open-label Extension Phase|Protocol Violation|2|||
131941720|NCT00755807|475076995|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
131941721|NCT00755807|475076996|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
131941722|NCT00755807|475076995|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
131941723|NCT00755807|475076996|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
131941724|NCT00755807|475076995|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
131941725|NCT00755807|475076996|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
131941726|NCT00755807|475076995|FG000|Open-label Extension Phase|Sponsor Decision|0|||
131941727|NCT00755807|475076996|FG001|Open-label Extension Phase|Sponsor Decision|1|||
131941728|NCT00529243|475076999|FG000|Overall Study|Adverse Event|1|||
131941729|NCT00529243|475076999|FG000|Overall Study|Death|1|||
131941730|NCT00529243|475076999|FG000|Overall Study|Relocated|1|||
131941731|NCT00272792|475077006|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
131941732|NCT00272792|475077007|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
131941733|NCT00272792|475077006|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
131941734|NCT00272792|475077007|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
131941735|NCT00272792|475077006|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
131941736|NCT00272792|475077007|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
131941737|NCT00272792|475077006|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
131941738|NCT00272792|475077007|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
131412880|NCT01999218|473133802|FG000|Overall Study|Participant moves|2|||
131941739|NCT05111145|475077008|FG000|Overall Study|Commercial drug is available for participant|76|||
131941740|NCT05111145|475077008|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
131941741|NCT00952705|475077009|FG000|Overall Study|Lost to Follow-up|24|||
131941742|NCT00952705|475077010|FG001|Overall Study|Lost to Follow-up|8|||
131941743|NCT00952705|475077011|FG002|Overall Study|Lost to Follow-up|9|||
131941744|NCT00952705|475077009|FG000|Overall Study|Withdrawal by Subject|2|||
131941745|NCT00952705|475077010|FG001|Overall Study|Withdrawal by Subject|1|||
131941746|NCT00952705|475077011|FG002|Overall Study|Withdrawal by Subject|1|||
131941747|NCT00952705|475077009|FG000|Overall Study|Death|2|||
131941748|NCT00952705|475077010|FG001|Overall Study|Death|0|||
131941749|NCT00952705|475077011|FG002|Overall Study|Death|0|||
131941750|NCT00952705|475077009|FG000|Overall Study|Incarcerated post dose|5|||
131941751|NCT00952705|475077010|FG001|Overall Study|Incarcerated post dose|0|||
131941752|NCT00952705|475077011|FG002|Overall Study|Incarcerated post dose|0|||
131941753|NCT00952705|475077009|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
131941754|NCT00952705|475077010|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
131941755|NCT00952705|475077011|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
131941756|NCT02921789|475077012|FG000|Overall Study|Adverse Event|0|||
131941757|NCT02921789|475077013|FG001|Overall Study|Adverse Event|1|||
131941758|NCT02921789|475077012|FG000|Overall Study|Lost to Follow-up|1|||
131941759|NCT02921789|475077013|FG001|Overall Study|Lost to Follow-up|0|||
131941760|NCT02921789|475077012|FG000|Overall Study|Protocol Deviation|2|||
131941761|NCT02921789|475077013|FG001|Overall Study|Protocol Deviation|0|||
131941762|NCT02921789|475077012|FG000|Overall Study|Withdrawal by Subject|2|||
131941763|NCT02921789|475077013|FG001|Overall Study|Withdrawal by Subject|1|||
131941764|NCT02921789|475077012|FG000|Overall Study|Miscellaneous|3|||
131941765|NCT02921789|475077013|FG001|Overall Study|Miscellaneous|2|||
131941766|NCT04099277|475077014|FG000|Overall Study|Physician Decision|1|||
131941767|NCT04099277|475077014|FG000|Overall Study|Withdrawal by Subject|1|||
131941768|NCT01354223|475077017|FG000|Overall Study|Withdrawal by Subject|3|||
131941769|NCT01354223|475077018|FG001|Overall Study|Withdrawal by Subject|1|||
131941770|NCT03759600|475077023|FG000|Overall Study|Adverse Event|2|||
131941771|NCT03759600|475077023|FG000|Overall Study|Progressive Disease|15|||
131941772|NCT03759600|475077023|FG000|Overall Study|Site Terminated by Sponsor|3|||
131941773|NCT05173974|475077024|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
131941774|NCT05173974|475077025|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
131941775|NCT05173974|475077026|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
131941776|NCT05173974|475077027|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
131941777|NCT05173974|475077024|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
131941778|NCT05173974|475077025|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
131941779|NCT05173974|475077026|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
131941780|NCT05173974|475077027|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
131941781|NCT03289143|475077029|FG000|Overall Study|Caregiver Unavailability|1|||
131941782|NCT03289143|475077030|FG001|Overall Study|Caregiver Unavailability|1|||
131941783|NCT03289143|475077031|FG002|Overall Study|Caregiver Unavailability|0|||
131941784|NCT03289143|475077032|FG003|Overall Study|Caregiver Unavailability|0|||
131941785|NCT03289143|475077029|FG000|Overall Study|Research Department Closure|0|||
131941786|NCT03289143|475077030|FG001|Overall Study|Research Department Closure|0|||
131941787|NCT03289143|475077031|FG002|Overall Study|Research Department Closure|1|||
131941788|NCT03289143|475077032|FG003|Overall Study|Research Department Closure|0|||
131941789|NCT03289143|475077029|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
131941790|NCT03289143|475077030|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
131941791|NCT03289143|475077031|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
131941792|NCT03289143|475077032|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
131941793|NCT03289143|475077029|FG000|Overall Study|Medical Monitor Decision|1|||
131941794|NCT03289143|475077030|FG001|Overall Study|Medical Monitor Decision|0|||
131941795|NCT03289143|475077031|FG002|Overall Study|Medical Monitor Decision|0|||
131941796|NCT03289143|475077032|FG003|Overall Study|Medical Monitor Decision|0|||
131941797|NCT03289143|475077029|FG000|Overall Study|Participant Non-Compliance|0|||
131941798|NCT03289143|475077030|FG001|Overall Study|Participant Non-Compliance|0|||
131941799|NCT03289143|475077031|FG002|Overall Study|Participant Non-Compliance|1|||
131941800|NCT03289143|475077032|FG003|Overall Study|Participant Non-Compliance|0|||
131941801|NCT03289143|475077029|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
131941802|NCT03289143|475077030|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
131941803|NCT03289143|475077031|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
131941804|NCT03289143|475077032|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
131941805|NCT03289143|475077029|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
131941806|NCT03289143|475077030|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
131941807|NCT03289143|475077031|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
131412881|NCT01999218|473133803|FG001|Overall Study|Participant moves|5|||
131941808|NCT03289143|475077032|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
131941809|NCT03289143|475077029|FG000|Overall Study|Caregiver Passed Away|1|||
131941810|NCT03289143|475077030|FG001|Overall Study|Caregiver Passed Away|0|||
131941811|NCT03289143|475077031|FG002|Overall Study|Caregiver Passed Away|0|||
131941812|NCT03289143|475077032|FG003|Overall Study|Caregiver Passed Away|0|||
131941813|NCT03289143|475077029|FG000|Overall Study|Physician Decision|0|||
131941814|NCT03289143|475077030|FG001|Overall Study|Physician Decision|2|||
131941815|NCT03289143|475077031|FG002|Overall Study|Physician Decision|2|||
131941816|NCT03289143|475077032|FG003|Overall Study|Physician Decision|2|||
131941817|NCT03289143|475077029|FG000|Overall Study|Protocol Deviation|2|||
131941818|NCT03289143|475077030|FG001|Overall Study|Protocol Deviation|1|||
131941819|NCT03289143|475077031|FG002|Overall Study|Protocol Deviation|3|||
131941820|NCT03289143|475077032|FG003|Overall Study|Protocol Deviation|1|||
131941821|NCT03289143|475077029|FG000|Overall Study|Study Terminated By Sponsor|101|||
131941822|NCT03289143|475077030|FG001|Overall Study|Study Terminated By Sponsor|75|||
131941823|NCT03289143|475077031|FG002|Overall Study|Study Terminated By Sponsor|100|||
131941824|NCT03289143|475077032|FG003|Overall Study|Study Terminated By Sponsor|69|||
131941825|NCT03289143|475077029|FG000|Overall Study|Withdrawal by Subject|14|||
131941826|NCT03289143|475077030|FG001|Overall Study|Withdrawal by Subject|6|||
131941827|NCT03289143|475077031|FG002|Overall Study|Withdrawal by Subject|14|||
131941828|NCT03289143|475077032|FG003|Overall Study|Withdrawal by Subject|12|||
131941829|NCT03289143|475077029|FG000|Overall Study|Adverse Event|10|||
131941830|NCT03289143|475077030|FG001|Overall Study|Adverse Event|7|||
131941831|NCT03289143|475077031|FG002|Overall Study|Adverse Event|6|||
131941832|NCT03289143|475077032|FG003|Overall Study|Adverse Event|5|||
131941833|NCT03289143|475077029|FG000|Overall Study|Death|2|||
131941834|NCT03289143|475077030|FG001|Overall Study|Death|0|||
131941835|NCT03289143|475077031|FG002|Overall Study|Death|2|||
131941836|NCT03289143|475077032|FG003|Overall Study|Death|1|||
131941837|NCT03289143|475077029|FG000|Overall Study|Lost to Follow-up|2|||
131941838|NCT03289143|475077030|FG001|Overall Study|Lost to Follow-up|1|||
131941839|NCT03289143|475077031|FG002|Overall Study|Lost to Follow-up|1|||
131941840|NCT03289143|475077032|FG003|Overall Study|Lost to Follow-up|0|||
131941841|NCT03289143|475077029|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
131941842|NCT03289143|475077030|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
131941843|NCT03289143|475077031|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
131941844|NCT03289143|475077032|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
131941845|NCT03289143|475077029|FG000|Overall Study|Withdrawal by Caregiver|0|||
131941846|NCT03289143|475077030|FG001|Overall Study|Withdrawal by Caregiver|1|||
131941847|NCT03289143|475077031|FG002|Overall Study|Withdrawal by Caregiver|0|||
131941848|NCT03289143|475077032|FG003|Overall Study|Withdrawal by Caregiver|0|||
131941849|NCT03289143|475077029|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
131941850|NCT03289143|475077030|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
131941851|NCT03289143|475077031|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
131941852|NCT03289143|475077032|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
131941853|NCT03289143|475077029|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
131941854|NCT03289143|475077030|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
131941855|NCT03289143|475077031|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
131941856|NCT03289143|475077032|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
131941857|NCT00730756|475077033|FG000|Overall Study|Adverse Event|2|||
131941858|NCT00730756|475077034|FG001|Overall Study|Adverse Event|0|||
131941859|NCT00730756|475077033|FG000|Overall Study|Lack of Efficacy|1|||
131941860|NCT00730756|475077034|FG001|Overall Study|Lack of Efficacy|1|||
131941861|NCT00730756|475077033|FG000|Overall Study|Protocol Deviation|1|||
131941862|NCT00730756|475077034|FG001|Overall Study|Protocol Deviation|2|||
131941863|NCT00730756|475077033|FG000|Overall Study|Lost to Follow-up|0|||
131941864|NCT00730756|475077034|FG001|Overall Study|Lost to Follow-up|1|||
131941865|NCT00730756|475077033|FG000|Overall Study|Withdrew Consent|0|||
131941866|NCT00730756|475077034|FG001|Overall Study|Withdrew Consent|1|||
131941867|NCT00305877|475077035|FG000|Overall Study|Lack of Efficacy|6|||
131941868|NCT00305877|475077036|FG001|Overall Study|Lack of Efficacy|9|||
131941869|NCT00305877|475077035|FG000|Overall Study|Adverse Event|9|||
131941870|NCT00305877|475077036|FG001|Overall Study|Adverse Event|14|||
131941871|NCT00305877|475077035|FG000|Overall Study|Death|0|||
131941872|NCT00305877|475077036|FG001|Overall Study|Death|1|||
131941873|NCT00305877|475077035|FG000|Overall Study|Withdrawal by Subject|4|||
131941874|NCT00305877|475077036|FG001|Overall Study|Withdrawal by Subject|2|||
131941875|NCT00305877|475077035|FG000|Overall Study|Physician Decision|1|||
131941876|NCT00305877|475077036|FG001|Overall Study|Physician Decision|1|||
131941877|NCT00305877|475077035|FG000|Overall Study|Never start treatment|2|||
131941878|NCT00305877|475077036|FG001|Overall Study|Never start treatment|5|||
131941879|NCT00305877|475077035|FG000|Overall Study|Ineligible|2|||
131941880|NCT00305877|475077036|FG001|Overall Study|Ineligible|1|||
131941881|NCT00305877|475077035|FG000|Overall Study|Transportation issue with daily RT|0|||
131941882|NCT00305877|475077036|FG001|Overall Study|Transportation issue with daily RT|1|||
131941883|NCT01126190|475077037|FG000|Double-Blind Phase|Death|0|||
131941884|NCT01126190|475077038|FG001|Double-Blind Phase|Death|1|||
131941885|NCT01126190|475077039|FG002|Double-Blind Phase|Death|0|||
131941886|NCT01126190|475077037|FG000|Double-Blind Phase|Adverse Event|1|||
131941887|NCT01126190|475077038|FG001|Double-Blind Phase|Adverse Event|2|||
131941888|NCT01126190|475077039|FG002|Double-Blind Phase|Adverse Event|0|||
131941889|NCT01126190|475077037|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
131941890|NCT01126190|475077038|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
131941891|NCT01126190|475077039|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131941892|NCT01126190|475077037|FG000|Double-Blind Phase|Request of Investigator|1|||
131941893|NCT01126190|475077038|FG001|Double-Blind Phase|Request of Investigator|0|||
131941894|NCT01126190|475077039|FG002|Double-Blind Phase|Request of Investigator|0|||
131941895|NCT01126190|475077037|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
131941896|NCT01126190|475077038|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
131941897|NCT01126190|475077039|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
131941898|NCT01126190|475077037|FG000|Double-Blind Phase|Non-compliance|1|||
131941899|NCT01126190|475077038|FG001|Double-Blind Phase|Non-compliance|0|||
131941900|NCT01126190|475077039|FG002|Double-Blind Phase|Non-compliance|0|||
131941901|NCT01126190|475077037|FG000|Double-Blind Phase|Lost to Follow-up|1|||
131941902|NCT01126190|475077038|FG001|Double-Blind Phase|Lost to Follow-up|3|||
131941903|NCT01126190|475077039|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131941904|NCT01126190|475077037|FG000|Open-Label Phase|Death|0|||
131941905|NCT01126190|475077038|FG001|Open-Label Phase|Death|0|||
131941906|NCT01126190|475077039|FG002|Open-Label Phase|Death|1|||
131941907|NCT01126190|475077037|FG000|Open-Label Phase|Adverse Event|0|||
131941908|NCT01126190|475077038|FG001|Open-Label Phase|Adverse Event|0|||
131941909|NCT01126190|475077039|FG002|Open-Label Phase|Adverse Event|4|||
131941910|NCT01126190|475077037|FG000|Open-Label Phase|Withdrawal by Subject|0|||
131941911|NCT01126190|475077038|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131941912|NCT01126190|475077039|FG002|Open-Label Phase|Withdrawal by Subject|6|||
131941913|NCT00524121|475077042|FG000|Overall Study|Disease progression|6|||
131941914|NCT00524121|475077042|FG000|Overall Study|Adverse Event|4|||
131941915|NCT00524121|475077042|FG000|Overall Study|Patient refused|2|||
131941916|NCT00524121|475077042|FG000|Overall Study|Other|1|||
131941917|NCT00524121|475077042|FG000|Overall Study|Death|1|||
131941918|NCT00524121|475077042|FG000|Overall Study|Not treated (became ineligible)|4|||
131941919|NCT00524121|475077042|FG000|Overall Study|Not treated (changed mind)|1|||
131941920|NCT01446874|475077043|FG000|Overall Study|Not eligible|1|||
131941921|NCT01446874|475077044|FG001|Overall Study|Not eligible|0|||
131941922|NCT01446874|475077045|FG002|Overall Study|Not eligible|0|||
131941923|NCT01446874|475077043|FG000|Overall Study|No surgery/No qualifying surgery|1|||
131941924|NCT01446874|475077044|FG001|Overall Study|No surgery/No qualifying surgery|0|||
131941925|NCT01446874|475077045|FG002|Overall Study|No surgery/No qualifying surgery|12|||
131941926|NCT01446874|475077043|FG000|Overall Study|Non-compliance|0|||
131941927|NCT01446874|475077044|FG001|Overall Study|Non-compliance|4|||
131941928|NCT01446874|475077045|FG002|Overall Study|Non-compliance|0|||
131941929|NCT01446874|475077043|FG000|Overall Study|Antibiotics for pre-op infection|0|||
131941930|NCT01446874|475077044|FG001|Overall Study|Antibiotics for pre-op infection|0|||
131941931|NCT01446874|475077045|FG002|Overall Study|Antibiotics for pre-op infection|2|||
131941932|NCT01446874|475077043|FG000|Overall Study|Withdrawal by Subject|0|||
131941933|NCT01446874|475077044|FG001|Overall Study|Withdrawal by Subject|0|||
131941934|NCT01446874|475077045|FG002|Overall Study|Withdrawal by Subject|4|||
131941935|NCT00457392|475077046|FG000|Overall Study|Objective Progression or Relapse|229|||
131941936|NCT00457392|475077047|FG001|Overall Study|Objective Progression or Relapse|296|||
131941937|NCT00457392|475077046|FG000|Overall Study|Death|106|||
131941938|NCT00457392|475077047|FG001|Overall Study|Death|106|||
131941939|NCT00457392|475077046|FG000|Overall Study|Adverse Event|84|||
131941940|NCT00457392|475077047|FG001|Overall Study|Adverse Event|41|||
131941941|NCT00457392|475077046|FG000|Overall Study|Global Deterioration of Health Status|22|||
131941942|NCT00457392|475077047|FG001|Overall Study|Global Deterioration of Health Status|8|||
131941943|NCT00457392|475077046|FG000|Overall Study|Withdrawal by Subject|14|||
131941944|NCT00457392|475077047|FG001|Overall Study|Withdrawal by Subject|8|||
131941945|NCT00457392|475077046|FG000|Overall Study|Lost to Follow-up|6|||
131941946|NCT00457392|475077047|FG001|Overall Study|Lost to Follow-up|7|||
131941947|NCT00457392|475077046|FG000|Overall Study|Protocol Violation|4|||
131941948|NCT00457392|475077047|FG001|Overall Study|Protocol Violation|3|||
131941949|NCT00457392|475077046|FG000|Overall Study|Other|7|||
131941950|NCT00457392|475077047|FG001|Overall Study|Other|4|||
131941951|NCT00457392|475077046|FG000|Overall Study|Study Terminated by Sponsor|1|||
131941952|NCT00457392|475077047|FG001|Overall Study|Study Terminated by Sponsor|4|||
131941953|NCT00457392|475077046|FG000|Overall Study|Randomized, Not Treated|7|||
131941954|NCT00457392|475077047|FG001|Overall Study|Randomized, Not Treated|3|||
131941955|NCT01466491|475077048|FG000|Overall Study|Protocol Violation|0|||
131941956|NCT01466491|475077049|FG001|Overall Study|Protocol Violation|3|||
131941957|NCT01466491|475077050|FG002|Overall Study|Protocol Violation|2|||
131941958|NCT01466491|475077051|FG003|Overall Study|Protocol Violation|0|||
131941959|NCT01466491|475077048|FG000|Overall Study|Missing Data|0|||
131941960|NCT01466491|475077049|FG001|Overall Study|Missing Data|0|||
131941961|NCT01466491|475077050|FG002|Overall Study|Missing Data|1|||
131941962|NCT01466491|475077051|FG003|Overall Study|Missing Data|0|||
131941963|NCT02727322|475077052|FG000|Overall Study|Withdrawal by Subject|1|||
131941964|NCT02727322|475077053|FG001|Overall Study|Withdrawal by Subject|1|||
131941965|NCT02727322|475077052|FG000|Overall Study|Protocol Violation|1|||
131941966|NCT02727322|475077053|FG001|Overall Study|Protocol Violation|0|||
131941967|NCT02852967|475077054|FG000|Overall Study|Adverse Event|3|||
131941968|NCT02852967|475077055|FG001|Overall Study|Adverse Event|1|||
131941969|NCT02852967|475077056|FG002|Overall Study|Adverse Event|0|||
131941970|NCT02852967|475077057|FG003|Overall Study|Adverse Event|1|||
131941971|NCT02852967|475077058|FG004|Overall Study|Adverse Event|0|||
131941972|NCT02852967|475077054|FG000|Overall Study|Death|1|||
131941973|NCT02852967|475077055|FG001|Overall Study|Death|0|||
131941974|NCT02852967|475077056|FG002|Overall Study|Death|0|||
131941975|NCT02852967|475077057|FG003|Overall Study|Death|0|||
131941976|NCT02852967|475077058|FG004|Overall Study|Death|0|||
131941977|NCT02852967|475077054|FG000|Overall Study|Lost to Follow-up|1|||
131941978|NCT02852967|475077055|FG001|Overall Study|Lost to Follow-up|2|||
131941979|NCT02852967|475077056|FG002|Overall Study|Lost to Follow-up|3|||
131941980|NCT02852967|475077057|FG003|Overall Study|Lost to Follow-up|4|||
131941981|NCT02852967|475077058|FG004|Overall Study|Lost to Follow-up|4|||
131941982|NCT02852967|475077054|FG000|Overall Study|Withdrawal by Subject|6|||
131941983|NCT02852967|475077055|FG001|Overall Study|Withdrawal by Subject|12|||
131941984|NCT02852967|475077056|FG002|Overall Study|Withdrawal by Subject|7|||
131941985|NCT02852967|475077057|FG003|Overall Study|Withdrawal by Subject|10|||
131941986|NCT02852967|475077058|FG004|Overall Study|Withdrawal by Subject|10|||
131941987|NCT02852967|475077054|FG000|Overall Study|SAE|0|||
131941988|NCT02852967|475077055|FG001|Overall Study|SAE|0|||
131941989|NCT02852967|475077056|FG002|Overall Study|SAE|0|||
131941990|NCT02852967|475077057|FG003|Overall Study|SAE|3|||
131941991|NCT02852967|475077058|FG004|Overall Study|SAE|0|||
131941992|NCT02852967|475077054|FG000|Overall Study|Elevated Liver Enzymes|2|||
131941993|NCT02852967|475077055|FG001|Overall Study|Elevated Liver Enzymes|0|||
131941994|NCT02852967|475077056|FG002|Overall Study|Elevated Liver Enzymes|0|||
131941995|NCT02852967|475077057|FG003|Overall Study|Elevated Liver Enzymes|2|||
131941996|NCT02852967|475077058|FG004|Overall Study|Elevated Liver Enzymes|2|||
131941997|NCT02852967|475077054|FG000|Overall Study|Physician Decision|0|||
131941998|NCT02852967|475077055|FG001|Overall Study|Physician Decision|0|||
131941999|NCT02852967|475077056|FG002|Overall Study|Physician Decision|0|||
131942000|NCT02852967|475077057|FG003|Overall Study|Physician Decision|1|||
131942001|NCT02852967|475077058|FG004|Overall Study|Physician Decision|0|||
131942002|NCT02852967|475077054|FG000|Overall Study|Lack of Efficacy|0|||
131942003|NCT02852967|475077055|FG001|Overall Study|Lack of Efficacy|1|||
131942004|NCT02852967|475077056|FG002|Overall Study|Lack of Efficacy|0|||
131942005|NCT02852967|475077057|FG003|Overall Study|Lack of Efficacy|0|||
131942006|NCT02852967|475077058|FG004|Overall Study|Lack of Efficacy|0|||
131942007|NCT02852967|475077054|FG000|Overall Study|Non-compliance|0|||
131942008|NCT02852967|475077055|FG001|Overall Study|Non-compliance|0|||
131942009|NCT02852967|475077056|FG002|Overall Study|Non-compliance|1|||
131942010|NCT02852967|475077057|FG003|Overall Study|Non-compliance|1|||
131942011|NCT02852967|475077058|FG004|Overall Study|Non-compliance|0|||
131942012|NCT02852967|475077054|FG000|Overall Study|Dispensing Drug Violation|0|||
131942013|NCT02852967|475077055|FG001|Overall Study|Dispensing Drug Violation|0|||
131942014|NCT02852967|475077056|FG002|Overall Study|Dispensing Drug Violation|1|||
131942015|NCT02852967|475077057|FG003|Overall Study|Dispensing Drug Violation|0|||
131942016|NCT02852967|475077058|FG004|Overall Study|Dispensing Drug Violation|0|||
131942017|NCT02852967|475077054|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
131942018|NCT02852967|475077055|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
131942019|NCT02852967|475077056|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
131942020|NCT02852967|475077057|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
131942021|NCT02852967|475077058|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
131942022|NCT00339040|475077059|FG000|Stage I|Not able to attend clinic|1|||
131942023|NCT00339040|475077060|FG001|Stage I|Not able to attend clinic|0|||
131942024|NCT00339040|475077059|FG000|Stage I|Protocol Violation|1|||
131942025|NCT00339040|475077060|FG001|Stage I|Protocol Violation|1|||
131942026|NCT00339040|475077059|FG000|Stage II|Lost to Follow-up|3|||
131942027|NCT00339040|475077060|FG001|Stage II|Lost to Follow-up|0|||
131942028|NCT00339040|475077059|FG000|Stage II|Withdrawal by Subject|1|||
131942029|NCT00339040|475077060|FG001|Stage II|Withdrawal by Subject|2|||
131942030|NCT00339040|475077059|FG000|Stage II|Protocol Violation|3|||
131454817|NCT00124306|473294262|FG000|Overall Study|Use of unacceptable medication|1|||
131454818|NCT00124306|473294263|FG001|Overall Study|Use of unacceptable medication|0|||
131454819|NCT00124306|473294262|FG000|Overall Study|Abnormal lab result|0|||
131942031|NCT00339040|475077060|FG001|Stage II|Protocol Violation|0|||
131942032|NCT00339040|475077059|FG000|Stage II|Not able to attend clinic|1|||
131942033|NCT00339040|475077060|FG001|Stage II|Not able to attend clinic|0|||
131942034|NCT00339040|475077059|FG000|Stage II|Site closing|2|||
131942035|NCT00339040|475077060|FG001|Stage II|Site closing|0|||
131942036|NCT03046446|475077061|FG000|Overall Study|Lack of Efficacy|7|||
131942037|NCT03046446|475077061|FG000|Overall Study|Adverse Event|6|||
131942038|NCT03046446|475077061|FG000|Overall Study|Lost to Follow-up|3|||
131942039|NCT03046446|475077061|FG000|Overall Study|Withdrawal by Subject|14|||
131942040|NCT03046446|475077061|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
131942041|NCT03046446|475077061|FG000|Overall Study|Disease Progression (see caveats)|25|||
131942042|NCT03046446|475077061|FG000|Overall Study|Non OA related knee surgery|1|||
131942043|NCT03036852|475077062|FG000|Overall Study|Death|2|||
131942044|NCT03036852|475077062|FG000|Overall Study|Lack of Efficacy|2|||
131454820|NCT00124306|473294263|FG001|Overall Study|Abnormal lab result|1|||
131454821|NCT00124306|473294262|FG000|Overall Study|Other|2|||
131942045|NCT03036852|475077062|FG000|Overall Study|Adverse Event|1|||
131942046|NCT03036852|475077062|FG000|Overall Study|Lost to Follow-up|1|||
131454822|NCT00124306|473294263|FG001|Overall Study|Other|0|||
131454823|NCT04238819|473294265|FG000|Overall Study|Ongoing Treatment|0|||
131454824|NCT04238819|473294266|FG001|Overall Study|Ongoing Treatment|0|||
131454825|NCT04238819|473294267|FG002|Overall Study|Ongoing Treatment|0|||
131454826|NCT04238819|473294268|FG003|Overall Study|Ongoing Treatment|0|||
131454827|NCT04238819|473294269|FG004|Overall Study|Ongoing Treatment|1|||
131454828|NCT04238819|473294270|FG005|Overall Study|Ongoing Treatment|4|||
131454829|NCT04238819|473294271|FG006|Overall Study|Ongoing Treatment|0|||
131454830|NCT04238819|473294265|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
131454831|NCT04238819|473294266|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
131454832|NCT04238819|473294267|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
131454833|NCT04238819|473294268|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
131454834|NCT04238819|473294269|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
131454835|NCT04238819|473294270|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
131454836|NCT04238819|473294271|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
131454837|NCT00924027|473294273|FG000|Overall Study|Lost to Further Follow-Up|4|||
131454838|NCT00924027|473294274|FG001|Overall Study|Lost to Further Follow-Up|0|||
131454839|NCT00924027|473294275|FG002|Overall Study|Lost to Further Follow-Up|0|||
131454840|NCT00924027|473294276|FG003|Overall Study|Lost to Further Follow-Up|0|||
131454841|NCT00924027|473294273|FG000|Overall Study|Physician Decision|1|||
131454842|NCT00924027|473294274|FG001|Overall Study|Physician Decision|0|||
131454843|NCT00924027|473294275|FG002|Overall Study|Physician Decision|0|||
131454844|NCT00924027|473294276|FG003|Overall Study|Physician Decision|1|||
131454845|NCT00924027|473294273|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
131454846|NCT00924027|473294274|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
131454847|NCT00924027|473294275|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
131454848|NCT00924027|473294276|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
131454849|NCT00924027|473294273|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
131454850|NCT00924027|473294274|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
131454851|NCT00924027|473294275|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
131454852|NCT00924027|473294276|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
131454853|NCT00924027|473294273|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
131454854|NCT00924027|473294274|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
131454855|NCT00924027|473294275|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
131454856|NCT00924027|473294276|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
131454857|NCT03568461|473294277|FG000|Overall Study|Death|7|||
131454858|NCT03568461|473294277|FG000|Overall Study|Physician Decision|5|||
131454859|NCT03568461|473294277|FG000|Overall Study|Subject decision|5|||
131454860|NCT03568461|473294277|FG000|Overall Study|Lost to Follow-up|1|||
131942047|NCT00163189|475077063|FG000|Overall Study|Other|6|||
131454873|NCT02355184|473294280|FG000|Overall Study|Lost to Follow-up|2|||
131454874|NCT02355184|473294280|FG000|Overall Study|Study Terminated|10|||
131454875|NCT04193189|473294281|FG000|Overall Study|Lost to Follow-up|9|||
131454876|NCT04193189|473294282|FG001|Overall Study|Lost to Follow-up|7|||
131454877|NCT04193189|473294283|FG002|Overall Study|Lost to Follow-up|9|||
131454878|NCT04193189|473294284|FG003|Overall Study|Lost to Follow-up|0|||
131942048|NCT00163189|475077063|FG000|Overall Study|Lost to Follow-up|1|||
131454879|NCT04193189|473294281|FG000|Overall Study|Withdrawal by Subject|1|||
131454880|NCT04193189|473294282|FG001|Overall Study|Withdrawal by Subject|2|||
131942049|NCT00163189|475077063|FG000|Overall Study|Protocol Violation|2|||
131942050|NCT00163189|475077063|FG000|Overall Study|Death|3|||
131454881|NCT04193189|473294283|FG002|Overall Study|Withdrawal by Subject|2|||
131454882|NCT04193189|473294284|FG003|Overall Study|Withdrawal by Subject|0|||
131454883|NCT04193189|473294281|FG000|Overall Study|Death|1|||
131454884|NCT04193189|473294282|FG001|Overall Study|Death|1|||
131454885|NCT04193189|473294283|FG002|Overall Study|Death|0|||
131454886|NCT04193189|473294284|FG003|Overall Study|Death|0|||
131454887|NCT04193189|473294281|FG000|Overall Study|Protocol Violation|0|||
131454888|NCT04193189|473294282|FG001|Overall Study|Protocol Violation|0|||
131454889|NCT04193189|473294283|FG002|Overall Study|Protocol Violation|0|||
131454890|NCT04193189|473294284|FG003|Overall Study|Protocol Violation|1|||
131454891|NCT02840799|473295453|FG000|Phase 1|Physician Decision|1|||
131454892|NCT02840799|473295454|FG001|Phase 1|Physician Decision|3|||
131942051|NCT00163189|475077063|FG000|Overall Study|Adverse Event|6|||
131942052|NCT00163189|475077063|FG000|Overall Study|Lack of Efficacy|7|||
131942053|NCT00163189|475077063|FG000|Overall Study|Study terminated by sponsor|11|||
131942054|NCT00163189|475077063|FG000|Overall Study|Withdrawal by Subject|11|||
131942055|NCT00163189|475077063|FG000|Overall Study|Did not meet continuation criterion|16|||
131942056|NCT01917318|475077067|FG000|First Treatment|Withdrawal by Subject|0|||
131942057|NCT01917318|475077068|FG001|First Treatment|Withdrawal by Subject|1|||
131942058|NCT01213082|475077071|FG000|Overall Study|Lost to Follow-up|6|||
131942059|NCT01213082|475077072|FG001|Overall Study|Lost to Follow-up|7|||
131942060|NCT01213082|475077073|FG002|Overall Study|Lost to Follow-up|4|||
131942061|NCT01213082|475077071|FG000|Overall Study|Physician Decision|0|||
131942062|NCT01213082|475077072|FG001|Overall Study|Physician Decision|0|||
131942063|NCT01213082|475077073|FG002|Overall Study|Physician Decision|1|||
131942064|NCT03848416|475077077|FG000|Overall Study|Withdrawal by Subject|1|||
131942065|NCT03848416|475077078|FG001|Overall Study|Withdrawal by Subject|0|||
131942066|NCT03848416|475077079|FG002|Overall Study|Withdrawal by Subject|0|||
131942067|NCT03848416|475077077|FG000|Overall Study|Death|0|||
131942068|NCT03848416|475077078|FG001|Overall Study|Death|0|||
131942069|NCT03848416|475077079|FG002|Overall Study|Death|1|||
131942070|NCT02639390|475077080|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
131942071|NCT02639390|475077081|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
131942072|NCT00698828|475077082|FG000|Overall Study|Adverse Event|3|||
131942073|NCT00698828|475077083|FG001|Overall Study|Adverse Event|4|||
131942074|NCT00698828|475077084|FG002|Overall Study|Adverse Event|4|||
131942075|NCT00698828|475077082|FG000|Overall Study|Death|0|||
131942076|NCT00698828|475077083|FG001|Overall Study|Death|0|||
131942077|NCT00698828|475077084|FG002|Overall Study|Death|1|||
131942078|NCT00698828|475077082|FG000|Overall Study|Exacerbation of COPD|1|||
131942079|NCT00698828|475077083|FG001|Overall Study|Exacerbation of COPD|3|||
131942080|NCT00698828|475077084|FG002|Overall Study|Exacerbation of COPD|0|||
131942081|NCT00698828|475077082|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
131942082|NCT00698828|475077083|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
131942083|NCT00698828|475077084|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
131942084|NCT00698828|475077082|FG000|Overall Study|Investigator/Sponsor decision|1|||
131942085|NCT00698828|475077083|FG001|Overall Study|Investigator/Sponsor decision|0|||
131942086|NCT00698828|475077084|FG002|Overall Study|Investigator/Sponsor decision|2|||
131942087|NCT00698828|475077082|FG000|Overall Study|Lost to Follow-up|1|||
131942088|NCT00698828|475077083|FG001|Overall Study|Lost to Follow-up|1|||
131942089|NCT00698828|475077084|FG002|Overall Study|Lost to Follow-up|0|||
131942090|NCT00698828|475077082|FG000|Overall Study|Withdrew consent|0|||
131942091|NCT00698828|475077083|FG001|Overall Study|Withdrew consent|7|||
131942092|NCT00698828|475077084|FG002|Overall Study|Withdrew consent|4|||
131942093|NCT00698828|475077082|FG000|Overall Study|Withdrew consent (not treated)|2|||
131942094|NCT00698828|475077083|FG001|Overall Study|Withdrew consent (not treated)|0|||
131942095|NCT00698828|475077084|FG002|Overall Study|Withdrew consent (not treated)|0|||
131942096|NCT02013609|475077085|FG000|Overall Study|Withdrawal by Subject|9|||
131942097|NCT02013609|475077085|FG000|Overall Study|Lost to Follow-up|3|||
131942098|NCT02013609|475077085|FG000|Overall Study|Adverse Event|3|||
131942099|NCT02013609|475077085|FG000|Overall Study|Met Withdrawal Criteria|3|||
131942100|NCT00856609|475077086|FG000|Overall Study|Adverse Event|1|||
131942101|NCT00856609|475077087|FG001|Overall Study|Adverse Event|0|||
131942102|NCT00783432|475077088|FG000|Overall Study|Adverse Event|22|||
131942103|NCT00783432|475077089|FG001|Overall Study|Adverse Event|17|||
131942104|NCT00783432|475077088|FG000|Overall Study|Lack of Efficacy|20|||
131942105|NCT00783432|475077089|FG001|Overall Study|Lack of Efficacy|21|||
131942106|NCT00783432|475077088|FG000|Overall Study|Lost to Follow-up|11|||
131942107|NCT00783432|475077089|FG001|Overall Study|Lost to Follow-up|6|||
131942108|NCT00783432|475077088|FG000|Overall Study|Withdrawal by Subject|23|||
131942109|NCT00783432|475077089|FG001|Overall Study|Withdrawal by Subject|20|||
131942110|NCT00783432|475077088|FG000|Overall Study|subject moved|3|||
131942111|NCT00783432|475077089|FG001|Overall Study|subject moved|5|||
131942112|NCT00783432|475077088|FG000|Overall Study|Protocol Violation|6|||
131942113|NCT00783432|475077089|FG001|Overall Study|Protocol Violation|9|||
131942114|NCT01436110|475077090|FG000|Overall Study|Lack of Efficacy|23|||
131942115|NCT01436110|475077091|FG001|Overall Study|Lack of Efficacy|14|||
131942116|NCT01436110|475077092|FG002|Overall Study|Lack of Efficacy|9|||
131412882|NCT01999218|473133804|FG002|Overall Study|Participant moves|3|||
131942117|NCT01436110|475077090|FG000|Overall Study|Withdrawal by Subject|6|||
131942118|NCT01436110|475077091|FG001|Overall Study|Withdrawal by Subject|8|||
131942119|NCT01436110|475077092|FG002|Overall Study|Withdrawal by Subject|4|||
131942120|NCT01436110|475077090|FG000|Overall Study|Adverse Event|2|||
131942121|NCT01436110|475077091|FG001|Overall Study|Adverse Event|1|||
131942122|NCT01436110|475077092|FG002|Overall Study|Adverse Event|2|||
131942123|NCT01436110|475077090|FG000|Overall Study|Physician Decision|3|||
131942124|NCT01436110|475077091|FG001|Overall Study|Physician Decision|1|||
131942125|NCT01436110|475077092|FG002|Overall Study|Physician Decision|1|||
131942126|NCT01436110|475077090|FG000|Overall Study|Lost to Follow-up|1|||
131942127|NCT01436110|475077091|FG001|Overall Study|Lost to Follow-up|1|||
131454893|NCT02840799|473295453|FG000|Phase 1|Withdrawal by Subject|4|||
131454894|NCT02840799|473295454|FG001|Phase 1|Withdrawal by Subject|0|||
131454895|NCT02840799|473295453|FG000|Phase 2 (Crossover)|Adverse Event|0|||
131454896|NCT02840799|473295454|FG001|Phase 2 (Crossover)|Adverse Event|1|||
131454897|NCT02840799|473295453|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
131454898|NCT02840799|473295454|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
131454899|NCT02565784|473295455|FG000|First Treatment|Adverse Event|1|||
131454900|NCT02565784|473295455|FG000|First Treatment|Withdrawal by Subject|1|||
131454901|NCT02565784|473295455|FG000|Second Treatment|Withdrawal by Subject|2|||
131454902|NCT00552188|473295465|FG000|Overall Study|Adverse Event|0|||
131454903|NCT00552188|473295466|FG001|Overall Study|Adverse Event|2|||
131454904|NCT00552188|473295465|FG000|Overall Study|Lost to Follow-up|2|||
131454905|NCT00552188|473295466|FG001|Overall Study|Lost to Follow-up|1|||
131454906|NCT00552188|473295465|FG000|Overall Study|Withdrawal of consent|0|||
131454907|NCT00552188|473295466|FG001|Overall Study|Withdrawal of consent|1|||
131454908|NCT00552188|473295465|FG000|Overall Study|Subject returned to home country|0|||
131454909|NCT00552188|473295466|FG001|Overall Study|Subject returned to home country|1|||
131454910|NCT00476008|473295479|FG000|Overall Study|Adverse Event|4|||
131454911|NCT00476008|473295480|FG001|Overall Study|Adverse Event|4|||
131454912|NCT00476008|473295479|FG000|Overall Study|Placebo concerns|2|||
131454913|NCT00476008|473295480|FG001|Overall Study|Placebo concerns|2|||
131454914|NCT00476008|473295479|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
131454915|NCT00476008|473295480|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
131454916|NCT00476008|473295479|FG000|Overall Study|Withdrawal by Subject|0|||
131454917|NCT00476008|473295480|FG001|Overall Study|Withdrawal by Subject|1|||
131454918|NCT00476008|473295479|FG000|Overall Study|Death|1|||
131454919|NCT00476008|473295480|FG001|Overall Study|Death|0|||
131454920|NCT00792571|473295482|FG000|Overall Study|Death|1|||
131454921|NCT00792571|473295482|FG000|Overall Study|Adverse Event|4|||
131454922|NCT00792571|473295482|FG000|Overall Study|Withdrawal by Subject|1|||
131454923|NCT00792571|473295482|FG000|Overall Study|Other|4|||
131454924|NCT02600819|473295483|FG000|GEN Phase|Adverse Event|2|||
131454925|NCT02600819|473295484|FG001|GEN Phase|Adverse Event|0|||
131454926|NCT02600819|473295483|FG000|GEN Phase|Death|2|||
131454927|NCT02600819|473295484|FG001|GEN Phase|Death|0|||
131454928|NCT02600819|473295483|FG000|GEN Phase|Investigator's Discretion|4|||
131454929|NCT02600819|473295484|FG001|GEN Phase|Investigator's Discretion|0|||
131454930|NCT02600819|473295483|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
131454931|NCT02600819|473295484|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
131454932|NCT02600819|473295483|FG000|GEN Phase|Withdrew Consent|5|||
131454933|NCT02600819|473295484|FG001|GEN Phase|Withdrew Consent|0|||
131454934|NCT02600819|473295483|FG000|GEN Phase|Lost to Follow-up|2|||
131454935|NCT02600819|473295484|FG001|GEN Phase|Lost to Follow-up|0|||
131454936|NCT01088048|473295485|FG000|Overall Study|Adverse Event|7|||
131454937|NCT01088048|473295486|FG001|Overall Study|Adverse Event|9|||
131454938|NCT01088048|473295487|FG002|Overall Study|Adverse Event|7|||
131454939|NCT01088048|473295488|FG003|Overall Study|Adverse Event|5|||
131454940|NCT01088048|473295489|FG004|Overall Study|Adverse Event|6|||
131454941|NCT01088048|473295490|FG005|Overall Study|Adverse Event|3|||
131454942|NCT01088048|473295491|FG006|Overall Study|Adverse Event|3|||
131454943|NCT01088048|473295492|FG007|Overall Study|Adverse Event|0|||
131454944|NCT01088048|473295493|FG008|Overall Study|Adverse Event|2|||
131454945|NCT01088048|473295494|FG009|Overall Study|Adverse Event|2|||
131454946|NCT01088048|473295485|FG000|Overall Study|Withdrew Consent|1|||
131454947|NCT01088048|473295486|FG001|Overall Study|Withdrew Consent|1|||
131454948|NCT01088048|473295487|FG002|Overall Study|Withdrew Consent|1|||
131454949|NCT01088048|473295488|FG003|Overall Study|Withdrew Consent|1|||
131454950|NCT01088048|473295489|FG004|Overall Study|Withdrew Consent|2|||
131454951|NCT01088048|473295490|FG005|Overall Study|Withdrew Consent|1|||
131454952|NCT01088048|473295491|FG006|Overall Study|Withdrew Consent|0|||
131454953|NCT01088048|473295492|FG007|Overall Study|Withdrew Consent|2|||
131454954|NCT01088048|473295493|FG008|Overall Study|Withdrew Consent|2|||
131454955|NCT01088048|473295494|FG009|Overall Study|Withdrew Consent|1|||
131454956|NCT01088048|473295485|FG000|Overall Study|Concomitant Medication Prohibited|1|||
131454957|NCT01088048|473295486|FG001|Overall Study|Concomitant Medication Prohibited|0|||
131454958|NCT01088048|473295487|FG002|Overall Study|Concomitant Medication Prohibited|0|||
131454959|NCT01088048|473295488|FG003|Overall Study|Concomitant Medication Prohibited|0|||
131454960|NCT01088048|473295489|FG004|Overall Study|Concomitant Medication Prohibited|0|||
131454961|NCT01088048|473295490|FG005|Overall Study|Concomitant Medication Prohibited|0|||
131454962|NCT01088048|473295491|FG006|Overall Study|Concomitant Medication Prohibited|0|||
131454963|NCT01088048|473295492|FG007|Overall Study|Concomitant Medication Prohibited|0|||
131454964|NCT01088048|473295493|FG008|Overall Study|Concomitant Medication Prohibited|0|||
131454965|NCT01088048|473295494|FG009|Overall Study|Concomitant Medication Prohibited|0|||
131454966|NCT01088048|473295485|FG000|Overall Study|Investigator Request|2|||
131454967|NCT01088048|473295486|FG001|Overall Study|Investigator Request|2|||
131454968|NCT01088048|473295487|FG002|Overall Study|Investigator Request|0|||
131454969|NCT01088048|473295488|FG003|Overall Study|Investigator Request|0|||
131454970|NCT01088048|473295489|FG004|Overall Study|Investigator Request|3|||
131942128|NCT01436110|475077092|FG002|Overall Study|Lost to Follow-up|3|||
131942129|NCT01436110|475077090|FG000|Overall Study|Protocol Violation|3|||
131942130|NCT01436110|475077091|FG001|Overall Study|Protocol Violation|1|||
131942131|NCT01436110|475077092|FG002|Overall Study|Protocol Violation|1|||
131942132|NCT01436110|475077090|FG000|Overall Study|Did Not Receive Trial Medication|1|||
131942133|NCT01436110|475077091|FG001|Overall Study|Did Not Receive Trial Medication|0|||
131942134|NCT01436110|475077092|FG002|Overall Study|Did Not Receive Trial Medication|3|||
131942135|NCT03273907|475077094|FG000|Overall Study|Death|1|||
131942136|NCT03273907|475077094|FG000|Overall Study|Lost to Follow-up|4|||
131942137|NCT03273907|475077094|FG000|Overall Study|Withdrawal by Subject|2|||
131942138|NCT03273907|475077094|FG000|Overall Study|COVID 19|2|||
131942139|NCT01088503|475077095|FG000|Overall Study|Withdrawal by Subject|118|||
131942140|NCT01088503|475077096|FG001|Overall Study|Withdrawal by Subject|327|||
131942141|NCT01088503|475077097|FG002|Overall Study|Withdrawal by Subject|10|||
131942142|NCT01088503|475077095|FG000|Overall Study|Death|64|||
131942143|NCT01088503|475077096|FG001|Overall Study|Death|358|||
131942144|NCT01088503|475077097|FG002|Overall Study|Death|7|||
131942145|NCT00110214|475077098|FG000|Overall Study|Never started treatment|21|||
131942146|NCT00110214|475077099|FG001|Overall Study|Never started treatment|20|||
131942147|NCT00110214|475077098|FG000|Overall Study|Disease progression or death|260|||
131942148|NCT00110214|475077099|FG001|Overall Study|Disease progression or death|151|||
131942149|NCT00110214|475077098|FG000|Overall Study|Adverse Event|115|||
131942150|NCT00110214|475077099|FG001|Overall Study|Adverse Event|192|||
131942151|NCT00110214|475077098|FG000|Overall Study|Refused further treatment|52|||
131942152|NCT00110214|475077099|FG001|Overall Study|Refused further treatment|65|||
131942153|NCT00110214|475077098|FG000|Overall Study|Other (not specified)|61|||
131942154|NCT00110214|475077099|FG001|Overall Study|Other (not specified)|75|||
131942155|NCT00811954|475077100|FG000|Overall Study|Death|10|||
131942156|NCT00811954|475077101|FG001|Overall Study|Death|6|||
131942157|NCT00811954|475077102|FG002|Overall Study|Death|13|||
131942158|NCT00811954|475077100|FG000|Overall Study|Lost to Follow-up|29|||
131942159|NCT00811954|475077101|FG001|Overall Study|Lost to Follow-up|23|||
131942160|NCT00811954|475077102|FG002|Overall Study|Lost to Follow-up|34|||
131942161|NCT00811954|475077100|FG000|Overall Study|Not able to get to clinic|28|||
131942162|NCT00811954|475077101|FG001|Overall Study|Not able to get to clinic|35|||
131942163|NCT00811954|475077102|FG002|Overall Study|Not able to get to clinic|30|||
131942164|NCT00811954|475077100|FG000|Overall Study|Not willing to adhere to requirements|12|||
131942165|NCT00811954|475077101|FG001|Overall Study|Not willing to adhere to requirements|2|||
131942166|NCT00811954|475077102|FG002|Overall Study|Not willing to adhere to requirements|16|||
131942167|NCT00811954|475077100|FG000|Overall Study|Withdraw consent prior study completion|4|||
131942168|NCT00811954|475077101|FG001|Overall Study|Withdraw consent prior study completion|6|||
131942169|NCT00811954|475077102|FG002|Overall Study|Withdraw consent prior study completion|5|||
131942170|NCT00811954|475077100|FG000|Overall Study|Site Closure|4|||
131942171|NCT00811954|475077101|FG001|Overall Study|Site Closure|0|||
131942172|NCT00811954|475077102|FG002|Overall Study|Site Closure|1|||
131942173|NCT00811954|475077100|FG000|Overall Study|Severe Debilitation|2|||
131942174|NCT00811954|475077101|FG001|Overall Study|Severe Debilitation|0|||
131942175|NCT00811954|475077102|FG002|Overall Study|Severe Debilitation|1|||
131942176|NCT00811954|475077100|FG000|Overall Study|Complete Protocol: No follow-up|0|||
131942177|NCT00811954|475077101|FG001|Overall Study|Complete Protocol: No follow-up|0|||
131942178|NCT00811954|475077102|FG002|Overall Study|Complete Protocol: No follow-up|1|||
131454971|NCT01088048|473295490|FG005|Overall Study|Investigator Request|1|||
131942179|NCT01016067|475077103|FG000|Overall Study|Lost to Follow-up|1|||
131942180|NCT01016067|475077104|FG001|Overall Study|Lost to Follow-up|2|||
131942181|NCT01016067|475077103|FG000|Overall Study|Physician Decision|1|||
131942182|NCT01016067|475077104|FG001|Overall Study|Physician Decision|1|||
131942183|NCT01016067|475077103|FG000|Overall Study|Withdrew due to Relocation|0|||
131942184|NCT01016067|475077104|FG001|Overall Study|Withdrew due to Relocation|1|||
131942185|NCT01531998|475077105|FG000|Overall Study|Withdrawal by Subject|3|||
131942186|NCT02581891|475077107|FG000|Overall Study|Adverse Event|4|||
131454972|NCT01088048|473295491|FG006|Overall Study|Investigator Request|1|||
131454973|NCT01088048|473295492|FG007|Overall Study|Investigator Request|0|||
131454974|NCT01088048|473295493|FG008|Overall Study|Investigator Request|0|||
131454975|NCT01088048|473295494|FG009|Overall Study|Investigator Request|0|||
131942187|NCT02581891|475077108|FG001|Overall Study|Adverse Event|6|||
131942188|NCT02581891|475077107|FG000|Overall Study|Death|3|||
131942189|NCT02581891|475077108|FG001|Overall Study|Death|4|||
131942190|NCT02581891|475077107|FG000|Overall Study|Lost to Follow-up|1|||
131942191|NCT02581891|475077108|FG001|Overall Study|Lost to Follow-up|2|||
131942192|NCT02581891|475077107|FG000|Overall Study|Physician Decision|0|||
131942193|NCT02581891|475077108|FG001|Overall Study|Physician Decision|1|||
131942194|NCT02581891|475077107|FG000|Overall Study|Withdrawal by Subject|4|||
131942195|NCT02581891|475077108|FG001|Overall Study|Withdrawal by Subject|5|||
131942196|NCT02581891|475077107|FG000|Overall Study|Other Reasons|3|||
131942197|NCT02581891|475077108|FG001|Overall Study|Other Reasons|1|||
131942198|NCT02581891|475077107|FG000|Overall Study|Discontinued during followup|1|||
131942199|NCT02581891|475077108|FG001|Overall Study|Discontinued during followup|0|||
131942200|NCT01188967|475077112|FG000|Overall Study|Withdrawal by Subject|1|||
131942201|NCT01188967|475077113|FG001|Overall Study|Withdrawal by Subject|1|||
131942202|NCT01188967|475077112|FG000|Overall Study|Physician Decision|1|||
131412883|NCT01999218|473133802|FG000|Overall Study|Withdrawal by Subject|28|||
131412884|NCT01999218|473133803|FG001|Overall Study|Withdrawal by Subject|29|||
131412885|NCT01999218|473133804|FG002|Overall Study|Withdrawal by Subject|34|||
131412886|NCT01999218|473133802|FG000|Overall Study|Creatinine/eGFR|0|||
131412887|NCT01999218|473133803|FG001|Overall Study|Creatinine/eGFR|0|||
131412888|NCT01999218|473133804|FG002|Overall Study|Creatinine/eGFR|1|||
131412889|NCT01999218|473133802|FG000|Overall Study|Death|7|||
131412890|NCT01999218|473133803|FG001|Overall Study|Death|1|||
131412891|NCT01999218|473133804|FG002|Overall Study|Death|2|||
131412892|NCT01999218|473133802|FG000|Overall Study|Excluded Medication|1|||
131412893|NCT01999218|473133803|FG001|Overall Study|Excluded Medication|1|||
131412894|NCT01999218|473133804|FG002|Overall Study|Excluded Medication|2|||
131412895|NCT01999218|473133802|FG000|Overall Study|Adverse Event|9|||
131412896|NCT01999218|473133803|FG001|Overall Study|Adverse Event|7|||
131412897|NCT01999218|473133804|FG002|Overall Study|Adverse Event|7|||
131412898|NCT01999218|473133802|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
131412899|NCT01999218|473133803|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
131412900|NCT01999218|473133804|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
131412901|NCT03647267|473135459|FG000|Overall Study|Lost to Follow-up|1|||
131412902|NCT03647267|473135460|FG001|Overall Study|Lost to Follow-up|0|||
131412903|NCT01350115|473135461|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
131412904|NCT01350115|473135462|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
131412905|NCT01350115|473135461|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
131412906|NCT01350115|473135462|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
131412907|NCT01350115|473135461|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
131412908|NCT01350115|473135462|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
131412909|NCT05079477|473135463|FG000|Overall Study|Lost to Follow-up|2|||
131412910|NCT05079477|473135464|FG001|Overall Study|Lost to Follow-up|0|||
131412911|NCT05079477|473135463|FG000|Overall Study|Withdrawal by Subject|1|||
131412912|NCT05079477|473135464|FG001|Overall Study|Withdrawal by Subject|0|||
131412913|NCT05079477|473135463|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
131412914|NCT05079477|473135464|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
131412915|NCT05079477|473135463|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
131412916|NCT05079477|473135464|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
131412917|NCT01688739|473135468|FG000|Overall Study|Administrative Decision|1|||
131412918|NCT01688739|473135469|FG001|Overall Study|Administrative Decision|0|||
131412919|NCT01688739|473135470|FG002|Overall Study|Administrative Decision|0|||
131412920|NCT01688739|473135471|FG003|Overall Study|Administrative Decision|0|||
131412921|NCT01688739|473135472|FG004|Overall Study|Administrative Decision|0|||
131412922|NCT01688739|473135473|FG005|Overall Study|Administrative Decision|0|||
131412923|NCT01688739|473135474|FG006|Overall Study|Administrative Decision|0|||
131412924|NCT01688739|473135475|FG007|Overall Study|Administrative Decision|0|||
131412925|NCT01688739|473135476|FG008|Overall Study|Administrative Decision|0|||
131412926|NCT01688739|473135477|FG009|Overall Study|Administrative Decision|0|||
131412927|NCT00996801|473135478|FG000|Overall Study|Adverse Event|6|||
131412928|NCT00996801|473135479|FG001|Overall Study|Adverse Event|4|||
131412929|NCT00996801|473135480|FG002|Overall Study|Adverse Event|12|||
131412930|NCT00996801|473135481|FG003|Overall Study|Adverse Event|17|||
131412931|NCT00996801|473135482|FG004|Overall Study|Adverse Event|31|||
131412932|NCT00996801|473135483|FG005|Overall Study|Adverse Event|3|||
131412933|NCT00996801|473135478|FG000|Overall Study|Lack of Efficacy|3|||
131412934|NCT00996801|473135479|FG001|Overall Study|Lack of Efficacy|0|||
131412935|NCT00996801|473135480|FG002|Overall Study|Lack of Efficacy|1|||
131412936|NCT00996801|473135481|FG003|Overall Study|Lack of Efficacy|3|||
131412937|NCT00996801|473135482|FG004|Overall Study|Lack of Efficacy|0|||
131412938|NCT00996801|473135483|FG005|Overall Study|Lack of Efficacy|1|||
131412939|NCT00996801|473135478|FG000|Overall Study|Lost to Follow-up|0|||
131412940|NCT00996801|473135479|FG001|Overall Study|Lost to Follow-up|0|||
131412941|NCT00996801|473135480|FG002|Overall Study|Lost to Follow-up|0|||
131412942|NCT00996801|473135481|FG003|Overall Study|Lost to Follow-up|3|||
131412943|NCT00996801|473135482|FG004|Overall Study|Lost to Follow-up|3|||
131412944|NCT00996801|473135483|FG005|Overall Study|Lost to Follow-up|2|||
131412945|NCT00996801|473135478|FG000|Overall Study|Physician Decision|0|||
131412946|NCT00996801|473135479|FG001|Overall Study|Physician Decision|0|||
131412947|NCT00996801|473135480|FG002|Overall Study|Physician Decision|0|||
131412948|NCT00996801|473135481|FG003|Overall Study|Physician Decision|1|||
131412949|NCT00996801|473135482|FG004|Overall Study|Physician Decision|0|||
131412950|NCT00996801|473135483|FG005|Overall Study|Physician Decision|0|||
131412951|NCT00996801|473135478|FG000|Overall Study|Progressive Disease|0|||
131412952|NCT00996801|473135479|FG001|Overall Study|Progressive Disease|1|||
131412953|NCT00996801|473135480|FG002|Overall Study|Progressive Disease|0|||
131942203|NCT01188967|475077113|FG001|Overall Study|Physician Decision|1|||
131942204|NCT01188967|475077112|FG000|Overall Study|Lost to Follow-up|3|||
131942205|NCT01188967|475077113|FG001|Overall Study|Lost to Follow-up|2|||
131942206|NCT04103450|475077117|FG000|Overall Study|Adverse Event|4|||
131942207|NCT04103450|475077118|FG001|Overall Study|Adverse Event|2|||
131942208|NCT04103450|475077117|FG000|Overall Study|Lack of Efficacy|3|||
131942209|NCT04103450|475077118|FG001|Overall Study|Lack of Efficacy|0|||
131942210|NCT04103450|475077117|FG000|Overall Study|Withdrawal by Subject|5|||
131942211|NCT04103450|475077118|FG001|Overall Study|Withdrawal by Subject|3|||
131942212|NCT04103450|475077117|FG000|Overall Study|Lost to Follow-up|1|||
131942213|NCT04103450|475077118|FG001|Overall Study|Lost to Follow-up|2|||
131942214|NCT04103450|475077117|FG000|Overall Study|Physician Decision|1|||
131942215|NCT04103450|475077118|FG001|Overall Study|Physician Decision|2|||
131942216|NCT04103450|475077117|FG000|Overall Study|Protocol Violation|1|||
131942217|NCT04103450|475077118|FG001|Overall Study|Protocol Violation|0|||
131942218|NCT04103450|475077117|FG000|Overall Study|Other|1|||
131942219|NCT04103450|475077118|FG001|Overall Study|Other|1|||
131942220|NCT02289469|475077119|FG000|Overall Study|Unable to match a control|6|||
131942221|NCT02289469|475077120|FG001|Overall Study|Unable to match a control|0|||
131942222|NCT02121509|475077123|FG000|Washout Period (35 Days)|Adverse Event|1|||
131942223|NCT02121509|475077124|FG001|Washout Period (35 Days)|Adverse Event|1|||
131942224|NCT02121509|475077125|FG002|Washout Period (35 Days)|Adverse Event|0|||
131942225|NCT02121509|475077126|FG003|Washout Period (35 Days)|Adverse Event|0|||
131942226|NCT02121509|475077123|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
131942227|NCT02121509|475077124|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
131942228|NCT02121509|475077125|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
131942229|NCT02121509|475077126|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
131942230|NCT02121509|475077123|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
131942231|NCT02121509|475077124|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
131942232|NCT02121509|475077125|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
131942233|NCT02121509|475077126|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
131942234|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
131942235|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
131942236|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
131942237|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
131942238|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
131942239|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
131942240|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
131942241|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
131942242|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
131942243|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
131942244|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
131942245|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
131942246|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
131942247|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
131942248|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
131942249|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
131942250|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
131942251|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
131942252|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
131942253|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
131942254|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
131942255|NCT04021290|475077127|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
131942256|NCT04021290|475077128|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
131942257|NCT04021290|475077129|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
131942258|NCT04021290|475077127|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
131942259|NCT04021290|475077128|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
131942260|NCT04021290|475077129|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
131942261|NCT04021290|475077127|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
131942262|NCT04021290|475077128|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
131942263|NCT04021290|475077129|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
131942264|NCT04021290|475077127|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
131942265|NCT04021290|475077128|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
131454976|NCT01088048|473295485|FG000|Overall Study|Patient Non-compliance|0|||
131454977|NCT01088048|473295486|FG001|Overall Study|Patient Non-compliance|1|||
131454978|NCT01088048|473295487|FG002|Overall Study|Patient Non-compliance|0|||
131942266|NCT04021290|475077129|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
131942267|NCT04021290|475077127|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
131942268|NCT04021290|475077128|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
131942269|NCT04021290|475077129|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
131942270|NCT01542788|475077135|FG000|Overall Study|Randomized but Not Treated|2|||
131942271|NCT01542788|475077136|FG001|Overall Study|Randomized but Not Treated|0|||
131942272|NCT01542788|475077135|FG000|Overall Study|Lack of Efficacy|41|||
131942273|NCT01542788|475077136|FG001|Overall Study|Lack of Efficacy|71|||
131942274|NCT01542788|475077135|FG000|Overall Study|Lost to Follow-up|5|||
131942275|NCT01542788|475077136|FG001|Overall Study|Lost to Follow-up|0|||
131942276|NCT01542788|475077135|FG000|Overall Study|Death|3|||
131942277|NCT01542788|475077136|FG001|Overall Study|Death|0|||
131942278|NCT01542788|475077135|FG000|Overall Study|Protocol Violation|2|||
131942279|NCT01542788|475077136|FG001|Overall Study|Protocol Violation|0|||
131942280|NCT01542788|475077135|FG000|Overall Study|Physician Decision|1|||
131942281|NCT01542788|475077136|FG001|Overall Study|Physician Decision|0|||
131942282|NCT01542788|475077135|FG000|Overall Study|Withdrawal by Subject|1|||
131942283|NCT01542788|475077136|FG001|Overall Study|Withdrawal by Subject|0|||
131942284|NCT03984188|475077137|FG000|Overall Study|Death|2|||
131942285|NCT03984188|475077138|FG001|Overall Study|Death|4|||
131942286|NCT03984188|475077137|FG000|Overall Study|Physician Decision|0|||
131942287|NCT03984188|475077138|FG001|Overall Study|Physician Decision|2|||
131942288|NCT03984188|475077137|FG000|Overall Study|Lost to Follow-up|3|||
131942289|NCT03984188|475077138|FG001|Overall Study|Lost to Follow-up|2|||
131942290|NCT03984188|475077137|FG000|Overall Study|Withdrawal by Subject|6|||
131942291|NCT03984188|475077138|FG001|Overall Study|Withdrawal by Subject|0|||
131942292|NCT03384875|475077139|FG000|Overall Study|Death|1|||
131942293|NCT03384875|475077140|FG001|Overall Study|Death|1|||
131942294|NCT03384875|475077141|FG002|Overall Study|Death|0|||
131942295|NCT03384875|475077139|FG000|Overall Study|Reason not provided|1|||
131942296|NCT03384875|475077140|FG001|Overall Study|Reason not provided|0|||
131942297|NCT03384875|475077141|FG002|Overall Study|Reason not provided|0|||
131942298|NCT00269113|475078870|FG000|Overall Study|Adverse Event|14|||
131942299|NCT00269113|475078871|FG001|Overall Study|Adverse Event|7|||
131942300|NCT00269113|475078870|FG000|Overall Study|Lack of Efficacy|35|||
131942301|NCT00269113|475078871|FG001|Overall Study|Lack of Efficacy|18|||
131942302|NCT00269113|475078870|FG000|Overall Study|Early Improvement|2|||
131942303|NCT00269113|475078871|FG001|Overall Study|Early Improvement|0|||
131942304|NCT00269113|475078870|FG000|Overall Study|Withdrawal by Subject|0|||
131942305|NCT00269113|475078871|FG001|Overall Study|Withdrawal by Subject|2|||
131942306|NCT00269113|475078870|FG000|Overall Study|Death|6|||
131942307|NCT00269113|475078871|FG001|Overall Study|Death|2|||
131942308|NCT00269113|475078870|FG000|Overall Study|Lost to Follow-up|2|||
131942309|NCT00269113|475078871|FG001|Overall Study|Lost to Follow-up|1|||
131942310|NCT00269113|475078870|FG000|Overall Study|Protocol Violation|15|||
131942311|NCT00269113|475078871|FG001|Overall Study|Protocol Violation|5|||
131942312|NCT00269113|475078870|FG000|Overall Study|Other|0|||
131942313|NCT00269113|475078871|FG001|Overall Study|Other|2|||
131942314|NCT01114737|475078872|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
131942315|NCT01114737|475078873|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
131942316|NCT01114737|475078872|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
131942317|NCT01114737|475078873|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
131942318|NCT01114737|475078872|FG000|Randomized Treatment Period|Pregnancy|1|||
131942319|NCT01114737|475078873|FG001|Randomized Treatment Period|Pregnancy|0|||
131942320|NCT01114737|475078872|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
131942321|NCT01114737|475078873|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
131942322|NCT01114737|475078872|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
131942323|NCT01114737|475078873|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
131942324|NCT01114737|475078872|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
131942325|NCT01114737|475078873|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
131942326|NCT00558636|475078883|FG000|Treatment|Adverse Event|9|||
131942327|NCT00558636|475078884|FG001|Treatment|Adverse Event|2|||
131942328|NCT00558636|475078883|FG000|Treatment|Withdrawal by Subject|2|||
131942329|NCT00558636|475078884|FG001|Treatment|Withdrawal by Subject|0|||
131942330|NCT00558636|475078883|FG000|Treatment|Premature termination of the study|35|||
131942331|NCT00558636|475078884|FG001|Treatment|Premature termination of the study|37|||
131942332|NCT00558636|475078883|FG000|Treatment|Disease progression|1|||
131942333|NCT00558636|475078884|FG001|Treatment|Disease progression|5|||
131942334|NCT00558636|475078883|FG000|Follow-up|Premature termination of the study|12|||
131942335|NCT00558636|475078884|FG001|Follow-up|Premature termination of the study|7|||
131942336|NCT04108273|475078885|FG000|Overall Study|COVID Pandemic|1|||
131942337|NCT04108273|475078886|FG001|Overall Study|COVID Pandemic|0|||
131942338|NCT01534481|475078887|FG000|Overall Study|Lost to Follow-up|29|||
131942339|NCT01534481|475078888|FG001|Overall Study|Lost to Follow-up|24|||
131942340|NCT01534481|475078887|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
131942341|NCT01534481|475078888|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
131942342|NCT01130337|475078889|FG000|Overall Study|Withdrawal by Subject|3|||
131942343|NCT01130337|475078889|FG000|Overall Study|Principal investigator decision|1|||
131942344|NCT01130337|475078889|FG000|Overall Study|Death|1|||
131942345|NCT01130337|475078889|FG000|Overall Study|Disease progression|1|||
131942346|NCT01130337|475078889|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
131942347|NCT01130337|475078889|FG000|Overall Study|Surgical resection (R2)|1|||
131942348|NCT05525910|475078890|FG000|Period 4|Per sponsor due to study timelines|0|||
131454979|NCT01088048|473295488|FG003|Overall Study|Patient Non-compliance|0|||
131454980|NCT01088048|473295489|FG004|Overall Study|Patient Non-compliance|0|||
131454981|NCT01088048|473295490|FG005|Overall Study|Patient Non-compliance|0|||
131454982|NCT01088048|473295491|FG006|Overall Study|Patient Non-compliance|0|||
131454983|NCT01088048|473295492|FG007|Overall Study|Patient Non-compliance|0|||
131454984|NCT01088048|473295493|FG008|Overall Study|Patient Non-compliance|0|||
131454985|NCT01088048|473295494|FG009|Overall Study|Patient Non-compliance|0|||
131454986|NCT01088048|473295485|FG000|Overall Study|Disease Progression|7|||
131454987|NCT01088048|473295486|FG001|Overall Study|Disease Progression|4|||
131454988|NCT01088048|473295487|FG002|Overall Study|Disease Progression|3|||
131454989|NCT01088048|473295488|FG003|Overall Study|Disease Progression|5|||
131454990|NCT01088048|473295489|FG004|Overall Study|Disease Progression|3|||
131454991|NCT01088048|473295490|FG005|Overall Study|Disease Progression|3|||
131454992|NCT01088048|473295491|FG006|Overall Study|Disease Progression|2|||
131454993|NCT01088048|473295492|FG007|Overall Study|Disease Progression|1|||
131454994|NCT01088048|473295493|FG008|Overall Study|Disease Progression|0|||
131454995|NCT01088048|473295494|FG009|Overall Study|Disease Progression|0|||
131454996|NCT01088048|473295485|FG000|Overall Study|Death|1|||
131454997|NCT01088048|473295486|FG001|Overall Study|Death|5|||
131454998|NCT01088048|473295487|FG002|Overall Study|Death|3|||
131454999|NCT01088048|473295488|FG003|Overall Study|Death|3|||
131455000|NCT01088048|473295489|FG004|Overall Study|Death|1|||
131455001|NCT01088048|473295490|FG005|Overall Study|Death|3|||
131455002|NCT01088048|473295491|FG006|Overall Study|Death|0|||
131455003|NCT01088048|473295492|FG007|Overall Study|Death|0|||
131942349|NCT05525910|475078891|FG001|Period 4|Per sponsor due to study timelines|0|||
131942350|NCT05525910|475078892|FG002|Period 4|Per sponsor due to study timelines|1|||
131942351|NCT05525910|475078893|FG003|Period 4|Per sponsor due to study timelines|1|||
131942352|NCT05525910|475078894|FG004|Period 4|Per sponsor due to study timelines|1|||
131942353|NCT03886493|475078895|FG000|Overall Study|Adverse Event|1|||
131942354|NCT03179761|475078897|FG000|Overall Study|Death|2|||
131942355|NCT03179761|475078898|FG001|Overall Study|Death|5|||
131942356|NCT03179761|475078897|FG000|Overall Study|Lost to Follow-up|2|||
131942357|NCT03179761|475078898|FG001|Overall Study|Lost to Follow-up|2|||
131942358|NCT03179761|475078897|FG000|Overall Study|Protocol Violation|1|||
131942359|NCT03179761|475078898|FG001|Overall Study|Protocol Violation|0|||
131942360|NCT03179761|475078897|FG000|Overall Study|Withdrawal by Subject|1|||
131942361|NCT03179761|475078898|FG001|Overall Study|Withdrawal by Subject|4|||
131942362|NCT03179761|475078897|FG000|Overall Study|Investigator Request|0|||
131942363|NCT03179761|475078898|FG001|Overall Study|Investigator Request|2|||
131942364|NCT03498716|475078899|FG000|Overall Study|Withdrawal by Subject|88|||
131942365|NCT03498716|475078900|FG001|Overall Study|Withdrawal by Subject|73|||
131942366|NCT03498716|475078899|FG000|Overall Study|Study Terminated By Sponsor|933|||
131942367|NCT03498716|475078900|FG001|Overall Study|Study Terminated By Sponsor|927|||
131942368|NCT03498716|475078899|FG000|Overall Study|Lost to Follow-up|15|||
131942369|NCT03498716|475078900|FG001|Overall Study|Lost to Follow-up|26|||
131942370|NCT03498716|475078899|FG000|Overall Study|Disease Relapse|0|||
131942371|NCT03498716|475078900|FG001|Overall Study|Disease Relapse|1|||
131942372|NCT03498716|475078899|FG000|Overall Study|Death|58|||
131942373|NCT03498716|475078900|FG001|Overall Study|Death|72|||
131942374|NCT03498716|475078899|FG000|Overall Study|Physician Decision|4|||
131942375|NCT03498716|475078900|FG001|Overall Study|Physician Decision|2|||
131942376|NCT02284191|475078901|FG000|Overall Study|Withdrawal by Subject|1|||
131942377|NCT02284191|475078902|FG001|Overall Study|Withdrawal by Subject|3|||
131942378|NCT02284191|475078901|FG000|Overall Study|Lost to Follow-up|1|||
131942379|NCT02284191|475078902|FG001|Overall Study|Lost to Follow-up|0|||
131942380|NCT03139448|475078905|FG000|Overall Study|Lack of Efficacy|6|||
131942381|NCT03139448|475078906|FG001|Overall Study|Lack of Efficacy|7|||
131942382|NCT03139448|475078905|FG000|Overall Study|Location of procedure changed|2|||
131942383|NCT03139448|475078906|FG001|Overall Study|Location of procedure changed|8|||
131455004|NCT01088048|473295493|FG008|Overall Study|Death|3|||
131455005|NCT01088048|473295494|FG009|Overall Study|Death|1|||
131455006|NCT01088048|473295485|FG000|Overall Study|Other|3|||
131455007|NCT01088048|473295486|FG001|Overall Study|Other|5|||
131942384|NCT03139448|475078905|FG000|Overall Study|Withdrawal by Subject|3|||
131942385|NCT03139448|475078906|FG001|Overall Study|Withdrawal by Subject|6|||
131942386|NCT03139448|475078905|FG000|Overall Study|Screen fail|1|||
131455008|NCT01088048|473295487|FG002|Overall Study|Other|0|||
131455009|NCT01088048|473295488|FG003|Overall Study|Other|0|||
131455010|NCT01088048|473295489|FG004|Overall Study|Other|2|||
131455011|NCT01088048|473295490|FG005|Overall Study|Other|0|||
131455012|NCT01088048|473295491|FG006|Overall Study|Other|0|||
131455013|NCT01088048|473295492|FG007|Overall Study|Other|2|||
131455014|NCT01088048|473295493|FG008|Overall Study|Other|0|||
131455015|NCT01088048|473295494|FG009|Overall Study|Other|0|||
131455016|NCT03790696|473295496|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
131942387|NCT03139448|475078906|FG001|Overall Study|Screen fail|3|||
131942388|NCT03139448|475078905|FG000|Overall Study|Physician Decision|0|||
131942389|NCT03139448|475078906|FG001|Overall Study|Physician Decision|2|||
131942390|NCT01832727|475078907|FG000|Overall Study|Adverse Event|4|||
131942391|NCT01832727|475078908|FG001|Overall Study|Adverse Event|6|||
131942392|NCT01832727|475078909|FG002|Overall Study|Adverse Event|1|||
131942393|NCT01832727|475078910|FG003|Overall Study|Adverse Event|0|||
131942394|NCT01832727|475078911|FG004|Overall Study|Adverse Event|1|||
131942395|NCT01832727|475078912|FG005|Overall Study|Adverse Event|1|||
131942396|NCT01832727|475078913|FG006|Overall Study|Adverse Event|2|||
131942397|NCT01832727|475078914|FG007|Overall Study|Adverse Event|1|||
131942398|NCT01832727|475078915|FG008|Overall Study|Adverse Event|9|||
131942399|NCT01832727|475078907|FG000|Overall Study|Disease progression|3|||
131942400|NCT01832727|475078908|FG001|Overall Study|Disease progression|0|||
131942401|NCT01832727|475078909|FG002|Overall Study|Disease progression|2|||
131942402|NCT01832727|475078910|FG003|Overall Study|Disease progression|1|||
131942403|NCT01832727|475078911|FG004|Overall Study|Disease progression|3|||
131942404|NCT01832727|475078912|FG005|Overall Study|Disease progression|3|||
131942405|NCT01832727|475078913|FG006|Overall Study|Disease progression|6|||
131942406|NCT01832727|475078914|FG007|Overall Study|Disease progression|2|||
131942407|NCT01832727|475078915|FG008|Overall Study|Disease progression|7|||
131942408|NCT01832727|475078907|FG000|Overall Study|Lost to Follow-up|0|||
131942409|NCT01832727|475078908|FG001|Overall Study|Lost to Follow-up|0|||
131942410|NCT01832727|475078909|FG002|Overall Study|Lost to Follow-up|0|||
131942411|NCT01832727|475078910|FG003|Overall Study|Lost to Follow-up|1|||
131942412|NCT01832727|475078911|FG004|Overall Study|Lost to Follow-up|0|||
131942413|NCT01832727|475078912|FG005|Overall Study|Lost to Follow-up|0|||
131942414|NCT01832727|475078913|FG006|Overall Study|Lost to Follow-up|0|||
131942415|NCT01832727|475078914|FG007|Overall Study|Lost to Follow-up|0|||
131942416|NCT01832727|475078915|FG008|Overall Study|Lost to Follow-up|0|||
131942417|NCT01832727|475078907|FG000|Overall Study|Physician Decision|1|||
131942418|NCT01832727|475078908|FG001|Overall Study|Physician Decision|0|||
131942419|NCT01832727|475078909|FG002|Overall Study|Physician Decision|0|||
131942420|NCT01832727|475078910|FG003|Overall Study|Physician Decision|1|||
131942421|NCT01832727|475078911|FG004|Overall Study|Physician Decision|0|||
131942422|NCT01832727|475078912|FG005|Overall Study|Physician Decision|1|||
131942423|NCT01832727|475078913|FG006|Overall Study|Physician Decision|0|||
131942424|NCT01832727|475078914|FG007|Overall Study|Physician Decision|0|||
131942425|NCT01832727|475078915|FG008|Overall Study|Physician Decision|0|||
131942426|NCT01832727|475078907|FG000|Overall Study|Withdrawal by Subject|1|||
131942427|NCT01832727|475078908|FG001|Overall Study|Withdrawal by Subject|1|||
131942428|NCT01832727|475078909|FG002|Overall Study|Withdrawal by Subject|0|||
131942429|NCT01832727|475078910|FG003|Overall Study|Withdrawal by Subject|1|||
131942430|NCT01832727|475078911|FG004|Overall Study|Withdrawal by Subject|0|||
131942431|NCT01832727|475078912|FG005|Overall Study|Withdrawal by Subject|1|||
131942432|NCT01832727|475078913|FG006|Overall Study|Withdrawal by Subject|0|||
131942433|NCT01832727|475078914|FG007|Overall Study|Withdrawal by Subject|2|||
131942434|NCT01832727|475078915|FG008|Overall Study|Withdrawal by Subject|1|||
131942435|NCT01832727|475078907|FG000|Overall Study|Study terminated by sponsor|0|||
131942436|NCT01832727|475078908|FG001|Overall Study|Study terminated by sponsor|0|||
131942437|NCT01832727|475078909|FG002|Overall Study|Study terminated by sponsor|0|||
131942438|NCT01832727|475078910|FG003|Overall Study|Study terminated by sponsor|0|||
131942439|NCT01832727|475078911|FG004|Overall Study|Study terminated by sponsor|0|||
131942440|NCT01832727|475078912|FG005|Overall Study|Study terminated by sponsor|0|||
131942441|NCT01832727|475078913|FG006|Overall Study|Study terminated by sponsor|0|||
131942442|NCT01832727|475078914|FG007|Overall Study|Study terminated by sponsor|1|||
131942443|NCT01832727|475078915|FG008|Overall Study|Study terminated by sponsor|1|||
131942444|NCT02216526|475078916|FG000|Overall Study|Adverse Event|1|||
131942445|NCT02216526|475078917|FG001|Overall Study|Adverse Event|1|||
131942446|NCT02216526|475078918|FG002|Overall Study|Adverse Event|0|||
131942447|NCT02216526|475078916|FG000|Overall Study|Death|0|||
131942448|NCT02216526|475078917|FG001|Overall Study|Death|1|||
131942449|NCT02216526|475078918|FG002|Overall Study|Death|3|||
131942450|NCT02216526|475078916|FG000|Overall Study|Protocol Violation|2|||
131942451|NCT02216526|475078917|FG001|Overall Study|Protocol Violation|0|||
131942452|NCT02216526|475078918|FG002|Overall Study|Protocol Violation|2|||
131942453|NCT02216526|475078916|FG000|Overall Study|Hospitalization|2|||
131942454|NCT02216526|475078917|FG001|Overall Study|Hospitalization|1|||
131942455|NCT02216526|475078918|FG002|Overall Study|Hospitalization|3|||
131942456|NCT02553629|475078919|FG000|Overall Study|Logistic reasons|3|||
131942457|NCT02553629|475078920|FG001|Overall Study|Logistic reasons|6|||
131942458|NCT01812057|475078921|FG000|Overall Study|Protocol Violation|1|||
131942459|NCT01812057|475078922|FG001|Overall Study|Protocol Violation|0|||
131942460|NCT01812057|475078921|FG000|Overall Study|Physician Decision|1|||
131942461|NCT01812057|475078922|FG001|Overall Study|Physician Decision|0|||
131942462|NCT00696878|475078930|FG000|Overall Study|Adverse Event|8|||
131942463|NCT00696878|475078930|FG000|Overall Study|Withdrawal by Subject|87|||
131942464|NCT00696878|475078930|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
131942465|NCT00696878|475078930|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
131942466|NCT00696878|475078930|FG000|Overall Study|Trial stopped|32|||
131942467|NCT00696878|475078930|FG000|Overall Study|Other reason (not specified)|55|||
131942468|NCT01133847|475078936|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
131942469|NCT01133847|475078937|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
131455017|NCT03790696|473295497|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
131455018|NCT01149148|473295498|FG000|Overall Study|Lost to Follow-up|1|||
131455019|NCT01149148|473295499|FG001|Overall Study|Lost to Follow-up|2|||
131455020|NCT01149148|473295498|FG000|Overall Study|Death|1|||
131455021|NCT01149148|473295499|FG001|Overall Study|Death|0|||
131455022|NCT03436082|473295500|FG000|Overall Study|Did not undergo procedure|1|||
131455023|NCT03436082|473295501|FG001|Overall Study|Did not undergo procedure|0|||
131455024|NCT00950859|473295504|FG000|Overall Study|Adverse Event|3|||
131455025|NCT00950859|473295505|FG001|Overall Study|Adverse Event|3|||
131455026|NCT00950859|473295504|FG000|Overall Study|Insufficient Viral Load Response|12|||
131455027|NCT00950859|473295505|FG001|Overall Study|Insufficient Viral Load Response|3|||
131455028|NCT00950859|473295504|FG000|Overall Study|Protocol Violation|1|||
131455029|NCT00950859|473295505|FG001|Overall Study|Protocol Violation|1|||
131455030|NCT00950859|473295504|FG000|Overall Study|Lost to Follow-up|0|||
131455031|NCT00950859|473295505|FG001|Overall Study|Lost to Follow-up|3|||
131455032|NCT02563067|473295508|FG000|Overall Study|Subject/guardian decision|14|||
131455033|NCT02563067|473295509|FG001|Overall Study|Subject/guardian decision|20|||
131455034|NCT02563067|473295510|FG002|Overall Study|Subject/guardian decision|16|||
131455035|NCT02563067|473295508|FG000|Overall Study|Physician Decision|0|||
131455036|NCT02563067|473295509|FG001|Overall Study|Physician Decision|1|||
131455037|NCT02563067|473295510|FG002|Overall Study|Physician Decision|3|||
131455038|NCT02563067|473295508|FG000|Overall Study|Lost to Follow-up|1|||
131455039|NCT02563067|473295509|FG001|Overall Study|Lost to Follow-up|2|||
131455040|NCT02563067|473295510|FG002|Overall Study|Lost to Follow-up|0|||
131455041|NCT02563067|473295508|FG000|Overall Study|Technical problems|0|||
131455042|NCT02563067|473295509|FG001|Overall Study|Technical problems|1|||
131455043|NCT02563067|473295510|FG002|Overall Study|Technical problems|0|||
131455044|NCT02563067|473295508|FG000|Overall Study|Lack of Efficacy|1|||
131455045|NCT02563067|473295509|FG001|Overall Study|Lack of Efficacy|0|||
131455046|NCT02563067|473295510|FG002|Overall Study|Lack of Efficacy|0|||
131455047|NCT02563067|473295508|FG000|Overall Study|Death|0|||
131455048|NCT02563067|473295509|FG001|Overall Study|Death|1|||
131455049|NCT02563067|473295510|FG002|Overall Study|Death|1|||
131455050|NCT02563067|473295508|FG000|Overall Study|Adverse Event|2|||
131455051|NCT02563067|473295509|FG001|Overall Study|Adverse Event|1|||
131455052|NCT02563067|473295510|FG002|Overall Study|Adverse Event|0|||
131455053|NCT02563067|473295508|FG000|Overall Study|Death post Treatment/safety period|1|||
131455054|NCT02563067|473295509|FG001|Overall Study|Death post Treatment/safety period|0|||
131455055|NCT02563067|473295510|FG002|Overall Study|Death post Treatment/safety period|0|||
131455056|NCT03544333|473295516|FG000|Overall Study|Withdrawal by Subject|1|||
131455057|NCT03544333|473295517|FG001|Overall Study|Withdrawal by Subject|0|||
131455058|NCT01039519|473295521|FG000|Treatment|Progressive disease|20|||
131455059|NCT01039519|473295521|FG000|Treatment|Treatment failure|2|||
131455060|NCT01039519|473295521|FG000|Treatment|Adverse Event|3|||
131455061|NCT01039519|473295521|FG000|Treatment|Physician Decision|2|||
131455062|NCT01039519|473295521|FG000|Survival Follow-up|Death|23|||
131455063|NCT01039519|473295521|FG000|Survival Follow-up|Sponsor decision|4|||
131455064|NCT01330108|473295524|FG000|Overall Study|Withdrawal by Subject|4|||
131455065|NCT00243269|473295525|FG000|Overall Study|Protocol Violation|2|||
131455066|NCT00243269|473295526|FG001|Overall Study|Protocol Violation|1|||
131455067|NCT00243269|473295527|FG002|Overall Study|Protocol Violation|0|||
131455068|NCT00243269|473295528|FG003|Overall Study|Protocol Violation|1|||
131455069|NCT00243269|473295525|FG000|Overall Study|Lost to Follow-up|1|||
131455070|NCT00243269|473295526|FG001|Overall Study|Lost to Follow-up|0|||
131455071|NCT00243269|473295527|FG002|Overall Study|Lost to Follow-up|1|||
131455072|NCT00243269|473295528|FG003|Overall Study|Lost to Follow-up|3|||
131455073|NCT00485134|473295530|FG000|Overall Study|Lost to Follow-up|1|||
131455074|NCT00485134|473295531|FG001|Overall Study|Lost to Follow-up|0|||
131455075|NCT00485134|473295532|FG002|Overall Study|Lost to Follow-up|0|||
131942470|NCT01133847|475078938|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
131942471|NCT01133847|475078936|FG000|Follow-Up Phase|Lost to Follow-up|1|||
131942472|NCT01133847|475078937|FG001|Follow-Up Phase|Lost to Follow-up|3|||
131942473|NCT01133847|475078938|FG002|Follow-Up Phase|Lost to Follow-up|7|||
131942474|NCT01463033|475078942|FG000|Overall Study|Lost to Follow-up|4|||
131455076|NCT00485134|473295533|FG003|Overall Study|Lost to Follow-up|0|||
131455077|NCT00485134|473295534|FG004|Overall Study|Lost to Follow-up|0|||
131455078|NCT00485134|473295535|FG005|Overall Study|Lost to Follow-up|0|||
131455079|NCT00485134|473295536|FG006|Overall Study|Lost to Follow-up|0|||
131455080|NCT00485134|473295537|FG007|Overall Study|Lost to Follow-up|0|||
131455081|NCT00485134|473295530|FG000|Overall Study|Withdrawal by Subject|0|||
131455082|NCT00485134|473295531|FG001|Overall Study|Withdrawal by Subject|1|||
131455083|NCT00485134|473295532|FG002|Overall Study|Withdrawal by Subject|0|||
131942475|NCT01463033|475078943|FG001|Overall Study|Lost to Follow-up|4|||
131455084|NCT00485134|473295533|FG003|Overall Study|Withdrawal by Subject|0|||
131455085|NCT00485134|473295534|FG004|Overall Study|Withdrawal by Subject|0|||
131455086|NCT00485134|473295535|FG005|Overall Study|Withdrawal by Subject|0|||
131455087|NCT00485134|473295536|FG006|Overall Study|Withdrawal by Subject|0|||
131455088|NCT00485134|473295537|FG007|Overall Study|Withdrawal by Subject|0|||
131942476|NCT01463033|475078942|FG000|Overall Study|Death|3|||
131942477|NCT01463033|475078943|FG001|Overall Study|Death|2|||
131942478|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
131942479|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
131942480|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
131942481|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
131942482|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
131942483|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
131942484|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
131942485|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
131942486|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
131942487|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
131942488|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
131942489|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
131942490|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
131942491|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
131942492|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
131942493|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
131942494|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
131942495|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
131942496|NCT03789292|475078944|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
131942497|NCT03789292|475078945|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
131942498|NCT03789292|475078946|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
131942499|NCT03789292|475078944|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
131942500|NCT03789292|475078945|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
131942501|NCT03789292|475078946|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
131942502|NCT03789292|475078944|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
131942503|NCT03789292|475078945|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
131942504|NCT03789292|475078946|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
131942505|NCT03789292|475078944|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
131942506|NCT03789292|475078945|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
131942507|NCT03789292|475078946|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
131942508|NCT03789292|475078944|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
131942509|NCT03789292|475078945|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
131942510|NCT03789292|475078946|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
131942511|NCT03789292|475078944|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
131942512|NCT03789292|475078945|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
131942513|NCT03789292|475078946|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
131942514|NCT03789292|475078944|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
131942515|NCT03789292|475078945|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
131942516|NCT03789292|475078946|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
131942517|NCT00967616|475078947|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
131942518|NCT00967616|475078948|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
131942519|NCT00967616|475078947|FG000|Overall Study|Death|0|||
131942520|NCT00967616|475078948|FG001|Overall Study|Death|3|||
131942521|NCT00967616|475078947|FG000|Overall Study|Withdrawal by Subject|8|||
131942522|NCT00967616|475078948|FG001|Overall Study|Withdrawal by Subject|4|||
131942523|NCT00967616|475078947|FG000|Overall Study|Progressive Disease|31|||
131942524|NCT00967616|475078948|FG001|Overall Study|Progressive Disease|18|||
131942525|NCT00967616|475078947|FG000|Overall Study|Other|8|||
131942526|NCT00967616|475078948|FG001|Overall Study|Other|8|||
131942527|NCT00967616|475078947|FG000|Overall Study|Protocol Violation|1|||
131942528|NCT00967616|475078948|FG001|Overall Study|Protocol Violation|0|||
131942529|NCT01696643|475078949|FG000|Overall Study|Adverse Event|15|||
131942530|NCT01696643|475078950|FG001|Overall Study|Adverse Event|7|||
131942531|NCT01696643|475078949|FG000|Overall Study|Death|1|||
131942532|NCT01696643|475078950|FG001|Overall Study|Death|2|||
131942533|NCT01696643|475078949|FG000|Overall Study|Lack of Efficacy|3|||
131942534|NCT01696643|475078950|FG001|Overall Study|Lack of Efficacy|0|||
131942535|NCT01696643|475078949|FG000|Overall Study|Lost to Follow-up|67|||
131942536|NCT01696643|475078950|FG001|Overall Study|Lost to Follow-up|67|||
131942537|NCT01696643|475078949|FG000|Overall Study|Physician Decision|3|||
131942538|NCT01696643|475078950|FG001|Overall Study|Physician Decision|2|||
131942539|NCT01696643|475078949|FG000|Overall Study|Pregnancy|0|||
131942540|NCT01696643|475078950|FG001|Overall Study|Pregnancy|1|||
131455089|NCT00485134|473295530|FG000|Overall Study|Change in health status|0|||
131455090|NCT00485134|473295531|FG001|Overall Study|Change in health status|1|||
131942541|NCT01696643|475078949|FG000|Overall Study|Protocol Violation|7|||
131942542|NCT01696643|475078950|FG001|Overall Study|Protocol Violation|7|||
131942543|NCT01696643|475078949|FG000|Overall Study|Study Terminated by Sponsor|286|||
131942544|NCT01696643|475078950|FG001|Overall Study|Study Terminated by Sponsor|294|||
131942545|NCT01696643|475078949|FG000|Overall Study|Withdrawal by Subject|142|||
131942546|NCT01696643|475078950|FG001|Overall Study|Withdrawal by Subject|149|||
131942547|NCT01696643|475078949|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
131942548|NCT01696643|475078950|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
131942549|NCT01696643|475078949|FG000|Overall Study|Site Error|2|||
131942550|NCT01696643|475078950|FG001|Overall Study|Site Error|1|||
131942551|NCT01696643|475078949|FG000|Overall Study|Participant Incarcerated|0|||
131942552|NCT01696643|475078950|FG001|Overall Study|Participant Incarcerated|1|||
131942553|NCT01696643|475078949|FG000|Overall Study|Medical Monitor Decision|0|||
131942554|NCT01696643|475078950|FG001|Overall Study|Medical Monitor Decision|2|||
131942555|NCT01696643|475078949|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
131942556|NCT01696643|475078950|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
131942557|NCT01374425|475078951|FG000|Overall Study|Radiographic Disease Progression|86|||
131942558|NCT01374425|475078952|FG001|Overall Study|Radiographic Disease Progression|81|||
131942559|NCT01374425|475078951|FG000|Overall Study|Clinical Disease Progression|9|||
131942560|NCT01374425|475078952|FG001|Overall Study|Clinical Disease Progression|6|||
131942561|NCT01374425|475078951|FG000|Overall Study|Adverse Event|29|||
131942562|NCT01374425|475078952|FG001|Overall Study|Adverse Event|18|||
131942563|NCT01374425|475078951|FG000|Overall Study|Death (Progression of Disease)|1|||
131942564|NCT01374425|475078952|FG001|Overall Study|Death (Progression of Disease)|0|||
131942565|NCT01374425|475078951|FG000|Overall Study|Death (Adverse Event)|2|||
131942566|NCT01374425|475078952|FG001|Overall Study|Death (Adverse Event)|4|||
131942567|NCT01374425|475078951|FG000|Overall Study|Withdrawal by Subject|6|||
131942568|NCT01374425|475078952|FG001|Overall Study|Withdrawal by Subject|7|||
131942569|NCT01374425|475078951|FG000|Overall Study|Refused Treatment|10|||
131942570|NCT01374425|475078952|FG001|Overall Study|Refused Treatment|24|||
131942571|NCT01374425|475078951|FG000|Overall Study|Protocol Violation|2|||
131942572|NCT01374425|475078952|FG001|Overall Study|Protocol Violation|3|||
131942573|NCT01374425|475078951|FG000|Overall Study|Sponsor Decision|0|||
131942574|NCT01374425|475078952|FG001|Overall Study|Sponsor Decision|1|||
131942575|NCT01374425|475078951|FG000|Overall Study|Lost to Follow-up|2|||
131942576|NCT01374425|475078952|FG001|Overall Study|Lost to Follow-up|1|||
131942577|NCT01374425|475078951|FG000|Overall Study|Other|41|||
131942578|NCT01374425|475078952|FG001|Overall Study|Other|43|||
131942579|NCT02359903|475078953|FG000|Overall Study|Adverse Event|0|||
131942580|NCT02359903|475078954|FG001|Overall Study|Adverse Event|2|||
131942581|NCT00546481|475078955|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
131942582|NCT00546481|475078956|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
131942583|NCT00546481|475078957|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
131942584|NCT00546481|475078955|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
131942585|NCT00546481|475078956|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
131942586|NCT00546481|475078957|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
131942587|NCT00546481|475078955|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
131942588|NCT00546481|475078956|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
131942589|NCT00546481|475078957|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
131942590|NCT00546481|475078955|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
131942591|NCT00546481|475078956|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
131942592|NCT00546481|475078957|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
131942593|NCT00546481|475078955|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
131942594|NCT00546481|475078956|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
131942595|NCT00546481|475078957|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
131942596|NCT00546481|475078955|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
131942597|NCT00546481|475078956|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
131942598|NCT00546481|475078957|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
131942599|NCT00546481|475078955|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
131942600|NCT00546481|475078956|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
131942601|NCT00546481|475078957|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
131942602|NCT00546481|475078955|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
131942603|NCT00546481|475078956|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
131942604|NCT00546481|475078957|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
131942605|NCT00546481|475078955|FG000|Maintenance Phase (CERA)|Other Reason|0|||
131942606|NCT00546481|475078956|FG001|Maintenance Phase (CERA)|Other Reason|0|||
131942607|NCT00546481|475078957|FG002|Maintenance Phase (CERA)|Other Reason|1|||
131942608|NCT02271529|475078963|FG000|Overall Study|Withdrawal by Subject|1|||
131942609|NCT02761642|475078964|FG000|Overall Study|Did not Receive Study Treatment|3|||
131942610|NCT02761642|475078964|FG000|Overall Study|Adverse Event|13|||
131942611|NCT02761642|475078964|FG000|Overall Study|Withdrawal by Subject|2|||
131942612|NCT02761642|475078964|FG000|Overall Study|Non-compliant|7|||
131942613|NCT02761642|475078964|FG000|Overall Study|Death|3|||
131942614|NCT02761642|475078964|FG000|Overall Study|Lack of Efficacy|20|||
131942615|NCT02761642|475078964|FG000|Overall Study|Physician Decision|1|||
131942616|NCT02761642|475078964|FG000|Overall Study|Reason Unspecified|21|||
131942617|NCT03783780|475078971|FG000|Overall Study|Withdrawn prior to completion|1|||
131942618|NCT03768427|475078972|FG000|Overall Study|Death|0|||
131942619|NCT03768427|475078973|FG001|Overall Study|Death|0|||
131942620|NCT03768427|475078974|FG002|Overall Study|Death|1|||
131942621|NCT03768427|475078975|FG003|Overall Study|Death|0|||
131942622|NCT03768427|475078972|FG000|Overall Study|Lost to Follow-up|2|||
131942623|NCT03768427|475078973|FG001|Overall Study|Lost to Follow-up|0|||
131942624|NCT03768427|475078974|FG002|Overall Study|Lost to Follow-up|0|||
131942625|NCT03768427|475078975|FG003|Overall Study|Lost to Follow-up|0|||
131942626|NCT03768427|475078972|FG000|Overall Study|Physician Decision|3|||
131942627|NCT03768427|475078973|FG001|Overall Study|Physician Decision|2|||
131942628|NCT03768427|475078974|FG002|Overall Study|Physician Decision|4|||
131942629|NCT03768427|475078975|FG003|Overall Study|Physician Decision|4|||
131942630|NCT03768427|475078972|FG000|Overall Study|Withdrawal by Subject|7|||
131942631|NCT03768427|475078973|FG001|Overall Study|Withdrawal by Subject|2|||
131942632|NCT03768427|475078974|FG002|Overall Study|Withdrawal by Subject|6|||
131942633|NCT03768427|475078975|FG003|Overall Study|Withdrawal by Subject|7|||
131942634|NCT02756403|475078978|FG000|Overall Study|Unable to swallow medication|0|||
131942635|NCT02756403|475078979|FG001|Overall Study|Unable to swallow medication|1|||
131942636|NCT02756403|475078980|FG002|Overall Study|Unable to swallow medication|1|||
131942637|NCT02756403|475078981|FG003|Overall Study|Unable to swallow medication|1|||
131942638|NCT02756403|475078978|FG000|Overall Study|Did not complete Procedure|0|||
131942639|NCT02756403|475078979|FG001|Overall Study|Did not complete Procedure|1|||
131942640|NCT02756403|475078980|FG002|Overall Study|Did not complete Procedure|0|||
131942641|NCT02756403|475078981|FG003|Overall Study|Did not complete Procedure|0|||
131942642|NCT02756403|475078978|FG000|Overall Study|Changed Mind About Procedure|0|||
131942643|NCT02756403|475078979|FG001|Overall Study|Changed Mind About Procedure|0|||
131942644|NCT02756403|475078980|FG002|Overall Study|Changed Mind About Procedure|1|||
131942645|NCT02756403|475078981|FG003|Overall Study|Changed Mind About Procedure|0|||
131942646|NCT02756403|475078978|FG000|Overall Study|Protocol Violation|0|||
131942647|NCT02756403|475078979|FG001|Overall Study|Protocol Violation|1|||
131942648|NCT02756403|475078980|FG002|Overall Study|Protocol Violation|0|||
131942649|NCT02756403|475078981|FG003|Overall Study|Protocol Violation|1|||
131942650|NCT01644643|475078982|FG000|Overall Study|Death|1|||
131942651|NCT01644643|475078983|FG001|Overall Study|Death|0|||
131942652|NCT01644643|475078984|FG002|Overall Study|Death|3|||
131942653|NCT01644643|475078985|FG003|Overall Study|Death|3|||
131942654|NCT01644643|475078982|FG000|Overall Study|Lost to Follow-up|0|||
131942655|NCT01644643|475078983|FG001|Overall Study|Lost to Follow-up|0|||
131942656|NCT01644643|475078984|FG002|Overall Study|Lost to Follow-up|0|||
131942657|NCT01644643|475078985|FG003|Overall Study|Lost to Follow-up|4|||
131942658|NCT01644643|475078982|FG000|Overall Study|Withdrawal by Subject|1|||
131942659|NCT01644643|475078983|FG001|Overall Study|Withdrawal by Subject|0|||
131942660|NCT01644643|475078984|FG002|Overall Study|Withdrawal by Subject|2|||
131942661|NCT01644643|475078985|FG003|Overall Study|Withdrawal by Subject|1|||
131942662|NCT01644643|475078982|FG000|Overall Study|Other Eligibility criteria|0|||
131942663|NCT01644643|475078983|FG001|Overall Study|Other Eligibility criteria|0|||
131942664|NCT01644643|475078984|FG002|Overall Study|Other Eligibility criteria|0|||
131942665|NCT01644643|475078985|FG003|Overall Study|Other Eligibility criteria|2|||
131942666|NCT00776789|475078990|FG000|Overall Study|Consent refusal|2|||
131942667|NCT00776789|475078991|FG001|Overall Study|Consent refusal|2|||
131942668|NCT00776789|475078990|FG000|Overall Study|Poor quality video|1|||
131942669|NCT00776789|475078991|FG001|Overall Study|Poor quality video|1|||
131942670|NCT02850978|475078994|FG000|Overall Study|Uncollectable CRF|27|||
131942671|NCT02850978|475078994|FG000|Overall Study|No visit since the first visit|35|||
131942672|NCT02850978|475078994|FG000|Overall Study|Adverse Event|81|||
131942673|NCT02850978|475078994|FG000|Overall Study|Lack of Efficacy|40|||
131942674|NCT02850978|475078994|FG000|Overall Study|Improvement in condition|34|||
131942675|NCT02850978|475078994|FG000|Overall Study|Lost to Follow-up|121|||
131942676|NCT02850978|475078994|FG000|Overall Study|Reason not listed|88|||
131942677|NCT00165789|475079006|FG000|Overall Study|Adverse Event|0|||
131942678|NCT00165789|475079007|FG001|Overall Study|Adverse Event|3|||
131942679|NCT00165789|475079008|FG002|Overall Study|Adverse Event|0|||
131942680|NCT00165789|475079009|FG003|Overall Study|Adverse Event|12|||
131942681|NCT00165789|475079006|FG000|Overall Study|Withdrawal by Subject|0|||
131942682|NCT00165789|475079007|FG001|Overall Study|Withdrawal by Subject|1|||
131942683|NCT00165789|475079008|FG002|Overall Study|Withdrawal by Subject|1|||
131455091|NCT00485134|473295532|FG002|Overall Study|Change in health status|2|||
131455092|NCT00485134|473295533|FG003|Overall Study|Change in health status|1|||
131942684|NCT00165789|475079009|FG003|Overall Study|Withdrawal by Subject|2|||
131942685|NCT01816048|475079010|FG000|Overall Study|Adverse Event|1|||
131942686|NCT01816048|475079010|FG000|Overall Study|Death|1|||
131942687|NCT01816048|475079010|FG000|Overall Study|Withdrawal by Subject|1|||
131942688|NCT01816048|475079010|FG000|Overall Study|Disease Progression|3|||
131942689|NCT03069716|475079012|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
131942690|NCT03069716|475079013|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
131455093|NCT00485134|473295534|FG004|Overall Study|Change in health status|0|||
131455094|NCT00485134|473295535|FG005|Overall Study|Change in health status|1|||
131455095|NCT00485134|473295536|FG006|Overall Study|Change in health status|0|||
131455096|NCT00485134|473295537|FG007|Overall Study|Change in health status|0|||
131455097|NCT00485134|473295530|FG000|Overall Study|Withdrew for adverse event|0|||
131455098|NCT00485134|473295531|FG001|Overall Study|Withdrew for adverse event|0|||
131455099|NCT00485134|473295532|FG002|Overall Study|Withdrew for adverse event|1|||
131455100|NCT00485134|473295533|FG003|Overall Study|Withdrew for adverse event|0|||
131455101|NCT00485134|473295534|FG004|Overall Study|Withdrew for adverse event|0|||
131455102|NCT00485134|473295535|FG005|Overall Study|Withdrew for adverse event|0|||
131455103|NCT00485134|473295536|FG006|Overall Study|Withdrew for adverse event|0|||
131455104|NCT00485134|473295537|FG007|Overall Study|Withdrew for adverse event|0|||
131455105|NCT00485134|473295530|FG000|Overall Study|Positive drug test|0|||
131455106|NCT00485134|473295531|FG001|Overall Study|Positive drug test|0|||
131455107|NCT00485134|473295532|FG002|Overall Study|Positive drug test|0|||
131455108|NCT00485134|473295533|FG003|Overall Study|Positive drug test|0|||
131455109|NCT00485134|473295534|FG004|Overall Study|Positive drug test|2|||
131455110|NCT00485134|473295535|FG005|Overall Study|Positive drug test|1|||
131455111|NCT00485134|473295536|FG006|Overall Study|Positive drug test|0|||
131455112|NCT00485134|473295537|FG007|Overall Study|Positive drug test|0|||
131455113|NCT00485134|473295530|FG000|Overall Study|Non-compliance|0|||
131455114|NCT00485134|473295531|FG001|Overall Study|Non-compliance|0|||
131455115|NCT00485134|473295532|FG002|Overall Study|Non-compliance|0|||
131455116|NCT00485134|473295533|FG003|Overall Study|Non-compliance|0|||
131455117|NCT00485134|473295534|FG004|Overall Study|Non-compliance|1|||
131455118|NCT00485134|473295535|FG005|Overall Study|Non-compliance|2|||
131455119|NCT00485134|473295536|FG006|Overall Study|Non-compliance|2|||
131455120|NCT00485134|473295537|FG007|Overall Study|Non-compliance|0|||
131455121|NCT00485134|473295530|FG000|Overall Study|Unable to comply with study schedule|0|||
131455122|NCT00485134|473295531|FG001|Overall Study|Unable to comply with study schedule|0|||
131455123|NCT00485134|473295532|FG002|Overall Study|Unable to comply with study schedule|0|||
131455124|NCT00485134|473295533|FG003|Overall Study|Unable to comply with study schedule|0|||
131455125|NCT00485134|473295534|FG004|Overall Study|Unable to comply with study schedule|0|||
131455126|NCT00485134|473295535|FG005|Overall Study|Unable to comply with study schedule|0|||
131455127|NCT00485134|473295536|FG006|Overall Study|Unable to comply with study schedule|0|||
131455128|NCT00485134|473295537|FG007|Overall Study|Unable to comply with study schedule|1|||
131455129|NCT00485134|473295530|FG000|Overall Study|Pregnancy|0|||
131455130|NCT00485134|473295531|FG001|Overall Study|Pregnancy|0|||
131942691|NCT03069716|475079014|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
131942692|NCT03069716|475079012|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
131942693|NCT03069716|475079013|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
131942694|NCT03069716|475079014|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
131942695|NCT03069716|475079012|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
131942696|NCT03069716|475079013|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
131942697|NCT03069716|475079014|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
131942698|NCT03069716|475079012|FG000|Randomized Treatment|Withdrawal by Subject|0|||
131942699|NCT03069716|475079013|FG001|Randomized Treatment|Withdrawal by Subject|2|||
131942700|NCT03069716|475079014|FG002|Randomized Treatment|Withdrawal by Subject|0|||
131942701|NCT01174563|475079015|FG000|Overall Study|Progressive Disease|45|||
131942702|NCT01174563|475079015|FG000|Overall Study|Death|5|||
131942703|NCT01174563|475079015|FG000|Overall Study|Investigator's Discretion|5|||
131942704|NCT01174563|475079015|FG000|Overall Study|Participant Withdrew Consent|3|||
131942705|NCT01174563|475079015|FG000|Overall Study|Rash Adverse Event|1|||
131942706|NCT01174563|475079015|FG000|Overall Study|Sponsor's decision|1|||
131942707|NCT01088906|475079019|FG000|Overall Study|Inclusion error|1|||
131942708|NCT01088906|475079019|FG000|Overall Study|Did not receive study treatment|3|||
131942709|NCT01088906|475079019|FG000|Overall Study|Missing data|1|||
131942710|NCT00457626|475079020|FG000|Overall Study|Adverse Event|3|||
131942711|NCT00457626|475079020|FG000|Overall Study|Administrative Problems|2|||
131455131|NCT00485134|473295532|FG002|Overall Study|Pregnancy|0|||
131455132|NCT00485134|473295533|FG003|Overall Study|Pregnancy|0|||
131455133|NCT00485134|473295534|FG004|Overall Study|Pregnancy|0|||
131942712|NCT00457626|475079020|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
131942713|NCT03257358|475080741|FG000|Overall Study|Adverse Event|25|||
131942714|NCT03257358|475080742|FG001|Overall Study|Adverse Event|12|||
131942715|NCT03257358|475080741|FG000|Overall Study|Lack of Efficacy|1|||
131455134|NCT00485134|473295535|FG005|Overall Study|Pregnancy|0|||
131455135|NCT00485134|473295536|FG006|Overall Study|Pregnancy|1|||
131942716|NCT03257358|475080742|FG001|Overall Study|Lack of Efficacy|1|||
131455136|NCT00485134|473295537|FG007|Overall Study|Pregnancy|0|||
131455137|NCT00970684|473295538|FG000|Overall Study|Lack of Efficacy|5|||
131455138|NCT00970684|473295538|FG000|Overall Study|Adverse Event|4|||
131455139|NCT00970684|473295538|FG000|Overall Study|Withdrawal by Subject|1|||
131455140|NCT00481091|473295539|FG000|Overall Study|Withdrawal by Subject|0|||
131455141|NCT00481091|473295540|FG001|Overall Study|Withdrawal by Subject|1|||
131455142|NCT00481091|473295541|FG002|Overall Study|Withdrawal by Subject|1|||
131942717|NCT03257358|475080741|FG000|Overall Study|Lost to Follow-up|12|||
131942718|NCT03257358|475080742|FG001|Overall Study|Lost to Follow-up|4|||
131942719|NCT03257358|475080741|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
131942720|NCT03257358|475080742|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
131942721|NCT03257358|475080741|FG000|Overall Study|Physician Decision|2|||
131942722|NCT03257358|475080742|FG001|Overall Study|Physician Decision|2|||
131942723|NCT03257358|475080741|FG000|Overall Study|Protocol Violation|5|||
131942724|NCT03257358|475080742|FG001|Overall Study|Protocol Violation|3|||
131942725|NCT03257358|475080741|FG000|Overall Study|Technical problems|4|||
131942726|NCT03257358|475080742|FG001|Overall Study|Technical problems|1|||
131942727|NCT03257358|475080741|FG000|Overall Study|Withdrawal by Subject|8|||
131942728|NCT03257358|475080742|FG001|Overall Study|Withdrawal by Subject|3|||
131942729|NCT03257358|475080741|FG000|Overall Study|Withdrawal of informed consent|9|||
131942730|NCT03257358|475080742|FG001|Overall Study|Withdrawal of informed consent|5|||
131942731|NCT03257358|475080741|FG000|Overall Study|New therapy for study indication|1|||
131942732|NCT03257358|475080742|FG001|Overall Study|New therapy for study indication|0|||
131942733|NCT03257358|475080741|FG000|Overall Study|No longer requires treatment|0|||
131942734|NCT03257358|475080742|FG001|Overall Study|No longer requires treatment|1|||
131942735|NCT01977898|475080743|FG000|Overall Study|Non functioning catheter|1|||
131942736|NCT01977898|475080744|FG001|Overall Study|Non functioning catheter|1|||
131942737|NCT01049373|475080745|FG000|Overall Study|Protocol Violation|9|||
131942738|NCT01049373|475080746|FG001|Overall Study|Protocol Violation|9|||
131942739|NCT01049373|475080745|FG000|Overall Study|Withdrawal by Subject|8|||
131942740|NCT01049373|475080746|FG001|Overall Study|Withdrawal by Subject|5|||
131942741|NCT01049373|475080745|FG000|Overall Study|Adverse Event|3|||
131942742|NCT01049373|475080746|FG001|Overall Study|Adverse Event|3|||
131942743|NCT01049373|475080745|FG000|Overall Study|Lost to Follow-up|9|||
131942744|NCT01049373|475080746|FG001|Overall Study|Lost to Follow-up|4|||
131942745|NCT01049373|475080745|FG000|Overall Study|no evaluable study values|9|||
131942746|NCT01049373|475080746|FG001|Overall Study|no evaluable study values|21|||
131942747|NCT01049373|475080745|FG000|Overall Study|Other|1|||
131942748|NCT01049373|475080746|FG001|Overall Study|Other|1|||
131942749|NCT01049373|475080745|FG000|Overall Study|Non-cooperation|0|||
131942750|NCT01049373|475080746|FG001|Overall Study|Non-cooperation|1|||
131942751|NCT02391311|475080747|FG000|Overall Study|Lost to Follow-up|2|||
131942752|NCT02391311|475080748|FG001|Overall Study|Lost to Follow-up|1|||
131942753|NCT02391311|475080747|FG000|Overall Study|deemed ineligible after baseline|1|||
131942754|NCT02391311|475080748|FG001|Overall Study|deemed ineligible after baseline|1|||
131412954|NCT00996801|473135481|FG003|Overall Study|Progressive Disease|0|||
131412955|NCT00996801|473135482|FG004|Overall Study|Progressive Disease|0|||
131412956|NCT00996801|473135483|FG005|Overall Study|Progressive Disease|0|||
131412957|NCT00996801|473135478|FG000|Overall Study|Protocol Violation|3|||
131412958|NCT00996801|473135479|FG001|Overall Study|Protocol Violation|4|||
131412959|NCT00996801|473135480|FG002|Overall Study|Protocol Violation|1|||
131412960|NCT00996801|473135481|FG003|Overall Study|Protocol Violation|2|||
131455143|NCT00481091|473295542|FG003|Overall Study|Withdrawal by Subject|0|||
131455144|NCT00481091|473295543|FG004|Overall Study|Withdrawal by Subject|0|||
131942755|NCT03374358|475080751|FG000|Overall Study|Withdrawal by Subject|0|||
131942756|NCT03374358|475080752|FG001|Overall Study|Withdrawal by Subject|2|||
131942757|NCT03183063|475080753|FG000|Overall Study|Withdrawal by Subject|2|||
131942758|NCT03183063|475080754|FG001|Overall Study|Withdrawal by Subject|0|||
131942759|NCT03183063|475080755|FG002|Overall Study|Withdrawal by Subject|0|||
131942760|NCT03183063|475080753|FG000|Overall Study|Physician Decision|3|||
131942761|NCT03183063|475080754|FG001|Overall Study|Physician Decision|4|||
131942762|NCT03183063|475080755|FG002|Overall Study|Physician Decision|4|||
131942763|NCT00305448|475080756|FG000|Overall Study|Protocol Violation|0|||
131942764|NCT00305448|475080757|FG001|Overall Study|Protocol Violation|1|||
131942765|NCT00305448|475080758|FG002|Overall Study|Protocol Violation|0|||
131942766|NCT00305448|475080756|FG000|Overall Study|Withdrawal by Subject|2|||
131942767|NCT00305448|475080757|FG001|Overall Study|Withdrawal by Subject|0|||
131942768|NCT00305448|475080758|FG002|Overall Study|Withdrawal by Subject|1|||
131942769|NCT00305448|475080756|FG000|Overall Study|Adverse Event|1|||
131942770|NCT00305448|475080757|FG001|Overall Study|Adverse Event|0|||
131942771|NCT00305448|475080758|FG002|Overall Study|Adverse Event|1|||
131942772|NCT00305448|475080756|FG000|Overall Study|Disease Progression|27|||
131942773|NCT00305448|475080757|FG001|Overall Study|Disease Progression|31|||
131942774|NCT00305448|475080758|FG002|Overall Study|Disease Progression|28|||
131942775|NCT00305448|475080756|FG000|Overall Study|Subjective Disease Progression|1|||
131942776|NCT00305448|475080757|FG001|Overall Study|Subjective Disease Progression|2|||
131942777|NCT00305448|475080758|FG002|Overall Study|Subjective Disease Progression|2|||
131942778|NCT00305448|475080756|FG000|Overall Study|Tumor Marker Elevation|0|||
131942779|NCT00305448|475080757|FG001|Overall Study|Tumor Marker Elevation|0|||
131942780|NCT00305448|475080758|FG002|Overall Study|Tumor Marker Elevation|1|||
131412961|NCT00996801|473135482|FG004|Overall Study|Protocol Violation|3|||
131942781|NCT00002766|475080759|FG000|Overall Study|Withdrawal by Subject|0|||
131412962|NCT00996801|473135483|FG005|Overall Study|Protocol Violation|4|||
131412963|NCT00996801|473135478|FG000|Overall Study|Study Terminated by Sponsor|0|||
131412964|NCT00996801|473135479|FG001|Overall Study|Study Terminated by Sponsor|1|||
131942782|NCT00002766|475080760|FG001|Overall Study|Withdrawal by Subject|1|||
131942783|NCT00002766|475080759|FG000|Overall Study|Patient Not Treated|1|||
131942784|NCT00002766|475080760|FG001|Overall Study|Patient Not Treated|2|||
131942785|NCT00002766|475080759|FG000|Overall Study|Adverse Event|1|||
131942786|NCT00002766|475080760|FG001|Overall Study|Adverse Event|1|||
131942787|NCT00002766|475080759|FG000|Overall Study|Protocol Violation|1|||
131942788|NCT00002766|475080760|FG001|Overall Study|Protocol Violation|0|||
131942789|NCT00328172|475080761|FG000|Overall Study|Adverse Event|3|||
131942790|NCT00328172|475080762|FG001|Overall Study|Adverse Event|2|||
131942791|NCT00328172|475080763|FG002|Overall Study|Adverse Event|1|||
131942792|NCT00328172|475080764|FG003|Overall Study|Adverse Event|2|||
131942793|NCT00328172|475080765|FG004|Overall Study|Adverse Event|1|||
131942794|NCT00328172|475080761|FG000|Overall Study|Protocol Violation|0|||
131942795|NCT00328172|475080762|FG001|Overall Study|Protocol Violation|1|||
131942796|NCT00328172|475080763|FG002|Overall Study|Protocol Violation|1|||
131942797|NCT00328172|475080764|FG003|Overall Study|Protocol Violation|0|||
131942798|NCT00328172|475080765|FG004|Overall Study|Protocol Violation|0|||
131942799|NCT00328172|475080761|FG000|Overall Study|Lost to Follow-up|1|||
131942800|NCT00328172|475080762|FG001|Overall Study|Lost to Follow-up|1|||
131942801|NCT00328172|475080763|FG002|Overall Study|Lost to Follow-up|2|||
131942802|NCT00328172|475080764|FG003|Overall Study|Lost to Follow-up|1|||
131942803|NCT00328172|475080765|FG004|Overall Study|Lost to Follow-up|1|||
131942804|NCT00328172|475080761|FG000|Overall Study|Withdrawal by Subject|1|||
131942805|NCT00328172|475080762|FG001|Overall Study|Withdrawal by Subject|1|||
131942806|NCT00328172|475080763|FG002|Overall Study|Withdrawal by Subject|1|||
131942807|NCT00328172|475080764|FG003|Overall Study|Withdrawal by Subject|6|||
131942808|NCT00328172|475080765|FG004|Overall Study|Withdrawal by Subject|0|||
131942809|NCT00328172|475080761|FG000|Overall Study|Lack of Efficacy|14|||
131942810|NCT00328172|475080762|FG001|Overall Study|Lack of Efficacy|9|||
131942811|NCT00328172|475080763|FG002|Overall Study|Lack of Efficacy|4|||
131942812|NCT00328172|475080764|FG003|Overall Study|Lack of Efficacy|4|||
131942813|NCT00328172|475080765|FG004|Overall Study|Lack of Efficacy|3|||
131942814|NCT00328172|475080761|FG000|Overall Study|Other reason (not specified)|3|||
131942815|NCT00328172|475080762|FG001|Overall Study|Other reason (not specified)|0|||
131942816|NCT00328172|475080763|FG002|Overall Study|Other reason (not specified)|1|||
131942817|NCT00328172|475080764|FG003|Overall Study|Other reason (not specified)|0|||
131942818|NCT00328172|475080765|FG004|Overall Study|Other reason (not specified)|0|||
131942819|NCT00077974|475080766|FG000|Overall Study|Adverse Event|22|||
131942820|NCT00077974|475080766|FG000|Overall Study|Protocol Violation|1|||
131942821|NCT00077974|475080766|FG000|Overall Study|Withdrawal by Subject|3|||
131942822|NCT00077974|475080766|FG000|Overall Study|Lack of Efficacy|76|||
131942823|NCT00077974|475080766|FG000|Overall Study|Decision of Sponsor|2|||
131942824|NCT01343888|475080767|FG000|Overall Study|Adverse Event|12|||
131942825|NCT01343888|475080768|FG001|Overall Study|Adverse Event|22|||
131942826|NCT01343888|475080769|FG002|Overall Study|Adverse Event|5|||
131942827|NCT01343888|475080767|FG000|Overall Study|Lack of Efficacy|9|||
131942828|NCT01343888|475080768|FG001|Overall Study|Lack of Efficacy|9|||
131942829|NCT01343888|475080769|FG002|Overall Study|Lack of Efficacy|13|||
131942830|NCT01343888|475080767|FG000|Overall Study|Lost to Follow-up|0|||
131942831|NCT01343888|475080768|FG001|Overall Study|Lost to Follow-up|2|||
131942832|NCT01343888|475080769|FG002|Overall Study|Lost to Follow-up|1|||
131942833|NCT01343888|475080767|FG000|Overall Study|Protocol Violation|0|||
131942834|NCT01343888|475080768|FG001|Overall Study|Protocol Violation|2|||
131942835|NCT01343888|475080769|FG002|Overall Study|Protocol Violation|0|||
131942836|NCT01343888|475080767|FG000|Overall Study|Withdrawal by Subject|4|||
131942837|NCT01343888|475080768|FG001|Overall Study|Withdrawal by Subject|4|||
131942838|NCT01343888|475080769|FG002|Overall Study|Withdrawal by Subject|2|||
131942839|NCT01343888|475080767|FG000|Overall Study|other than stated above|0|||
131942840|NCT01343888|475080768|FG001|Overall Study|other than stated above|0|||
131942841|NCT01343888|475080769|FG002|Overall Study|other than stated above|1|||
131942842|NCT02808429|475080778|FG000|Overall Study|Lost to Follow-up|1|||
131942843|NCT02808429|475080779|FG001|Overall Study|Lost to Follow-up|0|||
131942844|NCT02808429|475080780|FG002|Overall Study|Lost to Follow-up|0|||
131942845|NCT02808429|475080778|FG000|Overall Study|Protocol Violation|0|||
131942846|NCT02808429|475080779|FG001|Overall Study|Protocol Violation|1|||
131942847|NCT02808429|475080780|FG002|Overall Study|Protocol Violation|0|||
131942848|NCT02808429|475080778|FG000|Overall Study|Premature study termination by sponsor|2|||
131942849|NCT02808429|475080779|FG001|Overall Study|Premature study termination by sponsor|0|||
131942850|NCT02808429|475080780|FG002|Overall Study|Premature study termination by sponsor|1|||
131942851|NCT02808429|475080778|FG000|Overall Study|Relocation|0|||
131942852|NCT02808429|475080779|FG001|Overall Study|Relocation|0|||
131942853|NCT02808429|475080780|FG002|Overall Study|Relocation|1|||
131942854|NCT01063348|475080790|FG000|Overall Study|Lost to Follow-up|3|||
131942855|NCT01063348|475080791|FG001|Overall Study|Lost to Follow-up|10|||
131942856|NCT05518461|475080792|FG000|Overall Study|Lost to Follow-up|25|||
131942857|NCT00448448|475080793|FG000|Overall Study|Withdrawal by Subject|13|||
131942858|NCT00448448|475080794|FG001|Overall Study|Withdrawal by Subject|2|||
131942859|NCT00448448|475080793|FG000|Overall Study|On protocol when study ended|83|||
131942860|NCT00448448|475080794|FG001|Overall Study|On protocol when study ended|36|||
131942861|NCT00448448|475080793|FG000|Overall Study|Lost to Follow-up|2|||
131942862|NCT00448448|475080794|FG001|Overall Study|Lost to Follow-up|1|||
131942863|NCT00448448|475080793|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
131942864|NCT00448448|475080794|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
131942865|NCT00448448|475080793|FG000|Overall Study|Signed consent lost|0|||
131942866|NCT00448448|475080794|FG001|Overall Study|Signed consent lost|1|||
131942867|NCT04828707|475080795|FG000|Overall Study|Lost to Follow-up|3|||
131942868|NCT04828707|475080796|FG001|Overall Study|Lost to Follow-up|2|||
131942869|NCT04828707|475080795|FG000|Overall Study|Withdrawal by Subject|2|||
131942870|NCT04828707|475080796|FG001|Overall Study|Withdrawal by Subject|1|||
131942871|NCT00523978|475080799|FG000|Overall Study|Withdrawal by Subject|3|||
131942872|NCT00523978|475080800|FG001|Overall Study|Withdrawal by Subject|7|||
131942873|NCT00523978|475080799|FG000|Overall Study|Screen Failures|5|||
131942874|NCT00523978|475080800|FG001|Overall Study|Screen Failures|1|||
131942875|NCT00523978|475080799|FG000|Overall Study|Death|1|||
131942876|NCT00523978|475080800|FG001|Overall Study|Death|0|||
131942877|NCT00332696|475080801|FG000|Overall Study|Death|24|||
131942878|NCT00332696|475080802|FG001|Overall Study|Death|14|||
131942879|NCT00332696|475080801|FG000|Overall Study|Insufficient therapeutic effect|4|||
131942880|NCT00332696|475080802|FG001|Overall Study|Insufficient therapeutic effect|11|||
131942881|NCT00332696|475080801|FG000|Overall Study|Adverse Event|1|||
131942882|NCT00332696|475080802|FG001|Overall Study|Adverse Event|2|||
131942883|NCT00332696|475080801|FG000|Overall Study|Condition does not justify treatment|0|||
131942884|NCT00332696|475080802|FG001|Overall Study|Condition does not justify treatment|2|||
131942885|NCT00332696|475080801|FG000|Overall Study|Lost to Follow-up|0|||
131942886|NCT00332696|475080802|FG001|Overall Study|Lost to Follow-up|1|||
131942887|NCT00332696|475080801|FG000|Overall Study|Withdrawal by Subject|1|||
131942888|NCT00332696|475080802|FG001|Overall Study|Withdrawal by Subject|0|||
131942889|NCT02259114|475080803|FG000|Overall Study|Progressive Disease|14|||
131942890|NCT02259114|475080804|FG001|Overall Study|Progressive Disease|2|||
131942891|NCT02259114|475080805|FG002|Overall Study|Progressive Disease|10|||
131942892|NCT02259114|475080806|FG003|Overall Study|Progressive Disease|2|||
131942893|NCT02259114|475080807|FG004|Overall Study|Progressive Disease|5|||
131942894|NCT02259114|475080803|FG000|Overall Study|Adverse Event|2|||
131942895|NCT02259114|475080804|FG001|Overall Study|Adverse Event|1|||
131942896|NCT02259114|475080805|FG002|Overall Study|Adverse Event|0|||
131942897|NCT02259114|475080806|FG003|Overall Study|Adverse Event|0|||
131942898|NCT02259114|475080807|FG004|Overall Study|Adverse Event|1|||
131942899|NCT02259114|475080803|FG000|Overall Study|Death|3|||
131942900|NCT02259114|475080804|FG001|Overall Study|Death|0|||
131942901|NCT02259114|475080805|FG002|Overall Study|Death|1|||
131942902|NCT02259114|475080806|FG003|Overall Study|Death|0|||
131942903|NCT02259114|475080807|FG004|Overall Study|Death|0|||
131942904|NCT02259114|475080803|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
131942905|NCT02259114|475080804|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
131942906|NCT02259114|475080805|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
131942907|NCT02259114|475080806|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
131942908|NCT02259114|475080807|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
131942909|NCT02259114|475080803|FG000|Overall Study|Withdrawal by Subject|0|||
131942910|NCT02259114|475080804|FG001|Overall Study|Withdrawal by Subject|0|||
131942911|NCT02259114|475080805|FG002|Overall Study|Withdrawal by Subject|1|||
131942912|NCT02259114|475080806|FG003|Overall Study|Withdrawal by Subject|1|||
131942913|NCT02259114|475080807|FG004|Overall Study|Withdrawal by Subject|0|||
131942914|NCT02259114|475080803|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
131942915|NCT02259114|475080804|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
131942916|NCT02259114|475080805|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
131942917|NCT02259114|475080806|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
131942918|NCT02259114|475080807|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
131942919|NCT02259114|475080803|FG000|Overall Study|Not Treated|1|||
131942920|NCT02259114|475080804|FG001|Overall Study|Not Treated|0|||
131942921|NCT02259114|475080805|FG002|Overall Study|Not Treated|0|||
131942922|NCT02259114|475080806|FG003|Overall Study|Not Treated|0|||
131942923|NCT02259114|475080807|FG004|Overall Study|Not Treated|0|||
131942924|NCT03937479|475080808|FG000|Overall Study|Adverse Event|2|||
131942925|NCT03937479|475080809|FG001|Overall Study|Adverse Event|3|||
131942926|NCT03937479|475080810|FG002|Overall Study|Adverse Event|0|||
131942927|NCT03937479|475080811|FG003|Overall Study|Adverse Event|0|||
131942928|NCT03937479|475080812|FG004|Overall Study|Adverse Event|1|||
131942929|NCT03937479|475080808|FG000|Overall Study|Withdrawal by Subject|3|||
131942930|NCT03937479|475080809|FG001|Overall Study|Withdrawal by Subject|5|||
131942931|NCT03937479|475080810|FG002|Overall Study|Withdrawal by Subject|2|||
131942932|NCT03937479|475080811|FG003|Overall Study|Withdrawal by Subject|2|||
131942933|NCT03937479|475080812|FG004|Overall Study|Withdrawal by Subject|1|||
131942934|NCT03937479|475080808|FG000|Overall Study|Protocol Violation|5|||
131942935|NCT03937479|475080809|FG001|Overall Study|Protocol Violation|6|||
131942936|NCT03937479|475080810|FG002|Overall Study|Protocol Violation|4|||
131942937|NCT03937479|475080811|FG003|Overall Study|Protocol Violation|3|||
131455145|NCT00481091|473295544|FG005|Overall Study|Withdrawal by Subject|0|||
131455146|NCT00481091|473295545|FG006|Overall Study|Withdrawal by Subject|0|||
131455147|NCT00481091|473295546|FG007|Overall Study|Withdrawal by Subject|0|||
131455148|NCT00481091|473295547|FG008|Overall Study|Withdrawal by Subject|1|||
131455149|NCT00481091|473295548|FG009|Overall Study|Withdrawal by Subject|6|||
131455150|NCT00481091|473295539|FG000|Overall Study|Other, Not Specified|0|||
131455151|NCT00481091|473295540|FG001|Overall Study|Other, Not Specified|1|||
131455152|NCT00481091|473295541|FG002|Overall Study|Other, Not Specified|1|||
131455153|NCT00481091|473295542|FG003|Overall Study|Other, Not Specified|0|||
131455154|NCT00481091|473295543|FG004|Overall Study|Other, Not Specified|0|||
131455155|NCT00481091|473295544|FG005|Overall Study|Other, Not Specified|1|||
131455156|NCT00481091|473295545|FG006|Overall Study|Other, Not Specified|0|||
131455157|NCT00481091|473295546|FG007|Overall Study|Other, Not Specified|0|||
131455158|NCT00481091|473295547|FG008|Overall Study|Other, Not Specified|0|||
131455159|NCT00481091|473295548|FG009|Overall Study|Other, Not Specified|4|||
131455160|NCT00481091|473295539|FG000|Overall Study|Adverse Event|1|||
131455161|NCT00481091|473295540|FG001|Overall Study|Adverse Event|2|||
131455162|NCT00481091|473295541|FG002|Overall Study|Adverse Event|0|||
131455163|NCT00481091|473295542|FG003|Overall Study|Adverse Event|1|||
131455164|NCT00481091|473295543|FG004|Overall Study|Adverse Event|1|||
131455165|NCT00481091|473295544|FG005|Overall Study|Adverse Event|1|||
131455166|NCT00481091|473295545|FG006|Overall Study|Adverse Event|2|||
131455167|NCT00481091|473295546|FG007|Overall Study|Adverse Event|1|||
131455168|NCT00481091|473295547|FG008|Overall Study|Adverse Event|1|||
131455169|NCT00481091|473295548|FG009|Overall Study|Adverse Event|6|||
131455170|NCT00481091|473295539|FG000|Overall Study|Progressive disease clinical|0|||
131455171|NCT00481091|473295540|FG001|Overall Study|Progressive disease clinical|0|||
131455172|NCT00481091|473295541|FG002|Overall Study|Progressive disease clinical|0|||
131455173|NCT00481091|473295542|FG003|Overall Study|Progressive disease clinical|0|||
131455174|NCT00481091|473295543|FG004|Overall Study|Progressive disease clinical|0|||
131455175|NCT00481091|473295544|FG005|Overall Study|Progressive disease clinical|0|||
131455176|NCT00481091|473295545|FG006|Overall Study|Progressive disease clinical|0|||
131455177|NCT00481091|473295546|FG007|Overall Study|Progressive disease clinical|0|||
131455178|NCT00481091|473295547|FG008|Overall Study|Progressive disease clinical|1|||
131455179|NCT00481091|473295548|FG009|Overall Study|Progressive disease clinical|7|||
131455180|NCT00481091|473295539|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
131455181|NCT00481091|473295540|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
131455182|NCT00481091|473295541|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131455183|NCT00481091|473295542|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131455184|NCT00481091|473295543|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131455185|NCT00481091|473295544|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
131455186|NCT00481091|473295545|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131455187|NCT00481091|473295546|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131455188|NCT00481091|473295547|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131942938|NCT03937479|475080812|FG004|Overall Study|Protocol Violation|2|||
131942939|NCT03937479|475080808|FG000|Overall Study|Lost to Follow-up|0|||
131942940|NCT03937479|475080809|FG001|Overall Study|Lost to Follow-up|1|||
131942941|NCT03937479|475080810|FG002|Overall Study|Lost to Follow-up|0|||
131942942|NCT03937479|475080811|FG003|Overall Study|Lost to Follow-up|1|||
131942943|NCT03937479|475080812|FG004|Overall Study|Lost to Follow-up|0|||
131942944|NCT03937479|475080808|FG000|Overall Study|Physician Decision|0|||
131942945|NCT03937479|475080809|FG001|Overall Study|Physician Decision|0|||
131942946|NCT03937479|475080810|FG002|Overall Study|Physician Decision|1|||
131942947|NCT03937479|475080811|FG003|Overall Study|Physician Decision|0|||
131942948|NCT03937479|475080812|FG004|Overall Study|Physician Decision|1|||
131942949|NCT02712788|475080815|FG000|Overall Study|Physician Decision|1|||
131942950|NCT02712788|475080816|FG001|Overall Study|Physician Decision|0|||
131942951|NCT02712788|475080815|FG000|Overall Study|Protocol Violation|1|||
131942952|NCT02712788|475080816|FG001|Overall Study|Protocol Violation|0|||
131942953|NCT04436744|475080817|FG000|Overall Study|Adverse Event|1|||
131942954|NCT04436744|475080818|FG001|Overall Study|Adverse Event|1|||
131455189|NCT00481091|473295548|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
131455190|NCT00481091|473295539|FG000|Overall Study|Progressive disease other|1|||
131455191|NCT00481091|473295540|FG001|Overall Study|Progressive disease other|1|||
131455192|NCT00481091|473295541|FG002|Overall Study|Progressive disease other|0|||
131455193|NCT00481091|473295542|FG003|Overall Study|Progressive disease other|1|||
131455194|NCT00481091|473295543|FG004|Overall Study|Progressive disease other|1|||
131455195|NCT00481091|473295544|FG005|Overall Study|Progressive disease other|1|||
131455196|NCT00481091|473295545|FG006|Overall Study|Progressive disease other|0|||
131942955|NCT04436744|475080817|FG000|Overall Study|Death|1|||
131942956|NCT04436744|475080818|FG001|Overall Study|Death|0|||
131942957|NCT04436744|475080817|FG000|Overall Study|Lost to Follow-up|0|||
131942958|NCT04436744|475080818|FG001|Overall Study|Lost to Follow-up|2|||
131942959|NCT04436744|475080817|FG000|Overall Study|Physician Decision|0|||
131942960|NCT04436744|475080818|FG001|Overall Study|Physician Decision|1|||
131942961|NCT04436744|475080817|FG000|Overall Study|Progressive Disease|0|||
131942962|NCT04436744|475080818|FG001|Overall Study|Progressive Disease|4|||
131942963|NCT04436744|475080817|FG000|Overall Study|Protocol Deviation|1|||
131942964|NCT04436744|475080818|FG001|Overall Study|Protocol Deviation|1|||
131942965|NCT04436744|475080817|FG000|Overall Study|Withdrawal by Subject|1|||
131942966|NCT04436744|475080818|FG001|Overall Study|Withdrawal by Subject|2|||
131942967|NCT00940602|475080822|FG000|Overall Study|Administrative problems|1|||
131942968|NCT00940602|475080823|FG001|Overall Study|Administrative problems|1|||
131942969|NCT00940602|475080822|FG000|Overall Study|Patient/guardian decision|13|||
131942970|NCT00940602|475080823|FG001|Overall Study|Patient/guardian decision|28|||
131942971|NCT00940602|475080822|FG000|Overall Study|Physician Decision|8|||
131942972|NCT00940602|475080823|FG001|Overall Study|Physician Decision|5|||
131942973|NCT00940602|475080822|FG000|Overall Study|Pregnancy|1|||
131942974|NCT00940602|475080823|FG001|Overall Study|Pregnancy|0|||
131942975|NCT00940602|475080822|FG000|Overall Study|Protocol Deviation (untreated)|1|||
131942976|NCT00940602|475080823|FG001|Overall Study|Protocol Deviation (untreated)|0|||
131942977|NCT00940602|475080822|FG000|Overall Study|Disease progression|8|||
131942978|NCT00940602|475080823|FG001|Overall Study|Disease progression|2|||
131942979|NCT00940602|475080822|FG000|Overall Study|Death|38|||
131942980|NCT00940602|475080823|FG001|Overall Study|Death|19|||
131942981|NCT00940602|475080822|FG000|Overall Study|Lost to Follow-up|3|||
131942982|NCT00940602|475080823|FG001|Overall Study|Lost to Follow-up|1|||
131942983|NCT00940602|475080822|FG000|Overall Study|Patient withdrew consent|26|||
131942984|NCT00940602|475080823|FG001|Overall Study|Patient withdrew consent|13|||
131942985|NCT00940602|475080822|FG000|Overall Study|Adverse Event|7|||
131942986|NCT00940602|475080823|FG001|Overall Study|Adverse Event|2|||
131942987|NCT00940602|475080822|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
131942988|NCT00940602|475080823|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
131942989|NCT01880957|475080824|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
131942990|NCT01880957|475080825|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
131942991|NCT01880957|475080824|FG000|Overall Study|Lost to Follow-up|11|||
131942992|NCT01880957|475080825|FG001|Overall Study|Lost to Follow-up|0|||
131942993|NCT01880957|475080824|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
131942994|NCT01880957|475080825|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
131942995|NCT01854528|475080826|FG000|Overall Study|Adverse Event|0|||
131942996|NCT01854528|475080827|FG001|Overall Study|Adverse Event|4|||
131942997|NCT01854528|475080826|FG000|Overall Study|Withdrawal by Subject|0|||
131942998|NCT01854528|475080827|FG001|Overall Study|Withdrawal by Subject|2|||
131942999|NCT01854528|475080826|FG000|Overall Study|Virologic Failure|0|||
131943000|NCT01854528|475080827|FG001|Overall Study|Virologic Failure|9|||
131943001|NCT00575666|475080828|FG000|Overall Study|Withdrawal by Subject|3|||
131943002|NCT00575666|475080829|FG001|Overall Study|Withdrawal by Subject|2|||
131943003|NCT00575666|475080828|FG000|Overall Study|Physician Decision|1|||
131943004|NCT00575666|475080829|FG001|Overall Study|Physician Decision|1|||
131943005|NCT01368614|475080830|FG000|Screening Period|Screen Failure|58|||
131943006|NCT01368614|475080831|FG001|Screening Period|Screen Failure|0|||
131943007|NCT01368614|475080832|FG002|Screening Period|Screen Failure|0|||
131412965|NCT00996801|473135480|FG002|Overall Study|Study Terminated by Sponsor|0|||
131412966|NCT00996801|473135481|FG003|Overall Study|Study Terminated by Sponsor|0|||
131412967|NCT00996801|473135482|FG004|Overall Study|Study Terminated by Sponsor|46|||
131412968|NCT00996801|473135483|FG005|Overall Study|Study Terminated by Sponsor|0|||
131412969|NCT00996801|473135478|FG000|Overall Study|Withdrawal by Subject|8|||
131412970|NCT00996801|473135479|FG001|Overall Study|Withdrawal by Subject|6|||
131412971|NCT00996801|473135480|FG002|Overall Study|Withdrawal by Subject|9|||
131412972|NCT00996801|473135481|FG003|Overall Study|Withdrawal by Subject|5|||
131412973|NCT00996801|473135482|FG004|Overall Study|Withdrawal by Subject|5|||
131412974|NCT00996801|473135483|FG005|Overall Study|Withdrawal by Subject|9|||
131412975|NCT02804750|473135485|FG000|Period 1|Adverse Event|0|||
131412976|NCT02804750|473135486|FG001|Period 1|Adverse Event|2|||
131412977|NCT02804750|473135485|FG000|Period 1|Withdrawal by Subject|0|||
131412978|NCT02804750|473135486|FG001|Period 1|Withdrawal by Subject|1|||
131412979|NCT02804750|473135485|FG000|Period 2|Adverse Event|1|||
131412980|NCT02804750|473135486|FG001|Period 2|Adverse Event|0|||
131412981|NCT02804750|473135485|FG000|Period 3|Adverse Event|0|||
131943008|NCT01368614|475080833|FG003|Screening Period|Screen Failure|0|||
131943009|NCT01368614|475080830|FG000|Study Period|Withdrawal by Subject|0|||
131943010|NCT01368614|475080831|FG001|Study Period|Withdrawal by Subject|1|||
131943011|NCT01368614|475080832|FG002|Study Period|Withdrawal by Subject|1|||
131943012|NCT01368614|475080833|FG003|Study Period|Withdrawal by Subject|3|||
131943013|NCT01368614|475080830|FG000|Study Period|Lost to Follow-up|0|||
131943014|NCT01368614|475080831|FG001|Study Period|Lost to Follow-up|0|||
131943015|NCT01368614|475080832|FG002|Study Period|Lost to Follow-up|1|||
131943016|NCT01368614|475080833|FG003|Study Period|Lost to Follow-up|0|||
131943017|NCT02951780|475080834|FG000|Period 1|Adverse Event|0|||
131943018|NCT02951780|475080835|FG001|Period 1|Adverse Event|0|||
131943019|NCT02951780|475080836|FG002|Period 1|Adverse Event|0|||
131943020|NCT02951780|475080837|FG003|Period 1|Adverse Event|1|||
131943021|NCT02951780|475080838|FG004|Period 1|Adverse Event|0|||
131943022|NCT02951780|475080839|FG005|Period 1|Adverse Event|0|||
131943023|NCT02951780|475080840|FG006|Period 1|Adverse Event|0|||
131943024|NCT02951780|475080841|FG007|Period 1|Adverse Event|0|||
131943025|NCT02951780|475080842|FG008|Period 1|Adverse Event|0|||
131943026|NCT02951780|475080834|FG000|Period 1|Scheduling Conflicts|0|||
131943027|NCT02951780|475080835|FG001|Period 1|Scheduling Conflicts|0|||
131943028|NCT02951780|475080836|FG002|Period 1|Scheduling Conflicts|0|||
131943029|NCT02951780|475080837|FG003|Period 1|Scheduling Conflicts|0|||
131943030|NCT02951780|475080838|FG004|Period 1|Scheduling Conflicts|0|||
131943031|NCT02951780|475080839|FG005|Period 1|Scheduling Conflicts|0|||
131943032|NCT02951780|475080840|FG006|Period 1|Scheduling Conflicts|0|||
131943033|NCT02951780|475080841|FG007|Period 1|Scheduling Conflicts|1|||
131943034|NCT02951780|475080842|FG008|Period 1|Scheduling Conflicts|0|||
131943035|NCT02951780|475080834|FG000|Period 2|Scheduling Conflicts|0|||
131943036|NCT02951780|475080835|FG001|Period 2|Scheduling Conflicts|0|||
131943037|NCT02951780|475080836|FG002|Period 2|Scheduling Conflicts|0|||
131943038|NCT02951780|475080837|FG003|Period 2|Scheduling Conflicts|0|||
131943039|NCT02951780|475080838|FG004|Period 2|Scheduling Conflicts|0|||
131943040|NCT02951780|475080839|FG005|Period 2|Scheduling Conflicts|0|||
131943041|NCT02951780|475080840|FG006|Period 2|Scheduling Conflicts|0|||
131943042|NCT02951780|475080841|FG007|Period 2|Scheduling Conflicts|1|||
131943043|NCT02951780|475080842|FG008|Period 2|Scheduling Conflicts|0|||
131943044|NCT00508482|475080843|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
131943045|NCT00508482|475080844|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
131943046|NCT00508482|475080845|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
131943047|NCT00508482|475080843|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
131943048|NCT00508482|475080844|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
131943049|NCT00508482|475080845|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
131943050|NCT00508482|475080843|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
131943051|NCT00508482|475080844|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
131943052|NCT00508482|475080845|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
131943053|NCT01904721|475080847|FG000|Overall Study|Other Reasons|0|||
131943054|NCT01904721|475080848|FG001|Overall Study|Other Reasons|0|||
131943055|NCT01904721|475080849|FG002|Overall Study|Other Reasons|1|||
131943056|NCT01904721|475080850|FG003|Overall Study|Other Reasons|1|||
131943057|NCT01904721|475080851|FG004|Overall Study|Other Reasons|2|||
131943058|NCT01904721|475080852|FG005|Overall Study|Other Reasons|2|||
131943059|NCT01904721|475080853|FG006|Overall Study|Other Reasons|2|||
131943060|NCT01904721|475080847|FG000|Overall Study|Personal Reasons|0|||
131943061|NCT01904721|475080848|FG001|Overall Study|Personal Reasons|0|||
131943062|NCT01904721|475080849|FG002|Overall Study|Personal Reasons|0|||
131943063|NCT01904721|475080850|FG003|Overall Study|Personal Reasons|0|||
131943064|NCT01904721|475080851|FG004|Overall Study|Personal Reasons|2|||
131943065|NCT01904721|475080852|FG005|Overall Study|Personal Reasons|3|||
131943066|NCT01904721|475080853|FG006|Overall Study|Personal Reasons|3|||
131943067|NCT01904721|475080847|FG000|Overall Study|Lost to Follow-up|0|||
131943068|NCT01904721|475080848|FG001|Overall Study|Lost to Follow-up|0|||
131943069|NCT01904721|475080849|FG002|Overall Study|Lost to Follow-up|0|||
131943070|NCT01904721|475080850|FG003|Overall Study|Lost to Follow-up|0|||
131943071|NCT01904721|475080851|FG004|Overall Study|Lost to Follow-up|1|||
131943072|NCT01904721|475080852|FG005|Overall Study|Lost to Follow-up|3|||
131943073|NCT01904721|475080853|FG006|Overall Study|Lost to Follow-up|1|||
131943074|NCT01904721|475080847|FG000|Overall Study|Lack of Efficacy|0|||
131943075|NCT01904721|475080848|FG001|Overall Study|Lack of Efficacy|0|||
131943076|NCT01904721|475080849|FG002|Overall Study|Lack of Efficacy|0|||
131943077|NCT01904721|475080850|FG003|Overall Study|Lack of Efficacy|0|||
131412982|NCT02804750|473135486|FG001|Period 3|Adverse Event|2|||
131943078|NCT01904721|475080851|FG004|Overall Study|Lack of Efficacy|0|||
131943079|NCT01904721|475080852|FG005|Overall Study|Lack of Efficacy|0|||
131943080|NCT01904721|475080853|FG006|Overall Study|Lack of Efficacy|1|||
131943081|NCT01904721|475080847|FG000|Overall Study|Adverse Event|0|||
131943082|NCT01904721|475080848|FG001|Overall Study|Adverse Event|0|||
131943083|NCT01904721|475080849|FG002|Overall Study|Adverse Event|0|||
131943084|NCT01904721|475080850|FG003|Overall Study|Adverse Event|0|||
131943085|NCT01904721|475080851|FG004|Overall Study|Adverse Event|3|||
131943086|NCT01904721|475080852|FG005|Overall Study|Adverse Event|1|||
131943087|NCT01904721|475080853|FG006|Overall Study|Adverse Event|0|||
131943088|NCT01957865|475080854|FG000|Overall Study|Found HIV negative|0|||
131943089|NCT01957865|475080855|FG001|Overall Study|Found HIV negative|0|||
131943090|NCT01957865|475080856|FG002|Overall Study|Found HIV negative|1|||
131943091|NCT01957865|475080854|FG000|Overall Study|Lost to Follow-up|0|||
131943092|NCT01957865|475080855|FG001|Overall Study|Lost to Follow-up|2|||
131943093|NCT01957865|475080856|FG002|Overall Study|Lost to Follow-up|2|||
131943094|NCT01082614|475080857|FG000|Overall Study|Adverse Event|1|||
131943095|NCT01082614|475080858|FG001|Overall Study|Adverse Event|4|||
131943096|NCT01082614|475080857|FG000|Overall Study|Equipment Malfunction|0|||
131943097|NCT01082614|475080858|FG001|Overall Study|Equipment Malfunction|1|||
131943098|NCT01082614|475080857|FG000|Overall Study|Physician Decision|2|||
131943099|NCT01082614|475080858|FG001|Overall Study|Physician Decision|0|||
131943100|NCT00811720|475080862|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
131943101|NCT00811720|475080863|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
131943102|NCT00811720|475080862|FG000|All Treated Patients|Adverse Event|20|||
131943103|NCT00811720|475080863|FG001|All Treated Patients|Adverse Event|62|||
131943104|NCT00811720|475080862|FG000|All Treated Patients|Lack of Efficacy|22|||
131943105|NCT00811720|475080863|FG001|All Treated Patients|Lack of Efficacy|18|||
131943106|NCT00811720|475080862|FG000|All Treated Patients|Non-compliance|0|||
131943107|NCT00811720|475080863|FG001|All Treated Patients|Non-compliance|14|||
131943108|NCT00811720|475080862|FG000|All Treated Patients|Protocol Violation|9|||
131943109|NCT00811720|475080863|FG001|All Treated Patients|Protocol Violation|16|||
131943110|NCT00811720|475080862|FG000|All Treated Patients|Withdrawal by Subject|28|||
131943111|NCT00811720|475080863|FG001|All Treated Patients|Withdrawal by Subject|34|||
131943112|NCT00811720|475080862|FG000|All Treated Patients|Lost to Follow-up|10|||
131943113|NCT00811720|475080863|FG001|All Treated Patients|Lost to Follow-up|16|||
131943114|NCT00811720|475080862|FG000|All Treated Patients|Other Reason|7|||
131943115|NCT00811720|475080863|FG001|All Treated Patients|Other Reason|4|||
131943116|NCT01077063|475080864|FG000|Overall Study|Adverse Event|3|||
131943117|NCT01077063|475080865|FG001|Overall Study|Adverse Event|0|||
131943118|NCT01077063|475080864|FG000|Overall Study|Death|1|||
131943119|NCT01077063|475080865|FG001|Overall Study|Death|1|||
131943120|NCT01077063|475080864|FG000|Overall Study|Withdrawal by Subject|0|||
131943121|NCT01077063|475080865|FG001|Overall Study|Withdrawal by Subject|2|||
131943122|NCT02750930|475080866|FG000|Overall Study|Study closed/terminated|8|||
131943123|NCT00553631|475080868|FG000|Overall Study|Withdrawal by Subject|0|||
131943124|NCT00553631|475080869|FG001|Overall Study|Withdrawal by Subject|1|||
131943125|NCT00553631|475080868|FG000|Overall Study|Lost to Follow-up|1|||
131943126|NCT00553631|475080869|FG001|Overall Study|Lost to Follow-up|0|||
131943127|NCT01055613|475080871|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
131943128|NCT01055613|475080872|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131943129|NCT01055613|475080871|FG000|Overall Study|Unacceptable lens fit|1|||
131943130|NCT01055613|475080872|FG001|Overall Study|Unacceptable lens fit|0|||
131943131|NCT01055613|475080871|FG000|Overall Study|Discomfort|2|||
131943132|NCT01055613|475080872|FG001|Overall Study|Discomfort|1|||
131943133|NCT01055613|475080871|FG000|Overall Study|Lost to Follow-up|1|||
131943134|NCT01055613|475080872|FG001|Overall Study|Lost to Follow-up|1|||
131943135|NCT01055613|475080871|FG000|Overall Study|Protocol Violation|1|||
131943136|NCT01055613|475080872|FG001|Overall Study|Protocol Violation|1|||
131943137|NCT01055613|475080871|FG000|Overall Study|Subject Disinterest|1|||
131943138|NCT01055613|475080872|FG001|Overall Study|Subject Disinterest|1|||
131943139|NCT02765399|475080875|FG000|Overall Study|Nausea|1|||
131943140|NCT02765399|475080876|FG001|Overall Study|Nausea|0|||
131943141|NCT01182298|475080877|FG000|Overall Study|Lack of Efficacy|4|||
131943142|NCT01182298|475080877|FG000|Overall Study|Withdrawal by Subject|2|||
131943143|NCT02629861|475080879|FG000|Overall Study|Adverse Event|7|||
131943144|NCT02629861|475080880|FG001|Overall Study|Adverse Event|5|||
131943145|NCT02629861|475080881|FG002|Overall Study|Adverse Event|4|||
131943146|NCT02629861|475080879|FG000|Overall Study|Withdrawal by Subject|5|||
131943147|NCT02629861|475080880|FG001|Overall Study|Withdrawal by Subject|8|||
131943148|NCT02629861|475080881|FG002|Overall Study|Withdrawal by Subject|13|||
131943149|NCT02629861|475080879|FG000|Overall Study|Protocol Violation|2|||
131943150|NCT02629861|475080880|FG001|Overall Study|Protocol Violation|3|||
131943151|NCT02629861|475080881|FG002|Overall Study|Protocol Violation|7|||
131943152|NCT02629861|475080879|FG000|Overall Study|Lost to Follow-up|12|||
131943153|NCT02629861|475080880|FG001|Overall Study|Lost to Follow-up|9|||
131943154|NCT02629861|475080881|FG002|Overall Study|Lost to Follow-up|4|||
131943155|NCT02629861|475080879|FG000|Overall Study|Other|1|||
131943156|NCT02629861|475080880|FG001|Overall Study|Other|1|||
131943157|NCT02629861|475080881|FG002|Overall Study|Other|0|||
131943158|NCT02629861|475080879|FG000|Overall Study|Pregnancy|2|||
131943159|NCT02629861|475080880|FG001|Overall Study|Pregnancy|1|||
131412983|NCT02804750|473135485|FG000|Period 4|Adverse Event|0|||
131943160|NCT02629861|475080881|FG002|Overall Study|Pregnancy|0|||
131943161|NCT01822665|475080882|FG000|Overall Study|Adverse Event|3|||
131943162|NCT01822665|475080882|FG000|Overall Study|Other Reason|5|||
131943163|NCT00907621|475080883|FG000|Overall Study|Lost to Follow-up|6|||
131943164|NCT00907621|475080884|FG001|Overall Study|Lost to Follow-up|3|||
131943165|NCT00907621|475080883|FG000|Overall Study|intercurrent febrile illness|1|||
131943166|NCT00907621|475080884|FG001|Overall Study|intercurrent febrile illness|1|||
131943167|NCT00656370|475080888|FG000|Overall Study|Screen Failures|7|||
131943168|NCT00656370|475080888|FG000|Overall Study|Alternates|3|||
131943169|NCT01342094|475080889|FG000|Overall Study|Adverse Event|5|||
131943170|NCT01342094|475080890|FG001|Overall Study|Adverse Event|0|||
131943171|NCT01342094|475080889|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131943172|NCT01342094|475080890|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131943173|NCT01342094|475080889|FG000|Overall Study|Withdrawal by Subject|0|||
131943174|NCT01342094|475080890|FG001|Overall Study|Withdrawal by Subject|2|||
131943175|NCT03391882|475080895|FG000|Study Overall|Adverse Event|3|||
131943176|NCT03391882|475080896|FG001|Study Overall|Adverse Event|6|||
131943177|NCT03391882|475080897|FG002|Study Overall|Adverse Event|1|||
131943178|NCT03391882|475080898|FG003|Study Overall|Adverse Event|1|||
131943179|NCT03391882|475080899|FG004|Study Overall|Adverse Event|3|||
131943180|NCT03391882|475080900|FG005|Study Overall|Adverse Event|1|||
131943181|NCT03391882|475080895|FG000|Study Overall|Lack of Efficacy|13|||
131943182|NCT03391882|475080896|FG001|Study Overall|Lack of Efficacy|9|||
131943183|NCT03391882|475080897|FG002|Study Overall|Lack of Efficacy|0|||
131943184|NCT03391882|475080898|FG003|Study Overall|Lack of Efficacy|0|||
131943185|NCT03391882|475080899|FG004|Study Overall|Lack of Efficacy|0|||
131943186|NCT03391882|475080900|FG005|Study Overall|Lack of Efficacy|0|||
131943187|NCT03391882|475080895|FG000|Study Overall|Withdrawal by Subject|3|||
131943188|NCT03391882|475080896|FG001|Study Overall|Withdrawal by Subject|3|||
131943189|NCT03391882|475080897|FG002|Study Overall|Withdrawal by Subject|2|||
131943190|NCT03391882|475080898|FG003|Study Overall|Withdrawal by Subject|2|||
131943191|NCT03391882|475080899|FG004|Study Overall|Withdrawal by Subject|1|||
131943192|NCT03391882|475080900|FG005|Study Overall|Withdrawal by Subject|3|||
131943193|NCT03391882|475080895|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
131943194|NCT03391882|475080896|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
131943195|NCT03391882|475080897|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
131943196|NCT03391882|475080898|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
131943197|NCT03391882|475080899|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
131943198|NCT03391882|475080900|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
131943199|NCT03391882|475080895|FG000|Study Overall|Protocol Violation|1|||
131943200|NCT03391882|475080896|FG001|Study Overall|Protocol Violation|0|||
131943201|NCT03391882|475080897|FG002|Study Overall|Protocol Violation|0|||
131943202|NCT03391882|475080898|FG003|Study Overall|Protocol Violation|0|||
131943203|NCT03391882|475080899|FG004|Study Overall|Protocol Violation|0|||
131943204|NCT03391882|475080900|FG005|Study Overall|Protocol Violation|0|||
131943205|NCT03391882|475080895|FG000|Part A - Titration Phase|Adverse Event|3|||
131943206|NCT03391882|475080896|FG001|Part A - Titration Phase|Adverse Event|6|||
131943207|NCT03391882|475080897|FG002|Part A - Titration Phase|Adverse Event|0|||
131943208|NCT03391882|475080898|FG003|Part A - Titration Phase|Adverse Event|0|||
131943209|NCT03391882|475080899|FG004|Part A - Titration Phase|Adverse Event|0|||
131943210|NCT03391882|475080900|FG005|Part A - Titration Phase|Adverse Event|0|||
131943211|NCT03391882|475080895|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
131943212|NCT03391882|475080896|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
131943213|NCT03391882|475080897|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
131943214|NCT03391882|475080898|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
131943215|NCT03391882|475080899|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
131943216|NCT03391882|475080900|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
131943217|NCT03391882|475080895|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
131943218|NCT03391882|475080896|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
131943219|NCT03391882|475080897|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
131943220|NCT03391882|475080898|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
131943221|NCT03391882|475080899|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
131943222|NCT03391882|475080900|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
131943223|NCT03391882|475080895|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
131943224|NCT03391882|475080896|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
131943225|NCT03391882|475080897|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
131943226|NCT03391882|475080898|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
131943227|NCT03391882|475080899|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
131943228|NCT03391882|475080900|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
131943229|NCT03391882|475080895|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
131943230|NCT03391882|475080896|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
131943231|NCT03391882|475080897|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
131943232|NCT03391882|475080898|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
131943233|NCT03391882|475080899|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
131943234|NCT03391882|475080900|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
131943235|NCT03391882|475080895|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
131943236|NCT03391882|475080896|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
131943237|NCT03391882|475080897|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
131943238|NCT03391882|475080898|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
131943239|NCT03391882|475080899|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
131943240|NCT03391882|475080900|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
131943241|NCT03391882|475080895|FG000|Part B - Treatment Phase|Adverse Event|0|||
131943242|NCT03391882|475080896|FG001|Part B - Treatment Phase|Adverse Event|0|||
131943243|NCT03391882|475080897|FG002|Part B - Treatment Phase|Adverse Event|1|||
131943244|NCT03391882|475080898|FG003|Part B - Treatment Phase|Adverse Event|1|||
131943245|NCT03391882|475080899|FG004|Part B - Treatment Phase|Adverse Event|3|||
131943246|NCT03391882|475080900|FG005|Part B - Treatment Phase|Adverse Event|1|||
131943247|NCT03391882|475080895|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
131943248|NCT03391882|475080896|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
131943249|NCT03391882|475080897|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
131943250|NCT03391882|475080898|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
131943251|NCT03391882|475080899|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
131943252|NCT03391882|475080900|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
131943253|NCT04422431|475080901|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
131412984|NCT02804750|473135486|FG001|Period 4|Adverse Event|5|||
131412985|NCT02559414|473135487|FG000|Overall Study|Lost to Follow-up|0|||
131412986|NCT02559414|473135488|FG001|Overall Study|Lost to Follow-up|1|||
131412987|NCT02559414|473135489|FG002|Overall Study|Lost to Follow-up|0|||
131412988|NCT02559414|473135487|FG000|Overall Study|Withdrawal by Subject|1|||
131412989|NCT02559414|473135488|FG001|Overall Study|Withdrawal by Subject|0|||
131412990|NCT02559414|473135489|FG002|Overall Study|Withdrawal by Subject|1|||
131412991|NCT02559414|473135487|FG000|Overall Study|Other|0|||
131412992|NCT02559414|473135488|FG001|Overall Study|Other|1|||
131412993|NCT02559414|473135489|FG002|Overall Study|Other|1|||
131412994|NCT03369431|473135490|FG000|Overall Study|Lost to Follow-up|1|||
131412995|NCT03369431|473135491|FG001|Overall Study|Lost to Follow-up|3|||
131412996|NCT03369431|473135490|FG000|Overall Study|Withdrawal by Subject|2|||
131412997|NCT03369431|473135491|FG001|Overall Study|Withdrawal by Subject|3|||
131412998|NCT03369431|473135490|FG000|Overall Study|Protocol Violation|1|||
131412999|NCT03369431|473135491|FG001|Overall Study|Protocol Violation|1|||
131413000|NCT01657760|473135500|FG000|Overall Study|Withdrawal by Subject|0|||
131413001|NCT01657760|473135501|FG001|Overall Study|Withdrawal by Subject|0|||
131413002|NCT01657760|473135502|FG002|Overall Study|Withdrawal by Subject|0|||
131413003|NCT01657760|473135503|FG003|Overall Study|Withdrawal by Subject|1|||
131413004|NCT01657760|473135500|FG000|Overall Study|Physician Decision|1|||
131413005|NCT01657760|473135501|FG001|Overall Study|Physician Decision|1|||
131413006|NCT01657760|473135502|FG002|Overall Study|Physician Decision|1|||
131413007|NCT01657760|473135503|FG003|Overall Study|Physician Decision|2|||
131413008|NCT00940485|473135511|FG000|Overall Study|HBeAb positive at Baseline|3|||
131413009|NCT00940485|473135512|FG001|Overall Study|HBeAb positive at Baseline|2|||
131455197|NCT00481091|473295546|FG007|Overall Study|Progressive disease other|2|||
131943254|NCT04422431|475080901|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
131943255|NCT04422431|475080901|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
131943256|NCT04422431|475080901|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
131943257|NCT04422431|475080901|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
131943258|NCT04422431|475080901|FG000|Extension Period (48 Weeks)|Other than specified|2|||
131943259|NCT03913130|475080902|FG000|Overall Study|Sponsor Decision|1|||
131943260|NCT01152437|475080903|FG000|Overall Study|Other Adverse Event|8|||
131943261|NCT01152437|475080904|FG001|Overall Study|Other Adverse Event|1|||
131943262|NCT01152437|475080905|FG002|Overall Study|Other Adverse Event|7|||
131943263|NCT01152437|475080903|FG000|Overall Study|Not treated|0|||
131943264|NCT01152437|475080904|FG001|Overall Study|Not treated|1|||
131943265|NCT01152437|475080905|FG002|Overall Study|Not treated|2|||
131943266|NCT01152437|475080903|FG000|Overall Study|Progressive disease|27|||
131943267|NCT01152437|475080904|FG001|Overall Study|Progressive disease|13|||
131943268|NCT01152437|475080905|FG002|Overall Study|Progressive disease|32|||
131943269|NCT01152437|475080903|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
131943270|NCT01152437|475080904|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
131943271|NCT01152437|475080905|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
131943272|NCT02317627|475080907|FG000|Overall Study|Withdrawal by Subject|0|||
131943273|NCT02317627|475080908|FG001|Overall Study|Withdrawal by Subject|1|||
131943274|NCT02317627|475080909|FG002|Overall Study|Withdrawal by Subject|1|||
131943275|NCT02317627|475080907|FG000|Overall Study|Lost to Follow-up|2|||
131943276|NCT02317627|475080908|FG001|Overall Study|Lost to Follow-up|0|||
131943277|NCT02317627|475080909|FG002|Overall Study|Lost to Follow-up|0|||
131943278|NCT02317627|475080907|FG000|Overall Study|Stopped by Investigator|0|||
131943279|NCT02317627|475080908|FG001|Overall Study|Stopped by Investigator|1|||
131943280|NCT02317627|475080909|FG002|Overall Study|Stopped by Investigator|0|||
131943281|NCT02317627|475080907|FG000|Overall Study|Adverse Event|0|||
131943282|NCT02317627|475080908|FG001|Overall Study|Adverse Event|2|||
131943283|NCT02317627|475080909|FG002|Overall Study|Adverse Event|3|||
131943284|NCT02317627|475080907|FG000|Overall Study|Non-compliance with study drug|0|||
131413010|NCT00940485|473135511|FG000|Overall Study|Lost to Follow-up|2|||
131413011|NCT00940485|473135512|FG001|Overall Study|Lost to Follow-up|3|||
131413012|NCT00940485|473135511|FG000|Overall Study|Adverse Event|8|||
131413013|NCT00940485|473135512|FG001|Overall Study|Adverse Event|0|||
131943285|NCT02317627|475080908|FG001|Overall Study|Non-compliance with study drug|1|||
131943286|NCT02317627|475080909|FG002|Overall Study|Non-compliance with study drug|0|||
131413014|NCT00940485|473135511|FG000|Overall Study|Withdrawal by Subject|1|||
131943287|NCT00279214|475080910|FG000|Overall Study|Physician Decision|3|||
131413015|NCT00940485|473135512|FG001|Overall Study|Withdrawal by Subject|1|||
131413016|NCT00940485|473135511|FG000|Overall Study|Others|1|||
131943288|NCT00279214|475080911|FG001|Overall Study|Physician Decision|2|||
131943289|NCT01214837|475080913|FG000|Overall Study|Death|0|||
131943290|NCT01214837|475080914|FG001|Overall Study|Death|0|||
131943291|NCT01214837|475080915|FG002|Overall Study|Death|1|||
131943292|NCT01214837|475080913|FG000|Overall Study|Adverse Event|1|||
131455198|NCT00481091|473295547|FG008|Overall Study|Progressive disease other|0|||
131455199|NCT00481091|473295548|FG009|Overall Study|Progressive disease other|0|||
131455200|NCT00481091|473295539|FG000|Overall Study|No reason given|0|||
131943293|NCT01214837|475080914|FG001|Overall Study|Adverse Event|2|||
131943294|NCT01214837|475080915|FG002|Overall Study|Adverse Event|1|||
131943295|NCT01214837|475080913|FG000|Overall Study|Withdrawal by Subject|27|||
131943296|NCT01214837|475080914|FG001|Overall Study|Withdrawal by Subject|36|||
131943297|NCT01214837|475080915|FG002|Overall Study|Withdrawal by Subject|28|||
131943298|NCT01214837|475080913|FG000|Overall Study|Lost to Follow-up|20|||
131943299|NCT01214837|475080914|FG001|Overall Study|Lost to Follow-up|15|||
131943300|NCT01214837|475080915|FG002|Overall Study|Lost to Follow-up|21|||
131943301|NCT01214837|475080913|FG000|Overall Study|Inappropriate Enrolment|0|||
131943302|NCT01214837|475080914|FG001|Overall Study|Inappropriate Enrolment|1|||
131943303|NCT01214837|475080915|FG002|Overall Study|Inappropriate Enrolment|2|||
131943304|NCT01214837|475080913|FG000|Overall Study|Administrative Reason|2|||
131943305|NCT01214837|475080914|FG001|Overall Study|Administrative Reason|6|||
131943306|NCT01214837|475080915|FG002|Overall Study|Administrative Reason|4|||
131943307|NCT01214837|475080913|FG000|Overall Study|Protocol Violation|3|||
131943308|NCT01214837|475080914|FG001|Overall Study|Protocol Violation|1|||
131943309|NCT01214837|475080915|FG002|Overall Study|Protocol Violation|5|||
131943310|NCT01214837|475080913|FG000|Overall Study|Unable to Classify|1|||
131943311|NCT01214837|475080914|FG001|Overall Study|Unable to Classify|3|||
131943312|NCT01214837|475080915|FG002|Overall Study|Unable to Classify|0|||
131943313|NCT00027560|475080916|FG000|Overall Study|Withdrawal by Subject|1|||
131943314|NCT02735421|475082800|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
131943315|NCT02735421|475082800|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
131943316|NCT02735421|475082800|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
131943317|NCT02735421|475082800|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
131943318|NCT02735421|475082800|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
131943319|NCT02735421|475082800|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
131943320|NCT02735421|475082800|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
131943321|NCT03549338|475082801|FG000|Overall Study|Progressive Disease|1|||
131943322|NCT03549338|475082802|FG001|Overall Study|Progressive Disease|0|||
131943323|NCT03549338|475082803|FG002|Overall Study|Progressive Disease|0|||
131943324|NCT03549338|475082801|FG000|Overall Study|Clinical Progression|0|||
131943325|NCT03549338|475082802|FG001|Overall Study|Clinical Progression|1|||
131943326|NCT03549338|475082803|FG002|Overall Study|Clinical Progression|0|||
131943327|NCT00939107|475082804|FG000|Overall Study|Lost to Follow-up|14|||
131943328|NCT00939107|475082805|FG001|Overall Study|Lost to Follow-up|12|||
131943329|NCT05010070|475082806|FG000|Overall Study|Lost to Follow-up|1|||
131943330|NCT05010070|475082806|FG000|Overall Study|Withdrawal by Subject|1|||
131943331|NCT03247829|475082808|FG000|Overall Study|Death|3|||
131943332|NCT03247829|475082809|FG001|Overall Study|Death|4|||
131943333|NCT03247829|475082808|FG000|Overall Study|Enter Hospice Care|1|||
131943334|NCT03247829|475082809|FG001|Overall Study|Enter Hospice Care|0|||
131943335|NCT03247829|475082808|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
131943336|NCT03247829|475082809|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
131943337|NCT03247829|475082808|FG000|Overall Study|LVAD Explant|1|||
131943338|NCT03247829|475082809|FG001|Overall Study|LVAD Explant|1|||
131943339|NCT03247829|475082808|FG000|Overall Study|Transplant|1|||
131943340|NCT03247829|475082809|FG001|Overall Study|Transplant|1|||
131943341|NCT01783444|475082810|FG000|Treatment Phase|Adverse Event|9|||
131943342|NCT01783444|475082811|FG001|Treatment Phase|Adverse Event|20|||
131943343|NCT01783444|475082812|FG002|Treatment Phase|Adverse Event|19|||
131943344|NCT01783444|475082810|FG000|Treatment Phase|Disease Progression|76|||
131943345|NCT01783444|475082811|FG001|Treatment Phase|Disease Progression|66|||
131943346|NCT01783444|475082812|FG002|Treatment Phase|Disease Progression|64|||
131943347|NCT01783444|475082810|FG000|Treatment Phase|Death|2|||
131413017|NCT00940485|473135512|FG001|Overall Study|Others|1|||
131413018|NCT01113580|473135513|FG000|Overall Study|Protocol Violation|1|||
131413019|NCT01113580|473135514|FG001|Overall Study|Protocol Violation|0|||
131413020|NCT04271475|473135518|FG000|DB Period: Day 1 up to EODBT|Death|1|||
131413021|NCT04271475|473135519|FG001|DB Period: Day 1 up to EODBT|Death|0|||
131413022|NCT04271475|473135520|FG002|DB Period: Day 1 up to EODBT|Death|0|||
131413023|NCT04271475|473135521|FG003|DB Period: Day 1 up to EODBT|Death|0|||
131413024|NCT04271475|473135518|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
131413025|NCT04271475|473135519|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
131413026|NCT04271475|473135520|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
131413027|NCT04271475|473135521|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
131413028|NCT04271475|473135518|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
131943348|NCT01783444|475082811|FG001|Treatment Phase|Death|2|||
131943349|NCT01783444|475082812|FG002|Treatment Phase|Death|2|||
131943350|NCT01783444|475082810|FG000|Treatment Phase|Protocol Violation|1|||
131943351|NCT01783444|475082811|FG001|Treatment Phase|Protocol Violation|1|||
131943352|NCT01783444|475082812|FG002|Treatment Phase|Protocol Violation|2|||
131943353|NCT01783444|475082810|FG000|Treatment Phase|Withdrawal by Subject|6|||
131943354|NCT01783444|475082811|FG001|Treatment Phase|Withdrawal by Subject|8|||
131943355|NCT01783444|475082812|FG002|Treatment Phase|Withdrawal by Subject|9|||
131943356|NCT01783444|475082810|FG000|Treatment Phase|Administrative problems|2|||
131943357|NCT01783444|475082811|FG001|Treatment Phase|Administrative problems|0|||
131943358|NCT01783444|475082812|FG002|Treatment Phase|Administrative problems|1|||
131943359|NCT01783444|475082810|FG000|Treatment Phase|Physician Decision|8|||
131943360|NCT01783444|475082811|FG001|Treatment Phase|Physician Decision|6|||
131943361|NCT01783444|475082812|FG002|Treatment Phase|Physician Decision|5|||
131943362|NCT01783444|475082810|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
131943363|NCT01783444|475082811|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
131943364|NCT01783444|475082812|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
131943365|NCT01783444|475082810|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
131943366|NCT01783444|475082811|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
131943367|NCT01783444|475082812|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
131943368|NCT01783444|475082810|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
131943369|NCT01783444|475082811|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
131943370|NCT01783444|475082812|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
131943371|NCT01783444|475082810|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
131943372|NCT01783444|475082811|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
131943373|NCT01783444|475082812|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
131943374|NCT01783444|475082810|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
131943375|NCT01783444|475082811|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
131943376|NCT01783444|475082812|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
131943377|NCT01783444|475082810|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
131943378|NCT01783444|475082811|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
131943379|NCT01783444|475082812|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
131943380|NCT01334554|475082818|FG000|Overall Study|Adverse Event|4|||
131943381|NCT01334554|475082819|FG001|Overall Study|Adverse Event|2|||
131943382|NCT00954447|475082820|FG000|Overall Study|Adverse Event|33|||
131943383|NCT00954447|475082821|FG001|Overall Study|Adverse Event|25|||
131943384|NCT00954447|475082820|FG000|Overall Study|Lack of Efficacy|17|||
131943385|NCT00954447|475082821|FG001|Overall Study|Lack of Efficacy|3|||
131943386|NCT00954447|475082820|FG000|Overall Study|Protocol Violation|5|||
131943387|NCT00954447|475082821|FG001|Overall Study|Protocol Violation|7|||
131943388|NCT00954447|475082820|FG000|Overall Study|Lost to Follow-up|8|||
131943389|NCT00954447|475082821|FG001|Overall Study|Lost to Follow-up|14|||
131943390|NCT00954447|475082820|FG000|Overall Study|Withdrawal by Subject|26|||
131943391|NCT00954447|475082821|FG001|Overall Study|Withdrawal by Subject|21|||
131943392|NCT00954447|475082820|FG000|Overall Study|Other|21|||
131943393|NCT00954447|475082821|FG001|Overall Study|Other|18|||
131943394|NCT04592341|475082822|FG000|Overall Study|Physician Decision|5|||
131943395|NCT04592341|475082822|FG000|Overall Study|Study Terminated by Sponsor|5|||
131943396|NCT04592341|475082822|FG000|Overall Study|Withdrawal by Subject|53|||
131943397|NCT04592341|475082822|FG000|Overall Study|Lost to Follow-up|3|||
131943398|NCT04592341|475082822|FG000|Overall Study|Death|1|||
131943399|NCT04592341|475082822|FG000|Overall Study|Adverse Event|5|||
131943400|NCT04592341|475082822|FG000|Overall Study|other|4|||
131943401|NCT01944020|475082823|FG000|Overall Study|Withdrawal by Subject|5|||
131943402|NCT01944020|475082824|FG001|Overall Study|Withdrawal by Subject|0|||
131943403|NCT00692003|475082825|FG000|Overall Study|Sponsor Decision|5|||
131943404|NCT00692003|475082826|FG001|Overall Study|Sponsor Decision|1|||
131943405|NCT01248793|475082827|FG000|Overall Study|Lost to Follow-up|0|||
131943406|NCT01248793|475082828|FG001|Overall Study|Lost to Follow-up|1|||
131943407|NCT01248793|475082827|FG000|Overall Study|Adverse Event|1|||
131943408|NCT01248793|475082828|FG001|Overall Study|Adverse Event|1|||
131943409|NCT01248793|475082827|FG000|Overall Study|Protocol Violation|0|||
131943410|NCT01248793|475082828|FG001|Overall Study|Protocol Violation|1|||
131943411|NCT01248793|475082827|FG000|Overall Study|Withdrawal by Subject|3|||
131943412|NCT01248793|475082828|FG001|Overall Study|Withdrawal by Subject|3|||
131943413|NCT01840943|475082829|FG000|Overall Study|Withdrawal by Subject|5|||
131943414|NCT01840943|475082830|FG001|Overall Study|Withdrawal by Subject|6|||
131943415|NCT01840943|475082829|FG000|Overall Study|Physician Decision|4|||
131413029|NCT04271475|473135519|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
131413030|NCT04271475|473135520|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
131413031|NCT04271475|473135521|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
131943416|NCT01840943|475082830|FG001|Overall Study|Physician Decision|2|||
131943417|NCT01840943|475082829|FG000|Overall Study|Lost to Follow-up|4|||
131943418|NCT01840943|475082830|FG001|Overall Study|Lost to Follow-up|4|||
131413032|NCT04271475|473135518|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
131943419|NCT02580877|475082833|FG000|Overall Study|Withdrawal by Subject|1|||
131943420|NCT02580877|475082834|FG001|Overall Study|Withdrawal by Subject|3|||
131943421|NCT02580877|475082833|FG000|Overall Study|Adverse Event|0|||
131943422|NCT02580877|475082834|FG001|Overall Study|Adverse Event|1|||
131943423|NCT02903823|475082835|FG000|Overall Study|Physician Decision|5|||
131455201|NCT00481091|473295540|FG001|Overall Study|No reason given|0|||
131455202|NCT00481091|473295541|FG002|Overall Study|No reason given|1|||
131455203|NCT00481091|473295542|FG003|Overall Study|No reason given|1|||
131455204|NCT00481091|473295543|FG004|Overall Study|No reason given|1|||
131455205|NCT00481091|473295544|FG005|Overall Study|No reason given|0|||
131455206|NCT00481091|473295545|FG006|Overall Study|No reason given|1|||
131455207|NCT00481091|473295546|FG007|Overall Study|No reason given|1|||
131455208|NCT00481091|473295547|FG008|Overall Study|No reason given|1|||
131455209|NCT00481091|473295548|FG009|Overall Study|No reason given|4|||
131455210|NCT04294680|473295549|FG000|Overall Study|Withdrawal by Subject|2|||
131455211|NCT04294680|473295550|FG001|Overall Study|Withdrawal by Subject|1|||
131455212|NCT04294680|473295549|FG000|Overall Study|Follow-up visits completed outside of window|1|||
131455213|NCT04294680|473295550|FG001|Overall Study|Follow-up visits completed outside of window|0|||
131455214|NCT01296672|473295551|FG000|Overall Study|Lost to Follow-up|73|||
131455215|NCT01296672|473295552|FG001|Overall Study|Lost to Follow-up|18|||
131455216|NCT04027608|473295553|FG000|Overall Study|Withdrawal by Subject|13|||
131455217|NCT04027608|473295554|FG001|Overall Study|Withdrawal by Subject|2|||
131455218|NCT04027608|473295553|FG000|Overall Study|Protocol Violation|2|||
131455219|NCT04027608|473295554|FG001|Overall Study|Protocol Violation|1|||
131455220|NCT04027608|473295553|FG000|Overall Study|Physician Decision|1|||
131455221|NCT04027608|473295554|FG001|Overall Study|Physician Decision|0|||
131455222|NCT04027608|473295553|FG000|Overall Study|Lost to Follow-up|20|||
131455223|NCT04027608|473295554|FG001|Overall Study|Lost to Follow-up|4|||
131455224|NCT04661579|473295557|FG000|Overall Study|Lost to Follow-up|19|||
131455225|NCT04661579|473295558|FG001|Overall Study|Lost to Follow-up|10|||
131455226|NCT04661579|473295559|FG002|Overall Study|Lost to Follow-up|2|||
131455227|NCT04661579|473295560|FG003|Overall Study|Lost to Follow-up|7|||
131455228|NCT04661579|473295561|FG004|Overall Study|Lost to Follow-up|11|||
131455229|NCT04661579|473295557|FG000|Overall Study|Physician Decision|2|||
131455230|NCT04661579|473295558|FG001|Overall Study|Physician Decision|0|||
131455231|NCT04661579|473295559|FG002|Overall Study|Physician Decision|0|||
131455232|NCT04661579|473295560|FG003|Overall Study|Physician Decision|1|||
131455233|NCT04661579|473295561|FG004|Overall Study|Physician Decision|0|||
131455234|NCT04661579|473295557|FG000|Overall Study|Withdrawal by Subject|1|||
131455235|NCT04661579|473295558|FG001|Overall Study|Withdrawal by Subject|4|||
131455236|NCT04661579|473295559|FG002|Overall Study|Withdrawal by Subject|0|||
131455237|NCT04661579|473295560|FG003|Overall Study|Withdrawal by Subject|2|||
131455238|NCT04661579|473295561|FG004|Overall Study|Withdrawal by Subject|0|||
131455239|NCT04661579|473295557|FG000|Overall Study|Death|1|||
131455240|NCT04661579|473295558|FG001|Overall Study|Death|0|||
131455241|NCT04661579|473295559|FG002|Overall Study|Death|0|||
131455242|NCT04661579|473295560|FG003|Overall Study|Death|0|||
131455243|NCT04661579|473295561|FG004|Overall Study|Death|0|||
131455244|NCT04661579|473295557|FG000|Overall Study|Other|1|||
131455245|NCT04661579|473295558|FG001|Overall Study|Other|2|||
131455246|NCT04661579|473295559|FG002|Overall Study|Other|1|||
131455247|NCT04661579|473295560|FG003|Overall Study|Other|1|||
131455248|NCT04661579|473295561|FG004|Overall Study|Other|1|||
131455249|NCT04661579|473295557|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
131413033|NCT04271475|473135519|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
131413034|NCT04271475|473135520|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
131413035|NCT04271475|473135521|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
131413036|NCT04271475|473135518|FG000|DB Period: Day 1 up to EODBT|Other|8|||
131413037|NCT04271475|473135519|FG001|DB Period: Day 1 up to EODBT|Other|5|||
131413038|NCT04271475|473135520|FG002|DB Period: Day 1 up to EODBT|Other|0|||
131413039|NCT04271475|473135521|FG003|DB Period: Day 1 up to EODBT|Other|0|||
131413040|NCT04271475|473135518|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
131413041|NCT04271475|473135519|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
131413042|NCT04271475|473135520|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
131413043|NCT04271475|473135521|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
131413044|NCT04271475|473135518|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
131413045|NCT04271475|473135519|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
131413046|NCT04271475|473135520|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
131413047|NCT04271475|473135521|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
131413048|NCT06250738|473135524|FG000|Overall Study|Lost to Follow-up|1|||
131413049|NCT02936284|473135526|FG000|Overall Study|Withdrawal by Subject|3|||
131413050|NCT02936284|473135527|FG001|Overall Study|Withdrawal by Subject|1|||
131413051|NCT02936284|473135526|FG000|Overall Study|Lost to Follow-up|7|||
131455250|NCT04661579|473295558|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
131455251|NCT04661579|473295559|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
131455252|NCT04661579|473295560|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
131455253|NCT04661579|473295561|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
131455254|NCT00796978|473295563|FG000|Overall Study|Cardiac adverse event|5|||
131455255|NCT00796978|473295563|FG000|Overall Study|Adverse Event|4|||
131455256|NCT00796978|473295563|FG000|Overall Study|Withdrawal by Subject|3|||
131943424|NCT02903823|475082835|FG000|Overall Study|Could not advance catheter|1|||
131943425|NCT02903823|475082835|FG000|Overall Study|Catheter dislodgement|1|||
131943426|NCT01127633|475082838|FG000|Overall Study|Adverse Event|74|||
131943427|NCT01127633|475082839|FG001|Overall Study|Adverse Event|73|||
131943428|NCT01127633|475082838|FG000|Overall Study|Death|40|||
131943429|NCT01127633|475082839|FG001|Overall Study|Death|43|||
131943430|NCT01127633|475082838|FG000|Overall Study|Lost to Follow-up|4|||
131943431|NCT01127633|475082839|FG001|Overall Study|Lost to Follow-up|0|||
131943432|NCT01127633|475082838|FG000|Overall Study|Parent/Caregiver Decision|246|||
131943433|NCT01127633|475082839|FG001|Overall Study|Parent/Caregiver Decision|228|||
131943434|NCT01127633|475082838|FG000|Overall Study|Physician Decision|60|||
131943435|NCT01127633|475082839|FG001|Overall Study|Physician Decision|45|||
131943436|NCT01127633|475082838|FG000|Overall Study|Withdrawal by Subject|57|||
131943437|NCT01127633|475082839|FG001|Overall Study|Withdrawal by Subject|72|||
131943438|NCT01127633|475082838|FG000|Overall Study|Sponsor Decision|163|||
131943439|NCT01127633|475082839|FG001|Overall Study|Sponsor Decision|195|||
131943440|NCT01127633|475082838|FG000|Overall Study|Protocol Violation|8|||
131943441|NCT01127633|475082839|FG001|Overall Study|Protocol Violation|16|||
131943442|NCT01127633|475082838|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
131943443|NCT01127633|475082839|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
131943444|NCT01127633|475082838|FG000|Overall Study|Not treated|1|||
131943445|NCT01127633|475082839|FG001|Overall Study|Not treated|0|||
131943446|NCT00688467|475082840|FG000|Treatment Period 1|Adverse Event|2|||
131943447|NCT00688467|475082841|FG001|Treatment Period 1|Adverse Event|1|||
131943448|NCT00688467|475082840|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
131943449|NCT00688467|475082841|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
131943450|NCT00688467|475082840|FG000|Treatment Period 2|Protocol Violation|0|||
131413052|NCT02936284|473135527|FG001|Overall Study|Lost to Follow-up|8|||
131413053|NCT01068249|473135534|FG000|Overall Study|Death|1|||
131413054|NCT01068249|473135534|FG000|Overall Study|Withdrawal by Subject|3|||
131943451|NCT00688467|475082841|FG001|Treatment Period 2|Protocol Violation|1|||
131943452|NCT00688467|475082840|FG000|Treatment Period 2|Adverse Event|0|||
131943453|NCT00688467|475082841|FG001|Treatment Period 2|Adverse Event|1|||
131943454|NCT00925002|475082843|FG000|Overall Study|Other|1|||
131943455|NCT00925002|475082844|FG001|Overall Study|Other|4|||
131943456|NCT00925002|475082845|FG002|Overall Study|Other|0|||
131943457|NCT00925002|475082843|FG000|Overall Study|Death|1|||
131943458|NCT00925002|475082844|FG001|Overall Study|Death|1|||
131943459|NCT00925002|475082845|FG002|Overall Study|Death|5|||
131943460|NCT00925002|475082843|FG000|Overall Study|Adverse Event|3|||
131943461|NCT00925002|475082844|FG001|Overall Study|Adverse Event|1|||
131943462|NCT00925002|475082845|FG002|Overall Study|Adverse Event|2|||
131943463|NCT00925002|475082843|FG000|Overall Study|Participant withdrew consent|1|||
131943464|NCT00925002|475082844|FG001|Overall Study|Participant withdrew consent|3|||
131413055|NCT00875056|473135543|FG000|Overall Study|Adverse Event|6|||
131413056|NCT00875056|473135544|FG001|Overall Study|Adverse Event|1|||
131413057|NCT00875056|473135545|FG002|Overall Study|Adverse Event|2|||
131413058|NCT00875056|473135543|FG000|Overall Study|Progressive Disease|14|||
131413059|NCT00875056|473135544|FG001|Overall Study|Progressive Disease|8|||
131413060|NCT00875056|473135545|FG002|Overall Study|Progressive Disease|3|||
131413061|NCT00875056|473135543|FG000|Overall Study|Withdrawal by Subject|3|||
131413062|NCT00875056|473135544|FG001|Overall Study|Withdrawal by Subject|0|||
131413063|NCT00875056|473135545|FG002|Overall Study|Withdrawal by Subject|1|||
131413064|NCT02956850|473135546|FG000|Overall Study|Withdrawal by Subject|0|||
131413065|NCT02956850|473135547|FG001|Overall Study|Withdrawal by Subject|0|||
131413066|NCT02956850|473135548|FG002|Overall Study|Withdrawal by Subject|0|||
131413067|NCT02956850|473135549|FG003|Overall Study|Withdrawal by Subject|0|||
131413068|NCT02956850|473135550|FG004|Overall Study|Withdrawal by Subject|0|||
131413069|NCT02956850|473135551|FG005|Overall Study|Withdrawal by Subject|0|||
131413070|NCT02956850|473135552|FG006|Overall Study|Withdrawal by Subject|0|||
131413071|NCT02956850|473135553|FG007|Overall Study|Withdrawal by Subject|0|||
131413072|NCT02956850|473135554|FG008|Overall Study|Withdrawal by Subject|0|||
131413073|NCT02956850|473135555|FG009|Overall Study|Withdrawal by Subject|0|||
131413074|NCT02956850|473135556|FG010|Overall Study|Withdrawal by Subject|0|||
131413075|NCT02956850|473135557|FG011|Overall Study|Withdrawal by Subject|0|||
131413076|NCT02956850|473135558|FG012|Overall Study|Withdrawal by Subject|0|||
131413077|NCT02956850|473135559|FG013|Overall Study|Withdrawal by Subject|0|||
131455257|NCT00859456|473295564|FG000|Overall Study|Adverse Event|3|||
131943465|NCT00925002|475082845|FG002|Overall Study|Participant withdrew consent|3|||
131943466|NCT00690794|475082848|FG000|Overall Study|Adverse Event|12|||
131943467|NCT00690794|475082849|FG001|Overall Study|Adverse Event|10|||
131943468|NCT00690794|475082848|FG000|Overall Study|Lost to Follow-up|1|||
131455258|NCT00859456|473295564|FG000|Overall Study|Progressive disease|2|||
131943469|NCT00690794|475082849|FG001|Overall Study|Lost to Follow-up|4|||
131943470|NCT00690794|475082848|FG000|Overall Study|Withdrawal by Subject|0|||
131943471|NCT00690794|475082849|FG001|Overall Study|Withdrawal by Subject|9|||
131943472|NCT00690794|475082848|FG000|Overall Study|Protocol Violation|6|||
131943473|NCT00690794|475082849|FG001|Overall Study|Protocol Violation|7|||
131943474|NCT00690794|475082848|FG000|Overall Study|Noncompliance|1|||
131943475|NCT00690794|475082849|FG001|Overall Study|Noncompliance|2|||
131943476|NCT00690794|475082848|FG000|Overall Study|Other not specified|1|||
131943477|NCT00690794|475082849|FG001|Overall Study|Other not specified|3|||
131943478|NCT01496287|475082850|FG000|Overall Study|Lost to Follow-up|1|||
131943479|NCT01496287|475082850|FG000|Overall Study|Incomplete anesthesia|5|||
131943480|NCT01823107|475082851|FG000|Overall Study|Withdrawal by Subject|1|||
131943481|NCT01990742|475082853|FG000|Overall Study|Withdrawal by facility|407|||
131943482|NCT01990742|475082854|FG001|Overall Study|Withdrawal by facility|1083|||
131943483|NCT01990742|475082853|FG000|Overall Study|Facility closed|0|||
131943484|NCT01990742|475082854|FG001|Overall Study|Facility closed|270|||
131943485|NCT03443687|475082855|FG000|Overall Study|Lost to Follow-up|3|||
131943486|NCT03443687|475082856|FG001|Overall Study|Lost to Follow-up|5|||
131943487|NCT03443687|475082855|FG000|Overall Study|Withdrawal by Subject|1|||
131943488|NCT03443687|475082856|FG001|Overall Study|Withdrawal by Subject|0|||
131943489|NCT03443687|475082855|FG000|Overall Study|Discontinued intervention|1|||
131943490|NCT03443687|475082856|FG001|Overall Study|Discontinued intervention|1|||
131943491|NCT00800735|475082858|FG000|Overall Study|Administrative/Other|2|||
131943492|NCT00800735|475082858|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131943493|NCT00800735|475082858|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
131943494|NCT00800735|475082858|FG000|Overall Study|Withdrew Consent|3|||
131943495|NCT02805790|475082859|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
131943496|NCT02805790|475082860|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
131943497|NCT04460183|475082863|FG000|Overall Study|Lost to Follow-up|3|||
131943498|NCT04460183|475082864|FG001|Overall Study|Lost to Follow-up|1|||
131943499|NCT04460183|475082863|FG000|Overall Study|Withdrawal by Subject|1|||
131943500|NCT04460183|475082864|FG001|Overall Study|Withdrawal by Subject|0|||
131943501|NCT02897115|475082865|FG000|Overall Study|Early termination of study by sponsor|11|||
131943502|NCT02897115|475082866|FG001|Overall Study|Early termination of study by sponsor|8|||
131943503|NCT00487981|475082867|FG000|Overall Study|Hypothyroidism diagnosis|1|||
131943504|NCT00856323|475082868|FG000|Overall Study|Withdrawal by Subject|2|||
131943505|NCT01847092|475082870|FG000|Overall Study|Adverse Event|12|||
131943506|NCT01847092|475082871|FG001|Overall Study|Adverse Event|3|||
131943507|NCT01847092|475082870|FG000|Overall Study|Withdrawal by Subject|5|||
131943508|NCT01847092|475082871|FG001|Overall Study|Withdrawal by Subject|5|||
131943509|NCT01847092|475082870|FG000|Overall Study|Protocol Specified|8|||
131943510|NCT01847092|475082871|FG001|Overall Study|Protocol Specified|0|||
131943511|NCT01847092|475082870|FG000|Overall Study|Physician Decision|1|||
131943512|NCT01847092|475082871|FG001|Overall Study|Physician Decision|1|||
131943513|NCT01847092|475082870|FG000|Overall Study|Protocol Violation|0|||
131943514|NCT01847092|475082871|FG001|Overall Study|Protocol Violation|2|||
131943515|NCT00825994|475082872|FG000|Overall Study|Withdrawal by Subject|2|||
131943516|NCT00825994|475082872|FG000|Overall Study|Lost to Follow-up|1|||
131943517|NCT00825994|475082872|FG000|Overall Study|Protocol Violation|1|||
131943518|NCT00825994|475082872|FG000|Overall Study|Placebo Responder at V2|1|||
131943519|NCT00461708|475082874|FG000|Overall Study|Adverse Event|17|||
131943520|NCT00461708|475082875|FG001|Overall Study|Adverse Event|7|||
131943521|NCT00461708|475082874|FG000|Overall Study|Lack of Efficacy|68|||
131943522|NCT00461708|475082875|FG001|Overall Study|Lack of Efficacy|20|||
131943523|NCT00461708|475082874|FG000|Overall Study|Physician Decision|10|||
131943524|NCT00461708|475082875|FG001|Overall Study|Physician Decision|4|||
131943525|NCT00461708|475082874|FG000|Overall Study|Withdrawal by Subject|8|||
131943526|NCT00461708|475082875|FG001|Overall Study|Withdrawal by Subject|2|||
131943527|NCT00461708|475082874|FG000|Overall Study|Other|4|||
131943528|NCT00461708|475082875|FG001|Overall Study|Other|4|||
131943529|NCT00461708|475082874|FG000|Overall Study|Death|8|||
131943530|NCT00461708|475082875|FG001|Overall Study|Death|1|||
131943531|NCT00501644|475082876|FG000|Overall Study|Adverse Event|4|||
131943532|NCT00501644|475082876|FG000|Overall Study|Withdrawal by Subject|1|||
131943533|NCT02394561|475082877|FG000|CORE Phase|Adverse Event|7|||
131943534|NCT02394561|475082878|FG001|CORE Phase|Adverse Event|9|||
131943535|NCT02394561|475082877|FG000|CORE Phase|Death|0|||
131943536|NCT02394561|475082878|FG001|CORE Phase|Death|1|||
131943537|NCT02394561|475082877|FG000|CORE Phase|Pregnancy|1|||
131413078|NCT02956850|473135560|FG014|Overall Study|Withdrawal by Subject|0|||
131413079|NCT02956850|473135561|FG015|Overall Study|Withdrawal by Subject|0|||
131413080|NCT02956850|473135562|FG016|Overall Study|Withdrawal by Subject|0|||
131943538|NCT02394561|475082878|FG001|CORE Phase|Pregnancy|0|||
131943539|NCT02394561|475082877|FG000|CORE Phase|Lost to Follow-up|1|||
131943540|NCT02394561|475082878|FG001|CORE Phase|Lost to Follow-up|0|||
131943541|NCT02394561|475082877|FG000|CORE Phase|Physician Decision|1|||
131943542|NCT02394561|475082878|FG001|CORE Phase|Physician Decision|1|||
131943543|NCT02394561|475082877|FG000|CORE Phase|Withdrawal by Subject|2|||
131943544|NCT02394561|475082878|FG001|CORE Phase|Withdrawal by Subject|2|||
131943545|NCT02394561|475082877|FG000|CORE Phase|Lack of Efficacy|1|||
131943546|NCT02394561|475082878|FG001|CORE Phase|Lack of Efficacy|6|||
131943547|NCT02394561|475082877|FG000|Extension Phase|Adverse Event|6|||
131943548|NCT02394561|475082878|FG001|Extension Phase|Adverse Event|1|||
131943549|NCT02394561|475082877|FG000|Extension Phase|Death|0|||
131943550|NCT02394561|475082878|FG001|Extension Phase|Death|1|||
131943551|NCT02394561|475082877|FG000|Extension Phase|Protocol Violation|1|||
131943552|NCT02394561|475082878|FG001|Extension Phase|Protocol Violation|0|||
131943553|NCT02394561|475082877|FG000|Extension Phase|Lost to Follow-up|1|||
131943554|NCT02394561|475082878|FG001|Extension Phase|Lost to Follow-up|0|||
131943555|NCT02394561|475082877|FG000|Extension Phase|Physician Decision|0|||
131943556|NCT02394561|475082878|FG001|Extension Phase|Physician Decision|2|||
131943557|NCT02394561|475082877|FG000|Extension Phase|Withdrawal by Subject|0|||
131413081|NCT02956850|473135563|FG017|Overall Study|Withdrawal by Subject|1|||
131413082|NCT00870194|473135568|FG000|Overall Study|Adverse Event|10|||
131413083|NCT00870194|473135569|FG001|Overall Study|Adverse Event|5|||
131413084|NCT00870194|473135568|FG000|Overall Study|Lack of Efficacy|0|||
131413085|NCT00870194|473135569|FG001|Overall Study|Lack of Efficacy|1|||
131413086|NCT00870194|473135568|FG000|Overall Study|Lost to Follow-up|2|||
131413087|NCT00870194|473135569|FG001|Overall Study|Lost to Follow-up|0|||
131413088|NCT00870194|473135568|FG000|Overall Study|Physician Decision|3|||
131413089|NCT00870194|473135569|FG001|Overall Study|Physician Decision|1|||
131413090|NCT00870194|473135568|FG000|Overall Study|Protocol Violation|3|||
131413091|NCT00870194|473135569|FG001|Overall Study|Protocol Violation|3|||
131413092|NCT00870194|473135568|FG000|Overall Study|Entry Criteria Not Met|1|||
131413093|NCT00870194|473135569|FG001|Overall Study|Entry Criteria Not Met|2|||
131413094|NCT00870194|473135568|FG000|Overall Study|Subject Decision|7|||
131413095|NCT00870194|473135569|FG001|Overall Study|Subject Decision|2|||
131413096|NCT02322190|473135570|FG000|Overall Study|Death on study|1|||
131413097|NCT02322190|473135571|FG001|Overall Study|Death on study|0|||
131413098|NCT00973102|473135580|FG000|Overall Study|Protocol Violation|1|||
131413099|NCT00973102|473135581|FG001|Overall Study|Protocol Violation|0|||
131413100|NCT00973102|473135580|FG000|Overall Study|Prisoner|0|||
131413101|NCT00973102|473135581|FG001|Overall Study|Prisoner|1|||
131413102|NCT00966719|473135584|FG000|Overall Study|Lost to Follow-up|6|||
131413103|NCT00966719|473135585|FG001|Overall Study|Lost to Follow-up|11|||
131413104|NCT01710527|473135586|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
131413105|NCT01710527|473135587|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
131413106|NCT02635347|473135590|FG000|Overall Study|Failed screening|20|||
131413107|NCT02635347|473135591|FG001|Overall Study|Failed screening|7|||
131413108|NCT02124772|473135593|FG000|Overall Study|Lack of Efficacy|2|||
131413109|NCT02124772|473135594|FG001|Overall Study|Lack of Efficacy|0|||
131413110|NCT02124772|473135595|FG002|Overall Study|Lack of Efficacy|0|||
131413111|NCT02124772|473135596|FG003|Overall Study|Lack of Efficacy|1|||
131413112|NCT02124772|473135597|FG004|Overall Study|Lack of Efficacy|2|||
131413113|NCT02124772|473135598|FG005|Overall Study|Lack of Efficacy|3|||
131413114|NCT02124772|473135599|FG006|Overall Study|Lack of Efficacy|0|||
131413115|NCT02124772|473135600|FG007|Overall Study|Lack of Efficacy|2|||
131413116|NCT02124772|473135601|FG008|Overall Study|Lack of Efficacy|0|||
131413117|NCT02124772|473135602|FG009|Overall Study|Lack of Efficacy|1|||
131413118|NCT02124772|473135603|FG010|Overall Study|Lack of Efficacy|0|||
131413119|NCT02124772|473135604|FG011|Overall Study|Lack of Efficacy|0|||
131413120|NCT02124772|473135605|FG012|Overall Study|Lack of Efficacy|1|||
131413121|NCT02124772|473135593|FG000|Overall Study|Adverse Event|1|||
131413122|NCT02124772|473135594|FG001|Overall Study|Adverse Event|4|||
131413123|NCT02124772|473135595|FG002|Overall Study|Adverse Event|1|||
131413124|NCT02124772|473135596|FG003|Overall Study|Adverse Event|5|||
131413125|NCT02124772|473135597|FG004|Overall Study|Adverse Event|2|||
131413126|NCT02124772|473135598|FG005|Overall Study|Adverse Event|1|||
131413127|NCT02124772|473135599|FG006|Overall Study|Adverse Event|1|||
131413128|NCT02124772|473135600|FG007|Overall Study|Adverse Event|5|||
131413129|NCT02124772|473135601|FG008|Overall Study|Adverse Event|0|||
131413130|NCT02124772|473135602|FG009|Overall Study|Adverse Event|3|||
131413131|NCT02124772|473135603|FG010|Overall Study|Adverse Event|1|||
131413132|NCT02124772|473135604|FG011|Overall Study|Adverse Event|3|||
131413133|NCT02124772|473135605|FG012|Overall Study|Adverse Event|1|||
131413134|NCT02124772|473135593|FG000|Overall Study|Withdrawal consent|0|||
131413135|NCT02124772|473135594|FG001|Overall Study|Withdrawal consent|1|||
131943558|NCT02394561|475082878|FG001|Extension Phase|Withdrawal by Subject|5|||
131413136|NCT02124772|473135595|FG002|Overall Study|Withdrawal consent|1|||
131413137|NCT02124772|473135596|FG003|Overall Study|Withdrawal consent|1|||
131413138|NCT02124772|473135597|FG004|Overall Study|Withdrawal consent|0|||
131413139|NCT02124772|473135598|FG005|Overall Study|Withdrawal consent|1|||
131413140|NCT02124772|473135599|FG006|Overall Study|Withdrawal consent|1|||
131413141|NCT02124772|473135600|FG007|Overall Study|Withdrawal consent|0|||
131413142|NCT02124772|473135601|FG008|Overall Study|Withdrawal consent|0|||
131413143|NCT02124772|473135602|FG009|Overall Study|Withdrawal consent|1|||
131413144|NCT02124772|473135603|FG010|Overall Study|Withdrawal consent|0|||
131413145|NCT02124772|473135604|FG011|Overall Study|Withdrawal consent|1|||
131413146|NCT02124772|473135605|FG012|Overall Study|Withdrawal consent|0|||
131413147|NCT02124772|473135593|FG000|Overall Study|Investigator discretion|0|||
131413148|NCT02124772|473135594|FG001|Overall Study|Investigator discretion|2|||
131413149|NCT02124772|473135595|FG002|Overall Study|Investigator discretion|2|||
131943559|NCT02394561|475082877|FG000|Extension Phase|Lack of Efficacy|3|||
131413150|NCT02124772|473135596|FG003|Overall Study|Investigator discretion|1|||
131413151|NCT02124772|473135597|FG004|Overall Study|Investigator discretion|1|||
131455259|NCT00859456|473295564|FG000|Overall Study|Non-compliance|3|||
131455260|NCT00578292|473295565|FG000|Overall Study|Death|1|||
131455261|NCT00578292|473295565|FG000|Overall Study|Graft failure|2|||
131455262|NCT04849559|473295566|FG000|Overall Study|Withdrawal by Subject|2|||
131455263|NCT04849559|473295567|FG001|Overall Study|Withdrawal by Subject|1|||
131455264|NCT02910986|473295568|FG000|Overall Study|non-Latina|14|||
131455265|NCT02910986|473295569|FG001|Overall Study|non-Latina|13|||
131455266|NCT02910986|473295570|FG002|Overall Study|non-Latina|12|||
131455267|NCT02910986|473295568|FG000|Overall Study|Failure to return T! survey|72|||
131455268|NCT02910986|473295569|FG001|Overall Study|Failure to return T! survey|84|||
131455269|NCT02910986|473295570|FG002|Overall Study|Failure to return T! survey|72|||
131455270|NCT02910986|473295568|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
131455271|NCT02910986|473295569|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
131455272|NCT02910986|473295570|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
131455273|NCT02910986|473295568|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
131455274|NCT02910986|473295569|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
131455275|NCT02910986|473295570|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
131455276|NCT03527732|473295573|FG000|Overall Study|Lost to Follow-up|21|||
131455277|NCT03527732|473295574|FG001|Overall Study|Lost to Follow-up|23|||
131455278|NCT03527732|473295575|FG002|Overall Study|Lost to Follow-up|80|||
131455279|NCT03527732|473295576|FG003|Overall Study|Lost to Follow-up|62|||
131455280|NCT03527732|473295577|FG004|Overall Study|Lost to Follow-up|12|||
131455281|NCT03527732|473295578|FG005|Overall Study|Lost to Follow-up|20|||
131455282|NCT02280408|473295579|FG000|Overall Study|Lost to Follow-up|0|||
131455283|NCT02280408|473295580|FG001|Overall Study|Lost to Follow-up|2|||
131455284|NCT02280408|473295581|FG002|Overall Study|Lost to Follow-up|0|||
131455285|NCT02280408|473295582|FG003|Overall Study|Lost to Follow-up|0|||
131455286|NCT02474069|473295583|FG000|Selection Phase (SP)|Adverse Event|8|||
131455287|NCT02474069|473295584|FG001|Selection Phase (SP)|Adverse Event|0|||
131455288|NCT02474069|473295585|FG002|Selection Phase (SP)|Adverse Event|0|||
131455289|NCT02474069|473295583|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
131455290|NCT02474069|473295584|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
131455291|NCT02474069|473295585|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
131455292|NCT02474069|473295583|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
131455293|NCT02474069|473295584|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
131455294|NCT02474069|473295585|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
131455295|NCT02474069|473295583|FG000|Selection Phase (SP)|Physician Decision|1|||
131455296|NCT02474069|473295584|FG001|Selection Phase (SP)|Physician Decision|0|||
131455297|NCT02474069|473295585|FG002|Selection Phase (SP)|Physician Decision|0|||
131455298|NCT02474069|473295583|FG000|Selection Phase (SP)|Protocol Violation|1|||
131455299|NCT02474069|473295584|FG001|Selection Phase (SP)|Protocol Violation|0|||
131455300|NCT02474069|473295585|FG002|Selection Phase (SP)|Protocol Violation|0|||
131455301|NCT02474069|473295583|FG000|Selection Phase (SP)|No longer requires treatment|1|||
131455302|NCT02474069|473295584|FG001|Selection Phase (SP)|No longer requires treatment|0|||
131455303|NCT02474069|473295585|FG002|Selection Phase (SP)|No longer requires treatment|0|||
131455304|NCT02474069|473295583|FG000|Selection Phase (SP)|Technical Problem|1|||
131455305|NCT02474069|473295584|FG001|Selection Phase (SP)|Technical Problem|0|||
131455306|NCT02474069|473295585|FG002|Selection Phase (SP)|Technical Problem|0|||
131455307|NCT02474069|473295583|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
131455308|NCT02474069|473295584|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
131455309|NCT02474069|473295585|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
131455310|NCT02474069|473295583|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
131455311|NCT02474069|473295584|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
131455312|NCT02474069|473295585|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
131455313|NCT02474069|473295583|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
131455314|NCT02474069|473295584|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
131455315|NCT02474069|473295585|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
131455316|NCT02474069|473295583|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
131455317|NCT02474069|473295584|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
131455318|NCT02474069|473295585|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
131455319|NCT02474069|473295583|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
131455320|NCT02474069|473295584|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
131455321|NCT02474069|473295585|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
131455322|NCT02474069|473295583|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
131455323|NCT02474069|473295584|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
131455324|NCT02474069|473295585|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
131455325|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
131455326|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
131455327|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
131455328|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
131455329|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
131455330|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
131943560|NCT02394561|475082878|FG001|Extension Phase|Lack of Efficacy|3|||
131943561|NCT02750514|475082879|FG000|Track 1|Disease progression|20|||
131943562|NCT02750514|475082880|FG001|Track 1|Disease progression|1|||
131943563|NCT02750514|475082881|FG002|Track 1|Disease progression|0|||
131943564|NCT02750514|475082882|FG003|Track 1|Disease progression|1|||
131943565|NCT02750514|475082883|FG004|Track 1|Disease progression|0|||
131943566|NCT02750514|475082879|FG000|Track 1|Adverse event unrelated to study drug|1|||
131943567|NCT02750514|475082880|FG001|Track 1|Adverse event unrelated to study drug|0|||
131943568|NCT02750514|475082881|FG002|Track 1|Adverse event unrelated to study drug|0|||
131943569|NCT02750514|475082882|FG003|Track 1|Adverse event unrelated to study drug|0|||
131943570|NCT02750514|475082883|FG004|Track 1|Adverse event unrelated to study drug|0|||
131943571|NCT02750514|475082879|FG000|Track 1|Study drug toxicity|4|||
131943572|NCT02750514|475082880|FG001|Track 1|Study drug toxicity|1|||
131943573|NCT02750514|475082881|FG002|Track 1|Study drug toxicity|0|||
131943574|NCT02750514|475082882|FG003|Track 1|Study drug toxicity|1|||
131943575|NCT02750514|475082883|FG004|Track 1|Study drug toxicity|0|||
131943576|NCT02750514|475082879|FG000|Track 1|Participant request to discontinue|1|||
131943577|NCT02750514|475082880|FG001|Track 1|Participant request to discontinue|0|||
131943578|NCT02750514|475082881|FG002|Track 1|Participant request to discontinue|0|||
131943579|NCT02750514|475082882|FG003|Track 1|Participant request to discontinue|0|||
131943580|NCT02750514|475082883|FG004|Track 1|Participant request to discontinue|0|||
131943581|NCT02750514|475082879|FG000|Track 1|Other reasons|1|||
131943582|NCT02750514|475082880|FG001|Track 1|Other reasons|0|||
131943583|NCT02750514|475082881|FG002|Track 1|Other reasons|0|||
131943584|NCT02750514|475082882|FG003|Track 1|Other reasons|0|||
131943585|NCT02750514|475082883|FG004|Track 1|Other reasons|0|||
131943586|NCT02750514|475082879|FG000|Track 2|Disease progression|4|||
131943587|NCT02750514|475082880|FG001|Track 2|Disease progression|5|||
131943588|NCT02750514|475082881|FG002|Track 2|Disease progression|2|||
131943589|NCT02750514|475082882|FG003|Track 2|Disease progression|5|||
131943590|NCT02750514|475082883|FG004|Track 2|Disease progression|0|||
131943591|NCT02750514|475082879|FG000|Track 2|Adverse event unrelated to study drug|1|||
131943592|NCT02750514|475082880|FG001|Track 2|Adverse event unrelated to study drug|0|||
131943593|NCT02750514|475082881|FG002|Track 2|Adverse event unrelated to study drug|0|||
131943594|NCT02750514|475082882|FG003|Track 2|Adverse event unrelated to study drug|0|||
131943595|NCT02750514|475082883|FG004|Track 2|Adverse event unrelated to study drug|0|||
131943596|NCT02750514|475082879|FG000|Track 2|Study drug toxicity|1|||
131943597|NCT02750514|475082880|FG001|Track 2|Study drug toxicity|2|||
131943598|NCT02750514|475082881|FG002|Track 2|Study drug toxicity|0|||
131943599|NCT02750514|475082882|FG003|Track 2|Study drug toxicity|2|||
131943600|NCT02750514|475082883|FG004|Track 2|Study drug toxicity|0|||
131943601|NCT02750514|475082879|FG000|Track 2|Participant withdrew consent|0|||
131943602|NCT02750514|475082880|FG001|Track 2|Participant withdrew consent|1|||
131943603|NCT02750514|475082881|FG002|Track 2|Participant withdrew consent|0|||
131943604|NCT02750514|475082882|FG003|Track 2|Participant withdrew consent|0|||
131943605|NCT02750514|475082883|FG004|Track 2|Participant withdrew consent|0|||
131943606|NCT02750514|475082879|FG000|Track 3|Disease progression|0|||
131943607|NCT02750514|475082880|FG001|Track 3|Disease progression|24|||
131943608|NCT02750514|475082881|FG002|Track 3|Disease progression|13|||
131943609|NCT02750514|475082882|FG003|Track 3|Disease progression|14|||
131943610|NCT02750514|475082883|FG004|Track 3|Disease progression|0|||
131943611|NCT02750514|475082879|FG000|Track 3|Adverse event unrelated to study drug|0|||
131943612|NCT02750514|475082880|FG001|Track 3|Adverse event unrelated to study drug|1|||
131943613|NCT02750514|475082881|FG002|Track 3|Adverse event unrelated to study drug|1|||
131943614|NCT02750514|475082882|FG003|Track 3|Adverse event unrelated to study drug|1|||
131943615|NCT02750514|475082883|FG004|Track 3|Adverse event unrelated to study drug|0|||
131943616|NCT02750514|475082879|FG000|Track 3|Study drug toxicity|0|||
131943617|NCT02750514|475082880|FG001|Track 3|Study drug toxicity|3|||
131943618|NCT02750514|475082881|FG002|Track 3|Study drug toxicity|0|||
131943619|NCT02750514|475082882|FG003|Track 3|Study drug toxicity|1|||
131943620|NCT02750514|475082883|FG004|Track 3|Study drug toxicity|0|||
131943621|NCT02750514|475082879|FG000|Track 3|Participant request to discontinue|0|||
131413152|NCT02124772|473135598|FG005|Overall Study|Investigator discretion|0|||
131413153|NCT02124772|473135599|FG006|Overall Study|Investigator discretion|1|||
131413154|NCT02124772|473135600|FG007|Overall Study|Investigator discretion|0|||
131413155|NCT02124772|473135601|FG008|Overall Study|Investigator discretion|0|||
131413156|NCT02124772|473135602|FG009|Overall Study|Investigator discretion|1|||
131413157|NCT02124772|473135603|FG010|Overall Study|Investigator discretion|0|||
131943622|NCT02750514|475082880|FG001|Track 3|Participant request to discontinue|2|||
131943623|NCT02750514|475082881|FG002|Track 3|Participant request to discontinue|0|||
131943624|NCT02750514|475082882|FG003|Track 3|Participant request to discontinue|0|||
131943625|NCT02750514|475082883|FG004|Track 3|Participant request to discontinue|0|||
131943626|NCT02750514|475082879|FG000|Track 3|Participant withdrew consent|0|||
131943627|NCT02750514|475082880|FG001|Track 3|Participant withdrew consent|3|||
131943628|NCT02750514|475082881|FG002|Track 3|Participant withdrew consent|1|||
131943629|NCT02750514|475082882|FG003|Track 3|Participant withdrew consent|0|||
131943630|NCT02750514|475082883|FG004|Track 3|Participant withdrew consent|0|||
131943631|NCT02750514|475082879|FG000|Track 3|Other reasons|0|||
131413158|NCT02124772|473135604|FG011|Overall Study|Investigator discretion|1|||
131413159|NCT02124772|473135605|FG012|Overall Study|Investigator discretion|0|||
131413160|NCT02124772|473135593|FG000|Overall Study|Progressive disease|0|||
131413161|NCT02124772|473135594|FG001|Overall Study|Progressive disease|0|||
131413162|NCT02124772|473135595|FG002|Overall Study|Progressive disease|0|||
131413163|NCT02124772|473135596|FG003|Overall Study|Progressive disease|0|||
131413164|NCT02124772|473135597|FG004|Overall Study|Progressive disease|0|||
131413165|NCT02124772|473135598|FG005|Overall Study|Progressive disease|0|||
131413166|NCT02124772|473135599|FG006|Overall Study|Progressive disease|1|||
131413167|NCT02124772|473135600|FG007|Overall Study|Progressive disease|1|||
131413168|NCT02124772|473135601|FG008|Overall Study|Progressive disease|0|||
131413169|NCT02124772|473135602|FG009|Overall Study|Progressive disease|0|||
131413170|NCT02124772|473135603|FG010|Overall Study|Progressive disease|0|||
131413171|NCT02124772|473135604|FG011|Overall Study|Progressive disease|0|||
131413172|NCT02124772|473135605|FG012|Overall Study|Progressive disease|0|||
131413173|NCT02124772|473135593|FG000|Overall Study|Other|0|||
131413174|NCT02124772|473135594|FG001|Overall Study|Other|7|||
131413175|NCT02124772|473135595|FG002|Overall Study|Other|2|||
131413176|NCT02124772|473135596|FG003|Overall Study|Other|5|||
131413177|NCT02124772|473135597|FG004|Overall Study|Other|4|||
131413178|NCT02124772|473135598|FG005|Overall Study|Other|3|||
131413179|NCT02124772|473135599|FG006|Overall Study|Other|4|||
131413180|NCT02124772|473135600|FG007|Overall Study|Other|1|||
131413181|NCT02124772|473135601|FG008|Overall Study|Other|1|||
131413182|NCT02124772|473135602|FG009|Overall Study|Other|1|||
131413183|NCT02124772|473135603|FG010|Overall Study|Other|1|||
131413184|NCT02124772|473135604|FG011|Overall Study|Other|1|||
131413185|NCT02124772|473135605|FG012|Overall Study|Other|0|||
131413186|NCT00780273|473135606|FG000|Overall Study|Death|1|||
131413187|NCT00780273|473135606|FG000|Overall Study|Lost to Follow-up|1|||
131413188|NCT01688921|473135607|FG000|Overall Study|Lost to Follow-up|7|||
131413189|NCT01688921|473135608|FG001|Overall Study|Lost to Follow-up|13|||
131413190|NCT01688921|473135607|FG000|Overall Study|Physician Decision|6|||
131413191|NCT01688921|473135608|FG001|Overall Study|Physician Decision|1|||
131413192|NCT01688921|473135607|FG000|Overall Study|Protocol Violation|0|||
131413193|NCT01688921|473135608|FG001|Overall Study|Protocol Violation|1|||
131413194|NCT01688921|473135607|FG000|Overall Study|informed consent|3|||
131413195|NCT01688921|473135608|FG001|Overall Study|informed consent|0|||
131413196|NCT02358044|473135609|FG000|Overall Study|Adverse Event|0|||
131413197|NCT02358044|473135610|FG001|Overall Study|Adverse Event|1|||
131413198|NCT02358044|473135609|FG000|Overall Study|Lost to Follow-up|2|||
131413199|NCT02358044|473135610|FG001|Overall Study|Lost to Follow-up|1|||
131413200|NCT02358044|473135609|FG000|Overall Study|Physician Decision|0|||
131413201|NCT02358044|473135610|FG001|Overall Study|Physician Decision|1|||
131413202|NCT02358044|473135609|FG000|Overall Study|Withdrawal by Subject|0|||
131413203|NCT02358044|473135610|FG001|Overall Study|Withdrawal by Subject|4|||
131413204|NCT01739803|473135613|FG000|Overall Study|Lost to Follow-up|9|||
131413205|NCT01739803|473135614|FG001|Overall Study|Lost to Follow-up|6|||
131413206|NCT00969436|473135616|FG000|Overall Study|Protocol Violation|1|||
131413207|NCT00969436|473135617|FG001|Overall Study|Protocol Violation|3|||
131413208|NCT00969436|473135618|FG002|Overall Study|Protocol Violation|0|||
131413209|NCT00969436|473135616|FG000|Overall Study|Migrated/moved from study area|12|||
131413210|NCT00969436|473135617|FG001|Overall Study|Migrated/moved from study area|10|||
131413211|NCT00969436|473135618|FG002|Overall Study|Migrated/moved from study area|2|||
131413212|NCT00969436|473135616|FG000|Overall Study|Father - serious health problem|0|||
131413213|NCT00969436|473135617|FG001|Overall Study|Father - serious health problem|0|||
131413214|NCT00969436|473135618|FG002|Overall Study|Father - serious health problem|1|||
131413215|NCT00969436|473135616|FG000|Overall Study|Parents personal problem|0|||
131413216|NCT00969436|473135617|FG001|Overall Study|Parents personal problem|0|||
131413217|NCT00969436|473135618|FG002|Overall Study|Parents personal problem|1|||
131413218|NCT00969436|473135616|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
131413219|NCT00969436|473135617|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
131413220|NCT00969436|473135618|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
131413221|NCT00969436|473135616|FG000|Overall Study|Withdrawal by Subject|3|||
131413222|NCT00969436|473135617|FG001|Overall Study|Withdrawal by Subject|0|||
131413223|NCT00969436|473135618|FG002|Overall Study|Withdrawal by Subject|2|||
131455331|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
131455332|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
131413224|NCT00969436|473135616|FG000|Overall Study|Lost to Follow-up|8|||
131413225|NCT00969436|473135617|FG001|Overall Study|Lost to Follow-up|8|||
131413226|NCT00969436|473135618|FG002|Overall Study|Lost to Follow-up|5|||
131413227|NCT01825941|473137193|FG000|Overall Study|Lost to Follow-up|4|||
131413228|NCT01825941|473137194|FG001|Overall Study|Lost to Follow-up|1|||
131413229|NCT00151372|473137195|FG000|Overall Study|Death|12|||
131413230|NCT00151372|473137196|FG001|Overall Study|Death|11|||
131413231|NCT00151372|473137195|FG000|Overall Study|Lost to Follow-up|5|||
131413232|NCT00151372|473137196|FG001|Overall Study|Lost to Follow-up|5|||
131413233|NCT00151372|473137195|FG000|Overall Study|Too sick medically to continue|5|||
131413234|NCT00151372|473137196|FG001|Overall Study|Too sick medically to continue|6|||
131455333|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
131455334|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
131455335|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
131943632|NCT02750514|475082880|FG001|Track 3|Other reasons|3|||
131943633|NCT02750514|475082881|FG002|Track 3|Other reasons|0|||
131943634|NCT02750514|475082882|FG003|Track 3|Other reasons|0|||
131943635|NCT02750514|475082883|FG004|Track 3|Other reasons|0|||
131943636|NCT02750514|475082879|FG000|Track 4|Study drug toxicity|0|||
131943637|NCT02750514|475082880|FG001|Track 4|Study drug toxicity|6|||
131943638|NCT02750514|475082881|FG002|Track 4|Study drug toxicity|0|||
131943639|NCT02750514|475082882|FG003|Track 4|Study drug toxicity|5|||
131943640|NCT02750514|475082883|FG004|Track 4|Study drug toxicity|0|||
131943641|NCT02750514|475082879|FG000|Track 4|Participant request to discontinue|0|||
131943642|NCT02750514|475082880|FG001|Track 4|Participant request to discontinue|1|||
131943643|NCT02750514|475082881|FG002|Track 4|Participant request to discontinue|0|||
131943644|NCT02750514|475082882|FG003|Track 4|Participant request to discontinue|1|||
131943645|NCT02750514|475082883|FG004|Track 4|Participant request to discontinue|0|||
131943646|NCT02750514|475082879|FG000|Track 4|Participant withdrew consent|0|||
131943647|NCT02750514|475082880|FG001|Track 4|Participant withdrew consent|1|||
131943648|NCT02750514|475082881|FG002|Track 4|Participant withdrew consent|0|||
131943649|NCT02750514|475082882|FG003|Track 4|Participant withdrew consent|0|||
131943650|NCT02750514|475082883|FG004|Track 4|Participant withdrew consent|0|||
131943651|NCT02750514|475082879|FG000|Track 4|Other reasons|0|||
131943652|NCT02750514|475082880|FG001|Track 4|Other reasons|5|||
131943653|NCT02750514|475082881|FG002|Track 4|Other reasons|0|||
131943654|NCT02750514|475082882|FG003|Track 4|Other reasons|3|||
131943655|NCT02750514|475082883|FG004|Track 4|Other reasons|0|||
131943656|NCT02750514|475082879|FG000|Track 4|Disease progression|0|||
131943657|NCT02750514|475082880|FG001|Track 4|Disease progression|33|||
131943658|NCT02750514|475082881|FG002|Track 4|Disease progression|0|||
131943659|NCT02750514|475082882|FG003|Track 4|Disease progression|32|||
131943660|NCT02750514|475082883|FG004|Track 4|Disease progression|0|||
131943661|NCT02750514|475082879|FG000|Track 4|Adverse event unrelated to study drug|0|||
131943662|NCT02750514|475082880|FG001|Track 4|Adverse event unrelated to study drug|5|||
131943663|NCT02750514|475082881|FG002|Track 4|Adverse event unrelated to study drug|0|||
131943664|NCT02750514|475082882|FG003|Track 4|Adverse event unrelated to study drug|0|||
131943665|NCT02750514|475082883|FG004|Track 4|Adverse event unrelated to study drug|0|||
131943666|NCT02750514|475082879|FG000|Track 4|Death|0|||
131943667|NCT02750514|475082880|FG001|Track 4|Death|0|||
131943668|NCT02750514|475082881|FG002|Track 4|Death|0|||
131943669|NCT02750514|475082882|FG003|Track 4|Death|1|||
131943670|NCT02750514|475082883|FG004|Track 4|Death|0|||
131943671|NCT02750514|475082879|FG000|Track 5|Disease progression|0|||
131943672|NCT02750514|475082880|FG001|Track 5|Disease progression|0|||
131943673|NCT02750514|475082881|FG002|Track 5|Disease progression|0|||
131943674|NCT02750514|475082882|FG003|Track 5|Disease progression|0|||
131943675|NCT02750514|475082883|FG004|Track 5|Disease progression|34|||
131943676|NCT02750514|475082879|FG000|Track 5|Adverse event unrelated to study drug|0|||
131943677|NCT02750514|475082880|FG001|Track 5|Adverse event unrelated to study drug|0|||
131943678|NCT02750514|475082881|FG002|Track 5|Adverse event unrelated to study drug|0|||
131943679|NCT02750514|475082882|FG003|Track 5|Adverse event unrelated to study drug|0|||
131943680|NCT02750514|475082883|FG004|Track 5|Adverse event unrelated to study drug|2|||
131943681|NCT02750514|475082879|FG000|Track 5|Study drug toxicity|0|||
131943682|NCT02750514|475082880|FG001|Track 5|Study drug toxicity|0|||
131943683|NCT02750514|475082881|FG002|Track 5|Study drug toxicity|0|||
131943684|NCT02750514|475082882|FG003|Track 5|Study drug toxicity|0|||
131943685|NCT02750514|475082883|FG004|Track 5|Study drug toxicity|2|||
131943686|NCT02750514|475082879|FG000|Track 5|Participant request to discontinue|0|||
131943687|NCT02750514|475082880|FG001|Track 5|Participant request to discontinue|0|||
131943688|NCT02750514|475082881|FG002|Track 5|Participant request to discontinue|0|||
131943689|NCT02750514|475082882|FG003|Track 5|Participant request to discontinue|0|||
131943690|NCT02750514|475082883|FG004|Track 5|Participant request to discontinue|3|||
131943691|NCT02750514|475082879|FG000|Track 5|Other reasons|0|||
131943692|NCT02750514|475082880|FG001|Track 5|Other reasons|0|||
131943693|NCT02750514|475082881|FG002|Track 5|Other reasons|0|||
131943694|NCT02750514|475082882|FG003|Track 5|Other reasons|0|||
131943695|NCT02750514|475082883|FG004|Track 5|Other reasons|2|||
131943696|NCT01882465|475082884|FG000|Period 1|Lens Discomfort|0|||
131943697|NCT01882465|475082885|FG001|Period 1|Lens Discomfort|0|||
131943698|NCT01882465|475082886|FG002|Period 1|Lens Discomfort|0|||
131943699|NCT01882465|475082887|FG003|Period 1|Lens Discomfort|1|||
131943700|NCT01882465|475082888|FG004|Period 1|Lens Discomfort|0|||
131943701|NCT01882465|475082889|FG005|Period 1|Lens Discomfort|0|||
131943702|NCT01882465|475082890|FG006|Period 1|Lens Discomfort|0|||
131943703|NCT01882465|475082884|FG000|Period 1|Withdrawal by Subject|0|||
131943704|NCT01882465|475082885|FG001|Period 1|Withdrawal by Subject|0|||
131943705|NCT01882465|475082886|FG002|Period 1|Withdrawal by Subject|0|||
131943706|NCT01882465|475082887|FG003|Period 1|Withdrawal by Subject|0|||
131943707|NCT01882465|475082888|FG004|Period 1|Withdrawal by Subject|0|||
131943708|NCT01882465|475082889|FG005|Period 1|Withdrawal by Subject|0|||
131943709|NCT01882465|475082890|FG006|Period 1|Withdrawal by Subject|1|||
131943710|NCT01882465|475082884|FG000|Period 2|Protocol Violation|0|||
131943711|NCT01882465|475082885|FG001|Period 2|Protocol Violation|0|||
131943712|NCT01882465|475082886|FG002|Period 2|Protocol Violation|0|||
131943713|NCT01882465|475082887|FG003|Period 2|Protocol Violation|0|||
131943714|NCT01882465|475082888|FG004|Period 2|Protocol Violation|1|||
131943715|NCT01882465|475082889|FG005|Period 2|Protocol Violation|0|||
131943716|NCT01882465|475082890|FG006|Period 2|Protocol Violation|0|||
131943717|NCT01378117|475082892|FG000|Overall Study|withdrawal|2|||
131943718|NCT01378117|475082893|FG001|Overall Study|withdrawal|1|||
131943719|NCT01378117|475082894|FG002|Overall Study|withdrawal|2|||
131943720|NCT01378117|475082892|FG000|Overall Study|discharged before med given|2|||
131943721|NCT01378117|475082893|FG001|Overall Study|discharged before med given|0|||
131943722|NCT01378117|475082894|FG002|Overall Study|discharged before med given|1|||
131943723|NCT02961244|475082895|FG000|Overall Study|Protocol Violation|0|||
131943724|NCT02961244|475082896|FG001|Overall Study|Protocol Violation|1|||
131943725|NCT02961244|475082895|FG000|Overall Study|Withdrawal by Subject|1|||
131943726|NCT02961244|475082896|FG001|Overall Study|Withdrawal by Subject|2|||
131943727|NCT02961244|475082895|FG000|Overall Study|Surgery plan change after study approval|0|||
131943728|NCT02961244|475082896|FG001|Overall Study|Surgery plan change after study approval|2|||
131943729|NCT02961244|475082895|FG000|Overall Study|Lost to Follow-up|0|||
131943730|NCT02961244|475082896|FG001|Overall Study|Lost to Follow-up|2|||
131943731|NCT02961244|475082895|FG000|Overall Study|İnadequate data|0|||
131943732|NCT02961244|475082896|FG001|Overall Study|İnadequate data|2|||
131943733|NCT00950651|475082900|FG000|Overall Study|Adverse Event|17|||
131943734|NCT00950651|475082901|FG001|Overall Study|Adverse Event|20|||
131943735|NCT00950651|475082900|FG000|Overall Study|Death|1|||
131943736|NCT00950651|475082901|FG001|Overall Study|Death|0|||
131943737|NCT00950651|475082900|FG000|Overall Study|Lack of Efficacy|2|||
131943738|NCT00950651|475082901|FG001|Overall Study|Lack of Efficacy|2|||
131943739|NCT00950651|475082900|FG000|Overall Study|Protocol Violation|3|||
131943740|NCT00950651|475082901|FG001|Overall Study|Protocol Violation|4|||
131943741|NCT00950651|475082900|FG000|Overall Study|Withdrawal by Subject|8|||
131943742|NCT00950651|475082901|FG001|Overall Study|Withdrawal by Subject|9|||
131943743|NCT00527618|475082903|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
131943744|NCT00527618|475082904|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
131943745|NCT00527618|475082903|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
131943746|NCT00527618|475082904|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
131943747|NCT00527618|475082903|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
131943748|NCT00527618|475082904|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
131943749|NCT00527618|475082903|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
131943750|NCT00527618|475082904|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
131943751|NCT00527618|475082903|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
131943752|NCT00527618|475082904|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
131943753|NCT00527618|475082903|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
131943754|NCT00527618|475082904|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
131943755|NCT00114127|475082906|FG000|Overall Study|Adverse Event|2|||
131943756|NCT00114127|475082907|FG001|Overall Study|Adverse Event|1|||
131943757|NCT00114127|475082906|FG000|Overall Study|Lost to Follow-up|1|||
131943758|NCT00114127|475082907|FG001|Overall Study|Lost to Follow-up|0|||
131943759|NCT00114127|475082906|FG000|Overall Study|Withdrawal by Subject|1|||
131943760|NCT00114127|475082907|FG001|Overall Study|Withdrawal by Subject|3|||
131943761|NCT03188263|475082908|FG000|Overall Study|Withdrawal by Subject|3|||
131943762|NCT03188263|475082909|FG001|Overall Study|Withdrawal by Subject|0|||
131943763|NCT03188263|475082908|FG000|Overall Study|Physician Decision|1|||
131943764|NCT03188263|475082909|FG001|Overall Study|Physician Decision|0|||
131943765|NCT00881894|475082910|FG000|Overall Study|Consent withdrawn|0|||
131943766|NCT00881894|475082911|FG001|Overall Study|Consent withdrawn|1|||
131943767|NCT00881894|475082910|FG000|Overall Study|Other reasons for premature termination|1|||
131943768|NCT00881894|475082911|FG001|Overall Study|Other reasons for premature termination|2|||
131943769|NCT00469833|475082912|FG000|Overall Study|No IV access|2|||
131943770|NCT01253369|475082913|FG000|Overall Study|Adverse Event|4|||
131943771|NCT01253369|475082913|FG000|Overall Study|Withdrawal by Subject|2|||
131943772|NCT01253369|475082913|FG000|Overall Study|Death|1|||
131943773|NCT01253369|475082913|FG000|Overall Study|Progressive disease|23|||
131943774|NCT01253369|475082913|FG000|Overall Study|Not Evaluable|3|||
131943775|NCT00363311|475082918|FG000|Overall Study|Adverse Event|6|||
131943776|NCT00363311|475082919|FG001|Overall Study|Adverse Event|4|||
131943777|NCT00363311|475082918|FG000|Overall Study|Lost to Follow-up|3|||
131943778|NCT00363311|475082919|FG001|Overall Study|Lost to Follow-up|0|||
131943779|NCT00363311|475082918|FG000|Overall Study|Protocol Violation|1|||
131943780|NCT00363311|475082919|FG001|Overall Study|Protocol Violation|2|||
131943781|NCT00363311|475082918|FG000|Overall Study|Withdrawal by Subject|12|||
131943782|NCT00363311|475082919|FG001|Overall Study|Withdrawal by Subject|6|||
131943783|NCT00363311|475082918|FG000|Overall Study|Physician Decision|1|||
131943784|NCT00363311|475082919|FG001|Overall Study|Physician Decision|1|||
131943785|NCT00363311|475082918|FG000|Overall Study|Sponsor Terminated Study|2|||
131943786|NCT00363311|475082919|FG001|Overall Study|Sponsor Terminated Study|2|||
131943787|NCT00363311|475082918|FG000|Overall Study|Disease Progression|46|||
131943788|NCT00363311|475082919|FG001|Overall Study|Disease Progression|26|||
131943789|NCT00363311|475082918|FG000|Overall Study|Non-Compliance|1|||
131943790|NCT00363311|475082919|FG001|Overall Study|Non-Compliance|1|||
131943791|NCT00363311|475082918|FG000|Overall Study|Participant Refused Biopsy|1|||
131943792|NCT00363311|475082919|FG001|Overall Study|Participant Refused Biopsy|0|||
131943793|NCT00363311|475082918|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
131943794|NCT00363311|475082919|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
131943795|NCT00363311|475082918|FG000|Overall Study|Participant Opted for Treatment|1|||
131943796|NCT00363311|475082919|FG001|Overall Study|Participant Opted for Treatment|0|||
131943797|NCT00363311|475082918|FG000|Overall Study|Participant Moved to Another Country|1|||
131943798|NCT00363311|475082919|FG001|Overall Study|Participant Moved to Another Country|0|||
131943799|NCT00363311|475082918|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
131943800|NCT00363311|475082919|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
131943801|NCT00363311|475082918|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
131943802|NCT00363311|475082919|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
131943803|NCT00363311|475082918|FG000|Overall Study|Participant Moved to Louisiana|0|||
131943804|NCT00363311|475082919|FG001|Overall Study|Participant Moved to Louisiana|1|||
131943805|NCT01595529|475082920|FG000|Overall Study|Adverse Event|2|||
131943806|NCT01595529|475082921|FG001|Overall Study|Adverse Event|0|||
131943807|NCT01595529|475082920|FG000|Overall Study|Subject Non-Compliant|2|||
131943808|NCT01595529|475082921|FG001|Overall Study|Subject Non-Compliant|0|||
131943809|NCT01595529|475082920|FG000|Overall Study|Lost to Follow-up|8|||
131943810|NCT01595529|475082921|FG001|Overall Study|Lost to Follow-up|14|||
131943811|NCT01595529|475082920|FG000|Overall Study|Protocol Violation|1|||
131943812|NCT01595529|475082921|FG001|Overall Study|Protocol Violation|2|||
131943813|NCT01595529|475082920|FG000|Overall Study|Physician Decision|1|||
131943814|NCT01595529|475082921|FG001|Overall Study|Physician Decision|0|||
131943815|NCT01595529|475082920|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
131943816|NCT01595529|475082921|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
131943817|NCT01595529|475082920|FG000|Overall Study|Administrative Decision|1|||
131943818|NCT01595529|475082921|FG001|Overall Study|Administrative Decision|0|||
131943819|NCT01595529|475082920|FG000|Overall Study|Entry Failure/Screening Failure|6|||
131943820|NCT01595529|475082921|FG001|Overall Study|Entry Failure/Screening Failure|1|||
131943821|NCT04540367|475082938|FG000|Overall Study|Withdrawal by Subject|0|||
131943822|NCT04540367|475082939|FG001|Overall Study|Withdrawal by Subject|0|||
131943823|NCT04540367|475082940|FG002|Overall Study|Withdrawal by Subject|0|||
131943824|NCT04540367|475082941|FG003|Overall Study|Withdrawal by Subject|2|||
131943825|NCT04540367|475082938|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
131943826|NCT04540367|475082939|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
131943827|NCT04540367|475082940|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
131943828|NCT04540367|475082941|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
131943829|NCT04540367|475082938|FG000|Overall Study|Adverse Event|0|||
131943830|NCT04540367|475082939|FG001|Overall Study|Adverse Event|0|||
131943831|NCT04540367|475082940|FG002|Overall Study|Adverse Event|1|||
131943832|NCT04540367|475082941|FG003|Overall Study|Adverse Event|1|||
131943833|NCT00959907|475082944|FG000|Overall Study|Protocol Violation|0|||
131943834|NCT00959907|475082945|FG001|Overall Study|Protocol Violation|1|||
131943835|NCT00959907|475082944|FG000|Overall Study|Adverse Event|1|||
131943836|NCT00959907|475082945|FG001|Overall Study|Adverse Event|0|||
131943837|NCT00959907|475082944|FG000|Overall Study|Withdrawal by Subject|2|||
131943838|NCT00959907|475082945|FG001|Overall Study|Withdrawal by Subject|0|||
131943839|NCT00730886|475082946|FG000|Overall Study|Lost to Follow-up|1|||
131413235|NCT00151372|473137195|FG000|Overall Study|Withdrawal by Subject|7|||
131413236|NCT00151372|473137196|FG001|Overall Study|Withdrawal by Subject|7|||
131413237|NCT00541346|473137197|FG000|Follow-up|Adverse Event|1|||
131413238|NCT04732949|473137198|FG000|Overall Study|Withdrawal by Subject|23|||
131413239|NCT04732949|473137199|FG001|Overall Study|Withdrawal by Subject|27|||
131413240|NCT04732949|473137198|FG000|Overall Study|Protocol Violation|0|||
131943840|NCT00730886|475082947|FG001|Overall Study|Lost to Follow-up|0|||
131943841|NCT00730886|475082946|FG000|Overall Study|Physician Decision|1|||
131943842|NCT00730886|475082947|FG001|Overall Study|Physician Decision|0|||
131943843|NCT03958331|475082948|FG000|Overall Study|Withdrawal by Subject|3|||
131943844|NCT03958331|475082949|FG001|Overall Study|Withdrawal by Subject|1|||
131943845|NCT03958331|475082950|FG002|Overall Study|Withdrawal by Subject|5|||
131943846|NCT03958331|475082948|FG000|Overall Study|Weaned from medicine|2|||
131943847|NCT03958331|475082949|FG001|Overall Study|Weaned from medicine|0|||
131943848|NCT03958331|475082950|FG002|Overall Study|Weaned from medicine|0|||
131943849|NCT03958331|475082948|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
131943850|NCT03958331|475082949|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
131413241|NCT04732949|473137199|FG001|Overall Study|Protocol Violation|1|||
131413242|NCT04732949|473137198|FG000|Overall Study|Non-compliance|0|||
131413243|NCT04732949|473137199|FG001|Overall Study|Non-compliance|2|||
131943851|NCT03958331|475082950|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
131943852|NCT01991483|475082951|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
131943853|NCT01991483|475082952|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
131943854|NCT01991483|475082953|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
131943855|NCT01991483|475082954|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
131943856|NCT01991483|475082951|FG000|Dose Level 600 mg|Physician Decision|0|||
131943857|NCT01991483|475082952|FG001|Dose Level 600 mg|Physician Decision|0|||
131943858|NCT01991483|475082953|FG002|Dose Level 600 mg|Physician Decision|1|||
131943859|NCT01991483|475082954|FG003|Dose Level 600 mg|Physician Decision|0|||
131943860|NCT01991483|475082951|FG000|Dose Level 1000 mg|Protocol Violation|0|||
131943861|NCT01991483|475082952|FG001|Dose Level 1000 mg|Protocol Violation|0|||
131943862|NCT01991483|475082953|FG002|Dose Level 1000 mg|Protocol Violation|0|||
131943863|NCT01991483|475082954|FG003|Dose Level 1000 mg|Protocol Violation|1|||
131943864|NCT04290624|475082961|FG000|Overall Study|Adverse Event|1|||
131943865|NCT04290624|475082962|FG001|Overall Study|Adverse Event|0|||
131943866|NCT01171677|475082963|FG000|Overall Study|Withdrawal by Subject|0|||
131943867|NCT01171677|475082964|FG001|Overall Study|Withdrawal by Subject|3|||
131943868|NCT01171677|475082963|FG000|Overall Study|Adverse Event|1|||
131943869|NCT01171677|475082964|FG001|Overall Study|Adverse Event|0|||
131943870|NCT01171677|475082963|FG000|Overall Study|completed <70% IntenSati classes|5|||
131943871|NCT01171677|475082964|FG001|Overall Study|completed <70% IntenSati classes|0|||
131943872|NCT01085214|475082967|FG000|Overall Study|Alternate treatment required|1|||
131943873|NCT01634152|475082981|FG000|Overall Study|Adverse Event|2|||
131943874|NCT01634152|475082982|FG001|Overall Study|Adverse Event|0|||
131943875|NCT01634152|475082983|FG002|Overall Study|Adverse Event|2|||
131943876|NCT01634152|475082981|FG000|Overall Study|Consent withdrawn not due to AE|1|||
131943877|NCT01634152|475082982|FG001|Overall Study|Consent withdrawn not due to AE|0|||
131943878|NCT01634152|475082983|FG002|Overall Study|Consent withdrawn not due to AE|1|||
131943879|NCT01634152|475082981|FG000|Overall Study|Not treated|0|||
131943880|NCT01634152|475082982|FG001|Overall Study|Not treated|1|||
131943881|NCT01634152|475082983|FG002|Overall Study|Not treated|0|||
131943882|NCT01634152|475082981|FG000|Overall Study|Other reason not defined above|1|||
131943883|NCT01634152|475082982|FG001|Overall Study|Other reason not defined above|0|||
131943884|NCT01634152|475082983|FG002|Overall Study|Other reason not defined above|1|||
131943885|NCT01985022|475082984|FG000|Overall Study|Lost to Follow-up|0|||
131943886|NCT01985022|475082985|FG001|Overall Study|Lost to Follow-up|1|||
131943887|NCT01985022|475082984|FG000|Overall Study|Protocol Violation|0|||
131943888|NCT01985022|475082985|FG001|Overall Study|Protocol Violation|1|||
131943889|NCT01985022|475082984|FG000|Overall Study|Withdrawal by Subject|4|||
131943890|NCT01985022|475082985|FG001|Overall Study|Withdrawal by Subject|1|||
131943891|NCT00441272|475084782|FG000|Overall Study|Study terminated prior to enrollment|25|||
131943892|NCT00441272|475084783|FG001|Overall Study|Study terminated prior to enrollment|25|||
131943893|NCT01856322|475084784|FG000|Overall Study|off study due to lack of accrual|0|||
131943894|NCT01856322|475084785|FG001|Overall Study|off study due to lack of accrual|0|||
131943895|NCT01856322|475084786|FG002|Overall Study|off study due to lack of accrual|3|||
131943896|NCT00427011|475084787|FG000|Overall Study|Adverse Event|10|||
131943897|NCT00427011|475084787|FG000|Overall Study|Withdrawal by Subject|1|||
131943898|NCT00427011|475084787|FG000|Overall Study|Lack of Efficacy|2|||
131943899|NCT00427011|475084787|FG000|Overall Study|Other|12|||
131943900|NCT00288015|475084788|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
131943901|NCT00288015|475084788|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
131943902|NCT00288015|475084788|FG000|First Response Assessment|Withdrawal by Subject|1|||
131943903|NCT00288015|475084788|FG000|First Response Assessment|Death|1|||
131943904|NCT00288015|475084788|FG000|First Response Assessment|Physician Decision|2|||
131943905|NCT00288015|475084788|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
131943906|NCT00288015|475084788|FG000|Follow up for Survival x 2 Years|Death|13|||
131943907|NCT00288015|475084788|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
131943908|NCT00288015|475084788|FG000|Follow up for Survival x 2 Years|Other|9|||
131943909|NCT00443703|475084789|FG000|Overall Study|Never Treated|3|||
131943910|NCT00443703|475084790|FG001|Overall Study|Never Treated|1|||
131943911|NCT00443703|475084789|FG000|Overall Study|Adverse Event|7|||
131943912|NCT00443703|475084790|FG001|Overall Study|Adverse Event|3|||
131943913|NCT00443703|475084789|FG000|Overall Study|Lack of Efficacy|3|||
131413244|NCT04732949|473137198|FG000|Overall Study|Physician Decision|2|||
131413245|NCT04732949|473137199|FG001|Overall Study|Physician Decision|1|||
131413246|NCT04732949|473137198|FG000|Overall Study|Serious adverse event (Fatal)|16|||
131943914|NCT00443703|475084790|FG001|Overall Study|Lack of Efficacy|1|||
131943915|NCT00443703|475084789|FG000|Overall Study|Lost to Follow-up|0|||
131943916|NCT00443703|475084790|FG001|Overall Study|Lost to Follow-up|4|||
131943917|NCT00443703|475084789|FG000|Overall Study|Physician Decision|4|||
131943918|NCT00443703|475084790|FG001|Overall Study|Physician Decision|2|||
131943919|NCT00443703|475084789|FG000|Overall Study|Protocol Violation|1|||
131413247|NCT04732949|473137199|FG001|Overall Study|Serious adverse event (Fatal)|18|||
131943920|NCT00443703|475084790|FG001|Overall Study|Protocol Violation|1|||
131943921|NCT00443703|475084789|FG000|Overall Study|Withdrawal by Subject|9|||
131943922|NCT00443703|475084790|FG001|Overall Study|Withdrawal by Subject|6|||
131943923|NCT00443703|475084789|FG000|Overall Study|Progressive Disease|1|||
131943924|NCT00443703|475084790|FG001|Overall Study|Progressive Disease|0|||
131943925|NCT01333722|475084791|FG000|Overall Study|Lack of Efficacy|0|||
131943926|NCT01333722|475084792|FG001|Overall Study|Lack of Efficacy|2|||
131943927|NCT01333722|475084791|FG000|Overall Study|Withdrawal by Subject|0|||
131943928|NCT01333722|475084792|FG001|Overall Study|Withdrawal by Subject|1|||
131943929|NCT01047007|475084793|FG000|Overall Study|Adverse Event|0|||
131943930|NCT01047007|475084794|FG001|Overall Study|Adverse Event|2|||
131943931|NCT01047007|475084795|FG002|Overall Study|Adverse Event|1|||
131943932|NCT01047007|475084796|FG003|Overall Study|Adverse Event|0|||
131943933|NCT01047007|475084793|FG000|Overall Study|Progressive Disease|2|||
131943934|NCT01047007|475084794|FG001|Overall Study|Progressive Disease|4|||
131943935|NCT01047007|475084795|FG002|Overall Study|Progressive Disease|1|||
131943936|NCT01047007|475084796|FG003|Overall Study|Progressive Disease|0|||
131943937|NCT04776161|475084797|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
131943938|NCT04776161|475084798|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
131943939|NCT04776161|475084799|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
131943940|NCT04776161|475084797|FG000|Overall Study|Withdrawal by Subject|1|||
131943941|NCT04776161|475084798|FG001|Overall Study|Withdrawal by Subject|0|||
131943942|NCT04776161|475084799|FG002|Overall Study|Withdrawal by Subject|1|||
131943943|NCT04776161|475084797|FG000|Overall Study|Adverse Event|0|||
131943944|NCT04776161|475084798|FG001|Overall Study|Adverse Event|1|||
131943945|NCT04776161|475084799|FG002|Overall Study|Adverse Event|1|||
131943946|NCT02393859|475084802|FG000|Overall Study|Decision by Sponsor|2|||
131943947|NCT02393859|475084803|FG001|Overall Study|Decision by Sponsor|4|||
131943948|NCT02393859|475084802|FG000|Overall Study|Withdrawal by Subject|11|||
131943949|NCT02393859|475084803|FG001|Overall Study|Withdrawal by Subject|6|||
131943950|NCT02393859|475084802|FG000|Overall Study|Death|27|||
131943951|NCT02393859|475084803|FG001|Overall Study|Death|10|||
131943952|NCT02393859|475084802|FG000|Overall Study|Lost to Follow-up|1|||
131943953|NCT02393859|475084803|FG001|Overall Study|Lost to Follow-up|1|||
131943954|NCT00488514|475084804|FG000|Overall Study|Adverse Event|41|||
131943955|NCT00488514|475084804|FG000|Overall Study|Lost to Follow-up|44|||
131943956|NCT00488514|475084804|FG000|Overall Study|Protocol Violation|32|||
131943957|NCT00488514|475084804|FG000|Overall Study|Withdrawal by Subject|106|||
131943958|NCT00488514|475084804|FG000|Overall Study|Lack of Efficacy|28|||
131943959|NCT00488514|475084804|FG000|Overall Study|Did not meet criteria for treatment|30|||
131943960|NCT00488514|475084804|FG000|Overall Study|Postive drug screen|1|||
131943961|NCT00488514|475084804|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
131943962|NCT00488514|475084804|FG000|Overall Study|Investigator decision|1|||
131943963|NCT00488514|475084804|FG000|Overall Study|Participant had too few migraines|5|||
131943964|NCT00488514|475084804|FG000|Overall Study|Increase in number of migraines|2|||
131943965|NCT00488514|475084804|FG000|Overall Study|Increased use of concomitant medication|1|||
131943966|NCT00517699|475084805|FG000|Overall Study|Withdrawal by Subject|1|||
131943967|NCT00517699|475084805|FG000|Overall Study|Lack of Efficacy|1|||
131943968|NCT00517699|475084805|FG000|Overall Study|Administrative error|1|||
131943969|NCT00517699|475084805|FG000|Overall Study|Study terminated by Sponsor|2|||
131943970|NCT02332187|475084806|FG000|Overall Study|Withdrawal by Subject|2|||
131943971|NCT02332187|475084807|FG001|Overall Study|Withdrawal by Subject|2|||
131943972|NCT02332187|475084806|FG000|Overall Study|Adverse Event|0|||
131943973|NCT02332187|475084807|FG001|Overall Study|Adverse Event|1|||
131943974|NCT00355030|475084814|FG000|Study Period 1 Treatment|Adverse Event|1|||
131943975|NCT00355030|475084815|FG001|Study Period 1 Treatment|Adverse Event|1|||
131943976|NCT00355030|475084814|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
131943977|NCT00355030|475084815|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
131943978|NCT00355030|475084814|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
131943979|NCT00355030|475084815|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
131943980|NCT00355030|475084814|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
131943981|NCT00355030|475084815|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
131943982|NCT00355030|475084814|FG000|Study Period 1 Treatment|Physician Decision|0|||
131943983|NCT00355030|475084815|FG001|Study Period 1 Treatment|Physician Decision|1|||
131943984|NCT00355030|475084814|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
131943985|NCT00355030|475084815|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
131943986|NCT00355030|475084814|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
131943987|NCT00355030|475084815|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
131943988|NCT00355030|475084814|FG000|Study Period 1 Treatment|Other|2|||
131943989|NCT00355030|475084815|FG001|Study Period 1 Treatment|Other|6|||
131943990|NCT00355030|475084814|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
131943991|NCT00355030|475084815|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
131943992|NCT00355030|475084814|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
131943993|NCT00355030|475084815|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
131943994|NCT01123148|475084816|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
131943995|NCT01123148|475084816|FG000|Overall Study|Didn't meet milestone criteria|1|||
131943996|NCT01747915|475084817|FG000|Overall Study|Other|1|||
131943997|NCT01747915|475084818|FG001|Overall Study|Other|1|||
131943998|NCT01747915|475084819|FG002|Overall Study|Other|1|||
131943999|NCT01747915|475084817|FG000|Overall Study|Adverse Event|8|||
131944000|NCT01747915|475084818|FG001|Overall Study|Adverse Event|5|||
131944001|NCT01747915|475084819|FG002|Overall Study|Adverse Event|2|||
131944002|NCT01747915|475084817|FG000|Overall Study|Death|0|||
131944003|NCT01747915|475084818|FG001|Overall Study|Death|0|||
131944004|NCT01747915|475084819|FG002|Overall Study|Death|1|||
131944005|NCT01747915|475084817|FG000|Overall Study|Lack of Efficacy|0|||
131944006|NCT01747915|475084818|FG001|Overall Study|Lack of Efficacy|1|||
131944007|NCT01747915|475084819|FG002|Overall Study|Lack of Efficacy|0|||
131944008|NCT01747915|475084817|FG000|Overall Study|Lost to Follow-up|1|||
131944009|NCT01747915|475084818|FG001|Overall Study|Lost to Follow-up|0|||
131944010|NCT01747915|475084819|FG002|Overall Study|Lost to Follow-up|0|||
131944011|NCT01747915|475084817|FG000|Overall Study|Withdrawal by Subject|4|||
131944012|NCT01747915|475084818|FG001|Overall Study|Withdrawal by Subject|4|||
131944013|NCT01747915|475084819|FG002|Overall Study|Withdrawal by Subject|1|||
131944014|NCT01747915|475084817|FG000|Overall Study|Protocol Violation|1|||
131944015|NCT01747915|475084818|FG001|Overall Study|Protocol Violation|0|||
131944016|NCT01747915|475084819|FG002|Overall Study|Protocol Violation|0|||
131944017|NCT01747915|475084817|FG000|Overall Study|Pregnancy|0|||
131944018|NCT01747915|475084818|FG001|Overall Study|Pregnancy|0|||
131944019|NCT01747915|475084819|FG002|Overall Study|Pregnancy|1|||
131944020|NCT03341637|475084820|FG000|Overall Study|Lost to Follow-up|1|||
131944021|NCT03341637|475084821|FG001|Overall Study|Lost to Follow-up|0|||
131944022|NCT03341637|475084820|FG000|Overall Study|Withdrawal by Subject|3|||
131944023|NCT03341637|475084821|FG001|Overall Study|Withdrawal by Subject|3|||
131944024|NCT03341637|475084820|FG000|Overall Study|Reason not Specified|1|||
131944025|NCT03341637|475084821|FG001|Overall Study|Reason not Specified|1|||
131944026|NCT00887159|475084830|FG000|Overall Study|Disease progression|6|||
131944027|NCT00887159|475084831|FG001|Overall Study|Disease progression|39|||
131944028|NCT00887159|475084832|FG002|Overall Study|Disease progression|33|||
131944029|NCT00887159|475084830|FG000|Overall Study|Adverse Event|3|||
131944030|NCT00887159|475084831|FG001|Overall Study|Adverse Event|4|||
131944031|NCT00887159|475084832|FG002|Overall Study|Adverse Event|17|||
131944032|NCT00887159|475084830|FG000|Overall Study|Death|2|||
131944033|NCT00887159|475084831|FG001|Overall Study|Death|2|||
131944034|NCT00887159|475084832|FG002|Overall Study|Death|0|||
131944035|NCT00887159|475084830|FG000|Overall Study|Withdrawal by Subject|4|||
131944036|NCT00887159|475084831|FG001|Overall Study|Withdrawal by Subject|4|||
131944037|NCT00887159|475084832|FG002|Overall Study|Withdrawal by Subject|2|||
131944038|NCT00887159|475084830|FG000|Overall Study|Alternative therapy|2|||
131944039|NCT00887159|475084831|FG001|Overall Study|Alternative therapy|0|||
131944040|NCT00887159|475084832|FG002|Overall Study|Alternative therapy|0|||
131944041|NCT00887159|475084830|FG000|Overall Study|Physician Decision|1|||
131944042|NCT00887159|475084831|FG001|Overall Study|Physician Decision|1|||
131944043|NCT00887159|475084832|FG002|Overall Study|Physician Decision|0|||
131944044|NCT00887159|475084830|FG000|Overall Study|Sympomatic deterioration|1|||
131944045|NCT00887159|475084831|FG001|Overall Study|Sympomatic deterioration|0|||
131944046|NCT00887159|475084832|FG002|Overall Study|Sympomatic deterioration|0|||
131944047|NCT00887159|475084830|FG000|Overall Study|Treatment delayed|1|||
131944048|NCT00887159|475084831|FG001|Overall Study|Treatment delayed|1|||
131944049|NCT00887159|475084832|FG002|Overall Study|Treatment delayed|0|||
131944050|NCT00887159|475084830|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
131944051|NCT00887159|475084831|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
131944052|NCT00887159|475084832|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
131944053|NCT00887159|475084830|FG000|Overall Study|Received more tx instead of observation|1|||
131944054|NCT00887159|475084831|FG001|Overall Study|Received more tx instead of observation|0|||
131944055|NCT00887159|475084832|FG002|Overall Study|Received more tx instead of observation|0|||
131944056|NCT00887159|475084830|FG000|Overall Study|Ineligible|5|||
131944057|NCT00887159|475084831|FG001|Overall Study|Ineligible|1|||
131944058|NCT00887159|475084832|FG002|Overall Study|Ineligible|0|||
131944059|NCT00887159|475084830|FG000|Overall Study|Never started assigned therapy|3|||
131944060|NCT00887159|475084831|FG001|Overall Study|Never started assigned therapy|3|||
131944061|NCT00887159|475084832|FG002|Overall Study|Never started assigned therapy|4|||
131944062|NCT00812955|475084836|FG000|Overall Study|Adverse Event|7|||
131944063|NCT00812955|475084837|FG001|Overall Study|Adverse Event|6|||
131944064|NCT00812955|475084838|FG002|Overall Study|Adverse Event|3|||
131944065|NCT00812955|475084839|FG003|Overall Study|Adverse Event|4|||
131944066|NCT00812955|475084836|FG000|Overall Study|Lost to Follow-up|2|||
131944067|NCT00812955|475084837|FG001|Overall Study|Lost to Follow-up|1|||
131944068|NCT00812955|475084838|FG002|Overall Study|Lost to Follow-up|1|||
131944069|NCT00812955|475084839|FG003|Overall Study|Lost to Follow-up|2|||
131944070|NCT00812955|475084836|FG000|Overall Study|Withdrawal by Subject|1|||
131944071|NCT00812955|475084837|FG001|Overall Study|Withdrawal by Subject|0|||
131944072|NCT00812955|475084838|FG002|Overall Study|Withdrawal by Subject|1|||
131944073|NCT00812955|475084839|FG003|Overall Study|Withdrawal by Subject|2|||
131944074|NCT00812955|475084836|FG000|Overall Study|randomized in error|0|||
131944075|NCT00812955|475084837|FG001|Overall Study|randomized in error|0|||
131944076|NCT00812955|475084838|FG002|Overall Study|randomized in error|1|||
131944077|NCT00812955|475084839|FG003|Overall Study|randomized in error|0|||
131944078|NCT01772550|475084841|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
131944079|NCT01772550|475084842|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
131944080|NCT01772550|475084843|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
131944081|NCT01772550|475084841|FG000|Overall Study|Adverse Event|0|||
131944082|NCT01772550|475084842|FG001|Overall Study|Adverse Event|0|||
131944083|NCT01772550|475084843|FG002|Overall Study|Adverse Event|1|||
131944084|NCT01815424|475084844|FG000|Week 0 to 16|Adverse Event|1|||
131944085|NCT01815424|475084845|FG001|Week 0 to 16|Adverse Event|3|||
131944086|NCT01815424|475084846|FG002|Week 0 to 16|Adverse Event|3|||
131944087|NCT01815424|475084847|FG003|Week 0 to 16|Adverse Event|0|||
131944088|NCT01815424|475084848|FG004|Week 0 to 16|Adverse Event|0|||
131944089|NCT01815424|475084844|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
131944090|NCT01815424|475084845|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
131944091|NCT01815424|475084846|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
131944092|NCT01815424|475084847|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
131944093|NCT01815424|475084848|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
131944094|NCT01815424|475084844|FG000|Week 0 to 16|Lost to Follow-up|0|||
131944095|NCT01815424|475084845|FG001|Week 0 to 16|Lost to Follow-up|1|||
131944096|NCT01815424|475084846|FG002|Week 0 to 16|Lost to Follow-up|0|||
131944097|NCT01815424|475084847|FG003|Week 0 to 16|Lost to Follow-up|0|||
131944098|NCT01815424|475084848|FG004|Week 0 to 16|Lost to Follow-up|0|||
131944099|NCT01815424|475084844|FG000|Week 0 to 16|Withdrawal by Subject|0|||
131944100|NCT01815424|475084845|FG001|Week 0 to 16|Withdrawal by Subject|0|||
131944101|NCT01815424|475084846|FG002|Week 0 to 16|Withdrawal by Subject|1|||
131944102|NCT01815424|475084847|FG003|Week 0 to 16|Withdrawal by Subject|0|||
131944103|NCT01815424|475084848|FG004|Week 0 to 16|Withdrawal by Subject|0|||
131944104|NCT01815424|475084844|FG000|Week 0 to 16|Other|1|||
131944105|NCT01815424|475084845|FG001|Week 0 to 16|Other|0|||
131944106|NCT01815424|475084846|FG002|Week 0 to 16|Other|3|||
131944107|NCT01815424|475084847|FG003|Week 0 to 16|Other|0|||
131944108|NCT01815424|475084848|FG004|Week 0 to 16|Other|0|||
131944109|NCT01815424|475084844|FG000|Week 0 to 16|Protocol Violation|1|||
131944110|NCT01815424|475084845|FG001|Week 0 to 16|Protocol Violation|0|||
131944111|NCT01815424|475084846|FG002|Week 0 to 16|Protocol Violation|0|||
131944112|NCT01815424|475084847|FG003|Week 0 to 16|Protocol Violation|0|||
131944113|NCT01815424|475084848|FG004|Week 0 to 16|Protocol Violation|0|||
131944114|NCT01815424|475084844|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
131944115|NCT01815424|475084845|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
131944116|NCT01815424|475084846|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
131944117|NCT01815424|475084847|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
131944118|NCT01815424|475084848|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
131944119|NCT01815424|475084844|FG000|Week 16 to 52|Other|0|||
131944120|NCT01815424|475084845|FG001|Week 16 to 52|Other|1|||
131944121|NCT01815424|475084846|FG002|Week 16 to 52|Other|0|||
131944122|NCT01815424|475084847|FG003|Week 16 to 52|Other|0|||
131944123|NCT01815424|475084848|FG004|Week 16 to 52|Other|0|||
131944124|NCT01815424|475084844|FG000|Week 16 to 52|Adverse Event|0|||
131944125|NCT01815424|475084845|FG001|Week 16 to 52|Adverse Event|0|||
131944126|NCT01815424|475084846|FG002|Week 16 to 52|Adverse Event|0|||
131944127|NCT01815424|475084847|FG003|Week 16 to 52|Adverse Event|0|||
131944128|NCT01815424|475084848|FG004|Week 16 to 52|Adverse Event|1|||
131944129|NCT01815424|475084844|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
131944130|NCT01815424|475084845|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
131944131|NCT01815424|475084846|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
131944132|NCT01815424|475084847|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
131944133|NCT01815424|475084848|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
131944134|NCT01815424|475084844|FG000|Week 16 to 52|Lost to Follow-up|0|||
131944135|NCT01815424|475084845|FG001|Week 16 to 52|Lost to Follow-up|2|||
131944136|NCT01815424|475084846|FG002|Week 16 to 52|Lost to Follow-up|0|||
131944137|NCT01815424|475084847|FG003|Week 16 to 52|Lost to Follow-up|2|||
131944138|NCT01815424|475084848|FG004|Week 16 to 52|Lost to Follow-up|1|||
131944139|NCT01815424|475084844|FG000|Week 16 to 52|Withdrawal by Subject|1|||
131944140|NCT01815424|475084845|FG001|Week 16 to 52|Withdrawal by Subject|2|||
131944141|NCT01815424|475084846|FG002|Week 16 to 52|Withdrawal by Subject|0|||
131944142|NCT01815424|475084847|FG003|Week 16 to 52|Withdrawal by Subject|0|||
131944143|NCT01815424|475084848|FG004|Week 16 to 52|Withdrawal by Subject|0|||
131944144|NCT01309204|475084849|FG000|Overall Study|Adverse Event|48|||
131944145|NCT01309204|475084850|FG001|Overall Study|Adverse Event|58|||
131944146|NCT01309204|475084849|FG000|Overall Study|Lost to Follow-up|2|||
131944147|NCT01309204|475084850|FG001|Overall Study|Lost to Follow-up|2|||
131944148|NCT01309204|475084849|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
131944149|NCT01309204|475084850|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
131455336|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
131455337|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
131455338|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
131455339|NCT04173494|473295586|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
131455340|NCT04173494|473295587|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
131455341|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
131455342|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
131455343|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
131455344|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
131455345|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
131455346|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
131455347|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
131455348|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
131455349|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
131455350|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
131455351|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
131455352|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
131455353|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
131455354|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
131455355|NCT04173494|473295586|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
131455356|NCT04173494|473295587|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
131455357|NCT01623050|473295588|FG000|Overall Study|Lost to Follow-up|9|||
131455358|NCT01191762|473295591|FG000|Overall Study|Adverse Event|1|||
131455359|NCT01191762|473295592|FG001|Overall Study|Adverse Event|0|||
131455360|NCT00459186|473295593|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
131455361|NCT00459186|473295593|FG000|PET Imaging and Assessment|Adverse Event|3|||
131455362|NCT03710083|473295594|FG000|Overall Study|Withdrawal by Subject|2|||
131455363|NCT03710083|473295594|FG000|Overall Study|Unsuccessful Procedure|1|||
131455364|NCT02102204|473297086|FG000|Overall Study|Withdrawal by Subject|137|||
131455365|NCT02102204|473297086|FG000|Overall Study|Death|92|||
131455366|NCT02102204|473297086|FG000|Overall Study|Lost to Follow-up|65|||
131455367|NCT02102204|473297086|FG000|Overall Study|Sponsor Decision|5|||
131455368|NCT02102204|473297086|FG000|Overall Study|Ongoing|5|||
131455369|NCT02260180|473297087|FG000|Overall Study|Adverse Event|2|||
131455370|NCT02260180|473297088|FG001|Overall Study|Adverse Event|0|||
131455371|NCT02260180|473297089|FG002|Overall Study|Adverse Event|1|||
131455372|NCT01168219|473297094|FG000|Overall Study|off study before starting treatment|2|||
131455373|NCT01168219|473297094|FG000|Overall Study|withdrew before transplant|1|||
131455374|NCT01168219|473297094|FG000|Overall Study|ineligible due to CML|2|||
131455375|NCT00393861|473297095|FG000|Overall Study|Adverse Event|2|||
131455376|NCT00393861|473297095|FG000|Overall Study|Disease Progression|24|||
131455377|NCT05300763|473297096|FG000|Overall Study|Adverse Event|0|||
131455378|NCT05300763|473297097|FG001|Overall Study|Adverse Event|1|||
131455379|NCT05300763|473297096|FG000|Overall Study|Major Protocol Deviation|1|||
131455380|NCT05300763|473297097|FG001|Overall Study|Major Protocol Deviation|0|||
131455381|NCT05300763|473297096|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
131455382|NCT05300763|473297097|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
131455383|NCT02283762|473297101|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
131455384|NCT02283762|473297102|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
131455385|NCT02283762|473297101|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
131455386|NCT02283762|473297102|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
131455387|NCT02283762|473297101|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
131455388|NCT02283762|473297102|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
131455389|NCT02283762|473297101|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
131455390|NCT02283762|473297102|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
131455391|NCT02283762|473297101|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
131455392|NCT02283762|473297102|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
131455393|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
131455394|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
131455395|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
131455396|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
131455397|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
131455398|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
131455399|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
131455400|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
131455401|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
131944150|NCT01309204|475084849|FG000|Overall Study|Inadequate control of IOP|4|||
131455402|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
131455403|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
131455404|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
131944151|NCT01309204|475084850|FG001|Overall Study|Inadequate control of IOP|4|||
131944152|NCT01309204|475084849|FG000|Overall Study|Other|4|||
131944153|NCT01309204|475084850|FG001|Overall Study|Other|1|||
131944154|NCT03500211|475084851|FG000|Overall Study|Withdrawal by Subject|1|||
131944155|NCT03500211|475084852|FG001|Overall Study|Withdrawal by Subject|1|||
131944156|NCT01119443|475084855|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
131944157|NCT01119443|475084856|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
131944158|NCT02329743|475084859|FG000|Overall Study|Adverse Event|1|||
131944159|NCT02329743|475084860|FG001|Overall Study|Adverse Event|1|||
131944160|NCT02329743|475084861|FG002|Overall Study|Adverse Event|3|||
131944161|NCT02329743|475084859|FG000|Overall Study|Lost to Follow-up|1|||
131944162|NCT02329743|475084860|FG001|Overall Study|Lost to Follow-up|0|||
131944163|NCT02329743|475084861|FG002|Overall Study|Lost to Follow-up|1|||
131944164|NCT02329743|475084859|FG000|Overall Study|Withdrawal by Subject|4|||
131944165|NCT02329743|475084860|FG001|Overall Study|Withdrawal by Subject|4|||
131944166|NCT02329743|475084861|FG002|Overall Study|Withdrawal by Subject|1|||
131944167|NCT02329743|475084859|FG000|Overall Study|Other|0|||
131944168|NCT02329743|475084860|FG001|Overall Study|Other|2|||
131944169|NCT02329743|475084861|FG002|Overall Study|Other|3|||
131944170|NCT03604497|475084865|FG000|Overall Study|Protocol Violation|52|||
131944171|NCT01331681|475084871|FG000|Overall Study|Adverse Event|10|||
131944172|NCT01331681|475084872|FG001|Overall Study|Adverse Event|13|||
131944173|NCT01331681|475084873|FG002|Overall Study|Adverse Event|10|||
131944174|NCT01331681|475084871|FG000|Overall Study|Death|6|||
131944175|NCT01331681|475084872|FG001|Overall Study|Death|6|||
131944176|NCT01331681|475084873|FG002|Overall Study|Death|2|||
131944177|NCT01331681|475084871|FG000|Overall Study|Lack of Efficacy|0|||
131944178|NCT01331681|475084872|FG001|Overall Study|Lack of Efficacy|1|||
131944179|NCT01331681|475084873|FG002|Overall Study|Lack of Efficacy|0|||
131944180|NCT01331681|475084871|FG000|Overall Study|Withdrawal by Subject|12|||
131944181|NCT01331681|475084872|FG001|Overall Study|Withdrawal by Subject|8|||
131944182|NCT01331681|475084873|FG002|Overall Study|Withdrawal by Subject|15|||
131944183|NCT01331681|475084871|FG000|Overall Study|Protocol Violation|1|||
131944184|NCT01331681|475084872|FG001|Overall Study|Protocol Violation|1|||
131944185|NCT01331681|475084873|FG002|Overall Study|Protocol Violation|0|||
131944186|NCT01331681|475084871|FG000|Overall Study|Lost to Follow-up|2|||
131944187|NCT01331681|475084872|FG001|Overall Study|Lost to Follow-up|4|||
131944188|NCT01331681|475084873|FG002|Overall Study|Lost to Follow-up|1|||
131944189|NCT01331681|475084871|FG000|Overall Study|Physician Decision|2|||
131944190|NCT01331681|475084872|FG001|Overall Study|Physician Decision|0|||
131413248|NCT04732949|473137198|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
131413249|NCT04732949|473137199|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
131413250|NCT04732949|473137198|FG000|Overall Study|Non-serious adverse event|1|||
131413251|NCT04732949|473137199|FG001|Overall Study|Non-serious adverse event|3|||
131413252|NCT04732949|473137198|FG000|Overall Study|Lost to Follow-up|26|||
131413253|NCT04732949|473137199|FG001|Overall Study|Lost to Follow-up|27|||
131413254|NCT04732949|473137198|FG000|Overall Study|Other|6|||
131413255|NCT04732949|473137199|FG001|Overall Study|Other|3|||
131413256|NCT00203021|473137202|FG000|Overall Study|Death|4|||
131413257|NCT00203021|473137203|FG001|Overall Study|Death|1|||
131413258|NCT00203021|473137202|FG000|Overall Study|Adverse Event|10|||
131413259|NCT00203021|473137203|FG001|Overall Study|Adverse Event|5|||
131413260|NCT00203021|473137202|FG000|Overall Study|Withdrawal by Subject|45|||
131413261|NCT00203021|473137203|FG001|Overall Study|Withdrawal by Subject|48|||
131413262|NCT00203021|473137202|FG000|Overall Study|Lost to Follow-up|9|||
131413263|NCT00203021|473137203|FG001|Overall Study|Lost to Follow-up|7|||
131413264|NCT00203021|473137202|FG000|Overall Study|Other than specified|11|||
131413265|NCT00203021|473137203|FG001|Overall Study|Other than specified|16|||
131413266|NCT05160766|473137204|FG000|Overall Study|Adverse Event|0|||
131413267|NCT05160766|473137205|FG001|Overall Study|Adverse Event|1|||
131413268|NCT05160766|473137206|FG002|Overall Study|Adverse Event|0|||
131413269|NCT05160766|473137207|FG003|Overall Study|Adverse Event|0|||
131413270|NCT05160766|473137204|FG000|Overall Study|COVID-19 infection|0|||
131413271|NCT05160766|473137205|FG001|Overall Study|COVID-19 infection|1|||
131413272|NCT05160766|473137206|FG002|Overall Study|COVID-19 infection|0|||
131413273|NCT05160766|473137207|FG003|Overall Study|COVID-19 infection|0|||
131413274|NCT05160766|473137204|FG000|Overall Study|travel time|1|||
131944191|NCT01331681|475084873|FG002|Overall Study|Physician Decision|4|||
131944192|NCT01331681|475084871|FG000|Overall Study|Therapeutic procedure required|1|||
131413275|NCT05160766|473137205|FG001|Overall Study|travel time|0|||
131413276|NCT05160766|473137206|FG002|Overall Study|travel time|0|||
131944193|NCT01331681|475084872|FG001|Overall Study|Therapeutic procedure required|0|||
131944194|NCT01331681|475084873|FG002|Overall Study|Therapeutic procedure required|0|||
131944195|NCT01331681|475084871|FG000|Overall Study|Sponsor decision|1|||
131944196|NCT01331681|475084872|FG001|Overall Study|Sponsor decision|1|||
131944197|NCT01331681|475084873|FG002|Overall Study|Sponsor decision|0|||
131944198|NCT01331681|475084871|FG000|Overall Study|Switching to other therapy|0|||
131413277|NCT05160766|473137207|FG003|Overall Study|travel time|1|||
131944199|NCT01331681|475084872|FG001|Overall Study|Switching to other therapy|0|||
131944200|NCT01331681|475084873|FG002|Overall Study|Switching to other therapy|1|||
131455405|NCT02283762|473297101|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
131455406|NCT02283762|473297102|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
131455407|NCT00202878|473297103|FG000|Overall Study|Death|964|||
131455408|NCT00202878|473297104|FG001|Overall Study|Death|968|||
131455409|NCT00202878|473297103|FG000|Overall Study|Only Vital Status Known|357|||
131455410|NCT00202878|473297104|FG001|Overall Study|Only Vital Status Known|356|||
131455411|NCT00202878|473297103|FG000|Overall Study|Lost to Follow-up|44|||
131455412|NCT00202878|473297104|FG001|Overall Study|Lost to Follow-up|49|||
131455413|NCT00202878|473297103|FG000|Overall Study|Site Closure|39|||
131455414|NCT00202878|473297104|FG001|Overall Study|Site Closure|36|||
131455415|NCT00202878|473297103|FG000|Overall Study|Withdrawal by Subject|795|||
131455416|NCT00202878|473297104|FG001|Overall Study|Withdrawal by Subject|808|||
131455417|NCT02920242|473297105|FG000|Overall Study|Withdrawal by Subject|1|||
131944201|NCT01331681|475084871|FG000|Overall Study|Not Received Study Treatment|0|||
131944202|NCT01331681|475084872|FG001|Overall Study|Not Received Study Treatment|0|||
131944203|NCT01331681|475084873|FG002|Overall Study|Not Received Study Treatment|2|||
131413278|NCT05160766|473137204|FG000|Overall Study|Withdrawal by Subject|3|||
131413279|NCT05160766|473137205|FG001|Overall Study|Withdrawal by Subject|5|||
131413280|NCT05160766|473137206|FG002|Overall Study|Withdrawal by Subject|4|||
131413281|NCT05160766|473137207|FG003|Overall Study|Withdrawal by Subject|2|||
131413282|NCT05160766|473137204|FG000|Overall Study|Death|0|||
131413283|NCT05160766|473137205|FG001|Overall Study|Death|0|||
131413284|NCT05160766|473137206|FG002|Overall Study|Death|2|||
131413285|NCT05160766|473137207|FG003|Overall Study|Death|5|||
131413286|NCT05160766|473137204|FG000|Overall Study|Lost to Follow-up|0|||
131413287|NCT05160766|473137205|FG001|Overall Study|Lost to Follow-up|0|||
131413288|NCT05160766|473137206|FG002|Overall Study|Lost to Follow-up|1|||
131413289|NCT05160766|473137207|FG003|Overall Study|Lost to Follow-up|2|||
131413290|NCT05160766|473137204|FG000|Overall Study|No show|0|||
131413291|NCT05160766|473137205|FG001|Overall Study|No show|0|||
131413292|NCT05160766|473137206|FG002|Overall Study|No show|1|||
131413293|NCT05160766|473137207|FG003|Overall Study|No show|1|||
131413294|NCT05160766|473137204|FG000|Overall Study|Physician Decision|0|||
131413295|NCT05160766|473137205|FG001|Overall Study|Physician Decision|0|||
131413296|NCT05160766|473137206|FG002|Overall Study|Physician Decision|0|||
131413297|NCT05160766|473137207|FG003|Overall Study|Physician Decision|1|||
131413298|NCT05160766|473137204|FG000|Overall Study|Protocol Violation|0|||
131413299|NCT05160766|473137205|FG001|Overall Study|Protocol Violation|0|||
131413300|NCT05160766|473137206|FG002|Overall Study|Protocol Violation|1|||
131413301|NCT05160766|473137207|FG003|Overall Study|Protocol Violation|0|||
131413302|NCT02853435|473137208|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
131413303|NCT02853435|473137209|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
131413304|NCT02853435|473137210|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
131413305|NCT02853435|473137211|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
131413306|NCT02853435|473137212|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
131413307|NCT02853435|473137213|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
131413308|NCT03747120|473137216|FG000|Overall Study|treatment related toxicity|3|||
131413309|NCT03747120|473137217|FG001|Overall Study|treatment related toxicity|0|||
131413310|NCT03747120|473137218|FG002|Overall Study|treatment related toxicity|0|||
131413311|NCT03747120|473137216|FG000|Overall Study|Withdrawal by Subject|0|||
131413312|NCT03747120|473137217|FG001|Overall Study|Withdrawal by Subject|1|||
131413313|NCT03747120|473137218|FG002|Overall Study|Withdrawal by Subject|2|||
131413314|NCT03921554|473137227|FG000|Overall Study|Adverse Event|2|||
131413315|NCT03921554|473137227|FG000|Overall Study|Withdrawal by Subject|1|||
131413316|NCT03921554|473137227|FG000|Overall Study|Death|3|||
131413317|NCT01146652|473137232|FG000|Overall Study|Adverse Event|506|||
131413318|NCT01146652|473137233|FG001|Overall Study|Adverse Event|15|||
131413319|NCT01146652|473137232|FG000|Overall Study|Lack of Efficacy|91|||
131413320|NCT01146652|473137233|FG001|Overall Study|Lack of Efficacy|7|||
131413321|NCT01146652|473137232|FG000|Overall Study|Poor compliance to protocol|38|||
131413322|NCT01146652|473137233|FG001|Overall Study|Poor compliance to protocol|1|||
131413323|NCT01146652|473137232|FG000|Overall Study|Other unspecified reasons|314|||
131413324|NCT01146652|473137233|FG001|Overall Study|Other unspecified reasons|22|||
131413325|NCT01146652|473137232|FG000|Overall Study|Enrolled but not treated|2|||
131413326|NCT01146652|473137233|FG001|Overall Study|Enrolled but not treated|0|||
131413327|NCT00159913|473137237|FG000|Overall Study|Adverse Event|1|||
131413328|NCT00159913|473137238|FG001|Overall Study|Adverse Event|0|||
131413329|NCT00159913|473137239|FG002|Overall Study|Adverse Event|1|||
131413330|NCT00159913|473137240|FG003|Overall Study|Adverse Event|0|||
131455418|NCT02920242|473297106|FG001|Overall Study|Withdrawal by Subject|0|||
131944204|NCT00658541|475084875|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131455419|NCT02920242|473297107|FG002|Overall Study|Withdrawal by Subject|1|||
131455420|NCT02920242|473297105|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
131413331|NCT00159913|473137237|FG000|Overall Study|Withdrawal by Subject|0|||
131413332|NCT00159913|473137238|FG001|Overall Study|Withdrawal by Subject|0|||
131413333|NCT00159913|473137239|FG002|Overall Study|Withdrawal by Subject|0|||
131455421|NCT02920242|473297106|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
131944205|NCT00658541|475084876|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131944206|NCT00658541|475084875|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131944207|NCT00658541|475084876|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131944208|NCT00269087|475084877|FG000|Overall Study|Adverse Event|20|||
131944209|NCT00269087|475084877|FG000|Overall Study|Withdrawal by Subject|1|||
131944210|NCT00269087|475084877|FG000|Overall Study|Exacerbation of COPD|13|||
131944211|NCT03326063|475084878|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
131944212|NCT03326063|475084879|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
131944213|NCT03894891|475084880|FG000|Overall Study|Withdrawal by Subject|1|||
131944214|NCT03894891|475084880|FG000|Overall Study|Completed protocol treatment per protocol|5|||
131944215|NCT01824290|475084881|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
131944216|NCT01824290|475084882|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
131944217|NCT01824290|475084883|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
131944218|NCT01824290|475084884|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
131944219|NCT01824290|475084881|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
131944220|NCT01824290|475084882|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
131944221|NCT01824290|475084883|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
131944222|NCT01824290|475084884|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
131944223|NCT01824290|475084881|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
131944224|NCT01824290|475084882|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
131944225|NCT01824290|475084883|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
131944226|NCT01824290|475084884|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
131944227|NCT01824290|475084881|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
131944228|NCT01824290|475084882|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
131944229|NCT01824290|475084883|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
131944230|NCT01824290|475084884|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
131944231|NCT01824290|475084881|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
131944232|NCT01824290|475084882|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
131944233|NCT01824290|475084883|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
131944234|NCT01824290|475084884|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
131944235|NCT01824290|475084881|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
131944236|NCT01824290|475084882|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
131944237|NCT01824290|475084883|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
131944238|NCT01824290|475084884|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
131944239|NCT00421148|475084887|FG000|Overall Study|Lost to Follow-up|0|||
131944240|NCT00421148|475084888|FG001|Overall Study|Lost to Follow-up|0|||
131944241|NCT00421148|475084889|FG002|Overall Study|Lost to Follow-up|0|||
131944242|NCT00421148|475084890|FG003|Overall Study|Lost to Follow-up|0|||
131944243|NCT00421148|475084891|FG004|Overall Study|Lost to Follow-up|0|||
131944244|NCT00421148|475084892|FG005|Overall Study|Lost to Follow-up|0|||
131944245|NCT00421148|475084893|FG006|Overall Study|Lost to Follow-up|0|||
131944246|NCT00421148|475084894|FG007|Overall Study|Lost to Follow-up|0|||
131944247|NCT00421148|475084895|FG008|Overall Study|Lost to Follow-up|0|||
131944248|NCT00421148|475084896|FG009|Overall Study|Lost to Follow-up|0|||
131944249|NCT00421148|475084897|FG010|Overall Study|Lost to Follow-up|0|||
131944250|NCT00421148|475084898|FG011|Overall Study|Lost to Follow-up|0|||
131944251|NCT00421148|475084899|FG012|Overall Study|Lost to Follow-up|0|||
131944252|NCT00421148|475084900|FG013|Overall Study|Lost to Follow-up|0|||
131944253|NCT00421148|475084901|FG014|Overall Study|Lost to Follow-up|0|||
131944254|NCT00421148|475084902|FG015|Overall Study|Lost to Follow-up|0|||
131944255|NCT00421148|475084903|FG016|Overall Study|Lost to Follow-up|0|||
131944256|NCT00421148|475084904|FG017|Overall Study|Lost to Follow-up|1|||
131944257|NCT00421148|475084905|FG018|Overall Study|Lost to Follow-up|0|||
131944258|NCT00421148|475084906|FG019|Overall Study|Lost to Follow-up|0|||
131944259|NCT00421148|475084887|FG000|Overall Study|Withdrawal by Subject|0|||
131944260|NCT00421148|475084888|FG001|Overall Study|Withdrawal by Subject|0|||
131944261|NCT00421148|475084889|FG002|Overall Study|Withdrawal by Subject|0|||
131944262|NCT00421148|475084890|FG003|Overall Study|Withdrawal by Subject|0|||
131944263|NCT00421148|475084891|FG004|Overall Study|Withdrawal by Subject|0|||
131944264|NCT00421148|475084892|FG005|Overall Study|Withdrawal by Subject|0|||
131944265|NCT00421148|475084893|FG006|Overall Study|Withdrawal by Subject|0|||
131944266|NCT00421148|475084894|FG007|Overall Study|Withdrawal by Subject|0|||
131944267|NCT00421148|475084895|FG008|Overall Study|Withdrawal by Subject|0|||
131944268|NCT00421148|475084896|FG009|Overall Study|Withdrawal by Subject|0|||
131944269|NCT00421148|475084897|FG010|Overall Study|Withdrawal by Subject|0|||
131944270|NCT00421148|475084898|FG011|Overall Study|Withdrawal by Subject|0|||
131944271|NCT00421148|475084899|FG012|Overall Study|Withdrawal by Subject|0|||
131944272|NCT00421148|475084900|FG013|Overall Study|Withdrawal by Subject|0|||
131944273|NCT00421148|475084901|FG014|Overall Study|Withdrawal by Subject|0|||
131944274|NCT00421148|475084902|FG015|Overall Study|Withdrawal by Subject|0|||
131944275|NCT00421148|475084903|FG016|Overall Study|Withdrawal by Subject|0|||
131944276|NCT00421148|475084904|FG017|Overall Study|Withdrawal by Subject|1|||
131944277|NCT00421148|475084905|FG018|Overall Study|Withdrawal by Subject|0|||
131944278|NCT00421148|475084906|FG019|Overall Study|Withdrawal by Subject|0|||
131944279|NCT00421148|475084887|FG000|Overall Study|Protocol Violation|0|||
131944280|NCT00421148|475084888|FG001|Overall Study|Protocol Violation|0|||
131944281|NCT00421148|475084889|FG002|Overall Study|Protocol Violation|0|||
131944282|NCT00421148|475084890|FG003|Overall Study|Protocol Violation|0|||
131944283|NCT00421148|475084891|FG004|Overall Study|Protocol Violation|0|||
131944284|NCT00421148|475084892|FG005|Overall Study|Protocol Violation|1|||
131944285|NCT00421148|475084893|FG006|Overall Study|Protocol Violation|0|||
131944286|NCT00421148|475084894|FG007|Overall Study|Protocol Violation|0|||
131944287|NCT00421148|475084895|FG008|Overall Study|Protocol Violation|0|||
131944288|NCT00421148|475084896|FG009|Overall Study|Protocol Violation|0|||
131944289|NCT00421148|475084897|FG010|Overall Study|Protocol Violation|0|||
131944290|NCT00421148|475084898|FG011|Overall Study|Protocol Violation|0|||
131944291|NCT00421148|475084899|FG012|Overall Study|Protocol Violation|0|||
131944292|NCT00421148|475084900|FG013|Overall Study|Protocol Violation|0|||
131944293|NCT00421148|475084901|FG014|Overall Study|Protocol Violation|0|||
131944294|NCT00421148|475084902|FG015|Overall Study|Protocol Violation|0|||
131944295|NCT00421148|475084903|FG016|Overall Study|Protocol Violation|0|||
131944296|NCT00421148|475084904|FG017|Overall Study|Protocol Violation|0|||
131944297|NCT00421148|475084905|FG018|Overall Study|Protocol Violation|1|||
131944298|NCT00421148|475084906|FG019|Overall Study|Protocol Violation|0|||
131944299|NCT03289533|475084908|FG000|Overall Study|Death|12|||
131944300|NCT03289533|475084908|FG000|Overall Study|Terminated from study by sponsor|10|||
131944301|NCT01030822|475084909|FG000|Overall Study|Moved/migrated from study area|6|||
131944302|NCT01030822|475084910|FG001|Overall Study|Moved/migrated from study area|7|||
131944303|NCT01030822|475084911|FG002|Overall Study|Moved/migrated from study area|3|||
131944304|NCT01030822|475084909|FG000|Overall Study|Withdrawal by Subject|16|||
131944305|NCT01030822|475084910|FG001|Overall Study|Withdrawal by Subject|13|||
131944306|NCT01030822|475084911|FG002|Overall Study|Withdrawal by Subject|16|||
131944307|NCT01030822|475084909|FG000|Overall Study|Lost to Follow-up|9|||
131944308|NCT01030822|475084910|FG001|Overall Study|Lost to Follow-up|4|||
131944309|NCT01030822|475084911|FG002|Overall Study|Lost to Follow-up|7|||
131944310|NCT00539240|475084912|FG000|Overall Study|Withdrawal by Subject|0|||
131944311|NCT00539240|475084913|FG001|Overall Study|Withdrawal by Subject|2|||
131944312|NCT00539240|475084914|FG002|Overall Study|Withdrawal by Subject|0|||
131944313|NCT00539240|475084912|FG000|Overall Study|Protocol Violation|1|||
131944314|NCT00539240|475084913|FG001|Overall Study|Protocol Violation|1|||
131944315|NCT00539240|475084914|FG002|Overall Study|Protocol Violation|4|||
131944316|NCT00539240|475084912|FG000|Overall Study|Lost to Follow-up|2|||
131944317|NCT00539240|475084913|FG001|Overall Study|Lost to Follow-up|3|||
131944318|NCT00539240|475084914|FG002|Overall Study|Lost to Follow-up|1|||
131944319|NCT00539240|475084912|FG000|Overall Study|Adverse Event|3|||
131944320|NCT00539240|475084913|FG001|Overall Study|Adverse Event|1|||
131944321|NCT00539240|475084914|FG002|Overall Study|Adverse Event|10|||
131944322|NCT02103062|475084915|FG000|Overall Study|Adverse Event|1|||
131944323|NCT02103062|475084916|FG001|Overall Study|Adverse Event|2|||
131944324|NCT02103062|475084915|FG000|Overall Study|Progressive Disease|17|||
131944325|NCT02103062|475084916|FG001|Overall Study|Progressive Disease|20|||
131944326|NCT02103062|475084915|FG000|Overall Study|Death|0|||
131944327|NCT02103062|475084916|FG001|Overall Study|Death|1|||
131944328|NCT00120627|475084917|FG000|Overall Study|Withdrawal by Subject|5|||
131944329|NCT00120627|475084918|FG001|Overall Study|Withdrawal by Subject|5|||
131944330|NCT04016714|475084919|FG000|Overall Study|Death|1|||
131944331|NCT04016714|475084920|FG001|Overall Study|Death|0|||
131944332|NCT04016714|475084919|FG000|Overall Study|Lost to Follow-up|3|||
131944333|NCT04016714|475084920|FG001|Overall Study|Lost to Follow-up|1|||
131944334|NCT04016714|475084919|FG000|Overall Study|Physician Decision|3|||
131944335|NCT04016714|475084920|FG001|Overall Study|Physician Decision|3|||
131944336|NCT04016714|475084919|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
131944337|NCT04016714|475084920|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
131944338|NCT02030821|475084923|FG000|Overall Study|Physician Decision|2|||
131944339|NCT02030821|475084924|FG001|Overall Study|Physician Decision|2|||
131944340|NCT02030821|475084925|FG002|Overall Study|Physician Decision|5|||
131944341|NCT02030821|475084926|FG003|Overall Study|Physician Decision|2|||
131944342|NCT00716274|475084930|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
131944343|NCT00716274|475084931|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
131944344|NCT00716274|475084932|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
131944345|NCT00716274|475084933|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
131944346|NCT00716274|475084934|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
131944347|NCT00716274|475084935|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
131944348|NCT00716274|475084930|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
131944349|NCT00716274|475084931|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
131944350|NCT00716274|475084932|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
131944351|NCT00716274|475084933|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
131944352|NCT00716274|475084934|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
131944353|NCT00716274|475084935|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
131944354|NCT00716274|475084930|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
131944355|NCT00716274|475084931|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
131944356|NCT00716274|475084932|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
131944357|NCT00716274|475084933|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
131944358|NCT00716274|475084934|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
131944359|NCT00716274|475084935|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
131944360|NCT00716274|475084930|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
131944361|NCT00716274|475084931|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
131944362|NCT00716274|475084932|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
131944363|NCT00716274|475084933|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
131944364|NCT00716274|475084934|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
131944365|NCT00716274|475084935|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
131944366|NCT00716274|475084930|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
131944367|NCT00716274|475084931|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
131944368|NCT00716274|475084932|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
131944369|NCT00716274|475084933|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
131944370|NCT00716274|475084934|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
131944371|NCT00716274|475084935|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
131944372|NCT00716274|475084930|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
131944373|NCT00716274|475084931|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
131944374|NCT00716274|475084932|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
131944375|NCT00716274|475084933|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
131944376|NCT00716274|475084934|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
131944377|NCT00716274|475084935|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
131944378|NCT00716274|475084930|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
131944379|NCT00716274|475084931|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
131944380|NCT00716274|475084932|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
131944381|NCT00716274|475084933|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
131944382|NCT00716274|475084934|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
131944383|NCT00716274|475084935|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
131944384|NCT00716274|475084930|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
131944385|NCT00716274|475084931|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
131944386|NCT00716274|475084932|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
131944387|NCT00716274|475084933|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
131944388|NCT00716274|475084934|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
131944389|NCT00716274|475084935|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
131944390|NCT00716274|475084930|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
131944391|NCT00716274|475084931|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
131944392|NCT00716274|475084932|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
131944393|NCT00716274|475084933|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
131944394|NCT00716274|475084934|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
131944395|NCT00716274|475084935|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
131944396|NCT00716274|475084930|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
131944397|NCT00716274|475084931|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
131944398|NCT00716274|475084932|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
131944399|NCT00716274|475084933|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
131944400|NCT00716274|475084934|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
131944401|NCT00716274|475084935|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
131944402|NCT01932788|475084936|FG000|Overall Study|Protocol Violation|18|||
131944403|NCT01932788|475084937|FG001|Overall Study|Protocol Violation|0|||
131944404|NCT01932788|475084936|FG000|Overall Study|Lost to Follow-up|18|||
131944405|NCT01932788|475084937|FG001|Overall Study|Lost to Follow-up|46|||
131944406|NCT01932788|475084936|FG000|Overall Study|Lack of Efficacy|2|||
131944407|NCT01932788|475084937|FG001|Overall Study|Lack of Efficacy|0|||
131944408|NCT01932788|475084936|FG000|Overall Study|Withdrawal by Subject|0|||
131944409|NCT01932788|475084937|FG001|Overall Study|Withdrawal by Subject|5|||
131944410|NCT01847443|475084938|FG000|Study Period 1|Withdrawal by Subject|0|||
131944411|NCT01847443|475084939|FG001|Study Period 1|Withdrawal by Subject|1|||
131944412|NCT01847443|475084940|FG002|Study Period 1|Withdrawal by Subject|0|||
131944413|NCT01847443|475084941|FG003|Study Period 1|Withdrawal by Subject|0|||
131944414|NCT01847443|475084938|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
131944415|NCT01847443|475084939|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
131944416|NCT01847443|475084940|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
131944417|NCT01847443|475084941|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
131944418|NCT01847443|475084938|FG000|Washout Period Before Study Period 2|Other reason|1|||
131944419|NCT01847443|475084939|FG001|Washout Period Before Study Period 2|Other reason|0|||
131944420|NCT01847443|475084940|FG002|Washout Period Before Study Period 2|Other reason|0|||
131944421|NCT01847443|475084941|FG003|Washout Period Before Study Period 2|Other reason|0|||
131944422|NCT01847443|475084938|FG000|Washout Period Before Study Period 3|Other reason|1|||
131944423|NCT01847443|475084939|FG001|Washout Period Before Study Period 3|Other reason|0|||
131944424|NCT01847443|475084940|FG002|Washout Period Before Study Period 3|Other reason|0|||
131944425|NCT01847443|475084941|FG003|Washout Period Before Study Period 3|Other reason|0|||
131455422|NCT02920242|473297107|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
131455423|NCT01587014|473297108|FG000|Overall Study|Death|2|||
131455424|NCT02948088|473297109|FG000|Overall Study|Lost to Follow-up|8|||
131455425|NCT02948088|473297109|FG000|Overall Study|Death|1|||
131455426|NCT02948088|473297109|FG000|Overall Study|Withdrawal by Subject|4|||
131455427|NCT02948088|473297109|FG000|Overall Study|Other|2|||
131455428|NCT00634101|473297110|FG000|Overall Study|Study Terminated|3|||
131455429|NCT00634101|473297111|FG001|Overall Study|Study Terminated|3|||
131455430|NCT00634101|473297110|FG000|Overall Study|Lost to Follow-up|2|||
131455431|NCT00634101|473297111|FG001|Overall Study|Lost to Follow-up|0|||
131455432|NCT00838513|473297113|FG000|Screening Period|Screen Failure|3|||
131455433|NCT00838513|473297113|FG000|Extension Treatment Period|Death|1|||
131455434|NCT00838513|473297113|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
131455435|NCT00573144|473297120|FG000|Overall Study|Withdrawal by Subject|2|||
131455436|NCT00573144|473297121|FG001|Overall Study|Withdrawal by Subject|3|||
131455437|NCT02367833|473297123|FG000|Overall Study|Withdrawal by Subject|1|||
131455438|NCT02367833|473297124|FG001|Overall Study|Withdrawal by Subject|1|||
131455439|NCT02367833|473297125|FG002|Overall Study|Withdrawal by Subject|0|||
131455440|NCT01077076|473297126|FG000|First Intervention|Withdrawal by Subject|1|||
131455441|NCT01077076|473297127|FG001|First Intervention|Withdrawal by Subject|0|||
131455442|NCT01077076|473297128|FG002|First Intervention|Withdrawal by Subject|0|||
131455443|NCT01077076|473297129|FG003|First Intervention|Withdrawal by Subject|0|||
131455444|NCT01077076|473297130|FG004|First Intervention|Withdrawal by Subject|0|||
131455445|NCT01077076|473297131|FG005|First Intervention|Withdrawal by Subject|0|||
131455446|NCT01077076|473297126|FG000|Third Intervention|Death in the participant's family|0|||
131455447|NCT01077076|473297127|FG001|Third Intervention|Death in the participant's family|0|||
131455448|NCT01077076|473297128|FG002|Third Intervention|Death in the participant's family|0|||
131455449|NCT01077076|473297129|FG003|Third Intervention|Death in the participant's family|0|||
131455450|NCT01077076|473297130|FG004|Third Intervention|Death in the participant's family|0|||
131455451|NCT01077076|473297131|FG005|Third Intervention|Death in the participant's family|1|||
131455452|NCT00035932|473297132|FG000|Overall Study|Adverse Event|10|||
131455453|NCT00035932|473297133|FG001|Overall Study|Adverse Event|9|||
131455454|NCT00035932|473297134|FG002|Overall Study|Adverse Event|9|||
131455455|NCT00035932|473297132|FG000|Overall Study|Death|0|||
131455456|NCT00035932|473297133|FG001|Overall Study|Death|0|||
131455457|NCT00035932|473297134|FG002|Overall Study|Death|1|||
131944426|NCT01847443|475084938|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
131944427|NCT01847443|475084939|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
131455458|NCT00035932|473297132|FG000|Overall Study|Disease Progression / Relapse|1|||
131455459|NCT00035932|473297133|FG001|Overall Study|Disease Progression / Relapse|1|||
131455460|NCT00035932|473297134|FG002|Overall Study|Disease Progression / Relapse|0|||
131455461|NCT00035932|473297132|FG000|Overall Study|Lost to Follow-up|4|||
131455462|NCT00035932|473297133|FG001|Overall Study|Lost to Follow-up|4|||
131455463|NCT00035932|473297134|FG002|Overall Study|Lost to Follow-up|3|||
131455464|NCT00035932|473297132|FG000|Overall Study|Noncompliance|6|||
131455465|NCT00035932|473297133|FG001|Overall Study|Noncompliance|7|||
131455466|NCT00035932|473297134|FG002|Overall Study|Noncompliance|6|||
131455467|NCT00035932|473297132|FG000|Overall Study|Protocol Violation While on Study|0|||
131455468|NCT00035932|473297133|FG001|Overall Study|Protocol Violation While on Study|1|||
131455469|NCT00035932|473297134|FG002|Overall Study|Protocol Violation While on Study|2|||
131455470|NCT00035932|473297132|FG000|Overall Study|Withdrawal by Subject|1|||
131455471|NCT00035932|473297133|FG001|Overall Study|Withdrawal by Subject|5|||
131455472|NCT00035932|473297134|FG002|Overall Study|Withdrawal by Subject|0|||
131944428|NCT01847443|475084940|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
131944429|NCT01847443|475084941|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
131944430|NCT01847443|475084938|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
131944431|NCT01847443|475084939|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
131944432|NCT01847443|475084940|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
131944433|NCT01847443|475084941|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
131944434|NCT02015039|475084957|FG000|Overall Study|Not eligible|0|||
131455473|NCT00035932|473297132|FG000|Overall Study|Study Termination by Sponsor|1|||
131455474|NCT00035932|473297133|FG001|Overall Study|Study Termination by Sponsor|0|||
131455475|NCT00035932|473297134|FG002|Overall Study|Study Termination by Sponsor|0|||
131455476|NCT00035932|473297132|FG000|Overall Study|Lack of Efficacy|33|||
131455477|NCT00035932|473297133|FG001|Overall Study|Lack of Efficacy|33|||
131455478|NCT00035932|473297134|FG002|Overall Study|Lack of Efficacy|28|||
131455479|NCT01388335|473297135|FG000|Period 1|Progressive Disease|1|||
131455480|NCT01388335|473297135|FG000|Period 2|Progressive Disease|2|||
131455481|NCT01388335|473297135|FG000|Period 2|Sponsor Decision|1|||
131455482|NCT01388335|473297135|FG000|Safety Extension|Progressive Disease|7|||
131455483|NCT00889720|473297138|FG000|Overall Study|Withdrawal by Subject|4|||
131455484|NCT00889720|473297138|FG000|Overall Study|Other|4|||
131455485|NCT00670306|473297139|FG000|Overall Study|Adverse Event|8|||
131455486|NCT00670306|473297139|FG000|Overall Study|Lack of Efficacy|10|||
131455487|NCT00670306|473297139|FG000|Overall Study|Withdrawal by Subject|9|||
131944435|NCT02015039|475084958|FG001|Overall Study|Not eligible|1|||
131944436|NCT01897532|475084962|FG000|Discontinuation From Treatment|Not Treated|7|||
131944437|NCT01897532|475084963|FG001|Discontinuation From Treatment|Not Treated|5|||
131944438|NCT01897532|475084962|FG000|Discontinuation From Treatment|Other reason than specified|196|||
131944439|NCT01897532|475084963|FG001|Discontinuation From Treatment|Other reason than specified|176|||
131944440|NCT01897532|475084962|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
131944441|NCT01897532|475084963|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
131944442|NCT01897532|475084962|FG000|Discontinuation From Treatment|Non compliance|24|||
131944443|NCT01897532|475084963|FG001|Discontinuation From Treatment|Non compliance|15|||
131944444|NCT01897532|475084962|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
131413334|NCT00159913|473137240|FG003|Overall Study|Withdrawal by Subject|1|||
131413335|NCT00159913|473137237|FG000|Overall Study|Lost to Follow-up|0|||
131413336|NCT00159913|473137238|FG001|Overall Study|Lost to Follow-up|0|||
131413337|NCT00159913|473137239|FG002|Overall Study|Lost to Follow-up|0|||
131413338|NCT00159913|473137240|FG003|Overall Study|Lost to Follow-up|1|||
131413339|NCT00159913|473137237|FG000|Overall Study|Protocol Violation|1|||
131944445|NCT01897532|475084963|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
131944446|NCT01897532|475084962|FG000|Discontinuation From Trial|Not Treated|7|||
131944447|NCT01897532|475084963|FG001|Discontinuation From Trial|Not Treated|5|||
131944448|NCT01897532|475084962|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
131944449|NCT01897532|475084963|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
131944450|NCT03132467|475084964|FG000|Overall Study|Adverse Event|2|||
131944451|NCT03132467|475084964|FG000|Overall Study|Withdrawal by Subject|2|||
131944452|NCT03559270|475084967|FG000|Overall Study|Adverse Event|6|||
131944453|NCT03559270|475084968|FG001|Overall Study|Adverse Event|5|||
131944454|NCT03559270|475084969|FG002|Overall Study|Adverse Event|3|||
131944455|NCT03559270|475084970|FG003|Overall Study|Adverse Event|0|||
131944456|NCT03559270|475084967|FG000|Overall Study|Lack of Efficacy|34|||
131944457|NCT03559270|475084968|FG001|Overall Study|Lack of Efficacy|52|||
131944458|NCT03559270|475084969|FG002|Overall Study|Lack of Efficacy|37|||
131944459|NCT03559270|475084970|FG003|Overall Study|Lack of Efficacy|2|||
131944460|NCT03559270|475084967|FG000|Overall Study|Death|0|||
131944461|NCT03559270|475084968|FG001|Overall Study|Death|2|||
131944462|NCT03559270|475084969|FG002|Overall Study|Death|0|||
131944463|NCT03559270|475084970|FG003|Overall Study|Death|0|||
131944464|NCT03559270|475084967|FG000|Overall Study|Lost to Follow-up|16|||
131944465|NCT03559270|475084968|FG001|Overall Study|Lost to Follow-up|4|||
131944466|NCT03559270|475084969|FG002|Overall Study|Lost to Follow-up|12|||
131944467|NCT03559270|475084970|FG003|Overall Study|Lost to Follow-up|3|||
131944468|NCT03559270|475084967|FG000|Overall Study|Sponsor Decision|38|||
131944469|NCT03559270|475084968|FG001|Overall Study|Sponsor Decision|31|||
131944470|NCT03559270|475084969|FG002|Overall Study|Sponsor Decision|35|||
131944471|NCT03559270|475084970|FG003|Overall Study|Sponsor Decision|18|||
131944472|NCT03559270|475084967|FG000|Overall Study|Withdrawal by Subject|19|||
131944473|NCT03559270|475084968|FG001|Overall Study|Withdrawal by Subject|21|||
131944474|NCT03559270|475084969|FG002|Overall Study|Withdrawal by Subject|18|||
131944475|NCT03559270|475084970|FG003|Overall Study|Withdrawal by Subject|7|||
131944476|NCT03559270|475084967|FG000|Overall Study|Physician Decision|3|||
131944477|NCT03559270|475084968|FG001|Overall Study|Physician Decision|2|||
131944478|NCT03559270|475084969|FG002|Overall Study|Physician Decision|1|||
131944479|NCT03559270|475084970|FG003|Overall Study|Physician Decision|0|||
131944480|NCT03559270|475084967|FG000|Overall Study|Pregnancy|0|||
131944481|NCT03559270|475084968|FG001|Overall Study|Pregnancy|1|||
131944482|NCT03559270|475084969|FG002|Overall Study|Pregnancy|0|||
131944483|NCT03559270|475084970|FG003|Overall Study|Pregnancy|0|||
131413340|NCT00159913|473137238|FG001|Overall Study|Protocol Violation|0|||
131413341|NCT00159913|473137239|FG002|Overall Study|Protocol Violation|1|||
131413342|NCT00159913|473137240|FG003|Overall Study|Protocol Violation|0|||
131413343|NCT01318070|473137241|FG000|Overall Study|Adverse Event|1|||
131413344|NCT01318070|473137242|FG001|Overall Study|Adverse Event|1|||
131413345|NCT01318070|473137243|FG002|Overall Study|Adverse Event|5|||
131413346|NCT01318070|473137241|FG000|Overall Study|Withdrawal by Subject|0|||
131413347|NCT01318070|473137242|FG001|Overall Study|Withdrawal by Subject|1|||
131413348|NCT01318070|473137243|FG002|Overall Study|Withdrawal by Subject|1|||
131413349|NCT01318070|473137241|FG000|Overall Study|Lack of Efficacy|0|||
131413350|NCT01318070|473137242|FG001|Overall Study|Lack of Efficacy|0|||
131413351|NCT01318070|473137243|FG002|Overall Study|Lack of Efficacy|1|||
131413352|NCT01318070|473137241|FG000|Overall Study|Principal Investigator Discretion|1|||
131944484|NCT03559270|475084967|FG000|Overall Study|Protocol Violation|1|||
131944485|NCT03559270|475084968|FG001|Overall Study|Protocol Violation|0|||
131944486|NCT03559270|475084969|FG002|Overall Study|Protocol Violation|2|||
131944487|NCT03559270|475084970|FG003|Overall Study|Protocol Violation|0|||
131413353|NCT01318070|473137242|FG001|Overall Study|Principal Investigator Discretion|0|||
131413354|NCT01318070|473137243|FG002|Overall Study|Principal Investigator Discretion|0|||
131413355|NCT01287195|473137246|FG000|Overall Study|Withdrawal by Subject|2|||
131944488|NCT04472650|475086429|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
131944489|NCT04472650|475086430|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
131944490|NCT00937495|475086437|FG000|Overall Study|Protocol Violation|2|||
131944491|NCT00661830|475086442|FG000|Overall Study|Death|37|||
131944492|NCT00661830|475086443|FG001|Overall Study|Death|33|||
131944493|NCT00661830|475086442|FG000|Overall Study|Lost to Follow-up|1|||
131944494|NCT00661830|475086443|FG001|Overall Study|Lost to Follow-up|3|||
131944495|NCT00661830|475086442|FG000|Overall Study|Withdrawal by Subject|1|||
131944496|NCT00661830|475086443|FG001|Overall Study|Withdrawal by Subject|1|||
131944497|NCT00661830|475086442|FG000|Overall Study|Other reason|1|||
131944498|NCT00661830|475086443|FG001|Overall Study|Other reason|5|||
131944499|NCT01535287|475086446|FG000|Overall Study|drug not prepared in time|5|||
131944500|NCT01535287|475086447|FG001|Overall Study|drug not prepared in time|6|||
131944501|NCT00980148|475086448|FG000|Overall Study|Discharged from facility|89|||
131944502|NCT00980148|475086449|FG001|Overall Study|Discharged from facility|96|||
131944503|NCT00980148|475086448|FG000|Overall Study|Received other antichlamydia treatment|20|||
131944504|NCT00980148|475086449|FG001|Overall Study|Received other antichlamydia treatment|14|||
131944505|NCT00980148|475086448|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
131944506|NCT00980148|475086449|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
131944507|NCT00980148|475086448|FG000|Overall Study|Various other reasons|8|||
131944508|NCT00980148|475086449|FG001|Overall Study|Various other reasons|9|||
131944509|NCT00775268|475086459|FG000|Baseline|Drug not synthesize dose|1|||
131944510|NCT00775268|475086460|FG001|Baseline|Drug not synthesize dose|0|||
131944511|NCT00775268|475086459|FG000|Baseline|Not treated-ineligible per CT|0|||
131944512|NCT00775268|475086460|FG001|Baseline|Not treated-ineligible per CT|1|||
131944513|NCT00775268|475086459|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
131944514|NCT00775268|475086460|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
131944515|NCT00775268|475086459|FG000|After Completion|Participant missed scan appointment|1|||
131944516|NCT00775268|475086460|FG001|After Completion|Participant missed scan appointment|0|||
131944517|NCT02383862|475086461|FG000|3 Month Follow up|Lost to Follow-up|23|||
131944518|NCT02383862|475086462|FG001|3 Month Follow up|Lost to Follow-up|21|||
131944519|NCT01833494|475086463|FG000|Overall Study|Adverse Event|24|||
131944520|NCT01833494|475086463|FG000|Overall Study|Physician Decision|6|||
131944521|NCT01833494|475086463|FG000|Overall Study|Withdrawal by Subject|6|||
131944522|NCT01833494|475086463|FG000|Overall Study|Decrease in serum phosphorus|4|||
131944523|NCT01833494|475086463|FG000|Overall Study|Decrease in serum calcium|4|||
131944524|NCT01833494|475086463|FG000|Overall Study|Increase in serum ferritin|1|||
131944525|NCT01673646|475086477|FG000|Overall Study|Adverse Event|2|||
131944526|NCT01673646|475086478|FG001|Overall Study|Adverse Event|1|||
131944527|NCT01673646|475086479|FG002|Overall Study|Adverse Event|1|||
131944528|NCT01673646|475086477|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131944529|NCT01673646|475086478|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131944530|NCT01673646|475086479|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131944531|NCT01673646|475086477|FG000|Overall Study|Condition no longer requires study drug|0|||
131944532|NCT01673646|475086478|FG001|Overall Study|Condition no longer requires study drug|1|||
131944533|NCT01673646|475086479|FG002|Overall Study|Condition no longer requires study drug|0|||
131944534|NCT01673646|475086477|FG000|Overall Study|Withdrawal by Subject|0|||
131944535|NCT01673646|475086478|FG001|Overall Study|Withdrawal by Subject|2|||
131944536|NCT01673646|475086479|FG002|Overall Study|Withdrawal by Subject|2|||
131944537|NCT01673646|475086477|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
131944538|NCT01673646|475086478|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
131944539|NCT01673646|475086479|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
131944540|NCT01881009|475086480|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
131944541|NCT01881009|475086481|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
131944542|NCT03064074|475086482|FG000|Overall Study|Physician Decision|0|||
131944543|NCT03064074|475086483|FG001|Overall Study|Physician Decision|0|||
131944544|NCT03064074|475086484|FG002|Overall Study|Physician Decision|0|||
131944545|NCT03064074|475086485|FG003|Overall Study|Physician Decision|1|||
131944546|NCT01194245|475086489|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
131944547|NCT01194245|475086490|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
131944548|NCT01194245|475086491|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
131944549|NCT01194245|475086492|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
131944550|NCT01194245|475086493|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
131944551|NCT01194245|475086489|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
131413356|NCT00530920|473137248|FG000|Overall Study|Randomized but not treated|0|||
131944552|NCT01194245|475086490|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
131944553|NCT01194245|475086491|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
131944554|NCT01194245|475086492|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
131944555|NCT01194245|475086493|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
131944556|NCT01194245|475086489|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
131944557|NCT01194245|475086490|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
131944558|NCT01194245|475086491|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
131944559|NCT01194245|475086492|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
131944560|NCT01194245|475086493|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
131944561|NCT01194245|475086489|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
131944562|NCT01194245|475086490|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
131944563|NCT01194245|475086491|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
131944564|NCT01194245|475086492|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
131944565|NCT01194245|475086493|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
131944566|NCT01194245|475086489|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131944567|NCT01194245|475086490|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131944568|NCT01194245|475086491|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131944569|NCT01194245|475086492|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131944570|NCT01194245|475086493|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
131944571|NCT01194245|475086489|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131944572|NCT01194245|475086490|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131944573|NCT01194245|475086491|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
131944574|NCT01194245|475086492|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
131944575|NCT01194245|475086493|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
131944576|NCT01876381|475086495|FG000|Overall Study|Lack of Efficacy|5|||
131944577|NCT01876381|475086495|FG000|Overall Study|Physician Decision|1|||
131944578|NCT01876381|475086495|FG000|Overall Study|Withdrawal by Subject|1|||
131944579|NCT02803203|475086496|FG000|Overall Study|Adverse Event|4|||
131944580|NCT02803203|475086496|FG000|Overall Study|Death|4|||
131944581|NCT02803203|475086496|FG000|Overall Study|Progressive disease|29|||
131944582|NCT02803203|475086496|FG000|Overall Study|Withdrawal by Subject|8|||
131944583|NCT02803203|475086496|FG000|Overall Study|Complete resection of target disease|2|||
131944584|NCT02803203|475086496|FG000|Overall Study|Switched to commercial Osi|1|||
131944585|NCT02803203|475086496|FG000|Overall Study|Participant moved away|1|||
131944586|NCT00533429|475086497|FG000|Overall Study|Adverse Event|3|||
131944587|NCT00533429|475086498|FG001|Overall Study|Adverse Event|1|||
131944588|NCT00533429|475086497|FG000|Overall Study|Death|1|||
131944589|NCT00533429|475086498|FG001|Overall Study|Death|0|||
131944590|NCT00533429|475086497|FG000|Overall Study|Withdrawal by Subject|2|||
131944591|NCT00533429|475086498|FG001|Overall Study|Withdrawal by Subject|0|||
131944592|NCT00533429|475086497|FG000|Overall Study|Progressive Disease|12|||
131944593|NCT00533429|475086498|FG001|Overall Study|Progressive Disease|13|||
131944594|NCT00533429|475086497|FG000|Overall Study|Symptomatic deterioration|1|||
131944595|NCT00533429|475086498|FG001|Overall Study|Symptomatic deterioration|2|||
131944596|NCT04577781|475086499|FG000|Overall Study|Adverse Event|2|||
131944597|NCT04577781|475086500|FG001|Overall Study|Adverse Event|2|||
131944598|NCT04577781|475086499|FG000|Overall Study|Physician Decision|1|||
131944599|NCT04577781|475086500|FG001|Overall Study|Physician Decision|0|||
131944600|NCT01464879|475086501|FG000|Overall Study|Physician Decision|1|||
131944601|NCT01464879|475086501|FG000|Overall Study|Non-compliance|1|||
131944602|NCT01193101|475086505|FG000|Overall Study|Adverse Event|0|||
131944603|NCT01193101|475086506|FG001|Overall Study|Adverse Event|1|||
131944604|NCT01193101|475086507|FG002|Overall Study|Adverse Event|1|||
131944605|NCT01193101|475086508|FG003|Overall Study|Adverse Event|3|||
131944606|NCT01193101|475086505|FG000|Overall Study|Lack of Efficacy|3|||
131944607|NCT01193101|475086506|FG001|Overall Study|Lack of Efficacy|1|||
131944608|NCT01193101|475086507|FG002|Overall Study|Lack of Efficacy|0|||
131944609|NCT01193101|475086508|FG003|Overall Study|Lack of Efficacy|8|||
131944610|NCT01193101|475086505|FG000|Overall Study|Withdrawal by Subject|2|||
131944611|NCT01193101|475086506|FG001|Overall Study|Withdrawal by Subject|4|||
131944612|NCT01193101|475086507|FG002|Overall Study|Withdrawal by Subject|1|||
131944613|NCT01193101|475086508|FG003|Overall Study|Withdrawal by Subject|1|||
131944614|NCT01193101|475086505|FG000|Overall Study|Administrative problems|0|||
131944615|NCT01193101|475086506|FG001|Overall Study|Administrative problems|0|||
131944616|NCT01193101|475086507|FG002|Overall Study|Administrative problems|1|||
131944617|NCT01193101|475086508|FG003|Overall Study|Administrative problems|0|||
131944618|NCT01193101|475086505|FG000|Overall Study|Abnormal test procedure results|0|||
131944619|NCT01193101|475086506|FG001|Overall Study|Abnormal test procedure results|1|||
131944620|NCT01193101|475086507|FG002|Overall Study|Abnormal test procedure results|0|||
131944621|NCT01193101|475086508|FG003|Overall Study|Abnormal test procedure results|0|||
131944622|NCT02347085|475086511|FG000|Overall Study|Adverse Event|2|||
131944623|NCT02347085|475086511|FG000|Overall Study|Lack of Efficacy|1|||
131944624|NCT02347085|475086511|FG000|Overall Study|Withdrawal by Subject|4|||
131944625|NCT02347085|475086511|FG000|Overall Study|Lost to Follow-up|1|||
131944626|NCT02347085|475086511|FG000|Overall Study|Protocol Criteria|2|||
131944627|NCT04389866|475086514|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
131944628|NCT04389866|475086515|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
131944629|NCT00800982|475086518|FG000|Overall Study|Lost to Follow-up|1|||
131944630|NCT00800982|475086519|FG001|Overall Study|Lost to Follow-up|2|||
131944631|NCT00800982|475086518|FG000|Overall Study|Withdrawal by Subject|0|||
131944632|NCT00800982|475086519|FG001|Overall Study|Withdrawal by Subject|1|||
131944633|NCT00800982|475086518|FG000|Overall Study|Patient moved out of state|1|||
131944634|NCT00800982|475086519|FG001|Overall Study|Patient moved out of state|0|||
131944635|NCT01490918|475086520|FG000|Overall Study|Lost to Follow-up|2|||
131944636|NCT01490918|475086521|FG001|Overall Study|Lost to Follow-up|1|||
131944637|NCT01490918|475086522|FG002|Overall Study|Lost to Follow-up|0|||
131944638|NCT01490918|475086520|FG000|Overall Study|Withdrawal by Subject|7|||
131944639|NCT01490918|475086521|FG001|Overall Study|Withdrawal by Subject|8|||
131944640|NCT01490918|475086522|FG002|Overall Study|Withdrawal by Subject|3|||
131944641|NCT01490918|475086520|FG000|Overall Study|Adverse Event|0|||
131944642|NCT01490918|475086521|FG001|Overall Study|Adverse Event|0|||
131944643|NCT01490918|475086522|FG002|Overall Study|Adverse Event|1|||
131944644|NCT01490918|475086520|FG000|Overall Study|other cause|4|||
131944645|NCT01490918|475086521|FG001|Overall Study|other cause|5|||
131944646|NCT01490918|475086522|FG002|Overall Study|other cause|8|||
131944647|NCT00648037|475086527|FG000|Overall Study|Not Treated|1|||
131944648|NCT00648037|475086527|FG000|Overall Study|Withdrawal by Subject|1|||
131944649|NCT00648037|475086527|FG000|Overall Study|Adverse Event|11|||
131944650|NCT00648037|475086527|FG000|Overall Study|Relapse|2|||
131944651|NCT00648037|475086527|FG000|Overall Study|Other|1|||
131944652|NCT02967679|475086529|FG000|Overall Study|Adverse Event|1|||
131944653|NCT00600067|475086531|FG000|Overall Study|Adverse Event|0|||
131944654|NCT00600067|475086532|FG001|Overall Study|Adverse Event|1|||
131944655|NCT00600067|475086531|FG000|Overall Study|Lost to Follow-up|2|||
131944656|NCT00600067|475086532|FG001|Overall Study|Lost to Follow-up|3|||
131944657|NCT00600067|475086531|FG000|Overall Study|protocol non-compliance|0|||
131944658|NCT00600067|475086532|FG001|Overall Study|protocol non-compliance|3|||
131944659|NCT00600067|475086531|FG000|Overall Study|Lack of Efficacy|1|||
131944660|NCT00600067|475086532|FG001|Overall Study|Lack of Efficacy|0|||
131944661|NCT02737501|475086535|FG000|Randomized Phase|Died|41|||
131944662|NCT02737501|475086536|FG001|Randomized Phase|Died|29|||
131944663|NCT02737501|475086537|FG002|Randomized Phase|Died|0|||
131944664|NCT02737501|475086535|FG000|Randomized Phase|Withdrawal by Subject|16|||
131944665|NCT02737501|475086536|FG001|Randomized Phase|Withdrawal by Subject|6|||
131944666|NCT02737501|475086537|FG002|Randomized Phase|Withdrawal by Subject|0|||
131944667|NCT02737501|475086535|FG000|Randomized Phase|Lost to Follow-up|0|||
131944668|NCT02737501|475086536|FG001|Randomized Phase|Lost to Follow-up|1|||
131944669|NCT02737501|475086537|FG002|Randomized Phase|Lost to Follow-up|0|||
131944670|NCT02737501|475086535|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
131944671|NCT02737501|475086536|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
131944672|NCT02737501|475086537|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
131944673|NCT02737501|475086535|FG000|Randomized Phase|Reason not Specified|1|||
131413357|NCT00530920|473137249|FG001|Overall Study|Randomized but not treated|2|||
131413358|NCT00530920|473137250|FG002|Overall Study|Randomized but not treated|0|||
131413359|NCT00530920|473137248|FG000|Overall Study|Adverse Event|0|||
131413360|NCT00530920|473137249|FG001|Overall Study|Adverse Event|0|||
131413361|NCT00530920|473137250|FG002|Overall Study|Adverse Event|3|||
131413362|NCT00530920|473137248|FG000|Overall Study|Withdrawal by Subject|0|||
131413363|NCT00530920|473137249|FG001|Overall Study|Withdrawal by Subject|0|||
131413364|NCT00530920|473137250|FG002|Overall Study|Withdrawal by Subject|1|||
131413365|NCT04957758|473137252|FG000|Overall Study|Adverse Event|1|||
131413366|NCT04957758|473137253|FG001|Overall Study|Adverse Event|0|||
131413367|NCT04957758|473137252|FG000|Overall Study|Lost to Follow-up|0|||
131413368|NCT04957758|473137253|FG001|Overall Study|Lost to Follow-up|2|||
131413369|NCT04957758|473137252|FG000|Overall Study|Withdrawal by Subject|4|||
131413370|NCT04957758|473137253|FG001|Overall Study|Withdrawal by Subject|2|||
131413371|NCT04957758|473137252|FG000|Overall Study|Protocol Violation|0|||
131944674|NCT02737501|475086536|FG001|Randomized Phase|Reason not Specified|1|||
131944675|NCT02737501|475086537|FG002|Randomized Phase|Reason not Specified|0|||
131944676|NCT02737501|475086535|FG000|Randomized Phase|Never Treated|1|||
131944677|NCT02737501|475086536|FG001|Randomized Phase|Never Treated|1|||
131944678|NCT02737501|475086537|FG002|Randomized Phase|Never Treated|0|||
131944679|NCT02737501|475086535|FG000|Crossover Phase|Died|0|||
131944680|NCT02737501|475086536|FG001|Crossover Phase|Died|0|||
131944681|NCT02737501|475086537|FG002|Crossover Phase|Died|22|||
131944682|NCT02737501|475086535|FG000|Crossover Phase|Withdrew Consent|0|||
131944683|NCT02737501|475086536|FG001|Crossover Phase|Withdrew Consent|0|||
131944684|NCT02737501|475086537|FG002|Crossover Phase|Withdrew Consent|9|||
131944685|NCT02737501|475086535|FG000|Crossover Phase|Physician Decision|0|||
131944686|NCT02737501|475086536|FG001|Crossover Phase|Physician Decision|0|||
131944687|NCT02737501|475086537|FG002|Crossover Phase|Physician Decision|1|||
131944688|NCT02737501|475086535|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
131944689|NCT02737501|475086536|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
131944690|NCT02737501|475086537|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
131944691|NCT03571971|475086538|FG000|Overall Study|Lost to Follow-up|2|||
131944692|NCT03571971|475086539|FG001|Overall Study|Lost to Follow-up|2|||
131413372|NCT04957758|473137253|FG001|Overall Study|Protocol Violation|1|||
131413373|NCT00707746|473137254|FG000|Treatment Period|Adverse Event|2|||
131413374|NCT00707746|473137255|FG001|Treatment Period|Adverse Event|4|||
131944693|NCT03571971|475086538|FG000|Overall Study|Protocol Violation|2|||
131944694|NCT03571971|475086539|FG001|Overall Study|Protocol Violation|3|||
131944695|NCT03571971|475086538|FG000|Overall Study|Withdrawal by Subject|2|||
131944696|NCT03571971|475086539|FG001|Overall Study|Withdrawal by Subject|0|||
131944697|NCT03571971|475086538|FG000|Overall Study|Incomplete primary outcome data|2|||
131944698|NCT03571971|475086539|FG001|Overall Study|Incomplete primary outcome data|0|||
131944699|NCT04067492|475086540|FG000|Overall Study|Lost to Follow-up|0|||
131944700|NCT04067492|475086541|FG001|Overall Study|Lost to Follow-up|0|||
131944701|NCT04067492|475086542|FG002|Overall Study|Lost to Follow-up|0|||
131944702|NCT04067492|475086543|FG003|Overall Study|Lost to Follow-up|0|||
131944703|NCT04067492|475086544|FG004|Overall Study|Lost to Follow-up|0|||
131944704|NCT04067492|475086545|FG005|Overall Study|Lost to Follow-up|1|||
131944705|NCT04067492|475086540|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
131944706|NCT04067492|475086541|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
131944707|NCT04067492|475086542|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
131944708|NCT04067492|475086543|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
131944709|NCT04067492|475086544|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
131944710|NCT04067492|475086545|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
131944711|NCT04067492|475086540|FG000|Overall Study|COVID-19 epidemiological situation|0|||
131944712|NCT04067492|475086541|FG001|Overall Study|COVID-19 epidemiological situation|0|||
131944713|NCT04067492|475086542|FG002|Overall Study|COVID-19 epidemiological situation|0|||
131944714|NCT04067492|475086543|FG003|Overall Study|COVID-19 epidemiological situation|1|||
131944715|NCT04067492|475086544|FG004|Overall Study|COVID-19 epidemiological situation|0|||
131944716|NCT04067492|475086545|FG005|Overall Study|COVID-19 epidemiological situation|0|||
131944717|NCT00833027|475086546|FG000|Overall Study|Adverse Event|33|||
131944718|NCT00833027|475086546|FG000|Overall Study|Death|1|||
131944719|NCT00833027|475086546|FG000|Overall Study|Lack of Efficacy|12|||
131944720|NCT00833027|475086546|FG000|Overall Study|Lost to Follow-up|24|||
131944721|NCT00833027|475086546|FG000|Overall Study|Protocol Violation|115|||
131944722|NCT00833027|475086546|FG000|Overall Study|Withdrawal by Subject|16|||
131944723|NCT00833027|475086546|FG000|Overall Study|Missing|10|||
131944724|NCT02806414|475086556|FG000|Overall Study|Lost to Follow-up|2|||
131944725|NCT03092479|475086557|FG000|Overall Study|Lost to Follow-up|3|||
131944726|NCT03092479|475086558|FG001|Overall Study|Lost to Follow-up|2|||
131944727|NCT03092479|475086557|FG000|Overall Study|Withdrawal by Subject|4|||
131944728|NCT03092479|475086558|FG001|Overall Study|Withdrawal by Subject|0|||
131944729|NCT00543985|475086559|FG000|Overall Study|Withdrawal by Subject|4|||
131944730|NCT00444106|475086560|FG000|Overall Study|Lost to Follow-up|2|||
131944731|NCT00444106|475086561|FG001|Overall Study|Lost to Follow-up|1|||
131944732|NCT00444106|475086562|FG002|Overall Study|Lost to Follow-up|0|||
131944733|NCT00444106|475086560|FG000|Overall Study|Abnormal Test Procedure Results|0|||
131944734|NCT00444106|475086561|FG001|Overall Study|Abnormal Test Procedure Results|0|||
131944735|NCT00444106|475086562|FG002|Overall Study|Abnormal Test Procedure Results|1|||
131944736|NCT04046939|475086563|FG000|Primary Assessment Period|Adverse Event|1|||
131944737|NCT04046939|475086564|FG001|Primary Assessment Period|Adverse Event|0|||
131944738|NCT04046939|475086565|FG002|Primary Assessment Period|Adverse Event|0|||
131944739|NCT04046939|475086566|FG003|Primary Assessment Period|Adverse Event|0|||
131944740|NCT04046939|475086563|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
131944741|NCT04046939|475086564|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
131944742|NCT04046939|475086565|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
131944743|NCT04046939|475086566|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
131944744|NCT04046939|475086563|FG000|Primary Assessment Period|Physician Decision|0|||
131944745|NCT04046939|475086564|FG001|Primary Assessment Period|Physician Decision|0|||
131944746|NCT04046939|475086565|FG002|Primary Assessment Period|Physician Decision|1|||
131944747|NCT04046939|475086566|FG003|Primary Assessment Period|Physician Decision|0|||
131944748|NCT04046939|475086563|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
131944749|NCT04046939|475086564|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
131944750|NCT04046939|475086565|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
131944751|NCT04046939|475086566|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
131944752|NCT00403130|475086567|FG000|2 Years From Start of Treatment|Not Eligible|3|||
131944753|NCT00403130|475086567|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
131944754|NCT00403130|475086567|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
131944755|NCT00403130|475086567|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
131944756|NCT00806260|475086568|FG000|Period 1 (1 Day)|Adverse Event|0|||
131944757|NCT00806260|475086569|FG001|Period 1 (1 Day)|Adverse Event|0|||
131944758|NCT00806260|475086570|FG002|Period 1 (1 Day)|Adverse Event|0|||
131944759|NCT00806260|475086571|FG003|Period 1 (1 Day)|Adverse Event|0|||
131944760|NCT00806260|475086572|FG004|Period 1 (1 Day)|Adverse Event|3|||
131944761|NCT00806260|475086573|FG005|Period 1 (1 Day)|Adverse Event|0|||
131944762|NCT00806260|475086568|FG000|Period 2|Adverse Event|0|||
131944763|NCT00806260|475086569|FG001|Period 2|Adverse Event|0|||
131944764|NCT00806260|475086570|FG002|Period 2|Adverse Event|0|||
131944765|NCT00806260|475086571|FG003|Period 2|Adverse Event|1|||
131944766|NCT00806260|475086572|FG004|Period 2|Adverse Event|0|||
131944767|NCT00806260|475086573|FG005|Period 2|Adverse Event|0|||
131944768|NCT00806260|475086568|FG000|Period 2|Protocol Violation|1|||
131944769|NCT00806260|475086569|FG001|Period 2|Protocol Violation|0|||
131944770|NCT00806260|475086570|FG002|Period 2|Protocol Violation|1|||
131944771|NCT00806260|475086571|FG003|Period 2|Protocol Violation|0|||
131944772|NCT00806260|475086572|FG004|Period 2|Protocol Violation|0|||
131944773|NCT00806260|475086573|FG005|Period 2|Protocol Violation|0|||
131944774|NCT00806260|475086568|FG000|Period 2|Need to take concomitant medication|1|||
131944775|NCT00806260|475086569|FG001|Period 2|Need to take concomitant medication|0|||
131944776|NCT00806260|475086570|FG002|Period 2|Need to take concomitant medication|0|||
131944777|NCT00806260|475086571|FG003|Period 2|Need to take concomitant medication|0|||
131944778|NCT00806260|475086572|FG004|Period 2|Need to take concomitant medication|0|||
131944779|NCT00806260|475086573|FG005|Period 2|Need to take concomitant medication|0|||
131944780|NCT00806260|475086568|FG000|Period 2|sponsor request|0|||
131944781|NCT00806260|475086569|FG001|Period 2|sponsor request|0|||
131944782|NCT00806260|475086570|FG002|Period 2|sponsor request|1|||
131944783|NCT00806260|475086571|FG003|Period 2|sponsor request|1|||
131944784|NCT00806260|475086572|FG004|Period 2|sponsor request|0|||
131944785|NCT00806260|475086573|FG005|Period 2|sponsor request|0|||
131944786|NCT00806260|475086568|FG000|Period 3|Protocol Violation|0|||
131944787|NCT00806260|475086569|FG001|Period 3|Protocol Violation|1|||
131944788|NCT00806260|475086570|FG002|Period 3|Protocol Violation|1|||
131944789|NCT00806260|475086571|FG003|Period 3|Protocol Violation|0|||
131944790|NCT00806260|475086572|FG004|Period 3|Protocol Violation|0|||
131944791|NCT00806260|475086573|FG005|Period 3|Protocol Violation|0|||
131944792|NCT00806260|475086568|FG000|Period 3|Pregnancy|1|||
131944793|NCT00806260|475086569|FG001|Period 3|Pregnancy|0|||
131944794|NCT00806260|475086570|FG002|Period 3|Pregnancy|0|||
131944795|NCT00806260|475086571|FG003|Period 3|Pregnancy|0|||
131944796|NCT00806260|475086572|FG004|Period 3|Pregnancy|0|||
131944797|NCT00806260|475086573|FG005|Period 3|Pregnancy|0|||
131944798|NCT00237042|475086576|FG000|Treatment|Became ineligible post-randomization|0|||
131944799|NCT00237042|475086577|FG001|Treatment|Became ineligible post-randomization|1|||
131944800|NCT00237042|475086578|FG002|Treatment|Became ineligible post-randomization|16|||
131944801|NCT00237042|475086576|FG000|Treatment|Moved out of state|1|||
131944802|NCT00237042|475086577|FG001|Treatment|Moved out of state|1|||
131944803|NCT00237042|475086578|FG002|Treatment|Moved out of state|1|||
131944804|NCT00237042|475086576|FG000|Treatment|Completed no treatment|5|||
131944805|NCT00237042|475086577|FG001|Treatment|Completed no treatment|5|||
131944806|NCT00237042|475086578|FG002|Treatment|Completed no treatment|21|||
131944807|NCT00237042|475086576|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
131944808|NCT00237042|475086577|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
131944809|NCT00237042|475086578|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
131944810|NCT00237042|475086576|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
131944811|NCT00237042|475086577|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
131944812|NCT00237042|475086578|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
131944813|NCT01074931|475086583|FG000|Overall Study|Economic reasons|1|||
131944814|NCT01074931|475086583|FG000|Overall Study|Death|5|||
131944815|NCT00038948|475086584|FG000|Overall Study|Adverse Event|131|||
131944816|NCT00038948|475086585|FG001|Overall Study|Adverse Event|43|||
131944817|NCT00038948|475086584|FG000|Overall Study|Lost to Follow-up|4|||
131944818|NCT00038948|475086585|FG001|Overall Study|Lost to Follow-up|4|||
131944819|NCT00038948|475086584|FG000|Overall Study|Nonmedical event|5|||
131944820|NCT00038948|475086585|FG001|Overall Study|Nonmedical event|7|||
131944821|NCT00038948|475086584|FG000|Overall Study|Withdrawal by Subject|23|||
131944822|NCT00038948|475086585|FG001|Overall Study|Withdrawal by Subject|10|||
131944823|NCT00038948|475086584|FG000|Overall Study|Protocol Violation|3|||
131944824|NCT00038948|475086585|FG001|Overall Study|Protocol Violation|7|||
131944825|NCT00038948|475086584|FG000|Overall Study|Lack of Efficacy|3|||
131944826|NCT00038948|475086585|FG001|Overall Study|Lack of Efficacy|6|||
131944827|NCT01669902|475088297|FG000|Overall Study|Adverse Event|11|||
131944828|NCT01669902|475088297|FG000|Overall Study|Lack of Efficacy|10|||
131413375|NCT00707746|473137254|FG000|Treatment Period|Ineligibility|0|||
131413376|NCT00707746|473137255|FG001|Treatment Period|Ineligibility|1|||
131413377|NCT01685983|473137257|FG000|Overall Study|Adverse Event|7|||
131413378|NCT01685983|473137257|FG000|Overall Study|Death|1|||
131413379|NCT01685983|473137257|FG000|Overall Study|Withdrawal by Subject|19|||
131413380|NCT01685983|473137257|FG000|Overall Study|Protocol Violation|2|||
131944829|NCT01669902|475088297|FG000|Overall Study|Other|8|||
131413381|NCT01685983|473137257|FG000|Overall Study|Physician Decision|13|||
131413382|NCT01685983|473137257|FG000|Overall Study|Other|7|||
131944830|NCT00756275|475088300|FG000|Overall Study|Lost to Follow-up|25|||
131944831|NCT00756275|475088301|FG001|Overall Study|Lost to Follow-up|21|||
131944832|NCT00756275|475088300|FG000|Overall Study|Withdrawal by Subject|4|||
131944833|NCT00756275|475088301|FG001|Overall Study|Withdrawal by Subject|7|||
131944834|NCT00551031|475088302|FG000|Overall Study|Adverse Event|0|||
131944835|NCT00551031|475088303|FG001|Overall Study|Adverse Event|1|||
131944836|NCT00551031|475088304|FG002|Overall Study|Adverse Event|0|||
131944837|NCT00551031|475088305|FG003|Overall Study|Adverse Event|0|||
131944838|NCT00551031|475088306|FG004|Overall Study|Adverse Event|0|||
131944839|NCT00551031|475088302|FG000|Overall Study|Protocol Violation|1|||
131944840|NCT00551031|475088303|FG001|Overall Study|Protocol Violation|1|||
131944841|NCT00551031|475088304|FG002|Overall Study|Protocol Violation|0|||
131944842|NCT00551031|475088305|FG003|Overall Study|Protocol Violation|0|||
131944843|NCT00551031|475088306|FG004|Overall Study|Protocol Violation|0|||
131944844|NCT00551031|475088302|FG000|Overall Study|Lost to Follow-up|0|||
131944845|NCT00551031|475088303|FG001|Overall Study|Lost to Follow-up|1|||
131944846|NCT00551031|475088304|FG002|Overall Study|Lost to Follow-up|0|||
131944847|NCT00551031|475088305|FG003|Overall Study|Lost to Follow-up|1|||
131944848|NCT00551031|475088306|FG004|Overall Study|Lost to Follow-up|1|||
131944849|NCT00551031|475088302|FG000|Overall Study|Withdrawal by Subject|0|||
131944850|NCT00551031|475088303|FG001|Overall Study|Withdrawal by Subject|4|||
131944851|NCT00551031|475088304|FG002|Overall Study|Withdrawal by Subject|1|||
131944852|NCT00551031|475088305|FG003|Overall Study|Withdrawal by Subject|2|||
131944853|NCT00551031|475088306|FG004|Overall Study|Withdrawal by Subject|0|||
131944854|NCT00551031|475088302|FG000|Overall Study|Serious Adverse Event|0|||
131944855|NCT00551031|475088303|FG001|Overall Study|Serious Adverse Event|2|||
131944856|NCT00551031|475088304|FG002|Overall Study|Serious Adverse Event|1|||
131944857|NCT00551031|475088305|FG003|Overall Study|Serious Adverse Event|0|||
131944858|NCT00551031|475088306|FG004|Overall Study|Serious Adverse Event|0|||
131944859|NCT00551031|475088302|FG000|Overall Study|Did not receive vaccine|1|||
131944860|NCT00551031|475088303|FG001|Overall Study|Did not receive vaccine|2|||
131944861|NCT00551031|475088304|FG002|Overall Study|Did not receive vaccine|0|||
131944862|NCT00551031|475088305|FG003|Overall Study|Did not receive vaccine|0|||
131944863|NCT00551031|475088306|FG004|Overall Study|Did not receive vaccine|0|||
131944864|NCT04567524|475088307|FG000|Overall Study|Adverse Event|1|||
131944865|NCT04567524|475088308|FG001|Overall Study|Adverse Event|1|||
131944866|NCT04567524|475088309|FG002|Overall Study|Adverse Event|0|||
131944867|NCT04567524|475088310|FG003|Overall Study|Adverse Event|0|||
131944868|NCT04567524|475088307|FG000|Overall Study|Withdrawal by Subject|2|||
131944869|NCT04567524|475088308|FG001|Overall Study|Withdrawal by Subject|0|||
131944870|NCT04567524|475088309|FG002|Overall Study|Withdrawal by Subject|0|||
131944871|NCT04567524|475088310|FG003|Overall Study|Withdrawal by Subject|1|||
131944872|NCT02078752|475088315|FG000|Overall Study|Death|0|||
131944873|NCT02078752|475088316|FG001|Overall Study|Death|3|||
131944874|NCT02078752|475088317|FG002|Overall Study|Death|0|||
131944875|NCT02078752|475088318|FG003|Overall Study|Death|0|||
131944876|NCT02078752|475088319|FG004|Overall Study|Death|0|||
131944877|NCT02078752|475088320|FG005|Overall Study|Death|1|||
131944878|NCT02078752|475088321|FG006|Overall Study|Death|0|||
131944879|NCT02078752|475088322|FG007|Overall Study|Death|1|||
131944880|NCT02078752|475088323|FG008|Overall Study|Death|0|||
131944881|NCT02078752|475088324|FG009|Overall Study|Death|4|||
131944882|NCT02078752|475088315|FG000|Overall Study|Lost to Follow-up|1|||
131944883|NCT02078752|475088316|FG001|Overall Study|Lost to Follow-up|0|||
131944884|NCT02078752|475088317|FG002|Overall Study|Lost to Follow-up|0|||
131944885|NCT02078752|475088318|FG003|Overall Study|Lost to Follow-up|1|||
131944886|NCT02078752|475088319|FG004|Overall Study|Lost to Follow-up|0|||
131944887|NCT02078752|475088320|FG005|Overall Study|Lost to Follow-up|0|||
131944888|NCT02078752|475088321|FG006|Overall Study|Lost to Follow-up|0|||
131944889|NCT02078752|475088322|FG007|Overall Study|Lost to Follow-up|0|||
131944890|NCT02078752|475088323|FG008|Overall Study|Lost to Follow-up|0|||
131944891|NCT02078752|475088324|FG009|Overall Study|Lost to Follow-up|0|||
131944892|NCT02078752|475088315|FG000|Overall Study|Withdrawal by Subject|1|||
131944893|NCT02078752|475088316|FG001|Overall Study|Withdrawal by Subject|1|||
131944894|NCT02078752|475088317|FG002|Overall Study|Withdrawal by Subject|1|||
131944895|NCT02078752|475088318|FG003|Overall Study|Withdrawal by Subject|1|||
131944896|NCT02078752|475088319|FG004|Overall Study|Withdrawal by Subject|0|||
131944897|NCT02078752|475088320|FG005|Overall Study|Withdrawal by Subject|3|||
131944898|NCT02078752|475088321|FG006|Overall Study|Withdrawal by Subject|2|||
131944899|NCT02078752|475088322|FG007|Overall Study|Withdrawal by Subject|1|||
131944900|NCT02078752|475088323|FG008|Overall Study|Withdrawal by Subject|0|||
131944901|NCT02078752|475088324|FG009|Overall Study|Withdrawal by Subject|1|||
131944902|NCT02078752|475088315|FG000|Overall Study|Other|0|||
131944903|NCT02078752|475088316|FG001|Overall Study|Other|3|||
131944904|NCT02078752|475088317|FG002|Overall Study|Other|0|||
131944905|NCT02078752|475088318|FG003|Overall Study|Other|0|||
131944906|NCT02078752|475088319|FG004|Overall Study|Other|1|||
131944907|NCT02078752|475088320|FG005|Overall Study|Other|0|||
131944908|NCT02078752|475088321|FG006|Overall Study|Other|0|||
131944909|NCT02078752|475088322|FG007|Overall Study|Other|1|||
131944910|NCT02078752|475088323|FG008|Overall Study|Other|0|||
131944911|NCT02078752|475088324|FG009|Overall Study|Other|0|||
131455488|NCT00670306|473297139|FG000|Overall Study|Physician Decision|1|||
131944912|NCT02078752|475088315|FG000|Overall Study|Study terminated by sponsor|0|||
131944913|NCT02078752|475088316|FG001|Overall Study|Study terminated by sponsor|0|||
131944914|NCT02078752|475088317|FG002|Overall Study|Study terminated by sponsor|0|||
131944915|NCT02078752|475088318|FG003|Overall Study|Study terminated by sponsor|0|||
131944916|NCT02078752|475088319|FG004|Overall Study|Study terminated by sponsor|0|||
131944917|NCT02078752|475088320|FG005|Overall Study|Study terminated by sponsor|0|||
131944918|NCT02078752|475088321|FG006|Overall Study|Study terminated by sponsor|0|||
131944919|NCT02078752|475088322|FG007|Overall Study|Study terminated by sponsor|0|||
131944920|NCT02078752|475088323|FG008|Overall Study|Study terminated by sponsor|0|||
131944921|NCT02078752|475088324|FG009|Overall Study|Study terminated by sponsor|5|||
131944922|NCT01694433|475088327|FG000|Overall Study|Adverse Event|7|||
131944923|NCT01694433|475088328|FG001|Overall Study|Adverse Event|0|||
131944924|NCT01694433|475088327|FG000|Overall Study|Physician Decision|1|||
131944925|NCT01694433|475088328|FG001|Overall Study|Physician Decision|0|||
131944926|NCT01694433|475088327|FG000|Overall Study|Withdrawal by Subject|3|||
131944927|NCT01694433|475088328|FG001|Overall Study|Withdrawal by Subject|4|||
131944928|NCT00374595|475088329|FG000|Overall Study|Death|23|||
131944929|NCT00374595|475088329|FG000|Overall Study|Withdrawal by Subject|39|||
131944930|NCT00374595|475088329|FG000|Overall Study|Lost to Follow-up|3|||
131944931|NCT00374595|475088329|FG000|Overall Study|too much time commitment|1|||
131944932|NCT00374595|475088329|FG000|Overall Study|transfer care to other clinical site|1|||
131944933|NCT00374595|475088329|FG000|Overall Study|relocation|3|||
131944934|NCT03745768|475088330|FG000|Overall Study|discontinued study|2|||
131944935|NCT03745768|475088331|FG001|Overall Study|discontinued study|0|||
131944936|NCT00616642|475088332|FG000|Overall Study|Withdrawal by Subject|0|||
131944937|NCT00616642|475088333|FG001|Overall Study|Withdrawal by Subject|1|||
131944938|NCT01023217|475088338|FG000|Overall Study|Withdrawal by Subject|1|||
131944939|NCT01023217|475088339|FG001|Overall Study|Withdrawal by Subject|0|||
131944940|NCT00589797|475088340|FG000|Overall Study|Death|1|||
131944941|NCT00589797|475088341|FG001|Overall Study|Death|0|||
131944942|NCT00589797|475088340|FG000|Overall Study|Lost to Follow-up|12|||
131944943|NCT00589797|475088341|FG001|Overall Study|Lost to Follow-up|9|||
131944944|NCT00589797|475088340|FG000|Overall Study|Physician Decision|8|||
131944945|NCT00589797|475088341|FG001|Overall Study|Physician Decision|3|||
131944946|NCT00589797|475088340|FG000|Overall Study|Withdrawal by Subject|6|||
131944947|NCT00589797|475088341|FG001|Overall Study|Withdrawal by Subject|5|||
131944948|NCT00589797|475088340|FG000|Overall Study|Non-Randomized Training Subjects|46|||
131944949|NCT00589797|475088341|FG001|Overall Study|Non-Randomized Training Subjects|6|||
131944950|NCT03962855|475088348|FG000|Overall Study|Death|0|||
131944951|NCT03962855|475088349|FG001|Overall Study|Death|1|||
131944952|NCT03962855|475088348|FG000|Overall Study|Lost to Follow-up|0|||
131944953|NCT03962855|475088349|FG001|Overall Study|Lost to Follow-up|1|||
131944954|NCT03962855|475088348|FG000|Overall Study|Adverse Event|0|||
131944955|NCT03962855|475088349|FG001|Overall Study|Adverse Event|1|||
131944956|NCT03962855|475088348|FG000|Overall Study|Physician Decision|0|||
131944957|NCT03962855|475088349|FG001|Overall Study|Physician Decision|2|||
131944968|NCT02651116|475088354|FG000|Overall Study|Adverse Event|0|||
131944969|NCT02651116|475088355|FG001|Overall Study|Adverse Event|1|||
131944970|NCT02651116|475088354|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
131944971|NCT02651116|475088355|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
131944972|NCT02457247|475088356|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
131944973|NCT02457247|475088357|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
131944974|NCT02457247|475088358|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
131944975|NCT02457247|475088359|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
131944976|NCT02457247|475088356|FG000|Period 1|Significant Protocol Deviation|1|||
131944977|NCT02457247|475088357|FG001|Period 1|Significant Protocol Deviation|1|||
131944978|NCT02457247|475088358|FG002|Period 1|Significant Protocol Deviation|0|||
131944979|NCT02457247|475088359|FG003|Period 1|Significant Protocol Deviation|0|||
131944980|NCT02457247|475088356|FG000|Period 1|Voluntary Withdrawal|1|||
131944981|NCT02457247|475088357|FG001|Period 1|Voluntary Withdrawal|0|||
131944982|NCT02457247|475088358|FG002|Period 1|Voluntary Withdrawal|0|||
131944983|NCT02457247|475088359|FG003|Period 1|Voluntary Withdrawal|0|||
131413383|NCT01685983|473137257|FG000|Overall Study|Progressive Disease|32|||
131413384|NCT01685983|473137257|FG000|Overall Study|Noncompliance with Study Drug|1|||
131413385|NCT01443130|473137260|FG000|Overall Study|Lost to Follow-up|44|||
131413386|NCT01443130|473137261|FG001|Overall Study|Lost to Follow-up|42|||
131413387|NCT01443130|473137262|FG002|Overall Study|Lost to Follow-up|50|||
131944984|NCT02457247|475088356|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
131944985|NCT02457247|475088357|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
131944986|NCT02457247|475088358|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
131413388|NCT01443130|473137263|FG003|Overall Study|Lost to Follow-up|23|||
131413389|NCT01443130|473137264|FG004|Overall Study|Lost to Follow-up|25|||
131944987|NCT02457247|475088359|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
131944988|NCT02457247|475088356|FG000|Period 2|Significant Protocol Deviation|1|||
131944989|NCT02457247|475088357|FG001|Period 2|Significant Protocol Deviation|0|||
131944990|NCT02457247|475088358|FG002|Period 2|Significant Protocol Deviation|0|||
131944991|NCT02457247|475088359|FG003|Period 2|Significant Protocol Deviation|0|||
131944992|NCT02457247|475088356|FG000|Period 2|Lost to Follow-up|0|||
131944993|NCT02457247|475088357|FG001|Period 2|Lost to Follow-up|1|||
131944994|NCT02457247|475088358|FG002|Period 2|Lost to Follow-up|0|||
131944995|NCT02457247|475088359|FG003|Period 2|Lost to Follow-up|0|||
131944996|NCT02457247|475088356|FG000|Period 2|Voluntary Withdrawal|1|||
131944997|NCT02457247|475088357|FG001|Period 2|Voluntary Withdrawal|1|||
131944998|NCT02457247|475088358|FG002|Period 2|Voluntary Withdrawal|0|||
131944999|NCT02457247|475088359|FG003|Period 2|Voluntary Withdrawal|0|||
131945000|NCT00041470|475088367|FG000|Overall Study|Loss of Funding|38|||
131945001|NCT01061385|475088368|FG000|Overall Study|Lost to Follow-up|1|||
131945002|NCT01061385|475088369|FG001|Overall Study|Lost to Follow-up|0|||
131945003|NCT01061385|475088368|FG000|Overall Study|subject decision not related to AE|0|||
131945004|NCT01061385|475088369|FG001|Overall Study|subject decision not related to AE|1|||
131945005|NCT01492088|475088370|FG000|Overall Study|Withdrawal by Patient|0|||
131945006|NCT01492088|475088371|FG001|Overall Study|Withdrawal by Patient|2|||
131945007|NCT01492088|475088372|FG002|Overall Study|Withdrawal by Patient|0|||
131945008|NCT01492088|475088370|FG000|Overall Study|Death|1|||
131945009|NCT01492088|475088371|FG001|Overall Study|Death|6|||
131945010|NCT01492088|475088372|FG002|Overall Study|Death|2|||
131945011|NCT01492088|475088370|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
131945012|NCT01492088|475088371|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
131945013|NCT01492088|475088372|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
131945014|NCT01492088|475088370|FG000|Overall Study|Alive at Last Follow-up|0|||
131945015|NCT01492088|475088371|FG001|Overall Study|Alive at Last Follow-up|6|||
131945016|NCT01492088|475088372|FG002|Overall Study|Alive at Last Follow-up|11|||
131945017|NCT02230189|475088379|FG000|Overall Study|Withdrawal by Subject|3|||
131945018|NCT02230189|475088380|FG001|Overall Study|Withdrawal by Subject|0|||
131945019|NCT02230189|475088381|FG002|Overall Study|Withdrawal by Subject|1|||
131945020|NCT02230189|475088379|FG000|Overall Study|Lost to Follow-up|1|||
131945021|NCT02230189|475088380|FG001|Overall Study|Lost to Follow-up|0|||
131945022|NCT02230189|475088381|FG002|Overall Study|Lost to Follow-up|0|||
131945023|NCT02230189|475088379|FG000|Overall Study|Physician Decision|1|||
131945024|NCT02230189|475088380|FG001|Overall Study|Physician Decision|0|||
131945025|NCT02230189|475088381|FG002|Overall Study|Physician Decision|0|||
131945026|NCT03824392|475088382|FG000|Overall Study|Adverse Event|1|||
131945027|NCT03824392|475088383|FG001|Overall Study|Adverse Event|0|||
131945028|NCT03824392|475088384|FG002|Overall Study|Adverse Event|0|||
131945029|NCT03824392|475088385|FG003|Overall Study|Adverse Event|0|||
131945030|NCT03824392|475088382|FG000|Overall Study|Investigator Decision|0|||
131945031|NCT03824392|475088383|FG001|Overall Study|Investigator Decision|1|||
131945032|NCT03824392|475088384|FG002|Overall Study|Investigator Decision|0|||
131945033|NCT03824392|475088385|FG003|Overall Study|Investigator Decision|0|||
131945034|NCT03824392|475088382|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
131945035|NCT03824392|475088383|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
131945036|NCT03824392|475088384|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
131945037|NCT03824392|475088385|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
131945038|NCT02343302|475088386|FG000|Overall Study|Physician Decision|1|||
131945039|NCT02343302|475088387|FG001|Overall Study|Physician Decision|1|||
131945040|NCT01887717|475088388|FG000|Overall Study|Withdrawal by Subject|1|||
131945041|NCT01887717|475088389|FG001|Overall Study|Withdrawal by Subject|7|||
131945042|NCT01887717|475088388|FG000|Overall Study|Physician Decision|0|||
131945043|NCT01887717|475088389|FG001|Overall Study|Physician Decision|2|||
131945044|NCT01887717|475088388|FG000|Overall Study|Administrative reasons|5|||
131945045|NCT01887717|475088389|FG001|Overall Study|Administrative reasons|2|||
131945046|NCT02655887|475088390|FG000|Overall Study|Lost to Follow-up|3|||
131945047|NCT02655887|475088390|FG000|Overall Study|Death|4|||
131945048|NCT02655887|475088390|FG000|Overall Study|Withdrawal by Subject|3|||
131945049|NCT02655887|475088390|FG000|Overall Study|Missed 12-month follow-up visit|4|||
131945050|NCT00244621|475088391|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131945051|NCT00244621|475088392|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131945052|NCT00244621|475088393|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
131945053|NCT00244621|475088391|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131945054|NCT00244621|475088392|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131945055|NCT00244621|475088393|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131945056|NCT00244621|475088391|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
131945057|NCT00244621|475088392|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
131945058|NCT00244621|475088393|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
131945059|NCT00244621|475088391|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
131945060|NCT00244621|475088392|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
131945061|NCT00244621|475088393|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
131945062|NCT00244621|475088391|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131945063|NCT00244621|475088392|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
131945064|NCT00244621|475088393|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
131945065|NCT00244621|475088391|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
131455489|NCT00670306|473297139|FG000|Overall Study|Lost to Follow-up|8|||
131455490|NCT00670306|473297139|FG000|Overall Study|incl/excl criterias did not meet|19|||
131455491|NCT04413617|473297140|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
131455492|NCT04413617|473297141|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
131455493|NCT04413617|473297142|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
131455494|NCT04413617|473297143|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
131455495|NCT04413617|473297144|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
131455496|NCT04413617|473297140|FG000|Overall Study|Protocol Violation|0|||
131455497|NCT04413617|473297141|FG001|Overall Study|Protocol Violation|1|||
131455498|NCT04413617|473297142|FG002|Overall Study|Protocol Violation|0|||
131455499|NCT04413617|473297143|FG003|Overall Study|Protocol Violation|0|||
131455500|NCT04413617|473297144|FG004|Overall Study|Protocol Violation|1|||
131455501|NCT04413617|473297140|FG000|Overall Study|Lack of Efficacy|2|||
131455502|NCT04413617|473297141|FG001|Overall Study|Lack of Efficacy|0|||
131455503|NCT04413617|473297142|FG002|Overall Study|Lack of Efficacy|2|||
131455504|NCT04413617|473297143|FG003|Overall Study|Lack of Efficacy|1|||
131455505|NCT04413617|473297144|FG004|Overall Study|Lack of Efficacy|0|||
131455506|NCT04413617|473297140|FG000|Overall Study|Withdrawal by Subject|3|||
131455507|NCT04413617|473297141|FG001|Overall Study|Withdrawal by Subject|4|||
131455508|NCT04413617|473297142|FG002|Overall Study|Withdrawal by Subject|2|||
131455509|NCT04413617|473297143|FG003|Overall Study|Withdrawal by Subject|5|||
131455510|NCT04413617|473297144|FG004|Overall Study|Withdrawal by Subject|3|||
131455511|NCT04413617|473297140|FG000|Overall Study|Death|1|||
131455512|NCT04413617|473297141|FG001|Overall Study|Death|0|||
131455513|NCT04413617|473297142|FG002|Overall Study|Death|0|||
131455514|NCT04413617|473297143|FG003|Overall Study|Death|0|||
131455515|NCT04413617|473297144|FG004|Overall Study|Death|0|||
131455516|NCT04413617|473297140|FG000|Overall Study|Adverse Event|1|||
131455517|NCT04413617|473297141|FG001|Overall Study|Adverse Event|0|||
131455518|NCT04413617|473297142|FG002|Overall Study|Adverse Event|0|||
131455519|NCT04413617|473297143|FG003|Overall Study|Adverse Event|1|||
131455520|NCT04413617|473297144|FG004|Overall Study|Adverse Event|1|||
131455521|NCT04413617|473297140|FG000|Overall Study|COVID-19|0|||
131455522|NCT04413617|473297141|FG001|Overall Study|COVID-19|1|||
131455523|NCT04413617|473297142|FG002|Overall Study|COVID-19|0|||
131455524|NCT04413617|473297143|FG003|Overall Study|COVID-19|0|||
131455525|NCT04413617|473297144|FG004|Overall Study|COVID-19|0|||
131455526|NCT00775593|473297145|FG000|Overall Study|Unmet eligibility criteria|6|||
131455527|NCT00775593|473297145|FG000|Overall Study|Death|1|||
131455528|NCT01327482|473297146|FG000|Overall Study|Adverse Event|1|||
131455529|NCT00476229|473297147|FG000|Overall Study|Progressive shortness of breath|1|||
131455530|NCT02164461|473297148|FG000|Overall Study|Adverse Event|0|||
131455531|NCT02164461|473297149|FG001|Overall Study|Adverse Event|0|||
131455532|NCT02164461|473297150|FG002|Overall Study|Adverse Event|1|||
131455533|NCT02164461|473297148|FG000|Overall Study|Disease Progression|1|||
131455534|NCT02164461|473297149|FG001|Overall Study|Disease Progression|3|||
131455535|NCT02164461|473297150|FG002|Overall Study|Disease Progression|4|||
131455536|NCT02164461|473297148|FG000|Overall Study|Withdrawal by Subject|0|||
131455537|NCT02164461|473297149|FG001|Overall Study|Withdrawal by Subject|3|||
131455538|NCT02164461|473297150|FG002|Overall Study|Withdrawal by Subject|0|||
131455539|NCT03904693|473297152|FG000|Overall Study|Death|0|||
131455540|NCT03904693|473297153|FG001|Overall Study|Death|0|||
131455541|NCT03904693|473297154|FG002|Overall Study|Death|3|||
131455542|NCT03904693|473297152|FG000|Overall Study|Physician Decision|0|||
131455543|NCT03904693|473297153|FG001|Overall Study|Physician Decision|0|||
131455544|NCT03904693|473297154|FG002|Overall Study|Physician Decision|2|||
131455545|NCT03904693|473297152|FG000|Overall Study|Withdrawal by Subject|0|||
131455546|NCT03904693|473297153|FG001|Overall Study|Withdrawal by Subject|1|||
131455547|NCT03904693|473297154|FG002|Overall Study|Withdrawal by Subject|4|||
131455548|NCT02100696|473297155|FG000|Induction Phase|Adverse Event|0|||
131455549|NCT02100696|473297156|FG001|Induction Phase|Adverse Event|0|||
131945066|NCT00244621|475088392|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131945067|NCT00244621|475088393|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
131455550|NCT02100696|473297157|FG002|Induction Phase|Adverse Event|1|||
131455551|NCT02100696|473297158|FG003|Induction Phase|Adverse Event|0|||
131455552|NCT02100696|473297159|FG004|Induction Phase|Adverse Event|0|||
131455553|NCT02100696|473297160|FG005|Induction Phase|Adverse Event|0|||
131455554|NCT02100696|473297155|FG000|Induction Phase|Lost to Follow-up|1|||
131455555|NCT02100696|473297156|FG001|Induction Phase|Lost to Follow-up|0|||
131455556|NCT02100696|473297157|FG002|Induction Phase|Lost to Follow-up|1|||
131455557|NCT02100696|473297158|FG003|Induction Phase|Lost to Follow-up|0|||
131455558|NCT02100696|473297159|FG004|Induction Phase|Lost to Follow-up|0|||
131455559|NCT02100696|473297160|FG005|Induction Phase|Lost to Follow-up|0|||
131455560|NCT02100696|473297155|FG000|Induction Phase|Protocol Violation|0|||
131455561|NCT02100696|473297156|FG001|Induction Phase|Protocol Violation|1|||
131455562|NCT02100696|473297157|FG002|Induction Phase|Protocol Violation|1|||
131455563|NCT02100696|473297158|FG003|Induction Phase|Protocol Violation|0|||
131455564|NCT02100696|473297159|FG004|Induction Phase|Protocol Violation|0|||
131413390|NCT01443130|473137265|FG005|Overall Study|Lost to Follow-up|21|||
131413391|NCT01443130|473137260|FG000|Overall Study|Death|0|||
131413392|NCT01443130|473137261|FG001|Overall Study|Death|1|||
131413393|NCT01443130|473137262|FG002|Overall Study|Death|0|||
131413394|NCT01443130|473137263|FG003|Overall Study|Death|7|||
131413395|NCT01443130|473137264|FG004|Overall Study|Death|10|||
131413396|NCT01443130|473137265|FG005|Overall Study|Death|8|||
131413397|NCT01443130|473137260|FG000|Overall Study|Adverse Event|2|||
131413398|NCT01443130|473137261|FG001|Overall Study|Adverse Event|1|||
131413399|NCT01443130|473137262|FG002|Overall Study|Adverse Event|1|||
131413400|NCT01443130|473137263|FG003|Overall Study|Adverse Event|0|||
131413401|NCT01443130|473137264|FG004|Overall Study|Adverse Event|0|||
131413402|NCT01443130|473137265|FG005|Overall Study|Adverse Event|0|||
131413403|NCT01443130|473137260|FG000|Overall Study|Protocol Violation|2|||
131413404|NCT01443130|473137261|FG001|Overall Study|Protocol Violation|1|||
131413405|NCT01443130|473137262|FG002|Overall Study|Protocol Violation|3|||
131413406|NCT01443130|473137263|FG003|Overall Study|Protocol Violation|2|||
131413407|NCT01443130|473137264|FG004|Overall Study|Protocol Violation|2|||
131413408|NCT01443130|473137265|FG005|Overall Study|Protocol Violation|3|||
131413409|NCT01443130|473137260|FG000|Overall Study|Withdrawal by Subject|15|||
131413410|NCT01443130|473137261|FG001|Overall Study|Withdrawal by Subject|14|||
131413411|NCT01443130|473137262|FG002|Overall Study|Withdrawal by Subject|12|||
131413412|NCT01443130|473137263|FG003|Overall Study|Withdrawal by Subject|7|||
131413413|NCT01443130|473137264|FG004|Overall Study|Withdrawal by Subject|7|||
131413414|NCT01443130|473137265|FG005|Overall Study|Withdrawal by Subject|2|||
131413415|NCT01443130|473137260|FG000|Overall Study|Death of Subject's Infant|5|||
131413416|NCT01443130|473137261|FG001|Overall Study|Death of Subject's Infant|10|||
131413417|NCT01443130|473137262|FG002|Overall Study|Death of Subject's Infant|11|||
131413418|NCT01443130|473137263|FG003|Overall Study|Death of Subject's Infant|0|||
131413419|NCT01443130|473137264|FG004|Overall Study|Death of Subject's Infant|0|||
131413420|NCT01443130|473137265|FG005|Overall Study|Death of Subject's Infant|0|||
131413421|NCT00685373|473137266|FG000|Overall Study|Adverse Event|3|||
131413422|NCT00685373|473137266|FG000|Overall Study|Withdrawal by Subject|5|||
131413423|NCT00685373|473137266|FG000|Overall Study|Lack of Efficacy|3|||
131413424|NCT00685373|473137266|FG000|Overall Study|Condition no longer requires study drug|1|||
131413425|NCT00685373|473137266|FG000|Overall Study|Lost to Follow-up|2|||
131413426|NCT00685373|473137266|FG000|Overall Study|Protocol Violation|1|||
131413427|NCT02642965|473137268|FG000|Overall Study|Lack of Efficacy|4|||
131413428|NCT02642965|473137268|FG000|Overall Study|Physician Decision|9|||
131413429|NCT01167907|473137269|FG000|Overall Study|Protocol Violation|1|||
131413430|NCT01167907|473137270|FG001|Overall Study|Protocol Violation|0|||
131413431|NCT01167907|473137269|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
131413432|NCT01167907|473137270|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
131413433|NCT03077698|473137271|FG000|Progestin Monotherapy|Stable Disease|8|||
131413434|NCT03077698|473137272|FG001|Progestin Monotherapy|Stable Disease|0|||
131413435|NCT03077698|473137271|FG000|Progestin Monotherapy|Adverse Event|1|||
131413436|NCT03077698|473137272|FG001|Progestin Monotherapy|Adverse Event|0|||
131413437|NCT03077698|473137271|FG000|Progestin Monotherapy|Death|1|||
131413438|NCT03077698|473137272|FG001|Progestin Monotherapy|Death|0|||
131413439|NCT03077698|473137271|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
131413440|NCT03077698|473137272|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
131413441|NCT03077698|473137271|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
131413442|NCT03077698|473137272|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
131413443|NCT03077698|473137271|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
131413444|NCT03077698|473137272|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
131413445|NCT03077698|473137271|FG000|Safety Follow Up|Withdrawal by Subject|2|||
131413446|NCT03077698|473137272|FG001|Safety Follow Up|Withdrawal by Subject|1|||
131413447|NCT03077698|473137271|FG000|Safety Follow Up|Transfer of care to hospice|1|||
131413448|NCT03077698|473137272|FG001|Safety Follow Up|Transfer of care to hospice|0|||
131413449|NCT03461406|473137273|FG000|Overall Study|Death|1|||
131413450|NCT03461406|473137274|FG001|Overall Study|Death|2|||
131413451|NCT03461406|473137273|FG000|Overall Study|Consent Withdrawn by Participant|0|||
131413452|NCT03461406|473137274|FG001|Overall Study|Consent Withdrawn by Participant|1|||
131413453|NCT03461406|473137273|FG000|Overall Study|Screen Failure|3|||
131413454|NCT03461406|473137274|FG001|Overall Study|Screen Failure|1|||
131413455|NCT03461406|473137273|FG000|Overall Study|Reason not Specified|1|||
131413456|NCT03461406|473137274|FG001|Overall Study|Reason not Specified|3|||
131413457|NCT03461406|473137273|FG000|Overall Study|Lost to Follow-up|3|||
131413458|NCT03461406|473137274|FG001|Overall Study|Lost to Follow-up|0|||
131413459|NCT03099148|473137275|FG000|Wash-out|scheduling conflict|0|||
131413460|NCT03099148|473137276|FG001|Wash-out|scheduling conflict|1|||
131413461|NCT03099148|473137277|FG002|Wash-out|scheduling conflict|0|||
131413462|NCT03099148|473137278|FG003|Wash-out|scheduling conflict|0|||
131413463|NCT03099148|473137275|FG000|Wash-out|Adverse Event|0|||
131413464|NCT03099148|473137276|FG001|Wash-out|Adverse Event|1|||
131413465|NCT03099148|473137277|FG002|Wash-out|Adverse Event|0|||
131413466|NCT03099148|473137278|FG003|Wash-out|Adverse Event|0|||
131413467|NCT01439126|473137279|FG000|Overall Study|Adverse Event|2|||
131945068|NCT00244621|475088391|FG000|Open-label Treatment Period|Adverse Event|0|||
131945069|NCT00244621|475088392|FG001|Open-label Treatment Period|Adverse Event|0|||
131945070|NCT00244621|475088393|FG002|Open-label Treatment Period|Adverse Event|1|||
131945071|NCT00244621|475088391|FG000|Open-label Treatment Period|Moved abroad|0|||
131945072|NCT00244621|475088392|FG001|Open-label Treatment Period|Moved abroad|0|||
131945073|NCT00244621|475088393|FG002|Open-label Treatment Period|Moved abroad|1|||
131945074|NCT02834819|475088396|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
131945075|NCT02834819|475088397|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
131945076|NCT01925768|475088400|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131945077|NCT01925768|475088401|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131945078|NCT01925768|475088400|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131945079|NCT01925768|475088401|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
131945080|NCT01925768|475088400|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
131945081|NCT01925768|475088401|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
131945082|NCT01925768|475088400|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
131945083|NCT01925768|475088401|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
131945084|NCT01925768|475088400|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
131945085|NCT01925768|475088401|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
131945086|NCT01925768|475088400|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
131945087|NCT01925768|475088401|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
131945088|NCT01925768|475088400|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
131945089|NCT01925768|475088401|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
131945090|NCT01925768|475088400|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
131945091|NCT01925768|475088401|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
131945092|NCT01925768|475088400|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
131945093|NCT01925768|475088401|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
131945094|NCT01925768|475088400|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
131945095|NCT01925768|475088401|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
131945096|NCT01925768|475088400|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
131945097|NCT01925768|475088401|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
131945098|NCT00003631|475088412|FG000|Overall Study|Patient not treated|1|||
131945099|NCT00003631|475088413|FG001|Overall Study|Patient not treated|0|||
131945100|NCT00003631|475088414|FG002|Overall Study|Patient not treated|1|||
131945101|NCT00003631|475088412|FG000|Overall Study|Protocol Violation|1|||
131945102|NCT00003631|475088413|FG001|Overall Study|Protocol Violation|0|||
131945103|NCT00003631|475088414|FG002|Overall Study|Protocol Violation|0|||
131945104|NCT00003631|475088412|FG000|Overall Study|Adverse Event|1|||
131945105|NCT00003631|475088413|FG001|Overall Study|Adverse Event|1|||
131945106|NCT00003631|475088414|FG002|Overall Study|Adverse Event|5|||
131945107|NCT00003631|475088412|FG000|Overall Study|Death|0|||
131945108|NCT00003631|475088413|FG001|Overall Study|Death|0|||
131945109|NCT00003631|475088414|FG002|Overall Study|Death|1|||
131945110|NCT00003631|475088412|FG000|Overall Study|Evaluable for toxicity only|0|||
131945111|NCT00003631|475088413|FG001|Overall Study|Evaluable for toxicity only|0|||
131945112|NCT00003631|475088414|FG002|Overall Study|Evaluable for toxicity only|2|||
131945113|NCT04339413|475088416|FG000|Overall Study|Reason Not Specified|2|||
131945114|NCT04339413|475088417|FG001|Overall Study|Reason Not Specified|7|||
131945115|NCT04339413|475088416|FG000|Overall Study|Study Terminated by Sponsor|30|||
131945116|NCT04339413|475088417|FG001|Overall Study|Study Terminated by Sponsor|33|||
131945117|NCT04339413|475088416|FG000|Overall Study|Progressive Disease|9|||
131945118|NCT04339413|475088417|FG001|Overall Study|Progressive Disease|6|||
131945119|NCT04339413|475088416|FG000|Overall Study|Withdrawal by Subject|9|||
131945120|NCT04339413|475088417|FG001|Overall Study|Withdrawal by Subject|10|||
131945121|NCT04339413|475088416|FG000|Overall Study|Physician Decision|3|||
131945122|NCT04339413|475088417|FG001|Overall Study|Physician Decision|1|||
131945123|NCT04339413|475088416|FG000|Overall Study|Death|2|||
131945124|NCT04339413|475088417|FG001|Overall Study|Death|0|||
131945125|NCT04339413|475088416|FG000|Overall Study|Adverse Event|3|||
131945126|NCT04339413|475088417|FG001|Overall Study|Adverse Event|0|||
131945127|NCT00699413|475088420|FG000|Overall Study|Withdrawal by Subject|0|||
131945128|NCT00699413|475088421|FG001|Overall Study|Withdrawal by Subject|2|||
131945129|NCT00699413|475088420|FG000|Overall Study|Study terminated by sponsor|4|||
131945130|NCT00699413|475088421|FG001|Overall Study|Study terminated by sponsor|2|||
131945131|NCT00251693|475088422|FG000|Overall Study|Adverse Event|17|||
131945132|NCT00251693|475088423|FG001|Overall Study|Adverse Event|9|||
131945133|NCT00251693|475088424|FG002|Overall Study|Adverse Event|9|||
131945134|NCT00251693|475088422|FG000|Overall Study|Protocol Violation|2|||
131413468|NCT01439126|473137280|FG001|Overall Study|Adverse Event|0|||
131945135|NCT00251693|475088423|FG001|Overall Study|Protocol Violation|0|||
131945136|NCT00251693|475088424|FG002|Overall Study|Protocol Violation|2|||
131945137|NCT00251693|475088422|FG000|Overall Study|Lost to Follow-up|12|||
131945138|NCT00251693|475088423|FG001|Overall Study|Lost to Follow-up|7|||
131945139|NCT00251693|475088424|FG002|Overall Study|Lost to Follow-up|8|||
131945140|NCT00251693|475088422|FG000|Overall Study|Withdrawal by Subject|11|||
131455565|NCT02100696|473297160|FG005|Induction Phase|Protocol Violation|0|||
131455566|NCT02100696|473297155|FG000|Induction Phase|Withdrawal by Subject|8|||
131455567|NCT02100696|473297156|FG001|Induction Phase|Withdrawal by Subject|2|||
131455568|NCT02100696|473297157|FG002|Induction Phase|Withdrawal by Subject|13|||
131455569|NCT02100696|473297158|FG003|Induction Phase|Withdrawal by Subject|0|||
131455570|NCT02100696|473297159|FG004|Induction Phase|Withdrawal by Subject|0|||
131455571|NCT02100696|473297160|FG005|Induction Phase|Withdrawal by Subject|0|||
131455572|NCT02100696|473297155|FG000|Induction Phase|Physician Decision|1|||
131455573|NCT02100696|473297156|FG001|Induction Phase|Physician Decision|0|||
131455574|NCT02100696|473297157|FG002|Induction Phase|Physician Decision|2|||
131455575|NCT02100696|473297158|FG003|Induction Phase|Physician Decision|0|||
131455576|NCT02100696|473297159|FG004|Induction Phase|Physician Decision|0|||
131455577|NCT02100696|473297160|FG005|Induction Phase|Physician Decision|0|||
131455578|NCT02100696|473297155|FG000|Induction Phase|Multiple Reasons|5|||
131455579|NCT02100696|473297156|FG001|Induction Phase|Multiple Reasons|2|||
131455580|NCT02100696|473297157|FG002|Induction Phase|Multiple Reasons|8|||
131455581|NCT02100696|473297158|FG003|Induction Phase|Multiple Reasons|0|||
131455582|NCT02100696|473297159|FG004|Induction Phase|Multiple Reasons|0|||
131455583|NCT02100696|473297160|FG005|Induction Phase|Multiple Reasons|0|||
131455584|NCT02100696|473297155|FG000|Maintenance Phase|Adverse Event|0|||
131455585|NCT02100696|473297156|FG001|Maintenance Phase|Adverse Event|0|||
131455586|NCT02100696|473297157|FG002|Maintenance Phase|Adverse Event|0|||
131455587|NCT02100696|473297158|FG003|Maintenance Phase|Adverse Event|0|||
131455588|NCT02100696|473297159|FG004|Maintenance Phase|Adverse Event|0|||
131455589|NCT02100696|473297160|FG005|Maintenance Phase|Adverse Event|2|||
131455590|NCT02100696|473297155|FG000|Maintenance Phase|Lost to Follow-up|0|||
131455591|NCT02100696|473297156|FG001|Maintenance Phase|Lost to Follow-up|0|||
131455592|NCT02100696|473297157|FG002|Maintenance Phase|Lost to Follow-up|0|||
131455593|NCT02100696|473297158|FG003|Maintenance Phase|Lost to Follow-up|0|||
131455594|NCT02100696|473297159|FG004|Maintenance Phase|Lost to Follow-up|1|||
131455595|NCT02100696|473297160|FG005|Maintenance Phase|Lost to Follow-up|0|||
131455596|NCT02100696|473297155|FG000|Maintenance Phase|Protocol Violation|0|||
131455597|NCT02100696|473297156|FG001|Maintenance Phase|Protocol Violation|0|||
131455598|NCT02100696|473297157|FG002|Maintenance Phase|Protocol Violation|0|||
131455599|NCT02100696|473297158|FG003|Maintenance Phase|Protocol Violation|0|||
131455600|NCT02100696|473297159|FG004|Maintenance Phase|Protocol Violation|1|||
131455601|NCT02100696|473297160|FG005|Maintenance Phase|Protocol Violation|0|||
131455602|NCT02100696|473297155|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131455603|NCT02100696|473297156|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131455604|NCT02100696|473297157|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131455605|NCT02100696|473297158|FG003|Maintenance Phase|Withdrawal by Subject|1|||
131455606|NCT02100696|473297159|FG004|Maintenance Phase|Withdrawal by Subject|4|||
131455607|NCT02100696|473297160|FG005|Maintenance Phase|Withdrawal by Subject|2|||
131455608|NCT02100696|473297155|FG000|Maintenance Phase|Physician Decision|0|||
131455609|NCT02100696|473297156|FG001|Maintenance Phase|Physician Decision|0|||
131455610|NCT02100696|473297157|FG002|Maintenance Phase|Physician Decision|0|||
131455611|NCT02100696|473297158|FG003|Maintenance Phase|Physician Decision|0|||
131455612|NCT02100696|473297159|FG004|Maintenance Phase|Physician Decision|1|||
131455613|NCT02100696|473297160|FG005|Maintenance Phase|Physician Decision|0|||
131455614|NCT02100696|473297155|FG000|Maintenance Phase|Multiple Reasons|0|||
131455615|NCT02100696|473297156|FG001|Maintenance Phase|Multiple Reasons|0|||
131455616|NCT02100696|473297157|FG002|Maintenance Phase|Multiple Reasons|0|||
131455617|NCT02100696|473297158|FG003|Maintenance Phase|Multiple Reasons|0|||
131455618|NCT02100696|473297159|FG004|Maintenance Phase|Multiple Reasons|2|||
131455619|NCT02100696|473297160|FG005|Maintenance Phase|Multiple Reasons|1|||
131455620|NCT03865381|473297163|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
131455621|NCT03865381|473297163|FG000|Overall Study|Withdrawal by Subject|2|||
131455622|NCT05626322|473297164|FG000|Overall Study|Death|2|||
131455623|NCT05626322|473297165|FG001|Overall Study|Death|0|||
131455624|NCT05626322|473297166|FG002|Overall Study|Death|0|||
131455625|NCT05626322|473297164|FG000|Overall Study|Physician Decision|1|||
131455626|NCT05626322|473297165|FG001|Overall Study|Physician Decision|0|||
131455627|NCT05626322|473297166|FG002|Overall Study|Physician Decision|0|||
131455628|NCT05626322|473297164|FG000|Overall Study|Progressive Disease|0|||
131455629|NCT05626322|473297165|FG001|Overall Study|Progressive Disease|1|||
131455630|NCT05626322|473297166|FG002|Overall Study|Progressive Disease|1|||
131455631|NCT05626322|473297164|FG000|Overall Study|Study terminated by sponsor|0|||
131455632|NCT05626322|473297165|FG001|Overall Study|Study terminated by sponsor|1|||
131455633|NCT05626322|473297166|FG002|Overall Study|Study terminated by sponsor|0|||
131455634|NCT01192191|473297167|FG000|Overall Study|Adverse Event|7|||
131455635|NCT01192191|473297168|FG001|Overall Study|Adverse Event|12|||
131455636|NCT01192191|473297167|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
131455637|NCT01192191|473297168|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
131455638|NCT01192191|473297167|FG000|Overall Study|Lost to Follow-up|0|||
131455639|NCT01192191|473297168|FG001|Overall Study|Lost to Follow-up|1|||
131455640|NCT01192191|473297167|FG000|Overall Study|Withdrawal by Subject|1|||
131455641|NCT01192191|473297168|FG001|Overall Study|Withdrawal by Subject|6|||
131455642|NCT01047553|473297171|FG000|Overall Study|Adverse Event|10|||
131455643|NCT01047553|473297172|FG001|Overall Study|Adverse Event|5|||
131455644|NCT01047553|473297171|FG000|Overall Study|Withdrawal by Subject|4|||
131455645|NCT01047553|473297172|FG001|Overall Study|Withdrawal by Subject|2|||
131455646|NCT01047553|473297171|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
131455647|NCT01047553|473297172|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
131455648|NCT01047553|473297171|FG000|Overall Study|Lost to Follow-up|1|||
131455649|NCT01047553|473297172|FG001|Overall Study|Lost to Follow-up|0|||
131455650|NCT01047553|473297171|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
131455651|NCT01047553|473297172|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
131455652|NCT01047553|473297171|FG000|Overall Study|PI's decision|0|||
131455653|NCT01047553|473297172|FG001|Overall Study|PI's decision|1|||
131455654|NCT01583296|473297173|FG000|Overall Study|Withdrawal by Subject|11|||
131455655|NCT01583296|473297174|FG001|Overall Study|Withdrawal by Subject|10|||
131455656|NCT01063283|473297175|FG000|Cycle 1|Adverse Event|2|||
131455657|NCT01063283|473297176|FG001|Cycle 1|Adverse Event|0|||
131455658|NCT01063283|473297177|FG002|Cycle 1|Adverse Event|0|||
131455659|NCT01063283|473297175|FG000|Cycle 1|Technical failure in data collection|1|||
131455660|NCT01063283|473297176|FG001|Cycle 1|Technical failure in data collection|0|||
131455661|NCT01063283|473297177|FG002|Cycle 1|Technical failure in data collection|0|||
131455662|NCT03179319|473297178|FG000|Overall Study|Lost to Follow-up|6|||
131455663|NCT03179319|473297179|FG001|Overall Study|Lost to Follow-up|0|||
131455664|NCT01120717|473297180|FG000|Overall Study|Withdrawal by Subject|11|||
131455665|NCT01120717|473297181|FG001|Overall Study|Withdrawal by Subject|6|||
131455666|NCT01120717|473297180|FG000|Overall Study|Adverse Event|10|||
131455667|NCT01120717|473297181|FG001|Overall Study|Adverse Event|6|||
131455668|NCT01120717|473297180|FG000|Overall Study|Protocol Deviation|2|||
131455669|NCT01120717|473297181|FG001|Overall Study|Protocol Deviation|5|||
131455670|NCT01120717|473297180|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131413469|NCT01439126|473137279|FG000|Overall Study|Withdrawal by Subject|5|||
131413470|NCT01439126|473137280|FG001|Overall Study|Withdrawal by Subject|21|||
131413471|NCT01439126|473137279|FG000|Overall Study|Protocol Violation|6|||
131413472|NCT01439126|473137280|FG001|Overall Study|Protocol Violation|4|||
131413473|NCT01439126|473137279|FG000|Overall Study|Lost to Follow-up|6|||
131413474|NCT01439126|473137280|FG001|Overall Study|Lost to Follow-up|3|||
131413475|NCT01439126|473137279|FG000|Overall Study|Other-Use of prohibited treatment|0|||
131413476|NCT01439126|473137280|FG001|Overall Study|Other-Use of prohibited treatment|2|||
131413477|NCT01439126|473137279|FG000|Overall Study|Other-Miscellaneous|12|||
131413478|NCT01439126|473137280|FG001|Overall Study|Other-Miscellaneous|12|||
131413479|NCT01617447|473137281|FG000|Overall Study|Adverse Event|0|||
131413480|NCT01617447|473137282|FG001|Overall Study|Adverse Event|1|||
131413481|NCT01617447|473137281|FG000|Overall Study|Physician Decision|0|||
131413482|NCT01617447|473137282|FG001|Overall Study|Physician Decision|2|||
131413483|NCT02713529|473137283|FG000|Overall Study|Withdrawal by Subject|3|||
131413484|NCT02713529|473137284|FG001|Overall Study|Withdrawal by Subject|1|||
131413485|NCT02713529|473137285|FG002|Overall Study|Withdrawal by Subject|4|||
131413486|NCT02713529|473137286|FG003|Overall Study|Withdrawal by Subject|2|||
131413487|NCT02713529|473137287|FG004|Overall Study|Withdrawal by Subject|0|||
131413488|NCT02713529|473137288|FG005|Overall Study|Withdrawal by Subject|1|||
131413489|NCT02713529|473137289|FG006|Overall Study|Withdrawal by Subject|1|||
131413490|NCT02713529|473137283|FG000|Overall Study|Lost to Follow-up|1|||
131413491|NCT02713529|473137284|FG001|Overall Study|Lost to Follow-up|0|||
131413492|NCT02713529|473137285|FG002|Overall Study|Lost to Follow-up|1|||
131413493|NCT02713529|473137286|FG003|Overall Study|Lost to Follow-up|0|||
131413494|NCT02713529|473137287|FG004|Overall Study|Lost to Follow-up|0|||
131413495|NCT02713529|473137288|FG005|Overall Study|Lost to Follow-up|0|||
131413496|NCT02713529|473137289|FG006|Overall Study|Lost to Follow-up|0|||
131413497|NCT02713529|473137283|FG000|Overall Study|Death|3|||
131413498|NCT02713529|473137284|FG001|Overall Study|Death|3|||
131413499|NCT02713529|473137285|FG002|Overall Study|Death|26|||
131413500|NCT02713529|473137286|FG003|Overall Study|Death|27|||
131413501|NCT02713529|473137287|FG004|Overall Study|Death|3|||
131413502|NCT02713529|473137288|FG005|Overall Study|Death|13|||
131413503|NCT02713529|473137289|FG006|Overall Study|Death|3|||
131413504|NCT02827500|473137290|FG000|Overall Study|Death|7|||
131413505|NCT02827500|473137291|FG001|Overall Study|Death|3|||
131455671|NCT01120717|473297181|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131455672|NCT01120717|473297180|FG000|Overall Study|Lost to Follow-up|2|||
131455673|NCT01120717|473297181|FG001|Overall Study|Lost to Follow-up|3|||
131455674|NCT01120717|473297180|FG000|Overall Study|Death|3|||
131413506|NCT02827500|473137290|FG000|Overall Study|Lost to Follow-up|1|||
131413507|NCT02827500|473137291|FG001|Overall Study|Lost to Follow-up|1|||
131455675|NCT01120717|473297181|FG001|Overall Study|Death|1|||
131413508|NCT02827500|473137290|FG000|Overall Study|Withdrawal by Subject|3|||
131413509|NCT02827500|473137291|FG001|Overall Study|Withdrawal by Subject|1|||
131413510|NCT02827500|473137290|FG000|Overall Study|Missing primary endpoint data|3|||
131413511|NCT02827500|473137291|FG001|Overall Study|Missing primary endpoint data|1|||
131413512|NCT02827500|473137290|FG000|Overall Study|Other|5|||
131413513|NCT02827500|473137291|FG001|Overall Study|Other|1|||
131455676|NCT01120717|473297180|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
131455677|NCT01120717|473297181|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
131455678|NCT01668589|473297188|FG000|Overall Study|Lost to Follow-up|29|||
131455679|NCT01668589|473297189|FG001|Overall Study|Lost to Follow-up|37|||
131455680|NCT01668589|473297190|FG002|Overall Study|Lost to Follow-up|15|||
131455681|NCT01668589|473297191|FG003|Overall Study|Lost to Follow-up|5|||
131455682|NCT01668589|473297188|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
131455683|NCT01668589|473297189|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
131455684|NCT01668589|473297190|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
131455685|NCT01668589|473297191|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
131455686|NCT01668589|473297188|FG000|Overall Study|Death|12|||
131455687|NCT01668589|473297189|FG001|Overall Study|Death|3|||
131455688|NCT01668589|473297190|FG002|Overall Study|Death|2|||
131455689|NCT01668589|473297191|FG003|Overall Study|Death|11|||
131455690|NCT01668589|473297188|FG000|Overall Study|Other|44|||
131455691|NCT01668589|473297189|FG001|Overall Study|Other|10|||
131455692|NCT01668589|473297190|FG002|Overall Study|Other|7|||
131455693|NCT01668589|473297191|FG003|Overall Study|Other|15|||
131455694|NCT01519167|473297192|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
131455695|NCT01519167|473297193|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
131455696|NCT01519167|473297192|FG000|Overall Study|Adverse Event|0|||
131455697|NCT01519167|473297193|FG001|Overall Study|Adverse Event|1|||
131455698|NCT01519167|473297192|FG000|Overall Study|Lack of Efficacy|0|||
131455699|NCT01519167|473297193|FG001|Overall Study|Lack of Efficacy|1|||
131455700|NCT01519167|473297192|FG000|Overall Study|Medical condition changes&deep sedation|0|||
131455701|NCT01519167|473297193|FG001|Overall Study|Medical condition changes&deep sedation|2|||
131455702|NCT01519167|473297192|FG000|Overall Study|Physician Decision|0|||
131455703|NCT01519167|473297193|FG001|Overall Study|Physician Decision|1|||
131455704|NCT04200352|473297204|FG000|Overall Study|Death|1|||
131455705|NCT04200352|473297204|FG000|Overall Study|Adverse Event|6|||
131455706|NCT04200352|473297204|FG000|Overall Study|Withdrawal by parent/guardian|6|||
131455707|NCT04200352|473297204|FG000|Overall Study|Lack of Efficacy|1|||
131455708|NCT04200352|473297204|FG000|Overall Study|Other than specified|6|||
131455709|NCT00993148|473297205|FG000|Overall Study|Lost to Follow-up|2|||
131455710|NCT00993148|473297205|FG000|Overall Study|never initiated treatment|1|||
131455711|NCT00233064|473297206|FG000|Overall Study|Lost to Follow-up|7|||
131455712|NCT00233064|473297207|FG001|Overall Study|Lost to Follow-up|7|||
131455713|NCT00233064|473297206|FG000|Overall Study|Withdrawal by Subject|5|||
131455714|NCT00233064|473297207|FG001|Overall Study|Withdrawal by Subject|3|||
131455715|NCT00233064|473297206|FG000|Overall Study|Death|0|||
131455716|NCT00233064|473297207|FG001|Overall Study|Death|1|||
131945141|NCT00251693|475088423|FG001|Overall Study|Withdrawal by Subject|17|||
131945142|NCT00251693|475088424|FG002|Overall Study|Withdrawal by Subject|14|||
131945143|NCT00251693|475088422|FG000|Overall Study|Lack of Efficacy|0|||
131455717|NCT00233064|473297206|FG000|Overall Study|Relocation|0|||
131455718|NCT00233064|473297207|FG001|Overall Study|Relocation|1|||
131455719|NCT00233064|473297206|FG000|Overall Study|Protocol Violation|1|||
131455720|NCT00233064|473297207|FG001|Overall Study|Protocol Violation|0|||
131455721|NCT00233064|473297206|FG000|Overall Study|Moved to Dom. Republic|1|||
131455722|NCT00233064|473297207|FG001|Overall Study|Moved to Dom. Republic|0|||
131455723|NCT01120964|473297214|FG000|Overall Study|Did not receive full treatment|1|||
131455724|NCT01120964|473297215|FG001|Overall Study|Did not receive full treatment|0|||
131455725|NCT00829504|473297219|FG000|First Intervention|Adverse Event|1|||
131455726|NCT00829504|473297220|FG001|First Intervention|Adverse Event|0|||
131455727|NCT00829504|473297219|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131455728|NCT00829504|473297220|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131455729|NCT00829504|473297219|FG000|Second Intervention|Physician Decision|1|||
131455730|NCT00829504|473297220|FG001|Second Intervention|Physician Decision|0|||
131455731|NCT03212144|473297221|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
131455732|NCT03212144|473297222|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
131455733|NCT03212144|473297221|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
131455734|NCT03212144|473297222|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
131455735|NCT00599339|473297223|FG000|Overall Study|Adverse Event|79|||
131455736|NCT00599339|473297223|FG000|Overall Study|Withdrawal by Subject|137|||
131455737|NCT00599339|473297223|FG000|Overall Study|Other Reason|179|||
131455738|NCT00599339|473297223|FG000|Overall Study|Lost to Follow-up|221|||
131945144|NCT00251693|475088423|FG001|Overall Study|Lack of Efficacy|1|||
131945145|NCT00251693|475088424|FG002|Overall Study|Lack of Efficacy|0|||
131945146|NCT00251693|475088422|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
131945147|NCT00251693|475088423|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
131455739|NCT00599339|473297223|FG000|Overall Study|No valid data consent|36|||
131455740|NCT00599339|473297223|FG000|Overall Study|Study Termination Status Unknown|12|||
131455741|NCT05564052|473297224|FG000|Overall Study|Withdrawal by Subject|0|||
131455742|NCT05564052|473297225|FG001|Overall Study|Withdrawal by Subject|0|||
131455743|NCT05564052|473297226|FG002|Overall Study|Withdrawal by Subject|0|||
131945148|NCT00251693|475088424|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
131455744|NCT05564052|473297227|FG003|Overall Study|Withdrawal by Subject|1|||
131455745|NCT02923921|473298558|FG000|Overall Study|Sponsor Decision|39|||
131455746|NCT02923921|473298559|FG001|Overall Study|Sponsor Decision|38|||
131455747|NCT02923921|473298558|FG000|Overall Study|Lost to Follow-up|1|||
131455748|NCT02923921|473298559|FG001|Overall Study|Lost to Follow-up|0|||
131455749|NCT02923921|473298558|FG000|Overall Study|Withdrawal by Subject|6|||
131455750|NCT02923921|473298559|FG001|Overall Study|Withdrawal by Subject|13|||
131455751|NCT02923921|473298558|FG000|Overall Study|Unknown, Not Collected|7|||
131945149|NCT00251693|475088422|FG000|Overall Study|Noncompliant|0|||
131945150|NCT00251693|475088423|FG001|Overall Study|Noncompliant|0|||
131945151|NCT00251693|475088424|FG002|Overall Study|Noncompliant|2|||
131945152|NCT00251693|475088422|FG000|Overall Study|Possible Barrett's esophagus|3|||
131945153|NCT00251693|475088423|FG001|Overall Study|Possible Barrett's esophagus|5|||
131945154|NCT00251693|475088424|FG002|Overall Study|Possible Barrett's esophagus|2|||
131945155|NCT00251693|475088422|FG000|Overall Study|Subject request/subject unavailable|1|||
131945156|NCT00251693|475088423|FG001|Overall Study|Subject request/subject unavailable|2|||
131945157|NCT00251693|475088424|FG002|Overall Study|Subject request/subject unavailable|0|||
131945158|NCT00251693|475088422|FG000|Overall Study|Abnormal laboratory findings|0|||
131945159|NCT00251693|475088423|FG001|Overall Study|Abnormal laboratory findings|0|||
131945160|NCT00251693|475088424|FG002|Overall Study|Abnormal laboratory findings|1|||
131945161|NCT02779777|475088425|FG000|Overall Study|Disease Progression|1|||
131945162|NCT02779777|475088426|FG001|Overall Study|Disease Progression|0|||
131945163|NCT02779777|475088427|FG002|Overall Study|Disease Progression|0|||
131945164|NCT02779777|475088425|FG000|Overall Study|Adverse Event|3|||
131945165|NCT02779777|475088426|FG001|Overall Study|Adverse Event|1|||
131945166|NCT02779777|475088427|FG002|Overall Study|Adverse Event|0|||
131945167|NCT02779777|475088425|FG000|Overall Study|Physician Decision|9|||
131945168|NCT02779777|475088426|FG001|Overall Study|Physician Decision|0|||
131945169|NCT02779777|475088427|FG002|Overall Study|Physician Decision|1|||
131945170|NCT02779777|475088425|FG000|Overall Study|Withdrawal by Subject|1|||
131945171|NCT02779777|475088426|FG001|Overall Study|Withdrawal by Subject|0|||
131945172|NCT02779777|475088427|FG002|Overall Study|Withdrawal by Subject|0|||
131945173|NCT04571060|475088428|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
131945174|NCT04571060|475088429|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
131945175|NCT04571060|475088428|FG000|Overall Study|Never treated migraine|47|||
131945176|NCT04571060|475088429|FG001|Overall Study|Never treated migraine|36|||
131945177|NCT04571060|475088428|FG000|Overall Study|Protocol Violation|4|||
131945178|NCT04571060|475088429|FG001|Overall Study|Protocol Violation|2|||
131945179|NCT04571060|475088428|FG000|Overall Study|Withdrawal by Subject|6|||
131945180|NCT04571060|475088429|FG001|Overall Study|Withdrawal by Subject|2|||
131945181|NCT04571060|475088428|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
131945182|NCT04571060|475088429|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
131945183|NCT00442416|475088430|FG000|Overall Study|Adverse Event|4|||
131945184|NCT00442416|475088431|FG001|Overall Study|Adverse Event|1|||
131945185|NCT00442416|475088430|FG000|Overall Study|Death|1|||
131945186|NCT00442416|475088431|FG001|Overall Study|Death|0|||
131945187|NCT00442416|475088430|FG000|Overall Study|Lack of Efficacy|2|||
131455752|NCT02923921|473298559|FG001|Overall Study|Unknown, Not Collected|6|||
131455753|NCT00479687|473298560|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
131945188|NCT00442416|475088431|FG001|Overall Study|Lack of Efficacy|0|||
131945189|NCT00442416|475088430|FG000|Overall Study|Protocol Violation|2|||
131945190|NCT00442416|475088431|FG001|Overall Study|Protocol Violation|3|||
131945191|NCT00442416|475088430|FG000|Overall Study|Withdrew consent|1|||
131945192|NCT00442416|475088431|FG001|Overall Study|Withdrew consent|2|||
131945193|NCT00442416|475088430|FG000|Overall Study|Administrative/Other|27|||
131945194|NCT00442416|475088431|FG001|Overall Study|Administrative/Other|33|||
131945195|NCT00087698|475088433|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
131945196|NCT00087698|475088433|FG000|Overall Study|Death from Other Causes|3|||
131945197|NCT00087698|475088433|FG000|Overall Study|Adverse Event|4|||
131945198|NCT00087698|475088433|FG000|Overall Study|Withdrawal by Subject|4|||
131455754|NCT00479687|473298561|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
131455755|NCT00479687|473298562|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
131455756|NCT00479687|473298560|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
131945199|NCT00087698|475088433|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
131945200|NCT00087698|475088433|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
131945201|NCT00087698|475088433|FG000|Overall Study|Clinical Relapse|1|||
131945202|NCT00087698|475088433|FG000|Overall Study|Death from Study Disease|2|||
131945203|NCT00087698|475088433|FG000|Overall Study|Death from Study Drug Toxicity|2|||
131945204|NCT00087698|475088433|FG000|Overall Study|Protocol Violation|1|||
131945205|NCT01284959|475088436|FG000|Overall Study|Withdrawal by Subject|1|||
131945206|NCT01284959|475088437|FG001|Overall Study|Withdrawal by Subject|0|||
131455757|NCT00479687|473298561|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
131945207|NCT01284959|475088438|FG002|Overall Study|Withdrawal by Subject|0|||
131945208|NCT01284959|475088436|FG000|Overall Study|Adverse Event|0|||
131945209|NCT01284959|475088437|FG001|Overall Study|Adverse Event|0|||
131945210|NCT01284959|475088438|FG002|Overall Study|Adverse Event|1|||
131945211|NCT00401843|475088439|FG000|Overall Study|Achieved Complete Response|1|||
131945212|NCT00401843|475088440|FG001|Overall Study|Achieved Complete Response|5|||
131945213|NCT00401843|475088441|FG002|Overall Study|Achieved Complete Response|11|||
131945214|NCT00401843|475088439|FG000|Overall Study|Adverse Event|7|||
131945215|NCT00401843|475088440|FG001|Overall Study|Adverse Event|26|||
131945216|NCT00401843|475088441|FG002|Overall Study|Adverse Event|27|||
131945217|NCT00401843|475088439|FG000|Overall Study|Death|0|||
131945218|NCT00401843|475088440|FG001|Overall Study|Death|8|||
131945219|NCT00401843|475088441|FG002|Overall Study|Death|10|||
131945220|NCT00401843|475088439|FG000|Overall Study|Disease progression|10|||
131945221|NCT00401843|475088440|FG001|Overall Study|Disease progression|60|||
131945222|NCT00401843|475088441|FG002|Overall Study|Disease progression|49|||
131945223|NCT00401843|475088439|FG000|Overall Study|End of Study|1|||
131945224|NCT00401843|475088440|FG001|Overall Study|End of Study|1|||
131945225|NCT00401843|475088441|FG002|Overall Study|End of Study|2|||
131945226|NCT00401843|475088439|FG000|Overall Study|Lost to Follow-up|0|||
131945227|NCT00401843|475088440|FG001|Overall Study|Lost to Follow-up|0|||
131945228|NCT00401843|475088441|FG002|Overall Study|Lost to Follow-up|2|||
131945229|NCT00401843|475088439|FG000|Overall Study|Other Unspecified|0|||
131945230|NCT00401843|475088440|FG001|Overall Study|Other Unspecified|3|||
131945231|NCT00401843|475088441|FG002|Overall Study|Other Unspecified|5|||
131945232|NCT00401843|475088439|FG000|Overall Study|Physician Decision|0|||
131945233|NCT00401843|475088440|FG001|Overall Study|Physician Decision|16|||
131945234|NCT00401843|475088441|FG002|Overall Study|Physician Decision|10|||
131945235|NCT00401843|475088439|FG000|Overall Study|Protocol Violation|0|||
131945236|NCT00401843|475088440|FG001|Overall Study|Protocol Violation|0|||
131945237|NCT00401843|475088441|FG002|Overall Study|Protocol Violation|1|||
131945238|NCT00401843|475088439|FG000|Overall Study|Withdrawal by Subject|1|||
131945239|NCT00401843|475088440|FG001|Overall Study|Withdrawal by Subject|5|||
131945240|NCT00401843|475088441|FG002|Overall Study|Withdrawal by Subject|5|||
131945241|NCT00401843|475088439|FG000|Overall Study|Withdrawal of consent to study agent|1|||
131945242|NCT00401843|475088440|FG001|Overall Study|Withdrawal of consent to study agent|15|||
131945243|NCT00401843|475088441|FG002|Overall Study|Withdrawal of consent to study agent|17|||
131945244|NCT00401843|475088439|FG000|Overall Study|Randomized but not Treated|0|||
131945245|NCT00401843|475088440|FG001|Overall Study|Randomized but not Treated|2|||
131945246|NCT00401843|475088441|FG002|Overall Study|Randomized but not Treated|3|||
131945247|NCT00401843|475088439|FG000|Overall Study|Received incorrect treatment|0|||
131945248|NCT00401843|475088440|FG001|Overall Study|Received incorrect treatment|3|||
131945249|NCT00401843|475088441|FG002|Overall Study|Received incorrect treatment|0|||
131945250|NCT01508910|475088444|FG000|Treatment|Death|2|||
131945251|NCT01508910|475088445|FG001|Treatment|Death|3|||
131945252|NCT01508910|475088446|FG002|Treatment|Death|2|||
131945253|NCT01508910|475088447|FG003|Treatment|Death|0|||
131945254|NCT01508910|475088444|FG000|Treatment|Lost to Follow-up|0|||
131945255|NCT01508910|475088445|FG001|Treatment|Lost to Follow-up|0|||
131945256|NCT01508910|475088446|FG002|Treatment|Lost to Follow-up|2|||
131945257|NCT01508910|475088447|FG003|Treatment|Lost to Follow-up|1|||
131945258|NCT01508910|475088444|FG000|Treatment|Withdrawal by Subject|0|||
131945259|NCT01508910|475088445|FG001|Treatment|Withdrawal by Subject|1|||
131945260|NCT01508910|475088446|FG002|Treatment|Withdrawal by Subject|6|||
131945261|NCT01508910|475088447|FG003|Treatment|Withdrawal by Subject|1|||
131945262|NCT01508910|475088444|FG000|Treatment|Sponsor Decision|0|||
131945263|NCT01508910|475088445|FG001|Treatment|Sponsor Decision|0|||
131945264|NCT01508910|475088446|FG002|Treatment|Sponsor Decision|0|||
131945265|NCT01508910|475088447|FG003|Treatment|Sponsor Decision|1|||
131945266|NCT01900665|475088452|FG000|Placebo Controlled Period|Death|9|||
131945267|NCT01900665|475088453|FG001|Placebo Controlled Period|Death|16|||
131945268|NCT01900665|475088452|FG000|Placebo Controlled Period|Adverse Event|48|||
131945269|NCT01900665|475088453|FG001|Placebo Controlled Period|Adverse Event|39|||
131945270|NCT01900665|475088452|FG000|Placebo Controlled Period|Protocol Violation|1|||
131945271|NCT01900665|475088453|FG001|Placebo Controlled Period|Protocol Violation|7|||
131945272|NCT01900665|475088452|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
131945273|NCT01900665|475088453|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
131945274|NCT01900665|475088452|FG000|Placebo Controlled Period|Physician Decision|11|||
131945275|NCT01900665|475088453|FG001|Placebo Controlled Period|Physician Decision|7|||
131945276|NCT01900665|475088452|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
131945277|NCT01900665|475088453|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
131945278|NCT01900665|475088452|FG000|Placebo Controlled Period|Caregiver Decision|33|||
131945279|NCT01900665|475088453|FG001|Placebo Controlled Period|Caregiver Decision|41|||
131945280|NCT01900665|475088452|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
131945281|NCT01900665|475088453|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
131945282|NCT01900665|475088452|FG000|Open Label Period|Adverse Event|16|||
131945283|NCT01900665|475088453|FG001|Open Label Period|Adverse Event|20|||
131945284|NCT01900665|475088452|FG000|Open Label Period|Death|5|||
131945285|NCT01900665|475088453|FG001|Open Label Period|Death|6|||
131945286|NCT01900665|475088452|FG000|Open Label Period|Lost to Follow-up|1|||
131945287|NCT01900665|475088453|FG001|Open Label Period|Lost to Follow-up|1|||
131945288|NCT01900665|475088452|FG000|Open Label Period|Parent/Caregiver Decision|33|||
131945289|NCT01900665|475088453|FG001|Open Label Period|Parent/Caregiver Decision|34|||
131945290|NCT01900665|475088452|FG000|Open Label Period|Physician Decision|4|||
131945291|NCT01900665|475088453|FG001|Open Label Period|Physician Decision|4|||
131945292|NCT01900665|475088452|FG000|Open Label Period|Protocol Violation|0|||
131945293|NCT01900665|475088453|FG001|Open Label Period|Protocol Violation|1|||
131945294|NCT01900665|475088452|FG000|Open Label Period|Sponsor Decision|802|||
131945295|NCT01900665|475088453|FG001|Open Label Period|Sponsor Decision|765|||
131945296|NCT01900665|475088452|FG000|Open Label Period|Withdrawal by Subject|20|||
131945297|NCT01900665|475088453|FG001|Open Label Period|Withdrawal by Subject|28|||
131945298|NCT04749914|475088454|FG000|Period 1|Adverse Event|1|||
131945299|NCT04749914|475088455|FG001|Period 1|Adverse Event|0|||
131945300|NCT04749914|475088456|FG002|Period 1|Adverse Event|0|||
131945301|NCT04749914|475088457|FG003|Period 1|Adverse Event|0|||
131945302|NCT04749914|475088454|FG000|Period 1|Withdrawal by Subject|1|||
131945303|NCT04749914|475088455|FG001|Period 1|Withdrawal by Subject|0|||
131945304|NCT04749914|475088456|FG002|Period 1|Withdrawal by Subject|1|||
131945305|NCT04749914|475088457|FG003|Period 1|Withdrawal by Subject|0|||
131945306|NCT00953706|475088458|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
131945307|NCT00953706|475088459|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
131945308|NCT00953706|475088460|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
131945309|NCT00953706|475088461|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
131945310|NCT00953706|475088458|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
131945311|NCT00953706|475088459|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
131945312|NCT00953706|475088460|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
131945313|NCT00953706|475088461|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
131945314|NCT00953706|475088458|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
131945315|NCT00953706|475088459|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
131945316|NCT00953706|475088460|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
131945317|NCT00953706|475088461|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
131945318|NCT00953706|475088458|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
131945319|NCT00953706|475088459|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
131945320|NCT00953706|475088460|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
131945321|NCT00953706|475088461|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
131945322|NCT00953706|475088458|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
131945323|NCT00953706|475088459|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
131945324|NCT00953706|475088460|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
131945325|NCT00953706|475088461|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
131945326|NCT00953706|475088458|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
131945327|NCT00953706|475088459|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
131945328|NCT00953706|475088460|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
131945329|NCT00953706|475088461|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
131945330|NCT00953706|475088458|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
131945331|NCT00953706|475088459|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
131945332|NCT00953706|475088460|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
131945333|NCT00953706|475088461|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
131945334|NCT00953706|475088458|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
131945335|NCT00953706|475088459|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
131945336|NCT00953706|475088460|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
131945337|NCT00953706|475088461|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
131945338|NCT00953706|475088458|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
131945339|NCT00953706|475088459|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
131945340|NCT00953706|475088460|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
131945341|NCT00953706|475088461|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
131945342|NCT00953706|475088458|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
131945343|NCT00953706|475088459|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
131945344|NCT00953706|475088460|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
131945345|NCT00953706|475088461|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
131945346|NCT00953706|475088458|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
131945347|NCT00953706|475088459|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
131945348|NCT00953706|475088460|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
131945349|NCT00953706|475088461|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
131945350|NCT02670473|475088462|FG000|Overall Study|Withdrawal by Subject|1|||
131945351|NCT01404234|475088463|FG000|Overall Study|Withdrawal by Subject|2|||
131945352|NCT05223673|475088464|FG000|Overall Study|Protocol Violation|1|||
131945353|NCT05223673|475088464|FG000|Overall Study|Study termination|6|||
131945354|NCT00938912|475089826|FG000|Overall Study|Withdrawal by Subject|28|||
131455758|NCT00479687|473298562|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
131455759|NCT00479687|473298560|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
131455760|NCT00479687|473298561|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
131455761|NCT00479687|473298562|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
131455762|NCT00479687|473298560|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
131455763|NCT00479687|473298561|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
131455764|NCT00479687|473298562|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
131455765|NCT00479687|473298560|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
131455766|NCT00479687|473298561|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
131455767|NCT00479687|473298562|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
131455768|NCT00479687|473298560|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
131455769|NCT00479687|473298561|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
131455770|NCT00479687|473298562|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
131455771|NCT00479687|473298560|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
131455772|NCT00479687|473298561|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
131455773|NCT00479687|473298562|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
131455774|NCT00479687|473298560|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
131455775|NCT00479687|473298561|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
131455776|NCT00479687|473298562|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
131455777|NCT00479687|473298560|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
131455778|NCT00479687|473298561|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
131455779|NCT00479687|473298562|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
131455780|NCT00295880|473298563|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
131455781|NCT00295880|473298563|FG000|Overall Study|Unit randomization did not occur|1|||
131455782|NCT01474239|473298564|FG000|Overall Study|Disease Progression|37|||
131455783|NCT01474239|473298565|FG001|Overall Study|Disease Progression|25|||
131455784|NCT01474239|473298564|FG000|Overall Study|Adverse Event|12|||
131455785|NCT01474239|473298565|FG001|Overall Study|Adverse Event|3|||
131455786|NCT01474239|473298564|FG000|Overall Study|Withdrawal by Subject|1|||
131455787|NCT01474239|473298565|FG001|Overall Study|Withdrawal by Subject|2|||
131455788|NCT01474239|473298564|FG000|Overall Study|Death|1|||
131455789|NCT01474239|473298565|FG001|Overall Study|Death|1|||
131455790|NCT01474239|473298564|FG000|Overall Study|Clinical Disease Progression|7|||
131455791|NCT01474239|473298565|FG001|Overall Study|Clinical Disease Progression|1|||
131455792|NCT01474239|473298564|FG000|Overall Study|Withdrawal for Economic Reason|1|||
131455793|NCT01474239|473298565|FG001|Overall Study|Withdrawal for Economic Reason|0|||
131455794|NCT03860818|473298566|FG000|Overall Study|Death|144|||
131455795|NCT03860818|473298567|FG001|Overall Study|Death|195|||
131455796|NCT03860818|473298566|FG000|Overall Study|Graft Loss|32|||
131455797|NCT03860818|473298567|FG001|Overall Study|Graft Loss|45|||
131455798|NCT03126344|473298568|FG000|Overall Study|Lost to Follow-up|0|||
131455799|NCT03126344|473298569|FG001|Overall Study|Lost to Follow-up|0|||
131455800|NCT03126344|473298570|FG002|Overall Study|Lost to Follow-up|5|||
131455801|NCT01139008|473298571|FG000|Overall Study|Withdrawal by Subject|5|||
131455802|NCT01139008|473298571|FG000|Overall Study|Non-compliant, lost product|1|||
131455803|NCT01715857|473298572|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
131455804|NCT00505778|473298573|FG000|Overall Study|Adverse Event|2|||
131455805|NCT00505778|473298574|FG001|Overall Study|Adverse Event|7|||
131455806|NCT00505778|473298573|FG000|Overall Study|Physician Decision|8|||
131455807|NCT00505778|473298574|FG001|Overall Study|Physician Decision|14|||
131455808|NCT00505778|473298573|FG000|Overall Study|Lost to Follow-up|17|||
131455809|NCT00505778|473298574|FG001|Overall Study|Lost to Follow-up|23|||
131455810|NCT00505778|473298573|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
131455811|NCT00505778|473298574|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
131455812|NCT00505778|473298573|FG000|Overall Study|Protocol Violation|7|||
131455813|NCT00505778|473298574|FG001|Overall Study|Protocol Violation|9|||
131455814|NCT00505778|473298573|FG000|Overall Study|Withdrawal by Subject|29|||
131455815|NCT00505778|473298574|FG001|Overall Study|Withdrawal by Subject|14|||
131455816|NCT00505778|473298573|FG000|Overall Study|Relapse|65|||
131455817|NCT00505778|473298574|FG001|Overall Study|Relapse|65|||
131455818|NCT00505778|473298573|FG000|Overall Study|Took No Study Drug|2|||
131455819|NCT00505778|473298574|FG001|Overall Study|Took No Study Drug|2|||
131455820|NCT05367492|473298577|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
131455821|NCT05367492|473298578|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
131455822|NCT05367492|473298579|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
131945355|NCT00938912|475089826|FG000|Overall Study|Lost to Follow-up|4|||
131455823|NCT05367492|473298577|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
131455824|NCT05367492|473298578|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
131455825|NCT05367492|473298579|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
131455826|NCT05367492|473298577|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
131455827|NCT05367492|473298578|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
131455828|NCT05367492|473298579|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
131455829|NCT05367492|473298577|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
131455830|NCT05367492|473298578|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
131945356|NCT00938912|475089826|FG000|Overall Study|Lack of Efficacy|43|||
131945357|NCT00938912|475089826|FG000|Overall Study|Adverse event, non-fatal|24|||
131945358|NCT00938912|475089826|FG000|Overall Study|Adverse event, fatal|1|||
131945359|NCT00938912|475089826|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
131945360|NCT00938912|475089826|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
131945361|NCT00938912|475089826|FG000|Overall Study|Participant needed prohibit medication|1|||
131945362|NCT00938912|475089826|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
131945363|NCT00938912|475089826|FG000|Overall Study|Did not meet Eligibility criteria|1|||
131945364|NCT00938912|475089826|FG000|Overall Study|Participant relocated not related to AE|1|||
131945365|NCT00938912|475089826|FG000|Overall Study|Participant moved to another city|1|||
131945366|NCT00938912|475089826|FG000|Overall Study|Participant experienced break through seizures|1|||
131945367|NCT00938912|475089826|FG000|Overall Study|No longer wished to participate in the study|1|||
131945368|NCT00938912|475089826|FG000|Overall Study|Protocol Deviation|2|||
131945369|NCT02364037|475089827|FG000|Overall Study|Withdrawal by Subject|7|||
131945370|NCT02364037|475089828|FG001|Overall Study|Withdrawal by Subject|4|||
131945371|NCT02364037|475089827|FG000|Overall Study|Lost to Follow-up|37|||
131945372|NCT02364037|475089828|FG001|Overall Study|Lost to Follow-up|49|||
131945373|NCT00387088|475089833|FG000|Overall Study|Adverse Event|143|||
131945374|NCT00387088|475089834|FG001|Overall Study|Adverse Event|156|||
131945375|NCT00387088|475089833|FG000|Overall Study|Protocol Violation|47|||
131945376|NCT00387088|475089834|FG001|Overall Study|Protocol Violation|35|||
131945377|NCT00387088|475089833|FG000|Overall Study|Withdrawal by Subject|20|||
131945378|NCT00387088|475089834|FG001|Overall Study|Withdrawal by Subject|35|||
131945379|NCT00387088|475089833|FG000|Overall Study|Lack of Efficacy|28|||
131945380|NCT00387088|475089834|FG001|Overall Study|Lack of Efficacy|67|||
131945381|NCT00387088|475089833|FG000|Overall Study|Lost to Follow-up|22|||
131945382|NCT00387088|475089834|FG001|Overall Study|Lost to Follow-up|28|||
131945383|NCT00387088|475089833|FG000|Overall Study|Other|58|||
131945384|NCT00387088|475089834|FG001|Overall Study|Other|52|||
131945385|NCT02848092|475089837|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
131945386|NCT02848092|475089838|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
131945387|NCT02848092|475089837|FG000|1-month Post-training Follow-up|Adverse Event|2|||
131945388|NCT02848092|475089838|FG001|1-month Post-training Follow-up|Adverse Event|1|||
131945389|NCT02848092|475089837|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
131945390|NCT02848092|475089838|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
131945391|NCT02848092|475089837|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
131945392|NCT02848092|475089838|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
131945393|NCT02848092|475089837|FG000|1-month Post-training Follow-up|fatigue|0|||
131945394|NCT02848092|475089838|FG001|1-month Post-training Follow-up|fatigue|1|||
131945395|NCT02848092|475089837|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
131945396|NCT02848092|475089838|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
131945397|NCT02848092|475089837|FG000|6-month Post-training Follow-up|Adverse Event|1|||
131945398|NCT02848092|475089838|FG001|6-month Post-training Follow-up|Adverse Event|1|||
131945399|NCT02848092|475089837|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
131945400|NCT02848092|475089838|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
131945401|NCT02848092|475089837|FG000|6-month Post-training Follow-up|frustrated with task|1|||
131945402|NCT02848092|475089838|FG001|6-month Post-training Follow-up|frustrated with task|0|||
131945403|NCT02848092|475089837|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
131945404|NCT02848092|475089838|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
131945405|NCT02848092|475089837|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
131945406|NCT02848092|475089838|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
131945407|NCT01639469|475089839|FG000|Overall Study|Death|4|||
131413514|NCT03474081|473137296|FG000|Overall Study|Adverse Event|6|||
131413515|NCT03474081|473137297|FG001|Overall Study|Adverse Event|3|||
131413516|NCT03474081|473137296|FG000|Overall Study|Lost to Follow-up|2|||
131413517|NCT03474081|473137297|FG001|Overall Study|Lost to Follow-up|1|||
131413518|NCT03474081|473137296|FG000|Overall Study|Physician Decision|3|||
131413519|NCT03474081|473137297|FG001|Overall Study|Physician Decision|2|||
131413520|NCT03474081|473137296|FG000|Overall Study|Withdrawal by Subject|5|||
131413521|NCT03474081|473137297|FG001|Overall Study|Withdrawal by Subject|7|||
131413522|NCT03474081|473137296|FG000|Overall Study|Investigator site closed|1|||
131413523|NCT03474081|473137297|FG001|Overall Study|Investigator site closed|0|||
131413524|NCT01831817|473137298|FG000|Overall Study|Lost to Follow-up|1|||
131455831|NCT05367492|473298579|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
131945408|NCT01639469|475089840|FG001|Overall Study|Death|2|||
131945409|NCT01639469|475089839|FG000|Overall Study|Lost to Follow-up|1|||
131945410|NCT01639469|475089840|FG001|Overall Study|Lost to Follow-up|1|||
131413525|NCT01831817|473137299|FG001|Overall Study|Lost to Follow-up|0|||
131413526|NCT01831817|473137300|FG002|Overall Study|Lost to Follow-up|0|||
131945411|NCT00420381|475089843|FG000|Overall Study|Protocol Violation|1|||
131945412|NCT00592631|475089848|FG000|Overall Study|Lost to Follow-up|0|||
131945413|NCT00592631|475089849|FG001|Overall Study|Lost to Follow-up|2|||
131945414|NCT00443118|475089850|FG000|Overall Study|unknown primary outcome|3|||
131413527|NCT01831817|473137301|FG003|Overall Study|Lost to Follow-up|0|||
131413528|NCT01831817|473137298|FG000|Overall Study|Withdrawl of Consent|3|||
131413529|NCT01831817|473137299|FG001|Overall Study|Withdrawl of Consent|0|||
131413530|NCT01831817|473137300|FG002|Overall Study|Withdrawl of Consent|0|||
131413531|NCT01831817|473137301|FG003|Overall Study|Withdrawl of Consent|0|||
131413532|NCT02198235|473137303|FG000|Overall Study|Lost to Follow-up|3|||
131413533|NCT02198235|473137304|FG001|Overall Study|Lost to Follow-up|2|||
131413534|NCT02198235|473137305|FG002|Overall Study|Lost to Follow-up|2|||
131413535|NCT04573881|473137308|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
131413536|NCT00528996|473138856|FG000|Overall Study|Other reasons than listing|6|||
131413537|NCT00528996|473138857|FG001|Overall Study|Other reasons than listing|7|||
131413538|NCT00528996|473138858|FG002|Overall Study|Other reasons than listing|14|||
131413539|NCT00528996|473138859|FG003|Overall Study|Other reasons than listing|11|||
131413540|NCT00528996|473138860|FG004|Overall Study|Other reasons than listing|5|||
131413541|NCT00528996|473138856|FG000|Overall Study|Refused continue medication|16|||
131413542|NCT00528996|473138857|FG001|Overall Study|Refused continue medication|0|||
131413543|NCT00528996|473138858|FG002|Overall Study|Refused continue medication|3|||
131413544|NCT00528996|473138859|FG003|Overall Study|Refused continue medication|3|||
131413545|NCT00528996|473138860|FG004|Overall Study|Refused continue medication|6|||
131413546|NCT00528996|473138856|FG000|Overall Study|Lost to Follow-up|2|||
131413547|NCT00528996|473138857|FG001|Overall Study|Lost to Follow-up|0|||
131413548|NCT00528996|473138858|FG002|Overall Study|Lost to Follow-up|4|||
131413549|NCT00528996|473138859|FG003|Overall Study|Lost to Follow-up|1|||
131945415|NCT00443118|475089851|FG001|Overall Study|unknown primary outcome|1|||
131945416|NCT00443118|475089852|FG002|Overall Study|unknown primary outcome|0|||
131945417|NCT00443118|475089850|FG000|Overall Study|Withdrawal by Subject|1|||
131945418|NCT00443118|475089851|FG001|Overall Study|Withdrawal by Subject|0|||
131945419|NCT00443118|475089852|FG002|Overall Study|Withdrawal by Subject|0|||
131945420|NCT04512001|475089853|FG000|Week 0 to Week 24|Adverse Event|14|||
131945421|NCT04512001|475089854|FG001|Week 0 to Week 24|Adverse Event|10|||
131945422|NCT04512001|475089855|FG002|Week 0 to Week 24|Adverse Event|0|||
131945423|NCT04512001|475089856|FG003|Week 0 to Week 24|Adverse Event|0|||
131945424|NCT04512001|475089857|FG004|Week 0 to Week 24|Adverse Event|0|||
131945425|NCT04512001|475089853|FG000|Week 0 to Week 24|Death|0|||
131945426|NCT04512001|475089854|FG001|Week 0 to Week 24|Death|2|||
131945427|NCT04512001|475089855|FG002|Week 0 to Week 24|Death|0|||
131945428|NCT04512001|475089856|FG003|Week 0 to Week 24|Death|0|||
131945429|NCT04512001|475089857|FG004|Week 0 to Week 24|Death|0|||
131945430|NCT04512001|475089853|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
131413550|NCT00528996|473138860|FG004|Overall Study|Lost to Follow-up|3|||
131413551|NCT00528996|473138856|FG000|Overall Study|Protocol Violation|1|||
131413552|NCT00528996|473138857|FG001|Overall Study|Protocol Violation|2|||
131413553|NCT00528996|473138858|FG002|Overall Study|Protocol Violation|3|||
131413554|NCT00528996|473138859|FG003|Overall Study|Protocol Violation|3|||
131413555|NCT00528996|473138860|FG004|Overall Study|Protocol Violation|2|||
131413556|NCT00528996|473138856|FG000|Overall Study|Lack of Efficacy|7|||
131413557|NCT00528996|473138857|FG001|Overall Study|Lack of Efficacy|2|||
131413558|NCT00528996|473138858|FG002|Overall Study|Lack of Efficacy|1|||
131413559|NCT00528996|473138859|FG003|Overall Study|Lack of Efficacy|3|||
131413560|NCT00528996|473138860|FG004|Overall Study|Lack of Efficacy|3|||
131413561|NCT00528996|473138856|FG000|Overall Study|Adverse Event|32|||
131413562|NCT00528996|473138857|FG001|Overall Study|Adverse Event|13|||
131413563|NCT00528996|473138858|FG002|Overall Study|Adverse Event|18|||
131413564|NCT00528996|473138859|FG003|Overall Study|Adverse Event|29|||
131413565|NCT00528996|473138860|FG004|Overall Study|Adverse Event|18|||
131413566|NCT05565937|473138862|FG000|Overall Study|Adverse Event|0|||
131413567|NCT05565937|473138863|FG001|Overall Study|Adverse Event|1|||
131413568|NCT05565937|473138862|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
131413569|NCT05565937|473138863|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
131413570|NCT05565937|473138862|FG000|Overall Study|Lost to Follow-up|2|||
131413571|NCT05565937|473138863|FG001|Overall Study|Lost to Follow-up|0|||
131413572|NCT05565937|473138862|FG000|Overall Study|Pregnancy|0|||
131413573|NCT05565937|473138863|FG001|Overall Study|Pregnancy|2|||
131413574|NCT05565937|473138862|FG000|Overall Study|Anisometropia|0|||
131413575|NCT05565937|473138863|FG001|Overall Study|Anisometropia|1|||
131413576|NCT04544683|473138864|FG000|Overall Study|Lost to Follow-up|2|||
131413577|NCT04544683|473138864|FG000|Overall Study|Underwent cervical spine surgery|6|||
131945431|NCT04512001|475089854|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
131413578|NCT04938037|473138867|FG000|Overall Study|Lost to Follow-up|4|||
131413579|NCT04938037|473138868|FG001|Overall Study|Lost to Follow-up|3|||
131413580|NCT01806064|473138869|FG000|Overall Study|Randomized Not Enrolled|0|||
131413581|NCT01806064|473138870|FG001|Overall Study|Randomized Not Enrolled|0|||
131413582|NCT01806064|473138871|FG002|Overall Study|Randomized Not Enrolled|0|||
131413583|NCT01806064|473138872|FG003|Overall Study|Randomized Not Enrolled|1|||
131413584|NCT01806064|473138873|FG004|Overall Study|Randomized Not Enrolled|2|||
131413585|NCT01282294|473138877|FG000|Overall Study|Lost to Follow-up|14|||
131413586|NCT01282294|473138877|FG000|Overall Study|Screening failure|1|||
131455832|NCT01621802|473298580|FG000|Overall Study|Protocol Violation|0|||
131455833|NCT01621802|473298581|FG001|Overall Study|Protocol Violation|0|||
131455834|NCT01621802|473298582|FG002|Overall Study|Protocol Violation|0|||
131455835|NCT01621802|473298583|FG003|Overall Study|Protocol Violation|0|||
131455836|NCT01621802|473298584|FG004|Overall Study|Protocol Violation|0|||
131455837|NCT01621802|473298585|FG005|Overall Study|Protocol Violation|1|||
131455838|NCT01621802|473298580|FG000|Overall Study|Withdrawal by Subject|8|||
131455839|NCT01621802|473298581|FG001|Overall Study|Withdrawal by Subject|4|||
131455840|NCT01621802|473298582|FG002|Overall Study|Withdrawal by Subject|4|||
131455841|NCT01621802|473298583|FG003|Overall Study|Withdrawal by Subject|2|||
131455842|NCT01621802|473298584|FG004|Overall Study|Withdrawal by Subject|2|||
131455843|NCT01621802|473298585|FG005|Overall Study|Withdrawal by Subject|0|||
131455844|NCT01621802|473298580|FG000|Overall Study|Migrated/moved from study area|0|||
131455845|NCT01621802|473298581|FG001|Overall Study|Migrated/moved from study area|0|||
131455846|NCT01621802|473298582|FG002|Overall Study|Migrated/moved from study area|2|||
131455847|NCT01621802|473298583|FG003|Overall Study|Migrated/moved from study area|0|||
131455848|NCT01621802|473298584|FG004|Overall Study|Migrated/moved from study area|1|||
131455849|NCT01621802|473298585|FG005|Overall Study|Migrated/moved from study area|0|||
131455850|NCT01621802|473298580|FG000|Overall Study|Others|3|||
131455851|NCT01621802|473298581|FG001|Overall Study|Others|3|||
131455852|NCT01621802|473298582|FG002|Overall Study|Others|3|||
131455853|NCT01621802|473298583|FG003|Overall Study|Others|2|||
131455854|NCT01621802|473298584|FG004|Overall Study|Others|1|||
131455855|NCT01621802|473298585|FG005|Overall Study|Others|0|||
131455856|NCT01621802|473298580|FG000|Overall Study|Lost to Follow-up|36|||
131455857|NCT01621802|473298581|FG001|Overall Study|Lost to Follow-up|16|||
131455858|NCT01621802|473298582|FG002|Overall Study|Lost to Follow-up|24|||
131455859|NCT01621802|473298583|FG003|Overall Study|Lost to Follow-up|7|||
131455860|NCT01621802|473298584|FG004|Overall Study|Lost to Follow-up|31|||
131455861|NCT01621802|473298585|FG005|Overall Study|Lost to Follow-up|11|||
131455862|NCT04896086|473298586|FG000|Overall Study|Lost to Follow-up|0|||
131455863|NCT04896086|473298587|FG001|Overall Study|Lost to Follow-up|2|||
131455864|NCT04896086|473298588|FG002|Overall Study|Lost to Follow-up|1|||
131455865|NCT04896086|473298589|FG003|Overall Study|Lost to Follow-up|0|||
131455866|NCT04896086|473298590|FG004|Overall Study|Lost to Follow-up|0|||
131455867|NCT04896086|473298586|FG000|Overall Study|Physician Decision|0|||
131455868|NCT04896086|473298587|FG001|Overall Study|Physician Decision|1|||
131455869|NCT04896086|473298588|FG002|Overall Study|Physician Decision|0|||
131455870|NCT04896086|473298589|FG003|Overall Study|Physician Decision|0|||
131455871|NCT04896086|473298590|FG004|Overall Study|Physician Decision|0|||
131455872|NCT04896086|473298586|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
131455873|NCT04896086|473298587|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
131455874|NCT04896086|473298588|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
131455875|NCT04896086|473298589|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
131455876|NCT04896086|473298590|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
131455877|NCT04896086|473298586|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
131455878|NCT04896086|473298587|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
131455879|NCT04896086|473298588|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
131455880|NCT04896086|473298589|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
131455881|NCT04896086|473298590|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
131455882|NCT02249832|473298593|FG000|Overall Study|Withdrawal by Subject|3|||
131455883|NCT02249832|473298593|FG000|Overall Study|Lost to Follow-up|10|||
131455884|NCT00808080|473298601|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
131455885|NCT00423917|473298604|FG000|Overall Study|Cancel|2|||
131455886|NCT00423917|473298604|FG000|Overall Study|Ineligible|1|||
131455887|NCT03085797|473298605|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
131455888|NCT03085797|473298606|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
131455889|NCT03085797|473298605|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
131455890|NCT03085797|473298606|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
131455891|NCT03085797|473298605|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
131455892|NCT03085797|473298606|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
131455893|NCT01837823|473298607|FG000|Overall Study|Lost to Follow-up|6|||
131455894|NCT03052400|473298608|FG000|Overall Study|Lost to Follow-up|1|||
131455895|NCT03052400|473298609|FG001|Overall Study|Lost to Follow-up|0|||
131455896|NCT03052400|473298608|FG000|Overall Study|Withdrawal by Subject|0|||
131455897|NCT03052400|473298609|FG001|Overall Study|Withdrawal by Subject|1|||
131455898|NCT00555061|473298610|FG000|Overall Study|Adverse Event|3|||
131455899|NCT00555061|473298610|FG000|Overall Study|Protocol Violation|1|||
131455900|NCT00555061|473298610|FG000|Overall Study|Lost to Follow-up|2|||
131455901|NCT00555061|473298610|FG000|Overall Study|Withdrawal by Subject|2|||
131455902|NCT00555061|473298610|FG000|Overall Study|Participant enrolled, but never treated|1|||
131455903|NCT00436345|473298615|FG000|Overall Study|ICU resident beyond follow-up period|3|||
131455904|NCT00436345|473298616|FG001|Overall Study|ICU resident beyond follow-up period|0|||
131945432|NCT04512001|475089855|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
131945433|NCT04512001|475089856|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
131945434|NCT04512001|475089857|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
131945435|NCT04512001|475089853|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
131945436|NCT04512001|475089854|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
131945437|NCT04512001|475089855|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
131945438|NCT04512001|475089856|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
131945439|NCT04512001|475089857|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
131945440|NCT04512001|475089853|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
131945441|NCT04512001|475089854|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
131945442|NCT04512001|475089855|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
131945443|NCT04512001|475089856|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
131945444|NCT04512001|475089857|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
131945445|NCT04512001|475089853|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
131945446|NCT04512001|475089854|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
131945447|NCT04512001|475089855|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
131945448|NCT04512001|475089856|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
131945449|NCT04512001|475089857|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
131945450|NCT04512001|475089853|FG000|Week 24 to Week 63|Adverse Event|0|||
131945451|NCT04512001|475089854|FG001|Week 24 to Week 63|Adverse Event|0|||
131945452|NCT04512001|475089855|FG002|Week 24 to Week 63|Adverse Event|13|||
131945453|NCT04512001|475089856|FG003|Week 24 to Week 63|Adverse Event|8|||
131945454|NCT04512001|475089857|FG004|Week 24 to Week 63|Adverse Event|6|||
131945455|NCT04512001|475089853|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
131945456|NCT04512001|475089854|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
131945457|NCT04512001|475089855|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
131945458|NCT04512001|475089856|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
131945459|NCT04512001|475089857|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
131945460|NCT04512001|475089853|FG000|Week 24 to Week 63|Death|0|||
131945461|NCT04512001|475089854|FG001|Week 24 to Week 63|Death|0|||
131945462|NCT04512001|475089855|FG002|Week 24 to Week 63|Death|0|||
131945463|NCT04512001|475089856|FG003|Week 24 to Week 63|Death|1|||
131945464|NCT04512001|475089857|FG004|Week 24 to Week 63|Death|1|||
131945465|NCT04512001|475089853|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
131945466|NCT04512001|475089854|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
131945467|NCT04512001|475089855|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
131945468|NCT04512001|475089856|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
131945469|NCT04512001|475089857|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
131945470|NCT04512001|475089853|FG000|Week 24 to Week 63|Miscellaneous|0|||
131945471|NCT04512001|475089854|FG001|Week 24 to Week 63|Miscellaneous|0|||
131945472|NCT04512001|475089855|FG002|Week 24 to Week 63|Miscellaneous|3|||
131945473|NCT04512001|475089856|FG003|Week 24 to Week 63|Miscellaneous|2|||
131945474|NCT04512001|475089857|FG004|Week 24 to Week 63|Miscellaneous|1|||
131945475|NCT02776683|475089858|FG000|Pre-switch Period|Protocol Violation|1|||
131945476|NCT02776683|475089859|FG001|Pre-switch Period|Protocol Violation|0|||
131945477|NCT02776683|475089858|FG000|Pre-switch Period|Adverse Event|21|||
131945478|NCT02776683|475089859|FG001|Pre-switch Period|Adverse Event|0|||
131945479|NCT02776683|475089858|FG000|Pre-switch Period|Withdrawal by Subject|9|||
131945480|NCT02776683|475089859|FG001|Pre-switch Period|Withdrawal by Subject|0|||
131945481|NCT02776683|475089858|FG000|Pre-switch Period|Physician Decision|7|||
131945482|NCT02776683|475089859|FG001|Pre-switch Period|Physician Decision|0|||
131945483|NCT02776683|475089858|FG000|Pre-switch Period|Progressive disease|39|||
131945484|NCT02776683|475089859|FG001|Pre-switch Period|Progressive disease|0|||
131945485|NCT02776683|475089858|FG000|Pre-switch Period|Other than listed|3|||
131945486|NCT02776683|475089859|FG001|Pre-switch Period|Other than listed|0|||
131945487|NCT02776683|475089858|FG000|Post-switch Period|Adverse Event|0|||
131945488|NCT02776683|475089859|FG001|Post-switch Period|Adverse Event|3|||
131945489|NCT02776683|475089858|FG000|Post-switch Period|Withdrawal by Subject|0|||
131945490|NCT02776683|475089859|FG001|Post-switch Period|Withdrawal by Subject|2|||
131945491|NCT02776683|475089858|FG000|Post-switch Period|Physician Decision|0|||
131413587|NCT01282294|473138877|FG000|Overall Study|Adverse Event|1|||
131413588|NCT01282294|473138877|FG000|Overall Study|Patient non-compliance|2|||
131413589|NCT01282294|473138877|FG000|Overall Study|Physician Decision|1|||
131413590|NCT02943915|473138878|FG000|Overall Study|Withdrawal by Subject|2|||
131413591|NCT02943915|473138879|FG001|Overall Study|Withdrawal by Subject|1|||
131413592|NCT02943915|473138880|FG002|Overall Study|Withdrawal by Subject|0|||
131945492|NCT02776683|475089859|FG001|Post-switch Period|Physician Decision|3|||
131945493|NCT02776683|475089858|FG000|Post-switch Period|Progressive disease|0|||
131945494|NCT02776683|475089859|FG001|Post-switch Period|Progressive disease|20|||
131945495|NCT02776683|475089858|FG000|Post-switch Period|Other than listed|0|||
131945496|NCT02776683|475089859|FG001|Post-switch Period|Other than listed|15|||
131945497|NCT04232943|475089864|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
131945498|NCT04232943|475089865|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
131413593|NCT02943915|473138881|FG003|Overall Study|Withdrawal by Subject|0|||
131945499|NCT04232943|475089866|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
131945500|NCT04232943|475089864|FG000|Overall Study|Withdrawal by Subject|1|||
131945501|NCT04232943|475089865|FG001|Overall Study|Withdrawal by Subject|1|||
131945502|NCT04232943|475089866|FG002|Overall Study|Withdrawal by Subject|0|||
131945503|NCT01664247|475089868|FG000|Overall Study|Adverse Event|5|||
131945504|NCT01664247|475089869|FG001|Overall Study|Adverse Event|3|||
131945505|NCT01664247|475089868|FG000|Overall Study|Protocol Violation|3|||
131945506|NCT01664247|475089869|FG001|Overall Study|Protocol Violation|5|||
131945507|NCT01664247|475089868|FG000|Overall Study|Withdrawal Criteria|1|||
131945508|NCT01664247|475089869|FG001|Overall Study|Withdrawal Criteria|4|||
131945509|NCT01664247|475089868|FG000|Overall Study|Unclassified|5|||
131945510|NCT01664247|475089869|FG001|Overall Study|Unclassified|29|||
131945511|NCT01106157|475089870|FG000|Overall Study|Withdrawal by Subject|1|||
131945512|NCT01106157|475089871|FG001|Overall Study|Withdrawal by Subject|0|||
131945513|NCT02298868|475089872|FG000|Overall Study|Adverse Event|1|||
131945514|NCT02298868|475089872|FG000|Overall Study|Death|1|||
131945515|NCT02298868|475089872|FG000|Overall Study|Patient underwent transplant|1|||
131945516|NCT01000506|475089873|FG000|Overall Study|Adverse Event|6|||
131945517|NCT01000506|475089874|FG001|Overall Study|Adverse Event|5|||
131945518|NCT01000506|475089875|FG002|Overall Study|Adverse Event|8|||
131945519|NCT01000506|475089876|FG003|Overall Study|Adverse Event|9|||
131945520|NCT01000506|475089873|FG000|Overall Study|Lack of Efficacy|8|||
131945521|NCT01000506|475089874|FG001|Overall Study|Lack of Efficacy|6|||
131945522|NCT01000506|475089875|FG002|Overall Study|Lack of Efficacy|4|||
131945523|NCT01000506|475089876|FG003|Overall Study|Lack of Efficacy|4|||
131945524|NCT01000506|475089873|FG000|Overall Study|Protocol Violation|1|||
131945525|NCT01000506|475089874|FG001|Overall Study|Protocol Violation|1|||
131945526|NCT01000506|475089875|FG002|Overall Study|Protocol Violation|0|||
131945527|NCT01000506|475089876|FG003|Overall Study|Protocol Violation|0|||
131945528|NCT01000506|475089873|FG000|Overall Study|Lost to Follow-up|1|||
131945529|NCT01000506|475089874|FG001|Overall Study|Lost to Follow-up|1|||
131945530|NCT01000506|475089875|FG002|Overall Study|Lost to Follow-up|4|||
131945531|NCT01000506|475089876|FG003|Overall Study|Lost to Follow-up|0|||
131945532|NCT01000506|475089873|FG000|Overall Study|Physician Decision|1|||
131945533|NCT01000506|475089874|FG001|Overall Study|Physician Decision|3|||
131945534|NCT01000506|475089875|FG002|Overall Study|Physician Decision|3|||
131945535|NCT01000506|475089876|FG003|Overall Study|Physician Decision|3|||
131945536|NCT01000506|475089873|FG000|Overall Study|Withdrawal by Subject|11|||
131945537|NCT01000506|475089874|FG001|Overall Study|Withdrawal by Subject|8|||
131945538|NCT01000506|475089875|FG002|Overall Study|Withdrawal by Subject|2|||
131945539|NCT01000506|475089876|FG003|Overall Study|Withdrawal by Subject|7|||
131945540|NCT02141672|475089877|FG000|Overall Study|Adverse Event|0|||
131945541|NCT02141672|475089878|FG001|Overall Study|Adverse Event|1|||
131945542|NCT02141672|475089879|FG002|Overall Study|Adverse Event|0|||
131945543|NCT02141672|475089877|FG000|Overall Study|Death|10|||
131945544|NCT02141672|475089878|FG001|Overall Study|Death|2|||
131945545|NCT02141672|475089879|FG002|Overall Study|Death|1|||
131945546|NCT02141672|475089877|FG000|Overall Study|Lack of Efficacy|0|||
131945547|NCT02141672|475089878|FG001|Overall Study|Lack of Efficacy|0|||
131945548|NCT02141672|475089879|FG002|Overall Study|Lack of Efficacy|2|||
131945549|NCT02141672|475089877|FG000|Overall Study|Lost to Follow-up|1|||
131945550|NCT02141672|475089878|FG001|Overall Study|Lost to Follow-up|1|||
131945551|NCT02141672|475089879|FG002|Overall Study|Lost to Follow-up|3|||
131945552|NCT02141672|475089877|FG000|Overall Study|Physician Decision|1|||
131945553|NCT02141672|475089878|FG001|Overall Study|Physician Decision|2|||
131945554|NCT02141672|475089879|FG002|Overall Study|Physician Decision|5|||
131945555|NCT02141672|475089877|FG000|Overall Study|Protocol Violation|0|||
131945556|NCT02141672|475089878|FG001|Overall Study|Protocol Violation|0|||
131945557|NCT02141672|475089879|FG002|Overall Study|Protocol Violation|1|||
131945558|NCT02141672|475089877|FG000|Overall Study|Withdrawal by Subject|3|||
131945559|NCT02141672|475089878|FG001|Overall Study|Withdrawal by Subject|2|||
131945560|NCT02141672|475089879|FG002|Overall Study|Withdrawal by Subject|5|||
131945561|NCT02141672|475089877|FG000|Overall Study|refused to follow-up|1|||
131945562|NCT02141672|475089878|FG001|Overall Study|refused to follow-up|0|||
131945563|NCT02141672|475089879|FG002|Overall Study|refused to follow-up|1|||
131945564|NCT01118780|475089880|FG000|Overall Study|Adverse Event|15|||
131945565|NCT01118780|475089881|FG001|Overall Study|Adverse Event|15|||
131945566|NCT01118780|475089880|FG000|Overall Study|Death|1|||
131945567|NCT01118780|475089881|FG001|Overall Study|Death|0|||
131945568|NCT01118780|475089880|FG000|Overall Study|Lack of Efficacy|2|||
131945569|NCT01118780|475089881|FG001|Overall Study|Lack of Efficacy|6|||
131945570|NCT01118780|475089880|FG000|Overall Study|Physician Decision|2|||
131945571|NCT01118780|475089881|FG001|Overall Study|Physician Decision|0|||
131945572|NCT01118780|475089880|FG000|Overall Study|Protocol Violation|3|||
131945573|NCT01118780|475089881|FG001|Overall Study|Protocol Violation|6|||
131945574|NCT01118780|475089880|FG000|Overall Study|Withdrawal by Subject|13|||
131945575|NCT01118780|475089881|FG001|Overall Study|Withdrawal by Subject|8|||
131945576|NCT03637491|475089883|FG000|Overall Study|Death|9|||
131945577|NCT03637491|475089884|FG001|Overall Study|Death|9|||
131945578|NCT03637491|475089885|FG002|Overall Study|Death|5|||
131945579|NCT03637491|475089886|FG003|Overall Study|Death|3|||
131945580|NCT03637491|475089883|FG000|Overall Study|Lost to Follow-up|0|||
131945581|NCT03637491|475089884|FG001|Overall Study|Lost to Follow-up|1|||
131945582|NCT03637491|475089885|FG002|Overall Study|Lost to Follow-up|0|||
131945583|NCT03637491|475089886|FG003|Overall Study|Lost to Follow-up|1|||
131945584|NCT03637491|475089883|FG000|Overall Study|Study Terminated By Sponsor|0|||
131945585|NCT03637491|475089884|FG001|Overall Study|Study Terminated By Sponsor|2|||
131945586|NCT03637491|475089885|FG002|Overall Study|Study Terminated By Sponsor|1|||
131945587|NCT03637491|475089886|FG003|Overall Study|Study Terminated By Sponsor|0|||
131945588|NCT03637491|475089883|FG000|Overall Study|Withdrawal by Subject|1|||
131945589|NCT03637491|475089884|FG001|Overall Study|Withdrawal by Subject|0|||
131945590|NCT03637491|475089885|FG002|Overall Study|Withdrawal by Subject|1|||
131945591|NCT03637491|475089886|FG003|Overall Study|Withdrawal by Subject|2|||
131945592|NCT03465722|475089890|FG000|Overall Study|Withdrawal by Subject|21|||
131945593|NCT03465722|475089891|FG001|Overall Study|Withdrawal by Subject|14|||
131945594|NCT03465722|475089890|FG000|Overall Study|Death|89|||
131945595|NCT03465722|475089891|FG001|Overall Study|Death|87|||
131945596|NCT03465722|475089890|FG000|Overall Study|Lost to Follow-up|5|||
131945597|NCT03465722|475089891|FG001|Overall Study|Lost to Follow-up|3|||
131945598|NCT03465722|475089890|FG000|Overall Study|Administrative/Other|33|||
131945599|NCT03465722|475089891|FG001|Overall Study|Administrative/Other|32|||
131945600|NCT03465722|475089890|FG000|Overall Study|Not treated|1|||
131945601|NCT03465722|475089891|FG001|Overall Study|Not treated|2|||
131945602|NCT03465722|475089890|FG000|Overall Study|Sponsor decision|91|||
131945603|NCT03465722|475089891|FG001|Overall Study|Sponsor decision|98|||
131945604|NCT04940130|475089894|FG000|Overall Study|Travel|1|||
131945605|NCT04940130|475089895|FG001|Overall Study|Travel|0|||
131945606|NCT04940130|475089896|FG002|Overall Study|Travel|2|||
131945607|NCT04940130|475089894|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
131945608|NCT04940130|475089895|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
131945609|NCT04940130|475089896|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
131945610|NCT04940130|475089894|FG000|Overall Study|Adverse Event|0|||
131945611|NCT04940130|475089895|FG001|Overall Study|Adverse Event|0|||
131945612|NCT04940130|475089896|FG002|Overall Study|Adverse Event|2|||
131945613|NCT04940130|475089894|FG000|Overall Study|Disease progression/treatment failure|0|||
131945614|NCT04940130|475089895|FG001|Overall Study|Disease progression/treatment failure|0|||
131945615|NCT04940130|475089896|FG002|Overall Study|Disease progression/treatment failure|1|||
131945616|NCT04940130|475089894|FG000|Overall Study|Participant refusal|0|||
131945617|NCT04940130|475089895|FG001|Overall Study|Participant refusal|0|||
131945618|NCT04940130|475089896|FG002|Overall Study|Participant refusal|1|||
131945619|NCT02240121|475089897|FG000|Overall Study|Protocol Violation|1|||
131945620|NCT02240121|475089898|FG001|Overall Study|Protocol Violation|2|||
131945621|NCT02240121|475089897|FG000|Overall Study|Physician Decision|0|||
131945622|NCT02240121|475089898|FG001|Overall Study|Physician Decision|1|||
131945623|NCT02240121|475089897|FG000|Overall Study|Change in protocol interpretation|1|||
131945624|NCT02240121|475089898|FG001|Overall Study|Change in protocol interpretation|0|||
131945625|NCT02240121|475089897|FG000|Overall Study|Lack of Efficacy|2|||
131945626|NCT02240121|475089898|FG001|Overall Study|Lack of Efficacy|3|||
131945627|NCT02240121|475089897|FG000|Overall Study|Site closed|1|||
131945628|NCT02240121|475089898|FG001|Overall Study|Site closed|1|||
131945629|NCT02240121|475089897|FG000|Overall Study|Pregnancy|1|||
131945630|NCT02240121|475089898|FG001|Overall Study|Pregnancy|0|||
131945631|NCT02240121|475089897|FG000|Overall Study|Adverse Event|2|||
131945632|NCT02240121|475089898|FG001|Overall Study|Adverse Event|4|||
131945633|NCT02240121|475089897|FG000|Overall Study|Withdrawal by Subject|6|||
131945634|NCT02240121|475089898|FG001|Overall Study|Withdrawal by Subject|2|||
131945635|NCT02240121|475089897|FG000|Overall Study|Lost to Follow-up|3|||
131945636|NCT02240121|475089898|FG001|Overall Study|Lost to Follow-up|4|||
131945637|NCT02240121|475089897|FG000|Overall Study|Other than specified|1|||
131945638|NCT02240121|475089898|FG001|Overall Study|Other than specified|3|||
131945639|NCT00003869|475089899|FG000|Overall Study|Adverse Event|14|||
131945640|NCT00003869|475089900|FG001|Overall Study|Adverse Event|3|||
131945641|NCT00003869|475089899|FG000|Overall Study|Withdrawal by Subject|21|||
131945642|NCT00003869|475089900|FG001|Overall Study|Withdrawal by Subject|3|||
131945643|NCT00003869|475089899|FG000|Overall Study|Death|1|||
131945644|NCT00003869|475089900|FG001|Overall Study|Death|2|||
131945645|NCT00003869|475089899|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
131945646|NCT00003869|475089900|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
131945647|NCT03364231|475089901|FG000|Overall Study|Adverse Event|1|||
131945648|NCT03364231|475089902|FG001|Overall Study|Adverse Event|4|||
131945649|NCT03364231|475089901|FG000|Overall Study|Death|1|||
131945650|NCT03364231|475089902|FG001|Overall Study|Death|0|||
131945651|NCT03364231|475089901|FG000|Overall Study|Investigator Decision|2|||
131945652|NCT03364231|475089902|FG001|Overall Study|Investigator Decision|2|||
131945653|NCT03364231|475089901|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
131945654|NCT03364231|475089902|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
131945655|NCT03364231|475089901|FG000|Overall Study|Withdrawal of Subject Consent|1|||
131945656|NCT03364231|475089902|FG001|Overall Study|Withdrawal of Subject Consent|0|||
131455905|NCT01175083|473298617|FG000|Primary Epoch|Withdrawal by Subject|0|||
131455906|NCT01175083|473298618|FG001|Primary Epoch|Withdrawal by Subject|0|||
131455907|NCT01175083|473298619|FG002|Primary Epoch|Withdrawal by Subject|0|||
131455908|NCT01175083|473298620|FG003|Primary Epoch|Withdrawal by Subject|0|||
131455909|NCT01175083|473298621|FG004|Primary Epoch|Withdrawal by Subject|0|||
131455910|NCT01175083|473298622|FG005|Primary Epoch|Withdrawal by Subject|2|||
131455911|NCT01175083|473298617|FG000|Primary Epoch|Lost to Follow-up|0|||
131455912|NCT01175083|473298618|FG001|Primary Epoch|Lost to Follow-up|0|||
131455913|NCT01175083|473298619|FG002|Primary Epoch|Lost to Follow-up|0|||
131455914|NCT01175083|473298620|FG003|Primary Epoch|Lost to Follow-up|0|||
131455915|NCT01175083|473298621|FG004|Primary Epoch|Lost to Follow-up|0|||
131455916|NCT01175083|473298622|FG005|Primary Epoch|Lost to Follow-up|1|||
131455917|NCT01175083|473298617|FG000|Booster Epoch|Death|0|||
131455918|NCT01175083|473298618|FG001|Booster Epoch|Death|0|||
131455919|NCT01175083|473298619|FG002|Booster Epoch|Death|1|||
131455920|NCT01175083|473298620|FG003|Booster Epoch|Death|0|||
131455921|NCT01175083|473298621|FG004|Booster Epoch|Death|0|||
131455922|NCT01175083|473298622|FG005|Booster Epoch|Death|0|||
131455923|NCT01175083|473298617|FG000|Booster Epoch|Withdrawal by Subject|0|||
131455924|NCT01175083|473298618|FG001|Booster Epoch|Withdrawal by Subject|0|||
131455925|NCT01175083|473298619|FG002|Booster Epoch|Withdrawal by Subject|0|||
131455926|NCT01175083|473298620|FG003|Booster Epoch|Withdrawal by Subject|1|||
131455927|NCT01175083|473298621|FG004|Booster Epoch|Withdrawal by Subject|0|||
131455928|NCT01175083|473298622|FG005|Booster Epoch|Withdrawal by Subject|0|||
131455929|NCT00475306|473298623|FG000|Overall Study|Protocol Violation|1|||
131455930|NCT00475306|473298624|FG001|Overall Study|Protocol Violation|1|||
131455931|NCT00475306|473298625|FG002|Overall Study|Protocol Violation|0|||
131455932|NCT00475306|473298626|FG003|Overall Study|Protocol Violation|1|||
131455933|NCT01716052|473298627|FG000|Overall Study|Withdrawal of funding|1|||
131455934|NCT01716052|473298628|FG001|Overall Study|Withdrawal of funding|1|||
131455935|NCT02405442|473298629|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
131455936|NCT02405442|473298630|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
131455937|NCT02405442|473298631|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
131455938|NCT02405442|473298632|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
131455939|NCT02405442|473298629|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
131455940|NCT02405442|473298630|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
131455941|NCT02405442|473298631|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
131455942|NCT02405442|473298632|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
131455943|NCT02405442|473298629|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
131455944|NCT02405442|473298630|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
131455945|NCT02405442|473298631|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
131455946|NCT02405442|473298632|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
131455947|NCT02405442|473298629|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
131455948|NCT02405442|473298630|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
131455949|NCT02405442|473298631|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
131455950|NCT02405442|473298632|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
131455951|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
131455952|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
131455953|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
131455954|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
131455955|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
131945657|NCT03364231|475089901|FG000|Overall Study|Reason Not Specified|1|||
131945658|NCT03364231|475089902|FG001|Overall Study|Reason Not Specified|0|||
131945659|NCT03364231|475089901|FG000|Overall Study|Disease Progression|0|||
131945660|NCT03364231|475089902|FG001|Overall Study|Disease Progression|6|||
131945661|NCT03192137|475089904|FG000|Overall Study|Adverse Event|10|||
131945662|NCT03192137|475089905|FG001|Overall Study|Adverse Event|11|||
131945663|NCT03192137|475089904|FG000|Overall Study|Physician Decision|1|||
131945664|NCT03192137|475089905|FG001|Overall Study|Physician Decision|0|||
131945665|NCT03192137|475089904|FG000|Overall Study|Lack of Efficacy|20|||
131945666|NCT03192137|475089905|FG001|Overall Study|Lack of Efficacy|37|||
131945667|NCT03192137|475089904|FG000|Overall Study|Withdrawal by Subject|3|||
131945668|NCT03192137|475089905|FG001|Overall Study|Withdrawal by Subject|3|||
131945669|NCT03192137|475089904|FG000|Overall Study|Protocol Violation|4|||
131945670|NCT03192137|475089905|FG001|Overall Study|Protocol Violation|3|||
131455956|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
131455957|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
131455958|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
131455959|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
131455960|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
131945671|NCT03192137|475089904|FG000|Overall Study|Surgery Cancelled|4|||
131945672|NCT03192137|475089905|FG001|Overall Study|Surgery Cancelled|1|||
131945673|NCT03192137|475089904|FG000|Overall Study|Other - Various Administrative Reasons|8|||
131945674|NCT03192137|475089905|FG001|Overall Study|Other - Various Administrative Reasons|3|||
131945675|NCT00657267|475089906|FG000|Overall Study|Progressive disease|45|||
131945676|NCT00657267|475089906|FG000|Overall Study|Adverse Event|9|||
131945677|NCT01261975|475089910|FG000|Overall Study|Surgical complication|1|||
131945678|NCT01070979|475089913|FG000|Overall Study|Adverse Event|2|||
131945679|NCT01070979|475089914|FG001|Overall Study|Adverse Event|3|||
131945680|NCT01070979|475089915|FG002|Overall Study|Adverse Event|3|||
131945681|NCT01070979|475089913|FG000|Overall Study|Lost to Follow-up|2|||
131945682|NCT01070979|475089914|FG001|Overall Study|Lost to Follow-up|1|||
131945683|NCT01070979|475089915|FG002|Overall Study|Lost to Follow-up|1|||
131945684|NCT01070979|475089913|FG000|Overall Study|Protocol Violation|0|||
131945685|NCT01070979|475089914|FG001|Overall Study|Protocol Violation|2|||
131945686|NCT01070979|475089915|FG002|Overall Study|Protocol Violation|6|||
131945687|NCT01070979|475089913|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
131945688|NCT01070979|475089914|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
131945689|NCT01070979|475089915|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
131945690|NCT01070979|475089913|FG000|Overall Study|Withdrawal by Subject|3|||
131945691|NCT01070979|475089914|FG001|Overall Study|Withdrawal by Subject|1|||
131945692|NCT01070979|475089915|FG002|Overall Study|Withdrawal by Subject|1|||
131945693|NCT01070979|475089913|FG000|Overall Study|No study drug taken|0|||
131945694|NCT01070979|475089914|FG001|Overall Study|No study drug taken|1|||
131945695|NCT01070979|475089915|FG002|Overall Study|No study drug taken|0|||
131945696|NCT00142792|475089916|FG000|Overall Study|Death|0|||
131945697|NCT00142792|475089917|FG001|Overall Study|Death|0|||
131945698|NCT00142792|475089918|FG002|Overall Study|Death|1|||
131945699|NCT00142792|475089916|FG000|Overall Study|Withdrawal by Subject|3|||
131945700|NCT00142792|475089917|FG001|Overall Study|Withdrawal by Subject|2|||
131945701|NCT00142792|475089918|FG002|Overall Study|Withdrawal by Subject|3|||
131945702|NCT00142792|475089916|FG000|Overall Study|Lost to Follow-up|8|||
131945703|NCT00142792|475089917|FG001|Overall Study|Lost to Follow-up|11|||
131945704|NCT00142792|475089918|FG002|Overall Study|Lost to Follow-up|7|||
131945705|NCT00142792|475089916|FG000|Overall Study|No category|1|||
131945706|NCT00142792|475089917|FG001|Overall Study|No category|2|||
131945707|NCT00142792|475089918|FG002|Overall Study|No category|1|||
131945708|NCT04819113|475089919|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131945709|NCT04819113|475089919|FG000|Overall Study|Lost to Follow-up|1|||
131945710|NCT04819113|475089919|FG000|Overall Study|Withdrawn before vaccination|2|||
131945711|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Death|2|||
131945712|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
131945713|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
131945714|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Physician Decision|1|||
131945715|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
131945716|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
131945717|NCT00786422|475089921|FG000|Rivaroxaban Treatment|Adverse Event|2|||
131413594|NCT02943915|473138878|FG000|Overall Study|Lost to Follow-up|3|||
131413595|NCT02943915|473138879|FG001|Overall Study|Lost to Follow-up|1|||
131413596|NCT02943915|473138880|FG002|Overall Study|Lost to Follow-up|0|||
131413597|NCT02943915|473138881|FG003|Overall Study|Lost to Follow-up|0|||
131413598|NCT02943915|473138878|FG000|Overall Study|excluded|0|||
131413599|NCT02943915|473138879|FG001|Overall Study|excluded|1|||
131413600|NCT02943915|473138880|FG002|Overall Study|excluded|0|||
131413601|NCT02943915|473138881|FG003|Overall Study|excluded|0|||
131413602|NCT00004445|473138884|FG000|Overall Study|Physician Decision|2|||
131413603|NCT00004445|473138884|FG000|Overall Study|Withdrawal by Subject|1|||
131413604|NCT02753127|473138894|FG000|Overall Study|Lost to Follow-up|13|||
131413605|NCT02753127|473138895|FG001|Overall Study|Lost to Follow-up|11|||
131413606|NCT02753127|473138894|FG000|Overall Study|Withdrawal by Subject|37|||
131413607|NCT02753127|473138895|FG001|Overall Study|Withdrawal by Subject|47|||
131413608|NCT02753127|473138894|FG000|Overall Study|Other|3|||
131413609|NCT02753127|473138895|FG001|Overall Study|Other|8|||
131413610|NCT02753127|473138894|FG000|Overall Study|Hospice|0|||
131413611|NCT02753127|473138895|FG001|Overall Study|Hospice|2|||
131413612|NCT04284813|473138897|FG000|Overall Study|Withdrawal by Subject|1|||
131413613|NCT00431951|473138898|FG000|Overall Study|Inability to follow study procedures|1|||
131945718|NCT00786422|475089921|FG000|Follow-up Period|Death|1|||
131945719|NCT00786422|475089921|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
131945720|NCT05653700|475089924|FG000|Overall Study|Non Responders|9|||
131945721|NCT05653700|475089925|FG001|Overall Study|Non Responders|0|||
131945722|NCT04570384|475089926|FG000|Overall Study|Adverse Event|2|||
131945723|NCT04570384|475089927|FG001|Overall Study|Adverse Event|1|||
131945724|NCT04570384|475089926|FG000|Overall Study|Death|2|||
131413614|NCT00431951|473138899|FG001|Overall Study|Inability to follow study procedures|0|||
131413615|NCT00431951|473138900|FG002|Overall Study|Inability to follow study procedures|1|||
131945725|NCT04570384|475089927|FG001|Overall Study|Death|5|||
131945726|NCT04570384|475089926|FG000|Overall Study|Lost to Follow-up|1|||
131945727|NCT04570384|475089927|FG001|Overall Study|Lost to Follow-up|0|||
131945728|NCT04570384|475089926|FG000|Overall Study|Other|1|||
131945729|NCT04570384|475089927|FG001|Overall Study|Other|0|||
131945730|NCT04570384|475089926|FG000|Overall Study|Protocol Violation|0|||
131945731|NCT04570384|475089927|FG001|Overall Study|Protocol Violation|1|||
131945732|NCT04570384|475089926|FG000|Overall Study|Sponsor Decision|1|||
131945733|NCT04570384|475089927|FG001|Overall Study|Sponsor Decision|0|||
131945734|NCT04570384|475089926|FG000|Overall Study|Withdrawal by Subject|4|||
131945735|NCT04570384|475089927|FG001|Overall Study|Withdrawal by Subject|2|||
131945736|NCT02573948|475089928|FG000|Longitudinal Cohort|Death|9|||
131945737|NCT02573948|475089928|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
131945738|NCT02573948|475089928|FG000|Longitudinal Cohort|Incarcerated|25|||
131945739|NCT01673126|475089931|FG000|Overall Study|change of diagnosis|4|||
131945740|NCT01673126|475089932|FG001|Overall Study|change of diagnosis|3|||
131945741|NCT00707993|475089933|FG000|Overall Study|Adverse Event|16|||
131945742|NCT00707993|475089934|FG001|Overall Study|Adverse Event|20|||
131945743|NCT00707993|475089933|FG000|Overall Study|Protocol Violation|4|||
131945744|NCT00707993|475089934|FG001|Overall Study|Protocol Violation|7|||
131945745|NCT00707993|475089933|FG000|Overall Study|Lost to Follow-up|0|||
131945746|NCT00707993|475089934|FG001|Overall Study|Lost to Follow-up|4|||
131945747|NCT00707993|475089933|FG000|Overall Study|Withdrawal by Subject|12|||
131945748|NCT00707993|475089934|FG001|Overall Study|Withdrawal by Subject|16|||
131945749|NCT00707993|475089933|FG000|Overall Study|Hyperglycemic Rescue|55|||
131945750|NCT00707993|475089934|FG001|Overall Study|Hyperglycemic Rescue|47|||
131945751|NCT00707993|475089933|FG000|Overall Study|Other|2|||
131945752|NCT00707993|475089934|FG001|Overall Study|Other|0|||
131945753|NCT01913327|475089939|FG000|Overall Study|Withdrawal by Subject|0|||
131945754|NCT01913327|475089940|FG001|Overall Study|Withdrawal by Subject|1|||
131945755|NCT05414175|475089947|FG000|Overall Study|Withdrawal by Subject|1|||
131945756|NCT05414175|475089947|FG000|Overall Study|Other Reasons|1|||
131945757|NCT03965403|475089952|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
131945758|NCT03816176|475089953|FG000|Overall Study|Miscellaneous|5|||
131945759|NCT03816176|475089953|FG000|Overall Study|Lack of Efficacy|4|||
131945760|NCT03816176|475089953|FG000|Overall Study|Adverse Event|3|||
131945761|NCT00678288|475091524|FG000|Overall Study|Adverse Event|0|||
131945762|NCT00678288|475091525|FG001|Overall Study|Adverse Event|2|||
131945763|NCT00678288|475091524|FG000|Overall Study|Withdrawal by Subject|1|||
131945764|NCT00678288|475091525|FG001|Overall Study|Withdrawal by Subject|1|||
131945765|NCT00678288|475091524|FG000|Overall Study|Study terminated by the sponsor|2|||
131945766|NCT00678288|475091525|FG001|Overall Study|Study terminated by the sponsor|0|||
131945767|NCT00678288|475091524|FG000|Overall Study|Not compliant with study medication|0|||
131945768|NCT00678288|475091525|FG001|Overall Study|Not compliant with study medication|1|||
131945769|NCT00678288|475091524|FG000|Overall Study|Switch to commercial drug|0|||
131945770|NCT00678288|475091525|FG001|Overall Study|Switch to commercial drug|1|||
131945771|NCT00678288|475091524|FG000|Overall Study|Reason not reported|1|||
131945772|NCT00678288|475091525|FG001|Overall Study|Reason not reported|0|||
131945773|NCT00678288|475091524|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
131945774|NCT00678288|475091525|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
131945775|NCT00552071|475091526|FG000|Overall Study|Adverse Event|1|||
131945776|NCT00552071|475091527|FG001|Overall Study|Adverse Event|0|||
131945777|NCT00552071|475091526|FG000|Overall Study|Lack of Efficacy|1|||
131945778|NCT00552071|475091527|FG001|Overall Study|Lack of Efficacy|0|||
131945779|NCT00552071|475091526|FG000|Overall Study|Physician Decision|1|||
131945780|NCT00552071|475091527|FG001|Overall Study|Physician Decision|0|||
131945781|NCT00552071|475091526|FG000|Overall Study|Pregnancy|1|||
131945782|NCT00552071|475091527|FG001|Overall Study|Pregnancy|0|||
131945783|NCT00552071|475091526|FG000|Overall Study|Death|0|||
131945784|NCT00552071|475091527|FG001|Overall Study|Death|1|||
131945785|NCT00552071|475091526|FG000|Overall Study|Withdrawal by Subject|0|||
131945786|NCT00552071|475091527|FG001|Overall Study|Withdrawal by Subject|1|||
131945787|NCT02549989|475091528|FG000|Overall Study|Adverse Event|4|||
131945788|NCT02549989|475091528|FG000|Overall Study|Death|1|||
131945789|NCT02549989|475091528|FG000|Overall Study|Lack of Efficacy|19|||
131455961|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
131455962|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
131455963|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
131455964|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
131945790|NCT02549989|475091528|FG000|Overall Study|Withdrawal by Subject|3|||
131945791|NCT02628444|475091529|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
131945792|NCT02628444|475091530|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945793|NCT02628444|475091531|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945794|NCT02628444|475091532|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945795|NCT02628444|475091533|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945796|NCT02628444|475091534|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945797|NCT02628444|475091535|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945798|NCT02628444|475091536|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131945799|NCT02628444|475091537|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
131455965|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
131455966|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
131455967|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
131455968|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
131455969|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
131455970|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
131455971|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
131455972|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
131455973|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
131455974|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
131455975|NCT02405442|473298629|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
131455976|NCT02405442|473298630|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
131455977|NCT02405442|473298631|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
131455978|NCT02405442|473298632|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
131455979|NCT02405442|473298629|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
131455980|NCT02405442|473298630|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
131455981|NCT02405442|473298631|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
131455982|NCT02405442|473298632|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
131455983|NCT02405442|473298629|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
131455984|NCT02405442|473298630|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
131455985|NCT02405442|473298631|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
131455986|NCT02405442|473298632|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
131455987|NCT02405442|473298629|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
131455988|NCT02405442|473298630|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
131455989|NCT02405442|473298631|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
131455990|NCT02405442|473298632|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
131455991|NCT02078960|473298634|FG000|Treatment Period|Other|0|||
131455992|NCT02078960|473298635|FG001|Treatment Period|Other|0|||
131455993|NCT02078960|473298636|FG002|Treatment Period|Other|1|||
131455994|NCT02078960|473298634|FG000|Treatment Period|Lack of Efficacy|0|||
131455995|NCT02078960|473298635|FG001|Treatment Period|Lack of Efficacy|1|||
131455996|NCT02078960|473298636|FG002|Treatment Period|Lack of Efficacy|0|||
131455997|NCT02078960|473298634|FG000|Treatment Period|Disease progression - accelerated phase|0|||
131455998|NCT02078960|473298635|FG001|Treatment Period|Disease progression - accelerated phase|1|||
131455999|NCT02078960|473298636|FG002|Treatment Period|Disease progression - accelerated phase|0|||
131456000|NCT02078960|473298634|FG000|Treatment Period|Disease progression - blast phase|1|||
131456001|NCT02078960|473298635|FG001|Treatment Period|Disease progression - blast phase|0|||
131456002|NCT02078960|473298636|FG002|Treatment Period|Disease progression - blast phase|0|||
131456003|NCT02078960|473298634|FG000|Treatment Period|Withdrawal by Subject|0|||
131456004|NCT02078960|473298635|FG001|Treatment Period|Withdrawal by Subject|1|||
131456005|NCT02078960|473298636|FG002|Treatment Period|Withdrawal by Subject|1|||
131456006|NCT02078960|473298634|FG000|Treatment Period|Adverse Event|1|||
131456007|NCT02078960|473298635|FG001|Treatment Period|Adverse Event|0|||
131456008|NCT02078960|473298636|FG002|Treatment Period|Adverse Event|0|||
131456009|NCT02078960|473298634|FG000|Treatment Period|Death|0|||
131945800|NCT02628444|475091529|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945801|NCT02628444|475091530|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
131945802|NCT02628444|475091531|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
131945803|NCT02628444|475091532|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945804|NCT02628444|475091533|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945805|NCT02628444|475091534|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945806|NCT02628444|475091535|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945807|NCT02628444|475091536|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945808|NCT02628444|475091537|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
131945809|NCT02628444|475091529|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
131945810|NCT02628444|475091530|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
131945811|NCT02628444|475091531|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
131456010|NCT02078960|473298635|FG001|Treatment Period|Death|0|||
131456011|NCT02078960|473298636|FG002|Treatment Period|Death|1|||
131456012|NCT02078960|473298634|FG000|Follow-up Period|Death|2|||
131945812|NCT02628444|475091532|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
131456013|NCT02078960|473298635|FG001|Follow-up Period|Death|0|||
131456014|NCT02078960|473298636|FG002|Follow-up Period|Death|0|||
131456015|NCT02078960|473298634|FG000|Follow-up Period|Lost to Follow-up|0|||
131456016|NCT02078960|473298635|FG001|Follow-up Period|Lost to Follow-up|1|||
131456017|NCT02078960|473298636|FG002|Follow-up Period|Lost to Follow-up|0|||
131945813|NCT02628444|475091533|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945814|NCT02628444|475091534|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945815|NCT02628444|475091535|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945816|NCT02628444|475091536|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945817|NCT02628444|475091537|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945818|NCT02628444|475091529|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
131945819|NCT02628444|475091530|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
131945820|NCT02628444|475091531|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
131945821|NCT02628444|475091532|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
131945822|NCT02628444|475091533|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
131945823|NCT02628444|475091534|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
131945824|NCT02628444|475091535|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
131945825|NCT02628444|475091536|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
131945826|NCT02628444|475091537|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
131945827|NCT02628444|475091529|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
131945828|NCT02628444|475091530|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
131945829|NCT02628444|475091531|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
131945830|NCT02628444|475091532|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
131945831|NCT02628444|475091533|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
131945832|NCT02628444|475091534|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
131945833|NCT02628444|475091535|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
131945834|NCT02628444|475091536|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
131945835|NCT02628444|475091537|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
131945836|NCT02628444|475091529|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945837|NCT02628444|475091530|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945838|NCT02628444|475091531|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945839|NCT02628444|475091532|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
131945840|NCT02628444|475091533|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945841|NCT02628444|475091534|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945842|NCT02628444|475091535|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945843|NCT02628444|475091536|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945844|NCT02628444|475091537|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
131945845|NCT02628444|475091529|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
131945846|NCT02628444|475091530|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
131945847|NCT02628444|475091531|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
131945848|NCT02628444|475091532|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
131945849|NCT02628444|475091533|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
131945850|NCT02628444|475091534|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
131945851|NCT02628444|475091535|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
131945852|NCT02628444|475091536|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
131945853|NCT02628444|475091537|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
131945854|NCT02628444|475091529|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945855|NCT02628444|475091530|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945856|NCT02628444|475091531|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
131945857|NCT02628444|475091532|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
131945858|NCT02628444|475091533|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
131945859|NCT02628444|475091534|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
131945860|NCT02628444|475091535|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
131945861|NCT02628444|475091536|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
131945862|NCT02628444|475091537|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
131945863|NCT02628444|475091529|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
131945864|NCT02628444|475091530|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
131945865|NCT02628444|475091531|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
131945866|NCT02628444|475091532|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
131945867|NCT02628444|475091533|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
131945868|NCT02628444|475091534|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
131945869|NCT02628444|475091535|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
131945870|NCT02628444|475091536|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
131945871|NCT02628444|475091537|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
131456018|NCT03275350|473298637|FG000|Overall Study|Lost to Follow-up|4|||
131456019|NCT03275350|473298638|FG001|Overall Study|Lost to Follow-up|6|||
131945872|NCT02628444|475091529|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
131945873|NCT02628444|475091530|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
131945874|NCT02628444|475091531|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
131945875|NCT02628444|475091532|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
131945876|NCT02628444|475091533|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
131945877|NCT02628444|475091534|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
131945878|NCT02628444|475091535|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
131945879|NCT02628444|475091536|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
131945880|NCT02628444|475091537|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
131945881|NCT02237001|475091538|FG000|Overall Study|Lost to Follow-up|2|||
131945882|NCT02237001|475091538|FG000|Overall Study|Withdrawal by Subject|1|||
131945883|NCT02237001|475091538|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
131945884|NCT02237001|475091538|FG000|Overall Study|Re-operation|4|||
131945885|NCT02237001|475091538|FG000|Overall Study|Incarceration|1|||
131945886|NCT01713582|475091539|FG000|Overall Study|Disease progression|3|||
131945887|NCT01713582|475091540|FG001|Overall Study|Disease progression|3|||
131945888|NCT01713582|475091541|FG002|Overall Study|Disease progression|3|||
131945889|NCT01713582|475091542|FG003|Overall Study|Disease progression|2|||
131945890|NCT01713582|475091543|FG004|Overall Study|Disease progression|3|||
131945891|NCT01713582|475091544|FG005|Overall Study|Disease progression|3|||
131945892|NCT01713582|475091545|FG006|Overall Study|Disease progression|3|||
131945893|NCT01713582|475091546|FG007|Overall Study|Disease progression|3|||
131945894|NCT01713582|475091547|FG008|Overall Study|Disease progression|3|||
131945895|NCT01713582|475091548|FG009|Overall Study|Disease progression|11|||
131945896|NCT01713582|475091549|FG010|Overall Study|Disease progression|10|||
131945897|NCT01713582|475091550|FG011|Overall Study|Disease progression|5|||
131945898|NCT01713582|475091551|FG012|Overall Study|Disease progression|3|||
131945899|NCT01713582|475091552|FG013|Overall Study|Disease progression|3|||
131945900|NCT01713582|475091553|FG014|Overall Study|Disease progression|6|||
131945901|NCT01713582|475091554|FG015|Overall Study|Disease progression|6|||
131945902|NCT01713582|475091555|FG016|Overall Study|Disease progression|5|||
131945903|NCT01713582|475091556|FG017|Overall Study|Disease progression|2|||
131945904|NCT01713582|475091557|FG018|Overall Study|Disease progression|3|||
131945905|NCT01713582|475091558|FG019|Overall Study|Disease progression|5|||
131945906|NCT01713582|475091559|FG020|Overall Study|Disease progression|15|||
131945907|NCT01713582|475091539|FG000|Overall Study|Death|0|||
131945908|NCT01713582|475091540|FG001|Overall Study|Death|0|||
131945909|NCT01713582|475091541|FG002|Overall Study|Death|0|||
131945910|NCT01713582|475091542|FG003|Overall Study|Death|1|||
131945911|NCT01713582|475091543|FG004|Overall Study|Death|1|||
131945912|NCT01713582|475091544|FG005|Overall Study|Death|3|||
131945913|NCT01713582|475091545|FG006|Overall Study|Death|3|||
131945914|NCT01713582|475091546|FG007|Overall Study|Death|2|||
131945915|NCT01713582|475091547|FG008|Overall Study|Death|3|||
131945916|NCT01713582|475091548|FG009|Overall Study|Death|4|||
131945917|NCT01713582|475091549|FG010|Overall Study|Death|3|||
131945918|NCT01713582|475091550|FG011|Overall Study|Death|0|||
131945919|NCT01713582|475091551|FG012|Overall Study|Death|0|||
131945920|NCT01713582|475091552|FG013|Overall Study|Death|0|||
131945921|NCT01713582|475091553|FG014|Overall Study|Death|0|||
131945922|NCT01713582|475091554|FG015|Overall Study|Death|0|||
131945923|NCT01713582|475091555|FG016|Overall Study|Death|0|||
131945924|NCT01713582|475091556|FG017|Overall Study|Death|0|||
131945925|NCT01713582|475091557|FG018|Overall Study|Death|0|||
131945926|NCT01713582|475091558|FG019|Overall Study|Death|0|||
131945927|NCT01713582|475091559|FG020|Overall Study|Death|0|||
131945928|NCT01713582|475091539|FG000|Overall Study|Adverse event-related|0|||
131945929|NCT01713582|475091540|FG001|Overall Study|Adverse event-related|0|||
131945930|NCT01713582|475091541|FG002|Overall Study|Adverse event-related|0|||
131945931|NCT01713582|475091542|FG003|Overall Study|Adverse event-related|0|||
131945932|NCT01713582|475091543|FG004|Overall Study|Adverse event-related|0|||
131945933|NCT01713582|475091544|FG005|Overall Study|Adverse event-related|0|||
131945934|NCT01713582|475091545|FG006|Overall Study|Adverse event-related|0|||
131413616|NCT00431951|473138901|FG003|Overall Study|Inability to follow study procedures|2|||
131413617|NCT00431951|473138898|FG000|Overall Study|Lost to Follow-up|0|||
131413618|NCT00431951|473138899|FG001|Overall Study|Lost to Follow-up|1|||
131945935|NCT01713582|475091546|FG007|Overall Study|Adverse event-related|0|||
131945936|NCT01713582|475091547|FG008|Overall Study|Adverse event-related|0|||
131945937|NCT01713582|475091548|FG009|Overall Study|Adverse event-related|1|||
131945938|NCT01713582|475091549|FG010|Overall Study|Adverse event-related|1|||
131945939|NCT01713582|475091550|FG011|Overall Study|Adverse event-related|0|||
131945940|NCT01713582|475091551|FG012|Overall Study|Adverse event-related|0|||
131945941|NCT01713582|475091552|FG013|Overall Study|Adverse event-related|0|||
131945942|NCT01713582|475091553|FG014|Overall Study|Adverse event-related|0|||
131945943|NCT01713582|475091554|FG015|Overall Study|Adverse event-related|0|||
131945944|NCT01713582|475091555|FG016|Overall Study|Adverse event-related|0|||
131945945|NCT01713582|475091556|FG017|Overall Study|Adverse event-related|0|||
131945946|NCT01713582|475091557|FG018|Overall Study|Adverse event-related|1|||
131456020|NCT03275350|473298637|FG000|Overall Study|Death|2|||
131456021|NCT03275350|473298638|FG001|Overall Study|Death|1|||
131456022|NCT03275350|473298637|FG000|Overall Study|Physician Decision|1|||
131456023|NCT03275350|473298638|FG001|Overall Study|Physician Decision|0|||
131456024|NCT03275350|473298637|FG000|Overall Study|Incarcerated|1|||
131456025|NCT03275350|473298638|FG001|Overall Study|Incarcerated|1|||
131456026|NCT01396447|473298641|FG000|Overall Study|Did Not Receive Treatment|3|||
131456027|NCT01396447|473298642|FG001|Overall Study|Did Not Receive Treatment|2|||
131456028|NCT01396447|473298643|FG002|Overall Study|Did Not Receive Treatment|1|||
131456029|NCT01396447|473298644|FG003|Overall Study|Did Not Receive Treatment|0|||
131456030|NCT01396447|473298641|FG000|Overall Study|Adverse Event|15|||
131456031|NCT01396447|473298642|FG001|Overall Study|Adverse Event|12|||
131456032|NCT01396447|473298643|FG002|Overall Study|Adverse Event|12|||
131456033|NCT01396447|473298644|FG003|Overall Study|Adverse Event|17|||
131456034|NCT01396447|473298641|FG000|Overall Study|Insufficient Therapeutic Response|5|||
131456035|NCT01396447|473298642|FG001|Overall Study|Insufficient Therapeutic Response|5|||
131456036|NCT01396447|473298643|FG002|Overall Study|Insufficient Therapeutic Response|2|||
131456037|NCT01396447|473298644|FG003|Overall Study|Insufficient Therapeutic Response|4|||
131456038|NCT01396447|473298641|FG000|Overall Study|Protocol Violation|5|||
131456039|NCT01396447|473298642|FG001|Overall Study|Protocol Violation|2|||
131456040|NCT01396447|473298643|FG002|Overall Study|Protocol Violation|3|||
131456041|NCT01396447|473298644|FG003|Overall Study|Protocol Violation|7|||
131456042|NCT01396447|473298641|FG000|Overall Study|Withdrawal of Consent|11|||
131456043|NCT01396447|473298642|FG001|Overall Study|Withdrawal of Consent|9|||
131456044|NCT01396447|473298643|FG002|Overall Study|Withdrawal of Consent|4|||
131456045|NCT01396447|473298644|FG003|Overall Study|Withdrawal of Consent|15|||
131456046|NCT01396447|473298641|FG000|Overall Study|Lost to Follow-up|4|||
131456047|NCT01396447|473298642|FG001|Overall Study|Lost to Follow-up|8|||
131456048|NCT01396447|473298643|FG002|Overall Study|Lost to Follow-up|7|||
131456049|NCT01396447|473298644|FG003|Overall Study|Lost to Follow-up|9|||
131456050|NCT01396447|473298641|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131456051|NCT01396447|473298642|FG001|Overall Study|Other Miscellaneous Reasons|2|||
131456052|NCT01396447|473298643|FG002|Overall Study|Other Miscellaneous Reasons|1|||
131456053|NCT01396447|473298644|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131456054|NCT02597478|473298645|FG000|Overall Study|Withdrawal by Subject|2|||
131456055|NCT02597478|473298646|FG001|Overall Study|Withdrawal by Subject|0|||
131456056|NCT02597478|473298645|FG000|Overall Study|Change of opioid dose|1|||
131456057|NCT02597478|473298646|FG001|Overall Study|Change of opioid dose|0|||
131456058|NCT02597478|473298645|FG000|Overall Study|Insufficient exertional dyspnea|0|||
131456059|NCT02597478|473298646|FG001|Overall Study|Insufficient exertional dyspnea|1|||
131456060|NCT01402102|473298647|FG000|Overall Study|Protocol Violation|1|||
131456061|NCT01402102|473298648|FG001|Overall Study|Protocol Violation|0|||
131456062|NCT01402102|473298647|FG000|Overall Study|Insufficiency of compliance|1|||
131456063|NCT01402102|473298648|FG001|Overall Study|Insufficiency of compliance|1|||
131456064|NCT01402102|473298647|FG000|Overall Study|Withdrawal by Subject|0|||
131456065|NCT01402102|473298648|FG001|Overall Study|Withdrawal by Subject|2|||
131456066|NCT01386970|473298649|FG000|Overall Study|Withdrawal by Subject|0|||
131456067|NCT01386970|473298650|FG001|Overall Study|Withdrawal by Subject|1|||
131456068|NCT01386970|473298649|FG000|Overall Study|Adverse Event|4|||
131456069|NCT01386970|473298650|FG001|Overall Study|Adverse Event|1|||
131456070|NCT04881942|473298652|FG000|Overall Study|Adverse Event|0|||
131456071|NCT04881942|473298653|FG001|Overall Study|Adverse Event|0|||
131456072|NCT04881942|473298654|FG002|Overall Study|Adverse Event|0|||
131456073|NCT04881942|473298655|FG003|Overall Study|Adverse Event|0|||
131456074|NCT04881942|473298656|FG004|Overall Study|Adverse Event|1|||
131456075|NCT04881942|473298652|FG000|Overall Study|Alternates|0|||
131456076|NCT04881942|473298653|FG001|Overall Study|Alternates|0|||
131456077|NCT04881942|473298654|FG002|Overall Study|Alternates|0|||
131456078|NCT04881942|473298655|FG003|Overall Study|Alternates|0|||
131456079|NCT04881942|473298656|FG004|Overall Study|Alternates|2|||
131456080|NCT01349959|473298657|FG000|Overall Study|Adverse Event|7|||
131456081|NCT02675634|473298658|FG000|Test Period 1|Adverse Event|0|||
131456082|NCT02675634|473298659|FG001|Test Period 1|Adverse Event|1|||
131456083|NCT02675634|473298660|FG002|Test Period 1|Adverse Event|0|||
131456084|NCT02675634|473298661|FG003|Test Period 1|Adverse Event|1|||
131456085|NCT02675634|473298662|FG004|Test Period 1|Adverse Event|0|||
131456086|NCT02675634|473298663|FG005|Test Period 1|Adverse Event|0|||
131456087|NCT02675634|473298658|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
131456088|NCT02675634|473298659|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
131456089|NCT02675634|473298660|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
131456090|NCT02675634|473298661|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
131456091|NCT02675634|473298662|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
131456092|NCT02675634|473298663|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
131456093|NCT02675634|473298658|FG000|Test Period 2|Lack of Efficacy|1|||
131456094|NCT02675634|473298659|FG001|Test Period 2|Lack of Efficacy|0|||
131456095|NCT02675634|473298660|FG002|Test Period 2|Lack of Efficacy|0|||
131456096|NCT02675634|473298661|FG003|Test Period 2|Lack of Efficacy|0|||
131456097|NCT02675634|473298662|FG004|Test Period 2|Lack of Efficacy|0|||
131945947|NCT01713582|475091558|FG019|Overall Study|Adverse event-related|0|||
131945948|NCT01713582|475091559|FG020|Overall Study|Adverse event-related|0|||
131945949|NCT01713582|475091539|FG000|Overall Study|Adverse event-unrelated|0|||
131945950|NCT01713582|475091540|FG001|Overall Study|Adverse event-unrelated|0|||
131945951|NCT01713582|475091541|FG002|Overall Study|Adverse event-unrelated|0|||
131945952|NCT01713582|475091542|FG003|Overall Study|Adverse event-unrelated|0|||
131945953|NCT01713582|475091543|FG004|Overall Study|Adverse event-unrelated|0|||
131945954|NCT01713582|475091544|FG005|Overall Study|Adverse event-unrelated|1|||
131945955|NCT01713582|475091545|FG006|Overall Study|Adverse event-unrelated|1|||
131945956|NCT01713582|475091546|FG007|Overall Study|Adverse event-unrelated|1|||
131945957|NCT01713582|475091547|FG008|Overall Study|Adverse event-unrelated|0|||
131945958|NCT01713582|475091548|FG009|Overall Study|Adverse event-unrelated|0|||
131945959|NCT01713582|475091549|FG010|Overall Study|Adverse event-unrelated|0|||
131945960|NCT01713582|475091550|FG011|Overall Study|Adverse event-unrelated|0|||
131945961|NCT01713582|475091551|FG012|Overall Study|Adverse event-unrelated|0|||
131945962|NCT01713582|475091552|FG013|Overall Study|Adverse event-unrelated|1|||
131945963|NCT01713582|475091553|FG014|Overall Study|Adverse event-unrelated|1|||
131945964|NCT01713582|475091554|FG015|Overall Study|Adverse event-unrelated|0|||
131945965|NCT01713582|475091555|FG016|Overall Study|Adverse event-unrelated|0|||
131945966|NCT01713582|475091556|FG017|Overall Study|Adverse event-unrelated|0|||
131945967|NCT01713582|475091557|FG018|Overall Study|Adverse event-unrelated|0|||
131945968|NCT01713582|475091558|FG019|Overall Study|Adverse event-unrelated|0|||
131945969|NCT01713582|475091559|FG020|Overall Study|Adverse event-unrelated|0|||
131945970|NCT01713582|475091539|FG000|Overall Study|Withdrawal of consent|0|||
131945971|NCT01713582|475091540|FG001|Overall Study|Withdrawal of consent|0|||
131945972|NCT01713582|475091541|FG002|Overall Study|Withdrawal of consent|1|||
131945973|NCT01713582|475091542|FG003|Overall Study|Withdrawal of consent|0|||
131945974|NCT01713582|475091543|FG004|Overall Study|Withdrawal of consent|0|||
131945975|NCT01713582|475091544|FG005|Overall Study|Withdrawal of consent|1|||
131945976|NCT01713582|475091545|FG006|Overall Study|Withdrawal of consent|0|||
131945977|NCT01713582|475091546|FG007|Overall Study|Withdrawal of consent|0|||
131945978|NCT01713582|475091547|FG008|Overall Study|Withdrawal of consent|0|||
131945979|NCT01713582|475091548|FG009|Overall Study|Withdrawal of consent|1|||
131945980|NCT01713582|475091549|FG010|Overall Study|Withdrawal of consent|0|||
131945981|NCT01713582|475091550|FG011|Overall Study|Withdrawal of consent|0|||
131945982|NCT01713582|475091551|FG012|Overall Study|Withdrawal of consent|0|||
131945983|NCT01713582|475091552|FG013|Overall Study|Withdrawal of consent|0|||
131945984|NCT01713582|475091553|FG014|Overall Study|Withdrawal of consent|0|||
131945985|NCT01713582|475091554|FG015|Overall Study|Withdrawal of consent|0|||
131945986|NCT01713582|475091555|FG016|Overall Study|Withdrawal of consent|0|||
131945987|NCT01713582|475091556|FG017|Overall Study|Withdrawal of consent|0|||
131945988|NCT01713582|475091557|FG018|Overall Study|Withdrawal of consent|1|||
131945989|NCT01713582|475091558|FG019|Overall Study|Withdrawal of consent|0|||
131945990|NCT01713582|475091559|FG020|Overall Study|Withdrawal of consent|0|||
131945991|NCT01713582|475091539|FG000|Overall Study|Lack of Efficacy|0|||
131945992|NCT01713582|475091540|FG001|Overall Study|Lack of Efficacy|0|||
131945993|NCT01713582|475091541|FG002|Overall Study|Lack of Efficacy|0|||
131945994|NCT01713582|475091542|FG003|Overall Study|Lack of Efficacy|0|||
131945995|NCT01713582|475091543|FG004|Overall Study|Lack of Efficacy|0|||
131945996|NCT01713582|475091544|FG005|Overall Study|Lack of Efficacy|0|||
131945997|NCT01713582|475091545|FG006|Overall Study|Lack of Efficacy|0|||
131945998|NCT01713582|475091546|FG007|Overall Study|Lack of Efficacy|0|||
131945999|NCT01713582|475091547|FG008|Overall Study|Lack of Efficacy|0|||
131946000|NCT01713582|475091548|FG009|Overall Study|Lack of Efficacy|1|||
131946001|NCT01713582|475091549|FG010|Overall Study|Lack of Efficacy|2|||
131946002|NCT01713582|475091550|FG011|Overall Study|Lack of Efficacy|0|||
131946003|NCT01713582|475091551|FG012|Overall Study|Lack of Efficacy|0|||
131946004|NCT01713582|475091552|FG013|Overall Study|Lack of Efficacy|0|||
131946005|NCT01713582|475091553|FG014|Overall Study|Lack of Efficacy|0|||
131946006|NCT01713582|475091554|FG015|Overall Study|Lack of Efficacy|0|||
131946007|NCT01713582|475091555|FG016|Overall Study|Lack of Efficacy|0|||
131946008|NCT01713582|475091556|FG017|Overall Study|Lack of Efficacy|0|||
131946009|NCT01713582|475091557|FG018|Overall Study|Lack of Efficacy|0|||
131413619|NCT00431951|473138900|FG002|Overall Study|Lost to Follow-up|0|||
131413620|NCT00431951|473138901|FG003|Overall Study|Lost to Follow-up|0|||
131946010|NCT01713582|475091558|FG019|Overall Study|Lack of Efficacy|0|||
131946011|NCT01713582|475091559|FG020|Overall Study|Lack of Efficacy|0|||
131946012|NCT01713582|475091539|FG000|Overall Study|Withdrawal by Subject|0|||
131946013|NCT01713582|475091540|FG001|Overall Study|Withdrawal by Subject|0|||
131946014|NCT01713582|475091541|FG002|Overall Study|Withdrawal by Subject|0|||
131946015|NCT01713582|475091542|FG003|Overall Study|Withdrawal by Subject|0|||
131946016|NCT01713582|475091543|FG004|Overall Study|Withdrawal by Subject|0|||
131946017|NCT01713582|475091544|FG005|Overall Study|Withdrawal by Subject|0|||
131946018|NCT01713582|475091545|FG006|Overall Study|Withdrawal by Subject|0|||
131946019|NCT01713582|475091546|FG007|Overall Study|Withdrawal by Subject|0|||
131946020|NCT01713582|475091547|FG008|Overall Study|Withdrawal by Subject|0|||
131946021|NCT01713582|475091548|FG009|Overall Study|Withdrawal by Subject|0|||
131946022|NCT01713582|475091549|FG010|Overall Study|Withdrawal by Subject|0|||
131946023|NCT01713582|475091550|FG011|Overall Study|Withdrawal by Subject|0|||
131946024|NCT01713582|475091551|FG012|Overall Study|Withdrawal by Subject|0|||
131946025|NCT01713582|475091552|FG013|Overall Study|Withdrawal by Subject|0|||
131946026|NCT01713582|475091553|FG014|Overall Study|Withdrawal by Subject|0|||
131946027|NCT01713582|475091554|FG015|Overall Study|Withdrawal by Subject|0|||
131946028|NCT01713582|475091555|FG016|Overall Study|Withdrawal by Subject|0|||
131946029|NCT01713582|475091556|FG017|Overall Study|Withdrawal by Subject|1|||
131946030|NCT01713582|475091557|FG018|Overall Study|Withdrawal by Subject|0|||
131946031|NCT01713582|475091558|FG019|Overall Study|Withdrawal by Subject|0|||
131946032|NCT01713582|475091559|FG020|Overall Study|Withdrawal by Subject|0|||
131946033|NCT01713582|475091539|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
131946034|NCT01713582|475091540|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
131946035|NCT01713582|475091541|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
131946036|NCT01713582|475091542|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
131946037|NCT01713582|475091543|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
131946038|NCT01713582|475091544|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
131946039|NCT01713582|475091545|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
131946040|NCT01713582|475091546|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
131946041|NCT01713582|475091547|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
131946042|NCT01713582|475091548|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
131946043|NCT01713582|475091549|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
131946044|NCT01713582|475091550|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
131946045|NCT01713582|475091551|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
131946046|NCT01713582|475091552|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
131946047|NCT01713582|475091553|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
131946048|NCT01713582|475091554|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
131946049|NCT01713582|475091555|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
131946050|NCT01713582|475091556|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
131946051|NCT01713582|475091557|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
131946052|NCT01713582|475091558|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
131946053|NCT01713582|475091559|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
131946054|NCT01713582|475091539|FG000|Overall Study|Disease progression and adverse event|0|||
131946055|NCT01713582|475091540|FG001|Overall Study|Disease progression and adverse event|0|||
131946056|NCT01713582|475091541|FG002|Overall Study|Disease progression and adverse event|0|||
131946057|NCT01713582|475091542|FG003|Overall Study|Disease progression and adverse event|0|||
131946058|NCT01713582|475091543|FG004|Overall Study|Disease progression and adverse event|0|||
131946059|NCT01713582|475091544|FG005|Overall Study|Disease progression and adverse event|0|||
131946060|NCT01713582|475091545|FG006|Overall Study|Disease progression and adverse event|0|||
131946061|NCT01713582|475091546|FG007|Overall Study|Disease progression and adverse event|0|||
131946062|NCT01713582|475091547|FG008|Overall Study|Disease progression and adverse event|0|||
131946063|NCT01713582|475091548|FG009|Overall Study|Disease progression and adverse event|0|||
131946064|NCT01713582|475091549|FG010|Overall Study|Disease progression and adverse event|0|||
131946065|NCT01713582|475091550|FG011|Overall Study|Disease progression and adverse event|0|||
131946066|NCT01713582|475091551|FG012|Overall Study|Disease progression and adverse event|0|||
131946067|NCT01713582|475091552|FG013|Overall Study|Disease progression and adverse event|0|||
131946068|NCT01713582|475091553|FG014|Overall Study|Disease progression and adverse event|0|||
131946069|NCT01713582|475091554|FG015|Overall Study|Disease progression and adverse event|0|||
131946070|NCT01713582|475091555|FG016|Overall Study|Disease progression and adverse event|1|||
131413621|NCT00431951|473138898|FG000|Overall Study|Withdrawal by Subject|0|||
131413622|NCT00431951|473138899|FG001|Overall Study|Withdrawal by Subject|1|||
131413623|NCT00431951|473138900|FG002|Overall Study|Withdrawal by Subject|0|||
131413624|NCT00431951|473138901|FG003|Overall Study|Withdrawal by Subject|0|||
131413625|NCT00431951|473138898|FG000|Overall Study|Adverse Event|0|||
131413626|NCT00431951|473138899|FG001|Overall Study|Adverse Event|0|||
131413627|NCT00431951|473138900|FG002|Overall Study|Adverse Event|1|||
131413628|NCT00431951|473138901|FG003|Overall Study|Adverse Event|0|||
131413629|NCT01146288|473138902|FG000|First Intervention(1 Day)|Adverse Event|0|||
131413630|NCT01146288|473138903|FG001|First Intervention(1 Day)|Adverse Event|1|||
131413631|NCT00385723|473138904|FG000|Overall Study|Lost to Follow-up|1|||
131413632|NCT00385723|473138905|FG001|Overall Study|Lost to Follow-up|1|||
131413633|NCT00385723|473138906|FG002|Overall Study|Lost to Follow-up|0|||
131456098|NCT02675634|473298663|FG005|Test Period 2|Lack of Efficacy|0|||
131946071|NCT01713582|475091556|FG017|Overall Study|Disease progression and adverse event|0|||
131946072|NCT01713582|475091557|FG018|Overall Study|Disease progression and adverse event|0|||
131946073|NCT01713582|475091558|FG019|Overall Study|Disease progression and adverse event|0|||
131946074|NCT01713582|475091559|FG020|Overall Study|Disease progression and adverse event|0|||
131413634|NCT00385723|473138904|FG000|Overall Study|Withdrawal by Subject|1|||
131413635|NCT00385723|473138905|FG001|Overall Study|Withdrawal by Subject|0|||
131946075|NCT03427814|475091560|FG000|Overall Study|Withdrawal by Subject|4|||
131946076|NCT03427814|475091561|FG001|Overall Study|Withdrawal by Subject|4|||
131946077|NCT03427814|475091560|FG000|Overall Study|Lost to Follow-up|0|||
131946078|NCT03427814|475091561|FG001|Overall Study|Lost to Follow-up|2|||
131946079|NCT03427814|475091560|FG000|Overall Study|Death|42|||
131946080|NCT03427814|475091561|FG001|Overall Study|Death|31|||
131946081|NCT03427814|475091560|FG000|Overall Study|Sponsor's Decision|1|||
131946082|NCT03427814|475091561|FG001|Overall Study|Sponsor's Decision|0|||
131946083|NCT03427814|475091560|FG000|Overall Study|Investigator's Decision|1|||
131946084|NCT03427814|475091561|FG001|Overall Study|Investigator's Decision|2|||
131946085|NCT03427814|475091560|FG000|Overall Study|Disease progression|1|||
131946086|NCT03427814|475091561|FG001|Overall Study|Disease progression|0|||
131946087|NCT03427814|475091560|FG000|Overall Study|Treatment Completed|0|||
131946088|NCT03427814|475091561|FG001|Overall Study|Treatment Completed|1|||
131946089|NCT03427814|475091560|FG000|Overall Study|Sponsor's Decision to End study|21|||
131946090|NCT03427814|475091561|FG001|Overall Study|Sponsor's Decision to End study|25|||
131946091|NCT03427814|475091560|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
131946092|NCT03427814|475091561|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
131946093|NCT01979614|475091562|FG000|Overall Study|Adverse Event|1|||
131946094|NCT01979614|475091563|FG001|Overall Study|Adverse Event|1|||
131946095|NCT01475721|475091574|FG000|Overall Study|Death|3|||
131946096|NCT01475721|475091575|FG001|Overall Study|Death|6|||
131946097|NCT01475721|475091574|FG000|Overall Study|Withdrawal by Subject|8|||
131946098|NCT01475721|475091575|FG001|Overall Study|Withdrawal by Subject|8|||
131946099|NCT00803738|475091577|FG000|Overall Study|Adverse Event|3|||
131946100|NCT00803738|475091578|FG001|Overall Study|Adverse Event|5|||
131946101|NCT00803738|475091577|FG000|Overall Study|Lost to Follow-up|4|||
131946102|NCT00803738|475091578|FG001|Overall Study|Lost to Follow-up|4|||
131946103|NCT00803738|475091577|FG000|Overall Study|Protocol Violation|18|||
131946104|NCT00803738|475091578|FG001|Overall Study|Protocol Violation|10|||
131946105|NCT00803738|475091577|FG000|Overall Study|Withdrawal by Subject|1|||
131946106|NCT00803738|475091578|FG001|Overall Study|Withdrawal by Subject|4|||
131946107|NCT00803738|475091577|FG000|Overall Study|Lack of Efficacy|10|||
131946108|NCT00803738|475091578|FG001|Overall Study|Lack of Efficacy|16|||
131946109|NCT00803738|475091577|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
131946110|NCT00803738|475091578|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
131946111|NCT00803738|475091577|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
131946112|NCT00803738|475091578|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
131946113|NCT06164691|475091579|FG000|Overall Study|Withdrawal by Subject|2|||
131946114|NCT06164691|475091580|FG001|Overall Study|Withdrawal by Subject|0|||
131946115|NCT06164691|475091581|FG002|Overall Study|Withdrawal by Subject|0|||
131946116|NCT04723355|475091582|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
131946117|NCT04723355|475091582|FG000|Overall Study|Errors in the informed consent form|2|||
131946118|NCT00841776|475091585|FG000|Overall Study|Lack of Efficacy|0|||
131946119|NCT00841776|475091586|FG001|Overall Study|Lack of Efficacy|1|||
131946120|NCT00841776|475091585|FG000|Overall Study|Lost to Follow-up|2|||
131946121|NCT00841776|475091586|FG001|Overall Study|Lost to Follow-up|1|||
131946122|NCT00841776|475091585|FG000|Overall Study|Withdrawal by Subject|0|||
131946123|NCT00841776|475091586|FG001|Overall Study|Withdrawal by Subject|1|||
131946124|NCT02477527|475091587|FG000|Overall Study|Lost to Follow-up|2|||
131946125|NCT02477527|475091587|FG000|Overall Study|Withdrawal by Subject|1|||
131946126|NCT02477527|475091587|FG000|Overall Study|Screen Failure|3|||
131946127|NCT01428219|475091596|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
131946128|NCT02479880|475091597|FG000|Overall Study|Study Terminated by Sponsor|13|||
131946129|NCT02479880|475091598|FG001|Overall Study|Study Terminated by Sponsor|12|||
131946130|NCT02479880|475091597|FG000|Overall Study|Pregnancy|0|||
131946131|NCT02479880|475091598|FG001|Overall Study|Pregnancy|1|||
131946132|NCT03432494|475091612|FG000|Overall Study|Death|1|||
131946133|NCT03432494|475091612|FG000|Overall Study|Noncompliance|1|||
131946134|NCT02379052|475091613|FG000|Overall Study|Protocol Violation|0|||
131946135|NCT02379052|475091614|FG001|Overall Study|Protocol Violation|1|||
131946136|NCT02379052|475091613|FG000|Overall Study|Adverse Event|0|||
131946137|NCT02379052|475091614|FG001|Overall Study|Adverse Event|1|||
131946138|NCT02379052|475091613|FG000|Overall Study|Physician Decision|1|||
131946139|NCT02379052|475091614|FG001|Overall Study|Physician Decision|1|||
131946140|NCT02379052|475091613|FG000|Overall Study|Withdrawal by Subject|2|||
131946141|NCT02379052|475091614|FG001|Overall Study|Withdrawal by Subject|0|||
131456099|NCT02675634|473298658|FG000|Test Period 2|Adverse Event|0|||
131946142|NCT02379052|475091613|FG000|Overall Study|Lost to Follow-up|2|||
131946143|NCT02379052|475091614|FG001|Overall Study|Lost to Follow-up|1|||
131946144|NCT02379052|475091613|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
131946145|NCT02379052|475091614|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
131946146|NCT02379052|475091613|FG000|Overall Study|Subject was Incarcerated|0|||
131946147|NCT02379052|475091614|FG001|Overall Study|Subject was Incarcerated|1|||
131946148|NCT00127855|475091615|FG000|Primary Vaccination Course|Adverse Event|0|||
131946149|NCT00127855|475091616|FG001|Primary Vaccination Course|Adverse Event|0|||
131946150|NCT00127855|475091617|FG002|Primary Vaccination Course|Adverse Event|1|||
131946151|NCT00127855|475091618|FG003|Primary Vaccination Course|Adverse Event|0|||
131946152|NCT00127855|475091619|FG004|Primary Vaccination Course|Adverse Event|0|||
131946153|NCT00127855|475091615|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
131946154|NCT00127855|475091616|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
131946155|NCT00127855|475091617|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
131946156|NCT00127855|475091618|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
131946157|NCT00127855|475091619|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
131946158|NCT00127855|475091615|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
131946159|NCT00127855|475091616|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
131946160|NCT00127855|475091617|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
131946161|NCT00127855|475091618|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
131946162|NCT00127855|475091619|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
131946163|NCT00127855|475091615|FG000|Primary Vaccination Course|Other|0|||
131946164|NCT00127855|475091616|FG001|Primary Vaccination Course|Other|0|||
131946165|NCT00127855|475091617|FG002|Primary Vaccination Course|Other|0|||
131946166|NCT00127855|475091618|FG003|Primary Vaccination Course|Other|0|||
131946167|NCT00127855|475091619|FG004|Primary Vaccination Course|Other|1|||
131946168|NCT01847755|475091620|FG000|Overall Study|Adverse Event|2|||
131946169|NCT01847755|475091620|FG000|Overall Study|Withdrawal by Subject|2|||
131946170|NCT01847755|475091620|FG000|Overall Study|Physician Decision|1|||
131946171|NCT00532844|475091621|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
131946172|NCT00532844|475091622|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
131946173|NCT00532844|475091621|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
131946174|NCT00532844|475091622|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
131946175|NCT00532844|475091621|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
131946176|NCT00532844|475091622|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
131946177|NCT00532844|475091621|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
131946178|NCT00532844|475091622|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
131946179|NCT00532844|475091621|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
131946180|NCT00532844|475091622|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
131946181|NCT02185534|475091624|FG000|First Period|Withdrawal by Subject|0|||
131946182|NCT02185534|475091625|FG001|First Period|Withdrawal by Subject|0|||
131946183|NCT02185534|475091626|FG002|First Period|Withdrawal by Subject|0|||
131946184|NCT02185534|475091627|FG003|First Period|Withdrawal by Subject|1|||
131946185|NCT02185534|475091628|FG004|First Period|Withdrawal by Subject|0|||
131946186|NCT02185534|475091629|FG005|First Period|Withdrawal by Subject|0|||
131946187|NCT02185534|475091624|FG000|First Washout Period|Withdrawal by Subject|1|||
131946188|NCT02185534|475091625|FG001|First Washout Period|Withdrawal by Subject|0|||
131946189|NCT02185534|475091626|FG002|First Washout Period|Withdrawal by Subject|0|||
131946190|NCT02185534|475091627|FG003|First Washout Period|Withdrawal by Subject|0|||
131946191|NCT02185534|475091628|FG004|First Washout Period|Withdrawal by Subject|1|||
131946192|NCT02185534|475091629|FG005|First Washout Period|Withdrawal by Subject|0|||
131946193|NCT02185534|475091624|FG000|First Washout Period|Protocol Violation|0|||
131946194|NCT02185534|475091625|FG001|First Washout Period|Protocol Violation|0|||
131946195|NCT02185534|475091626|FG002|First Washout Period|Protocol Violation|0|||
131946196|NCT02185534|475091627|FG003|First Washout Period|Protocol Violation|0|||
131946197|NCT02185534|475091628|FG004|First Washout Period|Protocol Violation|0|||
131946198|NCT02185534|475091629|FG005|First Washout Period|Protocol Violation|1|||
131946199|NCT02389465|475091633|FG000|Overall Study|Lost to Follow-up|1|||
131946200|NCT02389465|475091634|FG001|Overall Study|Lost to Follow-up|3|||
131946201|NCT02389465|475091635|FG002|Overall Study|Lost to Follow-up|3|||
131946202|NCT02389465|475091636|FG003|Overall Study|Lost to Follow-up|0|||
131946203|NCT02389465|475091633|FG000|Overall Study|Physician Decision|0|||
131946204|NCT02389465|475091634|FG001|Overall Study|Physician Decision|0|||
131946205|NCT02389465|475091635|FG002|Overall Study|Physician Decision|0|||
131946206|NCT02389465|475091636|FG003|Overall Study|Physician Decision|1|||
131946207|NCT02389465|475091633|FG000|Overall Study|Withdrawal by Subject|0|||
131946208|NCT02389465|475091634|FG001|Overall Study|Withdrawal by Subject|1|||
131946209|NCT02389465|475091635|FG002|Overall Study|Withdrawal by Subject|2|||
131946210|NCT02389465|475091636|FG003|Overall Study|Withdrawal by Subject|2|||
131946211|NCT04419467|475091637|FG000|Overall Study|Not treated with IP|0|||
131946212|NCT04419467|475091638|FG001|Overall Study|Not treated with IP|0|||
131946213|NCT04419467|475091639|FG002|Overall Study|Not treated with IP|2|||
131946214|NCT04419467|475091637|FG000|Overall Study|Adverse Event|0|||
131946215|NCT04419467|475091638|FG001|Overall Study|Adverse Event|2|||
131946216|NCT04419467|475091639|FG002|Overall Study|Adverse Event|0|||
131946217|NCT04419467|475091637|FG000|Overall Study|Death|1|||
131946218|NCT04419467|475091638|FG001|Overall Study|Death|0|||
131946219|NCT04419467|475091639|FG002|Overall Study|Death|0|||
131946220|NCT04419467|475091637|FG000|Overall Study|Lost to Follow-up|0|||
131946221|NCT04419467|475091638|FG001|Overall Study|Lost to Follow-up|1|||
131946222|NCT04419467|475091639|FG002|Overall Study|Lost to Follow-up|2|||
131946223|NCT04419467|475091637|FG000|Overall Study|Withdrawal by Subject|0|||
131946224|NCT04419467|475091638|FG001|Overall Study|Withdrawal by Subject|0|||
131946225|NCT04419467|475091639|FG002|Overall Study|Withdrawal by Subject|4|||
131946226|NCT04419467|475091637|FG000|Overall Study|Pandemic related|0|||
131946227|NCT04419467|475091638|FG001|Overall Study|Pandemic related|0|||
131946228|NCT04419467|475091639|FG002|Overall Study|Pandemic related|1|||
131946229|NCT04419467|475091637|FG000|Overall Study|Reason not known|1|||
131946230|NCT04419467|475091638|FG001|Overall Study|Reason not known|0|||
131946231|NCT04419467|475091639|FG002|Overall Study|Reason not known|0|||
131946232|NCT01220401|475091650|FG000|Overall Study|Withdrawal by Subject|2|||
131946233|NCT01220401|475091650|FG000|Overall Study|Protocol Violation|1|||
131946234|NCT04068922|475091657|FG000|Overall Study|Lost to Follow-up|5|||
131946235|NCT04068922|475091657|FG000|Overall Study|Withdrawal by Subject|7|||
131946236|NCT04068922|475091657|FG000|Overall Study|Adverse Event|1|||
131946237|NCT03542266|475091658|FG000|Treatment Phase|Withdrawal by Subject|1|||
131946238|NCT03542266|475091658|FG000|Treatment Phase|Adverse Event|1|||
131946239|NCT03542266|475091658|FG000|Treatment Phase|PD|1|||
131946240|NCT00437268|475091663|FG000|Overall Study|Adverse Event|1|||
131946241|NCT00437268|475091664|FG001|Overall Study|Adverse Event|1|||
131946242|NCT00437268|475091663|FG000|Overall Study|Withdrawal by Subject|2|||
131946243|NCT00437268|475091664|FG001|Overall Study|Withdrawal by Subject|2|||
131946244|NCT00437268|475091663|FG000|Overall Study|Progressive disease|9|||
131946245|NCT00437268|475091664|FG001|Overall Study|Progressive disease|9|||
131946246|NCT00437268|475091663|FG000|Overall Study|Physician Decision|1|||
131946247|NCT00437268|475091664|FG001|Overall Study|Physician Decision|0|||
131946248|NCT00437268|475091663|FG000|Overall Study|Death|0|||
131946249|NCT00437268|475091664|FG001|Overall Study|Death|1|||
131946250|NCT00444925|475091665|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
131946251|NCT00444925|475091666|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
131946252|NCT00444925|475091667|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
131946253|NCT00444925|475091665|FG000|Double-blind Treatment Period|Death|2|||
131946254|NCT00444925|475091666|FG001|Double-blind Treatment Period|Death|0|||
131946255|NCT00444925|475091667|FG002|Double-blind Treatment Period|Death|0|||
131946256|NCT00444925|475091665|FG000|Double-blind Treatment Period|Adverse Event|6|||
131946257|NCT00444925|475091666|FG001|Double-blind Treatment Period|Adverse Event|28|||
131946258|NCT00444925|475091667|FG002|Double-blind Treatment Period|Adverse Event|44|||
131946259|NCT00444925|475091665|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
131946260|NCT00444925|475091666|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
131946261|NCT00444925|475091667|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
131946262|NCT00444925|475091665|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
131946263|NCT00444925|475091666|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
131946264|NCT00444925|475091667|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
131946265|NCT00444925|475091665|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
131946266|NCT00444925|475091666|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
131946267|NCT00444925|475091667|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
131946268|NCT00444925|475091665|FG000|Double-blind Treatment Period|Other|7|||
131946269|NCT00444925|475091666|FG001|Double-blind Treatment Period|Other|7|||
131946270|NCT00444925|475091667|FG002|Double-blind Treatment Period|Other|12|||
131946271|NCT03484429|475091673|FG000|Overall Study|Withdrawal by Subject|1|||
131946272|NCT03484429|475091674|FG001|Overall Study|Withdrawal by Subject|0|||
131946273|NCT03484429|475091673|FG000|Overall Study|Adverse Event|2|||
131946274|NCT03484429|475091674|FG001|Overall Study|Adverse Event|0|||
131946275|NCT00714948|475091675|FG000|Overall Study|Adverse Event|2|||
131946276|NCT02112656|475091680|FG000|Overall Study|Death|78|||
131946277|NCT02112656|475091681|FG001|Overall Study|Death|82|||
131946278|NCT02112656|475091680|FG000|Overall Study|Withdrawal by Subject|9|||
131946279|NCT02112656|475091681|FG001|Overall Study|Withdrawal by Subject|11|||
131946280|NCT02112656|475091680|FG000|Overall Study|Lost to Follow-up|2|||
131946281|NCT02112656|475091681|FG001|Overall Study|Lost to Follow-up|4|||
131946282|NCT02112656|475091680|FG000|Overall Study|Noncompliance|1|||
131946283|NCT02112656|475091681|FG001|Overall Study|Noncompliance|2|||
131946284|NCT03761056|475091682|FG000|Overall Study|Death|8|||
131946285|NCT03761056|475091682|FG000|Overall Study|Enrolled but never treated|2|||
131946286|NCT03761056|475091682|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
131946287|NCT03761056|475091682|FG000|Overall Study|Investigator decision|1|||
131946288|NCT04749745|475091683|FG000|Overall Study|Withdrawal by Subject|1|||
131946289|NCT04749745|475091684|FG001|Overall Study|Withdrawal by Subject|0|||
131946290|NCT04790279|475093044|FG000|Overall Study|Did not meet medication start criteria|27|||
131946291|NCT04790279|475093045|FG001|Overall Study|Did not meet medication start criteria|15|||
131946292|NCT04790279|475093044|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
131946293|NCT04790279|475093045|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
131946294|NCT04790279|475093044|FG000|Overall Study|Protocol Violation|8|||
131946295|NCT04790279|475093045|FG001|Overall Study|Protocol Violation|3|||
131413636|NCT00385723|473138906|FG002|Overall Study|Withdrawal by Subject|2|||
131946296|NCT04790279|475093044|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
131946297|NCT04790279|475093045|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
131413637|NCT03455829|473138907|FG000|Overall Study|Death|2|||
131946298|NCT00972023|475093060|FG000|Overall Study|Withdrawal by Subject|1|||
131946299|NCT00532129|475093063|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
131946300|NCT00532129|475093063|FG000|Treatment Period|Physician Decision|15|||
131946301|NCT00532129|475093063|FG000|Treatment Period|Disease progression|3|||
131946302|NCT00532129|475093063|FG000|Treatment Period|Protocol Violation|1|||
131946303|NCT00532129|475093063|FG000|Treatment Period|Other|5|||
131946304|NCT00532129|475093063|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
131946305|NCT00532129|475093063|FG000|Follow-up Period|Disease progression|57|||
131946306|NCT00532129|475093063|FG000|Follow-up Period|Lost to Follow-up|1|||
131946307|NCT00532129|475093063|FG000|Follow-up Period|Other|6|||
131946308|NCT00784368|475093064|FG000|Overall Study|Physician Decision|0|||
131946309|NCT00784368|475093065|FG001|Overall Study|Physician Decision|0|||
131946310|NCT00784368|475093066|FG002|Overall Study|Physician Decision|6|||
131946311|NCT00784368|475093064|FG000|Overall Study|Lack of Efficacy|2|||
131946312|NCT00784368|475093065|FG001|Overall Study|Lack of Efficacy|0|||
131946313|NCT00784368|475093066|FG002|Overall Study|Lack of Efficacy|1|||
131946314|NCT00784368|475093064|FG000|Overall Study|Adverse Event|6|||
131946315|NCT00784368|475093065|FG001|Overall Study|Adverse Event|9|||
131946316|NCT00784368|475093066|FG002|Overall Study|Adverse Event|2|||
131946317|NCT00784368|475093064|FG000|Overall Study|Diagnosis of fever|0|||
131946318|NCT00784368|475093065|FG001|Overall Study|Diagnosis of fever|0|||
131946319|NCT00784368|475093066|FG002|Overall Study|Diagnosis of fever|1|||
131946320|NCT00784368|475093064|FG000|Overall Study|Worsening of complications|0|||
131946321|NCT00784368|475093065|FG001|Overall Study|Worsening of complications|0|||
131946322|NCT00784368|475093066|FG002|Overall Study|Worsening of complications|1|||
131946323|NCT00784368|475093064|FG000|Overall Study|Worsening of symptoms|0|||
131946324|NCT00784368|475093065|FG001|Overall Study|Worsening of symptoms|1|||
131946325|NCT00784368|475093066|FG002|Overall Study|Worsening of symptoms|0|||
131946326|NCT00784368|475093064|FG000|Overall Study|Withdrawal of informed consent|0|||
131946327|NCT00784368|475093065|FG001|Overall Study|Withdrawal of informed consent|1|||
131946328|NCT00784368|475093066|FG002|Overall Study|Withdrawal of informed consent|0|||
131946329|NCT00342628|475093067|FG000|Overall Study|Withdrawal by Subject|19|||
131946330|NCT00342628|475093068|FG001|Overall Study|Withdrawal by Subject|19|||
131946331|NCT00342628|475093069|FG002|Overall Study|Withdrawal by Subject|18|||
131946332|NCT00342628|475093067|FG000|Overall Study|Death|1|||
131946333|NCT00342628|475093068|FG001|Overall Study|Death|1|||
131946334|NCT00342628|475093069|FG002|Overall Study|Death|0|||
131946335|NCT00342628|475093067|FG000|Overall Study|moved residence|0|||
131946336|NCT00342628|475093068|FG001|Overall Study|moved residence|1|||
131946337|NCT00342628|475093069|FG002|Overall Study|moved residence|1|||
131946338|NCT04551898|475093070|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
131946339|NCT04551898|475093071|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
131946340|NCT04551898|475093072|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
131946341|NCT04551898|475093073|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
131946342|NCT04551898|475093070|FG000|Overall Study|Withdrawal by Subject|5|||
131946343|NCT04551898|475093071|FG001|Overall Study|Withdrawal by Subject|1|||
131946344|NCT04551898|475093072|FG002|Overall Study|Withdrawal by Subject|2|||
131946345|NCT04551898|475093073|FG003|Overall Study|Withdrawal by Subject|2|||
131946346|NCT04551898|475093070|FG000|Overall Study|Lost to Follow-up|2|||
131946347|NCT04551898|475093071|FG001|Overall Study|Lost to Follow-up|1|||
131946348|NCT04551898|475093072|FG002|Overall Study|Lost to Follow-up|2|||
131946349|NCT04551898|475093073|FG003|Overall Study|Lost to Follow-up|2|||
131946350|NCT04551898|475093070|FG000|Overall Study|Death|1|||
131946351|NCT04551898|475093071|FG001|Overall Study|Death|0|||
131946352|NCT04551898|475093072|FG002|Overall Study|Death|0|||
131946353|NCT04551898|475093073|FG003|Overall Study|Death|0|||
131946354|NCT04551898|475093070|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
131946355|NCT04551898|475093071|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
131946356|NCT04551898|475093072|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
131946357|NCT04551898|475093073|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
131946358|NCT03846427|475093074|FG000|Overall Study|Death|13|||
131946359|NCT03846427|475093074|FG000|Overall Study|Withdrawal by Subject|3|||
131946360|NCT03846427|475093074|FG000|Overall Study|Physician Decision|1|||
131946361|NCT04971967|475093077|FG000|Overall Study|Lost to Follow-up|6|||
131946362|NCT04971967|475093078|FG001|Overall Study|Lost to Follow-up|7|||
131946363|NCT00682929|475093081|FG000|Overall Study|Adverse Event|4|||
131946364|NCT00682929|475093082|FG001|Overall Study|Adverse Event|1|||
131946365|NCT00682929|475093083|FG002|Overall Study|Adverse Event|1|||
131946366|NCT00682929|475093081|FG000|Overall Study|Withdrawal by Subject|1|||
131946367|NCT00682929|475093082|FG001|Overall Study|Withdrawal by Subject|2|||
131946368|NCT00682929|475093083|FG002|Overall Study|Withdrawal by Subject|1|||
131946369|NCT00682929|475093081|FG000|Overall Study|dosing compliance < 80%|0|||
131946370|NCT00682929|475093082|FG001|Overall Study|dosing compliance < 80%|2|||
131946371|NCT00682929|475093083|FG002|Overall Study|dosing compliance < 80%|0|||
131946372|NCT00682929|475093081|FG000|Overall Study|lag in DEA renewal|1|||
131946373|NCT00682929|475093082|FG001|Overall Study|lag in DEA renewal|0|||
131946374|NCT00682929|475093083|FG002|Overall Study|lag in DEA renewal|0|||
131946375|NCT01462929|475093084|FG000|Overall Study|Adverse Event|3|||
131946376|NCT01462929|475093085|FG001|Overall Study|Adverse Event|3|||
131946377|NCT01462929|475093086|FG002|Overall Study|Adverse Event|4|||
131946378|NCT01462929|475093084|FG000|Overall Study|Withdrawal by Subject|2|||
131946379|NCT01462929|475093085|FG001|Overall Study|Withdrawal by Subject|1|||
131946380|NCT01462929|475093086|FG002|Overall Study|Withdrawal by Subject|0|||
131946381|NCT01462929|475093084|FG000|Overall Study|Lack of Efficacy|0|||
131946382|NCT01462929|475093085|FG001|Overall Study|Lack of Efficacy|0|||
131946383|NCT01462929|475093086|FG002|Overall Study|Lack of Efficacy|1|||
131946384|NCT00456755|475093087|FG000|Overall Study|Lost to Follow-up|2|||
131946385|NCT00456755|475093088|FG001|Overall Study|Lost to Follow-up|1|||
131946386|NCT03333928|475093089|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
131946387|NCT03333928|475093090|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
131946388|NCT03333928|475093091|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
131946389|NCT03333928|475093089|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
131946390|NCT03333928|475093090|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
131946391|NCT03333928|475093091|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
131946392|NCT03333928|475093089|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
131946393|NCT03333928|475093090|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
131946394|NCT03333928|475093091|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
131946395|NCT03333928|475093089|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
131946396|NCT03333928|475093090|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
131946397|NCT03333928|475093091|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
131946398|NCT03333928|475093089|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
131946399|NCT03333928|475093090|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
131946400|NCT03333928|475093091|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
131946401|NCT03333928|475093089|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
131946402|NCT03333928|475093090|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
131946403|NCT03333928|475093091|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
131946404|NCT03333928|475093089|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
131946405|NCT03333928|475093090|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
131946406|NCT03333928|475093091|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
131946407|NCT03333928|475093089|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
131946408|NCT03333928|475093090|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
131946409|NCT03333928|475093091|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
131946410|NCT04072835|475093092|FG000|Overall Study|Overall trial ended|603|||
131946411|NCT04072835|475093092|FG000|Overall Study|Ablation|97|||
131946412|NCT04072835|475093092|FG000|Overall Study|Withdrawal of consent|66|||
131946413|NCT04072835|475093092|FG000|Overall Study|Physician Decision|50|||
131946414|NCT04072835|475093092|FG000|Overall Study|Lost to Follow-up|39|||
131946415|NCT04072835|475093092|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
131946416|NCT04072835|475093092|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
131946417|NCT04072835|475093092|FG000|Overall Study|Adverse Event|25|||
131946418|NCT04072835|475093092|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
131946419|NCT04072835|475093092|FG000|Overall Study|Death|11|||
131946420|NCT04072835|475093092|FG000|Overall Study|Participant felt the drug did not work|8|||
131946421|NCT04072835|475093092|FG000|Overall Study|Participant tolerability|5|||
131946422|NCT04072835|475093092|FG000|Overall Study|Missing|5|||
131946423|NCT04072835|475093092|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
131946424|NCT04072835|475093092|FG000|Overall Study|Pregnancy|3|||
131946425|NCT00399568|475093093|FG000|Overall Study|Adverse Event|1|||
131946426|NCT00399568|475093094|FG001|Overall Study|Adverse Event|2|||
131946427|NCT00399568|475093093|FG000|Overall Study|Withdrawal by Subject|7|||
131946428|NCT00399568|475093094|FG001|Overall Study|Withdrawal by Subject|3|||
131946429|NCT00399568|475093093|FG000|Overall Study|Protocol non-compliance|2|||
131946430|NCT00399568|475093094|FG001|Overall Study|Protocol non-compliance|2|||
131946431|NCT00399568|475093093|FG000|Overall Study|Lost to Follow-up|2|||
131946432|NCT00399568|475093094|FG001|Overall Study|Lost to Follow-up|2|||
131946433|NCT00856635|475093098|FG000|Overall Study|Lost to Follow-up|2|||
131946434|NCT00856635|475093099|FG001|Overall Study|Lost to Follow-up|5|||
131946435|NCT00856635|475093098|FG000|Overall Study|Pregnancy|1|||
131946436|NCT00856635|475093099|FG001|Overall Study|Pregnancy|0|||
131413638|NCT03455829|473138908|FG001|Overall Study|Death|3|||
131413639|NCT03455829|473138909|FG002|Overall Study|Death|2|||
131946437|NCT00856635|475093098|FG000|Overall Study|Withdrawal by Subject|3|||
131946438|NCT00856635|475093099|FG001|Overall Study|Withdrawal by Subject|1|||
131946439|NCT00856635|475093098|FG000|Overall Study|Serious Adverse Event|1|||
131946440|NCT00856635|475093099|FG001|Overall Study|Serious Adverse Event|0|||
131946441|NCT00856635|475093098|FG000|Overall Study|Other|1|||
131413640|NCT03455829|473138910|FG003|Overall Study|Death|4|||
131413641|NCT03455829|473138911|FG004|Overall Study|Death|2|||
131413642|NCT03455829|473138907|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
131946442|NCT00856635|475093099|FG001|Overall Study|Other|0|||
131946443|NCT00856635|475093098|FG000|Overall Study|Discontinued at Randomization|2|||
131946444|NCT00856635|475093099|FG001|Overall Study|Discontinued at Randomization|2|||
131946445|NCT01244035|475093100|FG000|Part 1: Period 1|Adverse Event|0|||
131946446|NCT01244035|475093101|FG001|Part 1: Period 1|Adverse Event|0|||
131946447|NCT01244035|475093102|FG002|Part 1: Period 1|Adverse Event|0|||
131946448|NCT01244035|475093103|FG003|Part 1: Period 1|Adverse Event|0|||
131946449|NCT01244035|475093104|FG004|Part 1: Period 1|Adverse Event|0|||
131946450|NCT01244035|475093105|FG005|Part 1: Period 1|Adverse Event|1|||
131946451|NCT01244035|475093100|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
131946452|NCT01244035|475093101|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
131946453|NCT01244035|475093102|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
131946454|NCT01244035|475093103|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
131946455|NCT01244035|475093104|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
131946456|NCT01244035|475093105|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
131946457|NCT01244035|475093100|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
131946458|NCT01244035|475093101|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
131946459|NCT01244035|475093102|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
131946460|NCT01244035|475093103|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
131946461|NCT01244035|475093104|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
131946462|NCT01244035|475093105|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
131946463|NCT01244035|475093100|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
131946464|NCT01244035|475093101|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
131946465|NCT01244035|475093102|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
131946466|NCT01244035|475093103|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
131946467|NCT01244035|475093104|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
131946468|NCT01244035|475093105|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
131946469|NCT01244035|475093100|FG000|Part 1: Period 3|Adverse Event|0|||
131946470|NCT01244035|475093101|FG001|Part 1: Period 3|Adverse Event|0|||
131946471|NCT01244035|475093102|FG002|Part 1: Period 3|Adverse Event|0|||
131946472|NCT01244035|475093103|FG003|Part 1: Period 3|Adverse Event|0|||
131946473|NCT01244035|475093104|FG004|Part 1: Period 3|Adverse Event|0|||
131946474|NCT01244035|475093105|FG005|Part 1: Period 3|Adverse Event|1|||
131946475|NCT01244035|475093100|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
131946476|NCT01244035|475093101|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
131946477|NCT01244035|475093102|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
131946478|NCT01244035|475093103|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
131946479|NCT01244035|475093104|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
131946480|NCT01244035|475093105|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
131946481|NCT01244035|475093100|FG000|Part 1: Period 3|Protocol Deviation|0|||
131946482|NCT01244035|475093101|FG001|Part 1: Period 3|Protocol Deviation|1|||
131946483|NCT01244035|475093102|FG002|Part 1: Period 3|Protocol Deviation|0|||
131946484|NCT01244035|475093103|FG003|Part 1: Period 3|Protocol Deviation|0|||
131946485|NCT01244035|475093104|FG004|Part 1: Period 3|Protocol Deviation|0|||
131946486|NCT01244035|475093105|FG005|Part 1: Period 3|Protocol Deviation|0|||
131946487|NCT03688919|475093110|FG000|Overall Study|Lost to Follow-up|2|||
131946488|NCT03688919|475093111|FG001|Overall Study|Lost to Follow-up|1|||
131946489|NCT03688919|475093110|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
131946490|NCT03688919|475093111|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
131946491|NCT02370368|475093112|FG000|Overall Study|Adverse Event|1|||
131946492|NCT02370368|475093113|FG001|Overall Study|Adverse Event|2|||
131946493|NCT02370368|475093112|FG000|Overall Study|Withdrawal by Subject|5|||
131946494|NCT02370368|475093113|FG001|Overall Study|Withdrawal by Subject|4|||
131946495|NCT00347932|475093116|FG000|Overall Study|Adverse Event|4|||
131946496|NCT00347932|475093117|FG001|Overall Study|Adverse Event|5|||
131946497|NCT00347932|475093116|FG000|Overall Study|Lack of Efficacy|3|||
131413643|NCT03455829|473138908|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
131946498|NCT00347932|475093117|FG001|Overall Study|Lack of Efficacy|14|||
131946499|NCT00347932|475093116|FG000|Overall Study|Lost to Follow-up|10|||
131946500|NCT00347932|475093117|FG001|Overall Study|Lost to Follow-up|9|||
131946501|NCT00347932|475093116|FG000|Overall Study|Withdrawal by Subject|10|||
131946502|NCT00347932|475093117|FG001|Overall Study|Withdrawal by Subject|16|||
131946503|NCT00347932|475093116|FG000|Overall Study|Did not meet inclusion criteria|4|||
131946504|NCT00347932|475093117|FG001|Overall Study|Did not meet inclusion criteria|8|||
131946505|NCT03389308|475093118|FG000|Overall Study|Withdrawal by Subject|5|||
131946506|NCT03389308|475093118|FG000|Overall Study|Lost to Follow-up|3|||
131946507|NCT03389308|475093118|FG000|Overall Study|Adverse Event|2|||
131946508|NCT03389308|475093118|FG000|Overall Study|Sponsor Request|2|||
131946509|NCT01791517|475093120|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
131946510|NCT01791517|475093121|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
131946511|NCT01791517|475093122|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
131946512|NCT01791517|475093123|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
131946513|NCT01791517|475093124|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
131946514|NCT01791517|475093125|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
131946515|NCT01791517|475093126|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
131946516|NCT01791517|475093127|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
131946517|NCT01791517|475093128|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
131946518|NCT01791517|475093129|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
131946519|NCT01791517|475093130|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
131946520|NCT01791517|475093131|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
131946521|NCT01791517|475093120|FG000|Phase I: Period 1|Adverse Event|0|||
131946522|NCT01791517|475093121|FG001|Phase I: Period 1|Adverse Event|0|||
131946523|NCT01791517|475093122|FG002|Phase I: Period 1|Adverse Event|1|||
131946524|NCT01791517|475093123|FG003|Phase I: Period 1|Adverse Event|1|||
131946525|NCT01791517|475093124|FG004|Phase I: Period 1|Adverse Event|0|||
131946526|NCT01791517|475093125|FG005|Phase I: Period 1|Adverse Event|0|||
131946527|NCT01791517|475093126|FG006|Phase I: Period 1|Adverse Event|0|||
131946528|NCT01791517|475093127|FG007|Phase I: Period 1|Adverse Event|0|||
131946529|NCT01791517|475093128|FG008|Phase I: Period 1|Adverse Event|0|||
131946530|NCT01791517|475093129|FG009|Phase I: Period 1|Adverse Event|0|||
131946531|NCT01791517|475093130|FG010|Phase I: Period 1|Adverse Event|0|||
131946532|NCT01791517|475093131|FG011|Phase I: Period 1|Adverse Event|0|||
131946533|NCT01791517|475093120|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
131946534|NCT01791517|475093121|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946535|NCT01791517|475093122|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946536|NCT01791517|475093123|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946537|NCT01791517|475093124|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946538|NCT01791517|475093125|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946539|NCT01791517|475093126|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946540|NCT01791517|475093127|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946541|NCT01791517|475093128|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946542|NCT01791517|475093129|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946543|NCT01791517|475093130|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946544|NCT01791517|475093131|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
131946545|NCT01791517|475093120|FG000|Phase I: Period 1|Protocol Violation|0|||
131946546|NCT01791517|475093121|FG001|Phase I: Period 1|Protocol Violation|1|||
131946547|NCT01791517|475093122|FG002|Phase I: Period 1|Protocol Violation|0|||
131946548|NCT01791517|475093123|FG003|Phase I: Period 1|Protocol Violation|0|||
131946549|NCT01791517|475093124|FG004|Phase I: Period 1|Protocol Violation|0|||
131946550|NCT01791517|475093125|FG005|Phase I: Period 1|Protocol Violation|0|||
131946551|NCT01791517|475093126|FG006|Phase I: Period 1|Protocol Violation|0|||
131946552|NCT01791517|475093127|FG007|Phase I: Period 1|Protocol Violation|0|||
131946553|NCT01791517|475093128|FG008|Phase I: Period 1|Protocol Violation|0|||
131946554|NCT01791517|475093129|FG009|Phase I: Period 1|Protocol Violation|0|||
131946555|NCT01791517|475093130|FG010|Phase I: Period 1|Protocol Violation|0|||
131946556|NCT01791517|475093131|FG011|Phase I: Period 1|Protocol Violation|0|||
131946557|NCT01791517|475093120|FG000|Phase I: Period 1|Lost to Follow-up|0|||
131946558|NCT01791517|475093121|FG001|Phase I: Period 1|Lost to Follow-up|0|||
131946559|NCT01791517|475093122|FG002|Phase I: Period 1|Lost to Follow-up|0|||
131946560|NCT01791517|475093123|FG003|Phase I: Period 1|Lost to Follow-up|1|||
131946561|NCT01791517|475093124|FG004|Phase I: Period 1|Lost to Follow-up|0|||
131946562|NCT01791517|475093125|FG005|Phase I: Period 1|Lost to Follow-up|0|||
131946563|NCT01791517|475093126|FG006|Phase I: Period 1|Lost to Follow-up|1|||
131946564|NCT01791517|475093127|FG007|Phase I: Period 1|Lost to Follow-up|0|||
131946565|NCT01791517|475093128|FG008|Phase I: Period 1|Lost to Follow-up|1|||
131946566|NCT01791517|475093129|FG009|Phase I: Period 1|Lost to Follow-up|1|||
131946567|NCT01791517|475093130|FG010|Phase I: Period 1|Lost to Follow-up|0|||
131946568|NCT01791517|475093131|FG011|Phase I: Period 1|Lost to Follow-up|0|||
131946569|NCT01791517|475093120|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946570|NCT01791517|475093121|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
131413644|NCT03455829|473138909|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
131946571|NCT01791517|475093122|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946572|NCT01791517|475093123|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946573|NCT01791517|475093124|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946574|NCT01791517|475093125|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946575|NCT01791517|475093126|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946576|NCT01791517|475093127|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946577|NCT01791517|475093128|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946578|NCT01791517|475093129|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946579|NCT01791517|475093130|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
131946580|NCT01791517|475093131|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
131946581|NCT01791517|475093120|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
131946582|NCT01791517|475093121|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131413645|NCT03455829|473138910|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
131946583|NCT01791517|475093122|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946584|NCT01791517|475093123|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131413646|NCT03455829|473138911|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
131413647|NCT03455829|473138907|FG000|Overall Study|Disease progression|0|||
131413648|NCT03455829|473138908|FG001|Overall Study|Disease progression|0|||
131413649|NCT03455829|473138909|FG002|Overall Study|Disease progression|0|||
131413650|NCT03455829|473138910|FG003|Overall Study|Disease progression|1|||
131413651|NCT03455829|473138911|FG004|Overall Study|Disease progression|1|||
131413652|NCT00096018|473138919|FG000|Overall Study|Became Ineligible (not treated)|0|||
131413653|NCT00096018|473138920|FG001|Overall Study|Became Ineligible (not treated)|3|||
131413654|NCT00096018|473138919|FG000|Overall Study|Miscellaneous (not treated)|0|||
131413655|NCT00096018|473138920|FG001|Overall Study|Miscellaneous (not treated)|2|||
131413656|NCT00096018|473138919|FG000|Overall Study|Adverse Event|0|||
131413657|NCT00096018|473138920|FG001|Overall Study|Adverse Event|5|||
131413658|NCT00096018|473138919|FG000|Overall Study|Death|0|||
131413659|NCT00096018|473138920|FG001|Overall Study|Death|1|||
131413660|NCT00096018|473138919|FG000|Overall Study|Withdrawal by Subject|0|||
131413661|NCT00096018|473138920|FG001|Overall Study|Withdrawal by Subject|2|||
131413662|NCT00096018|473138919|FG000|Overall Study|Miscellaneous|2|||
131413663|NCT00096018|473138920|FG001|Overall Study|Miscellaneous|1|||
131413664|NCT03689712|473138921|FG000|Overall Study|Adverse Event|1|||
131413665|NCT03689712|473138922|FG001|Overall Study|Adverse Event|0|||
131413666|NCT03689712|473138921|FG000|Overall Study|Death|20|||
131413667|NCT03689712|473138922|FG001|Overall Study|Death|10|||
131413668|NCT03689712|473138921|FG000|Overall Study|Lost to Follow-up|6|||
131413669|NCT03689712|473138922|FG001|Overall Study|Lost to Follow-up|6|||
131413670|NCT03689712|473138921|FG000|Overall Study|Other|1|||
131413671|NCT03689712|473138922|FG001|Overall Study|Other|0|||
131413672|NCT03689712|473138921|FG000|Overall Study|Patient Non-Compliance|0|||
131413673|NCT03689712|473138922|FG001|Overall Study|Patient Non-Compliance|1|||
131413674|NCT03689712|473138921|FG000|Overall Study|Withdrawal by Subject|20|||
131413675|NCT03689712|473138922|FG001|Overall Study|Withdrawal by Subject|4|||
131413676|NCT03689712|473138921|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
131413677|NCT03689712|473138922|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
131413678|NCT03689712|473138921|FG000|Overall Study|Randomized but not Treated|13|||
131413679|NCT03689712|473138922|FG001|Overall Study|Randomized but not Treated|7|||
131413680|NCT03689712|473138921|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
131413681|NCT03689712|473138922|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
131413682|NCT00689793|473138923|FG000|Overall Study|Lost to Follow-up|4|||
131413683|NCT00689793|473138924|FG001|Overall Study|Lost to Follow-up|5|||
131413684|NCT03968159|473138927|FG000|Overall Study|Adverse Event|4|||
131413685|NCT03968159|473138928|FG001|Overall Study|Adverse Event|4|||
131413686|NCT03968159|473138927|FG000|Overall Study|Lost to Follow-up|1|||
131413687|NCT03968159|473138928|FG001|Overall Study|Lost to Follow-up|1|||
131413688|NCT03968159|473138927|FG000|Overall Study|Use of prohibited medication|0|||
131413689|NCT03968159|473138928|FG001|Overall Study|Use of prohibited medication|1|||
131413690|NCT03968159|473138927|FG000|Overall Study|Protocol Violation|2|||
131413691|NCT03968159|473138928|FG001|Overall Study|Protocol Violation|2|||
131413692|NCT03968159|473138927|FG000|Overall Study|Withdrawal by Subject|4|||
131413693|NCT03968159|473138928|FG001|Overall Study|Withdrawal by Subject|6|||
131413694|NCT03968159|473138927|FG000|Overall Study|Lack of Efficacy|0|||
131413695|NCT03968159|473138928|FG001|Overall Study|Lack of Efficacy|1|||
131413696|NCT03968159|473138927|FG000|Overall Study|Not further specified|2|||
131413697|NCT03968159|473138928|FG001|Overall Study|Not further specified|0|||
131413698|NCT03283150|473138931|FG000|Overall Study|Withdrawal by Subject|6|||
131413699|NCT03283150|473138932|FG001|Overall Study|Withdrawal by Subject|0|||
131413700|NCT03283150|473138933|FG002|Overall Study|Withdrawal by Subject|0|||
131413701|NCT01299571|473138934|FG000|Overall Study|Protocol Violation|107|||
131413702|NCT00864851|473138935|FG000|Overall Study|Withdrawal by Subject|0|||
131413703|NCT00864851|473138936|FG001|Overall Study|Withdrawal by Subject|1|||
131413704|NCT00864851|473138937|FG002|Overall Study|Withdrawal by Subject|0|||
131413705|NCT00864851|473138935|FG000|Overall Study|Physician Decision|1|||
131413706|NCT00864851|473138936|FG001|Overall Study|Physician Decision|0|||
131413707|NCT00864851|473138937|FG002|Overall Study|Physician Decision|0|||
131413708|NCT00864851|473138935|FG000|Overall Study|Death|1|||
131413709|NCT00864851|473138936|FG001|Overall Study|Death|0|||
131413710|NCT00864851|473138937|FG002|Overall Study|Death|0|||
131413711|NCT00864851|473138935|FG000|Overall Study|Patient uncooperative|1|||
131946585|NCT01791517|475093124|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946586|NCT01791517|475093125|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131413712|NCT00864851|473138936|FG001|Overall Study|Patient uncooperative|0|||
131413713|NCT00864851|473138937|FG002|Overall Study|Patient uncooperative|0|||
131413714|NCT00708734|473138940|FG000|Overall Study|scheduling conflict|2|||
131413715|NCT00708734|473138940|FG000|Overall Study|moved|1|||
131413716|NCT00708734|473138940|FG000|Overall Study|leg injury|1|||
131413717|NCT00708734|473138940|FG000|Overall Study|knee replacement|1|||
131413718|NCT00708734|473138940|FG000|Overall Study|vertigo|1|||
131413719|NCT00708734|473138940|FG000|Overall Study|leg fracture|1|||
131413720|NCT01842581|473138944|FG000|Overall Study|Adverse Event|6|||
131413721|NCT01842581|473138945|FG001|Overall Study|Adverse Event|4|||
131413722|NCT01842581|473138944|FG000|Overall Study|HE breakthrough|26|||
131413723|NCT01842581|473138945|FG001|Overall Study|HE breakthrough|13|||
131413724|NCT01842581|473138944|FG000|Overall Study|Liver transplant|2|||
131413725|NCT01842581|473138945|FG001|Overall Study|Liver transplant|0|||
131413726|NCT01842581|473138944|FG000|Overall Study|Lost to Follow-up|2|||
131413727|NCT01842581|473138945|FG001|Overall Study|Lost to Follow-up|5|||
131413728|NCT01842581|473138944|FG000|Overall Study|Withdrawal by Subject|5|||
131413729|NCT01842581|473138945|FG001|Overall Study|Withdrawal by Subject|7|||
131413730|NCT01842581|473138944|FG000|Overall Study|Other than specified|3|||
131413731|NCT01842581|473138945|FG001|Overall Study|Other than specified|1|||
131413732|NCT00353873|473138946|FG000|Overall Study|Protocol Violation|1|||
131413733|NCT00353873|473138947|FG001|Overall Study|Protocol Violation|2|||
131413734|NCT00353873|473138946|FG000|Overall Study|Exacerbation|1|||
131413735|NCT00353873|473138947|FG001|Overall Study|Exacerbation|0|||
131413736|NCT00353873|473138946|FG000|Overall Study|Adverse Event|1|||
131413737|NCT00353873|473138947|FG001|Overall Study|Adverse Event|0|||
131413738|NCT00353873|473138946|FG000|Overall Study|Physician Decision|2|||
131413739|NCT00353873|473138947|FG001|Overall Study|Physician Decision|0|||
131413740|NCT00353873|473138946|FG000|Overall Study|Withdrawal by Subject|1|||
131413741|NCT00353873|473138947|FG001|Overall Study|Withdrawal by Subject|1|||
131413742|NCT02717130|473138948|FG000|Overall Study|Withdrawal by Subject|1|||
131413743|NCT02717130|473138948|FG000|Overall Study|Adverse Event|1|||
131413744|NCT02717130|473138948|FG000|Overall Study|Physician Decision|1|||
131413745|NCT02717130|473138948|FG000|Overall Study|Study Closure|4|||
131413746|NCT00106691|473138949|FG000|Overall Study|Adverse Event|60|||
131413747|NCT00106691|473138950|FG001|Overall Study|Adverse Event|64|||
131413748|NCT00106691|473138949|FG000|Overall Study|Lost to Follow-up|23|||
131413749|NCT00106691|473138950|FG001|Overall Study|Lost to Follow-up|18|||
131413750|NCT00106691|473138949|FG000|Overall Study|Physician Decision|18|||
131413751|NCT00106691|473138950|FG001|Overall Study|Physician Decision|21|||
131413752|NCT00106691|473138949|FG000|Overall Study|Protocol Violation|13|||
131413753|NCT00106691|473138950|FG001|Overall Study|Protocol Violation|18|||
131413754|NCT00106691|473138949|FG000|Overall Study|Withdrawal by Subject|75|||
131413755|NCT00106691|473138950|FG001|Overall Study|Withdrawal by Subject|70|||
131413756|NCT00106691|473138949|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
131413757|NCT00106691|473138950|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
131413758|NCT00106691|473138949|FG000|Overall Study|QTc>480|3|||
131413759|NCT00106691|473138950|FG001|Overall Study|QTc>480|1|||
131413760|NCT00106691|473138949|FG000|Overall Study|mililtary deployment|2|||
131413761|NCT00106691|473138950|FG001|Overall Study|mililtary deployment|0|||
131413762|NCT00106691|473138949|FG000|Overall Study|Study Site Closing/PI Moved|1|||
131413763|NCT00106691|473138950|FG001|Overall Study|Study Site Closing/PI Moved|2|||
131413764|NCT00106691|473138949|FG000|Overall Study|Cardiologist recommendation|1|||
131413765|NCT00106691|473138950|FG001|Overall Study|Cardiologist recommendation|0|||
131413766|NCT00106691|473138949|FG000|Overall Study|Pt. moved to another state|1|||
131413767|NCT00106691|473138950|FG001|Overall Study|Pt. moved to another state|0|||
131413768|NCT00106691|473138949|FG000|Overall Study|Taking exclusionary avodart|1|||
131413769|NCT00106691|473138950|FG001|Overall Study|Taking exclusionary avodart|0|||
131413770|NCT00106691|473138949|FG000|Overall Study|Not able to discontinue plavix|0|||
131413771|NCT00106691|473138950|FG001|Overall Study|Not able to discontinue plavix|1|||
131413772|NCT03149003|473138951|FG000|Overall Study|Randomized but not treated|0|||
131413773|NCT03149003|473138952|FG001|Overall Study|Randomized but not treated|1|||
131413774|NCT03149003|473138953|FG002|Overall Study|Randomized but not treated|18|||
131413775|NCT01703065|473138956|FG000|Overall Study|Lack of Efficacy|1|||
131413776|NCT01703065|473138957|FG001|Overall Study|Lack of Efficacy|0|||
131413777|NCT02308488|473138959|FG000|Overall Study|Withdrawal by Subject|2|||
131413778|NCT02356887|473138963|FG000|Overall Study|poor compliance|2|||
131413779|NCT01490294|473138964|FG000|Overall Study|Prematurely discontinuation|4|||
131413780|NCT01490294|473138965|FG001|Overall Study|Prematurely discontinuation|0|||
131413781|NCT01490294|473138966|FG002|Overall Study|Prematurely discontinuation|1|||
131413782|NCT01490294|473138967|FG003|Overall Study|Prematurely discontinuation|1|||
131413783|NCT01490294|473138964|FG000|Overall Study|Adverse Event|1|||
131456100|NCT02675634|473298659|FG001|Test Period 2|Adverse Event|0|||
131456101|NCT02675634|473298660|FG002|Test Period 2|Adverse Event|0|||
131946587|NCT01791517|475093126|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946588|NCT01791517|475093127|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946589|NCT01791517|475093128|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946590|NCT01791517|475093129|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946591|NCT01791517|475093130|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946592|NCT01791517|475093131|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
131946593|NCT01791517|475093120|FG000|Phase I: Period 2|Protocol Violation|0|||
131413784|NCT01490294|473138965|FG001|Overall Study|Adverse Event|0|||
131413785|NCT01490294|473138966|FG002|Overall Study|Adverse Event|0|||
131413786|NCT01490294|473138967|FG003|Overall Study|Adverse Event|0|||
131413787|NCT00160654|473138974|FG000|Overall Study|Adverse Event|14|||
131413788|NCT00160654|473138974|FG000|Overall Study|Lack of Efficacy|4|||
131413789|NCT00160654|473138974|FG000|Overall Study|Lost to Follow-up|2|||
131456102|NCT02675634|473298661|FG003|Test Period 2|Adverse Event|0|||
131946594|NCT01791517|475093121|FG001|Phase I: Period 2|Protocol Violation|0|||
131946595|NCT01791517|475093122|FG002|Phase I: Period 2|Protocol Violation|0|||
131946596|NCT01791517|475093123|FG003|Phase I: Period 2|Protocol Violation|1|||
131946597|NCT01791517|475093124|FG004|Phase I: Period 2|Protocol Violation|0|||
131946598|NCT01791517|475093125|FG005|Phase I: Period 2|Protocol Violation|0|||
131946599|NCT01791517|475093126|FG006|Phase I: Period 2|Protocol Violation|0|||
131946600|NCT01791517|475093127|FG007|Phase I: Period 2|Protocol Violation|0|||
131946601|NCT01791517|475093128|FG008|Phase I: Period 2|Protocol Violation|0|||
131946602|NCT01791517|475093129|FG009|Phase I: Period 2|Protocol Violation|0|||
131946603|NCT01791517|475093130|FG010|Phase I: Period 2|Protocol Violation|0|||
131946604|NCT01791517|475093131|FG011|Phase I: Period 2|Protocol Violation|0|||
131946605|NCT01791517|475093120|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
131946606|NCT01791517|475093121|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
131946607|NCT01791517|475093122|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
131946608|NCT01791517|475093123|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
131946609|NCT01791517|475093124|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
131946610|NCT01791517|475093125|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
131946611|NCT01791517|475093126|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
131946612|NCT01791517|475093127|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
131946613|NCT01791517|475093128|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
131946614|NCT01791517|475093129|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
131946615|NCT01791517|475093130|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
131946616|NCT01791517|475093131|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
131946617|NCT01791517|475093120|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946618|NCT01791517|475093121|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946619|NCT01791517|475093122|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946620|NCT01791517|475093123|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946621|NCT01791517|475093124|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946622|NCT01791517|475093125|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946623|NCT01791517|475093126|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946624|NCT01791517|475093127|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946625|NCT01791517|475093128|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946626|NCT01791517|475093129|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946627|NCT01791517|475093130|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
131946628|NCT01791517|475093131|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
131946629|NCT01791517|475093120|FG000|Phase I: Period 2|Lens Discomfort|0|||
131946630|NCT01791517|475093121|FG001|Phase I: Period 2|Lens Discomfort|0|||
131946631|NCT01791517|475093122|FG002|Phase I: Period 2|Lens Discomfort|0|||
131946632|NCT01791517|475093123|FG003|Phase I: Period 2|Lens Discomfort|0|||
131946633|NCT01791517|475093124|FG004|Phase I: Period 2|Lens Discomfort|0|||
131946634|NCT01791517|475093125|FG005|Phase I: Period 2|Lens Discomfort|1|||
131946635|NCT01791517|475093126|FG006|Phase I: Period 2|Lens Discomfort|0|||
131946636|NCT01791517|475093127|FG007|Phase I: Period 2|Lens Discomfort|0|||
131946637|NCT01791517|475093128|FG008|Phase I: Period 2|Lens Discomfort|0|||
131946638|NCT01791517|475093129|FG009|Phase I: Period 2|Lens Discomfort|0|||
131946639|NCT01791517|475093130|FG010|Phase I: Period 2|Lens Discomfort|0|||
131946640|NCT01791517|475093131|FG011|Phase I: Period 2|Lens Discomfort|0|||
131946641|NCT01791517|475093120|FG000|Phase I: Period 2|Lost to Follow-up|0|||
131946642|NCT01791517|475093121|FG001|Phase I: Period 2|Lost to Follow-up|3|||
131946643|NCT01791517|475093122|FG002|Phase I: Period 2|Lost to Follow-up|2|||
131946644|NCT01791517|475093123|FG003|Phase I: Period 2|Lost to Follow-up|0|||
131946645|NCT01791517|475093124|FG004|Phase I: Period 2|Lost to Follow-up|0|||
131946646|NCT01791517|475093125|FG005|Phase I: Period 2|Lost to Follow-up|0|||
131946647|NCT01791517|475093126|FG006|Phase I: Period 2|Lost to Follow-up|0|||
131946648|NCT01791517|475093127|FG007|Phase I: Period 2|Lost to Follow-up|0|||
131946649|NCT01791517|475093128|FG008|Phase I: Period 2|Lost to Follow-up|0|||
131946650|NCT01791517|475093129|FG009|Phase I: Period 2|Lost to Follow-up|0|||
131946651|NCT01791517|475093130|FG010|Phase I: Period 2|Lost to Follow-up|0|||
131946652|NCT01791517|475093131|FG011|Phase I: Period 2|Lost to Follow-up|0|||
131946653|NCT01791517|475093120|FG000|Phase I: Period 3|Lens Discomfort|0|||
131946654|NCT01791517|475093121|FG001|Phase I: Period 3|Lens Discomfort|0|||
131946655|NCT01791517|475093122|FG002|Phase I: Period 3|Lens Discomfort|0|||
131946656|NCT01791517|475093123|FG003|Phase I: Period 3|Lens Discomfort|0|||
131946657|NCT01791517|475093124|FG004|Phase I: Period 3|Lens Discomfort|0|||
131946658|NCT01791517|475093125|FG005|Phase I: Period 3|Lens Discomfort|0|||
131946659|NCT01791517|475093126|FG006|Phase I: Period 3|Lens Discomfort|0|||
131946660|NCT01791517|475093127|FG007|Phase I: Period 3|Lens Discomfort|0|||
131946661|NCT01791517|475093128|FG008|Phase I: Period 3|Lens Discomfort|0|||
131946662|NCT01791517|475093129|FG009|Phase I: Period 3|Lens Discomfort|0|||
131946663|NCT01791517|475093130|FG010|Phase I: Period 3|Lens Discomfort|0|||
131946664|NCT01791517|475093131|FG011|Phase I: Period 3|Lens Discomfort|1|||
131946665|NCT01791517|475093120|FG000|Phase I: Period 3|Lost to Follow-up|0|||
131946666|NCT01791517|475093121|FG001|Phase I: Period 3|Lost to Follow-up|1|||
131946667|NCT01791517|475093122|FG002|Phase I: Period 3|Lost to Follow-up|0|||
131946668|NCT01791517|475093123|FG003|Phase I: Period 3|Lost to Follow-up|0|||
131946669|NCT01791517|475093124|FG004|Phase I: Period 3|Lost to Follow-up|1|||
131946670|NCT01791517|475093125|FG005|Phase I: Period 3|Lost to Follow-up|0|||
131946671|NCT01791517|475093126|FG006|Phase I: Period 3|Lost to Follow-up|0|||
131946672|NCT01791517|475093127|FG007|Phase I: Period 3|Lost to Follow-up|0|||
131946673|NCT01791517|475093128|FG008|Phase I: Period 3|Lost to Follow-up|0|||
131946674|NCT01791517|475093129|FG009|Phase I: Period 3|Lost to Follow-up|0|||
131946675|NCT01791517|475093130|FG010|Phase I: Period 3|Lost to Follow-up|0|||
131946676|NCT01791517|475093131|FG011|Phase I: Period 3|Lost to Follow-up|0|||
131946677|NCT01791517|475093120|FG000|Phase I: Period 3|Adverse Event|0|||
131946678|NCT01791517|475093121|FG001|Phase I: Period 3|Adverse Event|0|||
131946679|NCT01791517|475093122|FG002|Phase I: Period 3|Adverse Event|0|||
131946680|NCT01791517|475093123|FG003|Phase I: Period 3|Adverse Event|1|||
131946681|NCT01791517|475093124|FG004|Phase I: Period 3|Adverse Event|0|||
131946682|NCT01791517|475093125|FG005|Phase I: Period 3|Adverse Event|0|||
131946683|NCT01791517|475093126|FG006|Phase I: Period 3|Adverse Event|0|||
131946684|NCT01791517|475093127|FG007|Phase I: Period 3|Adverse Event|0|||
131946685|NCT01791517|475093128|FG008|Phase I: Period 3|Adverse Event|0|||
131946686|NCT01791517|475093129|FG009|Phase I: Period 3|Adverse Event|0|||
131946687|NCT01791517|475093130|FG010|Phase I: Period 3|Adverse Event|0|||
131946688|NCT01791517|475093131|FG011|Phase I: Period 3|Adverse Event|0|||
131946689|NCT01791517|475093120|FG000|Phase II|Lost to Follow-up|1|||
131946690|NCT01791517|475093121|FG001|Phase II|Lost to Follow-up|0|||
131946691|NCT01791517|475093122|FG002|Phase II|Lost to Follow-up|1|||
131946692|NCT01791517|475093123|FG003|Phase II|Lost to Follow-up|0|||
131946693|NCT01791517|475093124|FG004|Phase II|Lost to Follow-up|1|||
131946694|NCT01791517|475093125|FG005|Phase II|Lost to Follow-up|2|||
131946695|NCT01791517|475093126|FG006|Phase II|Lost to Follow-up|0|||
131946696|NCT01791517|475093127|FG007|Phase II|Lost to Follow-up|1|||
131946697|NCT01791517|475093128|FG008|Phase II|Lost to Follow-up|1|||
131946698|NCT01791517|475093129|FG009|Phase II|Lost to Follow-up|1|||
131946699|NCT01791517|475093130|FG010|Phase II|Lost to Follow-up|0|||
131946700|NCT01791517|475093131|FG011|Phase II|Lost to Follow-up|0|||
131946701|NCT01791517|475093120|FG000|Phase II|Withdrawal by Subject|1|||
131946702|NCT01791517|475093121|FG001|Phase II|Withdrawal by Subject|0|||
131946703|NCT01791517|475093122|FG002|Phase II|Withdrawal by Subject|0|||
131946704|NCT01791517|475093123|FG003|Phase II|Withdrawal by Subject|0|||
131946705|NCT01791517|475093124|FG004|Phase II|Withdrawal by Subject|0|||
131946706|NCT01791517|475093125|FG005|Phase II|Withdrawal by Subject|2|||
131946707|NCT01791517|475093126|FG006|Phase II|Withdrawal by Subject|0|||
131946708|NCT01791517|475093127|FG007|Phase II|Withdrawal by Subject|1|||
131946709|NCT01791517|475093128|FG008|Phase II|Withdrawal by Subject|0|||
131946710|NCT01791517|475093129|FG009|Phase II|Withdrawal by Subject|0|||
131946711|NCT01791517|475093130|FG010|Phase II|Withdrawal by Subject|1|||
131946712|NCT01791517|475093131|FG011|Phase II|Withdrawal by Subject|0|||
131946713|NCT01791517|475093120|FG000|Phase II|Lack of Efficacy|0|||
131946714|NCT01791517|475093121|FG001|Phase II|Lack of Efficacy|0|||
131946715|NCT01791517|475093122|FG002|Phase II|Lack of Efficacy|0|||
131946716|NCT01791517|475093123|FG003|Phase II|Lack of Efficacy|0|||
131946717|NCT01791517|475093124|FG004|Phase II|Lack of Efficacy|1|||
131946718|NCT01791517|475093125|FG005|Phase II|Lack of Efficacy|0|||
131946719|NCT01791517|475093126|FG006|Phase II|Lack of Efficacy|0|||
131946720|NCT01791517|475093127|FG007|Phase II|Lack of Efficacy|0|||
131946721|NCT01791517|475093128|FG008|Phase II|Lack of Efficacy|0|||
131946722|NCT01791517|475093129|FG009|Phase II|Lack of Efficacy|0|||
131946723|NCT01791517|475093130|FG010|Phase II|Lack of Efficacy|0|||
131946724|NCT01791517|475093131|FG011|Phase II|Lack of Efficacy|0|||
131946725|NCT01791517|475093120|FG000|Phase II|Adverse Event|0|||
131946726|NCT01791517|475093121|FG001|Phase II|Adverse Event|0|||
131946727|NCT01791517|475093122|FG002|Phase II|Adverse Event|0|||
131946728|NCT01791517|475093123|FG003|Phase II|Adverse Event|0|||
131946729|NCT01791517|475093124|FG004|Phase II|Adverse Event|0|||
131946730|NCT01791517|475093125|FG005|Phase II|Adverse Event|0|||
131946731|NCT01791517|475093126|FG006|Phase II|Adverse Event|2|||
131946732|NCT01791517|475093127|FG007|Phase II|Adverse Event|1|||
131946733|NCT01791517|475093128|FG008|Phase II|Adverse Event|0|||
131413790|NCT00160654|473138974|FG000|Overall Study|Intake of expired drug|7|||
131413791|NCT00160654|473138974|FG000|Overall Study|Psychological trauma|1|||
131946734|NCT01791517|475093129|FG009|Phase II|Adverse Event|1|||
131946735|NCT01791517|475093130|FG010|Phase II|Adverse Event|0|||
131946736|NCT01791517|475093131|FG011|Phase II|Adverse Event|0|||
131946737|NCT01791517|475093120|FG000|Phase II|Lens Handling Difficulties|0|||
131946738|NCT01791517|475093121|FG001|Phase II|Lens Handling Difficulties|0|||
131946739|NCT01791517|475093122|FG002|Phase II|Lens Handling Difficulties|0|||
131946740|NCT01791517|475093123|FG003|Phase II|Lens Handling Difficulties|0|||
131946741|NCT01791517|475093124|FG004|Phase II|Lens Handling Difficulties|0|||
131946742|NCT01791517|475093125|FG005|Phase II|Lens Handling Difficulties|0|||
131946743|NCT01791517|475093126|FG006|Phase II|Lens Handling Difficulties|0|||
131946744|NCT01791517|475093127|FG007|Phase II|Lens Handling Difficulties|0|||
131946745|NCT01791517|475093128|FG008|Phase II|Lens Handling Difficulties|1|||
131946746|NCT01791517|475093129|FG009|Phase II|Lens Handling Difficulties|0|||
131946747|NCT01791517|475093130|FG010|Phase II|Lens Handling Difficulties|0|||
131946748|NCT01791517|475093131|FG011|Phase II|Lens Handling Difficulties|0|||
131946749|NCT01791517|475093120|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
131946750|NCT01791517|475093121|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
131946751|NCT01791517|475093122|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
131946752|NCT01791517|475093123|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
131946753|NCT01791517|475093124|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
131946754|NCT01791517|475093125|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
131946755|NCT01791517|475093126|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
131946756|NCT01791517|475093127|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
131946757|NCT01791517|475093128|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
131946758|NCT01791517|475093129|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
131946759|NCT01791517|475093130|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
131946760|NCT01791517|475093131|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
131946761|NCT01791517|475093120|FG000|Phase II|Pre-Existing Ocular Issue|0|||
131946762|NCT01791517|475093121|FG001|Phase II|Pre-Existing Ocular Issue|0|||
131946763|NCT01791517|475093122|FG002|Phase II|Pre-Existing Ocular Issue|0|||
131946764|NCT01791517|475093123|FG003|Phase II|Pre-Existing Ocular Issue|0|||
131946765|NCT01791517|475093124|FG004|Phase II|Pre-Existing Ocular Issue|0|||
131946766|NCT01791517|475093125|FG005|Phase II|Pre-Existing Ocular Issue|0|||
131946767|NCT01791517|475093126|FG006|Phase II|Pre-Existing Ocular Issue|0|||
131946768|NCT01791517|475093127|FG007|Phase II|Pre-Existing Ocular Issue|0|||
131946769|NCT01791517|475093128|FG008|Phase II|Pre-Existing Ocular Issue|0|||
131946770|NCT01791517|475093129|FG009|Phase II|Pre-Existing Ocular Issue|0|||
131946771|NCT01791517|475093130|FG010|Phase II|Pre-Existing Ocular Issue|0|||
131946772|NCT01791517|475093131|FG011|Phase II|Pre-Existing Ocular Issue|1|||
131946773|NCT00400517|475093132|FG000|Overall Study|Withdrawal by Subject|1|||
131946774|NCT00400517|475093132|FG000|Overall Study|Physician Decision|1|||
131946775|NCT00739310|475093141|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
131946776|NCT00739310|475093141|FG000|Overall Study|Withdrawal by Subject|1|||
131946777|NCT00739310|475093141|FG000|Overall Study|Lost to Follow-up|2|||
131946778|NCT02954887|475093142|FG000|Overall Study|Withdrawal by Subject|3|||
131946779|NCT02954887|475093142|FG000|Overall Study|Lack of Efficacy|3|||
131946780|NCT02954887|475093142|FG000|Overall Study|Other|1|||
131946781|NCT01071954|475093143|FG000|Overall Study|Noncompliance|4|||
131946782|NCT01071954|475093143|FG000|Overall Study|Adverse Event|1|||
131946783|NCT01071954|475093143|FG000|Overall Study|Withdrawal by Subject|11|||
131946784|NCT01071954|475093143|FG000|Overall Study|Requirement for Alternative Therapy|5|||
131946785|NCT01071954|475093143|FG000|Overall Study|Administrative Decision|5|||
131946786|NCT01071954|475093143|FG000|Overall Study|Protocol Specified Criteria|1|||
131946787|NCT01459666|475093145|FG000|Overall Study|PI left institution|5|||
131946788|NCT01459666|475093146|FG001|Overall Study|PI left institution|4|||
131946789|NCT00590967|475093148|FG000|Overall Study|Withdrawal by Subject|1|||
131946790|NCT00590967|475093149|FG001|Overall Study|Withdrawal by Subject|1|||
131946791|NCT00590967|475093148|FG000|Overall Study|Ineligible|1|||
131946792|NCT00590967|475093149|FG001|Overall Study|Ineligible|0|||
131946793|NCT00590967|475093148|FG000|Overall Study|Poor performance status|0|||
131946794|NCT00590967|475093149|FG001|Overall Study|Poor performance status|1|||
131946795|NCT00590967|475093148|FG000|Overall Study|Non-compliant|0|||
131946796|NCT00590967|475093149|FG001|Overall Study|Non-compliant|2|||
131946797|NCT00590967|475093148|FG000|Overall Study|Did not sign consent form|0|||
131946798|NCT00590967|475093149|FG001|Overall Study|Did not sign consent form|1|||
131946799|NCT00590967|475093148|FG000|Overall Study|Did not receive chemo per protocol|1|||
131946800|NCT00590967|475093149|FG001|Overall Study|Did not receive chemo per protocol|0|||
131946801|NCT01881789|475093150|FG000|Overall Study|Withdrawal by Subject|0|||
131946802|NCT01881789|475093151|FG001|Overall Study|Withdrawal by Subject|2|||
131946803|NCT01881789|475093152|FG002|Overall Study|Withdrawal by Subject|1|||
131946804|NCT01881789|475093153|FG003|Overall Study|Withdrawal by Subject|0|||
131946805|NCT01881789|475093154|FG004|Overall Study|Withdrawal by Subject|1|||
131946806|NCT01881789|475093155|FG005|Overall Study|Withdrawal by Subject|1|||
131946807|NCT01881789|475093150|FG000|Overall Study|Study Terminated by Sponsor|0|||
131946808|NCT01881789|475093151|FG001|Overall Study|Study Terminated by Sponsor|0|||
131946809|NCT01881789|475093152|FG002|Overall Study|Study Terminated by Sponsor|0|||
131946810|NCT01881789|475093153|FG003|Overall Study|Study Terminated by Sponsor|0|||
131946811|NCT01881789|475093154|FG004|Overall Study|Study Terminated by Sponsor|0|||
131413792|NCT00160654|473138974|FG000|Overall Study|Sponsor decision|1|||
131413793|NCT00160654|473138974|FG000|Overall Study|Patient met exclusion criteria|1|||
131413794|NCT00160654|473138974|FG000|Overall Study|Patient decision|1|||
131946812|NCT01881789|475093155|FG005|Overall Study|Study Terminated by Sponsor|1|||
131946813|NCT01881789|475093150|FG000|Overall Study|Other|3|||
131946814|NCT01881789|475093151|FG001|Overall Study|Other|5|||
131946815|NCT01881789|475093152|FG002|Overall Study|Other|2|||
131946816|NCT01881789|475093153|FG003|Overall Study|Other|3|||
131946817|NCT01881789|475093154|FG004|Overall Study|Other|1|||
131946818|NCT01881789|475093155|FG005|Overall Study|Other|1|||
131946819|NCT04245709|475093156|FG000|Overall Study|Adverse Event|13|||
131946820|NCT04245709|475093156|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
131946821|NCT04179305|475093160|FG000|Overall Study|Death|1|||
131946822|NCT04179305|475093161|FG001|Overall Study|Death|1|||
131946823|NCT04179305|475093162|FG002|Overall Study|Death|0|||
131946824|NCT04179305|475093163|FG003|Overall Study|Death|0|||
131946825|NCT04179305|475093160|FG000|Overall Study|Lost to Follow-up|1|||
131946826|NCT04179305|475093161|FG001|Overall Study|Lost to Follow-up|1|||
131946827|NCT04179305|475093162|FG002|Overall Study|Lost to Follow-up|0|||
131946828|NCT04179305|475093163|FG003|Overall Study|Lost to Follow-up|0|||
131946829|NCT04179305|475093160|FG000|Overall Study|Withdrawal by Subject|0|||
131946830|NCT04179305|475093161|FG001|Overall Study|Withdrawal by Subject|1|||
131946831|NCT04179305|475093162|FG002|Overall Study|Withdrawal by Subject|0|||
131946832|NCT04179305|475093163|FG003|Overall Study|Withdrawal by Subject|0|||
131946833|NCT04179305|475093160|FG000|Overall Study|Did not have scan|1|||
131946834|NCT04179305|475093161|FG001|Overall Study|Did not have scan|0|||
131946835|NCT04179305|475093162|FG002|Overall Study|Did not have scan|0|||
131946836|NCT04179305|475093163|FG003|Overall Study|Did not have scan|0|||
131946837|NCT04179305|475093160|FG000|Overall Study|In hospice care|3|||
131946838|NCT04179305|475093161|FG001|Overall Study|In hospice care|0|||
131946839|NCT04179305|475093162|FG002|Overall Study|In hospice care|0|||
131946840|NCT04179305|475093163|FG003|Overall Study|In hospice care|0|||
131946841|NCT00503425|475093164|FG000|Overall Study|Participant files lost|6|||
131946842|NCT00503425|475093164|FG000|Overall Study|Adverse Event|5|||
131946843|NCT00503425|475093164|FG000|Overall Study|Lack of Efficacy|25|||
131946844|NCT00503425|475093164|FG000|Overall Study|Withdrawal by Subject|8|||
131946845|NCT00503425|475093164|FG000|Overall Study|Lost to Follow-up|3|||
131946846|NCT00503425|475093164|FG000|Overall Study|Death|3|||
131946847|NCT00503425|475093164|FG000|Overall Study|Missing Data/Unknown|4|||
131946848|NCT02268383|475093183|FG000|Overall Study|Death|12|||
131946849|NCT02268383|475093183|FG000|Overall Study|Lost to Follow-up|2|||
131946850|NCT02268383|475093183|FG000|Overall Study|Withdrawal by Subject|9|||
131946851|NCT02268383|475093183|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
131946852|NCT02268383|475093183|FG000|Overall Study|Protocol deviation|3|||
131946853|NCT02268383|475093183|FG000|Overall Study|Sponsor decision|22|||
131946854|NCT02268383|475093183|FG000|Overall Study|Not reported|12|||
131946855|NCT01342926|475093186|FG000|Overall Study|Adverse Event|5|||
131946856|NCT01342926|475093187|FG001|Overall Study|Adverse Event|8|||
131946857|NCT01342926|475093188|FG002|Overall Study|Adverse Event|10|||
131946858|NCT01342926|475093189|FG003|Overall Study|Adverse Event|7|||
131946859|NCT01342926|475093186|FG000|Overall Study|Lost to Follow-up|0|||
131946860|NCT01342926|475093187|FG001|Overall Study|Lost to Follow-up|1|||
131946861|NCT01342926|475093188|FG002|Overall Study|Lost to Follow-up|1|||
131946862|NCT01342926|475093189|FG003|Overall Study|Lost to Follow-up|0|||
131946863|NCT01342926|475093186|FG000|Overall Study|Investigator Discretion|2|||
131946864|NCT01342926|475093187|FG001|Overall Study|Investigator Discretion|2|||
131946865|NCT01342926|475093188|FG002|Overall Study|Investigator Discretion|0|||
131946866|NCT01342926|475093189|FG003|Overall Study|Investigator Discretion|0|||
131946867|NCT01342926|475093186|FG000|Overall Study|Withdrawal by Subject|2|||
131946868|NCT01342926|475093187|FG001|Overall Study|Withdrawal by Subject|4|||
131946869|NCT01342926|475093188|FG002|Overall Study|Withdrawal by Subject|3|||
131946870|NCT01342926|475093189|FG003|Overall Study|Withdrawal by Subject|5|||
131946871|NCT03382912|475093190|FG000|Overall Study|Physician Decision|0|||
131946872|NCT03382912|475093191|FG001|Overall Study|Physician Decision|1|||
131946873|NCT03382912|475093190|FG000|Overall Study|Sponsor Decision|6|||
131946874|NCT03382912|475093191|FG001|Overall Study|Sponsor Decision|6|||
131946875|NCT03382912|475093190|FG000|Overall Study|Withdrawal by Subject|0|||
131946876|NCT03382912|475093191|FG001|Overall Study|Withdrawal by Subject|5|||
131946877|NCT02137070|475093194|FG000|Overall Study|Adverse Event|12|||
131946878|NCT02137070|475093195|FG001|Overall Study|Adverse Event|3|||
131946879|NCT02137070|475093194|FG000|Overall Study|Death|2|||
131946880|NCT02137070|475093195|FG001|Overall Study|Death|0|||
131946881|NCT02137070|475093194|FG000|Overall Study|Lost to Follow-up|24|||
131946882|NCT02137070|475093195|FG001|Overall Study|Lost to Follow-up|9|||
131946883|NCT02137070|475093194|FG000|Overall Study|Physician Decision|0|||
131946884|NCT02137070|475093195|FG001|Overall Study|Physician Decision|1|||
131946885|NCT02137070|475093194|FG000|Overall Study|Protocol Violation|18|||
131946886|NCT02137070|475093195|FG001|Overall Study|Protocol Violation|4|||
131946887|NCT02137070|475093194|FG000|Overall Study|Withdrawal by Subject|18|||
131946888|NCT02137070|475093195|FG001|Overall Study|Withdrawal by Subject|1|||
131946889|NCT00810277|475095499|FG000|Overall Study|Adverse Event|1|||
131946890|NCT02079909|475095500|FG000|Overall Study|Adverse Event|23|||
131946891|NCT02079909|475095501|FG001|Overall Study|Adverse Event|23|||
131946892|NCT02079909|475095502|FG002|Overall Study|Adverse Event|7|||
131946893|NCT02079909|475095500|FG000|Overall Study|Withdrawal by Subject|9|||
131946894|NCT02079909|475095501|FG001|Overall Study|Withdrawal by Subject|17|||
131946895|NCT02079909|475095502|FG002|Overall Study|Withdrawal by Subject|4|||
131946896|NCT02079909|475095500|FG000|Overall Study|Lost to Follow-up|2|||
131946897|NCT02079909|475095501|FG001|Overall Study|Lost to Follow-up|3|||
131946898|NCT02079909|475095502|FG002|Overall Study|Lost to Follow-up|1|||
131946899|NCT02079909|475095500|FG000|Overall Study|Death|2|||
131946900|NCT02079909|475095501|FG001|Overall Study|Death|2|||
131946901|NCT02079909|475095502|FG002|Overall Study|Death|0|||
131946902|NCT02079909|475095500|FG000|Overall Study|Lack of Efficacy|0|||
131456103|NCT02675634|473298662|FG004|Test Period 2|Adverse Event|0|||
131456104|NCT02675634|473298663|FG005|Test Period 2|Adverse Event|1|||
131456105|NCT01652534|473298664|FG000|Overall Study|Lack of Efficacy|1|||
131456106|NCT01652534|473298665|FG001|Overall Study|Lack of Efficacy|0|||
131456107|NCT02105961|473298666|FG000|Overall Study|Adverse Event|18|||
131456108|NCT02105961|473298667|FG001|Overall Study|Adverse Event|7|||
131456109|NCT02105961|473298668|FG002|Overall Study|Adverse Event|13|||
131456110|NCT02105961|473298666|FG000|Overall Study|Lack of Efficacy|3|||
131456111|NCT02105961|473298667|FG001|Overall Study|Lack of Efficacy|0|||
131456112|NCT02105961|473298668|FG002|Overall Study|Lack of Efficacy|3|||
131456113|NCT02105961|473298666|FG000|Overall Study|Lost to Follow-up|2|||
131456114|NCT02105961|473298667|FG001|Overall Study|Lost to Follow-up|0|||
131456115|NCT02105961|473298668|FG002|Overall Study|Lost to Follow-up|1|||
131456116|NCT02105961|473298666|FG000|Overall Study|Physician Decision|3|||
131456117|NCT02105961|473298667|FG001|Overall Study|Physician Decision|3|||
131456118|NCT02105961|473298668|FG002|Overall Study|Physician Decision|2|||
131456119|NCT02105961|473298666|FG000|Overall Study|Withdrawal by Subject|15|||
131456120|NCT02105961|473298667|FG001|Overall Study|Withdrawal by Subject|7|||
131456121|NCT02105961|473298668|FG002|Overall Study|Withdrawal by Subject|11|||
131456122|NCT03860259|473298669|FG000|Overall Study|Lost to Follow-up|5|||
131456123|NCT03860259|473298670|FG001|Overall Study|Lost to Follow-up|5|||
131946903|NCT02079909|475095501|FG001|Overall Study|Lack of Efficacy|0|||
131946904|NCT02079909|475095502|FG002|Overall Study|Lack of Efficacy|1|||
131946905|NCT02079909|475095500|FG000|Overall Study|Protocol Violation|0|||
131946906|NCT02079909|475095501|FG001|Overall Study|Protocol Violation|1|||
131946907|NCT02079909|475095502|FG002|Overall Study|Protocol Violation|1|||
131946908|NCT02079909|475095500|FG000|Overall Study|Physician Decision|0|||
131946909|NCT02079909|475095501|FG001|Overall Study|Physician Decision|1|||
131946910|NCT02079909|475095502|FG002|Overall Study|Physician Decision|1|||
131946911|NCT02079909|475095500|FG000|Overall Study|Relocation etc.|2|||
131946912|NCT02079909|475095501|FG001|Overall Study|Relocation etc.|2|||
131946913|NCT02079909|475095502|FG002|Overall Study|Relocation etc.|3|||
131946914|NCT00720356|475095507|FG000|Registration to Study|Determined to have methylated MGMT|67|||
131946915|NCT00720356|475095507|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
131946916|NCT00720356|475095507|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
131946917|NCT00720356|475095507|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
131946918|NCT00720356|475095507|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
131946919|NCT00720356|475095507|FG000|Follow up Until Death|Withdrawal by Subject|1|||
131946920|NCT00720356|475095507|FG000|Follow up Until Death|Alive at last data collection|4|||
131946921|NCT01396187|475095510|FG000|Overall Study|Adverse Event|0|||
131946922|NCT01396187|475095511|FG001|Overall Study|Adverse Event|1|||
131946923|NCT01396187|475095512|FG002|Overall Study|Adverse Event|0|||
131946924|NCT01396187|475095513|FG003|Overall Study|Adverse Event|0|||
131946925|NCT01396187|475095514|FG004|Overall Study|Adverse Event|0|||
131946926|NCT01396187|475095510|FG000|Overall Study|Withdrawal by Subject|0|||
131946927|NCT01396187|475095511|FG001|Overall Study|Withdrawal by Subject|1|||
131946928|NCT01396187|475095512|FG002|Overall Study|Withdrawal by Subject|1|||
131946929|NCT01396187|475095513|FG003|Overall Study|Withdrawal by Subject|0|||
131946930|NCT01396187|475095514|FG004|Overall Study|Withdrawal by Subject|0|||
131946931|NCT01396187|475095510|FG000|Overall Study|Other|1|||
131946932|NCT01396187|475095511|FG001|Overall Study|Other|1|||
131946933|NCT01396187|475095512|FG002|Overall Study|Other|0|||
131946934|NCT01396187|475095513|FG003|Overall Study|Other|0|||
131946935|NCT01396187|475095514|FG004|Overall Study|Other|1|||
131946936|NCT00559104|475095517|FG000|Overall Study|Lack of Efficacy|9|||
131946937|NCT00559104|475095518|FG001|Overall Study|Lack of Efficacy|0|||
131946938|NCT02071771|475095519|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
131946939|NCT02071771|475095520|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
131946940|NCT02071771|475095519|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
131946941|NCT02071771|475095520|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
131946942|NCT00355368|475095524|FG000|Overall Study|Protocol Violation|8|||
131946943|NCT00355368|475095525|FG001|Overall Study|Protocol Violation|7|||
131946944|NCT00355368|475095524|FG000|Overall Study|cardiac arrest prior to intubation|2|||
131946945|NCT00355368|475095525|FG001|Overall Study|cardiac arrest prior to intubation|2|||
131946946|NCT03198767|475095527|FG000|Overall Study|Protocol Violation|0|||
131946947|NCT03198767|475095528|FG001|Overall Study|Protocol Violation|0|||
131456124|NCT03860259|473298669|FG000|Overall Study|Protocol Violation|1|||
131456125|NCT03860259|473298670|FG001|Overall Study|Protocol Violation|0|||
131456126|NCT00811018|473298671|FG000|Overall Study|Additional Chronic Treatment|31|||
131946948|NCT03198767|475095529|FG002|Overall Study|Protocol Violation|0|||
131946949|NCT03198767|475095530|FG003|Overall Study|Protocol Violation|6|||
131946950|NCT03198767|475095531|FG004|Overall Study|Protocol Violation|0|||
131946951|NCT03198767|475095532|FG005|Overall Study|Protocol Violation|0|||
131946952|NCT03198767|475095533|FG006|Overall Study|Protocol Violation|0|||
131946953|NCT00570323|475095534|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
131456127|NCT00811018|473298671|FG000|Overall Study|Adverse Event|79|||
131456128|NCT00811018|473298671|FG000|Overall Study|Death|147|||
131456129|NCT00811018|473298671|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
131946954|NCT00570323|475095535|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
131946955|NCT00570323|475095534|FG000|Started Treatment After Randomization|Protocol Violation|1|||
131946956|NCT00570323|475095535|FG001|Started Treatment After Randomization|Protocol Violation|0|||
131946957|NCT00570323|475095534|FG000|Started Treatment After Randomization|Physician Decision|1|||
131946958|NCT00570323|475095535|FG001|Started Treatment After Randomization|Physician Decision|0|||
131946959|NCT00570323|475095534|FG000|Complete Study After Start|Lost to Follow-up|0|||
131946960|NCT00570323|475095535|FG001|Complete Study After Start|Lost to Follow-up|1|||
131946961|NCT00570323|475095534|FG000|Complete Study After Start|Withdrawal by Subject|2|||
131946962|NCT00570323|475095535|FG001|Complete Study After Start|Withdrawal by Subject|0|||
131946963|NCT00570323|475095534|FG000|Complete Study After Start|Physician Decision|1|||
131946964|NCT00570323|475095535|FG001|Complete Study After Start|Physician Decision|0|||
131946965|NCT02639247|475095538|FG000|Overall Study|Lost to Follow-up|2|||
131946966|NCT02639247|475095539|FG001|Overall Study|Lost to Follow-up|1|||
131946967|NCT02639247|475095538|FG000|Overall Study|Death|2|||
131946968|NCT02639247|475095539|FG001|Overall Study|Death|0|||
131946969|NCT02639247|475095538|FG000|Overall Study|Withdrew Consent|0|||
131946970|NCT02639247|475095539|FG001|Overall Study|Withdrew Consent|1|||
131946971|NCT02639247|475095538|FG000|Overall Study|Protocol Violation|1|||
131946972|NCT02639247|475095539|FG001|Overall Study|Protocol Violation|0|||
131946973|NCT03462758|475095540|FG000|Overall Study|Chose no or other method of contraception|20|||
131946974|NCT03462758|475095541|FG001|Overall Study|Chose no or other method of contraception|23|||
131946975|NCT03462758|475095540|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
131946976|NCT03462758|475095541|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
131946977|NCT03462758|475095540|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
131946978|NCT03462758|475095541|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
131946979|NCT03462758|475095540|FG000|Overall Study|Medical contraindication|2|||
131946980|NCT03462758|475095541|FG001|Overall Study|Medical contraindication|2|||
131946981|NCT03462758|475095540|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
131946982|NCT03462758|475095541|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
131946983|NCT02820844|475095542|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
131946984|NCT02820844|475095543|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
131946985|NCT02820844|475095544|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
131946986|NCT02820844|475095545|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
131946987|NCT02820844|475095546|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
131946988|NCT02820844|475095547|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
131946989|NCT02820844|475095542|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
131946990|NCT02820844|475095543|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
131946991|NCT02820844|475095544|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
131946992|NCT02820844|475095545|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
131946993|NCT02820844|475095546|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
131946994|NCT02820844|475095547|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
131946995|NCT02820844|475095542|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
131946996|NCT02820844|475095543|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
131946997|NCT02820844|475095544|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
131946998|NCT02820844|475095545|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
131946999|NCT02820844|475095546|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
131947000|NCT02820844|475095547|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
131947001|NCT02820844|475095542|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
131947002|NCT02820844|475095543|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
131947003|NCT02820844|475095544|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
131947004|NCT02820844|475095545|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
131947005|NCT02820844|475095546|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
131947006|NCT02820844|475095547|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
131947007|NCT02820844|475095542|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
131947008|NCT02820844|475095543|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
131947009|NCT02820844|475095544|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
131947010|NCT02820844|475095545|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
131947011|NCT02820844|475095546|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
131947012|NCT02820844|475095547|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
131947013|NCT02820844|475095542|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
131947014|NCT02820844|475095543|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
131947015|NCT02820844|475095544|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
131947016|NCT02820844|475095545|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
131947017|NCT02820844|475095546|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
131947018|NCT02820844|475095547|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
131947019|NCT02820844|475095542|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
131947020|NCT02820844|475095543|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
131947021|NCT02820844|475095544|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
131947022|NCT02820844|475095545|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
131947023|NCT02820844|475095546|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
131947024|NCT02820844|475095547|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
131947025|NCT02820844|475095542|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947026|NCT02820844|475095543|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947027|NCT02820844|475095544|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
131947028|NCT02820844|475095545|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
131947029|NCT02820844|475095546|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947030|NCT02820844|475095547|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947031|NCT02820844|475095542|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
131947032|NCT02820844|475095543|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
131947033|NCT02820844|475095544|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
131947034|NCT02820844|475095545|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
131947035|NCT02820844|475095546|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
131947036|NCT02820844|475095547|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
131947037|NCT02820844|475095542|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947038|NCT02820844|475095543|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947039|NCT02820844|475095544|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947040|NCT02820844|475095545|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947041|NCT02820844|475095546|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
131947042|NCT02820844|475095547|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
131947043|NCT02266147|475095549|FG000|PART 1: Dose Escalation|Physician Decision|0|||
131947044|NCT02266147|475095550|FG001|PART 1: Dose Escalation|Physician Decision|0|||
131947045|NCT02266147|475095551|FG002|PART 1: Dose Escalation|Physician Decision|1|||
131947046|NCT02266147|475095552|FG003|PART 1: Dose Escalation|Physician Decision|0|||
131947047|NCT02266147|475095549|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
131947048|NCT02266147|475095550|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
131947049|NCT02266147|475095551|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
131947050|NCT02266147|475095552|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
131947051|NCT02266147|475095549|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
131947052|NCT02266147|475095550|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
131947053|NCT02266147|475095551|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
131947054|NCT02266147|475095552|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
131947055|NCT02266147|475095549|FG000|PART 1: Dose Escalation|Other|1|||
131947056|NCT02266147|475095550|FG001|PART 1: Dose Escalation|Other|1|||
131947057|NCT02266147|475095551|FG002|PART 1: Dose Escalation|Other|0|||
131947058|NCT02266147|475095552|FG003|PART 1: Dose Escalation|Other|0|||
131947059|NCT02266147|475095549|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
131947060|NCT02266147|475095550|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
131947061|NCT02266147|475095551|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
131947062|NCT02266147|475095552|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
131947063|NCT02266147|475095549|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
131947064|NCT02266147|475095550|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
131947065|NCT02266147|475095551|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
131947066|NCT02266147|475095552|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
131947067|NCT01456130|475095553|FG000|Overall Study|Adverse Event|4|||
131947068|NCT01456130|475095553|FG000|Overall Study|Voluntary Withdrawal|1|||
131947069|NCT01456130|475095553|FG000|Overall Study|Lack of Efficacy|4|||
131947070|NCT01456130|475095553|FG000|Overall Study|Other|1|||
131947071|NCT00413660|475095556|FG000|Up To Week 12|Adverse Event|1|||
131947072|NCT00413660|475095557|FG001|Up To Week 12|Adverse Event|3|||
131947073|NCT00413660|475095558|FG002|Up To Week 12|Adverse Event|1|||
131947074|NCT00413660|475095559|FG003|Up To Week 12|Adverse Event|4|||
131947075|NCT00413660|475095560|FG004|Up To Week 12|Adverse Event|6|||
131947076|NCT00413660|475095561|FG005|Up To Week 12|Adverse Event|4|||
131947077|NCT00413660|475095562|FG006|Up To Week 12|Adverse Event|1|||
131947078|NCT00413660|475095563|FG007|Up To Week 12|Adverse Event|0|||
131947079|NCT00413660|475095564|FG008|Up To Week 12|Adverse Event|0|||
131947080|NCT00413660|475095565|FG009|Up To Week 12|Adverse Event|0|||
131947081|NCT00413660|475095566|FG010|Up To Week 12|Adverse Event|0|||
131947082|NCT00413660|475095556|FG000|Up To Week 12|Lack of Efficacy|2|||
131947083|NCT00413660|475095557|FG001|Up To Week 12|Lack of Efficacy|0|||
131947084|NCT00413660|475095558|FG002|Up To Week 12|Lack of Efficacy|0|||
131947085|NCT00413660|475095559|FG003|Up To Week 12|Lack of Efficacy|0|||
131947086|NCT00413660|475095560|FG004|Up To Week 12|Lack of Efficacy|0|||
131947087|NCT00413660|475095561|FG005|Up To Week 12|Lack of Efficacy|0|||
131947088|NCT00413660|475095562|FG006|Up To Week 12|Lack of Efficacy|5|||
131947089|NCT00413660|475095563|FG007|Up To Week 12|Lack of Efficacy|0|||
131947090|NCT00413660|475095564|FG008|Up To Week 12|Lack of Efficacy|0|||
131947091|NCT00413660|475095565|FG009|Up To Week 12|Lack of Efficacy|0|||
131947092|NCT00413660|475095566|FG010|Up To Week 12|Lack of Efficacy|0|||
131413795|NCT00160654|473138974|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
131413796|NCT00160654|473138974|FG000|Overall Study|Met exclusion criteria|1|||
131413797|NCT02404649|473138975|FG000|Overall Study|Adverse Event|1|||
131413798|NCT02404649|473138976|FG001|Overall Study|Adverse Event|2|||
131413799|NCT00330668|473138980|FG000|BID Dosing Period|Adverse Event|1|||
131413800|NCT00330668|473138980|FG000|BID Dosing Period|Lost to Follow-up|7|||
131413801|NCT00330668|473138980|FG000|BID Dosing Period|Non-Compliance|5|||
131413802|NCT00330668|473138980|FG000|BID Dosing Period|Withdrawal by Subject|19|||
131413803|NCT00330668|473138980|FG000|BID Dosing Period|Sponsor's decision|1|||
131413804|NCT00330668|473138980|FG000|BID Dosing Period|Other|3|||
131413805|NCT00330668|473138980|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
131413806|NCT00330668|473138980|FG000|QD Dosing Period|Other|1|||
131413807|NCT00330668|473138980|FG000|QD Dosing Period|Withdrawal by Subject|1|||
131413808|NCT00330668|473138980|FG000|QD Dosing Period|Lost to Follow-up|2|||
131413809|NCT01839656|473138981|FG000|Overall Study|Withdrawal by Subject|1|||
131413810|NCT01839656|473138982|FG001|Overall Study|Withdrawal by Subject|1|||
131413811|NCT01839656|473138981|FG000|Overall Study|Adverse event, serious fatal|1|||
131413812|NCT01839656|473138982|FG001|Overall Study|Adverse event, serious fatal|4|||
131413813|NCT01839656|473138981|FG000|Overall Study|Early study closure|0|||
131413814|NCT01839656|473138982|FG001|Overall Study|Early study closure|11|||
131413815|NCT01839656|473138981|FG000|Overall Study|Adverse Event|1|||
131413816|NCT01839656|473138982|FG001|Overall Study|Adverse Event|0|||
131413817|NCT02242981|473138992|FG000|Overall Study|Withdrawal by Subject|1|||
131413818|NCT02535416|473138993|FG000|Overall Study|Family bereavement overseas|1|||
131413819|NCT02535416|473138994|FG001|Overall Study|Family bereavement overseas|0|||
131413820|NCT02535416|473138995|FG002|Overall Study|Family bereavement overseas|0|||
131413821|NCT02535416|473138996|FG003|Overall Study|Family bereavement overseas|0|||
131413822|NCT02535416|473138997|FG004|Overall Study|Family bereavement overseas|0|||
131413823|NCT02535416|473138998|FG005|Overall Study|Family bereavement overseas|0|||
131413824|NCT02535416|473138999|FG006|Overall Study|Family bereavement overseas|0|||
131413825|NCT02535416|473139000|FG007|Overall Study|Family bereavement overseas|0|||
131413826|NCT02535416|473139001|FG008|Overall Study|Family bereavement overseas|0|||
131413827|NCT02644356|473139009|FG000|Overall Study|Withdrawal by Subject|2|||
131413828|NCT02739321|473139011|FG000|Overall Study|Lack of Efficacy|1|||
131413829|NCT02739321|473139012|FG001|Overall Study|Lack of Efficacy|1|||
131413830|NCT02739321|473139011|FG000|Overall Study|Lost to Follow-up|1|||
131413831|NCT02739321|473139012|FG001|Overall Study|Lost to Follow-up|1|||
131413832|NCT02739321|473139011|FG000|Overall Study|Withdrawal by Subject|1|||
131413833|NCT02739321|473139012|FG001|Overall Study|Withdrawal by Subject|2|||
131413834|NCT01711866|473139013|FG000|Overall Study|Noncompliant|3|||
131413835|NCT01711866|473139013|FG000|Overall Study|Withdrawal by Subject|3|||
131413836|NCT01711866|473139013|FG000|Overall Study|Adverse Event|2|||
131413837|NCT00897390|473139014|FG000|Overall Study|Adverse Event|2|||
131413838|NCT00897390|473139014|FG000|Overall Study|No Longer Met Study Criteria|1|||
131413839|NCT00897390|473139014|FG000|Overall Study|Personal Reasons|1|||
131413840|NCT00897390|473139014|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
131413841|NCT00958217|473139018|FG000|Overall Study|Death|2|||
131413842|NCT00958217|473139019|FG001|Overall Study|Death|1|||
131413843|NCT00958217|473139018|FG000|Overall Study|Withdrawal by Subject|4|||
131413844|NCT00958217|473139019|FG001|Overall Study|Withdrawal by Subject|3|||
131413845|NCT00958217|473139018|FG000|Overall Study|Lost to Follow-up|17|||
131413846|NCT00958217|473139019|FG001|Overall Study|Lost to Follow-up|19|||
131413847|NCT00958217|473139018|FG000|Overall Study|Moved out of area|1|||
131413848|NCT00958217|473139019|FG001|Overall Study|Moved out of area|1|||
131413849|NCT00958217|473139018|FG000|Overall Study|Inpatient hospitalization|0|||
131413850|NCT00958217|473139019|FG001|Overall Study|Inpatient hospitalization|1|||
131413851|NCT02564978|473139022|FG000|Overall Study|Adverse Event|8|||
131413852|NCT02564978|473139022|FG000|Overall Study|Death|1|||
131413853|NCT02564978|473139022|FG000|Overall Study|Lost to Follow-up|1|||
131413854|NCT02564978|473139022|FG000|Overall Study|Withdrawal by Subject|15|||
131413855|NCT02564978|473139022|FG000|Overall Study|Early Study Closure|2|||
131413856|NCT02564978|473139022|FG000|Overall Study|Other Reason|5|||
131413857|NCT01818284|473140394|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
131413858|NCT01818284|473140395|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
131413859|NCT01818284|473140394|FG000|Overall Study|Death|0|||
131413860|NCT01818284|473140395|FG001|Overall Study|Death|2|||
131413861|NCT03681678|473140396|FG000|Overall Study|Lost to Follow-up|20|||
131413862|NCT04619004|473140397|FG000|Overall Study|Death|114|||
131947093|NCT00413660|475095556|FG000|Up To Week 12|Lost to Follow-up|0|||
131947094|NCT00413660|475095557|FG001|Up To Week 12|Lost to Follow-up|1|||
131947095|NCT00413660|475095558|FG002|Up To Week 12|Lost to Follow-up|0|||
131947096|NCT00413660|475095559|FG003|Up To Week 12|Lost to Follow-up|0|||
131947097|NCT00413660|475095560|FG004|Up To Week 12|Lost to Follow-up|1|||
131947098|NCT00413660|475095561|FG005|Up To Week 12|Lost to Follow-up|0|||
131413863|NCT04619004|473140398|FG001|Overall Study|Death|28|||
131413864|NCT04619004|473140397|FG000|Overall Study|Lost to Follow-up|1|||
131413865|NCT04619004|473140398|FG001|Overall Study|Lost to Follow-up|1|||
131947099|NCT00413660|475095562|FG006|Up To Week 12|Lost to Follow-up|0|||
131456130|NCT00811018|473298671|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
131456131|NCT00811018|473298671|FG000|Overall Study|Investigator Decision|57|||
131947100|NCT00413660|475095563|FG007|Up To Week 12|Lost to Follow-up|0|||
131947101|NCT00413660|475095564|FG008|Up To Week 12|Lost to Follow-up|0|||
131947102|NCT00413660|475095565|FG009|Up To Week 12|Lost to Follow-up|0|||
131947103|NCT00413660|475095566|FG010|Up To Week 12|Lost to Follow-up|0|||
131947104|NCT00413660|475095556|FG000|Up To Week 12|Withdrawal by Subject|0|||
131947105|NCT00413660|475095557|FG001|Up To Week 12|Withdrawal by Subject|2|||
131947106|NCT00413660|475095558|FG002|Up To Week 12|Withdrawal by Subject|0|||
131947107|NCT00413660|475095559|FG003|Up To Week 12|Withdrawal by Subject|2|||
131947108|NCT00413660|475095560|FG004|Up To Week 12|Withdrawal by Subject|0|||
131947109|NCT00413660|475095561|FG005|Up To Week 12|Withdrawal by Subject|2|||
131947110|NCT00413660|475095562|FG006|Up To Week 12|Withdrawal by Subject|2|||
131947111|NCT00413660|475095563|FG007|Up To Week 12|Withdrawal by Subject|0|||
131947112|NCT00413660|475095564|FG008|Up To Week 12|Withdrawal by Subject|0|||
131947113|NCT00413660|475095565|FG009|Up To Week 12|Withdrawal by Subject|0|||
131947114|NCT00413660|475095566|FG010|Up To Week 12|Withdrawal by Subject|0|||
131947115|NCT00413660|475095556|FG000|Up To Week 12|Randomized, Not Treated|1|||
131947116|NCT00413660|475095557|FG001|Up To Week 12|Randomized, Not Treated|0|||
131947117|NCT00413660|475095558|FG002|Up To Week 12|Randomized, Not Treated|0|||
131947118|NCT00413660|475095559|FG003|Up To Week 12|Randomized, Not Treated|1|||
131947119|NCT00413660|475095560|FG004|Up To Week 12|Randomized, Not Treated|0|||
131947120|NCT00413660|475095561|FG005|Up To Week 12|Randomized, Not Treated|0|||
131947121|NCT00413660|475095562|FG006|Up To Week 12|Randomized, Not Treated|0|||
131947122|NCT00413660|475095563|FG007|Up To Week 12|Randomized, Not Treated|0|||
131947123|NCT00413660|475095564|FG008|Up To Week 12|Randomized, Not Treated|0|||
131947124|NCT00413660|475095565|FG009|Up To Week 12|Randomized, Not Treated|0|||
131947125|NCT00413660|475095566|FG010|Up To Week 12|Randomized, Not Treated|0|||
131947126|NCT00413660|475095556|FG000|Up To Week 12|Other|3|||
131947127|NCT00413660|475095557|FG001|Up To Week 12|Other|1|||
131947128|NCT00413660|475095558|FG002|Up To Week 12|Other|6|||
131947129|NCT00413660|475095559|FG003|Up To Week 12|Other|1|||
131947130|NCT00413660|475095560|FG004|Up To Week 12|Other|2|||
131947131|NCT00413660|475095561|FG005|Up To Week 12|Other|4|||
131947132|NCT00413660|475095562|FG006|Up To Week 12|Other|3|||
131947133|NCT00413660|475095563|FG007|Up To Week 12|Other|0|||
131947134|NCT00413660|475095564|FG008|Up To Week 12|Other|0|||
131947135|NCT00413660|475095565|FG009|Up To Week 12|Other|0|||
131947136|NCT00413660|475095566|FG010|Up To Week 12|Other|0|||
131947137|NCT00413660|475095556|FG000|Post Week 12|Adverse Event|2|||
131947138|NCT00413660|475095557|FG001|Post Week 12|Adverse Event|0|||
131947139|NCT00413660|475095558|FG002|Post Week 12|Adverse Event|2|||
131947140|NCT00413660|475095559|FG003|Post Week 12|Adverse Event|1|||
131947141|NCT00413660|475095560|FG004|Post Week 12|Adverse Event|4|||
131947142|NCT00413660|475095561|FG005|Post Week 12|Adverse Event|2|||
131947143|NCT00413660|475095562|FG006|Post Week 12|Adverse Event|2|||
131947144|NCT00413660|475095563|FG007|Post Week 12|Adverse Event|0|||
131947145|NCT00413660|475095564|FG008|Post Week 12|Adverse Event|0|||
131947146|NCT00413660|475095565|FG009|Post Week 12|Adverse Event|0|||
131947147|NCT00413660|475095566|FG010|Post Week 12|Adverse Event|0|||
131947148|NCT00413660|475095556|FG000|Post Week 12|Lack of Efficacy|0|||
131947149|NCT00413660|475095557|FG001|Post Week 12|Lack of Efficacy|0|||
131947150|NCT00413660|475095558|FG002|Post Week 12|Lack of Efficacy|1|||
131947151|NCT00413660|475095559|FG003|Post Week 12|Lack of Efficacy|0|||
131947152|NCT00413660|475095560|FG004|Post Week 12|Lack of Efficacy|0|||
131947153|NCT00413660|475095561|FG005|Post Week 12|Lack of Efficacy|0|||
131947154|NCT00413660|475095562|FG006|Post Week 12|Lack of Efficacy|0|||
131947155|NCT00413660|475095563|FG007|Post Week 12|Lack of Efficacy|0|||
131456132|NCT00811018|473298671|FG000|Overall Study|Lost to Follow-up|19|||
131456133|NCT00811018|473298671|FG000|Overall Study|Pregnancy|6|||
131456134|NCT00811018|473298671|FG000|Overall Study|Sponsor Decision|450|||
131456135|NCT00811018|473298671|FG000|Overall Study|Withdrawal by Subject|70|||
131947156|NCT00413660|475095564|FG008|Post Week 12|Lack of Efficacy|0|||
131947157|NCT00413660|475095565|FG009|Post Week 12|Lack of Efficacy|1|||
131947158|NCT00413660|475095566|FG010|Post Week 12|Lack of Efficacy|0|||
131947159|NCT00413660|475095556|FG000|Post Week 12|Lost to Follow-up|0|||
131947160|NCT00413660|475095557|FG001|Post Week 12|Lost to Follow-up|1|||
131947161|NCT00413660|475095558|FG002|Post Week 12|Lost to Follow-up|1|||
131947162|NCT00413660|475095559|FG003|Post Week 12|Lost to Follow-up|0|||
131947163|NCT00413660|475095560|FG004|Post Week 12|Lost to Follow-up|0|||
131947164|NCT00413660|475095561|FG005|Post Week 12|Lost to Follow-up|0|||
131947165|NCT00413660|475095562|FG006|Post Week 12|Lost to Follow-up|0|||
131947166|NCT00413660|475095563|FG007|Post Week 12|Lost to Follow-up|0|||
131947167|NCT00413660|475095564|FG008|Post Week 12|Lost to Follow-up|0|||
131947168|NCT00413660|475095565|FG009|Post Week 12|Lost to Follow-up|0|||
131947169|NCT00413660|475095566|FG010|Post Week 12|Lost to Follow-up|0|||
131947170|NCT00413660|475095556|FG000|Post Week 12|Withdrawal by Subject|0|||
131947171|NCT00413660|475095557|FG001|Post Week 12|Withdrawal by Subject|1|||
131947172|NCT00413660|475095558|FG002|Post Week 12|Withdrawal by Subject|1|||
131947173|NCT00413660|475095559|FG003|Post Week 12|Withdrawal by Subject|0|||
131947174|NCT00413660|475095560|FG004|Post Week 12|Withdrawal by Subject|1|||
131947175|NCT00413660|475095561|FG005|Post Week 12|Withdrawal by Subject|0|||
131947176|NCT00413660|475095562|FG006|Post Week 12|Withdrawal by Subject|0|||
131947177|NCT00413660|475095563|FG007|Post Week 12|Withdrawal by Subject|0|||
131947178|NCT00413660|475095564|FG008|Post Week 12|Withdrawal by Subject|0|||
131947179|NCT00413660|475095565|FG009|Post Week 12|Withdrawal by Subject|0|||
131947180|NCT00413660|475095566|FG010|Post Week 12|Withdrawal by Subject|1|||
131947181|NCT00413660|475095556|FG000|Post Week 12|Other|1|||
131947182|NCT00413660|475095557|FG001|Post Week 12|Other|2|||
131947183|NCT00413660|475095558|FG002|Post Week 12|Other|3|||
131947184|NCT00413660|475095559|FG003|Post Week 12|Other|0|||
131947185|NCT00413660|475095560|FG004|Post Week 12|Other|1|||
131947186|NCT00413660|475095561|FG005|Post Week 12|Other|1|||
131947187|NCT00413660|475095562|FG006|Post Week 12|Other|1|||
131947188|NCT00413660|475095563|FG007|Post Week 12|Other|0|||
131947189|NCT00413660|475095564|FG008|Post Week 12|Other|0|||
131947190|NCT00413660|475095565|FG009|Post Week 12|Other|0|||
131947191|NCT00413660|475095566|FG010|Post Week 12|Other|0|||
131947192|NCT03896477|475095569|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
131947193|NCT03896477|475095570|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
131947194|NCT03896477|475095571|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
131947195|NCT03896477|475095569|FG000|Overall Study|Parent Requested Withdrawal|8|||
131947196|NCT03896477|475095570|FG001|Overall Study|Parent Requested Withdrawal|12|||
131947197|NCT03896477|475095571|FG002|Overall Study|Parent Requested Withdrawal|9|||
131947198|NCT03896477|475095569|FG000|Overall Study|Adverse Event|0|||
131947199|NCT03896477|475095570|FG001|Overall Study|Adverse Event|0|||
131947200|NCT03896477|475095571|FG002|Overall Study|Adverse Event|1|||
131947201|NCT03896477|475095569|FG000|Overall Study|Death|1|||
131947202|NCT03896477|475095570|FG001|Overall Study|Death|0|||
131947203|NCT03896477|475095571|FG002|Overall Study|Death|0|||
131947204|NCT03896477|475095569|FG000|Overall Study|Other|5|||
131947205|NCT03896477|475095570|FG001|Overall Study|Other|6|||
131947206|NCT03896477|475095571|FG002|Overall Study|Other|7|||
131947207|NCT03896477|475095569|FG000|Overall Study|Lost to Follow-up|2|||
131947208|NCT03896477|475095570|FG001|Overall Study|Lost to Follow-up|1|||
131947209|NCT03896477|475095571|FG002|Overall Study|Lost to Follow-up|1|||
131947210|NCT04011735|475095572|FG000|Overall Study|Withdrawal by Subject|1|||
131947211|NCT04011735|475095573|FG001|Overall Study|Withdrawal by Subject|0|||
131947212|NCT04011735|475095574|FG002|Overall Study|Withdrawal by Subject|1|||
131947213|NCT04011735|475095572|FG000|Overall Study|Met exclusion criteria after study entry|0|||
131947214|NCT04011735|475095573|FG001|Overall Study|Met exclusion criteria after study entry|1|||
131947215|NCT04011735|475095574|FG002|Overall Study|Met exclusion criteria after study entry|0|||
131947216|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
131947217|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
131947218|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
131947219|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
131947220|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
131947221|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
131947222|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
131947223|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
131947224|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
131947225|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
131947226|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
131947227|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
131947228|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
131947229|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
131947230|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
131413866|NCT04619004|473140397|FG000|Overall Study|Withdrawal by Subject|24|||
131413867|NCT04619004|473140398|FG001|Overall Study|Withdrawal by Subject|7|||
131413868|NCT04619004|473140397|FG000|Overall Study|Other - Not specified|0|||
131947231|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
131947232|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
131947233|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
131413869|NCT04619004|473140398|FG001|Overall Study|Other - Not specified|1|||
131947234|NCT02831855|475095575|FG000|Open Label Phase (24 Weeks)|Other|4|||
131947235|NCT02831855|475095576|FG001|Open Label Phase (24 Weeks)|Other|0|||
131947236|NCT02831855|475095577|FG002|Open Label Phase (24 Weeks)|Other|0|||
131947237|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
131947238|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
131947239|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
131947240|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Death|0|||
131947241|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Death|0|||
131413870|NCT04030962|473140400|FG000|Stage 2|Adverse Event|0|||
131413871|NCT04030962|473140401|FG001|Stage 2|Adverse Event|0|||
131413872|NCT04030962|473140402|FG002|Stage 2|Adverse Event|0|||
131947242|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Death|2|||
131947243|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
131947244|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
131947245|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
131947246|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
131947247|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
131947248|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
131947249|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
131947250|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
131947251|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
131947252|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Other|0|||
131947253|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Other|2|||
131947254|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Other|5|||
131947255|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
131947256|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
131947257|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
131947258|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
131947259|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
131947260|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
131947261|NCT02831855|475095575|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
131947262|NCT02831855|475095576|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
131947263|NCT02831855|475095577|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
131947264|NCT01722994|475095578|FG000|Overall Study|Missing data|25|||
131947265|NCT01722994|475095579|FG001|Overall Study|Missing data|17|||
131947266|NCT01803880|475095583|FG000|Overall Study|Adverse Event|1|||
131947267|NCT01803880|475095584|FG001|Overall Study|Adverse Event|0|||
131947268|NCT01803880|475095585|FG002|Overall Study|Adverse Event|0|||
131947269|NCT01803880|475095583|FG000|Overall Study|Withdrawal by Subject|1|||
131947270|NCT01803880|475095584|FG001|Overall Study|Withdrawal by Subject|1|||
131947271|NCT01803880|475095585|FG002|Overall Study|Withdrawal by Subject|4|||
131947272|NCT01803880|475095583|FG000|Overall Study|Physician Decision|0|||
131947273|NCT01803880|475095584|FG001|Overall Study|Physician Decision|0|||
131947274|NCT01803880|475095585|FG002|Overall Study|Physician Decision|1|||
131947275|NCT01803880|475095583|FG000|Overall Study|Unable to return for follow-up visits|0|||
131947276|NCT01803880|475095584|FG001|Overall Study|Unable to return for follow-up visits|1|||
131947277|NCT01803880|475095585|FG002|Overall Study|Unable to return for follow-up visits|2|||
131947278|NCT01803880|475095583|FG000|Overall Study|Lost to Follow-up|1|||
131947279|NCT01803880|475095584|FG001|Overall Study|Lost to Follow-up|2|||
131947280|NCT01803880|475095585|FG002|Overall Study|Lost to Follow-up|3|||
131947281|NCT01803880|475095583|FG000|Overall Study|Protocol Violation|1|||
131947282|NCT01803880|475095584|FG001|Overall Study|Protocol Violation|0|||
131947283|NCT01803880|475095585|FG002|Overall Study|Protocol Violation|0|||
131947284|NCT01803880|475095583|FG000|Overall Study|Early study termination|0|||
131947285|NCT01803880|475095584|FG001|Overall Study|Early study termination|6|||
131947286|NCT01803880|475095585|FG002|Overall Study|Early study termination|5|||
131947287|NCT01803880|475095583|FG000|Overall Study|Incomplete data entry by sites|2|||
131947288|NCT01803880|475095584|FG001|Overall Study|Incomplete data entry by sites|0|||
131947289|NCT01803880|475095585|FG002|Overall Study|Incomplete data entry by sites|0|||
131947290|NCT05384834|475095586|FG000|Overall Study|Lost to Follow-up|43|||
131947291|NCT05384834|475095586|FG000|Overall Study|Withdrawal by Subject|5|||
131947292|NCT00920556|475095591|FG000|Overall Study|Adverse Event|16|||
131947293|NCT00920556|475095591|FG000|Overall Study|Physician Decision|7|||
131947294|NCT00920556|475095591|FG000|Overall Study|Withdrawal by Subject|1|||
131947295|NCT01299389|475095592|FG000|Double-blind|Adverse Event|45|||
131947296|NCT01299389|475095593|FG001|Double-blind|Adverse Event|27|||
131947297|NCT01299389|475095594|FG002|Double-blind|Adverse Event|0|||
131947298|NCT01299389|475095595|FG003|Double-blind|Adverse Event|0|||
131947299|NCT01299389|475095592|FG000|Double-blind|Lack of Efficacy|45|||
131947300|NCT01299389|475095593|FG001|Double-blind|Lack of Efficacy|21|||
131947301|NCT01299389|475095594|FG002|Double-blind|Lack of Efficacy|0|||
131947302|NCT01299389|475095595|FG003|Double-blind|Lack of Efficacy|0|||
131413873|NCT04030962|473140403|FG003|Stage 2|Adverse Event|0|||
131413874|NCT04030962|473140404|FG004|Stage 2|Adverse Event|0|||
131413875|NCT04030962|473140405|FG005|Stage 2|Adverse Event|0|||
131947303|NCT01299389|475095592|FG000|Double-blind|Lost to Follow-up|2|||
131947304|NCT01299389|475095593|FG001|Double-blind|Lost to Follow-up|1|||
131947305|NCT01299389|475095594|FG002|Double-blind|Lost to Follow-up|0|||
131947306|NCT01299389|475095595|FG003|Double-blind|Lost to Follow-up|0|||
131947307|NCT01299389|475095592|FG000|Double-blind|Withdrawal by Subject|16|||
131947308|NCT01299389|475095593|FG001|Double-blind|Withdrawal by Subject|13|||
131947309|NCT01299389|475095594|FG002|Double-blind|Withdrawal by Subject|0|||
131947310|NCT01299389|475095595|FG003|Double-blind|Withdrawal by Subject|0|||
131947311|NCT01299389|475095592|FG000|Double-blind|Other|1|||
131413876|NCT04030962|473140406|FG006|Stage 2|Adverse Event|0|||
131413877|NCT04030962|473140407|FG007|Stage 2|Adverse Event|0|||
131456136|NCT00811018|473298671|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
131456137|NCT00811018|473298671|FG000|Overall Study|Other|26|||
131456138|NCT00934362|473298675|FG000|Overall Study|Adverse Event|1|||
131456139|NCT00934362|473298676|FG001|Overall Study|Adverse Event|0|||
131456140|NCT01092117|473298677|FG000|Index Procedure to 1 Month|Death|1|||
131456141|NCT01092117|473298677|FG000|1 Month|Death|1|||
131456142|NCT01092117|473298677|FG000|1 Month|Withdrawal by Subject|1|||
131456143|NCT01092117|473298677|FG000|1 Month|Lost to Follow-up|1|||
131456144|NCT01092117|473298677|FG000|6 Months|Death|2|||
131456145|NCT01092117|473298677|FG000|6 Months|Withdrawal by Subject|3|||
131456146|NCT01092117|473298677|FG000|12 Month|Death|11|||
131456147|NCT01092117|473298677|FG000|12 Month|Withdrawal by Subject|2|||
131456148|NCT01092117|473298677|FG000|12 Month|Lost to Follow-up|1|||
131456149|NCT01092117|473298677|FG000|Year 2|Death|5|||
131456150|NCT01092117|473298677|FG000|Year 2|Withdrawal by Subject|4|||
131456151|NCT01092117|473298677|FG000|Year 2|Lost to Follow-up|1|||
131456152|NCT01092117|473298677|FG000|Year 3|Death|7|||
131456153|NCT01092117|473298677|FG000|Year 3|Withdrawal by Subject|9|||
131456154|NCT01092117|473298677|FG000|Year 3|Lost to Follow-up|3|||
131456155|NCT01092117|473298677|FG000|Year 4|Death|8|||
131456156|NCT01092117|473298677|FG000|Year 4|Withdrawal by Subject|4|||
131456157|NCT01092117|473298677|FG000|Year 4|Lost to Follow-up|4|||
131456158|NCT04380519|473298678|FG000|Overall Study|Withdrawal by Subject|4|||
131456159|NCT04380519|473298679|FG001|Overall Study|Withdrawal by Subject|0|||
131456160|NCT04380519|473298680|FG002|Overall Study|Withdrawal by Subject|1|||
131456161|NCT04380519|473298678|FG000|Overall Study|Death|14|||
131456162|NCT04380519|473298679|FG001|Overall Study|Death|9|||
131456163|NCT04380519|473298680|FG002|Overall Study|Death|6|||
131456164|NCT04380519|473298678|FG000|Overall Study|Adverse Event|0|||
131456165|NCT04380519|473298679|FG001|Overall Study|Adverse Event|1|||
131456166|NCT04380519|473298680|FG002|Overall Study|Adverse Event|0|||
131456167|NCT04380519|473298678|FG000|Overall Study|relatives' decision|0|||
131456168|NCT04380519|473298679|FG001|Overall Study|relatives' decision|1|||
131456169|NCT04380519|473298680|FG002|Overall Study|relatives' decision|0|||
131456170|NCT02147561|473298683|FG000|Overall Study|Lost to Follow-up|3|||
131456171|NCT02147561|473298683|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
131456172|NCT00948441|473298690|FG000|Overall Study|no longer meet inclusion criteria|1|||
131456173|NCT00948441|473298691|FG001|Overall Study|no longer meet inclusion criteria|4|||
131456174|NCT04237116|473298692|FG000|Overall Study|Adverse Event|0|||
131456175|NCT04237116|473298693|FG001|Overall Study|Adverse Event|1|||
131456176|NCT04237116|473298692|FG000|Overall Study|Study terminated by Sponsor|4|||
131456177|NCT04237116|473298693|FG001|Overall Study|Study terminated by Sponsor|1|||
131456178|NCT00472030|473298694|FG000|Overall Study|Physician Decision|1|||
131456179|NCT00472030|473298695|FG001|Overall Study|Physician Decision|0|||
131456180|NCT04198714|473298696|FG000|Overall Study|Physician Decision|0|||
131456181|NCT04198714|473298697|FG001|Overall Study|Physician Decision|1|||
131456182|NCT01865552|473301075|FG000|Period 1|Adverse Event|1|||
131456183|NCT01865552|473301076|FG001|Period 1|Adverse Event|0|||
131456184|NCT01865552|473301077|FG002|Period 1|Adverse Event|0|||
131456185|NCT01865552|473301078|FG003|Period 1|Adverse Event|1|||
131456186|NCT01865552|473301079|FG004|Period 1|Adverse Event|1|||
131456187|NCT01865552|473301080|FG005|Period 1|Adverse Event|1|||
131456188|NCT01865552|473301075|FG000|Period 1|Pathological lab|0|||
131456189|NCT01865552|473301076|FG001|Period 1|Pathological lab|0|||
131456190|NCT01865552|473301077|FG002|Period 1|Pathological lab|0|||
131456191|NCT01865552|473301078|FG003|Period 1|Pathological lab|0|||
131456192|NCT01865552|473301079|FG004|Period 1|Pathological lab|1|||
131456193|NCT01865552|473301080|FG005|Period 1|Pathological lab|0|||
131456194|NCT01865552|473301075|FG000|Period 1|Other|0|||
131456195|NCT01865552|473301076|FG001|Period 1|Other|0|||
131456196|NCT01865552|473301077|FG002|Period 1|Other|0|||
131456197|NCT01865552|473301078|FG003|Period 1|Other|0|||
131456198|NCT01865552|473301079|FG004|Period 1|Other|1|||
131456199|NCT01865552|473301080|FG005|Period 1|Other|0|||
131456200|NCT01761162|473301081|FG000|Overall Study|Withdrawal by Subject|3|||
131456201|NCT02741518|473301082|FG000|Overall Study|Withdrawal by Subject|1|||
131456202|NCT02741518|473301083|FG001|Overall Study|Withdrawal by Subject|1|||
131456203|NCT01349049|473301084|FG000|Overall Study|Disease progression|3|||
131456204|NCT01349049|473301085|FG001|Overall Study|Disease progression|5|||
131456205|NCT01349049|473301086|FG002|Overall Study|Disease progression|3|||
131456206|NCT01349049|473301087|FG003|Overall Study|Disease progression|2|||
131456207|NCT01349049|473301088|FG004|Overall Study|Disease progression|2|||
131456208|NCT01349049|473301089|FG005|Overall Study|Disease progression|2|||
131456209|NCT01349049|473301090|FG006|Overall Study|Disease progression|3|||
131456210|NCT01349049|473301091|FG007|Overall Study|Disease progression|2|||
131456211|NCT01349049|473301092|FG008|Overall Study|Disease progression|33|||
131456212|NCT01349049|473301084|FG000|Overall Study|Adverse Event|0|||
131456213|NCT01349049|473301085|FG001|Overall Study|Adverse Event|1|||
131456214|NCT01349049|473301086|FG002|Overall Study|Adverse Event|0|||
131456215|NCT01349049|473301087|FG003|Overall Study|Adverse Event|0|||
131456216|NCT01349049|473301088|FG004|Overall Study|Adverse Event|0|||
131456217|NCT01349049|473301089|FG005|Overall Study|Adverse Event|3|||
131456218|NCT01349049|473301090|FG006|Overall Study|Adverse Event|1|||
131947312|NCT01299389|475095593|FG001|Double-blind|Other|1|||
131947313|NCT01299389|475095594|FG002|Double-blind|Other|0|||
131947314|NCT01299389|475095595|FG003|Double-blind|Other|0|||
131947315|NCT01299389|475095592|FG000|Double-blind|"fail to meet study population criteria"|0|||
131947316|NCT01299389|475095593|FG001|Double-blind|"fail to meet study population criteria"|1|||
131947317|NCT01299389|475095594|FG002|Double-blind|"fail to meet study population criteria"|0|||
131947318|NCT01299389|475095595|FG003|Double-blind|"fail to meet study population criteria"|0|||
131947319|NCT01299389|475095592|FG000|Post-observational|Other|0|||
131947320|NCT01299389|475095593|FG001|Post-observational|Other|0|||
131947321|NCT01299389|475095594|FG002|Post-observational|Other|12|||
131947322|NCT01299389|475095595|FG003|Post-observational|Other|6|||
131413878|NCT04030962|473140408|FG008|Stage 2|Adverse Event|1|||
131413879|NCT04030962|473140409|FG009|Stage 2|Adverse Event|0|||
131413880|NCT04030962|473140410|FG010|Stage 2|Adverse Event|1|||
131413881|NCT04030962|473140411|FG011|Stage 2|Adverse Event|1|||
131413882|NCT04030962|473140412|FG012|Stage 2|Adverse Event|1|||
131413883|NCT04030962|473140400|FG000|Stage 2|Withdrawal by Subject|0|||
131413884|NCT04030962|473140401|FG001|Stage 2|Withdrawal by Subject|0|||
131413885|NCT04030962|473140402|FG002|Stage 2|Withdrawal by Subject|0|||
131413886|NCT04030962|473140403|FG003|Stage 2|Withdrawal by Subject|0|||
131413887|NCT04030962|473140404|FG004|Stage 2|Withdrawal by Subject|0|||
131413888|NCT04030962|473140405|FG005|Stage 2|Withdrawal by Subject|0|||
131413889|NCT04030962|473140406|FG006|Stage 2|Withdrawal by Subject|0|||
131413890|NCT04030962|473140407|FG007|Stage 2|Withdrawal by Subject|0|||
131413891|NCT04030962|473140408|FG008|Stage 2|Withdrawal by Subject|1|||
131413892|NCT04030962|473140409|FG009|Stage 2|Withdrawal by Subject|0|||
131413893|NCT04030962|473140410|FG010|Stage 2|Withdrawal by Subject|0|||
131413894|NCT04030962|473140411|FG011|Stage 2|Withdrawal by Subject|2|||
131413895|NCT04030962|473140412|FG012|Stage 2|Withdrawal by Subject|1|||
131413896|NCT04030962|473140400|FG000|Stage 2|Lost to Follow-up|0|||
131413897|NCT04030962|473140401|FG001|Stage 2|Lost to Follow-up|0|||
131413898|NCT04030962|473140402|FG002|Stage 2|Lost to Follow-up|0|||
131413899|NCT04030962|473140403|FG003|Stage 2|Lost to Follow-up|0|||
131413900|NCT04030962|473140404|FG004|Stage 2|Lost to Follow-up|0|||
131413901|NCT04030962|473140405|FG005|Stage 2|Lost to Follow-up|0|||
131413902|NCT04030962|473140406|FG006|Stage 2|Lost to Follow-up|0|||
131413903|NCT04030962|473140407|FG007|Stage 2|Lost to Follow-up|0|||
131413904|NCT04030962|473140408|FG008|Stage 2|Lost to Follow-up|1|||
131413905|NCT04030962|473140409|FG009|Stage 2|Lost to Follow-up|0|||
131413906|NCT04030962|473140410|FG010|Stage 2|Lost to Follow-up|0|||
131413907|NCT04030962|473140411|FG011|Stage 2|Lost to Follow-up|0|||
131413908|NCT04030962|473140412|FG012|Stage 2|Lost to Follow-up|0|||
131413909|NCT04030962|473140400|FG000|Stage 2|Technical Problems|0|||
131413910|NCT04030962|473140401|FG001|Stage 2|Technical Problems|0|||
131413911|NCT04030962|473140402|FG002|Stage 2|Technical Problems|0|||
131413912|NCT04030962|473140403|FG003|Stage 2|Technical Problems|0|||
131413913|NCT04030962|473140404|FG004|Stage 2|Technical Problems|0|||
131413914|NCT04030962|473140405|FG005|Stage 2|Technical Problems|0|||
131413915|NCT04030962|473140406|FG006|Stage 2|Technical Problems|0|||
131413916|NCT04030962|473140407|FG007|Stage 2|Technical Problems|0|||
131413917|NCT04030962|473140408|FG008|Stage 2|Technical Problems|0|||
131413918|NCT04030962|473140409|FG009|Stage 2|Technical Problems|0|||
131413919|NCT04030962|473140410|FG010|Stage 2|Technical Problems|0|||
131413920|NCT04030962|473140411|FG011|Stage 2|Technical Problems|1|||
131413921|NCT04030962|473140412|FG012|Stage 2|Technical Problems|0|||
131413922|NCT01114360|473140415|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
131413923|NCT01114360|473140416|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
131413924|NCT03007745|473140418|FG000|Overall Study|Sleep test negative for OSA|53|||
131413925|NCT03007745|473140419|FG001|Overall Study|Sleep test negative for OSA|49|||
131947323|NCT00889707|475095596|FG000|Overall Study|Adverse Event|1|||
131947324|NCT00889707|475095597|FG001|Overall Study|Adverse Event|0|||
131947325|NCT00889707|475095596|FG000|Overall Study|Withdrawal by Subject|4|||
131413926|NCT03007745|473140418|FG000|Overall Study|Physician Decision|6|||
131413927|NCT03007745|473140419|FG001|Overall Study|Physician Decision|9|||
131413928|NCT03007745|473140418|FG000|Overall Study|Withdrawal by Subject|38|||
131413929|NCT03007745|473140419|FG001|Overall Study|Withdrawal by Subject|16|||
131413930|NCT03007745|473140418|FG000|Overall Study|Lost to Follow-up|19|||
131413931|NCT03007745|473140419|FG001|Overall Study|Lost to Follow-up|25|||
131413932|NCT03007745|473140418|FG000|Overall Study|Unable to login to website|17|||
131413933|NCT03007745|473140419|FG001|Overall Study|Unable to login to website|4|||
131413934|NCT02981524|473140420|FG000|Overall Study|Progressive Disease|14|||
131413935|NCT02981524|473140420|FG000|Overall Study|Death (unrelated)|1|||
131413936|NCT02981524|473140420|FG000|Overall Study|Treatment Related Toxicity|1|||
131413937|NCT02981524|473140420|FG000|Overall Study|Withdrawal by Subject|1|||
131413938|NCT01300351|473140421|FG000|Overall Study|Did not receive treatment|2|||
131456219|NCT01349049|473301091|FG007|Overall Study|Adverse Event|0|||
131947326|NCT00889707|475095597|FG001|Overall Study|Withdrawal by Subject|3|||
131413939|NCT01300351|473140422|FG001|Overall Study|Did not receive treatment|0|||
131413940|NCT01300351|473140421|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
131413941|NCT01300351|473140422|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
131413942|NCT01300351|473140421|FG000|Overall Study|Lost to Follow-up|0|||
131947327|NCT00889707|475095596|FG000|Overall Study|Lost to Follow-up|0|||
131947328|NCT00889707|475095597|FG001|Overall Study|Lost to Follow-up|2|||
131947329|NCT00889707|475095596|FG000|Overall Study|Lack of Efficacy|2|||
131947330|NCT00889707|475095597|FG001|Overall Study|Lack of Efficacy|5|||
131947331|NCT02948582|475095598|FG000|Washout Period 1|Adverse Event|0|||
131947332|NCT02948582|475095599|FG001|Washout Period 1|Adverse Event|2|||
131947333|NCT02948582|475095600|FG002|Washout Period 1|Adverse Event|0|||
131947334|NCT02948582|475095601|FG003|Washout Period 1|Adverse Event|0|||
131947335|NCT02948582|475095602|FG004|Washout Period 1|Adverse Event|0|||
131947336|NCT02948582|475095603|FG005|Washout Period 1|Adverse Event|0|||
131947337|NCT02948582|475095598|FG000|Washout Period 1|Protocol Violation|0|||
131947338|NCT02948582|475095599|FG001|Washout Period 1|Protocol Violation|0|||
131947339|NCT02948582|475095600|FG002|Washout Period 1|Protocol Violation|0|||
131947340|NCT02948582|475095601|FG003|Washout Period 1|Protocol Violation|0|||
131947341|NCT02948582|475095602|FG004|Washout Period 1|Protocol Violation|0|||
131947342|NCT02948582|475095603|FG005|Washout Period 1|Protocol Violation|1|||
131947343|NCT02948582|475095598|FG000|Washout Period 2|Adverse Event|0|||
131947344|NCT02948582|475095599|FG001|Washout Period 2|Adverse Event|1|||
131947345|NCT02948582|475095600|FG002|Washout Period 2|Adverse Event|0|||
131947346|NCT02948582|475095601|FG003|Washout Period 2|Adverse Event|0|||
131947347|NCT02948582|475095602|FG004|Washout Period 2|Adverse Event|0|||
131947348|NCT02948582|475095603|FG005|Washout Period 2|Adverse Event|0|||
131947349|NCT02948582|475095598|FG000|Washout Period 2|personal reasons|0|||
131947350|NCT02948582|475095599|FG001|Washout Period 2|personal reasons|0|||
131947351|NCT02948582|475095600|FG002|Washout Period 2|personal reasons|0|||
131947352|NCT02948582|475095601|FG003|Washout Period 2|personal reasons|1|||
131947353|NCT02948582|475095602|FG004|Washout Period 2|personal reasons|0|||
131947354|NCT02948582|475095603|FG005|Washout Period 2|personal reasons|0|||
131947355|NCT02948582|475095598|FG000|Washout Period 4|Adverse Event|1|||
131947356|NCT02948582|475095599|FG001|Washout Period 4|Adverse Event|0|||
131947357|NCT02948582|475095600|FG002|Washout Period 4|Adverse Event|1|||
131947358|NCT02948582|475095601|FG003|Washout Period 4|Adverse Event|0|||
131947359|NCT02948582|475095602|FG004|Washout Period 4|Adverse Event|0|||
131947360|NCT02948582|475095603|FG005|Washout Period 4|Adverse Event|0|||
131947361|NCT01151020|475095607|FG000|Overall Study|Death|25|||
131947362|NCT01151020|475095607|FG000|Overall Study|Conversion to open repair|1|||
131947363|NCT01151020|475095607|FG000|Overall Study|Lost to Follow-up|4|||
131947364|NCT01151020|475095607|FG000|Overall Study|Withdrawal by Subject|22|||
131947365|NCT01151020|475095607|FG000|Overall Study|Patients did not receive the device|2|||
131947366|NCT02041299|475095608|FG000|Overall Study|Adverse Event|9|||
131947367|NCT02041299|475095609|FG001|Overall Study|Adverse Event|3|||
131947368|NCT02041299|475095608|FG000|Overall Study|Lost to Follow-up|4|||
131947369|NCT02041299|475095609|FG001|Overall Study|Lost to Follow-up|1|||
131947370|NCT02041299|475095608|FG000|Overall Study|Physician Decision|1|||
131947371|NCT02041299|475095609|FG001|Overall Study|Physician Decision|1|||
131947372|NCT02041299|475095608|FG000|Overall Study|Withdrawal by Subject|13|||
131947373|NCT02041299|475095609|FG001|Overall Study|Withdrawal by Subject|7|||
131947374|NCT02041299|475095608|FG000|Overall Study|Protocol Violation|11|||
131947375|NCT02041299|475095609|FG001|Overall Study|Protocol Violation|4|||
131947376|NCT02041299|475095608|FG000|Overall Study|Termination of the study|7|||
131947377|NCT02041299|475095609|FG001|Overall Study|Termination of the study|3|||
131947378|NCT02041299|475095608|FG000|Overall Study|Required bone marrow transplant|0|||
131947379|NCT02041299|475095609|FG001|Overall Study|Required bone marrow transplant|1|||
131947380|NCT02041299|475095608|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
131947381|NCT02041299|475095609|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
131947382|NCT01635998|475095610|FG000|Overall Study|Death|1|||
131947383|NCT01635998|475095611|FG001|Overall Study|Death|1|||
131947384|NCT01635998|475095610|FG000|Overall Study|Lost to Follow-up|2|||
131947385|NCT01635998|475095611|FG001|Overall Study|Lost to Follow-up|1|||
131947386|NCT01635998|475095610|FG000|Overall Study|Withdrawal by Subject|1|||
131947387|NCT01635998|475095611|FG001|Overall Study|Withdrawal by Subject|5|||
131947388|NCT00846846|475095612|FG000|Overall Study|Death|56|||
131947389|NCT00846846|475095612|FG000|Overall Study|Withdrawal by Subject|19|||
131947390|NCT01853462|475095625|FG000|Overall Study|Withdrawal by Subject|1|||
131947391|NCT01853462|475095626|FG001|Overall Study|Withdrawal by Subject|1|||
131947392|NCT03943290|475095627|FG000|Overall Study|Sponsor Terminated Study|6|||
131947393|NCT03943290|475095628|FG001|Overall Study|Sponsor Terminated Study|1|||
131947394|NCT03943290|475095629|FG002|Overall Study|Sponsor Terminated Study|11|||
131947395|NCT03943290|475095630|FG003|Overall Study|Sponsor Terminated Study|6|||
131947396|NCT03943290|475095631|FG004|Overall Study|Sponsor Terminated Study|7|||
131947397|NCT03943290|475095632|FG005|Overall Study|Sponsor Terminated Study|6|||
131947398|NCT03943290|475095633|FG006|Overall Study|Sponsor Terminated Study|6|||
131947399|NCT03943290|475095634|FG007|Overall Study|Sponsor Terminated Study|7|||
131947400|NCT03943290|475095635|FG008|Overall Study|Sponsor Terminated Study|8|||
131947401|NCT03943290|475095627|FG000|Overall Study|Lost to Follow-up|1|||
131947402|NCT03943290|475095628|FG001|Overall Study|Lost to Follow-up|0|||
131947403|NCT03943290|475095629|FG002|Overall Study|Lost to Follow-up|1|||
131947404|NCT03943290|475095630|FG003|Overall Study|Lost to Follow-up|0|||
131947405|NCT03943290|475095631|FG004|Overall Study|Lost to Follow-up|0|||
131947406|NCT03943290|475095632|FG005|Overall Study|Lost to Follow-up|0|||
131947407|NCT03943290|475095633|FG006|Overall Study|Lost to Follow-up|0|||
131947408|NCT03943290|475095634|FG007|Overall Study|Lost to Follow-up|1|||
131947409|NCT03943290|475095635|FG008|Overall Study|Lost to Follow-up|0|||
131947410|NCT03943290|475095627|FG000|Overall Study|Withdrawal by Subject|0|||
131947411|NCT03943290|475095628|FG001|Overall Study|Withdrawal by Subject|0|||
131947412|NCT03943290|475095629|FG002|Overall Study|Withdrawal by Subject|1|||
131947413|NCT03943290|475095630|FG003|Overall Study|Withdrawal by Subject|0|||
131947414|NCT03943290|475095631|FG004|Overall Study|Withdrawal by Subject|0|||
131947415|NCT03943290|475095632|FG005|Overall Study|Withdrawal by Subject|0|||
131947416|NCT03943290|475095633|FG006|Overall Study|Withdrawal by Subject|0|||
131947417|NCT03943290|475095634|FG007|Overall Study|Withdrawal by Subject|0|||
131947418|NCT03943290|475095635|FG008|Overall Study|Withdrawal by Subject|0|||
131947419|NCT00955474|475095636|FG000|Overall Study|Physician Decision|7|||
131947420|NCT00955474|475095637|FG001|Overall Study|Physician Decision|5|||
131947421|NCT01964378|475095638|FG000|Overall Study|Disc. due to death before first dosing|0|||
131947422|NCT01964378|475095639|FG001|Overall Study|Disc. due to death before first dosing|1|||
131947423|NCT01964378|475095638|FG000|Overall Study|Disc. due to AE before first dosing|1|||
131947424|NCT01964378|475095639|FG001|Overall Study|Disc. due to AE before first dosing|0|||
131947425|NCT01964378|475095638|FG000|Overall Study|Death|3|||
131947426|NCT01964378|475095639|FG001|Overall Study|Death|2|||
131947427|NCT01964378|475095638|FG000|Overall Study|Adverse Event|12|||
131947428|NCT01964378|475095639|FG001|Overall Study|Adverse Event|5|||
131947429|NCT01964378|475095638|FG000|Overall Study|Lack of Efficacy|0|||
131947430|NCT01964378|475095639|FG001|Overall Study|Lack of Efficacy|1|||
131947431|NCT01964378|475095638|FG000|Overall Study|Protocol Violation|0|||
131947432|NCT01964378|475095639|FG001|Overall Study|Protocol Violation|1|||
131947433|NCT01964378|475095638|FG000|Overall Study|Lost to Follow-up|0|||
131947434|NCT01964378|475095639|FG001|Overall Study|Lost to Follow-up|1|||
131947435|NCT01964378|475095638|FG000|Overall Study|Withdrawal by Subject|7|||
131947436|NCT01964378|475095639|FG001|Overall Study|Withdrawal by Subject|5|||
131947437|NCT01964378|475095638|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
131947438|NCT01964378|475095639|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
131947439|NCT01964378|475095638|FG000|Overall Study|Other|1|||
131947440|NCT01964378|475095639|FG001|Overall Study|Other|2|||
131947441|NCT00326599|475095640|FG000|Overall Study|Withdrawal by Subject|1|||
131947442|NCT00326599|475095641|FG001|Overall Study|Withdrawal by Subject|0|||
131947443|NCT00326599|475095642|FG002|Overall Study|Withdrawal by Subject|5|||
131947444|NCT00326599|475095643|FG003|Overall Study|Withdrawal by Subject|2|||
131947445|NCT00326599|475095640|FG000|Overall Study|Adverse Event|1|||
131947446|NCT00326599|475095641|FG001|Overall Study|Adverse Event|0|||
131947447|NCT00326599|475095642|FG002|Overall Study|Adverse Event|32|||
131947448|NCT00326599|475095643|FG003|Overall Study|Adverse Event|3|||
131947449|NCT00326599|475095640|FG000|Overall Study|Disease Progression|3|||
131947450|NCT00326599|475095641|FG001|Overall Study|Disease Progression|1|||
131947451|NCT00326599|475095642|FG002|Overall Study|Disease Progression|13|||
131947452|NCT00326599|475095643|FG003|Overall Study|Disease Progression|11|||
131947453|NCT00326599|475095640|FG000|Overall Study|Alternate Treatment|1|||
131947454|NCT00326599|475095641|FG001|Overall Study|Alternate Treatment|0|||
131947455|NCT00326599|475095642|FG002|Overall Study|Alternate Treatment|0|||
131947456|NCT00326599|475095643|FG003|Overall Study|Alternate Treatment|0|||
131947457|NCT00326599|475095640|FG000|Overall Study|Death|0|||
131947458|NCT00326599|475095641|FG001|Overall Study|Death|0|||
131947459|NCT00326599|475095642|FG002|Overall Study|Death|1|||
131947460|NCT00326599|475095643|FG003|Overall Study|Death|2|||
131947461|NCT00326599|475095640|FG000|Overall Study|Other Unspecified Reason|0|||
131947462|NCT00326599|475095641|FG001|Overall Study|Other Unspecified Reason|0|||
131947463|NCT00326599|475095642|FG002|Overall Study|Other Unspecified Reason|2|||
131947464|NCT00326599|475095643|FG003|Overall Study|Other Unspecified Reason|1|||
131947465|NCT01162473|475095644|FG000|Overall Study|Adverse Event|2|||
131947466|NCT01162473|475095645|FG001|Overall Study|Adverse Event|1|||
131947467|NCT01162473|475095644|FG000|Overall Study|Withdrawal by Subject|0|||
131947468|NCT01162473|475095645|FG001|Overall Study|Withdrawal by Subject|4|||
131947469|NCT00943761|475095649|FG000|Overall Study|Lost to Follow-up|2|||
131947470|NCT00943761|475095650|FG001|Overall Study|Lost to Follow-up|0|||
131947471|NCT00943761|475095649|FG000|Overall Study|Withdrawal by Subject|2|||
131947472|NCT00943761|475095650|FG001|Overall Study|Withdrawal by Subject|1|||
131947473|NCT02708680|475095651|FG000|Overall Study|Withdrawal by Subject|4|||
131947474|NCT02708680|475095652|FG001|Overall Study|Withdrawal by Subject|12|||
131947475|NCT02708680|475095653|FG002|Overall Study|Withdrawal by Subject|12|||
131947476|NCT02708680|475095651|FG000|Overall Study|Death|4|||
131947477|NCT02708680|475095652|FG001|Overall Study|Death|19|||
131947478|NCT02708680|475095653|FG002|Overall Study|Death|21|||
131947479|NCT02708680|475095651|FG000|Overall Study|Lost to Follow-up|0|||
131947480|NCT02708680|475095652|FG001|Overall Study|Lost to Follow-up|3|||
131947481|NCT02708680|475095653|FG002|Overall Study|Lost to Follow-up|3|||
131947482|NCT02708680|475095651|FG000|Overall Study|Study Terminated By Sponsor|0|||
131947483|NCT02708680|475095652|FG001|Overall Study|Study Terminated By Sponsor|5|||
131947484|NCT02708680|475095653|FG002|Overall Study|Study Terminated By Sponsor|4|||
131947485|NCT02708680|475095651|FG000|Overall Study|Other than Specified|0|||
131947486|NCT02708680|475095652|FG001|Overall Study|Other than Specified|0|||
131947487|NCT02708680|475095653|FG002|Overall Study|Other than Specified|1|||
131947488|NCT02708680|475095651|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
131947489|NCT02708680|475095652|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
131947490|NCT02708680|475095653|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
131947491|NCT04162470|475095654|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
131947492|NCT05588440|475095655|FG000|Overall Study|Sponsor Decision|2|||
131947493|NCT05588440|475095656|FG001|Overall Study|Sponsor Decision|0|||
131947494|NCT05588440|475095657|FG002|Overall Study|Sponsor Decision|1|||
131947495|NCT05588440|475095655|FG000|Overall Study|Death|1|||
131947496|NCT05588440|475095656|FG001|Overall Study|Death|1|||
131947497|NCT05588440|475095657|FG002|Overall Study|Death|1|||
131947498|NCT05588440|475095655|FG000|Overall Study|Screen Fail|0|||
131947499|NCT05588440|475095656|FG001|Overall Study|Screen Fail|1|||
131947500|NCT05588440|475095657|FG002|Overall Study|Screen Fail|1|||
131947501|NCT05588440|475095655|FG000|Overall Study|Withdrawal by Subject|0|||
131947502|NCT05588440|475095656|FG001|Overall Study|Withdrawal by Subject|0|||
131947503|NCT05588440|475095657|FG002|Overall Study|Withdrawal by Subject|1|||
131947504|NCT01445847|475095660|FG000|Overall Study|Protocol Violation|13|||
131947505|NCT01445847|475095661|FG001|Overall Study|Protocol Violation|14|||
131947506|NCT01445847|475095660|FG000|Overall Study|Missed Data|1|||
131947507|NCT01445847|475095661|FG001|Overall Study|Missed Data|0|||
131947508|NCT00436436|475095662|FG000|Overall Study|Progression|4|||
131947509|NCT00436436|475095662|FG000|Overall Study|Adverse Event|2|||
131947510|NCT00436436|475095662|FG000|Overall Study|Death|6|||
131947511|NCT01102491|475095669|FG000|Overall Study|Protocol Violation|11|||
131947512|NCT01102491|475095670|FG001|Overall Study|Protocol Violation|12|||
131947513|NCT03008070|475095671|FG000|Overall Study|Adverse Event|3|||
131947514|NCT03008070|475095672|FG001|Overall Study|Adverse Event|3|||
131947515|NCT03008070|475095673|FG002|Overall Study|Adverse Event|3|||
131947516|NCT03008070|475095671|FG000|Overall Study|Lost to Follow-up|1|||
131947517|NCT03008070|475095672|FG001|Overall Study|Lost to Follow-up|1|||
131947518|NCT03008070|475095673|FG002|Overall Study|Lost to Follow-up|0|||
131947519|NCT03008070|475095671|FG000|Overall Study|Non compliance|0|||
131947520|NCT03008070|475095672|FG001|Overall Study|Non compliance|1|||
131947521|NCT03008070|475095673|FG002|Overall Study|Non compliance|1|||
131947522|NCT03008070|475095671|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
131947523|NCT03008070|475095672|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
131947524|NCT03008070|475095673|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
131947525|NCT03008070|475095671|FG000|Overall Study|Withdrawal by Subject|2|||
131947526|NCT03008070|475095672|FG001|Overall Study|Withdrawal by Subject|0|||
131947527|NCT03008070|475095673|FG002|Overall Study|Withdrawal by Subject|1|||
131947528|NCT03008070|475095671|FG000|Overall Study|Use of prohibited drug|0|||
131947529|NCT03008070|475095672|FG001|Overall Study|Use of prohibited drug|0|||
131947530|NCT03008070|475095673|FG002|Overall Study|Use of prohibited drug|2|||
131947531|NCT04409834|475095676|FG000|Overall Study|Death|55|||
131947532|NCT04409834|475095677|FG001|Overall Study|Death|62|||
131947533|NCT02151786|475095678|FG000|Overall Study|Unavailability of Case Report Form|26|||
131947534|NCT02151786|475095678|FG000|Overall Study|Outside the Contract Period|1|||
131947535|NCT02151786|475095678|FG000|Overall Study|Randomized, not Treated|1|||
131947536|NCT02151786|475095678|FG000|Overall Study|Unavailability of Information|8|||
131947537|NCT01365455|475095679|FG000|Induction Period|Adverse Event|5|||
131947538|NCT01365455|475095680|FG001|Induction Period|Adverse Event|3|||
131947539|NCT01365455|475095681|FG002|Induction Period|Adverse Event|4|||
131947540|NCT01365455|475095682|FG003|Induction Period|Adverse Event|0|||
131947541|NCT01365455|475095683|FG004|Induction Period|Adverse Event|0|||
131947542|NCT01365455|475095679|FG000|Induction Period|Lack of Efficacy|1|||
131947543|NCT01365455|475095680|FG001|Induction Period|Lack of Efficacy|1|||
131947544|NCT01365455|475095681|FG002|Induction Period|Lack of Efficacy|0|||
131947545|NCT01365455|475095682|FG003|Induction Period|Lack of Efficacy|0|||
131947546|NCT01365455|475095683|FG004|Induction Period|Lack of Efficacy|0|||
131947547|NCT01365455|475095679|FG000|Induction Period|Pregnancy|0|||
131947548|NCT01365455|475095680|FG001|Induction Period|Pregnancy|1|||
131947549|NCT01365455|475095681|FG002|Induction Period|Pregnancy|0|||
131947550|NCT01365455|475095682|FG003|Induction Period|Pregnancy|0|||
131947551|NCT01365455|475095683|FG004|Induction Period|Pregnancy|0|||
131947552|NCT01365455|475095679|FG000|Induction Period|Protocol deviation|0|||
131947553|NCT01365455|475095680|FG001|Induction Period|Protocol deviation|1|||
131947554|NCT01365455|475095681|FG002|Induction Period|Protocol deviation|1|||
131947555|NCT01365455|475095682|FG003|Induction Period|Protocol deviation|0|||
131947556|NCT01365455|475095683|FG004|Induction Period|Protocol deviation|0|||
131947557|NCT01365455|475095679|FG000|Induction Period|Subject/guardian decision|9|||
131947558|NCT01365455|475095680|FG001|Induction Period|Subject/guardian decision|1|||
131947559|NCT01365455|475095681|FG002|Induction Period|Subject/guardian decision|8|||
131947560|NCT01365455|475095682|FG003|Induction Period|Subject/guardian decision|0|||
131947561|NCT01365455|475095683|FG004|Induction Period|Subject/guardian decision|0|||
131947562|NCT01365455|475095679|FG000|Induction Period|Lost to Follow-up|0|||
131947563|NCT01365455|475095680|FG001|Induction Period|Lost to Follow-up|0|||
131947564|NCT01365455|475095681|FG002|Induction Period|Lost to Follow-up|3|||
131947565|NCT01365455|475095682|FG003|Induction Period|Lost to Follow-up|0|||
131947566|NCT01365455|475095683|FG004|Induction Period|Lost to Follow-up|0|||
131947567|NCT01365455|475095679|FG000|Maintenance Period|Adverse Event|12|||
131947568|NCT01365455|475095680|FG001|Maintenance Period|Adverse Event|5|||
131947569|NCT01365455|475095681|FG002|Maintenance Period|Adverse Event|1|||
131947570|NCT01365455|475095682|FG003|Maintenance Period|Adverse Event|2|||
131947571|NCT01365455|475095683|FG004|Maintenance Period|Adverse Event|4|||
131947572|NCT01365455|475095679|FG000|Maintenance Period|Lack of Efficacy|10|||
131947573|NCT01365455|475095680|FG001|Maintenance Period|Lack of Efficacy|2|||
131947574|NCT01365455|475095681|FG002|Maintenance Period|Lack of Efficacy|0|||
131947575|NCT01365455|475095682|FG003|Maintenance Period|Lack of Efficacy|2|||
131947576|NCT01365455|475095683|FG004|Maintenance Period|Lack of Efficacy|2|||
131947577|NCT01365455|475095679|FG000|Maintenance Period|Lost to Follow-up|2|||
131947578|NCT01365455|475095680|FG001|Maintenance Period|Lost to Follow-up|4|||
131947579|NCT01365455|475095681|FG002|Maintenance Period|Lost to Follow-up|0|||
131947580|NCT01365455|475095682|FG003|Maintenance Period|Lost to Follow-up|0|||
131947581|NCT01365455|475095683|FG004|Maintenance Period|Lost to Follow-up|3|||
131947582|NCT01365455|475095679|FG000|Maintenance Period|Non-compliance with study treatment|0|||
131947583|NCT01365455|475095680|FG001|Maintenance Period|Non-compliance with study treatment|0|||
131947584|NCT01365455|475095681|FG002|Maintenance Period|Non-compliance with study treatment|0|||
131947585|NCT01365455|475095682|FG003|Maintenance Period|Non-compliance with study treatment|1|||
131947586|NCT01365455|475095683|FG004|Maintenance Period|Non-compliance with study treatment|0|||
131947587|NCT01365455|475095679|FG000|Maintenance Period|Physician Decision|0|||
131947588|NCT01365455|475095680|FG001|Maintenance Period|Physician Decision|1|||
131947589|NCT01365455|475095681|FG002|Maintenance Period|Physician Decision|0|||
131947590|NCT01365455|475095682|FG003|Maintenance Period|Physician Decision|0|||
131947591|NCT01365455|475095683|FG004|Maintenance Period|Physician Decision|1|||
131947592|NCT01365455|475095679|FG000|Maintenance Period|Pregnancy|0|||
131947593|NCT01365455|475095680|FG001|Maintenance Period|Pregnancy|4|||
131947594|NCT01365455|475095681|FG002|Maintenance Period|Pregnancy|0|||
131947595|NCT01365455|475095682|FG003|Maintenance Period|Pregnancy|0|||
131947596|NCT01365455|475095683|FG004|Maintenance Period|Pregnancy|2|||
131947597|NCT01365455|475095679|FG000|Maintenance Period|Protocol deviation|1|||
131947598|NCT01365455|475095680|FG001|Maintenance Period|Protocol deviation|1|||
131947599|NCT01365455|475095681|FG002|Maintenance Period|Protocol deviation|0|||
131947600|NCT01365455|475095682|FG003|Maintenance Period|Protocol deviation|0|||
131947601|NCT01365455|475095683|FG004|Maintenance Period|Protocol deviation|0|||
131947602|NCT01365455|475095679|FG000|Maintenance Period|Subject/guardian decision|4|||
131947603|NCT01365455|475095680|FG001|Maintenance Period|Subject/guardian decision|6|||
131947604|NCT01365455|475095681|FG002|Maintenance Period|Subject/guardian decision|2|||
131947605|NCT01365455|475095682|FG003|Maintenance Period|Subject/guardian decision|4|||
131947606|NCT01365455|475095683|FG004|Maintenance Period|Subject/guardian decision|1|||
131947607|NCT00928187|475095684|FG000|Overall Study|Death|1|||
131947608|NCT00928187|475095685|FG001|Overall Study|Death|2|||
131947609|NCT00928187|475095686|FG002|Overall Study|Death|3|||
131947610|NCT00928187|475095684|FG000|Overall Study|Lost to Follow-up|1|||
131947611|NCT00928187|475095685|FG001|Overall Study|Lost to Follow-up|2|||
131947612|NCT00928187|475095686|FG002|Overall Study|Lost to Follow-up|1|||
131947613|NCT00928187|475095684|FG000|Overall Study|Withdrawal by Subject|0|||
131947614|NCT00928187|475095685|FG001|Overall Study|Withdrawal by Subject|1|||
131947615|NCT00928187|475095686|FG002|Overall Study|Withdrawal by Subject|1|||
131947616|NCT00928187|475095684|FG000|Overall Study|Protocol Violation|0|||
131947617|NCT00928187|475095685|FG001|Overall Study|Protocol Violation|1|||
131947618|NCT00928187|475095686|FG002|Overall Study|Protocol Violation|0|||
131947619|NCT00628446|475097055|FG000|Overall Study|Lost to Follow-up|3|||
131947620|NCT00628446|475097055|FG000|Overall Study|Withdrawal by Subject|1|||
131947621|NCT00628446|475097055|FG000|Overall Study|Protocol Violation|3|||
131947622|NCT01898286|475097056|FG000|Overall Study|Withdrawal by Subject|1|||
131947623|NCT01898286|475097056|FG000|Overall Study|Protocol Violation|1|||
131947624|NCT01898286|475097056|FG000|Overall Study|Lost to Follow-up|1|||
131947625|NCT01650831|475097063|FG000|Overall Study|Screen failure|1|||
131947626|NCT01048242|475097064|FG000|Overall Study|See study flow chart|4|||
131947627|NCT01048242|475097065|FG001|Overall Study|See study flow chart|2|||
131947628|NCT02964273|475097066|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
131947629|NCT02964273|475097067|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
131947630|NCT02964273|475097068|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
131947631|NCT02964273|475097069|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
131947632|NCT02964273|475097066|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
131947633|NCT02964273|475097067|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
131947634|NCT02964273|475097068|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
131456220|NCT01349049|473301092|FG008|Overall Study|Adverse Event|4|||
131456221|NCT01349049|473301084|FG000|Overall Study|Physician Decision|0|||
131456222|NCT01349049|473301085|FG001|Overall Study|Physician Decision|1|||
131456223|NCT01349049|473301086|FG002|Overall Study|Physician Decision|0|||
131456224|NCT01349049|473301087|FG003|Overall Study|Physician Decision|0|||
131456225|NCT01349049|473301088|FG004|Overall Study|Physician Decision|0|||
131456226|NCT01349049|473301089|FG005|Overall Study|Physician Decision|0|||
131456227|NCT01349049|473301090|FG006|Overall Study|Physician Decision|0|||
131456228|NCT01349049|473301091|FG007|Overall Study|Physician Decision|0|||
131456229|NCT01349049|473301092|FG008|Overall Study|Physician Decision|2|||
131456230|NCT01349049|473301084|FG000|Overall Study|Protocol Violation|0|||
131456231|NCT01349049|473301085|FG001|Overall Study|Protocol Violation|0|||
131456232|NCT01349049|473301086|FG002|Overall Study|Protocol Violation|0|||
131456233|NCT01349049|473301087|FG003|Overall Study|Protocol Violation|0|||
131456234|NCT01349049|473301088|FG004|Overall Study|Protocol Violation|0|||
131456235|NCT01349049|473301089|FG005|Overall Study|Protocol Violation|0|||
131456236|NCT01349049|473301090|FG006|Overall Study|Protocol Violation|0|||
131456237|NCT01349049|473301091|FG007|Overall Study|Protocol Violation|0|||
131456238|NCT01349049|473301092|FG008|Overall Study|Protocol Violation|1|||
131456239|NCT01349049|473301084|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
131456240|NCT01349049|473301085|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
131456241|NCT01349049|473301086|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
131456242|NCT01349049|473301087|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
131456243|NCT01349049|473301088|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
131456244|NCT01349049|473301089|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
131456245|NCT01349049|473301090|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
131456246|NCT01349049|473301091|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
131456247|NCT01349049|473301092|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
131456248|NCT01349049|473301084|FG000|Overall Study|Other|0|||
131456249|NCT01349049|473301085|FG001|Overall Study|Other|0|||
131456250|NCT01349049|473301086|FG002|Overall Study|Other|0|||
131456251|NCT01349049|473301087|FG003|Overall Study|Other|0|||
131456252|NCT01349049|473301088|FG004|Overall Study|Other|0|||
131456253|NCT01349049|473301089|FG005|Overall Study|Other|1|||
131456254|NCT01349049|473301090|FG006|Overall Study|Other|0|||
131456255|NCT01349049|473301091|FG007|Overall Study|Other|0|||
131456256|NCT01349049|473301092|FG008|Overall Study|Other|4|||
131456257|NCT01349049|473301084|FG000|Overall Study|Death|0|||
131456258|NCT01349049|473301085|FG001|Overall Study|Death|0|||
131456259|NCT01349049|473301086|FG002|Overall Study|Death|0|||
131947635|NCT02964273|475097069|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
131947636|NCT02964273|475097066|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
131947637|NCT02964273|475097067|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
131456260|NCT01349049|473301087|FG003|Overall Study|Death|0|||
131456261|NCT01349049|473301088|FG004|Overall Study|Death|0|||
131456262|NCT01349049|473301089|FG005|Overall Study|Death|0|||
131456263|NCT01349049|473301090|FG006|Overall Study|Death|0|||
131456264|NCT01349049|473301091|FG007|Overall Study|Death|1|||
131456265|NCT01349049|473301092|FG008|Overall Study|Death|5|||
131456266|NCT01349049|473301084|FG000|Overall Study|Non-compliance|0|||
131456267|NCT01349049|473301085|FG001|Overall Study|Non-compliance|0|||
131456268|NCT01349049|473301086|FG002|Overall Study|Non-compliance|0|||
131456269|NCT01349049|473301087|FG003|Overall Study|Non-compliance|1|||
131456270|NCT01349049|473301088|FG004|Overall Study|Non-compliance|0|||
131456271|NCT01349049|473301089|FG005|Overall Study|Non-compliance|0|||
131456272|NCT01349049|473301090|FG006|Overall Study|Non-compliance|0|||
131456273|NCT01349049|473301091|FG007|Overall Study|Non-compliance|0|||
131456274|NCT01349049|473301092|FG008|Overall Study|Non-compliance|0|||
131456275|NCT01349049|473301084|FG000|Overall Study|Withdrawal by Subject|0|||
131947638|NCT02964273|475097068|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
131947639|NCT02964273|475097069|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
131947640|NCT02964273|475097066|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
131947641|NCT02964273|475097067|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
131456276|NCT01349049|473301085|FG001|Overall Study|Withdrawal by Subject|0|||
131947642|NCT02964273|475097068|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
131947643|NCT02964273|475097069|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
131456277|NCT01349049|473301086|FG002|Overall Study|Withdrawal by Subject|0|||
131456278|NCT01349049|473301087|FG003|Overall Study|Withdrawal by Subject|0|||
131456279|NCT01349049|473301088|FG004|Overall Study|Withdrawal by Subject|0|||
131456280|NCT01349049|473301089|FG005|Overall Study|Withdrawal by Subject|0|||
131456281|NCT01349049|473301090|FG006|Overall Study|Withdrawal by Subject|0|||
131456282|NCT01349049|473301091|FG007|Overall Study|Withdrawal by Subject|0|||
131456283|NCT01349049|473301092|FG008|Overall Study|Withdrawal by Subject|6|||
131456284|NCT04681352|473301099|FG000|Overall Study|Lost to Follow-up|2|||
131456285|NCT04681352|473301099|FG000|Overall Study|Withdrawal by Subject|22|||
131456286|NCT01643772|473301100|FG000|Overall Study|Protocol Violation|0|||
131456287|NCT01643772|473301101|FG001|Overall Study|Protocol Violation|0|||
131947644|NCT02964273|475097066|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
131947645|NCT02964273|475097067|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
131947646|NCT02964273|475097068|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
131947647|NCT02964273|475097069|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
131947648|NCT02964273|475097066|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
131947649|NCT02964273|475097067|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
131947650|NCT02964273|475097068|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
131947651|NCT02964273|475097069|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
131947652|NCT01453036|475097071|FG000|Overall Study|Lost to Follow-up|26|||
131947653|NCT01453036|475097072|FG001|Overall Study|Lost to Follow-up|115|||
131947654|NCT01453036|475097073|FG002|Overall Study|Lost to Follow-up|31|||
131947655|NCT01336712|475097074|FG000|Overall Study|Death|2|||
131947656|NCT01336712|475097074|FG000|Overall Study|Lack of Efficacy|1|||
131947657|NCT01976299|475097076|FG000|Overall Study|Withdrawal by Subject|3|||
131947658|NCT01976299|475097077|FG001|Overall Study|Withdrawal by Subject|1|||
131947659|NCT01976299|475097076|FG000|Overall Study|Death|4|||
131947660|NCT01976299|475097077|FG001|Overall Study|Death|2|||
131947661|NCT01976299|475097076|FG000|Overall Study|Lost to Follow-up|7|||
131947662|NCT01976299|475097077|FG001|Overall Study|Lost to Follow-up|1|||
131947663|NCT01976299|475097076|FG000|Overall Study|See clarification above in comments|9|||
131947664|NCT01976299|475097077|FG001|Overall Study|See clarification above in comments|2|||
131947665|NCT03692403|475097078|FG000|Overall Study|Withdrawal by Subject|1|||
131947666|NCT03692403|475097079|FG001|Overall Study|Withdrawal by Subject|0|||
131947667|NCT03692403|475097080|FG002|Overall Study|Withdrawal by Subject|1|||
131947668|NCT03692403|475097081|FG003|Overall Study|Withdrawal by Subject|0|||
131947669|NCT03692403|475097078|FG000|Overall Study|Adverse Event|0|||
131947670|NCT03692403|475097079|FG001|Overall Study|Adverse Event|0|||
131947671|NCT03692403|475097080|FG002|Overall Study|Adverse Event|0|||
131947672|NCT03692403|475097081|FG003|Overall Study|Adverse Event|1|||
131947673|NCT03692403|475097078|FG000|Overall Study|Pregnancy|0|||
131947674|NCT03692403|475097079|FG001|Overall Study|Pregnancy|1|||
131947675|NCT03692403|475097080|FG002|Overall Study|Pregnancy|0|||
131947676|NCT03692403|475097081|FG003|Overall Study|Pregnancy|0|||
131947677|NCT03692403|475097078|FG000|Overall Study|Other|0|||
131947678|NCT03692403|475097079|FG001|Overall Study|Other|0|||
131947679|NCT03692403|475097080|FG002|Overall Study|Other|1|||
131947680|NCT03692403|475097081|FG003|Overall Study|Other|0|||
131947681|NCT01306643|475097082|FG000|Overall Study|Adverse Event|5|||
131947682|NCT01306643|475097082|FG000|Overall Study|Disease Progression|7|||
131947683|NCT01306643|475097082|FG000|Overall Study|Other: Change in Eligibility Status|1|||
131947684|NCT01147393|475097085|FG000|Dose Level 1|Dose limiting Toxicity|2|||
131947685|NCT01147393|475097085|FG000|Dose Level -1|Dose Limited Toxicity|1|||
131947686|NCT00506779|475097092|FG000|Overall Study|Withdrawal by Subject|1|||
131947687|NCT00506779|475097093|FG001|Overall Study|Withdrawal by Subject|0|||
131947688|NCT00506779|475097094|FG002|Overall Study|Withdrawal by Subject|1|||
131947689|NCT00506779|475097095|FG003|Overall Study|Withdrawal by Subject|0|||
131947690|NCT00506779|475097092|FG000|Overall Study|Adverse Event|0|||
131947691|NCT00506779|475097093|FG001|Overall Study|Adverse Event|1|||
131947692|NCT00506779|475097094|FG002|Overall Study|Adverse Event|1|||
131947693|NCT00506779|475097095|FG003|Overall Study|Adverse Event|1|||
131947694|NCT01871545|475097097|FG000|Overall Study|Death|2|||
131947695|NCT01871545|475097098|FG001|Overall Study|Death|0|||
131947696|NCT01871545|475097097|FG000|Overall Study|Lack of Efficacy|11|||
131947697|NCT01871545|475097098|FG001|Overall Study|Lack of Efficacy|2|||
131947698|NCT01871545|475097097|FG000|Overall Study|Physician Decision|4|||
131947699|NCT01871545|475097098|FG001|Overall Study|Physician Decision|0|||
131947700|NCT01871545|475097097|FG000|Overall Study|Withdrawal by Subject|0|||
131413943|NCT01300351|473140422|FG001|Overall Study|Lost to Follow-up|1|||
131413944|NCT01300351|473140421|FG000|Overall Study|Adverse Event|0|||
131413945|NCT01300351|473140422|FG001|Overall Study|Adverse Event|4|||
131413946|NCT01300351|473140421|FG000|Overall Study|Withdrawal by Subject|7|||
131413947|NCT01300351|473140422|FG001|Overall Study|Withdrawal by Subject|10|||
131413948|NCT05824936|473140426|FG000|Overall Study|Lost to Follow-up|1|||
131413949|NCT00673881|473140427|FG000|Overall Study|Withdrawal by Subject|1|||
131456288|NCT01643772|473301102|FG002|Overall Study|Protocol Violation|0|||
131947701|NCT01871545|475097098|FG001|Overall Study|Withdrawal by Subject|1|||
131947702|NCT01152788|475097101|FG000|Overall Study|Withdrawal by Subject|0|||
131947703|NCT01152788|475097102|FG001|Overall Study|Withdrawal by Subject|3|||
131947704|NCT01152788|475097101|FG000|Overall Study|No treatment|0|||
131947705|NCT01152788|475097102|FG001|Overall Study|No treatment|1|||
131947706|NCT01282866|475097103|FG000|Overall Study|Adverse Event|1|||
131947707|NCT03810014|475097106|FG000|Overall Study|Pregnancy|2|||
131947708|NCT03810014|475097107|FG001|Overall Study|Pregnancy|2|||
131947709|NCT03810014|475097108|FG002|Overall Study|Pregnancy|0|||
131947710|NCT03810014|475097109|FG003|Overall Study|Pregnancy|2|||
131947711|NCT03606486|475097110|FG000|Overall Study|Unable to collect sample|5|||
131413950|NCT01100528|473140428|FG000|Overall Study|Death|1|||
131456289|NCT01643772|473301103|FG003|Overall Study|Protocol Violation|1|||
131947712|NCT01737762|475097115|FG000|Overall Study|Adverse Event|2|||
131947713|NCT01737762|475097116|FG001|Overall Study|Adverse Event|2|||
131947714|NCT01737762|475097115|FG000|Overall Study|Lost to Follow-up|1|||
131947715|NCT01737762|475097116|FG001|Overall Study|Lost to Follow-up|0|||
131947716|NCT01737762|475097115|FG000|Overall Study|Withdrawal by Subject|2|||
131947717|NCT01737762|475097116|FG001|Overall Study|Withdrawal by Subject|2|||
131947718|NCT01737762|475097115|FG000|Overall Study|Progressive disease|1|||
131947719|NCT01737762|475097116|FG001|Overall Study|Progressive disease|2|||
131947720|NCT01737762|475097115|FG000|Overall Study|Physician Decision|1|||
131947721|NCT01737762|475097116|FG001|Overall Study|Physician Decision|1|||
131947722|NCT01737762|475097115|FG000|Overall Study|Moved from area|2|||
131947723|NCT01737762|475097116|FG001|Overall Study|Moved from area|1|||
131947724|NCT01737762|475097115|FG000|Overall Study|Trial termination|11|||
131947725|NCT01737762|475097116|FG001|Overall Study|Trial termination|9|||
131947726|NCT02148263|475097117|FG000|Overall Study|Withdrawal by Subject|3|||
131947727|NCT02148263|475097118|FG001|Overall Study|Withdrawal by Subject|2|||
131947728|NCT03386435|475097119|FG000|Overall Study|Protocol Violation|5|||
131947729|NCT03386435|475097120|FG001|Overall Study|Protocol Violation|7|||
131947730|NCT00625586|475097121|FG000|Overall Study|Adverse Event|1|||
131947731|NCT00625586|475097121|FG000|Overall Study|Progressive disease|1|||
131947732|NCT00778336|475097122|FG000|Index Procedure-Discharge|Death|6|||
131947733|NCT00778336|475097123|FG001|Index Procedure-Discharge|Death|3|||
131947734|NCT00778336|475097124|FG002|Index Procedure-Discharge|Death|2|||
131947735|NCT00778336|475097125|FG003|Index Procedure-Discharge|Death|0|||
131947736|NCT00778336|475097122|FG000|3 Month Follow Up|Lost to Follow-up|15|||
131947737|NCT00778336|475097123|FG001|3 Month Follow Up|Lost to Follow-up|20|||
131947738|NCT00778336|475097124|FG002|3 Month Follow Up|Lost to Follow-up|3|||
131947739|NCT00778336|475097125|FG003|3 Month Follow Up|Lost to Follow-up|0|||
131947740|NCT00778336|475097122|FG000|3 Month Follow Up|Death|8|||
131947741|NCT00778336|475097123|FG001|3 Month Follow Up|Death|3|||
131947742|NCT00778336|475097124|FG002|3 Month Follow Up|Death|2|||
131947743|NCT00778336|475097125|FG003|3 Month Follow Up|Death|0|||
131947744|NCT00049257|475097126|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
131947745|NCT00049257|475097126|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
131947746|NCT00049257|475097126|FG000|Carboplatin, Paclitaxel|Death|2|||
131947747|NCT00049257|475097126|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
131947748|NCT04721158|475097127|FG000|Overall Study|Lost to Follow-up|4|||
131947749|NCT04721158|475097127|FG000|Overall Study|Device did not connect|1|||
131947750|NCT04872569|475097128|FG000|Overall Study|Withdrawal by Subject|2|||
131947751|NCT03929913|475097134|FG000|Overall Study|Death|4|||
131947752|NCT03929913|475097134|FG000|Overall Study|Lost to Follow-up|1|||
131947753|NCT03929913|475097134|FG000|Overall Study|Failed Procedure|2|||
131947754|NCT01544348|475097139|FG000|Overall Study|Lost to Follow-up|1|||
131947755|NCT01544348|475097140|FG001|Overall Study|Lost to Follow-up|0|||
131947756|NCT01544348|475097141|FG002|Overall Study|Lost to Follow-up|0|||
131947757|NCT01544348|475097142|FG003|Overall Study|Lost to Follow-up|0|||
131947758|NCT01544348|475097143|FG004|Overall Study|Lost to Follow-up|0|||
131947759|NCT01544348|475097144|FG005|Overall Study|Lost to Follow-up|0|||
131947760|NCT01544348|475097145|FG006|Overall Study|Lost to Follow-up|1|||
131947761|NCT01544348|475097146|FG007|Overall Study|Lost to Follow-up|0|||
131947762|NCT01544348|475097139|FG000|Overall Study|Withdrawal by Subject|1|||
131947763|NCT01544348|475097140|FG001|Overall Study|Withdrawal by Subject|0|||
131947764|NCT01544348|475097141|FG002|Overall Study|Withdrawal by Subject|0|||
131947765|NCT01544348|475097142|FG003|Overall Study|Withdrawal by Subject|0|||
131947766|NCT01544348|475097143|FG004|Overall Study|Withdrawal by Subject|1|||
131947767|NCT01544348|475097144|FG005|Overall Study|Withdrawal by Subject|2|||
131947768|NCT01544348|475097145|FG006|Overall Study|Withdrawal by Subject|1|||
131947769|NCT01544348|475097146|FG007|Overall Study|Withdrawal by Subject|0|||
131947770|NCT01544348|475097139|FG000|Overall Study|Physician Decision|0|||
131947771|NCT01544348|475097140|FG001|Overall Study|Physician Decision|0|||
131947772|NCT01544348|475097141|FG002|Overall Study|Physician Decision|0|||
131947773|NCT01544348|475097142|FG003|Overall Study|Physician Decision|0|||
131947774|NCT01544348|475097143|FG004|Overall Study|Physician Decision|0|||
131947775|NCT01544348|475097144|FG005|Overall Study|Physician Decision|1|||
131947776|NCT01544348|475097145|FG006|Overall Study|Physician Decision|0|||
131947777|NCT01544348|475097146|FG007|Overall Study|Physician Decision|0|||
131947778|NCT02891226|475097147|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
131947779|NCT02891226|475097148|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
131947780|NCT02891226|475097149|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
131947781|NCT02891226|475097150|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947782|NCT02891226|475097151|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947783|NCT02891226|475097152|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947784|NCT02891226|475097153|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947785|NCT02891226|475097154|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947786|NCT02891226|475097155|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947787|NCT02891226|475097156|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947788|NCT02891226|475097157|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947789|NCT02891226|475097158|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947790|NCT02891226|475097159|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947791|NCT02891226|475097160|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947792|NCT02891226|475097161|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947793|NCT02891226|475097162|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
131947794|NCT02891226|475097147|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
131947795|NCT02891226|475097148|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
131947796|NCT02891226|475097149|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947797|NCT02891226|475097150|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947798|NCT02891226|475097151|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947799|NCT02891226|475097152|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947800|NCT02891226|475097153|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947801|NCT02891226|475097154|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947802|NCT02891226|475097155|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947803|NCT02891226|475097156|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947804|NCT02891226|475097157|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947805|NCT02891226|475097158|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947806|NCT02891226|475097159|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947807|NCT02891226|475097160|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947808|NCT02891226|475097161|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947809|NCT02891226|475097162|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
131947810|NCT02891226|475097147|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947811|NCT02891226|475097148|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947812|NCT02891226|475097149|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947813|NCT02891226|475097150|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
131947814|NCT02891226|475097151|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947815|NCT02891226|475097152|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947816|NCT02891226|475097153|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947817|NCT02891226|475097154|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947818|NCT02891226|475097155|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947819|NCT02891226|475097156|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947820|NCT02891226|475097157|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947821|NCT02891226|475097158|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947822|NCT02891226|475097159|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947823|NCT02891226|475097160|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947824|NCT02891226|475097161|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947825|NCT02891226|475097162|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
131947826|NCT02891226|475097147|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947827|NCT02891226|475097148|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947828|NCT02891226|475097149|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
131947829|NCT02891226|475097150|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947830|NCT02891226|475097151|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947831|NCT02891226|475097152|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947832|NCT02891226|475097153|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947833|NCT02891226|475097154|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947834|NCT02891226|475097155|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947835|NCT02891226|475097156|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947836|NCT02891226|475097157|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947837|NCT02891226|475097158|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947838|NCT02891226|475097159|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947839|NCT02891226|475097160|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947840|NCT02891226|475097161|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947841|NCT02891226|475097162|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
131947842|NCT02891226|475097147|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947843|NCT02891226|475097148|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947844|NCT02891226|475097149|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947845|NCT02891226|475097150|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
131947846|NCT02891226|475097151|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947847|NCT02891226|475097152|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947848|NCT02891226|475097153|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131413951|NCT01100528|473140428|FG000|Overall Study|Withdrawal by Subject|2|||
131413952|NCT00413010|473140433|FG000|Overall Study|Adverse Event|8|||
131413953|NCT00413010|473140434|FG001|Overall Study|Adverse Event|4|||
131413954|NCT00413010|473140433|FG000|Overall Study|Laboratory abnormality|0|||
131413955|NCT00413010|473140434|FG001|Overall Study|Laboratory abnormality|2|||
131947849|NCT02891226|475097154|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131413956|NCT00413010|473140433|FG000|Overall Study|Lack of Efficacy|0|||
131947850|NCT02891226|475097155|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947851|NCT02891226|475097156|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131413957|NCT00413010|473140434|FG001|Overall Study|Lack of Efficacy|3|||
131456290|NCT01643772|473301100|FG000|Overall Study|Adverse Event|0|||
131947852|NCT02891226|475097157|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131413958|NCT00413010|473140433|FG000|Overall Study|Lost to Follow-up|3|||
131413959|NCT00413010|473140434|FG001|Overall Study|Lost to Follow-up|0|||
131456291|NCT01643772|473301101|FG001|Overall Study|Adverse Event|0|||
131456292|NCT01643772|473301102|FG002|Overall Study|Adverse Event|0|||
131456293|NCT01643772|473301103|FG003|Overall Study|Adverse Event|1|||
131456294|NCT02881567|473301108|FG000|Overall Study|Adverse Event|1|||
131456295|NCT02881567|473301108|FG000|Overall Study|Lost to Follow-up|3|||
131456296|NCT02881567|473301108|FG000|Overall Study|Consent withdrawn|1|||
131456297|NCT02881567|473301108|FG000|Overall Study|Investigator decision|1|||
131456298|NCT02881567|473301108|FG000|Overall Study|Study terminated by sponsor|9|||
131456299|NCT02881567|473301108|FG000|Overall Study|Reason not Specified|3|||
131456300|NCT01652469|473301111|FG000|Overall Study|Withdrawal by Subject|1|||
131947853|NCT02891226|475097158|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947854|NCT02891226|475097159|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947855|NCT02891226|475097160|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947856|NCT02891226|475097161|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947857|NCT02891226|475097162|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
131947858|NCT02891226|475097147|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947859|NCT02891226|475097148|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947860|NCT02891226|475097149|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947861|NCT02891226|475097150|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
131947862|NCT02891226|475097151|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947863|NCT02891226|475097152|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131413960|NCT00413010|473140433|FG000|Overall Study|Withdrawal by Subject|7|||
131413961|NCT00413010|473140434|FG001|Overall Study|Withdrawal by Subject|2|||
131413962|NCT00413010|473140433|FG000|Overall Study|Due to termination of the study|54|||
131413963|NCT00413010|473140434|FG001|Overall Study|Due to termination of the study|52|||
131413964|NCT01533922|473140436|FG000|Overall Study|Adverse Event|5|||
131413965|NCT01533922|473140437|FG001|Overall Study|Adverse Event|8|||
131413966|NCT01533922|473140438|FG002|Overall Study|Adverse Event|6|||
131413967|NCT01533922|473140439|FG003|Overall Study|Adverse Event|3|||
131413968|NCT01533922|473140440|FG004|Overall Study|Adverse Event|4|||
131413969|NCT01533922|473140436|FG000|Overall Study|Lack of Efficacy|0|||
131413970|NCT01533922|473140437|FG001|Overall Study|Lack of Efficacy|0|||
131413971|NCT01533922|473140438|FG002|Overall Study|Lack of Efficacy|1|||
131413972|NCT01533922|473140439|FG003|Overall Study|Lack of Efficacy|0|||
131413973|NCT01533922|473140440|FG004|Overall Study|Lack of Efficacy|0|||
131413974|NCT01533922|473140436|FG000|Overall Study|Protocol Violation|0|||
131413975|NCT01533922|473140437|FG001|Overall Study|Protocol Violation|3|||
131413976|NCT01533922|473140438|FG002|Overall Study|Protocol Violation|0|||
131456301|NCT01652469|473301112|FG001|Overall Study|Withdrawal by Subject|4|||
131456302|NCT01652469|473301111|FG000|Overall Study|Lost to Follow-up|0|||
131947864|NCT02891226|475097153|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947865|NCT02891226|475097154|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947866|NCT02891226|475097155|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947867|NCT02891226|475097156|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947868|NCT02891226|475097157|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947869|NCT02891226|475097158|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947870|NCT02891226|475097159|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947871|NCT02891226|475097160|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947872|NCT02891226|475097161|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947873|NCT02891226|475097162|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
131947874|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947875|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947876|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947877|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947878|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947879|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947880|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
131947881|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
131947882|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
131947883|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
131947884|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131413977|NCT01533922|473140439|FG003|Overall Study|Protocol Violation|0|||
131456303|NCT01652469|473301112|FG001|Overall Study|Lost to Follow-up|2|||
131413978|NCT01533922|473140440|FG004|Overall Study|Protocol Violation|1|||
131413979|NCT01533922|473140436|FG000|Overall Study|Withdrawal by Subject|3|||
131947885|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947886|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947887|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947888|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947889|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
131947890|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947891|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131413980|NCT01533922|473140437|FG001|Overall Study|Withdrawal by Subject|1|||
131456304|NCT01305577|473301114|FG000|Overall Study|Adverse Event|2|||
131947892|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131413981|NCT01533922|473140438|FG002|Overall Study|Withdrawal by Subject|2|||
131456305|NCT01305577|473301115|FG001|Overall Study|Adverse Event|2|||
131947893|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947894|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947895|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
131947896|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947897|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947898|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947899|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
131947900|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947901|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947902|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947903|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947904|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947905|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
131947906|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947907|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947908|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947909|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947910|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947911|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947912|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
131947913|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
131947914|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
131947915|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
131947916|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947917|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947918|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947919|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947920|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947921|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
131947922|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947923|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947924|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947925|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947926|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
131947927|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947928|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947929|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947930|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947931|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947932|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947933|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947934|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947935|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947936|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947937|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
131947938|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947939|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947940|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947941|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947942|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947943|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947944|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
131947945|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947946|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947947|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947948|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947949|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947950|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947951|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947952|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947953|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
131947954|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947955|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131413982|NCT01533922|473140439|FG003|Overall Study|Withdrawal by Subject|2|||
131947956|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947957|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947958|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947959|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947960|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947961|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
131947962|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
131947963|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
131947964|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947965|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947966|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947967|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947968|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947969|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
131947970|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947971|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947972|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947973|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947974|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947975|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947976|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947977|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
131947978|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947979|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947980|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947981|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947982|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947983|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947984|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947985|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
131947986|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947987|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947988|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947989|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947990|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947991|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947992|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947993|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947994|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
131947995|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947996|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947997|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947998|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131947999|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131948000|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131948001|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
131948002|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948003|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948004|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948005|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948006|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948007|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948008|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948009|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948010|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948011|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
131948012|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948013|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948014|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131456306|NCT01305577|473301116|FG002|Overall Study|Adverse Event|1|||
131456307|NCT01305577|473301114|FG000|Overall Study|Withdrawal by Subject|7|||
131456308|NCT01305577|473301115|FG001|Overall Study|Withdrawal by Subject|5|||
131456309|NCT01305577|473301116|FG002|Overall Study|Withdrawal by Subject|6|||
131948015|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948016|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948017|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
131948018|NCT02891226|475097147|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948019|NCT02891226|475097148|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948020|NCT02891226|475097149|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948021|NCT02891226|475097150|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948022|NCT02891226|475097151|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948023|NCT02891226|475097152|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948024|NCT02891226|475097153|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948025|NCT02891226|475097154|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948026|NCT02891226|475097155|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948027|NCT02891226|475097156|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
131948028|NCT02891226|475097157|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948029|NCT02891226|475097158|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948030|NCT02891226|475097159|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948031|NCT02891226|475097160|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948032|NCT02891226|475097161|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948033|NCT02891226|475097162|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
131948034|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948035|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948036|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948037|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948038|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948039|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948040|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948041|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948042|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948043|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948044|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
131948045|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948046|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948047|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948048|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948049|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
131948050|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948051|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948052|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948053|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948054|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948055|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948056|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948057|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948058|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948059|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948060|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
131948061|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948062|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948063|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948064|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948065|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
131948066|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948067|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948068|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948069|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948070|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948071|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948072|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948073|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948074|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948075|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948076|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
131948077|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948078|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948079|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948080|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948081|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
131948082|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131413983|NCT01533922|473140440|FG004|Overall Study|Withdrawal by Subject|1|||
131948083|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948084|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948085|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948086|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948087|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948088|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948089|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948090|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948091|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948092|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
131948093|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948094|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948095|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948096|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948097|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
131948098|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948099|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948100|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948101|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948102|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948103|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948104|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948105|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948106|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948107|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948108|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
131948109|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948110|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948111|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948112|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948113|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
131948114|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948115|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948116|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948117|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948118|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948119|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948120|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948121|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948122|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948123|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948124|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
131948125|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948126|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948127|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948128|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948129|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
131948130|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948131|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948132|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948133|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948134|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948135|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948136|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948137|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948138|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948139|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948140|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
131948141|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131456310|NCT01305577|473301114|FG000|Overall Study|Lost to Follow-up|4|||
131456311|NCT01305577|473301115|FG001|Overall Study|Lost to Follow-up|3|||
131948142|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948143|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948144|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948145|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
131948146|NCT02891226|475097147|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948147|NCT02891226|475097148|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948148|NCT02891226|475097149|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948149|NCT02891226|475097150|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948150|NCT02891226|475097151|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948151|NCT02891226|475097152|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948152|NCT02891226|475097153|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948153|NCT02891226|475097154|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948154|NCT02891226|475097155|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948155|NCT02891226|475097156|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948156|NCT02891226|475097157|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
131948157|NCT02891226|475097158|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948158|NCT02891226|475097159|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948159|NCT02891226|475097160|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948160|NCT02891226|475097161|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948161|NCT02891226|475097162|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
131948162|NCT02891226|475097147|FG000|Follow-up Period|Withdrawal by Subject|0|||
131948163|NCT02891226|475097148|FG001|Follow-up Period|Withdrawal by Subject|0|||
131948164|NCT02891226|475097149|FG002|Follow-up Period|Withdrawal by Subject|0|||
131948165|NCT02891226|475097150|FG003|Follow-up Period|Withdrawal by Subject|0|||
131948166|NCT02891226|475097151|FG004|Follow-up Period|Withdrawal by Subject|0|||
131948167|NCT02891226|475097152|FG005|Follow-up Period|Withdrawal by Subject|0|||
131948168|NCT02891226|475097153|FG006|Follow-up Period|Withdrawal by Subject|0|||
131948169|NCT02891226|475097154|FG007|Follow-up Period|Withdrawal by Subject|0|||
131948170|NCT02891226|475097155|FG008|Follow-up Period|Withdrawal by Subject|0|||
131948171|NCT02891226|475097156|FG009|Follow-up Period|Withdrawal by Subject|0|||
131948172|NCT02891226|475097157|FG010|Follow-up Period|Withdrawal by Subject|0|||
131948173|NCT02891226|475097158|FG011|Follow-up Period|Withdrawal by Subject|1|||
131948174|NCT02891226|475097159|FG012|Follow-up Period|Withdrawal by Subject|0|||
131948175|NCT02891226|475097160|FG013|Follow-up Period|Withdrawal by Subject|0|||
131948176|NCT02891226|475097161|FG014|Follow-up Period|Withdrawal by Subject|1|||
131948177|NCT02891226|475097162|FG015|Follow-up Period|Withdrawal by Subject|1|||
131948178|NCT01928433|475097163|FG000|Overall Study|Adverse Event|5|||
131948179|NCT01928433|475097164|FG001|Overall Study|Adverse Event|2|||
131948180|NCT01928433|475097165|FG002|Overall Study|Adverse Event|5|||
131948181|NCT01928433|475097163|FG000|Overall Study|Protocol Violation|0|||
131948182|NCT01928433|475097164|FG001|Overall Study|Protocol Violation|0|||
131948183|NCT01928433|475097165|FG002|Overall Study|Protocol Violation|2|||
131948184|NCT01928433|475097163|FG000|Overall Study|Lack of Efficacy|5|||
131948185|NCT01928433|475097164|FG001|Overall Study|Lack of Efficacy|4|||
131948186|NCT01928433|475097165|FG002|Overall Study|Lack of Efficacy|4|||
131948187|NCT01928433|475097163|FG000|Overall Study|Withdrawal by Subject|0|||
131948188|NCT01928433|475097164|FG001|Overall Study|Withdrawal by Subject|4|||
131948189|NCT01928433|475097165|FG002|Overall Study|Withdrawal by Subject|0|||
131948190|NCT01928433|475097163|FG000|Overall Study|Negative screening urine culture|7|||
131948191|NCT01928433|475097164|FG001|Overall Study|Negative screening urine culture|6|||
131948192|NCT01928433|475097165|FG002|Overall Study|Negative screening urine culture|10|||
131948193|NCT01928433|475097163|FG000|Overall Study|Lost to Follow-up|0|||
131948194|NCT01928433|475097164|FG001|Overall Study|Lost to Follow-up|2|||
131948195|NCT01928433|475097165|FG002|Overall Study|Lost to Follow-up|3|||
131948196|NCT01928433|475097163|FG000|Overall Study|Other reasons|3|||
131948197|NCT01928433|475097164|FG001|Overall Study|Other reasons|3|||
131948198|NCT01928433|475097165|FG002|Overall Study|Other reasons|4|||
131948199|NCT01392573|475097168|FG000|Overall Study|Adverse Event|1|||
131948200|NCT01392573|475097169|FG001|Overall Study|Adverse Event|3|||
131948201|NCT01392573|475097168|FG000|Overall Study|Lack of Efficacy|1|||
131948202|NCT01392573|475097169|FG001|Overall Study|Lack of Efficacy|2|||
131948203|NCT01392573|475097168|FG000|Overall Study|Protocol Violation|0|||
131948204|NCT01392573|475097169|FG001|Overall Study|Protocol Violation|2|||
131948205|NCT01392573|475097168|FG000|Overall Study|Withdrawal Criteria|13|||
131948206|NCT01392573|475097169|FG001|Overall Study|Withdrawal Criteria|15|||
131948207|NCT01392573|475097168|FG000|Overall Study|Site closure|8|||
131948208|NCT01392573|475097169|FG001|Overall Study|Site closure|7|||
131948209|NCT01392573|475097168|FG000|Overall Study|Unclassified|9|||
131948210|NCT01392573|475097169|FG001|Overall Study|Unclassified|6|||
131948211|NCT03381287|475097170|FG000|Overall Study|Withdrawal by Subject|0|||
131948212|NCT03381287|475097171|FG001|Overall Study|Withdrawal by Subject|1|||
131948213|NCT03381287|475097172|FG002|Overall Study|Withdrawal by Subject|0|||
131948214|NCT03381287|475097173|FG003|Overall Study|Withdrawal by Subject|0|||
131948215|NCT03381287|475097170|FG000|Overall Study|Adverse Event|0|||
131948216|NCT03381287|475097171|FG001|Overall Study|Adverse Event|0|||
131948217|NCT03381287|475097172|FG002|Overall Study|Adverse Event|0|||
131948218|NCT03381287|475097173|FG003|Overall Study|Adverse Event|1|||
131948219|NCT03381287|475097170|FG000|Overall Study|Physician Decision|0|||
131948220|NCT03381287|475097171|FG001|Overall Study|Physician Decision|0|||
131948221|NCT03381287|475097172|FG002|Overall Study|Physician Decision|0|||
131948222|NCT03381287|475097173|FG003|Overall Study|Physician Decision|1|||
131948223|NCT01265992|475097174|FG000|Overall Study|Lost to Follow-up|1|||
131948224|NCT01265992|475097174|FG000|Overall Study|Withdrawal by Subject|1|||
131948225|NCT01265992|475097174|FG000|Overall Study|Adverse Event|1|||
131948226|NCT01265992|475097174|FG000|Overall Study|Administrative reasons|2|||
131948227|NCT01265992|475097174|FG000|Overall Study|Stopped treatment|3|||
131948228|NCT01265992|475097174|FG000|Overall Study|Did not receive treatment|1|||
131948229|NCT03533660|475097175|FG000|Overall Study|Withdrawal by Subject|2|||
131948230|NCT03533660|475097176|FG001|Overall Study|Withdrawal by Subject|2|||
131948231|NCT03533660|475097175|FG000|Overall Study|Death|2|||
131948232|NCT03533660|475097176|FG001|Overall Study|Death|4|||
131948233|NCT03533660|475097175|FG000|Overall Study|Adverse Event|0|||
131948234|NCT03533660|475097176|FG001|Overall Study|Adverse Event|2|||
131948235|NCT03145064|475098862|FG000|Overall Study|Death|24|||
131948236|NCT03145064|475098862|FG000|Overall Study|Lost to Follow-up|3|||
131948237|NCT03145064|475098862|FG000|Overall Study|Withdrawal by Subject|6|||
131948238|NCT03145064|475098862|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
131948239|NCT03145064|475098862|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
131948240|NCT01693250|475098863|FG000|Overall Study|Lost to Follow-up|2|||
131948241|NCT01693250|475098864|FG001|Overall Study|Lost to Follow-up|2|||
131948242|NCT02257242|475098867|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
131948243|NCT02257242|475098868|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948244|NCT02257242|475098869|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948245|NCT02257242|475098870|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948246|NCT02257242|475098871|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948247|NCT02257242|475098872|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948248|NCT02257242|475098873|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948249|NCT02257242|475098874|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948250|NCT02257242|475098875|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
131948251|NCT00620373|475098876|FG000|Overall Study|Unverified cancer status|33|||
131948252|NCT04245449|475098877|FG000|Overall Study|COVID shutdown|7|||
131948253|NCT03073525|475098878|FG000|Overall Study|Withdrawal by Subject|0|||
131948254|NCT03073525|475098879|FG001|Overall Study|Withdrawal by Subject|0|||
131948255|NCT03073525|475098880|FG002|Overall Study|Withdrawal by Subject|3|||
131948256|NCT01273038|475098881|FG000|Second Intervention (14 Days)|Adverse Event|0|||
131948257|NCT01273038|475098882|FG001|Second Intervention (14 Days)|Adverse Event|1|||
131948258|NCT01273038|475098881|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
131948259|NCT01273038|475098882|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
131948260|NCT02197572|475098885|FG000|Overall Study|Progressive Disease|28|||
131948261|NCT02197572|475098885|FG000|Overall Study|Withdrawal by Subject|9|||
131948262|NCT02197572|475098885|FG000|Overall Study|Adverse Event|3|||
131948263|NCT02197572|475098885|FG000|Overall Study|Reason Not Specified|4|||
131948264|NCT01408277|475098889|FG000|Overall Study|Adverse Event|3|||
131948265|NCT01408277|475098890|FG001|Overall Study|Adverse Event|4|||
131948266|NCT01408277|475098889|FG000|Overall Study|Lost to Follow-up|1|||
131948267|NCT01408277|475098890|FG001|Overall Study|Lost to Follow-up|0|||
131948268|NCT01408277|475098889|FG000|Overall Study|Withdrawal by Subject|2|||
131948269|NCT01408277|475098890|FG001|Overall Study|Withdrawal by Subject|0|||
131948270|NCT01408277|475098889|FG000|Overall Study|Protocol Violation|2|||
131456312|NCT01305577|473301116|FG002|Overall Study|Lost to Follow-up|2|||
131456313|NCT01305577|473301114|FG000|Overall Study|Protocol Deviation|0|||
131456314|NCT01305577|473301115|FG001|Overall Study|Protocol Deviation|1|||
131456315|NCT01305577|473301116|FG002|Overall Study|Protocol Deviation|1|||
131456316|NCT00905645|473301117|FG000|Overall Study|Death (not device related)|10|||
131456317|NCT00905645|473301118|FG001|Overall Study|Death (not device related)|4|||
131948271|NCT01408277|475098890|FG001|Overall Study|Protocol Violation|0|||
131948272|NCT01349673|475098891|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
131948273|NCT01349673|475098891|FG000|Overall Study|No Longer Qualified For Study|1|||
131948274|NCT01349673|475098891|FG000|Overall Study|Site Closure|10|||
131948275|NCT01349673|475098891|FG000|Overall Study|Withdrawal by Subject|21|||
131456318|NCT00905645|473301119|FG002|Overall Study|Death (not device related)|15|||
131948276|NCT01349673|475098891|FG000|Overall Study|Lost to Follow-up|6|||
131413984|NCT01533922|473140436|FG000|Overall Study|Other reason not defined above|2|||
131413985|NCT01533922|473140437|FG001|Overall Study|Other reason not defined above|0|||
131413986|NCT01533922|473140438|FG002|Overall Study|Other reason not defined above|1|||
131413987|NCT01533922|473140439|FG003|Overall Study|Other reason not defined above|0|||
131413988|NCT01533922|473140440|FG004|Overall Study|Other reason not defined above|0|||
131413989|NCT02634606|473140443|FG000|Overall Study|unable to obtain the drug at start|13|||
131413990|NCT01267175|473140444|FG000|Overall Study|Withdrawal by Subject|1|||
131413991|NCT01267175|473140444|FG000|Overall Study|Lost to Follow-up|1|||
131413992|NCT00895661|473140446|FG000|Overall Study|Death|1|||
131413993|NCT00895661|473140446|FG000|Overall Study|reason unknown|2|||
131413994|NCT02006069|473140447|FG000|Overall Study|MPP other programming|239|||
131413995|NCT02006069|473140448|FG001|Overall Study|MPP other programming|0|||
131413996|NCT02006069|473140447|FG000|Overall Study|RV only pacing|0|||
131413997|NCT02006069|473140448|FG001|Overall Study|RV only pacing|3|||
131413998|NCT02066129|473140449|FG000|Overall Study|Lost to Follow-up|13|||
131413999|NCT02066129|473140450|FG001|Overall Study|Lost to Follow-up|12|||
131414000|NCT02066129|473140449|FG000|Overall Study|Withdrawal by Subject|7|||
131414001|NCT02066129|473140450|FG001|Overall Study|Withdrawal by Subject|10|||
131414002|NCT02066129|473140449|FG000|Overall Study|Lack of Efficacy|8|||
131414003|NCT02066129|473140450|FG001|Overall Study|Lack of Efficacy|10|||
131414004|NCT02066129|473140449|FG000|Overall Study|Physician Decision|1|||
131414005|NCT02066129|473140450|FG001|Overall Study|Physician Decision|1|||
131414006|NCT00357656|473140451|FG000|Overall Study|Other, No surgery performed|0|||
131414007|NCT00357656|473140452|FG001|Overall Study|Other, No surgery performed|3|||
131414008|NCT02573246|473140453|FG000|Overall Study|Lost to Follow-up|2|||
131414009|NCT02573246|473140454|FG001|Overall Study|Lost to Follow-up|0|||
131414010|NCT02573246|473140455|FG002|Overall Study|Lost to Follow-up|0|||
131414011|NCT02573246|473140456|FG003|Overall Study|Lost to Follow-up|0|||
131414012|NCT02573246|473140457|FG004|Overall Study|Lost to Follow-up|1|||
131948277|NCT01349673|475098891|FG000|Overall Study|Adverse Event|17|||
131948278|NCT01349673|475098891|FG000|Overall Study|Study Terminated By Sponsor|50|||
131948279|NCT01349673|475098891|FG000|Overall Study|Lack of Efficacy|8|||
131948280|NCT03801928|475098892|FG000|Overall Study|Adverse Event|1|||
131948281|NCT03801928|475098893|FG001|Overall Study|Adverse Event|0|||
131948282|NCT03801928|475098894|FG002|Overall Study|Adverse Event|1|||
131948283|NCT03801928|475098895|FG003|Overall Study|Adverse Event|2|||
131948284|NCT03801928|475098896|FG004|Overall Study|Adverse Event|0|||
131948285|NCT03801928|475098897|FG005|Overall Study|Adverse Event|2|||
131948286|NCT03801928|475098892|FG000|Overall Study|Lack of Efficacy|0|||
131948287|NCT03801928|475098893|FG001|Overall Study|Lack of Efficacy|0|||
131948288|NCT03801928|475098894|FG002|Overall Study|Lack of Efficacy|1|||
131948289|NCT03801928|475098895|FG003|Overall Study|Lack of Efficacy|0|||
131948290|NCT03801928|475098896|FG004|Overall Study|Lack of Efficacy|0|||
131948291|NCT03801928|475098897|FG005|Overall Study|Lack of Efficacy|0|||
131948292|NCT03801928|475098892|FG000|Overall Study|Lost to Follow-up|5|||
131948293|NCT03801928|475098893|FG001|Overall Study|Lost to Follow-up|1|||
131948294|NCT03801928|475098894|FG002|Overall Study|Lost to Follow-up|1|||
131948295|NCT03801928|475098895|FG003|Overall Study|Lost to Follow-up|4|||
131948296|NCT03801928|475098896|FG004|Overall Study|Lost to Follow-up|4|||
131948297|NCT03801928|475098897|FG005|Overall Study|Lost to Follow-up|2|||
131948298|NCT03801928|475098892|FG000|Overall Study|Withdrawal by Subject|0|||
131948299|NCT03801928|475098893|FG001|Overall Study|Withdrawal by Subject|0|||
131948300|NCT03801928|475098894|FG002|Overall Study|Withdrawal by Subject|2|||
131948301|NCT03801928|475098895|FG003|Overall Study|Withdrawal by Subject|1|||
131948302|NCT03801928|475098896|FG004|Overall Study|Withdrawal by Subject|0|||
131948303|NCT03801928|475098897|FG005|Overall Study|Withdrawal by Subject|0|||
131948304|NCT03801928|475098892|FG000|Overall Study|Other|0|||
131948305|NCT03801928|475098893|FG001|Overall Study|Other|2|||
131948306|NCT03801928|475098894|FG002|Overall Study|Other|0|||
131948307|NCT03801928|475098895|FG003|Overall Study|Other|1|||
131948308|NCT03801928|475098896|FG004|Overall Study|Other|0|||
131948309|NCT03801928|475098897|FG005|Overall Study|Other|1|||
131948310|NCT00175916|475098898|FG000|Overall Study|Death|19|||
131948311|NCT00175916|475098898|FG000|Overall Study|Adverse Event|81|||
131948312|NCT00175916|475098898|FG000|Overall Study|Lack of Efficacy|354|||
131948313|NCT00175916|475098898|FG000|Overall Study|Lost to Follow-up|17|||
131948314|NCT00175916|475098898|FG000|Overall Study|Subject Choice|98|||
131948315|NCT00175916|475098898|FG000|Overall Study|Lack of compliance|8|||
131948316|NCT00175916|475098898|FG000|Overall Study|Patient cannot record seizures|1|||
131948317|NCT00175916|475098898|FG000|Overall Study|Sponsor decision|17|||
131948318|NCT00175916|475098898|FG000|Overall Study|Vigabatrin intake|1|||
131948319|NCT00175916|475098898|FG000|Overall Study|Suicidal behaviour|1|||
131948320|NCT00175916|475098898|FG000|Overall Study|Withdrawal by Subject|1|||
131948321|NCT00175916|475098898|FG000|Overall Study|Seizure - free|4|||
131948322|NCT00175916|475098898|FG000|Overall Study|Administrative reason|1|||
131948323|NCT00175916|475098898|FG000|Overall Study|Pregnancy|1|||
131948324|NCT00175916|475098898|FG000|Overall Study|Patient's request|2|||
131948325|NCT00175916|475098898|FG000|Overall Study|Treating physiciant's choice|1|||
131948326|NCT00175916|475098898|FG000|Overall Study|Moved overseas|1|||
131948327|NCT00175916|475098898|FG000|Overall Study|Loss of job and economic burden|1|||
131948328|NCT00175916|475098898|FG000|Overall Study|Site was closed|9|||
131948329|NCT00175916|475098898|FG000|Overall Study|Patient went to prison|1|||
131948330|NCT00564733|475098899|FG000|Overall Study|Withdrawal by Subject|4|||
131948331|NCT00564733|475098899|FG000|Overall Study|Ineligible|5|||
131948332|NCT01014767|475098900|FG000|Overall Study|PI left institution, data unavailable|12|||
131948333|NCT01014767|475098901|FG001|Overall Study|PI left institution, data unavailable|1|||
131948334|NCT01014767|475098902|FG002|Overall Study|PI left institution, data unavailable|4|||
131948335|NCT01014767|475098903|FG003|Overall Study|PI left institution, data unavailable|1|||
131948336|NCT01484496|475098904|FG000|Period 1|Protocol Violation|3|||
131948337|NCT01484496|475098905|FG001|Period 1|Protocol Violation|4|||
131948338|NCT01484496|475098906|FG002|Period 1|Protocol Violation|0|||
131948339|NCT01484496|475098907|FG003|Period 1|Protocol Violation|0|||
131948340|NCT01484496|475098904|FG000|Period 1|Physician Decision|5|||
131948341|NCT01484496|475098905|FG001|Period 1|Physician Decision|1|||
131948342|NCT01484496|475098906|FG002|Period 1|Physician Decision|0|||
131948343|NCT01484496|475098907|FG003|Period 1|Physician Decision|0|||
131948344|NCT01484496|475098904|FG000|Period 1|Lack of Efficacy|10|||
131948345|NCT01484496|475098905|FG001|Period 1|Lack of Efficacy|15|||
131948346|NCT01484496|475098906|FG002|Period 1|Lack of Efficacy|0|||
131948347|NCT01484496|475098907|FG003|Period 1|Lack of Efficacy|0|||
131948348|NCT01484496|475098904|FG000|Period 1|Adverse Event|25|||
131948349|NCT01484496|475098905|FG001|Period 1|Adverse Event|40|||
131948350|NCT01484496|475098906|FG002|Period 1|Adverse Event|0|||
131948351|NCT01484496|475098907|FG003|Period 1|Adverse Event|0|||
131948352|NCT01484496|475098904|FG000|Period 1|Withdrawal by Subject|15|||
131948353|NCT01484496|475098905|FG001|Period 1|Withdrawal by Subject|12|||
131948354|NCT01484496|475098906|FG002|Period 1|Withdrawal by Subject|0|||
131948355|NCT01484496|475098907|FG003|Period 1|Withdrawal by Subject|0|||
131948356|NCT01484496|475098904|FG000|Period 1|Lost to Follow-up|2|||
131948357|NCT01484496|475098905|FG001|Period 1|Lost to Follow-up|6|||
131948358|NCT01484496|475098906|FG002|Period 1|Lost to Follow-up|0|||
131948359|NCT01484496|475098907|FG003|Period 1|Lost to Follow-up|0|||
131948360|NCT01484496|475098904|FG000|Period 1|Positive Pregnancy|1|||
131948361|NCT01484496|475098905|FG001|Period 1|Positive Pregnancy|6|||
131948362|NCT01484496|475098906|FG002|Period 1|Positive Pregnancy|0|||
131948363|NCT01484496|475098907|FG003|Period 1|Positive Pregnancy|0|||
131948364|NCT01484496|475098904|FG000|Period 1|Treatment Failure|3|||
131948365|NCT01484496|475098905|FG001|Period 1|Treatment Failure|6|||
131948366|NCT01484496|475098906|FG002|Period 1|Treatment Failure|0|||
131948367|NCT01484496|475098907|FG003|Period 1|Treatment Failure|0|||
131948368|NCT01484496|475098904|FG000|Period 1|Lack of Compliance|2|||
131948369|NCT01484496|475098905|FG001|Period 1|Lack of Compliance|1|||
131948370|NCT01484496|475098906|FG002|Period 1|Lack of Compliance|0|||
131948371|NCT01484496|475098907|FG003|Period 1|Lack of Compliance|0|||
131948372|NCT01484496|475098904|FG000|Period 1|Unable to Visit Site|0|||
131948373|NCT01484496|475098905|FG001|Period 1|Unable to Visit Site|2|||
131948374|NCT01484496|475098906|FG002|Period 1|Unable to Visit Site|0|||
131948375|NCT01484496|475098907|FG003|Period 1|Unable to Visit Site|0|||
131948376|NCT01484496|475098904|FG000|Period 2|Lack of Efficacy|0|||
131948377|NCT01484496|475098905|FG001|Period 2|Lack of Efficacy|0|||
131948378|NCT01484496|475098906|FG002|Period 2|Lack of Efficacy|1|||
131948379|NCT01484496|475098907|FG003|Period 2|Lack of Efficacy|3|||
131948380|NCT01484496|475098904|FG000|Period 2|Adverse Event|0|||
131948381|NCT01484496|475098905|FG001|Period 2|Adverse Event|0|||
131948382|NCT01484496|475098906|FG002|Period 2|Adverse Event|5|||
131948383|NCT01484496|475098907|FG003|Period 2|Adverse Event|13|||
131948384|NCT01484496|475098904|FG000|Period 2|Other|0|||
131948385|NCT01484496|475098905|FG001|Period 2|Other|0|||
131948386|NCT01484496|475098906|FG002|Period 2|Other|9|||
131948387|NCT01484496|475098907|FG003|Period 2|Other|6|||
131948388|NCT01645735|475098908|FG000|Overall Study|Physician Decision|2|||
131948389|NCT01645735|475098909|FG001|Overall Study|Physician Decision|0|||
131948390|NCT01645735|475098908|FG000|Overall Study|Withdrawal by Subject|1|||
131948391|NCT01645735|475098909|FG001|Overall Study|Withdrawal by Subject|0|||
131948392|NCT01645735|475098908|FG000|Overall Study|Protocol Violation|1|||
131948393|NCT01645735|475098909|FG001|Overall Study|Protocol Violation|0|||
131948394|NCT01645735|475098908|FG000|Overall Study|Adverse Event|0|||
131948395|NCT01645735|475098909|FG001|Overall Study|Adverse Event|1|||
131948396|NCT04263766|475098912|FG000|Overall Study|Withdrawal by Subject|6|||
131948397|NCT04263766|475098913|FG001|Overall Study|Withdrawal by Subject|4|||
131948398|NCT04263766|475098912|FG000|Overall Study|Lack of Efficacy|1|||
131948399|NCT04263766|475098913|FG001|Overall Study|Lack of Efficacy|3|||
131948400|NCT01891396|475098915|FG000|Overall Study|Withdrawal by Subject|4|||
131948401|NCT01891396|475098916|FG001|Overall Study|Withdrawal by Subject|4|||
131948402|NCT01891396|475098917|FG002|Overall Study|Withdrawal by Subject|3|||
131948403|NCT01891396|475098915|FG000|Overall Study|Lost to Follow-up|0|||
131948404|NCT01891396|475098916|FG001|Overall Study|Lost to Follow-up|1|||
131948405|NCT01891396|475098917|FG002|Overall Study|Lost to Follow-up|0|||
131948406|NCT00540592|475098918|FG000|Overall Study|Adverse Event|0|||
131948407|NCT00540592|475098919|FG001|Overall Study|Adverse Event|1|||
131948408|NCT00540592|475098920|FG002|Overall Study|Adverse Event|0|||
131948409|NCT00540592|475098921|FG003|Overall Study|Adverse Event|0|||
131948410|NCT00540592|475098922|FG004|Overall Study|Adverse Event|1|||
131948411|NCT00540592|475098923|FG005|Overall Study|Adverse Event|0|||
131948412|NCT00540592|475098924|FG006|Overall Study|Adverse Event|0|||
131948413|NCT00540592|475098925|FG007|Overall Study|Adverse Event|1|||
131768875|NCT02041533|474431889|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
131768876|NCT02041533|474431890|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
131768877|NCT02041533|474431889|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
131768878|NCT02041533|474431890|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
131768879|NCT02041533|474431889|FG000|Treatment Period|Participant withdrew consent|2|||
131768880|NCT02041533|474431890|FG001|Treatment Period|Participant withdrew consent|2|||
131768881|NCT02041533|474431889|FG000|Treatment Period|Maximum clinical benefit|0|||
131768882|NCT02041533|474431890|FG001|Treatment Period|Maximum clinical benefit|18|||
131768883|NCT02041533|474431889|FG000|Treatment Period|Poor/Non-compliance|1|||
131768884|NCT02041533|474431890|FG001|Treatment Period|Poor/Non-compliance|0|||
131768885|NCT02041533|474431889|FG000|Treatment Period|Administrative reason by sponsor|1|||
131768886|NCT02041533|474431890|FG001|Treatment Period|Administrative reason by sponsor|0|||
131768887|NCT02041533|474431889|FG000|Treatment Period|Other reasons|9|||
131768888|NCT02041533|474431890|FG001|Treatment Period|Other reasons|2|||
131768889|NCT02041533|474431889|FG000|Treatment Period|Not Reported|0|||
131768890|NCT02041533|474431890|FG001|Treatment Period|Not Reported|1|||
131768891|NCT00565721|474431893|FG000|Overall Study|Screen Failure|2|||
131948414|NCT00540592|475098926|FG008|Overall Study|Adverse Event|1|||
131948415|NCT00540592|475098927|FG009|Overall Study|Adverse Event|2|||
131948416|NCT00540592|475098918|FG000|Overall Study|Lost to Follow-up|2|||
131948417|NCT00540592|475098919|FG001|Overall Study|Lost to Follow-up|0|||
131948418|NCT00540592|475098920|FG002|Overall Study|Lost to Follow-up|0|||
131948419|NCT00540592|475098921|FG003|Overall Study|Lost to Follow-up|0|||
131948420|NCT00540592|475098922|FG004|Overall Study|Lost to Follow-up|0|||
131948421|NCT00540592|475098923|FG005|Overall Study|Lost to Follow-up|0|||
131948422|NCT00540592|475098924|FG006|Overall Study|Lost to Follow-up|0|||
131948423|NCT00540592|475098925|FG007|Overall Study|Lost to Follow-up|0|||
131948424|NCT00540592|475098926|FG008|Overall Study|Lost to Follow-up|0|||
131948425|NCT00540592|475098927|FG009|Overall Study|Lost to Follow-up|0|||
131948426|NCT00540592|475098918|FG000|Overall Study|Withdrawal by Subject|0|||
131948427|NCT00540592|475098919|FG001|Overall Study|Withdrawal by Subject|0|||
131948428|NCT00540592|475098920|FG002|Overall Study|Withdrawal by Subject|1|||
131948429|NCT00540592|475098921|FG003|Overall Study|Withdrawal by Subject|1|||
131948430|NCT00540592|475098922|FG004|Overall Study|Withdrawal by Subject|0|||
131948431|NCT00540592|475098923|FG005|Overall Study|Withdrawal by Subject|0|||
131948432|NCT00540592|475098924|FG006|Overall Study|Withdrawal by Subject|0|||
131948433|NCT00540592|475098925|FG007|Overall Study|Withdrawal by Subject|0|||
131948434|NCT00540592|475098926|FG008|Overall Study|Withdrawal by Subject|0|||
131948435|NCT00540592|475098927|FG009|Overall Study|Withdrawal by Subject|0|||
131948436|NCT00573391|475098928|FG000|Overall Study|study stopped|2|||
131948437|NCT00573391|475098929|FG001|Overall Study|study stopped|2|||
131948438|NCT00573391|475098928|FG000|Overall Study|Death|1|||
131948439|NCT00573391|475098929|FG001|Overall Study|Death|0|||
131948440|NCT01206140|475098933|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
131948441|NCT01206140|475098934|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
131948442|NCT02688192|475098935|FG000|Overall Study|Lost to Follow-up|11|||
131948443|NCT02688192|475098936|FG001|Overall Study|Lost to Follow-up|5|||
131948444|NCT02688192|475098935|FG000|Overall Study|Physician Decision|1|||
131948445|NCT02688192|475098936|FG001|Overall Study|Physician Decision|0|||
131948446|NCT00075764|475098937|FG000|Overall Study|Adverse Event|5|||
131948447|NCT00075764|475098938|FG001|Overall Study|Adverse Event|12|||
131948448|NCT00075764|475098937|FG000|Overall Study|Death|4|||
131948449|NCT00075764|475098938|FG001|Overall Study|Death|8|||
131948450|NCT00075764|475098937|FG000|Overall Study|Withdrawal by Subject|28|||
131948451|NCT00075764|475098938|FG001|Overall Study|Withdrawal by Subject|18|||
131948452|NCT00075764|475098937|FG000|Overall Study|Progression|269|||
131948453|NCT00075764|475098938|FG001|Overall Study|Progression|274|||
131948454|NCT00075764|475098937|FG000|Overall Study|Still on treatment|8|||
131948455|NCT00075764|475098938|FG001|Overall Study|Still on treatment|15|||
131948456|NCT00075764|475098937|FG000|Overall Study|Delinquent|4|||
131948457|NCT00075764|475098938|FG001|Overall Study|Delinquent|2|||
131948458|NCT00075764|475098937|FG000|Overall Study|Not protocol specified|27|||
131948459|NCT00075764|475098938|FG001|Overall Study|Not protocol specified|19|||
131948460|NCT00075764|475098937|FG000|Overall Study|Under review|0|||
131948461|NCT00075764|475098938|FG001|Overall Study|Under review|1|||
131414013|NCT02573246|473140453|FG000|Overall Study|Withdrawal by Subject|0|||
131948462|NCT02817594|475098939|FG000|Overall Study|Withdrawal by Subject|1|||
131948463|NCT02817594|475098939|FG000|Overall Study|Other|1|||
131948464|NCT02817594|475098939|FG000|Overall Study|Did Not Receive Treatment|1|||
131948465|NCT02010593|475098940|FG000|Overall Study|Lost to Follow-up|1|||
131948466|NCT02010593|475098941|FG001|Overall Study|Lost to Follow-up|0|||
131948467|NCT02010593|475098940|FG000|Overall Study|Physician Decision|1|||
131948468|NCT02010593|475098941|FG001|Overall Study|Physician Decision|0|||
131948469|NCT02010593|475098940|FG000|Overall Study|Unable to adhere to visit schedule|0|||
131948470|NCT02010593|475098941|FG001|Overall Study|Unable to adhere to visit schedule|2|||
131948471|NCT01773967|475098942|FG000|Overall Study|Lost to Follow-up|15|||
131948472|NCT01773967|475098943|FG001|Overall Study|Lost to Follow-up|13|||
131948473|NCT01135459|475098944|FG000|Overall Study|Adverse Event|8|||
131948474|NCT01135459|475098945|FG001|Overall Study|Adverse Event|10|||
131948475|NCT01135459|475098944|FG000|Overall Study|Lack of Efficacy|3|||
131948476|NCT01135459|475098945|FG001|Overall Study|Lack of Efficacy|1|||
131948477|NCT01135459|475098944|FG000|Overall Study|Withdrawal by Subject|2|||
131948478|NCT01135459|475098945|FG001|Overall Study|Withdrawal by Subject|3|||
131948479|NCT01135459|475098944|FG000|Overall Study|Protocol Violation|5|||
131948480|NCT01135459|475098945|FG001|Overall Study|Protocol Violation|3|||
131948481|NCT01135459|475098944|FG000|Overall Study|Lost to Follow-up|2|||
131948482|NCT01135459|475098945|FG001|Overall Study|Lost to Follow-up|1|||
131948483|NCT01135459|475098944|FG000|Overall Study|Non-compliance to study procedures|0|||
131948484|NCT01135459|475098945|FG001|Overall Study|Non-compliance to study procedures|1|||
131948485|NCT01135459|475098944|FG000|Overall Study|Other than specified|1|||
131948486|NCT01135459|475098945|FG001|Overall Study|Other than specified|1|||
131948487|NCT01766037|475098946|FG000|Overall Study|Adverse Event|1|||
131948488|NCT01766037|475098947|FG001|Overall Study|Adverse Event|0|||
131414014|NCT02573246|473140454|FG001|Overall Study|Withdrawal by Subject|0|||
131414015|NCT02573246|473140455|FG002|Overall Study|Withdrawal by Subject|0|||
131414016|NCT02573246|473140456|FG003|Overall Study|Withdrawal by Subject|0|||
131414017|NCT02573246|473140457|FG004|Overall Study|Withdrawal by Subject|1|||
131414018|NCT02573246|473140453|FG000|Overall Study|Physician Decision|1|||
131414019|NCT02573246|473140454|FG001|Overall Study|Physician Decision|1|||
131414020|NCT02573246|473140455|FG002|Overall Study|Physician Decision|3|||
131414021|NCT02573246|473140456|FG003|Overall Study|Physician Decision|2|||
131414022|NCT02573246|473140457|FG004|Overall Study|Physician Decision|2|||
131414023|NCT01219933|473140458|FG000|Overall Study|Adverse Event|8|||
131414024|NCT01219933|473140458|FG000|Overall Study|No LDA reached|5|||
131414025|NCT01219933|473140458|FG000|Overall Study|No LDA maintained|7|||
131414026|NCT01219933|473140458|FG000|Overall Study|Lost to Follow-up|3|||
131414027|NCT01219933|473140458|FG000|Overall Study|GC free|1|||
131414028|NCT01219933|473140458|FG000|Overall Study|Withdrawal by Subject|5|||
131414029|NCT01219933|473140458|FG000|Overall Study|Protocol Violation|8|||
131414030|NCT01219933|473140458|FG000|Overall Study|Lack of Efficacy|1|||
131414031|NCT00316888|473140462|FG000|Overall Study|Adverse Event|4|||
131414032|NCT00316888|473140463|FG001|Overall Study|Adverse Event|5|||
131414033|NCT00316888|473140462|FG000|Overall Study|Withdrawal by Subject|2|||
131414034|NCT00316888|473140463|FG001|Overall Study|Withdrawal by Subject|2|||
131414035|NCT00316888|473140462|FG000|Overall Study|Not start protocol therapy|0|||
131414036|NCT00316888|473140463|FG001|Overall Study|Not start protocol therapy|1|||
131414037|NCT00857948|473140464|FG000|Overall Study|Withdrawal by Subject|2|||
131414038|NCT00857948|473140465|FG001|Overall Study|Withdrawal by Subject|0|||
131414039|NCT00857948|473140466|FG002|Overall Study|Withdrawal by Subject|0|||
131414040|NCT00857948|473140467|FG003|Overall Study|Withdrawal by Subject|0|||
131414041|NCT00857948|473140464|FG000|Overall Study|Protocol Violation|1|||
131414042|NCT00857948|473140465|FG001|Overall Study|Protocol Violation|0|||
131414043|NCT00857948|473140466|FG002|Overall Study|Protocol Violation|1|||
131414044|NCT00857948|473140467|FG003|Overall Study|Protocol Violation|0|||
131414045|NCT00815191|473140469|FG000|Overall Study|Protocol Violation|1|||
131414046|NCT00815191|473140470|FG001|Overall Study|Protocol Violation|1|||
131414047|NCT01814670|473140473|FG000|Overall Study|Protocol Violation|12|||
131414048|NCT03443427|473140474|FG000|Overall Study|Adverse Event|2|||
131414049|NCT03443427|473140475|FG001|Overall Study|Adverse Event|3|||
131414050|NCT03443427|473140474|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
131414051|NCT03443427|473140475|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
131414052|NCT03443427|473140474|FG000|Overall Study|Other|4|||
131414053|NCT03443427|473140475|FG001|Overall Study|Other|6|||
131414054|NCT02576860|473140476|FG000|Overall Study|Adverse Event|6|||
131414055|NCT02576860|473140477|FG001|Overall Study|Adverse Event|6|||
131414056|NCT02576860|473140476|FG000|Overall Study|Lost to Follow-up|5|||
131948489|NCT01766037|475098946|FG000|Overall Study|Lack of Efficacy|1|||
131948490|NCT01766037|475098947|FG001|Overall Study|Lack of Efficacy|0|||
131948491|NCT01766037|475098946|FG000|Overall Study|Lost to Follow-up|0|||
131948492|NCT01766037|475098947|FG001|Overall Study|Lost to Follow-up|10|||
131948493|NCT01766037|475098946|FG000|Overall Study|Physician Decision|0|||
131414057|NCT02576860|473140477|FG001|Overall Study|Lost to Follow-up|7|||
131948494|NCT01766037|475098947|FG001|Overall Study|Physician Decision|1|||
131948495|NCT01766037|475098946|FG000|Overall Study|Withdrawal by Subject|18|||
131948496|NCT01766037|475098947|FG001|Overall Study|Withdrawal by Subject|16|||
131948497|NCT01766037|475098946|FG000|Overall Study|Moved from area|5|||
131414058|NCT02576860|473140476|FG000|Overall Study|Physician Decision|0|||
131414059|NCT02576860|473140477|FG001|Overall Study|Physician Decision|1|||
131414060|NCT02576860|473140476|FG000|Overall Study|Protocol Violation|0|||
131948498|NCT01766037|475098947|FG001|Overall Study|Moved from area|0|||
131948499|NCT01766037|475098946|FG000|Overall Study|medical - unrelated|1|||
131948500|NCT01766037|475098947|FG001|Overall Study|medical - unrelated|2|||
131948501|NCT01766037|475098946|FG000|Overall Study|nausea / discomfort|3|||
131948502|NCT01766037|475098947|FG001|Overall Study|nausea / discomfort|0|||
131948503|NCT01144416|475098953|FG000|Intervention Period|Adverse Event|5|||
131948504|NCT01144416|475098954|FG001|Intervention Period|Adverse Event|6|||
131948505|NCT01144416|475098953|FG000|Intervention Period|Insufficient ovarian response|11|||
131948506|NCT01144416|475098954|FG001|Intervention Period|Insufficient ovarian response|17|||
131948507|NCT01144416|475098953|FG000|Intervention Period|Risk of OHSS|0|||
131948508|NCT01144416|475098954|FG001|Intervention Period|Risk of OHSS|1|||
131948509|NCT01144416|475098953|FG000|Intervention Period|Too high ovarian response|4|||
131948510|NCT01144416|475098954|FG001|Intervention Period|Too high ovarian response|2|||
131948511|NCT01144416|475098953|FG000|Intervention Period|No/too few/bad oocytes|7|||
131948512|NCT01144416|475098954|FG001|Intervention Period|No/too few/bad oocytes|5|||
131948513|NCT01144416|475098953|FG000|Intervention Period|No or abnormal fertilization|25|||
131948514|NCT01144416|475098954|FG001|Intervention Period|No or abnormal fertilization|10|||
131948515|NCT01144416|475098953|FG000|Intervention Period|No/too few/bad quality embryos|3|||
131948516|NCT01144416|475098954|FG001|Intervention Period|No/too few/bad quality embryos|3|||
131948517|NCT01144416|475098953|FG000|Intervention Period|Other|7|||
131948518|NCT01144416|475098954|FG001|Intervention Period|Other|5|||
131948519|NCT00124072|475098955|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
131948520|NCT00124072|475098956|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
131948521|NCT00124072|475098957|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
131948522|NCT00124072|475098958|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
131948523|NCT00124072|475098955|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
131948524|NCT00124072|475098956|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
131948525|NCT00124072|475098957|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
131948526|NCT00124072|475098958|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
131948527|NCT00124072|475098955|FG000|Overall Study|Death|499|||
131948528|NCT00124072|475098956|FG001|Overall Study|Death|484|||
131948529|NCT00124072|475098957|FG002|Overall Study|Death|471|||
131948530|NCT00124072|475098958|FG003|Overall Study|Death|480|||
131948531|NCT02534883|475098959|FG000|Overall Study|Early Termination|8|||
131948532|NCT02534883|475098960|FG001|Overall Study|Early Termination|3|||
131948533|NCT03328832|475098961|FG000|Overall Study|Lost to Follow-up|0|||
131948534|NCT03328832|475098962|FG001|Overall Study|Lost to Follow-up|1|||
131948535|NCT00886769|475098963|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
131948536|NCT00886769|475098964|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
131948537|NCT00414076|475098967|FG000|Overall Study|Progression|1|||
131948538|NCT00414076|475098968|FG001|Overall Study|Progression|2|||
131948539|NCT00414076|475098967|FG000|Overall Study|Withdrawal by Subject|1|||
131948540|NCT00414076|475098968|FG001|Overall Study|Withdrawal by Subject|3|||
131948541|NCT00414076|475098967|FG000|Overall Study|Adverse Event|1|||
131948542|NCT00414076|475098968|FG001|Overall Study|Adverse Event|0|||
131948543|NCT04466384|475098969|FG000|First Phase|Protocol Violation|1|||
131948544|NCT04466384|475098970|FG001|First Phase|Protocol Violation|0|||
131948545|NCT04466384|475098969|FG000|First Phase|Missing data|1|||
131948546|NCT04466384|475098970|FG001|First Phase|Missing data|0|||
131948547|NCT04466384|475098969|FG000|Cross Over Phase|Physician Decision|1|||
131948548|NCT04466384|475098970|FG001|Cross Over Phase|Physician Decision|0|||
131948549|NCT04466384|475098969|FG000|Cross Over Phase|Withdrawal by Subject|0|||
131948550|NCT04466384|475098970|FG001|Cross Over Phase|Withdrawal by Subject|1|||
131948551|NCT03666988|475098971|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
131948552|NCT03666988|475098972|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
131948553|NCT03666988|475098973|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
131948554|NCT03666988|475098974|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
131948555|NCT03666988|475098975|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
131948556|NCT03666988|475098976|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
131948557|NCT03666988|475098971|FG000|Part 1 (Up to 28 Months)|Other|0|||
131948558|NCT03666988|475098972|FG001|Part 1 (Up to 28 Months)|Other|1|||
131948559|NCT03666988|475098973|FG002|Part 1 (Up to 28 Months)|Other|1|||
131948560|NCT03666988|475098974|FG003|Part 1 (Up to 28 Months)|Other|0|||
131948561|NCT03666988|475098975|FG004|Part 1 (Up to 28 Months)|Other|0|||
131948562|NCT03666988|475098976|FG005|Part 1 (Up to 28 Months)|Other|0|||
131948563|NCT03666988|475098971|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
131414061|NCT02576860|473140477|FG001|Overall Study|Protocol Violation|2|||
131414062|NCT02576860|473140476|FG000|Overall Study|Withdrawal by Subject|13|||
131414063|NCT02576860|473140477|FG001|Overall Study|Withdrawal by Subject|8|||
131414064|NCT02576860|473140476|FG000|Overall Study|Disallowed medication|1|||
131414065|NCT02576860|473140477|FG001|Overall Study|Disallowed medication|0|||
131414066|NCT01541917|473140478|FG000|Overall Study|Lost to Follow-up|2|||
131414067|NCT01541917|473140479|FG001|Overall Study|Lost to Follow-up|2|||
131414068|NCT01541917|473140478|FG000|Overall Study|Withdrawal by Subject|13|||
131414069|NCT01541917|473140479|FG001|Overall Study|Withdrawal by Subject|7|||
131948564|NCT03666988|475098972|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
131948565|NCT03666988|475098973|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
131948566|NCT03666988|475098974|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
131414070|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
131414071|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
131414072|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
131414073|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
131414074|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
131414075|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
131414076|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
131414077|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
131414078|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
131414079|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
131414080|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
131414081|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
131414082|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
131414083|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
131414084|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
131414085|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
131414086|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
131414087|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
131414088|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
131414089|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
131414090|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
131414091|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
131414092|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
131414093|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
131414094|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
131414095|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
131414096|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
131414097|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
131414098|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
131414099|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
131414100|NCT00121641|473140482|FG000|24-week Short-term Treatment Period|Other Reason|1|||
131414101|NCT00121641|473140483|FG001|24-week Short-term Treatment Period|Other Reason|0|||
131414102|NCT00121641|473140484|FG002|24-week Short-term Treatment Period|Other Reason|0|||
131414103|NCT00121641|473140485|FG003|24-week Short-term Treatment Period|Other Reason|0|||
131414104|NCT00121641|473140486|FG004|24-week Short-term Treatment Period|Other Reason|0|||
131414105|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
131414106|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
131414107|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
131414108|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
131414109|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
131414110|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
131414111|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
131414112|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
131414113|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
131414114|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
131414115|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
131414116|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
131414117|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
131414118|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
131414119|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
131414120|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
131414121|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
131414122|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
131414123|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
131414124|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
131414125|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
131414126|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
131414127|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
131414128|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
131414129|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
131414130|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
131414131|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
131414132|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
131768892|NCT00565721|474431893|FG000|Overall Study|Lost to Follow-up|6|||
131414133|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
131414134|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
131414135|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
131414136|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
131414137|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
131414138|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
131414139|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
131414140|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
131414141|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
131414142|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
131414143|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
131414144|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
131414145|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Death|0|||
131414146|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Death|0|||
131414147|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Death|0|||
131414148|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Death|1|||
131414149|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Death|0|||
131414150|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Missing|0|||
131414151|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Missing|0|||
131414152|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Missing|1|||
131414153|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Missing|0|||
131414154|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Missing|0|||
131414155|NCT00121641|473140482|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
131414156|NCT00121641|473140483|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
131414157|NCT00121641|473140484|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
131414158|NCT00121641|473140485|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
131414159|NCT00121641|473140486|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
131414160|NCT00094107|473140495|FG000|Overall Study|Lack of Efficacy|23|||
131414161|NCT00094107|473140495|FG000|Overall Study|Death|5|||
131414162|NCT00094107|473140495|FG000|Overall Study|Adverse Event|3|||
131414163|NCT00094107|473140495|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
131414164|NCT00525824|473140498|FG000|Overall Study|Adverse Event|7|||
131414165|NCT00525824|473140499|FG001|Overall Study|Adverse Event|11|||
131414166|NCT00525824|473140500|FG002|Overall Study|Adverse Event|6|||
131414167|NCT00525824|473140501|FG003|Overall Study|Adverse Event|7|||
131414168|NCT00525824|473140498|FG000|Overall Study|Withdrawal by Subject|5|||
131414169|NCT00525824|473140499|FG001|Overall Study|Withdrawal by Subject|9|||
131414170|NCT00525824|473140500|FG002|Overall Study|Withdrawal by Subject|3|||
131414171|NCT00525824|473140501|FG003|Overall Study|Withdrawal by Subject|4|||
131414172|NCT00525824|473140498|FG000|Overall Study|Lost to Follow-up|4|||
131414173|NCT00525824|473140499|FG001|Overall Study|Lost to Follow-up|2|||
131414174|NCT00525824|473140500|FG002|Overall Study|Lost to Follow-up|4|||
131414175|NCT00525824|473140501|FG003|Overall Study|Lost to Follow-up|0|||
131414176|NCT00525824|473140498|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
131414177|NCT00525824|473140499|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
131414178|NCT00525824|473140500|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
131414179|NCT00525824|473140501|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
131414180|NCT00525824|473140498|FG000|Overall Study|Severe non-compliance|0|||
131414181|NCT00525824|473140499|FG001|Overall Study|Severe non-compliance|1|||
131414182|NCT00525824|473140500|FG002|Overall Study|Severe non-compliance|1|||
131414183|NCT00525824|473140501|FG003|Overall Study|Severe non-compliance|1|||
131414184|NCT00525824|473140498|FG000|Overall Study|Safety reasons|1|||
131414185|NCT00525824|473140499|FG001|Overall Study|Safety reasons|0|||
131414186|NCT00525824|473140500|FG002|Overall Study|Safety reasons|1|||
131414187|NCT00525824|473140501|FG003|Overall Study|Safety reasons|0|||
131414188|NCT00525824|473140498|FG000|Overall Study|Other|1|||
131414189|NCT00525824|473140499|FG001|Overall Study|Other|3|||
131414190|NCT00525824|473140500|FG002|Overall Study|Other|3|||
131414191|NCT00525824|473140501|FG003|Overall Study|Other|1|||
131414192|NCT00806442|473140505|FG000|Overall Study|Lost to Follow-up|3|||
131414193|NCT00806442|473140506|FG001|Overall Study|Lost to Follow-up|2|||
131414194|NCT00806442|473140505|FG000|Overall Study|Withdrawal by Subject|1|||
131414195|NCT00806442|473140506|FG001|Overall Study|Withdrawal by Subject|5|||
131414196|NCT01264770|473140522|FG000|Overall Study|Not reported|0|||
131456319|NCT00905645|473301120|FG003|Overall Study|Death (not device related)|8|||
131414197|NCT01264770|473140523|FG001|Overall Study|Not reported|0|||
131414198|NCT01264770|473140524|FG002|Overall Study|Not reported|1|||
131414199|NCT01264770|473140525|FG003|Overall Study|Not reported|0|||
131414200|NCT01264770|473140526|FG004|Overall Study|Not reported|0|||
131414201|NCT01264770|473140527|FG005|Overall Study|Not reported|0|||
131414202|NCT01264770|473140522|FG000|Overall Study|e.g., change in circumstances|8|||
131414203|NCT01264770|473140523|FG001|Overall Study|e.g., change in circumstances|3|||
131768893|NCT00565721|474431893|FG000|Overall Study|Technical Problems|1|||
131948567|NCT03666988|475098975|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
131948568|NCT03666988|475098976|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
131948569|NCT03666988|475098971|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
131948570|NCT03666988|475098972|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
131948571|NCT03666988|475098973|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
131948572|NCT03666988|475098974|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
131948573|NCT03666988|475098975|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
131414204|NCT01264770|473140524|FG002|Overall Study|e.g., change in circumstances|3|||
131414205|NCT01264770|473140525|FG003|Overall Study|e.g., change in circumstances|3|||
131414206|NCT01264770|473140526|FG004|Overall Study|e.g., change in circumstances|4|||
131414207|NCT01264770|473140527|FG005|Overall Study|e.g., change in circumstances|4|||
131414208|NCT01264770|473140522|FG000|Overall Study|Severe non-compliance to protocol|0|||
131414209|NCT01264770|473140523|FG001|Overall Study|Severe non-compliance to protocol|0|||
131414210|NCT01264770|473140524|FG002|Overall Study|Severe non-compliance to protocol|1|||
131414211|NCT01264770|473140525|FG003|Overall Study|Severe non-compliance to protocol|1|||
131414212|NCT01264770|473140526|FG004|Overall Study|Severe non-compliance to protocol|0|||
131414213|NCT01264770|473140527|FG005|Overall Study|Severe non-compliance to protocol|0|||
131414214|NCT01264770|473140522|FG000|Overall Study|Lack of therapeutic response|1|||
131414215|NCT01264770|473140523|FG001|Overall Study|Lack of therapeutic response|0|||
131414216|NCT01264770|473140524|FG002|Overall Study|Lack of therapeutic response|2|||
131414217|NCT01264770|473140525|FG003|Overall Study|Lack of therapeutic response|1|||
131414218|NCT01264770|473140526|FG004|Overall Study|Lack of therapeutic response|1|||
131414219|NCT01264770|473140527|FG005|Overall Study|Lack of therapeutic response|0|||
131414220|NCT01264770|473140522|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
131414221|NCT01264770|473140523|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
131414222|NCT01264770|473140524|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
131414223|NCT01264770|473140525|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
131414224|NCT01264770|473140526|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
131414225|NCT01264770|473140527|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
131414226|NCT01264770|473140522|FG000|Overall Study|Lost to Follow-up|0|||
131414227|NCT01264770|473140523|FG001|Overall Study|Lost to Follow-up|0|||
131414228|NCT01264770|473140524|FG002|Overall Study|Lost to Follow-up|1|||
131414229|NCT01264770|473140525|FG003|Overall Study|Lost to Follow-up|1|||
131414230|NCT01264770|473140526|FG004|Overall Study|Lost to Follow-up|0|||
131414231|NCT01264770|473140527|FG005|Overall Study|Lost to Follow-up|0|||
131414232|NCT01264770|473140522|FG000|Overall Study|Adverse Event|7|||
131414233|NCT01264770|473140523|FG001|Overall Study|Adverse Event|7|||
131414234|NCT01264770|473140524|FG002|Overall Study|Adverse Event|8|||
131414235|NCT01264770|473140525|FG003|Overall Study|Adverse Event|0|||
131414236|NCT01264770|473140526|FG004|Overall Study|Adverse Event|2|||
131414237|NCT01264770|473140527|FG005|Overall Study|Adverse Event|1|||
131414238|NCT01595581|473140528|FG000|Overall Study|Withdrawal by Subject|1|||
131414239|NCT01595581|473140529|FG001|Overall Study|Withdrawal by Subject|0|||
131414240|NCT02831933|473142067|FG000|Overall Study|Physician Decision|11|||
131414241|NCT05065190|473142073|FG000|Overall Study|Other than listed|2|||
131414242|NCT05065190|473142074|FG001|Overall Study|Other than listed|12|||
131414243|NCT05065190|473142073|FG000|Overall Study|Lack of Efficacy|4|||
131414244|NCT05065190|473142074|FG001|Overall Study|Lack of Efficacy|0|||
131414245|NCT05065190|473142073|FG000|Overall Study|Adverse Event|1|||
131414246|NCT05065190|473142074|FG001|Overall Study|Adverse Event|10|||
131414247|NCT02769962|473142075|FG000|Overall Study|Physician Decision|0|||
131414248|NCT02769962|473142076|FG001|Overall Study|Physician Decision|0|||
131414249|NCT02769962|473142077|FG002|Overall Study|Physician Decision|0|||
131414250|NCT02769962|473142078|FG003|Overall Study|Physician Decision|0|||
131414251|NCT02769962|473142079|FG004|Overall Study|Physician Decision|0|||
131414252|NCT02769962|473142080|FG005|Overall Study|Physician Decision|1|||
131414253|NCT02769962|473142081|FG006|Overall Study|Physician Decision|0|||
131414254|NCT02769962|473142082|FG007|Overall Study|Physician Decision|1|||
131414255|NCT02769962|473142075|FG000|Overall Study|Refused further treatment|0|||
131414256|NCT02769962|473142076|FG001|Overall Study|Refused further treatment|0|||
131414257|NCT02769962|473142077|FG002|Overall Study|Refused further treatment|0|||
131414258|NCT02769962|473142078|FG003|Overall Study|Refused further treatment|0|||
131414259|NCT02769962|473142079|FG004|Overall Study|Refused further treatment|0|||
131414260|NCT02769962|473142080|FG005|Overall Study|Refused further treatment|1|||
131414261|NCT02769962|473142081|FG006|Overall Study|Refused further treatment|1|||
131414262|NCT02769962|473142082|FG007|Overall Study|Refused further treatment|0|||
131414263|NCT05432167|473142085|FG000|Overall Study|Adverse Event|0|||
131456320|NCT00905645|473301117|FG000|Overall Study|Explantation of study device(s)|78|||
131456321|NCT00905645|473301118|FG001|Overall Study|Explantation of study device(s)|47|||
131414264|NCT05432167|473142086|FG001|Overall Study|Adverse Event|2|||
131414265|NCT05432167|473142087|FG002|Overall Study|Adverse Event|1|||
131414266|NCT05432167|473142085|FG000|Overall Study|Lost to Follow-up|3|||
131414267|NCT05432167|473142086|FG001|Overall Study|Lost to Follow-up|3|||
131414268|NCT05432167|473142087|FG002|Overall Study|Lost to Follow-up|2|||
131948574|NCT03666988|475098976|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
131948575|NCT03666988|475098971|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
131948576|NCT03666988|475098972|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
131948577|NCT03666988|475098973|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
131948578|NCT03666988|475098974|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
131948579|NCT03666988|475098975|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
131948580|NCT03666988|475098976|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
131948581|NCT01402869|475098985|FG000|Overall Study|Required Tooth Extraction|0|||
131948582|NCT01402869|475098986|FG001|Overall Study|Required Tooth Extraction|0|||
131948583|NCT01402869|475098987|FG002|Overall Study|Required Tooth Extraction|1|||
131948584|NCT00145626|475098988|FG000|Overall Study|Did not have NK infusions|2|||
131948585|NCT00145626|475098988|FG000|Overall Study|Turned 2 years old before treatment|1|||
131948586|NCT00145626|475098988|FG000|Overall Study|Death|1|||
131948587|NCT00145626|475098988|FG000|Overall Study|Withdrawal by Subject|1|||
131948588|NCT03654274|475098989|FG000|Overall Study|Adverse Event|19|||
131948589|NCT03654274|475098990|FG001|Overall Study|Adverse Event|23|||
131948590|NCT03654274|475098991|FG002|Overall Study|Adverse Event|24|||
131948591|NCT03654274|475098989|FG000|Overall Study|Protocol Deviation|0|||
131948592|NCT03654274|475098990|FG001|Overall Study|Protocol Deviation|2|||
131948593|NCT03654274|475098991|FG002|Overall Study|Protocol Deviation|0|||
131948594|NCT03654274|475098989|FG000|Overall Study|Lost to Follow-up|8|||
131948595|NCT03654274|475098990|FG001|Overall Study|Lost to Follow-up|6|||
131948596|NCT03654274|475098991|FG002|Overall Study|Lost to Follow-up|5|||
131948597|NCT03654274|475098989|FG000|Overall Study|Withdrawal by Subject|46|||
131948598|NCT03654274|475098990|FG001|Overall Study|Withdrawal by Subject|25|||
131948599|NCT03654274|475098991|FG002|Overall Study|Withdrawal by Subject|33|||
131948600|NCT03654274|475098989|FG000|Overall Study|Lack of Efficacy|4|||
131948601|NCT03654274|475098990|FG001|Overall Study|Lack of Efficacy|5|||
131948602|NCT03654274|475098991|FG002|Overall Study|Lack of Efficacy|7|||
131414269|NCT05432167|473142085|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
131414270|NCT05432167|473142086|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
131414271|NCT05432167|473142087|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
131414272|NCT05432167|473142085|FG000|Overall Study|Physician Decision|1|||
131414273|NCT05432167|473142086|FG001|Overall Study|Physician Decision|0|||
131414274|NCT05432167|473142087|FG002|Overall Study|Physician Decision|0|||
131414275|NCT05432167|473142085|FG000|Overall Study|Withdrawal by Subject|7|||
131414276|NCT05432167|473142086|FG001|Overall Study|Withdrawal by Subject|4|||
131414277|NCT05432167|473142087|FG002|Overall Study|Withdrawal by Subject|11|||
131414278|NCT05432167|473142085|FG000|Overall Study|Other|0|||
131414279|NCT05432167|473142086|FG001|Overall Study|Other|0|||
131414280|NCT05432167|473142087|FG002|Overall Study|Other|1|||
131414281|NCT00286221|473142092|FG000|Overall Study|Protocol Violation|2|||
131414282|NCT00286221|473142093|FG001|Overall Study|Protocol Violation|1|||
131414283|NCT00286221|473142094|FG002|Overall Study|Protocol Violation|6|||
131414284|NCT00286221|473142095|FG003|Overall Study|Protocol Violation|4|||
131414285|NCT00286221|473142092|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
131414286|NCT00286221|473142093|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
131414287|NCT00286221|473142094|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
131414288|NCT00286221|473142095|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
131414289|NCT00286221|473142092|FG000|Overall Study|Inability to trigger PCA|2|||
131414290|NCT00286221|473142093|FG001|Overall Study|Inability to trigger PCA|0|||
131414291|NCT00286221|473142094|FG002|Overall Study|Inability to trigger PCA|0|||
131414292|NCT00286221|473142095|FG003|Overall Study|Inability to trigger PCA|0|||
131414293|NCT00286221|473142092|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
131414294|NCT00286221|473142093|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
131414295|NCT00286221|473142094|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
131414296|NCT00286221|473142095|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
131414297|NCT02553538|473142099|FG000|Overall Study|Could Not Reach by Telephone|133|||
131414298|NCT02553538|473142100|FG001|Overall Study|Could Not Reach by Telephone|0|||
131414299|NCT02553538|473142099|FG000|Overall Study|Died or Left Network|54|||
131414300|NCT02553538|473142100|FG001|Overall Study|Died or Left Network|56|||
131414301|NCT04094584|473142101|FG000|Overall Study|No interest in study|88|||
131414302|NCT04094584|473142101|FG000|Overall Study|Unwilling to undergo screening tests|36|||
131414303|NCT04094584|473142101|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
131414304|NCT04094584|473142101|FG000|Overall Study|Opioid use|7|||
131414305|NCT04094584|473142101|FG000|Overall Study|Need for major surgery in study period|4|||
131948603|NCT03654274|475098989|FG000|Overall Study|Pregnancy|2|||
131414306|NCT04094584|473142101|FG000|Overall Study|eligible but declined enrollment|4|||
131414307|NCT04094584|473142101|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
131414308|NCT04094584|473142101|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
131414309|NCT04094584|473142101|FG000|Overall Study|Lost to Follow-up|3|||
131948604|NCT03654274|475098990|FG001|Overall Study|Pregnancy|2|||
131948605|NCT03654274|475098991|FG002|Overall Study|Pregnancy|1|||
131948606|NCT03654274|475098989|FG000|Overall Study|Other|27|||
131948607|NCT03654274|475098990|FG001|Overall Study|Other|29|||
131948608|NCT03654274|475098991|FG002|Overall Study|Other|32|||
131948609|NCT03654274|475098989|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
131948610|NCT03654274|475098990|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
131948611|NCT03654274|475098991|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
131948612|NCT05005273|475098992|FG000|Overall Study|Study Terminated|1|||
131948613|NCT05005273|475098993|FG001|Overall Study|Study Terminated|0|||
131948614|NCT00996658|475098994|FG000|Overall Study|Adverse Event|2|||
131948615|NCT00996658|475098995|FG001|Overall Study|Adverse Event|5|||
131948616|NCT00996658|475098994|FG000|Overall Study|Protocol Violation|0|||
131948617|NCT00996658|475098995|FG001|Overall Study|Protocol Violation|1|||
131948618|NCT00996658|475098994|FG000|Overall Study|Lost to Follow-up|2|||
131948619|NCT00996658|475098995|FG001|Overall Study|Lost to Follow-up|5|||
131948620|NCT00996658|475098994|FG000|Overall Study|Non-compliance issues|3|||
131948621|NCT00996658|475098995|FG001|Overall Study|Non-compliance issues|3|||
131948622|NCT00996658|475098994|FG000|Overall Study|Other|9|||
131948623|NCT00996658|475098995|FG001|Overall Study|Other|7|||
131948624|NCT02840253|475100027|FG000|Overall Study|Unsuccessful block|4|||
131948625|NCT03783962|475100028|FG000|Overall Study|Lost to Follow-up|3|||
131948626|NCT03783962|475100029|FG001|Overall Study|Lost to Follow-up|6|||
131948627|NCT03783962|475100028|FG000|Overall Study|Protocol Violation|0|||
131948628|NCT03783962|475100029|FG001|Overall Study|Protocol Violation|1|||
131948629|NCT01724216|475100030|FG000|Overall Study|Scan was not completed|1|||
131414310|NCT04094584|473142101|FG000|Overall Study|Withdrawal by Subject|2|||
131414311|NCT02690649|473142102|FG000|Overall Study|Withdrawal by Subject|1|||
131414312|NCT02690649|473142103|FG001|Overall Study|Withdrawal by Subject|1|||
131414313|NCT02690649|473142102|FG000|Overall Study|Protocol Violation|0|||
131414314|NCT02690649|473142103|FG001|Overall Study|Protocol Violation|3|||
131414315|NCT02276547|473142104|FG000|Overall Study|Death|2|||
131414316|NCT02276547|473142104|FG000|Overall Study|Explant|2|||
131414317|NCT01754194|473142105|FG000|Overall Study|Lost to Follow-up|39|||
131414318|NCT01754194|473142106|FG001|Overall Study|Lost to Follow-up|14|||
131414319|NCT01754194|473142105|FG000|Overall Study|Withdrawal by Subject|4|||
131414320|NCT01754194|473142106|FG001|Overall Study|Withdrawal by Subject|5|||
131414321|NCT01754194|473142105|FG000|Overall Study|Other|9|||
131414322|NCT01754194|473142106|FG001|Overall Study|Other|8|||
131414323|NCT00907296|473142107|FG000|Overall Study|Ineligibility Determined|1|||
131414324|NCT00907296|473142108|FG001|Overall Study|Ineligibility Determined|0|||
131414325|NCT00907296|473142109|FG002|Overall Study|Ineligibility Determined|0|||
131414326|NCT00907296|473142110|FG003|Overall Study|Ineligibility Determined|1|||
131414327|NCT00907296|473142111|FG004|Overall Study|Ineligibility Determined|0|||
131414328|NCT00907296|473142112|FG005|Overall Study|Ineligibility Determined|0|||
131414329|NCT00907296|473142113|FG006|Overall Study|Ineligibility Determined|0|||
131414330|NCT00907296|473142114|FG007|Overall Study|Ineligibility Determined|1|||
131414331|NCT00907296|473142115|FG008|Overall Study|Ineligibility Determined|0|||
131414332|NCT00907296|473142116|FG009|Overall Study|Ineligibility Determined|0|||
131414333|NCT00907296|473142107|FG000|Overall Study|Protocol Deviation|0|||
131414334|NCT00907296|473142108|FG001|Overall Study|Protocol Deviation|1|||
131414335|NCT00907296|473142109|FG002|Overall Study|Protocol Deviation|0|||
131414336|NCT00907296|473142110|FG003|Overall Study|Protocol Deviation|0|||
131414337|NCT00907296|473142111|FG004|Overall Study|Protocol Deviation|0|||
131414338|NCT00907296|473142112|FG005|Overall Study|Protocol Deviation|0|||
131414339|NCT00907296|473142113|FG006|Overall Study|Protocol Deviation|0|||
131414340|NCT00907296|473142114|FG007|Overall Study|Protocol Deviation|0|||
131414341|NCT00907296|473142115|FG008|Overall Study|Protocol Deviation|0|||
131414342|NCT00907296|473142116|FG009|Overall Study|Protocol Deviation|0|||
131414343|NCT00907296|473142107|FG000|Overall Study|Noncompliance|1|||
131414344|NCT00907296|473142108|FG001|Overall Study|Noncompliance|1|||
131414345|NCT00907296|473142109|FG002|Overall Study|Noncompliance|1|||
131414346|NCT00907296|473142110|FG003|Overall Study|Noncompliance|0|||
131414347|NCT00907296|473142111|FG004|Overall Study|Noncompliance|0|||
131414348|NCT00907296|473142112|FG005|Overall Study|Noncompliance|1|||
131414349|NCT00907296|473142113|FG006|Overall Study|Noncompliance|0|||
131414350|NCT00907296|473142114|FG007|Overall Study|Noncompliance|2|||
131414351|NCT00907296|473142115|FG008|Overall Study|Noncompliance|0|||
131414352|NCT00907296|473142116|FG009|Overall Study|Noncompliance|0|||
131414353|NCT00907296|473142107|FG000|Overall Study|Adverse Event|2|||
131414354|NCT00907296|473142108|FG001|Overall Study|Adverse Event|0|||
131414355|NCT00907296|473142109|FG002|Overall Study|Adverse Event|0|||
131414356|NCT00907296|473142110|FG003|Overall Study|Adverse Event|0|||
131414357|NCT00907296|473142111|FG004|Overall Study|Adverse Event|0|||
131414358|NCT00907296|473142112|FG005|Overall Study|Adverse Event|0|||
131948630|NCT03650413|475100031|FG000|Overall Study|Adverse Event|1|||
131414359|NCT00907296|473142113|FG006|Overall Study|Adverse Event|1|||
131414360|NCT00907296|473142114|FG007|Overall Study|Adverse Event|0|||
131414361|NCT00907296|473142115|FG008|Overall Study|Adverse Event|0|||
131948631|NCT03650413|475100031|FG000|Overall Study|Lack of Efficacy|17|||
131948632|NCT03650413|475100031|FG000|Overall Study|Other|9|||
131414362|NCT00907296|473142116|FG009|Overall Study|Adverse Event|1|||
131414363|NCT00907296|473142107|FG000|Overall Study|Withdrawal by Subject|7|||
131948633|NCT03650413|475100031|FG000|Overall Study|Physician Decision|2|||
131948634|NCT03650413|475100031|FG000|Overall Study|Study Terminated By Sponsor|16|||
131948635|NCT03650413|475100031|FG000|Overall Study|Withdrawal by Subject|16|||
131948636|NCT03369665|475100032|FG000|Overall Study|Adverse Event|3|||
131948637|NCT03369665|475100032|FG000|Overall Study|Lost to Follow-up|7|||
131948638|NCT03369665|475100032|FG000|Overall Study|Withdrawal by Subject|15|||
131948639|NCT03369665|475100032|FG000|Overall Study|Progression Disease|2|||
131948640|NCT03369665|475100032|FG000|Overall Study|Not classified|3|||
131948641|NCT02553928|475100033|FG000|Overall Study|Adverse Event|2|||
131948642|NCT02553928|475100034|FG001|Overall Study|Adverse Event|1|||
131948643|NCT02553928|475100033|FG000|Overall Study|Lost to Follow-up|0|||
131948644|NCT02553928|475100034|FG001|Overall Study|Lost to Follow-up|1|||
131948645|NCT02553928|475100033|FG000|Overall Study|Administrative reason(s)|0|||
131948646|NCT02553928|475100034|FG001|Overall Study|Administrative reason(s)|1|||
131948647|NCT03230318|475100035|FG000|Overall Study|Radiographic disease progression|72|||
131948648|NCT03230318|475100036|FG001|Overall Study|Radiographic disease progression|19|||
131948649|NCT03230318|475100035|FG000|Overall Study|Clinical progression|17|||
131948650|NCT03230318|475100036|FG001|Overall Study|Clinical progression|7|||
131948651|NCT03230318|475100035|FG000|Overall Study|Adverse Event|5|||
131948652|NCT03230318|475100036|FG001|Overall Study|Adverse Event|3|||
131948653|NCT03230318|475100035|FG000|Overall Study|Physician Decision|2|||
131948654|NCT03230318|475100036|FG001|Overall Study|Physician Decision|3|||
131948655|NCT03230318|475100035|FG000|Overall Study|Death|3|||
131948656|NCT03230318|475100036|FG001|Overall Study|Death|2|||
131948657|NCT03230318|475100035|FG000|Overall Study|Lost to Follow-up|1|||
131948658|NCT03230318|475100036|FG001|Overall Study|Lost to Follow-up|0|||
131948659|NCT03230318|475100035|FG000|Overall Study|Withdrawal by Subject|1|||
131948660|NCT03230318|475100036|FG001|Overall Study|Withdrawal by Subject|3|||
131948661|NCT03230318|475100035|FG000|Overall Study|Other|3|||
131948662|NCT03230318|475100036|FG001|Overall Study|Other|7|||
131948663|NCT00770562|475100042|FG000|Overall Study|Did not take treatment|1|||
131948664|NCT00770562|475100043|FG001|Overall Study|Did not take treatment|1|||
131948665|NCT01643408|475100044|FG000|Overall Study|Adverse Event|12|||
131948666|NCT01643408|475100044|FG000|Overall Study|Other|2|||
131948667|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
131948668|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
131948669|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948670|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948671|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948672|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948673|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948674|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948675|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948676|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
131948677|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
131948678|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
131948679|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948680|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948681|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948682|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948683|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948684|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948685|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948686|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
131948687|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
131948688|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948689|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948690|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948691|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948692|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948693|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948694|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948695|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948696|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
131948697|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
131948698|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
131948699|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948700|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948701|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948702|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948703|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948704|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948705|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948706|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
131948707|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948708|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
131948709|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948710|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948711|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948712|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948713|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948714|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948715|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948716|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
131948717|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
131948718|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
131948719|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948720|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948721|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948722|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948723|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948724|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948725|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948726|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
131948727|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
131948728|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
131948729|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948730|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948731|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948732|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948733|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948734|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948735|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948736|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
131948737|NCT01194219|475100045|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
131948738|NCT01194219|475100046|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
131948739|NCT01194219|475100047|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948740|NCT01194219|475100048|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948741|NCT01194219|475100049|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948742|NCT01194219|475100050|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948743|NCT01194219|475100051|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948744|NCT01194219|475100052|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948745|NCT01194219|475100053|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948746|NCT01194219|475100054|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
131948747|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948748|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948749|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
131948750|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
131948751|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948752|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948753|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948754|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948755|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948756|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
131948757|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131948758|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131414364|NCT00907296|473142108|FG001|Overall Study|Withdrawal by Subject|2|||
131414365|NCT00907296|473142109|FG002|Overall Study|Withdrawal by Subject|1|||
131414366|NCT00907296|473142110|FG003|Overall Study|Withdrawal by Subject|1|||
131414367|NCT00907296|473142111|FG004|Overall Study|Withdrawal by Subject|1|||
131414368|NCT00907296|473142112|FG005|Overall Study|Withdrawal by Subject|5|||
131948759|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
131948760|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
131948761|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131948762|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131948763|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131948764|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131948765|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131414369|NCT00907296|473142113|FG006|Overall Study|Withdrawal by Subject|3|||
131948766|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
131948767|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948768|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948769|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
131948770|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
131948771|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948772|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948773|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948774|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948775|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948776|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
131948777|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948778|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948779|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
131948780|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
131948781|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948782|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948783|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948784|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948785|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948786|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
131948787|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948788|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948789|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
131948790|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948791|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948792|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948793|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948794|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948795|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948796|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
131948797|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948798|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948799|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948800|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
131948801|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948802|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948803|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948804|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948805|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948806|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
131948807|NCT01194219|475100045|FG000|Maintenance Phase Weeks16-32|Other|0|||
131948808|NCT01194219|475100046|FG001|Maintenance Phase Weeks16-32|Other|0|||
131948809|NCT01194219|475100047|FG002|Maintenance Phase Weeks16-32|Other|2|||
131948810|NCT01194219|475100048|FG003|Maintenance Phase Weeks16-32|Other|1|||
131948811|NCT01194219|475100049|FG004|Maintenance Phase Weeks16-32|Other|0|||
131948812|NCT01194219|475100050|FG005|Maintenance Phase Weeks16-32|Other|0|||
131948813|NCT01194219|475100051|FG006|Maintenance Phase Weeks16-32|Other|0|||
131948814|NCT01194219|475100052|FG007|Maintenance Phase Weeks16-32|Other|0|||
131948815|NCT01194219|475100053|FG008|Maintenance Phase Weeks16-32|Other|0|||
131948816|NCT01194219|475100054|FG009|Maintenance Phase Weeks16-32|Other|0|||
131948817|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948818|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948819|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948820|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948821|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948822|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
131948823|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
131948824|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
131948825|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948826|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
131948827|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
131414370|NCT00907296|473142114|FG007|Overall Study|Withdrawal by Subject|2|||
131414371|NCT00907296|473142115|FG008|Overall Study|Withdrawal by Subject|4|||
131414372|NCT00907296|473142116|FG009|Overall Study|Withdrawal by Subject|2|||
131414373|NCT00907296|473142107|FG000|Overall Study|Lost to Follow-up|9|||
131948828|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
131948829|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
131414374|NCT00907296|473142108|FG001|Overall Study|Lost to Follow-up|1|||
131948830|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
131948831|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
131948832|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
131948833|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
131948834|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
131948835|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
131948836|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
131948837|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948838|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948839|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948840|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948841|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
131948842|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948843|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
131948844|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948845|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948846|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
131948847|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948848|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948849|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948850|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948851|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
131948852|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948853|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
131948854|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
131948855|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948856|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
131948857|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948858|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948859|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948860|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948861|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
131948862|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
131948863|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
131948864|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948865|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948866|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
131948867|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948868|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948869|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948870|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948871|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948872|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948873|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948874|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
131948875|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948876|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
131948877|NCT01194219|475100045|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948878|NCT01194219|475100046|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948879|NCT01194219|475100047|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948880|NCT01194219|475100048|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948881|NCT01194219|475100049|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948882|NCT01194219|475100050|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948883|NCT01194219|475100051|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
131948884|NCT01194219|475100052|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948885|NCT01194219|475100053|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948886|NCT01194219|475100054|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
131948887|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948888|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948889|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948890|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948891|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948892|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948893|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131456322|NCT00905645|473301119|FG002|Overall Study|Explantation of study device(s)|28|||
131456323|NCT00905645|473301120|FG003|Overall Study|Explantation of study device(s)|21|||
131456324|NCT00905645|473301117|FG000|Overall Study|Subject Request|41|||
131456325|NCT00905645|473301118|FG001|Overall Study|Subject Request|17|||
131456326|NCT00905645|473301119|FG002|Overall Study|Subject Request|13|||
131456327|NCT00905645|473301120|FG003|Overall Study|Subject Request|11|||
131456328|NCT00905645|473301117|FG000|Overall Study|Lost to Follow-up|299|||
131456329|NCT00905645|473301118|FG001|Overall Study|Lost to Follow-up|103|||
131456330|NCT00905645|473301119|FG002|Overall Study|Lost to Follow-up|51|||
131456331|NCT00905645|473301120|FG003|Overall Study|Lost to Follow-up|12|||
131456332|NCT02364336|473301121|FG000|Overall Study|Adverse Event|0|||
131456333|NCT02364336|473301122|FG001|Overall Study|Adverse Event|1|||
131456334|NCT01731938|473301123|FG000|Preliminary Part I|Withdrawal by Subject|2|||
131456335|NCT01731938|473301124|FG001|Preliminary Part I|Withdrawal by Subject|2|||
131456336|NCT01731938|473301123|FG000|Preliminary Part I|Physician Decision|1|||
131456337|NCT01731938|473301124|FG001|Preliminary Part I|Physician Decision|0|||
131456338|NCT01731938|473301123|FG000|Preliminary Part I|Lost to Follow-up|0|||
131948894|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
131948895|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
131948896|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
131948897|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948898|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948899|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948900|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948901|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948902|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948903|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948904|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
131948905|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
131948906|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
131948907|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948908|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948909|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948910|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948911|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948912|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948913|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948914|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
131948915|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
131948916|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
131948917|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948918|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948919|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948920|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948921|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948922|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948923|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948924|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
131948925|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
131948926|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
131948927|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
131948928|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
131948929|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
131948930|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
131948931|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
131948932|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
131948933|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
131948934|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
131948935|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
131948936|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
131948937|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948938|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948939|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948940|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948941|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948942|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948943|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948944|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
131948945|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
131456339|NCT01731938|473301124|FG001|Preliminary Part I|Lost to Follow-up|3|||
131948946|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
131948947|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948948|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948949|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948950|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948951|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948952|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948953|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948954|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948955|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
131948956|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
131948957|NCT01194219|475100045|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948958|NCT01194219|475100046|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948959|NCT01194219|475100047|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948960|NCT01194219|475100048|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948961|NCT01194219|475100049|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948962|NCT01194219|475100050|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948963|NCT01194219|475100051|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948964|NCT01194219|475100052|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
131948965|NCT01194219|475100053|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
131948966|NCT01194219|475100054|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
131948967|NCT00292045|475100057|FG000|Core Study (Through Week 13)|Adverse Event|1|||
131948968|NCT00292045|475100057|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
131948969|NCT04474197|475100058|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
131948970|NCT04474197|475100059|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
131948971|NCT04474197|475100060|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
131948972|NCT04474197|475100061|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
131948973|NCT01057693|475100062|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
131948974|NCT01057693|475100063|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
131948975|NCT01057693|475100064|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
131948976|NCT01057693|475100062|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
131948977|NCT01057693|475100063|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
131948978|NCT01057693|475100064|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
131948979|NCT01057693|475100062|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
131948980|NCT01057693|475100063|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
131948981|NCT01057693|475100064|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
131948982|NCT01057693|475100062|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
131948983|NCT01057693|475100063|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
131948984|NCT01057693|475100064|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
131948985|NCT01057693|475100062|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
131948986|NCT01057693|475100063|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
131948987|NCT01057693|475100064|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
131948988|NCT01057693|475100062|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
131414375|NCT00907296|473142109|FG002|Overall Study|Lost to Follow-up|0|||
131414376|NCT00907296|473142110|FG003|Overall Study|Lost to Follow-up|2|||
131414377|NCT00907296|473142111|FG004|Overall Study|Lost to Follow-up|0|||
131414378|NCT00907296|473142112|FG005|Overall Study|Lost to Follow-up|3|||
131414379|NCT00907296|473142113|FG006|Overall Study|Lost to Follow-up|2|||
131414380|NCT00907296|473142114|FG007|Overall Study|Lost to Follow-up|2|||
131414381|NCT00907296|473142115|FG008|Overall Study|Lost to Follow-up|0|||
131414382|NCT00907296|473142116|FG009|Overall Study|Lost to Follow-up|4|||
131414383|NCT00791557|473142117|FG000|Overall Study|Adverse Event|1|||
131414384|NCT03344640|473142121|FG000|Overall Study|Adverse Event|1|||
131414385|NCT03344640|473142122|FG001|Overall Study|Adverse Event|0|||
131414386|NCT03344640|473142121|FG000|Overall Study|Physician Decision|1|||
131414387|NCT03344640|473142122|FG001|Overall Study|Physician Decision|1|||
131414388|NCT03344640|473142121|FG000|Overall Study|Withdrawal by Subject|1|||
131414389|NCT03344640|473142122|FG001|Overall Study|Withdrawal by Subject|2|||
131414390|NCT03344640|473142121|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
131414391|NCT03344640|473142122|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
131414392|NCT01902888|473142123|FG000|Overall Study|Study Terminated|3|||
131948989|NCT01057693|475100063|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
131948990|NCT01057693|475100064|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
131948991|NCT01057693|475100062|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
131948992|NCT01057693|475100063|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
131414393|NCT02616393|473142127|FG000|Overall Study|Death|5|||
131414394|NCT02616393|473142128|FG001|Overall Study|Death|12|||
131948993|NCT01057693|475100064|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
131768894|NCT00565721|474431893|FG000|Overall Study|Physician Decision|2|||
131414395|NCT02616393|473142129|FG002|Overall Study|Death|1|||
131948994|NCT01057693|475100062|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
131948995|NCT01057693|475100063|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
131948996|NCT01057693|475100064|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
131948997|NCT01057693|475100062|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
131948998|NCT01057693|475100063|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
131948999|NCT01057693|475100064|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
131949000|NCT01057693|475100062|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
131949001|NCT01057693|475100063|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
131949002|NCT01057693|475100064|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
131949003|NCT01057693|475100062|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
131949004|NCT01057693|475100063|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
131949005|NCT01057693|475100064|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
131949006|NCT01057693|475100062|FG000|Between Single-Blind and Double-Blind|Other|6|||
131949007|NCT01057693|475100063|FG001|Between Single-Blind and Double-Blind|Other|0|||
131949008|NCT01057693|475100064|FG002|Between Single-Blind and Double-Blind|Other|0|||
131949009|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
131949010|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
131949011|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
131949012|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
131949013|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
131949014|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
131949015|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
131949016|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
131949017|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
131949018|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
131949019|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
131949020|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
131949021|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
131949022|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
131949023|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
131949024|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
131949025|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
131949026|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
131949027|NCT01057693|475100062|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
131949028|NCT01057693|475100063|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
131949029|NCT01057693|475100064|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
131949030|NCT02413996|475100065|FG000|Overall Study|not comfortable with the intervention|9|||
131949031|NCT02413996|475100066|FG001|Overall Study|not comfortable with the intervention|2|||
131949032|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
131949033|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
131949034|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
131949035|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
131949036|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
131949037|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
131949038|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
131949039|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
131949040|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
131949041|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
131949042|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
131949043|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
131949044|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
131949045|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
131949046|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
131949047|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
131949048|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
131949049|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
131949050|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
131949051|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
131949052|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
131949053|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
131949054|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
131949055|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
131949056|NCT01672879|475100073|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
131949057|NCT01672879|475100074|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
131949058|NCT01672879|475100075|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
131768895|NCT00565721|474431893|FG000|Overall Study|Other reasons|6|||
131949059|NCT01672879|475100073|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
131949060|NCT01672879|475100074|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
131949061|NCT01672879|475100075|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
131949062|NCT01672879|475100073|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
131949063|NCT01672879|475100074|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
131949064|NCT01672879|475100075|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
131949065|NCT01672879|475100073|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
131949066|NCT01672879|475100074|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
131949067|NCT01672879|475100075|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
131949068|NCT01672879|475100073|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
131949069|NCT01672879|475100074|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
131949070|NCT01672879|475100075|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
131949071|NCT04860869|475100076|FG000|Overall Study|Withdrawal by Subject|1|||
131949072|NCT04860869|475100077|FG001|Overall Study|Withdrawal by Subject|0|||
131949073|NCT03951766|475100078|FG000|Treatment Phase|Lost to Follow-up|1|||
131949074|NCT03951766|475100078|FG000|Follow-up Phase|Lost to Follow-up|10|||
131949075|NCT04834726|475100080|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
131949076|NCT04834726|475100081|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
131949077|NCT04834726|475100082|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
131949078|NCT04834726|475100083|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
131949079|NCT04834726|475100084|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
131949080|NCT04834726|475100085|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
131949081|NCT04834726|475100086|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
131949082|NCT04834726|475100087|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
131949083|NCT04834726|475100088|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
131949084|NCT00363142|475100090|FG000|Overall Study|Adverse Event|2|||
131949085|NCT00363142|475100091|FG001|Overall Study|Adverse Event|0|||
131949086|NCT00363142|475100090|FG000|Overall Study|Lack of Efficacy|0|||
131949087|NCT00363142|475100091|FG001|Overall Study|Lack of Efficacy|1|||
131949088|NCT00363142|475100090|FG000|Overall Study|Lost to Follow-up|1|||
131949089|NCT00363142|475100091|FG001|Overall Study|Lost to Follow-up|0|||
131949090|NCT00363142|475100090|FG000|Overall Study|Non-compliance|1|||
131949091|NCT00363142|475100091|FG001|Overall Study|Non-compliance|1|||
131949092|NCT00363142|475100090|FG000|Overall Study|Withdrawal by Subject|3|||
131949093|NCT00363142|475100091|FG001|Overall Study|Withdrawal by Subject|1|||
131949094|NCT01467466|475100100|FG000|Overall Study|Withdrawal by Subject|15|||
131949095|NCT01467466|475100101|FG001|Overall Study|Withdrawal by Subject|18|||
131949096|NCT01467466|475100102|FG002|Overall Study|Withdrawal by Subject|13|||
131949097|NCT01467466|475100103|FG003|Overall Study|Withdrawal by Subject|11|||
131949098|NCT01467466|475100100|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
131949099|NCT01467466|475100101|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
131949100|NCT01467466|475100102|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
131949101|NCT01467466|475100103|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
131949102|NCT01467466|475100100|FG000|Overall Study|Procedure Cancelled|46|||
131949103|NCT01467466|475100101|FG001|Overall Study|Procedure Cancelled|45|||
131949104|NCT01467466|475100102|FG002|Overall Study|Procedure Cancelled|25|||
131949105|NCT01467466|475100103|FG003|Overall Study|Procedure Cancelled|29|||
131949106|NCT01467466|475100100|FG000|Overall Study|No Endpoint Blood Draw|38|||
131949107|NCT01467466|475100101|FG001|Overall Study|No Endpoint Blood Draw|32|||
131949108|NCT01467466|475100102|FG002|Overall Study|No Endpoint Blood Draw|51|||
131949109|NCT01467466|475100103|FG003|Overall Study|No Endpoint Blood Draw|43|||
131949110|NCT00132301|475100104|FG000|Overall Study|Death|7|||
131949111|NCT00132301|475100105|FG001|Overall Study|Death|6|||
131414396|NCT02616393|473142127|FG000|Overall Study|Termination by Sponsor|4|||
131414397|NCT02616393|473142128|FG001|Overall Study|Termination by Sponsor|5|||
131414398|NCT02616393|473142129|FG002|Overall Study|Termination by Sponsor|2|||
131414399|NCT02616393|473142127|FG000|Overall Study|Other|3|||
131414400|NCT02616393|473142128|FG001|Overall Study|Other|0|||
131414401|NCT02616393|473142129|FG002|Overall Study|Other|0|||
131414402|NCT02616393|473142127|FG000|Overall Study|Withdrawal by Subject|1|||
131949112|NCT00132301|475100104|FG000|Overall Study|Withdrawal by Subject|5|||
131949113|NCT00132301|475100105|FG001|Overall Study|Withdrawal by Subject|2|||
131949114|NCT00132301|475100104|FG000|Overall Study|Physician Decision|1|||
131949115|NCT00132301|475100105|FG001|Overall Study|Physician Decision|1|||
131949116|NCT00132301|475100104|FG000|Overall Study|Lost to Follow-up|5|||
131949117|NCT00132301|475100105|FG001|Overall Study|Lost to Follow-up|3|||
131949118|NCT00132301|475100104|FG000|Overall Study|Other|1|||
131949119|NCT00132301|475100105|FG001|Overall Study|Other|1|||
131949120|NCT00132301|475100104|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
131414403|NCT02616393|473142128|FG001|Overall Study|Withdrawal by Subject|1|||
131414404|NCT02616393|473142129|FG002|Overall Study|Withdrawal by Subject|0|||
131414405|NCT02616393|473142127|FG000|Overall Study|Lost to Follow-up|0|||
131414406|NCT02616393|473142128|FG001|Overall Study|Lost to Follow-up|2|||
131414407|NCT02616393|473142129|FG002|Overall Study|Lost to Follow-up|0|||
131414408|NCT00364533|473142131|FG000|Overall Study|Adverse Event|8|||
131414409|NCT00364533|473142132|FG001|Overall Study|Adverse Event|7|||
131414410|NCT00364533|473142133|FG002|Overall Study|Adverse Event|15|||
131414411|NCT00364533|473142134|FG003|Overall Study|Adverse Event|5|||
131414412|NCT00364533|473142135|FG004|Overall Study|Adverse Event|2|||
131414413|NCT00364533|473142131|FG000|Overall Study|Withdrawal by Subject|4|||
131414414|NCT00364533|473142132|FG001|Overall Study|Withdrawal by Subject|8|||
131414415|NCT00364533|473142133|FG002|Overall Study|Withdrawal by Subject|6|||
131414416|NCT00364533|473142134|FG003|Overall Study|Withdrawal by Subject|6|||
131414417|NCT00364533|473142135|FG004|Overall Study|Withdrawal by Subject|6|||
131414418|NCT00364533|473142131|FG000|Overall Study|Lack of Efficacy|22|||
131414419|NCT00364533|473142132|FG001|Overall Study|Lack of Efficacy|22|||
131414420|NCT00364533|473142133|FG002|Overall Study|Lack of Efficacy|21|||
131414421|NCT00364533|473142134|FG003|Overall Study|Lack of Efficacy|17|||
131414422|NCT00364533|473142135|FG004|Overall Study|Lack of Efficacy|42|||
131414423|NCT00364533|473142131|FG000|Overall Study|Subject discharged from hospital|4|||
131414424|NCT00364533|473142132|FG001|Overall Study|Subject discharged from hospital|1|||
131414425|NCT00364533|473142133|FG002|Overall Study|Subject discharged from hospital|2|||
131414426|NCT00364533|473142134|FG003|Overall Study|Subject discharged from hospital|3|||
131414427|NCT00364533|473142135|FG004|Overall Study|Subject discharged from hospital|1|||
131414428|NCT00364533|473142131|FG000|Overall Study|Variations in drug compliance|2|||
131414429|NCT00364533|473142132|FG001|Overall Study|Variations in drug compliance|1|||
131414430|NCT00364533|473142133|FG002|Overall Study|Variations in drug compliance|1|||
131414431|NCT00364533|473142134|FG003|Overall Study|Variations in drug compliance|0|||
131414432|NCT00364533|473142135|FG004|Overall Study|Variations in drug compliance|0|||
131414433|NCT00364533|473142131|FG000|Overall Study|Non-compliance|1|||
131414434|NCT00364533|473142132|FG001|Overall Study|Non-compliance|0|||
131414435|NCT00364533|473142133|FG002|Overall Study|Non-compliance|0|||
131414436|NCT00364533|473142134|FG003|Overall Study|Non-compliance|0|||
131414437|NCT00364533|473142135|FG004|Overall Study|Non-compliance|0|||
131414438|NCT00364533|473142131|FG000|Overall Study|Protocol Violation|1|||
131414439|NCT00364533|473142132|FG001|Overall Study|Protocol Violation|1|||
131414440|NCT00364533|473142133|FG002|Overall Study|Protocol Violation|0|||
131414441|NCT00364533|473142134|FG003|Overall Study|Protocol Violation|0|||
131414442|NCT00364533|473142135|FG004|Overall Study|Protocol Violation|0|||
131414443|NCT02758301|473142136|FG000|Overall Study|Death|12|||
131414444|NCT02758301|473142137|FG001|Overall Study|Death|0|||
131414445|NCT02758301|473142136|FG000|Overall Study|Physician Decision|10|||
131414446|NCT02758301|473142137|FG001|Overall Study|Physician Decision|1|||
131414447|NCT02758301|473142136|FG000|Overall Study|Withdrawal by Subject|5|||
131414448|NCT02758301|473142137|FG001|Overall Study|Withdrawal by Subject|6|||
131414449|NCT02758301|473142136|FG000|Overall Study|Lost to Follow-up|7|||
131414450|NCT02758301|473142137|FG001|Overall Study|Lost to Follow-up|0|||
131414451|NCT02758301|473142136|FG000|Overall Study|Protocol Violation|0|||
131414452|NCT02758301|473142137|FG001|Overall Study|Protocol Violation|1|||
131414453|NCT00582738|473142138|FG000|Overall Study|Administrative Problems|7|||
131414454|NCT00582738|473142139|FG001|Overall Study|Administrative Problems|8|||
131414455|NCT00582738|473142138|FG000|Overall Study|Adverse Event|0|||
131414456|NCT00582738|473142139|FG001|Overall Study|Adverse Event|5|||
131414457|NCT00582738|473142138|FG000|Overall Study|Graft Lost|0|||
131414458|NCT00582738|473142139|FG001|Overall Study|Graft Lost|1|||
131414459|NCT00582738|473142138|FG000|Overall Study|Other|1|||
131414460|NCT00582738|473142139|FG001|Overall Study|Other|0|||
131414461|NCT00582738|473142138|FG000|Overall Study|Protocol Violation|1|||
131414462|NCT00582738|473142139|FG001|Overall Study|Protocol Violation|1|||
131414463|NCT00582738|473142138|FG000|Overall Study|Withdrawal by Subject|0|||
131414464|NCT00582738|473142139|FG001|Overall Study|Withdrawal by Subject|3|||
131414465|NCT00652899|473142140|FG000|Overall Study|Death|1|||
131414466|NCT00652899|473142140|FG000|Overall Study|Treating physician decision|1|||
131414467|NCT02900170|473142142|FG000|Overall Study|Lost to Follow-up|8|||
131414468|NCT01565941|473142143|FG000|Overall Study|Withdrawn by parent/guardian|3|||
131414469|NCT01565941|473142144|FG001|Overall Study|Withdrawn by parent/guardian|2|||
131414470|NCT01565941|473142143|FG000|Overall Study|Randomized; did not receive intevention|8|||
131414471|NCT01565941|473142144|FG001|Overall Study|Randomized; did not receive intevention|2|||
131414472|NCT02365285|473142145|FG000|Overall Study|Physician Decision|0|||
131414473|NCT02365285|473142146|FG001|Overall Study|Physician Decision|1|||
131414474|NCT02365285|473142147|FG002|Overall Study|Physician Decision|1|||
131414475|NCT02365285|473142148|FG003|Overall Study|Physician Decision|0|||
131414476|NCT02365285|473142145|FG000|Overall Study|Adverse Event|0|||
131414477|NCT02365285|473142146|FG001|Overall Study|Adverse Event|0|||
131414478|NCT02365285|473142147|FG002|Overall Study|Adverse Event|0|||
131414479|NCT02365285|473142148|FG003|Overall Study|Adverse Event|2|||
131414480|NCT03262116|473142149|FG000|Overall Study|Physician Decision|0|||
131414481|NCT03262116|473142150|FG001|Overall Study|Physician Decision|2|||
131414482|NCT03262116|473142151|FG002|Overall Study|Physician Decision|1|||
131949121|NCT00132301|475100105|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
131949122|NCT02012218|475100106|FG000|Overall Study|Withdrawal by Subject|1|||
131949123|NCT02012218|475100107|FG001|Overall Study|Withdrawal by Subject|0|||
131949124|NCT02012218|475100108|FG002|Overall Study|Withdrawal by Subject|1|||
131949125|NCT02012218|475100109|FG003|Overall Study|Withdrawal by Subject|1|||
131949126|NCT02012218|475100110|FG004|Overall Study|Withdrawal by Subject|1|||
131949127|NCT02012218|475100106|FG000|Overall Study|Adverse Event|1|||
131949128|NCT02012218|475100107|FG001|Overall Study|Adverse Event|0|||
131949129|NCT02012218|475100108|FG002|Overall Study|Adverse Event|0|||
131949130|NCT02012218|475100109|FG003|Overall Study|Adverse Event|1|||
131949131|NCT02012218|475100110|FG004|Overall Study|Adverse Event|0|||
131949132|NCT02012218|475100106|FG000|Overall Study|Lost to Follow-up|0|||
131949133|NCT02012218|475100107|FG001|Overall Study|Lost to Follow-up|1|||
131949134|NCT02012218|475100108|FG002|Overall Study|Lost to Follow-up|1|||
131949135|NCT02012218|475100109|FG003|Overall Study|Lost to Follow-up|0|||
131949136|NCT02012218|475100110|FG004|Overall Study|Lost to Follow-up|0|||
131949137|NCT02012218|475100106|FG000|Overall Study|Protocol Specified|1|||
131949138|NCT02012218|475100107|FG001|Overall Study|Protocol Specified|0|||
131949139|NCT02012218|475100108|FG002|Overall Study|Protocol Specified|0|||
131949140|NCT02012218|475100109|FG003|Overall Study|Protocol Specified|0|||
131949141|NCT02012218|475100110|FG004|Overall Study|Protocol Specified|0|||
131949142|NCT02012218|475100106|FG000|Overall Study|Protocol Deviation|1|||
131949143|NCT02012218|475100107|FG001|Overall Study|Protocol Deviation|0|||
131949144|NCT02012218|475100108|FG002|Overall Study|Protocol Deviation|0|||
131949145|NCT02012218|475100109|FG003|Overall Study|Protocol Deviation|0|||
131949146|NCT02012218|475100110|FG004|Overall Study|Protocol Deviation|0|||
131949147|NCT01232127|475100111|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
131949148|NCT01232127|475100112|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
131949149|NCT01232127|475100113|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
131949150|NCT02382991|475100114|FG000|Overall Study|Adverse Event|1|||
131949151|NCT02382991|475100115|FG001|Overall Study|Adverse Event|2|||
131949152|NCT02382991|475100114|FG000|Overall Study|Lost to Follow-up|1|||
131949153|NCT02382991|475100115|FG001|Overall Study|Lost to Follow-up|0|||
131949154|NCT02382991|475100114|FG000|Overall Study|Withdrawal by Subject|0|||
131949155|NCT02382991|475100115|FG001|Overall Study|Withdrawal by Subject|1|||
131949156|NCT00100802|475100117|FG000|Overall Study|Adverse Event|9|||
131949157|NCT00100802|475100117|FG000|Overall Study|Death|1|||
131949158|NCT00100802|475100117|FG000|Overall Study|Lack of Efficacy|47|||
131949159|NCT00100802|475100117|FG000|Overall Study|Physician Decision|5|||
131949160|NCT00100802|475100117|FG000|Overall Study|Protocol Violation|1|||
131949161|NCT00100802|475100117|FG000|Overall Study|Withdrawal by Subject|5|||
131949162|NCT00100802|475100117|FG000|Overall Study|Ineligible|12|||
131949163|NCT01837680|475100120|FG000|Overall Study|Lost to Follow-up|2|||
131949164|NCT01837680|475100121|FG001|Overall Study|Lost to Follow-up|2|||
131949165|NCT01837680|475100120|FG000|Overall Study|lack of insurance|0|||
131949166|NCT01837680|475100121|FG001|Overall Study|lack of insurance|2|||
131949167|NCT01837680|475100120|FG000|Overall Study|allergic reaction|6|||
131949168|NCT01837680|475100121|FG001|Overall Study|allergic reaction|0|||
131949169|NCT01837680|475100120|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
131949170|NCT01837680|475100121|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
131949171|NCT00326001|475100122|FG000|Overall Study|Adverse Event|4|||
131949172|NCT00326001|475100123|FG001|Overall Study|Adverse Event|5|||
131949173|NCT00326001|475100122|FG000|Overall Study|Physician Decision|3|||
131949174|NCT00326001|475100123|FG001|Overall Study|Physician Decision|3|||
131949175|NCT03265145|475100124|FG000|Overall Study|Protocol Violation|2|||
131949176|NCT03265145|475100125|FG001|Overall Study|Protocol Violation|0|||
131949177|NCT03265145|475100124|FG000|Overall Study|Adverse Event|1|||
131949178|NCT03265145|475100125|FG001|Overall Study|Adverse Event|0|||
131949179|NCT03265145|475100124|FG000|Overall Study|Withdrawal by Subject|23|||
131949180|NCT03265145|475100125|FG001|Overall Study|Withdrawal by Subject|19|||
131949181|NCT03265145|475100124|FG000|Overall Study|Death|12|||
131949182|NCT03265145|475100125|FG001|Overall Study|Death|12|||
131414483|NCT03262116|473142152|FG003|Overall Study|Physician Decision|1|||
131414484|NCT03262116|473142153|FG004|Overall Study|Physician Decision|1|||
131414485|NCT03262116|473142154|FG005|Overall Study|Physician Decision|2|||
131414486|NCT02608450|473142157|FG000|Overall Study|Lost to Follow-up|39|||
131414487|NCT02608450|473142158|FG001|Overall Study|Lost to Follow-up|32|||
131414488|NCT02608450|473142157|FG000|Overall Study|Withdrawal by Subject|21|||
131414489|NCT02608450|473142158|FG001|Overall Study|Withdrawal by Subject|15|||
131414490|NCT02608450|473142157|FG000|Overall Study|Adverse Event|3|||
131414491|NCT02608450|473142158|FG001|Overall Study|Adverse Event|6|||
131414492|NCT02608450|473142157|FG000|Overall Study|Withdrawal by parent|2|||
131414493|NCT02608450|473142158|FG001|Overall Study|Withdrawal by parent|3|||
131414494|NCT02608450|473142157|FG000|Overall Study|Lack of Efficacy|0|||
131414495|NCT02608450|473142158|FG001|Overall Study|Lack of Efficacy|3|||
131414496|NCT02608450|473142157|FG000|Overall Study|Noncompliance with study drug|0|||
131414497|NCT02608450|473142158|FG001|Overall Study|Noncompliance with study drug|2|||
131414498|NCT02608450|473142157|FG000|Overall Study|Physician Decision|0|||
131414499|NCT02608450|473142158|FG001|Overall Study|Physician Decision|1|||
131949183|NCT03265145|475100124|FG000|Overall Study|Lost to Follow-up|13|||
131949184|NCT03265145|475100125|FG001|Overall Study|Lost to Follow-up|9|||
131949185|NCT03265145|475100124|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
131949186|NCT03265145|475100125|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
131949187|NCT03265145|475100124|FG000|Overall Study|Switched back to previous medication|1|||
131949188|NCT03265145|475100125|FG001|Overall Study|Switched back to previous medication|0|||
131949189|NCT03265145|475100124|FG000|Overall Study|Did not want to take medication|1|||
131949190|NCT03265145|475100125|FG001|Overall Study|Did not want to take medication|0|||
131949191|NCT03265145|475100124|FG000|Overall Study|Subject could not afford medication|0|||
131949192|NCT03265145|475100125|FG001|Overall Study|Subject could not afford medication|1|||
131949193|NCT03265145|475100124|FG000|Overall Study|Site closed|2|||
131949194|NCT03265145|475100125|FG001|Overall Study|Site closed|3|||
131949195|NCT03265145|475100124|FG000|Overall Study|Incorrectly randomized|16|||
131949196|NCT03265145|475100125|FG001|Overall Study|Incorrectly randomized|6|||
131949197|NCT03265145|475100124|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
131949198|NCT03265145|475100125|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
131949199|NCT03265145|475100124|FG000|Overall Study|Physician Decision|0|||
131949200|NCT03265145|475100125|FG001|Overall Study|Physician Decision|3|||
131949201|NCT03265145|475100124|FG000|Overall Study|Subject transferred to another facility|0|||
131949202|NCT03265145|475100125|FG001|Overall Study|Subject transferred to another facility|1|||
131949203|NCT01963767|475100126|FG000|Overall Study|Withdrawal by Subject|4|||
131949204|NCT01963767|475100127|FG001|Overall Study|Withdrawal by Subject|2|||
131949205|NCT01963767|475100126|FG000|Overall Study|Adverse Event|2|||
131949206|NCT01963767|475100127|FG001|Overall Study|Adverse Event|0|||
131949207|NCT03960684|475100128|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
131949208|NCT03941483|475100132|FG000|Overall Study|Miscellaneous|2|||
131949209|NCT03941483|475100133|FG001|Overall Study|Miscellaneous|3|||
131949210|NCT03941483|475100134|FG002|Overall Study|Miscellaneous|0|||
131949211|NCT03941483|475100132|FG000|Overall Study|Study Terminated by Sponsor|1|||
131949212|NCT03941483|475100133|FG001|Overall Study|Study Terminated by Sponsor|0|||
131949213|NCT03941483|475100134|FG002|Overall Study|Study Terminated by Sponsor|0|||
131949214|NCT03941483|475100132|FG000|Overall Study|Withdrawal by Subject|1|||
131949215|NCT03941483|475100133|FG001|Overall Study|Withdrawal by Subject|4|||
131949216|NCT03941483|475100134|FG002|Overall Study|Withdrawal by Subject|1|||
131949217|NCT03941483|475100132|FG000|Overall Study|Lost to Follow-up|2|||
131949218|NCT03941483|475100133|FG001|Overall Study|Lost to Follow-up|1|||
131949219|NCT03941483|475100134|FG002|Overall Study|Lost to Follow-up|8|||
131949220|NCT03941483|475100132|FG000|Overall Study|Death|3|||
131949221|NCT03941483|475100133|FG001|Overall Study|Death|2|||
131949222|NCT03941483|475100134|FG002|Overall Study|Death|6|||
131949223|NCT03154476|475100137|FG000|Overall Study|Lost to Follow-up|4|||
131949224|NCT03154476|475100138|FG001|Overall Study|Lost to Follow-up|4|||
131949225|NCT02685826|475100139|FG000|Overall Study|Adverse Event|2|||
131949226|NCT02685826|475100140|FG001|Overall Study|Adverse Event|0|||
131949227|NCT02685826|475100141|FG002|Overall Study|Adverse Event|1|||
131949228|NCT02685826|475100139|FG000|Overall Study|Progressive Disease|2|||
131949229|NCT02685826|475100140|FG001|Overall Study|Progressive Disease|1|||
131949230|NCT02685826|475100141|FG002|Overall Study|Progressive Disease|0|||
131949231|NCT02685826|475100139|FG000|Overall Study|Withdrawal by Subject|2|||
131949232|NCT02685826|475100140|FG001|Overall Study|Withdrawal by Subject|0|||
131949233|NCT02685826|475100141|FG002|Overall Study|Withdrawal by Subject|0|||
131949234|NCT02685826|475100139|FG000|Overall Study|Full Clinical Hold by FDA|19|||
131949235|NCT02685826|475100140|FG001|Overall Study|Full Clinical Hold by FDA|9|||
131949236|NCT02685826|475100141|FG002|Overall Study|Full Clinical Hold by FDA|20|||
131949237|NCT00200967|475100144|FG000|First Treatment Period|Withdrawal by Subject|5|||
131949238|NCT00200967|475100145|FG001|First Treatment Period|Withdrawal by Subject|1|||
131949239|NCT00200967|475100144|FG000|First Treatment Period|Pregnancy|1|||
131949240|NCT00200967|475100145|FG001|First Treatment Period|Pregnancy|0|||
131949241|NCT00200967|475100144|FG000|Wash-out Period|Lost to Follow-up|0|||
131949242|NCT00200967|475100145|FG001|Wash-out Period|Lost to Follow-up|1|||
131949243|NCT00200967|475100144|FG000|Second Treatment Period|Withdrawal by Subject|1|||
131949244|NCT00200967|475100145|FG001|Second Treatment Period|Withdrawal by Subject|2|||
131949245|NCT00200967|475100144|FG000|Run-out Period|Lost to Follow-up|1|||
131949246|NCT00200967|475100145|FG001|Run-out Period|Lost to Follow-up|0|||
131949247|NCT01444430|475100149|FG000|Overall Study|Withdrawal by Subject|53|||
131949248|NCT01444430|475100150|FG001|Overall Study|Withdrawal by Subject|72|||
131949249|NCT01444430|475100149|FG000|Overall Study|Death|6|||
131949250|NCT01444430|475100150|FG001|Overall Study|Death|8|||
131949251|NCT01444430|475100149|FG000|Overall Study|Lost to Follow-up|2|||
131949252|NCT01444430|475100150|FG001|Overall Study|Lost to Follow-up|0|||
131949253|NCT01444430|475100149|FG000|Overall Study|CRF termination module not completed.|0|||
131949254|NCT01444430|475100150|FG001|Overall Study|CRF termination module not completed.|1|||
131949255|NCT00600106|475101293|FG000|Overall Study|Withdrawal by Subject|1|||
131949256|NCT00600106|475101294|FG001|Overall Study|Withdrawal by Subject|1|||
131949257|NCT01061723|475101297|FG000|Overall Study|Adverse Event|0|||
131949258|NCT01061723|475101298|FG001|Overall Study|Adverse Event|2|||
131949259|NCT01061723|475101299|FG002|Overall Study|Adverse Event|5|||
131949260|NCT01061723|475101300|FG003|Overall Study|Adverse Event|5|||
131949261|NCT01061723|475101301|FG004|Overall Study|Adverse Event|2|||
131949262|NCT01061723|475101302|FG005|Overall Study|Adverse Event|6|||
131949263|NCT01061723|475101297|FG000|Overall Study|Lack of Efficacy|2|||
131949264|NCT01061723|475101298|FG001|Overall Study|Lack of Efficacy|3|||
131949265|NCT01061723|475101299|FG002|Overall Study|Lack of Efficacy|4|||
131949266|NCT01061723|475101300|FG003|Overall Study|Lack of Efficacy|2|||
131949267|NCT01061723|475101301|FG004|Overall Study|Lack of Efficacy|1|||
131949268|NCT01061723|475101302|FG005|Overall Study|Lack of Efficacy|1|||
131949269|NCT01061723|475101297|FG000|Overall Study|Randomized but not treated|0|||
131949270|NCT01061723|475101298|FG001|Overall Study|Randomized but not treated|0|||
131949271|NCT01061723|475101299|FG002|Overall Study|Randomized but not treated|0|||
131949272|NCT01061723|475101300|FG003|Overall Study|Randomized but not treated|0|||
131949273|NCT01061723|475101301|FG004|Overall Study|Randomized but not treated|0|||
131949274|NCT01061723|475101302|FG005|Overall Study|Randomized but not treated|1|||
131949275|NCT01061723|475101297|FG000|Overall Study|Other than specified above|2|||
131949276|NCT01061723|475101298|FG001|Overall Study|Other than specified above|1|||
131949277|NCT01061723|475101299|FG002|Overall Study|Other than specified above|1|||
131949278|NCT01061723|475101300|FG003|Overall Study|Other than specified above|1|||
131949279|NCT01061723|475101301|FG004|Overall Study|Other than specified above|0|||
131949280|NCT01061723|475101302|FG005|Overall Study|Other than specified above|1|||
131949281|NCT01734785|475101303|FG000|Open-Label Period|Adverse Event|0|||
131949282|NCT01734785|475101304|FG001|Open-Label Period|Adverse Event|0|||
131949283|NCT01734785|475101305|FG002|Open-Label Period|Adverse Event|0|||
131949284|NCT01734785|475101306|FG003|Open-Label Period|Adverse Event|9|||
131949285|NCT01734785|475101303|FG000|Open-Label Period|Lack of Efficacy|0|||
131949286|NCT01734785|475101304|FG001|Open-Label Period|Lack of Efficacy|0|||
131949287|NCT01734785|475101305|FG002|Open-Label Period|Lack of Efficacy|0|||
131949288|NCT01734785|475101306|FG003|Open-Label Period|Lack of Efficacy|1|||
131949289|NCT01734785|475101303|FG000|Open-Label Period|Protocol Violation|0|||
131949290|NCT01734785|475101304|FG001|Open-Label Period|Protocol Violation|0|||
131949291|NCT01734785|475101305|FG002|Open-Label Period|Protocol Violation|0|||
131949292|NCT01734785|475101306|FG003|Open-Label Period|Protocol Violation|13|||
131949293|NCT01734785|475101303|FG000|Open-Label Period|Lost to Follow-up|0|||
131949294|NCT01734785|475101304|FG001|Open-Label Period|Lost to Follow-up|0|||
131949295|NCT01734785|475101305|FG002|Open-Label Period|Lost to Follow-up|0|||
131949296|NCT01734785|475101306|FG003|Open-Label Period|Lost to Follow-up|14|||
131949297|NCT01734785|475101303|FG000|Open-Label Period|Withdrawal by Subject|0|||
131949298|NCT01734785|475101304|FG001|Open-Label Period|Withdrawal by Subject|0|||
131949299|NCT01734785|475101305|FG002|Open-Label Period|Withdrawal by Subject|0|||
131949300|NCT01734785|475101306|FG003|Open-Label Period|Withdrawal by Subject|12|||
131949301|NCT01734785|475101303|FG000|Open-Label Period|Other Reasons|0|||
131949302|NCT01734785|475101304|FG001|Open-Label Period|Other Reasons|0|||
131949303|NCT01734785|475101305|FG002|Open-Label Period|Other Reasons|0|||
131949304|NCT01734785|475101306|FG003|Open-Label Period|Other Reasons|224|||
131949305|NCT01734785|475101303|FG000|Double-Blind Period|Adverse Event|0|||
131949306|NCT01734785|475101304|FG001|Double-Blind Period|Adverse Event|3|||
131949307|NCT01734785|475101305|FG002|Double-Blind Period|Adverse Event|2|||
131949308|NCT01734785|475101306|FG003|Double-Blind Period|Adverse Event|0|||
131949309|NCT01734785|475101303|FG000|Double-Blind Period|Lack of Efficacy|0|||
131949310|NCT01734785|475101304|FG001|Double-Blind Period|Lack of Efficacy|1|||
131949311|NCT01734785|475101305|FG002|Double-Blind Period|Lack of Efficacy|0|||
131949312|NCT01734785|475101306|FG003|Double-Blind Period|Lack of Efficacy|0|||
131949313|NCT01734785|475101303|FG000|Double-Blind Period|Protocol Violation|0|||
131949314|NCT01734785|475101304|FG001|Double-Blind Period|Protocol Violation|1|||
131949315|NCT01734785|475101305|FG002|Double-Blind Period|Protocol Violation|1|||
131949316|NCT01734785|475101306|FG003|Double-Blind Period|Protocol Violation|0|||
131949317|NCT01734785|475101303|FG000|Double-Blind Period|Lost to Follow-up|2|||
131949318|NCT01734785|475101304|FG001|Double-Blind Period|Lost to Follow-up|4|||
131949319|NCT01734785|475101305|FG002|Double-Blind Period|Lost to Follow-up|2|||
131414500|NCT02608450|473142157|FG000|Overall Study|Pregnancy|0|||
131414501|NCT02608450|473142158|FG001|Overall Study|Pregnancy|1|||
131949320|NCT01734785|475101306|FG003|Double-Blind Period|Lost to Follow-up|0|||
131949321|NCT01734785|475101303|FG000|Double-Blind Period|Withdrawal by Subject|2|||
131949322|NCT01734785|475101304|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131949323|NCT01734785|475101305|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131949324|NCT01734785|475101306|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131949325|NCT01734785|475101303|FG000|Double-Blind Period|Not treated|1|||
131949326|NCT01734785|475101304|FG001|Double-Blind Period|Not treated|0|||
131949327|NCT01734785|475101305|FG002|Double-Blind Period|Not treated|0|||
131949328|NCT01734785|475101306|FG003|Double-Blind Period|Not treated|0|||
131949329|NCT02013778|475101309|FG000|Overall Study|Death|4|||
131949330|NCT02013778|475101309|FG000|Overall Study|Withdrawal by Subject|1|||
131949331|NCT02013778|475101309|FG000|Overall Study|Physician Decision|1|||
131949332|NCT02013778|475101309|FG000|Overall Study|Adverse Event|1|||
131949333|NCT00293813|475101310|FG000|Overall Study|Physician Decision|0|||
131949334|NCT00293813|475101311|FG001|Overall Study|Physician Decision|1|||
131949335|NCT00293813|475101312|FG002|Overall Study|Physician Decision|0|||
131949336|NCT00293813|475101310|FG000|Overall Study|Adverse Event|3|||
131949337|NCT00293813|475101311|FG001|Overall Study|Adverse Event|1|||
131949338|NCT00293813|475101312|FG002|Overall Study|Adverse Event|1|||
131949339|NCT00293813|475101310|FG000|Overall Study|Withdrawal by Subject|7|||
131949340|NCT00293813|475101311|FG001|Overall Study|Withdrawal by Subject|4|||
131949341|NCT00293813|475101312|FG002|Overall Study|Withdrawal by Subject|4|||
131949342|NCT00293813|475101310|FG000|Overall Study|Lost to Follow-up|3|||
131949343|NCT00293813|475101311|FG001|Overall Study|Lost to Follow-up|2|||
131949344|NCT00293813|475101312|FG002|Overall Study|Lost to Follow-up|3|||
131949345|NCT00293813|475101310|FG000|Overall Study|Noncompliance|0|||
131949346|NCT00293813|475101311|FG001|Overall Study|Noncompliance|1|||
131949347|NCT00293813|475101312|FG002|Overall Study|Noncompliance|0|||
131949348|NCT01465386|475101316|FG000|Overall Study|Lack of Efficacy|3|||
131949349|NCT01465386|475101316|FG000|Overall Study|Adverse Event|1|||
131949350|NCT03458325|475101317|FG000|Overall Study|Withdrawal by Subject|1|||
131949351|NCT00460655|475101322|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
131949352|NCT00460655|475101323|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131949353|NCT00460655|475101324|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131949354|NCT00460655|475101325|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131949355|NCT00460655|475101322|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
131949356|NCT00460655|475101323|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131949357|NCT00460655|475101324|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131949358|NCT00460655|475101325|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131949359|NCT00460655|475101322|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
131949360|NCT00460655|475101323|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
131949361|NCT00460655|475101324|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
131949362|NCT00460655|475101325|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
131949363|NCT00460655|475101322|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131949364|NCT00460655|475101323|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131949365|NCT00460655|475101324|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
131949366|NCT00460655|475101325|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
131949367|NCT00460655|475101322|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131949368|NCT00460655|475101323|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131949369|NCT00460655|475101324|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
131949370|NCT00460655|475101325|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
131949371|NCT00460655|475101322|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
131949372|NCT00460655|475101323|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
131949373|NCT00460655|475101324|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
131949374|NCT00460655|475101325|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
131949375|NCT03654040|475101326|FG000|Overall Study|Death|1|||
131949376|NCT03654040|475101327|FG001|Overall Study|Death|0|||
131949377|NCT03654040|475101326|FG000|Overall Study|Withdrawal by Subject|1|||
131949378|NCT03654040|475101327|FG001|Overall Study|Withdrawal by Subject|0|||
131949379|NCT03654040|475101326|FG000|Overall Study|Study terminated by sponsor|8|||
131949380|NCT03654040|475101327|FG001|Overall Study|Study terminated by sponsor|2|||
131949381|NCT03654040|475101326|FG000|Overall Study|Failure to initiate study therapy|2|||
131949382|NCT03654040|475101327|FG001|Overall Study|Failure to initiate study therapy|0|||
131949383|NCT03654040|475101326|FG000|Overall Study|Transplanted at another center|2|||
131949384|NCT03654040|475101327|FG001|Overall Study|Transplanted at another center|0|||
131949385|NCT03654040|475101326|FG000|Overall Study|Failure to meet eligibility criteria|14|||
131949386|NCT03654040|475101327|FG001|Overall Study|Failure to meet eligibility criteria|2|||
131949387|NCT03654040|475101326|FG000|Overall Study|No longer transplant candidate|1|||
131949388|NCT03654040|475101327|FG001|Overall Study|No longer transplant candidate|0|||
131949389|NCT03654040|475101326|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
131949390|NCT03654040|475101327|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
131949391|NCT03654040|475101326|FG000|Overall Study|Recipient ineligible|0|||
131949392|NCT03654040|475101327|FG001|Overall Study|Recipient ineligible|2|||
131949393|NCT03654040|475101326|FG000|Overall Study|Received deceased liver|0|||
131949394|NCT03654040|475101327|FG001|Overall Study|Received deceased liver|1|||
131949395|NCT00131352|475101333|FG000|Initial Treatment Period|Adverse Event|1|||
131949396|NCT00131352|475101334|FG001|Initial Treatment Period|Adverse Event|3|||
131949397|NCT00131352|475101333|FG000|Initial Treatment Period|Non-compliant|1|||
131949398|NCT00131352|475101334|FG001|Initial Treatment Period|Non-compliant|2|||
131949399|NCT00131352|475101333|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
131949400|NCT00131352|475101334|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
131949401|NCT00131352|475101333|FG000|Initial Treatment Period|Lack of Efficacy|6|||
131949402|NCT00131352|475101334|FG001|Initial Treatment Period|Lack of Efficacy|4|||
131949403|NCT00131352|475101333|FG000|Initial Treatment Period|Other|0|||
131949404|NCT00131352|475101334|FG001|Initial Treatment Period|Other|2|||
131949405|NCT00131352|475101333|FG000|Repeat Treatment Period|Adverse Event|1|||
131949406|NCT00131352|475101334|FG001|Repeat Treatment Period|Adverse Event|0|||
131949407|NCT00131352|475101333|FG000|Repeat Treatment Period|Other|1|||
131949408|NCT00131352|475101334|FG001|Repeat Treatment Period|Other|0|||
131949409|NCT00211172|475101337|FG000|Overall Study|Died or lost health plan eligibility|39|||
131949410|NCT00211172|475101338|FG001|Overall Study|Died or lost health plan eligibility|32|||
131949411|NCT02443337|475101339|FG000|Overall Study|Adverse Event|0|||
131949412|NCT02443337|475101340|FG001|Overall Study|Adverse Event|1|||
131949413|NCT02443337|475101339|FG000|Overall Study|Clinical Progressive Disease|3|||
131949414|NCT02443337|475101340|FG001|Overall Study|Clinical Progressive Disease|0|||
131949415|NCT02443337|475101339|FG000|Overall Study|Withdrawal by Subject|2|||
131949416|NCT02443337|475101340|FG001|Overall Study|Withdrawal by Subject|1|||
131949417|NCT00709319|475101341|FG000|Overall Study|Death|4|||
131949418|NCT00709319|475101341|FG000|Overall Study|Withdrawal by Subject|2|||
131949419|NCT00579553|475101342|FG000|Overall Study|Lost to Follow-up|16|||
131949420|NCT00579553|475101343|FG001|Overall Study|Lost to Follow-up|13|||
131949421|NCT00635349|475101344|FG000|Overall Study|Other|8|||
131949422|NCT00635349|475101345|FG001|Overall Study|Other|6|||
131949423|NCT00635349|475101344|FG000|Overall Study|Protocol Violation|18|||
131949424|NCT00635349|475101345|FG001|Overall Study|Protocol Violation|22|||
131949425|NCT00635349|475101344|FG000|Overall Study|Withdrawal by Subject|3|||
131949426|NCT00635349|475101345|FG001|Overall Study|Withdrawal by Subject|8|||
131949427|NCT00635349|475101344|FG000|Overall Study|Lost to Follow-up|4|||
131949428|NCT00635349|475101345|FG001|Overall Study|Lost to Follow-up|3|||
131949429|NCT00635349|475101344|FG000|Overall Study|Adverse Event|11|||
131949430|NCT00635349|475101345|FG001|Overall Study|Adverse Event|9|||
131949431|NCT00049322|475101347|FG000|Overall Study|disease burden|0|||
131949432|NCT00049322|475101348|FG001|Overall Study|disease burden|3|||
131949433|NCT00049322|475101347|FG000|Overall Study|Adverse Event|1|||
131949434|NCT00049322|475101348|FG001|Overall Study|Adverse Event|0|||
131949435|NCT00049322|475101347|FG000|Overall Study|refused angio|0|||
131949436|NCT00049322|475101348|FG001|Overall Study|refused angio|3|||
131949437|NCT00295646|475101364|FG000|Overall Study|Protocol Violation|18|||
131949438|NCT00295646|475101365|FG001|Overall Study|Protocol Violation|20|||
131949439|NCT00295646|475101366|FG002|Overall Study|Protocol Violation|20|||
131949440|NCT00295646|475101367|FG003|Overall Study|Protocol Violation|18|||
131949441|NCT00295646|475101364|FG000|Overall Study|Withdrawal by Subject|8|||
131949442|NCT00295646|475101365|FG001|Overall Study|Withdrawal by Subject|9|||
131949443|NCT00295646|475101366|FG002|Overall Study|Withdrawal by Subject|11|||
131949444|NCT00295646|475101367|FG003|Overall Study|Withdrawal by Subject|14|||
131414502|NCT02608450|473142157|FG000|Overall Study|Progressive disease|1|||
131414503|NCT02608450|473142158|FG001|Overall Study|Progressive disease|0|||
131414504|NCT02608450|473142157|FG000|Overall Study|Multiple reasons|0|||
131414505|NCT02608450|473142158|FG001|Overall Study|Multiple reasons|2|||
131414506|NCT02636946|473142159|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
131414507|NCT02636946|473142160|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
131414508|NCT02636946|473142159|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
131414509|NCT02636946|473142160|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
131414510|NCT02636946|473142159|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
131414511|NCT02636946|473142160|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
131414512|NCT02636946|473142159|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
131414513|NCT02636946|473142160|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
131414514|NCT02636946|473142159|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
131414515|NCT02636946|473142160|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
131414516|NCT02636946|473142159|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
131414517|NCT02636946|473142160|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
131414518|NCT02449018|473142170|FG000|Overall Study|Abnormal laboratory value|0|||
131414519|NCT02449018|473142171|FG001|Overall Study|Abnormal laboratory value|1|||
131414520|NCT02449018|473142170|FG000|Overall Study|Administrative problems|1|||
131414521|NCT02449018|473142171|FG001|Overall Study|Administrative problems|0|||
131414522|NCT02449018|473142170|FG000|Overall Study|Adverse Event|5|||
131414523|NCT02449018|473142171|FG001|Overall Study|Adverse Event|1|||
131414524|NCT02449018|473142170|FG000|Overall Study|Protocol deviation|4|||
131414525|NCT02449018|473142171|FG001|Overall Study|Protocol deviation|0|||
131414526|NCT02449018|473142170|FG000|Overall Study|Patient decision|2|||
131414527|NCT02449018|473142171|FG001|Overall Study|Patient decision|0|||
131414528|NCT03995355|473142172|FG000|Overall Study|Adverse Event|1|||
131414529|NCT03995355|473142173|FG001|Overall Study|Adverse Event|0|||
131414530|NCT03995355|473142172|FG000|Overall Study|Withdrawal by Subject|1|||
131456340|NCT01731938|473301123|FG000|Preliminary Part I|Missed Week 6 visit|0|||
131949445|NCT00295646|475101364|FG000|Overall Study|Lost to Follow-up|0|||
131949446|NCT00295646|475101365|FG001|Overall Study|Lost to Follow-up|5|||
131414531|NCT03995355|473142173|FG001|Overall Study|Withdrawal by Subject|0|||
131414532|NCT03995355|473142172|FG000|Overall Study|Scheduling Issues|0|||
131414533|NCT03995355|473142173|FG001|Overall Study|Scheduling Issues|1|||
131414534|NCT00249613|473142174|FG000|12 Month Follow-up|Death|1|||
131414535|NCT00249613|473142175|FG001|12 Month Follow-up|Death|1|||
131949447|NCT00295646|475101366|FG002|Overall Study|Lost to Follow-up|1|||
131949448|NCT00295646|475101367|FG003|Overall Study|Lost to Follow-up|5|||
131949449|NCT00295646|475101364|FG000|Overall Study|Death|9|||
131949450|NCT00295646|475101365|FG001|Overall Study|Death|7|||
131949451|NCT00295646|475101366|FG002|Overall Study|Death|18|||
131949452|NCT00295646|475101367|FG003|Overall Study|Death|8|||
131949453|NCT02441101|475101368|FG000|Overall Study|Withdrawal by Subject|1|||
131949454|NCT02441101|475101369|FG001|Overall Study|Withdrawal by Subject|0|||
131949455|NCT02441101|475101368|FG000|Overall Study|Lost to Follow-up|1|||
131949456|NCT02441101|475101369|FG001|Overall Study|Lost to Follow-up|0|||
131949457|NCT02441101|475101368|FG000|Overall Study|PI relocated and study terminated|1|||
131949458|NCT02441101|475101369|FG001|Overall Study|PI relocated and study terminated|0|||
131414536|NCT00249613|473142174|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
131414537|NCT00249613|473142175|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
131414538|NCT00249613|473142174|FG000|12 Month Follow-up|Lost to Follow-up|10|||
131414539|NCT00249613|473142175|FG001|12 Month Follow-up|Lost to Follow-up|8|||
131414540|NCT00424190|473142204|FG000|Overall Study|Withdrew consent|3|||
131414541|NCT00424190|473142205|FG001|Overall Study|Withdrew consent|4|||
131414542|NCT00424190|473142204|FG000|Overall Study|Death|3|||
131414543|NCT00424190|473142205|FG001|Overall Study|Death|0|||
131414544|NCT00424190|473142204|FG000|Overall Study|Noncompliance|1|||
131414545|NCT00424190|473142205|FG001|Overall Study|Noncompliance|2|||
131414546|NCT00424190|473142204|FG000|Overall Study|Request of sponsor or investigator|0|||
131414547|NCT00424190|473142205|FG001|Overall Study|Request of sponsor or investigator|2|||
131414548|NCT00424190|473142204|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
131414549|NCT00424190|473142205|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
131414550|NCT00424190|473142204|FG000|Overall Study|Other|15|||
131414551|NCT00424190|473142205|FG001|Overall Study|Other|21|||
131414552|NCT00351273|473142206|FG000|Overall Study|Lost to Follow-up|1|||
131414553|NCT00351273|473142207|FG001|Overall Study|Lost to Follow-up|2|||
131414554|NCT00351273|473142208|FG002|Overall Study|Lost to Follow-up|5|||
131414555|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
131414556|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
131414557|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
131414558|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
131414559|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
131414560|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
131414561|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
131414562|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
131414563|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
131414564|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
131949459|NCT00995436|475101370|FG000|Overall Study|Withdrawal by Subject|2|||
131949460|NCT00995436|475101371|FG001|Overall Study|Withdrawal by Subject|5|||
131949461|NCT00995436|475101372|FG002|Overall Study|Withdrawal by Subject|0|||
131949462|NCT02720523|475101376|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
131949463|NCT02720523|475101377|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
131949464|NCT02720523|475101378|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
131949465|NCT02720523|475101379|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
131414565|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
131414566|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
131414567|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
131414568|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
131414569|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
131414570|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
131414571|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
131414572|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
131414573|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
131414574|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
131414575|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
131414576|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
131414577|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
131414578|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
131414579|NCT01672866|473142209|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
131414580|NCT01672866|473142210|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
131414581|NCT01672866|473142211|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
131414582|NCT01672866|473142209|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
131414583|NCT01672866|473142210|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
131414584|NCT01672866|473142211|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
131414585|NCT01672866|473142209|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
131414586|NCT01672866|473142210|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
131414587|NCT01672866|473142211|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
131414588|NCT01672866|473142209|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
131414589|NCT01672866|473142210|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
131949466|NCT02720523|475101380|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
131456341|NCT01731938|473301124|FG001|Preliminary Part I|Missed Week 6 visit|3|||
131456342|NCT01731938|473301123|FG000|Primary Part II|Withdrawal by Subject|5|||
131456343|NCT01731938|473301124|FG001|Primary Part II|Withdrawal by Subject|4|||
131456344|NCT01731938|473301123|FG000|Primary Part II|Lost to Follow-up|4|||
131456345|NCT01731938|473301124|FG001|Primary Part II|Lost to Follow-up|5|||
131456346|NCT01731938|473301123|FG000|Primary Part II|Death|2|||
131456347|NCT01731938|473301124|FG001|Primary Part II|Death|1|||
131456348|NCT01731938|473301123|FG000|Primary Part II|Missed Week 6 visit|2|||
131456349|NCT01731938|473301124|FG001|Primary Part II|Missed Week 6 visit|3|||
131456350|NCT04931888|473301125|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
131456351|NCT04931888|473301126|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
131456352|NCT04931888|473301127|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
131456353|NCT04931888|473301128|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
131456354|NCT00771953|473301129|FG000|Overall Study|Adverse Event|5|||
131456355|NCT00771953|473301130|FG001|Overall Study|Adverse Event|3|||
131456356|NCT00771953|473301129|FG000|Overall Study|Death|2|||
131456357|NCT00771953|473301130|FG001|Overall Study|Death|2|||
131456358|NCT00771953|473301129|FG000|Overall Study|Progression before active Tx|1|||
131456359|NCT00771953|473301130|FG001|Overall Study|Progression before active Tx|2|||
131456360|NCT00771953|473301129|FG000|Overall Study|Sponsor decision|1|||
131456361|NCT00771953|473301130|FG001|Overall Study|Sponsor decision|0|||
131456362|NCT00771953|473301129|FG000|Overall Study|Other complicating disease|1|||
131456363|NCT00771953|473301130|FG001|Overall Study|Other complicating disease|0|||
131456364|NCT00771953|473301129|FG000|Overall Study|Withdrawal by Subject|0|||
131456365|NCT00771953|473301130|FG001|Overall Study|Withdrawal by Subject|3|||
131456366|NCT00856518|473301134|FG000|Overall Study|Lost to Follow-up|4|||
131456367|NCT00856518|473301135|FG001|Overall Study|Lost to Follow-up|2|||
131456368|NCT00947193|473301136|FG000|Overall Study|Lost to Follow-up|1|||
131456369|NCT00947193|473301137|FG001|Overall Study|Lost to Follow-up|0|||
131456370|NCT00947193|473301136|FG000|Overall Study|Withdrawal by Subject|1|||
131456371|NCT00947193|473301137|FG001|Overall Study|Withdrawal by Subject|0|||
131456372|NCT00947193|473301136|FG000|Overall Study|Factor VIII >1%|1|||
131456373|NCT00947193|473301137|FG001|Overall Study|Factor VIII >1%|0|||
131456374|NCT01727024|473301138|FG000|Period 1|Lost to Follow-up|1|||
131456375|NCT01727024|473301139|FG001|Period 1|Lost to Follow-up|1|||
131456376|NCT01727024|473301138|FG000|Period 1|Withdrawal by Subject|2|||
131456377|NCT01727024|473301139|FG001|Period 1|Withdrawal by Subject|3|||
131456378|NCT01485172|473301140|FG000|Overall Study|Adverse Event|2|||
131456379|NCT01485172|473301141|FG001|Overall Study|Adverse Event|1|||
131456380|NCT01485172|473301142|FG002|Overall Study|Adverse Event|2|||
131456381|NCT01485172|473301143|FG003|Overall Study|Adverse Event|2|||
131456382|NCT01485172|473301144|FG004|Overall Study|Adverse Event|1|||
131456383|NCT01485172|473301145|FG005|Overall Study|Adverse Event|2|||
131456384|NCT01485172|473301140|FG000|Overall Study|Lack of Efficacy|2|||
131456385|NCT01485172|473301141|FG001|Overall Study|Lack of Efficacy|0|||
131456386|NCT01485172|473301142|FG002|Overall Study|Lack of Efficacy|0|||
131456387|NCT01485172|473301143|FG003|Overall Study|Lack of Efficacy|0|||
131456388|NCT01485172|473301144|FG004|Overall Study|Lack of Efficacy|0|||
131456389|NCT01485172|473301145|FG005|Overall Study|Lack of Efficacy|0|||
131456390|NCT01485172|473301140|FG000|Overall Study|Protocol Violation|0|||
131456391|NCT01485172|473301141|FG001|Overall Study|Protocol Violation|0|||
131456392|NCT01485172|473301142|FG002|Overall Study|Protocol Violation|4|||
131456393|NCT01485172|473301143|FG003|Overall Study|Protocol Violation|5|||
131456394|NCT01485172|473301144|FG004|Overall Study|Protocol Violation|1|||
131456395|NCT01485172|473301145|FG005|Overall Study|Protocol Violation|0|||
131456396|NCT01485172|473301140|FG000|Overall Study|Protocol defined stopping criteria|1|||
131949467|NCT02720523|475101381|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
131949468|NCT02720523|475101382|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
131949469|NCT02720523|475101376|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
131949470|NCT02720523|475101377|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131949471|NCT02720523|475101378|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131456397|NCT01485172|473301141|FG001|Overall Study|Protocol defined stopping criteria|0|||
131456398|NCT01485172|473301142|FG002|Overall Study|Protocol defined stopping criteria|0|||
131456399|NCT01485172|473301143|FG003|Overall Study|Protocol defined stopping criteria|0|||
131456400|NCT01485172|473301144|FG004|Overall Study|Protocol defined stopping criteria|1|||
131456401|NCT01485172|473301145|FG005|Overall Study|Protocol defined stopping criteria|0|||
131456402|NCT01485172|473301140|FG000|Overall Study|Lost to Follow-up|0|||
131456403|NCT01485172|473301141|FG001|Overall Study|Lost to Follow-up|0|||
131456404|NCT01485172|473301142|FG002|Overall Study|Lost to Follow-up|1|||
131949472|NCT02720523|475101379|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131949473|NCT02720523|475101380|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131456405|NCT01485172|473301143|FG003|Overall Study|Lost to Follow-up|0|||
131456406|NCT01485172|473301144|FG004|Overall Study|Lost to Follow-up|0|||
131456407|NCT01485172|473301145|FG005|Overall Study|Lost to Follow-up|1|||
131456408|NCT01485172|473301140|FG000|Overall Study|Physician Decision|0|||
131456409|NCT01485172|473301141|FG001|Overall Study|Physician Decision|0|||
131949474|NCT02720523|475101381|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131949475|NCT02720523|475101382|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
131949476|NCT02720523|475101376|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
131949477|NCT02720523|475101377|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
131949478|NCT02720523|475101378|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
131949479|NCT02720523|475101379|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
131949480|NCT02720523|475101380|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
131949481|NCT02720523|475101381|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
131949482|NCT02720523|475101382|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
131949483|NCT02720523|475101376|FG000|Period 1: Placebo-controlled Period|Other|0|||
131949484|NCT02720523|475101377|FG001|Period 1: Placebo-controlled Period|Other|0|||
131949485|NCT02720523|475101378|FG002|Period 1: Placebo-controlled Period|Other|1|||
131949486|NCT02720523|475101379|FG003|Period 1: Placebo-controlled Period|Other|1|||
131949487|NCT02720523|475101380|FG004|Period 1: Placebo-controlled Period|Other|0|||
131949488|NCT02720523|475101381|FG005|Period 1: Placebo-controlled Period|Other|0|||
131949489|NCT02720523|475101382|FG006|Period 1: Placebo-controlled Period|Other|0|||
131949490|NCT02720523|475101376|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
131949491|NCT02720523|475101377|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
131949492|NCT02720523|475101378|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
131949493|NCT02720523|475101379|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
131949494|NCT02720523|475101380|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
131949495|NCT02720523|475101381|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
131949496|NCT02720523|475101382|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
131949497|NCT02720523|475101376|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
131949498|NCT02720523|475101377|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
131949499|NCT02720523|475101378|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
131949500|NCT02720523|475101379|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
131949501|NCT02720523|475101380|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
131949502|NCT02720523|475101381|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
131949503|NCT02720523|475101382|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
131949504|NCT02720523|475101376|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
131949505|NCT02720523|475101377|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
131949506|NCT02720523|475101378|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
131949507|NCT02720523|475101379|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
131949508|NCT02720523|475101380|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
131949509|NCT02720523|475101381|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
131949510|NCT02720523|475101382|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
131949511|NCT02720523|475101376|FG000|Period 2: Long-term Extension Period|Other|0|||
131949512|NCT02720523|475101377|FG001|Period 2: Long-term Extension Period|Other|0|||
131949513|NCT02720523|475101378|FG002|Period 2: Long-term Extension Period|Other|0|||
131949514|NCT02720523|475101379|FG003|Period 2: Long-term Extension Period|Other|0|||
131949515|NCT02720523|475101380|FG004|Period 2: Long-term Extension Period|Other|2|||
131949516|NCT02720523|475101381|FG005|Period 2: Long-term Extension Period|Other|0|||
131949517|NCT02720523|475101382|FG006|Period 2: Long-term Extension Period|Other|3|||
131949518|NCT01890265|475101384|FG000|Overall Study|Other (Unspecified reason)|0|||
131949519|NCT01890265|475101385|FG001|Overall Study|Other (Unspecified reason)|1|||
131949520|NCT01890265|475101386|FG002|Overall Study|Other (Unspecified reason)|0|||
131949521|NCT01890265|475101387|FG003|Overall Study|Other (Unspecified reason)|0|||
131949522|NCT01890265|475101388|FG004|Overall Study|Other (Unspecified reason)|0|||
131949523|NCT01890265|475101389|FG005|Overall Study|Other (Unspecified reason)|0|||
131949524|NCT01890265|475101384|FG000|Overall Study|Progressive disease|6|||
131949525|NCT01890265|475101385|FG001|Overall Study|Progressive disease|6|||
131949526|NCT01890265|475101386|FG002|Overall Study|Progressive disease|0|||
131949527|NCT01890265|475101387|FG003|Overall Study|Progressive disease|0|||
131949528|NCT01890265|475101388|FG004|Overall Study|Progressive disease|0|||
131949529|NCT01890265|475101389|FG005|Overall Study|Progressive disease|0|||
131949530|NCT01890265|475101384|FG000|Overall Study|Adverse Event|2|||
131949531|NCT01890265|475101385|FG001|Overall Study|Adverse Event|1|||
131949532|NCT01890265|475101386|FG002|Overall Study|Adverse Event|0|||
131949533|NCT01890265|475101387|FG003|Overall Study|Adverse Event|0|||
131949534|NCT01890265|475101388|FG004|Overall Study|Adverse Event|0|||
131949535|NCT01890265|475101389|FG005|Overall Study|Adverse Event|0|||
131949536|NCT01890265|475101384|FG000|Overall Study|Death|2|||
131949537|NCT01890265|475101385|FG001|Overall Study|Death|3|||
131949538|NCT01890265|475101386|FG002|Overall Study|Death|1|||
131949539|NCT01890265|475101387|FG003|Overall Study|Death|0|||
131949540|NCT01890265|475101388|FG004|Overall Study|Death|0|||
131949541|NCT01890265|475101389|FG005|Overall Study|Death|0|||
131949542|NCT01890265|475101384|FG000|Overall Study|Withdrawal by Subject|0|||
131949543|NCT01890265|475101385|FG001|Overall Study|Withdrawal by Subject|2|||
131949544|NCT01890265|475101386|FG002|Overall Study|Withdrawal by Subject|3|||
131949545|NCT01890265|475101387|FG003|Overall Study|Withdrawal by Subject|0|||
131949546|NCT01890265|475101388|FG004|Overall Study|Withdrawal by Subject|2|||
131949547|NCT01890265|475101389|FG005|Overall Study|Withdrawal by Subject|0|||
131949548|NCT01445613|475101390|FG000|30-day Follow-up|Withdrawal by Subject|6|||
131949549|NCT01445613|475101390|FG000|30-day Follow-up|Physician Decision|3|||
131949550|NCT01445613|475101390|FG000|30-day Follow-up|Missed visit|23|||
131949551|NCT01445613|475101390|FG000|30-day Follow-up|Death|3|||
131949552|NCT01445613|475101390|FG000|1-year Follow-up|Withdrawal by Subject|12|||
131949553|NCT01445613|475101390|FG000|1-year Follow-up|Missed visit|29|||
131949554|NCT01445613|475101390|FG000|1-year Follow-up|Lost to Follow-up|2|||
131949555|NCT01445613|475101390|FG000|1-year Follow-up|Death|30|||
131949556|NCT01445613|475101390|FG000|1-year Follow-up|Physician Decision|2|||
131949557|NCT01445613|475101390|FG000|1-year Follow-up|Received a non-study stent|2|||
131949558|NCT02131662|475101391|FG000|Overall Study|Protocol Violation|1|||
131949559|NCT02131662|475101392|FG001|Overall Study|Protocol Violation|0|||
131949560|NCT02131662|475101393|FG002|Overall Study|Protocol Violation|0|||
131949561|NCT02131662|475101394|FG003|Overall Study|Protocol Violation|0|||
131949562|NCT02131662|475101395|FG004|Overall Study|Protocol Violation|0|||
131949563|NCT02131662|475101391|FG000|Overall Study|Other|2|||
131949564|NCT02131662|475101392|FG001|Overall Study|Other|4|||
131949565|NCT02131662|475101393|FG002|Overall Study|Other|3|||
131949566|NCT02131662|475101394|FG003|Overall Study|Other|3|||
131949567|NCT02131662|475101395|FG004|Overall Study|Other|4|||
131949568|NCT02131662|475101391|FG000|Overall Study|Adverse Event|0|||
131949569|NCT02131662|475101392|FG001|Overall Study|Adverse Event|1|||
131949570|NCT02131662|475101393|FG002|Overall Study|Adverse Event|1|||
131949571|NCT02131662|475101394|FG003|Overall Study|Adverse Event|1|||
131949572|NCT02131662|475101395|FG004|Overall Study|Adverse Event|3|||
131949573|NCT02131662|475101391|FG000|Overall Study|Pregnancy|0|||
131949574|NCT02131662|475101392|FG001|Overall Study|Pregnancy|1|||
131949575|NCT02131662|475101393|FG002|Overall Study|Pregnancy|0|||
131949576|NCT02131662|475101394|FG003|Overall Study|Pregnancy|1|||
131949577|NCT02131662|475101395|FG004|Overall Study|Pregnancy|0|||
131949578|NCT02131662|475101391|FG000|Overall Study|Wish for pregnancy|0|||
131949579|NCT02131662|475101392|FG001|Overall Study|Wish for pregnancy|0|||
131949580|NCT02131662|475101393|FG002|Overall Study|Wish for pregnancy|0|||
131949581|NCT02131662|475101394|FG003|Overall Study|Wish for pregnancy|0|||
131949582|NCT02131662|475101395|FG004|Overall Study|Wish for pregnancy|1|||
131949583|NCT02131662|475101391|FG000|Overall Study|Lack of Efficacy|1|||
131949584|NCT02131662|475101392|FG001|Overall Study|Lack of Efficacy|0|||
131949585|NCT02131662|475101393|FG002|Overall Study|Lack of Efficacy|0|||
131949586|NCT02131662|475101394|FG003|Overall Study|Lack of Efficacy|0|||
131949587|NCT02131662|475101395|FG004|Overall Study|Lack of Efficacy|1|||
131949588|NCT02131662|475101391|FG000|Overall Study|Withdrawal by Subject|1|||
131949589|NCT02131662|475101392|FG001|Overall Study|Withdrawal by Subject|5|||
131949590|NCT02131662|475101393|FG002|Overall Study|Withdrawal by Subject|1|||
131949591|NCT02131662|475101394|FG003|Overall Study|Withdrawal by Subject|5|||
131949592|NCT02131662|475101395|FG004|Overall Study|Withdrawal by Subject|6|||
131949593|NCT02131662|475101391|FG000|Overall Study|Lost to Follow-up|1|||
131949594|NCT02131662|475101392|FG001|Overall Study|Lost to Follow-up|3|||
131949595|NCT02131662|475101393|FG002|Overall Study|Lost to Follow-up|0|||
131949596|NCT02131662|475101394|FG003|Overall Study|Lost to Follow-up|9|||
131949597|NCT02131662|475101395|FG004|Overall Study|Lost to Follow-up|0|||
131949598|NCT02131662|475101391|FG000|Overall Study|Not treated|2|||
131949599|NCT02131662|475101392|FG001|Overall Study|Not treated|0|||
131949600|NCT02131662|475101393|FG002|Overall Study|Not treated|2|||
131949601|NCT02131662|475101394|FG003|Overall Study|Not treated|2|||
131949602|NCT02131662|475101395|FG004|Overall Study|Not treated|3|||
131949603|NCT03554018|475101396|FG000|Overall Study|Lost to Follow-up|3|||
131949604|NCT03554018|475101397|FG001|Overall Study|Lost to Follow-up|7|||
131949605|NCT01154452|475101399|FG000|Phase Ib|Not Treated|1|||
131949606|NCT01154452|475101400|FG001|Phase Ib|Not Treated|0|||
131949607|NCT01154452|475101401|FG002|Phase Ib|Not Treated|0|||
131949608|NCT01154452|475101402|FG003|Phase Ib|Not Treated|0|||
131949609|NCT01154452|475101399|FG000|Phase Ib|Adverse Event|2|||
131949610|NCT01154452|475101400|FG001|Phase Ib|Adverse Event|1|||
131949611|NCT01154452|475101401|FG002|Phase Ib|Adverse Event|0|||
131949612|NCT01154452|475101402|FG003|Phase Ib|Adverse Event|0|||
131414590|NCT01672866|473142211|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
131414591|NCT01672866|473142209|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
131949613|NCT01154452|475101399|FG000|Phase II|Withdrawal by Subject|0|||
131949614|NCT01154452|475101400|FG001|Phase II|Withdrawal by Subject|0|||
131949615|NCT01154452|475101401|FG002|Phase II|Withdrawal by Subject|1|||
131949616|NCT01154452|475101402|FG003|Phase II|Withdrawal by Subject|2|||
131949617|NCT01154452|475101399|FG000|Phase II|Adverse Event|0|||
131949618|NCT01154452|475101400|FG001|Phase II|Adverse Event|0|||
131949619|NCT01154452|475101401|FG002|Phase II|Adverse Event|4|||
131949620|NCT01154452|475101402|FG003|Phase II|Adverse Event|4|||
131949621|NCT00809926|475101403|FG000|Overall Study|Adverse Event|18|||
131949622|NCT00809926|475101404|FG001|Overall Study|Adverse Event|10|||
131949623|NCT00809926|475101403|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
131949624|NCT00809926|475101404|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131949625|NCT00809926|475101403|FG000|Overall Study|Patient withdrew consent|8|||
131456410|NCT01485172|473301142|FG002|Overall Study|Physician Decision|0|||
131456411|NCT01485172|473301143|FG003|Overall Study|Physician Decision|0|||
131456412|NCT01485172|473301144|FG004|Overall Study|Physician Decision|1|||
131456413|NCT01485172|473301145|FG005|Overall Study|Physician Decision|0|||
131456414|NCT01485172|473301140|FG000|Overall Study|Withdrawal by Subject|2|||
131456415|NCT01485172|473301141|FG001|Overall Study|Withdrawal by Subject|0|||
131456416|NCT01485172|473301142|FG002|Overall Study|Withdrawal by Subject|0|||
131456417|NCT01485172|473301143|FG003|Overall Study|Withdrawal by Subject|1|||
131456418|NCT01485172|473301144|FG004|Overall Study|Withdrawal by Subject|1|||
131456419|NCT01485172|473301145|FG005|Overall Study|Withdrawal by Subject|1|||
131456420|NCT03801031|473301150|FG000|Overall Study|Lost to Follow-up|1|||
131456421|NCT03801031|473301151|FG001|Overall Study|Lost to Follow-up|0|||
131456422|NCT03801031|473301150|FG000|Overall Study|Unable to comply|1|||
131456423|NCT03801031|473301151|FG001|Overall Study|Unable to comply|0|||
131456424|NCT03801031|473301150|FG000|Overall Study|Withdrawal by Subject|0|||
131456425|NCT03801031|473301151|FG001|Overall Study|Withdrawal by Subject|1|||
131456426|NCT01409811|473301152|FG000|Overall Study|Insurance denial|1|||
131456427|NCT01942733|473301153|FG000|Overall Study|Lost to Follow-up|1|||
131456428|NCT01942733|473301153|FG000|Overall Study|Non-compliance with IMP|1|||
131456429|NCT01942733|473301153|FG000|Overall Study|Administrative|1|||
131456430|NCT00139477|473301154|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
131456431|NCT00139477|473301155|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
131456432|NCT00139477|473301154|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
131456433|NCT00139477|473301155|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
131456434|NCT00139477|473301154|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
131456435|NCT00139477|473301155|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
131456436|NCT00139477|473301154|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
131456437|NCT00139477|473301155|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
131456438|NCT00139477|473301154|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
131456439|NCT00139477|473301155|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
131456440|NCT00139477|473301154|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
131456441|NCT00139477|473301155|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
131456442|NCT00139477|473301154|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
131456443|NCT00139477|473301155|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
131456444|NCT00975780|473301159|FG000|Follow Up|Death|88|||
131456445|NCT00975780|473301160|FG001|Follow Up|Death|122|||
131456446|NCT00975780|473301159|FG000|Follow Up|Facility Withdrawal|7|||
131949626|NCT00809926|475101404|FG001|Overall Study|Patient withdrew consent|6|||
131949627|NCT00809926|475101403|FG000|Overall Study|Lost to Follow-up|2|||
131949628|NCT00809926|475101404|FG001|Overall Study|Lost to Follow-up|1|||
131949629|NCT00809926|475101403|FG000|Overall Study|Administrative Problems|0|||
131949630|NCT00809926|475101404|FG001|Overall Study|Administrative Problems|1|||
131949631|NCT00809926|475101403|FG000|Overall Study|Protocol deviation|0|||
131949632|NCT00809926|475101404|FG001|Overall Study|Protocol deviation|2|||
131949633|NCT00130039|475101409|FG000|Overall Study|Withdrawal by Subject|15|||
131949634|NCT00130039|475101410|FG001|Overall Study|Withdrawal by Subject|11|||
131949635|NCT00130039|475101409|FG000|Overall Study|Lost to Follow-up|3|||
131949636|NCT00130039|475101410|FG001|Overall Study|Lost to Follow-up|1|||
131949637|NCT00130039|475101409|FG000|Overall Study|Adverse Event|4|||
131949638|NCT00130039|475101410|FG001|Overall Study|Adverse Event|2|||
131949639|NCT00130039|475101409|FG000|Overall Study|Physician Decision|3|||
131949640|NCT00130039|475101410|FG001|Overall Study|Physician Decision|0|||
131949641|NCT00130039|475101409|FG000|Overall Study|clinical events without follow up MRI|5|||
131949642|NCT00130039|475101410|FG001|Overall Study|clinical events without follow up MRI|4|||
131949643|NCT00642707|475101411|FG000|Overall Study|Adverse Event|0|||
131949644|NCT00642707|475101412|FG001|Overall Study|Adverse Event|0|||
131414592|NCT01672866|473142210|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
131414593|NCT01672866|473142211|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
131414594|NCT01378429|473142214|FG000|Overall Study|Noncompliance with study drug|1|||
131414595|NCT01378429|473142215|FG001|Overall Study|Noncompliance with study drug|0|||
131414596|NCT02241187|473142216|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
131414597|NCT00199888|473142217|FG000|Overall Study|Lost to Follow-up|1|||
131414598|NCT05219669|473142218|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
131414599|NCT05219669|473142219|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
131414600|NCT05219669|473142220|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
131414601|NCT05219669|473142221|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
131414602|NCT05219669|473142222|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
131414603|NCT05219669|473142223|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
131414604|NCT02544373|473142225|FG000|Overall Study|Lost to Follow-up|5|||
131414605|NCT02544373|473142226|FG001|Overall Study|Lost to Follow-up|3|||
131456447|NCT00975780|473301160|FG001|Follow Up|Facility Withdrawal|23|||
131456448|NCT00975780|473301159|FG000|Follow Up|Discharged from Facility|7|||
131456449|NCT00975780|473301160|FG001|Follow Up|Discharged from Facility|12|||
131456450|NCT02625909|473301163|FG000|Overall Study|Death|2|||
131949645|NCT00642707|475101413|FG002|Overall Study|Adverse Event|0|||
131949646|NCT00642707|475101414|FG003|Overall Study|Adverse Event|2|||
131949647|NCT00642707|475101411|FG000|Overall Study|Withdrawal by Subject|1|||
131949648|NCT00642707|475101412|FG001|Overall Study|Withdrawal by Subject|0|||
131949649|NCT00642707|475101413|FG002|Overall Study|Withdrawal by Subject|0|||
131949650|NCT00642707|475101414|FG003|Overall Study|Withdrawal by Subject|0|||
131949651|NCT01740687|475101426|FG000|Overall Study|Lost to Follow-up|11|||
131949652|NCT01740687|475101426|FG000|Overall Study|Withdrawal by Subject|2|||
131949653|NCT01740687|475101426|FG000|Overall Study|other reason|22|||
131949654|NCT01740687|475101426|FG000|Overall Study|treatment not received|2|||
131949655|NCT02712996|475101430|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
131949656|NCT02712996|475101431|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
131949657|NCT03159468|475101433|FG000|Overall Study|Withdrawal by Subject|0|||
131949658|NCT03159468|475101434|FG001|Overall Study|Withdrawal by Subject|0|||
131949659|NCT03159468|475101435|FG002|Overall Study|Withdrawal by Subject|3|||
131949660|NCT03159468|475101436|FG003|Overall Study|Withdrawal by Subject|0|||
131949661|NCT03159468|475101437|FG004|Overall Study|Withdrawal by Subject|0|||
131949662|NCT03159468|475101438|FG005|Overall Study|Withdrawal by Subject|0|||
131949663|NCT00283803|475103151|FG000|Overall Study|Physician Decision|9|||
131949664|NCT00283803|475103151|FG000|Overall Study|Withdrawal by Subject|4|||
131949665|NCT01566149|475103153|FG000|Overall Study|Adverse Event|0|||
131949666|NCT01566149|475103154|FG001|Overall Study|Adverse Event|1|||
131949667|NCT01566149|475103153|FG000|Overall Study|Non-compliance with study medication|2|||
131949668|NCT01566149|475103154|FG001|Overall Study|Non-compliance with study medication|0|||
131949669|NCT01566149|475103153|FG000|Overall Study|Protocol Violation|0|||
131949670|NCT01566149|475103154|FG001|Overall Study|Protocol Violation|1|||
131949671|NCT01566149|475103153|FG000|Overall Study|Withdrawal by Subject|1|||
131949672|NCT01566149|475103154|FG001|Overall Study|Withdrawal by Subject|0|||
131949673|NCT03276728|475103156|FG000|Overall Study|Lost to Follow-up|0|||
131949674|NCT03276728|475103157|FG001|Overall Study|Lost to Follow-up|0|||
131949675|NCT03276728|475103158|FG002|Overall Study|Lost to Follow-up|2|||
131949676|NCT03276728|475103159|FG003|Overall Study|Lost to Follow-up|2|||
131949677|NCT03276728|475103160|FG004|Overall Study|Lost to Follow-up|0|||
131949678|NCT03276728|475103161|FG005|Overall Study|Lost to Follow-up|0|||
131949679|NCT03276728|475103162|FG006|Overall Study|Lost to Follow-up|0|||
131949680|NCT03276728|475103163|FG007|Overall Study|Lost to Follow-up|0|||
131949681|NCT03276728|475103156|FG000|Overall Study|Withdrawal by Subject|0|||
131949682|NCT03276728|475103157|FG001|Overall Study|Withdrawal by Subject|0|||
131949683|NCT03276728|475103158|FG002|Overall Study|Withdrawal by Subject|0|||
131949684|NCT03276728|475103159|FG003|Overall Study|Withdrawal by Subject|3|||
131949685|NCT03276728|475103160|FG004|Overall Study|Withdrawal by Subject|0|||
131949686|NCT03276728|475103161|FG005|Overall Study|Withdrawal by Subject|0|||
131949687|NCT03276728|475103162|FG006|Overall Study|Withdrawal by Subject|0|||
131949688|NCT03276728|475103163|FG007|Overall Study|Withdrawal by Subject|0|||
131949689|NCT03276728|475103156|FG000|Overall Study|Decision by sponsor|0|||
131949690|NCT03276728|475103157|FG001|Overall Study|Decision by sponsor|0|||
131949691|NCT03276728|475103158|FG002|Overall Study|Decision by sponsor|0|||
131949692|NCT03276728|475103159|FG003|Overall Study|Decision by sponsor|0|||
131949693|NCT03276728|475103160|FG004|Overall Study|Decision by sponsor|1|||
131949694|NCT03276728|475103161|FG005|Overall Study|Decision by sponsor|0|||
131949695|NCT03276728|475103162|FG006|Overall Study|Decision by sponsor|2|||
131949696|NCT03276728|475103163|FG007|Overall Study|Decision by sponsor|1|||
131949697|NCT03941873|475103164|FG000|Overall Study|Death|0|||
131949698|NCT03941873|475103165|FG001|Overall Study|Death|12|||
131949699|NCT03941873|475103166|FG002|Overall Study|Death|2|||
131949700|NCT03941873|475103167|FG003|Overall Study|Death|53|||
131949701|NCT03941873|475103164|FG000|Overall Study|Withdrawal by Subject|1|||
131949702|NCT03941873|475103165|FG001|Overall Study|Withdrawal by Subject|1|||
131949703|NCT03941873|475103166|FG002|Overall Study|Withdrawal by Subject|0|||
131949704|NCT03941873|475103167|FG003|Overall Study|Withdrawal by Subject|5|||
131949705|NCT03941873|475103164|FG000|Overall Study|Lost to Follow-up|1|||
131949706|NCT03941873|475103165|FG001|Overall Study|Lost to Follow-up|2|||
131949707|NCT03941873|475103166|FG002|Overall Study|Lost to Follow-up|0|||
131414606|NCT02544373|473142225|FG000|Overall Study|Withdrawal by Subject|8|||
131949708|NCT03941873|475103167|FG003|Overall Study|Lost to Follow-up|0|||
131949709|NCT03941873|475103164|FG000|Overall Study|Sponsor Decision|0|||
131949710|NCT03941873|475103165|FG001|Overall Study|Sponsor Decision|6|||
131949711|NCT03941873|475103166|FG002|Overall Study|Sponsor Decision|0|||
131414607|NCT02544373|473142226|FG001|Overall Study|Withdrawal by Subject|2|||
131949712|NCT03941873|475103167|FG003|Overall Study|Sponsor Decision|15|||
131949713|NCT01238991|475103170|FG000|Overall Study|Adverse Event|1|||
131949714|NCT01238991|475103171|FG001|Overall Study|Adverse Event|0|||
131949715|NCT01238991|475103172|FG002|Overall Study|Adverse Event|3|||
131949716|NCT01238991|475103173|FG003|Overall Study|Adverse Event|1|||
131949717|NCT01238991|475103174|FG004|Overall Study|Adverse Event|1|||
131414608|NCT02621073|473142227|FG000|Overall Study|Lost to Follow-up|0|||
131949718|NCT01238991|475103175|FG005|Overall Study|Adverse Event|0|||
131949719|NCT01238991|475103176|FG006|Overall Study|Adverse Event|1|||
131456451|NCT02625909|473301164|FG001|Overall Study|Death|0|||
131456452|NCT02625909|473301163|FG000|Overall Study|Lost to Follow-up|3|||
131456453|NCT02625909|473301164|FG001|Overall Study|Lost to Follow-up|5|||
131949720|NCT01238991|475103177|FG007|Overall Study|Adverse Event|1|||
131949721|NCT01238991|475103178|FG008|Overall Study|Adverse Event|0|||
131949722|NCT01238991|475103179|FG009|Overall Study|Adverse Event|0|||
131949723|NCT01238991|475103170|FG000|Overall Study|Death|0|||
131949724|NCT01238991|475103171|FG001|Overall Study|Death|0|||
131949725|NCT01238991|475103172|FG002|Overall Study|Death|0|||
131949726|NCT01238991|475103173|FG003|Overall Study|Death|1|||
131949727|NCT01238991|475103174|FG004|Overall Study|Death|0|||
131949728|NCT01238991|475103175|FG005|Overall Study|Death|0|||
131456454|NCT02625909|473301163|FG000|Overall Study|Lack of Efficacy|9|||
131456455|NCT02625909|473301164|FG001|Overall Study|Lack of Efficacy|2|||
131456456|NCT02625909|473301163|FG000|Overall Study|Reinfection|3|||
131949729|NCT01238991|475103176|FG006|Overall Study|Death|0|||
131949730|NCT01238991|475103177|FG007|Overall Study|Death|0|||
131949731|NCT01238991|475103178|FG008|Overall Study|Death|0|||
131949732|NCT01238991|475103179|FG009|Overall Study|Death|0|||
131949733|NCT01238991|475103170|FG000|Overall Study|Lack of Efficacy|0|||
131949734|NCT01238991|475103171|FG001|Overall Study|Lack of Efficacy|0|||
131949735|NCT01238991|475103172|FG002|Overall Study|Lack of Efficacy|1|||
131949736|NCT01238991|475103173|FG003|Overall Study|Lack of Efficacy|0|||
131949737|NCT01238991|475103174|FG004|Overall Study|Lack of Efficacy|0|||
131949738|NCT01238991|475103175|FG005|Overall Study|Lack of Efficacy|0|||
131456457|NCT02625909|473301164|FG001|Overall Study|Reinfection|2|||
131456458|NCT03051178|473301165|FG000|Overall Study|Withdrawal by Subject|5|||
131456459|NCT00953056|473301166|FG000|Overall Study|Withdrew Consent|0|||
131456460|NCT00953056|473301167|FG001|Overall Study|Withdrew Consent|0|||
131456461|NCT00953056|473301168|FG002|Overall Study|Withdrew Consent|0|||
131456462|NCT00953056|473301169|FG003|Overall Study|Withdrew Consent|0|||
131456463|NCT00953056|473301170|FG004|Overall Study|Withdrew Consent|2|||
131456464|NCT00953056|473301171|FG005|Overall Study|Withdrew Consent|3|||
131456465|NCT00953056|473301166|FG000|Overall Study|Serious Adverse Event|0|||
131456466|NCT00953056|473301167|FG001|Overall Study|Serious Adverse Event|0|||
131456467|NCT00953056|473301168|FG002|Overall Study|Serious Adverse Event|0|||
131456468|NCT00953056|473301169|FG003|Overall Study|Serious Adverse Event|0|||
131456469|NCT00953056|473301170|FG004|Overall Study|Serious Adverse Event|0|||
131456470|NCT00953056|473301171|FG005|Overall Study|Serious Adverse Event|1|||
131456471|NCT01598506|473301172|FG000|Overall Study|Withdrawal by Subject|2|||
131456472|NCT01976741|473301179|FG000|Overall Study|Withdrawal by Subject|1|||
131456473|NCT01976741|473301180|FG001|Overall Study|Withdrawal by Subject|0|||
131456474|NCT01976741|473301181|FG002|Overall Study|Withdrawal by Subject|1|||
131456475|NCT01976741|473301182|FG003|Overall Study|Withdrawal by Subject|1|||
131456476|NCT01976741|473301183|FG004|Overall Study|Withdrawal by Subject|0|||
131456477|NCT01976741|473301184|FG005|Overall Study|Withdrawal by Subject|0|||
131456478|NCT01976741|473301185|FG006|Overall Study|Withdrawal by Subject|1|||
131456479|NCT01976741|473301186|FG007|Overall Study|Withdrawal by Subject|4|||
131456480|NCT01976741|473301187|FG008|Overall Study|Withdrawal by Subject|0|||
131456481|NCT01976741|473301188|FG009|Overall Study|Withdrawal by Subject|0|||
131456482|NCT01976741|473301179|FG000|Overall Study|Adverse Event|0|||
131456483|NCT01976741|473301180|FG001|Overall Study|Adverse Event|0|||
131456484|NCT01976741|473301181|FG002|Overall Study|Adverse Event|2|||
131456485|NCT01976741|473301182|FG003|Overall Study|Adverse Event|0|||
131456486|NCT01976741|473301183|FG004|Overall Study|Adverse Event|0|||
131456487|NCT01976741|473301184|FG005|Overall Study|Adverse Event|0|||
131949739|NCT01238991|475103176|FG006|Overall Study|Lack of Efficacy|0|||
131949740|NCT01238991|475103177|FG007|Overall Study|Lack of Efficacy|0|||
131949741|NCT01238991|475103178|FG008|Overall Study|Lack of Efficacy|1|||
131949742|NCT01238991|475103179|FG009|Overall Study|Lack of Efficacy|0|||
131949743|NCT01238991|475103170|FG000|Overall Study|Withdrawal by Subject|0|||
131949744|NCT01238991|475103171|FG001|Overall Study|Withdrawal by Subject|0|||
131949745|NCT01238991|475103172|FG002|Overall Study|Withdrawal by Subject|1|||
131949746|NCT01238991|475103173|FG003|Overall Study|Withdrawal by Subject|0|||
131949747|NCT01238991|475103174|FG004|Overall Study|Withdrawal by Subject|0|||
131949748|NCT01238991|475103175|FG005|Overall Study|Withdrawal by Subject|0|||
131949749|NCT01238991|475103176|FG006|Overall Study|Withdrawal by Subject|0|||
131949750|NCT01238991|475103177|FG007|Overall Study|Withdrawal by Subject|0|||
131949751|NCT01238991|475103178|FG008|Overall Study|Withdrawal by Subject|0|||
131456488|NCT01976741|473301185|FG006|Overall Study|Adverse Event|3|||
131456489|NCT01976741|473301186|FG007|Overall Study|Adverse Event|8|||
131456490|NCT01976741|473301187|FG008|Overall Study|Adverse Event|1|||
131456491|NCT01976741|473301188|FG009|Overall Study|Adverse Event|4|||
131456492|NCT03350672|473301194|FG000|Overall Study|Withdrawal by Subject|7|||
131456493|NCT03350672|473301195|FG001|Overall Study|Withdrawal by Subject|0|||
131456494|NCT03350672|473301196|FG002|Overall Study|Withdrawal by Subject|0|||
131456495|NCT01459497|473301197|FG000|Overall Study|Inability to meet trial constraints.|1|||
131456496|NCT01459497|473301198|FG001|Overall Study|Inability to meet trial constraints.|0|||
131949752|NCT01238991|475103179|FG009|Overall Study|Withdrawal by Subject|0|||
131949753|NCT01238991|475103170|FG000|Overall Study|Study Terminated by Sponsor|0|||
131949754|NCT01238991|475103171|FG001|Overall Study|Study Terminated by Sponsor|0|||
131949755|NCT01238991|475103172|FG002|Overall Study|Study Terminated by Sponsor|0|||
131949756|NCT01238991|475103173|FG003|Overall Study|Study Terminated by Sponsor|0|||
131949757|NCT01238991|475103174|FG004|Overall Study|Study Terminated by Sponsor|1|||
131949758|NCT01238991|475103175|FG005|Overall Study|Study Terminated by Sponsor|0|||
131949759|NCT01238991|475103176|FG006|Overall Study|Study Terminated by Sponsor|7|||
131949760|NCT01238991|475103177|FG007|Overall Study|Study Terminated by Sponsor|4|||
131949761|NCT01238991|475103178|FG008|Overall Study|Study Terminated by Sponsor|2|||
131949762|NCT01238991|475103179|FG009|Overall Study|Study Terminated by Sponsor|2|||
131949763|NCT01238991|475103170|FG000|Overall Study|Caregiver's request|0|||
131949764|NCT01238991|475103171|FG001|Overall Study|Caregiver's request|0|||
131949765|NCT01238991|475103172|FG002|Overall Study|Caregiver's request|0|||
131949766|NCT01238991|475103173|FG003|Overall Study|Caregiver's request|0|||
131949767|NCT01238991|475103174|FG004|Overall Study|Caregiver's request|0|||
131949768|NCT01238991|475103175|FG005|Overall Study|Caregiver's request|0|||
131949769|NCT01238991|475103176|FG006|Overall Study|Caregiver's request|0|||
131949770|NCT01238991|475103177|FG007|Overall Study|Caregiver's request|0|||
131949771|NCT01238991|475103178|FG008|Overall Study|Caregiver's request|1|||
131949772|NCT01238991|475103179|FG009|Overall Study|Caregiver's request|0|||
131949773|NCT01238991|475103170|FG000|Overall Study|Admission to a nursing home|1|||
131949774|NCT01238991|475103171|FG001|Overall Study|Admission to a nursing home|0|||
131949775|NCT01238991|475103172|FG002|Overall Study|Admission to a nursing home|1|||
131949776|NCT01238991|475103173|FG003|Overall Study|Admission to a nursing home|0|||
131949777|NCT01238991|475103174|FG004|Overall Study|Admission to a nursing home|0|||
131949778|NCT01238991|475103175|FG005|Overall Study|Admission to a nursing home|0|||
131949779|NCT01238991|475103176|FG006|Overall Study|Admission to a nursing home|0|||
131949780|NCT01238991|475103177|FG007|Overall Study|Admission to a nursing home|0|||
131949781|NCT01238991|475103178|FG008|Overall Study|Admission to a nursing home|0|||
131949782|NCT01238991|475103179|FG009|Overall Study|Admission to a nursing home|0|||
131949783|NCT03370419|475103180|FG000|Overall Study|Lost to Follow-up|16|||
131949784|NCT02297815|475103186|FG000|Overall Study|Lost to Follow-up|236|||
131949785|NCT02297815|475103187|FG001|Overall Study|Lost to Follow-up|140|||
131949786|NCT00662831|475103188|FG000|Overall Study|Death|4|||
131949787|NCT00662831|475103189|FG001|Overall Study|Death|1|||
131949788|NCT00662831|475103188|FG000|Overall Study|Lack of Efficacy|6|||
131949789|NCT00662831|475103189|FG001|Overall Study|Lack of Efficacy|6|||
131949790|NCT00662831|475103188|FG000|Overall Study|Lost to Follow-up|1|||
131949791|NCT00662831|475103189|FG001|Overall Study|Lost to Follow-up|0|||
131949792|NCT00662831|475103188|FG000|Overall Study|Withdrawal by Subject|2|||
131949793|NCT00662831|475103189|FG001|Overall Study|Withdrawal by Subject|1|||
131949794|NCT00662831|475103188|FG000|Overall Study|Other|62|||
131949795|NCT00662831|475103189|FG001|Overall Study|Other|31|||
131949796|NCT00662831|475103188|FG000|Overall Study|Protocol Violation|8|||
131949797|NCT00662831|475103189|FG001|Overall Study|Protocol Violation|4|||
131949798|NCT00662831|475103188|FG000|Overall Study|Adverse Event|23|||
131949799|NCT00662831|475103189|FG001|Overall Study|Adverse Event|16|||
131949800|NCT01897727|475103190|FG000|Overall Study|Exclusion: central sleep apnea|0|||
131949801|NCT01897727|475103191|FG001|Overall Study|Exclusion: central sleep apnea|1|||
131949802|NCT00566982|475103192|FG000|Overall Study|Adverse Event|6|||
131949803|NCT00566982|475103193|FG001|Overall Study|Adverse Event|48|||
131949804|NCT00566982|475103192|FG000|Overall Study|Withdrawal by Subject|1|||
131949805|NCT00566982|475103193|FG001|Overall Study|Withdrawal by Subject|14|||
131949806|NCT00566982|475103192|FG000|Overall Study|Protocol Violation|1|||
131414609|NCT02621073|473142228|FG001|Overall Study|Lost to Follow-up|1|||
131414610|NCT02621073|473142227|FG000|Overall Study|Physician Decision|3|||
131414611|NCT02621073|473142228|FG001|Overall Study|Physician Decision|2|||
131414612|NCT01440881|473142229|FG000|Overall Study|Death|0|||
131414613|NCT01440881|473142230|FG001|Overall Study|Death|1|||
131949807|NCT00566982|475103193|FG001|Overall Study|Protocol Violation|4|||
131949808|NCT00566982|475103192|FG000|Overall Study|Lost to Follow-up|0|||
131949809|NCT00566982|475103193|FG001|Overall Study|Lost to Follow-up|1|||
131949810|NCT00566982|475103192|FG000|Overall Study|Other-family problems & doctor's request|0|||
131949811|NCT00566982|475103193|FG001|Overall Study|Other-family problems & doctor's request|2|||
131949812|NCT01521923|475103197|FG000|Overall Study|AE, serious fatal|1|||
131949813|NCT01521923|475103198|FG001|Overall Study|AE, serious fatal|0|||
131949814|NCT01521923|475103199|FG002|Overall Study|AE, serious fatal|0|||
131949815|NCT01521923|475103200|FG003|Overall Study|AE, serious fatal|0|||
131949816|NCT01521923|475103197|FG000|Overall Study|SAE, non-fatal|0|||
131949817|NCT01521923|475103198|FG001|Overall Study|SAE, non-fatal|2|||
131949818|NCT01521923|475103199|FG002|Overall Study|SAE, non-fatal|2|||
131949819|NCT01521923|475103200|FG003|Overall Study|SAE, non-fatal|0|||
131949820|NCT01521923|475103197|FG000|Overall Study|AE, non-serious, non-fatal|1|||
131949821|NCT01521923|475103198|FG001|Overall Study|AE, non-serious, non-fatal|3|||
131949822|NCT01521923|475103199|FG002|Overall Study|AE, non-serious, non-fatal|6|||
131949823|NCT01521923|475103200|FG003|Overall Study|AE, non-serious, non-fatal|2|||
131949824|NCT01521923|475103197|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
131414614|NCT02383433|473142233|FG000|Overall Study|Disease progression|2|||
131414615|NCT01977690|473142234|FG000|Overall Study|Withdrawal by Subject|0|||
131414616|NCT01977690|473142235|FG001|Overall Study|Withdrawal by Subject|4|||
131414617|NCT02920957|473142236|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
131414618|NCT02920957|473142237|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
131414619|NCT02920957|473142236|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
131414620|NCT02920957|473142237|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
131414621|NCT02920957|473142236|FG000|First Intervention : 1 Month|Adverse Event|1|||
131414622|NCT02920957|473142237|FG001|First Intervention : 1 Month|Adverse Event|0|||
131414623|NCT02920957|473142236|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
131414624|NCT02920957|473142237|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
131414625|NCT01345682|473142243|FG000|Overall Study|Progressive disease per RECIST|226|||
131414626|NCT01345682|473142244|FG001|Overall Study|Progressive disease per RECIST|93|||
131414627|NCT01345682|473142243|FG000|Overall Study|Worsening of underlying cancer disease|23|||
131414628|NCT01345682|473142244|FG001|Overall Study|Worsening of underlying cancer disease|12|||
131414629|NCT01345682|473142243|FG000|Overall Study|Adverse Event|51|||
131414630|NCT01345682|473142244|FG001|Overall Study|Adverse Event|41|||
131414631|NCT01345682|473142243|FG000|Overall Study|Non-compliance with protocol|0|||
131414632|NCT01345682|473142244|FG001|Overall Study|Non-compliance with protocol|1|||
131414633|NCT01345682|473142243|FG000|Overall Study|Lost to Follow-up|0|||
131414634|NCT01345682|473142244|FG001|Overall Study|Lost to Follow-up|1|||
131414635|NCT01345682|473142243|FG000|Overall Study|Refused to continue trial medication|16|||
131414636|NCT01345682|473142244|FG001|Overall Study|Refused to continue trial medication|9|||
131414637|NCT01345682|473142243|FG000|Overall Study|Not treated|2|||
131414638|NCT01345682|473142244|FG001|Overall Study|Not treated|1|||
131414639|NCT01345682|473142243|FG000|Overall Study|Reason other than those specified above|4|||
131414640|NCT01345682|473142244|FG001|Overall Study|Reason other than those specified above|3|||
131414641|NCT01075984|473142249|FG000|Treatment Phase|Adverse Event|0|||
131414642|NCT01075984|473142250|FG001|Treatment Phase|Adverse Event|1|||
131414643|NCT01075984|473142251|FG002|Treatment Phase|Adverse Event|3|||
131414644|NCT01075984|473142252|FG003|Treatment Phase|Adverse Event|7|||
131414645|NCT01075984|473142253|FG004|Treatment Phase|Adverse Event|35|||
131414646|NCT01075984|473142249|FG000|Treatment Phase|Protocol Violation|0|||
131414647|NCT01075984|473142250|FG001|Treatment Phase|Protocol Violation|0|||
131414648|NCT01075984|473142251|FG002|Treatment Phase|Protocol Violation|1|||
131414649|NCT01075984|473142252|FG003|Treatment Phase|Protocol Violation|0|||
131414650|NCT01075984|473142253|FG004|Treatment Phase|Protocol Violation|3|||
131414651|NCT01075984|473142249|FG000|Treatment Phase|Withdrawal by Subject|0|||
131414652|NCT01075984|473142250|FG001|Treatment Phase|Withdrawal by Subject|0|||
131414653|NCT01075984|473142251|FG002|Treatment Phase|Withdrawal by Subject|2|||
131414654|NCT01075984|473142252|FG003|Treatment Phase|Withdrawal by Subject|0|||
131414655|NCT01075984|473142253|FG004|Treatment Phase|Withdrawal by Subject|15|||
131414656|NCT01075984|473142249|FG000|Treatment Phase|Treatment Failure|0|||
131414657|NCT01075984|473142250|FG001|Treatment Phase|Treatment Failure|0|||
131414658|NCT01075984|473142251|FG002|Treatment Phase|Treatment Failure|1|||
131414659|NCT01075984|473142252|FG003|Treatment Phase|Treatment Failure|0|||
131414660|NCT01075984|473142253|FG004|Treatment Phase|Treatment Failure|5|||
131414661|NCT01075984|473142249|FG000|Treatment Phase|Progression of disease|0|||
131414662|NCT01075984|473142250|FG001|Treatment Phase|Progression of disease|0|||
131414663|NCT01075984|473142251|FG002|Treatment Phase|Progression of disease|0|||
131414664|NCT01075984|473142252|FG003|Treatment Phase|Progression of disease|0|||
131414665|NCT01075984|473142253|FG004|Treatment Phase|Progression of disease|2|||
131414666|NCT01075984|473142249|FG000|Follow-up Phase|Protocol Violation|0|||
131414667|NCT01075984|473142250|FG001|Follow-up Phase|Protocol Violation|0|||
131414668|NCT01075984|473142251|FG002|Follow-up Phase|Protocol Violation|1|||
131414669|NCT01075984|473142252|FG003|Follow-up Phase|Protocol Violation|0|||
131414670|NCT01075984|473142253|FG004|Follow-up Phase|Protocol Violation|3|||
131414671|NCT01075984|473142249|FG000|Follow-up Phase|Adverse Event|0|||
131414672|NCT01075984|473142250|FG001|Follow-up Phase|Adverse Event|0|||
131414673|NCT01075984|473142251|FG002|Follow-up Phase|Adverse Event|0|||
131414674|NCT01075984|473142252|FG003|Follow-up Phase|Adverse Event|2|||
131414675|NCT01075984|473142253|FG004|Follow-up Phase|Adverse Event|27|||
131414676|NCT01075984|473142249|FG000|Follow-up Phase|Administrative|0|||
131414677|NCT01075984|473142250|FG001|Follow-up Phase|Administrative|0|||
131414678|NCT01075984|473142251|FG002|Follow-up Phase|Administrative|0|||
131414679|NCT01075984|473142252|FG003|Follow-up Phase|Administrative|0|||
131414680|NCT01075984|473142253|FG004|Follow-up Phase|Administrative|1|||
131414681|NCT01075984|473142249|FG000|Follow-up Phase|Withdrawal by Subject|0|||
131414682|NCT01075984|473142250|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131414683|NCT01075984|473142251|FG002|Follow-up Phase|Withdrawal by Subject|0|||
131414684|NCT01075984|473142252|FG003|Follow-up Phase|Withdrawal by Subject|0|||
131414685|NCT01075984|473142253|FG004|Follow-up Phase|Withdrawal by Subject|10|||
131414686|NCT01075984|473142249|FG000|Follow-up Phase|Progression of disease|0|||
131414687|NCT01075984|473142250|FG001|Follow-up Phase|Progression of disease|0|||
131414688|NCT01075984|473142251|FG002|Follow-up Phase|Progression of disease|0|||
131414689|NCT01075984|473142252|FG003|Follow-up Phase|Progression of disease|0|||
131414690|NCT01075984|473142253|FG004|Follow-up Phase|Progression of disease|2|||
131414691|NCT01075984|473142249|FG000|Follow-up Phase|Treatment failure|0|||
131414692|NCT01075984|473142250|FG001|Follow-up Phase|Treatment failure|0|||
131414693|NCT01075984|473142251|FG002|Follow-up Phase|Treatment failure|0|||
131414694|NCT01075984|473142252|FG003|Follow-up Phase|Treatment failure|0|||
131414695|NCT01075984|473142253|FG004|Follow-up Phase|Treatment failure|4|||
131414696|NCT03442296|473142259|FG000|3 Month Follow-up|Death|3|||
131414697|NCT03442296|473142260|FG001|3 Month Follow-up|Death|1|||
131414698|NCT03442296|473142259|FG000|3 Month Follow-up|Lost to Follow-up|1|||
131414699|NCT03442296|473142260|FG001|3 Month Follow-up|Lost to Follow-up|1|||
131414700|NCT03442296|473142259|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
131414701|NCT03442296|473142260|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
131414702|NCT03442296|473142259|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
131414703|NCT03442296|473142260|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
131414704|NCT03442296|473142259|FG000|12 Month Follow-up|Incomplete measurement|1|||
131414705|NCT03442296|473142260|FG001|12 Month Follow-up|Incomplete measurement|1|||
131414706|NCT02440789|473142261|FG000|Overall Study|Withdrawal by Subject|3|||
131414707|NCT02440789|473142261|FG000|Overall Study|Not willing to adhere to reqs|1|||
131414708|NCT03684694|473142264|FG000|Phase 1|Withdrawal by Subject|1|||
131414709|NCT03684694|473142265|FG001|Phase 1|Withdrawal by Subject|0|||
131414710|NCT03684694|473142266|FG002|Phase 1|Withdrawal by Subject|0|||
131414711|NCT03684694|473142267|FG003|Phase 1|Withdrawal by Subject|0|||
131414712|NCT03684694|473142268|FG004|Phase 1|Withdrawal by Subject|0|||
131414713|NCT03684694|473142269|FG005|Phase 1|Withdrawal by Subject|0|||
131414714|NCT03684694|473142264|FG000|Phase 1|Investigator/Sponsor Decision|12|||
131414715|NCT03684694|473142265|FG001|Phase 1|Investigator/Sponsor Decision|2|||
131414716|NCT03684694|473142266|FG002|Phase 1|Investigator/Sponsor Decision|1|||
131414717|NCT03684694|473142267|FG003|Phase 1|Investigator/Sponsor Decision|0|||
131414718|NCT03684694|473142268|FG004|Phase 1|Investigator/Sponsor Decision|0|||
131414719|NCT03684694|473142269|FG005|Phase 1|Investigator/Sponsor Decision|0|||
131414720|NCT03684694|473142264|FG000|Phase 1|Death|24|||
131414721|NCT03684694|473142265|FG001|Phase 1|Death|0|||
131414722|NCT03684694|473142266|FG002|Phase 1|Death|3|||
131414723|NCT03684694|473142267|FG003|Phase 1|Death|0|||
131414724|NCT03684694|473142268|FG004|Phase 1|Death|0|||
131414725|NCT03684694|473142269|FG005|Phase 1|Death|0|||
131414726|NCT03684694|473142264|FG000|Phase 1|Lost to Follow-up|0|||
131414727|NCT03684694|473142265|FG001|Phase 1|Lost to Follow-up|0|||
131414728|NCT03684694|473142266|FG002|Phase 1|Lost to Follow-up|1|||
131414729|NCT03684694|473142267|FG003|Phase 1|Lost to Follow-up|0|||
131414730|NCT03684694|473142268|FG004|Phase 1|Lost to Follow-up|0|||
131414731|NCT03684694|473142269|FG005|Phase 1|Lost to Follow-up|0|||
131414732|NCT03684694|473142264|FG000|Phase 1|Miscellaneous|0|||
131414733|NCT03684694|473142265|FG001|Phase 1|Miscellaneous|1|||
131414734|NCT03684694|473142266|FG002|Phase 1|Miscellaneous|0|||
131414735|NCT03684694|473142267|FG003|Phase 1|Miscellaneous|0|||
131414736|NCT03684694|473142268|FG004|Phase 1|Miscellaneous|0|||
131414737|NCT03684694|473142269|FG005|Phase 1|Miscellaneous|0|||
131414738|NCT03684694|473142264|FG000|Phase 2|Withdrawal by Subject|0|||
131414739|NCT03684694|473142265|FG001|Phase 2|Withdrawal by Subject|0|||
131414740|NCT03684694|473142266|FG002|Phase 2|Withdrawal by Subject|0|||
131414741|NCT03684694|473142267|FG003|Phase 2|Withdrawal by Subject|0|||
131414742|NCT03684694|473142268|FG004|Phase 2|Withdrawal by Subject|0|||
131414743|NCT03684694|473142269|FG005|Phase 2|Withdrawal by Subject|1|||
131414744|NCT03684694|473142264|FG000|Phase 2|Investigator/Sponsor Decision|0|||
131414745|NCT03684694|473142265|FG001|Phase 2|Investigator/Sponsor Decision|0|||
131414746|NCT03684694|473142266|FG002|Phase 2|Investigator/Sponsor Decision|0|||
131414747|NCT03684694|473142267|FG003|Phase 2|Investigator/Sponsor Decision|17|||
131414748|NCT03684694|473142268|FG004|Phase 2|Investigator/Sponsor Decision|16|||
131414749|NCT03684694|473142269|FG005|Phase 2|Investigator/Sponsor Decision|6|||
131414750|NCT03684694|473142264|FG000|Phase 2|Death|0|||
131414751|NCT03684694|473142265|FG001|Phase 2|Death|0|||
131414752|NCT03684694|473142266|FG002|Phase 2|Death|0|||
131414753|NCT03684694|473142267|FG003|Phase 2|Death|28|||
131414754|NCT03684694|473142268|FG004|Phase 2|Death|14|||
131414755|NCT03684694|473142269|FG005|Phase 2|Death|3|||
131414756|NCT03684694|473142264|FG000|Phase 2|Lost to Follow-up|0|||
131414757|NCT03684694|473142265|FG001|Phase 2|Lost to Follow-up|0|||
131414758|NCT03684694|473142266|FG002|Phase 2|Lost to Follow-up|0|||
131414759|NCT03684694|473142267|FG003|Phase 2|Lost to Follow-up|1|||
131414760|NCT03684694|473142268|FG004|Phase 2|Lost to Follow-up|0|||
131414761|NCT03684694|473142269|FG005|Phase 2|Lost to Follow-up|0|||
131414762|NCT03684694|473142264|FG000|Phase 2|Miscellaneous|0|||
131414763|NCT03684694|473142265|FG001|Phase 2|Miscellaneous|0|||
131414764|NCT03684694|473142266|FG002|Phase 2|Miscellaneous|0|||
131414765|NCT03684694|473142267|FG003|Phase 2|Miscellaneous|3|||
131414766|NCT03684694|473142268|FG004|Phase 2|Miscellaneous|0|||
131414767|NCT03684694|473142269|FG005|Phase 2|Miscellaneous|0|||
131414768|NCT03172130|473143782|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
131414769|NCT03172130|473143783|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
131414770|NCT01073930|473143794|FG000|Overall Study|Withdrawal by Subject|3|||
131414771|NCT01073930|473143795|FG001|Overall Study|Withdrawal by Subject|2|||
131414772|NCT01073930|473143794|FG000|Overall Study|Lost to Follow-up|0|||
131456497|NCT01459497|473301197|FG000|Overall Study|Physician Decision|1|||
131456498|NCT01459497|473301198|FG001|Overall Study|Physician Decision|1|||
131456499|NCT01459497|473301197|FG000|Overall Study|Hospitalization.|0|||
131456500|NCT01459497|473301198|FG001|Overall Study|Hospitalization.|3|||
131456501|NCT01459497|473301197|FG000|Overall Study|Disease progression.|0|||
131949825|NCT01521923|475103198|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
131949826|NCT01521923|475103199|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
131949827|NCT01521923|475103200|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
131949828|NCT01521923|475103197|FG000|Overall Study|Lack of Efficacy|1|||
131949829|NCT01521923|475103198|FG001|Overall Study|Lack of Efficacy|1|||
131949830|NCT01521923|475103199|FG002|Overall Study|Lack of Efficacy|0|||
131949831|NCT01521923|475103200|FG003|Overall Study|Lack of Efficacy|0|||
131949832|NCT01521923|475103197|FG000|Overall Study|Protocol Violation|0|||
131949833|NCT01521923|475103198|FG001|Overall Study|Protocol Violation|0|||
131949834|NCT01521923|475103199|FG002|Overall Study|Protocol Violation|1|||
131949835|NCT01521923|475103200|FG003|Overall Study|Protocol Violation|0|||
131949836|NCT01521923|475103197|FG000|Overall Study|Lost to Follow-up|1|||
131949837|NCT01521923|475103198|FG001|Overall Study|Lost to Follow-up|0|||
131949838|NCT01521923|475103199|FG002|Overall Study|Lost to Follow-up|2|||
131949839|NCT01521923|475103200|FG003|Overall Study|Lost to Follow-up|1|||
131949840|NCT01521923|475103197|FG000|Overall Study|Withdrawal by Subject|1|||
131949841|NCT01521923|475103198|FG001|Overall Study|Withdrawal by Subject|1|||
131949842|NCT01521923|475103199|FG002|Overall Study|Withdrawal by Subject|1|||
131949843|NCT01521923|475103200|FG003|Overall Study|Withdrawal by Subject|2|||
131949844|NCT01521923|475103197|FG000|Overall Study|Other|2|||
131949845|NCT01521923|475103198|FG001|Overall Study|Other|1|||
131949846|NCT01521923|475103199|FG002|Overall Study|Other|3|||
131949847|NCT01521923|475103200|FG003|Overall Study|Other|6|||
131949848|NCT01521923|475103197|FG000|Overall Study|AE, captured in Period 1|0|||
131949849|NCT01521923|475103198|FG001|Overall Study|AE, captured in Period 1|1|||
131949850|NCT01521923|475103199|FG002|Overall Study|AE, captured in Period 1|0|||
131949851|NCT01521923|475103200|FG003|Overall Study|AE, captured in Period 1|1|||
131949852|NCT01279044|475103201|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
131949853|NCT01279044|475103202|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
131949854|NCT01279044|475103203|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
131949855|NCT01279044|475103201|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
131949856|NCT01279044|475103202|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
131949857|NCT01279044|475103203|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
131949858|NCT01279044|475103201|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
131949859|NCT01279044|475103202|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
131949860|NCT01279044|475103203|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
131949861|NCT01582009|475103204|FG000|Overall Study|Withdrawal by Subject|1|||
131949862|NCT01582009|475103204|FG000|Overall Study|Physician Decision|1|||
131949863|NCT00473889|475103205|FG000|Overall Study|Did not receive study medication|1|||
131949864|NCT00473889|475103206|FG001|Overall Study|Did not receive study medication|4|||
131949865|NCT00473889|475103205|FG000|Overall Study|Adverse Event|30|||
131949866|NCT00473889|475103206|FG001|Overall Study|Adverse Event|17|||
131949867|NCT00473889|475103205|FG000|Overall Study|Protocol Violation|4|||
131949868|NCT00473889|475103206|FG001|Overall Study|Protocol Violation|2|||
131949869|NCT00473889|475103205|FG000|Overall Study|Lack of Efficacy|28|||
131949870|NCT00473889|475103206|FG001|Overall Study|Lack of Efficacy|29|||
131456502|NCT01459497|473301198|FG001|Overall Study|Disease progression.|1|||
131456503|NCT03530124|473301201|FG000|Overall Study|Withdrawal by Subject|0|||
131456504|NCT03530124|473301202|FG001|Overall Study|Withdrawal by Subject|1|||
131456505|NCT03530124|473301201|FG000|Overall Study|Protocol Violation|1|||
131456506|NCT03530124|473301202|FG001|Overall Study|Protocol Violation|0|||
131949871|NCT00473889|475103205|FG000|Overall Study|Lost to Follow-up|2|||
131949872|NCT00473889|475103206|FG001|Overall Study|Lost to Follow-up|1|||
131949873|NCT00473889|475103205|FG000|Overall Study|Physician Decision|10|||
131949874|NCT00473889|475103206|FG001|Overall Study|Physician Decision|5|||
131949875|NCT00473889|475103205|FG000|Overall Study|Trial Terminated|3|||
131949876|NCT00473889|475103206|FG001|Overall Study|Trial Terminated|6|||
131949877|NCT00473889|475103205|FG000|Overall Study|Withdrawal by Subject|5|||
131949878|NCT00473889|475103206|FG001|Overall Study|Withdrawal by Subject|0|||
131949879|NCT00833469|475103207|FG000|Overall Study|Withdrawal by Subject|1|||
131949880|NCT00833469|475103207|FG000|Overall Study|Lost to Follow-up|1|||
131949881|NCT00310375|475103208|FG000|Primary Reporting Phase|Adverse Event|28|||
131949882|NCT00310375|475103209|FG001|Primary Reporting Phase|Adverse Event|22|||
131949883|NCT00310375|475103210|FG002|Primary Reporting Phase|Adverse Event|0|||
131949884|NCT00310375|475103208|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
131949885|NCT00310375|475103209|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
131949886|NCT00310375|475103210|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
131949887|NCT00310375|475103208|FG000|Primary Reporting Phase|Pregnancy|2|||
131949888|NCT00310375|475103209|FG001|Primary Reporting Phase|Pregnancy|2|||
131456507|NCT03530124|473301201|FG000|Overall Study|Discharged prior to study completion|1|||
131456508|NCT03530124|473301202|FG001|Overall Study|Discharged prior to study completion|0|||
131949889|NCT00310375|475103210|FG002|Primary Reporting Phase|Pregnancy|0|||
131949890|NCT00310375|475103208|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
131949891|NCT00310375|475103209|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
131949892|NCT00310375|475103210|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
131949893|NCT00310375|475103208|FG000|Primary Reporting Phase|Protocol Violation|8|||
131949894|NCT00310375|475103209|FG001|Primary Reporting Phase|Protocol Violation|5|||
131414773|NCT01073930|473143795|FG001|Overall Study|Lost to Follow-up|1|||
131414774|NCT01073930|473143794|FG000|Overall Study|Adverse Event|0|||
131414775|NCT01073930|473143795|FG001|Overall Study|Adverse Event|1|||
131414776|NCT01073930|473143794|FG000|Overall Study|Noncompliance with study drug|0|||
131414777|NCT01073930|473143795|FG001|Overall Study|Noncompliance with study drug|1|||
131414778|NCT01073930|473143794|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
131414779|NCT01073930|473143795|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
131414780|NCT01022424|473143796|FG000|Overall Study|Adverse Event|1|||
131414781|NCT01022424|473143796|FG000|Overall Study|Physician Decision|1|||
131414782|NCT01022424|473143796|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
131414783|NCT01266590|473143797|FG000|Overall Study|Adverse Event|3|||
131414784|NCT01266590|473143797|FG000|Overall Study|Lost to Follow-up|1|||
131414785|NCT01266590|473143797|FG000|Overall Study|Withdrawal by Subject|1|||
131414786|NCT01266590|473143797|FG000|Overall Study|Physician Decision|1|||
131414787|NCT02783170|473143802|FG000|Overall Study|Randomized but not Vaccinated|1|||
131414788|NCT02783170|473143803|FG001|Overall Study|Randomized but not Vaccinated|0|||
131414789|NCT03320330|473143804|FG000|Overall Study|Lack of Efficacy|5|||
131414790|NCT03320330|473143805|FG001|Overall Study|Lack of Efficacy|5|||
131414791|NCT03320330|473143806|FG002|Overall Study|Lack of Efficacy|14|||
131414792|NCT03320330|473143804|FG000|Overall Study|Physician Decision|1|||
131414793|NCT03320330|473143805|FG001|Overall Study|Physician Decision|0|||
131414794|NCT03320330|473143806|FG002|Overall Study|Physician Decision|0|||
131414795|NCT04256512|473143808|FG000|Overall Study|Withdrawal by Subject|1|||
131414796|NCT04435600|473143816|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414797|NCT04435600|473143817|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414798|NCT04435600|473143818|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
131414799|NCT04435600|473143819|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414800|NCT04435600|473143820|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414801|NCT04435600|473143821|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414802|NCT04435600|473143822|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414803|NCT04435600|473143823|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414804|NCT04435600|473143824|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414805|NCT04435600|473143825|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
131414806|NCT04435600|473143816|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414807|NCT04435600|473143817|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414808|NCT04435600|473143818|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414809|NCT04435600|473143819|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414810|NCT04435600|473143820|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414811|NCT04435600|473143821|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414812|NCT04435600|473143822|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414813|NCT04435600|473143823|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414814|NCT04435600|473143824|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
131414815|NCT04435600|473143825|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
131414816|NCT04435600|473143816|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414817|NCT04435600|473143817|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414818|NCT04435600|473143818|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414819|NCT04435600|473143819|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414820|NCT04435600|473143820|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414821|NCT04435600|473143821|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414822|NCT04435600|473143822|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414823|NCT04435600|473143823|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414824|NCT04435600|473143824|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
131414825|NCT04435600|473143825|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
131414826|NCT04435600|473143816|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414827|NCT04435600|473143817|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414828|NCT04435600|473143818|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414829|NCT04435600|473143819|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
131949895|NCT00310375|475103210|FG002|Primary Reporting Phase|Protocol Violation|0|||
131414830|NCT04435600|473143820|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414831|NCT04435600|473143821|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414832|NCT04435600|473143822|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414833|NCT04435600|473143823|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
131414834|NCT04435600|473143824|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
131456509|NCT02504216|473301203|FG000|Overall Study|Lost to Follow-up|3|||
131949896|NCT00310375|475103208|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
131949897|NCT00310375|475103209|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
131949898|NCT00310375|475103210|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
131949899|NCT00310375|475103208|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
131949900|NCT00310375|475103209|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
131949901|NCT00310375|475103210|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
131949902|NCT00310375|475103208|FG000|Primary Reporting Phase|Physician Decision|5|||
131949903|NCT00310375|475103209|FG001|Primary Reporting Phase|Physician Decision|3|||
131949904|NCT00310375|475103210|FG002|Primary Reporting Phase|Physician Decision|0|||
131949905|NCT00310375|475103208|FG000|Primary Reporting Phase|Request of the sponsor|2|||
131949906|NCT00310375|475103209|FG001|Primary Reporting Phase|Request of the sponsor|2|||
131949907|NCT00310375|475103210|FG002|Primary Reporting Phase|Request of the sponsor|0|||
131949908|NCT00310375|475103208|FG000|Primary Reporting Phase|Failed to return|1|||
131949909|NCT00310375|475103209|FG001|Primary Reporting Phase|Failed to return|3|||
131949910|NCT00310375|475103210|FG002|Primary Reporting Phase|Failed to return|0|||
131949911|NCT00310375|475103208|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
131949912|NCT00310375|475103209|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
131949913|NCT00310375|475103210|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
131949914|NCT00310375|475103208|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
131949915|NCT00310375|475103209|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
131949916|NCT00310375|475103210|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
131949917|NCT00310375|475103208|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
131949918|NCT00310375|475103209|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
131949919|NCT00310375|475103210|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
131949920|NCT00310375|475103208|FG000|Primary Reporting Phase|Site closure|3|||
131949921|NCT00310375|475103209|FG001|Primary Reporting Phase|Site closure|0|||
131949922|NCT00310375|475103210|FG002|Primary Reporting Phase|Site closure|0|||
131949923|NCT00310375|475103208|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
131949924|NCT00310375|475103209|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
131949925|NCT00310375|475103210|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
131949926|NCT00310375|475103208|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
131949927|NCT00310375|475103209|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
131949928|NCT00310375|475103210|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
131949929|NCT00310375|475103208|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
131949930|NCT00310375|475103209|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
131949931|NCT00310375|475103210|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
131949932|NCT00310375|475103208|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
131949933|NCT00310375|475103209|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
131949934|NCT00310375|475103210|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
131949935|NCT05507567|475103211|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
131949936|NCT05507567|475103212|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
131949937|NCT05507567|475103213|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
131949938|NCT05507567|475103211|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
131949939|NCT05507567|475103212|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
131949940|NCT05507567|475103213|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
131949941|NCT05507567|475103211|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
131949942|NCT05507567|475103212|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
131949943|NCT05507567|475103213|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
131949944|NCT05507567|475103211|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
131949945|NCT05507567|475103212|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
131949946|NCT05507567|475103213|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
131949947|NCT00910910|475103214|FG000|Overall Study|Adverse Event|63|||
131949948|NCT00910910|475103215|FG001|Overall Study|Adverse Event|35|||
131949949|NCT00910910|475103214|FG000|Overall Study|PD without histologic change|27|||
131949950|NCT00910910|475103215|FG001|Overall Study|PD without histologic change|23|||
131949951|NCT00910910|475103214|FG000|Overall Study|PD with histologic change|0|||
131949952|NCT00910910|475103215|FG001|Overall Study|PD with histologic change|2|||
131949953|NCT00910910|475103214|FG000|Overall Study|Withdrawal by Subject|7|||
131949954|NCT00910910|475103215|FG001|Overall Study|Withdrawal by Subject|5|||
131949955|NCT00910910|475103214|FG000|Overall Study|Lost to Follow-up|2|||
131949956|NCT00910910|475103215|FG001|Overall Study|Lost to Follow-up|2|||
131949957|NCT00910910|475103214|FG000|Overall Study|Death|9|||
131949958|NCT00910910|475103215|FG001|Overall Study|Death|3|||
131949959|NCT00910910|475103214|FG000|Overall Study|Protocol Violation|2|||
131949960|NCT00910910|475103215|FG001|Overall Study|Protocol Violation|2|||
131949961|NCT00910910|475103214|FG000|Overall Study|Completed 13 cycles of treatment|0|||
131949962|NCT00910910|475103215|FG001|Overall Study|Completed 13 cycles of treatment|118|||
131949963|NCT00910910|475103214|FG000|Overall Study|Other|114|||
131949964|NCT00910910|475103215|FG001|Overall Study|Other|32|||
131949965|NCT00910910|475103214|FG000|Overall Study|Untreated before cycle 1|1|||
131949966|NCT00910910|475103215|FG001|Overall Study|Untreated before cycle 1|2|||
131949967|NCT02236572|475103218|FG000|Overall Study|Withdrawal by Subject|1|||
131949968|NCT02236572|475103218|FG000|Overall Study|Protocol Violation|1|||
131949969|NCT02236572|475103218|FG000|Overall Study|Lost to Follow-up|1|||
131949970|NCT00090779|475103219|FG000|Step 1|Withdrawal by Subject|4|||
131949971|NCT00090779|475103220|FG001|Step 1|Withdrawal by Subject|2|||
131949972|NCT00090779|475103219|FG000|Step 1|Lost to Follow-up|3|||
131949973|NCT00090779|475103220|FG001|Step 1|Lost to Follow-up|2|||
131949974|NCT00090779|475103219|FG000|Step 1|Death|0|||
131949975|NCT00090779|475103220|FG001|Step 1|Death|2|||
131949976|NCT00090779|475103219|FG000|Step 1|Physician Decision|1|||
131949977|NCT00090779|475103220|FG001|Step 1|Physician Decision|0|||
131949978|NCT00090779|475103219|FG000|Step 1|Pregnancy|1|||
131949979|NCT00090779|475103220|FG001|Step 1|Pregnancy|0|||
131949980|NCT00090779|475103219|FG000|Step 1|Non-compliance to study requirements|0|||
131949981|NCT00090779|475103220|FG001|Step 1|Non-compliance to study requirements|1|||
131949982|NCT00090779|475103219|FG000|Step 1|Subject relocated|2|||
131949983|NCT00090779|475103220|FG001|Step 1|Subject relocated|8|||
131949984|NCT00090779|475103219|FG000|Step 2|Off study per study closure|6|||
131949985|NCT00090779|475103220|FG001|Step 2|Off study per study closure|16|||
131949986|NCT00090779|475103219|FG000|Step 2|Subject relocated|0|||
131949987|NCT00090779|475103220|FG001|Step 2|Subject relocated|1|||
131949988|NCT00090779|475103219|FG000|Step 2|Non-compliance to study requirements|0|||
131949989|NCT00090779|475103220|FG001|Step 2|Non-compliance to study requirements|1|||
131949990|NCT00090779|475103219|FG000|Step 3|Initiation of ART and off extended study|3|||
131949991|NCT00090779|475103220|FG001|Step 3|Initiation of ART and off extended study|2|||
131949992|NCT00090779|475103219|FG000|Step 3|Off extended study due to study closure|4|||
131949993|NCT00090779|475103220|FG001|Step 3|Off extended study due to study closure|3|||
131949994|NCT01318135|475103221|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
131949995|NCT01318135|475103222|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131949996|NCT01318135|475103223|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131949997|NCT01318135|475103224|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131949998|NCT01318135|475103225|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131949999|NCT01318135|475103226|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131950000|NCT01318135|475103227|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131950001|NCT01318135|475103228|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131950002|NCT01318135|475103221|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
131950003|NCT01318135|475103222|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950004|NCT01318135|475103223|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950005|NCT01318135|475103224|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950006|NCT01318135|475103225|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950007|NCT01318135|475103226|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950008|NCT01318135|475103227|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950009|NCT01318135|475103228|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
131950010|NCT01318135|475103221|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
131950011|NCT01318135|475103222|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
131950012|NCT01318135|475103223|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
131950013|NCT01318135|475103224|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
131950014|NCT01318135|475103225|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
131950015|NCT01318135|475103226|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
131950016|NCT01318135|475103227|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
131950017|NCT01318135|475103228|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
131950018|NCT01318135|475103221|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
131950019|NCT01318135|475103222|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
131950020|NCT01318135|475103223|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
131950021|NCT01318135|475103224|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
131950022|NCT01318135|475103225|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
131950023|NCT01318135|475103226|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
131950024|NCT01318135|475103227|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
131950025|NCT01318135|475103228|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
131950026|NCT01318135|475103221|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131950027|NCT01318135|475103222|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131950028|NCT01318135|475103223|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131950029|NCT01318135|475103224|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131950030|NCT01318135|475103225|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131950031|NCT01318135|475103226|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131950032|NCT01318135|475103227|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131950033|NCT01318135|475103228|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131950034|NCT01318135|475103221|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
131950035|NCT01318135|475103222|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
131456510|NCT02504216|473301204|FG001|Overall Study|Lost to Follow-up|3|||
131456511|NCT02504216|473301203|FG000|Overall Study|Withdrawal by Subject|8|||
131456512|NCT02504216|473301204|FG001|Overall Study|Withdrawal by Subject|12|||
131456513|NCT00223080|473301205|FG000|Overall Study|Withdrawal by Subject|253|||
131456514|NCT00223080|473301206|FG001|Overall Study|Withdrawal by Subject|232|||
131456515|NCT00223080|473301205|FG000|Overall Study|Required contraindicated med|0|||
131456516|NCT00223080|473301206|FG001|Overall Study|Required contraindicated med|1|||
131456517|NCT00223080|473301205|FG000|Overall Study|Non-compliant|7|||
131456518|NCT00223080|473301206|FG001|Overall Study|Non-compliant|7|||
131456519|NCT00223080|473301205|FG000|Overall Study|Moved from study area|37|||
131456520|NCT00223080|473301206|FG001|Overall Study|Moved from study area|47|||
131456521|NCT00223080|473301205|FG000|Overall Study|Lost to Follow-up|259|||
131456522|NCT00223080|473301206|FG001|Overall Study|Lost to Follow-up|284|||
131456523|NCT00223080|473301205|FG000|Overall Study|Death|85|||
131456524|NCT00223080|473301206|FG001|Overall Study|Death|74|||
131456525|NCT00223080|473301205|FG000|Overall Study|Other|14|||
131456526|NCT00223080|473301206|FG001|Overall Study|Other|11|||
131456527|NCT00223080|473301205|FG000|Overall Study|Reason not provided|141|||
131456528|NCT00223080|473301206|FG001|Overall Study|Reason not provided|140|||
131456529|NCT00223080|473301205|FG000|Overall Study|Adverse Event|0|||
131456530|NCT00223080|473301206|FG001|Overall Study|Adverse Event|1|||
131456531|NCT02598583|473301207|FG000|Extension Period|Withdrawal by Subject|1|||
131456532|NCT02598583|473301208|FG001|Extension Period|Withdrawal by Subject|0|||
131456533|NCT03237286|473301209|FG000|Overall Study|Withdrawal by Subject|1|||
131456534|NCT03237286|473301210|FG001|Overall Study|Withdrawal by Subject|0|||
131456535|NCT03237286|473301211|FG002|Overall Study|Withdrawal by Subject|2|||
131456536|NCT03237286|473301209|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
131456537|NCT03237286|473301210|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
131456538|NCT03237286|473301211|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
131456539|NCT00947882|473301221|FG000|Overall Study|Adverse Event|0|||
131456540|NCT00947882|473301222|FG001|Overall Study|Adverse Event|1|||
131456541|NCT00947882|473301223|FG002|Overall Study|Adverse Event|4|||
131456542|NCT00947882|473301224|FG003|Overall Study|Adverse Event|4|||
131456543|NCT00947882|473301221|FG000|Overall Study|Withdrawal by Subject|2|||
131456544|NCT00947882|473301222|FG001|Overall Study|Withdrawal by Subject|0|||
131456545|NCT00947882|473301223|FG002|Overall Study|Withdrawal by Subject|8|||
131456546|NCT00947882|473301224|FG003|Overall Study|Withdrawal by Subject|2|||
131456547|NCT00947882|473301221|FG000|Overall Study|Protocol Violation|0|||
131456548|NCT00947882|473301222|FG001|Overall Study|Protocol Violation|0|||
131456549|NCT00947882|473301223|FG002|Overall Study|Protocol Violation|1|||
131456550|NCT00947882|473301224|FG003|Overall Study|Protocol Violation|0|||
131456551|NCT00947882|473301221|FG000|Overall Study|Lost to Follow-up|0|||
131456552|NCT00947882|473301222|FG001|Overall Study|Lost to Follow-up|2|||
131456553|NCT00947882|473301223|FG002|Overall Study|Lost to Follow-up|1|||
131456554|NCT00947882|473301224|FG003|Overall Study|Lost to Follow-up|0|||
131456555|NCT00947882|473301221|FG000|Overall Study|Other/Unknown|10|||
131456556|NCT00947882|473301222|FG001|Overall Study|Other/Unknown|13|||
131456557|NCT00947882|473301223|FG002|Overall Study|Other/Unknown|3|||
131456558|NCT00947882|473301224|FG003|Overall Study|Other/Unknown|6|||
131456559|NCT00947882|473301221|FG000|Overall Study|Trial Terminated by Sponsor|62|||
131456560|NCT00947882|473301222|FG001|Overall Study|Trial Terminated by Sponsor|61|||
131456561|NCT00947882|473301223|FG002|Overall Study|Trial Terminated by Sponsor|62|||
131456562|NCT00947882|473301224|FG003|Overall Study|Trial Terminated by Sponsor|70|||
131456563|NCT01262820|473301225|FG000|Overall Study|Adverse Event|5|||
131456564|NCT01262820|473301225|FG000|Overall Study|Lack of Efficacy|9|||
131456565|NCT01262820|473301225|FG000|Overall Study|Drug held for 21+ days|1|||
131456566|NCT00104520|473301226|FG000|Overall Study|Unrelated adverse event|34|||
131456567|NCT00104520|473301227|FG001|Overall Study|Unrelated adverse event|47|||
131456568|NCT00104520|473301226|FG000|Overall Study|Study drug intolerance|0|||
131950036|NCT01318135|475103223|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
131950037|NCT01318135|475103224|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
131950038|NCT01318135|475103225|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
131950039|NCT01318135|475103226|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
131456569|NCT00104520|473301227|FG001|Overall Study|Study drug intolerance|1|||
131456570|NCT00104520|473301226|FG000|Overall Study|Related adverse event|13|||
131456571|NCT00104520|473301227|FG001|Overall Study|Related adverse event|15|||
131456572|NCT00104520|473301226|FG000|Overall Study|Lost to Follow-up|1|||
131456573|NCT00104520|473301227|FG001|Overall Study|Lost to Follow-up|0|||
131456574|NCT00104520|473301226|FG000|Overall Study|Noncompliance|0|||
131456575|NCT00104520|473301227|FG001|Overall Study|Noncompliance|2|||
131456576|NCT00104520|473301226|FG000|Overall Study|Personal/administrative|1|||
131456577|NCT00104520|473301227|FG001|Overall Study|Personal/administrative|1|||
131456578|NCT00104520|473301226|FG000|Overall Study|Other|1|||
131456579|NCT00104520|473301227|FG001|Overall Study|Other|5|||
131456580|NCT01026324|473301229|FG000|Follow up/Survival|Withdrawal by Subject|1|||
131456581|NCT01026324|473301230|FG001|Follow up/Survival|Withdrawal by Subject|0|||
131950040|NCT01318135|475103227|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131950041|NCT01318135|475103228|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131950042|NCT01318135|475103221|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131950043|NCT01318135|475103222|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131950044|NCT01318135|475103223|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131950045|NCT01318135|475103224|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131414835|NCT04435600|473143825|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
131950046|NCT01318135|475103225|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131950047|NCT01318135|475103226|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131950048|NCT01318135|475103227|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
131950049|NCT01318135|475103228|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
131950050|NCT01775553|475103234|FG000|Overall Study|Adverse Event|1|||
131950051|NCT01775553|475103234|FG000|Overall Study|Disease Progression|12|||
131950052|NCT01523743|475103235|FG000|Period 1|Adverse Event|1|||
131950053|NCT01523743|475103236|FG001|Period 1|Adverse Event|0|||
131950054|NCT01523743|475103235|FG000|Period 1|Withdrawal by Subject|6|||
131950055|NCT01523743|475103236|FG001|Period 1|Withdrawal by Subject|2|||
131950056|NCT01523743|475103235|FG000|Period 1|Lost to Follow-up|1|||
131950057|NCT01523743|475103236|FG001|Period 1|Lost to Follow-up|0|||
131950058|NCT01523743|475103235|FG000|Period 1|Lack of Efficacy|1|||
131950059|NCT01523743|475103236|FG001|Period 1|Lack of Efficacy|0|||
131950060|NCT01523743|475103235|FG000|Period 1|Felt unable to empty bladder|1|||
131950061|NCT01523743|475103236|FG001|Period 1|Felt unable to empty bladder|0|||
131950062|NCT01523743|475103235|FG000|Period 2|Withdrawal by Subject|0|||
131950063|NCT01523743|475103236|FG001|Period 2|Withdrawal by Subject|2|||
131950064|NCT01523743|475103235|FG000|Period 2|Adverse Event|1|||
131950065|NCT01523743|475103236|FG001|Period 2|Adverse Event|0|||
131950066|NCT02569476|475103237|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
131950067|NCT02569476|475103237|FG000|Overall Study|Death|33|||
131950068|NCT02569476|475103237|FG000|Overall Study|Withdrawal by Subject|9|||
131950069|NCT02569476|475103237|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
131950070|NCT02569476|475103237|FG000|Overall Study|Palliative care|1|||
131950071|NCT02569476|475103237|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
131950072|NCT02569476|475103237|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
131950073|NCT01434654|475103238|FG000|Overall Study|Withdrawal by Subject|1|||
131950074|NCT01434654|475103239|FG001|Overall Study|Withdrawal by Subject|0|||
131950075|NCT01434654|475103238|FG000|Overall Study|Lost to Follow-up|1|||
131950076|NCT01434654|475103239|FG001|Overall Study|Lost to Follow-up|0|||
131950077|NCT01541865|475103240|FG000|Overall Study|Lost to Follow-up|11|||
131950078|NCT01541865|475103240|FG000|Overall Study|Withdrawal by Subject|9|||
131950079|NCT01541865|475103240|FG000|Overall Study|Adverse Event|1|||
131950080|NCT01541865|475103240|FG000|Overall Study|Protocol Violation|1|||
131950081|NCT00703963|475103244|FG000|Overall Study|Withdrawal by Subject|7|||
131414836|NCT02797184|473143827|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
131414837|NCT02797184|473143828|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
131950082|NCT00703963|475103245|FG001|Overall Study|Withdrawal by Subject|13|||
131950083|NCT00703963|475103244|FG000|Overall Study|Physician Decision|0|||
131950084|NCT00703963|475103245|FG001|Overall Study|Physician Decision|1|||
131950085|NCT00402324|475103246|FG000|Overall Study|Lost to Follow-up|11|||
131950086|NCT00402324|475103247|FG001|Overall Study|Lost to Follow-up|11|||
131950087|NCT00402324|475103246|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
131950088|NCT00402324|475103247|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
131950089|NCT00402324|475103246|FG000|Overall Study|Protocol Violation|8|||
131950090|NCT00402324|475103247|FG001|Overall Study|Protocol Violation|7|||
131950091|NCT00402324|475103246|FG000|Overall Study|Withdrawal by Subject|5|||
131950092|NCT00402324|475103247|FG001|Overall Study|Withdrawal by Subject|2|||
131950093|NCT00402324|475103246|FG000|Overall Study|Physician Decision|2|||
131950094|NCT00402324|475103247|FG001|Overall Study|Physician Decision|4|||
131950095|NCT00402324|475103246|FG000|Overall Study|Sponsor Decision|4|||
131950096|NCT00402324|475103247|FG001|Overall Study|Sponsor Decision|5|||
131950097|NCT00402324|475103246|FG000|Overall Study|Lack of Efficacy|1|||
131950098|NCT00402324|475103247|FG001|Overall Study|Lack of Efficacy|4|||
131950099|NCT00402324|475103246|FG000|Overall Study|Adverse Event|6|||
131950100|NCT00402324|475103247|FG001|Overall Study|Adverse Event|4|||
131950101|NCT00402324|475103246|FG000|Overall Study|Death|1|||
131414838|NCT04692077|473143829|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
131414839|NCT05149313|473143830|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
131950102|NCT00402324|475103247|FG001|Overall Study|Death|0|||
131950103|NCT01340664|475103248|FG000|Overall Study|Adverse Event|0|||
131950104|NCT01340664|475103249|FG001|Overall Study|Adverse Event|1|||
131950105|NCT01340664|475103250|FG002|Overall Study|Adverse Event|7|||
131950106|NCT01340664|475103248|FG000|Overall Study|Lost to Follow-up|2|||
131950107|NCT01340664|475103249|FG001|Overall Study|Lost to Follow-up|0|||
131950108|NCT01340664|475103250|FG002|Overall Study|Lost to Follow-up|2|||
131456582|NCT01026324|473301231|FG002|Follow up/Survival|Withdrawal by Subject|0|||
131456583|NCT05188053|473301232|FG000|Overall Study|Lost to Follow-up|23|||
131456584|NCT05188053|473301233|FG001|Overall Study|Lost to Follow-up|30|||
131456585|NCT05188053|473301232|FG000|Overall Study|Protocol Violation|16|||
131456586|NCT05188053|473301233|FG001|Overall Study|Protocol Violation|16|||
131456587|NCT05188053|473301232|FG000|Overall Study|Physician Decision|3|||
131456588|NCT05188053|473301233|FG001|Overall Study|Physician Decision|0|||
131456589|NCT05188053|473301232|FG000|Overall Study|Withdrawal by Subject|0|||
131456590|NCT05188053|473301233|FG001|Overall Study|Withdrawal by Subject|1|||
131456591|NCT05334212|473301234|FG000|Overall Study|Study terminated prematurely|7|||
131456592|NCT01561313|473301235|FG000|Overall Study|Withdrawal by Subject|1|||
131456593|NCT01561313|473301236|FG001|Overall Study|Withdrawal by Subject|0|||
131456594|NCT01561313|473301235|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
131456595|NCT01561313|473301236|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
131456596|NCT04393454|473301237|FG000|Overall Study|Death|1|||
131456597|NCT04393454|473301237|FG000|Overall Study|Lost to Follow-up|1|||
131768896|NCT02500706|474431894|FG000|Overall Study|Adverse Event|0|||
131456599|NCT03304249|473301240|FG000|Overall Study|Lost to Follow-up|8|||
131456600|NCT03304249|473301241|FG001|Overall Study|Lost to Follow-up|10|||
131456601|NCT03304249|473301240|FG000|Overall Study|Withdrawal by Subject|12|||
131456602|NCT03304249|473301241|FG001|Overall Study|Withdrawal by Subject|2|||
131456603|NCT03304249|473301240|FG000|Overall Study|Moved Out of District|4|||
131456604|NCT03304249|473301241|FG001|Overall Study|Moved Out of District|2|||
131456605|NCT04189224|473301242|FG000|Period 2|Adverse Event|0|||
131456606|NCT04189224|473301243|FG001|Period 2|Adverse Event|1|||
131456607|NCT02970942|473301244|FG000|Overall Study|Death|0|||
131456608|NCT02970942|473301245|FG001|Overall Study|Death|1|||
131456609|NCT02970942|473301246|FG002|Overall Study|Death|0|||
131456610|NCT02970942|473301247|FG003|Overall Study|Death|0|||
131456611|NCT02970942|473301244|FG000|Overall Study|Lost to Follow-up|1|||
131456612|NCT02970942|473301245|FG001|Overall Study|Lost to Follow-up|0|||
131456613|NCT02970942|473301246|FG002|Overall Study|Lost to Follow-up|2|||
131456614|NCT02970942|473301247|FG003|Overall Study|Lost to Follow-up|1|||
131456615|NCT02970942|473301244|FG000|Overall Study|Withdrawal by Subject|3|||
131456616|NCT02970942|473301245|FG001|Overall Study|Withdrawal by Subject|5|||
131456617|NCT02970942|473301246|FG002|Overall Study|Withdrawal by Subject|3|||
131456618|NCT02970942|473301247|FG003|Overall Study|Withdrawal by Subject|2|||
131456619|NCT02529553|473301248|FG000|Overall Study|Progressive Disease|1|||
131456620|NCT02529553|473301249|FG001|Overall Study|Progressive Disease|0|||
131456621|NCT02529553|473301250|FG002|Overall Study|Progressive Disease|1|||
131456622|NCT02529553|473301251|FG003|Overall Study|Progressive Disease|3|||
131456623|NCT02529553|473301252|FG004|Overall Study|Progressive Disease|2|||
131456624|NCT02529553|473301253|FG005|Overall Study|Progressive Disease|3|||
131456625|NCT02529553|473301254|FG006|Overall Study|Progressive Disease|3|||
131456626|NCT02529553|473301255|FG007|Overall Study|Progressive Disease|5|||
131456627|NCT02529553|473301256|FG008|Overall Study|Progressive Disease|3|||
131456628|NCT02529553|473301248|FG000|Overall Study|Physician Decision|0|||
131456629|NCT02529553|473301249|FG001|Overall Study|Physician Decision|1|||
131456630|NCT02529553|473301250|FG002|Overall Study|Physician Decision|0|||
131456631|NCT02529553|473301251|FG003|Overall Study|Physician Decision|0|||
131456632|NCT02529553|473301252|FG004|Overall Study|Physician Decision|1|||
131456633|NCT02529553|473301253|FG005|Overall Study|Physician Decision|0|||
131456634|NCT02529553|473301254|FG006|Overall Study|Physician Decision|0|||
131456635|NCT02529553|473301255|FG007|Overall Study|Physician Decision|0|||
131456636|NCT02529553|473301256|FG008|Overall Study|Physician Decision|0|||
131456637|NCT02529553|473301248|FG000|Overall Study|Withdrawal by Subject|0|||
131456638|NCT02529553|473301249|FG001|Overall Study|Withdrawal by Subject|0|||
131456639|NCT02529553|473301250|FG002|Overall Study|Withdrawal by Subject|0|||
131456640|NCT02529553|473301251|FG003|Overall Study|Withdrawal by Subject|0|||
131456641|NCT02529553|473301252|FG004|Overall Study|Withdrawal by Subject|0|||
131456642|NCT02529553|473301253|FG005|Overall Study|Withdrawal by Subject|1|||
131456643|NCT02529553|473301254|FG006|Overall Study|Withdrawal by Subject|0|||
131456644|NCT02529553|473301255|FG007|Overall Study|Withdrawal by Subject|1|||
131456645|NCT02529553|473301256|FG008|Overall Study|Withdrawal by Subject|0|||
131456646|NCT00488683|473301257|FG000|Overall Study|Withdrawal by Subject|1|||
131456647|NCT00488683|473301258|FG001|Overall Study|Withdrawal by Subject|2|||
131456648|NCT00488683|473301259|FG002|Overall Study|Withdrawal by Subject|2|||
131456649|NCT00488683|473301257|FG000|Overall Study|Lost to Follow-up|5|||
131456650|NCT00488683|473301258|FG001|Overall Study|Lost to Follow-up|3|||
131456651|NCT00488683|473301259|FG002|Overall Study|Lost to Follow-up|0|||
131456652|NCT00488683|473301257|FG000|Overall Study|Protocol Violation|5|||
131456653|NCT00488683|473301258|FG001|Overall Study|Protocol Violation|1|||
131456654|NCT00488683|473301259|FG002|Overall Study|Protocol Violation|0|||
131456655|NCT00488683|473301257|FG000|Overall Study|Unable to Classify|1|||
131456656|NCT00488683|473301258|FG001|Overall Study|Unable to Classify|0|||
131456657|NCT00488683|473301259|FG002|Overall Study|Unable to Classify|0|||
131456658|NCT04549545|473302949|FG000|Initial Period|Withdrawal by Subject|4|||
131456659|NCT04549545|473302950|FG001|Initial Period|Withdrawal by Subject|0|||
131456660|NCT04549545|473302949|FG000|Initial Period|Additional ENT Procedure|3|||
131950109|NCT01340664|475103248|FG000|Overall Study|Withdrawal by Subject|2|||
131950110|NCT01340664|475103249|FG001|Overall Study|Withdrawal by Subject|4|||
131950111|NCT01340664|475103250|FG002|Overall Study|Withdrawal by Subject|0|||
131950112|NCT01340664|475103248|FG000|Overall Study|Glycemic withdrawal criteria|2|||
131950113|NCT01340664|475103249|FG001|Overall Study|Glycemic withdrawal criteria|0|||
131950114|NCT01340664|475103250|FG002|Overall Study|Glycemic withdrawal criteria|0|||
131950115|NCT01340664|475103248|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
131950116|NCT01340664|475103249|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
131950117|NCT01340664|475103250|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
131950118|NCT01340664|475103248|FG000|Overall Study|Other|1|||
131950119|NCT01340664|475103249|FG001|Overall Study|Other|2|||
131950120|NCT01340664|475103250|FG002|Overall Study|Other|2|||
131950121|NCT03994211|475103251|FG000|Core Phase|Adverse Event|0|||
131950122|NCT03994211|475103252|FG001|Core Phase|Adverse Event|1|||
131950123|NCT03994211|475103253|FG002|Core Phase|Adverse Event|0|||
131950124|NCT03994211|475103251|FG000|Extension Phase|Adverse Event|0|||
131950125|NCT03994211|475103252|FG001|Extension Phase|Adverse Event|0|||
131950126|NCT03994211|475103253|FG002|Extension Phase|Adverse Event|1|||
131950127|NCT03994211|475103251|FG000|Extension Phase|Physician Decision|0|||
131950128|NCT03994211|475103252|FG001|Extension Phase|Physician Decision|0|||
131950129|NCT03994211|475103253|FG002|Extension Phase|Physician Decision|1|||
131950130|NCT03994211|475103251|FG000|Extension Phase|Progressive Disease|0|||
131950131|NCT03994211|475103252|FG001|Extension Phase|Progressive Disease|0|||
131950132|NCT03994211|475103253|FG002|Extension Phase|Progressive Disease|20|||
131950133|NCT03994211|475103251|FG000|Extension Phase|Withdrawal by Subject|0|||
131950134|NCT03994211|475103252|FG001|Extension Phase|Withdrawal by Subject|0|||
131950135|NCT03994211|475103253|FG002|Extension Phase|Withdrawal by Subject|2|||
131950136|NCT02625220|475103254|FG000|Overall Study|Adverse Event|2|||
131950137|NCT02625220|475103254|FG000|Overall Study|Lost to Follow-up|2|||
131950138|NCT02625220|475103254|FG000|Overall Study|Protocol Violation|1|||
131950139|NCT02625220|475103254|FG000|Overall Study|Study discontinued at site|2|||
131950140|NCT01140867|475103255|FG000|Overall Study|Adverse Event|22|||
131950141|NCT01140867|475103255|FG000|Overall Study|Lack of Efficacy|3|||
131950142|NCT01140867|475103255|FG000|Overall Study|Lost to Follow-up|2|||
131950143|NCT01140867|475103255|FG000|Overall Study|Withdrawal by Subject|1|||
131950144|NCT01140867|475103255|FG000|Overall Study|Protocol Violation|1|||
131950145|NCT01140867|475103255|FG000|Overall Study|Uncooperative patient|2|||
131414840|NCT05149313|473143831|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
131950146|NCT01140867|475103255|FG000|Overall Study|Medication Noncompliance|2|||
131950147|NCT02997865|475103256|FG000|Overall Study|Death|2|||
131950148|NCT02997865|475103257|FG001|Overall Study|Death|1|||
131950149|NCT02997865|475103256|FG000|Overall Study|Lost to Follow-up|6|||
131950150|NCT02997865|475103257|FG001|Overall Study|Lost to Follow-up|3|||
131950151|NCT02997865|475103256|FG000|Overall Study|Withdrawal by Subject|5|||
131950152|NCT02997865|475103257|FG001|Overall Study|Withdrawal by Subject|0|||
131950153|NCT01926444|475103258|FG000|Overall Study|Colonoscopy not performed|0|||
131950154|NCT01926444|475103259|FG001|Overall Study|Colonoscopy not performed|0|||
131950155|NCT01926444|475103260|FG002|Overall Study|Colonoscopy not performed|4|||
131950156|NCT01926444|475103261|FG003|Overall Study|Colonoscopy not performed|2|||
131950157|NCT02528942|475103263|FG000|Overall Study|Did not meet imaging criteria|9|||
131950158|NCT02528942|475103263|FG000|Overall Study|Lost to Follow-up|25|||
131950159|NCT00881530|475103264|FG000|Overall Study|Adverse Event|5|||
131950160|NCT00881530|475103265|FG001|Overall Study|Adverse Event|1|||
131950161|NCT00881530|475103266|FG002|Overall Study|Adverse Event|1|||
131950162|NCT00881530|475103267|FG003|Overall Study|Adverse Event|4|||
131950163|NCT00881530|475103268|FG004|Overall Study|Adverse Event|10|||
131950164|NCT00881530|475103269|FG005|Overall Study|Adverse Event|2|||
131950165|NCT00881530|475103264|FG000|Overall Study|Lack of Efficacy|1|||
131950166|NCT00881530|475103265|FG001|Overall Study|Lack of Efficacy|0|||
131950167|NCT00881530|475103266|FG002|Overall Study|Lack of Efficacy|0|||
131950168|NCT00881530|475103267|FG003|Overall Study|Lack of Efficacy|0|||
131950169|NCT00881530|475103268|FG004|Overall Study|Lack of Efficacy|1|||
131950170|NCT00881530|475103269|FG005|Overall Study|Lack of Efficacy|1|||
131950171|NCT00881530|475103264|FG000|Overall Study|Not compliant with the protocol|0|||
131950172|NCT00881530|475103265|FG001|Overall Study|Not compliant with the protocol|0|||
131950173|NCT00881530|475103266|FG002|Overall Study|Not compliant with the protocol|0|||
131414841|NCT05149313|473143832|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
131950174|NCT00881530|475103267|FG003|Overall Study|Not compliant with the protocol|0|||
131950175|NCT00881530|475103268|FG004|Overall Study|Not compliant with the protocol|2|||
131950176|NCT00881530|475103269|FG005|Overall Study|Not compliant with the protocol|0|||
131950177|NCT00881530|475103264|FG000|Overall Study|Lost to Follow-up|0|||
131414842|NCT05149313|473143833|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
131950178|NCT00881530|475103265|FG001|Overall Study|Lost to Follow-up|1|||
131950179|NCT00881530|475103266|FG002|Overall Study|Lost to Follow-up|1|||
131950180|NCT00881530|475103267|FG003|Overall Study|Lost to Follow-up|3|||
131950181|NCT00881530|475103268|FG004|Overall Study|Lost to Follow-up|1|||
131950182|NCT00881530|475103269|FG005|Overall Study|Lost to Follow-up|0|||
131950183|NCT00881530|475103264|FG000|Overall Study|Refused to continue medication|7|||
131950184|NCT00881530|475103265|FG001|Overall Study|Refused to continue medication|2|||
131950185|NCT00881530|475103266|FG002|Overall Study|Refused to continue medication|1|||
131950186|NCT00881530|475103267|FG003|Overall Study|Refused to continue medication|2|||
131950187|NCT00881530|475103268|FG004|Overall Study|Refused to continue medication|0|||
131950188|NCT00881530|475103269|FG005|Overall Study|Refused to continue medication|0|||
131950189|NCT00881530|475103264|FG000|Overall Study|Other reason not defined above|1|||
131950190|NCT00881530|475103265|FG001|Overall Study|Other reason not defined above|1|||
131950191|NCT00881530|475103266|FG002|Overall Study|Other reason not defined above|2|||
131950192|NCT00881530|475103267|FG003|Overall Study|Other reason not defined above|0|||
131950193|NCT00881530|475103268|FG004|Overall Study|Other reason not defined above|0|||
131950194|NCT00881530|475103269|FG005|Overall Study|Other reason not defined above|2|||
131950195|NCT01509846|475103270|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
131950196|NCT01509846|475103271|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
131950197|NCT01509846|475103272|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
131950198|NCT01509846|475103273|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
131950199|NCT01509846|475103274|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
131950200|NCT01509846|475103270|FG000|Received Vaccination 2|Illness|0|||
131950201|NCT01509846|475103271|FG001|Received Vaccination 2|Illness|0|||
131950202|NCT01509846|475103272|FG002|Received Vaccination 2|Illness|0|||
131950203|NCT01509846|475103273|FG003|Received Vaccination 2|Illness|0|||
131950204|NCT01509846|475103274|FG004|Received Vaccination 2|Illness|1|||
131950205|NCT01509846|475103270|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
131414843|NCT05149313|473143830|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
131414844|NCT05149313|473143831|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
131414845|NCT05149313|473143832|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
131414846|NCT05149313|473143833|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
131414847|NCT05149313|473143830|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
131414848|NCT05149313|473143831|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
131414849|NCT05149313|473143832|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
131414850|NCT05149313|473143833|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
131414851|NCT05149313|473143830|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
131414852|NCT05149313|473143831|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
131414853|NCT05149313|473143832|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
131414854|NCT05149313|473143833|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
131414855|NCT05149313|473143830|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
131414856|NCT05149313|473143831|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
131414857|NCT05149313|473143832|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
131414858|NCT05149313|473143833|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
131414859|NCT05149313|473143830|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
131414860|NCT05149313|473143831|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
131414861|NCT05149313|473143832|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
131414862|NCT05149313|473143833|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
131414863|NCT05149313|473143830|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
131414864|NCT05149313|473143831|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
131414865|NCT05149313|473143832|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
131414866|NCT05149313|473143833|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
131414867|NCT05149313|473143830|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131414868|NCT05149313|473143831|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131414869|NCT05149313|473143832|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
131414870|NCT05149313|473143833|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
131414871|NCT05149313|473143830|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131414872|NCT05149313|473143831|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131414873|NCT05149313|473143832|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
131414874|NCT05149313|473143833|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
131414875|NCT05149313|473143830|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131414876|NCT05149313|473143831|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131414877|NCT05149313|473143832|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
131414878|NCT05149313|473143833|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131414879|NCT05149313|473143830|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
131414880|NCT05149313|473143831|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
131414881|NCT05149313|473143832|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
131414882|NCT05149313|473143833|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
131414883|NCT03199391|473143838|FG000|Overall Study|Death|1|||
131414884|NCT03199391|473143838|FG000|Overall Study|Lost to Follow-up|3|||
131414885|NCT03199391|473143838|FG000|Overall Study|Adverse Event|2|||
131414886|NCT03199391|473143838|FG000|Overall Study|Withdrawal by Subject|10|||
131950206|NCT01509846|475103271|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
131950207|NCT01509846|475103272|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
131950208|NCT01509846|475103273|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
131950209|NCT01509846|475103274|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
131950210|NCT01509846|475103270|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
131950211|NCT01509846|475103271|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
131950212|NCT01509846|475103272|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
131950213|NCT01509846|475103273|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
131950214|NCT01509846|475103274|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
131950215|NCT01509846|475103270|FG000|Received Vaccination 3|Pregnancy|0|||
131950216|NCT01509846|475103271|FG001|Received Vaccination 3|Pregnancy|0|||
131950217|NCT01509846|475103272|FG002|Received Vaccination 3|Pregnancy|0|||
131950218|NCT01509846|475103273|FG003|Received Vaccination 3|Pregnancy|1|||
131950219|NCT01509846|475103274|FG004|Received Vaccination 3|Pregnancy|0|||
131950220|NCT01509846|475103270|FG000|Received Vaccination 3|Lost to Follow-up|0|||
131950221|NCT01509846|475103271|FG001|Received Vaccination 3|Lost to Follow-up|0|||
131950222|NCT01509846|475103272|FG002|Received Vaccination 3|Lost to Follow-up|1|||
131950223|NCT01509846|475103273|FG003|Received Vaccination 3|Lost to Follow-up|0|||
131950224|NCT01509846|475103274|FG004|Received Vaccination 3|Lost to Follow-up|0|||
131950225|NCT01637584|475103275|FG000|Overall Study|Withdrawal by Subject|1|||
131950226|NCT01637584|475103276|FG001|Overall Study|Withdrawal by Subject|3|||
131950227|NCT02969915|475103278|FG000|Overall Study|Death|104|||
131950228|NCT02969915|475103279|FG001|Overall Study|Death|125|||
131950229|NCT02969915|475103278|FG000|Overall Study|Lost to Follow-up|108|||
131950230|NCT02969915|475103279|FG001|Overall Study|Lost to Follow-up|112|||
131950231|NCT02969915|475103278|FG000|Overall Study|Censored due to COVID-19|481|||
131950232|NCT02969915|475103279|FG001|Overall Study|Censored due to COVID-19|471|||
131950233|NCT01393899|475103282|FG000|Overall Study|Study terminated by sponsor|1|||
131950234|NCT01393899|475103283|FG001|Overall Study|Study terminated by sponsor|0|||
131950235|NCT01393899|475103284|FG002|Overall Study|Study terminated by sponsor|1|||
131950236|NCT01393899|475103282|FG000|Overall Study|Other|1|||
131950237|NCT01393899|475103283|FG001|Overall Study|Other|0|||
131950238|NCT01393899|475103284|FG002|Overall Study|Other|0|||
131950239|NCT01393899|475103282|FG000|Overall Study|Withdrawal by Subject|2|||
131950240|NCT01393899|475103283|FG001|Overall Study|Withdrawal by Subject|2|||
131950241|NCT01393899|475103284|FG002|Overall Study|Withdrawal by Subject|1|||
131950242|NCT01393899|475103282|FG000|Overall Study|Lost to Follow-up|0|||
131950243|NCT01393899|475103283|FG001|Overall Study|Lost to Follow-up|0|||
131950244|NCT01393899|475103284|FG002|Overall Study|Lost to Follow-up|1|||
131950245|NCT01393899|475103282|FG000|Overall Study|Does not meet entrance criteria|1|||
131950246|NCT01393899|475103283|FG001|Overall Study|Does not meet entrance criteria|0|||
131950247|NCT01393899|475103284|FG002|Overall Study|Does not meet entrance criteria|1|||
131950248|NCT01393899|475103282|FG000|Overall Study|Lack of Efficacy|26|||
131950249|NCT01393899|475103283|FG001|Overall Study|Lack of Efficacy|21|||
131950250|NCT01393899|475103284|FG002|Overall Study|Lack of Efficacy|16|||
131950251|NCT01393899|475103282|FG000|Overall Study|Adverse Event|1|||
131950252|NCT01393899|475103283|FG001|Overall Study|Adverse Event|5|||
131950253|NCT01393899|475103284|FG002|Overall Study|Adverse Event|3|||
131950254|NCT02503085|475103285|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
131950255|NCT02503085|475103286|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
131950256|NCT02503085|475103287|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
131950257|NCT02503085|475103288|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
131950258|NCT02709720|475103294|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
131950259|NCT02709720|475103294|FG000|Overall Study|Protocol Violation|1|||
131950260|NCT02709720|475103294|FG000|Overall Study|Not take study medication|1|||
131950261|NCT00325130|475103296|FG000|Overall Study|Lost to Follow-up|6|||
131950262|NCT00325130|475103297|FG001|Overall Study|Lost to Follow-up|14|||
131950263|NCT00325130|475103296|FG000|Overall Study|Withdrawal by Subject|12|||
131950264|NCT00325130|475103297|FG001|Overall Study|Withdrawal by Subject|14|||
131950265|NCT00325130|475103296|FG000|Overall Study|Protocol Deviation|0|||
131950266|NCT00325130|475103297|FG001|Overall Study|Protocol Deviation|1|||
131950267|NCT00325130|475103296|FG000|Overall Study|Moved|0|||
131950268|NCT00325130|475103297|FG001|Overall Study|Moved|1|||
131950269|NCT00325130|475103296|FG000|Overall Study|Patient Discontinued for Other|1|||
131950270|NCT00325130|475103297|FG001|Overall Study|Patient Discontinued for Other|0|||
131950271|NCT00104728|475103298|FG000|Overall Study|screen failures|19|||
131950272|NCT02949024|475103301|FG000|Overall Study|Withdrawal by Subject|0|||
131950273|NCT02949024|475103302|FG001|Overall Study|Withdrawal by Subject|1|||
131950274|NCT01082081|475103303|FG000|Overall Study|Lost to Follow-up|0|||
131950275|NCT01082081|475103304|FG001|Overall Study|Lost to Follow-up|0|||
131950276|NCT01082081|475103305|FG002|Overall Study|Lost to Follow-up|1|||
131950277|NCT01082081|475103303|FG000|Overall Study|Withdrawal by Subject|0|||
131950278|NCT01082081|475103304|FG001|Overall Study|Withdrawal by Subject|0|||
131950279|NCT01082081|475103305|FG002|Overall Study|Withdrawal by Subject|1|||
131950280|NCT01082081|475103303|FG000|Overall Study|Other Reason|0|||
131950281|NCT01082081|475103304|FG001|Overall Study|Other Reason|1|||
131950282|NCT01082081|475103305|FG002|Overall Study|Other Reason|0|||
131950283|NCT00670930|475103308|FG000|Overall Study|Adminstrative Problem|0|||
131950284|NCT00670930|475103309|FG001|Overall Study|Adminstrative Problem|1|||
131950285|NCT00670930|475103308|FG000|Overall Study|Lost to Follow-up|1|||
131950286|NCT00670930|475103309|FG001|Overall Study|Lost to Follow-up|0|||
131950287|NCT02524145|475103310|FG000|Overall Study|Withdrawal by Subject|2|||
131950288|NCT02524145|475103311|FG001|Overall Study|Withdrawal by Subject|2|||
131950289|NCT02524145|475103312|FG002|Overall Study|Withdrawal by Subject|3|||
131950290|NCT01127607|475105484|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
131950291|NCT01127607|475105485|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
131950292|NCT01127607|475105484|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
131950293|NCT01127607|475105485|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
131950294|NCT03640325|475105486|FG000|Overall Study|Withdrawal by Subject|4|||
131950295|NCT03640325|475105487|FG001|Overall Study|Withdrawal by Subject|1|||
131950296|NCT03640325|475105488|FG002|Overall Study|Withdrawal by Subject|0|||
131950297|NCT03640325|475105486|FG000|Overall Study|Lost to Follow-up|4|||
131950298|NCT03640325|475105487|FG001|Overall Study|Lost to Follow-up|5|||
131950299|NCT03640325|475105488|FG002|Overall Study|Lost to Follow-up|21|||
131950300|NCT03640325|475105486|FG000|Overall Study|Death|5|||
131950301|NCT03640325|475105487|FG001|Overall Study|Death|5|||
131950302|NCT03640325|475105488|FG002|Overall Study|Death|0|||
131950303|NCT03493451|475105489|FG000|Overall Study|Death|11|||
131950304|NCT03493451|475105490|FG001|Overall Study|Death|26|||
131950305|NCT03493451|475105491|FG002|Overall Study|Death|3|||
131950306|NCT03493451|475105489|FG000|Overall Study|Lost to Follow-up|1|||
131950307|NCT03493451|475105490|FG001|Overall Study|Lost to Follow-up|4|||
131950308|NCT03493451|475105491|FG002|Overall Study|Lost to Follow-up|1|||
131950309|NCT03493451|475105489|FG000|Overall Study|Withdrawal by Subject|1|||
131950310|NCT03493451|475105490|FG001|Overall Study|Withdrawal by Subject|1|||
131950311|NCT03493451|475105491|FG002|Overall Study|Withdrawal by Subject|2|||
131950312|NCT03493451|475105489|FG000|Overall Study|Progressive Disease|1|||
131950313|NCT03493451|475105490|FG001|Overall Study|Progressive Disease|0|||
131950314|NCT03493451|475105491|FG002|Overall Study|Progressive Disease|0|||
131950315|NCT03493451|475105489|FG000|Overall Study|Transferred to long term extension study|8|||
131950316|NCT03493451|475105490|FG001|Overall Study|Transferred to long term extension study|13|||
131950317|NCT03493451|475105491|FG002|Overall Study|Transferred to long term extension study|5|||
131950318|NCT01133756|475105494|FG000|Overall Study|Adverse Event|1|||
131950319|NCT01133756|475105495|FG001|Overall Study|Adverse Event|2|||
131950320|NCT01133756|475105496|FG002|Overall Study|Adverse Event|1|||
131950321|NCT01133756|475105494|FG000|Overall Study|Investigator Decision|1|||
131950322|NCT01133756|475105495|FG001|Overall Study|Investigator Decision|0|||
131950323|NCT01133756|475105496|FG002|Overall Study|Investigator Decision|0|||
131950324|NCT01133756|475105494|FG000|Overall Study|Withdrawal by Subject|0|||
131950325|NCT01133756|475105495|FG001|Overall Study|Withdrawal by Subject|1|||
131950326|NCT01133756|475105496|FG002|Overall Study|Withdrawal by Subject|0|||
131950327|NCT01133756|475105494|FG000|Overall Study|Progression of Disease|0|||
131950328|NCT01133756|475105495|FG001|Overall Study|Progression of Disease|0|||
131950329|NCT01133756|475105496|FG002|Overall Study|Progression of Disease|1|||
131950330|NCT02982772|475105499|FG000|Intervention|Lost to Follow-up|19|||
131950331|NCT02982772|475105500|FG001|Intervention|Lost to Follow-up|13|||
131950332|NCT02982772|475105499|FG000|1M Follow-Up|Lost to Follow-up|21|||
131950333|NCT02982772|475105500|FG001|1M Follow-Up|Lost to Follow-up|18|||
131950334|NCT02982772|475105499|FG000|3M Follow-Up|Lost to Follow-up|17|||
131950335|NCT02982772|475105500|FG001|3M Follow-Up|Lost to Follow-up|11|||
131950336|NCT02982772|475105499|FG000|6M Follow-Up|Lost to Follow-up|11|||
131950337|NCT02982772|475105500|FG001|6M Follow-Up|Lost to Follow-up|9|||
131950338|NCT02982772|475105499|FG000|12M Follow-Up|Lost to Follow-up|11|||
131950339|NCT02982772|475105500|FG001|12M Follow-Up|Lost to Follow-up|5|||
131950340|NCT01234480|475105501|FG000|Overall Study|Pregnancy|88|||
131950341|NCT01234480|475105501|FG000|Overall Study|>36/Normal History|50|||
131950342|NCT01234480|475105501|FG000|Overall Study|Age|3|||
131950343|NCT01234480|475105501|FG000|Overall Study|HPV Vaccine History|28|||
131950344|NCT01234480|475105501|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
131950345|NCT01234480|475105501|FG000|Overall Study|Hysterectomy|2|||
131950346|NCT01234480|475105501|FG000|Overall Study|Hysterectomy post enrollment|1|||
131950347|NCT01234480|475105501|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
131950348|NCT01234480|475105501|FG000|Overall Study|Informed Consent Form Violation|30|||
131950349|NCT01234480|475105501|FG000|Overall Study|Incorrect Visit|3|||
131950350|NCT01234480|475105501|FG000|Overall Study|No Florida Lab License|20|||
131950351|NCT01234480|475105501|FG000|Overall Study|Out of Window|42|||
131950352|NCT01234480|475105501|FG000|Overall Study|Sample Processing/Storage|92|||
131950353|NCT01234480|475105501|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
131950354|NCT01234480|475105501|FG000|Overall Study|Site/Subject non-compliance|44|||
131950355|NCT01234480|475105501|FG000|Overall Study|Missing Sample|9|||
131950356|NCT02974140|475105502|FG000|Overall Study|Adverse Event|2|||
131950357|NCT02974140|475105502|FG000|Overall Study|Lost to Follow-up|1|||
131950358|NCT02974140|475105502|FG000|Overall Study|Study Terminated by Sponsor|36|||
131950359|NCT00617084|475105505|FG000|Overall Study|Withdrawal by Subject|5|||
131950360|NCT00617084|475105506|FG001|Overall Study|Withdrawal by Subject|7|||
131950361|NCT00617084|475105505|FG000|Overall Study|Missed 12 Months visit|16|||
131950362|NCT00617084|475105506|FG001|Overall Study|Missed 12 Months visit|19|||
131950363|NCT02522429|475105509|FG000|Overall Study|Lost to Follow-up|8|||
131950364|NCT02522429|475105509|FG000|Overall Study|Adverse Event|2|||
131950365|NCT02522429|475105509|FG000|Overall Study|Death|1|||
131950366|NCT02522429|475105509|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
131950367|NCT03015363|475105513|FG000|Overall Study|Physician Decision|14|||
131950368|NCT03015363|475105513|FG000|Overall Study|Withdrawal by Subject|3|||
131950369|NCT00078806|475105514|FG000|Part 1A|Adverse Event|2|||
131950370|NCT00078806|475105515|FG001|Part 1A|Adverse Event|0|||
131950371|NCT00078806|475105516|FG002|Part 1A|Adverse Event|0|||
131950372|NCT00078806|475105517|FG003|Part 1A|Adverse Event|0|||
131950373|NCT00078806|475105514|FG000|Part 1A|Lack of Efficacy|7|||
131950374|NCT00078806|475105515|FG001|Part 1A|Lack of Efficacy|0|||
131950375|NCT00078806|475105516|FG002|Part 1A|Lack of Efficacy|0|||
131950376|NCT00078806|475105517|FG003|Part 1A|Lack of Efficacy|0|||
131950377|NCT00078806|475105514|FG000|Part 1A|Other|1|||
131950378|NCT00078806|475105515|FG001|Part 1A|Other|0|||
131950379|NCT00078806|475105516|FG002|Part 1A|Other|0|||
131950380|NCT00078806|475105517|FG003|Part 1A|Other|0|||
131950381|NCT00078806|475105514|FG000|Part 1B|Adverse Event|1|||
131950382|NCT00078806|475105515|FG001|Part 1B|Adverse Event|0|||
131950383|NCT00078806|475105516|FG002|Part 1B|Adverse Event|0|||
131950384|NCT00078806|475105517|FG003|Part 1B|Adverse Event|0|||
131950385|NCT00078806|475105514|FG000|Part 1B|Lack of Efficacy|7|||
131950386|NCT00078806|475105515|FG001|Part 1B|Lack of Efficacy|0|||
131950387|NCT00078806|475105516|FG002|Part 1B|Lack of Efficacy|0|||
131950388|NCT00078806|475105517|FG003|Part 1B|Lack of Efficacy|0|||
131950389|NCT00078806|475105514|FG000|Part 2|Adverse Event|0|||
131950390|NCT00078806|475105515|FG001|Part 2|Adverse Event|1|||
131950391|NCT00078806|475105516|FG002|Part 2|Adverse Event|0|||
131950392|NCT00078806|475105517|FG003|Part 2|Adverse Event|0|||
131950393|NCT03592771|475105522|FG000|Overall Study|Adverse Event|2|||
131950394|NCT03592771|475105523|FG001|Overall Study|Adverse Event|0|||
131950395|NCT03592771|475105524|FG002|Overall Study|Adverse Event|1|||
131950396|NCT03592771|475105522|FG000|Overall Study|Death|0|||
131950397|NCT03592771|475105523|FG001|Overall Study|Death|1|||
131950398|NCT03592771|475105524|FG002|Overall Study|Death|1|||
131950399|NCT03592771|475105522|FG000|Overall Study|Lost to Follow-up|5|||
131950400|NCT03592771|475105523|FG001|Overall Study|Lost to Follow-up|11|||
131950401|NCT03592771|475105524|FG002|Overall Study|Lost to Follow-up|15|||
131950402|NCT03592771|475105522|FG000|Overall Study|Withdrawal by Subject|0|||
131950403|NCT03592771|475105523|FG001|Overall Study|Withdrawal by Subject|2|||
131950404|NCT03592771|475105524|FG002|Overall Study|Withdrawal by Subject|0|||
131950405|NCT01665911|475105525|FG000|Overall Study|Protocol Violation|4|||
131950406|NCT01665911|475105525|FG000|Overall Study|Withdrawal by Subject|1|||
131950407|NCT01665911|475105525|FG000|Overall Study|Adverse Event|1|||
131950408|NCT00735553|475105526|FG000|Overall Study|Study prematurely terminated|77|||
131950409|NCT04556591|475105527|FG000|Overall Study|Lost to Follow-up|1|||
131950410|NCT04556591|475105528|FG001|Overall Study|Lost to Follow-up|0|||
131950411|NCT04556591|475105527|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
131950412|NCT04556591|475105528|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
131950413|NCT03332173|475105529|FG000|Overall Study|Death|7|||
131950414|NCT03332173|475105529|FG000|Overall Study|Withdrawal by Subject|6|||
131950415|NCT03332173|475105529|FG000|Overall Study|Lost to Follow-up|2|||
131950416|NCT03332173|475105529|FG000|Overall Study|Transferred to long-term extension study|29|||
131950417|NCT02168101|475105530|FG000|Overall Study|Death|2|||
131456661|NCT04549545|473302950|FG001|Initial Period|Additional ENT Procedure|0|||
131456662|NCT04549545|473302949|FG000|Initial Period|Lost to Follow-up|3|||
131456663|NCT04549545|473302950|FG001|Initial Period|Lost to Follow-up|1|||
131456664|NCT04549545|473302949|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
131456665|NCT04549545|473302950|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
131456666|NCT04549545|473302949|FG000|Crossover Period|Additional ENT Procedure|0|||
131456667|NCT04549545|473302950|FG001|Crossover Period|Additional ENT Procedure|6|||
131456668|NCT04549545|473302949|FG000|Crossover Period|Lost to Follow-up|0|||
131950418|NCT02168101|475105531|FG001|Overall Study|Death|2|||
131456669|NCT04549545|473302950|FG001|Crossover Period|Lost to Follow-up|1|||
131456670|NCT04549545|473302949|FG000|Crossover Period|Withdrawal by Subject|0|||
131456671|NCT04549545|473302950|FG001|Crossover Period|Withdrawal by Subject|4|||
131950419|NCT02168101|475105532|FG002|Overall Study|Death|1|||
131950420|NCT01973231|475105533|FG000|Overall Study|Protocol Violation|1|||
131950421|NCT01973231|475105534|FG001|Overall Study|Protocol Violation|1|||
131950422|NCT01973231|475105533|FG000|Overall Study|Lost to Follow-up|1|||
131950423|NCT01973231|475105534|FG001|Overall Study|Lost to Follow-up|1|||
131950424|NCT01973231|475105533|FG000|Overall Study|unclassified|2|||
131950425|NCT01973231|475105534|FG001|Overall Study|unclassified|1|||
131950426|NCT01973231|475105533|FG000|Overall Study|Withdrawal by Subject|7|||
131950427|NCT01973231|475105534|FG001|Overall Study|Withdrawal by Subject|9|||
131950428|NCT04830215|475105535|FG000|Overall Study|Adverse Event|6|||
131456672|NCT01006291|473302951|FG000|Overall Study|Adverse Event|2|||
131456673|NCT01006291|473302952|FG001|Overall Study|Adverse Event|1|||
131456674|NCT01006291|473302953|FG002|Overall Study|Adverse Event|2|||
131456675|NCT01006291|473302951|FG000|Overall Study|Lack of Efficacy|2|||
131456676|NCT01006291|473302952|FG001|Overall Study|Lack of Efficacy|2|||
131456677|NCT01006291|473302953|FG002|Overall Study|Lack of Efficacy|1|||
131456678|NCT01006291|473302951|FG000|Overall Study|Protocol Violation|3|||
131456679|NCT01006291|473302952|FG001|Overall Study|Protocol Violation|3|||
131456680|NCT01006291|473302953|FG002|Overall Study|Protocol Violation|3|||
131456681|NCT01006291|473302951|FG000|Overall Study|Withdrawal criteria|5|||
131456682|NCT01006291|473302952|FG001|Overall Study|Withdrawal criteria|4|||
131456683|NCT01006291|473302953|FG002|Overall Study|Withdrawal criteria|4|||
131456684|NCT01006291|473302951|FG000|Overall Study|Other|14|||
131456685|NCT01006291|473302952|FG001|Overall Study|Other|14|||
131456686|NCT01006291|473302953|FG002|Overall Study|Other|17|||
131456687|NCT03079102|473302954|FG000|Overall Study|Physician Decision|0|||
131456688|NCT03079102|473302955|FG001|Overall Study|Physician Decision|1|||
131456689|NCT02175199|473302958|FG000|Overall Study|Withdrawal by Subject|1|||
131456690|NCT02175199|473302959|FG001|Overall Study|Withdrawal by Subject|5|||
131456691|NCT02175199|473302958|FG000|Overall Study|Randomized in Error|1|||
131456692|NCT02175199|473302959|FG001|Overall Study|Randomized in Error|0|||
131456693|NCT02175199|473302958|FG000|Overall Study|Sponsor Decision|1|||
131456694|NCT02175199|473302959|FG001|Overall Study|Sponsor Decision|0|||
131456695|NCT03983317|473302966|FG000|Overall Study|Physician Decision|5|||
131456696|NCT02810444|473302967|FG000|Overall Study|Screen Failures|14|||
131456697|NCT02810444|473302967|FG000|Overall Study|Withdrawal by Subject|4|||
131456698|NCT02810444|473302967|FG000|Overall Study|Adverse Event|3|||
131456699|NCT02785770|473302968|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
131456700|NCT02785770|473302969|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
131456701|NCT02785770|473302970|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
131456702|NCT02785770|473302971|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
131456703|NCT02785770|473302968|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
131456704|NCT02785770|473302969|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
131456705|NCT02785770|473302970|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
131456706|NCT02785770|473302971|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
131456707|NCT02785770|473302968|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
131456708|NCT02785770|473302969|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
131456709|NCT02785770|473302970|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
131456710|NCT02785770|473302971|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
131456711|NCT02891070|473302976|FG000|Overall Study|Adverse Event|1|||
131456712|NCT02891070|473302977|FG001|Overall Study|Adverse Event|0|||
131456713|NCT02891070|473302976|FG000|Overall Study|Physician Decision|0|||
131456714|NCT02891070|473302977|FG001|Overall Study|Physician Decision|1|||
131456715|NCT02891070|473302976|FG000|Overall Study|Lost to Follow-up|4|||
131456716|NCT02891070|473302977|FG001|Overall Study|Lost to Follow-up|4|||
131456717|NCT02891070|473302976|FG000|Overall Study|Other|1|||
131456718|NCT02891070|473302977|FG001|Overall Study|Other|0|||
131456719|NCT02891070|473302976|FG000|Overall Study|Protocol Violation|0|||
131456720|NCT02891070|473302977|FG001|Overall Study|Protocol Violation|1|||
131456721|NCT02891070|473302976|FG000|Overall Study|Withdrawal by Subject|1|||
131456722|NCT02891070|473302977|FG001|Overall Study|Withdrawal by Subject|2|||
131456723|NCT02891070|473302976|FG000|Overall Study|Death|3|||
131456724|NCT02891070|473302977|FG001|Overall Study|Death|0|||
131456725|NCT04491604|473302980|FG000|Overall Study|Withdrawal by Subject|3|||
131456726|NCT00545272|473302981|FG000|Overall Study|Protocol deviation|0|||
131950429|NCT04830215|475105535|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
131950430|NCT04830215|475105535|FG000|Overall Study|Withdrawal by Subject|3|||
131950431|NCT04830215|475105535|FG000|Overall Study|Protocol Deviation|1|||
131950432|NCT03726658|475105537|FG000|Overall Study|Lost to Follow-up|0|||
131950433|NCT03726658|475105538|FG001|Overall Study|Lost to Follow-up|0|||
131950434|NCT03726658|475105539|FG002|Overall Study|Lost to Follow-up|2|||
131950435|NCT03726658|475105540|FG003|Overall Study|Lost to Follow-up|0|||
131950436|NCT03726658|475105541|FG004|Overall Study|Lost to Follow-up|0|||
131456727|NCT00545272|473302982|FG001|Overall Study|Protocol deviation|1|||
131456728|NCT00545272|473302983|FG002|Overall Study|Protocol deviation|0|||
131456729|NCT00545272|473302984|FG003|Overall Study|Protocol deviation|1|||
131456730|NCT00545272|473302985|FG004|Overall Study|Protocol deviation|0|||
131456731|NCT00545272|473302986|FG005|Overall Study|Protocol deviation|1|||
131456732|NCT00545272|473302981|FG000|Overall Study|Adverse Event|0|||
131456733|NCT00545272|473302982|FG001|Overall Study|Adverse Event|0|||
131456734|NCT00545272|473302983|FG002|Overall Study|Adverse Event|1|||
131456735|NCT00545272|473302984|FG003|Overall Study|Adverse Event|0|||
131456736|NCT00545272|473302985|FG004|Overall Study|Adverse Event|0|||
131456737|NCT00545272|473302986|FG005|Overall Study|Adverse Event|1|||
131456738|NCT00545272|473302981|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131456739|NCT00545272|473302982|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131456740|NCT00545272|473302983|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131950437|NCT03726658|475105542|FG005|Overall Study|Lost to Follow-up|1|||
131950438|NCT03726658|475105543|FG006|Overall Study|Lost to Follow-up|1|||
131950439|NCT03726658|475105537|FG000|Overall Study|Withdrawal by Subject|1|||
131950440|NCT03726658|475105538|FG001|Overall Study|Withdrawal by Subject|0|||
131950441|NCT03726658|475105539|FG002|Overall Study|Withdrawal by Subject|0|||
131950442|NCT03726658|475105540|FG003|Overall Study|Withdrawal by Subject|0|||
131950443|NCT03726658|475105541|FG004|Overall Study|Withdrawal by Subject|6|||
131950444|NCT03726658|475105542|FG005|Overall Study|Withdrawal by Subject|4|||
131950445|NCT03726658|475105543|FG006|Overall Study|Withdrawal by Subject|2|||
131950446|NCT03726658|475105537|FG000|Overall Study|Pregnancy|0|||
131950447|NCT03726658|475105538|FG001|Overall Study|Pregnancy|0|||
131950448|NCT03726658|475105539|FG002|Overall Study|Pregnancy|0|||
131950449|NCT03726658|475105540|FG003|Overall Study|Pregnancy|0|||
131950450|NCT03726658|475105541|FG004|Overall Study|Pregnancy|0|||
131950451|NCT03726658|475105542|FG005|Overall Study|Pregnancy|0|||
131950452|NCT03726658|475105543|FG006|Overall Study|Pregnancy|1|||
131950453|NCT03726658|475105537|FG000|Overall Study|Not Reported|0|||
131950454|NCT03726658|475105538|FG001|Overall Study|Not Reported|0|||
131950455|NCT03726658|475105539|FG002|Overall Study|Not Reported|0|||
131950456|NCT03726658|475105540|FG003|Overall Study|Not Reported|0|||
131950457|NCT03726658|475105541|FG004|Overall Study|Not Reported|0|||
131950458|NCT03726658|475105542|FG005|Overall Study|Not Reported|0|||
131950459|NCT03726658|475105543|FG006|Overall Study|Not Reported|1|||
131950460|NCT00988052|475105544|FG000|Overall Study|Missing|1|||
131950461|NCT00988052|475105545|FG001|Overall Study|Missing|0|||
131950462|NCT00988052|475105544|FG000|Overall Study|Teva requested subject withdrawal|3|||
131950463|NCT00988052|475105545|FG001|Overall Study|Teva requested subject withdrawal|1|||
131950464|NCT00988052|475105544|FG000|Overall Study|Death|1|||
131950465|NCT00988052|475105545|FG001|Overall Study|Death|3|||
131950466|NCT00988052|475105544|FG000|Overall Study|Protocol Violation|6|||
131950467|NCT00988052|475105545|FG001|Overall Study|Protocol Violation|5|||
131950468|NCT00988052|475105544|FG000|Overall Study|Pregnancy|6|||
131950469|NCT00988052|475105545|FG001|Overall Study|Pregnancy|6|||
131950470|NCT00988052|475105544|FG000|Overall Study|Lack of Efficacy|8|||
131950471|NCT00988052|475105545|FG001|Overall Study|Lack of Efficacy|7|||
131950472|NCT00988052|475105544|FG000|Overall Study|Lost to Follow-up|6|||
131950473|NCT00988052|475105545|FG001|Overall Study|Lost to Follow-up|11|||
131950474|NCT00988052|475105544|FG000|Overall Study|Physician Decision|27|||
131950475|NCT00988052|475105545|FG001|Overall Study|Physician Decision|28|||
131950476|NCT00988052|475105544|FG000|Overall Study|Adverse Event|35|||
131950477|NCT00988052|475105545|FG001|Overall Study|Adverse Event|28|||
131950478|NCT00988052|475105544|FG000|Overall Study|Withdrawal by Subject|90|||
131950479|NCT00988052|475105545|FG001|Overall Study|Withdrawal by Subject|91|||
131950480|NCT00988052|475105544|FG000|Overall Study|Study terminated by sponsor|240|||
131950481|NCT00988052|475105545|FG001|Overall Study|Study terminated by sponsor|236|||
131950482|NCT03782064|475105548|FG000|Overall Study|Lack of Efficacy|2|||
131950483|NCT03782064|475105548|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
131950484|NCT02446769|475105549|FG000|Screening Period|Screen Failure|11|||
131950485|NCT02446769|475105550|FG001|Screening Period|Screen Failure|0|||
131950486|NCT02446769|475105551|FG002|Screening Period|Screen Failure|0|||
131950487|NCT02446769|475105549|FG000|Study Period|Randomized in Error|0|||
131950488|NCT02446769|475105550|FG001|Study Period|Randomized in Error|2|||
131950489|NCT02446769|475105551|FG002|Study Period|Randomized in Error|0|||
131950490|NCT03072043|475105552|FG000|Overall Study|Death|0|||
131950491|NCT03072043|475105553|FG001|Overall Study|Death|0|||
131950492|NCT03072043|475105554|FG002|Overall Study|Death|3|||
131950493|NCT03072043|475105552|FG000|Overall Study|Adverse Event|0|||
131950494|NCT03072043|475105553|FG001|Overall Study|Adverse Event|0|||
131950495|NCT03072043|475105554|FG002|Overall Study|Adverse Event|2|||
131414887|NCT01867086|473143839|FG000|Overall Study|Disease Progression|1|||
131414888|NCT03826342|473143840|FG000|Overall Study|Withdrawal by Subject|8|||
131950496|NCT03072043|475105552|FG000|Overall Study|Withdrawal by Subject|0|||
131950497|NCT03072043|475105553|FG001|Overall Study|Withdrawal by Subject|0|||
131950498|NCT03072043|475105554|FG002|Overall Study|Withdrawal by Subject|4|||
131950499|NCT00645840|475105555|FG000|Overall Study|Protocol Violation|3|||
131950500|NCT01277822|475105556|FG000|Overall Study|Adverse Event|2|||
131950501|NCT01277822|475105557|FG001|Overall Study|Adverse Event|1|||
131950502|NCT01277822|475105556|FG000|Overall Study|Withdrawal by Subject|6|||
131950503|NCT01277822|475105557|FG001|Overall Study|Withdrawal by Subject|7|||
131950504|NCT01277822|475105556|FG000|Overall Study|Physician Decision|1|||
131950505|NCT01277822|475105557|FG001|Overall Study|Physician Decision|1|||
131950506|NCT01277822|475105556|FG000|Overall Study|Protocol Violation|1|||
131950507|NCT01277822|475105557|FG001|Overall Study|Protocol Violation|0|||
131950508|NCT01277822|475105556|FG000|Overall Study|Lost to Follow-up|2|||
131950509|NCT01277822|475105557|FG001|Overall Study|Lost to Follow-up|1|||
131950510|NCT01277822|475105556|FG000|Overall Study|Contraindicated medication used|2|||
131950511|NCT01277822|475105557|FG001|Overall Study|Contraindicated medication used|1|||
131950512|NCT01277822|475105556|FG000|Overall Study|Participant moved|1|||
131950513|NCT01277822|475105557|FG001|Overall Study|Participant moved|0|||
131950514|NCT02923531|475105558|FG000|Overall Study|Adverse Event|4|||
131950515|NCT02923531|475105558|FG000|Overall Study|Clinical Deterioration|1|||
131950516|NCT02923531|475105558|FG000|Overall Study|Disease Progression|3|||
131950517|NCT02923531|475105558|FG000|Overall Study|Study Termination|1|||
131950518|NCT00997984|475105559|FG000|Overall Study|Adverse Event|1|||
131950519|NCT00997984|475105560|FG001|Overall Study|Adverse Event|8|||
131950520|NCT00997984|475105561|FG002|Overall Study|Adverse Event|8|||
131950521|NCT00997984|475105559|FG000|Overall Study|Protocol Violation|1|||
131950522|NCT00997984|475105560|FG001|Overall Study|Protocol Violation|3|||
131950523|NCT00997984|475105561|FG002|Overall Study|Protocol Violation|0|||
131950524|NCT00997984|475105559|FG000|Overall Study|Withdrawal by Subject|6|||
131950525|NCT00997984|475105560|FG001|Overall Study|Withdrawal by Subject|9|||
131950526|NCT00997984|475105561|FG002|Overall Study|Withdrawal by Subject|5|||
131950527|NCT00997984|475105559|FG000|Overall Study|Lost to Follow-up|8|||
131950528|NCT00997984|475105560|FG001|Overall Study|Lost to Follow-up|5|||
131950529|NCT00997984|475105561|FG002|Overall Study|Lost to Follow-up|4|||
131950530|NCT00997984|475105559|FG000|Overall Study|Lack of Efficacy|20|||
131950531|NCT00997984|475105560|FG001|Overall Study|Lack of Efficacy|6|||
131950532|NCT00997984|475105561|FG002|Overall Study|Lack of Efficacy|3|||
131950533|NCT00997984|475105559|FG000|Overall Study|Met exclusion criteria|1|||
131950534|NCT00997984|475105560|FG001|Overall Study|Met exclusion criteria|0|||
131950535|NCT00997984|475105561|FG002|Overall Study|Met exclusion criteria|0|||
131950536|NCT00997984|475105559|FG000|Overall Study|non-compliance|0|||
131950537|NCT00997984|475105560|FG001|Overall Study|non-compliance|2|||
131950538|NCT00997984|475105561|FG002|Overall Study|non-compliance|3|||
131950539|NCT00997984|475105559|FG000|Overall Study|Wrong medication dispensed|0|||
131950540|NCT00997984|475105560|FG001|Overall Study|Wrong medication dispensed|1|||
131950541|NCT00997984|475105561|FG002|Overall Study|Wrong medication dispensed|0|||
131950542|NCT00997984|475105559|FG000|Overall Study|Suicidal ideation|0|||
131950543|NCT00997984|475105560|FG001|Overall Study|Suicidal ideation|0|||
131950544|NCT00997984|475105561|FG002|Overall Study|Suicidal ideation|1|||
131950545|NCT00997984|475105559|FG000|Overall Study|Work schedule|0|||
131950546|NCT00997984|475105560|FG001|Overall Study|Work schedule|0|||
131950547|NCT00997984|475105561|FG002|Overall Study|Work schedule|2|||
131950548|NCT03012828|475105564|FG000|Overall Study|Lost to Follow-up|1|||
131950549|NCT03012828|475105565|FG001|Overall Study|Lost to Follow-up|0|||
131950550|NCT03012828|475105566|FG002|Overall Study|Lost to Follow-up|1|||
131950551|NCT03012828|475105567|FG003|Overall Study|Lost to Follow-up|0|||
131950552|NCT03012828|475105568|FG004|Overall Study|Lost to Follow-up|1|||
131950553|NCT03012828|475105569|FG005|Overall Study|Lost to Follow-up|0|||
131950554|NCT03012828|475105564|FG000|Overall Study|Withdrawal by Subject|0|||
131950555|NCT03012828|475105565|FG001|Overall Study|Withdrawal by Subject|0|||
131950556|NCT03012828|475105566|FG002|Overall Study|Withdrawal by Subject|1|||
131950557|NCT03012828|475105567|FG003|Overall Study|Withdrawal by Subject|0|||
131950558|NCT03012828|475105568|FG004|Overall Study|Withdrawal by Subject|0|||
131950559|NCT03012828|475105569|FG005|Overall Study|Withdrawal by Subject|1|||
131950560|NCT03012828|475105564|FG000|Overall Study|Non-compliance with protocol|0|||
131950561|NCT03012828|475105565|FG001|Overall Study|Non-compliance with protocol|0|||
131950562|NCT03012828|475105566|FG002|Overall Study|Non-compliance with protocol|0|||
131950563|NCT03012828|475105567|FG003|Overall Study|Non-compliance with protocol|0|||
131950564|NCT03012828|475105568|FG004|Overall Study|Non-compliance with protocol|1|||
131950565|NCT03012828|475105569|FG005|Overall Study|Non-compliance with protocol|0|||
131950566|NCT03012828|475105564|FG000|Overall Study|Delay to last visit would delay DBL|0|||
131950567|NCT03012828|475105565|FG001|Overall Study|Delay to last visit would delay DBL|0|||
131950568|NCT03012828|475105566|FG002|Overall Study|Delay to last visit would delay DBL|0|||
131950569|NCT03012828|475105567|FG003|Overall Study|Delay to last visit would delay DBL|0|||
131950570|NCT03012828|475105568|FG004|Overall Study|Delay to last visit would delay DBL|0|||
131950571|NCT03012828|475105569|FG005|Overall Study|Delay to last visit would delay DBL|1|||
131950572|NCT02544750|475105571|FG000|Overall Study|Physician Decision|3|||
131950573|NCT02544750|475105572|FG001|Overall Study|Physician Decision|1|||
131950574|NCT02544750|475105571|FG000|Overall Study|Other reasons|69|||
131950575|NCT02544750|475105572|FG001|Overall Study|Other reasons|39|||
131950576|NCT02544750|475105571|FG000|Overall Study|Met withdrawal criteria|2|||
131950577|NCT02544750|475105572|FG001|Overall Study|Met withdrawal criteria|2|||
131950578|NCT02544750|475105571|FG000|Overall Study|Transition To Commercial Product|1|||
131950579|NCT02544750|475105572|FG001|Overall Study|Transition To Commercial Product|0|||
131950580|NCT02544750|475105571|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
131950581|NCT02544750|475105572|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
131950582|NCT02544750|475105571|FG000|Overall Study|Adverse Event|8|||
131950583|NCT02544750|475105572|FG001|Overall Study|Adverse Event|10|||
131950584|NCT02544750|475105571|FG000|Overall Study|Withdrawal by Subject|10|||
131950585|NCT02544750|475105572|FG001|Overall Study|Withdrawal by Subject|4|||
131950586|NCT02544750|475105571|FG000|Overall Study|Lost to Follow-up|1|||
131414889|NCT03826342|473143841|FG001|Overall Study|Withdrawal by Subject|1|||
131950587|NCT02544750|475105572|FG001|Overall Study|Lost to Follow-up|0|||
131950588|NCT04396795|475105575|FG000|Month 1|Lost to Follow-up|2|||
131950589|NCT04396795|475105576|FG001|Month 1|Lost to Follow-up|3|||
131950590|NCT04396795|475105575|FG000|Month 3|Lost to Follow-up|1|||
131456741|NCT00545272|473302984|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131456742|NCT00545272|473302985|FG004|Overall Study|Abnormal laboratory value(s)|0|||
131456743|NCT00545272|473302986|FG005|Overall Study|Abnormal laboratory value(s)|1|||
131456744|NCT00545272|473302981|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131456745|NCT00545272|473302982|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131456746|NCT00545272|473302983|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131768897|NCT02500706|474431895|FG001|Overall Study|Adverse Event|0|||
131414890|NCT03826342|473143840|FG000|Overall Study|Lost to Follow-up|7|||
131414891|NCT03826342|473143841|FG001|Overall Study|Lost to Follow-up|7|||
131414892|NCT03826342|473143840|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
131414893|NCT03826342|473143841|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
131414894|NCT02212678|473143845|FG000|Overall Study|Adverse Event|1|||
131414895|NCT02337634|473143846|FG000|Overall Study|Protocol Violation|3|||
131414896|NCT02337634|473143847|FG001|Overall Study|Protocol Violation|1|||
131414897|NCT02337634|473143846|FG000|Overall Study|Lost to Follow-up|1|||
131414898|NCT02337634|473143847|FG001|Overall Study|Lost to Follow-up|0|||
131414899|NCT04068610|473143848|FG000|Overall Study|Death|4|||
131414900|NCT04068610|473143849|FG001|Overall Study|Death|8|||
131414901|NCT04068610|473143850|FG002|Overall Study|Death|13|||
131414902|NCT04068610|473143848|FG000|Overall Study|Lost to Follow-up|0|||
131414903|NCT04068610|473143849|FG001|Overall Study|Lost to Follow-up|2|||
131414904|NCT04068610|473143850|FG002|Overall Study|Lost to Follow-up|0|||
131414905|NCT04068610|473143848|FG000|Overall Study|Withdrawal by Subject|0|||
131414906|NCT04068610|473143849|FG001|Overall Study|Withdrawal by Subject|4|||
131414907|NCT04068610|473143850|FG002|Overall Study|Withdrawal by Subject|2|||
131414908|NCT04068610|473143848|FG000|Overall Study|Other|3|||
131414909|NCT04068610|473143849|FG001|Overall Study|Other|12|||
131414910|NCT04068610|473143850|FG002|Overall Study|Other|11|||
131414911|NCT02428205|473143851|FG000|Overall Study|Lack of Efficacy|1|||
131414912|NCT02428205|473143852|FG001|Overall Study|Lack of Efficacy|0|||
131414913|NCT02428205|473143851|FG000|Overall Study|Lost to Follow-up|1|||
131414914|NCT02428205|473143852|FG001|Overall Study|Lost to Follow-up|1|||
131414915|NCT02428205|473143851|FG000|Overall Study|Worse behavior|0|||
131414916|NCT02428205|473143852|FG001|Overall Study|Worse behavior|1|||
131414917|NCT02046070|473143853|FG000|Overall Study|Progressive Disease|18|||
131414918|NCT02046070|473143854|FG001|Overall Study|Progressive Disease|11|||
131414919|NCT02046070|473143855|FG002|Overall Study|Progressive Disease|40|||
131414920|NCT02046070|473143853|FG000|Overall Study|Adverse Event|8|||
131414921|NCT02046070|473143854|FG001|Overall Study|Adverse Event|10|||
131414922|NCT02046070|473143855|FG002|Overall Study|Adverse Event|17|||
131414923|NCT02046070|473143853|FG000|Overall Study|Withdrawal by Subject|1|||
131414924|NCT02046070|473143854|FG001|Overall Study|Withdrawal by Subject|2|||
131414925|NCT02046070|473143855|FG002|Overall Study|Withdrawal by Subject|6|||
131414926|NCT02046070|473143853|FG000|Overall Study|Study Terminated by Sponsor|1|||
131414927|NCT02046070|473143854|FG001|Overall Study|Study Terminated by Sponsor|1|||
131414928|NCT02046070|473143855|FG002|Overall Study|Study Terminated by Sponsor|1|||
131414929|NCT02046070|473143853|FG000|Overall Study|Reason not Specified|4|||
131414930|NCT02046070|473143854|FG001|Overall Study|Reason not Specified|4|||
131414931|NCT02046070|473143855|FG002|Overall Study|Reason not Specified|6|||
131414932|NCT05601102|473143856|FG000|Overall Study|Death|1|||
131414933|NCT05601102|473143857|FG001|Overall Study|Death|2|||
131414934|NCT05601102|473143856|FG000|Overall Study|Withdrawal by Subject|1|||
131414935|NCT05601102|473143857|FG001|Overall Study|Withdrawal by Subject|1|||
131414936|NCT05601102|473143856|FG000|Overall Study|Lost to Follow-up|0|||
131414937|NCT05601102|473143857|FG001|Overall Study|Lost to Follow-up|2|||
131414938|NCT05288166|473143858|FG000|Overall Study|Adverse Event|1|||
131414939|NCT05288166|473143859|FG001|Overall Study|Adverse Event|0|||
131414940|NCT05288166|473143858|FG000|Overall Study|Lost to Follow-up|2|||
131414941|NCT05288166|473143859|FG001|Overall Study|Lost to Follow-up|0|||
131414942|NCT05288166|473143858|FG000|Overall Study|Physician Decision|0|||
131414943|NCT05288166|473143859|FG001|Overall Study|Physician Decision|2|||
131414944|NCT05288166|473143858|FG000|Overall Study|Screen Failure|1|||
131414945|NCT05288166|473143859|FG001|Overall Study|Screen Failure|1|||
131414946|NCT05288166|473143858|FG000|Overall Study|Withdrawal by Subject|4|||
131414947|NCT05288166|473143859|FG001|Overall Study|Withdrawal by Subject|2|||
131414948|NCT05288166|473143858|FG000|Overall Study|On Study Treatment|408|||
131414949|NCT05288166|473143859|FG001|Overall Study|On Study Treatment|418|||
131414950|NCT00527319|473143860|FG000|Overall Study|Withdrawal by Subject|5|||
131414951|NCT00527319|473143861|FG001|Overall Study|Withdrawal by Subject|0|||
131414952|NCT00527319|473143862|FG002|Overall Study|Withdrawal by Subject|1|||
131414953|NCT00527319|473143860|FG000|Overall Study|Lost to Follow-up|1|||
131414954|NCT00527319|473143861|FG001|Overall Study|Lost to Follow-up|0|||
131414955|NCT00527319|473143862|FG002|Overall Study|Lost to Follow-up|0|||
131414956|NCT00527319|473143860|FG000|Overall Study|Death|0|||
131414957|NCT00527319|473143861|FG001|Overall Study|Death|3|||
131414958|NCT00527319|473143862|FG002|Overall Study|Death|1|||
131950591|NCT04396795|475105576|FG001|Month 3|Lost to Follow-up|3|||
131414959|NCT00527319|473143860|FG000|Overall Study|Intercurrent Medical Illness|0|||
131414960|NCT00527319|473143861|FG001|Overall Study|Intercurrent Medical Illness|1|||
131950592|NCT04396795|475105575|FG000|Month 6|Lost to Follow-up|3|||
131950593|NCT04396795|475105576|FG001|Month 6|Lost to Follow-up|3|||
131950594|NCT02366923|475105577|FG000|Overall Study|Withdrawal by Subject|1|||
131950595|NCT02366923|475105577|FG000|Overall Study|Positive Slit Lamp Findings|2|||
131950596|NCT02366923|475105577|FG000|Overall Study|High Astigmatism|3|||
131950597|NCT02484443|475105578|FG000|Overall Study|Lack of Efficacy|28|||
131950598|NCT02484443|475105578|FG000|Overall Study|Physician Decision|2|||
131414961|NCT00527319|473143862|FG002|Overall Study|Intercurrent Medical Illness|3|||
131414962|NCT00527319|473143860|FG000|Overall Study|Adverse Event|0|||
131414963|NCT00527319|473143861|FG001|Overall Study|Adverse Event|0|||
131414964|NCT00527319|473143862|FG002|Overall Study|Adverse Event|1|||
131414965|NCT00483041|473143864|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
131414966|NCT00483041|473143865|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
131414967|NCT02258529|473143867|FG000|Overall Study|Study Terminated by Sponsor|9|||
131414968|NCT02258529|473143867|FG000|Overall Study|Adverse Event|1|||
131414969|NCT00443781|473143868|FG000|Overall Study|Lost to Follow-up|10|||
131414970|NCT00443781|473143868|FG000|Overall Study|Physician Decision|2|||
131414971|NCT00443781|473143868|FG000|Overall Study|Protocol Violation|1|||
131414972|NCT00443781|473143868|FG000|Overall Study|Withdrawal by Subject|6|||
131414973|NCT00443781|473143868|FG000|Overall Study|Unable to comply with study follow up|2|||
131414974|NCT00443781|473143868|FG000|Overall Study|Investigator terminated participation|1|||
131414975|NCT00443781|473143868|FG000|Overall Study|Insurance not covered|2|||
131414976|NCT00443781|473143868|FG000|Overall Study|PD/FAD not done|1|||
131414977|NCT02066415|473143869|FG000|Overall Study|Decision by Sponsor|5|||
131414978|NCT02066415|473143870|FG001|Overall Study|Decision by Sponsor|4|||
131414979|NCT02066415|473143871|FG002|Overall Study|Decision by Sponsor|2|||
131414980|NCT02066415|473143869|FG000|Overall Study|Withdrawal by Subject|9|||
131414981|NCT02066415|473143870|FG001|Overall Study|Withdrawal by Subject|1|||
131414982|NCT02066415|473143871|FG002|Overall Study|Withdrawal by Subject|4|||
131414983|NCT02066415|473143869|FG000|Overall Study|Lost to Follow-up|7|||
131414984|NCT02066415|473143870|FG001|Overall Study|Lost to Follow-up|2|||
131414985|NCT02066415|473143871|FG002|Overall Study|Lost to Follow-up|2|||
131414986|NCT04135859|473143873|FG000|Overall Study|Withdrawal by Subject|1|||
131414987|NCT04135859|473143874|FG001|Overall Study|Withdrawal by Subject|0|||
131414988|NCT04135859|473143873|FG000|Overall Study|Withdrawal due to screening failure|1|||
131414989|NCT04135859|473143874|FG001|Overall Study|Withdrawal due to screening failure|2|||
131414990|NCT04135859|473143873|FG000|Overall Study|Did not complete stress test|3|||
131414991|NCT04135859|473143874|FG001|Overall Study|Did not complete stress test|3|||
131414992|NCT04135859|473143873|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
131414993|NCT04135859|473143874|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
131414994|NCT00551291|473143875|FG000|Overall Study|Physician Decision|1|||
131414995|NCT01943552|473143876|FG000|Overall Study|Adverse Event|3|||
131414996|NCT01943552|473143877|FG001|Overall Study|Adverse Event|2|||
131414997|NCT01943552|473143876|FG000|Overall Study|Withdrawal by Subject|6|||
131414998|NCT01943552|473143877|FG001|Overall Study|Withdrawal by Subject|6|||
131414999|NCT01943552|473143876|FG000|Overall Study|Other Reasons|16|||
131415000|NCT01943552|473143877|FG001|Overall Study|Other Reasons|17|||
131415001|NCT01600053|473143878|FG000|Overall Study|Adverse Event|2|||
131415002|NCT01600053|473143878|FG000|Overall Study|trial will not meet the interim endpoint|9|||
131415003|NCT04047420|473143879|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
131415004|NCT04047420|473143879|FG000|Washout Period|Refused Participation|2|||
131415005|NCT00477269|473143881|FG000|Core Study|Adverse Event|6|||
131415006|NCT00477269|473143882|FG001|Core Study|Adverse Event|4|||
131415007|NCT00477269|473143883|FG002|Core Study|Adverse Event|0|||
131415008|NCT00477269|473143881|FG000|Core Study|Death|3|||
131415009|NCT00477269|473143882|FG001|Core Study|Death|3|||
131415010|NCT00477269|473143883|FG002|Core Study|Death|0|||
131415011|NCT00477269|473143881|FG000|Core Study|Withdrawn Consent|0|||
131415012|NCT00477269|473143882|FG001|Core Study|Withdrawn Consent|1|||
131415013|NCT00477269|473143883|FG002|Core Study|Withdrawn Consent|0|||
131415014|NCT00477269|473143881|FG000|Open Label Extension|Adverse Event|0|||
131415015|NCT00477269|473143882|FG001|Open Label Extension|Adverse Event|0|||
131415016|NCT00477269|473143883|FG002|Open Label Extension|Adverse Event|4|||
131415017|NCT00477269|473143881|FG000|Open Label Extension|Abnormal laboratory values|0|||
131415018|NCT00477269|473143882|FG001|Open Label Extension|Abnormal laboratory values|0|||
131415019|NCT00477269|473143883|FG002|Open Label Extension|Abnormal laboratory values|1|||
131415020|NCT00477269|473143881|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
131415021|NCT00477269|473143882|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
131415022|NCT00477269|473143883|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
131415023|NCT00477269|473143881|FG000|Open Label Extension|Adminiatrative problems|0|||
131950599|NCT02484443|475105578|FG000|Overall Study|Ineligible|2|||
131950600|NCT04677543|475105579|FG000|Overall Study|Withdrawal by Subject|4|||
131415024|NCT00477269|473143882|FG001|Open Label Extension|Adminiatrative problems|0|||
131415025|NCT00477269|473143883|FG002|Open Label Extension|Adminiatrative problems|2|||
131415026|NCT00477269|473143881|FG000|Open Label Extension|Death|0|||
131415027|NCT00477269|473143882|FG001|Open Label Extension|Death|0|||
131950601|NCT04677543|475105580|FG001|Overall Study|Withdrawal by Subject|1|||
131950602|NCT04677543|475105579|FG000|Overall Study|Physician Decision|0|||
131950603|NCT04677543|475105580|FG001|Overall Study|Physician Decision|1|||
131950604|NCT04677543|475105579|FG000|Overall Study|Adverse Event|0|||
131950605|NCT04677543|475105580|FG001|Overall Study|Adverse Event|1|||
131950606|NCT03799952|475105581|FG000|Overall Study|Program was too easy, discontinued|1|||
131950607|NCT03799952|475105582|FG001|Overall Study|Program was too easy, discontinued|0|||
131950608|NCT03799952|475105581|FG000|Overall Study|Lost to Follow-up|0|||
131950609|NCT03799952|475105582|FG001|Overall Study|Lost to Follow-up|2|||
131950610|NCT02595866|475105583|FG000|Overall Study|Adverse Event|2|||
131950611|NCT02595866|475105584|FG001|Overall Study|Adverse Event|5|||
131950612|NCT02595866|475105583|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
131950613|NCT02595866|475105584|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
131950614|NCT02595866|475105583|FG000|Overall Study|Death|0|||
131950615|NCT02595866|475105584|FG001|Overall Study|Death|1|||
131950616|NCT02595866|475105583|FG000|Overall Study|Incarceration|1|||
131950617|NCT02595866|475105584|FG001|Overall Study|Incarceration|0|||
131950618|NCT02595866|475105583|FG000|Overall Study|Lack of Efficacy|17|||
131950619|NCT02595866|475105584|FG001|Overall Study|Lack of Efficacy|7|||
131950620|NCT02595866|475105583|FG000|Overall Study|Physician Decision|4|||
131950621|NCT02595866|475105584|FG001|Overall Study|Physician Decision|3|||
131950622|NCT02595866|475105583|FG000|Overall Study|Switched to Alternative Treatment|1|||
131950623|NCT02595866|475105584|FG001|Overall Study|Switched to Alternative Treatment|0|||
131950624|NCT02595866|475105583|FG000|Overall Study|Study Terminated|0|||
131950625|NCT02595866|475105584|FG001|Overall Study|Study Terminated|4|||
131950626|NCT02595866|475105583|FG000|Overall Study|Withdrawal by Subject|6|||
131950627|NCT02595866|475105584|FG001|Overall Study|Withdrawal by Subject|1|||
131950628|NCT02520388|475105585|FG000|Overall Study|Physician Decision|1|||
131950629|NCT02520388|475105586|FG001|Overall Study|Physician Decision|0|||
131950630|NCT02520388|475105585|FG000|Overall Study|Subject or parent/guardian request|0|||
131950631|NCT02520388|475105586|FG001|Overall Study|Subject or parent/guardian request|6|||
131950632|NCT02520388|475105585|FG000|Overall Study|Adverse Event|1|||
131950633|NCT02520388|475105586|FG001|Overall Study|Adverse Event|4|||
131950634|NCT02520388|475105585|FG000|Overall Study|Lost to Follow-up|3|||
131950635|NCT02520388|475105586|FG001|Overall Study|Lost to Follow-up|2|||
131950636|NCT02520388|475105585|FG000|Overall Study|Other (reason not defined)|4|||
131950637|NCT02520388|475105586|FG001|Overall Study|Other (reason not defined)|4|||
131950638|NCT01437111|475105587|FG000|Overall Study|Adverse Event|2|||
131950639|NCT01437111|475105587|FG000|Overall Study|Withdrawal by Subject|4|||
131950640|NCT01437111|475105587|FG000|Overall Study|Not reported|5|||
131950641|NCT01437111|475105587|FG000|Overall Study|Physician Decision|1|||
131950642|NCT01437111|475105587|FG000|Overall Study|Lost to Follow-up|5|||
131950643|NCT01437111|475105587|FG000|Overall Study|Protocol Violation|1|||
131950644|NCT02131311|475105589|FG000|Overall Study|Adverse Event|2|||
131950645|NCT02131311|475105589|FG000|Overall Study|Protocol Violation|1|||
131950646|NCT02131311|475105589|FG000|Overall Study|Lost to Follow-up|1|||
131950647|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
131950648|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
131950649|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
131950650|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
131950651|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
131950652|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
131950653|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
131950654|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
131950655|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
131950656|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
131950657|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
131950658|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
131950659|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
131950660|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
131950661|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
131950662|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
131768898|NCT02500706|474431896|FG002|Overall Study|Adverse Event|1|||
131950663|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
131950664|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
131950665|NCT03162796|475105594|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
131950666|NCT03162796|475105595|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
131950667|NCT03162796|475105596|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
131950668|NCT03162796|475105594|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
131950669|NCT03162796|475105595|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
131950670|NCT03162796|475105596|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
131950671|NCT03162796|475105594|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
131950672|NCT03162796|475105595|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
131950673|NCT03162796|475105596|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
131950674|NCT03162796|475105594|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
131950675|NCT03162796|475105595|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
131950676|NCT03162796|475105596|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
131950677|NCT03162796|475105594|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
131950678|NCT03162796|475105595|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
131950679|NCT03162796|475105596|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
131950680|NCT03035864|475105597|FG000|Treatment Period|Adverse Event|1|||
131950681|NCT03035864|475105598|FG001|Treatment Period|Adverse Event|0|||
131950682|NCT03035864|475105597|FG000|Treatment Period|Other|3|||
131950683|NCT03035864|475105598|FG001|Treatment Period|Other|1|||
131950684|NCT03035864|475105597|FG000|Follow-up Period|Adverse Event|1|||
131950685|NCT03035864|475105598|FG001|Follow-up Period|Adverse Event|0|||
131950686|NCT03035864|475105597|FG000|Follow-up Period|Lost to Follow-up|6|||
131950687|NCT03035864|475105598|FG001|Follow-up Period|Lost to Follow-up|2|||
131950688|NCT03035864|475105597|FG000|Follow-up Period|Physician Decision|1|||
131950689|NCT03035864|475105598|FG001|Follow-up Period|Physician Decision|0|||
131950690|NCT03035864|475105597|FG000|Follow-up Period|Other|3|||
131950691|NCT03035864|475105598|FG001|Follow-up Period|Other|2|||
131950692|NCT02342288|475105599|FG000|Overall Study|no protocol anesthesiologist available|3|||
131950693|NCT02342288|475105600|FG001|Overall Study|no protocol anesthesiologist available|2|||
131950694|NCT02342288|475105599|FG000|Overall Study|anesthesia leak in system|1|||
131950695|NCT02342288|475105600|FG001|Overall Study|anesthesia leak in system|0|||
131950696|NCT02342288|475105599|FG000|Overall Study|Withdrawal by Subject|1|||
131950697|NCT02342288|475105600|FG001|Overall Study|Withdrawal by Subject|0|||
131950698|NCT02342288|475105599|FG000|Overall Study|coordinator contaminated with blood|0|||
131950699|NCT02342288|475105600|FG001|Overall Study|coordinator contaminated with blood|1|||
131950700|NCT02342288|475105599|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
131950701|NCT02342288|475105600|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
131950702|NCT02342288|475105599|FG000|Overall Study|coordinator not available|0|||
131950703|NCT02342288|475105600|FG001|Overall Study|coordinator not available|2|||
131950704|NCT03082677|475105601|FG000|Overall Study|Not Treated|2|||
131950705|NCT00391430|475105602|FG000|Overall Study|Withdrawal by Subject|3|||
131950706|NCT00391430|475105603|FG001|Overall Study|Withdrawal by Subject|0|||
131950707|NCT00391430|475105604|FG002|Overall Study|Withdrawal by Subject|12|||
131950708|NCT00577707|475105605|FG000|Overall Study|Withdrawal by Subject|3|||
131950709|NCT03299244|475105606|FG000|Overall Study|Withdrawal by Subject|34|||
131950710|NCT03299244|475105607|FG001|Overall Study|Withdrawal by Subject|29|||
131950711|NCT03299244|475105606|FG000|Overall Study|Decision by Sponsor|4|||
131950712|NCT03299244|475105607|FG001|Overall Study|Decision by Sponsor|5|||
131950713|NCT03299244|475105606|FG000|Overall Study|Death|9|||
131950714|NCT03299244|475105607|FG001|Overall Study|Death|4|||
131950715|NCT03146663|475105608|FG000|Overall Study|Did not receive study treatment|1|||
131950716|NCT03146663|475105609|FG001|Overall Study|Did not receive study treatment|1|||
131950717|NCT02517398|475105624|FG000|Overall Study|Death|2|||
131950718|NCT02517398|475105625|FG001|Overall Study|Death|3|||
131950719|NCT02517398|475105626|FG002|Overall Study|Death|4|||
131950720|NCT02517398|475105627|FG003|Overall Study|Death|2|||
131950721|NCT02517398|475105628|FG004|Overall Study|Death|3|||
131950722|NCT02517398|475105629|FG005|Overall Study|Death|8|||
131950723|NCT02517398|475105630|FG006|Overall Study|Death|3|||
131950724|NCT02517398|475105631|FG007|Overall Study|Death|2|||
131950725|NCT02517398|475105632|FG008|Overall Study|Death|6|||
131950726|NCT02517398|475105633|FG009|Overall Study|Death|24|||
131950727|NCT02517398|475105634|FG010|Overall Study|Death|53|||
131950728|NCT02517398|475105635|FG011|Overall Study|Death|25|||
131950729|NCT02517398|475105636|FG012|Overall Study|Death|73|||
131950730|NCT02517398|475105637|FG013|Overall Study|Death|29|||
131950731|NCT02517398|475105638|FG014|Overall Study|Death|26|||
131950732|NCT02517398|475105639|FG015|Overall Study|Death|23|||
131950733|NCT02517398|475105640|FG016|Overall Study|Death|26|||
131950734|NCT02517398|475105641|FG017|Overall Study|Death|25|||
131950735|NCT02517398|475105642|FG018|Overall Study|Death|22|||
131950736|NCT02517398|475105643|FG019|Overall Study|Death|7|||
131950737|NCT02517398|475105644|FG020|Overall Study|Death|26|||
131950738|NCT02517398|475105645|FG021|Overall Study|Death|30|||
131950739|NCT02517398|475105646|FG022|Overall Study|Death|20|||
131950740|NCT02517398|475105624|FG000|Overall Study|Other|0|||
131950741|NCT02517398|475105625|FG001|Overall Study|Other|0|||
131950742|NCT02517398|475105626|FG002|Overall Study|Other|0|||
131950743|NCT02517398|475105627|FG003|Overall Study|Other|1|||
131950744|NCT02517398|475105628|FG004|Overall Study|Other|0|||
131950745|NCT02517398|475105629|FG005|Overall Study|Other|0|||
131950746|NCT02517398|475105630|FG006|Overall Study|Other|0|||
131950747|NCT02517398|475105631|FG007|Overall Study|Other|0|||
131950748|NCT02517398|475105632|FG008|Overall Study|Other|0|||
131950749|NCT02517398|475105633|FG009|Overall Study|Other|1|||
131950750|NCT02517398|475105634|FG010|Overall Study|Other|0|||
131950751|NCT02517398|475105635|FG011|Overall Study|Other|0|||
131950752|NCT02517398|475105636|FG012|Overall Study|Other|0|||
131456747|NCT00545272|473302984|FG003|Overall Study|Abnormal test procedure result(s)|0|||
131456748|NCT00545272|473302985|FG004|Overall Study|Abnormal test procedure result(s)|1|||
131456749|NCT00545272|473302986|FG005|Overall Study|Abnormal test procedure result(s)|0|||
131456750|NCT00545272|473302981|FG000|Overall Study|Lost to Follow-up|0|||
131456751|NCT00545272|473302982|FG001|Overall Study|Lost to Follow-up|0|||
131456752|NCT00545272|473302983|FG002|Overall Study|Lost to Follow-up|0|||
131456753|NCT00545272|473302984|FG003|Overall Study|Lost to Follow-up|0|||
131456754|NCT00545272|473302985|FG004|Overall Study|Lost to Follow-up|1|||
131456755|NCT00545272|473302986|FG005|Overall Study|Lost to Follow-up|0|||
131456756|NCT02934503|473302987|FG000|Overall Study|progression of disease|3|||
131456757|NCT02934503|473302987|FG000|Overall Study|Withdrawal by Subject|1|||
131456758|NCT00724867|473302988|FG000|Overall Study|Adverse Event|25|||
131456759|NCT00724867|473302988|FG000|Overall Study|Lack of Efficacy|14|||
131456760|NCT00724867|473302988|FG000|Overall Study|Lost to Follow-up|12|||
131456761|NCT00724867|473302988|FG000|Overall Study|Non-compliance with study drug|6|||
131456762|NCT00724867|473302988|FG000|Overall Study|Physician Decision|17|||
131456763|NCT00724867|473302988|FG000|Overall Study|Protocol Violation|1|||
131456764|NCT00724867|473302988|FG000|Overall Study|Withdrawal by Subject|31|||
131456765|NCT00724867|473302988|FG000|Overall Study|Sponsor decision to end study|14|||
131456766|NCT00724867|473302988|FG000|Overall Study|Subject incarcerated|1|||
131456767|NCT00724867|473302988|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
131456768|NCT00724867|473302988|FG000|Overall Study|Subject moved out of state|1|||
131456769|NCT00724867|473302988|FG000|Overall Study|Elected to exit due to site closure|2|||
131456770|NCT00373113|473302989|FG000|Overall Study|Death|1|||
131456771|NCT00373113|473302990|FG001|Overall Study|Death|7|||
131456772|NCT00373113|473302989|FG000|Overall Study|Adverse Event|38|||
131456773|NCT00373113|473302990|FG001|Overall Study|Adverse Event|24|||
131456774|NCT00373113|473302989|FG000|Overall Study|Study terminated by sponsor|9|||
131456775|NCT00373113|473302990|FG001|Overall Study|Study terminated by sponsor|1|||
131456776|NCT00373113|473302989|FG000|Overall Study|Global deterioration of health status|10|||
131456777|NCT00373113|473302990|FG001|Overall Study|Global deterioration of health status|7|||
131456778|NCT00373113|473302989|FG000|Overall Study|Lost to Follow-up|1|||
131456779|NCT00373113|473302990|FG001|Overall Study|Lost to Follow-up|3|||
131456780|NCT00373113|473302989|FG000|Overall Study|Objective progression or relapse|150|||
131456781|NCT00373113|473302990|FG001|Overall Study|Objective progression or relapse|169|||
131456782|NCT00373113|473302989|FG000|Overall Study|Other|14|||
131456783|NCT00373113|473302990|FG001|Overall Study|Other|17|||
131456784|NCT00373113|473302989|FG000|Overall Study|Protocol Violation|5|||
131456785|NCT00373113|473302990|FG001|Overall Study|Protocol Violation|1|||
131456786|NCT00373113|473302989|FG000|Overall Study|Withdrawal by Subject|10|||
131456787|NCT00373113|473302990|FG001|Overall Study|Withdrawal by Subject|15|||
131456788|NCT04248491|473302992|FG000|Overall Study|Lost to Follow-up|1|||
131456789|NCT04248491|473302993|FG001|Overall Study|Lost to Follow-up|0|||
131456790|NCT00975689|473302997|FG000|Overall Study|Adverse Event|0|||
131456791|NCT00975689|473302998|FG001|Overall Study|Adverse Event|3|||
131456792|NCT00975689|473302997|FG000|Overall Study|Withdrawal by Subject|1|||
131456793|NCT00975689|473302998|FG001|Overall Study|Withdrawal by Subject|0|||
131456794|NCT00975689|473302997|FG000|Overall Study|Physician Decision|1|||
131456795|NCT00975689|473302998|FG001|Overall Study|Physician Decision|0|||
131456796|NCT04335136|473302999|FG000|Overall Study|Death|8|||
131456797|NCT04335136|473303000|FG001|Overall Study|Death|4|||
131456798|NCT04335136|473302999|FG000|Overall Study|Lost to Follow-up|2|||
131456799|NCT04335136|473303000|FG001|Overall Study|Lost to Follow-up|0|||
131456800|NCT04335136|473302999|FG000|Overall Study|Protocol Violation|1|||
131456801|NCT04335136|473303000|FG001|Overall Study|Protocol Violation|0|||
131456802|NCT04335136|473302999|FG000|Overall Study|Withdrawal by Subject|1|||
131456803|NCT04335136|473303000|FG001|Overall Study|Withdrawal by Subject|1|||
131456804|NCT04335136|473302999|FG000|Overall Study|Health-threatening condition|0|||
131456805|NCT04335136|473303000|FG001|Overall Study|Health-threatening condition|1|||
131456806|NCT04335136|473302999|FG000|Overall Study|Adverse Event|0|||
131456807|NCT04335136|473303000|FG001|Overall Study|Adverse Event|1|||
131456808|NCT04335136|473302999|FG000|Overall Study|Erroneously randomized|2|||
131456809|NCT04335136|473303000|FG001|Overall Study|Erroneously randomized|0|||
131456810|NCT01092546|473303005|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
131456811|NCT00622440|473303006|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
131456812|NCT00622440|473303007|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
131456813|NCT00622440|473303006|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
131456814|NCT00622440|473303007|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
131456815|NCT00622440|473303006|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
131456816|NCT00622440|473303007|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
131950753|NCT02517398|475105637|FG013|Overall Study|Other|1|||
131950754|NCT02517398|475105638|FG014|Overall Study|Other|0|||
131456817|NCT00622440|473303006|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
131456818|NCT00622440|473303007|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
131950755|NCT02517398|475105639|FG015|Overall Study|Other|1|||
131950756|NCT02517398|475105640|FG016|Overall Study|Other|1|||
131950757|NCT02517398|475105641|FG017|Overall Study|Other|0|||
131950758|NCT02517398|475105642|FG018|Overall Study|Other|0|||
131950759|NCT02517398|475105643|FG019|Overall Study|Other|1|||
131950760|NCT02517398|475105644|FG020|Overall Study|Other|0|||
131950761|NCT02517398|475105645|FG021|Overall Study|Other|0|||
131950762|NCT02517398|475105646|FG022|Overall Study|Other|0|||
131950763|NCT02517398|475105624|FG000|Overall Study|Lost to Follow-up|0|||
131950764|NCT02517398|475105625|FG001|Overall Study|Lost to Follow-up|0|||
131950765|NCT02517398|475105626|FG002|Overall Study|Lost to Follow-up|0|||
131950766|NCT02517398|475105627|FG003|Overall Study|Lost to Follow-up|0|||
131950767|NCT02517398|475105628|FG004|Overall Study|Lost to Follow-up|0|||
131950768|NCT02517398|475105629|FG005|Overall Study|Lost to Follow-up|0|||
131950769|NCT02517398|475105630|FG006|Overall Study|Lost to Follow-up|0|||
131950770|NCT02517398|475105631|FG007|Overall Study|Lost to Follow-up|0|||
131950771|NCT02517398|475105632|FG008|Overall Study|Lost to Follow-up|0|||
131950772|NCT02517398|475105633|FG009|Overall Study|Lost to Follow-up|1|||
131950773|NCT02517398|475105634|FG010|Overall Study|Lost to Follow-up|0|||
131950774|NCT02517398|475105635|FG011|Overall Study|Lost to Follow-up|2|||
131950775|NCT02517398|475105636|FG012|Overall Study|Lost to Follow-up|2|||
131950776|NCT02517398|475105637|FG013|Overall Study|Lost to Follow-up|0|||
131950777|NCT02517398|475105638|FG014|Overall Study|Lost to Follow-up|1|||
131950778|NCT02517398|475105639|FG015|Overall Study|Lost to Follow-up|1|||
131950779|NCT02517398|475105640|FG016|Overall Study|Lost to Follow-up|0|||
131950780|NCT02517398|475105641|FG017|Overall Study|Lost to Follow-up|3|||
131950781|NCT02517398|475105642|FG018|Overall Study|Lost to Follow-up|1|||
131950782|NCT02517398|475105643|FG019|Overall Study|Lost to Follow-up|0|||
131950783|NCT02517398|475105644|FG020|Overall Study|Lost to Follow-up|1|||
131950784|NCT02517398|475105645|FG021|Overall Study|Lost to Follow-up|0|||
131950785|NCT02517398|475105646|FG022|Overall Study|Lost to Follow-up|2|||
131950786|NCT02517398|475105624|FG000|Overall Study|Withdrew Consent|0|||
131950787|NCT02517398|475105625|FG001|Overall Study|Withdrew Consent|0|||
131950788|NCT02517398|475105626|FG002|Overall Study|Withdrew Consent|0|||
131950789|NCT02517398|475105627|FG003|Overall Study|Withdrew Consent|0|||
131950790|NCT02517398|475105628|FG004|Overall Study|Withdrew Consent|0|||
131950791|NCT02517398|475105629|FG005|Overall Study|Withdrew Consent|0|||
131950792|NCT02517398|475105630|FG006|Overall Study|Withdrew Consent|1|||
131950793|NCT02517398|475105631|FG007|Overall Study|Withdrew Consent|0|||
131950794|NCT02517398|475105632|FG008|Overall Study|Withdrew Consent|0|||
131950795|NCT02517398|475105633|FG009|Overall Study|Withdrew Consent|2|||
131950796|NCT02517398|475105634|FG010|Overall Study|Withdrew Consent|7|||
131950797|NCT02517398|475105635|FG011|Overall Study|Withdrew Consent|1|||
131950798|NCT02517398|475105636|FG012|Overall Study|Withdrew Consent|5|||
131950799|NCT02517398|475105637|FG013|Overall Study|Withdrew Consent|4|||
131950800|NCT02517398|475105638|FG014|Overall Study|Withdrew Consent|2|||
131950801|NCT02517398|475105639|FG015|Overall Study|Withdrew Consent|5|||
131950802|NCT02517398|475105640|FG016|Overall Study|Withdrew Consent|4|||
131950803|NCT02517398|475105641|FG017|Overall Study|Withdrew Consent|2|||
131950804|NCT02517398|475105642|FG018|Overall Study|Withdrew Consent|3|||
131950805|NCT02517398|475105643|FG019|Overall Study|Withdrew Consent|2|||
131950806|NCT02517398|475105644|FG020|Overall Study|Withdrew Consent|9|||
131950807|NCT02517398|475105645|FG021|Overall Study|Withdrew Consent|3|||
131950808|NCT02517398|475105646|FG022|Overall Study|Withdrew Consent|1|||
131950809|NCT01016132|475105647|FG000|Overall Study|Discomfort|1|||
131950810|NCT01451749|475105648|FG000|Overall Study|Protocol Violation|14|||
131950811|NCT01451749|475105649|FG001|Overall Study|Protocol Violation|7|||
131950812|NCT01451749|475105648|FG000|Overall Study|Lost to Follow-up|15|||
131950813|NCT01451749|475105649|FG001|Overall Study|Lost to Follow-up|5|||
131950814|NCT01451749|475105648|FG000|Overall Study|Meet the exclusion criteria,and|1|||
131950815|NCT01451749|475105649|FG001|Overall Study|Meet the exclusion criteria,and|1|||
131950816|NCT01451749|475105648|FG000|Overall Study|Adverse Event|2|||
131950817|NCT01451749|475105649|FG001|Overall Study|Adverse Event|0|||
131950818|NCT01451749|475105648|FG000|Overall Study|Withdrawal by Subject|0|||
131950819|NCT01451749|475105649|FG001|Overall Study|Withdrawal by Subject|1|||
131950820|NCT01198574|475105687|FG000|Overall Study|Resigned from schools|4|||
131950821|NCT01198574|475105688|FG001|Overall Study|Resigned from schools|1|||
131950822|NCT01198574|475105689|FG002|Overall Study|Resigned from schools|1|||
131950823|NCT01198574|475105690|FG003|Overall Study|Resigned from schools|4|||
131950824|NCT00556439|475105693|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
131950825|NCT00556439|475105694|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
131950826|NCT00556439|475105695|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
131950827|NCT00556439|475105696|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
131950828|NCT00556439|475105693|FG000|Study Entry to Week 12|Physician Decision|1|||
131950829|NCT00556439|475105694|FG001|Study Entry to Week 12|Physician Decision|0|||
131950830|NCT00556439|475105695|FG002|Study Entry to Week 12|Physician Decision|0|||
131950831|NCT00556439|475105696|FG003|Study Entry to Week 12|Physician Decision|0|||
131950832|NCT00556439|475105693|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
131950833|NCT00556439|475105694|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
131950834|NCT00556439|475105695|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
131950835|NCT00556439|475105696|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
131950836|NCT00556439|475105693|FG000|Study Entry to Week 12|Recurrent infection|1|||
131950837|NCT00556439|475105694|FG001|Study Entry to Week 12|Recurrent infection|0|||
131950838|NCT00556439|475105695|FG002|Study Entry to Week 12|Recurrent infection|0|||
131950839|NCT00556439|475105696|FG003|Study Entry to Week 12|Recurrent infection|0|||
131950840|NCT00556439|475105693|FG000|Study Entry to Week 12|Malignancy|0|||
131950841|NCT00556439|475105694|FG001|Study Entry to Week 12|Malignancy|0|||
131950842|NCT00556439|475105695|FG002|Study Entry to Week 12|Malignancy|1|||
131950843|NCT00556439|475105696|FG003|Study Entry to Week 12|Malignancy|0|||
131950844|NCT00556439|475105693|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
131950845|NCT00556439|475105694|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
131950846|NCT00556439|475105695|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
131950847|NCT00556439|475105696|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
131950848|NCT00556439|475105693|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
131950849|NCT00556439|475105694|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
131950850|NCT00556439|475105695|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
131950851|NCT00556439|475105696|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
131950852|NCT00556439|475105693|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
131950853|NCT00556439|475105694|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
131950854|NCT00556439|475105695|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
131950855|NCT00556439|475105696|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
131950856|NCT00556439|475105693|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
131950857|NCT00556439|475105694|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
131950858|NCT00556439|475105695|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
131950859|NCT00556439|475105696|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
131950860|NCT02100423|475105697|FG000|Overall Study|Death|1|||
131950861|NCT02100423|475105697|FG000|Overall Study|Withdrawal by Subject|3|||
131950862|NCT02100423|475105697|FG000|Overall Study|Adverse Event|1|||
131950863|NCT02100423|475105697|FG000|Overall Study|Physician Decision|1|||
131950864|NCT02454530|475105698|FG000|Overall Study|Other|8|||
131950865|NCT02454530|475105699|FG001|Overall Study|Other|13|||
131950866|NCT02454530|475105698|FG000|Overall Study|Missing information|56|||
131950867|NCT02454530|475105699|FG001|Overall Study|Missing information|69|||
131950868|NCT02454530|475105698|FG000|Overall Study|Death|2|||
131950869|NCT02454530|475105699|FG001|Overall Study|Death|41|||
131950870|NCT02454530|475105698|FG000|Overall Study|Lost to Follow-up|4|||
131950871|NCT02454530|475105699|FG001|Overall Study|Lost to Follow-up|4|||
131950872|NCT03110029|475105700|FG000|Overall Study|Withdrawal by Subject|1|||
131950873|NCT03110029|475105701|FG001|Overall Study|Withdrawal by Subject|1|||
131950874|NCT02222688|475107014|FG000|Overall Study|Withdrawal by Subject|0|||
131950875|NCT02222688|475107015|FG001|Overall Study|Withdrawal by Subject|0|||
131950876|NCT02222688|475107016|FG002|Overall Study|Withdrawal by Subject|0|||
131950877|NCT02222688|475107017|FG003|Overall Study|Withdrawal by Subject|2|||
131950878|NCT02222688|475107018|FG004|Overall Study|Withdrawal by Subject|1|||
131950879|NCT02222688|475107019|FG005|Overall Study|Withdrawal by Subject|0|||
131950880|NCT02222688|475107020|FG006|Overall Study|Withdrawal by Subject|1|||
131950881|NCT02222688|475107014|FG000|Overall Study|Disease progression|1|||
131950882|NCT02222688|475107015|FG001|Overall Study|Disease progression|0|||
131950883|NCT02222688|475107016|FG002|Overall Study|Disease progression|0|||
131950884|NCT02222688|475107017|FG003|Overall Study|Disease progression|0|||
131950885|NCT02222688|475107018|FG004|Overall Study|Disease progression|0|||
131950886|NCT02222688|475107019|FG005|Overall Study|Disease progression|0|||
131950887|NCT02222688|475107020|FG006|Overall Study|Disease progression|0|||
131950888|NCT00294671|475107025|FG000|Overall Study|Lack of Efficacy|11|||
131950889|NCT00294671|475107026|FG001|Overall Study|Lack of Efficacy|23|||
131950890|NCT00294671|475107025|FG000|Overall Study|Liver transplant|7|||
131950891|NCT00294671|475107026|FG001|Overall Study|Liver transplant|9|||
131950892|NCT00294671|475107025|FG000|Overall Study|Drug related adverse event (AE)|4|||
131950893|NCT00294671|475107026|FG001|Overall Study|Drug related adverse event (AE)|2|||
131950894|NCT00294671|475107025|FG000|Overall Study|Non-drug related AE|3|||
131950895|NCT00294671|475107026|FG001|Overall Study|Non-drug related AE|2|||
131950896|NCT00294671|475107025|FG000|Overall Study|Lost to Follow-up|1|||
131950897|NCT00294671|475107026|FG001|Overall Study|Lost to Follow-up|3|||
131950898|NCT00294671|475107025|FG000|Overall Study|Non-compliance|1|||
131950899|NCT00294671|475107026|FG001|Overall Study|Non-compliance|0|||
131950900|NCT00294671|475107025|FG000|Overall Study|Death|0|||
131950901|NCT00294671|475107026|FG001|Overall Study|Death|1|||
131950902|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
131950903|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
131950904|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
131950905|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
131950906|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
131950907|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
131950908|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
131950909|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
131950910|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
131950911|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
131950912|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
131950913|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
131950914|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
131950915|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
131950916|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
131950917|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
131950918|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
131950919|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
131950920|NCT03308968|475107031|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
131950921|NCT03308968|475107032|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
131950922|NCT03308968|475107033|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
131950923|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
131950924|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
131950925|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
131950926|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
131950927|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
131950928|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
131950929|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
131950930|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
131950931|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
131950932|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
131950933|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
131950934|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
131950935|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
131950936|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
131950937|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
131950938|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
131950939|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
131950940|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
131950941|NCT03308968|475107031|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
131950942|NCT03308968|475107032|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
131950943|NCT03308968|475107033|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
131950944|NCT01961297|475107036|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
131950945|NCT01961297|475107037|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
131950946|NCT02482298|475107038|FG000|Overall Study|Withdrawal by Subject|2|||
131950947|NCT02482298|475107039|FG001|Overall Study|Withdrawal by Subject|1|||
131950948|NCT02482298|475107040|FG002|Overall Study|Withdrawal by Subject|2|||
131950949|NCT02482298|475107038|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
131950950|NCT02482298|475107039|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
131950951|NCT02482298|475107040|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
131950952|NCT02482298|475107038|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
131950953|NCT02482298|475107039|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
131950954|NCT02482298|475107040|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
131950955|NCT02482298|475107038|FG000|Overall Study|Lost to Follow-up|0|||
131950956|NCT02482298|475107039|FG001|Overall Study|Lost to Follow-up|1|||
131950957|NCT02482298|475107040|FG002|Overall Study|Lost to Follow-up|0|||
131950958|NCT03053440|475107047|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
131950959|NCT03053440|475107048|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
131950960|NCT03053440|475107047|FG000|Overall Study|Death|18|||
131950961|NCT03053440|475107048|FG001|Overall Study|Death|14|||
131950962|NCT03053440|475107047|FG000|Overall Study|Withdrawal by Subject|9|||
131950963|NCT03053440|475107048|FG001|Overall Study|Withdrawal by Subject|8|||
131950964|NCT03053440|475107047|FG000|Overall Study|Lost to Follow-up|1|||
131950965|NCT03053440|475107048|FG001|Overall Study|Lost to Follow-up|0|||
131950966|NCT03053440|475107047|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
131950967|NCT03053440|475107048|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
131950968|NCT03053440|475107047|FG000|Overall Study|Physician Decision|2|||
131950969|NCT03053440|475107048|FG001|Overall Study|Physician Decision|1|||
131950970|NCT03053440|475107047|FG000|Overall Study|Participant Randomized but died before dosing|1|||
131950971|NCT03053440|475107048|FG001|Overall Study|Participant Randomized but died before dosing|0|||
131950972|NCT01188551|475107049|FG000|Overall Study|Pharmacy issues|1|||
131950973|NCT01188551|475107050|FG001|Overall Study|Pharmacy issues|0|||
131950974|NCT01188551|475107051|FG002|Overall Study|Pharmacy issues|0|||
131950975|NCT01188551|475107052|FG003|Overall Study|Pharmacy issues|0|||
131950976|NCT02140970|475107055|FG000|Overall Study|Lost to Follow-up|1|||
131950977|NCT02140970|475107056|FG001|Overall Study|Lost to Follow-up|2|||
131950978|NCT02140970|475107055|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
131950979|NCT02140970|475107056|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
131950980|NCT02140970|475107055|FG000|Overall Study|Did not meet inclusion criteria|0|||
131456819|NCT01667419|473303010|FG000|Overall Study|Reason Not Specified|1|||
131456820|NCT01667419|473303011|FG001|Overall Study|Reason Not Specified|0|||
131456821|NCT01667419|473303012|FG002|Overall Study|Reason Not Specified|0|||
131456822|NCT01667419|473303013|FG003|Overall Study|Reason Not Specified|0|||
131456823|NCT01667419|473303010|FG000|Overall Study|Withdrawal by Subject|16|||
131456824|NCT01667419|473303011|FG001|Overall Study|Withdrawal by Subject|8|||
131456825|NCT01667419|473303012|FG002|Overall Study|Withdrawal by Subject|9|||
131456826|NCT01667419|473303013|FG003|Overall Study|Withdrawal by Subject|8|||
131456827|NCT01667419|473303010|FG000|Overall Study|Non-compliance|0|||
131456828|NCT01667419|473303011|FG001|Overall Study|Non-compliance|0|||
131456829|NCT01667419|473303012|FG002|Overall Study|Non-compliance|0|||
131456830|NCT01667419|473303013|FG003|Overall Study|Non-compliance|1|||
131456831|NCT01667419|473303010|FG000|Overall Study|Protocol Violation|1|||
131456832|NCT01667419|473303011|FG001|Overall Study|Protocol Violation|0|||
131456833|NCT01667419|473303012|FG002|Overall Study|Protocol Violation|0|||
131456834|NCT01667419|473303013|FG003|Overall Study|Protocol Violation|0|||
131456835|NCT01667419|473303010|FG000|Overall Study|Lost to Follow-up|7|||
131456836|NCT01667419|473303011|FG001|Overall Study|Lost to Follow-up|6|||
131456837|NCT01667419|473303012|FG002|Overall Study|Lost to Follow-up|2|||
131456838|NCT01667419|473303013|FG003|Overall Study|Lost to Follow-up|4|||
131456839|NCT01667419|473303010|FG000|Overall Study|Death|18|||
131456840|NCT01667419|473303011|FG001|Overall Study|Death|33|||
131456841|NCT01667419|473303012|FG002|Overall Study|Death|25|||
131456842|NCT01667419|473303013|FG003|Overall Study|Death|26|||
131456843|NCT00926029|473303015|FG000|Overall Study|Lost to Follow-up|2|||
131456844|NCT00926029|473303016|FG001|Overall Study|Lost to Follow-up|1|||
131456845|NCT00926029|473303017|FG002|Overall Study|Lost to Follow-up|1|||
131456846|NCT05246514|473303018|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
131456847|NCT05246514|473303018|FG000|Overall Study|Withdrawal by Subject|1|||
131456848|NCT05246514|473303018|FG000|Overall Study|Death|13|||
131456849|NCT01941186|473303019|FG000|Follow-up|Lost to Follow-up|1|||
131456850|NCT01941186|473303020|FG001|Follow-up|Lost to Follow-up|0|||
131456851|NCT02722304|473303021|FG000|Overall Study|Study Terminated by Sponsor|1|||
131456852|NCT02722304|473303022|FG001|Overall Study|Study Terminated by Sponsor|0|||
131456853|NCT02722304|473303023|FG002|Overall Study|Study Terminated by Sponsor|2|||
131456854|NCT02722304|473303024|FG003|Overall Study|Study Terminated by Sponsor|1|||
131456855|NCT02722304|473303025|FG004|Overall Study|Study Terminated by Sponsor|1|||
131456856|NCT02722304|473303021|FG000|Overall Study|Other|0|||
131456857|NCT02722304|473303022|FG001|Overall Study|Other|0|||
131456858|NCT02722304|473303023|FG002|Overall Study|Other|0|||
131456859|NCT02722304|473303024|FG003|Overall Study|Other|1|||
131456860|NCT02722304|473303025|FG004|Overall Study|Other|1|||
131456861|NCT04154189|473303026|FG000|Overall Study|Withdrawal by Subject|4|||
131456862|NCT04154189|473303027|FG001|Overall Study|Withdrawal by Subject|6|||
131456863|NCT04154189|473303026|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
131456864|NCT04154189|473303027|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
131456865|NCT04154189|473303026|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
131456866|NCT04154189|473303027|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
131456867|NCT04154189|473303026|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
131950981|NCT02140970|475107056|FG001|Overall Study|Did not meet inclusion criteria|1|||
131950982|NCT01947283|475107060|FG000|Overall Study|Death|1|||
131950983|NCT01947283|475107061|FG001|Overall Study|Death|1|||
131950984|NCT01947283|475107062|FG002|Overall Study|Death|1|||
131950985|NCT01947283|475107063|FG003|Overall Study|Death|0|||
131950986|NCT01947283|475107064|FG004|Overall Study|Death|0|||
131950987|NCT01947283|475107065|FG005|Overall Study|Death|0|||
131950988|NCT01947283|475107066|FG006|Overall Study|Death|0|||
131950989|NCT01947283|475107060|FG000|Overall Study|Lost to Follow-up|4|||
131950990|NCT01947283|475107061|FG001|Overall Study|Lost to Follow-up|6|||
131950991|NCT01947283|475107062|FG002|Overall Study|Lost to Follow-up|5|||
131950992|NCT01947283|475107063|FG003|Overall Study|Lost to Follow-up|5|||
131950993|NCT01947283|475107064|FG004|Overall Study|Lost to Follow-up|0|||
131950994|NCT01947283|475107065|FG005|Overall Study|Lost to Follow-up|2|||
131950995|NCT01947283|475107066|FG006|Overall Study|Lost to Follow-up|5|||
131950996|NCT01947283|475107060|FG000|Overall Study|Withdrawal by Subject|10|||
131950997|NCT01947283|475107061|FG001|Overall Study|Withdrawal by Subject|8|||
131950998|NCT01947283|475107062|FG002|Overall Study|Withdrawal by Subject|4|||
131950999|NCT01947283|475107063|FG003|Overall Study|Withdrawal by Subject|1|||
131951000|NCT01947283|475107064|FG004|Overall Study|Withdrawal by Subject|0|||
131456868|NCT04154189|473303027|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
131456869|NCT04154189|473303026|FG000|Overall Study|Death|25|||
131456870|NCT04154189|473303027|FG001|Overall Study|Death|25|||
131456871|NCT01068600|473303028|FG000|Overall Study|Withdrawal by Subject|5|||
131456872|NCT01068600|473303029|FG001|Overall Study|Withdrawal by Subject|6|||
131456873|NCT01068600|473303028|FG000|Overall Study|Adverse Event|3|||
131951001|NCT01947283|475107065|FG005|Overall Study|Withdrawal by Subject|0|||
131456874|NCT01068600|473303029|FG001|Overall Study|Adverse Event|3|||
131456875|NCT01068600|473303028|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131951002|NCT01947283|475107066|FG006|Overall Study|Withdrawal by Subject|2|||
131951003|NCT01947283|475107060|FG000|Overall Study|No Clinical Recording|12|||
131951004|NCT01947283|475107061|FG001|Overall Study|No Clinical Recording|6|||
131951005|NCT01947283|475107062|FG002|Overall Study|No Clinical Recording|8|||
131951006|NCT01947283|475107063|FG003|Overall Study|No Clinical Recording|10|||
131951007|NCT01947283|475107064|FG004|Overall Study|No Clinical Recording|0|||
131951008|NCT01947283|475107065|FG005|Overall Study|No Clinical Recording|0|||
131951009|NCT01947283|475107066|FG006|Overall Study|No Clinical Recording|0|||
131951010|NCT01947283|475107060|FG000|Overall Study|Non-coding Clinical Recording language|0|||
131951011|NCT01947283|475107061|FG001|Overall Study|Non-coding Clinical Recording language|0|||
131951012|NCT01947283|475107062|FG002|Overall Study|Non-coding Clinical Recording language|0|||
131951013|NCT01947283|475107063|FG003|Overall Study|Non-coding Clinical Recording language|1|||
131951014|NCT01947283|475107064|FG004|Overall Study|Non-coding Clinical Recording language|0|||
131951015|NCT01947283|475107065|FG005|Overall Study|Non-coding Clinical Recording language|0|||
131951016|NCT01947283|475107066|FG006|Overall Study|Non-coding Clinical Recording language|0|||
131951017|NCT01947283|475107060|FG000|Overall Study|Missing Follow-up Assessment|2|||
131951018|NCT01947283|475107061|FG001|Overall Study|Missing Follow-up Assessment|2|||
131951019|NCT01947283|475107062|FG002|Overall Study|Missing Follow-up Assessment|3|||
131951020|NCT01947283|475107063|FG003|Overall Study|Missing Follow-up Assessment|0|||
131951021|NCT01947283|475107064|FG004|Overall Study|Missing Follow-up Assessment|0|||
131951022|NCT01947283|475107065|FG005|Overall Study|Missing Follow-up Assessment|2|||
131951023|NCT01947283|475107066|FG006|Overall Study|Missing Follow-up Assessment|0|||
131951024|NCT01947283|475107060|FG000|Overall Study|No patients were enrolled in study|0|||
131951025|NCT01947283|475107061|FG001|Overall Study|No patients were enrolled in study|0|||
131951026|NCT01947283|475107062|FG002|Overall Study|No patients were enrolled in study|0|||
131951027|NCT01947283|475107063|FG003|Overall Study|No patients were enrolled in study|0|||
131951028|NCT01947283|475107064|FG004|Overall Study|No patients were enrolled in study|0|||
131951029|NCT01947283|475107065|FG005|Overall Study|No patients were enrolled in study|3|||
131951030|NCT01947283|475107066|FG006|Overall Study|No patients were enrolled in study|1|||
131951031|NCT03782259|475107067|FG000|Overall Study|Lost to Follow-up|1|||
131951032|NCT03782259|475107068|FG001|Overall Study|Lost to Follow-up|1|||
131951033|NCT03782259|475107067|FG000|Overall Study|Moved out of state|0|||
131951034|NCT03782259|475107068|FG001|Overall Study|Moved out of state|2|||
131951035|NCT03782259|475107067|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
131951036|NCT03782259|475107068|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
131951037|NCT03782259|475107067|FG000|Overall Study|Subject discontinued intervention|1|||
131951038|NCT03782259|475107068|FG001|Overall Study|Subject discontinued intervention|0|||
131951039|NCT00603941|475107072|FG000|Overall Study|Disease progression|6|||
131951040|NCT00603941|475107073|FG001|Overall Study|Disease progression|7|||
131951041|NCT00603941|475107074|FG002|Overall Study|Disease progression|1|||
131951042|NCT00603941|475107072|FG000|Overall Study|Adverse Event|1|||
131951043|NCT00603941|475107073|FG001|Overall Study|Adverse Event|0|||
131951044|NCT00603941|475107074|FG002|Overall Study|Adverse Event|1|||
131951045|NCT00603941|475107072|FG000|Overall Study|Physician Decision|0|||
131951046|NCT00603941|475107073|FG001|Overall Study|Physician Decision|1|||
131951047|NCT00603941|475107074|FG002|Overall Study|Physician Decision|0|||
131951048|NCT00603941|475107072|FG000|Overall Study|Withdrawal by Subject|0|||
131951049|NCT00603941|475107073|FG001|Overall Study|Withdrawal by Subject|2|||
131951050|NCT00603941|475107074|FG002|Overall Study|Withdrawal by Subject|0|||
131951051|NCT05069597|475107075|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131951052|NCT05069597|475107076|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
131951053|NCT02705105|475107077|FG000|Treatment|Objective Disease Progression|1|||
131951054|NCT02705105|475107078|FG001|Treatment|Objective Disease Progression|50|||
131951055|NCT02705105|475107077|FG000|Treatment|Withdrawal by Subject|3|||
131951056|NCT02705105|475107078|FG001|Treatment|Withdrawal by Subject|5|||
131951057|NCT02705105|475107077|FG000|Treatment|Adverse Event|0|||
131951058|NCT02705105|475107078|FG001|Treatment|Adverse Event|17|||
131951059|NCT02705105|475107077|FG000|Treatment|Clinical Disease Progression|0|||
131951060|NCT02705105|475107078|FG001|Treatment|Clinical Disease Progression|32|||
131951061|NCT02705105|475107077|FG000|Treatment|Physician Decision|0|||
131951062|NCT02705105|475107078|FG001|Treatment|Physician Decision|3|||
131951063|NCT02705105|475107077|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
131951064|NCT02705105|475107078|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
131415028|NCT00477269|473143883|FG002|Open Label Extension|Death|4|||
131951065|NCT02705105|475107077|FG000|Follow-Up|Death|3|||
131951066|NCT02705105|475107078|FG001|Follow-Up|Death|68|||
131951067|NCT02705105|475107077|FG000|Follow-Up|Withdrawal by Subject|1|||
131951068|NCT02705105|475107078|FG001|Follow-Up|Withdrawal by Subject|14|||
131951069|NCT02705105|475107077|FG000|Follow-Up|Study Terminated|0|||
131951070|NCT02705105|475107078|FG001|Follow-Up|Study Terminated|26|||
131415029|NCT01792518|473143884|FG000|Overall Study|Adverse Event|3|||
131415030|NCT01792518|473143885|FG001|Overall Study|Adverse Event|4|||
131415031|NCT01792518|473143884|FG000|Overall Study|Protocol Violation|0|||
131951071|NCT02705105|475107077|FG000|Follow-Up|Discontinued per Amendment 3|0|||
131951072|NCT02705105|475107078|FG001|Follow-Up|Discontinued per Amendment 3|2|||
131951073|NCT02943070|475107079|FG000|Overall Study|Physician Decision|1|||
131951074|NCT02943070|475107079|FG000|Overall Study|Adverse Event|2|||
131951075|NCT02943070|475107079|FG000|Overall Study|Death|2|||
131951076|NCT02943070|475107079|FG000|Overall Study|Withdrawal by Subject|3|||
131951077|NCT02943070|475107079|FG000|Overall Study|Lost to Follow-up|4|||
131951078|NCT02943070|475107079|FG000|Overall Study|Retreatment or TURP|13|||
131951079|NCT02943070|475107079|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
131951080|NCT01709110|475107080|FG000|Overall Study|Adverse Event|56|||
131951081|NCT01709110|475107081|FG001|Overall Study|Adverse Event|48|||
131951082|NCT01709110|475107080|FG000|Overall Study|Death|14|||
131951083|NCT01709110|475107081|FG001|Overall Study|Death|6|||
131951084|NCT01709110|475107080|FG000|Overall Study|Lost to Follow-up|7|||
131951085|NCT01709110|475107081|FG001|Overall Study|Lost to Follow-up|5|||
131951086|NCT01709110|475107080|FG000|Overall Study|Protocol Violation|4|||
131951087|NCT01709110|475107081|FG001|Overall Study|Protocol Violation|6|||
131951088|NCT01709110|475107080|FG000|Overall Study|Withdrawal by Subject|96|||
131951089|NCT01709110|475107081|FG001|Overall Study|Withdrawal by Subject|89|||
131951090|NCT01709110|475107080|FG000|Overall Study|Physician Decision|4|||
131951091|NCT01709110|475107081|FG001|Overall Study|Physician Decision|10|||
131951092|NCT01709110|475107080|FG000|Overall Study|Sponsor Decision|2|||
131951093|NCT01709110|475107081|FG001|Overall Study|Sponsor Decision|2|||
131951094|NCT01709110|475107080|FG000|Overall Study|Lack of Efficacy|1|||
131951095|NCT01709110|475107081|FG001|Overall Study|Lack of Efficacy|1|||
131951096|NCT01709110|475107080|FG000|Overall Study|Caregiver Decision|1|||
131951097|NCT01709110|475107081|FG001|Overall Study|Caregiver Decision|1|||
131951098|NCT00606411|475107087|FG000|Overall Study|Adverse Event|1|||
131951099|NCT00606411|475107088|FG001|Overall Study|Adverse Event|2|||
131951100|NCT00606411|475107087|FG000|Overall Study|Lack of Adherence|1|||
131951101|NCT00606411|475107088|FG001|Overall Study|Lack of Adherence|1|||
131951102|NCT00606411|475107087|FG000|Overall Study|Lack of Efficacy|1|||
131951103|NCT00606411|475107088|FG001|Overall Study|Lack of Efficacy|1|||
131951104|NCT00606411|475107087|FG000|Overall Study|Withdrawal by Subject|2|||
131951105|NCT00606411|475107088|FG001|Overall Study|Withdrawal by Subject|0|||
131951106|NCT00606411|475107087|FG000|Overall Study|Lost to Follow-up|1|||
131951107|NCT00606411|475107088|FG001|Overall Study|Lost to Follow-up|2|||
131951108|NCT00606411|475107087|FG000|Overall Study|Move out of state|0|||
131951109|NCT00606411|475107088|FG001|Overall Study|Move out of state|1|||
131951110|NCT01390298|475107089|FG000|Overall Study|Death|1|||
131951111|NCT01390298|475107089|FG000|Overall Study|long term ICU admission|1|||
131951112|NCT01390298|475107089|FG000|Overall Study|Withdrawal by Subject|14|||
131951113|NCT01390298|475107089|FG000|Overall Study|Lost to Follow-up|7|||
131951114|NCT01390298|475107089|FG000|Overall Study|Surgery cancelled|1|||
131951115|NCT00040742|475107090|FG000|Overall Study|Death|0|||
131951116|NCT00040742|475107091|FG001|Overall Study|Death|0|||
131951117|NCT00040742|475107092|FG002|Overall Study|Death|1|||
131951118|NCT00040742|475107093|FG003|Overall Study|Death|0|||
131951119|NCT00040742|475107090|FG000|Overall Study|Adverse Event|15|||
131951120|NCT00040742|475107091|FG001|Overall Study|Adverse Event|16|||
131951121|NCT00040742|475107092|FG002|Overall Study|Adverse Event|21|||
131951122|NCT00040742|475107093|FG003|Overall Study|Adverse Event|9|||
131951123|NCT00040742|475107090|FG000|Overall Study|Withdrawal by Subject|7|||
131951124|NCT00040742|475107091|FG001|Overall Study|Withdrawal by Subject|15|||
131951125|NCT00040742|475107092|FG002|Overall Study|Withdrawal by Subject|10|||
131951126|NCT00040742|475107093|FG003|Overall Study|Withdrawal by Subject|13|||
131951127|NCT00040742|475107090|FG000|Overall Study|Chemotoxicity|4|||
131951128|NCT00040742|475107091|FG001|Overall Study|Chemotoxicity|3|||
131951129|NCT00040742|475107092|FG002|Overall Study|Chemotoxicity|5|||
131951130|NCT00040742|475107093|FG003|Overall Study|Chemotoxicity|2|||
131951131|NCT00040742|475107090|FG000|Overall Study|Incomplete Forms|6|||
131951132|NCT00040742|475107091|FG001|Overall Study|Incomplete Forms|10|||
131951133|NCT00040742|475107092|FG002|Overall Study|Incomplete Forms|4|||
131951134|NCT00040742|475107093|FG003|Overall Study|Incomplete Forms|5|||
131951135|NCT00040742|475107090|FG000|Overall Study|Other medical|7|||
131951136|NCT00040742|475107091|FG001|Overall Study|Other medical|5|||
131951137|NCT00040742|475107092|FG002|Overall Study|Other medical|5|||
131951138|NCT00040742|475107093|FG003|Overall Study|Other medical|5|||
131951139|NCT03520920|475107094|FG000|Overall Study|Death|13|||
131951140|NCT03520920|475107095|FG001|Overall Study|Death|1|||
131951141|NCT03520920|475107096|FG002|Overall Study|Death|0|||
131951142|NCT03520920|475107094|FG000|Overall Study|Withdrawal by Subject|2|||
131951143|NCT03520920|475107095|FG001|Overall Study|Withdrawal by Subject|1|||
131951144|NCT03520920|475107096|FG002|Overall Study|Withdrawal by Subject|0|||
131951145|NCT03520920|475107094|FG000|Overall Study|Study Terminated by the Sponsor|5|||
131951146|NCT03520920|475107095|FG001|Overall Study|Study Terminated by the Sponsor|14|||
131951147|NCT03520920|475107096|FG002|Overall Study|Study Terminated by the Sponsor|5|||
131951148|NCT00412958|475107097|FG000|Overall Study|Withdrawal by Subject|3|||
131951149|NCT00412958|475107098|FG001|Overall Study|Withdrawal by Subject|0|||
131951150|NCT00412958|475107099|FG002|Overall Study|Withdrawal by Subject|0|||
131951151|NCT00412958|475107100|FG003|Overall Study|Withdrawal by Subject|1|||
131951152|NCT00412958|475107097|FG000|Overall Study|Adverse Event|0|||
131951153|NCT00412958|475107098|FG001|Overall Study|Adverse Event|1|||
131951154|NCT00412958|475107099|FG002|Overall Study|Adverse Event|0|||
131951155|NCT00412958|475107100|FG003|Overall Study|Adverse Event|0|||
131951156|NCT00412958|475107097|FG000|Overall Study|Lost to Follow-up|0|||
131951157|NCT00412958|475107098|FG001|Overall Study|Lost to Follow-up|1|||
131951158|NCT00412958|475107099|FG002|Overall Study|Lost to Follow-up|0|||
131951159|NCT00412958|475107100|FG003|Overall Study|Lost to Follow-up|0|||
131951160|NCT00412958|475107097|FG000|Overall Study|Death|0|||
131951161|NCT00412958|475107098|FG001|Overall Study|Death|1|||
131951162|NCT00412958|475107099|FG002|Overall Study|Death|0|||
131951163|NCT00412958|475107100|FG003|Overall Study|Death|0|||
131951164|NCT00412958|475107097|FG000|Overall Study|Transport issue|0|||
131951165|NCT00412958|475107098|FG001|Overall Study|Transport issue|1|||
131951166|NCT00412958|475107099|FG002|Overall Study|Transport issue|0|||
131951167|NCT00412958|475107100|FG003|Overall Study|Transport issue|0|||
131951168|NCT01119066|475107104|FG000|Overall Study|Withdrawal by Subject|4|||
131951169|NCT01119066|475107105|FG001|Overall Study|Withdrawal by Subject|6|||
131951170|NCT01119066|475107106|FG002|Overall Study|Withdrawal by Subject|0|||
131951171|NCT01119066|475107107|FG003|Overall Study|Withdrawal by Subject|0|||
131951172|NCT01119066|475107104|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
131951173|NCT01119066|475107105|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
131951174|NCT01119066|475107106|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
131951175|NCT01119066|475107107|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
131951176|NCT01119066|475107104|FG000|Overall Study|Relapse identified before transplant|1|||
131951177|NCT01119066|475107105|FG001|Overall Study|Relapse identified before transplant|0|||
131951178|NCT01119066|475107106|FG002|Overall Study|Relapse identified before transplant|0|||
131951179|NCT01119066|475107107|FG003|Overall Study|Relapse identified before transplant|0|||
131951180|NCT01119066|475107104|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
131951181|NCT01119066|475107105|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
131951182|NCT01119066|475107106|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
131951183|NCT01119066|475107107|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
131951184|NCT01119066|475107104|FG000|Overall Study|Relapse identified before transplant|0|||
131951185|NCT01119066|475107105|FG001|Overall Study|Relapse identified before transplant|4|||
131951186|NCT01119066|475107106|FG002|Overall Study|Relapse identified before transplant|0|||
131951187|NCT01119066|475107107|FG003|Overall Study|Relapse identified before transplant|0|||
131951188|NCT00271856|475107108|FG000|Overall Study|Withdrawal by Subject|1|||
131951189|NCT00271856|475107109|FG001|Overall Study|Withdrawal by Subject|7|||
131951190|NCT00271856|475107108|FG000|Overall Study|Lost to Follow-up|10|||
131951191|NCT00271856|475107109|FG001|Overall Study|Lost to Follow-up|11|||
131951192|NCT04599803|475107110|FG000|Overall Study|Withdrawal by Subject|5|||
131951193|NCT04599803|475107110|FG000|Overall Study|Lost to Follow-up|26|||
131951194|NCT00763256|475107112|FG000|Overall Study|Didn't return for appointments|7|||
131951195|NCT00763256|475107113|FG001|Overall Study|Didn't return for appointments|10|||
131951196|NCT02623205|475107118|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
131951197|NCT02623205|475107119|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
131951198|NCT02375373|475107122|FG000|Overall Study|Withdrawal by Subject|11|||
131951199|NCT00407602|475107123|FG000|Overall Study|Death - unrelated to device|1|||
131951200|NCT00407602|475107123|FG000|Overall Study|Device explanted|5|||
131951201|NCT00407602|475107123|FG000|Overall Study|Withdrawal by Subject|1|||
131951202|NCT02467192|475107124|FG000|Overall Study|Death|1|||
131951203|NCT02467192|475107124|FG000|Overall Study|revealed to have pneumonia before|2|||
131951204|NCT00431444|475107127|FG000|Overall Study|Protocol Violation|1|||
131951205|NCT00431444|475107128|FG001|Overall Study|Protocol Violation|4|||
131951206|NCT00431444|475107127|FG000|Overall Study|Adverse Event|2|||
131951207|NCT00431444|475107128|FG001|Overall Study|Adverse Event|1|||
131951208|NCT00431444|475107127|FG000|Overall Study|Withdrawal by Subject|1|||
131951209|NCT00431444|475107128|FG001|Overall Study|Withdrawal by Subject|1|||
131951210|NCT00431444|475107127|FG000|Overall Study|Lost to Follow-up|1|||
131951211|NCT00431444|475107128|FG001|Overall Study|Lost to Follow-up|0|||
131951212|NCT00431444|475107127|FG000|Overall Study|Administrative Problems|0|||
131951213|NCT00431444|475107128|FG001|Overall Study|Administrative Problems|1|||
131951214|NCT01603043|475107130|FG000|Overall Study|Study Futility|7|||
131951215|NCT01603043|475107131|FG001|Overall Study|Study Futility|3|||
131951216|NCT03089047|475107132|FG000|Overall Study|Lost to Follow-up|1|||
131951217|NCT03089047|475107133|FG001|Overall Study|Lost to Follow-up|0|||
131951218|NCT00790582|475107136|FG000|Overall Study|Death|14|||
131951219|NCT00790582|475107137|FG001|Overall Study|Death|32|||
131951220|NCT00790582|475107136|FG000|Overall Study|Physician Decision|7|||
131415032|NCT01792518|473143885|FG001|Overall Study|Protocol Violation|1|||
131415033|NCT01792518|473143884|FG000|Overall Study|Lost to Follow-up|3|||
131951221|NCT00790582|475107137|FG001|Overall Study|Physician Decision|1|||
131415034|NCT01792518|473143885|FG001|Overall Study|Lost to Follow-up|1|||
131951222|NCT00790582|475107136|FG000|Overall Study|Lost to Follow-up|3|||
131951223|NCT00790582|475107137|FG001|Overall Study|Lost to Follow-up|3|||
131951224|NCT00790582|475107136|FG000|Overall Study|Withdrawal by Subject|7|||
131951225|NCT00790582|475107137|FG001|Overall Study|Withdrawal by Subject|51|||
131951226|NCT02931838|475107138|FG000|Overall Study|Reason not provided by investigator|1|||
131951227|NCT02931838|475107139|FG001|Overall Study|Reason not provided by investigator|0|||
131951228|NCT02931838|475107140|FG002|Overall Study|Reason not provided by investigator|1|||
131951229|NCT02931838|475107141|FG003|Overall Study|Reason not provided by investigator|0|||
131951230|NCT02931838|475107142|FG004|Overall Study|Reason not provided by investigator|0|||
131951231|NCT02931838|475107143|FG005|Overall Study|Reason not provided by investigator|0|||
131951232|NCT02931838|475107138|FG000|Overall Study|Poor/non-compliance|0|||
131951233|NCT02931838|475107139|FG001|Overall Study|Poor/non-compliance|0|||
131951234|NCT02931838|475107140|FG002|Overall Study|Poor/non-compliance|1|||
131951235|NCT02931838|475107141|FG003|Overall Study|Poor/non-compliance|0|||
131951236|NCT02931838|475107142|FG004|Overall Study|Poor/non-compliance|0|||
131951237|NCT02931838|475107143|FG005|Overall Study|Poor/non-compliance|0|||
131951238|NCT02931838|475107138|FG000|Overall Study|Lack of Efficacy|5|||
131951239|NCT02931838|475107139|FG001|Overall Study|Lack of Efficacy|4|||
131951240|NCT02931838|475107140|FG002|Overall Study|Lack of Efficacy|0|||
131951241|NCT02931838|475107141|FG003|Overall Study|Lack of Efficacy|0|||
131951242|NCT02931838|475107142|FG004|Overall Study|Lack of Efficacy|0|||
131951243|NCT02931838|475107143|FG005|Overall Study|Lack of Efficacy|1|||
131951244|NCT02931838|475107138|FG000|Overall Study|Lost to Follow-up|1|||
131951245|NCT02931838|475107139|FG001|Overall Study|Lost to Follow-up|0|||
131951246|NCT02931838|475107140|FG002|Overall Study|Lost to Follow-up|1|||
131951247|NCT02931838|475107141|FG003|Overall Study|Lost to Follow-up|1|||
131951248|NCT02931838|475107142|FG004|Overall Study|Lost to Follow-up|2|||
131951249|NCT02931838|475107143|FG005|Overall Study|Lost to Follow-up|0|||
131951250|NCT02931838|475107138|FG000|Overall Study|Subject request to discontinue treatment|4|||
131951251|NCT02931838|475107139|FG001|Overall Study|Subject request to discontinue treatment|3|||
131951252|NCT02931838|475107140|FG002|Overall Study|Subject request to discontinue treatment|3|||
131951253|NCT02931838|475107141|FG003|Overall Study|Subject request to discontinue treatment|0|||
131951254|NCT02931838|475107142|FG004|Overall Study|Subject request to discontinue treatment|1|||
131951255|NCT02931838|475107143|FG005|Overall Study|Subject request to discontinue treatment|0|||
131951256|NCT02931838|475107138|FG000|Overall Study|Withdrawal by Subject|1|||
131951257|NCT02931838|475107139|FG001|Overall Study|Withdrawal by Subject|2|||
131951258|NCT02931838|475107140|FG002|Overall Study|Withdrawal by Subject|0|||
131951259|NCT02931838|475107141|FG003|Overall Study|Withdrawal by Subject|1|||
131951260|NCT02931838|475107142|FG004|Overall Study|Withdrawal by Subject|0|||
131951261|NCT02931838|475107143|FG005|Overall Study|Withdrawal by Subject|0|||
131951262|NCT02931838|475107138|FG000|Overall Study|Adverse Event|2|||
131951263|NCT02931838|475107139|FG001|Overall Study|Adverse Event|1|||
131951264|NCT02931838|475107140|FG002|Overall Study|Adverse Event|2|||
131951265|NCT02931838|475107141|FG003|Overall Study|Adverse Event|1|||
131951266|NCT02931838|475107142|FG004|Overall Study|Adverse Event|3|||
131951267|NCT02931838|475107143|FG005|Overall Study|Adverse Event|1|||
131951268|NCT01027650|475107144|FG000|Overall Study|Personal Reasons|0|||
131951269|NCT01027650|475107145|FG001|Overall Study|Personal Reasons|0|||
131951270|NCT01027650|475107146|FG002|Overall Study|Personal Reasons|0|||
131951271|NCT01027650|475107147|FG003|Overall Study|Personal Reasons|0|||
131951272|NCT01027650|475107148|FG004|Overall Study|Personal Reasons|2|||
131951273|NCT01027650|475107149|FG005|Overall Study|Personal Reasons|1|||
131951274|NCT01027650|475107150|FG006|Overall Study|Personal Reasons|0|||
131951275|NCT01027650|475107151|FG007|Overall Study|Personal Reasons|0|||
131951276|NCT01027650|475107144|FG000|Overall Study|Lost to Follow-up|0|||
131951277|NCT01027650|475107145|FG001|Overall Study|Lost to Follow-up|0|||
131951278|NCT01027650|475107146|FG002|Overall Study|Lost to Follow-up|0|||
131951279|NCT01027650|475107147|FG003|Overall Study|Lost to Follow-up|0|||
131951280|NCT01027650|475107148|FG004|Overall Study|Lost to Follow-up|0|||
131951281|NCT01027650|475107149|FG005|Overall Study|Lost to Follow-up|0|||
131951282|NCT01027650|475107150|FG006|Overall Study|Lost to Follow-up|1|||
131951283|NCT01027650|475107151|FG007|Overall Study|Lost to Follow-up|0|||
131951284|NCT01027650|475107144|FG000|Overall Study|Lack of Efficacy|0|||
131951285|NCT01027650|475107145|FG001|Overall Study|Lack of Efficacy|0|||
131951286|NCT01027650|475107146|FG002|Overall Study|Lack of Efficacy|0|||
131415035|NCT01792518|473143884|FG000|Overall Study|Withdrawal by Subject|2|||
131415036|NCT01792518|473143885|FG001|Overall Study|Withdrawal by Subject|0|||
131415037|NCT01792518|473143884|FG000|Overall Study|Other Reason|0|||
131951287|NCT01027650|475107147|FG003|Overall Study|Lack of Efficacy|0|||
131951288|NCT01027650|475107148|FG004|Overall Study|Lack of Efficacy|0|||
131951289|NCT01027650|475107149|FG005|Overall Study|Lack of Efficacy|1|||
131951290|NCT01027650|475107150|FG006|Overall Study|Lack of Efficacy|0|||
131415038|NCT01792518|473143885|FG001|Overall Study|Other Reason|1|||
131951291|NCT01027650|475107151|FG007|Overall Study|Lack of Efficacy|0|||
131951292|NCT00912782|475107155|FG000|Overall Study|Death|2|||
131951293|NCT00912782|475107156|FG001|Overall Study|Death|1|||
131951294|NCT00912782|475107155|FG000|Overall Study|Lost to Follow-up|0|||
131951295|NCT00912782|475107156|FG001|Overall Study|Lost to Follow-up|1|||
131951296|NCT00912782|475107155|FG000|Overall Study|Did not receive vascular access type|1|||
131951297|NCT00912782|475107156|FG001|Overall Study|Did not receive vascular access type|2|||
131951298|NCT00912782|475107155|FG000|Overall Study|Relocated before study completion|0|||
131951299|NCT00912782|475107156|FG001|Overall Study|Relocated before study completion|1|||
131951300|NCT05823974|475109410|FG000|Overall Study|Lost to Follow-up|0|||
131951301|NCT05823974|475109411|FG001|Overall Study|Lost to Follow-up|3|||
131951302|NCT05823974|475109412|FG002|Overall Study|Lost to Follow-up|1|||
131951303|NCT05823974|475109413|FG003|Overall Study|Lost to Follow-up|0|||
131951304|NCT05823974|475109414|FG004|Overall Study|Lost to Follow-up|1|||
131951305|NCT05823974|475109415|FG005|Overall Study|Lost to Follow-up|0|||
131951306|NCT05823974|475109416|FG006|Overall Study|Lost to Follow-up|1|||
131951307|NCT05823974|475109417|FG007|Overall Study|Lost to Follow-up|0|||
131951308|NCT05823974|475109418|FG008|Overall Study|Lost to Follow-up|0|||
131951309|NCT05823974|475109419|FG009|Overall Study|Lost to Follow-up|1|||
131951310|NCT05823974|475109420|FG010|Overall Study|Lost to Follow-up|1|||
131951311|NCT05823974|475109421|FG011|Overall Study|Lost to Follow-up|0|||
131951312|NCT05823974|475109422|FG012|Overall Study|Lost to Follow-up|1|||
131951313|NCT05823974|475109423|FG013|Overall Study|Lost to Follow-up|2|||
131951314|NCT05823974|475109424|FG014|Overall Study|Lost to Follow-up|1|||
131951315|NCT05823974|475109425|FG015|Overall Study|Lost to Follow-up|1|||
131951316|NCT05823974|475109426|FG016|Overall Study|Lost to Follow-up|1|||
131951317|NCT05823974|475109427|FG017|Overall Study|Lost to Follow-up|0|||
131951318|NCT05823974|475109428|FG018|Overall Study|Lost to Follow-up|0|||
131951319|NCT05823974|475109429|FG019|Overall Study|Lost to Follow-up|2|||
131951320|NCT05823974|475109430|FG020|Overall Study|Lost to Follow-up|0|||
131951321|NCT05823974|475109410|FG000|Overall Study|Physician Decision|0|||
131951322|NCT05823974|475109411|FG001|Overall Study|Physician Decision|0|||
131951323|NCT05823974|475109412|FG002|Overall Study|Physician Decision|0|||
131951324|NCT05823974|475109413|FG003|Overall Study|Physician Decision|0|||
131951325|NCT05823974|475109414|FG004|Overall Study|Physician Decision|0|||
131951326|NCT05823974|475109415|FG005|Overall Study|Physician Decision|0|||
131951327|NCT05823974|475109416|FG006|Overall Study|Physician Decision|0|||
131951328|NCT05823974|475109417|FG007|Overall Study|Physician Decision|0|||
131951329|NCT05823974|475109418|FG008|Overall Study|Physician Decision|0|||
131951330|NCT05823974|475109419|FG009|Overall Study|Physician Decision|0|||
131951331|NCT05823974|475109420|FG010|Overall Study|Physician Decision|0|||
131951332|NCT05823974|475109421|FG011|Overall Study|Physician Decision|0|||
131951333|NCT05823974|475109422|FG012|Overall Study|Physician Decision|0|||
131951334|NCT05823974|475109423|FG013|Overall Study|Physician Decision|0|||
131951335|NCT05823974|475109424|FG014|Overall Study|Physician Decision|0|||
131951336|NCT05823974|475109425|FG015|Overall Study|Physician Decision|1|||
131951337|NCT05823974|475109426|FG016|Overall Study|Physician Decision|0|||
131951338|NCT05823974|475109427|FG017|Overall Study|Physician Decision|1|||
131951339|NCT05823974|475109428|FG018|Overall Study|Physician Decision|1|||
131951340|NCT05823974|475109429|FG019|Overall Study|Physician Decision|0|||
131951341|NCT05823974|475109430|FG020|Overall Study|Physician Decision|0|||
131951342|NCT05823974|475109410|FG000|Overall Study|Withdrawal by Subject|1|||
131951343|NCT05823974|475109411|FG001|Overall Study|Withdrawal by Subject|1|||
131951344|NCT05823974|475109412|FG002|Overall Study|Withdrawal by Subject|2|||
131951345|NCT05823974|475109413|FG003|Overall Study|Withdrawal by Subject|0|||
131951346|NCT05823974|475109414|FG004|Overall Study|Withdrawal by Subject|2|||
131951347|NCT05823974|475109415|FG005|Overall Study|Withdrawal by Subject|3|||
131951348|NCT05823974|475109416|FG006|Overall Study|Withdrawal by Subject|1|||
131951349|NCT05823974|475109417|FG007|Overall Study|Withdrawal by Subject|1|||
131951350|NCT05823974|475109418|FG008|Overall Study|Withdrawal by Subject|2|||
131951351|NCT05823974|475109419|FG009|Overall Study|Withdrawal by Subject|1|||
131951352|NCT05823974|475109420|FG010|Overall Study|Withdrawal by Subject|1|||
131951353|NCT05823974|475109421|FG011|Overall Study|Withdrawal by Subject|0|||
131951354|NCT05823974|475109422|FG012|Overall Study|Withdrawal by Subject|0|||
131415039|NCT03426631|473143888|FG000|Overall Study|Lost to Follow-up|0|||
131415040|NCT03426631|473143889|FG001|Overall Study|Lost to Follow-up|1|||
131415041|NCT00654004|473143890|FG000|Overall Study|Lost to Follow-up|1|||
131415042|NCT00654004|473143891|FG001|Overall Study|Lost to Follow-up|0|||
131415043|NCT00267150|473143898|FG000|Overall Study|Adverse Event|1|||
131951355|NCT05823974|475109423|FG013|Overall Study|Withdrawal by Subject|1|||
131951356|NCT05823974|475109424|FG014|Overall Study|Withdrawal by Subject|1|||
131951357|NCT05823974|475109425|FG015|Overall Study|Withdrawal by Subject|3|||
131951358|NCT05823974|475109426|FG016|Overall Study|Withdrawal by Subject|0|||
131951359|NCT05823974|475109427|FG017|Overall Study|Withdrawal by Subject|2|||
131951360|NCT05823974|475109428|FG018|Overall Study|Withdrawal by Subject|2|||
131951361|NCT05823974|475109429|FG019|Overall Study|Withdrawal by Subject|0|||
131951362|NCT05823974|475109430|FG020|Overall Study|Withdrawal by Subject|1|||
131951363|NCT05823974|475109410|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951364|NCT05823974|475109411|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951365|NCT05823974|475109412|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131415044|NCT03134183|473143899|FG000|Overall Study|Withdrawal by Subject|1|||
131415045|NCT03134183|473143900|FG001|Overall Study|Withdrawal by Subject|1|||
131951366|NCT05823974|475109413|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131456876|NCT01068600|473303029|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131456877|NCT01068600|473303028|FG000|Overall Study|Lost to Follow-up|1|||
131456878|NCT01068600|473303029|FG001|Overall Study|Lost to Follow-up|2|||
131456879|NCT01068600|473303028|FG000|Overall Study|Protocol deviation|1|||
131456880|NCT01068600|473303029|FG001|Overall Study|Protocol deviation|1|||
131456881|NCT01068600|473303028|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131456882|NCT01068600|473303029|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131456883|NCT01068600|473303028|FG000|Overall Study|Administrative problems|0|||
131456884|NCT01068600|473303029|FG001|Overall Study|Administrative problems|1|||
131456885|NCT00486291|473303034|FG000|Overall Study|Adverse Event|3|||
131456886|NCT00486291|473303035|FG001|Overall Study|Adverse Event|4|||
131456887|NCT00486291|473303034|FG000|Overall Study|Lost to Follow-up|3|||
131456888|NCT00486291|473303035|FG001|Overall Study|Lost to Follow-up|7|||
131456889|NCT00486291|473303034|FG000|Overall Study|protocol non-compliance|10|||
131456890|NCT00486291|473303035|FG001|Overall Study|protocol non-compliance|15|||
131456891|NCT00486291|473303034|FG000|Overall Study|requirement for restricted medication|0|||
131456892|NCT00486291|473303035|FG001|Overall Study|requirement for restricted medication|3|||
131456893|NCT00126490|473303036|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
131456894|NCT04080167|473303037|FG000|Overall Study|Lost to Follow-up-Patients|7|||
131456895|NCT04080167|473303038|FG001|Overall Study|Lost to Follow-up-Patients|14|||
131456896|NCT04080167|473303039|FG002|Overall Study|Lost to Follow-up-Patients|0|||
131456897|NCT04080167|473303037|FG000|Overall Study|Lost to Follow-up-Providers|2|||
131456898|NCT04080167|473303038|FG001|Overall Study|Lost to Follow-up-Providers|2|||
131456899|NCT04080167|473303039|FG002|Overall Study|Lost to Follow-up-Providers|0|||
131456900|NCT04080167|473303037|FG000|Overall Study|Withdrawal by Subject|1|||
131456901|NCT04080167|473303038|FG001|Overall Study|Withdrawal by Subject|2|||
131456902|NCT04080167|473303039|FG002|Overall Study|Withdrawal by Subject|0|||
131456903|NCT04080167|473303037|FG000|Overall Study|Withdrawal by Provider|0|||
131456904|NCT04080167|473303038|FG001|Overall Study|Withdrawal by Provider|0|||
131456905|NCT04080167|473303039|FG002|Overall Study|Withdrawal by Provider|4|||
131456906|NCT04080167|473303037|FG000|Overall Study|Death-Patient|2|||
131456907|NCT04080167|473303038|FG001|Overall Study|Death-Patient|1|||
131456908|NCT04080167|473303039|FG002|Overall Study|Death-Patient|0|||
131456909|NCT04080167|473303037|FG000|Overall Study|Hydroxyurea New Starts|0|||
131456910|NCT04080167|473303038|FG001|Overall Study|Hydroxyurea New Starts|0|||
131456911|NCT04080167|473303039|FG002|Overall Study|Hydroxyurea New Starts|1|||
131456912|NCT04080167|473303037|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
131456913|NCT04080167|473303038|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
131456914|NCT04080167|473303039|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
131456915|NCT02167139|473303040|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
131456916|NCT02167139|473303041|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
131456917|NCT02167139|473303042|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
131456918|NCT02167139|473303043|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
131456919|NCT02167139|473303040|FG000|Randomised, Double-blind|Adverse Event|2|||
131456920|NCT02167139|473303041|FG001|Randomised, Double-blind|Adverse Event|9|||
131456921|NCT02167139|473303042|FG002|Randomised, Double-blind|Adverse Event|0|||
131456922|NCT02167139|473303043|FG003|Randomised, Double-blind|Adverse Event|0|||
131456923|NCT02167139|473303040|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
131456924|NCT02167139|473303041|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
131456925|NCT02167139|473303042|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
131951367|NCT05823974|475109414|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951368|NCT05823974|475109415|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951369|NCT05823974|475109416|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951370|NCT05823974|475109417|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951371|NCT05823974|475109418|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951372|NCT05823974|475109419|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131456926|NCT02167139|473303043|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
131456927|NCT02167139|473303040|FG000|Randomised, Double-blind|Other|3|||
131456928|NCT02167139|473303041|FG001|Randomised, Double-blind|Other|0|||
131456929|NCT02167139|473303042|FG002|Randomised, Double-blind|Other|0|||
131456930|NCT02167139|473303043|FG003|Randomised, Double-blind|Other|0|||
131456931|NCT02167139|473303040|FG000|Transition-extension|Adverse Event|2|||
131456932|NCT02167139|473303041|FG001|Transition-extension|Adverse Event|0|||
131951373|NCT05823974|475109420|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951374|NCT05823974|475109421|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131456933|NCT02167139|473303042|FG002|Transition-extension|Adverse Event|2|||
131456934|NCT02167139|473303043|FG003|Transition-extension|Adverse Event|3|||
131456935|NCT02167139|473303040|FG000|Transition-extension|Withdrawal by Subject|2|||
131456936|NCT02167139|473303041|FG001|Transition-extension|Withdrawal by Subject|0|||
131951375|NCT05823974|475109422|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131456937|NCT02167139|473303042|FG002|Transition-extension|Withdrawal by Subject|4|||
131456938|NCT02167139|473303043|FG003|Transition-extension|Withdrawal by Subject|1|||
131456939|NCT02167139|473303040|FG000|Transition-extension|Lack of Efficacy|0|||
131951376|NCT05823974|475109423|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951377|NCT05823974|475109424|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131951378|NCT05823974|475109425|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951379|NCT05823974|475109426|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951380|NCT05823974|475109427|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951381|NCT05823974|475109428|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951382|NCT05823974|475109429|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951383|NCT05823974|475109430|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131951384|NCT05823974|475109410|FG000|Overall Study|Other|0|||
131951385|NCT05823974|475109411|FG001|Overall Study|Other|1|||
131951386|NCT05823974|475109412|FG002|Overall Study|Other|1|||
131951387|NCT05823974|475109413|FG003|Overall Study|Other|1|||
131951388|NCT05823974|475109414|FG004|Overall Study|Other|0|||
131951389|NCT05823974|475109415|FG005|Overall Study|Other|1|||
131951390|NCT05823974|475109416|FG006|Overall Study|Other|1|||
131951391|NCT05823974|475109417|FG007|Overall Study|Other|1|||
131951392|NCT05823974|475109418|FG008|Overall Study|Other|1|||
131951393|NCT05823974|475109419|FG009|Overall Study|Other|0|||
131951394|NCT05823974|475109420|FG010|Overall Study|Other|0|||
131951395|NCT05823974|475109421|FG011|Overall Study|Other|0|||
131951396|NCT05823974|475109422|FG012|Overall Study|Other|2|||
131951397|NCT05823974|475109423|FG013|Overall Study|Other|1|||
131951398|NCT05823974|475109424|FG014|Overall Study|Other|0|||
131951399|NCT05823974|475109425|FG015|Overall Study|Other|1|||
131951400|NCT05823974|475109426|FG016|Overall Study|Other|0|||
131951401|NCT05823974|475109427|FG017|Overall Study|Other|0|||
131951402|NCT05823974|475109428|FG018|Overall Study|Other|0|||
131951403|NCT05823974|475109429|FG019|Overall Study|Other|0|||
131951404|NCT05823974|475109430|FG020|Overall Study|Other|0|||
131951405|NCT00316706|475109431|FG000|Overall Study|Lost to Follow-up|38|||
131951406|NCT00316706|475109432|FG001|Overall Study|Lost to Follow-up|48|||
131951407|NCT03280303|475109433|FG000|Overall Study|Death|505|||
131951408|NCT03280303|475109433|FG000|Overall Study|Study terminated by sponsor|383|||
131951409|NCT03280303|475109433|FG000|Overall Study|Other|148|||
131951410|NCT03280303|475109433|FG000|Overall Study|No longer willing to participate in study|101|||
131415046|NCT00162266|473143901|FG000|Double-Blind Period|Adverse Event|5|||
131415047|NCT00162266|473143902|FG001|Double-Blind Period|Adverse Event|9|||
131415048|NCT00162266|473143903|FG002|Double-Blind Period|Adverse Event|11|||
131415049|NCT00162266|473143904|FG003|Double-Blind Period|Adverse Event|0|||
131415050|NCT00162266|473143901|FG000|Double-Blind Period|Death|0|||
131415051|NCT00162266|473143902|FG001|Double-Blind Period|Death|1|||
131415052|NCT00162266|473143903|FG002|Double-Blind Period|Death|0|||
131415053|NCT00162266|473143904|FG003|Double-Blind Period|Death|0|||
131415054|NCT00162266|473143901|FG000|Double-Blind Period|Lost to Follow-up|1|||
131415055|NCT00162266|473143902|FG001|Double-Blind Period|Lost to Follow-up|2|||
131415056|NCT00162266|473143903|FG002|Double-Blind Period|Lost to Follow-up|0|||
131415057|NCT00162266|473143904|FG003|Double-Blind Period|Lost to Follow-up|0|||
131415058|NCT00162266|473143901|FG000|Double-Blind Period|Other Reason|1|||
131415059|NCT00162266|473143902|FG001|Double-Blind Period|Other Reason|0|||
131415060|NCT00162266|473143903|FG002|Double-Blind Period|Other Reason|1|||
131415061|NCT00162266|473143904|FG003|Double-Blind Period|Other Reason|0|||
131415062|NCT00162266|473143901|FG000|Double-Blind Period|Lack of Efficacy|13|||
131415063|NCT00162266|473143902|FG001|Double-Blind Period|Lack of Efficacy|17|||
131415064|NCT00162266|473143903|FG002|Double-Blind Period|Lack of Efficacy|30|||
131415065|NCT00162266|473143904|FG003|Double-Blind Period|Lack of Efficacy|0|||
131415066|NCT00162266|473143901|FG000|Double-Blind Period|Withdrawal by Subject|5|||
131415067|NCT00162266|473143902|FG001|Double-Blind Period|Withdrawal by Subject|2|||
131415068|NCT00162266|473143903|FG002|Double-Blind Period|Withdrawal by Subject|6|||
131415069|NCT00162266|473143904|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131951411|NCT03280303|475109433|FG000|Overall Study|Lost to follow up|39|||
131951412|NCT03280303|475109433|FG000|Overall Study|Adverse Event|20|||
131951413|NCT03419897|475109434|FG000|Overall Study|Death|180|||
131951414|NCT03419897|475109434|FG000|Overall Study|Lost to Follow-up|1|||
131951415|NCT03419897|475109434|FG000|Overall Study|Withdrawal by Subject|6|||
131951416|NCT03419897|475109434|FG000|Overall Study|Sponsor Decision|61|||
131951417|NCT03419897|475109434|FG000|Overall Study|Physician Decision|1|||
131951418|NCT00958360|475109446|FG000|Overall Study|Withdrawal by Subject|3|||
131951419|NCT00958360|475109447|FG001|Overall Study|Withdrawal by Subject|1|||
131951420|NCT00958360|475109446|FG000|Overall Study|Death|6|||
131951421|NCT00958360|475109447|FG001|Overall Study|Death|7|||
131951422|NCT00958360|475109446|FG000|Overall Study|Physician Decision|2|||
131415070|NCT00162266|473143901|FG000|Open-Label Period|Death|0|||
131415071|NCT00162266|473143902|FG001|Open-Label Period|Death|0|||
131415072|NCT00162266|473143903|FG002|Open-Label Period|Death|0|||
131415073|NCT00162266|473143904|FG003|Open-Label Period|Death|7|||
131415074|NCT00162266|473143901|FG000|Open-Label Period|Adverse Event|0|||
131415075|NCT00162266|473143902|FG001|Open-Label Period|Adverse Event|0|||
131951423|NCT00958360|475109447|FG001|Overall Study|Physician Decision|1|||
131951424|NCT00958360|475109446|FG000|Overall Study|Lost to Follow-up|0|||
131951425|NCT00958360|475109447|FG001|Overall Study|Lost to Follow-up|1|||
131951426|NCT03107052|475109448|FG000|Overall Study|Adverse Event|6|||
131951427|NCT03107052|475109449|FG001|Overall Study|Adverse Event|1|||
131951428|NCT03107052|475109450|FG002|Overall Study|Adverse Event|2|||
131951429|NCT03107052|475109448|FG000|Overall Study|Withdrawal by Subject|9|||
131951430|NCT03107052|475109449|FG001|Overall Study|Withdrawal by Subject|5|||
131951431|NCT03107052|475109450|FG002|Overall Study|Withdrawal by Subject|8|||
131951432|NCT03107052|475109448|FG000|Overall Study|Protocol Violation|6|||
131951433|NCT03107052|475109449|FG001|Overall Study|Protocol Violation|0|||
131951434|NCT03107052|475109450|FG002|Overall Study|Protocol Violation|3|||
131951435|NCT03107052|475109448|FG000|Overall Study|Lost to Follow-up|4|||
131951436|NCT03107052|475109449|FG001|Overall Study|Lost to Follow-up|0|||
131951437|NCT03107052|475109450|FG002|Overall Study|Lost to Follow-up|1|||
131951438|NCT03107052|475109448|FG000|Overall Study|Lack of Efficacy|23|||
131951439|NCT03107052|475109449|FG001|Overall Study|Lack of Efficacy|7|||
131951440|NCT03107052|475109450|FG002|Overall Study|Lack of Efficacy|4|||
131951441|NCT03107052|475109448|FG000|Overall Study|Other than specified|4|||
131951442|NCT03107052|475109449|FG001|Overall Study|Other than specified|2|||
131951443|NCT03107052|475109450|FG002|Overall Study|Other than specified|0|||
131951444|NCT03107052|475109448|FG000|Overall Study|Study terminated due to futility|67|||
131951445|NCT03107052|475109449|FG001|Overall Study|Study terminated due to futility|31|||
131951446|NCT03107052|475109450|FG002|Overall Study|Study terminated due to futility|23|||
131951447|NCT02263326|475109451|FG000|Overall Study|Lost to Follow-up|1|||
131951448|NCT02263326|475109452|FG001|Overall Study|Lost to Follow-up|1|||
131951449|NCT00500357|475109453|FG000|Overall Study|Death|1|||
131951450|NCT01893411|475109454|FG000|Overall Study|Protocol Violation|1|||
131951451|NCT01893411|475109455|FG001|Overall Study|Protocol Violation|0|||
131951452|NCT01893411|475109456|FG002|Overall Study|Protocol Violation|0|||
131951453|NCT01893411|475109454|FG000|Overall Study|Physician Decision|1|||
131951454|NCT01893411|475109455|FG001|Overall Study|Physician Decision|1|||
131951455|NCT01893411|475109456|FG002|Overall Study|Physician Decision|2|||
131951456|NCT01893411|475109454|FG000|Overall Study|Lack of Efficacy|2|||
131951457|NCT01893411|475109455|FG001|Overall Study|Lack of Efficacy|1|||
131951458|NCT01893411|475109456|FG002|Overall Study|Lack of Efficacy|0|||
131951459|NCT01893411|475109454|FG000|Overall Study|Other|3|||
131951460|NCT01893411|475109455|FG001|Overall Study|Other|1|||
131951461|NCT01893411|475109456|FG002|Overall Study|Other|3|||
131951462|NCT01893411|475109454|FG000|Overall Study|Adverse Event|1|||
131951463|NCT01893411|475109455|FG001|Overall Study|Adverse Event|0|||
131951464|NCT01893411|475109456|FG002|Overall Study|Adverse Event|0|||
131951465|NCT01893411|475109454|FG000|Overall Study|Withdrawal by Subject|7|||
131951466|NCT01893411|475109455|FG001|Overall Study|Withdrawal by Subject|4|||
131951467|NCT01893411|475109456|FG002|Overall Study|Withdrawal by Subject|3|||
131951468|NCT01893411|475109454|FG000|Overall Study|Lost to Follow-up|2|||
131951469|NCT01893411|475109455|FG001|Overall Study|Lost to Follow-up|0|||
131951470|NCT01893411|475109456|FG002|Overall Study|Lost to Follow-up|1|||
131951471|NCT02397915|475109457|FG000|Period 1|Protocol Violation|0|||
131951472|NCT02397915|475109458|FG001|Period 1|Protocol Violation|1|||
131951473|NCT02397915|475109459|FG002|Period 1|Protocol Violation|0|||
131951474|NCT02397915|475109460|FG003|Period 1|Protocol Violation|0|||
131951475|NCT02397915|475109457|FG000|Period 1|Physician Decision|1|||
131951476|NCT02397915|475109458|FG001|Period 1|Physician Decision|0|||
131951477|NCT02397915|475109459|FG002|Period 1|Physician Decision|0|||
131951478|NCT02397915|475109460|FG003|Period 1|Physician Decision|0|||
131951479|NCT03292874|475109461|FG000|Overall Study|Due to pandemic|5|||
131951480|NCT00161616|475109462|FG000|Overall Study|Withdrawal by Subject|6|||
131951481|NCT00161616|475109463|FG001|Overall Study|Withdrawal by Subject|5|||
131951482|NCT00161616|475109462|FG000|Overall Study|Physician Decision|1|||
131951483|NCT00161616|475109463|FG001|Overall Study|Physician Decision|0|||
131951484|NCT00161616|475109462|FG000|Overall Study|Death|1|||
131951485|NCT00161616|475109463|FG001|Overall Study|Death|1|||
131951486|NCT00161616|475109462|FG000|Overall Study|Lost to Follow-up|17|||
131951487|NCT00161616|475109463|FG001|Overall Study|Lost to Follow-up|13|||
131951488|NCT00161616|475109462|FG000|Overall Study|Protocol deviation|1|||
131951489|NCT00161616|475109463|FG001|Overall Study|Protocol deviation|0|||
131951490|NCT00854724|475109464|FG000|First Intervention|Withdrawal by Subject|1|||
131951491|NCT00854724|475109465|FG001|First Intervention|Withdrawal by Subject|1|||
131951492|NCT00854724|475109464|FG000|Washout|Protocol Violation|1|||
131415076|NCT00162266|473143903|FG002|Open-Label Period|Adverse Event|0|||
131415077|NCT00162266|473143904|FG003|Open-Label Period|Adverse Event|46|||
131415078|NCT00162266|473143901|FG000|Open-Label Period|Lack of Efficacy|0|||
131415079|NCT00162266|473143902|FG001|Open-Label Period|Lack of Efficacy|0|||
131415080|NCT00162266|473143903|FG002|Open-Label Period|Lack of Efficacy|0|||
131415081|NCT00162266|473143904|FG003|Open-Label Period|Lack of Efficacy|26|||
131951493|NCT00854724|475109465|FG001|Washout|Protocol Violation|0|||
131951494|NCT00854724|475109464|FG000|Washout|Withdrawal by Subject|0|||
131951495|NCT00854724|475109465|FG001|Washout|Withdrawal by Subject|1|||
131951496|NCT00854724|475109464|FG000|Second Intervention|Protocol Violation|1|||
131951497|NCT00854724|475109465|FG001|Second Intervention|Protocol Violation|0|||
131951498|NCT00854724|475109464|FG000|Second Intervention|Physician Decision|0|||
131951499|NCT00854724|475109465|FG001|Second Intervention|Physician Decision|1|||
131951500|NCT00933608|475109467|FG000|Overall Study|Adverse Event|4|||
131951501|NCT00933608|475109468|FG001|Overall Study|Adverse Event|2|||
131951502|NCT00933608|475109467|FG000|Overall Study|Physician Decision|1|||
131951503|NCT00933608|475109468|FG001|Overall Study|Physician Decision|0|||
131951504|NCT02719691|475109469|FG000|Overall Study|Physician Decision|0|||
131951505|NCT02719691|475109470|FG001|Overall Study|Physician Decision|0|||
131951506|NCT02719691|475109471|FG002|Overall Study|Physician Decision|1|||
131951507|NCT02719691|475109472|FG003|Overall Study|Physician Decision|0|||
131951508|NCT02719691|475109473|FG004|Overall Study|Physician Decision|0|||
131951509|NCT02719691|475109474|FG005|Overall Study|Physician Decision|0|||
131951510|NCT02719691|475109475|FG006|Overall Study|Physician Decision|0|||
131951511|NCT02719691|475109469|FG000|Overall Study|Withdrawal by Subject|0|||
131951512|NCT02719691|475109470|FG001|Overall Study|Withdrawal by Subject|0|||
131951513|NCT02719691|475109471|FG002|Overall Study|Withdrawal by Subject|0|||
131951514|NCT02719691|475109472|FG003|Overall Study|Withdrawal by Subject|0|||
131951515|NCT02719691|475109473|FG004|Overall Study|Withdrawal by Subject|0|||
131951516|NCT02719691|475109474|FG005|Overall Study|Withdrawal by Subject|1|||
131951517|NCT02719691|475109475|FG006|Overall Study|Withdrawal by Subject|0|||
131951518|NCT00336284|475109476|FG000|Overall Study|Death|52|||
131951519|NCT00336284|475109477|FG001|Overall Study|Death|26|||
131951520|NCT00336284|475109476|FG000|Overall Study|Lost to Follow-up|82|||
131951521|NCT00336284|475109477|FG001|Overall Study|Lost to Follow-up|61|||
131951522|NCT00336284|475109476|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
131951523|NCT00336284|475109477|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
131951524|NCT00861757|475109482|FG000|Overall Study|Adverse Event|1|||
131951525|NCT00861757|475109483|FG001|Overall Study|Adverse Event|5|||
131951526|NCT00861757|475109484|FG002|Overall Study|Adverse Event|7|||
131951527|NCT00861757|475109485|FG003|Overall Study|Adverse Event|2|||
131951528|NCT00861757|475109482|FG000|Overall Study|Entry Criteria Not Met|1|||
131951529|NCT00861757|475109483|FG001|Overall Study|Entry Criteria Not Met|2|||
131951530|NCT00861757|475109484|FG002|Overall Study|Entry Criteria Not Met|1|||
131951531|NCT00861757|475109485|FG003|Overall Study|Entry Criteria Not Met|1|||
131951532|NCT00861757|475109482|FG000|Overall Study|Lack of Efficacy|3|||
131951533|NCT00861757|475109483|FG001|Overall Study|Lack of Efficacy|1|||
131951534|NCT00861757|475109484|FG002|Overall Study|Lack of Efficacy|0|||
131951535|NCT00861757|475109485|FG003|Overall Study|Lack of Efficacy|1|||
131951536|NCT00861757|475109482|FG000|Overall Study|Lost to Follow-up|1|||
131951537|NCT00861757|475109483|FG001|Overall Study|Lost to Follow-up|0|||
131951538|NCT00861757|475109484|FG002|Overall Study|Lost to Follow-up|1|||
131951539|NCT00861757|475109485|FG003|Overall Study|Lost to Follow-up|1|||
131951540|NCT00861757|475109482|FG000|Overall Study|Physician Decision|0|||
131951541|NCT00861757|475109483|FG001|Overall Study|Physician Decision|0|||
131951542|NCT00861757|475109484|FG002|Overall Study|Physician Decision|0|||
131951543|NCT00861757|475109485|FG003|Overall Study|Physician Decision|1|||
131951544|NCT00861757|475109482|FG000|Overall Study|Protocol Violation|2|||
131951545|NCT00861757|475109483|FG001|Overall Study|Protocol Violation|2|||
131951546|NCT00861757|475109484|FG002|Overall Study|Protocol Violation|4|||
131951547|NCT00861757|475109485|FG003|Overall Study|Protocol Violation|1|||
131951548|NCT00861757|475109482|FG000|Overall Study|Withdrawal by Subject|1|||
131951549|NCT00861757|475109483|FG001|Overall Study|Withdrawal by Subject|5|||
131951550|NCT00861757|475109484|FG002|Overall Study|Withdrawal by Subject|5|||
131951551|NCT00861757|475109485|FG003|Overall Study|Withdrawal by Subject|2|||
131951552|NCT02141633|475109489|FG000|Overall Study|Physician Decision|1|||
131951553|NCT02141633|475109490|FG001|Overall Study|Physician Decision|0|||
131951554|NCT00391053|475109493|FG000|Overall Study|Serious Adverse Events|1|||
131951555|NCT00391053|475109494|FG001|Overall Study|Serious Adverse Events|0|||
131951556|NCT00391053|475109495|FG002|Overall Study|Serious Adverse Events|1|||
131951557|NCT00391053|475109496|FG003|Overall Study|Serious Adverse Events|4|||
131951558|NCT00391053|475109493|FG000|Overall Study|Protocol Violation|2|||
131951559|NCT00391053|475109494|FG001|Overall Study|Protocol Violation|0|||
131951560|NCT00391053|475109495|FG002|Overall Study|Protocol Violation|0|||
131951561|NCT00391053|475109496|FG003|Overall Study|Protocol Violation|0|||
131951562|NCT00391053|475109493|FG000|Overall Study|Lost to Follow-up|1|||
131951563|NCT00391053|475109494|FG001|Overall Study|Lost to Follow-up|0|||
131951564|NCT00391053|475109495|FG002|Overall Study|Lost to Follow-up|0|||
131951565|NCT00391053|475109496|FG003|Overall Study|Lost to Follow-up|5|||
131951566|NCT00391053|475109493|FG000|Overall Study|Withdrawal by Subject|5|||
131951567|NCT00391053|475109494|FG001|Overall Study|Withdrawal by Subject|1|||
131951568|NCT00391053|475109495|FG002|Overall Study|Withdrawal by Subject|1|||
131951569|NCT00391053|475109496|FG003|Overall Study|Withdrawal by Subject|1|||
131951570|NCT05002985|475109498|FG000|Overall Study|Withdrawal by Subject|1|||
131951571|NCT04123093|475109505|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
131951572|NCT04123093|475109506|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
131951573|NCT04123093|475109505|FG000|Phase 2|Physician Decision|0|||
131951574|NCT04123093|475109506|FG001|Phase 2|Physician Decision|1|||
131951575|NCT04123093|475109505|FG000|Phase 2|Withdrawal by Subject|0|||
131951576|NCT04123093|475109506|FG001|Phase 2|Withdrawal by Subject|1|||
131951577|NCT01485796|475109508|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
131951578|NCT01485796|475109508|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
131951579|NCT01485796|475109508|FG000|Period 2: Epoch 2|Adverse Event|3|||
131951580|NCT01485796|475109508|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
131951581|NCT01485796|475109508|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
131951582|NCT01485796|475109508|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
131951583|NCT01485796|475109508|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
131951584|NCT01485796|475109508|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
131951585|NCT02526212|475109510|FG000|Overall Study|Incarceration|1|||
131951586|NCT02526212|475109511|FG001|Overall Study|Incarceration|0|||
131951587|NCT02526212|475109510|FG000|Overall Study|Lost to Follow-up|1|||
131951588|NCT02526212|475109511|FG001|Overall Study|Lost to Follow-up|0|||
131951589|NCT02526212|475109510|FG000|Overall Study|Death|0|||
131951590|NCT02526212|475109511|FG001|Overall Study|Death|1|||
131951591|NCT00405392|475109512|FG000|Overall Study|Adverse Event|15|||
131951592|NCT00405392|475109513|FG001|Overall Study|Adverse Event|14|||
131415082|NCT00162266|473143901|FG000|Open-Label Period|Lost to Follow-up|0|||
131415083|NCT00162266|473143902|FG001|Open-Label Period|Lost to Follow-up|0|||
131415084|NCT00162266|473143903|FG002|Open-Label Period|Lost to Follow-up|0|||
131415085|NCT00162266|473143904|FG003|Open-Label Period|Lost to Follow-up|3|||
131415086|NCT00162266|473143901|FG000|Open-Label Period|Withdrawal by Subject|0|||
131415087|NCT00162266|473143902|FG001|Open-Label Period|Withdrawal by Subject|0|||
131415088|NCT00162266|473143903|FG002|Open-Label Period|Withdrawal by Subject|0|||
131415089|NCT00162266|473143904|FG003|Open-Label Period|Withdrawal by Subject|31|||
131415090|NCT00162266|473143901|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
131415091|NCT00162266|473143902|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
131415092|NCT00162266|473143903|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
131415093|NCT00162266|473143904|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
131415094|NCT00162266|473143901|FG000|Open-Label Period|Other Reasons|0|||
131415095|NCT00162266|473143902|FG001|Open-Label Period|Other Reasons|0|||
131415096|NCT00162266|473143903|FG002|Open-Label Period|Other Reasons|0|||
131415097|NCT00162266|473143904|FG003|Open-Label Period|Other Reasons|15|||
131415098|NCT02299076|473143905|FG000|Overall Study|Fraudulent Entries|20|||
131415099|NCT02299076|473143906|FG001|Overall Study|Fraudulent Entries|14|||
131415100|NCT04208087|473143907|FG000|Overall Study|Adverse Event|1|||
131415101|NCT04208087|473143908|FG001|Overall Study|Adverse Event|0|||
131415102|NCT04208087|473143909|FG002|Overall Study|Adverse Event|0|||
131415103|NCT04208087|473143910|FG003|Overall Study|Adverse Event|0|||
131415104|NCT04208087|473143911|FG004|Overall Study|Adverse Event|0|||
131415105|NCT04208087|473143907|FG000|Overall Study|Withdrawal by Subject|0|||
131415106|NCT04208087|473143908|FG001|Overall Study|Withdrawal by Subject|0|||
131415107|NCT04208087|473143909|FG002|Overall Study|Withdrawal by Subject|1|||
131415108|NCT04208087|473143910|FG003|Overall Study|Withdrawal by Subject|0|||
131415109|NCT04208087|473143911|FG004|Overall Study|Withdrawal by Subject|0|||
131415110|NCT04208087|473143907|FG000|Overall Study|Other|0|||
131415111|NCT04208087|473143908|FG001|Overall Study|Other|0|||
131415112|NCT04208087|473143909|FG002|Overall Study|Other|0|||
131415113|NCT04208087|473143910|FG003|Overall Study|Other|0|||
131415114|NCT04208087|473143911|FG004|Overall Study|Other|1|||
131415115|NCT01969721|473143912|FG000|Overall Study|Adverse Event|3|||
131415116|NCT01969721|473143913|FG001|Overall Study|Adverse Event|8|||
131415117|NCT01969721|473143914|FG002|Overall Study|Adverse Event|3|||
131415118|NCT01969721|473143915|FG003|Overall Study|Adverse Event|2|||
131415119|NCT01969721|473143912|FG000|Overall Study|Lack of Efficacy|0|||
131415120|NCT01969721|473143913|FG001|Overall Study|Lack of Efficacy|0|||
131415121|NCT01969721|473143914|FG002|Overall Study|Lack of Efficacy|1|||
131415122|NCT01969721|473143915|FG003|Overall Study|Lack of Efficacy|0|||
131415123|NCT01969721|473143912|FG000|Overall Study|Non compliant with protocol|1|||
131415124|NCT01969721|473143913|FG001|Overall Study|Non compliant with protocol|1|||
131415125|NCT01969721|473143914|FG002|Overall Study|Non compliant with protocol|0|||
131415126|NCT01969721|473143915|FG003|Overall Study|Non compliant with protocol|2|||
131415127|NCT01969721|473143912|FG000|Overall Study|Other not defined above|0|||
131415128|NCT01969721|473143913|FG001|Overall Study|Other not defined above|2|||
131415129|NCT01969721|473143914|FG002|Overall Study|Other not defined above|0|||
131415130|NCT01969721|473143915|FG003|Overall Study|Other not defined above|0|||
131415131|NCT01969721|473143912|FG000|Overall Study|Discontinued during washout periods.|0|||
131415132|NCT01969721|473143913|FG001|Overall Study|Discontinued during washout periods.|1|||
131415133|NCT01969721|473143914|FG002|Overall Study|Discontinued during washout periods.|1|||
131951593|NCT00405392|475109512|FG000|Overall Study|Did not meet Eligibility criteria|7|||
131415134|NCT01969721|473143915|FG003|Overall Study|Discontinued during washout periods.|2|||
131415135|NCT01012323|473143917|FG000|Overall Study|Investigator Judgment|1|||
131415136|NCT00495755|473143918|FG000|Overall Study|Adverse Event|3|||
131415137|NCT02117349|473143919|FG000|Overall Study|Withdrawal by Subject|1|||
131415138|NCT02117349|473143920|FG001|Overall Study|Withdrawal by Subject|0|||
131415139|NCT02117349|473143919|FG000|Overall Study|Lost to Follow-up|1|||
131951594|NCT00405392|475109513|FG001|Overall Study|Did not meet Eligibility criteria|2|||
131415140|NCT02117349|473143920|FG001|Overall Study|Lost to Follow-up|1|||
131951595|NCT00405392|475109512|FG000|Overall Study|Withdrawal by Subject|4|||
131951596|NCT00405392|475109513|FG001|Overall Study|Withdrawal by Subject|3|||
131951597|NCT00405392|475109512|FG000|Overall Study|Lost to Follow-up|1|||
131951598|NCT00405392|475109513|FG001|Overall Study|Lost to Follow-up|2|||
131951599|NCT00405392|475109512|FG000|Overall Study|Data missing|2|||
131951600|NCT00405392|475109513|FG001|Overall Study|Data missing|0|||
131951601|NCT00405392|475109512|FG000|Overall Study|Non-compliance|0|||
131951602|NCT00405392|475109513|FG001|Overall Study|Non-compliance|1|||
131951603|NCT00405392|475109512|FG000|Overall Study|Other|1|||
131951604|NCT00405392|475109513|FG001|Overall Study|Other|5|||
131951605|NCT01703091|475109522|FG000|Overall Study|Adverse Event|5|||
131951606|NCT01703091|475109523|FG001|Overall Study|Adverse Event|3|||
131951607|NCT01703091|475109522|FG000|Overall Study|Physician Decision|2|||
131951608|NCT01703091|475109523|FG001|Overall Study|Physician Decision|1|||
131951609|NCT01703091|475109522|FG000|Overall Study|Withdrawal by Subject|1|||
131951610|NCT01703091|475109523|FG001|Overall Study|Withdrawal by Subject|0|||
131951611|NCT01703091|475109522|FG000|Overall Study|Sponsor Decision|1|||
131951612|NCT01703091|475109523|FG001|Overall Study|Sponsor Decision|0|||
131951613|NCT01262638|475109529|FG000|Overall Study|Adverse Event|3|||
131951614|NCT01262638|475109530|FG001|Overall Study|Adverse Event|4|||
131951615|NCT01262638|475109531|FG002|Overall Study|Adverse Event|3|||
131951616|NCT01262638|475109532|FG003|Overall Study|Adverse Event|4|||
131951617|NCT01262638|475109529|FG000|Overall Study|Protocol Violation|1|||
131951618|NCT01262638|475109530|FG001|Overall Study|Protocol Violation|0|||
131951619|NCT01262638|475109531|FG002|Overall Study|Protocol Violation|0|||
131951620|NCT01262638|475109532|FG003|Overall Study|Protocol Violation|1|||
131951621|NCT01262638|475109529|FG000|Overall Study|Withdrawal by Subject|2|||
131951622|NCT01262638|475109530|FG001|Overall Study|Withdrawal by Subject|1|||
131951623|NCT01262638|475109531|FG002|Overall Study|Withdrawal by Subject|0|||
131951624|NCT01262638|475109532|FG003|Overall Study|Withdrawal by Subject|1|||
131951625|NCT01262638|475109529|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
131951626|NCT01262638|475109530|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
131951627|NCT01262638|475109531|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
131951628|NCT01262638|475109532|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
131951629|NCT01262638|475109529|FG000|Overall Study|Lost to Follow-up|1|||
131951630|NCT01262638|475109530|FG001|Overall Study|Lost to Follow-up|1|||
131951631|NCT01262638|475109531|FG002|Overall Study|Lost to Follow-up|1|||
131951632|NCT01262638|475109532|FG003|Overall Study|Lost to Follow-up|1|||
131951633|NCT01262638|475109529|FG000|Overall Study|Participant Went Out of Town|0|||
131951634|NCT01262638|475109530|FG001|Overall Study|Participant Went Out of Town|0|||
131951635|NCT01262638|475109531|FG002|Overall Study|Participant Went Out of Town|1|||
131951636|NCT01262638|475109532|FG003|Overall Study|Participant Went Out of Town|0|||
131951637|NCT02243371|475109537|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
131951638|NCT02243371|475109538|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
131951639|NCT02243371|475109537|FG000|Overall Study|Death (unrelated)|2|||
131951640|NCT02243371|475109538|FG001|Overall Study|Death (unrelated)|4|||
131951641|NCT02243371|475109537|FG000|Overall Study|Adverse Event (unrelated)|0|||
131951642|NCT02243371|475109538|FG001|Overall Study|Adverse Event (unrelated)|1|||
131951643|NCT02243371|475109537|FG000|Overall Study|Lack of Clinical Benefit|0|||
131951644|NCT02243371|475109538|FG001|Overall Study|Lack of Clinical Benefit|1|||
131951645|NCT02243371|475109537|FG000|Overall Study|Withdrawal by Subject|0|||
131951646|NCT02243371|475109538|FG001|Overall Study|Withdrawal by Subject|2|||
131951647|NCT00470262|475109539|FG000|Overall Study|Withdrawal by Subject|2|||
131951648|NCT00470262|475109540|FG001|Overall Study|Withdrawal by Subject|0|||
131951649|NCT03900728|475109541|FG000|Overall Study|No text responses|0|||
131951650|NCT03900728|475109542|FG001|Overall Study|No text responses|0|||
131951651|NCT03900728|475109543|FG002|Overall Study|No text responses|4|||
131951652|NCT03902392|475109547|FG000|Overall Study|Lost to Follow-up|7|||
131951653|NCT03902392|475109548|FG001|Overall Study|Lost to Follow-up|7|||
131951654|NCT00244725|475109549|FG000|Overall Study|Lost to Follow-up|3|||
131951655|NCT00244725|475109550|FG001|Overall Study|Lost to Follow-up|4|||
131951656|NCT00244725|475109551|FG002|Overall Study|Lost to Follow-up|9|||
131951657|NCT00244725|475109552|FG003|Overall Study|Lost to Follow-up|2|||
131951658|NCT00244725|475109549|FG000|Overall Study|Withdrawal by Subject|9|||
131951659|NCT00244725|475109550|FG001|Overall Study|Withdrawal by Subject|7|||
131951660|NCT00244725|475109551|FG002|Overall Study|Withdrawal by Subject|7|||
131951661|NCT00244725|475109552|FG003|Overall Study|Withdrawal by Subject|8|||
131951662|NCT00244725|475109549|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
131951663|NCT00244725|475109550|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
131951664|NCT00244725|475109551|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
131951665|NCT00244725|475109552|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
131951666|NCT00244725|475109549|FG000|Overall Study|Physician Decision|3|||
131951667|NCT00244725|475109550|FG001|Overall Study|Physician Decision|0|||
131951668|NCT00244725|475109551|FG002|Overall Study|Physician Decision|1|||
131951669|NCT00244725|475109552|FG003|Overall Study|Physician Decision|2|||
131951670|NCT00244725|475109549|FG000|Overall Study|Adverse Events|3|||
131951671|NCT00244725|475109550|FG001|Overall Study|Adverse Events|1|||
131951672|NCT00244725|475109551|FG002|Overall Study|Adverse Events|4|||
131951673|NCT00244725|475109552|FG003|Overall Study|Adverse Events|4|||
131951674|NCT00244725|475109549|FG000|Overall Study|Withdrwal by participant|1|||
131951675|NCT00244725|475109550|FG001|Overall Study|Withdrwal by participant|0|||
131951676|NCT00244725|475109551|FG002|Overall Study|Withdrwal by participant|0|||
131951677|NCT00244725|475109552|FG003|Overall Study|Withdrwal by participant|1|||
131951678|NCT00244725|475109549|FG000|Overall Study|Liver function test abnormality|2|||
131951679|NCT00244725|475109550|FG001|Overall Study|Liver function test abnormality|0|||
131951680|NCT00244725|475109551|FG002|Overall Study|Liver function test abnormality|0|||
131951681|NCT00244725|475109552|FG003|Overall Study|Liver function test abnormality|1|||
131951682|NCT00244725|475109549|FG000|Overall Study|Sponsor withdrew the participant|1|||
131951683|NCT00244725|475109550|FG001|Overall Study|Sponsor withdrew the participant|0|||
131951684|NCT00244725|475109551|FG002|Overall Study|Sponsor withdrew the participant|0|||
131951685|NCT00244725|475109552|FG003|Overall Study|Sponsor withdrew the participant|1|||
131951686|NCT00244725|475109549|FG000|Overall Study|Mediciation Error|0|||
131951687|NCT00244725|475109550|FG001|Overall Study|Mediciation Error|1|||
131951688|NCT00244725|475109551|FG002|Overall Study|Mediciation Error|0|||
131951689|NCT00244725|475109552|FG003|Overall Study|Mediciation Error|0|||
131951690|NCT00244725|475109549|FG000|Overall Study|Rehab Refused to allow participantion|0|||
131951691|NCT00244725|475109550|FG001|Overall Study|Rehab Refused to allow participantion|1|||
131951692|NCT00244725|475109551|FG002|Overall Study|Rehab Refused to allow participantion|0|||
131951693|NCT00244725|475109552|FG003|Overall Study|Rehab Refused to allow participantion|0|||
131951694|NCT00244725|475109549|FG000|Overall Study|Headache|0|||
131951695|NCT00244725|475109550|FG001|Overall Study|Headache|1|||
131951696|NCT00244725|475109551|FG002|Overall Study|Headache|0|||
131951697|NCT00244725|475109552|FG003|Overall Study|Headache|0|||
131951698|NCT00244725|475109549|FG000|Overall Study|Received prohibited medication|0|||
131951699|NCT00244725|475109550|FG001|Overall Study|Received prohibited medication|1|||
131951700|NCT00244725|475109551|FG002|Overall Study|Received prohibited medication|0|||
131951701|NCT00244725|475109552|FG003|Overall Study|Received prohibited medication|1|||
131951702|NCT00244725|475109549|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
131951703|NCT00244725|475109550|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
131951704|NCT00244725|475109551|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
131951705|NCT00244725|475109552|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
131951706|NCT00244725|475109549|FG000|Overall Study|Administrative reason|0|||
131951707|NCT00244725|475109550|FG001|Overall Study|Administrative reason|0|||
131951708|NCT00244725|475109551|FG002|Overall Study|Administrative reason|1|||
131951709|NCT00244725|475109552|FG003|Overall Study|Administrative reason|0|||
131951710|NCT00244725|475109549|FG000|Overall Study|Vomit|0|||
131951711|NCT00244725|475109550|FG001|Overall Study|Vomit|0|||
131951712|NCT00244725|475109551|FG002|Overall Study|Vomit|1|||
131951713|NCT00244725|475109552|FG003|Overall Study|Vomit|0|||
131951714|NCT00244725|475109549|FG000|Overall Study|Failed to follow-up|0|||
131951715|NCT00244725|475109550|FG001|Overall Study|Failed to follow-up|0|||
131951716|NCT00244725|475109551|FG002|Overall Study|Failed to follow-up|1|||
131951717|NCT00244725|475109552|FG003|Overall Study|Failed to follow-up|1|||
131951718|NCT02122146|475109553|FG000|Part 1: Dose Escalation|Death|0|||
131951719|NCT02122146|475109554|FG001|Part 1: Dose Escalation|Death|1|||
131951720|NCT02122146|475109555|FG002|Part 1: Dose Escalation|Death|1|||
131951721|NCT02122146|475109556|FG003|Part 1: Dose Escalation|Death|0|||
131951722|NCT02122146|475109557|FG004|Part 1: Dose Escalation|Death|0|||
131951723|NCT02122146|475109558|FG005|Part 1: Dose Escalation|Death|0|||
131951724|NCT02122146|475109559|FG006|Part 1: Dose Escalation|Death|0|||
131951725|NCT02122146|475109560|FG007|Part 1: Dose Escalation|Death|0|||
131951726|NCT02122146|475109553|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
131951727|NCT02122146|475109554|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
131951728|NCT02122146|475109555|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
131951729|NCT02122146|475109556|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
131951730|NCT02122146|475109557|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
131951731|NCT02122146|475109558|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
131951732|NCT02122146|475109559|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
131951733|NCT02122146|475109560|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
131951734|NCT02122146|475109553|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951735|NCT02122146|475109554|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951736|NCT02122146|475109555|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951737|NCT02122146|475109556|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
131951738|NCT02122146|475109557|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951739|NCT02122146|475109558|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951740|NCT02122146|475109559|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951741|NCT02122146|475109560|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131951742|NCT02122146|475109553|FG000|Part 1: Dose Escalation|Other|1|||
131951743|NCT02122146|475109554|FG001|Part 1: Dose Escalation|Other|0|||
131951744|NCT02122146|475109555|FG002|Part 1: Dose Escalation|Other|0|||
131951745|NCT02122146|475109556|FG003|Part 1: Dose Escalation|Other|0|||
131951746|NCT02122146|475109557|FG004|Part 1: Dose Escalation|Other|0|||
131951747|NCT02122146|475109558|FG005|Part 1: Dose Escalation|Other|1|||
131951748|NCT02122146|475109559|FG006|Part 1: Dose Escalation|Other|1|||
131951749|NCT02122146|475109560|FG007|Part 1: Dose Escalation|Other|2|||
131951750|NCT03472495|475109561|FG000|Overall Study|Treatment no longer indicated|1|||
131951751|NCT03472495|475109562|FG001|Overall Study|Treatment no longer indicated|2|||
131951752|NCT03472495|475109561|FG000|Overall Study|Physician Decision|0|||
131951753|NCT03472495|475109562|FG001|Overall Study|Physician Decision|2|||
131951754|NCT01107392|475109563|FG000|Overall Study|Adverse Event|2|||
131951755|NCT01107392|475109564|FG001|Overall Study|Adverse Event|0|||
131951756|NCT01107392|475109563|FG000|Overall Study|Personal Reasons|2|||
131951757|NCT01107392|475109564|FG001|Overall Study|Personal Reasons|3|||
131951758|NCT01107392|475109563|FG000|Overall Study|Administrative decision|1|||
131951759|NCT01107392|475109564|FG001|Overall Study|Administrative decision|0|||
131951760|NCT02998671|475109568|FG000|Period 1|Study Terminated By Sponsor|2|||
131951761|NCT02998671|475109569|FG001|Period 1|Study Terminated By Sponsor|1|||
131951762|NCT02998671|475109570|FG002|Period 1|Study Terminated By Sponsor|0|||
131951763|NCT02998671|475109571|FG003|Period 1|Study Terminated By Sponsor|0|||
131951764|NCT02998671|475109572|FG004|Period 1|Study Terminated By Sponsor|1|||
131951765|NCT02998671|475109568|FG000|Period 1|Withdrawal by Subject|1|||
131951766|NCT02998671|475109569|FG001|Period 1|Withdrawal by Subject|2|||
131951767|NCT02998671|475109570|FG002|Period 1|Withdrawal by Subject|0|||
131951768|NCT02998671|475109571|FG003|Period 1|Withdrawal by Subject|0|||
131951769|NCT02998671|475109572|FG004|Period 1|Withdrawal by Subject|2|||
131951770|NCT02998671|475109568|FG000|Period 1|Pregnancy|1|||
131951771|NCT02998671|475109569|FG001|Period 1|Pregnancy|0|||
131951772|NCT02998671|475109570|FG002|Period 1|Pregnancy|0|||
131951773|NCT02998671|475109571|FG003|Period 1|Pregnancy|0|||
131951774|NCT02998671|475109572|FG004|Period 1|Pregnancy|0|||
131951775|NCT02998671|475109568|FG000|Period 1|Adverse Event|0|||
131951776|NCT02998671|475109569|FG001|Period 1|Adverse Event|0|||
131951777|NCT02998671|475109570|FG002|Period 1|Adverse Event|0|||
131951778|NCT02998671|475109571|FG003|Period 1|Adverse Event|0|||
131951779|NCT02998671|475109572|FG004|Period 1|Adverse Event|1|||
131951780|NCT02998671|475109568|FG000|Period 2|Adverse Event|0|||
131951781|NCT02998671|475109569|FG001|Period 2|Adverse Event|1|||
131951782|NCT02998671|475109570|FG002|Period 2|Adverse Event|0|||
131951783|NCT02998671|475109571|FG003|Period 2|Adverse Event|0|||
131951784|NCT02998671|475109572|FG004|Period 2|Adverse Event|0|||
131951785|NCT02998671|475109568|FG000|Period 2|Study Terminated By Sponsor|3|||
131951786|NCT02998671|475109569|FG001|Period 2|Study Terminated By Sponsor|5|||
131951787|NCT02998671|475109570|FG002|Period 2|Study Terminated By Sponsor|1|||
131951788|NCT02998671|475109571|FG003|Period 2|Study Terminated By Sponsor|3|||
131951789|NCT02998671|475109572|FG004|Period 2|Study Terminated By Sponsor|0|||
131951790|NCT02998671|475109568|FG000|Period 2|Withdrawal by Subject|0|||
131951791|NCT02998671|475109569|FG001|Period 2|Withdrawal by Subject|1|||
131951792|NCT02998671|475109570|FG002|Period 2|Withdrawal by Subject|0|||
131951793|NCT02998671|475109571|FG003|Period 2|Withdrawal by Subject|0|||
131951794|NCT02998671|475109572|FG004|Period 2|Withdrawal by Subject|0|||
131951795|NCT02998671|475109568|FG000|Period 2|Lost to Follow-up|0|||
131951796|NCT02998671|475109569|FG001|Period 2|Lost to Follow-up|0|||
131951797|NCT02998671|475109570|FG002|Period 2|Lost to Follow-up|0|||
131951798|NCT02998671|475109571|FG003|Period 2|Lost to Follow-up|1|||
131951799|NCT02998671|475109572|FG004|Period 2|Lost to Follow-up|0|||
131415141|NCT02117349|473143919|FG000|Overall Study|Death|1|||
131415142|NCT02117349|473143920|FG001|Overall Study|Death|0|||
131415143|NCT02265796|473143921|FG000|Overall Study|Death|1|||
131415144|NCT02265796|473143922|FG001|Overall Study|Death|0|||
131415145|NCT02265796|473143921|FG000|Overall Study|started on excluded medication|1|||
131415146|NCT02265796|473143922|FG001|Overall Study|started on excluded medication|0|||
131415147|NCT02265796|473143921|FG000|Overall Study|Withdrawal by Subject|1|||
131415148|NCT02265796|473143922|FG001|Overall Study|Withdrawal by Subject|1|||
131951800|NCT02038946|475109574|FG000|Overall Study|Death|5|||
131951801|NCT02038946|475109574|FG000|Overall Study|Withdrawal by Subject|3|||
131415149|NCT00483002|473143923|FG000|Overall Study|Adverse Event|68|||
131415150|NCT00483002|473143923|FG000|Overall Study|Lack of Efficacy|555|||
131951802|NCT02038946|475109574|FG000|Overall Study|Lost to Follow-up|2|||
131951803|NCT02038946|475109574|FG000|Overall Study|Other reasons|2|||
131951804|NCT01916824|475109579|FG000|Overall Study|Lost to Follow-up|3|||
131951805|NCT01916824|475109580|FG001|Overall Study|Lost to Follow-up|6|||
131951806|NCT01916824|475109579|FG000|Overall Study|Physician Decision|2|||
131951807|NCT01916824|475109580|FG001|Overall Study|Physician Decision|0|||
131951808|NCT01916824|475109579|FG000|Overall Study|Withdrawal by Subject|2|||
131951809|NCT01916824|475109580|FG001|Overall Study|Withdrawal by Subject|3|||
131951810|NCT00771927|475109581|FG000|Overall Study|Adverse Event|100|||
131951811|NCT00771927|475109582|FG001|Overall Study|Adverse Event|105|||
131951812|NCT00771927|475109581|FG000|Overall Study|Lack of Efficacy|70|||
131951813|NCT00771927|475109582|FG001|Overall Study|Lack of Efficacy|42|||
131951814|NCT00771927|475109581|FG000|Overall Study|Lost to Follow-up|46|||
131951815|NCT00771927|475109582|FG001|Overall Study|Lost to Follow-up|46|||
131951816|NCT00771927|475109581|FG000|Overall Study|Withdrawal by Subject|16|||
131951817|NCT00771927|475109582|FG001|Overall Study|Withdrawal by Subject|17|||
131951818|NCT00771927|475109581|FG000|Overall Study|Other reason|23|||
131951819|NCT00771927|475109582|FG001|Overall Study|Other reason|27|||
131951820|NCT03711370|475109584|FG000|Overall Study|Lost to Follow-up|16|||
131951821|NCT03711370|475109585|FG001|Overall Study|Lost to Follow-up|10|||
131951822|NCT03711370|475109584|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
131951823|NCT03711370|475109585|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
131951824|NCT02063984|475109586|FG000|Overall Study|Lost to Follow-up|6|||
131951825|NCT02063984|475109587|FG001|Overall Study|Lost to Follow-up|5|||
131951826|NCT02455336|475109590|FG000|Overall Study|Withdrawal by Subject|0|||
131951827|NCT02455336|475109591|FG001|Overall Study|Withdrawal by Subject|2|||
131951828|NCT02455336|475109590|FG000|Overall Study|Adverse Event|3|||
131951829|NCT02455336|475109591|FG001|Overall Study|Adverse Event|0|||
131951830|NCT02455336|475109590|FG000|Overall Study|Non-responder to treatment|2|||
131951831|NCT02455336|475109591|FG001|Overall Study|Non-responder to treatment|0|||
131951832|NCT03599518|475109592|FG000|Overall Study|Clinical progression|0|||
131951833|NCT03599518|475109593|FG001|Overall Study|Clinical progression|0|||
131951834|NCT03599518|475109594|FG002|Overall Study|Clinical progression|0|||
131951835|NCT03599518|475109595|FG003|Overall Study|Clinical progression|0|||
131951836|NCT03599518|475109596|FG004|Overall Study|Clinical progression|1|||
131951837|NCT03599518|475109592|FG000|Overall Study|Adverse Event|0|||
131951838|NCT03599518|475109593|FG001|Overall Study|Adverse Event|0|||
131951839|NCT03599518|475109594|FG002|Overall Study|Adverse Event|0|||
131951840|NCT03599518|475109595|FG003|Overall Study|Adverse Event|0|||
131951841|NCT03599518|475109596|FG004|Overall Study|Adverse Event|1|||
131951842|NCT03599518|475109592|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
131951843|NCT03599518|475109593|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
131951844|NCT03599518|475109594|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
131951845|NCT03599518|475109595|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
131951846|NCT03599518|475109596|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
131951847|NCT03599518|475109592|FG000|Overall Study|Participant withdrawal from study treatment|0|||
131951848|NCT03599518|475109593|FG001|Overall Study|Participant withdrawal from study treatment|0|||
131951849|NCT03599518|475109594|FG002|Overall Study|Participant withdrawal from study treatment|1|||
131951850|NCT03599518|475109595|FG003|Overall Study|Participant withdrawal from study treatment|0|||
131951851|NCT03599518|475109596|FG004|Overall Study|Participant withdrawal from study treatment|0|||
131951852|NCT00005947|475109601|FG000|Overall Study|Death|54|||
131951853|NCT00005947|475109602|FG001|Overall Study|Death|40|||
131951854|NCT00005947|475109601|FG000|Overall Study|Patient Refused to Continue|2|||
131951855|NCT00005947|475109602|FG001|Overall Study|Patient Refused to Continue|1|||
131951856|NCT00005947|475109601|FG000|Overall Study|Site Closure|1|||
131951857|NCT00005947|475109602|FG001|Overall Study|Site Closure|0|||
131951858|NCT00429182|475109603|FG000|Overall Study|Not evaluable, Disease Progression|2|||
131951859|NCT00429182|475109603|FG000|Overall Study|Not eligible|5|||
131951860|NCT02195700|475109604|FG000|Overall Study|Protocol Violation|0|||
131951861|NCT02195700|475109605|FG001|Overall Study|Protocol Violation|2|||
131951862|NCT02195700|475109604|FG000|Overall Study|Noncompliance|1|||
131951863|NCT02195700|475109605|FG001|Overall Study|Noncompliance|0|||
131951864|NCT02195700|475109604|FG000|Overall Study|Adverse Event|1|||
131951865|NCT02195700|475109605|FG001|Overall Study|Adverse Event|2|||
131951866|NCT02195700|475109604|FG000|Overall Study|Withdrawal by Subject|3|||
131951867|NCT02195700|475109605|FG001|Overall Study|Withdrawal by Subject|2|||
131951868|NCT02195700|475109604|FG000|Overall Study|Lost to Follow-up|1|||
131951869|NCT02195700|475109605|FG001|Overall Study|Lost to Follow-up|1|||
131951870|NCT01597908|475109606|FG000|Randomized Phase|Death|217|||
131951871|NCT01597908|475109607|FG001|Randomized Phase|Death|238|||
131951872|NCT01597908|475109608|FG002|Randomized Phase|Death|0|||
131951873|NCT01597908|475109606|FG000|Randomized Phase|Sponsor Decision|93|||
131951874|NCT01597908|475109607|FG001|Randomized Phase|Sponsor Decision|39|||
131951875|NCT01597908|475109608|FG002|Randomized Phase|Sponsor Decision|0|||
131951876|NCT01597908|475109606|FG000|Randomized Phase|Lost to Follow-up|9|||
131951877|NCT01597908|475109607|FG001|Randomized Phase|Lost to Follow-up|16|||
131456940|NCT02167139|473303041|FG001|Transition-extension|Lack of Efficacy|0|||
131456941|NCT02167139|473303042|FG002|Transition-extension|Lack of Efficacy|1|||
131951878|NCT01597908|475109608|FG002|Randomized Phase|Lost to Follow-up|0|||
131951879|NCT01597908|475109606|FG000|Randomized Phase|Physician Decision|6|||
131951880|NCT01597908|475109607|FG001|Randomized Phase|Physician Decision|3|||
131951881|NCT01597908|475109608|FG002|Randomized Phase|Physician Decision|0|||
131951882|NCT01597908|475109606|FG000|Randomized Phase|Withdrawal by Subject|26|||
131951883|NCT01597908|475109607|FG001|Randomized Phase|Withdrawal by Subject|22|||
131951884|NCT01597908|475109608|FG002|Randomized Phase|Withdrawal by Subject|0|||
131456942|NCT02167139|473303043|FG003|Transition-extension|Lack of Efficacy|1|||
131951885|NCT01597908|475109606|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
131951886|NCT01597908|475109607|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
131951887|NCT01597908|475109608|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
131951888|NCT01597908|475109606|FG000|Crossover Phase|Death|0|||
131951889|NCT01597908|475109607|FG001|Crossover Phase|Death|0|||
131951890|NCT01597908|475109608|FG002|Crossover Phase|Death|11|||
131951891|NCT01597908|475109606|FG000|Crossover Phase|Withdrawal by Subject|0|||
131951892|NCT01597908|475109607|FG001|Crossover Phase|Withdrawal by Subject|0|||
131951893|NCT01597908|475109608|FG002|Crossover Phase|Withdrawal by Subject|3|||
131951894|NCT01597908|475109606|FG000|Crossover Phase|Sponsor Decision|0|||
131951895|NCT01597908|475109607|FG001|Crossover Phase|Sponsor Decision|0|||
131951896|NCT01597908|475109608|FG002|Crossover Phase|Sponsor Decision|20|||
131951897|NCT02709577|475109609|FG000|Overall Study|non-accommodating anatomy|0|||
131951898|NCT02709577|475109610|FG001|Overall Study|non-accommodating anatomy|1|||
131951899|NCT02709577|475109611|FG002|Overall Study|non-accommodating anatomy|0|||
131951900|NCT02709577|475109612|FG003|Overall Study|non-accommodating anatomy|0|||
131951901|NCT02709577|475109609|FG000|Overall Study|procedural complication|0|||
131951902|NCT02709577|475109610|FG001|Overall Study|procedural complication|1|||
131951903|NCT02709577|475109611|FG002|Overall Study|procedural complication|0|||
131951904|NCT02709577|475109612|FG003|Overall Study|procedural complication|0|||
131951905|NCT02709577|475109609|FG000|Overall Study|Withdrawal by Subject|2|||
131951906|NCT02709577|475109610|FG001|Overall Study|Withdrawal by Subject|3|||
131951907|NCT02709577|475109611|FG002|Overall Study|Withdrawal by Subject|2|||
131951908|NCT02709577|475109612|FG003|Overall Study|Withdrawal by Subject|0|||
131951909|NCT01042158|475109613|FG000|Overall Study|Physician Decision|1|||
131951910|NCT02220855|475111417|FG000|Overall Study|Adverse Event|8|||
131951911|NCT02220855|475111417|FG000|Overall Study|Disease Progression|5|||
131951912|NCT02220855|475111417|FG000|Overall Study|Withdrawal by Subject|1|||
131951913|NCT02403817|475111426|FG000|Overall Study|Withdrawal by Subject|5|||
131951914|NCT02403817|475111427|FG001|Overall Study|Withdrawal by Subject|0|||
131951915|NCT03050450|475111428|FG000|Overall Study|Physician Decision|1|||
131951916|NCT03050450|475111429|FG001|Overall Study|Physician Decision|0|||
131951917|NCT03050450|475111430|FG002|Overall Study|Physician Decision|0|||
131951918|NCT03050450|475111431|FG003|Overall Study|Physician Decision|0|||
131951919|NCT03050450|475111432|FG004|Overall Study|Physician Decision|0|||
131951920|NCT01642901|475111433|FG000|12-month Follow-up|Withdrawal by Subject|1|||
131951921|NCT01642901|475111434|FG001|12-month Follow-up|Withdrawal by Subject|0|||
131951922|NCT00485758|475111440|FG000|Overall Study|Adverse Event|102|||
131951923|NCT00485758|475111441|FG001|Overall Study|Adverse Event|31|||
131951924|NCT00485758|475111440|FG000|Overall Study|Death|0|||
131951925|NCT00485758|475111441|FG001|Overall Study|Death|1|||
131951926|NCT00485758|475111440|FG000|Overall Study|Lost to Follow-up|5|||
131951927|NCT00485758|475111441|FG001|Overall Study|Lost to Follow-up|1|||
131951928|NCT00485758|475111440|FG000|Overall Study|Physician Decision|3|||
131951929|NCT00485758|475111441|FG001|Overall Study|Physician Decision|3|||
131951930|NCT00485758|475111440|FG000|Overall Study|Protocol Violation|11|||
131951931|NCT00485758|475111441|FG001|Overall Study|Protocol Violation|2|||
131951932|NCT00485758|475111440|FG000|Overall Study|Withdrawal by Subject|32|||
131951933|NCT00485758|475111441|FG001|Overall Study|Withdrawal by Subject|27|||
131951934|NCT00485758|475111440|FG000|Overall Study|Study Terminated by Sponsor|3|||
131951935|NCT00485758|475111441|FG001|Overall Study|Study Terminated by Sponsor|0|||
131415151|NCT00483002|473143923|FG000|Overall Study|Lost to Follow-up|962|||
131415152|NCT00483002|473143923|FG000|Overall Study|Other|2|||
131415153|NCT00483002|473143923|FG000|Overall Study|Other|967|||
131951936|NCT04551963|475111442|FG000|Overall Study|Physician Decision|1|||
131951937|NCT04551963|475111443|FG001|Overall Study|Physician Decision|1|||
131951938|NCT04551963|475111442|FG000|Overall Study|Death|1|||
131951939|NCT04551963|475111443|FG001|Overall Study|Death|0|||
131951940|NCT03379259|475111444|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
131951941|NCT03379259|475111445|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
131951942|NCT03379259|475111446|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
131951943|NCT03379259|475111447|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
131951944|NCT03379259|475111448|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
131951945|NCT03379259|475111449|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
131951946|NCT03379259|475111444|FG000|Overall Study|Death|0|||
131951947|NCT03379259|475111445|FG001|Overall Study|Death|1|||
131951948|NCT03379259|475111446|FG002|Overall Study|Death|2|||
131951949|NCT03379259|475111447|FG003|Overall Study|Death|1|||
131951950|NCT03379259|475111448|FG004|Overall Study|Death|4|||
131951951|NCT03379259|475111449|FG005|Overall Study|Death|2|||
131951952|NCT03379259|475111444|FG000|Overall Study|Withdrawal by Subject|0|||
131951953|NCT03379259|475111445|FG001|Overall Study|Withdrawal by Subject|0|||
131951954|NCT03379259|475111446|FG002|Overall Study|Withdrawal by Subject|1|||
131951955|NCT03379259|475111447|FG003|Overall Study|Withdrawal by Subject|0|||
131951956|NCT03379259|475111448|FG004|Overall Study|Withdrawal by Subject|2|||
131951957|NCT03379259|475111449|FG005|Overall Study|Withdrawal by Subject|0|||
131951958|NCT03379259|475111444|FG000|Overall Study|Study terminated by sponsor|0|||
131456943|NCT02167139|473303040|FG000|Transition-extension|Other|1|||
131951959|NCT03379259|475111445|FG001|Overall Study|Study terminated by sponsor|0|||
131951960|NCT03379259|475111446|FG002|Overall Study|Study terminated by sponsor|0|||
131951961|NCT03379259|475111447|FG003|Overall Study|Study terminated by sponsor|1|||
131951962|NCT03379259|475111448|FG004|Overall Study|Study terminated by sponsor|1|||
131951963|NCT03379259|475111449|FG005|Overall Study|Study terminated by sponsor|4|||
131951964|NCT03379259|475111444|FG000|Overall Study|Disease progression|0|||
131951965|NCT03379259|475111445|FG001|Overall Study|Disease progression|0|||
131951966|NCT03379259|475111446|FG002|Overall Study|Disease progression|0|||
131951967|NCT03379259|475111447|FG003|Overall Study|Disease progression|1|||
131951968|NCT03379259|475111448|FG004|Overall Study|Disease progression|0|||
131951969|NCT03379259|475111449|FG005|Overall Study|Disease progression|1|||
131951970|NCT03379259|475111444|FG000|Overall Study|Lost to Follow-up|0|||
131951971|NCT03379259|475111445|FG001|Overall Study|Lost to Follow-up|0|||
131951972|NCT03379259|475111446|FG002|Overall Study|Lost to Follow-up|0|||
131951973|NCT03379259|475111447|FG003|Overall Study|Lost to Follow-up|0|||
131951974|NCT03379259|475111448|FG004|Overall Study|Lost to Follow-up|1|||
131951975|NCT03379259|475111449|FG005|Overall Study|Lost to Follow-up|0|||
131951976|NCT03379259|475111444|FG000|Overall Study|Deteriorating condition|0|||
131951977|NCT03379259|475111445|FG001|Overall Study|Deteriorating condition|0|||
131951978|NCT03379259|475111446|FG002|Overall Study|Deteriorating condition|0|||
131951979|NCT03379259|475111447|FG003|Overall Study|Deteriorating condition|0|||
131951980|NCT03379259|475111448|FG004|Overall Study|Deteriorating condition|1|||
131951981|NCT03379259|475111449|FG005|Overall Study|Deteriorating condition|0|||
131951982|NCT00700622|475111450|FG000|Overall Study|Adverse Event|4|||
131951983|NCT00700622|475111451|FG001|Overall Study|Adverse Event|0|||
131951984|NCT00700622|475111450|FG000|Overall Study|Lost to Follow-up|0|||
131951985|NCT00700622|475111451|FG001|Overall Study|Lost to Follow-up|1|||
131951986|NCT00700622|475111450|FG000|Overall Study|Physician Decision|2|||
131951987|NCT00700622|475111451|FG001|Overall Study|Physician Decision|1|||
131951988|NCT00700622|475111450|FG000|Overall Study|Protocol Violation|0|||
131951989|NCT00700622|475111451|FG001|Overall Study|Protocol Violation|1|||
131951990|NCT00700622|475111450|FG000|Overall Study|Withdrawal by Subject|4|||
131951991|NCT00700622|475111451|FG001|Overall Study|Withdrawal by Subject|1|||
131951992|NCT00700622|475111450|FG000|Overall Study|Other|3|||
131951993|NCT00700622|475111451|FG001|Overall Study|Other|1|||
131951994|NCT03850093|475111458|FG000|Overall Study|Withdrawal by Subject|1|||
131951995|NCT03850093|475111459|FG001|Overall Study|Withdrawal by Subject|0|||
131951996|NCT03850093|475111460|FG002|Overall Study|Withdrawal by Subject|2|||
131951997|NCT03226249|475111468|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
131951998|NCT03226249|475111468|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
131951999|NCT03226249|475111468|FG000|Survival Follow-up|Patients still in follow-up.|30|||
131952000|NCT01532921|475111469|FG000|Overall Study|Death|3|||
131952001|NCT01532921|475111469|FG000|Overall Study|Withdrawal by Subject|2|||
131952002|NCT01532921|475111469|FG000|Overall Study|Lost to Follow-up|3|||
131952003|NCT01532921|475111469|FG000|Overall Study|Physician Decision|7|||
131952004|NCT01532921|475111469|FG000|Overall Study|Device was explanted during procedure|1|||
131952005|NCT00070109|475111470|FG000|Overall Study|Death|1|||
131952006|NCT00070109|475111471|FG001|Overall Study|Death|1|||
131952007|NCT00070109|475111472|FG002|Overall Study|Death|0|||
131952008|NCT00070109|475111473|FG003|Overall Study|Death|0|||
131952009|NCT00070109|475111474|FG004|Overall Study|Death|1|||
131952010|NCT00070109|475111470|FG000|Overall Study|Lack of Efficacy|6|||
131952011|NCT00070109|475111471|FG001|Overall Study|Lack of Efficacy|4|||
131952012|NCT00070109|475111472|FG002|Overall Study|Lack of Efficacy|5|||
131952013|NCT00070109|475111473|FG003|Overall Study|Lack of Efficacy|15|||
131952014|NCT00070109|475111474|FG004|Overall Study|Lack of Efficacy|5|||
131952015|NCT00070109|475111470|FG000|Overall Study|Physician Decision|1|||
131952016|NCT00070109|475111471|FG001|Overall Study|Physician Decision|0|||
131952017|NCT00070109|475111472|FG002|Overall Study|Physician Decision|0|||
131952018|NCT00070109|475111473|FG003|Overall Study|Physician Decision|0|||
131952019|NCT00070109|475111474|FG004|Overall Study|Physician Decision|0|||
131952020|NCT00070109|475111470|FG000|Overall Study|Withdrawal by Subject|0|||
131952021|NCT00070109|475111471|FG001|Overall Study|Withdrawal by Subject|1|||
131952022|NCT00070109|475111472|FG002|Overall Study|Withdrawal by Subject|1|||
131952023|NCT00070109|475111473|FG003|Overall Study|Withdrawal by Subject|0|||
131952024|NCT00070109|475111474|FG004|Overall Study|Withdrawal by Subject|0|||
131952025|NCT00070109|475111470|FG000|Overall Study|Adverse Event|0|||
131952026|NCT00070109|475111471|FG001|Overall Study|Adverse Event|0|||
131952027|NCT00070109|475111472|FG002|Overall Study|Adverse Event|2|||
131952028|NCT00070109|475111473|FG003|Overall Study|Adverse Event|4|||
131952029|NCT00070109|475111474|FG004|Overall Study|Adverse Event|2|||
131952030|NCT00070109|475111470|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
131952031|NCT00070109|475111471|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
131952032|NCT00070109|475111472|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
131952033|NCT00070109|475111473|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
131952034|NCT00070109|475111474|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
131952035|NCT02550288|475111488|FG000|Overall Study|Adverse Event|0|||
131952036|NCT02550288|475111489|FG001|Overall Study|Adverse Event|1|||
131952037|NCT02550288|475111490|FG002|Overall Study|Adverse Event|0|||
131952038|NCT02550288|475111491|FG003|Overall Study|Adverse Event|0|||
131952039|NCT02550288|475111492|FG004|Overall Study|Adverse Event|0|||
131952040|NCT02550288|475111488|FG000|Overall Study|Physician Decision|0|||
131952041|NCT02550288|475111489|FG001|Overall Study|Physician Decision|0|||
131952042|NCT02550288|475111490|FG002|Overall Study|Physician Decision|0|||
131456944|NCT02167139|473303041|FG001|Transition-extension|Other|0|||
131456945|NCT02167139|473303042|FG002|Transition-extension|Other|1|||
131952043|NCT02550288|475111491|FG003|Overall Study|Physician Decision|1|||
131952044|NCT02550288|475111492|FG004|Overall Study|Physician Decision|0|||
131952045|NCT02550288|475111488|FG000|Overall Study|Protocol Violation|2|||
131952046|NCT02550288|475111489|FG001|Overall Study|Protocol Violation|2|||
131952047|NCT02550288|475111490|FG002|Overall Study|Protocol Violation|1|||
131952048|NCT02550288|475111491|FG003|Overall Study|Protocol Violation|0|||
131952049|NCT02550288|475111492|FG004|Overall Study|Protocol Violation|3|||
131952050|NCT02550288|475111488|FG000|Overall Study|Participant moved|0|||
131952051|NCT02550288|475111489|FG001|Overall Study|Participant moved|0|||
131952052|NCT02550288|475111490|FG002|Overall Study|Participant moved|0|||
131952053|NCT02550288|475111491|FG003|Overall Study|Participant moved|1|||
131952054|NCT02550288|475111492|FG004|Overall Study|Participant moved|0|||
131952055|NCT02550288|475111488|FG000|Overall Study|Withdrawal by Subject|0|||
131952056|NCT02550288|475111489|FG001|Overall Study|Withdrawal by Subject|0|||
131952057|NCT02550288|475111490|FG002|Overall Study|Withdrawal by Subject|0|||
131952058|NCT02550288|475111491|FG003|Overall Study|Withdrawal by Subject|1|||
131952059|NCT02550288|475111492|FG004|Overall Study|Withdrawal by Subject|0|||
131952060|NCT02819297|475111493|FG000|Overall Study|Withdrawal by Subject|25|||
131952061|NCT02819297|475111494|FG001|Overall Study|Withdrawal by Subject|13|||
131952062|NCT02819297|475111493|FG000|Overall Study|Lost to Follow-up|12|||
131952063|NCT02819297|475111494|FG001|Overall Study|Lost to Follow-up|14|||
131952064|NCT02819297|475111493|FG000|Overall Study|Adverse Event|12|||
131952065|NCT02819297|475111494|FG001|Overall Study|Adverse Event|10|||
131952066|NCT02819297|475111493|FG000|Overall Study|Physician Decision|5|||
131952067|NCT02819297|475111494|FG001|Overall Study|Physician Decision|5|||
131952068|NCT02819297|475111493|FG000|Overall Study|Lack of Efficacy|5|||
131952069|NCT02819297|475111494|FG001|Overall Study|Lack of Efficacy|8|||
131952070|NCT02819297|475111493|FG000|Overall Study|Protocol Violation|1|||
131952071|NCT02819297|475111494|FG001|Overall Study|Protocol Violation|2|||
131952072|NCT01823198|475111498|FG000|Overall Study|Physician Decision|0|||
131952073|NCT01823198|475111499|FG001|Overall Study|Physician Decision|1|||
131952074|NCT01823198|475111500|FG002|Overall Study|Physician Decision|0|||
131952075|NCT01823198|475111501|FG003|Overall Study|Physician Decision|0|||
131952076|NCT01823198|475111502|FG004|Overall Study|Physician Decision|0|||
131952077|NCT01823198|475111503|FG005|Overall Study|Physician Decision|3|||
131952078|NCT01823198|475111504|FG006|Overall Study|Physician Decision|3|||
131952079|NCT01369199|475111505|FG000|Overall Study|Withdrawal by Subject|1|||
131952080|NCT01369199|475111505|FG000|Overall Study|Lost to Follow-up|2|||
131952081|NCT01071252|475111506|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
131952082|NCT01071252|475111507|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
131952083|NCT01071252|475111508|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
131952084|NCT01071252|475111509|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
131952085|NCT01071252|475111510|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
131952086|NCT01071252|475111506|FG000|Overall Study|Withdrawal by Subject|8|||
131952087|NCT01071252|475111507|FG001|Overall Study|Withdrawal by Subject|2|||
131952088|NCT01071252|475111508|FG002|Overall Study|Withdrawal by Subject|1|||
131952089|NCT01071252|475111509|FG003|Overall Study|Withdrawal by Subject|2|||
131952090|NCT01071252|475111510|FG004|Overall Study|Withdrawal by Subject|3|||
131952091|NCT01071252|475111506|FG000|Overall Study|administrative problems|1|||
131952092|NCT01071252|475111507|FG001|Overall Study|administrative problems|1|||
131952093|NCT01071252|475111508|FG002|Overall Study|administrative problems|0|||
131952094|NCT01071252|475111509|FG003|Overall Study|administrative problems|2|||
131952095|NCT01071252|475111510|FG004|Overall Study|administrative problems|1|||
131952096|NCT01071252|475111506|FG000|Overall Study|Lost to Follow-up|1|||
131952097|NCT01071252|475111507|FG001|Overall Study|Lost to Follow-up|0|||
131952098|NCT01071252|475111508|FG002|Overall Study|Lost to Follow-up|1|||
131952099|NCT01071252|475111509|FG003|Overall Study|Lost to Follow-up|2|||
131952100|NCT01071252|475111510|FG004|Overall Study|Lost to Follow-up|0|||
131952101|NCT01071252|475111506|FG000|Overall Study|Adverse Event|1|||
131952102|NCT01071252|475111507|FG001|Overall Study|Adverse Event|1|||
131952103|NCT01071252|475111508|FG002|Overall Study|Adverse Event|0|||
131952104|NCT01071252|475111509|FG003|Overall Study|Adverse Event|1|||
131952105|NCT01071252|475111510|FG004|Overall Study|Adverse Event|0|||
131952106|NCT01071252|475111506|FG000|Overall Study|Death|0|||
131952107|NCT01071252|475111507|FG001|Overall Study|Death|0|||
131952108|NCT01071252|475111508|FG002|Overall Study|Death|0|||
131456946|NCT02167139|473303043|FG003|Transition-extension|Other|0|||
131952109|NCT01071252|475111509|FG003|Overall Study|Death|0|||
131952110|NCT01071252|475111510|FG004|Overall Study|Death|1|||
131952111|NCT03248167|475111513|FG000|Overall Study|Withdrawal by Subject|2|||
131952112|NCT03248167|475111514|FG001|Overall Study|Withdrawal by Subject|2|||
131952113|NCT03248167|475111513|FG000|Overall Study|Physician Decision|0|||
131952114|NCT03248167|475111514|FG001|Overall Study|Physician Decision|1|||
131952115|NCT03248167|475111513|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
131952116|NCT03248167|475111514|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
131456947|NCT02167139|473303040|FG000|Transition-extension|Lost to Follow-up|1|||
131952117|NCT03248167|475111513|FG000|Overall Study|Lost to Follow-up|1|||
131952118|NCT03248167|475111514|FG001|Overall Study|Lost to Follow-up|0|||
131952119|NCT02473471|475111515|FG000|Overall Study|poor oral hygiene|2|||
131952120|NCT02473471|475111515|FG000|Overall Study|Lost to Follow-up|1|||
131952121|NCT01667133|475111518|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
131952122|NCT01667133|475111519|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
131952123|NCT01667133|475111520|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
131952124|NCT01667133|475111521|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
131952125|NCT01667133|475111522|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
131952126|NCT01667133|475111523|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
131952127|NCT01667133|475111524|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
131952128|NCT01667133|475111525|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
131952129|NCT01667133|475111526|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
131952130|NCT01667133|475111527|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
131952131|NCT01667133|475111528|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
131952132|NCT01667133|475111529|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
131952133|NCT01667133|475111518|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952134|NCT01667133|475111519|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952135|NCT01667133|475111520|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
131952136|NCT01667133|475111521|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952137|NCT01667133|475111522|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952138|NCT01667133|475111523|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952139|NCT01667133|475111524|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952140|NCT01667133|475111525|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952141|NCT01667133|475111526|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952142|NCT01667133|475111527|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952143|NCT01667133|475111528|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952144|NCT01667133|475111529|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
131952145|NCT01667133|475111518|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
131952146|NCT01667133|475111519|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
131952147|NCT01667133|475111520|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
131952148|NCT01667133|475111521|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
131952149|NCT01667133|475111522|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
131952150|NCT01667133|475111523|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
131952151|NCT01667133|475111524|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
131952152|NCT01667133|475111525|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
131952153|NCT01667133|475111526|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
131952154|NCT01667133|475111527|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
131952155|NCT01667133|475111528|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
131952156|NCT01667133|475111529|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
131952157|NCT01667133|475111518|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952158|NCT01667133|475111519|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952159|NCT01667133|475111520|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952160|NCT01667133|475111521|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
131952161|NCT01667133|475111522|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952162|NCT01667133|475111523|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952163|NCT01667133|475111524|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952164|NCT01667133|475111525|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952165|NCT01667133|475111526|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952166|NCT01667133|475111527|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952167|NCT01667133|475111528|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952168|NCT01667133|475111529|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
131952169|NCT01667133|475111518|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
131952170|NCT01667133|475111519|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
131952171|NCT01667133|475111520|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
131952172|NCT01667133|475111521|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
131952173|NCT01667133|475111522|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
131952174|NCT01667133|475111523|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
131952175|NCT01667133|475111524|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
131952176|NCT01667133|475111525|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
131952177|NCT01667133|475111526|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
131952178|NCT01667133|475111527|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
131952179|NCT01667133|475111528|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
131952180|NCT01667133|475111529|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
131952181|NCT01667133|475111518|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952182|NCT01667133|475111519|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952183|NCT01667133|475111520|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952184|NCT01667133|475111521|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952185|NCT01667133|475111522|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952186|NCT01667133|475111523|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952187|NCT01667133|475111524|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952188|NCT01667133|475111525|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952189|NCT01667133|475111526|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952190|NCT01667133|475111527|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
131952191|NCT01667133|475111528|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952192|NCT01667133|475111529|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
131952193|NCT01667133|475111518|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
131952194|NCT01667133|475111519|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
131952195|NCT01667133|475111520|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
131952196|NCT01667133|475111521|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
131952197|NCT01667133|475111522|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
131952198|NCT01667133|475111523|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
131952199|NCT01667133|475111524|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
131952200|NCT01667133|475111525|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
131952201|NCT01667133|475111526|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
131952202|NCT01667133|475111527|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
131952203|NCT01667133|475111528|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
131952204|NCT01667133|475111529|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
131952205|NCT01667133|475111518|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952206|NCT01667133|475111519|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952207|NCT01667133|475111520|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952208|NCT01667133|475111521|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952209|NCT01667133|475111522|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952210|NCT01667133|475111523|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952211|NCT01667133|475111524|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952212|NCT01667133|475111525|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952213|NCT01667133|475111526|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952214|NCT01667133|475111527|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
131952215|NCT01667133|475111528|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952216|NCT01667133|475111529|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
131952217|NCT01667133|475111518|FG000|Phase 2: Dose-expansion|Death|0|||
131952218|NCT01667133|475111519|FG001|Phase 2: Dose-expansion|Death|0|||
131952219|NCT01667133|475111520|FG002|Phase 2: Dose-expansion|Death|0|||
131952220|NCT01667133|475111521|FG003|Phase 2: Dose-expansion|Death|0|||
131952221|NCT01667133|475111522|FG004|Phase 2: Dose-expansion|Death|0|||
131952222|NCT01667133|475111523|FG005|Phase 2: Dose-expansion|Death|0|||
131952223|NCT01667133|475111524|FG006|Phase 2: Dose-expansion|Death|0|||
131952224|NCT01667133|475111525|FG007|Phase 2: Dose-expansion|Death|0|||
131952225|NCT01667133|475111526|FG008|Phase 2: Dose-expansion|Death|0|||
131952226|NCT01667133|475111527|FG009|Phase 2: Dose-expansion|Death|1|||
131952227|NCT01667133|475111528|FG010|Phase 2: Dose-expansion|Death|0|||
131952228|NCT01667133|475111529|FG011|Phase 2: Dose-expansion|Death|0|||
131952229|NCT01667133|475111518|FG000|Phase 2: Dose-expansion|Other|0|||
131952230|NCT01667133|475111519|FG001|Phase 2: Dose-expansion|Other|0|||
131952231|NCT01667133|475111520|FG002|Phase 2: Dose-expansion|Other|0|||
131952232|NCT01667133|475111521|FG003|Phase 2: Dose-expansion|Other|0|||
131952233|NCT01667133|475111522|FG004|Phase 2: Dose-expansion|Other|0|||
131952234|NCT01667133|475111523|FG005|Phase 2: Dose-expansion|Other|0|||
131952235|NCT01667133|475111524|FG006|Phase 2: Dose-expansion|Other|0|||
131952236|NCT01667133|475111525|FG007|Phase 2: Dose-expansion|Other|0|||
131952237|NCT01667133|475111526|FG008|Phase 2: Dose-expansion|Other|0|||
131952238|NCT01667133|475111527|FG009|Phase 2: Dose-expansion|Other|0|||
131952239|NCT01667133|475111528|FG010|Phase 2: Dose-expansion|Other|0|||
131952240|NCT01667133|475111529|FG011|Phase 2: Dose-expansion|Other|1|||
131952241|NCT00255723|475111533|FG000|Overall Study|Adverse Event|1|||
131952242|NCT00255723|475111534|FG001|Overall Study|Adverse Event|1|||
131952243|NCT00255723|475111533|FG000|Overall Study|Death|0|||
131952244|NCT00255723|475111534|FG001|Overall Study|Death|1|||
131952245|NCT00255723|475111533|FG000|Overall Study|Response Data Not Available|1|||
131952246|NCT00255723|475111534|FG001|Overall Study|Response Data Not Available|0|||
131952247|NCT00191945|475111535|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
131952248|NCT00191945|475111536|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
131952249|NCT00191945|475111535|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
131952250|NCT00191945|475111536|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
131952251|NCT00191945|475111535|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
131952252|NCT00191945|475111536|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
131952253|NCT00191945|475111535|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
131952254|NCT00191945|475111536|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
131952255|NCT02725476|475111537|FG000|Overall Study|Physician Decision|2|||
131952256|NCT02725476|475111538|FG001|Overall Study|Physician Decision|0|||
131952257|NCT02725476|475111537|FG000|Overall Study|Adverse Event|1|||
131952258|NCT02725476|475111538|FG001|Overall Study|Adverse Event|1|||
131952259|NCT00289289|475111545|FG000|Overall Study|Withdrawal by Subject|5|||
131952260|NCT00289289|475111546|FG001|Overall Study|Withdrawal by Subject|3|||
131952261|NCT00289289|475111547|FG002|Overall Study|Withdrawal by Subject|15|||
131952262|NCT00289289|475111545|FG000|Overall Study|Lost to Follow-up|1|||
131952263|NCT00289289|475111546|FG001|Overall Study|Lost to Follow-up|0|||
131952264|NCT00289289|475111547|FG002|Overall Study|Lost to Follow-up|1|||
131952265|NCT00289289|475111545|FG000|Overall Study|Death|4|||
131952266|NCT00289289|475111546|FG001|Overall Study|Death|2|||
131456948|NCT02167139|473303041|FG001|Transition-extension|Lost to Follow-up|0|||
131456949|NCT02167139|473303042|FG002|Transition-extension|Lost to Follow-up|0|||
131456950|NCT02167139|473303043|FG003|Transition-extension|Lost to Follow-up|0|||
131456951|NCT00312195|473303044|FG000|Overall Study|Adverse Event|4|||
131456952|NCT00312195|473303045|FG001|Overall Study|Adverse Event|6|||
131456953|NCT00312195|473303044|FG000|Overall Study|Lost to Follow-up|1|||
131456954|NCT00312195|473303045|FG001|Overall Study|Lost to Follow-up|0|||
131456955|NCT00312195|473303044|FG000|Overall Study|Protocol Violation|1|||
131456956|NCT00312195|473303045|FG001|Overall Study|Protocol Violation|0|||
131456957|NCT02511106|473303046|FG000|Overall Study|Lost to Follow-up|6|||
131456958|NCT02511106|473303047|FG001|Overall Study|Lost to Follow-up|4|||
131456959|NCT02511106|473303046|FG000|Overall Study|Withdrawal by Subject|24|||
131456960|NCT02511106|473303047|FG001|Overall Study|Withdrawal by Subject|21|||
131456961|NCT02511106|473303046|FG000|Overall Study|Death|42|||
131456962|NCT02511106|473303047|FG001|Overall Study|Death|82|||
131456963|NCT02511106|473303046|FG000|Overall Study|Ongoing study at data cut-off|3|||
131456964|NCT02511106|473303047|FG001|Overall Study|Ongoing study at data cut-off|2|||
131456965|NCT02511106|473303046|FG000|Overall Study|Without specified reason|3|||
131456966|NCT02511106|473303047|FG001|Overall Study|Without specified reason|0|||
131456967|NCT02657408|473303049|FG000|Overall Study|Adverse Event|3|||
131456968|NCT02657408|473303050|FG001|Overall Study|Adverse Event|7|||
131456969|NCT00324961|473303051|FG000|Overall Study|Adverse Event|5|||
131456970|NCT00324961|473303051|FG000|Overall Study|Consent Withdrawn|11|||
131456971|NCT00324961|473303051|FG000|Overall Study|Lost to Follow-up|22|||
131456972|NCT00324961|473303051|FG000|Overall Study|Protocol Violation|3|||
131456973|NCT00324961|473303051|FG000|Overall Study|Other|2|||
131456974|NCT00344487|473303052|FG000|Overall Study|immunologic failure|1|||
131456975|NCT01324401|473303054|FG000|Overall Study|Withdrawn before any treatment|0|||
131456976|NCT01324401|473303055|FG001|Overall Study|Withdrawn before any treatment|3|||
131456977|NCT01324401|473303054|FG000|Overall Study|Adverse Event|1|||
131456978|NCT01324401|473303055|FG001|Overall Study|Adverse Event|3|||
131456979|NCT01708902|473303057|FG000|Overall Study|Adverse Event|3|||
131456980|NCT01708902|473303058|FG001|Overall Study|Adverse Event|4|||
131456981|NCT01708902|473303059|FG002|Overall Study|Adverse Event|9|||
131456982|NCT01708902|473303060|FG003|Overall Study|Adverse Event|2|||
131456983|NCT01708902|473303061|FG004|Overall Study|Adverse Event|7|||
131456984|NCT01708902|473303062|FG005|Overall Study|Adverse Event|3|||
131456985|NCT01708902|473303063|FG006|Overall Study|Adverse Event|5|||
131456986|NCT01708902|473303057|FG000|Overall Study|Lack of Efficacy|3|||
131456987|NCT01708902|473303058|FG001|Overall Study|Lack of Efficacy|1|||
131456988|NCT01708902|473303059|FG002|Overall Study|Lack of Efficacy|0|||
131456989|NCT01708902|473303060|FG003|Overall Study|Lack of Efficacy|0|||
131456990|NCT01708902|473303061|FG004|Overall Study|Lack of Efficacy|0|||
131456991|NCT01708902|473303062|FG005|Overall Study|Lack of Efficacy|1|||
131456992|NCT01708902|473303063|FG006|Overall Study|Lack of Efficacy|0|||
131456993|NCT01708902|473303057|FG000|Overall Study|Non compliance with protocol|0|||
131456994|NCT01708902|473303058|FG001|Overall Study|Non compliance with protocol|2|||
131456995|NCT01708902|473303059|FG002|Overall Study|Non compliance with protocol|1|||
131456996|NCT01708902|473303060|FG003|Overall Study|Non compliance with protocol|3|||
131456997|NCT01708902|473303061|FG004|Overall Study|Non compliance with protocol|0|||
131456998|NCT01708902|473303062|FG005|Overall Study|Non compliance with protocol|0|||
131456999|NCT01708902|473303063|FG006|Overall Study|Non compliance with protocol|0|||
131457000|NCT01708902|473303057|FG000|Overall Study|Lost to Follow-up|2|||
131457001|NCT01708902|473303058|FG001|Overall Study|Lost to Follow-up|1|||
131457002|NCT01708902|473303059|FG002|Overall Study|Lost to Follow-up|2|||
131457003|NCT01708902|473303060|FG003|Overall Study|Lost to Follow-up|2|||
131457004|NCT01708902|473303061|FG004|Overall Study|Lost to Follow-up|0|||
131457005|NCT01708902|473303062|FG005|Overall Study|Lost to Follow-up|0|||
131457006|NCT01708902|473303063|FG006|Overall Study|Lost to Follow-up|1|||
131457007|NCT01708902|473303057|FG000|Overall Study|Refused to continue trial medication|8|||
131457008|NCT01708902|473303058|FG001|Overall Study|Refused to continue trial medication|0|||
131457009|NCT01708902|473303059|FG002|Overall Study|Refused to continue trial medication|4|||
131457010|NCT01708902|473303060|FG003|Overall Study|Refused to continue trial medication|2|||
131457011|NCT01708902|473303061|FG004|Overall Study|Refused to continue trial medication|8|||
131457012|NCT01708902|473303062|FG005|Overall Study|Refused to continue trial medication|1|||
131457013|NCT01708902|473303063|FG006|Overall Study|Refused to continue trial medication|1|||
131457014|NCT01708902|473303057|FG000|Overall Study|Other Reason|1|||
131457015|NCT01708902|473303058|FG001|Overall Study|Other Reason|0|||
131457016|NCT01708902|473303059|FG002|Overall Study|Other Reason|1|||
131457017|NCT01708902|473303060|FG003|Overall Study|Other Reason|1|||
131457018|NCT01708902|473303061|FG004|Overall Study|Other Reason|1|||
131457019|NCT01708902|473303062|FG005|Overall Study|Other Reason|2|||
131457020|NCT01708902|473303063|FG006|Overall Study|Other Reason|0|||
131457021|NCT00530816|473303065|FG000|Overall Study|Progressive Disease|16|||
131457022|NCT00530816|473303066|FG001|Overall Study|Progressive Disease|24|||
131457023|NCT00530816|473303067|FG002|Overall Study|Progressive Disease|24|||
131457024|NCT00530816|473303065|FG000|Overall Study|Adverse Event|6|||
131952267|NCT00289289|475111547|FG002|Overall Study|Death|5|||
131952268|NCT00289289|475111545|FG000|Overall Study|No implant attempted|0|||
131952269|NCT00289289|475111546|FG001|Overall Study|No implant attempted|0|||
131952270|NCT00289289|475111547|FG002|Overall Study|No implant attempted|1|||
131952271|NCT00289289|475111545|FG000|Overall Study|Physician Decision|1|||
131952272|NCT00289289|475111546|FG001|Overall Study|Physician Decision|0|||
131952273|NCT00289289|475111547|FG002|Overall Study|Physician Decision|6|||
131952274|NCT00289289|475111545|FG000|Overall Study|Non-study device implanted|2|||
131952275|NCT00289289|475111546|FG001|Overall Study|Non-study device implanted|1|||
131952276|NCT00289289|475111547|FG002|Overall Study|Non-study device implanted|3|||
131952277|NCT00289289|475111545|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
131952278|NCT00289289|475111546|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
131952279|NCT00289289|475111547|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
131952280|NCT00289289|475111545|FG000|Overall Study|Other Exit Reason|6|||
131952281|NCT00289289|475111546|FG001|Overall Study|Other Exit Reason|4|||
131952282|NCT00289289|475111547|FG002|Overall Study|Other Exit Reason|12|||
131952283|NCT01169701|475111556|FG000|Overall Study|Lost to Follow-up|1|||
131952284|NCT01169701|475111557|FG001|Overall Study|Lost to Follow-up|1|||
131952285|NCT01169701|475111556|FG000|Overall Study|Withdrawal by Subject|1|||
131952286|NCT01169701|475111557|FG001|Overall Study|Withdrawal by Subject|3|||
131952287|NCT01169701|475111556|FG000|Overall Study|Adverse Event|1|||
131952288|NCT01169701|475111557|FG001|Overall Study|Adverse Event|2|||
131952289|NCT01169701|475111556|FG000|Overall Study|Exclusion criteria|2|||
131952290|NCT01169701|475111557|FG001|Overall Study|Exclusion criteria|0|||
131952291|NCT01169701|475111556|FG000|Overall Study|Death|0|||
131952292|NCT01169701|475111557|FG001|Overall Study|Death|1|||
131952293|NCT01169701|475111556|FG000|Overall Study|Administrative problems|0|||
131952294|NCT01169701|475111557|FG001|Overall Study|Administrative problems|1|||
131952295|NCT01169701|475111556|FG000|Overall Study|Serious adverse event|0|||
131952296|NCT01169701|475111557|FG001|Overall Study|Serious adverse event|1|||
131952297|NCT01169701|475111556|FG000|Overall Study|Sponsor decision|0|||
131952298|NCT01169701|475111557|FG001|Overall Study|Sponsor decision|1|||
131952299|NCT00553436|475111558|FG000|Overall Study|Conversion to another procedure|1|||
131952300|NCT04188834|475111559|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
131952301|NCT01030952|475111560|FG000|Overall Study|Protocol Violation|0|||
131952302|NCT01030952|475111561|FG001|Overall Study|Protocol Violation|1|||
131952303|NCT01030952|475111560|FG000|Overall Study|Informed consent withdrawal|1|||
131952304|NCT01030952|475111561|FG001|Overall Study|Informed consent withdrawal|0|||
131952305|NCT01030952|475111560|FG000|Overall Study|Lost to Follow-up|0|||
131952306|NCT01030952|475111561|FG001|Overall Study|Lost to Follow-up|1|||
131952307|NCT01030952|475111560|FG000|Overall Study|Unexplained|1|||
131952308|NCT01030952|475111561|FG001|Overall Study|Unexplained|1|||
131952309|NCT01814046|475111566|FG000|Drug Administration|Death due to complications of RSV|1|||
131952310|NCT01814046|475111567|FG001|Drug Administration|Death due to complications of RSV|0|||
131952311|NCT01814046|475111568|FG002|Drug Administration|Death due to complications of RSV|0|||
131952312|NCT00958347|475111569|FG000|Overall Study|Death|43|||
131952313|NCT00958347|475111569|FG000|Overall Study|Withdrawal by Subject|23|||
131952314|NCT00958347|475111569|FG000|Overall Study|Lost to Follow-up|15|||
131952315|NCT00958347|475111569|FG000|Overall Study|revision/removal|10|||
131952316|NCT00958347|475111569|FG000|Overall Study|study termination|135|||
131952317|NCT01831466|475111574|FG000|Overall Study|Protocol Violation|1|||
131952318|NCT01831466|475111575|FG001|Overall Study|Protocol Violation|1|||
131952319|NCT01831466|475111576|FG002|Overall Study|Protocol Violation|2|||
131952320|NCT01831466|475111577|FG003|Overall Study|Protocol Violation|0|||
131952321|NCT01831466|475111578|FG004|Overall Study|Protocol Violation|0|||
131952322|NCT01831466|475111579|FG005|Overall Study|Protocol Violation|1|||
131952323|NCT01831466|475111580|FG006|Overall Study|Protocol Violation|0|||
131952324|NCT01831466|475111581|FG007|Overall Study|Protocol Violation|0|||
131952325|NCT01831466|475111582|FG008|Overall Study|Protocol Violation|0|||
131952326|NCT01831466|475111583|FG009|Overall Study|Protocol Violation|0|||
131952327|NCT01831466|475111584|FG010|Overall Study|Protocol Violation|0|||
131952328|NCT01831466|475111585|FG011|Overall Study|Protocol Violation|0|||
131952329|NCT01831466|475111574|FG000|Overall Study|Other|2|||
131952330|NCT01831466|475111575|FG001|Overall Study|Other|3|||
131952331|NCT01831466|475111576|FG002|Overall Study|Other|2|||
131952332|NCT01831466|475111577|FG003|Overall Study|Other|2|||
131952333|NCT01831466|475111578|FG004|Overall Study|Other|2|||
131952334|NCT01831466|475111579|FG005|Overall Study|Other|1|||
131952335|NCT01831466|475111580|FG006|Overall Study|Other|0|||
131952336|NCT01831466|475111581|FG007|Overall Study|Other|0|||
131952337|NCT01831466|475111582|FG008|Overall Study|Other|0|||
131952338|NCT01831466|475111583|FG009|Overall Study|Other|0|||
131952339|NCT01831466|475111584|FG010|Overall Study|Other|0|||
131952340|NCT01831466|475111585|FG011|Overall Study|Other|0|||
131952341|NCT01831466|475111574|FG000|Overall Study|Non-compliance with study treatment|2|||
131952342|NCT01831466|475111575|FG001|Overall Study|Non-compliance with study treatment|1|||
131952343|NCT01831466|475111576|FG002|Overall Study|Non-compliance with study treatment|1|||
131952344|NCT01831466|475111577|FG003|Overall Study|Non-compliance with study treatment|0|||
131952345|NCT01831466|475111578|FG004|Overall Study|Non-compliance with study treatment|0|||
131952346|NCT01831466|475111579|FG005|Overall Study|Non-compliance with study treatment|1|||
131952347|NCT01831466|475111580|FG006|Overall Study|Non-compliance with study treatment|0|||
131952348|NCT01831466|475111581|FG007|Overall Study|Non-compliance with study treatment|0|||
131952349|NCT01831466|475111582|FG008|Overall Study|Non-compliance with study treatment|0|||
131952350|NCT01831466|475111583|FG009|Overall Study|Non-compliance with study treatment|0|||
131952351|NCT01831466|475111584|FG010|Overall Study|Non-compliance with study treatment|0|||
131952352|NCT01831466|475111585|FG011|Overall Study|Non-compliance with study treatment|0|||
131952353|NCT01831466|475111574|FG000|Overall Study|Death|0|||
131952354|NCT01831466|475111575|FG001|Overall Study|Death|1|||
131952355|NCT01831466|475111576|FG002|Overall Study|Death|0|||
131952356|NCT01831466|475111577|FG003|Overall Study|Death|0|||
131952357|NCT01831466|475111578|FG004|Overall Study|Death|0|||
131952358|NCT01831466|475111579|FG005|Overall Study|Death|0|||
131952359|NCT01831466|475111580|FG006|Overall Study|Death|0|||
131952360|NCT01831466|475111581|FG007|Overall Study|Death|0|||
131952361|NCT01831466|475111582|FG008|Overall Study|Death|0|||
131952362|NCT01831466|475111583|FG009|Overall Study|Death|0|||
131952363|NCT01831466|475111584|FG010|Overall Study|Death|0|||
131952364|NCT01831466|475111585|FG011|Overall Study|Death|0|||
131952365|NCT01831466|475111574|FG000|Overall Study|Withdrawal by Subject|6|||
131952366|NCT01831466|475111575|FG001|Overall Study|Withdrawal by Subject|3|||
131952367|NCT01831466|475111576|FG002|Overall Study|Withdrawal by Subject|3|||
131952368|NCT01831466|475111577|FG003|Overall Study|Withdrawal by Subject|3|||
131952369|NCT01831466|475111578|FG004|Overall Study|Withdrawal by Subject|3|||
131952370|NCT01831466|475111579|FG005|Overall Study|Withdrawal by Subject|5|||
131952371|NCT01831466|475111580|FG006|Overall Study|Withdrawal by Subject|0|||
131952372|NCT01831466|475111581|FG007|Overall Study|Withdrawal by Subject|0|||
131952373|NCT01831466|475111582|FG008|Overall Study|Withdrawal by Subject|0|||
131952374|NCT01831466|475111583|FG009|Overall Study|Withdrawal by Subject|1|||
131952375|NCT01831466|475111584|FG010|Overall Study|Withdrawal by Subject|0|||
131952376|NCT01831466|475111585|FG011|Overall Study|Withdrawal by Subject|1|||
131952377|NCT01831466|475111574|FG000|Overall Study|Lost to Follow-up|0|||
131952378|NCT01831466|475111575|FG001|Overall Study|Lost to Follow-up|1|||
131952379|NCT01831466|475111576|FG002|Overall Study|Lost to Follow-up|4|||
131952380|NCT01831466|475111577|FG003|Overall Study|Lost to Follow-up|2|||
131415154|NCT00447122|473143925|FG000|Overall Study|worsening medical condition -came off|0|||
131415155|NCT00447122|473143926|FG001|Overall Study|worsening medical condition -came off|1|||
131415156|NCT00447122|473143927|FG002|Overall Study|worsening medical condition -came off|0|||
131415157|NCT00447122|473143928|FG003|Overall Study|worsening medical condition -came off|0|||
131415158|NCT01174173|473143931|FG000|Overall Study|drug-drug interaction|1|||
131415159|NCT02666105|473143932|FG000|Overall Study|Death|1|||
131952381|NCT01831466|475111578|FG004|Overall Study|Lost to Follow-up|0|||
131952382|NCT01831466|475111579|FG005|Overall Study|Lost to Follow-up|3|||
131952383|NCT01831466|475111580|FG006|Overall Study|Lost to Follow-up|0|||
131952384|NCT01831466|475111581|FG007|Overall Study|Lost to Follow-up|0|||
131952385|NCT01831466|475111582|FG008|Overall Study|Lost to Follow-up|0|||
131952386|NCT01831466|475111583|FG009|Overall Study|Lost to Follow-up|1|||
131952387|NCT01831466|475111584|FG010|Overall Study|Lost to Follow-up|0|||
131952388|NCT01831466|475111585|FG011|Overall Study|Lost to Follow-up|1|||
131952389|NCT01831466|475111574|FG000|Overall Study|Lack of Efficacy|5|||
131952390|NCT01831466|475111575|FG001|Overall Study|Lack of Efficacy|8|||
131952391|NCT01831466|475111576|FG002|Overall Study|Lack of Efficacy|7|||
131952392|NCT01831466|475111577|FG003|Overall Study|Lack of Efficacy|6|||
131952393|NCT01831466|475111578|FG004|Overall Study|Lack of Efficacy|9|||
131952394|NCT01831466|475111579|FG005|Overall Study|Lack of Efficacy|8|||
131952395|NCT01831466|475111580|FG006|Overall Study|Lack of Efficacy|1|||
131952396|NCT01831466|475111581|FG007|Overall Study|Lack of Efficacy|1|||
131952397|NCT01831466|475111582|FG008|Overall Study|Lack of Efficacy|2|||
131952398|NCT01831466|475111583|FG009|Overall Study|Lack of Efficacy|2|||
131415160|NCT00720343|473145207|FG000|Overall Study|Lost to Follow-up|1|||
131415161|NCT00720343|473145208|FG001|Overall Study|Lost to Follow-up|0|||
131415162|NCT00720343|473145207|FG000|Overall Study|Protocol Violation|0|||
131952399|NCT01831466|475111584|FG010|Overall Study|Lack of Efficacy|2|||
131952400|NCT01831466|475111585|FG011|Overall Study|Lack of Efficacy|0|||
131952401|NCT01831466|475111574|FG000|Overall Study|Adverse Event|0|||
131952402|NCT01831466|475111575|FG001|Overall Study|Adverse Event|0|||
131952403|NCT01831466|475111576|FG002|Overall Study|Adverse Event|4|||
131952404|NCT01831466|475111577|FG003|Overall Study|Adverse Event|6|||
131952405|NCT01831466|475111578|FG004|Overall Study|Adverse Event|3|||
131952406|NCT01831466|475111579|FG005|Overall Study|Adverse Event|7|||
131952407|NCT01831466|475111580|FG006|Overall Study|Adverse Event|0|||
131952408|NCT01831466|475111581|FG007|Overall Study|Adverse Event|1|||
131952409|NCT01831466|475111582|FG008|Overall Study|Adverse Event|1|||
131952410|NCT01831466|475111583|FG009|Overall Study|Adverse Event|1|||
131952411|NCT01831466|475111584|FG010|Overall Study|Adverse Event|0|||
131952412|NCT01831466|475111585|FG011|Overall Study|Adverse Event|2|||
131952413|NCT03497039|475111586|FG000|Overall Study|Withdrawal by Subject|1|||
131952414|NCT03497039|475111587|FG001|Overall Study|Withdrawal by Subject|0|||
131952415|NCT03497039|475111586|FG000|Overall Study|Protocol Violation|0|||
131457025|NCT00530816|473303066|FG001|Overall Study|Adverse Event|13|||
131457026|NCT00530816|473303067|FG002|Overall Study|Adverse Event|7|||
131952416|NCT03497039|475111587|FG001|Overall Study|Protocol Violation|1|||
131952417|NCT00861692|475111591|FG000|Overall Study|Death|6|||
131952418|NCT03292640|475111592|FG000|Overall Study|Withdrawal by Subject|17|||
131952419|NCT03292640|475111593|FG001|Overall Study|Withdrawal by Subject|16|||
131952420|NCT03292640|475111592|FG000|Overall Study|Adverse Event|20|||
131952421|NCT03292640|475111593|FG001|Overall Study|Adverse Event|2|||
131952422|NCT03292640|475111592|FG000|Overall Study|Lost to Follow-up|24|||
131952423|NCT03292640|475111593|FG001|Overall Study|Lost to Follow-up|24|||
131952424|NCT02218697|475111594|FG000|Overall Study|Adverse Event|0|||
131952425|NCT02218697|475111595|FG001|Overall Study|Adverse Event|2|||
131952426|NCT02218697|475111594|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
131952427|NCT02218697|475111595|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
131952428|NCT02218697|475111594|FG000|Overall Study|Withdrawal by Subject|2|||
131952429|NCT02218697|475111595|FG001|Overall Study|Withdrawal by Subject|3|||
131952430|NCT04380753|475111596|FG000|Overall Study|Participants continuing study|4|||
131952431|NCT04380753|475111596|FG000|Overall Study|Death|2|||
131952432|NCT03306433|475111597|FG000|Overall Study|Lost to Follow-up|3|||
131952433|NCT03306433|475111597|FG000|Overall Study|Patient did not have teeth extracted|1|||
131952434|NCT03306433|475111597|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
131952435|NCT00803595|475111598|FG000|Overall Study|Adverse Event|3|||
131952436|NCT00803595|475111599|FG001|Overall Study|Adverse Event|4|||
131952437|NCT00803595|475111600|FG002|Overall Study|Adverse Event|1|||
131952438|NCT00803595|475111598|FG000|Overall Study|Protocol Violation|7|||
131952439|NCT00803595|475111599|FG001|Overall Study|Protocol Violation|2|||
131952440|NCT00803595|475111600|FG002|Overall Study|Protocol Violation|12|||
131952441|NCT00803595|475111598|FG000|Overall Study|Withdrawal by Subject|5|||
131952442|NCT00803595|475111599|FG001|Overall Study|Withdrawal by Subject|2|||
131952443|NCT00803595|475111600|FG002|Overall Study|Withdrawal by Subject|3|||
131952444|NCT02701764|475111602|FG000|Overall Study|Lost to Follow-up|0|||
131952445|NCT02701764|475111603|FG001|Overall Study|Lost to Follow-up|1|||
131952446|NCT01575808|475111605|FG000|Overall Study|Death|2|||
131952447|NCT01575808|475111606|FG001|Overall Study|Death|0|||
131952448|NCT01575808|475111605|FG000|Overall Study|Withdrawal by Subject|1|||
131952449|NCT01575808|475111606|FG001|Overall Study|Withdrawal by Subject|0|||
131952450|NCT04908384|475113353|FG000|Overall Study|Lost to Follow-up|4|||
131952451|NCT04908384|475113354|FG001|Overall Study|Lost to Follow-up|4|||
131952452|NCT04908384|475113355|FG002|Overall Study|Lost to Follow-up|0|||
131952453|NCT04908384|475113356|FG003|Overall Study|Lost to Follow-up|0|||
131952454|NCT00430989|475113357|FG000|Overall Study|Lost to Follow-up|2|||
131952455|NCT00430989|475113358|FG001|Overall Study|Lost to Follow-up|3|||
131952456|NCT00430989|475113357|FG000|Overall Study|Withdrawal by Subject|15|||
131952457|NCT00430989|475113358|FG001|Overall Study|Withdrawal by Subject|14|||
131952458|NCT00430989|475113357|FG000|Overall Study|Protocol Violation|30|||
131952459|NCT00430989|475113358|FG001|Overall Study|Protocol Violation|37|||
131952460|NCT00430989|475113357|FG000|Overall Study|Not eligible|13|||
131952461|NCT00430989|475113358|FG001|Overall Study|Not eligible|6|||
131952462|NCT01701362|475113360|FG000|Overall Study|Adverse events not related to study drug|1|||
131952463|NCT01701362|475113361|FG001|Overall Study|Adverse events not related to study drug|6|||
131952464|NCT01701362|475113360|FG000|Overall Study|Adverse events related to study drug|12|||
131952465|NCT01701362|475113361|FG001|Overall Study|Adverse events related to study drug|10|||
131952466|NCT01701362|475113360|FG000|Overall Study|Protocol Violation|5|||
131952467|NCT01701362|475113361|FG001|Overall Study|Protocol Violation|3|||
131952468|NCT01701362|475113360|FG000|Overall Study|No longer willing to participate|8|||
131952469|NCT01701362|475113361|FG001|Overall Study|No longer willing to participate|14|||
131952470|NCT01701362|475113360|FG000|Overall Study|Lost to Follow-up|6|||
131952471|NCT01701362|475113361|FG001|Overall Study|Lost to Follow-up|9|||
131952472|NCT01701362|475113360|FG000|Overall Study|Insufficient clinical response|6|||
131952473|NCT01701362|475113361|FG001|Overall Study|Insufficient clinical response|6|||
131952474|NCT01701362|475113360|FG000|Overall Study|Death|0|||
131952475|NCT01701362|475113361|FG001|Overall Study|Death|1|||
131952476|NCT01701362|475113360|FG000|Overall Study|Randomized but not treated|1|||
131952477|NCT01701362|475113361|FG001|Overall Study|Randomized but not treated|2|||
131952478|NCT01701362|475113360|FG000|Overall Study|Reasons other than those mentioned above|3|||
131952479|NCT01701362|475113361|FG001|Overall Study|Reasons other than those mentioned above|5|||
131952480|NCT00570778|475113362|FG000|Overall Study|Protocol deviation|2|||
131952481|NCT00570778|475113363|FG001|Overall Study|Protocol deviation|1|||
131952482|NCT00570778|475113364|FG002|Overall Study|Protocol deviation|2|||
131952483|NCT00570778|475113365|FG003|Overall Study|Protocol deviation|2|||
131952484|NCT00570778|475113362|FG000|Overall Study|Adverse Event|0|||
131952485|NCT00570778|475113363|FG001|Overall Study|Adverse Event|1|||
131952486|NCT00570778|475113364|FG002|Overall Study|Adverse Event|4|||
131952487|NCT00570778|475113365|FG003|Overall Study|Adverse Event|1|||
131952488|NCT00570778|475113362|FG000|Overall Study|Subject withdrew consent|0|||
131952489|NCT00570778|475113363|FG001|Overall Study|Subject withdrew consent|1|||
131952490|NCT00570778|475113364|FG002|Overall Study|Subject withdrew consent|0|||
131457027|NCT00530816|473303065|FG000|Overall Study|Other|3|||
131457028|NCT00530816|473303066|FG001|Overall Study|Other|3|||
131457029|NCT00530816|473303067|FG002|Overall Study|Other|4|||
131457030|NCT00530816|473303065|FG000|Overall Study|Withdrawal by Subject|1|||
131457031|NCT00530816|473303066|FG001|Overall Study|Withdrawal by Subject|2|||
131457032|NCT00530816|473303067|FG002|Overall Study|Withdrawal by Subject|6|||
131457033|NCT02152956|473303068|FG000|Overall Study|Adverse Event|0|||
131457034|NCT02152956|473303069|FG001|Overall Study|Adverse Event|0|||
131457035|NCT02152956|473303070|FG002|Overall Study|Adverse Event|0|||
131457036|NCT02152956|473303071|FG003|Overall Study|Adverse Event|0|||
131457037|NCT02152956|473303072|FG004|Overall Study|Adverse Event|0|||
131457038|NCT02152956|473303073|FG005|Overall Study|Adverse Event|0|||
131457039|NCT02152956|473303074|FG006|Overall Study|Adverse Event|0|||
131457040|NCT02152956|473303075|FG007|Overall Study|Adverse Event|0|||
131457041|NCT02152956|473303076|FG008|Overall Study|Adverse Event|0|||
131457042|NCT02152956|473303077|FG009|Overall Study|Adverse Event|0|||
131457043|NCT02152956|473303078|FG010|Overall Study|Adverse Event|0|||
131457044|NCT02152956|473303079|FG011|Overall Study|Adverse Event|4|||
131457045|NCT02152956|473303080|FG012|Overall Study|Adverse Event|0|||
131457046|NCT02152956|473303068|FG000|Overall Study|Death|0|||
131457047|NCT02152956|473303069|FG001|Overall Study|Death|3|||
131457048|NCT02152956|473303070|FG002|Overall Study|Death|3|||
131457049|NCT02152956|473303071|FG003|Overall Study|Death|4|||
131457050|NCT02152956|473303072|FG004|Overall Study|Death|1|||
131457051|NCT02152956|473303073|FG005|Overall Study|Death|2|||
131457052|NCT02152956|473303074|FG006|Overall Study|Death|6|||
131457053|NCT02152956|473303075|FG007|Overall Study|Death|6|||
131457054|NCT02152956|473303076|FG008|Overall Study|Death|4|||
131457055|NCT02152956|473303077|FG009|Overall Study|Death|5|||
131952491|NCT00570778|475113365|FG003|Overall Study|Subject withdrew consent|1|||
131952492|NCT00570778|475113362|FG000|Overall Study|Abnormal test procedure|1|||
131952493|NCT00570778|475113363|FG001|Overall Study|Abnormal test procedure|0|||
131952494|NCT00570778|475113364|FG002|Overall Study|Abnormal test procedure|0|||
131952495|NCT00570778|475113365|FG003|Overall Study|Abnormal test procedure|0|||
131952496|NCT00570778|475113362|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131952497|NCT00570778|475113363|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131952498|NCT00570778|475113364|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131952499|NCT00570778|475113365|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131952500|NCT00570778|475113362|FG000|Overall Study|Lost to Follow-up|0|||
131952501|NCT00570778|475113363|FG001|Overall Study|Lost to Follow-up|0|||
131952502|NCT00570778|475113364|FG002|Overall Study|Lost to Follow-up|1|||
131952503|NCT00570778|475113365|FG003|Overall Study|Lost to Follow-up|0|||
131952504|NCT00570778|475113362|FG000|Overall Study|Subject no longer requires study drug|0|||
131952505|NCT00570778|475113363|FG001|Overall Study|Subject no longer requires study drug|1|||
131952506|NCT00570778|475113364|FG002|Overall Study|Subject no longer requires study drug|0|||
131952507|NCT00570778|475113365|FG003|Overall Study|Subject no longer requires study drug|0|||
131952508|NCT00443872|475113366|FG000|Overall Study|Protocol Violation|7|||
131952509|NCT00443872|475113366|FG000|Overall Study|Lost to Follow-up|2|||
131952510|NCT00443872|475113366|FG000|Overall Study|Adverse Event|8|||
131952511|NCT00383331|475113369|FG000|Overall Study|Protocol Violation|0|||
131415163|NCT00720343|473145208|FG001|Overall Study|Protocol Violation|2|||
131415164|NCT02008773|473145209|FG000|Overall Study|Adverse Event|3|||
131415165|NCT02008773|473145210|FG001|Overall Study|Adverse Event|3|||
131415166|NCT02008773|473145211|FG002|Overall Study|Adverse Event|1|||
131415167|NCT02008773|473145212|FG003|Overall Study|Adverse Event|2|||
131415168|NCT02008773|473145209|FG000|Overall Study|Medication Non-compliance|2|||
131415169|NCT02008773|473145210|FG001|Overall Study|Medication Non-compliance|1|||
131415170|NCT02008773|473145211|FG002|Overall Study|Medication Non-compliance|3|||
131415171|NCT02008773|473145212|FG003|Overall Study|Medication Non-compliance|2|||
131415172|NCT02008773|473145209|FG000|Overall Study|Withdrawal by Subject|8|||
131415173|NCT02008773|473145210|FG001|Overall Study|Withdrawal by Subject|4|||
131415174|NCT02008773|473145211|FG002|Overall Study|Withdrawal by Subject|7|||
131415175|NCT02008773|473145212|FG003|Overall Study|Withdrawal by Subject|6|||
131415176|NCT02008773|473145209|FG000|Overall Study|Lost to Follow-up|0|||
131415177|NCT02008773|473145210|FG001|Overall Study|Lost to Follow-up|1|||
131952512|NCT00383331|475113370|FG001|Overall Study|Protocol Violation|1|||
131952513|NCT00375427|475113371|FG000|Overall Study|Adverse Event|21|||
131952514|NCT00375427|475113372|FG001|Overall Study|Adverse Event|27|||
131952515|NCT00375427|475113371|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131415178|NCT02008773|473145211|FG002|Overall Study|Lost to Follow-up|3|||
131415179|NCT02008773|473145212|FG003|Overall Study|Lost to Follow-up|2|||
131457056|NCT02152956|473303078|FG010|Overall Study|Death|3|||
131457057|NCT02152956|473303079|FG011|Overall Study|Death|143|||
131457058|NCT02152956|473303080|FG012|Overall Study|Death|12|||
131457059|NCT02152956|473303068|FG000|Overall Study|Lost to Follow-up|0|||
131457060|NCT02152956|473303069|FG001|Overall Study|Lost to Follow-up|1|||
131457061|NCT02152956|473303070|FG002|Overall Study|Lost to Follow-up|0|||
131457062|NCT02152956|473303071|FG003|Overall Study|Lost to Follow-up|0|||
131457063|NCT02152956|473303072|FG004|Overall Study|Lost to Follow-up|0|||
131952516|NCT00375427|475113372|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131952517|NCT00375427|475113371|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131952518|NCT00375427|475113372|FG001|Overall Study|Abnormal laboratory value(s)|2|||
131952519|NCT00375427|475113371|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131952520|NCT00375427|475113372|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131952521|NCT00375427|475113371|FG000|Overall Study|Patient no longer requires study drug|3|||
131952522|NCT00375427|475113372|FG001|Overall Study|Patient no longer requires study drug|7|||
131952523|NCT00375427|475113371|FG000|Overall Study|Protocol Violation|10|||
131952524|NCT00375427|475113372|FG001|Overall Study|Protocol Violation|8|||
131952525|NCT00375427|475113371|FG000|Overall Study|Withdrawal by Subject|9|||
131952526|NCT00375427|475113372|FG001|Overall Study|Withdrawal by Subject|13|||
131952527|NCT00375427|475113371|FG000|Overall Study|Lost to Follow-up|1|||
131952528|NCT00375427|475113372|FG001|Overall Study|Lost to Follow-up|1|||
131952529|NCT00375427|475113371|FG000|Overall Study|Administrative reasons|0|||
131952530|NCT00375427|475113372|FG001|Overall Study|Administrative reasons|1|||
131952531|NCT00375427|475113371|FG000|Overall Study|Death|11|||
131952532|NCT00375427|475113372|FG001|Overall Study|Death|10|||
131952533|NCT02229825|475113373|FG000|Overall Study|Personal Reasons|0|||
131952534|NCT02229825|475113374|FG001|Overall Study|Personal Reasons|1|||
131952535|NCT02229825|475113373|FG000|Overall Study|Refused continuing medication|7|||
131952536|NCT02229825|475113374|FG001|Overall Study|Refused continuing medication|6|||
131952537|NCT02229825|475113373|FG000|Overall Study|Lost to Follow-up|1|||
131952538|NCT02229825|475113374|FG001|Overall Study|Lost to Follow-up|2|||
131952539|NCT02229825|475113373|FG000|Overall Study|Protocol Violation|1|||
131952540|NCT02229825|475113374|FG001|Overall Study|Protocol Violation|1|||
131952541|NCT02229825|475113373|FG000|Overall Study|Lack of Efficacy|4|||
131952542|NCT02229825|475113374|FG001|Overall Study|Lack of Efficacy|10|||
131952543|NCT02229825|475113373|FG000|Overall Study|Adverse Event|11|||
131952544|NCT02229825|475113374|FG001|Overall Study|Adverse Event|9|||
131952545|NCT02229825|475113373|FG000|Overall Study|Not treated|0|||
131952546|NCT02229825|475113374|FG001|Overall Study|Not treated|1|||
131952547|NCT00624468|475113375|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
131952548|NCT00624468|475113376|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
131952549|NCT00624468|475113377|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
131952550|NCT00624468|475113378|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
131952551|NCT00624468|475113375|FG000|Double-blind Period|Withdrew Prematurely|1|||
131952552|NCT00624468|475113376|FG001|Double-blind Period|Withdrew Prematurely|1|||
131952553|NCT00624468|475113377|FG002|Double-blind Period|Withdrew Prematurely|0|||
131952554|NCT00624468|475113378|FG003|Double-blind Period|Withdrew Prematurely|0|||
131952555|NCT00624468|475113375|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
131952556|NCT00624468|475113376|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
131952557|NCT00624468|475113377|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
131952558|NCT00624468|475113378|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
131952559|NCT00624468|475113375|FG000|Safety Follow-up (SFU) Period|Other|0|||
131952560|NCT00624468|475113376|FG001|Safety Follow-up (SFU) Period|Other|0|||
131952561|NCT00624468|475113377|FG002|Safety Follow-up (SFU) Period|Other|1|||
131952562|NCT00624468|475113378|FG003|Safety Follow-up (SFU) Period|Other|1|||
131952563|NCT00803361|475113388|FG000|Overall Study|Adverse Event|13|||
131952564|NCT00803361|475113389|FG001|Overall Study|Adverse Event|3|||
131952565|NCT00803361|475113388|FG000|Overall Study|Lack of Efficacy|4|||
131952566|NCT00803361|475113389|FG001|Overall Study|Lack of Efficacy|13|||
131952567|NCT00803361|475113388|FG000|Overall Study|Lost to Follow-up|1|||
131952568|NCT00803361|475113389|FG001|Overall Study|Lost to Follow-up|2|||
131952569|NCT00803361|475113388|FG000|Overall Study|Physician Decision|1|||
131952570|NCT00803361|475113389|FG001|Overall Study|Physician Decision|0|||
131952571|NCT00803361|475113388|FG000|Overall Study|Protocol Violation|2|||
131952572|NCT00803361|475113389|FG001|Overall Study|Protocol Violation|4|||
131952573|NCT00803361|475113388|FG000|Overall Study|Withdrawal by Subject|5|||
131952574|NCT00803361|475113389|FG001|Overall Study|Withdrawal by Subject|6|||
131952575|NCT04482439|475113390|FG000|Overall Study|Lost to Follow-up|1|||
131952576|NCT04482439|475113390|FG000|Overall Study|Unrelated illness|1|||
131952577|NCT02858440|475113391|FG000|Overall Study|Lost to Follow-up|3|||
131952578|NCT02858440|475113391|FG000|Overall Study|Protocol Violation|2|||
131952579|NCT02858440|475113391|FG000|Overall Study|Consent withdrawal|3|||
131952580|NCT02858440|475113391|FG000|Overall Study|Migrated/moved from study area|4|||
131952581|NCT01670279|475113392|FG000|Overall Study|Adverse Event|0|||
131952582|NCT01670279|475113393|FG001|Overall Study|Adverse Event|1|||
131952583|NCT01670279|475113394|FG002|Overall Study|Adverse Event|0|||
131952584|NCT01670279|475113395|FG003|Overall Study|Adverse Event|0|||
131952585|NCT01670279|475113392|FG000|Overall Study|Physician Decision|0|||
131952586|NCT01670279|475113393|FG001|Overall Study|Physician Decision|1|||
131952587|NCT01670279|475113394|FG002|Overall Study|Physician Decision|0|||
131952588|NCT01670279|475113395|FG003|Overall Study|Physician Decision|0|||
131952589|NCT01670279|475113392|FG000|Overall Study|Participant met withdrawal criteria|0|||
131952590|NCT01670279|475113393|FG001|Overall Study|Participant met withdrawal criteria|0|||
131952591|NCT01670279|475113394|FG002|Overall Study|Participant met withdrawal criteria|0|||
131952592|NCT01670279|475113395|FG003|Overall Study|Participant met withdrawal criteria|1|||
131952593|NCT01901614|475113396|FG000|Overall Study|Adverse Event|0|||
131952594|NCT01901614|475113397|FG001|Overall Study|Adverse Event|1|||
131952595|NCT01901614|475113396|FG000|Overall Study|Lost to Follow-up|1|||
131952596|NCT01901614|475113397|FG001|Overall Study|Lost to Follow-up|0|||
131952597|NCT01901614|475113396|FG000|Overall Study|Screen Fail|1|||
131952598|NCT01901614|475113397|FG001|Overall Study|Screen Fail|0|||
131952599|NCT03629223|475113398|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
131952600|NCT03629223|475113399|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
131952601|NCT03629223|475113400|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
131952602|NCT03629223|475113401|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
131952603|NCT03629223|475113402|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
131952604|NCT03629223|475113403|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
131952605|NCT03629223|475113398|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
131952606|NCT03629223|475113399|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
131952607|NCT03629223|475113400|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
131952608|NCT03629223|475113401|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
131952609|NCT03629223|475113402|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
131952610|NCT03629223|475113403|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
131952611|NCT03629223|475113398|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
131952612|NCT03629223|475113399|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
131952613|NCT03629223|475113400|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
131952614|NCT03629223|475113401|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
131952615|NCT03629223|475113402|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
131952616|NCT03629223|475113403|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
131952617|NCT03629223|475113398|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
131952618|NCT03629223|475113399|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
131952619|NCT03629223|475113400|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
131952620|NCT03629223|475113401|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
131952621|NCT03629223|475113402|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
131952622|NCT03629223|475113403|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
131952623|NCT03629223|475113398|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
131952624|NCT03629223|475113399|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
131952625|NCT03629223|475113400|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
131952626|NCT03629223|475113401|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
131952627|NCT03629223|475113402|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
131952628|NCT03629223|475113403|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
131952629|NCT01534351|475113404|FG000|Overall Study|Study Terminated Early|1|||
131952630|NCT01534351|475113405|FG001|Overall Study|Study Terminated Early|0|||
131952631|NCT01534351|475113406|FG002|Overall Study|Study Terminated Early|0|||
131952632|NCT02702609|475113407|FG000|Overall Study|Lost to Follow-up|8|||
131952633|NCT02702609|475113408|FG001|Overall Study|Lost to Follow-up|4|||
131952634|NCT02702609|475113407|FG000|Overall Study|Physician Decision|1|||
131952635|NCT02702609|475113408|FG001|Overall Study|Physician Decision|0|||
131952636|NCT02674464|475113409|FG000|Overall Study|Death|10|||
131952637|NCT02674464|475113410|FG001|Overall Study|Death|21|||
131952638|NCT02674464|475113409|FG000|Overall Study|Withdrawal by Subject|24|||
131952639|NCT02674464|475113410|FG001|Overall Study|Withdrawal by Subject|44|||
131952640|NCT02674464|475113409|FG000|Overall Study|Lost to Follow-up|97|||
131952641|NCT02674464|475113410|FG001|Overall Study|Lost to Follow-up|92|||
131952642|NCT02674464|475113409|FG000|Overall Study|Outside survey window|6|||
131952643|NCT02674464|475113410|FG001|Overall Study|Outside survey window|3|||
131952644|NCT00783835|475113411|FG000|Overall Study|Adverse Event|3|||
131952645|NCT00783835|475113411|FG000|Overall Study|Medical Criteria|1|||
131952646|NCT00783835|475113411|FG000|Overall Study|Withdrawal by Subject|2|||
131952647|NCT00783835|475113411|FG000|Overall Study|Lost to Follow-up|1|||
131952648|NCT00783835|475113411|FG000|Overall Study|Participant not Adherent|3|||
131952649|NCT01555073|475113412|FG000|Overall Study|Lost to Follow-up|1|||
131952650|NCT01555073|475113413|FG001|Overall Study|Lost to Follow-up|2|||
131952651|NCT01555073|475113414|FG002|Overall Study|Lost to Follow-up|0|||
131952652|NCT01555073|475113415|FG003|Overall Study|Lost to Follow-up|5|||
131952653|NCT01066104|475113417|FG000|Overall Study|Adverse Event|1|||
131952654|NCT01066104|475113418|FG001|Overall Study|Adverse Event|1|||
131952655|NCT01066104|475113417|FG000|Overall Study|Protocol Violation|1|||
131952656|NCT01066104|475113418|FG001|Overall Study|Protocol Violation|0|||
131952657|NCT01945996|475113419|FG000|Overall Study|Lost to Follow-up|3|||
131952658|NCT01945996|475113420|FG001|Overall Study|Lost to Follow-up|5|||
131952659|NCT04660552|475113421|FG000|Overall Study|Withdrawal by Subject|3|||
131952660|NCT04660552|475113422|FG001|Overall Study|Withdrawal by Subject|1|||
131952661|NCT03928418|475113423|FG000|Overall Study|Lost to Follow-up|5|||
131952662|NCT03928418|475113424|FG001|Overall Study|Lost to Follow-up|3|||
131952663|NCT03928418|475113425|FG002|Overall Study|Lost to Follow-up|5|||
131952664|NCT03928418|475113423|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
131952665|NCT03928418|475113424|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
131952666|NCT03928418|475113425|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
131952667|NCT01970241|475113428|FG000|Overall Study|Withdrawal by Subject|2|||
131952668|NCT01970241|475113429|FG001|Overall Study|Withdrawal by Subject|0|||
131952669|NCT01970241|475113428|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
131952670|NCT01970241|475113429|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
131952671|NCT01001767|475113430|FG000|Overall Study|no baseline study performed|1|||
131952672|NCT01001767|475113431|FG001|Overall Study|no baseline study performed|0|||
131952673|NCT01001767|475113430|FG000|Overall Study|Protocol Violation|1|||
131952674|NCT01001767|475113431|FG001|Overall Study|Protocol Violation|0|||
131952675|NCT01001767|475113430|FG000|Overall Study|Lost to Follow-up|1|||
131952676|NCT01001767|475113431|FG001|Overall Study|Lost to Follow-up|0|||
131952677|NCT01001767|475113430|FG000|Overall Study|Physician Decision|1|||
131952678|NCT01001767|475113431|FG001|Overall Study|Physician Decision|0|||
131952679|NCT03835481|475113433|FG000|Double-blind Period|Other not stated below|0|||
131952680|NCT03835481|475113434|FG001|Double-blind Period|Other not stated below|0|||
131952681|NCT03835481|475113435|FG002|Double-blind Period|Other not stated below|0|||
131952682|NCT03835481|475113436|FG003|Double-blind Period|Other not stated below|1|||
131952683|NCT03835481|475113437|FG004|Double-blind Period|Other not stated below|1|||
131952684|NCT03835481|475113433|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
131952685|NCT03835481|475113434|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
131952686|NCT03835481|475113435|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
131952687|NCT03835481|475113436|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
131952688|NCT03835481|475113437|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
131952689|NCT03835481|475113433|FG000|Double-blind Period|Withdrawal by Subject|0|||
131952690|NCT03835481|475113434|FG001|Double-blind Period|Withdrawal by Subject|0|||
131952691|NCT03835481|475113435|FG002|Double-blind Period|Withdrawal by Subject|1|||
131952692|NCT03835481|475113436|FG003|Double-blind Period|Withdrawal by Subject|0|||
131952693|NCT03835481|475113437|FG004|Double-blind Period|Withdrawal by Subject|5|||
131952694|NCT03835481|475113433|FG000|Double-blind Period|Lost to Follow-up|0|||
131952695|NCT03835481|475113434|FG001|Double-blind Period|Lost to Follow-up|0|||
131952696|NCT03835481|475113435|FG002|Double-blind Period|Lost to Follow-up|0|||
131952697|NCT03835481|475113436|FG003|Double-blind Period|Lost to Follow-up|1|||
131952698|NCT03835481|475113437|FG004|Double-blind Period|Lost to Follow-up|0|||
131952699|NCT03835481|475113433|FG000|Double-blind Period|Protocol Violation|0|||
131952700|NCT03835481|475113434|FG001|Double-blind Period|Protocol Violation|2|||
131952701|NCT03835481|475113435|FG002|Double-blind Period|Protocol Violation|0|||
131952702|NCT03835481|475113436|FG003|Double-blind Period|Protocol Violation|1|||
131952703|NCT03835481|475113437|FG004|Double-blind Period|Protocol Violation|0|||
131952704|NCT03835481|475113433|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
131952705|NCT03835481|475113434|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
131952706|NCT03835481|475113435|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
131952707|NCT03835481|475113436|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
131952708|NCT03835481|475113437|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
131952709|NCT03835481|475113433|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
131952710|NCT03835481|475113434|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
131952711|NCT03835481|475113435|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
131952712|NCT03835481|475113436|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
131952713|NCT03835481|475113437|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
131952714|NCT03835481|475113433|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
131952715|NCT03835481|475113434|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
131952716|NCT03835481|475113435|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
131952717|NCT03835481|475113436|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
131952718|NCT03835481|475113437|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
131952719|NCT03835481|475113433|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
131952720|NCT03835481|475113434|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
131952721|NCT03835481|475113435|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
131952722|NCT03835481|475113436|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
131952723|NCT03835481|475113437|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
131952724|NCT03835481|475113433|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
131952725|NCT03835481|475113434|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
131457064|NCT02152956|473303073|FG005|Overall Study|Lost to Follow-up|0|||
131952726|NCT03835481|475113435|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
131952727|NCT03835481|475113436|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
131952728|NCT03835481|475113437|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
131952729|NCT03835481|475113433|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
131952730|NCT03835481|475113434|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
131952731|NCT03835481|475113435|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
131952732|NCT03835481|475113436|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
131457065|NCT02152956|473303074|FG006|Overall Study|Lost to Follow-up|0|||
131457066|NCT02152956|473303075|FG007|Overall Study|Lost to Follow-up|0|||
131457067|NCT02152956|473303076|FG008|Overall Study|Lost to Follow-up|0|||
131457068|NCT02152956|473303077|FG009|Overall Study|Lost to Follow-up|0|||
131457069|NCT02152956|473303078|FG010|Overall Study|Lost to Follow-up|0|||
131457070|NCT02152956|473303079|FG011|Overall Study|Lost to Follow-up|3|||
131457071|NCT02152956|473303080|FG012|Overall Study|Lost to Follow-up|0|||
131457072|NCT02152956|473303068|FG000|Overall Study|Withdrawal by Subject|1|||
131457073|NCT02152956|473303069|FG001|Overall Study|Withdrawal by Subject|0|||
131457074|NCT02152956|473303070|FG002|Overall Study|Withdrawal by Subject|1|||
131457075|NCT02152956|473303071|FG003|Overall Study|Withdrawal by Subject|0|||
131457076|NCT02152956|473303072|FG004|Overall Study|Withdrawal by Subject|2|||
131457077|NCT02152956|473303073|FG005|Overall Study|Withdrawal by Subject|2|||
131457078|NCT02152956|473303074|FG006|Overall Study|Withdrawal by Subject|0|||
131457079|NCT02152956|473303075|FG007|Overall Study|Withdrawal by Subject|0|||
131457080|NCT02152956|473303076|FG008|Overall Study|Withdrawal by Subject|1|||
131457081|NCT02152956|473303077|FG009|Overall Study|Withdrawal by Subject|0|||
131457082|NCT02152956|473303078|FG010|Overall Study|Withdrawal by Subject|0|||
131457083|NCT02152956|473303079|FG011|Overall Study|Withdrawal by Subject|4|||
131457084|NCT02152956|473303080|FG012|Overall Study|Withdrawal by Subject|0|||
131457085|NCT02152956|473303068|FG000|Overall Study|Physician Decision|0|||
131952733|NCT03835481|475113437|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
131952734|NCT00564902|475113439|FG000|Overall Study|Withdrawal by Subject|0|||
131952735|NCT00564902|475113440|FG001|Overall Study|Withdrawal by Subject|3|||
131952736|NCT00564902|475113441|FG002|Overall Study|Withdrawal by Subject|4|||
131952737|NCT00564902|475113439|FG000|Overall Study|Death|1|||
131952738|NCT00564902|475113440|FG001|Overall Study|Death|1|||
131952739|NCT00564902|475113441|FG002|Overall Study|Death|0|||
131952740|NCT03583359|475113444|FG000|Overall Study|Withdrawal by Subject|15|||
131952741|NCT03583359|475113445|FG001|Overall Study|Withdrawal by Subject|6|||
131952742|NCT03583359|475113444|FG000|Overall Study|Lost to Follow-up|12|||
131952743|NCT03583359|475113445|FG001|Overall Study|Lost to Follow-up|3|||
131952744|NCT03583359|475113444|FG000|Overall Study|Adverse Event|0|||
131952745|NCT03583359|475113445|FG001|Overall Study|Adverse Event|1|||
131952746|NCT03583359|475113444|FG000|Overall Study|Protocol Violation|0|||
131952747|NCT03583359|475113445|FG001|Overall Study|Protocol Violation|1|||
131952748|NCT03583359|475113444|FG000|Overall Study|Other|2|||
131952749|NCT03583359|475113445|FG001|Overall Study|Other|1|||
131952750|NCT00375505|475113449|FG000|Overall Study|Adverse Event|1|||
131952751|NCT00375505|475113450|FG001|Overall Study|Adverse Event|2|||
131952752|NCT02470585|475113453|FG000|Overall Study|Death|224|||
131952753|NCT02470585|475113454|FG001|Overall Study|Death|227|||
131952754|NCT02470585|475113455|FG002|Overall Study|Death|199|||
131952755|NCT02470585|475113453|FG000|Overall Study|Withdrew consent|21|||
131952756|NCT02470585|475113454|FG001|Overall Study|Withdrew consent|22|||
131952757|NCT02470585|475113455|FG002|Overall Study|Withdrew consent|31|||
131952758|NCT02470585|475113453|FG000|Overall Study|Lost to Follow-up|8|||
131952759|NCT02470585|475113454|FG001|Overall Study|Lost to Follow-up|15|||
131952760|NCT02470585|475113455|FG002|Overall Study|Lost to Follow-up|13|||
131952761|NCT02470585|475113453|FG000|Overall Study|Sponsor discontinued study|117|||
131952762|NCT02470585|475113454|FG001|Overall Study|Sponsor discontinued study|110|||
131952763|NCT02470585|475113455|FG002|Overall Study|Sponsor discontinued study|122|||
131952764|NCT02470585|475113453|FG000|Overall Study|Other, not specified|5|||
131952765|NCT02470585|475113454|FG001|Overall Study|Other, not specified|7|||
131952766|NCT02470585|475113455|FG002|Overall Study|Other, not specified|14|||
131952767|NCT02470585|475113453|FG000|Overall Study|Missing due to site non-compliance|0|||
131952768|NCT02470585|475113454|FG001|Overall Study|Missing due to site non-compliance|2|||
131952769|NCT02470585|475113455|FG002|Overall Study|Missing due to site non-compliance|3|||
131952770|NCT02146131|475113459|FG000|Overall Study|Physician Decision|61|||
131952771|NCT02146131|475113460|FG001|Overall Study|Physician Decision|56|||
131952772|NCT02567799|475113461|FG000|Concurrent Chemoradiotherapy|Death|1|||
131952773|NCT02567799|475113462|FG001|Concurrent Chemoradiotherapy|Death|0|||
131952774|NCT02567799|475113463|FG002|Concurrent Chemoradiotherapy|Death|0|||
131952775|NCT02567799|475113461|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
131952776|NCT02567799|475113462|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
131457086|NCT02152956|473303069|FG001|Overall Study|Physician Decision|0|||
131457087|NCT02152956|473303070|FG002|Overall Study|Physician Decision|0|||
131457088|NCT02152956|473303071|FG003|Overall Study|Physician Decision|0|||
131457089|NCT02152956|473303072|FG004|Overall Study|Physician Decision|0|||
131952777|NCT02567799|475113463|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
131952778|NCT02567799|475113461|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
131952779|NCT02567799|475113462|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
131952780|NCT02567799|475113463|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
131952781|NCT02567799|475113461|FG000|Follow-up|Death|1|||
131952782|NCT02567799|475113462|FG001|Follow-up|Death|0|||
131952783|NCT02567799|475113463|FG002|Follow-up|Death|1|||
131952784|NCT02567799|475113461|FG000|Follow-up|Progressive Disease|1|||
131952785|NCT02567799|475113462|FG001|Follow-up|Progressive Disease|1|||
131952786|NCT02567799|475113463|FG002|Follow-up|Progressive Disease|3|||
131952787|NCT00465972|475113465|FG000|Overall Study|Withdrawal by Subject|2|||
131952788|NCT00465972|475113466|FG001|Overall Study|Withdrawal by Subject|1|||
131952789|NCT00349349|475113467|FG000|Overall Study|Adverse Event|5|||
131952790|NCT00349349|475113468|FG001|Overall Study|Adverse Event|6|||
131952791|NCT00349349|475113469|FG002|Overall Study|Adverse Event|2|||
131952792|NCT00349349|475113467|FG000|Overall Study|Withdrawal by Subject|5|||
131952793|NCT00349349|475113468|FG001|Overall Study|Withdrawal by Subject|2|||
131952794|NCT00349349|475113469|FG002|Overall Study|Withdrawal by Subject|1|||
131952795|NCT00349349|475113467|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
131952796|NCT00349349|475113468|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
131952797|NCT00349349|475113469|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
131952798|NCT00349349|475113467|FG000|Overall Study|Death|13|||
131952799|NCT00349349|475113468|FG001|Overall Study|Death|10|||
131952800|NCT00349349|475113469|FG002|Overall Study|Death|1|||
131952801|NCT00349349|475113467|FG000|Overall Study|Other Treatment Selected|2|||
131952802|NCT00349349|475113468|FG001|Overall Study|Other Treatment Selected|0|||
131952803|NCT00349349|475113469|FG002|Overall Study|Other Treatment Selected|0|||
131952804|NCT00349349|475113467|FG000|Overall Study|Participant Reduced General Condition|0|||
131952805|NCT00349349|475113468|FG001|Overall Study|Participant Reduced General Condition|1|||
131952806|NCT00349349|475113469|FG002|Overall Study|Participant Reduced General Condition|0|||
131952807|NCT00349349|475113467|FG000|Overall Study|Physician Decision|1|||
131952808|NCT00349349|475113468|FG001|Overall Study|Physician Decision|2|||
131952809|NCT00349349|475113469|FG002|Overall Study|Physician Decision|1|||
131952810|NCT00349349|475113467|FG000|Overall Study|No Response|0|||
131952811|NCT00349349|475113468|FG001|Overall Study|No Response|3|||
131952812|NCT00349349|475113469|FG002|Overall Study|No Response|0|||
131952813|NCT00349349|475113467|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
131952814|NCT00349349|475113468|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
131952815|NCT00349349|475113469|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
131952816|NCT01854775|475113477|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
131952817|NCT01854775|475113478|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
131952818|NCT01854775|475113479|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
131952819|NCT01854775|475113477|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
131952820|NCT01854775|475113478|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
131952821|NCT01854775|475113479|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
131952822|NCT01854775|475113477|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
131952823|NCT01854775|475113478|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
131952824|NCT01854775|475113479|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
131952825|NCT01854775|475113477|FG000|Extension Phase|Pregnancy|3|||
131952826|NCT01854775|475113478|FG001|Extension Phase|Pregnancy|0|||
131952827|NCT01854775|475113479|FG002|Extension Phase|Pregnancy|0|||
131952828|NCT01854775|475113477|FG000|Extension Phase|Investigator's Discretion|1|||
131952829|NCT01854775|475113478|FG001|Extension Phase|Investigator's Discretion|0|||
131952830|NCT01854775|475113479|FG002|Extension Phase|Investigator's Discretion|0|||
131952831|NCT01854775|475113477|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
131952832|NCT01854775|475113478|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
131952833|NCT01854775|475113479|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
131952834|NCT01854775|475113477|FG000|Extension Phase|Lost to Follow-up|2|||
131952835|NCT01854775|475113478|FG001|Extension Phase|Lost to Follow-up|0|||
131952836|NCT01854775|475113479|FG002|Extension Phase|Lost to Follow-up|0|||
131952837|NCT01854775|475113477|FG000|Extension Phase|Still on Study|32|||
131952838|NCT01854775|475113478|FG001|Extension Phase|Still on Study|47|||
131952839|NCT01854775|475113479|FG002|Extension Phase|Still on Study|18|||
131952840|NCT05111002|475113482|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
131952841|NCT05111002|475113483|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
131952842|NCT05111002|475113482|FG000|Secondary Outcome|Lost to Follow-up|1|||
131952843|NCT05111002|475113483|FG001|Secondary Outcome|Lost to Follow-up|0|||
131952844|NCT04776720|475113488|FG000|Overall Study|COVID Related|4|||
131952845|NCT04776720|475113489|FG001|Overall Study|COVID Related|2|||
131952846|NCT04776720|475113488|FG000|Overall Study|Adverse Event|2|||
131952847|NCT04776720|475113489|FG001|Overall Study|Adverse Event|0|||
131952848|NCT04776720|475113488|FG000|Overall Study|Serious Adverse Event|0|||
131952849|NCT04776720|475113489|FG001|Overall Study|Serious Adverse Event|1|||
131952850|NCT04776720|475113488|FG000|Overall Study|Too Busy|3|||
131952851|NCT04776720|475113489|FG001|Overall Study|Too Busy|1|||
131952852|NCT04776720|475113488|FG000|Overall Study|Lost to Follow-up|1|||
131415180|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
131952853|NCT04776720|475113489|FG001|Overall Study|Lost to Follow-up|2|||
131952854|NCT04776720|475113488|FG000|Overall Study|Family|2|||
131952855|NCT04776720|475113489|FG001|Overall Study|Family|2|||
131952856|NCT04776720|475113488|FG000|Overall Study|No remote technology access|0|||
131952857|NCT04776720|475113489|FG001|Overall Study|No remote technology access|1|||
131952858|NCT04776720|475113488|FG000|Overall Study|Withdrawal by Subject|1|||
131952859|NCT04776720|475113489|FG001|Overall Study|Withdrawal by Subject|0|||
131952860|NCT04776720|475113488|FG000|Overall Study|Cannot tolerate intervention|1|||
131952861|NCT04776720|475113489|FG001|Overall Study|Cannot tolerate intervention|0|||
131952862|NCT04776720|475113488|FG000|Overall Study|Incomplete outcome data|6|||
131952863|NCT04776720|475113489|FG001|Overall Study|Incomplete outcome data|1|||
131952864|NCT05356910|475113490|FG000|Overall Study|Lost to Follow-up|10|||
131952865|NCT05356910|475113491|FG001|Overall Study|Lost to Follow-up|19|||
131952866|NCT05356910|475113492|FG002|Overall Study|Lost to Follow-up|0|||
131952867|NCT05356910|475113493|FG003|Overall Study|Lost to Follow-up|0|||
131952868|NCT05356910|475113490|FG000|Overall Study|Withdrawal by Subject|4|||
131952869|NCT05356910|475113491|FG001|Overall Study|Withdrawal by Subject|2|||
131952870|NCT05356910|475113492|FG002|Overall Study|Withdrawal by Subject|0|||
131952871|NCT05356910|475113493|FG003|Overall Study|Withdrawal by Subject|0|||
131952872|NCT02311881|475113497|FG000|Overall Study|Did not meet the study criteria|2|||
131952873|NCT02311881|475113498|FG001|Overall Study|Did not meet the study criteria|2|||
131952874|NCT02311881|475113499|FG002|Overall Study|Did not meet the study criteria|0|||
131952875|NCT02311881|475113497|FG000|Overall Study|Adverse Event|7|||
131952876|NCT02311881|475113498|FG001|Overall Study|Adverse Event|15|||
131952877|NCT02311881|475113499|FG002|Overall Study|Adverse Event|8|||
131952878|NCT02311881|475113497|FG000|Overall Study|Lost to Follow-up|3|||
131952879|NCT02311881|475113498|FG001|Overall Study|Lost to Follow-up|3|||
131952880|NCT02311881|475113499|FG002|Overall Study|Lost to Follow-up|2|||
131952881|NCT02311881|475113497|FG000|Overall Study|Protocol Violation|1|||
131952882|NCT02311881|475113498|FG001|Overall Study|Protocol Violation|2|||
131952883|NCT02311881|475113499|FG002|Overall Study|Protocol Violation|3|||
131952884|NCT02311881|475113497|FG000|Overall Study|Withdrawal of consent|14|||
131952885|NCT02311881|475113498|FG001|Overall Study|Withdrawal of consent|16|||
131952886|NCT02311881|475113499|FG002|Overall Study|Withdrawal of consent|17|||
131952887|NCT02311881|475113497|FG000|Overall Study|Other|0|||
131952888|NCT02311881|475113498|FG001|Overall Study|Other|0|||
131952889|NCT02311881|475113499|FG002|Overall Study|Other|1|||
131952890|NCT02311881|475113497|FG000|Overall Study|Lack of Efficacy|1|||
131415181|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
131415182|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
131415183|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
131415184|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
131415185|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
131415186|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
131415187|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
131415188|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
131415189|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
131415190|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
131415191|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
131415192|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
131415193|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
131415194|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
131415195|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
131415196|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
131415197|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
131415198|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
131415199|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
131415200|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
131415201|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
131415202|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
131415203|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
131415204|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
131415205|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
131415206|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
131415207|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
131415208|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
131415209|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
131415210|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
131415211|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
131415212|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
131415213|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
131415214|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
131457090|NCT02152956|473303073|FG005|Overall Study|Physician Decision|0|||
131952891|NCT02311881|475113498|FG001|Overall Study|Lack of Efficacy|2|||
131952892|NCT02311881|475113499|FG002|Overall Study|Lack of Efficacy|0|||
131952893|NCT02311881|475113497|FG000|Overall Study|Subject has border line pregnancy test|1|||
131952894|NCT02311881|475113498|FG001|Overall Study|Subject has border line pregnancy test|0|||
131952895|NCT02311881|475113499|FG002|Overall Study|Subject has border line pregnancy test|0|||
131952896|NCT02311881|475113497|FG000|Overall Study|Withdrawal by Subject|3|||
131952897|NCT02311881|475113498|FG001|Overall Study|Withdrawal by Subject|1|||
131952898|NCT02311881|475113499|FG002|Overall Study|Withdrawal by Subject|4|||
131952899|NCT02311881|475113497|FG000|Overall Study|Sponsor Decision|1|||
131952900|NCT02311881|475113498|FG001|Overall Study|Sponsor Decision|1|||
131952901|NCT02311881|475113499|FG002|Overall Study|Sponsor Decision|1|||
131952902|NCT02311881|475113497|FG000|Overall Study|Protocol Deviation|1|||
131952903|NCT02311881|475113498|FG001|Overall Study|Protocol Deviation|0|||
131952904|NCT02311881|475113499|FG002|Overall Study|Protocol Deviation|0|||
131952905|NCT02311881|475113497|FG000|Overall Study|Non-Compliance|1|||
131952906|NCT02311881|475113498|FG001|Overall Study|Non-Compliance|0|||
131952907|NCT02311881|475113499|FG002|Overall Study|Non-Compliance|2|||
131952908|NCT02311881|475113497|FG000|Overall Study|Physician Decision|0|||
131952909|NCT02311881|475113498|FG001|Overall Study|Physician Decision|0|||
131952910|NCT02311881|475113499|FG002|Overall Study|Physician Decision|1|||
131952911|NCT02311881|475113497|FG000|Overall Study|Medical Monitor Discretion|0|||
131952912|NCT02311881|475113498|FG001|Overall Study|Medical Monitor Discretion|0|||
131952913|NCT02311881|475113499|FG002|Overall Study|Medical Monitor Discretion|1|||
131952914|NCT02311881|475113497|FG000|Overall Study|Participant taking another medication|0|||
131952915|NCT02311881|475113498|FG001|Overall Study|Participant taking another medication|0|||
131952916|NCT02311881|475113499|FG002|Overall Study|Participant taking another medication|1|||
131952917|NCT02311881|475113497|FG000|Overall Study|Serious Adverse Event|0|||
131952918|NCT02311881|475113498|FG001|Overall Study|Serious Adverse Event|1|||
131952919|NCT02311881|475113499|FG002|Overall Study|Serious Adverse Event|0|||
131952920|NCT00819156|475113502|FG000|Overall Study|Adverse Event|1|||
131952921|NCT00819156|475113503|FG001|Overall Study|Adverse Event|4|||
131952922|NCT00819156|475113504|FG002|Overall Study|Adverse Event|2|||
131415215|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
131415216|NCT02198794|473145213|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
131415217|NCT02198794|473145214|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
131415218|NCT02198794|473145215|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
131415219|NCT02198794|473145216|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
131415220|NCT02198794|473145213|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
131415221|NCT02198794|473145214|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
131415222|NCT02198794|473145215|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
131415223|NCT02198794|473145216|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
131415224|NCT02198794|473145213|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
131415225|NCT02198794|473145214|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
131415226|NCT02198794|473145215|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
131415227|NCT02198794|473145216|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
131415228|NCT02198794|473145213|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
131415229|NCT02198794|473145214|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
131415230|NCT02198794|473145215|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
131415231|NCT02198794|473145216|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
131415232|NCT02198794|473145213|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
131415233|NCT02198794|473145214|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
131415234|NCT02198794|473145215|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
131415235|NCT02198794|473145216|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
131415236|NCT02198794|473145213|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
131415237|NCT02198794|473145214|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
131415238|NCT02198794|473145215|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
131415239|NCT02198794|473145216|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
131415240|NCT01918332|473145217|FG000|Overall Study|Adverse Event|0|||
131415241|NCT01918332|473145218|FG001|Overall Study|Adverse Event|0|||
131415242|NCT01918332|473145219|FG002|Overall Study|Adverse Event|0|||
131415243|NCT01918332|473145220|FG003|Overall Study|Adverse Event|1|||
131415244|NCT01918332|473145217|FG000|Overall Study|Withdrawal by Subject|2|||
131415245|NCT01918332|473145218|FG001|Overall Study|Withdrawal by Subject|3|||
131415246|NCT01918332|473145219|FG002|Overall Study|Withdrawal by Subject|2|||
131415247|NCT01918332|473145220|FG003|Overall Study|Withdrawal by Subject|3|||
131415248|NCT01918332|473145217|FG000|Overall Study|Protocol Violation|6|||
131415249|NCT01918332|473145218|FG001|Overall Study|Protocol Violation|2|||
131415250|NCT01918332|473145219|FG002|Overall Study|Protocol Violation|6|||
131415251|NCT01918332|473145220|FG003|Overall Study|Protocol Violation|3|||
131415252|NCT01918332|473145217|FG000|Overall Study|lipid result by central lab did not meet|0|||
131415253|NCT01918332|473145218|FG001|Overall Study|lipid result by central lab did not meet|0|||
131415254|NCT01918332|473145219|FG002|Overall Study|lipid result by central lab did not meet|1|||
131415255|NCT01918332|473145220|FG003|Overall Study|lipid result by central lab did not meet|0|||
131415256|NCT02408523|473145221|FG000|Overall Study|Adverse Event|4|||
131415257|NCT02408523|473145222|FG001|Overall Study|Adverse Event|10|||
131415258|NCT02408523|473145221|FG000|Overall Study|Lack of Efficacy|0|||
131415259|NCT02408523|473145222|FG001|Overall Study|Lack of Efficacy|1|||
131457091|NCT02152956|473303074|FG006|Overall Study|Physician Decision|0|||
131952923|NCT00819156|475113505|FG003|Overall Study|Adverse Event|1|||
131952924|NCT00819156|475113506|FG004|Overall Study|Adverse Event|2|||
131952925|NCT00819156|475113507|FG005|Overall Study|Adverse Event|3|||
131952926|NCT00819156|475113502|FG000|Overall Study|Withdrawal by Subject|0|||
131952927|NCT00819156|475113503|FG001|Overall Study|Withdrawal by Subject|3|||
131952928|NCT00819156|475113504|FG002|Overall Study|Withdrawal by Subject|2|||
131952929|NCT00819156|475113505|FG003|Overall Study|Withdrawal by Subject|0|||
131952930|NCT00819156|475113506|FG004|Overall Study|Withdrawal by Subject|1|||
131952931|NCT00819156|475113507|FG005|Overall Study|Withdrawal by Subject|0|||
131952932|NCT00819156|475113502|FG000|Overall Study|Protocol Violation|1|||
131952933|NCT00819156|475113503|FG001|Overall Study|Protocol Violation|0|||
131952934|NCT00819156|475113504|FG002|Overall Study|Protocol Violation|1|||
131952935|NCT00819156|475113505|FG003|Overall Study|Protocol Violation|0|||
131952936|NCT00819156|475113506|FG004|Overall Study|Protocol Violation|0|||
131952937|NCT00819156|475113507|FG005|Overall Study|Protocol Violation|1|||
131952938|NCT00819156|475113502|FG000|Overall Study|Lost to Follow-up|0|||
131952939|NCT00819156|475113503|FG001|Overall Study|Lost to Follow-up|1|||
131952940|NCT00819156|475113504|FG002|Overall Study|Lost to Follow-up|0|||
131952941|NCT00819156|475113505|FG003|Overall Study|Lost to Follow-up|0|||
131952942|NCT00819156|475113506|FG004|Overall Study|Lost to Follow-up|0|||
131952943|NCT00819156|475113507|FG005|Overall Study|Lost to Follow-up|2|||
131952944|NCT00819156|475113502|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
131952945|NCT00819156|475113503|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
131952946|NCT00819156|475113504|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
131952947|NCT00819156|475113505|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
131952948|NCT00819156|475113506|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
131952949|NCT00819156|475113507|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
131952950|NCT00819156|475113502|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
131952951|NCT00819156|475113503|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
131952952|NCT00819156|475113504|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
131952953|NCT00819156|475113505|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
131952954|NCT00819156|475113506|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
131952955|NCT00819156|475113507|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
131952956|NCT00819156|475113502|FG000|Overall Study|Prostate-specific antigen progression|0|||
131952957|NCT00819156|475113503|FG001|Overall Study|Prostate-specific antigen progression|0|||
131952958|NCT00819156|475113504|FG002|Overall Study|Prostate-specific antigen progression|0|||
131952959|NCT00819156|475113505|FG003|Overall Study|Prostate-specific antigen progression|0|||
131952960|NCT00819156|475113506|FG004|Overall Study|Prostate-specific antigen progression|1|||
131952961|NCT00819156|475113507|FG005|Overall Study|Prostate-specific antigen progression|0|||
131952962|NCT03122145|475113509|FG000|Overall Study|Concurrent respiratory disease|3|||
131952963|NCT03122145|475113510|FG001|Overall Study|Concurrent respiratory disease|0|||
131952964|NCT00837161|475113511|FG000|Overall Study|refused hysterectomy|2|||
131952965|NCT01659996|475113514|FG000|Overall Study|Protocol Violation|3|||
131952966|NCT01659996|475113515|FG001|Overall Study|Protocol Violation|3|||
131952967|NCT01659996|475113516|FG002|Overall Study|Protocol Violation|3|||
131952968|NCT01659996|475113514|FG000|Overall Study|Lost to Follow-up|1|||
131952969|NCT01659996|475113515|FG001|Overall Study|Lost to Follow-up|3|||
131952970|NCT01659996|475113516|FG002|Overall Study|Lost to Follow-up|2|||
131952971|NCT01659996|475113514|FG000|Overall Study|Adverse Event|0|||
131952972|NCT01659996|475113515|FG001|Overall Study|Adverse Event|0|||
131952973|NCT01659996|475113516|FG002|Overall Study|Adverse Event|1|||
131952974|NCT01659996|475113514|FG000|Overall Study|Withdrawal by Subject|4|||
131952975|NCT01659996|475113515|FG001|Overall Study|Withdrawal by Subject|1|||
131952976|NCT01659996|475113516|FG002|Overall Study|Withdrawal by Subject|5|||
131952977|NCT00451958|475113519|FG000|CS21A (NCT00451958)|Adverse Event|21|||
131952978|NCT00451958|475113520|FG001|CS21A (NCT00451958)|Adverse Event|34|||
131952979|NCT00451958|475113521|FG002|CS21A (NCT00451958)|Adverse Event|14|||
131952980|NCT00451958|475113522|FG003|CS21A (NCT00451958)|Adverse Event|17|||
131952981|NCT00451958|475113523|FG004|CS21A (NCT00451958)|Adverse Event|0|||
131952982|NCT00451958|475113519|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
131952983|NCT00451958|475113520|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
131952984|NCT00451958|475113521|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
131952985|NCT00451958|475113522|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
131952986|NCT00451958|475113523|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
131952987|NCT00451958|475113519|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
131952988|NCT00451958|475113520|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
131415260|NCT02408523|473145221|FG000|Overall Study|Protocol Violation|1|||
131415261|NCT02408523|473145222|FG001|Overall Study|Protocol Violation|2|||
131952989|NCT00451958|475113521|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
131952990|NCT00451958|475113522|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
131952991|NCT00451958|475113523|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
131952992|NCT00451958|475113519|FG000|CS21A (NCT00451958)|Physician Decision|2|||
131952993|NCT00451958|475113520|FG001|CS21A (NCT00451958)|Physician Decision|4|||
131952994|NCT00451958|475113521|FG002|CS21A (NCT00451958)|Physician Decision|4|||
131952995|NCT00451958|475113522|FG003|CS21A (NCT00451958)|Physician Decision|4|||
131952996|NCT00451958|475113523|FG004|CS21A (NCT00451958)|Physician Decision|0|||
131952997|NCT00451958|475113519|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
131415262|NCT02408523|473145221|FG000|Overall Study|Lost to Follow-up|2|||
131952998|NCT00451958|475113520|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
131952999|NCT00451958|475113521|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
131953000|NCT00451958|475113522|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
131953001|NCT00451958|475113523|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
131953002|NCT00451958|475113519|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
131953003|NCT00451958|475113520|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
131953004|NCT00451958|475113521|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
131953005|NCT00451958|475113522|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
131953006|NCT00451958|475113523|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
131953007|NCT03281629|475113524|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
131953008|NCT03281629|475113525|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
131953009|NCT03281629|475113524|FG000|Overall Study|Death|0|||
131953010|NCT03281629|475113525|FG001|Overall Study|Death|1|||
131953011|NCT03281629|475113524|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
131953012|NCT03281629|475113525|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
131953013|NCT02175277|475113526|FG000|Overall Study|Protocol-specified Criteria|1|||
131953014|NCT03744910|475115683|FG000|Overall Study|Withdrew Consent|1|||
131953015|NCT03744910|475115684|FG001|Overall Study|Withdrew Consent|8|||
131953016|NCT03744910|475115683|FG000|Overall Study|Physician Decision|5|||
131953017|NCT03744910|475115684|FG001|Overall Study|Physician Decision|4|||
131953018|NCT03744910|475115683|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
131953019|NCT03744910|475115684|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
131953020|NCT03744910|475115683|FG000|Overall Study|Lost to Follow-up|0|||
131953021|NCT03744910|475115684|FG001|Overall Study|Lost to Follow-up|1|||
131953022|NCT03744910|475115683|FG000|Overall Study|Other-unspecified|4|||
131953023|NCT03744910|475115684|FG001|Overall Study|Other-unspecified|1|||
131953024|NCT00064259|475115685|FG000|Overall Study|Adverse Event|1|||
131953025|NCT00064259|475115686|FG001|Overall Study|Adverse Event|0|||
131953026|NCT00064259|475115687|FG002|Overall Study|Adverse Event|0|||
131953027|NCT00064259|475115688|FG003|Overall Study|Adverse Event|1|||
131953028|NCT01132651|475115691|FG000|Overall Study|Lost to Follow-up|1|||
131953029|NCT01132651|475115692|FG001|Overall Study|Lost to Follow-up|1|||
131953030|NCT00948857|475115693|FG000|Overall Study|Lost to Follow-up|1|||
131953031|NCT00948857|475115694|FG001|Overall Study|Lost to Follow-up|0|||
131953032|NCT03430843|475115697|FG000|Overall Study|Death|233|||
131953033|NCT03430843|475115698|FG001|Overall Study|Death|233|||
131953034|NCT03430843|475115697|FG000|Overall Study|Sponsor Decision|17|||
131953035|NCT03430843|475115698|FG001|Overall Study|Sponsor Decision|6|||
131953036|NCT03430843|475115697|FG000|Overall Study|Withdrawal by Subject|5|||
131953037|NCT03430843|475115698|FG001|Overall Study|Withdrawal by Subject|14|||
131953038|NCT03430843|475115697|FG000|Overall Study|Lost to Follow-up|1|||
131953039|NCT03430843|475115698|FG001|Overall Study|Lost to Follow-up|3|||
131953040|NCT01905943|475115705|FG000|Overall Study|Withdrawal of consent|90|||
131953041|NCT01905943|475115705|FG000|Overall Study|Lost to Follow-up|16|||
131953042|NCT01905943|475115705|FG000|Overall Study|Investigator discretion|7|||
131953043|NCT01905943|475115705|FG000|Overall Study|Death|186|||
131953044|NCT01905943|475115705|FG000|Overall Study|Adverse Event|3|||
131953045|NCT01905943|475115705|FG000|Overall Study|Other|12|||
131953046|NCT02574078|475115706|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953047|NCT02574078|475115707|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953048|NCT02574078|475115708|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953049|NCT02574078|475115709|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953050|NCT02574078|475115710|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953051|NCT02574078|475115711|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131953052|NCT02574078|475115712|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
131953053|NCT02574078|475115713|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953054|NCT02574078|475115714|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131953055|NCT02574078|475115715|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953056|NCT02574078|475115716|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953057|NCT02574078|475115717|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953058|NCT02574078|475115718|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131953059|NCT02574078|475115706|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
131457092|NCT02152956|473303075|FG007|Overall Study|Physician Decision|0|||
131457093|NCT02152956|473303076|FG008|Overall Study|Physician Decision|0|||
131953060|NCT02574078|475115707|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131457094|NCT02152956|473303077|FG009|Overall Study|Physician Decision|0|||
131457095|NCT02152956|473303078|FG010|Overall Study|Physician Decision|0|||
131953061|NCT02574078|475115708|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
131457096|NCT02152956|473303079|FG011|Overall Study|Physician Decision|1|||
131457097|NCT02152956|473303080|FG012|Overall Study|Physician Decision|0|||
131953062|NCT02574078|475115709|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
131953063|NCT02574078|475115710|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
131953064|NCT02574078|475115711|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
131953065|NCT02574078|475115712|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
131953066|NCT02574078|475115713|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
131953067|NCT02574078|475115714|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
131953068|NCT02574078|475115715|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
131953069|NCT02574078|475115716|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
131953070|NCT02574078|475115717|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
131953071|NCT02574078|475115718|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
131953072|NCT02574078|475115706|FG000|Pre-Treatment Period|Other reasons|0|||
131953073|NCT02574078|475115707|FG001|Pre-Treatment Period|Other reasons|0|||
131953074|NCT02574078|475115708|FG002|Pre-Treatment Period|Other reasons|0|||
131953075|NCT02574078|475115709|FG003|Pre-Treatment Period|Other reasons|0|||
131953076|NCT02574078|475115710|FG004|Pre-Treatment Period|Other reasons|0|||
131953077|NCT02574078|475115711|FG005|Pre-Treatment Period|Other reasons|0|||
131953078|NCT02574078|475115712|FG006|Pre-Treatment Period|Other reasons|2|||
131953079|NCT02574078|475115713|FG007|Pre-Treatment Period|Other reasons|0|||
131953080|NCT02574078|475115714|FG008|Pre-Treatment Period|Other reasons|0|||
131953081|NCT02574078|475115715|FG009|Pre-Treatment Period|Other reasons|0|||
131953082|NCT02574078|475115716|FG010|Pre-Treatment Period|Other reasons|2|||
131953083|NCT02574078|475115717|FG011|Pre-Treatment Period|Other reasons|0|||
131953084|NCT02574078|475115718|FG012|Pre-Treatment Period|Other reasons|0|||
131953085|NCT02574078|475115706|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
131953086|NCT02574078|475115707|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
131953087|NCT02574078|475115708|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
131953088|NCT02574078|475115709|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
131953089|NCT02574078|475115710|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
131953090|NCT02574078|475115711|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
131953091|NCT02574078|475115712|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
131953092|NCT02574078|475115713|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
131953093|NCT02574078|475115714|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
131953094|NCT02574078|475115715|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
131953095|NCT02574078|475115716|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
131953096|NCT02574078|475115717|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
131953097|NCT02574078|475115718|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
131953098|NCT02574078|475115706|FG000|Treatment Period|Disease progression|6|||
131953099|NCT02574078|475115707|FG001|Treatment Period|Disease progression|4|||
131953100|NCT02574078|475115708|FG002|Treatment Period|Disease progression|7|||
131953101|NCT02574078|475115709|FG003|Treatment Period|Disease progression|18|||
131953102|NCT02574078|475115710|FG004|Treatment Period|Disease progression|16|||
131953103|NCT02574078|475115711|FG005|Treatment Period|Disease progression|26|||
131953104|NCT02574078|475115712|FG006|Treatment Period|Disease progression|5|||
131953105|NCT02574078|475115713|FG007|Treatment Period|Disease progression|9|||
131953106|NCT02574078|475115714|FG008|Treatment Period|Disease progression|8|||
131953107|NCT02574078|475115715|FG009|Treatment Period|Disease progression|5|||
131953108|NCT02574078|475115716|FG010|Treatment Period|Disease progression|20|||
131953109|NCT02574078|475115717|FG011|Treatment Period|Disease progression|29|||
131953110|NCT02574078|475115718|FG012|Treatment Period|Disease progression|2|||
131953111|NCT02574078|475115706|FG000|Treatment Period|Study drug toxicity|1|||
131953112|NCT02574078|475115707|FG001|Treatment Period|Study drug toxicity|1|||
131953113|NCT02574078|475115708|FG002|Treatment Period|Study drug toxicity|0|||
131953114|NCT02574078|475115709|FG003|Treatment Period|Study drug toxicity|5|||
131953115|NCT02574078|475115710|FG004|Treatment Period|Study drug toxicity|3|||
131953116|NCT02574078|475115711|FG005|Treatment Period|Study drug toxicity|1|||
131953117|NCT02574078|475115712|FG006|Treatment Period|Study drug toxicity|2|||
131953118|NCT02574078|475115713|FG007|Treatment Period|Study drug toxicity|0|||
131953119|NCT02574078|475115714|FG008|Treatment Period|Study drug toxicity|2|||
131953120|NCT02574078|475115715|FG009|Treatment Period|Study drug toxicity|1|||
131953121|NCT02574078|475115716|FG010|Treatment Period|Study drug toxicity|16|||
131953122|NCT02574078|475115717|FG011|Treatment Period|Study drug toxicity|2|||
131953123|NCT02574078|475115718|FG012|Treatment Period|Study drug toxicity|4|||
131953124|NCT02574078|475115706|FG000|Treatment Period|Death|2|||
131953125|NCT02574078|475115707|FG001|Treatment Period|Death|0|||
131953126|NCT02574078|475115708|FG002|Treatment Period|Death|0|||
131953127|NCT02574078|475115709|FG003|Treatment Period|Death|0|||
131953128|NCT02574078|475115710|FG004|Treatment Period|Death|1|||
131953129|NCT02574078|475115711|FG005|Treatment Period|Death|1|||
131953130|NCT02574078|475115712|FG006|Treatment Period|Death|1|||
131953131|NCT02574078|475115713|FG007|Treatment Period|Death|1|||
131953132|NCT02574078|475115714|FG008|Treatment Period|Death|7|||
131953133|NCT02574078|475115715|FG009|Treatment Period|Death|1|||
131953134|NCT02574078|475115716|FG010|Treatment Period|Death|0|||
131953135|NCT02574078|475115717|FG011|Treatment Period|Death|2|||
131953136|NCT02574078|475115718|FG012|Treatment Period|Death|1|||
131953137|NCT02574078|475115706|FG000|Treatment Period|Adverse event unrelated to drug|0|||
131953138|NCT02574078|475115707|FG001|Treatment Period|Adverse event unrelated to drug|0|||
131953139|NCT02574078|475115708|FG002|Treatment Period|Adverse event unrelated to drug|1|||
131953140|NCT02574078|475115709|FG003|Treatment Period|Adverse event unrelated to drug|0|||
131953141|NCT02574078|475115710|FG004|Treatment Period|Adverse event unrelated to drug|2|||
131953142|NCT02574078|475115711|FG005|Treatment Period|Adverse event unrelated to drug|3|||
131953143|NCT02574078|475115712|FG006|Treatment Period|Adverse event unrelated to drug|0|||
131953144|NCT02574078|475115713|FG007|Treatment Period|Adverse event unrelated to drug|0|||
131953145|NCT02574078|475115714|FG008|Treatment Period|Adverse event unrelated to drug|1|||
131953146|NCT02574078|475115715|FG009|Treatment Period|Adverse event unrelated to drug|2|||
131953147|NCT02574078|475115716|FG010|Treatment Period|Adverse event unrelated to drug|4|||
131953148|NCT02574078|475115717|FG011|Treatment Period|Adverse event unrelated to drug|1|||
131953149|NCT02574078|475115718|FG012|Treatment Period|Adverse event unrelated to drug|0|||
131953150|NCT02574078|475115706|FG000|Treatment Period|Administrative reason by Sponsor|0|||
131953151|NCT02574078|475115707|FG001|Treatment Period|Administrative reason by Sponsor|1|||
131953152|NCT02574078|475115708|FG002|Treatment Period|Administrative reason by Sponsor|0|||
131953153|NCT02574078|475115709|FG003|Treatment Period|Administrative reason by Sponsor|0|||
131953154|NCT02574078|475115710|FG004|Treatment Period|Administrative reason by Sponsor|0|||
131953155|NCT02574078|475115711|FG005|Treatment Period|Administrative reason by Sponsor|0|||
131953156|NCT02574078|475115712|FG006|Treatment Period|Administrative reason by Sponsor|1|||
131953157|NCT02574078|475115713|FG007|Treatment Period|Administrative reason by Sponsor|0|||
131953158|NCT02574078|475115714|FG008|Treatment Period|Administrative reason by Sponsor|0|||
131953159|NCT02574078|475115715|FG009|Treatment Period|Administrative reason by Sponsor|0|||
131953160|NCT02574078|475115716|FG010|Treatment Period|Administrative reason by Sponsor|0|||
131953161|NCT02574078|475115717|FG011|Treatment Period|Administrative reason by Sponsor|0|||
131953162|NCT02574078|475115718|FG012|Treatment Period|Administrative reason by Sponsor|3|||
131953163|NCT02574078|475115706|FG000|Treatment Period|Other reasons|1|||
131953164|NCT02574078|475115707|FG001|Treatment Period|Other reasons|0|||
131953165|NCT02574078|475115708|FG002|Treatment Period|Other reasons|1|||
131953166|NCT02574078|475115709|FG003|Treatment Period|Other reasons|3|||
131953167|NCT02574078|475115710|FG004|Treatment Period|Other reasons|3|||
131953168|NCT02574078|475115711|FG005|Treatment Period|Other reasons|1|||
131953169|NCT02574078|475115712|FG006|Treatment Period|Other reasons|2|||
131953170|NCT02574078|475115713|FG007|Treatment Period|Other reasons|1|||
131953171|NCT02574078|475115714|FG008|Treatment Period|Other reasons|3|||
131953172|NCT02574078|475115715|FG009|Treatment Period|Other reasons|1|||
131953173|NCT02574078|475115716|FG010|Treatment Period|Other reasons|1|||
131953174|NCT02574078|475115717|FG011|Treatment Period|Other reasons|3|||
131953175|NCT02574078|475115718|FG012|Treatment Period|Other reasons|1|||
131953176|NCT02574078|475115706|FG000|Treatment Period|Participant request to stop drug|0|||
131953177|NCT02574078|475115707|FG001|Treatment Period|Participant request to stop drug|0|||
131953178|NCT02574078|475115708|FG002|Treatment Period|Participant request to stop drug|0|||
131953179|NCT02574078|475115709|FG003|Treatment Period|Participant request to stop drug|2|||
131953180|NCT02574078|475115710|FG004|Treatment Period|Participant request to stop drug|4|||
131953181|NCT02574078|475115711|FG005|Treatment Period|Participant request to stop drug|0|||
131953182|NCT02574078|475115712|FG006|Treatment Period|Participant request to stop drug|1|||
131953183|NCT02574078|475115713|FG007|Treatment Period|Participant request to stop drug|0|||
131953184|NCT02574078|475115714|FG008|Treatment Period|Participant request to stop drug|3|||
131953185|NCT02574078|475115715|FG009|Treatment Period|Participant request to stop drug|2|||
131953186|NCT02574078|475115716|FG010|Treatment Period|Participant request to stop drug|2|||
131953187|NCT02574078|475115717|FG011|Treatment Period|Participant request to stop drug|4|||
131953188|NCT02574078|475115718|FG012|Treatment Period|Participant request to stop drug|1|||
131953189|NCT02574078|475115706|FG000|Treatment Period|Participant withdrew consent|0|||
131953190|NCT02574078|475115707|FG001|Treatment Period|Participant withdrew consent|0|||
131953191|NCT02574078|475115708|FG002|Treatment Period|Participant withdrew consent|0|||
131953192|NCT02574078|475115709|FG003|Treatment Period|Participant withdrew consent|0|||
131953193|NCT02574078|475115710|FG004|Treatment Period|Participant withdrew consent|1|||
131953194|NCT02574078|475115711|FG005|Treatment Period|Participant withdrew consent|1|||
131953195|NCT02574078|475115712|FG006|Treatment Period|Participant withdrew consent|0|||
131953196|NCT02574078|475115713|FG007|Treatment Period|Participant withdrew consent|1|||
131953197|NCT02574078|475115714|FG008|Treatment Period|Participant withdrew consent|0|||
131953198|NCT02574078|475115715|FG009|Treatment Period|Participant withdrew consent|2|||
131953199|NCT02574078|475115716|FG010|Treatment Period|Participant withdrew consent|1|||
131953200|NCT02574078|475115717|FG011|Treatment Period|Participant withdrew consent|4|||
131415263|NCT02408523|473145222|FG001|Overall Study|Lost to Follow-up|3|||
131415264|NCT02408523|473145221|FG000|Overall Study|Withdrawal by Subject|3|||
131953201|NCT02574078|475115718|FG012|Treatment Period|Participant withdrew consent|1|||
131953202|NCT02574078|475115706|FG000|Treatment Period|Participant no longer meets criteria|0|||
131953203|NCT02574078|475115707|FG001|Treatment Period|Participant no longer meets criteria|0|||
131953204|NCT02574078|475115708|FG002|Treatment Period|Participant no longer meets criteria|0|||
131953205|NCT02574078|475115709|FG003|Treatment Period|Participant no longer meets criteria|0|||
131953206|NCT02574078|475115710|FG004|Treatment Period|Participant no longer meets criteria|1|||
131953207|NCT02574078|475115711|FG005|Treatment Period|Participant no longer meets criteria|0|||
131953208|NCT02574078|475115712|FG006|Treatment Period|Participant no longer meets criteria|0|||
131415265|NCT02408523|473145222|FG001|Overall Study|Withdrawal by Subject|1|||
131953209|NCT02574078|475115713|FG007|Treatment Period|Participant no longer meets criteria|0|||
131953210|NCT02574078|475115714|FG008|Treatment Period|Participant no longer meets criteria|0|||
131953211|NCT02574078|475115715|FG009|Treatment Period|Participant no longer meets criteria|1|||
131953212|NCT02574078|475115716|FG010|Treatment Period|Participant no longer meets criteria|1|||
131953213|NCT02574078|475115717|FG011|Treatment Period|Participant no longer meets criteria|1|||
131953214|NCT02574078|475115718|FG012|Treatment Period|Participant no longer meets criteria|0|||
131953215|NCT02574078|475115706|FG000|Treatment Period|Lost to Follow-up|0|||
131953216|NCT02574078|475115707|FG001|Treatment Period|Lost to Follow-up|0|||
131953217|NCT02574078|475115708|FG002|Treatment Period|Lost to Follow-up|0|||
131953218|NCT02574078|475115709|FG003|Treatment Period|Lost to Follow-up|0|||
131953219|NCT02574078|475115710|FG004|Treatment Period|Lost to Follow-up|0|||
131953220|NCT02574078|475115711|FG005|Treatment Period|Lost to Follow-up|0|||
131953221|NCT02574078|475115712|FG006|Treatment Period|Lost to Follow-up|0|||
131953222|NCT02574078|475115713|FG007|Treatment Period|Lost to Follow-up|0|||
131953223|NCT02574078|475115714|FG008|Treatment Period|Lost to Follow-up|0|||
131953224|NCT02574078|475115715|FG009|Treatment Period|Lost to Follow-up|1|||
131953225|NCT02574078|475115716|FG010|Treatment Period|Lost to Follow-up|0|||
131953226|NCT02574078|475115717|FG011|Treatment Period|Lost to Follow-up|1|||
131953227|NCT02574078|475115718|FG012|Treatment Period|Lost to Follow-up|0|||
131953228|NCT02574078|475115706|FG000|Treatment Period|Maximum clinical benefit|0|||
131953229|NCT02574078|475115707|FG001|Treatment Period|Maximum clinical benefit|0|||
131953230|NCT02574078|475115708|FG002|Treatment Period|Maximum clinical benefit|0|||
131953231|NCT02574078|475115709|FG003|Treatment Period|Maximum clinical benefit|0|||
131953232|NCT02574078|475115710|FG004|Treatment Period|Maximum clinical benefit|0|||
131953233|NCT02574078|475115711|FG005|Treatment Period|Maximum clinical benefit|0|||
131953234|NCT02574078|475115712|FG006|Treatment Period|Maximum clinical benefit|0|||
131953235|NCT02574078|475115713|FG007|Treatment Period|Maximum clinical benefit|0|||
131953236|NCT02574078|475115714|FG008|Treatment Period|Maximum clinical benefit|0|||
131953237|NCT02574078|475115715|FG009|Treatment Period|Maximum clinical benefit|1|||
131953238|NCT02574078|475115716|FG010|Treatment Period|Maximum clinical benefit|0|||
131953239|NCT02574078|475115717|FG011|Treatment Period|Maximum clinical benefit|0|||
131953240|NCT02574078|475115718|FG012|Treatment Period|Maximum clinical benefit|0|||
131953241|NCT03037476|475115722|FG000|Overall Study|Lost to Follow-up|63|||
131953242|NCT03037476|475115723|FG001|Overall Study|Lost to Follow-up|46|||
131953243|NCT00711594|475115724|FG000|Overall Study|Progressive disease|2|||
131953244|NCT00711594|475115725|FG001|Overall Study|Progressive disease|2|||
131953245|NCT00711594|475115726|FG002|Overall Study|Progressive disease|6|||
131953246|NCT00711594|475115727|FG003|Overall Study|Progressive disease|44|||
131953247|NCT00711594|475115724|FG000|Overall Study|Other Adverse Event|1|||
131953248|NCT00711594|475115725|FG001|Overall Study|Other Adverse Event|0|||
131953249|NCT00711594|475115726|FG002|Overall Study|Other Adverse Event|0|||
131953250|NCT00711594|475115727|FG003|Overall Study|Other Adverse Event|16|||
131953251|NCT00711594|475115724|FG000|Overall Study|Withdrawal by Subject|0|||
131953252|NCT00711594|475115725|FG001|Overall Study|Withdrawal by Subject|1|||
131953253|NCT00711594|475115726|FG002|Overall Study|Withdrawal by Subject|0|||
131953254|NCT00711594|475115727|FG003|Overall Study|Withdrawal by Subject|2|||
131953255|NCT00984165|475115728|FG000|Overall Study|Death on study|2|||
131953256|NCT00984165|475115729|FG001|Overall Study|Death on study|0|||
131953257|NCT00984165|475115730|FG002|Overall Study|Death on study|0|||
131953258|NCT00984165|475115731|FG003|Overall Study|Death on study|0|||
131953259|NCT00984165|475115728|FG000|Overall Study|Disease progression on study|5|||
131953260|NCT00984165|475115729|FG001|Overall Study|Disease progression on study|1|||
131953261|NCT00984165|475115730|FG002|Overall Study|Disease progression on study|0|||
131953262|NCT00984165|475115731|FG003|Overall Study|Disease progression on study|0|||
131953263|NCT00984165|475115728|FG000|Overall Study|Death of recipient|0|||
131953264|NCT00984165|475115729|FG001|Overall Study|Death of recipient|0|||
131953265|NCT00984165|475115730|FG002|Overall Study|Death of recipient|0|||
131953266|NCT00984165|475115731|FG003|Overall Study|Death of recipient|1|||
131953267|NCT00984165|475115728|FG000|Overall Study|New protocol|0|||
131953268|NCT00984165|475115729|FG001|Overall Study|New protocol|0|||
131953269|NCT00984165|475115730|FG002|Overall Study|New protocol|0|||
131953270|NCT00984165|475115731|FG003|Overall Study|New protocol|1|||
131953271|NCT00984165|475115728|FG000|Overall Study|P+/donor pair removed from protocol|0|||
131953272|NCT00984165|475115729|FG001|Overall Study|P+/donor pair removed from protocol|0|||
131457098|NCT02152956|473303068|FG000|Overall Study|Study terminated by sponsor|0|||
131953273|NCT00984165|475115730|FG002|Overall Study|P+/donor pair removed from protocol|0|||
131953274|NCT00984165|475115731|FG003|Overall Study|P+/donor pair removed from protocol|1|||
131953275|NCT00984165|475115728|FG000|Overall Study|removed with a pair recipient|0|||
131953276|NCT00984165|475115729|FG001|Overall Study|removed with a pair recipient|0|||
131953277|NCT00984165|475115730|FG002|Overall Study|removed with a pair recipient|0|||
131953278|NCT00984165|475115731|FG003|Overall Study|removed with a pair recipient|1|||
131953279|NCT00466947|475115732|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
131457099|NCT02152956|473303069|FG001|Overall Study|Study terminated by sponsor|0|||
131457100|NCT02152956|473303070|FG002|Overall Study|Study terminated by sponsor|0|||
131953280|NCT00466947|475115733|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
131953281|NCT00466947|475115732|FG000|Study End Analysis Period|Adverse Event|35|||
131953282|NCT00466947|475115733|FG001|Study End Analysis Period|Adverse Event|43|||
131953283|NCT00466947|475115732|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
131953284|NCT00466947|475115733|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
131953285|NCT00466947|475115732|FG000|Study End Analysis Period|Physician Decision|29|||
131953286|NCT00466947|475115733|FG001|Study End Analysis Period|Physician Decision|29|||
131953287|NCT00466947|475115732|FG000|Study End Analysis Period|Protocol Violation|9|||
131953288|NCT00466947|475115733|FG001|Study End Analysis Period|Protocol Violation|17|||
131953289|NCT00466947|475115732|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
131953290|NCT00466947|475115733|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
131953291|NCT00466947|475115732|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
131953292|NCT00466947|475115733|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
131953293|NCT00466947|475115732|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
131953294|NCT00466947|475115733|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
131953295|NCT00466947|475115732|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
131953296|NCT00466947|475115733|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
131953297|NCT01995526|475115734|FG000|Overall Study|Physician Decision|1|||
131953298|NCT00135330|475115739|FG000|Overall Study|Adverse Event|2|||
131953299|NCT00135330|475115740|FG001|Overall Study|Adverse Event|5|||
131953300|NCT00135330|475115741|FG002|Overall Study|Adverse Event|1|||
131953301|NCT00135330|475115739|FG000|Overall Study|Lost to Follow-up|0|||
131953302|NCT00135330|475115740|FG001|Overall Study|Lost to Follow-up|2|||
131953303|NCT00135330|475115741|FG002|Overall Study|Lost to Follow-up|3|||
131953304|NCT00135330|475115739|FG000|Overall Study|Physician Decision|1|||
131953305|NCT00135330|475115740|FG001|Overall Study|Physician Decision|1|||
131953306|NCT00135330|475115741|FG002|Overall Study|Physician Decision|0|||
131953307|NCT00135330|475115739|FG000|Overall Study|Protocol Violation|4|||
131953308|NCT00135330|475115740|FG001|Overall Study|Protocol Violation|3|||
131953309|NCT00135330|475115741|FG002|Overall Study|Protocol Violation|3|||
131953310|NCT00135330|475115739|FG000|Overall Study|Patient Decision|5|||
131953311|NCT00135330|475115740|FG001|Overall Study|Patient Decision|1|||
131953312|NCT00135330|475115741|FG002|Overall Study|Patient Decision|4|||
131953313|NCT00135330|475115739|FG000|Overall Study|Sponsor Decision|0|||
131953314|NCT00135330|475115740|FG001|Overall Study|Sponsor Decision|1|||
131953315|NCT00135330|475115741|FG002|Overall Study|Sponsor Decision|0|||
131953316|NCT00104416|475115743|FG000|Double-Blind Phase|Adverse Event|2|||
131953317|NCT00104416|475115744|FG001|Double-Blind Phase|Adverse Event|1|||
131953318|NCT00104416|475115745|FG002|Double-Blind Phase|Adverse Event|0|||
131953319|NCT00104416|475115746|FG003|Double-Blind Phase|Adverse Event|0|||
131953320|NCT00104416|475115747|FG004|Double-Blind Phase|Adverse Event|0|||
131953321|NCT00104416|475115743|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131953322|NCT00104416|475115744|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131953323|NCT00104416|475115745|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131953324|NCT00104416|475115746|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131953325|NCT00104416|475115747|FG004|Double-Blind Phase|Lost to Follow-up|0|||
131953326|NCT00104416|475115743|FG000|Double-Blind Phase|Protocol Violation|0|||
131953327|NCT00104416|475115744|FG001|Double-Blind Phase|Protocol Violation|1|||
131953328|NCT00104416|475115745|FG002|Double-Blind Phase|Protocol Violation|0|||
131953329|NCT00104416|475115746|FG003|Double-Blind Phase|Protocol Violation|0|||
131953330|NCT00104416|475115747|FG004|Double-Blind Phase|Protocol Violation|0|||
131953331|NCT00104416|475115743|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
131953332|NCT00104416|475115744|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
131953333|NCT00104416|475115745|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131953334|NCT00104416|475115746|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131953335|NCT00104416|475115747|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
131953336|NCT00104416|475115743|FG000|Double-Blind Phase|Pregnancy|1|||
131953337|NCT00104416|475115744|FG001|Double-Blind Phase|Pregnancy|0|||
131953338|NCT00104416|475115745|FG002|Double-Blind Phase|Pregnancy|0|||
131415266|NCT02408523|473145221|FG000|Overall Study|Sponsor request|1|||
131415267|NCT02408523|473145222|FG001|Overall Study|Sponsor request|0|||
131415268|NCT02408523|473145221|FG000|Overall Study|Did not satisfy extension conditions|0|||
131415269|NCT02408523|473145222|FG001|Overall Study|Did not satisfy extension conditions|1|||
131415270|NCT00701805|473145223|FG000|Overall Study|Withdrawal by Subject|3|||
131953339|NCT00104416|475115746|FG003|Double-Blind Phase|Pregnancy|0|||
131953340|NCT00104416|475115747|FG004|Double-Blind Phase|Pregnancy|0|||
131953341|NCT00104416|475115743|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
131953342|NCT00104416|475115744|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
131953343|NCT00104416|475115745|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
131953344|NCT00104416|475115746|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
131953345|NCT00104416|475115747|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
131953346|NCT00104416|475115743|FG000|Continuation Phase|Adverse Event|0|||
131953347|NCT00104416|475115744|FG001|Continuation Phase|Adverse Event|0|||
131953348|NCT00104416|475115745|FG002|Continuation Phase|Adverse Event|2|||
131953349|NCT00104416|475115746|FG003|Continuation Phase|Adverse Event|0|||
131953350|NCT00104416|475115747|FG004|Continuation Phase|Adverse Event|2|||
131953351|NCT00104416|475115743|FG000|Continuation Phase|Lost to Follow-up|0|||
131953352|NCT00104416|475115744|FG001|Continuation Phase|Lost to Follow-up|0|||
131953353|NCT00104416|475115745|FG002|Continuation Phase|Lost to Follow-up|1|||
131953354|NCT00104416|475115746|FG003|Continuation Phase|Lost to Follow-up|0|||
131953355|NCT00104416|475115747|FG004|Continuation Phase|Lost to Follow-up|1|||
131953356|NCT00104416|475115743|FG000|Continuation Phase|Withdrawal by Subject|0|||
131953357|NCT00104416|475115744|FG001|Continuation Phase|Withdrawal by Subject|0|||
131953358|NCT00104416|475115745|FG002|Continuation Phase|Withdrawal by Subject|2|||
131953359|NCT00104416|475115746|FG003|Continuation Phase|Withdrawal by Subject|1|||
131953360|NCT00104416|475115747|FG004|Continuation Phase|Withdrawal by Subject|1|||
131953361|NCT00104416|475115743|FG000|Continuation Phase|Pregnancy|0|||
131953362|NCT00104416|475115744|FG001|Continuation Phase|Pregnancy|0|||
131953363|NCT00104416|475115745|FG002|Continuation Phase|Pregnancy|1|||
131953364|NCT00104416|475115746|FG003|Continuation Phase|Pregnancy|1|||
131953365|NCT00104416|475115747|FG004|Continuation Phase|Pregnancy|0|||
131953366|NCT00104416|475115743|FG000|Continuation Phase|Non-compliance|0|||
131953367|NCT00104416|475115744|FG001|Continuation Phase|Non-compliance|0|||
131953368|NCT00104416|475115745|FG002|Continuation Phase|Non-compliance|0|||
131953369|NCT00104416|475115746|FG003|Continuation Phase|Non-compliance|0|||
131953370|NCT00104416|475115747|FG004|Continuation Phase|Non-compliance|1|||
131953371|NCT01309997|475115748|FG000|Overall Study|Adverse Event|1|||
131953372|NCT01309997|475115749|FG001|Overall Study|Adverse Event|0|||
131953373|NCT01309997|475115748|FG000|Overall Study|Death|1|||
131953374|NCT01309997|475115749|FG001|Overall Study|Death|3|||
131953375|NCT01309997|475115748|FG000|Overall Study|Lack of Efficacy|2|||
131953376|NCT01309997|475115749|FG001|Overall Study|Lack of Efficacy|2|||
131953377|NCT01309997|475115748|FG000|Overall Study|Withdrawal by Subject|1|||
131953378|NCT01309997|475115749|FG001|Overall Study|Withdrawal by Subject|1|||
131953379|NCT03462641|475115752|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
131953380|NCT03462641|475115753|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
131953381|NCT03462641|475115752|FG000|Visit 2|Withdrawal by Subject|0|||
131953382|NCT03462641|475115753|FG001|Visit 2|Withdrawal by Subject|1|||
131953383|NCT02096952|475115754|FG000|Overall Study|Adverse Event|1|||
131953384|NCT00372619|475115755|FG000|Overall Study|Ineligible|0|||
131953385|NCT00372619|475115756|FG001|Overall Study|Ineligible|0|||
131953386|NCT00372619|475115757|FG002|Overall Study|Ineligible|0|||
131953387|NCT00372619|475115758|FG003|Overall Study|Ineligible|0|||
131953388|NCT00372619|475115759|FG004|Overall Study|Ineligible|0|||
131953389|NCT00372619|475115760|FG005|Overall Study|Ineligible|2|||
131953390|NCT00372619|475115761|FG006|Overall Study|Ineligible|0|||
131953391|NCT00372619|475115755|FG000|Overall Study|Inevaluable|0|||
131953392|NCT00372619|475115756|FG001|Overall Study|Inevaluable|0|||
131953393|NCT00372619|475115757|FG002|Overall Study|Inevaluable|0|||
131953394|NCT00372619|475115758|FG003|Overall Study|Inevaluable|0|||
131953395|NCT00372619|475115759|FG004|Overall Study|Inevaluable|0|||
131953396|NCT00372619|475115760|FG005|Overall Study|Inevaluable|1|||
131953397|NCT00372619|475115761|FG006|Overall Study|Inevaluable|0|||
131953398|NCT02684617|475115762|FG000|Overall Study|Adverse Event|1|||
131953399|NCT02684617|475115763|FG001|Overall Study|Adverse Event|0|||
131953400|NCT02684617|475115764|FG002|Overall Study|Adverse Event|1|||
131953401|NCT02684617|475115762|FG000|Overall Study|Death|8|||
131953402|NCT02684617|475115763|FG001|Overall Study|Death|16|||
131953403|NCT02684617|475115764|FG002|Overall Study|Death|28|||
131953404|NCT02684617|475115762|FG000|Overall Study|Withdrawal by Subject|2|||
131953405|NCT02684617|475115763|FG001|Overall Study|Withdrawal by Subject|0|||
131953406|NCT02684617|475115764|FG002|Overall Study|Withdrawal by Subject|4|||
131953407|NCT02684617|475115762|FG000|Overall Study|Screen Failure|1|||
131953408|NCT02684617|475115763|FG001|Overall Study|Screen Failure|0|||
131415271|NCT00701805|473145224|FG001|Overall Study|Withdrawal by Subject|1|||
131415272|NCT00701805|473145225|FG002|Overall Study|Withdrawal by Subject|4|||
131415273|NCT00701805|473145226|FG003|Overall Study|Withdrawal by Subject|3|||
131953409|NCT02684617|475115764|FG002|Overall Study|Screen Failure|2|||
131953410|NCT02684617|475115762|FG000|Overall Study|Study Terminated by Sponsor|6|||
131953411|NCT02684617|475115763|FG001|Overall Study|Study Terminated by Sponsor|1|||
131953412|NCT02684617|475115764|FG002|Overall Study|Study Terminated by Sponsor|5|||
131953413|NCT01524224|475115771|FG000|Overall Study|Progressive Disease|1|||
131953414|NCT01524224|475115772|FG001|Overall Study|Progressive Disease|0|||
131953415|NCT01524224|475115773|FG002|Overall Study|Progressive Disease|2|||
131953416|NCT01524224|475115774|FG003|Overall Study|Progressive Disease|1|||
131953417|NCT01524224|475115775|FG004|Overall Study|Progressive Disease|2|||
131953418|NCT01524224|475115776|FG005|Overall Study|Progressive Disease|1|||
131953419|NCT01524224|475115777|FG006|Overall Study|Progressive Disease|1|||
131953420|NCT01524224|475115778|FG007|Overall Study|Progressive Disease|5|||
131953421|NCT01524224|475115771|FG000|Overall Study|Withdrawal by Subject|2|||
131953422|NCT01524224|475115772|FG001|Overall Study|Withdrawal by Subject|0|||
131953423|NCT01524224|475115773|FG002|Overall Study|Withdrawal by Subject|0|||
131953424|NCT01524224|475115774|FG003|Overall Study|Withdrawal by Subject|0|||
131953425|NCT01524224|475115775|FG004|Overall Study|Withdrawal by Subject|0|||
131953426|NCT01524224|475115776|FG005|Overall Study|Withdrawal by Subject|0|||
131953427|NCT01524224|475115777|FG006|Overall Study|Withdrawal by Subject|2|||
131953428|NCT01524224|475115778|FG007|Overall Study|Withdrawal by Subject|0|||
131953429|NCT01524224|475115771|FG000|Overall Study|Adverse Event|0|||
131953430|NCT01524224|475115772|FG001|Overall Study|Adverse Event|1|||
131953431|NCT01524224|475115773|FG002|Overall Study|Adverse Event|0|||
131953432|NCT01524224|475115774|FG003|Overall Study|Adverse Event|0|||
131953433|NCT01524224|475115775|FG004|Overall Study|Adverse Event|0|||
131953434|NCT01524224|475115776|FG005|Overall Study|Adverse Event|1|||
131953435|NCT01524224|475115777|FG006|Overall Study|Adverse Event|0|||
131953436|NCT01524224|475115778|FG007|Overall Study|Adverse Event|0|||
131953437|NCT01524224|475115771|FG000|Overall Study|Physician Decision|0|||
131953438|NCT01524224|475115772|FG001|Overall Study|Physician Decision|0|||
131953439|NCT01524224|475115773|FG002|Overall Study|Physician Decision|0|||
131953440|NCT01524224|475115774|FG003|Overall Study|Physician Decision|1|||
131953441|NCT01524224|475115775|FG004|Overall Study|Physician Decision|1|||
131953442|NCT01524224|475115776|FG005|Overall Study|Physician Decision|0|||
131953443|NCT01524224|475115777|FG006|Overall Study|Physician Decision|0|||
131953444|NCT01524224|475115778|FG007|Overall Study|Physician Decision|1|||
131953445|NCT01524224|475115771|FG000|Overall Study|Sponsor Decision|0|||
131953446|NCT01524224|475115772|FG001|Overall Study|Sponsor Decision|0|||
131953447|NCT01524224|475115773|FG002|Overall Study|Sponsor Decision|0|||
131953448|NCT01524224|475115774|FG003|Overall Study|Sponsor Decision|0|||
131953449|NCT01524224|475115775|FG004|Overall Study|Sponsor Decision|1|||
131953450|NCT01524224|475115776|FG005|Overall Study|Sponsor Decision|0|||
131953451|NCT01524224|475115777|FG006|Overall Study|Sponsor Decision|0|||
131953452|NCT01524224|475115778|FG007|Overall Study|Sponsor Decision|0|||
131953453|NCT05420961|475115780|FG000|Overall Study|Withdrawal by Subject|2|||
131953454|NCT05420961|475115781|FG001|Overall Study|Withdrawal by Subject|1|||
131953455|NCT05420961|475115782|FG002|Overall Study|Withdrawal by Subject|1|||
131953456|NCT05420961|475115783|FG003|Overall Study|Withdrawal by Subject|0|||
131953457|NCT05420961|475115784|FG004|Overall Study|Withdrawal by Subject|0|||
131953458|NCT05420961|475115780|FG000|Overall Study|Lost to Follow-up|0|||
131953459|NCT05420961|475115781|FG001|Overall Study|Lost to Follow-up|0|||
131953460|NCT05420961|475115782|FG002|Overall Study|Lost to Follow-up|1|||
131953461|NCT05420961|475115783|FG003|Overall Study|Lost to Follow-up|0|||
131953462|NCT05420961|475115784|FG004|Overall Study|Lost to Follow-up|0|||
131953463|NCT05420961|475115780|FG000|Overall Study|Randomized by mistake without study treatment|0|||
131953464|NCT05420961|475115781|FG001|Overall Study|Randomized by mistake without study treatment|0|||
131953465|NCT05420961|475115782|FG002|Overall Study|Randomized by mistake without study treatment|1|||
131953466|NCT05420961|475115783|FG003|Overall Study|Randomized by mistake without study treatment|0|||
131953467|NCT05420961|475115784|FG004|Overall Study|Randomized by mistake without study treatment|1|||
131953468|NCT04283656|475115785|FG000|Overall Study|Adverse Event|1|||
131953469|NCT04283656|475115786|FG001|Overall Study|Adverse Event|0|||
131953470|NCT04283656|475115785|FG000|Overall Study|Lost to Follow-up|0|||
131953471|NCT04283656|475115786|FG001|Overall Study|Lost to Follow-up|1|||
131953472|NCT02318368|475115787|FG000|Overall Study|Withdrawal by Subject|2|||
131953473|NCT02318368|475115788|FG001|Overall Study|Withdrawal by Subject|0|||
131953474|NCT02318368|475115787|FG000|Overall Study|Study terminated by the sponsor|5|||
131953475|NCT02318368|475115788|FG001|Overall Study|Study terminated by the sponsor|2|||
131953476|NCT02318368|475115787|FG000|Overall Study|Death|0|||
131953477|NCT02318368|475115788|FG001|Overall Study|Death|1|||
131953478|NCT02201329|475115789|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
131953479|NCT02201329|475115789|FG000|Overall Study|Withdrawal by Subject|2|||
131953480|NCT00935493|475115790|FG000|Overall Study|Lost to Follow-up|1|||
131953481|NCT00935493|475115791|FG001|Overall Study|Lost to Follow-up|1|||
131953482|NCT00935493|475115792|FG002|Overall Study|Lost to Follow-up|1|||
131953483|NCT00935493|475115790|FG000|Overall Study|Treatment Discontinued|0|||
131953484|NCT00935493|475115791|FG001|Overall Study|Treatment Discontinued|1|||
131953485|NCT00935493|475115792|FG002|Overall Study|Treatment Discontinued|0|||
131953486|NCT02091362|475115804|FG000|Period 1|Protocol Violation|1|||
131953487|NCT02091362|475115805|FG001|Period 1|Protocol Violation|0|||
131415274|NCT00701805|473145223|FG000|Overall Study|Adverse Event|0|||
131415275|NCT00701805|473145224|FG001|Overall Study|Adverse Event|1|||
131415276|NCT00701805|473145225|FG002|Overall Study|Adverse Event|1|||
131953488|NCT02091362|475115804|FG000|Period 1|Withdrawal by Subject|2|||
131953489|NCT02091362|475115805|FG001|Period 1|Withdrawal by Subject|3|||
131953490|NCT02091362|475115804|FG000|Period 1|Lost to Follow-up|0|||
131953491|NCT02091362|475115805|FG001|Period 1|Lost to Follow-up|1|||
131953492|NCT02091362|475115804|FG000|Period 1|Adverse Event|2|||
131415277|NCT00701805|473145226|FG003|Overall Study|Adverse Event|0|||
131953493|NCT02091362|475115805|FG001|Period 1|Adverse Event|0|||
131953494|NCT02091362|475115804|FG000|Wash-out|Lost to Follow-up|1|||
131953495|NCT02091362|475115805|FG001|Wash-out|Lost to Follow-up|1|||
131953496|NCT02091362|475115804|FG000|Wash-out|Withdrawal by Subject|0|||
131953497|NCT02091362|475115805|FG001|Wash-out|Withdrawal by Subject|2|||
131953498|NCT02091362|475115804|FG000|Period 2|Adverse Event|1|||
131953499|NCT02091362|475115805|FG001|Period 2|Adverse Event|0|||
131953500|NCT02091362|475115804|FG000|Period 2|Lost to Follow-up|0|||
131953501|NCT02091362|475115805|FG001|Period 2|Lost to Follow-up|1|||
131953502|NCT02091362|475115804|FG000|Period 2|Withdrawal by Subject|1|||
131953503|NCT02091362|475115805|FG001|Period 2|Withdrawal by Subject|1|||
131953504|NCT00690430|475115806|FG000|Core Phase|Abnormal Laboratory value|0|||
131953505|NCT00690430|475115807|FG001|Core Phase|Abnormal Laboratory value|1|||
131953506|NCT00690430|475115808|FG002|Core Phase|Abnormal Laboratory value|0|||
131953507|NCT00690430|475115806|FG000|Core Phase|Adverse Event|5|||
131953508|NCT00690430|475115807|FG001|Core Phase|Adverse Event|1|||
131953509|NCT00690430|475115808|FG002|Core Phase|Adverse Event|0|||
131953510|NCT00690430|475115806|FG000|Core Phase|Death|0|||
131953511|NCT00690430|475115807|FG001|Core Phase|Death|2|||
131953512|NCT00690430|475115808|FG002|Core Phase|Death|0|||
131953513|NCT00690430|475115806|FG000|Core Phase|Protocol Violation|1|||
131953514|NCT00690430|475115807|FG001|Core Phase|Protocol Violation|0|||
131953515|NCT00690430|475115808|FG002|Core Phase|Protocol Violation|0|||
131953516|NCT00690430|475115806|FG000|Core Phase|Withdrawal by Subject|3|||
131953517|NCT00690430|475115807|FG001|Core Phase|Withdrawal by Subject|3|||
131953518|NCT00690430|475115808|FG002|Core Phase|Withdrawal by Subject|0|||
131953519|NCT00690430|475115806|FG000|Core Phase|Subject no longer requires study drug|1|||
131953520|NCT00690430|475115807|FG001|Core Phase|Subject no longer requires study drug|0|||
131953521|NCT00690430|475115808|FG002|Core Phase|Subject no longer requires study drug|0|||
131953522|NCT00690430|475115806|FG000|Core Phase|Lack of Efficacy|8|||
131953523|NCT00690430|475115807|FG001|Core Phase|Lack of Efficacy|10|||
131953524|NCT00690430|475115808|FG002|Core Phase|Lack of Efficacy|0|||
131953525|NCT00690430|475115806|FG000|Core Phase|Administrative Problems|0|||
131953526|NCT00690430|475115807|FG001|Core Phase|Administrative Problems|1|||
131953527|NCT00690430|475115808|FG002|Core Phase|Administrative Problems|0|||
131953528|NCT00690430|475115806|FG000|Core Phase|Early Termination|0|||
131953529|NCT00690430|475115807|FG001|Core Phase|Early Termination|5|||
131953530|NCT00690430|475115808|FG002|Core Phase|Early Termination|0|||
131953531|NCT00690430|475115806|FG000|Extension Phase|Lack of Efficacy|3|||
131953532|NCT00690430|475115807|FG001|Extension Phase|Lack of Efficacy|1|||
131953533|NCT00690430|475115808|FG002|Extension Phase|Lack of Efficacy|4|||
131953534|NCT00690430|475115806|FG000|Extension Phase|Abnormal Lab Values|1|||
131953535|NCT00690430|475115807|FG001|Extension Phase|Abnormal Lab Values|0|||
131953536|NCT00690430|475115808|FG002|Extension Phase|Abnormal Lab Values|0|||
131953537|NCT00690430|475115806|FG000|Extension Phase|Abnormal test procedure results|1|||
131953538|NCT00690430|475115807|FG001|Extension Phase|Abnormal test procedure results|0|||
131953539|NCT00690430|475115808|FG002|Extension Phase|Abnormal test procedure results|0|||
131953540|NCT00690430|475115806|FG000|Extension Phase|Administrative Problems|0|||
131953541|NCT00690430|475115807|FG001|Extension Phase|Administrative Problems|1|||
131953542|NCT00690430|475115808|FG002|Extension Phase|Administrative Problems|1|||
131953543|NCT00690430|475115806|FG000|Extension Phase|Adverse Event|2|||
131953544|NCT00690430|475115807|FG001|Extension Phase|Adverse Event|1|||
131953545|NCT00690430|475115808|FG002|Extension Phase|Adverse Event|2|||
131953546|NCT00690430|475115806|FG000|Extension Phase|Death|1|||
131953547|NCT00690430|475115807|FG001|Extension Phase|Death|1|||
131953548|NCT00690430|475115808|FG002|Extension Phase|Death|1|||
131953549|NCT00690430|475115806|FG000|Extension Phase|Withdrawal by Subject|0|||
131953550|NCT00690430|475115807|FG001|Extension Phase|Withdrawal by Subject|0|||
131953551|NCT00690430|475115808|FG002|Extension Phase|Withdrawal by Subject|2|||
131953552|NCT00690430|475115806|FG000|Extension Phase|Early Termination|10|||
131953553|NCT00690430|475115807|FG001|Extension Phase|Early Termination|1|||
131953554|NCT00690430|475115808|FG002|Extension Phase|Early Termination|3|||
131953555|NCT02125838|475115817|FG000|Overall Study|Lost to Follow-up|4|||
131953556|NCT02125838|475115818|FG001|Overall Study|Lost to Follow-up|4|||
131953557|NCT00787839|475115819|FG000|Overall Study|Failure to have the OGTT was most common|404|||
131953558|NCT02584452|475115826|FG000|Overall Study|Physician Decision|1|||
131953559|NCT02584452|475115827|FG001|Overall Study|Physician Decision|1|||
131953560|NCT02584452|475115826|FG000|Overall Study|Lost to Follow-up|1|||
131457101|NCT02152956|473303071|FG003|Overall Study|Study terminated by sponsor|0|||
131457102|NCT02152956|473303072|FG004|Overall Study|Study terminated by sponsor|0|||
131953561|NCT02584452|475115827|FG001|Overall Study|Lost to Follow-up|1|||
131953562|NCT02689206|475115828|FG000|Overall Study|Adverse Event|0|||
131953563|NCT02689206|475115829|FG001|Overall Study|Adverse Event|0|||
131457103|NCT02152956|473303073|FG005|Overall Study|Study terminated by sponsor|0|||
131457104|NCT02152956|473303074|FG006|Overall Study|Study terminated by sponsor|0|||
131457105|NCT02152956|473303075|FG007|Overall Study|Study terminated by sponsor|0|||
131457106|NCT02152956|473303076|FG008|Overall Study|Study terminated by sponsor|0|||
131953564|NCT02689206|475115830|FG002|Overall Study|Adverse Event|1|||
131953565|NCT02689206|475115831|FG003|Overall Study|Adverse Event|0|||
131953566|NCT02689206|475115832|FG004|Overall Study|Adverse Event|2|||
131953567|NCT02689206|475115828|FG000|Overall Study|Protocol Violation|1|||
131953568|NCT02689206|475115829|FG001|Overall Study|Protocol Violation|0|||
131953569|NCT02689206|475115830|FG002|Overall Study|Protocol Violation|0|||
131953570|NCT02689206|475115831|FG003|Overall Study|Protocol Violation|1|||
131953571|NCT02689206|475115832|FG004|Overall Study|Protocol Violation|2|||
131953572|NCT02689206|475115828|FG000|Overall Study|Other: Reached stopping criteria|0|||
131953573|NCT02689206|475115829|FG001|Overall Study|Other: Reached stopping criteria|1|||
131953574|NCT02689206|475115830|FG002|Overall Study|Other: Reached stopping criteria|2|||
131953575|NCT02689206|475115831|FG003|Overall Study|Other: Reached stopping criteria|3|||
131953576|NCT02689206|475115832|FG004|Overall Study|Other: Reached stopping criteria|4|||
131953577|NCT02689206|475115828|FG000|Overall Study|Physician Decision|1|||
131953578|NCT02689206|475115829|FG001|Overall Study|Physician Decision|0|||
131953579|NCT02689206|475115830|FG002|Overall Study|Physician Decision|0|||
131953580|NCT02689206|475115831|FG003|Overall Study|Physician Decision|0|||
131953581|NCT02689206|475115832|FG004|Overall Study|Physician Decision|0|||
131953582|NCT02689206|475115828|FG000|Overall Study|Withdrawal by Subject|1|||
131953583|NCT02689206|475115829|FG001|Overall Study|Withdrawal by Subject|0|||
131953584|NCT02689206|475115830|FG002|Overall Study|Withdrawal by Subject|1|||
131953585|NCT02689206|475115831|FG003|Overall Study|Withdrawal by Subject|0|||
131953586|NCT02689206|475115832|FG004|Overall Study|Withdrawal by Subject|0|||
131953587|NCT01558596|475115833|FG000|Overall Study|Withdrawal by Subject|1|||
131953588|NCT01558596|475115834|FG001|Overall Study|Withdrawal by Subject|0|||
131953589|NCT01558596|475115833|FG000|Overall Study|surgery elsewhere or cancelled|1|||
131953590|NCT01558596|475115834|FG001|Overall Study|surgery elsewhere or cancelled|1|||
131953591|NCT01558596|475115833|FG000|Overall Study|Protocol Violation|1|||
131953592|NCT01558596|475115834|FG001|Overall Study|Protocol Violation|0|||
131953593|NCT00902850|475115836|FG000|Overall Study|Physician Decision|2|||
131953594|NCT00902850|475115837|FG001|Overall Study|Physician Decision|2|||
131953595|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
131953596|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
131953597|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
131953598|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131953599|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131953600|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131953601|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131953602|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
131953603|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131953604|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131953605|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131953606|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131953607|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131953608|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
131953609|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
131953610|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
131953611|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
131953612|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131953613|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131953614|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131953615|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131953616|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
131953617|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
131953618|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131953619|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131953620|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131953621|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131953622|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131953623|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
131953624|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
131953625|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
131953626|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
131953627|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
131953628|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
131953629|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
131953630|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131953631|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
131953632|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131953633|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131953634|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131953635|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131953636|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131953637|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
131953638|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
131953639|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
131415278|NCT00701805|473145223|FG000|Overall Study|Missed 7 consecutive doses|0|||
131415279|NCT00701805|473145224|FG001|Overall Study|Missed 7 consecutive doses|1|||
131415280|NCT00701805|473145225|FG002|Overall Study|Missed 7 consecutive doses|0|||
131953640|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131953641|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131953642|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131953643|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131953644|NCT03745638|475115838|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
131953645|NCT03745638|475115839|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
131953646|NCT03745638|475115840|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
131953647|NCT03745638|475115841|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
131953648|NCT03745638|475115842|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
131953649|NCT03745638|475115843|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
131953650|NCT03745638|475115844|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
131953651|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131953652|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131953653|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131953654|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131953655|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131953656|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
131953657|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
131953658|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131953659|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131953660|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131953661|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
131953662|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131953663|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
131953664|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
131953665|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131953666|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131953667|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131953668|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
131953669|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
131953670|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
131953671|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
131953672|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131953673|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131953674|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131953675|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131953676|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
131953677|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
131953678|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131953679|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131953680|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131953681|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131953682|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131953683|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131953684|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
131953685|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131953686|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131953687|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131953688|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131953689|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
131953690|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
131953691|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
131953692|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
131953693|NCT03745638|475115838|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
131953694|NCT03745638|475115839|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
131953695|NCT03745638|475115840|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
131953696|NCT03745638|475115841|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
131953697|NCT03745638|475115842|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
131953698|NCT03745638|475115843|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
131953699|NCT03745638|475115844|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
131953700|NCT04470050|475115845|FG000|Double-blind Treatment Phase|Adverse Event|0|||
131953701|NCT04470050|475115846|FG001|Double-blind Treatment Phase|Adverse Event|0|||
131768899|NCT02500706|474431894|FG000|Overall Study|Lost to Follow-up|0|||
131953702|NCT04470050|475115847|FG002|Double-blind Treatment Phase|Adverse Event|0|||
131953703|NCT04470050|475115848|FG003|Double-blind Treatment Phase|Adverse Event|1|||
131953704|NCT04470050|475115849|FG004|Double-blind Treatment Phase|Adverse Event|0|||
131953705|NCT04470050|475115850|FG005|Double-blind Treatment Phase|Adverse Event|0|||
131953706|NCT04470050|475115851|FG006|Double-blind Treatment Phase|Adverse Event|0|||
131953707|NCT04470050|475115845|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131953708|NCT04470050|475115846|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
131953709|NCT04470050|475115847|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
131953710|NCT04470050|475115848|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
131953711|NCT04470050|475115849|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
131953712|NCT04470050|475115850|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
131953713|NCT04470050|475115851|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
131953714|NCT04470050|475115845|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
131953715|NCT04470050|475115846|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
131953716|NCT04470050|475115847|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
131953717|NCT04470050|475115848|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
131953718|NCT04470050|475115849|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
131953719|NCT04470050|475115850|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
131953720|NCT04470050|475115851|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
131953721|NCT04295759|475115852|FG000|Overall Study|Lack of Efficacy|9|||
131953722|NCT04295759|475115852|FG000|Overall Study|Death|1|||
131953723|NCT04295759|475115852|FG000|Overall Study|Withdrawal by Subject|2|||
131953724|NCT04295759|475115852|FG000|Overall Study|Deemed ineligible|1|||
131953725|NCT02798315|475115853|FG000|Overall Study|Failure to return|1|||
131953726|NCT03335150|475115855|FG000|Overall Study|Withdrawal by Subject|10|||
131953727|NCT03335150|475115856|FG001|Overall Study|Withdrawal by Subject|4|||
131953728|NCT03335150|475115855|FG000|Overall Study|Adverse Event|0|||
131953729|NCT03335150|475115856|FG001|Overall Study|Adverse Event|1|||
131953730|NCT02097719|475115857|FG000|Overall Study|Subject Withdrew Consent|1|||
131953731|NCT02097719|475115858|FG001|Overall Study|Subject Withdrew Consent|0|||
131953732|NCT02097719|475115857|FG000|Overall Study|Lost to Follow-up|0|||
131953733|NCT02097719|475115858|FG001|Overall Study|Lost to Follow-up|1|||
131953734|NCT02097719|475115857|FG000|Overall Study|Adverse Event|2|||
131953735|NCT02097719|475115858|FG001|Overall Study|Adverse Event|0|||
131953736|NCT03108521|475115859|FG000|Overall Study|Lost to Follow-up|3|||
131953737|NCT03108521|475115860|FG001|Overall Study|Lost to Follow-up|0|||
131953738|NCT03108521|475115859|FG000|Overall Study|Lack of Efficacy|2|||
131953739|NCT03108521|475115860|FG001|Overall Study|Lack of Efficacy|0|||
131953740|NCT03108521|475115859|FG000|Overall Study|Physician Decision|4|||
131953741|NCT03108521|475115860|FG001|Overall Study|Physician Decision|0|||
131953742|NCT03108521|475115859|FG000|Overall Study|Adverse Event|3|||
131953743|NCT03108521|475115860|FG001|Overall Study|Adverse Event|0|||
131953744|NCT06899737|475115865|FG000|Overall Study|Lost to Follow-up|19|||
131953745|NCT06899737|475115866|FG001|Overall Study|Lost to Follow-up|7|||
131953746|NCT00375674|475115873|FG000|Overall Study|Other|26|||
131953747|NCT00375674|475115874|FG001|Overall Study|Other|18|||
131953748|NCT00375674|475115873|FG000|Overall Study|Death|67|||
131953749|NCT00375674|475115874|FG001|Overall Study|Death|76|||
131953750|NCT00375674|475115873|FG000|Overall Study|Participants refused further follow-up|31|||
131953751|NCT00375674|475115874|FG001|Overall Study|Participants refused further follow-up|30|||
131953752|NCT00375674|475115873|FG000|Overall Study|Lost to Follow-up|17|||
131953753|NCT00375674|475115874|FG001|Overall Study|Lost to Follow-up|15|||
131953754|NCT00375674|475115873|FG000|Overall Study|Enrolled but not treated|3|||
131953755|NCT00375674|475115874|FG001|Overall Study|Enrolled but not treated|2|||
131953756|NCT02744612|475117813|FG000|Overall Study|Withdrawal by Subject|0|||
131953757|NCT02744612|475117814|FG001|Overall Study|Withdrawal by Subject|2|||
131953758|NCT02712983|475117816|FG000|Treatment Phase|Adverse Event|3|||
131953759|NCT02712983|475117817|FG001|Treatment Phase|Adverse Event|1|||
131953760|NCT02712983|475117818|FG002|Treatment Phase|Adverse Event|1|||
131953761|NCT02712983|475117819|FG003|Treatment Phase|Adverse Event|4|||
131415281|NCT00701805|473145226|FG003|Overall Study|Missed 7 consecutive doses|0|||
131953762|NCT02712983|475117820|FG004|Treatment Phase|Adverse Event|3|||
131953763|NCT02712983|475117821|FG005|Treatment Phase|Adverse Event|0|||
131953764|NCT02712983|475117822|FG006|Treatment Phase|Adverse Event|6|||
131953765|NCT02712983|475117823|FG007|Treatment Phase|Adverse Event|6|||
131953766|NCT02712983|475117824|FG008|Treatment Phase|Adverse Event|1|||
131953767|NCT02712983|475117816|FG000|Treatment Phase|Protocol Deviation|0|||
131953768|NCT02712983|475117817|FG001|Treatment Phase|Protocol Deviation|0|||
131415282|NCT00701805|473145223|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
131415283|NCT00701805|473145224|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
131953769|NCT02712983|475117818|FG002|Treatment Phase|Protocol Deviation|0|||
131953770|NCT02712983|475117819|FG003|Treatment Phase|Protocol Deviation|2|||
131953771|NCT02712983|475117820|FG004|Treatment Phase|Protocol Deviation|0|||
131953772|NCT02712983|475117821|FG005|Treatment Phase|Protocol Deviation|0|||
131953773|NCT02712983|475117822|FG006|Treatment Phase|Protocol Deviation|1|||
131953774|NCT02712983|475117823|FG007|Treatment Phase|Protocol Deviation|0|||
131953775|NCT02712983|475117824|FG008|Treatment Phase|Protocol Deviation|0|||
131953776|NCT02712983|475117816|FG000|Treatment Phase|Technical Problems|0|||
131953777|NCT02712983|475117817|FG001|Treatment Phase|Technical Problems|0|||
131953778|NCT02712983|475117818|FG002|Treatment Phase|Technical Problems|0|||
131953779|NCT02712983|475117819|FG003|Treatment Phase|Technical Problems|0|||
131953780|NCT02712983|475117820|FG004|Treatment Phase|Technical Problems|0|||
131953781|NCT02712983|475117821|FG005|Treatment Phase|Technical Problems|0|||
131953782|NCT02712983|475117822|FG006|Treatment Phase|Technical Problems|1|||
131953783|NCT02712983|475117823|FG007|Treatment Phase|Technical Problems|0|||
131953784|NCT02712983|475117824|FG008|Treatment Phase|Technical Problems|0|||
131953785|NCT02712983|475117816|FG000|Treatment Phase|Physician Decision|0|||
131953786|NCT02712983|475117817|FG001|Treatment Phase|Physician Decision|0|||
131953787|NCT02712983|475117818|FG002|Treatment Phase|Physician Decision|0|||
131953788|NCT02712983|475117819|FG003|Treatment Phase|Physician Decision|0|||
131953789|NCT02712983|475117820|FG004|Treatment Phase|Physician Decision|0|||
131953790|NCT02712983|475117821|FG005|Treatment Phase|Physician Decision|0|||
131953791|NCT02712983|475117822|FG006|Treatment Phase|Physician Decision|0|||
131953792|NCT02712983|475117823|FG007|Treatment Phase|Physician Decision|1|||
131953793|NCT02712983|475117824|FG008|Treatment Phase|Physician Decision|1|||
131953794|NCT02712983|475117816|FG000|Treatment Phase|Subject Decision|2|||
131953795|NCT02712983|475117817|FG001|Treatment Phase|Subject Decision|0|||
131953796|NCT02712983|475117818|FG002|Treatment Phase|Subject Decision|0|||
131953797|NCT02712983|475117819|FG003|Treatment Phase|Subject Decision|2|||
131953798|NCT02712983|475117820|FG004|Treatment Phase|Subject Decision|1|||
131953799|NCT02712983|475117821|FG005|Treatment Phase|Subject Decision|0|||
131953800|NCT02712983|475117822|FG006|Treatment Phase|Subject Decision|1|||
131953801|NCT02712983|475117823|FG007|Treatment Phase|Subject Decision|2|||
131953802|NCT02712983|475117824|FG008|Treatment Phase|Subject Decision|0|||
131953803|NCT02712983|475117816|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131953804|NCT02712983|475117817|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
131953805|NCT02712983|475117818|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131953806|NCT02712983|475117819|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131953807|NCT02712983|475117820|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131953808|NCT02712983|475117821|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131953809|NCT02712983|475117822|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
131953810|NCT02712983|475117823|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
131953811|NCT02712983|475117824|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131953812|NCT02712983|475117816|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953813|NCT02712983|475117817|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953814|NCT02712983|475117818|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953815|NCT02712983|475117819|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
131953816|NCT02712983|475117820|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953817|NCT02712983|475117821|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953818|NCT02712983|475117822|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953819|NCT02712983|475117823|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953820|NCT02712983|475117824|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
131953821|NCT02712983|475117816|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
131953822|NCT02712983|475117817|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
131953823|NCT02712983|475117818|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
131953824|NCT02712983|475117819|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
131953825|NCT02712983|475117820|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
131953826|NCT02712983|475117821|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
131953827|NCT02712983|475117822|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
131953828|NCT02712983|475117823|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
131953829|NCT02712983|475117824|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
131953830|NCT01945216|475117825|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
131953831|NCT01945216|475117825|FG000|Overall Study|Protocol Violation|42|||
131953832|NCT01945216|475117825|FG000|Overall Study|CRF not assured by investigators|5|||
131457107|NCT02152956|473303077|FG009|Overall Study|Study terminated by sponsor|0|||
131457108|NCT02152956|473303078|FG010|Overall Study|Study terminated by sponsor|0|||
131457109|NCT02152956|473303079|FG011|Overall Study|Study terminated by sponsor|29|||
131953833|NCT05360966|475117829|FG000|Overall Study|Adverse Event|5|||
131953834|NCT05360966|475117830|FG001|Overall Study|Adverse Event|5|||
131953835|NCT05360966|475117829|FG000|Overall Study|Withdrawal of Consent|5|||
131953836|NCT05360966|475117830|FG001|Overall Study|Withdrawal of Consent|3|||
131953837|NCT05360966|475117829|FG000|Overall Study|Noncompliance|2|||
131953838|NCT05360966|475117830|FG001|Overall Study|Noncompliance|1|||
131457110|NCT02152956|473303080|FG012|Overall Study|Study terminated by sponsor|0|||
131457111|NCT02152956|473303068|FG000|Overall Study|progressive disease|0|||
131457112|NCT02152956|473303069|FG001|Overall Study|progressive disease|0|||
131953839|NCT05360966|475117829|FG000|Overall Study|Lost to Follow-up|2|||
131953840|NCT05360966|475117830|FG001|Overall Study|Lost to Follow-up|3|||
131953841|NCT05360966|475117829|FG000|Overall Study|Protocol Deviation|2|||
131953842|NCT05360966|475117830|FG001|Overall Study|Protocol Deviation|1|||
131953843|NCT05360966|475117829|FG000|Overall Study|As specified in the Clinical Study Report|1|||
131953844|NCT05360966|475117830|FG001|Overall Study|As specified in the Clinical Study Report|3|||
131953845|NCT03062280|475117831|FG000|Overall Study|Adverse Event|1|||
131953846|NCT03062280|475117831|FG000|Overall Study|Death|1|||
131953847|NCT03062280|475117831|FG000|Overall Study|Fertility Treatment|2|||
131953848|NCT03062280|475117831|FG000|Overall Study|Physician Decision|2|||
131953849|NCT03062280|475117831|FG000|Overall Study|Pregnancy|5|||
131953850|NCT03062280|475117831|FG000|Overall Study|Withdrawal by Subject|11|||
131953851|NCT04299308|475117833|FG000|Overall Study|Withdrawal by Subject|1|||
131953852|NCT04299308|475117834|FG001|Overall Study|Withdrawal by Subject|0|||
131953853|NCT04299308|475117833|FG000|Overall Study|issue with PET image (1)|1|||
131953854|NCT04299308|475117834|FG001|Overall Study|issue with PET image (1)|0|||
131953855|NCT00301262|475117835|FG000|Double Blind Phase (DB)|Adverse Event|1|||
131953856|NCT00301262|475117836|FG001|Double Blind Phase (DB)|Adverse Event|0|||
131953857|NCT00301262|475117835|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
131953858|NCT00301262|475117836|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
131953859|NCT00301262|475117835|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
131953860|NCT00301262|475117836|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
131953861|NCT00301262|475117835|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
131953862|NCT00301262|475117836|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
131953863|NCT00301262|475117835|FG000|Double Blind Phase (DB)|Other|1|||
131953864|NCT00301262|475117836|FG001|Double Blind Phase (DB)|Other|4|||
131953865|NCT00301262|475117835|FG000|Open Label Phase (OL)|Adverse Event|1|||
131953866|NCT00301262|475117836|FG001|Open Label Phase (OL)|Adverse Event|0|||
131953867|NCT00301262|475117835|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
131953868|NCT00301262|475117836|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
131953869|NCT00301262|475117835|FG000|Open Label Phase (OL)|Other|2|||
131953870|NCT00301262|475117836|FG001|Open Label Phase (OL)|Other|0|||
131953871|NCT00368745|475117837|FG000|Double-blind Treatment Period|Adverse Event|6|||
131953872|NCT00368745|475117838|FG001|Double-blind Treatment Period|Adverse Event|6|||
131953873|NCT00368745|475117837|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
131953874|NCT00368745|475117838|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
131953875|NCT00368745|475117837|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
131953876|NCT00368745|475117838|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131953877|NCT00368745|475117837|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
131953878|NCT00368745|475117838|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
131953879|NCT00368745|475117837|FG000|Double-blind Treatment Period|Other|7|||
131953880|NCT00368745|475117838|FG001|Double-blind Treatment Period|Other|6|||
131953881|NCT01498692|475117846|FG000|Overall Study|Death|4|||
131953882|NCT01498692|475117846|FG000|Overall Study|Withdrawal by Subject|1|||
131953883|NCT01498692|475117846|FG000|Overall Study|Missed 12-month visit|3|||
131953884|NCT00590122|475117847|FG000|Overall Study|swallowed oral dissolving dose|1|||
131953885|NCT00590122|475117848|FG001|Overall Study|swallowed oral dissolving dose|0|||
131953886|NCT01208324|475117849|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
131953887|NCT01208324|475117850|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
131953888|NCT01208324|475117851|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
131953889|NCT01208324|475117852|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
131953890|NCT02707965|475117853|FG000|Overall Study|Withdrawal by Subject|0|||
131953891|NCT02707965|475117854|FG001|Overall Study|Withdrawal by Subject|0|||
131953892|NCT02707965|475117855|FG002|Overall Study|Withdrawal by Subject|1|||
131953893|NCT02707965|475117856|FG003|Overall Study|Withdrawal by Subject|0|||
131953894|NCT02707965|475117857|FG004|Overall Study|Withdrawal by Subject|0|||
131953895|NCT02707965|475117858|FG005|Overall Study|Withdrawal by Subject|0|||
131953896|NCT02707965|475117859|FG006|Overall Study|Withdrawal by Subject|0|||
131953897|NCT02707965|475117860|FG007|Overall Study|Withdrawal by Subject|2|||
131953898|NCT02707965|475117861|FG008|Overall Study|Withdrawal by Subject|0|||
131953899|NCT02707965|475117862|FG009|Overall Study|Withdrawal by Subject|0|||
131953900|NCT02707965|475117863|FG010|Overall Study|Withdrawal by Subject|0|||
131953901|NCT02707965|475117864|FG011|Overall Study|Withdrawal by Subject|0|||
131953902|NCT02707965|475117865|FG012|Overall Study|Withdrawal by Subject|0|||
131953903|NCT02707965|475117866|FG013|Overall Study|Withdrawal by Subject|0|||
131953904|NCT02707965|475117867|FG014|Overall Study|Withdrawal by Subject|0|||
131953905|NCT02707965|475117868|FG015|Overall Study|Withdrawal by Subject|0|||
131953906|NCT02707965|475117853|FG000|Overall Study|PI decisions|0|||
131953907|NCT02707965|475117854|FG001|Overall Study|PI decisions|0|||
131953908|NCT02707965|475117855|FG002|Overall Study|PI decisions|0|||
131953909|NCT02707965|475117856|FG003|Overall Study|PI decisions|0|||
131953910|NCT02707965|475117857|FG004|Overall Study|PI decisions|0|||
131953911|NCT02707965|475117858|FG005|Overall Study|PI decisions|0|||
131953912|NCT02707965|475117859|FG006|Overall Study|PI decisions|0|||
131953913|NCT02707965|475117860|FG007|Overall Study|PI decisions|0|||
131953914|NCT02707965|475117861|FG008|Overall Study|PI decisions|0|||
131953915|NCT02707965|475117862|FG009|Overall Study|PI decisions|0|||
131953916|NCT02707965|475117863|FG010|Overall Study|PI decisions|0|||
131953917|NCT02707965|475117864|FG011|Overall Study|PI decisions|0|||
131953918|NCT02707965|475117865|FG012|Overall Study|PI decisions|0|||
131953919|NCT02707965|475117866|FG013|Overall Study|PI decisions|0|||
131953920|NCT02707965|475117867|FG014|Overall Study|PI decisions|2|||
131953921|NCT02707965|475117868|FG015|Overall Study|PI decisions|0|||
131953922|NCT02707965|475117853|FG000|Overall Study|Protocol deviation|1|||
131953923|NCT02707965|475117854|FG001|Overall Study|Protocol deviation|1|||
131953924|NCT02707965|475117855|FG002|Overall Study|Protocol deviation|0|||
131953925|NCT02707965|475117856|FG003|Overall Study|Protocol deviation|0|||
131953926|NCT02707965|475117857|FG004|Overall Study|Protocol deviation|0|||
131953927|NCT02707965|475117858|FG005|Overall Study|Protocol deviation|0|||
131953928|NCT02707965|475117859|FG006|Overall Study|Protocol deviation|0|||
131953929|NCT02707965|475117860|FG007|Overall Study|Protocol deviation|1|||
131953930|NCT02707965|475117861|FG008|Overall Study|Protocol deviation|0|||
131953931|NCT02707965|475117862|FG009|Overall Study|Protocol deviation|0|||
131953932|NCT02707965|475117863|FG010|Overall Study|Protocol deviation|0|||
131953933|NCT02707965|475117864|FG011|Overall Study|Protocol deviation|0|||
131953934|NCT02707965|475117865|FG012|Overall Study|Protocol deviation|0|||
131953935|NCT02707965|475117866|FG013|Overall Study|Protocol deviation|0|||
131953936|NCT02707965|475117867|FG014|Overall Study|Protocol deviation|0|||
131953937|NCT02707965|475117868|FG015|Overall Study|Protocol deviation|0|||
131953938|NCT00576628|475117869|FG000|Overall Study|Adverse Event|11|||
131953939|NCT00576628|475117869|FG000|Overall Study|Death|2|||
131953940|NCT00576628|475117869|FG000|Overall Study|Failure to return|1|||
131953941|NCT00576628|475117869|FG000|Overall Study|Refused Treatment|8|||
131953942|NCT00576628|475117869|FG000|Overall Study|Pregnancy|1|||
131953943|NCT00576628|475117869|FG000|Overall Study|RBC transfusion|1|||
131953944|NCT00576628|475117869|FG000|Overall Study|Progression of Kidney Disease|1|||
131953945|NCT00576628|475117869|FG000|Overall Study|Progression of Renal Failure|1|||
131953946|NCT00576628|475117869|FG000|Overall Study|The patient move into other town|1|||
131953947|NCT00576628|475117869|FG000|Overall Study|Transplantation|1|||
131953948|NCT00576628|475117869|FG000|Overall Study|Dialysis|15|||
131953949|NCT00249808|475117870|FG000|Overall Study|Other|27|||
131953950|NCT00249808|475117870|FG000|Overall Study|Protocol Violation|3|||
131953951|NCT00249808|475117870|FG000|Overall Study|Lost to Follow-up|8|||
131953952|NCT00249808|475117870|FG000|Overall Study|Adverse Event|81|||
131953953|NCT00249808|475117870|FG000|Overall Study|Lack of Efficacy|52|||
131953954|NCT00249808|475117870|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
131953955|NCT02789345|475117871|FG000|Overall Study|Adverse Event|0|||
131953956|NCT02789345|475117872|FG001|Overall Study|Adverse Event|0|||
131953957|NCT02789345|475117873|FG002|Overall Study|Adverse Event|1|||
131953958|NCT02789345|475117871|FG000|Overall Study|Death|0|||
131953959|NCT02789345|475117872|FG001|Overall Study|Death|0|||
131953960|NCT02789345|475117873|FG002|Overall Study|Death|1|||
131953961|NCT02789345|475117871|FG000|Overall Study|Physician Decision|2|||
131953962|NCT02789345|475117872|FG001|Overall Study|Physician Decision|0|||
131953963|NCT02789345|475117873|FG002|Overall Study|Physician Decision|1|||
131953964|NCT02789345|475117871|FG000|Overall Study|Progressive Disease|1|||
131953965|NCT02789345|475117872|FG001|Overall Study|Progressive Disease|3|||
131953966|NCT02789345|475117873|FG002|Overall Study|Progressive Disease|14|||
131953967|NCT00962741|475117875|FG000|Overall Study|Failed to return|3|||
131953968|NCT00962741|475117875|FG000|Overall Study|Lost to Follow-up|2|||
131953969|NCT00962741|475117875|FG000|Overall Study|Withdrawal by Subject|1|||
131953970|NCT00962741|475117875|FG000|Overall Study|Lack of Efficacy|1|||
131953971|NCT00962741|475117875|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
131953972|NCT03645421|475117879|FG000|Overall Study|Adverse Event|0|||
131953973|NCT03645421|475117880|FG001|Overall Study|Adverse Event|0|||
131953974|NCT03645421|475117881|FG002|Overall Study|Adverse Event|4|||
131953975|NCT03645421|475117882|FG003|Overall Study|Adverse Event|1|||
131953976|NCT03645421|475117879|FG000|Overall Study|Withdrawal by patient|0|||
131953977|NCT03645421|475117880|FG001|Overall Study|Withdrawal by patient|0|||
131415284|NCT00701805|473145225|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
131953978|NCT03645421|475117881|FG002|Overall Study|Withdrawal by patient|0|||
131953979|NCT03645421|475117882|FG003|Overall Study|Withdrawal by patient|3|||
131953980|NCT03645421|475117879|FG000|Overall Study|Study specific withdrawal criteria|0|||
131953981|NCT03645421|475117880|FG001|Overall Study|Study specific withdrawal criteria|0|||
131953982|NCT03645421|475117881|FG002|Overall Study|Study specific withdrawal criteria|1|||
131953983|NCT03645421|475117882|FG003|Overall Study|Study specific withdrawal criteria|0|||
131953984|NCT02120781|475117885|FG000|Overall Study|Physician Decision|2|||
131953985|NCT02120781|475117886|FG001|Overall Study|Physician Decision|0|||
131953986|NCT02120781|475117885|FG000|Overall Study|Completion not documented|2|||
131953987|NCT02120781|475117886|FG001|Overall Study|Completion not documented|1|||
131953988|NCT00654745|475117891|FG000|Overall Study|Adverse Event|12|||
131953989|NCT00654745|475117891|FG000|Overall Study|Lost to Follow-up|7|||
131953990|NCT00654745|475117891|FG000|Overall Study|Protocol Violation|11|||
131953991|NCT00654745|475117891|FG000|Overall Study|Withdrawal by Subject|10|||
131953992|NCT00654745|475117891|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
131953993|NCT00748618|475117892|FG000|Overall Study|Adverse Event|1|||
131953994|NCT00748618|475117893|FG001|Overall Study|Adverse Event|0|||
131953995|NCT02253433|475117894|FG000|Overall Study|Unable to Contact|9|||
131953996|NCT02253433|475117895|FG001|Overall Study|Unable to Contact|16|||
131953997|NCT02253433|475117894|FG000|Overall Study|Death|1|||
131953998|NCT02253433|475117895|FG001|Overall Study|Death|1|||
131953999|NCT02253433|475117894|FG000|Overall Study|No Longer Interested|3|||
131954000|NCT02253433|475117895|FG001|Overall Study|No Longer Interested|15|||
131954001|NCT02253433|475117894|FG000|Overall Study|Out of Study Area|2|||
131954002|NCT02253433|475117895|FG001|Overall Study|Out of Study Area|7|||
131954003|NCT02253433|475117894|FG000|Overall Study|Uncomfortable with home visitors|0|||
131954004|NCT02253433|475117895|FG001|Overall Study|Uncomfortable with home visitors|3|||
131954005|NCT02253433|475117894|FG000|Overall Study|Unstable Housing/Homeless|0|||
131954006|NCT02253433|475117895|FG001|Overall Study|Unstable Housing/Homeless|7|||
131954007|NCT02253433|475117894|FG000|Overall Study|Too Busy|0|||
131954008|NCT02253433|475117895|FG001|Overall Study|Too Busy|4|||
131954009|NCT02253433|475117894|FG000|Overall Study|Medical or Other Concerns|1|||
131954010|NCT02253433|475117895|FG001|Overall Study|Medical or Other Concerns|2|||
131954011|NCT00224120|475117901|FG000|Overall Study|Adverse Event|10|||
131954012|NCT00224120|475117902|FG001|Overall Study|Adverse Event|4|||
131954013|NCT00224120|475117901|FG000|Overall Study|Protocol Violation|1|||
131954014|NCT00224120|475117902|FG001|Overall Study|Protocol Violation|0|||
131954015|NCT00224120|475117901|FG000|Overall Study|Withdrawal by Subject|5|||
131954016|NCT00224120|475117902|FG001|Overall Study|Withdrawal by Subject|10|||
131954017|NCT00224120|475117901|FG000|Overall Study|Lack of Efficacy|0|||
131954018|NCT00224120|475117902|FG001|Overall Study|Lack of Efficacy|2|||
131954019|NCT00224120|475117901|FG000|Overall Study|Lost to Follow-up|2|||
131954020|NCT00224120|475117902|FG001|Overall Study|Lost to Follow-up|3|||
131954021|NCT00224120|475117901|FG000|Overall Study|Other|4|||
131954022|NCT00224120|475117902|FG001|Overall Study|Other|5|||
131954023|NCT00066222|475117903|FG000|Overall Study|No protocol treatment received|1|||
131954024|NCT00615719|475117904|FG000|Overall Study|Physician Decision|5|||
131954025|NCT00964002|475117909|FG000|Overall Study|Protocol Violation|8|||
131954026|NCT02565147|475117910|FG000|Overall Study|Withdrawal by Subject|5|||
131954027|NCT02565147|475117911|FG001|Overall Study|Withdrawal by Subject|1|||
131954028|NCT02565147|475117910|FG000|Overall Study|Lost to Follow-up|0|||
131954029|NCT02565147|475117911|FG001|Overall Study|Lost to Follow-up|1|||
131954030|NCT02565147|475117910|FG000|Overall Study|Death|1|||
131954031|NCT02565147|475117911|FG001|Overall Study|Death|1|||
131954032|NCT03423238|475117912|FG000|Overall Study|Lost to Follow-up|1|||
131954033|NCT03423238|475117913|FG001|Overall Study|Lost to Follow-up|0|||
131954034|NCT03423238|475117912|FG000|Overall Study|Withdrawal by Subject|1|||
131954035|NCT03423238|475117913|FG001|Overall Study|Withdrawal by Subject|0|||
131954036|NCT00506454|475117914|FG000|Overall Study|Withdrawal by Subject|1|||
131954037|NCT00506454|475117915|FG001|Overall Study|Withdrawal by Subject|1|||
131954038|NCT04222699|475117920|FG000|Overall Study|Lost to Follow-up|2|||
131954039|NCT00923351|475117921|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
131954040|NCT00923351|475117922|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
131954041|NCT00923351|475117923|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
131954042|NCT01536561|475117928|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
131954043|NCT01536561|475117928|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
131954044|NCT01536561|475117928|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
131954045|NCT01536561|475117928|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
131954046|NCT01536561|475117928|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
131954047|NCT01536561|475117928|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
131954048|NCT04552288|475117934|FG000|Overall Study|Death|3|||
131954049|NCT04552288|475117934|FG000|Overall Study|Lost to Follow-up|6|||
131954050|NCT04552288|475117934|FG000|Overall Study|Physician Decision|3|||
131954051|NCT04552288|475117934|FG000|Overall Study|Protocol Violation|9|||
131954052|NCT04552288|475117934|FG000|Overall Study|Withdrawal by Subject|6|||
131954053|NCT04552288|475117934|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
131954054|NCT05285644|475117935|FG000|Overall Study|Adverse Event|3|||
131954055|NCT05285644|475117936|FG001|Overall Study|Adverse Event|3|||
131954056|NCT05285644|475117935|FG000|Overall Study|Withdrawal of Consent|2|||
131954057|NCT05285644|475117936|FG001|Overall Study|Withdrawal of Consent|5|||
131954058|NCT05285644|475117935|FG000|Overall Study|Noncompliance|0|||
131954059|NCT05285644|475117936|FG001|Overall Study|Noncompliance|4|||
131954060|NCT05285644|475117935|FG000|Overall Study|Lost to Follow-up|4|||
131954061|NCT05285644|475117936|FG001|Overall Study|Lost to Follow-up|6|||
131954062|NCT05285644|475117935|FG000|Overall Study|Disallowed Concurrent Medication|1|||
131954063|NCT05285644|475117936|FG001|Overall Study|Disallowed Concurrent Medication|1|||
131954064|NCT05285644|475117935|FG000|Overall Study|Investigator Decision|2|||
131954065|NCT05285644|475117936|FG001|Overall Study|Investigator Decision|0|||
131954066|NCT05285644|475117935|FG000|Overall Study|Protocol Deviation|1|||
131954067|NCT05285644|475117936|FG001|Overall Study|Protocol Deviation|0|||
131954068|NCT05285644|475117935|FG000|Overall Study|As specified in the Clinical Study Report|7|||
131954069|NCT05285644|475117936|FG001|Overall Study|As specified in the Clinical Study Report|3|||
131954070|NCT04532294|475117937|FG000|Overall Study|Withdrawal by Subject|0|||
131954071|NCT04532294|475117938|FG001|Overall Study|Withdrawal by Subject|0|||
131954072|NCT04532294|475117939|FG002|Overall Study|Withdrawal by Subject|1|||
131954073|NCT04532294|475117937|FG000|Overall Study|Participants Not Dosed|0|||
131954074|NCT04532294|475117938|FG001|Overall Study|Participants Not Dosed|0|||
131954075|NCT04532294|475117939|FG002|Overall Study|Participants Not Dosed|2|||
131954076|NCT01696981|475117940|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
131954077|NCT01696981|475117941|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
131954078|NCT01696981|475117940|FG000|Overall Study|Died Before Randomization|3|||
131954079|NCT01696981|475117941|FG001|Overall Study|Died Before Randomization|8|||
131954080|NCT01696981|475117940|FG000|Overall Study|Died Before ASU (Control)|278|||
131954081|NCT01696981|475117941|FG001|Overall Study|Died Before ASU (Control)|0|||
131954082|NCT01696981|475117940|FG000|Overall Study|Refused ASU (Control)|920|||
131954083|NCT01696981|475117941|FG001|Overall Study|Refused ASU (Control)|0|||
131954084|NCT01696981|475117940|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
131954085|NCT01696981|475117941|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
131954086|NCT00972517|475117942|FG000|Overall Study|Adverse Event|0|||
131954087|NCT00972517|475117943|FG001|Overall Study|Adverse Event|0|||
131954088|NCT00972517|475117944|FG002|Overall Study|Adverse Event|0|||
131954089|NCT00972517|475117945|FG003|Overall Study|Adverse Event|1|||
131954090|NCT00972517|475117946|FG004|Overall Study|Adverse Event|0|||
131954091|NCT00972517|475117947|FG005|Overall Study|Adverse Event|0|||
131954092|NCT00972517|475117942|FG000|Overall Study|Withdrawal by Subject|0|||
131954093|NCT00972517|475117943|FG001|Overall Study|Withdrawal by Subject|1|||
131954094|NCT00972517|475117944|FG002|Overall Study|Withdrawal by Subject|0|||
131954095|NCT00972517|475117945|FG003|Overall Study|Withdrawal by Subject|2|||
131954096|NCT00972517|475117946|FG004|Overall Study|Withdrawal by Subject|1|||
131954097|NCT00972517|475117947|FG005|Overall Study|Withdrawal by Subject|0|||
131954098|NCT00984594|475117948|FG000|Overall Study|Lost to Follow-up|1|||
131954099|NCT00984594|475117949|FG001|Overall Study|Lost to Follow-up|0|||
131954100|NCT00984594|475117948|FG000|Overall Study|Withdrawal by Subject|0|||
131954101|NCT00984594|475117949|FG001|Overall Study|Withdrawal by Subject|1|||
131954102|NCT00851890|475117950|FG000|Overall Study|Lost to Follow-up|0|||
131954103|NCT00851890|475117951|FG001|Overall Study|Lost to Follow-up|1|||
131954104|NCT00851890|475117952|FG002|Overall Study|Lost to Follow-up|0|||
131954105|NCT00851890|475117953|FG003|Overall Study|Lost to Follow-up|1|||
131954106|NCT03135431|475117954|FG000|Overall Study|Study Surgeon not available|2|||
131954107|NCT03135431|475117955|FG001|Overall Study|Study Surgeon not available|0|||
131954108|NCT04601532|475117956|FG000|Overall Study|Lost to Follow-up|1|||
131954109|NCT04601532|475117957|FG001|Overall Study|Lost to Follow-up|2|||
131954110|NCT04601532|475117956|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
131954111|NCT04601532|475117957|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
131954112|NCT00281099|475117960|FG000|Overall Study|Death|46|||
131954113|NCT00281099|475117961|FG001|Overall Study|Death|57|||
131954114|NCT00281099|475117960|FG000|Overall Study|Lost to Follow-up|10|||
131954115|NCT00281099|475117961|FG001|Overall Study|Lost to Follow-up|19|||
131954116|NCT00281099|475117960|FG000|Overall Study|Withdrawal by Subject|65|||
131954117|NCT00281099|475117961|FG001|Overall Study|Withdrawal by Subject|70|||
131954118|NCT00281099|475117960|FG000|Overall Study|Physician Decision|79|||
131954119|NCT00281099|475117961|FG001|Overall Study|Physician Decision|72|||
131954120|NCT00281099|475117960|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
131954121|NCT00281099|475117961|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
131954122|NCT03823287|475117962|FG000|Overall Study|Withdrawal by Subject|25|||
131954123|NCT03823287|475117963|FG001|Overall Study|Withdrawal by Subject|17|||
131954124|NCT03823287|475117962|FG000|Overall Study|Death|13|||
131954125|NCT03823287|475117963|FG001|Overall Study|Death|7|||
131954126|NCT03823287|475117962|FG000|Overall Study|Lost to Follow-up|7|||
131954127|NCT03823287|475117963|FG001|Overall Study|Lost to Follow-up|8|||
131954128|NCT03823287|475117962|FG000|Overall Study|Adverse Event|6|||
131954129|NCT03823287|475117963|FG001|Overall Study|Adverse Event|8|||
131954130|NCT03823287|475117962|FG000|Overall Study|Physician Decision|5|||
131954131|NCT03823287|475117963|FG001|Overall Study|Physician Decision|2|||
131954132|NCT03823287|475117962|FG000|Overall Study|Lack of Efficacy|2|||
131954133|NCT03823287|475117963|FG001|Overall Study|Lack of Efficacy|0|||
131954134|NCT03823287|475117962|FG000|Overall Study|Other|2|||
131954135|NCT03823287|475117963|FG001|Overall Study|Other|4|||
131954136|NCT01059864|475117968|FG000|Open-Label Run-In Phase|Adverse Event|7|||
131954137|NCT01059864|475117969|FG001|Open-Label Run-In Phase|Adverse Event|0|||
131954138|NCT01059864|475117970|FG002|Open-Label Run-In Phase|Adverse Event|0|||
131954139|NCT01059864|475117968|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
131954140|NCT01059864|475117969|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
131954141|NCT01059864|475117970|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
131954142|NCT01059864|475117968|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
131954143|NCT01059864|475117969|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
131954144|NCT01059864|475117970|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
131954145|NCT01059864|475117968|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
131954146|NCT01059864|475117969|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
131954147|NCT01059864|475117970|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
131954148|NCT01059864|475117968|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
131954149|NCT01059864|475117969|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
131954150|NCT01059864|475117970|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
131954151|NCT01059864|475117968|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131954152|NCT01059864|475117969|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
131954153|NCT01059864|475117970|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
131954154|NCT05396014|475119733|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
131954155|NCT05396014|475119734|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954156|NCT05396014|475119735|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954157|NCT05396014|475119736|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954158|NCT05396014|475119737|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954159|NCT05396014|475119738|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954160|NCT05396014|475119739|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954161|NCT05396014|475119740|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954162|NCT05396014|475119741|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954163|NCT05396014|475119742|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954164|NCT05396014|475119743|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954165|NCT05396014|475119744|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954166|NCT05396014|475119745|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954167|NCT05396014|475119746|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
131954168|NCT05396014|475119747|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954169|NCT05396014|475119748|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954170|NCT05396014|475119749|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954171|NCT05396014|475119750|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954172|NCT05396014|475119751|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954173|NCT05396014|475119752|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954174|NCT05396014|475119753|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954175|NCT05396014|475119754|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954176|NCT05396014|475119755|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954177|NCT05396014|475119756|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954178|NCT05396014|475119757|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954179|NCT05396014|475119758|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954180|NCT05396014|475119759|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
131954181|NCT05396014|475119760|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954182|NCT05396014|475119761|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954183|NCT05396014|475119762|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954184|NCT05396014|475119763|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954185|NCT05396014|475119764|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954186|NCT05396014|475119765|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954187|NCT05396014|475119766|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954188|NCT05396014|475119767|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954189|NCT05396014|475119768|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954190|NCT05396014|475119769|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954191|NCT05396014|475119770|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954192|NCT05396014|475119771|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954193|NCT05396014|475119772|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
131954194|NCT05396014|475119773|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954195|NCT05396014|475119774|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954196|NCT05396014|475119775|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
131954197|NCT05396014|475119733|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
131954198|NCT05396014|475119734|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954199|NCT05396014|475119735|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131415285|NCT00701805|473145226|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
131415286|NCT00701805|473145223|FG000|Overall Study|Physician decision, change of therapy|0|||
131415287|NCT00701805|473145224|FG001|Overall Study|Physician decision, change of therapy|0|||
131415288|NCT00701805|473145225|FG002|Overall Study|Physician decision, change of therapy|0|||
131415289|NCT00701805|473145226|FG003|Overall Study|Physician decision, change of therapy|1|||
131415290|NCT00701805|473145223|FG000|Overall Study|Difficult to travel to dialysis site|0|||
131954200|NCT05396014|475119736|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954201|NCT05396014|475119737|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954202|NCT05396014|475119738|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954203|NCT05396014|475119739|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954204|NCT05396014|475119740|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954205|NCT05396014|475119741|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954206|NCT05396014|475119742|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131457113|NCT02152956|473303070|FG002|Overall Study|progressive disease|0|||
131457114|NCT02152956|473303071|FG003|Overall Study|progressive disease|0|||
131457115|NCT02152956|473303072|FG004|Overall Study|progressive disease|0|||
131457116|NCT02152956|473303073|FG005|Overall Study|progressive disease|0|||
131457117|NCT02152956|473303074|FG006|Overall Study|progressive disease|0|||
131457118|NCT02152956|473303075|FG007|Overall Study|progressive disease|0|||
131457119|NCT02152956|473303076|FG008|Overall Study|progressive disease|1|||
131457120|NCT02152956|473303077|FG009|Overall Study|progressive disease|0|||
131457121|NCT02152956|473303078|FG010|Overall Study|progressive disease|0|||
131457122|NCT02152956|473303079|FG011|Overall Study|progressive disease|1|||
131457123|NCT02152956|473303080|FG012|Overall Study|progressive disease|0|||
131457124|NCT02445794|473303081|FG000|Overall Study|Adverse Event|0|||
131457125|NCT02445794|473303082|FG001|Overall Study|Adverse Event|0|||
131954207|NCT05396014|475119743|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954208|NCT05396014|475119744|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954209|NCT05396014|475119745|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954210|NCT05396014|475119746|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
131954211|NCT05396014|475119747|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954212|NCT05396014|475119748|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954213|NCT05396014|475119749|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954214|NCT05396014|475119750|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954215|NCT05396014|475119751|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954216|NCT05396014|475119752|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954217|NCT05396014|475119753|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954218|NCT05396014|475119754|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954219|NCT05396014|475119755|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131415291|NCT00701805|473145224|FG001|Overall Study|Difficult to travel to dialysis site|0|||
131415292|NCT00701805|473145225|FG002|Overall Study|Difficult to travel to dialysis site|1|||
131415293|NCT00701805|473145226|FG003|Overall Study|Difficult to travel to dialysis site|0|||
131415294|NCT00701805|473145223|FG000|Overall Study|Resumption criteria were not met|0|||
131415295|NCT00701805|473145224|FG001|Overall Study|Resumption criteria were not met|1|||
131415296|NCT00701805|473145225|FG002|Overall Study|Resumption criteria were not met|0|||
131415297|NCT00701805|473145226|FG003|Overall Study|Resumption criteria were not met|0|||
131415298|NCT02252965|473145230|FG000|Overall Study|Adverse Event|9|||
131415299|NCT02252965|473145231|FG001|Overall Study|Adverse Event|14|||
131415300|NCT02252965|473145230|FG000|Overall Study|Lost to Follow-up|16|||
131415301|NCT02252965|473145231|FG001|Overall Study|Lost to Follow-up|8|||
131415302|NCT02252965|473145230|FG000|Overall Study|Protocol Violation|4|||
131415303|NCT02252965|473145231|FG001|Overall Study|Protocol Violation|5|||
131415304|NCT02252965|473145230|FG000|Overall Study|Lack of Efficacy|0|||
131415305|NCT02252965|473145231|FG001|Overall Study|Lack of Efficacy|2|||
131415306|NCT02252965|473145230|FG000|Overall Study|Withdrawal by Subject|7|||
131415307|NCT02252965|473145231|FG001|Overall Study|Withdrawal by Subject|9|||
131415308|NCT02252965|473145230|FG000|Overall Study|Other|4|||
131415309|NCT02252965|473145231|FG001|Overall Study|Other|5|||
131415310|NCT03344172|473145234|FG000|Overall Study|Received <1 dose of treatment|1|||
131415311|NCT03344172|473145235|FG001|Overall Study|Received <1 dose of treatment|0|||
131415312|NCT00680368|473145238|FG000|Overall Study|not supervised, not eligible|15|||
131415313|NCT00430937|473145239|FG000|Overall Study|Adverse Event|3|||
131415314|NCT00430937|473145240|FG001|Overall Study|Adverse Event|8|||
131415315|NCT00430937|473145239|FG000|Overall Study|Death|0|||
131415316|NCT00430937|473145240|FG001|Overall Study|Death|1|||
131415317|NCT00430937|473145239|FG000|Overall Study|Lost to Follow-up|6|||
131415318|NCT00430937|473145240|FG001|Overall Study|Lost to Follow-up|6|||
131415319|NCT00430937|473145239|FG000|Overall Study|Withdrawal by Subject|5|||
131415320|NCT00430937|473145240|FG001|Overall Study|Withdrawal by Subject|2|||
131415321|NCT00430937|473145239|FG000|Overall Study|Protocol Violation|3|||
131415322|NCT00430937|473145240|FG001|Overall Study|Protocol Violation|2|||
131415323|NCT00430937|473145239|FG000|Overall Study|Lack of Efficacy|6|||
131415324|NCT00430937|473145240|FG001|Overall Study|Lack of Efficacy|5|||
131415325|NCT00430937|473145239|FG000|Overall Study|Inappropriate enrollment|2|||
131415326|NCT00430937|473145240|FG001|Overall Study|Inappropriate enrollment|1|||
131415327|NCT00430937|473145239|FG000|Overall Study|Administrative reasons|1|||
131415328|NCT00430937|473145240|FG001|Overall Study|Administrative reasons|0|||
131415329|NCT00430937|473145239|FG000|Overall Study|Protocol discontinuation criteria met|1|||
131415330|NCT00430937|473145240|FG001|Overall Study|Protocol discontinuation criteria met|2|||
131457126|NCT02445794|473303083|FG002|Overall Study|Adverse Event|2|||
131457127|NCT02445794|473303084|FG003|Overall Study|Adverse Event|0|||
131954220|NCT05396014|475119756|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954221|NCT05396014|475119757|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131415331|NCT00430937|473145239|FG000|Overall Study|Unable to classify|0|||
131415332|NCT00430937|473145240|FG001|Overall Study|Unable to classify|1|||
131457128|NCT01136785|473303085|FG000|Overall Study|Protocol Violation|2|||
131457129|NCT01136785|473303086|FG001|Overall Study|Protocol Violation|1|||
131457130|NCT01388985|473303087|FG000|Overall Study|Death|0|||
131954222|NCT05396014|475119758|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954223|NCT05396014|475119759|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
131954224|NCT05396014|475119760|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954225|NCT05396014|475119761|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954226|NCT05396014|475119762|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954227|NCT05396014|475119763|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954228|NCT05396014|475119764|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954229|NCT05396014|475119765|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954230|NCT05396014|475119766|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954231|NCT05396014|475119767|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954232|NCT05396014|475119768|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954233|NCT05396014|475119769|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954234|NCT05396014|475119770|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954235|NCT05396014|475119771|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954236|NCT05396014|475119772|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
131954237|NCT05396014|475119773|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954238|NCT05396014|475119774|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954239|NCT05396014|475119775|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
131954240|NCT05396014|475119733|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
131954241|NCT05396014|475119734|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954242|NCT05396014|475119735|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954243|NCT05396014|475119736|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954244|NCT05396014|475119737|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954245|NCT05396014|475119738|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954246|NCT05396014|475119739|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954247|NCT05396014|475119740|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954248|NCT05396014|475119741|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954249|NCT05396014|475119742|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954250|NCT05396014|475119743|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954251|NCT05396014|475119744|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954252|NCT05396014|475119745|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954253|NCT05396014|475119746|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
131954254|NCT05396014|475119747|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954255|NCT05396014|475119748|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954256|NCT05396014|475119749|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954257|NCT05396014|475119750|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954258|NCT05396014|475119751|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954259|NCT05396014|475119752|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954260|NCT05396014|475119753|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954261|NCT05396014|475119754|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954262|NCT05396014|475119755|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954263|NCT05396014|475119756|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954264|NCT05396014|475119757|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954265|NCT05396014|475119758|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954266|NCT05396014|475119759|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
131954267|NCT05396014|475119760|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954268|NCT05396014|475119761|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954269|NCT05396014|475119762|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954270|NCT05396014|475119763|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954271|NCT05396014|475119764|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954272|NCT05396014|475119765|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954273|NCT05396014|475119766|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954274|NCT05396014|475119767|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954275|NCT05396014|475119768|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954276|NCT05396014|475119769|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954277|NCT05396014|475119770|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954278|NCT05396014|475119771|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954279|NCT05396014|475119772|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
131954280|NCT05396014|475119773|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954281|NCT05396014|475119774|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954282|NCT05396014|475119775|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
131954283|NCT05396014|475119733|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954284|NCT05396014|475119734|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131415333|NCT02989805|473145241|FG000|Overall Study|invalid consent|6|||
131415334|NCT02989805|473145242|FG001|Overall Study|invalid consent|4|||
131954285|NCT05396014|475119735|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954286|NCT05396014|475119736|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954287|NCT05396014|475119737|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954288|NCT05396014|475119738|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954289|NCT05396014|475119739|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954290|NCT05396014|475119740|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954291|NCT05396014|475119741|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954292|NCT05396014|475119742|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954293|NCT05396014|475119743|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954294|NCT05396014|475119744|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954295|NCT05396014|475119745|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954296|NCT05396014|475119746|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954297|NCT05396014|475119747|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954298|NCT05396014|475119748|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954299|NCT05396014|475119749|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954300|NCT05396014|475119750|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954301|NCT05396014|475119751|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954302|NCT05396014|475119752|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954303|NCT05396014|475119753|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954304|NCT05396014|475119754|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954305|NCT05396014|475119755|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954306|NCT05396014|475119756|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954307|NCT05396014|475119757|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954308|NCT05396014|475119758|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954309|NCT05396014|475119759|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
131954310|NCT05396014|475119760|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131415335|NCT02211313|473145243|FG000|Overall Study|Treatment Failure|5|||
131415336|NCT02211313|473145244|FG001|Overall Study|Treatment Failure|2|||
131415337|NCT02211313|473145243|FG000|Overall Study|No Follow up Questionnaires|1|||
131415338|NCT02211313|473145244|FG001|Overall Study|No Follow up Questionnaires|1|||
131415339|NCT03743064|473145245|FG000|Overall Study|Adverse Event|7|||
131415340|NCT03743064|473145246|FG001|Overall Study|Adverse Event|9|||
131415341|NCT03743064|473145245|FG000|Overall Study|Death|25|||
131415342|NCT03743064|473145246|FG001|Overall Study|Death|28|||
131415343|NCT03743064|473145245|FG000|Overall Study|Lost to Follow-up|3|||
131415344|NCT03743064|473145246|FG001|Overall Study|Lost to Follow-up|6|||
131457131|NCT01388985|473303088|FG001|Overall Study|Death|1|||
131457132|NCT01388985|473303087|FG000|Overall Study|Lost to Follow-up|30|||
131457133|NCT01388985|473303088|FG001|Overall Study|Lost to Follow-up|30|||
131457134|NCT01388985|473303087|FG000|Overall Study|Withdrawal by Subject|13|||
131457135|NCT01388985|473303088|FG001|Overall Study|Withdrawal by Subject|4|||
131457136|NCT01388985|473303087|FG000|Overall Study|Subject unavailable|1|||
131457137|NCT01388985|473303088|FG001|Overall Study|Subject unavailable|1|||
131457138|NCT01388985|473303087|FG000|Overall Study|Other (no reason)|0|||
131457139|NCT01388985|473303088|FG001|Overall Study|Other (no reason)|1|||
131457140|NCT01388985|473303087|FG000|Overall Study|Error of nurse|5|||
131457141|NCT01388985|473303088|FG001|Overall Study|Error of nurse|1|||
131457142|NCT01057589|473303089|FG000|Overall Study|Disease Progression|35|||
131457143|NCT01057589|473303089|FG000|Overall Study|Adverse Event|10|||
131457144|NCT01057589|473303089|FG000|Overall Study|Physician Decision|8|||
131954311|NCT05396014|475119761|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954312|NCT05396014|475119762|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954313|NCT05396014|475119763|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954314|NCT05396014|475119764|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954315|NCT05396014|475119765|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954316|NCT05396014|475119766|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954317|NCT05396014|475119767|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954318|NCT05396014|475119768|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954319|NCT05396014|475119769|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954320|NCT05396014|475119770|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954321|NCT05396014|475119771|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954322|NCT05396014|475119772|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
131954323|NCT05396014|475119773|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954324|NCT05396014|475119774|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954325|NCT05396014|475119775|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
131954326|NCT05396014|475119733|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954327|NCT05396014|475119734|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131415345|NCT03743064|473145245|FG000|Overall Study|Withdrawal by Subject|28|||
131415346|NCT03743064|473145246|FG001|Overall Study|Withdrawal by Subject|25|||
131457145|NCT01057589|473303089|FG000|Overall Study|Withdrawal by Subject|3|||
131415347|NCT03743064|473145245|FG000|Overall Study|Physician Decision|2|||
131457146|NCT01057589|473303089|FG000|Overall Study|Sponsor Decision|1|||
131457147|NCT01057589|473303089|FG000|Overall Study|Death|8|||
131457148|NCT01057589|473303089|FG000|Overall Study|Lost to Follow-up|1|||
131415348|NCT03743064|473145246|FG001|Overall Study|Physician Decision|4|||
131457149|NCT02954172|473303092|FG000|Overall Study|Protocol Violation|3|||
131457150|NCT02954172|473303093|FG001|Overall Study|Protocol Violation|0|||
131457151|NCT02954172|473303092|FG000|Overall Study|allergic reaction|2|||
131457152|NCT02954172|473303093|FG001|Overall Study|allergic reaction|1|||
131457153|NCT02954172|473303092|FG000|Overall Study|non-measurable lesions at baseline|1|||
131457154|NCT02954172|473303093|FG001|Overall Study|non-measurable lesions at baseline|2|||
131457155|NCT00853567|473303094|FG000|Overall Study|Study prematurely terminated|71|||
131457156|NCT01497366|473303095|FG000|Overall Study|Virologic failure|2|||
131457157|NCT01497366|473303096|FG001|Overall Study|Virologic failure|50|||
131457158|NCT01497366|473303095|FG000|Overall Study|Lost to Follow-up|11|||
131457159|NCT01497366|473303096|FG001|Overall Study|Lost to Follow-up|10|||
131457160|NCT01497366|473303095|FG000|Overall Study|Withdrawal by Subject|6|||
131457161|NCT01497366|473303096|FG001|Overall Study|Withdrawal by Subject|6|||
131457162|NCT01497366|473303095|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
131457163|NCT01497366|473303096|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
131457164|NCT01497366|473303095|FG000|Overall Study|Other|5|||
131457165|NCT01497366|473303096|FG001|Overall Study|Other|0|||
131457166|NCT01497366|473303095|FG000|Overall Study|Death|1|||
131457167|NCT01497366|473303096|FG001|Overall Study|Death|1|||
131457168|NCT01497366|473303095|FG000|Overall Study|Randomized but not treated|7|||
131457169|NCT01497366|473303096|FG001|Overall Study|Randomized but not treated|21|||
131457170|NCT01064947|473303103|FG000|Overall Study|negative culture|41|||
131457171|NCT00843284|473304524|FG000|Overall Study|Adverse Event|39|||
131457172|NCT00843284|473304524|FG000|Overall Study|Lack of Efficacy|5|||
131457173|NCT00843284|473304524|FG000|Overall Study|Lost to Follow-up|11|||
131457174|NCT00843284|473304524|FG000|Overall Study|Other|10|||
131457175|NCT00843284|473304524|FG000|Overall Study|Withdrawal by Subject|4|||
131457176|NCT00843284|473304524|FG000|Overall Study|Death|3|||
131457177|NCT00798759|473304525|FG000|Overall Study|Adverse Event|3|||
131457178|NCT00798759|473304526|FG001|Overall Study|Adverse Event|3|||
131457179|NCT00798759|473304525|FG000|Overall Study|Lost to Follow-up|1|||
131457180|NCT00798759|473304526|FG001|Overall Study|Lost to Follow-up|1|||
131457181|NCT00798759|473304525|FG000|Overall Study|Protocol Violation|4|||
131457182|NCT00798759|473304526|FG001|Overall Study|Protocol Violation|8|||
131457183|NCT00798759|473304525|FG000|Overall Study|Other|0|||
131457184|NCT00798759|473304526|FG001|Overall Study|Other|1|||
131457185|NCT00724711|473304527|FG000|Overall Study|Adverse Event|7|||
131457186|NCT00724711|473304528|FG001|Overall Study|Adverse Event|3|||
131457187|NCT00724711|473304527|FG000|Overall Study|Pregnancy|0|||
131457188|NCT00724711|473304528|FG001|Overall Study|Pregnancy|1|||
131457189|NCT00724711|473304527|FG000|Overall Study|Lack of Efficacy|0|||
131457190|NCT00724711|473304528|FG001|Overall Study|Lack of Efficacy|1|||
131457191|NCT00724711|473304527|FG000|Overall Study|Physician Decision|0|||
131457192|NCT00724711|473304528|FG001|Overall Study|Physician Decision|3|||
131457193|NCT00724711|473304527|FG000|Overall Study|Withdrawal by Subject|5|||
131457194|NCT00724711|473304528|FG001|Overall Study|Withdrawal by Subject|4|||
131457195|NCT00724711|473304527|FG000|Overall Study|Lost to Follow-up|4|||
131457196|NCT00724711|473304528|FG001|Overall Study|Lost to Follow-up|5|||
131457197|NCT00724711|473304527|FG000|Overall Study|Protocol Violation|1|||
131457198|NCT00724711|473304528|FG001|Overall Study|Protocol Violation|0|||
131457199|NCT04518995|473304529|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
131457200|NCT04518995|473304530|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
131457201|NCT04518995|473304531|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
131457202|NCT04518995|473304529|FG000|Overall Study|Lack of Efficacy|2|||
131457203|NCT04518995|473304530|FG001|Overall Study|Lack of Efficacy|1|||
131954328|NCT05396014|475119735|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954329|NCT05396014|475119736|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954330|NCT05396014|475119737|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954331|NCT05396014|475119738|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954332|NCT05396014|475119739|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954333|NCT05396014|475119740|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954334|NCT05396014|475119741|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954335|NCT05396014|475119742|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954336|NCT05396014|475119743|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131457204|NCT04518995|473304531|FG002|Overall Study|Lack of Efficacy|0|||
131457205|NCT04518995|473304529|FG000|Overall Study|Non-compliance With Study Drug|0|||
131457206|NCT04518995|473304530|FG001|Overall Study|Non-compliance With Study Drug|3|||
131457207|NCT04518995|473304531|FG002|Overall Study|Non-compliance With Study Drug|2|||
131457208|NCT04518995|473304529|FG000|Overall Study|Pregnancy|0|||
131457209|NCT04518995|473304530|FG001|Overall Study|Pregnancy|0|||
131457210|NCT04518995|473304531|FG002|Overall Study|Pregnancy|1|||
131457211|NCT04518995|473304529|FG000|Overall Study|Protocol Violation|2|||
131457212|NCT04518995|473304530|FG001|Overall Study|Protocol Violation|0|||
131457213|NCT04518995|473304531|FG002|Overall Study|Protocol Violation|1|||
131457214|NCT04518995|473304529|FG000|Overall Study|Reason not Specified|4|||
131457215|NCT04518995|473304530|FG001|Overall Study|Reason not Specified|11|||
131457216|NCT04518995|473304531|FG002|Overall Study|Reason not Specified|2|||
131457217|NCT04518995|473304529|FG000|Overall Study|Lost to Follow-up|1|||
131457218|NCT04518995|473304530|FG001|Overall Study|Lost to Follow-up|10|||
131457219|NCT04518995|473304531|FG002|Overall Study|Lost to Follow-up|6|||
131457220|NCT02834793|473304532|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
131457221|NCT02834793|473304533|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
131457222|NCT02834793|473304534|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
131457223|NCT02834793|473304535|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
131457224|NCT02834793|473304532|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
131457225|NCT02834793|473304533|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
131457226|NCT02834793|473304534|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
131457227|NCT02834793|473304535|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
131457228|NCT02834793|473304532|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
131457229|NCT02834793|473304533|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
131457230|NCT02834793|473304534|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
131457231|NCT02834793|473304535|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
131457232|NCT02834793|473304532|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
131457233|NCT02834793|473304533|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
131457234|NCT02834793|473304534|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
131457235|NCT02834793|473304535|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
131457236|NCT02834793|473304532|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
131457237|NCT02834793|473304533|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
131457238|NCT02834793|473304534|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
131457239|NCT02834793|473304535|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
131457240|NCT02834793|473304532|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
131457241|NCT02834793|473304533|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
131457242|NCT02834793|473304534|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
131457243|NCT02834793|473304535|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
131457244|NCT02834793|473304532|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
131457245|NCT02834793|473304533|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
131457246|NCT02834793|473304534|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
131457247|NCT02834793|473304535|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
131457248|NCT02834793|473304532|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
131457249|NCT02834793|473304533|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
131457250|NCT02834793|473304534|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
131457251|NCT02834793|473304535|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
131457252|NCT02834793|473304532|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
131457253|NCT02834793|473304533|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
131457254|NCT02834793|473304534|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
131457255|NCT02834793|473304535|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
131457256|NCT02834793|473304532|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
131457257|NCT02834793|473304533|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
131457258|NCT02834793|473304534|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
131457259|NCT02834793|473304535|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
131457260|NCT02834793|473304532|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
131457261|NCT02834793|473304533|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
131457262|NCT02834793|473304534|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
131457263|NCT02834793|473304535|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
131457264|NCT02834793|473304532|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
131457265|NCT02834793|473304533|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
131457266|NCT02834793|473304534|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
131457267|NCT02834793|473304535|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
131457268|NCT02834793|473304532|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
131457269|NCT02834793|473304533|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
131457270|NCT02834793|473304534|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
131457271|NCT02834793|473304535|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
131457272|NCT02834793|473304532|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
131457273|NCT02834793|473304533|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
131457274|NCT02834793|473304534|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
131457275|NCT02834793|473304535|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
131457276|NCT02834793|473304532|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
131457277|NCT02834793|473304533|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
131457278|NCT02834793|473304534|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
131457279|NCT02834793|473304535|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
131457280|NCT01049009|473304536|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
131457281|NCT01049009|473304537|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
131457282|NCT01049009|473304536|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131457283|NCT01049009|473304537|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131457284|NCT01049009|473304536|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
131457285|NCT01049009|473304537|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
131954337|NCT05396014|475119744|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954338|NCT05396014|475119745|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954339|NCT05396014|475119746|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954340|NCT05396014|475119747|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954341|NCT05396014|475119748|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954342|NCT05396014|475119749|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954343|NCT05396014|475119750|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954344|NCT05396014|475119751|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954345|NCT05396014|475119752|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954346|NCT05396014|475119753|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954347|NCT05396014|475119754|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954348|NCT05396014|475119755|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954349|NCT05396014|475119756|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954350|NCT05396014|475119757|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954351|NCT05396014|475119758|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954352|NCT05396014|475119759|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
131954353|NCT05396014|475119760|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954354|NCT05396014|475119761|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954355|NCT05396014|475119762|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954356|NCT05396014|475119763|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954357|NCT05396014|475119764|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954358|NCT05396014|475119765|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954359|NCT05396014|475119766|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954360|NCT05396014|475119767|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954361|NCT05396014|475119768|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954362|NCT05396014|475119769|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954363|NCT05396014|475119770|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954364|NCT05396014|475119771|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954365|NCT05396014|475119772|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954366|NCT05396014|475119773|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954367|NCT05396014|475119774|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954368|NCT05396014|475119775|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
131954369|NCT05396014|475119733|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954370|NCT05396014|475119734|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954371|NCT05396014|475119735|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954372|NCT05396014|475119736|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954373|NCT05396014|475119737|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954374|NCT05396014|475119738|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954375|NCT05396014|475119739|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954376|NCT05396014|475119740|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954377|NCT05396014|475119741|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954378|NCT05396014|475119742|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954379|NCT05396014|475119743|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954380|NCT05396014|475119744|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954381|NCT05396014|475119745|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954382|NCT05396014|475119746|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
131954383|NCT05396014|475119747|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954384|NCT05396014|475119748|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954385|NCT05396014|475119749|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954386|NCT05396014|475119750|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954387|NCT05396014|475119751|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954388|NCT05396014|475119752|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954389|NCT05396014|475119753|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954390|NCT05396014|475119754|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954391|NCT05396014|475119755|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954392|NCT05396014|475119756|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954393|NCT05396014|475119757|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954394|NCT05396014|475119758|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954395|NCT05396014|475119759|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954396|NCT05396014|475119760|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954397|NCT05396014|475119761|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954398|NCT05396014|475119762|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954399|NCT05396014|475119763|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954400|NCT05396014|475119764|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954401|NCT05396014|475119765|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954402|NCT05396014|475119766|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954403|NCT05396014|475119767|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954404|NCT05396014|475119768|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954405|NCT05396014|475119769|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954406|NCT05396014|475119770|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954407|NCT05396014|475119771|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954408|NCT05396014|475119772|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954409|NCT05396014|475119773|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954410|NCT05396014|475119774|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954411|NCT05396014|475119775|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
131954412|NCT05396014|475119733|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
131954413|NCT05396014|475119734|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954414|NCT05396014|475119735|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954415|NCT05396014|475119736|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954416|NCT05396014|475119737|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954417|NCT05396014|475119738|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954418|NCT05396014|475119739|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954419|NCT05396014|475119740|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954420|NCT05396014|475119741|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954421|NCT05396014|475119742|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954422|NCT05396014|475119743|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954423|NCT05396014|475119744|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954424|NCT05396014|475119745|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954425|NCT05396014|475119746|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
131954426|NCT05396014|475119747|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954427|NCT05396014|475119748|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954428|NCT05396014|475119749|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954429|NCT05396014|475119750|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954430|NCT05396014|475119751|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954431|NCT05396014|475119752|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954432|NCT05396014|475119753|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954433|NCT05396014|475119754|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954434|NCT05396014|475119755|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954435|NCT05396014|475119756|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954436|NCT05396014|475119757|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954437|NCT05396014|475119758|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954438|NCT05396014|475119759|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954439|NCT05396014|475119760|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954440|NCT05396014|475119761|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954441|NCT05396014|475119762|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954442|NCT05396014|475119763|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954443|NCT05396014|475119764|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954444|NCT05396014|475119765|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954445|NCT05396014|475119766|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954446|NCT05396014|475119767|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954447|NCT05396014|475119768|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954448|NCT05396014|475119769|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954449|NCT05396014|475119770|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954450|NCT05396014|475119771|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954451|NCT05396014|475119772|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
131954452|NCT05396014|475119773|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954453|NCT05396014|475119774|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954454|NCT05396014|475119775|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
131954455|NCT05396014|475119733|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
131954456|NCT05396014|475119734|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954457|NCT05396014|475119735|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954458|NCT05396014|475119736|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954459|NCT05396014|475119737|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954460|NCT05396014|475119738|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954461|NCT05396014|475119739|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954462|NCT05396014|475119740|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954463|NCT05396014|475119741|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954464|NCT05396014|475119742|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954465|NCT05396014|475119743|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954466|NCT05396014|475119744|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954467|NCT05396014|475119745|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954468|NCT05396014|475119746|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954469|NCT05396014|475119747|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954470|NCT05396014|475119748|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954471|NCT05396014|475119749|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954472|NCT05396014|475119750|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954473|NCT05396014|475119751|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954474|NCT05396014|475119752|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954475|NCT05396014|475119753|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954476|NCT05396014|475119754|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954477|NCT05396014|475119755|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954478|NCT05396014|475119756|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954479|NCT05396014|475119757|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954480|NCT05396014|475119758|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954481|NCT05396014|475119759|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
131954482|NCT05396014|475119760|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954483|NCT05396014|475119761|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954484|NCT05396014|475119762|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954485|NCT05396014|475119763|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954486|NCT05396014|475119764|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954487|NCT05396014|475119765|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954488|NCT05396014|475119766|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954489|NCT05396014|475119767|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954490|NCT05396014|475119768|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954491|NCT05396014|475119769|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954492|NCT05396014|475119770|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954493|NCT05396014|475119771|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954494|NCT05396014|475119772|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954495|NCT05396014|475119773|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954496|NCT05396014|475119774|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954497|NCT05396014|475119775|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
131954498|NCT05396014|475119733|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954499|NCT05396014|475119734|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954500|NCT05396014|475119735|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954501|NCT05396014|475119736|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954502|NCT05396014|475119737|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954503|NCT05396014|475119738|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954504|NCT05396014|475119739|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954505|NCT05396014|475119740|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954506|NCT05396014|475119741|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954507|NCT05396014|475119742|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954508|NCT05396014|475119743|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954509|NCT05396014|475119744|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954510|NCT05396014|475119745|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954511|NCT05396014|475119746|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
131954512|NCT05396014|475119747|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954513|NCT05396014|475119748|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954514|NCT05396014|475119749|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954515|NCT05396014|475119750|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954516|NCT05396014|475119751|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954517|NCT05396014|475119752|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954518|NCT05396014|475119753|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954519|NCT05396014|475119754|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954520|NCT05396014|475119755|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954521|NCT05396014|475119756|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954522|NCT05396014|475119757|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954523|NCT05396014|475119758|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954524|NCT05396014|475119759|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954525|NCT05396014|475119760|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954526|NCT05396014|475119761|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954527|NCT05396014|475119762|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954528|NCT05396014|475119763|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954529|NCT05396014|475119764|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954530|NCT05396014|475119765|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954531|NCT05396014|475119766|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954532|NCT05396014|475119767|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954533|NCT05396014|475119768|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954534|NCT05396014|475119769|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954535|NCT05396014|475119770|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954536|NCT05396014|475119771|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954537|NCT05396014|475119772|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954538|NCT05396014|475119773|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954539|NCT05396014|475119774|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954540|NCT05396014|475119775|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
131954541|NCT05396014|475119733|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954542|NCT05396014|475119734|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954543|NCT05396014|475119735|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954544|NCT05396014|475119736|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
131954545|NCT05396014|475119737|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954546|NCT05396014|475119738|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131415349|NCT03743064|473145245|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
131415350|NCT03743064|473145246|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
131954547|NCT05396014|475119739|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954548|NCT05396014|475119740|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954549|NCT05396014|475119741|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
131954550|NCT05396014|475119742|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954551|NCT05396014|475119743|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954552|NCT05396014|475119744|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954553|NCT05396014|475119745|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954554|NCT05396014|475119746|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954555|NCT05396014|475119747|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954556|NCT05396014|475119748|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954557|NCT05396014|475119749|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954558|NCT05396014|475119750|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954559|NCT05396014|475119751|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954560|NCT05396014|475119752|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954561|NCT05396014|475119753|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954562|NCT05396014|475119754|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954563|NCT05396014|475119755|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954564|NCT05396014|475119756|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954565|NCT05396014|475119757|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954566|NCT05396014|475119758|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
131954567|NCT05396014|475119759|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954568|NCT05396014|475119760|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954569|NCT05396014|475119761|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954570|NCT05396014|475119762|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954571|NCT05396014|475119763|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954572|NCT05396014|475119764|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954573|NCT05396014|475119765|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954574|NCT05396014|475119766|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954575|NCT05396014|475119767|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954576|NCT05396014|475119768|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954577|NCT05396014|475119769|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954578|NCT05396014|475119770|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954579|NCT05396014|475119771|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954580|NCT05396014|475119772|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
131954581|NCT05396014|475119773|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
131954582|NCT05396014|475119774|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
131954583|NCT05396014|475119775|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
131954584|NCT05396014|475119733|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954585|NCT05396014|475119734|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954586|NCT05396014|475119735|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954587|NCT05396014|475119736|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954588|NCT05396014|475119737|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954589|NCT05396014|475119738|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954590|NCT05396014|475119739|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954591|NCT05396014|475119740|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954592|NCT05396014|475119741|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
131457286|NCT01049009|473304536|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
131457287|NCT01049009|473304537|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
131457288|NCT02423902|473304538|FG000|Overall Study|Disease progression|1|||
131457289|NCT02423902|473304539|FG001|Overall Study|Disease progression|4|||
131457290|NCT02136069|473304540|FG000|Overall Study|UC flare-up|1|||
131457291|NCT02136069|473304541|FG001|Overall Study|UC flare-up|0|||
131457292|NCT02136069|473304540|FG000|Overall Study|Adverse Event|6|||
131457293|NCT02136069|473304541|FG001|Overall Study|Adverse Event|8|||
131954593|NCT05396014|475119742|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954594|NCT05396014|475119743|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954595|NCT05396014|475119744|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954596|NCT05396014|475119745|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954597|NCT05396014|475119746|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954598|NCT05396014|475119747|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954599|NCT05396014|475119748|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954600|NCT05396014|475119749|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954601|NCT05396014|475119750|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954602|NCT05396014|475119751|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954603|NCT05396014|475119752|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954604|NCT05396014|475119753|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954605|NCT05396014|475119754|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954606|NCT05396014|475119755|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
131954607|NCT05396014|475119756|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954608|NCT05396014|475119757|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954609|NCT05396014|475119758|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954610|NCT05396014|475119759|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954611|NCT05396014|475119760|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954612|NCT05396014|475119761|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954613|NCT05396014|475119762|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954614|NCT05396014|475119763|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954615|NCT05396014|475119764|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954616|NCT05396014|475119765|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954617|NCT05396014|475119766|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954618|NCT05396014|475119767|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954619|NCT05396014|475119768|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
131954620|NCT05396014|475119769|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954621|NCT05396014|475119770|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954622|NCT05396014|475119771|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954623|NCT05396014|475119772|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
131954624|NCT05396014|475119773|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954625|NCT05396014|475119774|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
131954626|NCT05396014|475119775|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
131954627|NCT05396014|475119733|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954628|NCT05396014|475119734|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954629|NCT05396014|475119735|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954630|NCT05396014|475119736|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954631|NCT05396014|475119737|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954632|NCT05396014|475119738|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954633|NCT05396014|475119739|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954634|NCT05396014|475119740|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954635|NCT05396014|475119741|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954636|NCT05396014|475119742|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954637|NCT05396014|475119743|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954638|NCT05396014|475119744|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954639|NCT05396014|475119745|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954640|NCT05396014|475119746|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
131954641|NCT05396014|475119747|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954642|NCT05396014|475119748|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954643|NCT05396014|475119749|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954644|NCT05396014|475119750|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954645|NCT05396014|475119751|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954646|NCT05396014|475119752|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954647|NCT05396014|475119753|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954648|NCT05396014|475119754|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954649|NCT05396014|475119755|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954650|NCT05396014|475119756|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131457294|NCT02136069|473304540|FG000|Overall Study|Death|0|||
131457295|NCT02136069|473304541|FG001|Overall Study|Death|1|||
131954651|NCT05396014|475119757|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954652|NCT05396014|475119758|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954653|NCT05396014|475119759|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
131954654|NCT05396014|475119760|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954655|NCT05396014|475119761|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954656|NCT05396014|475119762|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954657|NCT05396014|475119763|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954658|NCT05396014|475119764|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954659|NCT05396014|475119765|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954660|NCT05396014|475119766|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131457296|NCT02136069|473304540|FG000|Overall Study|Lack of Efficacy|10|||
131457297|NCT02136069|473304541|FG001|Overall Study|Lack of Efficacy|4|||
131457298|NCT02136069|473304540|FG000|Overall Study|Lost to Follow-up|1|||
131457299|NCT02136069|473304541|FG001|Overall Study|Lost to Follow-up|0|||
131457300|NCT02136069|473304540|FG000|Overall Study|Non-Compliance|1|||
131457301|NCT02136069|473304541|FG001|Overall Study|Non-Compliance|0|||
131457302|NCT02136069|473304540|FG000|Overall Study|Physician Decision|5|||
131457303|NCT02136069|473304541|FG001|Overall Study|Physician Decision|4|||
131954661|NCT05396014|475119767|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
131954662|NCT05396014|475119768|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954663|NCT05396014|475119769|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954664|NCT05396014|475119770|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954665|NCT05396014|475119771|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954666|NCT05396014|475119772|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954667|NCT05396014|475119773|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954668|NCT05396014|475119774|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
131954669|NCT05396014|475119775|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
131954670|NCT05396014|475119733|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954671|NCT05396014|475119734|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954672|NCT05396014|475119735|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954673|NCT05396014|475119736|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954674|NCT05396014|475119737|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954675|NCT05396014|475119738|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954676|NCT05396014|475119739|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954677|NCT05396014|475119740|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954678|NCT05396014|475119741|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954679|NCT05396014|475119742|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954680|NCT05396014|475119743|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954681|NCT05396014|475119744|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954682|NCT05396014|475119745|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954683|NCT05396014|475119746|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954684|NCT05396014|475119747|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954685|NCT05396014|475119748|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954686|NCT05396014|475119749|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954687|NCT05396014|475119750|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954688|NCT05396014|475119751|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954689|NCT05396014|475119752|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954690|NCT05396014|475119753|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954691|NCT05396014|475119754|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954692|NCT05396014|475119755|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954693|NCT05396014|475119756|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954694|NCT05396014|475119757|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954695|NCT05396014|475119758|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954696|NCT05396014|475119759|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
131954697|NCT05396014|475119760|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954698|NCT05396014|475119761|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954699|NCT05396014|475119762|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954700|NCT05396014|475119763|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954701|NCT05396014|475119764|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954702|NCT05396014|475119765|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954703|NCT05396014|475119766|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954704|NCT05396014|475119767|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954705|NCT05396014|475119768|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954706|NCT05396014|475119769|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954707|NCT05396014|475119770|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954708|NCT05396014|475119771|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131457304|NCT02136069|473304540|FG000|Overall Study|Withdrawal by Subject|10|||
131457305|NCT02136069|473304541|FG001|Overall Study|Withdrawal by Subject|11|||
131954709|NCT05396014|475119772|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954710|NCT05396014|475119773|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954711|NCT05396014|475119774|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954712|NCT05396014|475119775|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
131954713|NCT05258890|475119776|FG000|Overall Study|Patient withdrawal|6|||
131954714|NCT05258890|475119777|FG001|Overall Study|Patient withdrawal|7|||
131954715|NCT05258890|475119776|FG000|Overall Study|Patient lost to follow-up|10|||
131954716|NCT05258890|475119777|FG001|Overall Study|Patient lost to follow-up|3|||
131954717|NCT05258890|475119776|FG000|Overall Study|Social network member withdrawal|1|||
131954718|NCT05258890|475119777|FG001|Overall Study|Social network member withdrawal|0|||
131954719|NCT05258890|475119776|FG000|Overall Study|Social network member lost to follow-up|5|||
131954720|NCT05258890|475119777|FG001|Overall Study|Social network member lost to follow-up|0|||
131954721|NCT00516893|475119780|FG000|Overall Study|Lost to Follow-up|4|||
131954722|NCT00516893|475119780|FG000|Overall Study|Adverse Event|3|||
131954723|NCT00516893|475119780|FG000|Overall Study|Withdrawal by Subject|2|||
131954724|NCT00516893|475119780|FG000|Overall Study|Noncompliance|2|||
131954725|NCT00516893|475119780|FG000|Overall Study|Death|1|||
131954726|NCT00516893|475119780|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
131954727|NCT00516893|475119780|FG000|Overall Study|Relocated|1|||
131954728|NCT00516893|475119780|FG000|Overall Study|Pregnancy|1|||
131954729|NCT00516893|475119780|FG000|Overall Study|Received Medication From Another Study|1|||
131954730|NCT05935878|475119786|FG000|Overall Study|Death|1|||
131954731|NCT05935878|475119787|FG001|Overall Study|Death|2|||
131954732|NCT05935878|475119786|FG000|Overall Study|Withdrawal by Subject|5|||
131954733|NCT05935878|475119787|FG001|Overall Study|Withdrawal by Subject|5|||
131954734|NCT05935878|475119786|FG000|Overall Study|Revision of implant|1|||
131954735|NCT05935878|475119787|FG001|Overall Study|Revision of implant|1|||
131954736|NCT05935878|475119786|FG000|Overall Study|Mobile bearing dislocation|0|||
131954737|NCT05935878|475119787|FG001|Overall Study|Mobile bearing dislocation|1|||
131954738|NCT05924165|475119788|FG000|Overall Study|Physician Decision|2|||
131954739|NCT05924165|475119789|FG001|Overall Study|Physician Decision|3|||
131954740|NCT05959447|475119790|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
131954741|NCT05959447|475119791|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
131954742|NCT05959447|475119790|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
131954743|NCT05959447|475119791|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
131954744|NCT05959447|475119790|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
131954745|NCT05959447|475119791|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
131954746|NCT05959447|475119790|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
131954747|NCT05959447|475119791|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
131954748|NCT03206970|475119793|FG000|Overall Study|Death|21|||
131954749|NCT03206970|475119793|FG000|Overall Study|Withdrawal by Subject|13|||
131954750|NCT03206970|475119793|FG000|Overall Study|Lost to Follow-up|3|||
131954751|NCT03206970|475119793|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
131954752|NCT00282087|475119794|FG000|Overall Study|Death|1|||
131954753|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
131954754|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
131954755|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
131954756|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
131954757|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
131954758|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
131954759|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
131954760|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
131954761|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131954762|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131954763|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131954764|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
131954765|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
131954766|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
131954767|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131954768|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131954769|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131954770|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
131954771|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
131954772|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
131954773|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
131954774|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
131954775|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
131954776|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
131954777|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131415351|NCT02648217|473145247|FG000|Overall Study|Adverse Event|0|||
131954778|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
131954779|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131954780|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131954781|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131954782|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
131954783|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
131954784|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
131954785|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
131954786|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
131954787|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
131954788|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
131954789|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
131954790|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
131954791|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
131954792|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
131954793|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
131954794|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
131954795|NCT03985943|475119799|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
131954796|NCT03985943|475119800|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
131954797|NCT03985943|475119801|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
131954798|NCT03985943|475119802|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
131954799|NCT03985943|475119803|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
131954800|NCT03985943|475119804|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
131954801|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131954802|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131954803|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
131954804|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
131954805|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
131954806|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
131954807|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131954808|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131954809|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
131954810|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
131954811|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
131954812|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
131954813|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
131954814|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
131954815|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
131954816|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
131954817|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
131954818|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
131954819|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131954820|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131954821|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131954822|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
131954823|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
131954824|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
131954825|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
131954826|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
131954827|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
131954828|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
131954829|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
131954830|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
131954831|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
131954832|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
131954833|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
131954834|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
131954835|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
131954836|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
131954837|NCT03985943|475119799|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
131954838|NCT03985943|475119800|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
131954839|NCT03985943|475119801|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
131954840|NCT03985943|475119802|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
131954841|NCT03985943|475119803|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
131954842|NCT03985943|475119804|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
131954843|NCT00338286|475119805|FG000|Overall Study|Withdrawal by Subject|50|||
131954844|NCT00338286|475119806|FG001|Overall Study|Withdrawal by Subject|54|||
131954845|NCT00338286|475119805|FG000|Overall Study|Lost to Follow-up|80|||
131954846|NCT00338286|475119806|FG001|Overall Study|Lost to Follow-up|66|||
131954847|NCT00338286|475119805|FG000|Overall Study|Other|103|||
131954848|NCT00338286|475119806|FG001|Overall Study|Other|93|||
131954849|NCT00022763|475119810|FG000|Overall Study|Adverse Event|1|||
131954850|NCT00022763|475119811|FG001|Overall Study|Adverse Event|2|||
131954851|NCT00022763|475119810|FG000|Overall Study|Injection Site Reactions|0|||
131954852|NCT00022763|475119811|FG001|Overall Study|Injection Site Reactions|2|||
131954853|NCT00022763|475119810|FG000|Overall Study|Death|0|||
131954854|NCT00022763|475119811|FG001|Overall Study|Death|1|||
131954855|NCT00022763|475119810|FG000|Overall Study|Lost to Follow-up|0|||
131954856|NCT00022763|475119811|FG001|Overall Study|Lost to Follow-up|3|||
131954857|NCT00022763|475119810|FG000|Overall Study|Withdrawal by Subject|4|||
131954858|NCT00022763|475119811|FG001|Overall Study|Withdrawal by Subject|7|||
131954859|NCT00022763|475119810|FG000|Overall Study|Insufficient Therapy|1|||
131954860|NCT00022763|475119811|FG001|Overall Study|Insufficient Therapy|0|||
131954861|NCT00022763|475119810|FG000|Overall Study|Admin|3|||
131954862|NCT00022763|475119811|FG001|Overall Study|Admin|2|||
131954863|NCT00716482|475119812|FG000|Overall Study|Lost to Follow-up|6|||
131954864|NCT00716482|475119812|FG000|Overall Study|Inadequate acquisition or analysis|50|||
131954865|NCT00716482|475119812|FG000|Overall Study|no pathology obtained|10|||
131954866|NCT00716482|475119812|FG000|Overall Study|technical/machine error|28|||
131954867|NCT00716482|475119812|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
131954868|NCT03248531|475119813|FG000|Overall Study|Adverse Event|0|||
131954869|NCT03248531|475119814|FG001|Overall Study|Adverse Event|0|||
131954870|NCT03248531|475119815|FG002|Overall Study|Adverse Event|1|||
131954871|NCT03248531|475119813|FG000|Overall Study|Lost to Follow-up|1|||
131954872|NCT03248531|475119814|FG001|Overall Study|Lost to Follow-up|0|||
131954873|NCT03248531|475119815|FG002|Overall Study|Lost to Follow-up|5|||
131954874|NCT03248531|475119813|FG000|Overall Study|Withdrawal by Subject|3|||
131954875|NCT03248531|475119814|FG001|Overall Study|Withdrawal by Subject|3|||
131954876|NCT03248531|475119815|FG002|Overall Study|Withdrawal by Subject|2|||
131954877|NCT03248531|475119813|FG000|Overall Study|Sponsor Request|0|||
131954878|NCT03248531|475119814|FG001|Overall Study|Sponsor Request|2|||
131954879|NCT03248531|475119815|FG002|Overall Study|Sponsor Request|0|||
131954880|NCT04075513|475119816|FG000|Overall Study|Withdrawal by Subject|2|||
131954881|NCT04075513|475119817|FG001|Overall Study|Withdrawal by Subject|2|||
131954882|NCT04075513|475119816|FG000|Overall Study|Lack of Efficacy|1|||
131954883|NCT04075513|475119817|FG001|Overall Study|Lack of Efficacy|0|||
131954884|NCT04075513|475119816|FG000|Overall Study|Lost to Follow-up|4|||
131954885|NCT04075513|475119817|FG001|Overall Study|Lost to Follow-up|2|||
131954886|NCT04075513|475119816|FG000|Overall Study|Switch to insulin pump|1|||
131954887|NCT04075513|475119817|FG001|Overall Study|Switch to insulin pump|0|||
131954888|NCT03748706|475119819|FG000|Overall Study|Lost to Follow-up|1|||
131954889|NCT03517371|475119820|FG000|Overall Study|Adverse Event|8|||
131954890|NCT03517371|475119821|FG001|Overall Study|Adverse Event|9|||
131954891|NCT03517371|475119820|FG000|Overall Study|Lost to Follow-up|1|||
131954892|NCT03517371|475119821|FG001|Overall Study|Lost to Follow-up|2|||
131954893|NCT03517371|475119820|FG000|Overall Study|Withdrawal by Subject|4|||
131954894|NCT03517371|475119821|FG001|Overall Study|Withdrawal by Subject|4|||
131954895|NCT03517371|475119820|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
131954896|NCT03517371|475119821|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
131954897|NCT03517371|475119820|FG000|Overall Study|COVID restrictions|2|||
131954898|NCT03517371|475119821|FG001|Overall Study|COVID restrictions|0|||
131954899|NCT03517371|475119820|FG000|Overall Study|Receiving DBS Surgery|0|||
131954900|NCT03517371|475119821|FG001|Overall Study|Receiving DBS Surgery|1|||
131954901|NCT04153981|475119824|FG000|Overall Study|Death|1|||
131954902|NCT04153981|475119824|FG000|Overall Study|Withdrawal by Subject|24|||
131954903|NCT04153981|475119824|FG000|Overall Study|Lost to Follow-up|1|||
131954904|NCT04153981|475119824|FG000|Overall Study|Physician Decision|1|||
131954905|NCT04153981|475119824|FG000|Overall Study|Due to Unavailable Glucometer|1|||
131954906|NCT04153981|475119824|FG000|Overall Study|Covid 19|52|||
131954907|NCT04153981|475119824|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
131954908|NCT04153981|475119824|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
131954909|NCT03490292|475119825|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
131954910|NCT03490292|475119826|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
131954911|NCT03490292|475119825|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
131954912|NCT03490292|475119826|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
131954913|NCT03490292|475119825|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
131954914|NCT03490292|475119826|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
131954915|NCT03490292|475119825|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
131954916|NCT03490292|475119826|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
131954917|NCT03490292|475119825|FG000|1 Year Follow Up Post Last Dose|Death|1|||
131954918|NCT03490292|475119826|FG001|1 Year Follow Up Post Last Dose|Death|1|||
131954919|NCT02936869|475119835|FG000|Overall Study|Lost to Follow-up|1|||
131954920|NCT02936869|475119836|FG001|Overall Study|Lost to Follow-up|3|||
131954921|NCT02936869|475119835|FG000|Overall Study|Death|0|||
131954922|NCT02936869|475119836|FG001|Overall Study|Death|1|||
131954923|NCT02936869|475119835|FG000|Overall Study|Legal Case|0|||
131954924|NCT02936869|475119836|FG001|Overall Study|Legal Case|1|||
131954925|NCT02936869|475119835|FG000|Overall Study|Protocol Violation|1|||
131954926|NCT02936869|475119836|FG001|Overall Study|Protocol Violation|0|||
131954927|NCT00335738|475119837|FG000|Overall Study|Physician Decision|6|||
131954928|NCT00335738|475119838|FG001|Overall Study|Physician Decision|0|||
131954929|NCT00335738|475119837|FG000|Overall Study|Withdrawal by Subject|2|||
131954930|NCT00335738|475119838|FG001|Overall Study|Withdrawal by Subject|0|||
131954931|NCT00335738|475119837|FG000|Overall Study|Ineligible|3|||
131954932|NCT00335738|475119838|FG001|Overall Study|Ineligible|4|||
131954933|NCT04004221|475119845|FG000|Overall Study|Death|89|||
131954934|NCT04004221|475119845|FG000|Overall Study|Withdrawal by Subject|5|||
131954935|NCT04004221|475119845|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
131954936|NCT04004221|475119845|FG000|Overall Study|Sponsor Decision|9|||
131954937|NCT04004221|475119845|FG000|Overall Study|Participant refused to enter LTE|1|||
131954938|NCT02036580|475119846|FG000|Overall Study|Withdrawal by Subject|0|||
131954939|NCT02036580|475119847|FG001|Overall Study|Withdrawal by Subject|1|||
131954940|NCT02036580|475119848|FG002|Overall Study|Withdrawal by Subject|0|||
131954941|NCT02036580|475119846|FG000|Overall Study|Adverse Event|1|||
131954942|NCT02036580|475119847|FG001|Overall Study|Adverse Event|0|||
131954943|NCT02036580|475119848|FG002|Overall Study|Adverse Event|0|||
131954944|NCT00992056|475119849|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
131954945|NCT00992056|475119850|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
131954946|NCT00992056|475119849|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
131954947|NCT00992056|475119850|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
131954948|NCT00260832|475119851|FG000|Overall Study|Adverse Event|26|||
131954949|NCT00260832|475119852|FG001|Overall Study|Adverse Event|19|||
131954950|NCT00260832|475119851|FG000|Overall Study|Progression|116|||
131954951|NCT00260832|475119852|FG001|Overall Study|Progression|96|||
131954952|NCT00260832|475119851|FG000|Overall Study|Withdrawal by Subject|15|||
131954953|NCT00260832|475119852|FG001|Overall Study|Withdrawal by Subject|17|||
131954954|NCT00260832|475119851|FG000|Overall Study|Physician Decision|15|||
131954955|NCT00260832|475119852|FG001|Overall Study|Physician Decision|9|||
131954956|NCT00260832|475119851|FG000|Overall Study|Death|43|||
131954957|NCT00260832|475119852|FG001|Overall Study|Death|62|||
131954958|NCT00260832|475119851|FG000|Overall Study|Other|10|||
131954959|NCT00260832|475119852|FG001|Overall Study|Other|7|||
131954960|NCT00260832|475119851|FG000|Overall Study|Protocol Violation|3|||
131954961|NCT00260832|475119852|FG001|Overall Study|Protocol Violation|1|||
131954962|NCT03604172|475119854|FG000|Overall Study|Lost to Follow-up|1|||
131954963|NCT03604172|475119855|FG001|Overall Study|Lost to Follow-up|2|||
131954964|NCT02676895|475119856|FG000|Overall Study|Administrative reason|1|||
131954965|NCT02676895|475119857|FG001|Overall Study|Administrative reason|0|||
131954966|NCT02676895|475119858|FG002|Overall Study|Administrative reason|0|||
131954967|NCT02676895|475119856|FG000|Overall Study|Protocol Violation|1|||
131954968|NCT02676895|475119857|FG001|Overall Study|Protocol Violation|0|||
131954969|NCT02676895|475119858|FG002|Overall Study|Protocol Violation|0|||
131954970|NCT02676895|475119856|FG000|Overall Study|Adverse Event|0|||
131954971|NCT02676895|475119857|FG001|Overall Study|Adverse Event|3|||
131954972|NCT02676895|475119858|FG002|Overall Study|Adverse Event|1|||
131415352|NCT02648217|473145248|FG001|Overall Study|Adverse Event|1|||
131415353|NCT02648217|473145247|FG000|Overall Study|Lost to Follow-up|1|||
131415354|NCT02648217|473145248|FG001|Overall Study|Lost to Follow-up|1|||
131415355|NCT02648217|473145247|FG000|Overall Study|Withdrawal by Subject|4|||
131415356|NCT02648217|473145248|FG001|Overall Study|Withdrawal by Subject|3|||
131954973|NCT02676895|475119856|FG000|Overall Study|Lost to Follow-up|0|||
131954974|NCT02676895|475119857|FG001|Overall Study|Lost to Follow-up|0|||
131954975|NCT02676895|475119858|FG002|Overall Study|Lost to Follow-up|1|||
131954976|NCT02676895|475119856|FG000|Overall Study|Withdrawal by Subject|0|||
131954977|NCT02676895|475119857|FG001|Overall Study|Withdrawal by Subject|0|||
131954978|NCT02676895|475119858|FG002|Overall Study|Withdrawal by Subject|1|||
131954979|NCT00976716|475119864|FG000|Overall Study|Adverse Event|1|||
131954980|NCT03028129|475119870|FG000|Overall Study|Adverse Event|13|||
131954981|NCT03028129|475119871|FG001|Overall Study|Adverse Event|2|||
131954982|NCT03028129|475119870|FG000|Overall Study|Lost to Follow-up|50|||
131954983|NCT03028129|475119871|FG001|Overall Study|Lost to Follow-up|38|||
131954984|NCT03028129|475119870|FG000|Overall Study|Physician Decision|0|||
131954985|NCT03028129|475119871|FG001|Overall Study|Physician Decision|1|||
131954986|NCT03028129|475119870|FG000|Overall Study|Protocol Violation|1|||
131954987|NCT03028129|475119871|FG001|Overall Study|Protocol Violation|1|||
131954988|NCT03028129|475119870|FG000|Overall Study|Withdrawal by Subject|62|||
131954989|NCT03028129|475119871|FG001|Overall Study|Withdrawal by Subject|45|||
131954990|NCT02993822|475119872|FG000|Overall Study|Lack of Efficacy|1|||
131954991|NCT02993822|475119873|FG001|Overall Study|Lack of Efficacy|1|||
131954992|NCT02993822|475119874|FG002|Overall Study|Lack of Efficacy|0|||
131954993|NCT02993822|475119875|FG003|Overall Study|Lack of Efficacy|0|||
131954994|NCT02993822|475119872|FG000|Overall Study|Protocol Violation|1|||
131954995|NCT02993822|475119873|FG001|Overall Study|Protocol Violation|0|||
131954996|NCT02993822|475119874|FG002|Overall Study|Protocol Violation|0|||
131954997|NCT02993822|475119875|FG003|Overall Study|Protocol Violation|0|||
131954998|NCT02993822|475119872|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
131954999|NCT02993822|475119873|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
131955000|NCT02993822|475119874|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
131955001|NCT02993822|475119875|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
131955002|NCT02993822|475119872|FG000|Overall Study|Adverse Event|3|||
131955003|NCT02993822|475119873|FG001|Overall Study|Adverse Event|1|||
131955004|NCT02993822|475119874|FG002|Overall Study|Adverse Event|7|||
131955005|NCT02993822|475119875|FG003|Overall Study|Adverse Event|0|||
131955006|NCT02993822|475119872|FG000|Overall Study|Withdrawal by Subject|4|||
131955007|NCT02993822|475119873|FG001|Overall Study|Withdrawal by Subject|2|||
131955008|NCT02993822|475119874|FG002|Overall Study|Withdrawal by Subject|2|||
131955009|NCT02993822|475119875|FG003|Overall Study|Withdrawal by Subject|3|||
131955010|NCT02993822|475119872|FG000|Overall Study|Lost to Follow-up|1|||
131955011|NCT02993822|475119873|FG001|Overall Study|Lost to Follow-up|0|||
131955012|NCT02993822|475119874|FG002|Overall Study|Lost to Follow-up|1|||
131955013|NCT02993822|475119875|FG003|Overall Study|Lost to Follow-up|0|||
131955014|NCT01221753|475119876|FG000|Overall Study|Adverse Event|1|||
131955015|NCT01939977|475119877|FG000|Overall Study|Adverse Event|4|||
131955016|NCT01939977|475119878|FG001|Overall Study|Adverse Event|3|||
131955017|NCT01939977|475119877|FG000|Overall Study|Lack of Efficacy|3|||
131955018|NCT01939977|475119878|FG001|Overall Study|Lack of Efficacy|0|||
131955019|NCT01939977|475119877|FG000|Overall Study|Physician Decision|1|||
131955020|NCT01939977|475119878|FG001|Overall Study|Physician Decision|1|||
131955021|NCT01939977|475119877|FG000|Overall Study|Withdrawal by Subject|0|||
131955022|NCT01939977|475119878|FG001|Overall Study|Withdrawal by Subject|2|||
131955023|NCT01939977|475119877|FG000|Overall Study|Did not meet inclusion criteria|1|||
131955024|NCT01939977|475119878|FG001|Overall Study|Did not meet inclusion criteria|0|||
131955025|NCT01939977|475119877|FG000|Overall Study|Did not receive study medication|0|||
131955026|NCT01939977|475119878|FG001|Overall Study|Did not receive study medication|1|||
131955027|NCT02952313|475119882|FG000|Primary Endpoint|Lost to Follow-up|4|||
131955028|NCT02952313|475119882|FG000|Primary Endpoint|Withdrawal by Subject|1|||
131955029|NCT02952313|475119882|FG000|Primary Endpoint|Lack of Efficacy|1|||
131955030|NCT02952313|475119882|FG000|Primary Endpoint|Missed visit|1|||
131955031|NCT02952313|475119882|FG000|Long-term Follow-up|Lost to Follow-up|12|||
131955032|NCT02952313|475119882|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
131955033|NCT02952313|475119882|FG000|Long-term Follow-up|Lack of Efficacy|6|||
131955034|NCT02952313|475119882|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
131955035|NCT02952313|475119882|FG000|Long-term Follow-up|Physician Decision|1|||
131955036|NCT02952313|475119882|FG000|Long-term Follow-up|Death|1|||
131955037|NCT03028415|475119883|FG000|Overall Study|Lost to Follow-up|6|||
131955038|NCT03028415|475119884|FG001|Overall Study|Lost to Follow-up|3|||
131955039|NCT03028415|475119883|FG000|Overall Study|Withdrawal by Subject|1|||
131955040|NCT03028415|475119884|FG001|Overall Study|Withdrawal by Subject|0|||
131955041|NCT03028415|475119883|FG000|Overall Study|Discontinued due to COVID-19|1|||
131955042|NCT03028415|475119884|FG001|Overall Study|Discontinued due to COVID-19|0|||
131955043|NCT02485639|475119885|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
131955044|NCT02485639|475119885|FG000|Overall Study|Early termination|4|||
131955045|NCT02485639|475119885|FG000|Overall Study|Withdrawal by Subject|4|||
131955046|NCT02015481|475119886|FG000|Overall Study|Death|1|||
131955047|NCT01170273|475119895|FG000|Overall Study|Lost to Follow-up|6|||
131955048|NCT01170273|475119896|FG001|Overall Study|Lost to Follow-up|8|||
131955049|NCT01170273|475119895|FG000|Overall Study|Protocol Violation|1|||
131955050|NCT01170273|475119896|FG001|Overall Study|Protocol Violation|0|||
131955051|NCT01170273|475119895|FG000|Overall Study|Death|1|||
131955052|NCT01170273|475119896|FG001|Overall Study|Death|0|||
131955053|NCT01170273|475119895|FG000|Overall Study|Adverse Event|0|||
131955054|NCT01170273|475119896|FG001|Overall Study|Adverse Event|1|||
131955055|NCT02316353|475119897|FG000|Overall Study|Pregnancy|1|||
131955056|NCT02316353|475119898|FG001|Overall Study|Pregnancy|3|||
131955057|NCT02316353|475119897|FG000|Overall Study|Adverse Event|1|||
131955058|NCT02316353|475119898|FG001|Overall Study|Adverse Event|3|||
131955059|NCT02316353|475119897|FG000|Overall Study|Withdrawal by Subject|6|||
131955060|NCT02316353|475119898|FG001|Overall Study|Withdrawal by Subject|2|||
131955061|NCT04459416|475123624|FG000|Overall Study|Lost to Follow-up|2|||
131955062|NCT04459416|475123625|FG001|Overall Study|Lost to Follow-up|0|||
131955063|NCT04459416|475123624|FG000|Overall Study|Withdrawal by Subject|8|||
131955064|NCT04459416|475123625|FG001|Overall Study|Withdrawal by Subject|10|||
131955065|NCT04459416|475123624|FG000|Overall Study|Disease progression|0|||
131955066|NCT04459416|475123625|FG001|Overall Study|Disease progression|3|||
131955067|NCT05328375|475123626|FG000|Overall Study|Withdrawal by Subject|0|||
131955068|NCT05328375|475123627|FG001|Overall Study|Withdrawal by Subject|1|||
131955069|NCT03529110|475123628|FG000|Overall Study|Progressive Disease|66|||
131955070|NCT03529110|475123629|FG001|Overall Study|Progressive Disease|158|||
131955071|NCT03529110|475123628|FG000|Overall Study|Clinical Progression|4|||
131955072|NCT03529110|475123629|FG001|Overall Study|Clinical Progression|12|||
131955073|NCT03529110|475123628|FG000|Overall Study|Adverse Event|35|||
131955074|NCT03529110|475123629|FG001|Overall Study|Adverse Event|17|||
131955075|NCT03529110|475123628|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
131955076|NCT03529110|475123629|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
131955077|NCT03529110|475123628|FG000|Overall Study|Lack of Efficacy|3|||
131955078|NCT03529110|475123629|FG001|Overall Study|Lack of Efficacy|3|||
131955079|NCT03529110|475123628|FG000|Overall Study|Physician Decision|2|||
131955080|NCT03529110|475123629|FG001|Overall Study|Physician Decision|8|||
131955081|NCT03529110|475123628|FG000|Overall Study|Miscellaneous|2|||
131955082|NCT03529110|475123629|FG001|Overall Study|Miscellaneous|5|||
131955083|NCT05104450|475123630|FG000|Overall Study|Death|1|||
131955084|NCT05104450|475123631|FG001|Overall Study|Death|2|||
131955085|NCT05104450|475123630|FG000|Overall Study|Withdrawal by Subject|3|||
131955086|NCT05104450|475123631|FG001|Overall Study|Withdrawal by Subject|1|||
131955087|NCT04736199|475123632|FG000|Overall Study|Adverse Event|28|||
131955088|NCT04736199|475123633|FG001|Overall Study|Adverse Event|22|||
131955089|NCT04736199|475123632|FG000|Overall Study|Death|9|||
131955090|NCT04736199|475123633|FG001|Overall Study|Death|3|||
131955091|NCT04736199|475123632|FG000|Overall Study|Lost to Follow-up|4|||
131955092|NCT04736199|475123633|FG001|Overall Study|Lost to Follow-up|1|||
131955093|NCT04736199|475123632|FG000|Overall Study|Physician Decision|5|||
131955094|NCT04736199|475123633|FG001|Overall Study|Physician Decision|9|||
131955095|NCT04736199|475123632|FG000|Overall Study|Withdrawal by Subject|21|||
131955096|NCT04736199|475123633|FG001|Overall Study|Withdrawal by Subject|9|||
131955097|NCT04736199|475123632|FG000|Overall Study|Progressive disease|120|||
131955098|NCT04736199|475123633|FG001|Overall Study|Progressive disease|101|||
131955099|NCT04736199|475123632|FG000|Overall Study|Subject decision|13|||
131955100|NCT04736199|475123633|FG001|Overall Study|Subject decision|13|||
131955101|NCT04736199|475123632|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
131955102|NCT04736199|475123633|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
131955103|NCT04736199|475123632|FG000|Overall Study|Additional primary malignancy|1|||
131955104|NCT04736199|475123633|FG001|Overall Study|Additional primary malignancy|0|||
131955105|NCT04736199|475123632|FG000|Overall Study|Non-compliance with study drug|0|||
131955106|NCT04736199|475123633|FG001|Overall Study|Non-compliance with study drug|1|||
131955107|NCT04736199|475123632|FG000|Overall Study|Other reason|0|||
131955108|NCT04736199|475123633|FG001|Overall Study|Other reason|1|||
131955109|NCT04736199|475123632|FG000|Overall Study|Ongoing with study drug|240|||
131955110|NCT04736199|475123633|FG001|Overall Study|Ongoing with study drug|63|||
131955111|NCT04736199|475123632|FG000|Overall Study|Study drug never administered|3|||
131955112|NCT04736199|475123633|FG001|Overall Study|Study drug never administered|0|||
131955113|NCT04579380|475123634|FG000|Overall Study|Death|9|||
131955114|NCT04579380|475123635|FG001|Overall Study|Death|22|||
131955115|NCT04579380|475123636|FG002|Overall Study|Death|22|||
131955116|NCT04579380|475123637|FG003|Overall Study|Death|17|||
131955117|NCT04579380|475123638|FG004|Overall Study|Death|6|||
131955118|NCT04579380|475123639|FG005|Overall Study|Death|21|||
131955119|NCT04579380|475123640|FG006|Overall Study|Death|10|||
131955120|NCT04579380|475123641|FG007|Overall Study|Death|11|||
131955121|NCT04579380|475123642|FG008|Overall Study|Death|25|||
131955122|NCT04579380|475123634|FG000|Overall Study|Withdrawal by Subject|0|||
131415357|NCT02648217|473145247|FG000|Overall Study|Unclassified|5|||
131415358|NCT02648217|473145248|FG001|Overall Study|Unclassified|0|||
131415359|NCT03316950|473145249|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
131415360|NCT03316950|473145250|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
131415361|NCT03316950|473145251|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
131415362|NCT03316950|473145252|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
131955123|NCT04579380|475123635|FG001|Overall Study|Withdrawal by Subject|3|||
131955124|NCT04579380|475123636|FG002|Overall Study|Withdrawal by Subject|4|||
131955125|NCT04579380|475123637|FG003|Overall Study|Withdrawal by Subject|0|||
131415363|NCT03316950|473145249|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
131415364|NCT03316950|473145250|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
131955126|NCT04579380|475123638|FG004|Overall Study|Withdrawal by Subject|1|||
131955127|NCT04579380|475123639|FG005|Overall Study|Withdrawal by Subject|2|||
131955128|NCT04579380|475123640|FG006|Overall Study|Withdrawal by Subject|0|||
131955129|NCT04579380|475123641|FG007|Overall Study|Withdrawal by Subject|1|||
131955130|NCT04579380|475123642|FG008|Overall Study|Withdrawal by Subject|2|||
131955131|NCT04579380|475123634|FG000|Overall Study|Ongoing|2|||
131955132|NCT04579380|475123635|FG001|Overall Study|Ongoing|6|||
131955133|NCT04579380|475123636|FG002|Overall Study|Ongoing|4|||
131955134|NCT04579380|475123637|FG003|Overall Study|Ongoing|8|||
131955135|NCT04579380|475123638|FG004|Overall Study|Ongoing|5|||
131457306|NCT04538144|473304542|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
131457307|NCT04538144|473304543|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
131457308|NCT04538144|473304544|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
131457309|NCT04538144|473304545|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
131955136|NCT04579380|475123639|FG005|Overall Study|Ongoing|8|||
131955137|NCT04579380|475123640|FG006|Overall Study|Ongoing|3|||
131955138|NCT04579380|475123641|FG007|Overall Study|Ongoing|19|||
131955139|NCT04579380|475123642|FG008|Overall Study|Ongoing|6|||
131457310|NCT04364984|473304548|FG000|Overall Study|Death|2|||
131457311|NCT04364984|473304549|FG001|Overall Study|Death|2|||
131457312|NCT04364984|473304550|FG002|Overall Study|Death|0|||
131457313|NCT02644109|473304551|FG000|Overall Study|Adverse Event|0|||
131457314|NCT02644109|473304552|FG001|Overall Study|Adverse Event|4|||
131457315|NCT01519869|473304555|FG000|Overall Study|Lost to Follow-up|1|||
131457316|NCT03023813|473304556|FG000|Overall Study|Lost to Follow-up|1|||
131457317|NCT03023813|473304557|FG001|Overall Study|Lost to Follow-up|2|||
131457318|NCT03023813|473304558|FG002|Overall Study|Lost to Follow-up|0|||
131457319|NCT05343624|473304567|FG000|Overall Study|Chart review not completed|1|||
131955140|NCT03937713|475123643|FG000|Overall Study|Withdrawal by Subject|3|||
131955141|NCT03937713|475123644|FG001|Overall Study|Withdrawal by Subject|6|||
131955142|NCT03937713|475123643|FG000|Overall Study|Lost to Follow-up|1|||
131955143|NCT03937713|475123644|FG001|Overall Study|Lost to Follow-up|0|||
131955144|NCT01991977|475123645|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
131955145|NCT01991977|475123645|FG000|Overall Study|Withdrew after start of treatment|5|||
131955146|NCT02562235|475123647|FG000|Overall Study|Adverse Event|3|||
131955147|NCT03913195|475123648|FG000|Overall Study|Adverse Event|0|||
131955148|NCT03913195|475123649|FG001|Overall Study|Adverse Event|0|||
131955149|NCT03913195|475123650|FG002|Overall Study|Adverse Event|1|||
131955150|NCT03913195|475123651|FG003|Overall Study|Adverse Event|1|||
131955151|NCT03913195|475123652|FG004|Overall Study|Adverse Event|0|||
131955152|NCT03913195|475123648|FG000|Overall Study|Withdrawal by Subject|0|||
131955153|NCT03913195|475123649|FG001|Overall Study|Withdrawal by Subject|0|||
131955154|NCT03913195|475123650|FG002|Overall Study|Withdrawal by Subject|1|||
131955155|NCT03913195|475123651|FG003|Overall Study|Withdrawal by Subject|0|||
131955156|NCT03913195|475123652|FG004|Overall Study|Withdrawal by Subject|1|||
131955157|NCT03913195|475123648|FG000|Overall Study|non adherence to study|0|||
131955158|NCT03913195|475123649|FG001|Overall Study|non adherence to study|0|||
131955159|NCT03913195|475123650|FG002|Overall Study|non adherence to study|1|||
131955160|NCT03913195|475123651|FG003|Overall Study|non adherence to study|0|||
131955161|NCT03913195|475123652|FG004|Overall Study|non adherence to study|0|||
131955162|NCT05030350|475123656|FG000|Overall Study|Adverse Event|13|||
131955163|NCT05030350|475123656|FG000|Overall Study|Lack of Efficacy|8|||
131955164|NCT05030350|475123656|FG000|Overall Study|Lost to Follow-up|35|||
131955165|NCT05030350|475123656|FG000|Overall Study|Pregnancy|2|||
131955166|NCT05030350|475123656|FG000|Overall Study|Protocol Violation|2|||
131955167|NCT05030350|475123656|FG000|Overall Study|Withdrawal by Subject|60|||
131955168|NCT05030350|475123656|FG000|Overall Study|Study terminated by sponsor|349|||
131955169|NCT05030350|475123656|FG000|Overall Study|Positive Drug Screen|4|||
131955170|NCT05030350|475123656|FG000|Overall Study|Other|8|||
131955171|NCT02711137|475123657|FG000|Overall Study|Death|1|||
131955172|NCT02711137|475123658|FG001|Overall Study|Death|4|||
131955173|NCT02711137|475123659|FG002|Overall Study|Death|5|||
131955174|NCT02711137|475123660|FG003|Overall Study|Death|5|||
131955175|NCT02711137|475123661|FG004|Overall Study|Death|3|||
131955176|NCT02711137|475123662|FG005|Overall Study|Death|1|||
131955177|NCT02711137|475123663|FG006|Overall Study|Death|61|||
131955178|NCT02711137|475123664|FG007|Overall Study|Death|3|||
131955179|NCT02711137|475123665|FG008|Overall Study|Death|0|||
131955180|NCT02711137|475123666|FG009|Overall Study|Death|1|||
131955181|NCT02711137|475123667|FG010|Overall Study|Death|1|||
131955182|NCT02711137|475123668|FG011|Overall Study|Death|1|||
131955183|NCT02711137|475123669|FG012|Overall Study|Death|0|||
131955184|NCT02711137|475123670|FG013|Overall Study|Death|0|||
131955185|NCT02711137|475123671|FG014|Overall Study|Death|0|||
131457320|NCT00862082|473304568|FG000|Overall Study|Sponsor decision to terminate the study|5|||
131955186|NCT02711137|475123657|FG000|Overall Study|Study Terminated by Sponsor|0|||
131955187|NCT02711137|475123658|FG001|Overall Study|Study Terminated by Sponsor|0|||
131955188|NCT02711137|475123659|FG002|Overall Study|Study Terminated by Sponsor|1|||
131457321|NCT00862082|473304569|FG001|Overall Study|Sponsor decision to terminate the study|0|||
131457322|NCT00862082|473304568|FG000|Overall Study|Withdrawal by Subject|0|||
131955189|NCT02711137|475123660|FG003|Overall Study|Study Terminated by Sponsor|0|||
131955190|NCT02711137|475123661|FG004|Overall Study|Study Terminated by Sponsor|0|||
131955191|NCT02711137|475123662|FG005|Overall Study|Study Terminated by Sponsor|0|||
131457323|NCT00862082|473304569|FG001|Overall Study|Withdrawal by Subject|1|||
131457324|NCT02447302|473304581|FG000|Overall Study|Physician Decision|1|||
131457325|NCT02447302|473304582|FG001|Overall Study|Physician Decision|0|||
131457326|NCT02447302|473304583|FG002|Overall Study|Physician Decision|0|||
131955192|NCT02711137|475123663|FG006|Overall Study|Study Terminated by Sponsor|1|||
131955193|NCT02711137|475123664|FG007|Overall Study|Study Terminated by Sponsor|0|||
131955194|NCT02711137|475123665|FG008|Overall Study|Study Terminated by Sponsor|0|||
131955195|NCT02711137|475123666|FG009|Overall Study|Study Terminated by Sponsor|0|||
131955196|NCT02711137|475123667|FG010|Overall Study|Study Terminated by Sponsor|0|||
131955197|NCT02711137|475123668|FG011|Overall Study|Study Terminated by Sponsor|0|||
131955198|NCT02711137|475123669|FG012|Overall Study|Study Terminated by Sponsor|0|||
131955199|NCT02711137|475123670|FG013|Overall Study|Study Terminated by Sponsor|0|||
131955200|NCT02711137|475123671|FG014|Overall Study|Study Terminated by Sponsor|0|||
131955201|NCT02711137|475123657|FG000|Overall Study|Physician Decision|1|||
131955202|NCT02711137|475123658|FG001|Overall Study|Physician Decision|0|||
131955203|NCT02711137|475123659|FG002|Overall Study|Physician Decision|2|||
131955204|NCT02711137|475123660|FG003|Overall Study|Physician Decision|1|||
131955205|NCT02711137|475123661|FG004|Overall Study|Physician Decision|1|||
131955206|NCT02711137|475123662|FG005|Overall Study|Physician Decision|0|||
131955207|NCT02711137|475123663|FG006|Overall Study|Physician Decision|12|||
131955208|NCT02711137|475123664|FG007|Overall Study|Physician Decision|2|||
131955209|NCT02711137|475123665|FG008|Overall Study|Physician Decision|1|||
131955210|NCT02711137|475123666|FG009|Overall Study|Physician Decision|1|||
131955211|NCT02711137|475123667|FG010|Overall Study|Physician Decision|3|||
131955212|NCT02711137|475123668|FG011|Overall Study|Physician Decision|2|||
131955213|NCT02711137|475123669|FG012|Overall Study|Physician Decision|1|||
131955214|NCT02711137|475123670|FG013|Overall Study|Physician Decision|1|||
131955215|NCT02711137|475123671|FG014|Overall Study|Physician Decision|2|||
131955216|NCT02711137|475123657|FG000|Overall Study|Other|0|||
131955217|NCT02711137|475123658|FG001|Overall Study|Other|1|||
131955218|NCT02711137|475123659|FG002|Overall Study|Other|0|||
131955219|NCT02711137|475123660|FG003|Overall Study|Other|0|||
131955220|NCT02711137|475123661|FG004|Overall Study|Other|0|||
131955221|NCT02711137|475123662|FG005|Overall Study|Other|0|||
131955222|NCT02711137|475123663|FG006|Overall Study|Other|3|||
131955223|NCT02711137|475123664|FG007|Overall Study|Other|0|||
131955224|NCT02711137|475123665|FG008|Overall Study|Other|0|||
131955225|NCT02711137|475123666|FG009|Overall Study|Other|0|||
131955226|NCT02711137|475123667|FG010|Overall Study|Other|0|||
131955227|NCT02711137|475123668|FG011|Overall Study|Other|0|||
131955228|NCT02711137|475123669|FG012|Overall Study|Other|0|||
131955229|NCT02711137|475123670|FG013|Overall Study|Other|0|||
131955230|NCT02711137|475123671|FG014|Overall Study|Other|1|||
131955231|NCT02711137|475123657|FG000|Overall Study|Withdrawal by Subject|1|||
131955232|NCT02711137|475123658|FG001|Overall Study|Withdrawal by Subject|0|||
131955233|NCT02711137|475123659|FG002|Overall Study|Withdrawal by Subject|0|||
131955234|NCT02711137|475123660|FG003|Overall Study|Withdrawal by Subject|1|||
131955235|NCT02711137|475123661|FG004|Overall Study|Withdrawal by Subject|1|||
131955236|NCT02711137|475123662|FG005|Overall Study|Withdrawal by Subject|0|||
131955237|NCT02711137|475123663|FG006|Overall Study|Withdrawal by Subject|7|||
131955238|NCT02711137|475123664|FG007|Overall Study|Withdrawal by Subject|0|||
131955239|NCT02711137|475123665|FG008|Overall Study|Withdrawal by Subject|0|||
131955240|NCT02711137|475123666|FG009|Overall Study|Withdrawal by Subject|0|||
131955241|NCT02711137|475123667|FG010|Overall Study|Withdrawal by Subject|0|||
131955242|NCT02711137|475123668|FG011|Overall Study|Withdrawal by Subject|0|||
131955243|NCT02711137|475123669|FG012|Overall Study|Withdrawal by Subject|0|||
131955244|NCT02711137|475123670|FG013|Overall Study|Withdrawal by Subject|1|||
131955245|NCT02711137|475123671|FG014|Overall Study|Withdrawal by Subject|0|||
131955246|NCT02711137|475123657|FG000|Overall Study|Lost to Follow-up|1|||
131955247|NCT02711137|475123658|FG001|Overall Study|Lost to Follow-up|0|||
131955248|NCT02711137|475123659|FG002|Overall Study|Lost to Follow-up|0|||
131955249|NCT02711137|475123660|FG003|Overall Study|Lost to Follow-up|0|||
131955250|NCT02711137|475123661|FG004|Overall Study|Lost to Follow-up|0|||
131955251|NCT02711137|475123662|FG005|Overall Study|Lost to Follow-up|0|||
131955252|NCT02711137|475123663|FG006|Overall Study|Lost to Follow-up|2|||
131955253|NCT02711137|475123664|FG007|Overall Study|Lost to Follow-up|0|||
131955254|NCT02711137|475123665|FG008|Overall Study|Lost to Follow-up|0|||
131457327|NCT02447302|473304581|FG000|Overall Study|Adverse Event|4|||
131457328|NCT02447302|473304582|FG001|Overall Study|Adverse Event|3|||
131955255|NCT02711137|475123666|FG009|Overall Study|Lost to Follow-up|0|||
131955256|NCT02711137|475123667|FG010|Overall Study|Lost to Follow-up|0|||
131457329|NCT02447302|473304583|FG002|Overall Study|Adverse Event|0|||
131457330|NCT02447302|473304581|FG000|Overall Study|Withdrawal by Subject|0|||
131955257|NCT02711137|475123668|FG011|Overall Study|Lost to Follow-up|0|||
131955258|NCT02711137|475123669|FG012|Overall Study|Lost to Follow-up|0|||
131955259|NCT02711137|475123670|FG013|Overall Study|Lost to Follow-up|0|||
131955260|NCT02711137|475123671|FG014|Overall Study|Lost to Follow-up|0|||
131955261|NCT05514119|475123672|FG000|Overall Study|Ineligible due to disease progression|1|||
131955262|NCT04070989|475123673|FG000|Overall Study|Death|1|||
131955263|NCT04070989|475123674|FG001|Overall Study|Death|0|||
131955264|NCT04070989|475123675|FG002|Overall Study|Death|0|||
131955265|NCT04070989|475123673|FG000|Overall Study|Study Terminated by Sponsor|7|||
131955266|NCT04070989|475123674|FG001|Overall Study|Study Terminated by Sponsor|8|||
131457331|NCT02447302|473304582|FG001|Overall Study|Withdrawal by Subject|1|||
131955267|NCT04070989|475123675|FG002|Overall Study|Study Terminated by Sponsor|23|||
131955268|NCT04070989|475123673|FG000|Overall Study|Withdrawal by Subject|0|||
131955269|NCT04070989|475123674|FG001|Overall Study|Withdrawal by Subject|1|||
131955270|NCT04070989|475123675|FG002|Overall Study|Withdrawal by Subject|0|||
131955271|NCT04070989|475123673|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
131955272|NCT04070989|475123674|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
131955273|NCT04070989|475123675|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
131955274|NCT04070989|475123673|FG000|Overall Study|Other|1|||
131955275|NCT04070989|475123674|FG001|Overall Study|Other|1|||
131955276|NCT04070989|475123675|FG002|Overall Study|Other|0|||
131955277|NCT03215030|475123693|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
131955278|NCT03215030|475123694|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
131955279|NCT03215030|475123695|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955280|NCT03215030|475123696|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
131955281|NCT03215030|475123697|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955282|NCT03215030|475123698|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955283|NCT03215030|475123699|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955284|NCT03215030|475123700|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955285|NCT03215030|475123701|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955286|NCT03215030|475123702|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955287|NCT03215030|475123703|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955288|NCT03215030|475123704|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
131955289|NCT03215030|475123693|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131955290|NCT03215030|475123694|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955291|NCT03215030|475123695|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955292|NCT03215030|475123696|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131955293|NCT03215030|475123697|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955294|NCT03215030|475123698|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955295|NCT03215030|475123699|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955296|NCT03215030|475123700|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955297|NCT03215030|475123701|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955298|NCT03215030|475123702|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955299|NCT03215030|475123703|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955300|NCT03215030|475123704|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131955301|NCT03215030|475123693|FG000|Part 1: Dose Escalation|Death|15|||
131955302|NCT03215030|475123694|FG001|Part 1: Dose Escalation|Death|6|||
131955303|NCT03215030|475123695|FG002|Part 1: Dose Escalation|Death|6|||
131955304|NCT03215030|475123696|FG003|Part 1: Dose Escalation|Death|8|||
131955305|NCT03215030|475123697|FG004|Part 1: Dose Escalation|Death|0|||
131955306|NCT03215030|475123698|FG005|Part 1: Dose Escalation|Death|0|||
131955307|NCT03215030|475123699|FG006|Part 1: Dose Escalation|Death|0|||
131955308|NCT03215030|475123700|FG007|Part 1: Dose Escalation|Death|0|||
131955309|NCT03215030|475123701|FG008|Part 1: Dose Escalation|Death|0|||
131955310|NCT03215030|475123702|FG009|Part 1: Dose Escalation|Death|0|||
131955311|NCT03215030|475123703|FG010|Part 1: Dose Escalation|Death|0|||
131955312|NCT03215030|475123704|FG011|Part 1: Dose Escalation|Death|0|||
131955313|NCT03215030|475123693|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
131955314|NCT03215030|475123694|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
131955315|NCT03215030|475123695|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
131955316|NCT03215030|475123696|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
131955317|NCT03215030|475123697|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
131955318|NCT03215030|475123698|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
131955319|NCT03215030|475123699|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
131955320|NCT03215030|475123700|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
131955321|NCT03215030|475123701|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
131955322|NCT03215030|475123702|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
131955323|NCT03215030|475123703|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
131955324|NCT03215030|475123704|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
131955325|NCT03215030|475123693|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955326|NCT03215030|475123694|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955327|NCT03215030|475123695|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955328|NCT03215030|475123696|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955329|NCT03215030|475123697|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955330|NCT03215030|475123698|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955331|NCT03215030|475123699|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955332|NCT03215030|475123700|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
131955333|NCT03215030|475123701|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955334|NCT03215030|475123702|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955335|NCT03215030|475123703|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955336|NCT03215030|475123704|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131955337|NCT03215030|475123693|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955338|NCT03215030|475123694|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955339|NCT03215030|475123695|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131415365|NCT03316950|473145251|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
131415366|NCT03316950|473145252|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
131955340|NCT03215030|475123696|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955341|NCT03215030|475123697|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131955342|NCT03215030|475123698|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131955343|NCT03215030|475123699|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
131955344|NCT03215030|475123700|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
131955345|NCT03215030|475123701|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955346|NCT03215030|475123702|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955347|NCT03215030|475123703|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955348|NCT03215030|475123704|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131955349|NCT03215030|475123693|FG000|Part 2: Dose Expansion|Death|0|||
131955350|NCT03215030|475123694|FG001|Part 2: Dose Expansion|Death|0|||
131955351|NCT03215030|475123695|FG002|Part 2: Dose Expansion|Death|0|||
131955352|NCT03215030|475123696|FG003|Part 2: Dose Expansion|Death|0|||
131955353|NCT03215030|475123697|FG004|Part 2: Dose Expansion|Death|3|||
131955354|NCT03215030|475123698|FG005|Part 2: Dose Expansion|Death|1|||
131955355|NCT03215030|475123699|FG006|Part 2: Dose Expansion|Death|5|||
131955356|NCT03215030|475123700|FG007|Part 2: Dose Expansion|Death|4|||
131955357|NCT03215030|475123701|FG008|Part 2: Dose Expansion|Death|0|||
131955358|NCT03215030|475123702|FG009|Part 2: Dose Expansion|Death|0|||
131955359|NCT03215030|475123703|FG010|Part 2: Dose Expansion|Death|0|||
131955360|NCT03215030|475123704|FG011|Part 2: Dose Expansion|Death|0|||
131955361|NCT03215030|475123693|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
131955362|NCT03215030|475123694|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
131955363|NCT03215030|475123695|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
131955364|NCT03215030|475123696|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
131955365|NCT03215030|475123697|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
131955366|NCT03215030|475123698|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
131955367|NCT03215030|475123699|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
131955368|NCT03215030|475123700|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
131955369|NCT03215030|475123701|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
131955370|NCT03215030|475123702|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
131955371|NCT03215030|475123703|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
131955372|NCT03215030|475123704|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
131955373|NCT03215030|475123693|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
131955374|NCT03215030|475123694|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
131955375|NCT03215030|475123695|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
131955376|NCT03215030|475123696|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
131955377|NCT03215030|475123697|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
131955378|NCT03215030|475123698|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
131955379|NCT03215030|475123699|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
131955380|NCT03215030|475123700|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
131955381|NCT03215030|475123701|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
131955382|NCT03215030|475123702|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
131955383|NCT03215030|475123703|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
131955384|NCT03215030|475123704|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
131955385|NCT03215030|475123693|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955386|NCT03215030|475123694|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955387|NCT03215030|475123695|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955388|NCT03215030|475123696|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955389|NCT03215030|475123697|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955390|NCT03215030|475123698|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131415367|NCT03316950|473145249|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
131415368|NCT03316950|473145250|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
131415369|NCT03316950|473145251|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
131415370|NCT03316950|473145252|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
131415371|NCT02392403|473145253|FG000|Overall Study|Adverse Event|1|||
131415372|NCT02392403|473145253|FG000|Overall Study|Death|1|||
131415373|NCT02392403|473145253|FG000|Overall Study|Withdrawal by Subject|1|||
131415374|NCT02335424|473145257|FG000|Overall Study|Withdrawal by Subject|19|||
131415375|NCT02335424|473145257|FG000|Overall Study|Adverse Event|25|||
131415376|NCT02335424|473145257|FG000|Overall Study|Death|273|||
131415377|NCT02335424|473145257|FG000|Overall Study|Lost to Follow-up|3|||
131415378|NCT02335424|473145257|FG000|Overall Study|Physician Decision|13|||
131415379|NCT02335424|473145257|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
131415380|NCT02335424|473145257|FG000|Overall Study|Protocol Violation|1|||
131415381|NCT02335424|473145257|FG000|Overall Study|Screen failure|1|||
131415382|NCT02776033|473145260|FG000|Overall Study|Withdrawal by Subject|0|||
131457332|NCT02447302|473304583|FG002|Overall Study|Withdrawal by Subject|5|||
131457333|NCT02447302|473304581|FG000|Overall Study|Sponsor Decision|0|||
131955391|NCT03215030|475123699|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955392|NCT03215030|475123700|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955393|NCT03215030|475123701|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
131955394|NCT03215030|475123702|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
131955395|NCT03215030|475123703|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955396|NCT03215030|475123704|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131955397|NCT03215030|475123693|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955398|NCT03215030|475123694|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955399|NCT03215030|475123695|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955400|NCT03215030|475123696|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955401|NCT03215030|475123697|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955402|NCT03215030|475123698|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955403|NCT03215030|475123699|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955404|NCT03215030|475123700|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955405|NCT03215030|475123701|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
131955406|NCT03215030|475123702|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
131955407|NCT03215030|475123703|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955408|NCT03215030|475123704|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
131955409|NCT03215030|475123693|FG000|Part 3: Dose Extension|Death|0|||
131955410|NCT03215030|475123694|FG001|Part 3: Dose Extension|Death|0|||
131955411|NCT03215030|475123695|FG002|Part 3: Dose Extension|Death|0|||
131955412|NCT03215030|475123696|FG003|Part 3: Dose Extension|Death|0|||
131955413|NCT03215030|475123697|FG004|Part 3: Dose Extension|Death|0|||
131955414|NCT03215030|475123698|FG005|Part 3: Dose Extension|Death|0|||
131955415|NCT03215030|475123699|FG006|Part 3: Dose Extension|Death|0|||
131955416|NCT03215030|475123700|FG007|Part 3: Dose Extension|Death|0|||
131955417|NCT03215030|475123701|FG008|Part 3: Dose Extension|Death|19|||
131955418|NCT03215030|475123702|FG009|Part 3: Dose Extension|Death|20|||
131955419|NCT03215030|475123703|FG010|Part 3: Dose Extension|Death|0|||
131955420|NCT03215030|475123704|FG011|Part 3: Dose Extension|Death|0|||
131955421|NCT03215030|475123693|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
131955422|NCT03215030|475123694|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
131955423|NCT03215030|475123695|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
131955424|NCT03215030|475123696|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
131955425|NCT03215030|475123697|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
131955426|NCT03215030|475123698|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
131955427|NCT03215030|475123699|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
131955428|NCT03215030|475123700|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
131955429|NCT03215030|475123701|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
131955430|NCT03215030|475123702|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
131955431|NCT03215030|475123703|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
131955432|NCT03215030|475123704|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
131955433|NCT03215030|475123693|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955434|NCT03215030|475123694|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955435|NCT03215030|475123695|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955436|NCT03215030|475123696|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955437|NCT03215030|475123697|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955438|NCT03215030|475123698|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955439|NCT03215030|475123699|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955440|NCT03215030|475123700|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955441|NCT03215030|475123701|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955442|NCT03215030|475123702|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131955443|NCT03215030|475123703|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
131955444|NCT03215030|475123704|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
131955445|NCT06629454|475123705|FG000|Overall Study|Withdraw by Clinician Decision|1|||
131955446|NCT03584516|475123706|FG000|Part 1|Death|2|||
131955447|NCT03584516|475123707|FG001|Part 1|Death|3|||
131955448|NCT03584516|475123708|FG002|Part 1|Death|0|||
131955449|NCT03584516|475123709|FG003|Part 1|Death|0|||
131955450|NCT03584516|475123710|FG004|Part 1|Death|0|||
131955451|NCT03584516|475123711|FG005|Part 1|Death|0|||
131955452|NCT03584516|475123706|FG000|Part 1|Withdrawal by Subject|2|||
131955453|NCT03584516|475123707|FG001|Part 1|Withdrawal by Subject|0|||
131955454|NCT03584516|475123708|FG002|Part 1|Withdrawal by Subject|0|||
131955455|NCT03584516|475123709|FG003|Part 1|Withdrawal by Subject|0|||
131955456|NCT03584516|475123710|FG004|Part 1|Withdrawal by Subject|0|||
131955457|NCT03584516|475123711|FG005|Part 1|Withdrawal by Subject|0|||
131955458|NCT03584516|475123706|FG000|Part 1|Lost to Follow-up|1|||
131955459|NCT03584516|475123707|FG001|Part 1|Lost to Follow-up|0|||
131955460|NCT03584516|475123708|FG002|Part 1|Lost to Follow-up|0|||
131955461|NCT03584516|475123709|FG003|Part 1|Lost to Follow-up|0|||
131955462|NCT03584516|475123710|FG004|Part 1|Lost to Follow-up|0|||
131955463|NCT03584516|475123711|FG005|Part 1|Lost to Follow-up|0|||
131955464|NCT03584516|475123706|FG000|Part 1|Study Terminated by Sponsor|0|||
131955465|NCT03584516|475123707|FG001|Part 1|Study Terminated by Sponsor|2|||
131955466|NCT03584516|475123708|FG002|Part 1|Study Terminated by Sponsor|0|||
131955467|NCT03584516|475123709|FG003|Part 1|Study Terminated by Sponsor|0|||
131955468|NCT03584516|475123710|FG004|Part 1|Study Terminated by Sponsor|0|||
131955469|NCT03584516|475123711|FG005|Part 1|Study Terminated by Sponsor|0|||
131955470|NCT03584516|475123706|FG000|Part 1 Expansion|Death|0|||
131955471|NCT03584516|475123707|FG001|Part 1 Expansion|Death|0|||
131955472|NCT03584516|475123708|FG002|Part 1 Expansion|Death|9|||
131955473|NCT03584516|475123709|FG003|Part 1 Expansion|Death|8|||
131955474|NCT03584516|475123710|FG004|Part 1 Expansion|Death|4|||
131955475|NCT03584516|475123711|FG005|Part 1 Expansion|Death|5|||
131955476|NCT03584516|475123706|FG000|Part 1 Expansion|Lost to Follow-up|0|||
131955477|NCT03584516|475123707|FG001|Part 1 Expansion|Lost to Follow-up|0|||
131955478|NCT03584516|475123708|FG002|Part 1 Expansion|Lost to Follow-up|0|||
131955479|NCT03584516|475123709|FG003|Part 1 Expansion|Lost to Follow-up|1|||
131955480|NCT03584516|475123710|FG004|Part 1 Expansion|Lost to Follow-up|0|||
131955481|NCT03584516|475123711|FG005|Part 1 Expansion|Lost to Follow-up|0|||
131955482|NCT03584516|475123706|FG000|Part 1 Expansion|Physician Decision|0|||
131955483|NCT03584516|475123707|FG001|Part 1 Expansion|Physician Decision|0|||
131955484|NCT03584516|475123708|FG002|Part 1 Expansion|Physician Decision|4|||
131955485|NCT03584516|475123709|FG003|Part 1 Expansion|Physician Decision|3|||
131955486|NCT03584516|475123710|FG004|Part 1 Expansion|Physician Decision|2|||
131457334|NCT02447302|473304582|FG001|Overall Study|Sponsor Decision|0|||
131457335|NCT02447302|473304583|FG002|Overall Study|Sponsor Decision|1|||
131457336|NCT01456897|473304588|FG000|Overall Study|Adverse Event|19|||
131457337|NCT01456897|473304589|FG001|Overall Study|Adverse Event|22|||
131457338|NCT01456897|473304588|FG000|Overall Study|Protocol Violation|3|||
131457339|NCT01456897|473304589|FG001|Overall Study|Protocol Violation|4|||
131955487|NCT03584516|475123711|FG005|Part 1 Expansion|Physician Decision|3|||
131955488|NCT03584516|475123706|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
131955489|NCT03584516|475123707|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
131955490|NCT03584516|475123708|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
131955491|NCT03584516|475123709|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
131955492|NCT03584516|475123710|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
131955493|NCT03584516|475123711|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
131955494|NCT03584516|475123706|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
131955495|NCT03584516|475123707|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
131955496|NCT03584516|475123708|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
131955497|NCT03584516|475123709|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
131955498|NCT03584516|475123710|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
131415383|NCT02776033|473145261|FG001|Overall Study|Withdrawal by Subject|0|||
131415384|NCT02776033|473145262|FG002|Overall Study|Withdrawal by Subject|2|||
131415385|NCT02776033|473145260|FG000|Overall Study|Physician Decision|2|||
131415386|NCT02776033|473145261|FG001|Overall Study|Physician Decision|0|||
131415387|NCT02776033|473145262|FG002|Overall Study|Physician Decision|0|||
131415388|NCT02776033|473145260|FG000|Overall Study|Lost to Follow-up|1|||
131415389|NCT02776033|473145261|FG001|Overall Study|Lost to Follow-up|0|||
131415390|NCT02776033|473145262|FG002|Overall Study|Lost to Follow-up|0|||
131415391|NCT02776033|473145260|FG000|Overall Study|Adverse Event|1|||
131415392|NCT02776033|473145261|FG001|Overall Study|Adverse Event|2|||
131415393|NCT02776033|473145262|FG002|Overall Study|Adverse Event|0|||
131415394|NCT02712424|473145263|FG000|Overall Study|Lost to Follow-up|34|||
131415395|NCT02712424|473145264|FG001|Overall Study|Lost to Follow-up|32|||
131415396|NCT00657371|473145265|FG000|Overall Study|Poor bowel preparation|15|||
131415397|NCT00657371|473145265|FG000|Overall Study|Unable to intubate the cecum|5|||
131415398|NCT00657371|473145265|FG000|Overall Study|Protocol Violation|2|||
131415399|NCT00657371|473145265|FG000|Overall Study|Device- related reasons|13|||
131415400|NCT00657371|473145265|FG000|Overall Study|Pre-existing medical condition|4|||
131415401|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
131415402|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
131415403|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
131415404|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
131415405|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
131415406|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
131415407|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
131415408|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
131415409|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
131415410|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
131457340|NCT01456897|473304588|FG000|Overall Study|Physician Decision|5|||
131415411|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
131415412|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
131415413|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
131415414|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
131457341|NCT01456897|473304589|FG001|Overall Study|Physician Decision|3|||
131457342|NCT01456897|473304588|FG000|Overall Study|Withdrawal by Subject|44|||
131955499|NCT03584516|475123711|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
131955500|NCT03584516|475123706|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131955501|NCT03584516|475123707|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131955502|NCT03584516|475123708|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131955503|NCT03584516|475123709|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
131955504|NCT03584516|475123710|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131955505|NCT03584516|475123711|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131955506|NCT03584516|475123706|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131955507|NCT03584516|475123707|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131955508|NCT03584516|475123708|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131955509|NCT03584516|475123709|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131955510|NCT03584516|475123710|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131955511|NCT03584516|475123711|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
131955512|NCT05568225|475123712|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
131955513|NCT05568225|475123713|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
131955514|NCT05568225|475123714|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
131955515|NCT05568225|475123712|FG000|Primary Treatment Period|Physician Decision|0|||
131955516|NCT05568225|475123713|FG001|Primary Treatment Period|Physician Decision|1|||
131955517|NCT05568225|475123714|FG002|Primary Treatment Period|Physician Decision|0|||
131955518|NCT05568225|475123712|FG000|Primary Treatment Period|Disease progression|0|||
131955519|NCT05568225|475123713|FG001|Primary Treatment Period|Disease progression|1|||
131955520|NCT05568225|475123714|FG002|Primary Treatment Period|Disease progression|0|||
131955521|NCT05568225|475123712|FG000|Primary Treatment Period|Lack of Efficacy|0|||
131955522|NCT05568225|475123713|FG001|Primary Treatment Period|Lack of Efficacy|1|||
131955523|NCT05568225|475123714|FG002|Primary Treatment Period|Lack of Efficacy|0|||
131955524|NCT05568225|475123712|FG000|Primary Treatment Period|Withdrawal of conset|1|||
131955525|NCT05568225|475123713|FG001|Primary Treatment Period|Withdrawal of conset|0|||
131955526|NCT05568225|475123714|FG002|Primary Treatment Period|Withdrawal of conset|4|||
131955527|NCT05568225|475123712|FG000|Primary Treatment Period|Adverse Event|1|||
131955528|NCT05568225|475123713|FG001|Primary Treatment Period|Adverse Event|0|||
131955529|NCT05568225|475123714|FG002|Primary Treatment Period|Adverse Event|0|||
131955530|NCT05568225|475123712|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
131955531|NCT05568225|475123713|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
131955532|NCT05568225|475123714|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
131955533|NCT05568225|475123712|FG000|Extension Treatment Period|Protocol Violation|0|||
131955534|NCT05568225|475123713|FG001|Extension Treatment Period|Protocol Violation|0|||
131955535|NCT05568225|475123714|FG002|Extension Treatment Period|Protocol Violation|1|||
131955536|NCT05568225|475123712|FG000|Extension Treatment Period|Lack of Efficacy|0|||
131955537|NCT05568225|475123713|FG001|Extension Treatment Period|Lack of Efficacy|0|||
131955538|NCT05568225|475123714|FG002|Extension Treatment Period|Lack of Efficacy|1|||
131955539|NCT05846646|475123715|FG000|Overall Study|Physician Decision|1|||
131955540|NCT05846646|475123716|FG001|Overall Study|Physician Decision|0|||
131955541|NCT05846646|475123717|FG002|Overall Study|Physician Decision|0|||
131955542|NCT05846646|475123715|FG000|Overall Study|Lack of Efficacy|1|||
131955543|NCT05846646|475123716|FG001|Overall Study|Lack of Efficacy|1|||
131955544|NCT05846646|475123717|FG002|Overall Study|Lack of Efficacy|0|||
131955545|NCT05846646|475123715|FG000|Overall Study|Early Study Termination|1|||
131955546|NCT05846646|475123716|FG001|Overall Study|Early Study Termination|2|||
131955547|NCT05846646|475123717|FG002|Overall Study|Early Study Termination|0|||
131955548|NCT01508312|475123723|FG000|Overall Study|Lost to Follow-up|1|||
131955549|NCT01508312|475123724|FG001|Overall Study|Lost to Follow-up|0|||
131955550|NCT01508312|475123725|FG002|Overall Study|Lost to Follow-up|0|||
131955551|NCT01508312|475123726|FG003|Overall Study|Lost to Follow-up|0|||
131955552|NCT01508312|475123723|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
131955553|NCT01508312|475123724|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
131955554|NCT01508312|475123725|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
131955555|NCT01508312|475123726|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
131955556|NCT01508312|475123723|FG000|Overall Study|Adverse Event|0|||
131955557|NCT01508312|475123724|FG001|Overall Study|Adverse Event|0|||
131955558|NCT01508312|475123725|FG002|Overall Study|Adverse Event|2|||
131955559|NCT01508312|475123726|FG003|Overall Study|Adverse Event|0|||
131955560|NCT01508312|475123723|FG000|Overall Study|Lack of Efficacy|0|||
131415415|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
131415416|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
131415417|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
131415418|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
131415419|NCT01302054|473145271|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
131415420|NCT01302054|473145272|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
131415421|NCT01302054|473145273|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
131955561|NCT01508312|475123724|FG001|Overall Study|Lack of Efficacy|0|||
131955562|NCT01508312|475123725|FG002|Overall Study|Lack of Efficacy|1|||
131955563|NCT01508312|475123726|FG003|Overall Study|Lack of Efficacy|0|||
131955564|NCT01508312|475123723|FG000|Overall Study|Withdrawal by Subject|0|||
131955565|NCT01508312|475123724|FG001|Overall Study|Withdrawal by Subject|0|||
131955566|NCT01508312|475123725|FG002|Overall Study|Withdrawal by Subject|1|||
131415422|NCT01302054|473145271|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
131415423|NCT01302054|473145272|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
131415424|NCT01302054|473145273|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
131415425|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131415426|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
131415427|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
131415428|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131415429|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
131415430|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131415431|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131415432|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
131415433|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
131415434|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
131415435|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
131415436|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
131415437|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131415438|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
131415439|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
131415440|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
131415441|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
131415442|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
131415443|NCT01302054|473145271|FG000|Double-Blind Treatment Phase|Other|0|||
131415444|NCT01302054|473145272|FG001|Double-Blind Treatment Phase|Other|4|||
131415445|NCT01302054|473145273|FG002|Double-Blind Treatment Phase|Other|9|||
131415446|NCT02713867|473145274|FG000|Randomization|Other Reason|2|||
131457343|NCT01456897|473304589|FG001|Overall Study|Withdrawal by Subject|17|||
131457344|NCT01456897|473304588|FG000|Overall Study|Lack of Efficacy|4|||
131955567|NCT01508312|475123726|FG003|Overall Study|Withdrawal by Subject|0|||
131955568|NCT02107703|475123727|FG000|Overall Study|Withdrawal by Subject|46|||
131955569|NCT02107703|475123728|FG001|Overall Study|Withdrawal by Subject|21|||
131955570|NCT02107703|475123727|FG000|Overall Study|Lost to Follow-up|20|||
131955571|NCT02107703|475123728|FG001|Overall Study|Lost to Follow-up|9|||
131955572|NCT02107703|475123727|FG000|Overall Study|On study treatment/follow up|48|||
131955573|NCT02107703|475123728|FG001|Overall Study|On study treatment/follow up|5|||
131955574|NCT03456076|475123730|FG000|Overall Study|Withdrawal by Subject|5|||
131955575|NCT03456076|475123731|FG001|Overall Study|Withdrawal by Subject|9|||
131955576|NCT03456076|475123730|FG000|Overall Study|Protocol deviation|0|||
131955577|NCT03456076|475123731|FG001|Overall Study|Protocol deviation|1|||
131955578|NCT03456076|475123730|FG000|Overall Study|Lost to Follow-up|0|||
131955579|NCT03456076|475123731|FG001|Overall Study|Lost to Follow-up|1|||
131955580|NCT03456076|475123730|FG000|Overall Study|Death|2|||
131955581|NCT03456076|475123731|FG001|Overall Study|Death|5|||
131955582|NCT03456076|475123730|FG000|Overall Study|Study ongoing|123|||
131955583|NCT03456076|475123731|FG001|Overall Study|Study ongoing|111|||
131955584|NCT05415410|475123732|FG000|Overall Study|Death|3|||
131955585|NCT05415410|475123733|FG001|Overall Study|Death|6|||
131955586|NCT05415410|475123734|FG002|Overall Study|Death|1|||
131955587|NCT05415410|475123732|FG000|Overall Study|Trial Terminated by Sponsor|1|||
131955588|NCT05415410|475123733|FG001|Overall Study|Trial Terminated by Sponsor|5|||
131955589|NCT05415410|475123734|FG002|Overall Study|Trial Terminated by Sponsor|0|||
131955590|NCT05415410|475123732|FG000|Overall Study|Adverse Event|2|||
131955591|NCT05415410|475123733|FG001|Overall Study|Adverse Event|1|||
131955592|NCT05415410|475123734|FG002|Overall Study|Adverse Event|0|||
131955593|NCT05415410|475123732|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
131955594|NCT05415410|475123733|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
131955595|NCT05415410|475123734|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
131955596|NCT05415410|475123732|FG000|Overall Study|Withdrawal by Subject|1|||
131955597|NCT05415410|475123733|FG001|Overall Study|Withdrawal by Subject|0|||
131955598|NCT05415410|475123734|FG002|Overall Study|Withdrawal by Subject|0|||
131955599|NCT05415410|475123732|FG000|Overall Study|Pregnancy|5|||
131955600|NCT05415410|475123733|FG001|Overall Study|Pregnancy|2|||
131955601|NCT05415410|475123734|FG002|Overall Study|Pregnancy|0|||
131415447|NCT02713867|473145275|FG001|Randomization|Other Reason|1|||
131415448|NCT02713867|473145274|FG000|Randomization|Participant Withdrew consent|0|||
131415449|NCT02713867|473145275|FG001|Randomization|Participant Withdrew consent|2|||
131415450|NCT02713867|473145274|FG000|Treatment Period|Other Reasons|22|||
131955602|NCT04424927|475123738|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
131955603|NCT04424927|475123739|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
131955604|NCT04424927|475123740|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
131955605|NCT04424927|475123741|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
131955606|NCT04424927|475123742|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
131955607|NCT04424927|475123738|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
131955608|NCT04424927|475123739|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
131955609|NCT04424927|475123740|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
131955610|NCT04424927|475123741|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
131955611|NCT04424927|475123742|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
131955612|NCT04424927|475123738|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
131955613|NCT04424927|475123739|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131955614|NCT04424927|475123740|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131955615|NCT04424927|475123741|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131955616|NCT04424927|475123742|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131955617|NCT04424927|475123738|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
131955618|NCT04424927|475123739|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131955619|NCT04424927|475123740|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131955620|NCT04424927|475123741|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131955621|NCT04424927|475123742|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131955622|NCT04424927|475123738|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
131955623|NCT04424927|475123739|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
131955624|NCT04424927|475123740|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
131955625|NCT04424927|475123741|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
131955626|NCT04424927|475123742|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
131955627|NCT04424927|475123738|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
131955628|NCT04424927|475123739|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
131955629|NCT04424927|475123740|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
131955630|NCT04424927|475123741|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
131955631|NCT04424927|475123742|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
131955632|NCT04424927|475123738|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
131955633|NCT04424927|475123739|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
131955634|NCT04424927|475123740|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
131955635|NCT04424927|475123741|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
131955636|NCT04424927|475123742|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
131955637|NCT04424927|475123738|FG000|Double-blind Period (24 Weeks)|Other|0|||
131955638|NCT04424927|475123739|FG001|Double-blind Period (24 Weeks)|Other|1|||
131955639|NCT04424927|475123740|FG002|Double-blind Period (24 Weeks)|Other|3|||
131955640|NCT04424927|475123741|FG003|Double-blind Period (24 Weeks)|Other|1|||
131955641|NCT04424927|475123742|FG004|Double-blind Period (24 Weeks)|Other|0|||
131955642|NCT03906071|475123743|FG000|Overall Study|Death|180|||
131955643|NCT03906071|475123744|FG001|Overall Study|Death|185|||
131955644|NCT03906071|475123743|FG000|Overall Study|Lost to Follow-up|3|||
131955645|NCT03906071|475123744|FG001|Overall Study|Lost to Follow-up|3|||
131955646|NCT03906071|475123743|FG000|Overall Study|Withdrawal by Subject|15|||
131955647|NCT03906071|475123744|FG001|Overall Study|Withdrawal by Subject|27|||
131955648|NCT03906071|475123743|FG000|Overall Study|Other|2|||
131955649|NCT03906071|475123744|FG001|Overall Study|Other|1|||
131955650|NCT04791709|475123747|FG000|Overall Study|Withdrawal by Subject|3|||
131955651|NCT04373434|475123748|FG000|Overall Study|Lost to Follow-up|37|||
131955652|NCT04373434|475123749|FG001|Overall Study|Lost to Follow-up|32|||
131955653|NCT04373434|475123748|FG000|Overall Study|Refused at 9 months|1|||
131955654|NCT04373434|475123749|FG001|Overall Study|Refused at 9 months|2|||
131955655|NCT04373434|475123748|FG000|Overall Study|Refused at 4 months|7|||
131955656|NCT04373434|475123749|FG001|Overall Study|Refused at 4 months|3|||
131955657|NCT04373434|475123748|FG000|Overall Study|Excluded|2|||
131955658|NCT04373434|475123749|FG001|Overall Study|Excluded|0|||
131955659|NCT01696773|475123750|FG000|Days 15-27, Washout|Adverse Event|1|||
131955660|NCT01696773|475123751|FG001|Days 15-27, Washout|Adverse Event|0|||
131955661|NCT02386553|475123752|FG000|Overall Study|Reason Not Specified|1|||
131955662|NCT02386553|475123753|FG001|Overall Study|Reason Not Specified|1|||
131955663|NCT02386553|475123752|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
131955664|NCT02386553|475123753|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
131955665|NCT04649359|475123754|FG000|Overall Study|Withdrawal by Subject|7|||
131955666|NCT04649359|475123755|FG001|Overall Study|Withdrawal by Subject|7|||
131955667|NCT04649359|475123754|FG000|Overall Study|Death|41|||
131955668|NCT04649359|475123755|FG001|Overall Study|Death|26|||
131955669|NCT04649359|475123754|FG000|Overall Study|Ongoing in the study|75|||
131955670|NCT04649359|475123755|FG001|Overall Study|Ongoing in the study|31|||
131955671|NCT04425018|475123756|FG000|Overall Study|Withdrawal by Subject|1|||
131415451|NCT02713867|473145275|FG001|Treatment Period|Other Reasons|28|||
131415452|NCT02713867|473145274|FG000|Treatment Period|Administrative reason by sponsor|21|||
131955672|NCT04425018|475123757|FG001|Overall Study|Withdrawal by Subject|2|||
131955673|NCT02152982|475123758|FG000|Overall Study|Withdrawal by Subject|17|||
131955674|NCT02152982|475123759|FG001|Overall Study|Withdrawal by Subject|16|||
131955675|NCT02152982|475123758|FG000|Overall Study|Did not start treatment|11|||
131955676|NCT02152982|475123759|FG001|Overall Study|Did not start treatment|5|||
131955677|NCT02152982|475123758|FG000|Overall Study|Disease progression|41|||
131955678|NCT02152982|475123759|FG001|Overall Study|Disease progression|52|||
131955679|NCT02152982|475123758|FG000|Overall Study|Adverse Event|7|||
131955680|NCT02152982|475123759|FG001|Overall Study|Adverse Event|12|||
131955681|NCT02152982|475123758|FG000|Overall Study|Complicating disease|1|||
131955682|NCT02152982|475123759|FG001|Overall Study|Complicating disease|1|||
131955683|NCT02152982|475123758|FG000|Overall Study|Death|0|||
131955684|NCT02152982|475123759|FG001|Overall Study|Death|3|||
131955685|NCT02152982|475123758|FG000|Overall Study|Physician Decision|3|||
131955686|NCT02152982|475123759|FG001|Overall Study|Physician Decision|0|||
131955687|NCT04435366|475123766|FG000|Year 1 (12 Months)|Adverse Event|3|||
131955688|NCT04435366|475123767|FG001|Year 1 (12 Months)|Adverse Event|0|||
131955689|NCT04435366|475123768|FG002|Year 1 (12 Months)|Adverse Event|2|||
131955690|NCT04435366|475123766|FG000|Year 1 (12 Months)|Death|2|||
131955691|NCT04435366|475123767|FG001|Year 1 (12 Months)|Death|0|||
131955692|NCT04435366|475123768|FG002|Year 1 (12 Months)|Death|1|||
131955693|NCT04435366|475123766|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
131955694|NCT04435366|475123767|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
131955695|NCT04435366|475123768|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
131955696|NCT04435366|475123766|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
131955697|NCT04435366|475123767|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
131955698|NCT04435366|475123768|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
131955699|NCT04435366|475123766|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
131955700|NCT04435366|475123767|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
131955701|NCT04435366|475123768|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
131955702|NCT04435366|475123766|FG000|Year 1 (12 Months)|Not treated|0|||
131955703|NCT04435366|475123767|FG001|Year 1 (12 Months)|Not treated|0|||
131955704|NCT04435366|475123768|FG002|Year 1 (12 Months)|Not treated|1|||
131415453|NCT02713867|473145275|FG001|Treatment Period|Administrative reason by sponsor|16|||
131415454|NCT02713867|473145274|FG000|Treatment Period|No longer meets study criteria|2|||
131955705|NCT04435366|475123766|FG000|Year 2 (12 Months)|Death|1|||
131955706|NCT04435366|475123767|FG001|Year 2 (12 Months)|Death|4|||
131955707|NCT04435366|475123768|FG002|Year 2 (12 Months)|Death|6|||
131955708|NCT04435366|475123766|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
131955709|NCT04435366|475123767|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
131955710|NCT04435366|475123768|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
131955711|NCT04435366|475123766|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
131955712|NCT04435366|475123767|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
131955713|NCT04435366|475123768|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
131955714|NCT04435366|475123766|FG000|Year 2 (12 Months)|Adverse Event|2|||
131955715|NCT04435366|475123767|FG001|Year 2 (12 Months)|Adverse Event|1|||
131955716|NCT04435366|475123768|FG002|Year 2 (12 Months)|Adverse Event|6|||
131955717|NCT03188432|475123769|FG000|Overall Study|Death|3|||
131955718|NCT03188432|475123769|FG000|Overall Study|Withdrawal by Subject|15|||
131955719|NCT03188432|475123769|FG000|Overall Study|Did not complete protocol treatment|9|||
131955720|NCT05218499|475123771|FG000|Overall Study|Not treated|1|||
131955721|NCT05218499|475123772|FG001|Overall Study|Not treated|1|||
131955722|NCT05218499|475123773|FG002|Overall Study|Not treated|8|||
131955723|NCT05218499|475123771|FG000|Overall Study|Death|2|||
131955724|NCT05218499|475123772|FG001|Overall Study|Death|0|||
131955725|NCT05218499|475123773|FG002|Overall Study|Death|0|||
131955726|NCT05218499|475123771|FG000|Overall Study|Other than listed|3|||
131955727|NCT05218499|475123772|FG001|Overall Study|Other than listed|7|||
131955728|NCT05218499|475123773|FG002|Overall Study|Other than listed|10|||
131955729|NCT05218499|475123771|FG000|Overall Study|Protocol deviation|5|||
131415455|NCT02713867|473145275|FG001|Treatment Period|No longer meets study criteria|1|||
131415456|NCT02713867|473145274|FG000|Treatment Period|Poor/Non Compliance|1|||
131955730|NCT05218499|475123772|FG001|Overall Study|Protocol deviation|6|||
131415457|NCT02713867|473145275|FG001|Treatment Period|Poor/Non Compliance|0|||
131415458|NCT02713867|473145274|FG000|Treatment Period|Maximum Clinical Benefit|5|||
131415459|NCT02713867|473145275|FG001|Treatment Period|Maximum Clinical Benefit|6|||
131415460|NCT02713867|473145274|FG000|Treatment Period|Withdrew consent|3|||
131415461|NCT02713867|473145275|FG001|Treatment Period|Withdrew consent|6|||
131415462|NCT02713867|473145274|FG000|Treatment Period|Requested to Discontinue|8|||
131415463|NCT02713867|473145275|FG001|Treatment Period|Requested to Discontinue|8|||
131415464|NCT02713867|473145274|FG000|Treatment Period|AE unrelated to Study Drug|11|||
131415465|NCT02713867|473145275|FG001|Treatment Period|AE unrelated to Study Drug|10|||
131415466|NCT02713867|473145274|FG000|Treatment Period|Death|7|||
131955731|NCT05218499|475123773|FG002|Overall Study|Protocol deviation|4|||
131955732|NCT05218499|475123771|FG000|Overall Study|Technical problems|0|||
131955733|NCT05218499|475123772|FG001|Overall Study|Technical problems|1|||
131955734|NCT05218499|475123773|FG002|Overall Study|Technical problems|0|||
131955735|NCT05218499|475123771|FG000|Overall Study|Burden of trial procedures|0|||
131955736|NCT05218499|475123772|FG001|Overall Study|Burden of trial procedures|1|||
131955737|NCT05218499|475123773|FG002|Overall Study|Burden of trial procedures|2|||
131955738|NCT05218499|475123771|FG000|Overall Study|Clinical disease progression|6|||
131955739|NCT05218499|475123772|FG001|Overall Study|Clinical disease progression|6|||
131955740|NCT05218499|475123773|FG002|Overall Study|Clinical disease progression|11|||
131955741|NCT05218499|475123771|FG000|Overall Study|Objective disease progression|44|||
131955742|NCT05218499|475123772|FG001|Overall Study|Objective disease progression|61|||
131955743|NCT05218499|475123773|FG002|Overall Study|Objective disease progression|42|||
131955744|NCT05218499|475123771|FG000|Overall Study|Adverse Event|11|||
131955745|NCT05218499|475123772|FG001|Overall Study|Adverse Event|36|||
131955746|NCT05218499|475123773|FG002|Overall Study|Adverse Event|9|||
131955747|NCT05218499|475123771|FG000|Overall Study|On treatment at time of snapshot|18|||
131955748|NCT05218499|475123772|FG001|Overall Study|On treatment at time of snapshot|29|||
131955749|NCT05218499|475123773|FG002|Overall Study|On treatment at time of snapshot|0|||
131955750|NCT06331156|475123778|FG000|Overall Study|Adverse Event|1|||
131955751|NCT06331156|475123779|FG001|Overall Study|Adverse Event|0|||
131955752|NCT06331156|475123778|FG000|Overall Study|Lost to Follow-up|1|||
131955753|NCT06331156|475123779|FG001|Overall Study|Lost to Follow-up|0|||
131955754|NCT06331156|475123778|FG000|Overall Study|Migrated / Moved from the study area|4|||
131955755|NCT06331156|475123779|FG001|Overall Study|Migrated / Moved from the study area|3|||
131955756|NCT06331156|475123778|FG000|Overall Study|Other|7|||
131955757|NCT06331156|475123779|FG001|Overall Study|Other|0|||
131955758|NCT06331156|475123778|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
131955759|NCT06331156|475123779|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
131955760|NCT06179108|475123780|FG000|Overall Study|Withdrawal by Subject|16|||
131955761|NCT06179108|475123781|FG001|Overall Study|Withdrawal by Subject|19|||
131955762|NCT06179108|475123782|FG002|Overall Study|Withdrawal by Subject|10|||
131955763|NCT06179108|475123783|FG003|Overall Study|Withdrawal by Subject|11|||
131955764|NCT06179108|475123780|FG000|Overall Study|Lost to Follow-up|12|||
131955765|NCT06179108|475123781|FG001|Overall Study|Lost to Follow-up|4|||
131955766|NCT06179108|475123782|FG002|Overall Study|Lost to Follow-up|1|||
131955767|NCT06179108|475123783|FG003|Overall Study|Lost to Follow-up|9|||
131955768|NCT06179108|475123780|FG000|Overall Study|Adverse Event|2|||
131955769|NCT06179108|475123781|FG001|Overall Study|Adverse Event|3|||
131955770|NCT06179108|475123782|FG002|Overall Study|Adverse Event|3|||
131955771|NCT06179108|475123783|FG003|Overall Study|Adverse Event|2|||
131955772|NCT06179108|475123780|FG000|Overall Study|Protocol Violation|0|||
131955773|NCT06179108|475123781|FG001|Overall Study|Protocol Violation|1|||
131955774|NCT06179108|475123782|FG002|Overall Study|Protocol Violation|0|||
131955775|NCT06179108|475123783|FG003|Overall Study|Protocol Violation|1|||
131955776|NCT06179108|475123780|FG000|Overall Study|Physician Decision|1|||
131955777|NCT06179108|475123781|FG001|Overall Study|Physician Decision|1|||
131955778|NCT06179108|475123782|FG002|Overall Study|Physician Decision|0|||
131955779|NCT06179108|475123783|FG003|Overall Study|Physician Decision|0|||
131955780|NCT06179108|475123780|FG000|Overall Study|Lack of Efficacy|0|||
131955781|NCT06179108|475123781|FG001|Overall Study|Lack of Efficacy|0|||
131955782|NCT06179108|475123782|FG002|Overall Study|Lack of Efficacy|0|||
131955783|NCT06179108|475123783|FG003|Overall Study|Lack of Efficacy|1|||
131955784|NCT06179108|475123780|FG000|Overall Study|Death|0|||
131955785|NCT06179108|475123781|FG001|Overall Study|Death|0|||
131955786|NCT06179108|475123782|FG002|Overall Study|Death|0|||
131955787|NCT06179108|475123783|FG003|Overall Study|Death|1|||
131955788|NCT04431726|475123784|FG000|Overall Study|Ongoing in the Study|55|||
131955789|NCT04112810|475123785|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
131955790|NCT03732820|475123786|FG000|Overall Study|Death|168|||
131955791|NCT03732820|475123787|FG001|Overall Study|Death|203|||
131955792|NCT03732820|475123786|FG000|Overall Study|Other|2|||
131955793|NCT03732820|475123787|FG001|Overall Study|Other|2|||
131955794|NCT03732820|475123786|FG000|Overall Study|Failure to meet randomisation criteria|1|||
131955795|NCT03732820|475123787|FG001|Overall Study|Failure to meet randomisation criteria|1|||
131955796|NCT03732820|475123786|FG000|Overall Study|Patient decision|14|||
131955797|NCT03732820|475123787|FG001|Overall Study|Patient decision|10|||
131955798|NCT03732820|475123786|FG000|Overall Study|Screen failure|0|||
131955799|NCT03732820|475123787|FG001|Overall Study|Screen failure|1|||
131955800|NCT03732820|475123786|FG000|Overall Study|Patients ongoing study at data cut off|210|||
131955801|NCT03732820|475123787|FG001|Overall Study|Patients ongoing study at data cut off|178|||
131955802|NCT03732820|475123786|FG000|Overall Study|Lost to Follow-up|4|||
131955803|NCT03732820|475123787|FG001|Overall Study|Lost to Follow-up|2|||
131955804|NCT04497116|475123788|FG000|Overall Study|Lost to Follow-up|1|||
131955805|NCT04497116|475123789|FG001|Overall Study|Lost to Follow-up|0|||
131955806|NCT04497116|475123790|FG002|Overall Study|Lost to Follow-up|0|||
131955807|NCT04497116|475123791|FG003|Overall Study|Lost to Follow-up|0|||
131955808|NCT04497116|475123792|FG004|Overall Study|Lost to Follow-up|0|||
131955809|NCT04497116|475123793|FG005|Overall Study|Lost to Follow-up|0|||
131955810|NCT04497116|475123794|FG006|Overall Study|Lost to Follow-up|0|||
131955811|NCT04497116|475123795|FG007|Overall Study|Lost to Follow-up|3|||
131955812|NCT04497116|475123796|FG008|Overall Study|Lost to Follow-up|3|||
131955813|NCT04497116|475123797|FG009|Overall Study|Lost to Follow-up|0|||
131955814|NCT04497116|475123798|FG010|Overall Study|Lost to Follow-up|0|||
131955815|NCT04497116|475123799|FG011|Overall Study|Lost to Follow-up|0|||
131955816|NCT04497116|475123800|FG012|Overall Study|Lost to Follow-up|0|||
131955817|NCT04497116|475123801|FG013|Overall Study|Lost to Follow-up|0|||
131955818|NCT04497116|475123802|FG014|Overall Study|Lost to Follow-up|0|||
131955819|NCT04497116|475123803|FG015|Overall Study|Lost to Follow-up|0|||
131955820|NCT04497116|475123804|FG016|Overall Study|Lost to Follow-up|0|||
131955821|NCT04497116|475123805|FG017|Overall Study|Lost to Follow-up|0|||
131955822|NCT04497116|475123806|FG018|Overall Study|Lost to Follow-up|0|||
131955823|NCT04497116|475123807|FG019|Overall Study|Lost to Follow-up|0|||
131955824|NCT04497116|475123808|FG020|Overall Study|Lost to Follow-up|0|||
131955825|NCT04497116|475123809|FG021|Overall Study|Lost to Follow-up|0|||
131955826|NCT04497116|475123810|FG022|Overall Study|Lost to Follow-up|1|||
131955827|NCT04497116|475123811|FG023|Overall Study|Lost to Follow-up|0|||
131955828|NCT04497116|475123812|FG024|Overall Study|Lost to Follow-up|0|||
131955829|NCT04497116|475123788|FG000|Overall Study|Sponsor decision to terminate study|0|||
131955830|NCT04497116|475123789|FG001|Overall Study|Sponsor decision to terminate study|0|||
131955831|NCT04497116|475123790|FG002|Overall Study|Sponsor decision to terminate study|0|||
131955832|NCT04497116|475123791|FG003|Overall Study|Sponsor decision to terminate study|0|||
131955833|NCT04497116|475123792|FG004|Overall Study|Sponsor decision to terminate study|0|||
131955834|NCT04497116|475123793|FG005|Overall Study|Sponsor decision to terminate study|0|||
131955835|NCT04497116|475123794|FG006|Overall Study|Sponsor decision to terminate study|1|||
131955836|NCT04497116|475123795|FG007|Overall Study|Sponsor decision to terminate study|0|||
131955837|NCT04497116|475123796|FG008|Overall Study|Sponsor decision to terminate study|0|||
131955838|NCT04497116|475123797|FG009|Overall Study|Sponsor decision to terminate study|1|||
131955839|NCT04497116|475123798|FG010|Overall Study|Sponsor decision to terminate study|0|||
131955840|NCT04497116|475123799|FG011|Overall Study|Sponsor decision to terminate study|0|||
131955841|NCT04497116|475123800|FG012|Overall Study|Sponsor decision to terminate study|0|||
131955842|NCT04497116|475123801|FG013|Overall Study|Sponsor decision to terminate study|0|||
131955843|NCT04497116|475123802|FG014|Overall Study|Sponsor decision to terminate study|0|||
131955844|NCT04497116|475123803|FG015|Overall Study|Sponsor decision to terminate study|0|||
131955845|NCT04497116|475123804|FG016|Overall Study|Sponsor decision to terminate study|0|||
131955846|NCT04497116|475123805|FG017|Overall Study|Sponsor decision to terminate study|0|||
131955847|NCT04497116|475123806|FG018|Overall Study|Sponsor decision to terminate study|0|||
131955848|NCT04497116|475123807|FG019|Overall Study|Sponsor decision to terminate study|1|||
131955849|NCT04497116|475123808|FG020|Overall Study|Sponsor decision to terminate study|0|||
131955850|NCT04497116|475123809|FG021|Overall Study|Sponsor decision to terminate study|0|||
131955851|NCT04497116|475123810|FG022|Overall Study|Sponsor decision to terminate study|0|||
131955852|NCT04497116|475123811|FG023|Overall Study|Sponsor decision to terminate study|0|||
131955853|NCT04497116|475123812|FG024|Overall Study|Sponsor decision to terminate study|0|||
131955854|NCT04497116|475123788|FG000|Overall Study|Death|4|||
131955855|NCT04497116|475123789|FG001|Overall Study|Death|5|||
131955856|NCT04497116|475123790|FG002|Overall Study|Death|2|||
131955857|NCT04497116|475123791|FG003|Overall Study|Death|2|||
131955858|NCT04497116|475123792|FG004|Overall Study|Death|1|||
131955859|NCT04497116|475123793|FG005|Overall Study|Death|1|||
131955860|NCT04497116|475123794|FG006|Overall Study|Death|3|||
131955861|NCT04497116|475123795|FG007|Overall Study|Death|10|||
131955862|NCT04497116|475123796|FG008|Overall Study|Death|37|||
131955863|NCT04497116|475123797|FG009|Overall Study|Death|17|||
131955864|NCT04497116|475123798|FG010|Overall Study|Death|2|||
131955865|NCT04497116|475123799|FG011|Overall Study|Death|1|||
131955866|NCT04497116|475123800|FG012|Overall Study|Death|1|||
131955867|NCT04497116|475123801|FG013|Overall Study|Death|3|||
131955868|NCT04497116|475123802|FG014|Overall Study|Death|18|||
131955869|NCT04497116|475123803|FG015|Overall Study|Death|3|||
131955870|NCT04497116|475123804|FG016|Overall Study|Death|2|||
131955871|NCT04497116|475123805|FG017|Overall Study|Death|1|||
131955872|NCT04497116|475123806|FG018|Overall Study|Death|4|||
131955873|NCT04497116|475123807|FG019|Overall Study|Death|17|||
131955874|NCT04497116|475123808|FG020|Overall Study|Death|1|||
131955875|NCT04497116|475123809|FG021|Overall Study|Death|0|||
131955876|NCT04497116|475123810|FG022|Overall Study|Death|3|||
131955877|NCT04497116|475123811|FG023|Overall Study|Death|5|||
131955878|NCT04497116|475123812|FG024|Overall Study|Death|4|||
131955879|NCT04497116|475123788|FG000|Overall Study|Withdrawal by Subject|1|||
131955880|NCT04497116|475123789|FG001|Overall Study|Withdrawal by Subject|0|||
131955881|NCT04497116|475123790|FG002|Overall Study|Withdrawal by Subject|1|||
131955882|NCT04497116|475123791|FG003|Overall Study|Withdrawal by Subject|0|||
131955883|NCT04497116|475123792|FG004|Overall Study|Withdrawal by Subject|0|||
131955884|NCT04497116|475123793|FG005|Overall Study|Withdrawal by Subject|0|||
131955885|NCT04497116|475123794|FG006|Overall Study|Withdrawal by Subject|0|||
131955886|NCT04497116|475123795|FG007|Overall Study|Withdrawal by Subject|7|||
131955887|NCT04497116|475123796|FG008|Overall Study|Withdrawal by Subject|14|||
131955888|NCT04497116|475123797|FG009|Overall Study|Withdrawal by Subject|3|||
131955889|NCT04497116|475123798|FG010|Overall Study|Withdrawal by Subject|3|||
131955890|NCT04497116|475123799|FG011|Overall Study|Withdrawal by Subject|0|||
131955891|NCT04497116|475123800|FG012|Overall Study|Withdrawal by Subject|1|||
131955892|NCT04497116|475123801|FG013|Overall Study|Withdrawal by Subject|0|||
131955893|NCT04497116|475123802|FG014|Overall Study|Withdrawal by Subject|7|||
131955894|NCT04497116|475123803|FG015|Overall Study|Withdrawal by Subject|1|||
131955895|NCT04497116|475123804|FG016|Overall Study|Withdrawal by Subject|3|||
131955896|NCT04497116|475123805|FG017|Overall Study|Withdrawal by Subject|1|||
131955897|NCT04497116|475123806|FG018|Overall Study|Withdrawal by Subject|1|||
131955898|NCT04497116|475123807|FG019|Overall Study|Withdrawal by Subject|5|||
131955899|NCT04497116|475123808|FG020|Overall Study|Withdrawal by Subject|2|||
131955900|NCT04497116|475123809|FG021|Overall Study|Withdrawal by Subject|2|||
131955901|NCT04497116|475123810|FG022|Overall Study|Withdrawal by Subject|2|||
131955902|NCT04497116|475123811|FG023|Overall Study|Withdrawal by Subject|4|||
131955903|NCT04497116|475123812|FG024|Overall Study|Withdrawal by Subject|3|||
131955904|NCT04497116|475123788|FG000|Overall Study|Physician Decision|0|||
131955905|NCT04497116|475123789|FG001|Overall Study|Physician Decision|0|||
131955906|NCT04497116|475123790|FG002|Overall Study|Physician Decision|0|||
131955907|NCT04497116|475123791|FG003|Overall Study|Physician Decision|0|||
131955908|NCT04497116|475123792|FG004|Overall Study|Physician Decision|0|||
131955909|NCT04497116|475123793|FG005|Overall Study|Physician Decision|0|||
131955910|NCT04497116|475123794|FG006|Overall Study|Physician Decision|0|||
131955911|NCT04497116|475123795|FG007|Overall Study|Physician Decision|0|||
131955912|NCT04497116|475123796|FG008|Overall Study|Physician Decision|0|||
131955913|NCT04497116|475123797|FG009|Overall Study|Physician Decision|0|||
131955914|NCT04497116|475123798|FG010|Overall Study|Physician Decision|0|||
131955915|NCT04497116|475123799|FG011|Overall Study|Physician Decision|0|||
131955916|NCT04497116|475123800|FG012|Overall Study|Physician Decision|0|||
131955917|NCT04497116|475123801|FG013|Overall Study|Physician Decision|0|||
131955918|NCT04497116|475123802|FG014|Overall Study|Physician Decision|0|||
131955919|NCT04497116|475123803|FG015|Overall Study|Physician Decision|0|||
131955920|NCT04497116|475123804|FG016|Overall Study|Physician Decision|0|||
131955921|NCT04497116|475123805|FG017|Overall Study|Physician Decision|0|||
131955922|NCT04497116|475123806|FG018|Overall Study|Physician Decision|0|||
131955923|NCT04497116|475123807|FG019|Overall Study|Physician Decision|0|||
131955924|NCT04497116|475123808|FG020|Overall Study|Physician Decision|0|||
131955925|NCT04497116|475123809|FG021|Overall Study|Physician Decision|0|||
131955926|NCT04497116|475123810|FG022|Overall Study|Physician Decision|0|||
131955927|NCT04497116|475123811|FG023|Overall Study|Physician Decision|1|||
131955928|NCT04497116|475123812|FG024|Overall Study|Physician Decision|0|||
131955929|NCT04497116|475123788|FG000|Overall Study|Clinical Progression Related|0|||
131955930|NCT04497116|475123789|FG001|Overall Study|Clinical Progression Related|0|||
131955931|NCT04497116|475123790|FG002|Overall Study|Clinical Progression Related|0|||
131955932|NCT04497116|475123791|FG003|Overall Study|Clinical Progression Related|0|||
131955933|NCT04497116|475123792|FG004|Overall Study|Clinical Progression Related|0|||
131955934|NCT04497116|475123793|FG005|Overall Study|Clinical Progression Related|0|||
131955935|NCT04497116|475123794|FG006|Overall Study|Clinical Progression Related|0|||
131955936|NCT04497116|475123795|FG007|Overall Study|Clinical Progression Related|0|||
131955937|NCT04497116|475123796|FG008|Overall Study|Clinical Progression Related|0|||
131955938|NCT04497116|475123797|FG009|Overall Study|Clinical Progression Related|1|||
131955939|NCT04497116|475123798|FG010|Overall Study|Clinical Progression Related|0|||
131955940|NCT04497116|475123799|FG011|Overall Study|Clinical Progression Related|0|||
131955941|NCT04497116|475123800|FG012|Overall Study|Clinical Progression Related|0|||
131955942|NCT04497116|475123801|FG013|Overall Study|Clinical Progression Related|0|||
131955943|NCT04497116|475123802|FG014|Overall Study|Clinical Progression Related|0|||
131955944|NCT04497116|475123803|FG015|Overall Study|Clinical Progression Related|0|||
131955945|NCT04497116|475123804|FG016|Overall Study|Clinical Progression Related|0|||
131955946|NCT04497116|475123805|FG017|Overall Study|Clinical Progression Related|0|||
131955947|NCT04497116|475123806|FG018|Overall Study|Clinical Progression Related|0|||
131955948|NCT04497116|475123807|FG019|Overall Study|Clinical Progression Related|0|||
131955949|NCT04497116|475123808|FG020|Overall Study|Clinical Progression Related|0|||
131955950|NCT04497116|475123809|FG021|Overall Study|Clinical Progression Related|0|||
131955951|NCT04497116|475123810|FG022|Overall Study|Clinical Progression Related|0|||
131955952|NCT04497116|475123811|FG023|Overall Study|Clinical Progression Related|0|||
131955953|NCT04497116|475123812|FG024|Overall Study|Clinical Progression Related|0|||
131955954|NCT04281485|475123813|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
131955955|NCT04281485|475123814|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
131955956|NCT04281485|475123813|FG000|Overall Study|Ongoing (Safety data collection)|10|||
131955957|NCT04281485|475123814|FG001|Overall Study|Ongoing (Safety data collection)|5|||
131955958|NCT05963022|475123818|FG000|Overall Study|Adverse Event|0|||
131955959|NCT05963022|475123819|FG001|Overall Study|Adverse Event|1|||
131955960|NCT05963022|475123820|FG002|Overall Study|Adverse Event|1|||
131955961|NCT05963022|475123821|FG003|Overall Study|Adverse Event|0|||
131955962|NCT05963022|475123818|FG000|Overall Study|Protocol Violation|0|||
131955963|NCT05963022|475123819|FG001|Overall Study|Protocol Violation|3|||
131955964|NCT05963022|475123820|FG002|Overall Study|Protocol Violation|0|||
131955965|NCT05963022|475123821|FG003|Overall Study|Protocol Violation|0|||
131955966|NCT05963022|475123818|FG000|Overall Study|Pregnancy|0|||
131955967|NCT05963022|475123819|FG001|Overall Study|Pregnancy|1|||
131955968|NCT05963022|475123820|FG002|Overall Study|Pregnancy|1|||
131955969|NCT05963022|475123821|FG003|Overall Study|Pregnancy|1|||
131955970|NCT05963022|475123818|FG000|Overall Study|Withdrawal by Subject|0|||
131955971|NCT05963022|475123819|FG001|Overall Study|Withdrawal by Subject|0|||
131955972|NCT05963022|475123820|FG002|Overall Study|Withdrawal by Subject|2|||
131955973|NCT05963022|475123821|FG003|Overall Study|Withdrawal by Subject|1|||
131955974|NCT05963022|475123818|FG000|Overall Study|Lost to Follow-up|0|||
131955975|NCT05963022|475123819|FG001|Overall Study|Lost to Follow-up|0|||
131955976|NCT05963022|475123820|FG002|Overall Study|Lost to Follow-up|0|||
131955977|NCT05963022|475123821|FG003|Overall Study|Lost to Follow-up|1|||
131955978|NCT05963022|475123818|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
131955979|NCT05963022|475123819|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
131955980|NCT05963022|475123820|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
131955981|NCT05963022|475123821|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
131955982|NCT05295953|475123826|FG000|Overall Study|Withdrawal by Subject|0|||
131955983|NCT05295953|475123827|FG001|Overall Study|Withdrawal by Subject|1|||
131955984|NCT05694013|475123828|FG000|Overall Study|Death|6|||
131955985|NCT05694013|475123829|FG001|Overall Study|Death|2|||
131955986|NCT05694013|475123828|FG000|Overall Study|Participant Decision|0|||
131955987|NCT05694013|475123829|FG001|Overall Study|Participant Decision|1|||
131955988|NCT05694013|475123828|FG000|Overall Study|Physician Decision|1|||
131955989|NCT05694013|475123829|FG001|Overall Study|Physician Decision|0|||
131955990|NCT05694013|475123828|FG000|Overall Study|Progressive Disease|0|||
131955991|NCT05694013|475123829|FG001|Overall Study|Progressive Disease|1|||
131955992|NCT05694013|475123828|FG000|Overall Study|Study Terminated by Sponsor|12|||
131955993|NCT05694013|475123829|FG001|Overall Study|Study Terminated by Sponsor|17|||
131955994|NCT05694013|475123828|FG000|Overall Study|Withdrawal by Subject|3|||
131955995|NCT05694013|475123829|FG001|Overall Study|Withdrawal by Subject|0|||
131955996|NCT04817891|475123830|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
131955997|NCT04817891|475123830|FG000|Overall Study|Adverse Event|1|||
131955998|NCT04817891|475123830|FG000|Overall Study|Withdrawal by Subject|1|||
131955999|NCT01711632|475123831|FG000|Overall Study|Adverse Event|4|||
131956000|NCT01711632|475123831|FG000|Overall Study|Death|3|||
131956001|NCT01711632|475123831|FG000|Overall Study|Lost to Follow-up|3|||
131956002|NCT01711632|475123831|FG000|Overall Study|Withdrawal by Subject|4|||
131956003|NCT01711632|475123831|FG000|Overall Study|Progressive disease|2|||
131956004|NCT01711632|475123831|FG000|Overall Study|No follow up required in re-treatment|3|||
131956005|NCT01711632|475123831|FG000|Overall Study|No follow up required in re-treatment|3|||
131956006|NCT04315181|475123832|FG000|Overall Study|Non-responsive to drug conditions.|1|||
131956007|NCT03066596|475123833|FG000|Overall Study|Withdrawal by Subject|4|||
131956008|NCT03066596|475123834|FG001|Overall Study|Withdrawal by Subject|2|||
131956009|NCT03066596|475123833|FG000|Overall Study|Lost to Follow-up|14|||
131956010|NCT03066596|475123834|FG001|Overall Study|Lost to Follow-up|10|||
131956011|NCT04257929|475123835|FG000|Overall Study|Adverse Event|1|||
131956012|NCT04257929|475123836|FG001|Overall Study|Adverse Event|0|||
131956013|NCT04257929|475123837|FG002|Overall Study|Adverse Event|1|||
131956014|NCT04257929|475123835|FG000|Overall Study|Withdrawal by Subject|1|||
131956015|NCT04257929|475123836|FG001|Overall Study|Withdrawal by Subject|0|||
131956016|NCT04257929|475123837|FG002|Overall Study|Withdrawal by Subject|0|||
131956017|NCT04257929|475123835|FG000|Overall Study|COVID-19|0|||
131956018|NCT04257929|475123836|FG001|Overall Study|COVID-19|1|||
131956019|NCT04257929|475123837|FG002|Overall Study|COVID-19|1|||
131956020|NCT04257929|475123835|FG000|Overall Study|Lost to Follow-up|0|||
131956021|NCT04257929|475123836|FG001|Overall Study|Lost to Follow-up|0|||
131956022|NCT04257929|475123837|FG002|Overall Study|Lost to Follow-up|1|||
131956023|NCT05049460|475123838|FG000|Overall Study|Withdrawal by Subject|2|||
131956024|NCT05049460|475123839|FG001|Overall Study|Withdrawal by Subject|2|||
131956025|NCT05049460|475123838|FG000|Overall Study|Lost to Follow-up|2|||
131956026|NCT05049460|475123839|FG001|Overall Study|Lost to Follow-up|2|||
131956027|NCT04948333|475123840|FG000|Overall Study|Adverse Event|6|||
131956028|NCT04948333|475123841|FG001|Overall Study|Adverse Event|4|||
131956029|NCT04948333|475123842|FG002|Overall Study|Adverse Event|0|||
131956030|NCT04948333|475123843|FG003|Overall Study|Adverse Event|2|||
131956031|NCT04948333|475123840|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
131956032|NCT04948333|475123841|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131956033|NCT04948333|475123842|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131956034|NCT04948333|475123843|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131956035|NCT04948333|475123840|FG000|Overall Study|Progressive Disease|1|||
131956036|NCT04948333|475123841|FG001|Overall Study|Progressive Disease|5|||
131956037|NCT04948333|475123842|FG002|Overall Study|Progressive Disease|0|||
131956038|NCT04948333|475123843|FG003|Overall Study|Progressive Disease|0|||
131956039|NCT04948333|475123840|FG000|Overall Study|Physician Decision|2|||
131956040|NCT04948333|475123841|FG001|Overall Study|Physician Decision|2|||
131956041|NCT04948333|475123842|FG002|Overall Study|Physician Decision|0|||
131956042|NCT04948333|475123843|FG003|Overall Study|Physician Decision|0|||
131956043|NCT04948333|475123840|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
131956044|NCT04948333|475123841|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
131956045|NCT04948333|475123842|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
131956046|NCT04948333|475123843|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
131956047|NCT04948333|475123840|FG000|Overall Study|Withdrawal by Subject|2|||
131956048|NCT04948333|475123841|FG001|Overall Study|Withdrawal by Subject|0|||
131956049|NCT04948333|475123842|FG002|Overall Study|Withdrawal by Subject|0|||
131956050|NCT04948333|475123843|FG003|Overall Study|Withdrawal by Subject|1|||
131956051|NCT04948333|475123840|FG000|Overall Study|Protocol Violation|0|||
131956052|NCT04948333|475123841|FG001|Overall Study|Protocol Violation|1|||
131956053|NCT04948333|475123842|FG002|Overall Study|Protocol Violation|0|||
131956054|NCT04948333|475123843|FG003|Overall Study|Protocol Violation|0|||
131956055|NCT04948333|475123840|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
131956056|NCT04948333|475123841|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
131956057|NCT04948333|475123842|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
131956058|NCT04948333|475123843|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
131956059|NCT03517969|475123844|FG000|Overall Study|Never started protocol treatment|3|||
131956060|NCT03517969|475123845|FG001|Overall Study|Never started protocol treatment|5|||
131956061|NCT03517969|475123844|FG000|Overall Study|Disease progression|11|||
131956062|NCT03517969|475123845|FG001|Overall Study|Disease progression|16|||
131956063|NCT03517969|475123844|FG000|Overall Study|PSA progression|8|||
131956064|NCT03517969|475123845|FG001|Overall Study|PSA progression|1|||
131956065|NCT03517969|475123844|FG000|Overall Study|Clinical progression|4|||
131956066|NCT03517969|475123845|FG001|Overall Study|Clinical progression|2|||
131956067|NCT03517969|475123844|FG000|Overall Study|Adverse Event|5|||
131956068|NCT03517969|475123845|FG001|Overall Study|Adverse Event|4|||
131956069|NCT03517969|475123844|FG000|Overall Study|Intercurrent illness|1|||
131956070|NCT03517969|475123845|FG001|Overall Study|Intercurrent illness|2|||
131956071|NCT03517969|475123844|FG000|Overall Study|Death|1|||
131956072|NCT03517969|475123845|FG001|Overall Study|Death|1|||
131956073|NCT03517969|475123844|FG000|Overall Study|Withdrawal by Subject|1|||
131956074|NCT03517969|475123845|FG001|Overall Study|Withdrawal by Subject|2|||
131956075|NCT03517969|475123844|FG000|Overall Study|Physician Decision|1|||
131956076|NCT03517969|475123845|FG001|Overall Study|Physician Decision|1|||
131956077|NCT03517969|475123844|FG000|Overall Study|No clinical benefit|1|||
131956078|NCT03517969|475123845|FG001|Overall Study|No clinical benefit|0|||
131956079|NCT03517969|475123844|FG000|Overall Study|Delayed treatment for dental treatment|1|||
131956080|NCT03517969|475123845|FG001|Overall Study|Delayed treatment for dental treatment|0|||
131956081|NCT03517969|475123844|FG000|Overall Study|Difficult to maintain appointment|0|||
131956082|NCT03517969|475123845|FG001|Overall Study|Difficult to maintain appointment|1|||
131956083|NCT03517969|475123844|FG000|Overall Study|Protocol Violation|0|||
131956084|NCT03517969|475123845|FG001|Overall Study|Protocol Violation|1|||
131956085|NCT02959437|475123846|FG000|Overall Study|Death|33|||
131956086|NCT02959437|475123847|FG001|Overall Study|Death|3|||
131956087|NCT02959437|475123848|FG002|Overall Study|Death|0|||
131956088|NCT02959437|475123849|FG003|Overall Study|Death|0|||
131956089|NCT02959437|475123846|FG000|Overall Study|Lost to Follow-up|3|||
131956090|NCT02959437|475123847|FG001|Overall Study|Lost to Follow-up|1|||
131956091|NCT02959437|475123848|FG002|Overall Study|Lost to Follow-up|0|||
131956092|NCT02959437|475123849|FG003|Overall Study|Lost to Follow-up|0|||
131956093|NCT02959437|475123846|FG000|Overall Study|Withdrawal by Subject|11|||
131956094|NCT02959437|475123847|FG001|Overall Study|Withdrawal by Subject|3|||
131956095|NCT02959437|475123848|FG002|Overall Study|Withdrawal by Subject|0|||
131956096|NCT02959437|475123849|FG003|Overall Study|Withdrawal by Subject|0|||
131956097|NCT02959437|475123846|FG000|Overall Study|Progressive Disease|9|||
131956098|NCT02959437|475123847|FG001|Overall Study|Progressive Disease|1|||
131956099|NCT02959437|475123848|FG002|Overall Study|Progressive Disease|0|||
131956100|NCT02959437|475123849|FG003|Overall Study|Progressive Disease|0|||
131956101|NCT02959437|475123846|FG000|Overall Study|Study Terminated by Sponsor|4|||
131956102|NCT02959437|475123847|FG001|Overall Study|Study Terminated by Sponsor|0|||
131956103|NCT02959437|475123848|FG002|Overall Study|Study Terminated by Sponsor|0|||
131956104|NCT02959437|475123849|FG003|Overall Study|Study Terminated by Sponsor|0|||
131956105|NCT02959437|475123846|FG000|Overall Study|Other Unspecified|2|||
131956106|NCT02959437|475123847|FG001|Overall Study|Other Unspecified|0|||
131956107|NCT02959437|475123848|FG002|Overall Study|Other Unspecified|0|||
131956108|NCT02959437|475123849|FG003|Overall Study|Other Unspecified|0|||
131956109|NCT04445662|475123850|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
131956110|NCT04445662|475123851|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
131956111|NCT04445662|475123850|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
131956112|NCT04445662|475123851|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
131956113|NCT04445662|475123850|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
131956114|NCT04445662|475123851|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
131956115|NCT04445662|475123850|FG000|Post-treatment (12-24 weeks)|Death|1|||
131956116|NCT04445662|475123851|FG001|Post-treatment (12-24 weeks)|Death|0|||
131956117|NCT01467427|475123852|FG000|Overall Study|Withdrawal by Subject|1|||
131956118|NCT01467427|475123853|FG001|Overall Study|Withdrawal by Subject|0|||
131956119|NCT01467427|475123852|FG000|Overall Study|Not continuing in extension phase|0|||
131956120|NCT01467427|475123853|FG001|Overall Study|Not continuing in extension phase|2|||
131956121|NCT01467427|475123852|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
131956122|NCT01467427|475123853|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
131956123|NCT01467427|475123852|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
131956124|NCT01467427|475123853|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
131956125|NCT01467427|475123852|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
131956126|NCT01467427|475123853|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
131956127|NCT01467427|475123852|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
131956128|NCT01467427|475123853|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
131956129|NCT04333095|475123854|FG000|Overall Study|Protocol Violation|4|||
131956130|NCT04333095|475123855|FG001|Overall Study|Protocol Violation|0|||
131956131|NCT04333095|475123854|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
131956132|NCT04333095|475123855|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
131956133|NCT04333095|475123854|FG000|Overall Study|Mini Sternotomy|4|||
131956134|NCT04333095|475123855|FG001|Overall Study|Mini Sternotomy|5|||
131956135|NCT03957551|475123856|FG000|Overall Study|Adverse Event|2|||
131956136|NCT03957551|475123857|FG001|Overall Study|Adverse Event|2|||
131956137|NCT03957551|475123858|FG002|Overall Study|Adverse Event|6|||
131956138|NCT03957551|475123856|FG000|Overall Study|Physician Decision|1|||
131956139|NCT03957551|475123857|FG001|Overall Study|Physician Decision|0|||
131956140|NCT03957551|475123858|FG002|Overall Study|Physician Decision|2|||
131956141|NCT03957551|475123856|FG000|Overall Study|Withdrawal by Subject|1|||
131956142|NCT03957551|475123857|FG001|Overall Study|Withdrawal by Subject|0|||
131956143|NCT03957551|475123858|FG002|Overall Study|Withdrawal by Subject|2|||
131956144|NCT03957551|475123856|FG000|Overall Study|Disease progression|1|||
131956145|NCT03957551|475123857|FG001|Overall Study|Disease progression|0|||
131956146|NCT03957551|475123858|FG002|Overall Study|Disease progression|8|||
131956147|NCT04251533|475123859|FG000|Overall Study|Progressive disease|33|||
131956148|NCT04251533|475123860|FG001|Overall Study|Progressive disease|29|||
131956149|NCT04251533|475123861|FG002|Overall Study|Progressive disease|22|||
131956150|NCT04251533|475123859|FG000|Overall Study|Death|5|||
131956151|NCT04251533|475123860|FG001|Overall Study|Death|1|||
131956152|NCT04251533|475123861|FG002|Overall Study|Death|3|||
131956153|NCT04251533|475123859|FG000|Overall Study|Physician Decision|3|||
131956154|NCT04251533|475123860|FG001|Overall Study|Physician Decision|2|||
131956155|NCT04251533|475123861|FG002|Overall Study|Physician Decision|4|||
131956156|NCT04251533|475123859|FG000|Overall Study|Participant decision|1|||
131956157|NCT04251533|475123860|FG001|Overall Study|Participant decision|3|||
131956158|NCT04251533|475123861|FG002|Overall Study|Participant decision|1|||
131956159|NCT04251533|475123859|FG000|Overall Study|Adverse Event|2|||
131956160|NCT04251533|475123860|FG001|Overall Study|Adverse Event|1|||
131956161|NCT04251533|475123861|FG002|Overall Study|Adverse Event|1|||
131956162|NCT03257462|475123862|FG000|Cohort A|Lost to Follow-up|1|||
131956163|NCT03257462|475123863|FG001|Cohort A|Lost to Follow-up|0|||
131956164|NCT03257462|475123864|FG002|Cohort A|Lost to Follow-up|0|||
131956165|NCT03257462|475123865|FG003|Cohort A|Lost to Follow-up|0|||
131956166|NCT03257462|475123862|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
131956167|NCT03257462|475123863|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
131956168|NCT03257462|475123864|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
131956169|NCT03257462|475123865|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
131956170|NCT06061081|475123866|FG000|Overall Study|Withdrawal by Subject|1|||
131956171|NCT06061081|475123867|FG001|Overall Study|Withdrawal by Subject|0|||
131956172|NCT06061081|475123868|FG002|Overall Study|Withdrawal by Subject|0|||
131956173|NCT06061081|475123869|FG003|Overall Study|Withdrawal by Subject|0|||
131956174|NCT06061081|475123870|FG004|Overall Study|Withdrawal by Subject|0|||
131956175|NCT03740165|475123873|FG000|Overall Study|Death|232|||
131956176|NCT03740165|475123874|FG001|Overall Study|Death|242|||
131956177|NCT03740165|475123875|FG002|Overall Study|Death|229|||
131956178|NCT03740165|475123873|FG000|Overall Study|Lost to Follow-up|0|||
131956179|NCT03740165|475123874|FG001|Overall Study|Lost to Follow-up|0|||
131956180|NCT03740165|475123875|FG002|Overall Study|Lost to Follow-up|1|||
131956181|NCT03740165|475123873|FG000|Overall Study|Withdrawal by Subject|7|||
131956182|NCT03740165|475123874|FG001|Overall Study|Withdrawal by Subject|4|||
131956183|NCT03740165|475123875|FG002|Overall Study|Withdrawal by Subject|3|||
131956184|NCT03740165|475123873|FG000|Overall Study|Ongoing in Study|216|||
131956185|NCT03740165|475123874|FG001|Overall Study|Ongoing in Study|212|||
131956186|NCT03740165|475123875|FG002|Overall Study|Ongoing in Study|221|||
131956187|NCT05167825|475123876|FG000|Overall Study|Ongoing|3|||
131956188|NCT04689828|475123877|FG000|Overall Study|Subject decision|5|||
131956189|NCT04689828|475123878|FG001|Overall Study|Subject decision|5|||
131956190|NCT04689828|475123877|FG000|Overall Study|Adverse Event|12|||
131956191|NCT04689828|475123878|FG001|Overall Study|Adverse Event|12|||
131956192|NCT04689828|475123877|FG000|Overall Study|Physician Decision|24|||
131956193|NCT04689828|475123878|FG001|Overall Study|Physician Decision|32|||
131956194|NCT04689828|475123877|FG000|Overall Study|Progressive disease|54|||
131956195|NCT04689828|475123878|FG001|Overall Study|Progressive disease|173|||
131956196|NCT04689828|475123877|FG000|Overall Study|Death|0|||
131956197|NCT04689828|475123878|FG001|Overall Study|Death|1|||
131956198|NCT04689828|475123877|FG000|Overall Study|Lost to Follow-up|1|||
131956199|NCT04689828|475123878|FG001|Overall Study|Lost to Follow-up|0|||
131956200|NCT04689828|475123877|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
131956201|NCT04689828|475123878|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
131956202|NCT04689828|475123877|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
131956203|NCT04689828|475123878|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
131956204|NCT04689828|475123877|FG000|Overall Study|Participants not treated|7|||
131956205|NCT04689828|475123878|FG001|Overall Study|Participants not treated|2|||
131956206|NCT03049618|475123880|FG000|Overall Study|Death|1|||
131956207|NCT03049618|475123881|FG001|Overall Study|Death|0|||
131956208|NCT03049618|475123880|FG000|Overall Study|Lack of Efficacy|1|||
131956209|NCT03049618|475123881|FG001|Overall Study|Lack of Efficacy|2|||
131956210|NCT03269994|475123884|FG000|Overall Study|Withdrawal by Subject|4|||
131956211|NCT03269994|475123885|FG001|Overall Study|Withdrawal by Subject|5|||
131956212|NCT03269994|475123884|FG000|Overall Study|Unresectable at surgery|39|||
131956213|NCT03269994|475123885|FG001|Overall Study|Unresectable at surgery|58|||
131956214|NCT03269994|475123884|FG000|Overall Study|Patient canceled surgery|5|||
131956215|NCT03269994|475123885|FG001|Overall Study|Patient canceled surgery|14|||
131956216|NCT03269994|475123884|FG000|Overall Study|Preoperative progression|14|||
131956217|NCT03269994|475123885|FG001|Overall Study|Preoperative progression|9|||
131956218|NCT03269994|475123884|FG000|Overall Study|Preoperative infection|10|||
131956219|NCT03269994|475123885|FG001|Overall Study|Preoperative infection|4|||
131956220|NCT03269994|475123884|FG000|Overall Study|Kidney insufficiency|1|||
131956221|NCT03269994|475123885|FG001|Overall Study|Kidney insufficiency|0|||
131956222|NCT03269994|475123884|FG000|Overall Study|Drug allergy|0|||
131956223|NCT03269994|475123885|FG001|Overall Study|Drug allergy|2|||
131956224|NCT03269994|475123884|FG000|Overall Study|Operation changed to different resection|9|||
131956225|NCT03269994|475123885|FG001|Overall Study|Operation changed to different resection|0|||
131956226|NCT03269994|475123884|FG000|Overall Study|Preoperative steroid|0|||
131956227|NCT03269994|475123885|FG001|Overall Study|Preoperative steroid|3|||
131956228|NCT03269994|475123884|FG000|Overall Study|Accrual Closed|2|||
131956229|NCT03269994|475123885|FG001|Overall Study|Accrual Closed|0|||
131956230|NCT03269994|475123884|FG000|Overall Study|Operation changed to different resection|0|||
131956231|NCT03269994|475123885|FG001|Overall Study|Operation changed to different resection|10|||
131956232|NCT00843882|475123886|FG000|Step 1|Lack of Efficacy|14|||
131956233|NCT00843882|475123887|FG001|Step 1|Lack of Efficacy|10|||
131956234|NCT00843882|475123888|FG002|Step 1|Lack of Efficacy|21|||
131956235|NCT00843882|475123886|FG000|Step 1|Adverse Event|8|||
131956236|NCT00843882|475123887|FG001|Step 1|Adverse Event|17|||
131956237|NCT00843882|475123888|FG002|Step 1|Adverse Event|20|||
131956238|NCT00843882|475123886|FG000|Step 1|Death|1|||
131956239|NCT00843882|475123887|FG001|Step 1|Death|2|||
131956240|NCT00843882|475123888|FG002|Step 1|Death|4|||
131956241|NCT00843882|475123886|FG000|Step 1|Withdrawal by Subject|6|||
131956242|NCT00843882|475123887|FG001|Step 1|Withdrawal by Subject|12|||
131956243|NCT00843882|475123888|FG002|Step 1|Withdrawal by Subject|9|||
131956244|NCT00843882|475123886|FG000|Step 1|Physician Decision|0|||
131956245|NCT00843882|475123887|FG001|Step 1|Physician Decision|5|||
131956246|NCT00843882|475123888|FG002|Step 1|Physician Decision|1|||
131956247|NCT00843882|475123886|FG000|Step 1|Patient and physician's decision|0|||
131956248|NCT00843882|475123887|FG001|Step 1|Patient and physician's decision|0|||
131956249|NCT00843882|475123888|FG002|Step 1|Patient and physician's decision|1|||
131956250|NCT00843882|475123886|FG000|Step 1|Other complicating disease|1|||
131956251|NCT00843882|475123887|FG001|Step 1|Other complicating disease|3|||
131956252|NCT00843882|475123888|FG002|Step 1|Other complicating disease|4|||
131956253|NCT00843882|475123886|FG000|Step 1|Alternative therapy|0|||
131956254|NCT00843882|475123887|FG001|Step 1|Alternative therapy|1|||
131956255|NCT00843882|475123888|FG002|Step 1|Alternative therapy|1|||
131956256|NCT00843882|475123886|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
131956257|NCT00843882|475123887|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
131956258|NCT00843882|475123888|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
131956259|NCT00843882|475123886|FG000|Step 1|Off treatment reason unknown|0|||
131956260|NCT00843882|475123887|FG001|Step 1|Off treatment reason unknown|1|||
131956261|NCT00843882|475123888|FG002|Step 1|Off treatment reason unknown|4|||
131956262|NCT00843882|475123886|FG000|Step 1|Never started treatment|2|||
131956263|NCT00843882|475123887|FG001|Step 1|Never started treatment|0|||
131956264|NCT00843882|475123888|FG002|Step 1|Never started treatment|0|||
131956265|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
131956266|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
131956267|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
131956268|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
131956269|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
131956270|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
131956271|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
131956272|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
131956273|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
131956274|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
131956275|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
131956276|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
131956277|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
131956278|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
131956279|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
131956280|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
131956281|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
131956282|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
131956283|NCT00843882|475123886|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
131956284|NCT00843882|475123887|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
131956285|NCT00843882|475123888|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
131956286|NCT02252172|475123889|FG000|Overall Study|Lost to Follow-up|9|||
131956287|NCT02252172|475123890|FG001|Overall Study|Lost to Follow-up|6|||
131956288|NCT02252172|475123889|FG000|Overall Study|Death|218|||
131956289|NCT02252172|475123890|FG001|Overall Study|Death|175|||
131956290|NCT02252172|475123889|FG000|Overall Study|Withdrawal by Subject|20|||
131956291|NCT02252172|475123890|FG001|Overall Study|Withdrawal by Subject|15|||
131956292|NCT02252172|475123889|FG000|Overall Study|Physician Decision|0|||
131956293|NCT02252172|475123890|FG001|Overall Study|Physician Decision|1|||
131956294|NCT02252172|475123889|FG000|Overall Study|End of data collection|122|||
131956295|NCT02252172|475123890|FG001|Overall Study|End of data collection|170|||
131956296|NCT02252172|475123889|FG000|Overall Study|Site closure|0|||
131956297|NCT02252172|475123890|FG001|Overall Study|Site closure|1|||
131956298|NCT04582539|475123891|FG000|Overall Study|Death|1|||
131956299|NCT04582539|475123892|FG001|Overall Study|Death|1|||
131956300|NCT04582539|475123893|FG002|Overall Study|Death|0|||
131956301|NCT04582539|475123894|FG003|Overall Study|Death|1|||
131956302|NCT04582539|475123895|FG004|Overall Study|Death|0|||
131956303|NCT04582539|475123891|FG000|Overall Study|Lost to Follow-up|1|||
131956304|NCT04582539|475123892|FG001|Overall Study|Lost to Follow-up|0|||
131956305|NCT04582539|475123893|FG002|Overall Study|Lost to Follow-up|0|||
131956306|NCT04582539|475123894|FG003|Overall Study|Lost to Follow-up|0|||
131956307|NCT04582539|475123895|FG004|Overall Study|Lost to Follow-up|0|||
131956308|NCT04582539|475123891|FG000|Overall Study|Study Terminated by Sponsor|1|||
131956309|NCT04582539|475123892|FG001|Overall Study|Study Terminated by Sponsor|3|||
131956310|NCT04582539|475123893|FG002|Overall Study|Study Terminated by Sponsor|2|||
131956311|NCT04582539|475123894|FG003|Overall Study|Study Terminated by Sponsor|2|||
131956312|NCT04582539|475123895|FG004|Overall Study|Study Terminated by Sponsor|3|||
131956313|NCT04582539|475123891|FG000|Overall Study|Physician Decision|0|||
131956314|NCT04582539|475123892|FG001|Overall Study|Physician Decision|1|||
131956315|NCT04582539|475123893|FG002|Overall Study|Physician Decision|0|||
131956316|NCT04582539|475123894|FG003|Overall Study|Physician Decision|0|||
131956317|NCT04582539|475123895|FG004|Overall Study|Physician Decision|0|||
131956318|NCT04582539|475123891|FG000|Overall Study|Withdrawal by Subject|1|||
131956319|NCT04582539|475123892|FG001|Overall Study|Withdrawal by Subject|0|||
131956320|NCT04582539|475123893|FG002|Overall Study|Withdrawal by Subject|2|||
131956321|NCT04582539|475123894|FG003|Overall Study|Withdrawal by Subject|1|||
131956322|NCT04582539|475123895|FG004|Overall Study|Withdrawal by Subject|0|||
131956323|NCT04582539|475123891|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
131956324|NCT04582539|475123892|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
131956325|NCT04582539|475123893|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
131956326|NCT04582539|475123894|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
131956327|NCT04582539|475123895|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
131956328|NCT04707469|475123897|FG000|Overall Study|Site closure|0|||
131956329|NCT04707469|475123898|FG001|Overall Study|Site closure|2|||
131956330|NCT04707469|475123899|FG002|Overall Study|Site closure|0|||
131956331|NCT04707469|475123897|FG000|Overall Study|Physician Decision|2|||
131956332|NCT04707469|475123898|FG001|Overall Study|Physician Decision|2|||
131956333|NCT04707469|475123899|FG002|Overall Study|Physician Decision|2|||
131956334|NCT04707469|475123897|FG000|Overall Study|Death|1|||
131956335|NCT04707469|475123898|FG001|Overall Study|Death|6|||
131956336|NCT04707469|475123899|FG002|Overall Study|Death|2|||
131956337|NCT04707469|475123897|FG000|Overall Study|Lost to Follow-up|9|||
131956338|NCT04707469|475123898|FG001|Overall Study|Lost to Follow-up|19|||
131956339|NCT04707469|475123899|FG002|Overall Study|Lost to Follow-up|14|||
131956340|NCT04707469|475123897|FG000|Overall Study|Withdrawal by Subject|17|||
131956341|NCT04707469|475123898|FG001|Overall Study|Withdrawal by Subject|16|||
131956342|NCT04707469|475123899|FG002|Overall Study|Withdrawal by Subject|12|||
131956343|NCT04838613|475123903|FG000|Overall Study|Withdrawal by Subject|3|||
131956344|NCT04838613|475123904|FG001|Overall Study|Withdrawal by Subject|6|||
131956345|NCT04838613|475123903|FG000|Overall Study|Protocol Deviation|3|||
131956346|NCT04838613|475123904|FG001|Overall Study|Protocol Deviation|2|||
131956347|NCT04838613|475123903|FG000|Overall Study|Technical Problems|0|||
131956348|NCT04838613|475123904|FG001|Overall Study|Technical Problems|5|||
131956349|NCT04838613|475123903|FG000|Overall Study|Physician Decision|2|||
131956350|NCT04838613|475123904|FG001|Overall Study|Physician Decision|0|||
131956351|NCT04970654|475123905|FG000|Overall Study|Withdrawal by parents/guardian|1|||
131956352|NCT04970654|475123906|FG001|Overall Study|Withdrawal by parents/guardian|2|||
131956353|NCT04970654|475123905|FG000|Overall Study|Unclassified|2|||
131956354|NCT04970654|475123906|FG001|Overall Study|Unclassified|1|||
131956355|NCT04970654|475123905|FG000|Overall Study|Lost to Follow-up|1|||
131956356|NCT04970654|475123906|FG001|Overall Study|Lost to Follow-up|0|||
131956357|NCT05275998|475123907|FG000|Overall Study|Adverse Event|0|||
131956358|NCT05275998|475123908|FG001|Overall Study|Adverse Event|0|||
131956359|NCT05275998|475123909|FG002|Overall Study|Adverse Event|0|||
131956360|NCT05275998|475123910|FG003|Overall Study|Adverse Event|1|||
131956361|NCT05275998|475123907|FG000|Overall Study|Withdrawal by Subject|0|||
131956362|NCT05275998|475123908|FG001|Overall Study|Withdrawal by Subject|0|||
131956363|NCT05275998|475123909|FG002|Overall Study|Withdrawal by Subject|0|||
131956364|NCT05275998|475123910|FG003|Overall Study|Withdrawal by Subject|1|||
131956365|NCT05275998|475123907|FG000|Overall Study|Physician Decision|0|||
131956366|NCT05275998|475123908|FG001|Overall Study|Physician Decision|0|||
131956367|NCT05275998|475123909|FG002|Overall Study|Physician Decision|0|||
131956368|NCT05275998|475123910|FG003|Overall Study|Physician Decision|1|||
131956369|NCT05275998|475123907|FG000|Overall Study|Protocol Violation|0|||
131956370|NCT05275998|475123908|FG001|Overall Study|Protocol Violation|0|||
131956371|NCT05275998|475123909|FG002|Overall Study|Protocol Violation|1|||
131956372|NCT05275998|475123910|FG003|Overall Study|Protocol Violation|0|||
131956373|NCT02137850|475123911|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
131956374|NCT02137850|475123912|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
131956375|NCT02137850|475123913|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
131956376|NCT02137850|475123911|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
131956377|NCT02137850|475123912|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
131956378|NCT02137850|475123913|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
131956379|NCT02137850|475123911|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
131956380|NCT02137850|475123912|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
131956381|NCT02137850|475123913|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
131956382|NCT02137850|475123911|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
131956383|NCT02137850|475123912|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
131956384|NCT02137850|475123913|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
131956385|NCT02137850|475123911|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
131956386|NCT02137850|475123912|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
131956387|NCT02137850|475123913|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
131956388|NCT02137850|475123911|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
131956389|NCT02137850|475123912|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
131956390|NCT02137850|475123913|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
131956391|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131956392|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
131956393|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131956394|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
131956395|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
131956396|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
131956397|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
131956398|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
131956399|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
131956400|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
131956401|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
131956402|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
131956403|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Other|0|||
131956404|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Other|1|||
131956405|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Other|0|||
131956406|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
131956407|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
131956408|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
131956409|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Early site closure|0|||
131956410|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Early site closure|2|||
131956411|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Early site closure|0|||
131956412|NCT02137850|475123911|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
131956413|NCT02137850|475123912|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
131415467|NCT02713867|473145275|FG001|Treatment Period|Death|3|||
131415468|NCT02713867|473145274|FG000|Treatment Period|Study Drug Toxicity|16|||
131956414|NCT02137850|475123913|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
131956415|NCT02137850|475123911|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
131956416|NCT02137850|475123912|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
131956417|NCT02137850|475123913|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
131956418|NCT02137850|475123911|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
131956419|NCT02137850|475123912|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
131956420|NCT02137850|475123913|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
131956421|NCT02137850|475123911|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
131956422|NCT02137850|475123912|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
131956423|NCT02137850|475123913|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
131415469|NCT02713867|473145275|FG001|Treatment Period|Study Drug Toxicity|19|||
131956424|NCT02137850|475123911|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
131956425|NCT02137850|475123912|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
131956426|NCT02137850|475123913|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
131956427|NCT02137850|475123911|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
131956428|NCT02137850|475123912|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
131956429|NCT02137850|475123913|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
131956430|NCT02137850|475123911|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131956431|NCT02137850|475123912|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
131956432|NCT02137850|475123913|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131956433|NCT02137850|475123911|FG000|Extension Phase: Prophylaxis|Other|0|||
131956434|NCT02137850|475123912|FG001|Extension Phase: Prophylaxis|Other|1|||
131956435|NCT02137850|475123913|FG002|Extension Phase: Prophylaxis|Other|0|||
131956436|NCT02137850|475123911|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
131956437|NCT02137850|475123912|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
131956438|NCT02137850|475123913|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
131956439|NCT05494788|475123914|FG000|Initial Treatment Period|Adverse Event|2|||
131956440|NCT05494788|475123914|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
131956441|NCT05494788|475123914|FG000|Extension Period|Adverse Event|1|||
131956442|NCT05494788|475123914|FG000|Extension Period|Withdrawal by Subject|1|||
131956443|NCT05030753|475123915|FG000|9-week|Lost to Follow-up|10|||
131956444|NCT05030753|475123916|FG001|9-week|Lost to Follow-up|7|||
131956445|NCT05030753|475123915|FG000|9-week|Withdrawal by Subject|1|||
131956446|NCT05030753|475123916|FG001|9-week|Withdrawal by Subject|0|||
131956447|NCT05030753|475123915|FG000|9-week|Excluded from analysis due to missing covariates|2|||
131956448|NCT05030753|475123916|FG001|9-week|Excluded from analysis due to missing covariates|1|||
131956449|NCT05030753|475123915|FG000|6-month post intervention|Lost to Follow-up|5|||
131956450|NCT05030753|475123916|FG001|6-month post intervention|Lost to Follow-up|4|||
131956451|NCT05030753|475123915|FG000|6-month post intervention|Withdrawal by Subject|4|||
131956452|NCT05030753|475123916|FG001|6-month post intervention|Withdrawal by Subject|0|||
131956453|NCT05030753|475123915|FG000|18-month post intervention|Lost to Follow-up|3|||
131956454|NCT05030753|475123916|FG001|18-month post intervention|Lost to Follow-up|1|||
131956455|NCT04661150|475123917|FG000|Overall Study|Ongoing in study|19|||
131956456|NCT04661150|475123918|FG001|Overall Study|Ongoing in study|20|||
131956457|NCT04661150|475123917|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
131956458|NCT04661150|475123918|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
131956459|NCT04661150|475123917|FG000|Overall Study|Death|2|||
131956460|NCT04661150|475123918|FG001|Overall Study|Death|0|||
131956461|NCT05480943|475123919|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
131956462|NCT05480943|475123919|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
131956463|NCT05480943|475123919|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
131956464|NCT05480943|475123919|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
131956465|NCT03775486|475123920|FG000|Initial Therapy Phase|Other reason provided|0|||
131956466|NCT03775486|475123921|FG001|Initial Therapy Phase|Other reason provided|15|||
131956467|NCT03775486|475123920|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
131956468|NCT03775486|475123921|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
131956469|NCT03775486|475123920|FG000|Initial Therapy Phase|Protocol Violation|0|||
131956470|NCT03775486|475123921|FG001|Initial Therapy Phase|Protocol Violation|2|||
131956471|NCT03775486|475123920|FG000|Initial Therapy Phase|Adverse Event|0|||
131956472|NCT03775486|475123921|FG001|Initial Therapy Phase|Adverse Event|34|||
131956473|NCT03775486|475123920|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
131956474|NCT03775486|475123921|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
131956475|NCT03775486|475123920|FG000|Maintenance Phase|Withdrawal by Subject|13|||
131956476|NCT03775486|475123921|FG001|Maintenance Phase|Withdrawal by Subject|12|||
131956477|NCT03775486|475123920|FG000|Maintenance Phase|Death|44|||
131956478|NCT03775486|475123921|FG001|Maintenance Phase|Death|45|||
131956479|NCT00136435|475123922|FG000|Overall Study|Ineligible|8|||
131956480|NCT00136435|475123922|FG000|Overall Study|Induction Death|1|||
131956481|NCT00136435|475123922|FG000|Overall Study|Induction Failure|10|||
131956482|NCT00136435|475123922|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
131956483|NCT00136435|475123922|FG000|Overall Study|Withdrawal by Subject|3|||
131956484|NCT00136435|475123922|FG000|Overall Study|Adverse Event|19|||
131956485|NCT00136435|475123922|FG000|Overall Study|Relapse|4|||
131956486|NCT00136435|475123922|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
131956487|NCT05477485|475123923|FG000|Overall Study|Lost to Follow-up|0|||
131415470|NCT02713867|473145274|FG000|Treatment Period|Disease Progression|82|||
131415471|NCT02713867|473145275|FG001|Treatment Period|Disease Progression|83|||
131956488|NCT05477485|475123924|FG001|Overall Study|Lost to Follow-up|4|||
131956489|NCT02141074|475123925|FG000|Pre-prophylaxis|Adverse Event|3|||
131956490|NCT02141074|475123926|FG001|Pre-prophylaxis|Adverse Event|0|||
131956491|NCT02141074|475123925|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
131956492|NCT02141074|475123926|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
131415472|NCT01177969|473145276|FG000|Overall Study|Protocol Violation|2|||
131956493|NCT02141074|475123925|FG000|Prophylaxis|Adverse Event|0|||
131956494|NCT02141074|475123926|FG001|Prophylaxis|Adverse Event|4|||
131956495|NCT02141074|475123925|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
131956496|NCT02141074|475123926|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
131956497|NCT02141074|475123925|FG000|Prophylaxis|Withdrawal by Subject|0|||
131956498|NCT02141074|475123926|FG001|Prophylaxis|Withdrawal by Subject|1|||
131956499|NCT03210714|475123927|FG000|Overall Study|Adverse Event|6|||
131956500|NCT03210714|475123927|FG000|Overall Study|Physician Decision|1|||
131956501|NCT03210714|475123927|FG000|Overall Study|Progressive disease|11|||
131956502|NCT03210714|475123927|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
131956503|NCT05321069|475123935|FG000|Overall Study|Adverse Event|52|||
131956504|NCT05321069|475123936|FG001|Overall Study|Adverse Event|52|||
131956505|NCT05321069|475123937|FG002|Overall Study|Adverse Event|64|||
131956506|NCT05321069|475123935|FG000|Overall Study|Protocol Violation|1|||
131956507|NCT05321069|475123936|FG001|Overall Study|Protocol Violation|1|||
131956508|NCT05321069|475123937|FG002|Overall Study|Protocol Violation|0|||
131956509|NCT05321069|475123935|FG000|Overall Study|Withdrawal by Subject|23|||
131956510|NCT05321069|475123936|FG001|Overall Study|Withdrawal by Subject|18|||
131956511|NCT05321069|475123937|FG002|Overall Study|Withdrawal by Subject|12|||
131956512|NCT05321069|475123935|FG000|Overall Study|Lost to Follow-up|1|||
131956513|NCT05321069|475123936|FG001|Overall Study|Lost to Follow-up|0|||
131956514|NCT05321069|475123937|FG002|Overall Study|Lost to Follow-up|1|||
131956515|NCT05321069|475123935|FG000|Overall Study|No reason stated by the participants|23|||
131956516|NCT05321069|475123936|FG001|Overall Study|No reason stated by the participants|22|||
131956517|NCT05321069|475123937|FG002|Overall Study|No reason stated by the participants|16|||
131956518|NCT05321069|475123935|FG000|Overall Study|Lack of Efficacy|1|||
131956519|NCT05321069|475123936|FG001|Overall Study|Lack of Efficacy|1|||
131956520|NCT05321069|475123937|FG002|Overall Study|Lack of Efficacy|0|||
131956521|NCT03635424|475123938|FG000|Overall Study|Adverse Event|1|||
131956522|NCT03635424|475123938|FG000|Overall Study|Death|1|||
131956523|NCT03635424|475123938|FG000|Overall Study|Device not implanted|1|||
131956524|NCT05663866|475123939|FG000|Overall Study|Adverse Event|0|||
131956525|NCT05663866|475123940|FG001|Overall Study|Adverse Event|0|||
131956526|NCT05663866|475123941|FG002|Overall Study|Adverse Event|1|||
131956527|NCT05663866|475123942|FG003|Overall Study|Adverse Event|0|||
131956528|NCT05663866|475123939|FG000|Overall Study|Physician Decision|0|||
131956529|NCT05663866|475123940|FG001|Overall Study|Physician Decision|0|||
131956530|NCT05663866|475123941|FG002|Overall Study|Physician Decision|0|||
131956531|NCT05663866|475123942|FG003|Overall Study|Physician Decision|1|||
131956532|NCT05663866|475123939|FG000|Overall Study|Withdrawal by Subject|0|||
131956533|NCT05663866|475123940|FG001|Overall Study|Withdrawal by Subject|2|||
131956534|NCT05663866|475123941|FG002|Overall Study|Withdrawal by Subject|1|||
131956535|NCT05663866|475123942|FG003|Overall Study|Withdrawal by Subject|2|||
131956536|NCT05663866|475123939|FG000|Overall Study|Progressive disease|4|||
131956537|NCT05663866|475123940|FG001|Overall Study|Progressive disease|8|||
131956538|NCT05663866|475123941|FG002|Overall Study|Progressive disease|5|||
131956539|NCT05663866|475123942|FG003|Overall Study|Progressive disease|2|||
131956540|NCT05663866|475123939|FG000|Overall Study|Other|1|||
131956541|NCT05663866|475123940|FG001|Overall Study|Other|0|||
131956542|NCT05663866|475123941|FG002|Overall Study|Other|0|||
131956543|NCT05663866|475123942|FG003|Overall Study|Other|0|||
131415473|NCT01177969|473145277|FG001|Overall Study|Protocol Violation|1|||
131415474|NCT01177969|473145276|FG000|Overall Study|Withdrawal by Subject|1|||
131956544|NCT05663866|475123939|FG000|Overall Study|Ongoing|1|||
131956545|NCT05663866|475123940|FG001|Overall Study|Ongoing|27|||
131956546|NCT05663866|475123941|FG002|Overall Study|Ongoing|6|||
131956547|NCT05663866|475123942|FG003|Overall Study|Ongoing|1|||
131956548|NCT02879643|475123943|FG000|Overall Study|Adverse Event|0|||
131956549|NCT02879643|475123944|FG001|Overall Study|Adverse Event|0|||
131956550|NCT02879643|475123945|FG002|Overall Study|Adverse Event|1|||
131956551|NCT02879643|475123946|FG003|Overall Study|Adverse Event|1|||
131956552|NCT02879643|475123947|FG004|Overall Study|Adverse Event|0|||
131956553|NCT05368558|475123948|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
131956554|NCT05368558|475123949|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
131956555|NCT05368558|475123950|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
131956556|NCT05368558|475123951|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956557|NCT05368558|475123952|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956558|NCT05368558|475123953|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956559|NCT05368558|475123954|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956560|NCT05368558|475123955|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131415475|NCT01177969|473145277|FG001|Overall Study|Withdrawal by Subject|2|||
131956561|NCT05368558|475123956|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956562|NCT05368558|475123957|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956563|NCT05368558|475123958|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956564|NCT05368558|475123959|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131956565|NCT05368558|475123948|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956566|NCT05368558|475123949|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956567|NCT05368558|475123950|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956568|NCT05368558|475123951|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
131956569|NCT05368558|475123952|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956570|NCT05368558|475123953|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
131956571|NCT05368558|475123954|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956572|NCT05368558|475123955|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956573|NCT05368558|475123956|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956574|NCT05368558|475123957|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956575|NCT05368558|475123958|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956576|NCT05368558|475123959|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131956577|NCT05368558|475123948|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956578|NCT05368558|475123949|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956579|NCT05368558|475123950|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956580|NCT05368558|475123951|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
131956581|NCT05368558|475123952|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956582|NCT05368558|475123953|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956583|NCT05368558|475123954|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956584|NCT05368558|475123955|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956585|NCT05368558|475123956|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956586|NCT05368558|475123957|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956587|NCT05368558|475123958|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956588|NCT05368558|475123959|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131956589|NCT05368558|475123948|FG000|Blinded Extension Period (BEP)|other|0|||
131956590|NCT05368558|475123949|FG001|Blinded Extension Period (BEP)|other|0|||
131956591|NCT05368558|475123950|FG002|Blinded Extension Period (BEP)|other|0|||
131956592|NCT05368558|475123951|FG003|Blinded Extension Period (BEP)|other|0|||
131956593|NCT05368558|475123952|FG004|Blinded Extension Period (BEP)|other|0|||
131956594|NCT05368558|475123953|FG005|Blinded Extension Period (BEP)|other|1|||
131956595|NCT05368558|475123954|FG006|Blinded Extension Period (BEP)|other|0|||
131956596|NCT05368558|475123955|FG007|Blinded Extension Period (BEP)|other|0|||
131956597|NCT05368558|475123956|FG008|Blinded Extension Period (BEP)|other|0|||
131956598|NCT05368558|475123957|FG009|Blinded Extension Period (BEP)|other|0|||
131956599|NCT05368558|475123958|FG010|Blinded Extension Period (BEP)|other|0|||
131956600|NCT05368558|475123959|FG011|Blinded Extension Period (BEP)|other|0|||
131956601|NCT04623775|475123960|FG000|Randomization|No Longer Meets Study Criteria|2|||
131956602|NCT04623775|475123961|FG001|Randomization|No Longer Meets Study Criteria|1|||
131956603|NCT04623775|475123962|FG002|Randomization|No Longer Meets Study Criteria|0|||
131956604|NCT04623775|475123963|FG003|Randomization|No Longer Meets Study Criteria|0|||
131956605|NCT04623775|475123960|FG000|Randomization|Withdrew Consent|0|||
131956606|NCT04623775|475123961|FG001|Randomization|Withdrew Consent|0|||
131956607|NCT04623775|475123962|FG002|Randomization|Withdrew Consent|0|||
131956608|NCT04623775|475123963|FG003|Randomization|Withdrew Consent|1|||
131956609|NCT04623775|475123960|FG000|Randomization|Other Reasons|0|||
131956610|NCT04623775|475123961|FG001|Randomization|Other Reasons|0|||
131956611|NCT04623775|475123962|FG002|Randomization|Other Reasons|0|||
131956612|NCT04623775|475123963|FG003|Randomization|Other Reasons|1|||
131956613|NCT04623775|475123960|FG000|Treatment Period|participant withdrew consent|4|||
131956614|NCT04623775|475123961|FG001|Treatment Period|participant withdrew consent|0|||
131956615|NCT04623775|475123962|FG002|Treatment Period|participant withdrew consent|1|||
131956616|NCT04623775|475123963|FG003|Treatment Period|participant withdrew consent|2|||
131956617|NCT04623775|475123960|FG000|Treatment Period|Death|3|||
131956618|NCT04623775|475123961|FG001|Treatment Period|Death|1|||
131956619|NCT04623775|475123962|FG002|Treatment Period|Death|4|||
131956620|NCT04623775|475123963|FG003|Treatment Period|Death|2|||
131956621|NCT04623775|475123960|FG000|Treatment Period|Lost to Follow-up|0|||
131956622|NCT04623775|475123961|FG001|Treatment Period|Lost to Follow-up|2|||
131956623|NCT04623775|475123962|FG002|Treatment Period|Lost to Follow-up|0|||
131956624|NCT04623775|475123963|FG003|Treatment Period|Lost to Follow-up|0|||
131956625|NCT04623775|475123960|FG000|Treatment Period|poor/non compliance|0|||
131956626|NCT04623775|475123961|FG001|Treatment Period|poor/non compliance|0|||
131956627|NCT04623775|475123962|FG002|Treatment Period|poor/non compliance|1|||
131956628|NCT04623775|475123963|FG003|Treatment Period|poor/non compliance|0|||
131956629|NCT04623775|475123960|FG000|Treatment Period|participant no longer meets study criteria|0|||
131956630|NCT04623775|475123961|FG001|Treatment Period|participant no longer meets study criteria|1|||
131956631|NCT04623775|475123962|FG002|Treatment Period|participant no longer meets study criteria|0|||
131956632|NCT04623775|475123963|FG003|Treatment Period|participant no longer meets study criteria|0|||
131956633|NCT04623775|475123960|FG000|Treatment Period|administrative reasons by sponsor|3|||
131956634|NCT04623775|475123961|FG001|Treatment Period|administrative reasons by sponsor|2|||
131956635|NCT04623775|475123962|FG002|Treatment Period|administrative reasons by sponsor|0|||
131956636|NCT04623775|475123963|FG003|Treatment Period|administrative reasons by sponsor|0|||
131956637|NCT04623775|475123960|FG000|Treatment Period|other reasons|2|||
131956638|NCT04623775|475123961|FG001|Treatment Period|other reasons|0|||
131956639|NCT04623775|475123962|FG002|Treatment Period|other reasons|1|||
131956640|NCT04623775|475123963|FG003|Treatment Period|other reasons|1|||
131956641|NCT04623775|475123960|FG000|Treatment Period|disease progression|40|||
131956642|NCT04623775|475123961|FG001|Treatment Period|disease progression|35|||
131956643|NCT04623775|475123962|FG002|Treatment Period|disease progression|63|||
131956644|NCT04623775|475123963|FG003|Treatment Period|disease progression|63|||
131956645|NCT04623775|475123960|FG000|Treatment Period|study drug toxicity|12|||
131956646|NCT04623775|475123961|FG001|Treatment Period|study drug toxicity|15|||
131956647|NCT04623775|475123962|FG002|Treatment Period|study drug toxicity|13|||
131956648|NCT04623775|475123963|FG003|Treatment Period|study drug toxicity|12|||
131956649|NCT04623775|475123960|FG000|Treatment Period|AE unrelated to study drug|4|||
131956650|NCT04623775|475123961|FG001|Treatment Period|AE unrelated to study drug|9|||
131956651|NCT04623775|475123962|FG002|Treatment Period|AE unrelated to study drug|12|||
131956652|NCT04623775|475123963|FG003|Treatment Period|AE unrelated to study drug|9|||
131956653|NCT04623775|475123960|FG000|Treatment Period|participant request to discontinue treatment|0|||
131956654|NCT04623775|475123961|FG001|Treatment Period|participant request to discontinue treatment|2|||
131956655|NCT04623775|475123962|FG002|Treatment Period|participant request to discontinue treatment|2|||
131956656|NCT04623775|475123963|FG003|Treatment Period|participant request to discontinue treatment|0|||
131956657|NCT02112916|475123964|FG000|Overall Study|Adverse Event|6|||
131956658|NCT02112916|475123965|FG001|Overall Study|Adverse Event|9|||
131956659|NCT02112916|475123966|FG002|Overall Study|Adverse Event|3|||
131956660|NCT02112916|475123967|FG003|Overall Study|Adverse Event|2|||
131956661|NCT02112916|475123964|FG000|Overall Study|Death|9|||
131956662|NCT02112916|475123965|FG001|Overall Study|Death|9|||
131956663|NCT02112916|475123966|FG002|Overall Study|Death|3|||
131956664|NCT02112916|475123967|FG003|Overall Study|Death|4|||
131956665|NCT02112916|475123964|FG000|Overall Study|Lost to Follow-up|1|||
131956666|NCT02112916|475123965|FG001|Overall Study|Lost to Follow-up|0|||
131956667|NCT02112916|475123966|FG002|Overall Study|Lost to Follow-up|0|||
131956668|NCT02112916|475123967|FG003|Overall Study|Lost to Follow-up|0|||
131956669|NCT02112916|475123964|FG000|Overall Study|Physician Decision|94|||
131956670|NCT02112916|475123965|FG001|Overall Study|Physician Decision|72|||
131956671|NCT02112916|475123966|FG002|Overall Study|Physician Decision|24|||
131956672|NCT02112916|475123967|FG003|Overall Study|Physician Decision|15|||
131956673|NCT02112916|475123964|FG000|Overall Study|Withdrawal by Subject|5|||
131956674|NCT02112916|475123965|FG001|Overall Study|Withdrawal by Subject|3|||
131956675|NCT02112916|475123966|FG002|Overall Study|Withdrawal by Subject|1|||
131956676|NCT02112916|475123967|FG003|Overall Study|Withdrawal by Subject|1|||
131956677|NCT02112916|475123964|FG000|Overall Study|Ineligible|4|||
131956678|NCT02112916|475123965|FG001|Overall Study|Ineligible|8|||
131956679|NCT02112916|475123966|FG002|Overall Study|Ineligible|3|||
131956680|NCT02112916|475123967|FG003|Overall Study|Ineligible|8|||
131956681|NCT02112916|475123964|FG000|Overall Study|Inevaluable|6|||
131956682|NCT02112916|475123965|FG001|Overall Study|Inevaluable|4|||
131956683|NCT02112916|475123966|FG002|Overall Study|Inevaluable|5|||
131956684|NCT02112916|475123967|FG003|Overall Study|Inevaluable|5|||
131956685|NCT02112916|475123964|FG000|Overall Study|Refusal of further protocol therapy|19|||
131415476|NCT02445573|473145278|FG000|Overall Study|Withdrawal by Subject|1|||
131415477|NCT02445573|473145279|FG001|Overall Study|Withdrawal by Subject|1|||
131415478|NCT02445573|473145278|FG000|Overall Study|Lost to Follow-up|0|||
131415479|NCT02445573|473145279|FG001|Overall Study|Lost to Follow-up|1|||
131415480|NCT02855944|473145280|FG000|Period 1: Treatment|Ongoing|14|||
131415481|NCT02855944|473145281|FG001|Period 1: Treatment|Ongoing|0|||
131415482|NCT02855944|473145280|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
131415483|NCT02855944|473145281|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
131415484|NCT02855944|473145280|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
131457345|NCT01456897|473304589|FG001|Overall Study|Lack of Efficacy|11|||
131457346|NCT01396070|473304596|FG000|Overall Study|Withdrawal by Subject|2|||
131457347|NCT01396070|473304596|FG000|Overall Study|Death|2|||
131956686|NCT02112916|475123965|FG001|Overall Study|Refusal of further protocol therapy|16|||
131415485|NCT02855944|473145281|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
131415486|NCT01639755|473145282|FG000|Overall Study|Study Ongoing|15|||
131415487|NCT01639755|473145282|FG000|Overall Study|Patient had device explantation|4|||
131415488|NCT03242018|473145291|FG000|Overall Study|Adverse Event|7|||
131956687|NCT02112916|475123966|FG002|Overall Study|Refusal of further protocol therapy|1|||
131956688|NCT02112916|475123967|FG003|Overall Study|Refusal of further protocol therapy|7|||
131956689|NCT02112916|475123964|FG000|Overall Study|Development of SMN|1|||
131956690|NCT02112916|475123965|FG001|Overall Study|Development of SMN|0|||
131956691|NCT02112916|475123966|FG002|Overall Study|Development of SMN|0|||
131415489|NCT03242018|473145292|FG001|Overall Study|Adverse Event|7|||
131415490|NCT03242018|473145293|FG002|Overall Study|Adverse Event|6|||
131415491|NCT03242018|473145291|FG000|Overall Study|Lost to Follow-up|2|||
131415492|NCT03242018|473145292|FG001|Overall Study|Lost to Follow-up|2|||
131956692|NCT02112916|475123967|FG003|Overall Study|Development of SMN|1|||
131956693|NCT02112916|475123964|FG000|Overall Study|Relapse/Progression|10|||
131956694|NCT02112916|475123965|FG001|Overall Study|Relapse/Progression|18|||
131956695|NCT02112916|475123966|FG002|Overall Study|Relapse/Progression|15|||
131457348|NCT01396070|473304596|FG000|Overall Study|Adverse Event|8|||
131956696|NCT02112916|475123967|FG003|Overall Study|Relapse/Progression|2|||
131956697|NCT02112916|475123964|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
131956698|NCT02112916|475123965|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
131956699|NCT02112916|475123966|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
131956700|NCT02112916|475123967|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
131956701|NCT02112916|475123964|FG000|Overall Study|Still on Therapy|44|||
131956702|NCT02112916|475123965|FG001|Overall Study|Still on Therapy|47|||
131956703|NCT02112916|475123966|FG002|Overall Study|Still on Therapy|3|||
131956704|NCT02112916|475123967|FG003|Overall Study|Still on Therapy|2|||
131956705|NCT02112916|475123964|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
131956706|NCT02112916|475123965|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
131956707|NCT02112916|475123966|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
131956708|NCT02112916|475123967|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
131956709|NCT02112916|475123964|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
131956710|NCT02112916|475123965|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
131956711|NCT02112916|475123966|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
131956712|NCT02112916|475123967|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
131956713|NCT04194944|475123968|FG000|Overall Study|Lost to Follow-up|3|||
131956714|NCT04194944|475123969|FG001|Overall Study|Lost to Follow-up|0|||
131956715|NCT04194944|475123968|FG000|Overall Study|Withdrawal by Subject|2|||
131956716|NCT04194944|475123969|FG001|Overall Study|Withdrawal by Subject|2|||
131956717|NCT04194944|475123968|FG000|Overall Study|On Treatment|93|||
131956718|NCT04194944|475123969|FG001|Overall Study|On Treatment|30|||
131956719|NCT01592370|475123970|FG000|Overall Study|Disease Progression|62|||
131956720|NCT01592370|475123971|FG001|Overall Study|Disease Progression|16|||
131956721|NCT01592370|475123972|FG002|Overall Study|Disease Progression|52|||
131956722|NCT01592370|475123973|FG003|Overall Study|Disease Progression|3|||
131956723|NCT01592370|475123974|FG004|Overall Study|Disease Progression|3|||
131956724|NCT01592370|475123975|FG005|Overall Study|Disease Progression|31|||
131956725|NCT01592370|475123976|FG006|Overall Study|Disease Progression|14|||
131956726|NCT01592370|475123970|FG000|Overall Study|Study Drug Toxicity|14|||
131956727|NCT01592370|475123971|FG001|Overall Study|Study Drug Toxicity|3|||
131956728|NCT01592370|475123972|FG002|Overall Study|Study Drug Toxicity|0|||
131956729|NCT01592370|475123973|FG003|Overall Study|Study Drug Toxicity|0|||
131956730|NCT01592370|475123974|FG004|Overall Study|Study Drug Toxicity|0|||
131956731|NCT01592370|475123975|FG005|Overall Study|Study Drug Toxicity|0|||
131956732|NCT01592370|475123976|FG006|Overall Study|Study Drug Toxicity|1|||
131956733|NCT01592370|475123970|FG000|Overall Study|AE unrelated to study drug|4|||
131956734|NCT01592370|475123971|FG001|Overall Study|AE unrelated to study drug|3|||
131956735|NCT01592370|475123972|FG002|Overall Study|AE unrelated to study drug|0|||
131956736|NCT01592370|475123973|FG003|Overall Study|AE unrelated to study drug|0|||
131956737|NCT01592370|475123974|FG004|Overall Study|AE unrelated to study drug|0|||
131956738|NCT01592370|475123975|FG005|Overall Study|AE unrelated to study drug|0|||
131956739|NCT01592370|475123976|FG006|Overall Study|AE unrelated to study drug|1|||
131956740|NCT01592370|475123970|FG000|Overall Study|Request to discontinue study treatment|5|||
131956741|NCT01592370|475123971|FG001|Overall Study|Request to discontinue study treatment|0|||
131956742|NCT01592370|475123972|FG002|Overall Study|Request to discontinue study treatment|2|||
131956743|NCT01592370|475123973|FG003|Overall Study|Request to discontinue study treatment|0|||
131956744|NCT01592370|475123974|FG004|Overall Study|Request to discontinue study treatment|1|||
131956745|NCT01592370|475123975|FG005|Overall Study|Request to discontinue study treatment|2|||
131956746|NCT01592370|475123976|FG006|Overall Study|Request to discontinue study treatment|0|||
131956747|NCT01592370|475123970|FG000|Overall Study|Withdrew consent|1|||
131956748|NCT01592370|475123971|FG001|Overall Study|Withdrew consent|2|||
131956749|NCT01592370|475123972|FG002|Overall Study|Withdrew consent|1|||
131956750|NCT01592370|475123973|FG003|Overall Study|Withdrew consent|1|||
131956751|NCT01592370|475123974|FG004|Overall Study|Withdrew consent|0|||
131956752|NCT01592370|475123975|FG005|Overall Study|Withdrew consent|0|||
131956753|NCT01592370|475123976|FG006|Overall Study|Withdrew consent|0|||
131956754|NCT01592370|475123970|FG000|Overall Study|Maximum clinical benefit|11|||
131956755|NCT01592370|475123971|FG001|Overall Study|Maximum clinical benefit|1|||
131956756|NCT01592370|475123972|FG002|Overall Study|Maximum clinical benefit|7|||
131956757|NCT01592370|475123973|FG003|Overall Study|Maximum clinical benefit|1|||
131956758|NCT01592370|475123974|FG004|Overall Study|Maximum clinical benefit|0|||
131956759|NCT01592370|475123975|FG005|Overall Study|Maximum clinical benefit|0|||
131956760|NCT01592370|475123976|FG006|Overall Study|Maximum clinical benefit|0|||
131956761|NCT01592370|475123970|FG000|Overall Study|No longer meets study criteria|1|||
131956762|NCT01592370|475123971|FG001|Overall Study|No longer meets study criteria|0|||
131956763|NCT01592370|475123972|FG002|Overall Study|No longer meets study criteria|0|||
131956764|NCT01592370|475123973|FG003|Overall Study|No longer meets study criteria|0|||
131956765|NCT01592370|475123974|FG004|Overall Study|No longer meets study criteria|0|||
131956766|NCT01592370|475123975|FG005|Overall Study|No longer meets study criteria|0|||
131956767|NCT01592370|475123976|FG006|Overall Study|No longer meets study criteria|0|||
131956768|NCT01592370|475123970|FG000|Overall Study|Other Reasons|6|||
131457349|NCT01396070|473304596|FG000|Overall Study|Physician Decision|3|||
131457350|NCT01396070|473304596|FG000|Overall Study|Lack of Efficacy|4|||
131457351|NCT04254913|473304597|FG000|Overall Study|Adverse Event|1|||
131457352|NCT01396057|473304598|FG000|Overall Study|Adverse Event|2|||
131457353|NCT01396057|473304599|FG001|Overall Study|Adverse Event|6|||
131457354|NCT01396057|473304598|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131457355|NCT01396057|473304599|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131457356|NCT01396057|473304598|FG000|Overall Study|Protocol deviation|4|||
131457357|NCT01396057|473304599|FG001|Overall Study|Protocol deviation|4|||
131457358|NCT01396057|473304598|FG000|Overall Study|Consent withdrawn|3|||
131457359|NCT01396057|473304599|FG001|Overall Study|Consent withdrawn|2|||
131457360|NCT02695420|473304600|FG000|Overall Study|Death|0|||
131457361|NCT02695420|473304601|FG001|Overall Study|Death|1|||
131457362|NCT02695420|473304602|FG002|Overall Study|Death|0|||
131457363|NCT02695420|473304603|FG003|Overall Study|Death|0|||
131457364|NCT00916929|473304604|FG000|Overall Study|Lost to Follow-up|1|||
131457365|NCT00916929|473304605|FG001|Overall Study|Lost to Follow-up|3|||
131457366|NCT00916929|473304604|FG000|Overall Study|Death|5|||
131457367|NCT00916929|473304605|FG001|Overall Study|Death|10|||
131457368|NCT00916929|473304604|FG000|Overall Study|Withdrawal by Subject|1|||
131457369|NCT00916929|473304605|FG001|Overall Study|Withdrawal by Subject|5|||
131457370|NCT00916929|473304604|FG000|Overall Study|Left ventricular epicardial lead|1|||
131457371|NCT00916929|473304605|FG001|Overall Study|Left ventricular epicardial lead|2|||
131457372|NCT00916929|473304604|FG000|Overall Study|Transferred to hospice care|1|||
131457373|NCT00916929|473304605|FG001|Overall Study|Transferred to hospice care|1|||
131457374|NCT00916929|473304604|FG000|Overall Study|System explant|1|||
131457375|NCT00916929|473304605|FG001|Overall Study|System explant|0|||
131457376|NCT00916929|473304604|FG000|Overall Study|Moved to another state|0|||
131457377|NCT00916929|473304605|FG001|Overall Study|Moved to another state|1|||
131457378|NCT00916929|473304604|FG000|Overall Study|Device unable to process impedance data|0|||
131457379|NCT00916929|473304605|FG001|Overall Study|Device unable to process impedance data|7|||
131457380|NCT01742286|473304607|FG000|Escalation Phase|Administrative problems|1|||
131457381|NCT01742286|473304608|FG001|Escalation Phase|Administrative problems|1|||
131457382|NCT01742286|473304609|FG002|Escalation Phase|Administrative problems|0|||
131457383|NCT01742286|473304610|FG003|Escalation Phase|Administrative problems|0|||
131457384|NCT01742286|473304611|FG004|Escalation Phase|Administrative problems|0|||
131457385|NCT01742286|473304612|FG005|Escalation Phase|Administrative problems|0|||
131457386|NCT01742286|473304613|FG006|Escalation Phase|Administrative problems|2|||
131457387|NCT01742286|473304607|FG000|Escalation Phase|Adverse Event|0|||
131457388|NCT01742286|473304608|FG001|Escalation Phase|Adverse Event|1|||
131457389|NCT01742286|473304609|FG002|Escalation Phase|Adverse Event|2|||
131457390|NCT01742286|473304610|FG003|Escalation Phase|Adverse Event|0|||
131457391|NCT01742286|473304611|FG004|Escalation Phase|Adverse Event|0|||
131457392|NCT01742286|473304612|FG005|Escalation Phase|Adverse Event|1|||
131457393|NCT01742286|473304613|FG006|Escalation Phase|Adverse Event|0|||
131457394|NCT01742286|473304607|FG000|Escalation Phase|Disease progression|3|||
131457395|NCT01742286|473304608|FG001|Escalation Phase|Disease progression|7|||
131457396|NCT01742286|473304609|FG002|Escalation Phase|Disease progression|4|||
131457397|NCT01742286|473304610|FG003|Escalation Phase|Disease progression|1|||
131457398|NCT01742286|473304611|FG004|Escalation Phase|Disease progression|4|||
131956769|NCT01592370|475123971|FG001|Overall Study|Other Reasons|0|||
131956770|NCT01592370|475123972|FG002|Overall Study|Other Reasons|10|||
131956771|NCT01592370|475123973|FG003|Overall Study|Other Reasons|0|||
131956772|NCT01592370|475123974|FG004|Overall Study|Other Reasons|0|||
131956773|NCT01592370|475123975|FG005|Overall Study|Other Reasons|1|||
131956774|NCT01592370|475123976|FG006|Overall Study|Other Reasons|0|||
131956775|NCT01592370|475123970|FG000|Overall Study|Not Treated|0|||
131956776|NCT01592370|475123971|FG001|Overall Study|Not Treated|0|||
131956777|NCT01592370|475123972|FG002|Overall Study|Not Treated|0|||
131956778|NCT01592370|475123973|FG003|Overall Study|Not Treated|0|||
131956779|NCT01592370|475123974|FG004|Overall Study|Not Treated|2|||
131956780|NCT01592370|475123975|FG005|Overall Study|Not Treated|2|||
131956781|NCT01592370|475123976|FG006|Overall Study|Not Treated|0|||
131956782|NCT05081219|475123977|FG000|Overall Study|Withdrawal by Subject|4|||
131956783|NCT05081219|475123978|FG001|Overall Study|Withdrawal by Subject|0|||
131956784|NCT05081219|475123979|FG002|Overall Study|Withdrawal by Subject|0|||
131956785|NCT05081219|475123980|FG003|Overall Study|Withdrawal by Subject|1|||
131457399|NCT01742286|473304612|FG005|Escalation Phase|Disease progression|3|||
131457400|NCT01742286|473304613|FG006|Escalation Phase|Disease progression|2|||
131457401|NCT01742286|473304607|FG000|Escalation Phase|Death|0|||
131457402|NCT01742286|473304608|FG001|Escalation Phase|Death|0|||
131457403|NCT01742286|473304609|FG002|Escalation Phase|Death|0|||
131457404|NCT01742286|473304610|FG003|Escalation Phase|Death|0|||
131457405|NCT01742286|473304611|FG004|Escalation Phase|Death|0|||
131457406|NCT01742286|473304612|FG005|Escalation Phase|Death|1|||
131457407|NCT01742286|473304613|FG006|Escalation Phase|Death|0|||
131457408|NCT01742286|473304607|FG000|Escalation Phase|Physician Decision|0|||
131457409|NCT01742286|473304608|FG001|Escalation Phase|Physician Decision|3|||
131956786|NCT05239039|475123981|FG000|Overall Study|Withdrawal by Subject|0|||
131457410|NCT01742286|473304609|FG002|Escalation Phase|Physician Decision|0|||
131457411|NCT01742286|473304610|FG003|Escalation Phase|Physician Decision|1|||
131457412|NCT01742286|473304611|FG004|Escalation Phase|Physician Decision|0|||
131457413|NCT01742286|473304612|FG005|Escalation Phase|Physician Decision|0|||
131457414|NCT01742286|473304613|FG006|Escalation Phase|Physician Decision|2|||
131457415|NCT01742286|473304607|FG000|Escalation Phase|Subject/guardian decision|1|||
131956787|NCT05239039|475123982|FG001|Overall Study|Withdrawal by Subject|1|||
131956788|NCT04116853|475123983|FG000|Overall Study|Adverse Event|1|||
131956789|NCT04116853|475123984|FG001|Overall Study|Adverse Event|3|||
131956790|NCT04116853|475123983|FG000|Overall Study|Lost to Follow-up|2|||
131956791|NCT04116853|475123984|FG001|Overall Study|Lost to Follow-up|0|||
131956792|NCT04116853|475123983|FG000|Overall Study|Incarceration|0|||
131956793|NCT04116853|475123984|FG001|Overall Study|Incarceration|1|||
131956794|NCT04116853|475123983|FG000|Overall Study|Pregnancy|1|||
131956795|NCT04116853|475123984|FG001|Overall Study|Pregnancy|1|||
131956796|NCT04116853|475123983|FG000|Overall Study|Began Other Weight Loss program|4|||
131956797|NCT04116853|475123984|FG001|Overall Study|Began Other Weight Loss program|8|||
131956798|NCT04116853|475123983|FG000|Overall Study|Began Anti-Obesity Medication|3|||
131956799|NCT04116853|475123984|FG001|Overall Study|Began Anti-Obesity Medication|3|||
131956800|NCT04116853|475123983|FG000|Overall Study|Protocol Violation|0|||
131956801|NCT04116853|475123984|FG001|Overall Study|Protocol Violation|1|||
131956802|NCT02701283|475123985|FG000|Overall Study|Death|25|||
131956803|NCT02701283|475123986|FG001|Overall Study|Death|29|||
131956804|NCT02701283|475123987|FG002|Overall Study|Death|19|||
131956805|NCT02701283|475123985|FG000|Overall Study|Lost to Follow-up|3|||
131956806|NCT02701283|475123986|FG001|Overall Study|Lost to Follow-up|8|||
131956807|NCT02701283|475123987|FG002|Overall Study|Lost to Follow-up|1|||
131956808|NCT02701283|475123985|FG000|Overall Study|Withdrawal by Subject|12|||
131956809|NCT02701283|475123986|FG001|Overall Study|Withdrawal by Subject|41|||
131956810|NCT02701283|475123987|FG002|Overall Study|Withdrawal by Subject|1|||
131956811|NCT02701283|475123985|FG000|Overall Study|Missed 2-year visit|22|||
131956812|NCT02701283|475123986|FG001|Overall Study|Missed 2-year visit|27|||
131956813|NCT02701283|475123987|FG002|Overall Study|Missed 2-year visit|0|||
131956814|NCT02701283|475123985|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
131956815|NCT02701283|475123986|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
131956816|NCT02701283|475123987|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
131956817|NCT04272801|475123988|FG000|Overall Study|Withdrawal by Subject|4|||
131956818|NCT04272801|475123988|FG000|Overall Study|Lost to Follow-up|4|||
131956819|NCT04272801|475123988|FG000|Overall Study|Ineligible|1|||
131956820|NCT05214768|475123989|FG000|Induction Period|Withdrawal by Subject|1|||
131956821|NCT05214768|475123990|FG001|Induction Period|Withdrawal by Subject|0|||
131956822|NCT05214768|475123991|FG002|Induction Period|Withdrawal by Subject|0|||
131956823|NCT05214768|475123992|FG003|Induction Period|Withdrawal by Subject|0|||
131956824|NCT05214768|475123993|FG004|Induction Period|Withdrawal by Subject|0|||
131956825|NCT05214768|475123994|FG005|Induction Period|Withdrawal by Subject|0|||
131956826|NCT05214768|475123989|FG000|Induction Period|Physician Decision|1|||
131956827|NCT05214768|475123990|FG001|Induction Period|Physician Decision|0|||
131956828|NCT05214768|475123991|FG002|Induction Period|Physician Decision|0|||
131956829|NCT05214768|475123992|FG003|Induction Period|Physician Decision|0|||
131956830|NCT05214768|475123993|FG004|Induction Period|Physician Decision|0|||
131956831|NCT05214768|475123994|FG005|Induction Period|Physician Decision|0|||
131415493|NCT03242018|473145293|FG002|Overall Study|Lost to Follow-up|2|||
131415494|NCT03242018|473145291|FG000|Overall Study|At the Participant's Own Request|5|||
131415495|NCT03242018|473145292|FG001|Overall Study|At the Participant's Own Request|1|||
131415496|NCT03242018|473145293|FG002|Overall Study|At the Participant's Own Request|4|||
131415497|NCT03242018|473145291|FG000|Overall Study|Reason Not Specified|3|||
131415498|NCT03242018|473145292|FG001|Overall Study|Reason Not Specified|4|||
131415499|NCT03242018|473145293|FG002|Overall Study|Reason Not Specified|1|||
131415500|NCT03242018|473145291|FG000|Overall Study|Study Terminated by Sponsor|1|||
131415501|NCT03242018|473145292|FG001|Overall Study|Study Terminated by Sponsor|0|||
131457416|NCT01742286|473304608|FG001|Escalation Phase|Subject/guardian decision|0|||
131457417|NCT01742286|473304609|FG002|Escalation Phase|Subject/guardian decision|0|||
131457418|NCT01742286|473304610|FG003|Escalation Phase|Subject/guardian decision|0|||
131956832|NCT05214768|475123989|FG000|Maintenance Period|Other Reasons|0|||
131956833|NCT05214768|475123990|FG001|Maintenance Period|Other Reasons|0|||
131956834|NCT05214768|475123991|FG002|Maintenance Period|Other Reasons|1|||
131956835|NCT05214768|475123992|FG003|Maintenance Period|Other Reasons|1|||
131956836|NCT05214768|475123993|FG004|Maintenance Period|Other Reasons|0|||
131956837|NCT05214768|475123994|FG005|Maintenance Period|Other Reasons|0|||
131956838|NCT05214768|475123989|FG000|Maintenance Period|Withdrawal by Subject|0|||
131956839|NCT05214768|475123990|FG001|Maintenance Period|Withdrawal by Subject|0|||
131956840|NCT05214768|475123991|FG002|Maintenance Period|Withdrawal by Subject|0|||
131956841|NCT05214768|475123992|FG003|Maintenance Period|Withdrawal by Subject|1|||
131956842|NCT05214768|475123993|FG004|Maintenance Period|Withdrawal by Subject|0|||
131956843|NCT05214768|475123994|FG005|Maintenance Period|Withdrawal by Subject|0|||
131956844|NCT05214768|475123989|FG000|Maintenance Period|Lack of Efficacy|0|||
131956845|NCT05214768|475123990|FG001|Maintenance Period|Lack of Efficacy|0|||
131956846|NCT05214768|475123991|FG002|Maintenance Period|Lack of Efficacy|1|||
131956847|NCT05214768|475123992|FG003|Maintenance Period|Lack of Efficacy|0|||
131956848|NCT05214768|475123993|FG004|Maintenance Period|Lack of Efficacy|1|||
131956849|NCT05214768|475123994|FG005|Maintenance Period|Lack of Efficacy|0|||
131956850|NCT05214768|475123989|FG000|Open Label Extension Period|Physician Decision|0|||
131956851|NCT05214768|475123990|FG001|Open Label Extension Period|Physician Decision|0|||
131956852|NCT05214768|475123991|FG002|Open Label Extension Period|Physician Decision|0|||
131956853|NCT05214768|475123992|FG003|Open Label Extension Period|Physician Decision|0|||
131956854|NCT05214768|475123993|FG004|Open Label Extension Period|Physician Decision|0|||
131956855|NCT05214768|475123994|FG005|Open Label Extension Period|Physician Decision|1|||
131956856|NCT05214768|475123989|FG000|Open Label Extension Period|Lack of Efficacy|0|||
131956857|NCT05214768|475123990|FG001|Open Label Extension Period|Lack of Efficacy|0|||
131956858|NCT05214768|475123991|FG002|Open Label Extension Period|Lack of Efficacy|0|||
131956859|NCT05214768|475123992|FG003|Open Label Extension Period|Lack of Efficacy|0|||
131956860|NCT05214768|475123993|FG004|Open Label Extension Period|Lack of Efficacy|0|||
131956861|NCT05214768|475123994|FG005|Open Label Extension Period|Lack of Efficacy|1|||
131956862|NCT05214768|475123989|FG000|Open Label Extension Period|Ongoing Study|0|||
131956863|NCT05214768|475123990|FG001|Open Label Extension Period|Ongoing Study|0|||
131956864|NCT05214768|475123991|FG002|Open Label Extension Period|Ongoing Study|0|||
131956865|NCT05214768|475123992|FG003|Open Label Extension Period|Ongoing Study|0|||
131956866|NCT05214768|475123993|FG004|Open Label Extension Period|Ongoing Study|0|||
131956867|NCT05214768|475123994|FG005|Open Label Extension Period|Ongoing Study|42|||
131956868|NCT03365947|475123995|FG000|Overall Study|Lost to Follow-up|0|||
131956869|NCT03365947|475123996|FG001|Overall Study|Lost to Follow-up|0|||
131956870|NCT03365947|475123997|FG002|Overall Study|Lost to Follow-up|0|||
131956871|NCT03365947|475123998|FG003|Overall Study|Lost to Follow-up|0|||
131956872|NCT03365947|475123999|FG004|Overall Study|Lost to Follow-up|0|||
131956873|NCT03365947|475124000|FG005|Overall Study|Lost to Follow-up|1|||
131956874|NCT03365947|475124001|FG006|Overall Study|Lost to Follow-up|0|||
131956875|NCT03365947|475124002|FG007|Overall Study|Lost to Follow-up|0|||
131956876|NCT03365947|475124003|FG008|Overall Study|Lost to Follow-up|0|||
131956877|NCT03365947|475124004|FG009|Overall Study|Lost to Follow-up|0|||
131956878|NCT03365947|475124005|FG010|Overall Study|Lost to Follow-up|0|||
131956879|NCT03365947|475124006|FG011|Overall Study|Lost to Follow-up|0|||
131956880|NCT03365947|475124007|FG012|Overall Study|Lost to Follow-up|0|||
131956881|NCT03365947|475124008|FG013|Overall Study|Lost to Follow-up|0|||
131956882|NCT03365947|475124009|FG014|Overall Study|Lost to Follow-up|0|||
131956883|NCT03365947|475124010|FG015|Overall Study|Lost to Follow-up|0|||
131956884|NCT03365947|475124011|FG016|Overall Study|Lost to Follow-up|0|||
131956885|NCT03365947|475124012|FG017|Overall Study|Lost to Follow-up|0|||
131956886|NCT03365947|475124013|FG018|Overall Study|Lost to Follow-up|0|||
131956887|NCT04266795|475124014|FG000|Overall Study|Adverse Event|10|||
131956888|NCT04266795|475124015|FG001|Overall Study|Adverse Event|19|||
131956889|NCT04266795|475124014|FG000|Overall Study|Death|7|||
131956890|NCT04266795|475124015|FG001|Overall Study|Death|8|||
131956891|NCT04266795|475124014|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
131956892|NCT04266795|475124015|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
131956893|NCT04266795|475124014|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131956894|NCT04266795|475124015|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131956895|NCT04266795|475124014|FG000|Overall Study|Progressive Disease|12|||
131956896|NCT04266795|475124015|FG001|Overall Study|Progressive Disease|9|||
131956897|NCT04266795|475124014|FG000|Overall Study|Withdrawal by Patient|5|||
131956898|NCT04266795|475124015|FG001|Overall Study|Withdrawal by Patient|6|||
131956899|NCT04266795|475124014|FG000|Overall Study|Disease Relapse|3|||
131956900|NCT04266795|475124015|FG001|Overall Study|Disease Relapse|6|||
131956901|NCT04266795|475124014|FG000|Overall Study|Reason not Specified|12|||
131956902|NCT04266795|475124015|FG001|Overall Study|Reason not Specified|10|||
131956903|NCT04266795|475124014|FG000|Overall Study|Participants Ongoing on Treatment|25|||
131956904|NCT04266795|475124015|FG001|Overall Study|Participants Ongoing on Treatment|23|||
131956905|NCT03043872|475124016|FG000|Overall Study|Withdrawal by Subject|6|||
131956906|NCT03043872|475124017|FG001|Overall Study|Withdrawal by Subject|6|||
131956907|NCT03043872|475124018|FG002|Overall Study|Withdrawal by Subject|15|||
131415502|NCT03242018|473145293|FG002|Overall Study|Study Terminated by Sponsor|1|||
131415503|NCT03629912|473145294|FG000|Overall Study|Lost to Follow-up|19|||
131956908|NCT03043872|475124016|FG000|Overall Study|Lost to Follow-up|2|||
131956909|NCT03043872|475124017|FG001|Overall Study|Lost to Follow-up|1|||
131956910|NCT03043872|475124018|FG002|Overall Study|Lost to Follow-up|1|||
131956911|NCT03043872|475124016|FG000|Overall Study|Death|270|||
131956912|NCT03043872|475124017|FG001|Overall Study|Death|269|||
131956913|NCT03043872|475124018|FG002|Overall Study|Death|296|||
131956914|NCT03421808|475124732|FG000|Overall Study|COVID related problems|2|||
131956915|NCT03421808|475124733|FG001|Overall Study|COVID related problems|0|||
131956916|NCT03421808|475124732|FG000|Overall Study|Withdrawal by Subject|1|||
131956917|NCT03421808|475124733|FG001|Overall Study|Withdrawal by Subject|0|||
131956918|NCT03421808|475124732|FG000|Overall Study|Protocol Violation|0|||
131956919|NCT03421808|475124733|FG001|Overall Study|Protocol Violation|1|||
131956920|NCT05109234|475124734|FG000|Overall Study|Adverse Event|2|||
131956921|NCT05109234|475124735|FG001|Overall Study|Adverse Event|2|||
131956922|NCT05109234|475124734|FG000|Overall Study|Lack of Efficacy|5|||
131956923|NCT05109234|475124735|FG001|Overall Study|Lack of Efficacy|0|||
131956924|NCT05109234|475124734|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
131956925|NCT05109234|475124735|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
131956926|NCT05109234|475124734|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
131956927|NCT05109234|475124735|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
131956928|NCT05109234|475124734|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
131956929|NCT05109234|475124735|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
131956930|NCT05109234|475124734|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
131956931|NCT05109234|475124735|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
131956932|NCT03570892|475124737|FG000|Overall Study|Death|51|||
131956933|NCT03570892|475124738|FG001|Overall Study|Death|45|||
131956934|NCT03570892|475124737|FG000|Overall Study|Subject decision|5|||
131956935|NCT03570892|475124738|FG001|Overall Study|Subject decision|3|||
131956936|NCT03570892|475124737|FG000|Overall Study|Protocol Violation|1|||
131956937|NCT03570892|475124738|FG001|Overall Study|Protocol Violation|4|||
131956938|NCT03570892|475124737|FG000|Overall Study|Physician Decision|0|||
131956939|NCT03570892|475124738|FG001|Overall Study|Physician Decision|2|||
131956940|NCT04266912|475124739|FG000|Overall Study|Withdrawal by Subject|1|||
131956941|NCT04266912|475124740|FG001|Overall Study|Withdrawal by Subject|0|||
131956942|NCT04266912|475124741|FG002|Overall Study|Withdrawal by Subject|0|||
131956943|NCT04266912|475124742|FG003|Overall Study|Withdrawal by Subject|0|||
131956944|NCT04266912|475124739|FG000|Overall Study|Progression|6|||
131956945|NCT04266912|475124740|FG001|Overall Study|Progression|6|||
131956946|NCT04266912|475124741|FG002|Overall Study|Progression|0|||
131956947|NCT04266912|475124742|FG003|Overall Study|Progression|10|||
131956948|NCT04153149|475124743|FG000|Double Blind Period|Death|63|||
131956949|NCT04153149|475124744|FG001|Double Blind Period|Death|49|||
131956950|NCT04153149|475124745|FG002|Double Blind Period|Death|0|||
131956951|NCT04153149|475124746|FG003|Double Blind Period|Death|0|||
131956952|NCT04153149|475124743|FG000|Double Blind Period|Withdrawal by Subject|16|||
131956953|NCT04153149|475124744|FG001|Double Blind Period|Withdrawal by Subject|11|||
131956954|NCT04153149|475124745|FG002|Double Blind Period|Withdrawal by Subject|0|||
131956955|NCT04153149|475124746|FG003|Double Blind Period|Withdrawal by Subject|0|||
131956956|NCT04153149|475124743|FG000|Double Blind Period|Adverse Event|6|||
131956957|NCT04153149|475124744|FG001|Double Blind Period|Adverse Event|2|||
131956958|NCT04153149|475124745|FG002|Double Blind Period|Adverse Event|0|||
131956959|NCT04153149|475124746|FG003|Double Blind Period|Adverse Event|0|||
131956960|NCT04153149|475124743|FG000|Double Blind Period|Lost to Follow-up|2|||
131956961|NCT04153149|475124744|FG001|Double Blind Period|Lost to Follow-up|1|||
131956962|NCT04153149|475124745|FG002|Double Blind Period|Lost to Follow-up|0|||
131956963|NCT04153149|475124746|FG003|Double Blind Period|Lost to Follow-up|0|||
131956964|NCT04153149|475124743|FG000|Double Blind Period|Withdrawal by guardian|0|||
131956965|NCT04153149|475124744|FG001|Double Blind Period|Withdrawal by guardian|2|||
131956966|NCT04153149|475124745|FG002|Double Blind Period|Withdrawal by guardian|0|||
131956967|NCT04153149|475124746|FG003|Double Blind Period|Withdrawal by guardian|0|||
131956968|NCT04153149|475124743|FG000|Double Blind Period|Reason Not Specified|5|||
131956969|NCT04153149|475124744|FG001|Double Blind Period|Reason Not Specified|4|||
131956970|NCT04153149|475124745|FG002|Double Blind Period|Reason Not Specified|0|||
131956971|NCT04153149|475124746|FG003|Double Blind Period|Reason Not Specified|0|||
131956972|NCT04153149|475124743|FG000|Double Blind Period|Physician Decision|2|||
131956973|NCT04153149|475124744|FG001|Double Blind Period|Physician Decision|0|||
131956974|NCT04153149|475124745|FG002|Double Blind Period|Physician Decision|0|||
131415504|NCT03629912|473145295|FG001|Overall Study|Lost to Follow-up|7|||
131415505|NCT03629912|473145296|FG002|Overall Study|Lost to Follow-up|5|||
131415506|NCT03629912|473145297|FG003|Overall Study|Lost to Follow-up|1|||
131415507|NCT03629912|473145294|FG000|Overall Study|Withdrawal by Subject|6|||
131415508|NCT03629912|473145295|FG001|Overall Study|Withdrawal by Subject|0|||
131415509|NCT03629912|473145296|FG002|Overall Study|Withdrawal by Subject|1|||
131956975|NCT04153149|475124746|FG003|Double Blind Period|Physician Decision|0|||
131956976|NCT04153149|475124743|FG000|Open Label Extension Period|Death|0|||
131956977|NCT04153149|475124744|FG001|Open Label Extension Period|Death|0|||
131956978|NCT04153149|475124745|FG002|Open Label Extension Period|Death|7|||
131956979|NCT04153149|475124746|FG003|Open Label Extension Period|Death|3|||
131956980|NCT04153149|475124743|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
131956981|NCT04153149|475124744|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
131956982|NCT04153149|475124745|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
131956983|NCT04153149|475124746|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
131956984|NCT04153149|475124743|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
131956985|NCT04153149|475124744|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
131956986|NCT04153149|475124745|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
131415510|NCT03629912|473145297|FG003|Overall Study|Withdrawal by Subject|2|||
131415511|NCT03629912|473145294|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
131415512|NCT03629912|473145295|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
131415513|NCT03629912|473145296|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
131415514|NCT03629912|473145297|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
131415515|NCT03629912|473145294|FG000|Overall Study|Death|1|||
131415516|NCT03629912|473145295|FG001|Overall Study|Death|0|||
131415517|NCT03629912|473145296|FG002|Overall Study|Death|0|||
131415518|NCT03629912|473145297|FG003|Overall Study|Death|0|||
131415519|NCT01475162|473145299|FG000|Overall Study|Physician Decision|1|||
131415520|NCT01475162|473145299|FG000|Overall Study|Death|10|||
131415521|NCT01475162|473145299|FG000|Overall Study|Study closed for safety|3|||
131415522|NCT00490022|473145300|FG000|Overall Study|Adverse Event|0|||
131415523|NCT00490022|473145301|FG001|Overall Study|Adverse Event|2|||
131415524|NCT00490022|473145300|FG000|Overall Study|Withdrawal by Subject|1|||
131415525|NCT00490022|473145301|FG001|Overall Study|Withdrawal by Subject|0|||
131415526|NCT00490022|473145300|FG000|Overall Study|Subject failed to disclose concommitant|0|||
131457419|NCT01742286|473304611|FG004|Escalation Phase|Subject/guardian decision|0|||
131457420|NCT01742286|473304612|FG005|Escalation Phase|Subject/guardian decision|0|||
131956987|NCT04153149|475124746|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
131956988|NCT04153149|475124743|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
131956989|NCT04153149|475124744|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
131956990|NCT04153149|475124745|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
131457421|NCT01742286|473304613|FG006|Escalation Phase|Subject/guardian decision|0|||
131457422|NCT01742286|473304607|FG000|Expansion Phase|Administrative problems|0|||
131457423|NCT01742286|473304608|FG001|Expansion Phase|Administrative problems|0|||
131457424|NCT01742286|473304609|FG002|Expansion Phase|Administrative problems|0|||
131457425|NCT01742286|473304610|FG003|Expansion Phase|Administrative problems|0|||
131457426|NCT01742286|473304611|FG004|Expansion Phase|Administrative problems|0|||
131457427|NCT01742286|473304612|FG005|Expansion Phase|Administrative problems|0|||
131457428|NCT01742286|473304613|FG006|Expansion Phase|Administrative problems|5|||
131457429|NCT01742286|473304607|FG000|Expansion Phase|Physician Decision|0|||
131457430|NCT01742286|473304608|FG001|Expansion Phase|Physician Decision|0|||
131457431|NCT01742286|473304609|FG002|Expansion Phase|Physician Decision|4|||
131457432|NCT01742286|473304610|FG003|Expansion Phase|Physician Decision|0|||
131457433|NCT01742286|473304611|FG004|Expansion Phase|Physician Decision|0|||
131457434|NCT01742286|473304612|FG005|Expansion Phase|Physician Decision|0|||
131457435|NCT01742286|473304613|FG006|Expansion Phase|Physician Decision|9|||
131956991|NCT04153149|475124746|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
131956992|NCT03978637|475124751|FG000|Overall Study|Death|0|||
131956993|NCT03978637|475124752|FG001|Overall Study|Death|2|||
131956994|NCT03978637|475124753|FG002|Overall Study|Death|2|||
131956995|NCT03978637|475124754|FG003|Overall Study|Death|0|||
131956996|NCT03978637|475124751|FG000|Overall Study|Withdrawal by Subject|0|||
131956997|NCT03978637|475124752|FG001|Overall Study|Withdrawal by Subject|0|||
131956998|NCT03978637|475124753|FG002|Overall Study|Withdrawal by Subject|1|||
131956999|NCT03978637|475124754|FG003|Overall Study|Withdrawal by Subject|0|||
131957000|NCT03978637|475124751|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
131957001|NCT03978637|475124752|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
131957002|NCT03978637|475124753|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
131957003|NCT03978637|475124754|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
131957004|NCT06235905|475124755|FG000|Overall Study|Adverse Event|1|||
131957005|NCT06235905|475124755|FG000|Overall Study|Non-compliant with protocol procedures|1|||
131957006|NCT03578367|475124756|FG000|Overall Study|Adverse Event|0|||
131957007|NCT03578367|475124757|FG001|Overall Study|Adverse Event|3|||
131957008|NCT03578367|475124758|FG002|Overall Study|Adverse Event|0|||
131957009|NCT03578367|475124759|FG003|Overall Study|Adverse Event|5|||
131957010|NCT03578367|475124756|FG000|Overall Study|Withdrawal by Subject|2|||
131957011|NCT03578367|475124757|FG001|Overall Study|Withdrawal by Subject|2|||
131957012|NCT03578367|475124758|FG002|Overall Study|Withdrawal by Subject|1|||
131957013|NCT03578367|475124759|FG003|Overall Study|Withdrawal by Subject|3|||
131957014|NCT03578367|475124756|FG000|Overall Study|Physician Decision|0|||
131415527|NCT00490022|473145301|FG001|Overall Study|Subject failed to disclose concommitant|1|||
131415528|NCT00635089|473145302|FG000|Overall Study|Adverse Event|7|||
131415529|NCT00635089|473145302|FG000|Overall Study|Lack of Efficacy|28|||
131415530|NCT00635089|473145302|FG000|Overall Study|Protocol Deviation|4|||
131415531|NCT00635089|473145302|FG000|Overall Study|Lost to Follow-up|8|||
131457436|NCT01742286|473304607|FG000|Expansion Phase|Adverse Event|0|||
131957015|NCT03578367|475124757|FG001|Overall Study|Physician Decision|0|||
131957016|NCT03578367|475124758|FG002|Overall Study|Physician Decision|14|||
131957017|NCT03578367|475124759|FG003|Overall Study|Physician Decision|0|||
131957018|NCT03578367|475124756|FG000|Overall Study|Death|1|||
131957019|NCT03578367|475124757|FG001|Overall Study|Death|0|||
131957020|NCT03578367|475124758|FG002|Overall Study|Death|0|||
131957021|NCT03578367|475124759|FG003|Overall Study|Death|0|||
131957022|NCT03578367|475124756|FG000|Overall Study|Not treated|0|||
131957023|NCT03578367|475124757|FG001|Overall Study|Not treated|0|||
131957024|NCT03578367|475124758|FG002|Overall Study|Not treated|1|||
131957025|NCT03578367|475124759|FG003|Overall Study|Not treated|0|||
131957026|NCT03868943|475124760|FG000|Overall Study|Adverse Event|1|||
131957027|NCT04551066|475124761|FG000|Overall Study|Death|5|||
131957028|NCT04551066|475124762|FG001|Overall Study|Death|3|||
131957029|NCT04551066|475124761|FG000|Overall Study|Lost to Follow-up|1|||
131957030|NCT04551066|475124762|FG001|Overall Study|Lost to Follow-up|0|||
131957031|NCT04551066|475124761|FG000|Overall Study|Sponsor Decision|104|||
131957032|NCT04551066|475124762|FG001|Overall Study|Sponsor Decision|117|||
131957033|NCT04551066|475124761|FG000|Overall Study|Withdrawal by Subject|8|||
131957034|NCT04551066|475124762|FG001|Overall Study|Withdrawal by Subject|2|||
131957035|NCT04551066|475124761|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
131957036|NCT04551066|475124762|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
131957037|NCT04551066|475124761|FG000|Overall Study|Adverse Event|2|||
131957038|NCT04551066|475124762|FG001|Overall Study|Adverse Event|0|||
131957039|NCT04551066|475124761|FG000|Overall Study|Physician Decision|2|||
131957040|NCT04551066|475124762|FG001|Overall Study|Physician Decision|0|||
131957041|NCT04551066|475124761|FG000|Overall Study|Protocol Violation|1|||
131957042|NCT04551066|475124762|FG001|Overall Study|Protocol Violation|0|||
131957043|NCT04551066|475124761|FG000|Overall Study|Lack of Efficacy|0|||
131957044|NCT04551066|475124762|FG001|Overall Study|Lack of Efficacy|1|||
131957045|NCT04551066|475124761|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
131957046|NCT04551066|475124762|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
131957047|NCT04256421|475124767|FG000|Overall Study|Death|171|||
131957048|NCT04256421|475124768|FG001|Overall Study|Death|180|||
131957049|NCT04256421|475124767|FG000|Overall Study|Lost to Follow-up|1|||
131957050|NCT04256421|475124768|FG001|Overall Study|Lost to Follow-up|1|||
131957051|NCT04256421|475124767|FG000|Overall Study|Withdrawal by Subject|9|||
131957052|NCT04256421|475124768|FG001|Overall Study|Withdrawal by Subject|10|||
131957053|NCT04256421|475124767|FG000|Overall Study|Ongoing in Study|66|||
131957054|NCT04256421|475124768|FG001|Overall Study|Ongoing in Study|52|||
131415532|NCT00635089|473145302|FG000|Overall Study|Other|31|||
131415533|NCT01283542|473145304|FG000|Main Phase|Acute or progressive vision loss|1|||
131415534|NCT01283542|473145304|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
131415535|NCT01283542|473145304|FG000|Main Phase|abnormal laboratory values|5|||
131415536|NCT01283542|473145304|FG000|Extension Phase|Physician Decision|1|||
131415537|NCT01283542|473145304|FG000|Extension Phase|Adverse Event|1|||
131415538|NCT01283542|473145304|FG000|Extension Phase|Administrative problems|1|||
131415539|NCT05059977|473145305|FG000|Overall Study|Withdrawal by Subject|0|||
131415540|NCT05059977|473145306|FG001|Overall Study|Withdrawal by Subject|0|||
131415541|NCT05059977|473145307|FG002|Overall Study|Withdrawal by Subject|1|||
131415542|NCT04405245|473145308|FG000|Overall Study|Adverse Event|0|||
131415543|NCT04405245|473145309|FG001|Overall Study|Adverse Event|1|||
131415544|NCT04405245|473145310|FG002|Overall Study|Adverse Event|0|||
131415545|NCT00576472|473145311|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415546|NCT00576472|473145312|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415547|NCT00576472|473145313|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415548|NCT00576472|473145314|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
131415549|NCT00576472|473145315|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415550|NCT00576472|473145316|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415551|NCT00576472|473145317|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415552|NCT00576472|473145318|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415553|NCT00576472|473145319|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
131457437|NCT01742286|473304608|FG001|Expansion Phase|Adverse Event|0|||
131415554|NCT00576472|473145320|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415555|NCT00576472|473145321|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415556|NCT00576472|473145322|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415557|NCT00576472|473145323|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415558|NCT00576472|473145324|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415559|NCT00576472|473145325|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
131415560|NCT00576472|473145311|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
131457438|NCT01742286|473304609|FG002|Expansion Phase|Adverse Event|0|||
131415561|NCT00576472|473145312|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
131415562|NCT00576472|473145313|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
131415563|NCT00576472|473145314|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
131415564|NCT00576472|473145315|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
131415565|NCT00576472|473145316|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
131415566|NCT00576472|473145317|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
131415567|NCT00576472|473145318|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
131457439|NCT01742286|473304610|FG003|Expansion Phase|Adverse Event|0|||
131457440|NCT01742286|473304611|FG004|Expansion Phase|Adverse Event|0|||
131457441|NCT01742286|473304612|FG005|Expansion Phase|Adverse Event|0|||
131457442|NCT01742286|473304613|FG006|Expansion Phase|Adverse Event|6|||
131457443|NCT01742286|473304607|FG000|Expansion Phase|Disease progression|0|||
131768900|NCT02500706|474431895|FG001|Overall Study|Lost to Follow-up|1|||
131415568|NCT00576472|473145319|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
131415569|NCT00576472|473145320|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
131415570|NCT00576472|473145321|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
131415571|NCT00576472|473145322|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
131415572|NCT00576472|473145323|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
131415573|NCT00576472|473145324|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
131415574|NCT00576472|473145325|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
131768901|NCT02500706|474431896|FG002|Overall Study|Lost to Follow-up|1|||
131415575|NCT00576472|473145311|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415576|NCT00576472|473145312|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415577|NCT00576472|473145313|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415578|NCT00576472|473145314|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
131415579|NCT00576472|473145315|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415580|NCT00576472|473145316|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415581|NCT00576472|473145317|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415582|NCT00576472|473145318|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415583|NCT00576472|473145319|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415584|NCT00576472|473145320|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415585|NCT00576472|473145321|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415586|NCT00576472|473145322|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415587|NCT00576472|473145323|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415588|NCT00576472|473145324|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415589|NCT00576472|473145325|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
131415590|NCT00576472|473145311|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
131415591|NCT00576472|473145312|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
131415592|NCT00576472|473145313|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
131415593|NCT00576472|473145314|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
131415594|NCT00576472|473145315|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
131415595|NCT00576472|473145316|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
131415596|NCT00576472|473145317|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
131415597|NCT00576472|473145318|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
131415598|NCT00576472|473145319|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
131415599|NCT00576472|473145320|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
131415600|NCT00576472|473145321|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
131415601|NCT00576472|473145322|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
131415602|NCT00576472|473145323|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
131415603|NCT00576472|473145324|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
131415604|NCT00576472|473145325|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
131415605|NCT00576472|473145311|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415606|NCT00576472|473145312|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415607|NCT00576472|473145313|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415608|NCT00576472|473145314|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
131415609|NCT00576472|473145315|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415610|NCT00576472|473145316|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415611|NCT00576472|473145317|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415612|NCT00576472|473145318|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415613|NCT00576472|473145319|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415614|NCT00576472|473145320|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415615|NCT00576472|473145321|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415616|NCT00576472|473145322|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415617|NCT00576472|473145323|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415618|NCT00576472|473145324|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415619|NCT00576472|473145325|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
131415620|NCT00576472|473145311|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415621|NCT00576472|473145312|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415622|NCT00576472|473145313|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
131457444|NCT01742286|473304608|FG001|Expansion Phase|Disease progression|0|||
131457445|NCT01742286|473304609|FG002|Expansion Phase|Disease progression|3|||
131457446|NCT01742286|473304610|FG003|Expansion Phase|Disease progression|0|||
131415623|NCT00576472|473145314|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415624|NCT00576472|473145315|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415625|NCT00576472|473145316|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415626|NCT00576472|473145317|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
131415627|NCT00576472|473145318|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415628|NCT00576472|473145319|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415629|NCT00576472|473145320|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415630|NCT00576472|473145321|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415631|NCT00576472|473145322|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415632|NCT00576472|473145323|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415633|NCT00576472|473145324|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415634|NCT00576472|473145325|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
131415635|NCT00576472|473145311|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
131415636|NCT00576472|473145312|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
131415637|NCT00576472|473145313|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
131415638|NCT00576472|473145314|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
131415639|NCT00576472|473145315|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
131415640|NCT00576472|473145316|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
131415641|NCT00576472|473145317|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
131415642|NCT00576472|473145318|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
131415643|NCT00576472|473145319|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
131415644|NCT00576472|473145320|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
131415645|NCT00576472|473145321|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
131415646|NCT00576472|473145322|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
131415647|NCT00576472|473145323|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
131415648|NCT00576472|473145324|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
131415649|NCT00576472|473145325|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
131415650|NCT00576472|473145311|FG000|MPH Cross Over Phase|Physician Decision|0|||
131415651|NCT00576472|473145312|FG001|MPH Cross Over Phase|Physician Decision|0|||
131415652|NCT00576472|473145313|FG002|MPH Cross Over Phase|Physician Decision|0|||
131415653|NCT00576472|473145314|FG003|MPH Cross Over Phase|Physician Decision|0|||
131415654|NCT00576472|473145315|FG004|MPH Cross Over Phase|Physician Decision|0|||
131415655|NCT00576472|473145316|FG005|MPH Cross Over Phase|Physician Decision|0|||
131415656|NCT00576472|473145317|FG006|MPH Cross Over Phase|Physician Decision|4|||
131415657|NCT00576472|473145318|FG007|MPH Cross Over Phase|Physician Decision|0|||
131415658|NCT00576472|473145319|FG008|MPH Cross Over Phase|Physician Decision|0|||
131415659|NCT00576472|473145320|FG009|MPH Cross Over Phase|Physician Decision|0|||
131415660|NCT00576472|473145321|FG010|MPH Cross Over Phase|Physician Decision|0|||
131415661|NCT00576472|473145322|FG011|MPH Cross Over Phase|Physician Decision|0|||
131415662|NCT00576472|473145323|FG012|MPH Cross Over Phase|Physician Decision|0|||
131415663|NCT00576472|473145324|FG013|MPH Cross Over Phase|Physician Decision|0|||
131415664|NCT00576472|473145325|FG014|MPH Cross Over Phase|Physician Decision|0|||
131415665|NCT00576472|473145311|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415666|NCT00576472|473145312|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415667|NCT00576472|473145313|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
131457447|NCT01742286|473304611|FG004|Expansion Phase|Disease progression|0|||
131415668|NCT00576472|473145314|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415669|NCT00576472|473145315|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415670|NCT00576472|473145316|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
131457448|NCT01742286|473304612|FG005|Expansion Phase|Disease progression|0|||
131415671|NCT00576472|473145317|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415672|NCT00576472|473145318|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415673|NCT00576472|473145319|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
131415674|NCT00576472|473145320|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
131457449|NCT01742286|473304613|FG006|Expansion Phase|Disease progression|15|||
131457450|NCT01742286|473304607|FG000|Expansion Phase|Withdrawal by Subject|0|||
131457451|NCT01742286|473304608|FG001|Expansion Phase|Withdrawal by Subject|0|||
131457452|NCT01742286|473304609|FG002|Expansion Phase|Withdrawal by Subject|0|||
131457453|NCT01742286|473304610|FG003|Expansion Phase|Withdrawal by Subject|0|||
131457454|NCT01742286|473304611|FG004|Expansion Phase|Withdrawal by Subject|0|||
131457455|NCT01742286|473304612|FG005|Expansion Phase|Withdrawal by Subject|0|||
131457456|NCT01742286|473304613|FG006|Expansion Phase|Withdrawal by Subject|1|||
131457457|NCT04530136|473304614|FG000|Overall Study|Lost to Follow-up|2|||
131457458|NCT04530136|473304615|FG001|Overall Study|Lost to Follow-up|3|||
131457459|NCT04530136|473304614|FG000|Overall Study|Withdrawal by Subject|1|||
131457460|NCT04530136|473304615|FG001|Overall Study|Withdrawal by Subject|0|||
131457461|NCT04530136|473304614|FG000|Overall Study|Death|0|||
131457462|NCT04530136|473304615|FG001|Overall Study|Death|1|||
131457463|NCT01233232|473304618|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
131457464|NCT01233232|473304619|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
131457465|NCT01233232|473304620|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
131457466|NCT02762370|473304621|FG000|Overall Study|Protocol Violation|1|||
131457467|NCT02762370|473304622|FG001|Overall Study|Protocol Violation|0|||
131457468|NCT03500224|473304623|FG000|Overall Study|Withdrawal by Subject|2|||
131457469|NCT00499590|473304626|FG000|Overall Study|Study Terminated|112|||
131457470|NCT00499590|473304627|FG001|Overall Study|Study Terminated|112|||
131457471|NCT00499590|473304628|FG002|Overall Study|Study Terminated|112|||
131457472|NCT00499590|473304626|FG000|Overall Study|Not treated|1|||
131457473|NCT00499590|473304627|FG001|Overall Study|Not treated|0|||
131457474|NCT00499590|473304628|FG002|Overall Study|Not treated|1|||
131415675|NCT00576472|473145321|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
131415676|NCT00576472|473145322|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
131415677|NCT00576472|473145323|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415678|NCT00576472|473145324|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415679|NCT00576472|473145325|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
131415680|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415681|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415682|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131457475|NCT02633020|473304630|FG000|Overall Study|Adverse Event|1|||
131415683|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131457476|NCT02633020|473304631|FG001|Overall Study|Adverse Event|0|||
131457477|NCT05661851|473304632|FG000|Overall Study|Protocol Violation|1|||
131457478|NCT05661851|473304633|FG001|Overall Study|Protocol Violation|1|||
131457479|NCT05661851|473304632|FG000|Overall Study|Covid-19 Related|3|||
131457480|NCT05661851|473304633|FG001|Overall Study|Covid-19 Related|4|||
131457481|NCT05661851|473304632|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
131496722|NCT02289690|473446360|FG001|Overall Study|Sponsor Discontinued Study|0|||
131415684|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415685|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415686|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415687|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415688|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415689|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415690|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415691|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415692|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415693|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
131415694|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
131415695|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
131415696|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
131415697|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
131415698|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
131415699|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
131415700|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
131415701|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
131415702|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
131415703|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
131415704|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
131415705|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
131415706|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
131415707|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
131415708|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
131415709|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
131415710|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
131415711|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
131415712|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
131415713|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
131415714|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
131415715|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
131415716|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
131415717|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
131415718|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
131415719|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
131415720|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
131415721|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
131415722|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
131415723|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
131415724|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
131415725|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Side effects|0|||
131415726|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Side effects|0|||
131415727|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Side effects|0|||
131415728|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Side effects|0|||
131415729|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Side effects|0|||
131415730|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Side effects|0|||
131415731|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Side effects|0|||
131415732|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Side effects|0|||
131496723|NCT02289690|473446361|FG002|Overall Study|Sponsor Discontinued Study|0|||
131457482|NCT05661851|473304633|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
131496724|NCT02289690|473446362|FG003|Overall Study|Sponsor Discontinued Study|0|||
131415733|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Side effects|0|||
131415734|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Side effects|0|||
131415735|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Side effects|0|||
131415736|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Side effects|0|||
131415737|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Side effects|0|||
131415738|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Side effects|0|||
131415739|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Side effects|8|||
131415740|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415741|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415742|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415743|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415744|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415745|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415746|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415747|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415748|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415749|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415750|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415751|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415752|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415753|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
131415754|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
131496725|NCT02289690|473446363|FG004|Overall Study|Sponsor Discontinued Study|0|||
131415755|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
131415756|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
131415757|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
131415758|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
131415759|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
131415760|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
131496726|NCT02289690|473446364|FG005|Overall Study|Sponsor Discontinued Study|0|||
131415761|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
131415762|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
131457483|NCT05661851|473304632|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
131415763|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
131415764|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
131415765|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
131415766|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
131415767|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
131415768|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
131415769|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
131415770|NCT00576472|473145311|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415771|NCT00576472|473145312|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415772|NCT00576472|473145313|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415773|NCT00576472|473145314|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415774|NCT00576472|473145315|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415775|NCT00576472|473145316|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415776|NCT00576472|473145317|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415777|NCT00576472|473145318|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415778|NCT00576472|473145319|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415779|NCT00576472|473145320|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415780|NCT00576472|473145321|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415781|NCT00576472|473145322|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415782|NCT00576472|473145323|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415783|NCT00576472|473145324|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
131415784|NCT00576472|473145325|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
131415785|NCT02391961|473145331|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
131415786|NCT02391961|473145332|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
131415787|NCT02391961|473145331|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
131415788|NCT02391961|473145332|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
131415789|NCT02391961|473145331|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131457484|NCT05661851|473304633|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
131457485|NCT02745080|473304643|FG000|Overall Study|Adverse Event|13|||
131457486|NCT02745080|473304644|FG001|Overall Study|Adverse Event|21|||
131457487|NCT02745080|473304643|FG000|Overall Study|Lack of Efficacy|11|||
131457488|NCT02745080|473304644|FG001|Overall Study|Lack of Efficacy|23|||
131457489|NCT02745080|473304643|FG000|Overall Study|Lost to Follow-up|3|||
131457490|NCT02745080|473304644|FG001|Overall Study|Lost to Follow-up|3|||
131415790|NCT02391961|473145332|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131415791|NCT03263780|473145335|FG000|Overall Study|Withdrawal by Subject|3|||
131415792|NCT03263780|473145335|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
131415793|NCT00903331|473145336|FG000|Overall Study|Death|4|||
131415794|NCT00903331|473145337|FG001|Overall Study|Death|8|||
131415795|NCT00903331|473145336|FG000|Overall Study|Withdrawal of consent|1|||
131415796|NCT00903331|473145337|FG001|Overall Study|Withdrawal of consent|8|||
131415797|NCT00903331|473145336|FG000|Overall Study|Lung transplant|0|||
131415798|NCT00903331|473145337|FG001|Overall Study|Lung transplant|2|||
131415799|NCT00257660|473145338|FG000|Overall Study|Lack of Efficacy|5|||
131415800|NCT00257660|473145339|FG001|Overall Study|Lack of Efficacy|23|||
131415801|NCT00257660|473145338|FG000|Overall Study|Withdrawal by Subject|2|||
131415802|NCT00257660|473145339|FG001|Overall Study|Withdrawal by Subject|0|||
131415803|NCT00257660|473145338|FG000|Overall Study|Lost to Follow-up|1|||
131415804|NCT00257660|473145339|FG001|Overall Study|Lost to Follow-up|0|||
131415805|NCT00257660|473145338|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
131415806|NCT00257660|473145339|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
131415807|NCT00257660|473145338|FG000|Overall Study|No longer wanted to do blood draws|1|||
131415808|NCT00257660|473145339|FG001|Overall Study|No longer wanted to do blood draws|0|||
131415809|NCT02477553|473145342|FG000|Overall Study|Screening up-to-date|12|||
131415810|NCT02477553|473145343|FG001|Overall Study|Screening up-to-date|13|||
131415811|NCT02477553|473145342|FG000|Overall Study|No MD visit|1|||
131415812|NCT02477553|473145343|FG001|Overall Study|No MD visit|1|||
131415813|NCT02477553|473145342|FG000|Overall Study|Workup consistent w/CRC|1|||
131415814|NCT02477553|473145343|FG001|Overall Study|Workup consistent w/CRC|1|||
131415815|NCT02477553|473145342|FG000|Overall Study|Technical issues with intervention|2|||
131415816|NCT02477553|473145343|FG001|Overall Study|Technical issues with intervention|0|||
131415817|NCT02477553|473145342|FG000|Overall Study|Elevated risk for CRC|2|||
131415818|NCT02477553|473145343|FG001|Overall Study|Elevated risk for CRC|2|||
131415819|NCT02477553|473145342|FG000|Overall Study|MD advised against screening|1|||
131415820|NCT02477553|473145343|FG001|Overall Study|MD advised against screening|3|||
131415821|NCT02477553|473145342|FG000|Overall Study|patient deceased|1|||
131415822|NCT02477553|473145343|FG001|Overall Study|patient deceased|0|||
131415823|NCT00637572|473145345|FG000|Overall Study|Adverse Event|1|||
131415824|NCT00637572|473145346|FG001|Overall Study|Adverse Event|2|||
131457491|NCT02745080|473304643|FG000|Overall Study|Physician Decision|3|||
131457492|NCT02745080|473304644|FG001|Overall Study|Physician Decision|0|||
131415825|NCT00637572|473145345|FG000|Overall Study|Death|0|||
131415826|NCT00637572|473145346|FG001|Overall Study|Death|1|||
131415827|NCT00637572|473145345|FG000|Overall Study|Lost to Follow-up|0|||
131415828|NCT00637572|473145346|FG001|Overall Study|Lost to Follow-up|1|||
131415829|NCT00637572|473145345|FG000|Overall Study|Physician Decision|1|||
131457493|NCT02745080|473304643|FG000|Overall Study|Protocol Violation|3|||
131415830|NCT00637572|473145346|FG001|Overall Study|Physician Decision|1|||
131415831|NCT00637572|473145345|FG000|Overall Study|Withdrawal by Subject|0|||
131415832|NCT00637572|473145346|FG001|Overall Study|Withdrawal by Subject|2|||
131415833|NCT00637572|473145345|FG000|Overall Study|Illicit Drug Use|1|||
131415834|NCT00637572|473145346|FG001|Overall Study|Illicit Drug Use|0|||
131415835|NCT00896649|473145347|FG000|Overall Study|Physician Decision|1|||
131415836|NCT00896649|473145347|FG000|Overall Study|Pregnancy|1|||
131415837|NCT00896649|473145347|FG000|Overall Study|missing documentation|1|||
131415838|NCT00896649|473145347|FG000|Overall Study|technical difficulties|2|||
131415839|NCT04576897|473145352|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
131415840|NCT03938324|473146615|FG000|Overall Study|Lost to Follow-up|42|||
131415841|NCT03938324|473146616|FG001|Overall Study|Lost to Follow-up|21|||
131415842|NCT03938324|473146615|FG000|Overall Study|Withdrawal by Subject|6|||
131415843|NCT03938324|473146616|FG001|Overall Study|Withdrawal by Subject|1|||
131415844|NCT00837759|473146617|FG000|Overall Study|Protocol Violation|3|||
131415845|NCT00837759|473146617|FG000|Overall Study|Lost to Follow-up|1|||
131415846|NCT02100969|473146618|FG000|Overall Study|Did not pass screening phase|1|||
131415847|NCT02081599|473146619|FG000|Period 1：Double-blind Period|Adverse Event|3|||
131415848|NCT02081599|473146620|FG001|Period 1：Double-blind Period|Adverse Event|0|||
131457494|NCT02745080|473304644|FG001|Overall Study|Protocol Violation|1|||
131415849|NCT02081599|473146619|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
131415850|NCT02081599|473146620|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
131415851|NCT02081599|473146619|FG000|Period 1：Double-blind Period|Physician Decision|1|||
131415852|NCT02081599|473146620|FG001|Period 1：Double-blind Period|Physician Decision|0|||
131415853|NCT02081599|473146619|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
131415854|NCT02081599|473146620|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
131415855|NCT02081599|473146619|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
131415856|NCT02081599|473146620|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
131415857|NCT02081599|473146619|FG000|Period 1：Double-blind Period|stopping criteria|1|||
131415858|NCT02081599|473146620|FG001|Period 1：Double-blind Period|stopping criteria|0|||
131415859|NCT02081599|473146619|FG000|Period 2：Open-label Period|Adverse Event|1|||
131415860|NCT02081599|473146620|FG001|Period 2：Open-label Period|Adverse Event|0|||
131415861|NCT02081599|473146619|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
131415862|NCT02081599|473146620|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
131415863|NCT02081599|473146619|FG000|Period 2：Open-label Period|Physician Decision|1|||
131415864|NCT02081599|473146620|FG001|Period 2：Open-label Period|Physician Decision|0|||
131415865|NCT02081599|473146619|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
131415866|NCT02081599|473146620|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
131415867|NCT01629953|473146621|FG000|Overall Study|Death|3|||
131415868|NCT01629953|473146622|FG001|Overall Study|Death|1|||
131415869|NCT01629953|473146621|FG000|Overall Study|Lost to Follow-up|10|||
131415870|NCT01629953|473146622|FG001|Overall Study|Lost to Follow-up|14|||
131415871|NCT01286077|473146623|FG000|Overall Study|Adverse Event|2|||
131415872|NCT01286077|473146624|FG001|Overall Study|Adverse Event|0|||
131415873|NCT01286077|473146623|FG000|Overall Study|Death|1|||
131415874|NCT01286077|473146624|FG001|Overall Study|Death|0|||
131415875|NCT01286077|473146623|FG000|Overall Study|Protocol Violation|1|||
131415876|NCT01286077|473146624|FG001|Overall Study|Protocol Violation|1|||
131415877|NCT01286077|473146623|FG000|Overall Study|Withdrawal by Subject|0|||
131415878|NCT01286077|473146624|FG001|Overall Study|Withdrawal by Subject|2|||
131415879|NCT01286077|473146623|FG000|Overall Study|Intercurrent illness|1|||
131415880|NCT01286077|473146624|FG001|Overall Study|Intercurrent illness|0|||
131415881|NCT01286077|473146623|FG000|Overall Study|Non-compliance|1|||
131415882|NCT01286077|473146624|FG001|Overall Study|Non-compliance|0|||
131415883|NCT01286077|473146623|FG000|Overall Study|The subject starts with alternative MMY|0|||
131415884|NCT01286077|473146624|FG001|Overall Study|The subject starts with alternative MMY|3|||
131415885|NCT01286077|473146623|FG000|Overall Study|Patient's decision to stop treatment|3|||
131415886|NCT01286077|473146624|FG001|Overall Study|Patient's decision to stop treatment|0|||
131415887|NCT01286077|473146623|FG000|Overall Study|Progression of disease|0|||
131415888|NCT01286077|473146624|FG001|Overall Study|Progression of disease|1|||
131415889|NCT01286077|473146623|FG000|Overall Study|refill medication not received in time|1|||
131415890|NCT01286077|473146624|FG001|Overall Study|refill medication not received in time|0|||
131415891|NCT05063539|473146625|FG000|Overall Study|Adverse Event|1|||
131415892|NCT05063539|473146626|FG001|Overall Study|Adverse Event|2|||
131415893|NCT05063539|473146627|FG002|Overall Study|Adverse Event|1|||
131415894|NCT05063539|473146625|FG000|Overall Study|Death|0|||
131415895|NCT05063539|473146626|FG001|Overall Study|Death|1|||
131415896|NCT05063539|473146627|FG002|Overall Study|Death|1|||
131457495|NCT02745080|473304643|FG000|Overall Study|Withdrawal by Subject|22|||
131457496|NCT02745080|473304644|FG001|Overall Study|Withdrawal by Subject|41|||
131415897|NCT05063539|473146625|FG000|Overall Study|Lost to Follow-up|0|||
131415898|NCT05063539|473146626|FG001|Overall Study|Lost to Follow-up|1|||
131415899|NCT05063539|473146627|FG002|Overall Study|Lost to Follow-up|0|||
131457497|NCT01001325|473304647|FG000|Overall Study|Lost to Follow-up|16|||
131415900|NCT05063539|473146625|FG000|Overall Study|Physician Decision|4|||
131415901|NCT05063539|473146626|FG001|Overall Study|Physician Decision|3|||
131415902|NCT05063539|473146627|FG002|Overall Study|Physician Decision|1|||
131415903|NCT05063539|473146625|FG000|Overall Study|Progressive Disease|0|||
131415904|NCT05063539|473146626|FG001|Overall Study|Progressive Disease|2|||
131415905|NCT05063539|473146627|FG002|Overall Study|Progressive Disease|0|||
131415906|NCT05063539|473146625|FG000|Overall Study|Withdrawal by Subject|17|||
131415907|NCT05063539|473146626|FG001|Overall Study|Withdrawal by Subject|26|||
131415908|NCT05063539|473146627|FG002|Overall Study|Withdrawal by Subject|14|||
131415909|NCT05063539|473146625|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
131415910|NCT05063539|473146626|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
131415911|NCT05063539|473146627|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
131415912|NCT05063539|473146625|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
131457498|NCT01001325|473304648|FG001|Overall Study|Lost to Follow-up|10|||
131457499|NCT01001325|473304647|FG000|Overall Study|Protocol Violation|2|||
131457500|NCT01001325|473304648|FG001|Overall Study|Protocol Violation|0|||
131457501|NCT01584440|473304649|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
131457502|NCT01584440|473304650|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
131457503|NCT01584440|473304651|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
131457504|NCT01584440|473304652|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
131457505|NCT01584440|473304653|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
131457506|NCT01584440|473304649|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
131457507|NCT01584440|473304650|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
131457508|NCT01584440|473304651|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
131457509|NCT01584440|473304652|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
131457510|NCT01584440|473304653|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
131415913|NCT05063539|473146626|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
131415914|NCT05063539|473146627|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
131457511|NCT01584440|473304649|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
131457512|NCT01584440|473304650|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
131457513|NCT01584440|473304651|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
131457514|NCT01584440|473304652|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
131457515|NCT01584440|473304653|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
131457516|NCT01584440|473304649|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
131457517|NCT01584440|473304650|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
131415915|NCT05063539|473146625|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
131434028|NCT01188772|473214620|FG002|Overall Study|Randomized but Not Treated|0|||
131415916|NCT05063539|473146626|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
131415917|NCT05063539|473146627|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
131415918|NCT05063539|473146625|FG000|Overall Study|Discontinued due to Common Close Design|0|||
131415919|NCT05063539|473146626|FG001|Overall Study|Discontinued due to Common Close Design|1|||
131415920|NCT05063539|473146627|FG002|Overall Study|Discontinued due to Common Close Design|0|||
131415921|NCT05063539|473146625|FG000|Overall Study|Participant not co-operative|0|||
131415922|NCT05063539|473146626|FG001|Overall Study|Participant not co-operative|1|||
131415923|NCT05063539|473146627|FG002|Overall Study|Participant not co-operative|0|||
131415924|NCT05063539|473146625|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
131415925|NCT05063539|473146626|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
131415926|NCT05063539|473146627|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
131415927|NCT05063539|473146625|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
131415928|NCT05063539|473146626|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
131415929|NCT05063539|473146627|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
131415930|NCT01751139|473146628|FG000|Overall Study|Other|135|||
131415931|NCT01751139|473146628|FG000|Overall Study|Sponsor study termination|1609|||
131415932|NCT01751139|473146628|FG000|Overall Study|Lost to Follow-up|240|||
131415933|NCT01751139|473146628|FG000|Overall Study|Withdrawal by Subject|251|||
131415934|NCT01751139|473146628|FG000|Overall Study|Adverse Event|1|||
131415935|NCT01751139|473146628|FG000|Overall Study|Death|31|||
131415936|NCT04736628|473146629|FG000|Overall Study|Not treated|0|||
131415937|NCT04736628|473146630|FG001|Overall Study|Not treated|0|||
131415938|NCT04736628|473146631|FG002|Overall Study|Not treated|0|||
131415939|NCT04736628|473146632|FG003|Overall Study|Not treated|2|||
131415940|NCT04736628|473146629|FG000|Overall Study|Other reason than listed|1|||
131415941|NCT04736628|473146630|FG001|Overall Study|Other reason than listed|2|||
131415942|NCT04736628|473146631|FG002|Overall Study|Other reason than listed|2|||
131415943|NCT04736628|473146632|FG003|Overall Study|Other reason than listed|3|||
131415944|NCT04736628|473146629|FG000|Overall Study|Protocol deviation|0|||
131415945|NCT04736628|473146630|FG001|Overall Study|Protocol deviation|0|||
131415946|NCT04736628|473146631|FG002|Overall Study|Protocol deviation|0|||
131415947|NCT04736628|473146632|FG003|Overall Study|Protocol deviation|1|||
131415948|NCT04736628|473146629|FG000|Overall Study|Burden of study procedures|1|||
131415949|NCT04736628|473146630|FG001|Overall Study|Burden of study procedures|0|||
131415950|NCT04736628|473146631|FG002|Overall Study|Burden of study procedures|0|||
131415951|NCT04736628|473146632|FG003|Overall Study|Burden of study procedures|1|||
131415952|NCT04736628|473146629|FG000|Overall Study|Change of residence|0|||
131415953|NCT04736628|473146630|FG001|Overall Study|Change of residence|1|||
131415954|NCT04736628|473146631|FG002|Overall Study|Change of residence|0|||
131415955|NCT04736628|473146632|FG003|Overall Study|Change of residence|0|||
131415956|NCT04736628|473146629|FG000|Overall Study|Perceived lack of efficacy|1|||
131415957|NCT04736628|473146630|FG001|Overall Study|Perceived lack of efficacy|0|||
131415958|NCT04736628|473146631|FG002|Overall Study|Perceived lack of efficacy|0|||
131415959|NCT04736628|473146632|FG003|Overall Study|Perceived lack of efficacy|1|||
131415960|NCT04736628|473146629|FG000|Overall Study|Adverse Event|3|||
131415961|NCT04736628|473146630|FG001|Overall Study|Adverse Event|2|||
131415962|NCT04736628|473146631|FG002|Overall Study|Adverse Event|4|||
131415963|NCT04736628|473146632|FG003|Overall Study|Adverse Event|3|||
131415964|NCT04279613|473146633|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
131415965|NCT04279613|473146634|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
131415966|NCT04279613|473146635|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
131415967|NCT04279613|473146636|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
131415968|NCT04279613|473146637|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
131415969|NCT04279613|473146633|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
131415970|NCT04279613|473146634|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
131415971|NCT04279613|473146635|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
131415972|NCT04279613|473146636|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
131415973|NCT04279613|473146637|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
131415974|NCT04279613|473146633|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
131415975|NCT04279613|473146634|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
131415976|NCT04279613|473146635|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
131415977|NCT04279613|473146636|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
131415978|NCT04279613|473146637|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
131415979|NCT04279613|473146633|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
131415980|NCT04279613|473146634|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
131415981|NCT04279613|473146635|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
131415982|NCT04279613|473146636|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
131415983|NCT04279613|473146637|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
131415984|NCT04279613|473146633|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
131415985|NCT04279613|473146634|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
131415986|NCT04279613|473146635|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
131415987|NCT04279613|473146636|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
131415988|NCT04279613|473146637|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
131415989|NCT02704689|473146638|FG000|Overall Study|Physician Decision|1|||
131415990|NCT02704689|473146638|FG000|Overall Study|Study device not implanted|2|||
131415991|NCT01646203|473146641|FG000|Overall Study|Adverse Event|2|||
131415992|NCT01646203|473146642|FG001|Overall Study|Adverse Event|0|||
131415993|NCT01646203|473146643|FG002|Overall Study|Adverse Event|1|||
131415994|NCT01646203|473146641|FG000|Overall Study|Withdrawal by Subject|0|||
131415995|NCT01646203|473146642|FG001|Overall Study|Withdrawal by Subject|1|||
131415996|NCT01646203|473146643|FG002|Overall Study|Withdrawal by Subject|0|||
131415997|NCT01646203|473146641|FG000|Overall Study|Physician's Decision|0|||
131415998|NCT01646203|473146642|FG001|Overall Study|Physician's Decision|1|||
131415999|NCT01646203|473146643|FG002|Overall Study|Physician's Decision|0|||
131416000|NCT03242252|473146648|FG000|Overall Study|At the Participant's own Request|18|||
131416001|NCT03242252|473146649|FG001|Overall Study|At the Participant's own Request|10|||
131416002|NCT03242252|473146650|FG002|Overall Study|At the Participant's own Request|15|||
131416003|NCT03242252|473146648|FG000|Overall Study|Adverse Event|8|||
131416004|NCT03242252|473146649|FG001|Overall Study|Adverse Event|6|||
131416005|NCT03242252|473146650|FG002|Overall Study|Adverse Event|9|||
131416006|NCT03242252|473146648|FG000|Overall Study|Poor Compliance to Protocol|0|||
131416007|NCT03242252|473146649|FG001|Overall Study|Poor Compliance to Protocol|2|||
131416008|NCT03242252|473146650|FG002|Overall Study|Poor Compliance to Protocol|3|||
131416009|NCT03242252|473146648|FG000|Overall Study|Study Terminated by Sponsor|1|||
131416010|NCT03242252|473146649|FG001|Overall Study|Study Terminated by Sponsor|0|||
131416011|NCT03242252|473146650|FG002|Overall Study|Study Terminated by Sponsor|0|||
131416012|NCT03242252|473146648|FG000|Overall Study|Reason not Specified|4|||
131416013|NCT03242252|473146649|FG001|Overall Study|Reason not Specified|4|||
131416014|NCT03242252|473146650|FG002|Overall Study|Reason not Specified|1|||
131416015|NCT03242252|473146648|FG000|Overall Study|Lost to Follow-up|5|||
131416016|NCT03242252|473146649|FG001|Overall Study|Lost to Follow-up|1|||
131416017|NCT03242252|473146650|FG002|Overall Study|Lost to Follow-up|4|||
131416018|NCT01659255|473146651|FG000|Overall Study|Adverse Event|0|||
131416019|NCT01659255|473146652|FG001|Overall Study|Adverse Event|0|||
131416020|NCT01659255|473146653|FG002|Overall Study|Adverse Event|0|||
131416021|NCT01659255|473146654|FG003|Overall Study|Adverse Event|0|||
131416022|NCT01659255|473146655|FG004|Overall Study|Adverse Event|0|||
131416023|NCT01659255|473146656|FG005|Overall Study|Adverse Event|1|||
131416024|NCT01659255|473146657|FG006|Overall Study|Adverse Event|1|||
131416025|NCT01659255|473146658|FG007|Overall Study|Adverse Event|0|||
131416026|NCT01659255|473146659|FG008|Overall Study|Adverse Event|0|||
131416027|NCT01659255|473146660|FG009|Overall Study|Adverse Event|1|||
131416028|NCT01659255|473146661|FG010|Overall Study|Adverse Event|0|||
131416029|NCT01659255|473146662|FG011|Overall Study|Adverse Event|1|||
131416030|NCT01659255|473146663|FG012|Overall Study|Adverse Event|0|||
131416031|NCT01659255|473146664|FG013|Overall Study|Adverse Event|2|||
131416032|NCT01659255|473146665|FG014|Overall Study|Adverse Event|0|||
131416033|NCT01659255|473146666|FG015|Overall Study|Adverse Event|1|||
131416034|NCT01659255|473146667|FG016|Overall Study|Adverse Event|0|||
131416035|NCT01659255|473146651|FG000|Overall Study|Death|0|||
131416036|NCT01659255|473146652|FG001|Overall Study|Death|1|||
131416037|NCT01659255|473146653|FG002|Overall Study|Death|0|||
131416038|NCT01659255|473146654|FG003|Overall Study|Death|0|||
131416039|NCT01659255|473146655|FG004|Overall Study|Death|0|||
131416040|NCT01659255|473146656|FG005|Overall Study|Death|0|||
131416041|NCT01659255|473146657|FG006|Overall Study|Death|0|||
131416042|NCT01659255|473146658|FG007|Overall Study|Death|1|||
131416043|NCT01659255|473146659|FG008|Overall Study|Death|1|||
131416044|NCT01659255|473146660|FG009|Overall Study|Death|0|||
131416045|NCT01659255|473146661|FG010|Overall Study|Death|0|||
131416046|NCT01659255|473146662|FG011|Overall Study|Death|0|||
131416047|NCT01659255|473146663|FG012|Overall Study|Death|1|||
131416048|NCT01659255|473146664|FG013|Overall Study|Death|1|||
131416049|NCT01659255|473146665|FG014|Overall Study|Death|2|||
131416050|NCT01659255|473146666|FG015|Overall Study|Death|1|||
131416051|NCT01659255|473146667|FG016|Overall Study|Death|0|||
131416052|NCT01659255|473146651|FG000|Overall Study|Progressive Disease|2|||
131416053|NCT01659255|473146652|FG001|Overall Study|Progressive Disease|0|||
131416054|NCT01659255|473146653|FG002|Overall Study|Progressive Disease|0|||
131416055|NCT01659255|473146654|FG003|Overall Study|Progressive Disease|0|||
131416056|NCT01659255|473146655|FG004|Overall Study|Progressive Disease|0|||
131416057|NCT01659255|473146656|FG005|Overall Study|Progressive Disease|0|||
131416058|NCT01659255|473146657|FG006|Overall Study|Progressive Disease|0|||
131416059|NCT01659255|473146658|FG007|Overall Study|Progressive Disease|1|||
131416060|NCT01659255|473146659|FG008|Overall Study|Progressive Disease|0|||
131416061|NCT01659255|473146660|FG009|Overall Study|Progressive Disease|2|||
131416062|NCT01659255|473146661|FG010|Overall Study|Progressive Disease|2|||
131416063|NCT01659255|473146662|FG011|Overall Study|Progressive Disease|3|||
131416064|NCT01659255|473146663|FG012|Overall Study|Progressive Disease|5|||
131416065|NCT01659255|473146664|FG013|Overall Study|Progressive Disease|13|||
131416066|NCT01659255|473146665|FG014|Overall Study|Progressive Disease|6|||
131416067|NCT01659255|473146666|FG015|Overall Study|Progressive Disease|2|||
131416068|NCT01659255|473146667|FG016|Overall Study|Progressive Disease|3|||
131416069|NCT01659255|473146651|FG000|Overall Study|Withdrew Consent|0|||
131416070|NCT01659255|473146652|FG001|Overall Study|Withdrew Consent|0|||
131416071|NCT01659255|473146653|FG002|Overall Study|Withdrew Consent|0|||
131416072|NCT01659255|473146654|FG003|Overall Study|Withdrew Consent|0|||
131416073|NCT01659255|473146655|FG004|Overall Study|Withdrew Consent|0|||
131416074|NCT01659255|473146656|FG005|Overall Study|Withdrew Consent|0|||
131416075|NCT01659255|473146657|FG006|Overall Study|Withdrew Consent|0|||
131416076|NCT01659255|473146658|FG007|Overall Study|Withdrew Consent|0|||
131416077|NCT01659255|473146659|FG008|Overall Study|Withdrew Consent|0|||
131416078|NCT01659255|473146660|FG009|Overall Study|Withdrew Consent|0|||
131416079|NCT01659255|473146661|FG010|Overall Study|Withdrew Consent|1|||
131416080|NCT01659255|473146662|FG011|Overall Study|Withdrew Consent|0|||
131416081|NCT01659255|473146663|FG012|Overall Study|Withdrew Consent|0|||
131416082|NCT01659255|473146664|FG013|Overall Study|Withdrew Consent|1|||
131416083|NCT01659255|473146665|FG014|Overall Study|Withdrew Consent|0|||
131416084|NCT01659255|473146666|FG015|Overall Study|Withdrew Consent|0|||
131416085|NCT01659255|473146667|FG016|Overall Study|Withdrew Consent|0|||
131416086|NCT01659255|473146651|FG000|Overall Study|Investigator Decision|0|||
131416087|NCT01659255|473146652|FG001|Overall Study|Investigator Decision|0|||
131416088|NCT01659255|473146653|FG002|Overall Study|Investigator Decision|0|||
131416089|NCT01659255|473146654|FG003|Overall Study|Investigator Decision|0|||
131416090|NCT01659255|473146655|FG004|Overall Study|Investigator Decision|0|||
131416091|NCT01659255|473146656|FG005|Overall Study|Investigator Decision|0|||
131416092|NCT01659255|473146657|FG006|Overall Study|Investigator Decision|0|||
131416093|NCT01659255|473146658|FG007|Overall Study|Investigator Decision|0|||
131416094|NCT01659255|473146659|FG008|Overall Study|Investigator Decision|0|||
131416095|NCT01659255|473146660|FG009|Overall Study|Investigator Decision|0|||
131416096|NCT01659255|473146661|FG010|Overall Study|Investigator Decision|0|||
131416097|NCT01659255|473146662|FG011|Overall Study|Investigator Decision|0|||
131416098|NCT01659255|473146663|FG012|Overall Study|Investigator Decision|1|||
131416099|NCT01659255|473146664|FG013|Overall Study|Investigator Decision|1|||
131416100|NCT01659255|473146665|FG014|Overall Study|Investigator Decision|0|||
131416101|NCT01659255|473146666|FG015|Overall Study|Investigator Decision|0|||
131416102|NCT01659255|473146667|FG016|Overall Study|Investigator Decision|0|||
131457518|NCT01584440|473304651|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
131416103|NCT01659255|473146651|FG000|Overall Study|Sponsor's Decision|0|||
131416104|NCT01659255|473146652|FG001|Overall Study|Sponsor's Decision|0|||
131416105|NCT01659255|473146653|FG002|Overall Study|Sponsor's Decision|0|||
131416106|NCT01659255|473146654|FG003|Overall Study|Sponsor's Decision|0|||
131416107|NCT01659255|473146655|FG004|Overall Study|Sponsor's Decision|0|||
131416108|NCT01659255|473146656|FG005|Overall Study|Sponsor's Decision|0|||
131416109|NCT01659255|473146657|FG006|Overall Study|Sponsor's Decision|1|||
131457519|NCT01584440|473304652|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
131416110|NCT01659255|473146658|FG007|Overall Study|Sponsor's Decision|0|||
131416111|NCT01659255|473146659|FG008|Overall Study|Sponsor's Decision|0|||
131416112|NCT01659255|473146660|FG009|Overall Study|Sponsor's Decision|0|||
131416113|NCT01659255|473146661|FG010|Overall Study|Sponsor's Decision|0|||
131416114|NCT01659255|473146662|FG011|Overall Study|Sponsor's Decision|0|||
131416115|NCT01659255|473146663|FG012|Overall Study|Sponsor's Decision|0|||
131457520|NCT01584440|473304653|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
131416116|NCT01659255|473146664|FG013|Overall Study|Sponsor's Decision|0|||
131416117|NCT01659255|473146665|FG014|Overall Study|Sponsor's Decision|0|||
131416118|NCT01659255|473146666|FG015|Overall Study|Sponsor's Decision|0|||
131416119|NCT01659255|473146667|FG016|Overall Study|Sponsor's Decision|0|||
131416120|NCT01659255|473146651|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416121|NCT01659255|473146652|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416122|NCT01659255|473146653|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416123|NCT01659255|473146654|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416124|NCT01659255|473146655|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416125|NCT01659255|473146656|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416126|NCT01659255|473146657|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416127|NCT01659255|473146658|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416128|NCT01659255|473146659|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416129|NCT01659255|473146660|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416130|NCT01659255|473146661|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416131|NCT01659255|473146662|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416132|NCT01659255|473146663|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416133|NCT01659255|473146664|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416134|NCT01659255|473146665|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416135|NCT01659255|473146666|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
131416136|NCT01659255|473146667|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
131416137|NCT01659255|473146651|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
131416138|NCT01659255|473146652|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
131416139|NCT01659255|473146653|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
131416140|NCT01659255|473146654|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
131416141|NCT01659255|473146655|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
131416142|NCT01659255|473146656|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
131416143|NCT01659255|473146657|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
131416144|NCT01659255|473146658|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
131416145|NCT01659255|473146659|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
131416146|NCT01659255|473146660|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
131416147|NCT01659255|473146661|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
131416148|NCT01659255|473146662|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
131416149|NCT01659255|473146663|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
131416150|NCT01659255|473146664|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
131416151|NCT01659255|473146665|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
131416152|NCT01659255|473146666|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
131416153|NCT01659255|473146667|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
131416154|NCT01116427|473146668|FG000|Core Phase|Adverse Event|0|||
131416155|NCT01116427|473146669|FG001|Core Phase|Adverse Event|1|||
131416156|NCT01116427|473146668|FG000|Core Phase|Lost to Follow-up|1|||
131416157|NCT01116427|473146669|FG001|Core Phase|Lost to Follow-up|0|||
131416158|NCT01116427|473146668|FG000|Core Phase|Withdrawal by Subject|3|||
131416159|NCT01116427|473146669|FG001|Core Phase|Withdrawal by Subject|0|||
131416160|NCT01116427|473146668|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
131416161|NCT01116427|473146669|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
131416162|NCT01116427|473146668|FG000|Extension Phase|Adverse Event|1|||
131416163|NCT01116427|473146669|FG001|Extension Phase|Adverse Event|1|||
131416164|NCT01116427|473146668|FG000|Extension Phase|Lost to Follow-up|2|||
131416165|NCT01116427|473146669|FG001|Extension Phase|Lost to Follow-up|0|||
131416166|NCT01116427|473146668|FG000|Extension Phase|Withdrawal by Subject|5|||
131416167|NCT01116427|473146669|FG001|Extension Phase|Withdrawal by Subject|1|||
131416168|NCT01116427|473146668|FG000|Extension Phase|Not using appropriate birth control|1|||
131416169|NCT01116427|473146669|FG001|Extension Phase|Not using appropriate birth control|0|||
131416170|NCT02771626|473146672|FG000|Overall Study|Adverse Event|1|||
131416171|NCT02771626|473146673|FG001|Overall Study|Adverse Event|5|||
131416172|NCT02771626|473146674|FG002|Overall Study|Adverse Event|3|||
131416173|NCT02771626|473146675|FG003|Overall Study|Adverse Event|0|||
131416174|NCT02771626|473146676|FG004|Overall Study|Adverse Event|1|||
131416175|NCT02771626|473146677|FG005|Overall Study|Adverse Event|1|||
131457521|NCT01584440|473304649|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
131457522|NCT01584440|473304650|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
131457523|NCT01584440|473304651|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
131457524|NCT01584440|473304652|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
131457525|NCT01584440|473304653|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
131457526|NCT01584440|473304649|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
131416176|NCT02771626|473146672|FG000|Overall Study|Radiologic Disease Progression|6|||
131416177|NCT02771626|473146673|FG001|Overall Study|Radiologic Disease Progression|13|||
131457527|NCT01584440|473304650|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
131457528|NCT01584440|473304651|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
131416178|NCT02771626|473146674|FG002|Overall Study|Radiologic Disease Progression|10|||
131416179|NCT02771626|473146675|FG003|Overall Study|Radiologic Disease Progression|7|||
131416180|NCT02771626|473146676|FG004|Overall Study|Radiologic Disease Progression|28|||
131416181|NCT02771626|473146677|FG005|Overall Study|Radiologic Disease Progression|15|||
131416182|NCT02771626|473146672|FG000|Overall Study|Symptomatic Deterioration|0|||
131416183|NCT02771626|473146673|FG001|Overall Study|Symptomatic Deterioration|4|||
131416184|NCT02771626|473146674|FG002|Overall Study|Symptomatic Deterioration|2|||
131416185|NCT02771626|473146675|FG003|Overall Study|Symptomatic Deterioration|0|||
131416186|NCT02771626|473146676|FG004|Overall Study|Symptomatic Deterioration|5|||
131416187|NCT02771626|473146677|FG005|Overall Study|Symptomatic Deterioration|2|||
131416188|NCT02771626|473146672|FG000|Overall Study|Participant Request|0|||
131416189|NCT02771626|473146673|FG001|Overall Study|Participant Request|1|||
131416190|NCT02771626|473146674|FG002|Overall Study|Participant Request|0|||
131416191|NCT02771626|473146675|FG003|Overall Study|Participant Request|2|||
131416192|NCT02771626|473146676|FG004|Overall Study|Participant Request|0|||
131416193|NCT02771626|473146677|FG005|Overall Study|Participant Request|1|||
131416194|NCT02771626|473146672|FG000|Overall Study|Investigator Decision|0|||
131416195|NCT02771626|473146673|FG001|Overall Study|Investigator Decision|1|||
131416196|NCT02771626|473146674|FG002|Overall Study|Investigator Decision|0|||
131416197|NCT02771626|473146675|FG003|Overall Study|Investigator Decision|0|||
131416198|NCT02771626|473146676|FG004|Overall Study|Investigator Decision|1|||
131416199|NCT02771626|473146677|FG005|Overall Study|Investigator Decision|0|||
131416200|NCT02771626|473146672|FG000|Overall Study|Study Termination by Sponsor|0|||
131416201|NCT02771626|473146673|FG001|Overall Study|Study Termination by Sponsor|2|||
131416202|NCT02771626|473146674|FG002|Overall Study|Study Termination by Sponsor|1|||
131416203|NCT02771626|473146675|FG003|Overall Study|Study Termination by Sponsor|0|||
131416204|NCT02771626|473146676|FG004|Overall Study|Study Termination by Sponsor|1|||
131416205|NCT02771626|473146677|FG005|Overall Study|Study Termination by Sponsor|0|||
131416206|NCT02771626|473146672|FG000|Overall Study|Informed Consent Withdrawn|0|||
131416207|NCT02771626|473146673|FG001|Overall Study|Informed Consent Withdrawn|0|||
131416208|NCT02771626|473146674|FG002|Overall Study|Informed Consent Withdrawn|1|||
131416209|NCT02771626|473146675|FG003|Overall Study|Informed Consent Withdrawn|0|||
131416210|NCT02771626|473146676|FG004|Overall Study|Informed Consent Withdrawn|1|||
131416211|NCT02771626|473146677|FG005|Overall Study|Informed Consent Withdrawn|1|||
131416212|NCT02771626|473146672|FG000|Overall Study|Other, Not Specified|1|||
131416213|NCT02771626|473146673|FG001|Overall Study|Other, Not Specified|0|||
131416214|NCT02771626|473146674|FG002|Overall Study|Other, Not Specified|0|||
131416215|NCT02771626|473146675|FG003|Overall Study|Other, Not Specified|0|||
131416216|NCT02771626|473146676|FG004|Overall Study|Other, Not Specified|0|||
131416217|NCT02771626|473146677|FG005|Overall Study|Other, Not Specified|1|||
131416218|NCT02565810|473146681|FG000|Overall Study|Withdrawal by Subject|1|||
131416219|NCT01504204|473146684|FG000|Overall Study|Lost to Follow-up|1|||
131416220|NCT01504204|473146685|FG001|Overall Study|Lost to Follow-up|1|||
131416221|NCT02723175|473146686|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
131416222|NCT02723175|473146687|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
131416223|NCT02723175|473146686|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
131416224|NCT02723175|473146687|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
131416225|NCT04109976|473146691|FG000|Overall Study|Withdrawal by Subject|1|||
131416226|NCT04109976|473146692|FG001|Overall Study|Withdrawal by Subject|0|||
131416227|NCT00491608|473146693|FG000|Overall Study|Death|2|||
131416228|NCT00491608|473146693|FG000|Overall Study|Withdrawal by Subject|1|||
131416229|NCT00413374|473146694|FG000|Overall Study|Ineligible due to screening criteria.|3|||
131416230|NCT00413374|473146695|FG001|Overall Study|Ineligible due to screening criteria.|0|||
131416231|NCT00413374|473146694|FG000|Overall Study|Adverse Event|1|||
131416232|NCT00413374|473146695|FG001|Overall Study|Adverse Event|0|||
131416233|NCT00413374|473146694|FG000|Overall Study|Lost to Follow-up|1|||
131416234|NCT00413374|473146695|FG001|Overall Study|Lost to Follow-up|0|||
131416235|NCT00413374|473146694|FG000|Overall Study|Surgery|1|||
131416236|NCT00413374|473146695|FG001|Overall Study|Surgery|0|||
131416237|NCT02613169|473146697|FG000|Overall Study|Withdrawal by Subject|4|||
131416238|NCT02613169|473146698|FG001|Overall Study|Withdrawal by Subject|1|||
131416239|NCT02613169|473146697|FG000|Overall Study|Lost to Follow-up|0|||
131416240|NCT02613169|473146698|FG001|Overall Study|Lost to Follow-up|5|||
131416241|NCT02613169|473146697|FG000|Overall Study|HIV|0|||
131416242|NCT02613169|473146698|FG001|Overall Study|HIV|2|||
131416243|NCT02613169|473146697|FG000|Overall Study|No TB infection endpoint|14|||
131416244|NCT02613169|473146698|FG001|Overall Study|No TB infection endpoint|9|||
131416245|NCT00343382|473146699|FG000|Overall Study|Adverse Event|2|||
131416246|NCT00343382|473146700|FG001|Overall Study|Adverse Event|10|||
131416247|NCT00343382|473146701|FG002|Overall Study|Adverse Event|7|||
131416248|NCT00343382|473146699|FG000|Overall Study|Withdrawal by Subject|1|||
131416249|NCT00343382|473146700|FG001|Overall Study|Withdrawal by Subject|2|||
131416250|NCT00343382|473146701|FG002|Overall Study|Withdrawal by Subject|6|||
131416251|NCT00343382|473146699|FG000|Overall Study|Other Reason Not Specified|1|||
131416252|NCT00343382|473146700|FG001|Overall Study|Other Reason Not Specified|2|||
131416253|NCT00343382|473146701|FG002|Overall Study|Other Reason Not Specified|4|||
131416254|NCT03691779|473146706|FG000|Part B (24 Weeks)|Adverse Event|0|||
131416255|NCT03691779|473146707|FG001|Part B (24 Weeks)|Adverse Event|1|||
131416256|NCT03691779|473146706|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
131416257|NCT03691779|473146707|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
131416258|NCT01561963|473146708|FG000|Overall Study|Adverse Event|1|||
131416259|NCT01183468|473146711|FG000|Overall Study|Lost to Follow-up|2|||
131416260|NCT01183468|473146712|FG001|Overall Study|Lost to Follow-up|1|||
131416261|NCT01183468|473146713|FG002|Overall Study|Lost to Follow-up|0|||
131416262|NCT01183468|473146714|FG003|Overall Study|Lost to Follow-up|0|||
131416263|NCT01183468|473146711|FG000|Overall Study|Physician Decision|1|||
131416264|NCT01183468|473146712|FG001|Overall Study|Physician Decision|0|||
131416265|NCT01183468|473146713|FG002|Overall Study|Physician Decision|0|||
131416266|NCT01183468|473146714|FG003|Overall Study|Physician Decision|0|||
131416267|NCT01183468|473146711|FG000|Overall Study|Withdrawal by Subject|0|||
131416268|NCT01183468|473146712|FG001|Overall Study|Withdrawal by Subject|1|||
131416269|NCT01183468|473146713|FG002|Overall Study|Withdrawal by Subject|0|||
131416270|NCT01183468|473146714|FG003|Overall Study|Withdrawal by Subject|0|||
131416271|NCT00845065|473146715|FG000|Overall Study|Adverse Event|3|||
131416272|NCT00845065|473146716|FG001|Overall Study|Adverse Event|23|||
131416273|NCT00845065|473146715|FG000|Overall Study|Lack of Efficacy|43|||
131416274|NCT00845065|473146716|FG001|Overall Study|Lack of Efficacy|21|||
131416275|NCT00845065|473146715|FG000|Overall Study|Non-Medical Reasons|1|||
131416276|NCT00845065|473146716|FG001|Overall Study|Non-Medical Reasons|11|||
131416277|NCT01198509|473146717|FG000|Overall Study|Withdrawal by Subject|1|||
131416278|NCT01198509|473146718|FG001|Overall Study|Withdrawal by Subject|0|||
131416279|NCT01198509|473146719|FG002|Overall Study|Withdrawal by Subject|0|||
131416280|NCT01198509|473146720|FG003|Overall Study|Withdrawal by Subject|0|||
131416281|NCT01198509|473146721|FG004|Overall Study|Withdrawal by Subject|0|||
131416282|NCT01198509|473146722|FG005|Overall Study|Withdrawal by Subject|0|||
131416283|NCT00499746|473146723|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
131416284|NCT00499746|473146723|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
131416285|NCT00499746|473146723|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
131416286|NCT00499746|473146723|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
131416287|NCT02273960|473146724|FG000|Short Term Period|Lost to Follow-up|1|||
131416288|NCT02273960|473146725|FG001|Short Term Period|Lost to Follow-up|0|||
131416289|NCT02273960|473146726|FG002|Short Term Period|Lost to Follow-up|0|||
131416290|NCT02273960|473146727|FG003|Short Term Period|Lost to Follow-up|0|||
131416291|NCT02273960|473146724|FG000|Short Term Period|Lack of Efficacy|0|||
131416292|NCT02273960|473146725|FG001|Short Term Period|Lack of Efficacy|0|||
131416293|NCT02273960|473146726|FG002|Short Term Period|Lack of Efficacy|0|||
131416294|NCT02273960|473146727|FG003|Short Term Period|Lack of Efficacy|1|||
131416295|NCT02273960|473146724|FG000|Short Term Period|ST complete, not entering LTE|4|||
131416296|NCT02273960|473146725|FG001|Short Term Period|ST complete, not entering LTE|6|||
131416297|NCT02273960|473146726|FG002|Short Term Period|ST complete, not entering LTE|4|||
131416298|NCT02273960|473146727|FG003|Short Term Period|ST complete, not entering LTE|5|||
131416299|NCT02273960|473146724|FG000|Long Term Extension|Death|0|||
131416300|NCT02273960|473146725|FG001|Long Term Extension|Death|0|||
131416301|NCT02273960|473146726|FG002|Long Term Extension|Death|0|||
131416302|NCT02273960|473146727|FG003|Long Term Extension|Death|1|||
131416303|NCT00952614|473146728|FG000|Overall Study|Death|3|||
131416304|NCT00952614|473146728|FG000|Overall Study|Lost to Follow-up|3|||
131416305|NCT00952614|473146728|FG000|Overall Study|other reason|1|||
131416306|NCT04023682|473146729|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
131416307|NCT03652675|473146730|FG000|Overall Study|Lost to Follow-up|4|||
131416308|NCT03652675|473146731|FG001|Overall Study|Lost to Follow-up|4|||
131416309|NCT01638559|473146733|FG000|Overall Study|Lost to Follow-up|1|||
131416310|NCT01638559|473146733|FG000|Overall Study|Withdrawal by Subject|1|||
131416311|NCT01638559|473146733|FG000|Overall Study|Subject declined to travel for biopsy|1|||
131416312|NCT02014584|473146739|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131416313|NCT02014584|473146740|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
131416314|NCT02014584|473146741|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131416315|NCT02014584|473146742|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131416316|NCT02014584|473146743|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131416317|NCT02014584|473146744|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131416318|NCT02014584|473146739|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
131416319|NCT02014584|473146740|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
131416320|NCT02014584|473146741|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131416321|NCT02014584|473146742|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131416322|NCT02014584|473146743|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131416323|NCT02014584|473146744|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131416324|NCT02014584|473146739|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
131416325|NCT02014584|473146740|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
131416326|NCT02014584|473146741|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
131416327|NCT02014584|473146742|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
131416328|NCT02014584|473146743|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
131416329|NCT02014584|473146744|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
131416330|NCT02014584|473146739|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
131416331|NCT02014584|473146740|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
131416332|NCT02014584|473146741|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
131416333|NCT02014584|473146742|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
131416334|NCT02014584|473146743|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
131416335|NCT02014584|473146744|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
131416336|NCT02014584|473146739|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
131416337|NCT02014584|473146740|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
131416338|NCT02014584|473146741|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
131416339|NCT02014584|473146742|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
131416340|NCT02014584|473146743|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
131416341|NCT02014584|473146744|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
131416342|NCT00772109|473146745|FG000|Overall Study|Serious adverse event|1|||
131416343|NCT00772109|473146746|FG001|Overall Study|Serious adverse event|0|||
131416344|NCT00772109|473146747|FG002|Overall Study|Serious adverse event|1|||
131416345|NCT00772109|473146748|FG003|Overall Study|Serious adverse event|0|||
131416346|NCT00772109|473146745|FG000|Overall Study|Protocol Violation|5|||
131416347|NCT00772109|473146746|FG001|Overall Study|Protocol Violation|8|||
131416348|NCT00772109|473146747|FG002|Overall Study|Protocol Violation|7|||
131416349|NCT00772109|473146748|FG003|Overall Study|Protocol Violation|6|||
131416350|NCT00772109|473146745|FG000|Overall Study|Lost to Follow-up|7|||
131416351|NCT00772109|473146746|FG001|Overall Study|Lost to Follow-up|3|||
131416352|NCT00772109|473146747|FG002|Overall Study|Lost to Follow-up|5|||
131416353|NCT00772109|473146748|FG003|Overall Study|Lost to Follow-up|9|||
131416354|NCT00772109|473146745|FG000|Overall Study|Withdrawal by Subject|8|||
131416355|NCT00772109|473146746|FG001|Overall Study|Withdrawal by Subject|8|||
131416356|NCT00772109|473146747|FG002|Overall Study|Withdrawal by Subject|6|||
131416357|NCT00772109|473146748|FG003|Overall Study|Withdrawal by Subject|16|||
131416358|NCT01403116|473146749|FG000|Overall Study|Adverse Event|7|||
131416359|NCT01403116|473146750|FG001|Overall Study|Adverse Event|4|||
131416360|NCT01403116|473146749|FG000|Overall Study|Lost to Follow-up|7|||
131416361|NCT01403116|473146750|FG001|Overall Study|Lost to Follow-up|5|||
131416362|NCT01403116|473146749|FG000|Overall Study|Withdrawal by Subject|12|||
131416363|NCT01403116|473146750|FG001|Overall Study|Withdrawal by Subject|15|||
131416364|NCT01403116|473146749|FG000|Overall Study|Non-compliance of study drug|3|||
131416365|NCT01403116|473146750|FG001|Overall Study|Non-compliance of study drug|0|||
131416366|NCT01403116|473146749|FG000|Overall Study|Protocol Violation|0|||
131416367|NCT01403116|473146750|FG001|Overall Study|Protocol Violation|1|||
131416368|NCT01403116|473146749|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
131416369|NCT01403116|473146750|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
131416370|NCT01403116|473146749|FG000|Overall Study|Hct >54%|2|||
131416371|NCT01403116|473146750|FG001|Overall Study|Hct >54%|0|||
131416372|NCT01403116|473146749|FG000|Overall Study|unable to keep appointments|0|||
131416373|NCT01403116|473146750|FG001|Overall Study|unable to keep appointments|2|||
131416374|NCT01895309|473146751|FG000|Overall Study|Adverse Event|13|||
131416375|NCT01895309|473146752|FG001|Overall Study|Adverse Event|17|||
131416376|NCT01895309|473146751|FG000|Overall Study|Protocol Violation|1|||
131416377|NCT01895309|473146752|FG001|Overall Study|Protocol Violation|0|||
131416378|NCT01895309|473146751|FG000|Overall Study|Lack of Efficacy|1|||
131416379|NCT01895309|473146752|FG001|Overall Study|Lack of Efficacy|3|||
131416380|NCT01895309|473146751|FG000|Overall Study|Lost to Follow-up|1|||
131416381|NCT01895309|473146752|FG001|Overall Study|Lost to Follow-up|3|||
131416382|NCT01895309|473146751|FG000|Overall Study|Physician Decision|15|||
131416383|NCT01895309|473146752|FG001|Overall Study|Physician Decision|10|||
131416384|NCT01895309|473146751|FG000|Overall Study|Withdrawal by Subject|9|||
131416385|NCT01895309|473146752|FG001|Overall Study|Withdrawal by Subject|18|||
131416386|NCT00042666|473146753|FG000|Overall Study|Adverse Event|2|||
131416387|NCT00042666|473146753|FG000|Overall Study|Death|4|||
131416388|NCT00042666|473146753|FG000|Overall Study|Protocol Violation|1|||
131416389|NCT00042666|473146753|FG000|Overall Study|Participant/Physician Perception|1|||
131416390|NCT00042666|473146753|FG000|Overall Study|Progressive Disease|41|||
131416391|NCT00042666|473146753|FG000|Overall Study|Other|1|||
131416392|NCT00042666|473146753|FG000|Overall Study|Other|4|||
131416393|NCT04268745|473146754|FG000|Overall Study|Lost to Follow-up|2|||
131416394|NCT04268745|473146755|FG001|Overall Study|Lost to Follow-up|3|||
131416395|NCT04268745|473146754|FG000|Overall Study|Withdrawal by Subject|4|||
131416396|NCT04268745|473146755|FG001|Overall Study|Withdrawal by Subject|2|||
131416397|NCT04268745|473146754|FG000|Overall Study|Death in the family|1|||
131416398|NCT04268745|473146755|FG001|Overall Study|Death in the family|0|||
131416399|NCT04046250|473146758|FG000|Overall Study|Death|0|||
131416400|NCT04046250|473146759|FG001|Overall Study|Death|1|||
131416401|NCT04046250|473146758|FG000|Overall Study|Withdrawal by Subject|3|||
131416402|NCT04046250|473146759|FG001|Overall Study|Withdrawal by Subject|3|||
131416403|NCT00527332|473146762|FG000|Overall Study|Protocol Violation|4|||
131416404|NCT00527332|473146763|FG001|Overall Study|Protocol Violation|8|||
131416405|NCT00527332|473146762|FG000|Overall Study|Withdrew consent|5|||
131416406|NCT00527332|473146763|FG001|Overall Study|Withdrew consent|1|||
131416407|NCT00707954|473148712|FG000|Overall Study|Physician Decision|0|||
131416408|NCT00707954|473148713|FG001|Overall Study|Physician Decision|0|||
131416409|NCT00707954|473148714|FG002|Overall Study|Physician Decision|0|||
131416410|NCT00707954|473148715|FG003|Overall Study|Physician Decision|0|||
131416411|NCT00707954|473148716|FG004|Overall Study|Physician Decision|1|||
131416412|NCT04037254|473148717|FG000|Overall Study|Protocol Violation|1|||
131416413|NCT04037254|473148718|FG001|Overall Study|Protocol Violation|0|||
131416414|NCT04037254|473148719|FG002|Overall Study|Protocol Violation|0|||
131416415|NCT04037254|473148720|FG003|Overall Study|Protocol Violation|0|||
131416416|NCT04037254|473148721|FG004|Overall Study|Protocol Violation|0|||
131416417|NCT04037254|473148717|FG000|Overall Study|Withdrawal by Subject|0|||
131416418|NCT04037254|473148718|FG001|Overall Study|Withdrawal by Subject|0|||
131416419|NCT04037254|473148719|FG002|Overall Study|Withdrawal by Subject|1|||
131416420|NCT04037254|473148720|FG003|Overall Study|Withdrawal by Subject|0|||
131416421|NCT04037254|473148721|FG004|Overall Study|Withdrawal by Subject|0|||
131416422|NCT04037254|473148717|FG000|Overall Study|Delayed or incomplete treatment|0|||
131416423|NCT04037254|473148718|FG001|Overall Study|Delayed or incomplete treatment|2|||
131416424|NCT04037254|473148719|FG002|Overall Study|Delayed or incomplete treatment|1|||
131416425|NCT04037254|473148720|FG003|Overall Study|Delayed or incomplete treatment|0|||
131416426|NCT04037254|473148721|FG004|Overall Study|Delayed or incomplete treatment|0|||
131416427|NCT00448747|473148723|FG000|Overall Study|collapsed veins|1|||
131416428|NCT00448747|473148724|FG001|Overall Study|collapsed veins|0|||
131416429|NCT01424566|473148725|FG000|Single-blind Treatment|Adverse Event|71|||
131416430|NCT01424566|473148726|FG001|Single-blind Treatment|Adverse Event|0|||
131416431|NCT01424566|473148727|FG002|Single-blind Treatment|Adverse Event|0|||
131416432|NCT01424566|473148725|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
131416433|NCT01424566|473148726|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
131416434|NCT01424566|473148727|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
131416435|NCT01424566|473148725|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
131416436|NCT01424566|473148726|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
131416437|NCT01424566|473148727|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
131416438|NCT01424566|473148725|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
131416439|NCT01424566|473148726|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
131416440|NCT01424566|473148727|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
131416441|NCT01424566|473148725|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
131416442|NCT01424566|473148726|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
131416443|NCT01424566|473148727|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
131416444|NCT01424566|473148725|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
131416445|NCT01424566|473148726|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
131416446|NCT01424566|473148727|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
131416447|NCT01424566|473148725|FG000|Double-blind Treatment|Adverse Event|0|||
131416448|NCT01424566|473148726|FG001|Double-blind Treatment|Adverse Event|21|||
131416449|NCT01424566|473148727|FG002|Double-blind Treatment|Adverse Event|13|||
131416450|NCT01424566|473148725|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
131416451|NCT01424566|473148726|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
131416452|NCT01424566|473148727|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
131416453|NCT01424566|473148725|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
131416454|NCT01424566|473148726|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
131416455|NCT01424566|473148727|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
131416456|NCT01424566|473148725|FG000|Double-blind Treatment|Lack of Efficacy|0|||
131416457|NCT01424566|473148726|FG001|Double-blind Treatment|Lack of Efficacy|1|||
131416458|NCT01424566|473148727|FG002|Double-blind Treatment|Lack of Efficacy|1|||
131416459|NCT03779503|473148728|FG000|First Intervention|Adverse Event|0|||
131416460|NCT03779503|473148729|FG001|First Intervention|Adverse Event|1|||
131416461|NCT03779503|473148728|FG000|First Intervention|Withdrawal by Subject|1|||
131416462|NCT03779503|473148729|FG001|First Intervention|Withdrawal by Subject|0|||
131416463|NCT00548717|473148730|FG000|Overall Study|Death|5|||
131416464|NCT00548717|473148731|FG001|Overall Study|Death|2|||
131416465|NCT00548717|473148730|FG000|Overall Study|Relapse|3|||
131416466|NCT00548717|473148731|FG001|Overall Study|Relapse|0|||
131416467|NCT00548717|473148730|FG000|Overall Study|Alternative treatment for GVHD|1|||
131416468|NCT00548717|473148731|FG001|Overall Study|Alternative treatment for GVHD|0|||
131416469|NCT02809053|473148732|FG000|Overall Study|Death|0|||
131416470|NCT02809053|473148733|FG001|Overall Study|Death|1|||
131416471|NCT02809053|473148732|FG000|Overall Study|Lost to Follow-up|3|||
131416472|NCT02809053|473148733|FG001|Overall Study|Lost to Follow-up|1|||
131416473|NCT02809053|473148732|FG000|Overall Study|Withdrawal by Subject|2|||
131416474|NCT02809053|473148733|FG001|Overall Study|Withdrawal by Subject|3|||
131416475|NCT02809053|473148732|FG000|Overall Study|Disease Progression|2|||
131416476|NCT02809053|473148733|FG001|Overall Study|Disease Progression|1|||
131416477|NCT02715726|473148739|FG000|Overall Study|Adverse Event|2|||
131416478|NCT02715726|473148740|FG001|Overall Study|Adverse Event|6|||
131416479|NCT02715726|473148739|FG000|Overall Study|Protocol Violation|1|||
131416480|NCT02715726|473148740|FG001|Overall Study|Protocol Violation|0|||
131416481|NCT02715726|473148739|FG000|Overall Study|Death|2|||
131416482|NCT02715726|473148740|FG001|Overall Study|Death|1|||
131416483|NCT02715726|473148739|FG000|Overall Study|Participant moved|1|||
131416484|NCT02715726|473148740|FG001|Overall Study|Participant moved|3|||
131416485|NCT02715726|473148739|FG000|Overall Study|Other than specified above|11|||
131416486|NCT02715726|473148740|FG001|Overall Study|Other than specified above|15|||
131416487|NCT02715726|473148739|FG000|Overall Study|Randomized but not treated|1|||
131416488|NCT02715726|473148740|FG001|Overall Study|Randomized but not treated|2|||
131416489|NCT03230292|473148741|FG000|Overall Study|Adverse Event|1|||
131416490|NCT03230292|473148741|FG000|Overall Study|Protocol Violation|1|||
131416491|NCT03230292|473148741|FG000|Overall Study|Lost to Follow-up|1|||
131416492|NCT03230292|473148741|FG000|Overall Study|Withdrawal by Subject|3|||
131416493|NCT00687609|473148742|FG000|Overall Study|Physician Decision|1|||
131416494|NCT00687609|473148742|FG000|Overall Study|Withdrawal by Subject|2|||
131416495|NCT00908037|473148743|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416496|NCT00908037|473148744|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416497|NCT00908037|473148745|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416498|NCT00908037|473148746|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416499|NCT00908037|473148747|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
131416500|NCT00908037|473148748|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416501|NCT00908037|473148749|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
131416502|NCT00908037|473148750|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131457529|NCT01584440|473304652|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
131457530|NCT01584440|473304653|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
131457531|NCT01584440|473304649|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
131457532|NCT01584440|473304650|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
131457533|NCT01584440|473304651|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
131416503|NCT00908037|473148751|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
131416504|NCT00908037|473148752|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416505|NCT00908037|473148753|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416506|NCT00908037|473148754|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
131416507|NCT00908037|473148743|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416508|NCT00908037|473148744|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416509|NCT00908037|473148745|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416510|NCT00908037|473148746|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416511|NCT00908037|473148747|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
131416512|NCT00908037|473148748|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416513|NCT00908037|473148749|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416514|NCT00908037|473148750|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416515|NCT00908037|473148751|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
131416516|NCT00908037|473148752|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416517|NCT00908037|473148753|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416518|NCT00908037|473148754|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
131416519|NCT00908037|473148743|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416520|NCT00908037|473148744|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416521|NCT00908037|473148745|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416522|NCT00908037|473148746|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
131416523|NCT00908037|473148747|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416524|NCT00908037|473148748|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416525|NCT00908037|473148749|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
131416526|NCT00908037|473148750|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416527|NCT00908037|473148751|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416528|NCT00908037|473148752|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416529|NCT00908037|473148753|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416530|NCT00908037|473148754|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
131416531|NCT00908037|473148743|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416532|NCT00908037|473148744|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416533|NCT00908037|473148745|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416534|NCT00908037|473148746|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416535|NCT00908037|473148747|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416536|NCT00908037|473148748|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416537|NCT00908037|473148749|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416538|NCT00908037|473148750|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416539|NCT00908037|473148751|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416540|NCT00908037|473148752|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416541|NCT00908037|473148753|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
131416542|NCT00908037|473148754|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
131416543|NCT00908037|473148743|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416544|NCT00908037|473148744|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416545|NCT00908037|473148745|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416546|NCT00908037|473148746|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416547|NCT00908037|473148747|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416548|NCT00908037|473148748|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416549|NCT00908037|473148749|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416550|NCT00908037|473148750|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416551|NCT00908037|473148751|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416552|NCT00908037|473148752|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
131416553|NCT00908037|473148753|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
131416554|NCT00908037|473148754|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
131416555|NCT00908037|473148743|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416556|NCT00908037|473148744|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416557|NCT00908037|473148745|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416558|NCT00908037|473148746|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416559|NCT00908037|473148747|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416560|NCT00908037|473148748|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416561|NCT00908037|473148749|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416562|NCT00908037|473148750|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416563|NCT00908037|473148751|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416564|NCT00908037|473148752|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
131416565|NCT00908037|473148753|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416566|NCT00908037|473148754|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
131416567|NCT00908037|473148743|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416568|NCT00908037|473148744|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416569|NCT00908037|473148745|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416570|NCT00908037|473148746|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416571|NCT00908037|473148747|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416572|NCT00908037|473148748|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416573|NCT00908037|473148749|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416574|NCT00908037|473148750|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416575|NCT00908037|473148751|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416576|NCT00908037|473148752|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416577|NCT00908037|473148753|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
131416578|NCT00908037|473148754|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
131416579|NCT00908037|473148743|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416580|NCT00908037|473148744|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416581|NCT00908037|473148745|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416582|NCT00908037|473148746|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416583|NCT00908037|473148747|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416584|NCT00908037|473148748|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416585|NCT00908037|473148749|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416586|NCT00908037|473148750|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416587|NCT00908037|473148751|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416588|NCT00908037|473148752|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
131416589|NCT00908037|473148753|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416590|NCT00908037|473148754|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
131416591|NCT00908037|473148743|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416592|NCT00908037|473148744|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416593|NCT00908037|473148745|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416594|NCT00908037|473148746|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416595|NCT00908037|473148747|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416596|NCT00908037|473148748|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416597|NCT00908037|473148749|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416598|NCT00908037|473148750|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416599|NCT00908037|473148751|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416600|NCT00908037|473148752|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416601|NCT00908037|473148753|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
131416602|NCT00908037|473148754|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
131416603|NCT00924404|473148758|FG000|Overall Study|Lost to Follow-up|6|||
131416604|NCT00924404|473148759|FG001|Overall Study|Lost to Follow-up|4|||
131416605|NCT00710385|473148761|FG000|Overall Study|Did not qualify|1|||
131416606|NCT00710385|473148761|FG000|Overall Study|Withdrawal by Subject|1|||
131416607|NCT00710385|473148761|FG000|Overall Study|Undisclosed back pain|1|||
131416608|NCT00710385|473148761|FG000|Overall Study|Physician Decision|1|||
131416609|NCT00710385|473148761|FG000|Overall Study|Undisclosed excessive methadone use|1|||
131416610|NCT01985360|473148762|FG000|Overall Study|Withdrawal by Subject|4|||
131416611|NCT01985360|473148763|FG001|Overall Study|Withdrawal by Subject|0|||
131416612|NCT01985360|473148762|FG000|Overall Study|Lost to Follow-up|5|||
131416613|NCT01985360|473148763|FG001|Overall Study|Lost to Follow-up|3|||
131416614|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
131416615|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
131416616|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
131416617|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
131416618|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
131416619|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
131416620|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
131416621|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
131416622|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
131416623|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
131416624|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
131416625|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
131416626|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
131416627|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
131416628|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
131416629|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
131416630|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
131416631|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
131416632|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
131416633|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
131416634|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
131416635|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
131416636|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
131416637|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
131416638|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
131416639|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
131416640|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
131416641|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
131416642|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
131416643|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
131416644|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
131416645|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
131416646|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
131416647|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
131416648|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
131416649|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
131416650|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
131416651|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
131416652|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
131416653|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
131416654|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
131416655|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
131416656|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
131416657|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
131416658|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416659|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416660|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
131416661|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416662|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416663|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
131416664|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416665|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416666|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416667|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416668|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
131416669|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
131416670|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416671|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416672|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416673|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416674|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416675|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416676|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416677|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416678|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416679|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
131416680|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416681|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416682|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
131416683|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416684|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416685|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416686|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416687|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416688|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416689|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416690|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
131416691|NCT02914561|473148764|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
131416692|NCT02914561|473148765|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
131416693|NCT02914561|473148766|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
131416694|NCT02914561|473148767|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
131416695|NCT02914561|473148768|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
131416696|NCT02914561|473148769|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
131416697|NCT02914561|473148770|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
131416698|NCT02914561|473148771|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
131416699|NCT02914561|473148772|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
131416700|NCT02914561|473148773|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
131416701|NCT02914561|473148774|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
131416702|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
131416703|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
131416704|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
131416705|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
131416706|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
131416707|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
131416708|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
131416709|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
131416710|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
131416711|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
131416712|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
131416713|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
131416714|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
131416715|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
131416716|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
131416717|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
131416718|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
131416719|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
131416720|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
131416721|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
131416722|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
131416723|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
131416724|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
131416725|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
131416726|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
131416727|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
131416728|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
131416729|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
131416730|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
131416731|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
131416732|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
131416733|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
131416734|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
131416735|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416736|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416737|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416738|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416739|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416740|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416741|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
131416742|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416743|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
131416744|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
131416745|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
131416746|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416747|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416748|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416749|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416750|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416751|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416752|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
131416753|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
131416754|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
131416755|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
131416756|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
131416757|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416758|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416759|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416760|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416761|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416762|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131457534|NCT01584440|473304652|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
131457535|NCT01584440|473304653|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
131416763|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
131416764|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416765|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
131416766|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416767|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
131416768|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416769|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416770|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416771|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416772|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416773|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416774|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416775|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416776|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
131416777|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416778|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
131416779|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416780|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416781|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416782|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416783|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416784|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416785|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
131416786|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416787|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416788|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416789|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
131416790|NCT02914561|473148764|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416791|NCT02914561|473148765|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416792|NCT02914561|473148766|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416793|NCT02914561|473148767|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416794|NCT02914561|473148768|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416795|NCT02914561|473148769|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416796|NCT02914561|473148770|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416797|NCT02914561|473148771|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
131416798|NCT02914561|473148772|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
131416799|NCT02914561|473148773|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
131416800|NCT02914561|473148774|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
131416801|NCT01455220|473148779|FG000|Overall Study|screen fail|30|||
131416802|NCT04881747|473148781|FG000|Period 2 Washout|Adverse Event|1|||
131416803|NCT04881747|473148782|FG001|Period 2 Washout|Adverse Event|0|||
131416804|NCT04881747|473148783|FG002|Period 2 Washout|Adverse Event|0|||
131416805|NCT04881747|473148784|FG003|Period 2 Washout|Adverse Event|0|||
131416806|NCT04881747|473148785|FG004|Period 2 Washout|Adverse Event|1|||
131416807|NCT04881747|473148786|FG005|Period 2 Washout|Adverse Event|0|||
131416808|NCT04881747|473148781|FG000|Period 2 Washout|Withdrawal by Subject|1|||
131416809|NCT04881747|473148782|FG001|Period 2 Washout|Withdrawal by Subject|0|||
131416810|NCT04881747|473148783|FG002|Period 2 Washout|Withdrawal by Subject|0|||
131416811|NCT04881747|473148784|FG003|Period 2 Washout|Withdrawal by Subject|1|||
131416812|NCT04881747|473148785|FG004|Period 2 Washout|Withdrawal by Subject|0|||
131416813|NCT04881747|473148786|FG005|Period 2 Washout|Withdrawal by Subject|0|||
131416814|NCT00521222|473148787|FG000|Overall Study|Lost to Follow-up|0|||
131416815|NCT00521222|473148788|FG001|Overall Study|Lost to Follow-up|0|||
131416816|NCT00521222|473148789|FG002|Overall Study|Lost to Follow-up|1|||
131416817|NCT00521222|473148790|FG003|Overall Study|Lost to Follow-up|1|||
131416818|NCT00521222|473148787|FG000|Overall Study|Withdrawal by Subject|0|||
131416819|NCT00521222|473148788|FG001|Overall Study|Withdrawal by Subject|0|||
131416820|NCT00521222|473148789|FG002|Overall Study|Withdrawal by Subject|2|||
131416821|NCT00521222|473148790|FG003|Overall Study|Withdrawal by Subject|0|||
131416822|NCT00521222|473148787|FG000|Overall Study|Physician Decision|0|||
131416823|NCT00521222|473148788|FG001|Overall Study|Physician Decision|1|||
131416824|NCT00521222|473148789|FG002|Overall Study|Physician Decision|0|||
131416825|NCT00521222|473148790|FG003|Overall Study|Physician Decision|1|||
131416826|NCT03332160|473148793|FG000|Overall Study|Withdrawal by Subject|1|||
131416827|NCT03332160|473148794|FG001|Overall Study|Withdrawal by Subject|1|||
131416828|NCT03332160|473148793|FG000|Overall Study|Adverse Event|0|||
131416829|NCT03332160|473148794|FG001|Overall Study|Adverse Event|1|||
131416830|NCT03332160|473148793|FG000|Overall Study|Developed Exclusion Criteria|0|||
131416831|NCT03332160|473148794|FG001|Overall Study|Developed Exclusion Criteria|1|||
131416832|NCT03332160|473148793|FG000|Overall Study|Non-adherence to treatment|0|||
131416833|NCT03332160|473148794|FG001|Overall Study|Non-adherence to treatment|2|||
131416834|NCT03869333|473148798|FG000|Overall Study|Lost to Follow-up|1|||
131416835|NCT03869333|473148799|FG001|Overall Study|Lost to Follow-up|0|||
131416836|NCT03869333|473148800|FG002|Overall Study|Lost to Follow-up|0|||
131416837|NCT03869333|473148801|FG003|Overall Study|Lost to Follow-up|0|||
131416838|NCT03869333|473148798|FG000|Overall Study|Pregnancy|1|||
131416839|NCT03869333|473148799|FG001|Overall Study|Pregnancy|0|||
131416840|NCT03869333|473148800|FG002|Overall Study|Pregnancy|0|||
131416841|NCT03869333|473148801|FG003|Overall Study|Pregnancy|0|||
131416842|NCT03869333|473148798|FG000|Overall Study|Physician Decision|0|||
131416843|NCT03869333|473148799|FG001|Overall Study|Physician Decision|1|||
131416844|NCT03869333|473148800|FG002|Overall Study|Physician Decision|0|||
131416845|NCT03869333|473148801|FG003|Overall Study|Physician Decision|0|||
131416846|NCT01927055|473148802|FG000|Open-label|Adverse Event|6|||
131416847|NCT01927055|473148803|FG001|Open-label|Adverse Event|0|||
131416848|NCT01927055|473148804|FG002|Open-label|Adverse Event|0|||
131416849|NCT01927055|473148802|FG000|Open-label|Withdrawal by Subject|1|||
131416850|NCT01927055|473148803|FG001|Open-label|Withdrawal by Subject|0|||
131416851|NCT01927055|473148804|FG002|Open-label|Withdrawal by Subject|0|||
131416852|NCT01927055|473148802|FG000|Open-label|Study Stopped|4|||
131416853|NCT01927055|473148803|FG001|Open-label|Study Stopped|0|||
131416854|NCT01927055|473148804|FG002|Open-label|Study Stopped|0|||
131416855|NCT01927055|473148802|FG000|Open-label|Supine Hypertension|4|||
131416856|NCT01927055|473148803|FG001|Open-label|Supine Hypertension|0|||
131416857|NCT01927055|473148804|FG002|Open-label|Supine Hypertension|0|||
131416858|NCT01927055|473148802|FG000|Open-label|Difficulty attending study visits|1|||
131416859|NCT01927055|473148803|FG001|Open-label|Difficulty attending study visits|0|||
131416860|NCT01927055|473148804|FG002|Open-label|Difficulty attending study visits|0|||
131416861|NCT01927055|473148802|FG000|Double-Blind|Adverse Event|0|||
131416862|NCT01927055|473148803|FG001|Double-Blind|Adverse Event|1|||
131416863|NCT01927055|473148804|FG002|Double-Blind|Adverse Event|1|||
131416864|NCT01927055|473148802|FG000|Double-Blind|Protocol Violation|0|||
131416865|NCT01927055|473148803|FG001|Double-Blind|Protocol Violation|0|||
131416866|NCT01927055|473148804|FG002|Double-Blind|Protocol Violation|1|||
131416867|NCT01927055|473148802|FG000|Double-Blind|Withdrawal by Subject|0|||
131416868|NCT01927055|473148803|FG001|Double-Blind|Withdrawal by Subject|2|||
131416869|NCT01927055|473148804|FG002|Double-Blind|Withdrawal by Subject|3|||
131416870|NCT01927055|473148802|FG000|Double-Blind|Study Stopped|0|||
131416871|NCT01927055|473148803|FG001|Double-Blind|Study Stopped|7|||
131416872|NCT01927055|473148804|FG002|Double-Blind|Study Stopped|7|||
131416873|NCT01927055|473148802|FG000|Double-Blind|Supine Hypertension|0|||
131416874|NCT01927055|473148803|FG001|Double-Blind|Supine Hypertension|0|||
131416875|NCT01927055|473148804|FG002|Double-Blind|Supine Hypertension|1|||
131416876|NCT01927055|473148802|FG000|Double-Blind|Extended Vacation|0|||
131416877|NCT01927055|473148803|FG001|Double-Blind|Extended Vacation|1|||
131416878|NCT01927055|473148804|FG002|Double-Blind|Extended Vacation|0|||
131416879|NCT02598128|473148805|FG000|Period A: Days -7 to -1|Adverse Event|1|||
131416880|NCT02598128|473148806|FG001|Period A: Days -7 to -1|Adverse Event|0|||
131416881|NCT02598128|473148807|FG002|Period A: Days -7 to -1|Adverse Event|0|||
131416882|NCT02598128|473148808|FG003|Period A: Days -7 to -1|Adverse Event|0|||
131416883|NCT01459913|473148809|FG000|Overall Study|Adverse Event|0|||
131416884|NCT01459913|473148810|FG001|Overall Study|Adverse Event|0|||
131416885|NCT01459913|473148811|FG002|Overall Study|Adverse Event|0|||
131416886|NCT01459913|473148812|FG003|Overall Study|Adverse Event|3|||
131416887|NCT01459913|473148809|FG000|Overall Study|Withdrawal by Subject|4|||
131416888|NCT01459913|473148810|FG001|Overall Study|Withdrawal by Subject|0|||
131416889|NCT01459913|473148811|FG002|Overall Study|Withdrawal by Subject|0|||
131416890|NCT01459913|473148812|FG003|Overall Study|Withdrawal by Subject|5|||
131416891|NCT01459913|473148809|FG000|Overall Study|Lost to Follow-up|7|||
131416892|NCT01459913|473148810|FG001|Overall Study|Lost to Follow-up|4|||
131416893|NCT01459913|473148811|FG002|Overall Study|Lost to Follow-up|1|||
131416894|NCT01459913|473148812|FG003|Overall Study|Lost to Follow-up|8|||
131416895|NCT01459913|473148809|FG000|Overall Study|Death|0|||
131416896|NCT01459913|473148810|FG001|Overall Study|Death|0|||
131416897|NCT01459913|473148811|FG002|Overall Study|Death|0|||
131416898|NCT01459913|473148812|FG003|Overall Study|Death|1|||
131416899|NCT01459913|473148809|FG000|Overall Study|Non- Compliance|0|||
131416900|NCT01459913|473148810|FG001|Overall Study|Non- Compliance|0|||
131416901|NCT01459913|473148811|FG002|Overall Study|Non- Compliance|0|||
131416902|NCT01459913|473148812|FG003|Overall Study|Non- Compliance|3|||
131416903|NCT01459913|473148809|FG000|Overall Study|Physician Decision|0|||
131416904|NCT01459913|473148810|FG001|Overall Study|Physician Decision|1|||
131416905|NCT01459913|473148811|FG002|Overall Study|Physician Decision|0|||
131416906|NCT01459913|473148812|FG003|Overall Study|Physician Decision|0|||
131457536|NCT01584440|473304649|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
131416907|NCT01459913|473148809|FG000|Overall Study|Study Terminated by Sponsor|30|||
131416908|NCT01459913|473148810|FG001|Overall Study|Study Terminated by Sponsor|15|||
131416909|NCT01459913|473148811|FG002|Overall Study|Study Terminated by Sponsor|9|||
131416910|NCT01459913|473148812|FG003|Overall Study|Study Terminated by Sponsor|11|||
131416911|NCT01459913|473148809|FG000|Overall Study|Other|0|||
131416912|NCT01459913|473148810|FG001|Overall Study|Other|0|||
131416913|NCT01459913|473148811|FG002|Overall Study|Other|3|||
131416914|NCT01459913|473148812|FG003|Overall Study|Other|1|||
131416915|NCT01459913|473148809|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
131416916|NCT01459913|473148810|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
131416917|NCT01459913|473148811|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
131416918|NCT01459913|473148812|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
131416919|NCT01064687|473148817|FG000|Overall Study|Adverse Event|9|||
131416920|NCT01064687|473148818|FG001|Overall Study|Adverse Event|4|||
131416921|NCT01064687|473148819|FG002|Overall Study|Adverse Event|10|||
131416922|NCT01064687|473148820|FG003|Overall Study|Adverse Event|3|||
131416923|NCT01064687|473148817|FG000|Overall Study|Death|1|||
131416924|NCT01064687|473148818|FG001|Overall Study|Death|1|||
131416925|NCT01064687|473148819|FG002|Overall Study|Death|0|||
131416926|NCT01064687|473148820|FG003|Overall Study|Death|0|||
131416927|NCT01064687|473148817|FG000|Overall Study|Entry Criteria Not Met|3|||
131416928|NCT01064687|473148818|FG001|Overall Study|Entry Criteria Not Met|0|||
131416929|NCT01064687|473148819|FG002|Overall Study|Entry Criteria Not Met|0|||
131416930|NCT01064687|473148820|FG003|Overall Study|Entry Criteria Not Met|0|||
131416931|NCT01064687|473148817|FG000|Overall Study|Lack of Efficacy|1|||
131416932|NCT01064687|473148818|FG001|Overall Study|Lack of Efficacy|0|||
131416933|NCT01064687|473148819|FG002|Overall Study|Lack of Efficacy|2|||
131416934|NCT01064687|473148820|FG003|Overall Study|Lack of Efficacy|3|||
131416935|NCT01064687|473148817|FG000|Overall Study|Lost to Follow-up|7|||
131416936|NCT01064687|473148818|FG001|Overall Study|Lost to Follow-up|10|||
131416937|NCT01064687|473148819|FG002|Overall Study|Lost to Follow-up|13|||
131416938|NCT01064687|473148820|FG003|Overall Study|Lost to Follow-up|5|||
131416939|NCT01064687|473148817|FG000|Overall Study|Physician Decision|2|||
131416940|NCT01064687|473148818|FG001|Overall Study|Physician Decision|2|||
131416941|NCT01064687|473148819|FG002|Overall Study|Physician Decision|0|||
131416942|NCT01064687|473148820|FG003|Overall Study|Physician Decision|0|||
131416943|NCT01064687|473148817|FG000|Overall Study|Protocol Violation|1|||
131416944|NCT01064687|473148818|FG001|Overall Study|Protocol Violation|1|||
131416945|NCT01064687|473148819|FG002|Overall Study|Protocol Violation|0|||
131416946|NCT01064687|473148820|FG003|Overall Study|Protocol Violation|1|||
131416947|NCT01064687|473148817|FG000|Overall Study|Sponsor Decision|0|||
131416948|NCT01064687|473148818|FG001|Overall Study|Sponsor Decision|0|||
131416949|NCT01064687|473148819|FG002|Overall Study|Sponsor Decision|3|||
131416950|NCT01064687|473148820|FG003|Overall Study|Sponsor Decision|0|||
131416951|NCT01064687|473148817|FG000|Overall Study|Withdrawal by Subject|9|||
131416952|NCT01064687|473148818|FG001|Overall Study|Withdrawal by Subject|7|||
131416953|NCT01064687|473148819|FG002|Overall Study|Withdrawal by Subject|12|||
131416954|NCT01064687|473148820|FG003|Overall Study|Withdrawal by Subject|5|||
131416955|NCT01064687|473148817|FG000|Overall Study|Treatment Noncompliance|1|||
131416956|NCT01064687|473148818|FG001|Overall Study|Treatment Noncompliance|1|||
131416957|NCT01064687|473148819|FG002|Overall Study|Treatment Noncompliance|1|||
131416958|NCT01064687|473148820|FG003|Overall Study|Treatment Noncompliance|0|||
131416959|NCT00619489|473148821|FG000|Overall Study|Adverse Event|0|||
131416960|NCT00619489|473148822|FG001|Overall Study|Adverse Event|7|||
131416961|NCT00619489|473148821|FG000|Overall Study|Withdrawal by Subject|1|||
131416962|NCT00619489|473148822|FG001|Overall Study|Withdrawal by Subject|1|||
131416963|NCT00619489|473148821|FG000|Overall Study|Lack of Efficacy|0|||
131416964|NCT00619489|473148822|FG001|Overall Study|Lack of Efficacy|11|||
131416965|NCT00619489|473148821|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
131416966|NCT00619489|473148822|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
131416967|NCT02966015|473148823|FG000|Inclusion Visit|did not answer questionnaire|8|||
131416968|NCT02966015|473148824|FG001|Inclusion Visit|did not answer questionnaire|3|||
131416969|NCT03040986|473148831|FG000|Overall Study|Hospice|1|||
131416970|NCT03040986|473148832|FG001|Overall Study|Hospice|0|||
131416971|NCT03040986|473148831|FG000|Overall Study|Adverse Event|2|||
131416972|NCT03040986|473148832|FG001|Overall Study|Adverse Event|1|||
131457537|NCT01584440|473304650|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
131416973|NCT03040986|473148831|FG000|Overall Study|Disease progression on study|3|||
131416974|NCT03040986|473148832|FG001|Overall Study|Disease progression on study|1|||
131416975|NCT02228096|473148842|FG000|Overall Study|Study terminated by Sponsor|24|||
131416976|NCT02228096|473148842|FG000|Overall Study|Lack of Efficacy|18|||
131416977|NCT02228096|473148842|FG000|Overall Study|Death|12|||
131416978|NCT02228096|473148842|FG000|Overall Study|Physician Decision|3|||
131416979|NCT02228096|473148842|FG000|Overall Study|Subject/guardian decision|2|||
131416980|NCT02228096|473148842|FG000|Overall Study|New therapy for study indication|1|||
131416981|NCT02228096|473148842|FG000|Overall Study|Enrolled, not infused|11|||
131416982|NCT00558272|473148843|FG000|Overall Study|Adverse Event|10|||
131416983|NCT00558272|473148844|FG001|Overall Study|Adverse Event|0|||
131416984|NCT00558272|473148843|FG000|Overall Study|Death|1|||
131416985|NCT00558272|473148844|FG001|Overall Study|Death|0|||
131416986|NCT00558272|473148843|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
131416987|NCT00558272|473148844|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
131416988|NCT00558272|473148843|FG000|Overall Study|AZ study team decision|0|||
131416989|NCT00558272|473148844|FG001|Overall Study|AZ study team decision|1|||
131416990|NCT00558272|473148843|FG000|Overall Study|Incorrectly enrolled|1|||
131416991|NCT00558272|473148844|FG001|Overall Study|Incorrectly enrolled|0|||
131416992|NCT00558272|473148843|FG000|Overall Study|Withdrawal by Subject|0|||
131416993|NCT00558272|473148844|FG001|Overall Study|Withdrawal by Subject|1|||
131416994|NCT02745535|473148846|FG000|Overall Study|Death|1|||
131416995|NCT02745535|473148846|FG000|Overall Study|Adverse Event|3|||
131416996|NCT02745535|473148846|FG000|Overall Study|Lost to Follow-up|2|||
131416997|NCT01789606|473148847|FG000|Overall Study|Participant not Purchased the Product|0|||
131416998|NCT01789606|473148848|FG001|Overall Study|Participant not Purchased the Product|20|||
131416999|NCT01789606|473148847|FG000|Overall Study|Withdrawal by Subject|0|||
131417000|NCT01789606|473148848|FG001|Overall Study|Withdrawal by Subject|1|||
131417001|NCT01789606|473148847|FG000|Overall Study|Ineligible|6|||
131417002|NCT01789606|473148848|FG001|Overall Study|Ineligible|2|||
131417003|NCT01789606|473148847|FG000|Overall Study|Administrative Reasons|17|||
131417004|NCT01789606|473148848|FG001|Overall Study|Administrative Reasons|6|||
131417005|NCT01789606|473148847|FG000|Overall Study|No Study Medication Taken|0|||
131417006|NCT01789606|473148848|FG001|Overall Study|No Study Medication Taken|1|||
131417007|NCT01789606|473148847|FG000|Overall Study|Protocol Violation|0|||
131417008|NCT01789606|473148848|FG001|Overall Study|Protocol Violation|55|||
131417009|NCT01789606|473148847|FG000|Overall Study|Adverse Event|0|||
131417010|NCT01789606|473148848|FG001|Overall Study|Adverse Event|3|||
131417011|NCT01789606|473148847|FG000|Overall Study|Lost to Follow-up|0|||
131417012|NCT01789606|473148848|FG001|Overall Study|Lost to Follow-up|14|||
131417013|NCT01789606|473148847|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
131417014|NCT01789606|473148848|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
131417015|NCT01291277|473148849|FG000|Overall Study|Death|2|||
131417016|NCT01291277|473148850|FG001|Overall Study|Death|2|||
131417017|NCT01291277|473148849|FG000|Overall Study|Lost to Follow-up|3|||
131417018|NCT01291277|473148850|FG001|Overall Study|Lost to Follow-up|1|||
131417019|NCT00849108|473148851|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
131417020|NCT00849108|473148852|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
131417021|NCT00849108|473148851|FG000|Cohort 2 Efficacy|Adverse Event|0|||
131417022|NCT00849108|473148852|FG001|Cohort 2 Efficacy|Adverse Event|1|||
131417023|NCT00849108|473148851|FG000|Cohort 2 Efficacy|Other|0|||
131417024|NCT00849108|473148852|FG001|Cohort 2 Efficacy|Other|9|||
131417025|NCT02963701|473148856|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
131417026|NCT02963701|473148857|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
131417027|NCT03480009|473148858|FG000|Overall Study|Lost to Follow-up|4|||
131417028|NCT03480009|473148859|FG001|Overall Study|Lost to Follow-up|5|||
131417029|NCT03480009|473148860|FG002|Overall Study|Lost to Follow-up|4|||
131417030|NCT03480009|473148861|FG003|Overall Study|Lost to Follow-up|0|||
131417031|NCT01563172|473148864|FG000|Overall Study|Adverse Event|5|||
131417032|NCT01563172|473148864|FG000|Overall Study|Lost to Follow-up|2|||
131417033|NCT01563172|473148864|FG000|Overall Study|Other (Protocol deviation)|5|||
131417034|NCT01563172|473148864|FG000|Overall Study|Other (Not specified)|1|||
131417035|NCT01105377|473148865|FG000|Overall Study|Withdrawal by Subject|0|||
131417036|NCT01105377|473148866|FG001|Overall Study|Withdrawal by Subject|1|||
131417037|NCT01624090|473148868|FG000|Overall Study|DLT, taken off therapy|0|||
131417038|NCT01624090|473148869|FG001|Overall Study|DLT, taken off therapy|1|||
131417039|NCT01624090|473148870|FG002|Overall Study|DLT, taken off therapy|0|||
131417040|NCT01624090|473148871|FG003|Overall Study|DLT, taken off therapy|0|||
131417041|NCT01624090|473148868|FG000|Overall Study|Withdrew prior to treatment|0|||
131417042|NCT01624090|473148869|FG001|Overall Study|Withdrew prior to treatment|1|||
131417043|NCT01624090|473148870|FG002|Overall Study|Withdrew prior to treatment|0|||
131417044|NCT01624090|473148871|FG003|Overall Study|Withdrew prior to treatment|0|||
131417045|NCT01624090|473148868|FG000|Overall Study|Died on study|0|||
131417046|NCT01624090|473148869|FG001|Overall Study|Died on study|0|||
131417047|NCT01624090|473148870|FG002|Overall Study|Died on study|2|||
131417048|NCT01624090|473148871|FG003|Overall Study|Died on study|0|||
131417049|NCT01624090|473148868|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
131417050|NCT01624090|473148869|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
131417051|NCT01624090|473148870|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
131417052|NCT01624090|473148871|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
131417053|NCT01624090|473148868|FG000|Overall Study|Dose escalated|0|||
131417054|NCT01624090|473148869|FG001|Overall Study|Dose escalated|0|||
131417055|NCT01624090|473148870|FG002|Overall Study|Dose escalated|3|||
131417056|NCT01624090|473148871|FG003|Overall Study|Dose escalated|0|||
131417057|NCT00752726|473148872|FG000|Overall Study|Lost to Follow-up|2|||
131417058|NCT00752726|473148873|FG001|Overall Study|Lost to Follow-up|1|||
131417059|NCT00752726|473148872|FG000|Overall Study|Adverse Event|3|||
131417060|NCT00752726|473148873|FG001|Overall Study|Adverse Event|0|||
131457538|NCT01584440|473304651|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
131417061|NCT00752726|473148872|FG000|Overall Study|Withdrawal by Subject|5|||
131417062|NCT00752726|473148873|FG001|Overall Study|Withdrawal by Subject|10|||
131417063|NCT00752726|473148872|FG000|Overall Study|Other Reason|1|||
131417064|NCT00752726|473148873|FG001|Overall Study|Other Reason|2|||
131417065|NCT04232215|473148874|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131417066|NCT04232215|473148875|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
131417067|NCT01555125|473148878|FG000|Induction Period|Lost to Follow-up|0|||
131417068|NCT01555125|473148879|FG001|Induction Period|Lost to Follow-up|2|||
131417069|NCT01555125|473148880|FG002|Induction Period|Lost to Follow-up|0|||
131417070|NCT01555125|473148881|FG003|Induction Period|Lost to Follow-up|0|||
131417071|NCT01555125|473148882|FG004|Induction Period|Lost to Follow-up|0|||
131417072|NCT01555125|473148878|FG000|Induction Period|Adverse Event|0|||
131417073|NCT01555125|473148879|FG001|Induction Period|Adverse Event|1|||
131417074|NCT01555125|473148880|FG002|Induction Period|Adverse Event|0|||
131417075|NCT01555125|473148881|FG003|Induction Period|Adverse Event|0|||
131417076|NCT01555125|473148882|FG004|Induction Period|Adverse Event|1|||
131417077|NCT01555125|473148878|FG000|Induction Period|Subject / guardian decision|0|||
131417078|NCT01555125|473148879|FG001|Induction Period|Subject / guardian decision|0|||
131417079|NCT01555125|473148880|FG002|Induction Period|Subject / guardian decision|0|||
131417080|NCT01555125|473148881|FG003|Induction Period|Subject / guardian decision|0|||
131417081|NCT01555125|473148882|FG004|Induction Period|Subject / guardian decision|2|||
131417082|NCT01555125|473148878|FG000|Induction Period|Death|1|||
131417083|NCT01555125|473148879|FG001|Induction Period|Death|0|||
131417084|NCT01555125|473148880|FG002|Induction Period|Death|0|||
131417085|NCT01555125|473148881|FG003|Induction Period|Death|0|||
131417086|NCT01555125|473148882|FG004|Induction Period|Death|0|||
131417087|NCT01555125|473148878|FG000|Maintenance Period|Adverse Event|1|||
131417088|NCT01555125|473148879|FG001|Maintenance Period|Adverse Event|1|||
131417089|NCT01555125|473148880|FG002|Maintenance Period|Adverse Event|0|||
131417090|NCT01555125|473148881|FG003|Maintenance Period|Adverse Event|0|||
131417091|NCT01555125|473148882|FG004|Maintenance Period|Adverse Event|0|||
131417092|NCT01555125|473148878|FG000|Maintenance Period|Subject / guardian decision|1|||
131417093|NCT01555125|473148879|FG001|Maintenance Period|Subject / guardian decision|2|||
131417094|NCT01555125|473148880|FG002|Maintenance Period|Subject / guardian decision|0|||
131417095|NCT01555125|473148881|FG003|Maintenance Period|Subject / guardian decision|0|||
131417096|NCT01555125|473148882|FG004|Maintenance Period|Subject / guardian decision|0|||
131417097|NCT01555125|473148878|FG000|Maintenance Period|Lost to Follow-up|2|||
131417098|NCT01555125|473148879|FG001|Maintenance Period|Lost to Follow-up|0|||
131417099|NCT01555125|473148880|FG002|Maintenance Period|Lost to Follow-up|0|||
131417100|NCT01555125|473148881|FG003|Maintenance Period|Lost to Follow-up|1|||
131417101|NCT01555125|473148882|FG004|Maintenance Period|Lost to Follow-up|0|||
131417102|NCT01555125|473148878|FG000|Maintenance Period|Lack of Efficacy|6|||
131417103|NCT01555125|473148879|FG001|Maintenance Period|Lack of Efficacy|1|||
131417104|NCT01555125|473148880|FG002|Maintenance Period|Lack of Efficacy|3|||
131417105|NCT01555125|473148881|FG003|Maintenance Period|Lack of Efficacy|0|||
131417106|NCT01555125|473148882|FG004|Maintenance Period|Lack of Efficacy|0|||
131417107|NCT01555125|473148878|FG000|Maintenance Period|Physician Decision|0|||
131417108|NCT01555125|473148879|FG001|Maintenance Period|Physician Decision|0|||
131417109|NCT01555125|473148880|FG002|Maintenance Period|Physician Decision|1|||
131417110|NCT01555125|473148881|FG003|Maintenance Period|Physician Decision|0|||
131417111|NCT01555125|473148882|FG004|Maintenance Period|Physician Decision|0|||
131417112|NCT01555125|473148878|FG000|Maintenance Period|Death|0|||
131417113|NCT01555125|473148879|FG001|Maintenance Period|Death|0|||
131417114|NCT01555125|473148880|FG002|Maintenance Period|Death|0|||
131417115|NCT01555125|473148881|FG003|Maintenance Period|Death|1|||
131417116|NCT01555125|473148882|FG004|Maintenance Period|Death|0|||
131417117|NCT01555125|473148878|FG000|Extension|Adverse Event|1|||
131417118|NCT01555125|473148879|FG001|Extension|Adverse Event|2|||
131417119|NCT01555125|473148880|FG002|Extension|Adverse Event|1|||
131417120|NCT01555125|473148881|FG003|Extension|Adverse Event|1|||
131457539|NCT01584440|473304652|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
131457540|NCT01584440|473304653|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
131457541|NCT01584440|473304649|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
131417121|NCT01555125|473148882|FG004|Extension|Adverse Event|0|||
131417122|NCT01555125|473148878|FG000|Extension|Protocol deviation|1|||
131417123|NCT01555125|473148879|FG001|Extension|Protocol deviation|0|||
131417124|NCT01555125|473148880|FG002|Extension|Protocol deviation|0|||
131417125|NCT01555125|473148881|FG003|Extension|Protocol deviation|0|||
131417126|NCT01555125|473148882|FG004|Extension|Protocol deviation|0|||
131417127|NCT01555125|473148878|FG000|Extension|Lack of Efficacy|7|||
131417128|NCT01555125|473148879|FG001|Extension|Lack of Efficacy|6|||
131417129|NCT01555125|473148880|FG002|Extension|Lack of Efficacy|3|||
131417130|NCT01555125|473148881|FG003|Extension|Lack of Efficacy|0|||
131417131|NCT01555125|473148882|FG004|Extension|Lack of Efficacy|0|||
131417132|NCT01555125|473148878|FG000|Extension|Lost to Follow-up|2|||
131417133|NCT01555125|473148879|FG001|Extension|Lost to Follow-up|1|||
131417134|NCT01555125|473148880|FG002|Extension|Lost to Follow-up|2|||
131417135|NCT01555125|473148881|FG003|Extension|Lost to Follow-up|0|||
131457542|NCT01584440|473304650|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
131457543|NCT01584440|473304651|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
131417136|NCT01555125|473148882|FG004|Extension|Lost to Follow-up|0|||
131417137|NCT01555125|473148878|FG000|Extension|Study terminated by sponsor|32|||
131417138|NCT01555125|473148879|FG001|Extension|Study terminated by sponsor|33|||
131417139|NCT01555125|473148880|FG002|Extension|Study terminated by sponsor|16|||
131417140|NCT01555125|473148881|FG003|Extension|Study terminated by sponsor|20|||
131417141|NCT01555125|473148882|FG004|Extension|Study terminated by sponsor|0|||
131417142|NCT01555125|473148878|FG000|Extension|Subject/guardian decision|1|||
131417143|NCT01555125|473148879|FG001|Extension|Subject/guardian decision|9|||
131417144|NCT01555125|473148880|FG002|Extension|Subject/guardian decision|1|||
131417145|NCT01555125|473148881|FG003|Extension|Subject/guardian decision|0|||
131417146|NCT01555125|473148882|FG004|Extension|Subject/guardian decision|0|||
131417147|NCT01555125|473148878|FG000|Extension|Technical Problems|1|||
131417148|NCT01555125|473148879|FG001|Extension|Technical Problems|0|||
131417149|NCT01555125|473148880|FG002|Extension|Technical Problems|0|||
131417150|NCT01555125|473148881|FG003|Extension|Technical Problems|1|||
131417151|NCT01555125|473148882|FG004|Extension|Technical Problems|0|||
131417152|NCT01555125|473148878|FG000|Follow-Up Period|Lost to Follow-up|1|||
131417153|NCT01555125|473148879|FG001|Follow-Up Period|Lost to Follow-up|0|||
131417154|NCT01555125|473148880|FG002|Follow-Up Period|Lost to Follow-up|0|||
131417155|NCT01555125|473148881|FG003|Follow-Up Period|Lost to Follow-up|0|||
131417156|NCT01555125|473148882|FG004|Follow-Up Period|Lost to Follow-up|0|||
131417157|NCT01555125|473148878|FG000|Follow-Up Period|Subject / guardian decision|3|||
131417158|NCT01555125|473148879|FG001|Follow-Up Period|Subject / guardian decision|1|||
131417159|NCT01555125|473148880|FG002|Follow-Up Period|Subject / guardian decision|1|||
131417160|NCT01555125|473148881|FG003|Follow-Up Period|Subject / guardian decision|1|||
131417161|NCT01555125|473148882|FG004|Follow-Up Period|Subject / guardian decision|0|||
131417162|NCT02651220|473148883|FG000|Overall Study|Adverse Event|1|||
131417163|NCT02651220|473148884|FG001|Overall Study|Adverse Event|5|||
131417164|NCT02651220|473148885|FG002|Overall Study|Adverse Event|1|||
131417165|NCT02651220|473148883|FG000|Overall Study|Lost to Follow-up|8|||
131417166|NCT02651220|473148884|FG001|Overall Study|Lost to Follow-up|14|||
131417167|NCT02651220|473148885|FG002|Overall Study|Lost to Follow-up|14|||
131417168|NCT02651220|473148883|FG000|Overall Study|Non-Compliance with Study Drug|4|||
131417169|NCT02651220|473148884|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131417170|NCT02651220|473148885|FG002|Overall Study|Non-Compliance with Study Drug|1|||
131417171|NCT02651220|473148883|FG000|Overall Study|Pregnancy|1|||
131417172|NCT02651220|473148884|FG001|Overall Study|Pregnancy|0|||
131417173|NCT02651220|473148885|FG002|Overall Study|Pregnancy|1|||
131417174|NCT02651220|473148883|FG000|Overall Study|Protocol Violation|0|||
131417175|NCT02651220|473148884|FG001|Overall Study|Protocol Violation|0|||
131417176|NCT02651220|473148885|FG002|Overall Study|Protocol Violation|1|||
131417177|NCT02651220|473148883|FG000|Overall Study|Withdrawal by Subject|5|||
131417178|NCT02651220|473148884|FG001|Overall Study|Withdrawal by Subject|6|||
131417179|NCT02651220|473148885|FG002|Overall Study|Withdrawal by Subject|8|||
131417180|NCT02651220|473148883|FG000|Overall Study|Miscellaneous|4|||
131417181|NCT02651220|473148884|FG001|Overall Study|Miscellaneous|1|||
131417182|NCT02651220|473148885|FG002|Overall Study|Miscellaneous|2|||
131417183|NCT02651220|473148883|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131417184|NCT02651220|473148884|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131417185|NCT02651220|473148885|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
131417186|NCT02540291|473148886|FG000|Overall Study|Death|7|||
131417187|NCT02540291|473148887|FG001|Overall Study|Death|7|||
131417188|NCT02540291|473148888|FG002|Overall Study|Death|5|||
131417189|NCT02540291|473148889|FG003|Overall Study|Death|7|||
131417190|NCT02540291|473148886|FG000|Overall Study|Lost to Follow-up|0|||
131417191|NCT02540291|473148887|FG001|Overall Study|Lost to Follow-up|0|||
131417192|NCT02540291|473148888|FG002|Overall Study|Lost to Follow-up|1|||
131417193|NCT02540291|473148889|FG003|Overall Study|Lost to Follow-up|0|||
131417194|NCT02540291|473148886|FG000|Overall Study|Withdrawal Of Consent|0|||
131417195|NCT02540291|473148887|FG001|Overall Study|Withdrawal Of Consent|1|||
131417196|NCT02540291|473148888|FG002|Overall Study|Withdrawal Of Consent|0|||
131417197|NCT02540291|473148889|FG003|Overall Study|Withdrawal Of Consent|0|||
131417198|NCT02540291|473148886|FG000|Overall Study|Study Terminated By Sponsor|1|||
131417199|NCT02540291|473148887|FG001|Overall Study|Study Terminated By Sponsor|0|||
131417200|NCT02540291|473148888|FG002|Overall Study|Study Terminated By Sponsor|0|||
131417201|NCT02540291|473148889|FG003|Overall Study|Study Terminated By Sponsor|0|||
131417202|NCT02540291|473148886|FG000|Overall Study|Other|0|||
131417203|NCT02540291|473148887|FG001|Overall Study|Other|0|||
131417204|NCT02540291|473148888|FG002|Overall Study|Other|1|||
131417205|NCT02540291|473148889|FG003|Overall Study|Other|0|||
131417206|NCT01078168|473148905|FG000|Overall Study|Physician Decision|0|||
131417207|NCT01078168|473148906|FG001|Overall Study|Physician Decision|1|||
131417208|NCT01264419|473148910|FG000|Overall Study|Lost to Follow-up|3|||
131417209|NCT01306656|473150581|FG000|Overall Study|Lost to Follow-up|1|||
131417210|NCT01306656|473150582|FG001|Overall Study|Lost to Follow-up|0|||
131417211|NCT00477152|473150583|FG000|Overall Study|Parent withdrew consent|2|||
131417212|NCT00477152|473150583|FG000|Overall Study|Adverse Event|1|||
131417213|NCT02504580|473150584|FG000|Overall Study|Other|1|||
131417214|NCT02504580|473150585|FG001|Overall Study|Other|0|||
131417215|NCT02504580|473150586|FG002|Overall Study|Other|0|||
131417216|NCT02504580|473150587|FG003|Overall Study|Other|2|||
131417217|NCT02504580|473150588|FG004|Overall Study|Other|1|||
131417218|NCT02504580|473150589|FG005|Overall Study|Other|1|||
131417219|NCT02504580|473150590|FG006|Overall Study|Other|1|||
131417220|NCT02504580|473150591|FG007|Overall Study|Other|2|||
131417221|NCT02504580|473150592|FG008|Overall Study|Other|0|||
131417222|NCT02504580|473150593|FG009|Overall Study|Other|0|||
131417223|NCT02504580|473150594|FG010|Overall Study|Other|0|||
131417224|NCT02504580|473150595|FG011|Overall Study|Other|2|||
131417225|NCT02504580|473150584|FG000|Overall Study|Subject refusal to continue|0|||
131417226|NCT02504580|473150585|FG001|Overall Study|Subject refusal to continue|1|||
131417227|NCT02504580|473150586|FG002|Overall Study|Subject refusal to continue|0|||
131417228|NCT02504580|473150587|FG003|Overall Study|Subject refusal to continue|0|||
131417229|NCT02504580|473150588|FG004|Overall Study|Subject refusal to continue|0|||
131417230|NCT02504580|473150589|FG005|Overall Study|Subject refusal to continue|0|||
131417231|NCT02504580|473150590|FG006|Overall Study|Subject refusal to continue|0|||
131417232|NCT02504580|473150591|FG007|Overall Study|Subject refusal to continue|0|||
131417233|NCT02504580|473150592|FG008|Overall Study|Subject refusal to continue|0|||
131417234|NCT02504580|473150593|FG009|Overall Study|Subject refusal to continue|0|||
131417235|NCT02504580|473150594|FG010|Overall Study|Subject refusal to continue|0|||
131417236|NCT02504580|473150595|FG011|Overall Study|Subject refusal to continue|0|||
131417237|NCT04201093|473150601|FG000|Overall Study|Adverse Event|6|||
131417238|NCT04201093|473150602|FG001|Overall Study|Adverse Event|29|||
131417239|NCT04201093|473150603|FG002|Overall Study|Adverse Event|35|||
131417240|NCT04201093|473150601|FG000|Overall Study|Death|2|||
131417241|NCT04201093|473150602|FG001|Overall Study|Death|1|||
131417242|NCT04201093|473150603|FG002|Overall Study|Death|0|||
131417243|NCT04201093|473150601|FG000|Overall Study|Lack of Efficacy|5|||
131417244|NCT04201093|473150602|FG001|Overall Study|Lack of Efficacy|1|||
131417245|NCT04201093|473150603|FG002|Overall Study|Lack of Efficacy|2|||
131417246|NCT04201093|473150601|FG000|Overall Study|Lost to Follow-up|0|||
131417247|NCT04201093|473150602|FG001|Overall Study|Lost to Follow-up|0|||
131417248|NCT04201093|473150603|FG002|Overall Study|Lost to Follow-up|1|||
131417249|NCT04201093|473150601|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
131417250|NCT04201093|473150602|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
131417251|NCT04201093|473150603|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
131417252|NCT04201093|473150601|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
131417253|NCT04201093|473150602|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
131417254|NCT04201093|473150603|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
131417255|NCT04201093|473150601|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
131417256|NCT04201093|473150602|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
131417257|NCT04201093|473150603|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
131417258|NCT04201093|473150601|FG000|Overall Study|Physician Decision|1|||
131417259|NCT04201093|473150602|FG001|Overall Study|Physician Decision|0|||
131417260|NCT04201093|473150603|FG002|Overall Study|Physician Decision|0|||
131417261|NCT04201093|473150601|FG000|Overall Study|Protocol Deviation|1|||
131417262|NCT04201093|473150602|FG001|Overall Study|Protocol Deviation|0|||
131417263|NCT04201093|473150603|FG002|Overall Study|Protocol Deviation|0|||
131417264|NCT04201093|473150601|FG000|Overall Study|Site Terminated by Sponsor|5|||
131417265|NCT04201093|473150602|FG001|Overall Study|Site Terminated by Sponsor|3|||
131417266|NCT04201093|473150603|FG002|Overall Study|Site Terminated by Sponsor|1|||
131417267|NCT04201093|473150601|FG000|Overall Study|Withdrawal by Subject|7|||
131417268|NCT04201093|473150602|FG001|Overall Study|Withdrawal by Subject|8|||
131417269|NCT04201093|473150603|FG002|Overall Study|Withdrawal by Subject|15|||
131417270|NCT04201093|473150601|FG000|Overall Study|Other|0|||
131417271|NCT04201093|473150602|FG001|Overall Study|Other|1|||
131417272|NCT04201093|473150603|FG002|Overall Study|Other|2|||
131417273|NCT00881504|473150604|FG000|Overall Study|Withdrawal by Subject|1|||
131417274|NCT00007020|473150605|FG000|Overall Study|Death|16|||
131417275|NCT00007020|473150605|FG000|Overall Study|Lost to Follow-up|13|||
131417276|NCT00007020|473150605|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
131417277|NCT00007020|473150605|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
131417278|NCT00007020|473150605|FG000|Overall Study|Pt cared for by outside physician|4|||
131417279|NCT00007020|473150605|FG000|Overall Study|No evidence of treatment|6|||
131417280|NCT02017522|473150606|FG000|Overall Study|Withdrawal by Subject|1|||
131417281|NCT05856227|473150607|FG000|Overall Study|Adverse Event|0|||
131417282|NCT05856227|473150608|FG001|Overall Study|Adverse Event|1|||
131417283|NCT05856227|473150607|FG000|Overall Study|Due to Investigator absence|1|||
131417284|NCT05856227|473150608|FG001|Overall Study|Due to Investigator absence|0|||
131417285|NCT05856227|473150607|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
131417286|NCT05856227|473150608|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
131417287|NCT04051827|473150610|FG000|Overall Study|Death|1|||
131417288|NCT04051827|473150610|FG000|Overall Study|Withdrawal by Subject|4|||
131417289|NCT04051827|473150610|FG000|Overall Study|Progressive disease|16|||
131417290|NCT04051827|473150610|FG000|Overall Study|Physician Decision|1|||
131417291|NCT04051827|473150610|FG000|Overall Study|Other|4|||
131417292|NCT04676867|473150615|FG000|Overall Study|Screen failure|0|||
131417293|NCT04676867|473150616|FG001|Overall Study|Screen failure|0|||
131417294|NCT04676867|473150617|FG002|Overall Study|Screen failure|6|||
131417295|NCT04676867|473150618|FG003|Overall Study|Screen failure|2|||
131417296|NCT04676867|473150615|FG000|Overall Study|Death|0|||
131417297|NCT04676867|473150616|FG001|Overall Study|Death|0|||
131417298|NCT04676867|473150617|FG002|Overall Study|Death|1|||
131417299|NCT04676867|473150618|FG003|Overall Study|Death|0|||
131417300|NCT04676867|473150615|FG000|Overall Study|Withdrawal by Subject|2|||
131417301|NCT04676867|473150616|FG001|Overall Study|Withdrawal by Subject|2|||
131417302|NCT04676867|473150617|FG002|Overall Study|Withdrawal by Subject|4|||
131417303|NCT04676867|473150618|FG003|Overall Study|Withdrawal by Subject|4|||
131417304|NCT04676867|473150615|FG000|Overall Study|Lost to Follow-up|1|||
131417305|NCT04676867|473150616|FG001|Overall Study|Lost to Follow-up|0|||
131417306|NCT04676867|473150617|FG002|Overall Study|Lost to Follow-up|0|||
131417307|NCT04676867|473150618|FG003|Overall Study|Lost to Follow-up|0|||
131417308|NCT00549770|473150623|FG000|Overall Study|Protocol deviation|1|||
131417309|NCT00549770|473150624|FG001|Overall Study|Protocol deviation|1|||
131417310|NCT00549770|473150625|FG002|Overall Study|Protocol deviation|1|||
131417311|NCT00549770|473150626|FG003|Overall Study|Protocol deviation|2|||
131417312|NCT00549770|473150627|FG004|Overall Study|Protocol deviation|2|||
131417313|NCT00549770|473150628|FG005|Overall Study|Protocol deviation|2|||
131417314|NCT00549770|473150629|FG006|Overall Study|Protocol deviation|1|||
131417315|NCT00549770|473150630|FG007|Overall Study|Protocol deviation|2|||
131417316|NCT00549770|473150623|FG000|Overall Study|Administrative problems|0|||
131417317|NCT00549770|473150624|FG001|Overall Study|Administrative problems|1|||
131417318|NCT00549770|473150625|FG002|Overall Study|Administrative problems|0|||
131417319|NCT00549770|473150626|FG003|Overall Study|Administrative problems|0|||
131417320|NCT00549770|473150627|FG004|Overall Study|Administrative problems|0|||
131417321|NCT00549770|473150628|FG005|Overall Study|Administrative problems|0|||
131417322|NCT00549770|473150629|FG006|Overall Study|Administrative problems|0|||
131417323|NCT00549770|473150630|FG007|Overall Study|Administrative problems|1|||
131417324|NCT00549770|473150623|FG000|Overall Study|Lost to Follow-up|0|||
131417325|NCT00549770|473150624|FG001|Overall Study|Lost to Follow-up|0|||
131417326|NCT00549770|473150625|FG002|Overall Study|Lost to Follow-up|2|||
131417327|NCT00549770|473150626|FG003|Overall Study|Lost to Follow-up|2|||
131417328|NCT00549770|473150627|FG004|Overall Study|Lost to Follow-up|3|||
131417329|NCT00549770|473150628|FG005|Overall Study|Lost to Follow-up|2|||
131417330|NCT00549770|473150629|FG006|Overall Study|Lost to Follow-up|0|||
131417331|NCT00549770|473150630|FG007|Overall Study|Lost to Follow-up|0|||
131417332|NCT00549770|473150623|FG000|Overall Study|Withdrawal by Subject|4|||
131417333|NCT00549770|473150624|FG001|Overall Study|Withdrawal by Subject|6|||
131417334|NCT00549770|473150625|FG002|Overall Study|Withdrawal by Subject|4|||
131417335|NCT00549770|473150626|FG003|Overall Study|Withdrawal by Subject|5|||
131417336|NCT00549770|473150627|FG004|Overall Study|Withdrawal by Subject|6|||
131417337|NCT00549770|473150628|FG005|Overall Study|Withdrawal by Subject|6|||
131417338|NCT00549770|473150629|FG006|Overall Study|Withdrawal by Subject|4|||
131417339|NCT00549770|473150630|FG007|Overall Study|Withdrawal by Subject|9|||
131417340|NCT00549770|473150623|FG000|Overall Study|Lack of Efficacy|1|||
131417341|NCT00549770|473150624|FG001|Overall Study|Lack of Efficacy|0|||
131417342|NCT00549770|473150625|FG002|Overall Study|Lack of Efficacy|2|||
131417343|NCT00549770|473150626|FG003|Overall Study|Lack of Efficacy|3|||
131417344|NCT00549770|473150627|FG004|Overall Study|Lack of Efficacy|5|||
131417345|NCT00549770|473150628|FG005|Overall Study|Lack of Efficacy|1|||
131417346|NCT00549770|473150629|FG006|Overall Study|Lack of Efficacy|3|||
131417347|NCT00549770|473150630|FG007|Overall Study|Lack of Efficacy|8|||
131417348|NCT00549770|473150623|FG000|Overall Study|Abnormal test procedure results|0|||
131417349|NCT00549770|473150624|FG001|Overall Study|Abnormal test procedure results|0|||
131417350|NCT00549770|473150625|FG002|Overall Study|Abnormal test procedure results|0|||
131417351|NCT00549770|473150626|FG003|Overall Study|Abnormal test procedure results|2|||
131417352|NCT00549770|473150627|FG004|Overall Study|Abnormal test procedure results|0|||
131417353|NCT00549770|473150628|FG005|Overall Study|Abnormal test procedure results|1|||
131417354|NCT00549770|473150629|FG006|Overall Study|Abnormal test procedure results|1|||
131417355|NCT00549770|473150630|FG007|Overall Study|Abnormal test procedure results|1|||
131417356|NCT00549770|473150623|FG000|Overall Study|Abnormal laboratory values|0|||
131417357|NCT00549770|473150624|FG001|Overall Study|Abnormal laboratory values|0|||
131417358|NCT00549770|473150625|FG002|Overall Study|Abnormal laboratory values|0|||
131417359|NCT00549770|473150626|FG003|Overall Study|Abnormal laboratory values|0|||
131417360|NCT00549770|473150627|FG004|Overall Study|Abnormal laboratory values|0|||
131417361|NCT00549770|473150628|FG005|Overall Study|Abnormal laboratory values|1|||
131417362|NCT00549770|473150629|FG006|Overall Study|Abnormal laboratory values|0|||
131417363|NCT00549770|473150630|FG007|Overall Study|Abnormal laboratory values|0|||
131417364|NCT00549770|473150623|FG000|Overall Study|Adverse Event|1|||
131417365|NCT00549770|473150624|FG001|Overall Study|Adverse Event|3|||
131417366|NCT00549770|473150625|FG002|Overall Study|Adverse Event|1|||
131417367|NCT00549770|473150626|FG003|Overall Study|Adverse Event|2|||
131417368|NCT00549770|473150627|FG004|Overall Study|Adverse Event|1|||
131417369|NCT00549770|473150628|FG005|Overall Study|Adverse Event|0|||
131417370|NCT00549770|473150629|FG006|Overall Study|Adverse Event|5|||
131417371|NCT00549770|473150630|FG007|Overall Study|Adverse Event|4|||
131417372|NCT01079936|473150631|FG000|Phase I: MTD|First Remission Status|2|||
131417373|NCT01079936|473150632|FG001|Phase I: MTD|First Remission Status|0|||
131417374|NCT01079936|473150633|FG002|Phase I: MTD|First Remission Status|0|||
131417375|NCT01079936|473150634|FG003|Phase I: MTD|First Remission Status|0|||
131417376|NCT01079936|473150635|FG004|Phase I: MTD|First Remission Status|0|||
131417377|NCT01079936|473150631|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
131417378|NCT01079936|473150632|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
131417379|NCT01079936|473150633|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
131417380|NCT01079936|473150634|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
131417381|NCT01079936|473150635|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
131417382|NCT01079936|473150631|FG000|Phase II|Adverse Event|0|||
131417383|NCT01079936|473150632|FG001|Phase II|Adverse Event|0|||
131417384|NCT01079936|473150633|FG002|Phase II|Adverse Event|1|||
131417385|NCT01079936|473150634|FG003|Phase II|Adverse Event|0|||
131417386|NCT01079936|473150635|FG004|Phase II|Adverse Event|0|||
131417387|NCT01079936|473150631|FG000|Phase II|Insurance Issue|0|||
131417388|NCT01079936|473150632|FG001|Phase II|Insurance Issue|0|||
131417389|NCT01079936|473150633|FG002|Phase II|Insurance Issue|0|||
131417390|NCT01079936|473150634|FG003|Phase II|Insurance Issue|0|||
131417391|NCT01079936|473150635|FG004|Phase II|Insurance Issue|1|||
131417392|NCT03157583|473150636|FG000|Overall Study|Other (did not meet study criteria)|1|||
131417393|NCT00869401|473150651|FG000|Overall Study|Withdrawal by Subject|0|||
131417394|NCT00869401|473150652|FG001|Overall Study|Withdrawal by Subject|0|||
131417395|NCT00869401|473150653|FG002|Overall Study|Withdrawal by Subject|0|||
131417396|NCT00869401|473150654|FG003|Overall Study|Withdrawal by Subject|5|||
131417397|NCT00869401|473150655|FG004|Overall Study|Withdrawal by Subject|3|||
131417398|NCT00975143|473150656|FG000|Overall Study|Adverse Event|19|||
131417399|NCT00975143|473150657|FG001|Overall Study|Adverse Event|15|||
131417400|NCT00975143|473150656|FG000|Overall Study|Withdrawal by Subject|15|||
131417401|NCT00975143|473150657|FG001|Overall Study|Withdrawal by Subject|15|||
131417402|NCT00975143|473150656|FG000|Overall Study|Lost to Follow-up|20|||
131417403|NCT00975143|473150657|FG001|Overall Study|Lost to Follow-up|16|||
131417404|NCT00975143|473150656|FG000|Overall Study|Non-compliance|5|||
131417405|NCT00975143|473150657|FG001|Overall Study|Non-compliance|8|||
131417406|NCT00975143|473150656|FG000|Overall Study|Physician Decision|1|||
131417407|NCT00975143|473150657|FG001|Overall Study|Physician Decision|2|||
131417408|NCT00975143|473150656|FG000|Overall Study|Details not available|10|||
131417409|NCT00975143|473150657|FG001|Overall Study|Details not available|4|||
131417410|NCT01147900|473150658|FG000|At Year 10|Lost to Follow-up|0|||
131417411|NCT01147900|473150659|FG001|At Year 10|Lost to Follow-up|1|||
131417412|NCT01147900|473150660|FG002|At Year 10|Lost to Follow-up|0|||
131417413|NCT00581360|473150661|FG000|Overall Study|Withdrawal by Subject|1|||
131417414|NCT01953913|473150662|FG000|Overall Study|Disease Progression|349|||
131417415|NCT01953913|473150662|FG000|Overall Study|Worsening of underlying cancer|22|||
131417416|NCT01953913|473150662|FG000|Overall Study|Adverse Event|20|||
131417417|NCT01953913|473150662|FG000|Overall Study|Protocol Violation|6|||
131417418|NCT01953913|473150662|FG000|Overall Study|Lost to Follow-up|4|||
131417419|NCT01953913|473150662|FG000|Overall Study|Withdrawal by Subject|32|||
131417420|NCT01953913|473150662|FG000|Overall Study|Other than listed|108|||
131417421|NCT01953913|473150662|FG000|Overall Study|Not Treated|1|||
131417422|NCT01732913|473150665|FG000|Overall Study|Study Terminated by Sponsor|105|||
131417423|NCT01732913|473150666|FG001|Overall Study|Study Terminated by Sponsor|55|||
131417424|NCT01732913|473150665|FG000|Overall Study|Withdrawal by Subject|27|||
131457544|NCT01584440|473304652|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
131457545|NCT01584440|473304653|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
131417425|NCT01732913|473150666|FG001|Overall Study|Withdrawal by Subject|4|||
131417426|NCT01732913|473150665|FG000|Overall Study|Physician Decision|14|||
131417427|NCT01732913|473150666|FG001|Overall Study|Physician Decision|7|||
131417428|NCT01732913|473150665|FG000|Overall Study|Other|7|||
131417429|NCT01732913|473150666|FG001|Overall Study|Other|1|||
131417430|NCT01732913|473150665|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
131417431|NCT01732913|473150666|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
131417432|NCT00552760|473150667|FG000|Overall Study|Adverse Event|3|||
131417433|NCT00552760|473150668|FG001|Overall Study|Adverse Event|5|||
131417434|NCT00552760|473150667|FG000|Overall Study|Relapsed- Depressed Event|10|||
131417435|NCT00552760|473150668|FG001|Overall Study|Relapsed- Depressed Event|16|||
131417436|NCT00552760|473150667|FG000|Overall Study|Relapse- Manic Event|3|||
131417437|NCT00552760|473150668|FG001|Overall Study|Relapse- Manic Event|3|||
131417438|NCT00552760|473150667|FG000|Overall Study|Relapsed- Mixed Event|3|||
131417439|NCT00552760|473150668|FG001|Overall Study|Relapsed- Mixed Event|5|||
131417440|NCT00552760|473150667|FG000|Overall Study|Protocol Violation|0|||
131417441|NCT00552760|473150668|FG001|Overall Study|Protocol Violation|1|||
131417442|NCT00552760|473150667|FG000|Overall Study|Lost to Follow-up|1|||
131417443|NCT00552760|473150668|FG001|Overall Study|Lost to Follow-up|1|||
131417444|NCT00552760|473150667|FG000|Overall Study|Non-compliance|1|||
131417445|NCT00552760|473150668|FG001|Overall Study|Non-compliance|1|||
131417446|NCT00552760|473150667|FG000|Overall Study|Medical Condition|1|||
131417447|NCT00552760|473150668|FG001|Overall Study|Medical Condition|1|||
131417448|NCT00552760|473150667|FG000|Overall Study|Withdrawal by Subject|3|||
131417449|NCT00552760|473150668|FG001|Overall Study|Withdrawal by Subject|0|||
131417450|NCT00552760|473150667|FG000|Overall Study|Medication Change|1|||
131417451|NCT00552760|473150668|FG001|Overall Study|Medication Change|0|||
131417452|NCT03831945|473150669|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
131417453|NCT03831945|473150670|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
131417454|NCT03831945|473150669|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
131417455|NCT03831945|473150670|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
131417456|NCT03831945|473150669|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
131417457|NCT03831945|473150670|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
131417458|NCT00444067|473150671|FG000|Overall Study|Lost to Follow-up|0|||
131417459|NCT00444067|473150672|FG001|Overall Study|Lost to Follow-up|1|||
131417460|NCT03178669|473150673|FG000|Overall Study|Adverse Event|4|||
131417461|NCT03178669|473150674|FG001|Overall Study|Adverse Event|1|||
131417462|NCT03178669|473150675|FG002|Overall Study|Adverse Event|4|||
131417463|NCT03178669|473150676|FG003|Overall Study|Adverse Event|2|||
131417464|NCT03178669|473150677|FG004|Overall Study|Adverse Event|2|||
131417465|NCT03178669|473150673|FG000|Overall Study|Lack of Efficacy|0|||
131417466|NCT03178669|473150674|FG001|Overall Study|Lack of Efficacy|0|||
131417467|NCT03178669|473150675|FG002|Overall Study|Lack of Efficacy|2|||
131417468|NCT03178669|473150676|FG003|Overall Study|Lack of Efficacy|0|||
131417469|NCT03178669|473150677|FG004|Overall Study|Lack of Efficacy|1|||
131417470|NCT03178669|473150673|FG000|Overall Study|Physician Decision|0|||
131417471|NCT03178669|473150674|FG001|Overall Study|Physician Decision|0|||
131417472|NCT03178669|473150675|FG002|Overall Study|Physician Decision|0|||
131417473|NCT03178669|473150676|FG003|Overall Study|Physician Decision|0|||
131417474|NCT03178669|473150677|FG004|Overall Study|Physician Decision|1|||
131417475|NCT03178669|473150673|FG000|Overall Study|Withdrawal by Subject|1|||
131417476|NCT03178669|473150674|FG001|Overall Study|Withdrawal by Subject|0|||
131417477|NCT03178669|473150675|FG002|Overall Study|Withdrawal by Subject|1|||
131417478|NCT03178669|473150676|FG003|Overall Study|Withdrawal by Subject|1|||
131417479|NCT03178669|473150677|FG004|Overall Study|Withdrawal by Subject|0|||
131417480|NCT03178669|473150673|FG000|Overall Study|Lost to Follow-up|0|||
131417481|NCT03178669|473150674|FG001|Overall Study|Lost to Follow-up|0|||
131417482|NCT03178669|473150675|FG002|Overall Study|Lost to Follow-up|0|||
131417483|NCT03178669|473150676|FG003|Overall Study|Lost to Follow-up|1|||
131417484|NCT03178669|473150677|FG004|Overall Study|Lost to Follow-up|0|||
131457546|NCT00899431|473304654|FG000|Overall Study|Physician Decision|1|||
131417485|NCT02976103|473150678|FG000|Overall Study|Withdrawal by Subject|1|||
131417486|NCT02976103|473150679|FG001|Overall Study|Withdrawal by Subject|0|||
131417487|NCT02976103|473150678|FG000|Overall Study|Lost to Follow-up|12|||
131417488|NCT02976103|473150679|FG001|Overall Study|Lost to Follow-up|8|||
131417489|NCT01300455|473150680|FG000|Washout|Withdrawal by Subject|1|||
131417490|NCT01300455|473150681|FG001|Washout|Withdrawal by Subject|0|||
131417491|NCT00084487|473150682|FG000|Overall Study|Death|1|||
131417492|NCT00565136|473150683|FG000|Overall Study|Lost to Follow-up|1|||
131417493|NCT00565136|473150683|FG000|Overall Study|Withdrawal by Subject|1|||
131417494|NCT00565136|473150683|FG000|Overall Study|Protocol Violation|1|||
131417495|NCT02528357|473150684|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417496|NCT02528357|473150685|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
131417497|NCT02528357|473150686|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417498|NCT02528357|473150687|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417499|NCT02528357|473150688|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417500|NCT02528357|473150689|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417501|NCT02528357|473150690|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417502|NCT02528357|473150691|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417503|NCT02528357|473150692|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417504|NCT02528357|473150693|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417505|NCT02528357|473150694|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417506|NCT02528357|473150695|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417507|NCT02528357|473150696|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417508|NCT02528357|473150697|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417509|NCT02528357|473150698|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417510|NCT02528357|473150699|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417511|NCT02528357|473150700|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417512|NCT02528357|473150701|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131417513|NCT02528357|473150702|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
131457547|NCT00899431|473304655|FG001|Overall Study|Physician Decision|0|||
131417514|NCT02528357|473150684|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417515|NCT02528357|473150685|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417516|NCT02528357|473150686|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417517|NCT02528357|473150687|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
131417518|NCT02528357|473150688|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417519|NCT02528357|473150689|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
131417520|NCT02528357|473150690|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417521|NCT02528357|473150691|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
131417522|NCT02528357|473150692|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417523|NCT02528357|473150693|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417524|NCT02528357|473150694|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417525|NCT02528357|473150695|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417526|NCT02528357|473150696|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417527|NCT02528357|473150697|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417528|NCT02528357|473150698|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417529|NCT02528357|473150699|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417530|NCT02528357|473150700|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417531|NCT02528357|473150701|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417532|NCT02528357|473150702|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
131417533|NCT02528357|473150684|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417534|NCT02528357|473150685|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417535|NCT02528357|473150686|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
131417536|NCT02528357|473150687|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417537|NCT02528357|473150688|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
131417538|NCT02528357|473150689|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417539|NCT02528357|473150690|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
131417540|NCT02528357|473150691|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
131417541|NCT02528357|473150692|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417542|NCT02528357|473150693|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417543|NCT02528357|473150694|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417544|NCT02528357|473150695|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417545|NCT02528357|473150696|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417546|NCT02528357|473150697|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417547|NCT02528357|473150698|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417548|NCT02528357|473150699|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417549|NCT02528357|473150700|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417550|NCT02528357|473150701|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417551|NCT02528357|473150702|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
131417552|NCT02528357|473150684|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417553|NCT02528357|473150685|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417554|NCT02528357|473150686|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417555|NCT02528357|473150687|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417556|NCT02528357|473150688|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
131417557|NCT02528357|473150689|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417558|NCT02528357|473150690|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417559|NCT02528357|473150691|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417560|NCT02528357|473150692|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417561|NCT02528357|473150693|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417562|NCT02528357|473150694|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417563|NCT02528357|473150695|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417564|NCT02528357|473150696|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417565|NCT02528357|473150697|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417566|NCT02528357|473150698|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417567|NCT02528357|473150699|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417568|NCT02528357|473150700|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417569|NCT02528357|473150701|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417570|NCT02528357|473150702|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417571|NCT02528357|473150684|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417572|NCT02528357|473150685|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131457548|NCT00899431|473304656|FG002|Overall Study|Physician Decision|0|||
131417573|NCT02528357|473150686|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417574|NCT02528357|473150687|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417575|NCT02528357|473150688|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417576|NCT02528357|473150689|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417577|NCT02528357|473150690|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417578|NCT02528357|473150691|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417579|NCT02528357|473150692|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417580|NCT02528357|473150693|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417581|NCT02528357|473150694|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417582|NCT02528357|473150695|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417583|NCT02528357|473150696|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417584|NCT02528357|473150697|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
131417585|NCT02528357|473150698|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
131417586|NCT02528357|473150699|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417587|NCT02528357|473150700|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417588|NCT02528357|473150701|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417589|NCT02528357|473150702|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
131417590|NCT02528357|473150684|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417591|NCT02528357|473150685|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417592|NCT02528357|473150686|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417593|NCT02528357|473150687|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417594|NCT02528357|473150688|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417595|NCT02528357|473150689|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417596|NCT02528357|473150690|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417597|NCT02528357|473150691|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417598|NCT02528357|473150692|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417599|NCT02528357|473150693|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417600|NCT02528357|473150694|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417601|NCT02528357|473150695|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417602|NCT02528357|473150696|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417603|NCT02528357|473150697|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
131417604|NCT02528357|473150698|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417605|NCT02528357|473150699|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417606|NCT02528357|473150700|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417607|NCT02528357|473150701|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417608|NCT02528357|473150702|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
131417609|NCT02528357|473150684|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417610|NCT02528357|473150685|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417611|NCT02528357|473150686|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417612|NCT02528357|473150687|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417613|NCT02528357|473150688|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417614|NCT02528357|473150689|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417615|NCT02528357|473150690|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417616|NCT02528357|473150691|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417617|NCT02528357|473150692|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417618|NCT02528357|473150693|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417619|NCT02528357|473150694|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
131417620|NCT02528357|473150695|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417621|NCT02528357|473150696|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
131417622|NCT02528357|473150697|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
131417623|NCT02528357|473150698|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
131417624|NCT02528357|473150699|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417625|NCT02528357|473150700|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417626|NCT02528357|473150701|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417627|NCT02528357|473150702|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
131417628|NCT02528357|473150684|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417629|NCT02528357|473150685|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417630|NCT02528357|473150686|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417631|NCT02528357|473150687|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131457549|NCT00661427|473304657|FG000|Overall Study|Adverse Event|5|||
131457550|NCT00661427|473304658|FG001|Overall Study|Adverse Event|5|||
131457551|NCT00661427|473304657|FG000|Overall Study|Patient not treated|0|||
131457552|NCT00661427|473304658|FG001|Overall Study|Patient not treated|2|||
131457553|NCT00531427|473304659|FG000|Overall Study|Withdrawal by Subject|7|||
131457554|NCT00531427|473304660|FG001|Overall Study|Withdrawal by Subject|13|||
131457555|NCT00531427|473304659|FG000|Overall Study|Adverse Event|44|||
131457556|NCT00531427|473304660|FG001|Overall Study|Adverse Event|30|||
131457557|NCT00531427|473304659|FG000|Overall Study|Lost to Follow-up|4|||
131417632|NCT02528357|473150688|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417633|NCT02528357|473150689|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417634|NCT02528357|473150690|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417635|NCT02528357|473150691|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417636|NCT02528357|473150692|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
131417637|NCT02528357|473150693|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
131417638|NCT02528357|473150694|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417639|NCT02528357|473150695|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
131417640|NCT02528357|473150696|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
131417641|NCT02528357|473150697|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
131417642|NCT02528357|473150698|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
131417643|NCT02528357|473150699|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417644|NCT02528357|473150700|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417645|NCT02528357|473150701|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417646|NCT02528357|473150702|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417647|NCT02528357|473150684|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417648|NCT02528357|473150685|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417649|NCT02528357|473150686|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417650|NCT02528357|473150687|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417651|NCT02528357|473150688|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417652|NCT02528357|473150689|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417653|NCT02528357|473150690|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417654|NCT02528357|473150691|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417655|NCT02528357|473150692|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417656|NCT02528357|473150693|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417657|NCT02528357|473150694|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417658|NCT02528357|473150695|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417659|NCT02528357|473150696|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417660|NCT02528357|473150697|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417661|NCT02528357|473150698|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417662|NCT02528357|473150699|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417663|NCT02528357|473150700|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
131417664|NCT02528357|473150701|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417665|NCT02528357|473150702|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
131417666|NCT02528357|473150684|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417667|NCT02528357|473150685|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417668|NCT02528357|473150686|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417669|NCT02528357|473150687|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417670|NCT02528357|473150688|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417671|NCT02528357|473150689|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417672|NCT02528357|473150690|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417673|NCT02528357|473150691|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417674|NCT02528357|473150692|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417675|NCT02528357|473150693|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417676|NCT02528357|473150694|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417677|NCT02528357|473150695|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417678|NCT02528357|473150696|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417679|NCT02528357|473150697|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417680|NCT02528357|473150698|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417681|NCT02528357|473150699|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
131417682|NCT02528357|473150700|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
131417683|NCT02528357|473150701|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
131457558|NCT00531427|473304660|FG001|Overall Study|Lost to Follow-up|3|||
131457559|NCT00531427|473304659|FG000|Overall Study|Lack of Efficacy|14|||
131417684|NCT02528357|473150702|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
131417685|NCT02438813|473150708|FG000|Overall Study|Patient Decision|59|||
131457560|NCT00531427|473304660|FG001|Overall Study|Lack of Efficacy|39|||
131417686|NCT02438813|473150708|FG000|Overall Study|Patient Lost to Follow-Up|137|||
131417687|NCT02438813|473150708|FG000|Overall Study|Study Ended by Sponsor|80|||
131417688|NCT02438813|473150708|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
131417689|NCT04598269|473150709|FG000|Overall Study|Adverse Event|0|||
131417690|NCT04598269|473150710|FG001|Overall Study|Adverse Event|3|||
131417691|NCT04598269|473150709|FG000|Overall Study|Withdrawal by Subject|1|||
131417692|NCT04598269|473150710|FG001|Overall Study|Withdrawal by Subject|4|||
131417693|NCT04598269|473150709|FG000|Overall Study|Lost to Follow-up|1|||
131417694|NCT04598269|473150710|FG001|Overall Study|Lost to Follow-up|0|||
131417695|NCT04598269|473150709|FG000|Overall Study|Not Treated|2|||
131417696|NCT04598269|473150710|FG001|Overall Study|Not Treated|0|||
131417697|NCT05327361|473150718|FG000|Overall Study|Lost to Follow-up|4|||
131417698|NCT01439373|473150724|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
131417699|NCT01439373|473150725|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
131417700|NCT01439373|473150724|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
131417701|NCT01439373|473150725|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
131417702|NCT00626405|473150726|FG000|Overall Study|Deemed Ineligible|1|||
131417703|NCT00626405|473150727|FG001|Overall Study|Deemed Ineligible|0|||
131417704|NCT00626405|473150726|FG000|Overall Study|Withdrawal by Subject|0|||
131417705|NCT00626405|473150727|FG001|Overall Study|Withdrawal by Subject|1|||
131417706|NCT03834220|473150732|FG000|Overall Study|Adverse Event|1|||
131417707|NCT03834220|473150733|FG001|Overall Study|Adverse Event|0|||
131417708|NCT03834220|473150734|FG002|Overall Study|Adverse Event|0|||
131417709|NCT03834220|473150732|FG000|Overall Study|Death|8|||
131417710|NCT03834220|473150733|FG001|Overall Study|Death|1|||
131417711|NCT03834220|473150734|FG002|Overall Study|Death|17|||
131417712|NCT03834220|473150732|FG000|Overall Study|Reason not Specified|9|||
131417713|NCT03834220|473150733|FG001|Overall Study|Reason not Specified|0|||
131417714|NCT03834220|473150734|FG002|Overall Study|Reason not Specified|6|||
131417715|NCT03834220|473150732|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
131417716|NCT03834220|473150733|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
131417717|NCT03834220|473150734|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
131417718|NCT03834220|473150732|FG000|Overall Study|Withdrawal of Consent|2|||
131417719|NCT03834220|473150733|FG001|Overall Study|Withdrawal of Consent|2|||
131417720|NCT03834220|473150734|FG002|Overall Study|Withdrawal of Consent|2|||
131417721|NCT02593318|473150735|FG000|Overall Study|Withdrawal by Subject|1|||
131417722|NCT02593318|473150736|FG001|Overall Study|Withdrawal by Subject|1|||
131417723|NCT02720692|473153029|FG000|Overall Study|Withdrawal by Subject|3|||
131417724|NCT02720692|473153030|FG001|Overall Study|Withdrawal by Subject|0|||
131417725|NCT02720692|473153029|FG000|Overall Study|Physician Decision|1|||
131417726|NCT02720692|473153030|FG001|Overall Study|Physician Decision|0|||
131417727|NCT02720692|473153029|FG000|Overall Study|Lost to Follow-up|8|||
131417728|NCT02720692|473153030|FG001|Overall Study|Lost to Follow-up|3|||
131417729|NCT02720692|473153029|FG000|Overall Study|Subject unable to return for visit|1|||
131417730|NCT02720692|473153030|FG001|Overall Study|Subject unable to return for visit|0|||
131417731|NCT05011513|473153031|FG000|Overall Study|Death|0|||
131417732|NCT05011513|473153032|FG001|Overall Study|Death|1|||
131417733|NCT05011513|473153031|FG000|Overall Study|Lost to Follow-up|4|||
131417734|NCT05011513|473153032|FG001|Overall Study|Lost to Follow-up|0|||
131417735|NCT05011513|473153031|FG000|Overall Study|Withdrawal by Subject|18|||
131417736|NCT05011513|473153032|FG001|Overall Study|Withdrawal by Subject|17|||
131417737|NCT05011513|473153031|FG000|Overall Study|Other|4|||
131417738|NCT05011513|473153032|FG001|Overall Study|Other|2|||
131417739|NCT03878758|473153033|FG000|Overall Study|Withdrawal by Subject|1|||
131417740|NCT03878758|473153033|FG000|Overall Study|Protocol defined|2|||
131417741|NCT03878758|473153033|FG000|Overall Study|Improper consent documentation|1|||
131417742|NCT02315560|473153034|FG000|Overall Study|noncompliance by subjects|3|||
131417743|NCT03495102|473153035|FG000|Overall Study|Adverse Event|5|||
131417744|NCT03495102|473153036|FG001|Overall Study|Adverse Event|7|||
131417745|NCT03495102|473153037|FG002|Overall Study|Adverse Event|10|||
131417746|NCT03495102|473153035|FG000|Overall Study|Death|3|||
131417747|NCT03495102|473153036|FG001|Overall Study|Death|4|||
131417748|NCT03495102|473153037|FG002|Overall Study|Death|4|||
131417749|NCT03495102|473153035|FG000|Overall Study|Lost to Follow-up|15|||
131417750|NCT03495102|473153036|FG001|Overall Study|Lost to Follow-up|16|||
131417751|NCT03495102|473153037|FG002|Overall Study|Lost to Follow-up|17|||
131417752|NCT03495102|473153035|FG000|Overall Study|Physician Decision|2|||
131417753|NCT03495102|473153036|FG001|Overall Study|Physician Decision|0|||
131417754|NCT03495102|473153037|FG002|Overall Study|Physician Decision|2|||
131417755|NCT03495102|473153035|FG000|Overall Study|Withdrawal by Subject|25|||
131417756|NCT03495102|473153036|FG001|Overall Study|Withdrawal by Subject|36|||
131417757|NCT03495102|473153037|FG002|Overall Study|Withdrawal by Subject|18|||
131417758|NCT03495102|473153035|FG000|Overall Study|Protocol Violation|1|||
131417759|NCT03495102|473153036|FG001|Overall Study|Protocol Violation|1|||
131417760|NCT03495102|473153037|FG002|Overall Study|Protocol Violation|0|||
131417761|NCT03495102|473153035|FG000|Overall Study|Site Closure|3|||
131417762|NCT03495102|473153036|FG001|Overall Study|Site Closure|1|||
131417763|NCT03495102|473153037|FG002|Overall Study|Site Closure|2|||
131417764|NCT03495102|473153035|FG000|Overall Study|Non-compliance|1|||
131417765|NCT03495102|473153036|FG001|Overall Study|Non-compliance|0|||
131417766|NCT03495102|473153037|FG002|Overall Study|Non-compliance|0|||
131417767|NCT03495102|473153035|FG000|Overall Study|Participant Duplicated at Another Site|0|||
131417768|NCT03495102|473153036|FG001|Overall Study|Participant Duplicated at Another Site|0|||
131417769|NCT03495102|473153037|FG002|Overall Study|Participant Duplicated at Another Site|1|||
131417770|NCT03495102|473153035|FG000|Overall Study|Primary Care Physician Recommendation|0|||
131417771|NCT03495102|473153036|FG001|Overall Study|Primary Care Physician Recommendation|1|||
131417772|NCT03495102|473153037|FG002|Overall Study|Primary Care Physician Recommendation|0|||
131417773|NCT03495102|473153035|FG000|Overall Study|Relocated to Another Country|0|||
131417774|NCT03495102|473153036|FG001|Overall Study|Relocated to Another Country|1|||
131417775|NCT03495102|473153037|FG002|Overall Study|Relocated to Another Country|0|||
131417776|NCT03495102|473153035|FG000|Overall Study|Participant was in Rehabilitation|1|||
131417777|NCT03495102|473153036|FG001|Overall Study|Participant was in Rehabilitation|0|||
131417778|NCT03495102|473153037|FG002|Overall Study|Participant was in Rehabilitation|0|||
131417779|NCT01161537|473153040|FG000|Part B|Withdrawal by Subject|2|||
131417780|NCT00358436|473153043|FG000|Overall Study|Adverse Event|29|||
131417781|NCT00358436|473153044|FG001|Overall Study|Adverse Event|13|||
131417782|NCT00358436|473153043|FG000|Overall Study|Lack of Efficacy|34|||
131417783|NCT00358436|473153044|FG001|Overall Study|Lack of Efficacy|36|||
131417784|NCT00358436|473153043|FG000|Overall Study|Lost to Follow-up|11|||
131417785|NCT00358436|473153044|FG001|Overall Study|Lost to Follow-up|6|||
131417786|NCT00358436|473153043|FG000|Overall Study|Protocol Violation|8|||
131417787|NCT00358436|473153044|FG001|Overall Study|Protocol Violation|3|||
131417788|NCT00358436|473153043|FG000|Overall Study|Withdrawal by Subject|40|||
131417789|NCT00358436|473153044|FG001|Overall Study|Withdrawal by Subject|17|||
131417790|NCT00358436|473153043|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
131417791|NCT00358436|473153044|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
131417792|NCT00358436|473153043|FG000|Overall Study|COPD exacerbation|22|||
131417793|NCT00358436|473153044|FG001|Overall Study|COPD exacerbation|10|||
131417794|NCT00358436|473153043|FG000|Overall Study|Other|6|||
131417795|NCT00358436|473153044|FG001|Overall Study|Other|1|||
131417796|NCT00321464|473153045|FG000|Overall Study|Death|169|||
131417797|NCT00321464|473153046|FG001|Overall Study|Death|174|||
131417798|NCT00321464|473153045|FG000|Overall Study|Disease progression|124|||
131417799|NCT00321464|473153046|FG001|Overall Study|Disease progression|124|||
131417800|NCT00321464|473153045|FG000|Overall Study|Withdrawal by Subject|117|||
131417801|NCT00321464|473153046|FG001|Overall Study|Withdrawal by Subject|118|||
131417802|NCT00321464|473153045|FG000|Overall Study|Participant request|57|||
131417803|NCT00321464|473153046|FG001|Overall Study|Participant request|61|||
131417804|NCT00321464|473153045|FG000|Overall Study|Adverse Event|43|||
131417805|NCT00321464|473153046|FG001|Overall Study|Adverse Event|28|||
131417806|NCT00321464|473153045|FG000|Overall Study|Physician Decision|15|||
131417807|NCT00321464|473153046|FG001|Overall Study|Physician Decision|14|||
131417808|NCT00321464|473153045|FG000|Overall Study|Noncompliance|4|||
131417809|NCT00321464|473153046|FG001|Overall Study|Noncompliance|10|||
131417810|NCT00321464|473153045|FG000|Overall Study|Lost to Follow-up|7|||
131417811|NCT00321464|473153046|FG001|Overall Study|Lost to Follow-up|8|||
131417812|NCT00321464|473153045|FG000|Overall Study|Protocol deviation|0|||
131417813|NCT00321464|473153046|FG001|Overall Study|Protocol deviation|2|||
131417814|NCT00321464|473153045|FG000|Overall Study|Ineligibility determined|2|||
131417815|NCT00321464|473153046|FG001|Overall Study|Ineligibility determined|1|||
131417816|NCT00321464|473153045|FG000|Overall Study|Other|21|||
131417817|NCT00321464|473153046|FG001|Overall Study|Other|18|||
131417818|NCT04327024|473153047|FG000|Overall Study|Death|1|||
131417819|NCT04327024|473153048|FG001|Overall Study|Death|2|||
131417820|NCT04327024|473153049|FG002|Overall Study|Death|1|||
131417821|NCT04327024|473153047|FG000|Overall Study|Non-compliance with study drug|0|||
131417822|NCT04327024|473153048|FG001|Overall Study|Non-compliance with study drug|1|||
131417823|NCT04327024|473153049|FG002|Overall Study|Non-compliance with study drug|0|||
131417824|NCT04327024|473153047|FG000|Overall Study|Withdrawal by Subject|1|||
131417825|NCT04327024|473153048|FG001|Overall Study|Withdrawal by Subject|1|||
131417826|NCT04327024|473153049|FG002|Overall Study|Withdrawal by Subject|2|||
131417827|NCT00652951|473153053|FG000|Booster Phase|Adverse event, non-fatal|0|||
131417828|NCT00652951|473153054|FG001|Booster Phase|Adverse event, non-fatal|1|||
131417829|NCT00652951|473153055|FG002|Booster Phase|Adverse event, non-fatal|0|||
131417830|NCT00652951|473153053|FG000|Booster Phase|Other|1|||
131417831|NCT00652951|473153054|FG001|Booster Phase|Other|0|||
131417832|NCT00652951|473153055|FG002|Booster Phase|Other|0|||
131417833|NCT01192568|473153056|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
131417834|NCT01192568|473153057|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
131417835|NCT01192568|473153058|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
131417836|NCT01192568|473153059|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
131417837|NCT01192568|473153056|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
131417838|NCT01192568|473153057|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
131417839|NCT01192568|473153058|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
131417840|NCT01192568|473153059|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
131417841|NCT01206582|473153060|FG000|Overall Study|Withdrew prior to study|1|||
131417842|NCT01206582|473153061|FG001|Overall Study|Withdrew prior to study|0|||
131417843|NCT01206582|473153060|FG000|Overall Study|Discontinued intervention before week 8|1|||
131417844|NCT01206582|473153061|FG001|Overall Study|Discontinued intervention before week 8|2|||
131417845|NCT00511134|473153062|FG000|Overall Study|Withdrawal by Subject|0|||
131417846|NCT00511134|473153063|FG001|Overall Study|Withdrawal by Subject|2|||
131417847|NCT01949090|473153064|FG000|Overall Study|Serious Adverse Event|0|||
131417848|NCT01949090|473153065|FG001|Overall Study|Serious Adverse Event|1|||
131417849|NCT01949090|473153066|FG002|Overall Study|Serious Adverse Event|2|||
131417850|NCT01949090|473153067|FG003|Overall Study|Serious Adverse Event|0|||
131417851|NCT01949090|473153068|FG004|Overall Study|Serious Adverse Event|1|||
131417852|NCT01949090|473153064|FG000|Overall Study|Withdrawal by Subject|2|||
131417853|NCT01949090|473153065|FG001|Overall Study|Withdrawal by Subject|0|||
131417854|NCT01949090|473153066|FG002|Overall Study|Withdrawal by Subject|0|||
131457561|NCT00531427|473304659|FG000|Overall Study|Administrative|4|||
131457562|NCT00531427|473304660|FG001|Overall Study|Administrative|9|||
131457563|NCT00721968|473304661|FG000|Overall Study|Lost to Follow-up|2|||
131457564|NCT00721968|473304662|FG001|Overall Study|Lost to Follow-up|0|||
131457565|NCT05601544|473304663|FG000|Phase 2 Period 1|Adverse Event|0|||
131457566|NCT05601544|473304664|FG001|Phase 2 Period 1|Adverse Event|1|||
131457567|NCT05601544|473304665|FG002|Phase 2 Period 1|Adverse Event|0|||
131457568|NCT05601544|473304666|FG003|Phase 2 Period 1|Adverse Event|0|||
131457569|NCT05601544|473304667|FG004|Phase 2 Period 1|Adverse Event|0|||
131457570|NCT05601544|473304668|FG005|Phase 2 Period 1|Adverse Event|0|||
131457571|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
131457572|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
131457573|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
131457574|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
131457575|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
131457576|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
131457577|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
131457578|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
131457579|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
131457580|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
131457581|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
131457582|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
131457583|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
131457584|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
131457585|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
131457586|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
131457587|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
131457588|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
131457589|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
131457590|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
131457591|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
131457592|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
131457593|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
131457594|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
131457595|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
131457596|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
131457597|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
131417855|NCT01949090|473153067|FG003|Overall Study|Withdrawal by Subject|0|||
131417856|NCT01949090|473153068|FG004|Overall Study|Withdrawal by Subject|1|||
131417857|NCT01949090|473153064|FG000|Overall Study|Protocol non-compliance|0|||
131457598|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
131457599|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
131457600|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
131457601|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
131457602|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
131457603|NCT03818035|473304673|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
131417858|NCT01949090|473153065|FG001|Overall Study|Protocol non-compliance|0|||
131417859|NCT01949090|473153066|FG002|Overall Study|Protocol non-compliance|0|||
131417860|NCT01949090|473153067|FG003|Overall Study|Protocol non-compliance|0|||
131417861|NCT01949090|473153068|FG004|Overall Study|Protocol non-compliance|1|||
131417862|NCT01949090|473153064|FG000|Overall Study|Lost to Follow-up|2|||
131417863|NCT01949090|473153065|FG001|Overall Study|Lost to Follow-up|1|||
131417864|NCT01949090|473153066|FG002|Overall Study|Lost to Follow-up|0|||
131417865|NCT01949090|473153067|FG003|Overall Study|Lost to Follow-up|1|||
131417866|NCT01949090|473153068|FG004|Overall Study|Lost to Follow-up|1|||
131417867|NCT03459365|473153071|FG000|Overall Study|Withdrawal by Subject|6|||
131417868|NCT03459365|473153071|FG000|Overall Study|Protocol Violation|8|||
131417869|NCT02905006|473153073|FG000|Overall Study|Adverse Event|1|||
131417870|NCT02905006|473153074|FG001|Overall Study|Adverse Event|1|||
131417871|NCT02905006|473153075|FG002|Overall Study|Adverse Event|1|||
131417872|NCT02905006|473153076|FG003|Overall Study|Adverse Event|1|||
131417873|NCT02905006|473153077|FG004|Overall Study|Adverse Event|0|||
131417874|NCT02905006|473153078|FG005|Overall Study|Adverse Event|1|||
131417875|NCT02905006|473153073|FG000|Overall Study|Lack of Efficacy|1|||
131417876|NCT02905006|473153074|FG001|Overall Study|Lack of Efficacy|0|||
131417877|NCT02905006|473153075|FG002|Overall Study|Lack of Efficacy|0|||
131417878|NCT02905006|473153076|FG003|Overall Study|Lack of Efficacy|0|||
131417879|NCT02905006|473153077|FG004|Overall Study|Lack of Efficacy|0|||
131417880|NCT02905006|473153078|FG005|Overall Study|Lack of Efficacy|0|||
131417881|NCT02905006|473153073|FG000|Overall Study|Protocol Violation|2|||
131417882|NCT02905006|473153074|FG001|Overall Study|Protocol Violation|0|||
131417883|NCT02905006|473153075|FG002|Overall Study|Protocol Violation|0|||
131417884|NCT02905006|473153076|FG003|Overall Study|Protocol Violation|0|||
131417885|NCT02905006|473153077|FG004|Overall Study|Protocol Violation|0|||
131417886|NCT02905006|473153078|FG005|Overall Study|Protocol Violation|0|||
131417887|NCT02905006|473153073|FG000|Overall Study|Lost to Follow-up|0|||
131417888|NCT02905006|473153074|FG001|Overall Study|Lost to Follow-up|0|||
131417889|NCT02905006|473153075|FG002|Overall Study|Lost to Follow-up|0|||
131417890|NCT02905006|473153076|FG003|Overall Study|Lost to Follow-up|1|||
131417891|NCT02905006|473153077|FG004|Overall Study|Lost to Follow-up|1|||
131417892|NCT02905006|473153078|FG005|Overall Study|Lost to Follow-up|0|||
131417893|NCT02905006|473153073|FG000|Overall Study|Withdrawal by Subject|0|||
131417894|NCT02905006|473153074|FG001|Overall Study|Withdrawal by Subject|0|||
131417895|NCT02905006|473153075|FG002|Overall Study|Withdrawal by Subject|1|||
131417896|NCT02905006|473153076|FG003|Overall Study|Withdrawal by Subject|1|||
131417897|NCT02905006|473153077|FG004|Overall Study|Withdrawal by Subject|0|||
131417898|NCT02905006|473153078|FG005|Overall Study|Withdrawal by Subject|1|||
131417899|NCT02905006|473153073|FG000|Overall Study|Screening exclusion criteria met|1|||
131417900|NCT02905006|473153074|FG001|Overall Study|Screening exclusion criteria met|0|||
131417901|NCT02905006|473153075|FG002|Overall Study|Screening exclusion criteria met|0|||
131417902|NCT02905006|473153076|FG003|Overall Study|Screening exclusion criteria met|0|||
131417903|NCT02905006|473153077|FG004|Overall Study|Screening exclusion criteria met|0|||
131417904|NCT02905006|473153078|FG005|Overall Study|Screening exclusion criteria met|0|||
131417905|NCT02905006|473153073|FG000|Overall Study|Lab withdrawal criterion met|0|||
131417906|NCT02905006|473153074|FG001|Overall Study|Lab withdrawal criterion met|1|||
131457604|NCT03818035|473304674|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
131457605|NCT03818035|473304675|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
131457606|NCT03818035|473304676|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
131457607|NCT03818035|473304673|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
131457608|NCT03818035|473304674|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
131457609|NCT03818035|473304675|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
131457610|NCT03818035|473304676|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
131457611|NCT03818035|473304673|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
131417907|NCT02905006|473153075|FG002|Overall Study|Lab withdrawal criterion met|2|||
131417908|NCT02905006|473153076|FG003|Overall Study|Lab withdrawal criterion met|2|||
131417909|NCT02905006|473153077|FG004|Overall Study|Lab withdrawal criterion met|2|||
131417910|NCT02905006|473153078|FG005|Overall Study|Lab withdrawal criterion met|1|||
131417911|NCT02905006|473153073|FG000|Overall Study|Positive for Tuberculosis|0|||
131417912|NCT02905006|473153074|FG001|Overall Study|Positive for Tuberculosis|1|||
131417913|NCT02905006|473153075|FG002|Overall Study|Positive for Tuberculosis|0|||
131417914|NCT02905006|473153076|FG003|Overall Study|Positive for Tuberculosis|0|||
131417915|NCT02905006|473153077|FG004|Overall Study|Positive for Tuberculosis|0|||
131417916|NCT02905006|473153078|FG005|Overall Study|Positive for Tuberculosis|0|||
131417917|NCT02905006|473153073|FG000|Overall Study|Subject positive for Hep B|0|||
131417918|NCT02905006|473153074|FG001|Overall Study|Subject positive for Hep B|0|||
131417919|NCT02905006|473153075|FG002|Overall Study|Subject positive for Hep B|1|||
131417920|NCT02905006|473153076|FG003|Overall Study|Subject positive for Hep B|0|||
131417921|NCT02905006|473153077|FG004|Overall Study|Subject positive for Hep B|0|||
131417922|NCT02905006|473153078|FG005|Overall Study|Subject positive for Hep B|0|||
131417923|NCT02905006|473153073|FG000|Overall Study|Patient moved abroad|0|||
131417924|NCT02905006|473153074|FG001|Overall Study|Patient moved abroad|0|||
131417925|NCT02905006|473153075|FG002|Overall Study|Patient moved abroad|0|||
131417926|NCT02905006|473153076|FG003|Overall Study|Patient moved abroad|1|||
131417927|NCT02905006|473153077|FG004|Overall Study|Patient moved abroad|0|||
131417928|NCT02905006|473153078|FG005|Overall Study|Patient moved abroad|0|||
131417929|NCT02905006|473153073|FG000|Overall Study|Patient randomized by mistake|0|||
131417930|NCT02905006|473153074|FG001|Overall Study|Patient randomized by mistake|0|||
131417931|NCT02905006|473153075|FG002|Overall Study|Patient randomized by mistake|0|||
131417932|NCT02905006|473153076|FG003|Overall Study|Patient randomized by mistake|0|||
131417933|NCT02905006|473153077|FG004|Overall Study|Patient randomized by mistake|0|||
131417934|NCT02905006|473153078|FG005|Overall Study|Patient randomized by mistake|1|||
131417935|NCT02429791|473153079|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
131417936|NCT02429791|473153080|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
131417937|NCT02429791|473153079|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
131417938|NCT02429791|473153080|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
131417939|NCT02429791|473153079|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
131417940|NCT02429791|473153080|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
131417941|NCT02429791|473153079|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
131417942|NCT02429791|473153080|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
131417943|NCT02429791|473153079|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
131417944|NCT02429791|473153080|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
131417945|NCT02429791|473153079|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
131417946|NCT02429791|473153080|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
131417947|NCT02429791|473153079|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
131417948|NCT02429791|473153080|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
131417949|NCT02429791|473153079|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
131417950|NCT02429791|473153080|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
131417951|NCT02429791|473153079|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
131417952|NCT02429791|473153080|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
131417953|NCT02429791|473153079|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
131457612|NCT03818035|473304674|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
131457613|NCT03818035|473304675|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
131417954|NCT02429791|473153080|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
131417955|NCT02429791|473153079|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
131417956|NCT02429791|473153080|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
131417957|NCT02429791|473153079|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
131417958|NCT02429791|473153080|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
131417959|NCT02429791|473153079|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
131417960|NCT02429791|473153080|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
131417961|NCT02429791|473153079|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
131417962|NCT02429791|473153080|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
131417963|NCT02429791|473153079|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
131417964|NCT02429791|473153080|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
131457614|NCT03818035|473304676|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
131417965|NCT02429791|473153079|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
131417966|NCT02429791|473153080|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
131417967|NCT02429791|473153079|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
131417968|NCT02429791|473153080|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
131417969|NCT02429791|473153079|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
131417970|NCT02429791|473153080|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
131417971|NCT01276223|473153081|FG000|Overall Study|Adverse Event|7|||
131417972|NCT01276223|473153082|FG001|Overall Study|Adverse Event|4|||
131417973|NCT01276223|473153083|FG002|Overall Study|Adverse Event|1|||
131417974|NCT01276223|473153081|FG000|Overall Study|Lost to Follow-up|0|||
131417975|NCT01276223|473153082|FG001|Overall Study|Lost to Follow-up|0|||
131417976|NCT01276223|473153083|FG002|Overall Study|Lost to Follow-up|1|||
131417977|NCT01276223|473153081|FG000|Overall Study|Other|0|||
131417978|NCT01276223|473153082|FG001|Overall Study|Other|0|||
131417979|NCT01276223|473153083|FG002|Overall Study|Other|1|||
131417980|NCT01276223|473153081|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
131417981|NCT01276223|473153082|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
131417982|NCT01276223|473153083|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
131417983|NCT01276223|473153081|FG000|Overall Study|Protocol Violation|1|||
131417984|NCT01276223|473153082|FG001|Overall Study|Protocol Violation|0|||
131417985|NCT01276223|473153083|FG002|Overall Study|Protocol Violation|0|||
131417986|NCT02166463|473153084|FG000|Overall Study|Lost to Follow-up|0|||
131417987|NCT02166463|473153085|FG001|Overall Study|Lost to Follow-up|1|||
131417988|NCT02166463|473153084|FG000|Overall Study|Physician Decision|10|||
131417989|NCT02166463|473153085|FG001|Overall Study|Physician Decision|10|||
131417990|NCT02166463|473153084|FG000|Overall Study|Ineligible|11|||
131417991|NCT02166463|473153085|FG001|Overall Study|Ineligible|2|||
131417992|NCT02166463|473153084|FG000|Overall Study|Progressive Disease|9|||
131417993|NCT02166463|473153085|FG001|Overall Study|Progressive Disease|6|||
131417994|NCT02166463|473153084|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
131417995|NCT02166463|473153085|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
131417996|NCT02166463|473153084|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
131417997|NCT02166463|473153085|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
131417998|NCT02166463|473153084|FG000|Overall Study|Refusal of further protocol therapy|5|||
131417999|NCT02166463|473153085|FG001|Overall Study|Refusal of further protocol therapy|6|||
131418000|NCT01571232|473153087|FG000|Overall Study|Lost to Follow-up|0|||
131418001|NCT01571232|473153088|FG001|Overall Study|Lost to Follow-up|1|||
131418002|NCT01571232|473153087|FG000|Overall Study|Withdrawal by Subject|1|||
131418003|NCT01571232|473153088|FG001|Overall Study|Withdrawal by Subject|0|||
131418004|NCT00771615|473153089|FG000|Overall Study|Withdrawal by Subject|0|||
131418005|NCT00771615|473153090|FG001|Overall Study|Withdrawal by Subject|1|||
131418006|NCT00771615|473153091|FG002|Overall Study|Withdrawal by Subject|0|||
131418007|NCT00771615|473153092|FG003|Overall Study|Withdrawal by Subject|0|||
131418008|NCT00771615|473153093|FG004|Overall Study|Withdrawal by Subject|0|||
131418009|NCT00771615|473153094|FG005|Overall Study|Withdrawal by Subject|0|||
131418010|NCT00771615|473153095|FG006|Overall Study|Withdrawal by Subject|0|||
131418011|NCT00771615|473153096|FG007|Overall Study|Withdrawal by Subject|1|||
131418012|NCT00771615|473153097|FG008|Overall Study|Withdrawal by Subject|0|||
131418013|NCT00771615|473153089|FG000|Overall Study|Lost to Follow-up|1|||
131418014|NCT00771615|473153090|FG001|Overall Study|Lost to Follow-up|1|||
131418015|NCT00771615|473153091|FG002|Overall Study|Lost to Follow-up|1|||
131418016|NCT00771615|473153092|FG003|Overall Study|Lost to Follow-up|1|||
131418017|NCT00771615|473153093|FG004|Overall Study|Lost to Follow-up|0|||
131418018|NCT00771615|473153094|FG005|Overall Study|Lost to Follow-up|1|||
131418019|NCT00771615|473153095|FG006|Overall Study|Lost to Follow-up|1|||
131418020|NCT00771615|473153096|FG007|Overall Study|Lost to Follow-up|0|||
131418021|NCT00771615|473153097|FG008|Overall Study|Lost to Follow-up|0|||
131418022|NCT02455076|473153098|FG000|Inpatient|Withdrawal by Subject|1|||
131418023|NCT02455076|473153099|FG001|Inpatient|Withdrawal by Subject|0|||
131418024|NCT02455076|473153100|FG002|Inpatient|Withdrawal by Subject|0|||
131418025|NCT02455076|473153101|FG003|Inpatient|Withdrawal by Subject|0|||
131418026|NCT02455076|473153102|FG004|Inpatient|Withdrawal by Subject|0|||
131418027|NCT02455076|473153098|FG000|Inpatient|Discharged <24 h after admission|0|||
131418028|NCT02455076|473153099|FG001|Inpatient|Discharged <24 h after admission|1|||
131418029|NCT02455076|473153100|FG002|Inpatient|Discharged <24 h after admission|0|||
131418030|NCT02455076|473153101|FG003|Inpatient|Discharged <24 h after admission|0|||
131418031|NCT02455076|473153102|FG004|Inpatient|Discharged <24 h after admission|0|||
131418032|NCT02455076|473153098|FG000|Inpatient|Adverse Event|3|||
131418033|NCT02455076|473153099|FG001|Inpatient|Adverse Event|0|||
131418034|NCT02455076|473153100|FG002|Inpatient|Adverse Event|0|||
131418035|NCT02455076|473153101|FG003|Inpatient|Adverse Event|0|||
131418036|NCT02455076|473153102|FG004|Inpatient|Adverse Event|0|||
131418037|NCT02455076|473153098|FG000|Outpatient|Adverse Event|0|||
131418038|NCT02455076|473153099|FG001|Outpatient|Adverse Event|0|||
131418039|NCT02455076|473153100|FG002|Outpatient|Adverse Event|0|||
131418040|NCT02455076|473153101|FG003|Outpatient|Adverse Event|5|||
131418041|NCT02455076|473153102|FG004|Outpatient|Adverse Event|0|||
131418042|NCT02455076|473153098|FG000|Outpatient|Lost to Follow-up|0|||
131418043|NCT02455076|473153099|FG001|Outpatient|Lost to Follow-up|0|||
131418044|NCT02455076|473153100|FG002|Outpatient|Lost to Follow-up|0|||
131418045|NCT02455076|473153101|FG003|Outpatient|Lost to Follow-up|1|||
131418046|NCT02455076|473153102|FG004|Outpatient|Lost to Follow-up|12|||
131418047|NCT00859937|473153103|FG000|Overall Study|Protocol Violation|1|||
131418048|NCT00859937|473153104|FG001|Overall Study|Protocol Violation|0|||
131418049|NCT02478164|473153105|FG000|Overall Study|Lack of Efficacy|13|||
131418050|NCT02478164|473153105|FG000|Overall Study|Adverse Event|1|||
131418051|NCT02478164|473153105|FG000|Overall Study|Withdrawal by Subject|1|||
131418052|NCT05194267|473153106|FG000|Overall Study|Withdrawal by Subject|2|||
131418053|NCT00802893|473153107|FG000|Overall Study|study terminated|3|||
131418054|NCT06151288|473153108|FG000|Overall Study|Lost to Follow-up|4|||
131418055|NCT06151288|473153109|FG001|Overall Study|Lost to Follow-up|2|||
131418056|NCT06151288|473153110|FG002|Overall Study|Lost to Follow-up|4|||
131418057|NCT06151288|473153111|FG003|Overall Study|Lost to Follow-up|3|||
131418058|NCT06151288|473153108|FG000|Overall Study|Withdrawal by Subject|4|||
131418059|NCT06151288|473153109|FG001|Overall Study|Withdrawal by Subject|5|||
131418060|NCT06151288|473153110|FG002|Overall Study|Withdrawal by Subject|1|||
131418061|NCT06151288|473153111|FG003|Overall Study|Withdrawal by Subject|1|||
131418062|NCT04588389|473153112|FG000|Overall Study|Issues with anesthesia during surgery|2|||
131418063|NCT04588389|473153113|FG001|Overall Study|Issues with anesthesia during surgery|0|||
131418064|NCT04588389|473153114|FG002|Overall Study|Issues with anesthesia during surgery|0|||
131418065|NCT02911142|473153119|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
131418066|NCT02911142|473153119|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
131418067|NCT02911142|473153119|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
131418068|NCT02911142|473153119|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
131418069|NCT05779007|473153120|FG000|Overall Study|not meeting eligibility criteria|3517|||
131418070|NCT05779007|473153121|FG001|Overall Study|not meeting eligibility criteria|2009|||
131418071|NCT00026312|473153122|FG000|Overall Study|Adverse Event|0|||
131418072|NCT00026312|473153123|FG001|Overall Study|Adverse Event|32|||
131418073|NCT00026312|473153122|FG000|Overall Study|Death|1|||
131418074|NCT00026312|473153123|FG001|Overall Study|Death|7|||
131418075|NCT00026312|473153122|FG000|Overall Study|Lack of Efficacy|19|||
131418076|NCT00026312|473153123|FG001|Overall Study|Lack of Efficacy|114|||
131418077|NCT00026312|473153122|FG000|Overall Study|Lost to Follow-up|0|||
131418078|NCT00026312|473153123|FG001|Overall Study|Lost to Follow-up|5|||
131418079|NCT00026312|473153122|FG000|Overall Study|Physician Decision|1|||
131418080|NCT00026312|473153123|FG001|Overall Study|Physician Decision|37|||
131418081|NCT00026312|473153122|FG000|Overall Study|Protocol Violation|0|||
131418082|NCT00026312|473153123|FG001|Overall Study|Protocol Violation|3|||
131418083|NCT00026312|473153122|FG000|Overall Study|Withdrawal by Subject|1|||
131418084|NCT00026312|473153123|FG001|Overall Study|Withdrawal by Subject|6|||
131418085|NCT00026312|473153122|FG000|Overall Study|Ineligible|4|||
131418086|NCT00026312|473153123|FG001|Overall Study|Ineligible|5|||
131418087|NCT00026312|473153122|FG000|Overall Study|Entry onto another COG study|0|||
131418088|NCT00026312|473153123|FG001|Overall Study|Entry onto another COG study|1|||
131418089|NCT00026312|473153122|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
131418090|NCT00026312|473153123|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
131418091|NCT05147662|473153138|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131418092|NCT05147662|473153138|FG000|Overall Study|Assigned to treatment but never treated|1|||
131418093|NCT02294734|473153139|FG000|Overall Study|Adverse Event|5|||
131418094|NCT02294734|473153140|FG001|Overall Study|Adverse Event|5|||
131418095|NCT02294734|473153139|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
131418096|NCT02294734|473153140|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
131418097|NCT02294734|473153139|FG000|Overall Study|Lost to Follow-up|2|||
131418098|NCT02294734|473153140|FG001|Overall Study|Lost to Follow-up|0|||
131418099|NCT02294734|473153139|FG000|Overall Study|Physician Decision|2|||
131418100|NCT02294734|473153140|FG001|Overall Study|Physician Decision|1|||
131418101|NCT02294734|473153139|FG000|Overall Study|Withdrawal by Subject|4|||
131418102|NCT02294734|473153140|FG001|Overall Study|Withdrawal by Subject|2|||
131418103|NCT00847015|473153141|FG000|Overall Study|Withdrawal by Subject|1|||
131418104|NCT00847015|473153141|FG000|Overall Study|declined any surgery|1|||
131418105|NCT00847015|473153141|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
131418106|NCT01141478|473153142|FG000|Overall Study|Withdrawal by Subject|1|||
131418107|NCT01141478|473153143|FG001|Overall Study|Withdrawal by Subject|1|||
131418108|NCT03847909|473153146|FG000|Overall Study|Withdrawal by Subject|1|||
131418109|NCT03847909|473153147|FG001|Overall Study|Withdrawal by Subject|1|||
131418110|NCT01375608|473153148|FG000|Overall Study|Withdrawal by Subject|2|||
131418111|NCT00082381|473153149|FG000|Overall Study|Adverse Event|27|||
131418112|NCT00082381|473153150|FG001|Overall Study|Adverse Event|2|||
131418113|NCT00082381|473153149|FG000|Overall Study|Lost to Follow-up|5|||
131418114|NCT00082381|473153150|FG001|Overall Study|Lost to Follow-up|7|||
131418115|NCT00082381|473153149|FG000|Overall Study|Patient Decision|8|||
131418116|NCT00082381|473153150|FG001|Overall Study|Patient Decision|4|||
131418117|NCT00082381|473153149|FG000|Overall Study|Physician Decision|1|||
131418118|NCT00082381|473153150|FG001|Overall Study|Physician Decision|2|||
131418119|NCT00082381|473153149|FG000|Overall Study|Protocol Violation|10|||
131418120|NCT00082381|473153150|FG001|Overall Study|Protocol Violation|11|||
131418121|NCT00082381|473153149|FG000|Overall Study|Loss of Glucose Control|4|||
131418122|NCT00082381|473153150|FG001|Overall Study|Loss of Glucose Control|0|||
131418123|NCT02049138|473153151|FG000|Overall Study|Adverse Event|46|||
131418124|NCT02049138|473153152|FG001|Overall Study|Adverse Event|25|||
131418125|NCT02049138|473153153|FG002|Overall Study|Adverse Event|1|||
131418126|NCT02049138|473153151|FG000|Overall Study|Withdrawal by Subject|57|||
131418127|NCT02049138|473153152|FG001|Overall Study|Withdrawal by Subject|21|||
131418128|NCT02049138|473153153|FG002|Overall Study|Withdrawal by Subject|5|||
131418129|NCT02049138|473153151|FG000|Overall Study|Lost to Follow-up|18|||
131418130|NCT02049138|473153152|FG001|Overall Study|Lost to Follow-up|5|||
131418131|NCT02049138|473153153|FG002|Overall Study|Lost to Follow-up|1|||
131418132|NCT02049138|473153151|FG000|Overall Study|Lack of Efficacy|10|||
131418133|NCT02049138|473153152|FG001|Overall Study|Lack of Efficacy|26|||
131418134|NCT02049138|473153153|FG002|Overall Study|Lack of Efficacy|1|||
131418135|NCT02049138|473153151|FG000|Overall Study|Non-Compliance|15|||
131418136|NCT02049138|473153152|FG001|Overall Study|Non-Compliance|6|||
131418137|NCT02049138|473153153|FG002|Overall Study|Non-Compliance|0|||
131418138|NCT02049138|473153151|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
131418139|NCT02049138|473153152|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
131418140|NCT02049138|473153153|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
131418141|NCT02049138|473153151|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
131418142|NCT02049138|473153152|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131418143|NCT02049138|473153153|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131418144|NCT02049138|473153151|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
131418145|NCT02049138|473153152|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
131418146|NCT02049138|473153153|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
131418147|NCT02049138|473153151|FG000|Overall Study|Other|15|||
131418148|NCT02049138|473153152|FG001|Overall Study|Other|13|||
131418149|NCT02049138|473153153|FG002|Overall Study|Other|0|||
131418150|NCT02049138|473153151|FG000|Overall Study|Missing|0|||
131418151|NCT02049138|473153152|FG001|Overall Study|Missing|1|||
131418152|NCT02049138|473153153|FG002|Overall Study|Missing|0|||
131418153|NCT02925741|473153154|FG000|Overall Study|Withdrawal by Subject|11|||
131418154|NCT02925741|473153155|FG001|Overall Study|Withdrawal by Subject|0|||
131418155|NCT00025155|473153156|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
131418156|NCT00025155|473153156|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
131418157|NCT05086510|473153157|FG000|Overall Study|Lost to Follow-up|0|||
131418158|NCT05086510|473153158|FG001|Overall Study|Lost to Follow-up|2|||
131418159|NCT05086510|473153157|FG000|Overall Study|Death|0|||
131418160|NCT05086510|473153158|FG001|Overall Study|Death|2|||
131418161|NCT03022981|473153159|FG000|Overall Study|Adverse Event|0|||
131418162|NCT03022981|473153160|FG001|Overall Study|Adverse Event|1|||
131418163|NCT03022981|473153161|FG002|Overall Study|Adverse Event|0|||
131418164|NCT03022981|473153159|FG000|Overall Study|Investigator's Discretion|0|||
131418165|NCT03022981|473153160|FG001|Overall Study|Investigator's Discretion|1|||
131418166|NCT03022981|473153161|FG002|Overall Study|Investigator's Discretion|2|||
131418167|NCT03022981|473153159|FG000|Overall Study|Lost to Follow-up|6|||
131418168|NCT03022981|473153160|FG001|Overall Study|Lost to Follow-up|2|||
131418169|NCT03022981|473153161|FG002|Overall Study|Lost to Follow-up|1|||
131418170|NCT03022981|473153159|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131418171|NCT03022981|473153160|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131457615|NCT03818035|473304673|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
131457616|NCT03818035|473304674|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
131457617|NCT03818035|473304675|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
131457618|NCT03818035|473304676|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
131457619|NCT03818035|473304673|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
131457620|NCT03818035|473304674|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
131457621|NCT03818035|473304675|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
131418172|NCT03022981|473153161|FG002|Overall Study|Non-Compliance With Study Drug|2|||
131418173|NCT03022981|473153159|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
131418174|NCT03022981|473153160|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
131418175|NCT03022981|473153161|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
131418176|NCT00295932|473153162|FG000|Overall Study|Not Treated|0|||
131418177|NCT00295932|473153163|FG001|Overall Study|Not Treated|0|||
131418178|NCT00295932|473153164|FG002|Overall Study|Not Treated|0|||
131418179|NCT00295932|473153165|FG003|Overall Study|Not Treated|0|||
131418180|NCT00295932|473153166|FG004|Overall Study|Not Treated|0|||
131418181|NCT00295932|473153167|FG005|Overall Study|Not Treated|0|||
131418182|NCT00295932|473153168|FG006|Overall Study|Not Treated|0|||
131418183|NCT00295932|473153169|FG007|Overall Study|Not Treated|0|||
131418184|NCT00295932|473153170|FG008|Overall Study|Not Treated|0|||
131418185|NCT00295932|473153171|FG009|Overall Study|Not Treated|0|||
131418186|NCT00295932|473153172|FG010|Overall Study|Not Treated|1|||
131418187|NCT00109577|473153173|FG000|Overall Study|Withdrawal by Subject|3|||
131418188|NCT00109577|473153174|FG001|Overall Study|Withdrawal by Subject|3|||
131418189|NCT00884832|473153175|FG000|Overall Study|Withdrawal by Subject|0|||
131418190|NCT00884832|473153176|FG001|Overall Study|Withdrawal by Subject|1|||
131418191|NCT01600092|473153177|FG000|Overall Study|Adverse Event|2|||
131418192|NCT01600092|473153178|FG001|Overall Study|Adverse Event|0|||
131418193|NCT01600092|473153177|FG000|Overall Study|Lost to Follow-up|4|||
131418194|NCT01600092|473153178|FG001|Overall Study|Lost to Follow-up|6|||
131418195|NCT01600092|473153177|FG000|Overall Study|Withdrawal by parent/guardian|8|||
131418196|NCT01600092|473153178|FG001|Overall Study|Withdrawal by parent/guardian|6|||
131418197|NCT01600092|473153177|FG000|Overall Study|Physician Decision|1|||
131418198|NCT01600092|473153178|FG001|Overall Study|Physician Decision|1|||
131418199|NCT01600092|473153177|FG000|Overall Study|Randomized but not vaccinated|3|||
131418200|NCT01600092|473153178|FG001|Overall Study|Randomized but not vaccinated|3|||
131418201|NCT00079677|473153179|FG000|Overall Study|Adverse Event|5|||
131418202|NCT00079677|473153180|FG001|Overall Study|Adverse Event|6|||
131418203|NCT00079677|473153179|FG000|Overall Study|Lack of Efficacy|1|||
131418204|NCT00079677|473153180|FG001|Overall Study|Lack of Efficacy|0|||
131418205|NCT00079677|473153179|FG000|Overall Study|Lost to Follow-up|2|||
131418206|NCT00079677|473153180|FG001|Overall Study|Lost to Follow-up|2|||
131418207|NCT00079677|473153179|FG000|Overall Study|Physician Decision|3|||
131418208|NCT00079677|473153180|FG001|Overall Study|Physician Decision|0|||
131418209|NCT00079677|473153179|FG000|Overall Study|Protocol Violation|2|||
131418210|NCT00079677|473153180|FG001|Overall Study|Protocol Violation|3|||
131418211|NCT00079677|473153179|FG000|Overall Study|Withdrawal by Subject|5|||
131418212|NCT00079677|473153180|FG001|Overall Study|Withdrawal by Subject|3|||
131418213|NCT00079677|473153179|FG000|Overall Study|Miscellaneous|2|||
131418214|NCT00079677|473153180|FG001|Overall Study|Miscellaneous|0|||
131418215|NCT00454649|473153186|FG000|Overall Study|Lack of Efficacy|2|||
131418216|NCT00454649|473153187|FG001|Overall Study|Lack of Efficacy|2|||
131418217|NCT00454649|473153188|FG002|Overall Study|Lack of Efficacy|10|||
131418218|NCT00454649|473153189|FG003|Overall Study|Lack of Efficacy|3|||
131418219|NCT00454649|473153190|FG004|Overall Study|Lack of Efficacy|0|||
131418220|NCT00454649|473153191|FG005|Overall Study|Lack of Efficacy|4|||
131418221|NCT00454649|473153192|FG006|Overall Study|Lack of Efficacy|5|||
131418222|NCT00454649|473153193|FG007|Overall Study|Lack of Efficacy|13|||
131418223|NCT00454649|473153194|FG008|Overall Study|Lack of Efficacy|10|||
131418224|NCT00454649|473153195|FG009|Overall Study|Lack of Efficacy|2|||
131418225|NCT00454649|473153186|FG000|Overall Study|Adverse Event|0|||
131418226|NCT00454649|473153187|FG001|Overall Study|Adverse Event|1|||
131418227|NCT00454649|473153188|FG002|Overall Study|Adverse Event|3|||
131418228|NCT00454649|473153189|FG003|Overall Study|Adverse Event|0|||
131418229|NCT00454649|473153190|FG004|Overall Study|Adverse Event|1|||
131418230|NCT00454649|473153191|FG005|Overall Study|Adverse Event|2|||
131418231|NCT00454649|473153192|FG006|Overall Study|Adverse Event|3|||
131418232|NCT00454649|473153193|FG007|Overall Study|Adverse Event|4|||
131418233|NCT00454649|473153194|FG008|Overall Study|Adverse Event|6|||
131418234|NCT00454649|473153195|FG009|Overall Study|Adverse Event|2|||
131418235|NCT00454649|473153186|FG000|Overall Study|Lost to Follow-up|0|||
131418236|NCT00454649|473153187|FG001|Overall Study|Lost to Follow-up|0|||
131418237|NCT00454649|473153188|FG002|Overall Study|Lost to Follow-up|1|||
131418238|NCT00454649|473153189|FG003|Overall Study|Lost to Follow-up|0|||
131418239|NCT00454649|473153190|FG004|Overall Study|Lost to Follow-up|0|||
131418240|NCT00454649|473153191|FG005|Overall Study|Lost to Follow-up|0|||
131418241|NCT00454649|473153192|FG006|Overall Study|Lost to Follow-up|1|||
131418242|NCT00454649|473153193|FG007|Overall Study|Lost to Follow-up|0|||
131457622|NCT03818035|473304676|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
131418243|NCT00454649|473153194|FG008|Overall Study|Lost to Follow-up|0|||
131418244|NCT00454649|473153195|FG009|Overall Study|Lost to Follow-up|0|||
131418245|NCT00454649|473153186|FG000|Overall Study|Other|1|||
131418246|NCT00454649|473153187|FG001|Overall Study|Other|1|||
131418247|NCT00454649|473153188|FG002|Overall Study|Other|5|||
131418248|NCT00454649|473153189|FG003|Overall Study|Other|3|||
131418249|NCT00454649|473153190|FG004|Overall Study|Other|0|||
131418250|NCT00454649|473153191|FG005|Overall Study|Other|0|||
131418251|NCT00454649|473153192|FG006|Overall Study|Other|0|||
131418252|NCT00454649|473153193|FG007|Overall Study|Other|0|||
131418253|NCT00454649|473153194|FG008|Overall Study|Other|3|||
131418254|NCT00454649|473153195|FG009|Overall Study|Other|1|||
131418255|NCT00454649|473153186|FG000|Overall Study|Withdrawal by Subject|0|||
131418256|NCT00454649|473153187|FG001|Overall Study|Withdrawal by Subject|0|||
131418257|NCT00454649|473153188|FG002|Overall Study|Withdrawal by Subject|0|||
131418258|NCT00454649|473153189|FG003|Overall Study|Withdrawal by Subject|0|||
131418259|NCT00454649|473153190|FG004|Overall Study|Withdrawal by Subject|0|||
131418260|NCT00454649|473153191|FG005|Overall Study|Withdrawal by Subject|1|||
131418261|NCT00454649|473153192|FG006|Overall Study|Withdrawal by Subject|0|||
131418262|NCT00454649|473153193|FG007|Overall Study|Withdrawal by Subject|2|||
131418263|NCT00454649|473153194|FG008|Overall Study|Withdrawal by Subject|1|||
131418264|NCT00454649|473153195|FG009|Overall Study|Withdrawal by Subject|0|||
131418265|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
131418266|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
131418267|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
131418268|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
131418269|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
131418270|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
131418271|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
131418272|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
131418273|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Death|0|||
131418274|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Death|1|||
131418275|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
131418276|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
131418277|NCT03281304|473153200|FG000|Treatment Phase (up to 42 Months)|Other|0|||
131418278|NCT03281304|473153201|FG001|Treatment Phase (up to 42 Months)|Other|2|||
131418279|NCT03281304|473153200|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
131418280|NCT03281304|473153201|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
131418281|NCT03268941|473154959|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
131418282|NCT03268941|473154960|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
131418283|NCT03268941|473154961|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
131418284|NCT03268941|473154962|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
131418285|NCT03268941|473154963|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
131418286|NCT03268941|473154964|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
131418287|NCT03268941|473154965|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
131418288|NCT03268941|473154959|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
131418289|NCT03268941|473154960|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
131418290|NCT03268941|473154961|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
131418291|NCT03268941|473154962|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
131418292|NCT03268941|473154963|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
131418293|NCT03268941|473154964|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
131418294|NCT03268941|473154965|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
131418295|NCT03268941|473154959|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
131418296|NCT03268941|473154960|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
131418297|NCT03268941|473154961|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
131418298|NCT03268941|473154962|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
131418299|NCT03268941|473154963|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
131418300|NCT03268941|473154964|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
131418301|NCT03268941|473154965|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
131418302|NCT03268941|473154959|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
131418303|NCT03268941|473154960|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
131418304|NCT03268941|473154961|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
131418305|NCT03268941|473154962|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
131418306|NCT03268941|473154963|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
131418307|NCT03268941|473154964|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
131418308|NCT03268941|473154965|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
131418309|NCT03268941|473154959|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
131418310|NCT03268941|473154960|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
131418311|NCT03268941|473154961|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
131418312|NCT03268941|473154962|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
131418313|NCT03268941|473154963|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
131418314|NCT03268941|473154964|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
131418315|NCT03268941|473154965|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
131418316|NCT01216683|473154966|FG000|Induction|Never started treatment|0|||
131418317|NCT01216683|473154967|FG001|Induction|Never started treatment|6|||
131418318|NCT01216683|473154968|FG002|Induction|Never started treatment|3|||
131418319|NCT01216683|473154966|FG000|Induction|Lack of Efficacy|4|||
131418320|NCT01216683|473154967|FG001|Induction|Lack of Efficacy|3|||
131418321|NCT01216683|473154968|FG002|Induction|Lack of Efficacy|7|||
131418322|NCT01216683|473154966|FG000|Induction|Adverse Event|0|||
131418323|NCT01216683|473154967|FG001|Induction|Adverse Event|5|||
131418324|NCT01216683|473154968|FG002|Induction|Adverse Event|5|||
131418325|NCT01216683|473154966|FG000|Induction|Death|0|||
131418326|NCT01216683|473154967|FG001|Induction|Death|0|||
131418327|NCT01216683|473154968|FG002|Induction|Death|2|||
131418328|NCT01216683|473154966|FG000|Induction|Withdrawal by Subject|0|||
131418329|NCT01216683|473154967|FG001|Induction|Withdrawal by Subject|4|||
131418330|NCT01216683|473154968|FG002|Induction|Withdrawal by Subject|2|||
131418331|NCT01216683|473154966|FG000|Induction|Other disease|0|||
131418332|NCT01216683|473154967|FG001|Induction|Other disease|1|||
131418333|NCT01216683|473154968|FG002|Induction|Other disease|2|||
131418334|NCT01216683|473154966|FG000|Continuation|Lack of Efficacy|3|||
131418335|NCT01216683|473154967|FG001|Continuation|Lack of Efficacy|2|||
131418336|NCT01216683|473154968|FG002|Continuation|Lack of Efficacy|7|||
131418337|NCT01216683|473154966|FG000|Continuation|Adverse Event|5|||
131418338|NCT01216683|473154967|FG001|Continuation|Adverse Event|3|||
131418339|NCT01216683|473154968|FG002|Continuation|Adverse Event|16|||
131418340|NCT01216683|473154966|FG000|Continuation|Death|1|||
131418341|NCT01216683|473154967|FG001|Continuation|Death|0|||
131418342|NCT01216683|473154968|FG002|Continuation|Death|2|||
131418343|NCT01216683|473154966|FG000|Continuation|Withdrawal by Subject|4|||
131418344|NCT01216683|473154967|FG001|Continuation|Withdrawal by Subject|5|||
131418345|NCT01216683|473154968|FG002|Continuation|Withdrawal by Subject|9|||
131418346|NCT01216683|473154966|FG000|Continuation|Other diseases|0|||
131418347|NCT01216683|473154967|FG001|Continuation|Other diseases|2|||
131418348|NCT01216683|473154968|FG002|Continuation|Other diseases|1|||
131418349|NCT01216683|473154966|FG000|Continuation|Physician Decision|1|||
131418350|NCT01216683|473154967|FG001|Continuation|Physician Decision|0|||
131418351|NCT01216683|473154968|FG002|Continuation|Physician Decision|1|||
131418352|NCT01216683|473154966|FG000|Continuation|Non-compliance|1|||
131418353|NCT01216683|473154967|FG001|Continuation|Non-compliance|0|||
131418354|NCT01216683|473154968|FG002|Continuation|Non-compliance|1|||
131418355|NCT01216683|473154966|FG000|Continuation|Insurance change|0|||
131418356|NCT01216683|473154967|FG001|Continuation|Insurance change|1|||
131418357|NCT01216683|473154968|FG002|Continuation|Insurance change|0|||
131418358|NCT01216683|473154966|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
131418359|NCT01216683|473154967|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
131418360|NCT01216683|473154968|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
131418361|NCT01216683|473154966|FG000|Continuation|Not reported|0|||
131418362|NCT01216683|473154967|FG001|Continuation|Not reported|0|||
131418363|NCT01216683|473154968|FG002|Continuation|Not reported|1|||
131418364|NCT01216683|473154966|FG000|Continuation|Never started treatment|0|||
131418365|NCT01216683|473154967|FG001|Continuation|Never started treatment|1|||
131418366|NCT01216683|473154968|FG002|Continuation|Never started treatment|5|||
131418367|NCT00765063|473154975|FG000|Overall Study|Lack of Efficacy|5|||
131418368|NCT00765063|473154975|FG000|Overall Study|Withdrawal by Subject|1|||
131418369|NCT00765063|473154975|FG000|Overall Study|Other|16|||
131418370|NCT00765063|473154975|FG000|Overall Study|Protocol Violation|6|||
131418371|NCT00765063|473154975|FG000|Overall Study|Adverse Event|4|||
131418372|NCT03614325|473154978|FG000|Overall Study|Withdrawal by Subject|0|||
131418373|NCT03614325|473154979|FG001|Overall Study|Withdrawal by Subject|2|||
131418374|NCT03614325|473154978|FG000|Overall Study|Surgery Cancelled|2|||
131418375|NCT03614325|473154979|FG001|Overall Study|Surgery Cancelled|1|||
131418376|NCT03614325|473154978|FG000|Overall Study|Lost to Follow-up|2|||
131418377|NCT03614325|473154979|FG001|Overall Study|Lost to Follow-up|1|||
131418378|NCT03614325|473154978|FG000|Overall Study|Surgery never scheduled|1|||
131418379|NCT03614325|473154979|FG001|Overall Study|Surgery never scheduled|0|||
131418380|NCT01041287|473154980|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
131418381|NCT01041287|473154981|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
131418382|NCT01041287|473154980|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
131418383|NCT01041287|473154981|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
131418384|NCT02814175|473154982|FG000|Part 1|Adverse Event|2|||
131418385|NCT02814175|473154983|FG001|Part 1|Adverse Event|3|||
131418386|NCT02814175|473154984|FG002|Part 1|Adverse Event|0|||
131418387|NCT02814175|473154985|FG003|Part 1|Adverse Event|0|||
131418388|NCT02814175|473154986|FG004|Part 1|Adverse Event|0|||
131418389|NCT02814175|473154987|FG005|Part 1|Adverse Event|0|||
131418390|NCT02814175|473154982|FG000|Part 1|Withdrawal Consent|8|||
131418391|NCT02814175|473154983|FG001|Part 1|Withdrawal Consent|1|||
131418392|NCT02814175|473154984|FG002|Part 1|Withdrawal Consent|0|||
131418393|NCT02814175|473154985|FG003|Part 1|Withdrawal Consent|0|||
131418394|NCT02814175|473154986|FG004|Part 1|Withdrawal Consent|0|||
131418395|NCT02814175|473154987|FG005|Part 1|Withdrawal Consent|0|||
131418396|NCT02814175|473154982|FG000|Part 1|Lost to Follow-up|1|||
131418397|NCT02814175|473154983|FG001|Part 1|Lost to Follow-up|0|||
131418398|NCT02814175|473154984|FG002|Part 1|Lost to Follow-up|0|||
131418399|NCT02814175|473154985|FG003|Part 1|Lost to Follow-up|0|||
131418400|NCT02814175|473154986|FG004|Part 1|Lost to Follow-up|0|||
131418401|NCT02814175|473154987|FG005|Part 1|Lost to Follow-up|0|||
131418402|NCT02814175|473154982|FG000|Part 1|Lack of Efficacy|1|||
131418403|NCT02814175|473154983|FG001|Part 1|Lack of Efficacy|2|||
131418404|NCT02814175|473154984|FG002|Part 1|Lack of Efficacy|0|||
131418405|NCT02814175|473154985|FG003|Part 1|Lack of Efficacy|0|||
131418406|NCT02814175|473154986|FG004|Part 1|Lack of Efficacy|0|||
131418407|NCT02814175|473154987|FG005|Part 1|Lack of Efficacy|0|||
131418408|NCT02814175|473154982|FG000|Part 2|Adverse Event|0|||
131418409|NCT02814175|473154983|FG001|Part 2|Adverse Event|0|||
131418410|NCT02814175|473154984|FG002|Part 2|Adverse Event|0|||
131418411|NCT02814175|473154985|FG003|Part 2|Adverse Event|1|||
131418412|NCT02814175|473154986|FG004|Part 2|Adverse Event|1|||
131418413|NCT02814175|473154987|FG005|Part 2|Adverse Event|2|||
131418414|NCT02814175|473154982|FG000|Part 2|Withdrawal Consent|0|||
131418415|NCT02814175|473154983|FG001|Part 2|Withdrawal Consent|0|||
131418416|NCT02814175|473154984|FG002|Part 2|Withdrawal Consent|0|||
131418417|NCT02814175|473154985|FG003|Part 2|Withdrawal Consent|2|||
131418418|NCT02814175|473154986|FG004|Part 2|Withdrawal Consent|1|||
131418419|NCT02814175|473154987|FG005|Part 2|Withdrawal Consent|1|||
131418420|NCT02814175|473154982|FG000|Part 2|Lost to Follow-up|0|||
131418421|NCT02814175|473154983|FG001|Part 2|Lost to Follow-up|0|||
131418422|NCT02814175|473154984|FG002|Part 2|Lost to Follow-up|0|||
131418423|NCT02814175|473154985|FG003|Part 2|Lost to Follow-up|1|||
131418424|NCT02814175|473154986|FG004|Part 2|Lost to Follow-up|0|||
131418425|NCT02814175|473154987|FG005|Part 2|Lost to Follow-up|0|||
131418426|NCT02814175|473154982|FG000|Part 2|Lack of Efficacy|0|||
131418427|NCT02814175|473154983|FG001|Part 2|Lack of Efficacy|0|||
131418428|NCT02814175|473154984|FG002|Part 2|Lack of Efficacy|0|||
131418429|NCT02814175|473154985|FG003|Part 2|Lack of Efficacy|0|||
131418430|NCT02814175|473154986|FG004|Part 2|Lack of Efficacy|0|||
131418431|NCT02814175|473154987|FG005|Part 2|Lack of Efficacy|3|||
131418432|NCT01673620|473154993|FG000|Overall Study|Adverse Event|1|||
131418433|NCT01673620|473154994|FG001|Overall Study|Adverse Event|0|||
131418434|NCT01597635|473154995|FG000|Part A|Adverse Event|3|||
131418435|NCT01597635|473154996|FG001|Part A|Adverse Event|0|||
131418436|NCT01597635|473154997|FG002|Part A|Adverse Event|0|||
131418437|NCT01597635|473154995|FG000|Part B|Adverse Event|0|||
131418438|NCT01597635|473154996|FG001|Part B|Adverse Event|0|||
131418439|NCT01597635|473154997|FG002|Part B|Adverse Event|1|||
131418440|NCT01597635|473154995|FG000|Part B|Protocol Violation|0|||
131418441|NCT01597635|473154996|FG001|Part B|Protocol Violation|1|||
131418442|NCT01597635|473154997|FG002|Part B|Protocol Violation|0|||
131418443|NCT01597635|473154995|FG000|Part B|Protocol-defined stopping criteria|0|||
131418444|NCT01597635|473154996|FG001|Part B|Protocol-defined stopping criteria|4|||
131418445|NCT01597635|473154997|FG002|Part B|Protocol-defined stopping criteria|3|||
131418446|NCT01597635|473154995|FG000|Part B|Withdrawal by Subject|0|||
131418447|NCT01597635|473154996|FG001|Part B|Withdrawal by Subject|1|||
131418448|NCT01597635|473154997|FG002|Part B|Withdrawal by Subject|0|||
131418449|NCT02593825|473154998|FG000|Intervention|Lost to Follow-up|10|||
131418450|NCT02593825|473154999|FG001|Intervention|Lost to Follow-up|12|||
131418451|NCT02522325|473155000|FG000|Overall Study|Adverse Event|0|||
131418452|NCT02522325|473155001|FG001|Overall Study|Adverse Event|1|||
131418453|NCT01209078|473155002|FG000|Overall Study|Adverse Event|5|||
131418454|NCT01209078|473155003|FG001|Overall Study|Adverse Event|0|||
131418455|NCT01209078|473155002|FG000|Overall Study|Lost to Follow-up|4|||
131418456|NCT01209078|473155003|FG001|Overall Study|Lost to Follow-up|0|||
131418457|NCT01209078|473155002|FG000|Overall Study|Physician Decision|5|||
131418458|NCT01209078|473155003|FG001|Overall Study|Physician Decision|2|||
131418459|NCT01209078|473155002|FG000|Overall Study|Withdrawal by Subject|2|||
131418460|NCT01209078|473155003|FG001|Overall Study|Withdrawal by Subject|1|||
131418461|NCT00924508|473155006|FG000|Overall Study|Withdrawal by Subject|3|||
131418462|NCT00495625|473155007|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
131418463|NCT01912339|473155008|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
131418464|NCT01912339|473155009|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
131418465|NCT01912339|473155010|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
131418466|NCT01912339|473155008|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
131418467|NCT01912339|473155009|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
131418468|NCT01912339|473155010|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
131418469|NCT01912339|473155008|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
131418470|NCT01912339|473155009|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
131418471|NCT01912339|473155010|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
131418472|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
131418473|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
131418474|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
131418475|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
131418476|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
131418477|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
131418478|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
131418479|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
131418480|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
131418481|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
131418482|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
131418483|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
131418484|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
131418485|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
131418486|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
131418487|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
131418488|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
131418489|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
131418490|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
131418491|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
131418492|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
131418493|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
131418494|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
131418495|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
131418496|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
131418497|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
131418498|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
131418499|NCT01912339|473155008|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
131418500|NCT01912339|473155009|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
131418501|NCT01912339|473155010|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
131418502|NCT06359080|473155011|FG000|Overall Study|Withdrawal by Subject|3|||
131418503|NCT00306527|473155015|FG000|Overall Study|Lost to Follow-up|3|||
131418504|NCT00306527|473155016|FG001|Overall Study|Lost to Follow-up|4|||
131418505|NCT00306527|473155017|FG002|Overall Study|Lost to Follow-up|3|||
131418506|NCT00306527|473155018|FG003|Overall Study|Lost to Follow-up|0|||
131418507|NCT00306527|473155015|FG000|Overall Study|Withdrawal by Subject|2|||
131418508|NCT00306527|473155016|FG001|Overall Study|Withdrawal by Subject|3|||
131418509|NCT00306527|473155017|FG002|Overall Study|Withdrawal by Subject|0|||
131418510|NCT00306527|473155018|FG003|Overall Study|Withdrawal by Subject|3|||
131418511|NCT00306527|473155015|FG000|Overall Study|Adverse Event|0|||
131418512|NCT00306527|473155016|FG001|Overall Study|Adverse Event|0|||
131418513|NCT00306527|473155017|FG002|Overall Study|Adverse Event|1|||
131418514|NCT00306527|473155018|FG003|Overall Study|Adverse Event|1|||
131418515|NCT00306527|473155015|FG000|Overall Study|Death|1|||
131418516|NCT00306527|473155016|FG001|Overall Study|Death|0|||
131418517|NCT00306527|473155017|FG002|Overall Study|Death|1|||
131418518|NCT00306527|473155018|FG003|Overall Study|Death|2|||
131418519|NCT00785980|473155019|FG000|7 Day Washout Period|Protocol Violation|3|||
131418520|NCT03055013|473155020|FG000|Overall Study|Adverse Event|78|||
131418521|NCT03055013|473155021|FG001|Overall Study|Adverse Event|0|||
131418522|NCT03055013|473155020|FG000|Overall Study|Death|6|||
131418523|NCT03055013|473155021|FG001|Overall Study|Death|0|||
131418524|NCT03055013|473155020|FG000|Overall Study|Disease relapse|33|||
131418525|NCT03055013|473155021|FG001|Overall Study|Disease relapse|0|||
131418526|NCT03055013|473155020|FG000|Overall Study|Withdrawal by Subject|28|||
131418527|NCT03055013|473155021|FG001|Overall Study|Withdrawal by Subject|0|||
131418528|NCT03055013|473155020|FG000|Overall Study|Other complicating disease|5|||
131418529|NCT03055013|473155021|FG001|Overall Study|Other complicating disease|0|||
131418530|NCT03055013|473155020|FG000|Overall Study|Physician Decision|1|||
131418531|NCT03055013|473155021|FG001|Overall Study|Physician Decision|0|||
131418532|NCT03055013|473155020|FG000|Overall Study|Benign mass/non-RCC|4|||
131418533|NCT03055013|473155021|FG001|Overall Study|Benign mass/non-RCC|0|||
131418534|NCT03055013|473155020|FG000|Overall Study|Enrolled in another trial|1|||
131418535|NCT03055013|473155021|FG001|Overall Study|Enrolled in another trial|0|||
131418536|NCT03055013|473155020|FG000|Overall Study|Non-protocol therapy|1|||
131418537|NCT03055013|473155021|FG001|Overall Study|Non-protocol therapy|0|||
131418538|NCT03055013|473155020|FG000|Overall Study|Incompliance|1|||
131418539|NCT03055013|473155021|FG001|Overall Study|Incompliance|0|||
131418540|NCT03055013|473155020|FG000|Overall Study|Insurance issues|1|||
131418541|NCT03055013|473155021|FG001|Overall Study|Insurance issues|0|||
131418542|NCT03055013|473155020|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
131418543|NCT03055013|473155021|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
131418544|NCT03055013|473155020|FG000|Overall Study|Did not receive nivolumab|10|||
131418545|NCT03055013|473155021|FG001|Overall Study|Did not receive nivolumab|0|||
131418546|NCT03055013|473155020|FG000|Overall Study|Did not receive surgery|0|||
131418547|NCT03055013|473155021|FG001|Overall Study|Did not receive surgery|28|||
131418548|NCT00528801|473155022|FG000|Overall Study|Withdrawal by Subject|1|||
131418549|NCT00528801|473155023|FG001|Overall Study|Withdrawal by Subject|1|||
131418550|NCT00528801|473155022|FG000|Overall Study|Protocol Violation|11|||
131418551|NCT00528801|473155023|FG001|Overall Study|Protocol Violation|5|||
131418552|NCT00528801|473155022|FG000|Overall Study|Lost to Follow-up|15|||
131418553|NCT00528801|473155023|FG001|Overall Study|Lost to Follow-up|4|||
131418554|NCT00528801|473155022|FG000|Overall Study|Administrative Reasons|0|||
131418555|NCT00528801|473155023|FG001|Overall Study|Administrative Reasons|1|||
131418556|NCT00344500|473155024|FG000|Overall Study|Adverse Event|6|||
131418557|NCT00344500|473155025|FG001|Overall Study|Adverse Event|2|||
131418558|NCT00344500|473155026|FG002|Overall Study|Adverse Event|0|||
131418559|NCT00344500|473155024|FG000|Overall Study|Lost to Follow-up|5|||
131418560|NCT00344500|473155025|FG001|Overall Study|Lost to Follow-up|13|||
131418561|NCT00344500|473155026|FG002|Overall Study|Lost to Follow-up|1|||
131418562|NCT00344500|473155024|FG000|Overall Study|Withdrawal by Subject|7|||
131418563|NCT00344500|473155025|FG001|Overall Study|Withdrawal by Subject|10|||
131418564|NCT00344500|473155026|FG002|Overall Study|Withdrawal by Subject|0|||
131418565|NCT00344500|473155024|FG000|Overall Study|Protocol Violation|4|||
131418566|NCT00344500|473155025|FG001|Overall Study|Protocol Violation|7|||
131418567|NCT00344500|473155026|FG002|Overall Study|Protocol Violation|1|||
131418568|NCT00344500|473155024|FG000|Overall Study|Not Noted|1|||
131418569|NCT00344500|473155025|FG001|Overall Study|Not Noted|3|||
131418570|NCT00344500|473155026|FG002|Overall Study|Not Noted|0|||
131418571|NCT02207491|473155027|FG000|Overall Study|Adverse Event|20|||
131418572|NCT02207491|473155028|FG001|Overall Study|Adverse Event|4|||
131418573|NCT02207491|473155027|FG000|Overall Study|Withdrawal by Subject|3|||
131418574|NCT02207491|473155028|FG001|Overall Study|Withdrawal by Subject|2|||
131418575|NCT02207491|473155027|FG000|Overall Study|Non-compliant|0|||
131418576|NCT02207491|473155028|FG001|Overall Study|Non-compliant|1|||
131418577|NCT02207491|473155027|FG000|Overall Study|Lost to Follow-up|0|||
131418578|NCT02207491|473155028|FG001|Overall Study|Lost to Follow-up|1|||
131418579|NCT02207491|473155027|FG000|Overall Study|Lack of Efficacy|3|||
131418580|NCT02207491|473155028|FG001|Overall Study|Lack of Efficacy|0|||
131418581|NCT02207491|473155027|FG000|Overall Study|Physician Decision|2|||
131418582|NCT02207491|473155028|FG001|Overall Study|Physician Decision|0|||
131418583|NCT02207491|473155027|FG000|Overall Study|Protocol Violation|3|||
131418584|NCT02207491|473155028|FG001|Overall Study|Protocol Violation|5|||
131418585|NCT00599755|473155029|FG000|Overall Study|Adverse Event|11|||
131418586|NCT00599755|473155029|FG000|Overall Study|Withdrawal by Subject|2|||
131418587|NCT00599755|473155029|FG000|Overall Study|Progression of Disease|3|||
131418588|NCT00599755|473155029|FG000|Overall Study|Other Reason|2|||
131418589|NCT00599755|473155029|FG000|Overall Study|No data available|1|||
131418590|NCT00417963|473155033|FG000|Overall Study|Lost to Follow-up|3|||
131418591|NCT00417963|473155033|FG000|Overall Study|Withdrawal by Subject|18|||
131418592|NCT00417963|473155033|FG000|Overall Study|Death|17|||
131418593|NCT00417963|473155033|FG000|Overall Study|Study device could not be deployed|3|||
131418594|NCT01023672|473155047|FG000|Overall Study|Worsening disease|2|||
131418595|NCT01023672|473155047|FG000|Overall Study|Death|1|||
131418596|NCT00387725|473155048|FG000|Overall Study|Adverse Event|0|||
131418597|NCT00387725|473155049|FG001|Overall Study|Adverse Event|0|||
131418598|NCT00387725|473155050|FG002|Overall Study|Adverse Event|0|||
131418599|NCT00387725|473155051|FG003|Overall Study|Adverse Event|1|||
131418600|NCT00387725|473155048|FG000|Overall Study|Protocol Violation|0|||
131418601|NCT00387725|473155049|FG001|Overall Study|Protocol Violation|1|||
131418602|NCT00387725|473155050|FG002|Overall Study|Protocol Violation|0|||
131418603|NCT00387725|473155051|FG003|Overall Study|Protocol Violation|0|||
131418604|NCT00387725|473155048|FG000|Overall Study|Withdrawal by Subject|1|||
131418605|NCT00387725|473155049|FG001|Overall Study|Withdrawal by Subject|0|||
131418606|NCT00387725|473155050|FG002|Overall Study|Withdrawal by Subject|1|||
131418607|NCT00387725|473155051|FG003|Overall Study|Withdrawal by Subject|0|||
131418608|NCT00387725|473155048|FG000|Overall Study|Parent/legal guardian request|0|||
131418609|NCT00387725|473155049|FG001|Overall Study|Parent/legal guardian request|0|||
131418610|NCT00387725|473155050|FG002|Overall Study|Parent/legal guardian request|1|||
131418611|NCT00387725|473155051|FG003|Overall Study|Parent/legal guardian request|1|||
131418612|NCT00231413|473155052|FG000|Overall Study|Non-serious AE|0|||
131418613|NCT00231413|473155053|FG001|Overall Study|Non-serious AE|0|||
131418614|NCT00231413|473155054|FG002|Overall Study|Non-serious AE|1|||
131418615|NCT00231413|473155055|FG003|Overall Study|Non-serious AE|0|||
131418616|NCT00231413|473155056|FG004|Overall Study|Non-serious AE|0|||
131418617|NCT00231413|473155057|FG005|Overall Study|Non-serious AE|0|||
131418618|NCT00231413|473155058|FG006|Overall Study|Non-serious AE|1|||
131418619|NCT00231413|473155052|FG000|Overall Study|Withdrawal by Subject|3|||
131418620|NCT00231413|473155053|FG001|Overall Study|Withdrawal by Subject|1|||
131418621|NCT00231413|473155054|FG002|Overall Study|Withdrawal by Subject|4|||
131418622|NCT00231413|473155055|FG003|Overall Study|Withdrawal by Subject|2|||
131418623|NCT00231413|473155056|FG004|Overall Study|Withdrawal by Subject|2|||
131418624|NCT00231413|473155057|FG005|Overall Study|Withdrawal by Subject|0|||
131418625|NCT00231413|473155058|FG006|Overall Study|Withdrawal by Subject|3|||
131418626|NCT00231413|473155052|FG000|Overall Study|Migrated/moved from study area|0|||
131418627|NCT00231413|473155053|FG001|Overall Study|Migrated/moved from study area|0|||
131418628|NCT00231413|473155054|FG002|Overall Study|Migrated/moved from study area|1|||
131418629|NCT00231413|473155055|FG003|Overall Study|Migrated/moved from study area|0|||
131418630|NCT00231413|473155056|FG004|Overall Study|Migrated/moved from study area|0|||
131418631|NCT00231413|473155057|FG005|Overall Study|Migrated/moved from study area|1|||
131418632|NCT00231413|473155058|FG006|Overall Study|Migrated/moved from study area|0|||
131418633|NCT00231413|473155052|FG000|Overall Study|Lost to Follow-up|4|||
131418634|NCT00231413|473155053|FG001|Overall Study|Lost to Follow-up|4|||
131418635|NCT00231413|473155054|FG002|Overall Study|Lost to Follow-up|1|||
131418636|NCT00231413|473155055|FG003|Overall Study|Lost to Follow-up|1|||
131418637|NCT00231413|473155056|FG004|Overall Study|Lost to Follow-up|1|||
131418638|NCT00231413|473155057|FG005|Overall Study|Lost to Follow-up|4|||
131418639|NCT00231413|473155058|FG006|Overall Study|Lost to Follow-up|0|||
131418640|NCT00231413|473155052|FG000|Overall Study|Pregnancy|1|||
131418641|NCT00231413|473155053|FG001|Overall Study|Pregnancy|0|||
131418642|NCT00231413|473155054|FG002|Overall Study|Pregnancy|0|||
131418643|NCT00231413|473155055|FG003|Overall Study|Pregnancy|0|||
131418644|NCT00231413|473155056|FG004|Overall Study|Pregnancy|0|||
131418645|NCT00231413|473155057|FG005|Overall Study|Pregnancy|0|||
131418646|NCT00231413|473155058|FG006|Overall Study|Pregnancy|0|||
131418647|NCT03322423|473155059|FG000|Period 1|Subject no longer eligible|0|||
131418648|NCT03322423|473155060|FG001|Period 1|Subject no longer eligible|1|||
131418649|NCT03322423|473155059|FG000|Period 1|Withdrawal by Subject|0|||
131418650|NCT03322423|473155060|FG001|Period 1|Withdrawal by Subject|1|||
131418651|NCT03322423|473155059|FG000|Period 1|Incorrect Lens Dispensed|1|||
131418652|NCT03322423|473155060|FG001|Period 1|Incorrect Lens Dispensed|0|||
131418653|NCT03322423|473155059|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
131418654|NCT03322423|473155060|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
131418655|NCT03322423|473155059|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
131418656|NCT03322423|473155060|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
131418657|NCT03322423|473155059|FG000|Period 2|Protocol Violation|1|||
131418658|NCT03322423|473155060|FG001|Period 2|Protocol Violation|0|||
131418659|NCT03322423|473155059|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
131418660|NCT03322423|473155060|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
131418661|NCT02096263|473155061|FG000|Overall Study|Adverse Event|1|||
131418662|NCT02096263|473155062|FG001|Overall Study|Adverse Event|0|||
131418663|NCT02096263|473155063|FG002|Overall Study|Adverse Event|1|||
131418664|NCT02096263|473155061|FG000|Overall Study|Lost to Follow-up|14|||
131418665|NCT02096263|473155062|FG001|Overall Study|Lost to Follow-up|18|||
131418666|NCT02096263|473155063|FG002|Overall Study|Lost to Follow-up|15|||
131418667|NCT02096263|473155061|FG000|Overall Study|Other|7|||
131418668|NCT02096263|473155062|FG001|Overall Study|Other|9|||
131418669|NCT02096263|473155063|FG002|Overall Study|Other|6|||
131418670|NCT02096263|473155061|FG000|Overall Study|Sponsor study termination|0|||
131418671|NCT02096263|473155062|FG001|Overall Study|Sponsor study termination|0|||
131418672|NCT02096263|473155063|FG002|Overall Study|Sponsor study termination|1|||
131418673|NCT02096263|473155061|FG000|Overall Study|Protocol Violation|7|||
131418674|NCT02096263|473155062|FG001|Overall Study|Protocol Violation|2|||
131418675|NCT02096263|473155063|FG002|Overall Study|Protocol Violation|8|||
131418676|NCT02096263|473155061|FG000|Overall Study|Withdrawal by Subject|5|||
131418677|NCT02096263|473155062|FG001|Overall Study|Withdrawal by Subject|7|||
131418678|NCT02096263|473155063|FG002|Overall Study|Withdrawal by Subject|8|||
131418679|NCT02337725|473155064|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
131418680|NCT02337725|473155065|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
131418681|NCT02337725|473155064|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
131418682|NCT02337725|473155065|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
131418683|NCT02337725|473155064|FG000|Overall Study|Major Protocol Deviation|0|||
131418684|NCT02337725|473155065|FG001|Overall Study|Major Protocol Deviation|1|||
131418685|NCT02337725|473155064|FG000|Overall Study|Voluntary Withdrawal|14|||
131418686|NCT02337725|473155065|FG001|Overall Study|Voluntary Withdrawal|3|||
131418687|NCT02337725|473155064|FG000|Overall Study|Lack of Efficacy|4|||
131418688|NCT02337725|473155065|FG001|Overall Study|Lack of Efficacy|0|||
131418689|NCT00500760|473155072|FG000|Overall Study|Death|32|||
131418690|NCT00500760|473155073|FG001|Overall Study|Death|15|||
131418691|NCT00500760|473155072|FG000|Overall Study|Withdrawal by Subject|5|||
131418692|NCT00500760|473155073|FG001|Overall Study|Withdrawal by Subject|7|||
131418693|NCT00500760|473155072|FG000|Overall Study|Administrative decision|2|||
131418694|NCT00500760|473155073|FG001|Overall Study|Administrative decision|0|||
131418695|NCT00500760|473155072|FG000|Overall Study|Lost to Follow-up|3|||
131418696|NCT00500760|473155073|FG001|Overall Study|Lost to Follow-up|0|||
131418697|NCT00500760|473155072|FG000|Overall Study|Other|1|||
131418698|NCT00500760|473155073|FG001|Overall Study|Other|2|||
131418699|NCT04284774|473155075|FG000|Overall Study|Progressive disease|5|||
131418700|NCT02879578|473155076|FG000|Overall Study|Adverse Event|1|||
131418701|NCT02879578|473155077|FG001|Overall Study|Adverse Event|2|||
131418702|NCT02879578|473155078|FG002|Overall Study|Adverse Event|14|||
131418703|NCT02879578|473155076|FG000|Overall Study|Protocol Violation|0|||
131418704|NCT02879578|473155077|FG001|Overall Study|Protocol Violation|1|||
131418705|NCT02879578|473155078|FG002|Overall Study|Protocol Violation|1|||
131418706|NCT02879578|473155076|FG000|Overall Study|Withdrawal by Subject|8|||
131418707|NCT02879578|473155077|FG001|Overall Study|Withdrawal by Subject|6|||
131418708|NCT02879578|473155078|FG002|Overall Study|Withdrawal by Subject|9|||
131418709|NCT02879578|473155076|FG000|Overall Study|Lost to Follow-up|1|||
131418710|NCT02879578|473155077|FG001|Overall Study|Lost to Follow-up|0|||
131418711|NCT02879578|473155078|FG002|Overall Study|Lost to Follow-up|4|||
131418712|NCT02879578|473155076|FG000|Overall Study|Physician Decision|0|||
131418713|NCT02879578|473155077|FG001|Overall Study|Physician Decision|0|||
131418714|NCT02879578|473155078|FG002|Overall Study|Physician Decision|4|||
131418715|NCT02925728|473155087|FG000|Overall Study|Death|3|||
131418716|NCT02925728|473155088|FG001|Overall Study|Death|5|||
131418717|NCT02925728|473155087|FG000|Overall Study|Physician Decision|1|||
131418718|NCT02925728|473155088|FG001|Overall Study|Physician Decision|0|||
131418719|NCT02925728|473155087|FG000|Overall Study|Withdrawal by Subject|1|||
131418720|NCT02925728|473155088|FG001|Overall Study|Withdrawal by Subject|0|||
131418721|NCT05098509|473155089|FG000|Overall Study|Withdrawal by Subject|0|||
131418722|NCT05098509|473155090|FG001|Overall Study|Withdrawal by Subject|0|||
131418723|NCT05098509|473155091|FG002|Overall Study|Withdrawal by Subject|1|||
131418724|NCT05098509|473155092|FG003|Overall Study|Withdrawal by Subject|0|||
131418725|NCT05098509|473155089|FG000|Overall Study|Early study termination|1|||
131418726|NCT05098509|473155090|FG001|Overall Study|Early study termination|1|||
131418727|NCT05098509|473155091|FG002|Overall Study|Early study termination|1|||
131418728|NCT05098509|473155092|FG003|Overall Study|Early study termination|0|||
131418729|NCT04033068|473155093|FG000|Overall Study|Withdrawal by Subject|0|||
131418730|NCT04033068|473155094|FG001|Overall Study|Withdrawal by Subject|0|||
131418731|NCT04033068|473155095|FG002|Overall Study|Withdrawal by Subject|1|||
131418732|NCT04033068|473155096|FG003|Overall Study|Withdrawal by Subject|0|||
131418733|NCT04033068|473155093|FG000|Overall Study|Lost to Follow-up|0|||
131418734|NCT04033068|473155094|FG001|Overall Study|Lost to Follow-up|1|||
131418735|NCT04033068|473155095|FG002|Overall Study|Lost to Follow-up|0|||
131418736|NCT04033068|473155096|FG003|Overall Study|Lost to Follow-up|0|||
131418737|NCT04033068|473155093|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
131418738|NCT04033068|473155094|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
131418739|NCT04033068|473155095|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
131418740|NCT04033068|473155096|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
131418741|NCT02986854|473155098|FG000|Overall Study|Withdrawal by Subject|0|||
131418742|NCT02986854|473155099|FG001|Overall Study|Withdrawal by Subject|1|||
131418743|NCT02986854|473155100|FG002|Overall Study|Withdrawal by Subject|1|||
131418744|NCT02986854|473155098|FG000|Overall Study|Lost to Follow-up|3|||
131418745|NCT02986854|473155099|FG001|Overall Study|Lost to Follow-up|11|||
131418746|NCT02986854|473155100|FG002|Overall Study|Lost to Follow-up|2|||
131418747|NCT00324233|473155103|FG000|First Period|unable to insert catheter|1|||
131418748|NCT00324233|473155104|FG001|First Period|unable to insert catheter|0|||
131418749|NCT00324233|473155103|FG000|Second Period|unable to insert catheter|1|||
131418750|NCT00324233|473155104|FG001|Second Period|unable to insert catheter|1|||
131418751|NCT00324233|473155103|FG000|Second Period|Protocol Violation|4|||
131418752|NCT00324233|473155104|FG001|Second Period|Protocol Violation|6|||
131418753|NCT01972789|473155107|FG000|Overall Study|Adverse Event|11|||
131418754|NCT01972789|473155108|FG001|Overall Study|Adverse Event|4|||
131418755|NCT01972789|473155107|FG000|Overall Study|Subject withdrew consent|14|||
131418756|NCT01972789|473155108|FG001|Overall Study|Subject withdrew consent|12|||
131418757|NCT01972789|473155107|FG000|Overall Study|Lost to Follow-up|4|||
131418758|NCT01972789|473155108|FG001|Overall Study|Lost to Follow-up|7|||
131418759|NCT01972789|473155107|FG000|Overall Study|Death|7|||
131418760|NCT01972789|473155108|FG001|Overall Study|Death|5|||
131418761|NCT01972789|473155107|FG000|Overall Study|Protocol deviation|1|||
131418762|NCT01972789|473155108|FG001|Overall Study|Protocol deviation|0|||
131418763|NCT01972789|473155107|FG000|Overall Study|Physician Decision|3|||
131418764|NCT01972789|473155108|FG001|Overall Study|Physician Decision|2|||
131418765|NCT00086411|473155116|FG000|Overall Study|Lost to Follow-up|11|||
131418766|NCT00086411|473155117|FG001|Overall Study|Lost to Follow-up|11|||
131418767|NCT00086411|473155118|FG002|Overall Study|Lost to Follow-up|13|||
131418768|NCT00086411|473155119|FG003|Overall Study|Lost to Follow-up|12|||
131418769|NCT02409342|473155120|FG000|Overall Study|Death|211|||
131418770|NCT02409342|473155121|FG001|Overall Study|Death|201|||
131418771|NCT02409342|473155120|FG000|Overall Study|Withdrawal by Subject|24|||
131418772|NCT02409342|473155121|FG001|Overall Study|Withdrawal by Subject|17|||
131418773|NCT02409342|473155120|FG000|Overall Study|Study Terminated By Sponsor|48|||
131418774|NCT02409342|473155121|FG001|Overall Study|Study Terminated By Sponsor|59|||
131418775|NCT02409342|473155120|FG000|Overall Study|Lost to Follow-up|3|||
131418776|NCT02409342|473155121|FG001|Overall Study|Lost to Follow-up|5|||
131418777|NCT02409342|473155120|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
131418778|NCT02409342|473155121|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
131418779|NCT02409342|473155120|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
131418780|NCT02409342|473155121|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
131418781|NCT02409342|473155120|FG000|Overall Study|Sponsor Decision|1|||
131418782|NCT02409342|473155121|FG001|Overall Study|Sponsor Decision|0|||
131418783|NCT00279812|473155122|FG000|Overall Study|Protocol Violation|1|||
131418784|NCT00279812|473155123|FG001|Overall Study|Protocol Violation|1|||
131418785|NCT00279812|473155124|FG002|Overall Study|Protocol Violation|0|||
131418786|NCT00279812|473155125|FG003|Overall Study|Protocol Violation|0|||
131418787|NCT00279812|473155126|FG004|Overall Study|Protocol Violation|1|||
131418788|NCT00279812|473155127|FG005|Overall Study|Protocol Violation|0|||
131418789|NCT00279812|473155122|FG000|Overall Study|Withdrawal by Subject|0|||
131418790|NCT00279812|473155123|FG001|Overall Study|Withdrawal by Subject|4|||
131418791|NCT00279812|473155124|FG002|Overall Study|Withdrawal by Subject|2|||
131418792|NCT00279812|473155125|FG003|Overall Study|Withdrawal by Subject|0|||
131418793|NCT00279812|473155126|FG004|Overall Study|Withdrawal by Subject|0|||
131418794|NCT00279812|473155127|FG005|Overall Study|Withdrawal by Subject|0|||
131418795|NCT00279812|473155122|FG000|Overall Study|Adverse Event|0|||
131418796|NCT00279812|473155123|FG001|Overall Study|Adverse Event|1|||
131418797|NCT00279812|473155124|FG002|Overall Study|Adverse Event|1|||
131418798|NCT00279812|473155125|FG003|Overall Study|Adverse Event|0|||
131418799|NCT00279812|473155126|FG004|Overall Study|Adverse Event|2|||
131418800|NCT00279812|473155127|FG005|Overall Study|Adverse Event|1|||
131418801|NCT01274429|473155128|FG000|Overall Study|Study closed do to lack of funding|5|||
131418802|NCT01879072|473155130|FG000|Overall Study|Withdrawal by Subject|121|||
131418803|NCT01879072|473155130|FG000|Overall Study|Not Transplanted|30|||
131418804|NCT02503501|473157045|FG000|Overall Study|Physician Decision|1|||
131418805|NCT02503501|473157046|FG001|Overall Study|Physician Decision|0|||
131418806|NCT02503501|473157045|FG000|Overall Study|Protocol Violation|0|||
131418807|NCT02503501|473157046|FG001|Overall Study|Protocol Violation|1|||
131418808|NCT02503501|473157045|FG000|Overall Study|Withdrawal by Subject|0|||
131418809|NCT02503501|473157046|FG001|Overall Study|Withdrawal by Subject|2|||
131418810|NCT01740401|473157047|FG000|Overall Study|Progression of disease|6|||
131418811|NCT01740401|473157047|FG000|Overall Study|Adverse Event|2|||
131418812|NCT01740401|473157047|FG000|Overall Study|Did not reach primary endpoint|2|||
131418813|NCT02806960|473157048|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
131418814|NCT02806960|473157049|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
131418815|NCT02806960|473157050|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
131418816|NCT02806960|473157051|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
131418817|NCT03667690|473157052|FG000|Overall Study|Adverse Event|0|||
131418818|NCT03667690|473157053|FG001|Overall Study|Adverse Event|3|||
131418819|NCT03667690|473157052|FG000|Overall Study|Death|22|||
131418820|NCT03667690|473157053|FG001|Overall Study|Death|21|||
131418821|NCT03667690|473157052|FG000|Overall Study|Lost to Follow-up|4|||
131418822|NCT03667690|473157053|FG001|Overall Study|Lost to Follow-up|5|||
131418823|NCT03667690|473157052|FG000|Overall Study|Withdrawal by Subject|7|||
131418824|NCT03667690|473157053|FG001|Overall Study|Withdrawal by Subject|8|||
131418825|NCT03667690|473157052|FG000|Overall Study|Subject could not return for additional investigational product|1|||
131418826|NCT03667690|473157053|FG001|Overall Study|Subject could not return for additional investigational product|0|||
131418827|NCT03667690|473157052|FG000|Overall Study|Subject discharged to hospice care|2|||
131418828|NCT03667690|473157053|FG001|Overall Study|Subject discharged to hospice care|0|||
131418829|NCT03667690|473157052|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
131418830|NCT03667690|473157053|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
131418831|NCT03667690|473157052|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
131418832|NCT03667690|473157053|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
131418833|NCT03667690|473157052|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
131418834|NCT03667690|473157053|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
131418835|NCT03667690|473157052|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
131418836|NCT03667690|473157053|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
131418837|NCT03667690|473157052|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
131418838|NCT03667690|473157053|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
131418839|NCT03464019|473157055|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
131418840|NCT03464019|473157056|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
131418841|NCT03464019|473157057|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
131418842|NCT03464019|473157055|FG000|NODE-301 Part 1|Ablation|0|||
131418843|NCT03464019|473157056|FG001|NODE-301 Part 1|Ablation|0|||
131418844|NCT03464019|473157057|FG002|NODE-301 Part 1|Ablation|16|||
131418845|NCT03464019|473157055|FG000|NODE-301 Part 1|Test Dose Failure|0|||
131418846|NCT03464019|473157056|FG001|NODE-301 Part 1|Test Dose Failure|0|||
131418847|NCT03464019|473157057|FG002|NODE-301 Part 1|Test Dose Failure|8|||
131418848|NCT03464019|473157055|FG000|NODE-301 Part 1|Adverse Event|0|||
131418849|NCT03464019|473157056|FG001|NODE-301 Part 1|Adverse Event|0|||
131418850|NCT03464019|473157057|FG002|NODE-301 Part 1|Adverse Event|5|||
131418851|NCT03464019|473157055|FG000|NODE-301 Part 1|Physician Decision|0|||
131418852|NCT03464019|473157056|FG001|NODE-301 Part 1|Physician Decision|0|||
131418853|NCT03464019|473157057|FG002|NODE-301 Part 1|Physician Decision|4|||
131418854|NCT03464019|473157055|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
131418855|NCT03464019|473157056|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
131418856|NCT03464019|473157057|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
131418857|NCT03464019|473157055|FG000|NODE-301 Part 1|Protocol Violation|0|||
131457623|NCT03818035|473304673|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
131418858|NCT03464019|473157056|FG001|NODE-301 Part 1|Protocol Violation|0|||
131418859|NCT03464019|473157057|FG002|NODE-301 Part 1|Protocol Violation|2|||
131418860|NCT03464019|473157055|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
131418861|NCT03464019|473157056|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
131418862|NCT03464019|473157057|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
131418863|NCT03464019|473157055|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
131418864|NCT03464019|473157056|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
131418865|NCT03464019|473157057|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
131418866|NCT03464019|473157055|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
131418867|NCT03464019|473157056|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
131418868|NCT03464019|473157057|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
131418869|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
131418870|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
131418871|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
131418872|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
131418873|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
131418874|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
131418875|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
131418876|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
131418877|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
131418878|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
131418879|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
131418880|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
131418881|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
131418882|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
131418883|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
131418884|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
131418885|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
131418886|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
131418887|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
131418888|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
131418889|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
131418890|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
131418891|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
131418892|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
131418893|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
131418894|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
131418895|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
131418896|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
131418897|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
131418898|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
131418899|NCT03464019|473157055|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
131418900|NCT03464019|473157056|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
131418901|NCT03464019|473157057|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
131418902|NCT04680975|473157058|FG000|Overall Study|Adverse Event|3|||
131418903|NCT04680975|473157058|FG000|Overall Study|Death|1|||
131418904|NCT04680975|473157058|FG000|Overall Study|Progressive Disease|1|||
131418905|NCT04680975|473157058|FG000|Overall Study|Withdrawal by Subject|1|||
131418906|NCT03909152|473157059|FG000|Overall Study|Adverse Event|14|||
131418907|NCT03909152|473157060|FG001|Overall Study|Adverse Event|5|||
131418908|NCT03909152|473157061|FG002|Overall Study|Adverse Event|1|||
131418909|NCT03909152|473157062|FG003|Overall Study|Adverse Event|14|||
131418910|NCT02615691|473157063|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
131418911|NCT02615691|473157063|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
131418912|NCT02615691|473157063|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
131418913|NCT02615691|473157063|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
131418914|NCT02702414|473157064|FG000|Overall Study|Death|96|||
131418915|NCT02702414|473157065|FG001|Overall Study|Death|42|||
131418916|NCT02702414|473157064|FG000|Overall Study|Lost to Follow-up|0|||
131418917|NCT02702414|473157065|FG001|Overall Study|Lost to Follow-up|1|||
131418918|NCT02702414|473157064|FG000|Overall Study|Withdrawal by Subject|0|||
131418919|NCT02702414|473157065|FG001|Overall Study|Withdrawal by Subject|1|||
131418920|NCT02702414|473157064|FG000|Overall Study|Protocol Violation|1|||
131418921|NCT02702414|473157065|FG001|Overall Study|Protocol Violation|0|||
131418922|NCT02702414|473157064|FG000|Overall Study|Sponsor Decision|8|||
131418923|NCT02702414|473157065|FG001|Overall Study|Sponsor Decision|7|||
131418924|NCT02596230|473157066|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
131418925|NCT02596230|473157067|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
131418926|NCT02596230|473157068|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
131418927|NCT02596230|473157069|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
131418928|NCT02596230|473157070|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
131418929|NCT02596230|473157066|FG000|Objective 2, One Year|Lost to Follow-up|0|||
131418930|NCT02596230|473157067|FG001|Objective 2, One Year|Lost to Follow-up|41|||
131418931|NCT02596230|473157068|FG002|Objective 2, One Year|Lost to Follow-up|41|||
131418932|NCT02596230|473157069|FG003|Objective 2, One Year|Lost to Follow-up|32|||
131418933|NCT02596230|473157070|FG004|Objective 2, One Year|Lost to Follow-up|46|||
131418934|NCT02596230|473157066|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
131418935|NCT02596230|473157067|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
131418936|NCT02596230|473157068|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
131418937|NCT02596230|473157069|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
131418938|NCT02596230|473157070|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
131418939|NCT02596230|473157066|FG000|Objective 2, One Year|Adverse drug reaction|0|||
131418940|NCT02596230|473157067|FG001|Objective 2, One Year|Adverse drug reaction|1|||
131418941|NCT02596230|473157068|FG002|Objective 2, One Year|Adverse drug reaction|0|||
131418942|NCT02596230|473157069|FG003|Objective 2, One Year|Adverse drug reaction|0|||
131418943|NCT02596230|473157070|FG004|Objective 2, One Year|Adverse drug reaction|0|||
131418944|NCT02596230|473157066|FG000|Objective 2, One Year|Death|0|||
131418945|NCT02596230|473157067|FG001|Objective 2, One Year|Death|12|||
131418946|NCT02596230|473157068|FG002|Objective 2, One Year|Death|41|||
131418947|NCT02596230|473157069|FG003|Objective 2, One Year|Death|21|||
131418948|NCT02596230|473157070|FG004|Objective 2, One Year|Death|30|||
131418949|NCT02596230|473157066|FG000|Objective 2, One Year|Other|0|||
131418950|NCT02596230|473157067|FG001|Objective 2, One Year|Other|3|||
131418951|NCT02596230|473157068|FG002|Objective 2, One Year|Other|2|||
131418952|NCT02596230|473157069|FG003|Objective 2, One Year|Other|0|||
131418953|NCT02596230|473157070|FG004|Objective 2, One Year|Other|0|||
131418954|NCT01272869|473157071|FG000|Period 2 (14 Days)|Adverse Event|1|||
131418955|NCT01272869|473157072|FG001|Period 2 (14 Days)|Adverse Event|0|||
131418956|NCT03908476|473157074|FG000|Overall Study|Death|3|||
131418957|NCT03908476|473157075|FG001|Overall Study|Death|0|||
131418958|NCT03908476|473157074|FG000|Overall Study|Lost to Follow-up|3|||
131418959|NCT03908476|473157075|FG001|Overall Study|Lost to Follow-up|1|||
131418960|NCT03908476|473157074|FG000|Overall Study|Withdrawal by Subject|7|||
131418961|NCT03908476|473157075|FG001|Overall Study|Withdrawal by Subject|1|||
131418962|NCT03908476|473157074|FG000|Overall Study|Physician Decision|2|||
131418963|NCT03908476|473157075|FG001|Overall Study|Physician Decision|0|||
131418964|NCT03908476|473157074|FG000|Overall Study|System Explanted and not Replaced|4|||
131418965|NCT03908476|473157075|FG001|Overall Study|System Explanted and not Replaced|0|||
131418966|NCT03908476|473157074|FG000|Overall Study|Intrathecal Pump|1|||
131418967|NCT03908476|473157075|FG001|Overall Study|Intrathecal Pump|0|||
131418968|NCT03908476|473157074|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
131418969|NCT03908476|473157075|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
131418970|NCT02868229|473157076|FG000|Overall Study|Adverse Event|1|||
131418971|NCT02868229|473157077|FG001|Overall Study|Adverse Event|0|||
131418972|NCT02868229|473157078|FG002|Overall Study|Adverse Event|0|||
131418973|NCT02868229|473157079|FG003|Overall Study|Adverse Event|1|||
131418974|NCT02868229|473157076|FG000|Overall Study|Death|0|||
131418975|NCT02868229|473157077|FG001|Overall Study|Death|0|||
131418976|NCT02868229|473157078|FG002|Overall Study|Death|1|||
131418977|NCT02868229|473157079|FG003|Overall Study|Death|1|||
131418978|NCT02868229|473157076|FG000|Overall Study|Missed dose|0|||
131418979|NCT02868229|473157077|FG001|Overall Study|Missed dose|0|||
131418980|NCT02868229|473157078|FG002|Overall Study|Missed dose|0|||
131418981|NCT02868229|473157079|FG003|Overall Study|Missed dose|3|||
131418982|NCT02540668|473157080|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
131418983|NCT02540668|473157081|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
131457624|NCT03818035|473304674|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
131457625|NCT03818035|473304675|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
131418984|NCT03270891|473157082|FG000|Overall Study|Lost to Follow-up|3|||
131418985|NCT03270891|473157083|FG001|Overall Study|Lost to Follow-up|6|||
131418986|NCT03270891|473157084|FG002|Overall Study|Lost to Follow-up|0|||
131418987|NCT03270891|473157082|FG000|Overall Study|Withdrawal by Subject|1|||
131418988|NCT03270891|473157083|FG001|Overall Study|Withdrawal by Subject|0|||
131418989|NCT03270891|473157084|FG002|Overall Study|Withdrawal by Subject|0|||
131418990|NCT03270891|473157082|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
131496727|NCT02289690|473446365|FG006|Overall Study|Sponsor Discontinued Study|0|||
131418991|NCT03270891|473157083|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
131418992|NCT03270891|473157084|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
131418993|NCT02888743|473157086|FG000|Overall Study|Withdrawal by Subject|1|||
131418994|NCT02888743|473157087|FG001|Overall Study|Withdrawal by Subject|2|||
131418995|NCT02888743|473157088|FG002|Overall Study|Withdrawal by Subject|2|||
131418996|NCT02888743|473157089|FG003|Overall Study|Withdrawal by Subject|0|||
131418997|NCT02888743|473157090|FG004|Overall Study|Withdrawal by Subject|1|||
131418998|NCT02888743|473157086|FG000|Overall Study|Disease progression before treatment|2|||
131418999|NCT02888743|473157087|FG001|Overall Study|Disease progression before treatment|0|||
131419000|NCT02888743|473157088|FG002|Overall Study|Disease progression before treatment|2|||
131419001|NCT02888743|473157089|FG003|Overall Study|Disease progression before treatment|0|||
131419002|NCT02888743|473157090|FG004|Overall Study|Disease progression before treatment|0|||
131419003|NCT02888743|473157086|FG000|Overall Study|Patient ineligible|1|||
131419004|NCT02888743|473157087|FG001|Overall Study|Patient ineligible|2|||
131419005|NCT02888743|473157088|FG002|Overall Study|Patient ineligible|0|||
131419006|NCT02888743|473157089|FG003|Overall Study|Patient ineligible|0|||
131419007|NCT02888743|473157090|FG004|Overall Study|Patient ineligible|0|||
131419008|NCT04816721|473157095|FG000|Overall Study|Withdrawal by Subject|0|||
131419009|NCT04816721|473157096|FG001|Overall Study|Withdrawal by Subject|2|||
131419010|NCT04816721|473157097|FG002|Overall Study|Withdrawal by Subject|0|||
131419011|NCT04816721|473157098|FG003|Overall Study|Withdrawal by Subject|1|||
131419012|NCT04816721|473157099|FG004|Overall Study|Withdrawal by Subject|1|||
131419013|NCT04816721|473157100|FG005|Overall Study|Withdrawal by Subject|0|||
131419014|NCT04816721|473157101|FG006|Overall Study|Withdrawal by Subject|0|||
131419015|NCT04816721|473157102|FG007|Overall Study|Withdrawal by Subject|0|||
131419016|NCT04816721|473157095|FG000|Overall Study|Miscellaneous|0|||
131419017|NCT04816721|473157096|FG001|Overall Study|Miscellaneous|0|||
131419018|NCT04816721|473157097|FG002|Overall Study|Miscellaneous|0|||
131419019|NCT04816721|473157098|FG003|Overall Study|Miscellaneous|0|||
131419020|NCT04816721|473157099|FG004|Overall Study|Miscellaneous|0|||
131419021|NCT04816721|473157100|FG005|Overall Study|Miscellaneous|1|||
131419022|NCT04816721|473157101|FG006|Overall Study|Miscellaneous|0|||
131419023|NCT04816721|473157102|FG007|Overall Study|Miscellaneous|0|||
131419024|NCT04816721|473157095|FG000|Overall Study|Lost to Follow-up|0|||
131419025|NCT04816721|473157096|FG001|Overall Study|Lost to Follow-up|0|||
131419026|NCT04816721|473157097|FG002|Overall Study|Lost to Follow-up|0|||
131419027|NCT04816721|473157098|FG003|Overall Study|Lost to Follow-up|1|||
131419028|NCT04816721|473157099|FG004|Overall Study|Lost to Follow-up|0|||
131419029|NCT04816721|473157100|FG005|Overall Study|Lost to Follow-up|0|||
131419030|NCT04816721|473157101|FG006|Overall Study|Lost to Follow-up|0|||
131419031|NCT04816721|473157102|FG007|Overall Study|Lost to Follow-up|0|||
131419032|NCT03194438|473157103|FG000|Overall Study|Withdrawal by Subject|2|||
131419033|NCT01286740|473157104|FG000|Overall Study|Enrolled but not treated|1|||
131419034|NCT01286740|473157104|FG000|Overall Study|Protocol Violation|1|||
131419035|NCT02708485|473157106|FG000|Overall Study|Withdrawal by Subject|3|||
131419036|NCT02708485|473157107|FG001|Overall Study|Withdrawal by Subject|2|||
131419037|NCT02250664|473157108|FG000|Overall Study|Lost to Follow-up|18|||
131419038|NCT02250664|473157109|FG001|Overall Study|Lost to Follow-up|28|||
131419039|NCT02250664|473157110|FG002|Overall Study|Lost to Follow-up|33|||
131419040|NCT02250664|473157108|FG000|Overall Study|Personal Reasons|7|||
131419041|NCT02250664|473157109|FG001|Overall Study|Personal Reasons|8|||
131419042|NCT02250664|473157110|FG002|Overall Study|Personal Reasons|14|||
131419043|NCT02250664|473157108|FG000|Overall Study|Adverse Event|6|||
131419044|NCT02250664|473157109|FG001|Overall Study|Adverse Event|3|||
131419045|NCT02250664|473157110|FG002|Overall Study|Adverse Event|8|||
131419046|NCT02250664|473157108|FG000|Overall Study|Incarcerated|2|||
131419047|NCT02250664|473157109|FG001|Overall Study|Incarcerated|1|||
131419048|NCT02250664|473157110|FG002|Overall Study|Incarcerated|2|||
131419049|NCT02250664|473157108|FG000|Overall Study|Withdrawal by Subject|0|||
131419050|NCT02250664|473157109|FG001|Overall Study|Withdrawal by Subject|1|||
131419051|NCT02250664|473157110|FG002|Overall Study|Withdrawal by Subject|2|||
131419052|NCT02250664|473157108|FG000|Overall Study|Death|0|||
131419053|NCT02250664|473157109|FG001|Overall Study|Death|1|||
131419054|NCT02250664|473157110|FG002|Overall Study|Death|1|||
131419055|NCT02250664|473157108|FG000|Overall Study|Physician Decision|1|||
131419056|NCT02250664|473157109|FG001|Overall Study|Physician Decision|3|||
131419057|NCT02250664|473157110|FG002|Overall Study|Physician Decision|1|||
131419058|NCT02250664|473157108|FG000|Overall Study|Protocol Violation|1|||
131419059|NCT02250664|473157109|FG001|Overall Study|Protocol Violation|0|||
131419060|NCT02250664|473157110|FG002|Overall Study|Protocol Violation|1|||
131419061|NCT02250664|473157108|FG000|Overall Study|Reason unknown|1|||
131419062|NCT02250664|473157109|FG001|Overall Study|Reason unknown|0|||
131419063|NCT02250664|473157110|FG002|Overall Study|Reason unknown|0|||
131419064|NCT00117793|473157111|FG000|Overall Study|Withdrawal by Subject|12|||
131419065|NCT04268173|473157112|FG000|Overall Study|Lost to Follow-up|75|||
131419066|NCT04268173|473157113|FG001|Overall Study|Lost to Follow-up|108|||
131419067|NCT00545103|473157114|FG000|Overall Study|Lack of Efficacy|48|||
131419068|NCT00545103|473157115|FG001|Overall Study|Lack of Efficacy|45|||
131419069|NCT00545103|473157116|FG002|Overall Study|Lack of Efficacy|31|||
131419070|NCT00545103|473157117|FG003|Overall Study|Lack of Efficacy|27|||
131419071|NCT00545103|473157114|FG000|Overall Study|Withdrawal by Subject|6|||
131419072|NCT00545103|473157115|FG001|Overall Study|Withdrawal by Subject|10|||
131419073|NCT00545103|473157116|FG002|Overall Study|Withdrawal by Subject|18|||
131419074|NCT00545103|473157117|FG003|Overall Study|Withdrawal by Subject|22|||
131419075|NCT00545103|473157114|FG000|Overall Study|Adverse Event|11|||
131419076|NCT00545103|473157115|FG001|Overall Study|Adverse Event|12|||
131419077|NCT00545103|473157116|FG002|Overall Study|Adverse Event|17|||
131419078|NCT00545103|473157117|FG003|Overall Study|Adverse Event|10|||
131419079|NCT00545103|473157114|FG000|Overall Study|Lost to Follow-up|4|||
131419080|NCT00545103|473157115|FG001|Overall Study|Lost to Follow-up|6|||
131419081|NCT00545103|473157116|FG002|Overall Study|Lost to Follow-up|3|||
131419082|NCT00545103|473157117|FG003|Overall Study|Lost to Follow-up|4|||
131419083|NCT00545103|473157114|FG000|Overall Study|Protocol Violation|1|||
131419084|NCT00545103|473157115|FG001|Overall Study|Protocol Violation|2|||
131419085|NCT00545103|473157116|FG002|Overall Study|Protocol Violation|3|||
131419086|NCT00545103|473157117|FG003|Overall Study|Protocol Violation|0|||
131419087|NCT00545103|473157114|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
131419088|NCT00545103|473157115|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
131419089|NCT00545103|473157116|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
131419090|NCT00545103|473157117|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
131419091|NCT00545103|473157114|FG000|Overall Study|Difficult to open package|0|||
131419092|NCT00545103|473157115|FG001|Overall Study|Difficult to open package|0|||
131419093|NCT00545103|473157116|FG002|Overall Study|Difficult to open package|0|||
131419094|NCT00545103|473157117|FG003|Overall Study|Difficult to open package|1|||
131419095|NCT00545103|473157114|FG000|Overall Study|Investigational product not taken|1|||
131419096|NCT00545103|473157115|FG001|Overall Study|Investigational product not taken|0|||
131419097|NCT00545103|473157116|FG002|Overall Study|Investigational product not taken|0|||
131419098|NCT00545103|473157117|FG003|Overall Study|Investigational product not taken|1|||
131419099|NCT00545103|473157114|FG000|Overall Study|Wish to start a family|0|||
131419100|NCT00545103|473157115|FG001|Overall Study|Wish to start a family|0|||
131419101|NCT00545103|473157116|FG002|Overall Study|Wish to start a family|0|||
131419102|NCT00545103|473157117|FG003|Overall Study|Wish to start a family|1|||
131419103|NCT00545103|473157114|FG000|Overall Study|Diverticulitis crisis|0|||
131419104|NCT00545103|473157115|FG001|Overall Study|Diverticulitis crisis|0|||
131419105|NCT00545103|473157116|FG002|Overall Study|Diverticulitis crisis|0|||
131419106|NCT00545103|473157117|FG003|Overall Study|Diverticulitis crisis|1|||
131419107|NCT00545103|473157114|FG000|Overall Study|Personal reasons|1|||
131419108|NCT00545103|473157115|FG001|Overall Study|Personal reasons|0|||
131419109|NCT00545103|473157116|FG002|Overall Study|Personal reasons|0|||
131419110|NCT00545103|473157117|FG003|Overall Study|Personal reasons|0|||
131419111|NCT00545103|473157114|FG000|Overall Study|Subject's decision|1|||
131419112|NCT00545103|473157115|FG001|Overall Study|Subject's decision|0|||
131419113|NCT00545103|473157116|FG002|Overall Study|Subject's decision|0|||
131419114|NCT00545103|473157117|FG003|Overall Study|Subject's decision|0|||
131419115|NCT00545103|473157114|FG000|Overall Study|Noncompliance|0|||
131419116|NCT00545103|473157115|FG001|Overall Study|Noncompliance|1|||
131419117|NCT00545103|473157116|FG002|Overall Study|Noncompliance|0|||
131419118|NCT00545103|473157117|FG003|Overall Study|Noncompliance|0|||
131419119|NCT00545103|473157114|FG000|Overall Study|Investigator decision|0|||
131419120|NCT00545103|473157115|FG001|Overall Study|Investigator decision|0|||
131419121|NCT00545103|473157116|FG002|Overall Study|Investigator decision|1|||
131419122|NCT00545103|473157117|FG003|Overall Study|Investigator decision|0|||
131419123|NCT00545103|473157114|FG000|Overall Study|Subject moved|0|||
131419124|NCT00545103|473157115|FG001|Overall Study|Subject moved|1|||
131419125|NCT00545103|473157116|FG002|Overall Study|Subject moved|0|||
131419126|NCT00545103|473157117|FG003|Overall Study|Subject moved|0|||
131419127|NCT00545103|473157114|FG000|Overall Study|Use of prohibited medication|0|||
131419128|NCT00545103|473157115|FG001|Overall Study|Use of prohibited medication|0|||
131419129|NCT00545103|473157116|FG002|Overall Study|Use of prohibited medication|1|||
131419130|NCT00545103|473157117|FG003|Overall Study|Use of prohibited medication|0|||
131419131|NCT00545103|473157114|FG000|Overall Study|Does not want to take study drug anymore|1|||
131419132|NCT00545103|473157115|FG001|Overall Study|Does not want to take study drug anymore|0|||
131419133|NCT00545103|473157116|FG002|Overall Study|Does not want to take study drug anymore|1|||
131419134|NCT00545103|473157117|FG003|Overall Study|Does not want to take study drug anymore|0|||
131419135|NCT00545103|473157114|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
131419136|NCT00545103|473157115|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
131419137|NCT00545103|473157116|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
131419138|NCT00545103|473157117|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
131419139|NCT00545103|473157114|FG000|Overall Study|Death|0|||
131419140|NCT00545103|473157115|FG001|Overall Study|Death|1|||
131419141|NCT00545103|473157116|FG002|Overall Study|Death|0|||
131419142|NCT00545103|473157117|FG003|Overall Study|Death|0|||
131419143|NCT03615066|473157118|FG000|Main Study|Withdrew Consent|0|||
131419144|NCT03615066|473157119|FG001|Main Study|Withdrew Consent|1|||
131419145|NCT03615066|473157120|FG002|Main Study|Withdrew Consent|1|||
131419146|NCT03615066|473157118|FG000|Main Study|Lost to Follow-up|0|||
131419147|NCT03615066|473157119|FG001|Main Study|Lost to Follow-up|0|||
131419148|NCT03615066|473157120|FG002|Main Study|Lost to Follow-up|1|||
131419149|NCT03615066|473157118|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
131419150|NCT03615066|473157119|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
131419151|NCT03615066|473157120|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
131419152|NCT03615066|473157118|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
131419153|NCT03615066|473157119|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
131419154|NCT03615066|473157120|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
131419155|NCT03615066|473157118|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
131419156|NCT03615066|473157119|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
131419157|NCT03615066|473157120|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
131419158|NCT04891107|473157121|FG000|Overall Study|Physician Decision|1|||
131419159|NCT04891107|473157121|FG000|Overall Study|Withdrawal by Subject|1|||
131419160|NCT04891107|473157121|FG000|Overall Study|Screen failure after consent|1|||
131419161|NCT01571453|473157122|FG000|Overall Study|Adverse Event|14|||
131419162|NCT01571453|473157123|FG001|Overall Study|Adverse Event|32|||
131419163|NCT01571453|473157122|FG000|Overall Study|Lack of Efficacy|8|||
131419164|NCT01571453|473157123|FG001|Overall Study|Lack of Efficacy|3|||
131419165|NCT01571453|473157122|FG000|Overall Study|Non-compliance|2|||
131419166|NCT01571453|473157123|FG001|Overall Study|Non-compliance|4|||
131419167|NCT01571453|473157122|FG000|Overall Study|Protocol Violation|1|||
131419168|NCT01571453|473157123|FG001|Overall Study|Protocol Violation|5|||
131419169|NCT01571453|473157122|FG000|Overall Study|Withdrawal of consent|5|||
131419170|NCT01571453|473157123|FG001|Overall Study|Withdrawal of consent|13|||
131419171|NCT01571453|473157122|FG000|Overall Study|Lost to Follow-up|4|||
131419172|NCT01571453|473157123|FG001|Overall Study|Lost to Follow-up|2|||
131419173|NCT01571453|473157122|FG000|Overall Study|Administrative or other reason(s)|4|||
131419174|NCT01571453|473157123|FG001|Overall Study|Administrative or other reason(s)|3|||
131419175|NCT02453555|473157124|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
131419176|NCT02453555|473157125|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
131419177|NCT02453555|473157126|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
131419178|NCT02453555|473157127|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
131419179|NCT02453555|473157128|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
131419180|NCT02453555|473157129|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
131419181|NCT02453555|473157124|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
131419182|NCT02453555|473157125|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
131419183|NCT02453555|473157126|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
131419184|NCT02453555|473157127|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
131419185|NCT02453555|473157128|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
131419186|NCT02453555|473157129|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
131419187|NCT02453555|473157124|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
131419188|NCT02453555|473157125|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
131419189|NCT02453555|473157126|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131419190|NCT02453555|473157127|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131419191|NCT02453555|473157128|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131419192|NCT02453555|473157129|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131419193|NCT02453555|473157124|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
131419194|NCT02453555|473157125|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
131419195|NCT02453555|473157126|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
131457626|NCT03818035|473304676|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
131457627|NCT03818035|473304673|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
131457628|NCT03818035|473304674|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
131457629|NCT03818035|473304675|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
131457630|NCT03818035|473304676|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
131457631|NCT03374202|473304679|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
131457632|NCT03374202|473304680|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
131419196|NCT02453555|473157127|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
131419197|NCT02453555|473157128|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
131419198|NCT02453555|473157129|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
131419199|NCT02453555|473157124|FG000|Extension Period|Adverse Event|0|||
131419200|NCT02453555|473157125|FG001|Extension Period|Adverse Event|0|||
131419201|NCT02453555|473157126|FG002|Extension Period|Adverse Event|1|||
131419202|NCT02453555|473157127|FG003|Extension Period|Adverse Event|2|||
131419203|NCT02453555|473157128|FG004|Extension Period|Adverse Event|1|||
131419204|NCT02453555|473157129|FG005|Extension Period|Adverse Event|1|||
131419205|NCT02453555|473157124|FG000|Extension Period|Protocol Violation|0|||
131419206|NCT02453555|473157125|FG001|Extension Period|Protocol Violation|0|||
131457633|NCT03374202|473304681|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
131457634|NCT03374202|473304679|FG000|Five Year Long Term Follow Up|Death|0|||
131419207|NCT02453555|473157126|FG002|Extension Period|Protocol Violation|1|||
131419208|NCT02453555|473157127|FG003|Extension Period|Protocol Violation|0|||
131419209|NCT02453555|473157128|FG004|Extension Period|Protocol Violation|0|||
131419210|NCT02453555|473157129|FG005|Extension Period|Protocol Violation|0|||
131419211|NCT02453555|473157124|FG000|Extension Period|Withdrawal by Subject|0|||
131419212|NCT02453555|473157125|FG001|Extension Period|Withdrawal by Subject|0|||
131419213|NCT02453555|473157126|FG002|Extension Period|Withdrawal by Subject|1|||
131419214|NCT02453555|473157127|FG003|Extension Period|Withdrawal by Subject|0|||
131419215|NCT02453555|473157128|FG004|Extension Period|Withdrawal by Subject|0|||
131419216|NCT02453555|473157129|FG005|Extension Period|Withdrawal by Subject|0|||
131419217|NCT00129961|473157133|FG000|Overall Study|Adverse Event|1|||
131419218|NCT00129961|473157134|FG001|Overall Study|Adverse Event|0|||
131419219|NCT00129961|473157133|FG000|Overall Study|Death|1|||
131419220|NCT00129961|473157134|FG001|Overall Study|Death|1|||
131419221|NCT00129961|473157133|FG000|Overall Study|Withdrawal by Sponsor|14|||
131419222|NCT00129961|473157134|FG001|Overall Study|Withdrawal by Sponsor|20|||
131419223|NCT00129961|473157133|FG000|Overall Study|Physician Decision|1|||
131419224|NCT00129961|473157134|FG001|Overall Study|Physician Decision|0|||
131419225|NCT00129961|473157133|FG000|Overall Study|Withdrawal by Subject|2|||
131419226|NCT00129961|473157134|FG001|Overall Study|Withdrawal by Subject|1|||
131419227|NCT00129961|473157133|FG000|Overall Study|Missing Record|0|||
131419228|NCT00129961|473157134|FG001|Overall Study|Missing Record|1|||
131419229|NCT00989781|473157141|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
131419230|NCT00989781|473157142|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
131419231|NCT00694304|473157143|FG000|Overall Study|Adverse Event|42|||
131419232|NCT00694304|473157143|FG000|Overall Study|Lack of Efficacy|35|||
131419233|NCT00694304|473157143|FG000|Overall Study|Non-compliance With Study Product|16|||
131419234|NCT00694304|473157143|FG000|Overall Study|Protocol Violation|6|||
131419235|NCT00694304|473157143|FG000|Overall Study|Withdrawal of Consent|61|||
131419236|NCT00694304|473157143|FG000|Overall Study|Lost to Follow-up|15|||
131419237|NCT00694304|473157143|FG000|Overall Study|Administrative or Other Reasons|32|||
131419238|NCT00576576|473157146|FG000|Overall Study|Lost to Follow-up|6|||
131419239|NCT00576576|473157146|FG000|Overall Study|Protocol Violation|1|||
131419240|NCT01270256|473157152|FG000|Overall Study|Withdrawal by Subject|1|||
131419241|NCT01270256|473157153|FG001|Overall Study|Withdrawal by Subject|0|||
131419242|NCT03203291|473157156|FG000|Overall Study|Withdrawal by Subject|1|||
131419243|NCT02540265|473157160|FG000|Overall Study|Lost to Follow-up|0|||
131419244|NCT02540265|473157161|FG001|Overall Study|Lost to Follow-up|0|||
131419245|NCT02540265|473157162|FG002|Overall Study|Lost to Follow-up|1|||
131419246|NCT02102399|473157168|FG000|Overall Study|Withdrawal by Subject|6|||
131419247|NCT02102399|473157169|FG001|Overall Study|Withdrawal by Subject|4|||
131419248|NCT03101085|473157170|FG000|Overall Study|Lost to Follow-up|0|||
131419249|NCT03101085|473157171|FG001|Overall Study|Lost to Follow-up|1|||
131419250|NCT02039856|473157172|FG000|Overall Study|Death|5|||
131419251|NCT02039856|473157173|FG001|Overall Study|Death|3|||
131419252|NCT02039856|473157172|FG000|Overall Study|Partial survey completion|61|||
131419253|NCT02039856|473157173|FG001|Overall Study|Partial survey completion|26|||
131419254|NCT02039856|473157172|FG000|Overall Study|Lost to Follow-up|388|||
131419255|NCT02039856|473157173|FG001|Overall Study|Lost to Follow-up|206|||
131419256|NCT02039856|473157172|FG000|Overall Study|Withdrawal by Subject|1573|||
131419257|NCT02039856|473157173|FG001|Overall Study|Withdrawal by Subject|618|||
131419258|NCT04407234|473157176|FG000|Overall Study|Adverse Event|3|||
131419259|NCT04407234|473157177|FG001|Overall Study|Adverse Event|3|||
131419260|NCT03908970|473157178|FG000|Overall Study|Adverse Event|7|||
131419261|NCT03908970|473157179|FG001|Overall Study|Adverse Event|21|||
131419262|NCT03908970|473157178|FG000|Overall Study|Physician Decision|1|||
131457635|NCT03374202|473304680|FG001|Five Year Long Term Follow Up|Death|1|||
131457636|NCT03374202|473304681|FG002|Five Year Long Term Follow Up|Death|0|||
131457637|NCT01945710|473307021|FG000|Overall Study|Progressive Disease|5|||
131419263|NCT03908970|473157179|FG001|Overall Study|Physician Decision|4|||
131419264|NCT03908970|473157178|FG000|Overall Study|Withdrawal by Subject|9|||
131419265|NCT03908970|473157179|FG001|Overall Study|Withdrawal by Subject|22|||
131419266|NCT00126776|473159231|FG000|Overall Study|follow up complete on all patients|0|||
131419267|NCT00126776|473159232|FG001|Overall Study|follow up complete on all patients|0|||
131419268|NCT03626545|473159236|FG000|Overall Study|Progressive disease|3|||
131419269|NCT03626545|473159237|FG001|Overall Study|Progressive disease|82|||
131419270|NCT03626545|473159238|FG002|Overall Study|Progressive disease|85|||
131419271|NCT03626545|473159236|FG000|Overall Study|Adverse Event|3|||
131419272|NCT03626545|473159237|FG001|Overall Study|Adverse Event|13|||
131419273|NCT03626545|473159238|FG002|Overall Study|Adverse Event|10|||
131419274|NCT03626545|473159236|FG000|Overall Study|Physician Decision|1|||
131419275|NCT03626545|473159237|FG001|Overall Study|Physician Decision|18|||
131419276|NCT03626545|473159238|FG002|Overall Study|Physician Decision|14|||
131457638|NCT01945710|473307022|FG001|Overall Study|Progressive Disease|4|||
131419277|NCT03626545|473159236|FG000|Overall Study|Subject Decision|0|||
131419278|NCT03626545|473159237|FG001|Overall Study|Subject Decision|5|||
131419279|NCT03626545|473159238|FG002|Overall Study|Subject Decision|5|||
131419280|NCT03626545|473159236|FG000|Overall Study|Death|1|||
131419281|NCT03626545|473159237|FG001|Overall Study|Death|1|||
131419282|NCT03626545|473159238|FG002|Overall Study|Death|1|||
131419283|NCT03626545|473159236|FG000|Overall Study|Protocol Deviation|0|||
131419284|NCT03626545|473159237|FG001|Overall Study|Protocol Deviation|1|||
131419285|NCT03626545|473159238|FG002|Overall Study|Protocol Deviation|1|||
131419286|NCT03626545|473159236|FG000|Overall Study|Guardian Decision|0|||
131419287|NCT03626545|473159237|FG001|Overall Study|Guardian Decision|0|||
131419288|NCT03626545|473159238|FG002|Overall Study|Guardian Decision|1|||
131419289|NCT00568126|473159241|FG000|Overall Study|Adverse Event|3|||
131419290|NCT00568126|473159242|FG001|Overall Study|Adverse Event|0|||
131419291|NCT00568126|473159241|FG000|Overall Study|Withdrawal by Subject|2|||
131419292|NCT00568126|473159242|FG001|Overall Study|Withdrawal by Subject|3|||
131419293|NCT00568126|473159241|FG000|Overall Study|Lost to Follow-up|4|||
131419294|NCT00568126|473159242|FG001|Overall Study|Lost to Follow-up|3|||
131419295|NCT00568126|473159241|FG000|Overall Study|Lack of Efficacy|0|||
131419296|NCT00568126|473159242|FG001|Overall Study|Lack of Efficacy|1|||
131419297|NCT00568126|473159241|FG000|Overall Study|Physician Decision|2|||
131419298|NCT00568126|473159242|FG001|Overall Study|Physician Decision|2|||
131419299|NCT04395690|473159243|FG000|Overall Study|Lost to Follow-up|1|||
131419300|NCT04395690|473159244|FG001|Overall Study|Lost to Follow-up|1|||
131419301|NCT03387020|473159246|FG000|Overall Study|Adverse Event|0|||
131419302|NCT03387020|473159247|FG001|Overall Study|Adverse Event|2|||
131419303|NCT03387020|473159248|FG002|Overall Study|Adverse Event|0|||
131419304|NCT03387020|473159246|FG000|Overall Study|Withdrawal by Subject|2|||
131419305|NCT03387020|473159247|FG001|Overall Study|Withdrawal by Subject|0|||
131419306|NCT03387020|473159248|FG002|Overall Study|Withdrawal by Subject|0|||
131419307|NCT00434642|473159249|FG000|Blinded Treatment Phase|Adverse Event|12|||
131419308|NCT00434642|473159250|FG001|Blinded Treatment Phase|Adverse Event|58|||
131419309|NCT00434642|473159249|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
131419310|NCT00434642|473159250|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
131419311|NCT00434642|473159249|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
131419312|NCT00434642|473159250|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
131419313|NCT00434642|473159249|FG000|Blinded Treatment Phase|Physician Decision|19|||
131419314|NCT00434642|473159250|FG001|Blinded Treatment Phase|Physician Decision|27|||
131419315|NCT00434642|473159249|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
131419316|NCT00434642|473159250|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
131419317|NCT00434642|473159249|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
131419318|NCT00434642|473159250|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
131419319|NCT00434642|473159249|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
131419320|NCT00434642|473159250|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
131419321|NCT00434642|473159249|FG000|Open-label Treatment Phase|Adverse Event|0|||
131419322|NCT00434642|473159250|FG001|Open-label Treatment Phase|Adverse Event|5|||
131419323|NCT00434642|473159249|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
131419324|NCT00434642|473159250|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
131419325|NCT04512976|473159251|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
131419326|NCT04512976|473159252|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
131419327|NCT04512976|473159253|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
131419328|NCT04512976|473159254|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
131419329|NCT04512976|473159255|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
131419330|NCT04512976|473159256|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
131419331|NCT01939366|473159261|FG000|Overall Study|Adverse Event|8|||
131419332|NCT01939366|473159262|FG001|Overall Study|Adverse Event|17|||
131419333|NCT01939366|473159263|FG002|Overall Study|Adverse Event|30|||
131419334|NCT01939366|473159264|FG003|Overall Study|Adverse Event|8|||
131419335|NCT01939366|473159265|FG004|Overall Study|Adverse Event|5|||
131419336|NCT01939366|473159261|FG000|Overall Study|Lack of Efficacy|2|||
131419337|NCT01939366|473159262|FG001|Overall Study|Lack of Efficacy|1|||
131419338|NCT01939366|473159263|FG002|Overall Study|Lack of Efficacy|1|||
131419339|NCT01939366|473159264|FG003|Overall Study|Lack of Efficacy|1|||
131419340|NCT01939366|473159265|FG004|Overall Study|Lack of Efficacy|3|||
131419341|NCT01939366|473159261|FG000|Overall Study|Lost to Follow-up|1|||
131419342|NCT01939366|473159262|FG001|Overall Study|Lost to Follow-up|1|||
131419343|NCT01939366|473159263|FG002|Overall Study|Lost to Follow-up|0|||
131419344|NCT01939366|473159264|FG003|Overall Study|Lost to Follow-up|0|||
131419345|NCT01939366|473159265|FG004|Overall Study|Lost to Follow-up|0|||
131419346|NCT01939366|473159261|FG000|Overall Study|Withdrawal by Subject|1|||
131419347|NCT01939366|473159262|FG001|Overall Study|Withdrawal by Subject|0|||
131419348|NCT01939366|473159263|FG002|Overall Study|Withdrawal by Subject|2|||
131419349|NCT01939366|473159264|FG003|Overall Study|Withdrawal by Subject|2|||
131419350|NCT01939366|473159265|FG004|Overall Study|Withdrawal by Subject|3|||
131419351|NCT01939366|473159261|FG000|Overall Study|Inclusion criteria not met|0|||
131419352|NCT01939366|473159262|FG001|Overall Study|Inclusion criteria not met|1|||
131419353|NCT01939366|473159263|FG002|Overall Study|Inclusion criteria not met|1|||
131419354|NCT01939366|473159264|FG003|Overall Study|Inclusion criteria not met|0|||
131419355|NCT01939366|473159265|FG004|Overall Study|Inclusion criteria not met|1|||
131419356|NCT01939366|473159261|FG000|Overall Study|Other|0|||
131419357|NCT01939366|473159262|FG001|Overall Study|Other|0|||
131419358|NCT01939366|473159263|FG002|Overall Study|Other|2|||
131419359|NCT01939366|473159264|FG003|Overall Study|Other|2|||
131419360|NCT01939366|473159265|FG004|Overall Study|Other|1|||
131419361|NCT01939366|473159261|FG000|Overall Study|Protocol Violation|0|||
131419362|NCT01939366|473159262|FG001|Overall Study|Protocol Violation|0|||
131419363|NCT01939366|473159263|FG002|Overall Study|Protocol Violation|0|||
131419364|NCT01939366|473159264|FG003|Overall Study|Protocol Violation|1|||
131419365|NCT01939366|473159265|FG004|Overall Study|Protocol Violation|0|||
131419366|NCT01939366|473159261|FG000|Overall Study|Sponsor decision|0|||
131419367|NCT01939366|473159262|FG001|Overall Study|Sponsor decision|0|||
131419368|NCT01939366|473159263|FG002|Overall Study|Sponsor decision|0|||
131419369|NCT01939366|473159264|FG003|Overall Study|Sponsor decision|0|||
131419370|NCT01939366|473159265|FG004|Overall Study|Sponsor decision|2|||
131419371|NCT01939366|473159261|FG000|Overall Study|GCP non-compliance at site|2|||
131419372|NCT01939366|473159262|FG001|Overall Study|GCP non-compliance at site|3|||
131419373|NCT01939366|473159263|FG002|Overall Study|GCP non-compliance at site|2|||
131419374|NCT01939366|473159264|FG003|Overall Study|GCP non-compliance at site|3|||
131419375|NCT01939366|473159265|FG004|Overall Study|GCP non-compliance at site|3|||
131419376|NCT00753454|473159270|FG000|Overall Study|Adverse Event|4|||
131419377|NCT00753454|473159270|FG000|Overall Study|Lack of Efficacy|1|||
131419378|NCT00753454|473159270|FG000|Overall Study|Lost to Follow-up|3|||
131419379|NCT00753454|473159270|FG000|Overall Study|Withdrawal by Subject|5|||
131419380|NCT00753454|473159270|FG000|Overall Study|Investigator Decision|1|||
131419381|NCT04541628|473159271|FG000|Overall Study|Study Terminated|1|||
131419382|NCT04541628|473159272|FG001|Overall Study|Study Terminated|1|||
131419383|NCT04541628|473159273|FG002|Overall Study|Study Terminated|1|||
131419384|NCT02271945|473159277|FG000|Overall Study|Death|3|||
131419385|NCT02271945|473159278|FG001|Overall Study|Death|3|||
131419386|NCT02271945|473159277|FG000|Overall Study|Withdrawal by Subject|1|||
131419387|NCT02271945|473159278|FG001|Overall Study|Withdrawal by Subject|1|||
131419388|NCT02271945|473159277|FG000|Overall Study|Other|1|||
131419389|NCT02271945|473159278|FG001|Overall Study|Other|1|||
131419390|NCT01192412|473159279|FG000|Overall Study|Lost to Follow-up|2|||
131419391|NCT01192412|473159280|FG001|Overall Study|Lost to Follow-up|1|||
131419392|NCT01192412|473159279|FG000|Overall Study|Withdrawal by Subject|2|||
131419393|NCT01192412|473159280|FG001|Overall Study|Withdrawal by Subject|1|||
131419394|NCT00615030|473159281|FG000|Period I|Administrative problem|0|||
131419395|NCT00615030|473159282|FG001|Period I|Administrative problem|0|||
131419396|NCT00615030|473159283|FG002|Period I|Administrative problem|0|||
131419397|NCT00615030|473159284|FG003|Period I|Administrative problem|0|||
131419398|NCT00615030|473159285|FG004|Period I|Administrative problem|1|||
131419399|NCT00615030|473159286|FG005|Period I|Administrative problem|0|||
131419400|NCT00615030|473159287|FG006|Period I|Administrative problem|0|||
131419401|NCT00615030|473159288|FG007|Period I|Administrative problem|0|||
131419402|NCT00615030|473159289|FG008|Period I|Administrative problem|0|||
131419403|NCT00615030|473159290|FG009|Period I|Administrative problem|0|||
131419404|NCT00615030|473159291|FG010|Period I|Administrative problem|0|||
131419405|NCT00615030|473159292|FG011|Period I|Administrative problem|0|||
131419406|NCT00615030|473159281|FG000|Period I|Protocol deviation|1|||
131419407|NCT00615030|473159282|FG001|Period I|Protocol deviation|0|||
131419408|NCT00615030|473159283|FG002|Period I|Protocol deviation|0|||
131419409|NCT00615030|473159284|FG003|Period I|Protocol deviation|0|||
131419410|NCT00615030|473159285|FG004|Period I|Protocol deviation|0|||
131419411|NCT00615030|473159286|FG005|Period I|Protocol deviation|0|||
131419412|NCT00615030|473159287|FG006|Period I|Protocol deviation|0|||
131419413|NCT00615030|473159288|FG007|Period I|Protocol deviation|0|||
131419414|NCT00615030|473159289|FG008|Period I|Protocol deviation|0|||
131419415|NCT00615030|473159290|FG009|Period I|Protocol deviation|0|||
131419416|NCT00615030|473159291|FG010|Period I|Protocol deviation|0|||
131419417|NCT00615030|473159292|FG011|Period I|Protocol deviation|0|||
131457639|NCT01945710|473307023|FG002|Overall Study|Progressive Disease|3|||
131457640|NCT01945710|473307024|FG003|Overall Study|Progressive Disease|2|||
131457641|NCT01945710|473307025|FG004|Overall Study|Progressive Disease|7|||
131419418|NCT00615030|473159281|FG000|Period I|Subject withdrew consent|0|||
131419419|NCT00615030|473159282|FG001|Period I|Subject withdrew consent|0|||
131419420|NCT00615030|473159283|FG002|Period I|Subject withdrew consent|0|||
131419421|NCT00615030|473159284|FG003|Period I|Subject withdrew consent|0|||
131419422|NCT00615030|473159285|FG004|Period I|Subject withdrew consent|0|||
131419423|NCT00615030|473159286|FG005|Period I|Subject withdrew consent|0|||
131419424|NCT00615030|473159287|FG006|Period I|Subject withdrew consent|0|||
131419425|NCT00615030|473159288|FG007|Period I|Subject withdrew consent|0|||
131419426|NCT00615030|473159289|FG008|Period I|Subject withdrew consent|1|||
131419427|NCT00615030|473159290|FG009|Period I|Subject withdrew consent|0|||
131419428|NCT00615030|473159291|FG010|Period I|Subject withdrew consent|1|||
131419429|NCT00615030|473159292|FG011|Period I|Subject withdrew consent|1|||
131419430|NCT00615030|473159281|FG000|Period I|Abnormal laboratory value(s)|0|||
131419431|NCT00615030|473159282|FG001|Period I|Abnormal laboratory value(s)|0|||
131419432|NCT00615030|473159283|FG002|Period I|Abnormal laboratory value(s)|0|||
131457642|NCT01945710|473307026|FG005|Overall Study|Progressive Disease|3|||
131419433|NCT00615030|473159284|FG003|Period I|Abnormal laboratory value(s)|0|||
131419434|NCT00615030|473159285|FG004|Period I|Abnormal laboratory value(s)|0|||
131419435|NCT00615030|473159286|FG005|Period I|Abnormal laboratory value(s)|1|||
131419436|NCT00615030|473159287|FG006|Period I|Abnormal laboratory value(s)|0|||
131419437|NCT00615030|473159288|FG007|Period I|Abnormal laboratory value(s)|0|||
131419438|NCT00615030|473159289|FG008|Period I|Abnormal laboratory value(s)|0|||
131419439|NCT00615030|473159290|FG009|Period I|Abnormal laboratory value(s)|0|||
131419440|NCT00615030|473159291|FG010|Period I|Abnormal laboratory value(s)|0|||
131419441|NCT00615030|473159292|FG011|Period I|Abnormal laboratory value(s)|0|||
131419442|NCT00615030|473159281|FG000|Period II|Adverse Event|0|||
131419443|NCT00615030|473159282|FG001|Period II|Adverse Event|0|||
131419444|NCT00615030|473159283|FG002|Period II|Adverse Event|1|||
131419445|NCT00615030|473159284|FG003|Period II|Adverse Event|0|||
131419446|NCT00615030|473159285|FG004|Period II|Adverse Event|0|||
131419447|NCT00615030|473159286|FG005|Period II|Adverse Event|0|||
131419448|NCT00615030|473159287|FG006|Period II|Adverse Event|0|||
131419449|NCT00615030|473159288|FG007|Period II|Adverse Event|0|||
131419450|NCT00615030|473159289|FG008|Period II|Adverse Event|1|||
131419451|NCT00615030|473159290|FG009|Period II|Adverse Event|0|||
131419452|NCT00615030|473159291|FG010|Period II|Adverse Event|0|||
131419453|NCT00615030|473159292|FG011|Period II|Adverse Event|0|||
131419454|NCT00615030|473159281|FG000|Period II|Subject withdrew consent|0|||
131419455|NCT00615030|473159282|FG001|Period II|Subject withdrew consent|0|||
131419456|NCT00615030|473159283|FG002|Period II|Subject withdrew consent|0|||
131419457|NCT00615030|473159284|FG003|Period II|Subject withdrew consent|1|||
131419458|NCT00615030|473159285|FG004|Period II|Subject withdrew consent|0|||
131419459|NCT00615030|473159286|FG005|Period II|Subject withdrew consent|0|||
131419460|NCT00615030|473159287|FG006|Period II|Subject withdrew consent|1|||
131419461|NCT00615030|473159288|FG007|Period II|Subject withdrew consent|0|||
131419462|NCT00615030|473159289|FG008|Period II|Subject withdrew consent|0|||
131419463|NCT00615030|473159290|FG009|Period II|Subject withdrew consent|0|||
131419464|NCT00615030|473159291|FG010|Period II|Subject withdrew consent|0|||
131419465|NCT00615030|473159292|FG011|Period II|Subject withdrew consent|0|||
131419466|NCT00615030|473159281|FG000|Period III|Administrative problems|1|||
131419467|NCT00615030|473159282|FG001|Period III|Administrative problems|0|||
131419468|NCT00615030|473159283|FG002|Period III|Administrative problems|0|||
131419469|NCT00615030|473159284|FG003|Period III|Administrative problems|1|||
131419470|NCT00615030|473159285|FG004|Period III|Administrative problems|0|||
131419471|NCT00615030|473159286|FG005|Period III|Administrative problems|0|||
131419472|NCT00615030|473159287|FG006|Period III|Administrative problems|0|||
131419473|NCT00615030|473159288|FG007|Period III|Administrative problems|0|||
131419474|NCT00615030|473159289|FG008|Period III|Administrative problems|0|||
131419475|NCT00615030|473159290|FG009|Period III|Administrative problems|0|||
131419476|NCT00615030|473159291|FG010|Period III|Administrative problems|0|||
131419477|NCT00615030|473159292|FG011|Period III|Administrative problems|0|||
131419478|NCT00151476|473159293|FG000|FAP Identified Subjects|Protocol Violation|0|||
131419479|NCT00151476|473159294|FG001|FAP Identified Subjects|Protocol Violation|1|||
131419480|NCT00151476|473159293|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
131419481|NCT00151476|473159294|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
131419482|NCT00151476|473159293|FG000|FAP Analyzed Subjects|Other study participation|0|||
131419483|NCT00151476|473159294|FG001|FAP Analyzed Subjects|Other study participation|1|||
131419484|NCT03446456|473159295|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
131419485|NCT03446456|473159296|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
131419486|NCT03446456|473159295|FG000|Overall Study|Lost to Follow-up|1|||
131419487|NCT03446456|473159296|FG001|Overall Study|Lost to Follow-up|3|||
131419488|NCT03446456|473159295|FG000|Overall Study|Participant failed the toxicology test|1|||
131419489|NCT03446456|473159296|FG001|Overall Study|Participant failed the toxicology test|0|||
131419490|NCT03446456|473159295|FG000|Overall Study|Break down of the experimental equipment|1|||
131419491|NCT03446456|473159296|FG001|Overall Study|Break down of the experimental equipment|0|||
131419492|NCT04099511|473159303|FG000|Overall Study|Lost to Follow-up|2|||
131419493|NCT04099511|473159304|FG001|Overall Study|Lost to Follow-up|2|||
131419494|NCT04099511|473159303|FG000|Overall Study|Withdrawal by Subject|8|||
131419495|NCT04099511|473159304|FG001|Overall Study|Withdrawal by Subject|4|||
131419496|NCT03002311|473159309|FG000|Overall Study|Lost to Follow-up|13|||
131419497|NCT03002311|473159310|FG001|Overall Study|Lost to Follow-up|26|||
131419498|NCT03002311|473159309|FG000|Overall Study|Referral provider called to schedule app|3|||
131419499|NCT03002311|473159310|FG001|Overall Study|Referral provider called to schedule app|3|||
131457643|NCT01945710|473307027|FG006|Overall Study|Progressive Disease|19|||
131457644|NCT01945710|473307021|FG000|Overall Study|Adverse Event|0|||
131419500|NCT03002311|473159309|FG000|Overall Study|Physician Decision|3|||
131419501|NCT03002311|473159310|FG001|Overall Study|Physician Decision|1|||
131419502|NCT00320424|473159311|FG000|Overall Study|Adverse Event|3|||
131419503|NCT00320424|473159311|FG000|Overall Study|Other|3|||
131457645|NCT01945710|473307022|FG001|Overall Study|Adverse Event|1|||
131419504|NCT02649894|473159317|FG000|Overall Study|Adverse Event|1|||
131419505|NCT02649894|473159318|FG001|Overall Study|Adverse Event|0|||
131419506|NCT02649894|473159317|FG000|Overall Study|Physician Decision|0|||
131419507|NCT02649894|473159318|FG001|Overall Study|Physician Decision|1|||
131419508|NCT02649894|473159317|FG000|Overall Study|Withdrawal by Subject|5|||
131419509|NCT02649894|473159318|FG001|Overall Study|Withdrawal by Subject|2|||
131419510|NCT02649894|473159317|FG000|Overall Study|Lost to Follow-up|2|||
131419511|NCT02649894|473159318|FG001|Overall Study|Lost to Follow-up|1|||
131419512|NCT02649894|473159317|FG000|Overall Study|Death|30|||
131419513|NCT02649894|473159318|FG001|Overall Study|Death|7|||
131419514|NCT02649894|473159317|FG000|Overall Study|Other, not specified|6|||
131419515|NCT02649894|473159318|FG001|Overall Study|Other, not specified|0|||
131419516|NCT00719680|473159319|FG000|Overall Study|Adverse Event|1|||
131419517|NCT00719680|473159319|FG000|Overall Study|Lost to Follow-up|1|||
131419518|NCT00719680|473159319|FG000|Overall Study|Withdrawal by Subject|3|||
131419519|NCT00658814|473159320|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
131419520|NCT00658814|473159321|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
131419521|NCT00658814|473159320|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
131419522|NCT00658814|473159321|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
131419523|NCT00658814|473159320|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
131419524|NCT00658814|473159321|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
131419525|NCT00658814|473159320|FG000|Remission Induction Chemotherapy|Death|1|||
131419526|NCT00658814|473159321|FG001|Remission Induction Chemotherapy|Death|4|||
131419527|NCT00658814|473159320|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
131419528|NCT00658814|473159321|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
131419529|NCT00658814|473159320|FG000|Remission Induction Chemotherapy|Not eligible|1|||
131419530|NCT00658814|473159321|FG001|Remission Induction Chemotherapy|Not eligible|2|||
131419531|NCT00658814|473159320|FG000|Consolidation Therapy|Not protocol specified|0|||
131419532|NCT00658814|473159321|FG001|Consolidation Therapy|Not protocol specified|1|||
131419533|NCT00658814|473159320|FG000|Consolidation Therapy|Not eligible|2|||
131419534|NCT00658814|473159321|FG001|Consolidation Therapy|Not eligible|2|||
131419535|NCT00658814|473159320|FG000|Maintenance Therapy|Adverse Event|1|||
131419536|NCT00658814|473159321|FG001|Maintenance Therapy|Adverse Event|1|||
131419537|NCT00658814|473159320|FG000|Maintenance Therapy|Not protocol specified|1|||
131419538|NCT00658814|473159321|FG001|Maintenance Therapy|Not protocol specified|0|||
131419539|NCT00658814|473159320|FG000|Maintenance Therapy|Not eligible|1|||
131419540|NCT00658814|473159321|FG001|Maintenance Therapy|Not eligible|0|||
131419541|NCT04071158|473159322|FG000|Overall Study|Lost to Follow-up|1|||
131419542|NCT04071158|473159323|FG001|Overall Study|Lost to Follow-up|2|||
131419543|NCT04071158|473159324|FG002|Overall Study|Lost to Follow-up|3|||
131419544|NCT04071158|473159325|FG003|Overall Study|Lost to Follow-up|3|||
131419545|NCT04071158|473159326|FG004|Overall Study|Lost to Follow-up|5|||
131419546|NCT04071158|473159322|FG000|Overall Study|Randomized but not treated|2|||
131419547|NCT04071158|473159323|FG001|Overall Study|Randomized but not treated|2|||
131419548|NCT04071158|473159324|FG002|Overall Study|Randomized but not treated|0|||
131419549|NCT04071158|473159325|FG003|Overall Study|Randomized but not treated|0|||
131419550|NCT04071158|473159326|FG004|Overall Study|Randomized but not treated|0|||
131419551|NCT03266172|473159327|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
131419552|NCT03266172|473159328|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
131419553|NCT03266172|473159329|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
131419554|NCT03266172|473159327|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
131419555|NCT03266172|473159328|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
131419556|NCT03266172|473159329|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
131419557|NCT03266172|473159327|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
131419558|NCT03266172|473159328|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
131419559|NCT03266172|473159329|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
131419560|NCT03266172|473159327|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
131419561|NCT03266172|473159328|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
131419562|NCT03266172|473159329|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
131419563|NCT03266172|473159327|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
131419564|NCT03266172|473159328|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
131419565|NCT03266172|473159329|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
131419566|NCT03266172|473159327|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
131419567|NCT03266172|473159328|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
131419568|NCT03266172|473159329|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
131419569|NCT01554514|473159332|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
131419570|NCT01554514|473159332|FG000|Overall Study|Physician Decision|1|||
131419571|NCT00300365|473159333|FG000|Overall Study|Lost to Follow-up|1|||
131419572|NCT00300365|473159334|FG001|Overall Study|Lost to Follow-up|0|||
131419573|NCT00300365|473159333|FG000|Overall Study|Physician Decision|2|||
131419574|NCT00300365|473159334|FG001|Overall Study|Physician Decision|0|||
131419575|NCT00300365|473159333|FG000|Overall Study|Withdrawal by Subject|1|||
131419576|NCT00300365|473159334|FG001|Overall Study|Withdrawal by Subject|0|||
131419577|NCT00300365|473159333|FG000|Overall Study|Adverse Event|0|||
131419578|NCT00300365|473159334|FG001|Overall Study|Adverse Event|2|||
131419579|NCT00902174|473159335|FG000|Overall Study|Adverse Event|27|||
131419580|NCT00902174|473159336|FG001|Overall Study|Adverse Event|7|||
131419581|NCT00902174|473159335|FG000|Overall Study|Lack of Efficacy|1|||
131419582|NCT00902174|473159336|FG001|Overall Study|Lack of Efficacy|5|||
131419583|NCT00902174|473159335|FG000|Overall Study|Death|2|||
131419584|NCT00902174|473159336|FG001|Overall Study|Death|2|||
131419585|NCT00902174|473159335|FG000|Overall Study|Withdrawal by Subject|2|||
131419586|NCT00902174|473159336|FG001|Overall Study|Withdrawal by Subject|1|||
131419587|NCT00902174|473159335|FG000|Overall Study|Abnormal labs|1|||
131419588|NCT00902174|473159336|FG001|Overall Study|Abnormal labs|1|||
131419589|NCT00902174|473159335|FG000|Overall Study|Protocol Violation|1|||
131419590|NCT00902174|473159336|FG001|Overall Study|Protocol Violation|1|||
131419591|NCT00902174|473159335|FG000|Overall Study|Administration problem|0|||
131419592|NCT00902174|473159336|FG001|Overall Study|Administration problem|1|||
131419593|NCT00290498|473159337|FG000|Overall Study|Death|2|||
131419594|NCT00290498|473159338|FG001|Overall Study|Death|0|||
131419595|NCT00290498|473159337|FG000|Overall Study|Physician Decision|1|||
131419596|NCT00290498|473159338|FG001|Overall Study|Physician Decision|0|||
131419597|NCT00290498|473159337|FG000|Overall Study|Withdrawal by Subject|1|||
131419598|NCT00290498|473159338|FG001|Overall Study|Withdrawal by Subject|0|||
131419599|NCT00290498|473159337|FG000|Overall Study|Ineligible|3|||
131419600|NCT00290498|473159338|FG001|Overall Study|Ineligible|0|||
131419601|NCT00290498|473159337|FG000|Overall Study|Non-Compliance|1|||
131419602|NCT00290498|473159338|FG001|Overall Study|Non-Compliance|0|||
131419603|NCT01716104|473159340|FG000|Overall Study|Do not meet inclusion criteria|6|||
131419604|NCT01716104|473159341|FG001|Overall Study|Do not meet inclusion criteria|7|||
131419605|NCT01753401|473159342|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
131419606|NCT01753401|473159343|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
131419607|NCT01753401|473159344|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
131419608|NCT01753401|473159345|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
131419609|NCT01753401|473159342|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
131419610|NCT01753401|473159343|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
131419611|NCT01753401|473159344|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
131419612|NCT01753401|473159345|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
131419613|NCT01753401|473159342|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
131419614|NCT01753401|473159343|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
131419615|NCT01753401|473159344|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
131419616|NCT01753401|473159345|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
131419617|NCT01753401|473159342|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
131419618|NCT01753401|473159343|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
131419619|NCT01753401|473159344|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
131419620|NCT01753401|473159345|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
131419621|NCT01753401|473159342|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
131419622|NCT01753401|473159343|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
131419623|NCT01753401|473159344|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
131419624|NCT01753401|473159345|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
131419625|NCT01753401|473159342|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
131419626|NCT01753401|473159343|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
131419627|NCT01753401|473159344|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
131419628|NCT01753401|473159345|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
131419629|NCT01753401|473159342|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
131419630|NCT01753401|473159343|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
131419631|NCT01753401|473159344|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
131419632|NCT01753401|473159345|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
131419633|NCT05026853|473159346|FG000|Overall Study|Cancelled appointment|1|||
131419634|NCT05026853|473159347|FG001|Overall Study|Cancelled appointment|0|||
131419635|NCT05026853|473159346|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
131419636|NCT05026853|473159347|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
131419637|NCT05026853|473159346|FG000|Overall Study|Did not complete 12-week survey|16|||
131419638|NCT05026853|473159347|FG001|Overall Study|Did not complete 12-week survey|16|||
131419639|NCT01353911|473159348|FG000|Overall Study|Lost to Follow-up|2|||
131419640|NCT01353911|473159349|FG001|Overall Study|Lost to Follow-up|6|||
131419641|NCT01353911|473159350|FG002|Overall Study|Lost to Follow-up|4|||
131419642|NCT01353911|473159351|FG003|Overall Study|Lost to Follow-up|0|||
131419643|NCT01353911|473159352|FG004|Overall Study|Lost to Follow-up|4|||
131419644|NCT01353911|473159353|FG005|Overall Study|Lost to Follow-up|4|||
131419645|NCT01353911|473159354|FG006|Overall Study|Lost to Follow-up|3|||
131419646|NCT01353911|473159355|FG007|Overall Study|Lost to Follow-up|6|||
131419647|NCT01353911|473159348|FG000|Overall Study|Withdrawal by Subject|2|||
131419648|NCT01353911|473159349|FG001|Overall Study|Withdrawal by Subject|3|||
131419649|NCT01353911|473159350|FG002|Overall Study|Withdrawal by Subject|4|||
131419650|NCT01353911|473159351|FG003|Overall Study|Withdrawal by Subject|2|||
131419651|NCT01353911|473159352|FG004|Overall Study|Withdrawal by Subject|2|||
131419652|NCT01353911|473159353|FG005|Overall Study|Withdrawal by Subject|3|||
131419653|NCT01353911|473159354|FG006|Overall Study|Withdrawal by Subject|3|||
131419654|NCT01353911|473159355|FG007|Overall Study|Withdrawal by Subject|9|||
131419655|NCT01353911|473159348|FG000|Overall Study|Status Not Recorded|4|||
131419656|NCT01353911|473159349|FG001|Overall Study|Status Not Recorded|0|||
131419657|NCT01353911|473159350|FG002|Overall Study|Status Not Recorded|1|||
131419658|NCT01353911|473159351|FG003|Overall Study|Status Not Recorded|0|||
131419659|NCT01353911|473159352|FG004|Overall Study|Status Not Recorded|0|||
131419660|NCT01353911|473159353|FG005|Overall Study|Status Not Recorded|0|||
131419661|NCT01353911|473159354|FG006|Overall Study|Status Not Recorded|0|||
131419662|NCT01353911|473159355|FG007|Overall Study|Status Not Recorded|0|||
131419663|NCT00462748|473159360|FG000|Overall Study|Adverse Event|7|||
131419664|NCT00462748|473159361|FG001|Overall Study|Adverse Event|5|||
131419665|NCT00462748|473159362|FG002|Overall Study|Adverse Event|9|||
131419666|NCT00462748|473159360|FG000|Overall Study|Protocol Violation|0|||
131419667|NCT00462748|473159361|FG001|Overall Study|Protocol Violation|2|||
131419668|NCT00462748|473159362|FG002|Overall Study|Protocol Violation|1|||
131419669|NCT00462748|473159360|FG000|Overall Study|Withdrew consent|3|||
131419670|NCT00462748|473159361|FG001|Overall Study|Withdrew consent|3|||
131419671|NCT00462748|473159362|FG002|Overall Study|Withdrew consent|0|||
131419672|NCT00462748|473159360|FG000|Overall Study|Lost to Follow-up|1|||
131419673|NCT00462748|473159361|FG001|Overall Study|Lost to Follow-up|1|||
131419674|NCT00462748|473159362|FG002|Overall Study|Lost to Follow-up|1|||
131419675|NCT00462748|473159360|FG000|Overall Study|Discontinued after 41 days Rx|1|||
131419676|NCT00462748|473159361|FG001|Overall Study|Discontinued after 41 days Rx|0|||
131419677|NCT00462748|473159362|FG002|Overall Study|Discontinued after 41 days Rx|0|||
131419678|NCT03233438|473159363|FG000|Overall Study|Lost to Follow-up|4|||
131419679|NCT03233438|473159364|FG001|Overall Study|Lost to Follow-up|9|||
131419680|NCT03233438|473159363|FG000|Overall Study|Withdrawal by Subject|2|||
131419681|NCT03233438|473159364|FG001|Overall Study|Withdrawal by Subject|1|||
131419682|NCT03233438|473159363|FG000|Overall Study|No recording of dalbavancin|0|||
131419683|NCT03233438|473159364|FG001|Overall Study|No recording of dalbavancin|1|||
131419684|NCT03429543|473159365|FG000|Overall Study|Adverse Event|1|||
131419685|NCT03429543|473159366|FG001|Overall Study|Adverse Event|1|||
131419686|NCT03429543|473159367|FG002|Overall Study|Adverse Event|0|||
131419687|NCT03429543|473159368|FG003|Overall Study|Adverse Event|0|||
131419688|NCT03429543|473159369|FG004|Overall Study|Adverse Event|0|||
131419689|NCT03429543|473159370|FG005|Overall Study|Adverse Event|2|||
131419690|NCT03429543|473159371|FG006|Overall Study|Adverse Event|0|||
131419691|NCT03429543|473159365|FG000|Overall Study|Lost to Follow-up|1|||
131419692|NCT03429543|473159366|FG001|Overall Study|Lost to Follow-up|0|||
131419693|NCT03429543|473159367|FG002|Overall Study|Lost to Follow-up|0|||
131419694|NCT03429543|473159368|FG003|Overall Study|Lost to Follow-up|0|||
131419695|NCT03429543|473159369|FG004|Overall Study|Lost to Follow-up|1|||
131419696|NCT03429543|473159370|FG005|Overall Study|Lost to Follow-up|0|||
131419697|NCT03429543|473159371|FG006|Overall Study|Lost to Follow-up|0|||
131419698|NCT03429543|473159365|FG000|Overall Study|Withdrawal by Subject|5|||
131419699|NCT03429543|473159366|FG001|Overall Study|Withdrawal by Subject|0|||
131419700|NCT03429543|473159367|FG002|Overall Study|Withdrawal by Subject|1|||
131419701|NCT03429543|473159368|FG003|Overall Study|Withdrawal by Subject|2|||
131419702|NCT03429543|473159369|FG004|Overall Study|Withdrawal by Subject|6|||
131419703|NCT03429543|473159370|FG005|Overall Study|Withdrawal by Subject|3|||
131419704|NCT03429543|473159371|FG006|Overall Study|Withdrawal by Subject|1|||
131419705|NCT03429543|473159365|FG000|Overall Study|Other reason than listed|0|||
131419706|NCT03429543|473159366|FG001|Overall Study|Other reason than listed|1|||
131419707|NCT03429543|473159367|FG002|Overall Study|Other reason than listed|0|||
131419708|NCT03429543|473159368|FG003|Overall Study|Other reason than listed|0|||
131419709|NCT03429543|473159369|FG004|Overall Study|Other reason than listed|4|||
131419710|NCT03429543|473159370|FG005|Overall Study|Other reason than listed|4|||
131419711|NCT03429543|473159371|FG006|Overall Study|Other reason than listed|0|||
131419712|NCT03429543|473159365|FG000|Overall Study|Not treated|0|||
131419713|NCT03429543|473159366|FG001|Overall Study|Not treated|0|||
131419714|NCT03429543|473159367|FG002|Overall Study|Not treated|0|||
131419715|NCT03429543|473159368|FG003|Overall Study|Not treated|0|||
131419716|NCT03429543|473159369|FG004|Overall Study|Not treated|1|||
131419717|NCT03429543|473159370|FG005|Overall Study|Not treated|0|||
131419718|NCT03429543|473159371|FG006|Overall Study|Not treated|0|||
131419719|NCT01729208|473159372|FG000|Baseline|Physician Decision|5|||
131419720|NCT01729208|473159373|FG001|Baseline|Physician Decision|4|||
131419721|NCT01729208|473159372|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
131419722|NCT01729208|473159373|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
131419723|NCT01729208|473159372|FG000|12 Months Follow-up|Lost to Follow-up|3|||
131419724|NCT01729208|473159373|FG001|12 Months Follow-up|Lost to Follow-up|3|||
131419725|NCT01729208|473159372|FG000|24 Months Follow-up|Lost to Follow-up|3|||
131419726|NCT01729208|473159373|FG001|24 Months Follow-up|Lost to Follow-up|0|||
131419727|NCT01729208|473159372|FG000|36 Months Follow-up|Physician Decision|1|||
131419728|NCT01729208|473159373|FG001|36 Months Follow-up|Physician Decision|0|||
131419729|NCT01729208|473159372|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
131419730|NCT01729208|473159373|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
131419731|NCT02428413|473159374|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
131419732|NCT02428413|473159375|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
131419733|NCT02428413|473159374|FG000|Overall Study|Protocol Violation|1|||
131419734|NCT02428413|473159375|FG001|Overall Study|Protocol Violation|2|||
131419735|NCT02428413|473159374|FG000|Overall Study|Case Cancelled|2|||
131419736|NCT02428413|473159375|FG001|Overall Study|Case Cancelled|0|||
131419737|NCT02428413|473159374|FG000|Overall Study|Missed Cases|1|||
131419738|NCT02428413|473159375|FG001|Overall Study|Missed Cases|2|||
131419739|NCT02428413|473159374|FG000|Overall Study|Nurse Refusal|1|||
131419740|NCT02428413|473159375|FG001|Overall Study|Nurse Refusal|0|||
131419741|NCT03688100|473159378|FG000|Overall Study|Lost to Follow-up|21|||
131419742|NCT03688100|473159379|FG001|Overall Study|Lost to Follow-up|15|||
131419743|NCT03688100|473159380|FG002|Overall Study|Lost to Follow-up|15|||
131419744|NCT03688100|473159381|FG003|Overall Study|Lost to Follow-up|18|||
131419745|NCT03688100|473159378|FG000|Overall Study|Withdrawal by Subject|19|||
131419746|NCT03688100|473159379|FG001|Overall Study|Withdrawal by Subject|16|||
131419747|NCT03688100|473159380|FG002|Overall Study|Withdrawal by Subject|0|||
131419748|NCT03688100|473159381|FG003|Overall Study|Withdrawal by Subject|0|||
131419749|NCT03688100|473159378|FG000|Overall Study|Death|36|||
131419750|NCT03688100|473159379|FG001|Overall Study|Death|27|||
131419751|NCT03688100|473159380|FG002|Overall Study|Death|0|||
131419752|NCT03688100|473159381|FG003|Overall Study|Death|0|||
131419753|NCT00494507|473159384|FG000|Double-Blind Phase|Adverse Event|2|||
131419754|NCT00494507|473159385|FG001|Double-Blind Phase|Adverse Event|0|||
131419755|NCT00494507|473159386|FG002|Double-Blind Phase|Adverse Event|1|||
131419756|NCT00494507|473159387|FG003|Double-Blind Phase|Adverse Event|0|||
131419757|NCT00494507|473159384|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
131419758|NCT00494507|473159385|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
131419759|NCT00494507|473159386|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131419760|NCT00494507|473159387|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131419761|NCT00494507|473159384|FG000|Double-Blind Phase|Subject Non-compliance|0|||
131419762|NCT00494507|473159385|FG001|Double-Blind Phase|Subject Non-compliance|0|||
131419763|NCT00494507|473159386|FG002|Double-Blind Phase|Subject Non-compliance|1|||
131419764|NCT00494507|473159387|FG003|Double-Blind Phase|Subject Non-compliance|0|||
131419765|NCT00494507|473159384|FG000|Double-Blind Phase|Negative DNA test|0|||
131419766|NCT00494507|473159385|FG001|Double-Blind Phase|Negative DNA test|0|||
131419767|NCT00494507|473159386|FG002|Double-Blind Phase|Negative DNA test|0|||
131419768|NCT00494507|473159387|FG003|Double-Blind Phase|Negative DNA test|1|||
131419769|NCT00494507|473159384|FG000|Open-Label Phase|Adverse Event|0|||
131419770|NCT00494507|473159385|FG001|Open-Label Phase|Adverse Event|1|||
131419771|NCT00494507|473159386|FG002|Open-Label Phase|Adverse Event|5|||
131419772|NCT00494507|473159387|FG003|Open-Label Phase|Adverse Event|3|||
131419773|NCT00494507|473159384|FG000|Open-Label Phase|Worsening Disease|0|||
131419774|NCT00494507|473159385|FG001|Open-Label Phase|Worsening Disease|0|||
131419775|NCT00494507|473159386|FG002|Open-Label Phase|Worsening Disease|0|||
131419776|NCT00494507|473159387|FG003|Open-Label Phase|Worsening Disease|2|||
131419777|NCT02437084|473159389|FG000|Overall Study|Withdrawal by Subject|2|||
131419778|NCT02437084|473159389|FG000|Overall Study|Physician Decision|1|||
131419779|NCT00587847|473159390|FG000|Overall Study|Lack of Efficacy|5|||
131419780|NCT00587847|473159390|FG000|Overall Study|Adverse Event|2|||
131419781|NCT03729245|473159391|FG000|Overall Study|Lost to Follow-up|5|||
131419782|NCT03729245|473159392|FG001|Overall Study|Lost to Follow-up|6|||
131419783|NCT03729245|473159391|FG000|Overall Study|Withdrawal by Subject|16|||
131419784|NCT03729245|473159392|FG001|Overall Study|Withdrawal by Subject|19|||
131419785|NCT03729245|473159391|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
131419786|NCT03729245|473159392|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
131419787|NCT04032080|473159393|FG000|Overall Study|Death|6|||
131419788|NCT01805037|473159394|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
131419789|NCT01805037|473159395|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
131419790|NCT01805037|473159394|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
131419791|NCT01805037|473159395|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
131419792|NCT01805037|473159394|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
131419793|NCT01805037|473159395|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
131419794|NCT01805037|473159394|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
131419795|NCT01805037|473159395|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
131419796|NCT01805037|473159394|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
131419797|NCT01805037|473159395|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
131419798|NCT01805037|473159394|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
131457646|NCT01945710|473307023|FG002|Overall Study|Adverse Event|0|||
131457647|NCT01945710|473307024|FG003|Overall Study|Adverse Event|0|||
131457648|NCT01945710|473307025|FG004|Overall Study|Adverse Event|0|||
131457649|NCT01945710|473307026|FG005|Overall Study|Adverse Event|0|||
131457650|NCT01945710|473307027|FG006|Overall Study|Adverse Event|0|||
131457651|NCT01945710|473307021|FG000|Overall Study|Other|2|||
131419799|NCT01805037|473159395|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
131419800|NCT01805037|473159394|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
131419801|NCT01805037|473159395|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
131419802|NCT01805037|473159394|FG000|Follow Up (up to 3 Years)|Death|0|||
131457652|NCT01945710|473307022|FG001|Overall Study|Other|0|||
131457653|NCT01945710|473307023|FG002|Overall Study|Other|3|||
131457654|NCT01945710|473307024|FG003|Overall Study|Other|1|||
131419803|NCT01805037|473159395|FG001|Follow Up (up to 3 Years)|Death|2|||
131419804|NCT01805037|473159394|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
131419805|NCT01805037|473159395|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
131419806|NCT01805037|473159394|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
131419807|NCT01805037|473159395|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
131419808|NCT02177838|473159396|FG000|Overall Study|Withdrawal by Subject|1|||
131419809|NCT02177838|473159396|FG000|Overall Study|Physician Decision|1|||
131419810|NCT02177838|473159396|FG000|Overall Study|Death|1|||
131419811|NCT03517566|473159397|FG000|Overall Study|Adverse Event|5|||
131419812|NCT03517566|473159398|FG001|Overall Study|Adverse Event|2|||
131419813|NCT03517566|473159399|FG002|Overall Study|Adverse Event|2|||
131419814|NCT03517566|473159400|FG003|Overall Study|Adverse Event|8|||
131419815|NCT03517566|473159401|FG004|Overall Study|Adverse Event|7|||
131419816|NCT03517566|473159397|FG000|Overall Study|Lack of Efficacy|3|||
131419817|NCT03517566|473159398|FG001|Overall Study|Lack of Efficacy|2|||
131419818|NCT03517566|473159399|FG002|Overall Study|Lack of Efficacy|1|||
131419819|NCT03517566|473159400|FG003|Overall Study|Lack of Efficacy|1|||
131419820|NCT03517566|473159401|FG004|Overall Study|Lack of Efficacy|4|||
131419821|NCT03517566|473159397|FG000|Overall Study|Lost to Follow-up|3|||
131419822|NCT03517566|473159398|FG001|Overall Study|Lost to Follow-up|1|||
131419823|NCT03517566|473159399|FG002|Overall Study|Lost to Follow-up|1|||
131419824|NCT03517566|473159400|FG003|Overall Study|Lost to Follow-up|1|||
131419825|NCT03517566|473159401|FG004|Overall Study|Lost to Follow-up|0|||
131419826|NCT03517566|473159397|FG000|Overall Study|Physician Decision|1|||
131419827|NCT03517566|473159398|FG001|Overall Study|Physician Decision|1|||
131419828|NCT03517566|473159399|FG002|Overall Study|Physician Decision|0|||
131419829|NCT03517566|473159400|FG003|Overall Study|Physician Decision|1|||
131419830|NCT03517566|473159401|FG004|Overall Study|Physician Decision|0|||
131419831|NCT03517566|473159397|FG000|Overall Study|Pregnancy|0|||
131419832|NCT03517566|473159398|FG001|Overall Study|Pregnancy|1|||
131419833|NCT03517566|473159399|FG002|Overall Study|Pregnancy|0|||
131419834|NCT03517566|473159400|FG003|Overall Study|Pregnancy|0|||
131419835|NCT03517566|473159401|FG004|Overall Study|Pregnancy|0|||
131419836|NCT03517566|473159397|FG000|Overall Study|Protocol Deviation|0|||
131419837|NCT03517566|473159398|FG001|Overall Study|Protocol Deviation|1|||
131419838|NCT03517566|473159399|FG002|Overall Study|Protocol Deviation|0|||
131419839|NCT03517566|473159400|FG003|Overall Study|Protocol Deviation|1|||
131419840|NCT03517566|473159401|FG004|Overall Study|Protocol Deviation|1|||
131419841|NCT03517566|473159397|FG000|Overall Study|Study terminated by Sponsor|11|||
131419842|NCT03517566|473159398|FG001|Overall Study|Study terminated by Sponsor|5|||
131419843|NCT03517566|473159399|FG002|Overall Study|Study terminated by Sponsor|6|||
131419844|NCT03517566|473159400|FG003|Overall Study|Study terminated by Sponsor|14|||
131419845|NCT03517566|473159401|FG004|Overall Study|Study terminated by Sponsor|12|||
131419846|NCT03517566|473159397|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
131419847|NCT03517566|473159398|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
131419848|NCT03517566|473159399|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
131419849|NCT03517566|473159400|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
131419850|NCT03517566|473159401|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
131419851|NCT04311463|473159404|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
131419852|NCT04311463|473159405|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
131419853|NCT04311463|473159404|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
131419854|NCT04311463|473159405|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
131419855|NCT04311463|473159404|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
131419856|NCT04311463|473159405|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
131419857|NCT00737633|473159407|FG000|Overall Study|Study terminated by sponsor|44|||
131419858|NCT00737633|473159408|FG001|Overall Study|Study terminated by sponsor|55|||
131419859|NCT00737633|473159407|FG000|Overall Study|Lost to Follow-up|0|||
131419860|NCT00737633|473159408|FG001|Overall Study|Lost to Follow-up|1|||
131419861|NCT00737633|473159407|FG000|Overall Study|protocol non-compliance|0|||
131419862|NCT00737633|473159408|FG001|Overall Study|protocol non-compliance|1|||
131419863|NCT01704456|473159413|FG000|Overall Study|Lost to Follow-up|8|||
131419864|NCT01704456|473159414|FG001|Overall Study|Lost to Follow-up|14|||
131419865|NCT00695864|473159415|FG000|Placebo|Withdrawal by Subject|1|||
131419866|NCT00695864|473159415|FG000|Placebo|Physician Decision|4|||
131419867|NCT00718770|473159416|FG000|Overall Study|Adverse Event|1|||
131419868|NCT00718770|473159416|FG000|Overall Study|Lack of Efficacy|1|||
131419869|NCT00718770|473159416|FG000|Overall Study|Lack of Efficacy|1|||
131419870|NCT00718770|473159416|FG000|Overall Study|Adverse Event|1|||
131419871|NCT00718770|473159416|FG000|Overall Study|Lack of Efficacy|1|||
131419872|NCT00718770|473159416|FG000|Overall Study|Adverse Event|1|||
131419873|NCT00718770|473159416|FG000|Overall Study|Lack of Efficacy|1|||
131419874|NCT00718770|473159416|FG000|Overall Study|Adverse Event|1|||
131419875|NCT00498355|473159419|FG000|Overall Study|Lost to Follow-up|1|||
131419876|NCT04583956|473159420|FG000|Overall Study|Death|9|||
131419877|NCT04583956|473159421|FG001|Overall Study|Death|11|||
131419878|NCT04583956|473159420|FG000|Overall Study|Lost to Follow-up|7|||
131419879|NCT04583956|473159421|FG001|Overall Study|Lost to Follow-up|9|||
131419880|NCT04583956|473159420|FG000|Overall Study|Protocol Violation|2|||
131419881|NCT04583956|473159421|FG001|Overall Study|Protocol Violation|0|||
131419882|NCT04583956|473159420|FG000|Overall Study|Withdrawal by Subject|0|||
131419883|NCT04583956|473159421|FG001|Overall Study|Withdrawal by Subject|2|||
131419884|NCT04583956|473159420|FG000|Overall Study|Randomized but not dosed|2|||
131419885|NCT04583956|473159421|FG001|Overall Study|Randomized but not dosed|3|||
131419886|NCT04583956|473159420|FG000|Overall Study|Withdrawal of consent before product administration|1|||
131419887|NCT04583956|473159421|FG001|Overall Study|Withdrawal of consent before product administration|0|||
131419888|NCT00727558|473159424|FG000|Overall Study|Lens issue|0|||
131419889|NCT00727558|473159425|FG001|Overall Study|Lens issue|1|||
131419890|NCT00727558|473159424|FG000|Overall Study|Adverse Event|0|||
131419891|NCT00727558|473159425|FG001|Overall Study|Adverse Event|1|||
131419892|NCT00727558|473159424|FG000|Overall Study|Subject unable to return for follow-up|1|||
131419893|NCT00727558|473159425|FG001|Overall Study|Subject unable to return for follow-up|1|||
131419894|NCT00727558|473159424|FG000|Overall Study|Lost to Follow-up|1|||
131419895|NCT00727558|473159425|FG001|Overall Study|Lost to Follow-up|0|||
131419896|NCT01754493|473160860|FG000|Overall Study|Adverse Event|1|||
131419897|NCT01754493|473160860|FG000|Overall Study|Lost to Follow-up|3|||
131419898|NCT01754493|473160860|FG000|Overall Study|Withdrawal by Subject|1|||
131419899|NCT01754493|473160860|FG000|Overall Study|Moved out of town|1|||
131419900|NCT01754493|473160860|FG000|Overall Study|Scheduling conflict|1|||
131419901|NCT01543776|473160861|FG000|Overall Study|Withdrawal by Subject|2|||
131419902|NCT01543776|473160862|FG001|Overall Study|Withdrawal by Subject|2|||
131419903|NCT00372697|473160863|FG000|Overall Study|Protocol Violation|1|||
131419904|NCT00372697|473160864|FG001|Overall Study|Protocol Violation|1|||
131419905|NCT01815840|473160865|FG000|Overall Study|Missing|1|||
131419906|NCT01815840|473160866|FG001|Overall Study|Missing|0|||
131419907|NCT01815840|473160865|FG000|Overall Study|Withdrew Consent|31|||
131419908|NCT01815840|473160866|FG001|Overall Study|Withdrew Consent|30|||
131419909|NCT01815840|473160865|FG000|Overall Study|Administrative/Other|1|||
131419910|NCT01815840|473160866|FG001|Overall Study|Administrative/Other|3|||
131419911|NCT01815840|473160865|FG000|Overall Study|Adverse Event|10|||
131419912|NCT01815840|473160866|FG001|Overall Study|Adverse Event|16|||
131419913|NCT01815840|473160865|FG000|Overall Study|Death|2|||
131419914|NCT01815840|473160866|FG001|Overall Study|Death|2|||
131419915|NCT01815840|473160865|FG000|Overall Study|Disease progression|3|||
131419916|NCT01815840|473160866|FG001|Overall Study|Disease progression|2|||
131419917|NCT01815840|473160865|FG000|Overall Study|Investigators Decision|2|||
131419918|NCT01815840|473160866|FG001|Overall Study|Investigators Decision|3|||
131419919|NCT01815840|473160865|FG000|Overall Study|Lost to Follow-up|3|||
131419920|NCT01815840|473160866|FG001|Overall Study|Lost to Follow-up|6|||
131457655|NCT01945710|473307025|FG004|Overall Study|Other|1|||
131457656|NCT01945710|473307026|FG005|Overall Study|Other|0|||
131457657|NCT01945710|473307027|FG006|Overall Study|Other|4|||
131419921|NCT01815840|473160865|FG000|Overall Study|Refused Treatment|5|||
131419922|NCT01815840|473160866|FG001|Overall Study|Refused Treatment|1|||
131419923|NCT01815840|473160865|FG000|Overall Study|Sponsor Termination Treatment|1|||
131419924|NCT01815840|473160866|FG001|Overall Study|Sponsor Termination Treatment|0|||
131419925|NCT00527982|473160872|FG000|Overall Study|Physician Decision|1|||
131419926|NCT00527982|473160873|FG001|Overall Study|Physician Decision|0|||
131457658|NCT01945710|473307021|FG000|Overall Study|Withdrawal by Subject|0|||
131419927|NCT03927144|473160876|FG000|Core Phase|Adverse Event|9|||
131419928|NCT03927144|473160877|FG001|Core Phase|Adverse Event|5|||
131419929|NCT03927144|473160876|FG000|Core Phase|Lost to Follow-up|3|||
131419930|NCT03927144|473160877|FG001|Core Phase|Lost to Follow-up|2|||
131419931|NCT03927144|473160876|FG000|Core Phase|New Therapy for Study Indication|0|||
131419932|NCT03927144|473160877|FG001|Core Phase|New Therapy for Study Indication|1|||
131419933|NCT03927144|473160876|FG000|Core Phase|No Longer Clinically Benefiting|4|||
131419934|NCT03927144|473160877|FG001|Core Phase|No Longer Clinically Benefiting|4|||
131419935|NCT03927144|473160876|FG000|Core Phase|Physician Decision|2|||
131419936|NCT03927144|473160877|FG001|Core Phase|Physician Decision|8|||
131419937|NCT03927144|473160876|FG000|Core Phase|Protocol Violation|2|||
131419938|NCT03927144|473160877|FG001|Core Phase|Protocol Violation|2|||
131419939|NCT03927144|473160876|FG000|Core Phase|Withdrawal by Subject|16|||
131419940|NCT03927144|473160877|FG001|Core Phase|Withdrawal by Subject|40|||
131419941|NCT03927144|473160876|FG000|Extension Phase|Adverse Event|2|||
131419942|NCT03927144|473160877|FG001|Extension Phase|Adverse Event|1|||
131419943|NCT03927144|473160876|FG000|Extension Phase|No longer clinically benefiting|4|||
131419944|NCT03927144|473160877|FG001|Extension Phase|No longer clinically benefiting|5|||
131419945|NCT03927144|473160876|FG000|Extension Phase|Pregnancy|1|||
131419946|NCT03927144|473160877|FG001|Extension Phase|Pregnancy|0|||
131419947|NCT03927144|473160876|FG000|Extension Phase|Protocol Violation|0|||
131419948|NCT03927144|473160877|FG001|Extension Phase|Protocol Violation|1|||
131419949|NCT03927144|473160876|FG000|Extension Phase|Withdrawal by Subject|8|||
131419950|NCT03927144|473160877|FG001|Extension Phase|Withdrawal by Subject|3|||
131419951|NCT05011058|473160880|FG000|Overall Study|Sponsor Decision|2|||
131419952|NCT05011058|473160881|FG001|Overall Study|Sponsor Decision|0|||
131419953|NCT05011058|473160882|FG002|Overall Study|Sponsor Decision|14|||
131419954|NCT05011058|473160883|FG003|Overall Study|Sponsor Decision|0|||
131419955|NCT05011058|473160884|FG004|Overall Study|Sponsor Decision|0|||
131419956|NCT05011058|473160885|FG005|Overall Study|Sponsor Decision|1|||
131419957|NCT05011058|473160886|FG006|Overall Study|Sponsor Decision|0|||
131419958|NCT05011058|473160887|FG007|Overall Study|Sponsor Decision|5|||
131419959|NCT01452919|473160888|FG000|Open-Label Treatment|Adverse Event|5|||
131419960|NCT01452919|473160889|FG001|Open-Label Treatment|Adverse Event|0|||
131419961|NCT01452919|473160890|FG002|Open-Label Treatment|Adverse Event|0|||
131419962|NCT01452919|473160888|FG000|Open-Label Treatment|Lost to Follow-up|4|||
131419963|NCT01452919|473160889|FG001|Open-Label Treatment|Lost to Follow-up|0|||
131419964|NCT01452919|473160890|FG002|Open-Label Treatment|Lost to Follow-up|0|||
131419965|NCT01452919|473160888|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
131419966|NCT01452919|473160889|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
131419967|NCT01452919|473160890|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
131419968|NCT01452919|473160888|FG000|Open-Label Treatment|Protocol Violation|4|||
131419969|NCT01452919|473160889|FG001|Open-Label Treatment|Protocol Violation|0|||
131419970|NCT01452919|473160890|FG002|Open-Label Treatment|Protocol Violation|0|||
131419971|NCT01452919|473160888|FG000|Open-Label Treatment|Sponsor Decision|1|||
131419972|NCT01452919|473160889|FG001|Open-Label Treatment|Sponsor Decision|0|||
131419973|NCT01452919|473160890|FG002|Open-Label Treatment|Sponsor Decision|0|||
131419974|NCT01452919|473160888|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
131419975|NCT01452919|473160889|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
131419976|NCT01452919|473160890|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
131419977|NCT01452919|473160888|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
131419978|NCT01452919|473160889|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
131419979|NCT01452919|473160890|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
131419980|NCT01452919|473160888|FG000|Randomization Treatment|Adverse Event|0|||
131419981|NCT01452919|473160889|FG001|Randomization Treatment|Adverse Event|0|||
131419982|NCT01452919|473160890|FG002|Randomization Treatment|Adverse Event|2|||
131419983|NCT01452919|473160888|FG000|Randomization Treatment|Sponsor Decision|0|||
131419984|NCT01452919|473160889|FG001|Randomization Treatment|Sponsor Decision|1|||
131419985|NCT01452919|473160890|FG002|Randomization Treatment|Sponsor Decision|0|||
131419986|NCT01452919|473160888|FG000|Randomization Treatment|Withdrawal by Subject|0|||
131419987|NCT01452919|473160889|FG001|Randomization Treatment|Withdrawal by Subject|1|||
131419988|NCT01452919|473160890|FG002|Randomization Treatment|Withdrawal by Subject|0|||
131419989|NCT01452919|473160888|FG000|Randomization Treatment|Subject is moving or has moved|0|||
131419990|NCT01452919|473160889|FG001|Randomization Treatment|Subject is moving or has moved|1|||
131419991|NCT01452919|473160890|FG002|Randomization Treatment|Subject is moving or has moved|0|||
131419992|NCT02421588|473160891|FG000|Overall Study|Non-treatment-related AE|8|||
131419993|NCT02421588|473160892|FG001|Overall Study|Non-treatment-related AE|8|||
131419994|NCT02421588|473160891|FG000|Overall Study|Progressive disease|152|||
131419995|NCT02421588|473160892|FG001|Overall Study|Progressive disease|135|||
131419996|NCT02421588|473160891|FG000|Overall Study|Death|11|||
131419997|NCT02421588|473160892|FG001|Overall Study|Death|3|||
131419998|NCT02421588|473160891|FG000|Overall Study|Physician Decision|8|||
131419999|NCT02421588|473160892|FG001|Overall Study|Physician Decision|17|||
131420000|NCT02421588|473160891|FG000|Overall Study|Other reason not specified|3|||
131420001|NCT02421588|473160892|FG001|Overall Study|Other reason not specified|1|||
131420002|NCT02421588|473160891|FG000|Overall Study|Symptomatic deterioration|13|||
131420003|NCT02421588|473160892|FG001|Overall Study|Symptomatic deterioration|19|||
131420004|NCT02421588|473160891|FG000|Overall Study|Treatment-related AE|10|||
131420005|NCT02421588|473160892|FG001|Overall Study|Treatment-related AE|14|||
131420006|NCT02421588|473160891|FG000|Overall Study|Withdrawal by Subject|14|||
131420007|NCT02421588|473160892|FG001|Overall Study|Withdrawal by Subject|16|||
131420008|NCT02421588|473160891|FG000|Overall Study|Not treated|2|||
131420009|NCT02421588|473160892|FG001|Overall Study|Not treated|8|||
131420010|NCT01359943|473160895|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
131420011|NCT01359943|473160896|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
131420012|NCT01359943|473160897|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
131420013|NCT01359943|473160895|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
131420014|NCT01359943|473160896|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
131420015|NCT01359943|473160897|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
131420016|NCT01359943|473160895|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
131420017|NCT01359943|473160896|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
131420018|NCT01359943|473160897|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
131420019|NCT01359943|473160895|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
131420020|NCT01359943|473160896|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
131420021|NCT01359943|473160897|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
131420022|NCT01359943|473160895|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
131420023|NCT01359943|473160896|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
131420024|NCT01359943|473160897|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
131420025|NCT01359943|473160895|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
131420026|NCT01359943|473160896|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
131420027|NCT01359943|473160897|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
131420028|NCT01359943|473160895|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
131420029|NCT01359943|473160896|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
131420030|NCT01359943|473160897|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
131420031|NCT01359943|473160895|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
131420032|NCT01359943|473160896|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
131420033|NCT01359943|473160897|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
131420034|NCT01359943|473160895|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
131420035|NCT01359943|473160896|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
131420036|NCT01359943|473160897|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
131420037|NCT01359943|473160895|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
131420038|NCT01359943|473160896|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
131420039|NCT01359943|473160897|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
131420040|NCT01359943|473160895|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
131420041|NCT01359943|473160896|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
131420042|NCT01359943|473160897|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
131420043|NCT01359943|473160895|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
131420044|NCT01359943|473160896|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
131420045|NCT01359943|473160897|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
131420046|NCT01359943|473160895|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
131420047|NCT01359943|473160896|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
131420048|NCT01359943|473160897|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
131420049|NCT01359943|473160895|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
131420050|NCT01359943|473160896|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
131420051|NCT01359943|473160897|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
131420052|NCT01359943|473160895|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
131420053|NCT01359943|473160896|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
131420054|NCT01359943|473160897|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
131420055|NCT00308074|473160901|FG000|Overall Study|Withdrawal by Subject|1|||
131457659|NCT01945710|473307022|FG001|Overall Study|Withdrawal by Subject|1|||
131457660|NCT01945710|473307023|FG002|Overall Study|Withdrawal by Subject|1|||
131457661|NCT01945710|473307024|FG003|Overall Study|Withdrawal by Subject|0|||
131457662|NCT01945710|473307025|FG004|Overall Study|Withdrawal by Subject|1|||
131420056|NCT01329939|473160905|FG000|Overall Study|Lost to Follow-up|3|||
131420057|NCT01329939|473160906|FG001|Overall Study|Lost to Follow-up|0|||
131420058|NCT01329939|473160907|FG002|Overall Study|Lost to Follow-up|1|||
131420059|NCT01329939|473160908|FG003|Overall Study|Lost to Follow-up|2|||
131420060|NCT01329939|473160905|FG000|Overall Study|Withdrawal by Subject|0|||
131420061|NCT01329939|473160906|FG001|Overall Study|Withdrawal by Subject|1|||
131420062|NCT01329939|473160907|FG002|Overall Study|Withdrawal by Subject|0|||
131420063|NCT01329939|473160908|FG003|Overall Study|Withdrawal by Subject|0|||
131420064|NCT01329939|473160905|FG000|Overall Study|Adverse Event|0|||
131420065|NCT01329939|473160906|FG001|Overall Study|Adverse Event|0|||
131420066|NCT01329939|473160907|FG002|Overall Study|Adverse Event|0|||
131420067|NCT01329939|473160908|FG003|Overall Study|Adverse Event|3|||
131420068|NCT02942485|473160909|FG000|Overall Study|Lost to Follow-up|1|||
131420069|NCT02942485|473160910|FG001|Overall Study|Lost to Follow-up|0|||
131420070|NCT04369950|473160912|FG000|Overall Study|Protocol Violation|2|||
131420071|NCT04369950|473160913|FG001|Overall Study|Protocol Violation|2|||
131420072|NCT00989963|473160914|FG000|Overall Study|Adverse Event|1|||
131420073|NCT00989963|473160915|FG001|Overall Study|Adverse Event|1|||
131420074|NCT00989963|473160916|FG002|Overall Study|Adverse Event|1|||
131420075|NCT01240200|473160920|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
131420076|NCT01240200|473160921|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
131420077|NCT01529034|473160924|FG000|Overall Study|Discontinued prior to study treatment|14|||
131420078|NCT01529034|473160924|FG000|Overall Study|Site closure|62|||
131420079|NCT01529034|473160924|FG000|Overall Study|Study termination|29|||
131420080|NCT01529034|473160924|FG000|Overall Study|Withdrawal by Subject|25|||
131420081|NCT01529034|473160924|FG000|Overall Study|No treated SCs within protocol window|13|||
131420082|NCT01529034|473160924|FG000|Overall Study|Noncompliance|8|||
131420083|NCT01529034|473160924|FG000|Overall Study|Caregiver no longer available|7|||
131420084|NCT01529034|473160924|FG000|Overall Study|Adverse Event|4|||
131420085|NCT01529034|473160924|FG000|Overall Study|Protocol Violation|4|||
131420086|NCT01529034|473160924|FG000|Overall Study|Lack of Efficacy|4|||
131420087|NCT01529034|473160924|FG000|Overall Study|Investigator no longer available|2|||
131420088|NCT01529034|473160924|FG000|Overall Study|Study drug not available|2|||
131420089|NCT03194646|473160927|FG000|Overall Study|Adverse Event|24|||
131420090|NCT03194646|473160928|FG001|Overall Study|Adverse Event|25|||
131420091|NCT03194646|473160929|FG002|Overall Study|Adverse Event|14|||
131420092|NCT03194646|473160930|FG003|Overall Study|Adverse Event|17|||
131420093|NCT03194646|473160927|FG000|Overall Study|Lack of Efficacy|4|||
131420094|NCT03194646|473160928|FG001|Overall Study|Lack of Efficacy|2|||
131420095|NCT03194646|473160929|FG002|Overall Study|Lack of Efficacy|2|||
131420096|NCT03194646|473160930|FG003|Overall Study|Lack of Efficacy|12|||
131420097|NCT03194646|473160927|FG000|Overall Study|Lost to Follow-up|30|||
131420098|NCT03194646|473160928|FG001|Overall Study|Lost to Follow-up|22|||
131420099|NCT03194646|473160929|FG002|Overall Study|Lost to Follow-up|12|||
131420100|NCT03194646|473160930|FG003|Overall Study|Lost to Follow-up|35|||
131420101|NCT03194646|473160927|FG000|Overall Study|Non-compliance with study drug|4|||
131420102|NCT03194646|473160928|FG001|Overall Study|Non-compliance with study drug|0|||
131420103|NCT03194646|473160929|FG002|Overall Study|Non-compliance with study drug|1|||
131420104|NCT03194646|473160930|FG003|Overall Study|Non-compliance with study drug|1|||
131420105|NCT03194646|473160927|FG000|Overall Study|Other|89|||
131420106|NCT03194646|473160928|FG001|Overall Study|Other|68|||
131420107|NCT03194646|473160929|FG002|Overall Study|Other|34|||
131420108|NCT03194646|473160930|FG003|Overall Study|Other|31|||
131420109|NCT03194646|473160927|FG000|Overall Study|Physician Decision|7|||
131420110|NCT03194646|473160928|FG001|Overall Study|Physician Decision|9|||
131420111|NCT03194646|473160929|FG002|Overall Study|Physician Decision|5|||
131420112|NCT03194646|473160930|FG003|Overall Study|Physician Decision|4|||
131420113|NCT03194646|473160927|FG000|Overall Study|Pregnancy|4|||
131420114|NCT03194646|473160928|FG001|Overall Study|Pregnancy|5|||
131420115|NCT03194646|473160929|FG002|Overall Study|Pregnancy|1|||
131420116|NCT03194646|473160930|FG003|Overall Study|Pregnancy|2|||
131420117|NCT03194646|473160927|FG000|Overall Study|Protocol Violation|4|||
131420118|NCT03194646|473160928|FG001|Overall Study|Protocol Violation|2|||
131420119|NCT03194646|473160929|FG002|Overall Study|Protocol Violation|1|||
131420120|NCT03194646|473160930|FG003|Overall Study|Protocol Violation|1|||
131420121|NCT03194646|473160927|FG000|Overall Study|Site terminated by sponsor|0|||
131420122|NCT03194646|473160928|FG001|Overall Study|Site terminated by sponsor|0|||
131420123|NCT03194646|473160929|FG002|Overall Study|Site terminated by sponsor|2|||
131420124|NCT03194646|473160930|FG003|Overall Study|Site terminated by sponsor|0|||
131420125|NCT03194646|473160927|FG000|Overall Study|Study terminated by sponsor|62|||
131420126|NCT03194646|473160928|FG001|Overall Study|Study terminated by sponsor|61|||
131420127|NCT03194646|473160929|FG002|Overall Study|Study terminated by sponsor|30|||
131420128|NCT03194646|473160930|FG003|Overall Study|Study terminated by sponsor|34|||
131420129|NCT03194646|473160927|FG000|Overall Study|Withdrawal by Subject|75|||
131420130|NCT03194646|473160928|FG001|Overall Study|Withdrawal by Subject|74|||
131420131|NCT03194646|473160929|FG002|Overall Study|Withdrawal by Subject|36|||
131420132|NCT03194646|473160930|FG003|Overall Study|Withdrawal by Subject|131|||
131420133|NCT03194646|473160927|FG000|Overall Study|Missing|1|||
131420134|NCT03194646|473160928|FG001|Overall Study|Missing|0|||
131420135|NCT03194646|473160929|FG002|Overall Study|Missing|1|||
131420136|NCT03194646|473160930|FG003|Overall Study|Missing|12|||
131420137|NCT02141360|473160932|FG000|Overall Study|Withdrawal by Subject|6|||
131420138|NCT02141360|473160933|FG001|Overall Study|Withdrawal by Subject|0|||
131420139|NCT02141360|473160934|FG002|Overall Study|Withdrawal by Subject|0|||
131420140|NCT02141360|473160932|FG000|Overall Study|Study Terminated before Visit|1|||
131420141|NCT02141360|473160933|FG001|Overall Study|Study Terminated before Visit|0|||
131420142|NCT02141360|473160934|FG002|Overall Study|Study Terminated before Visit|0|||
131420143|NCT00646399|473160935|FG000|Overall Study|Death|63|||
131420144|NCT00646399|473160936|FG001|Overall Study|Death|53|||
131420145|NCT00646399|473160935|FG000|Overall Study|Withdrawal by Subject|9|||
131420146|NCT00646399|473160936|FG001|Overall Study|Withdrawal by Subject|10|||
131420147|NCT00646399|473160935|FG000|Overall Study|Other Reason|11|||
131420148|NCT00646399|473160936|FG001|Overall Study|Other Reason|11|||
131420149|NCT01178099|473160937|FG000|Overall Study|Physician Decision|0|||
131420150|NCT01178099|473160938|FG001|Overall Study|Physician Decision|1|||
131420151|NCT02516592|473160941|FG000|Overall Study|Patient withdrew consent|5|||
131420152|NCT02516592|473160942|FG001|Overall Study|Patient withdrew consent|2|||
131420153|NCT02516592|473160941|FG000|Overall Study|Protocol deviation|4|||
131420154|NCT02516592|473160942|FG001|Overall Study|Protocol deviation|4|||
131420155|NCT02516592|473160941|FG000|Overall Study|Lost to Follow-up|2|||
131420156|NCT02516592|473160942|FG001|Overall Study|Lost to Follow-up|3|||
131420157|NCT02516592|473160941|FG000|Overall Study|Patient/guardian decision|2|||
131420158|NCT02516592|473160942|FG001|Overall Study|Patient/guardian decision|1|||
131420159|NCT02516592|473160941|FG000|Overall Study|Adverse Event|1|||
131420160|NCT02516592|473160942|FG001|Overall Study|Adverse Event|2|||
131420161|NCT02516592|473160941|FG000|Overall Study|Abnormal test procedure result|1|||
131420162|NCT02516592|473160942|FG001|Overall Study|Abnormal test procedure result|0|||
131420163|NCT02516592|473160941|FG000|Overall Study|Death|1|||
131420164|NCT02516592|473160942|FG001|Overall Study|Death|1|||
131420165|NCT02473367|473160943|FG000|Wait 1|Withdrawal by Subject|1|||
131420166|NCT02473367|473160943|FG000|Period 4|Lost to Follow-up|1|||
131420167|NCT00455143|473160947|FG000|Overall Study|Physician Decision|1|||
131420168|NCT00455143|473160947|FG000|Overall Study|Withdrawal by Subject|1|||
131420169|NCT00455143|473160947|FG000|Overall Study|Staff was not avail to follow patient|2|||
131420170|NCT00455143|473160947|FG000|Overall Study|No longer met Inclusion Criteria|1|||
131420171|NCT00455143|473160947|FG000|Overall Study|Surgical time, staff not available|1|||
131420172|NCT01110382|473160948|FG000|Overall Study|Withdrawal by Subject|0|||
131420173|NCT01110382|473160949|FG001|Overall Study|Withdrawal by Subject|1|||
131420174|NCT01110382|473160948|FG000|Overall Study|Protocol Violation|0|||
131420175|NCT01110382|473160949|FG001|Overall Study|Protocol Violation|1|||
131420176|NCT05222555|473160950|FG000|Overall Study|Ongoing|2|||
131420177|NCT05222555|473160951|FG001|Overall Study|Ongoing|18|||
131420178|NCT05222555|473160950|FG000|Overall Study|Adverse Event|1|||
131420179|NCT05222555|473160951|FG001|Overall Study|Adverse Event|1|||
131420180|NCT05222555|473160950|FG000|Overall Study|Death|0|||
131420181|NCT05222555|473160951|FG001|Overall Study|Death|6|||
131420182|NCT05222555|473160950|FG000|Overall Study|Withdrawal by Subject|0|||
131420183|NCT05222555|473160951|FG001|Overall Study|Withdrawal by Subject|11|||
131420184|NCT01422824|473160952|FG000|Overall Study|Case record form not evaluated|1|||
131420185|NCT01422824|473160952|FG000|Overall Study|Lost to Follow-up|37|||
131420186|NCT01581619|473160953|FG000|Overall Study|Withdrawal by Subject|1|||
131420187|NCT01581619|473160953|FG000|Overall Study|Lost to Follow-up|1|||
131420188|NCT03129360|473160956|FG000|Overall Study|Did not meet entry criteria|0|||
131420189|NCT03129360|473160957|FG001|Overall Study|Did not meet entry criteria|2|||
131420190|NCT03129360|473160958|FG002|Overall Study|Did not meet entry criteria|1|||
131420191|NCT03129360|473160956|FG000|Overall Study|Excluded due to motion in scanner|1|||
131420192|NCT03129360|473160957|FG001|Overall Study|Excluded due to motion in scanner|0|||
131420193|NCT03129360|473160958|FG002|Overall Study|Excluded due to motion in scanner|0|||
131420194|NCT03006887|473160959|FG000|Overall Study|Adverse Event|1|||
131420195|NCT03836677|473160960|FG000|Period 1|Adverse Event|0|||
131420196|NCT03836677|473160961|FG001|Period 1|Adverse Event|1|||
131420197|NCT03836677|473160960|FG000|Period 2|Severe non-compliance to protocol|1|||
131420198|NCT03836677|473160961|FG001|Period 2|Severe non-compliance to protocol|0|||
131420199|NCT01818492|473160962|FG000|Overall Study|Adverse Event|2|||
131420200|NCT01818492|473160962|FG000|Overall Study|Death|3|||
131420201|NCT01818492|473160962|FG000|Overall Study|Withdrawal by Subject|1|||
131420202|NCT01818492|473160962|FG000|Overall Study|Additional therapy when not allowed PP|4|||
131420203|NCT02345330|473160964|FG000|Overall Study|Death|1|||
131420204|NCT02345330|473160964|FG000|Overall Study|Progressive Disease|2|||
131420205|NCT04566692|473160967|FG000|Overall Study|Adverse Event|2|||
131420206|NCT04566692|473160968|FG001|Overall Study|Adverse Event|0|||
131420207|NCT04566692|473160967|FG000|Overall Study|Withdrawal by Subject|1|||
131420208|NCT04566692|473160968|FG001|Overall Study|Withdrawal by Subject|1|||
131420209|NCT01300260|473160969|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
131420210|NCT01300260|473160970|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
131420211|NCT01300260|473160969|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
131420212|NCT01300260|473160970|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
131420213|NCT01300260|473160969|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
131420214|NCT01300260|473160970|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
131420215|NCT00377364|473160971|FG000|Overall Study|Lost to Follow-up|1|||
131420216|NCT00377364|473160972|FG001|Overall Study|Lost to Follow-up|0|||
131420217|NCT00377364|473160971|FG000|Overall Study|Withdrawal by Subject|1|||
131420218|NCT00377364|473160972|FG001|Overall Study|Withdrawal by Subject|0|||
131420219|NCT00293020|473160981|FG000|Overall Study|Withdrawal by Subject|34|||
131420220|NCT00293020|473160981|FG000|Overall Study|Adverse Event|30|||
131420221|NCT00293020|473160981|FG000|Overall Study|Death|32|||
131420222|NCT00293020|473160981|FG000|Overall Study|Lack of Efficacy|12|||
131420223|NCT00293020|473160981|FG000|Overall Study|Lost to Follow-up|4|||
131420224|NCT00293020|473160981|FG000|Overall Study|Protocol Violation|6|||
131420225|NCT00293020|473160981|FG000|Overall Study|Physician Decision|21|||
131420226|NCT00293020|473160981|FG000|Overall Study|Other Reason|22|||
131420227|NCT00293020|473160981|FG000|Overall Study|No dose taken|1|||
131420228|NCT01147848|473160982|FG000|Run-in Period|Screen Failure|623|||
131420229|NCT01147848|473160983|FG001|Run-in Period|Screen Failure|0|||
131420230|NCT01147848|473160984|FG002|Run-in Period|Screen Failure|0|||
131420231|NCT01147848|473160982|FG000|Run-in Period|Run-in Failure|135|||
131420232|NCT01147848|473160983|FG001|Run-in Period|Run-in Failure|0|||
131420233|NCT01147848|473160984|FG002|Run-in Period|Run-in Failure|0|||
131420234|NCT01147848|473160982|FG000|Randomized Phase|Adverse Event|0|||
131420235|NCT01147848|473160983|FG001|Randomized Phase|Adverse Event|6|||
131420236|NCT01147848|473160984|FG002|Randomized Phase|Adverse Event|8|||
131420237|NCT01147848|473160982|FG000|Randomized Phase|Lack of Efficacy|0|||
131420238|NCT01147848|473160983|FG001|Randomized Phase|Lack of Efficacy|20|||
131420239|NCT01147848|473160984|FG002|Randomized Phase|Lack of Efficacy|11|||
131420240|NCT01147848|473160982|FG000|Randomized Phase|Protocol Violation|0|||
131420241|NCT01147848|473160983|FG001|Randomized Phase|Protocol Violation|7|||
131420242|NCT01147848|473160984|FG002|Randomized Phase|Protocol Violation|10|||
131420243|NCT01147848|473160982|FG000|Randomized Phase|Lost to Follow-up|0|||
131420244|NCT01147848|473160983|FG001|Randomized Phase|Lost to Follow-up|5|||
131420245|NCT01147848|473160984|FG002|Randomized Phase|Lost to Follow-up|7|||
131420246|NCT01147848|473160982|FG000|Randomized Phase|Physician Decision|0|||
131420247|NCT01147848|473160983|FG001|Randomized Phase|Physician Decision|0|||
131420248|NCT01147848|473160984|FG002|Randomized Phase|Physician Decision|1|||
131420249|NCT01147848|473160982|FG000|Randomized Phase|Withdrawal by Subject|0|||
131420250|NCT01147848|473160983|FG001|Randomized Phase|Withdrawal by Subject|7|||
131420251|NCT01147848|473160984|FG002|Randomized Phase|Withdrawal by Subject|9|||
131420252|NCT03180307|473160985|FG000|Overall Study|Lost to Follow-up|2|||
131420253|NCT03180307|473160986|FG001|Overall Study|Lost to Follow-up|0|||
131420254|NCT03180307|473160985|FG000|Overall Study|Death|1|||
131420255|NCT03180307|473160986|FG001|Overall Study|Death|0|||
131420256|NCT03180307|473160985|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
131420257|NCT03180307|473160986|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
131420258|NCT03157037|473160988|FG000|Overall Study|Death|1|||
131420259|NCT03596450|473160989|FG000|Overall Study|Death|9|||
131420260|NCT03596450|473160990|FG001|Overall Study|Death|9|||
131420261|NCT03596450|473160989|FG000|Overall Study|Protocol Violation|18|||
131420262|NCT03596450|473160990|FG001|Overall Study|Protocol Violation|26|||
131420263|NCT03596450|473160989|FG000|Overall Study|Lost to Follow-up|50|||
131420264|NCT03596450|473160990|FG001|Overall Study|Lost to Follow-up|56|||
131420265|NCT03596450|473160989|FG000|Overall Study|Adverse Event|14|||
131420266|NCT03596450|473160990|FG001|Overall Study|Adverse Event|7|||
131420267|NCT03596450|473160989|FG000|Overall Study|Withdrawal by Subject|38|||
131420268|NCT03596450|473160990|FG001|Overall Study|Withdrawal by Subject|36|||
131420269|NCT03596450|473160989|FG000|Overall Study|Accidentally Randomized|2|||
131420270|NCT03596450|473160990|FG001|Overall Study|Accidentally Randomized|0|||
131420271|NCT03596450|473160989|FG000|Overall Study|Other reasons|48|||
131420272|NCT03596450|473160990|FG001|Overall Study|Other reasons|53|||
131420273|NCT03596450|473160989|FG000|Overall Study|Pregnancy|2|||
131420274|NCT03596450|473160990|FG001|Overall Study|Pregnancy|0|||
131420275|NCT00410605|473160994|FG000|Overall Study|Adverse Event|12|||
131420276|NCT00410605|473160994|FG000|Overall Study|Physician Decision|3|||
131420277|NCT00410605|473160994|FG000|Overall Study|Withdrawal by Subject|5|||
131420278|NCT00410605|473160994|FG000|Overall Study|Started Non-Protocol Therapy|3|||
131420279|NCT00410605|473160994|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
131420280|NCT00410605|473160994|FG000|Overall Study|Transferred to another Institution|1|||
131420281|NCT02100475|473162938|FG000|Overall Study|Unclassified|1|||
131420282|NCT02100475|473162939|FG001|Overall Study|Unclassified|2|||
131420283|NCT02100475|473162938|FG000|Overall Study|Withdrawal criteria|1|||
131420284|NCT02100475|473162939|FG001|Overall Study|Withdrawal criteria|0|||
131420285|NCT00649428|473162940|FG000|Overall Study|Adverse Event|2|||
131420286|NCT00649428|473162941|FG001|Overall Study|Adverse Event|2|||
131420287|NCT00649428|473162940|FG000|Overall Study|Withdrawal by Subject|6|||
131420288|NCT00649428|473162941|FG001|Overall Study|Withdrawal by Subject|6|||
131420289|NCT00649428|473162940|FG000|Overall Study|Lost to Follow-up|1|||
131420290|NCT00649428|473162941|FG001|Overall Study|Lost to Follow-up|3|||
131420291|NCT00649428|473162940|FG000|Overall Study|Insufficient manufacturing yield|5|||
131420292|NCT00649428|473162941|FG001|Overall Study|Insufficient manufacturing yield|1|||
131420293|NCT00649428|473162940|FG000|Overall Study|Protocol Violation|6|||
131420294|NCT00649428|473162941|FG001|Overall Study|Protocol Violation|2|||
131420295|NCT00649428|473162940|FG000|Overall Study|Physician Decision|0|||
131420296|NCT00649428|473162941|FG001|Overall Study|Physician Decision|1|||
131420297|NCT04599465|473162944|FG000|Overall Study|Physician Decision|1|||
131420298|NCT04599465|473162944|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
131420299|NCT00742417|473162945|FG000|Randomized|Withdrawal by legal representative|0|||
131420300|NCT00742417|473162946|FG001|Randomized|Withdrawal by legal representative|1|||
131420301|NCT00742417|473162945|FG000|Randomized|Withdrawal by Subject|1|||
131420302|NCT00742417|473162946|FG001|Randomized|Withdrawal by Subject|0|||
131420303|NCT00742417|473162945|FG000|Randomized|Physician Decision|1|||
131420304|NCT00742417|473162946|FG001|Randomized|Physician Decision|0|||
131420305|NCT00742417|473162945|FG000|Intensive Period|Withdrawal by Subject|1|||
131420306|NCT00742417|473162946|FG001|Intensive Period|Withdrawal by Subject|1|||
131420307|NCT00742417|473162945|FG000|Intensive Period|Adverse Event|2|||
131420308|NCT00742417|473162946|FG001|Intensive Period|Adverse Event|0|||
131420309|NCT04566601|473162947|FG000|Overall Study|Other than listed|13|||
131420310|NCT04566601|473162948|FG001|Overall Study|Other than listed|4|||
131420311|NCT04566601|473162949|FG002|Overall Study|Other than listed|2|||
131420312|NCT04566601|473162950|FG003|Overall Study|Other than listed|1|||
131420313|NCT04566601|473162951|FG004|Overall Study|Other than listed|4|||
131420314|NCT04566601|473162947|FG000|Overall Study|Protocol deviation|3|||
131420315|NCT04566601|473162948|FG001|Overall Study|Protocol deviation|0|||
131420316|NCT04566601|473162949|FG002|Overall Study|Protocol deviation|1|||
131420317|NCT04566601|473162950|FG003|Overall Study|Protocol deviation|1|||
131420318|NCT04566601|473162951|FG004|Overall Study|Protocol deviation|1|||
131420319|NCT04566601|473162947|FG000|Overall Study|Technical problems|0|||
131420320|NCT04566601|473162948|FG001|Overall Study|Technical problems|0|||
131420321|NCT04566601|473162949|FG002|Overall Study|Technical problems|1|||
131420322|NCT04566601|473162950|FG003|Overall Study|Technical problems|0|||
131420323|NCT04566601|473162951|FG004|Overall Study|Technical problems|0|||
131420324|NCT04566601|473162947|FG000|Overall Study|No reason available|3|||
131420325|NCT04566601|473162948|FG001|Overall Study|No reason available|2|||
131420326|NCT04566601|473162949|FG002|Overall Study|No reason available|7|||
131420327|NCT04566601|473162950|FG003|Overall Study|No reason available|1|||
131420328|NCT04566601|473162951|FG004|Overall Study|No reason available|5|||
131420329|NCT04566601|473162947|FG000|Overall Study|Burden of study procedures|3|||
131420330|NCT04566601|473162948|FG001|Overall Study|Burden of study procedures|0|||
131420331|NCT04566601|473162949|FG002|Overall Study|Burden of study procedures|0|||
131420332|NCT04566601|473162950|FG003|Overall Study|Burden of study procedures|3|||
131420333|NCT04566601|473162951|FG004|Overall Study|Burden of study procedures|1|||
131420334|NCT04566601|473162947|FG000|Overall Study|Change of residence|2|||
131420335|NCT04566601|473162948|FG001|Overall Study|Change of residence|2|||
131420336|NCT04566601|473162949|FG002|Overall Study|Change of residence|0|||
131420337|NCT04566601|473162950|FG003|Overall Study|Change of residence|1|||
131420338|NCT04566601|473162951|FG004|Overall Study|Change of residence|2|||
131420339|NCT04566601|473162947|FG000|Overall Study|Perceived lack of efficacy|2|||
131420340|NCT04566601|473162948|FG001|Overall Study|Perceived lack of efficacy|0|||
131420341|NCT04566601|473162949|FG002|Overall Study|Perceived lack of efficacy|1|||
131420342|NCT04566601|473162950|FG003|Overall Study|Perceived lack of efficacy|1|||
131420343|NCT04566601|473162951|FG004|Overall Study|Perceived lack of efficacy|2|||
131420344|NCT04566601|473162947|FG000|Overall Study|Adverse Event|7|||
131420345|NCT04566601|473162948|FG001|Overall Study|Adverse Event|4|||
131420346|NCT04566601|473162949|FG002|Overall Study|Adverse Event|6|||
131420347|NCT04566601|473162950|FG003|Overall Study|Adverse Event|5|||
131420348|NCT04566601|473162951|FG004|Overall Study|Adverse Event|12|||
131420349|NCT01363661|473162953|FG000|Overall Study|Adverse Event|9|||
131420350|NCT01363661|473162954|FG001|Overall Study|Adverse Event|2|||
131420351|NCT01363661|473162953|FG000|Overall Study|Withdrawal by Subject|1|||
131420352|NCT01363661|473162954|FG001|Overall Study|Withdrawal by Subject|1|||
131420353|NCT01363661|473162953|FG000|Overall Study|Protocol Violation|1|||
131420354|NCT01363661|473162954|FG001|Overall Study|Protocol Violation|0|||
131420355|NCT01363661|473162953|FG000|Overall Study|Lost to Follow-up|3|||
131420356|NCT01363661|473162954|FG001|Overall Study|Lost to Follow-up|1|||
131420357|NCT03416127|473162955|FG000|Overall Study|Withdrawal by Subject|0|||
131420358|NCT03416127|473162956|FG001|Overall Study|Withdrawal by Subject|1|||
131420359|NCT03416127|473162957|FG002|Overall Study|Withdrawal by Subject|1|||
131420360|NCT01971008|473162958|FG000|Overall Study|Protocol Violation|2|||
131420361|NCT01971008|473162959|FG001|Overall Study|Protocol Violation|1|||
131420362|NCT03775512|473162960|FG000|Overall Study|Death|1|||
131420363|NCT03775512|473162961|FG001|Overall Study|Death|1|||
131420364|NCT03775512|473162960|FG000|Overall Study|Withdrawal by Subject|7|||
131420365|NCT03775512|473162961|FG001|Overall Study|Withdrawal by Subject|4|||
131420366|NCT03775512|473162960|FG000|Overall Study|Lost to Follow-up|5|||
131420367|NCT03775512|473162961|FG001|Overall Study|Lost to Follow-up|5|||
131420368|NCT03775512|473162960|FG000|Overall Study|Excluded before Catheter insertion|14|||
131420369|NCT03775512|473162961|FG001|Overall Study|Excluded before Catheter insertion|5|||
131420370|NCT03775512|473162960|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
131420371|NCT03775512|473162961|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
131420372|NCT03775512|473162960|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
131420373|NCT03775512|473162961|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
131420374|NCT01378325|473162964|FG000|Overall Study|Protocol Violation|0|||
131420375|NCT01378325|473162965|FG001|Overall Study|Protocol Violation|1|||
131420376|NCT00767806|473162968|FG000|Overall Study|Adverse Event|30|||
131420377|NCT00767806|473162969|FG001|Overall Study|Adverse Event|11|||
131420378|NCT00767806|473162968|FG000|Overall Study|Withdrawal by Subject|8|||
131420379|NCT00767806|473162969|FG001|Overall Study|Withdrawal by Subject|13|||
131420380|NCT00767806|473162968|FG000|Overall Study|Protocol Violation|6|||
131420381|NCT00767806|473162969|FG001|Overall Study|Protocol Violation|5|||
131420382|NCT00767806|473162968|FG000|Overall Study|Lack of Efficacy|1|||
131420383|NCT00767806|473162969|FG001|Overall Study|Lack of Efficacy|9|||
131420384|NCT00767806|473162968|FG000|Overall Study|Physician Decision|4|||
131420385|NCT00767806|473162969|FG001|Overall Study|Physician Decision|3|||
131420386|NCT00767806|473162968|FG000|Overall Study|Lost to Follow-up|1|||
131420387|NCT00767806|473162969|FG001|Overall Study|Lost to Follow-up|4|||
131420388|NCT00767806|473162968|FG000|Overall Study|Entry Criteria Not Met|1|||
131420389|NCT00767806|473162969|FG001|Overall Study|Entry Criteria Not Met|1|||
131420390|NCT00767806|473162968|FG000|Overall Study|Sponsor Decision|0|||
131420391|NCT00767806|473162969|FG001|Overall Study|Sponsor Decision|1|||
131420392|NCT02489942|473162970|FG000|Overall Study|Request by patient|602|||
131420393|NCT02489942|473162970|FG000|Overall Study|Improvement/remission|157|||
131420394|NCT02489942|473162970|FG000|Overall Study|No change/Progressive disease|263|||
131420395|NCT02489942|473162970|FG000|Overall Study|Adverse Event|522|||
131420396|NCT02489942|473162970|FG000|Overall Study|Other personal reasons|1218|||
131420397|NCT02489942|473162970|FG000|Overall Study|Lost to Follow-up|456|||
131420398|NCT02489942|473162970|FG000|Overall Study|Not continuously investigated|7|||
131420399|NCT02489942|473162970|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
131420400|NCT02489942|473162970|FG000|Overall Study|Multiple registration|1|||
131420401|NCT02489942|473162970|FG000|Overall Study|No patient visit after entry|100|||
131420402|NCT02489942|473162970|FG000|Overall Study|No treatment with Jardiance|2|||
131420403|NCT02489942|473162970|FG000|Overall Study|Patient received Jardiance before registration|1|||
131420404|NCT02489942|473162970|FG000|Overall Study|No CRF collected|86|||
131420405|NCT00858208|473162971|FG000|Overall Study|Adverse Event|3|||
131420406|NCT00858208|473162971|FG000|Overall Study|Lost to Follow-up|26|||
131420407|NCT00858208|473162971|FG000|Overall Study|Participant refused|40|||
131420408|NCT00858208|473162971|FG000|Overall Study|Other|10|||
131420409|NCT01272635|473162972|FG000|Overall Study|Lost to Follow-up|31|||
131420410|NCT01272635|473162973|FG001|Overall Study|Lost to Follow-up|20|||
131420411|NCT01272635|473162974|FG002|Overall Study|Lost to Follow-up|31|||
131420412|NCT01272635|473162975|FG003|Overall Study|Lost to Follow-up|23|||
131420413|NCT02702180|473162978|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131420414|NCT02702180|473162979|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131420415|NCT02702180|473162980|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131420416|NCT02702180|473162978|FG000|Double-blind Treatment Period|Adverse Event|0|||
131420417|NCT02702180|473162979|FG001|Double-blind Treatment Period|Adverse Event|0|||
131420418|NCT02702180|473162980|FG002|Double-blind Treatment Period|Adverse Event|1|||
131420419|NCT02702180|473162978|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
131420420|NCT02702180|473162979|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
131420421|NCT02702180|473162980|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
131420422|NCT02702180|473162978|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131420423|NCT02702180|473162979|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131420424|NCT02702180|473162980|FG002|Double-blind Treatment Period|Protocol Violation|2|||
131420425|NCT02702180|473162978|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
131420426|NCT02702180|473162979|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
131420427|NCT02702180|473162980|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
131420428|NCT02702180|473162978|FG000|Open-label Treatment Period|Withdrawn in error|0|||
131420429|NCT02702180|473162979|FG001|Open-label Treatment Period|Withdrawn in error|0|||
131420430|NCT02702180|473162980|FG002|Open-label Treatment Period|Withdrawn in error|1|||
131420431|NCT00567359|473162981|FG000|Overall Study|Withdrawal by Subject|1|||
131420432|NCT02397057|473162982|FG000|Overall Study|Withdrawal by Subject|6|||
131420433|NCT02397057|473162983|FG001|Overall Study|Withdrawal by Subject|7|||
131420434|NCT02397057|473162982|FG000|Overall Study|Lost to Follow-up|4|||
131420435|NCT02397057|473162983|FG001|Overall Study|Lost to Follow-up|3|||
131420436|NCT02397057|473162982|FG000|Overall Study|Death|1|||
131420437|NCT02397057|473162983|FG001|Overall Study|Death|0|||
131420438|NCT02397057|473162982|FG000|Overall Study|Adverse Event|0|||
131420439|NCT02397057|473162983|FG001|Overall Study|Adverse Event|1|||
131420440|NCT02397057|473162982|FG000|Overall Study|Physician Decision|0|||
131420441|NCT02397057|473162983|FG001|Overall Study|Physician Decision|1|||
131420442|NCT02397057|473162982|FG000|Overall Study|Subject did not receive study drug|0|||
131420443|NCT02397057|473162983|FG001|Overall Study|Subject did not receive study drug|1|||
131420444|NCT01393639|473162984|FG000|Overall Study|Protocol Violation|0|||
131420445|NCT01393639|473162985|FG001|Overall Study|Protocol Violation|0|||
131420446|NCT01393639|473162986|FG002|Overall Study|Protocol Violation|0|||
131420447|NCT01393639|473162987|FG003|Overall Study|Protocol Violation|1|||
131420448|NCT01393639|473162988|FG004|Overall Study|Protocol Violation|0|||
131420449|NCT01393639|473162989|FG005|Overall Study|Protocol Violation|0|||
131420450|NCT01393639|473162990|FG006|Overall Study|Protocol Violation|0|||
131420451|NCT01393639|473162984|FG000|Overall Study|Other|0|||
131420452|NCT01393639|473162985|FG001|Overall Study|Other|2|||
131420453|NCT01393639|473162986|FG002|Overall Study|Other|0|||
131420454|NCT01393639|473162987|FG003|Overall Study|Other|2|||
131420455|NCT01393639|473162988|FG004|Overall Study|Other|1|||
131420456|NCT01393639|473162989|FG005|Overall Study|Other|0|||
131420457|NCT01393639|473162990|FG006|Overall Study|Other|1|||
131420458|NCT01393639|473162984|FG000|Overall Study|Withdrawal by Subject|1|||
131420459|NCT01393639|473162985|FG001|Overall Study|Withdrawal by Subject|1|||
131420460|NCT01393639|473162986|FG002|Overall Study|Withdrawal by Subject|0|||
131420461|NCT01393639|473162987|FG003|Overall Study|Withdrawal by Subject|0|||
131420462|NCT01393639|473162988|FG004|Overall Study|Withdrawal by Subject|0|||
131420463|NCT01393639|473162989|FG005|Overall Study|Withdrawal by Subject|0|||
131420464|NCT01393639|473162990|FG006|Overall Study|Withdrawal by Subject|1|||
131420465|NCT01393639|473162984|FG000|Overall Study|Medication error without associated AE|0|||
131420466|NCT01393639|473162985|FG001|Overall Study|Medication error without associated AE|0|||
131420467|NCT01393639|473162986|FG002|Overall Study|Medication error without associated AE|0|||
131420468|NCT01393639|473162987|FG003|Overall Study|Medication error without associated AE|0|||
131420469|NCT01393639|473162988|FG004|Overall Study|Medication error without associated AE|0|||
131420470|NCT01393639|473162989|FG005|Overall Study|Medication error without associated AE|0|||
131420471|NCT01393639|473162990|FG006|Overall Study|Medication error without associated AE|1|||
131420472|NCT01393639|473162984|FG000|Overall Study|Lost to Follow-up|0|||
131420473|NCT01393639|473162985|FG001|Overall Study|Lost to Follow-up|1|||
131420474|NCT01393639|473162986|FG002|Overall Study|Lost to Follow-up|0|||
131420475|NCT01393639|473162987|FG003|Overall Study|Lost to Follow-up|0|||
131420476|NCT01393639|473162988|FG004|Overall Study|Lost to Follow-up|0|||
131420477|NCT01393639|473162989|FG005|Overall Study|Lost to Follow-up|0|||
131420478|NCT01393639|473162990|FG006|Overall Study|Lost to Follow-up|1|||
131420479|NCT01393639|473162984|FG000|Overall Study|Lack of Efficacy|0|||
131420480|NCT01393639|473162985|FG001|Overall Study|Lack of Efficacy|0|||
131420481|NCT01393639|473162986|FG002|Overall Study|Lack of Efficacy|0|||
131420482|NCT01393639|473162987|FG003|Overall Study|Lack of Efficacy|0|||
131420483|NCT01393639|473162988|FG004|Overall Study|Lack of Efficacy|0|||
131420484|NCT01393639|473162989|FG005|Overall Study|Lack of Efficacy|0|||
131420485|NCT01393639|473162990|FG006|Overall Study|Lack of Efficacy|1|||
131420486|NCT01393639|473162984|FG000|Overall Study|Adverse Event|2|||
131420487|NCT01393639|473162985|FG001|Overall Study|Adverse Event|3|||
131420488|NCT01393639|473162986|FG002|Overall Study|Adverse Event|1|||
131420489|NCT01393639|473162987|FG003|Overall Study|Adverse Event|2|||
131420490|NCT01393639|473162988|FG004|Overall Study|Adverse Event|0|||
131420491|NCT01393639|473162989|FG005|Overall Study|Adverse Event|2|||
131420492|NCT01393639|473162990|FG006|Overall Study|Adverse Event|3|||
131420493|NCT00679172|473162991|FG000|Overall Study|Non-compliance|1|||
131420494|NCT00679172|473162992|FG001|Overall Study|Non-compliance|1|||
131420495|NCT00679172|473162993|FG002|Overall Study|Non-compliance|0|||
131420496|NCT00679172|473162994|FG003|Overall Study|Non-compliance|1|||
131420497|NCT00679172|473162995|FG004|Overall Study|Non-compliance|0|||
131420498|NCT00679172|473162991|FG000|Overall Study|Other not specified|0|||
131420499|NCT00679172|473162992|FG001|Overall Study|Other not specified|0|||
131420500|NCT00679172|473162993|FG002|Overall Study|Other not specified|1|||
131420501|NCT00679172|473162994|FG003|Overall Study|Other not specified|0|||
131420502|NCT00679172|473162995|FG004|Overall Study|Other not specified|0|||
131420503|NCT00793325|473162996|FG000|Overall Study|Protocol Violation|18|||
131420504|NCT00793325|473162996|FG000|Overall Study|Lost to Follow-up|1|||
131420505|NCT03221842|473162997|FG000|Period 1 (Open-label)|Adverse Event|4|||
131420506|NCT03221842|473162998|FG001|Period 1 (Open-label)|Adverse Event|0|||
131420507|NCT03221842|473162997|FG000|Period 1 (Open-label)|Physician Decision|2|||
131420508|NCT03221842|473162998|FG001|Period 1 (Open-label)|Physician Decision|0|||
131420509|NCT03221842|473162997|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
131420510|NCT03221842|473162998|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
131420511|NCT03221842|473162997|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
131420512|NCT03221842|473162998|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
131420513|NCT03221842|473162997|FG000|Period 1 (Open-label)|Other|2|||
131420514|NCT03221842|473162998|FG001|Period 1 (Open-label)|Other|0|||
131420515|NCT03221842|473162997|FG000|Period 2 (Randomized, Blinded)|Death|0|||
131420516|NCT03221842|473162998|FG001|Period 2 (Randomized, Blinded)|Death|1|||
131420517|NCT03221842|473162997|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
131420518|NCT03221842|473162998|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
131420519|NCT00704288|473162999|FG000|Overall Treatment Period|Adverse Event|11|||
131420520|NCT00704288|473163000|FG001|Overall Treatment Period|Adverse Event|8|||
131420521|NCT00704288|473163001|FG002|Overall Treatment Period|Adverse Event|22|||
131420522|NCT00704288|473162999|FG000|Overall Treatment Period|Death|0|||
131457663|NCT01945710|473307026|FG005|Overall Study|Withdrawal by Subject|0|||
131457664|NCT01945710|473307027|FG006|Overall Study|Withdrawal by Subject|0|||
131457665|NCT00375609|473307028|FG000|Overall Study|Did not receive treatment|1|||
131457666|NCT00375609|473307029|FG001|Overall Study|Did not receive treatment|0|||
131457667|NCT00375609|473307030|FG002|Overall Study|Did not receive treatment|0|||
131457668|NCT00375609|473307028|FG000|Overall Study|Adverse Event|0|||
131457669|NCT00375609|473307029|FG001|Overall Study|Adverse Event|3|||
131457670|NCT00375609|473307030|FG002|Overall Study|Adverse Event|0|||
131457671|NCT00375609|473307028|FG000|Overall Study|Lost to Follow-up|1|||
131457672|NCT00375609|473307029|FG001|Overall Study|Lost to Follow-up|0|||
131457673|NCT00375609|473307030|FG002|Overall Study|Lost to Follow-up|0|||
131457674|NCT00375609|473307028|FG000|Overall Study|Physician Decision|0|||
131457675|NCT00375609|473307029|FG001|Overall Study|Physician Decision|0|||
131457676|NCT00375609|473307030|FG002|Overall Study|Physician Decision|1|||
131457677|NCT00375609|473307028|FG000|Overall Study|Withdrawal by Subject|1|||
131457678|NCT00375609|473307029|FG001|Overall Study|Withdrawal by Subject|4|||
131420523|NCT00704288|473163000|FG001|Overall Treatment Period|Death|0|||
131420524|NCT00704288|473163001|FG002|Overall Treatment Period|Death|1|||
131420525|NCT00704288|473162999|FG000|Overall Treatment Period|Physician Decision|0|||
131420526|NCT00704288|473163000|FG001|Overall Treatment Period|Physician Decision|2|||
131420527|NCT00704288|473163001|FG002|Overall Treatment Period|Physician Decision|0|||
131420528|NCT00704288|473162999|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
131420529|NCT00704288|473163000|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
131420530|NCT00704288|473163001|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
131420531|NCT00704288|473162999|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
131420532|NCT00704288|473163000|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
131420533|NCT00704288|473163001|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
131420534|NCT00704288|473162999|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
131420535|NCT00704288|473163000|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
131420536|NCT00704288|473163001|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
131420537|NCT00704288|473162999|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
131420538|NCT00704288|473163000|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
131420539|NCT00704288|473163001|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
131420540|NCT00704288|473162999|FG000|Overall Treatment Period|Roll-over to another study|1|||
131420541|NCT00704288|473163000|FG001|Overall Treatment Period|Roll-over to another study|0|||
131420542|NCT00704288|473163001|FG002|Overall Treatment Period|Roll-over to another study|4|||
131420543|NCT00704288|473162999|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
131420544|NCT00704288|473163000|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
131420545|NCT00704288|473163001|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
131420546|NCT00704288|473162999|FG000|Extended Post Treatment Follow Up Period|Death|41|||
131420547|NCT00704288|473163000|FG001|Extended Post Treatment Follow Up Period|Death|50|||
131420548|NCT00704288|473163001|FG002|Extended Post Treatment Follow Up Period|Death|93|||
131420549|NCT00704288|473162999|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
131420550|NCT00704288|473163000|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
131420551|NCT00704288|473163001|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
131420552|NCT00704288|473162999|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
131420553|NCT00704288|473163000|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
131420554|NCT00704288|473163001|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
131420555|NCT00704288|473162999|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
131420556|NCT00704288|473163000|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
131420557|NCT00704288|473163001|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
131420558|NCT02241343|473163004|FG000|Overall Study|Adverse Event|1|||
131420559|NCT05249569|473163007|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
131420560|NCT03722524|473163010|FG000|Overall Study|Protocol Violation|86|||
131420561|NCT03722524|473163010|FG000|Overall Study|Adverse Event|7|||
131420562|NCT03722524|473163010|FG000|Overall Study|Lost to Follow-up|1|||
131420563|NCT03722524|473163010|FG000|Overall Study|Reason is not stated|1|||
131457679|NCT00375609|473307030|FG002|Overall Study|Withdrawal by Subject|0|||
131457680|NCT00375609|473307028|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
131457681|NCT00375609|473307029|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
131457682|NCT00375609|473307030|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
131420564|NCT03722524|473163010|FG000|Overall Study|Physician Decision|1|||
131420565|NCT03722524|473163010|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
131420566|NCT02678923|473163011|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
131457683|NCT01368562|473307031|FG000|Overall Study|Adverse Event|1|||
131457684|NCT01368562|473307031|FG000|Overall Study|Disease progression|1|||
131457685|NCT01368562|473307031|FG000|Overall Study|Lost to Follow-up|1|||
131457686|NCT01368562|473307031|FG000|Overall Study|Death|6|||
131420567|NCT02678923|473163012|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
131420568|NCT02678923|473163011|FG000|Overall Study|Withdrawal by Subject|3|||
131420569|NCT02678923|473163012|FG001|Overall Study|Withdrawal by Subject|2|||
131420570|NCT02678923|473163011|FG000|Overall Study|Lost to Follow-up|1|||
131420571|NCT02678923|473163012|FG001|Overall Study|Lost to Follow-up|0|||
131420572|NCT02678923|473163011|FG000|Overall Study|Did Not Return for Study Visits|1|||
131420573|NCT02678923|473163012|FG001|Overall Study|Did Not Return for Study Visits|0|||
131420574|NCT00098306|473163016|FG000|Double Blind|Randomized, not treated|9|||
131420575|NCT00098306|473163017|FG001|Double Blind|Randomized, not treated|5|||
131420576|NCT00098306|473163018|FG002|Double Blind|Randomized, not treated|2|||
131420577|NCT00098306|473163019|FG003|Double Blind|Randomized, not treated|0|||
131420578|NCT00098306|473163020|FG004|Double Blind|Randomized, not treated|0|||
131420579|NCT00098306|473163021|FG005|Double Blind|Randomized, not treated|0|||
131420580|NCT00098306|473163022|FG006|Double Blind|Randomized, not treated|0|||
131420581|NCT00098306|473163016|FG000|Double Blind|Ongoing at cut-off date|151|||
131420582|NCT00098306|473163017|FG001|Double Blind|Ongoing at cut-off date|166|||
131420583|NCT00098306|473163018|FG002|Double Blind|Ongoing at cut-off date|72|||
131420584|NCT00098306|473163019|FG003|Double Blind|Ongoing at cut-off date|0|||
131420585|NCT00098306|473163020|FG004|Double Blind|Ongoing at cut-off date|0|||
131420586|NCT00098306|473163021|FG005|Double Blind|Ongoing at cut-off date|0|||
131420587|NCT00098306|473163022|FG006|Double Blind|Ongoing at cut-off date|0|||
131420588|NCT00098306|473163016|FG000|Double Blind|Adverse Event|11|||
131420589|NCT00098306|473163017|FG001|Double Blind|Adverse Event|10|||
131420590|NCT00098306|473163018|FG002|Double Blind|Adverse Event|6|||
131420591|NCT00098306|473163019|FG003|Double Blind|Adverse Event|0|||
131420592|NCT00098306|473163020|FG004|Double Blind|Adverse Event|0|||
131420593|NCT00098306|473163021|FG005|Double Blind|Adverse Event|0|||
131420594|NCT00098306|473163022|FG006|Double Blind|Adverse Event|0|||
131420595|NCT00098306|473163016|FG000|Double Blind|Lack of Efficacy|43|||
131420596|NCT00098306|473163017|FG001|Double Blind|Lack of Efficacy|34|||
131420597|NCT00098306|473163018|FG002|Double Blind|Lack of Efficacy|17|||
131420598|NCT00098306|473163019|FG003|Double Blind|Lack of Efficacy|0|||
131420599|NCT00098306|473163020|FG004|Double Blind|Lack of Efficacy|0|||
131420600|NCT00098306|473163021|FG005|Double Blind|Lack of Efficacy|0|||
131420601|NCT00098306|473163022|FG006|Double Blind|Lack of Efficacy|0|||
131420602|NCT00098306|473163016|FG000|Double Blind|Death|1|||
131420603|NCT00098306|473163017|FG001|Double Blind|Death|4|||
131420604|NCT00098306|473163018|FG002|Double Blind|Death|1|||
131420605|NCT00098306|473163019|FG003|Double Blind|Death|0|||
131420606|NCT00098306|473163020|FG004|Double Blind|Death|0|||
131420607|NCT00098306|473163021|FG005|Double Blind|Death|0|||
131420608|NCT00098306|473163022|FG006|Double Blind|Death|0|||
131420609|NCT00098306|473163016|FG000|Double Blind|Participant defaulted|19|||
131420610|NCT00098306|473163017|FG001|Double Blind|Participant defaulted|18|||
131420611|NCT00098306|473163018|FG002|Double Blind|Participant defaulted|11|||
131420612|NCT00098306|473163019|FG003|Double Blind|Participant defaulted|0|||
131420613|NCT00098306|473163020|FG004|Double Blind|Participant defaulted|0|||
131420614|NCT00098306|473163021|FG005|Double Blind|Participant defaulted|0|||
131420615|NCT00098306|473163022|FG006|Double Blind|Participant defaulted|0|||
131420616|NCT00098306|473163016|FG000|Double Blind|Un-specified|7|||
131420617|NCT00098306|473163017|FG001|Double Blind|Un-specified|3|||
131420618|NCT00098306|473163018|FG002|Double Blind|Un-specified|11|||
131420619|NCT00098306|473163019|FG003|Double Blind|Un-specified|0|||
131420620|NCT00098306|473163020|FG004|Double Blind|Un-specified|0|||
131420621|NCT00098306|473163021|FG005|Double Blind|Un-specified|0|||
131420622|NCT00098306|473163022|FG006|Double Blind|Un-specified|0|||
131420623|NCT00098306|473163016|FG000|Open Label|Lack of Efficacy|0|||
131420624|NCT00098306|473163017|FG001|Open Label|Lack of Efficacy|0|||
131420625|NCT00098306|473163018|FG002|Open Label|Lack of Efficacy|0|||
131420626|NCT00098306|473163019|FG003|Open Label|Lack of Efficacy|13|||
131420627|NCT00098306|473163020|FG004|Open Label|Lack of Efficacy|0|||
131420628|NCT00098306|473163021|FG005|Open Label|Lack of Efficacy|0|||
131420629|NCT00098306|473163022|FG006|Open Label|Lack of Efficacy|0|||
131420630|NCT00098306|473163016|FG000|Open Label|Adverse Event|0|||
131420631|NCT00098306|473163017|FG001|Open Label|Adverse Event|0|||
131420632|NCT00098306|473163018|FG002|Open Label|Adverse Event|0|||
131420633|NCT00098306|473163019|FG003|Open Label|Adverse Event|2|||
131420634|NCT00098306|473163020|FG004|Open Label|Adverse Event|0|||
131420635|NCT00098306|473163021|FG005|Open Label|Adverse Event|0|||
131420636|NCT00098306|473163022|FG006|Open Label|Adverse Event|0|||
131420637|NCT00098306|473163016|FG000|Open Label|Death|0|||
131420638|NCT00098306|473163017|FG001|Open Label|Death|0|||
131420639|NCT00098306|473163018|FG002|Open Label|Death|0|||
131420640|NCT00098306|473163019|FG003|Open Label|Death|4|||
131420641|NCT00098306|473163020|FG004|Open Label|Death|0|||
131420642|NCT00098306|473163021|FG005|Open Label|Death|0|||
131420643|NCT00098306|473163022|FG006|Open Label|Death|0|||
131420644|NCT00098306|473163016|FG000|Open Label|Participant defaulted|0|||
131420645|NCT00098306|473163017|FG001|Open Label|Participant defaulted|0|||
131420646|NCT00098306|473163018|FG002|Open Label|Participant defaulted|0|||
131420647|NCT00098306|473163019|FG003|Open Label|Participant defaulted|24|||
131420648|NCT00098306|473163020|FG004|Open Label|Participant defaulted|0|||
131457687|NCT01368562|473307031|FG000|Overall Study|Unresponsive to treatment|5|||
131457688|NCT01368562|473307031|FG000|Overall Study|Other|3|||
131457689|NCT01368562|473307031|FG000|Overall Study|Other than specified|2|||
131457690|NCT01754727|473307032|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
131457691|NCT00669409|473307041|FG000|Part 2|Withdrawal by Subject|0|||
131457692|NCT00669409|473307042|FG001|Part 2|Withdrawal by Subject|0|||
131457693|NCT00669409|473307043|FG002|Part 2|Withdrawal by Subject|0|||
131457694|NCT00669409|473307044|FG003|Part 2|Withdrawal by Subject|0|||
131457695|NCT00669409|473307045|FG004|Part 2|Withdrawal by Subject|0|||
131457696|NCT00669409|473307046|FG005|Part 2|Withdrawal by Subject|0|||
131457697|NCT00669409|473307047|FG006|Part 2|Withdrawal by Subject|0|||
131457698|NCT00669409|473307048|FG007|Part 2|Withdrawal by Subject|0|||
131457699|NCT00669409|473307049|FG008|Part 2|Withdrawal by Subject|0|||
131457700|NCT00669409|473307050|FG009|Part 2|Withdrawal by Subject|1|||
131457701|NCT00669409|473307051|FG010|Part 2|Withdrawal by Subject|0|||
131457702|NCT04838977|473307052|FG000|Overall Study|Lost to Follow-up|2|||
131457703|NCT04838977|473307053|FG001|Overall Study|Lost to Follow-up|3|||
131457704|NCT04838977|473307052|FG000|Overall Study|Withdrawal by Subject|1|||
131457705|NCT04838977|473307053|FG001|Overall Study|Withdrawal by Subject|1|||
131457706|NCT01256190|473307055|FG000|Overall Study|Lost to Follow-up|2|||
131457707|NCT01256190|473307056|FG001|Overall Study|Lost to Follow-up|0|||
131457708|NCT04693234|473307057|FG000|Overall Study|Death|79|||
131457709|NCT04693234|473307058|FG001|Overall Study|Death|19|||
131457710|NCT04693234|473307057|FG000|Overall Study|Sponsor Ended Study|47|||
131457711|NCT04693234|473307058|FG001|Overall Study|Sponsor Ended Study|18|||
131457712|NCT04693234|473307057|FG000|Overall Study|Withdrawal by Subject|10|||
131457713|NCT04693234|473307058|FG001|Overall Study|Withdrawal by Subject|2|||
131457714|NCT04693234|473307057|FG000|Overall Study|Lost to Follow-up|2|||
131457715|NCT04693234|473307058|FG001|Overall Study|Lost to Follow-up|1|||
131457716|NCT02888119|473307071|FG000|Overall Study|Lost to Follow-up|5|||
131457717|NCT02888119|473307072|FG001|Overall Study|Lost to Follow-up|4|||
131457718|NCT02888119|473307073|FG002|Overall Study|Lost to Follow-up|0|||
131457719|NCT02123472|473307081|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
131457720|NCT02123472|473307082|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
131457721|NCT01474018|473307083|FG000|Overall Study|Lost to Follow-up|0|||
131457722|NCT01474018|473307084|FG001|Overall Study|Lost to Follow-up|1|||
131457723|NCT01474018|473307083|FG000|Overall Study|Withdrawal by Subject|0|||
131457724|NCT01474018|473307084|FG001|Overall Study|Withdrawal by Subject|2|||
131457725|NCT02433080|473307085|FG000|Overall Study|Lost to Follow-up|1|||
131457726|NCT02433080|473307086|FG001|Overall Study|Lost to Follow-up|2|||
131457727|NCT02433080|473307085|FG000|Overall Study|Withdrawal by Subject|0|||
131457728|NCT02433080|473307086|FG001|Overall Study|Withdrawal by Subject|2|||
131457729|NCT01015638|473307089|FG000|Overall Study|Withdrawal by Subject|1|||
131457730|NCT01015638|473307090|FG001|Overall Study|Withdrawal by Subject|0|||
131457731|NCT03679754|473307093|FG000|Overall Study|Investigator request|1|||
131457732|NCT00964171|473307094|FG000|Overall Study|Death|5|||
131457733|NCT00329797|473307098|FG000|Overall Study|Protocol Violation|1|||
131457734|NCT00329797|473307099|FG001|Overall Study|Protocol Violation|0|||
131457735|NCT00329797|473307098|FG000|Overall Study|Withdrawal by Subject|6|||
131457736|NCT00329797|473307099|FG001|Overall Study|Withdrawal by Subject|6|||
131457737|NCT00910299|473307100|FG000|Overall Study|Withdrawal by Subject|16|||
131457738|NCT00910299|473307101|FG001|Overall Study|Withdrawal by Subject|13|||
131457739|NCT00910299|473307100|FG000|Overall Study|Sponsor Decision|58|||
131457740|NCT00910299|473307101|FG001|Overall Study|Sponsor Decision|60|||
131457741|NCT00910299|473307100|FG000|Overall Study|Didn't receive any study drug|2|||
131420649|NCT00098306|473163021|FG005|Open Label|Participant defaulted|0|||
131420650|NCT00098306|473163022|FG006|Open Label|Participant defaulted|0|||
131420651|NCT00098306|473163016|FG000|Open Label|Un-specified|0|||
131420652|NCT00098306|473163017|FG001|Open Label|Un-specified|0|||
131420653|NCT00098306|473163018|FG002|Open Label|Un-specified|0|||
131420654|NCT00098306|473163019|FG003|Open Label|Un-specified|15|||
131420655|NCT00098306|473163020|FG004|Open Label|Un-specified|0|||
131420656|NCT00098306|473163021|FG005|Open Label|Un-specified|0|||
131420657|NCT00098306|473163022|FG006|Open Label|Un-specified|0|||
131420658|NCT00098306|473163016|FG000|Open Label|Ongoing at cut-off date|0|||
131420659|NCT00098306|473163017|FG001|Open Label|Ongoing at cut-off date|0|||
131420660|NCT00098306|473163018|FG002|Open Label|Ongoing at cut-off date|0|||
131420661|NCT00098306|473163019|FG003|Open Label|Ongoing at cut-off date|269|||
131420662|NCT00098306|473163020|FG004|Open Label|Ongoing at cut-off date|62|||
131420663|NCT00098306|473163021|FG005|Open Label|Ongoing at cut-off date|0|||
131420664|NCT00098306|473163022|FG006|Open Label|Ongoing at cut-off date|0|||
131420665|NCT00098306|473163016|FG000|Observational Phase|Death|0|||
131420666|NCT00098306|473163017|FG001|Observational Phase|Death|0|||
131420667|NCT00098306|473163018|FG002|Observational Phase|Death|0|||
131420668|NCT00098306|473163019|FG003|Observational Phase|Death|0|||
131420669|NCT00098306|473163020|FG004|Observational Phase|Death|0|||
131420670|NCT00098306|473163021|FG005|Observational Phase|Death|5|||
131420671|NCT00098306|473163022|FG006|Observational Phase|Death|4|||
131420672|NCT00098306|473163016|FG000|Observational Phase|Participant defaulted|0|||
131420673|NCT00098306|473163017|FG001|Observational Phase|Participant defaulted|0|||
131420674|NCT00098306|473163018|FG002|Observational Phase|Participant defaulted|0|||
131420675|NCT00098306|473163019|FG003|Observational Phase|Participant defaulted|0|||
131420676|NCT00098306|473163020|FG004|Observational Phase|Participant defaulted|0|||
131420677|NCT00098306|473163021|FG005|Observational Phase|Participant defaulted|34|||
131420678|NCT00098306|473163022|FG006|Observational Phase|Participant defaulted|18|||
131420679|NCT00098306|473163016|FG000|Observational Phase|Un-specified|0|||
131420680|NCT00098306|473163017|FG001|Observational Phase|Un-specified|0|||
131420681|NCT00098306|473163018|FG002|Observational Phase|Un-specified|0|||
131420682|NCT00098306|473163019|FG003|Observational Phase|Un-specified|0|||
131420683|NCT00098306|473163020|FG004|Observational Phase|Un-specified|0|||
131420684|NCT00098306|473163021|FG005|Observational Phase|Un-specified|7|||
131420685|NCT00098306|473163022|FG006|Observational Phase|Un-specified|4|||
131420686|NCT01423916|473163023|FG000|Overall Study|Adverse Event|5|||
131420687|NCT01423916|473163024|FG001|Overall Study|Adverse Event|9|||
131420688|NCT01423916|473163025|FG002|Overall Study|Adverse Event|2|||
131420689|NCT01423916|473163023|FG000|Overall Study|Met Withdrawal Criteria|1|||
131420690|NCT01423916|473163024|FG001|Overall Study|Met Withdrawal Criteria|1|||
131420691|NCT01423916|473163025|FG002|Overall Study|Met Withdrawal Criteria|1|||
131420692|NCT01423916|473163023|FG000|Overall Study|Physician Decision|1|||
131420693|NCT01423916|473163024|FG001|Overall Study|Physician Decision|0|||
131420694|NCT01423916|473163025|FG002|Overall Study|Physician Decision|1|||
131420695|NCT01423916|473163023|FG000|Overall Study|Withdrawal by Subject|3|||
131420696|NCT01423916|473163024|FG001|Overall Study|Withdrawal by Subject|10|||
131420697|NCT01423916|473163025|FG002|Overall Study|Withdrawal by Subject|3|||
131420698|NCT01423916|473163023|FG000|Overall Study|Protocol Deviation|1|||
131420699|NCT01423916|473163024|FG001|Overall Study|Protocol Deviation|0|||
131420700|NCT01423916|473163025|FG002|Overall Study|Protocol Deviation|0|||
131420701|NCT00454584|473163028|FG000|Controlled Period|Adverse Event|5|||
131420702|NCT00454584|473163029|FG001|Controlled Period|Adverse Event|2|||
131420703|NCT00454584|473163030|FG002|Controlled Period|Adverse Event|1|||
131420704|NCT00454584|473163031|FG003|Controlled Period|Adverse Event|0|||
131420705|NCT00454584|473163032|FG004|Controlled Period|Adverse Event|0|||
131420706|NCT00454584|473163033|FG005|Controlled Period|Adverse Event|0|||
131420707|NCT00454584|473163028|FG000|Controlled Period|Lost to Follow-up|1|||
131420708|NCT00454584|473163029|FG001|Controlled Period|Lost to Follow-up|2|||
131457742|NCT00910299|473307101|FG001|Overall Study|Didn't receive any study drug|1|||
131457743|NCT04535453|473307103|FG000|Overall Study|Death|0|||
131457744|NCT04535453|473307104|FG001|Overall Study|Death|1|||
131457745|NCT04535453|473307105|FG002|Overall Study|Death|0|||
131457746|NCT04535453|473307106|FG003|Overall Study|Death|0|||
131457747|NCT04535453|473307107|FG004|Overall Study|Death|0|||
131457748|NCT04535453|473307108|FG005|Overall Study|Death|0|||
131457749|NCT04535453|473307109|FG006|Overall Study|Death|0|||
131457750|NCT04535453|473307110|FG007|Overall Study|Death|0|||
131457751|NCT04535453|473307111|FG008|Overall Study|Death|0|||
131457752|NCT04535453|473307112|FG009|Overall Study|Death|0|||
131457753|NCT04535453|473307113|FG010|Overall Study|Death|0|||
131457754|NCT04535453|473307114|FG011|Overall Study|Death|0|||
131457755|NCT04535453|473307103|FG000|Overall Study|Lost to Follow-up|1|||
131457756|NCT04535453|473307104|FG001|Overall Study|Lost to Follow-up|1|||
131457757|NCT04535453|473307105|FG002|Overall Study|Lost to Follow-up|1|||
131457758|NCT04535453|473307106|FG003|Overall Study|Lost to Follow-up|0|||
131457759|NCT04535453|473307107|FG004|Overall Study|Lost to Follow-up|3|||
131457760|NCT04535453|473307108|FG005|Overall Study|Lost to Follow-up|1|||
131457761|NCT04535453|473307109|FG006|Overall Study|Lost to Follow-up|0|||
131457762|NCT04535453|473307110|FG007|Overall Study|Lost to Follow-up|0|||
131457763|NCT04535453|473307111|FG008|Overall Study|Lost to Follow-up|1|||
131457764|NCT04535453|473307112|FG009|Overall Study|Lost to Follow-up|1|||
131420709|NCT00454584|473163030|FG002|Controlled Period|Lost to Follow-up|2|||
131420710|NCT00454584|473163031|FG003|Controlled Period|Lost to Follow-up|0|||
131420711|NCT00454584|473163032|FG004|Controlled Period|Lost to Follow-up|0|||
131420712|NCT00454584|473163033|FG005|Controlled Period|Lost to Follow-up|0|||
131420713|NCT00454584|473163028|FG000|Controlled Period|Other|5|||
131420714|NCT00454584|473163029|FG001|Controlled Period|Other|4|||
131420715|NCT00454584|473163030|FG002|Controlled Period|Other|2|||
131420716|NCT00454584|473163031|FG003|Controlled Period|Other|0|||
131420717|NCT00454584|473163032|FG004|Controlled Period|Other|0|||
131420718|NCT00454584|473163033|FG005|Controlled Period|Other|0|||
131420719|NCT00454584|473163028|FG000|After Controlled Period|Adverse Event|0|||
131420720|NCT00454584|473163029|FG001|After Controlled Period|Adverse Event|0|||
131420721|NCT00454584|473163030|FG002|After Controlled Period|Adverse Event|0|||
131420722|NCT00454584|473163031|FG003|After Controlled Period|Adverse Event|9|||
131420723|NCT00454584|473163032|FG004|After Controlled Period|Adverse Event|3|||
131420724|NCT00454584|473163033|FG005|After Controlled Period|Adverse Event|9|||
131420725|NCT00454584|473163028|FG000|After Controlled Period|Lack of Efficacy|0|||
131420726|NCT00454584|473163029|FG001|After Controlled Period|Lack of Efficacy|0|||
131457765|NCT04535453|473307113|FG010|Overall Study|Lost to Follow-up|0|||
131457766|NCT04535453|473307114|FG011|Overall Study|Lost to Follow-up|0|||
131457767|NCT04535453|473307103|FG000|Overall Study|Physician Decision|0|||
131457768|NCT04535453|473307104|FG001|Overall Study|Physician Decision|0|||
131457769|NCT04535453|473307105|FG002|Overall Study|Physician Decision|0|||
131457770|NCT04535453|473307106|FG003|Overall Study|Physician Decision|1|||
131457771|NCT04535453|473307107|FG004|Overall Study|Physician Decision|0|||
131420727|NCT00454584|473163030|FG002|After Controlled Period|Lack of Efficacy|0|||
131420728|NCT00454584|473163031|FG003|After Controlled Period|Lack of Efficacy|1|||
131420729|NCT00454584|473163032|FG004|After Controlled Period|Lack of Efficacy|0|||
131420730|NCT00454584|473163033|FG005|After Controlled Period|Lack of Efficacy|0|||
131457772|NCT04535453|473307108|FG005|Overall Study|Physician Decision|0|||
131457773|NCT04535453|473307109|FG006|Overall Study|Physician Decision|0|||
131457774|NCT04535453|473307110|FG007|Overall Study|Physician Decision|0|||
131420731|NCT00454584|473163028|FG000|After Controlled Period|Lost to Follow-up|0|||
131420732|NCT00454584|473163029|FG001|After Controlled Period|Lost to Follow-up|0|||
131420733|NCT00454584|473163030|FG002|After Controlled Period|Lost to Follow-up|0|||
131420734|NCT00454584|473163031|FG003|After Controlled Period|Lost to Follow-up|2|||
131420735|NCT00454584|473163032|FG004|After Controlled Period|Lost to Follow-up|4|||
131420736|NCT00454584|473163033|FG005|After Controlled Period|Lost to Follow-up|6|||
131420737|NCT00454584|473163028|FG000|After Controlled Period|Other|0|||
131420738|NCT00454584|473163029|FG001|After Controlled Period|Other|0|||
131420739|NCT00454584|473163030|FG002|After Controlled Period|Other|0|||
131420740|NCT00454584|473163031|FG003|After Controlled Period|Other|1|||
131420741|NCT00454584|473163032|FG004|After Controlled Period|Other|0|||
131420742|NCT00454584|473163033|FG005|After Controlled Period|Other|0|||
131420743|NCT00454584|473163028|FG000|After Controlled Period|Other|0|||
131420744|NCT00454584|473163029|FG001|After Controlled Period|Other|0|||
131420745|NCT00454584|473163030|FG002|After Controlled Period|Other|0|||
131420746|NCT00454584|473163031|FG003|After Controlled Period|Other|13|||
131420747|NCT00454584|473163032|FG004|After Controlled Period|Other|5|||
131420748|NCT00454584|473163033|FG005|After Controlled Period|Other|17|||
131420749|NCT00470418|473163034|FG000|Overall Study|Withdrawal by Subject|1|||
131420750|NCT00470418|473163035|FG001|Overall Study|Withdrawal by Subject|0|||
131420751|NCT00454181|473163037|FG000|Overall Study|Adverse Event|1|||
131420752|NCT00454181|473163038|FG001|Overall Study|Adverse Event|1|||
131420753|NCT00454181|473163037|FG000|Overall Study|Lost to Follow-up|11|||
131420754|NCT00454181|473163038|FG001|Overall Study|Lost to Follow-up|1|||
131420755|NCT00454181|473163037|FG000|Overall Study|Protocol Violation|1|||
131420756|NCT00454181|473163038|FG001|Overall Study|Protocol Violation|1|||
131420757|NCT00454181|473163037|FG000|Overall Study|Withdrawal by Subject|2|||
131457775|NCT04535453|473307111|FG008|Overall Study|Physician Decision|0|||
131457776|NCT04535453|473307112|FG009|Overall Study|Physician Decision|0|||
131457777|NCT04535453|473307113|FG010|Overall Study|Physician Decision|0|||
131457778|NCT04535453|473307114|FG011|Overall Study|Physician Decision|0|||
131457779|NCT04535453|473307103|FG000|Overall Study|Withdrawal by Subject|3|||
131457780|NCT04535453|473307104|FG001|Overall Study|Withdrawal by Subject|6|||
131457781|NCT04535453|473307105|FG002|Overall Study|Withdrawal by Subject|3|||
131457782|NCT04535453|473307106|FG003|Overall Study|Withdrawal by Subject|3|||
131457783|NCT04535453|473307107|FG004|Overall Study|Withdrawal by Subject|2|||
131457784|NCT04535453|473307108|FG005|Overall Study|Withdrawal by Subject|1|||
131457785|NCT04535453|473307109|FG006|Overall Study|Withdrawal by Subject|1|||
131457786|NCT04535453|473307110|FG007|Overall Study|Withdrawal by Subject|1|||
131457787|NCT04535453|473307111|FG008|Overall Study|Withdrawal by Subject|1|||
131457788|NCT04535453|473307112|FG009|Overall Study|Withdrawal by Subject|1|||
131457789|NCT04535453|473307113|FG010|Overall Study|Withdrawal by Subject|0|||
131457790|NCT04535453|473307114|FG011|Overall Study|Withdrawal by Subject|1|||
131457791|NCT04535453|473307103|FG000|Overall Study|Other|0|||
131457792|NCT04535453|473307104|FG001|Overall Study|Other|0|||
131457793|NCT04535453|473307105|FG002|Overall Study|Other|1|||
131457794|NCT04535453|473307106|FG003|Overall Study|Other|0|||
131457795|NCT04535453|473307107|FG004|Overall Study|Other|1|||
131457796|NCT04535453|473307108|FG005|Overall Study|Other|0|||
131457797|NCT04535453|473307109|FG006|Overall Study|Other|1|||
131457798|NCT04535453|473307110|FG007|Overall Study|Other|1|||
131457799|NCT04535453|473307111|FG008|Overall Study|Other|1|||
131457800|NCT04535453|473307112|FG009|Overall Study|Other|0|||
131457801|NCT04535453|473307113|FG010|Overall Study|Other|0|||
131457802|NCT04535453|473307114|FG011|Overall Study|Other|0|||
131457803|NCT02442804|473307117|FG000|Overall Study|Withdrawal by Subject|0|||
131457804|NCT02442804|473307118|FG001|Overall Study|Withdrawal by Subject|1|||
131457805|NCT02442804|473307117|FG000|Overall Study|Adverse Event|1|||
131457806|NCT02442804|473307118|FG001|Overall Study|Adverse Event|0|||
131457807|NCT01309282|473307119|FG000|Overall Study|Lost to Follow-up|1|||
131457808|NCT02087423|473307120|FG000|Overall Study|Withdrawal by Subject|20|||
131457809|NCT02087423|473307121|FG001|Overall Study|Withdrawal by Subject|20|||
131457810|NCT02087423|473307122|FG002|Overall Study|Withdrawal by Subject|3|||
131420758|NCT00454181|473163038|FG001|Overall Study|Withdrawal by Subject|0|||
131457811|NCT02087423|473307120|FG000|Overall Study|Death|68|||
131457812|NCT02087423|473307121|FG001|Overall Study|Death|207|||
131420759|NCT02409719|473163050|FG000|Overall Study|Lost to Follow-up|3|||
131457813|NCT02087423|473307122|FG002|Overall Study|Death|40|||
131420760|NCT02409719|473163051|FG001|Overall Study|Lost to Follow-up|3|||
131420761|NCT03689855|473163052|FG000|Overall Study|Adverse Event|3|||
131420762|NCT03689855|473163052|FG000|Overall Study|Withdrawal by Subject|1|||
131420763|NCT02479139|473163053|FG000|Overall Study|Lost to Follow-up|2|||
131420764|NCT02479139|473163054|FG001|Overall Study|Lost to Follow-up|4|||
131420765|NCT02479139|473163055|FG002|Overall Study|Lost to Follow-up|4|||
131420766|NCT02479139|473163056|FG003|Overall Study|Lost to Follow-up|2|||
131457814|NCT02087423|473307120|FG000|Overall Study|Lost to Follow-up|0|||
131457815|NCT02087423|473307121|FG001|Overall Study|Lost to Follow-up|2|||
131457816|NCT02087423|473307122|FG002|Overall Study|Lost to Follow-up|0|||
131457817|NCT02087423|473307120|FG000|Overall Study|Terminated from study at final DCO|23|||
131457818|NCT02087423|473307121|FG001|Overall Study|Terminated from study at final DCO|36|||
131420767|NCT02479139|473163057|FG004|Overall Study|Lost to Follow-up|3|||
131420768|NCT02479139|473163058|FG005|Overall Study|Lost to Follow-up|5|||
131420769|NCT02479139|473163053|FG000|Overall Study|Withdrew Consent|5|||
131420770|NCT02479139|473163054|FG001|Overall Study|Withdrew Consent|6|||
131420771|NCT02479139|473163055|FG002|Overall Study|Withdrew Consent|1|||
131420772|NCT02479139|473163056|FG003|Overall Study|Withdrew Consent|4|||
131420773|NCT02479139|473163057|FG004|Overall Study|Withdrew Consent|1|||
131420774|NCT02479139|473163058|FG005|Overall Study|Withdrew Consent|1|||
131420775|NCT02479139|473163053|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
131420776|NCT02479139|473163054|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
131420777|NCT02479139|473163055|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
131420778|NCT02479139|473163056|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
131420779|NCT02479139|473163057|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
131420780|NCT02479139|473163058|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
131420781|NCT02479139|473163053|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131420782|NCT02479139|473163054|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131420783|NCT02479139|473163055|FG002|Overall Study|Other Miscellaneous Reasons|1|||
131420784|NCT02479139|473163056|FG003|Overall Study|Other Miscellaneous Reasons|1|||
131420785|NCT02479139|473163057|FG004|Overall Study|Other Miscellaneous Reasons|1|||
131420786|NCT02479139|473163058|FG005|Overall Study|Other Miscellaneous Reasons|0|||
131420787|NCT00764673|473163059|FG000|Overall Study|Death|1|||
131420788|NCT00764673|473163059|FG000|Overall Study|Lost to Follow-up|3|||
131420789|NCT00764673|473163059|FG000|Overall Study|Withdrawal by Subject|6|||
131420790|NCT00764673|473163059|FG000|Overall Study|Revision of Device|2|||
131420791|NCT01438177|473163060|FG000|Overall Study|Withdrawal by Subject|1|||
131420792|NCT01438177|473163060|FG000|Overall Study|Initiation of new therapy|1|||
131420793|NCT01727336|473163063|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
131420794|NCT01727336|473163064|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
131420795|NCT01727336|473163065|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
131420796|NCT01727336|473163066|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
131420797|NCT01727336|473163067|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
131420798|NCT01727336|473163068|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
131420799|NCT01727336|473163063|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
131420800|NCT01727336|473163064|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
131420801|NCT01727336|473163065|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
131420802|NCT01727336|473163066|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
131420803|NCT01727336|473163067|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
131420804|NCT01727336|473163068|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
131420805|NCT01727336|473163063|FG000|Part 2 Blinded|Death|0|||
131420806|NCT01727336|473163064|FG001|Part 2 Blinded|Death|0|||
131420807|NCT01727336|473163065|FG002|Part 2 Blinded|Death|0|||
131420808|NCT01727336|473163066|FG003|Part 2 Blinded|Death|0|||
131420809|NCT01727336|473163067|FG004|Part 2 Blinded|Death|20|||
131420810|NCT01727336|473163068|FG005|Part 2 Blinded|Death|16|||
131420811|NCT01727336|473163063|FG000|Part 2 Blinded|Lack of Efficacy|0|||
131420812|NCT01727336|473163064|FG001|Part 2 Blinded|Lack of Efficacy|0|||
131420813|NCT01727336|473163065|FG002|Part 2 Blinded|Lack of Efficacy|0|||
131420814|NCT01727336|473163066|FG003|Part 2 Blinded|Lack of Efficacy|0|||
131420815|NCT01727336|473163067|FG004|Part 2 Blinded|Lack of Efficacy|42|||
131420816|NCT01727336|473163068|FG005|Part 2 Blinded|Lack of Efficacy|44|||
131420817|NCT01727336|473163063|FG000|Part 2 Blinded|Lost to Follow-up|0|||
131420818|NCT01727336|473163064|FG001|Part 2 Blinded|Lost to Follow-up|0|||
131420819|NCT01727336|473163065|FG002|Part 2 Blinded|Lost to Follow-up|0|||
131420820|NCT01727336|473163066|FG003|Part 2 Blinded|Lost to Follow-up|0|||
131420821|NCT01727336|473163067|FG004|Part 2 Blinded|Lost to Follow-up|0|||
131420822|NCT01727336|473163068|FG005|Part 2 Blinded|Lost to Follow-up|1|||
131420823|NCT01727336|473163063|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
131420824|NCT01727336|473163064|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
131420825|NCT01727336|473163065|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
131420826|NCT01727336|473163066|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
131420827|NCT01727336|473163067|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
131420828|NCT01727336|473163068|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
131420829|NCT01727336|473163063|FG000|Part 2 Blinded|use of prohibited medications|0|||
131420830|NCT01727336|473163064|FG001|Part 2 Blinded|use of prohibited medications|0|||
131420831|NCT01727336|473163065|FG002|Part 2 Blinded|use of prohibited medications|0|||
131420832|NCT01727336|473163066|FG003|Part 2 Blinded|use of prohibited medications|0|||
131420833|NCT01727336|473163067|FG004|Part 2 Blinded|use of prohibited medications|1|||
131420834|NCT01727336|473163068|FG005|Part 2 Blinded|use of prohibited medications|3|||
131420835|NCT00619099|473163069|FG000|Overall Study|Progressive Disease|7|||
131420836|NCT00619099|473163070|FG001|Overall Study|Progressive Disease|5|||
131420837|NCT00619099|473163069|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
131420838|NCT00619099|473163070|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
131420839|NCT00619099|473163069|FG000|Overall Study|Adverse Event|4|||
131420840|NCT00619099|473163070|FG001|Overall Study|Adverse Event|3|||
131420841|NCT00619099|473163069|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
131420842|NCT00619099|473163070|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
131420843|NCT00619099|473163069|FG000|Overall Study|Withdrawal by Subject|10|||
131420844|NCT00619099|473163070|FG001|Overall Study|Withdrawal by Subject|2|||
131420845|NCT00619099|473163069|FG000|Overall Study|Physician Decision|9|||
131420846|NCT00619099|473163070|FG001|Overall Study|Physician Decision|6|||
131420847|NCT00885482|473163071|FG000|Overall Study|Pregnancy|1|||
131420848|NCT00885482|473163071|FG000|Overall Study|Lack of Efficacy|1|||
131420849|NCT00885482|473163071|FG000|Overall Study|Death|1|||
131420850|NCT00885482|473163071|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
131420851|NCT00129467|473163072|FG000|Received Intervention|Death|1|||
131420852|NCT00129467|473163073|FG001|Received Intervention|Death|1|||
131420853|NCT00129467|473163072|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
131420854|NCT00129467|473163073|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
131420855|NCT00129467|473163072|FG000|Received Intervention|Delirium|2|||
131420856|NCT00129467|473163073|FG001|Received Intervention|Delirium|0|||
131420857|NCT00129467|473163072|FG000|Received Intervention|Withdrawal by Subject|1|||
131420858|NCT00129467|473163073|FG001|Received Intervention|Withdrawal by Subject|0|||
131420859|NCT00129467|473163072|FG000|Received Intervention|Nausea|1|||
131420860|NCT00129467|473163073|FG001|Received Intervention|Nausea|0|||
131420861|NCT00129467|473163072|FG000|Received Intervention|Intolerance to citalopram|0|||
131420862|NCT00129467|473163073|FG001|Received Intervention|Intolerance to citalopram|1|||
131420863|NCT00129467|473163072|FG000|Received Intervention|Dizzyness, fatigue|0|||
131420864|NCT00129467|473163073|FG001|Received Intervention|Dizzyness, fatigue|1|||
131420865|NCT00129467|473163072|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
131420866|NCT00129467|473163073|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
131420867|NCT00129467|473163072|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
131420868|NCT00129467|473163073|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
131420869|NCT01424228|473163079|FG000|Overall Study|Withdrawal by Subject|27|||
131420870|NCT01424228|473163080|FG001|Overall Study|Withdrawal by Subject|11|||
131420871|NCT01424228|473163079|FG000|Overall Study|Adverse Event|10|||
131420872|NCT01424228|473163080|FG001|Overall Study|Adverse Event|14|||
131420873|NCT01424228|473163079|FG000|Overall Study|Sponsor's decision|9|||
131420874|NCT01424228|473163080|FG001|Overall Study|Sponsor's decision|12|||
131420875|NCT01424228|473163079|FG000|Overall Study|Lack of Efficacy|5|||
131420876|NCT01424228|473163080|FG001|Overall Study|Lack of Efficacy|7|||
131420877|NCT01424228|473163079|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
131420878|NCT01424228|473163080|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
131420879|NCT01424228|473163079|FG000|Overall Study|Non-compliance|2|||
131420880|NCT01424228|473163080|FG001|Overall Study|Non-compliance|0|||
131420881|NCT01424228|473163079|FG000|Overall Study|Worsening of symptoms|1|||
131420882|NCT01424228|473163080|FG001|Overall Study|Worsening of symptoms|0|||
131420883|NCT01424228|473163079|FG000|Overall Study|Unplanned journey|0|||
131420884|NCT01424228|473163080|FG001|Overall Study|Unplanned journey|1|||
131420885|NCT00671437|473163083|FG000|Overall Study|Progressive disease before C1 week 8|8|||
131420886|NCT00671437|473163083|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
131420887|NCT00671437|473163083|FG000|Overall Study|Adverse Event|3|||
131420888|NCT00671437|473163083|FG000|Overall Study|Ineligible post-hoc|1|||
131420889|NCT03927404|473163085|FG000|Overall Study|Withdrawal by Subject|1|||
131420890|NCT01229449|473163086|FG000|Overall Study|Withdrawal by Subject|0|||
131420891|NCT01229449|473163087|FG001|Overall Study|Withdrawal by Subject|3|||
131420892|NCT01229449|473163088|FG002|Overall Study|Withdrawal by Subject|0|||
131420893|NCT01229449|473163089|FG003|Overall Study|Withdrawal by Subject|1|||
131420894|NCT01229449|473163090|FG004|Overall Study|Withdrawal by Subject|1|||
131420895|NCT01229449|473163086|FG000|Overall Study|Lost to Follow-up|1|||
131420896|NCT01229449|473163087|FG001|Overall Study|Lost to Follow-up|1|||
131420897|NCT01229449|473163088|FG002|Overall Study|Lost to Follow-up|1|||
131420898|NCT01229449|473163089|FG003|Overall Study|Lost to Follow-up|0|||
131420899|NCT01229449|473163090|FG004|Overall Study|Lost to Follow-up|0|||
131420900|NCT01229449|473163086|FG000|Overall Study|Physician Decision|0|||
131420901|NCT01229449|473163087|FG001|Overall Study|Physician Decision|0|||
131420902|NCT01229449|473163088|FG002|Overall Study|Physician Decision|1|||
131420903|NCT01229449|473163089|FG003|Overall Study|Physician Decision|0|||
131420904|NCT01229449|473163090|FG004|Overall Study|Physician Decision|0|||
131420905|NCT00559988|473163091|FG000|Overall Study|Death|147|||
131420906|NCT00559988|473163092|FG001|Overall Study|Death|140|||
131420907|NCT00559988|473163091|FG000|Overall Study|Withdrawal by Subject|152|||
131420908|NCT00559988|473163092|FG001|Overall Study|Withdrawal by Subject|139|||
131420909|NCT00559988|473163091|FG000|Overall Study|Lost to Follow-up|42|||
131420910|NCT00559988|473163092|FG001|Overall Study|Lost to Follow-up|56|||
131420911|NCT00559988|473163091|FG000|Overall Study|ICD device explanted|10|||
131420912|NCT00559988|473163092|FG001|Overall Study|ICD device explanted|17|||
131420913|NCT01455194|473163093|FG000|Overall Study|Screen Failure|20|||
131420914|NCT01455194|473163094|FG001|Overall Study|Screen Failure|0|||
131420915|NCT01455194|473163095|FG002|Overall Study|Screen Failure|0|||
131420916|NCT01455194|473163096|FG003|Overall Study|Screen Failure|0|||
131420917|NCT01455194|473163093|FG000|Overall Study|Randomisation Failure|90|||
131420918|NCT01455194|473163094|FG001|Overall Study|Randomisation Failure|0|||
131420919|NCT01455194|473163095|FG002|Overall Study|Randomisation Failure|0|||
131420920|NCT01455194|473163096|FG003|Overall Study|Randomisation Failure|0|||
131420921|NCT01455194|473163093|FG000|Overall Study|Deterioration in asthma|12|||
131420922|NCT01455194|473163094|FG001|Overall Study|Deterioration in asthma|6|||
131420923|NCT01455194|473163095|FG002|Overall Study|Deterioration in asthma|14|||
131420924|NCT01455194|473163096|FG003|Overall Study|Deterioration in asthma|9|||
131420925|NCT01455194|473163093|FG000|Overall Study|Adverse Event|1|||
131420926|NCT01455194|473163094|FG001|Overall Study|Adverse Event|1|||
131420927|NCT01455194|473163095|FG002|Overall Study|Adverse Event|1|||
131420928|NCT01455194|473163096|FG003|Overall Study|Adverse Event|3|||
131420929|NCT01455194|473163093|FG000|Overall Study|Withdrawal by Subject|21|||
131420930|NCT01455194|473163094|FG001|Overall Study|Withdrawal by Subject|16|||
131420931|NCT01455194|473163095|FG002|Overall Study|Withdrawal by Subject|12|||
131420932|NCT01455194|473163096|FG003|Overall Study|Withdrawal by Subject|9|||
131420933|NCT01455194|473163093|FG000|Overall Study|Lost to Follow-up|2|||
131420934|NCT01455194|473163094|FG001|Overall Study|Lost to Follow-up|0|||
131420935|NCT01455194|473163095|FG002|Overall Study|Lost to Follow-up|1|||
131420936|NCT01455194|473163096|FG003|Overall Study|Lost to Follow-up|1|||
131420937|NCT01455194|473163093|FG000|Overall Study|Pregnancy|0|||
131420938|NCT01455194|473163094|FG001|Overall Study|Pregnancy|1|||
131420939|NCT01455194|473163095|FG002|Overall Study|Pregnancy|1|||
131420940|NCT01455194|473163096|FG003|Overall Study|Pregnancy|0|||
131420941|NCT01455194|473163093|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
131420942|NCT01455194|473163094|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
131420943|NCT01455194|473163095|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
131420944|NCT01455194|473163096|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
131420945|NCT01455194|473163093|FG000|Overall Study|Miscellaneous|4|||
131420946|NCT01455194|473163094|FG001|Overall Study|Miscellaneous|5|||
131420947|NCT01455194|473163095|FG002|Overall Study|Miscellaneous|1|||
131420948|NCT01455194|473163096|FG003|Overall Study|Miscellaneous|4|||
131420949|NCT02249182|473163097|FG000|Treatment Phase|Lost to Follow-up|4|||
131420950|NCT02249182|473163098|FG001|Treatment Phase|Lost to Follow-up|0|||
131420951|NCT02249182|473163099|FG002|Treatment Phase|Lost to Follow-up|0|||
131420952|NCT02249182|473163100|FG003|Treatment Phase|Lost to Follow-up|0|||
131420953|NCT02249182|473163101|FG004|Treatment Phase|Lost to Follow-up|0|||
131420954|NCT00788710|473163104|FG000|Overall Study|Adverse Event|1|||
131420955|NCT00788710|473163105|FG001|Overall Study|Adverse Event|3|||
131420956|NCT00788710|473163106|FG002|Overall Study|Adverse Event|4|||
131420957|NCT00788710|473163104|FG000|Overall Study|Lack of Efficacy|0|||
131420958|NCT00788710|473163105|FG001|Overall Study|Lack of Efficacy|0|||
131420959|NCT00788710|473163106|FG002|Overall Study|Lack of Efficacy|1|||
131420960|NCT00788710|473163104|FG000|Overall Study|Lost to Follow-up|0|||
131420961|NCT00788710|473163105|FG001|Overall Study|Lost to Follow-up|1|||
131420962|NCT00788710|473163106|FG002|Overall Study|Lost to Follow-up|0|||
131420963|NCT00788710|473163104|FG000|Overall Study|Physician Decision|2|||
131420964|NCT00788710|473163105|FG001|Overall Study|Physician Decision|1|||
131420965|NCT00788710|473163106|FG002|Overall Study|Physician Decision|0|||
131420966|NCT00788710|473163104|FG000|Overall Study|Protocol Violation|0|||
131420967|NCT00788710|473163105|FG001|Overall Study|Protocol Violation|1|||
131420968|NCT00788710|473163106|FG002|Overall Study|Protocol Violation|1|||
131420969|NCT00788710|473163104|FG000|Overall Study|Withdrawal by Subject|2|||
131420970|NCT00788710|473163105|FG001|Overall Study|Withdrawal by Subject|2|||
131420971|NCT00788710|473163106|FG002|Overall Study|Withdrawal by Subject|0|||
131420972|NCT01990859|473163107|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
131420973|NCT01990859|473163107|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
131420974|NCT01717326|473163108|FG000|Overall Study|Death|0|||
131420975|NCT01717326|473163109|FG001|Overall Study|Death|0|||
131420976|NCT01717326|473163110|FG002|Overall Study|Death|0|||
131420977|NCT01717326|473163111|FG003|Overall Study|Death|0|||
131420978|NCT01717326|473163112|FG004|Overall Study|Death|0|||
131420979|NCT01717326|473163113|FG005|Overall Study|Death|0|||
131420980|NCT01717326|473163114|FG006|Overall Study|Death|0|||
131420981|NCT01717326|473163115|FG007|Overall Study|Death|0|||
131420982|NCT01717326|473163116|FG008|Overall Study|Death|0|||
131420983|NCT01717326|473163117|FG009|Overall Study|Death|0|||
131420984|NCT01717326|473163118|FG010|Overall Study|Death|1|||
131420985|NCT01717326|473163119|FG011|Overall Study|Death|0|||
131420986|NCT01717326|473163120|FG012|Overall Study|Death|0|||
131420987|NCT01717326|473163121|FG013|Overall Study|Death|0|||
131420988|NCT01717326|473163122|FG014|Overall Study|Death|0|||
131420989|NCT01717326|473163123|FG015|Overall Study|Death|0|||
131420990|NCT01717326|473163124|FG016|Overall Study|Death|0|||
131420991|NCT01717326|473163125|FG017|Overall Study|Death|0|||
131420992|NCT01717326|473163126|FG018|Overall Study|Death|0|||
131420993|NCT01717326|473163127|FG019|Overall Study|Death|0|||
131420994|NCT01717326|473163108|FG000|Overall Study|Lost to Follow-up|3|||
131420995|NCT01717326|473163109|FG001|Overall Study|Lost to Follow-up|0|||
131420996|NCT01717326|473163110|FG002|Overall Study|Lost to Follow-up|0|||
131420997|NCT01717326|473163111|FG003|Overall Study|Lost to Follow-up|2|||
131420998|NCT01717326|473163112|FG004|Overall Study|Lost to Follow-up|1|||
131420999|NCT01717326|473163113|FG005|Overall Study|Lost to Follow-up|0|||
131421000|NCT01717326|473163114|FG006|Overall Study|Lost to Follow-up|1|||
131421001|NCT01717326|473163115|FG007|Overall Study|Lost to Follow-up|0|||
131457819|NCT02087423|473307122|FG002|Overall Study|Terminated from study at final DCO|25|||
131457820|NCT01387542|473307123|FG000|Overall Study|Adverse Event|3|||
131457821|NCT01387542|473307123|FG000|Overall Study|Withdrawal by Subject|1|||
131457822|NCT01387542|473307123|FG000|Overall Study|Changed diagnosis|1|||
131457823|NCT01387542|473307123|FG000|Overall Study|Insufficient response|1|||
131457824|NCT01387542|473307123|FG000|Overall Study|Non-compliant|1|||
131457825|NCT01387542|473307123|FG000|Overall Study|Lost to Follow-up|1|||
131457826|NCT01010867|473307124|FG000|Overall Study|< 50% adherence to probiotic|1|||
131457827|NCT01014910|473307127|FG000|Overall Study|Withdrawal by Subject|0|||
131457828|NCT01014910|473307128|FG001|Overall Study|Withdrawal by Subject|2|||
131457829|NCT00612807|473307129|FG000|Overall Study|Withdrawal by Subject|2|||
131457830|NCT00612807|473307130|FG001|Overall Study|Withdrawal by Subject|0|||
131457831|NCT02055118|473307141|FG000|Overall Study|Withdrawal by Subject|0|||
131457832|NCT02055118|473307142|FG001|Overall Study|Withdrawal by Subject|2|||
131457833|NCT02055118|473307143|FG002|Overall Study|Withdrawal by Subject|0|||
131457834|NCT02281383|473307144|FG000|Overall Study|Progressive Disease|1|||
131457835|NCT02281383|473307144|FG000|Overall Study|Withdrawal by Subject|6|||
131457836|NCT02281383|473307144|FG000|Overall Study|Protocol Violation|2|||
131457837|NCT02281383|473307144|FG000|Overall Study|Death|1|||
131457838|NCT02281383|473307144|FG000|Overall Study|Adverse Event|2|||
131457839|NCT01215097|473307145|FG000|Overall Study|Adverse Event|1|||
131457840|NCT01215097|473307146|FG001|Overall Study|Adverse Event|3|||
131457841|NCT01215097|473307145|FG000|Overall Study|Protocol Violation|0|||
131457842|NCT01215097|473307146|FG001|Overall Study|Protocol Violation|2|||
131421002|NCT01717326|473163116|FG008|Overall Study|Lost to Follow-up|0|||
131421003|NCT01717326|473163117|FG009|Overall Study|Lost to Follow-up|0|||
131421004|NCT01717326|473163118|FG010|Overall Study|Lost to Follow-up|1|||
131421005|NCT01717326|473163119|FG011|Overall Study|Lost to Follow-up|0|||
131421006|NCT01717326|473163120|FG012|Overall Study|Lost to Follow-up|0|||
131421007|NCT01717326|473163121|FG013|Overall Study|Lost to Follow-up|0|||
131421008|NCT01717326|473163122|FG014|Overall Study|Lost to Follow-up|0|||
131421009|NCT01717326|473163123|FG015|Overall Study|Lost to Follow-up|2|||
131421010|NCT01717326|473163124|FG016|Overall Study|Lost to Follow-up|1|||
131421011|NCT01717326|473163125|FG017|Overall Study|Lost to Follow-up|0|||
131421012|NCT01717326|473163126|FG018|Overall Study|Lost to Follow-up|2|||
131421013|NCT01717326|473163127|FG019|Overall Study|Lost to Follow-up|3|||
131421014|NCT01717326|473163108|FG000|Overall Study|Physician Decision|0|||
131421015|NCT01717326|473163109|FG001|Overall Study|Physician Decision|0|||
131421016|NCT01717326|473163110|FG002|Overall Study|Physician Decision|0|||
131457843|NCT01215097|473307145|FG000|Overall Study|Lost to Follow-up|2|||
131421017|NCT01717326|473163111|FG003|Overall Study|Physician Decision|0|||
131421018|NCT01717326|473163112|FG004|Overall Study|Physician Decision|0|||
131421019|NCT01717326|473163113|FG005|Overall Study|Physician Decision|0|||
131421020|NCT01717326|473163114|FG006|Overall Study|Physician Decision|0|||
131421021|NCT01717326|473163115|FG007|Overall Study|Physician Decision|0|||
131421022|NCT01717326|473163116|FG008|Overall Study|Physician Decision|0|||
131457844|NCT01215097|473307146|FG001|Overall Study|Lost to Follow-up|0|||
131457845|NCT01215097|473307145|FG000|Overall Study|Withdrawal by Subject|6|||
131457846|NCT01215097|473307146|FG001|Overall Study|Withdrawal by Subject|3|||
131421023|NCT01717326|473163117|FG009|Overall Study|Physician Decision|1|||
131421024|NCT01717326|473163118|FG010|Overall Study|Physician Decision|0|||
131421025|NCT01717326|473163119|FG011|Overall Study|Physician Decision|0|||
131421026|NCT01717326|473163120|FG012|Overall Study|Physician Decision|0|||
131421027|NCT01717326|473163121|FG013|Overall Study|Physician Decision|0|||
131421028|NCT01717326|473163122|FG014|Overall Study|Physician Decision|0|||
131421029|NCT01717326|473163123|FG015|Overall Study|Physician Decision|0|||
131421030|NCT01717326|473163124|FG016|Overall Study|Physician Decision|0|||
131421031|NCT01717326|473163125|FG017|Overall Study|Physician Decision|0|||
131421032|NCT01717326|473163126|FG018|Overall Study|Physician Decision|0|||
131421033|NCT01717326|473163127|FG019|Overall Study|Physician Decision|0|||
131421034|NCT01717326|473163108|FG000|Overall Study|Protocol Violation|0|||
131421035|NCT01717326|473163109|FG001|Overall Study|Protocol Violation|0|||
131421036|NCT01717326|473163110|FG002|Overall Study|Protocol Violation|0|||
131421037|NCT01717326|473163111|FG003|Overall Study|Protocol Violation|0|||
131421038|NCT01717326|473163112|FG004|Overall Study|Protocol Violation|1|||
131421039|NCT01717326|473163113|FG005|Overall Study|Protocol Violation|0|||
131421040|NCT01717326|473163114|FG006|Overall Study|Protocol Violation|0|||
131421041|NCT01717326|473163115|FG007|Overall Study|Protocol Violation|0|||
131421042|NCT01717326|473163116|FG008|Overall Study|Protocol Violation|0|||
131421043|NCT01717326|473163117|FG009|Overall Study|Protocol Violation|0|||
131421044|NCT01717326|473163118|FG010|Overall Study|Protocol Violation|0|||
131421045|NCT01717326|473163119|FG011|Overall Study|Protocol Violation|0|||
131421046|NCT01717326|473163120|FG012|Overall Study|Protocol Violation|0|||
131421047|NCT01717326|473163121|FG013|Overall Study|Protocol Violation|0|||
131421048|NCT01717326|473163122|FG014|Overall Study|Protocol Violation|0|||
131421049|NCT01717326|473163123|FG015|Overall Study|Protocol Violation|0|||
131421050|NCT01717326|473163124|FG016|Overall Study|Protocol Violation|0|||
131421051|NCT01717326|473163125|FG017|Overall Study|Protocol Violation|0|||
131421052|NCT01717326|473163126|FG018|Overall Study|Protocol Violation|0|||
131421053|NCT01717326|473163127|FG019|Overall Study|Protocol Violation|0|||
131421054|NCT01717326|473163108|FG000|Overall Study|Withdrawal by Subject|0|||
131421055|NCT01717326|473163109|FG001|Overall Study|Withdrawal by Subject|1|||
131421056|NCT01717326|473163110|FG002|Overall Study|Withdrawal by Subject|0|||
131421057|NCT01717326|473163111|FG003|Overall Study|Withdrawal by Subject|0|||
131421058|NCT01717326|473163112|FG004|Overall Study|Withdrawal by Subject|0|||
131421059|NCT01717326|473163113|FG005|Overall Study|Withdrawal by Subject|0|||
131421060|NCT01717326|473163114|FG006|Overall Study|Withdrawal by Subject|0|||
131421061|NCT01717326|473163115|FG007|Overall Study|Withdrawal by Subject|0|||
131421062|NCT01717326|473163116|FG008|Overall Study|Withdrawal by Subject|0|||
131421063|NCT01717326|473163117|FG009|Overall Study|Withdrawal by Subject|1|||
131421064|NCT01717326|473163118|FG010|Overall Study|Withdrawal by Subject|0|||
131421065|NCT01717326|473163119|FG011|Overall Study|Withdrawal by Subject|0|||
131421066|NCT01717326|473163120|FG012|Overall Study|Withdrawal by Subject|1|||
131421067|NCT01717326|473163121|FG013|Overall Study|Withdrawal by Subject|0|||
131421068|NCT01717326|473163122|FG014|Overall Study|Withdrawal by Subject|0|||
131421069|NCT01717326|473163123|FG015|Overall Study|Withdrawal by Subject|1|||
131421070|NCT01717326|473163124|FG016|Overall Study|Withdrawal by Subject|0|||
131421071|NCT01717326|473163125|FG017|Overall Study|Withdrawal by Subject|0|||
131421072|NCT01717326|473163126|FG018|Overall Study|Withdrawal by Subject|2|||
131421073|NCT01717326|473163127|FG019|Overall Study|Withdrawal by Subject|3|||
131421074|NCT03208088|473163133|FG000|Period 2|Withdrawal by Subject|0|||
131421075|NCT03208088|473163134|FG001|Period 2|Withdrawal by Subject|0|||
131421076|NCT03208088|473163135|FG002|Period 2|Withdrawal by Subject|0|||
131421077|NCT03208088|473163136|FG003|Period 2|Withdrawal by Subject|0|||
131421078|NCT03208088|473163137|FG004|Period 2|Withdrawal by Subject|0|||
131421079|NCT03208088|473163138|FG005|Period 2|Withdrawal by Subject|0|||
131421080|NCT03208088|473163139|FG006|Period 2|Withdrawal by Subject|0|||
131421081|NCT03208088|473163140|FG007|Period 2|Withdrawal by Subject|0|||
131421082|NCT03208088|473163141|FG008|Period 2|Withdrawal by Subject|1|||
131421083|NCT03208088|473163142|FG009|Period 2|Withdrawal by Subject|0|||
131421084|NCT03208088|473163133|FG000|Period 3|Unsatisfactory Test Article|0|||
131421085|NCT03208088|473163134|FG001|Period 3|Unsatisfactory Test Article|0|||
131421086|NCT03208088|473163135|FG002|Period 3|Unsatisfactory Test Article|0|||
131421087|NCT03208088|473163136|FG003|Period 3|Unsatisfactory Test Article|1|||
131421088|NCT03208088|473163137|FG004|Period 3|Unsatisfactory Test Article|0|||
131421089|NCT03208088|473163138|FG005|Period 3|Unsatisfactory Test Article|0|||
131421090|NCT03208088|473163139|FG006|Period 3|Unsatisfactory Test Article|0|||
131421091|NCT03208088|473163140|FG007|Period 3|Unsatisfactory Test Article|0|||
131421092|NCT03208088|473163141|FG008|Period 3|Unsatisfactory Test Article|0|||
131421093|NCT03208088|473163142|FG009|Period 3|Unsatisfactory Test Article|0|||
131421094|NCT03208088|473163133|FG000|Period 4|Unsatisfactory Test Article|0|||
131421095|NCT03208088|473163134|FG001|Period 4|Unsatisfactory Test Article|0|||
131421096|NCT03208088|473163135|FG002|Period 4|Unsatisfactory Test Article|0|||
131421097|NCT03208088|473163136|FG003|Period 4|Unsatisfactory Test Article|1|||
131421098|NCT03208088|473163137|FG004|Period 4|Unsatisfactory Test Article|0|||
131421099|NCT03208088|473163138|FG005|Period 4|Unsatisfactory Test Article|0|||
131421100|NCT03208088|473163139|FG006|Period 4|Unsatisfactory Test Article|0|||
131421101|NCT03208088|473163140|FG007|Period 4|Unsatisfactory Test Article|0|||
131421102|NCT03208088|473163141|FG008|Period 4|Unsatisfactory Test Article|0|||
131421103|NCT03208088|473163142|FG009|Period 4|Unsatisfactory Test Article|0|||
131421104|NCT05066165|473165386|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
131421105|NCT05066165|473165387|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
131421106|NCT05066165|473165386|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
131421107|NCT05066165|473165387|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
131421108|NCT03738618|473165388|FG000|Overall Study|Protocol deviation|23|||
131421109|NCT03738618|473165389|FG001|Overall Study|Protocol deviation|0|||
131421110|NCT03738618|473165388|FG000|Overall Study|Adverse Event|4|||
131421111|NCT03738618|473165389|FG001|Overall Study|Adverse Event|0|||
131421112|NCT03738618|473165388|FG000|Overall Study|Lost to Follow-up|2|||
131421113|NCT03738618|473165389|FG001|Overall Study|Lost to Follow-up|0|||
131421114|NCT03738618|473165388|FG000|Overall Study|Randomization failure|1|||
131421115|NCT03738618|473165389|FG001|Overall Study|Randomization failure|0|||
131421116|NCT03738618|473165388|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
131421117|NCT03738618|473165389|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
131421118|NCT03738618|473165388|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
131421119|NCT03738618|473165389|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
131421120|NCT01769196|473165390|FG000|Overall Study|Adverse Event|24|||
131421121|NCT01769196|473165391|FG001|Overall Study|Adverse Event|20|||
131421122|NCT01769196|473165390|FG000|Overall Study|Death|21|||
131421123|NCT01769196|473165391|FG001|Overall Study|Death|26|||
131421124|NCT01769196|473165390|FG000|Overall Study|Investigator Discretion|7|||
131421125|NCT01769196|473165391|FG001|Overall Study|Investigator Discretion|3|||
131421126|NCT01769196|473165390|FG000|Overall Study|Lack of Efficacy|3|||
131421127|NCT01769196|473165391|FG001|Overall Study|Lack of Efficacy|2|||
131421128|NCT01769196|473165390|FG000|Overall Study|Progressive disease|11|||
131421129|NCT01769196|473165391|FG001|Overall Study|Progressive disease|6|||
131421130|NCT01769196|473165390|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
131421131|NCT01769196|473165391|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
131421132|NCT01769196|473165390|FG000|Overall Study|Protocol Violation|0|||
131421133|NCT01769196|473165391|FG001|Overall Study|Protocol Violation|3|||
131421134|NCT01769196|473165390|FG000|Overall Study|Study terminated by sponsor|160|||
131421135|NCT01769196|473165391|FG001|Overall Study|Study terminated by sponsor|161|||
131421136|NCT01769196|473165390|FG000|Overall Study|Participant never dosed with study drug|1|||
131421137|NCT01769196|473165391|FG001|Overall Study|Participant never dosed with study drug|0|||
131421138|NCT01769196|473165390|FG000|Overall Study|Withdrew consent|36|||
131421139|NCT01769196|473165391|FG001|Overall Study|Withdrew consent|40|||
131421140|NCT01450098|473165398|FG000|Period 3|Protocol Violation|0|||
131421141|NCT01450098|473165399|FG001|Period 3|Protocol Violation|1|||
131421142|NCT01450098|473165398|FG000|Period 3|Withdrawal by Subject|0|||
131421143|NCT01450098|473165399|FG001|Period 3|Withdrawal by Subject|2|||
131421144|NCT00655629|473165400|FG000|Overall Study|Adverse Event|4|||
131421145|NCT00655629|473165401|FG001|Overall Study|Adverse Event|1|||
131421146|NCT00655629|473165400|FG000|Overall Study|Lack of Efficacy|2|||
131421147|NCT00655629|473165401|FG001|Overall Study|Lack of Efficacy|12|||
131421148|NCT00655629|473165400|FG000|Overall Study|Lost to Follow-up|4|||
131421149|NCT00655629|473165401|FG001|Overall Study|Lost to Follow-up|3|||
131421150|NCT00655629|473165400|FG000|Overall Study|Protocol Violation|5|||
131421151|NCT00655629|473165401|FG001|Overall Study|Protocol Violation|3|||
131421152|NCT00655629|473165400|FG000|Overall Study|consent withdrawn|6|||
131421153|NCT00655629|473165401|FG001|Overall Study|consent withdrawn|4|||
131421154|NCT00705367|473165402|FG000|Long-term Extension Period|Adverse Event|2|||
131421155|NCT00705367|473165403|FG001|Long-term Extension Period|Adverse Event|0|||
131421156|NCT00705367|473165402|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
131421157|NCT00705367|473165403|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
131421158|NCT00705367|473165402|FG000|Long-term Extension Period|Lack of Efficacy|1|||
131421159|NCT00705367|473165403|FG001|Long-term Extension Period|Lack of Efficacy|0|||
131421160|NCT00705367|473165402|FG000|Long-term Extension Period|No longer met study criteria|1|||
131421161|NCT00705367|473165403|FG001|Long-term Extension Period|No longer met study criteria|0|||
131421162|NCT00705367|473165402|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
131421163|NCT00705367|473165403|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
131421164|NCT01832155|473165404|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
131421165|NCT01832155|473165405|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
131421166|NCT01832155|473165404|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
131421167|NCT01832155|473165405|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
131421168|NCT01055314|473165406|FG000|Overall Study|Adverse Event|7|||
131421169|NCT01055314|473165407|FG001|Overall Study|Adverse Event|4|||
131421170|NCT01055314|473165406|FG000|Overall Study|Death|2|||
131421171|NCT01055314|473165407|FG001|Overall Study|Death|1|||
131421172|NCT01055314|473165406|FG000|Overall Study|Lack of Efficacy|11|||
131421173|NCT01055314|473165407|FG001|Overall Study|Lack of Efficacy|19|||
131421174|NCT01055314|473165406|FG000|Overall Study|Physician Decision|10|||
131421175|NCT01055314|473165407|FG001|Overall Study|Physician Decision|5|||
131421176|NCT01055314|473165406|FG000|Overall Study|Withdrawal by Subject|1|||
131421177|NCT01055314|473165407|FG001|Overall Study|Withdrawal by Subject|0|||
131421178|NCT01055314|473165406|FG000|Overall Study|Ineligible|3|||
131421179|NCT01055314|473165407|FG001|Overall Study|Ineligible|5|||
131421180|NCT01055314|473165406|FG000|Overall Study|Refusal of further protocol therapy|10|||
131421181|NCT01055314|473165407|FG001|Overall Study|Refusal of further protocol therapy|4|||
131421182|NCT01055314|473165406|FG000|Overall Study|No treatment|1|||
131421183|NCT01055314|473165407|FG001|Overall Study|No treatment|0|||
131421184|NCT01279616|473165408|FG000|Overall Study|donor could not be located|5|||
131421185|NCT01279616|473165408|FG000|Overall Study|no signs of sickle cell disease|2|||
131421186|NCT02462720|473165409|FG000|Part 2|Withdrawal by Subject|1|||
131421187|NCT02462720|473165410|FG001|Part 2|Withdrawal by Subject|0|||
131421188|NCT02462720|473165409|FG000|Part 2|Protocol Violation|0|||
131421189|NCT02462720|473165410|FG001|Part 2|Protocol Violation|1|||
131421190|NCT00183625|473165413|FG000|Overall Study|Withdrawal by Subject|18|||
131421191|NCT00183625|473165414|FG001|Overall Study|Withdrawal by Subject|18|||
131421192|NCT00183625|473165415|FG002|Overall Study|Withdrawal by Subject|19|||
131421193|NCT00183625|473165416|FG003|Overall Study|Withdrawal by Subject|14|||
131421194|NCT01966445|473165421|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
131421195|NCT01966445|473165422|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
131421196|NCT01966445|473165423|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
131421197|NCT01966445|473165424|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
131421198|NCT01966445|473165425|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
131421199|NCT01966445|473165426|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
131421200|NCT01966445|473165427|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
131421201|NCT01966445|473165421|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
131421202|NCT01966445|473165422|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
131421203|NCT01966445|473165423|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
131421204|NCT01966445|473165424|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
131421205|NCT01966445|473165425|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
131421206|NCT01966445|473165426|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
131421207|NCT01966445|473165427|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
131457847|NCT01215097|473307145|FG000|Overall Study|Lack of Efficacy|0|||
131457848|NCT01215097|473307146|FG001|Overall Study|Lack of Efficacy|3|||
131457849|NCT01215097|473307145|FG000|Overall Study|patient's refusal to come|2|||
131421208|NCT01966445|473165421|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
131421209|NCT01966445|473165422|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
131421210|NCT01966445|473165423|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
131421211|NCT01966445|473165424|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
131421212|NCT01966445|473165425|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
131421213|NCT01966445|473165426|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
131421214|NCT01966445|473165427|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
131457850|NCT01215097|473307146|FG001|Overall Study|patient's refusal to come|2|||
131421215|NCT01966445|473165421|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
131421216|NCT01966445|473165422|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
131421217|NCT01966445|473165423|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
131421218|NCT01966445|473165424|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
131421219|NCT01966445|473165425|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
131421220|NCT01966445|473165426|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
131421221|NCT01966445|473165427|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
131421222|NCT01966445|473165421|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
131421223|NCT01966445|473165422|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
131421224|NCT01966445|473165423|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
131421225|NCT01966445|473165424|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
131421226|NCT01966445|473165425|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
131421227|NCT01966445|473165426|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
131421228|NCT01966445|473165427|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
131421229|NCT01374178|473165428|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
131421230|NCT01374178|473165429|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
131421231|NCT01374178|473165428|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
131421232|NCT01374178|473165429|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
131421233|NCT04856904|473165430|FG000|Overall Study|Physician Decision|1|||
131421234|NCT04856904|473165431|FG001|Overall Study|Physician Decision|1|||
131421235|NCT04856904|473165430|FG000|Overall Study|Withdrawal by Subject|13|||
131421236|NCT04856904|473165431|FG001|Overall Study|Withdrawal by Subject|13|||
131421237|NCT04856904|473165430|FG000|Overall Study|Adverse Event|1|||
131421238|NCT04856904|473165431|FG001|Overall Study|Adverse Event|1|||
131421239|NCT04856904|473165430|FG000|Overall Study|Non-compliance with study drug|1|||
131421240|NCT04856904|473165431|FG001|Overall Study|Non-compliance with study drug|1|||
131421241|NCT04856904|473165430|FG000|Overall Study|Lost to Follow-up|4|||
131421242|NCT04856904|473165431|FG001|Overall Study|Lost to Follow-up|4|||
131421243|NCT04856904|473165430|FG000|Overall Study|Withdrawal by Subject|1|||
131421244|NCT04856904|473165431|FG001|Overall Study|Withdrawal by Subject|1|||
131421245|NCT04856904|473165430|FG000|Overall Study|Protocol Violation|1|||
131421246|NCT04856904|473165431|FG001|Overall Study|Protocol Violation|1|||
131421247|NCT00077649|473165432|FG000|Overall Study|Adverse Event|5|||
131421248|NCT00077649|473165433|FG001|Overall Study|Adverse Event|1|||
131421249|NCT00077649|473165434|FG002|Overall Study|Adverse Event|7|||
131421250|NCT00077649|473165435|FG003|Overall Study|Adverse Event|9|||
131421251|NCT00077649|473165432|FG000|Overall Study|Lack of Efficacy|5|||
131421252|NCT00077649|473165433|FG001|Overall Study|Lack of Efficacy|3|||
131421253|NCT00077649|473165434|FG002|Overall Study|Lack of Efficacy|3|||
131421254|NCT00077649|473165435|FG003|Overall Study|Lack of Efficacy|2|||
131421255|NCT00077649|473165432|FG000|Overall Study|Withdrawal by Subject|0|||
131421256|NCT00077649|473165433|FG001|Overall Study|Withdrawal by Subject|1|||
131421257|NCT00077649|473165434|FG002|Overall Study|Withdrawal by Subject|1|||
131421258|NCT00077649|473165435|FG003|Overall Study|Withdrawal by Subject|2|||
131421259|NCT00077649|473165432|FG000|Overall Study|Lost to Follow-up|2|||
131421260|NCT00077649|473165433|FG001|Overall Study|Lost to Follow-up|2|||
131421261|NCT00077649|473165434|FG002|Overall Study|Lost to Follow-up|3|||
131421262|NCT00077649|473165435|FG003|Overall Study|Lost to Follow-up|2|||
131421263|NCT00077649|473165432|FG000|Overall Study|Abnormality of Laboratory Test|1|||
131421264|NCT00077649|473165433|FG001|Overall Study|Abnormality of Laboratory Test|2|||
131421265|NCT00077649|473165434|FG002|Overall Study|Abnormality of Laboratory Test|1|||
131421266|NCT00077649|473165435|FG003|Overall Study|Abnormality of Laboratory Test|2|||
131421267|NCT00077649|473165432|FG000|Overall Study|Randomized but never dosed|1|||
131421268|NCT00077649|473165433|FG001|Overall Study|Randomized but never dosed|0|||
131421269|NCT00077649|473165434|FG002|Overall Study|Randomized but never dosed|0|||
131421270|NCT00077649|473165435|FG003|Overall Study|Randomized but never dosed|0|||
131421271|NCT01641822|473165436|FG000|Run-in Phase|Noncompliance with study drug|1|||
131421272|NCT01641822|473165437|FG001|Run-in Phase|Noncompliance with study drug|0|||
131421273|NCT01641822|473165438|FG002|Run-in Phase|Noncompliance with study drug|0|||
131421274|NCT01641822|473165436|FG000|Run-in Phase|Adverse Event|3|||
131421275|NCT01641822|473165437|FG001|Run-in Phase|Adverse Event|0|||
131421276|NCT01641822|473165438|FG002|Run-in Phase|Adverse Event|0|||
131421277|NCT01641822|473165436|FG000|Run-in Phase|Withdrew consent|1|||
131421278|NCT01641822|473165437|FG001|Run-in Phase|Withdrew consent|0|||
131421279|NCT01641822|473165438|FG002|Run-in Phase|Withdrew consent|0|||
131421280|NCT01641822|473165436|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
131421281|NCT01641822|473165437|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
131421282|NCT01641822|473165438|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
131421283|NCT01641822|473165436|FG000|Comparative Phase|Noncompliance with study drug|0|||
131421284|NCT01641822|473165437|FG001|Comparative Phase|Noncompliance with study drug|1|||
131421285|NCT01641822|473165438|FG002|Comparative Phase|Noncompliance with study drug|0|||
131421286|NCT01641822|473165436|FG000|Comparative Phase|Investigator's discretion|0|||
131421287|NCT01641822|473165437|FG001|Comparative Phase|Investigator's discretion|0|||
131421288|NCT01641822|473165438|FG002|Comparative Phase|Investigator's discretion|1|||
131421289|NCT01641822|473165436|FG000|Comparative Phase|Pregnancy|0|||
131421290|NCT01641822|473165437|FG001|Comparative Phase|Pregnancy|0|||
131421291|NCT01641822|473165438|FG002|Comparative Phase|Pregnancy|1|||
131421292|NCT01641822|473165436|FG000|Comparative Phase|Adverse event, serious fatal|0|||
131421293|NCT01641822|473165437|FG001|Comparative Phase|Adverse event, serious fatal|1|||
131421294|NCT01641822|473165438|FG002|Comparative Phase|Adverse event, serious fatal|0|||
131421295|NCT01641822|473165436|FG000|Comparative Phase|Withdrew consent|0|||
131421296|NCT01641822|473165437|FG001|Comparative Phase|Withdrew consent|3|||
131421297|NCT01641822|473165438|FG002|Comparative Phase|Withdrew consent|7|||
131421298|NCT01641822|473165436|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
131421299|NCT01641822|473165437|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
131421300|NCT01641822|473165438|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
131421301|NCT02421601|473165439|FG000|Overall Study|Adverse Event|4|||
131421302|NCT02421601|473165439|FG000|Overall Study|Lack of Efficacy|5|||
131421303|NCT02421601|473165439|FG000|Overall Study|Physician Decision|1|||
131421304|NCT02421601|473165439|FG000|Overall Study|Withdrawal by Subject|31|||
131421305|NCT02421601|473165439|FG000|Overall Study|Others|41|||
131421306|NCT00599638|473165440|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
131421307|NCT00599638|473165441|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
131421308|NCT00599638|473165442|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
131421309|NCT00599638|473165443|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
131421310|NCT00599638|473165440|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
131421311|NCT00599638|473165441|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
131421312|NCT00599638|473165442|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
131421313|NCT00599638|473165443|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
131421314|NCT00599638|473165440|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
131421315|NCT00599638|473165441|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
131421316|NCT00599638|473165442|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
131421317|NCT00599638|473165443|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
131421318|NCT00599638|473165440|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
131421319|NCT00599638|473165441|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
131421320|NCT00599638|473165442|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
131421321|NCT00599638|473165443|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
131421322|NCT00599638|473165440|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
131421323|NCT00599638|473165441|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
131421324|NCT00599638|473165442|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
131421325|NCT00599638|473165443|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
131421326|NCT00599638|473165440|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
131421327|NCT00599638|473165441|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
131421328|NCT00599638|473165442|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
131421329|NCT00599638|473165443|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
131421330|NCT00599638|473165440|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
131421331|NCT00599638|473165441|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
131421332|NCT00599638|473165442|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
131421333|NCT00599638|473165443|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
131421334|NCT00599638|473165440|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
131421335|NCT00599638|473165441|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
131421336|NCT00599638|473165442|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
131421337|NCT00599638|473165443|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
131421338|NCT00599638|473165440|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
131421339|NCT00599638|473165441|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
131421340|NCT00599638|473165442|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
131421341|NCT00599638|473165443|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
131421342|NCT02895945|473165446|FG000|Overall Study|Physician Decision|2|||
131421343|NCT02895945|473165447|FG001|Overall Study|Physician Decision|1|||
131421344|NCT00084656|473165451|FG000|Overall Study|Other reasons|0|||
131421345|NCT00084656|473165452|FG001|Overall Study|Other reasons|12|||
131421346|NCT00084656|473165453|FG002|Overall Study|Other reasons|11|||
131421347|NCT00084656|473165451|FG000|Overall Study|Withdrawal by Subject|15|||
131421348|NCT00084656|473165452|FG001|Overall Study|Withdrawal by Subject|4|||
131421349|NCT00084656|473165453|FG002|Overall Study|Withdrawal by Subject|4|||
131421350|NCT00084656|473165451|FG000|Overall Study|Disease relapse|0|||
131421351|NCT00084656|473165452|FG001|Overall Study|Disease relapse|9|||
131421352|NCT00084656|473165453|FG002|Overall Study|Disease relapse|10|||
131421353|NCT00084656|473165451|FG000|Overall Study|Disease progression|9|||
131421354|NCT00084656|473165452|FG001|Overall Study|Disease progression|0|||
131421355|NCT00084656|473165453|FG002|Overall Study|Disease progression|0|||
131421356|NCT00084656|473165451|FG000|Overall Study|Lost to Follow-up|1|||
131421357|NCT00084656|473165452|FG001|Overall Study|Lost to Follow-up|0|||
131421358|NCT00084656|473165453|FG002|Overall Study|Lost to Follow-up|1|||
131421359|NCT02772978|473165454|FG000|Overall Study|Withdrawal by Subject|1|||
131421360|NCT02772978|473165455|FG001|Overall Study|Withdrawal by Subject|1|||
131421361|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
131421362|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
131421363|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
131421364|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
131421365|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
131421366|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
131421367|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
131421368|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
131421369|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
131421370|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
131421371|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
131421372|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
131421373|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
131421374|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
131421375|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
131421376|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
131421377|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
131421378|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
131421379|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
131421380|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
131421381|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
131421382|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
131421383|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
131421384|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
131421385|NCT01532869|473165456|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
131421386|NCT01532869|473165457|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
131421387|NCT01532869|473165456|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
131421388|NCT01532869|473165457|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
131421389|NCT01532869|473165456|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
131421390|NCT01532869|473165457|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
131421391|NCT01532869|473165456|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
131421392|NCT01532869|473165457|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
131457851|NCT01215097|473307145|FG000|Overall Study|patient's private reason|1|||
131457852|NCT01215097|473307146|FG001|Overall Study|patient's private reason|1|||
131457853|NCT02259088|473307147|FG000|Overall Study|Adverse Event|6|||
131457854|NCT02259088|473307148|FG001|Overall Study|Adverse Event|4|||
131457855|NCT02259088|473307147|FG000|Overall Study|Lost to Follow-up|2|||
131457856|NCT02259088|473307148|FG001|Overall Study|Lost to Follow-up|0|||
131457857|NCT02259088|473307147|FG000|Overall Study|Death|2|||
131457858|NCT02259088|473307148|FG001|Overall Study|Death|0|||
131457859|NCT02259088|473307147|FG000|Overall Study|Physician Decision|5|||
131457860|NCT02259088|473307148|FG001|Overall Study|Physician Decision|2|||
131457861|NCT02259088|473307147|FG000|Overall Study|Protocol deviation|5|||
131457862|NCT02259088|473307148|FG001|Overall Study|Protocol deviation|0|||
131457863|NCT02259088|473307147|FG000|Overall Study|Subject/guardian decision|8|||
131457864|NCT02259088|473307148|FG001|Overall Study|Subject/guardian decision|8|||
131457865|NCT02252939|473307149|FG000|Overall Study|Lost to Follow-up|3|||
131457866|NCT01033448|473307151|FG000|Overall Study|Withdrawal by Subject|4|||
131457867|NCT01033448|473307151|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
131457868|NCT01033448|473307151|FG000|Overall Study|Lost to Follow-up|3|||
131457869|NCT01033448|473307151|FG000|Overall Study|Withdrew due to other reasons|3|||
131457870|NCT01033448|473307151|FG000|Overall Study|Unknown disposition|1|||
131457871|NCT01818752|473307152|FG000|Overall Study|Adverse Event|64|||
131457872|NCT01818752|473307153|FG001|Overall Study|Adverse Event|74|||
131457873|NCT01818752|473307152|FG000|Overall Study|Death|14|||
131457874|NCT01818752|473307153|FG001|Overall Study|Death|18|||
131457875|NCT01818752|473307152|FG000|Overall Study|Non-compliance|16|||
131457876|NCT01818752|473307153|FG001|Overall Study|Non-compliance|20|||
131457877|NCT01818752|473307152|FG000|Overall Study|Withdrawal by Subject|15|||
131457878|NCT01818752|473307153|FG001|Overall Study|Withdrawal by Subject|14|||
131457879|NCT01818752|473307152|FG000|Overall Study|Physician Decision|9|||
131457880|NCT01818752|473307153|FG001|Overall Study|Physician Decision|8|||
131457881|NCT01818752|473307152|FG000|Overall Study|Disease Progression|54|||
131457882|NCT01818752|473307153|FG001|Overall Study|Disease Progression|48|||
131457883|NCT01818752|473307152|FG000|Overall Study|Other|7|||
131457884|NCT01818752|473307153|FG001|Overall Study|Other|8|||
131457885|NCT01818752|473307152|FG000|Overall Study|Continuing Treatment|1|||
131457886|NCT01818752|473307153|FG001|Overall Study|Continuing Treatment|4|||
131457887|NCT01818752|473307152|FG000|Overall Study|Randomized but not Dosed|7|||
131457888|NCT01818752|473307153|FG001|Overall Study|Randomized but not Dosed|4|||
131457889|NCT04270370|473307154|FG000|Overall Study|Lost to Follow-up|1|||
131457890|NCT04270370|473307155|FG001|Overall Study|Lost to Follow-up|0|||
131421393|NCT01532869|473165456|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
131421394|NCT01532869|473165457|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
131421395|NCT01331291|473165458|FG000|Overall Study|Lack of Efficacy|2|||
131421396|NCT01331291|473165459|FG001|Overall Study|Lack of Efficacy|8|||
131421397|NCT01331291|473165458|FG000|Overall Study|Death|0|||
131421398|NCT01331291|473165459|FG001|Overall Study|Death|1|||
131421399|NCT01026220|473165460|FG000|Induction|Death|1|||
131421400|NCT01026220|473165461|FG001|Induction|Death|0|||
131421401|NCT01026220|473165462|FG002|Induction|Death|0|||
131421402|NCT01026220|473165460|FG000|Induction|Lack of Efficacy|2|||
131421403|NCT01026220|473165461|FG001|Induction|Lack of Efficacy|0|||
131421404|NCT01026220|473165462|FG002|Induction|Lack of Efficacy|0|||
131421405|NCT01026220|473165460|FG000|Induction|Physician Decision|12|||
131421406|NCT01026220|473165461|FG001|Induction|Physician Decision|0|||
131421407|NCT01026220|473165462|FG002|Induction|Physician Decision|0|||
131421408|NCT01026220|473165460|FG000|Induction|Withdrawal by Subject|9|||
131421409|NCT01026220|473165461|FG001|Induction|Withdrawal by Subject|0|||
131421410|NCT01026220|473165462|FG002|Induction|Withdrawal by Subject|0|||
131421411|NCT01026220|473165460|FG000|Induction|Ineligible|1|||
131421412|NCT01026220|473165461|FG001|Induction|Ineligible|0|||
131421413|NCT01026220|473165462|FG002|Induction|Ineligible|0|||
131421414|NCT01026220|473165460|FG000|Consolidation Maintenance|Death|0|||
131421415|NCT01026220|473165461|FG001|Consolidation Maintenance|Death|1|||
131421416|NCT01026220|473165462|FG002|Consolidation Maintenance|Death|0|||
131421417|NCT01026220|473165460|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
131421418|NCT01026220|473165461|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
131421419|NCT01026220|473165462|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
131421420|NCT01026220|473165460|FG000|Consolidation Maintenance|Physician Decision|0|||
131421421|NCT01026220|473165461|FG001|Consolidation Maintenance|Physician Decision|2|||
131421422|NCT01026220|473165462|FG002|Consolidation Maintenance|Physician Decision|7|||
131421423|NCT01026220|473165460|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
131421424|NCT01026220|473165461|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
131421425|NCT01026220|473165462|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
131421426|NCT00778895|473165463|FG000|Active Phase|Adverse Event|3|||
131421427|NCT00778895|473165464|FG001|Active Phase|Adverse Event|1|||
131421428|NCT00778895|473165465|FG002|Active Phase|Adverse Event|0|||
131421429|NCT00778895|473165463|FG000|Active Phase|Withdrawal by Subject|1|||
131421430|NCT00778895|473165464|FG001|Active Phase|Withdrawal by Subject|4|||
131421431|NCT00778895|473165465|FG002|Active Phase|Withdrawal by Subject|0|||
131421432|NCT00778895|473165463|FG000|Active Phase|Lost to Follow-up|1|||
131421433|NCT00778895|473165464|FG001|Active Phase|Lost to Follow-up|1|||
131421434|NCT00778895|473165465|FG002|Active Phase|Lost to Follow-up|0|||
131421435|NCT00778895|473165463|FG000|Active Phase|Other|2|||
131421436|NCT00778895|473165464|FG001|Active Phase|Other|0|||
131421437|NCT00778895|473165465|FG002|Active Phase|Other|0|||
131421438|NCT00778895|473165463|FG000|ESFU Phase|Adverse Event|2|||
131421439|NCT00778895|473165464|FG001|ESFU Phase|Adverse Event|1|||
131421440|NCT00778895|473165465|FG002|ESFU Phase|Adverse Event|0|||
131421441|NCT00778895|473165463|FG000|ESFU Phase|Withdrawal by Subject|1|||
131421442|NCT00778895|473165464|FG001|ESFU Phase|Withdrawal by Subject|4|||
131421443|NCT00778895|473165465|FG002|ESFU Phase|Withdrawal by Subject|0|||
131421444|NCT00778895|473165463|FG000|ESFU Phase|Lost to Follow-up|6|||
131421445|NCT00778895|473165464|FG001|ESFU Phase|Lost to Follow-up|7|||
131421446|NCT00778895|473165465|FG002|ESFU Phase|Lost to Follow-up|2|||
131421447|NCT00778895|473165463|FG000|ESFU Phase|Other|2|||
131421448|NCT00778895|473165464|FG001|ESFU Phase|Other|0|||
131421449|NCT00778895|473165465|FG002|ESFU Phase|Other|0|||
131421450|NCT02540993|473165467|FG000|Overall Study|Lost to Follow-up|5|||
131421451|NCT02540993|473165468|FG001|Overall Study|Lost to Follow-up|3|||
131421452|NCT02540993|473165467|FG000|Overall Study|Withdrawal by Subject|4|||
131421453|NCT02540993|473165468|FG001|Overall Study|Withdrawal by Subject|6|||
131421454|NCT02540993|473165467|FG000|Overall Study|GCP violations|33|||
131421455|NCT02540993|473165468|FG001|Overall Study|GCP violations|27|||
131421456|NCT00409344|473165469|FG000|Overall Study|no enrollment|0|||
131421457|NCT00409344|473165470|FG001|Overall Study|no enrollment|0|||
131421458|NCT03550404|473165471|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
131421459|NCT03550404|473165472|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
131421460|NCT03550404|473165473|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
131421461|NCT03550404|473165471|FG000|Phase 2|Vacated position|1|||
131421462|NCT03550404|473165472|FG001|Phase 2|Vacated position|0|||
131421463|NCT03550404|473165473|FG002|Phase 2|Vacated position|0|||
131421464|NCT01009086|473165475|FG000|Overall Study|Lack of Efficacy|16|||
131421465|NCT01009086|473165476|FG001|Overall Study|Lack of Efficacy|15|||
131421466|NCT01009086|473165477|FG002|Overall Study|Lack of Efficacy|9|||
131421467|NCT01009086|473165475|FG000|Overall Study|Lost to Follow-up|4|||
131421468|NCT01009086|473165476|FG001|Overall Study|Lost to Follow-up|5|||
131421469|NCT01009086|473165477|FG002|Overall Study|Lost to Follow-up|3|||
131421470|NCT01009086|473165475|FG000|Overall Study|Adverse Event|12|||
131421471|NCT01009086|473165476|FG001|Overall Study|Adverse Event|11|||
131421472|NCT01009086|473165477|FG002|Overall Study|Adverse Event|8|||
131421473|NCT01009086|473165475|FG000|Overall Study|Withdrawal by Subject|9|||
131421474|NCT01009086|473165476|FG001|Overall Study|Withdrawal by Subject|11|||
131421475|NCT01009086|473165477|FG002|Overall Study|Withdrawal by Subject|13|||
131421476|NCT01009086|473165475|FG000|Overall Study|Other|3|||
131421477|NCT01009086|473165476|FG001|Overall Study|Other|5|||
131421478|NCT01009086|473165477|FG002|Overall Study|Other|1|||
131421479|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
131421480|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
131421481|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
131421482|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
131421483|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
131421484|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
131421485|NCT01389323|473165478|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
131421486|NCT01389323|473165478|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
131421487|NCT01389323|473165478|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
131421488|NCT01389323|473165478|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
131421489|NCT01389323|473165478|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
131421490|NCT05096312|473165479|FG000|Overall Study|Lost to Follow-up|2|||
131421491|NCT05096312|473165480|FG001|Overall Study|Lost to Follow-up|4|||
131421492|NCT05096312|473165479|FG000|Overall Study|Adverse Event|1|||
131421493|NCT05096312|473165480|FG001|Overall Study|Adverse Event|0|||
131421494|NCT03135210|473165481|FG000|Overall Study|Death|0|||
131421495|NCT03135210|473165482|FG001|Overall Study|Death|1|||
131421496|NCT00590577|473165484|FG000|Overall Study|Lack of Efficacy|31|||
131421497|NCT00590577|473165485|FG001|Overall Study|Lack of Efficacy|28|||
131421498|NCT00590577|473165486|FG002|Overall Study|Lack of Efficacy|23|||
131421499|NCT00590577|473165487|FG003|Overall Study|Lack of Efficacy|45|||
131421500|NCT00590577|473165484|FG000|Overall Study|Withdrawal by Subject|23|||
131421501|NCT00590577|473165485|FG001|Overall Study|Withdrawal by Subject|28|||
131421502|NCT00590577|473165486|FG002|Overall Study|Withdrawal by Subject|30|||
131421503|NCT00590577|473165487|FG003|Overall Study|Withdrawal by Subject|26|||
131421504|NCT00590577|473165484|FG000|Overall Study|Adverse Event|10|||
131421505|NCT00590577|473165485|FG001|Overall Study|Adverse Event|10|||
131421506|NCT00590577|473165486|FG002|Overall Study|Adverse Event|13|||
131421507|NCT00590577|473165487|FG003|Overall Study|Adverse Event|11|||
131421508|NCT00590577|473165484|FG000|Overall Study|Lost to Follow-up|12|||
131421509|NCT00590577|473165485|FG001|Overall Study|Lost to Follow-up|6|||
131421510|NCT00590577|473165486|FG002|Overall Study|Lost to Follow-up|6|||
131421511|NCT00590577|473165487|FG003|Overall Study|Lost to Follow-up|9|||
131421512|NCT00590577|473165484|FG000|Overall Study|Pregnancy|0|||
131421513|NCT00590577|473165485|FG001|Overall Study|Pregnancy|1|||
131421514|NCT00590577|473165486|FG002|Overall Study|Pregnancy|0|||
131421515|NCT00590577|473165487|FG003|Overall Study|Pregnancy|0|||
131421516|NCT00590577|473165484|FG000|Overall Study|Various reasons|1|||
131421517|NCT00590577|473165485|FG001|Overall Study|Various reasons|3|||
131421518|NCT00590577|473165486|FG002|Overall Study|Various reasons|1|||
131421519|NCT00590577|473165487|FG003|Overall Study|Various reasons|2|||
131421520|NCT04349033|473165488|FG000|Overall Study|Lost to Follow-up|3|||
131421521|NCT04349033|473165489|FG001|Overall Study|Lost to Follow-up|1|||
131421522|NCT04349033|473165490|FG002|Overall Study|Lost to Follow-up|1|||
131421523|NCT04058886|473165505|FG000|Overall Study|Withdrawal by Subject|4|||
131421524|NCT04058886|473165505|FG000|Overall Study|Inadequate deafness interpreter service|1|||
131421525|NCT05392803|473165506|FG000|Overall Study|Lost to Follow-up|0|||
131421526|NCT05392803|473165507|FG001|Overall Study|Lost to Follow-up|2|||
131421527|NCT04294147|473165508|FG000|Overall Study|Protocol Violation|2|||
131421528|NCT04294147|473165509|FG001|Overall Study|Protocol Violation|0|||
131421529|NCT02332291|473165512|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
131421530|NCT02332291|473165513|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
131421531|NCT02332291|473165512|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
131421532|NCT02332291|473165513|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
131421533|NCT02332291|473165512|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
131421534|NCT02332291|473165513|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
131421535|NCT02332291|473165512|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
131421536|NCT02332291|473165513|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
131421537|NCT02332291|473165512|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
131421538|NCT02332291|473165513|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
131421539|NCT02332291|473165512|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
131421540|NCT02332291|473165513|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
131421541|NCT02220712|473165517|FG000|Overall Study|Adverse Event|1|||
131421542|NCT02220712|473165517|FG000|Overall Study|Withdrawal by Subject|2|||
131421543|NCT02220712|473165517|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
131421544|NCT00760838|473165518|FG000|Overall Study|Adverse Event|1|||
131421545|NCT00760838|473165519|FG001|Overall Study|Adverse Event|1|||
131421546|NCT00760838|473165518|FG000|Overall Study|Lack of Efficacy|1|||
131421547|NCT00760838|473165519|FG001|Overall Study|Lack of Efficacy|0|||
131421548|NCT00760838|473165518|FG000|Overall Study|Lost to Follow-up|2|||
131421549|NCT00760838|473165519|FG001|Overall Study|Lost to Follow-up|0|||
131421550|NCT00760838|473165518|FG000|Overall Study|Withdrawal by Subject|1|||
131421551|NCT00760838|473165519|FG001|Overall Study|Withdrawal by Subject|1|||
131421552|NCT03624127|473165520|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
131421553|NCT03624127|473165521|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
131421554|NCT03624127|473165522|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
131421555|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
131421556|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
131421557|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
131421558|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Death|0|||
131421559|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Death|1|||
131421560|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Death|0|||
131421561|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
131421562|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
131421563|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
131421564|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
131421565|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
131421566|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
131421567|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
131421568|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
131421569|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
131421570|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
131421571|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
131421572|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
131421573|NCT03624127|473165520|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
131421574|NCT03624127|473165521|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
131421575|NCT03624127|473165522|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
131457891|NCT04270370|473307156|FG002|Overall Study|Lost to Follow-up|0|||
131457892|NCT04270370|473307157|FG003|Overall Study|Lost to Follow-up|0|||
131457893|NCT04270370|473307158|FG004|Overall Study|Lost to Follow-up|0|||
131457894|NCT04270370|473307159|FG005|Overall Study|Lost to Follow-up|0|||
131421576|NCT03624127|473165520|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
131421577|NCT03624127|473165521|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
131421578|NCT03624127|473165522|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
131421579|NCT03624127|473165520|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
131421580|NCT03624127|473165521|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
131421581|NCT03624127|473165522|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
131421582|NCT03624127|473165520|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
131421583|NCT03624127|473165521|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
131421584|NCT03624127|473165522|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
131421585|NCT03624127|473165520|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
131421586|NCT03624127|473165521|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
131421587|NCT03624127|473165522|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
131421588|NCT03624127|473165520|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
131421589|NCT03624127|473165521|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
131421590|NCT03624127|473165522|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
131457895|NCT04270370|473307160|FG006|Overall Study|Lost to Follow-up|0|||
131421591|NCT03624127|473165520|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
131421592|NCT03624127|473165521|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
131421593|NCT03624127|473165522|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
131421594|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
131421595|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
131421596|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
131421597|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
131421598|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
131421599|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
131421600|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
131421601|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
131421602|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
131421603|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
131421604|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
131421605|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
131421606|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
131421607|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
131421608|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
131421609|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
131421610|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
131421611|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
131421612|NCT03624127|473165520|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
131421613|NCT03624127|473165521|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
131421614|NCT03624127|473165522|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
131421615|NCT02607228|473165523|FG000|Overall Study|Progressive Disease|4|||
131421616|NCT02607228|473165524|FG001|Overall Study|Progressive Disease|3|||
131421617|NCT02607228|473165525|FG002|Overall Study|Progressive Disease|1|||
131421618|NCT02607228|473165526|FG003|Overall Study|Progressive Disease|5|||
131421619|NCT02607228|473165527|FG004|Overall Study|Progressive Disease|4|||
131421620|NCT02607228|473165528|FG005|Overall Study|Progressive Disease|3|||
131421621|NCT02607228|473165529|FG006|Overall Study|Progressive Disease|1|||
131421622|NCT02607228|473165523|FG000|Overall Study|Adverse Event|1|||
131421623|NCT02607228|473165524|FG001|Overall Study|Adverse Event|0|||
131421624|NCT02607228|473165525|FG002|Overall Study|Adverse Event|1|||
131421625|NCT02607228|473165526|FG003|Overall Study|Adverse Event|0|||
131421626|NCT02607228|473165527|FG004|Overall Study|Adverse Event|1|||
131421627|NCT02607228|473165528|FG005|Overall Study|Adverse Event|1|||
131421628|NCT02607228|473165529|FG006|Overall Study|Adverse Event|1|||
131421629|NCT02607228|473165523|FG000|Overall Study|Investigator's Discretion|0|||
131421630|NCT02607228|473165524|FG001|Overall Study|Investigator's Discretion|0|||
131421631|NCT02607228|473165525|FG002|Overall Study|Investigator's Discretion|1|||
131421632|NCT02607228|473165526|FG003|Overall Study|Investigator's Discretion|0|||
131421633|NCT02607228|473165527|FG004|Overall Study|Investigator's Discretion|0|||
131421634|NCT02607228|473165528|FG005|Overall Study|Investigator's Discretion|1|||
131421635|NCT02607228|473165529|FG006|Overall Study|Investigator's Discretion|0|||
131421636|NCT02607228|473165523|FG000|Overall Study|Withdrew Consent|0|||
131421637|NCT02607228|473165524|FG001|Overall Study|Withdrew Consent|1|||
131421638|NCT02607228|473165525|FG002|Overall Study|Withdrew Consent|0|||
131421639|NCT02607228|473165526|FG003|Overall Study|Withdrew Consent|0|||
131421640|NCT02607228|473165527|FG004|Overall Study|Withdrew Consent|0|||
131421641|NCT02607228|473165528|FG005|Overall Study|Withdrew Consent|1|||
131421642|NCT02607228|473165529|FG006|Overall Study|Withdrew Consent|0|||
131421643|NCT02607228|473165523|FG000|Overall Study|Study Terminated by Sponsor|0|||
131421644|NCT02607228|473165524|FG001|Overall Study|Study Terminated by Sponsor|0|||
131421645|NCT02607228|473165525|FG002|Overall Study|Study Terminated by Sponsor|0|||
131421646|NCT02607228|473165526|FG003|Overall Study|Study Terminated by Sponsor|1|||
131421647|NCT02607228|473165527|FG004|Overall Study|Study Terminated by Sponsor|0|||
131421648|NCT02607228|473165528|FG005|Overall Study|Study Terminated by Sponsor|0|||
131421649|NCT02607228|473165529|FG006|Overall Study|Study Terminated by Sponsor|0|||
131421650|NCT03576716|473165532|FG000|Overall Study|Withdrawal by Subject|0|||
131421651|NCT03576716|473165533|FG001|Overall Study|Withdrawal by Subject|1|||
131421652|NCT04356040|473165534|FG000|Overall Study|Death|2|||
131421653|NCT04356040|473165535|FG001|Overall Study|Death|0|||
131421654|NCT04356040|473165534|FG000|Overall Study|Lost to Follow-up|1|||
131421655|NCT04356040|473165535|FG001|Overall Study|Lost to Follow-up|0|||
131421656|NCT04356040|473165534|FG000|Overall Study|Physician Decision|0|||
131421657|NCT04356040|473165535|FG001|Overall Study|Physician Decision|1|||
131421658|NCT04356040|473165534|FG000|Overall Study|Withdrawal by Subject|13|||
131421659|NCT04356040|473165535|FG001|Overall Study|Withdrawal by Subject|1|||
131421660|NCT04356040|473165534|FG000|Overall Study|Enrollment Pause|10|||
131421661|NCT04356040|473165535|FG001|Overall Study|Enrollment Pause|0|||
131421662|NCT04356040|473165534|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
131421663|NCT04356040|473165535|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
131421664|NCT04356040|473165534|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
131421665|NCT04356040|473165535|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
131421666|NCT04356040|473165534|FG000|Overall Study|PI left institution|3|||
131421667|NCT04356040|473165535|FG001|Overall Study|PI left institution|0|||
131421668|NCT02262754|473165536|FG000|Overall Study|Adverse Event|3|||
131421669|NCT02262754|473165537|FG001|Overall Study|Adverse Event|4|||
131421670|NCT02262754|473165538|FG002|Overall Study|Adverse Event|0|||
131421671|NCT02262754|473165536|FG000|Overall Study|Lack of Efficacy|2|||
131421672|NCT02262754|473165537|FG001|Overall Study|Lack of Efficacy|0|||
131421673|NCT02262754|473165538|FG002|Overall Study|Lack of Efficacy|1|||
131421674|NCT02262754|473165536|FG000|Overall Study|Lost to Follow-up|0|||
131421675|NCT02262754|473165537|FG001|Overall Study|Lost to Follow-up|0|||
131421676|NCT02262754|473165538|FG002|Overall Study|Lost to Follow-up|1|||
131421677|NCT02262754|473165536|FG000|Overall Study|No longer meets eligibility criteria|0|||
131421678|NCT02262754|473165537|FG001|Overall Study|No longer meets eligibility criteria|1|||
131421679|NCT02262754|473165538|FG002|Overall Study|No longer meets eligibility criteria|0|||
131421680|NCT02262754|473165536|FG000|Overall Study|Study terminated by sponsor|5|||
131421681|NCT02262754|473165537|FG001|Overall Study|Study terminated by sponsor|4|||
131421682|NCT02262754|473165538|FG002|Overall Study|Study terminated by sponsor|4|||
131421683|NCT02262754|473165536|FG000|Overall Study|Protocol Violation|1|||
131421684|NCT02262754|473165537|FG001|Overall Study|Protocol Violation|0|||
131421685|NCT02262754|473165538|FG002|Overall Study|Protocol Violation|0|||
131421686|NCT02262754|473165536|FG000|Overall Study|Withdrawal by Subject|1|||
131421687|NCT02262754|473165537|FG001|Overall Study|Withdrawal by Subject|0|||
131421688|NCT02262754|473165538|FG002|Overall Study|Withdrawal by Subject|1|||
131421689|NCT02262754|473165536|FG000|Overall Study|Other|4|||
131421690|NCT02262754|473165537|FG001|Overall Study|Other|0|||
131421691|NCT02262754|473165538|FG002|Overall Study|Other|2|||
131421692|NCT01067469|473165539|FG000|Overall Study|Withdrawal by Subject|0|||
131421693|NCT01067469|473165540|FG001|Overall Study|Withdrawal by Subject|1|||
131421694|NCT01067469|473165539|FG000|Overall Study|Disease Progression|0|||
131421695|NCT01067469|473165540|FG001|Overall Study|Disease Progression|1|||
131421696|NCT01123707|473165543|FG000|Overall Study|Lost to Follow-up|3|||
131421697|NCT01123707|473165544|FG001|Overall Study|Lost to Follow-up|1|||
131421698|NCT01123707|473165545|FG002|Overall Study|Lost to Follow-up|3|||
131421699|NCT01123707|473165546|FG003|Overall Study|Lost to Follow-up|2|||
131421700|NCT01123707|473165543|FG000|Overall Study|Adverse Event|5|||
131421701|NCT01123707|473165544|FG001|Overall Study|Adverse Event|7|||
131421702|NCT01123707|473165545|FG002|Overall Study|Adverse Event|5|||
131421703|NCT01123707|473165546|FG003|Overall Study|Adverse Event|3|||
131421704|NCT01123707|473165543|FG000|Overall Study|Sponsor Discontinued Study|30|||
131421705|NCT01123707|473165544|FG001|Overall Study|Sponsor Discontinued Study|24|||
131421706|NCT01123707|473165545|FG002|Overall Study|Sponsor Discontinued Study|25|||
131421707|NCT01123707|473165546|FG003|Overall Study|Sponsor Discontinued Study|40|||
131421708|NCT01123707|473165543|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
131421709|NCT01123707|473165544|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
131421710|NCT01123707|473165545|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
131421711|NCT01123707|473165546|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
131421712|NCT01123707|473165543|FG000|Overall Study|Investigator Withdrew Participant|0|||
131421713|NCT01123707|473165544|FG001|Overall Study|Investigator Withdrew Participant|1|||
131421714|NCT01123707|473165545|FG002|Overall Study|Investigator Withdrew Participant|1|||
131421715|NCT01123707|473165546|FG003|Overall Study|Investigator Withdrew Participant|1|||
131421716|NCT01123707|473165543|FG000|Overall Study|Subject Withdrew Consent|4|||
131421717|NCT01123707|473165544|FG001|Overall Study|Subject Withdrew Consent|5|||
131421718|NCT01123707|473165545|FG002|Overall Study|Subject Withdrew Consent|1|||
131421719|NCT01123707|473165546|FG003|Overall Study|Subject Withdrew Consent|2|||
131421720|NCT01123707|473165543|FG000|Overall Study|Lack of Efficacy|1|||
131421721|NCT01123707|473165544|FG001|Overall Study|Lack of Efficacy|2|||
131421722|NCT01123707|473165545|FG002|Overall Study|Lack of Efficacy|1|||
131421723|NCT01123707|473165546|FG003|Overall Study|Lack of Efficacy|0|||
131421724|NCT01123707|473165543|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
131421725|NCT01123707|473165544|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
131421726|NCT01123707|473165545|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
131421727|NCT01123707|473165546|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
131421728|NCT04667104|473165549|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
131421729|NCT04667104|473165550|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
131421730|NCT04667104|473165551|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
131421731|NCT01630889|473165552|FG000|Overall Study|Death|2|||
131421732|NCT01630889|473165552|FG000|Overall Study|Withdrawal by Subject|1|||
131421733|NCT01630889|473165552|FG000|Overall Study|Other than Specified|2|||
131421734|NCT01630889|473165552|FG000|Overall Study|Lost to Follow-up|4|||
131421735|NCT01630889|473165552|FG000|Overall Study|Other|1|||
131421736|NCT00605345|473165553|FG000|Overall Study|Withdrawal by Subject|1|||
131421737|NCT00605345|473165554|FG001|Overall Study|Withdrawal by Subject|0|||
131421738|NCT00605345|473165553|FG000|Overall Study|Adverse Event|0|||
131421739|NCT00605345|473165554|FG001|Overall Study|Adverse Event|1|||
131421740|NCT00605345|473165553|FG000|Overall Study|Protocol Violation|0|||
131421741|NCT00605345|473165554|FG001|Overall Study|Protocol Violation|2|||
131421742|NCT02577016|473165555|FG000|Overall Study|Adverse Event|2|||
131421743|NCT02577016|473165556|FG001|Overall Study|Adverse Event|1|||
131421744|NCT02577016|473165555|FG000|Overall Study|Physician Decision|0|||
131421745|NCT02577016|473165556|FG001|Overall Study|Physician Decision|1|||
131421746|NCT02126839|473165557|FG000|Overall Study|Adverse Event|0|||
131421747|NCT02126839|473165558|FG001|Overall Study|Adverse Event|1|||
131421748|NCT02126839|473165557|FG000|Overall Study|Withdrawal by Subject|1|||
131421749|NCT02126839|473165558|FG001|Overall Study|Withdrawal by Subject|0|||
131421750|NCT02126839|473165557|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131421751|NCT02126839|473165558|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131421752|NCT02126839|473165557|FG000|Overall Study|Protocol Violation|2|||
131421753|NCT02126839|473165558|FG001|Overall Study|Protocol Violation|3|||
131421754|NCT02126839|473165557|FG000|Overall Study|Sponsor request|0|||
131421755|NCT02126839|473165558|FG001|Overall Study|Sponsor request|1|||
131421756|NCT02126839|473165557|FG000|Overall Study|Lost to Follow-up|1|||
131421757|NCT02126839|473165558|FG001|Overall Study|Lost to Follow-up|4|||
131421758|NCT02126839|473165557|FG000|Overall Study|Other|5|||
131421759|NCT02126839|473165558|FG001|Overall Study|Other|5|||
131421760|NCT00812565|473165559|FG000|Overall Study|Did Not Receive Study Medication|1|||
131421761|NCT00812565|473165560|FG001|Overall Study|Did Not Receive Study Medication|1|||
131421762|NCT00812565|473165561|FG002|Overall Study|Did Not Receive Study Medication|0|||
131421763|NCT00812565|473165562|FG003|Overall Study|Did Not Receive Study Medication|0|||
131421764|NCT00812565|473165563|FG004|Overall Study|Did Not Receive Study Medication|0|||
131421765|NCT00812565|473165564|FG005|Overall Study|Did Not Receive Study Medication|0|||
131421766|NCT00812565|473165565|FG006|Overall Study|Did Not Receive Study Medication|0|||
131421767|NCT00812565|473165566|FG007|Overall Study|Did Not Receive Study Medication|0|||
131421768|NCT00812565|473165559|FG000|Overall Study|Adverse Event|0|||
131421769|NCT00812565|473165560|FG001|Overall Study|Adverse Event|0|||
131421770|NCT00812565|473165561|FG002|Overall Study|Adverse Event|0|||
131421771|NCT00812565|473165562|FG003|Overall Study|Adverse Event|2|||
131421772|NCT00812565|473165563|FG004|Overall Study|Adverse Event|0|||
131421773|NCT00812565|473165564|FG005|Overall Study|Adverse Event|0|||
131421774|NCT00812565|473165565|FG006|Overall Study|Adverse Event|0|||
131421775|NCT00812565|473165566|FG007|Overall Study|Adverse Event|1|||
131421776|NCT00812565|473165559|FG000|Overall Study|Did Not Come to Study Visit|1|||
131421777|NCT00812565|473165560|FG001|Overall Study|Did Not Come to Study Visit|0|||
131421778|NCT00812565|473165561|FG002|Overall Study|Did Not Come to Study Visit|0|||
131421779|NCT00812565|473165562|FG003|Overall Study|Did Not Come to Study Visit|0|||
131421780|NCT00812565|473165563|FG004|Overall Study|Did Not Come to Study Visit|0|||
131421781|NCT00812565|473165564|FG005|Overall Study|Did Not Come to Study Visit|0|||
131421782|NCT00812565|473165565|FG006|Overall Study|Did Not Come to Study Visit|0|||
131421783|NCT00812565|473165566|FG007|Overall Study|Did Not Come to Study Visit|0|||
131421784|NCT00812565|473165559|FG000|Overall Study|Withdrawal of Consent|1|||
131421785|NCT00812565|473165560|FG001|Overall Study|Withdrawal of Consent|0|||
131421786|NCT00812565|473165561|FG002|Overall Study|Withdrawal of Consent|0|||
131421787|NCT00812565|473165562|FG003|Overall Study|Withdrawal of Consent|0|||
131421788|NCT00812565|473165563|FG004|Overall Study|Withdrawal of Consent|1|||
131421789|NCT00812565|473165564|FG005|Overall Study|Withdrawal of Consent|0|||
131421790|NCT00812565|473165565|FG006|Overall Study|Withdrawal of Consent|0|||
131421791|NCT00812565|473165566|FG007|Overall Study|Withdrawal of Consent|0|||
131421792|NCT00812565|473165559|FG000|Overall Study|Reason Not Specified|0|||
131421793|NCT00812565|473165560|FG001|Overall Study|Reason Not Specified|0|||
131421794|NCT00812565|473165561|FG002|Overall Study|Reason Not Specified|0|||
131421795|NCT00812565|473165562|FG003|Overall Study|Reason Not Specified|0|||
131421796|NCT00812565|473165563|FG004|Overall Study|Reason Not Specified|0|||
131421797|NCT00812565|473165564|FG005|Overall Study|Reason Not Specified|1|||
131421798|NCT00812565|473165565|FG006|Overall Study|Reason Not Specified|0|||
131421799|NCT00812565|473165566|FG007|Overall Study|Reason Not Specified|0|||
131421800|NCT02596945|473165569|FG000|Overall Study|No documentation of study drug dosing|3|||
131421801|NCT02596945|473165569|FG000|Overall Study|Other|32|||
131421802|NCT02596945|473165569|FG000|Overall Study|Change to hemodialysis|15|||
131421803|NCT02596945|473165569|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
131421804|NCT02596945|473165569|FG000|Overall Study|Withdrawal by Subject|1|||
131421805|NCT02596945|473165569|FG000|Overall Study|Missing|1|||
131421806|NCT00422383|473165570|FG000|Overall Study|Adverse Event|5|||
131421807|NCT00422383|473165571|FG001|Overall Study|Adverse Event|3|||
131421808|NCT00422383|473165572|FG002|Overall Study|Adverse Event|1|||
131421809|NCT00422383|473165573|FG003|Overall Study|Adverse Event|1|||
131421810|NCT00422383|473165574|FG004|Overall Study|Adverse Event|0|||
131421811|NCT00422383|473165570|FG000|Overall Study|Lack of Efficacy|4|||
131421812|NCT00422383|473165571|FG001|Overall Study|Lack of Efficacy|4|||
131421813|NCT00422383|473165572|FG002|Overall Study|Lack of Efficacy|2|||
131421814|NCT00422383|473165573|FG003|Overall Study|Lack of Efficacy|1|||
131421815|NCT00422383|473165574|FG004|Overall Study|Lack of Efficacy|1|||
131421816|NCT00422383|473165570|FG000|Overall Study|Lost to Follow-up|0|||
131421817|NCT00422383|473165571|FG001|Overall Study|Lost to Follow-up|1|||
131421818|NCT00422383|473165572|FG002|Overall Study|Lost to Follow-up|0|||
131421819|NCT00422383|473165573|FG003|Overall Study|Lost to Follow-up|0|||
131421820|NCT00422383|473165574|FG004|Overall Study|Lost to Follow-up|1|||
131421821|NCT00422383|473165570|FG000|Overall Study|Protocol Violation|1|||
131421822|NCT00422383|473165571|FG001|Overall Study|Protocol Violation|1|||
131421823|NCT00422383|473165572|FG002|Overall Study|Protocol Violation|1|||
131421824|NCT00422383|473165573|FG003|Overall Study|Protocol Violation|0|||
131421825|NCT00422383|473165574|FG004|Overall Study|Protocol Violation|0|||
131421826|NCT00422383|473165570|FG000|Overall Study|Withdrawal by Subject|5|||
131421827|NCT00422383|473165571|FG001|Overall Study|Withdrawal by Subject|5|||
131421828|NCT00422383|473165572|FG002|Overall Study|Withdrawal by Subject|0|||
131421829|NCT00422383|473165573|FG003|Overall Study|Withdrawal by Subject|0|||
131421830|NCT00422383|473165574|FG004|Overall Study|Withdrawal by Subject|1|||
131421831|NCT00566254|473165575|FG000|Overall Study|Adverse Event|3|||
131421832|NCT00566254|473165576|FG001|Overall Study|Adverse Event|1|||
131421833|NCT00566254|473165575|FG000|Overall Study|Protocol Violation|1|||
131421834|NCT00566254|473165576|FG001|Overall Study|Protocol Violation|3|||
131421835|NCT00566254|473165575|FG000|Overall Study|Withdrawal by Subject|1|||
131421836|NCT00566254|473165576|FG001|Overall Study|Withdrawal by Subject|2|||
131421837|NCT00566254|473165575|FG000|Overall Study|Lack of Efficacy|5|||
131421838|NCT00566254|473165576|FG001|Overall Study|Lack of Efficacy|6|||
131421839|NCT00566254|473165575|FG000|Overall Study|Other|0|||
131421840|NCT00566254|473165576|FG001|Overall Study|Other|2|||
131421841|NCT00238238|473165582|FG000|Overall Study|Withdrawal by Subject|0|||
131421842|NCT00238238|473165583|FG001|Overall Study|Withdrawal by Subject|3|||
131421843|NCT00238238|473165584|FG002|Overall Study|Withdrawal by Subject|0|||
131421844|NCT01345669|473165585|FG000|Overall Study|Primary tumour recurrence|53|||
131421845|NCT01345669|473165586|FG001|Overall Study|Primary tumour recurrence|32|||
131421846|NCT01345669|473165585|FG000|Overall Study|Second primary tumour|4|||
131421847|NCT01345669|473165586|FG001|Overall Study|Second primary tumour|3|||
131421848|NCT01345669|473165585|FG000|Overall Study|Adverse Event|63|||
131421849|NCT01345669|473165586|FG001|Overall Study|Adverse Event|9|||
131421850|NCT01345669|473165585|FG000|Overall Study|Protocol Violation|3|||
131421851|NCT01345669|473165586|FG001|Overall Study|Protocol Violation|1|||
131421852|NCT01345669|473165585|FG000|Overall Study|Lost to Follow-up|1|||
131421853|NCT01345669|473165586|FG001|Overall Study|Lost to Follow-up|1|||
131421854|NCT01345669|473165585|FG000|Overall Study|Withdrawal by Subject|52|||
131421855|NCT01345669|473165586|FG001|Overall Study|Withdrawal by Subject|13|||
131421856|NCT01345669|473165585|FG000|Overall Study|Other Reasons|111|||
131421857|NCT01345669|473165586|FG001|Overall Study|Other Reasons|60|||
131421858|NCT01793883|473165587|FG000|Overall Study|Withdrawal by Subject|3|||
131421859|NCT01793883|473165588|FG001|Overall Study|Withdrawal by Subject|7|||
131421860|NCT01793883|473165589|FG002|Overall Study|Withdrawal by Subject|3|||
131421861|NCT01793883|473165587|FG000|Overall Study|Subject noncompliance|0|||
131421862|NCT01793883|473165588|FG001|Overall Study|Subject noncompliance|1|||
131457896|NCT04270370|473307161|FG007|Overall Study|Lost to Follow-up|0|||
131457897|NCT04270370|473307162|FG008|Overall Study|Lost to Follow-up|1|||
131421863|NCT01793883|473165589|FG002|Overall Study|Subject noncompliance|1|||
131421864|NCT01793883|473165587|FG000|Overall Study|Lost to Follow-up|5|||
131421865|NCT01793883|473165588|FG001|Overall Study|Lost to Follow-up|1|||
131421866|NCT01793883|473165589|FG002|Overall Study|Lost to Follow-up|3|||
131421867|NCT01793883|473165587|FG000|Overall Study|Randomized in error|1|||
131421868|NCT01793883|473165588|FG001|Overall Study|Randomized in error|0|||
131421869|NCT01793883|473165589|FG002|Overall Study|Randomized in error|0|||
131421870|NCT01793883|473165587|FG000|Overall Study|Unable to complete spriometry|1|||
131421871|NCT01793883|473165588|FG001|Overall Study|Unable to complete spriometry|0|||
131421872|NCT01793883|473165589|FG002|Overall Study|Unable to complete spriometry|0|||
131421873|NCT01793883|473165587|FG000|Overall Study|Unable to complete measurements|1|||
131457898|NCT04270370|473307163|FG009|Overall Study|Lost to Follow-up|0|||
131421874|NCT01793883|473165588|FG001|Overall Study|Unable to complete measurements|0|||
131421875|NCT01793883|473165589|FG002|Overall Study|Unable to complete measurements|0|||
131421876|NCT01793883|473165587|FG000|Overall Study|Met exclusion criteria|1|||
131421877|NCT01793883|473165588|FG001|Overall Study|Met exclusion criteria|0|||
131421878|NCT01793883|473165589|FG002|Overall Study|Met exclusion criteria|0|||
131421879|NCT01793883|473165587|FG000|Overall Study|Dosing error|0|||
131421880|NCT01793883|473165588|FG001|Overall Study|Dosing error|1|||
131421881|NCT01793883|473165589|FG002|Overall Study|Dosing error|0|||
131421882|NCT01793883|473165587|FG000|Overall Study|Respiratory distress during spirometry|0|||
131421883|NCT01793883|473165588|FG001|Overall Study|Respiratory distress during spirometry|0|||
131421884|NCT01793883|473165589|FG002|Overall Study|Respiratory distress during spirometry|1|||
131457899|NCT04270370|473307164|FG010|Overall Study|Lost to Follow-up|0|||
131457900|NCT04270370|473307165|FG011|Overall Study|Lost to Follow-up|0|||
131457901|NCT01324141|473307166|FG000|Overall Study|Declined to participate before treatment started|1|||
131457902|NCT01324141|473307166|FG000|Overall Study|Disease progression on study|1|||
131457903|NCT00870584|473307169|FG000|Overall Study|Adverse Event|3|||
131421885|NCT02478255|473165590|FG000|Overall Study|Physician Decision|6|||
131421886|NCT02478255|473165591|FG001|Overall Study|Physician Decision|0|||
131421887|NCT02478255|473165590|FG000|Overall Study|Withdrawal by Subject|2|||
131421888|NCT02478255|473165591|FG001|Overall Study|Withdrawal by Subject|0|||
131421889|NCT00061633|473165593|FG000|Overall Study|Adverse Event|1|||
131421890|NCT00061633|473165594|FG001|Overall Study|Adverse Event|2|||
131421891|NCT00061633|473165593|FG000|Overall Study|Withdrawal by Subject|2|||
131421892|NCT00061633|473165594|FG001|Overall Study|Withdrawal by Subject|2|||
131421893|NCT00061633|473165593|FG000|Overall Study|Lost to Follow-up|1|||
131421894|NCT00061633|473165594|FG001|Overall Study|Lost to Follow-up|4|||
131421895|NCT00061633|473165593|FG000|Overall Study|Other|1|||
131421896|NCT00061633|473165594|FG001|Overall Study|Other|1|||
131421897|NCT00061633|473165593|FG000|Overall Study|Never received study treatment|0|||
131421898|NCT00061633|473165594|FG001|Overall Study|Never received study treatment|2|||
131421899|NCT03210961|473168234|FG000|Overall Study|Adverse Event|0|||
131421900|NCT03210961|473168235|FG001|Overall Study|Adverse Event|0|||
131421901|NCT03210961|473168236|FG002|Overall Study|Adverse Event|0|||
131421902|NCT03210961|473168237|FG003|Overall Study|Adverse Event|0|||
131421903|NCT03210961|473168238|FG004|Overall Study|Adverse Event|0|||
131421904|NCT03210961|473168239|FG005|Overall Study|Adverse Event|0|||
131421905|NCT03210961|473168240|FG006|Overall Study|Adverse Event|0|||
131421906|NCT03210961|473168241|FG007|Overall Study|Adverse Event|0|||
131421907|NCT03210961|473168242|FG008|Overall Study|Adverse Event|0|||
131421908|NCT03210961|473168243|FG009|Overall Study|Adverse Event|0|||
131421909|NCT03210961|473168244|FG010|Overall Study|Adverse Event|0|||
131421910|NCT03210961|473168245|FG011|Overall Study|Adverse Event|0|||
131421911|NCT03210961|473168246|FG012|Overall Study|Adverse Event|0|||
131421912|NCT03210961|473168247|FG013|Overall Study|Adverse Event|1|||
131421913|NCT03210961|473168248|FG014|Overall Study|Adverse Event|0|||
131421914|NCT03210961|473168234|FG000|Overall Study|Lost to Follow-up|0|||
131421915|NCT03210961|473168235|FG001|Overall Study|Lost to Follow-up|0|||
131421916|NCT03210961|473168236|FG002|Overall Study|Lost to Follow-up|0|||
131421917|NCT03210961|473168237|FG003|Overall Study|Lost to Follow-up|0|||
131421918|NCT03210961|473168238|FG004|Overall Study|Lost to Follow-up|0|||
131421919|NCT03210961|473168239|FG005|Overall Study|Lost to Follow-up|0|||
131421920|NCT03210961|473168240|FG006|Overall Study|Lost to Follow-up|0|||
131421921|NCT03210961|473168241|FG007|Overall Study|Lost to Follow-up|0|||
131421922|NCT03210961|473168242|FG008|Overall Study|Lost to Follow-up|0|||
131421923|NCT03210961|473168243|FG009|Overall Study|Lost to Follow-up|0|||
131421924|NCT03210961|473168244|FG010|Overall Study|Lost to Follow-up|0|||
131421925|NCT03210961|473168245|FG011|Overall Study|Lost to Follow-up|0|||
131421926|NCT03210961|473168246|FG012|Overall Study|Lost to Follow-up|0|||
131421927|NCT03210961|473168247|FG013|Overall Study|Lost to Follow-up|0|||
131421928|NCT03210961|473168248|FG014|Overall Study|Lost to Follow-up|1|||
131421929|NCT03210961|473168234|FG000|Overall Study|Withdrawal by Subject|0|||
131421930|NCT03210961|473168235|FG001|Overall Study|Withdrawal by Subject|0|||
131421931|NCT03210961|473168236|FG002|Overall Study|Withdrawal by Subject|0|||
131421932|NCT03210961|473168237|FG003|Overall Study|Withdrawal by Subject|0|||
131421933|NCT03210961|473168238|FG004|Overall Study|Withdrawal by Subject|0|||
131421934|NCT03210961|473168239|FG005|Overall Study|Withdrawal by Subject|0|||
131421935|NCT03210961|473168240|FG006|Overall Study|Withdrawal by Subject|0|||
131421936|NCT03210961|473168241|FG007|Overall Study|Withdrawal by Subject|0|||
131421937|NCT03210961|473168242|FG008|Overall Study|Withdrawal by Subject|0|||
131421938|NCT03210961|473168243|FG009|Overall Study|Withdrawal by Subject|0|||
131421939|NCT03210961|473168244|FG010|Overall Study|Withdrawal by Subject|0|||
131421940|NCT03210961|473168245|FG011|Overall Study|Withdrawal by Subject|0|||
131421941|NCT03210961|473168246|FG012|Overall Study|Withdrawal by Subject|0|||
131421942|NCT03210961|473168247|FG013|Overall Study|Withdrawal by Subject|0|||
131421943|NCT03210961|473168248|FG014|Overall Study|Withdrawal by Subject|1|||
131421944|NCT03210961|473168234|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421945|NCT03210961|473168235|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421946|NCT03210961|473168236|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
131457904|NCT00870584|473307170|FG001|Overall Study|Adverse Event|3|||
131421947|NCT03210961|473168237|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421948|NCT03210961|473168238|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421949|NCT03210961|473168239|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421950|NCT03210961|473168240|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421951|NCT03210961|473168241|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421952|NCT03210961|473168242|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421953|NCT03210961|473168243|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421954|NCT03210961|473168244|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421955|NCT03210961|473168245|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421956|NCT03210961|473168246|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421957|NCT03210961|473168247|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
131421958|NCT03210961|473168248|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
131421959|NCT03210961|473168234|FG000|Overall Study|Other|0|||
131421960|NCT03210961|473168235|FG001|Overall Study|Other|0|||
131421961|NCT03210961|473168236|FG002|Overall Study|Other|0|||
131421962|NCT03210961|473168237|FG003|Overall Study|Other|1|||
131421963|NCT03210961|473168238|FG004|Overall Study|Other|0|||
131421964|NCT03210961|473168239|FG005|Overall Study|Other|0|||
131421965|NCT03210961|473168240|FG006|Overall Study|Other|1|||
131421966|NCT03210961|473168241|FG007|Overall Study|Other|0|||
131421967|NCT03210961|473168242|FG008|Overall Study|Other|0|||
131421968|NCT03210961|473168243|FG009|Overall Study|Other|0|||
131421969|NCT03210961|473168244|FG010|Overall Study|Other|1|||
131421970|NCT03210961|473168245|FG011|Overall Study|Other|0|||
131421971|NCT03210961|473168246|FG012|Overall Study|Other|2|||
131421972|NCT03210961|473168247|FG013|Overall Study|Other|2|||
131421973|NCT03210961|473168248|FG014|Overall Study|Other|0|||
131421974|NCT00602420|473168249|FG000|Overall Study|Death|1|||
131421975|NCT00602420|473168250|FG001|Overall Study|Death|4|||
131421976|NCT00602420|473168249|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
131421977|NCT00602420|473168250|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
131421978|NCT00602420|473168249|FG000|Overall Study|Withdrawal by Subject|18|||
131421979|NCT00602420|473168250|FG001|Overall Study|Withdrawal by Subject|17|||
131421980|NCT00602420|473168249|FG000|Overall Study|Adverse Event|1|||
131421981|NCT00602420|473168250|FG001|Overall Study|Adverse Event|0|||
131421982|NCT00703924|473168259|FG000|Overall Study|Withdrawal by Subject|1|||
131421983|NCT00703924|473168260|FG001|Overall Study|Withdrawal by Subject|1|||
131421984|NCT03077919|473168261|FG000|Overall Study|Lost to Follow-up|4|||
131421985|NCT03077919|473168262|FG001|Overall Study|Lost to Follow-up|1|||
131421986|NCT03592368|473168263|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
131421987|NCT03592368|473168264|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
131421988|NCT03592368|473168265|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
131421989|NCT03592368|473168266|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
131421990|NCT03592368|473168263|FG000|Overall Study|Adverse Event|0|||
131421991|NCT03592368|473168264|FG001|Overall Study|Adverse Event|0|||
131421992|NCT03592368|473168265|FG002|Overall Study|Adverse Event|0|||
131421993|NCT03592368|473168266|FG003|Overall Study|Adverse Event|1|||
131421994|NCT03592368|473168263|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
131421995|NCT03592368|473168264|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
131421996|NCT03592368|473168265|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
131421997|NCT03592368|473168266|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
131421998|NCT03499314|473168267|FG000|Overall Study|Time Commitment|1|||
131421999|NCT03499314|473168268|FG001|Overall Study|Time Commitment|2|||
131422000|NCT03499314|473168267|FG000|Overall Study|Medical issue unrelated to research study|1|||
131422001|NCT03499314|473168268|FG001|Overall Study|Medical issue unrelated to research study|1|||
131422002|NCT01618695|473168270|FG000|Core Phase|Adverse Event|4|||
131422003|NCT01618695|473168271|FG001|Core Phase|Adverse Event|5|||
131422004|NCT01618695|473168272|FG002|Core Phase|Adverse Event|15|||
131422005|NCT01618695|473168273|FG003|Core Phase|Adverse Event|20|||
131422006|NCT01618695|473168270|FG000|Core Phase|Lost to Follow-up|0|||
131422007|NCT01618695|473168271|FG001|Core Phase|Lost to Follow-up|0|||
131422008|NCT01618695|473168272|FG002|Core Phase|Lost to Follow-up|1|||
131422009|NCT01618695|473168273|FG003|Core Phase|Lost to Follow-up|0|||
131422010|NCT01618695|473168270|FG000|Core Phase|Withdrawal by Subject|16|||
131422011|NCT01618695|473168271|FG001|Core Phase|Withdrawal by Subject|11|||
131422012|NCT01618695|473168272|FG002|Core Phase|Withdrawal by Subject|9|||
131422013|NCT01618695|473168273|FG003|Core Phase|Withdrawal by Subject|13|||
131422014|NCT01618695|473168270|FG000|Core Phase|Pregnancy|2|||
131422015|NCT01618695|473168271|FG001|Core Phase|Pregnancy|0|||
131422016|NCT01618695|473168272|FG002|Core Phase|Pregnancy|0|||
131422017|NCT01618695|473168273|FG003|Core Phase|Pregnancy|0|||
131422018|NCT01618695|473168270|FG000|Core Phase|Lack of Efficacy|1|||
131422019|NCT01618695|473168271|FG001|Core Phase|Lack of Efficacy|2|||
131422020|NCT01618695|473168272|FG002|Core Phase|Lack of Efficacy|1|||
131422021|NCT01618695|473168273|FG003|Core Phase|Lack of Efficacy|1|||
131422022|NCT01618695|473168270|FG000|Core Phase|Other than specified|1|||
131422023|NCT01618695|473168271|FG001|Core Phase|Other than specified|2|||
131422024|NCT01618695|473168272|FG002|Core Phase|Other than specified|2|||
131422025|NCT01618695|473168273|FG003|Core Phase|Other than specified|2|||
131422026|NCT01618695|473168270|FG000|Core Phase|Not treated|1|||
131422027|NCT01618695|473168271|FG001|Core Phase|Not treated|0|||
131422028|NCT01618695|473168272|FG002|Core Phase|Not treated|2|||
131422029|NCT01618695|473168273|FG003|Core Phase|Not treated|0|||
131422030|NCT01618695|473168270|FG000|Extension Phase|Lack of Efficacy|17|||
131422031|NCT01618695|473168271|FG001|Extension Phase|Lack of Efficacy|33|||
131422032|NCT01618695|473168272|FG002|Extension Phase|Lack of Efficacy|26|||
131422033|NCT01618695|473168273|FG003|Extension Phase|Lack of Efficacy|24|||
131422034|NCT01618695|473168270|FG000|Extension Phase|Pregnancy|2|||
131422035|NCT01618695|473168271|FG001|Extension Phase|Pregnancy|0|||
131422036|NCT01618695|473168272|FG002|Extension Phase|Pregnancy|1|||
131422037|NCT01618695|473168273|FG003|Extension Phase|Pregnancy|1|||
131422038|NCT01618695|473168270|FG000|Extension Phase|Withdrawal by Subject|43|||
131422039|NCT01618695|473168271|FG001|Extension Phase|Withdrawal by Subject|48|||
131422040|NCT01618695|473168272|FG002|Extension Phase|Withdrawal by Subject|42|||
131422041|NCT01618695|473168273|FG003|Extension Phase|Withdrawal by Subject|33|||
131422042|NCT01618695|473168270|FG000|Extension Phase|Adverse Event|18|||
131422043|NCT01618695|473168271|FG001|Extension Phase|Adverse Event|16|||
131422044|NCT01618695|473168272|FG002|Extension Phase|Adverse Event|9|||
131422045|NCT01618695|473168273|FG003|Extension Phase|Adverse Event|20|||
131422046|NCT01618695|473168270|FG000|Extension Phase|Lost to Follow-up|2|||
131422047|NCT01618695|473168271|FG001|Extension Phase|Lost to Follow-up|1|||
131422048|NCT01618695|473168272|FG002|Extension Phase|Lost to Follow-up|1|||
131422049|NCT01618695|473168273|FG003|Extension Phase|Lost to Follow-up|1|||
131422050|NCT01618695|473168270|FG000|Extension Phase|Other than specified|13|||
131422051|NCT01618695|473168271|FG001|Extension Phase|Other than specified|18|||
131422052|NCT01618695|473168272|FG002|Extension Phase|Other than specified|13|||
131422053|NCT01618695|473168273|FG003|Extension Phase|Other than specified|18|||
131422054|NCT02352753|473168279|FG000|6-Month Dosing Period|Decision by sponsor|2|||
131422055|NCT02352753|473168279|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
131422056|NCT02352753|473168279|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
131422057|NCT02352753|473168279|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
131422058|NCT02352753|473168279|FG000|3-Month Dosing Period|Decision by sponsor|14|||
131422059|NCT02352753|473168279|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
131422060|NCT00539305|473168280|FG000|Overall Study|Adverse Event|1|||
131422061|NCT00539305|473168281|FG001|Overall Study|Adverse Event|0|||
131422062|NCT00539305|473168280|FG000|Overall Study|Substance Use|0|||
131422063|NCT00539305|473168281|FG001|Overall Study|Substance Use|1|||
131422064|NCT00539305|473168280|FG000|Overall Study|Withdrawal by Subject|0|||
131422065|NCT00539305|473168281|FG001|Overall Study|Withdrawal by Subject|1|||
131422066|NCT00842543|473168287|FG000|Overall Study|Withdrawal by Subject|2|||
131422067|NCT00842543|473168288|FG001|Overall Study|Withdrawal by Subject|0|||
131422068|NCT00842543|473168289|FG002|Overall Study|Withdrawal by Subject|3|||
131422069|NCT00842543|473168290|FG003|Overall Study|Withdrawal by Subject|4|||
131422070|NCT01483183|473168295|FG000|Overall Study|Physician Decision|0|||
131422071|NCT01483183|473168296|FG001|Overall Study|Physician Decision|0|||
131422072|NCT01483183|473168297|FG002|Overall Study|Physician Decision|0|||
131422073|NCT01483183|473168298|FG003|Overall Study|Physician Decision|0|||
131422074|NCT01483183|473168299|FG004|Overall Study|Physician Decision|0|||
131422075|NCT01483183|473168300|FG005|Overall Study|Physician Decision|0|||
131422076|NCT01483183|473168301|FG006|Overall Study|Physician Decision|2|||
131422077|NCT01483183|473168302|FG007|Overall Study|Physician Decision|0|||
131422078|NCT01483183|473168303|FG008|Overall Study|Physician Decision|0|||
131422079|NCT01483183|473168304|FG009|Overall Study|Physician Decision|0|||
131422080|NCT01483183|473168295|FG000|Overall Study|Withdrawal by Subject|0|||
131422081|NCT01483183|473168296|FG001|Overall Study|Withdrawal by Subject|0|||
131422082|NCT01483183|473168297|FG002|Overall Study|Withdrawal by Subject|0|||
131422083|NCT01483183|473168298|FG003|Overall Study|Withdrawal by Subject|0|||
131422084|NCT01483183|473168299|FG004|Overall Study|Withdrawal by Subject|0|||
131422085|NCT01483183|473168300|FG005|Overall Study|Withdrawal by Subject|0|||
131422086|NCT01483183|473168301|FG006|Overall Study|Withdrawal by Subject|0|||
131422087|NCT01483183|473168302|FG007|Overall Study|Withdrawal by Subject|0|||
131422088|NCT01483183|473168303|FG008|Overall Study|Withdrawal by Subject|0|||
131422089|NCT01483183|473168304|FG009|Overall Study|Withdrawal by Subject|1|||
131422090|NCT00239928|473168305|FG000|Overall Study|Lack of Efficacy|1|||
131422091|NCT00239928|473168305|FG000|Overall Study|Adverse Event|4|||
131422092|NCT00239928|473168305|FG000|Overall Study|Not need to continue study|3|||
131422093|NCT00239928|473168305|FG000|Overall Study|Withdrawal by Subject|2|||
131422094|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422095|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422096|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
131422097|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
131422098|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
131422099|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422100|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
131422101|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
131422102|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
131422103|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422104|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422105|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422106|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
131422107|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
131422108|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
131422109|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
131422110|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
131422111|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
131422112|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
131422113|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
131422114|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
131422115|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
131422116|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
131422117|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
131422118|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
131422119|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
131422120|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422121|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
131422122|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
131422123|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422124|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422125|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
131422126|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
131422127|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422128|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422129|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422130|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422131|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422132|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
131422133|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422134|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
131422135|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
131422136|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422137|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422138|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422139|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
131422140|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422141|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
131422142|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422143|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422144|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422145|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
131422146|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422147|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422148|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422149|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
131422150|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422151|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422152|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131457905|NCT00870584|473307169|FG000|Overall Study|Withdrawal by Subject|6|||
131422153|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
131422154|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422155|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422156|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422157|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422158|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
131422159|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422160|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422161|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422162|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
131422163|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422164|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422165|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
131422166|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422167|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422168|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422169|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422170|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422171|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
131422172|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422173|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
131422174|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422175|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422176|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422177|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422178|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422179|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422180|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422181|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422182|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422183|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422184|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
131422185|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
131422186|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422187|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422188|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422189|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422190|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422191|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422192|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422193|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422194|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422195|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422196|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422197|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
131422198|NCT03100058|473168307|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422199|NCT03100058|473168308|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422200|NCT03100058|473168309|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422201|NCT03100058|473168310|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422202|NCT03100058|473168311|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422203|NCT03100058|473168312|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422204|NCT03100058|473168313|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
131422205|NCT03100058|473168314|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422206|NCT03100058|473168315|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422207|NCT03100058|473168316|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422208|NCT03100058|473168317|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422209|NCT03100058|473168318|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422210|NCT03100058|473168319|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
131422211|NCT03100058|473168307|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422212|NCT03100058|473168308|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422213|NCT03100058|473168309|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422214|NCT03100058|473168310|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422215|NCT03100058|473168311|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422216|NCT03100058|473168312|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422217|NCT03100058|473168313|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422218|NCT03100058|473168314|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422219|NCT03100058|473168315|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422220|NCT03100058|473168316|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
131422221|NCT03100058|473168317|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
131422222|NCT03100058|473168318|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
131422223|NCT03100058|473168319|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
131422224|NCT03100058|473168307|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422225|NCT03100058|473168308|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422226|NCT03100058|473168309|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131457906|NCT00870584|473307170|FG001|Overall Study|Withdrawal by Subject|7|||
131457907|NCT00870584|473307169|FG000|Overall Study|Lost to Follow-up|5|||
131422227|NCT03100058|473168310|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422228|NCT03100058|473168311|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422229|NCT03100058|473168312|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422230|NCT03100058|473168313|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422231|NCT03100058|473168314|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422232|NCT03100058|473168315|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422233|NCT03100058|473168316|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422234|NCT03100058|473168317|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
131422235|NCT03100058|473168318|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
131422236|NCT03100058|473168319|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
131422237|NCT03100058|473168307|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422238|NCT03100058|473168308|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422239|NCT03100058|473168309|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422240|NCT03100058|473168310|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422241|NCT03100058|473168311|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422242|NCT03100058|473168312|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422243|NCT03100058|473168313|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422244|NCT03100058|473168314|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422245|NCT03100058|473168315|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422246|NCT03100058|473168316|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
131422247|NCT03100058|473168317|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
131422248|NCT03100058|473168318|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
131422249|NCT03100058|473168319|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
131422250|NCT03100058|473168307|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422251|NCT03100058|473168308|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422252|NCT03100058|473168309|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422253|NCT03100058|473168310|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422254|NCT03100058|473168311|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422255|NCT03100058|473168312|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422256|NCT03100058|473168313|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422257|NCT03100058|473168314|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422258|NCT03100058|473168315|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422259|NCT03100058|473168316|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422260|NCT03100058|473168317|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
131422261|NCT03100058|473168318|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422262|NCT03100058|473168319|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
131422263|NCT03100058|473168307|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422264|NCT03100058|473168308|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422265|NCT03100058|473168309|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422266|NCT03100058|473168310|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422267|NCT03100058|473168311|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422268|NCT03100058|473168312|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422269|NCT03100058|473168313|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422270|NCT03100058|473168314|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422271|NCT03100058|473168315|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422272|NCT03100058|473168316|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422273|NCT03100058|473168317|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422274|NCT03100058|473168318|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
131422275|NCT03100058|473168319|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
131422276|NCT03100058|473168307|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422277|NCT03100058|473168308|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422278|NCT03100058|473168309|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422279|NCT03100058|473168310|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422280|NCT03100058|473168311|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422281|NCT03100058|473168312|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422282|NCT03100058|473168313|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422283|NCT03100058|473168314|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422284|NCT03100058|473168315|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422285|NCT03100058|473168316|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
131422286|NCT03100058|473168317|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422287|NCT03100058|473168318|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422288|NCT03100058|473168319|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
131422289|NCT00844558|473168322|FG000|Overall Study|Withdrawal by Subject|9|||
131422290|NCT00844558|473168323|FG001|Overall Study|Withdrawal by Subject|2|||
131422291|NCT00844558|473168322|FG000|Overall Study|Death|1|||
131422292|NCT00844558|473168323|FG001|Overall Study|Death|0|||
131422293|NCT00844558|473168322|FG000|Overall Study|Protocol Violation|1|||
131422294|NCT00844558|473168323|FG001|Overall Study|Protocol Violation|1|||
131422295|NCT00844558|473168322|FG000|Overall Study|Lost to Follow-up|0|||
131457908|NCT00870584|473307170|FG001|Overall Study|Lost to Follow-up|1|||
131422296|NCT00844558|473168323|FG001|Overall Study|Lost to Follow-up|1|||
131422297|NCT00844558|473168322|FG000|Overall Study|Physician Decision|1|||
131422298|NCT00844558|473168323|FG001|Overall Study|Physician Decision|0|||
131422299|NCT01894022|473168334|FG000|Overall Study|Death|1|||
131422300|NCT01894022|473168335|FG001|Overall Study|Death|0|||
131422301|NCT01894022|473168334|FG000|Overall Study|Adverse Event, non-fatal|1|||
131422302|NCT01894022|473168335|FG001|Overall Study|Adverse Event, non-fatal|0|||
131422303|NCT01894022|473168334|FG000|Overall Study|Study Closed/terminated|7|||
131422304|NCT01894022|473168335|FG001|Overall Study|Study Closed/terminated|10|||
131422305|NCT00699335|473168338|FG000|Overall Study|Combination of multiple reasons|176|||
131422306|NCT00699335|473168338|FG000|Overall Study|Missing data|52|||
131422307|NCT01887353|473168339|FG000|Overall Study|Study stopped early|4|||
131422308|NCT01887353|473168340|FG001|Overall Study|Study stopped early|3|||
131422309|NCT01069705|473168341|FG000|Overall Study|Adverse Event|1|||
131422310|NCT01069705|473168341|FG000|Overall Study|Withdrawal by Subject|2|||
131422311|NCT02999633|473168342|FG000|Overall Study|Adverse Event|2|||
131422312|NCT02999633|473168342|FG000|Overall Study|Progressive disease|12|||
131422313|NCT03262441|473168343|FG000|Overall Study|Withdrawal by Subject|1|||
131422314|NCT01545050|473168344|FG000|Overall Study|Lack of Efficacy|0|||
131422315|NCT01545050|473168345|FG001|Overall Study|Lack of Efficacy|0|||
131422316|NCT01545050|473168346|FG002|Overall Study|Lack of Efficacy|0|||
131422317|NCT01545050|473168347|FG003|Overall Study|Lack of Efficacy|3|||
131422318|NCT01545050|473168348|FG004|Overall Study|Lack of Efficacy|2|||
131422319|NCT01545050|473168344|FG000|Overall Study|Adverse Event|1|||
131422320|NCT01545050|473168345|FG001|Overall Study|Adverse Event|1|||
131422321|NCT01545050|473168346|FG002|Overall Study|Adverse Event|2|||
131422322|NCT01545050|473168347|FG003|Overall Study|Adverse Event|2|||
131422323|NCT01545050|473168348|FG004|Overall Study|Adverse Event|0|||
131422324|NCT01545050|473168344|FG000|Overall Study|Discontinued study treatment|1|||
131422325|NCT01545050|473168345|FG001|Overall Study|Discontinued study treatment|0|||
131422326|NCT01545050|473168346|FG002|Overall Study|Discontinued study treatment|0|||
131422327|NCT01545050|473168347|FG003|Overall Study|Discontinued study treatment|0|||
131422328|NCT01545050|473168348|FG004|Overall Study|Discontinued study treatment|0|||
131422329|NCT01545050|473168344|FG000|Overall Study|Withdrawal by Subject|1|||
131422330|NCT01545050|473168345|FG001|Overall Study|Withdrawal by Subject|0|||
131422331|NCT01545050|473168346|FG002|Overall Study|Withdrawal by Subject|0|||
131422332|NCT01545050|473168347|FG003|Overall Study|Withdrawal by Subject|2|||
131422333|NCT01545050|473168348|FG004|Overall Study|Withdrawal by Subject|1|||
131422334|NCT01545050|473168344|FG000|Overall Study|Participant no longer meets study criteria|0|||
131422335|NCT01545050|473168345|FG001|Overall Study|Participant no longer meets study criteria|2|||
131422336|NCT01545050|473168346|FG002|Overall Study|Participant no longer meets study criteria|0|||
131422337|NCT01545050|473168347|FG003|Overall Study|Participant no longer meets study criteria|0|||
131422338|NCT01545050|473168348|FG004|Overall Study|Participant no longer meets study criteria|1|||
131422339|NCT01545050|473168344|FG000|Overall Study|Administrative reason by sponsor|4|||
131422340|NCT01545050|473168345|FG001|Overall Study|Administrative reason by sponsor|2|||
131422341|NCT01545050|473168346|FG002|Overall Study|Administrative reason by sponsor|3|||
131422342|NCT01545050|473168347|FG003|Overall Study|Administrative reason by sponsor|5|||
131422343|NCT01545050|473168348|FG004|Overall Study|Administrative reason by sponsor|5|||
131422344|NCT03235089|473168349|FG000|Overall Study|Lost to Follow-up|1|||
131422345|NCT03235089|473168350|FG001|Overall Study|Lost to Follow-up|1|||
131422346|NCT03235089|473168349|FG000|Overall Study|Physician Decision|2|||
131422347|NCT03235089|473168350|FG001|Overall Study|Physician Decision|2|||
131422348|NCT03238924|473168352|FG000|Overall Study|Withdrawal by Subject|2|||
131422349|NCT03238924|473168353|FG001|Overall Study|Withdrawal by Subject|2|||
131422350|NCT02516228|473168354|FG000|Overall Study|Lost to Follow-up|1|||
131422351|NCT02516228|473168354|FG000|Overall Study|Withdrawal by Subject|1|||
131422352|NCT02516228|473168354|FG000|Overall Study|Physician Decision|1|||
131422353|NCT03916484|473168357|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131422354|NCT03916484|473168358|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
131422355|NCT03916484|473168359|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131422356|NCT03916484|473168360|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
131422357|NCT03916484|473168357|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
131422358|NCT03916484|473168358|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
131422359|NCT03916484|473168359|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
131422360|NCT03916484|473168360|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
131422361|NCT00504894|473168367|FG000|Overall Study|fMRI technical problems|1|||
131422362|NCT00504894|473168368|FG001|Overall Study|fMRI technical problems|1|||
131422363|NCT00504894|473168369|FG002|Overall Study|fMRI technical problems|0|||
131422364|NCT00504894|473168367|FG000|Overall Study|Withdrawal by Subject|0|||
131422365|NCT00504894|473168368|FG001|Overall Study|Withdrawal by Subject|1|||
131422366|NCT00504894|473168369|FG002|Overall Study|Withdrawal by Subject|0|||
131422367|NCT00504894|473168367|FG000|Overall Study|Infusion technical problems|0|||
131422368|NCT00504894|473168368|FG001|Overall Study|Infusion technical problems|1|||
131422369|NCT00504894|473168369|FG002|Overall Study|Infusion technical problems|0|||
131422370|NCT00504894|473168367|FG000|Overall Study|poor subject data|2|||
131422371|NCT00504894|473168368|FG001|Overall Study|poor subject data|0|||
131422372|NCT00504894|473168369|FG002|Overall Study|poor subject data|0|||
131422373|NCT05090852|473168370|FG000|Overall Study|Physician Decision|5|||
131422374|NCT01196416|473168373|FG000|Overall Study|Withdrawal by Subject|2|||
131422375|NCT00148941|473168375|FG000|Overall Study|Lost to Follow-up|17|||
131422376|NCT00148941|473168376|FG001|Overall Study|Lost to Follow-up|24|||
131422377|NCT00148941|473168377|FG002|Overall Study|Lost to Follow-up|18|||
131422378|NCT00148941|473168378|FG003|Overall Study|Lost to Follow-up|22|||
131422379|NCT00148941|473168375|FG000|Overall Study|Withdrawal by Subject|1|||
131422380|NCT00148941|473168376|FG001|Overall Study|Withdrawal by Subject|0|||
131422381|NCT00148941|473168377|FG002|Overall Study|Withdrawal by Subject|1|||
131422382|NCT00148941|473168378|FG003|Overall Study|Withdrawal by Subject|0|||
131422383|NCT00148941|473168375|FG000|Overall Study|Other|0|||
131422384|NCT00148941|473168376|FG001|Overall Study|Other|0|||
131422385|NCT00148941|473168377|FG002|Overall Study|Other|1|||
131422386|NCT00148941|473168378|FG003|Overall Study|Other|2|||
131422387|NCT02673684|473168379|FG000|Overall Study|Study not completed d/t loss of funding|9|||
131422388|NCT02673684|473168380|FG001|Overall Study|Study not completed d/t loss of funding|8|||
131422389|NCT01092663|473168381|FG000|Overall Study|Withdrawal by Subject|3|||
131422390|NCT01092663|473168382|FG001|Overall Study|Withdrawal by Subject|2|||
131422391|NCT01092663|473168381|FG000|Overall Study|Glucose >300mg/dL|1|||
131422392|NCT01092663|473168382|FG001|Overall Study|Glucose >300mg/dL|0|||
131422393|NCT01092663|473168381|FG000|Overall Study|High fasting triglyceride|2|||
131422394|NCT01092663|473168382|FG001|Overall Study|High fasting triglyceride|0|||
131422395|NCT01092663|473168381|FG000|Overall Study|Adverse Event|1|||
131422396|NCT01092663|473168382|FG001|Overall Study|Adverse Event|1|||
131422397|NCT01092663|473168381|FG000|Overall Study|Protocol Violation|0|||
131422398|NCT01092663|473168382|FG001|Overall Study|Protocol Violation|1|||
131422399|NCT03688620|473168383|FG000|Overall Study|Other|0|||
131422400|NCT03688620|473168384|FG001|Overall Study|Other|0|||
131422401|NCT03688620|473168385|FG002|Overall Study|Other|1|||
131422402|NCT03688620|473168383|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
131422403|NCT03688620|473168384|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
131422404|NCT03688620|473168385|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
131422405|NCT03688620|473168383|FG000|Overall Study|Lost to Follow-up|16|||
131422406|NCT03688620|473168384|FG001|Overall Study|Lost to Follow-up|0|||
131422407|NCT03688620|473168385|FG002|Overall Study|Lost to Follow-up|1|||
131422408|NCT03688620|473168383|FG000|Overall Study|Withdrawal by Subject|0|||
131422409|NCT03688620|473168384|FG001|Overall Study|Withdrawal by Subject|0|||
131422410|NCT03688620|473168385|FG002|Overall Study|Withdrawal by Subject|6|||
131422411|NCT01008904|473168386|FG000|Overall Study|Lost to Follow-up|1|||
131422412|NCT01008904|473168386|FG000|Overall Study|Adverse Event|2|||
131422413|NCT01008904|473168386|FG000|Overall Study|unexpected unrelated surgery|1|||
131422414|NCT01183065|473168387|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
131422415|NCT02456857|473168388|FG000|Overall Study|Disease Progression|4|||
131422416|NCT00781859|473168389|FG000|Overall Study|Adverse Event|2|||
131422417|NCT00781859|473168390|FG001|Overall Study|Adverse Event|2|||
131422418|NCT00781859|473168389|FG000|Overall Study|Withdrawal by Subject|8|||
131422419|NCT00781859|473168390|FG001|Overall Study|Withdrawal by Subject|4|||
131422420|NCT00781859|473168389|FG000|Overall Study|Lost to Follow-up|6|||
131422421|NCT00781859|473168390|FG001|Overall Study|Lost to Follow-up|3|||
131422422|NCT00781859|473168389|FG000|Overall Study|Death|3|||
131422423|NCT00781859|473168390|FG001|Overall Study|Death|0|||
131422424|NCT01983774|473168394|FG000|Overall Study|Lung Transplant|0|||
131422425|NCT01983774|473168395|FG001|Overall Study|Lung Transplant|1|||
131422426|NCT01983774|473168394|FG000|Overall Study|Lost to Follow-up|1|||
131422427|NCT01983774|473168395|FG001|Overall Study|Lost to Follow-up|0|||
131422428|NCT01008449|473168396|FG000|Overall Study|Lost to Follow-up|29|||
131422429|NCT01008449|473168397|FG001|Overall Study|Lost to Follow-up|19|||
131422430|NCT01220180|473168398|FG000|Overall Study|Lost to Follow-up|76|||
131422431|NCT01220180|473168398|FG000|Overall Study|Other|72|||
131422432|NCT01220180|473168398|FG000|Overall Study|Adverse Event|35|||
131422433|NCT01220180|473168398|FG000|Overall Study|Lack of Efficacy|22|||
131422434|NCT01220180|473168398|FG000|Overall Study|Death|1|||
131422435|NCT01220180|473168398|FG000|Overall Study|Randomized but not treated|1|||
131422436|NCT01299116|473168404|FG000|Overall Study|Lost to Follow-up|65|||
131422437|NCT01299116|473168405|FG001|Overall Study|Lost to Follow-up|9|||
131422438|NCT01299116|473168406|FG002|Overall Study|Lost to Follow-up|11|||
131422439|NCT01620944|473168407|FG000|Overall Study|Early termination of Study|2|||
131422440|NCT01620944|473168408|FG001|Overall Study|Early termination of Study|1|||
131422441|NCT04378114|473168409|FG000|Overall Study|Withdrawal by Subject|5|||
131422442|NCT01959243|473168410|FG000|Overall Study|Investigator Decision|3|||
131422443|NCT01959243|473168411|FG001|Overall Study|Investigator Decision|0|||
131422444|NCT01959243|473168410|FG000|Overall Study|Adverse Event|5|||
131422445|NCT01959243|473168411|FG001|Overall Study|Adverse Event|2|||
131422446|NCT01959243|473168410|FG000|Overall Study|Administrative reasons|2|||
131422447|NCT01959243|473168411|FG001|Overall Study|Administrative reasons|1|||
131422448|NCT01959243|473168410|FG000|Overall Study|Lost to Follow-up|3|||
131422449|NCT01959243|473168411|FG001|Overall Study|Lost to Follow-up|1|||
131422450|NCT00629798|473168414|FG000|Overall Study|Not Treated|4|||
131422451|NCT02188849|473168416|FG000|Overall Study|Lost to Follow-up|3|||
131422452|NCT02188849|473168417|FG001|Overall Study|Lost to Follow-up|8|||
131422453|NCT01730586|473168418|FG000|Overall Study|Progressive Disease|2|||
131422454|NCT01730586|473168418|FG000|Overall Study|Inadequate Trial|8|||
131422455|NCT01730586|473168418|FG000|Overall Study|Adverse Event|2|||
131422456|NCT01730586|473168418|FG000|Overall Study|Hospice|1|||
131422457|NCT02921087|473168419|FG000|Overall Study|Withdrawal by Subject|0|||
131422458|NCT02921087|473168420|FG001|Overall Study|Withdrawal by Subject|1|||
131422459|NCT00687531|473168421|FG000|Overall Study|Did not meet protocol eligibility|104|||
131422460|NCT00687531|473168421|FG000|Overall Study|Adverse Event|5|||
131422461|NCT00687531|473168421|FG000|Overall Study|Lost to Follow-up|26|||
131422462|NCT00619307|473168422|FG000|Overall Study|Adverse Event|0|||
131422463|NCT00619307|473168423|FG001|Overall Study|Adverse Event|1|||
131422464|NCT00619307|473168422|FG000|Overall Study|Lost to Follow-up|0|||
131422465|NCT00619307|473168423|FG001|Overall Study|Lost to Follow-up|1|||
131422466|NCT00619307|473168422|FG000|Overall Study|Protocol Violation|3|||
131422467|NCT00619307|473168423|FG001|Overall Study|Protocol Violation|0|||
131422468|NCT00619307|473168422|FG000|Overall Study|Withdrew consent|1|||
131422469|NCT00619307|473168423|FG001|Overall Study|Withdrew consent|0|||
131422470|NCT00619307|473168422|FG000|Overall Study|Severe migraine|0|||
131422471|NCT00619307|473168423|FG001|Overall Study|Severe migraine|1|||
131422472|NCT00619307|473168422|FG000|Overall Study|MS attack plus steroids|0|||
131422473|NCT00619307|473168423|FG001|Overall Study|MS attack plus steroids|1|||
131422474|NCT02454478|473169612|FG000|Overall Study|Incomplete DLT Evaluation|1|||
131422475|NCT00193180|473169613|FG000|Overall Study|Lack of Efficacy|1|||
131422476|NCT00193180|473169613|FG000|Overall Study|Adverse Event|8|||
131422477|NCT00193180|473169613|FG000|Overall Study|Protocol Violation|1|||
131422478|NCT01357551|473169614|FG000|Overall Study|Withdrawal by Subject|6|||
131422479|NCT01357551|473169615|FG001|Overall Study|Withdrawal by Subject|4|||
131422480|NCT01357551|473169614|FG000|Overall Study|Death|0|||
131422481|NCT01357551|473169615|FG001|Overall Study|Death|1|||
131422482|NCT01357551|473169614|FG000|Overall Study|Lost to Follow-up|16|||
131422483|NCT01357551|473169615|FG001|Overall Study|Lost to Follow-up|6|||
131422484|NCT00413036|473169616|FG000|Overall Study|Adverse Event|44|||
131422485|NCT00413036|473169616|FG000|Overall Study|Lack of Efficacy|129|||
131422486|NCT00413036|473169616|FG000|Overall Study|Withdrawal by Subject|7|||
131422487|NCT00413036|473169616|FG000|Overall Study|Death|9|||
131422488|NCT00413036|473169616|FG000|Overall Study|Other|26|||
131422489|NCT00413036|473169616|FG000|Overall Study|Missing|2|||
131422490|NCT01369641|473169619|FG000|Overall Study|Withdrawal by Subject|1|||
131422491|NCT00774800|473169622|FG000|Intervention 4|Withdrawal by Subject|1|||
131422492|NCT01331109|473169627|FG000|Overall Study|Adverse Event|6|||
131422493|NCT01331109|473169627|FG000|Overall Study|Lack of Efficacy|2|||
131422494|NCT01331109|473169627|FG000|Overall Study|Protocol Violation|3|||
131422495|NCT01331109|473169627|FG000|Overall Study|Withdrawal by Subject|7|||
131422496|NCT01331109|473169627|FG000|Overall Study|Lost to Follow-up|1|||
131422497|NCT01331109|473169627|FG000|Overall Study|Study Terminated by Sponsor|38|||
131422498|NCT00479856|473169628|FG000|Overall Study|Adverse Event|1|||
131422499|NCT00479856|473169628|FG000|Overall Study|Withdrawal by Subject|1|||
131422500|NCT00479856|473169628|FG000|Overall Study|Physician Decision|1|||
131422501|NCT00661622|473169631|FG000|Overall Study|Protocol Violation|1|||
131422502|NCT00661622|473169632|FG001|Overall Study|Protocol Violation|0|||
131422503|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
131422504|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
131422505|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
131422506|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
131422507|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Death|2|||
131422508|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Death|2|||
131422509|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Death|0|||
131422510|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Death|0|||
131422511|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
131422512|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
131422513|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
131422514|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
131422515|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
131422516|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
131422517|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
131422518|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
131422519|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
131422520|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
131422521|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
131422522|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
131422523|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
131422524|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
131422525|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
131422526|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
131422527|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
131422528|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
131422529|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
131422530|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
131422531|NCT03068754|473169636|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
131422532|NCT03068754|473169637|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
131422533|NCT03068754|473169638|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
131422534|NCT03068754|473169639|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
131422535|NCT03068754|473169636|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
131422536|NCT03068754|473169637|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
131422537|NCT03068754|473169638|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
131422538|NCT03068754|473169639|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
131422539|NCT03068754|473169636|FG000|Open Label Extension Period (OLE)|Death|0|||
131422540|NCT03068754|473169637|FG001|Open Label Extension Period (OLE)|Death|0|||
131422541|NCT03068754|473169638|FG002|Open Label Extension Period (OLE)|Death|0|||
131422542|NCT03068754|473169639|FG003|Open Label Extension Period (OLE)|Death|1|||
131422543|NCT03068754|473169636|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
131422544|NCT03068754|473169637|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
131422545|NCT03068754|473169638|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
131422546|NCT03068754|473169639|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
131422547|NCT03068754|473169636|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
131422548|NCT03068754|473169637|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
131422549|NCT03068754|473169638|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
131422550|NCT03068754|473169639|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
131422551|NCT03068754|473169636|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
131422552|NCT03068754|473169637|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
131422553|NCT03068754|473169638|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
131422554|NCT03068754|473169639|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
131422555|NCT03068754|473169636|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
131422556|NCT03068754|473169637|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
131422557|NCT03068754|473169638|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
131422558|NCT03068754|473169639|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
131422559|NCT02760810|473169641|FG000|Overall Study|Protocol Violation|1|||
131422560|NCT00820222|473169642|FG000|Overall Study|Lost to Follow-up|10|||
131422561|NCT00820222|473169643|FG001|Overall Study|Lost to Follow-up|9|||
131422562|NCT00820222|473169642|FG000|Overall Study|Withdrawal by Subject|19|||
131422563|NCT00820222|473169643|FG001|Overall Study|Withdrawal by Subject|21|||
131422564|NCT00820222|473169642|FG000|Overall Study|Physician Decision|93|||
131422565|NCT00820222|473169643|FG001|Overall Study|Physician Decision|88|||
131422566|NCT00820222|473169642|FG000|Overall Study|Sponsor Terminated Study|43|||
131422567|NCT00820222|473169643|FG001|Overall Study|Sponsor Terminated Study|65|||
131422568|NCT00820222|473169642|FG000|Overall Study|Unkown|11|||
131422569|NCT00820222|473169643|FG001|Overall Study|Unkown|7|||
131422570|NCT00932165|473169644|FG000|Overall Study|Lost to Follow-up|1|||
131422571|NCT00588094|473169645|FG000|Overall Study|Adverse Event|3|||
131422572|NCT00588094|473169645|FG000|Overall Study|Progression of Disease|2|||
131422573|NCT01336023|473169646|FG000|Week 0 to Week 26|Adverse Event|8|||
131422574|NCT01336023|473169647|FG001|Week 0 to Week 26|Adverse Event|10|||
131422575|NCT01336023|473169648|FG002|Week 0 to Week 26|Adverse Event|24|||
131422576|NCT01336023|473169646|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
131422577|NCT01336023|473169647|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
131422578|NCT01336023|473169648|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
131422579|NCT01336023|473169646|FG000|Week 0 to Week 26|Protocol Violation|1|||
131422580|NCT01336023|473169647|FG001|Week 0 to Week 26|Protocol Violation|2|||
131422581|NCT01336023|473169648|FG002|Week 0 to Week 26|Protocol Violation|0|||
131422582|NCT01336023|473169646|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
131422583|NCT01336023|473169647|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
131422584|NCT01336023|473169648|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
131422585|NCT01336023|473169646|FG000|Week 0 to Week 26|Unclassified|5|||
131422586|NCT01336023|473169647|FG001|Week 0 to Week 26|Unclassified|16|||
131422587|NCT01336023|473169648|FG002|Week 0 to Week 26|Unclassified|9|||
131422588|NCT01336023|473169646|FG000|Week 27 to 52|Adverse Event|1|||
131422589|NCT01336023|473169647|FG001|Week 27 to 52|Adverse Event|5|||
131422590|NCT01336023|473169648|FG002|Week 27 to 52|Adverse Event|2|||
131422591|NCT01336023|473169646|FG000|Week 27 to 52|Protocol Violation|0|||
131422592|NCT01336023|473169647|FG001|Week 27 to 52|Protocol Violation|2|||
131422593|NCT01336023|473169648|FG002|Week 27 to 52|Protocol Violation|1|||
131422594|NCT01336023|473169646|FG000|Week 27 to 52|Withdrawal Criteria|14|||
131422595|NCT01336023|473169647|FG001|Week 27 to 52|Withdrawal Criteria|19|||
131422596|NCT01336023|473169648|FG002|Week 27 to 52|Withdrawal Criteria|16|||
131422597|NCT01336023|473169646|FG000|Week 27 to 52|Unclassified|13|||
131422598|NCT01336023|473169647|FG001|Week 27 to 52|Unclassified|18|||
131422599|NCT01336023|473169648|FG002|Week 27 to 52|Unclassified|9|||
131422600|NCT00666965|473169653|FG000|Overall Study|Adverse Event|0|||
131422601|NCT00666965|473169654|FG001|Overall Study|Adverse Event|2|||
131422602|NCT00666965|473169655|FG002|Overall Study|Adverse Event|1|||
131422603|NCT00666965|473169656|FG003|Overall Study|Adverse Event|9|||
131422604|NCT00666965|473169653|FG000|Overall Study|Lack of Efficacy|1|||
131422605|NCT00666965|473169654|FG001|Overall Study|Lack of Efficacy|1|||
131422606|NCT00666965|473169655|FG002|Overall Study|Lack of Efficacy|0|||
131422607|NCT00666965|473169656|FG003|Overall Study|Lack of Efficacy|0|||
131422608|NCT00666965|473169653|FG000|Overall Study|Protocol Violation|0|||
131422609|NCT00666965|473169654|FG001|Overall Study|Protocol Violation|0|||
131422610|NCT00666965|473169655|FG002|Overall Study|Protocol Violation|0|||
131422611|NCT00666965|473169656|FG003|Overall Study|Protocol Violation|2|||
131422612|NCT00666965|473169653|FG000|Overall Study|Discontinuation criteria|2|||
131422613|NCT00666965|473169654|FG001|Overall Study|Discontinuation criteria|1|||
131422614|NCT00666965|473169655|FG002|Overall Study|Discontinuation criteria|1|||
131422615|NCT00666965|473169656|FG003|Overall Study|Discontinuation criteria|2|||
131422616|NCT00666965|473169653|FG000|Overall Study|Withdrawal by Subject|0|||
131422617|NCT00666965|473169654|FG001|Overall Study|Withdrawal by Subject|0|||
131422618|NCT00666965|473169655|FG002|Overall Study|Withdrawal by Subject|0|||
131422619|NCT00666965|473169656|FG003|Overall Study|Withdrawal by Subject|2|||
131422620|NCT04496453|473169664|FG000|Overall Study|Lost to Follow-up|6|||
131422621|NCT03997825|473169665|FG000|Overall Study|Death|3|||
131422622|NCT03997825|473169665|FG000|Overall Study|Lost to Follow-up|10|||
131422623|NCT03997825|473169665|FG000|Overall Study|Withdrawal by Subject|3|||
131422624|NCT03997825|473169665|FG000|Overall Study|Refused participation|1|||
131422625|NCT00383162|473169666|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
131422626|NCT00383162|473169667|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
131422627|NCT00383162|473169666|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
131422628|NCT00383162|473169667|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
131422629|NCT00383162|473169666|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
131422630|NCT00383162|473169667|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
131422631|NCT00383162|473169666|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
131422632|NCT00383162|473169667|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
131422633|NCT00383162|473169666|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
131422634|NCT00383162|473169667|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
131422635|NCT00383162|473169666|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
131422636|NCT00383162|473169667|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
131422637|NCT00383162|473169666|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
131422638|NCT00383162|473169667|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
131422639|NCT00383162|473169666|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
131422640|NCT00383162|473169667|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
131422641|NCT00383162|473169666|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
131422642|NCT00383162|473169667|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
131422643|NCT00767819|473169668|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
131422644|NCT00767819|473169669|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
131422645|NCT00767819|473169670|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131422646|NCT00767819|473169668|FG000|Overall Study|Withdrawal by Subject|1|||
131422647|NCT00767819|473169669|FG001|Overall Study|Withdrawal by Subject|1|||
131457909|NCT00870584|473307169|FG000|Overall Study|Protocol Deviation|2|||
131457910|NCT00870584|473307170|FG001|Overall Study|Protocol Deviation|2|||
131457911|NCT02560025|473307171|FG000|Overall Study|Ineligible after consent/ registration|3|||
131422648|NCT00767819|473169670|FG002|Overall Study|Withdrawal by Subject|0|||
131422649|NCT00767819|473169668|FG000|Overall Study|Administrative problems|0|||
131422650|NCT00767819|473169669|FG001|Overall Study|Administrative problems|1|||
131422651|NCT00767819|473169670|FG002|Overall Study|Administrative problems|0|||
131422652|NCT00767819|473169668|FG000|Overall Study|Death|2|||
131422653|NCT00767819|473169669|FG001|Overall Study|Death|3|||
131422654|NCT00767819|473169670|FG002|Overall Study|Death|0|||
131422655|NCT00767819|473169668|FG000|Overall Study|Adverse Event|2|||
131422656|NCT00767819|473169669|FG001|Overall Study|Adverse Event|0|||
131422657|NCT00767819|473169670|FG002|Overall Study|Adverse Event|0|||
131422658|NCT00767819|473169668|FG000|Overall Study|Abnormal lab values|1|||
131422659|NCT00767819|473169669|FG001|Overall Study|Abnormal lab values|0|||
131422660|NCT00767819|473169670|FG002|Overall Study|Abnormal lab values|0|||
131422661|NCT00767819|473169668|FG000|Overall Study|Lost to Follow-up|1|||
131422662|NCT00767819|473169669|FG001|Overall Study|Lost to Follow-up|0|||
131422663|NCT00767819|473169670|FG002|Overall Study|Lost to Follow-up|0|||
131422664|NCT02726022|473169672|FG000|Overall Study|Adverse Event|14|||
131422665|NCT02726022|473169672|FG000|Overall Study|Treatment Failure|8|||
131422666|NCT02726022|473169672|FG000|Overall Study|Poor Compliance|13|||
131422667|NCT02726022|473169672|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
131422668|NCT00915551|473169673|FG000|Overall Study|Withdrawal by Subject|0|||
131422669|NCT00915551|473169674|FG001|Overall Study|Withdrawal by Subject|1|||
131422670|NCT00235716|473169675|FG000|Overall Study|Death|26|||
131422671|NCT00235716|473169676|FG001|Overall Study|Death|39|||
131422672|NCT00235716|473169677|FG002|Overall Study|Death|32|||
131422673|NCT00235716|473169678|FG003|Overall Study|Death|31|||
131422674|NCT00235716|473169675|FG000|Overall Study|Withdrawal by Subject|23|||
131422675|NCT00235716|473169676|FG001|Overall Study|Withdrawal by Subject|19|||
131422676|NCT00235716|473169677|FG002|Overall Study|Withdrawal by Subject|17|||
131422677|NCT00235716|473169678|FG003|Overall Study|Withdrawal by Subject|18|||
131422678|NCT00235716|473169675|FG000|Overall Study|Lost to Follow-up|12|||
131422679|NCT00235716|473169676|FG001|Overall Study|Lost to Follow-up|7|||
131422680|NCT00235716|473169677|FG002|Overall Study|Lost to Follow-up|14|||
131422681|NCT00235716|473169678|FG003|Overall Study|Lost to Follow-up|10|||
131422682|NCT00235716|473169675|FG000|Overall Study|Adverse Event|1|||
131422683|NCT00235716|473169676|FG001|Overall Study|Adverse Event|1|||
131422684|NCT00235716|473169677|FG002|Overall Study|Adverse Event|1|||
131422685|NCT00235716|473169678|FG003|Overall Study|Adverse Event|0|||
131422686|NCT00235716|473169675|FG000|Overall Study|Physician Decision|0|||
131422687|NCT00235716|473169676|FG001|Overall Study|Physician Decision|1|||
131422688|NCT00235716|473169677|FG002|Overall Study|Physician Decision|1|||
131422689|NCT00235716|473169678|FG003|Overall Study|Physician Decision|3|||
131422690|NCT04390841|473169679|FG000|Overall Study|Withdrawal by Subject|2|||
131422691|NCT02891382|473169692|FG000|Overall Study|Lost to Follow-up|3|||
131422692|NCT02891382|473169693|FG001|Overall Study|Lost to Follow-up|4|||
131422693|NCT02891382|473169694|FG002|Overall Study|Lost to Follow-up|5|||
131422694|NCT02891382|473169695|FG003|Overall Study|Lost to Follow-up|3|||
131422695|NCT02891382|473169696|FG004|Overall Study|Lost to Follow-up|4|||
131422696|NCT02554981|473169699|FG000|Overall Study|Adverse Event|1|||
131422697|NCT02554981|473169699|FG000|Overall Study|Administrative Reasons|1|||
131422698|NCT02554981|473169699|FG000|Overall Study|Other Miscellaneous Reasons|3|||
131422699|NCT01114438|473169700|FG000|Overall Study|Adverse Event|10|||
131422700|NCT01114438|473169700|FG000|Overall Study|concomitant medication|1|||
131422701|NCT01114438|473169700|FG000|Overall Study|Physician Decision|1|||
131422702|NCT01114438|473169700|FG000|Overall Study|Withdrawal by Subject|2|||
131422703|NCT00428844|473169701|FG000|Completed Study Drug Treatment|Adverse Event|2|||
131422704|NCT00428844|473169702|FG001|Completed Study Drug Treatment|Adverse Event|4|||
131422705|NCT00428844|473169703|FG002|Completed Study Drug Treatment|Adverse Event|4|||
131422706|NCT00428844|473169701|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
131422707|NCT00428844|473169702|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
131422708|NCT00428844|473169703|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
131422709|NCT00428844|473169701|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
131422710|NCT00428844|473169702|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
131422711|NCT00428844|473169703|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
131422712|NCT00428844|473169701|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
131422713|NCT00428844|473169702|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
131422714|NCT00428844|473169703|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
131422715|NCT00428844|473169701|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
131422716|NCT00428844|473169702|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
131422717|NCT00428844|473169703|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
131422718|NCT00428844|473169701|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
131422719|NCT00428844|473169702|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
131422720|NCT00428844|473169703|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
131422721|NCT00428844|473169701|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
131422722|NCT00428844|473169702|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
131422723|NCT00428844|473169703|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
131422724|NCT00428844|473169701|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
131422725|NCT00428844|473169702|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
131422726|NCT00428844|473169703|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
131422727|NCT00428844|473169701|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
131422728|NCT00428844|473169702|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
131457912|NCT02703337|473307172|FG000|Period One (Part A)|Withdrawal by Subject|0|||
131457913|NCT02703337|473307173|FG001|Period One (Part A)|Withdrawal by Subject|0|||
131457914|NCT02703337|473307174|FG002|Period One (Part A)|Withdrawal by Subject|0|||
131457915|NCT02703337|473307175|FG003|Period One (Part A)|Withdrawal by Subject|0|||
131457916|NCT02703337|473307176|FG004|Period One (Part A)|Withdrawal by Subject|1|||
131457917|NCT02703337|473307177|FG005|Period One (Part A)|Withdrawal by Subject|0|||
131457918|NCT02703337|473307178|FG006|Period One (Part A)|Withdrawal by Subject|0|||
131457919|NCT02703337|473307179|FG007|Period One (Part A)|Withdrawal by Subject|0|||
131457920|NCT00282308|473307184|FG000|Treatment Period|Lost to Follow-up|1|||
131457921|NCT00282308|473307185|FG001|Treatment Period|Lost to Follow-up|0|||
131457922|NCT00282308|473307186|FG002|Treatment Period|Lost to Follow-up|0|||
131457923|NCT00282308|473307184|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
131457924|NCT00282308|473307185|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
131457925|NCT00282308|473307186|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
131457926|NCT00282308|473307184|FG000|Treatment Period|Adverse Event|0|||
131457927|NCT00282308|473307185|FG001|Treatment Period|Adverse Event|2|||
131457928|NCT00282308|473307186|FG002|Treatment Period|Adverse Event|0|||
131457929|NCT00282308|473307184|FG000|Treatment Period|Not Treated with Study Drug|1|||
131457930|NCT00282308|473307185|FG001|Treatment Period|Not Treated with Study Drug|0|||
131422729|NCT00428844|473169703|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
131422730|NCT00488826|473169708|FG000|Overall Study|Withdrawal by Subject|40|||
131422731|NCT00488826|473169709|FG001|Overall Study|Withdrawal by Subject|35|||
131422732|NCT00488826|473169710|FG002|Overall Study|Withdrawal by Subject|19|||
131422733|NCT00488826|473169708|FG000|Overall Study|Protocol Violation|0|||
131422734|NCT00488826|473169709|FG001|Overall Study|Protocol Violation|0|||
131422735|NCT00488826|473169710|FG002|Overall Study|Protocol Violation|2|||
131422736|NCT00488826|473169708|FG000|Overall Study|Adverse Event|9|||
131422737|NCT00488826|473169709|FG001|Overall Study|Adverse Event|15|||
131422738|NCT00488826|473169710|FG002|Overall Study|Adverse Event|4|||
131422739|NCT00488826|473169708|FG000|Overall Study|Lost to Follow-up|5|||
131422740|NCT00488826|473169709|FG001|Overall Study|Lost to Follow-up|1|||
131422741|NCT00488826|473169710|FG002|Overall Study|Lost to Follow-up|0|||
131422742|NCT00488826|473169708|FG000|Overall Study|Protocol Deviations|2|||
131422743|NCT00488826|473169709|FG001|Overall Study|Protocol Deviations|1|||
131422744|NCT00488826|473169710|FG002|Overall Study|Protocol Deviations|1|||
131422745|NCT02292706|473169711|FG000|Overall Study|Lost to Follow-up|20|||
131422746|NCT02292706|473169712|FG001|Overall Study|Lost to Follow-up|44|||
131422747|NCT02292706|473169713|FG002|Overall Study|Lost to Follow-up|24|||
131422748|NCT02292706|473169714|FG003|Overall Study|Lost to Follow-up|61|||
131422749|NCT02292706|473169715|FG004|Overall Study|Lost to Follow-up|21|||
131422750|NCT02292706|473169716|FG005|Overall Study|Lost to Follow-up|52|||
131422751|NCT02292706|473169717|FG006|Overall Study|Lost to Follow-up|25|||
131422752|NCT02292706|473169718|FG007|Overall Study|Lost to Follow-up|0|||
131422753|NCT02292706|473169711|FG000|Overall Study|Withdrew consent|15|||
131422754|NCT02292706|473169712|FG001|Overall Study|Withdrew consent|56|||
131422755|NCT02292706|473169713|FG002|Overall Study|Withdrew consent|43|||
131422756|NCT02292706|473169714|FG003|Overall Study|Withdrew consent|36|||
131422757|NCT02292706|473169715|FG004|Overall Study|Withdrew consent|13|||
131422758|NCT02292706|473169716|FG005|Overall Study|Withdrew consent|51|||
131422759|NCT02292706|473169717|FG006|Overall Study|Withdrew consent|20|||
131422760|NCT02292706|473169718|FG007|Overall Study|Withdrew consent|0|||
131422761|NCT02292706|473169711|FG000|Overall Study|Death|3|||
131422762|NCT02292706|473169712|FG001|Overall Study|Death|11|||
131422763|NCT02292706|473169713|FG002|Overall Study|Death|16|||
131422764|NCT02292706|473169714|FG003|Overall Study|Death|22|||
131422765|NCT02292706|473169715|FG004|Overall Study|Death|8|||
131422766|NCT02292706|473169716|FG005|Overall Study|Death|17|||
131422767|NCT02292706|473169717|FG006|Overall Study|Death|3|||
131422768|NCT02292706|473169718|FG007|Overall Study|Death|0|||
131422769|NCT02292706|473169711|FG000|Overall Study|Study terminated by sponsor|0|||
131422770|NCT02292706|473169712|FG001|Overall Study|Study terminated by sponsor|9|||
131422771|NCT02292706|473169713|FG002|Overall Study|Study terminated by sponsor|4|||
131422772|NCT02292706|473169714|FG003|Overall Study|Study terminated by sponsor|21|||
131422773|NCT02292706|473169715|FG004|Overall Study|Study terminated by sponsor|11|||
131422774|NCT02292706|473169716|FG005|Overall Study|Study terminated by sponsor|13|||
131422775|NCT02292706|473169717|FG006|Overall Study|Study terminated by sponsor|3|||
131422776|NCT02292706|473169718|FG007|Overall Study|Study terminated by sponsor|0|||
131422777|NCT02292706|473169711|FG000|Overall Study|Investigator's discretion|4|||
131422778|NCT02292706|473169712|FG001|Overall Study|Investigator's discretion|9|||
131422779|NCT02292706|473169713|FG002|Overall Study|Investigator's discretion|7|||
131422780|NCT02292706|473169714|FG003|Overall Study|Investigator's discretion|11|||
131422781|NCT02292706|473169715|FG004|Overall Study|Investigator's discretion|4|||
131422782|NCT02292706|473169716|FG005|Overall Study|Investigator's discretion|10|||
131422783|NCT02292706|473169717|FG006|Overall Study|Investigator's discretion|1|||
131422784|NCT02292706|473169718|FG007|Overall Study|Investigator's discretion|0|||
131422785|NCT02292706|473169711|FG000|Overall Study|Liver transplant|1|||
131422786|NCT02292706|473169712|FG001|Overall Study|Liver transplant|1|||
131422787|NCT02292706|473169713|FG002|Overall Study|Liver transplant|11|||
131422788|NCT02292706|473169714|FG003|Overall Study|Liver transplant|16|||
131457931|NCT00282308|473307186|FG002|Treatment Period|Not Treated with Study Drug|0|||
131422789|NCT02292706|473169715|FG004|Overall Study|Liver transplant|5|||
131422790|NCT02292706|473169716|FG005|Overall Study|Liver transplant|6|||
131422791|NCT02292706|473169717|FG006|Overall Study|Liver transplant|5|||
131422792|NCT02292706|473169718|FG007|Overall Study|Liver transplant|0|||
131422793|NCT02292706|473169711|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
131422794|NCT02292706|473169712|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
131422795|NCT02292706|473169713|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
131422796|NCT02292706|473169714|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
131422797|NCT02292706|473169715|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
131422798|NCT02292706|473169716|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
131457932|NCT00282308|473307184|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
131422799|NCT02292706|473169717|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
131422800|NCT02292706|473169718|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
131422801|NCT02292706|473169711|FG000|Overall Study|Subject terminated by sponsor|1|||
131422802|NCT02292706|473169712|FG001|Overall Study|Subject terminated by sponsor|0|||
131422803|NCT02292706|473169713|FG002|Overall Study|Subject terminated by sponsor|0|||
131422804|NCT02292706|473169714|FG003|Overall Study|Subject terminated by sponsor|2|||
131422805|NCT02292706|473169715|FG004|Overall Study|Subject terminated by sponsor|1|||
131422806|NCT02292706|473169716|FG005|Overall Study|Subject terminated by sponsor|0|||
131422807|NCT02292706|473169717|FG006|Overall Study|Subject terminated by sponsor|0|||
131422808|NCT02292706|473169718|FG007|Overall Study|Subject terminated by sponsor|0|||
131422809|NCT02292706|473169711|FG000|Overall Study|Missing|0|||
131422810|NCT02292706|473169712|FG001|Overall Study|Missing|0|||
131422811|NCT02292706|473169713|FG002|Overall Study|Missing|1|||
131422812|NCT02292706|473169714|FG003|Overall Study|Missing|1|||
131422813|NCT02292706|473169715|FG004|Overall Study|Missing|0|||
131422814|NCT02292706|473169716|FG005|Overall Study|Missing|1|||
131422815|NCT02292706|473169717|FG006|Overall Study|Missing|0|||
131422816|NCT02292706|473169718|FG007|Overall Study|Missing|0|||
131422817|NCT02292706|473169711|FG000|Overall Study|Virologic relapse or reinfection|1|||
131422818|NCT02292706|473169712|FG001|Overall Study|Virologic relapse or reinfection|0|||
131422819|NCT02292706|473169713|FG002|Overall Study|Virologic relapse or reinfection|0|||
131422820|NCT02292706|473169714|FG003|Overall Study|Virologic relapse or reinfection|1|||
131422821|NCT02292706|473169715|FG004|Overall Study|Virologic relapse or reinfection|0|||
131422822|NCT02292706|473169716|FG005|Overall Study|Virologic relapse or reinfection|1|||
131457933|NCT00282308|473307185|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
131457934|NCT00282308|473307186|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
131457935|NCT00282308|473307184|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
131457936|NCT00282308|473307185|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
131457937|NCT00282308|473307186|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
131457938|NCT00282308|473307184|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
131457939|NCT00282308|473307185|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
131457940|NCT00282308|473307186|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
131457941|NCT00282308|473307184|FG000|Safety Follow-up Period|Adverse Event|0|||
131457942|NCT00282308|473307185|FG001|Safety Follow-up Period|Adverse Event|0|||
131457943|NCT00282308|473307186|FG002|Safety Follow-up Period|Adverse Event|1|||
131457944|NCT00282308|473307184|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
131457945|NCT00282308|473307185|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
131457946|NCT00282308|473307186|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
131457947|NCT00282308|473307184|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
131457948|NCT00282308|473307185|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
131457949|NCT00282308|473307186|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
131457950|NCT00282308|473307184|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
131457951|NCT00282308|473307185|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
131422823|NCT02292706|473169717|FG006|Overall Study|Virologic relapse or reinfection|0|||
131422824|NCT02292706|473169718|FG007|Overall Study|Virologic relapse or reinfection|0|||
131422825|NCT02725866|473169721|FG000|Overall Study|Failure to return|6|||
131422826|NCT02725866|473169721|FG000|Overall Study|Withdrew consent|3|||
131422827|NCT02725866|473169721|FG000|Overall Study|Insufficient virological response|1|||
131422828|NCT02725866|473169721|FG000|Overall Study|Other, not specified|4|||
131422829|NCT03043651|473169727|FG000|Overall Study|Death|1|||
131422830|NCT03043651|473169727|FG000|Overall Study|Progressive Disease|2|||
131457952|NCT00282308|473307186|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
131457953|NCT01821560|473307187|FG000|Overall Study|Lost to Follow-up|5|||
131457954|NCT01821560|473307188|FG001|Overall Study|Lost to Follow-up|5|||
131457955|NCT01821560|473307187|FG000|Overall Study|Withdrawal by Subject|1|||
131457956|NCT01821560|473307188|FG001|Overall Study|Withdrawal by Subject|1|||
131457957|NCT01821560|473307187|FG000|Overall Study|Protocol Violation|0|||
131457958|NCT01821560|473307188|FG001|Overall Study|Protocol Violation|1|||
131457959|NCT01338298|473307189|FG000|Overall Study|Withdrawal by Subject|1|||
131457960|NCT01338298|473307190|FG001|Overall Study|Withdrawal by Subject|1|||
131422831|NCT03043651|473169727|FG000|Overall Study|Adverse Event|2|||
131422832|NCT03043651|473169727|FG000|Overall Study|Withdrawal by Subject|4|||
131422833|NCT03043651|473169727|FG000|Overall Study|Study Terminated by Sponsor|39|||
131422834|NCT03597061|473169735|FG000|Overall Study|Lost to Follow-up|1|||
131422835|NCT03597061|473169736|FG001|Overall Study|Lost to Follow-up|0|||
131422836|NCT03597061|473169735|FG000|Overall Study|Protocol Violation|0|||
131457961|NCT01338298|473307189|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
131457962|NCT01338298|473307190|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
131422837|NCT03597061|473169736|FG001|Overall Study|Protocol Violation|1|||
131422838|NCT00411632|473169737|FG000|Overall Study|Death|1|||
131422839|NCT00761527|473169742|FG000|Overall Study|Adverse Event|3|||
131422840|NCT00761527|473169742|FG000|Overall Study|Poor Compliance|8|||
131457963|NCT01338298|473307189|FG000|Overall Study|Administrative error|0|||
131457964|NCT01338298|473307190|FG001|Overall Study|Administrative error|1|||
131422841|NCT00761527|473169742|FG000|Overall Study|Lost to Follow-up|9|||
131422842|NCT00761527|473169742|FG000|Overall Study|Unknown reason|2|||
131422843|NCT01431963|473169743|FG000|Overall Study|Adverse Event|18|||
131422844|NCT01431963|473169743|FG000|Overall Study|Lack of Efficacy|7|||
131422845|NCT01431963|473169743|FG000|Overall Study|Protocol Violation|1|||
131422846|NCT01431963|473169743|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
131422847|NCT01431963|473169743|FG000|Overall Study|Physician Decision|4|||
131422848|NCT01431963|473169743|FG000|Overall Study|Withdrawal by Subject|3|||
131422849|NCT03848949|473169746|FG000|Overall Study|Lost to Follow-up|5|||
131422850|NCT03848949|473169747|FG001|Overall Study|Lost to Follow-up|7|||
131422851|NCT02353728|473169748|FG000|Overall Study|Subject non-compliance|1|||
131422852|NCT02301624|473169751|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
131422853|NCT02301624|473169752|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
131422854|NCT02301624|473169751|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
131422855|NCT02301624|473169752|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
131422856|NCT02301624|473169751|FG000|Open-label Maintenance Phase|Adverse Event|2|||
131422857|NCT02301624|473169752|FG001|Open-label Maintenance Phase|Adverse Event|5|||
131422858|NCT02301624|473169751|FG000|Open-label Maintenance Phase|Physician Decision|3|||
131422859|NCT02301624|473169752|FG001|Open-label Maintenance Phase|Physician Decision|3|||
131422860|NCT02301624|473169751|FG000|Open-label Maintenance Phase|Death|2|||
131422861|NCT02301624|473169752|FG001|Open-label Maintenance Phase|Death|1|||
131422862|NCT02301624|473169751|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
131422863|NCT02301624|473169752|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
131422864|NCT00895310|473169753|FG000|Overall Study|Withdrawal by Subject|1|||
131422865|NCT00659230|473169754|FG000|Overall Study|Lost to Follow-up|2|||
131422866|NCT00659230|473169755|FG001|Overall Study|Lost to Follow-up|5|||
131422867|NCT00659230|473169754|FG000|Overall Study|Lost source documentation|5|||
131422868|NCT00659230|473169755|FG001|Overall Study|Lost source documentation|4|||
131422869|NCT00659230|473169754|FG000|Overall Study|Did not return post-randomization|2|||
131422870|NCT00659230|473169755|FG001|Overall Study|Did not return post-randomization|3|||
131422871|NCT00547521|473169756|FG000|Short Term Study (4 Months)|Adverse Event|1|||
131422872|NCT00547521|473169757|FG001|Short Term Study (4 Months)|Adverse Event|0|||
131422873|NCT00547521|473169756|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
131422874|NCT00547521|473169757|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
131422875|NCT00547521|473169756|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
131422876|NCT00547521|473169757|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
131422877|NCT00547521|473169756|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
131422878|NCT00547521|473169757|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
131422879|NCT00547521|473169756|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
131422880|NCT00547521|473169757|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
131422881|NCT00547521|473169756|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
131422882|NCT00547521|473169757|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
131422883|NCT00547521|473169756|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
131422884|NCT00547521|473169757|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
131422885|NCT00547521|473169756|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
131422886|NCT00547521|473169757|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
131422887|NCT00547521|473169756|FG000|Long Term Extension (LTE) Study|Other|0|||
131422888|NCT00547521|473169757|FG001|Long Term Extension (LTE) Study|Other|2|||
131422889|NCT00547521|473169756|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
131422890|NCT00547521|473169757|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
131422891|NCT03109184|473171766|FG000|Overall Study|Lost to Follow-up|6|||
131422892|NCT03109184|473171767|FG001|Overall Study|Lost to Follow-up|6|||
131422893|NCT03109184|473171766|FG000|Overall Study|Withdrawal by Subject|1|||
131422894|NCT03109184|473171767|FG001|Overall Study|Withdrawal by Subject|1|||
131422895|NCT02467582|473171768|FG000|Allocation|Withdrawal by Subject|1|||
131422896|NCT02467582|473171769|FG001|Allocation|Withdrawal by Subject|0|||
131422897|NCT02467582|473171768|FG000|Follow-up|Death|5|||
131422898|NCT02467582|473171769|FG001|Follow-up|Death|4|||
131422899|NCT02467582|473171768|FG000|Follow-up|Lost to Follow-up|6|||
131422900|NCT02467582|473171769|FG001|Follow-up|Lost to Follow-up|5|||
131422901|NCT01031979|473171772|FG000|Overall Study|Lost to Follow-up|5|||
131422902|NCT01031979|473171773|FG001|Overall Study|Lost to Follow-up|4|||
131422903|NCT03831100|473171775|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
131422904|NCT03831100|473171776|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
131422905|NCT02008227|473171780|FG000|Overall Study|Lost to Follow-up|7|||
131422906|NCT02008227|473171781|FG001|Overall Study|Lost to Follow-up|9|||
131422907|NCT02008227|473171780|FG000|Overall Study|Death|494|||
131422908|NCT02008227|473171781|FG001|Overall Study|Death|485|||
131422909|NCT02008227|473171780|FG000|Overall Study|Withdrawal by Subject|67|||
131422910|NCT02008227|473171781|FG001|Overall Study|Withdrawal by Subject|36|||
131422911|NCT02008227|473171780|FG000|Overall Study|Study Terminated By Sponsor|44|||
131422912|NCT02008227|473171781|FG001|Overall Study|Study Terminated By Sponsor|83|||
131422913|NCT01487265|473171784|FG000|Overall Study|Adverse Event|8|||
131422914|NCT01487265|473171784|FG000|Overall Study|Withdrawal by Subject|5|||
131422915|NCT01487265|473171784|FG000|Overall Study|Disease Progression|21|||
131422916|NCT01487265|473171784|FG000|Overall Study|Death|2|||
131422917|NCT01487265|473171784|FG000|Overall Study|Still on Treatment|1|||
131422918|NCT02291419|473171785|FG000|Overall Study|Early study termination|1|||
131422919|NCT02291419|473171786|FG001|Overall Study|Early study termination|5|||
131422920|NCT00965575|473171790|FG000|Overall Study|subject unwillingness to swallow study c|1|||
131422921|NCT00965575|473171791|FG001|Overall Study|subject unwillingness to swallow study c|0|||
131422922|NCT03047031|473171800|FG000|Overall Study|Other than listed|1|||
131422923|NCT03047031|473171801|FG001|Overall Study|Other than listed|0|||
131422924|NCT03047031|473171802|FG002|Overall Study|Other than listed|0|||
131422925|NCT03047031|473171800|FG000|Overall Study|Lost to Follow-up|4|||
131422926|NCT03047031|473171801|FG001|Overall Study|Lost to Follow-up|0|||
131422927|NCT03047031|473171802|FG002|Overall Study|Lost to Follow-up|0|||
131422928|NCT03047031|473171800|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
131422929|NCT03047031|473171801|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
131422930|NCT03047031|473171802|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
131422931|NCT03047031|473171800|FG000|Overall Study|Adverse Event|1|||
131422932|NCT03047031|473171801|FG001|Overall Study|Adverse Event|0|||
131422933|NCT03047031|473171802|FG002|Overall Study|Adverse Event|0|||
131422934|NCT03047031|473171800|FG000|Overall Study|Withdrawal by Subject|2|||
131422935|NCT03047031|473171801|FG001|Overall Study|Withdrawal by Subject|0|||
131422936|NCT03047031|473171802|FG002|Overall Study|Withdrawal by Subject|0|||
131422937|NCT03047031|473171800|FG000|Overall Study|Change to other medication|2|||
131422938|NCT03047031|473171801|FG001|Overall Study|Change to other medication|0|||
131422939|NCT03047031|473171802|FG002|Overall Study|Change to other medication|0|||
131422940|NCT03047031|473171800|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
131422941|NCT03047031|473171801|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
131422942|NCT03047031|473171802|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
131422943|NCT01959841|473171803|FG000|Overall Study|Adverse Event|1|||
131422944|NCT01959841|473171804|FG001|Overall Study|Adverse Event|3|||
131422945|NCT01959841|473171805|FG002|Overall Study|Adverse Event|2|||
131422946|NCT01959841|473171803|FG000|Overall Study|Lack of Efficacy|5|||
131422947|NCT01959841|473171804|FG001|Overall Study|Lack of Efficacy|0|||
131422948|NCT01959841|473171805|FG002|Overall Study|Lack of Efficacy|0|||
131422949|NCT01959841|473171803|FG000|Overall Study|Lost to Follow-up|1|||
131422950|NCT01959841|473171804|FG001|Overall Study|Lost to Follow-up|1|||
131422951|NCT01959841|473171805|FG002|Overall Study|Lost to Follow-up|0|||
131422952|NCT01959841|473171803|FG000|Overall Study|Physician Decision|0|||
131422953|NCT01959841|473171804|FG001|Overall Study|Physician Decision|2|||
131422954|NCT01959841|473171805|FG002|Overall Study|Physician Decision|3|||
131422955|NCT01959841|473171803|FG000|Overall Study|Protocol Violation|16|||
131422956|NCT01959841|473171804|FG001|Overall Study|Protocol Violation|23|||
131422957|NCT01959841|473171805|FG002|Overall Study|Protocol Violation|16|||
131422958|NCT01959841|473171803|FG000|Overall Study|Withdrawal by Subject|7|||
131422959|NCT01959841|473171804|FG001|Overall Study|Withdrawal by Subject|7|||
131422960|NCT01959841|473171805|FG002|Overall Study|Withdrawal by Subject|5|||
131422961|NCT01959841|473171803|FG000|Overall Study|Clinical laboratory value|2|||
131422962|NCT01959841|473171804|FG001|Overall Study|Clinical laboratory value|6|||
131422963|NCT01959841|473171805|FG002|Overall Study|Clinical laboratory value|6|||
131422964|NCT01959841|473171803|FG000|Overall Study|Platelet count below on day1 or 4|11|||
131422965|NCT01959841|473171804|FG001|Overall Study|Platelet count below on day1 or 4|15|||
131422966|NCT01959841|473171805|FG002|Overall Study|Platelet count below on day1 or 4|11|||
131422967|NCT00780416|473171806|FG000|Overall Study|Physician Decision|3|||
131422968|NCT00780416|473171807|FG001|Overall Study|Physician Decision|3|||
131422969|NCT00780416|473171806|FG000|Overall Study|Protocol Violation|1|||
131422970|NCT00780416|473171807|FG001|Overall Study|Protocol Violation|0|||
131422971|NCT00780416|473171806|FG000|Overall Study|Withdrawal by Subject|8|||
131422972|NCT00780416|473171807|FG001|Overall Study|Withdrawal by Subject|6|||
131422973|NCT00666224|473171810|FG000|Double-Blind|Adverse Event|15|||
131422974|NCT00666224|473171811|FG001|Double-Blind|Adverse Event|5|||
131422975|NCT00666224|473171810|FG000|Double-Blind|Lost to Follow-up|2|||
131422976|NCT00666224|473171811|FG001|Double-Blind|Lost to Follow-up|2|||
131422977|NCT00666224|473171810|FG000|Double-Blind|Withdrawal by Subject|18|||
131422978|NCT00666224|473171811|FG001|Double-Blind|Withdrawal by Subject|14|||
131422979|NCT00666224|473171810|FG000|Double-Blind|Physician Decision|0|||
131422980|NCT00666224|473171811|FG001|Double-Blind|Physician Decision|3|||
131422981|NCT00666224|473171810|FG000|Double-Blind|Sponsor decision|1|||
131422982|NCT00666224|473171811|FG001|Double-Blind|Sponsor decision|0|||
131422983|NCT00666224|473171810|FG000|Double-Blind|Pregnancy|3|||
131422984|NCT00666224|473171811|FG001|Double-Blind|Pregnancy|2|||
131422985|NCT00666224|473171810|FG000|Double-Blind|Noncompliance|1|||
131422986|NCT00666224|473171811|FG001|Double-Blind|Noncompliance|0|||
131422987|NCT00666224|473171810|FG000|Double-Blind|Death|1|||
131422988|NCT00666224|473171811|FG001|Double-Blind|Death|0|||
131422989|NCT00666224|473171810|FG000|Double-Blind|Undefined/Unknown|4|||
131422990|NCT00666224|473171811|FG001|Double-Blind|Undefined/Unknown|1|||
131422991|NCT00666224|473171810|FG000|Open-Label|Adverse Event|8|||
131422992|NCT00666224|473171811|FG001|Open-Label|Adverse Event|43|||
131422993|NCT00666224|473171810|FG000|Open-Label|Lost to Follow-up|4|||
131422994|NCT00666224|473171811|FG001|Open-Label|Lost to Follow-up|5|||
131422995|NCT00666224|473171810|FG000|Open-Label|Withdrawal by Subject|12|||
131422996|NCT00666224|473171811|FG001|Open-Label|Withdrawal by Subject|25|||
131422997|NCT00666224|473171810|FG000|Open-Label|Physician Decision|7|||
131422998|NCT00666224|473171811|FG001|Open-Label|Physician Decision|5|||
131422999|NCT00666224|473171810|FG000|Open-Label|Pregnancy|1|||
131423000|NCT00666224|473171811|FG001|Open-Label|Pregnancy|5|||
131423001|NCT00666224|473171810|FG000|Open-Label|Noncompliance|2|||
131423002|NCT00666224|473171811|FG001|Open-Label|Noncompliance|1|||
131423003|NCT00666224|473171810|FG000|Open-Label|Undefined/Unknown|1|||
131457965|NCT01338298|473307189|FG000|Overall Study|Positive symptom worsening|1|||
131457966|NCT01338298|473307190|FG001|Overall Study|Positive symptom worsening|0|||
131423004|NCT00666224|473171811|FG001|Open-Label|Undefined/Unknown|1|||
131423005|NCT03521141|473171815|FG000|Overall Study|Death|1|||
131423006|NCT03521141|473171816|FG001|Overall Study|Death|0|||
131423007|NCT03521141|473171817|FG002|Overall Study|Death|1|||
131423008|NCT01271725|473171825|FG000|Part A|Progressive disease according to RECIST|8|||
131423009|NCT01271725|473171826|FG001|Part A|Progressive disease according to RECIST|0|||
131423010|NCT01271725|473171825|FG000|Part A|Clinical signs/symptoms of progression|2|||
131423011|NCT01271725|473171826|FG001|Part A|Clinical signs/symptoms of progression|0|||
131423012|NCT01271725|473171825|FG000|Part A|Other Adverse Event|8|||
131423013|NCT01271725|473171826|FG001|Part A|Other Adverse Event|0|||
131423014|NCT01271725|473171825|FG000|Part A|Lost to Follow-up|1|||
131423015|NCT01271725|473171826|FG001|Part A|Lost to Follow-up|0|||
131423016|NCT01271725|473171825|FG000|Part A|Withdrawal by Subject|12|||
131423017|NCT01271725|473171826|FG001|Part A|Withdrawal by Subject|0|||
131423018|NCT01271725|473171825|FG000|Part A|Other than specified|3|||
131423019|NCT01271725|473171826|FG001|Part A|Other than specified|0|||
131423020|NCT01271725|473171825|FG000|Part A|Protocol Violation|1|||
131423021|NCT01271725|473171826|FG001|Part A|Protocol Violation|0|||
131423022|NCT01271725|473171825|FG000|Part B|Other than specified|0|||
131423023|NCT01271725|473171826|FG001|Part B|Other than specified|2|||
131423024|NCT01271725|473171825|FG000|Part B|Clinical signs/symptoms of progression|0|||
131423025|NCT01271725|473171826|FG001|Part B|Clinical signs/symptoms of progression|2|||
131423026|NCT01271725|473171825|FG000|Part B|Other Adverse Event|0|||
131423027|NCT01271725|473171826|FG001|Part B|Other Adverse Event|1|||
131423028|NCT01271725|473171825|FG000|Part B|Protocol Violation|0|||
131423029|NCT01271725|473171826|FG001|Part B|Protocol Violation|1|||
131423030|NCT01271725|473171825|FG000|Part B|Withdrawal by Subject|0|||
131423031|NCT01271725|473171826|FG001|Part B|Withdrawal by Subject|6|||
131423032|NCT01702025|473171827|FG000|Overall Study|Equipment failure|1|||
131423033|NCT01702025|473171828|FG001|Overall Study|Equipment failure|0|||
131423034|NCT01702025|473171829|FG002|Overall Study|Equipment failure|0|||
131423035|NCT01702025|473171830|FG003|Overall Study|Equipment failure|0|||
131423036|NCT01702025|473171827|FG000|Overall Study|Adverse Event|1|||
131423037|NCT01702025|473171828|FG001|Overall Study|Adverse Event|1|||
131423038|NCT01702025|473171829|FG002|Overall Study|Adverse Event|1|||
131423039|NCT01702025|473171830|FG003|Overall Study|Adverse Event|0|||
131423040|NCT03354273|473171831|FG000|Overall Study|Adverse Event|5|||
131423041|NCT03354273|473171831|FG000|Overall Study|Screen Failure|21|||
131423042|NCT03354273|473171831|FG000|Overall Study|Withdrawal by Subject|34|||
131423043|NCT03354273|473171831|FG000|Overall Study|Technical Problems|30|||
131423044|NCT03354273|473171831|FG000|Overall Study|Lost to Follow-up|4|||
131423045|NCT03354273|473171831|FG000|Overall Study|Investigator Decision|3|||
131423046|NCT03354273|473171831|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
131423047|NCT03354273|473171831|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
131423048|NCT03354273|473171831|FG000|Overall Study|COVID-19 Restrictions|9|||
131423049|NCT03354273|473171831|FG000|Overall Study|Other|5|||
131423050|NCT03229109|473171839|FG000|Overall Study|Withdrawal by Subject|0|||
131423051|NCT03229109|473171840|FG001|Overall Study|Withdrawal by Subject|0|||
131423052|NCT03229109|473171841|FG002|Overall Study|Withdrawal by Subject|0|||
131423053|NCT03229109|473171842|FG003|Overall Study|Withdrawal by Subject|1|||
131423054|NCT04207749|473171845|FG000|Overall Study|Lost to Follow-up|0|||
131423055|NCT04207749|473171846|FG001|Overall Study|Lost to Follow-up|2|||
131423056|NCT04207749|473171845|FG000|Overall Study|Protocol Violation|0|||
131423057|NCT04207749|473171846|FG001|Overall Study|Protocol Violation|1|||
131423058|NCT04207749|473171845|FG000|Overall Study|Withdrawal by Subject|3|||
131423059|NCT04207749|473171846|FG001|Overall Study|Withdrawal by Subject|0|||
131423060|NCT04207749|473171845|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
131423061|NCT04207749|473171846|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
131423062|NCT01835223|473171849|FG000|Overall Study|Adverse Event|1|||
131423063|NCT01835223|473171850|FG001|Overall Study|Adverse Event|0|||
131423064|NCT01835223|473171849|FG000|Overall Study|Withdrawal by Subject|2|||
131423065|NCT01835223|473171850|FG001|Overall Study|Withdrawal by Subject|0|||
131423066|NCT01835223|473171849|FG000|Overall Study|Disease progression|2|||
131423067|NCT01835223|473171850|FG001|Overall Study|Disease progression|1|||
131423068|NCT01835223|473171849|FG000|Overall Study|Became Inelligible|4|||
131423069|NCT01835223|473171850|FG001|Overall Study|Became Inelligible|0|||
131423070|NCT01504841|473171854|FG000|Overall Study|Withdrawal by Subject|1|||
131423071|NCT01504841|473171855|FG001|Overall Study|Withdrawal by Subject|1|||
131423072|NCT01504841|473171856|FG002|Overall Study|Withdrawal by Subject|0|||
131423073|NCT01959139|473171857|FG000|Phase II|Disease progression|0|||
131423074|NCT01959139|473171858|FG001|Phase II|Disease progression|0|||
131423075|NCT01959139|473171859|FG002|Phase II|Disease progression|26|||
131423076|NCT01959139|473171860|FG003|Phase II|Disease progression|34|||
131423077|NCT01959139|473171857|FG000|Phase II|Adverse Event|0|||
131423078|NCT01959139|473171858|FG001|Phase II|Adverse Event|0|||
131423079|NCT01959139|473171859|FG002|Phase II|Adverse Event|10|||
131423080|NCT01959139|473171860|FG003|Phase II|Adverse Event|11|||
131423081|NCT01959139|473171857|FG000|Phase II|Patient Refusal|0|||
131423082|NCT01959139|473171858|FG001|Phase II|Patient Refusal|0|||
131423083|NCT01959139|473171859|FG002|Phase II|Patient Refusal|5|||
131423084|NCT01959139|473171860|FG003|Phase II|Patient Refusal|4|||
131423085|NCT01959139|473171857|FG000|Phase II|Death|0|||
131423086|NCT01959139|473171858|FG001|Phase II|Death|0|||
131423087|NCT01959139|473171859|FG002|Phase II|Death|3|||
131423088|NCT01959139|473171860|FG003|Phase II|Death|1|||
131423089|NCT01959139|473171857|FG000|Phase II|Other/Unknown|0|||
131423090|NCT01959139|473171858|FG001|Phase II|Other/Unknown|0|||
131423091|NCT01959139|473171859|FG002|Phase II|Other/Unknown|8|||
131423092|NCT01959139|473171860|FG003|Phase II|Other/Unknown|5|||
131423093|NCT01959139|473171857|FG000|Phase II|On treatment|0|||
131423094|NCT01959139|473171858|FG001|Phase II|On treatment|0|||
131423095|NCT01959139|473171859|FG002|Phase II|On treatment|4|||
131423096|NCT01959139|473171860|FG003|Phase II|On treatment|0|||
131423097|NCT03149055|473171865|FG000|Overall Study|Not treated|4|||
131423098|NCT01610336|473171866|FG000|Overall Study|Progressive Disease|4|||
131423099|NCT01610336|473171867|FG001|Overall Study|Progressive Disease|6|||
131423100|NCT01610336|473171868|FG002|Overall Study|Progressive Disease|6|||
131423101|NCT01610336|473171869|FG003|Overall Study|Progressive Disease|5|||
131423102|NCT01610336|473171870|FG004|Overall Study|Progressive Disease|3|||
131423103|NCT01610336|473171871|FG005|Overall Study|Progressive Disease|10|||
131423104|NCT01610336|473171872|FG006|Overall Study|Progressive Disease|1|||
131423105|NCT01610336|473171873|FG007|Overall Study|Progressive Disease|6|||
131423106|NCT01610336|473171874|FG008|Overall Study|Progressive Disease|6|||
131423107|NCT01610336|473171875|FG009|Overall Study|Progressive Disease|40|||
131423108|NCT01610336|473171876|FG010|Overall Study|Progressive Disease|36|||
131423109|NCT01610336|473171866|FG000|Overall Study|Adverse Event|0|||
131423110|NCT01610336|473171867|FG001|Overall Study|Adverse Event|0|||
131423111|NCT01610336|473171868|FG002|Overall Study|Adverse Event|0|||
131423112|NCT01610336|473171869|FG003|Overall Study|Adverse Event|1|||
131423113|NCT01610336|473171870|FG004|Overall Study|Adverse Event|1|||
131423114|NCT01610336|473171871|FG005|Overall Study|Adverse Event|1|||
131423115|NCT01610336|473171872|FG006|Overall Study|Adverse Event|0|||
131423116|NCT01610336|473171873|FG007|Overall Study|Adverse Event|0|||
131423117|NCT01610336|473171874|FG008|Overall Study|Adverse Event|2|||
131423118|NCT01610336|473171875|FG009|Overall Study|Adverse Event|8|||
131423119|NCT01610336|473171876|FG010|Overall Study|Adverse Event|6|||
131423120|NCT01610336|473171866|FG000|Overall Study|Subject/Guardian decision|1|||
131423121|NCT01610336|473171867|FG001|Overall Study|Subject/Guardian decision|1|||
131423122|NCT01610336|473171868|FG002|Overall Study|Subject/Guardian decision|0|||
131423123|NCT01610336|473171869|FG003|Overall Study|Subject/Guardian decision|1|||
131423124|NCT01610336|473171870|FG004|Overall Study|Subject/Guardian decision|0|||
131423125|NCT01610336|473171871|FG005|Overall Study|Subject/Guardian decision|0|||
131423126|NCT01610336|473171872|FG006|Overall Study|Subject/Guardian decision|0|||
131423127|NCT01610336|473171873|FG007|Overall Study|Subject/Guardian decision|1|||
131423128|NCT01610336|473171874|FG008|Overall Study|Subject/Guardian decision|0|||
131423129|NCT01610336|473171875|FG009|Overall Study|Subject/Guardian decision|2|||
131423130|NCT01610336|473171876|FG010|Overall Study|Subject/Guardian decision|2|||
131423131|NCT01610336|473171866|FG000|Overall Study|Death|0|||
131423132|NCT01610336|473171867|FG001|Overall Study|Death|0|||
131423133|NCT01610336|473171868|FG002|Overall Study|Death|0|||
131423134|NCT01610336|473171869|FG003|Overall Study|Death|0|||
131423135|NCT01610336|473171870|FG004|Overall Study|Death|0|||
131423136|NCT01610336|473171871|FG005|Overall Study|Death|1|||
131423137|NCT01610336|473171872|FG006|Overall Study|Death|3|||
131457967|NCT01338298|473307189|FG000|Overall Study|Depressive symptoms and nausea|1|||
131457968|NCT01338298|473307190|FG001|Overall Study|Depressive symptoms and nausea|0|||
131423138|NCT01610336|473171873|FG007|Overall Study|Death|0|||
131423139|NCT01610336|473171874|FG008|Overall Study|Death|0|||
131423140|NCT01610336|473171875|FG009|Overall Study|Death|1|||
131423141|NCT01610336|473171876|FG010|Overall Study|Death|2|||
131423142|NCT01610336|473171866|FG000|Overall Study|Non-Compliance with study treatment|0|||
131423143|NCT01610336|473171867|FG001|Overall Study|Non-Compliance with study treatment|0|||
131423144|NCT01610336|473171868|FG002|Overall Study|Non-Compliance with study treatment|0|||
131423145|NCT01610336|473171869|FG003|Overall Study|Non-Compliance with study treatment|0|||
131423146|NCT01610336|473171870|FG004|Overall Study|Non-Compliance with study treatment|0|||
131423147|NCT01610336|473171871|FG005|Overall Study|Non-Compliance with study treatment|0|||
131423148|NCT01610336|473171872|FG006|Overall Study|Non-Compliance with study treatment|0|||
131423149|NCT01610336|473171873|FG007|Overall Study|Non-Compliance with study treatment|0|||
131423150|NCT01610336|473171874|FG008|Overall Study|Non-Compliance with study treatment|0|||
131423151|NCT01610336|473171875|FG009|Overall Study|Non-Compliance with study treatment|1|||
131423152|NCT01610336|473171876|FG010|Overall Study|Non-Compliance with study treatment|0|||
131423153|NCT01610336|473171866|FG000|Overall Study|Physician Decision|0|||
131423154|NCT01610336|473171867|FG001|Overall Study|Physician Decision|0|||
131423155|NCT01610336|473171868|FG002|Overall Study|Physician Decision|0|||
131423156|NCT01610336|473171869|FG003|Overall Study|Physician Decision|0|||
131423157|NCT01610336|473171870|FG004|Overall Study|Physician Decision|0|||
131423158|NCT01610336|473171871|FG005|Overall Study|Physician Decision|0|||
131423159|NCT01610336|473171872|FG006|Overall Study|Physician Decision|1|||
131423160|NCT01610336|473171873|FG007|Overall Study|Physician Decision|0|||
131423161|NCT01610336|473171874|FG008|Overall Study|Physician Decision|0|||
131423162|NCT01610336|473171875|FG009|Overall Study|Physician Decision|0|||
131423163|NCT01610336|473171876|FG010|Overall Study|Physician Decision|0|||
131423164|NCT01610336|473171866|FG000|Overall Study|Protocol Deviation|0|||
131423165|NCT01610336|473171867|FG001|Overall Study|Protocol Deviation|0|||
131423166|NCT01610336|473171868|FG002|Overall Study|Protocol Deviation|0|||
131423167|NCT01610336|473171869|FG003|Overall Study|Protocol Deviation|0|||
131423168|NCT01610336|473171870|FG004|Overall Study|Protocol Deviation|0|||
131423169|NCT01610336|473171871|FG005|Overall Study|Protocol Deviation|0|||
131423170|NCT01610336|473171872|FG006|Overall Study|Protocol Deviation|0|||
131423171|NCT01610336|473171873|FG007|Overall Study|Protocol Deviation|0|||
131423172|NCT01610336|473171874|FG008|Overall Study|Protocol Deviation|0|||
131423173|NCT01610336|473171875|FG009|Overall Study|Protocol Deviation|1|||
131423174|NCT01610336|473171876|FG010|Overall Study|Protocol Deviation|0|||
131423175|NCT01610336|473171866|FG000|Overall Study|Transfer to another trial|0|||
131423176|NCT01610336|473171867|FG001|Overall Study|Transfer to another trial|0|||
131423177|NCT01610336|473171868|FG002|Overall Study|Transfer to another trial|0|||
131423178|NCT01610336|473171869|FG003|Overall Study|Transfer to another trial|0|||
131423179|NCT01610336|473171870|FG004|Overall Study|Transfer to another trial|0|||
131423180|NCT01610336|473171871|FG005|Overall Study|Transfer to another trial|0|||
131423181|NCT01610336|473171872|FG006|Overall Study|Transfer to another trial|0|||
131423182|NCT01610336|473171873|FG007|Overall Study|Transfer to another trial|0|||
131423183|NCT01610336|473171874|FG008|Overall Study|Transfer to another trial|0|||
131423184|NCT01610336|473171875|FG009|Overall Study|Transfer to another trial|0|||
131423185|NCT01610336|473171876|FG010|Overall Study|Transfer to another trial|1|||
131423186|NCT03679624|473171877|FG000|Overall Study|Adverse Event|1|||
131423187|NCT03679624|473171878|FG001|Overall Study|Adverse Event|0|||
131423188|NCT02629822|473171879|FG000|Base Study|Lost to Follow-up|2|||
131423189|NCT02629822|473171879|FG000|Base Study|Non-Compliance With Study Drug|1|||
131423190|NCT02629822|473171879|FG000|Extension Study|Adverse Event|1|||
131423191|NCT02629822|473171879|FG000|Extension Study|Lost to Follow-up|1|||
131423192|NCT04440813|473171880|FG000|Overall Study|Lost to Follow-up|5|||
131423193|NCT04440813|473171881|FG001|Overall Study|Lost to Follow-up|5|||
131423194|NCT00741013|473171882|FG000|Overall Study|Adverse Event|1|||
131423195|NCT00741013|473171883|FG001|Overall Study|Adverse Event|0|||
131423196|NCT00741013|473171884|FG002|Overall Study|Adverse Event|0|||
131423197|NCT00741013|473171882|FG000|Overall Study|Withdrawal by Subject|0|||
131423198|NCT00741013|473171883|FG001|Overall Study|Withdrawal by Subject|0|||
131423199|NCT00741013|473171884|FG002|Overall Study|Withdrawal by Subject|1|||
131423200|NCT00741013|473171882|FG000|Overall Study|Discovered failed screen after enrolled|0|||
131423201|NCT00741013|473171883|FG001|Overall Study|Discovered failed screen after enrolled|2|||
131423202|NCT00741013|473171884|FG002|Overall Study|Discovered failed screen after enrolled|0|||
131423203|NCT01559675|473171888|FG000|Overall Study|Protocol Violation|1|||
131423204|NCT01559675|473171889|FG001|Overall Study|Protocol Violation|2|||
131423205|NCT01559675|473171888|FG000|Overall Study|2nd operation on same patient excluded|14|||
131423206|NCT01559675|473171889|FG001|Overall Study|2nd operation on same patient excluded|12|||
131423207|NCT01496469|473171890|FG000|Overall Study|Adverse Event|1|||
131423208|NCT01496469|473171891|FG001|Overall Study|Adverse Event|0|||
131423209|NCT01496469|473171890|FG000|Overall Study|Protocol Violation|2|||
131423210|NCT01496469|473171891|FG001|Overall Study|Protocol Violation|0|||
131423211|NCT01496469|473171890|FG000|Overall Study|Lost to Follow-up|1|||
131423212|NCT01496469|473171891|FG001|Overall Study|Lost to Follow-up|1|||
131423213|NCT01496469|473171890|FG000|Overall Study|Withdrawal by Subject|4|||
131423214|NCT01496469|473171891|FG001|Overall Study|Withdrawal by Subject|4|||
131423215|NCT01496469|473171890|FG000|Overall Study|BP exceeds protocol limits|1|||
131423216|NCT01496469|473171891|FG001|Overall Study|BP exceeds protocol limits|2|||
131423217|NCT01496469|473171890|FG000|Overall Study|Other|1|||
131423218|NCT01496469|473171891|FG001|Overall Study|Other|1|||
131423219|NCT00291018|473171892|FG000|Overall Study|Not Consented or Declined PAS|12|||
131423220|NCT00291018|473171893|FG001|Overall Study|Not Consented or Declined PAS|15|||
131423221|NCT00291018|473171894|FG002|Overall Study|Not Consented or Declined PAS|15|||
131423222|NCT00291018|473171892|FG000|Overall Study|Death|3|||
131423223|NCT00291018|473171893|FG001|Overall Study|Death|3|||
131423224|NCT00291018|473171894|FG002|Overall Study|Death|4|||
131423225|NCT00291018|473171892|FG000|Overall Study|Withdrawal by Subject|2|||
131423226|NCT00291018|473171893|FG001|Overall Study|Withdrawal by Subject|8|||
131423227|NCT00291018|473171894|FG002|Overall Study|Withdrawal by Subject|1|||
131423228|NCT00291018|473171892|FG000|Overall Study|Failures|5|||
131423229|NCT00291018|473171893|FG001|Overall Study|Failures|12|||
131423230|NCT00291018|473171894|FG002|Overall Study|Failures|5|||
131423231|NCT00291018|473171892|FG000|Overall Study|Lost to Follow-up|3|||
131423232|NCT00291018|473171893|FG001|Overall Study|Lost to Follow-up|4|||
131423233|NCT00291018|473171894|FG002|Overall Study|Lost to Follow-up|18|||
131423234|NCT00630344|473171895|FG000|Overall Study|Adverse Event|5|||
131423235|NCT00630344|473171895|FG000|Overall Study|Progressive Disease|19|||
131423236|NCT00630344|473171895|FG000|Overall Study|Physician Decision|9|||
131423237|NCT00630344|473171895|FG000|Overall Study|Withdrawal by Subject|1|||
131423238|NCT00630344|473171895|FG000|Overall Study|Intercurrent Illness|1|||
131423239|NCT00630344|473171895|FG000|Overall Study|Other|1|||
131423240|NCT05362058|473171896|FG000|Treatment Period|Adverse Event|3|||
131423241|NCT05362058|473171897|FG001|Treatment Period|Adverse Event|3|||
131423242|NCT05362058|473171896|FG000|Treatment Period|Assigned treatment by mistake|3|||
131423243|NCT05362058|473171897|FG001|Treatment Period|Assigned treatment by mistake|4|||
131423244|NCT05362058|473171896|FG000|Treatment Period|Death|1|||
131423245|NCT05362058|473171897|FG001|Treatment Period|Death|1|||
131423246|NCT05362058|473171896|FG000|Treatment Period|Lost to Follow-up|6|||
131423247|NCT05362058|473171897|FG001|Treatment Period|Lost to Follow-up|3|||
131423248|NCT05362058|473171896|FG000|Treatment Period|Non-compliance with study drug|0|||
131423249|NCT05362058|473171897|FG001|Treatment Period|Non-compliance with study drug|1|||
131423250|NCT05362058|473171896|FG000|Treatment Period|Physician Decision|1|||
131423251|NCT05362058|473171897|FG001|Treatment Period|Physician Decision|0|||
131423252|NCT05362058|473171896|FG000|Treatment Period|Protocol deviation|1|||
131423253|NCT05362058|473171897|FG001|Treatment Period|Protocol deviation|0|||
131423254|NCT05362058|473171896|FG000|Treatment Period|Withdrawal by Subject|10|||
131423255|NCT05362058|473171897|FG001|Treatment Period|Withdrawal by Subject|11|||
131423256|NCT05362058|473171896|FG000|Follow-Up Period|Death|1|||
131423257|NCT05362058|473171897|FG001|Follow-Up Period|Death|0|||
131423258|NCT05362058|473171896|FG000|Follow-Up Period|Lost to Follow-up|2|||
131423259|NCT05362058|473171897|FG001|Follow-Up Period|Lost to Follow-up|1|||
131423260|NCT05362058|473171896|FG000|Follow-Up Period|Protocol deviation|1|||
131423261|NCT05362058|473171897|FG001|Follow-Up Period|Protocol deviation|1|||
131423262|NCT05362058|473171896|FG000|Follow-Up Period|Withdrawal by Subject|0|||
131423263|NCT05362058|473171897|FG001|Follow-Up Period|Withdrawal by Subject|3|||
131423264|NCT00930553|473171900|FG000|Overall Study|Adverse Event|1|||
131423265|NCT00930553|473171900|FG000|Overall Study|Lack of Efficacy|7|||
131423266|NCT00930553|473171900|FG000|Overall Study|Physician Decision|39|||
131423267|NCT00930553|473171900|FG000|Overall Study|Protocol Violation|1|||
131423268|NCT00930553|473171900|FG000|Overall Study|Pregnancy|1|||
131423269|NCT00930553|473171900|FG000|Overall Study|Withdrawal by Subject|88|||
131423270|NCT00930553|473171900|FG000|Overall Study|Lost to Follow-up|25|||
131423271|NCT00930553|473171900|FG000|Overall Study|Death|9|||
131423272|NCT00930553|473171900|FG000|Overall Study|Study terminated by sponsor|24|||
131423273|NCT00930553|473171900|FG000|Overall Study|Other than specified above|28|||
131423274|NCT01235234|473171901|FG000|Overall Study|Adverse Event|2|||
131423275|NCT01235234|473171902|FG001|Overall Study|Adverse Event|2|||
131423276|NCT01235234|473171903|FG002|Overall Study|Adverse Event|1|||
131423277|NCT02690714|473171904|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
131423278|NCT02690714|473171904|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
131423279|NCT02202538|473171905|FG000|Overall Study|Withdrawal by Subject|5|||
131423280|NCT02202538|473171905|FG000|Overall Study|Did not meet all inclusion criteria|2|||
131423281|NCT02202538|473171905|FG000|Overall Study|Investigator Decision|1|||
131423282|NCT01457846|473171906|FG000|Overall Study|Death before treatment|1|||
131423283|NCT01457846|473171907|FG001|Overall Study|Death before treatment|2|||
131423284|NCT01457846|473171906|FG000|Overall Study|Did not receive treatment|0|||
131423285|NCT01457846|473171907|FG001|Overall Study|Did not receive treatment|1|||
131423286|NCT01457846|473171906|FG000|Overall Study|Death|27|||
131423287|NCT01457846|473171907|FG001|Overall Study|Death|16|||
131423288|NCT01457846|473171906|FG000|Overall Study|Unclassified reason for not completed|11|||
131423289|NCT01457846|473171907|FG001|Overall Study|Unclassified reason for not completed|10|||
131423290|NCT01457846|473171906|FG000|Overall Study|Withdrawal by Subject|1|||
131423291|NCT01457846|473171907|FG001|Overall Study|Withdrawal by Subject|1|||
131423292|NCT01457846|473171906|FG000|Overall Study|Lost to Follow-up|1|||
131423293|NCT01457846|473171907|FG001|Overall Study|Lost to Follow-up|0|||
131423294|NCT01853878|473171908|FG000|Overall Study|Recurrence|2|||
131423295|NCT01853878|473171909|FG001|Overall Study|Recurrence|0|||
131457969|NCT01338298|473307189|FG000|Overall Study|Non-adherence|1|||
131457970|NCT01338298|473307190|FG001|Overall Study|Non-adherence|0|||
131457971|NCT02872285|473307191|FG000|Overall Study|Withdrawal by Subject|2|||
131457972|NCT02872285|473307192|FG001|Overall Study|Withdrawal by Subject|0|||
131457973|NCT02872285|473307191|FG000|Overall Study|Lost to Follow-up|2|||
131457974|NCT02872285|473307192|FG001|Overall Study|Lost to Follow-up|2|||
131457975|NCT02872285|473307191|FG000|Overall Study|Discontinued due to back surgery|1|||
131457976|NCT02872285|473307192|FG001|Overall Study|Discontinued due to back surgery|0|||
131457977|NCT01253577|473307195|FG000|Overall Study|Lost to Follow-up|3|||
131457978|NCT00334113|473307196|FG000|Overall Study|Lost to Follow-up|2|||
131457979|NCT00334113|473307197|FG001|Overall Study|Lost to Follow-up|2|||
131423296|NCT01853878|473171908|FG000|Overall Study|Adverse Event|2|||
131423297|NCT01853878|473171909|FG001|Overall Study|Adverse Event|0|||
131423298|NCT01853878|473171908|FG000|Overall Study|Withdrawal by Subject|3|||
131423299|NCT01853878|473171909|FG001|Overall Study|Withdrawal by Subject|1|||
131423300|NCT01853878|473171908|FG000|Overall Study|Migrated/moved from the study area|1|||
131423301|NCT01853878|473171909|FG001|Overall Study|Migrated/moved from the study area|0|||
131423302|NCT01853878|473171908|FG000|Overall Study|Other|55|||
131423303|NCT01853878|473171909|FG001|Overall Study|Other|43|||
131423304|NCT02161757|473171910|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
131423305|NCT02161757|473171911|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
131423306|NCT02161757|473171912|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
131423307|NCT02161757|473171910|FG000|Treatment Through Study Completion|Adverse Event|1|||
131423308|NCT02161757|473171911|FG001|Treatment Through Study Completion|Adverse Event|1|||
131423309|NCT02161757|473171912|FG002|Treatment Through Study Completion|Adverse Event|0|||
131423310|NCT02161757|473171910|FG000|Treatment Through Study Completion|Protocol Violation|0|||
131423311|NCT02161757|473171911|FG001|Treatment Through Study Completion|Protocol Violation|1|||
131423312|NCT02161757|473171912|FG002|Treatment Through Study Completion|Protocol Violation|2|||
131423313|NCT02161757|473171910|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
131423314|NCT02161757|473171911|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
131423315|NCT02161757|473171912|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
131423316|NCT02161757|473171910|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
131423317|NCT02161757|473171911|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
131423318|NCT02161757|473171912|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
131423319|NCT02161757|473171910|FG000|Treatment Through Study Completion|Other|20|||
131423320|NCT02161757|473171911|FG001|Treatment Through Study Completion|Other|19|||
131423321|NCT02161757|473171912|FG002|Treatment Through Study Completion|Other|12|||
131423322|NCT02161757|473171910|FG000|Treatment Through Study Completion|Death|2|||
131423323|NCT02161757|473171911|FG001|Treatment Through Study Completion|Death|1|||
131423324|NCT02161757|473171912|FG002|Treatment Through Study Completion|Death|1|||
131423325|NCT01361178|473171913|FG000|Overall Study|Death|13|||
131423326|NCT01361178|473171914|FG001|Overall Study|Death|0|||
131423327|NCT00391625|473171915|FG000|Month 14|Withdrawal by Subject|1|||
131423328|NCT00391625|473171915|FG000|Month 50|Physician Decision|1|||
131423329|NCT03916081|473171918|FG000|Overall Study|Adverse Event|1|||
131423330|NCT03916081|473171919|FG001|Overall Study|Adverse Event|0|||
131423331|NCT03916081|473171920|FG002|Overall Study|Adverse Event|0|||
131423332|NCT03916081|473171918|FG000|Overall Study|Physician Decision|0|||
131423333|NCT03916081|473171919|FG001|Overall Study|Physician Decision|0|||
131423334|NCT03916081|473171920|FG002|Overall Study|Physician Decision|1|||
131423335|NCT03916081|473171918|FG000|Overall Study|Lost to Follow-up|0|||
131423336|NCT03916081|473171919|FG001|Overall Study|Lost to Follow-up|1|||
131423337|NCT03916081|473171920|FG002|Overall Study|Lost to Follow-up|0|||
131423338|NCT03916081|473171918|FG000|Overall Study|Withdrawal by Subject|3|||
131423339|NCT03916081|473171919|FG001|Overall Study|Withdrawal by Subject|0|||
131423340|NCT03916081|473171920|FG002|Overall Study|Withdrawal by Subject|1|||
131423341|NCT03916081|473171918|FG000|Overall Study|Worsening of AD|0|||
131423342|NCT03916081|473171919|FG001|Overall Study|Worsening of AD|0|||
131423343|NCT03916081|473171920|FG002|Overall Study|Worsening of AD|1|||
131423344|NCT00465647|473171923|FG000|Overall Study|Administrative|2|||
131423345|NCT00465647|473171924|FG001|Overall Study|Administrative|2|||
131423346|NCT00465647|473171925|FG002|Overall Study|Administrative|3|||
131423347|NCT00465647|473171926|FG003|Overall Study|Administrative|2|||
131423348|NCT00465647|473171923|FG000|Overall Study|Adverse Event|2|||
131423349|NCT00465647|473171924|FG001|Overall Study|Adverse Event|0|||
131423350|NCT00465647|473171925|FG002|Overall Study|Adverse Event|3|||
131423351|NCT00465647|473171926|FG003|Overall Study|Adverse Event|2|||
131423352|NCT00465647|473171923|FG000|Overall Study|Withdrawal by Subject|1|||
131423353|NCT00465647|473171924|FG001|Overall Study|Withdrawal by Subject|2|||
131423354|NCT00465647|473171925|FG002|Overall Study|Withdrawal by Subject|2|||
131423355|NCT00465647|473171926|FG003|Overall Study|Withdrawal by Subject|7|||
131423356|NCT00465647|473171923|FG000|Overall Study|"The other reasons included loss of IV"|8|||
131423357|NCT00465647|473171924|FG001|Overall Study|"The other reasons included loss of IV"|4|||
131423358|NCT00465647|473171925|FG002|Overall Study|"The other reasons included loss of IV"|3|||
131423359|NCT00465647|473171926|FG003|Overall Study|"The other reasons included loss of IV"|2|||
131423360|NCT01240135|473171927|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
131423361|NCT01240135|473171928|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
131423362|NCT01240135|473171927|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
131423363|NCT01240135|473171928|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
131423364|NCT01371305|473171929|FG000|Overall Study|Adverse Event|0|||
131423365|NCT01371305|473171930|FG001|Overall Study|Adverse Event|0|||
131423366|NCT01371305|473171931|FG002|Overall Study|Adverse Event|0|||
131423367|NCT01371305|473171932|FG003|Overall Study|Adverse Event|2|||
131423368|NCT01371305|473171933|FG004|Overall Study|Adverse Event|1|||
131423369|NCT01371305|473171934|FG005|Overall Study|Adverse Event|0|||
131423370|NCT01371305|473171929|FG000|Overall Study|Study terminated by sponsor|0|||
131423371|NCT01371305|473171930|FG001|Overall Study|Study terminated by sponsor|0|||
131457980|NCT00334113|473307196|FG000|Overall Study|Withdrawal by Subject|0|||
131457981|NCT00334113|473307197|FG001|Overall Study|Withdrawal by Subject|1|||
131457982|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
131457983|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
131457984|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
131457985|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
131457986|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Other|2|||
131457987|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
131457988|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
131457989|NCT02509026|473307198|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
131457990|NCT02509026|473307198|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
131457991|NCT02509026|473307198|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
131457992|NCT02509026|473307198|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
131423372|NCT01371305|473171931|FG002|Overall Study|Study terminated by sponsor|0|||
131423373|NCT01371305|473171932|FG003|Overall Study|Study terminated by sponsor|0|||
131423374|NCT01371305|473171933|FG004|Overall Study|Study terminated by sponsor|3|||
131423375|NCT01371305|473171934|FG005|Overall Study|Study terminated by sponsor|1|||
131423376|NCT01371305|473171929|FG000|Overall Study|Subject request|0|||
131423377|NCT01371305|473171930|FG001|Overall Study|Subject request|0|||
131423378|NCT01371305|473171931|FG002|Overall Study|Subject request|0|||
131423379|NCT01371305|473171932|FG003|Overall Study|Subject request|0|||
131423380|NCT01371305|473171933|FG004|Overall Study|Subject request|0|||
131423381|NCT01371305|473171934|FG005|Overall Study|Subject request|1|||
131423382|NCT03244826|473171935|FG000|Overall Study|Withdrawal by Subject|2|||
131423383|NCT03244826|473171936|FG001|Overall Study|Withdrawal by Subject|0|||
131423384|NCT03244826|473171935|FG000|Overall Study|Transplant delayed or withdrawn|12|||
131423385|NCT03244826|473171936|FG001|Overall Study|Transplant delayed or withdrawn|10|||
131423386|NCT00416455|473171943|FG000|Overall Study|PET / CT not done|3|||
131423387|NCT00416455|473171944|FG001|Overall Study|PET / CT not done|5|||
131423388|NCT00416455|473171943|FG000|Overall Study|PET / CT poor quality|2|||
131423389|NCT00416455|473171944|FG001|Overall Study|PET / CT poor quality|1|||
131423390|NCT00416455|473171943|FG000|Overall Study|Inadequate pathology|11|||
131423391|NCT00416455|473171944|FG001|Overall Study|Inadequate pathology|2|||
131423392|NCT00348309|473171945|FG000|Overall Study|Adverse Event|56|||
131423393|NCT00348309|473171946|FG001|Overall Study|Adverse Event|28|||
131423394|NCT00348309|473171947|FG002|Overall Study|Adverse Event|63|||
131423395|NCT00348309|473171945|FG000|Overall Study|Lost to Follow-up|6|||
131423396|NCT00348309|473171946|FG001|Overall Study|Lost to Follow-up|7|||
131423397|NCT00348309|473171947|FG002|Overall Study|Lost to Follow-up|4|||
131423398|NCT00348309|473171945|FG000|Overall Study|Protocol Violation|7|||
131423399|NCT00348309|473171946|FG001|Overall Study|Protocol Violation|12|||
131423400|NCT00348309|473171947|FG002|Overall Study|Protocol Violation|7|||
131423401|NCT00348309|473171945|FG000|Overall Study|Withdrawal by Subject|33|||
131423402|NCT00348309|473171946|FG001|Overall Study|Withdrawal by Subject|37|||
131423403|NCT00348309|473171947|FG002|Overall Study|Withdrawal by Subject|40|||
131423404|NCT00348309|473171945|FG000|Overall Study|Non-compliance|8|||
131457993|NCT02509026|473307198|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
131457994|NCT02509026|473307198|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
131423405|NCT00348309|473171946|FG001|Overall Study|Non-compliance|6|||
131423406|NCT00348309|473171947|FG002|Overall Study|Non-compliance|8|||
131423407|NCT00348309|473171945|FG000|Overall Study|Death of caregiver|1|||
131423408|NCT00348309|473171946|FG001|Overall Study|Death of caregiver|0|||
131423409|NCT00348309|473171947|FG002|Overall Study|Death of caregiver|1|||
131423410|NCT00348309|473171945|FG000|Overall Study|Lack of insight, dementia|1|||
131423411|NCT00348309|473171946|FG001|Overall Study|Lack of insight, dementia|0|||
131423412|NCT00348309|473171947|FG002|Overall Study|Lack of insight, dementia|0|||
131423413|NCT00348309|473171945|FG000|Overall Study|Wrong bottle allocated|1|||
131423414|NCT00348309|473171946|FG001|Overall Study|Wrong bottle allocated|0|||
131423415|NCT00348309|473171947|FG002|Overall Study|Wrong bottle allocated|0|||
131423416|NCT00348309|473171945|FG000|Overall Study|Caregiver sick|1|||
131423417|NCT00348309|473171946|FG001|Overall Study|Caregiver sick|0|||
131423418|NCT00348309|473171947|FG002|Overall Study|Caregiver sick|0|||
131423419|NCT00348309|473171945|FG000|Overall Study|Use of prohibited medication|5|||
131423420|NCT00348309|473171946|FG001|Overall Study|Use of prohibited medication|2|||
131423421|NCT00348309|473171947|FG002|Overall Study|Use of prohibited medication|2|||
131423422|NCT00348309|473171945|FG000|Overall Study|Caregiver withdrawal|3|||
131423423|NCT00348309|473171946|FG001|Overall Study|Caregiver withdrawal|0|||
131423424|NCT00348309|473171947|FG002|Overall Study|Caregiver withdrawal|7|||
131423425|NCT00348309|473171945|FG000|Overall Study|Unable to complete ET visit|1|||
131423426|NCT00348309|473171946|FG001|Overall Study|Unable to complete ET visit|0|||
131423427|NCT00348309|473171947|FG002|Overall Study|Unable to complete ET visit|0|||
131423428|NCT00348309|473171945|FG000|Overall Study|PI closing medical practice|1|||
131423429|NCT00348309|473171946|FG001|Overall Study|PI closing medical practice|0|||
131423430|NCT00348309|473171947|FG002|Overall Study|PI closing medical practice|0|||
131423431|NCT00348309|473171945|FG000|Overall Study|Principal investigator's decision|1|||
131423432|NCT00348309|473171946|FG001|Overall Study|Principal investigator's decision|0|||
131423433|NCT00348309|473171947|FG002|Overall Study|Principal investigator's decision|0|||
131423434|NCT00348309|473171945|FG000|Overall Study|No disponibility of medication|1|||
131423435|NCT00348309|473171946|FG001|Overall Study|No disponibility of medication|0|||
131423436|NCT00348309|473171947|FG002|Overall Study|No disponibility of medication|0|||
131423437|NCT00348309|473171945|FG000|Overall Study|Worsened neurodegenerative disease|1|||
131423438|NCT00348309|473171946|FG001|Overall Study|Worsened neurodegenerative disease|0|||
131423439|NCT00348309|473171947|FG002|Overall Study|Worsened neurodegenerative disease|0|||
131423440|NCT00348309|473171945|FG000|Overall Study|Cognitive and behaviour worsening|2|||
131423441|NCT00348309|473171946|FG001|Overall Study|Cognitive and behaviour worsening|0|||
131423442|NCT00348309|473171947|FG002|Overall Study|Cognitive and behaviour worsening|0|||
131423443|NCT00348309|473171945|FG000|Overall Study|Worsening of alzheimer|1|||
131423444|NCT00348309|473171946|FG001|Overall Study|Worsening of alzheimer|0|||
131423445|NCT00348309|473171947|FG002|Overall Study|Worsening of alzheimer|1|||
131423446|NCT00348309|473171945|FG000|Overall Study|Did not appear in time for Visit 3|1|||
131423447|NCT00348309|473171946|FG001|Overall Study|Did not appear in time for Visit 3|0|||
131423448|NCT00348309|473171947|FG002|Overall Study|Did not appear in time for Visit 3|0|||
131423449|NCT00348309|473171945|FG000|Overall Study|Participant died|2|||
131423450|NCT00348309|473171946|FG001|Overall Study|Participant died|1|||
131423451|NCT00348309|473171947|FG002|Overall Study|Participant died|1|||
131423452|NCT00348309|473171945|FG000|Overall Study|Decision of sponsor|1|||
131423453|NCT00348309|473171946|FG001|Overall Study|Decision of sponsor|0|||
131423454|NCT00348309|473171947|FG002|Overall Study|Decision of sponsor|0|||
131423455|NCT00348309|473171945|FG000|Overall Study|Ineffectiveness of treatment|0|||
131423456|NCT00348309|473171946|FG001|Overall Study|Ineffectiveness of treatment|1|||
131423457|NCT00348309|473171947|FG002|Overall Study|Ineffectiveness of treatment|0|||
131423458|NCT00348309|473171945|FG000|Overall Study|A foul of exclusion criteria|0|||
131423459|NCT00348309|473171946|FG001|Overall Study|A foul of exclusion criteria|1|||
131423460|NCT00348309|473171947|FG002|Overall Study|A foul of exclusion criteria|0|||
131423461|NCT00348309|473171945|FG000|Overall Study|Participant was hospitalized|0|||
131423462|NCT00348309|473171946|FG001|Overall Study|Participant was hospitalized|1|||
131457995|NCT04303195|473307199|FG000|Overall Study|Adverse Event|1|||
131457996|NCT04303195|473307200|FG001|Overall Study|Adverse Event|3|||
131457997|NCT04303195|473307201|FG002|Overall Study|Adverse Event|7|||
131423463|NCT00348309|473171947|FG002|Overall Study|Participant was hospitalized|0|||
131423464|NCT00348309|473171945|FG000|Overall Study|Sponsor refuseal|0|||
131423465|NCT00348309|473171946|FG001|Overall Study|Sponsor refuseal|1|||
131423466|NCT00348309|473171947|FG002|Overall Study|Sponsor refuseal|1|||
131423467|NCT00348309|473171945|FG000|Overall Study|Forgot often medication|0|||
131423468|NCT00348309|473171946|FG001|Overall Study|Forgot often medication|1|||
131423469|NCT00348309|473171947|FG002|Overall Study|Forgot often medication|0|||
131423470|NCT00348309|473171945|FG000|Overall Study|Medical Monitor decision|0|||
131423471|NCT00348309|473171946|FG001|Overall Study|Medical Monitor decision|0|||
131423472|NCT00348309|473171947|FG002|Overall Study|Medical Monitor decision|1|||
131423473|NCT00348309|473171945|FG000|Overall Study|Increased dose of Aricept|0|||
131423474|NCT00348309|473171946|FG001|Overall Study|Increased dose of Aricept|0|||
131423475|NCT00348309|473171947|FG002|Overall Study|Increased dose of Aricept|1|||
131423476|NCT00348309|473171945|FG000|Overall Study|Site closure|0|||
131423477|NCT00348309|473171946|FG001|Overall Study|Site closure|0|||
131423478|NCT00348309|473171947|FG002|Overall Study|Site closure|1|||
131423479|NCT00348309|473171945|FG000|Overall Study|Adverse event not attended|0|||
131423480|NCT00348309|473171946|FG001|Overall Study|Adverse event not attended|0|||
131423481|NCT00348309|473171947|FG002|Overall Study|Adverse event not attended|1|||
131423482|NCT00348309|473171945|FG000|Overall Study|ECG abnormal|0|||
131423483|NCT00348309|473171946|FG001|Overall Study|ECG abnormal|0|||
131423484|NCT00348309|473171947|FG002|Overall Study|ECG abnormal|2|||
131423485|NCT00348309|473171945|FG000|Overall Study|Cardiologist recommendations|0|||
131423486|NCT00348309|473171946|FG001|Overall Study|Cardiologist recommendations|0|||
131423487|NCT00348309|473171947|FG002|Overall Study|Cardiologist recommendations|1|||
131423488|NCT00348309|473171945|FG000|Overall Study|HCV career|0|||
131423489|NCT00348309|473171946|FG001|Overall Study|HCV career|0|||
131423490|NCT00348309|473171947|FG002|Overall Study|HCV career|1|||
131423491|NCT00622388|473171948|FG000|Overall Study|Disease Progression|47|||
131423492|NCT00622388|473171948|FG000|Overall Study|Adverse Event|6|||
131423493|NCT00622388|473171948|FG000|Overall Study|Protocol Violation|3|||
131423494|NCT00622388|473171948|FG000|Overall Study|Participant Refusal|1|||
131423495|NCT00622388|473171948|FG000|Overall Study|Death|3|||
131423496|NCT00622388|473171948|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
131423497|NCT00622388|473171948|FG000|Overall Study|Took Prohibited Medication|2|||
131423498|NCT00622388|473171948|FG000|Overall Study|Withdrew Consent|1|||
131423499|NCT00622388|473171948|FG000|Overall Study|Insurance Expired|1|||
131423500|NCT00828750|473171949|FG000|Overall Study|Lack of Efficacy|3|||
131423501|NCT00828750|473171949|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
131423502|NCT04079114|473171950|FG000|Overall Study|Study prematuely terminated.|166|||
131423503|NCT01364389|473171951|FG000|Overall Study|Withdrawal by Subject|0|||
131423504|NCT01364389|473171952|FG001|Overall Study|Withdrawal by Subject|1|||
131423505|NCT01364389|473171953|FG002|Overall Study|Withdrawal by Subject|0|||
131423506|NCT01364389|473171951|FG000|Overall Study|Protocol deviation|0|||
131423507|NCT01364389|473171952|FG001|Overall Study|Protocol deviation|0|||
131423508|NCT01364389|473171953|FG002|Overall Study|Protocol deviation|1|||
131423509|NCT01364389|473171951|FG000|Overall Study|Administrative problems|1|||
131423510|NCT01364389|473171952|FG001|Overall Study|Administrative problems|0|||
131423511|NCT01364389|473171953|FG002|Overall Study|Administrative problems|0|||
131423512|NCT01364389|473171951|FG000|Overall Study|Adverse Event|1|||
131423513|NCT01364389|473171952|FG001|Overall Study|Adverse Event|0|||
131423514|NCT01364389|473171953|FG002|Overall Study|Adverse Event|0|||
131423515|NCT01068158|473171954|FG000|Overall Study|Withdrawal by Subject|1|||
131423516|NCT01068158|473171955|FG001|Overall Study|Withdrawal by Subject|2|||
131423517|NCT01068158|473171954|FG000|Overall Study|Lost to Follow-up|7|||
131423518|NCT01068158|473171955|FG001|Overall Study|Lost to Follow-up|0|||
131423519|NCT01068158|473171954|FG000|Overall Study|Protocol Violation|0|||
131423520|NCT01068158|473171955|FG001|Overall Study|Protocol Violation|2|||
131423521|NCT00991406|473171956|FG000|Overall Study|One participant did not respond to FES.|1|||
131423522|NCT01300572|473171957|FG000|Overall Study|HAMA + post dosimetry|1|||
131423523|NCT02160145|473171959|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
131423524|NCT02160145|473171960|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
131423525|NCT02160145|473171961|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
131423526|NCT02160145|473171959|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
131423527|NCT02160145|473171960|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
131423528|NCT02160145|473171961|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
131423529|NCT02160145|473171959|FG000|Randomized Double-blind Period|Subject decision|0|||
131423530|NCT02160145|473171960|FG001|Randomized Double-blind Period|Subject decision|21|||
131423531|NCT02160145|473171961|FG002|Randomized Double-blind Period|Subject decision|20|||
131423532|NCT02160145|473171959|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
131457998|NCT04303195|473307202|FG003|Overall Study|Adverse Event|0|||
131457999|NCT04303195|473307199|FG000|Overall Study|Lost to Follow-up|1|||
131423533|NCT02160145|473171960|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
131423534|NCT02160145|473171961|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
131423535|NCT02160145|473171959|FG000|Randomized Double-blind Period|Physician Decision|0|||
131423536|NCT02160145|473171960|FG001|Randomized Double-blind Period|Physician Decision|7|||
131458000|NCT04303195|473307200|FG001|Overall Study|Lost to Follow-up|0|||
131423537|NCT02160145|473171961|FG002|Randomized Double-blind Period|Physician Decision|5|||
131423538|NCT00375518|473171962|FG000|Overall Study|Withdrawal by Subject|2|||
131423539|NCT00375518|473171963|FG001|Overall Study|Withdrawal by Subject|10|||
131423540|NCT00375518|473171962|FG000|Overall Study|Patient Not Treated|6|||
131423541|NCT00375518|473171963|FG001|Overall Study|Patient Not Treated|6|||
131423542|NCT00375518|473171962|FG000|Overall Study|Death|0|||
131423543|NCT00375518|473171963|FG001|Overall Study|Death|1|||
131423544|NCT01108523|473171964|FG000|Overall Study|Protocol Violation|4|||
131423545|NCT01440816|473174390|FG000|Overall Study|Disease Progression|0|||
131423546|NCT01440816|473174391|FG001|Overall Study|Disease Progression|9|||
131423547|NCT01440816|473174390|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
131423548|NCT01440816|473174391|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
131423549|NCT00847886|473174392|FG000|Overall Study|Adverse Event|0|||
131423550|NCT00847886|473174393|FG001|Overall Study|Adverse Event|1|||
131423551|NCT00709618|473174394|FG000|Overall Study|Withdrawal by Subject|4|||
131423552|NCT00709618|473174394|FG000|Overall Study|Lost to Follow-up|1|||
131423553|NCT00709618|473174394|FG000|Overall Study|Study Closed/Terminated|25|||
131423554|NCT04042909|473174395|FG000|Overall Study|Withdrawal by Subject|1|||
131423555|NCT04042909|473174396|FG001|Overall Study|Withdrawal by Subject|0|||
131423556|NCT04042909|473174397|FG002|Overall Study|Withdrawal by Subject|0|||
131423557|NCT04042909|473174395|FG000|Overall Study|duplicate cases|2|||
131423558|NCT04042909|473174396|FG001|Overall Study|duplicate cases|0|||
131423559|NCT04042909|473174397|FG002|Overall Study|duplicate cases|0|||
131423560|NCT04042909|473174395|FG000|Overall Study|technical problem|0|||
131423561|NCT04042909|473174396|FG001|Overall Study|technical problem|1|||
131423562|NCT04042909|473174397|FG002|Overall Study|technical problem|0|||
131423563|NCT00286494|473174402|FG000|Overall Study|Hyperglycemic rescue|12|||
131423564|NCT00286494|473174403|FG001|Overall Study|Hyperglycemic rescue|19|||
131423565|NCT00286494|473174404|FG002|Overall Study|Hyperglycemic rescue|18|||
131423566|NCT00286494|473174402|FG000|Overall Study|Withdrawal by Subject|2|||
131423567|NCT00286494|473174403|FG001|Overall Study|Withdrawal by Subject|10|||
131423568|NCT00286494|473174404|FG002|Overall Study|Withdrawal by Subject|9|||
131423569|NCT00286494|473174402|FG000|Overall Study|Adverse Event|3|||
131423570|NCT00286494|473174403|FG001|Overall Study|Adverse Event|8|||
131423571|NCT00286494|473174404|FG002|Overall Study|Adverse Event|6|||
131423572|NCT00286494|473174402|FG000|Overall Study|Physician Decision|5|||
131423573|NCT00286494|473174403|FG001|Overall Study|Physician Decision|5|||
131423574|NCT00286494|473174404|FG002|Overall Study|Physician Decision|1|||
131423575|NCT00286494|473174402|FG000|Overall Study|Lost to Follow-up|3|||
131423576|NCT00286494|473174403|FG001|Overall Study|Lost to Follow-up|1|||
131423577|NCT00286494|473174404|FG002|Overall Study|Lost to Follow-up|3|||
131423578|NCT00286494|473174402|FG000|Overall Study|Protocol Violation|1|||
131423579|NCT00286494|473174403|FG001|Overall Study|Protocol Violation|1|||
131423580|NCT00286494|473174404|FG002|Overall Study|Protocol Violation|2|||
131423581|NCT04776317|473174405|FG000|Overall Study|Physician Decision|0|||
131423582|NCT04776317|473174406|FG001|Overall Study|Physician Decision|1|||
131423583|NCT04776317|473174407|FG002|Overall Study|Physician Decision|0|||
131423584|NCT04776317|473174408|FG003|Overall Study|Physician Decision|0|||
131423585|NCT04776317|473174409|FG004|Overall Study|Physician Decision|0|||
131423586|NCT04776317|473174410|FG005|Overall Study|Physician Decision|0|||
131423587|NCT04776317|473174411|FG006|Overall Study|Physician Decision|0|||
131423588|NCT04776317|473174412|FG007|Overall Study|Physician Decision|0|||
131423589|NCT04776317|473174413|FG008|Overall Study|Physician Decision|0|||
131423590|NCT04776317|473174414|FG009|Overall Study|Physician Decision|0|||
131423591|NCT04776317|473174415|FG010|Overall Study|Physician Decision|0|||
131423592|NCT04776317|473174416|FG011|Overall Study|Physician Decision|0|||
131423593|NCT04776317|473174417|FG012|Overall Study|Physician Decision|0|||
131423594|NCT04776317|473174418|FG013|Overall Study|Physician Decision|0|||
131423595|NCT04776317|473174419|FG014|Overall Study|Physician Decision|0|||
131423596|NCT04776317|473174405|FG000|Overall Study|Protocol Violation|0|||
131423597|NCT04776317|473174406|FG001|Overall Study|Protocol Violation|0|||
131423598|NCT04776317|473174407|FG002|Overall Study|Protocol Violation|1|||
131423599|NCT04776317|473174408|FG003|Overall Study|Protocol Violation|0|||
131423600|NCT04776317|473174409|FG004|Overall Study|Protocol Violation|0|||
131423601|NCT04776317|473174410|FG005|Overall Study|Protocol Violation|0|||
131423602|NCT04776317|473174411|FG006|Overall Study|Protocol Violation|0|||
131423603|NCT04776317|473174412|FG007|Overall Study|Protocol Violation|0|||
131423604|NCT04776317|473174413|FG008|Overall Study|Protocol Violation|0|||
131423605|NCT04776317|473174414|FG009|Overall Study|Protocol Violation|0|||
131423606|NCT04776317|473174415|FG010|Overall Study|Protocol Violation|0|||
131423607|NCT04776317|473174416|FG011|Overall Study|Protocol Violation|0|||
131423608|NCT04776317|473174417|FG012|Overall Study|Protocol Violation|0|||
131423609|NCT04776317|473174418|FG013|Overall Study|Protocol Violation|0|||
131423610|NCT04776317|473174419|FG014|Overall Study|Protocol Violation|0|||
131423611|NCT04776317|473174405|FG000|Overall Study|Withdrawal by Subject|0|||
131423612|NCT04776317|473174406|FG001|Overall Study|Withdrawal by Subject|0|||
131423613|NCT04776317|473174407|FG002|Overall Study|Withdrawal by Subject|0|||
131423614|NCT04776317|473174408|FG003|Overall Study|Withdrawal by Subject|0|||
131423615|NCT04776317|473174409|FG004|Overall Study|Withdrawal by Subject|1|||
131423616|NCT04776317|473174410|FG005|Overall Study|Withdrawal by Subject|0|||
131423617|NCT04776317|473174411|FG006|Overall Study|Withdrawal by Subject|0|||
131423618|NCT04776317|473174412|FG007|Overall Study|Withdrawal by Subject|0|||
131423619|NCT04776317|473174413|FG008|Overall Study|Withdrawal by Subject|0|||
131423620|NCT04776317|473174414|FG009|Overall Study|Withdrawal by Subject|0|||
131423621|NCT04776317|473174415|FG010|Overall Study|Withdrawal by Subject|0|||
131423622|NCT04776317|473174416|FG011|Overall Study|Withdrawal by Subject|0|||
131423623|NCT04776317|473174417|FG012|Overall Study|Withdrawal by Subject|0|||
131423624|NCT04776317|473174418|FG013|Overall Study|Withdrawal by Subject|0|||
131423625|NCT04776317|473174419|FG014|Overall Study|Withdrawal by Subject|0|||
131423626|NCT04207060|473174420|FG000|Overall Study|Lost to Follow-up|2|||
131423627|NCT04207060|473174421|FG001|Overall Study|Lost to Follow-up|0|||
131423628|NCT02524158|473174422|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
131423629|NCT02524158|473174423|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
131423630|NCT02524158|473174422|FG000|12-weeks Assessment|Lost to Follow-up|18|||
131423631|NCT02524158|473174423|FG001|12-weeks Assessment|Lost to Follow-up|12|||
131423632|NCT02524158|473174422|FG000|6-month Assessment|Withdrawal by Subject|1|||
131423633|NCT02524158|473174423|FG001|6-month Assessment|Withdrawal by Subject|1|||
131423634|NCT02524158|473174422|FG000|6-month Assessment|Lost to Follow-up|21|||
131423635|NCT02524158|473174423|FG001|6-month Assessment|Lost to Follow-up|20|||
131423636|NCT03671304|473174424|FG000|Overall Study|study terminated|7|||
131423637|NCT02718716|473174425|FG000|Overall Study|Lack of Efficacy|1|||
131423638|NCT02718716|473174426|FG001|Overall Study|Lack of Efficacy|0|||
131423639|NCT02718716|473174427|FG002|Overall Study|Lack of Efficacy|0|||
131423640|NCT02718716|473174428|FG003|Overall Study|Lack of Efficacy|0|||
131423641|NCT02718716|473174429|FG004|Overall Study|Lack of Efficacy|0|||
131423642|NCT00296140|473174433|FG000|Overall Study|Lost to Follow-up|1|||
131423643|NCT00296140|473174434|FG001|Overall Study|Lost to Follow-up|0|||
131423644|NCT00296140|473174433|FG000|Overall Study|Withdrawal by Subject|1|||
131423645|NCT00296140|473174434|FG001|Overall Study|Withdrawal by Subject|0|||
131423646|NCT00296140|473174433|FG000|Overall Study|Discharge to Nursing Home|1|||
131423647|NCT00296140|473174434|FG001|Overall Study|Discharge to Nursing Home|0|||
131423648|NCT01856582|473174435|FG000|Overall Study|Died prior to Boost infusion|1|||
131423649|NCT00596830|473174436|FG000|Overall Study|Death|258|||
131423650|NCT00596830|473174437|FG001|Overall Study|Death|247|||
131423651|NCT00596830|473174436|FG000|Overall Study|Lost to Follow-up|7|||
131423652|NCT00596830|473174437|FG001|Overall Study|Lost to Follow-up|11|||
131423653|NCT00596830|473174436|FG000|Overall Study|Withdrawal by Subject|22|||
131423654|NCT00596830|473174437|FG001|Overall Study|Withdrawal by Subject|12|||
131423655|NCT00596830|473174436|FG000|Overall Study|Study terminated by sponsor|51|||
131423656|NCT00596830|473174437|FG001|Overall Study|Study terminated by sponsor|62|||
131423657|NCT00596830|473174436|FG000|Overall Study|Follow-up was discontinued|1|||
131423658|NCT00596830|473174437|FG001|Overall Study|Follow-up was discontinued|0|||
131423659|NCT00596830|473174436|FG000|Overall Study|Randomized but not treated|3|||
131423660|NCT00596830|473174437|FG001|Overall Study|Randomized but not treated|7|||
131423661|NCT00887926|473174438|FG000|Overall Study|Withdrawal by Subject|0|||
131423662|NCT00887926|473174439|FG001|Overall Study|Withdrawal by Subject|1|||
131423663|NCT00887926|473174440|FG002|Overall Study|Withdrawal by Subject|0|||
131423664|NCT00887926|473174441|FG003|Overall Study|Withdrawal by Subject|0|||
131423665|NCT00880191|473174442|FG000|Overall Study|Refused further treatment|4|||
131423666|NCT00880191|473174443|FG001|Overall Study|Refused further treatment|1|||
131423667|NCT00880191|473174442|FG000|Overall Study|Adverse Event|8|||
131423668|NCT00880191|473174443|FG001|Overall Study|Adverse Event|6|||
131423669|NCT00880191|473174442|FG000|Overall Study|Hospitalization/efficacy|1|||
131423670|NCT00880191|473174443|FG001|Overall Study|Hospitalization/efficacy|1|||
131423671|NCT02097030|473174444|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
131423672|NCT02097030|473174445|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
131423673|NCT02097030|473174444|FG000|First Intervention (3 Days)|Visual Acuity|0|||
131423674|NCT02097030|473174445|FG001|First Intervention (3 Days)|Visual Acuity|1|||
131423675|NCT01919801|473174446|FG000|Overall Study|Withdrawal by Subject|1|||
131423676|NCT01919801|473174447|FG001|Overall Study|Withdrawal by Subject|0|||
131423677|NCT01919801|473174446|FG000|Overall Study|Physician Decision|0|||
131423678|NCT01919801|473174447|FG001|Overall Study|Physician Decision|1|||
131423679|NCT01919801|473174446|FG000|Overall Study|Lost to Follow-up|0|||
131423680|NCT01919801|473174447|FG001|Overall Study|Lost to Follow-up|1|||
131423681|NCT01919801|473174446|FG000|Overall Study|Other|0|||
131423682|NCT01919801|473174447|FG001|Overall Study|Other|1|||
131423683|NCT01843062|473174448|FG000|Overall Study|Protocol Violation|1|||
131423684|NCT01843062|473174449|FG001|Overall Study|Protocol Violation|0|||
131423685|NCT01843062|473174448|FG000|Overall Study|New treatment following progression|2|||
131423686|NCT01843062|473174449|FG001|Overall Study|New treatment following progression|0|||
131423687|NCT01843062|473174448|FG000|Overall Study|Pregnancy|1|||
131423688|NCT01843062|473174449|FG001|Overall Study|Pregnancy|0|||
131423689|NCT01843062|473174448|FG000|Overall Study|Adverse Event|2|||
131423690|NCT01843062|473174449|FG001|Overall Study|Adverse Event|0|||
131423691|NCT01843062|473174448|FG000|Overall Study|Incorrect randomisation|1|||
131423692|NCT01843062|473174449|FG001|Overall Study|Incorrect randomisation|0|||
131423693|NCT01843062|473174448|FG000|Overall Study|Withdrawal by Subject|12|||
131423694|NCT01843062|473174449|FG001|Overall Study|Withdrawal by Subject|3|||
131423695|NCT01843062|473174448|FG000|Overall Study|Death|1|||
131423696|NCT01843062|473174449|FG001|Overall Study|Death|2|||
131423697|NCT01843062|473174448|FG000|Overall Study|Lost to Follow-up|2|||
131423698|NCT01843062|473174449|FG001|Overall Study|Lost to Follow-up|4|||
131423699|NCT01677858|473174450|FG000|Overall Study|Adverse Event|0|||
131423700|NCT01677858|473174451|FG001|Overall Study|Adverse Event|0|||
131423701|NCT01677858|473174452|FG002|Overall Study|Adverse Event|2|||
131423702|NCT01677858|473174453|FG003|Overall Study|Adverse Event|3|||
131423703|NCT01677858|473174454|FG004|Overall Study|Adverse Event|13|||
131423704|NCT01677858|473174450|FG000|Overall Study|Death|0|||
131423705|NCT01677858|473174451|FG001|Overall Study|Death|0|||
131423706|NCT01677858|473174452|FG002|Overall Study|Death|0|||
131423707|NCT01677858|473174453|FG003|Overall Study|Death|0|||
131423708|NCT01677858|473174454|FG004|Overall Study|Death|1|||
131423709|NCT01677858|473174450|FG000|Overall Study|Physician Decision|1|||
131423710|NCT01677858|473174451|FG001|Overall Study|Physician Decision|0|||
131423711|NCT01677858|473174452|FG002|Overall Study|Physician Decision|2|||
131423712|NCT01677858|473174453|FG003|Overall Study|Physician Decision|0|||
131423713|NCT01677858|473174454|FG004|Overall Study|Physician Decision|12|||
131423714|NCT01677858|473174450|FG000|Overall Study|Progressive Disease|2|||
131423715|NCT01677858|473174451|FG001|Overall Study|Progressive Disease|1|||
131423716|NCT01677858|473174452|FG002|Overall Study|Progressive Disease|9|||
131423717|NCT01677858|473174453|FG003|Overall Study|Progressive Disease|3|||
131423718|NCT01677858|473174454|FG004|Overall Study|Progressive Disease|43|||
131423719|NCT01677858|473174450|FG000|Overall Study|Withdrawal by Subject|0|||
131423720|NCT01677858|473174451|FG001|Overall Study|Withdrawal by Subject|1|||
131423721|NCT01677858|473174452|FG002|Overall Study|Withdrawal by Subject|1|||
131423722|NCT01677858|473174453|FG003|Overall Study|Withdrawal by Subject|0|||
131423723|NCT01677858|473174454|FG004|Overall Study|Withdrawal by Subject|15|||
131423724|NCT01677858|473174450|FG000|Overall Study|Lost to Follow-up|0|||
131423725|NCT01677858|473174451|FG001|Overall Study|Lost to Follow-up|0|||
131423726|NCT01677858|473174452|FG002|Overall Study|Lost to Follow-up|0|||
131423727|NCT01677858|473174453|FG003|Overall Study|Lost to Follow-up|0|||
131423728|NCT01677858|473174454|FG004|Overall Study|Lost to Follow-up|1|||
131423729|NCT00773747|473174455|FG000|Overall Study|Lack of Efficacy|112|||
131423730|NCT00773747|473174456|FG001|Overall Study|Lack of Efficacy|144|||
131423731|NCT00773747|473174455|FG000|Overall Study|Physician Decision|26|||
131423732|NCT00773747|473174456|FG001|Overall Study|Physician Decision|18|||
131423733|NCT00773747|473174455|FG000|Overall Study|Lost to Follow-up|0|||
131423734|NCT00773747|473174456|FG001|Overall Study|Lost to Follow-up|1|||
131458001|NCT04303195|473307201|FG002|Overall Study|Lost to Follow-up|1|||
131458002|NCT04303195|473307202|FG003|Overall Study|Lost to Follow-up|4|||
131458003|NCT04303195|473307199|FG000|Overall Study|Withdrawal by Subject|3|||
131458004|NCT04303195|473307200|FG001|Overall Study|Withdrawal by Subject|1|||
131458005|NCT04303195|473307201|FG002|Overall Study|Withdrawal by Subject|1|||
131458006|NCT04303195|473307202|FG003|Overall Study|Withdrawal by Subject|1|||
131458007|NCT04303195|473307199|FG000|Overall Study|No study drug administered or protocol deviation|0|||
131458008|NCT04303195|473307200|FG001|Overall Study|No study drug administered or protocol deviation|2|||
131458009|NCT04303195|473307201|FG002|Overall Study|No study drug administered or protocol deviation|0|||
131458010|NCT04303195|473307202|FG003|Overall Study|No study drug administered or protocol deviation|2|||
131458011|NCT06457204|473307203|FG000|Washout|Adverse Event|0|||
131458012|NCT06457204|473307204|FG001|Washout|Adverse Event|2|||
131458013|NCT02626624|473307213|FG000|Overall Study|Adverse Event|1|||
131458014|NCT02626624|473307213|FG000|Overall Study|Lost to Follow-up|3|||
131458015|NCT02626624|473307213|FG000|Overall Study|Protocol Violation|4|||
131458016|NCT02626624|473307213|FG000|Overall Study|Death|2|||
131458017|NCT01395524|473308773|FG000|Overall Study|Non-compliance with study schedule|1|||
131458018|NCT01395524|473308774|FG001|Overall Study|Non-compliance with study schedule|0|||
131458019|NCT01395524|473308775|FG002|Overall Study|Non-compliance with study schedule|1|||
131458020|NCT01395524|473308773|FG000|Overall Study|Lost to Follow-up|3|||
131458021|NCT01395524|473308774|FG001|Overall Study|Lost to Follow-up|1|||
131423735|NCT00773747|473174455|FG000|Overall Study|Protocol Violation|2|||
131423736|NCT00773747|473174456|FG001|Overall Study|Protocol Violation|2|||
131423737|NCT00773747|473174455|FG000|Overall Study|Withdrawal by Subject|89|||
131423738|NCT00773747|473174456|FG001|Overall Study|Withdrawal by Subject|61|||
131423739|NCT00773747|473174455|FG000|Overall Study|Adverse Event|61|||
131423740|NCT00773747|473174456|FG001|Overall Study|Adverse Event|62|||
131423741|NCT00773747|473174455|FG000|Overall Study|Death|5|||
131423742|NCT00773747|473174456|FG001|Overall Study|Death|8|||
131423743|NCT00773747|473174455|FG000|Overall Study|Not Treated|2|||
131423744|NCT00773747|473174456|FG001|Overall Study|Not Treated|0|||
131423745|NCT02669212|473174459|FG000|Overall Study|Lost to Follow-up|1|||
131423746|NCT02669212|473174460|FG001|Overall Study|Lost to Follow-up|0|||
131423747|NCT02669212|473174459|FG000|Overall Study|Medical Condition|3|||
131423748|NCT02669212|473174460|FG001|Overall Study|Medical Condition|4|||
131423749|NCT02669212|473174459|FG000|Overall Study|Withdrawal by Subject|0|||
131423750|NCT02669212|473174460|FG001|Overall Study|Withdrawal by Subject|2|||
131423751|NCT02669212|473174459|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
131423752|NCT02669212|473174460|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
131423753|NCT03078855|473174461|FG000|Overall Study|Lack of Efficacy|62|||
131423754|NCT03078855|473174462|FG001|Overall Study|Lack of Efficacy|31|||
131423755|NCT03078855|473174461|FG000|Overall Study|Death|1|||
131423756|NCT03078855|473174462|FG001|Overall Study|Death|0|||
131423757|NCT03078855|473174461|FG000|Overall Study|Withdrawal by Subject|12|||
131423758|NCT03078855|473174462|FG001|Overall Study|Withdrawal by Subject|6|||
131423759|NCT03078855|473174461|FG000|Overall Study|Physician Decision|3|||
131423760|NCT03078855|473174462|FG001|Overall Study|Physician Decision|2|||
131423761|NCT03078855|473174461|FG000|Overall Study|Second Malignancy|4|||
131423762|NCT03078855|473174462|FG001|Overall Study|Second Malignancy|0|||
131423763|NCT03078855|473174461|FG000|Overall Study|Ineligible|2|||
131423764|NCT03078855|473174462|FG001|Overall Study|Ineligible|0|||
131423765|NCT03078855|473174461|FG000|Overall Study|Withdrew before day 1 treatment|2|||
131423766|NCT03078855|473174462|FG001|Overall Study|Withdrew before day 1 treatment|1|||
131423767|NCT00391027|473174463|FG000|Overall Study|Adverse Event|8|||
131423768|NCT00391027|473174464|FG001|Overall Study|Adverse Event|8|||
131423769|NCT00391027|473174463|FG000|Overall Study|Lack of Efficacy|3|||
131423770|NCT00391027|473174464|FG001|Overall Study|Lack of Efficacy|0|||
131423771|NCT00391027|473174463|FG000|Overall Study|Withdrawal by Subject|10|||
131458022|NCT01395524|473308775|FG002|Overall Study|Lost to Follow-up|1|||
131458023|NCT01395524|473308773|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
131458024|NCT01395524|473308774|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
131423772|NCT00391027|473174464|FG001|Overall Study|Withdrawal by Subject|1|||
131423773|NCT00391027|473174463|FG000|Overall Study|Other|4|||
131423774|NCT00391027|473174464|FG001|Overall Study|Other|3|||
131423775|NCT04869358|473174467|FG000|Overall Study|Wish to have children.|1|||
131458025|NCT01395524|473308775|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
131458026|NCT01395524|473308773|FG000|Overall Study|Severe noncompliance with protocol|1|||
131458027|NCT01395524|473308774|FG001|Overall Study|Severe noncompliance with protocol|0|||
131423776|NCT04869358|473174468|FG001|Overall Study|Wish to have children.|0|||
131423777|NCT04869358|473174469|FG002|Overall Study|Wish to have children.|0|||
131423778|NCT04869358|473174470|FG003|Overall Study|Wish to have children.|0|||
131423779|NCT04164732|473174471|FG000|Treatment run-in Period|Adverse Event|4|||
131423780|NCT04164732|473174472|FG001|Treatment run-in Period|Adverse Event|0|||
131423781|NCT04164732|473174473|FG002|Treatment run-in Period|Adverse Event|0|||
131423782|NCT04164732|473174471|FG000|Treatment run-in Period|Physician Decision|1|||
131423783|NCT04164732|473174472|FG001|Treatment run-in Period|Physician Decision|0|||
131423784|NCT04164732|473174473|FG002|Treatment run-in Period|Physician Decision|0|||
131423785|NCT04164732|473174471|FG000|Treatment run-in Period|Screen Failure|1|||
131423786|NCT04164732|473174472|FG001|Treatment run-in Period|Screen Failure|0|||
131423787|NCT04164732|473174473|FG002|Treatment run-in Period|Screen Failure|0|||
131423788|NCT04164732|473174471|FG000|Randomized Treatment Period|Adverse Event|0|||
131423789|NCT04164732|473174472|FG001|Randomized Treatment Period|Adverse Event|1|||
131423790|NCT04164732|473174473|FG002|Randomized Treatment Period|Adverse Event|0|||
131423791|NCT04164732|473174471|FG000|Randomized Treatment Period|Protocol Deviation|0|||
131423792|NCT04164732|473174472|FG001|Randomized Treatment Period|Protocol Deviation|1|||
131423793|NCT04164732|473174473|FG002|Randomized Treatment Period|Protocol Deviation|1|||
131423794|NCT04164732|473174471|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
131423795|NCT04164732|473174472|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
131423796|NCT04164732|473174473|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
131423797|NCT04302545|473174474|FG000|Overall Study|Lost to Follow-up|3|||
131423798|NCT04302545|473174475|FG001|Overall Study|Lost to Follow-up|4|||
131423799|NCT02828020|473174481|FG000|Treatment Period|Adverse Event|3|||
131423800|NCT02828020|473174482|FG001|Treatment Period|Adverse Event|1|||
131423801|NCT02828020|473174483|FG002|Treatment Period|Adverse Event|1|||
131423802|NCT02828020|473174481|FG000|Treatment Period|Withdrawal of Consent|10|||
131423803|NCT02828020|473174482|FG001|Treatment Period|Withdrawal of Consent|14|||
131423804|NCT02828020|473174483|FG002|Treatment Period|Withdrawal of Consent|9|||
131423805|NCT02828020|473174481|FG000|Treatment Period|Lost to Follow-up|21|||
131423806|NCT02828020|473174482|FG001|Treatment Period|Lost to Follow-up|24|||
131423807|NCT02828020|473174483|FG002|Treatment Period|Lost to Follow-up|18|||
131423808|NCT02828020|473174481|FG000|Treatment Period|Lack of Qualifying Event|44|||
131423809|NCT02828020|473174482|FG001|Treatment Period|Lack of Qualifying Event|53|||
131423810|NCT02828020|473174483|FG002|Treatment Period|Lack of Qualifying Event|43|||
131423811|NCT02828020|473174481|FG000|Treatment Period|Pregnancy|0|||
131423812|NCT02828020|473174482|FG001|Treatment Period|Pregnancy|2|||
131423813|NCT02828020|473174483|FG002|Treatment Period|Pregnancy|0|||
131423814|NCT02828020|473174481|FG000|Treatment Period|Protocol Violation|2|||
131423815|NCT02828020|473174482|FG001|Treatment Period|Protocol Violation|4|||
131423816|NCT02828020|473174483|FG002|Treatment Period|Protocol Violation|7|||
131423817|NCT02828020|473174481|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
131423818|NCT02828020|473174482|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
131423819|NCT02828020|473174483|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
131423820|NCT02828020|473174481|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
131423821|NCT02828020|473174482|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
131423822|NCT02828020|473174483|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
131423823|NCT02828020|473174481|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
131423824|NCT02828020|473174482|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
131423825|NCT02828020|473174483|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
131423826|NCT02828020|473174481|FG000|Safety Follow-up Period|Protocol Violation|0|||
131423827|NCT02828020|473174482|FG001|Safety Follow-up Period|Protocol Violation|2|||
131423828|NCT02828020|473174483|FG002|Safety Follow-up Period|Protocol Violation|1|||
131423829|NCT02828020|473174481|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
131423830|NCT02828020|473174482|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
131423831|NCT02828020|473174483|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
131423832|NCT01138501|473174484|FG000|Overall Study|Protocol Violation|2|||
131423833|NCT01138501|473174484|FG000|Overall Study|Withdrawal by Subject|3|||
131423834|NCT01339897|473174485|FG000|Overall Study|Adverse Event|1|||
131423835|NCT01339897|473174486|FG001|Overall Study|Adverse Event|0|||
131423836|NCT01339897|473174487|FG002|Overall Study|Adverse Event|0|||
131423837|NCT01339897|473174488|FG003|Overall Study|Adverse Event|1|||
131423838|NCT00360568|473174490|FG000|Overall Study|Adverse Event|1|||
131423839|NCT00360568|473174491|FG001|Overall Study|Adverse Event|2|||
131423840|NCT00360568|473174490|FG000|Overall Study|Lack of Efficacy|1|||
131423841|NCT00360568|473174491|FG001|Overall Study|Lack of Efficacy|0|||
131423842|NCT00360568|473174490|FG000|Overall Study|Withdrawal by Subject|0|||
131423843|NCT00360568|473174491|FG001|Overall Study|Withdrawal by Subject|3|||
131423844|NCT00847197|473174495|FG000|Overall Study|Adverse Event|21|||
131423845|NCT00847197|473174496|FG001|Overall Study|Adverse Event|3|||
131423846|NCT00847197|473174495|FG000|Overall Study|Protocol Violation|0|||
131423847|NCT00847197|473174496|FG001|Overall Study|Protocol Violation|1|||
131423848|NCT00847197|473174495|FG000|Overall Study|Withdrawal by Subject|3|||
131423849|NCT00847197|473174496|FG001|Overall Study|Withdrawal by Subject|1|||
131423850|NCT01894243|473174497|FG000|Overall Study|Adverse Event|0|||
131423851|NCT01894243|473174498|FG001|Overall Study|Adverse Event|1|||
131423852|NCT01894243|473174499|FG002|Overall Study|Adverse Event|2|||
131423853|NCT01894243|473174497|FG000|Overall Study|Death|0|||
131423854|NCT01894243|473174498|FG001|Overall Study|Death|0|||
131423855|NCT01894243|473174499|FG002|Overall Study|Death|3|||
131423856|NCT01894243|473174497|FG000|Overall Study|Lack of Efficacy|3|||
131423857|NCT01894243|473174498|FG001|Overall Study|Lack of Efficacy|3|||
131423858|NCT01894243|473174499|FG002|Overall Study|Lack of Efficacy|1|||
131423859|NCT01894243|473174497|FG000|Overall Study|Condition under investigation worsened|8|||
131423860|NCT01894243|473174498|FG001|Overall Study|Condition under investigation worsened|6|||
131423861|NCT01894243|473174499|FG002|Overall Study|Condition under investigation worsened|2|||
131423862|NCT01894243|473174497|FG000|Overall Study|Subject decision|1|||
131423863|NCT01894243|473174498|FG001|Overall Study|Subject decision|0|||
131423864|NCT01894243|473174499|FG002|Overall Study|Subject decision|0|||
131423865|NCT01894243|473174497|FG000|Overall Study|Other|1|||
131423866|NCT01894243|473174498|FG001|Overall Study|Other|0|||
131423867|NCT01894243|473174499|FG002|Overall Study|Other|0|||
131423868|NCT01743040|473174500|FG000|Overall Study|Death|1|||
131423869|NCT01743040|473174500|FG000|Overall Study|Lost to Follow-up|66|||
131423870|NCT01743040|473174500|FG000|Overall Study|Physician Decision|40|||
131423871|NCT01743040|473174500|FG000|Overall Study|Protocol Violation|1|||
131423872|NCT01743040|473174500|FG000|Overall Study|Withdrawal by Subject|121|||
131423873|NCT00830180|473174504|FG000|Overall Study|Adverse Event|6|||
131423874|NCT00830180|473174504|FG000|Overall Study|Death|11|||
131423875|NCT00830180|473174504|FG000|Overall Study|Insufficient clinical response|1|||
131423876|NCT00830180|473174504|FG000|Overall Study|Withdrawal by Subject|5|||
131423877|NCT00830180|473174504|FG000|Overall Study|Progressive disease|2|||
131423878|NCT00830180|473174504|FG000|Overall Study|Other - Unspecified|1|||
131423879|NCT01832532|473174505|FG000|Overall Study|Withdrawal by Subject|5|||
131423880|NCT01832532|473174506|FG001|Overall Study|Withdrawal by Subject|2|||
131423881|NCT02687581|473174508|FG000|Overall Study|Withdrawal by Subject|1|||
131423882|NCT02687581|473174509|FG001|Overall Study|Withdrawal by Subject|0|||
131423883|NCT02687581|473174510|FG002|Overall Study|Withdrawal by Subject|0|||
131423884|NCT02687581|473174511|FG003|Overall Study|Withdrawal by Subject|1|||
131423885|NCT02687581|473174508|FG000|Overall Study|Lost to Follow-up|2|||
131423886|NCT02687581|473174509|FG001|Overall Study|Lost to Follow-up|2|||
131423887|NCT02687581|473174510|FG002|Overall Study|Lost to Follow-up|0|||
131423888|NCT02687581|473174511|FG003|Overall Study|Lost to Follow-up|0|||
131423889|NCT02687581|473174508|FG000|Overall Study|the device is too small for the patient.|1|||
131423890|NCT02687581|473174509|FG001|Overall Study|the device is too small for the patient.|0|||
131423891|NCT02687581|473174510|FG002|Overall Study|the device is too small for the patient.|0|||
131423892|NCT02687581|473174511|FG003|Overall Study|the device is too small for the patient.|0|||
131423893|NCT01990612|473174514|FG000|Overall Study|Lost to Follow-up|2|||
131423894|NCT01990612|473174515|FG001|Overall Study|Lost to Follow-up|1|||
131423895|NCT01990612|473174514|FG000|Overall Study|Withdrawal by Subject|5|||
131423896|NCT01990612|473174515|FG001|Overall Study|Withdrawal by Subject|2|||
131423897|NCT02974842|473174516|FG000|Overall Study|Withdrawal by Subject|4|||
131423898|NCT02974842|473174516|FG000|Overall Study|Screen failures|4|||
131423899|NCT03824587|473174529|FG000|Run-in Period|Screen Failure|0|||
131423900|NCT03824587|473174530|FG001|Run-in Period|Screen Failure|275|||
131423901|NCT03824587|473174529|FG000|Treatment Period|Adverse Event|4|||
131423902|NCT03824587|473174530|FG001|Treatment Period|Adverse Event|1|||
131423903|NCT03824587|473174529|FG000|Treatment Period|Withdrawal by Subject|0|||
131423904|NCT03824587|473174530|FG001|Treatment Period|Withdrawal by Subject|1|||
131423905|NCT03824587|473174529|FG000|Treatment Period|Kidney Transplant|1|||
131458028|NCT01395524|473308775|FG002|Overall Study|Severe noncompliance with protocol|0|||
131458029|NCT01395524|473308773|FG000|Overall Study|Adverse Event|4|||
131423906|NCT03824587|473174530|FG001|Treatment Period|Kidney Transplant|1|||
131423907|NCT00986362|473174531|FG000|Overall Study|Death|2|||
131423908|NCT00986362|473174532|FG001|Overall Study|Death|0|||
131423909|NCT00986362|473174531|FG000|Overall Study|Lost to Follow-up|0|||
131423910|NCT00986362|473174532|FG001|Overall Study|Lost to Follow-up|1|||
131423911|NCT02006979|473174533|FG000|Overall Study|Withdrawal by Subject|1|||
131458030|NCT01395524|473308774|FG001|Overall Study|Adverse Event|4|||
131423912|NCT02006979|473174534|FG001|Overall Study|Withdrawal by Subject|1|||
131423913|NCT02006979|473174533|FG000|Overall Study|Protocol Violation|0|||
131423914|NCT02006979|473174534|FG001|Overall Study|Protocol Violation|1|||
131423915|NCT03170193|473174535|FG000|Overall Study|Withdrawal by Subject|0|||
131423916|NCT03170193|473174536|FG001|Overall Study|Withdrawal by Subject|0|||
131423917|NCT03170193|473174537|FG002|Overall Study|Withdrawal by Subject|0|||
131423918|NCT03170193|473174538|FG003|Overall Study|Withdrawal by Subject|1|||
131423919|NCT03170193|473174539|FG004|Overall Study|Withdrawal by Subject|0|||
131423920|NCT03170193|473174540|FG005|Overall Study|Withdrawal by Subject|0|||
131423921|NCT03170193|473174541|FG006|Overall Study|Withdrawal by Subject|0|||
131423922|NCT03170193|473174535|FG000|Overall Study|Lost to Follow-up|1|||
131423923|NCT03170193|473174536|FG001|Overall Study|Lost to Follow-up|1|||
131423924|NCT03170193|473174537|FG002|Overall Study|Lost to Follow-up|0|||
131423925|NCT03170193|473174538|FG003|Overall Study|Lost to Follow-up|0|||
131423926|NCT03170193|473174539|FG004|Overall Study|Lost to Follow-up|0|||
131423927|NCT03170193|473174540|FG005|Overall Study|Lost to Follow-up|0|||
131423928|NCT03170193|473174541|FG006|Overall Study|Lost to Follow-up|0|||
131423929|NCT01368081|473174542|FG000|Overall Study|Adverse Event|4|||
131423930|NCT01368081|473174543|FG001|Overall Study|Adverse Event|4|||
131423931|NCT01368081|473174544|FG002|Overall Study|Adverse Event|3|||
131423932|NCT01368081|473174545|FG003|Overall Study|Adverse Event|2|||
131423933|NCT01368081|473174546|FG004|Overall Study|Adverse Event|2|||
131423934|NCT01368081|473174547|FG005|Overall Study|Adverse Event|5|||
131423935|NCT01368081|473174548|FG006|Overall Study|Adverse Event|6|||
131423936|NCT01368081|473174549|FG007|Overall Study|Adverse Event|2|||
131423937|NCT01368081|473174550|FG008|Overall Study|Adverse Event|3|||
131423938|NCT01368081|473174551|FG009|Overall Study|Adverse Event|5|||
131423939|NCT01368081|473174552|FG010|Overall Study|Adverse Event|6|||
131423940|NCT01368081|473174553|FG011|Overall Study|Adverse Event|1|||
131423941|NCT01368081|473174554|FG012|Overall Study|Adverse Event|3|||
131423942|NCT01368081|473174542|FG000|Overall Study|Lack of Efficacy|0|||
131423943|NCT01368081|473174543|FG001|Overall Study|Lack of Efficacy|1|||
131423944|NCT01368081|473174544|FG002|Overall Study|Lack of Efficacy|0|||
131423945|NCT01368081|473174545|FG003|Overall Study|Lack of Efficacy|1|||
131423946|NCT01368081|473174546|FG004|Overall Study|Lack of Efficacy|0|||
131423947|NCT01368081|473174547|FG005|Overall Study|Lack of Efficacy|0|||
131423948|NCT01368081|473174548|FG006|Overall Study|Lack of Efficacy|0|||
131423949|NCT01368081|473174549|FG007|Overall Study|Lack of Efficacy|2|||
131423950|NCT01368081|473174550|FG008|Overall Study|Lack of Efficacy|0|||
131423951|NCT01368081|473174551|FG009|Overall Study|Lack of Efficacy|0|||
131423952|NCT01368081|473174552|FG010|Overall Study|Lack of Efficacy|0|||
131423953|NCT01368081|473174553|FG011|Overall Study|Lack of Efficacy|0|||
131423954|NCT01368081|473174554|FG012|Overall Study|Lack of Efficacy|0|||
131423955|NCT01368081|473174542|FG000|Overall Study|Protocol Violation|0|||
131423956|NCT01368081|473174543|FG001|Overall Study|Protocol Violation|0|||
131423957|NCT01368081|473174544|FG002|Overall Study|Protocol Violation|0|||
131423958|NCT01368081|473174545|FG003|Overall Study|Protocol Violation|0|||
131423959|NCT01368081|473174546|FG004|Overall Study|Protocol Violation|0|||
131423960|NCT01368081|473174547|FG005|Overall Study|Protocol Violation|1|||
131423961|NCT01368081|473174548|FG006|Overall Study|Protocol Violation|0|||
131423962|NCT01368081|473174549|FG007|Overall Study|Protocol Violation|1|||
131423963|NCT01368081|473174550|FG008|Overall Study|Protocol Violation|0|||
131423964|NCT01368081|473174551|FG009|Overall Study|Protocol Violation|0|||
131423965|NCT01368081|473174552|FG010|Overall Study|Protocol Violation|0|||
131423966|NCT01368081|473174553|FG011|Overall Study|Protocol Violation|0|||
131423967|NCT01368081|473174554|FG012|Overall Study|Protocol Violation|0|||
131423968|NCT01368081|473174542|FG000|Overall Study|Lost to Follow-up|0|||
131423969|NCT01368081|473174543|FG001|Overall Study|Lost to Follow-up|0|||
131423970|NCT01368081|473174544|FG002|Overall Study|Lost to Follow-up|0|||
131423971|NCT01368081|473174545|FG003|Overall Study|Lost to Follow-up|0|||
131423972|NCT01368081|473174546|FG004|Overall Study|Lost to Follow-up|0|||
131423973|NCT01368081|473174547|FG005|Overall Study|Lost to Follow-up|0|||
131423974|NCT01368081|473174548|FG006|Overall Study|Lost to Follow-up|0|||
131423975|NCT01368081|473174549|FG007|Overall Study|Lost to Follow-up|0|||
131423976|NCT01368081|473174550|FG008|Overall Study|Lost to Follow-up|0|||
131423977|NCT01368081|473174551|FG009|Overall Study|Lost to Follow-up|0|||
131423978|NCT01368081|473174552|FG010|Overall Study|Lost to Follow-up|0|||
131423979|NCT01368081|473174553|FG011|Overall Study|Lost to Follow-up|0|||
131423980|NCT01368081|473174554|FG012|Overall Study|Lost to Follow-up|1|||
131423981|NCT01368081|473174542|FG000|Overall Study|Withdrawal by Subject|4|||
131423982|NCT01368081|473174543|FG001|Overall Study|Withdrawal by Subject|4|||
131423983|NCT01368081|473174544|FG002|Overall Study|Withdrawal by Subject|1|||
131423984|NCT01368081|473174545|FG003|Overall Study|Withdrawal by Subject|1|||
131423985|NCT01368081|473174546|FG004|Overall Study|Withdrawal by Subject|0|||
131423986|NCT01368081|473174547|FG005|Overall Study|Withdrawal by Subject|3|||
131423987|NCT01368081|473174548|FG006|Overall Study|Withdrawal by Subject|4|||
131423988|NCT01368081|473174549|FG007|Overall Study|Withdrawal by Subject|2|||
131423989|NCT01368081|473174550|FG008|Overall Study|Withdrawal by Subject|5|||
131423990|NCT01368081|473174551|FG009|Overall Study|Withdrawal by Subject|4|||
131423991|NCT01368081|473174552|FG010|Overall Study|Withdrawal by Subject|3|||
131423992|NCT01368081|473174553|FG011|Overall Study|Withdrawal by Subject|2|||
131423993|NCT01368081|473174554|FG012|Overall Study|Withdrawal by Subject|0|||
131423994|NCT01368081|473174542|FG000|Overall Study|Other reason not defined above|2|||
131423995|NCT01368081|473174543|FG001|Overall Study|Other reason not defined above|0|||
131423996|NCT01368081|473174544|FG002|Overall Study|Other reason not defined above|0|||
131423997|NCT01368081|473174545|FG003|Overall Study|Other reason not defined above|1|||
131423998|NCT01368081|473174546|FG004|Overall Study|Other reason not defined above|0|||
131423999|NCT01368081|473174547|FG005|Overall Study|Other reason not defined above|1|||
131424000|NCT01368081|473174548|FG006|Overall Study|Other reason not defined above|2|||
131424001|NCT01368081|473174549|FG007|Overall Study|Other reason not defined above|0|||
131424002|NCT01368081|473174550|FG008|Overall Study|Other reason not defined above|0|||
131424003|NCT01368081|473174551|FG009|Overall Study|Other reason not defined above|1|||
131424004|NCT01368081|473174552|FG010|Overall Study|Other reason not defined above|0|||
131424005|NCT01368081|473174553|FG011|Overall Study|Other reason not defined above|0|||
131424006|NCT01368081|473174554|FG012|Overall Study|Other reason not defined above|3|||
131424007|NCT02277119|473174557|FG000|Overall Study|Lack of Efficacy|1|||
131424008|NCT02277119|473174558|FG001|Overall Study|Lack of Efficacy|1|||
131424009|NCT02277119|473174559|FG002|Overall Study|Lack of Efficacy|1|||
131424010|NCT02277119|473174557|FG000|Overall Study|Protocol Violation|2|||
131424011|NCT02277119|473174558|FG001|Overall Study|Protocol Violation|3|||
131424012|NCT02277119|473174559|FG002|Overall Study|Protocol Violation|7|||
131424013|NCT04699461|473174560|FG000|Overall Study|Withdrawal by Subject|1|||
131424014|NCT04699461|473174561|FG001|Overall Study|Withdrawal by Subject|0|||
131424015|NCT04699461|473174560|FG000|Overall Study|Study termination by sponsor|2|||
131424016|NCT04699461|473174561|FG001|Overall Study|Study termination by sponsor|1|||
131424017|NCT04699461|473174560|FG000|Overall Study|Death|1|||
131424018|NCT04699461|473174561|FG001|Overall Study|Death|0|||
131424019|NCT04699461|473174560|FG000|Overall Study|Radiographic progression|0|||
131424020|NCT04699461|473174561|FG001|Overall Study|Radiographic progression|1|||
131424021|NCT03068767|473174562|FG000|Overall Study|Lost to Follow-up|7|||
131424022|NCT03068767|473174563|FG001|Overall Study|Lost to Follow-up|3|||
131424023|NCT03068767|473174562|FG000|Overall Study|Protocol Violation|3|||
131424024|NCT03068767|473174563|FG001|Overall Study|Protocol Violation|0|||
131424025|NCT04167137|473174564|FG000|Overall Study|Disease progression|1|||
131424026|NCT04167137|473174565|FG001|Overall Study|Disease progression|1|||
131424027|NCT04167137|473174566|FG002|Overall Study|Disease progression|3|||
131424028|NCT04167137|473174567|FG003|Overall Study|Disease progression|3|||
131424029|NCT04167137|473174568|FG004|Overall Study|Disease progression|2|||
131424030|NCT04167137|473174569|FG005|Overall Study|Disease progression|3|||
131424031|NCT04167137|473174570|FG006|Overall Study|Disease progression|2|||
131424032|NCT04167137|473174571|FG007|Overall Study|Disease progression|2|||
131424033|NCT04167137|473174564|FG000|Overall Study|Withdrawal by Subject|1|||
131424034|NCT04167137|473174565|FG001|Overall Study|Withdrawal by Subject|0|||
131424035|NCT04167137|473174566|FG002|Overall Study|Withdrawal by Subject|0|||
131424036|NCT04167137|473174567|FG003|Overall Study|Withdrawal by Subject|1|||
131424037|NCT04167137|473174568|FG004|Overall Study|Withdrawal by Subject|0|||
131424038|NCT04167137|473174569|FG005|Overall Study|Withdrawal by Subject|2|||
131424039|NCT04167137|473174570|FG006|Overall Study|Withdrawal by Subject|1|||
131424040|NCT04167137|473174571|FG007|Overall Study|Withdrawal by Subject|0|||
131424041|NCT04167137|473174564|FG000|Overall Study|Adverse Event|0|||
131424042|NCT04167137|473174565|FG001|Overall Study|Adverse Event|0|||
131424043|NCT04167137|473174566|FG002|Overall Study|Adverse Event|0|||
131424044|NCT04167137|473174567|FG003|Overall Study|Adverse Event|0|||
131424045|NCT04167137|473174568|FG004|Overall Study|Adverse Event|0|||
131424046|NCT04167137|473174569|FG005|Overall Study|Adverse Event|1|||
131424047|NCT04167137|473174570|FG006|Overall Study|Adverse Event|0|||
131424048|NCT04167137|473174571|FG007|Overall Study|Adverse Event|1|||
131424049|NCT04167137|473174564|FG000|Overall Study|Physician Decision|0|||
131424050|NCT04167137|473174565|FG001|Overall Study|Physician Decision|0|||
131424051|NCT04167137|473174566|FG002|Overall Study|Physician Decision|0|||
131424052|NCT04167137|473174567|FG003|Overall Study|Physician Decision|1|||
131424053|NCT04167137|473174568|FG004|Overall Study|Physician Decision|0|||
131424054|NCT04167137|473174569|FG005|Overall Study|Physician Decision|0|||
131424055|NCT04167137|473174570|FG006|Overall Study|Physician Decision|1|||
131424056|NCT04167137|473174571|FG007|Overall Study|Physician Decision|0|||
131424057|NCT04167137|473174564|FG000|Overall Study|Death|0|||
131424058|NCT04167137|473174565|FG001|Overall Study|Death|1|||
131424059|NCT04167137|473174566|FG002|Overall Study|Death|0|||
131424060|NCT04167137|473174567|FG003|Overall Study|Death|0|||
131424061|NCT04167137|473174568|FG004|Overall Study|Death|0|||
131424062|NCT04167137|473174569|FG005|Overall Study|Death|0|||
131424063|NCT04167137|473174570|FG006|Overall Study|Death|0|||
131424064|NCT04167137|473174571|FG007|Overall Study|Death|0|||
131424065|NCT04167137|473174564|FG000|Overall Study|Study terminated by Sponsor|0|||
131424066|NCT04167137|473174565|FG001|Overall Study|Study terminated by Sponsor|0|||
131424067|NCT04167137|473174566|FG002|Overall Study|Study terminated by Sponsor|0|||
131424068|NCT04167137|473174567|FG003|Overall Study|Study terminated by Sponsor|0|||
131424069|NCT04167137|473174568|FG004|Overall Study|Study terminated by Sponsor|0|||
131424070|NCT04167137|473174569|FG005|Overall Study|Study terminated by Sponsor|0|||
131424071|NCT04167137|473174570|FG006|Overall Study|Study terminated by Sponsor|0|||
131424072|NCT04167137|473174571|FG007|Overall Study|Study terminated by Sponsor|1|||
131424073|NCT01748825|473174574|FG000|Dose Escalation|Refused further treatment|2|||
131424074|NCT01748825|473174575|FG001|Dose Escalation|Refused further treatment|2|||
131424075|NCT01748825|473174576|FG002|Dose Escalation|Refused further treatment|0|||
131424076|NCT01748825|473174577|FG003|Dose Escalation|Refused further treatment|0|||
131424077|NCT01748825|473174578|FG004|Dose Escalation|Refused further treatment|1|||
131424078|NCT01748825|473174579|FG005|Dose Escalation|Refused further treatment|2|||
131424079|NCT01748825|473174580|FG006|Dose Escalation|Refused further treatment|0|||
131424080|NCT01748825|473174581|FG007|Dose Escalation|Refused further treatment|0|||
131424081|NCT01748825|473174582|FG008|Dose Escalation|Refused further treatment|0|||
131424082|NCT01748825|473174583|FG009|Dose Escalation|Refused further treatment|0|||
131424083|NCT01748825|473174574|FG000|Dose Escalation|Switched to alternative treatment|0|||
131424084|NCT01748825|473174575|FG001|Dose Escalation|Switched to alternative treatment|0|||
131424085|NCT01748825|473174576|FG002|Dose Escalation|Switched to alternative treatment|0|||
131424086|NCT01748825|473174577|FG003|Dose Escalation|Switched to alternative treatment|1|||
131424087|NCT01748825|473174578|FG004|Dose Escalation|Switched to alternative treatment|0|||
131424088|NCT01748825|473174579|FG005|Dose Escalation|Switched to alternative treatment|0|||
131424089|NCT01748825|473174580|FG006|Dose Escalation|Switched to alternative treatment|0|||
131424090|NCT01748825|473174581|FG007|Dose Escalation|Switched to alternative treatment|0|||
131424091|NCT01748825|473174582|FG008|Dose Escalation|Switched to alternative treatment|0|||
131424092|NCT01748825|473174583|FG009|Dose Escalation|Switched to alternative treatment|0|||
131424093|NCT01748825|473174574|FG000|Dose Escalation|Adverse Event|0|||
131424094|NCT01748825|473174575|FG001|Dose Escalation|Adverse Event|0|||
131424095|NCT01748825|473174576|FG002|Dose Escalation|Adverse Event|0|||
131424096|NCT01748825|473174577|FG003|Dose Escalation|Adverse Event|0|||
131424097|NCT01748825|473174578|FG004|Dose Escalation|Adverse Event|0|||
131424098|NCT01748825|473174579|FG005|Dose Escalation|Adverse Event|0|||
131424099|NCT01748825|473174580|FG006|Dose Escalation|Adverse Event|1|||
131424100|NCT01748825|473174581|FG007|Dose Escalation|Adverse Event|0|||
131424101|NCT01748825|473174582|FG008|Dose Escalation|Adverse Event|0|||
131424102|NCT01748825|473174583|FG009|Dose Escalation|Adverse Event|0|||
131424103|NCT01748825|473174574|FG000|Dose Expansion|Refused further treatment|0|||
131424104|NCT01748825|473174575|FG001|Dose Expansion|Refused further treatment|0|||
131424105|NCT01748825|473174576|FG002|Dose Expansion|Refused further treatment|0|||
131424106|NCT01748825|473174577|FG003|Dose Expansion|Refused further treatment|0|||
131424107|NCT01748825|473174578|FG004|Dose Expansion|Refused further treatment|0|||
131424108|NCT01748825|473174579|FG005|Dose Expansion|Refused further treatment|0|||
131424109|NCT01748825|473174580|FG006|Dose Expansion|Refused further treatment|0|||
131424110|NCT01748825|473174581|FG007|Dose Expansion|Refused further treatment|0|||
131424111|NCT01748825|473174582|FG008|Dose Expansion|Refused further treatment|1|||
131424112|NCT01748825|473174583|FG009|Dose Expansion|Refused further treatment|1|||
131424113|NCT01748825|473174574|FG000|Dose Expansion|Switched to alternative treatment|0|||
131424114|NCT01748825|473174575|FG001|Dose Expansion|Switched to alternative treatment|0|||
131424115|NCT01748825|473174576|FG002|Dose Expansion|Switched to alternative treatment|0|||
131424116|NCT01748825|473174577|FG003|Dose Expansion|Switched to alternative treatment|0|||
131424117|NCT01748825|473174578|FG004|Dose Expansion|Switched to alternative treatment|0|||
131424118|NCT01748825|473174579|FG005|Dose Expansion|Switched to alternative treatment|0|||
131424119|NCT01748825|473174580|FG006|Dose Expansion|Switched to alternative treatment|0|||
131424120|NCT01748825|473174581|FG007|Dose Expansion|Switched to alternative treatment|0|||
131424121|NCT01748825|473174582|FG008|Dose Expansion|Switched to alternative treatment|0|||
131424122|NCT01748825|473174583|FG009|Dose Expansion|Switched to alternative treatment|1|||
131424123|NCT01748825|473174574|FG000|Dose Expansion|Adverse Event|0|||
131424124|NCT01748825|473174575|FG001|Dose Expansion|Adverse Event|0|||
131424125|NCT01748825|473174576|FG002|Dose Expansion|Adverse Event|0|||
131424126|NCT01748825|473174577|FG003|Dose Expansion|Adverse Event|0|||
131424127|NCT01748825|473174578|FG004|Dose Expansion|Adverse Event|0|||
131424128|NCT01748825|473174579|FG005|Dose Expansion|Adverse Event|0|||
131424129|NCT01748825|473174580|FG006|Dose Expansion|Adverse Event|0|||
131424130|NCT01748825|473174581|FG007|Dose Expansion|Adverse Event|0|||
131424131|NCT01748825|473174582|FG008|Dose Expansion|Adverse Event|0|||
131424132|NCT01748825|473174583|FG009|Dose Expansion|Adverse Event|3|||
131424133|NCT01748825|473174574|FG000|Dose Expansion|Physician Decision|0|||
131424134|NCT01748825|473174575|FG001|Dose Expansion|Physician Decision|0|||
131424135|NCT01748825|473174576|FG002|Dose Expansion|Physician Decision|0|||
131424136|NCT01748825|473174577|FG003|Dose Expansion|Physician Decision|0|||
131424137|NCT01748825|473174578|FG004|Dose Expansion|Physician Decision|0|||
131424138|NCT01748825|473174579|FG005|Dose Expansion|Physician Decision|0|||
131424139|NCT01748825|473174580|FG006|Dose Expansion|Physician Decision|0|||
131424140|NCT01748825|473174581|FG007|Dose Expansion|Physician Decision|0|||
131424141|NCT01748825|473174582|FG008|Dose Expansion|Physician Decision|1|||
131424142|NCT01748825|473174583|FG009|Dose Expansion|Physician Decision|0|||
131424143|NCT01370265|473176313|FG000|First Intervention|Adverse Event|1|||
131424144|NCT01370265|473176314|FG001|First Intervention|Adverse Event|1|||
131424145|NCT02611817|473176315|FG000|Open-label Induction Phase|Reason not Specified|9|||
131424146|NCT02611817|473176316|FG001|Open-label Induction Phase|Reason not Specified|0|||
131424147|NCT02611817|473176317|FG002|Open-label Induction Phase|Reason not Specified|0|||
131424148|NCT02611817|473176315|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
131424149|NCT02611817|473176316|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
131424150|NCT02611817|473176317|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
131424151|NCT02611817|473176315|FG000|Open-label Induction Phase|Pregnancy|1|||
131424152|NCT02611817|473176316|FG001|Open-label Induction Phase|Pregnancy|0|||
131424153|NCT02611817|473176317|FG002|Open-label Induction Phase|Pregnancy|0|||
131424154|NCT02611817|473176315|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
131424155|NCT02611817|473176316|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
131424156|NCT02611817|473176317|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
131424157|NCT02611817|473176315|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
131424158|NCT02611817|473176316|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
131458031|NCT01395524|473308775|FG002|Overall Study|Adverse Event|3|||
131458032|NCT01395524|473308773|FG000|Overall Study|Death|1|||
131458033|NCT01395524|473308774|FG001|Overall Study|Death|0|||
131424159|NCT02611817|473176317|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
131424160|NCT02611817|473176315|FG000|Open-label Induction Phase|Protocol Violation|5|||
131458034|NCT01395524|473308775|FG002|Overall Study|Death|0|||
131424161|NCT02611817|473176316|FG001|Open-label Induction Phase|Protocol Violation|0|||
131424162|NCT02611817|473176317|FG002|Open-label Induction Phase|Protocol Violation|0|||
131424163|NCT02611817|473176315|FG000|Open-label Induction Phase|Adverse Event|16|||
131424164|NCT02611817|473176316|FG001|Open-label Induction Phase|Adverse Event|0|||
131424165|NCT02611817|473176317|FG002|Open-label Induction Phase|Adverse Event|0|||
131424166|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
131424167|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
131424168|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
131424169|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
131424170|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
131424171|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
131424172|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
131424173|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
131424174|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
131424175|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
131424176|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
131424177|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
131424178|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
131424179|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
131424180|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
131424181|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
131424182|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
131424183|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
131424184|NCT02611817|473176315|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
131424185|NCT02611817|473176316|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
131424186|NCT02611817|473176317|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
131424187|NCT01732770|473176319|FG000|Overall Study|Lost to Follow-up|2|||
131424188|NCT01732770|473176320|FG001|Overall Study|Lost to Follow-up|3|||
131424189|NCT01732770|473176319|FG000|Overall Study|Withdrawal by Subject|5|||
131424190|NCT01732770|473176320|FG001|Overall Study|Withdrawal by Subject|3|||
131424191|NCT01732770|473176319|FG000|Overall Study|Decision by Sponsor|2|||
131424192|NCT01732770|473176320|FG001|Overall Study|Decision by Sponsor|2|||
131424193|NCT01732770|473176319|FG000|Overall Study|Death|1|||
131424194|NCT01732770|473176320|FG001|Overall Study|Death|0|||
131424195|NCT00931606|473176321|FG000|Overall Study|Death|1|||
131424196|NCT00931606|473176322|FG001|Overall Study|Death|3|||
131424197|NCT00931606|473176323|FG002|Overall Study|Death|2|||
131424198|NCT00931606|473176324|FG003|Overall Study|Death|0|||
131424199|NCT00931606|473176321|FG000|Overall Study|Lost to Follow-up|0|||
131424200|NCT00931606|473176322|FG001|Overall Study|Lost to Follow-up|1|||
131424201|NCT00931606|473176323|FG002|Overall Study|Lost to Follow-up|0|||
131424202|NCT00931606|473176324|FG003|Overall Study|Lost to Follow-up|0|||
131424203|NCT00931606|473176321|FG000|Overall Study|Physician Decision|0|||
131424204|NCT00931606|473176322|FG001|Overall Study|Physician Decision|0|||
131424205|NCT00931606|473176323|FG002|Overall Study|Physician Decision|3|||
131424206|NCT00931606|473176324|FG003|Overall Study|Physician Decision|0|||
131424207|NCT00931606|473176321|FG000|Overall Study|Sponsor Decision|1|||
131424208|NCT00931606|473176322|FG001|Overall Study|Sponsor Decision|4|||
131424209|NCT00931606|473176323|FG002|Overall Study|Sponsor Decision|0|||
131424210|NCT00931606|473176324|FG003|Overall Study|Sponsor Decision|2|||
131424211|NCT00931606|473176321|FG000|Overall Study|Withdrawal by Subject|3|||
131424212|NCT00931606|473176322|FG001|Overall Study|Withdrawal by Subject|1|||
131424213|NCT00931606|473176323|FG002|Overall Study|Withdrawal by Subject|1|||
131424214|NCT00931606|473176324|FG003|Overall Study|Withdrawal by Subject|1|||
131424215|NCT03412812|473176331|FG000|Level 1|Death|3|||
131424216|NCT03412812|473176332|FG001|Level 1|Death|0|||
131424217|NCT03412812|473176331|FG000|Level 1|Adverse Event|0|||
131424218|NCT03412812|473176332|FG001|Level 1|Adverse Event|1|||
131424219|NCT00871338|473176338|FG000|Prior to Booster|Withdrawal by Subject|1|||
131424220|NCT00871338|473176339|FG001|Prior to Booster|Withdrawal by Subject|3|||
131424221|NCT00871338|473176338|FG000|Prior to Booster|Lost to Follow-up|1|||
131424222|NCT00871338|473176339|FG001|Prior to Booster|Lost to Follow-up|0|||
131424223|NCT02391363|473176340|FG000|Overall Study|Lost to Follow-up|5|||
131424224|NCT02391363|473176341|FG001|Overall Study|Lost to Follow-up|5|||
131424225|NCT02391363|473176340|FG000|Overall Study|Withdrawal by Subject|6|||
131424226|NCT02391363|473176341|FG001|Overall Study|Withdrawal by Subject|3|||
131424227|NCT03828617|473176342|FG000|Overall Study|Lost to Follow-up|22|||
131424228|NCT03828617|473176343|FG001|Overall Study|Lost to Follow-up|12|||
131424229|NCT03828617|473176344|FG002|Overall Study|Lost to Follow-up|23|||
131424230|NCT03828617|473176345|FG003|Overall Study|Lost to Follow-up|7|||
131424231|NCT03828617|473176342|FG000|Overall Study|No longer met eligibility criteria|0|||
131424232|NCT03828617|473176343|FG001|Overall Study|No longer met eligibility criteria|1|||
131424233|NCT03828617|473176344|FG002|Overall Study|No longer met eligibility criteria|1|||
131424234|NCT03828617|473176345|FG003|Overall Study|No longer met eligibility criteria|3|||
131424235|NCT03828617|473176342|FG000|Overall Study|Protocol Violation|0|||
131424236|NCT03828617|473176343|FG001|Overall Study|Protocol Violation|2|||
131424237|NCT03828617|473176344|FG002|Overall Study|Protocol Violation|0|||
131424238|NCT03828617|473176345|FG003|Overall Study|Protocol Violation|0|||
131424239|NCT03828617|473176342|FG000|Overall Study|Withdrawal by Subject|2|||
131424240|NCT03828617|473176343|FG001|Overall Study|Withdrawal by Subject|0|||
131424241|NCT03828617|473176344|FG002|Overall Study|Withdrawal by Subject|2|||
131424242|NCT03828617|473176345|FG003|Overall Study|Withdrawal by Subject|0|||
131424243|NCT04794270|473176346|FG000|Period 1|Non Compliance|1|||
131424244|NCT04794270|473176347|FG001|Period 1|Non Compliance|0|||
131424245|NCT04794270|473176346|FG000|Period 1|Adverse Event|1|||
131424246|NCT04794270|473176347|FG001|Period 1|Adverse Event|0|||
131424247|NCT04794270|473176346|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
131424248|NCT04794270|473176347|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
131424249|NCT00265317|473176350|FG000|Lead-In|Objective progression or relapse|6|||
131424250|NCT00265317|473176351|FG001|Lead-In|Objective progression or relapse|11|||
131424251|NCT00265317|473176352|FG002|Lead-In|Objective progression or relapse|0|||
131424252|NCT00265317|473176353|FG003|Lead-In|Objective progression or relapse|0|||
131424253|NCT00265317|473176350|FG000|Lead-In|Adverse Event|2|||
131424254|NCT00265317|473176351|FG001|Lead-In|Adverse Event|1|||
131424255|NCT00265317|473176352|FG002|Lead-In|Adverse Event|0|||
131424256|NCT00265317|473176353|FG003|Lead-In|Adverse Event|0|||
131424257|NCT00265317|473176350|FG000|Lead-In|Death|3|||
131424258|NCT00265317|473176351|FG001|Lead-In|Death|5|||
131424259|NCT00265317|473176352|FG002|Lead-In|Death|0|||
131424260|NCT00265317|473176353|FG003|Lead-In|Death|0|||
131424261|NCT00265317|473176350|FG000|Lead-In|Withdrawal/other than adverse event|1|||
131424262|NCT00265317|473176351|FG001|Lead-In|Withdrawal/other than adverse event|0|||
131424263|NCT00265317|473176352|FG002|Lead-In|Withdrawal/other than adverse event|0|||
131424264|NCT00265317|473176353|FG003|Lead-In|Withdrawal/other than adverse event|0|||
131424265|NCT00265317|473176350|FG000|Phase 2|Objective progression or relapse|0|||
131424266|NCT00265317|473176351|FG001|Phase 2|Objective progression or relapse|0|||
131424267|NCT00265317|473176352|FG002|Phase 2|Objective progression or relapse|37|||
131424268|NCT00265317|473176353|FG003|Phase 2|Objective progression or relapse|38|||
131424269|NCT00265317|473176350|FG000|Phase 2|Global deterioration of health status|0|||
131424270|NCT00265317|473176351|FG001|Phase 2|Global deterioration of health status|0|||
131424271|NCT00265317|473176352|FG002|Phase 2|Global deterioration of health status|3|||
131424272|NCT00265317|473176353|FG003|Phase 2|Global deterioration of health status|0|||
131424273|NCT00265317|473176350|FG000|Phase 2|Adverse Event|0|||
131424274|NCT00265317|473176351|FG001|Phase 2|Adverse Event|0|||
131424275|NCT00265317|473176352|FG002|Phase 2|Adverse Event|7|||
131424276|NCT00265317|473176353|FG003|Phase 2|Adverse Event|5|||
131424277|NCT00265317|473176350|FG000|Phase 2|Death|0|||
131424278|NCT00265317|473176351|FG001|Phase 2|Death|0|||
131424279|NCT00265317|473176352|FG002|Phase 2|Death|12|||
131424280|NCT00265317|473176353|FG003|Phase 2|Death|15|||
131424281|NCT00265317|473176350|FG000|Phase 2|Protocol Violation|0|||
131424282|NCT00265317|473176351|FG001|Phase 2|Protocol Violation|0|||
131424283|NCT00265317|473176352|FG002|Phase 2|Protocol Violation|1|||
131424284|NCT00265317|473176353|FG003|Phase 2|Protocol Violation|4|||
131424285|NCT00265317|473176350|FG000|Phase 2|Lost to Follow-up|0|||
131424286|NCT00265317|473176351|FG001|Phase 2|Lost to Follow-up|0|||
131424287|NCT00265317|473176352|FG002|Phase 2|Lost to Follow-up|0|||
131424288|NCT00265317|473176353|FG003|Phase 2|Lost to Follow-up|1|||
131424289|NCT00265317|473176350|FG000|Phase 2|Withdrawal/other than adverse event|0|||
131424290|NCT00265317|473176351|FG001|Phase 2|Withdrawal/other than adverse event|0|||
131424291|NCT00265317|473176352|FG002|Phase 2|Withdrawal/other than adverse event|2|||
131424292|NCT00265317|473176353|FG003|Phase 2|Withdrawal/other than adverse event|1|||
131424293|NCT00265317|473176350|FG000|Phase 2|Study terminated by sponsor|0|||
131424294|NCT00265317|473176351|FG001|Phase 2|Study terminated by sponsor|0|||
131424295|NCT00265317|473176352|FG002|Phase 2|Study terminated by sponsor|1|||
131424296|NCT00265317|473176353|FG003|Phase 2|Study terminated by sponsor|0|||
131424297|NCT00265317|473176350|FG000|Phase 2|Other|0|||
131424298|NCT00265317|473176351|FG001|Phase 2|Other|0|||
131424299|NCT00265317|473176352|FG002|Phase 2|Other|1|||
131424300|NCT00265317|473176353|FG003|Phase 2|Other|1|||
131424301|NCT03826186|473176354|FG000|Overall Study|Protocol Violation|2|||
131424302|NCT03826186|473176355|FG001|Overall Study|Protocol Violation|0|||
131424303|NCT03826186|473176354|FG000|Overall Study|Withdrawal by Subject|1|||
131424304|NCT03826186|473176355|FG001|Overall Study|Withdrawal by Subject|0|||
131424305|NCT02510001|473176356|FG000|Overall Study|Early disease progression|0|||
131424306|NCT02510001|473176357|FG001|Overall Study|Early disease progression|0|||
131424307|NCT02510001|473176358|FG002|Overall Study|Early disease progression|0|||
131424308|NCT02510001|473176359|FG003|Overall Study|Early disease progression|1|||
131424309|NCT02510001|473176360|FG004|Overall Study|Early disease progression|1|||
131424310|NCT02510001|473176361|FG005|Overall Study|Early disease progression|1|||
131424311|NCT02510001|473176362|FG006|Overall Study|Early disease progression|0|||
131424312|NCT02510001|473176363|FG007|Overall Study|Early disease progression|0|||
131424313|NCT02510001|473176356|FG000|Overall Study|Adverse Event|0|||
131424314|NCT02510001|473176357|FG001|Overall Study|Adverse Event|0|||
131424315|NCT02510001|473176358|FG002|Overall Study|Adverse Event|0|||
131424316|NCT02510001|473176359|FG003|Overall Study|Adverse Event|1|||
131424317|NCT02510001|473176360|FG004|Overall Study|Adverse Event|2|||
131424318|NCT02510001|473176361|FG005|Overall Study|Adverse Event|1|||
131424319|NCT02510001|473176362|FG006|Overall Study|Adverse Event|2|||
131424320|NCT02510001|473176363|FG007|Overall Study|Adverse Event|5|||
131424321|NCT02510001|473176356|FG000|Overall Study|Physician Decision|0|||
131424322|NCT02510001|473176357|FG001|Overall Study|Physician Decision|0|||
131424323|NCT02510001|473176358|FG002|Overall Study|Physician Decision|0|||
131424324|NCT02510001|473176359|FG003|Overall Study|Physician Decision|0|||
131424325|NCT02510001|473176360|FG004|Overall Study|Physician Decision|1|||
131424326|NCT02510001|473176361|FG005|Overall Study|Physician Decision|0|||
131424327|NCT02510001|473176362|FG006|Overall Study|Physician Decision|0|||
131424328|NCT02510001|473176363|FG007|Overall Study|Physician Decision|0|||
131424329|NCT02510001|473176356|FG000|Overall Study|Withdrawal by Subject|0|||
131424330|NCT02510001|473176357|FG001|Overall Study|Withdrawal by Subject|0|||
131424331|NCT02510001|473176358|FG002|Overall Study|Withdrawal by Subject|0|||
131424332|NCT02510001|473176359|FG003|Overall Study|Withdrawal by Subject|0|||
131424333|NCT02510001|473176360|FG004|Overall Study|Withdrawal by Subject|0|||
131424334|NCT02510001|473176361|FG005|Overall Study|Withdrawal by Subject|0|||
131424335|NCT02510001|473176362|FG006|Overall Study|Withdrawal by Subject|0|||
131424336|NCT02510001|473176363|FG007|Overall Study|Withdrawal by Subject|2|||
131424337|NCT02950480|473176368|FG000|Overall Study|Withdrawal by Subject|1|||
131424338|NCT02950480|473176369|FG001|Overall Study|Withdrawal by Subject|0|||
131424339|NCT00082407|473176372|FG000|Overall Study|Adverse Event|20|||
131424340|NCT00082407|473176373|FG001|Overall Study|Adverse Event|0|||
131424341|NCT00082407|473176372|FG000|Overall Study|Protocol Violation|14|||
131424342|NCT00082407|473176373|FG001|Overall Study|Protocol Violation|12|||
131424343|NCT00082407|473176372|FG000|Overall Study|Patient Decision|13|||
131424344|NCT00082407|473176373|FG001|Overall Study|Patient Decision|6|||
131424345|NCT00082407|473176372|FG000|Overall Study|Physician Decision|5|||
131424346|NCT00082407|473176373|FG001|Overall Study|Physician Decision|3|||
131424347|NCT00082407|473176372|FG000|Overall Study|Loss of Glucose Control|2|||
131424348|NCT00082407|473176373|FG001|Overall Study|Loss of Glucose Control|2|||
131424349|NCT00082407|473176372|FG000|Overall Study|Death|2|||
131424350|NCT00082407|473176373|FG001|Overall Study|Death|1|||
131424351|NCT00082407|473176372|FG000|Overall Study|Lost to Follow-up|0|||
131424352|NCT00082407|473176373|FG001|Overall Study|Lost to Follow-up|3|||
131424353|NCT00891228|473176375|FG000|Overall Study|Adverse Event|0|||
131424354|NCT00891228|473176376|FG001|Overall Study|Adverse Event|2|||
131424355|NCT00891228|473176377|FG002|Overall Study|Adverse Event|3|||
131424356|NCT00891228|473176375|FG000|Overall Study|Withdrawal by Subject|2|||
131424357|NCT00891228|473176376|FG001|Overall Study|Withdrawal by Subject|4|||
131424358|NCT00891228|473176377|FG002|Overall Study|Withdrawal by Subject|5|||
131424359|NCT00891228|473176375|FG000|Overall Study|Protocol Violation|3|||
131424360|NCT00891228|473176376|FG001|Overall Study|Protocol Violation|1|||
131424361|NCT00891228|473176377|FG002|Overall Study|Protocol Violation|2|||
131424362|NCT00891228|473176375|FG000|Overall Study|Physician Decision|2|||
131424363|NCT00891228|473176376|FG001|Overall Study|Physician Decision|1|||
131424364|NCT00891228|473176377|FG002|Overall Study|Physician Decision|0|||
131424365|NCT00891228|473176375|FG000|Overall Study|Lost to Follow-up|4|||
131424366|NCT00891228|473176376|FG001|Overall Study|Lost to Follow-up|4|||
131424367|NCT00891228|473176377|FG002|Overall Study|Lost to Follow-up|5|||
131424368|NCT00891228|473176375|FG000|Overall Study|Pregnancy|0|||
131424369|NCT00891228|473176376|FG001|Overall Study|Pregnancy|1|||
131424370|NCT00891228|473176377|FG002|Overall Study|Pregnancy|0|||
131424371|NCT02688985|473176380|FG000|Overall Study|Adverse Event|1|||
131424372|NCT02688985|473176381|FG001|Overall Study|Adverse Event|2|||
131424373|NCT02688985|473176382|FG002|Overall Study|Adverse Event|2|||
131424374|NCT02688985|473176383|FG003|Overall Study|Adverse Event|0|||
131424375|NCT02688985|473176384|FG004|Overall Study|Adverse Event|0|||
131424376|NCT02688985|473176380|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
131424377|NCT02688985|473176381|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
131424378|NCT02688985|473176382|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
131424379|NCT02688985|473176383|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
131424380|NCT02688985|473176384|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
131424381|NCT02688985|473176380|FG000|Overall Study|Death|0|||
131424382|NCT02688985|473176381|FG001|Overall Study|Death|0|||
131424383|NCT02688985|473176382|FG002|Overall Study|Death|0|||
131424384|NCT02688985|473176383|FG003|Overall Study|Death|0|||
131424385|NCT02688985|473176384|FG004|Overall Study|Death|1|||
131424386|NCT02688985|473176380|FG000|Overall Study|Lack of Efficacy|0|||
131458035|NCT01395524|473308773|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
131424387|NCT02688985|473176381|FG001|Overall Study|Lack of Efficacy|0|||
131424388|NCT02688985|473176382|FG002|Overall Study|Lack of Efficacy|0|||
131424389|NCT02688985|473176383|FG003|Overall Study|Lack of Efficacy|0|||
131424390|NCT02688985|473176384|FG004|Overall Study|Lack of Efficacy|1|||
131424391|NCT02688985|473176380|FG000|Overall Study|Lost to Follow-up|2|||
131424392|NCT02688985|473176381|FG001|Overall Study|Lost to Follow-up|0|||
131424393|NCT02688985|473176382|FG002|Overall Study|Lost to Follow-up|1|||
131424394|NCT02688985|473176383|FG003|Overall Study|Lost to Follow-up|1|||
131424395|NCT02688985|473176384|FG004|Overall Study|Lost to Follow-up|1|||
131424396|NCT02688985|473176380|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131424397|NCT02688985|473176381|FG001|Overall Study|Non-Compliance With Study Drug|3|||
131424398|NCT02688985|473176382|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131424399|NCT02688985|473176383|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131424400|NCT02688985|473176384|FG004|Overall Study|Non-Compliance With Study Drug|1|||
131424401|NCT02688985|473176380|FG000|Overall Study|Other|3|||
131424402|NCT02688985|473176381|FG001|Overall Study|Other|4|||
131424403|NCT02688985|473176382|FG002|Overall Study|Other|1|||
131424404|NCT02688985|473176383|FG003|Overall Study|Other|0|||
131424405|NCT02688985|473176384|FG004|Overall Study|Other|0|||
131424406|NCT02688985|473176380|FG000|Overall Study|Physician Decision|2|||
131424407|NCT02688985|473176381|FG001|Overall Study|Physician Decision|2|||
131424408|NCT02688985|473176382|FG002|Overall Study|Physician Decision|0|||
131424409|NCT02688985|473176383|FG003|Overall Study|Physician Decision|0|||
131424410|NCT02688985|473176384|FG004|Overall Study|Physician Decision|1|||
131424411|NCT02688985|473176380|FG000|Overall Study|Pregnancy|0|||
131424412|NCT02688985|473176381|FG001|Overall Study|Pregnancy|0|||
131424413|NCT02688985|473176382|FG002|Overall Study|Pregnancy|2|||
131424414|NCT02688985|473176383|FG003|Overall Study|Pregnancy|1|||
131424415|NCT02688985|473176384|FG004|Overall Study|Pregnancy|0|||
131424416|NCT02688985|473176380|FG000|Overall Study|Study Terminated By Sponsor|0|||
131424417|NCT02688985|473176381|FG001|Overall Study|Study Terminated By Sponsor|0|||
131424418|NCT02688985|473176382|FG002|Overall Study|Study Terminated By Sponsor|0|||
131424419|NCT02688985|473176383|FG003|Overall Study|Study Terminated By Sponsor|1|||
131424420|NCT02688985|473176384|FG004|Overall Study|Study Terminated By Sponsor|0|||
131424421|NCT02688985|473176380|FG000|Overall Study|Withdrawal by Subject|2|||
131424422|NCT02688985|473176381|FG001|Overall Study|Withdrawal by Subject|8|||
131424423|NCT02688985|473176382|FG002|Overall Study|Withdrawal by Subject|7|||
131424424|NCT02688985|473176383|FG003|Overall Study|Withdrawal by Subject|1|||
131424425|NCT02688985|473176384|FG004|Overall Study|Withdrawal by Subject|4|||
131424426|NCT01964963|473176387|FG000|Overall Study|Case Report Forms Uncollected|888|||
131424427|NCT01964963|473176387|FG000|Overall Study|Protocol Deviation|50|||
131424428|NCT01964963|473176387|FG000|Overall Study|Data Reliability was not Assured|5|||
131424429|NCT00711971|473176390|FG000|Overall Study|Lost to Follow-up|3|||
131424430|NCT00711971|473176391|FG001|Overall Study|Lost to Follow-up|4|||
131424431|NCT00711971|473176392|FG002|Overall Study|Lost to Follow-up|1|||
131424432|NCT02644343|473176393|FG000|Overall Study|Withdrawal by Subject|1|||
131424433|NCT03437577|473176398|FG000|Pre-Randomization|Withdrawal by Subject|0|||
131424434|NCT03437577|473176399|FG001|Pre-Randomization|Withdrawal by Subject|0|||
131424435|NCT03437577|473176400|FG002|Pre-Randomization|Withdrawal by Subject|10|||
131424436|NCT03437577|473176398|FG000|Post-Randomization|Physician Decision|0|||
131424437|NCT03437577|473176399|FG001|Post-Randomization|Physician Decision|2|||
131424438|NCT03437577|473176400|FG002|Post-Randomization|Physician Decision|0|||
131424439|NCT03704688|473176405|FG000|Overall Study|Adverse Event|0|||
131424440|NCT03704688|473176406|FG001|Overall Study|Adverse Event|0|||
131424441|NCT03704688|473176407|FG002|Overall Study|Adverse Event|0|||
131424442|NCT03704688|473176408|FG003|Overall Study|Adverse Event|4|||
131424443|NCT03704688|473176409|FG004|Overall Study|Adverse Event|1|||
131424444|NCT03704688|473176410|FG005|Overall Study|Adverse Event|0|||
131424445|NCT03704688|473176405|FG000|Overall Study|Disease Progression|0|||
131424446|NCT03704688|473176406|FG001|Overall Study|Disease Progression|0|||
131424447|NCT03704688|473176407|FG002|Overall Study|Disease Progression|0|||
131424448|NCT03704688|473176408|FG003|Overall Study|Disease Progression|3|||
131424449|NCT03704688|473176409|FG004|Overall Study|Disease Progression|1|||
131424450|NCT03704688|473176410|FG005|Overall Study|Disease Progression|0|||
131424451|NCT03704688|473176405|FG000|Overall Study|Death|0|||
131424452|NCT03704688|473176406|FG001|Overall Study|Death|0|||
131424453|NCT03704688|473176407|FG002|Overall Study|Death|0|||
131424454|NCT03704688|473176408|FG003|Overall Study|Death|0|||
131424455|NCT03704688|473176409|FG004|Overall Study|Death|3|||
131424456|NCT03704688|473176410|FG005|Overall Study|Death|0|||
131424457|NCT00856544|473176422|FG000|Overall Study|Randomized but not treated|3|||
131424458|NCT00856544|473176423|FG001|Overall Study|Randomized but not treated|0|||
131424459|NCT00856544|473176424|FG002|Overall Study|Randomized but not treated|0|||
131424460|NCT00856544|473176425|FG003|Overall Study|Randomized but not treated|0|||
131424461|NCT00856544|473176422|FG000|Overall Study|Death|0|||
131424462|NCT00856544|473176423|FG001|Overall Study|Death|2|||
131424463|NCT00856544|473176424|FG002|Overall Study|Death|0|||
131424464|NCT00856544|473176425|FG003|Overall Study|Death|0|||
131424465|NCT00856544|473176422|FG000|Overall Study|Adverse Event|20|||
131424466|NCT00856544|473176423|FG001|Overall Study|Adverse Event|29|||
131424467|NCT00856544|473176424|FG002|Overall Study|Adverse Event|2|||
131424468|NCT00856544|473176425|FG003|Overall Study|Adverse Event|3|||
131424469|NCT00856544|473176422|FG000|Overall Study|Lack of Efficacy|16|||
131424470|NCT00856544|473176423|FG001|Overall Study|Lack of Efficacy|12|||
131424471|NCT00856544|473176424|FG002|Overall Study|Lack of Efficacy|3|||
131424472|NCT00856544|473176425|FG003|Overall Study|Lack of Efficacy|3|||
131424473|NCT00856544|473176422|FG000|Overall Study|Other|9|||
131424474|NCT00856544|473176423|FG001|Overall Study|Other|16|||
131424475|NCT00856544|473176424|FG002|Overall Study|Other|1|||
131424476|NCT00856544|473176425|FG003|Overall Study|Other|6|||
131424477|NCT00856544|473176422|FG000|Overall Study|Lost to Follow-up|1|||
131424478|NCT00856544|473176423|FG001|Overall Study|Lost to Follow-up|2|||
131424479|NCT00856544|473176424|FG002|Overall Study|Lost to Follow-up|2|||
131424480|NCT00856544|473176425|FG003|Overall Study|Lost to Follow-up|0|||
131424481|NCT00856544|473176422|FG000|Overall Study|Withdrawal by Subject|8|||
131424482|NCT00856544|473176423|FG001|Overall Study|Withdrawal by Subject|5|||
131424483|NCT00856544|473176424|FG002|Overall Study|Withdrawal by Subject|0|||
131424484|NCT00856544|473176425|FG003|Overall Study|Withdrawal by Subject|1|||
131424485|NCT00787189|473176426|FG000|Overall Study|Lost to Follow-up|2|||
131424486|NCT00787189|473176427|FG001|Overall Study|Lost to Follow-up|2|||
131424487|NCT01687101|473176428|FG000|Overall Study|Lost to Follow-up|7|||
131424488|NCT03920254|473176430|FG000|Overall Study|Adverse Event|1|||
131424489|NCT03920254|473176431|FG001|Overall Study|Adverse Event|0|||
131424490|NCT03920254|473176432|FG002|Overall Study|Adverse Event|0|||
131424491|NCT03920254|473176430|FG000|Overall Study|Physician Decision|0|||
131424492|NCT03920254|473176431|FG001|Overall Study|Physician Decision|1|||
131424493|NCT03920254|473176432|FG002|Overall Study|Physician Decision|2|||
131424494|NCT03920254|473176430|FG000|Overall Study|Study Terminated By Sponsor|12|||
131424495|NCT03920254|473176431|FG001|Overall Study|Study Terminated By Sponsor|17|||
131424496|NCT03920254|473176432|FG002|Overall Study|Study Terminated By Sponsor|12|||
131424497|NCT03920254|473176430|FG000|Overall Study|Withdrawal by Subject|0|||
131424498|NCT03920254|473176431|FG001|Overall Study|Withdrawal by Subject|0|||
131424499|NCT03920254|473176432|FG002|Overall Study|Withdrawal by Subject|1|||
131424500|NCT03250182|473176433|FG000|Overall Study|Withdrawal by Subject|1|||
131424501|NCT05274269|473176434|FG000|Overall Study|Adverse Event|0|||
131424502|NCT05274269|473176435|FG001|Overall Study|Adverse Event|3|||
131424503|NCT05274269|473176434|FG000|Overall Study|Death|0|||
131424504|NCT05274269|473176435|FG001|Overall Study|Death|1|||
131424505|NCT05274269|473176434|FG000|Overall Study|Other|0|||
131424506|NCT05274269|473176435|FG001|Overall Study|Other|2|||
131424507|NCT05274269|473176434|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131424508|NCT05274269|473176435|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
131424509|NCT01858740|473176439|FG000|Overall Study|Death|4|||
131424510|NCT01068769|473176440|FG000|Overall Study|Ineligible|1|||
131424511|NCT00894361|473176443|FG000|Overall Study|deaths and less than 2 years followup|24|||
131424512|NCT00894361|473176444|FG001|Overall Study|deaths and less than 2 years followup|64|||
131424513|NCT00988091|473176453|FG000|Double-blind Period|Withdrawal by Subject|15|||
131424514|NCT00988091|473176454|FG001|Double-blind Period|Withdrawal by Subject|13|||
131424515|NCT00988091|473176453|FG000|Double-blind Period|Lost to Follow-up|12|||
131424516|NCT00988091|473176454|FG001|Double-blind Period|Lost to Follow-up|14|||
131424517|NCT00988091|473176453|FG000|Double-blind Period|Other|8|||
131424518|NCT00988091|473176454|FG001|Double-blind Period|Other|8|||
131424519|NCT00988091|473176453|FG000|Double-blind Period|Adverse Event|6|||
131424520|NCT00988091|473176454|FG001|Double-blind Period|Adverse Event|9|||
131424521|NCT00988091|473176453|FG000|Double-blind Period|Use of exclusionary medication|2|||
131424522|NCT00988091|473176454|FG001|Double-blind Period|Use of exclusionary medication|3|||
131424523|NCT00988091|473176453|FG000|Open-label Period|Adverse Event|4|||
131424524|NCT00988091|473176454|FG001|Open-label Period|Adverse Event|7|||
131424525|NCT00988091|473176453|FG000|Open-label Period|Use of exclusionary medication|1|||
131424526|NCT00988091|473176454|FG001|Open-label Period|Use of exclusionary medication|1|||
131424527|NCT00988091|473176453|FG000|Open-label Period|Protocol Violation|1|||
131424528|NCT00988091|473176454|FG001|Open-label Period|Protocol Violation|1|||
131424529|NCT00988091|473176453|FG000|Open-label Period|Withdrawal by Subject|10|||
131424530|NCT00988091|473176454|FG001|Open-label Period|Withdrawal by Subject|16|||
131424531|NCT00988091|473176453|FG000|Open-label Period|Lost to Follow-up|3|||
131424532|NCT00988091|473176454|FG001|Open-label Period|Lost to Follow-up|5|||
131424533|NCT00988091|473176453|FG000|Open-label Period|Other|2|||
131424534|NCT00988091|473176454|FG001|Open-label Period|Other|3|||
131424535|NCT03549104|473176455|FG000|Overall Study|Withdrawal by Subject|5|||
131424536|NCT03549104|473176456|FG001|Overall Study|Withdrawal by Subject|2|||
131424537|NCT03549104|473176455|FG000|Overall Study|Covid shelter in place|1|||
131424538|NCT03549104|473176456|FG001|Overall Study|Covid shelter in place|2|||
131424539|NCT04124705|473176460|FG000|Titration Period|Adverse Event|9|||
131424540|NCT04124705|473176461|FG001|Titration Period|Adverse Event|5|||
131424541|NCT04124705|473176460|FG000|Titration Period|Withdrawal by Subject|6|||
131424542|NCT04124705|473176461|FG001|Titration Period|Withdrawal by Subject|3|||
131424543|NCT04124705|473176460|FG000|Titration Period|Lost to Follow-up|0|||
131424544|NCT04124705|473176461|FG001|Titration Period|Lost to Follow-up|1|||
131424545|NCT04124705|473176460|FG000|Titration Period|Death|1|||
131424546|NCT04124705|473176461|FG001|Titration Period|Death|1|||
131424547|NCT04124705|473176460|FG000|Titration Period|Lack of Efficacy|2|||
131424548|NCT04124705|473176461|FG001|Titration Period|Lack of Efficacy|0|||
131424549|NCT04124705|473176460|FG000|Titration Period|Physician Decision|2|||
131424550|NCT04124705|473176461|FG001|Titration Period|Physician Decision|0|||
131424551|NCT04124705|473176460|FG000|Titration Period|Non-compliance with Study Drug|2|||
131424552|NCT04124705|473176461|FG001|Titration Period|Non-compliance with Study Drug|0|||
131424553|NCT04124705|473176460|FG000|Titration Period|Other|4|||
131424554|NCT04124705|473176461|FG001|Titration Period|Other|9|||
131424555|NCT04124705|473176460|FG000|Stabilization Period|Adverse Event|4|||
131424556|NCT04124705|473176461|FG001|Stabilization Period|Adverse Event|2|||
131424557|NCT04124705|473176460|FG000|Stabilization Period|Withdrawal by Subject|1|||
131424558|NCT04124705|473176461|FG001|Stabilization Period|Withdrawal by Subject|1|||
131424559|NCT04124705|473176460|FG000|Stabilization Period|Lost to Follow-up|0|||
131424560|NCT04124705|473176461|FG001|Stabilization Period|Lost to Follow-up|1|||
131424561|NCT04124705|473176460|FG000|Stabilization Period|Lack of Efficacy|4|||
131424562|NCT04124705|473176461|FG001|Stabilization Period|Lack of Efficacy|2|||
131424563|NCT04124705|473176460|FG000|Stabilization Period|Protocol Deviation|0|||
131424564|NCT04124705|473176461|FG001|Stabilization Period|Protocol Deviation|2|||
131424565|NCT04124705|473176460|FG000|Stabilization Period|Other|2|||
131424566|NCT04124705|473176461|FG001|Stabilization Period|Other|2|||
131424567|NCT01973998|473176462|FG000|Overall Study|Death|2|||
131424568|NCT01973998|473176463|FG001|Overall Study|Death|2|||
131424569|NCT01846741|473176469|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
131424570|NCT01628965|473176470|FG000|Overall Study|Adverse Event|30|||
131424571|NCT01628965|473176470|FG000|Overall Study|Lack of Efficacy|7|||
131424572|NCT01628965|473176470|FG000|Overall Study|Withdrawal by Subject|3|||
131424573|NCT01628965|473176470|FG000|Overall Study|Lost to Follow-up|1|||
131424574|NCT01628965|473176470|FG000|Overall Study|Discontinuation criteria|8|||
131424575|NCT04006392|473176471|FG000|Overall Study|Lost to Follow-up|0|||
131424576|NCT04006392|473176472|FG001|Overall Study|Lost to Follow-up|1|||
131424577|NCT03755661|473176473|FG000|Overall Study|Lost to Follow-up|1|||
131424578|NCT03755661|473176474|FG001|Overall Study|Lost to Follow-up|0|||
131424579|NCT04412707|473176477|FG000|Cycle 1|Death|0|||
131424580|NCT04412707|473176478|FG001|Cycle 1|Death|3|||
131424581|NCT04412707|473176477|FG000|Cycle 1|Disease progression|1|||
131424582|NCT04412707|473176478|FG001|Cycle 1|Disease progression|2|||
131424583|NCT04412707|473176477|FG000|Cycle 2|Death|0|||
131424584|NCT04412707|473176478|FG001|Cycle 2|Death|1|||
131424585|NCT04412707|473176477|FG000|Cycle 2|Disease progression|3|||
131424586|NCT04412707|473176478|FG001|Cycle 2|Disease progression|0|||
131424587|NCT04412707|473176477|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
131424588|NCT04412707|473176478|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
131424589|NCT04412707|473176477|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
131424590|NCT04412707|473176478|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
131424591|NCT04412707|473176477|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
131424592|NCT04412707|473176478|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
131424593|NCT04412707|473176477|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
131424594|NCT04412707|473176478|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
131424595|NCT01726582|473178593|FG000|Overall Study|Physician Decision|99|||
131424596|NCT01726582|473178593|FG000|Overall Study|Death|85|||
131424597|NCT00536471|473178594|FG000|Overall Study|Lost to Follow-up|48|||
131424598|NCT00536471|473178595|FG001|Overall Study|Lost to Follow-up|23|||
131424599|NCT00536471|473178596|FG002|Overall Study|Lost to Follow-up|48|||
131424600|NCT00536471|473178597|FG003|Overall Study|Lost to Follow-up|22|||
131424601|NCT00536471|473178594|FG000|Overall Study|Adverse Event|32|||
131424602|NCT00536471|473178595|FG001|Overall Study|Adverse Event|16|||
131424603|NCT00536471|473178596|FG002|Overall Study|Adverse Event|28|||
131424604|NCT00536471|473178597|FG003|Overall Study|Adverse Event|13|||
131424605|NCT00536471|473178594|FG000|Overall Study|Withdrawal by Subject|40|||
131424606|NCT00536471|473178595|FG001|Overall Study|Withdrawal by Subject|24|||
131424607|NCT00536471|473178596|FG002|Overall Study|Withdrawal by Subject|43|||
131424608|NCT00536471|473178597|FG003|Overall Study|Withdrawal by Subject|21|||
131424609|NCT00536471|473178594|FG000|Overall Study|Lack of Efficacy|17|||
131424610|NCT00536471|473178595|FG001|Overall Study|Lack of Efficacy|18|||
131424611|NCT00536471|473178596|FG002|Overall Study|Lack of Efficacy|11|||
131424612|NCT00536471|473178597|FG003|Overall Study|Lack of Efficacy|9|||
131424613|NCT00536471|473178594|FG000|Overall Study|Protocol Violation|8|||
131424614|NCT00536471|473178595|FG001|Overall Study|Protocol Violation|1|||
131424615|NCT00536471|473178596|FG002|Overall Study|Protocol Violation|2|||
131424616|NCT00536471|473178597|FG003|Overall Study|Protocol Violation|3|||
131424617|NCT00536471|473178594|FG000|Overall Study|Physician Decision|11|||
131424618|NCT00536471|473178595|FG001|Overall Study|Physician Decision|1|||
131424619|NCT00536471|473178596|FG002|Overall Study|Physician Decision|3|||
131424620|NCT00536471|473178597|FG003|Overall Study|Physician Decision|2|||
131424621|NCT00536471|473178594|FG000|Overall Study|Death|0|||
131424622|NCT00536471|473178595|FG001|Overall Study|Death|0|||
131424623|NCT00536471|473178596|FG002|Overall Study|Death|1|||
131424624|NCT00536471|473178597|FG003|Overall Study|Death|2|||
131424625|NCT00536471|473178594|FG000|Overall Study|Sponsor Decision|0|||
131424626|NCT00536471|473178595|FG001|Overall Study|Sponsor Decision|1|||
131424627|NCT00536471|473178596|FG002|Overall Study|Sponsor Decision|3|||
131424628|NCT00536471|473178597|FG003|Overall Study|Sponsor Decision|2|||
131424629|NCT00994422|473178601|FG000|Overall Study|Lost to Follow-up|7|||
131424630|NCT00994422|473178602|FG001|Overall Study|Lost to Follow-up|1|||
131424631|NCT00836186|473178604|FG000|Overall Study|Blood could not be drawn|1|||
131424632|NCT00532298|473178605|FG000|Overall Study|Adverse Event|1|||
131424633|NCT00532298|473178606|FG001|Overall Study|Adverse Event|0|||
131424634|NCT00532298|473178607|FG002|Overall Study|Adverse Event|0|||
131424635|NCT00532298|473178608|FG003|Overall Study|Adverse Event|0|||
131424636|NCT00532298|473178609|FG004|Overall Study|Adverse Event|1|||
131424637|NCT00532298|473178610|FG005|Overall Study|Adverse Event|1|||
131424638|NCT00532298|473178605|FG000|Overall Study|Lost to Follow-up|1|||
131424639|NCT00532298|473178606|FG001|Overall Study|Lost to Follow-up|1|||
131424640|NCT00532298|473178607|FG002|Overall Study|Lost to Follow-up|1|||
131424641|NCT00532298|473178608|FG003|Overall Study|Lost to Follow-up|0|||
131424642|NCT00532298|473178609|FG004|Overall Study|Lost to Follow-up|0|||
131424643|NCT00532298|473178610|FG005|Overall Study|Lost to Follow-up|1|||
131424644|NCT01636986|473178613|FG000|Overall Study|Withdrawal by Subject|0|||
131424645|NCT01636986|473178614|FG001|Overall Study|Withdrawal by Subject|1|||
131424646|NCT01636986|473178613|FG000|Overall Study|Corneal Staining|0|||
131424647|NCT01636986|473178614|FG001|Overall Study|Corneal Staining|1|||
131424648|NCT01844778|473178621|FG000|Overall Study|Protocol deviation|0|||
131424649|NCT01844778|473178622|FG001|Overall Study|Protocol deviation|1|||
131424650|NCT01844778|473178623|FG002|Overall Study|Protocol deviation|2|||
131424651|NCT01844778|473178621|FG000|Overall Study|Withdrawal by Subject|2|||
131424652|NCT01844778|473178622|FG001|Overall Study|Withdrawal by Subject|0|||
131424653|NCT01844778|473178623|FG002|Overall Study|Withdrawal by Subject|0|||
131424654|NCT01844778|473178621|FG000|Overall Study|Adverse Event|0|||
131424655|NCT01844778|473178622|FG001|Overall Study|Adverse Event|2|||
131424656|NCT01844778|473178623|FG002|Overall Study|Adverse Event|2|||
131424657|NCT02951429|473178625|FG000|Overall Study|Adverse Event|3|||
131424658|NCT02951429|473178626|FG001|Overall Study|Adverse Event|7|||
131424659|NCT02951429|473178625|FG000|Overall Study|Death|28|||
131424660|NCT02951429|473178626|FG001|Overall Study|Death|36|||
131424661|NCT02951429|473178625|FG000|Overall Study|Lack of Efficacy|0|||
131424662|NCT02951429|473178626|FG001|Overall Study|Lack of Efficacy|1|||
131424663|NCT02951429|473178625|FG000|Overall Study|Lost to Follow-up|0|||
131424664|NCT02951429|473178626|FG001|Overall Study|Lost to Follow-up|1|||
131424665|NCT02951429|473178625|FG000|Overall Study|Lung Transplantation|9|||
131424666|NCT02951429|473178626|FG001|Overall Study|Lung Transplantation|6|||
131424667|NCT02951429|473178625|FG000|Overall Study|Other|1|||
131424668|NCT02951429|473178626|FG001|Overall Study|Other|3|||
131424669|NCT02951429|473178625|FG000|Overall Study|Progressive Disease|1|||
131424670|NCT02951429|473178626|FG001|Overall Study|Progressive Disease|1|||
131424671|NCT02951429|473178625|FG000|Overall Study|Withdrawal by Subject|7|||
131424672|NCT02951429|473178626|FG001|Overall Study|Withdrawal by Subject|11|||
131424673|NCT02951429|473178625|FG000|Overall Study|Participant ongoing in the study|23|||
131424674|NCT02951429|473178626|FG001|Overall Study|Participant ongoing in the study|17|||
131424675|NCT01620528|473178627|FG000|Treatment Period|Did Not Receive Study Drug|0|||
131424676|NCT01620528|473178628|FG001|Treatment Period|Did Not Receive Study Drug|0|||
131424677|NCT01620528|473178629|FG002|Treatment Period|Did Not Receive Study Drug|1|||
131424678|NCT01620528|473178627|FG000|Treatment Period|Withdrawal by Subject|35|||
131424679|NCT01620528|473178628|FG001|Treatment Period|Withdrawal by Subject|21|||
131424680|NCT01620528|473178629|FG002|Treatment Period|Withdrawal by Subject|16|||
131424681|NCT01620528|473178627|FG000|Treatment Period|Adverse Event|17|||
131424682|NCT01620528|473178628|FG001|Treatment Period|Adverse Event|13|||
131424683|NCT01620528|473178629|FG002|Treatment Period|Adverse Event|21|||
131424684|NCT01620528|473178627|FG000|Treatment Period|Lost to Follow-up|16|||
131424685|NCT01620528|473178628|FG001|Treatment Period|Lost to Follow-up|8|||
131424686|NCT01620528|473178629|FG002|Treatment Period|Lost to Follow-up|14|||
131424687|NCT01620528|473178627|FG000|Treatment Period|Other|9|||
131424688|NCT01620528|473178628|FG001|Treatment Period|Other|5|||
131424689|NCT01620528|473178629|FG002|Treatment Period|Other|7|||
131424690|NCT01620528|473178627|FG000|Treatment Period|Subject Noncompliant|11|||
131424691|NCT01620528|473178628|FG001|Treatment Period|Subject Noncompliant|2|||
131424692|NCT01620528|473178629|FG002|Treatment Period|Subject Noncompliant|2|||
131424693|NCT01620528|473178627|FG000|Treatment Period|Pregnancy|7|||
131424694|NCT01620528|473178628|FG001|Treatment Period|Pregnancy|2|||
131424695|NCT01620528|473178629|FG002|Treatment Period|Pregnancy|2|||
131424696|NCT01620528|473178627|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
131424697|NCT01620528|473178628|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
131424698|NCT01620528|473178629|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
131424699|NCT01620528|473178627|FG000|Treatment Period|Exclusionary Medication Received|0|||
131424700|NCT01620528|473178628|FG001|Treatment Period|Exclusionary Medication Received|1|||
131424701|NCT01620528|473178629|FG002|Treatment Period|Exclusionary Medication Received|0|||
131424702|NCT01620528|473178627|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
131424703|NCT01620528|473178628|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
131424704|NCT01620528|473178629|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
131424705|NCT01620528|473178627|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
131424706|NCT01620528|473178628|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
131424707|NCT01620528|473178629|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
131424708|NCT01620528|473178627|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
131424709|NCT01620528|473178628|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
131424710|NCT01620528|473178629|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
131424711|NCT01620528|473178627|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
131424712|NCT01620528|473178628|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
131424713|NCT01620528|473178629|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
131424714|NCT01620528|473178627|FG000|Post-Treatment Follow-Up Period|Other|6|||
131424715|NCT01620528|473178628|FG001|Post-Treatment Follow-Up Period|Other|4|||
131424716|NCT01620528|473178629|FG002|Post-Treatment Follow-Up Period|Other|2|||
131424717|NCT03664765|473178630|FG000|Overall Study|Withdrawal by Subject|4|||
131424718|NCT03664765|473178631|FG001|Overall Study|Withdrawal by Subject|1|||
131424719|NCT03664765|473178630|FG000|Overall Study|Lost to Follow-up|0|||
131424720|NCT03664765|473178631|FG001|Overall Study|Lost to Follow-up|1|||
131424721|NCT01153698|473178632|FG000|Overall Study|Adverse Event|12|||
131424722|NCT01153698|473178632|FG000|Overall Study|Lost to Follow-up|4|||
131424723|NCT01153698|473178632|FG000|Overall Study|Withdrawal by Subject|2|||
131424724|NCT01153698|473178632|FG000|Overall Study|Switch to other anticoagulants|4|||
131424725|NCT01153698|473178632|FG000|Overall Study|Other|2|||
131424726|NCT01153698|473178632|FG000|Overall Study|Not treated with Pradaxa|5|||
131424727|NCT02106403|473178635|FG000|Follow-Up Visit 3|Other Reason|0|||
131424728|NCT02106403|473178636|FG001|Follow-Up Visit 3|Other Reason|0|||
131424729|NCT02106403|473178637|FG002|Follow-Up Visit 3|Other Reason|0|||
131424730|NCT02106403|473178638|FG003|Follow-Up Visit 3|Other Reason|0|||
131424731|NCT02106403|473178639|FG004|Follow-Up Visit 3|Other Reason|0|||
131424732|NCT02106403|473178640|FG005|Follow-Up Visit 3|Other Reason|1|||
131424733|NCT04038567|473178641|FG000|Overall Study|Lost to Follow-up|6|||
131424734|NCT04038567|473178642|FG001|Overall Study|Lost to Follow-up|4|||
131424735|NCT04038567|473178643|FG002|Overall Study|Lost to Follow-up|5|||
131424736|NCT04038567|473178644|FG003|Overall Study|Lost to Follow-up|4|||
131424737|NCT04038567|473178645|FG004|Overall Study|Lost to Follow-up|6|||
131424738|NCT04038567|473178646|FG005|Overall Study|Lost to Follow-up|4|||
131424739|NCT04038567|473178647|FG006|Overall Study|Lost to Follow-up|4|||
131424740|NCT04038567|473178648|FG007|Overall Study|Lost to Follow-up|1|||
131424741|NCT04038567|473178641|FG000|Overall Study|Withdrawal by Subject|2|||
131424742|NCT04038567|473178642|FG001|Overall Study|Withdrawal by Subject|1|||
131424743|NCT04038567|473178643|FG002|Overall Study|Withdrawal by Subject|1|||
131424744|NCT04038567|473178644|FG003|Overall Study|Withdrawal by Subject|1|||
131424745|NCT04038567|473178645|FG004|Overall Study|Withdrawal by Subject|4|||
131424746|NCT04038567|473178646|FG005|Overall Study|Withdrawal by Subject|1|||
131424747|NCT04038567|473178647|FG006|Overall Study|Withdrawal by Subject|1|||
131424748|NCT04038567|473178648|FG007|Overall Study|Withdrawal by Subject|1|||
131424749|NCT04038567|473178641|FG000|Overall Study|missed survey window|1|||
131424750|NCT04038567|473178642|FG001|Overall Study|missed survey window|2|||
131424751|NCT04038567|473178643|FG002|Overall Study|missed survey window|0|||
131424752|NCT04038567|473178644|FG003|Overall Study|missed survey window|0|||
131424753|NCT04038567|473178645|FG004|Overall Study|missed survey window|1|||
131424754|NCT04038567|473178646|FG005|Overall Study|missed survey window|1|||
131424755|NCT04038567|473178647|FG006|Overall Study|missed survey window|2|||
131424756|NCT04038567|473178648|FG007|Overall Study|missed survey window|2|||
131424757|NCT04038567|473178641|FG000|Overall Study|technical issues|0|||
131424758|NCT04038567|473178642|FG001|Overall Study|technical issues|0|||
131424759|NCT04038567|473178643|FG002|Overall Study|technical issues|0|||
131424760|NCT04038567|473178644|FG003|Overall Study|technical issues|0|||
131424761|NCT04038567|473178645|FG004|Overall Study|technical issues|0|||
131424762|NCT04038567|473178646|FG005|Overall Study|technical issues|0|||
131424763|NCT04038567|473178647|FG006|Overall Study|technical issues|1|||
131424764|NCT04038567|473178648|FG007|Overall Study|technical issues|0|||
131424765|NCT04038567|473178641|FG000|Overall Study|Medical issues (i.e., illness)|0|||
131424766|NCT04038567|473178642|FG001|Overall Study|Medical issues (i.e., illness)|1|||
131424767|NCT04038567|473178643|FG002|Overall Study|Medical issues (i.e., illness)|2|||
131424768|NCT04038567|473178644|FG003|Overall Study|Medical issues (i.e., illness)|1|||
131424769|NCT04038567|473178645|FG004|Overall Study|Medical issues (i.e., illness)|1|||
131424770|NCT04038567|473178646|FG005|Overall Study|Medical issues (i.e., illness)|1|||
131424771|NCT04038567|473178647|FG006|Overall Study|Medical issues (i.e., illness)|0|||
131424772|NCT04038567|473178648|FG007|Overall Study|Medical issues (i.e., illness)|0|||
131424773|NCT04038567|473178641|FG000|Overall Study|Death|0|||
131424774|NCT04038567|473178642|FG001|Overall Study|Death|0|||
131424775|NCT04038567|473178643|FG002|Overall Study|Death|0|||
131424776|NCT04038567|473178644|FG003|Overall Study|Death|1|||
131424777|NCT04038567|473178645|FG004|Overall Study|Death|1|||
131424778|NCT04038567|473178646|FG005|Overall Study|Death|0|||
131424779|NCT04038567|473178647|FG006|Overall Study|Death|0|||
131424780|NCT04038567|473178648|FG007|Overall Study|Death|1|||
131424781|NCT01496846|473178652|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
131424782|NCT01496846|473178653|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
131424783|NCT01496846|473178654|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
131424784|NCT01496846|473178655|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
131424785|NCT01496846|473178656|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
131424786|NCT01496846|473178657|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
131424787|NCT01817959|473178658|FG000|Overall Study|Graft loss|1|||
131424788|NCT01817959|473178659|FG001|Overall Study|Graft loss|1|||
131424789|NCT01817959|473178658|FG000|Overall Study|forbidden medication|1|||
131424790|NCT01817959|473178659|FG001|Overall Study|forbidden medication|1|||
131424791|NCT01817959|473178658|FG000|Overall Study|Adverse Event|1|||
131424792|NCT01817959|473178659|FG001|Overall Study|Adverse Event|0|||
131424793|NCT01817959|473178658|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
131458036|NCT01395524|473308774|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131424794|NCT01817959|473178659|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
131424795|NCT01772576|473178662|FG000|Overall Study|Death|15|||
131424796|NCT01772576|473178662|FG000|Overall Study|Protocol Violation|1|||
131424797|NCT01772576|473178662|FG000|Overall Study|Lost to Follow-up|3|||
131424798|NCT01772576|473178662|FG000|Overall Study|Study device not used|3|||
131424799|NCT01772576|473178662|FG000|Overall Study|Adverse Event|6|||
131424800|NCT01772576|473178662|FG000|Overall Study|Withdrawal by Subject|6|||
131424801|NCT04356352|473178670|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
131424802|NCT04356352|473178671|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
131424803|NCT04356352|473178672|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
131424804|NCT04356352|473178670|FG000|Overall Study|Protocol Violation|0|||
131424805|NCT04356352|473178671|FG001|Overall Study|Protocol Violation|3|||
131424806|NCT04356352|473178672|FG002|Overall Study|Protocol Violation|1|||
131424807|NCT00330681|473178675|FG000|Overall Study|Adverse Event|3|||
131424808|NCT00330681|473178676|FG001|Overall Study|Adverse Event|6|||
131424809|NCT00330681|473178675|FG000|Overall Study|Protocol Violation|0|||
131424810|NCT00330681|473178676|FG001|Overall Study|Protocol Violation|1|||
131424811|NCT00330681|473178675|FG000|Overall Study|Withdrawal by Subject|5|||
131424812|NCT00330681|473178676|FG001|Overall Study|Withdrawal by Subject|5|||
131424813|NCT00330681|473178675|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
131424814|NCT00330681|473178676|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
131424815|NCT00379912|473178679|FG000|Overall Study|Lack of Efficacy|1|||
131424816|NCT00379912|473178680|FG001|Overall Study|Lack of Efficacy|0|||
131424817|NCT01128946|473178681|FG000|Period I|Protocol Violation|0|||
131424818|NCT01128946|473178682|FG001|Period I|Protocol Violation|1|||
131424819|NCT01128946|473178683|FG002|Period I|Protocol Violation|0|||
131424820|NCT01128946|473178684|FG003|Period I|Protocol Violation|0|||
131424821|NCT01128946|473178681|FG000|Period I|Withdrawal by Subject|0|||
131424822|NCT01128946|473178682|FG001|Period I|Withdrawal by Subject|0|||
131424823|NCT01128946|473178683|FG002|Period I|Withdrawal by Subject|1|||
131424824|NCT01128946|473178684|FG003|Period I|Withdrawal by Subject|1|||
131424825|NCT01128946|473178681|FG000|Period II|Protocol Violation|0|||
131424826|NCT01128946|473178682|FG001|Period II|Protocol Violation|1|||
131424827|NCT01128946|473178683|FG002|Period II|Protocol Violation|0|||
131424828|NCT01128946|473178684|FG003|Period II|Protocol Violation|0|||
131424829|NCT01128946|473178681|FG000|Period II|Withdrawal by Subject|0|||
131424830|NCT01128946|473178682|FG001|Period II|Withdrawal by Subject|0|||
131424831|NCT01128946|473178683|FG002|Period II|Withdrawal by Subject|0|||
131424832|NCT01128946|473178684|FG003|Period II|Withdrawal by Subject|1|||
131424833|NCT01128946|473178681|FG000|Period III|Protocol Violation|1|||
131424834|NCT01128946|473178682|FG001|Period III|Protocol Violation|0|||
131424835|NCT01128946|473178683|FG002|Period III|Protocol Violation|0|||
131424836|NCT01128946|473178684|FG003|Period III|Protocol Violation|0|||
131424837|NCT00621140|473178685|FG000|Overall Study|Adverse Event|4|||
131424838|NCT00621140|473178686|FG001|Overall Study|Adverse Event|5|||
131424839|NCT00621140|473178685|FG000|Overall Study|Lost to Follow-up|1|||
131424840|NCT00621140|473178686|FG001|Overall Study|Lost to Follow-up|2|||
131424841|NCT00621140|473178685|FG000|Overall Study|Withdrawal by Subject|4|||
131424842|NCT00621140|473178686|FG001|Overall Study|Withdrawal by Subject|6|||
131424843|NCT00621140|473178685|FG000|Overall Study|Other incl. lack of efficacy|6|||
131424844|NCT00621140|473178686|FG001|Overall Study|Other incl. lack of efficacy|5|||
131424845|NCT01371734|473178687|FG000|Overall Study|Other|2|||
131424846|NCT01371734|473178688|FG001|Overall Study|Other|1|||
131424847|NCT01371734|473178689|FG002|Overall Study|Other|2|||
131424848|NCT01371734|473178687|FG000|Overall Study|Withdrawal by Subject|3|||
131424849|NCT01371734|473178688|FG001|Overall Study|Withdrawal by Subject|4|||
131424850|NCT01371734|473178689|FG002|Overall Study|Withdrawal by Subject|9|||
131424851|NCT01371734|473178687|FG000|Overall Study|Lost to Follow-up|5|||
131424852|NCT01371734|473178688|FG001|Overall Study|Lost to Follow-up|3|||
131424853|NCT01371734|473178689|FG002|Overall Study|Lost to Follow-up|1|||
131424854|NCT01371734|473178687|FG000|Overall Study|Protocol Violation|3|||
131424855|NCT01371734|473178688|FG001|Overall Study|Protocol Violation|1|||
131424856|NCT01371734|473178689|FG002|Overall Study|Protocol Violation|2|||
131424857|NCT01371734|473178687|FG000|Overall Study|Adverse Event|8|||
131424858|NCT01371734|473178688|FG001|Overall Study|Adverse Event|8|||
131424859|NCT01371734|473178689|FG002|Overall Study|Adverse Event|3|||
131424860|NCT01371734|473178687|FG000|Overall Study|Lack of Efficacy|2|||
131424861|NCT01371734|473178688|FG001|Overall Study|Lack of Efficacy|2|||
131424862|NCT01371734|473178689|FG002|Overall Study|Lack of Efficacy|0|||
131424863|NCT03565237|473178693|FG000|Overall Study|Non-compliance of Investigational Product|1|||
131424864|NCT03565237|473178693|FG000|Overall Study|Physician Decision|1|||
131424865|NCT02873338|473178694|FG000|Overall Study|Adverse Event|0|||
131424866|NCT02873338|473178695|FG001|Overall Study|Adverse Event|2|||
131424867|NCT02873338|473178696|FG002|Overall Study|Adverse Event|1|||
131424868|NCT02873338|473178694|FG000|Overall Study|Death|2|||
131424869|NCT02873338|473178695|FG001|Overall Study|Death|1|||
131424870|NCT02873338|473178696|FG002|Overall Study|Death|1|||
131424871|NCT02873338|473178694|FG000|Overall Study|Withdrawal by Subject|2|||
131424872|NCT02873338|473178695|FG001|Overall Study|Withdrawal by Subject|1|||
131424873|NCT02873338|473178696|FG002|Overall Study|Withdrawal by Subject|3|||
131424874|NCT02873338|473178694|FG000|Overall Study|Lack of Efficacy|0|||
131424875|NCT02873338|473178695|FG001|Overall Study|Lack of Efficacy|2|||
131424876|NCT02873338|473178696|FG002|Overall Study|Lack of Efficacy|0|||
131424877|NCT02873338|473178694|FG000|Overall Study|Other or Missing|14|||
131424878|NCT02873338|473178695|FG001|Overall Study|Other or Missing|15|||
131424879|NCT02873338|473178696|FG002|Overall Study|Other or Missing|13|||
131424880|NCT03657095|473178697|FG000|Overall Study|Withdrawal by Subject|1|||
131424881|NCT03657095|473178698|FG001|Overall Study|Withdrawal by Subject|1|||
131458037|NCT01395524|473308775|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131458038|NCT01395524|473308773|FG000|Overall Study|Withdrawal by Subject|4|||
131458039|NCT01395524|473308774|FG001|Overall Study|Withdrawal by Subject|8|||
131458040|NCT01395524|473308775|FG002|Overall Study|Withdrawal by Subject|8|||
131458041|NCT01395524|473308773|FG000|Overall Study|Did not receive treatment|1|||
131424882|NCT03657095|473178697|FG000|Overall Study|Adverse Event|0|||
131424883|NCT03657095|473178698|FG001|Overall Study|Adverse Event|3|||
131424884|NCT03657095|473178697|FG000|Overall Study|Study Terminated by Sponsor|58|||
131424885|NCT03657095|473178698|FG001|Overall Study|Study Terminated by Sponsor|49|||
131424886|NCT01140061|473178699|FG000|Part I|Adverse Event|1|||
131424887|NCT01140061|473178700|FG001|Part I|Adverse Event|0|||
131424888|NCT01140061|473178701|FG002|Part I|Adverse Event|0|||
131424889|NCT01140061|473178702|FG003|Part I|Adverse Event|0|||
131424890|NCT01140061|473178703|FG004|Part I|Adverse Event|0|||
131424891|NCT01140061|473178704|FG005|Part I|Adverse Event|0|||
131424892|NCT01140061|473178705|FG006|Part I|Adverse Event|0|||
131424893|NCT01140061|473178706|FG007|Part I|Adverse Event|0|||
131424894|NCT01140061|473178707|FG008|Part I|Adverse Event|0|||
131424895|NCT01140061|473178708|FG009|Part I|Adverse Event|0|||
131424896|NCT01140061|473178699|FG000|Extension|Laboratory Adverse Event|0|||
131424897|NCT01140061|473178700|FG001|Extension|Laboratory Adverse Event|0|||
131424898|NCT01140061|473178701|FG002|Extension|Laboratory Adverse Event|0|||
131424899|NCT01140061|473178702|FG003|Extension|Laboratory Adverse Event|0|||
131424900|NCT01140061|473178703|FG004|Extension|Laboratory Adverse Event|0|||
131424901|NCT01140061|473178704|FG005|Extension|Laboratory Adverse Event|0|||
131424902|NCT01140061|473178705|FG006|Extension|Laboratory Adverse Event|0|||
131424903|NCT01140061|473178706|FG007|Extension|Laboratory Adverse Event|0|||
131424904|NCT01140061|473178707|FG008|Extension|Laboratory Adverse Event|0|||
131424905|NCT01140061|473178708|FG009|Extension|Laboratory Adverse Event|1|||
131458042|NCT01395524|473308774|FG001|Overall Study|Did not receive treatment|1|||
131458043|NCT01395524|473308775|FG002|Overall Study|Did not receive treatment|3|||
131424906|NCT00428389|473178709|FG000|Core Phase|Adverse Event|6|||
131424907|NCT00428389|473178710|FG001|Core Phase|Adverse Event|4|||
131424908|NCT00428389|473178709|FG000|Core Phase|Lack of Efficacy|2|||
131424909|NCT00428389|473178710|FG001|Core Phase|Lack of Efficacy|0|||
131424910|NCT00428389|473178709|FG000|Core Phase|Abnormal test procedure result(s)|0|||
131424911|NCT00428389|473178710|FG001|Core Phase|Abnormal test procedure result(s)|1|||
131424912|NCT00428389|473178709|FG000|Core Phase|Withdrawal by Subject|3|||
131424913|NCT00428389|473178710|FG001|Core Phase|Withdrawal by Subject|4|||
131424914|NCT00428389|473178709|FG000|Core Phase|Protocol deviation|0|||
131424915|NCT00428389|473178710|FG001|Core Phase|Protocol deviation|2|||
131424916|NCT00428389|473178709|FG000|Extension Phase|Adverse Event|17|||
131424917|NCT00428389|473178710|FG001|Extension Phase|Adverse Event|11|||
131424918|NCT00428389|473178709|FG000|Extension Phase|Lack of Efficacy|4|||
131424919|NCT00428389|473178710|FG001|Extension Phase|Lack of Efficacy|3|||
131458044|NCT01395524|473308773|FG000|Overall Study|Subject had spinal surgery|0|||
131458045|NCT01395524|473308774|FG001|Overall Study|Subject had spinal surgery|0|||
131424920|NCT00428389|473178709|FG000|Extension Phase|Withdrawal by Subject|6|||
131424921|NCT00428389|473178710|FG001|Extension Phase|Withdrawal by Subject|6|||
131424922|NCT00428389|473178709|FG000|Extension Phase|Lost to Follow-up|0|||
131424923|NCT00428389|473178710|FG001|Extension Phase|Lost to Follow-up|3|||
131424924|NCT00428389|473178709|FG000|Extension Phase|Death|1|||
131424925|NCT00428389|473178710|FG001|Extension Phase|Death|0|||
131424926|NCT00428389|473178709|FG000|Extension Phase|Protocol Violation|3|||
131424927|NCT00428389|473178710|FG001|Extension Phase|Protocol Violation|2|||
131424928|NCT00428389|473178709|FG000|Extension Phase|Administrative problems|1|||
131424929|NCT00428389|473178710|FG001|Extension Phase|Administrative problems|1|||
131424930|NCT01534195|473178711|FG000|Overall Study|Withdrawal by Subject|1|||
131424931|NCT01534195|473178712|FG001|Overall Study|Withdrawal by Subject|1|||
131424932|NCT02669121|473178713|FG000|Overall Study|Adverse Event|4|||
131424933|NCT02669121|473178714|FG001|Overall Study|Adverse Event|5|||
131424934|NCT02669121|473178713|FG000|Overall Study|Lost to Follow-up|15|||
131424935|NCT02669121|473178714|FG001|Overall Study|Lost to Follow-up|27|||
131424936|NCT02669121|473178713|FG000|Overall Study|Withdrawal by Subject|132|||
131424937|NCT02669121|473178714|FG001|Overall Study|Withdrawal by Subject|140|||
131424938|NCT02669121|473178713|FG000|Overall Study|Pregnancy|0|||
131424939|NCT02669121|473178714|FG001|Overall Study|Pregnancy|1|||
131424940|NCT02669121|473178713|FG000|Overall Study|Discharged from US Military Active Service|117|||
131424941|NCT02669121|473178714|FG001|Overall Study|Discharged from US Military Active Service|91|||
131424942|NCT02669121|473178713|FG000|Overall Study|Reason not Specified|22|||
131424943|NCT02669121|473178714|FG001|Overall Study|Reason not Specified|18|||
131424944|NCT03216746|473178715|FG000|Overall Study|Lost to Follow-up|6|||
131424945|NCT03216746|473178716|FG001|Overall Study|Lost to Follow-up|8|||
131424946|NCT03216746|473178717|FG002|Overall Study|Lost to Follow-up|5|||
131424947|NCT03216746|473178718|FG003|Overall Study|Lost to Follow-up|6|||
131424948|NCT04384523|473178719|FG000|Overall Study|Lost to Follow-up|0|||
131424949|NCT04384523|473178720|FG001|Overall Study|Lost to Follow-up|0|||
131424950|NCT04384523|473178721|FG002|Overall Study|Lost to Follow-up|0|||
131424951|NCT04384523|473178722|FG003|Overall Study|Lost to Follow-up|0|||
131424952|NCT04384523|473178723|FG004|Overall Study|Lost to Follow-up|0|||
131424953|NCT04384523|473178724|FG005|Overall Study|Lost to Follow-up|1|||
131424954|NCT04384523|473178719|FG000|Overall Study|Protocol Violation|0|||
131424955|NCT04384523|473178720|FG001|Overall Study|Protocol Violation|1|||
131424956|NCT04384523|473178721|FG002|Overall Study|Protocol Violation|0|||
131424957|NCT04384523|473178722|FG003|Overall Study|Protocol Violation|0|||
131424958|NCT04384523|473178723|FG004|Overall Study|Protocol Violation|0|||
131424959|NCT04384523|473178724|FG005|Overall Study|Protocol Violation|0|||
131424960|NCT04384523|473178719|FG000|Overall Study|Withdrawal by Subject|1|||
131424961|NCT04384523|473178720|FG001|Overall Study|Withdrawal by Subject|0|||
131424962|NCT04384523|473178721|FG002|Overall Study|Withdrawal by Subject|0|||
131424963|NCT04384523|473178722|FG003|Overall Study|Withdrawal by Subject|0|||
131424964|NCT04384523|473178723|FG004|Overall Study|Withdrawal by Subject|0|||
131424965|NCT04384523|473178724|FG005|Overall Study|Withdrawal by Subject|0|||
131424966|NCT01320202|473178725|FG000|Overall Study|Adverse Event|5|||
131424967|NCT01320202|473178726|FG001|Overall Study|Adverse Event|5|||
131424968|NCT01320202|473178725|FG000|Overall Study|Death|5|||
131424969|NCT01320202|473178726|FG001|Overall Study|Death|3|||
131424970|NCT01320202|473178725|FG000|Overall Study|Lost to Follow-up|1|||
131424971|NCT01320202|473178726|FG001|Overall Study|Lost to Follow-up|0|||
131424972|NCT01320202|473178725|FG000|Overall Study|Physician Decision|3|||
131424973|NCT01320202|473178726|FG001|Overall Study|Physician Decision|1|||
131424974|NCT01320202|473178725|FG000|Overall Study|Protocol Violation|2|||
131424975|NCT01320202|473178726|FG001|Overall Study|Protocol Violation|1|||
131424976|NCT01320202|473178725|FG000|Overall Study|Withdrawal by Subject|10|||
131424977|NCT01320202|473178726|FG001|Overall Study|Withdrawal by Subject|3|||
131424978|NCT01320202|473178725|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
131424979|NCT01320202|473178726|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
131424980|NCT01320202|473178725|FG000|Overall Study|kidney transplant|1|||
131424981|NCT01320202|473178726|FG001|Overall Study|kidney transplant|2|||
131424982|NCT01320202|473178725|FG000|Overall Study|blood transfusion|1|||
131424983|NCT01320202|473178726|FG001|Overall Study|blood transfusion|7|||
131424984|NCT01320202|473178725|FG000|Overall Study|moved/changed dialysis|5|||
131424985|NCT01320202|473178726|FG001|Overall Study|moved/changed dialysis|2|||
131424986|NCT01320202|473178725|FG000|Overall Study|sponsor request|2|||
131424987|NCT01320202|473178726|FG001|Overall Study|sponsor request|0|||
131424988|NCT01320202|473178725|FG000|Overall Study|ineligible|3|||
131424989|NCT01320202|473178726|FG001|Overall Study|ineligible|0|||
131424990|NCT01320202|473178725|FG000|Overall Study|regained renal function|1|||
131424991|NCT01320202|473178726|FG001|Overall Study|regained renal function|0|||
131424992|NCT00635882|473178727|FG000|Overall Study|Protocol Violation|1|||
131424993|NCT00635882|473178728|FG001|Overall Study|Protocol Violation|0|||
131424994|NCT00635882|473178729|FG002|Overall Study|Protocol Violation|0|||
131424995|NCT00635882|473178730|FG003|Overall Study|Protocol Violation|0|||
131424996|NCT00635882|473178731|FG004|Overall Study|Protocol Violation|0|||
131424997|NCT00635882|473178732|FG005|Overall Study|Protocol Violation|0|||
131424998|NCT00835341|473178733|FG000|Overall Study|Lost to Follow-up|3|||
131424999|NCT00835341|473178734|FG001|Overall Study|Lost to Follow-up|12|||
131425000|NCT00392990|473178737|FG000|Treatment on Study|Adverse Event|3|||
131425001|NCT00392990|473178738|FG001|Treatment on Study|Adverse Event|1|||
131425002|NCT00392990|473178737|FG000|Follow up for 2 Years|Death|4|||
131425003|NCT00392990|473178738|FG001|Follow up for 2 Years|Death|0|||
131425004|NCT02980133|473178741|FG000|Overall Study|Other than specified|1|||
131425005|NCT02980133|473178742|FG001|Overall Study|Other than specified|1|||
131425006|NCT02980133|473178743|FG002|Overall Study|Other than specified|2|||
131425007|NCT02980133|473178744|FG003|Overall Study|Other than specified|2|||
131425008|NCT02980133|473178741|FG000|Overall Study|Lost to Follow-up|0|||
131425009|NCT02980133|473178742|FG001|Overall Study|Lost to Follow-up|0|||
131425010|NCT02980133|473178743|FG002|Overall Study|Lost to Follow-up|1|||
131425011|NCT02980133|473178744|FG003|Overall Study|Lost to Follow-up|3|||
131425012|NCT02980133|473178741|FG000|Overall Study|Protocol Violation|0|||
131425013|NCT02980133|473178742|FG001|Overall Study|Protocol Violation|1|||
131425014|NCT02980133|473178743|FG002|Overall Study|Protocol Violation|0|||
131425015|NCT02980133|473178744|FG003|Overall Study|Protocol Violation|0|||
131425016|NCT02980133|473178741|FG000|Overall Study|Withdrawal by parent/guardian|6|||
131425017|NCT02980133|473178742|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131425018|NCT02980133|473178743|FG002|Overall Study|Withdrawal by parent/guardian|3|||
131425019|NCT02980133|473178744|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131425020|NCT02980133|473178741|FG000|Overall Study|Withdrawal by Subject|0|||
131425021|NCT02980133|473178742|FG001|Overall Study|Withdrawal by Subject|0|||
131425022|NCT02980133|473178743|FG002|Overall Study|Withdrawal by Subject|1|||
131425023|NCT02980133|473178744|FG003|Overall Study|Withdrawal by Subject|0|||
131425024|NCT00384332|473178745|FG000|Overall Study|Lost to Follow-up|4|||
131425025|NCT00384332|473178746|FG001|Overall Study|Lost to Follow-up|0|||
131425026|NCT02560012|473178747|FG000|Overall Study|Study Terminated|2|||
131425027|NCT01007838|473178748|FG000|Overall Study|Withdrawal by Subject|1|||
131425028|NCT01007838|473178749|FG001|Overall Study|Withdrawal by Subject|0|||
131425029|NCT01007838|473178750|FG002|Overall Study|Withdrawal by Subject|0|||
131425030|NCT01007838|473178751|FG003|Overall Study|Withdrawal by Subject|0|||
131425031|NCT01007838|473178748|FG000|Overall Study|Physician Decision|1|||
131425032|NCT01007838|473178749|FG001|Overall Study|Physician Decision|0|||
131425033|NCT01007838|473178750|FG002|Overall Study|Physician Decision|0|||
131425034|NCT01007838|473178751|FG003|Overall Study|Physician Decision|0|||
131425035|NCT01007838|473178748|FG000|Overall Study|Started home haemodialysis|1|||
131425036|NCT01007838|473178749|FG001|Overall Study|Started home haemodialysis|0|||
131425037|NCT01007838|473178750|FG002|Overall Study|Started home haemodialysis|0|||
131425038|NCT01007838|473178751|FG003|Overall Study|Started home haemodialysis|0|||
131425039|NCT03052816|473178752|FG000|Overall Study|Withdrawal by Subject|1|||
131425040|NCT03052816|473178753|FG001|Overall Study|Withdrawal by Subject|0|||
131425041|NCT03052816|473178752|FG000|Overall Study|Desired opioids|2|||
131425042|NCT03052816|473178753|FG001|Overall Study|Desired opioids|0|||
131425043|NCT00895453|473178754|FG000|Overall Study|Lost to Follow-up|25|||
131425044|NCT00895453|473178755|FG001|Overall Study|Lost to Follow-up|25|||
131425045|NCT00895453|473178756|FG002|Overall Study|Lost to Follow-up|23|||
131425046|NCT01736618|473178763|FG000|Overall Study|Death|294|||
131425047|NCT01736618|473178763|FG000|Overall Study|Lost to Follow-up|193|||
131425048|NCT01736618|473178763|FG000|Overall Study|Withdrawal by Subject|54|||
131425049|NCT01736618|473178763|FG000|Overall Study|Subject unable to be followed at study location|223|||
131425050|NCT01736618|473178763|FG000|Overall Study|Physician Decision|33|||
131425051|NCT01736618|473178763|FG000|Overall Study|Transplant or removal of target organ|19|||
131425052|NCT01736618|473178763|FG000|Overall Study|Change in indication or condition|78|||
131425053|NCT01736618|473178763|FG000|Overall Study|Study device explant|103|||
131425054|NCT01736618|473178763|FG000|Overall Study|Unable to complete implant|2|||
131425055|NCT00400569|473178768|FG000|Overall Study|Death|1|||
131425056|NCT00620113|473178771|FG000|Overall Study|Adverse Event|3|||
131425057|NCT00620113|473178772|FG001|Overall Study|Adverse Event|2|||
131425058|NCT00620113|473178773|FG002|Overall Study|Adverse Event|2|||
131425059|NCT00620113|473178774|FG003|Overall Study|Adverse Event|1|||
131425060|NCT00620113|473178771|FG000|Overall Study|Lack of Efficacy|2|||
131425061|NCT00620113|473178772|FG001|Overall Study|Lack of Efficacy|3|||
131425062|NCT00620113|473178773|FG002|Overall Study|Lack of Efficacy|0|||
131425063|NCT00620113|473178774|FG003|Overall Study|Lack of Efficacy|2|||
131425064|NCT00620113|473178771|FG000|Overall Study|Physician Decision|1|||
131425065|NCT00620113|473178772|FG001|Overall Study|Physician Decision|0|||
131425066|NCT00620113|473178773|FG002|Overall Study|Physician Decision|0|||
131425067|NCT00620113|473178774|FG003|Overall Study|Physician Decision|2|||
131425068|NCT00620113|473178771|FG000|Overall Study|Protocol Violation|2|||
131425069|NCT00620113|473178772|FG001|Overall Study|Protocol Violation|1|||
131425070|NCT00620113|473178773|FG002|Overall Study|Protocol Violation|0|||
131425071|NCT00620113|473178774|FG003|Overall Study|Protocol Violation|0|||
131425072|NCT00620113|473178771|FG000|Overall Study|Withdrawal by Subject|5|||
131425073|NCT00620113|473178772|FG001|Overall Study|Withdrawal by Subject|1|||
131425074|NCT00620113|473178773|FG002|Overall Study|Withdrawal by Subject|3|||
131425075|NCT00620113|473178774|FG003|Overall Study|Withdrawal by Subject|5|||
131425076|NCT02461745|473178779|FG000|Overall Study|Lack of Efficacy|9|||
131425077|NCT02461745|473178780|FG001|Overall Study|Lack of Efficacy|1|||
131425078|NCT02461745|473178779|FG000|Overall Study|Lost to Follow-up|2|||
131425079|NCT02461745|473178780|FG001|Overall Study|Lost to Follow-up|2|||
131425080|NCT02461745|473178779|FG000|Overall Study|Withdrawal by Subject|3|||
131425081|NCT02461745|473178780|FG001|Overall Study|Withdrawal by Subject|1|||
131425082|NCT00852241|473178781|FG000|Overall Study|Physician Decision|18|||
131425083|NCT00118430|473178783|FG000|Overall Study|Withdrawal by Subject|6|||
131425084|NCT00118430|473178784|FG001|Overall Study|Withdrawal by Subject|2|||
131425085|NCT00118430|473178785|FG002|Overall Study|Withdrawal by Subject|0|||
131425086|NCT00118430|473178783|FG000|Overall Study|Lost to Follow-up|15|||
131425087|NCT00118430|473178784|FG001|Overall Study|Lost to Follow-up|22|||
131425088|NCT00118430|473178785|FG002|Overall Study|Lost to Follow-up|28|||
131425089|NCT02147288|473178786|FG000|Overall Study|post-operative hematoma|1|||
131425090|NCT02147288|473178787|FG001|Overall Study|post-operative hematoma|1|||
131425091|NCT02147288|473178788|FG002|Overall Study|post-operative hematoma|0|||
131425092|NCT02147288|473178789|FG003|Overall Study|post-operative hematoma|0|||
131425093|NCT02147288|473178790|FG004|Overall Study|post-operative hematoma|0|||
131425094|NCT02147288|473178791|FG005|Overall Study|post-operative hematoma|0|||
131425095|NCT02147288|473178792|FG006|Overall Study|post-operative hematoma|0|||
131425096|NCT02147288|473178793|FG007|Overall Study|post-operative hematoma|0|||
131425097|NCT02147288|473178794|FG008|Overall Study|post-operative hematoma|0|||
131425098|NCT02147288|473178795|FG009|Overall Study|post-operative hematoma|0|||
131425099|NCT02147288|473178786|FG000|Overall Study|complications from concurrent hernia rep|0|||
131425100|NCT02147288|473178787|FG001|Overall Study|complications from concurrent hernia rep|1|||
131425101|NCT02147288|473178788|FG002|Overall Study|complications from concurrent hernia rep|0|||
131425102|NCT02147288|473178789|FG003|Overall Study|complications from concurrent hernia rep|0|||
131425103|NCT02147288|473178790|FG004|Overall Study|complications from concurrent hernia rep|0|||
131425104|NCT02147288|473178791|FG005|Overall Study|complications from concurrent hernia rep|0|||
131425105|NCT02147288|473178792|FG006|Overall Study|complications from concurrent hernia rep|0|||
131425106|NCT02147288|473178793|FG007|Overall Study|complications from concurrent hernia rep|0|||
131425107|NCT02147288|473178794|FG008|Overall Study|complications from concurrent hernia rep|0|||
131425108|NCT02147288|473178795|FG009|Overall Study|complications from concurrent hernia rep|0|||
131425109|NCT02069392|473178798|FG000|Overall Study|Withdrawal by Subject|4|||
131425110|NCT02069392|473178799|FG001|Overall Study|Withdrawal by Subject|2|||
131425111|NCT00269633|473178800|FG000|Overall Study|Withdrawal by Subject|1|||
131425112|NCT00269633|473178801|FG001|Overall Study|Withdrawal by Subject|0|||
131425113|NCT02927938|473178802|FG000|Overall Study|Death|0|||
131425114|NCT02927938|473178803|FG001|Overall Study|Death|1|||
131425115|NCT02927938|473178804|FG002|Overall Study|Death|0|||
131425116|NCT02927938|473178805|FG003|Overall Study|Death|4|||
131425117|NCT02927938|473178802|FG000|Overall Study|Early Study Termination|1|||
131425118|NCT02927938|473178803|FG001|Overall Study|Early Study Termination|5|||
131425119|NCT02927938|473178804|FG002|Overall Study|Early Study Termination|4|||
131425120|NCT02927938|473178805|FG003|Overall Study|Early Study Termination|3|||
131425121|NCT02476006|473178806|FG000|Overall Study|Death|4|||
131425122|NCT02476006|473178806|FG000|Overall Study|Lack of treatment efficacy|2|||
131425123|NCT02476006|473178806|FG000|Overall Study|Pregnancy|1|||
131425124|NCT02476006|473178806|FG000|Overall Study|Participant did not wish to continue|39|||
131425125|NCT02476006|473178806|FG000|Overall Study|Adverse Event|41|||
131425126|NCT02476006|473178806|FG000|Overall Study|Poor compliance to study protocol|3|||
131425127|NCT02476006|473178806|FG000|Overall Study|Sponsor decision|6|||
131425128|NCT02476006|473178806|FG000|Overall Study|Lost to Follow-up|5|||
131425129|NCT02476006|473178806|FG000|Overall Study|Physician Decision|5|||
131425130|NCT02476006|473178806|FG000|Overall Study|Study ended treatment not available|4|||
131425131|NCT02476006|473178806|FG000|Overall Study|Switched to commercial drug|4|||
131425132|NCT02476006|473178806|FG000|Overall Study|Excluded from study|1|||
131425133|NCT02476006|473178806|FG000|Overall Study|Protocol Violation|1|||
131425134|NCT02476006|473178806|FG000|Overall Study|Enrolled but not treated|4|||
131425135|NCT00826618|473179979|FG000|Overall Study|Withdrawal by Subject|1|||
131425136|NCT00872599|473179981|FG000|Second Washout Period|Adverse Event|1|||
131425137|NCT00872599|473179982|FG001|Second Washout Period|Adverse Event|1|||
131425138|NCT00303485|473179991|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
131425139|NCT00303485|473179992|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
131425140|NCT00303485|473179991|FG000|Overall Study|Failure to return|0|||
131425141|NCT00303485|473179992|FG001|Overall Study|Failure to return|1|||
131425142|NCT00303485|473179991|FG000|Overall Study|Withdrawal by Subject|1|||
131425143|NCT00303485|473179992|FG001|Overall Study|Withdrawal by Subject|0|||
131425144|NCT02219334|473180000|FG000|Overall Study|Withdrawal by Subject|1|||
131425145|NCT02219334|473180001|FG001|Overall Study|Withdrawal by Subject|0|||
131425146|NCT02219334|473180000|FG000|Overall Study|Protocol Violation|7|||
131425147|NCT02219334|473180001|FG001|Overall Study|Protocol Violation|3|||
131425148|NCT01363908|473180003|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
131425149|NCT01363908|473180004|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
131425150|NCT01363908|473180003|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
131425151|NCT01363908|473180004|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
131425152|NCT01363908|473180003|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
131425153|NCT01363908|473180004|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
131425154|NCT01363908|473180003|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
131425155|NCT01363908|473180004|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
131425156|NCT04774926|473180007|FG000|Overall Study|Adverse Event|15|||
131425157|NCT04774926|473180007|FG000|Overall Study|Lost to Follow-up|3|||
131425158|NCT04774926|473180007|FG000|Overall Study|Physician Decision|6|||
131458046|NCT01395524|473308775|FG002|Overall Study|Subject had spinal surgery|1|||
131425159|NCT04774926|473180007|FG000|Overall Study|Withdrawal by Subject|3|||
131425160|NCT04774926|473180007|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
131425161|NCT02783599|473180008|FG000|Overall Study|Progressive disease|23|||
131425162|NCT02783599|473180008|FG000|Overall Study|Surgical Resection|10|||
131425163|NCT02783599|473180008|FG000|Overall Study|Adverse Event|4|||
131425164|NCT02783599|473180008|FG000|Overall Study|Physician Decision|2|||
131425165|NCT02783599|473180008|FG000|Overall Study|Death|1|||
131458047|NCT01657461|473308776|FG000|Overall Study|Death|9|||
131425166|NCT03040674|473180012|FG000|Overall Study|Lost to Follow-up|225|||
131425167|NCT03040674|473180012|FG000|Overall Study|Death|23|||
131425168|NCT01934010|473180013|FG000|Overall Study|Adverse Event|1|||
131425169|NCT01934010|473180014|FG001|Overall Study|Adverse Event|1|||
131425170|NCT01934010|473180015|FG002|Overall Study|Adverse Event|0|||
131425171|NCT01934010|473180013|FG000|Overall Study|Withdrawal by Subject|15|||
131425172|NCT01934010|473180014|FG001|Overall Study|Withdrawal by Subject|6|||
131425173|NCT01934010|473180015|FG002|Overall Study|Withdrawal by Subject|2|||
131425174|NCT01934010|473180013|FG000|Overall Study|Lost to Follow-up|7|||
131425175|NCT01934010|473180014|FG001|Overall Study|Lost to Follow-up|4|||
131425176|NCT01934010|473180015|FG002|Overall Study|Lost to Follow-up|0|||
131425177|NCT05173012|473180016|FG000|Overall Study|Adverse Event|2|||
131425178|NCT05173012|473180017|FG001|Overall Study|Adverse Event|3|||
131425179|NCT05173012|473180018|FG002|Overall Study|Adverse Event|4|||
131458048|NCT01657461|473308777|FG001|Overall Study|Death|12|||
131425180|NCT05173012|473180019|FG003|Overall Study|Adverse Event|13|||
131425181|NCT05173012|473180020|FG004|Overall Study|Adverse Event|0|||
131425182|NCT05173012|473180021|FG005|Overall Study|Adverse Event|0|||
131425183|NCT05173012|473180022|FG006|Overall Study|Adverse Event|2|||
131425184|NCT05173012|473180023|FG007|Overall Study|Adverse Event|4|||
131425185|NCT05173012|473180016|FG000|Overall Study|Lost to Follow-up|0|||
131425186|NCT05173012|473180017|FG001|Overall Study|Lost to Follow-up|0|||
131425187|NCT05173012|473180018|FG002|Overall Study|Lost to Follow-up|0|||
131425188|NCT05173012|473180019|FG003|Overall Study|Lost to Follow-up|1|||
131425189|NCT05173012|473180020|FG004|Overall Study|Lost to Follow-up|0|||
131425190|NCT05173012|473180021|FG005|Overall Study|Lost to Follow-up|0|||
131425191|NCT05173012|473180022|FG006|Overall Study|Lost to Follow-up|0|||
131425192|NCT05173012|473180023|FG007|Overall Study|Lost to Follow-up|0|||
131425193|NCT05173012|473180016|FG000|Overall Study|Withdrawal by Subject|1|||
131425194|NCT05173012|473180017|FG001|Overall Study|Withdrawal by Subject|0|||
131425195|NCT05173012|473180018|FG002|Overall Study|Withdrawal by Subject|1|||
131425196|NCT05173012|473180019|FG003|Overall Study|Withdrawal by Subject|3|||
131425197|NCT05173012|473180020|FG004|Overall Study|Withdrawal by Subject|1|||
131425198|NCT05173012|473180021|FG005|Overall Study|Withdrawal by Subject|0|||
131425199|NCT05173012|473180022|FG006|Overall Study|Withdrawal by Subject|1|||
131425200|NCT05173012|473180023|FG007|Overall Study|Withdrawal by Subject|0|||
131425201|NCT05173012|473180016|FG000|Overall Study|Protocol Deviation|0|||
131425202|NCT05173012|473180017|FG001|Overall Study|Protocol Deviation|0|||
131425203|NCT05173012|473180018|FG002|Overall Study|Protocol Deviation|0|||
131425204|NCT05173012|473180019|FG003|Overall Study|Protocol Deviation|1|||
131425205|NCT05173012|473180020|FG004|Overall Study|Protocol Deviation|0|||
131425206|NCT05173012|473180021|FG005|Overall Study|Protocol Deviation|0|||
131425207|NCT05173012|473180022|FG006|Overall Study|Protocol Deviation|0|||
131425208|NCT05173012|473180023|FG007|Overall Study|Protocol Deviation|0|||
131425209|NCT05173012|473180016|FG000|Overall Study|Other|0|||
131425210|NCT05173012|473180017|FG001|Overall Study|Other|0|||
131425211|NCT05173012|473180018|FG002|Overall Study|Other|0|||
131425212|NCT05173012|473180019|FG003|Overall Study|Other|2|||
131425213|NCT05173012|473180020|FG004|Overall Study|Other|0|||
131425214|NCT05173012|473180021|FG005|Overall Study|Other|0|||
131425215|NCT05173012|473180022|FG006|Overall Study|Other|0|||
131425216|NCT05173012|473180023|FG007|Overall Study|Other|0|||
131425217|NCT02936843|473180024|FG000|Overall Study|Lost to Follow-up|3|||
131425218|NCT02936843|473180025|FG001|Overall Study|Lost to Follow-up|1|||
131425219|NCT02936843|473180024|FG000|Overall Study|Withdrawal by Subject|1|||
131425220|NCT02936843|473180025|FG001|Overall Study|Withdrawal by Subject|1|||
131425221|NCT02703324|473180026|FG000|Period Two|Withdrawal by Subject|0|||
131425222|NCT02703324|473180027|FG001|Period Two|Withdrawal by Subject|0|||
131425223|NCT02703324|473180028|FG002|Period Two|Withdrawal by Subject|1|||
131425224|NCT02703324|473180029|FG003|Period Two|Withdrawal by Subject|0|||
131425225|NCT02703324|473180030|FG004|Period Two|Withdrawal by Subject|0|||
131425226|NCT02703324|473180031|FG005|Period Two|Withdrawal by Subject|0|||
131425227|NCT06312592|473180032|FG000|Overall Study|Lost to Follow-up|29|||
131425228|NCT06312592|473180033|FG001|Overall Study|Lost to Follow-up|13|||
131425229|NCT01948063|473180036|FG000|Overall Study|Boston MCI halted research protocol|0|||
131425230|NCT01948063|473180037|FG001|Overall Study|Boston MCI halted research protocol|1|||
131425231|NCT01948063|473180036|FG000|Overall Study|Discovered an enrollment in other study|0|||
131425232|NCT01948063|473180037|FG001|Overall Study|Discovered an enrollment in other study|1|||
131425233|NCT01948063|473180036|FG000|Overall Study|Blood samples were accidentally thawed|1|||
131425234|NCT01948063|473180037|FG001|Overall Study|Blood samples were accidentally thawed|0|||
131425235|NCT00395850|473180044|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
131425236|NCT00395850|473180045|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
131425237|NCT00395850|473180046|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
131425238|NCT00395850|473180047|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
131425239|NCT00395850|473180044|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
131425240|NCT00395850|473180045|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
131425241|NCT00395850|473180046|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
131425242|NCT00395850|473180047|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
131425243|NCT00395850|473180044|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
131425244|NCT00395850|473180045|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
131425245|NCT00395850|473180046|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
131425246|NCT00395850|473180047|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
131425247|NCT00395850|473180044|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
131425248|NCT00395850|473180045|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
131425249|NCT00395850|473180046|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
131425250|NCT00395850|473180047|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
131425251|NCT00395850|473180044|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
131425252|NCT00395850|473180045|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
131425253|NCT00395850|473180046|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
131425254|NCT00395850|473180047|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
131425255|NCT00395850|473180044|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
131425256|NCT00395850|473180045|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
131425257|NCT00395850|473180046|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
131425258|NCT00395850|473180047|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
131425259|NCT00395850|473180044|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
131425260|NCT00395850|473180045|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
131425261|NCT00395850|473180046|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
131425262|NCT00395850|473180047|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
131425263|NCT01620762|473180050|FG000|Overall Study|Protocol Violation|1|||
131425264|NCT01620762|473180051|FG001|Overall Study|Protocol Violation|1|||
131425265|NCT01620762|473180052|FG002|Overall Study|Protocol Violation|1|||
131425266|NCT01620762|473180050|FG000|Overall Study|Adverse Event|9|||
131425267|NCT01620762|473180051|FG001|Overall Study|Adverse Event|5|||
131425268|NCT01620762|473180052|FG002|Overall Study|Adverse Event|2|||
131425269|NCT01620762|473180050|FG000|Overall Study|Withdrawal by Subject|23|||
131425270|NCT01620762|473180051|FG001|Overall Study|Withdrawal by Subject|26|||
131425271|NCT01620762|473180052|FG002|Overall Study|Withdrawal by Subject|27|||
131425272|NCT01620762|473180050|FG000|Overall Study|Lost to Follow-up|11|||
131425273|NCT01620762|473180051|FG001|Overall Study|Lost to Follow-up|17|||
131425274|NCT01620762|473180052|FG002|Overall Study|Lost to Follow-up|10|||
131425275|NCT01620762|473180050|FG000|Overall Study|Protocol deviation|1|||
131425276|NCT01620762|473180051|FG001|Overall Study|Protocol deviation|1|||
131425277|NCT01620762|473180052|FG002|Overall Study|Protocol deviation|6|||
131425278|NCT01620762|473180050|FG000|Overall Study|Subject deterioration|0|||
131425279|NCT01620762|473180051|FG001|Overall Study|Subject deterioration|1|||
131425280|NCT01620762|473180052|FG002|Overall Study|Subject deterioration|1|||
131425281|NCT01620762|473180050|FG000|Overall Study|Non-specified|3|||
131425282|NCT01620762|473180051|FG001|Overall Study|Non-specified|6|||
131425283|NCT01620762|473180052|FG002|Overall Study|Non-specified|5|||
131425284|NCT01620762|473180050|FG000|Overall Study|Use of prohibted therapies|0|||
131425285|NCT01620762|473180051|FG001|Overall Study|Use of prohibted therapies|1|||
131425286|NCT01620762|473180052|FG002|Overall Study|Use of prohibted therapies|1|||
131425287|NCT00705146|473180057|FG000|Overall Study|Lost to Follow-up|1|||
131425288|NCT00705146|473180058|FG001|Overall Study|Lost to Follow-up|1|||
131425289|NCT00095173|473180061|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
131425290|NCT00095173|473180062|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
131425291|NCT00095173|473180063|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
131425292|NCT00095173|473180064|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
131425293|NCT00095173|473180065|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
131425294|NCT00095173|473180066|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
131425295|NCT00095173|473180061|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
131425296|NCT00095173|473180062|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
131425297|NCT00095173|473180063|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
131425298|NCT00095173|473180064|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
131425299|NCT00095173|473180065|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
131425300|NCT00095173|473180066|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
131425301|NCT00095173|473180061|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
131425302|NCT00095173|473180062|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
131425303|NCT00095173|473180063|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
131425304|NCT00095173|473180064|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
131425305|NCT00095173|473180065|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
131425306|NCT00095173|473180066|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
131425307|NCT00095173|473180061|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
131425308|NCT00095173|473180062|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
131425309|NCT00095173|473180063|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
131425310|NCT00095173|473180064|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
131425311|NCT00095173|473180065|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
131425312|NCT00095173|473180066|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
131425313|NCT00095173|473180061|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
131425314|NCT00095173|473180062|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
131425315|NCT00095173|473180063|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
131425316|NCT00095173|473180064|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
131425317|NCT00095173|473180065|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
131425318|NCT00095173|473180066|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
131425319|NCT00095173|473180061|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
131425320|NCT00095173|473180062|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
131425321|NCT00095173|473180063|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
131425322|NCT00095173|473180064|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
131425323|NCT00095173|473180065|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
131425324|NCT00095173|473180066|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
131425325|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Death|0|||
131425326|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Death|0|||
131425327|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Death|0|||
131425328|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Death|0|||
131425329|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Death|0|||
131425330|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Death|1|||
131425331|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
131425332|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
131425333|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
131425334|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
131425335|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
131425336|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
131425337|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
131425338|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
131425339|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
131425340|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
131425341|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
131425342|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
131425343|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
131425344|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
131425345|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
131425346|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
131425347|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
131425348|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
131425349|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
131425350|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
131425351|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
131425352|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
131425353|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
131425354|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
131425355|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
131425356|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
131425357|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
131425358|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
131425359|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
131458049|NCT01657461|473308776|FG000|Overall Study|Lost to Follow-up|0|||
131425360|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
131425361|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
131425362|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
131425363|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
131425364|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
131425365|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
131425366|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
131425367|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
131425368|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
131425369|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
131425370|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
131425371|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
131425372|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
131425373|NCT00095173|473180061|FG000|Open-Label Extension Phase (Period C)|Other|0|||
131425374|NCT00095173|473180062|FG001|Open-Label Extension Phase (Period C)|Other|0|||
131425375|NCT00095173|473180063|FG002|Open-Label Extension Phase (Period C)|Other|0|||
131425376|NCT00095173|473180064|FG003|Open-Label Extension Phase (Period C)|Other|4|||
131425377|NCT00095173|473180065|FG004|Open-Label Extension Phase (Period C)|Other|6|||
131425378|NCT00095173|473180066|FG005|Open-Label Extension Phase (Period C)|Other|8|||
131425379|NCT01090063|473180073|FG000|Screen|Screen Failed|4|||
131425380|NCT01090063|473180073|FG000|Treatment|Withdrawal by Subject|4|||
131425381|NCT00923845|473180078|FG000|Induction Therapy|Poor performance status|0|||
131425382|NCT00923845|473180079|FG001|Induction Therapy|Poor performance status|2|||
131425383|NCT04698993|473180083|FG000|Overall Study|PCR results not accessible|2|||
131425384|NCT04698993|473180084|FG001|Overall Study|PCR results not accessible|7|||
131425385|NCT04698993|473180083|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
131425386|NCT04698993|473180084|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
131425387|NCT02578186|473180085|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
131425388|NCT02578186|473180086|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
131425389|NCT02578186|473180085|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
131425390|NCT02578186|473180086|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
131425391|NCT00527904|473180087|FG000|Overall Study|Adverse Event|45|||
131425392|NCT00527904|473180087|FG000|Overall Study|Withdrawal by Subject|21|||
131425393|NCT00527904|473180087|FG000|Overall Study|Lost to Follow-up|8|||
131425394|NCT00527904|473180087|FG000|Overall Study|misc|22|||
131425395|NCT02708355|473180088|FG000|Overall Study|Adverse Event|1|||
131425396|NCT02708355|473180089|FG001|Overall Study|Adverse Event|0|||
131425397|NCT02708355|473180090|FG002|Overall Study|Adverse Event|0|||
131425398|NCT04405076|473180092|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
131425399|NCT04405076|473180093|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
131425400|NCT04405076|473180094|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
131425401|NCT04405076|473180095|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
131425402|NCT04405076|473180096|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
131425403|NCT04405076|473180097|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
131425404|NCT04405076|473180098|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
131425405|NCT04405076|473180099|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
131425406|NCT04405076|473180100|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
131425407|NCT04405076|473180092|FG000|Part A (Blinded Phase)|Physician Decision|1|||
131425408|NCT04405076|473180093|FG001|Part A (Blinded Phase)|Physician Decision|2|||
131425409|NCT04405076|473180094|FG002|Part A (Blinded Phase)|Physician Decision|0|||
131425410|NCT04405076|473180095|FG003|Part A (Blinded Phase)|Physician Decision|0|||
131425411|NCT04405076|473180096|FG004|Part A (Blinded Phase)|Physician Decision|0|||
131425412|NCT04405076|473180097|FG005|Part A (Blinded Phase)|Physician Decision|0|||
131425413|NCT04405076|473180098|FG006|Part A (Blinded Phase)|Physician Decision|0|||
131425414|NCT04405076|473180099|FG007|Part A (Blinded Phase)|Physician Decision|0|||
131425415|NCT04405076|473180100|FG008|Part A (Blinded Phase)|Physician Decision|0|||
131425416|NCT04405076|473180092|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
131425417|NCT04405076|473180093|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
131425418|NCT04405076|473180094|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
131425419|NCT04405076|473180095|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
131425420|NCT04405076|473180096|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
131425421|NCT04405076|473180097|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
131425422|NCT04405076|473180098|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
131425423|NCT04405076|473180099|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
131425424|NCT04405076|473180100|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
131425425|NCT04405076|473180092|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
131425426|NCT04405076|473180093|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425427|NCT04405076|473180094|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131458050|NCT01657461|473308777|FG001|Overall Study|Lost to Follow-up|3|||
131425428|NCT04405076|473180095|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425429|NCT04405076|473180096|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425430|NCT04405076|473180097|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425431|NCT04405076|473180098|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425432|NCT04405076|473180099|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425433|NCT04405076|473180100|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
131425434|NCT04405076|473180092|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
131425435|NCT04405076|473180093|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
131425436|NCT04405076|473180094|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425437|NCT04405076|473180095|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425438|NCT04405076|473180096|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425439|NCT04405076|473180097|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425440|NCT04405076|473180098|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425441|NCT04405076|473180099|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425442|NCT04405076|473180100|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
131425443|NCT04405076|473180092|FG000|Part A (Blinded Phase)|Other than Specified|0|||
131425444|NCT04405076|473180093|FG001|Part A (Blinded Phase)|Other than Specified|0|||
131425445|NCT04405076|473180094|FG002|Part A (Blinded Phase)|Other than Specified|3|||
131425446|NCT04405076|473180095|FG003|Part A (Blinded Phase)|Other than Specified|0|||
131425447|NCT04405076|473180096|FG004|Part A (Blinded Phase)|Other than Specified|0|||
131425448|NCT04405076|473180097|FG005|Part A (Blinded Phase)|Other than Specified|0|||
131425449|NCT04405076|473180098|FG006|Part A (Blinded Phase)|Other than Specified|0|||
131425450|NCT04405076|473180099|FG007|Part A (Blinded Phase)|Other than Specified|0|||
131425451|NCT04405076|473180100|FG008|Part A (Blinded Phase)|Other than Specified|0|||
131425452|NCT04405076|473180092|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
131425453|NCT04405076|473180093|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
131425454|NCT04405076|473180094|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
131425455|NCT04405076|473180095|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
131425456|NCT04405076|473180096|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
131425457|NCT04405076|473180097|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
131425458|NCT04405076|473180098|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
131425459|NCT04405076|473180099|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
131425460|NCT04405076|473180100|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
131425461|NCT04405076|473180092|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425462|NCT04405076|473180093|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425463|NCT04405076|473180094|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425464|NCT04405076|473180095|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425465|NCT04405076|473180096|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
131425466|NCT04405076|473180097|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425467|NCT04405076|473180098|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425468|NCT04405076|473180099|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425469|NCT04405076|473180100|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
131425470|NCT04405076|473180092|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
131425471|NCT04405076|473180093|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
131425472|NCT04405076|473180094|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
131425473|NCT04405076|473180095|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
131425474|NCT04405076|473180096|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
131425475|NCT04405076|473180097|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
131425476|NCT04405076|473180098|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
131425477|NCT04405076|473180099|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
131425478|NCT04405076|473180100|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
131425479|NCT04405076|473180092|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425480|NCT04405076|473180093|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425481|NCT04405076|473180094|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425482|NCT04405076|473180095|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425483|NCT04405076|473180096|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425484|NCT04405076|473180097|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425485|NCT04405076|473180098|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
131425486|NCT04405076|473180099|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
131425487|NCT04405076|473180100|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
131425488|NCT04405076|473180092|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425489|NCT04405076|473180093|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131458051|NCT01657461|473308776|FG000|Overall Study|Physician Decision|0|||
131425490|NCT04405076|473180094|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425491|NCT04405076|473180095|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425492|NCT04405076|473180096|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425493|NCT04405076|473180097|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425494|NCT04405076|473180098|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
131425495|NCT04405076|473180099|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425496|NCT04405076|473180100|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
131425497|NCT00825812|473180101|FG000|Overall Study|Never entered follow up|0|||
131425498|NCT00825812|473180102|FG001|Overall Study|Never entered follow up|0|||
131425499|NCT00825812|473180103|FG002|Overall Study|Never entered follow up|0|||
131425500|NCT00825812|473180104|FG003|Overall Study|Never entered follow up|1|||
131425501|NCT00825812|473180101|FG000|Overall Study|Adverse Event|0|||
131425502|NCT00825812|473180102|FG001|Overall Study|Adverse Event|0|||
131425503|NCT00825812|473180103|FG002|Overall Study|Adverse Event|0|||
131425504|NCT00825812|473180104|FG003|Overall Study|Adverse Event|1|||
131425505|NCT00825812|473180101|FG000|Overall Study|Subject withdrew consent|0|||
131425506|NCT00825812|473180102|FG001|Overall Study|Subject withdrew consent|0|||
131425507|NCT00825812|473180103|FG002|Overall Study|Subject withdrew consent|3|||
131425508|NCT00825812|473180104|FG003|Overall Study|Subject withdrew consent|2|||
131425509|NCT00825812|473180101|FG000|Overall Study|Non-compliance with protocol|0|||
131425510|NCT00825812|473180102|FG001|Overall Study|Non-compliance with protocol|0|||
131425511|NCT00825812|473180103|FG002|Overall Study|Non-compliance with protocol|0|||
131425512|NCT00825812|473180104|FG003|Overall Study|Non-compliance with protocol|1|||
131425513|NCT00825812|473180101|FG000|Overall Study|Administrative|0|||
131425514|NCT00825812|473180102|FG001|Overall Study|Administrative|1|||
131425515|NCT00825812|473180103|FG002|Overall Study|Administrative|3|||
131425516|NCT00825812|473180104|FG003|Overall Study|Administrative|5|||
131425517|NCT00408434|473180107|FG000|Overall Study|Adverse Event|0|||
131425518|NCT00408434|473180108|FG001|Overall Study|Adverse Event|0|||
131425519|NCT00408434|473180109|FG002|Overall Study|Adverse Event|1|||
131425520|NCT00408434|473180110|FG003|Overall Study|Adverse Event|0|||
131425521|NCT00408434|473180111|FG004|Overall Study|Adverse Event|0|||
131425522|NCT00408434|473180112|FG005|Overall Study|Adverse Event|0|||
131425523|NCT00408434|473180113|FG006|Overall Study|Adverse Event|0|||
131425524|NCT00408434|473180107|FG000|Overall Study|Progressive disease|6|||
131425525|NCT00408434|473180108|FG001|Overall Study|Progressive disease|3|||
131425526|NCT00408434|473180109|FG002|Overall Study|Progressive disease|4|||
131425527|NCT00408434|473180110|FG003|Overall Study|Progressive disease|3|||
131425528|NCT00408434|473180111|FG004|Overall Study|Progressive disease|3|||
131425529|NCT00408434|473180112|FG005|Overall Study|Progressive disease|1|||
131425530|NCT00408434|473180113|FG006|Overall Study|Progressive disease|4|||
131425531|NCT00408434|473180107|FG000|Overall Study|Other|0|||
131425532|NCT00408434|473180108|FG001|Overall Study|Other|0|||
131425533|NCT00408434|473180109|FG002|Overall Study|Other|1|||
131425534|NCT00408434|473180110|FG003|Overall Study|Other|0|||
131425535|NCT00408434|473180111|FG004|Overall Study|Other|2|||
131425536|NCT00408434|473180112|FG005|Overall Study|Other|1|||
131425537|NCT00408434|473180113|FG006|Overall Study|Other|0|||
131425538|NCT00408434|473180107|FG000|Overall Study|Terminated by Investigator|0|||
131425539|NCT00408434|473180108|FG001|Overall Study|Terminated by Investigator|0|||
131425540|NCT00408434|473180109|FG002|Overall Study|Terminated by Investigator|0|||
131425541|NCT00408434|473180110|FG003|Overall Study|Terminated by Investigator|0|||
131425542|NCT00408434|473180111|FG004|Overall Study|Terminated by Investigator|1|||
131425543|NCT00408434|473180112|FG005|Overall Study|Terminated by Investigator|1|||
131425544|NCT00408434|473180113|FG006|Overall Study|Terminated by Investigator|0|||
131425545|NCT01278797|473180114|FG000|Period 1|Adverse Event|0|||
131425546|NCT01278797|473180115|FG001|Period 1|Adverse Event|1|||
131425547|NCT01278797|473180114|FG000|Period 1|Protocol Violation|1|||
131425548|NCT01278797|473180115|FG001|Period 1|Protocol Violation|0|||
131425549|NCT00588354|473180116|FG000|Baseline to 2 Weeks|Adverse Event|1|||
131425550|NCT00588354|473180117|FG001|Baseline to 2 Weeks|Adverse Event|0|||
131425551|NCT00588354|473180116|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
131425552|NCT00588354|473180117|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
131425553|NCT00588354|473180116|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
131425554|NCT00588354|473180117|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
131425555|NCT04000581|473180118|FG000|Overall Study|Withdrawal by Subject|0|||
131425556|NCT04000581|473180119|FG001|Overall Study|Withdrawal by Subject|1|||
131425557|NCT00211887|473180120|FG000|Overall Study|Adverse Event|8|||
131425558|NCT00211887|473180121|FG001|Overall Study|Adverse Event|4|||
131425559|NCT00211887|473180122|FG002|Overall Study|Adverse Event|6|||
131425560|NCT00211887|473180120|FG000|Overall Study|Death|1|||
131425561|NCT00211887|473180121|FG001|Overall Study|Death|1|||
131425562|NCT00211887|473180122|FG002|Overall Study|Death|1|||
131425563|NCT00211887|473180120|FG000|Overall Study|Lost to Follow-up|28|||
131425564|NCT00211887|473180121|FG001|Overall Study|Lost to Follow-up|13|||
131425565|NCT00211887|473180122|FG002|Overall Study|Lost to Follow-up|9|||
131425566|NCT00211887|473180120|FG000|Overall Study|Non-medical reason|31|||
131425567|NCT00211887|473180121|FG001|Overall Study|Non-medical reason|14|||
131425568|NCT00211887|473180122|FG002|Overall Study|Non-medical reason|8|||
131425569|NCT00211887|473180120|FG000|Overall Study|Other medical reason|15|||
131425570|NCT00211887|473180121|FG001|Overall Study|Other medical reason|11|||
131425571|NCT00211887|473180122|FG002|Overall Study|Other medical reason|7|||
131425572|NCT00211887|473180120|FG000|Overall Study|Side effects|19|||
131425573|NCT00211887|473180121|FG001|Overall Study|Side effects|13|||
131425574|NCT00211887|473180122|FG002|Overall Study|Side effects|5|||
131425575|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Adverse Event|33|||
131425576|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
131425577|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
131425578|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
131425579|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Physician Decision|6|||
131425580|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
131425581|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
131425582|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
131425583|NCT00965419|473180126|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
131425584|NCT00965419|473180126|FG000|Follow-up Phase|Adverse Event|9|||
131425585|NCT00965419|473180126|FG000|Follow-up Phase|Protocol Violation|4|||
131425586|NCT00965419|473180126|FG000|Follow-up Phase|Withdrawal by Subject|8|||
131425587|NCT00965419|473180126|FG000|Follow-up Phase|Physician Decision|4|||
131425588|NCT00965419|473180126|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
131425589|NCT00965419|473180126|FG000|Follow-up Phase|Lack of Efficacy|28|||
131425590|NCT03712787|473182400|FG000|Overall Study|Adverse Event|2|||
131425591|NCT03712787|473182401|FG001|Overall Study|Adverse Event|3|||
131425592|NCT03712787|473182402|FG002|Overall Study|Adverse Event|0|||
131425593|NCT03712787|473182403|FG003|Overall Study|Adverse Event|4|||
131425594|NCT03712787|473182400|FG000|Overall Study|Withdrawal by Subject|4|||
131425595|NCT03712787|473182401|FG001|Overall Study|Withdrawal by Subject|14|||
131425596|NCT03712787|473182402|FG002|Overall Study|Withdrawal by Subject|12|||
131425597|NCT03712787|473182403|FG003|Overall Study|Withdrawal by Subject|8|||
131425598|NCT03712787|473182400|FG000|Overall Study|Lost to Follow-up|1|||
131425599|NCT03712787|473182401|FG001|Overall Study|Lost to Follow-up|1|||
131425600|NCT03712787|473182402|FG002|Overall Study|Lost to Follow-up|2|||
131425601|NCT03712787|473182403|FG003|Overall Study|Lost to Follow-up|1|||
131425602|NCT03712787|473182400|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
131425603|NCT03712787|473182401|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
131425604|NCT03712787|473182402|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
131425605|NCT03712787|473182403|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
131425606|NCT03712787|473182400|FG000|Overall Study|COVID-19 Infection|0|||
131425607|NCT03712787|473182401|FG001|Overall Study|COVID-19 Infection|1|||
131425608|NCT03712787|473182402|FG002|Overall Study|COVID-19 Infection|0|||
131425609|NCT03712787|473182403|FG003|Overall Study|COVID-19 Infection|0|||
131425610|NCT03712787|473182400|FG000|Overall Study|Other, Not Specified|79|||
131425611|NCT03712787|473182401|FG001|Overall Study|Other, Not Specified|77|||
131425612|NCT03712787|473182402|FG002|Overall Study|Other, Not Specified|74|||
131425613|NCT03712787|473182403|FG003|Overall Study|Other, Not Specified|78|||
131425614|NCT05128578|473182404|FG000|Overall Study|Withdrawal by Subject|9|||
131425615|NCT05128578|473182404|FG000|Overall Study|Lost to Follow-up|5|||
131425616|NCT00801229|473182409|FG000|Signed Consent|Withdrawal by Subject|2|||
131425617|NCT00801229|473182410|FG001|Signed Consent|Withdrawal by Subject|2|||
131425618|NCT00801229|473182409|FG000|Signed Consent|Found Ineligible|1|||
131425619|NCT00801229|473182410|FG001|Signed Consent|Found Ineligible|1|||
131425620|NCT00801229|473182409|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
131425621|NCT00801229|473182410|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
131425622|NCT00801229|473182409|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
131425623|NCT00801229|473182410|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
131425624|NCT00801229|473182409|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
131425625|NCT00801229|473182410|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
131425626|NCT00801229|473182409|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
131425627|NCT00801229|473182410|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
131425628|NCT00801229|473182409|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
131425629|NCT00801229|473182410|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
131425630|NCT00801229|473182409|FG000|Received Study Drug/Placebo|Adverse Event|1|||
131425631|NCT00801229|473182410|FG001|Received Study Drug/Placebo|Adverse Event|1|||
131425632|NCT02610777|473182411|FG000|Overall Study|Lost to Follow-up|1|||
131425633|NCT02610777|473182412|FG001|Overall Study|Lost to Follow-up|0|||
131425634|NCT02610777|473182411|FG000|Overall Study|Site Terminated by Sponsor|9|||
131425635|NCT02610777|473182412|FG001|Overall Study|Site Terminated by Sponsor|8|||
131425636|NCT02610777|473182411|FG000|Overall Study|Withdrawal by Subject|2|||
131425637|NCT02610777|473182412|FG001|Overall Study|Withdrawal by Subject|2|||
131425638|NCT02610777|473182411|FG000|Overall Study|Reason not Specified|0|||
131425639|NCT02610777|473182412|FG001|Overall Study|Reason not Specified|1|||
131425640|NCT02610777|473182411|FG000|Overall Study|Death|50|||
131425641|NCT02610777|473182412|FG001|Overall Study|Death|47|||
131425642|NCT00732875|473182413|FG000|Overall Study|Adverse Event|16|||
131425643|NCT00732875|473182413|FG000|Overall Study|Withdrawal by Subject|6|||
131425644|NCT00732875|473182413|FG000|Overall Study|Lack of Efficacy|13|||
131425645|NCT02300259|473182414|FG000|Period 1|Adverse Event|0|||
131425646|NCT02300259|473182415|FG001|Period 1|Adverse Event|0|||
131425647|NCT02300259|473182416|FG002|Period 1|Adverse Event|1|||
131425648|NCT02300259|473182414|FG000|Period 1|Withdrawal by Subject|0|||
131425649|NCT02300259|473182415|FG001|Period 1|Withdrawal by Subject|0|||
131425650|NCT02300259|473182416|FG002|Period 1|Withdrawal by Subject|1|||
131425651|NCT02300259|473182414|FG000|Period 2|Adverse Event|1|||
131425652|NCT02300259|473182415|FG001|Period 2|Adverse Event|0|||
131425653|NCT02300259|473182416|FG002|Period 2|Adverse Event|0|||
131425654|NCT02300259|473182414|FG000|Period 2|Withdrawal by Subject|0|||
131425655|NCT02300259|473182415|FG001|Period 2|Withdrawal by Subject|0|||
131425656|NCT02300259|473182416|FG002|Period 2|Withdrawal by Subject|1|||
131425657|NCT02737475|473182417|FG000|Overall Study|Other reasons|0|||
131425658|NCT02737475|473182418|FG001|Overall Study|Other reasons|0|||
131425659|NCT02737475|473182419|FG002|Overall Study|Other reasons|0|||
131425660|NCT02737475|473182420|FG003|Overall Study|Other reasons|0|||
131425661|NCT02737475|473182421|FG004|Overall Study|Other reasons|1|||
131425662|NCT02737475|473182422|FG005|Overall Study|Other reasons|1|||
131425663|NCT02737475|473182423|FG006|Overall Study|Other reasons|0|||
131425664|NCT02737475|473182424|FG007|Overall Study|Other reasons|0|||
131425665|NCT02737475|473182425|FG008|Overall Study|Other reasons|1|||
131425666|NCT02737475|473182426|FG009|Overall Study|Other reasons|0|||
131425667|NCT02737475|473182427|FG010|Overall Study|Other reasons|1|||
131425668|NCT02737475|473182428|FG011|Overall Study|Other reasons|0|||
131425669|NCT02737475|473182429|FG012|Overall Study|Other reasons|0|||
131425670|NCT02737475|473182430|FG013|Overall Study|Other reasons|0|||
131425671|NCT02737475|473182431|FG014|Overall Study|Other reasons|0|||
131425672|NCT02737475|473182432|FG015|Overall Study|Other reasons|0|||
131425673|NCT02737475|473182433|FG016|Overall Study|Other reasons|0|||
131425674|NCT02737475|473182434|FG017|Overall Study|Other reasons|0|||
131425675|NCT02737475|473182435|FG018|Overall Study|Other reasons|0|||
131425676|NCT02737475|473182436|FG019|Overall Study|Other reasons|0|||
131425677|NCT02737475|473182437|FG020|Overall Study|Other reasons|0|||
131425678|NCT02737475|473182438|FG021|Overall Study|Other reasons|1|||
131425679|NCT02737475|473182439|FG022|Overall Study|Other reasons|0|||
131425680|NCT02737475|473182440|FG023|Overall Study|Other reasons|1|||
131425681|NCT02737475|473182441|FG024|Overall Study|Other reasons|1|||
131425682|NCT02737475|473182442|FG025|Overall Study|Other reasons|1|||
131425683|NCT02737475|473182443|FG026|Overall Study|Other reasons|0|||
131425684|NCT02737475|473182417|FG000|Overall Study|Death|1|||
131425685|NCT02737475|473182418|FG001|Overall Study|Death|0|||
131425686|NCT02737475|473182419|FG002|Overall Study|Death|0|||
131425687|NCT02737475|473182420|FG003|Overall Study|Death|1|||
131425688|NCT02737475|473182421|FG004|Overall Study|Death|0|||
131425689|NCT02737475|473182422|FG005|Overall Study|Death|0|||
131425690|NCT02737475|473182423|FG006|Overall Study|Death|0|||
131425691|NCT02737475|473182424|FG007|Overall Study|Death|2|||
131425692|NCT02737475|473182425|FG008|Overall Study|Death|0|||
131425693|NCT02737475|473182426|FG009|Overall Study|Death|0|||
131425694|NCT02737475|473182427|FG010|Overall Study|Death|0|||
131425695|NCT02737475|473182428|FG011|Overall Study|Death|4|||
131425696|NCT02737475|473182429|FG012|Overall Study|Death|2|||
131425697|NCT02737475|473182430|FG013|Overall Study|Death|2|||
131425698|NCT02737475|473182431|FG014|Overall Study|Death|0|||
131425699|NCT02737475|473182432|FG015|Overall Study|Death|2|||
131425700|NCT02737475|473182433|FG016|Overall Study|Death|2|||
131425701|NCT02737475|473182434|FG017|Overall Study|Death|2|||
131425702|NCT02737475|473182435|FG018|Overall Study|Death|1|||
131425703|NCT02737475|473182436|FG019|Overall Study|Death|0|||
131425704|NCT02737475|473182437|FG020|Overall Study|Death|0|||
131425705|NCT02737475|473182438|FG021|Overall Study|Death|0|||
131425706|NCT02737475|473182439|FG022|Overall Study|Death|0|||
131425707|NCT02737475|473182440|FG023|Overall Study|Death|0|||
131425708|NCT02737475|473182441|FG024|Overall Study|Death|0|||
131425709|NCT02737475|473182442|FG025|Overall Study|Death|0|||
131425710|NCT02737475|473182443|FG026|Overall Study|Death|0|||
131425711|NCT02737475|473182417|FG000|Overall Study|Participant withdrew consent|0|||
131425712|NCT02737475|473182418|FG001|Overall Study|Participant withdrew consent|0|||
131425713|NCT02737475|473182419|FG002|Overall Study|Participant withdrew consent|0|||
131425714|NCT02737475|473182420|FG003|Overall Study|Participant withdrew consent|0|||
131425715|NCT02737475|473182421|FG004|Overall Study|Participant withdrew consent|0|||
131425716|NCT02737475|473182422|FG005|Overall Study|Participant withdrew consent|2|||
131425717|NCT02737475|473182423|FG006|Overall Study|Participant withdrew consent|0|||
131425718|NCT02737475|473182424|FG007|Overall Study|Participant withdrew consent|0|||
131425719|NCT02737475|473182425|FG008|Overall Study|Participant withdrew consent|0|||
131425720|NCT02737475|473182426|FG009|Overall Study|Participant withdrew consent|0|||
131425721|NCT02737475|473182427|FG010|Overall Study|Participant withdrew consent|0|||
131425722|NCT02737475|473182428|FG011|Overall Study|Participant withdrew consent|0|||
131425723|NCT02737475|473182429|FG012|Overall Study|Participant withdrew consent|0|||
131425724|NCT02737475|473182430|FG013|Overall Study|Participant withdrew consent|0|||
131425725|NCT02737475|473182431|FG014|Overall Study|Participant withdrew consent|1|||
131425726|NCT02737475|473182432|FG015|Overall Study|Participant withdrew consent|0|||
131425727|NCT02737475|473182433|FG016|Overall Study|Participant withdrew consent|0|||
131425728|NCT02737475|473182434|FG017|Overall Study|Participant withdrew consent|2|||
131425729|NCT02737475|473182435|FG018|Overall Study|Participant withdrew consent|1|||
131425730|NCT02737475|473182436|FG019|Overall Study|Participant withdrew consent|0|||
131425731|NCT02737475|473182437|FG020|Overall Study|Participant withdrew consent|2|||
131425732|NCT02737475|473182438|FG021|Overall Study|Participant withdrew consent|0|||
131425733|NCT02737475|473182439|FG022|Overall Study|Participant withdrew consent|0|||
131425734|NCT02737475|473182440|FG023|Overall Study|Participant withdrew consent|0|||
131425735|NCT02737475|473182441|FG024|Overall Study|Participant withdrew consent|0|||
131425736|NCT02737475|473182442|FG025|Overall Study|Participant withdrew consent|0|||
131425737|NCT02737475|473182443|FG026|Overall Study|Participant withdrew consent|0|||
131425738|NCT02737475|473182417|FG000|Overall Study|Lost to Follow-up|0|||
131425739|NCT02737475|473182418|FG001|Overall Study|Lost to Follow-up|0|||
131425740|NCT02737475|473182419|FG002|Overall Study|Lost to Follow-up|0|||
131425741|NCT02737475|473182420|FG003|Overall Study|Lost to Follow-up|0|||
131425742|NCT02737475|473182421|FG004|Overall Study|Lost to Follow-up|0|||
131425743|NCT02737475|473182422|FG005|Overall Study|Lost to Follow-up|0|||
131425744|NCT02737475|473182423|FG006|Overall Study|Lost to Follow-up|0|||
131425745|NCT02737475|473182424|FG007|Overall Study|Lost to Follow-up|0|||
131425746|NCT02737475|473182425|FG008|Overall Study|Lost to Follow-up|0|||
131425747|NCT02737475|473182426|FG009|Overall Study|Lost to Follow-up|0|||
131425748|NCT02737475|473182427|FG010|Overall Study|Lost to Follow-up|0|||
131425749|NCT02737475|473182428|FG011|Overall Study|Lost to Follow-up|0|||
131425750|NCT02737475|473182429|FG012|Overall Study|Lost to Follow-up|0|||
131425751|NCT02737475|473182430|FG013|Overall Study|Lost to Follow-up|0|||
131425752|NCT02737475|473182431|FG014|Overall Study|Lost to Follow-up|0|||
131425753|NCT02737475|473182432|FG015|Overall Study|Lost to Follow-up|1|||
131425754|NCT02737475|473182433|FG016|Overall Study|Lost to Follow-up|0|||
131425755|NCT02737475|473182434|FG017|Overall Study|Lost to Follow-up|0|||
131425756|NCT02737475|473182435|FG018|Overall Study|Lost to Follow-up|0|||
131425757|NCT02737475|473182436|FG019|Overall Study|Lost to Follow-up|0|||
131425758|NCT02737475|473182437|FG020|Overall Study|Lost to Follow-up|0|||
131425759|NCT02737475|473182438|FG021|Overall Study|Lost to Follow-up|0|||
131425760|NCT02737475|473182439|FG022|Overall Study|Lost to Follow-up|0|||
131425761|NCT02737475|473182440|FG023|Overall Study|Lost to Follow-up|0|||
131425762|NCT02737475|473182441|FG024|Overall Study|Lost to Follow-up|0|||
131425763|NCT02737475|473182442|FG025|Overall Study|Lost to Follow-up|0|||
131425764|NCT02737475|473182443|FG026|Overall Study|Lost to Follow-up|0|||
131425765|NCT02737475|473182417|FG000|Overall Study|Disease Progression|0|||
131425766|NCT02737475|473182418|FG001|Overall Study|Disease Progression|0|||
131425767|NCT02737475|473182419|FG002|Overall Study|Disease Progression|0|||
131425768|NCT02737475|473182420|FG003|Overall Study|Disease Progression|0|||
131425769|NCT02737475|473182421|FG004|Overall Study|Disease Progression|0|||
131425770|NCT02737475|473182422|FG005|Overall Study|Disease Progression|0|||
131425771|NCT02737475|473182423|FG006|Overall Study|Disease Progression|0|||
131425772|NCT02737475|473182424|FG007|Overall Study|Disease Progression|0|||
131425773|NCT02737475|473182425|FG008|Overall Study|Disease Progression|0|||
131425774|NCT02737475|473182426|FG009|Overall Study|Disease Progression|0|||
131425775|NCT02737475|473182427|FG010|Overall Study|Disease Progression|0|||
131425776|NCT02737475|473182428|FG011|Overall Study|Disease Progression|0|||
131425777|NCT02737475|473182429|FG012|Overall Study|Disease Progression|0|||
131425778|NCT02737475|473182430|FG013|Overall Study|Disease Progression|0|||
131425779|NCT02737475|473182431|FG014|Overall Study|Disease Progression|0|||
131425780|NCT02737475|473182432|FG015|Overall Study|Disease Progression|0|||
131425781|NCT02737475|473182433|FG016|Overall Study|Disease Progression|0|||
131425782|NCT02737475|473182434|FG017|Overall Study|Disease Progression|0|||
131425783|NCT02737475|473182435|FG018|Overall Study|Disease Progression|0|||
131425784|NCT02737475|473182436|FG019|Overall Study|Disease Progression|0|||
131425785|NCT02737475|473182437|FG020|Overall Study|Disease Progression|0|||
131425786|NCT02737475|473182438|FG021|Overall Study|Disease Progression|0|||
131425787|NCT02737475|473182439|FG022|Overall Study|Disease Progression|0|||
131425788|NCT02737475|473182440|FG023|Overall Study|Disease Progression|0|||
131425789|NCT02737475|473182441|FG024|Overall Study|Disease Progression|0|||
131425790|NCT02737475|473182442|FG025|Overall Study|Disease Progression|0|||
131425791|NCT02737475|473182443|FG026|Overall Study|Disease Progression|1|||
131425792|NCT03688074|473182444|FG000|Overall Study|Adverse Event|0|||
131425793|NCT03688074|473182445|FG001|Overall Study|Adverse Event|1|||
131425794|NCT03688074|473182444|FG000|Overall Study|Other|1|||
131425795|NCT03688074|473182445|FG001|Overall Study|Other|0|||
131425796|NCT00660179|473182447|FG000|Overall Study|Death|44|||
131425797|NCT00660179|473182448|FG001|Overall Study|Death|47|||
131425798|NCT00660179|473182449|FG002|Overall Study|Death|34|||
131425799|NCT00660179|473182447|FG000|Overall Study|Withdrawal of consent|4|||
131425800|NCT00660179|473182448|FG001|Overall Study|Withdrawal of consent|6|||
131425801|NCT00660179|473182449|FG002|Overall Study|Withdrawal of consent|4|||
131425802|NCT00660179|473182447|FG000|Overall Study|Lost to Follow-up|7|||
131425803|NCT00660179|473182448|FG001|Overall Study|Lost to Follow-up|5|||
131425804|NCT00660179|473182449|FG002|Overall Study|Lost to Follow-up|2|||
131425805|NCT00660179|473182447|FG000|Overall Study|Administrative reason|0|||
131425806|NCT00660179|473182448|FG001|Overall Study|Administrative reason|0|||
131425807|NCT00660179|473182449|FG002|Overall Study|Administrative reason|1|||
131425808|NCT00660179|473182447|FG000|Overall Study|Incorrect randomization|1|||
131425809|NCT00660179|473182448|FG001|Overall Study|Incorrect randomization|0|||
131425810|NCT00660179|473182449|FG002|Overall Study|Incorrect randomization|0|||
131425811|NCT02255461|473182450|FG000|Overall Study|Adverse Event|0|||
131425812|NCT02255461|473182451|FG001|Overall Study|Adverse Event|1|||
131425813|NCT02255461|473182452|FG002|Overall Study|Adverse Event|0|||
131425814|NCT02255461|473182453|FG003|Overall Study|Adverse Event|0|||
131425815|NCT02255461|473182454|FG004|Overall Study|Adverse Event|1|||
131425816|NCT02255461|473182450|FG000|Overall Study|Withdrawal by Subject|0|||
131425817|NCT02255461|473182451|FG001|Overall Study|Withdrawal by Subject|0|||
131425818|NCT02255461|473182452|FG002|Overall Study|Withdrawal by Subject|1|||
131425819|NCT02255461|473182453|FG003|Overall Study|Withdrawal by Subject|0|||
131425820|NCT02255461|473182454|FG004|Overall Study|Withdrawal by Subject|1|||
131425821|NCT02255461|473182450|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
131425822|NCT02255461|473182451|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
131425823|NCT02255461|473182452|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
131425824|NCT02255461|473182453|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
131425825|NCT02255461|473182454|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
131425826|NCT03056339|473182459|FG000|Overall Study|Failed Requirements|0|||
131425827|NCT03056339|473182460|FG001|Overall Study|Failed Requirements|2|||
131425828|NCT03056339|473182461|FG002|Overall Study|Failed Requirements|7|||
131425829|NCT03056339|473182462|FG003|Overall Study|Failed Requirements|1|||
131425830|NCT01504412|473182465|FG000|Overall Study|Adverse Event|1|||
131425831|NCT01504412|473182466|FG001|Overall Study|Adverse Event|8|||
131425832|NCT01504412|473182467|FG002|Overall Study|Adverse Event|1|||
131425833|NCT01504412|473182468|FG003|Overall Study|Adverse Event|7|||
131425834|NCT01504412|473182469|FG004|Overall Study|Adverse Event|10|||
131425835|NCT01504412|473182465|FG000|Overall Study|Withdrawal by Subject|2|||
131458052|NCT01657461|473308777|FG001|Overall Study|Physician Decision|2|||
131458053|NCT01657461|473308776|FG000|Overall Study|Withdrawal by Subject|1|||
131425836|NCT01504412|473182466|FG001|Overall Study|Withdrawal by Subject|1|||
131425837|NCT01504412|473182467|FG002|Overall Study|Withdrawal by Subject|1|||
131425838|NCT01504412|473182468|FG003|Overall Study|Withdrawal by Subject|5|||
131425839|NCT01504412|473182469|FG004|Overall Study|Withdrawal by Subject|1|||
131458054|NCT01657461|473308777|FG001|Overall Study|Withdrawal by Subject|3|||
131458055|NCT01868542|473308778|FG000|Overall Study|Protocol Violation|0|||
131425840|NCT01504412|473182465|FG000|Overall Study|Other|2|||
131425841|NCT01504412|473182466|FG001|Overall Study|Other|1|||
131425842|NCT01504412|473182467|FG002|Overall Study|Other|1|||
131425843|NCT01504412|473182468|FG003|Overall Study|Other|6|||
131458056|NCT01868542|473308779|FG001|Overall Study|Protocol Violation|1|||
131425844|NCT01504412|473182469|FG004|Overall Study|Other|1|||
131425845|NCT01504412|473182465|FG000|Overall Study|Lost to Follow-up|0|||
131458057|NCT01868542|473308778|FG000|Overall Study|Unclassified|0|||
131425846|NCT01504412|473182466|FG001|Overall Study|Lost to Follow-up|2|||
131425847|NCT01504412|473182467|FG002|Overall Study|Lost to Follow-up|0|||
131425848|NCT01504412|473182468|FG003|Overall Study|Lost to Follow-up|0|||
131425849|NCT01504412|473182469|FG004|Overall Study|Lost to Follow-up|0|||
131425850|NCT01504412|473182465|FG000|Overall Study|Lack of Efficacy|0|||
131425851|NCT01504412|473182466|FG001|Overall Study|Lack of Efficacy|0|||
131425852|NCT01504412|473182467|FG002|Overall Study|Lack of Efficacy|1|||
131425853|NCT01504412|473182468|FG003|Overall Study|Lack of Efficacy|0|||
131425854|NCT01504412|473182469|FG004|Overall Study|Lack of Efficacy|1|||
131425855|NCT01504412|473182465|FG000|Overall Study|Death|0|||
131425856|NCT01504412|473182466|FG001|Overall Study|Death|0|||
131425857|NCT01504412|473182467|FG002|Overall Study|Death|0|||
131425858|NCT01504412|473182468|FG003|Overall Study|Death|1|||
131425859|NCT01504412|473182469|FG004|Overall Study|Death|0|||
131425860|NCT04809285|473182476|FG000|Phase 1|Lost to Follow-up|6|||
131425861|NCT04809285|473182476|FG000|Phase 1|Protocol Violation|2|||
131425862|NCT04809285|473182476|FG000|Phase 1|Physician Decision|3|||
131425863|NCT04809285|473182476|FG000|Phase 1|Withdrawal by Subject|29|||
131425864|NCT04809285|473182476|FG000|Phase 2|Protocol Violation|3|||
131425865|NCT04809285|473182476|FG000|Phase 2|Withdrawal by Subject|4|||
131425866|NCT02630472|473182481|FG000|Overall Study|Physician Decision|10|||
131425867|NCT02630472|473182482|FG001|Overall Study|Physician Decision|0|||
131425868|NCT04878211|473182483|FG000|Overall Study|Lost to Follow-up|0|||
131425869|NCT04878211|473182484|FG001|Overall Study|Lost to Follow-up|0|||
131425870|NCT04878211|473182485|FG002|Overall Study|Lost to Follow-up|0|||
131425871|NCT04878211|473182486|FG003|Overall Study|Lost to Follow-up|1|||
131425872|NCT04878211|473182487|FG004|Overall Study|Lost to Follow-up|0|||
131425873|NCT04878211|473182488|FG005|Overall Study|Lost to Follow-up|1|||
131425874|NCT04878211|473182483|FG000|Overall Study|Protocol deviation|1|||
131425875|NCT04878211|473182484|FG001|Overall Study|Protocol deviation|0|||
131425876|NCT04878211|473182485|FG002|Overall Study|Protocol deviation|0|||
131425877|NCT04878211|473182486|FG003|Overall Study|Protocol deviation|0|||
131425878|NCT04878211|473182487|FG004|Overall Study|Protocol deviation|0|||
131425879|NCT04878211|473182488|FG005|Overall Study|Protocol deviation|0|||
131458058|NCT01868542|473308779|FG001|Overall Study|Unclassified|1|||
131458059|NCT00122980|473308780|FG000|Overall Study|Death|0|||
131458060|NCT00122980|473308781|FG001|Overall Study|Death|1|||
131458061|NCT00122980|473308780|FG000|Overall Study|Physician Decision|2|||
131458062|NCT00122980|473308781|FG001|Overall Study|Physician Decision|0|||
131458063|NCT00122980|473308780|FG000|Overall Study|Protocol Violation|5|||
131458064|NCT00122980|473308781|FG001|Overall Study|Protocol Violation|1|||
131458065|NCT00122980|473308780|FG000|Overall Study|Withdrawal by Subject|2|||
131458066|NCT00122980|473308781|FG001|Overall Study|Withdrawal by Subject|3|||
131458067|NCT00122980|473308780|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
131458068|NCT00122980|473308781|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
131458069|NCT00122980|473308780|FG000|Overall Study|Study termination|27|||
131425880|NCT04878211|473182483|FG000|Overall Study|Study terminated by sponsor|0|||
131458070|NCT00122980|473308781|FG001|Overall Study|Study termination|35|||
131458071|NCT01124864|473308782|FG000|Overall Study|Follow up phase competed as per protocol|18|||
131425881|NCT04878211|473182484|FG001|Overall Study|Study terminated by sponsor|0|||
131425882|NCT04878211|473182485|FG002|Overall Study|Study terminated by sponsor|0|||
131458072|NCT01124864|473308783|FG001|Overall Study|Follow up phase competed as per protocol|22|||
131425883|NCT04878211|473182486|FG003|Overall Study|Study terminated by sponsor|0|||
131425884|NCT04878211|473182487|FG004|Overall Study|Study terminated by sponsor|9|||
131425885|NCT04878211|473182488|FG005|Overall Study|Study terminated by sponsor|4|||
131425886|NCT04878211|473182483|FG000|Overall Study|Subject decision|0|||
131425887|NCT04878211|473182484|FG001|Overall Study|Subject decision|0|||
131425888|NCT04878211|473182485|FG002|Overall Study|Subject decision|0|||
131425889|NCT04878211|473182486|FG003|Overall Study|Subject decision|0|||
131425890|NCT04878211|473182487|FG004|Overall Study|Subject decision|1|||
131425891|NCT04878211|473182488|FG005|Overall Study|Subject decision|0|||
131425892|NCT02206035|473182489|FG000|Overall Study|Physician Decision|10|||
131425893|NCT02206035|473182490|FG001|Overall Study|Physician Decision|0|||
131425894|NCT02206035|473182491|FG002|Overall Study|Physician Decision|175|||
131425895|NCT03668613|473182492|FG000|Overall Study|Adverse Event|1|||
131425896|NCT03668613|473182493|FG001|Overall Study|Adverse Event|2|||
131425897|NCT03668613|473182492|FG000|Overall Study|Lack of Efficacy|5|||
131425898|NCT03668613|473182493|FG001|Overall Study|Lack of Efficacy|1|||
131425899|NCT03668613|473182492|FG000|Overall Study|Pregnancy|0|||
131425900|NCT03668613|473182493|FG001|Overall Study|Pregnancy|2|||
131425901|NCT03668613|473182492|FG000|Overall Study|Protocol Violation|1|||
131425902|NCT03668613|473182493|FG001|Overall Study|Protocol Violation|0|||
131425903|NCT03668613|473182492|FG000|Overall Study|Physician Decision|1|||
131425904|NCT03668613|473182493|FG001|Overall Study|Physician Decision|0|||
131425905|NCT03668613|473182492|FG000|Overall Study|Withdrawal by Subject|2|||
131425906|NCT03668613|473182493|FG001|Overall Study|Withdrawal by Subject|1|||
131425907|NCT03668613|473182492|FG000|Overall Study|Guardian decision|1|||
131425908|NCT03668613|473182493|FG001|Overall Study|Guardian decision|0|||
131425909|NCT01393821|473182494|FG000|Overall Study|Cancel|1|||
131425910|NCT01393821|473182495|FG001|Overall Study|Cancel|1|||
131425911|NCT01393821|473182494|FG000|Overall Study|not evaluable for primary endpoint|4|||
131425912|NCT01393821|473182495|FG001|Overall Study|not evaluable for primary endpoint|2|||
131425913|NCT03386487|473182496|FG000|Overall Study|Lost to Follow-up|5|||
131425914|NCT03386487|473182497|FG001|Overall Study|Lost to Follow-up|6|||
131425915|NCT03386487|473182496|FG000|Overall Study|Withdrawal by Subject|11|||
131425916|NCT03386487|473182497|FG001|Overall Study|Withdrawal by Subject|7|||
131425917|NCT03386487|473182496|FG000|Overall Study|Physician Decision|11|||
131425918|NCT03386487|473182497|FG001|Overall Study|Physician Decision|8|||
131425919|NCT04303572|473182498|FG000|Overall Study|Study closed due to poor enrollment|1|||
131425920|NCT01858766|473182499|FG000|Overall Study|Randomized but Never Treated|0|||
131425921|NCT01858766|473182500|FG001|Overall Study|Randomized but Never Treated|0|||
131425922|NCT01858766|473182501|FG002|Overall Study|Randomized but Never Treated|0|||
131425923|NCT01858766|473182502|FG003|Overall Study|Randomized but Never Treated|0|||
131425924|NCT01858766|473182503|FG004|Overall Study|Randomized but Never Treated|0|||
131425925|NCT01858766|473182504|FG005|Overall Study|Randomized but Never Treated|1|||
131425926|NCT01858766|473182505|FG006|Overall Study|Randomized but Never Treated|0|||
131425927|NCT01858766|473182506|FG007|Overall Study|Randomized but Never Treated|0|||
131425928|NCT01858766|473182507|FG008|Overall Study|Randomized but Never Treated|0|||
131425929|NCT01858766|473182508|FG009|Overall Study|Randomized but Never Treated|0|||
131425930|NCT01858766|473182509|FG010|Overall Study|Randomized but Never Treated|0|||
131425931|NCT01858766|473182510|FG011|Overall Study|Randomized but Never Treated|0|||
131425932|NCT01858766|473182511|FG012|Overall Study|Randomized but Never Treated|0|||
131425933|NCT01858766|473182512|FG013|Overall Study|Randomized but Never Treated|0|||
131425934|NCT01858766|473182513|FG014|Overall Study|Randomized but Never Treated|0|||
131425935|NCT01858766|473182514|FG015|Overall Study|Randomized but Never Treated|0|||
131425936|NCT01858766|473182515|FG016|Overall Study|Randomized but Never Treated|0|||
131425937|NCT01858766|473182516|FG017|Overall Study|Randomized but Never Treated|1|||
131425938|NCT01858766|473182517|FG018|Overall Study|Randomized but Never Treated|0|||
131425939|NCT01858766|473182499|FG000|Overall Study|Death|0|||
131425940|NCT01858766|473182500|FG001|Overall Study|Death|0|||
131425941|NCT01858766|473182501|FG002|Overall Study|Death|1|||
131425942|NCT01858766|473182502|FG003|Overall Study|Death|0|||
131425943|NCT01858766|473182503|FG004|Overall Study|Death|0|||
131425944|NCT01858766|473182504|FG005|Overall Study|Death|0|||
131425945|NCT01858766|473182505|FG006|Overall Study|Death|0|||
131425946|NCT01858766|473182506|FG007|Overall Study|Death|0|||
131425947|NCT01858766|473182507|FG008|Overall Study|Death|0|||
131425948|NCT01858766|473182508|FG009|Overall Study|Death|0|||
131425949|NCT01858766|473182509|FG010|Overall Study|Death|0|||
131425950|NCT01858766|473182510|FG011|Overall Study|Death|0|||
131425951|NCT01858766|473182511|FG012|Overall Study|Death|0|||
131425952|NCT01858766|473182512|FG013|Overall Study|Death|0|||
131425953|NCT01858766|473182513|FG014|Overall Study|Death|0|||
131458073|NCT01124864|473308784|FG002|Overall Study|Follow up phase competed as per protocol|24|||
131425954|NCT01858766|473182514|FG015|Overall Study|Death|0|||
131425955|NCT01858766|473182515|FG016|Overall Study|Death|0|||
131425956|NCT01858766|473182516|FG017|Overall Study|Death|0|||
131425957|NCT01858766|473182517|FG018|Overall Study|Death|0|||
131425958|NCT01858766|473182499|FG000|Overall Study|Lack of Efficacy|1|||
131425959|NCT01858766|473182500|FG001|Overall Study|Lack of Efficacy|0|||
131425960|NCT01858766|473182501|FG002|Overall Study|Lack of Efficacy|0|||
131425961|NCT01858766|473182502|FG003|Overall Study|Lack of Efficacy|0|||
131425962|NCT01858766|473182503|FG004|Overall Study|Lack of Efficacy|1|||
131425963|NCT01858766|473182504|FG005|Overall Study|Lack of Efficacy|2|||
131425964|NCT01858766|473182505|FG006|Overall Study|Lack of Efficacy|0|||
131425965|NCT01858766|473182506|FG007|Overall Study|Lack of Efficacy|0|||
131425966|NCT01858766|473182507|FG008|Overall Study|Lack of Efficacy|0|||
131425967|NCT01858766|473182508|FG009|Overall Study|Lack of Efficacy|0|||
131425968|NCT01858766|473182509|FG010|Overall Study|Lack of Efficacy|0|||
131425969|NCT01858766|473182510|FG011|Overall Study|Lack of Efficacy|3|||
131425970|NCT01858766|473182511|FG012|Overall Study|Lack of Efficacy|5|||
131425971|NCT01858766|473182512|FG013|Overall Study|Lack of Efficacy|3|||
131425972|NCT01858766|473182513|FG014|Overall Study|Lack of Efficacy|5|||
131425973|NCT01858766|473182514|FG015|Overall Study|Lack of Efficacy|5|||
131425974|NCT01858766|473182515|FG016|Overall Study|Lack of Efficacy|2|||
131425975|NCT01858766|473182516|FG017|Overall Study|Lack of Efficacy|3|||
131425976|NCT01858766|473182517|FG018|Overall Study|Lack of Efficacy|3|||
131425977|NCT01858766|473182499|FG000|Overall Study|Lost to Follow-up|0|||
131425978|NCT01858766|473182500|FG001|Overall Study|Lost to Follow-up|0|||
131425979|NCT01858766|473182501|FG002|Overall Study|Lost to Follow-up|0|||
131425980|NCT01858766|473182502|FG003|Overall Study|Lost to Follow-up|0|||
131425981|NCT01858766|473182503|FG004|Overall Study|Lost to Follow-up|0|||
131425982|NCT01858766|473182504|FG005|Overall Study|Lost to Follow-up|1|||
131425983|NCT01858766|473182505|FG006|Overall Study|Lost to Follow-up|0|||
131425984|NCT01858766|473182506|FG007|Overall Study|Lost to Follow-up|2|||
131425985|NCT01858766|473182507|FG008|Overall Study|Lost to Follow-up|0|||
131425986|NCT01858766|473182508|FG009|Overall Study|Lost to Follow-up|0|||
131425987|NCT01858766|473182509|FG010|Overall Study|Lost to Follow-up|0|||
131425988|NCT01858766|473182510|FG011|Overall Study|Lost to Follow-up|1|||
131425989|NCT01858766|473182511|FG012|Overall Study|Lost to Follow-up|0|||
131425990|NCT01858766|473182512|FG013|Overall Study|Lost to Follow-up|0|||
131425991|NCT01858766|473182513|FG014|Overall Study|Lost to Follow-up|3|||
131425992|NCT01858766|473182514|FG015|Overall Study|Lost to Follow-up|1|||
131425993|NCT01858766|473182515|FG016|Overall Study|Lost to Follow-up|1|||
131425994|NCT01858766|473182516|FG017|Overall Study|Lost to Follow-up|0|||
131425995|NCT01858766|473182517|FG018|Overall Study|Lost to Follow-up|1|||
131425996|NCT01858766|473182499|FG000|Overall Study|Withdrew Consent|0|||
131425997|NCT01858766|473182500|FG001|Overall Study|Withdrew Consent|0|||
131425998|NCT01858766|473182501|FG002|Overall Study|Withdrew Consent|0|||
131425999|NCT01858766|473182502|FG003|Overall Study|Withdrew Consent|0|||
131426000|NCT01858766|473182503|FG004|Overall Study|Withdrew Consent|0|||
131426001|NCT01858766|473182504|FG005|Overall Study|Withdrew Consent|0|||
131426002|NCT01858766|473182505|FG006|Overall Study|Withdrew Consent|0|||
131426003|NCT01858766|473182506|FG007|Overall Study|Withdrew Consent|0|||
131426004|NCT01858766|473182507|FG008|Overall Study|Withdrew Consent|0|||
131426005|NCT01858766|473182508|FG009|Overall Study|Withdrew Consent|0|||
131426006|NCT01858766|473182509|FG010|Overall Study|Withdrew Consent|0|||
131426007|NCT01858766|473182510|FG011|Overall Study|Withdrew Consent|1|||
131426008|NCT01858766|473182511|FG012|Overall Study|Withdrew Consent|0|||
131426009|NCT01858766|473182512|FG013|Overall Study|Withdrew Consent|0|||
131426010|NCT01858766|473182513|FG014|Overall Study|Withdrew Consent|0|||
131426011|NCT01858766|473182514|FG015|Overall Study|Withdrew Consent|0|||
131426012|NCT01858766|473182515|FG016|Overall Study|Withdrew Consent|0|||
131426013|NCT01858766|473182516|FG017|Overall Study|Withdrew Consent|0|||
131426014|NCT01858766|473182517|FG018|Overall Study|Withdrew Consent|0|||
131426015|NCT03517228|473182520|FG000|Overall Study|Withdrawal by Subject|2|||
131426016|NCT03517228|473182520|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
131426017|NCT03517228|473182520|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
131426018|NCT03517228|473182520|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
131426019|NCT03517228|473182520|FG000|Overall Study|Canceled due to device being updated|1|||
131426020|NCT03517228|473182520|FG000|Overall Study|No V Cares in stock|1|||
131426021|NCT03517228|473182520|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
131426022|NCT03781414|473182531|FG000|Overall Study|Study terminated by sponsor|39|||
131426023|NCT03781414|473182532|FG001|Overall Study|Study terminated by sponsor|34|||
131426024|NCT03781414|473182533|FG002|Overall Study|Study terminated by sponsor|25|||
131426025|NCT03781414|473182531|FG000|Overall Study|Adverse Event|3|||
131426026|NCT03781414|473182532|FG001|Overall Study|Adverse Event|6|||
131426027|NCT03781414|473182533|FG002|Overall Study|Adverse Event|3|||
131426028|NCT03781414|473182531|FG000|Overall Study|Physician Decision|2|||
131426029|NCT03781414|473182532|FG001|Overall Study|Physician Decision|0|||
131426030|NCT03781414|473182533|FG002|Overall Study|Physician Decision|1|||
131426031|NCT03781414|473182531|FG000|Overall Study|Withdrawal by Subject|2|||
131426032|NCT03781414|473182532|FG001|Overall Study|Withdrawal by Subject|3|||
131426033|NCT03781414|473182533|FG002|Overall Study|Withdrawal by Subject|3|||
131426034|NCT03781414|473182531|FG000|Overall Study|Death|1|||
131426035|NCT03781414|473182532|FG001|Overall Study|Death|4|||
131426036|NCT03781414|473182533|FG002|Overall Study|Death|0|||
131426037|NCT03781414|473182531|FG000|Overall Study|Lost to Follow-up|1|||
131426038|NCT03781414|473182532|FG001|Overall Study|Lost to Follow-up|1|||
131426039|NCT03781414|473182533|FG002|Overall Study|Lost to Follow-up|0|||
131426040|NCT01067144|473182538|FG000|Treatment|Did not receive allocated intervention|4|||
131426041|NCT01067144|473182539|FG001|Treatment|Did not receive allocated intervention|7|||
131426042|NCT01067144|473182538|FG000|Follow-up|Lost to Follow-up|22|||
131426043|NCT01067144|473182539|FG001|Follow-up|Lost to Follow-up|12|||
131426044|NCT01067144|473182538|FG000|Follow-up|Censored owing to second surgery|19|||
131426045|NCT01067144|473182539|FG001|Follow-up|Censored owing to second surgery|28|||
131426046|NCT01067144|473182538|FG000|Follow-up|Withdrawal by Subject|18|||
131426047|NCT01067144|473182539|FG001|Follow-up|Withdrawal by Subject|14|||
131426048|NCT01067144|473182538|FG000|Follow-up|Surgery cancelled|0|||
131426049|NCT01067144|473182539|FG001|Follow-up|Surgery cancelled|1|||
131426050|NCT01067144|473182538|FG000|Follow-up|Death|0|||
131426051|NCT01067144|473182539|FG001|Follow-up|Death|1|||
131426052|NCT04752358|473182540|FG000|Overall Study|Death|2|||
131426053|NCT04752358|473182541|FG001|Overall Study|Death|1|||
131426054|NCT00719355|473182548|FG000|Overall Study|Death|0|||
131426055|NCT00719355|473182549|FG001|Overall Study|Death|1|||
131426056|NCT00719355|473182548|FG000|Overall Study|Medical|14|||
131426057|NCT00719355|473182549|FG001|Overall Study|Medical|5|||
131426058|NCT00719355|473182548|FG000|Overall Study|Compliance|4|||
131426059|NCT00719355|473182549|FG001|Overall Study|Compliance|6|||
131426060|NCT00719355|473182548|FG000|Overall Study|Moved|0|||
131426061|NCT00719355|473182549|FG001|Overall Study|Moved|1|||
131426062|NCT01835158|473182550|FG000|Overall Study|Withdrawal by Subject|1|||
131426063|NCT01835158|473182551|FG001|Overall Study|Withdrawal by Subject|6|||
131426064|NCT03364738|473182553|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
131426065|NCT03364738|473182553|FG000|Overall Study|Withdrawal by Subject|1|||
131426066|NCT03364738|473182553|FG000|Overall Study|Adverse Event|1|||
131426067|NCT03245398|473182557|FG000|Overall Study|Travelled to another island|1|||
131426068|NCT03245398|473182558|FG001|Overall Study|Travelled to another island|0|||
131426069|NCT01415401|473182559|FG000|Overall Study|Adverse Event|5|||
131426070|NCT01415401|473182559|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
131426071|NCT01415401|473182559|FG000|Overall Study|Terminated by Sponsor|1|||
131426072|NCT03422536|473182566|FG000|Randomized|Physician Decision|1|||
131426073|NCT03422536|473182567|FG001|Randomized|Physician Decision|1|||
131426074|NCT03422536|473182566|FG000|Allocation - Received Intervention|Disease progression|19|||
131426075|NCT03422536|473182567|FG001|Allocation - Received Intervention|Disease progression|25|||
131426076|NCT03422536|473182566|FG000|Allocation - Received Intervention|Death|1|||
131426077|NCT03422536|473182567|FG001|Allocation - Received Intervention|Death|3|||
131426078|NCT03422536|473182566|FG000|Allocation - Received Intervention|Adverse Event|1|||
131426079|NCT03422536|473182567|FG001|Allocation - Received Intervention|Adverse Event|0|||
131426080|NCT03422536|473182566|FG000|Allocation - Received Intervention|Physician Decision|1|||
131426081|NCT03422536|473182567|FG001|Allocation - Received Intervention|Physician Decision|1|||
131426082|NCT03422536|473182566|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
131426083|NCT03422536|473182567|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
131426084|NCT03422536|473182566|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
131426085|NCT03422536|473182567|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
131426086|NCT04531241|473182568|FG000|Period 1|Withdrawal by Subject|2|||
131426087|NCT04531241|473182569|FG001|Period 1|Withdrawal by Subject|0|||
131426088|NCT04531241|473182568|FG000|Period 1|Dispesed incorrect lens power|1|||
131426089|NCT04531241|473182569|FG001|Period 1|Dispesed incorrect lens power|0|||
131426090|NCT04531241|473182568|FG000|Period 1|Protocol Violation|1|||
131426091|NCT04531241|473182569|FG001|Period 1|Protocol Violation|0|||
131426092|NCT04531241|473182568|FG000|Period 1|No longer eligible|0|||
131426093|NCT04531241|473182569|FG001|Period 1|No longer eligible|1|||
131426094|NCT04531241|473182568|FG000|Period 1|Lens Discomfort|0|||
131426095|NCT04531241|473182569|FG001|Period 1|Lens Discomfort|1|||
131426096|NCT04531241|473182568|FG000|Period 2|Covid-19 Related|1|||
131426097|NCT04531241|473182569|FG001|Period 2|Covid-19 Related|1|||
131426098|NCT02023996|473182570|FG000|Overall Study|Protocol Violation|6|||
131426099|NCT04929249|473182571|FG000|Overall Study|Adverse Event|2|||
131426100|NCT04929249|473182572|FG001|Overall Study|Adverse Event|1|||
131426101|NCT04929249|473182571|FG000|Overall Study|Death|2|||
131426102|NCT04929249|473182572|FG001|Overall Study|Death|1|||
131426103|NCT04929249|473182571|FG000|Overall Study|Lost to Follow-up|3|||
131426104|NCT04929249|473182572|FG001|Overall Study|Lost to Follow-up|11|||
131426105|NCT04929249|473182571|FG000|Overall Study|Technical problems|0|||
131426106|NCT04929249|473182572|FG001|Overall Study|Technical problems|1|||
131426107|NCT04929249|473182571|FG000|Overall Study|Subject decision|6|||
131426108|NCT04929249|473182572|FG001|Overall Study|Subject decision|8|||
131426109|NCT04929249|473182571|FG000|Overall Study|Withdrew consent|0|||
131426110|NCT04929249|473182572|FG001|Overall Study|Withdrew consent|8|||
131426111|NCT02218008|473182583|FG000|Stage 1 (S1)|Adverse Event|6|||
131426112|NCT02218008|473182584|FG001|Stage 1 (S1)|Adverse Event|5|||
131426113|NCT02218008|473182585|FG002|Stage 1 (S1)|Adverse Event|11|||
131426114|NCT02218008|473182586|FG003|Stage 1 (S1)|Adverse Event|0|||
131426115|NCT02218008|473182587|FG004|Stage 1 (S1)|Adverse Event|0|||
131426116|NCT02218008|473182588|FG005|Stage 1 (S1)|Adverse Event|0|||
131426117|NCT02218008|473182583|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
131426118|NCT02218008|473182584|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
131426119|NCT02218008|473182585|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
131426120|NCT02218008|473182586|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
131426121|NCT02218008|473182587|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
131426122|NCT02218008|473182588|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
131426123|NCT02218008|473182583|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
131426124|NCT02218008|473182584|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
131426125|NCT02218008|473182585|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
131426126|NCT02218008|473182586|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
131426127|NCT02218008|473182587|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
131426128|NCT02218008|473182588|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
131426129|NCT02218008|473182583|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
131458074|NCT01124864|473308785|FG003|Overall Study|Follow up phase competed as per protocol|18|||
131426130|NCT02218008|473182584|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
131426131|NCT02218008|473182585|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
131426132|NCT02218008|473182586|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
131426133|NCT02218008|473182587|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
131426134|NCT02218008|473182588|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
131426135|NCT02218008|473182583|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
131426136|NCT02218008|473182584|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
131426137|NCT02218008|473182585|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
131426138|NCT02218008|473182586|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
131426139|NCT02218008|473182587|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
131426140|NCT02218008|473182588|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
131426141|NCT02218008|473182583|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
131426142|NCT02218008|473182584|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
131426143|NCT02218008|473182585|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
131426144|NCT02218008|473182586|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
131426145|NCT02218008|473182587|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
131426146|NCT02218008|473182588|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
131426147|NCT02218008|473182583|FG000|Stage 1 (S1)|Pregnancy|0|||
131426148|NCT02218008|473182584|FG001|Stage 1 (S1)|Pregnancy|0|||
131426149|NCT02218008|473182585|FG002|Stage 1 (S1)|Pregnancy|1|||
131426150|NCT02218008|473182586|FG003|Stage 1 (S1)|Pregnancy|0|||
131426151|NCT02218008|473182587|FG004|Stage 1 (S1)|Pregnancy|0|||
131426152|NCT02218008|473182588|FG005|Stage 1 (S1)|Pregnancy|0|||
131426153|NCT02218008|473182583|FG000|Stage 1 (S1)|Protocol Violation|0|||
131426154|NCT02218008|473182584|FG001|Stage 1 (S1)|Protocol Violation|0|||
131426155|NCT02218008|473182585|FG002|Stage 1 (S1)|Protocol Violation|1|||
131426156|NCT02218008|473182586|FG003|Stage 1 (S1)|Protocol Violation|0|||
131426157|NCT02218008|473182587|FG004|Stage 1 (S1)|Protocol Violation|0|||
131426158|NCT02218008|473182588|FG005|Stage 1 (S1)|Protocol Violation|0|||
131426159|NCT02218008|473182583|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
131426160|NCT02218008|473182584|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
131426161|NCT02218008|473182585|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
131426162|NCT02218008|473182586|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
131426163|NCT02218008|473182587|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
131426164|NCT02218008|473182588|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
131426165|NCT02218008|473182583|FG000|Stage 2 (S2)|Adverse Event|0|||
131426166|NCT02218008|473182584|FG001|Stage 2 (S2)|Adverse Event|0|||
131426167|NCT02218008|473182585|FG002|Stage 2 (S2)|Adverse Event|0|||
131426168|NCT02218008|473182586|FG003|Stage 2 (S2)|Adverse Event|2|||
131426169|NCT02218008|473182587|FG004|Stage 2 (S2)|Adverse Event|3|||
131426170|NCT02218008|473182588|FG005|Stage 2 (S2)|Adverse Event|3|||
131426171|NCT02218008|473182583|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
131426172|NCT02218008|473182584|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
131426173|NCT02218008|473182585|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
131426174|NCT02218008|473182586|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
131426175|NCT02218008|473182587|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
131426176|NCT02218008|473182588|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
131426177|NCT02218008|473182583|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
131426178|NCT02218008|473182584|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
131426179|NCT02218008|473182585|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
131426180|NCT02218008|473182586|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
131426181|NCT02218008|473182587|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
131426182|NCT02218008|473182588|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
131426183|NCT02218008|473182583|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
131426184|NCT02218008|473182584|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
131426185|NCT02218008|473182585|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
131426186|NCT02218008|473182586|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
131426187|NCT02218008|473182587|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
131426188|NCT02218008|473182588|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
131426189|NCT02218008|473182583|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
131426190|NCT02218008|473182584|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
131426191|NCT02218008|473182585|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
131426192|NCT02218008|473182586|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
131426193|NCT02218008|473182587|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
131426194|NCT02218008|473182588|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
131426195|NCT02038075|473182589|FG000|Overall Study|Withdrawal by Subject|3|||
131426196|NCT02038075|473182590|FG001|Overall Study|Withdrawal by Subject|0|||
131426197|NCT00106353|473182591|FG000|Part 1|Disease progression|3|||
131426198|NCT00106353|473182592|FG001|Part 1|Disease progression|4|||
131426199|NCT00106353|473182593|FG002|Part 1|Disease progression|1|||
131426200|NCT00106353|473182594|FG003|Part 1|Disease progression|3|||
131426201|NCT00106353|473182595|FG004|Part 1|Disease progression|0|||
131426202|NCT00106353|473182596|FG005|Part 1|Disease progression|0|||
131426203|NCT00106353|473182597|FG006|Part 1|Disease progression|0|||
131426204|NCT00106353|473182591|FG000|Part 1|Withdrawal by Subject|0|||
131426205|NCT00106353|473182592|FG001|Part 1|Withdrawal by Subject|0|||
131426206|NCT00106353|473182593|FG002|Part 1|Withdrawal by Subject|1|||
131426207|NCT00106353|473182594|FG003|Part 1|Withdrawal by Subject|2|||
131426208|NCT00106353|473182595|FG004|Part 1|Withdrawal by Subject|0|||
131426209|NCT00106353|473182596|FG005|Part 1|Withdrawal by Subject|0|||
131426210|NCT00106353|473182597|FG006|Part 1|Withdrawal by Subject|0|||
131426211|NCT00106353|473182591|FG000|Part 1|Symptomatic deterioration|0|||
131426212|NCT00106353|473182592|FG001|Part 1|Symptomatic deterioration|0|||
131426213|NCT00106353|473182593|FG002|Part 1|Symptomatic deterioration|1|||
131426214|NCT00106353|473182594|FG003|Part 1|Symptomatic deterioration|0|||
131426215|NCT00106353|473182595|FG004|Part 1|Symptomatic deterioration|0|||
131426216|NCT00106353|473182596|FG005|Part 1|Symptomatic deterioration|0|||
131426217|NCT00106353|473182597|FG006|Part 1|Symptomatic deterioration|0|||
131426218|NCT00106353|473182591|FG000|Part 1|Entered follow-up phase|1|||
131426219|NCT00106353|473182592|FG001|Part 1|Entered follow-up phase|1|||
131426220|NCT00106353|473182593|FG002|Part 1|Entered follow-up phase|0|||
131426221|NCT00106353|473182594|FG003|Part 1|Entered follow-up phase|1|||
131426222|NCT00106353|473182595|FG004|Part 1|Entered follow-up phase|0|||
131426223|NCT00106353|473182596|FG005|Part 1|Entered follow-up phase|0|||
131426224|NCT00106353|473182597|FG006|Part 1|Entered follow-up phase|0|||
131426225|NCT00106353|473182591|FG000|Part 1|Adverse Event|0|||
131426226|NCT00106353|473182592|FG001|Part 1|Adverse Event|0|||
131426227|NCT00106353|473182593|FG002|Part 1|Adverse Event|0|||
131426228|NCT00106353|473182594|FG003|Part 1|Adverse Event|1|||
131426229|NCT00106353|473182595|FG004|Part 1|Adverse Event|0|||
131426230|NCT00106353|473182596|FG005|Part 1|Adverse Event|0|||
131426231|NCT00106353|473182597|FG006|Part 1|Adverse Event|0|||
131426232|NCT00106353|473182591|FG000|Part 2|Disease progression|0|||
131426233|NCT00106353|473182592|FG001|Part 2|Disease progression|0|||
131426234|NCT00106353|473182593|FG002|Part 2|Disease progression|0|||
131426235|NCT00106353|473182594|FG003|Part 2|Disease progression|0|||
131426236|NCT00106353|473182595|FG004|Part 2|Disease progression|8|||
131426237|NCT00106353|473182596|FG005|Part 2|Disease progression|14|||
131426238|NCT00106353|473182597|FG006|Part 2|Disease progression|13|||
131426239|NCT00106353|473182591|FG000|Part 2|Death|0|||
131426240|NCT00106353|473182592|FG001|Part 2|Death|0|||
131426241|NCT00106353|473182593|FG002|Part 2|Death|0|||
131426242|NCT00106353|473182594|FG003|Part 2|Death|0|||
131426243|NCT00106353|473182595|FG004|Part 2|Death|3|||
131426244|NCT00106353|473182596|FG005|Part 2|Death|0|||
131426245|NCT00106353|473182597|FG006|Part 2|Death|1|||
131426246|NCT00106353|473182591|FG000|Part 2|Symptomatic deterioration|0|||
131426247|NCT00106353|473182592|FG001|Part 2|Symptomatic deterioration|0|||
131426248|NCT00106353|473182593|FG002|Part 2|Symptomatic deterioration|0|||
131426249|NCT00106353|473182594|FG003|Part 2|Symptomatic deterioration|0|||
131426250|NCT00106353|473182595|FG004|Part 2|Symptomatic deterioration|3|||
131426251|NCT00106353|473182596|FG005|Part 2|Symptomatic deterioration|0|||
131426252|NCT00106353|473182597|FG006|Part 2|Symptomatic deterioration|0|||
131426253|NCT00106353|473182591|FG000|Part 2|Adverse Event|0|||
131426254|NCT00106353|473182592|FG001|Part 2|Adverse Event|0|||
131426255|NCT00106353|473182593|FG002|Part 2|Adverse Event|0|||
131426256|NCT00106353|473182594|FG003|Part 2|Adverse Event|0|||
131426257|NCT00106353|473182595|FG004|Part 2|Adverse Event|0|||
131426258|NCT00106353|473182596|FG005|Part 2|Adverse Event|2|||
131426259|NCT00106353|473182597|FG006|Part 2|Adverse Event|1|||
131426260|NCT00106353|473182591|FG000|Part 2|Other|0|||
131426261|NCT00106353|473182592|FG001|Part 2|Other|0|||
131426262|NCT00106353|473182593|FG002|Part 2|Other|0|||
131426263|NCT00106353|473182594|FG003|Part 2|Other|0|||
131426264|NCT00106353|473182595|FG004|Part 2|Other|1|||
131426265|NCT00106353|473182596|FG005|Part 2|Other|1|||
131426266|NCT00106353|473182597|FG006|Part 2|Other|1|||
131426267|NCT00106353|473182591|FG000|Part 2|Withdrawal by Subject|0|||
131426268|NCT00106353|473182592|FG001|Part 2|Withdrawal by Subject|0|||
131426269|NCT00106353|473182593|FG002|Part 2|Withdrawal by Subject|0|||
131426270|NCT00106353|473182594|FG003|Part 2|Withdrawal by Subject|0|||
131426271|NCT00106353|473182595|FG004|Part 2|Withdrawal by Subject|1|||
131426272|NCT00106353|473182596|FG005|Part 2|Withdrawal by Subject|0|||
131426273|NCT00106353|473182597|FG006|Part 2|Withdrawal by Subject|0|||
131426274|NCT00106353|473182591|FG000|Part 2|Physician Decision|0|||
131426275|NCT00106353|473182592|FG001|Part 2|Physician Decision|0|||
131426276|NCT00106353|473182593|FG002|Part 2|Physician Decision|0|||
131426277|NCT00106353|473182594|FG003|Part 2|Physician Decision|0|||
131426278|NCT00106353|473182595|FG004|Part 2|Physician Decision|0|||
131426279|NCT00106353|473182596|FG005|Part 2|Physician Decision|1|||
131426280|NCT00106353|473182597|FG006|Part 2|Physician Decision|0|||
131426281|NCT03477838|473182601|FG000|Overall Study|Lost to Follow-up|14|||
131426282|NCT01088399|473182602|FG000|Overall Study|Adverse Event|211|||
131426283|NCT01088399|473182603|FG001|Overall Study|Adverse Event|16|||
131426284|NCT01088399|473182604|FG002|Overall Study|Adverse Event|0|||
131426285|NCT01088399|473182602|FG000|Overall Study|Death|204|||
131426286|NCT01088399|473182603|FG001|Overall Study|Death|45|||
131426287|NCT01088399|473182604|FG002|Overall Study|Death|0|||
131426288|NCT01088399|473182602|FG000|Overall Study|Lack of Efficacy|298|||
131426289|NCT01088399|473182603|FG001|Overall Study|Lack of Efficacy|7|||
131426290|NCT01088399|473182604|FG002|Overall Study|Lack of Efficacy|5|||
131426291|NCT01088399|473182602|FG000|Overall Study|Lost to Follow-up|1070|||
131426292|NCT01088399|473182603|FG001|Overall Study|Lost to Follow-up|278|||
131426293|NCT01088399|473182604|FG002|Overall Study|Lost to Follow-up|58|||
131426294|NCT01088399|473182602|FG000|Overall Study|Physician Decision|531|||
131426295|NCT01088399|473182603|FG001|Overall Study|Physician Decision|88|||
131426296|NCT01088399|473182604|FG002|Overall Study|Physician Decision|16|||
131426297|NCT01088399|473182602|FG000|Overall Study|Withdrawal by Subject|544|||
131426298|NCT01088399|473182603|FG001|Overall Study|Withdrawal by Subject|195|||
131426299|NCT01088399|473182604|FG002|Overall Study|Withdrawal by Subject|33|||
131426300|NCT01088399|473182602|FG000|Overall Study|Change to or start of somatropin therapy|234|||
131426301|NCT01088399|473182603|FG001|Overall Study|Change to or start of somatropin therapy|17|||
131426302|NCT01088399|473182604|FG002|Overall Study|Change to or start of somatropin therapy|12|||
131426303|NCT01088399|473182602|FG000|Overall Study|Sponsor decision|1573|||
131426304|NCT01088399|473182603|FG001|Overall Study|Sponsor decision|298|||
131426305|NCT01088399|473182604|FG002|Overall Study|Sponsor decision|7|||
131426306|NCT01088399|473182602|FG000|Overall Study|Protocol Violation|10|||
131426307|NCT01088399|473182603|FG001|Overall Study|Protocol Violation|1|||
131426308|NCT01088399|473182604|FG002|Overall Study|Protocol Violation|0|||
131426309|NCT01088399|473182602|FG000|Overall Study|Enrollment criteria not met|48|||
131426310|NCT01088399|473182603|FG001|Overall Study|Enrollment criteria not met|119|||
131426311|NCT01088399|473182604|FG002|Overall Study|Enrollment criteria not met|70|||
131426312|NCT01088399|473182602|FG000|Overall Study|Study summary visit not completed|2398|||
131426313|NCT01088399|473182603|FG001|Overall Study|Study summary visit not completed|283|||
131426314|NCT01088399|473182604|FG002|Overall Study|Study summary visit not completed|80|||
131426315|NCT00782483|473182605|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
131426316|NCT03343626|473184722|FG000|Overall Study|Lost to Follow-up|4|||
131426317|NCT03343626|473184723|FG001|Overall Study|Lost to Follow-up|3|||
131426318|NCT03343626|473184724|FG002|Overall Study|Lost to Follow-up|2|||
131426319|NCT03343626|473184725|FG003|Overall Study|Lost to Follow-up|5|||
131426320|NCT03343626|473184726|FG004|Overall Study|Lost to Follow-up|4|||
131426321|NCT03343626|473184727|FG005|Overall Study|Lost to Follow-up|4|||
131426322|NCT03343626|473184728|FG006|Overall Study|Lost to Follow-up|4|||
131426323|NCT03343626|473184729|FG007|Overall Study|Lost to Follow-up|7|||
131426324|NCT03343626|473184722|FG000|Overall Study|Withdrawal of Consent|2|||
131426325|NCT03343626|473184723|FG001|Overall Study|Withdrawal of Consent|1|||
131426326|NCT03343626|473184724|FG002|Overall Study|Withdrawal of Consent|0|||
131426327|NCT03343626|473184725|FG003|Overall Study|Withdrawal of Consent|3|||
131426328|NCT03343626|473184726|FG004|Overall Study|Withdrawal of Consent|3|||
131426329|NCT03343626|473184727|FG005|Overall Study|Withdrawal of Consent|1|||
131426330|NCT03343626|473184728|FG006|Overall Study|Withdrawal of Consent|1|||
131426331|NCT03343626|473184729|FG007|Overall Study|Withdrawal of Consent|2|||
131426332|NCT03343626|473184722|FG000|Overall Study|Reason not Specified|0|||
131426333|NCT03343626|473184723|FG001|Overall Study|Reason not Specified|1|||
131426334|NCT03343626|473184724|FG002|Overall Study|Reason not Specified|0|||
131426335|NCT03343626|473184725|FG003|Overall Study|Reason not Specified|0|||
131426336|NCT03343626|473184726|FG004|Overall Study|Reason not Specified|0|||
131426337|NCT03343626|473184727|FG005|Overall Study|Reason not Specified|0|||
131426338|NCT03343626|473184728|FG006|Overall Study|Reason not Specified|0|||
131426339|NCT03343626|473184729|FG007|Overall Study|Reason not Specified|1|||
131426340|NCT03343626|473184722|FG000|Overall Study|Data Entry Error|0|||
131426341|NCT03343626|473184723|FG001|Overall Study|Data Entry Error|0|||
131426342|NCT03343626|473184724|FG002|Overall Study|Data Entry Error|0|||
131426343|NCT03343626|473184725|FG003|Overall Study|Data Entry Error|0|||
131426344|NCT03343626|473184726|FG004|Overall Study|Data Entry Error|0|||
131426345|NCT03343626|473184727|FG005|Overall Study|Data Entry Error|0|||
131426346|NCT03343626|473184728|FG006|Overall Study|Data Entry Error|0|||
131426347|NCT03343626|473184729|FG007|Overall Study|Data Entry Error|1|||
131426348|NCT02475278|473184732|FG000|Overall Study|Lost to Follow-up|1|||
131458075|NCT01124864|473308786|FG004|Overall Study|Follow up phase competed as per protocol|26|||
131458076|NCT01124864|473308787|FG005|Overall Study|Follow up phase competed as per protocol|2|||
131458077|NCT01124864|473308782|FG000|Overall Study|Death|6|||
131426349|NCT02475278|473184732|FG000|Overall Study|Reason Not Specified|1|||
131426350|NCT01946152|473184733|FG000|Overall Study|Adverse Event|1|||
131426351|NCT01946152|473184734|FG001|Overall Study|Adverse Event|0|||
131426352|NCT01946152|473184735|FG002|Overall Study|Adverse Event|0|||
131458078|NCT01124864|473308783|FG001|Overall Study|Death|9|||
131458079|NCT01124864|473308784|FG002|Overall Study|Death|6|||
131426353|NCT01946152|473184736|FG003|Overall Study|Adverse Event|0|||
131426354|NCT01946152|473184733|FG000|Overall Study|Withdrawal by Subject|0|||
131426355|NCT01946152|473184734|FG001|Overall Study|Withdrawal by Subject|2|||
131426356|NCT01946152|473184735|FG002|Overall Study|Withdrawal by Subject|0|||
131426357|NCT01946152|473184736|FG003|Overall Study|Withdrawal by Subject|0|||
131426358|NCT01946152|473184733|FG000|Overall Study|Progression|0|||
131426359|NCT01946152|473184734|FG001|Overall Study|Progression|1|||
131426360|NCT01946152|473184735|FG002|Overall Study|Progression|4|||
131426361|NCT01946152|473184736|FG003|Overall Study|Progression|7|||
131426362|NCT01946152|473184733|FG000|Overall Study|Physician Decision|0|||
131426363|NCT01946152|473184734|FG001|Overall Study|Physician Decision|0|||
131426364|NCT01946152|473184735|FG002|Overall Study|Physician Decision|1|||
131426365|NCT01946152|473184736|FG003|Overall Study|Physician Decision|0|||
131426366|NCT01946152|473184733|FG000|Overall Study|Second malignancy|0|||
131426367|NCT01946152|473184734|FG001|Overall Study|Second malignancy|0|||
131426368|NCT01946152|473184735|FG002|Overall Study|Second malignancy|1|||
131426369|NCT01946152|473184736|FG003|Overall Study|Second malignancy|0|||
131426370|NCT01946152|473184733|FG000|Overall Study|Adverse Event|0|||
131426371|NCT01946152|473184734|FG001|Overall Study|Adverse Event|0|||
131426372|NCT01946152|473184735|FG002|Overall Study|Adverse Event|0|||
131426373|NCT01946152|473184736|FG003|Overall Study|Adverse Event|1|||
131426374|NCT01865448|473184737|FG000|Overall Study|Adverse Event|1|||
131426375|NCT01865448|473184738|FG001|Overall Study|Adverse Event|1|||
131426376|NCT01865448|473184737|FG000|Overall Study|Pregnancy|0|||
131426377|NCT01865448|473184738|FG001|Overall Study|Pregnancy|1|||
131426378|NCT01865448|473184737|FG000|Overall Study|dropout unrelated to study|1|||
131426379|NCT01865448|473184738|FG001|Overall Study|dropout unrelated to study|1|||
131426380|NCT05111249|473184746|FG000|Overall Study|Lost to Follow-up|0|||
131426381|NCT05111249|473184747|FG001|Overall Study|Lost to Follow-up|2|||
131426382|NCT05111249|473184746|FG000|Overall Study|Physician Decision|0|||
131426383|NCT05111249|473184747|FG001|Overall Study|Physician Decision|1|||
131426384|NCT05111249|473184746|FG000|Overall Study|Participant decision|1|||
131426385|NCT05111249|473184747|FG001|Overall Study|Participant decision|5|||
131426386|NCT00799266|473184751|FG000|Overall Study|Adverse Event|0|||
131426387|NCT00799266|473184752|FG001|Overall Study|Adverse Event|1|||
131426388|NCT00799266|473184751|FG000|Overall Study|Subject withdrew consent|3|||
131426389|NCT00799266|473184752|FG001|Overall Study|Subject withdrew consent|0|||
131426390|NCT01016600|473184753|FG000|Overall Study|Did not start treatment|1|||
131426391|NCT01016600|473184754|FG001|Overall Study|Did not start treatment|0|||
131426392|NCT01016600|473184755|FG002|Overall Study|Did not start treatment|0|||
131426393|NCT01016600|473184756|FG003|Overall Study|Did not start treatment|0|||
131426394|NCT02679755|473184758|FG000|Overall Study|Death|0|||
131426395|NCT02679755|473184759|FG001|Overall Study|Death|3|||
131426396|NCT02679755|473184758|FG000|Overall Study|Global deterioration of health status|1|||
131426397|NCT02679755|473184759|FG001|Overall Study|Global deterioration of health status|8|||
131426398|NCT02679755|473184758|FG000|Overall Study|Lost to Follow-up|1|||
131426399|NCT02679755|473184759|FG001|Overall Study|Lost to Follow-up|0|||
131426400|NCT02679755|473184758|FG000|Overall Study|Objective progression or relapse|24|||
131426401|NCT02679755|473184759|FG001|Overall Study|Objective progression or relapse|83|||
131426402|NCT02679755|473184758|FG000|Overall Study|Not defined|0|||
131426403|NCT02679755|473184759|FG001|Overall Study|Not defined|2|||
131426404|NCT02679755|473184758|FG000|Overall Study|Withdrawal by participant|6|||
131426405|NCT02679755|473184759|FG001|Overall Study|Withdrawal by participant|3|||
131426406|NCT02679755|473184758|FG000|Overall Study|Adverse Event|1|||
131426407|NCT02679755|473184759|FG001|Overall Study|Adverse Event|4|||
131426408|NCT02679755|473184758|FG000|Overall Study|Adverse events not related to study drug|1|||
131426409|NCT02679755|473184759|FG001|Overall Study|Adverse events not related to study drug|2|||
131426410|NCT01061359|473184760|FG000|Overall Study|Death|32|||
131426411|NCT01061359|473184760|FG000|Overall Study|Lost to Follow-up|1072|||
131426412|NCT01061359|473184760|FG000|Overall Study|Relapse|187|||
131426413|NCT01061359|473184760|FG000|Overall Study|Secondary neoplasm|11|||
131426414|NCT02451917|473184763|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
131426415|NCT02451917|473184764|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
131426416|NCT02451917|473184763|FG000|First Intervention (24 Weeks)|Death|0|||
131426417|NCT02451917|473184764|FG001|First Intervention (24 Weeks)|Death|1|||
131426418|NCT02451917|473184763|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
131426419|NCT02451917|473184764|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
131426420|NCT04737278|473184767|FG000|Overall Study|Lost to Follow-up|1|||
131426421|NCT04737278|473184768|FG001|Overall Study|Lost to Follow-up|1|||
131426422|NCT04737278|473184767|FG000|Overall Study|Withdrawal by Subject|1|||
131426423|NCT04737278|473184768|FG001|Overall Study|Withdrawal by Subject|0|||
131426424|NCT04737278|473184767|FG000|Overall Study|Protocol Violation|1|||
131426425|NCT04737278|473184768|FG001|Overall Study|Protocol Violation|1|||
131426426|NCT04737278|473184767|FG000|Overall Study|failure to complete questionnaire|1|||
131426427|NCT04737278|473184768|FG001|Overall Study|failure to complete questionnaire|1|||
131426428|NCT00546000|473184769|FG000|Overall Study|Adverse Event|1|||
131426429|NCT00546000|473184769|FG000|Overall Study|Lost to Follow-up|1|||
131426430|NCT00546000|473184769|FG000|Overall Study|Baseline HPA Axis Supression|2|||
131426431|NCT01128244|473184773|FG000|Overall Study|Adverse Event|1|||
131426432|NCT01128244|473184773|FG000|Overall Study|Scheduling conflict|2|||
131426433|NCT04171219|473184774|FG000|Overall Study|Adverse Event|1|||
131426434|NCT04171219|473184775|FG001|Overall Study|Adverse Event|0|||
131426435|NCT04171219|473184774|FG000|Overall Study|Death|0|||
131426436|NCT04171219|473184775|FG001|Overall Study|Death|1|||
131426437|NCT04171219|473184774|FG000|Overall Study|Lack of Efficacy|9|||
131426438|NCT04171219|473184775|FG001|Overall Study|Lack of Efficacy|13|||
131426439|NCT04171219|473184774|FG000|Overall Study|Withdrawal by Subject|1|||
131426440|NCT04171219|473184775|FG001|Overall Study|Withdrawal by Subject|2|||
131426441|NCT04171219|473184774|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
131426442|NCT04171219|473184775|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
131426443|NCT04171219|473184774|FG000|Overall Study|Clinical PD/Patient choice|1|||
131426444|NCT04171219|473184775|FG001|Overall Study|Clinical PD/Patient choice|0|||
131426445|NCT04171219|473184774|FG000|Overall Study|Toxicity/ Patient choice|1|||
131426446|NCT04171219|473184775|FG001|Overall Study|Toxicity/ Patient choice|0|||
131426447|NCT02974257|473184780|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
131426448|NCT02974257|473184781|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
131426449|NCT02974257|473184780|FG000|Overall Study|Clinical indication for thiamine|1|||
131426450|NCT02974257|473184781|FG001|Overall Study|Clinical indication for thiamine|0|||
131426451|NCT02974257|473184780|FG000|Overall Study|Already on thiamine|1|||
131426452|NCT02974257|473184781|FG001|Overall Study|Already on thiamine|0|||
131426453|NCT02974257|473184780|FG000|Overall Study|Extubated prior to study drug|0|||
131426454|NCT02974257|473184781|FG001|Overall Study|Extubated prior to study drug|1|||
131426455|NCT02974257|473184780|FG000|Overall Study|Death|0|||
131426456|NCT02974257|473184781|FG001|Overall Study|Death|1|||
131426457|NCT01449006|473184782|FG000|Overall Study|Lost to Follow-up|1|||
131426458|NCT01449006|473184783|FG001|Overall Study|Lost to Follow-up|0|||
131426459|NCT01449006|473184782|FG000|Overall Study|Withdrawal by Subject|1|||
131426460|NCT01449006|473184783|FG001|Overall Study|Withdrawal by Subject|0|||
131426461|NCT01449006|473184782|FG000|Overall Study|Protocol Violation|1|||
131426462|NCT01449006|473184783|FG001|Overall Study|Protocol Violation|0|||
131426463|NCT00398567|473184784|FG000|Overall Study|Disease Progression|3|||
131426464|NCT00398567|473184785|FG001|Overall Study|Disease Progression|4|||
131426465|NCT00398567|473184786|FG002|Overall Study|Disease Progression|27|||
131426466|NCT00398567|473184784|FG000|Overall Study|Withdrawal by Subject|1|||
131426467|NCT00398567|473184785|FG001|Overall Study|Withdrawal by Subject|0|||
131426468|NCT00398567|473184786|FG002|Overall Study|Withdrawal by Subject|4|||
131426469|NCT00398567|473184784|FG000|Overall Study|Adverse Event|0|||
131426470|NCT00398567|473184785|FG001|Overall Study|Adverse Event|0|||
131426471|NCT00398567|473184786|FG002|Overall Study|Adverse Event|2|||
131426472|NCT00398567|473184784|FG000|Overall Study|Protocol Violation|0|||
131426473|NCT00398567|473184785|FG001|Overall Study|Protocol Violation|0|||
131426474|NCT00398567|473184786|FG002|Overall Study|Protocol Violation|1|||
131426475|NCT01036321|473184799|FG000|Overall Study|Ineligible after randomization|0|||
131426476|NCT01036321|473184800|FG001|Overall Study|Ineligible after randomization|1|||
131426477|NCT01036321|473184799|FG000|Overall Study|Withdrawal by Subject|3|||
131426478|NCT01036321|473184800|FG001|Overall Study|Withdrawal by Subject|2|||
131426479|NCT01036321|473184799|FG000|Overall Study|Adverse Event|2|||
131426480|NCT01036321|473184800|FG001|Overall Study|Adverse Event|1|||
131426481|NCT05438576|473184801|FG000|Overall Study|Death|1|||
131426482|NCT05438576|473184802|FG001|Overall Study|Death|1|||
131426483|NCT05438576|473184801|FG000|Overall Study|Withdrawal by Subject|4|||
131426484|NCT05438576|473184802|FG001|Overall Study|Withdrawal by Subject|2|||
131426485|NCT05438576|473184801|FG000|Overall Study|Not Eligible|2|||
131426486|NCT05438576|473184802|FG001|Overall Study|Not Eligible|1|||
131426487|NCT05438576|473184801|FG000|Overall Study|Did not complete baseline testing|22|||
131426488|NCT05438576|473184802|FG001|Overall Study|Did not complete baseline testing|4|||
131426489|NCT00475709|473184807|FG000|Overall Study|Did not meet eligibility criteria|8|||
131426490|NCT00475709|473184807|FG000|Overall Study|Death|41|||
131426491|NCT00475709|473184807|FG000|Overall Study|Device Explant|6|||
131426492|NCT00475709|473184807|FG000|Overall Study|Lost to Follow-up|21|||
131426493|NCT00555672|473184808|FG000|Overall Study|Death|0|||
131426494|NCT00555672|473184809|FG001|Overall Study|Death|2|||
131426495|NCT00555672|473184808|FG000|Overall Study|Adverse Event|8|||
131426496|NCT00555672|473184809|FG001|Overall Study|Adverse Event|2|||
131426497|NCT00555672|473184808|FG000|Overall Study|Objective progression or relapse|11|||
131426498|NCT00555672|473184809|FG001|Overall Study|Objective progression or relapse|5|||
131426499|NCT00555672|473184808|FG000|Overall Study|Other|3|||
131426500|NCT00555672|473184809|FG001|Overall Study|Other|1|||
131426501|NCT00555672|473184808|FG000|Overall Study|Participant refused|2|||
131426502|NCT00555672|473184809|FG001|Overall Study|Participant refused|0|||
131426503|NCT04765202|473184812|FG000|Overall Study|Lost to Follow-up|1|||
131426504|NCT04765202|473184813|FG001|Overall Study|Lost to Follow-up|1|||
131426505|NCT04765202|473184814|FG002|Overall Study|Lost to Follow-up|2|||
131426506|NCT04765202|473184815|FG003|Overall Study|Lost to Follow-up|2|||
131426507|NCT04765202|473184812|FG000|Overall Study|Physician Decision|0|||
131426508|NCT04765202|473184813|FG001|Overall Study|Physician Decision|0|||
131426509|NCT04765202|473184814|FG002|Overall Study|Physician Decision|1|||
131426510|NCT04765202|473184815|FG003|Overall Study|Physician Decision|1|||
131426511|NCT02305238|473184817|FG000|Overall Study|Death|2|||
131426512|NCT02305238|473184818|FG001|Overall Study|Death|1|||
131426513|NCT02305238|473184819|FG002|Overall Study|Death|0|||
131426514|NCT02305238|473184817|FG000|Overall Study|Progressive disease|4|||
131426515|NCT02305238|473184818|FG001|Overall Study|Progressive disease|4|||
131426516|NCT02305238|473184819|FG002|Overall Study|Progressive disease|0|||
131426517|NCT02305238|473184817|FG000|Overall Study|Logistical difficulties|1|||
131426518|NCT02305238|473184818|FG001|Overall Study|Logistical difficulties|3|||
131426519|NCT02305238|473184819|FG002|Overall Study|Logistical difficulties|0|||
131426520|NCT02305238|473184817|FG000|Overall Study|Protocol Violation|0|||
131426521|NCT02305238|473184818|FG001|Overall Study|Protocol Violation|3|||
131426522|NCT02305238|473184819|FG002|Overall Study|Protocol Violation|0|||
131426523|NCT02305238|473184817|FG000|Overall Study|Physician Decision|2|||
131426524|NCT02305238|473184818|FG001|Overall Study|Physician Decision|1|||
131426525|NCT02305238|473184819|FG002|Overall Study|Physician Decision|0|||
131426526|NCT02305238|473184817|FG000|Overall Study|Adverse Event|4|||
131426527|NCT02305238|473184818|FG001|Overall Study|Adverse Event|2|||
131426528|NCT02305238|473184819|FG002|Overall Study|Adverse Event|0|||
131426529|NCT02305238|473184817|FG000|Overall Study|Withdrawal by Subject|3|||
131426530|NCT02305238|473184818|FG001|Overall Study|Withdrawal by Subject|4|||
131426531|NCT02305238|473184819|FG002|Overall Study|Withdrawal by Subject|0|||
131426532|NCT02305238|473184817|FG000|Overall Study|Randomized failure|0|||
131426533|NCT02305238|473184818|FG001|Overall Study|Randomized failure|0|||
131426534|NCT02305238|473184819|FG002|Overall Study|Randomized failure|8|||
131426535|NCT02305238|473184817|FG000|Overall Study|Required procedure failed|0|||
131426536|NCT02305238|473184818|FG001|Overall Study|Required procedure failed|1|||
131426537|NCT02305238|473184819|FG002|Overall Study|Required procedure failed|0|||
131426538|NCT02513472|473184820|FG000|Overall Study|Radiological Disease Progression|45|||
131426539|NCT02513472|473184821|FG001|Overall Study|Radiological Disease Progression|57|||
131426540|NCT02513472|473184820|FG000|Overall Study|Clinical Disease Progression|5|||
131426541|NCT02513472|473184821|FG001|Overall Study|Clinical Disease Progression|13|||
131426542|NCT02513472|473184820|FG000|Overall Study|Adverse Event|8|||
131426543|NCT02513472|473184821|FG001|Overall Study|Adverse Event|11|||
131426544|NCT02513472|473184820|FG000|Overall Study|Withdrawal by Subject|0|||
131426545|NCT02513472|473184821|FG001|Overall Study|Withdrawal by Subject|4|||
131426546|NCT02513472|473184820|FG000|Overall Study|Subject Choice|2|||
131426547|NCT02513472|473184821|FG001|Overall Study|Subject Choice|7|||
131426548|NCT02513472|473184820|FG000|Overall Study|Treatment Completed as per Protocol|3|||
131426549|NCT02513472|473184821|FG001|Overall Study|Treatment Completed as per Protocol|3|||
131426550|NCT02513472|473184820|FG000|Overall Study|Other|3|||
131426551|NCT02513472|473184821|FG001|Overall Study|Other|6|||
131426552|NCT04310566|473184822|FG000|Period 1|Study Termination due to COVID-19|15|||
131426553|NCT04310566|473184823|FG001|Period 1|Study Termination due to COVID-19|17|||
131426554|NCT04310566|473184822|FG000|Period 1|Protocol Violation|0|||
131426555|NCT04310566|473184823|FG001|Period 1|Protocol Violation|1|||
131426556|NCT04310566|473184822|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
131426557|NCT04310566|473184823|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
131426558|NCT04310566|473184822|FG000|Period 1|Lost to Follow-up|1|||
131426559|NCT04310566|473184823|FG001|Period 1|Lost to Follow-up|0|||
131426560|NCT04310566|473184822|FG000|Period 1|Withdrawal by Subject|0|||
131426561|NCT04310566|473184823|FG001|Period 1|Withdrawal by Subject|1|||
131426562|NCT04310566|473184822|FG000|Period 2|Study Termination|7|||
131426563|NCT04310566|473184823|FG001|Period 2|Study Termination|5|||
131426564|NCT01711645|473184832|FG000|Overall Study|Withdrawal by Subject|8|||
131426565|NCT01711645|473184832|FG000|Overall Study|Lost to Follow-up|6|||
131426566|NCT01711645|473184832|FG000|Overall Study|Physician Decision|5|||
131426567|NCT00172042|473184834|FG000|Overall Study|Adverse Event|27|||
131426568|NCT00172042|473184835|FG001|Overall Study|Adverse Event|13|||
131426569|NCT00172042|473184834|FG000|Overall Study|Abnormal laboratory value(s)|5|||
131426570|NCT00172042|473184835|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131426571|NCT00172042|473184834|FG000|Overall Study|Abnormal test procedure(s)|0|||
131426572|NCT00172042|473184835|FG001|Overall Study|Abnormal test procedure(s)|3|||
131426573|NCT00172042|473184834|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
131426574|NCT00172042|473184835|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
131426575|NCT00172042|473184834|FG000|Overall Study|Patient no longer requires study drug|10|||
131426576|NCT00172042|473184835|FG001|Overall Study|Patient no longer requires study drug|8|||
131426577|NCT00172042|473184834|FG000|Overall Study|Protocol Violation|8|||
131426578|NCT00172042|473184835|FG001|Overall Study|Protocol Violation|7|||
131426579|NCT00172042|473184834|FG000|Overall Study|Withdrawal by Subject|37|||
131426580|NCT00172042|473184835|FG001|Overall Study|Withdrawal by Subject|25|||
131426581|NCT00172042|473184834|FG000|Overall Study|Lost to Follow-up|3|||
131426582|NCT00172042|473184835|FG001|Overall Study|Lost to Follow-up|5|||
131426583|NCT00172042|473184834|FG000|Overall Study|Administrative problems|13|||
131426584|NCT00172042|473184835|FG001|Overall Study|Administrative problems|10|||
131426585|NCT00172042|473184834|FG000|Overall Study|Death|42|||
131426586|NCT00172042|473184835|FG001|Overall Study|Death|42|||
131426587|NCT01771250|473184836|FG000|Period 1|Met exclusion criteria|1|||
131426588|NCT01771250|473184837|FG001|Period 1|Met exclusion criteria|0|||
131426589|NCT00483938|473184838|FG000|Overall Study|Protocol Violation|0|||
131426590|NCT00483938|473184839|FG001|Overall Study|Protocol Violation|0|||
131426591|NCT00483938|473184840|FG002|Overall Study|Protocol Violation|0|||
131426592|NCT00483938|473184841|FG003|Overall Study|Protocol Violation|0|||
131426593|NCT00483938|473184842|FG004|Overall Study|Protocol Violation|0|||
131426594|NCT00483938|473184843|FG005|Overall Study|Protocol Violation|0|||
131426595|NCT00483938|473184844|FG006|Overall Study|Protocol Violation|3|||
131426596|NCT00483938|473184838|FG000|Overall Study|Withdrawal by Subject|1|||
131426597|NCT00483938|473184839|FG001|Overall Study|Withdrawal by Subject|6|||
131426598|NCT00483938|473184840|FG002|Overall Study|Withdrawal by Subject|0|||
131426599|NCT00483938|473184841|FG003|Overall Study|Withdrawal by Subject|0|||
131426600|NCT00483938|473184842|FG004|Overall Study|Withdrawal by Subject|1|||
131426601|NCT00483938|473184843|FG005|Overall Study|Withdrawal by Subject|3|||
131426602|NCT00483938|473184844|FG006|Overall Study|Withdrawal by Subject|2|||
131426603|NCT00483938|473184838|FG000|Overall Study|Lost to Follow-up|1|||
131426604|NCT00483938|473184839|FG001|Overall Study|Lost to Follow-up|2|||
131426605|NCT00483938|473184840|FG002|Overall Study|Lost to Follow-up|0|||
131426606|NCT00483938|473184841|FG003|Overall Study|Lost to Follow-up|2|||
131426607|NCT00483938|473184842|FG004|Overall Study|Lost to Follow-up|1|||
131426608|NCT00483938|473184843|FG005|Overall Study|Lost to Follow-up|1|||
131426609|NCT00483938|473184844|FG006|Overall Study|Lost to Follow-up|3|||
131426610|NCT00483938|473184838|FG000|Overall Study|Death|0|||
131426611|NCT00483938|473184839|FG001|Overall Study|Death|2|||
131426612|NCT00483938|473184840|FG002|Overall Study|Death|0|||
131426613|NCT00483938|473184841|FG003|Overall Study|Death|0|||
131426614|NCT00483938|473184842|FG004|Overall Study|Death|0|||
131426615|NCT00483938|473184843|FG005|Overall Study|Death|0|||
131426616|NCT00483938|473184844|FG006|Overall Study|Death|0|||
131426617|NCT00483938|473184838|FG000|Overall Study|Other|3|||
131426618|NCT00483938|473184839|FG001|Overall Study|Other|9|||
131426619|NCT00483938|473184840|FG002|Overall Study|Other|0|||
131426620|NCT00483938|473184841|FG003|Overall Study|Other|4|||
131426621|NCT00483938|473184842|FG004|Overall Study|Other|0|||
131426622|NCT00483938|473184843|FG005|Overall Study|Other|4|||
131426623|NCT00483938|473184844|FG006|Overall Study|Other|32|||
131426624|NCT02519595|473184845|FG000|Overall Study|Protocol Violation|8|||
131426625|NCT02519595|473184846|FG001|Overall Study|Protocol Violation|22|||
131426626|NCT02519595|473184847|FG002|Overall Study|Protocol Violation|16|||
131426627|NCT00850538|473184850|FG000|Overall Study|unable/unwilling to complete MRI|13|||
131426628|NCT00850538|473184850|FG000|Overall Study|specimen missed due to scheduling error|14|||
131426629|NCT00850538|473184850|FG000|Overall Study|specimen unusable|7|||
131426630|NCT00850538|473184850|FG000|Overall Study|Withdrawal by Subject|3|||
131426631|NCT00850538|473184850|FG000|Overall Study|radiology error|2|||
131426632|NCT00850538|473184850|FG000|Overall Study|Protocol Violation|2|||
131426633|NCT03188510|473184856|FG000|Overall Study|Inappropriate behavior with site staff|0|||
131426634|NCT03188510|473184857|FG001|Overall Study|Inappropriate behavior with site staff|1|||
131426635|NCT03188510|473184858|FG002|Overall Study|Inappropriate behavior with site staff|0|||
131426636|NCT03052049|473184860|FG000|Overall Study|Withdrawal by Subject|2|||
131426637|NCT02328027|473184861|FG000|Overall Study|Withdrawal by Subject|0|||
131426638|NCT02328027|473184862|FG001|Overall Study|Withdrawal by Subject|1|||
131426639|NCT00999518|473184866|FG000|Overall Study|Adverse Event|1|||
131426640|NCT00999518|473184867|FG001|Overall Study|Adverse Event|6|||
131426641|NCT00999518|473184868|FG002|Overall Study|Adverse Event|3|||
131426642|NCT00999518|473184869|FG003|Overall Study|Adverse Event|1|||
131426643|NCT00999518|473184870|FG004|Overall Study|Adverse Event|2|||
131426644|NCT00999518|473184866|FG000|Overall Study|Lack of Efficacy|2|||
131426645|NCT00999518|473184867|FG001|Overall Study|Lack of Efficacy|0|||
131426646|NCT00999518|473184868|FG002|Overall Study|Lack of Efficacy|0|||
131426647|NCT00999518|473184869|FG003|Overall Study|Lack of Efficacy|2|||
131426648|NCT00999518|473184870|FG004|Overall Study|Lack of Efficacy|2|||
131426649|NCT00999518|473184866|FG000|Overall Study|Lost to Follow-up|0|||
131426650|NCT00999518|473184867|FG001|Overall Study|Lost to Follow-up|0|||
131426651|NCT00999518|473184868|FG002|Overall Study|Lost to Follow-up|0|||
131426652|NCT00999518|473184869|FG003|Overall Study|Lost to Follow-up|4|||
131426653|NCT00999518|473184870|FG004|Overall Study|Lost to Follow-up|1|||
131426654|NCT00999518|473184866|FG000|Overall Study|Did not meet entrance criteria|0|||
131426655|NCT00999518|473184867|FG001|Overall Study|Did not meet entrance criteria|0|||
131426656|NCT00999518|473184868|FG002|Overall Study|Did not meet entrance criteria|0|||
131426657|NCT00999518|473184869|FG003|Overall Study|Did not meet entrance criteria|0|||
131426658|NCT00999518|473184870|FG004|Overall Study|Did not meet entrance criteria|1|||
131426659|NCT00999518|473184866|FG000|Overall Study|Study terminated by sponsor|10|||
131426660|NCT00999518|473184867|FG001|Overall Study|Study terminated by sponsor|6|||
131426661|NCT00999518|473184868|FG002|Overall Study|Study terminated by sponsor|5|||
131426662|NCT00999518|473184869|FG003|Overall Study|Study terminated by sponsor|5|||
131426663|NCT00999518|473184870|FG004|Overall Study|Study terminated by sponsor|9|||
131426664|NCT00999518|473184866|FG000|Overall Study|Pregnancy|0|||
131426665|NCT00999518|473184867|FG001|Overall Study|Pregnancy|0|||
131426666|NCT00999518|473184868|FG002|Overall Study|Pregnancy|1|||
131426667|NCT00999518|473184869|FG003|Overall Study|Pregnancy|0|||
131426668|NCT00999518|473184870|FG004|Overall Study|Pregnancy|0|||
131426669|NCT00999518|473184866|FG000|Overall Study|Protocol Violation|0|||
131426670|NCT00999518|473184867|FG001|Overall Study|Protocol Violation|1|||
131426671|NCT00999518|473184868|FG002|Overall Study|Protocol Violation|0|||
131426672|NCT00999518|473184869|FG003|Overall Study|Protocol Violation|0|||
131426673|NCT00999518|473184870|FG004|Overall Study|Protocol Violation|2|||
131426674|NCT00999518|473184866|FG000|Overall Study|Withdrawal by Subject|5|||
131426675|NCT00999518|473184867|FG001|Overall Study|Withdrawal by Subject|4|||
131426676|NCT00999518|473184868|FG002|Overall Study|Withdrawal by Subject|10|||
131426677|NCT00999518|473184869|FG003|Overall Study|Withdrawal by Subject|6|||
131426678|NCT00999518|473184870|FG004|Overall Study|Withdrawal by Subject|1|||
131426679|NCT00999518|473184866|FG000|Overall Study|Other|5|||
131426680|NCT00999518|473184867|FG001|Overall Study|Other|7|||
131426681|NCT00999518|473184868|FG002|Overall Study|Other|1|||
131426682|NCT00999518|473184869|FG003|Overall Study|Other|4|||
131426683|NCT00999518|473184870|FG004|Overall Study|Other|5|||
131426684|NCT00999518|473184866|FG000|Overall Study|Randomized but not Treated|1|||
131426685|NCT00999518|473184867|FG001|Overall Study|Randomized but not Treated|1|||
131426686|NCT00999518|473184868|FG002|Overall Study|Randomized but not Treated|2|||
131426687|NCT00999518|473184869|FG003|Overall Study|Randomized but not Treated|0|||
131426688|NCT00999518|473184870|FG004|Overall Study|Randomized but not Treated|1|||
131426689|NCT03304873|473184871|FG000|Overall Study|Lost to Follow-up|1|||
131426690|NCT03304873|473184872|FG001|Overall Study|Lost to Follow-up|8|||
131426691|NCT03319212|473184873|FG000|Overall Study|Discontinued as moving out of local area|0|||
131426692|NCT03319212|473184874|FG001|Overall Study|Discontinued as moving out of local area|1|||
131426693|NCT03319212|473184873|FG000|Overall Study|Adverse Event|2|||
131426694|NCT03319212|473184874|FG001|Overall Study|Adverse Event|2|||
131426695|NCT03319212|473184873|FG000|Overall Study|Withdrawal by Subject|0|||
131426696|NCT03319212|473184874|FG001|Overall Study|Withdrawal by Subject|1|||
131426697|NCT03319212|473184873|FG000|Overall Study|Lost to Follow-up|0|||
131426698|NCT03319212|473184874|FG001|Overall Study|Lost to Follow-up|1|||
131426699|NCT03319212|473184873|FG000|Overall Study|Physician Decision|1|||
131426700|NCT03319212|473184874|FG001|Overall Study|Physician Decision|0|||
131426701|NCT00250276|473184875|FG000|Overall Study|Serious Adverse Event|0|||
131426702|NCT00250276|473184876|FG001|Overall Study|Serious Adverse Event|0|||
131426703|NCT00250276|473184877|FG002|Overall Study|Serious Adverse Event|1|||
131426704|NCT00250276|473184878|FG003|Overall Study|Serious Adverse Event|0|||
131426705|NCT00250276|473184875|FG000|Overall Study|Non-serious Adverse Event|2|||
131426706|NCT00250276|473184876|FG001|Overall Study|Non-serious Adverse Event|0|||
131426707|NCT00250276|473184877|FG002|Overall Study|Non-serious Adverse Event|0|||
131426708|NCT00250276|473184878|FG003|Overall Study|Non-serious Adverse Event|2|||
131426709|NCT00250276|473184875|FG000|Overall Study|Protocol Violation|0|||
131426710|NCT00250276|473184876|FG001|Overall Study|Protocol Violation|1|||
131426711|NCT00250276|473184877|FG002|Overall Study|Protocol Violation|0|||
131426712|NCT00250276|473184878|FG003|Overall Study|Protocol Violation|0|||
131426713|NCT00250276|473184875|FG000|Overall Study|Withdrawal by Subject|1|||
131426714|NCT00250276|473184876|FG001|Overall Study|Withdrawal by Subject|2|||
131426715|NCT00250276|473184877|FG002|Overall Study|Withdrawal by Subject|3|||
131426716|NCT00250276|473184878|FG003|Overall Study|Withdrawal by Subject|2|||
131426717|NCT00250276|473184875|FG000|Overall Study|Migrated/moved from study area|3|||
131426718|NCT00250276|473184876|FG001|Overall Study|Migrated/moved from study area|0|||
131426719|NCT00250276|473184877|FG002|Overall Study|Migrated/moved from study area|2|||
131426720|NCT00250276|473184878|FG003|Overall Study|Migrated/moved from study area|7|||
131426721|NCT00250276|473184875|FG000|Overall Study|Lost to Follow-up|11|||
131426722|NCT00250276|473184876|FG001|Overall Study|Lost to Follow-up|18|||
131426723|NCT00250276|473184877|FG002|Overall Study|Lost to Follow-up|13|||
131426724|NCT00250276|473184878|FG003|Overall Study|Lost to Follow-up|8|||
131426725|NCT01546688|473184879|FG000|Overall Study|Adverse Event|0|||
131426726|NCT01546688|473184880|FG001|Overall Study|Adverse Event|4|||
131426727|NCT01546688|473184879|FG000|Overall Study|Withdrawal by Subject|2|||
131426728|NCT01546688|473184880|FG001|Overall Study|Withdrawal by Subject|1|||
131426729|NCT01546688|473184879|FG000|Overall Study|Lack of Efficacy|1|||
131426730|NCT01546688|473184880|FG001|Overall Study|Lack of Efficacy|0|||
131426731|NCT01811186|473184881|FG000|Overall Study|Adverse Event|54|||
131426732|NCT01811186|473184882|FG001|Overall Study|Adverse Event|38|||
131426733|NCT01811186|473184881|FG000|Overall Study|Protocol Violation|5|||
131426734|NCT01811186|473184882|FG001|Overall Study|Protocol Violation|6|||
131426735|NCT01811186|473184881|FG000|Overall Study|Withdrawal by Subject|5|||
131426736|NCT01811186|473184882|FG001|Overall Study|Withdrawal by Subject|10|||
131426737|NCT01811186|473184881|FG000|Overall Study|Lack of Efficacy|3|||
131426738|NCT01811186|473184882|FG001|Overall Study|Lack of Efficacy|6|||
131426739|NCT01811186|473184881|FG000|Overall Study|Lost to Follow-up|4|||
131426740|NCT01811186|473184882|FG001|Overall Study|Lost to Follow-up|2|||
131426741|NCT03369236|473184885|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
131426742|NCT03369236|473184886|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
131426743|NCT03369236|473184885|FG000|Open-label Extension Period|Lack of Efficacy|2|||
131426744|NCT03369236|473184886|FG001|Open-label Extension Period|Lack of Efficacy|1|||
131426745|NCT03369236|473184885|FG000|Open-label Extension Period|Adverse Event|0|||
131426746|NCT03369236|473184886|FG001|Open-label Extension Period|Adverse Event|1|||
131426747|NCT03369236|473184885|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
131426748|NCT03369236|473184886|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
131426749|NCT01153724|473184891|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131426750|NCT01153724|473184891|FG000|Treatment Period 2|Adverse Event|1|||
131426751|NCT01153724|473184891|FG000|Treatment Period 2|Other reason not defined above|1|||
131426752|NCT03350815|473186416|FG000|Period 1|Adverse Event|10|||
131426753|NCT03350815|473186417|FG001|Period 1|Adverse Event|0|||
131426754|NCT03350815|473186418|FG002|Period 1|Adverse Event|0|||
131426755|NCT03350815|473186419|FG003|Period 1|Adverse Event|0|||
131426756|NCT03350815|473186416|FG000|Period 1|Technical problems|1|||
131426757|NCT03350815|473186417|FG001|Period 1|Technical problems|0|||
131426758|NCT03350815|473186418|FG002|Period 1|Technical problems|0|||
131426759|NCT03350815|473186419|FG003|Period 1|Technical problems|0|||
131426760|NCT03350815|473186416|FG000|Period 1|Lost to Follow-up|3|||
131426761|NCT03350815|473186417|FG001|Period 1|Lost to Follow-up|0|||
131426762|NCT03350815|473186418|FG002|Period 1|Lost to Follow-up|0|||
131426763|NCT03350815|473186419|FG003|Period 1|Lost to Follow-up|0|||
131426764|NCT03350815|473186416|FG000|Period 1|Physician Decision|1|||
131426765|NCT03350815|473186417|FG001|Period 1|Physician Decision|0|||
131426766|NCT03350815|473186418|FG002|Period 1|Physician Decision|0|||
131426767|NCT03350815|473186419|FG003|Period 1|Physician Decision|0|||
131426768|NCT03350815|473186416|FG000|Period 1|Withdrawal by Subject|8|||
131426769|NCT03350815|473186417|FG001|Period 1|Withdrawal by Subject|0|||
131426770|NCT03350815|473186418|FG002|Period 1|Withdrawal by Subject|0|||
131426771|NCT03350815|473186419|FG003|Period 1|Withdrawal by Subject|0|||
131426772|NCT03350815|473186416|FG000|Period 1|Lack of Efficacy|15|||
131426773|NCT03350815|473186417|FG001|Period 1|Lack of Efficacy|0|||
131426774|NCT03350815|473186418|FG002|Period 1|Lack of Efficacy|0|||
131426775|NCT03350815|473186419|FG003|Period 1|Lack of Efficacy|0|||
131426776|NCT03350815|473186416|FG000|Period 1|Non-compliance with study treatment|2|||
131426777|NCT03350815|473186417|FG001|Period 1|Non-compliance with study treatment|0|||
131426778|NCT03350815|473186418|FG002|Period 1|Non-compliance with study treatment|0|||
131426779|NCT03350815|473186419|FG003|Period 1|Non-compliance with study treatment|0|||
131426780|NCT03350815|473186416|FG000|Period 1|Protocol Violation|3|||
131426781|NCT03350815|473186417|FG001|Period 1|Protocol Violation|0|||
131426782|NCT03350815|473186418|FG002|Period 1|Protocol Violation|0|||
131426783|NCT03350815|473186419|FG003|Period 1|Protocol Violation|0|||
131426784|NCT03350815|473186416|FG000|Period 2|Adverse Event|0|||
131426785|NCT03350815|473186417|FG001|Period 2|Adverse Event|3|||
131426786|NCT03350815|473186418|FG002|Period 2|Adverse Event|5|||
131426787|NCT03350815|473186419|FG003|Period 2|Adverse Event|0|||
131426788|NCT03350815|473186416|FG000|Period 2|Technical problem|0|||
131426789|NCT03350815|473186417|FG001|Period 2|Technical problem|1|||
131426790|NCT03350815|473186418|FG002|Period 2|Technical problem|0|||
131426791|NCT03350815|473186419|FG003|Period 2|Technical problem|0|||
131426792|NCT03350815|473186416|FG000|Period 2|Lost to Follow-up|0|||
131426793|NCT03350815|473186417|FG001|Period 2|Lost to Follow-up|3|||
131426794|NCT03350815|473186418|FG002|Period 2|Lost to Follow-up|3|||
131426795|NCT03350815|473186419|FG003|Period 2|Lost to Follow-up|0|||
131426796|NCT03350815|473186416|FG000|Period 2|Physician Decision|0|||
131426797|NCT03350815|473186417|FG001|Period 2|Physician Decision|0|||
131426798|NCT03350815|473186418|FG002|Period 2|Physician Decision|1|||
131426799|NCT03350815|473186419|FG003|Period 2|Physician Decision|0|||
131426800|NCT03350815|473186416|FG000|Period 2|Withdrawal by Subject|0|||
131426801|NCT03350815|473186417|FG001|Period 2|Withdrawal by Subject|3|||
131426802|NCT03350815|473186418|FG002|Period 2|Withdrawal by Subject|4|||
131426803|NCT03350815|473186419|FG003|Period 2|Withdrawal by Subject|0|||
131426804|NCT03350815|473186416|FG000|Period 2|Lack of Efficacy|0|||
131426805|NCT03350815|473186417|FG001|Period 2|Lack of Efficacy|6|||
131426806|NCT03350815|473186418|FG002|Period 2|Lack of Efficacy|2|||
131426807|NCT03350815|473186419|FG003|Period 2|Lack of Efficacy|0|||
131426808|NCT03350815|473186416|FG000|Period 2|Protocol Violation|0|||
131426809|NCT03350815|473186417|FG001|Period 2|Protocol Violation|0|||
131426810|NCT03350815|473186418|FG002|Period 2|Protocol Violation|1|||
131426811|NCT03350815|473186419|FG003|Period 2|Protocol Violation|0|||
131426812|NCT03350815|473186416|FG000|Period 2|New therapy for study indication|0|||
131426813|NCT03350815|473186417|FG001|Period 2|New therapy for study indication|0|||
131426814|NCT03350815|473186418|FG002|Period 2|New therapy for study indication|1|||
131426815|NCT03350815|473186419|FG003|Period 2|New therapy for study indication|0|||
131426816|NCT02837029|473186422|FG000|Screening|Failed to meet screening requirements.|7|||
131426817|NCT02837029|473186423|FG001|Screening|Failed to meet screening requirements.|3|||
131426818|NCT02837029|473186424|FG002|Screening|Failed to meet screening requirements.|0|||
131426819|NCT02837029|473186422|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
131426820|NCT02837029|473186423|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
131426821|NCT02837029|473186424|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
131426822|NCT02837029|473186422|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
131426823|NCT02837029|473186423|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
131426824|NCT02837029|473186424|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
131426825|NCT02837029|473186422|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
131426826|NCT02837029|473186423|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
131426827|NCT02837029|473186424|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
131426828|NCT02837029|473186422|FG000|Cycle 2 and Beyond|Adverse Event|1|||
131426829|NCT02837029|473186423|FG001|Cycle 2 and Beyond|Adverse Event|0|||
131426830|NCT02837029|473186424|FG002|Cycle 2 and Beyond|Adverse Event|0|||
131426831|NCT02837029|473186422|FG000|2 Year Follow-up|Death|6|||
131426832|NCT02837029|473186423|FG001|2 Year Follow-up|Death|7|||
131426833|NCT02837029|473186424|FG002|2 Year Follow-up|Death|0|||
131426834|NCT02034877|473186425|FG000|Overall Study|Lost to Follow-up|0|||
131426835|NCT02034877|473186426|FG001|Overall Study|Lost to Follow-up|3|||
131426836|NCT02034877|473186425|FG000|Overall Study|No Longer Willing to Participate|0|||
131426837|NCT02034877|473186426|FG001|Overall Study|No Longer Willing to Participate|3|||
131426838|NCT04273893|473186429|FG000|Overall Study|Withdrawal by Subject|0|||
131426839|NCT04273893|473186430|FG001|Overall Study|Withdrawal by Subject|2|||
131426840|NCT04273893|473186429|FG000|Overall Study|Treatment of Disease Progression|0|||
131426841|NCT04273893|473186430|FG001|Overall Study|Treatment of Disease Progression|2|||
131426842|NCT04273893|473186429|FG000|Overall Study|Death|1|||
131426843|NCT04273893|473186430|FG001|Overall Study|Death|2|||
131426844|NCT04273893|473186429|FG000|Overall Study|Lost to Follow-up|0|||
131426845|NCT04273893|473186430|FG001|Overall Study|Lost to Follow-up|2|||
131426846|NCT04273893|473186429|FG000|Overall Study|Physician Decision|1|||
131426847|NCT04273893|473186430|FG001|Overall Study|Physician Decision|0|||
131768902|NCT02500706|474431894|FG000|Overall Study|Withdrawal by Subject|4|||
131768903|NCT02500706|474431895|FG001|Overall Study|Withdrawal by Subject|6|||
131458080|NCT01124864|473308785|FG003|Overall Study|Death|2|||
131458081|NCT01124864|473308786|FG004|Overall Study|Death|1|||
131458082|NCT01124864|473308787|FG005|Overall Study|Death|0|||
131458083|NCT01124864|473308782|FG000|Overall Study|Withdrawal by Subject|2|||
131458084|NCT01124864|473308783|FG001|Overall Study|Withdrawal by Subject|3|||
131768904|NCT02500706|474431896|FG002|Overall Study|Withdrawal by Subject|4|||
131768905|NCT02500706|474431894|FG000|Overall Study|Unclassified|0|||
131768906|NCT02500706|474431895|FG001|Overall Study|Unclassified|0|||
131768907|NCT02500706|474431896|FG002|Overall Study|Unclassified|1|||
131768908|NCT01497899|474431897|FG000|Double-Blind Phase|Randomized but not Treated|1|||
131426856|NCT01564732|473186435|FG000|Overall Study|Early termination by the study sponsor|6|||
131426857|NCT01564732|473186436|FG001|Overall Study|Early termination by the study sponsor|5|||
131426858|NCT00381693|473186439|FG000|Overall Study|Death|1|||
131426859|NCT00381693|473186439|FG000|Overall Study|Adverse Event|4|||
131426860|NCT00381693|473186439|FG000|Overall Study|Patient Choice|1|||
131426861|NCT00381693|473186439|FG000|Overall Study|Progression|2|||
131426862|NCT02598297|473186440|FG000|Overall Study|Study terminated by Sponsor|21|||
131426863|NCT02598297|473186441|FG001|Overall Study|Study terminated by Sponsor|23|||
131426864|NCT02598297|473186440|FG000|Overall Study|Adverse Event|1|||
131426865|NCT02598297|473186441|FG001|Overall Study|Adverse Event|1|||
131426866|NCT02598297|473186440|FG000|Overall Study|Physician Decision|1|||
131426867|NCT02598297|473186441|FG001|Overall Study|Physician Decision|0|||
131426868|NCT02598297|473186440|FG000|Overall Study|Subject/guardian decision|1|||
131426869|NCT02598297|473186441|FG001|Overall Study|Subject/guardian decision|0|||
131426870|NCT02598297|473186440|FG000|Overall Study|Followed for survival|1|||
131426871|NCT02598297|473186441|FG001|Overall Study|Followed for survival|0|||
131426872|NCT00394706|473186452|FG000|Overall Study|Withdrawal by Subject|2|||
131426873|NCT00394706|473186453|FG001|Overall Study|Withdrawal by Subject|0|||
131426874|NCT00394706|473186454|FG002|Overall Study|Withdrawal by Subject|1|||
131426875|NCT00394706|473186455|FG003|Overall Study|Withdrawal by Subject|0|||
131426876|NCT00394706|473186456|FG004|Overall Study|Withdrawal by Subject|0|||
131426877|NCT00394706|473186457|FG005|Overall Study|Withdrawal by Subject|2|||
131426878|NCT00394706|473186458|FG006|Overall Study|Withdrawal by Subject|1|||
131426879|NCT00394706|473186459|FG007|Overall Study|Withdrawal by Subject|0|||
131426880|NCT00394706|473186452|FG000|Overall Study|Lost to Follow-up|2|||
131426881|NCT00394706|473186453|FG001|Overall Study|Lost to Follow-up|2|||
131426882|NCT00394706|473186454|FG002|Overall Study|Lost to Follow-up|8|||
131426883|NCT00394706|473186455|FG003|Overall Study|Lost to Follow-up|1|||
131426884|NCT00394706|473186456|FG004|Overall Study|Lost to Follow-up|2|||
131426885|NCT00394706|473186457|FG005|Overall Study|Lost to Follow-up|5|||
131426886|NCT00394706|473186458|FG006|Overall Study|Lost to Follow-up|2|||
131426887|NCT00394706|473186459|FG007|Overall Study|Lost to Follow-up|0|||
131426888|NCT02003534|473186463|FG000|Overall Study|Lost to Follow-up|47|||
131426889|NCT02506192|473186466|FG000|Overall Study|Withdrawal by Subject|1|||
131426890|NCT02506192|473186467|FG001|Overall Study|Withdrawal by Subject|1|||
131426891|NCT05292131|473186470|FG000|Overall Study|Lost to Follow-up|1|||
131426892|NCT05292131|473186471|FG001|Overall Study|Lost to Follow-up|1|||
131426893|NCT05292131|473186470|FG000|Overall Study|Withdrawal by Subject|0|||
131426894|NCT05292131|473186471|FG001|Overall Study|Withdrawal by Subject|1|||
131426895|NCT06136897|473186472|FG000|Overall Study|Ineligible|3|||
131426896|NCT06136897|473186472|FG000|Overall Study|Mutation status not confirmed|7|||
131426897|NCT06136897|473186472|FG000|Overall Study|Adverse Event|2|||
131426898|NCT06136897|473186472|FG000|Overall Study|Death|1|||
131426899|NCT06136897|473186472|FG000|Overall Study|Disease progression|18|||
131426900|NCT06136897|473186472|FG000|Overall Study|Other complicating disease|1|||
131426901|NCT06136897|473186472|FG000|Overall Study|Withdrawal by Subject|1|||
131426902|NCT06136897|473186472|FG000|Overall Study|Still on treatment|1|||
131426903|NCT06136897|473186472|FG000|Overall Study|Lost to Follow-up|1|||
131426904|NCT03785405|473186473|FG000|Overall Study|Adverse Event|16|||
131426905|NCT03785405|473186474|FG001|Overall Study|Adverse Event|1|||
131426906|NCT03785405|473186473|FG000|Overall Study|Death|6|||
131426907|NCT03785405|473186474|FG001|Overall Study|Death|4|||
131426908|NCT03785405|473186473|FG000|Overall Study|Guardian decision|4|||
131426909|NCT03785405|473186474|FG001|Overall Study|Guardian decision|1|||
131426910|NCT03785405|473186473|FG000|Overall Study|Lost to Follow-up|1|||
131426911|NCT03785405|473186474|FG001|Overall Study|Lost to Follow-up|0|||
131426912|NCT03785405|473186473|FG000|Overall Study|Physician Decision|8|||
131426913|NCT03785405|473186474|FG001|Overall Study|Physician Decision|5|||
131426914|NCT03785405|473186473|FG000|Overall Study|Participant decision|2|||
131426915|NCT03785405|473186474|FG001|Overall Study|Participant decision|0|||
131426916|NCT03785405|473186473|FG000|Overall Study|Other|1|||
131426917|NCT03785405|473186474|FG001|Overall Study|Other|0|||
131426918|NCT03785405|473186473|FG000|Overall Study|No treatment was received|0|||
131426919|NCT03785405|473186474|FG001|Overall Study|No treatment was received|1|||
131458085|NCT01124864|473308784|FG002|Overall Study|Withdrawal by Subject|4|||
131458086|NCT01124864|473308785|FG003|Overall Study|Withdrawal by Subject|0|||
131458087|NCT01124864|473308786|FG004|Overall Study|Withdrawal by Subject|2|||
131458088|NCT01124864|473308787|FG005|Overall Study|Withdrawal by Subject|1|||
131458089|NCT01124864|473308782|FG000|Overall Study|Lost to Follow-up|1|||
131458090|NCT01124864|473308783|FG001|Overall Study|Lost to Follow-up|1|||
131458091|NCT01124864|473308784|FG002|Overall Study|Lost to Follow-up|0|||
131458092|NCT01124864|473308785|FG003|Overall Study|Lost to Follow-up|1|||
131426920|NCT03705559|473186475|FG000|Overall Study|COVID Shut down|1|||
131426921|NCT01979952|473186478|FG000|Overall Study|Adverse Event|4|||
131426922|NCT01979952|473186479|FG001|Overall Study|Adverse Event|5|||
131426923|NCT01979952|473186478|FG000|Overall Study|Protocol Violation|1|||
131426924|NCT01979952|473186479|FG001|Overall Study|Protocol Violation|0|||
131426925|NCT01979952|473186478|FG000|Overall Study|Withdrawal by Subject|2|||
131426926|NCT01979952|473186479|FG001|Overall Study|Withdrawal by Subject|1|||
131426927|NCT01979952|473186478|FG000|Overall Study|Other than specified above|1|||
131426928|NCT01979952|473186479|FG001|Overall Study|Other than specified above|0|||
131426929|NCT02881762|473186480|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131426930|NCT02881762|473186481|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131426931|NCT00203424|473186485|FG000|Treatment Period|Withdrawal by Subject|4|||
131426932|NCT00203424|473186485|FG000|Treatment Period|Adverse Event|5|||
131426933|NCT00203424|473186485|FG000|Treatment Period|progressive disease|2|||
131426934|NCT00203424|473186485|FG000|Follow-up Period|Withdrawal by Subject|1|||
131426935|NCT00203424|473186485|FG000|Follow-up Period|progressive disease|4|||
131426936|NCT00203424|473186485|FG000|Follow-up Period|Lost to Follow-up|1|||
131426937|NCT01053988|473186486|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
131426938|NCT01053988|473186487|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131426939|NCT01053988|473186488|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131426940|NCT01053988|473186489|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131426941|NCT01053988|473186490|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131426942|NCT01053988|473186491|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131426943|NCT01053988|473186486|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
131426944|NCT01053988|473186487|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131426945|NCT01053988|473186488|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131426946|NCT01053988|473186489|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131426947|NCT01053988|473186490|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131426948|NCT01053988|473186491|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
131426949|NCT01053988|473186486|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
131426950|NCT01053988|473186487|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131426951|NCT01053988|473186488|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131426952|NCT01053988|473186489|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131426953|NCT01053988|473186490|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131426954|NCT01053988|473186491|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131426955|NCT01053988|473186486|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
131426956|NCT01053988|473186487|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
131426957|NCT01053988|473186488|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
131426958|NCT01053988|473186489|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
131426959|NCT01053988|473186490|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
131426960|NCT01053988|473186491|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
131426961|NCT01053988|473186486|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
131426962|NCT01053988|473186487|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
131426963|NCT01053988|473186488|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
131426964|NCT01053988|473186489|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
131426965|NCT01053988|473186490|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
131426966|NCT01053988|473186491|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
131426967|NCT01053988|473186486|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
131426968|NCT01053988|473186487|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131426969|NCT01053988|473186488|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131426970|NCT01053988|473186489|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131426971|NCT01053988|473186490|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131426972|NCT01053988|473186491|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131426973|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
131426974|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
131426975|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
131426976|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
131426977|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
131426978|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
131426979|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131426980|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
131426981|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
131426982|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
131426983|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
131426984|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131426985|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
131426986|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
131426987|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
131426988|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
131426989|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
131426990|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
131426991|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131426992|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
131426993|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
131426994|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
131426995|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
131426996|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
131426997|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131426998|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
131426999|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
131427000|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
131427001|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
131427002|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
131427003|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131427004|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
131427005|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131427006|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
131427007|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131427008|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
131427009|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
131427010|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
131427011|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
131427012|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
131427013|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
131427014|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
131427015|NCT01053988|473186486|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131427016|NCT01053988|473186487|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
131427017|NCT01053988|473186488|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
131427018|NCT01053988|473186489|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
131427019|NCT01053988|473186490|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
131427020|NCT01053988|473186491|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
131427021|NCT01922271|473186492|FG000|WASHOUT Period|Withdrawal by Subject|1|||
131427022|NCT01922271|473186493|FG001|WASHOUT Period|Withdrawal by Subject|0|||
131427023|NCT01824355|473186494|FG000|Overall Study|Adverse Event|2|||
131427024|NCT01824355|473186494|FG000|Overall Study|unevaluable reference method results per|1|||
131427025|NCT02104947|473186506|FG000|Overall Study|Withdrawal by Subject|10|||
131427026|NCT02104947|473186507|FG001|Overall Study|Withdrawal by Subject|3|||
131427027|NCT02104947|473186506|FG000|Overall Study|Lost to Follow-up|4|||
131427028|NCT02104947|473186507|FG001|Overall Study|Lost to Follow-up|4|||
131427029|NCT02104947|473186506|FG000|Overall Study|Protocol Violation|6|||
131427030|NCT02104947|473186507|FG001|Overall Study|Protocol Violation|8|||
131427031|NCT02104947|473186506|FG000|Overall Study|Adverse Event|57|||
131427032|NCT02104947|473186507|FG001|Overall Study|Adverse Event|38|||
131427033|NCT02104947|473186506|FG000|Overall Study|Other than stated above|2|||
131427034|NCT02104947|473186507|FG001|Overall Study|Other than stated above|3|||
131427035|NCT00206440|473186508|FG000|Overall Study|Protocol Violation|1|||
131427036|NCT00206440|473186509|FG001|Overall Study|Protocol Violation|2|||
131427037|NCT00206440|473186508|FG000|Overall Study|Adverse Event|4|||
131427038|NCT00206440|473186509|FG001|Overall Study|Adverse Event|2|||
131427039|NCT04090242|473186510|FG000|Overall Study|Withdrawal by Subject|1|||
131427040|NCT04090242|473186511|FG001|Overall Study|Withdrawal by Subject|0|||
131427041|NCT01019369|473186512|FG000|Overall Study|Lost to Follow-up|10|||
131427042|NCT01019369|473186513|FG001|Overall Study|Lost to Follow-up|6|||
131427043|NCT01019369|473186512|FG000|Overall Study|Withdrawal by Subject|0|||
131427044|NCT01019369|473186513|FG001|Overall Study|Withdrawal by Subject|1|||
131427045|NCT01380834|473186514|FG000|Overall Study|Physician Decision|1|||
131427046|NCT01380834|473186515|FG001|Overall Study|Physician Decision|0|||
131427047|NCT04565951|473186516|FG000|Overall Study|Lost to Follow-up|66|||
131427048|NCT04565951|473186517|FG001|Overall Study|Lost to Follow-up|38|||
131427049|NCT04565951|473186516|FG000|Overall Study|Withdrawal by Subject|14|||
131427050|NCT04565951|473186517|FG001|Overall Study|Withdrawal by Subject|7|||
131427051|NCT04565951|473186516|FG000|Overall Study|Death|0|||
131427052|NCT04565951|473186517|FG001|Overall Study|Death|1|||
131427053|NCT00429169|473186518|FG000|Overall Study|Lost to Follow-up|0|||
131427054|NCT00429169|473186519|FG001|Overall Study|Lost to Follow-up|1|||
131427055|NCT00429169|473186518|FG000|Overall Study|Ineligibility discovered after entry|2|||
131427056|NCT00429169|473186519|FG001|Overall Study|Ineligibility discovered after entry|1|||
131427057|NCT01746173|473186525|FG000|Overall Study|Disease Progression|2|||
131427058|NCT01371552|473186529|FG000|Part 1, First 3 Days|Inconvenience|0|||
131427059|NCT01371552|473186530|FG001|Part 1, First 3 Days|Inconvenience|0|||
131427060|NCT01371552|473186531|FG002|Part 1, First 3 Days|Inconvenience|1|||
131427061|NCT01371552|473186532|FG003|Part 1, First 3 Days|Inconvenience|0|||
131427062|NCT01371552|473186533|FG004|Part 1, First 3 Days|Inconvenience|0|||
131427063|NCT01371552|473186534|FG005|Part 1, First 3 Days|Inconvenience|0|||
131427064|NCT01052077|473186535|FG000|Phase A|Lost to Follow-up|22|||
131427065|NCT01052077|473186536|FG001|Phase A|Lost to Follow-up|0|||
131427066|NCT01052077|473186537|FG002|Phase A|Lost to Follow-up|0|||
131427067|NCT01052077|473186538|FG003|Phase A|Lost to Follow-up|0|||
131427068|NCT01052077|473186535|FG000|Phase A|Adverse Event|32|||
131427069|NCT01052077|473186536|FG001|Phase A|Adverse Event|0|||
131427070|NCT01052077|473186537|FG002|Phase A|Adverse Event|0|||
131427071|NCT01052077|473186538|FG003|Phase A|Adverse Event|0|||
131427072|NCT01052077|473186535|FG000|Phase A|Met Withdrawal Criteria|26|||
131427073|NCT01052077|473186536|FG001|Phase A|Met Withdrawal Criteria|0|||
131427074|NCT01052077|473186537|FG002|Phase A|Met Withdrawal Criteria|0|||
131427075|NCT01052077|473186538|FG003|Phase A|Met Withdrawal Criteria|0|||
131427076|NCT01052077|473186535|FG000|Phase A|Physician Decision|10|||
131427077|NCT01052077|473186536|FG001|Phase A|Physician Decision|0|||
131427078|NCT01052077|473186537|FG002|Phase A|Physician Decision|0|||
131427079|NCT01052077|473186538|FG003|Phase A|Physician Decision|0|||
131427080|NCT01052077|473186535|FG000|Phase A|Withdrawal by Subject|29|||
131427081|NCT01052077|473186536|FG001|Phase A|Withdrawal by Subject|0|||
131427082|NCT01052077|473186537|FG002|Phase A|Withdrawal by Subject|0|||
131427083|NCT01052077|473186538|FG003|Phase A|Withdrawal by Subject|0|||
131427084|NCT01052077|473186535|FG000|Phase A|Protocol Deviation|27|||
131427085|NCT01052077|473186536|FG001|Phase A|Protocol Deviation|0|||
131427086|NCT01052077|473186537|FG002|Phase A|Protocol Deviation|0|||
131427087|NCT01052077|473186538|FG003|Phase A|Protocol Deviation|0|||
131427088|NCT01052077|473186535|FG000|Phase B|Lost to Follow-up|0|||
131427089|NCT01052077|473186536|FG001|Phase B|Lost to Follow-up|2|||
131427090|NCT01052077|473186537|FG002|Phase B|Lost to Follow-up|3|||
131427091|NCT01052077|473186538|FG003|Phase B|Lost to Follow-up|0|||
131427092|NCT01052077|473186535|FG000|Phase B|Adverse Event|0|||
131427093|NCT01052077|473186536|FG001|Phase B|Adverse Event|9|||
131427094|NCT01052077|473186537|FG002|Phase B|Adverse Event|2|||
131427095|NCT01052077|473186538|FG003|Phase B|Adverse Event|0|||
131427096|NCT01052077|473186535|FG000|Phase B|Met Withdrawal Criteria|0|||
131427097|NCT01052077|473186536|FG001|Phase B|Met Withdrawal Criteria|2|||
131427098|NCT01052077|473186537|FG002|Phase B|Met Withdrawal Criteria|1|||
131427099|NCT01052077|473186538|FG003|Phase B|Met Withdrawal Criteria|0|||
131427100|NCT01052077|473186535|FG000|Phase B|Physician Decision|0|||
131427101|NCT01052077|473186536|FG001|Phase B|Physician Decision|1|||
131427102|NCT01052077|473186537|FG002|Phase B|Physician Decision|1|||
131427103|NCT01052077|473186538|FG003|Phase B|Physician Decision|0|||
131427104|NCT01052077|473186535|FG000|Phase B|Withdrawal by Subject|0|||
131427105|NCT01052077|473186536|FG001|Phase B|Withdrawal by Subject|0|||
131427106|NCT01052077|473186537|FG002|Phase B|Withdrawal by Subject|5|||
131427107|NCT01052077|473186538|FG003|Phase B|Withdrawal by Subject|0|||
131427108|NCT01052077|473186535|FG000|Phase B|Protocol Deviation|0|||
131427109|NCT01052077|473186536|FG001|Phase B|Protocol Deviation|3|||
131427110|NCT01052077|473186537|FG002|Phase B|Protocol Deviation|4|||
131427111|NCT01052077|473186538|FG003|Phase B|Protocol Deviation|0|||
131427112|NCT01052077|473186535|FG000|Phase B|Lack of Efficacy|0|||
131427113|NCT01052077|473186536|FG001|Phase B|Lack of Efficacy|1|||
131427114|NCT01052077|473186537|FG002|Phase B|Lack of Efficacy|0|||
131427115|NCT01052077|473186538|FG003|Phase B|Lack of Efficacy|0|||
131427116|NCT01052077|473186535|FG000|Phase A+|Lost to Follow-up|0|||
131427117|NCT01052077|473186536|FG001|Phase A+|Lost to Follow-up|0|||
131427118|NCT01052077|473186537|FG002|Phase A+|Lost to Follow-up|0|||
131427119|NCT01052077|473186538|FG003|Phase A+|Lost to Follow-up|8|||
131427120|NCT01052077|473186535|FG000|Phase A+|Adverse Event|0|||
131427121|NCT01052077|473186536|FG001|Phase A+|Adverse Event|0|||
131427122|NCT01052077|473186537|FG002|Phase A+|Adverse Event|0|||
131427123|NCT01052077|473186538|FG003|Phase A+|Adverse Event|4|||
131427124|NCT01052077|473186535|FG000|Phase A+|Met Withdrawal Criteria|0|||
131427125|NCT01052077|473186536|FG001|Phase A+|Met Withdrawal Criteria|0|||
131427126|NCT01052077|473186537|FG002|Phase A+|Met Withdrawal Criteria|0|||
131427127|NCT01052077|473186538|FG003|Phase A+|Met Withdrawal Criteria|2|||
131427128|NCT01052077|473186535|FG000|Phase A+|Withdrawal by Subject|0|||
131427129|NCT01052077|473186536|FG001|Phase A+|Withdrawal by Subject|0|||
131427130|NCT01052077|473186537|FG002|Phase A+|Withdrawal by Subject|0|||
131427131|NCT01052077|473186538|FG003|Phase A+|Withdrawal by Subject|7|||
131427132|NCT04230213|473186539|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
131427133|NCT04230213|473186540|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
131427134|NCT04230213|473186541|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
131427135|NCT04230213|473186539|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
131427136|NCT04230213|473186540|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
131427137|NCT04230213|473186541|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
131427138|NCT04230213|473186539|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
131427139|NCT04230213|473186540|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
131427140|NCT04230213|473186541|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
131427141|NCT04230213|473186539|FG000|TP2: Week 10 to Week 16|Other|0|||
131427142|NCT04230213|473186540|FG001|TP2: Week 10 to Week 16|Other|2|||
131427143|NCT04230213|473186541|FG002|TP2: Week 10 to Week 16|Other|1|||
131427144|NCT04230213|473186539|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
131427145|NCT04230213|473186540|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
131427146|NCT04230213|473186541|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
131427147|NCT04230213|473186539|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
131427148|NCT04230213|473186540|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
131427149|NCT04230213|473186541|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
131427150|NCT04230213|473186539|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
131427151|NCT04230213|473186540|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
131427152|NCT04230213|473186541|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
131427153|NCT04230213|473186539|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
131427154|NCT04230213|473186540|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
131427155|NCT04230213|473186541|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
131427156|NCT04230213|473186539|FG000|TP3: Week 16 to Week 22|Other|0|||
131427157|NCT04230213|473186540|FG001|TP3: Week 16 to Week 22|Other|1|||
131427158|NCT04230213|473186541|FG002|TP3: Week 16 to Week 22|Other|3|||
131427159|NCT04230213|473186539|FG000|TP4: Week 22 to Week 32|Other|0|||
131427160|NCT04230213|473186540|FG001|TP4: Week 22 to Week 32|Other|5|||
131427161|NCT04230213|473186541|FG002|TP4: Week 22 to Week 32|Other|5|||
131427162|NCT04230213|473186539|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
131427163|NCT04230213|473186540|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
131427164|NCT04230213|473186541|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
131427165|NCT04230213|473186539|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
131427166|NCT04230213|473186540|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
131427167|NCT04230213|473186541|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
131427168|NCT04230213|473186539|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
131427169|NCT04230213|473186540|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
131427170|NCT04230213|473186541|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
131427171|NCT04230213|473186539|FG000|Follow up: Week 32 to Week 36|Other|0|||
131427172|NCT04230213|473186540|FG001|Follow up: Week 32 to Week 36|Other|1|||
131427173|NCT04230213|473186541|FG002|Follow up: Week 32 to Week 36|Other|1|||
131427174|NCT02508428|473186544|FG000|Overall Study|Death|32|||
131427175|NCT02508428|473186545|FG001|Overall Study|Death|33|||
131427176|NCT02508428|473186544|FG000|Overall Study|Liner revised|3|||
131427177|NCT02508428|473186545|FG001|Overall Study|Liner revised|19|||
131427178|NCT02508428|473186544|FG000|Overall Study|Incomplete follow-up|17|||
131427179|NCT02508428|473186545|FG001|Overall Study|Incomplete follow-up|15|||
131427180|NCT04371666|473186555|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
131427181|NCT04371666|473186556|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
131427182|NCT04371666|473186555|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
131427183|NCT04371666|473186556|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
131427184|NCT04371666|473186555|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
131427185|NCT04371666|473186556|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
131427186|NCT04371666|473186555|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
131427187|NCT04371666|473186556|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
131427188|NCT04371666|473186555|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
131427189|NCT04371666|473186556|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
131427190|NCT04371666|473186555|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
131427191|NCT04371666|473186556|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
131427192|NCT00534976|473186565|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
131427193|NCT00534976|473186566|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
131427194|NCT00534976|473186565|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
131427195|NCT00534976|473186566|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
131427196|NCT00534976|473186565|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
131427197|NCT00534976|473186566|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
131427198|NCT00861471|473186567|FG000|Overall Study|Withdrawal by Subject|1|||
131427199|NCT00861471|473186567|FG000|Overall Study|Adverse Event|2|||
131427200|NCT00861471|473186567|FG000|Overall Study|Lack of Efficacy|3|||
131427201|NCT00861471|473186567|FG000|Overall Study|treatment for lumbar laminectomy|1|||
131427202|NCT00861471|473186567|FG000|Overall Study|Physician Decision|2|||
131427203|NCT01445080|473186568|FG000|Overall Study|Adverse Event|5|||
131427204|NCT01445080|473186569|FG001|Overall Study|Adverse Event|3|||
131458093|NCT01124864|473308786|FG004|Overall Study|Lost to Follow-up|0|||
131427205|NCT01445080|473186570|FG002|Overall Study|Adverse Event|11|||
131427206|NCT01445080|473186571|FG003|Overall Study|Adverse Event|6|||
131427207|NCT01445080|473186572|FG004|Overall Study|Adverse Event|2|||
131427208|NCT01445080|473186573|FG005|Overall Study|Adverse Event|3|||
131427209|NCT01445080|473186574|FG006|Overall Study|Adverse Event|0|||
131427210|NCT01445080|473186575|FG007|Overall Study|Adverse Event|3|||
131427211|NCT01445080|473186576|FG008|Overall Study|Adverse Event|10|||
131427212|NCT01445080|473186568|FG000|Overall Study|Physician Decision|0|||
131427213|NCT01445080|473186569|FG001|Overall Study|Physician Decision|0|||
131427214|NCT01445080|473186570|FG002|Overall Study|Physician Decision|1|||
131427215|NCT01445080|473186571|FG003|Overall Study|Physician Decision|0|||
131427216|NCT01445080|473186572|FG004|Overall Study|Physician Decision|0|||
131427217|NCT01445080|473186573|FG005|Overall Study|Physician Decision|3|||
131427218|NCT01445080|473186574|FG006|Overall Study|Physician Decision|2|||
131427219|NCT01445080|473186575|FG007|Overall Study|Physician Decision|2|||
131427220|NCT01445080|473186576|FG008|Overall Study|Physician Decision|0|||
131427221|NCT01445080|473186568|FG000|Overall Study|Withdrawal by Subject|1|||
131427222|NCT01445080|473186569|FG001|Overall Study|Withdrawal by Subject|0|||
131427223|NCT01445080|473186570|FG002|Overall Study|Withdrawal by Subject|0|||
131427224|NCT01445080|473186571|FG003|Overall Study|Withdrawal by Subject|1|||
131427225|NCT01445080|473186572|FG004|Overall Study|Withdrawal by Subject|0|||
131427226|NCT01445080|473186573|FG005|Overall Study|Withdrawal by Subject|0|||
131427227|NCT01445080|473186574|FG006|Overall Study|Withdrawal by Subject|0|||
131427228|NCT01445080|473186575|FG007|Overall Study|Withdrawal by Subject|0|||
131427229|NCT01445080|473186576|FG008|Overall Study|Withdrawal by Subject|2|||
131427230|NCT01445080|473186568|FG000|Overall Study|Ineligible/Inevaluable|1|||
131427231|NCT01445080|473186569|FG001|Overall Study|Ineligible/Inevaluable|2|||
131427232|NCT01445080|473186570|FG002|Overall Study|Ineligible/Inevaluable|0|||
131427233|NCT01445080|473186571|FG003|Overall Study|Ineligible/Inevaluable|1|||
131427234|NCT01445080|473186572|FG004|Overall Study|Ineligible/Inevaluable|2|||
131427235|NCT01445080|473186573|FG005|Overall Study|Ineligible/Inevaluable|3|||
131427236|NCT01445080|473186574|FG006|Overall Study|Ineligible/Inevaluable|0|||
131427237|NCT01445080|473186575|FG007|Overall Study|Ineligible/Inevaluable|0|||
131427238|NCT01445080|473186576|FG008|Overall Study|Ineligible/Inevaluable|6|||
131427239|NCT00445770|473186577|FG000|Overall Study|Adverse Event|9|||
131427240|NCT00445770|473186578|FG001|Overall Study|Adverse Event|15|||
131427241|NCT00445770|473186579|FG002|Overall Study|Adverse Event|19|||
131427242|NCT00445770|473186577|FG000|Overall Study|Lack of Efficacy|38|||
131427243|NCT00445770|473186578|FG001|Overall Study|Lack of Efficacy|13|||
131427244|NCT00445770|473186579|FG002|Overall Study|Lack of Efficacy|6|||
131427245|NCT00445770|473186577|FG000|Overall Study|Lost to Follow-up|0|||
131427246|NCT00445770|473186578|FG001|Overall Study|Lost to Follow-up|2|||
131427247|NCT00445770|473186579|FG002|Overall Study|Lost to Follow-up|0|||
131427248|NCT00445770|473186577|FG000|Overall Study|Other|6|||
131427249|NCT00445770|473186578|FG001|Overall Study|Other|5|||
131427250|NCT00445770|473186579|FG002|Overall Study|Other|6|||
131427251|NCT03857542|473186580|FG000|Overall Study|Adverse Event|1|||
131427252|NCT03857542|473186581|FG001|Overall Study|Adverse Event|3|||
131427253|NCT03857542|473186580|FG000|Overall Study|Withdrawal by Subject|2|||
131427254|NCT03857542|473186581|FG001|Overall Study|Withdrawal by Subject|1|||
131427255|NCT03857542|473186580|FG000|Overall Study|Lost to Follow-up|2|||
131427256|NCT03857542|473186581|FG001|Overall Study|Lost to Follow-up|1|||
131427257|NCT03857542|473186580|FG000|Overall Study|Reason not Specified|1|||
131427258|NCT03857542|473186581|FG001|Overall Study|Reason not Specified|0|||
131427259|NCT02123576|473186584|FG000|Overall Study|Adverse Event|1|||
131427260|NCT02123576|473186585|FG001|Overall Study|Adverse Event|0|||
131427261|NCT00934128|473186586|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
131427262|NCT00934128|473186587|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
131427263|NCT00934128|473186586|FG000|First Intervention (2 Hours)|Adverse Event|4|||
131427264|NCT00934128|473186587|FG001|First Intervention (2 Hours)|Adverse Event|1|||
131427265|NCT00934128|473186586|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
131427266|NCT00934128|473186587|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
131427267|NCT00934128|473186586|FG000|Washout Period (1 Hour)|Patient preference|1|||
131427268|NCT00934128|473186587|FG001|Washout Period (1 Hour)|Patient preference|3|||
131427269|NCT00934128|473186586|FG000|Washout Period (1 Hour)|Pain|1|||
131427270|NCT00934128|473186587|FG001|Washout Period (1 Hour)|Pain|0|||
131427271|NCT00934128|473186586|FG000|Washout Period (1 Hour)|Too tired|1|||
131427272|NCT00934128|473186587|FG001|Washout Period (1 Hour)|Too tired|0|||
131427273|NCT00934128|473186586|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
131427274|NCT00934128|473186587|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
131427275|NCT00934128|473186586|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
131427276|NCT00934128|473186587|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
131427277|NCT02834247|473186588|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
131427278|NCT02834247|473186589|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
131427279|NCT02834247|473186590|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
131427280|NCT02834247|473186591|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
131427281|NCT02834247|473186588|FG000|Dose Escalation Phase|Death|5|||
131427282|NCT02834247|473186589|FG001|Dose Escalation Phase|Death|6|||
131427283|NCT02834247|473186590|FG002|Dose Escalation Phase|Death|5|||
131427284|NCT02834247|473186591|FG003|Dose Escalation Phase|Death|0|||
131427285|NCT02834247|473186588|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
131427286|NCT02834247|473186589|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
131427287|NCT02834247|473186590|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
131427288|NCT02834247|473186591|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
131427289|NCT02834247|473186588|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
131427290|NCT02834247|473186589|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
131427291|NCT02834247|473186590|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131427292|NCT02834247|473186591|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131427293|NCT02834247|473186588|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
131427294|NCT02834247|473186589|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
131427295|NCT02834247|473186590|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
131427296|NCT02834247|473186591|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
131427297|NCT02834247|473186588|FG000|Dose Expansion Phase|Death|0|||
131427298|NCT02834247|473186589|FG001|Dose Expansion Phase|Death|0|||
131427299|NCT02834247|473186590|FG002|Dose Expansion Phase|Death|0|||
131427300|NCT02834247|473186591|FG003|Dose Expansion Phase|Death|8|||
131427301|NCT02834247|473186588|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
131427302|NCT02834247|473186589|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
131427303|NCT02834247|473186590|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
131427304|NCT02834247|473186591|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
131427305|NCT02834247|473186588|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
131427306|NCT02834247|473186589|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
131427307|NCT02834247|473186590|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
131427308|NCT02834247|473186591|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
131427309|NCT04426318|473188352|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
131427310|NCT04426318|473188353|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
131427311|NCT02221674|473188359|FG000|Overall Study|Lost to Follow-up|1|||
131427312|NCT02221674|473188360|FG001|Overall Study|Lost to Follow-up|0|||
131427313|NCT02221674|473188361|FG002|Overall Study|Lost to Follow-up|0|||
131427314|NCT04390880|473188363|FG000|Overall Study|Withdrawal by Subject|1|||
131427315|NCT02557542|473188364|FG000|Overall Study|Poor recruitment|3|||
131427316|NCT02557542|473188365|FG001|Overall Study|Poor recruitment|0|||
131427317|NCT00245037|473188366|FG000|Overall Study|Death|17|||
131427318|NCT02576795|473188371|FG000|Overall Study|Lost to Follow-up|0|||
131427319|NCT02576795|473188372|FG001|Overall Study|Lost to Follow-up|0|||
131427320|NCT02576795|473188373|FG002|Overall Study|Lost to Follow-up|1|||
131427321|NCT02576795|473188374|FG003|Overall Study|Lost to Follow-up|0|||
131427322|NCT03724890|473188375|FG000|Overall Study|Death|2|||
131427323|NCT03724890|473188376|FG001|Overall Study|Death|6|||
131427324|NCT03724890|473188377|FG002|Overall Study|Death|3|||
131427325|NCT03724890|473188378|FG003|Overall Study|Death|5|||
131427326|NCT03724890|473188379|FG004|Overall Study|Death|2|||
131427327|NCT03724890|473188380|FG005|Overall Study|Death|0|||
131427328|NCT03724890|473188381|FG006|Overall Study|Death|2|||
131427329|NCT03724890|473188382|FG007|Overall Study|Death|3|||
131427330|NCT03724890|473188383|FG008|Overall Study|Death|4|||
131427331|NCT03724890|473188384|FG009|Overall Study|Death|2|||
131427332|NCT03724890|473188385|FG010|Overall Study|Death|2|||
131427333|NCT03724890|473188375|FG000|Overall Study|Lost to Follow-up|0|||
131427334|NCT03724890|473188376|FG001|Overall Study|Lost to Follow-up|3|||
131427335|NCT03724890|473188377|FG002|Overall Study|Lost to Follow-up|0|||
131427336|NCT03724890|473188378|FG003|Overall Study|Lost to Follow-up|1|||
131427337|NCT03724890|473188379|FG004|Overall Study|Lost to Follow-up|2|||
131427338|NCT03724890|473188380|FG005|Overall Study|Lost to Follow-up|2|||
131427339|NCT03724890|473188381|FG006|Overall Study|Lost to Follow-up|1|||
131427340|NCT03724890|473188382|FG007|Overall Study|Lost to Follow-up|0|||
131427341|NCT03724890|473188383|FG008|Overall Study|Lost to Follow-up|2|||
131427342|NCT03724890|473188384|FG009|Overall Study|Lost to Follow-up|0|||
131427343|NCT03724890|473188385|FG010|Overall Study|Lost to Follow-up|0|||
131427344|NCT03724890|473188375|FG000|Overall Study|Withdrawal by Subject|1|||
131427345|NCT03724890|473188376|FG001|Overall Study|Withdrawal by Subject|2|||
131427346|NCT03724890|473188377|FG002|Overall Study|Withdrawal by Subject|1|||
131427347|NCT03724890|473188378|FG003|Overall Study|Withdrawal by Subject|0|||
131427348|NCT03724890|473188379|FG004|Overall Study|Withdrawal by Subject|0|||
131427349|NCT03724890|473188380|FG005|Overall Study|Withdrawal by Subject|1|||
131427350|NCT03724890|473188381|FG006|Overall Study|Withdrawal by Subject|0|||
131458094|NCT01124864|473308787|FG005|Overall Study|Lost to Follow-up|0|||
131427351|NCT03724890|473188382|FG007|Overall Study|Withdrawal by Subject|0|||
131427352|NCT03724890|473188383|FG008|Overall Study|Withdrawal by Subject|2|||
131427353|NCT03724890|473188384|FG009|Overall Study|Withdrawal by Subject|2|||
131427354|NCT03724890|473188385|FG010|Overall Study|Withdrawal by Subject|1|||
131427355|NCT03724890|473188375|FG000|Overall Study|Other|1|||
131427356|NCT03724890|473188376|FG001|Overall Study|Other|0|||
131427357|NCT03724890|473188377|FG002|Overall Study|Other|0|||
131427358|NCT03724890|473188378|FG003|Overall Study|Other|0|||
131427359|NCT03724890|473188379|FG004|Overall Study|Other|0|||
131427360|NCT03724890|473188380|FG005|Overall Study|Other|0|||
131427361|NCT03724890|473188381|FG006|Overall Study|Other|0|||
131427362|NCT03724890|473188382|FG007|Overall Study|Other|1|||
131427363|NCT03724890|473188383|FG008|Overall Study|Other|1|||
131427364|NCT03724890|473188384|FG009|Overall Study|Other|0|||
131427365|NCT03724890|473188385|FG010|Overall Study|Other|2|||
131427366|NCT04427072|473188389|FG000|Randomized Treatment Phase|Progressive disease|9|||
131427367|NCT04427072|473188390|FG001|Randomized Treatment Phase|Progressive disease|4|||
131427368|NCT04427072|473188389|FG000|Randomized Treatment Phase|Adverse Event|3|||
131427369|NCT04427072|473188390|FG001|Randomized Treatment Phase|Adverse Event|1|||
131427370|NCT04427072|473188389|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
131427371|NCT04427072|473188390|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
131427372|NCT04427072|473188389|FG000|Randomized Treatment Phase|Death|0|||
131427373|NCT04427072|473188390|FG001|Randomized Treatment Phase|Death|1|||
131427374|NCT04427072|473188389|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
131427375|NCT04427072|473188390|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
131427376|NCT04427072|473188389|FG000|Extension Treatment Phase|Progressive disease|0|||
131427377|NCT04427072|473188390|FG001|Extension Treatment Phase|Progressive disease|5|||
131427378|NCT05232864|473188391|FG000|Overall Study|Adverse Event|0|||
131427379|NCT05232864|473188392|FG001|Overall Study|Adverse Event|1|||
131427380|NCT05232864|473188391|FG000|Overall Study|Study terminated by sponsor|16|||
131427381|NCT05232864|473188392|FG001|Overall Study|Study terminated by sponsor|14|||
131427382|NCT00465452|473188399|FG000|Overall Study|Adverse Event|1|||
131427383|NCT01635855|473188404|FG000|Overall Study|Withdrawal by Subject|4|||
131427384|NCT05870865|473188407|FG000|Randomized|Did not receive study treatment|2|||
131427385|NCT05870865|473188408|FG001|Randomized|Did not receive study treatment|4|||
131427386|NCT05870865|473188409|FG002|Randomized|Did not receive study treatment|4|||
131427387|NCT05870865|473188410|FG003|Randomized|Did not receive study treatment|3|||
131427388|NCT05870865|473188407|FG000|Treatment Period|Adverse Event|1|||
131427389|NCT05870865|473188408|FG001|Treatment Period|Adverse Event|1|||
131427390|NCT05870865|473188409|FG002|Treatment Period|Adverse Event|1|||
131427391|NCT05870865|473188410|FG003|Treatment Period|Adverse Event|1|||
131427392|NCT05870865|473188407|FG000|Treatment Period|Lost to Follow-up|0|||
131427393|NCT05870865|473188408|FG001|Treatment Period|Lost to Follow-up|1|||
131427394|NCT05870865|473188409|FG002|Treatment Period|Lost to Follow-up|2|||
131427395|NCT05870865|473188410|FG003|Treatment Period|Lost to Follow-up|0|||
131427396|NCT05870865|473188407|FG000|Treatment Period|Protocol Violation|0|||
131427397|NCT05870865|473188408|FG001|Treatment Period|Protocol Violation|0|||
131427398|NCT05870865|473188409|FG002|Treatment Period|Protocol Violation|0|||
131427399|NCT05870865|473188410|FG003|Treatment Period|Protocol Violation|1|||
131427400|NCT05870865|473188407|FG000|Treatment Period|Withdrawal by Subject|0|||
131427401|NCT05870865|473188408|FG001|Treatment Period|Withdrawal by Subject|1|||
131427402|NCT05870865|473188409|FG002|Treatment Period|Withdrawal by Subject|1|||
131427403|NCT05870865|473188410|FG003|Treatment Period|Withdrawal by Subject|1|||
131427404|NCT00145574|473188414|FG000|Double Blind|Adverse Event|0|||
131427405|NCT00145574|473188415|FG001|Double Blind|Adverse Event|3|||
131427406|NCT00145574|473188416|FG002|Double Blind|Adverse Event|1|||
131427407|NCT00145574|473188414|FG000|Double Blind|Withdrawal by Subject|1|||
131427408|NCT00145574|473188415|FG001|Double Blind|Withdrawal by Subject|1|||
131427409|NCT00145574|473188416|FG002|Double Blind|Withdrawal by Subject|1|||
131427410|NCT00145574|473188414|FG000|Double Blind|required restricted medicine|0|||
131427411|NCT00145574|473188415|FG001|Double Blind|required restricted medicine|1|||
131427412|NCT00145574|473188416|FG002|Double Blind|required restricted medicine|0|||
131427413|NCT00145574|473188414|FG000|Open Label Long-term Extension|Adverse Event|0|||
131427414|NCT00145574|473188415|FG001|Open Label Long-term Extension|Adverse Event|0|||
131427415|NCT00145574|473188416|FG002|Open Label Long-term Extension|Adverse Event|5|||
131427416|NCT00145574|473188414|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
131427417|NCT00145574|473188415|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
131427418|NCT00145574|473188416|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
131427419|NCT00145574|473188414|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
131427420|NCT00145574|473188415|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
131427421|NCT00145574|473188416|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
131427422|NCT00145574|473188414|FG000|Open Label Long-term Extension|required restricted medicine|0|||
131427423|NCT00145574|473188415|FG001|Open Label Long-term Extension|required restricted medicine|0|||
131427424|NCT00145574|473188416|FG002|Open Label Long-term Extension|required restricted medicine|1|||
131427425|NCT00858637|473188421|FG000|Active Comparison Phase|Adverse Event|14|||
131427426|NCT00858637|473188422|FG001|Active Comparison Phase|Adverse Event|0|||
131427427|NCT00858637|473188423|FG002|Active Comparison Phase|Adverse Event|0|||
131427428|NCT00858637|473188424|FG003|Active Comparison Phase|Adverse Event|9|||
131427429|NCT00858637|473188425|FG004|Active Comparison Phase|Adverse Event|0|||
131427430|NCT00858637|473188426|FG005|Active Comparison Phase|Adverse Event|0|||
131427431|NCT00858637|473188421|FG000|Active Comparison Phase|Death|1|||
131427432|NCT00858637|473188422|FG001|Active Comparison Phase|Death|0|||
131427433|NCT00858637|473188423|FG002|Active Comparison Phase|Death|0|||
131427434|NCT00858637|473188424|FG003|Active Comparison Phase|Death|1|||
131427435|NCT00858637|473188425|FG004|Active Comparison Phase|Death|0|||
131427436|NCT00858637|473188426|FG005|Active Comparison Phase|Death|0|||
131427437|NCT00858637|473188421|FG000|Active Comparison Phase|Physician Decision|1|||
131427438|NCT00858637|473188422|FG001|Active Comparison Phase|Physician Decision|0|||
131427439|NCT00858637|473188423|FG002|Active Comparison Phase|Physician Decision|0|||
131427440|NCT00858637|473188424|FG003|Active Comparison Phase|Physician Decision|1|||
131427441|NCT00858637|473188425|FG004|Active Comparison Phase|Physician Decision|0|||
131427442|NCT00858637|473188426|FG005|Active Comparison Phase|Physician Decision|0|||
131427443|NCT00858637|473188421|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
131427444|NCT00858637|473188422|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
131427445|NCT00858637|473188423|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
131427446|NCT00858637|473188424|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
131427447|NCT00858637|473188425|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
131427448|NCT00858637|473188426|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
131427449|NCT00858637|473188421|FG000|Active Comparison Phase|Other Reasons|1|||
131427450|NCT00858637|473188422|FG001|Active Comparison Phase|Other Reasons|0|||
131427451|NCT00858637|473188423|FG002|Active Comparison Phase|Other Reasons|0|||
131427452|NCT00858637|473188424|FG003|Active Comparison Phase|Other Reasons|1|||
131427453|NCT00858637|473188425|FG004|Active Comparison Phase|Other Reasons|0|||
131427454|NCT00858637|473188426|FG005|Active Comparison Phase|Other Reasons|0|||
131427455|NCT00858637|473188421|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
131427456|NCT00858637|473188422|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
131427457|NCT00858637|473188423|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
131427458|NCT00858637|473188424|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
131427459|NCT00858637|473188425|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
131427460|NCT00858637|473188426|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
131427461|NCT00858637|473188421|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
131458095|NCT01124864|473308782|FG000|Overall Study|Protocol Violation|1|||
131458096|NCT01124864|473308783|FG001|Overall Study|Protocol Violation|0|||
131427462|NCT00858637|473188422|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
131427463|NCT00858637|473188423|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
131427464|NCT00858637|473188424|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
131427465|NCT00858637|473188425|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
131427466|NCT00858637|473188426|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
131427467|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
131427468|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
131427469|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
131427470|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Death|0|||
131427471|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Death|2|||
131427472|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Death|0|||
131427473|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
131427474|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
131427475|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
131427476|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
131427477|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
131427478|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
131427479|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
131427480|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
131427481|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
131427482|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
131427483|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
131427484|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
131427485|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
131427486|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
131427487|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
131427488|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Recovery|1|||
131427489|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Recovery|0|||
131427490|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Recovery|1|||
131427491|NCT00195663|473188427|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
131427492|NCT00195663|473188428|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
131427493|NCT00195663|473188429|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
131427494|NCT00195663|473188427|FG000|Open-Label Extension Period|Adverse Event|21|||
131427495|NCT00195663|473188428|FG001|Open-Label Extension Period|Adverse Event|32|||
131427496|NCT00195663|473188429|FG002|Open-Label Extension Period|Adverse Event|36|||
131427497|NCT00195663|473188427|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
131427498|NCT00195663|473188428|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
131427499|NCT00195663|473188429|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
131427500|NCT00195663|473188427|FG000|Open-Label Extension Period|Recovery|0|||
131427501|NCT00195663|473188428|FG001|Open-Label Extension Period|Recovery|2|||
131427502|NCT00195663|473188429|FG002|Open-Label Extension Period|Recovery|2|||
131427503|NCT00195663|473188427|FG000|Open-Label Extension Period|Protocol Violation|3|||
131427504|NCT00195663|473188428|FG001|Open-Label Extension Period|Protocol Violation|4|||
131427505|NCT00195663|473188429|FG002|Open-Label Extension Period|Protocol Violation|4|||
131427506|NCT00195663|473188427|FG000|Open-Label Extension Period|Death|2|||
131427507|NCT00195663|473188428|FG001|Open-Label Extension Period|Death|2|||
131427508|NCT00195663|473188429|FG002|Open-Label Extension Period|Death|2|||
131427509|NCT00195663|473188427|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
131427510|NCT00195663|473188428|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
131427511|NCT00195663|473188429|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
131427512|NCT00195663|473188427|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
131427513|NCT00195663|473188428|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
131427514|NCT00195663|473188429|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
131427515|NCT00195663|473188427|FG000|Open-Label Extension Period|Administrative reasons|11|||
131427516|NCT00195663|473188428|FG001|Open-Label Extension Period|Administrative reasons|11|||
131427517|NCT00195663|473188429|FG002|Open-Label Extension Period|Administrative reasons|13|||
131427518|NCT03214406|473188430|FG000|Overall Study|did not meet enrollment criteria|9|||
131427519|NCT03214406|473188431|FG001|Overall Study|did not meet enrollment criteria|13|||
131427520|NCT03214406|473188430|FG000|Overall Study|Withdrawal by Subject|1|||
131427521|NCT03214406|473188431|FG001|Overall Study|Withdrawal by Subject|0|||
131427522|NCT03214406|473188430|FG000|Overall Study|Lost to Follow-up|0|||
131427523|NCT03214406|473188431|FG001|Overall Study|Lost to Follow-up|2|||
131427524|NCT00604695|473188432|FG000|Overall Study|Did not receive first bolus.|0|||
131427525|NCT00604695|473188433|FG001|Overall Study|Did not receive first bolus.|4|||
131427526|NCT01098305|473188436|FG000|Overall Study|Lost to Follow-up|31|||
131427527|NCT01098305|473188437|FG001|Overall Study|Lost to Follow-up|33|||
131427528|NCT04677504|473188446|FG000|Overall Study|Death|51|||
131427529|NCT04677504|473188447|FG001|Overall Study|Death|49|||
131458097|NCT01124864|473308784|FG002|Overall Study|Protocol Violation|0|||
131458098|NCT01124864|473308785|FG003|Overall Study|Protocol Violation|0|||
131427530|NCT04677504|473188446|FG000|Overall Study|Progressive Disease|1|||
131427531|NCT04677504|473188447|FG001|Overall Study|Progressive Disease|0|||
131427532|NCT04677504|473188446|FG000|Overall Study|Symptomatic Deterioration|1|||
131427533|NCT04677504|473188447|FG001|Overall Study|Symptomatic Deterioration|0|||
131427534|NCT04677504|473188446|FG000|Overall Study|Withdrawal by Subject|2|||
131427535|NCT04677504|473188447|FG001|Overall Study|Withdrawal by Subject|5|||
131427536|NCT04677504|473188446|FG000|Overall Study|Study Terminated By Sponsor|28|||
131427537|NCT04677504|473188447|FG001|Overall Study|Study Terminated By Sponsor|24|||
131427538|NCT04677504|473188446|FG000|Overall Study|Adverse Event|0|||
131427539|NCT04677504|473188447|FG001|Overall Study|Adverse Event|1|||
131427540|NCT03182907|473188448|FG000|Overall Study|Death|3|||
131427541|NCT03182907|473188449|FG001|Overall Study|Death|0|||
131427542|NCT03182907|473188448|FG000|Overall Study|Protocol Violation|4|||
131427543|NCT03182907|473188449|FG001|Overall Study|Protocol Violation|0|||
131427544|NCT03182907|473188448|FG000|Overall Study|Lost to Follow-up|1|||
131427545|NCT03182907|473188449|FG001|Overall Study|Lost to Follow-up|0|||
131427546|NCT03182907|473188448|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131427547|NCT03182907|473188449|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131427548|NCT01180296|473188456|FG000|Overall Study|Protocol Violation|1|||
131427549|NCT01180296|473188457|FG001|Overall Study|Protocol Violation|2|||
131427550|NCT00166439|473188458|FG000|Overall Study|Ineligible|5|||
131427551|NCT03364309|473188461|FG000|Induction Period|Adverse Event|4|||
131427552|NCT03364309|473188462|FG001|Induction Period|Adverse Event|0|||
131427553|NCT03364309|473188463|FG002|Induction Period|Adverse Event|1|||
131427554|NCT03364309|473188464|FG003|Induction Period|Adverse Event|0|||
131427555|NCT03364309|473188465|FG004|Induction Period|Adverse Event|0|||
131427556|NCT03364309|473188466|FG005|Induction Period|Adverse Event|0|||
131427557|NCT03364309|473188467|FG006|Induction Period|Adverse Event|0|||
131427558|NCT03364309|473188468|FG007|Induction Period|Adverse Event|0|||
131427559|NCT03364309|473188469|FG008|Induction Period|Adverse Event|0|||
131427560|NCT03364309|473188470|FG009|Induction Period|Adverse Event|0|||
131427561|NCT03364309|473188471|FG010|Induction Period|Adverse Event|0|||
131427562|NCT03364309|473188472|FG011|Induction Period|Adverse Event|0|||
131427563|NCT03364309|473188473|FG012|Induction Period|Adverse Event|0|||
131427564|NCT03364309|473188474|FG013|Induction Period|Adverse Event|0|||
131427565|NCT03364309|473188475|FG014|Induction Period|Adverse Event|0|||
131427566|NCT03364309|473188476|FG015|Induction Period|Adverse Event|0|||
131427567|NCT03364309|473188477|FG016|Induction Period|Adverse Event|0|||
131427568|NCT03364309|473188478|FG017|Induction Period|Adverse Event|0|||
131427569|NCT03364309|473188479|FG018|Induction Period|Adverse Event|0|||
131427570|NCT03364309|473188461|FG000|Induction Period|Withdrawal by Subject|1|||
131427571|NCT03364309|473188462|FG001|Induction Period|Withdrawal by Subject|3|||
131427572|NCT03364309|473188463|FG002|Induction Period|Withdrawal by Subject|0|||
131427573|NCT03364309|473188464|FG003|Induction Period|Withdrawal by Subject|0|||
131427574|NCT03364309|473188465|FG004|Induction Period|Withdrawal by Subject|0|||
131427575|NCT03364309|473188466|FG005|Induction Period|Withdrawal by Subject|0|||
131427576|NCT03364309|473188467|FG006|Induction Period|Withdrawal by Subject|0|||
131427577|NCT03364309|473188468|FG007|Induction Period|Withdrawal by Subject|0|||
131427578|NCT03364309|473188469|FG008|Induction Period|Withdrawal by Subject|0|||
131427579|NCT03364309|473188470|FG009|Induction Period|Withdrawal by Subject|0|||
131427580|NCT03364309|473188471|FG010|Induction Period|Withdrawal by Subject|0|||
131427581|NCT03364309|473188472|FG011|Induction Period|Withdrawal by Subject|0|||
131427582|NCT03364309|473188473|FG012|Induction Period|Withdrawal by Subject|0|||
131427583|NCT03364309|473188474|FG013|Induction Period|Withdrawal by Subject|0|||
131427584|NCT03364309|473188475|FG014|Induction Period|Withdrawal by Subject|0|||
131458099|NCT01124864|473308786|FG004|Overall Study|Protocol Violation|1|||
131458100|NCT01124864|473308787|FG005|Overall Study|Protocol Violation|0|||
131427585|NCT03364309|473188476|FG015|Induction Period|Withdrawal by Subject|0|||
131427586|NCT03364309|473188477|FG016|Induction Period|Withdrawal by Subject|0|||
131427587|NCT03364309|473188478|FG017|Induction Period|Withdrawal by Subject|0|||
131427588|NCT03364309|473188479|FG018|Induction Period|Withdrawal by Subject|0|||
131427589|NCT03364309|473188461|FG000|Induction Period|Lost to Follow-up|1|||
131427590|NCT03364309|473188462|FG001|Induction Period|Lost to Follow-up|0|||
131427591|NCT03364309|473188463|FG002|Induction Period|Lost to Follow-up|0|||
131427592|NCT03364309|473188464|FG003|Induction Period|Lost to Follow-up|0|||
131427593|NCT03364309|473188465|FG004|Induction Period|Lost to Follow-up|0|||
131427594|NCT03364309|473188466|FG005|Induction Period|Lost to Follow-up|0|||
131427595|NCT03364309|473188467|FG006|Induction Period|Lost to Follow-up|0|||
131427596|NCT03364309|473188468|FG007|Induction Period|Lost to Follow-up|0|||
131458101|NCT01243242|473308788|FG000|Overall Study|Adverse Event|1|||
131427597|NCT03364309|473188469|FG008|Induction Period|Lost to Follow-up|0|||
131427598|NCT03364309|473188470|FG009|Induction Period|Lost to Follow-up|0|||
131427599|NCT03364309|473188471|FG010|Induction Period|Lost to Follow-up|0|||
131427600|NCT03364309|473188472|FG011|Induction Period|Lost to Follow-up|0|||
131427601|NCT03364309|473188473|FG012|Induction Period|Lost to Follow-up|0|||
131427602|NCT03364309|473188474|FG013|Induction Period|Lost to Follow-up|0|||
131427603|NCT03364309|473188475|FG014|Induction Period|Lost to Follow-up|0|||
131427604|NCT03364309|473188476|FG015|Induction Period|Lost to Follow-up|0|||
131427605|NCT03364309|473188477|FG016|Induction Period|Lost to Follow-up|0|||
131427606|NCT03364309|473188478|FG017|Induction Period|Lost to Follow-up|0|||
131427607|NCT03364309|473188479|FG018|Induction Period|Lost to Follow-up|0|||
131427608|NCT03364309|473188461|FG000|Induction Period|Physician Decision|0|||
131427609|NCT03364309|473188462|FG001|Induction Period|Physician Decision|1|||
131427610|NCT03364309|473188463|FG002|Induction Period|Physician Decision|0|||
131427611|NCT03364309|473188464|FG003|Induction Period|Physician Decision|0|||
131427612|NCT03364309|473188465|FG004|Induction Period|Physician Decision|0|||
131427613|NCT03364309|473188466|FG005|Induction Period|Physician Decision|0|||
131427614|NCT03364309|473188467|FG006|Induction Period|Physician Decision|0|||
131427615|NCT03364309|473188468|FG007|Induction Period|Physician Decision|0|||
131427616|NCT03364309|473188469|FG008|Induction Period|Physician Decision|0|||
131427617|NCT03364309|473188470|FG009|Induction Period|Physician Decision|0|||
131427618|NCT03364309|473188471|FG010|Induction Period|Physician Decision|0|||
131427619|NCT03364309|473188472|FG011|Induction Period|Physician Decision|0|||
131427620|NCT03364309|473188473|FG012|Induction Period|Physician Decision|0|||
131427621|NCT03364309|473188474|FG013|Induction Period|Physician Decision|0|||
131427622|NCT03364309|473188475|FG014|Induction Period|Physician Decision|0|||
131427623|NCT03364309|473188476|FG015|Induction Period|Physician Decision|0|||
131427624|NCT03364309|473188477|FG016|Induction Period|Physician Decision|0|||
131427625|NCT03364309|473188478|FG017|Induction Period|Physician Decision|0|||
131427626|NCT03364309|473188479|FG018|Induction Period|Physician Decision|0|||
131427627|NCT03364309|473188461|FG000|Maintenance Period|Withdrawal by Subject|0|||
131427628|NCT03364309|473188462|FG001|Maintenance Period|Withdrawal by Subject|0|||
131427629|NCT03364309|473188463|FG002|Maintenance Period|Withdrawal by Subject|0|||
131427630|NCT03364309|473188464|FG003|Maintenance Period|Withdrawal by Subject|1|||
131427631|NCT03364309|473188465|FG004|Maintenance Period|Withdrawal by Subject|3|||
131427632|NCT03364309|473188466|FG005|Maintenance Period|Withdrawal by Subject|1|||
131427633|NCT03364309|473188467|FG006|Maintenance Period|Withdrawal by Subject|3|||
131427634|NCT03364309|473188468|FG007|Maintenance Period|Withdrawal by Subject|0|||
131427635|NCT03364309|473188469|FG008|Maintenance Period|Withdrawal by Subject|1|||
131427636|NCT03364309|473188470|FG009|Maintenance Period|Withdrawal by Subject|1|||
131427637|NCT03364309|473188471|FG010|Maintenance Period|Withdrawal by Subject|2|||
131427638|NCT03364309|473188472|FG011|Maintenance Period|Withdrawal by Subject|0|||
131427639|NCT03364309|473188473|FG012|Maintenance Period|Withdrawal by Subject|0|||
131427640|NCT03364309|473188474|FG013|Maintenance Period|Withdrawal by Subject|0|||
131427641|NCT03364309|473188475|FG014|Maintenance Period|Withdrawal by Subject|0|||
131427642|NCT03364309|473188476|FG015|Maintenance Period|Withdrawal by Subject|0|||
131427643|NCT03364309|473188477|FG016|Maintenance Period|Withdrawal by Subject|0|||
131427644|NCT03364309|473188478|FG017|Maintenance Period|Withdrawal by Subject|0|||
131427645|NCT03364309|473188479|FG018|Maintenance Period|Withdrawal by Subject|0|||
131427646|NCT03364309|473188461|FG000|Maintenance Period|Adverse Event|0|||
131427647|NCT03364309|473188462|FG001|Maintenance Period|Adverse Event|0|||
131427648|NCT03364309|473188463|FG002|Maintenance Period|Adverse Event|0|||
131427649|NCT03364309|473188464|FG003|Maintenance Period|Adverse Event|0|||
131427650|NCT03364309|473188465|FG004|Maintenance Period|Adverse Event|2|||
131427651|NCT03364309|473188466|FG005|Maintenance Period|Adverse Event|0|||
131427652|NCT03364309|473188467|FG006|Maintenance Period|Adverse Event|3|||
131427653|NCT03364309|473188468|FG007|Maintenance Period|Adverse Event|0|||
131427654|NCT03364309|473188469|FG008|Maintenance Period|Adverse Event|1|||
131427655|NCT03364309|473188470|FG009|Maintenance Period|Adverse Event|0|||
131427656|NCT03364309|473188471|FG010|Maintenance Period|Adverse Event|2|||
131427657|NCT03364309|473188472|FG011|Maintenance Period|Adverse Event|0|||
131427658|NCT03364309|473188473|FG012|Maintenance Period|Adverse Event|0|||
131427659|NCT03364309|473188474|FG013|Maintenance Period|Adverse Event|0|||
131427660|NCT03364309|473188475|FG014|Maintenance Period|Adverse Event|0|||
131427661|NCT03364309|473188476|FG015|Maintenance Period|Adverse Event|0|||
131427662|NCT03364309|473188477|FG016|Maintenance Period|Adverse Event|0|||
131427663|NCT03364309|473188478|FG017|Maintenance Period|Adverse Event|0|||
131427664|NCT03364309|473188479|FG018|Maintenance Period|Adverse Event|0|||
131427665|NCT03364309|473188461|FG000|Maintenance Period|Relapsed|0|||
131427666|NCT03364309|473188462|FG001|Maintenance Period|Relapsed|0|||
131427667|NCT03364309|473188463|FG002|Maintenance Period|Relapsed|0|||
131427668|NCT03364309|473188464|FG003|Maintenance Period|Relapsed|43|||
131427669|NCT03364309|473188465|FG004|Maintenance Period|Relapsed|7|||
131427670|NCT03364309|473188466|FG005|Maintenance Period|Relapsed|45|||
131427671|NCT03364309|473188467|FG006|Maintenance Period|Relapsed|10|||
131427672|NCT03364309|473188468|FG007|Maintenance Period|Relapsed|2|||
131427673|NCT03364309|473188469|FG008|Maintenance Period|Relapsed|0|||
131427674|NCT03364309|473188470|FG009|Maintenance Period|Relapsed|0|||
131427675|NCT03364309|473188471|FG010|Maintenance Period|Relapsed|0|||
131427676|NCT03364309|473188472|FG011|Maintenance Period|Relapsed|0|||
131427677|NCT03364309|473188473|FG012|Maintenance Period|Relapsed|0|||
131427678|NCT03364309|473188474|FG013|Maintenance Period|Relapsed|0|||
131427679|NCT03364309|473188475|FG014|Maintenance Period|Relapsed|0|||
131427680|NCT03364309|473188476|FG015|Maintenance Period|Relapsed|0|||
131427681|NCT03364309|473188477|FG016|Maintenance Period|Relapsed|0|||
131427682|NCT03364309|473188478|FG017|Maintenance Period|Relapsed|0|||
131427683|NCT03364309|473188479|FG018|Maintenance Period|Relapsed|0|||
131427684|NCT03364309|473188461|FG000|Maintenance Period|Lack of Efficacy|0|||
131427685|NCT03364309|473188462|FG001|Maintenance Period|Lack of Efficacy|0|||
131427686|NCT03364309|473188463|FG002|Maintenance Period|Lack of Efficacy|0|||
131427687|NCT03364309|473188464|FG003|Maintenance Period|Lack of Efficacy|0|||
131427688|NCT03364309|473188465|FG004|Maintenance Period|Lack of Efficacy|0|||
131427689|NCT03364309|473188466|FG005|Maintenance Period|Lack of Efficacy|0|||
131427690|NCT03364309|473188467|FG006|Maintenance Period|Lack of Efficacy|0|||
131427691|NCT03364309|473188468|FG007|Maintenance Period|Lack of Efficacy|0|||
131427692|NCT03364309|473188469|FG008|Maintenance Period|Lack of Efficacy|1|||
131427693|NCT03364309|473188470|FG009|Maintenance Period|Lack of Efficacy|3|||
131427694|NCT03364309|473188471|FG010|Maintenance Period|Lack of Efficacy|2|||
131427695|NCT03364309|473188472|FG011|Maintenance Period|Lack of Efficacy|0|||
131427696|NCT03364309|473188473|FG012|Maintenance Period|Lack of Efficacy|0|||
131427697|NCT03364309|473188474|FG013|Maintenance Period|Lack of Efficacy|0|||
131427698|NCT03364309|473188475|FG014|Maintenance Period|Lack of Efficacy|0|||
131427699|NCT03364309|473188476|FG015|Maintenance Period|Lack of Efficacy|0|||
131427700|NCT03364309|473188477|FG016|Maintenance Period|Lack of Efficacy|0|||
131427701|NCT03364309|473188478|FG017|Maintenance Period|Lack of Efficacy|0|||
131427702|NCT03364309|473188479|FG018|Maintenance Period|Lack of Efficacy|0|||
131427703|NCT03364309|473188461|FG000|Maintenance Period|Death|0|||
131427704|NCT03364309|473188462|FG001|Maintenance Period|Death|0|||
131427705|NCT03364309|473188463|FG002|Maintenance Period|Death|0|||
131427706|NCT03364309|473188464|FG003|Maintenance Period|Death|0|||
131427707|NCT03364309|473188465|FG004|Maintenance Period|Death|0|||
131427708|NCT03364309|473188466|FG005|Maintenance Period|Death|0|||
131427709|NCT03364309|473188467|FG006|Maintenance Period|Death|0|||
131427710|NCT03364309|473188468|FG007|Maintenance Period|Death|0|||
131427711|NCT03364309|473188469|FG008|Maintenance Period|Death|1|||
131427712|NCT03364309|473188470|FG009|Maintenance Period|Death|0|||
131427713|NCT03364309|473188471|FG010|Maintenance Period|Death|0|||
131427714|NCT03364309|473188472|FG011|Maintenance Period|Death|0|||
131427715|NCT03364309|473188473|FG012|Maintenance Period|Death|0|||
131427716|NCT03364309|473188474|FG013|Maintenance Period|Death|0|||
131427717|NCT03364309|473188475|FG014|Maintenance Period|Death|0|||
131427718|NCT03364309|473188476|FG015|Maintenance Period|Death|0|||
131427719|NCT03364309|473188477|FG016|Maintenance Period|Death|0|||
131427720|NCT03364309|473188478|FG017|Maintenance Period|Death|0|||
131427721|NCT03364309|473188479|FG018|Maintenance Period|Death|0|||
131427722|NCT03364309|473188461|FG000|Maintenance Period|Lost to Follow-up|0|||
131427723|NCT03364309|473188462|FG001|Maintenance Period|Lost to Follow-up|0|||
131427724|NCT03364309|473188463|FG002|Maintenance Period|Lost to Follow-up|0|||
131427725|NCT03364309|473188464|FG003|Maintenance Period|Lost to Follow-up|0|||
131427726|NCT03364309|473188465|FG004|Maintenance Period|Lost to Follow-up|0|||
131427727|NCT03364309|473188466|FG005|Maintenance Period|Lost to Follow-up|0|||
131427728|NCT03364309|473188467|FG006|Maintenance Period|Lost to Follow-up|0|||
131427729|NCT03364309|473188468|FG007|Maintenance Period|Lost to Follow-up|0|||
131427730|NCT03364309|473188469|FG008|Maintenance Period|Lost to Follow-up|1|||
131427731|NCT03364309|473188470|FG009|Maintenance Period|Lost to Follow-up|0|||
131427732|NCT03364309|473188471|FG010|Maintenance Period|Lost to Follow-up|0|||
131427733|NCT03364309|473188472|FG011|Maintenance Period|Lost to Follow-up|0|||
131427734|NCT03364309|473188473|FG012|Maintenance Period|Lost to Follow-up|0|||
131427735|NCT03364309|473188474|FG013|Maintenance Period|Lost to Follow-up|0|||
131427736|NCT03364309|473188475|FG014|Maintenance Period|Lost to Follow-up|0|||
131427737|NCT03364309|473188476|FG015|Maintenance Period|Lost to Follow-up|0|||
131427738|NCT03364309|473188477|FG016|Maintenance Period|Lost to Follow-up|0|||
131427739|NCT03364309|473188478|FG017|Maintenance Period|Lost to Follow-up|0|||
131427740|NCT03364309|473188479|FG018|Maintenance Period|Lost to Follow-up|0|||
131427741|NCT03364309|473188461|FG000|Maintenance Period|Miscellaneous|0|||
131427742|NCT03364309|473188462|FG001|Maintenance Period|Miscellaneous|0|||
131427743|NCT03364309|473188463|FG002|Maintenance Period|Miscellaneous|0|||
131427744|NCT03364309|473188464|FG003|Maintenance Period|Miscellaneous|0|||
131427745|NCT03364309|473188465|FG004|Maintenance Period|Miscellaneous|0|||
131427746|NCT03364309|473188466|FG005|Maintenance Period|Miscellaneous|0|||
131427747|NCT03364309|473188467|FG006|Maintenance Period|Miscellaneous|0|||
131427748|NCT03364309|473188468|FG007|Maintenance Period|Miscellaneous|0|||
131427749|NCT03364309|473188469|FG008|Maintenance Period|Miscellaneous|1|||
131427750|NCT03364309|473188470|FG009|Maintenance Period|Miscellaneous|0|||
131427751|NCT03364309|473188471|FG010|Maintenance Period|Miscellaneous|0|||
131427752|NCT03364309|473188472|FG011|Maintenance Period|Miscellaneous|0|||
131427753|NCT03364309|473188473|FG012|Maintenance Period|Miscellaneous|0|||
131427754|NCT03364309|473188474|FG013|Maintenance Period|Miscellaneous|0|||
131427755|NCT03364309|473188475|FG014|Maintenance Period|Miscellaneous|0|||
131427756|NCT03364309|473188476|FG015|Maintenance Period|Miscellaneous|0|||
131427757|NCT03364309|473188477|FG016|Maintenance Period|Miscellaneous|0|||
131427758|NCT03364309|473188478|FG017|Maintenance Period|Miscellaneous|0|||
131427759|NCT03364309|473188479|FG018|Maintenance Period|Miscellaneous|0|||
131427760|NCT03364309|473188461|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427761|NCT03364309|473188462|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427762|NCT03364309|473188463|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427763|NCT03364309|473188464|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427764|NCT03364309|473188465|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427765|NCT03364309|473188466|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427766|NCT03364309|473188467|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427767|NCT03364309|473188468|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427768|NCT03364309|473188469|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427769|NCT03364309|473188470|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427770|NCT03364309|473188471|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427771|NCT03364309|473188472|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427772|NCT03364309|473188473|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427773|NCT03364309|473188474|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
131427774|NCT03364309|473188475|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
131427775|NCT03364309|473188476|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
131427776|NCT03364309|473188477|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427777|NCT03364309|473188478|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427778|NCT03364309|473188479|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
131427779|NCT03364309|473188461|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427780|NCT03364309|473188462|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427781|NCT03364309|473188463|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427782|NCT03364309|473188464|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427783|NCT03364309|473188465|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427784|NCT03364309|473188466|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427785|NCT03364309|473188467|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427786|NCT03364309|473188468|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427787|NCT03364309|473188469|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427788|NCT03364309|473188470|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427789|NCT03364309|473188471|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427790|NCT03364309|473188472|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427791|NCT03364309|473188473|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
131458102|NCT01243242|473308789|FG001|Overall Study|Adverse Event|1|||
131427792|NCT03364309|473188474|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427793|NCT03364309|473188475|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
131427794|NCT03364309|473188476|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427795|NCT03364309|473188477|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427796|NCT03364309|473188478|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427797|NCT03364309|473188479|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
131427798|NCT03364309|473188461|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
131427799|NCT03364309|473188462|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
131427800|NCT03364309|473188463|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
131427801|NCT03364309|473188464|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
131427802|NCT03364309|473188465|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
131427803|NCT03364309|473188466|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
131427804|NCT03364309|473188467|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
131427805|NCT03364309|473188468|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
131427806|NCT03364309|473188469|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
131427807|NCT03364309|473188470|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
131427808|NCT03364309|473188471|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
131427809|NCT03364309|473188472|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
131427810|NCT03364309|473188473|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
131427811|NCT03364309|473188474|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
131427812|NCT03364309|473188475|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
131427813|NCT03364309|473188476|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
131427814|NCT03364309|473188477|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
131427815|NCT03364309|473188478|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
131427816|NCT03364309|473188479|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
131427817|NCT03364309|473188461|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427818|NCT03364309|473188462|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427819|NCT03364309|473188463|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427820|NCT03364309|473188464|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427821|NCT03364309|473188465|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427822|NCT03364309|473188466|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427823|NCT03364309|473188467|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427824|NCT03364309|473188468|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427825|NCT03364309|473188469|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427826|NCT03364309|473188470|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427827|NCT03364309|473188471|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427828|NCT03364309|473188472|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427829|NCT03364309|473188473|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427830|NCT03364309|473188474|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427831|NCT03364309|473188475|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427832|NCT03364309|473188476|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
131427833|NCT03364309|473188477|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
131427834|NCT03364309|473188478|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
131427835|NCT03364309|473188479|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
131427836|NCT03364309|473188461|FG000|Post-Treatment Followup Period|Adverse Event|0|||
131427837|NCT03364309|473188462|FG001|Post-Treatment Followup Period|Adverse Event|0|||
131427838|NCT03364309|473188463|FG002|Post-Treatment Followup Period|Adverse Event|0|||
131427839|NCT03364309|473188464|FG003|Post-Treatment Followup Period|Adverse Event|0|||
131427840|NCT03364309|473188465|FG004|Post-Treatment Followup Period|Adverse Event|0|||
131427841|NCT03364309|473188466|FG005|Post-Treatment Followup Period|Adverse Event|0|||
131427842|NCT03364309|473188467|FG006|Post-Treatment Followup Period|Adverse Event|0|||
131427843|NCT03364309|473188468|FG007|Post-Treatment Followup Period|Adverse Event|0|||
131427844|NCT03364309|473188469|FG008|Post-Treatment Followup Period|Adverse Event|0|||
131427845|NCT03364309|473188470|FG009|Post-Treatment Followup Period|Adverse Event|0|||
131427846|NCT03364309|473188471|FG010|Post-Treatment Followup Period|Adverse Event|0|||
131458103|NCT01243242|473308788|FG000|Overall Study|Withdrawal by Subject|1|||
131458104|NCT01243242|473308789|FG001|Overall Study|Withdrawal by Subject|1|||
131458105|NCT01243242|473308788|FG000|Overall Study|Physician Decision|0|||
131458106|NCT01243242|473308789|FG001|Overall Study|Physician Decision|1|||
131458107|NCT01243242|473308788|FG000|Overall Study|sponsor decision|0|||
131458108|NCT01243242|473308789|FG001|Overall Study|sponsor decision|1|||
131458109|NCT01243242|473308788|FG000|Overall Study|non compliance|1|||
131458110|NCT01243242|473308789|FG001|Overall Study|non compliance|0|||
131458111|NCT02160899|473308803|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
131427847|NCT03364309|473188472|FG011|Post-Treatment Followup Period|Adverse Event|0|||
131427848|NCT03364309|473188473|FG012|Post-Treatment Followup Period|Adverse Event|0|||
131427849|NCT03364309|473188474|FG013|Post-Treatment Followup Period|Adverse Event|0|||
131427850|NCT03364309|473188475|FG014|Post-Treatment Followup Period|Adverse Event|0|||
131427851|NCT03364309|473188476|FG015|Post-Treatment Followup Period|Adverse Event|0|||
131427852|NCT03364309|473188477|FG016|Post-Treatment Followup Period|Adverse Event|2|||
131427853|NCT03364309|473188478|FG017|Post-Treatment Followup Period|Adverse Event|6|||
131427854|NCT03364309|473188479|FG018|Post-Treatment Followup Period|Adverse Event|1|||
131427855|NCT03364309|473188461|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427856|NCT03364309|473188462|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427857|NCT03364309|473188463|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427858|NCT03364309|473188464|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427859|NCT03364309|473188465|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427860|NCT03364309|473188466|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427861|NCT03364309|473188467|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427862|NCT03364309|473188468|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427863|NCT03364309|473188469|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427864|NCT03364309|473188470|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427865|NCT03364309|473188471|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427866|NCT03364309|473188472|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427867|NCT03364309|473188473|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427868|NCT03364309|473188474|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427869|NCT03364309|473188475|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427870|NCT03364309|473188476|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427871|NCT03364309|473188477|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427872|NCT03364309|473188478|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
131427873|NCT03364309|473188479|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
131427874|NCT03364309|473188461|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
131458112|NCT02160899|473308804|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
131458113|NCT02160899|473308805|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
131458114|NCT02160899|473308806|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
131458115|NCT02160899|473308807|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
131458116|NCT02160899|473308808|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
131458117|NCT01256294|473308809|FG000|Overall Study|Adverse Event|1|||
131458118|NCT01256294|473308810|FG001|Overall Study|Adverse Event|0|||
131458119|NCT01256294|473308809|FG000|Overall Study|Withdrawal by Subject|1|||
131458120|NCT01256294|473308810|FG001|Overall Study|Withdrawal by Subject|1|||
131458121|NCT01256294|473308809|FG000|Overall Study|Protocol deviation|2|||
131458122|NCT01256294|473308810|FG001|Overall Study|Protocol deviation|1|||
131458123|NCT02338882|473308812|FG000|Overall Study|Death|1|||
131427875|NCT03364309|473188462|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
131427876|NCT03364309|473188463|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
131427877|NCT03364309|473188464|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
131427878|NCT03364309|473188465|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
131427879|NCT03364309|473188466|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
131427880|NCT03364309|473188467|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
131427881|NCT03364309|473188468|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
131427882|NCT03364309|473188469|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
131458124|NCT02338882|473308813|FG001|Overall Study|Death|0|||
131458125|NCT02338882|473308812|FG000|Overall Study|Lost to Follow-up|6|||
131458126|NCT02338882|473308813|FG001|Overall Study|Lost to Follow-up|3|||
131458127|NCT00942994|473308814|FG000|Overall Study|Adverse Event|7|||
131458128|NCT00942994|473308815|FG001|Overall Study|Adverse Event|4|||
131427883|NCT03364309|473188470|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
131427884|NCT03364309|473188471|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
131427885|NCT03364309|473188472|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
131427886|NCT03364309|473188473|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
131427887|NCT03364309|473188474|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
131427888|NCT03364309|473188475|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
131427889|NCT03364309|473188476|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
131427890|NCT03364309|473188477|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
131427891|NCT03364309|473188478|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
131427892|NCT03364309|473188479|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
131427893|NCT00615992|473188480|FG000|Overall Study|Protocol Violation|67|||
131427894|NCT00167310|473188481|FG000|Overall Study|Protocol Violation|5|||
131427895|NCT00167310|473188482|FG001|Overall Study|Protocol Violation|3|||
131427896|NCT00167310|473188481|FG000|Overall Study|Withdrawal by Subject|3|||
131427897|NCT00167310|473188482|FG001|Overall Study|Withdrawal by Subject|7|||
131427898|NCT03543137|473188486|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
131427899|NCT03543137|473188487|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
131427900|NCT03543137|473188486|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
131427901|NCT03543137|473188487|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
131458129|NCT00942994|473308814|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131458130|NCT00942994|473308815|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131427902|NCT03543137|473188486|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
131427903|NCT03543137|473188487|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
131427904|NCT02465203|473188488|FG000|Overall Study|Protocol Violation|1|||
131427905|NCT02465203|473188489|FG001|Overall Study|Protocol Violation|1|||
131427906|NCT02465203|473188490|FG002|Overall Study|Protocol Violation|1|||
131427907|NCT02465203|473188488|FG000|Overall Study|Study terminated by sponsor|50|||
131427908|NCT02465203|473188489|FG001|Overall Study|Study terminated by sponsor|34|||
131458131|NCT00942994|473308814|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131427909|NCT02465203|473188490|FG002|Overall Study|Study terminated by sponsor|11|||
131427910|NCT02465203|473188488|FG000|Overall Study|New therapy for study indication|4|||
131427911|NCT02465203|473188489|FG001|Overall Study|New therapy for study indication|0|||
131427912|NCT02465203|473188490|FG002|Overall Study|New therapy for study indication|0|||
131427913|NCT02465203|473188488|FG000|Overall Study|Patient/guardian decision|1|||
131427914|NCT02465203|473188489|FG001|Overall Study|Patient/guardian decision|1|||
131427915|NCT02465203|473188490|FG002|Overall Study|Patient/guardian decision|1|||
131427916|NCT00042991|473188491|FG000|Overall Study|Adverse Event|1|||
131427917|NCT00042991|473188492|FG001|Overall Study|Adverse Event|4|||
131427918|NCT00042991|473188493|FG002|Overall Study|Adverse Event|2|||
131427919|NCT00042991|473188494|FG003|Overall Study|Adverse Event|0|||
131427920|NCT00042991|473188495|FG004|Overall Study|Adverse Event|0|||
131427921|NCT00042991|473188496|FG005|Overall Study|Adverse Event|1|||
131427922|NCT00042991|473188497|FG006|Overall Study|Adverse Event|0|||
131427923|NCT00042991|473188491|FG000|Overall Study|Withdrawal by Subject|0|||
131427924|NCT00042991|473188492|FG001|Overall Study|Withdrawal by Subject|7|||
131427925|NCT00042991|473188493|FG002|Overall Study|Withdrawal by Subject|2|||
131427926|NCT00042991|473188494|FG003|Overall Study|Withdrawal by Subject|0|||
131427927|NCT00042991|473188495|FG004|Overall Study|Withdrawal by Subject|1|||
131427928|NCT00042991|473188496|FG005|Overall Study|Withdrawal by Subject|0|||
131427929|NCT00042991|473188497|FG006|Overall Study|Withdrawal by Subject|0|||
131427930|NCT00042991|473188491|FG000|Overall Study|Disease Progression|5|||
131427931|NCT00042991|473188492|FG001|Overall Study|Disease Progression|29|||
131427932|NCT00042991|473188493|FG002|Overall Study|Disease Progression|2|||
131427933|NCT00042991|473188494|FG003|Overall Study|Disease Progression|2|||
131427934|NCT00042991|473188495|FG004|Overall Study|Disease Progression|1|||
131427935|NCT00042991|473188496|FG005|Overall Study|Disease Progression|4|||
131427936|NCT00042991|473188497|FG006|Overall Study|Disease Progression|2|||
131427937|NCT00042991|473188491|FG000|Overall Study|Alternative Therapy|0|||
131427938|NCT00042991|473188492|FG001|Overall Study|Alternative Therapy|0|||
131427939|NCT00042991|473188493|FG002|Overall Study|Alternative Therapy|0|||
131427940|NCT00042991|473188494|FG003|Overall Study|Alternative Therapy|0|||
131427941|NCT00042991|473188495|FG004|Overall Study|Alternative Therapy|1|||
131427942|NCT00042991|473188496|FG005|Overall Study|Alternative Therapy|0|||
131427943|NCT00042991|473188497|FG006|Overall Study|Alternative Therapy|0|||
131427944|NCT04072887|473188502|FG000|Overall Study|Withdrawal by Subject|3|||
131427945|NCT04072887|473188503|FG001|Overall Study|Withdrawal by Subject|8|||
131427946|NCT04072887|473188504|FG002|Overall Study|Withdrawal by Subject|1|||
131427947|NCT04072887|473188505|FG003|Overall Study|Withdrawal by Subject|3|||
131427948|NCT04072887|473188506|FG004|Overall Study|Withdrawal by Subject|3|||
131427949|NCT04072887|473188507|FG005|Overall Study|Withdrawal by Subject|13|||
131427950|NCT04072887|473188502|FG000|Overall Study|Adverse Event|2|||
131427951|NCT04072887|473188503|FG001|Overall Study|Adverse Event|4|||
131427952|NCT04072887|473188504|FG002|Overall Study|Adverse Event|1|||
131427953|NCT04072887|473188505|FG003|Overall Study|Adverse Event|4|||
131427954|NCT04072887|473188506|FG004|Overall Study|Adverse Event|0|||
131427955|NCT04072887|473188507|FG005|Overall Study|Adverse Event|1|||
131427956|NCT04072887|473188502|FG000|Overall Study|Physician Decision|2|||
131427957|NCT04072887|473188503|FG001|Overall Study|Physician Decision|0|||
131427958|NCT04072887|473188504|FG002|Overall Study|Physician Decision|0|||
131427959|NCT04072887|473188505|FG003|Overall Study|Physician Decision|0|||
131427960|NCT04072887|473188506|FG004|Overall Study|Physician Decision|0|||
131427961|NCT04072887|473188507|FG005|Overall Study|Physician Decision|1|||
131427962|NCT04072887|473188502|FG000|Overall Study|Lost to Follow-up|1|||
131427963|NCT04072887|473188503|FG001|Overall Study|Lost to Follow-up|3|||
131427964|NCT04072887|473188504|FG002|Overall Study|Lost to Follow-up|0|||
131458132|NCT00942994|473308815|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131458133|NCT00942994|473308814|FG000|Overall Study|Patient withdrew consent|5|||
131458134|NCT00942994|473308815|FG001|Overall Study|Patient withdrew consent|8|||
131458135|NCT00942994|473308814|FG000|Overall Study|Lost to Follow-up|1|||
131458136|NCT00942994|473308815|FG001|Overall Study|Lost to Follow-up|4|||
131458137|NCT00942994|473308814|FG000|Overall Study|Protocol deviation|1|||
131458138|NCT00942994|473308815|FG001|Overall Study|Protocol deviation|2|||
131458139|NCT00095940|473308818|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
131458140|NCT00095940|473308819|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
131458141|NCT00095940|473308820|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
131458142|NCT00095940|473308821|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
131458143|NCT00095940|473308822|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
131458144|NCT00095940|473308823|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
131458145|NCT00095940|473308824|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
131427965|NCT04072887|473188505|FG003|Overall Study|Lost to Follow-up|0|||
131427966|NCT04072887|473188506|FG004|Overall Study|Lost to Follow-up|0|||
131427967|NCT04072887|473188507|FG005|Overall Study|Lost to Follow-up|0|||
131427968|NCT04072887|473188502|FG000|Overall Study|Death|0|||
131427969|NCT04072887|473188503|FG001|Overall Study|Death|2|||
131427970|NCT04072887|473188504|FG002|Overall Study|Death|0|||
131427971|NCT04072887|473188505|FG003|Overall Study|Death|2|||
131427972|NCT04072887|473188506|FG004|Overall Study|Death|3|||
131427973|NCT04072887|473188507|FG005|Overall Study|Death|0|||
131427974|NCT03193736|473188508|FG000|Overall Study|Death|2|||
131427975|NCT03193736|473188508|FG000|Overall Study|Withdrawal by Subject|1|||
131427976|NCT03193736|473188508|FG000|Overall Study|Lost to Follow-up|1|||
131427977|NCT03193736|473188508|FG000|Overall Study|implant not received|1|||
131427978|NCT00856297|473188509|FG000|Overall Study|Unable to classify|2|||
131427979|NCT00856297|473188510|FG001|Overall Study|Unable to classify|0|||
131427980|NCT00856297|473188511|FG002|Overall Study|Unable to classify|0|||
131427981|NCT00856297|473188512|FG003|Overall Study|Unable to classify|0|||
131427982|NCT00856297|473188513|FG004|Overall Study|Unable to classify|0|||
131427983|NCT03058692|473190404|FG000|Overall Study|Lost to Follow-up|2|||
131427984|NCT03058692|473190405|FG001|Overall Study|Lost to Follow-up|1|||
131427985|NCT03058692|473190404|FG000|Overall Study|Withdrawal by Subject|1|||
131427986|NCT03058692|473190405|FG001|Overall Study|Withdrawal by Subject|1|||
131427987|NCT01698814|473190408|FG000|Overall Study|Adverse Event|0|||
131427988|NCT01698814|473190409|FG001|Overall Study|Adverse Event|2|||
131427989|NCT01698814|473190408|FG000|Overall Study|Lost to Follow-up|0|||
131427990|NCT01698814|473190409|FG001|Overall Study|Lost to Follow-up|1|||
131427991|NCT01698814|473190408|FG000|Overall Study|Pregnancy|1|||
131427992|NCT01698814|473190409|FG001|Overall Study|Pregnancy|0|||
131427993|NCT01698814|473190408|FG000|Overall Study|Randomized in error|1|||
131427994|NCT01698814|473190409|FG001|Overall Study|Randomized in error|0|||
131427995|NCT00855959|473190410|FG000|Overall Study|Adverse Event|2|||
131427996|NCT00855959|473190410|FG000|Overall Study|Lost to Follow-up|2|||
131458146|NCT00095940|473308825|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
131427997|NCT00855959|473190410|FG000|Overall Study|Withdrawal by Subject|3|||
131427998|NCT00855959|473190410|FG000|Overall Study|Pregnancy|1|||
131458147|NCT00095940|473308826|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
131458148|NCT00095940|473308818|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
131458149|NCT00095940|473308819|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
131427999|NCT00855959|473190410|FG000|Overall Study|Incorrect enrolment|1|||
131428000|NCT02813889|473190411|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
131428001|NCT02813889|473190412|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
131428002|NCT04014062|473190415|FG000|Period I: Dosing|Medical Grounds|4|||
131428003|NCT04014062|473190416|FG001|Period I: Dosing|Medical Grounds|5|||
131428004|NCT04014062|473190415|FG000|Period I: Dosing|Withdrawal by Subject|3|||
131428005|NCT04014062|473190416|FG001|Period I: Dosing|Withdrawal by Subject|1|||
131428006|NCT03038126|473190418|FG000|Overall Study|Death|1|||
131428007|NCT03038126|473190419|FG001|Overall Study|Death|1|||
131428008|NCT03038126|473190418|FG000|Overall Study|Withdrawal by Subject|5|||
131428009|NCT03038126|473190419|FG001|Overall Study|Withdrawal by Subject|0|||
131428010|NCT03038126|473190418|FG000|Overall Study|Lost to Follow-up|0|||
131428011|NCT03038126|473190419|FG001|Overall Study|Lost to Follow-up|1|||
131428012|NCT03038126|473190418|FG000|Overall Study|Long Term Hospitalization|2|||
131428013|NCT03038126|473190419|FG001|Overall Study|Long Term Hospitalization|0|||
131428014|NCT03038126|473190418|FG000|Overall Study|Too Ill to Participate|1|||
131428015|NCT03038126|473190419|FG001|Overall Study|Too Ill to Participate|2|||
131428016|NCT01724866|473190420|FG000|Overall Study|Adverse Event|0|||
131428017|NCT01724866|473190421|FG001|Overall Study|Adverse Event|0|||
131428018|NCT01724866|473190422|FG002|Overall Study|Adverse Event|1|||
131428019|NCT01724866|473190423|FG003|Overall Study|Adverse Event|1|||
131428020|NCT01724866|473190420|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
131428021|NCT01724866|473190421|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
131428022|NCT01724866|473190422|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
131428023|NCT01724866|473190423|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
131428024|NCT01724866|473190420|FG000|Overall Study|Investigator's Discretion|0|||
131428025|NCT01724866|473190421|FG001|Overall Study|Investigator's Discretion|1|||
131428026|NCT01724866|473190422|FG002|Overall Study|Investigator's Discretion|1|||
131428027|NCT01724866|473190423|FG003|Overall Study|Investigator's Discretion|0|||
131428028|NCT01724866|473190420|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
131428029|NCT01724866|473190421|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
131428030|NCT01724866|473190422|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
131428031|NCT01724866|473190423|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
131428032|NCT01724866|473190420|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
131428033|NCT01724866|473190421|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
131428034|NCT01724866|473190422|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
131428035|NCT01724866|473190423|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
131428036|NCT01424501|473190426|FG000|Overall Study|Withdrawal by Subject|1|||
131428037|NCT01424501|473190427|FG001|Overall Study|Withdrawal by Subject|0|||
131428038|NCT01424501|473190428|FG002|Overall Study|Withdrawal by Subject|1|||
131458150|NCT00095940|473308820|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
131458151|NCT00095940|473308821|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
131458152|NCT00095940|473308822|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
131458153|NCT00095940|473308823|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
131458154|NCT00095940|473308824|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
131458155|NCT00095940|473308825|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
131428039|NCT01424501|473190429|FG003|Overall Study|Withdrawal by Subject|0|||
131428040|NCT01424501|473190430|FG004|Overall Study|Withdrawal by Subject|0|||
131428041|NCT01424501|473190431|FG005|Overall Study|Withdrawal by Subject|0|||
131428042|NCT01424501|473190426|FG000|Overall Study|Lost to Follow-up|0|||
131428043|NCT01424501|473190427|FG001|Overall Study|Lost to Follow-up|1|||
131428044|NCT01424501|473190428|FG002|Overall Study|Lost to Follow-up|1|||
131428045|NCT01424501|473190429|FG003|Overall Study|Lost to Follow-up|0|||
131458156|NCT00095940|473308826|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
131458157|NCT00095940|473308818|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458158|NCT00095940|473308819|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458159|NCT00095940|473308820|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458160|NCT00095940|473308821|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458161|NCT00095940|473308822|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458162|NCT00095940|473308823|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458163|NCT00095940|473308824|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458164|NCT00095940|473308825|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
131458165|NCT00095940|473308826|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
131458166|NCT02314637|473308827|FG000|Overall Study|Adverse Event|4|||
131458167|NCT02314637|473308828|FG001|Overall Study|Adverse Event|8|||
131458168|NCT02314637|473308827|FG000|Overall Study|Lack of Efficacy|1|||
131458169|NCT02314637|473308828|FG001|Overall Study|Lack of Efficacy|0|||
131458170|NCT02314637|473308827|FG000|Overall Study|Physician Decision|5|||
131458171|NCT02314637|473308828|FG001|Overall Study|Physician Decision|2|||
131458172|NCT02314637|473308827|FG000|Overall Study|Withdrawal by Subject|5|||
131458173|NCT02314637|473308828|FG001|Overall Study|Withdrawal by Subject|4|||
131458174|NCT02314637|473308827|FG000|Overall Study|Other Reason|1|||
131458175|NCT02314637|473308828|FG001|Overall Study|Other Reason|0|||
131458176|NCT03539549|473308830|FG000|Overall Study|Adverse Event|12|||
131458177|NCT03539549|473308830|FG000|Overall Study|Lost to Follow-up|1|||
131458178|NCT03539549|473308830|FG000|Overall Study|Death|2|||
131458179|NCT03539549|473308830|FG000|Overall Study|Progressive Disease|1|||
131458180|NCT03539549|473308830|FG000|Overall Study|Reason not Specified|1|||
131458181|NCT02864862|473308837|FG000|Overall Study|Lost to Follow-up|1|||
131458182|NCT02864862|473308838|FG001|Overall Study|Lost to Follow-up|0|||
131458183|NCT02864862|473308839|FG002|Overall Study|Lost to Follow-up|1|||
131458184|NCT02864862|473308837|FG000|Overall Study|Protocol Violation|0|||
131458185|NCT02864862|473308838|FG001|Overall Study|Protocol Violation|0|||
131458186|NCT02864862|473308839|FG002|Overall Study|Protocol Violation|1|||
131458187|NCT01311024|473308840|FG000|Overall Study|Protocol Violation|35|||
131458188|NCT01311024|473308841|FG001|Overall Study|Protocol Violation|22|||
131458189|NCT01523275|473308845|FG000|Overall Study|Lost to Follow-up|1|||
131458190|NCT01523275|473308846|FG001|Overall Study|Lost to Follow-up|2|||
131458191|NCT01523275|473308845|FG000|Overall Study|Withdrawal by Subject|1|||
131458192|NCT01523275|473308846|FG001|Overall Study|Withdrawal by Subject|0|||
131458193|NCT01536067|473308850|FG000|Overall Study|Disease Progression|1|||
131458194|NCT03120351|473308851|FG000|Overall Study|Physician Decision|1|||
131458195|NCT03120351|473308852|FG001|Overall Study|Physician Decision|1|||
131458196|NCT04643158|473308853|FG000|Overall Study|Study terminated by sponsor|0|||
131458197|NCT04643158|473308854|FG001|Overall Study|Study terminated by sponsor|0|||
131458198|NCT04643158|473308855|FG002|Overall Study|Study terminated by sponsor|1|||
131458199|NCT04643158|473308856|FG003|Overall Study|Study terminated by sponsor|0|||
131458200|NCT04643158|473308857|FG004|Overall Study|Study terminated by sponsor|0|||
131458201|NCT04643158|473308858|FG005|Overall Study|Study terminated by sponsor|1|||
131458202|NCT04643158|473308859|FG006|Overall Study|Study terminated by sponsor|0|||
131458203|NCT04643158|473308853|FG000|Overall Study|Global/country situation|0|||
131458204|NCT04643158|473308854|FG001|Overall Study|Global/country situation|0|||
131458205|NCT04643158|473308855|FG002|Overall Study|Global/country situation|1|||
131458206|NCT04643158|473308856|FG003|Overall Study|Global/country situation|0|||
131458207|NCT04643158|473308857|FG004|Overall Study|Global/country situation|0|||
131458208|NCT04643158|473308858|FG005|Overall Study|Global/country situation|0|||
131458209|NCT04643158|473308859|FG006|Overall Study|Global/country situation|0|||
131458210|NCT04643158|473308853|FG000|Overall Study|Withdrawal by Subject|0|||
131458211|NCT04643158|473308854|FG001|Overall Study|Withdrawal by Subject|0|||
131458212|NCT04643158|473308855|FG002|Overall Study|Withdrawal by Subject|0|||
131458213|NCT04643158|473308856|FG003|Overall Study|Withdrawal by Subject|0|||
131428046|NCT01424501|473190430|FG004|Overall Study|Lost to Follow-up|0|||
131428047|NCT01424501|473190431|FG005|Overall Study|Lost to Follow-up|0|||
131428048|NCT01980095|473190432|FG000|Overall Study|Lost to Follow-up|6|||
131428049|NCT01980095|473190433|FG001|Overall Study|Lost to Follow-up|7|||
131428050|NCT01980095|473190432|FG000|Overall Study|Withdrawal by Subject|2|||
131428051|NCT01980095|473190433|FG001|Overall Study|Withdrawal by Subject|3|||
131428052|NCT01980095|473190432|FG000|Overall Study|Poor compliance|5|||
131428053|NCT01980095|473190433|FG001|Overall Study|Poor compliance|0|||
131428054|NCT01980095|473190432|FG000|Overall Study|Safety issue|0|||
131428055|NCT01980095|473190433|FG001|Overall Study|Safety issue|1|||
131428056|NCT01980095|473190432|FG000|Overall Study|Study drug discontinued|1|||
131428057|NCT01980095|473190433|FG001|Overall Study|Study drug discontinued|0|||
131458214|NCT04643158|473308857|FG004|Overall Study|Withdrawal by Subject|0|||
131458215|NCT04643158|473308858|FG005|Overall Study|Withdrawal by Subject|1|||
131428058|NCT01980095|473190432|FG000|Overall Study|Randomized by mistake|1|||
131428059|NCT01980095|473190433|FG001|Overall Study|Randomized by mistake|0|||
131458216|NCT04643158|473308859|FG006|Overall Study|Withdrawal by Subject|0|||
131458217|NCT04540198|473308860|FG000|Overall Study|Lost to Follow-up|25|||
131458218|NCT04540198|473308861|FG001|Overall Study|Lost to Follow-up|23|||
131458219|NCT04540198|473308860|FG000|Overall Study|Withdrawal by Subject|15|||
131458220|NCT04540198|473308861|FG001|Overall Study|Withdrawal by Subject|9|||
131458221|NCT04540198|473308860|FG000|Overall Study|Discontinued|1|||
131458222|NCT04540198|473308861|FG001|Overall Study|Discontinued|0|||
131458223|NCT02350478|473308862|FG000|Overall Study|Lost to Follow-up|5|||
131458224|NCT02350478|473308863|FG001|Overall Study|Lost to Follow-up|1|||
131458225|NCT05573386|473308864|FG000|Overall Study|Withdrawal by Subject|3|||
131458226|NCT05573386|473308865|FG001|Overall Study|Withdrawal by Subject|2|||
131458227|NCT03646123|473308866|FG000|Overall Study|Withdrawal by Subject|2|||
131458228|NCT03646123|473308867|FG001|Overall Study|Withdrawal by Subject|2|||
131458229|NCT03646123|473308868|FG002|Overall Study|Withdrawal by Subject|3|||
131458230|NCT03646123|473308866|FG000|Overall Study|Study termination by sponsor|0|||
131458231|NCT03646123|473308867|FG001|Overall Study|Study termination by sponsor|45|||
131458232|NCT03646123|473308868|FG002|Overall Study|Study termination by sponsor|139|||
131458233|NCT03646123|473308866|FG000|Overall Study|Lost to Follow-up|4|||
131458234|NCT03646123|473308867|FG001|Overall Study|Lost to Follow-up|10|||
131458235|NCT03646123|473308868|FG002|Overall Study|Lost to Follow-up|10|||
131458236|NCT03646123|473308866|FG000|Overall Study|Death|2|||
131458237|NCT03646123|473308867|FG001|Overall Study|Death|1|||
131458238|NCT03646123|473308868|FG002|Overall Study|Death|1|||
131458239|NCT03646123|473308866|FG000|Overall Study|Other|2|||
131458240|NCT03646123|473308867|FG001|Overall Study|Other|0|||
131458241|NCT03646123|473308868|FG002|Overall Study|Other|2|||
131458242|NCT04195893|473308869|FG000|Second Intervention|Withdrawal by Subject|1|||
131458243|NCT04195893|473308870|FG001|Second Intervention|Withdrawal by Subject|0|||
131458244|NCT01802073|473308871|FG000|Overall Study|Lost to Follow-up|0|||
131458245|NCT01802073|473308872|FG001|Overall Study|Lost to Follow-up|1|||
131458246|NCT01802073|473308871|FG000|Overall Study|Non-compliant|4|||
131458247|NCT01802073|473308872|FG001|Overall Study|Non-compliant|2|||
131458248|NCT01802073|473308871|FG000|Overall Study|Withdrawal by Subject|1|||
131458249|NCT01802073|473308872|FG001|Overall Study|Withdrawal by Subject|1|||
131458250|NCT01802073|473308871|FG000|Overall Study|Physician Decision|0|||
131458251|NCT01802073|473308872|FG001|Overall Study|Physician Decision|7|||
131458252|NCT00918736|473308875|FG000|Overall Study|Withdrawal by Subject|4|||
131458253|NCT01137604|473308876|FG000|Overall Study|Adverse Event|3|||
131458254|NCT01137604|473308877|FG001|Overall Study|Adverse Event|6|||
131458255|NCT01137604|473308878|FG002|Overall Study|Adverse Event|9|||
131458256|NCT01137604|473308879|FG003|Overall Study|Adverse Event|9|||
131458257|NCT01137604|473308876|FG000|Overall Study|Participant Choice|0|||
131458258|NCT01137604|473308877|FG001|Overall Study|Participant Choice|2|||
131458259|NCT01137604|473308878|FG002|Overall Study|Participant Choice|2|||
131458260|NCT01137604|473308879|FG003|Overall Study|Participant Choice|0|||
131458261|NCT01137604|473308876|FG000|Overall Study|Withdrawal of consent|0|||
131458262|NCT01137604|473308877|FG001|Overall Study|Withdrawal of consent|0|||
131458263|NCT01137604|473308878|FG002|Overall Study|Withdrawal of consent|0|||
131458264|NCT01137604|473308879|FG003|Overall Study|Withdrawal of consent|2|||
131458265|NCT01137604|473308876|FG000|Overall Study|Clinical progression/deterioration|1|||
131458266|NCT01137604|473308877|FG001|Overall Study|Clinical progression/deterioration|2|||
131458267|NCT01137604|473308878|FG002|Overall Study|Clinical progression/deterioration|2|||
131458268|NCT01137604|473308879|FG003|Overall Study|Clinical progression/deterioration|0|||
131458269|NCT00200356|473308883|FG000|Overall Study|Lack of Efficacy|3|||
131458270|NCT00200356|473308884|FG001|Overall Study|Lack of Efficacy|3|||
131458271|NCT00200356|473308883|FG000|Overall Study|Protocol Violation|4|||
131458272|NCT00200356|473308884|FG001|Overall Study|Protocol Violation|4|||
131458273|NCT00200356|473308883|FG000|Overall Study|Nontreatment|1|||
131458274|NCT00200356|473308884|FG001|Overall Study|Nontreatment|0|||
131458275|NCT02424578|473308885|FG000|Overall Study|Withdrawal by Subject|0|||
131458276|NCT02424578|473308886|FG001|Overall Study|Withdrawal by Subject|1|||
131458277|NCT02792829|473308890|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458278|NCT02792829|473308891|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
131458279|NCT02792829|473308892|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458280|NCT02792829|473308893|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458281|NCT02792829|473308894|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458282|NCT02792829|473308895|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458283|NCT02792829|473308896|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458284|NCT02792829|473308897|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
131458285|NCT02792829|473308890|FG000|Treatment Period 2|Adverse Event|0|||
131458286|NCT02792829|473308891|FG001|Treatment Period 2|Adverse Event|0|||
131458287|NCT02792829|473308892|FG002|Treatment Period 2|Adverse Event|0|||
131458288|NCT02792829|473308893|FG003|Treatment Period 2|Adverse Event|0|||
131458289|NCT02792829|473308894|FG004|Treatment Period 2|Adverse Event|1|||
131458290|NCT02792829|473308895|FG005|Treatment Period 2|Adverse Event|0|||
131458291|NCT02792829|473308896|FG006|Treatment Period 2|Adverse Event|1|||
131458292|NCT02792829|473308897|FG007|Treatment Period 2|Adverse Event|1|||
131428060|NCT01362608|473190438|FG000|Overall Study|Protocol Violation|0|||
131428061|NCT01362608|473190439|FG001|Overall Study|Protocol Violation|1|||
131428062|NCT01362608|473190438|FG000|Overall Study|Lost to Follow-up|3|||
131428063|NCT01362608|473190439|FG001|Overall Study|Lost to Follow-up|1|||
131428064|NCT01362608|473190438|FG000|Overall Study|Withdrawal by Subject|1|||
131428065|NCT01362608|473190439|FG001|Overall Study|Withdrawal by Subject|2|||
131428066|NCT01362608|473190438|FG000|Overall Study|Lack of Efficacy|0|||
131428067|NCT01362608|473190439|FG001|Overall Study|Lack of Efficacy|2|||
131428068|NCT01362608|473190438|FG000|Overall Study|Adverse Event|0|||
131428069|NCT01362608|473190439|FG001|Overall Study|Adverse Event|2|||
131428070|NCT04506502|473190443|FG000|Overall Study|Withdrawal by Subject|1|||
131428071|NCT04506502|473190443|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
131428072|NCT03574779|473190444|FG000|Overall Study|Screening failure|13|||
131428073|NCT03574779|473190445|FG001|Overall Study|Screening failure|83|||
131428074|NCT02588261|473190446|FG000|Overall Study|Study Terminated by Sponsor|157|||
131428075|NCT02588261|473190447|FG001|Overall Study|Study Terminated by Sponsor|142|||
131428076|NCT02588261|473190446|FG000|Overall Study|Protocol Deviation|1|||
131428077|NCT02588261|473190447|FG001|Overall Study|Protocol Deviation|0|||
131428078|NCT02588261|473190446|FG000|Overall Study|Death|1|||
131428079|NCT02588261|473190447|FG001|Overall Study|Death|2|||
131428080|NCT02588261|473190446|FG000|Overall Study|Withdrawal by Subject|12|||
131428081|NCT02588261|473190447|FG001|Overall Study|Withdrawal by Subject|8|||
131428082|NCT02588261|473190446|FG000|Overall Study|Noncompliance with Study Drug|0|||
131428083|NCT02588261|473190447|FG001|Overall Study|Noncompliance with Study Drug|1|||
131428084|NCT02588261|473190446|FG000|Overall Study|Miscellaneous|5|||
131428085|NCT02588261|473190447|FG001|Overall Study|Miscellaneous|4|||
131428086|NCT02588261|473190446|FG000|Overall Study|Progressive Disease|61|||
131428087|NCT02588261|473190447|FG001|Overall Study|Progressive Disease|82|||
131428088|NCT02588261|473190446|FG000|Overall Study|Adverse Event|29|||
131428089|NCT02588261|473190447|FG001|Overall Study|Adverse Event|24|||
131428090|NCT02588261|473190446|FG000|Overall Study|Lost to Follow-up|1|||
131428091|NCT02588261|473190447|FG001|Overall Study|Lost to Follow-up|0|||
131428092|NCT03781778|473190449|FG000|Overall Study|Withdrawal by Subject|2|||
131428093|NCT03781778|473190450|FG001|Overall Study|Withdrawal by Subject|2|||
131428094|NCT02287467|473190451|FG000|Overall Study|Protocol Violation|12|||
131428095|NCT02287467|473190452|FG001|Overall Study|Protocol Violation|9|||
131428096|NCT01957202|473190453|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428097|NCT01957202|473190454|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
131428098|NCT01957202|473190455|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428099|NCT01957202|473190456|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131458293|NCT02792829|473308890|FG000|Treatment Period 2|Use of proscribed medications|0|||
131458294|NCT02792829|473308891|FG001|Treatment Period 2|Use of proscribed medications|0|||
131458295|NCT02792829|473308892|FG002|Treatment Period 2|Use of proscribed medications|0|||
131458296|NCT02792829|473308893|FG003|Treatment Period 2|Use of proscribed medications|0|||
131458297|NCT02792829|473308894|FG004|Treatment Period 2|Use of proscribed medications|0|||
131458298|NCT02792829|473308895|FG005|Treatment Period 2|Use of proscribed medications|0|||
131458299|NCT02792829|473308896|FG006|Treatment Period 2|Use of proscribed medications|0|||
131458300|NCT02792829|473308897|FG007|Treatment Period 2|Use of proscribed medications|1|||
131458301|NCT00776919|473308898|FG000|Overall Study|Withdrawal by Subject|16|||
131458302|NCT00776919|473308899|FG001|Overall Study|Withdrawal by Subject|14|||
131458303|NCT00776919|473308900|FG002|Overall Study|Withdrawal by Subject|15|||
131458304|NCT00776919|473308901|FG003|Overall Study|Withdrawal by Subject|26|||
131458305|NCT00776919|473308898|FG000|Overall Study|Lost to Follow-up|8|||
131458306|NCT00776919|473308899|FG001|Overall Study|Lost to Follow-up|12|||
131458307|NCT00776919|473308900|FG002|Overall Study|Lost to Follow-up|11|||
131458308|NCT00776919|473308901|FG003|Overall Study|Lost to Follow-up|8|||
131458309|NCT00776919|473308898|FG000|Overall Study|Adverse Event|1|||
131458310|NCT00776919|473308899|FG001|Overall Study|Adverse Event|0|||
131458311|NCT00776919|473308900|FG002|Overall Study|Adverse Event|2|||
131428100|NCT01957202|473190457|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428101|NCT01957202|473190458|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428102|NCT01957202|473190459|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428103|NCT01957202|473190460|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428104|NCT01957202|473190461|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428105|NCT01957202|473190462|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428106|NCT01957202|473190463|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428107|NCT01957202|473190464|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428108|NCT01957202|473190465|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428109|NCT01957202|473190466|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428110|NCT01957202|473190467|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428111|NCT01957202|473190468|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428112|NCT01957202|473190469|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
131428113|NCT01957202|473190470|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
131428114|NCT01957202|473190453|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428115|NCT01957202|473190454|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428116|NCT01957202|473190455|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428117|NCT01957202|473190456|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428118|NCT01957202|473190457|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428119|NCT01957202|473190458|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428120|NCT01957202|473190459|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428121|NCT01957202|473190460|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428122|NCT01957202|473190461|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428123|NCT01957202|473190462|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428124|NCT01957202|473190463|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428125|NCT01957202|473190464|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428126|NCT01957202|473190465|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428127|NCT01957202|473190466|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428128|NCT01957202|473190467|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428129|NCT01957202|473190468|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428130|NCT01957202|473190469|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
131428131|NCT01957202|473190470|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
131428132|NCT01456169|473190471|FG000|Overall Study|Adverse Event|1|||
131428133|NCT01456169|473190472|FG001|Overall Study|Adverse Event|2|||
131428134|NCT01456169|473190473|FG002|Overall Study|Adverse Event|7|||
131428135|NCT01456169|473190471|FG000|Overall Study|Major Protocol Deviation|3|||
131428136|NCT01456169|473190472|FG001|Overall Study|Major Protocol Deviation|2|||
131428137|NCT01456169|473190473|FG002|Overall Study|Major Protocol Deviation|3|||
131428138|NCT01456169|473190471|FG000|Overall Study|Voluntary Withdrawal|3|||
131428139|NCT01456169|473190472|FG001|Overall Study|Voluntary Withdrawal|0|||
131428140|NCT01456169|473190473|FG002|Overall Study|Voluntary Withdrawal|2|||
131428141|NCT01456169|473190471|FG000|Overall Study|Lack of Efficacy|2|||
131428142|NCT01456169|473190472|FG001|Overall Study|Lack of Efficacy|0|||
131428143|NCT01456169|473190473|FG002|Overall Study|Lack of Efficacy|0|||
131428144|NCT01456169|473190471|FG000|Overall Study|Other|1|||
131428145|NCT01456169|473190472|FG001|Overall Study|Other|1|||
131428146|NCT01456169|473190473|FG002|Overall Study|Other|0|||
131428147|NCT02652156|473190478|FG000|Overall Study|Physician Decision|1|||
131428148|NCT02652156|473190479|FG001|Overall Study|Physician Decision|0|||
131428149|NCT02652156|473190480|FG002|Overall Study|Physician Decision|0|||
131428150|NCT02342223|473190481|FG000|Overall Study|Lost to Follow-up|1|||
131428151|NCT01200368|473190482|FG000|Infant Series|Adverse Event|2|||
131428152|NCT01200368|473190483|FG001|Infant Series|Adverse Event|2|||
131428153|NCT01200368|473190484|FG002|Infant Series|Adverse Event|3|||
131428154|NCT01200368|473190482|FG000|Infant Series|Withdrawal by Subject|0|||
131428155|NCT01200368|473190483|FG001|Infant Series|Withdrawal by Subject|2|||
131428156|NCT01200368|473190484|FG002|Infant Series|Withdrawal by Subject|2|||
131428157|NCT01200368|473190482|FG000|Infant Series|Did not meet entrance criteria|0|||
131428158|NCT01200368|473190483|FG001|Infant Series|Did not meet entrance criteria|1|||
131458312|NCT00776919|473308901|FG003|Overall Study|Adverse Event|2|||
131458313|NCT00776919|473308898|FG000|Overall Study|Protocol Violation|1|||
131458314|NCT00776919|473308899|FG001|Overall Study|Protocol Violation|2|||
131458315|NCT00776919|473308900|FG002|Overall Study|Protocol Violation|0|||
131428159|NCT01200368|473190484|FG002|Infant Series|Did not meet entrance criteria|0|||
131428160|NCT01200368|473190482|FG000|Infant Series|Randomized, not vaccinated|0|||
131428161|NCT01200368|473190483|FG001|Infant Series|Randomized, not vaccinated|1|||
131428162|NCT01200368|473190484|FG002|Infant Series|Randomized, not vaccinated|1|||
131428163|NCT01200368|473190482|FG000|Infant Series|Other|1|||
131428164|NCT01200368|473190483|FG001|Infant Series|Other|0|||
131428165|NCT01200368|473190484|FG002|Infant Series|Other|0|||
131428166|NCT01200368|473190482|FG000|After Infant Series|Adverse Event|6|||
131428167|NCT01200368|473190483|FG001|After Infant Series|Adverse Event|6|||
131428168|NCT01200368|473190484|FG002|After Infant Series|Adverse Event|3|||
131458316|NCT00776919|473308901|FG003|Overall Study|Protocol Violation|1|||
131428169|NCT01200368|473190482|FG000|After Infant Series|Withdrawal by Subject|10|||
131428170|NCT01200368|473190483|FG001|After Infant Series|Withdrawal by Subject|8|||
131428171|NCT01200368|473190484|FG002|After Infant Series|Withdrawal by Subject|4|||
131428172|NCT01200368|473190482|FG000|After Infant Series|Lost to Follow-up|1|||
131428173|NCT01200368|473190483|FG001|After Infant Series|Lost to Follow-up|0|||
131458317|NCT00776919|473308898|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
131458318|NCT00776919|473308899|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
131458319|NCT00776919|473308900|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
131458320|NCT00776919|473308901|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
131458321|NCT00635999|473308904|FG000|Overall Study|Withdrawal by Subject|4|||
131458322|NCT00635999|473308905|FG001|Overall Study|Withdrawal by Subject|2|||
131458323|NCT00635999|473308906|FG002|Overall Study|Withdrawal by Subject|1|||
131458324|NCT02929407|473308910|FG000|Overall Study|Adverse Event|1|||
131458325|NCT02410343|473308914|FG000|Core Period (24 Weeks)|Adverse Event|1|||
131458326|NCT02410343|473308915|FG001|Core Period (24 Weeks)|Adverse Event|0|||
131458327|NCT02410343|473308914|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
131458328|NCT02410343|473308915|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
131458329|NCT02410343|473308914|FG000|Extension Period (12 Months)|Adverse Event|1|||
131458330|NCT02410343|473308915|FG001|Extension Period (12 Months)|Adverse Event|0|||
131458331|NCT02410343|473308914|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
131458332|NCT02410343|473308915|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
131458333|NCT03037580|473308916|FG000|Overall Study|Withdrawal by Subject|3|||
131458334|NCT03037580|473308917|FG001|Overall Study|Withdrawal by Subject|0|||
131458335|NCT03037580|473308916|FG000|Overall Study|Adverse Event|1|||
131458336|NCT03037580|473308917|FG001|Overall Study|Adverse Event|0|||
131458337|NCT03037580|473308916|FG000|Overall Study|Study Terminated by Sponsor|12|||
131458338|NCT03037580|473308917|FG001|Overall Study|Study Terminated by Sponsor|15|||
131458339|NCT03037580|473308916|FG000|Overall Study|Death|0|||
131458340|NCT03037580|473308917|FG001|Overall Study|Death|1|||
131458341|NCT02036853|473308918|FG000|Overall Study|Adverse Event|0|||
131458342|NCT02036853|473308919|FG001|Overall Study|Adverse Event|2|||
131458343|NCT02036853|473308918|FG000|Overall Study|Lack of Efficacy|0|||
131428174|NCT01200368|473190484|FG002|After Infant Series|Lost to Follow-up|0|||
131428175|NCT01200368|473190482|FG000|After Infant Series|Other|1|||
131428176|NCT01200368|473190483|FG001|After Infant Series|Other|2|||
131428177|NCT01200368|473190484|FG002|After Infant Series|Other|2|||
131428178|NCT01200368|473190482|FG000|Toddler Dose|Adverse Event|0|||
131428179|NCT01200368|473190483|FG001|Toddler Dose|Adverse Event|3|||
131428180|NCT01200368|473190484|FG002|Toddler Dose|Adverse Event|1|||
131428181|NCT00108862|473190485|FG000|Overall Study|Death|31|||
131428182|NCT00108862|473190486|FG001|Overall Study|Death|37|||
131428183|NCT00108862|473190485|FG000|Overall Study|Withdrawal by Subject|10|||
131428184|NCT00108862|473190486|FG001|Overall Study|Withdrawal by Subject|6|||
131428185|NCT00108862|473190485|FG000|Overall Study|Lost to Follow-up|27|||
131428186|NCT00108862|473190486|FG001|Overall Study|Lost to Follow-up|19|||
131428187|NCT03534141|473190490|FG000|Overall Study|Enrolled in other clinical trial|1|||
131428188|NCT03534141|473190491|FG001|Overall Study|Enrolled in other clinical trial|0|||
131428189|NCT03534141|473190490|FG000|Overall Study|Liver transplant aborted after randomization|0|||
131428190|NCT03534141|473190491|FG001|Overall Study|Liver transplant aborted after randomization|2|||
131428191|NCT03534141|473190490|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
131428192|NCT03534141|473190491|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
131428193|NCT00517361|473190492|FG000|Overall Study|Death|6|||
131428194|NCT00517361|473190492|FG000|Overall Study|The study was terminated|5|||
131428195|NCT01685697|473190493|FG000|Overall Study|Protocol Violation|3|||
131428196|NCT01685697|473190494|FG001|Overall Study|Protocol Violation|3|||
131428197|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Death|0|||
131428198|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Death|0|||
131428199|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Death|0|||
131428200|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Death|0|||
131428201|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Death|1|||
131428202|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Death|0|||
131428203|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Death|0|||
131428204|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Death|0|||
131428205|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
131428206|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
131458344|NCT02036853|473308919|FG001|Overall Study|Lack of Efficacy|2|||
131458345|NCT02036853|473308918|FG000|Overall Study|Physician Decision|0|||
131458346|NCT02036853|473308919|FG001|Overall Study|Physician Decision|1|||
131458347|NCT02036853|473308918|FG000|Overall Study|Withdrawal by Subject|0|||
131428207|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
131428208|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
131428209|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
131428210|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
131458348|NCT02036853|473308919|FG001|Overall Study|Withdrawal by Subject|1|||
131428211|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
131428212|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
131458349|NCT00884741|473308923|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
131428213|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
131428214|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
131428215|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
131428216|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
131428217|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
131428218|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
131428219|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
131428220|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
131428221|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
131428222|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
131428223|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
131428224|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
131458350|NCT00884741|473308924|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
131458351|NCT00884741|473308925|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
131458352|NCT00884741|473308926|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
131458353|NCT00884741|473308923|FG000|Step 1 Registration: Tissue Screening|Death|3|||
131428225|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
131428226|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
131428227|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
131428228|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
131428229|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
131428230|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
131428231|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
131428232|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
131428233|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
131428234|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
131428235|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
131428236|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
131428237|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
131428238|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
131428239|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
131428240|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
131428241|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
131428242|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
131428243|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
131428244|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
131428245|NCT00726232|473190496|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
131428246|NCT00726232|473190497|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428247|NCT00726232|473190498|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428248|NCT00726232|473190499|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428249|NCT00726232|473190500|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428250|NCT00726232|473190501|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428251|NCT00726232|473190502|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428252|NCT00726232|473190503|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
131428253|NCT00726232|473190496|FG000|Expansion Phase|Death|0|||
131428254|NCT00726232|473190497|FG001|Expansion Phase|Death|0|||
131428255|NCT00726232|473190498|FG002|Expansion Phase|Death|0|||
131428256|NCT00726232|473190499|FG003|Expansion Phase|Death|0|||
131428257|NCT00726232|473190500|FG004|Expansion Phase|Death|0|||
131428258|NCT00726232|473190501|FG005|Expansion Phase|Death|0|||
131428259|NCT00726232|473190502|FG006|Expansion Phase|Death|0|||
131428260|NCT00726232|473190503|FG007|Expansion Phase|Death|1|||
131428261|NCT00726232|473190496|FG000|Expansion Phase|Adverse Event|0|||
131428262|NCT00726232|473190497|FG001|Expansion Phase|Adverse Event|0|||
131428263|NCT00726232|473190498|FG002|Expansion Phase|Adverse Event|0|||
131428264|NCT00726232|473190499|FG003|Expansion Phase|Adverse Event|0|||
131428265|NCT00726232|473190500|FG004|Expansion Phase|Adverse Event|0|||
131428266|NCT00726232|473190501|FG005|Expansion Phase|Adverse Event|0|||
131428267|NCT00726232|473190502|FG006|Expansion Phase|Adverse Event|6|||
131428268|NCT00726232|473190503|FG007|Expansion Phase|Adverse Event|11|||
131428269|NCT00726232|473190496|FG000|Expansion Phase|Withdrawal by Subject|0|||
131428270|NCT00726232|473190497|FG001|Expansion Phase|Withdrawal by Subject|0|||
131428271|NCT00726232|473190498|FG002|Expansion Phase|Withdrawal by Subject|0|||
131428272|NCT00726232|473190499|FG003|Expansion Phase|Withdrawal by Subject|0|||
131428273|NCT00726232|473190500|FG004|Expansion Phase|Withdrawal by Subject|0|||
131428274|NCT00726232|473190501|FG005|Expansion Phase|Withdrawal by Subject|0|||
131428275|NCT00726232|473190502|FG006|Expansion Phase|Withdrawal by Subject|2|||
131428276|NCT00726232|473190503|FG007|Expansion Phase|Withdrawal by Subject|3|||
131428277|NCT00726232|473190496|FG000|Expansion Phase|Disease progression|0|||
131428278|NCT00726232|473190497|FG001|Expansion Phase|Disease progression|0|||
131428279|NCT00726232|473190498|FG002|Expansion Phase|Disease progression|0|||
131428280|NCT00726232|473190499|FG003|Expansion Phase|Disease progression|0|||
131428281|NCT00726232|473190500|FG004|Expansion Phase|Disease progression|0|||
131428282|NCT00726232|473190501|FG005|Expansion Phase|Disease progression|0|||
131428283|NCT00726232|473190502|FG006|Expansion Phase|Disease progression|4|||
131428284|NCT00726232|473190503|FG007|Expansion Phase|Disease progression|0|||
131428285|NCT00726232|473190496|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
131428286|NCT00726232|473190497|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
131428287|NCT00726232|473190498|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
131428288|NCT00726232|473190499|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
131428289|NCT00726232|473190500|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
131428290|NCT00726232|473190501|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
131428291|NCT00726232|473190502|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
131428292|NCT00726232|473190503|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
131428293|NCT00726232|473190496|FG000|Expansion Phase|Per Investigator: lack of response|0|||
131428294|NCT00726232|473190497|FG001|Expansion Phase|Per Investigator: lack of response|0|||
131428295|NCT00726232|473190498|FG002|Expansion Phase|Per Investigator: lack of response|0|||
131428296|NCT00726232|473190499|FG003|Expansion Phase|Per Investigator: lack of response|0|||
131428297|NCT00726232|473190500|FG004|Expansion Phase|Per Investigator: lack of response|0|||
131428298|NCT00726232|473190501|FG005|Expansion Phase|Per Investigator: lack of response|0|||
131428299|NCT00726232|473190502|FG006|Expansion Phase|Per Investigator: lack of response|1|||
131428300|NCT00726232|473190503|FG007|Expansion Phase|Per Investigator: lack of response|7|||
131458354|NCT00884741|473308924|FG001|Step 1 Registration: Tissue Screening|Death|0|||
131458355|NCT00884741|473308925|FG002|Step 1 Registration: Tissue Screening|Death|0|||
131458356|NCT00884741|473308926|FG003|Step 1 Registration: Tissue Screening|Death|0|||
131458357|NCT00884741|473308923|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
131458358|NCT00884741|473308924|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
131428301|NCT00726232|473190496|FG000|Expansion Phase|Unspecified reason|0|||
131428302|NCT00726232|473190497|FG001|Expansion Phase|Unspecified reason|0|||
131428303|NCT00726232|473190498|FG002|Expansion Phase|Unspecified reason|0|||
131428304|NCT00726232|473190499|FG003|Expansion Phase|Unspecified reason|0|||
131428305|NCT00726232|473190500|FG004|Expansion Phase|Unspecified reason|0|||
131428306|NCT00726232|473190501|FG005|Expansion Phase|Unspecified reason|0|||
131428307|NCT00726232|473190502|FG006|Expansion Phase|Unspecified reason|1|||
131428308|NCT00726232|473190503|FG007|Expansion Phase|Unspecified reason|0|||
131428309|NCT04526145|473190504|FG000|Overall Study|Withdrawal by Subject|5|||
131428310|NCT00566852|473190511|FG000|Overall Study|Protocol Violation|22|||
131428311|NCT00566852|473190512|FG001|Overall Study|Protocol Violation|24|||
131428312|NCT00566852|473190511|FG000|Overall Study|Death|95|||
131428313|NCT00566852|473190512|FG001|Overall Study|Death|78|||
131428314|NCT00566852|473190511|FG000|Overall Study|Withdrawal by Subject|30|||
131428315|NCT00566852|473190512|FG001|Overall Study|Withdrawal by Subject|25|||
131428316|NCT00566852|473190511|FG000|Overall Study|Patient refusal|37|||
131428317|NCT00566852|473190512|FG001|Overall Study|Patient refusal|37|||
131428318|NCT00566852|473190511|FG000|Overall Study|Not tested due to disability|6|||
131428319|NCT00566852|473190512|FG001|Overall Study|Not tested due to disability|12|||
131428320|NCT00566852|473190511|FG000|Overall Study|Missing reason not specified|1|||
131428321|NCT00566852|473190512|FG001|Overall Study|Missing reason not specified|2|||
131428322|NCT00566852|473190511|FG000|Overall Study|Missing reason not reported|16|||
131428323|NCT00566852|473190512|FG001|Overall Study|Missing reason not reported|20|||
131428324|NCT04079816|473190513|FG000|Overall Study|Request of Subject|2|||
131428325|NCT04079816|473190513|FG000|Overall Study|Unable to draw samples|1|||
131428326|NCT04137731|473190514|FG000|Overall Study|Surgery Cancellation|1|||
131428327|NCT04137731|473190515|FG001|Overall Study|Surgery Cancellation|2|||
131428328|NCT04137731|473190514|FG000|Overall Study|Withdrawal by Subject|2|||
131428329|NCT04137731|473190515|FG001|Overall Study|Withdrawal by Subject|0|||
131428330|NCT04137731|473190514|FG000|Overall Study|Protocol Violation|0|||
131428331|NCT04137731|473190515|FG001|Overall Study|Protocol Violation|1|||
131428332|NCT00310817|473190516|FG000|Overall Study|AE or Death|3|||
131428333|NCT00310817|473190517|FG001|Overall Study|AE or Death|1|||
131428334|NCT00310817|473190518|FG002|Overall Study|AE or Death|0|||
131428335|NCT00310817|473190519|FG003|Overall Study|AE or Death|0|||
131428336|NCT00310817|473190516|FG000|Overall Study|Withdrawal by Subject|1|||
131428337|NCT00310817|473190517|FG001|Overall Study|Withdrawal by Subject|4|||
131428338|NCT00310817|473190518|FG002|Overall Study|Withdrawal by Subject|6|||
131428339|NCT00310817|473190519|FG003|Overall Study|Withdrawal by Subject|7|||
131428340|NCT00310817|473190516|FG000|Overall Study|Lost to Follow-up|2|||
131428341|NCT00310817|473190517|FG001|Overall Study|Lost to Follow-up|1|||
131428342|NCT00310817|473190518|FG002|Overall Study|Lost to Follow-up|0|||
131428343|NCT00310817|473190519|FG003|Overall Study|Lost to Follow-up|0|||
131428344|NCT00310817|473190516|FG000|Overall Study|Inappropriate Enrollment|1|||
131428345|NCT00310817|473190517|FG001|Overall Study|Inappropriate Enrollment|0|||
131428346|NCT00310817|473190518|FG002|Overall Study|Inappropriate Enrollment|1|||
131428347|NCT00310817|473190519|FG003|Overall Study|Inappropriate Enrollment|0|||
131428348|NCT00310817|473190516|FG000|Overall Study|Protocol Violation|1|||
131428349|NCT00310817|473190517|FG001|Overall Study|Protocol Violation|1|||
131428350|NCT00310817|473190518|FG002|Overall Study|Protocol Violation|1|||
131428351|NCT00310817|473190519|FG003|Overall Study|Protocol Violation|1|||
131428352|NCT00310817|473190516|FG000|Overall Study|Unable to classify|3|||
131428353|NCT00310817|473190517|FG001|Overall Study|Unable to classify|1|||
131428354|NCT00310817|473190518|FG002|Overall Study|Unable to classify|0|||
131428355|NCT00310817|473190519|FG003|Overall Study|Unable to classify|0|||
131428356|NCT01702246|473190520|FG000|Overall Study|Lost to Follow-up|2|||
131428357|NCT01702246|473190520|FG000|Overall Study|Withdrawal by Subject|2|||
131428358|NCT01702246|473190520|FG000|Overall Study|Physician Decision|1|||
131428359|NCT02123823|473190521|FG000|Overall Study|Lack of Efficacy|0|||
131428360|NCT02123823|473190522|FG001|Overall Study|Lack of Efficacy|2|||
131428361|NCT02123823|473190523|FG002|Overall Study|Lack of Efficacy|8|||
131428362|NCT02123823|473190524|FG003|Overall Study|Lack of Efficacy|10|||
131428363|NCT02123823|473190521|FG000|Overall Study|Progressive disease|3|||
131428364|NCT02123823|473190522|FG001|Overall Study|Progressive disease|19|||
131428365|NCT02123823|473190523|FG002|Overall Study|Progressive disease|52|||
131428366|NCT02123823|473190524|FG003|Overall Study|Progressive disease|53|||
131428367|NCT02123823|473190521|FG000|Overall Study|Withdrawal by Subject|0|||
131428368|NCT02123823|473190522|FG001|Overall Study|Withdrawal by Subject|0|||
131428369|NCT02123823|473190523|FG002|Overall Study|Withdrawal by Subject|7|||
131428370|NCT02123823|473190524|FG003|Overall Study|Withdrawal by Subject|2|||
131428371|NCT02123823|473190521|FG000|Overall Study|Adverse Event|0|||
131428372|NCT02123823|473190522|FG001|Overall Study|Adverse Event|0|||
131428373|NCT02123823|473190523|FG002|Overall Study|Adverse Event|3|||
131428374|NCT02123823|473190524|FG003|Overall Study|Adverse Event|5|||
131428375|NCT03828019|473190529|FG000|Overall Study|Withdrawal by Subject|3|||
131428376|NCT03828019|473190530|FG001|Overall Study|Withdrawal by Subject|8|||
131428377|NCT03828019|473190529|FG000|Overall Study|Lost to Follow-up|1|||
131428378|NCT03828019|473190530|FG001|Overall Study|Lost to Follow-up|6|||
131428379|NCT03828019|473190529|FG000|Overall Study|Incarcerated|1|||
131428380|NCT03828019|473190530|FG001|Overall Study|Incarcerated|0|||
131428381|NCT03828019|473190529|FG000|Overall Study|Adverse Event|0|||
131428382|NCT03828019|473190530|FG001|Overall Study|Adverse Event|1|||
131428383|NCT05715242|473190531|FG000|Overall Study|Lost to Follow-up|0|||
131428384|NCT05715242|473190532|FG001|Overall Study|Lost to Follow-up|0|||
131428385|NCT05715242|473190533|FG002|Overall Study|Lost to Follow-up|1|||
131428386|NCT05715242|473190534|FG003|Overall Study|Lost to Follow-up|0|||
131428387|NCT05715242|473190535|FG004|Overall Study|Lost to Follow-up|0|||
131428388|NCT05715242|473190536|FG005|Overall Study|Lost to Follow-up|1|||
131428389|NCT05715242|473190537|FG006|Overall Study|Lost to Follow-up|0|||
131428390|NCT05715242|473190538|FG007|Overall Study|Lost to Follow-up|0|||
131428391|NCT05715242|473190539|FG008|Overall Study|Lost to Follow-up|0|||
131428392|NCT05715242|473190540|FG009|Overall Study|Lost to Follow-up|0|||
131428393|NCT05715242|473190541|FG010|Overall Study|Lost to Follow-up|0|||
131428394|NCT05715242|473190542|FG011|Overall Study|Lost to Follow-up|0|||
131428395|NCT05715242|473190543|FG012|Overall Study|Lost to Follow-up|0|||
131428396|NCT05715242|473190544|FG013|Overall Study|Lost to Follow-up|0|||
131428397|NCT05715242|473190545|FG014|Overall Study|Lost to Follow-up|0|||
131428398|NCT05715242|473190546|FG015|Overall Study|Lost to Follow-up|0|||
131428399|NCT03400176|473190547|FG000|Dose Escalation|Progressive disease|1|||
131428400|NCT03400176|473190548|FG001|Dose Escalation|Progressive disease|1|||
131428401|NCT03400176|473190549|FG002|Dose Escalation|Progressive disease|0|||
131428402|NCT03400176|473190550|FG003|Dose Escalation|Progressive disease|0|||
131428403|NCT03400176|473190551|FG004|Dose Escalation|Progressive disease|1|||
131428404|NCT03400176|473190547|FG000|Dose Escalation|Patient decision|0|||
131428405|NCT03400176|473190548|FG001|Dose Escalation|Patient decision|0|||
131428406|NCT03400176|473190549|FG002|Dose Escalation|Patient decision|0|||
131428407|NCT03400176|473190550|FG003|Dose Escalation|Patient decision|0|||
131428408|NCT03400176|473190551|FG004|Dose Escalation|Patient decision|1|||
131428409|NCT03400176|473190547|FG000|Dose Expansion|Patient decision|0|||
131428410|NCT03400176|473190548|FG001|Dose Expansion|Patient decision|0|||
131428411|NCT03400176|473190549|FG002|Dose Expansion|Patient decision|0|||
131428412|NCT03400176|473190550|FG003|Dose Expansion|Patient decision|1|||
131428413|NCT03400176|473190551|FG004|Dose Expansion|Patient decision|0|||
131428414|NCT03400176|473190547|FG000|Dose Expansion|Adverse Event|0|||
131428415|NCT03400176|473190548|FG001|Dose Expansion|Adverse Event|0|||
131428416|NCT03400176|473190549|FG002|Dose Expansion|Adverse Event|0|||
131428417|NCT03400176|473190550|FG003|Dose Expansion|Adverse Event|1|||
131428418|NCT03400176|473190551|FG004|Dose Expansion|Adverse Event|0|||
131428419|NCT03400176|473190547|FG000|Dose Expansion|Physician Decision|0|||
131428420|NCT03400176|473190548|FG001|Dose Expansion|Physician Decision|0|||
131428421|NCT03400176|473190549|FG002|Dose Expansion|Physician Decision|0|||
131428422|NCT03400176|473190550|FG003|Dose Expansion|Physician Decision|1|||
131428423|NCT03400176|473190551|FG004|Dose Expansion|Physician Decision|0|||
131428424|NCT03400176|473190547|FG000|Dose Expansion|Progressive disease|0|||
131458359|NCT00884741|473308925|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
131428425|NCT03400176|473190548|FG001|Dose Expansion|Progressive disease|0|||
131428426|NCT03400176|473190549|FG002|Dose Expansion|Progressive disease|1|||
131428427|NCT03400176|473190550|FG003|Dose Expansion|Progressive disease|1|||
131428428|NCT03400176|473190551|FG004|Dose Expansion|Progressive disease|0|||
131428429|NCT02343406|473190552|FG000|Overall Study|Progressive disease|72|||
131428430|NCT02343406|473190553|FG001|Overall Study|Progressive disease|70|||
131428431|NCT02343406|473190554|FG002|Overall Study|Progressive disease|43|||
131428432|NCT02343406|473190555|FG003|Overall Study|Progressive disease|15|||
131428433|NCT02343406|473190556|FG004|Overall Study|Progressive disease|5|||
131428434|NCT02343406|473190552|FG000|Overall Study|Adverse Event|6|||
131428435|NCT02343406|473190553|FG001|Overall Study|Adverse Event|8|||
131428436|NCT02343406|473190554|FG002|Overall Study|Adverse Event|6|||
131428437|NCT02343406|473190555|FG003|Overall Study|Adverse Event|3|||
131428438|NCT02343406|473190556|FG004|Overall Study|Adverse Event|0|||
131428439|NCT02343406|473190552|FG000|Overall Study|Withdrawal by Subject|6|||
131428440|NCT02343406|473190553|FG001|Overall Study|Withdrawal by Subject|4|||
131428441|NCT02343406|473190554|FG002|Overall Study|Withdrawal by Subject|8|||
131428442|NCT02343406|473190555|FG003|Overall Study|Withdrawal by Subject|3|||
131428443|NCT02343406|473190556|FG004|Overall Study|Withdrawal by Subject|0|||
131428444|NCT02343406|473190552|FG000|Overall Study|Death|2|||
131428445|NCT02343406|473190553|FG001|Overall Study|Death|1|||
131428446|NCT02343406|473190554|FG002|Overall Study|Death|0|||
131428447|NCT02343406|473190555|FG003|Overall Study|Death|0|||
131428448|NCT02343406|473190556|FG004|Overall Study|Death|0|||
131428449|NCT02343406|473190552|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
131428450|NCT02343406|473190553|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
131458360|NCT00884741|473308926|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
131458361|NCT00884741|473308923|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
131428451|NCT02343406|473190554|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
131428452|NCT02343406|473190555|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
131428453|NCT02343406|473190556|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
131428454|NCT02343406|473190552|FG000|Overall Study|Other primary malignancy|0|||
131428455|NCT02343406|473190553|FG001|Overall Study|Other primary malignancy|1|||
131458362|NCT00884741|473308924|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
131428456|NCT02343406|473190554|FG002|Overall Study|Other primary malignancy|0|||
131428457|NCT02343406|473190555|FG003|Overall Study|Other primary malignancy|0|||
131428458|NCT02343406|473190556|FG004|Overall Study|Other primary malignancy|0|||
131428459|NCT02343406|473190552|FG000|Overall Study|Other, not specified|2|||
131428460|NCT02343406|473190553|FG001|Overall Study|Other, not specified|1|||
131428461|NCT02343406|473190554|FG002|Overall Study|Other, not specified|1|||
131428462|NCT02343406|473190555|FG003|Overall Study|Other, not specified|4|||
131428463|NCT02343406|473190556|FG004|Overall Study|Other, not specified|0|||
131428464|NCT00958165|473190557|FG000|Overall Study|Lost to Follow-up|5|||
131428465|NCT00958165|473190557|FG000|Overall Study|Not eligible|9|||
131458363|NCT00884741|473308925|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
131458364|NCT00884741|473308926|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
131458365|NCT00884741|473308923|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
131458366|NCT00884741|473308924|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
131458367|NCT00884741|473308925|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
131458368|NCT00884741|473308926|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
131458369|NCT00884741|473308923|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
131458370|NCT00884741|473308924|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
131458371|NCT00884741|473308925|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
131458372|NCT00884741|473308926|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
131458373|NCT00884741|473308923|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
131458374|NCT00884741|473308924|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
131458375|NCT00884741|473308925|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
131458376|NCT00884741|473308926|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
131458377|NCT00884741|473308923|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
131458378|NCT00884741|473308924|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
131458379|NCT00884741|473308925|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
131458380|NCT00884741|473308926|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
131458381|NCT00884741|473308923|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
131458382|NCT00884741|473308924|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
131458383|NCT00884741|473308925|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
131458384|NCT00884741|473308926|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
131458385|NCT00884741|473308923|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
131458386|NCT00884741|473308924|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
131458387|NCT00884741|473308925|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
131458388|NCT00884741|473308926|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
131458389|NCT00884741|473308923|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
131458390|NCT00884741|473308924|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
131458391|NCT00884741|473308925|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
131458392|NCT00884741|473308926|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
131458393|NCT00884741|473308923|FG000|Randomization|Protocol Violation|0|||
131458394|NCT00884741|473308924|FG001|Randomization|Protocol Violation|0|||
131458395|NCT00884741|473308925|FG002|Randomization|Protocol Violation|8|||
131458396|NCT00884741|473308926|FG003|Randomization|Protocol Violation|8|||
131458397|NCT01065454|473308927|FG000|Treatment|Adverse Event|7|||
131458398|NCT01065454|473308928|FG001|Treatment|Adverse Event|4|||
131458399|NCT01065454|473308929|FG002|Treatment|Adverse Event|3|||
131458400|NCT01065454|473308930|FG003|Treatment|Adverse Event|6|||
131458401|NCT01065454|473308927|FG000|Treatment|Death|1|||
131458402|NCT01065454|473308928|FG001|Treatment|Death|0|||
131458403|NCT01065454|473308929|FG002|Treatment|Death|0|||
131458404|NCT01065454|473308930|FG003|Treatment|Death|0|||
131458405|NCT01065454|473308927|FG000|Treatment|Non-compliance|1|||
131458406|NCT01065454|473308928|FG001|Treatment|Non-compliance|0|||
131458407|NCT01065454|473308929|FG002|Treatment|Non-compliance|0|||
131458408|NCT01065454|473308930|FG003|Treatment|Non-compliance|1|||
131458409|NCT01065454|473308927|FG000|Treatment|Protocol Decision|0|||
131458410|NCT01065454|473308928|FG001|Treatment|Protocol Decision|0|||
131458411|NCT01065454|473308929|FG002|Treatment|Protocol Decision|3|||
131458412|NCT01065454|473308930|FG003|Treatment|Protocol Decision|2|||
131458413|NCT01065454|473308927|FG000|Treatment|Protocol Violation|1|||
131458414|NCT01065454|473308928|FG001|Treatment|Protocol Violation|0|||
131458415|NCT01065454|473308929|FG002|Treatment|Protocol Violation|1|||
131428466|NCT01298765|473190558|FG000|Titration Period|Adverse Event|26|||
131428467|NCT01298765|473190558|FG000|Titration Period|Death|1|||
131458416|NCT01065454|473308930|FG003|Treatment|Protocol Violation|0|||
131458417|NCT01065454|473308927|FG000|Treatment|Withdrawal by Subject|3|||
131458418|NCT01065454|473308928|FG001|Treatment|Withdrawal by Subject|1|||
131458419|NCT01065454|473308929|FG002|Treatment|Withdrawal by Subject|2|||
131458420|NCT01065454|473308930|FG003|Treatment|Withdrawal by Subject|3|||
131458421|NCT01065454|473308927|FG000|Follow up|Adverse Event|1|||
131458422|NCT01065454|473308928|FG001|Follow up|Adverse Event|0|||
131458423|NCT01065454|473308929|FG002|Follow up|Adverse Event|0|||
131458424|NCT01065454|473308930|FG003|Follow up|Adverse Event|1|||
131458425|NCT01065454|473308927|FG000|Follow up|Death|0|||
131458426|NCT01065454|473308928|FG001|Follow up|Death|1|||
131428468|NCT01298765|473190558|FG000|Titration Period|Lack of Efficacy|21|||
131428469|NCT01298765|473190558|FG000|Titration Period|Lost to Follow-up|9|||
131428470|NCT01298765|473190558|FG000|Titration Period|Physician Decision|1|||
131428471|NCT01298765|473190558|FG000|Titration Period|Withdrawal by Subject|10|||
131428472|NCT01298765|473190558|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
131428473|NCT01298765|473190558|FG000|Long-Term Treatment Period|Adverse Event|19|||
131428474|NCT01298765|473190558|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
131428475|NCT01298765|473190558|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
131428476|NCT01298765|473190558|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
131428477|NCT01298765|473190558|FG000|Long-Term Treatment Period|Physician Decision|1|||
131428478|NCT01298765|473190558|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
131428479|NCT00766051|473190559|FG000|Overall Study|Withdrawal by Subject|2|||
131428480|NCT00766051|473190560|FG001|Overall Study|Withdrawal by Subject|0|||
131428481|NCT03302247|473190563|FG000|Overall Study|the study has closed prematurely|2|||
131428482|NCT03302247|473190563|FG000|Overall Study|Death|1|||
131428483|NCT02058563|473190564|FG000|Overall Study|Lost to Follow-up|26|||
131428484|NCT02058563|473190565|FG001|Overall Study|Lost to Follow-up|22|||
131428485|NCT02058563|473190564|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
131428486|NCT02058563|473190565|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
131428487|NCT02058563|473190564|FG000|Overall Study|Consent Withdrawal|1|||
131428488|NCT02058563|473190565|FG001|Overall Study|Consent Withdrawal|1|||
131428489|NCT02058563|473190564|FG000|Overall Study|Other (patient incarcerated)|0|||
131428490|NCT02058563|473190565|FG001|Overall Study|Other (patient incarcerated)|1|||
131428491|NCT04039217|473190566|FG000|Overall Study|Lost to Follow-up|1|||
131428492|NCT04522141|473190567|FG000|Overall Study|Withdrawal by Subject|1|||
131428493|NCT04522141|473190568|FG001|Overall Study|Withdrawal by Subject|0|||
131428494|NCT03508609|473190569|FG000|Overall Study|Withdrawal by Subject|1|||
131428495|NCT00423449|473190570|FG000|Overall Study|Clinical Adverse Event|1|||
131428496|NCT00423449|473190571|FG001|Overall Study|Clinical Adverse Event|0|||
131428497|NCT00423449|473190572|FG002|Overall Study|Clinical Adverse Event|1|||
131428498|NCT00423449|473190573|FG003|Overall Study|Clinical Adverse Event|8|||
131428499|NCT00423449|473190574|FG004|Overall Study|Clinical Adverse Event|2|||
131428500|NCT00423449|473190570|FG000|Overall Study|Death|1|||
131428501|NCT00423449|473190571|FG001|Overall Study|Death|0|||
131428502|NCT00423449|473190572|FG002|Overall Study|Death|2|||
131428503|NCT00423449|473190573|FG003|Overall Study|Death|1|||
131428504|NCT00423449|473190574|FG004|Overall Study|Death|1|||
131428505|NCT00423449|473190570|FG000|Overall Study|Progressive Disease|1|||
131428506|NCT00423449|473190571|FG001|Overall Study|Progressive Disease|3|||
131428507|NCT00423449|473190572|FG002|Overall Study|Progressive Disease|8|||
131428508|NCT00423449|473190573|FG003|Overall Study|Progressive Disease|11|||
131428509|NCT00423449|473190574|FG004|Overall Study|Progressive Disease|4|||
131428510|NCT00423449|473190570|FG000|Overall Study|Laboratory Adverse Event|0|||
131428511|NCT00423449|473190571|FG001|Overall Study|Laboratory Adverse Event|1|||
131428512|NCT00423449|473190572|FG002|Overall Study|Laboratory Adverse Event|2|||
131428513|NCT00423449|473190573|FG003|Overall Study|Laboratory Adverse Event|0|||
131428514|NCT00423449|473190574|FG004|Overall Study|Laboratory Adverse Event|0|||
131428515|NCT00423449|473190570|FG000|Overall Study|Other|0|||
131428516|NCT00423449|473190571|FG001|Overall Study|Other|0|||
131428517|NCT00423449|473190572|FG002|Overall Study|Other|0|||
131428518|NCT00423449|473190573|FG003|Overall Study|Other|1|||
131428519|NCT00423449|473190574|FG004|Overall Study|Other|0|||
131428520|NCT00423449|473190570|FG000|Overall Study|Protocol Violation|0|||
131428521|NCT00423449|473190571|FG001|Overall Study|Protocol Violation|0|||
131428522|NCT00423449|473190572|FG002|Overall Study|Protocol Violation|2|||
131428523|NCT00423449|473190573|FG003|Overall Study|Protocol Violation|1|||
131428524|NCT00423449|473190574|FG004|Overall Study|Protocol Violation|0|||
131428525|NCT02697435|473190575|FG000|Overall Study|Withdrawal by Subject|1|||
131428526|NCT02697435|473190576|FG001|Overall Study|Withdrawal by Subject|0|||
131428527|NCT02697435|473190575|FG000|Overall Study|Physician Decision|0|||
131428528|NCT02697435|473190576|FG001|Overall Study|Physician Decision|4|||
131428529|NCT00615017|473192205|FG000|Overall Study|Adverse Event|0|||
131428530|NCT00615017|473192206|FG001|Overall Study|Adverse Event|1|||
131428531|NCT00615017|473192207|FG002|Overall Study|Adverse Event|2|||
131428532|NCT00615017|473192208|FG003|Overall Study|Adverse Event|0|||
131428533|NCT00615017|473192209|FG004|Overall Study|Adverse Event|0|||
131428534|NCT00615017|473192210|FG005|Overall Study|Adverse Event|1|||
131428535|NCT00615017|473192205|FG000|Overall Study|Death|0|||
131428536|NCT00615017|473192206|FG001|Overall Study|Death|0|||
131428537|NCT00615017|473192207|FG002|Overall Study|Death|2|||
131428538|NCT00615017|473192208|FG003|Overall Study|Death|0|||
131428539|NCT00615017|473192209|FG004|Overall Study|Death|1|||
131428540|NCT00615017|473192210|FG005|Overall Study|Death|1|||
131428541|NCT00615017|473192205|FG000|Overall Study|Sepsis resolved|0|||
131428542|NCT00615017|473192206|FG001|Overall Study|Sepsis resolved|0|||
131428543|NCT00615017|473192207|FG002|Overall Study|Sepsis resolved|1|||
131428544|NCT00615017|473192208|FG003|Overall Study|Sepsis resolved|0|||
131428545|NCT00615017|473192209|FG004|Overall Study|Sepsis resolved|0|||
131428546|NCT00615017|473192210|FG005|Overall Study|Sepsis resolved|0|||
131428547|NCT00615017|473192205|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
131428548|NCT00615017|473192206|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
131428549|NCT00615017|473192207|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
131428550|NCT00615017|473192208|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
131428551|NCT00615017|473192209|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
131428552|NCT00615017|473192210|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
131428553|NCT00615017|473192205|FG000|Overall Study|Physician discontinued drug|0|||
131428554|NCT00615017|473192206|FG001|Overall Study|Physician discontinued drug|0|||
131428555|NCT00615017|473192207|FG002|Overall Study|Physician discontinued drug|0|||
131428556|NCT00615017|473192208|FG003|Overall Study|Physician discontinued drug|0|||
131428557|NCT00615017|473192209|FG004|Overall Study|Physician discontinued drug|0|||
131428558|NCT00615017|473192210|FG005|Overall Study|Physician discontinued drug|1|||
131428559|NCT00806988|473192211|FG000|Overall Study|Death|15|||
131428560|NCT00806988|473192212|FG001|Overall Study|Death|16|||
131428561|NCT00806988|473192211|FG000|Overall Study|Withdrawal by Subject|8|||
131428562|NCT00806988|473192212|FG001|Overall Study|Withdrawal by Subject|8|||
131428563|NCT00806988|473192211|FG000|Overall Study|Lost to Follow-up|4|||
131428564|NCT00806988|473192212|FG001|Overall Study|Lost to Follow-up|19|||
131428565|NCT00368641|473192213|FG000|Overall Study|Adverse Event|2|||
131428566|NCT00368641|473192214|FG001|Overall Study|Adverse Event|1|||
131428567|NCT00368641|473192213|FG000|Overall Study|Death|1|||
131428568|NCT00368641|473192214|FG001|Overall Study|Death|0|||
131428569|NCT00368641|473192213|FG000|Overall Study|Withdrawal by Subject|1|||
131428570|NCT00368641|473192214|FG001|Overall Study|Withdrawal by Subject|0|||
131428571|NCT00368641|473192213|FG000|Overall Study|Sponsor decision to terminate study|2|||
131428572|NCT00368641|473192214|FG001|Overall Study|Sponsor decision to terminate study|5|||
131428573|NCT03526146|473192221|FG000|Overall Study|Lost to Follow-up|5|||
131428574|NCT03526146|473192221|FG000|Overall Study|Withdrawal by Subject|6|||
131428575|NCT03526146|473192221|FG000|Overall Study|class canceled due to COVID-19|4|||
131428576|NCT02517541|473192224|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
131428577|NCT02517541|473192224|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
131428578|NCT02517541|473192224|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
131428579|NCT02517541|473192224|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
131428580|NCT02517541|473192224|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
131428581|NCT02517541|473192224|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
131428582|NCT00699608|473192225|FG000|First Intervention|Withdrawal by Subject|0|||
131428583|NCT00699608|473192226|FG001|First Intervention|Withdrawal by Subject|0|||
131428584|NCT00699608|473192227|FG002|First Intervention|Withdrawal by Subject|1|||
131428585|NCT00699608|473192228|FG003|First Intervention|Withdrawal by Subject|0|||
131428586|NCT00699608|473192229|FG004|First Intervention|Withdrawal by Subject|0|||
131428587|NCT00699608|473192230|FG005|First Intervention|Withdrawal by Subject|0|||
131428588|NCT00699608|473192225|FG000|First Intervention|Protocol Violation|0|||
131428589|NCT00699608|473192226|FG001|First Intervention|Protocol Violation|0|||
131428590|NCT00699608|473192227|FG002|First Intervention|Protocol Violation|0|||
131428591|NCT00699608|473192228|FG003|First Intervention|Protocol Violation|0|||
131428592|NCT00699608|473192229|FG004|First Intervention|Protocol Violation|1|||
131428593|NCT00699608|473192230|FG005|First Intervention|Protocol Violation|0|||
131428594|NCT00699608|473192225|FG000|Second Intervention|Adverse Event|0|||
131428595|NCT00699608|473192226|FG001|Second Intervention|Adverse Event|0|||
131428596|NCT00699608|473192227|FG002|Second Intervention|Adverse Event|1|||
131428597|NCT00699608|473192228|FG003|Second Intervention|Adverse Event|0|||
131428598|NCT00699608|473192229|FG004|Second Intervention|Adverse Event|0|||
131428599|NCT00699608|473192230|FG005|Second Intervention|Adverse Event|0|||
131428600|NCT00699608|473192225|FG000|Second Intervention|Withdrawal by Subject|0|||
131428601|NCT00699608|473192226|FG001|Second Intervention|Withdrawal by Subject|0|||
131428602|NCT00699608|473192227|FG002|Second Intervention|Withdrawal by Subject|0|||
131428603|NCT00699608|473192228|FG003|Second Intervention|Withdrawal by Subject|1|||
131428604|NCT00699608|473192229|FG004|Second Intervention|Withdrawal by Subject|0|||
131428605|NCT00699608|473192230|FG005|Second Intervention|Withdrawal by Subject|0|||
131428606|NCT02828436|473192231|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
131428607|NCT02828436|473192232|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
131428608|NCT02828436|473192231|FG000|Period 1|Lost to Follow-up|0|||
131428609|NCT02828436|473192232|FG001|Period 1|Lost to Follow-up|1|||
131428610|NCT02828436|473192231|FG000|Period 2|Withdrawal by Subject|4|||
131428611|NCT02828436|473192232|FG001|Period 2|Withdrawal by Subject|0|||
131428612|NCT02828436|473192231|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
131428613|NCT02828436|473192232|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
131428614|NCT02828436|473192231|FG000|Period 2|Lost to Follow-up|1|||
131428615|NCT02828436|473192232|FG001|Period 2|Lost to Follow-up|0|||
131428616|NCT01136408|473192233|FG000|Overall Study|Adverse Event|4|||
131428617|NCT01136408|473192234|FG001|Overall Study|Adverse Event|8|||
131428618|NCT01136408|473192235|FG002|Overall Study|Adverse Event|4|||
131428619|NCT01136408|473192233|FG000|Overall Study|Protocol Violation|1|||
131428620|NCT01136408|473192234|FG001|Overall Study|Protocol Violation|1|||
131428621|NCT01136408|473192235|FG002|Overall Study|Protocol Violation|1|||
131428622|NCT03078556|473192240|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
131428623|NCT03078556|473192241|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
131428624|NCT03078556|473192242|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
131428625|NCT03078556|473192243|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
131428626|NCT03078556|473192240|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
131428627|NCT03078556|473192241|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
131428628|NCT03078556|473192242|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
131428629|NCT03078556|473192243|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
131428630|NCT03078556|473192240|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
131428631|NCT03078556|473192241|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
131428632|NCT03078556|473192242|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
131428633|NCT03078556|473192243|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
131428634|NCT03078556|473192240|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
131428635|NCT03078556|473192241|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
131428636|NCT03078556|473192242|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
131428637|NCT03078556|473192243|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
131428638|NCT04421482|473192244|FG000|Overall Study|Physician Decision|1|||
131428639|NCT03010319|473192247|FG000|Overall Study|Adverse Event|15|||
131428640|NCT03010319|473192248|FG001|Overall Study|Adverse Event|9|||
131428641|NCT03010319|473192247|FG000|Overall Study|Withdrawal by Subject|1|||
131428642|NCT03010319|473192248|FG001|Overall Study|Withdrawal by Subject|6|||
131428643|NCT03010319|473192247|FG000|Overall Study|Physician Decision|2|||
131428644|NCT03010319|473192248|FG001|Overall Study|Physician Decision|4|||
131428645|NCT03010319|473192247|FG000|Overall Study|Sponsor requested withdrawal|2|||
131428646|NCT03010319|473192248|FG001|Overall Study|Sponsor requested withdrawal|2|||
131428647|NCT03010319|473192247|FG000|Overall Study|Death|1|||
131428648|NCT03010319|473192248|FG001|Overall Study|Death|0|||
131428649|NCT03010319|473192247|FG000|Overall Study|Lost to Follow-up|0|||
131428650|NCT03010319|473192248|FG001|Overall Study|Lost to Follow-up|1|||
131428651|NCT03010319|473192247|FG000|Overall Study|Other Reason|5|||
131428652|NCT03010319|473192248|FG001|Overall Study|Other Reason|7|||
131428653|NCT02128724|473192249|FG000|Overall Study|Death|1|||
131428654|NCT02128724|473192250|FG001|Overall Study|Death|0|||
131428655|NCT02128724|473192251|FG002|Overall Study|Death|0|||
131428656|NCT02128724|473192252|FG003|Overall Study|Death|0|||
131428657|NCT02128724|473192249|FG000|Overall Study|Adverse Event|0|||
131428658|NCT02128724|473192250|FG001|Overall Study|Adverse Event|1|||
131428659|NCT02128724|473192251|FG002|Overall Study|Adverse Event|0|||
131428660|NCT02128724|473192252|FG003|Overall Study|Adverse Event|0|||
131428661|NCT02128724|473192249|FG000|Overall Study|Physician Decision|0|||
131428662|NCT02128724|473192250|FG001|Overall Study|Physician Decision|0|||
131428663|NCT02128724|473192251|FG002|Overall Study|Physician Decision|0|||
131428664|NCT02128724|473192252|FG003|Overall Study|Physician Decision|2|||
131428665|NCT02128724|473192249|FG000|Overall Study|Withdrawal by Subject|0|||
131428666|NCT02128724|473192250|FG001|Overall Study|Withdrawal by Subject|0|||
131428667|NCT02128724|473192251|FG002|Overall Study|Withdrawal by Subject|0|||
131428668|NCT02128724|473192252|FG003|Overall Study|Withdrawal by Subject|1|||
131428669|NCT03329092|473192253|FG000|Overall Study|Other|2|||
131428670|NCT03329092|473192254|FG001|Overall Study|Other|2|||
131428671|NCT03329092|473192253|FG000|Overall Study|Withdrawal by Subject|16|||
131428672|NCT03329092|473192254|FG001|Overall Study|Withdrawal by Subject|3|||
131428673|NCT03329092|473192253|FG000|Overall Study|Physician Decision|1|||
131428674|NCT03329092|473192254|FG001|Overall Study|Physician Decision|0|||
131428675|NCT03329092|473192253|FG000|Overall Study|Death|17|||
131428676|NCT03329092|473192254|FG001|Overall Study|Death|11|||
131428677|NCT03329092|473192253|FG000|Overall Study|Adverse Event|3|||
131428678|NCT03329092|473192254|FG001|Overall Study|Adverse Event|1|||
131428679|NCT03329092|473192253|FG000|Overall Study|Lost to Follow-up|1|||
131428680|NCT03329092|473192254|FG001|Overall Study|Lost to Follow-up|1|||
131458427|NCT01065454|473308929|FG002|Follow up|Death|1|||
131428681|NCT05786508|473192255|FG000|Overall Study|Withdrawal by Subject|2|||
131428682|NCT05786508|473192256|FG001|Overall Study|Withdrawal by Subject|0|||
131428683|NCT02292446|473192257|FG000|Overall Study|Adverse Event|12|||
131428684|NCT02292446|473192257|FG000|Overall Study|Death|1|||
131428685|NCT02292446|473192257|FG000|Overall Study|Disease progression|2|||
131428686|NCT02292446|473192257|FG000|Overall Study|Subject/guardian decision|2|||
131428687|NCT02292446|473192257|FG000|Overall Study|Withdrawal by Subject|3|||
131428688|NCT00496080|473192260|FG000|Overall Study|Lost to Follow-up|9|||
131428689|NCT00496080|473192260|FG000|Overall Study|Surgical re-intervention|7|||
131428690|NCT00496080|473192260|FG000|Overall Study|Withdrawal by Subject|5|||
131428691|NCT00496080|473192260|FG000|Overall Study|Physician Decision|6|||
131428692|NCT00887549|473192261|FG000|Induction Therapy|Adverse Event|8|||
131428693|NCT00887549|473192261|FG000|Induction Therapy|Physician Decision|1|||
131428694|NCT00887549|473192261|FG000|Induction Therapy|Progressive Disease|13|||
131428695|NCT00887549|473192261|FG000|Induction Therapy|Death due to Study Disease|4|||
131428696|NCT00887549|473192261|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
131428697|NCT00887549|473192261|FG000|Maintenance Therapy|Adverse Event|16|||
131428698|NCT00887549|473192261|FG000|Maintenance Therapy|Physician Decision|1|||
131428699|NCT00887549|473192261|FG000|Maintenance Therapy|Progressive Disease|25|||
131428700|NCT00887549|473192261|FG000|Maintenance Therapy|Death due to adverse event|1|||
131428701|NCT04112303|473192263|FG000|Overall Study|Death|1|||
131428702|NCT03472950|473192265|FG000|Overall Study|Lost to Follow-up|0|||
131428703|NCT03472950|473192266|FG001|Overall Study|Lost to Follow-up|1|||
131428704|NCT03472950|473192265|FG000|Overall Study|Adverse Event|0|||
131428705|NCT03472950|473192266|FG001|Overall Study|Adverse Event|3|||
131428706|NCT05636852|473192277|FG000|Overall Study|Withdrawal by Subject|1|||
131428707|NCT05636852|473192277|FG000|Overall Study|Other than specified|1|||
131428708|NCT00377858|473192278|FG000|Overall Study|Withdrawal by Subject|12|||
131428709|NCT00377858|473192279|FG001|Overall Study|Withdrawal by Subject|11|||
131428710|NCT00377858|473192278|FG000|Overall Study|Lost to Follow-up|6|||
131428711|NCT00377858|473192279|FG001|Overall Study|Lost to Follow-up|1|||
131428712|NCT00377858|473192278|FG000|Overall Study|Physician Decision|5|||
131428713|NCT00377858|473192279|FG001|Overall Study|Physician Decision|5|||
131428714|NCT00377858|473192278|FG000|Overall Study|Protocol Violation|3|||
131428715|NCT00377858|473192279|FG001|Overall Study|Protocol Violation|4|||
131428716|NCT00377858|473192278|FG000|Overall Study|Adverse Event|2|||
131428717|NCT00377858|473192279|FG001|Overall Study|Adverse Event|1|||
131428718|NCT00377858|473192278|FG000|Overall Study|Entry Criteria Not Met|2|||
131428719|NCT00377858|473192279|FG001|Overall Study|Entry Criteria Not Met|0|||
131428720|NCT00377858|473192278|FG000|Overall Study|Sponsor Decision|1|||
131428721|NCT00377858|473192279|FG001|Overall Study|Sponsor Decision|2|||
131428722|NCT00377858|473192278|FG000|Overall Study|Death|0|||
131428723|NCT00377858|473192279|FG001|Overall Study|Death|3|||
131428724|NCT01076036|473192280|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
131428725|NCT00195091|473192281|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
131428726|NCT04034004|473192286|FG000|Overall Study|Withdrawal by Subject|1|||
131428727|NCT04034004|473192287|FG001|Overall Study|Withdrawal by Subject|2|||
131428728|NCT04034004|473192288|FG002|Overall Study|Withdrawal by Subject|2|||
131428729|NCT04034004|473192289|FG003|Overall Study|Withdrawal by Subject|3|||
131428730|NCT04034004|473192286|FG000|Overall Study|could not find vein to administer IV|2|||
131428731|NCT04034004|473192287|FG001|Overall Study|could not find vein to administer IV|1|||
131428732|NCT04034004|473192288|FG002|Overall Study|could not find vein to administer IV|0|||
131428733|NCT04034004|473192289|FG003|Overall Study|could not find vein to administer IV|0|||
131428734|NCT04034004|473192286|FG000|Overall Study|nurse accidentally unblinded subject|0|||
131428735|NCT04034004|473192287|FG001|Overall Study|nurse accidentally unblinded subject|0|||
131428736|NCT04034004|473192288|FG002|Overall Study|nurse accidentally unblinded subject|0|||
131428737|NCT04034004|473192289|FG003|Overall Study|nurse accidentally unblinded subject|1|||
131428738|NCT01502228|473192299|FG000|Overall Study|Death|1|||
131428739|NCT06964165|473192300|FG000|Overall Study|Withdrawal by Subject|0|||
131428740|NCT06964165|473192301|FG001|Overall Study|Withdrawal by Subject|1|||
131428741|NCT06964165|473192300|FG000|Overall Study|Ongoing at the time of analysis|15|||
131428742|NCT06964165|473192301|FG001|Overall Study|Ongoing at the time of analysis|14|||
131428743|NCT06964165|473192300|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
131428744|NCT06964165|473192301|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
131428745|NCT06964165|473192300|FG000|Overall Study|Participant removed due to non-compliance|0|||
131428746|NCT06964165|473192301|FG001|Overall Study|Participant removed due to non-compliance|1|||
131428747|NCT01587040|473192304|FG000|Overall Study|Protocol Violation|0|||
131428748|NCT01587040|473192305|FG001|Overall Study|Protocol Violation|0|||
131428749|NCT01587040|473192306|FG002|Overall Study|Protocol Violation|1|||
131428750|NCT01587040|473192307|FG003|Overall Study|Protocol Violation|0|||
131428751|NCT01587040|473192304|FG000|Overall Study|Adverse Event|0|||
131428752|NCT01587040|473192305|FG001|Overall Study|Adverse Event|1|||
131428753|NCT01587040|473192306|FG002|Overall Study|Adverse Event|10|||
131428754|NCT01587040|473192307|FG003|Overall Study|Adverse Event|0|||
131428755|NCT01587040|473192304|FG000|Overall Study|Disease progression|12|||
131428756|NCT01587040|473192305|FG001|Overall Study|Disease progression|1|||
131428757|NCT01587040|473192306|FG002|Overall Study|Disease progression|15|||
131428758|NCT01587040|473192307|FG003|Overall Study|Disease progression|3|||
131428759|NCT01587040|473192304|FG000|Overall Study|Other than specified|5|||
131428760|NCT01587040|473192305|FG001|Overall Study|Other than specified|1|||
131428761|NCT01587040|473192306|FG002|Overall Study|Other than specified|11|||
131428762|NCT01587040|473192307|FG003|Overall Study|Other than specified|1|||
131428763|NCT01518374|473192310|FG000|Overall Study|Withdrawal by Subject|2|||
131428764|NCT01518374|473192310|FG000|Overall Study|Protocol Violation|3|||
131428765|NCT01518374|473192310|FG000|Overall Study|Lost to Follow-up|2|||
131428766|NCT04300309|473192311|FG000|Overall Study|Lost to Follow-up|1|||
131428767|NCT04300309|473192312|FG001|Overall Study|Lost to Follow-up|0|||
131428768|NCT04607837|473192315|FG000|Overall Study|Adverse Event|8|||
131428769|NCT04607837|473192316|FG001|Overall Study|Adverse Event|2|||
131428770|NCT04607837|473192315|FG000|Overall Study|Withdrawal by Subject|8|||
131428771|NCT04607837|473192316|FG001|Overall Study|Withdrawal by Subject|7|||
131428772|NCT04607837|473192315|FG000|Overall Study|Physician Decision|2|||
131428773|NCT04607837|473192316|FG001|Overall Study|Physician Decision|0|||
131428774|NCT04607837|473192315|FG000|Overall Study|Lack of Efficacy|2|||
131428775|NCT04607837|473192316|FG001|Overall Study|Lack of Efficacy|0|||
131428776|NCT04607837|473192315|FG000|Overall Study|Participant terminated by sponsor|1|||
131428777|NCT04607837|473192316|FG001|Overall Study|Participant terminated by sponsor|0|||
131428778|NCT04607837|473192315|FG000|Overall Study|Disease worsening|36|||
131428779|NCT04607837|473192316|FG001|Overall Study|Disease worsening|36|||
131428780|NCT04607837|473192315|FG000|Overall Study|Other|1|||
131428781|NCT04607837|473192316|FG001|Overall Study|Other|0|||
131428782|NCT02362464|473192317|FG000|Overall Study|Switched to alternative therapy|1|||
131428783|NCT02362464|473192317|FG000|Overall Study|Refused further treatment|1|||
131428784|NCT02362464|473192317|FG000|Overall Study|Physician Decision|4|||
131428785|NCT04346654|473192318|FG000|Overall Study|Adverse Event|2|||
131428786|NCT04346654|473192319|FG001|Overall Study|Adverse Event|0|||
131428787|NCT04346654|473192318|FG000|Overall Study|Non-response|1|||
131428788|NCT04346654|473192319|FG001|Overall Study|Non-response|1|||
131428789|NCT04346654|473192318|FG000|Overall Study|Withdrawal by Subject|2|||
131428790|NCT04346654|473192319|FG001|Overall Study|Withdrawal by Subject|0|||
131428791|NCT04346654|473192318|FG000|Overall Study|Lost to Follow-up|0|||
131428792|NCT04346654|473192319|FG001|Overall Study|Lost to Follow-up|1|||
131428793|NCT04346654|473192318|FG000|Overall Study|Pregnancy|0|||
131428794|NCT04346654|473192319|FG001|Overall Study|Pregnancy|1|||
131428795|NCT04209205|473192320|FG000|Overall Study|Adverse Event|2|||
131428796|NCT04209205|473192321|FG001|Overall Study|Adverse Event|3|||
131428797|NCT04209205|473192320|FG000|Overall Study|Lost to Follow-up|3|||
131428798|NCT04209205|473192321|FG001|Overall Study|Lost to Follow-up|1|||
131428799|NCT04209205|473192320|FG000|Overall Study|Physician Decision|1|||
131428800|NCT04209205|473192321|FG001|Overall Study|Physician Decision|1|||
131428801|NCT04209205|473192320|FG000|Overall Study|Subject decision|10|||
131428802|NCT04209205|473192321|FG001|Overall Study|Subject decision|10|||
131428803|NCT04209205|473192320|FG000|Overall Study|Progressive disease|1|||
131428804|NCT04209205|473192321|FG001|Overall Study|Progressive disease|0|||
131428805|NCT04209205|473192320|FG000|Overall Study|Protocol deviation|0|||
131428806|NCT04209205|473192321|FG001|Overall Study|Protocol deviation|1|||
131428807|NCT04209205|473192320|FG000|Overall Study|New therapy for study indication|1|||
131428808|NCT04209205|473192321|FG001|Overall Study|New therapy for study indication|0|||
131428809|NCT04209205|473192320|FG000|Overall Study|Adverse event - placebo not switched|0|||
131428810|NCT04209205|473192321|FG001|Overall Study|Adverse event - placebo not switched|1|||
131428811|NCT04209205|473192320|FG000|Overall Study|Subject decision - placebo not switched|0|||
131428812|NCT04209205|473192321|FG001|Overall Study|Subject decision - placebo not switched|5|||
131428813|NCT04209205|473192320|FG000|Overall Study|Death - placebo not switched|0|||
131428814|NCT04209205|473192321|FG001|Overall Study|Death - placebo not switched|1|||
131428815|NCT04752332|473192322|FG000|Overall Study|Adverse Event|3|||
131428816|NCT04752332|473192323|FG001|Overall Study|Adverse Event|1|||
131428817|NCT04752332|473192322|FG000|Overall Study|Disease Relapse|1|||
131428818|NCT04752332|473192323|FG001|Overall Study|Disease Relapse|0|||
131428819|NCT04752332|473192322|FG000|Overall Study|Non-compliance With Study Drug|2|||
131428820|NCT04752332|473192323|FG001|Overall Study|Non-compliance With Study Drug|0|||
131428821|NCT04752332|473192322|FG000|Overall Study|Physician Decision|2|||
131428822|NCT04752332|473192323|FG001|Overall Study|Physician Decision|1|||
131428823|NCT04752332|473192322|FG000|Overall Study|Protocol Violation|1|||
131428824|NCT04752332|473192323|FG001|Overall Study|Protocol Violation|1|||
131428825|NCT04752332|473192322|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
131428826|NCT04752332|473192323|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
131428827|NCT04752332|473192322|FG000|Overall Study|Study Terminated by Sponsor|10|||
131428828|NCT04752332|473192323|FG001|Overall Study|Study Terminated by Sponsor|48|||
131428829|NCT04752332|473192322|FG000|Overall Study|Withdrawal by Subject|11|||
131428830|NCT04752332|473192323|FG001|Overall Study|Withdrawal by Subject|3|||
131428831|NCT02915978|473192324|FG000|Overall Study|Adverse Event|2|||
131428832|NCT02915978|473192325|FG001|Overall Study|Adverse Event|1|||
131428833|NCT02915978|473192326|FG002|Overall Study|Adverse Event|0|||
131428834|NCT00048347|473192330|FG000|Overall Study|Screen failure|2|||
131428835|NCT02451124|473192331|FG000|Overall Study|Withdrawal by Subject|1|||
131428836|NCT00555217|473192332|FG000|Overall Study|Withdrawal by Subject|35|||
131428837|NCT00555217|473192333|FG001|Overall Study|Withdrawal by Subject|31|||
131428838|NCT00555217|473192332|FG000|Overall Study|Lost to Follow-up|19|||
131428839|NCT00555217|473192333|FG001|Overall Study|Lost to Follow-up|20|||
131428840|NCT00555217|473192332|FG000|Overall Study|close out sites|21|||
131428841|NCT00555217|473192333|FG001|Overall Study|close out sites|17|||
131428842|NCT01868477|473192334|FG000|Overall Study|Adverse Event|2|||
131428843|NCT01868477|473192335|FG001|Overall Study|Adverse Event|4|||
131428844|NCT01868477|473192334|FG000|Overall Study|Disease progression|1|||
131428845|NCT01868477|473192335|FG001|Overall Study|Disease progression|1|||
131428846|NCT01868477|473192334|FG000|Overall Study|Withdrawal by Subject|1|||
131428847|NCT01868477|473192335|FG001|Overall Study|Withdrawal by Subject|0|||
131428848|NCT00367835|473192338|FG000|Overall Study|Adverse Event|14|||
131428849|NCT00367835|473192339|FG001|Overall Study|Adverse Event|1|||
131428850|NCT00367835|473192338|FG000|Overall Study|Protocol Violation|1|||
131428851|NCT00367835|473192339|FG001|Overall Study|Protocol Violation|7|||
131428852|NCT00367835|473192338|FG000|Overall Study|Withdrawal by Subject|7|||
131428853|NCT00367835|473192339|FG001|Overall Study|Withdrawal by Subject|6|||
131428854|NCT00367835|473192338|FG000|Overall Study|Lost to Follow-up|1|||
131428855|NCT00367835|473192339|FG001|Overall Study|Lost to Follow-up|4|||
131428856|NCT00367835|473192338|FG000|Overall Study|Lack of Efficacy|3|||
131428857|NCT00367835|473192339|FG001|Overall Study|Lack of Efficacy|12|||
131428858|NCT00367835|473192338|FG000|Overall Study|Subject in juvenile detention center|1|||
131428859|NCT00367835|473192339|FG001|Overall Study|Subject in juvenile detention center|0|||
131428860|NCT00367835|473192338|FG000|Overall Study|refused blood collection|1|||
131428861|NCT00367835|473192339|FG001|Overall Study|refused blood collection|0|||
131428862|NCT00367835|473192338|FG000|Overall Study|Did not respond to calls|1|||
131428863|NCT00367835|473192339|FG001|Overall Study|Did not respond to calls|0|||
131428864|NCT00367835|473192338|FG000|Overall Study|History of lead poisoning|0|||
131428865|NCT00367835|473192339|FG001|Overall Study|History of lead poisoning|1|||
131428866|NCT03761810|473192341|FG000|Overall Study|Adverse Event|12|||
131428867|NCT03761810|473192342|FG001|Overall Study|Adverse Event|0|||
131428868|NCT03761810|473192341|FG000|Overall Study|Lost to Follow-up|15|||
131428869|NCT03761810|473192342|FG001|Overall Study|Lost to Follow-up|7|||
131428870|NCT03761810|473192341|FG000|Overall Study|Pregnancy|1|||
131428871|NCT03761810|473192342|FG001|Overall Study|Pregnancy|0|||
131428872|NCT03761810|473192341|FG000|Overall Study|Withdrawal by Subject|14|||
131428873|NCT03761810|473192342|FG001|Overall Study|Withdrawal by Subject|5|||
131428874|NCT03761810|473192341|FG000|Overall Study|Physician Decision|1|||
131428875|NCT03761810|473192342|FG001|Overall Study|Physician Decision|0|||
131428876|NCT03761810|473192341|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
131428877|NCT03761810|473192342|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131428878|NCT03761810|473192341|FG000|Overall Study|Other Than Specified|1|||
131428879|NCT03761810|473192342|FG001|Overall Study|Other Than Specified|0|||
131428880|NCT01574651|473192343|FG000|Overall Study|Lost to Follow-up|2|||
131428881|NCT01574651|473192344|FG001|Overall Study|Lost to Follow-up|4|||
131428882|NCT01574651|473192343|FG000|Overall Study|Administrative problems|0|||
131428883|NCT01574651|473192344|FG001|Overall Study|Administrative problems|1|||
131428884|NCT01574651|473192343|FG000|Overall Study|Death|3|||
131428885|NCT01574651|473192344|FG001|Overall Study|Death|3|||
131428886|NCT01574651|473192343|FG000|Overall Study|Patient's inability to use the device|0|||
131428887|NCT01574651|473192344|FG001|Overall Study|Patient's inability to use the device|1|||
131428888|NCT01574651|473192343|FG000|Overall Study|Adverse Event|36|||
131428889|NCT01574651|473192344|FG001|Overall Study|Adverse Event|27|||
131428890|NCT01574651|473192343|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131428891|NCT01574651|473192344|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131428892|NCT01574651|473192343|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131428893|NCT01574651|473192344|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131428894|NCT01574651|473192343|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
131428895|NCT01574651|473192344|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131428896|NCT01574651|473192343|FG000|Overall Study|Protocol Violation|3|||
131428897|NCT01574651|473192344|FG001|Overall Study|Protocol Violation|5|||
131428898|NCT01574651|473192343|FG000|Overall Study|Withdrawal by Subject|9|||
131428899|NCT01574651|473192344|FG001|Overall Study|Withdrawal by Subject|10|||
131428900|NCT01807299|473192346|FG000|Overall Study|Protocol Violation|3|||
131428901|NCT01807299|473192347|FG001|Overall Study|Protocol Violation|1|||
131428902|NCT01807299|473192348|FG002|Overall Study|Protocol Violation|0|||
131428903|NCT01807299|473192349|FG003|Overall Study|Protocol Violation|2|||
131428904|NCT00811174|473192350|FG000|Overall Study|Protocol Violation|2|||
131428905|NCT00811174|473192350|FG000|Overall Study|Sponsors Decision|1|||
131428906|NCT01392547|473193709|FG000|Overall Study|Adverse Event|2|||
131428907|NCT01392547|473193709|FG000|Overall Study|Non-compliance|2|||
131428908|NCT01392547|473193709|FG000|Overall Study|Withdrawal criteria|3|||
131428909|NCT01392547|473193709|FG000|Overall Study|Unclassified|1|||
131428910|NCT02936635|473193710|FG000|Overall Study|Adverse Event|43|||
131428911|NCT02936635|473193711|FG001|Overall Study|Adverse Event|25|||
131428912|NCT02936635|473193710|FG000|Overall Study|Progressive Disease|10|||
131428913|NCT02936635|473193711|FG001|Overall Study|Progressive Disease|18|||
131428914|NCT02936635|473193710|FG000|Overall Study|Sponsor Discretion|10|||
131428915|NCT02936635|473193711|FG001|Overall Study|Sponsor Discretion|16|||
131428916|NCT02936635|473193710|FG000|Overall Study|Death|9|||
131428917|NCT02936635|473193711|FG001|Overall Study|Death|15|||
131428918|NCT02936635|473193710|FG000|Overall Study|Withdrawal by Subject|8|||
131428919|NCT02936635|473193711|FG001|Overall Study|Withdrawal by Subject|15|||
131428920|NCT02936635|473193710|FG000|Overall Study|Physician Decision|2|||
131428921|NCT02936635|473193711|FG001|Overall Study|Physician Decision|9|||
131428922|NCT02936635|473193710|FG000|Overall Study|Lost to Follow-up|1|||
131428923|NCT02936635|473193711|FG001|Overall Study|Lost to Follow-up|2|||
131428924|NCT02936635|473193710|FG000|Overall Study|Protocol Violation|1|||
131428925|NCT02936635|473193711|FG001|Overall Study|Protocol Violation|0|||
131428926|NCT02936635|473193710|FG000|Overall Study|Lack of effect/Entry into other study|31|||
131428927|NCT02936635|473193711|FG001|Overall Study|Lack of effect/Entry into other study|65|||
131428928|NCT02407223|473193712|FG000|Overall Study|Adverse Event|1|||
131428929|NCT02407223|473193713|FG001|Overall Study|Adverse Event|0|||
131428930|NCT02407223|473193714|FG002|Overall Study|Adverse Event|1|||
131428931|NCT02407223|473193712|FG000|Overall Study|Lack of Efficacy|6|||
131428932|NCT02407223|473193713|FG001|Overall Study|Lack of Efficacy|6|||
131428933|NCT02407223|473193714|FG002|Overall Study|Lack of Efficacy|4|||
131428934|NCT02407223|473193712|FG000|Overall Study|Lost to Follow-up|1|||
131428935|NCT02407223|473193713|FG001|Overall Study|Lost to Follow-up|0|||
131428936|NCT02407223|473193714|FG002|Overall Study|Lost to Follow-up|2|||
131428937|NCT02407223|473193712|FG000|Overall Study|Withdrawal by Subject|2|||
131428938|NCT02407223|473193713|FG001|Overall Study|Withdrawal by Subject|4|||
131428939|NCT02407223|473193714|FG002|Overall Study|Withdrawal by Subject|4|||
131428940|NCT02407223|473193712|FG000|Overall Study|Study Terminated by Sponsor|77|||
131428941|NCT02407223|473193713|FG001|Overall Study|Study Terminated by Sponsor|80|||
131428942|NCT02407223|473193714|FG002|Overall Study|Study Terminated by Sponsor|86|||
131428943|NCT02407223|473193712|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
131428944|NCT02407223|473193713|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
131428945|NCT02407223|473193714|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
131428946|NCT02407223|473193712|FG000|Overall Study|Other|29|||
131428947|NCT02407223|473193713|FG001|Overall Study|Other|27|||
131428948|NCT02407223|473193714|FG002|Overall Study|Other|25|||
131428949|NCT04775953|473193715|FG000|Overall Study|Lost to Follow-up|6|||
131428950|NCT04775953|473193716|FG001|Overall Study|Lost to Follow-up|11|||
131428951|NCT04775953|473193715|FG000|Overall Study|Death|5|||
131428952|NCT04775953|473193716|FG001|Overall Study|Death|4|||
131428953|NCT04775953|473193715|FG000|Overall Study|Withdrawal by Subject|3|||
131428954|NCT04775953|473193716|FG001|Overall Study|Withdrawal by Subject|3|||
131428955|NCT04775953|473193715|FG000|Overall Study|Protocol Violation|2|||
131428956|NCT04775953|473193716|FG001|Overall Study|Protocol Violation|0|||
131428957|NCT04775953|473193715|FG000|Overall Study|Participant non-compliance|0|||
131428958|NCT04775953|473193716|FG001|Overall Study|Participant non-compliance|1|||
131428959|NCT02451943|473193722|FG000|Overall Study|Withdrawal by Subject|13|||
131428960|NCT02451943|473193723|FG001|Overall Study|Withdrawal by Subject|16|||
131428961|NCT02451943|473193722|FG000|Overall Study|Lost to Follow-up|3|||
131428962|NCT02451943|473193723|FG001|Overall Study|Lost to Follow-up|4|||
131428963|NCT02451943|473193722|FG000|Overall Study|Sponsor Decision|0|||
131428964|NCT02451943|473193723|FG001|Overall Study|Sponsor Decision|4|||
131428965|NCT01442714|473193725|FG000|Overall Study|Death|11|||
131428966|NCT01442714|473193725|FG000|Overall Study|Withdrawal by Subject|1|||
131428967|NCT04306510|473193726|FG000|Overall Study|Voluntarily withdrawal|1|||
131428968|NCT04306510|473193726|FG000|Overall Study|Enrolled but Not Treated|1|||
131428969|NCT04720417|473193727|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
131428970|NCT03314987|473193728|FG000|Overall Study|Lost to Follow-up|13|||
131428971|NCT03314987|473193729|FG001|Overall Study|Lost to Follow-up|13|||
131428972|NCT02751580|473193730|FG000|Overall Study|Lost to Follow-up|4|||
131428973|NCT02751580|473193730|FG000|Overall Study|Death|2|||
131428974|NCT04829916|473193736|FG000|Overall Study|Withdrawal by Subject|1|||
131428975|NCT04829916|473193737|FG001|Overall Study|Withdrawal by Subject|0|||
131428976|NCT02152761|473193744|FG000|Epoch: Treatment Epoch|Technical problems|0|||
131428977|NCT02152761|473193745|FG001|Epoch: Treatment Epoch|Technical problems|0|||
131428978|NCT02152761|473193746|FG002|Epoch: Treatment Epoch|Technical problems|0|||
131428979|NCT02152761|473193747|FG003|Epoch: Treatment Epoch|Technical problems|1|||
131428980|NCT02152761|473193744|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
131428981|NCT02152761|473193745|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
131428982|NCT02152761|473193746|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
131428983|NCT02152761|473193747|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
131428984|NCT02152761|473193744|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
131428985|NCT02152761|473193745|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
131428986|NCT02152761|473193746|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
131428987|NCT02152761|473193747|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
131428988|NCT02152761|473193744|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
131428989|NCT02152761|473193745|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
131428990|NCT02152761|473193746|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
131428991|NCT02152761|473193747|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
131428992|NCT02152761|473193744|FG000|Epoch: Treatment Epoch|Death|0|||
131428993|NCT02152761|473193745|FG001|Epoch: Treatment Epoch|Death|3|||
131428994|NCT02152761|473193746|FG002|Epoch: Treatment Epoch|Death|1|||
131428995|NCT02152761|473193747|FG003|Epoch: Treatment Epoch|Death|0|||
131428996|NCT02152761|473193744|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
131428997|NCT02152761|473193745|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
131428998|NCT02152761|473193746|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
131428999|NCT02152761|473193747|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
131429000|NCT02152761|473193744|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
131429001|NCT02152761|473193745|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
131429002|NCT02152761|473193746|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
131429003|NCT02152761|473193747|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
131429004|NCT02152761|473193744|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
131429005|NCT02152761|473193745|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
131429006|NCT02152761|473193746|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
131429007|NCT02152761|473193747|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
131429008|NCT02152761|473193744|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
131429009|NCT02152761|473193745|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
131429010|NCT02152761|473193746|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
131429011|NCT02152761|473193747|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
131429012|NCT02152761|473193744|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
131429013|NCT02152761|473193745|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
131429014|NCT02152761|473193746|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
131429015|NCT02152761|473193747|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
131429016|NCT04343755|473193748|FG000|Overall Study|Death|11|||
131429017|NCT04343755|473193748|FG000|Overall Study|Screen Failure|1|||
131429018|NCT03755882|473193749|FG000|Period 1|Protocol Violation|1|||
131429019|NCT03755882|473193750|FG001|Period 1|Protocol Violation|0|||
131429020|NCT03755882|473193749|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
131429021|NCT03755882|473193750|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
131429022|NCT00570310|473193754|FG000|Overall Study|Adverse Event|1|||
131429023|NCT00570310|473193755|FG001|Overall Study|Adverse Event|2|||
131429024|NCT00570310|473193754|FG000|Overall Study|Lack of Efficacy|1|||
131429025|NCT00570310|473193755|FG001|Overall Study|Lack of Efficacy|4|||
131429026|NCT03088917|473193756|FG000|Overall Study|In care/cured elsewhere|15|||
131429027|NCT03088917|473193756|FG000|Overall Study|Refuse re-evaluation|13|||
131429028|NCT03088917|473193756|FG000|Overall Study|Contact not established|13|||
131429029|NCT03088917|473193756|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
131429030|NCT03088917|473193756|FG000|Overall Study|Moved outside study region|50|||
131429031|NCT01345188|473193757|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
131429032|NCT01345188|473193757|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
131429033|NCT05150990|473193758|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
131429034|NCT05150990|473193759|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
131429035|NCT05150990|473193758|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
131429036|NCT05150990|473193759|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
131429037|NCT05150990|473193758|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
131429038|NCT05150990|473193759|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
131429039|NCT05150990|473193758|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
131429040|NCT05150990|473193759|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
131429041|NCT05150990|473193758|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
131429042|NCT05150990|473193759|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
131429043|NCT05150990|473193758|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
131429044|NCT05150990|473193759|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
131429045|NCT05150990|473193758|FG000|Overall Study|Death (unrelated to the intervention)|1|||
131429046|NCT05150990|473193759|FG001|Overall Study|Death (unrelated to the intervention)|2|||
131429047|NCT00466921|473193760|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
131429048|NCT00466921|473193760|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
131429049|NCT00466921|473193760|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
131429050|NCT00466921|473193760|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
131429051|NCT00466921|473193760|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
131429052|NCT00466921|473193760|FG000|Follow up for a Minimum of 1 Year|Death|6|||
131429053|NCT01397461|473193762|FG000|Overall Study|Withdrawal by Subject|2|||
131429054|NCT01397461|473193763|FG001|Overall Study|Withdrawal by Subject|1|||
131429055|NCT01397461|473193764|FG002|Overall Study|Withdrawal by Subject|0|||
131429056|NCT01397461|473193762|FG000|Overall Study|Lost to Follow-up|0|||
131429057|NCT01397461|473193763|FG001|Overall Study|Lost to Follow-up|2|||
131429058|NCT01397461|473193764|FG002|Overall Study|Lost to Follow-up|1|||
131429059|NCT01397461|473193762|FG000|Overall Study|Lack of Efficacy|0|||
131429060|NCT01397461|473193763|FG001|Overall Study|Lack of Efficacy|3|||
131429061|NCT01397461|473193764|FG002|Overall Study|Lack of Efficacy|0|||
131429062|NCT01397461|473193762|FG000|Overall Study|Not treated|0|||
131429063|NCT01397461|473193763|FG001|Overall Study|Not treated|0|||
131429064|NCT01397461|473193764|FG002|Overall Study|Not treated|1|||
131429065|NCT05729568|473193781|FG000|Overall Study|Still on Study|52|||
131429066|NCT05729568|473193782|FG001|Overall Study|Still on Study|26|||
131429067|NCT05729568|473193781|FG000|Overall Study|Randomized but Never Treated|3|||
131429068|NCT05729568|473193782|FG001|Overall Study|Randomized but Never Treated|0|||
131429069|NCT05729568|473193781|FG000|Overall Study|Adverse Event|0|||
131429070|NCT05729568|473193782|FG001|Overall Study|Adverse Event|1|||
131429071|NCT05729568|473193781|FG000|Overall Study|Investigator's Discretion|1|||
131429072|NCT05729568|473193782|FG001|Overall Study|Investigator's Discretion|0|||
131429073|NCT04181762|473193783|FG000|Overall Study|Adverse Event|1|||
131429074|NCT04181762|473193784|FG001|Overall Study|Adverse Event|3|||
131429075|NCT04181762|473193783|FG000|Overall Study|Lost to Follow-up|1|||
131429076|NCT04181762|473193784|FG001|Overall Study|Lost to Follow-up|1|||
131429077|NCT04181762|473193783|FG000|Overall Study|Physician Decision|1|||
131429078|NCT04181762|473193784|FG001|Overall Study|Physician Decision|3|||
131429079|NCT04181762|473193783|FG000|Overall Study|Pregnancy|0|||
131429080|NCT04181762|473193784|FG001|Overall Study|Pregnancy|1|||
131429081|NCT04181762|473193783|FG000|Overall Study|Lack of Efficacy|2|||
131429082|NCT04181762|473193784|FG001|Overall Study|Lack of Efficacy|2|||
131429083|NCT04181762|473193783|FG000|Overall Study|Study terminated by sponsor|95|||
131429084|NCT04181762|473193784|FG001|Overall Study|Study terminated by sponsor|97|||
131429085|NCT04181762|473193783|FG000|Overall Study|Subject decision|11|||
131429086|NCT04181762|473193784|FG001|Overall Study|Subject decision|4|||
131429087|NCT04181762|473193783|FG000|Overall Study|Death|1|||
131429088|NCT04181762|473193784|FG001|Overall Study|Death|1|||
131429089|NCT04181762|473193783|FG000|Overall Study|Protocol deviation|1|||
131429090|NCT04181762|473193784|FG001|Overall Study|Protocol deviation|0|||
131429091|NCT04181762|473193783|FG000|Overall Study|Withdrawal of informed consent|1|||
131429092|NCT04181762|473193784|FG001|Overall Study|Withdrawal of informed consent|3|||
131429093|NCT06041919|473193785|FG000|Overall Study|Lost to Follow-up|1|||
131429094|NCT06041919|473193786|FG001|Overall Study|Lost to Follow-up|0|||
131429095|NCT06041919|473193787|FG002|Overall Study|Lost to Follow-up|0|||
131429096|NCT06041919|473193788|FG003|Overall Study|Lost to Follow-up|0|||
131429097|NCT06041919|473193789|FG004|Overall Study|Lost to Follow-up|0|||
131429098|NCT06041919|473193785|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
131429099|NCT06041919|473193786|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
131429100|NCT06041919|473193787|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
131429101|NCT06041919|473193788|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
131429102|NCT06041919|473193789|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
131429103|NCT01221350|473193802|FG000|Overall Study|Discontinued intervention (GERD)|1|||
131429104|NCT01221350|473193803|FG001|Overall Study|Discontinued intervention (GERD)|0|||
131429105|NCT01221350|473193802|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
131429106|NCT01221350|473193803|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
131429107|NCT01221350|473193802|FG000|Overall Study|Withdrawal by Subject|4|||
131429108|NCT01221350|473193803|FG001|Overall Study|Withdrawal by Subject|2|||
131429109|NCT01514201|473193808|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
131429110|NCT01514201|473193809|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
131429111|NCT01514201|473193810|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
131429112|NCT01514201|473193811|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
131429113|NCT01514201|473193808|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
131429114|NCT01514201|473193809|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
131429115|NCT01514201|473193810|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
131429116|NCT01514201|473193811|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
131429117|NCT01514201|473193808|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
131429118|NCT01514201|473193809|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
131429119|NCT01514201|473193810|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
131429120|NCT01514201|473193811|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
131429121|NCT01514201|473193808|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
131429122|NCT01514201|473193809|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
131429123|NCT01514201|473193810|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
131429124|NCT01514201|473193811|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
131429125|NCT01514201|473193808|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
131429126|NCT01514201|473193809|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
131429127|NCT01514201|473193810|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
131429128|NCT01514201|473193811|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
131429129|NCT01514201|473193808|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
131429130|NCT01514201|473193809|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
131429131|NCT01514201|473193810|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
131429132|NCT01514201|473193811|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
131429133|NCT01514201|473193808|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
131429134|NCT01514201|473193809|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
131429135|NCT01514201|473193810|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
131429136|NCT01514201|473193811|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
131429137|NCT01514201|473193808|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
131429138|NCT01514201|473193809|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
131429139|NCT01514201|473193810|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
131429140|NCT01514201|473193811|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
131429141|NCT01514201|473193808|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
131429142|NCT01514201|473193809|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
131429143|NCT01514201|473193810|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
131429144|NCT01514201|473193811|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
131429145|NCT01514201|473193808|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
131429146|NCT01514201|473193809|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
131429147|NCT01514201|473193810|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
131429148|NCT01514201|473193811|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
131429149|NCT01514201|473193808|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
131429150|NCT01514201|473193809|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
131429151|NCT01514201|473193810|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
131429152|NCT01514201|473193811|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
131429153|NCT01514201|473193808|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
131429154|NCT01514201|473193809|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
131429155|NCT01514201|473193810|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
131429156|NCT01514201|473193811|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
131429157|NCT05888181|473193813|FG000|Overall Study|Lost to Follow-up|1|||
131429158|NCT05888181|473193814|FG001|Overall Study|Lost to Follow-up|1|||
131429159|NCT05888181|473193815|FG002|Overall Study|Lost to Follow-up|0|||
131429160|NCT02534909|473193822|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
131429161|NCT01625000|473193825|FG000|Overall Study|Physician Decision|15|||
131429162|NCT01625000|473193826|FG001|Overall Study|Physician Decision|7|||
131429163|NCT01625000|473193827|FG002|Overall Study|Physician Decision|7|||
131429164|NCT01625000|473193828|FG003|Overall Study|Physician Decision|2|||
131429165|NCT01625000|473193829|FG004|Overall Study|Physician Decision|15|||
131429166|NCT01625000|473193825|FG000|Overall Study|Protocol Violation|3|||
131429167|NCT01625000|473193826|FG001|Overall Study|Protocol Violation|10|||
131429168|NCT01625000|473193827|FG002|Overall Study|Protocol Violation|4|||
131429169|NCT01625000|473193828|FG003|Overall Study|Protocol Violation|1|||
131429170|NCT01625000|473193829|FG004|Overall Study|Protocol Violation|2|||
131429171|NCT01625000|473193825|FG000|Overall Study|Withdrawal by Subject|19|||
131429172|NCT01625000|473193826|FG001|Overall Study|Withdrawal by Subject|16|||
131429173|NCT01625000|473193827|FG002|Overall Study|Withdrawal by Subject|11|||
131429174|NCT01625000|473193828|FG003|Overall Study|Withdrawal by Subject|9|||
131429175|NCT01625000|473193829|FG004|Overall Study|Withdrawal by Subject|17|||
131429176|NCT01625000|473193825|FG000|Overall Study|Adverse Event (including Death)|15|||
131429177|NCT01625000|473193826|FG001|Overall Study|Adverse Event (including Death)|19|||
131429178|NCT01625000|473193827|FG002|Overall Study|Adverse Event (including Death)|11|||
131429179|NCT01625000|473193828|FG003|Overall Study|Adverse Event (including Death)|7|||
131429180|NCT01625000|473193829|FG004|Overall Study|Adverse Event (including Death)|21|||
131429181|NCT00577824|473193832|FG000|Overall Study|Adverse Event|6|||
131429182|NCT00577824|473193833|FG001|Overall Study|Adverse Event|18|||
131429183|NCT00577824|473193834|FG002|Overall Study|Adverse Event|1|||
131429184|NCT00577824|473193832|FG000|Overall Study|Patient decision|0|||
131429185|NCT00577824|473193833|FG001|Overall Study|Patient decision|1|||
131429186|NCT00577824|473193834|FG002|Overall Study|Patient decision|1|||
131429187|NCT00577824|473193832|FG000|Overall Study|Protocol Violation|1|||
131429188|NCT00577824|473193833|FG001|Overall Study|Protocol Violation|1|||
131429189|NCT00577824|473193834|FG002|Overall Study|Protocol Violation|0|||
131429190|NCT00362648|473193838|FG000|Overall Study|Adverse Event|12|||
131429191|NCT00362648|473193839|FG001|Overall Study|Adverse Event|21|||
131429192|NCT00362648|473193840|FG002|Overall Study|Adverse Event|1|||
131429193|NCT00362648|473193841|FG003|Overall Study|Adverse Event|0|||
131429194|NCT00362648|473193838|FG000|Overall Study|Lost to Follow-up|62|||
131429195|NCT00362648|473193839|FG001|Overall Study|Lost to Follow-up|69|||
131429196|NCT00362648|473193840|FG002|Overall Study|Lost to Follow-up|4|||
131429197|NCT00362648|473193841|FG003|Overall Study|Lost to Follow-up|3|||
131429198|NCT00362648|473193838|FG000|Overall Study|Protocol Violation|4|||
131429199|NCT00362648|473193839|FG001|Overall Study|Protocol Violation|2|||
131429200|NCT00362648|473193840|FG002|Overall Study|Protocol Violation|2|||
131429201|NCT00362648|473193841|FG003|Overall Study|Protocol Violation|2|||
131429202|NCT00362648|473193838|FG000|Overall Study|Withdrawal by Subject|48|||
131429203|NCT00362648|473193839|FG001|Overall Study|Withdrawal by Subject|42|||
131429204|NCT00362648|473193840|FG002|Overall Study|Withdrawal by Subject|2|||
131429205|NCT00362648|473193841|FG003|Overall Study|Withdrawal by Subject|6|||
131429206|NCT02204072|473193842|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
131429207|NCT02204072|473193843|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
131429208|NCT02204072|473193844|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
131429209|NCT02204072|473193845|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
131429210|NCT02204072|473193846|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
131429211|NCT02204072|473193842|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
131429212|NCT02204072|473193843|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
131429213|NCT02204072|473193844|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
131429214|NCT02204072|473193845|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
131429215|NCT02204072|473193846|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
131429216|NCT02204072|473193842|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
131429217|NCT02204072|473193843|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
131429218|NCT02204072|473193844|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
131429219|NCT02204072|473193845|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
131429220|NCT02204072|473193846|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
131429221|NCT02204072|473193842|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
131429222|NCT02204072|473193843|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
131429223|NCT02204072|473193844|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
131429224|NCT02204072|473193845|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
131429225|NCT02204072|473193846|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
131429226|NCT03983304|473193847|FG000|Overall Study|Withdrawal by Subject|5|||
131429227|NCT03983304|473193847|FG000|Overall Study|Lost to Follow-up|2|||
131429228|NCT03197376|473193851|FG000|Primary and Booster Phase|Adverse Event|0|||
131429229|NCT03197376|473193852|FG001|Primary and Booster Phase|Adverse Event|0|||
131429230|NCT03197376|473193853|FG002|Primary and Booster Phase|Adverse Event|0|||
131429231|NCT03197376|473193854|FG003|Primary and Booster Phase|Adverse Event|1|||
131429232|NCT03197376|473193851|FG000|Primary and Booster Phase|Death|1|||
131429233|NCT03197376|473193852|FG001|Primary and Booster Phase|Death|0|||
131429234|NCT03197376|473193853|FG002|Primary and Booster Phase|Death|0|||
131429235|NCT03197376|473193854|FG003|Primary and Booster Phase|Death|2|||
131429236|NCT03197376|473193851|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
131429237|NCT03197376|473193852|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
131429238|NCT03197376|473193853|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
131429239|NCT03197376|473193854|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
131429240|NCT03197376|473193851|FG000|Primary and Booster Phase|Physician Decision|1|||
131429241|NCT03197376|473193852|FG001|Primary and Booster Phase|Physician Decision|0|||
131429242|NCT03197376|473193853|FG002|Primary and Booster Phase|Physician Decision|1|||
131429243|NCT03197376|473193854|FG003|Primary and Booster Phase|Physician Decision|3|||
131429244|NCT03197376|473193851|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
131429245|NCT03197376|473193852|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
131429246|NCT03197376|473193853|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
131429247|NCT03197376|473193854|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
131429248|NCT03197376|473193851|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
131458428|NCT01065454|473308930|FG003|Follow up|Death|0|||
131458429|NCT01065454|473308927|FG000|Follow up|Lost to Follow-up|0|||
131458430|NCT01065454|473308928|FG001|Follow up|Lost to Follow-up|0|||
131458431|NCT01065454|473308929|FG002|Follow up|Lost to Follow-up|0|||
131458432|NCT01065454|473308930|FG003|Follow up|Lost to Follow-up|1|||
131429249|NCT03197376|473193852|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
131429250|NCT03197376|473193853|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
131429251|NCT03197376|473193854|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
131429252|NCT03197376|473193851|FG000|Primary and Booster Phase|Not vaccine related|1|||
131429253|NCT03197376|473193852|FG001|Primary and Booster Phase|Not vaccine related|2|||
131429254|NCT03197376|473193853|FG002|Primary and Booster Phase|Not vaccine related|0|||
131429255|NCT03197376|473193854|FG003|Primary and Booster Phase|Not vaccine related|6|||
131429256|NCT03197376|473193851|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
131429257|NCT03197376|473193852|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
131429258|NCT03197376|473193853|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
131429259|NCT03197376|473193854|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
131429260|NCT03197376|473193851|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
131429261|NCT03197376|473193852|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
131429262|NCT03197376|473193853|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
131429263|NCT03197376|473193854|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
131429264|NCT03197376|473193851|FG000|Immune Persistence Phase|Not vaccine related|1|||
131429265|NCT03197376|473193852|FG001|Immune Persistence Phase|Not vaccine related|0|||
131429266|NCT03197376|473193853|FG002|Immune Persistence Phase|Not vaccine related|1|||
131429267|NCT03197376|473193854|FG003|Immune Persistence Phase|Not vaccine related|1|||
131429268|NCT01123395|473193855|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
131429269|NCT01123395|473193856|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
131429270|NCT03691571|473193857|FG000|Overall Study|Withdrawal by Subject|9|||
131429271|NCT03691571|473193858|FG001|Overall Study|Withdrawal by Subject|2|||
131429272|NCT03887221|473193866|FG000|Overall Study|Protocol Violation|1|||
131429273|NCT03887221|473193867|FG001|Overall Study|Protocol Violation|0|||
131429274|NCT02487030|473193868|FG000|Overall Study|Lack of Efficacy|2|||
131429275|NCT02487030|473193869|FG001|Overall Study|Lack of Efficacy|4|||
131429276|NCT02487030|473193870|FG002|Overall Study|Lack of Efficacy|1|||
131429277|NCT02487030|473193871|FG003|Overall Study|Lack of Efficacy|0|||
131429278|NCT02487030|473193872|FG004|Overall Study|Lack of Efficacy|1|||
131429279|NCT02487030|473193873|FG005|Overall Study|Lack of Efficacy|0|||
131429280|NCT02487030|473193874|FG006|Overall Study|Lack of Efficacy|0|||
131429281|NCT02487030|473193868|FG000|Overall Study|Lost to Follow-up|0|||
131429282|NCT02487030|473193869|FG001|Overall Study|Lost to Follow-up|0|||
131429283|NCT02487030|473193870|FG002|Overall Study|Lost to Follow-up|1|||
131429284|NCT02487030|473193871|FG003|Overall Study|Lost to Follow-up|1|||
131429285|NCT02487030|473193872|FG004|Overall Study|Lost to Follow-up|0|||
131429286|NCT02487030|473193873|FG005|Overall Study|Lost to Follow-up|1|||
131429287|NCT02487030|473193874|FG006|Overall Study|Lost to Follow-up|0|||
131429288|NCT02487030|473193868|FG000|Overall Study|Adverse Event|0|||
131429289|NCT02487030|473193869|FG001|Overall Study|Adverse Event|0|||
131429290|NCT02487030|473193870|FG002|Overall Study|Adverse Event|0|||
131429291|NCT02487030|473193871|FG003|Overall Study|Adverse Event|1|||
131429292|NCT02487030|473193872|FG004|Overall Study|Adverse Event|0|||
131429293|NCT02487030|473193873|FG005|Overall Study|Adverse Event|0|||
131429294|NCT02487030|473193874|FG006|Overall Study|Adverse Event|0|||
131429295|NCT02487030|473193868|FG000|Overall Study|Death|0|||
131429296|NCT02487030|473193869|FG001|Overall Study|Death|0|||
131429297|NCT02487030|473193870|FG002|Overall Study|Death|0|||
131429298|NCT02487030|473193871|FG003|Overall Study|Death|0|||
131429299|NCT02487030|473193872|FG004|Overall Study|Death|1|||
131429300|NCT02487030|473193873|FG005|Overall Study|Death|0|||
131429301|NCT02487030|473193874|FG006|Overall Study|Death|0|||
131429302|NCT02092025|473193875|FG000|Overall Study|Case Report Forms Uncollected|44|||
131429303|NCT02092025|473193875|FG000|Overall Study|Protocol Deviation|24|||
131429304|NCT00264537|473193876|FG000|Overall Study|Death|0|||
131429305|NCT00264537|473193877|FG001|Overall Study|Death|3|||
131429306|NCT00264537|473193878|FG002|Overall Study|Death|3|||
131429307|NCT00264537|473193879|FG003|Overall Study|Death|2|||
131429308|NCT00264537|473193876|FG000|Overall Study|Lost to Follow-up|3|||
131429309|NCT00264537|473193877|FG001|Overall Study|Lost to Follow-up|4|||
131429310|NCT00264537|473193878|FG002|Overall Study|Lost to Follow-up|7|||
131429311|NCT00264537|473193879|FG003|Overall Study|Lost to Follow-up|6|||
131429312|NCT00264537|473193876|FG000|Overall Study|Adverse Event|21|||
131429313|NCT00264537|473193877|FG001|Overall Study|Adverse Event|32|||
131429314|NCT00264537|473193878|FG002|Overall Study|Adverse Event|24|||
131429315|NCT00264537|473193879|FG003|Overall Study|Adverse Event|34|||
131429316|NCT00264537|473193876|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131429317|NCT00264537|473193877|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131429318|NCT00264537|473193878|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
131429319|NCT00264537|473193879|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
131429320|NCT00264537|473193876|FG000|Overall Study|Other|21|||
131429321|NCT00264537|473193877|FG001|Overall Study|Other|11|||
131429322|NCT00264537|473193878|FG002|Overall Study|Other|10|||
131429323|NCT00264537|473193879|FG003|Overall Study|Other|11|||
131429324|NCT00264537|473193876|FG000|Overall Study|Not treated|0|||
131429325|NCT00264537|473193877|FG001|Overall Study|Not treated|2|||
131429326|NCT00264537|473193878|FG002|Overall Study|Not treated|1|||
131429327|NCT00264537|473193879|FG003|Overall Study|Not treated|0|||
131429328|NCT03228212|473193880|FG000|Period 1|Adverse Event|1|||
131429329|NCT03228212|473193881|FG001|Period 1|Adverse Event|0|||
131429330|NCT03228212|473193880|FG000|Period 1|no longer meets eligibility criteria|0|||
131429331|NCT03228212|473193881|FG001|Period 1|no longer meets eligibility criteria|1|||
131429332|NCT03228212|473193880|FG000|Period 2|Lost to Follow-up|1|||
131429333|NCT03228212|473193881|FG001|Period 2|Lost to Follow-up|0|||
131429334|NCT00999544|473195077|FG000|Overall Study|Withdrawal by Subject|1|||
131429335|NCT03553758|473195082|FG000|Overall Study|Lost to Follow-up|1|||
131429336|NCT01101035|473195085|FG000|Overall Study|Adverse Event|191|||
131429337|NCT01101035|473195086|FG001|Overall Study|Adverse Event|172|||
131429338|NCT01101035|473195085|FG000|Overall Study|Major Protocol Deviation|52|||
131429339|NCT01101035|473195086|FG001|Overall Study|Major Protocol Deviation|46|||
131429340|NCT01101035|473195085|FG000|Overall Study|Lost to Follow-up|226|||
131429341|NCT01101035|473195086|FG001|Overall Study|Lost to Follow-up|223|||
131429342|NCT01101035|473195085|FG000|Overall Study|Voluntary Withdrawal|595|||
131429343|NCT01101035|473195086|FG001|Overall Study|Voluntary Withdrawal|587|||
131429344|NCT01101035|473195085|FG000|Overall Study|Reason not Specified|333|||
131429345|NCT01101035|473195086|FG001|Overall Study|Reason not Specified|363|||
131429346|NCT00681629|473195087|FG000|Overall Study|Study termination|4|||
131429347|NCT00681629|473195088|FG001|Overall Study|Study termination|2|||
131429348|NCT00681629|473195087|FG000|Overall Study|Adverse Event|1|||
131429349|NCT00681629|473195088|FG001|Overall Study|Adverse Event|0|||
131429350|NCT03951077|473195091|FG000|Overall Study|Adverse Event|1|||
131429351|NCT03951077|473195092|FG001|Overall Study|Adverse Event|0|||
131429352|NCT03951077|473195093|FG002|Overall Study|Adverse Event|0|||
131429353|NCT03951077|473195094|FG003|Overall Study|Adverse Event|0|||
131429354|NCT03951077|473195095|FG004|Overall Study|Adverse Event|0|||
131429355|NCT03951077|473195096|FG005|Overall Study|Adverse Event|0|||
131429356|NCT03951077|473195091|FG000|Overall Study|Withdrawal by Subject|3|||
131429357|NCT03951077|473195092|FG001|Overall Study|Withdrawal by Subject|3|||
131429358|NCT03951077|473195093|FG002|Overall Study|Withdrawal by Subject|0|||
131429359|NCT03951077|473195094|FG003|Overall Study|Withdrawal by Subject|3|||
131429360|NCT03951077|473195095|FG004|Overall Study|Withdrawal by Subject|3|||
131429361|NCT03951077|473195096|FG005|Overall Study|Withdrawal by Subject|2|||
131429362|NCT03951077|473195091|FG000|Overall Study|Lost to Follow-up|1|||
131429363|NCT03951077|473195092|FG001|Overall Study|Lost to Follow-up|1|||
131429364|NCT03951077|473195093|FG002|Overall Study|Lost to Follow-up|2|||
131429365|NCT03951077|473195094|FG003|Overall Study|Lost to Follow-up|3|||
131429366|NCT03951077|473195095|FG004|Overall Study|Lost to Follow-up|2|||
131429367|NCT03951077|473195096|FG005|Overall Study|Lost to Follow-up|3|||
131429368|NCT03951077|473195091|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
131429369|NCT03951077|473195092|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
131429370|NCT03951077|473195093|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
131429371|NCT03951077|473195094|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
131429372|NCT03951077|473195095|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
131429373|NCT03951077|473195096|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
131429374|NCT03951077|473195091|FG000|Overall Study|Other, Not Specified|12|||
131429375|NCT03951077|473195092|FG001|Overall Study|Other, Not Specified|10|||
131429376|NCT03951077|473195093|FG002|Overall Study|Other, Not Specified|10|||
131429377|NCT03951077|473195094|FG003|Overall Study|Other, Not Specified|5|||
131429378|NCT03951077|473195095|FG004|Overall Study|Other, Not Specified|9|||
131429379|NCT03951077|473195096|FG005|Overall Study|Other, Not Specified|6|||
131429380|NCT03951077|473195091|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
131429381|NCT03951077|473195092|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
131429382|NCT03951077|473195093|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
131429383|NCT03951077|473195094|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
131429384|NCT03951077|473195095|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
131429385|NCT03951077|473195096|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
131429386|NCT00713544|473195100|FG000|Overall Study|Adverse Event|5|||
131429387|NCT00713544|473195101|FG001|Overall Study|Adverse Event|3|||
131429388|NCT00713544|473195102|FG002|Overall Study|Adverse Event|7|||
131429389|NCT00713544|473195103|FG003|Overall Study|Adverse Event|7|||
131429390|NCT00713544|473195104|FG004|Overall Study|Adverse Event|3|||
131429391|NCT00713544|473195105|FG005|Overall Study|Adverse Event|5|||
131429392|NCT00713544|473195100|FG000|Overall Study|Withdrawal by Subject|2|||
131429393|NCT00713544|473195101|FG001|Overall Study|Withdrawal by Subject|0|||
131429394|NCT00713544|473195102|FG002|Overall Study|Withdrawal by Subject|3|||
131429395|NCT00713544|473195103|FG003|Overall Study|Withdrawal by Subject|2|||
131429396|NCT00713544|473195104|FG004|Overall Study|Withdrawal by Subject|3|||
131429397|NCT00713544|473195105|FG005|Overall Study|Withdrawal by Subject|1|||
131429398|NCT00713544|473195100|FG000|Overall Study|Protocol Violation|0|||
131429399|NCT00713544|473195101|FG001|Overall Study|Protocol Violation|0|||
131429400|NCT00713544|473195102|FG002|Overall Study|Protocol Violation|0|||
131429401|NCT00713544|473195103|FG003|Overall Study|Protocol Violation|0|||
131429402|NCT00713544|473195104|FG004|Overall Study|Protocol Violation|0|||
131429403|NCT00713544|473195105|FG005|Overall Study|Protocol Violation|1|||
131429404|NCT00713544|473195100|FG000|Overall Study|Physician Decision|0|||
131429405|NCT00713544|473195101|FG001|Overall Study|Physician Decision|0|||
131429406|NCT00713544|473195102|FG002|Overall Study|Physician Decision|0|||
131429407|NCT00713544|473195103|FG003|Overall Study|Physician Decision|0|||
131429408|NCT00713544|473195104|FG004|Overall Study|Physician Decision|0|||
131429409|NCT00713544|473195105|FG005|Overall Study|Physician Decision|2|||
131429410|NCT00713544|473195100|FG000|Overall Study|Lack of Efficacy|0|||
131429411|NCT00713544|473195101|FG001|Overall Study|Lack of Efficacy|1|||
131429412|NCT00713544|473195102|FG002|Overall Study|Lack of Efficacy|0|||
131429413|NCT00713544|473195103|FG003|Overall Study|Lack of Efficacy|1|||
131429414|NCT00713544|473195104|FG004|Overall Study|Lack of Efficacy|1|||
131429415|NCT00713544|473195105|FG005|Overall Study|Lack of Efficacy|0|||
131429416|NCT00713544|473195100|FG000|Overall Study|Lost to Follow-up|0|||
131429417|NCT00713544|473195101|FG001|Overall Study|Lost to Follow-up|0|||
131429418|NCT00713544|473195102|FG002|Overall Study|Lost to Follow-up|1|||
131429419|NCT00713544|473195103|FG003|Overall Study|Lost to Follow-up|0|||
131429420|NCT00713544|473195104|FG004|Overall Study|Lost to Follow-up|0|||
131429421|NCT00713544|473195105|FG005|Overall Study|Lost to Follow-up|0|||
131429422|NCT00713544|473195100|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
131429423|NCT00713544|473195101|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
131429424|NCT00713544|473195102|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
131429425|NCT00713544|473195103|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
131429426|NCT00713544|473195104|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
131429427|NCT00713544|473195105|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
131429428|NCT00713544|473195100|FG000|Overall Study|Incorrect enrollment|0|||
131429429|NCT00713544|473195101|FG001|Overall Study|Incorrect enrollment|1|||
131429430|NCT00713544|473195102|FG002|Overall Study|Incorrect enrollment|0|||
131429431|NCT00713544|473195103|FG003|Overall Study|Incorrect enrollment|0|||
131429432|NCT00713544|473195104|FG004|Overall Study|Incorrect enrollment|0|||
131429433|NCT00713544|473195105|FG005|Overall Study|Incorrect enrollment|0|||
131429434|NCT00713544|473195100|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
131429435|NCT00713544|473195101|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
131429436|NCT00713544|473195102|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
131429437|NCT00713544|473195103|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
131429438|NCT00713544|473195104|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
131429439|NCT00713544|473195105|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
131429440|NCT00950846|473195106|FG000|Overall Study|Death|6|||
131429441|NCT00950846|473195106|FG000|Overall Study|Lost to Follow-up|3|||
131429442|NCT00950846|473195106|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
131429443|NCT01510158|473195111|FG000|Overall Study|Adverse Event|7|||
131429444|NCT01510158|473195112|FG001|Overall Study|Adverse Event|8|||
131429445|NCT01510158|473195113|FG002|Overall Study|Adverse Event|5|||
131429446|NCT01510158|473195111|FG000|Overall Study|Gout flare|1|||
131429447|NCT01510158|473195112|FG001|Overall Study|Gout flare|0|||
131429448|NCT01510158|473195113|FG002|Overall Study|Gout flare|0|||
131429449|NCT01510158|473195111|FG000|Overall Study|Protocol Violation|17|||
131429450|NCT01510158|473195112|FG001|Overall Study|Protocol Violation|16|||
131429451|NCT01510158|473195113|FG002|Overall Study|Protocol Violation|24|||
131429452|NCT01510158|473195111|FG000|Overall Study|Sponsor terminated study.|2|||
131429453|NCT01510158|473195112|FG001|Overall Study|Sponsor terminated study.|0|||
131429454|NCT01510158|473195113|FG002|Overall Study|Sponsor terminated study.|2|||
131429455|NCT01510158|473195111|FG000|Overall Study|Lost to Follow-up|13|||
131429456|NCT01510158|473195112|FG001|Overall Study|Lost to Follow-up|16|||
131429457|NCT01510158|473195113|FG002|Overall Study|Lost to Follow-up|9|||
131429458|NCT01510158|473195111|FG000|Overall Study|Withdrawal by Subject|10|||
131429459|NCT01510158|473195112|FG001|Overall Study|Withdrawal by Subject|13|||
131429460|NCT01510158|473195113|FG002|Overall Study|Withdrawal by Subject|10|||
131429461|NCT01510158|473195111|FG000|Overall Study|Death|1|||
131429462|NCT01510158|473195112|FG001|Overall Study|Death|0|||
131429463|NCT01510158|473195113|FG002|Overall Study|Death|0|||
131429464|NCT05258149|473195120|FG000|Period 1|Protocol Deviation|1|||
131429465|NCT05258149|473195121|FG001|Period 1|Protocol Deviation|0|||
131429466|NCT05258149|473195120|FG000|Period 1|Adverse Event|0|||
131429467|NCT05258149|473195121|FG001|Period 1|Adverse Event|1|||
131429468|NCT05258149|473195120|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
131429469|NCT05258149|473195121|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131429470|NCT05258149|473195120|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
131429471|NCT05258149|473195121|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
131429472|NCT05258149|473195120|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
131429473|NCT05258149|473195121|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
131429474|NCT01290757|473195124|FG000|Overall Study|Adverse Event|1|||
131429475|NCT01290757|473195125|FG001|Overall Study|Adverse Event|0|||
131429476|NCT01290757|473195124|FG000|Overall Study|Protocol Violation|1|||
131429477|NCT01290757|473195125|FG001|Overall Study|Protocol Violation|1|||
131429478|NCT01290757|473195124|FG000|Overall Study|Other|0|||
131429479|NCT01290757|473195125|FG001|Overall Study|Other|1|||
131429480|NCT00479336|473195127|FG000|Overall Study|Adverse Event|1|||
131429481|NCT00479336|473195128|FG001|Overall Study|Adverse Event|1|||
131429482|NCT00479336|473195129|FG002|Overall Study|Adverse Event|1|||
131429483|NCT00479336|473195130|FG003|Overall Study|Adverse Event|3|||
131429484|NCT00479336|473195127|FG000|Overall Study|Lack of Efficacy|1|||
131429485|NCT00479336|473195128|FG001|Overall Study|Lack of Efficacy|0|||
131429486|NCT00479336|473195129|FG002|Overall Study|Lack of Efficacy|0|||
131429487|NCT00479336|473195130|FG003|Overall Study|Lack of Efficacy|0|||
131429488|NCT00479336|473195127|FG000|Overall Study|Protocol Violation|0|||
131429489|NCT00479336|473195128|FG001|Overall Study|Protocol Violation|1|||
131429490|NCT00479336|473195129|FG002|Overall Study|Protocol Violation|0|||
131429491|NCT00479336|473195130|FG003|Overall Study|Protocol Violation|0|||
131429492|NCT00479336|473195127|FG000|Overall Study|Withdrawal by Subject|1|||
131429493|NCT00479336|473195128|FG001|Overall Study|Withdrawal by Subject|2|||
131429494|NCT00479336|473195129|FG002|Overall Study|Withdrawal by Subject|0|||
131429495|NCT00479336|473195130|FG003|Overall Study|Withdrawal by Subject|0|||
131429496|NCT00479336|473195127|FG000|Overall Study|Physician Decision|0|||
131429497|NCT00479336|473195128|FG001|Overall Study|Physician Decision|1|||
131429498|NCT00479336|473195129|FG002|Overall Study|Physician Decision|0|||
131429499|NCT00479336|473195130|FG003|Overall Study|Physician Decision|2|||
131429500|NCT00479336|473195127|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
131429501|NCT00479336|473195128|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
131429502|NCT00479336|473195129|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
131429503|NCT00479336|473195130|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
131429504|NCT03329846|473195131|FG000|Overall Study|Disease progression|4|||
131429505|NCT03329846|473195132|FG001|Overall Study|Disease progression|6|||
131429506|NCT03329846|473195131|FG000|Overall Study|Study drug toxicity|1|||
131429507|NCT03329846|473195132|FG001|Overall Study|Study drug toxicity|0|||
131429508|NCT03329846|473195131|FG000|Overall Study|Participant request to discontinue treatment|0|||
131429509|NCT03329846|473195132|FG001|Overall Study|Participant request to discontinue treatment|1|||
131429510|NCT03329846|473195131|FG000|Overall Study|Participant withdrew consent|1|||
131429511|NCT03329846|473195132|FG001|Overall Study|Participant withdrew consent|0|||
131429512|NCT03329846|473195131|FG000|Overall Study|Other reasons|2|||
131429513|NCT03329846|473195132|FG001|Overall Study|Other reasons|2|||
131429514|NCT03066193|473195133|FG000|Overall Study|Withdrawal by Subject|1|||
131429515|NCT02021643|473195134|FG000|Overall Study|Enrolled but Never Treated|1|||
131458433|NCT01065454|473308927|FG000|Follow up|Progressive disease|0|||
131429516|NCT02021643|473195135|FG001|Overall Study|Enrolled but Never Treated|0|||
131429517|NCT02021643|473195136|FG002|Overall Study|Enrolled but Never Treated|0|||
131429518|NCT02021643|473195137|FG003|Overall Study|Enrolled but Never Treated|0|||
131429519|NCT02021643|473195134|FG000|Overall Study|Adverse Event|0|||
131429520|NCT02021643|473195135|FG001|Overall Study|Adverse Event|1|||
131429521|NCT02021643|473195136|FG002|Overall Study|Adverse Event|0|||
131429522|NCT02021643|473195137|FG003|Overall Study|Adverse Event|0|||
131429523|NCT02021643|473195134|FG000|Overall Study|Death|0|||
131429524|NCT02021643|473195135|FG001|Overall Study|Death|1|||
131429525|NCT02021643|473195136|FG002|Overall Study|Death|0|||
131429526|NCT02021643|473195137|FG003|Overall Study|Death|0|||
131429527|NCT02021643|473195134|FG000|Overall Study|Investigator's Discretion|1|||
131429528|NCT02021643|473195135|FG001|Overall Study|Investigator's Discretion|0|||
131429529|NCT02021643|473195136|FG002|Overall Study|Investigator's Discretion|0|||
131429530|NCT02021643|473195137|FG003|Overall Study|Investigator's Discretion|0|||
131429531|NCT02021643|473195134|FG000|Overall Study|Lack of Efficacy|7|||
131429532|NCT02021643|473195135|FG001|Overall Study|Lack of Efficacy|6|||
131429533|NCT02021643|473195136|FG002|Overall Study|Lack of Efficacy|0|||
131429534|NCT02021643|473195137|FG003|Overall Study|Lack of Efficacy|12|||
131429535|NCT02021643|473195134|FG000|Overall Study|Lost to Follow-up|0|||
131429536|NCT02021643|473195135|FG001|Overall Study|Lost to Follow-up|1|||
131429537|NCT02021643|473195136|FG002|Overall Study|Lost to Follow-up|0|||
131429538|NCT02021643|473195137|FG003|Overall Study|Lost to Follow-up|0|||
131429539|NCT02021643|473195134|FG000|Overall Study|Withdrew Consent|0|||
131429540|NCT02021643|473195135|FG001|Overall Study|Withdrew Consent|1|||
131429541|NCT02021643|473195136|FG002|Overall Study|Withdrew Consent|0|||
131429542|NCT02021643|473195137|FG003|Overall Study|Withdrew Consent|0|||
131429543|NCT04854551|473195138|FG000|Overall Study|Withdrawal by Subject|1|||
131429544|NCT04854551|473195139|FG001|Overall Study|Withdrawal by Subject|1|||
131429545|NCT02631551|473195140|FG000|Overall Study|Adverse Event|1|||
131429546|NCT02631551|473195141|FG001|Overall Study|Adverse Event|2|||
131429547|NCT02631551|473195142|FG002|Overall Study|Adverse Event|4|||
131429548|NCT02631551|473195143|FG003|Overall Study|Adverse Event|0|||
131429549|NCT02631551|473195140|FG000|Overall Study|Lack of Efficacy|0|||
131429550|NCT02631551|473195141|FG001|Overall Study|Lack of Efficacy|0|||
131429551|NCT02631551|473195142|FG002|Overall Study|Lack of Efficacy|1|||
131429552|NCT02631551|473195143|FG003|Overall Study|Lack of Efficacy|0|||
131429553|NCT02631551|473195140|FG000|Overall Study|Lost to Follow-up|1|||
131429554|NCT02631551|473195141|FG001|Overall Study|Lost to Follow-up|2|||
131429555|NCT02631551|473195142|FG002|Overall Study|Lost to Follow-up|0|||
131429556|NCT02631551|473195143|FG003|Overall Study|Lost to Follow-up|3|||
131429557|NCT02631551|473195140|FG000|Overall Study|Withdrawal by Subject|2|||
131429558|NCT02631551|473195141|FG001|Overall Study|Withdrawal by Subject|2|||
131429559|NCT02631551|473195142|FG002|Overall Study|Withdrawal by Subject|0|||
131429560|NCT02631551|473195143|FG003|Overall Study|Withdrawal by Subject|5|||
131429561|NCT02631551|473195140|FG000|Overall Study|Protocol deviation|3|||
131429562|NCT02631551|473195141|FG001|Overall Study|Protocol deviation|6|||
131429563|NCT02631551|473195142|FG002|Overall Study|Protocol deviation|3|||
131429564|NCT02631551|473195143|FG003|Overall Study|Protocol deviation|0|||
131429565|NCT02631551|473195140|FG000|Overall Study|Non-compliance with study procedures|0|||
131429566|NCT02631551|473195141|FG001|Overall Study|Non-compliance with study procedures|0|||
131429567|NCT02631551|473195142|FG002|Overall Study|Non-compliance with study procedures|1|||
131429568|NCT02631551|473195143|FG003|Overall Study|Non-compliance with study procedures|1|||
131429569|NCT02631551|473195140|FG000|Overall Study|Non-compliance with study drug|1|||
131429570|NCT02631551|473195141|FG001|Overall Study|Non-compliance with study drug|0|||
131429571|NCT02631551|473195142|FG002|Overall Study|Non-compliance with study drug|0|||
131429572|NCT02631551|473195143|FG003|Overall Study|Non-compliance with study drug|0|||
131429573|NCT02631551|473195140|FG000|Overall Study|Other, specific reasons not collected|5|||
131429574|NCT02631551|473195141|FG001|Overall Study|Other, specific reasons not collected|7|||
131429575|NCT02631551|473195142|FG002|Overall Study|Other, specific reasons not collected|2|||
131429576|NCT02631551|473195143|FG003|Overall Study|Other, specific reasons not collected|2|||
131429577|NCT00100789|473195144|FG000|Overall Study|Adverse Event|10|||
131429578|NCT00100789|473195144|FG000|Overall Study|Withdrawal by Subject|1|||
131429579|NCT00100789|473195144|FG000|Overall Study|Progression/relapse|42|||
131429580|NCT00100789|473195144|FG000|Overall Study|Death|2|||
131429581|NCT00100789|473195144|FG000|Overall Study|Not protocol specified|5|||
131429582|NCT00100789|473195144|FG000|Overall Study|Ineligible|3|||
131429583|NCT00100789|473195144|FG000|Overall Study|Never received treatment|1|||
131458434|NCT01065454|473308928|FG001|Follow up|Progressive disease|0|||
131429584|NCT01746368|473195145|FG000|Overall Study|Lost to Follow-up|2|||
131429585|NCT01746368|473195146|FG001|Overall Study|Lost to Follow-up|0|||
131429586|NCT01746368|473195145|FG000|Overall Study|Withdrawal by Subject|0|||
131429587|NCT01746368|473195146|FG001|Overall Study|Withdrawal by Subject|1|||
131429588|NCT05280717|473195147|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
131429589|NCT05280717|473195148|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
131429590|NCT05280717|473195149|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
131429591|NCT05280717|473195150|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
131429592|NCT05280717|473195151|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
131429593|NCT05280717|473195152|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
131429594|NCT05280717|473195153|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
131429595|NCT05280717|473195147|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
131429596|NCT05280717|473195148|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
131429597|NCT05280717|473195149|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
131429598|NCT05280717|473195150|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
131429599|NCT05280717|473195151|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
131429600|NCT05280717|473195152|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
131429601|NCT05280717|473195153|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
131429602|NCT05280717|473195147|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
131429603|NCT05280717|473195148|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
131429604|NCT05280717|473195149|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
131429605|NCT05280717|473195150|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
131429606|NCT05280717|473195151|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
131429607|NCT05280717|473195152|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
131429608|NCT05280717|473195153|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
131429609|NCT05280717|473195147|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
131429610|NCT05280717|473195148|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
131429611|NCT05280717|473195149|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
131429612|NCT05280717|473195150|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
131429613|NCT05280717|473195151|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
131429614|NCT05280717|473195152|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
131429615|NCT05280717|473195153|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
131429616|NCT05280717|473195147|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
131429617|NCT05280717|473195148|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
131429618|NCT05280717|473195149|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
131429619|NCT05280717|473195150|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
131429620|NCT05280717|473195151|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
131429621|NCT05280717|473195152|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
131429622|NCT05280717|473195153|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
131429623|NCT05280717|473195147|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
131429624|NCT05280717|473195148|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
131429625|NCT05280717|473195149|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
131429626|NCT05280717|473195150|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
131429627|NCT05280717|473195151|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
131429628|NCT05280717|473195152|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
131429629|NCT05280717|473195153|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
131429630|NCT00080301|473195154|FG000|Overall Study|Randomized but Never Treated|5|||
131429631|NCT00080301|473195155|FG001|Overall Study|Randomized but Never Treated|10|||
131429632|NCT00080301|473195154|FG000|Overall Study|Still on Treatment as of CSR date|0|||
131429633|NCT00080301|473195155|FG001|Overall Study|Still on Treatment as of CSR date|1|||
131429634|NCT02518971|473195156|FG000|Overall Study|Lost to Follow-up|0|||
131429635|NCT02518971|473195157|FG001|Overall Study|Lost to Follow-up|1|||
131429636|NCT02518971|473195156|FG000|Overall Study|Physician Decision|6|||
131429637|NCT02518971|473195157|FG001|Overall Study|Physician Decision|6|||
131429638|NCT02518971|473195156|FG000|Overall Study|Protocol Violation|6|||
131429639|NCT02518971|473195157|FG001|Overall Study|Protocol Violation|4|||
131429640|NCT02518971|473195156|FG000|Overall Study|Withdrawal by Subject|4|||
131429641|NCT02518971|473195157|FG001|Overall Study|Withdrawal by Subject|5|||
131429642|NCT02518971|473195156|FG000|Overall Study|Side effects|1|||
131429643|NCT02518971|473195157|FG001|Overall Study|Side effects|0|||
131429644|NCT02518971|473195156|FG000|Overall Study|medication lost in mail|0|||
131429645|NCT02518971|473195157|FG001|Overall Study|medication lost in mail|1|||
131429646|NCT02518971|473195156|FG000|Overall Study|eligibility criteria no longer met|6|||
131429647|NCT02518971|473195157|FG001|Overall Study|eligibility criteria no longer met|3|||
131429648|NCT02524171|473195158|FG000|6-month Follow-up|Lost to Follow-up|53|||
131429649|NCT02524171|473195159|FG001|6-month Follow-up|Lost to Follow-up|45|||
131429650|NCT02524171|473195158|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
131429651|NCT02524171|473195159|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
131429652|NCT00757237|473195162|FG000|Overall Study|Lost to Follow-up|0|||
131429653|NCT00757237|473195163|FG001|Overall Study|Lost to Follow-up|1|||
131429654|NCT00757237|473195162|FG000|Overall Study|Protocol Violation|0|||
131429655|NCT00757237|473195163|FG001|Overall Study|Protocol Violation|2|||
131429656|NCT00757237|473195162|FG000|Overall Study|Physician Decision|2|||
131429657|NCT00757237|473195163|FG001|Overall Study|Physician Decision|3|||
131429658|NCT00757237|473195162|FG000|Overall Study|Withdrawal by Subject|8|||
131429659|NCT00757237|473195163|FG001|Overall Study|Withdrawal by Subject|12|||
131429660|NCT00757237|473195162|FG000|Overall Study|Safety or Tolerability|3|||
131429661|NCT00757237|473195163|FG001|Overall Study|Safety or Tolerability|5|||
131429662|NCT00757237|473195162|FG000|Overall Study|Other|0|||
131429663|NCT00757237|473195163|FG001|Overall Study|Other|2|||
131429664|NCT02735343|473195167|FG000|Overall Study|screen fail|0|||
131429665|NCT02735343|473195168|FG001|Overall Study|screen fail|2|||
131429666|NCT00637416|473195169|FG000|Overall Study|Lost to Follow-up|1|||
131429667|NCT00637416|473195170|FG001|Overall Study|Lost to Follow-up|1|||
131429668|NCT00637416|473195169|FG000|Overall Study|Unable to take study drug|0|||
131429669|NCT00637416|473195170|FG001|Overall Study|Unable to take study drug|1|||
131429670|NCT01147055|473195171|FG000|First Intervention Period|Lost to Follow-up|1|||
131429671|NCT01147055|473195172|FG001|First Intervention Period|Lost to Follow-up|0|||
131429672|NCT05236257|473195211|FG000|Overall Study|Ongoing with study treatment|29|||
131429673|NCT05236257|473195212|FG001|Overall Study|Ongoing with study treatment|1|||
131429674|NCT05236257|473195211|FG000|Overall Study|Discontinued study treatment|22|||
131429675|NCT05236257|473195212|FG001|Overall Study|Discontinued study treatment|41|||
131429676|NCT00874848|473195217|FG000|Overall Study|Adverse Event|13|||
131429677|NCT00874848|473195218|FG001|Overall Study|Adverse Event|2|||
131429678|NCT00874848|473195217|FG000|Overall Study|Progressive neoplastic disease|38|||
131429679|NCT00874848|473195218|FG001|Overall Study|Progressive neoplastic disease|18|||
131429680|NCT00874848|473195217|FG000|Overall Study|Withdrawal by Subject|7|||
131429681|NCT00874848|473195218|FG001|Overall Study|Withdrawal by Subject|4|||
131429682|NCT00874848|473195217|FG000|Overall Study|Noncompliance|1|||
131429683|NCT00874848|473195218|FG001|Overall Study|Noncompliance|1|||
131429684|NCT00874848|473195217|FG000|Overall Study|Failure to comply with protocol|0|||
131429685|NCT00874848|473195218|FG001|Overall Study|Failure to comply with protocol|1|||
131429686|NCT00874848|473195217|FG000|Overall Study|Physician Decision|0|||
131429687|NCT00874848|473195218|FG001|Overall Study|Physician Decision|2|||
131429688|NCT02713828|473195220|FG000|Overall Study|Death|2|||
131429689|NCT02713828|473195221|FG001|Overall Study|Death|0|||
131429690|NCT02713828|473195220|FG000|Overall Study|Withdrawal by Subject|1|||
131429691|NCT02713828|473195221|FG001|Overall Study|Withdrawal by Subject|0|||
131429692|NCT02713828|473195220|FG000|Overall Study|study terminated but patient allowed to|2|||
131429693|NCT02713828|473195221|FG001|Overall Study|study terminated but patient allowed to|0|||
131429694|NCT00186901|473195224|FG000|Overall Study|Pregnancy|6|||
131429695|NCT00186901|473195225|FG001|Overall Study|Pregnancy|3|||
131429696|NCT00186901|473195226|FG002|Overall Study|Pregnancy|0|||
131429697|NCT00186901|473195224|FG000|Overall Study|Lost to Follow-up|6|||
131429698|NCT00186901|473195225|FG001|Overall Study|Lost to Follow-up|3|||
131429699|NCT00186901|473195226|FG002|Overall Study|Lost to Follow-up|0|||
131429700|NCT00186901|473195224|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
131429701|NCT00186901|473195225|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
131429702|NCT00186901|473195226|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
131429703|NCT00186901|473195224|FG000|Overall Study|ALL relapse or second malignancy|1|||
131429704|NCT00186901|473195225|FG001|Overall Study|ALL relapse or second malignancy|2|||
131429705|NCT00186901|473195226|FG002|Overall Study|ALL relapse or second malignancy|0|||
131429706|NCT00186901|473195224|FG000|Overall Study|Withdrawal by Subject|4|||
131429707|NCT00186901|473195225|FG001|Overall Study|Withdrawal by Subject|5|||
131429708|NCT00186901|473195226|FG002|Overall Study|Withdrawal by Subject|0|||
131429709|NCT00186901|473195224|FG000|Overall Study|Open label|3|||
131429710|NCT00186901|473195225|FG001|Overall Study|Open label|2|||
131429711|NCT00186901|473195226|FG002|Overall Study|Open label|0|||
131429712|NCT00186901|473195224|FG000|Overall Study|Limited adherence to study requirements|20|||
131429713|NCT00186901|473195225|FG001|Overall Study|Limited adherence to study requirements|23|||
131429714|NCT00186901|473195226|FG002|Overall Study|Limited adherence to study requirements|0|||
131458435|NCT01065454|473308929|FG002|Follow up|Progressive disease|0|||
131429715|NCT00186901|473195224|FG000|Overall Study|Bone Mineral Density > 0|0|||
131429716|NCT00186901|473195225|FG001|Overall Study|Bone Mineral Density > 0|0|||
131429717|NCT00186901|473195226|FG002|Overall Study|Bone Mineral Density > 0|149|||
131429718|NCT00291486|473195232|FG000|Overall Study|Adverse Event|0|||
131429719|NCT00291486|473195233|FG001|Overall Study|Adverse Event|3|||
131429720|NCT00291486|473195234|FG002|Overall Study|Adverse Event|0|||
131458436|NCT01065454|473308930|FG003|Follow up|Progressive disease|1|||
131429721|NCT00291486|473195235|FG003|Overall Study|Adverse Event|1|||
131429722|NCT00291486|473195236|FG004|Overall Study|Adverse Event|0|||
131429723|NCT00291486|473195232|FG000|Overall Study|Withdrawal by Subject|0|||
131429724|NCT00291486|473195233|FG001|Overall Study|Withdrawal by Subject|0|||
131429725|NCT00291486|473195234|FG002|Overall Study|Withdrawal by Subject|0|||
131429726|NCT00291486|473195235|FG003|Overall Study|Withdrawal by Subject|0|||
131429727|NCT00291486|473195236|FG004|Overall Study|Withdrawal by Subject|1|||
131429728|NCT00291486|473195232|FG000|Overall Study|Disease progression|1|||
131429729|NCT00291486|473195233|FG001|Overall Study|Disease progression|0|||
131429730|NCT00291486|473195234|FG002|Overall Study|Disease progression|1|||
131429731|NCT00291486|473195235|FG003|Overall Study|Disease progression|0|||
131429732|NCT00291486|473195236|FG004|Overall Study|Disease progression|0|||
131429733|NCT01099397|473195237|FG000|Overall Study|Lost to Follow-up|4|||
131429734|NCT01099397|473195237|FG000|Overall Study|Protocol Violation|4|||
131429735|NCT01099397|473195237|FG000|Overall Study|Withdrawal by Subject|5|||
131429736|NCT00003199|473195238|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
131429737|NCT00003199|473195238|FG000|Overall Study|Lack of insurance clearance|2|||
131429738|NCT00003199|473195238|FG000|Overall Study|Screen fail|15|||
131429739|NCT00947115|473195239|FG000|Overall Study|Missed reporting interval|3|||
131429740|NCT00947115|473195240|FG001|Overall Study|Missed reporting interval|4|||
131429741|NCT00947115|473195241|FG002|Overall Study|Missed reporting interval|2|||
131429742|NCT00947115|473195239|FG000|Overall Study|Physician Decision|0|||
131429743|NCT00947115|473195240|FG001|Overall Study|Physician Decision|2|||
131429744|NCT00947115|473195241|FG002|Overall Study|Physician Decision|0|||
131429745|NCT00947115|473195239|FG000|Overall Study|Death|0|||
131429746|NCT00947115|473195240|FG001|Overall Study|Death|1|||
131429747|NCT00947115|473195241|FG002|Overall Study|Death|1|||
131429748|NCT00947115|473195239|FG000|Overall Study|Migrated from study area|2|||
131429749|NCT00947115|473195240|FG001|Overall Study|Migrated from study area|0|||
131429750|NCT00947115|473195241|FG002|Overall Study|Migrated from study area|0|||
131429751|NCT00947115|473195239|FG000|Overall Study|Withdrawal by Subject|1|||
131429752|NCT00947115|473195240|FG001|Overall Study|Withdrawal by Subject|3|||
131429753|NCT00947115|473195241|FG002|Overall Study|Withdrawal by Subject|4|||
131429754|NCT00947115|473195239|FG000|Overall Study|Lost to Follow-up|11|||
131429755|NCT00947115|473195240|FG001|Overall Study|Lost to Follow-up|12|||
131429756|NCT00947115|473195241|FG002|Overall Study|Lost to Follow-up|8|||
131429757|NCT04864639|473197053|FG000|Overall Study|Death|1|||
131429758|NCT04864639|473197053|FG000|Overall Study|Lost to Follow-up|1|||
131429759|NCT00447226|473197054|FG000|12-Week Open-label Phase|Adverse Event|0|||
131429760|NCT00447226|473197055|FG001|12-Week Open-label Phase|Adverse Event|3|||
131429761|NCT00447226|473197054|FG000|12-Week Open-label Phase|Protocol Violation|0|||
131429762|NCT00447226|473197055|FG001|12-Week Open-label Phase|Protocol Violation|1|||
131429763|NCT00447226|473197054|FG000|12-Week Open-label Phase|Disease Progression|0|||
131429764|NCT00447226|473197055|FG001|12-Week Open-label Phase|Disease Progression|20|||
131429765|NCT00447226|473197054|FG000|12-Week Open-label Phase|Physician Decision|0|||
131429766|NCT00447226|473197055|FG001|12-Week Open-label Phase|Physician Decision|1|||
131429767|NCT00447226|473197054|FG000|Double-blind Phase|Disease Progression|4|||
131429768|NCT00447226|473197055|FG001|Double-blind Phase|Disease Progression|3|||
131429769|NCT01478971|473197064|FG000|Standard of Care Period|Adverse Event|1|||
131429770|NCT01478971|473197064|FG000|Standard of Care Period|Withdrawal by Subject|3|||
131429771|NCT01478971|473197064|FG000|Standard of Care Period|Death|8|||
131429772|NCT01478971|473197064|FG000|Standard of Care Period|Lost to Follow-up|9|||
131429773|NCT01478971|473197064|FG000|Standard of Care Period|Other|4|||
131429774|NCT01478971|473197064|FG000|Peginesatide Treatment Period|Adverse Event|1|||
131429775|NCT01478971|473197064|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
131429776|NCT01478971|473197064|FG000|Peginesatide Treatment Period|Death|4|||
131429777|NCT01478971|473197064|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
131429778|NCT01478971|473197064|FG000|Peginesatide Treatment Period|Other|4|||
131429779|NCT00584012|473197065|FG000|Overall Study|Withdrawal by Subject|1|||
131429780|NCT01525615|473197066|FG000|Overall Study|Adverse Event|11|||
131429781|NCT01525615|473197067|FG001|Overall Study|Adverse Event|7|||
131429782|NCT01525615|473197068|FG002|Overall Study|Adverse Event|5|||
131429783|NCT01525615|473197066|FG000|Overall Study|Lost to Follow-up|1|||
131429784|NCT01525615|473197067|FG001|Overall Study|Lost to Follow-up|0|||
131429785|NCT01525615|473197068|FG002|Overall Study|Lost to Follow-up|0|||
131429786|NCT01525615|473197066|FG000|Overall Study|Withdrawal by Subject|1|||
131429787|NCT01525615|473197067|FG001|Overall Study|Withdrawal by Subject|0|||
131429788|NCT01525615|473197068|FG002|Overall Study|Withdrawal by Subject|0|||
131429789|NCT01525615|473197066|FG000|Overall Study|Other reason not described above|1|||
131429790|NCT01525615|473197067|FG001|Overall Study|Other reason not described above|0|||
131429791|NCT01525615|473197068|FG002|Overall Study|Other reason not described above|1|||
131429792|NCT04050618|473197069|FG000|First Intervention|Withdrawal by Subject|2|||
131429793|NCT04050618|473197070|FG001|First Intervention|Withdrawal by Subject|0|||
131429794|NCT04050618|473197069|FG000|Second Intervention|Withdrawal by Subject|1|||
131429795|NCT04050618|473197070|FG001|Second Intervention|Withdrawal by Subject|0|||
131429796|NCT04404556|473197071|FG000|Intervention|Withdrawal by Subject|15|||
131429797|NCT04404556|473197072|FG001|Intervention|Withdrawal by Subject|3|||
131429798|NCT04404556|473197071|FG000|Intervention|Did not complete all intervention sessions|2|||
131429799|NCT04404556|473197072|FG001|Intervention|Did not complete all intervention sessions|1|||
131429800|NCT04404556|473197071|FG000|Post-Intervention|Missing Data|1|||
131429801|NCT04404556|473197072|FG001|Post-Intervention|Missing Data|2|||
131429802|NCT04404556|473197071|FG000|Follow-up 1|Withdrawal by Subject|5|||
131429803|NCT04404556|473197072|FG001|Follow-up 1|Withdrawal by Subject|1|||
131429804|NCT04404556|473197071|FG000|Follow-up 1|Missing Data|4|||
131429805|NCT04404556|473197072|FG001|Follow-up 1|Missing Data|7|||
131429806|NCT04404556|473197071|FG000|Follow-up 2|Withdrawal by Subject|1|||
131429807|NCT04404556|473197072|FG001|Follow-up 2|Withdrawal by Subject|1|||
131429808|NCT04404556|473197071|FG000|Follow-up 2|Missing Data|6|||
131429809|NCT04404556|473197072|FG001|Follow-up 2|Missing Data|5|||
131429810|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
131429811|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
131429812|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
131429813|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
131429814|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
131429815|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
131429816|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
131429817|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
131429818|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
131429819|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
131429820|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
131429821|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
131429822|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
131429823|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
131429824|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
131429825|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
131429826|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
131429827|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
131429828|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
131429829|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
131429830|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
131429831|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
131429832|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
131429833|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
131429834|NCT03777059|473197073|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
131429835|NCT03777059|473197074|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
131429836|NCT03777059|473197075|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
131429837|NCT03777059|473197076|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
131429838|NCT03777059|473197073|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
131429839|NCT03777059|473197074|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
131429840|NCT03777059|473197075|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
131429841|NCT03777059|473197076|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
131429842|NCT03777059|473197073|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
131429843|NCT03777059|473197074|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
131429844|NCT03777059|473197075|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
131429845|NCT03777059|473197076|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
131429846|NCT03777059|473197073|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
131429847|NCT03777059|473197074|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
131429848|NCT03777059|473197075|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
131429849|NCT03777059|473197076|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
131429850|NCT03777059|473197073|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
131429851|NCT03777059|473197074|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
131429852|NCT03777059|473197075|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
131429853|NCT03777059|473197076|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
131429854|NCT00763386|473197080|FG000|Overall Study|Adverse Event|43|||
131429855|NCT00763386|473197081|FG001|Overall Study|Adverse Event|33|||
131429856|NCT00763386|473197080|FG000|Overall Study|Death|1|||
131429857|NCT00763386|473197081|FG001|Overall Study|Death|2|||
131429858|NCT00763386|473197080|FG000|Overall Study|Lost to Follow-up|3|||
131429859|NCT00763386|473197081|FG001|Overall Study|Lost to Follow-up|3|||
131429860|NCT00763386|473197080|FG000|Overall Study|Withdrawal by Subject|0|||
131429861|NCT00763386|473197081|FG001|Overall Study|Withdrawal by Subject|1|||
131429862|NCT00763386|473197080|FG000|Overall Study|CRF missing|0|||
131429863|NCT00763386|473197081|FG001|Overall Study|CRF missing|1|||
131429864|NCT00763386|473197080|FG000|Overall Study|Study Prosthesis Removed|1|||
131429865|NCT00763386|473197081|FG001|Overall Study|Study Prosthesis Removed|0|||
131429866|NCT00502671|473197082|FG000|Overall Study|Disease Progression|13|||
131429867|NCT00502671|473197082|FG000|Overall Study|Personal Reasons|22|||
131429868|NCT00502671|473197082|FG000|Overall Study|Lost to Follow-up|7|||
131429869|NCT00502671|473197082|FG000|Overall Study|Protocol Violation|16|||
131429870|NCT00502671|473197082|FG000|Overall Study|Adverse Event|19|||
131429871|NCT00411671|473197085|FG000|Overall Study|Adverse Event|15|||
131429872|NCT00411671|473197085|FG000|Overall Study|Death|2|||
131429873|NCT00411671|473197085|FG000|Overall Study|Lost to Follow-up|3|||
131429874|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
131429875|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131429876|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131429877|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131429878|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131429879|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
131429880|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131429881|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131429882|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131429883|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131429884|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
131429885|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131429886|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131429887|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131429888|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131429889|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
131429890|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131429891|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131429892|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131429893|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131429894|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
131429895|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131429896|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131429897|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131429898|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131429899|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
131429900|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131429901|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131429902|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131429903|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131429904|NCT01173601|473197087|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
131429905|NCT01173601|473197088|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131429906|NCT01173601|473197089|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131429907|NCT01173601|473197090|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131429908|NCT01173601|473197091|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131429909|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
131429910|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
131429911|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
131458437|NCT01065454|473308927|FG000|Follow up|Withdrawal by Subject|1|||
131429912|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
131429913|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
131429914|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
131429915|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
131429916|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
131429917|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
131429918|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
131429919|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
131429920|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
131429921|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
131429922|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
131429923|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
131458438|NCT01065454|473308928|FG001|Follow up|Withdrawal by Subject|1|||
131429924|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131458439|NCT01065454|473308929|FG002|Follow up|Withdrawal by Subject|1|||
131429925|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
131429926|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131429927|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
131429928|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131429929|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
131429930|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
131429931|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131429932|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
131429933|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131429934|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
131429935|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
131429936|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
131429937|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
131429938|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
131429939|NCT01173601|473197087|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131429940|NCT01173601|473197088|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131429941|NCT01173601|473197089|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131429942|NCT01173601|473197090|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131429943|NCT01173601|473197091|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
131429944|NCT00412893|473197092|FG000|Overall Study|Adverse Event|31|||
131429945|NCT00412893|473197093|FG001|Overall Study|Adverse Event|53|||
131429946|NCT00412893|473197092|FG000|Overall Study|Death|17|||
131429947|NCT00412893|473197093|FG001|Overall Study|Death|21|||
131429948|NCT00412893|473197092|FG000|Overall Study|Insufficient Therapeutic Response|39|||
131429949|NCT00412893|473197093|FG001|Overall Study|Insufficient Therapeutic Response|23|||
131429950|NCT00412893|473197092|FG000|Overall Study|Lost to Follow-up|2|||
131429951|NCT00412893|473197093|FG001|Overall Study|Lost to Follow-up|1|||
131429952|NCT00412893|473197092|FG000|Overall Study|Violation of Selection at Entry|17|||
131429953|NCT00412893|473197093|FG001|Overall Study|Violation of Selection at Entry|10|||
131429954|NCT00412893|473197092|FG000|Overall Study|Other Protocol Violation|10|||
131429955|NCT00412893|473197093|FG001|Overall Study|Other Protocol Violation|6|||
131429956|NCT00412893|473197092|FG000|Overall Study|Did Not Cooperate|12|||
131429957|NCT00412893|473197093|FG001|Overall Study|Did Not Cooperate|9|||
131429958|NCT00412893|473197092|FG000|Overall Study|Administrative Reason|12|||
131429959|NCT00412893|473197093|FG001|Overall Study|Administrative Reason|15|||
131429960|NCT00412893|473197092|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
131429961|NCT00412893|473197093|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
131429962|NCT01395901|473197096|FG000|Overall Study|Lost to Follow-up|4|||
131429963|NCT01395901|473197097|FG001|Overall Study|Lost to Follow-up|0|||
131429964|NCT01395901|473197096|FG000|Overall Study|Randomized but not received study drug|5|||
131429965|NCT01395901|473197097|FG001|Overall Study|Randomized but not received study drug|4|||
131429966|NCT01395901|473197096|FG000|Overall Study|Adverse Event|0|||
131429967|NCT01395901|473197097|FG001|Overall Study|Adverse Event|1|||
131429968|NCT01395901|473197096|FG000|Overall Study|Withdrawal of consent|1|||
131429969|NCT01395901|473197097|FG001|Overall Study|Withdrawal of consent|0|||
131429970|NCT02380287|473197101|FG000|Overall Study|Adverse Event|0|||
131429971|NCT02380287|473197102|FG001|Overall Study|Adverse Event|0|||
131429972|NCT02380287|473197103|FG002|Overall Study|Adverse Event|1|||
131429973|NCT02380287|473197104|FG003|Overall Study|Adverse Event|0|||
131429974|NCT02380287|473197105|FG004|Overall Study|Adverse Event|0|||
131429975|NCT02380287|473197106|FG005|Overall Study|Adverse Event|0|||
131429976|NCT02380287|473197107|FG006|Overall Study|Adverse Event|0|||
131429977|NCT02380287|473197108|FG007|Overall Study|Adverse Event|0|||
131429978|NCT01641601|473197109|FG000|Overall Study|Study discontinued.|3|||
131429979|NCT01641601|473197110|FG001|Overall Study|Study discontinued.|5|||
131429980|NCT01799226|473197116|FG000|Overall Study|Withdrawal by Subject|1|||
131429981|NCT01799226|473197117|FG001|Overall Study|Withdrawal by Subject|0|||
131429982|NCT01799226|473197116|FG000|Overall Study|Disqualified at Day 14|1|||
131429983|NCT01799226|473197117|FG001|Overall Study|Disqualified at Day 14|0|||
131429984|NCT02178995|473197118|FG000|Double Blind|Adverse Event|0|||
131429985|NCT02178995|473197119|FG001|Double Blind|Adverse Event|0|||
131429986|NCT02178995|473197120|FG002|Double Blind|Adverse Event|0|||
131429987|NCT02178995|473197121|FG003|Double Blind|Adverse Event|0|||
131429988|NCT02178995|473197122|FG004|Double Blind|Adverse Event|0|||
131429989|NCT02178995|473197123|FG005|Double Blind|Adverse Event|1|||
131429990|NCT02178995|473197124|FG006|Double Blind|Adverse Event|0|||
131429991|NCT02178995|473197125|FG007|Double Blind|Adverse Event|1|||
131429992|NCT02178995|473197126|FG008|Double Blind|Adverse Event|1|||
131429993|NCT02178995|473197118|FG000|Double Blind|Lost to Follow-up|0|||
131429994|NCT02178995|473197119|FG001|Double Blind|Lost to Follow-up|1|||
131429995|NCT02178995|473197120|FG002|Double Blind|Lost to Follow-up|0|||
131429996|NCT02178995|473197121|FG003|Double Blind|Lost to Follow-up|0|||
131429997|NCT02178995|473197122|FG004|Double Blind|Lost to Follow-up|0|||
131429998|NCT02178995|473197123|FG005|Double Blind|Lost to Follow-up|0|||
131429999|NCT02178995|473197124|FG006|Double Blind|Lost to Follow-up|0|||
131430000|NCT02178995|473197125|FG007|Double Blind|Lost to Follow-up|1|||
131430001|NCT02178995|473197126|FG008|Double Blind|Lost to Follow-up|0|||
131430002|NCT02178995|473197118|FG000|Open Label|Adverse Event|2|||
131430003|NCT02178995|473197119|FG001|Open Label|Adverse Event|0|||
131430004|NCT02178995|473197120|FG002|Open Label|Adverse Event|0|||
131430005|NCT02178995|473197121|FG003|Open Label|Adverse Event|0|||
131430006|NCT02178995|473197122|FG004|Open Label|Adverse Event|0|||
131430007|NCT02178995|473197123|FG005|Open Label|Adverse Event|0|||
131430008|NCT02178995|473197124|FG006|Open Label|Adverse Event|0|||
131430009|NCT02178995|473197125|FG007|Open Label|Adverse Event|0|||
131430010|NCT02178995|473197126|FG008|Open Label|Adverse Event|0|||
131430011|NCT00587158|473197127|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
131430012|NCT00587158|473197128|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
131430013|NCT00587158|473197127|FG000|Overall Study|Physician Decision|0|||
131430014|NCT00587158|473197128|FG001|Overall Study|Physician Decision|1|||
131430015|NCT00587158|473197127|FG000|Overall Study|Lost to Follow-up|1|||
131430016|NCT00587158|473197128|FG001|Overall Study|Lost to Follow-up|2|||
131430017|NCT00587158|473197127|FG000|Overall Study|Death|0|||
131430018|NCT00587158|473197128|FG001|Overall Study|Death|1|||
131430019|NCT00587158|473197127|FG000|Overall Study|Subject did not want to take study med|0|||
131430020|NCT00587158|473197128|FG001|Overall Study|Subject did not want to take study med|1|||
131430021|NCT02274792|473197129|FG000|Overall Study|Withdrawal by Subject|13|||
131430022|NCT02274792|473197129|FG000|Overall Study|Lost to Follow-up|8|||
131430023|NCT02274792|473197129|FG000|Overall Study|Protocol Specified Criteria|2|||
131430024|NCT02274792|473197129|FG000|Overall Study|Sponsor Decision|2|||
131430025|NCT00832416|473197130|FG000|Overall Study|Lack of Efficacy|17|||
131430026|NCT00832416|473197131|FG001|Overall Study|Lack of Efficacy|15|||
131430027|NCT00832416|473197132|FG002|Overall Study|Lack of Efficacy|13|||
131430028|NCT00832416|473197133|FG003|Overall Study|Lack of Efficacy|52|||
131430029|NCT00832416|473197130|FG000|Overall Study|Withdrawal by Subject|5|||
131430030|NCT00832416|473197131|FG001|Overall Study|Withdrawal by Subject|7|||
131430031|NCT00832416|473197132|FG002|Overall Study|Withdrawal by Subject|2|||
131430032|NCT00832416|473197133|FG003|Overall Study|Withdrawal by Subject|10|||
131430033|NCT00832416|473197130|FG000|Overall Study|Physician Decision|2|||
131430034|NCT00832416|473197131|FG001|Overall Study|Physician Decision|12|||
131430035|NCT00832416|473197132|FG002|Overall Study|Physician Decision|5|||
131430036|NCT00832416|473197133|FG003|Overall Study|Physician Decision|10|||
131430037|NCT00832416|473197130|FG000|Overall Study|Administrative|0|||
131430038|NCT00832416|473197131|FG001|Overall Study|Administrative|0|||
131430039|NCT00832416|473197132|FG002|Overall Study|Administrative|0|||
131430040|NCT00832416|473197133|FG003|Overall Study|Administrative|1|||
131430041|NCT00832416|473197130|FG000|Overall Study|Adverse Event|21|||
131430042|NCT00832416|473197131|FG001|Overall Study|Adverse Event|19|||
131430043|NCT00832416|473197132|FG002|Overall Study|Adverse Event|41|||
131430044|NCT00832416|473197133|FG003|Overall Study|Adverse Event|10|||
131430045|NCT00832416|473197130|FG000|Overall Study|Death|1|||
131430046|NCT00832416|473197131|FG001|Overall Study|Death|0|||
131430047|NCT00832416|473197132|FG002|Overall Study|Death|0|||
131430048|NCT00832416|473197133|FG003|Overall Study|Death|0|||
131430049|NCT02741596|473197140|FG000|Overall Study|Adverse Event|1|||
131430050|NCT02741596|473197141|FG001|Overall Study|Adverse Event|5|||
131430051|NCT02741596|473197140|FG000|Overall Study|Lost to Follow-up|1|||
131430052|NCT02741596|473197141|FG001|Overall Study|Lost to Follow-up|1|||
131430053|NCT02741596|473197140|FG000|Overall Study|Physician Decision|2|||
131430054|NCT02741596|473197141|FG001|Overall Study|Physician Decision|1|||
131430055|NCT02741596|473197140|FG000|Overall Study|Pregnancy|3|||
131430056|NCT02741596|473197141|FG001|Overall Study|Pregnancy|1|||
131430057|NCT02741596|473197140|FG000|Overall Study|Other (Unspecified)|0|||
131430058|NCT02741596|473197141|FG001|Overall Study|Other (Unspecified)|3|||
131430059|NCT02741596|473197140|FG000|Overall Study|Subject withdrawn-Other|17|||
131430060|NCT02741596|473197141|FG001|Overall Study|Subject withdrawn-Other|4|||
131430061|NCT02741596|473197140|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
131430062|NCT02741596|473197141|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
131430063|NCT02859246|473197144|FG000|Overall Study|Screen fails|3|||
131430064|NCT02859246|473197144|FG000|Overall Study|Adverse Event|1|||
131430065|NCT02859246|473197144|FG000|Overall Study|Withdrawal by Subject|1|||
131430066|NCT00181766|473197145|FG000|Overall Study|Lost to Follow-up|6|||
131430067|NCT00181766|473197145|FG000|Overall Study|Adverse Event|4|||
131430068|NCT00181766|473197145|FG000|Overall Study|non-compliance|2|||
131430069|NCT01196026|473197148|FG000|Overall Study|Withdrawal by Subject|1|||
131430070|NCT01196026|473197149|FG001|Overall Study|Withdrawal by Subject|4|||
131430071|NCT01196026|473197150|FG002|Overall Study|Withdrawal by Subject|0|||
131430072|NCT01196026|473197151|FG003|Overall Study|Withdrawal by Subject|0|||
131430073|NCT01196026|473197152|FG004|Overall Study|Withdrawal by Subject|0|||
131430074|NCT01196026|473197153|FG005|Overall Study|Withdrawal by Subject|0|||
131430075|NCT01196026|473197148|FG000|Overall Study|Lost to Follow-up|0|||
131430076|NCT01196026|473197149|FG001|Overall Study|Lost to Follow-up|3|||
131430077|NCT01196026|473197150|FG002|Overall Study|Lost to Follow-up|0|||
131430078|NCT01196026|473197151|FG003|Overall Study|Lost to Follow-up|0|||
131430079|NCT01196026|473197152|FG004|Overall Study|Lost to Follow-up|1|||
131430080|NCT01196026|473197153|FG005|Overall Study|Lost to Follow-up|0|||
131430081|NCT01196026|473197148|FG000|Overall Study|Other|0|||
131430082|NCT01196026|473197149|FG001|Overall Study|Other|1|||
131430083|NCT01196026|473197150|FG002|Overall Study|Other|0|||
131430084|NCT01196026|473197151|FG003|Overall Study|Other|0|||
131430085|NCT01196026|473197152|FG004|Overall Study|Other|0|||
131430086|NCT01196026|473197153|FG005|Overall Study|Other|0|||
131430087|NCT01687296|473197154|FG000|Overall Study|Lack of Efficacy|1|||
131430088|NCT01687296|473197155|FG001|Overall Study|Lack of Efficacy|1|||
131430089|NCT01687296|473197154|FG000|Overall Study|Protocol Violation|0|||
131430090|NCT01687296|473197155|FG001|Overall Study|Protocol Violation|1|||
131430091|NCT01687296|473197154|FG000|Overall Study|Withdrawal by Subject|6|||
131430092|NCT01687296|473197155|FG001|Overall Study|Withdrawal by Subject|3|||
131430093|NCT03672292|473197157|FG000|Overall Study|Adverse Event|3|||
131430094|NCT03672292|473197158|FG001|Overall Study|Adverse Event|1|||
131430095|NCT03672292|473197157|FG000|Overall Study|Physician Decision|0|||
131430096|NCT03672292|473197158|FG001|Overall Study|Physician Decision|1|||
131430097|NCT03672292|473197157|FG000|Overall Study|Withdrawal by Subject|1|||
131430098|NCT03672292|473197158|FG001|Overall Study|Withdrawal by Subject|2|||
131430099|NCT02336230|473197159|FG000|Overall Study|Adverse Event|1|||
131430100|NCT02336230|473197159|FG000|Overall Study|Withdrawal of consent|1|||
131430101|NCT02336230|473197159|FG000|Overall Study|Death|9|||
131430102|NCT02336230|473197159|FG000|Overall Study|Dose not received due to shipping delay|1|||
131430103|NCT02336230|473197159|FG000|Overall Study|Discontinuation of MSC infusion|1|||
131430104|NCT00556998|473197164|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
131430105|NCT00556998|473197164|FG000|Voriconazole Intravenous (IV)|Other|4|||
131430106|NCT00556998|473197164|FG000|Voriconazole Oral|Adverse Event|1|||
131430107|NCT00556998|473197164|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
131430108|NCT05447663|473197165|FG000|Overall Study|Study terminated by Sponsor|5|||
131430109|NCT05447663|473197165|FG000|Overall Study|Death|2|||
131430110|NCT05447663|473197165|FG000|Overall Study|Withdrawal by Subject|1|||
131430111|NCT02864901|473197166|FG000|Overall Study|Withdrawal by Subject|1|||
131430112|NCT02864901|473197167|FG001|Overall Study|Withdrawal by Subject|0|||
131430113|NCT01219985|473197168|FG000|Overall Study|Physician Decision|20|||
131430114|NCT04797780|473197169|FG000|Overall Study|Lost to Follow-up|1|||
131430115|NCT04797780|473197170|FG001|Overall Study|Lost to Follow-up|1|||
131430116|NCT04797780|473197169|FG000|Overall Study|Withdrawal by Subject|14|||
131430117|NCT04797780|473197170|FG001|Overall Study|Withdrawal by Subject|9|||
131430118|NCT04797780|473197169|FG000|Overall Study|Death|49|||
131430119|NCT04797780|473197170|FG001|Overall Study|Death|20|||
131430120|NCT05973006|473197171|FG000|Overall Study|Early termination|3|||
131430121|NCT05973006|473197172|FG001|Overall Study|Early termination|9|||
131430122|NCT00132808|473197180|FG000|Stratum I|Adverse Event|2|||
131430123|NCT00132808|473197181|FG001|Stratum I|Adverse Event|1|||
131430124|NCT00132808|473197182|FG002|Stratum I|Adverse Event|0|||
131430125|NCT00132808|473197180|FG000|Stratum I|Lost to Follow-up|3|||
131430126|NCT00132808|473197181|FG001|Stratum I|Lost to Follow-up|4|||
131430127|NCT00132808|473197182|FG002|Stratum I|Lost to Follow-up|1|||
131430128|NCT00132808|473197180|FG000|Stratum I|Withdrawal by Subject|4|||
131430129|NCT00132808|473197181|FG001|Stratum I|Withdrawal by Subject|7|||
131430130|NCT00132808|473197182|FG002|Stratum I|Withdrawal by Subject|3|||
131430131|NCT00132808|473197180|FG000|Stratum I|Abnormal test procedure result (s)|0|||
131430132|NCT00132808|473197181|FG001|Stratum I|Abnormal test procedure result (s)|0|||
131430133|NCT00132808|473197182|FG002|Stratum I|Abnormal test procedure result (s)|1|||
131430134|NCT00132808|473197180|FG000|Stratum II|Adverse Event|1|||
131430135|NCT00132808|473197181|FG001|Stratum II|Adverse Event|2|||
131430136|NCT00132808|473197182|FG002|Stratum II|Adverse Event|1|||
131458440|NCT01065454|473308930|FG003|Follow up|Withdrawal by Subject|0|||
131458441|NCT01065454|473308927|FG000|Follow up|study ongoing|37|||
131430137|NCT00132808|473197180|FG000|Stratum II|Death|1|||
131430138|NCT00132808|473197181|FG001|Stratum II|Death|0|||
131430139|NCT00132808|473197182|FG002|Stratum II|Death|0|||
131430140|NCT00132808|473197180|FG000|Stratum II|Lost to Follow-up|2|||
131430141|NCT00132808|473197181|FG001|Stratum II|Lost to Follow-up|2|||
131430142|NCT00132808|473197182|FG002|Stratum II|Lost to Follow-up|1|||
131430143|NCT00132808|473197180|FG000|Stratum II|Protocol Violation|0|||
131430144|NCT00132808|473197181|FG001|Stratum II|Protocol Violation|2|||
131430145|NCT00132808|473197182|FG002|Stratum II|Protocol Violation|1|||
131430146|NCT00132808|473197180|FG000|Stratum II|Withdrawal by Subject|4|||
131430147|NCT00132808|473197181|FG001|Stratum II|Withdrawal by Subject|9|||
131430148|NCT00132808|473197182|FG002|Stratum II|Withdrawal by Subject|6|||
131430149|NCT03405818|473197183|FG000|Overall Study|Withdrawal by Subject|4|||
131430150|NCT03405818|473197183|FG000|Overall Study|Lost to Follow-up|4|||
131430151|NCT02363959|473197184|FG000|Overall Study|Medical instability|1|||
131430152|NCT02363959|473197185|FG001|Overall Study|Medical instability|0|||
131430153|NCT00950248|473197188|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
131430154|NCT00950248|473197189|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
131458442|NCT01065454|473308928|FG001|Follow up|study ongoing|22|||
131458443|NCT01065454|473308929|FG002|Follow up|study ongoing|15|||
131430155|NCT00950248|473197190|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
131430156|NCT00950248|473197188|FG000|Year 1: Baseline|worsening of symptoms|2|||
131430157|NCT00950248|473197189|FG001|Year 1: Baseline|worsening of symptoms|0|||
131430158|NCT00950248|473197190|FG002|Year 1: Baseline|worsening of symptoms|0|||
131430159|NCT00950248|473197188|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
131430160|NCT00950248|473197189|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
131430161|NCT00950248|473197190|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
131430162|NCT00950248|473197188|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
131430163|NCT00950248|473197189|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
131430164|NCT00950248|473197190|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
131430165|NCT00950248|473197188|FG000|Year 2&3 Treatment Randomization|Death|0|||
131430166|NCT00950248|473197189|FG001|Year 2&3 Treatment Randomization|Death|0|||
131430167|NCT00950248|473197190|FG002|Year 2&3 Treatment Randomization|Death|1|||
131430168|NCT00950248|473197188|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
131430169|NCT00950248|473197189|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
131430170|NCT00950248|473197190|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
131430171|NCT01900652|473197192|FG000|Overall Study|Progressive Disease|1|||
131430172|NCT01900652|473197193|FG001|Overall Study|Progressive Disease|0|||
131430173|NCT01900652|473197192|FG000|Overall Study|Consent withdrawn by subject|1|||
131430174|NCT01900652|473197193|FG001|Overall Study|Consent withdrawn by subject|1|||
131430175|NCT01900652|473197192|FG000|Overall Study|Death|3|||
131430176|NCT01900652|473197193|FG001|Overall Study|Death|0|||
131430177|NCT01900652|473197192|FG000|Overall Study|Adverse Event|2|||
131430178|NCT01900652|473197193|FG001|Overall Study|Adverse Event|1|||
131430179|NCT01900652|473197192|FG000|Overall Study|Physician Decision|1|||
131430180|NCT01900652|473197193|FG001|Overall Study|Physician Decision|1|||
131430181|NCT00869518|473197196|FG000|Overall Study|Lost to Follow-up|1|||
131430182|NCT00869518|473197197|FG001|Overall Study|Lost to Follow-up|1|||
131430183|NCT01223183|473197201|FG000|Imaging Day 1|Physician Decision|0|||
131430184|NCT01223183|473197202|FG001|Imaging Day 1|Physician Decision|1|||
131430185|NCT01223183|473197201|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
131430186|NCT01223183|473197202|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
131430187|NCT01223183|473197201|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
131430188|NCT01223183|473197202|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
131430189|NCT02663622|473197203|FG000|Overall Study|Death|3|||
131430190|NCT02663622|473197204|FG001|Overall Study|Death|1|||
131430191|NCT02663622|473197205|FG002|Overall Study|Death|1|||
131430192|NCT02663622|473197206|FG003|Overall Study|Death|8|||
131430193|NCT02663622|473197203|FG000|Overall Study|Protocol Violation|0|||
131430194|NCT02663622|473197204|FG001|Overall Study|Protocol Violation|0|||
131430195|NCT02663622|473197205|FG002|Overall Study|Protocol Violation|0|||
131430196|NCT02663622|473197206|FG003|Overall Study|Protocol Violation|1|||
131430197|NCT00900029|473197209|FG000|Overall Study|Lost to Follow-up|0|||
131430198|NCT00900029|473197210|FG001|Overall Study|Lost to Follow-up|2|||
131430199|NCT00900029|473197211|FG002|Overall Study|Lost to Follow-up|1|||
131430200|NCT00900029|473197212|FG003|Overall Study|Lost to Follow-up|4|||
131430201|NCT00900029|473197213|FG004|Overall Study|Lost to Follow-up|4|||
131430202|NCT00900029|473197209|FG000|Overall Study|Withdrawal by Subject|2|||
131430203|NCT00900029|473197210|FG001|Overall Study|Withdrawal by Subject|2|||
131430204|NCT00900029|473197211|FG002|Overall Study|Withdrawal by Subject|1|||
131430205|NCT00900029|473197212|FG003|Overall Study|Withdrawal by Subject|1|||
131430206|NCT00900029|473197213|FG004|Overall Study|Withdrawal by Subject|1|||
131430207|NCT00900029|473197209|FG000|Overall Study|Adverse Event|0|||
131430208|NCT00900029|473197210|FG001|Overall Study|Adverse Event|0|||
131430209|NCT00900029|473197211|FG002|Overall Study|Adverse Event|1|||
131430210|NCT00900029|473197212|FG003|Overall Study|Adverse Event|1|||
131430211|NCT00900029|473197213|FG004|Overall Study|Adverse Event|1|||
131430212|NCT00900029|473197209|FG000|Overall Study|Death|1|||
131430213|NCT00900029|473197210|FG001|Overall Study|Death|0|||
131430214|NCT00900029|473197211|FG002|Overall Study|Death|0|||
131430215|NCT00900029|473197212|FG003|Overall Study|Death|1|||
131430216|NCT00900029|473197213|FG004|Overall Study|Death|0|||
131430217|NCT00511238|473197216|FG000|Overall Study|Adverse Event|13|||
131430218|NCT00511238|473197217|FG001|Overall Study|Adverse Event|33|||
131430219|NCT00511238|473197216|FG000|Overall Study|Withdrawal by Subject|2|||
131430220|NCT00511238|473197217|FG001|Overall Study|Withdrawal by Subject|22|||
131430221|NCT00511238|473197216|FG000|Overall Study|Progressive Disease|23|||
131430222|NCT00511238|473197217|FG001|Overall Study|Progressive Disease|157|||
131430223|NCT00511238|473197216|FG000|Overall Study|various reasons|4|||
131430224|NCT00511238|473197217|FG001|Overall Study|various reasons|14|||
131430225|NCT00163020|473197218|FG000|Overall Study|Lost to Follow-up|0|||
131430226|NCT00163020|473197219|FG001|Overall Study|Lost to Follow-up|2|||
131430227|NCT03772665|473197220|FG000|Overall Study|Protocol Violation|1|||
131430228|NCT03772665|473197221|FG001|Overall Study|Protocol Violation|0|||
131430229|NCT01594931|473199841|FG000|Overall Study|Adverse Event|3|||
131430230|NCT01594931|473199842|FG001|Overall Study|Adverse Event|1|||
131430231|NCT01594931|473199843|FG002|Overall Study|Adverse Event|1|||
131430232|NCT01594931|473199841|FG000|Overall Study|Withdrawal by Subject|2|||
131430233|NCT01594931|473199842|FG001|Overall Study|Withdrawal by Subject|1|||
131430234|NCT01594931|473199843|FG002|Overall Study|Withdrawal by Subject|1|||
131430235|NCT01594931|473199841|FG000|Overall Study|Lack of Efficacy|7|||
131430236|NCT01594931|473199842|FG001|Overall Study|Lack of Efficacy|2|||
131430237|NCT01594931|473199843|FG002|Overall Study|Lack of Efficacy|2|||
131430238|NCT01594931|473199841|FG000|Overall Study|Lost to Follow-up|4|||
131430239|NCT01594931|473199842|FG001|Overall Study|Lost to Follow-up|3|||
131430240|NCT01594931|473199843|FG002|Overall Study|Lost to Follow-up|3|||
131430241|NCT01594931|473199841|FG000|Overall Study|Protocol Violation|2|||
131430242|NCT01594931|473199842|FG001|Overall Study|Protocol Violation|1|||
131430243|NCT01594931|473199843|FG002|Overall Study|Protocol Violation|0|||
131430244|NCT01594931|473199841|FG000|Overall Study|No defiined|11|||
131430245|NCT01594931|473199842|FG001|Overall Study|No defiined|4|||
131430246|NCT01594931|473199843|FG002|Overall Study|No defiined|7|||
131430247|NCT01467505|473199847|FG000|Overall Study|Adverse Event|1|||
131430248|NCT01467505|473199848|FG001|Overall Study|Adverse Event|0|||
131430249|NCT01467505|473199847|FG000|Overall Study|Withdrawal by Subject|4|||
131430250|NCT01467505|473199848|FG001|Overall Study|Withdrawal by Subject|0|||
131430251|NCT01467505|473199847|FG000|Overall Study|Study Terminated by Sponsor|28|||
131430252|NCT01467505|473199848|FG001|Overall Study|Study Terminated by Sponsor|3|||
131430253|NCT00922623|473199852|FG000|Overall Study|Other|4|||
131430254|NCT00922623|473199852|FG000|Overall Study|Lost to Follow-up|1|||
131430255|NCT02871635|473199853|FG000|Overall Study|Primary lack of efficacy|4|||
131430256|NCT02871635|473199854|FG001|Overall Study|Primary lack of efficacy|4|||
131430257|NCT02871635|473199853|FG000|Overall Study|Protocol Violation|3|||
131430258|NCT02871635|473199854|FG001|Overall Study|Protocol Violation|1|||
131430259|NCT02871635|473199853|FG000|Overall Study|Lost to Follow-up|1|||
131430260|NCT02871635|473199854|FG001|Overall Study|Lost to Follow-up|2|||
131430261|NCT02871635|473199853|FG000|Overall Study|Pregnancy|0|||
131430262|NCT02871635|473199854|FG001|Overall Study|Pregnancy|2|||
131430263|NCT02871635|473199853|FG000|Overall Study|Physician Decision|1|||
131430264|NCT02871635|473199854|FG001|Overall Study|Physician Decision|1|||
131430265|NCT02871635|473199853|FG000|Overall Study|Withdrawal by Subject|3|||
131430266|NCT02871635|473199854|FG001|Overall Study|Withdrawal by Subject|4|||
131430267|NCT02871635|473199853|FG000|Overall Study|Adverse Event|4|||
131430268|NCT02871635|473199854|FG001|Overall Study|Adverse Event|4|||
131430269|NCT02871635|473199853|FG000|Overall Study|Secondary lack of efficacy|2|||
131430270|NCT02871635|473199854|FG001|Overall Study|Secondary lack of efficacy|1|||
131430271|NCT02420379|473199855|FG000|Overall Study|Withdrawal by Subject|0|||
131430272|NCT02420379|473199856|FG001|Overall Study|Withdrawal by Subject|3|||
131430273|NCT02420379|473199855|FG000|Overall Study|Unable to complete due to schooling|0|||
131430274|NCT02420379|473199856|FG001|Overall Study|Unable to complete due to schooling|1|||
131430275|NCT02420379|473199855|FG000|Overall Study|Transitioned to commercial drug|1|||
131430276|NCT02420379|473199856|FG001|Overall Study|Transitioned to commercial drug|0|||
131430277|NCT01402817|473199857|FG000|Overall Study|Withdrawal by Subject|3|||
131430278|NCT01402817|473199857|FG000|Overall Study|Study Suspended by FDA|8|||
131430279|NCT01473732|473199859|FG000|Overall Study|Adverse Event|1|||
131430280|NCT01473732|473199860|FG001|Overall Study|Adverse Event|0|||
131430281|NCT01473732|473199859|FG000|Overall Study|Death|1|||
131430282|NCT01473732|473199860|FG001|Overall Study|Death|0|||
131430283|NCT01217944|473199864|FG000|Overall Study|Protocol Violation|1|||
131430284|NCT01217944|473199865|FG001|Overall Study|Protocol Violation|1|||
131430285|NCT01217944|473199866|FG002|Overall Study|Protocol Violation|0|||
131430286|NCT01217944|473199864|FG000|Overall Study|Lost to Follow-up|3|||
131430287|NCT01217944|473199865|FG001|Overall Study|Lost to Follow-up|1|||
131430288|NCT01217944|473199866|FG002|Overall Study|Lost to Follow-up|0|||
131430289|NCT01217944|473199864|FG000|Overall Study|Withdrawal by Subject|1|||
131430290|NCT01217944|473199865|FG001|Overall Study|Withdrawal by Subject|2|||
131430291|NCT01217944|473199866|FG002|Overall Study|Withdrawal by Subject|0|||
131430292|NCT01217944|473199864|FG000|Overall Study|Lack of Efficacy|1|||
131430293|NCT01217944|473199865|FG001|Overall Study|Lack of Efficacy|0|||
131430294|NCT01217944|473199866|FG002|Overall Study|Lack of Efficacy|0|||
131430295|NCT04473963|473199867|FG000|Overall Study|Withdrawal by Subject|1|||
131430296|NCT04473963|473199868|FG001|Overall Study|Withdrawal by Subject|1|||
131430297|NCT04473963|473199869|FG002|Overall Study|Withdrawal by Subject|0|||
131430298|NCT04473963|473199867|FG000|Overall Study|Not inducible in AF|0|||
131430299|NCT04473963|473199868|FG001|Overall Study|Not inducible in AF|0|||
131430300|NCT04473963|473199869|FG002|Overall Study|Not inducible in AF|2|||
131430301|NCT02114606|473199870|FG000|Overall Study|Unable to swallow Cytosponge|6|||
131430302|NCT00981461|473199871|FG000|Overall Study|Lost to Follow-up|5|||
131430303|NCT00981461|473199872|FG001|Overall Study|Lost to Follow-up|2|||
131430304|NCT03361293|473199881|FG000|Overall Study|Lost to Follow-up|0|||
131430305|NCT03361293|473199882|FG001|Overall Study|Lost to Follow-up|2|||
131430306|NCT03361293|473199881|FG000|Overall Study|Withdrawal by Subject|1|||
131430307|NCT03361293|473199882|FG001|Overall Study|Withdrawal by Subject|3|||
131430308|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
131430309|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
131430310|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
131458444|NCT01065454|473308930|FG003|Follow up|study ongoing|41|||
131430311|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
131430312|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
131430313|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
131430314|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
131430315|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
131430316|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
131430317|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
131430318|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
131430319|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
131430320|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
131430321|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
131430322|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
131430323|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
131430324|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
131430325|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
131430326|NCT01910402|473199883|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
131430327|NCT01910402|473199884|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
131430328|NCT01910402|473199885|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
131430329|NCT01910402|473199883|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
131430330|NCT01910402|473199884|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
131430331|NCT01910402|473199885|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
131430332|NCT01910402|473199883|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
131430333|NCT01910402|473199884|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
131430334|NCT01910402|473199885|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
131430335|NCT01910402|473199883|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
131430336|NCT01910402|473199884|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
131430337|NCT01910402|473199885|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
131430338|NCT01910402|473199883|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
131430339|NCT01910402|473199884|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
131430340|NCT01910402|473199885|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
131430341|NCT01910402|473199883|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
131430342|NCT01910402|473199884|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
131430343|NCT01910402|473199885|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
131430344|NCT01910402|473199883|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
131430345|NCT01910402|473199884|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
131430346|NCT01910402|473199885|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
131430347|NCT00483405|473199888|FG000|Overall Study|Adverse Event|8|||
131430348|NCT00483405|473199888|FG000|Overall Study|Lack of Efficacy|14|||
131430349|NCT00483405|473199888|FG000|Overall Study|Death|3|||
131430350|NCT00483405|473199888|FG000|Overall Study|Withdrawal by Subject|2|||
131430351|NCT00483405|473199888|FG000|Overall Study|Other complicating disease|1|||
131430352|NCT00571038|473199889|FG000|Overall Study|Lost to Follow-up|1|||
131430353|NCT00571038|473199890|FG001|Overall Study|Lost to Follow-up|4|||
131430354|NCT00571038|473199889|FG000|Overall Study|Death|7|||
131430355|NCT00571038|473199890|FG001|Overall Study|Death|5|||
131430356|NCT00571038|473199889|FG000|Overall Study|Withdrawal by Subject|1|||
131430357|NCT00571038|473199890|FG001|Overall Study|Withdrawal by Subject|3|||
131430358|NCT00571038|473199889|FG000|Overall Study|Moved out of state|2|||
131430359|NCT00571038|473199890|FG001|Overall Study|Moved out of state|2|||
131430360|NCT01550757|473199891|FG000|Overall Study|Lost to Follow-up|21|||
131430361|NCT01550757|473199892|FG001|Overall Study|Lost to Follow-up|14|||
131430362|NCT01550757|473199893|FG002|Overall Study|Lost to Follow-up|42|||
131430363|NCT01550757|473199894|FG003|Overall Study|Lost to Follow-up|53|||
131430364|NCT01550757|473199891|FG000|Overall Study|Withdrawal by Subject|2|||
131430365|NCT01550757|473199892|FG001|Overall Study|Withdrawal by Subject|0|||
131430366|NCT01550757|473199893|FG002|Overall Study|Withdrawal by Subject|3|||
131430367|NCT01550757|473199894|FG003|Overall Study|Withdrawal by Subject|1|||
131430368|NCT04098809|473199896|FG000|Overall Study|Withdrawal by Subject|1|||
131430369|NCT04098809|473199897|FG001|Overall Study|Withdrawal by Subject|3|||
131430370|NCT04098809|473199896|FG000|Overall Study|Physician Decision|2|||
131430371|NCT04098809|473199897|FG001|Overall Study|Physician Decision|1|||
131430372|NCT00193206|473199898|FG000|Preoperative Therapy|Lack of Efficacy|2|||
131430373|NCT00193206|473199898|FG000|Preoperative Therapy|Adverse Event|2|||
131430374|NCT00193206|473199898|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
131430375|NCT00193206|473199898|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
131430376|NCT00193206|473199898|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
131430377|NCT00193206|473199898|FG000|Postoperative Therapy|Physician Decision|3|||
131430378|NCT00193206|473199898|FG000|Postoperative Therapy|Intercurrent Illness|2|||
131458445|NCT01601652|473308931|FG000|Overall Study|Death|1|||
131430379|NCT00193206|473199898|FG000|Postoperative Therapy|Lack of Efficacy|1|||
131430380|NCT00193206|473199898|FG000|Postoperative Therapy|Protocol Violation|1|||
131430381|NCT01426958|473199899|FG000|Overall Study|Adverse Event|2|||
131430382|NCT00991939|473199902|FG000|Overall Study|Lost to Follow-up|0|||
131430383|NCT00991939|473199903|FG001|Overall Study|Lost to Follow-up|1|||
131430384|NCT00991939|473199902|FG000|Overall Study|Withdrawal by Subject|1|||
131430385|NCT00991939|473199903|FG001|Overall Study|Withdrawal by Subject|0|||
131430386|NCT00991939|473199902|FG000|Overall Study|Entire study terminated|4|||
131430387|NCT00991939|473199903|FG001|Overall Study|Entire study terminated|1|||
131430388|NCT00740584|473199904|FG000|Overall Study|Withdrawal by Subject|1|||
131430389|NCT02073682|473199909|FG000|Overall Study|Low Creatinine Clearance|1|||
131430390|NCT02073682|473199910|FG001|Overall Study|Low Creatinine Clearance|2|||
131430391|NCT02073682|473199909|FG000|Overall Study|Death|86|||
131430392|NCT02073682|473199910|FG001|Overall Study|Death|100|||
131430393|NCT02073682|473199909|FG000|Overall Study|Cancer Cured|10|||
131430394|NCT02073682|473199910|FG001|Overall Study|Cancer Cured|15|||
131430395|NCT02073682|473199909|FG000|Overall Study|ID: Patient Noncompliance|1|||
131430396|NCT02073682|473199910|FG001|Overall Study|ID: Patient Noncompliance|2|||
131430397|NCT02073682|473199909|FG000|Overall Study|ID: Palliative Treatment Only|10|||
131430398|NCT02073682|473199910|FG001|Overall Study|ID: Palliative Treatment Only|7|||
131430399|NCT02073682|473199909|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
131430400|NCT02073682|473199910|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
131430401|NCT02073682|473199909|FG000|Overall Study|Platelet Count <50,000/mL|1|||
131430402|NCT02073682|473199910|FG001|Overall Study|Platelet Count <50,000/mL|2|||
131430403|NCT02073682|473199909|FG000|Overall Study|Surgery/Medical Procedure|3|||
131430404|NCT02073682|473199910|FG001|Overall Study|Surgery/Medical Procedure|1|||
131430405|NCT02073682|473199909|FG000|Overall Study|Withdrawal by Subject|6|||
131430406|NCT02073682|473199910|FG001|Overall Study|Withdrawal by Subject|8|||
131430407|NCT02073682|473199909|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
131430408|NCT02073682|473199910|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
131430409|NCT02073682|473199909|FG000|Overall Study|Cancer Progression|53|||
131430410|NCT02073682|473199910|FG001|Overall Study|Cancer Progression|33|||
131430411|NCT02073682|473199909|FG000|Overall Study|Protocol Violation|1|||
131430412|NCT02073682|473199910|FG001|Overall Study|Protocol Violation|0|||
131430413|NCT02073682|473199909|FG000|Overall Study|Adverse Event|79|||
131430414|NCT02073682|473199910|FG001|Overall Study|Adverse Event|62|||
131430415|NCT02073682|473199909|FG000|Overall Study|No reason provided|11|||
131430416|NCT02073682|473199910|FG001|Overall Study|No reason provided|9|||
131430417|NCT02073682|473199909|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
131430418|NCT02073682|473199910|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
131430419|NCT02073682|473199909|FG000|Overall Study|Lost to Follow-up|1|||
131430420|NCT02073682|473199910|FG001|Overall Study|Lost to Follow-up|1|||
131430421|NCT02073682|473199909|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
131430422|NCT02073682|473199910|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
131430423|NCT00413218|473199911|FG000|Overall Study|Randomized but didn't receive study drug|2|||
131430424|NCT00413218|473199912|FG001|Overall Study|Randomized but didn't receive study drug|8|||
131430425|NCT00413218|473199911|FG000|Overall Study|Death|57|||
131430426|NCT00413218|473199912|FG001|Overall Study|Death|56|||
131430427|NCT00413218|473199911|FG000|Overall Study|Lost to Follow-up|14|||
131430428|NCT00413218|473199912|FG001|Overall Study|Lost to Follow-up|17|||
131430429|NCT00413218|473199911|FG000|Overall Study|Admin|20|||
131430430|NCT00413218|473199912|FG001|Overall Study|Admin|14|||
131430431|NCT00413218|473199911|FG000|Overall Study|Missing|1|||
131430432|NCT00413218|473199912|FG001|Overall Study|Missing|0|||
131430433|NCT00413218|473199911|FG000|Overall Study|Withdrawal by Subject|9|||
131430434|NCT00413218|473199912|FG001|Overall Study|Withdrawal by Subject|1|||
131430435|NCT00216671|473199917|FG000|Overall Study|Adverse Event|4|||
131430436|NCT00216671|473199918|FG001|Overall Study|Adverse Event|9|||
131430437|NCT00216671|473199917|FG000|Overall Study|Pregnancy|0|||
131430438|NCT00216671|473199918|FG001|Overall Study|Pregnancy|1|||
131430439|NCT00216671|473199917|FG000|Overall Study|Withdrawal by Subject|4|||
131430440|NCT00216671|473199918|FG001|Overall Study|Withdrawal by Subject|2|||
131430441|NCT00216671|473199917|FG000|Overall Study|Refused Injections|3|||
131430442|NCT00216671|473199918|FG001|Overall Study|Refused Injections|13|||
131430443|NCT00216671|473199917|FG000|Overall Study|No Need to Continue Medication|1|||
131430444|NCT00216671|473199918|FG001|Overall Study|No Need to Continue Medication|1|||
131430445|NCT00216671|473199917|FG000|Overall Study|Insufficient Response|9|||
131430446|NCT00216671|473199918|FG001|Overall Study|Insufficient Response|4|||
131430447|NCT00216671|473199917|FG000|Overall Study|Lost to Follow-up|3|||
131430448|NCT00216671|473199918|FG001|Overall Study|Lost to Follow-up|5|||
131430449|NCT00216671|473199917|FG000|Overall Study|Non compliant|2|||
131430450|NCT00216671|473199918|FG001|Overall Study|Non compliant|2|||
131430451|NCT00216671|473199917|FG000|Overall Study|Ineligible|0|||
131430452|NCT00216671|473199918|FG001|Overall Study|Ineligible|2|||
131430453|NCT00216671|473199917|FG000|Overall Study|Physician Decision|1|||
131430454|NCT00216671|473199918|FG001|Overall Study|Physician Decision|1|||
131430455|NCT00216671|473199917|FG000|Overall Study|Protocol Violation|3|||
131430456|NCT00216671|473199918|FG001|Overall Study|Protocol Violation|5|||
131430457|NCT00216671|473199917|FG000|Overall Study|Relapse|1|||
131430458|NCT00216671|473199918|FG001|Overall Study|Relapse|0|||
131430459|NCT00216671|473199917|FG000|Overall Study|Investigator Illness|0|||
131430460|NCT00216671|473199918|FG001|Overall Study|Investigator Illness|1|||
131430461|NCT00216671|473199917|FG000|Overall Study|Patient Moved|0|||
131430462|NCT00216671|473199918|FG001|Overall Study|Patient Moved|1|||
131430463|NCT00216671|473199917|FG000|Overall Study|Ineligible, no efficacy data|2|||
131430464|NCT00216671|473199918|FG001|Overall Study|Ineligible, no efficacy data|2|||
131430465|NCT00216671|473199917|FG000|Overall Study|Insufficient Response Adverse Event|2|||
131430466|NCT00216671|473199918|FG001|Overall Study|Insufficient Response Adverse Event|1|||
131430467|NCT04961541|473199919|FG000|Overall Study|Adverse Event|0|||
131430468|NCT04961541|473199920|FG001|Overall Study|Adverse Event|0|||
131430469|NCT04961541|473199921|FG002|Overall Study|Adverse Event|0|||
131430470|NCT04961541|473199922|FG003|Overall Study|Adverse Event|0|||
131430471|NCT04961541|473199923|FG004|Overall Study|Adverse Event|0|||
131430472|NCT04961541|473199924|FG005|Overall Study|Adverse Event|1|||
131430473|NCT04961541|473199925|FG006|Overall Study|Adverse Event|0|||
131430474|NCT04961541|473199926|FG007|Overall Study|Adverse Event|0|||
131430475|NCT04961541|473199927|FG008|Overall Study|Adverse Event|0|||
131430476|NCT04961541|473199928|FG009|Overall Study|Adverse Event|0|||
131430477|NCT04961541|473199929|FG010|Overall Study|Adverse Event|0|||
131430478|NCT04961541|473199930|FG011|Overall Study|Adverse Event|0|||
131430479|NCT04961541|473199931|FG012|Overall Study|Adverse Event|0|||
131430480|NCT04961541|473199932|FG013|Overall Study|Adverse Event|0|||
131430481|NCT04961541|473199919|FG000|Overall Study|Lost to Follow-up|0|||
131430482|NCT04961541|473199920|FG001|Overall Study|Lost to Follow-up|0|||
131430483|NCT04961541|473199921|FG002|Overall Study|Lost to Follow-up|3|||
131430484|NCT04961541|473199922|FG003|Overall Study|Lost to Follow-up|0|||
131430485|NCT04961541|473199923|FG004|Overall Study|Lost to Follow-up|0|||
131430486|NCT04961541|473199924|FG005|Overall Study|Lost to Follow-up|0|||
131430487|NCT04961541|473199925|FG006|Overall Study|Lost to Follow-up|1|||
131430488|NCT04961541|473199926|FG007|Overall Study|Lost to Follow-up|1|||
131430489|NCT04961541|473199927|FG008|Overall Study|Lost to Follow-up|0|||
131430490|NCT04961541|473199928|FG009|Overall Study|Lost to Follow-up|1|||
131430491|NCT04961541|473199929|FG010|Overall Study|Lost to Follow-up|0|||
131430492|NCT04961541|473199930|FG011|Overall Study|Lost to Follow-up|0|||
131430493|NCT04961541|473199931|FG012|Overall Study|Lost to Follow-up|1|||
131430494|NCT04961541|473199932|FG013|Overall Study|Lost to Follow-up|0|||
131430495|NCT04961541|473199919|FG000|Overall Study|Withdrawal by Subject|0|||
131430496|NCT04961541|473199920|FG001|Overall Study|Withdrawal by Subject|0|||
131430497|NCT04961541|473199921|FG002|Overall Study|Withdrawal by Subject|1|||
131430498|NCT04961541|473199922|FG003|Overall Study|Withdrawal by Subject|1|||
131430499|NCT04961541|473199923|FG004|Overall Study|Withdrawal by Subject|0|||
131430500|NCT04961541|473199924|FG005|Overall Study|Withdrawal by Subject|0|||
131430501|NCT04961541|473199925|FG006|Overall Study|Withdrawal by Subject|0|||
131430502|NCT04961541|473199926|FG007|Overall Study|Withdrawal by Subject|0|||
131430503|NCT04961541|473199927|FG008|Overall Study|Withdrawal by Subject|0|||
131430504|NCT04961541|473199928|FG009|Overall Study|Withdrawal by Subject|1|||
131430505|NCT04961541|473199929|FG010|Overall Study|Withdrawal by Subject|0|||
131430506|NCT04961541|473199930|FG011|Overall Study|Withdrawal by Subject|0|||
131430507|NCT04961541|473199931|FG012|Overall Study|Withdrawal by Subject|0|||
131430508|NCT04961541|473199932|FG013|Overall Study|Withdrawal by Subject|0|||
131430509|NCT03539601|473199934|FG000|Overall Study|Withdraw by parent/guardian|1|||
131430510|NCT03539601|473199935|FG001|Overall Study|Withdraw by parent/guardian|0|||
131430511|NCT03539601|473199936|FG002|Overall Study|Withdraw by parent/guardian|1|||
131430512|NCT03539601|473199937|FG003|Overall Study|Withdraw by parent/guardian|0|||
131430513|NCT03539601|473199934|FG000|Overall Study|Adverse Event|0|||
131430514|NCT03539601|473199935|FG001|Overall Study|Adverse Event|2|||
131430515|NCT03539601|473199936|FG002|Overall Study|Adverse Event|0|||
131430516|NCT03539601|473199937|FG003|Overall Study|Adverse Event|0|||
131430517|NCT03539601|473199934|FG000|Overall Study|Lost to Follow-up|2|||
131430518|NCT03539601|473199935|FG001|Overall Study|Lost to Follow-up|4|||
131430519|NCT03539601|473199936|FG002|Overall Study|Lost to Follow-up|5|||
131430520|NCT03539601|473199937|FG003|Overall Study|Lost to Follow-up|0|||
131430521|NCT03539601|473199934|FG000|Overall Study|Withdrawal by Subject|2|||
131430522|NCT03539601|473199935|FG001|Overall Study|Withdrawal by Subject|0|||
131430523|NCT03539601|473199936|FG002|Overall Study|Withdrawal by Subject|0|||
131430524|NCT03539601|473199937|FG003|Overall Study|Withdrawal by Subject|1|||
131430525|NCT03539601|473199934|FG000|Overall Study|Randomized but not treated|1|||
131430526|NCT03539601|473199935|FG001|Overall Study|Randomized but not treated|1|||
131430527|NCT03539601|473199936|FG002|Overall Study|Randomized but not treated|0|||
131430528|NCT03539601|473199937|FG003|Overall Study|Randomized but not treated|0|||
131430529|NCT01970306|473199938|FG000|Overall Study|Not eligible|3|||
131430530|NCT01970306|473199938|FG000|Overall Study|Not able to be treated|9|||
131430531|NCT03081884|473199939|FG000|Overall Study|deferred prostate cancer treatment|1|||
131430532|NCT03081884|473199939|FG000|Overall Study|metastasis managed with systemic therapy|3|||
131430533|NCT03948334|473199941|FG000|Overall Study|Adverse Event|1|||
131430534|NCT03948334|473199942|FG001|Overall Study|Adverse Event|4|||
131430535|NCT03948334|473199941|FG000|Overall Study|Lack of Efficacy|2|||
131430536|NCT03948334|473199942|FG001|Overall Study|Lack of Efficacy|0|||
131430537|NCT03948334|473199941|FG000|Overall Study|Lost to Follow-up|1|||
131430538|NCT03948334|473199942|FG001|Overall Study|Lost to Follow-up|0|||
131430539|NCT03948334|473199941|FG000|Overall Study|Physician Decision|1|||
131430540|NCT03948334|473199942|FG001|Overall Study|Physician Decision|0|||
131430541|NCT03948334|473199941|FG000|Overall Study|Pregnancy|0|||
131430542|NCT03948334|473199942|FG001|Overall Study|Pregnancy|1|||
131430543|NCT03948334|473199941|FG000|Overall Study|Protocol Deviation|1|||
131430544|NCT03948334|473199942|FG001|Overall Study|Protocol Deviation|0|||
131430545|NCT03948334|473199941|FG000|Overall Study|Study terminated by Sponsor|50|||
131430546|NCT03948334|473199942|FG001|Overall Study|Study terminated by Sponsor|51|||
131430547|NCT03948334|473199941|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
131430548|NCT03948334|473199942|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
131430549|NCT00700713|473199944|FG000|Overall Study|Protocol Violation|1|||
131430550|NCT00700713|473199945|FG001|Overall Study|Protocol Violation|0|||
131430551|NCT00700713|473199946|FG002|Overall Study|Protocol Violation|1|||
131430552|NCT00700713|473199944|FG000|Overall Study|Withdrawal by Subject|0|||
131430553|NCT00700713|473199945|FG001|Overall Study|Withdrawal by Subject|0|||
131430554|NCT00700713|473199946|FG002|Overall Study|Withdrawal by Subject|1|||
131430555|NCT01100320|473199948|FG000|Period 1|Withdrawal by Subject|2|||
131430556|NCT01100320|473199949|FG001|Period 1|Withdrawal by Subject|4|||
131430557|NCT01100320|473199948|FG000|Period 1|Positive Drug Screen|1|||
131430558|NCT01100320|473199949|FG001|Period 1|Positive Drug Screen|1|||
131430559|NCT01100320|473199948|FG000|Period 1|Adverse Event|2|||
131430560|NCT01100320|473199949|FG001|Period 1|Adverse Event|2|||
131430561|NCT01100320|473199948|FG000|Period 2|Withdrawal by Subject|1|||
131430562|NCT01100320|473199949|FG001|Period 2|Withdrawal by Subject|1|||
131430563|NCT00550953|473199950|FG000|Overall Study|Adverse Event|4|||
131430564|NCT00550953|473199951|FG001|Overall Study|Adverse Event|3|||
131430565|NCT00550953|473199950|FG000|Overall Study|Not able to visit the site|2|||
131430566|NCT00550953|473199951|FG001|Overall Study|Not able to visit the site|3|||
131430567|NCT03797586|473199952|FG000|Overall Study|Lost to Follow-up|3|||
131430568|NCT03797586|473199953|FG001|Overall Study|Lost to Follow-up|6|||
131430569|NCT03797586|473199952|FG000|Overall Study|Death|1|||
131430570|NCT03797586|473199953|FG001|Overall Study|Death|1|||
131430571|NCT03797586|473199952|FG000|Overall Study|Adverse Event|0|||
131430572|NCT03797586|473199953|FG001|Overall Study|Adverse Event|2|||
131430573|NCT04980612|473199954|FG000|Overall Study|Withdrawal by Subject|7|||
131430574|NCT04980612|473199955|FG001|Overall Study|Withdrawal by Subject|5|||
131430575|NCT05730387|473199956|FG000|Overall Study|Stillbirth|0|||
131430576|NCT05730387|473199957|FG001|Overall Study|Stillbirth|262|||
131430577|NCT05730387|473199956|FG000|Overall Study|Died during or after delivery|2|||
131430578|NCT05730387|473199957|FG001|Overall Study|Died during or after delivery|85|||
131430579|NCT05730387|473199956|FG000|Overall Study|Died after being admitted|0|||
131430580|NCT05730387|473199957|FG001|Overall Study|Died after being admitted|44|||
131430581|NCT05730387|473199956|FG000|Overall Study|Lost to Follow-up|69|||
131430582|NCT05730387|473199957|FG001|Overall Study|Lost to Follow-up|77|||
131430583|NCT02446717|473199958|FG000|Overall Study|Adverse Event|0|||
131430584|NCT02446717|473199959|FG001|Overall Study|Adverse Event|0|||
131430585|NCT02446717|473199960|FG002|Overall Study|Adverse Event|1|||
131430586|NCT02446717|473199961|FG003|Overall Study|Adverse Event|0|||
131430587|NCT02446717|473199962|FG004|Overall Study|Adverse Event|0|||
131430588|NCT02446717|473199958|FG000|Overall Study|Lost to Follow-up|0|||
131430589|NCT02446717|473199959|FG001|Overall Study|Lost to Follow-up|1|||
131430590|NCT02446717|473199960|FG002|Overall Study|Lost to Follow-up|1|||
131430591|NCT02446717|473199961|FG003|Overall Study|Lost to Follow-up|0|||
131430592|NCT02446717|473199962|FG004|Overall Study|Lost to Follow-up|1|||
131430593|NCT02446717|473199958|FG000|Overall Study|Withdrew consent|0|||
131430594|NCT02446717|473199959|FG001|Overall Study|Withdrew consent|0|||
131430595|NCT02446717|473199960|FG002|Overall Study|Withdrew consent|0|||
131430596|NCT02446717|473199961|FG003|Overall Study|Withdrew consent|1|||
131430597|NCT02446717|473199962|FG004|Overall Study|Withdrew consent|0|||
131430598|NCT02680665|473199963|FG000|Overall Study|No visit after the first prescription|5|||
131430599|NCT00596752|473199964|FG000|Overall Study|Other Reason|44|||
131430600|NCT00596752|473199965|FG001|Overall Study|Other Reason|49|||
131430601|NCT00596752|473199964|FG000|Overall Study|Adverse Event|34|||
131430602|NCT00596752|473199965|FG001|Overall Study|Adverse Event|34|||
131430603|NCT00596752|473199964|FG000|Overall Study|Lost to Follow-up|22|||
131430604|NCT00596752|473199965|FG001|Overall Study|Lost to Follow-up|38|||
131430605|NCT00596752|473199964|FG000|Overall Study|Withdrawal by Subject|12|||
131430606|NCT00596752|473199965|FG001|Overall Study|Withdrawal by Subject|9|||
131430607|NCT00596752|473199964|FG000|Overall Study|Unsatisfactory Compliance|9|||
131430608|NCT00596752|473199965|FG001|Overall Study|Unsatisfactory Compliance|6|||
131430609|NCT00596752|473199964|FG000|Overall Study|Lack of Efficacy|4|||
131430610|NCT00596752|473199965|FG001|Overall Study|Lack of Efficacy|7|||
131430611|NCT00596752|473199964|FG000|Overall Study|Protocol Violation|1|||
131430612|NCT00596752|473199965|FG001|Overall Study|Protocol Violation|0|||
131430613|NCT04669301|473199966|FG000|Overall Study|Lost to Follow-up|0|||
131430614|NCT04669301|473199967|FG001|Overall Study|Lost to Follow-up|1|||
131458446|NCT05688670|473308932|FG000|Overall Study|Change in surgery plan|1|||
131430615|NCT04669301|473199968|FG002|Overall Study|Lost to Follow-up|0|||
131430616|NCT04669301|473199966|FG000|Overall Study|Withdrawal by Subject|3|||
131430617|NCT04669301|473199967|FG001|Overall Study|Withdrawal by Subject|2|||
131430618|NCT04669301|473199968|FG002|Overall Study|Withdrawal by Subject|0|||
131430619|NCT02940496|473199969|FG000|Overall Study|Adverse Event|1|||
131430620|NCT02940496|473199970|FG001|Overall Study|Adverse Event|0|||
131430621|NCT02940496|473199969|FG000|Overall Study|Death|2|||
131430622|NCT02940496|473199970|FG001|Overall Study|Death|0|||
131430623|NCT02940496|473199969|FG000|Overall Study|Hospice Care|1|||
131430624|NCT02940496|473199970|FG001|Overall Study|Hospice Care|0|||
131430625|NCT02940496|473199969|FG000|Overall Study|No MRE Done|1|||
131430626|NCT02940496|473199970|FG001|Overall Study|No MRE Done|0|||
131430627|NCT02940496|473199969|FG000|Overall Study|MRE Failure|1|||
131430628|NCT02940496|473199970|FG001|Overall Study|MRE Failure|0|||
131430629|NCT02715609|473199972|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
131430630|NCT02715609|473199973|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
131430631|NCT02715609|473199974|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
131430632|NCT02715609|473199972|FG000|Overall Study|Withdrawal by Subject|0|||
131430633|NCT02715609|473199973|FG001|Overall Study|Withdrawal by Subject|0|||
131430634|NCT02715609|473199974|FG002|Overall Study|Withdrawal by Subject|1|||
131430635|NCT00924443|473199979|FG000|Overall Study|Physician Decision|2|||
131430636|NCT00924443|473199979|FG000|Overall Study|Protocol Violation|1|||
131430637|NCT00595478|473199986|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
131430638|NCT00595478|473199987|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
131430639|NCT00595478|473199986|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
131430640|NCT00595478|473199987|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
131430641|NCT02978833|473199992|FG000|Overall Study|Study terminated|1|||
131430642|NCT02978833|473199993|FG001|Overall Study|Study terminated|1|||
131430643|NCT00103740|473199994|FG000|Period 1 - Core|Adverse Event|1|||
131430644|NCT00103740|473199995|FG001|Period 1 - Core|Adverse Event|0|||
131430645|NCT00103740|473199994|FG000|Period 1 - Core|Protocol Violation|3|||
131430646|NCT00103740|473199995|FG001|Period 1 - Core|Protocol Violation|2|||
131430647|NCT00103740|473199994|FG000|Period 1 - Core|Patient withdrew consent|3|||
131430648|NCT00103740|473199995|FG001|Period 1 - Core|Patient withdrew consent|2|||
131430649|NCT00103740|473199994|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
131430650|NCT00103740|473199995|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
131430651|NCT00103740|473199994|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
131430652|NCT00103740|473199995|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
131430653|NCT00103740|473199994|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
131430654|NCT00103740|473199995|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
131430655|NCT00103740|473199994|FG000|Period 2 - Extended Observation Period|Death|6|||
131430656|NCT00103740|473199995|FG001|Period 2 - Extended Observation Period|Death|2|||
131430657|NCT00103740|473199994|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
131430658|NCT00103740|473199995|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
131430659|NCT02587819|473199999|FG000|Overall Study|Adverse Event|1|||
131430660|NCT02587819|473199999|FG000|Overall Study|Lost to Follow-up|1|||
131430661|NCT03449758|473201986|FG000|Overall Study|Major protocol deviation|1|||
131430662|NCT03449758|473201986|FG000|Overall Study|Treatment inefficacy|5|||
131430663|NCT03449758|473201986|FG000|Overall Study|Adverse Event|9|||
131430664|NCT03449758|473201986|FG000|Overall Study|Consent withdrawal|1|||
131430665|NCT03449758|473201986|FG000|Overall Study|Other unspecified reason|3|||
131430666|NCT00671034|473201997|FG000|Overall Study|Adverse Event|5|||
131430667|NCT00671034|473201998|FG001|Overall Study|Adverse Event|7|||
131430668|NCT00671034|473201999|FG002|Overall Study|Adverse Event|1|||
131430669|NCT00671034|473201997|FG000|Overall Study|Death|3|||
131430670|NCT00671034|473201998|FG001|Overall Study|Death|2|||
131430671|NCT00671034|473201999|FG002|Overall Study|Death|1|||
131430672|NCT00671034|473201997|FG000|Overall Study|Physician Decision|12|||
131430673|NCT00671034|473201998|FG001|Overall Study|Physician Decision|4|||
131430674|NCT00671034|473201999|FG002|Overall Study|Physician Decision|5|||
131430675|NCT00671034|473201997|FG000|Overall Study|VHR ALL feature|8|||
131430676|NCT00671034|473201998|FG001|Overall Study|VHR ALL feature|3|||
131458447|NCT05688670|473308933|FG001|Overall Study|Change in surgery plan|4|||
131458448|NCT05688670|473308932|FG000|Overall Study|Inability to extubate|1|||
131458449|NCT05688670|473308933|FG001|Overall Study|Inability to extubate|2|||
131458450|NCT05688670|473308932|FG000|Overall Study|Day of surgery cancellation|0|||
131458451|NCT05688670|473308933|FG001|Overall Study|Day of surgery cancellation|1|||
131458452|NCT05688670|473308932|FG000|Overall Study|Reintubated on PCICU arrival|0|||
131458453|NCT05688670|473308933|FG001|Overall Study|Reintubated on PCICU arrival|1|||
131430677|NCT00671034|473201999|FG002|Overall Study|VHR ALL feature|5|||
131430678|NCT00671034|473201997|FG000|Overall Study|Refusal|5|||
131430679|NCT00671034|473201998|FG001|Overall Study|Refusal|3|||
131430680|NCT00671034|473201999|FG002|Overall Study|Refusal|5|||
131430681|NCT00671034|473201997|FG000|Overall Study|includes Alternative therapy, etc.|6|||
131430682|NCT00671034|473201998|FG001|Overall Study|includes Alternative therapy, etc.|1|||
131430683|NCT00671034|473201999|FG002|Overall Study|includes Alternative therapy, etc.|7|||
131430684|NCT00853151|473202000|FG000|Overall Study|Adverse Event|1|||
131430685|NCT00853151|473202001|FG001|Overall Study|Adverse Event|4|||
131430686|NCT00853151|473202002|FG002|Overall Study|Adverse Event|2|||
131430687|NCT00853151|473202003|FG003|Overall Study|Adverse Event|0|||
131430688|NCT00853151|473202000|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131430689|NCT00853151|473202001|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131430690|NCT00853151|473202002|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131430691|NCT00853151|473202003|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131430692|NCT00853151|473202000|FG000|Overall Study|Lost to Follow-up|2|||
131430693|NCT00853151|473202001|FG001|Overall Study|Lost to Follow-up|0|||
131430694|NCT00853151|473202002|FG002|Overall Study|Lost to Follow-up|3|||
131430695|NCT00853151|473202003|FG003|Overall Study|Lost to Follow-up|0|||
131430696|NCT00853151|473202000|FG000|Overall Study|Death|1|||
131430697|NCT00853151|473202001|FG001|Overall Study|Death|0|||
131430698|NCT00853151|473202002|FG002|Overall Study|Death|0|||
131430699|NCT00853151|473202003|FG003|Overall Study|Death|1|||
131430700|NCT00853151|473202000|FG000|Overall Study|Protocol Violation|0|||
131430701|NCT00853151|473202001|FG001|Overall Study|Protocol Violation|0|||
131430702|NCT00853151|473202002|FG002|Overall Study|Protocol Violation|0|||
131430703|NCT00853151|473202003|FG003|Overall Study|Protocol Violation|1|||
131430704|NCT00853151|473202000|FG000|Overall Study|Withdrawal by Subject|5|||
131430705|NCT00853151|473202001|FG001|Overall Study|Withdrawal by Subject|4|||
131430706|NCT00853151|473202002|FG002|Overall Study|Withdrawal by Subject|2|||
131430707|NCT00853151|473202003|FG003|Overall Study|Withdrawal by Subject|1|||
131430708|NCT00853151|473202000|FG000|Overall Study|Physician Decision|0|||
131430709|NCT00853151|473202001|FG001|Overall Study|Physician Decision|2|||
131430710|NCT00853151|473202002|FG002|Overall Study|Physician Decision|1|||
131430711|NCT00853151|473202003|FG003|Overall Study|Physician Decision|0|||
131430712|NCT00853151|473202000|FG000|Overall Study|Sponsor Decision|0|||
131430713|NCT00853151|473202001|FG001|Overall Study|Sponsor Decision|3|||
131430714|NCT00853151|473202002|FG002|Overall Study|Sponsor Decision|0|||
131430715|NCT00853151|473202003|FG003|Overall Study|Sponsor Decision|0|||
131430716|NCT00269919|473202004|FG000|Overall Study|Other|26|||
131430717|NCT00269919|473202004|FG000|Overall Study|Started but not treated|1|||
131430718|NCT02471014|473202007|FG000|Overall Study|Lost to Follow-up|2|||
131430719|NCT02471014|473202008|FG001|Overall Study|Lost to Follow-up|2|||
131430720|NCT01751984|473202009|FG000|Overall Study|Adverse Event|5|||
131430721|NCT01751984|473202010|FG001|Overall Study|Adverse Event|3|||
131430722|NCT01751984|473202009|FG000|Overall Study|Withdrawal by Subject|0|||
131430723|NCT01751984|473202010|FG001|Overall Study|Withdrawal by Subject|1|||
131430724|NCT01751984|473202009|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
131430725|NCT01751984|473202010|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
131430726|NCT01388907|473202011|FG000|Overall Study|Adverse Event|2|||
131430727|NCT01388907|473202012|FG001|Overall Study|Adverse Event|0|||
131430728|NCT01797263|473202013|FG000|Overall Study|Withdrawal by Subject|21|||
131430729|NCT01797263|473202014|FG001|Overall Study|Withdrawal by Subject|25|||
131430730|NCT01797263|473202013|FG000|Overall Study|Death|1|||
131430731|NCT01797263|473202014|FG001|Overall Study|Death|0|||
131430732|NCT01797263|473202013|FG000|Overall Study|Lost to Follow-up|15|||
131430733|NCT01797263|473202014|FG001|Overall Study|Lost to Follow-up|15|||
131430734|NCT03187132|473202015|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
131430735|NCT03187132|473202016|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
131430736|NCT03187132|473202015|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
131430737|NCT03187132|473202016|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
131430738|NCT03187132|473202015|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
131430739|NCT03187132|473202016|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
131430740|NCT03187132|473202015|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
131430741|NCT03187132|473202016|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
131430742|NCT03187132|473202015|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
131430743|NCT03187132|473202016|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
131430744|NCT03187132|473202015|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
131430745|NCT03187132|473202016|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
131430746|NCT03187132|473202015|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
131430747|NCT03187132|473202016|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
131430748|NCT03187132|473202015|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
131430749|NCT03187132|473202016|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
131430750|NCT03187132|473202015|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
131430751|NCT03187132|473202016|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
131430752|NCT03187132|473202015|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
131430753|NCT03187132|473202016|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
131430754|NCT03187132|473202015|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
131430755|NCT03187132|473202016|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
131430756|NCT02045095|473202017|FG000|Overall Study|Other|0|||
131430757|NCT02045095|473202018|FG001|Overall Study|Other|0|||
131430758|NCT02045095|473202019|FG002|Overall Study|Other|1|||
131430759|NCT02045095|473202020|FG003|Overall Study|Other|0|||
131430760|NCT02045095|473202021|FG004|Overall Study|Other|0|||
131458454|NCT01097005|473308943|FG000|Overall Study|Case Report Form not collected|18|||
131430761|NCT02045095|473202022|FG005|Overall Study|Other|2|||
131430762|NCT02045095|473202023|FG006|Overall Study|Other|0|||
131430763|NCT02045095|473202017|FG000|Overall Study|Progressive Disease|3|||
131430764|NCT02045095|473202018|FG001|Overall Study|Progressive Disease|3|||
131430765|NCT02045095|473202019|FG002|Overall Study|Progressive Disease|2|||
131430766|NCT02045095|473202020|FG003|Overall Study|Progressive Disease|4|||
131430767|NCT02045095|473202021|FG004|Overall Study|Progressive Disease|2|||
131430768|NCT02045095|473202022|FG005|Overall Study|Progressive Disease|4|||
131430769|NCT02045095|473202023|FG006|Overall Study|Progressive Disease|1|||
131430770|NCT02045095|473202017|FG000|Overall Study|Withdrawal by Subject|0|||
131430771|NCT02045095|473202018|FG001|Overall Study|Withdrawal by Subject|0|||
131430772|NCT02045095|473202019|FG002|Overall Study|Withdrawal by Subject|0|||
131430773|NCT02045095|473202020|FG003|Overall Study|Withdrawal by Subject|0|||
131430774|NCT02045095|473202021|FG004|Overall Study|Withdrawal by Subject|3|||
131430775|NCT02045095|473202022|FG005|Overall Study|Withdrawal by Subject|0|||
131430776|NCT02045095|473202023|FG006|Overall Study|Withdrawal by Subject|0|||
131430777|NCT02045095|473202017|FG000|Overall Study|Adverse Event|0|||
131430778|NCT02045095|473202018|FG001|Overall Study|Adverse Event|1|||
131430779|NCT02045095|473202019|FG002|Overall Study|Adverse Event|1|||
131430780|NCT02045095|473202020|FG003|Overall Study|Adverse Event|0|||
131430781|NCT02045095|473202021|FG004|Overall Study|Adverse Event|0|||
131430782|NCT02045095|473202022|FG005|Overall Study|Adverse Event|2|||
131430783|NCT02045095|473202023|FG006|Overall Study|Adverse Event|0|||
131430784|NCT03594773|473202024|FG000|Overall Study|Withdrawal by Subject|3|||
131430785|NCT03594773|473202025|FG001|Overall Study|Withdrawal by Subject|2|||
131430786|NCT03594773|473202024|FG000|Overall Study|Lost to Follow-up|3|||
131430787|NCT03594773|473202025|FG001|Overall Study|Lost to Follow-up|4|||
131430788|NCT00714415|473202027|FG000|Overall Study|Lack of Efficacy|1|||
131430789|NCT00714415|473202028|FG001|Overall Study|Lack of Efficacy|0|||
131430790|NCT00714415|473202027|FG000|Overall Study|Death|1|||
131430791|NCT00714415|473202028|FG001|Overall Study|Death|0|||
131430792|NCT01461707|473202031|FG000|Overall Study|Withdrawal by Subject|1|||
131430793|NCT01461707|473202032|FG001|Overall Study|Withdrawal by Subject|0|||
131430794|NCT00855816|473202038|FG000|Overall Study|Withdrawal by Subject|22|||
131430795|NCT00855816|473202039|FG001|Overall Study|Withdrawal by Subject|15|||
131430796|NCT00855816|473202038|FG000|Overall Study|Lost to Follow-up|3|||
131430797|NCT00855816|473202039|FG001|Overall Study|Lost to Follow-up|5|||
131430798|NCT00855816|473202038|FG000|Overall Study|Death|1|||
131430799|NCT00855816|473202039|FG001|Overall Study|Death|0|||
131430800|NCT00855816|473202038|FG000|Overall Study|Became ineligible|0|||
131430801|NCT00855816|473202039|FG001|Overall Study|Became ineligible|1|||
131430802|NCT01965704|473202043|FG000|Overall Study|Withdrawal by Subject|2|||
131430803|NCT01965704|473202044|FG001|Overall Study|Withdrawal by Subject|2|||
131430804|NCT01965704|473202045|FG002|Overall Study|Withdrawal by Subject|1|||
131430805|NCT01965704|473202046|FG003|Overall Study|Withdrawal by Subject|1|||
131430806|NCT01965704|473202043|FG000|Overall Study|Delivered at home|1|||
131430807|NCT01965704|473202044|FG001|Overall Study|Delivered at home|1|||
131430808|NCT01965704|473202045|FG002|Overall Study|Delivered at home|0|||
131430809|NCT01965704|473202046|FG003|Overall Study|Delivered at home|0|||
131430810|NCT01965704|473202043|FG000|Overall Study|Experienced complications|0|||
131430811|NCT01965704|473202044|FG001|Overall Study|Experienced complications|0|||
131430812|NCT01965704|473202045|FG002|Overall Study|Experienced complications|2|||
131430813|NCT01965704|473202046|FG003|Overall Study|Experienced complications|2|||
131430814|NCT01965704|473202043|FG000|Overall Study|Adverse Event|0|||
131430815|NCT01965704|473202044|FG001|Overall Study|Adverse Event|0|||
131430816|NCT01965704|473202045|FG002|Overall Study|Adverse Event|1|||
131430817|NCT01965704|473202046|FG003|Overall Study|Adverse Event|1|||
131430818|NCT01965704|473202043|FG000|Overall Study|Did not meet inclusion criteria|0|||
131430819|NCT01965704|473202044|FG001|Overall Study|Did not meet inclusion criteria|0|||
131430820|NCT01965704|473202045|FG002|Overall Study|Did not meet inclusion criteria|1|||
131430821|NCT01965704|473202046|FG003|Overall Study|Did not meet inclusion criteria|1|||
131430822|NCT00687804|473202054|FG000|Core Study|Adverse Event|5|||
131430823|NCT00687804|473202055|FG001|Core Study|Adverse Event|3|||
131430824|NCT00687804|473202056|FG002|Core Study|Adverse Event|3|||
131430825|NCT00687804|473202054|FG000|Core Study|Abnormal laboratory value(s)|1|||
131430826|NCT00687804|473202055|FG001|Core Study|Abnormal laboratory value(s)|0|||
131430827|NCT00687804|473202056|FG002|Core Study|Abnormal laboratory value(s)|0|||
131430828|NCT00687804|473202054|FG000|Core Study|Lack of Efficacy|1|||
131430829|NCT00687804|473202055|FG001|Core Study|Lack of Efficacy|1|||
131430830|NCT00687804|473202056|FG002|Core Study|Lack of Efficacy|1|||
131430831|NCT00687804|473202054|FG000|Core Study|Withdrawal by Subject|4|||
131430832|NCT00687804|473202055|FG001|Core Study|Withdrawal by Subject|7|||
131430833|NCT00687804|473202056|FG002|Core Study|Withdrawal by Subject|7|||
131430834|NCT00687804|473202054|FG000|Core Study|Lost to Follow-up|0|||
131430835|NCT00687804|473202055|FG001|Core Study|Lost to Follow-up|1|||
131430836|NCT00687804|473202056|FG002|Core Study|Lost to Follow-up|0|||
131430837|NCT00687804|473202054|FG000|Core Study|Death|2|||
131430838|NCT00687804|473202055|FG001|Core Study|Death|2|||
131430839|NCT00687804|473202056|FG002|Core Study|Death|2|||
131430840|NCT00687804|473202054|FG000|Core Study|Protocol Violation|1|||
131430841|NCT00687804|473202055|FG001|Core Study|Protocol Violation|1|||
131430842|NCT00687804|473202056|FG002|Core Study|Protocol Violation|0|||
131430843|NCT00687804|473202054|FG000|Open-Label Extension Study|Adverse Event|2|||
131430844|NCT00687804|473202055|FG001|Open-Label Extension Study|Adverse Event|2|||
131430845|NCT00687804|473202056|FG002|Open-Label Extension Study|Adverse Event|2|||
131430846|NCT00687804|473202054|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
131430847|NCT00687804|473202055|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
131430848|NCT00687804|473202056|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
131430849|NCT00687804|473202054|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
131430850|NCT00687804|473202055|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
131430851|NCT00687804|473202056|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
131430852|NCT00687804|473202054|FG000|Open-Label Extension Study|Administrative problems|1|||
131430853|NCT00687804|473202055|FG001|Open-Label Extension Study|Administrative problems|1|||
131430854|NCT00687804|473202056|FG002|Open-Label Extension Study|Administrative problems|0|||
131430855|NCT00687804|473202054|FG000|Open-Label Extension Study|Death|2|||
131430856|NCT00687804|473202055|FG001|Open-Label Extension Study|Death|3|||
131430857|NCT00687804|473202056|FG002|Open-Label Extension Study|Death|3|||
131430858|NCT04390243|473202057|FG000|Overall Study|Death|1|||
131430859|NCT04390243|473202057|FG000|Overall Study|Disease Progression|4|||
131430860|NCT04390243|473202057|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
131430861|NCT04317040|473202060|FG000|Overall Study|Lost to Follow-up|2|||
131430862|NCT04317040|473202061|FG001|Overall Study|Lost to Follow-up|0|||
131430863|NCT04317040|473202060|FG000|Overall Study|Death|16|||
131430864|NCT04317040|473202061|FG001|Overall Study|Death|18|||
131430865|NCT04317040|473202060|FG000|Overall Study|Withdrawal by Subject|0|||
131430866|NCT04317040|473202061|FG001|Overall Study|Withdrawal by Subject|1|||
131430867|NCT04317040|473202060|FG000|Overall Study|Incomplete assessments|0|||
131430868|NCT04317040|473202061|FG001|Overall Study|Incomplete assessments|1|||
131430869|NCT00799903|473202062|FG000|Overall Study|Investigator Site Closed|25|||
131430870|NCT00799903|473202063|FG001|Overall Study|Investigator Site Closed|23|||
131430871|NCT00799903|473202062|FG000|Overall Study|Withdrawal by Subject|179|||
131430872|NCT00799903|473202063|FG001|Overall Study|Withdrawal by Subject|175|||
131430873|NCT00799903|473202062|FG000|Overall Study|Lost to Follow-up|69|||
131430874|NCT00799903|473202063|FG001|Overall Study|Lost to Follow-up|80|||
131430875|NCT01338818|473202067|FG000|Overall Study|Adverse Event|8|||
131430876|NCT01338818|473202067|FG000|Overall Study|Lack of Efficacy|5|||
131430877|NCT01338818|473202067|FG000|Overall Study|no longer require study drug|1|||
131430878|NCT01338818|473202067|FG000|Overall Study|Withdrawal by Subject|11|||
131430879|NCT01338818|473202067|FG000|Overall Study|Lost to Follow-up|4|||
131430880|NCT01338818|473202067|FG000|Overall Study|Administrative problems|3|||
131430881|NCT01338818|473202067|FG000|Overall Study|Protocol Deviation|4|||
131430882|NCT00191308|473202074|FG000|Overall Study|Adverse Event|1|||
131430883|NCT03305770|473202075|FG000|Overall Study|Physician Decision - prior to dispense|0|||
131430884|NCT03305770|473202076|FG001|Overall Study|Physician Decision - prior to dispense|1|||
131430885|NCT03305770|473202075|FG000|Overall Study|Subject moved|1|||
131430886|NCT03305770|473202076|FG001|Overall Study|Subject moved|0|||
131430887|NCT00226811|473202077|FG000|Overall Study|Death|8|||
131430888|NCT00226811|473202077|FG000|Overall Study|Adverse Event|11|||
131430889|NCT00226811|473202077|FG000|Overall Study|Lack of Efficacy|55|||
131430890|NCT00226811|473202077|FG000|Overall Study|Withdrawal by Subject|2|||
131430891|NCT03472326|473202078|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
131430892|NCT03472326|473202079|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
131430893|NCT03472326|473202080|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
131458455|NCT01097005|473308943|FG000|Overall Study|Subjects cannot visit the hospital|1|||
131430894|NCT03472326|473202081|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
131430895|NCT03472326|473202078|FG000|Part 2: Combination Therapy|Pregnancy|0|||
131430896|NCT03472326|473202079|FG001|Part 2: Combination Therapy|Pregnancy|0|||
131430897|NCT03472326|473202080|FG002|Part 2: Combination Therapy|Pregnancy|0|||
131430898|NCT03472326|473202081|FG003|Part 2: Combination Therapy|Pregnancy|1|||
131430899|NCT01369784|473202085|FG000|Overall Study|Protocol Violation|12|||
131458456|NCT01097005|473308943|FG000|Overall Study|Poor medication compliance|1|||
131430900|NCT00782717|473202086|FG000|Overall Study|Adverse Event|2|||
131430901|NCT00782717|473202087|FG001|Overall Study|Adverse Event|5|||
131430902|NCT00782717|473202086|FG000|Overall Study|Patient decision unrelated to AE|6|||
131430903|NCT00782717|473202087|FG001|Overall Study|Patient decision unrelated to AE|3|||
131430904|NCT00782717|473202086|FG000|Overall Study|Noncompliance|2|||
131430905|NCT00782717|473202087|FG001|Overall Study|Noncompliance|1|||
131458457|NCT01097005|473308943|FG000|Overall Study|No examination data available|244|||
131458458|NCT01097005|473308943|FG000|Overall Study|Deviation from exclusion criteria|37|||
131430906|NCT00782717|473202086|FG000|Overall Study|Treatment failure|3|||
131458459|NCT01097005|473308943|FG000|Overall Study|Adverse Event|14|||
131430907|NCT00782717|473202087|FG001|Overall Study|Treatment failure|14|||
131430908|NCT00782717|473202086|FG000|Overall Study|Enrollment close prior to surgery|1|||
131430909|NCT00782717|473202087|FG001|Overall Study|Enrollment close prior to surgery|0|||
131430910|NCT00782717|473202086|FG000|Overall Study|Did not meet entrance criteria|1|||
131430911|NCT00782717|473202087|FG001|Overall Study|Did not meet entrance criteria|3|||
131430912|NCT00782717|473202086|FG000|Overall Study|Exited in error|0|||
131430913|NCT00782717|473202087|FG001|Overall Study|Exited in error|2|||
131430914|NCT02905266|473202088|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
131430915|NCT02905266|473202089|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
131430916|NCT02905266|473202088|FG000|Treatment Phase Part 1|Disease Progression|6|||
131430917|NCT02905266|473202089|FG001|Treatment Phase Part 1|Disease Progression|7|||
131430918|NCT02905266|473202088|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
131430919|NCT02905266|473202089|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
131430920|NCT02905266|473202088|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
131430921|NCT02905266|473202089|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
131430922|NCT02905266|473202088|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
131430923|NCT02905266|473202089|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
131430924|NCT02905266|473202088|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
131430925|NCT02905266|473202089|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
131430926|NCT02905266|473202088|FG000|Transition From Part 1 to Part 2|Death|0|||
131430927|NCT02905266|473202089|FG001|Transition From Part 1 to Part 2|Death|1|||
131430928|NCT02905266|473202088|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
131430929|NCT02905266|473202089|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
131430930|NCT02905266|473202088|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
131430931|NCT02905266|473202089|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
131430932|NCT02905266|473202088|FG000|Maintenance Phase Part 2|Disease Progression|9|||
131430933|NCT02905266|473202089|FG001|Maintenance Phase Part 2|Disease Progression|2|||
131430934|NCT02905266|473202088|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
131430935|NCT02905266|473202089|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
131430936|NCT02905266|473202088|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
131430937|NCT02905266|473202089|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
131430938|NCT02292719|473202095|FG000|Overall Study|Withdrawal by Subject|0|||
131430939|NCT02292719|473202096|FG001|Overall Study|Withdrawal by Subject|0|||
131430940|NCT02292719|473202097|FG002|Overall Study|Withdrawal by Subject|0|||
131430941|NCT02292719|473202098|FG003|Overall Study|Withdrawal by Subject|1|||
131430942|NCT02292719|473202099|FG004|Overall Study|Withdrawal by Subject|1|||
131430943|NCT02292719|473202100|FG005|Overall Study|Withdrawal by Subject|0|||
131430944|NCT02292719|473202095|FG000|Overall Study|Subject enrolled in new study.|0|||
131430945|NCT02292719|473202096|FG001|Overall Study|Subject enrolled in new study.|0|||
131430946|NCT02292719|473202097|FG002|Overall Study|Subject enrolled in new study.|1|||
131430947|NCT02292719|473202098|FG003|Overall Study|Subject enrolled in new study.|0|||
131458460|NCT01097005|473308943|FG000|Overall Study|Discontinuance by complication|50|||
131458461|NCT03425253|473308944|FG000|Overall Study|Adverse Event|2|||
131430948|NCT02292719|473202099|FG004|Overall Study|Subject enrolled in new study.|0|||
131430949|NCT02292719|473202100|FG005|Overall Study|Subject enrolled in new study.|0|||
131430950|NCT02586727|473202101|FG000|Overall Study|Lost to Follow-up|1|||
131430951|NCT02586727|473202102|FG001|Overall Study|Lost to Follow-up|0|||
131430952|NCT05907395|473202104|FG000|Period 1|No longer met eligibility criteria|0|||
131430953|NCT05907395|473202105|FG001|Period 1|No longer met eligibility criteria|1|||
131430954|NCT05907395|473202106|FG002|Period 1|No longer met eligibility criteria|0|||
131430955|NCT05907395|473202107|FG003|Period 1|No longer met eligibility criteria|0|||
131430956|NCT05907395|473202108|FG004|Period 1|No longer met eligibility criteria|0|||
131430957|NCT05907395|473202109|FG005|Period 1|No longer met eligibility criteria|1|||
131430958|NCT05907395|473202110|FG006|Period 1|No longer met eligibility criteria|1|||
131430959|NCT05907395|473202111|FG007|Period 1|No longer met eligibility criteria|0|||
131430960|NCT05907395|473202112|FG008|Period 1|No longer met eligibility criteria|0|||
131430961|NCT05907395|473202113|FG009|Period 1|No longer met eligibility criteria|0|||
131430962|NCT05907395|473202114|FG010|Period 1|No longer met eligibility criteria|0|||
131430963|NCT05907395|473202115|FG011|Period 1|No longer met eligibility criteria|0|||
131430964|NCT05907395|473202104|FG000|Period 2|Adverse Event|0|||
131430965|NCT05907395|473202105|FG001|Period 2|Adverse Event|0|||
131430966|NCT05907395|473202106|FG002|Period 2|Adverse Event|0|||
131430967|NCT05907395|473202107|FG003|Period 2|Adverse Event|1|||
131430968|NCT05907395|473202108|FG004|Period 2|Adverse Event|0|||
131430969|NCT05907395|473202109|FG005|Period 2|Adverse Event|0|||
131430970|NCT05907395|473202110|FG006|Period 2|Adverse Event|0|||
131430971|NCT05907395|473202111|FG007|Period 2|Adverse Event|1|||
131430972|NCT05907395|473202112|FG008|Period 2|Adverse Event|0|||
131430973|NCT05907395|473202113|FG009|Period 2|Adverse Event|0|||
131430974|NCT05907395|473202114|FG010|Period 2|Adverse Event|0|||
131430975|NCT05907395|473202115|FG011|Period 2|Adverse Event|0|||
131430976|NCT05907395|473202104|FG000|Period 2|Personal reason|0|||
131430977|NCT05907395|473202105|FG001|Period 2|Personal reason|0|||
131430978|NCT05907395|473202106|FG002|Period 2|Personal reason|0|||
131430979|NCT05907395|473202107|FG003|Period 2|Personal reason|0|||
131430980|NCT05907395|473202108|FG004|Period 2|Personal reason|0|||
131430981|NCT05907395|473202109|FG005|Period 2|Personal reason|0|||
131430982|NCT05907395|473202110|FG006|Period 2|Personal reason|0|||
131430983|NCT05907395|473202111|FG007|Period 2|Personal reason|0|||
131430984|NCT05907395|473202112|FG008|Period 2|Personal reason|0|||
131430985|NCT05907395|473202113|FG009|Period 2|Personal reason|1|||
131430986|NCT05907395|473202114|FG010|Period 2|Personal reason|0|||
131430987|NCT05907395|473202115|FG011|Period 2|Personal reason|0|||
131430988|NCT05907395|473202104|FG000|Period 3|Adverse Event|0|||
131430989|NCT05907395|473202105|FG001|Period 3|Adverse Event|0|||
131430990|NCT05907395|473202106|FG002|Period 3|Adverse Event|0|||
131430991|NCT05907395|473202107|FG003|Period 3|Adverse Event|0|||
131430992|NCT05907395|473202108|FG004|Period 3|Adverse Event|1|||
131430993|NCT05907395|473202109|FG005|Period 3|Adverse Event|0|||
131430994|NCT05907395|473202110|FG006|Period 3|Adverse Event|0|||
131430995|NCT05907395|473202111|FG007|Period 3|Adverse Event|0|||
131430996|NCT05907395|473202112|FG008|Period 3|Adverse Event|0|||
131430997|NCT05907395|473202113|FG009|Period 3|Adverse Event|0|||
131430998|NCT05907395|473202114|FG010|Period 3|Adverse Event|0|||
131430999|NCT05907395|473202115|FG011|Period 3|Adverse Event|0|||
131431000|NCT04544956|473202116|FG000|Overall Study|Withdrawal by Subject|1|||
131431001|NCT00548145|473202119|FG000|Overall Study|Death|0|||
131431002|NCT00548145|473202120|FG001|Overall Study|Death|1|||
131431003|NCT00548145|473202119|FG000|Overall Study|Withdrawal by Subject|0|||
131431004|NCT00548145|473202120|FG001|Overall Study|Withdrawal by Subject|2|||
131431005|NCT00548145|473202119|FG000|Overall Study|Physician Decision|1|||
131431006|NCT00548145|473202120|FG001|Overall Study|Physician Decision|1|||
131431007|NCT02119663|473202121|FG000|Overall Study|Disease progression|26|||
131431008|NCT02119663|473202122|FG001|Overall Study|Disease progression|27|||
131431009|NCT02119663|473202121|FG000|Overall Study|Adverse Event|5|||
131431010|NCT02119663|473202122|FG001|Overall Study|Adverse Event|5|||
131431011|NCT02119663|473202121|FG000|Overall Study|Death|3|||
131431012|NCT02119663|473202122|FG001|Overall Study|Death|2|||
131431013|NCT02119663|473202121|FG000|Overall Study|Physician Decision|1|||
131431014|NCT02119663|473202122|FG001|Overall Study|Physician Decision|2|||
131431015|NCT02119663|473202121|FG000|Overall Study|Other unspecified|2|||
131431016|NCT02119663|473202122|FG001|Overall Study|Other unspecified|0|||
131431017|NCT02119663|473202121|FG000|Overall Study|Subject decision|0|||
131431018|NCT02119663|473202122|FG001|Overall Study|Subject decision|1|||
131431019|NCT02119663|473202121|FG000|Overall Study|Study Terminated by the Sponsor|3|||
131431020|NCT02119663|473202122|FG001|Overall Study|Study Terminated by the Sponsor|4|||
131431021|NCT02863328|473202123|FG000|Overall Study|Lost to Follow-up|4|||
131431022|NCT02863328|473202124|FG001|Overall Study|Lost to Follow-up|10|||
131431023|NCT02863328|473202123|FG000|Overall Study|Withdrawal by Subject|7|||
131431024|NCT02863328|473202124|FG001|Overall Study|Withdrawal by Subject|12|||
131431025|NCT02863328|473202123|FG000|Overall Study|Died|0|||
131431026|NCT02863328|473202124|FG001|Overall Study|Died|1|||
131431027|NCT00892775|473202125|FG000|Overall Study|Protocol Violation|1|||
131431028|NCT00892775|473202126|FG001|Overall Study|Protocol Violation|0|||
131431029|NCT00892775|473202125|FG000|Overall Study|Subject difficulties with blood drawing|1|||
131431030|NCT00892775|473202126|FG001|Overall Study|Subject difficulties with blood drawing|0|||
131431031|NCT00892775|473202125|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
131431032|NCT00892775|473202126|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
131431033|NCT00892775|473202125|FG000|Overall Study|Migrated/ moved from study area|1|||
131431034|NCT00892775|473202126|FG001|Overall Study|Migrated/ moved from study area|0|||
131431035|NCT00892775|473202125|FG000|Overall Study|Withdrawal by Subject|0|||
131431036|NCT00892775|473202126|FG001|Overall Study|Withdrawal by Subject|1|||
131431037|NCT00892775|473202125|FG000|Overall Study|Lost to Follow-up|1|||
131431038|NCT00892775|473202126|FG001|Overall Study|Lost to Follow-up|0|||
131431039|NCT00699660|473202127|FG000|Overall Study|Lost to Follow-up|4|||
131431040|NCT00699660|473202128|FG001|Overall Study|Lost to Follow-up|2|||
131431041|NCT00699660|473202127|FG000|Overall Study|missing reports and recording failures|10|||
131431042|NCT00699660|473202128|FG001|Overall Study|missing reports and recording failures|6|||
131431043|NCT00398320|473202129|FG000|Overall Study|Death|1|||
131431044|NCT00398320|473202129|FG000|Overall Study|Adverse Event|4|||
131431045|NCT00398320|473202129|FG000|Overall Study|Physician Decision|1|||
131431046|NCT00064792|473202130|FG000|Overall Study|Withdrawal by Subject|2|||
131431047|NCT00064792|473202131|FG001|Overall Study|Withdrawal by Subject|0|||
131431048|NCT00064792|473202130|FG000|Overall Study|Adverse Event|3|||
131431049|NCT00064792|473202131|FG001|Overall Study|Adverse Event|0|||
131431050|NCT01870726|473202132|FG000|Overall Study|Withdrawal of informed consent|0|||
131431051|NCT01870726|473202133|FG001|Overall Study|Withdrawal of informed consent|0|||
131431052|NCT01870726|473202134|FG002|Overall Study|Withdrawal of informed consent|0|||
131431053|NCT01870726|473202135|FG003|Overall Study|Withdrawal of informed consent|1|||
131431054|NCT01870726|473202136|FG004|Overall Study|Withdrawal of informed consent|0|||
131431055|NCT01870726|473202137|FG005|Overall Study|Withdrawal of informed consent|0|||
131431056|NCT01870726|473202138|FG006|Overall Study|Withdrawal of informed consent|0|||
131431057|NCT01870726|473202132|FG000|Overall Study|Withdrawal by Subject|0|||
131431058|NCT01870726|473202133|FG001|Overall Study|Withdrawal by Subject|1|||
131431059|NCT01870726|473202134|FG002|Overall Study|Withdrawal by Subject|0|||
131431060|NCT01870726|473202135|FG003|Overall Study|Withdrawal by Subject|0|||
131431061|NCT01870726|473202136|FG004|Overall Study|Withdrawal by Subject|0|||
131431062|NCT01870726|473202137|FG005|Overall Study|Withdrawal by Subject|0|||
131431063|NCT01870726|473202138|FG006|Overall Study|Withdrawal by Subject|0|||
131431064|NCT01870726|473202132|FG000|Overall Study|Adverse Event|0|||
131431065|NCT01870726|473202133|FG001|Overall Study|Adverse Event|0|||
131431066|NCT01870726|473202134|FG002|Overall Study|Adverse Event|0|||
131431067|NCT01870726|473202135|FG003|Overall Study|Adverse Event|0|||
131431068|NCT01870726|473202136|FG004|Overall Study|Adverse Event|1|||
131431069|NCT01870726|473202137|FG005|Overall Study|Adverse Event|1|||
131431070|NCT01870726|473202138|FG006|Overall Study|Adverse Event|0|||
131431071|NCT01870726|473202132|FG000|Overall Study|Progressive disease|5|||
131431072|NCT01870726|473202133|FG001|Overall Study|Progressive disease|5|||
131431073|NCT01870726|473202134|FG002|Overall Study|Progressive disease|4|||
131431074|NCT01870726|473202135|FG003|Overall Study|Progressive disease|5|||
131431075|NCT01870726|473202136|FG004|Overall Study|Progressive disease|6|||
131431076|NCT01870726|473202137|FG005|Overall Study|Progressive disease|4|||
131431077|NCT01870726|473202138|FG006|Overall Study|Progressive disease|10|||
131431078|NCT03301350|473202139|FG000|Overall Study|Withdrawal by Subject|4|||
131431079|NCT03301350|473202139|FG000|Overall Study|Adverse Event|1|||
131431080|NCT03301350|473202139|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
131431081|NCT03301350|473202139|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
131431082|NCT03301350|473202139|FG000|Overall Study|no detail provided|1|||
131431083|NCT01248949|473202142|FG000|Overall Study|Lost to Follow-up|2|||
131431084|NCT01248949|473202143|FG001|Overall Study|Lost to Follow-up|2|||
131431085|NCT01248949|473202144|FG002|Overall Study|Lost to Follow-up|2|||
131431086|NCT01248949|473202145|FG003|Overall Study|Lost to Follow-up|1|||
131431087|NCT01248949|473202146|FG004|Overall Study|Lost to Follow-up|0|||
131431088|NCT01248949|473202142|FG000|Overall Study|Withdrawal by Subject|5|||
131431089|NCT01248949|473202143|FG001|Overall Study|Withdrawal by Subject|3|||
131431090|NCT01248949|473202144|FG002|Overall Study|Withdrawal by Subject|11|||
131431091|NCT01248949|473202145|FG003|Overall Study|Withdrawal by Subject|3|||
131431092|NCT01248949|473202146|FG004|Overall Study|Withdrawal by Subject|1|||
131431093|NCT01248949|473202142|FG000|Overall Study|Death|22|||
131431094|NCT01248949|473202143|FG001|Overall Study|Death|7|||
131431095|NCT01248949|473202144|FG002|Overall Study|Death|21|||
131431096|NCT01248949|473202145|FG003|Overall Study|Death|6|||
131431097|NCT01248949|473202146|FG004|Overall Study|Death|2|||
131431098|NCT01248949|473202142|FG000|Overall Study|Alternative Therapy|1|||
131431099|NCT01248949|473202143|FG001|Overall Study|Alternative Therapy|0|||
131431100|NCT01248949|473202144|FG002|Overall Study|Alternative Therapy|0|||
131431101|NCT01248949|473202145|FG003|Overall Study|Alternative Therapy|0|||
131431102|NCT01248949|473202146|FG004|Overall Study|Alternative Therapy|0|||
131431103|NCT01248949|473202142|FG000|Overall Study|Alternative Therapy.|1|||
131431104|NCT01248949|473202143|FG001|Overall Study|Alternative Therapy.|0|||
131431105|NCT01248949|473202144|FG002|Overall Study|Alternative Therapy.|0|||
131431106|NCT01248949|473202145|FG003|Overall Study|Alternative Therapy.|0|||
131431107|NCT01248949|473202146|FG004|Overall Study|Alternative Therapy.|0|||
131431108|NCT01248949|473202142|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
131431109|NCT01248949|473202143|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
131431110|NCT01248949|473202144|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
131431111|NCT01248949|473202145|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
131431112|NCT01248949|473202146|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
131431113|NCT01248949|473202142|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
131431114|NCT01248949|473202143|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
131431115|NCT01248949|473202144|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
131431116|NCT01248949|473202145|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
131431117|NCT01248949|473202146|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
131431118|NCT01248949|473202142|FG000|Overall Study|Participant Went To Hospice|0|||
131431119|NCT01248949|473202143|FG001|Overall Study|Participant Went To Hospice|0|||
131431120|NCT01248949|473202144|FG002|Overall Study|Participant Went To Hospice|1|||
131431121|NCT01248949|473202145|FG003|Overall Study|Participant Went To Hospice|0|||
131431122|NCT01248949|473202146|FG004|Overall Study|Participant Went To Hospice|0|||
131431123|NCT01248949|473202142|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
131431124|NCT01248949|473202143|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
131431125|NCT01248949|473202144|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
131431126|NCT01248949|473202145|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
131431127|NCT01248949|473202146|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
131431128|NCT01248949|473202142|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
131431129|NCT01248949|473202143|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
131431130|NCT01248949|473202144|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
131431131|NCT01248949|473202145|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
131431132|NCT01248949|473202146|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
131431133|NCT01248949|473202142|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
131431134|NCT01248949|473202143|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
131431135|NCT01248949|473202144|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
131431136|NCT01248949|473202145|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
131431137|NCT01248949|473202146|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
131431138|NCT01248949|473202142|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
131431139|NCT01248949|473202143|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
131431140|NCT01248949|473202144|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
131431141|NCT01248949|473202145|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
131431142|NCT01248949|473202146|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
131431143|NCT00286429|473202147|FG000|Overall Study|Adverse Event|4|||
131431144|NCT00286429|473202148|FG001|Overall Study|Adverse Event|1|||
131431145|NCT00286429|473202149|FG002|Overall Study|Adverse Event|6|||
131431146|NCT00286429|473202147|FG000|Overall Study|Lack of Efficacy|52|||
131431147|NCT00286429|473202148|FG001|Overall Study|Lack of Efficacy|27|||
131431148|NCT00286429|473202149|FG002|Overall Study|Lack of Efficacy|25|||
131431149|NCT00286429|473202147|FG000|Overall Study|Lost to Follow-up|2|||
131431150|NCT00286429|473202148|FG001|Overall Study|Lost to Follow-up|4|||
131431151|NCT00286429|473202149|FG002|Overall Study|Lost to Follow-up|3|||
131431152|NCT00286429|473202147|FG000|Overall Study|Physician Decision|10|||
131431153|NCT00286429|473202148|FG001|Overall Study|Physician Decision|7|||
131431154|NCT00286429|473202149|FG002|Overall Study|Physician Decision|7|||
131431155|NCT00286429|473202147|FG000|Overall Study|Protocol Violation|3|||
131431156|NCT00286429|473202148|FG001|Overall Study|Protocol Violation|5|||
131431157|NCT00286429|473202149|FG002|Overall Study|Protocol Violation|4|||
131431158|NCT00286429|473202147|FG000|Overall Study|Withdrawal by Subject|3|||
131431159|NCT00286429|473202148|FG001|Overall Study|Withdrawal by Subject|2|||
131431160|NCT00286429|473202149|FG002|Overall Study|Withdrawal by Subject|6|||
131431161|NCT00286429|473202147|FG000|Overall Study|Administrative Error|1|||
131431162|NCT00286429|473202148|FG001|Overall Study|Administrative Error|1|||
131431163|NCT00286429|473202149|FG002|Overall Study|Administrative Error|1|||
131431164|NCT00286429|473202147|FG000|Overall Study|Administrative Decision|0|||
131431165|NCT00286429|473202148|FG001|Overall Study|Administrative Decision|1|||
131431166|NCT00286429|473202149|FG002|Overall Study|Administrative Decision|0|||
131431167|NCT01746225|473202152|FG000|Overall Study|Death|1|||
131431168|NCT01746225|473202153|FG001|Overall Study|Death|0|||
131431169|NCT01746225|473202154|FG002|Overall Study|Death|1|||
131431170|NCT01746225|473202152|FG000|Overall Study|Withdrawal by Subject|5|||
131431171|NCT01746225|473202153|FG001|Overall Study|Withdrawal by Subject|15|||
131431172|NCT01746225|473202154|FG002|Overall Study|Withdrawal by Subject|19|||
131431173|NCT01746225|473202152|FG000|Overall Study|Physician Decision|14|||
131431174|NCT01746225|473202153|FG001|Overall Study|Physician Decision|11|||
131431175|NCT01746225|473202154|FG002|Overall Study|Physician Decision|3|||
131431176|NCT01746225|473202152|FG000|Overall Study|Adverse Event|15|||
131431177|NCT01746225|473202153|FG001|Overall Study|Adverse Event|12|||
131431178|NCT01746225|473202154|FG002|Overall Study|Adverse Event|17|||
131431179|NCT01746225|473202152|FG000|Overall Study|Continuing Treatment|5|||
131431180|NCT01746225|473202153|FG001|Overall Study|Continuing Treatment|8|||
131431181|NCT01746225|473202154|FG002|Overall Study|Continuing Treatment|3|||
131431182|NCT03915470|473202155|FG000|Overall Study|Death|3|||
131431183|NCT03915470|473202156|FG001|Overall Study|Death|1|||
131431184|NCT03915470|473202155|FG000|Overall Study|Adverse Event|1|||
131431185|NCT03915470|473202156|FG001|Overall Study|Adverse Event|0|||
131431186|NCT03915470|473202155|FG000|Overall Study|Physician Decision|1|||
131431187|NCT03915470|473202156|FG001|Overall Study|Physician Decision|0|||
131431188|NCT03915470|473202155|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
131431189|NCT03915470|473202156|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
131431190|NCT03160898|473202157|FG000|Overall Study|Adverse Event|4|||
131431191|NCT03160898|473202158|FG001|Overall Study|Adverse Event|8|||
131431192|NCT03160898|473202159|FG002|Overall Study|Adverse Event|7|||
131431193|NCT03160898|473202160|FG003|Overall Study|Adverse Event|10|||
131431194|NCT03160898|473202157|FG000|Overall Study|Death|1|||
131431195|NCT03160898|473202158|FG001|Overall Study|Death|0|||
131431196|NCT03160898|473202159|FG002|Overall Study|Death|0|||
131431197|NCT03160898|473202160|FG003|Overall Study|Death|1|||
131431198|NCT03160898|473202157|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
131431199|NCT03160898|473202158|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
131431200|NCT03160898|473202159|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
131431201|NCT03160898|473202160|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
131431202|NCT03160898|473202157|FG000|Overall Study|Lost to Follow-up|1|||
131431203|NCT03160898|473202158|FG001|Overall Study|Lost to Follow-up|1|||
131431204|NCT03160898|473202159|FG002|Overall Study|Lost to Follow-up|1|||
131431205|NCT03160898|473202160|FG003|Overall Study|Lost to Follow-up|2|||
131431206|NCT03160898|473202157|FG000|Overall Study|Physician Decision|1|||
131431207|NCT03160898|473202158|FG001|Overall Study|Physician Decision|0|||
131431208|NCT03160898|473202159|FG002|Overall Study|Physician Decision|0|||
131431209|NCT03160898|473202160|FG003|Overall Study|Physician Decision|1|||
131431210|NCT03160898|473202157|FG000|Overall Study|Progressive Disease|4|||
131431211|NCT03160898|473202158|FG001|Overall Study|Progressive Disease|1|||
131431212|NCT03160898|473202159|FG002|Overall Study|Progressive Disease|2|||
131431213|NCT03160898|473202160|FG003|Overall Study|Progressive Disease|1|||
131431214|NCT03160898|473202157|FG000|Overall Study|Protocol Violation|1|||
131431215|NCT03160898|473202158|FG001|Overall Study|Protocol Violation|0|||
131431216|NCT03160898|473202159|FG002|Overall Study|Protocol Violation|2|||
131431217|NCT03160898|473202160|FG003|Overall Study|Protocol Violation|0|||
131431218|NCT03160898|473202157|FG000|Overall Study|Sponsor Discretion|2|||
131431219|NCT03160898|473202158|FG001|Overall Study|Sponsor Discretion|0|||
131431220|NCT03160898|473202159|FG002|Overall Study|Sponsor Discretion|0|||
131431221|NCT03160898|473202160|FG003|Overall Study|Sponsor Discretion|0|||
131431222|NCT03160898|473202157|FG000|Overall Study|Withdrawal by Subject|1|||
131431223|NCT03160898|473202158|FG001|Overall Study|Withdrawal by Subject|3|||
131431224|NCT03160898|473202159|FG002|Overall Study|Withdrawal by Subject|2|||
131431225|NCT03160898|473202160|FG003|Overall Study|Withdrawal by Subject|1|||
131431226|NCT03160898|473202157|FG000|Overall Study|Other|2|||
131431227|NCT03160898|473202158|FG001|Overall Study|Other|0|||
131431228|NCT03160898|473202159|FG002|Overall Study|Other|2|||
131431229|NCT03160898|473202160|FG003|Overall Study|Other|2|||
131431230|NCT03245775|473202161|FG000|Overall Study|Lost to Follow-up|25|||
131431231|NCT03245775|473202162|FG001|Overall Study|Lost to Follow-up|26|||
131431232|NCT03245775|473202163|FG002|Overall Study|Lost to Follow-up|16|||
131431233|NCT03245775|473202164|FG003|Overall Study|Lost to Follow-up|16|||
131431234|NCT00086047|473204252|FG000|Overall Study|Lost to Follow-up|7|||
131431235|NCT00086047|473204253|FG001|Overall Study|Lost to Follow-up|6|||
131431236|NCT00086047|473204252|FG000|Overall Study|Physician Decision|0|||
131431237|NCT00086047|473204253|FG001|Overall Study|Physician Decision|1|||
131458462|NCT03425253|473308944|FG000|Overall Study|Lost to Follow-up|3|||
131458463|NCT03425253|473308944|FG000|Overall Study|Withdrew Consent|6|||
131458464|NCT03425253|473308944|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
131458465|NCT04129151|473310085|FG000|Overall Study|Adverse Event|1|||
131458466|NCT04129151|473310085|FG000|Overall Study|Disease Progression|7|||
131458467|NCT04129151|473310085|FG000|Overall Study|Study closure|1|||
131458468|NCT02730195|473310086|FG000|Overall Study|Withdrawal by Subject|1|||
131458469|NCT01463007|473310088|FG000|Overall Study|Physician Decision|1|||
131458470|NCT03583385|473310089|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131458471|NCT03583385|473310090|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131458472|NCT03583385|473310089|FG000|Treatment Period 2|Adverse Event|1|||
131458473|NCT03583385|473310090|FG001|Treatment Period 2|Adverse Event|0|||
131458474|NCT01206322|473310093|FG000|Overall Study|Adverse Event|0|||
131458475|NCT01206322|473310094|FG001|Overall Study|Adverse Event|0|||
131458476|NCT01206322|473310095|FG002|Overall Study|Adverse Event|0|||
131458477|NCT01206322|473310096|FG003|Overall Study|Adverse Event|1|||
131458478|NCT02471612|473310099|FG000|Overall Study|Lost to Follow-up|2|||
131458479|NCT02082340|473310100|FG000|Overall Study|Lost to Follow-up|1|||
131458480|NCT02082340|473310101|FG001|Overall Study|Lost to Follow-up|1|||
131458481|NCT03462511|473310104|FG000|Overall Study|Withdrawal by Subject|2|||
131458482|NCT03462511|473310105|FG001|Overall Study|Withdrawal by Subject|3|||
131458483|NCT02925416|473310106|FG000|Overall Study|Adverse Event|2|||
131458484|NCT02925416|473310107|FG001|Overall Study|Adverse Event|0|||
131458485|NCT00435045|473310111|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
131458486|NCT00435045|473310112|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
131458487|NCT00435045|473310111|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
131458488|NCT00435045|473310112|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
131458489|NCT00435045|473310111|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
131458490|NCT00435045|473310112|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
131458491|NCT00435045|473310111|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
131458492|NCT00435045|473310112|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
131458493|NCT00435045|473310111|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
131458494|NCT00435045|473310112|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
131458495|NCT00435045|473310111|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
131458496|NCT00435045|473310112|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
131458497|NCT00435045|473310111|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
131458498|NCT00435045|473310112|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
131458499|NCT00435045|473310111|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
131458500|NCT00435045|473310112|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
131458501|NCT00435045|473310111|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
131458502|NCT00435045|473310112|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
131458503|NCT00435045|473310111|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
131458504|NCT00435045|473310112|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
131458505|NCT00435045|473310111|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
131458506|NCT00435045|473310112|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
131458507|NCT01297491|473310113|FG000|Overall Study|Adverse Event|11|||
131458508|NCT01297491|473310114|FG001|Overall Study|Adverse Event|6|||
131458509|NCT01297491|473310113|FG000|Overall Study|Physician Decision|3|||
131458510|NCT01297491|473310114|FG001|Overall Study|Physician Decision|2|||
131458511|NCT01297491|473310113|FG000|Overall Study|Progressive disease|11|||
131458512|NCT01297491|473310114|FG001|Overall Study|Progressive disease|20|||
131431238|NCT03579940|473204257|FG000|Period 2|Withdrawal by Subject|0|||
131431239|NCT03579940|473204258|FG001|Period 2|Withdrawal by Subject|0|||
131431240|NCT03579940|473204259|FG002|Period 2|Withdrawal by Subject|1|||
131431241|NCT03579940|473204260|FG003|Period 2|Withdrawal by Subject|0|||
131431242|NCT03579940|473204261|FG004|Period 2|Withdrawal by Subject|0|||
131431243|NCT03579940|473204262|FG005|Period 2|Withdrawal by Subject|0|||
131431244|NCT03579940|473204263|FG006|Period 2|Withdrawal by Subject|0|||
131431245|NCT03579940|473204264|FG007|Period 2|Withdrawal by Subject|0|||
131431246|NCT03579940|473204265|FG008|Period 2|Withdrawal by Subject|0|||
131431247|NCT03579940|473204266|FG009|Period 2|Withdrawal by Subject|0|||
131431248|NCT03579940|473204267|FG010|Period 2|Withdrawal by Subject|0|||
131458513|NCT01297491|473310113|FG000|Overall Study|Patient/Guardian decision|3|||
131458514|NCT01297491|473310114|FG001|Overall Study|Patient/Guardian decision|4|||
131431249|NCT01367834|473204268|FG000|Overall Study|Withdrawal by Subject|2|||
131458515|NCT01297491|473310113|FG000|Overall Study|Death|2|||
131458516|NCT01297491|473310114|FG001|Overall Study|Death|1|||
131431250|NCT01367834|473204269|FG001|Overall Study|Withdrawal by Subject|2|||
131458517|NCT00984620|473310115|FG000|Overall Study|Adverse Event|5|||
131458518|NCT00984620|473310116|FG001|Overall Study|Adverse Event|5|||
131458519|NCT00984620|473310115|FG000|Overall Study|Lost to Follow-up|1|||
131458520|NCT00984620|473310116|FG001|Overall Study|Lost to Follow-up|1|||
131431251|NCT01367834|473204268|FG000|Overall Study|Study was ended.|0|||
131431252|NCT01367834|473204269|FG001|Overall Study|Study was ended.|1|||
131431253|NCT01172535|473204270|FG000|Overall Study|Death|3|||
131431254|NCT01172535|473204270|FG000|Overall Study|Withdrawal by Subject|2|||
131431255|NCT01172535|473204270|FG000|Overall Study|Lost to Follow-up|1|||
131431256|NCT01172535|473204270|FG000|Overall Study|Ineligible at study entry|1|||
131431257|NCT01172535|473204270|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
131431258|NCT00988598|473204276|FG000|Overall Study|Withdrawal by Subject|2|||
131431259|NCT00988598|473204277|FG001|Overall Study|Withdrawal by Subject|0|||
131431260|NCT01450761|473204284|FG000|Randomization|Subject no longer meets study criteria|1|||
131431261|NCT01450761|473204285|FG001|Randomization|Subject no longer meets study criteria|2|||
131431262|NCT01450761|473204284|FG000|Randomization|Withdrawal by Subject|2|||
131431263|NCT01450761|473204285|FG001|Randomization|Withdrawal by Subject|0|||
131431264|NCT01450761|473204284|FG000|Randomization|Disease progression|0|||
131431265|NCT01450761|473204285|FG001|Randomization|Disease progression|2|||
131431266|NCT01450761|473204284|FG000|Randomization|Adverse Event unrelated to study drug|1|||
131431267|NCT01450761|473204285|FG001|Randomization|Adverse Event unrelated to study drug|0|||
131431268|NCT01450761|473204284|FG000|Randomization|Other|0|||
131431269|NCT01450761|473204285|FG001|Randomization|Other|1|||
131431270|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Disease progression|33|||
131431271|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Disease progression|32|||
131431272|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
131431273|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
131431274|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
131431275|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
131431276|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
131431277|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
131431278|NCT01450761|473204284|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
131431279|NCT01450761|473204285|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
131431280|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Death|3|||
131431281|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Death|3|||
131431282|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Other|2|||
131431283|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Other|2|||
131431284|NCT01450761|473204284|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
131431285|NCT01450761|473204285|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
131431286|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
131431287|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
131431288|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
131431289|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
131431290|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
131431291|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
131431292|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
131431293|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
131431294|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
131431295|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
131431296|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Death|5|||
131431297|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Death|6|||
131431298|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
131431299|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
131431300|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
131431301|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
131431302|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
131431303|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
131431304|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
131431305|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
131431306|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
131431307|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
131431308|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
131431309|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
131431310|NCT01450761|473204284|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
131431311|NCT01450761|473204285|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
131431312|NCT01818596|473204296|FG000|Overall Study|Enrolled but Not Treated|4|||
131431313|NCT01818596|473204297|FG001|Overall Study|Enrolled but Not Treated|0|||
131431314|NCT01818596|473204296|FG000|Overall Study|Adverse Event|7|||
131431315|NCT01818596|473204297|FG001|Overall Study|Adverse Event|0|||
131431316|NCT01818596|473204296|FG000|Overall Study|Death|3|||
131431317|NCT01818596|473204297|FG001|Overall Study|Death|0|||
131431318|NCT01818596|473204296|FG000|Overall Study|Investigator's Discretion|4|||
131431319|NCT01818596|473204297|FG001|Overall Study|Investigator's Discretion|0|||
131458521|NCT00984620|473310115|FG000|Overall Study|Withdrawal by Subject|0|||
131458522|NCT00984620|473310116|FG001|Overall Study|Withdrawal by Subject|2|||
131458523|NCT00984620|473310115|FG000|Overall Study|reason other than listed above|0|||
131431320|NCT01818596|473204296|FG000|Overall Study|Protocol Violation|1|||
131431321|NCT01818596|473204297|FG001|Overall Study|Protocol Violation|0|||
131431322|NCT01818596|473204296|FG000|Overall Study|Withdrew Consent|5|||
131431323|NCT01818596|473204297|FG001|Overall Study|Withdrew Consent|0|||
131431324|NCT01818596|473204296|FG000|Overall Study|Lost to Follow-up|7|||
131431325|NCT01818596|473204297|FG001|Overall Study|Lost to Follow-up|0|||
131431326|NCT03461146|473204300|FG000|Overall Study|Adverse Event|2|||
131431327|NCT03461146|473204300|FG000|Overall Study|Physician Decision|1|||
131431328|NCT03801174|473204301|FG000|Overall Study|Withdrawal by Subject|14|||
131431329|NCT03801174|473204302|FG001|Overall Study|Withdrawal by Subject|15|||
131431330|NCT03801174|473204301|FG000|Overall Study|Death|1|||
131431331|NCT03801174|473204302|FG001|Overall Study|Death|0|||
131431332|NCT03801174|473204301|FG000|Overall Study|Pregnancy|2|||
131431333|NCT03801174|473204302|FG001|Overall Study|Pregnancy|2|||
131431334|NCT03801174|473204301|FG000|Overall Study|Lost to Follow-up|19|||
131431335|NCT03801174|473204302|FG001|Overall Study|Lost to Follow-up|10|||
131431336|NCT03801174|473204301|FG000|Overall Study|Other|4|||
131431337|NCT03801174|473204302|FG001|Overall Study|Other|3|||
131431338|NCT03801174|473204301|FG000|Overall Study|Lack of Efficacy|4|||
131431339|NCT03801174|473204302|FG001|Overall Study|Lack of Efficacy|0|||
131431340|NCT03801174|473204301|FG000|Overall Study|Unwilling to complete activities|5|||
131431341|NCT03801174|473204302|FG001|Overall Study|Unwilling to complete activities|6|||
131431342|NCT03801174|473204301|FG000|Overall Study|Moved out of area|3|||
131431343|NCT03801174|473204302|FG001|Overall Study|Moved out of area|0|||
131431344|NCT00337207|473204307|FG000|Overall Study|Withdrawal by Subject|3|||
131431345|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
131431346|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
131431347|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
131431348|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
131431349|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
131431350|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
131431351|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
131431352|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
131431353|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
131431354|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
131431355|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
131431356|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
131431357|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
131431358|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
131431359|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
131431360|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
131431361|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
131431362|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
131431363|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
131431364|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
131431365|NCT03573323|473204308|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
131431366|NCT03573323|473204309|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
131431367|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
131431368|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
131431369|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
131768909|NCT01497899|474431898|FG001|Double-Blind Phase|Randomized but not Treated|0|||
131768910|NCT01497899|474431899|FG002|Double-Blind Phase|Randomized but not Treated|0|||
131768911|NCT01497899|474431900|FG003|Double-Blind Phase|Randomized but not Treated|0|||
131768912|NCT01497899|474431897|FG000|Double-Blind Phase|Adverse Event|1|||
131768913|NCT01497899|474431898|FG001|Double-Blind Phase|Adverse Event|0|||
131768914|NCT01497899|474431899|FG002|Double-Blind Phase|Adverse Event|0|||
131431370|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
131431371|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
131431372|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
131431373|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
131431374|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
131431375|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
131431376|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
131431377|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
131431378|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
131431379|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
131431380|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
131431381|NCT03573323|473204308|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
131431382|NCT03573323|473204309|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
131431383|NCT00837213|473204319|FG000|Overall Study|Lost to Follow-up|3|||
131431384|NCT00837213|473204320|FG001|Overall Study|Lost to Follow-up|2|||
131431385|NCT00837213|473204319|FG000|Overall Study|Withdrawal by Subject|2|||
131431386|NCT00837213|473204320|FG001|Overall Study|Withdrawal by Subject|2|||
131431387|NCT00837213|473204319|FG000|Overall Study|not stated|1|||
131431388|NCT00837213|473204320|FG001|Overall Study|not stated|1|||
131431389|NCT02698826|473204322|FG000|Overall Study|Death|13|||
131431390|NCT02698826|473204322|FG000|Overall Study|Adverse Event|1|||
131431391|NCT02915263|473204325|FG000|Overall Study|Covid|3|||
131431392|NCT02915263|473204326|FG001|Overall Study|Covid|2|||
131431393|NCT01879683|473204330|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
131431394|NCT01618669|473204331|FG000|Overall Study|Lost to Follow-up|1|||
131431395|NCT01618669|473204332|FG001|Overall Study|Lost to Follow-up|1|||
131431396|NCT01618669|473204331|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
131431397|NCT01618669|473204332|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
131431398|NCT01618669|473204331|FG000|Overall Study|Adverse Event|16|||
131431399|NCT01618669|473204332|FG001|Overall Study|Adverse Event|7|||
131431400|NCT01618669|473204331|FG000|Overall Study|Protocol Violation|5|||
131431401|NCT01618669|473204332|FG001|Overall Study|Protocol Violation|3|||
131431402|NCT01618669|473204331|FG000|Overall Study|Withdrawal by Subject|9|||
131431403|NCT01618669|473204332|FG001|Overall Study|Withdrawal by Subject|9|||
131431404|NCT01618669|473204331|FG000|Overall Study|Miscellaneous Reason|0|||
131431405|NCT01618669|473204332|FG001|Overall Study|Miscellaneous Reason|1|||
131431406|NCT01177007|473204335|FG000|Overall Study|Lost to Follow-up|2|||
131431407|NCT01177007|473204335|FG000|Overall Study|Death|4|||
131431408|NCT01177007|473204335|FG000|Overall Study|Entered hospice care|5|||
131431409|NCT01177007|473204335|FG000|Overall Study|Required additional Y90 treatment|6|||
131431410|NCT01177007|473204335|FG000|Overall Study|Change in treatment modality|21|||
131431411|NCT01078441|473204338|FG000|Overall Study|Withdrawal by Subject|1|||
131431412|NCT01425801|473204339|FG000|Period 1|Withdrawal by Subject|0|||
131431413|NCT01425801|473204340|FG001|Period 1|Withdrawal by Subject|0|||
131431414|NCT01425801|473204341|FG002|Period 1|Withdrawal by Subject|0|||
131431415|NCT01425801|473204342|FG003|Period 1|Withdrawal by Subject|0|||
131431416|NCT01425801|473204343|FG004|Period 1|Withdrawal by Subject|1|||
131431417|NCT01425801|473204344|FG005|Period 1|Withdrawal by Subject|0|||
131431418|NCT01425801|473204339|FG000|Period 2|Withdrawal by Subject|0|||
131431419|NCT01425801|473204340|FG001|Period 2|Withdrawal by Subject|0|||
131431420|NCT01425801|473204341|FG002|Period 2|Withdrawal by Subject|0|||
131431421|NCT01425801|473204342|FG003|Period 2|Withdrawal by Subject|0|||
131431422|NCT01425801|473204343|FG004|Period 2|Withdrawal by Subject|1|||
131431423|NCT01425801|473204344|FG005|Period 2|Withdrawal by Subject|0|||
131431424|NCT01425801|473204339|FG000|Period 3|Stability criteria not fullfilled|0|||
131431425|NCT01425801|473204340|FG001|Period 3|Stability criteria not fullfilled|0|||
131431426|NCT01425801|473204341|FG002|Period 3|Stability criteria not fullfilled|1|||
131431427|NCT01425801|473204342|FG003|Period 3|Stability criteria not fullfilled|0|||
131431428|NCT01425801|473204343|FG004|Period 3|Stability criteria not fullfilled|0|||
131431429|NCT01425801|473204344|FG005|Period 3|Stability criteria not fullfilled|0|||
131431430|NCT01425801|473204339|FG000|Period 4|Not able to maintain visit schedule|0|||
131768915|NCT01497899|474431900|FG003|Double-Blind Phase|Adverse Event|0|||
131458524|NCT00984620|473310116|FG001|Overall Study|reason other than listed above|4|||
131458525|NCT01703754|473310121|FG000|Overall Study|Clinically significant disease progression|2|||
131458526|NCT01703754|473310122|FG001|Overall Study|Clinically significant disease progression|2|||
131458527|NCT01703754|473310123|FG002|Overall Study|Clinically significant disease progression|1|||
131458528|NCT01703754|473310121|FG000|Overall Study|Adverse Event|1|||
131458529|NCT01703754|473310122|FG001|Overall Study|Adverse Event|1|||
131458530|NCT01703754|473310123|FG002|Overall Study|Adverse Event|0|||
131458531|NCT01703754|473310121|FG000|Overall Study|Withdrawal by Subject|2|||
131458532|NCT01703754|473310122|FG001|Overall Study|Withdrawal by Subject|0|||
131458533|NCT01703754|473310123|FG002|Overall Study|Withdrawal by Subject|0|||
131458534|NCT01989208|473310126|FG000|200 mg (7 Days)|Protocol Violation|0|||
131458535|NCT01989208|473310127|FG001|200 mg (7 Days)|Protocol Violation|1|||
131458536|NCT04973436|473310128|FG000|Overall Study|Lost to Follow-up|3|||
131458537|NCT04973436|473310128|FG000|Overall Study|Withdrawal by Subject|1|||
131458538|NCT04973436|473310128|FG000|Overall Study|Death|2|||
131458539|NCT00566696|473310129|FG000|Overall Study|Met Exclusion Criteria|2|||
131458540|NCT00566696|473310129|FG000|Overall Study|Muromonab not available|1|||
131458541|NCT00566696|473310129|FG000|Overall Study|Health Status Change|1|||
131458542|NCT00566696|473310129|FG000|Overall Study|Physician Decision|1|||
131458543|NCT00566696|473310129|FG000|Overall Study|Non-Patient Donors|37|||
131458544|NCT02872935|473310130|FG000|Overall Study|Other|0|||
131458545|NCT02872935|473310131|FG001|Overall Study|Other|1|||
131458546|NCT01276054|473310135|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
131431431|NCT01425801|473204340|FG001|Period 4|Not able to maintain visit schedule|0|||
131431432|NCT01425801|473204341|FG002|Period 4|Not able to maintain visit schedule|1|||
131431433|NCT01425801|473204342|FG003|Period 4|Not able to maintain visit schedule|0|||
131431434|NCT01425801|473204343|FG004|Period 4|Not able to maintain visit schedule|0|||
131431435|NCT01425801|473204344|FG005|Period 4|Not able to maintain visit schedule|0|||
131431436|NCT02868554|473204345|FG000|Overall Study|Lost to Follow-up|3|||
131431437|NCT02868554|473204346|FG001|Overall Study|Lost to Follow-up|0|||
131431438|NCT02868554|473204347|FG002|Overall Study|Lost to Follow-up|1|||
131431439|NCT02175017|473204348|FG000|Overall Study|Did not receive the investigational product|1|||
131431440|NCT02175017|473204349|FG001|Overall Study|Did not receive the investigational product|2|||
131431441|NCT02175017|473204348|FG000|Overall Study|Withdrawal by Subject|6|||
131431442|NCT02175017|473204349|FG001|Overall Study|Withdrawal by Subject|3|||
131431443|NCT02175017|473204348|FG000|Overall Study|Met an exclusion criteria|0|||
131431444|NCT02175017|473204349|FG001|Overall Study|Met an exclusion criteria|1|||
131431445|NCT02175017|473204348|FG000|Overall Study|Adverse Event|3|||
131431446|NCT02175017|473204349|FG001|Overall Study|Adverse Event|10|||
131431447|NCT02175017|473204348|FG000|Overall Study|Disease progression|20|||
131431448|NCT02175017|473204349|FG001|Overall Study|Disease progression|27|||
131431449|NCT02175017|473204348|FG000|Overall Study|Other than above reasons|3|||
131431450|NCT02175017|473204349|FG001|Overall Study|Other than above reasons|0|||
131431451|NCT02491983|473204350|FG000|Overall Study|Physician Decision|1|||
131431452|NCT02491983|473204351|FG001|Overall Study|Physician Decision|0|||
131431453|NCT02491983|473204350|FG000|Overall Study|Not meet selection criteria|1|||
131431454|NCT02491983|473204351|FG001|Overall Study|Not meet selection criteria|0|||
131431455|NCT02491983|473204350|FG000|Overall Study|Withdrawal by Subject|0|||
131431456|NCT02491983|473204351|FG001|Overall Study|Withdrawal by Subject|1|||
131431457|NCT02714569|473204352|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
131431458|NCT02714569|473204353|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
131431459|NCT02714569|473204354|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
131431460|NCT02714569|473204355|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
131431461|NCT02714569|473204356|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
131431462|NCT02714569|473204357|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
131431463|NCT02714569|473204358|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
131431464|NCT02714569|473204359|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
131431465|NCT02714569|473204360|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
131431466|NCT02714569|473204361|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
131431467|NCT02714569|473204362|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
131431468|NCT02714569|473204352|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431469|NCT02714569|473204353|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431470|NCT02714569|473204354|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431471|NCT02714569|473204355|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
131431472|NCT02714569|473204356|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431473|NCT02714569|473204357|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431474|NCT02714569|473204358|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431475|NCT02714569|473204359|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431476|NCT02714569|473204360|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431477|NCT02714569|473204361|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431478|NCT02714569|473204362|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
131431479|NCT02714569|473204352|FG000|Part A Third Intervention|Adverse Event|0|||
131431480|NCT02714569|473204353|FG001|Part A Third Intervention|Adverse Event|0|||
131431481|NCT02714569|473204354|FG002|Part A Third Intervention|Adverse Event|1|||
131431482|NCT02714569|473204355|FG003|Part A Third Intervention|Adverse Event|0|||
131431483|NCT02714569|473204356|FG004|Part A Third Intervention|Adverse Event|0|||
131431484|NCT02714569|473204357|FG005|Part A Third Intervention|Adverse Event|0|||
131431485|NCT02714569|473204358|FG006|Part A Third Intervention|Adverse Event|0|||
131431486|NCT02714569|473204359|FG007|Part A Third Intervention|Adverse Event|0|||
131431487|NCT02714569|473204360|FG008|Part A Third Intervention|Adverse Event|0|||
131431488|NCT02714569|473204361|FG009|Part A Third Intervention|Adverse Event|0|||
131431489|NCT02714569|473204362|FG010|Part A Third Intervention|Adverse Event|0|||
131431490|NCT02714569|473204352|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
131431491|NCT02714569|473204353|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431492|NCT02714569|473204354|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431493|NCT02714569|473204355|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431494|NCT02714569|473204356|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431495|NCT02714569|473204357|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
131431496|NCT02714569|473204358|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431497|NCT02714569|473204359|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431498|NCT02714569|473204360|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431499|NCT02714569|473204361|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431500|NCT02714569|473204362|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
131431501|NCT02714569|473204352|FG000|Part B (Overall)|Lost to Follow-up|0|||
131431502|NCT02714569|473204353|FG001|Part B (Overall)|Lost to Follow-up|0|||
131431503|NCT02714569|473204354|FG002|Part B (Overall)|Lost to Follow-up|0|||
131431504|NCT02714569|473204355|FG003|Part B (Overall)|Lost to Follow-up|0|||
131431505|NCT02714569|473204356|FG004|Part B (Overall)|Lost to Follow-up|0|||
131431506|NCT02714569|473204357|FG005|Part B (Overall)|Lost to Follow-up|0|||
131431507|NCT02714569|473204358|FG006|Part B (Overall)|Lost to Follow-up|1|||
131431508|NCT02714569|473204359|FG007|Part B (Overall)|Lost to Follow-up|0|||
131431509|NCT02714569|473204360|FG008|Part B (Overall)|Lost to Follow-up|0|||
131431510|NCT02714569|473204361|FG009|Part B (Overall)|Lost to Follow-up|0|||
131431511|NCT02714569|473204362|FG010|Part B (Overall)|Lost to Follow-up|0|||
131431512|NCT02714569|473204352|FG000|Part B (Overall)|Withdrawal by Subject|0|||
131431513|NCT02714569|473204353|FG001|Part B (Overall)|Withdrawal by Subject|0|||
131431514|NCT02714569|473204354|FG002|Part B (Overall)|Withdrawal by Subject|0|||
131431515|NCT02714569|473204355|FG003|Part B (Overall)|Withdrawal by Subject|0|||
131431516|NCT02714569|473204356|FG004|Part B (Overall)|Withdrawal by Subject|0|||
131431517|NCT02714569|473204357|FG005|Part B (Overall)|Withdrawal by Subject|0|||
131431518|NCT02714569|473204358|FG006|Part B (Overall)|Withdrawal by Subject|0|||
131431519|NCT02714569|473204359|FG007|Part B (Overall)|Withdrawal by Subject|1|||
131431520|NCT02714569|473204360|FG008|Part B (Overall)|Withdrawal by Subject|0|||
131431521|NCT02714569|473204361|FG009|Part B (Overall)|Withdrawal by Subject|1|||
131431522|NCT02714569|473204362|FG010|Part B (Overall)|Withdrawal by Subject|0|||
131431523|NCT02714569|473204352|FG000|Part B (Overall)|Adverse Event|0|||
131431524|NCT02714569|473204353|FG001|Part B (Overall)|Adverse Event|0|||
131431525|NCT02714569|473204354|FG002|Part B (Overall)|Adverse Event|0|||
131431526|NCT02714569|473204355|FG003|Part B (Overall)|Adverse Event|0|||
131431527|NCT02714569|473204356|FG004|Part B (Overall)|Adverse Event|0|||
131431528|NCT02714569|473204357|FG005|Part B (Overall)|Adverse Event|0|||
131431529|NCT02714569|473204358|FG006|Part B (Overall)|Adverse Event|0|||
131431530|NCT02714569|473204359|FG007|Part B (Overall)|Adverse Event|0|||
131431531|NCT02714569|473204360|FG008|Part B (Overall)|Adverse Event|0|||
131431532|NCT02714569|473204361|FG009|Part B (Overall)|Adverse Event|1|||
131431533|NCT02714569|473204362|FG010|Part B (Overall)|Adverse Event|0|||
131431534|NCT04915729|473204363|FG000|Overall Study|Lost to Follow-up|20|||
131431535|NCT04915729|473204364|FG001|Overall Study|Lost to Follow-up|10|||
131431536|NCT04915729|473204363|FG000|Overall Study|Withdrawal by Subject|12|||
131431537|NCT04915729|473204364|FG001|Overall Study|Withdrawal by Subject|5|||
131431538|NCT04915729|473204363|FG000|Overall Study|Death|34|||
131431539|NCT04915729|473204364|FG001|Overall Study|Death|44|||
131431540|NCT04915729|473204363|FG000|Overall Study|not treated|3|||
131431541|NCT04915729|473204364|FG001|Overall Study|not treated|6|||
131431542|NCT04915729|473204363|FG000|Overall Study|Investigator removed subject|1|||
131431543|NCT04915729|473204364|FG001|Overall Study|Investigator removed subject|2|||
131431544|NCT04915729|473204363|FG000|Overall Study|questionnaire result not evaluated|1|||
131431545|NCT04915729|473204364|FG001|Overall Study|questionnaire result not evaluated|0|||
131431546|NCT04915729|473204363|FG000|Overall Study|refuse of hospital visit|1|||
131431547|NCT04915729|473204364|FG001|Overall Study|refuse of hospital visit|3|||
131431548|NCT04915729|473204363|FG000|Overall Study|Subject withdrew|1|||
131431549|NCT04915729|473204364|FG001|Overall Study|Subject withdrew|0|||
131431550|NCT01684202|473204365|FG000|Dose-escalation Period|Adverse Event|0|||
131431551|NCT01684202|473204366|FG001|Dose-escalation Period|Adverse Event|1|||
131431552|NCT01684202|473204367|FG002|Dose-escalation Period|Adverse Event|0|||
131431553|NCT01684202|473204368|FG003|Dose-escalation Period|Adverse Event|0|||
131431554|NCT01684202|473204365|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
131431555|NCT01684202|473204366|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
131431556|NCT01684202|473204367|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
131431557|NCT01684202|473204368|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
131431558|NCT01684202|473204365|FG000|Maintenance Period|Adverse Event|1|||
131431559|NCT01684202|473204366|FG001|Maintenance Period|Adverse Event|1|||
131431560|NCT01684202|473204367|FG002|Maintenance Period|Adverse Event|1|||
131431561|NCT01684202|473204368|FG003|Maintenance Period|Adverse Event|1|||
131431562|NCT01684202|473204365|FG000|Maintenance Period|Physician Decision|0|||
131431563|NCT01684202|473204366|FG001|Maintenance Period|Physician Decision|1|||
131431564|NCT01684202|473204367|FG002|Maintenance Period|Physician Decision|0|||
131431565|NCT01684202|473204368|FG003|Maintenance Period|Physician Decision|0|||
131431566|NCT01684202|473204365|FG000|Maintenance Period|Withdrawal by Subject|0|||
131431567|NCT01684202|473204366|FG001|Maintenance Period|Withdrawal by Subject|1|||
131431568|NCT01684202|473204367|FG002|Maintenance Period|Withdrawal by Subject|0|||
131431569|NCT01684202|473204368|FG003|Maintenance Period|Withdrawal by Subject|0|||
131431570|NCT01843023|473204369|FG000|Overall Study|Death|1|||
131431571|NCT01843023|473204370|FG001|Overall Study|Death|0|||
131431572|NCT01843023|473204369|FG000|Overall Study|Lost to Follow-up|24|||
131431573|NCT01843023|473204370|FG001|Overall Study|Lost to Follow-up|29|||
131431574|NCT01843023|473204369|FG000|Overall Study|Withdrawal by Subject|8|||
131431575|NCT01843023|473204370|FG001|Overall Study|Withdrawal by Subject|6|||
131431576|NCT00779025|473204371|FG000|Overall Study|Withdrawal by Subject|1|||
131431577|NCT03710642|473204375|FG000|Overall Study|Adverse Event|5|||
131458547|NCT01276054|473310136|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
131458548|NCT02640508|473310137|FG000|Overall Study|Death|19|||
131458549|NCT02640508|473310137|FG000|Overall Study|Withdrawal by Subject|8|||
131458550|NCT02640508|473310137|FG000|Overall Study|Physician Decision|1|||
131458551|NCT02640508|473310137|FG000|Overall Study|Lost to Follow-up|1|||
131458552|NCT05405257|473310138|FG000|Overall Study|Withdrawal by Subject|1|||
131458553|NCT00452361|473310139|FG000|Overall Study|Adverse Event|8|||
131458554|NCT00452361|473310140|FG001|Overall Study|Adverse Event|0|||
131458555|NCT00452361|473310139|FG000|Overall Study|Withdrawal by Subject|0|||
131458556|NCT00452361|473310140|FG001|Overall Study|Withdrawal by Subject|1|||
131458557|NCT00452361|473310139|FG000|Overall Study|Premature termination|13|||
131458558|NCT00452361|473310140|FG001|Overall Study|Premature termination|9|||
131458559|NCT03116152|473310143|FG000|Overall Study|Disease Progression|49|||
131458560|NCT03116152|473310144|FG001|Overall Study|Disease Progression|47|||
131458561|NCT03116152|473310143|FG000|Overall Study|Death|5|||
131458562|NCT03116152|473310144|FG001|Overall Study|Death|2|||
131458563|NCT03116152|473310143|FG000|Overall Study|Adverse Event|21|||
131458564|NCT03116152|473310144|FG001|Overall Study|Adverse Event|7|||
131458565|NCT03116152|473310143|FG000|Overall Study|Protocol Violation|2|||
131458566|NCT03116152|473310144|FG001|Overall Study|Protocol Violation|2|||
131458567|NCT03116152|473310143|FG000|Overall Study|Withdrawal by Subject|0|||
131458568|NCT03116152|473310144|FG001|Overall Study|Withdrawal by Subject|1|||
131458569|NCT03116152|473310143|FG000|Overall Study|Physician Decision|3|||
131458570|NCT03116152|473310144|FG001|Overall Study|Physician Decision|2|||
131458571|NCT03116152|473310143|FG000|Overall Study|other|11|||
131458572|NCT03116152|473310144|FG001|Overall Study|other|34|||
131458573|NCT02379637|473310146|FG000|Overall Study|Protocol Violation|0|||
131458574|NCT02379637|473310147|FG001|Overall Study|Protocol Violation|1|||
131458575|NCT02379637|473310146|FG000|Overall Study|Adverse Event|1|||
131458576|NCT02379637|473310147|FG001|Overall Study|Adverse Event|0|||
131458577|NCT02379637|473310146|FG000|Overall Study|Withdrawal by Subject|1|||
131458578|NCT02379637|473310147|FG001|Overall Study|Withdrawal by Subject|0|||
131458579|NCT02791763|473310148|FG000|Overall Study|Protocol Violation|0|||
131458580|NCT02791763|473310149|FG001|Overall Study|Protocol Violation|0|||
131458581|NCT02791763|473310150|FG002|Overall Study|Protocol Violation|1|||
131458582|NCT02791763|473310148|FG000|Overall Study|Withdrawal by Subject|5|||
131458583|NCT02791763|473310149|FG001|Overall Study|Withdrawal by Subject|1|||
131458584|NCT02791763|473310150|FG002|Overall Study|Withdrawal by Subject|0|||
131458585|NCT02791763|473310148|FG000|Overall Study|Physician Decision|0|||
131458586|NCT02791763|473310149|FG001|Overall Study|Physician Decision|1|||
131458587|NCT02791763|473310150|FG002|Overall Study|Physician Decision|0|||
131458588|NCT02791763|473310148|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
131458589|NCT02791763|473310149|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
131458590|NCT02791763|473310150|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
131458591|NCT02791763|473310148|FG000|Overall Study|Cancer event|1|||
131458592|NCT02791763|473310149|FG001|Overall Study|Cancer event|3|||
131458593|NCT02791763|473310150|FG002|Overall Study|Cancer event|0|||
131458594|NCT02791763|473310148|FG000|Overall Study|Participant had renal transplant|3|||
131458595|NCT02791763|473310149|FG001|Overall Study|Participant had renal transplant|0|||
131458596|NCT02791763|473310150|FG002|Overall Study|Participant had renal transplant|0|||
131458597|NCT02791763|473310148|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
131458598|NCT02791763|473310149|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
131458599|NCT02791763|473310150|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
131458600|NCT02791763|473310148|FG000|Overall Study|Adverse Event|12|||
131458601|NCT02791763|473310149|FG001|Overall Study|Adverse Event|13|||
131458602|NCT02791763|473310150|FG002|Overall Study|Adverse Event|7|||
131458603|NCT03179605|473310151|FG000|Overall Study|Withdrawal by Subject|1|||
131458604|NCT00711477|473310152|FG000|Overall Study|Adverse Event|3|||
131431578|NCT03710642|473204376|FG001|Overall Study|Adverse Event|1|||
131431579|NCT03710642|473204375|FG000|Overall Study|non-site physician recommendation|1|||
131431580|NCT03710642|473204376|FG001|Overall Study|non-site physician recommendation|0|||
131431581|NCT03710642|473204375|FG000|Overall Study|Participant unwilling or unable to participate|1|||
131431582|NCT03710642|473204376|FG001|Overall Study|Participant unwilling or unable to participate|1|||
131431583|NCT03710642|473204375|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
131431584|NCT03710642|473204376|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
131431585|NCT03710642|473204375|FG000|Overall Study|NA-no code provided|1|||
131431586|NCT03710642|473204376|FG001|Overall Study|NA-no code provided|0|||
131431587|NCT03710642|473204375|FG000|Overall Study|Withdrawal by Subject|1|||
131431588|NCT03710642|473204376|FG001|Overall Study|Withdrawal by Subject|0|||
131431589|NCT02741635|473204379|FG000|Overall Study|Withdrawal by Subject|1|||
131431590|NCT01427933|473204383|FG000|Overall Study|Withdrawal by Subject|5|||
131431591|NCT01427933|473204384|FG001|Overall Study|Withdrawal by Subject|8|||
131431592|NCT01427933|473204383|FG000|Overall Study|Lost to Follow-up|1|||
131431593|NCT01427933|473204384|FG001|Overall Study|Lost to Follow-up|5|||
131431594|NCT01427933|473204383|FG000|Overall Study|Other|1|||
131431595|NCT01427933|473204384|FG001|Overall Study|Other|0|||
131431596|NCT01427933|473204383|FG000|Overall Study|Investigator's Decision|1|||
131431597|NCT01427933|473204384|FG001|Overall Study|Investigator's Decision|0|||
131431598|NCT01633541|473204385|FG000|Overall Study|Death|1|||
131431599|NCT01633541|473204386|FG001|Overall Study|Death|0|||
131431600|NCT01010971|473204389|FG000|Overall Study|Adverse Event|2|||
131431601|NCT01010971|473204390|FG001|Overall Study|Adverse Event|4|||
131431602|NCT01010971|473204391|FG002|Overall Study|Adverse Event|3|||
131431603|NCT01010971|473204389|FG000|Overall Study|Withdrawal by Subject|0|||
131431604|NCT01010971|473204390|FG001|Overall Study|Withdrawal by Subject|2|||
131431605|NCT01010971|473204391|FG002|Overall Study|Withdrawal by Subject|5|||
131431606|NCT01010971|473204389|FG000|Overall Study|Lost to Follow-up|0|||
131431607|NCT01010971|473204390|FG001|Overall Study|Lost to Follow-up|2|||
131431608|NCT01010971|473204391|FG002|Overall Study|Lost to Follow-up|3|||
131431609|NCT01010971|473204389|FG000|Overall Study|Other|1|||
131431610|NCT01010971|473204390|FG001|Overall Study|Other|0|||
131431611|NCT01010971|473204391|FG002|Overall Study|Other|2|||
131431612|NCT03386721|473204392|FG000|Overall Study|Death|12|||
131431613|NCT03386721|473204393|FG001|Overall Study|Death|21|||
131431614|NCT03386721|473204394|FG002|Overall Study|Death|2|||
131431615|NCT03386721|473204395|FG003|Overall Study|Death|5|||
131431616|NCT03386721|473204396|FG004|Overall Study|Death|1|||
131431617|NCT03386721|473204397|FG005|Overall Study|Death|12|||
131431618|NCT03386721|473204398|FG006|Overall Study|Death|1|||
131431619|NCT03386721|473204399|FG007|Overall Study|Death|1|||
131431620|NCT03386721|473204400|FG008|Overall Study|Death|12|||
131431621|NCT03386721|473204401|FG009|Overall Study|Death|20|||
131431622|NCT03386721|473204402|FG010|Overall Study|Death|21|||
131431623|NCT03386721|473204403|FG011|Overall Study|Death|21|||
131431624|NCT03386721|473204404|FG012|Overall Study|Death|14|||
131431625|NCT03386721|473204405|FG013|Overall Study|Death|2|||
131431626|NCT03386721|473204406|FG014|Overall Study|Death|1|||
131431627|NCT03386721|473204392|FG000|Overall Study|Lost to Follow-up|1|||
131431628|NCT03386721|473204393|FG001|Overall Study|Lost to Follow-up|3|||
131431629|NCT03386721|473204394|FG002|Overall Study|Lost to Follow-up|0|||
131431630|NCT03386721|473204395|FG003|Overall Study|Lost to Follow-up|0|||
131431631|NCT03386721|473204396|FG004|Overall Study|Lost to Follow-up|0|||
131431632|NCT03386721|473204397|FG005|Overall Study|Lost to Follow-up|2|||
131431633|NCT03386721|473204398|FG006|Overall Study|Lost to Follow-up|1|||
131431634|NCT03386721|473204399|FG007|Overall Study|Lost to Follow-up|0|||
131431635|NCT03386721|473204400|FG008|Overall Study|Lost to Follow-up|1|||
131431636|NCT03386721|473204401|FG009|Overall Study|Lost to Follow-up|2|||
131431637|NCT03386721|473204402|FG010|Overall Study|Lost to Follow-up|1|||
131431638|NCT03386721|473204403|FG011|Overall Study|Lost to Follow-up|0|||
131431639|NCT03386721|473204404|FG012|Overall Study|Lost to Follow-up|0|||
131431640|NCT03386721|473204405|FG013|Overall Study|Lost to Follow-up|0|||
131431641|NCT03386721|473204406|FG014|Overall Study|Lost to Follow-up|0|||
131431642|NCT03386721|473204392|FG000|Overall Study|Reason not specified|3|||
131431643|NCT03386721|473204393|FG001|Overall Study|Reason not specified|0|||
131431644|NCT03386721|473204394|FG002|Overall Study|Reason not specified|0|||
131431645|NCT03386721|473204395|FG003|Overall Study|Reason not specified|0|||
131431646|NCT03386721|473204396|FG004|Overall Study|Reason not specified|0|||
131431647|NCT03386721|473204397|FG005|Overall Study|Reason not specified|3|||
131431648|NCT03386721|473204398|FG006|Overall Study|Reason not specified|1|||
131431649|NCT03386721|473204399|FG007|Overall Study|Reason not specified|0|||
131431650|NCT03386721|473204400|FG008|Overall Study|Reason not specified|0|||
131431651|NCT03386721|473204401|FG009|Overall Study|Reason not specified|1|||
131431652|NCT03386721|473204402|FG010|Overall Study|Reason not specified|2|||
131431653|NCT03386721|473204403|FG011|Overall Study|Reason not specified|6|||
131431654|NCT03386721|473204404|FG012|Overall Study|Reason not specified|1|||
131431655|NCT03386721|473204405|FG013|Overall Study|Reason not specified|0|||
131431656|NCT03386721|473204406|FG014|Overall Study|Reason not specified|0|||
131431657|NCT03386721|473204392|FG000|Overall Study|Progressive Disease|0|||
131431658|NCT03386721|473204393|FG001|Overall Study|Progressive Disease|0|||
131431659|NCT03386721|473204394|FG002|Overall Study|Progressive Disease|1|||
131431660|NCT03386721|473204395|FG003|Overall Study|Progressive Disease|0|||
131431661|NCT03386721|473204396|FG004|Overall Study|Progressive Disease|0|||
131431662|NCT03386721|473204397|FG005|Overall Study|Progressive Disease|1|||
131431663|NCT03386721|473204398|FG006|Overall Study|Progressive Disease|0|||
131431664|NCT03386721|473204399|FG007|Overall Study|Progressive Disease|0|||
131431665|NCT03386721|473204400|FG008|Overall Study|Progressive Disease|2|||
131431666|NCT03386721|473204401|FG009|Overall Study|Progressive Disease|1|||
131431667|NCT03386721|473204402|FG010|Overall Study|Progressive Disease|1|||
131431668|NCT03386721|473204403|FG011|Overall Study|Progressive Disease|0|||
131431669|NCT03386721|473204404|FG012|Overall Study|Progressive Disease|1|||
131431670|NCT03386721|473204405|FG013|Overall Study|Progressive Disease|0|||
131431671|NCT03386721|473204406|FG014|Overall Study|Progressive Disease|0|||
131431672|NCT03386721|473204392|FG000|Overall Study|Site Terminated by Sponsor|5|||
131431673|NCT03386721|473204393|FG001|Overall Study|Site Terminated by Sponsor|5|||
131431674|NCT03386721|473204394|FG002|Overall Study|Site Terminated by Sponsor|0|||
131431675|NCT03386721|473204395|FG003|Overall Study|Site Terminated by Sponsor|0|||
131431676|NCT03386721|473204396|FG004|Overall Study|Site Terminated by Sponsor|1|||
131431677|NCT03386721|473204397|FG005|Overall Study|Site Terminated by Sponsor|3|||
131431678|NCT03386721|473204398|FG006|Overall Study|Site Terminated by Sponsor|0|||
131431679|NCT03386721|473204399|FG007|Overall Study|Site Terminated by Sponsor|1|||
131431680|NCT03386721|473204400|FG008|Overall Study|Site Terminated by Sponsor|4|||
131431681|NCT03386721|473204401|FG009|Overall Study|Site Terminated by Sponsor|5|||
131431682|NCT03386721|473204402|FG010|Overall Study|Site Terminated by Sponsor|3|||
131431683|NCT03386721|473204403|FG011|Overall Study|Site Terminated by Sponsor|11|||
131431684|NCT03386721|473204404|FG012|Overall Study|Site Terminated by Sponsor|6|||
131431685|NCT03386721|473204405|FG013|Overall Study|Site Terminated by Sponsor|0|||
131431686|NCT03386721|473204406|FG014|Overall Study|Site Terminated by Sponsor|0|||
131431687|NCT03386721|473204392|FG000|Overall Study|Symptomatic Deterioration|0|||
131431688|NCT03386721|473204393|FG001|Overall Study|Symptomatic Deterioration|0|||
131431689|NCT03386721|473204394|FG002|Overall Study|Symptomatic Deterioration|0|||
131431690|NCT03386721|473204395|FG003|Overall Study|Symptomatic Deterioration|0|||
131431691|NCT03386721|473204396|FG004|Overall Study|Symptomatic Deterioration|0|||
131431692|NCT03386721|473204397|FG005|Overall Study|Symptomatic Deterioration|0|||
131431693|NCT03386721|473204398|FG006|Overall Study|Symptomatic Deterioration|0|||
131431694|NCT03386721|473204399|FG007|Overall Study|Symptomatic Deterioration|0|||
131431695|NCT03386721|473204400|FG008|Overall Study|Symptomatic Deterioration|1|||
131431696|NCT03386721|473204401|FG009|Overall Study|Symptomatic Deterioration|0|||
131431697|NCT03386721|473204402|FG010|Overall Study|Symptomatic Deterioration|0|||
131431698|NCT03386721|473204403|FG011|Overall Study|Symptomatic Deterioration|1|||
131431699|NCT03386721|473204404|FG012|Overall Study|Symptomatic Deterioration|0|||
131431700|NCT03386721|473204405|FG013|Overall Study|Symptomatic Deterioration|0|||
131431701|NCT03386721|473204406|FG014|Overall Study|Symptomatic Deterioration|0|||
131431702|NCT03386721|473204392|FG000|Overall Study|Withdrawal by Subject|1|||
131431703|NCT03386721|473204393|FG001|Overall Study|Withdrawal by Subject|2|||
131431704|NCT03386721|473204394|FG002|Overall Study|Withdrawal by Subject|0|||
131431705|NCT03386721|473204395|FG003|Overall Study|Withdrawal by Subject|0|||
131431706|NCT03386721|473204396|FG004|Overall Study|Withdrawal by Subject|0|||
131431707|NCT03386721|473204397|FG005|Overall Study|Withdrawal by Subject|0|||
131431708|NCT03386721|473204398|FG006|Overall Study|Withdrawal by Subject|0|||
131431709|NCT03386721|473204399|FG007|Overall Study|Withdrawal by Subject|0|||
131431710|NCT03386721|473204400|FG008|Overall Study|Withdrawal by Subject|2|||
131431711|NCT03386721|473204401|FG009|Overall Study|Withdrawal by Subject|1|||
131431712|NCT03386721|473204402|FG010|Overall Study|Withdrawal by Subject|3|||
131431713|NCT03386721|473204403|FG011|Overall Study|Withdrawal by Subject|2|||
131431714|NCT03386721|473204404|FG012|Overall Study|Withdrawal by Subject|3|||
131431715|NCT03386721|473204405|FG013|Overall Study|Withdrawal by Subject|0|||
131431716|NCT03386721|473204406|FG014|Overall Study|Withdrawal by Subject|0|||
131431717|NCT05114473|473204407|FG000|Overall Study|Lost to Follow-up|2|||
131431718|NCT05114473|473204408|FG001|Overall Study|Lost to Follow-up|2|||
131431719|NCT05114473|473204409|FG002|Overall Study|Lost to Follow-up|0|||
131431720|NCT02330055|473204410|FG000|Overall Study|technical issues|2|||
131431721|NCT02330055|473204411|FG001|Overall Study|technical issues|0|||
131431722|NCT02330055|473204410|FG000|Overall Study|participant forgot to wear device|5|||
131431723|NCT02330055|473204411|FG001|Overall Study|participant forgot to wear device|5|||
131431724|NCT02330055|473204410|FG000|Overall Study|data for less than 60 minutes|3|||
131431725|NCT02330055|473204411|FG001|Overall Study|data for less than 60 minutes|3|||
131431726|NCT02330055|473204410|FG000|Overall Study|participant did not sleep|0|||
131431727|NCT02330055|473204411|FG001|Overall Study|participant did not sleep|1|||
131431728|NCT02728089|473204412|FG000|Overall Study|Physician Decision|2|||
131431729|NCT02728089|473204412|FG000|Overall Study|Withdrawal by Subject|1|||
131431730|NCT04378270|473204418|FG000|Overall Study|Lack of Efficacy|1|||
131431731|NCT04378270|473204418|FG000|Overall Study|Withdrawal by Subject|1|||
131431732|NCT04378270|473204418|FG000|Overall Study|Screen Failure|1|||
131431733|NCT04378270|473204418|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
131431734|NCT01327599|473204419|FG000|Overall Study|Adverse Event|1|||
131431735|NCT01327599|473204419|FG000|Overall Study|Could Not Attend Visit|1|||
131431736|NCT01327599|473204419|FG000|Overall Study|Withdrawal of Consent|1|||
131431737|NCT01132313|473204420|FG000|Overall Study|Lack of Efficacy|1|||
131431738|NCT01132313|473204421|FG001|Overall Study|Lack of Efficacy|0|||
131431739|NCT01132313|473204422|FG002|Overall Study|Lack of Efficacy|0|||
131431740|NCT01132313|473204423|FG003|Overall Study|Lack of Efficacy|0|||
131431741|NCT01132313|473204424|FG004|Overall Study|Lack of Efficacy|0|||
131431742|NCT01132313|473204425|FG005|Overall Study|Lack of Efficacy|0|||
131431743|NCT01132313|473204426|FG006|Overall Study|Lack of Efficacy|0|||
131431744|NCT01132313|473204427|FG007|Overall Study|Lack of Efficacy|3|||
131431745|NCT01132313|473204428|FG008|Overall Study|Lack of Efficacy|14|||
131431746|NCT01132313|473204429|FG009|Overall Study|Lack of Efficacy|16|||
131431747|NCT01132313|473204430|FG010|Overall Study|Lack of Efficacy|0|||
131431748|NCT01132313|473204431|FG011|Overall Study|Lack of Efficacy|0|||
131431749|NCT01132313|473204420|FG000|Overall Study|Not treated|2|||
131431750|NCT01132313|473204421|FG001|Overall Study|Not treated|0|||
131431751|NCT01132313|473204422|FG002|Overall Study|Not treated|0|||
131431752|NCT01132313|473204423|FG003|Overall Study|Not treated|0|||
131431753|NCT01132313|473204424|FG004|Overall Study|Not treated|2|||
131431754|NCT01132313|473204425|FG005|Overall Study|Not treated|1|||
131431755|NCT01132313|473204426|FG006|Overall Study|Not treated|3|||
131431756|NCT01132313|473204427|FG007|Overall Study|Not treated|0|||
131431757|NCT01132313|473204428|FG008|Overall Study|Not treated|0|||
131431758|NCT01132313|473204429|FG009|Overall Study|Not treated|0|||
131431759|NCT01132313|473204430|FG010|Overall Study|Not treated|0|||
131431760|NCT01132313|473204431|FG011|Overall Study|Not treated|0|||
131431761|NCT01132313|473204420|FG000|Overall Study|Adverse Event|0|||
131431762|NCT01132313|473204421|FG001|Overall Study|Adverse Event|0|||
131431763|NCT01132313|473204422|FG002|Overall Study|Adverse Event|4|||
131431764|NCT01132313|473204423|FG003|Overall Study|Adverse Event|10|||
131431765|NCT01132313|473204424|FG004|Overall Study|Adverse Event|19|||
131431766|NCT01132313|473204425|FG005|Overall Study|Adverse Event|6|||
131431767|NCT01132313|473204426|FG006|Overall Study|Adverse Event|5|||
131431768|NCT01132313|473204427|FG007|Overall Study|Adverse Event|3|||
131431769|NCT01132313|473204428|FG008|Overall Study|Adverse Event|7|||
131431770|NCT01132313|473204429|FG009|Overall Study|Adverse Event|2|||
131431771|NCT01132313|473204430|FG010|Overall Study|Adverse Event|0|||
131431772|NCT01132313|473204431|FG011|Overall Study|Adverse Event|0|||
131431773|NCT01132313|473204420|FG000|Overall Study|Protocol Violation|0|||
131431774|NCT01132313|473204421|FG001|Overall Study|Protocol Violation|0|||
131431775|NCT01132313|473204422|FG002|Overall Study|Protocol Violation|0|||
131431776|NCT01132313|473204423|FG003|Overall Study|Protocol Violation|1|||
131431777|NCT01132313|473204424|FG004|Overall Study|Protocol Violation|0|||
131431778|NCT01132313|473204425|FG005|Overall Study|Protocol Violation|0|||
131431779|NCT01132313|473204426|FG006|Overall Study|Protocol Violation|0|||
131431780|NCT01132313|473204427|FG007|Overall Study|Protocol Violation|0|||
131431781|NCT01132313|473204428|FG008|Overall Study|Protocol Violation|0|||
131431782|NCT01132313|473204429|FG009|Overall Study|Protocol Violation|0|||
131431783|NCT01132313|473204430|FG010|Overall Study|Protocol Violation|0|||
131431784|NCT01132313|473204431|FG011|Overall Study|Protocol Violation|0|||
131431785|NCT01132313|473204420|FG000|Overall Study|Lost to Follow-up|0|||
131431786|NCT01132313|473204421|FG001|Overall Study|Lost to Follow-up|0|||
131431787|NCT01132313|473204422|FG002|Overall Study|Lost to Follow-up|1|||
131431788|NCT01132313|473204423|FG003|Overall Study|Lost to Follow-up|0|||
131431789|NCT01132313|473204424|FG004|Overall Study|Lost to Follow-up|0|||
131431790|NCT01132313|473204425|FG005|Overall Study|Lost to Follow-up|0|||
131431791|NCT01132313|473204426|FG006|Overall Study|Lost to Follow-up|0|||
131431792|NCT01132313|473204427|FG007|Overall Study|Lost to Follow-up|1|||
131431793|NCT01132313|473204428|FG008|Overall Study|Lost to Follow-up|0|||
131431794|NCT01132313|473204429|FG009|Overall Study|Lost to Follow-up|0|||
131431795|NCT01132313|473204430|FG010|Overall Study|Lost to Follow-up|0|||
131431796|NCT01132313|473204431|FG011|Overall Study|Lost to Follow-up|0|||
131431797|NCT01132313|473204420|FG000|Overall Study|Withdrawal by Subject|0|||
131431798|NCT01132313|473204421|FG001|Overall Study|Withdrawal by Subject|0|||
131431799|NCT01132313|473204422|FG002|Overall Study|Withdrawal by Subject|3|||
131431800|NCT01132313|473204423|FG003|Overall Study|Withdrawal by Subject|3|||
131431801|NCT01132313|473204424|FG004|Overall Study|Withdrawal by Subject|6|||
131431802|NCT01132313|473204425|FG005|Overall Study|Withdrawal by Subject|0|||
131431803|NCT01132313|473204426|FG006|Overall Study|Withdrawal by Subject|1|||
131431804|NCT01132313|473204427|FG007|Overall Study|Withdrawal by Subject|0|||
131431805|NCT01132313|473204428|FG008|Overall Study|Withdrawal by Subject|0|||
131431806|NCT01132313|473204429|FG009|Overall Study|Withdrawal by Subject|2|||
131431807|NCT01132313|473204430|FG010|Overall Study|Withdrawal by Subject|0|||
131431808|NCT01132313|473204431|FG011|Overall Study|Withdrawal by Subject|0|||
131431809|NCT01132313|473204420|FG000|Overall Study|Lack of antiviral response|0|||
131431810|NCT01132313|473204421|FG001|Overall Study|Lack of antiviral response|0|||
131431811|NCT01132313|473204422|FG002|Overall Study|Lack of antiviral response|12|||
131431812|NCT01132313|473204423|FG003|Overall Study|Lack of antiviral response|18|||
131431813|NCT01132313|473204424|FG004|Overall Study|Lack of antiviral response|18|||
131431814|NCT01132313|473204425|FG005|Overall Study|Lack of antiviral response|18|||
131431815|NCT01132313|473204426|FG006|Overall Study|Lack of antiviral response|21|||
131431816|NCT01132313|473204427|FG007|Overall Study|Lack of antiviral response|0|||
131458605|NCT00711477|473310153|FG001|Overall Study|Adverse Event|1|||
131458606|NCT00711477|473310152|FG000|Overall Study|Lost to Follow-up|0|||
131458607|NCT00711477|473310153|FG001|Overall Study|Lost to Follow-up|1|||
131458608|NCT00711477|473310152|FG000|Overall Study|Noncompliance|0|||
131458609|NCT00711477|473310153|FG001|Overall Study|Noncompliance|1|||
131458610|NCT02878798|473310154|FG000|Overall Study|Withdrawal by Subject|5|||
131458611|NCT02878798|473310155|FG001|Overall Study|Withdrawal by Subject|4|||
131458612|NCT02878798|473310154|FG000|Overall Study|Lost to Follow-up|2|||
131458613|NCT02878798|473310155|FG001|Overall Study|Lost to Follow-up|2|||
131458614|NCT02878798|473310154|FG000|Overall Study|Protocol Violation|0|||
131458615|NCT02878798|473310155|FG001|Overall Study|Protocol Violation|1|||
131458616|NCT00101452|473310160|FG000|Overall Study|Adverse Event|2|||
131458617|NCT00101452|473310161|FG001|Overall Study|Adverse Event|0|||
131458618|NCT00101452|473310162|FG002|Overall Study|Adverse Event|1|||
131458619|NCT00101452|473310160|FG000|Overall Study|Lost to Follow-up|13|||
131458620|NCT00101452|473310161|FG001|Overall Study|Lost to Follow-up|8|||
131458621|NCT00101452|473310162|FG002|Overall Study|Lost to Follow-up|14|||
131458622|NCT00101452|473310160|FG000|Overall Study|Withdrawal by Subject|10|||
131458623|NCT00101452|473310161|FG001|Overall Study|Withdrawal by Subject|14|||
131458624|NCT00101452|473310162|FG002|Overall Study|Withdrawal by Subject|9|||
131458625|NCT00101452|473310160|FG000|Overall Study|Baseline Fail|2|||
131458626|NCT00101452|473310161|FG001|Overall Study|Baseline Fail|1|||
131458627|NCT00101452|473310162|FG002|Overall Study|Baseline Fail|2|||
131458628|NCT00101452|473310160|FG000|Overall Study|Physician Decision|0|||
131458629|NCT00101452|473310161|FG001|Overall Study|Physician Decision|3|||
131458630|NCT00101452|473310162|FG002|Overall Study|Physician Decision|2|||
131458631|NCT00101452|473310160|FG000|Overall Study|Protocol Violation|2|||
131458632|NCT00101452|473310161|FG001|Overall Study|Protocol Violation|1|||
131458633|NCT00101452|473310162|FG002|Overall Study|Protocol Violation|3|||
131458634|NCT00101452|473310160|FG000|Overall Study|Other|15|||
131458635|NCT00101452|473310161|FG001|Overall Study|Other|16|||
131458636|NCT00101452|473310162|FG002|Overall Study|Other|12|||
131458637|NCT02969655|473310164|FG000|Overall Study|Withdrawal by Subject|3|||
131458638|NCT02969655|473310165|FG001|Overall Study|Withdrawal by Subject|2|||
131458639|NCT02969655|473310164|FG000|Overall Study|Physician Decision|4|||
131458640|NCT02969655|473310165|FG001|Overall Study|Physician Decision|3|||
131458641|NCT02969655|473310164|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
131458642|NCT02969655|473310165|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
131458643|NCT02969655|473310164|FG000|Overall Study|Adverse Event|10|||
131458644|NCT02969655|473310165|FG001|Overall Study|Adverse Event|8|||
131458645|NCT01510769|473310166|FG000|Overall Study|Adverse Event|7|||
131458646|NCT01510769|473310167|FG001|Overall Study|Adverse Event|6|||
131458647|NCT01510769|473310168|FG002|Overall Study|Adverse Event|4|||
131458648|NCT01510769|473310166|FG000|Overall Study|Gout Flare|0|||
131458649|NCT01510769|473310167|FG001|Overall Study|Gout Flare|3|||
131458650|NCT01510769|473310168|FG002|Overall Study|Gout Flare|1|||
131458651|NCT01510769|473310166|FG000|Overall Study|Protocol Violation|11|||
131458652|NCT01510769|473310167|FG001|Overall Study|Protocol Violation|10|||
131458653|NCT01510769|473310168|FG002|Overall Study|Protocol Violation|9|||
131458654|NCT01510769|473310166|FG000|Overall Study|Lost to Follow-up|5|||
131458655|NCT01510769|473310167|FG001|Overall Study|Lost to Follow-up|1|||
131458656|NCT01510769|473310168|FG002|Overall Study|Lost to Follow-up|5|||
131458657|NCT01510769|473310166|FG000|Overall Study|Withdrawal by Subject|3|||
131458658|NCT01510769|473310167|FG001|Overall Study|Withdrawal by Subject|4|||
131458659|NCT01510769|473310168|FG002|Overall Study|Withdrawal by Subject|3|||
131458660|NCT01510769|473310166|FG000|Overall Study|Death|1|||
131458661|NCT01510769|473310167|FG001|Overall Study|Death|1|||
131458662|NCT01510769|473310168|FG002|Overall Study|Death|0|||
131458663|NCT00145977|473310169|FG000|Overall Study|Lack of Efficacy|0|||
131458664|NCT00145977|473310170|FG001|Overall Study|Lack of Efficacy|4|||
131458665|NCT00145977|473310169|FG000|Overall Study|Lost to Follow-up|1|||
131458666|NCT00145977|473310170|FG001|Overall Study|Lost to Follow-up|0|||
131458667|NCT00145977|473310169|FG000|Overall Study|Withdrawal by Subject|1|||
131458668|NCT00145977|473310170|FG001|Overall Study|Withdrawal by Subject|0|||
131458669|NCT00782834|473310171|FG000|Treatment Phase|fibrous tumor not GIST|1|||
131458670|NCT01516034|473310173|FG000|Overall Study|Physician Decision|1|||
131458671|NCT01516034|473310173|FG000|Overall Study|Lack of Efficacy|7|||
131458672|NCT03060551|473310174|FG000|Overall Study|Withdrawal by Subject|1|||
131458673|NCT03060551|473310174|FG000|Overall Study|Adverse Event|1|||
131458674|NCT05477108|473310179|FG000|Overall Study|Participants randomized, not treated|1|||
131431817|NCT01132313|473204428|FG008|Overall Study|Lack of antiviral response|0|||
131431818|NCT01132313|473204429|FG009|Overall Study|Lack of antiviral response|0|||
131431819|NCT01132313|473204430|FG010|Overall Study|Lack of antiviral response|1|||
131431820|NCT01132313|473204431|FG011|Overall Study|Lack of antiviral response|0|||
131431821|NCT01132313|473204420|FG000|Overall Study|Other reason not defined above|0|||
131431822|NCT01132313|473204421|FG001|Overall Study|Other reason not defined above|0|||
131431823|NCT01132313|473204422|FG002|Overall Study|Other reason not defined above|0|||
131431824|NCT01132313|473204423|FG003|Overall Study|Other reason not defined above|0|||
131431825|NCT01132313|473204424|FG004|Overall Study|Other reason not defined above|0|||
131431826|NCT01132313|473204425|FG005|Overall Study|Other reason not defined above|0|||
131431827|NCT01132313|473204426|FG006|Overall Study|Other reason not defined above|0|||
131431828|NCT01132313|473204427|FG007|Overall Study|Other reason not defined above|1|||
131431829|NCT01132313|473204428|FG008|Overall Study|Other reason not defined above|0|||
131431830|NCT01132313|473204429|FG009|Overall Study|Other reason not defined above|0|||
131431831|NCT01132313|473204430|FG010|Overall Study|Other reason not defined above|0|||
131431832|NCT01132313|473204431|FG011|Overall Study|Other reason not defined above|0|||
131431833|NCT03201419|473204432|FG000|Overall Study|Adverse Event|3|||
131431834|NCT03201419|473204433|FG001|Overall Study|Adverse Event|1|||
131431835|NCT03201419|473204434|FG002|Overall Study|Adverse Event|0|||
131431836|NCT03201419|473204435|FG003|Overall Study|Adverse Event|0|||
131431837|NCT03201419|473204436|FG004|Overall Study|Adverse Event|1|||
131431838|NCT03201419|473204437|FG005|Overall Study|Adverse Event|1|||
131431839|NCT03201419|473204438|FG006|Overall Study|Adverse Event|5|||
131431840|NCT03201419|473204439|FG007|Overall Study|Adverse Event|0|||
131431841|NCT03201419|473204440|FG008|Overall Study|Adverse Event|0|||
131431842|NCT03201419|473204432|FG000|Overall Study|Lost to Follow-up|1|||
131431843|NCT03201419|473204433|FG001|Overall Study|Lost to Follow-up|0|||
131431844|NCT03201419|473204434|FG002|Overall Study|Lost to Follow-up|0|||
131431845|NCT03201419|473204435|FG003|Overall Study|Lost to Follow-up|0|||
131431846|NCT03201419|473204436|FG004|Overall Study|Lost to Follow-up|0|||
131431847|NCT03201419|473204437|FG005|Overall Study|Lost to Follow-up|0|||
131431848|NCT03201419|473204438|FG006|Overall Study|Lost to Follow-up|0|||
131431849|NCT03201419|473204439|FG007|Overall Study|Lost to Follow-up|0|||
131431850|NCT03201419|473204440|FG008|Overall Study|Lost to Follow-up|0|||
131431851|NCT03201419|473204432|FG000|Overall Study|Protocol Deviation|0|||
131431852|NCT03201419|473204433|FG001|Overall Study|Protocol Deviation|0|||
131431853|NCT03201419|473204434|FG002|Overall Study|Protocol Deviation|0|||
131431854|NCT03201419|473204435|FG003|Overall Study|Protocol Deviation|0|||
131431855|NCT03201419|473204436|FG004|Overall Study|Protocol Deviation|0|||
131431856|NCT03201419|473204437|FG005|Overall Study|Protocol Deviation|0|||
131431857|NCT03201419|473204438|FG006|Overall Study|Protocol Deviation|1|||
131431858|NCT03201419|473204439|FG007|Overall Study|Protocol Deviation|0|||
131431859|NCT03201419|473204440|FG008|Overall Study|Protocol Deviation|0|||
131431860|NCT03201419|473204432|FG000|Overall Study|Withdrawal by Subject|4|||
131431861|NCT03201419|473204433|FG001|Overall Study|Withdrawal by Subject|2|||
131431862|NCT03201419|473204434|FG002|Overall Study|Withdrawal by Subject|1|||
131431863|NCT03201419|473204435|FG003|Overall Study|Withdrawal by Subject|0|||
131431864|NCT03201419|473204436|FG004|Overall Study|Withdrawal by Subject|0|||
131431865|NCT03201419|473204437|FG005|Overall Study|Withdrawal by Subject|0|||
131431866|NCT03201419|473204438|FG006|Overall Study|Withdrawal by Subject|0|||
131431867|NCT03201419|473204439|FG007|Overall Study|Withdrawal by Subject|1|||
131431868|NCT03201419|473204440|FG008|Overall Study|Withdrawal by Subject|2|||
131431869|NCT03201419|473204432|FG000|Overall Study|Other|0|||
131431870|NCT03201419|473204433|FG001|Overall Study|Other|0|||
131431871|NCT03201419|473204434|FG002|Overall Study|Other|1|||
131431872|NCT03201419|473204435|FG003|Overall Study|Other|0|||
131431873|NCT03201419|473204436|FG004|Overall Study|Other|0|||
131431874|NCT03201419|473204437|FG005|Overall Study|Other|0|||
131431875|NCT03201419|473204438|FG006|Overall Study|Other|0|||
131431876|NCT03201419|473204439|FG007|Overall Study|Other|0|||
131431877|NCT03201419|473204440|FG008|Overall Study|Other|0|||
131431878|NCT00434109|473204441|FG000|Overall Study|Physician Decision|9|||
131431879|NCT00434109|473204441|FG000|Overall Study|Adverse Event|5|||
131431880|NCT00434109|473204441|FG000|Overall Study|Protocol Violation|1|||
131431881|NCT00434109|473204441|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
131431882|NCT04178720|473204442|FG000|Overall Study|Withdrawal by Subject|2|||
131431883|NCT04178720|473204443|FG001|Overall Study|Withdrawal by Subject|0|||
131431884|NCT04178720|473204442|FG000|Overall Study|Relocation|0|||
131431885|NCT04178720|473204443|FG001|Overall Study|Relocation|1|||
131431886|NCT01301833|473204444|FG000|Overall Study|Adverse Event|7|||
131431887|NCT01301833|473204445|FG001|Overall Study|Adverse Event|5|||
131431888|NCT01301833|473204446|FG002|Overall Study|Adverse Event|5|||
131431889|NCT01301833|473204447|FG003|Overall Study|Adverse Event|5|||
131431890|NCT01301833|473204444|FG000|Overall Study|Lack of Efficacy|1|||
131431891|NCT01301833|473204445|FG001|Overall Study|Lack of Efficacy|1|||
131431892|NCT01301833|473204446|FG002|Overall Study|Lack of Efficacy|0|||
131431893|NCT01301833|473204447|FG003|Overall Study|Lack of Efficacy|0|||
131431894|NCT01301833|473204444|FG000|Overall Study|Physician Decision|3|||
131431895|NCT01301833|473204445|FG001|Overall Study|Physician Decision|1|||
131431896|NCT01301833|473204446|FG002|Overall Study|Physician Decision|1|||
131431897|NCT01301833|473204447|FG003|Overall Study|Physician Decision|0|||
131431898|NCT01301833|473204444|FG000|Overall Study|Withdrawal by Subject|3|||
131431899|NCT01301833|473204445|FG001|Overall Study|Withdrawal by Subject|1|||
131431900|NCT01301833|473204446|FG002|Overall Study|Withdrawal by Subject|1|||
131431901|NCT01301833|473204447|FG003|Overall Study|Withdrawal by Subject|2|||
131431902|NCT01301833|473204444|FG000|Overall Study|Personal matter|1|||
131431903|NCT01301833|473204445|FG001|Overall Study|Personal matter|0|||
131431904|NCT01301833|473204446|FG002|Overall Study|Personal matter|0|||
131431905|NCT01301833|473204447|FG003|Overall Study|Personal matter|0|||
131431906|NCT03922620|473204448|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
131431907|NCT03922620|473204449|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
131431908|NCT04177212|473204450|FG000|Overall Study|Withdrawal by Subject|9|||
131431909|NCT04177212|473204451|FG001|Overall Study|Withdrawal by Subject|7|||
131431910|NCT04177212|473204450|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
131431911|NCT04177212|473204451|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
131431912|NCT04177212|473204450|FG000|Overall Study|Physician Decision|1|||
131431913|NCT04177212|473204451|FG001|Overall Study|Physician Decision|0|||
131431914|NCT04177212|473204450|FG000|Overall Study|Lost to Follow-up|0|||
131431915|NCT04177212|473204451|FG001|Overall Study|Lost to Follow-up|3|||
131431916|NCT04177212|473204450|FG000|Overall Study|Adverse Event|0|||
131431917|NCT04177212|473204451|FG001|Overall Study|Adverse Event|1|||
131431918|NCT04177212|473204450|FG000|Overall Study|Other|1|||
131431919|NCT04177212|473204451|FG001|Overall Study|Other|2|||
131431920|NCT00930930|473204452|FG000|Overall Study|Death|1|||
131431921|NCT00930930|473204453|FG001|Overall Study|Death|0|||
131431922|NCT00930930|473204452|FG000|Overall Study|Physician Decision|1|||
131431923|NCT00930930|473204453|FG001|Overall Study|Physician Decision|0|||
131431924|NCT00930930|473204452|FG000|Overall Study|Adverse Event|13|||
131431925|NCT00930930|473204453|FG001|Overall Study|Adverse Event|3|||
131431926|NCT00930930|473204452|FG000|Overall Study|Withdrawal by Subject|3|||
131431927|NCT00930930|473204453|FG001|Overall Study|Withdrawal by Subject|1|||
131431928|NCT00930930|473204452|FG000|Overall Study|Disease progression|2|||
131431929|NCT00930930|473204453|FG001|Overall Study|Disease progression|3|||
131431930|NCT00930930|473204452|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
131431931|NCT00930930|473204453|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
131431932|NCT00930930|473204452|FG000|Overall Study|patients not compliant|1|||
131431933|NCT00930930|473204453|FG001|Overall Study|patients not compliant|1|||
131431934|NCT02709330|473204454|FG000|Overall Study|Death|5|||
131431935|NCT02709330|473204455|FG001|Overall Study|Death|0|||
131431936|NCT02709330|473204454|FG000|Overall Study|Lost to Follow-up|2|||
131431937|NCT02709330|473204455|FG001|Overall Study|Lost to Follow-up|0|||
131431938|NCT02709330|473204454|FG000|Overall Study|Physician Decision|2|||
131431939|NCT02709330|473204455|FG001|Overall Study|Physician Decision|0|||
131431940|NCT02709330|473204454|FG000|Overall Study|Withdrawal by Subject|4|||
131431941|NCT02709330|473204455|FG001|Overall Study|Withdrawal by Subject|0|||
131431942|NCT01279681|473204456|FG000|Overall Study|Disease Progression|9|||
131431943|NCT01279681|473204457|FG001|Overall Study|Disease Progression|6|||
131431944|NCT01279681|473204456|FG000|Overall Study|Withdrawal by Subject|3|||
131431945|NCT01279681|473204457|FG001|Overall Study|Withdrawal by Subject|4|||
131431946|NCT01279681|473204456|FG000|Overall Study|Adverse Event|2|||
131431947|NCT01279681|473204457|FG001|Overall Study|Adverse Event|3|||
131431948|NCT01279681|473204456|FG000|Overall Study|Death|0|||
131431949|NCT01279681|473204457|FG001|Overall Study|Death|1|||
131431950|NCT01279681|473204456|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
131431951|NCT01279681|473204457|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
131431952|NCT01279681|473204456|FG000|Overall Study|Physician Decision|1|||
131431953|NCT01279681|473204457|FG001|Overall Study|Physician Decision|0|||
131431954|NCT01279681|473204456|FG000|Overall Study|Other Reason|0|||
131431955|NCT01279681|473204457|FG001|Overall Study|Other Reason|2|||
131431956|NCT00859547|473206209|FG000|Overall Study|Lost to Follow-up|1|||
131458675|NCT05477108|473310180|FG001|Overall Study|Participants randomized, not treated|1|||
131458676|NCT05477108|473310181|FG002|Overall Study|Participants randomized, not treated|1|||
131458677|NCT05477108|473310179|FG000|Overall Study|Physician Decision|0|||
131431957|NCT00859547|473206209|FG000|Overall Study|Parent withdrew consent|1|||
131431958|NCT03310723|473206210|FG000|Overall Study|Withdrawal by Subject|0|||
131431959|NCT03310723|473206211|FG001|Overall Study|Withdrawal by Subject|1|||
131431960|NCT03310723|473206210|FG000|Overall Study|Protocol Violation|0|||
131431961|NCT03310723|473206211|FG001|Overall Study|Protocol Violation|2|||
131431962|NCT02098746|473206212|FG000|Overall Study|Changes of Investigator|2|||
131431963|NCT02098746|473206212|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131431964|NCT02098746|473206212|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
131431965|NCT02098746|473206212|FG000|Overall Study|Data Not Available After Treatment|1|||
131431966|NCT01410890|473206213|FG000|Overall Study|Withdrawal by Subject|0|||
131431967|NCT01410890|473206214|FG001|Overall Study|Withdrawal by Subject|1|||
131431968|NCT00217425|473206215|FG000|Overall Study|Never started treatment|2|||
131458678|NCT05477108|473310180|FG001|Overall Study|Physician Decision|0|||
131431969|NCT00217425|473206215|FG000|Overall Study|Patient ineligible|5|||
131431970|NCT00217425|473206215|FG000|Overall Study|Lack of Efficacy|13|||
131431971|NCT00217425|473206215|FG000|Overall Study|Adverse Event|8|||
131431972|NCT00217425|473206215|FG000|Overall Study|Withdrawal by Subject|4|||
131431973|NCT00217425|473206215|FG000|Overall Study|Other complicating disease|1|||
131431974|NCT00217425|473206215|FG000|Overall Study|Other|4|||
131431975|NCT01121146|473206216|FG000|Overall Study|Death|17|||
131431976|NCT01121146|473206217|FG001|Overall Study|Death|15|||
131431977|NCT01121146|473206216|FG000|Overall Study|Adverse Event|2|||
131431978|NCT01121146|473206217|FG001|Overall Study|Adverse Event|11|||
131431979|NCT01121146|473206216|FG000|Overall Study|Lost to Follow-up|7|||
131431980|NCT01121146|473206217|FG001|Overall Study|Lost to Follow-up|16|||
131431981|NCT00330759|473206218|FG000|Overall Study|Death|316|||
131431982|NCT00330759|473206219|FG001|Overall Study|Death|310|||
131431983|NCT00330759|473206218|FG000|Overall Study|Disease progression|104|||
131431984|NCT00330759|473206219|FG001|Overall Study|Disease progression|126|||
131431985|NCT00330759|473206218|FG000|Overall Study|Withdrawal by Subject|143|||
131431986|NCT00330759|473206219|FG001|Overall Study|Withdrawal by Subject|124|||
131431987|NCT00330759|473206218|FG000|Overall Study|Adverse Event|48|||
131431988|NCT00330759|473206219|FG001|Overall Study|Adverse Event|36|||
131431989|NCT00330759|473206218|FG000|Overall Study|Participant request|31|||
131431990|NCT00330759|473206219|FG001|Overall Study|Participant request|22|||
131431991|NCT00330759|473206218|FG000|Overall Study|Lost to Follow-up|16|||
131431992|NCT00330759|473206219|FG001|Overall Study|Lost to Follow-up|22|||
131431993|NCT00330759|473206218|FG000|Overall Study|Noncompliance|15|||
131431994|NCT00330759|473206219|FG001|Overall Study|Noncompliance|17|||
131431995|NCT00330759|473206218|FG000|Overall Study|Physician Decision|1|||
131431996|NCT00330759|473206219|FG001|Overall Study|Physician Decision|2|||
131431997|NCT00330759|473206218|FG000|Overall Study|Protocol deviation|0|||
131431998|NCT00330759|473206219|FG001|Overall Study|Protocol deviation|2|||
131431999|NCT00330759|473206218|FG000|Overall Study|Ineligibility determined|2|||
131432000|NCT00330759|473206219|FG001|Overall Study|Ineligibility determined|1|||
131432001|NCT00330759|473206218|FG000|Overall Study|Other|36|||
131432002|NCT00330759|473206219|FG001|Overall Study|Other|44|||
131432003|NCT00997035|473206220|FG000|3-week Followup Visit|Lost to Follow-up|9|||
131432004|NCT00997035|473206221|FG001|3-week Followup Visit|Lost to Follow-up|6|||
131432005|NCT00997035|473206220|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
131432006|NCT00997035|473206221|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
131432007|NCT01380769|473206226|FG000|Overall Study|Withdrawal by Subject|7|||
131432008|NCT01380769|473206227|FG001|Overall Study|Withdrawal by Subject|11|||
131432009|NCT01380769|473206226|FG000|Overall Study|Physician Decision|1|||
131432010|NCT01380769|473206227|FG001|Overall Study|Physician Decision|1|||
131432011|NCT01380769|473206226|FG000|Overall Study|Adverse Event|1|||
131432012|NCT01380769|473206227|FG001|Overall Study|Adverse Event|1|||
131432013|NCT01380769|473206226|FG000|Overall Study|Protocol Violation|0|||
131432014|NCT01380769|473206227|FG001|Overall Study|Protocol Violation|1|||
131432015|NCT03654690|473206228|FG000|Overall Study|Withdrawal by Subject|1|||
131432016|NCT03654690|473206229|FG001|Overall Study|Withdrawal by Subject|0|||
131432017|NCT03654690|473206230|FG002|Overall Study|Withdrawal by Subject|0|||
131432018|NCT00742183|473206233|FG000|Overall Study|Adverse Event|2|||
131432019|NCT00742183|473206234|FG001|Overall Study|Adverse Event|2|||
131432020|NCT00742183|473206233|FG000|Overall Study|Death|1|||
131432021|NCT00742183|473206234|FG001|Overall Study|Death|0|||
131432022|NCT00742183|473206233|FG000|Overall Study|Physician Decision|0|||
131432023|NCT00742183|473206234|FG001|Overall Study|Physician Decision|2|||
131432024|NCT00742183|473206233|FG000|Overall Study|Lost to Follow-up|4|||
131432025|NCT00742183|473206234|FG001|Overall Study|Lost to Follow-up|4|||
131432026|NCT00742183|473206233|FG000|Overall Study|Required skin-graft|1|||
131432027|NCT00742183|473206234|FG001|Overall Study|Required skin-graft|1|||
131458679|NCT05477108|473310181|FG002|Overall Study|Physician Decision|1|||
131458680|NCT05477108|473310179|FG000|Overall Study|withdrawn from study|0|||
131458681|NCT05477108|473310180|FG001|Overall Study|withdrawn from study|0|||
131458682|NCT05477108|473310181|FG002|Overall Study|withdrawn from study|1|||
131458683|NCT02660983|473310182|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
131458684|NCT02660983|473310183|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
131432028|NCT00742183|473206233|FG000|Overall Study|Withdrawal by Subject|1|||
131432029|NCT00742183|473206234|FG001|Overall Study|Withdrawal by Subject|0|||
131432030|NCT00742183|473206233|FG000|Overall Study|Lack of Efficacy|0|||
131432031|NCT00742183|473206234|FG001|Overall Study|Lack of Efficacy|3|||
131432032|NCT00786799|473206237|FG000|Overall Study|Lost to Follow-up|1|||
131432033|NCT00786799|473206238|FG001|Overall Study|Lost to Follow-up|1|||
131432034|NCT02544503|473206239|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
131458685|NCT02660983|473310182|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
131432035|NCT02544503|473206240|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
131432036|NCT02544503|473206239|FG000|Overall Study|Lost to Follow-up|9|||
131432037|NCT02544503|473206240|FG001|Overall Study|Lost to Follow-up|0|||
131432038|NCT02544503|473206239|FG000|Overall Study|Withdrawal by Subject|1|||
131432039|NCT02544503|473206240|FG001|Overall Study|Withdrawal by Subject|0|||
131432040|NCT01080807|473206244|FG000|Overall Study|Adverse Event|9|||
131432041|NCT01080807|473206245|FG001|Overall Study|Adverse Event|1|||
131432042|NCT01080807|473206244|FG000|Overall Study|Lack of Efficacy|0|||
131432043|NCT01080807|473206245|FG001|Overall Study|Lack of Efficacy|1|||
131432044|NCT01080807|473206244|FG000|Overall Study|Withdrawal by Subject|7|||
131432045|NCT01080807|473206245|FG001|Overall Study|Withdrawal by Subject|2|||
131432046|NCT01080807|473206244|FG000|Overall Study|Protocol Violation|7|||
131432047|NCT01080807|473206245|FG001|Overall Study|Protocol Violation|6|||
131432048|NCT01080807|473206244|FG000|Overall Study|Lost to Follow-up|6|||
131432049|NCT01080807|473206245|FG001|Overall Study|Lost to Follow-up|4|||
131432050|NCT01080807|473206244|FG000|Overall Study|Noncompliance with drug administration|1|||
131432051|NCT01080807|473206245|FG001|Overall Study|Noncompliance with drug administration|1|||
131432052|NCT01080807|473206244|FG000|Overall Study|Noncompliance to study procedures|1|||
131432053|NCT01080807|473206245|FG001|Overall Study|Noncompliance to study procedures|1|||
131432054|NCT01080807|473206244|FG000|Overall Study|Began working day shift|0|||
131432055|NCT01080807|473206245|FG001|Overall Study|Began working day shift|2|||
131432056|NCT01080807|473206244|FG000|Overall Study|Laid off or terminated from job|1|||
131432057|NCT01080807|473206245|FG001|Overall Study|Laid off or terminated from job|2|||
131432058|NCT01080807|473206244|FG000|Overall Study|Stopped working consistent night shifts|0|||
131432059|NCT01080807|473206245|FG001|Overall Study|Stopped working consistent night shifts|1|||
131432060|NCT01080807|473206244|FG000|Overall Study|Work schedule changing|1|||
131432061|NCT01080807|473206245|FG001|Overall Study|Work schedule changing|1|||
131432062|NCT01080807|473206244|FG000|Overall Study|Work schedule and travel|0|||
131432063|NCT01080807|473206245|FG001|Overall Study|Work schedule and travel|1|||
131432064|NCT01080807|473206244|FG000|Overall Study|Switched to first shift|1|||
131432065|NCT01080807|473206245|FG001|Overall Study|Switched to first shift|0|||
131432066|NCT01080807|473206244|FG000|Overall Study|Moved away without notifying center|1|||
131432067|NCT01080807|473206245|FG001|Overall Study|Moved away without notifying center|0|||
131432068|NCT01020786|473206253|FG000|Induction Period|Entry Criteria Not Met|2|||
131432069|NCT01020786|473206253|FG000|Induction Period|Adverse Event|10|||
131432070|NCT01020786|473206253|FG000|Induction Period|Progressive Disease|31|||
131432071|NCT01020786|473206253|FG000|Induction Period|Investigator Decision|3|||
131432072|NCT01020786|473206253|FG000|Induction Period|Withdrawal by Subject|3|||
131432073|NCT01020786|473206253|FG000|Maintenance Period|Adverse Event|8|||
131432074|NCT01020786|473206253|FG000|Maintenance Period|Progressive Disease|43|||
131432075|NCT01020786|473206253|FG000|Maintenance Period|Withdrawal by Subject|8|||
131432076|NCT01020786|473206253|FG000|Maintenance Period|Sponsor Decision|1|||
131432077|NCT01702558|473206256|FG000|Overall Study|Withdrawal by Subject|0|||
131432078|NCT01702558|473206257|FG001|Overall Study|Withdrawal by Subject|0|||
131432079|NCT01702558|473206258|FG002|Overall Study|Withdrawal by Subject|0|||
131432080|NCT01702558|473206259|FG003|Overall Study|Withdrawal by Subject|12|||
131432081|NCT01702558|473206260|FG004|Overall Study|Withdrawal by Subject|4|||
131432082|NCT01702558|473206256|FG000|Overall Study|Lost to Follow-up|0|||
131432083|NCT01702558|473206257|FG001|Overall Study|Lost to Follow-up|0|||
131432084|NCT01702558|473206258|FG002|Overall Study|Lost to Follow-up|0|||
131432085|NCT01702558|473206259|FG003|Overall Study|Lost to Follow-up|3|||
131432086|NCT01702558|473206260|FG004|Overall Study|Lost to Follow-up|0|||
131432087|NCT01702558|473206256|FG000|Overall Study|Death|4|||
131432088|NCT01702558|473206257|FG001|Overall Study|Death|3|||
131432089|NCT01702558|473206258|FG002|Overall Study|Death|3|||
131432090|NCT01702558|473206259|FG003|Overall Study|Death|16|||
131432091|NCT01702558|473206260|FG004|Overall Study|Death|20|||
131432092|NCT01702558|473206256|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
131432093|NCT01702558|473206257|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
131432094|NCT01702558|473206258|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
131432095|NCT01702558|473206259|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
131432096|NCT01702558|473206260|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
131432097|NCT01702558|473206256|FG000|Overall Study|Study Terminated by Sponsor|0|||
131432098|NCT01702558|473206257|FG001|Overall Study|Study Terminated by Sponsor|1|||
131432099|NCT01702558|473206258|FG002|Overall Study|Study Terminated by Sponsor|0|||
131432100|NCT01702558|473206259|FG003|Overall Study|Study Terminated by Sponsor|0|||
131432101|NCT01702558|473206260|FG004|Overall Study|Study Terminated by Sponsor|1|||
131432102|NCT01702558|473206256|FG000|Overall Study|Other|0|||
131432103|NCT01702558|473206257|FG001|Overall Study|Other|0|||
131432104|NCT01702558|473206258|FG002|Overall Study|Other|0|||
131432105|NCT01702558|473206259|FG003|Overall Study|Other|16|||
131432106|NCT01702558|473206260|FG004|Overall Study|Other|17|||
131432107|NCT03259087|473206265|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
131432108|NCT03259087|473206266|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
131432109|NCT03259087|473206267|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
131432110|NCT03259087|473206268|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
131432111|NCT03259087|473206269|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
131432112|NCT03259087|473206265|FG000|Period 2 of Part 2|Adverse Event|0|||
131432113|NCT03259087|473206266|FG001|Period 2 of Part 2|Adverse Event|0|||
131432114|NCT03259087|473206267|FG002|Period 2 of Part 2|Adverse Event|0|||
131432115|NCT03259087|473206268|FG003|Period 2 of Part 2|Adverse Event|0|||
131432116|NCT03259087|473206269|FG004|Period 2 of Part 2|Adverse Event|1|||
131432117|NCT04950465|473206270|FG000|Overall Study|Lost to Follow-up|1|||
131432118|NCT04950465|473206271|FG001|Overall Study|Lost to Follow-up|0|||
131432119|NCT04950465|473206272|FG002|Overall Study|Lost to Follow-up|0|||
131432120|NCT02366195|473206276|FG000|Overall Study|Protocol-specified criteria|3|||
131432121|NCT02366195|473206276|FG000|Overall Study|Withdrawal by Subject|9|||
131432122|NCT02366195|473206276|FG000|Overall Study|Lost to Follow-up|1|||
131432123|NCT02366195|473206276|FG000|Overall Study|Death|41|||
131432124|NCT01788566|473206277|FG000|Overall Study|Death|4|||
131432125|NCT01788566|473206277|FG000|Overall Study|Adverse Event|1|||
131432126|NCT01788566|473206277|FG000|Overall Study|Clinical Progressive Disease|3|||
131432127|NCT01620086|473206280|FG000|Overall Study|Withdrawal by Subject|3|||
131432128|NCT01620086|473206281|FG001|Overall Study|Withdrawal by Subject|3|||
131432129|NCT01620086|473206282|FG002|Overall Study|Withdrawal by Subject|0|||
131432130|NCT01620086|473206280|FG000|Overall Study|failed study criteria|1|||
131432131|NCT01620086|473206281|FG001|Overall Study|failed study criteria|4|||
131432132|NCT01620086|473206282|FG002|Overall Study|failed study criteria|0|||
131432133|NCT01620086|473206280|FG000|Overall Study|Physician Decision|1|||
131432134|NCT01620086|473206281|FG001|Overall Study|Physician Decision|0|||
131432135|NCT01620086|473206282|FG002|Overall Study|Physician Decision|0|||
131432136|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Progressive disease|50|||
131432137|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Progressive disease|110|||
131432138|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Progressive disease|0|||
131432139|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Progressive disease|0|||
131432140|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
131432141|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
131432142|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131432143|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131432144|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Adverse Event|7|||
131432145|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Adverse Event|7|||
131432146|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Adverse Event|0|||
131432147|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Adverse Event|0|||
131432148|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Other|1|||
131432149|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Other|3|||
131432150|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Other|0|||
131432151|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Other|0|||
131432152|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Physician Decision|6|||
131432153|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Physician Decision|3|||
131432154|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Physician Decision|0|||
131432155|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Physician Decision|0|||
131432156|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Death|1|||
131432157|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Death|1|||
131432158|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Death|0|||
131432159|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Death|0|||
131432160|NCT01695135|473206283|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
131432161|NCT01695135|473206284|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
131432162|NCT01695135|473206285|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
131432163|NCT01695135|473206286|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
131432164|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
131432165|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
131432166|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
131432167|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
131458686|NCT02660983|473310183|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
131432168|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
131432169|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
131432170|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
131458687|NCT02660983|473310182|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
131432171|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
131432172|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
131432173|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
131432174|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
131432175|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
131432176|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Other|0|||
131432177|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Other|0|||
131432178|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Other|4|||
131432179|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Other|7|||
131432180|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
131432181|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
131432182|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
131432183|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
131432184|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Death|0|||
131432185|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Death|0|||
131432186|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Death|2|||
131432187|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Death|7|||
131432188|NCT01695135|473206283|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
131432189|NCT01695135|473206284|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
131432190|NCT01695135|473206285|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
131432191|NCT01695135|473206286|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
131432192|NCT02562716|473206287|FG000|Overall Study|Adverse Event|7|||
131432193|NCT02562716|473206288|FG001|Overall Study|Adverse Event|14|||
131432194|NCT02562716|473206287|FG000|Overall Study|Withdrawal unrelated to AE|7|||
131432195|NCT02562716|473206288|FG001|Overall Study|Withdrawal unrelated to AE|1|||
131432196|NCT02562716|473206287|FG000|Overall Study|Progression|8|||
131432197|NCT02562716|473206288|FG001|Overall Study|Progression|10|||
131432198|NCT02562716|473206287|FG000|Overall Study|Death|2|||
131432199|NCT02562716|473206288|FG001|Overall Study|Death|1|||
131432200|NCT02562716|473206287|FG000|Overall Study|Not protocol specified|4|||
131432201|NCT02562716|473206288|FG001|Overall Study|Not protocol specified|2|||
131432202|NCT00684996|473206289|FG000|Overall Study|Adverse Event|1|||
131432203|NCT00684996|473206289|FG000|Overall Study|Refusal unrelated to adverse event|1|||
131432204|NCT00684996|473206289|FG000|Overall Study|Progression/relapse|2|||
131432205|NCT00684996|473206289|FG000|Overall Study|Other reasons not protocol specified|1|||
131432206|NCT03030417|473206292|FG000|Dose Expansion|Disease progression before treatment|0|||
131432207|NCT03030417|473206293|FG001|Dose Expansion|Disease progression before treatment|0|||
131432208|NCT03030417|473206294|FG002|Dose Expansion|Disease progression before treatment|0|||
131432209|NCT03030417|473206295|FG003|Dose Expansion|Disease progression before treatment|0|||
131432210|NCT03030417|473206296|FG004|Dose Expansion|Disease progression before treatment|0|||
131432211|NCT03030417|473206297|FG005|Dose Expansion|Disease progression before treatment|0|||
131432212|NCT03030417|473206298|FG006|Dose Expansion|Disease progression before treatment|0|||
131432213|NCT03030417|473206299|FG007|Dose Expansion|Disease progression before treatment|0|||
131432214|NCT03030417|473206300|FG008|Dose Expansion|Disease progression before treatment|0|||
131432215|NCT03030417|473206301|FG009|Dose Expansion|Disease progression before treatment|0|||
131432216|NCT03030417|473206302|FG010|Dose Expansion|Disease progression before treatment|0|||
131432217|NCT03030417|473206303|FG011|Dose Expansion|Disease progression before treatment|0|||
131432218|NCT03030417|473206304|FG012|Dose Expansion|Disease progression before treatment|1|||
131432219|NCT01539759|473206305|FG000|Overall Study|Lost to Follow-up|6|||
131432220|NCT01539759|473206306|FG001|Overall Study|Lost to Follow-up|8|||
131432221|NCT01076959|473206307|FG000|Overall Study|Adverse Event|767|||
131432222|NCT01076959|473206307|FG000|Overall Study|Lack of Efficacy|849|||
131432223|NCT01076959|473206307|FG000|Overall Study|Non-compliance|274|||
131432224|NCT01076959|473206307|FG000|Overall Study|Lost to Follow-up|241|||
131432225|NCT01076959|473206307|FG000|Overall Study|Other|119|||
131432226|NCT00731679|473206310|FG000|Overall Study|Adverse Event|7|||
131432227|NCT00731679|473206311|FG001|Overall Study|Adverse Event|8|||
131432228|NCT00731679|473206310|FG000|Overall Study|Withdrawal by Subject|8|||
131458688|NCT02660983|473310183|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
131458689|NCT02660983|473310182|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
131458690|NCT02660983|473310183|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
131458691|NCT02660983|473310182|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
131458692|NCT02660983|473310183|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
131432229|NCT00731679|473206311|FG001|Overall Study|Withdrawal by Subject|8|||
131432230|NCT00731679|473206310|FG000|Overall Study|Lost to Follow-up|7|||
131432231|NCT00731679|473206311|FG001|Overall Study|Lost to Follow-up|8|||
131458693|NCT02660983|473310182|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
131458694|NCT02660983|473310183|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
131432232|NCT00731679|473206310|FG000|Overall Study|Noncompliance|0|||
131432233|NCT00731679|473206311|FG001|Overall Study|Noncompliance|1|||
131458695|NCT02660983|473310182|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
131458696|NCT02660983|473310183|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
131458697|NCT01165216|473310191|FG000|Overall Study|Adverse Event|6|||
131458698|NCT01165216|473310192|FG001|Overall Study|Adverse Event|3|||
131458699|NCT01165216|473310191|FG000|Overall Study|Withdrawal by Subject|1|||
131458700|NCT01165216|473310192|FG001|Overall Study|Withdrawal by Subject|1|||
131458701|NCT01165216|473310191|FG000|Overall Study|Disease progression|1|||
131458702|NCT01165216|473310192|FG001|Overall Study|Disease progression|3|||
131458703|NCT04614324|473310196|FG000|Overall Study|Lost to Follow-up|3|||
131458704|NCT04614324|473310196|FG000|Overall Study|Physician Decision|1|||
131458705|NCT04614324|473310196|FG000|Overall Study|Withdrawal by Subject|2|||
131458706|NCT04614324|473310196|FG000|Overall Study|Remaining in Follow up|123|||
131458707|NCT05141448|473310197|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
131458708|NCT05141448|473310198|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
131458709|NCT05141448|473310199|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
131458710|NCT05141448|473310200|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
131458711|NCT05141448|473310201|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
131458712|NCT05141448|473310202|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
131458713|NCT05141448|473310197|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131458714|NCT05141448|473310198|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131458715|NCT05141448|473310199|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131458716|NCT05141448|473310200|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131458717|NCT05141448|473310201|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
131458718|NCT05141448|473310202|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131458719|NCT05141448|473310197|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131458720|NCT05141448|473310198|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
131458721|NCT05141448|473310199|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131458722|NCT05141448|473310200|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131458723|NCT05141448|473310201|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131458724|NCT05141448|473310202|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
131458725|NCT05141448|473310197|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131458726|NCT05141448|473310198|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131458727|NCT05141448|473310199|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131458728|NCT05141448|473310200|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131458729|NCT05141448|473310201|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131458730|NCT05141448|473310202|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
131458731|NCT05141448|473310197|FG000|Period 2|COVID-19 Related|0|||
131458732|NCT05141448|473310198|FG001|Period 2|COVID-19 Related|0|||
131458733|NCT05141448|473310199|FG002|Period 2|COVID-19 Related|0|||
131458734|NCT05141448|473310200|FG003|Period 2|COVID-19 Related|1|||
131458735|NCT05141448|473310201|FG004|Period 2|COVID-19 Related|0|||
131458736|NCT05141448|473310202|FG005|Period 2|COVID-19 Related|1|||
131458737|NCT05141448|473310197|FG000|3|Covid-19 related|2|||
131458738|NCT05141448|473310198|FG001|3|Covid-19 related|0|||
131458739|NCT05141448|473310199|FG002|3|Covid-19 related|0|||
131458740|NCT05141448|473310200|FG003|3|Covid-19 related|0|||
131458741|NCT05141448|473310201|FG004|3|Covid-19 related|0|||
131458742|NCT05141448|473310202|FG005|3|Covid-19 related|1|||
131458743|NCT05141448|473310197|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
131458744|NCT05141448|473310198|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
131458745|NCT05141448|473310199|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
131458746|NCT05141448|473310200|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
131458747|NCT05141448|473310201|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
131458748|NCT05141448|473310202|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
131458749|NCT04627285|473310203|FG000|Overall Study|Adverse Event|0|||
131458750|NCT04627285|473310204|FG001|Overall Study|Adverse Event|2|||
131458751|NCT04627285|473310203|FG000|Overall Study|Lost to Follow-up|1|||
131458752|NCT04627285|473310204|FG001|Overall Study|Lost to Follow-up|0|||
131458753|NCT04627285|473310203|FG000|Overall Study|Withdrawal by Subject|1|||
131458754|NCT04627285|473310204|FG001|Overall Study|Withdrawal by Subject|1|||
131458755|NCT04627285|473310203|FG000|Overall Study|Sponsor decision|5|||
131458756|NCT04627285|473310204|FG001|Overall Study|Sponsor decision|0|||
131458757|NCT04627285|473310203|FG000|Overall Study|Participant left country; aunt informed the site|0|||
131458758|NCT04627285|473310204|FG001|Overall Study|Participant left country; aunt informed the site|1|||
131458759|NCT01217307|473311699|FG000|Overall Study|Withdrawal by Subject|0|||
131458760|NCT01217307|473311700|FG001|Overall Study|Withdrawal by Subject|1|||
131458761|NCT00220779|473311703|FG000|Overall Study|Adverse Event|1|||
131458762|NCT00220779|473311704|FG001|Overall Study|Adverse Event|0|||
131458763|NCT00220779|473311705|FG002|Overall Study|Adverse Event|0|||
131458764|NCT00220779|473311703|FG000|Overall Study|Withdrawal by Subject|1|||
131458765|NCT00220779|473311704|FG001|Overall Study|Withdrawal by Subject|4|||
131432234|NCT00731679|473206310|FG000|Overall Study|Pregnancy|0|||
131432235|NCT00731679|473206311|FG001|Overall Study|Pregnancy|1|||
131432236|NCT02488005|473206312|FG000|Overall Study|Lost to Follow-up|2|||
131432237|NCT02326597|473206319|FG000|Overall Study|Lost to Follow-up|42|||
131432238|NCT02326597|473206320|FG001|Overall Study|Lost to Follow-up|32|||
131432239|NCT04089761|473206323|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
131432240|NCT04089761|473206323|FG000|"Run In Phase"|Lost to Follow-up|1|||
131432241|NCT04089761|473206323|FG000|"Treatment Phase"|No evaluable data|5|||
131432242|NCT04089761|473206323|FG000|"Treatment Phase"|Lost to Follow-up|1|||
131432243|NCT00770601|473206324|FG000|Overall Study|Withdrawal by Subject|1|||
131432244|NCT04739436|473206326|FG000|Overall Study|Lost to Follow-up|21|||
131432245|NCT04739436|473206327|FG001|Overall Study|Lost to Follow-up|23|||
131432246|NCT04739436|473206326|FG000|Overall Study|Withdrawal by Subject|4|||
131432247|NCT04739436|473206327|FG001|Overall Study|Withdrawal by Subject|6|||
131432248|NCT04739436|473206326|FG000|Overall Study|not randomized properly|1|||
131432249|NCT04739436|473206327|FG001|Overall Study|not randomized properly|0|||
131432250|NCT04628780|473206328|FG000|Overall Study|Death|0|||
131432251|NCT04628780|473206329|FG001|Overall Study|Death|1|||
131432252|NCT04628780|473206330|FG002|Overall Study|Death|0|||
131432253|NCT04628780|473206331|FG003|Overall Study|Death|0|||
131432254|NCT04628780|473206332|FG004|Overall Study|Death|1|||
131432255|NCT04628780|473206333|FG005|Overall Study|Death|0|||
131432256|NCT04628780|473206328|FG000|Overall Study|Physician Decision|2|||
131432257|NCT04628780|473206329|FG001|Overall Study|Physician Decision|0|||
131432258|NCT04628780|473206330|FG002|Overall Study|Physician Decision|0|||
131432259|NCT04628780|473206331|FG003|Overall Study|Physician Decision|0|||
131432260|NCT04628780|473206332|FG004|Overall Study|Physician Decision|2|||
131432261|NCT04628780|473206333|FG005|Overall Study|Physician Decision|0|||
131432262|NCT04628780|473206328|FG000|Overall Study|Progressive disease|2|||
131432263|NCT04628780|473206329|FG001|Overall Study|Progressive disease|2|||
131432264|NCT04628780|473206330|FG002|Overall Study|Progressive disease|2|||
131432265|NCT04628780|473206331|FG003|Overall Study|Progressive disease|3|||
131432266|NCT04628780|473206332|FG004|Overall Study|Progressive disease|9|||
131432267|NCT04628780|473206333|FG005|Overall Study|Progressive disease|4|||
131432268|NCT04628780|473206328|FG000|Overall Study|Withdrawal by Subject|0|||
131432269|NCT04628780|473206329|FG001|Overall Study|Withdrawal by Subject|1|||
131432270|NCT04628780|473206330|FG002|Overall Study|Withdrawal by Subject|2|||
131432271|NCT04628780|473206331|FG003|Overall Study|Withdrawal by Subject|0|||
131432272|NCT04628780|473206332|FG004|Overall Study|Withdrawal by Subject|3|||
131432273|NCT04628780|473206333|FG005|Overall Study|Withdrawal by Subject|1|||
131432274|NCT04628780|473206328|FG000|Overall Study|Global deterioration of health status|0|||
131432275|NCT04628780|473206329|FG001|Overall Study|Global deterioration of health status|0|||
131432276|NCT04628780|473206330|FG002|Overall Study|Global deterioration of health status|0|||
131432277|NCT04628780|473206331|FG003|Overall Study|Global deterioration of health status|0|||
131432278|NCT04628780|473206332|FG004|Overall Study|Global deterioration of health status|1|||
131432279|NCT04628780|473206333|FG005|Overall Study|Global deterioration of health status|1|||
131432280|NCT00428948|473206335|FG000|Overall Study|Lost to Follow-up|15|||
131432281|NCT00428948|473206336|FG001|Overall Study|Lost to Follow-up|8|||
131432282|NCT00428948|473206335|FG000|Overall Study|Adverse Event|148|||
131432283|NCT00428948|473206336|FG001|Overall Study|Adverse Event|24|||
131432284|NCT00428948|473206335|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
131432285|NCT00428948|473206336|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
131432286|NCT00428948|473206335|FG000|Overall Study|Investigator Withdrew Subject|3|||
131432287|NCT00428948|473206336|FG001|Overall Study|Investigator Withdrew Subject|4|||
131432288|NCT00428948|473206335|FG000|Overall Study|Subject Withdrew Consent|50|||
131432289|NCT00428948|473206336|FG001|Overall Study|Subject Withdrew Consent|30|||
131432290|NCT00428948|473206335|FG000|Overall Study|Protocol Deviation|1|||
131432291|NCT00428948|473206336|FG001|Overall Study|Protocol Deviation|1|||
131432292|NCT03622814|473206338|FG000|Overall Study|Lost to Follow-up|8|||
131432293|NCT03622814|473206339|FG001|Overall Study|Lost to Follow-up|14|||
131432294|NCT04896593|473206340|FG000|Overall Study|Withdrawal by Subject|2|||
131432295|NCT04896593|473206340|FG000|Overall Study|Lost to Follow-up|1|||
131432296|NCT04896593|473206340|FG000|Overall Study|Did not complete onboarding|2|||
131432297|NCT01657292|473206346|FG000|Overall Study|Adverse Event|6|||
131432298|NCT01657292|473206346|FG000|Overall Study|Withdrawal by Subject|2|||
131432299|NCT01657292|473206346|FG000|Overall Study|Violation of eligibility criteria|1|||
131432300|NCT01657292|473206346|FG000|Overall Study|Change of therapy|1|||
131432301|NCT00650845|473206347|FG000|Overall Study|Withdrawal by Subject|5|||
131432302|NCT00650845|473206348|FG001|Overall Study|Withdrawal by Subject|0|||
131432303|NCT00650845|473206347|FG000|Overall Study|Protocol Violation|0|||
131432304|NCT00650845|473206348|FG001|Overall Study|Protocol Violation|13|||
131432305|NCT04725500|473206349|FG000|Screening|Screen Failure|26|||
131432306|NCT04725500|473206349|FG000|Screening|Withdrawal by Subject|1|||
131432307|NCT04725500|473206349|FG000|2 Week Take Home|Screen Fail|5|||
131432308|NCT01792115|473206350|FG000|Overall Study|Lost to Follow-up|0|||
131432309|NCT01792115|473206351|FG001|Overall Study|Lost to Follow-up|1|||
131432310|NCT01792115|473206352|FG002|Overall Study|Lost to Follow-up|0|||
131432311|NCT04618744|473206354|FG000|Overall Study|Adverse Event|0|||
131432312|NCT04618744|473206355|FG001|Overall Study|Adverse Event|1|||
131432313|NCT04618744|473206354|FG000|Overall Study|Withdrawal by Subject|0|||
131432314|NCT04618744|473206355|FG001|Overall Study|Withdrawal by Subject|1|||
131432315|NCT01633788|473208160|FG000|Overall Study|Adverse Event|1|||
131432316|NCT01633788|473208161|FG001|Overall Study|Adverse Event|3|||
131432317|NCT01633788|473208162|FG002|Overall Study|Adverse Event|3|||
131432318|NCT01633788|473208163|FG003|Overall Study|Adverse Event|3|||
131432319|NCT01633788|473208160|FG000|Overall Study|Lost to Follow-up|2|||
131432320|NCT01633788|473208161|FG001|Overall Study|Lost to Follow-up|2|||
131432321|NCT01633788|473208162|FG002|Overall Study|Lost to Follow-up|2|||
131432322|NCT01633788|473208163|FG003|Overall Study|Lost to Follow-up|0|||
131432323|NCT01633788|473208160|FG000|Overall Study|Personal Reasons|3|||
131432324|NCT01633788|473208161|FG001|Overall Study|Personal Reasons|1|||
131432325|NCT01633788|473208162|FG002|Overall Study|Personal Reasons|1|||
131432326|NCT01633788|473208163|FG003|Overall Study|Personal Reasons|3|||
131432327|NCT01633788|473208160|FG000|Overall Study|Protocol Violation|1|||
131432328|NCT01633788|473208161|FG001|Overall Study|Protocol Violation|0|||
131432329|NCT01633788|473208162|FG002|Overall Study|Protocol Violation|1|||
131432330|NCT01633788|473208163|FG003|Overall Study|Protocol Violation|0|||
131432331|NCT01633788|473208160|FG000|Overall Study|Other Reasons|0|||
131432332|NCT01633788|473208161|FG001|Overall Study|Other Reasons|2|||
131432333|NCT01633788|473208162|FG002|Overall Study|Other Reasons|3|||
131432334|NCT01633788|473208163|FG003|Overall Study|Other Reasons|7|||
131432335|NCT01929226|473208164|FG000|Overall Study|Lost to Follow-up|4|||
131432336|NCT01929226|473208165|FG001|Overall Study|Lost to Follow-up|0|||
131432337|NCT01929226|473208164|FG000|Overall Study|Withdrawal by Subject|1|||
131432338|NCT01929226|473208165|FG001|Overall Study|Withdrawal by Subject|1|||
131432339|NCT02807623|473208166|FG000|Overall Study|Lost to Follow-up|23|||
131432340|NCT02807623|473208167|FG001|Overall Study|Lost to Follow-up|18|||
131432341|NCT02807623|473208168|FG002|Overall Study|Lost to Follow-up|22|||
131432342|NCT02807623|473208166|FG000|Overall Study|Drug intolerance|0|||
131432343|NCT02807623|473208167|FG001|Overall Study|Drug intolerance|1|||
131432344|NCT02807623|473208168|FG002|Overall Study|Drug intolerance|0|||
131432345|NCT02807623|473208166|FG000|Overall Study|incomplete blood draw|0|||
131432346|NCT02807623|473208167|FG001|Overall Study|incomplete blood draw|2|||
131432347|NCT02807623|473208168|FG002|Overall Study|incomplete blood draw|1|||
131432348|NCT03922581|473208183|FG000|Overall Study|Lost to Follow-up|20|||
131432349|NCT03922581|473208184|FG001|Overall Study|Lost to Follow-up|9|||
131432350|NCT03922581|473208183|FG000|Overall Study|Physician Decision|1|||
131432351|NCT03922581|473208184|FG001|Overall Study|Physician Decision|1|||
131432352|NCT03922581|473208183|FG000|Overall Study|Withdrawal by Subject|1|||
131432353|NCT03922581|473208184|FG001|Overall Study|Withdrawal by Subject|0|||
131432354|NCT04685798|473208187|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
131432355|NCT04640311|473208188|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
131432356|NCT04640311|473208189|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432357|NCT04640311|473208190|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432358|NCT04640311|473208191|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432359|NCT04640311|473208192|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432360|NCT04640311|473208193|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432361|NCT04640311|473208194|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432362|NCT04640311|473208195|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432363|NCT04640311|473208196|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432364|NCT04640311|473208197|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432365|NCT04640311|473208198|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432366|NCT04640311|473208199|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432367|NCT04640311|473208200|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432368|NCT04640311|473208188|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432369|NCT04640311|473208189|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
131432370|NCT04640311|473208190|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432371|NCT04640311|473208191|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432372|NCT04640311|473208192|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432373|NCT04640311|473208193|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432374|NCT04640311|473208194|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432375|NCT04640311|473208195|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432376|NCT04640311|473208196|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432377|NCT04640311|473208197|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432378|NCT04640311|473208198|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432379|NCT04640311|473208199|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131432380|NCT04640311|473208200|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
131434029|NCT01188772|473214621|FG003|Overall Study|Randomized but Not Treated|0|||
131432381|NCT04640311|473208188|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432382|NCT04640311|473208189|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
131432383|NCT04640311|473208190|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432384|NCT04640311|473208191|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432385|NCT04640311|473208192|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432386|NCT04640311|473208193|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432387|NCT04640311|473208194|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432388|NCT04640311|473208195|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432389|NCT04640311|473208196|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432390|NCT04640311|473208197|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432391|NCT04640311|473208198|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432392|NCT04640311|473208199|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432393|NCT04640311|473208200|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432394|NCT04640311|473208188|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
131432395|NCT04640311|473208189|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
131432396|NCT04640311|473208190|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
131432397|NCT04640311|473208191|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432398|NCT04640311|473208192|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432399|NCT04640311|473208193|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432400|NCT04640311|473208194|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432401|NCT04640311|473208195|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432402|NCT04640311|473208196|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432403|NCT04640311|473208197|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432404|NCT04640311|473208198|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432405|NCT04640311|473208199|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432406|NCT04640311|473208200|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
131432407|NCT04640311|473208188|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432408|NCT04640311|473208189|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432409|NCT04640311|473208190|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
131432410|NCT04640311|473208191|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432411|NCT04640311|473208192|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432412|NCT04640311|473208193|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432413|NCT04640311|473208194|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432414|NCT04640311|473208195|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432415|NCT04640311|473208196|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432416|NCT04640311|473208197|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432417|NCT04640311|473208198|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432418|NCT04640311|473208199|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432419|NCT04640311|473208200|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
131432420|NCT04640311|473208188|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432421|NCT04640311|473208189|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432422|NCT04640311|473208190|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432423|NCT04640311|473208191|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
131432424|NCT04640311|473208192|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432425|NCT04640311|473208193|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432426|NCT04640311|473208194|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
131432427|NCT04640311|473208195|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432428|NCT04640311|473208196|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432429|NCT04640311|473208197|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432430|NCT04640311|473208198|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432431|NCT04640311|473208199|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432432|NCT04640311|473208200|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
131432433|NCT04640311|473208188|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432434|NCT04640311|473208189|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131434030|NCT01188772|473214618|FG000|Overall Study|Adverse Event|0|||
131458766|NCT00220779|473311705|FG002|Overall Study|Withdrawal by Subject|1|||
131458767|NCT00220779|473311703|FG000|Overall Study|Non-compliance|1|||
131458768|NCT00220779|473311704|FG001|Overall Study|Non-compliance|0|||
131458769|NCT00220779|473311705|FG002|Overall Study|Non-compliance|0|||
131432435|NCT04640311|473208190|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432436|NCT04640311|473208191|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432437|NCT04640311|473208192|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432438|NCT04640311|473208193|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
131432439|NCT04640311|473208194|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432440|NCT04640311|473208195|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432441|NCT04640311|473208196|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
131432442|NCT04640311|473208197|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432443|NCT04640311|473208198|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432444|NCT04640311|473208199|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432445|NCT04640311|473208200|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
131432446|NCT04640311|473208188|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432447|NCT04640311|473208189|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432448|NCT04640311|473208190|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432449|NCT04640311|473208191|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432450|NCT04640311|473208192|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432451|NCT04640311|473208193|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432452|NCT04640311|473208194|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
131432453|NCT04640311|473208195|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432454|NCT04640311|473208196|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432455|NCT04640311|473208197|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432456|NCT04640311|473208198|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
131432457|NCT04640311|473208199|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432458|NCT04640311|473208200|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
131432459|NCT04640311|473208188|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432460|NCT04640311|473208189|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432461|NCT04640311|473208190|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432462|NCT04640311|473208191|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432463|NCT04640311|473208192|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432464|NCT04640311|473208193|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432465|NCT04640311|473208194|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432466|NCT04640311|473208195|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432467|NCT04640311|473208196|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432468|NCT04640311|473208197|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432469|NCT04640311|473208198|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432470|NCT04640311|473208199|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
131432471|NCT04640311|473208200|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
131432472|NCT02223715|473208201|FG000|Overall Study|Death|31|||
131432473|NCT02223715|473208201|FG000|Overall Study|Lost to Follow-up|73|||
131432474|NCT03956550|473208202|FG000|Overall Study|Sponsor decision|65|||
131432475|NCT03956550|473208203|FG001|Overall Study|Sponsor decision|66|||
131432476|NCT03956550|473208204|FG002|Overall Study|Sponsor decision|64|||
131432477|NCT03956550|473208202|FG000|Overall Study|Adverse Event|0|||
131432478|NCT03956550|473208203|FG001|Overall Study|Adverse Event|1|||
131432479|NCT03956550|473208204|FG002|Overall Study|Adverse Event|0|||
131432480|NCT03956550|473208202|FG000|Overall Study|Withdrawal by Subject|5|||
131432481|NCT03956550|473208203|FG001|Overall Study|Withdrawal by Subject|5|||
131432482|NCT03956550|473208204|FG002|Overall Study|Withdrawal by Subject|6|||
131432483|NCT01745367|473208207|FG000|Overall Study|Death|1|||
131432484|NCT01745367|473208208|FG001|Overall Study|Death|0|||
131432485|NCT01745367|473208207|FG000|Overall Study|Withdrawal by Subject|1|||
131432486|NCT01745367|473208208|FG001|Overall Study|Withdrawal by Subject|2|||
131432487|NCT01745367|473208207|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
131432488|NCT01745367|473208208|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
131432489|NCT01745367|473208207|FG000|Overall Study|Other Reasons Unspecified|0|||
131458770|NCT00220779|473311703|FG000|Overall Study|Too time consuming|1|||
131458771|NCT00220779|473311704|FG001|Overall Study|Too time consuming|0|||
131432490|NCT01745367|473208208|FG001|Overall Study|Other Reasons Unspecified|2|||
131432491|NCT00592904|473208210|FG000|Overall Study|Adverse Event|15|||
131432492|NCT00592904|473208211|FG001|Overall Study|Adverse Event|25|||
131458772|NCT00220779|473311705|FG002|Overall Study|Too time consuming|0|||
131432493|NCT00592904|473208212|FG002|Overall Study|Adverse Event|13|||
131432494|NCT00592904|473208213|FG003|Overall Study|Adverse Event|5|||
131432495|NCT00592904|473208210|FG000|Overall Study|Protocol Violation|1|||
131432496|NCT00592904|473208211|FG001|Overall Study|Protocol Violation|1|||
131432497|NCT00592904|473208212|FG002|Overall Study|Protocol Violation|0|||
131432498|NCT00592904|473208213|FG003|Overall Study|Protocol Violation|1|||
131432499|NCT00592904|473208210|FG000|Overall Study|Withdrawal by Subject|4|||
131432500|NCT00592904|473208211|FG001|Overall Study|Withdrawal by Subject|16|||
131432501|NCT00592904|473208212|FG002|Overall Study|Withdrawal by Subject|1|||
131432502|NCT00592904|473208213|FG003|Overall Study|Withdrawal by Subject|2|||
131432503|NCT00592904|473208210|FG000|Overall Study|Lack of Efficacy|2|||
131432504|NCT00592904|473208211|FG001|Overall Study|Lack of Efficacy|7|||
131432505|NCT00592904|473208212|FG002|Overall Study|Lack of Efficacy|2|||
131432506|NCT00592904|473208213|FG003|Overall Study|Lack of Efficacy|3|||
131432507|NCT00592904|473208210|FG000|Overall Study|Physician Decision|0|||
131432508|NCT00592904|473208211|FG001|Overall Study|Physician Decision|3|||
131432509|NCT00592904|473208212|FG002|Overall Study|Physician Decision|1|||
131432510|NCT00592904|473208213|FG003|Overall Study|Physician Decision|0|||
131432511|NCT00592904|473208210|FG000|Overall Study|Other|3|||
131432512|NCT00592904|473208211|FG001|Overall Study|Other|3|||
131432513|NCT00592904|473208212|FG002|Overall Study|Other|0|||
131432514|NCT00592904|473208213|FG003|Overall Study|Other|0|||
131432515|NCT00824473|473208214|FG000|Overall Study|Adverse Event|4|||
131432516|NCT00824473|473208215|FG001|Overall Study|Adverse Event|5|||
131432517|NCT00824473|473208214|FG000|Overall Study|Lack of Efficacy|2|||
131432518|NCT00824473|473208215|FG001|Overall Study|Lack of Efficacy|2|||
131432519|NCT00824473|473208214|FG000|Overall Study|Protocol Violation|2|||
131432520|NCT00824473|473208215|FG001|Overall Study|Protocol Violation|0|||
131432521|NCT00824473|473208214|FG000|Overall Study|Non-Compliance|4|||
131432522|NCT00824473|473208215|FG001|Overall Study|Non-Compliance|2|||
131432523|NCT00824473|473208214|FG000|Overall Study|Withdrawal by Subject|2|||
131432524|NCT00824473|473208215|FG001|Overall Study|Withdrawal by Subject|3|||
131432525|NCT00824473|473208214|FG000|Overall Study|Other|1|||
131432526|NCT00824473|473208215|FG001|Overall Study|Other|1|||
131432527|NCT01359904|473208216|FG000|Overall Study|Withdrawal by Subject|1|||
131432528|NCT01359904|473208217|FG001|Overall Study|Withdrawal by Subject|0|||
131432529|NCT03191630|473208219|FG000|Overall Study|Lost to Follow-up|7|||
131432530|NCT03191630|473208220|FG001|Overall Study|Lost to Follow-up|7|||
131432531|NCT02640547|473208223|FG000|Overall Study|Failure to Return|1|||
131432532|NCT02640547|473208223|FG000|Overall Study|Withdrawal by Subject|1|||
131432533|NCT02640547|473208223|FG000|Overall Study|Death|6|||
131432534|NCT02640547|473208223|FG000|Overall Study|Miscellaneous|3|||
131432535|NCT02525588|473208224|FG000|Overall Study|Death|3|||
131432536|NCT02525588|473208225|FG001|Overall Study|Death|1|||
131432537|NCT02525588|473208224|FG000|Overall Study|Lost to Follow-up|2|||
131432538|NCT02525588|473208225|FG001|Overall Study|Lost to Follow-up|0|||
131432539|NCT02525588|473208224|FG000|Overall Study|Withdrawal by Subject|1|||
131432540|NCT02525588|473208225|FG001|Overall Study|Withdrawal by Subject|1|||
131432541|NCT02525588|473208224|FG000|Overall Study|Adverse Event|0|||
131432542|NCT02525588|473208225|FG001|Overall Study|Adverse Event|1|||
131432543|NCT03018691|473208229|FG000|Overall Study|Adverse Event|1|||
131432544|NCT03018691|473208230|FG001|Overall Study|Adverse Event|1|||
131432545|NCT03018691|473208231|FG002|Overall Study|Adverse Event|4|||
131432546|NCT03018691|473208229|FG000|Overall Study|Lack of Efficacy|0|||
131432547|NCT03018691|473208230|FG001|Overall Study|Lack of Efficacy|0|||
131432548|NCT03018691|473208231|FG002|Overall Study|Lack of Efficacy|1|||
131432549|NCT03018691|473208229|FG000|Overall Study|Withdrawal by Subject|0|||
131432550|NCT03018691|473208230|FG001|Overall Study|Withdrawal by Subject|0|||
131432551|NCT03018691|473208231|FG002|Overall Study|Withdrawal by Subject|1|||
131432552|NCT03018691|473208229|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131432553|NCT03018691|473208230|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131432554|NCT03018691|473208231|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131432555|NCT03369418|473208233|FG000|Overall Study|Withdrawal by Subject|3|||
131432556|NCT03369418|473208234|FG001|Overall Study|Withdrawal by Subject|3|||
131432557|NCT01485094|473208235|FG000|Overall Study|Adverse Event|1|||
131432558|NCT01485094|473208236|FG001|Overall Study|Adverse Event|1|||
131432559|NCT01485094|473208237|FG002|Overall Study|Adverse Event|1|||
131432560|NCT01485094|473208235|FG000|Overall Study|Lost to Follow-up|1|||
131432561|NCT01485094|473208236|FG001|Overall Study|Lost to Follow-up|0|||
131432562|NCT01485094|473208237|FG002|Overall Study|Lost to Follow-up|0|||
131432563|NCT01485094|473208235|FG000|Overall Study|Withdrawal by Subject|1|||
131432564|NCT01485094|473208236|FG001|Overall Study|Withdrawal by Subject|1|||
131432565|NCT01485094|473208237|FG002|Overall Study|Withdrawal by Subject|0|||
131432566|NCT01521507|473208247|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
131432567|NCT01521507|473208248|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
131432568|NCT01521507|473208247|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
131432569|NCT01521507|473208248|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
131432570|NCT01521507|473208247|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
131432571|NCT01521507|473208248|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
131432572|NCT01521507|473208247|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
131432573|NCT01521507|473208248|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
131432574|NCT01521507|473208247|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
131432575|NCT01521507|473208248|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
131432576|NCT01521507|473208247|FG000|Stage 2: Observational Design|Physician Decision|1|||
131432577|NCT01521507|473208248|FG001|Stage 2: Observational Design|Physician Decision|0|||
131432578|NCT02478463|473208251|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
131432579|NCT02478463|473208251|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
131432580|NCT02478463|473208251|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
131432581|NCT01358825|473208254|FG000|Overall Study|Blood sample not drawn|0|||
131432582|NCT01358825|473208255|FG001|Overall Study|Blood sample not drawn|1|||
131432583|NCT01479868|473208256|FG000|Overall Study|Adverse Event|1|||
131432584|NCT01479868|473208256|FG000|Overall Study|Lost to Follow-up|4|||
131432585|NCT01479868|473208256|FG000|Overall Study|Protocol Violation|1|||
131432586|NCT01479868|473208256|FG000|Overall Study|Withdrawal by Subject|1|||
131432587|NCT01479868|473208256|FG000|Overall Study|Sponsor's Decision|1|||
131432588|NCT01479868|473208256|FG000|Overall Study|Initiation of new HCV Therapy|1|||
131432589|NCT01508169|473208260|FG000|Overall Study|Adverse Event|1|||
131432590|NCT01508169|473208261|FG001|Overall Study|Adverse Event|0|||
131432591|NCT01508169|473208260|FG000|Overall Study|Withdrawal by Subject|1|||
131432592|NCT01508169|473208261|FG001|Overall Study|Withdrawal by Subject|0|||
131432593|NCT01508169|473208260|FG000|Overall Study|Lost to Follow-up|1|||
131432594|NCT01508169|473208261|FG001|Overall Study|Lost to Follow-up|2|||
131432595|NCT01814527|473208265|FG000|Overall Study|RTP greater than 30 days|6|||
131432596|NCT01814527|473208266|FG001|Overall Study|RTP greater than 30 days|1|||
131432597|NCT04524858|473208267|FG000|Overall Study|Adverse Event|1|||
131432598|NCT01363700|473208270|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
131432599|NCT01363700|473208271|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
131432600|NCT01363700|473208272|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
131432601|NCT01363700|473208273|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
131432602|NCT01363700|473208274|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
131432603|NCT00113841|473208280|FG000|Overall Study|Disease progression|0|||
131432604|NCT00113841|473208281|FG001|Overall Study|Disease progression|2|||
131432605|NCT00113841|473208280|FG000|Overall Study|Non-compliant|1|||
131432606|NCT00113841|473208281|FG001|Overall Study|Non-compliant|0|||
131432607|NCT02717494|473208286|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
131432608|NCT02717494|473208287|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
131432609|NCT02717494|473208288|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
131432610|NCT02717494|473208286|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
131432611|NCT02717494|473208287|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
131432612|NCT02717494|473208288|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
131432613|NCT02717494|473208286|FG000|First Intervention (Step 1)|Death|0|||
131432614|NCT02717494|473208287|FG001|First Intervention (Step 1)|Death|0|||
131432615|NCT02717494|473208288|FG002|First Intervention (Step 1)|Death|1|||
131432616|NCT02717494|473208286|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
131432617|NCT02717494|473208287|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
131432618|NCT02717494|473208288|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
131432619|NCT04417361|473208290|FG000|Overall Study|Withdrawal by Subject|1|||
131432620|NCT04417361|473208291|FG001|Overall Study|Withdrawal by Subject|0|||
131432621|NCT04417361|473208290|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
131432622|NCT04417361|473208291|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
131432623|NCT01288989|473208294|FG000|Overall Study|Death|0|||
131432624|NCT01288989|473208295|FG001|Overall Study|Death|0|||
131432625|NCT01288989|473208296|FG002|Overall Study|Death|0|||
131432626|NCT01288989|473208297|FG003|Overall Study|Death|1|||
131432627|NCT01288989|473208298|FG004|Overall Study|Death|0|||
131432628|NCT01288989|473208294|FG000|Overall Study|Dose limiting toxicity|1|||
131432629|NCT01288989|473208295|FG001|Overall Study|Dose limiting toxicity|0|||
131432630|NCT01288989|473208296|FG002|Overall Study|Dose limiting toxicity|0|||
131432631|NCT01288989|473208297|FG003|Overall Study|Dose limiting toxicity|0|||
131432632|NCT01288989|473208298|FG004|Overall Study|Dose limiting toxicity|0|||
131432633|NCT01288989|473208294|FG000|Overall Study|Adverse Event|0|||
131432634|NCT01288989|473208295|FG001|Overall Study|Adverse Event|0|||
131432635|NCT01288989|473208296|FG002|Overall Study|Adverse Event|0|||
131432636|NCT01288989|473208297|FG003|Overall Study|Adverse Event|0|||
131432637|NCT01288989|473208298|FG004|Overall Study|Adverse Event|2|||
131432638|NCT01288989|473208294|FG000|Overall Study|Physician Decision|0|||
131432639|NCT01288989|473208295|FG001|Overall Study|Physician Decision|0|||
131432640|NCT01288989|473208296|FG002|Overall Study|Physician Decision|0|||
131432641|NCT01288989|473208297|FG003|Overall Study|Physician Decision|0|||
131432642|NCT01288989|473208298|FG004|Overall Study|Physician Decision|1|||
131432643|NCT01288989|473208294|FG000|Overall Study|Withdrawal by Subject|0|||
131432644|NCT01288989|473208295|FG001|Overall Study|Withdrawal by Subject|0|||
131432645|NCT01288989|473208296|FG002|Overall Study|Withdrawal by Subject|0|||
131432646|NCT01288989|473208297|FG003|Overall Study|Withdrawal by Subject|0|||
131432647|NCT01288989|473208298|FG004|Overall Study|Withdrawal by Subject|3|||
131432648|NCT01156714|473208299|FG000|Overall Study|Withdrawal by Subject|9|||
131432649|NCT01156714|473208300|FG001|Overall Study|Withdrawal by Subject|4|||
131432650|NCT01156714|473208301|FG002|Overall Study|Withdrawal by Subject|3|||
131432651|NCT00165672|473208306|FG000|Overall Study|Adverse Event|0|||
131432652|NCT00165672|473208307|FG001|Overall Study|Adverse Event|1|||
131432653|NCT04965688|473208315|FG000|Overall Study|Withdrawal by Subject|2|||
131432654|NCT05864586|473208316|FG000|Overall Study|Ineligible|4|||
131432655|NCT05864586|473208317|FG001|Overall Study|Ineligible|12|||
131432656|NCT05864586|473208316|FG000|Overall Study|Pregnancy|0|||
131432657|NCT05864586|473208317|FG001|Overall Study|Pregnancy|1|||
131432658|NCT05864586|473208316|FG000|Overall Study|Withdrawal by Subject|0|||
131432659|NCT05864586|473208317|FG001|Overall Study|Withdrawal by Subject|1|||
131432660|NCT02777827|473208318|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
131432661|NCT02777827|473208319|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
131432662|NCT02777827|473208320|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
131432663|NCT02777827|473208321|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
131432664|NCT02777827|473208322|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
131432665|NCT02777827|473208323|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
131432666|NCT00369577|473208324|FG000|Overall Study|Withdrawal by Subject|0|||
131432667|NCT00369577|473208325|FG001|Overall Study|Withdrawal by Subject|0|||
131432668|NCT00369577|473208326|FG002|Overall Study|Withdrawal by Subject|1|||
131432669|NCT00176462|473208331|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
131432670|NCT00176462|473208332|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
131432671|NCT00176462|473208331|FG000|Induction (4 Weeks)|Death|1|||
131432672|NCT00176462|473208332|FG001|Induction (4 Weeks)|Death|2|||
131432673|NCT00176462|473208331|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
131432674|NCT00176462|473208332|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
131432675|NCT00176462|473208331|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
131432676|NCT00176462|473208332|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
131432677|NCT00176462|473208331|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
131432678|NCT00176462|473208332|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
131432679|NCT00176462|473208331|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
131432680|NCT00176462|473208332|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
131432681|NCT00176462|473208331|FG000|Consolidation (12 Weeks)|Not documented|0|||
131432682|NCT00176462|473208332|FG001|Consolidation (12 Weeks)|Not documented|1|||
131432683|NCT00176462|473208331|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
131432684|NCT00176462|473208332|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
131432685|NCT00176462|473208331|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
131432686|NCT00176462|473208332|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
131432687|NCT01408459|473208333|FG000|Overall Study|Withdrawal by Subject|1|||
131432688|NCT01408459|473208334|FG001|Overall Study|Withdrawal by Subject|1|||
131432689|NCT01012258|473209902|FG000|Overall Study|Death|14|||
131432690|NCT01012258|473209902|FG000|Overall Study|Lost to Follow-up|1|||
131432691|NCT01012258|473209902|FG000|Overall Study|Adverse Event|1|||
131432692|NCT01012258|473209902|FG000|Overall Study|Progressive Disease (PD)|18|||
131432693|NCT01012258|473209902|FG000|Overall Study|Symptomatic Deterioration|1|||
131432694|NCT01012258|473209902|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
131432695|NCT01012258|473209902|FG000|Overall Study|Another Tumor Discovered|1|||
131432696|NCT01012258|473209902|FG000|Overall Study|Ongoing|29|||
131432697|NCT03600740|473209903|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
131432698|NCT03571204|473209904|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
131432699|NCT03571204|473209905|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
131432700|NCT03571204|473209906|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
131432701|NCT03571204|473209904|FG000|Overall Study|Physician Decision|0|||
131432702|NCT03571204|473209905|FG001|Overall Study|Physician Decision|1|||
131432703|NCT03571204|473209906|FG002|Overall Study|Physician Decision|0|||
131432704|NCT02396212|473209907|FG000|Overall Study|Adverse Event|1|||
131432705|NCT02396212|473209907|FG000|Overall Study|Lack of Efficacy|2|||
131432706|NCT01623115|473209908|FG000|Overall Study|Randomized but not treated|0|||
131432707|NCT01623115|473209909|FG001|Overall Study|Randomized but not treated|1|||
131432708|NCT01623115|473209908|FG000|Overall Study|Physician Decision|1|||
131432709|NCT01623115|473209909|FG001|Overall Study|Physician Decision|0|||
131432710|NCT01623115|473209908|FG000|Overall Study|Participants moved|1|||
131432711|NCT01623115|473209909|FG001|Overall Study|Participants moved|5|||
131432712|NCT01623115|473209908|FG000|Overall Study|Adverse Event|10|||
131432713|NCT01623115|473209909|FG001|Overall Study|Adverse Event|13|||
131432714|NCT01623115|473209908|FG000|Overall Study|Poor compliance to protocol|4|||
131432715|NCT01623115|473209909|FG001|Overall Study|Poor compliance to protocol|10|||
131432716|NCT01623115|473209908|FG000|Overall Study|Consent withdrawn by participant|2|||
131432717|NCT01623115|473209909|FG001|Overall Study|Consent withdrawn by participant|6|||
131432718|NCT01623115|473209908|FG000|Overall Study|Related to study drug administration|0|||
131432719|NCT01623115|473209909|FG001|Overall Study|Related to study drug administration|2|||
131432720|NCT01623115|473209908|FG000|Overall Study|Last visit outside protocol visit window|14|||
131432721|NCT01623115|473209909|FG001|Overall Study|Last visit outside protocol visit window|26|||
131432722|NCT01623115|473209908|FG000|Overall Study|Site closure|1|||
131458773|NCT00220779|473311703|FG000|Overall Study|Pregnancy|0|||
131458774|NCT00220779|473311704|FG001|Overall Study|Pregnancy|0|||
131458775|NCT00220779|473311705|FG002|Overall Study|Pregnancy|2|||
131458776|NCT00220779|473311703|FG000|Overall Study|Lack of Efficacy|3|||
131458777|NCT00220779|473311704|FG001|Overall Study|Lack of Efficacy|0|||
131458778|NCT00220779|473311705|FG002|Overall Study|Lack of Efficacy|1|||
131458779|NCT00813943|473311706|FG000|Overall Study|Ongoing at cut-off date|5|||
131458780|NCT00813943|473311707|FG001|Overall Study|Ongoing at cut-off date|5|||
131458781|NCT00813943|473311708|FG002|Overall Study|Ongoing at cut-off date|3|||
131458782|NCT00265148|473311709|FG000|Overall Study|Adverse Event|2|||
131458783|NCT00265148|473311710|FG001|Overall Study|Adverse Event|2|||
131458784|NCT00265148|473311709|FG000|Overall Study|Lack of Efficacy|0|||
131458785|NCT00265148|473311710|FG001|Overall Study|Lack of Efficacy|2|||
131458786|NCT00265148|473311709|FG000|Overall Study|Protocol Violation|3|||
131458787|NCT00265148|473311710|FG001|Overall Study|Protocol Violation|2|||
131458788|NCT00265148|473311709|FG000|Overall Study|Lost to Follow-up|0|||
131458789|NCT00265148|473311710|FG001|Overall Study|Lost to Follow-up|1|||
131458790|NCT00265148|473311709|FG000|Overall Study|Withdrawal by Subject|2|||
131458791|NCT00265148|473311710|FG001|Overall Study|Withdrawal by Subject|1|||
131458792|NCT00265148|473311709|FG000|Overall Study|Physician Decision|1|||
131458793|NCT00265148|473311710|FG001|Overall Study|Physician Decision|0|||
131458794|NCT00265148|473311709|FG000|Overall Study|Increasing frailty|0|||
131458795|NCT00265148|473311710|FG001|Overall Study|Increasing frailty|1|||
131458796|NCT00265148|473311709|FG000|Overall Study|Subject chose to change of the dose|1|||
131458797|NCT00265148|473311710|FG001|Overall Study|Subject chose to change of the dose|0|||
131458798|NCT00689117|473311721|FG000|Overall Study|Adverse Event|6|||
131458799|NCT00689117|473311722|FG001|Overall Study|Adverse Event|0|||
131458800|NCT00689117|473311723|FG002|Overall Study|Adverse Event|5|||
131458801|NCT00689117|473311724|FG003|Overall Study|Adverse Event|0|||
131458802|NCT00689117|473311721|FG000|Overall Study|Lost to Follow-up|26|||
131458803|NCT00689117|473311722|FG001|Overall Study|Lost to Follow-up|19|||
131458804|NCT00689117|473311723|FG002|Overall Study|Lost to Follow-up|17|||
131458805|NCT00689117|473311724|FG003|Overall Study|Lost to Follow-up|11|||
131458806|NCT00689117|473311721|FG000|Overall Study|Lack of Efficacy|1|||
131432723|NCT01623115|473209909|FG001|Overall Study|Site closure|7|||
131432724|NCT01623115|473209908|FG000|Overall Study|Death|0|||
131432725|NCT01623115|473209909|FG001|Overall Study|Death|4|||
131432726|NCT01623115|473209908|FG000|Overall Study|Other than specified above|0|||
131432727|NCT01623115|473209909|FG001|Overall Study|Other than specified above|3|||
131432728|NCT00580723|473209915|FG000|Overall Study|Did not want to participate in extension|3|||
131432729|NCT00580723|473209915|FG000|Overall Study|Lost to Follow-up|5|||
131432730|NCT00148759|473209916|FG000|Overall Study|Withdrawal by Subject|1|||
131432731|NCT00148759|473209917|FG001|Overall Study|Withdrawal by Subject|1|||
131432732|NCT00148759|473209916|FG000|Overall Study|Lost to Follow-up|1|||
131432733|NCT00148759|473209917|FG001|Overall Study|Lost to Follow-up|0|||
131432734|NCT05202418|473209918|FG000|Overall Study|Withdrawal by Subject|2|||
131432735|NCT05202418|473209919|FG001|Overall Study|Withdrawal by Subject|1|||
131432736|NCT05202418|473209918|FG000|Overall Study|Lost to Follow-up|1|||
131432737|NCT05202418|473209919|FG001|Overall Study|Lost to Follow-up|1|||
131432738|NCT02753946|473209920|FG000|Overall Study|Adverse Event|7|||
131432739|NCT02753946|473209921|FG001|Overall Study|Adverse Event|6|||
131432740|NCT02753946|473209920|FG000|Overall Study|Withdrawal by Subject|6|||
131432741|NCT02753946|473209921|FG001|Overall Study|Withdrawal by Subject|1|||
131432742|NCT02753946|473209920|FG000|Overall Study|Lack of Efficacy|1|||
131432743|NCT02753946|473209921|FG001|Overall Study|Lack of Efficacy|0|||
131432744|NCT02753946|473209920|FG000|Overall Study|Physician Decision|0|||
131432745|NCT02753946|473209921|FG001|Overall Study|Physician Decision|2|||
131432746|NCT02519439|473209922|FG000|Overall Study|Study Termination|19|||
131432747|NCT02519439|473209922|FG000|Overall Study|Withdrawal by Subject|1|||
131432748|NCT02519439|473209922|FG000|Overall Study|Adverse Event|1|||
131432749|NCT02721875|473209923|FG000|Overall Study|Progressive disease/relapse|1|||
131432750|NCT02721875|473209924|FG001|Overall Study|Progressive disease/relapse|0|||
131432751|NCT03901144|473209930|FG000|Overall Study|Lost to Follow-up|1|||
131432752|NCT03901144|473209931|FG001|Overall Study|Lost to Follow-up|1|||
131432753|NCT03901144|473209932|FG002|Overall Study|Lost to Follow-up|1|||
131432754|NCT03901144|473209933|FG003|Overall Study|Lost to Follow-up|1|||
131432755|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
131432756|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
131432757|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
131432758|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
131432759|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
131432760|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
131458807|NCT00689117|473311722|FG001|Overall Study|Lack of Efficacy|2|||
131458808|NCT00689117|473311723|FG002|Overall Study|Lack of Efficacy|2|||
131458809|NCT00689117|473311724|FG003|Overall Study|Lack of Efficacy|2|||
131458810|NCT00689117|473311721|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
131458811|NCT00689117|473311722|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
131458812|NCT00689117|473311723|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
131432761|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Death|7|||
131432762|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Death|5|||
131432763|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Death|6|||
131432764|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
131432765|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
131432766|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
131432767|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
131432768|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
131432769|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
131432770|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Other|1|||
131432771|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Other|0|||
131432772|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Other|0|||
131432773|NCT00104650|473209936|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
131432774|NCT00104650|473209937|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
131432775|NCT00104650|473209938|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
131432776|NCT00104650|473209936|FG000|Follow-up Period|Physician Decision|1|||
131432777|NCT00104650|473209937|FG001|Follow-up Period|Physician Decision|1|||
131432778|NCT00104650|473209938|FG002|Follow-up Period|Physician Decision|0|||
131432779|NCT00104650|473209936|FG000|Follow-up Period|Adverse Event|1|||
131432780|NCT00104650|473209937|FG001|Follow-up Period|Adverse Event|0|||
131432781|NCT00104650|473209938|FG002|Follow-up Period|Adverse Event|1|||
131432782|NCT00104650|473209936|FG000|Follow-up Period|Withdrawal by Subject|0|||
131432783|NCT00104650|473209937|FG001|Follow-up Period|Withdrawal by Subject|3|||
131432784|NCT00104650|473209938|FG002|Follow-up Period|Withdrawal by Subject|3|||
131432785|NCT00104650|473209936|FG000|Follow-up Period|Death|6|||
131432786|NCT00104650|473209937|FG001|Follow-up Period|Death|6|||
131432787|NCT00104650|473209938|FG002|Follow-up Period|Death|4|||
131432788|NCT00104650|473209936|FG000|Follow-up Period|Disease progression|3|||
131432789|NCT00104650|473209937|FG001|Follow-up Period|Disease progression|1|||
131432790|NCT00104650|473209938|FG002|Follow-up Period|Disease progression|0|||
131432791|NCT00104650|473209936|FG000|Follow-up Period|Lost to Follow-up|0|||
131432792|NCT00104650|473209937|FG001|Follow-up Period|Lost to Follow-up|1|||
131432793|NCT00104650|473209938|FG002|Follow-up Period|Lost to Follow-up|2|||
131432794|NCT00104650|473209936|FG000|Follow-up Period|Other|0|||
131432795|NCT00104650|473209937|FG001|Follow-up Period|Other|1|||
131432796|NCT00104650|473209938|FG002|Follow-up Period|Other|0|||
131432797|NCT02294058|473209939|FG000|Overall Study|Adverse Event|16|||
131432798|NCT02294058|473209940|FG001|Overall Study|Adverse Event|7|||
131432799|NCT02294058|473209941|FG002|Overall Study|Adverse Event|13|||
131432800|NCT02294058|473209939|FG000|Overall Study|Lack of Efficacy|3|||
131432801|NCT02294058|473209940|FG001|Overall Study|Lack of Efficacy|3|||
131432802|NCT02294058|473209941|FG002|Overall Study|Lack of Efficacy|0|||
131432803|NCT02294058|473209939|FG000|Overall Study|Lost to Follow-up|1|||
131432804|NCT02294058|473209940|FG001|Overall Study|Lost to Follow-up|0|||
131432805|NCT02294058|473209941|FG002|Overall Study|Lost to Follow-up|2|||
131432806|NCT02294058|473209939|FG000|Overall Study|Withdrawal by Subject|10|||
131432807|NCT02294058|473209940|FG001|Overall Study|Withdrawal by Subject|14|||
131432808|NCT02294058|473209941|FG002|Overall Study|Withdrawal by Subject|13|||
131432809|NCT02294058|473209939|FG000|Overall Study|Physician Decision|2|||
131432810|NCT02294058|473209940|FG001|Overall Study|Physician Decision|1|||
131432811|NCT02294058|473209941|FG002|Overall Study|Physician Decision|0|||
131432812|NCT02294058|473209939|FG000|Overall Study|Miscellaneous|4|||
131432813|NCT02294058|473209940|FG001|Overall Study|Miscellaneous|1|||
131432814|NCT02294058|473209941|FG002|Overall Study|Miscellaneous|1|||
131432815|NCT03575403|473209943|FG000|Overall Study|Adverse Event|1|||
131432816|NCT03575403|473209944|FG001|Overall Study|Adverse Event|0|||
131432817|NCT03575403|473209945|FG002|Overall Study|Adverse Event|0|||
131432818|NCT03575403|473209943|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
131432819|NCT03575403|473209944|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
131432820|NCT03575403|473209945|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
131432821|NCT00773513|473209946|FG000|Overall Study|Renal Transplant|254|||
131432822|NCT00773513|473209947|FG001|Overall Study|Renal Transplant|263|||
131432823|NCT00773513|473209946|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
131432824|NCT00773513|473209947|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
131432825|NCT00773513|473209946|FG000|Overall Study|Withdrew Consent|68|||
131432826|NCT00773513|473209947|FG001|Overall Study|Withdrew Consent|69|||
131432827|NCT00773513|473209946|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
131432828|NCT00773513|473209947|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
131432829|NCT00773513|473209946|FG000|Overall Study|Failure to Return|22|||
131432830|NCT00773513|473209947|FG001|Overall Study|Failure to Return|8|||
131432831|NCT00773513|473209946|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131432832|NCT00773513|473209947|FG001|Overall Study|Insufficient Therapeutic Response|18|||
131432833|NCT00773513|473209946|FG000|Overall Study|Reason Not Specified|159|||
131432834|NCT00773513|473209947|FG001|Overall Study|Reason Not Specified|126|||
131432835|NCT00773513|473209946|FG000|Overall Study|Death|531|||
131458813|NCT00689117|473311724|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
131458814|NCT00689117|473311721|FG000|Overall Study|Withdrawal by Subject|19|||
131458815|NCT00689117|473311722|FG001|Overall Study|Withdrawal by Subject|18|||
131458816|NCT00689117|473311723|FG002|Overall Study|Withdrawal by Subject|26|||
131458817|NCT00689117|473311724|FG003|Overall Study|Withdrawal by Subject|13|||
131458818|NCT00689117|473311721|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
131458819|NCT00689117|473311722|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
131458820|NCT00689117|473311723|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
131458821|NCT00689117|473311724|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
131458822|NCT00689117|473311721|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131458823|NCT00689117|473311722|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
131458824|NCT00689117|473311723|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131458825|NCT00689117|473311724|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131458826|NCT00689117|473311721|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
131458827|NCT00689117|473311722|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
131458828|NCT00689117|473311723|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
131458829|NCT00689117|473311724|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
131458830|NCT00689117|473311721|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
131458831|NCT00689117|473311722|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
131458832|NCT00689117|473311723|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
131458833|NCT00689117|473311724|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
131458834|NCT00689117|473311721|FG000|Overall Study|Use of Prohibitive Medication|2|||
131458835|NCT00689117|473311722|FG001|Overall Study|Use of Prohibitive Medication|1|||
131458836|NCT00689117|473311723|FG002|Overall Study|Use of Prohibitive Medication|3|||
131458837|NCT00689117|473311724|FG003|Overall Study|Use of Prohibitive Medication|0|||
131458838|NCT00689117|473311721|FG000|Overall Study|Pregnancy|0|||
131458839|NCT00689117|473311722|FG001|Overall Study|Pregnancy|2|||
131458840|NCT00689117|473311723|FG002|Overall Study|Pregnancy|0|||
131458841|NCT00689117|473311724|FG003|Overall Study|Pregnancy|2|||
131458842|NCT00689117|473311721|FG000|Overall Study|Incarceration|2|||
131458843|NCT00689117|473311722|FG001|Overall Study|Incarceration|0|||
131458844|NCT00689117|473311723|FG002|Overall Study|Incarceration|0|||
131458845|NCT00689117|473311724|FG003|Overall Study|Incarceration|0|||
131458846|NCT00689117|473311721|FG000|Overall Study|Fear of Birth Defects|0|||
131458847|NCT00689117|473311722|FG001|Overall Study|Fear of Birth Defects|0|||
131458848|NCT00689117|473311723|FG002|Overall Study|Fear of Birth Defects|1|||
131458849|NCT00689117|473311724|FG003|Overall Study|Fear of Birth Defects|0|||
131458850|NCT00689117|473311721|FG000|Overall Study|Transportation|1|||
131458851|NCT00689117|473311722|FG001|Overall Study|Transportation|0|||
131458852|NCT00689117|473311723|FG002|Overall Study|Transportation|0|||
131458853|NCT00689117|473311724|FG003|Overall Study|Transportation|0|||
131458854|NCT00689117|473311721|FG000|Overall Study|Patient Withdrew from Study|0|||
131458855|NCT00689117|473311722|FG001|Overall Study|Patient Withdrew from Study|0|||
131458856|NCT00689117|473311723|FG002|Overall Study|Patient Withdrew from Study|0|||
131458857|NCT00689117|473311724|FG003|Overall Study|Patient Withdrew from Study|1|||
131458858|NCT00689117|473311721|FG000|Overall Study|Personal Reason|0|||
131432836|NCT00773513|473209947|FG001|Overall Study|Death|545|||
131432837|NCT03359174|473209950|FG000|Overall Study|Adverse Event|1|||
131432838|NCT01332994|473209954|FG000|Overall Study|Adverse Event|34|||
131432839|NCT01332994|473209954|FG000|Overall Study|Death|1|||
131432840|NCT01332994|473209954|FG000|Overall Study|Lack of Efficacy|1|||
131432841|NCT01332994|473209954|FG000|Overall Study|Lost to Follow-up|4|||
131432842|NCT01332994|473209954|FG000|Overall Study|Protocol Violation|6|||
131432843|NCT01332994|473209954|FG000|Overall Study|Withdrawal by Subject|15|||
131432844|NCT01332994|473209954|FG000|Overall Study|Administrative Problem|2|||
131432845|NCT01332994|473209954|FG000|Overall Study|Other|8|||
131432846|NCT02800863|473209955|FG000|Overall Study|Adverse Event|14|||
131432847|NCT02800863|473209955|FG000|Overall Study|Another Device Implanted|1|||
131432848|NCT02800863|473209955|FG000|Overall Study|Device Explanted|1|||
131432849|NCT02800863|473209955|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
131458859|NCT00689117|473311722|FG001|Overall Study|Personal Reason|1|||
131458860|NCT00689117|473311723|FG002|Overall Study|Personal Reason|0|||
131458861|NCT00689117|473311724|FG003|Overall Study|Personal Reason|0|||
131458862|NCT00689117|473311721|FG000|Overall Study|Dispensing Error|0|||
131432850|NCT02800863|473209955|FG000|Overall Study|Health Issues|1|||
131432851|NCT02800863|473209955|FG000|Overall Study|Insurance Denial|8|||
131432852|NCT02800863|473209955|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
131432853|NCT02800863|473209955|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
131432854|NCT02800863|473209955|FG000|Overall Study|Screen Failure|1|||
131458863|NCT00689117|473311722|FG001|Overall Study|Dispensing Error|1|||
131458864|NCT00689117|473311723|FG002|Overall Study|Dispensing Error|0|||
131458865|NCT00689117|473311724|FG003|Overall Study|Dispensing Error|0|||
131458866|NCT03179202|473311729|FG000|Overall Study|Screen Failure|67|||
131458867|NCT03179202|473311729|FG000|Overall Study|Subject Lost to Follow Up|12|||
131458868|NCT03179202|473311729|FG000|Overall Study|Withdrawal by Subject|7|||
131432855|NCT02800863|473209955|FG000|Overall Study|Sponsor Request|6|||
131432856|NCT02800863|473209955|FG000|Overall Study|Death|3|||
131432857|NCT02800863|473209955|FG000|Overall Study|Subject Implant at Another Facility|1|||
131432858|NCT02800863|473209955|FG000|Overall Study|Lost to Follow-up|26|||
131432859|NCT02800863|473209955|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
131432860|NCT02800863|473209955|FG000|Overall Study|Subject and/or Family Request|64|||
131432861|NCT02800863|473209955|FG000|Overall Study|Trial Failure|81|||
131432862|NCT02800863|473209955|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
131432863|NCT00279916|473209956|FG000|Overall Study|Withdrawal by Subject|4|||
131432864|NCT00279916|473209957|FG001|Overall Study|Withdrawal by Subject|3|||
131432865|NCT00279916|473209956|FG000|Overall Study|Lost to Follow-up|3|||
131432866|NCT00279916|473209957|FG001|Overall Study|Lost to Follow-up|2|||
131432867|NCT01807598|473209958|FG000|Overall Study|Withdrawal by Subject|4|||
131432868|NCT01807598|473209958|FG000|Overall Study|Adverse Event|1|||
131432869|NCT01807598|473209958|FG000|Overall Study|Other Physician Decision|1|||
131432870|NCT03384940|473209962|FG000|Overall Study|Progressive disease|36|||
131432871|NCT03384940|473209963|FG001|Overall Study|Progressive disease|11|||
131432872|NCT03384940|473209964|FG002|Overall Study|Progressive disease|13|||
131432873|NCT03384940|473209962|FG000|Overall Study|Clinical progression|4|||
131432874|NCT03384940|473209963|FG001|Overall Study|Clinical progression|0|||
131432875|NCT03384940|473209964|FG002|Overall Study|Clinical progression|3|||
131432876|NCT03384940|473209962|FG000|Overall Study|Adverse Event|7|||
131432877|NCT03384940|473209963|FG001|Overall Study|Adverse Event|1|||
131432878|NCT03384940|473209964|FG002|Overall Study|Adverse Event|1|||
131432879|NCT03384940|473209962|FG000|Overall Study|Withdrawal by Subject|3|||
131432880|NCT03384940|473209963|FG001|Overall Study|Withdrawal by Subject|1|||
131432881|NCT03384940|473209964|FG002|Overall Study|Withdrawal by Subject|0|||
131432882|NCT03384940|473209962|FG000|Overall Study|Physician Decision|1|||
131432883|NCT03384940|473209963|FG001|Overall Study|Physician Decision|1|||
131432884|NCT03384940|473209964|FG002|Overall Study|Physician Decision|0|||
131432885|NCT03384940|473209962|FG000|Overall Study|Death|2|||
131432886|NCT03384940|473209963|FG001|Overall Study|Death|1|||
131432887|NCT03384940|473209964|FG002|Overall Study|Death|0|||
131432888|NCT03384940|473209962|FG000|Overall Study|Other|0|||
131432889|NCT03384940|473209963|FG001|Overall Study|Other|0|||
131432890|NCT03384940|473209964|FG002|Overall Study|Other|1|||
131432891|NCT03089580|473209968|FG000|Overall Study|Lost to Follow-up|2|||
131432892|NCT04170543|473209969|FG000|Overall Study|Death|1|||
131432893|NCT04170543|473209970|FG001|Overall Study|Death|1|||
131432894|NCT04170543|473209971|FG002|Overall Study|Death|1|||
131432895|NCT04170543|473209972|FG003|Overall Study|Death|1|||
131432896|NCT04170543|473209973|FG004|Overall Study|Death|1|||
131432897|NCT04170543|473209969|FG000|Overall Study|Lost to Follow-up|3|||
131432898|NCT04170543|473209970|FG001|Overall Study|Lost to Follow-up|3|||
131432899|NCT04170543|473209971|FG002|Overall Study|Lost to Follow-up|0|||
131432900|NCT04170543|473209972|FG003|Overall Study|Lost to Follow-up|3|||
131432901|NCT04170543|473209973|FG004|Overall Study|Lost to Follow-up|1|||
131432902|NCT04170543|473209969|FG000|Overall Study|Withdrawal by Subject|13|||
131432903|NCT04170543|473209970|FG001|Overall Study|Withdrawal by Subject|6|||
131432904|NCT04170543|473209971|FG002|Overall Study|Withdrawal by Subject|5|||
131432905|NCT04170543|473209972|FG003|Overall Study|Withdrawal by Subject|4|||
131432906|NCT04170543|473209973|FG004|Overall Study|Withdrawal by Subject|9|||
131432907|NCT04170543|473209969|FG000|Overall Study|Not able to transition to phase 2b|8|||
131432908|NCT04170543|473209970|FG001|Overall Study|Not able to transition to phase 2b|0|||
131432909|NCT04170543|473209971|FG002|Overall Study|Not able to transition to phase 2b|10|||
131432910|NCT04170543|473209972|FG003|Overall Study|Not able to transition to phase 2b|0|||
131432911|NCT04170543|473209973|FG004|Overall Study|Not able to transition to phase 2b|6|||
131432912|NCT04170543|473209969|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
131432913|NCT04170543|473209970|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
131432914|NCT04170543|473209971|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
131432915|NCT04170543|473209972|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
131432916|NCT04170543|473209973|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
131432917|NCT04170543|473209969|FG000|Overall Study|Not Treated|0|||
131432918|NCT04170543|473209970|FG001|Overall Study|Not Treated|0|||
131432919|NCT04170543|473209971|FG002|Overall Study|Not Treated|0|||
131432920|NCT04170543|473209972|FG003|Overall Study|Not Treated|0|||
131432921|NCT04170543|473209973|FG004|Overall Study|Not Treated|2|||
131432922|NCT04170543|473209969|FG000|Overall Study|(CRF)|16|||
131432923|NCT04170543|473209970|FG001|Overall Study|(CRF)|15|||
131432924|NCT04170543|473209971|FG002|Overall Study|(CRF)|12|||
131432925|NCT04170543|473209972|FG003|Overall Study|(CRF)|17|||
131432926|NCT04170543|473209973|FG004|Overall Study|(CRF)|17|||
131432927|NCT04170543|473209969|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
131458869|NCT03179202|473311729|FG000|Overall Study|Adverse Event|3|||
131458870|NCT03179202|473311729|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
131432928|NCT04170543|473209970|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
131432929|NCT04170543|473209971|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
131432930|NCT04170543|473209972|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
131432931|NCT04170543|473209973|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
131432932|NCT00801216|473209974|FG000|Overall Study|Screening Failure|2|||
131432933|NCT05481359|473209975|FG000|Overall Study|Lost to Follow-up|3|||
131432934|NCT05481359|473209975|FG000|Overall Study|Withdrawal by Subject|1|||
131432935|NCT00452790|473209976|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
131432936|NCT00452790|473209977|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
131432937|NCT00452790|473209976|FG000|Infant Series|Parent/legal guardian request|8|||
131432938|NCT00452790|473209977|FG001|Infant Series|Parent/legal guardian request|6|||
131432939|NCT00452790|473209976|FG000|Infant Series|Failed to return|4|||
131432940|NCT00452790|473209977|FG001|Infant Series|Failed to return|1|||
131432941|NCT00452790|473209976|FG000|Infant Series|Protocol Violation|1|||
131432942|NCT00452790|473209977|FG001|Infant Series|Protocol Violation|3|||
131432943|NCT00452790|473209976|FG000|Infant Series|Lost to Follow-up|2|||
131432944|NCT00452790|473209977|FG001|Infant Series|Lost to Follow-up|2|||
131432945|NCT00452790|473209976|FG000|Infant Series|Adverse Event|1|||
131432946|NCT00452790|473209977|FG001|Infant Series|Adverse Event|2|||
131432947|NCT00452790|473209976|FG000|Infant Series|Other reasons|1|||
131432948|NCT00452790|473209977|FG001|Infant Series|Other reasons|2|||
131432949|NCT00452790|473209976|FG000|Infant Series|Investigator request|0|||
131432950|NCT00452790|473209977|FG001|Infant Series|Investigator request|1|||
131432951|NCT00452790|473209976|FG000|Infant Series|Death|0|||
131432952|NCT00452790|473209977|FG001|Infant Series|Death|1|||
131432953|NCT00452790|473209976|FG000|After Infant Series|Investigator request|10|||
131432954|NCT00452790|473209977|FG001|After Infant Series|Investigator request|10|||
131432955|NCT00452790|473209976|FG000|After Infant Series|Adverse Event|4|||
131432956|NCT00452790|473209977|FG001|After Infant Series|Adverse Event|1|||
131432957|NCT00452790|473209976|FG000|After Infant Series|Parent/legal guardian request|1|||
131432958|NCT00452790|473209977|FG001|After Infant Series|Parent/legal guardian request|3|||
131432959|NCT00452790|473209976|FG000|After Infant Series|Lost to Follow-up|4|||
131432960|NCT00452790|473209977|FG001|After Infant Series|Lost to Follow-up|0|||
131432961|NCT00452790|473209976|FG000|After Infant Series|Failed to return|1|||
131432962|NCT00452790|473209977|FG001|After Infant Series|Failed to return|0|||
131432963|NCT00452790|473209976|FG000|After Infant Series|Other reasons|1|||
131432964|NCT00452790|473209977|FG001|After Infant Series|Other reasons|0|||
131432965|NCT00452790|473209976|FG000|Toddler Dose|Failed to return|0|||
131432966|NCT00452790|473209977|FG001|Toddler Dose|Failed to return|1|||
131432967|NCT00452790|473209976|FG000|Toddler Dose|Parent/legal guardian request|0|||
131432968|NCT00452790|473209977|FG001|Toddler Dose|Parent/legal guardian request|1|||
131432969|NCT00319254|473209980|FG000|Overall Study|Withdrawal by Subject|4|||
131432970|NCT00319254|473209980|FG000|Overall Study|Death|46|||
131432971|NCT00319254|473209980|FG000|Overall Study|Lost to Follow-up|2|||
131432972|NCT00319254|473209980|FG000|Overall Study|Enrolled, Not Treated|2|||
131432973|NCT01505374|473209981|FG000|Overall Study|Lost to Follow-up|1|||
131432974|NCT01505374|473209982|FG001|Overall Study|Lost to Follow-up|0|||
131432975|NCT02360228|473209983|FG000|Overall Study|Withdrawal by Subject|1|||
131432976|NCT02360228|473209984|FG001|Overall Study|Withdrawal by Subject|0|||
131432977|NCT02360228|473209985|FG002|Overall Study|Withdrawal by Subject|0|||
131432978|NCT02360228|473209983|FG000|Overall Study|Self-discontinued medication|0|||
131432979|NCT02360228|473209984|FG001|Overall Study|Self-discontinued medication|1|||
131432980|NCT02360228|473209985|FG002|Overall Study|Self-discontinued medication|0|||
131432981|NCT02360228|473209983|FG000|Overall Study|Unstable symptoms during screening|0|||
131432982|NCT02360228|473209984|FG001|Overall Study|Unstable symptoms during screening|0|||
131432983|NCT02360228|473209985|FG002|Overall Study|Unstable symptoms during screening|1|||
131432984|NCT02452424|473209986|FG000|Overall Study|Death|2|||
131432985|NCT02452424|473209987|FG001|Overall Study|Death|2|||
131432986|NCT02452424|473209988|FG002|Overall Study|Death|2|||
131432987|NCT02452424|473209989|FG003|Overall Study|Death|6|||
131432988|NCT02452424|473209990|FG004|Overall Study|Death|2|||
131432989|NCT02452424|473209991|FG005|Overall Study|Death|0|||
131432990|NCT02452424|473209992|FG006|Overall Study|Death|5|||
131432991|NCT02452424|473209993|FG007|Overall Study|Death|1|||
131432992|NCT02452424|473209994|FG008|Overall Study|Death|3|||
131432993|NCT02452424|473209995|FG009|Overall Study|Death|1|||
131432994|NCT02452424|473209996|FG010|Overall Study|Death|0|||
131432995|NCT02452424|473209986|FG000|Overall Study|Lost to Follow-up|0|||
131432996|NCT02452424|473209987|FG001|Overall Study|Lost to Follow-up|1|||
131432997|NCT02452424|473209988|FG002|Overall Study|Lost to Follow-up|1|||
131432998|NCT02452424|473209989|FG003|Overall Study|Lost to Follow-up|0|||
131432999|NCT02452424|473209990|FG004|Overall Study|Lost to Follow-up|0|||
131433000|NCT02452424|473209991|FG005|Overall Study|Lost to Follow-up|0|||
131433001|NCT02452424|473209992|FG006|Overall Study|Lost to Follow-up|0|||
131433002|NCT02452424|473209993|FG007|Overall Study|Lost to Follow-up|0|||
131433003|NCT02452424|473209994|FG008|Overall Study|Lost to Follow-up|0|||
131433004|NCT02452424|473209995|FG009|Overall Study|Lost to Follow-up|0|||
131433005|NCT02452424|473209996|FG010|Overall Study|Lost to Follow-up|0|||
131433006|NCT02452424|473209986|FG000|Overall Study|Withdrawal by Subject|0|||
131433007|NCT02452424|473209987|FG001|Overall Study|Withdrawal by Subject|0|||
131433008|NCT02452424|473209988|FG002|Overall Study|Withdrawal by Subject|3|||
131433009|NCT02452424|473209989|FG003|Overall Study|Withdrawal by Subject|2|||
131433010|NCT02452424|473209990|FG004|Overall Study|Withdrawal by Subject|0|||
131433011|NCT02452424|473209991|FG005|Overall Study|Withdrawal by Subject|0|||
131433012|NCT02452424|473209992|FG006|Overall Study|Withdrawal by Subject|1|||
131433013|NCT02452424|473209993|FG007|Overall Study|Withdrawal by Subject|0|||
131433014|NCT02452424|473209994|FG008|Overall Study|Withdrawal by Subject|1|||
131433015|NCT02452424|473209995|FG009|Overall Study|Withdrawal by Subject|1|||
131433016|NCT02452424|473209996|FG010|Overall Study|Withdrawal by Subject|0|||
131433017|NCT02452424|473209986|FG000|Overall Study|Other|0|||
131433018|NCT02452424|473209987|FG001|Overall Study|Other|0|||
131458871|NCT03179202|473311729|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
131433019|NCT02452424|473209988|FG002|Overall Study|Other|1|||
131433020|NCT02452424|473209989|FG003|Overall Study|Other|0|||
131433021|NCT02452424|473209990|FG004|Overall Study|Other|0|||
131433022|NCT02452424|473209991|FG005|Overall Study|Other|1|||
131433023|NCT02452424|473209992|FG006|Overall Study|Other|4|||
131433024|NCT02452424|473209993|FG007|Overall Study|Other|3|||
131433025|NCT02452424|473209994|FG008|Overall Study|Other|0|||
131433026|NCT02452424|473209995|FG009|Overall Study|Other|0|||
131433027|NCT02452424|473209996|FG010|Overall Study|Other|1|||
131433028|NCT02452424|473209986|FG000|Overall Study|Progressive disease (per RECIST)|0|||
131433029|NCT02452424|473209987|FG001|Overall Study|Progressive disease (per RECIST)|0|||
131433030|NCT02452424|473209988|FG002|Overall Study|Progressive disease (per RECIST)|0|||
131433031|NCT02452424|473209989|FG003|Overall Study|Progressive disease (per RECIST)|0|||
131433032|NCT02452424|473209990|FG004|Overall Study|Progressive disease (per RECIST)|0|||
131434031|NCT01188772|473214619|FG001|Overall Study|Adverse Event|1|||
131433033|NCT02452424|473209991|FG005|Overall Study|Progressive disease (per RECIST)|0|||
131433034|NCT02452424|473209992|FG006|Overall Study|Progressive disease (per RECIST)|0|||
131433035|NCT02452424|473209993|FG007|Overall Study|Progressive disease (per RECIST)|0|||
131433036|NCT02452424|473209994|FG008|Overall Study|Progressive disease (per RECIST)|2|||
131433037|NCT02452424|473209995|FG009|Overall Study|Progressive disease (per RECIST)|0|||
131433038|NCT02452424|473209996|FG010|Overall Study|Progressive disease (per RECIST)|0|||
131433039|NCT02452424|473209986|FG000|Overall Study|Adverse Event|0|||
131433040|NCT02452424|473209987|FG001|Overall Study|Adverse Event|0|||
131433041|NCT02452424|473209988|FG002|Overall Study|Adverse Event|0|||
131433042|NCT02452424|473209989|FG003|Overall Study|Adverse Event|0|||
131433043|NCT02452424|473209990|FG004|Overall Study|Adverse Event|0|||
131433044|NCT02452424|473209991|FG005|Overall Study|Adverse Event|0|||
131433045|NCT02452424|473209992|FG006|Overall Study|Adverse Event|0|||
131433046|NCT02452424|473209993|FG007|Overall Study|Adverse Event|0|||
131433047|NCT02452424|473209994|FG008|Overall Study|Adverse Event|0|||
131433048|NCT02452424|473209995|FG009|Overall Study|Adverse Event|0|||
131433049|NCT02452424|473209996|FG010|Overall Study|Adverse Event|1|||
131433050|NCT01463306|473209997|FG000|Overall Study|Adverse Event|6|||
131433051|NCT01463306|473209998|FG001|Overall Study|Adverse Event|9|||
131433052|NCT01463306|473209999|FG002|Overall Study|Adverse Event|3|||
131433053|NCT01463306|473209997|FG000|Overall Study|Death|3|||
131433054|NCT01463306|473209998|FG001|Overall Study|Death|3|||
131433055|NCT01463306|473209999|FG002|Overall Study|Death|0|||
131433056|NCT01463306|473209997|FG000|Overall Study|Lack of Efficacy|22|||
131433057|NCT01463306|473209998|FG001|Overall Study|Lack of Efficacy|16|||
131433058|NCT01463306|473209999|FG002|Overall Study|Lack of Efficacy|1|||
131433059|NCT01463306|473209997|FG000|Overall Study|Lost to Follow-up|5|||
131433060|NCT01463306|473209998|FG001|Overall Study|Lost to Follow-up|2|||
131433061|NCT01463306|473209999|FG002|Overall Study|Lost to Follow-up|0|||
131433062|NCT01463306|473209997|FG000|Overall Study|Protocol Violation|4|||
131433063|NCT01463306|473209998|FG001|Overall Study|Protocol Violation|0|||
131433064|NCT01463306|473209999|FG002|Overall Study|Protocol Violation|0|||
131433065|NCT01463306|473209997|FG000|Overall Study|Withdrawal by Subject|19|||
131433066|NCT01463306|473209998|FG001|Overall Study|Withdrawal by Subject|9|||
131433067|NCT01463306|473209999|FG002|Overall Study|Withdrawal by Subject|1|||
131433068|NCT01463306|473209997|FG000|Overall Study|Other|26|||
131433069|NCT01463306|473209998|FG001|Overall Study|Other|13|||
131433070|NCT01463306|473209999|FG002|Overall Study|Other|0|||
131433071|NCT01463306|473209997|FG000|Overall Study|Approval expiry at site|1|||
131433072|NCT01463306|473209998|FG001|Overall Study|Approval expiry at site|0|||
131433073|NCT01463306|473209999|FG002|Overall Study|Approval expiry at site|0|||
131433074|NCT01059318|473210000|FG000|Core Study (26 Week)|Adverse Event|3|||
131433075|NCT01059318|473210000|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
131433076|NCT01059318|473210000|FG000|Extension (36 Week)|Adverse Event|3|||
131433077|NCT03790917|473210003|FG000|Overall Study|Death|1|||
131433078|NCT04186871|473210004|FG000|Overall Study|Lack of Efficacy|0|||
131433079|NCT04186871|473210005|FG001|Overall Study|Lack of Efficacy|1|||
131433080|NCT04186871|473210006|FG002|Overall Study|Lack of Efficacy|0|||
131433081|NCT04186871|473210007|FG003|Overall Study|Lack of Efficacy|0|||
131433082|NCT04186871|473210008|FG004|Overall Study|Lack of Efficacy|1|||
131433083|NCT04186871|473210009|FG005|Overall Study|Lack of Efficacy|1|||
131433084|NCT04186871|473210004|FG000|Overall Study|Adverse Event|1|||
131433085|NCT04186871|473210005|FG001|Overall Study|Adverse Event|1|||
131433086|NCT04186871|473210006|FG002|Overall Study|Adverse Event|0|||
131433087|NCT04186871|473210007|FG003|Overall Study|Adverse Event|0|||
131433088|NCT04186871|473210008|FG004|Overall Study|Adverse Event|0|||
131433089|NCT04186871|473210009|FG005|Overall Study|Adverse Event|2|||
131433090|NCT04186871|473210004|FG000|Overall Study|Study terminated by sponsor|1|||
131433091|NCT04186871|473210005|FG001|Overall Study|Study terminated by sponsor|2|||
131433092|NCT04186871|473210006|FG002|Overall Study|Study terminated by sponsor|0|||
131433093|NCT04186871|473210007|FG003|Overall Study|Study terminated by sponsor|1|||
131433094|NCT04186871|473210008|FG004|Overall Study|Study terminated by sponsor|0|||
131433095|NCT04186871|473210009|FG005|Overall Study|Study terminated by sponsor|0|||
131433096|NCT04186871|473210004|FG000|Overall Study|Other reasons|0|||
131433097|NCT04186871|473210005|FG001|Overall Study|Other reasons|0|||
131433098|NCT04186871|473210006|FG002|Overall Study|Other reasons|0|||
131433099|NCT04186871|473210007|FG003|Overall Study|Other reasons|0|||
131433100|NCT04186871|473210008|FG004|Overall Study|Other reasons|0|||
131433101|NCT04186871|473210009|FG005|Overall Study|Other reasons|1|||
131433102|NCT04186871|473210004|FG000|Overall Study|Withdrawal by Subject|0|||
131433103|NCT04186871|473210005|FG001|Overall Study|Withdrawal by Subject|0|||
131433104|NCT04186871|473210006|FG002|Overall Study|Withdrawal by Subject|0|||
131433105|NCT04186871|473210007|FG003|Overall Study|Withdrawal by Subject|0|||
131433106|NCT04186871|473210008|FG004|Overall Study|Withdrawal by Subject|0|||
131433107|NCT04186871|473210009|FG005|Overall Study|Withdrawal by Subject|1|||
131433108|NCT04186871|473210004|FG000|Overall Study|Lost to Follow-up|0|||
131433109|NCT04186871|473210005|FG001|Overall Study|Lost to Follow-up|0|||
131433110|NCT04186871|473210006|FG002|Overall Study|Lost to Follow-up|0|||
131433111|NCT04186871|473210007|FG003|Overall Study|Lost to Follow-up|0|||
131433112|NCT04186871|473210008|FG004|Overall Study|Lost to Follow-up|0|||
131433113|NCT04186871|473210009|FG005|Overall Study|Lost to Follow-up|1|||
131433114|NCT02464410|473210010|FG000|Overall Study|Death|3|||
131433115|NCT02464410|473210011|FG001|Overall Study|Death|4|||
131433116|NCT02464410|473210010|FG000|Overall Study|Lost to Follow-up|7|||
131433117|NCT02464410|473210011|FG001|Overall Study|Lost to Follow-up|9|||
131433118|NCT02464410|473210010|FG000|Overall Study|Withdrawal by Subject|12|||
131433119|NCT02464410|473210011|FG001|Overall Study|Withdrawal by Subject|3|||
131433120|NCT02679287|473210022|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
131433121|NCT02679287|473210023|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
131433122|NCT02679287|473210022|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
131433123|NCT02679287|473210023|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
131433124|NCT02679287|473210022|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
131433125|NCT02679287|473210023|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
131433126|NCT02679287|473210022|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
131433127|NCT02679287|473210023|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
131433128|NCT02679287|473210022|FG000|Period 2|Work/Scheduling Conflict|1|||
131433129|NCT02679287|473210023|FG001|Period 2|Work/Scheduling Conflict|0|||
131433130|NCT02679287|473210022|FG000|Period 2|Disliked Mobile System|2|||
131433131|NCT02679287|473210023|FG001|Period 2|Disliked Mobile System|0|||
131433132|NCT02679287|473210022|FG000|Period 3|Work/Scheduling Conflict|0|||
131433133|NCT02679287|473210023|FG001|Period 3|Work/Scheduling Conflict|1|||
131433134|NCT01045694|473210025|FG000|Overall Study|Withdrawal by Subject|2|||
131433135|NCT01150097|473210033|FG000|Months 24 to 36 Post-transplantation|Death|2|||
131433136|NCT01150097|473210034|FG001|Months 24 to 36 Post-transplantation|Death|0|||
131433137|NCT01150097|473210035|FG002|Months 24 to 36 Post-transplantation|Death|0|||
131433138|NCT01150097|473210033|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
131433139|NCT01150097|473210034|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
131433140|NCT01150097|473210035|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
131433141|NCT01150097|473210033|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
131433142|NCT01150097|473210034|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
131433143|NCT01150097|473210035|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
131433144|NCT01150097|473210033|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
131433145|NCT01150097|473210034|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
131433146|NCT01150097|473210035|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
131433147|NCT01150097|473210033|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
131433148|NCT01150097|473210034|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
131433149|NCT01150097|473210035|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
131433150|NCT01150097|473210033|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
131433151|NCT01150097|473210034|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
131433152|NCT01150097|473210035|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
131433153|NCT01150097|473210033|FG000|Months 24 to 48 Post-transplantation|Death|2|||
131433154|NCT01150097|473210034|FG001|Months 24 to 48 Post-transplantation|Death|0|||
131433155|NCT01150097|473210035|FG002|Months 24 to 48 Post-transplantation|Death|0|||
131433156|NCT00992459|473210036|FG000|Overall Study|Withdrawal by Subject|0|||
131433157|NCT00992459|473210037|FG001|Overall Study|Withdrawal by Subject|1|||
131433158|NCT00992459|473210036|FG000|Overall Study|Adverse Event|1|||
131433159|NCT00992459|473210037|FG001|Overall Study|Adverse Event|0|||
131433160|NCT00543387|473210040|FG000|Panel 1 + Panel 2|Adverse Event|0|||
131433161|NCT00543387|473210041|FG001|Panel 1 + Panel 2|Adverse Event|1|||
131433162|NCT00543387|473210042|FG002|Panel 1 + Panel 2|Adverse Event|0|||
131433163|NCT00543387|473210043|FG003|Panel 1 + Panel 2|Adverse Event|0|||
131433164|NCT00543387|473210044|FG004|Panel 1 + Panel 2|Adverse Event|0|||
131433165|NCT00543387|473210045|FG005|Panel 1 + Panel 2|Adverse Event|0|||
131433166|NCT00543387|473210046|FG006|Panel 1 + Panel 2|Adverse Event|0|||
131433167|NCT00543387|473210047|FG007|Panel 1 + Panel 2|Adverse Event|1|||
131433168|NCT00543387|473210048|FG008|Panel 1 + Panel 2|Adverse Event|1|||
131433169|NCT00543387|473210049|FG009|Panel 1 + Panel 2|Adverse Event|0|||
131433170|NCT00543387|473210050|FG010|Panel 1 + Panel 2|Adverse Event|0|||
131433171|NCT00543387|473210040|FG000|Panel 1 + Panel 2|Physician Decision|0|||
131433172|NCT00543387|473210041|FG001|Panel 1 + Panel 2|Physician Decision|0|||
131433173|NCT00543387|473210042|FG002|Panel 1 + Panel 2|Physician Decision|1|||
131433174|NCT00543387|473210043|FG003|Panel 1 + Panel 2|Physician Decision|0|||
131433175|NCT00543387|473210044|FG004|Panel 1 + Panel 2|Physician Decision|0|||
131433176|NCT00543387|473210045|FG005|Panel 1 + Panel 2|Physician Decision|0|||
131433177|NCT00543387|473210046|FG006|Panel 1 + Panel 2|Physician Decision|0|||
131433178|NCT00543387|473210047|FG007|Panel 1 + Panel 2|Physician Decision|1|||
131433179|NCT00543387|473210048|FG008|Panel 1 + Panel 2|Physician Decision|0|||
131433180|NCT00543387|473210049|FG009|Panel 1 + Panel 2|Physician Decision|0|||
131433181|NCT00543387|473210050|FG010|Panel 1 + Panel 2|Physician Decision|0|||
131433182|NCT00543387|473210040|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
131433183|NCT00543387|473210041|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
131433184|NCT00543387|473210042|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
131433185|NCT00543387|473210043|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
131433186|NCT00543387|473210044|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
131433187|NCT00543387|473210045|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
131433188|NCT00543387|473210046|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
131433189|NCT00543387|473210047|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
131433190|NCT00543387|473210048|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
131433191|NCT00543387|473210049|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
131433192|NCT00543387|473210050|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
131433193|NCT00543387|473210040|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433194|NCT00543387|473210041|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433195|NCT00543387|473210042|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433196|NCT00543387|473210043|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433197|NCT00543387|473210044|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433198|NCT00543387|473210045|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433199|NCT00543387|473210046|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
131433200|NCT00543387|473210047|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433201|NCT00543387|473210048|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433202|NCT00543387|473210049|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433203|NCT00543387|473210050|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
131433204|NCT00543387|473210040|FG000|Crossover Participants|Progressive Disease|0|||
131433205|NCT00543387|473210041|FG001|Crossover Participants|Progressive Disease|0|||
131433206|NCT00543387|473210042|FG002|Crossover Participants|Progressive Disease|0|||
131433207|NCT00543387|473210043|FG003|Crossover Participants|Progressive Disease|0|||
131433208|NCT00543387|473210044|FG004|Crossover Participants|Progressive Disease|0|||
131458872|NCT03255629|473311730|FG000|Overall Study|Adverse Event|1|||
131458873|NCT03255629|473311731|FG001|Overall Study|Adverse Event|0|||
131433209|NCT00543387|473210045|FG005|Crossover Participants|Progressive Disease|0|||
131433210|NCT00543387|473210046|FG006|Crossover Participants|Progressive Disease|0|||
131433211|NCT00543387|473210047|FG007|Crossover Participants|Progressive Disease|0|||
131433212|NCT00543387|473210048|FG008|Crossover Participants|Progressive Disease|0|||
131433213|NCT00543387|473210049|FG009|Crossover Participants|Progressive Disease|1|||
131433214|NCT00543387|473210050|FG010|Crossover Participants|Progressive Disease|2|||
131458874|NCT03255629|473311730|FG000|Overall Study|did not experience hypoglycemia|2|||
131458875|NCT03255629|473311731|FG001|Overall Study|did not experience hypoglycemia|1|||
131433215|NCT00543387|473210040|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
131433216|NCT00543387|473210041|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
131433217|NCT00543387|473210042|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
131433218|NCT00543387|473210043|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
131433219|NCT00543387|473210044|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
131433220|NCT00543387|473210045|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
131433221|NCT00543387|473210046|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
131433222|NCT00543387|473210047|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
131433223|NCT00543387|473210048|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
131433224|NCT00543387|473210049|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
131433225|NCT00543387|473210050|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
131433226|NCT01114828|473210051|FG000|Overall Study|Adverse Event|1|||
131433227|NCT01114828|473210052|FG001|Overall Study|Adverse Event|1|||
131433228|NCT01114828|473210051|FG000|Overall Study|Lack of Efficacy|0|||
131433229|NCT01114828|473210052|FG001|Overall Study|Lack of Efficacy|2|||
131433230|NCT01114828|473210051|FG000|Overall Study|Protocol Violation|2|||
131433231|NCT01114828|473210052|FG001|Overall Study|Protocol Violation|0|||
131433232|NCT01114828|473210051|FG000|Overall Study|Withdrawal by Subject|0|||
131433233|NCT01114828|473210052|FG001|Overall Study|Withdrawal by Subject|1|||
131433234|NCT00940498|473210053|FG000|Overall Study|Death|2|||
131433235|NCT00940498|473210054|FG001|Overall Study|Death|0|||
131433236|NCT00940498|473210055|FG002|Overall Study|Death|0|||
131433237|NCT00940498|473210056|FG003|Overall Study|Death|1|||
131433238|NCT00940498|473210057|FG004|Overall Study|Death|5|||
131433239|NCT00940498|473210058|FG005|Overall Study|Death|0|||
131433240|NCT00940498|473210059|FG006|Overall Study|Death|1|||
131433241|NCT00940498|473210060|FG007|Overall Study|Death|0|||
131433242|NCT00940498|473210053|FG000|Overall Study|Lost to Follow-up|1|||
131433243|NCT00940498|473210054|FG001|Overall Study|Lost to Follow-up|1|||
131433244|NCT00940498|473210055|FG002|Overall Study|Lost to Follow-up|2|||
131433245|NCT00940498|473210056|FG003|Overall Study|Lost to Follow-up|0|||
131433246|NCT00940498|473210057|FG004|Overall Study|Lost to Follow-up|1|||
131433247|NCT00940498|473210058|FG005|Overall Study|Lost to Follow-up|0|||
131433248|NCT00940498|473210059|FG006|Overall Study|Lost to Follow-up|0|||
131433249|NCT00940498|473210060|FG007|Overall Study|Lost to Follow-up|1|||
131433250|NCT00940498|473210053|FG000|Overall Study|Disease Progression|0|||
131433251|NCT00940498|473210054|FG001|Overall Study|Disease Progression|0|||
131433252|NCT00940498|473210055|FG002|Overall Study|Disease Progression|1|||
131433253|NCT00940498|473210056|FG003|Overall Study|Disease Progression|1|||
131433254|NCT00940498|473210057|FG004|Overall Study|Disease Progression|0|||
131433255|NCT00940498|473210058|FG005|Overall Study|Disease Progression|1|||
131433256|NCT00940498|473210059|FG006|Overall Study|Disease Progression|0|||
131433257|NCT00940498|473210060|FG007|Overall Study|Disease Progression|0|||
131433258|NCT00940498|473210053|FG000|Overall Study|Physician Decision|0|||
131433259|NCT00940498|473210054|FG001|Overall Study|Physician Decision|0|||
131433260|NCT00940498|473210055|FG002|Overall Study|Physician Decision|0|||
131433261|NCT00940498|473210056|FG003|Overall Study|Physician Decision|0|||
131433262|NCT00940498|473210057|FG004|Overall Study|Physician Decision|2|||
131433263|NCT00940498|473210058|FG005|Overall Study|Physician Decision|0|||
131433264|NCT00940498|473210059|FG006|Overall Study|Physician Decision|0|||
131433265|NCT00940498|473210060|FG007|Overall Study|Physician Decision|0|||
131433266|NCT00940498|473210053|FG000|Overall Study|Not treated due to disease related pain|0|||
131433267|NCT00940498|473210054|FG001|Overall Study|Not treated due to disease related pain|0|||
131458876|NCT00859638|473311732|FG000|Overall Study|Lost to Follow-up|6|||
131458877|NCT00859638|473311733|FG001|Overall Study|Lost to Follow-up|1|||
131458878|NCT00859638|473311732|FG000|Overall Study|Withdrawal by Subject|3|||
131458879|NCT00859638|473311733|FG001|Overall Study|Withdrawal by Subject|2|||
131458880|NCT00859638|473311732|FG000|Overall Study|Ill health|1|||
131458881|NCT00859638|473311733|FG001|Overall Study|Ill health|1|||
131433268|NCT00940498|473210055|FG002|Overall Study|Not treated due to disease related pain|0|||
131433269|NCT00940498|473210056|FG003|Overall Study|Not treated due to disease related pain|0|||
131433270|NCT00940498|473210057|FG004|Overall Study|Not treated due to disease related pain|1|||
131458882|NCT02969408|473311735|FG000|Overall Study|Adverse Event|2|||
131458883|NCT02969408|473311735|FG000|Overall Study|Withdrawal by Subject|8|||
131458884|NCT02969408|473311735|FG000|Overall Study|Lost to Follow-up|4|||
131458885|NCT02969408|473311735|FG000|Overall Study|Protocol Violation|1|||
131433271|NCT00940498|473210058|FG005|Overall Study|Not treated due to disease related pain|0|||
131433272|NCT00940498|473210059|FG006|Overall Study|Not treated due to disease related pain|0|||
131433273|NCT00940498|473210060|FG007|Overall Study|Not treated due to disease related pain|0|||
131433274|NCT00549445|473210061|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
131433275|NCT00549445|473210062|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
131433276|NCT03932760|473210063|FG000|Overall Study|Became Ineligible|2|||
131433277|NCT03932760|473210064|FG001|Overall Study|Became Ineligible|5|||
131433278|NCT03932760|473210063|FG000|Overall Study|Withdrawal by Subject|6|||
131433279|NCT03932760|473210064|FG001|Overall Study|Withdrawal by Subject|6|||
131458886|NCT02969408|473311735|FG000|Overall Study|Other than specified|1|||
131433280|NCT03566082|473210065|FG000|Overall Study|Death|7|||
131433281|NCT03566082|473210065|FG000|Overall Study|Failures (revision required)|2|||
131433282|NCT03566082|473210065|FG000|Overall Study|Lost to Follow-up|8|||
131433283|NCT00983385|473210068|FG000|Observation Period|Not eligible to be dosed|20|||
131433284|NCT00983385|473210068|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
131433285|NCT00227721|473211293|FG000|Overall Study|On study, but never treated.|1|||
131433286|NCT00961181|473211298|FG000|Overall Study|Death|2|||
131433287|NCT00961181|473211298|FG000|Overall Study|Withdrawal by Subject|2|||
131433288|NCT00961181|473211298|FG000|Overall Study|Lost to Follow-up|1|||
131433289|NCT00280917|473211299|FG000|Overall Study|Adverse Event|1|||
131433290|NCT00280917|473211300|FG001|Overall Study|Adverse Event|1|||
131433291|NCT00280917|473211301|FG002|Overall Study|Adverse Event|4|||
131433292|NCT00280917|473211302|FG003|Overall Study|Adverse Event|1|||
131433293|NCT00280917|473211299|FG000|Overall Study|Change Therapy|1|||
131433294|NCT00280917|473211300|FG001|Overall Study|Change Therapy|2|||
131433295|NCT00280917|473211301|FG002|Overall Study|Change Therapy|0|||
131433296|NCT00280917|473211302|FG003|Overall Study|Change Therapy|0|||
131433297|NCT00280917|473211299|FG000|Overall Study|Withdrawal by Subject|0|||
131433298|NCT00280917|473211300|FG001|Overall Study|Withdrawal by Subject|2|||
131433299|NCT00280917|473211301|FG002|Overall Study|Withdrawal by Subject|0|||
131433300|NCT00280917|473211302|FG003|Overall Study|Withdrawal by Subject|1|||
131433301|NCT00280917|473211299|FG000|Overall Study|Noncompliance|0|||
131433302|NCT00280917|473211300|FG001|Overall Study|Noncompliance|1|||
131433303|NCT00280917|473211301|FG002|Overall Study|Noncompliance|2|||
131433304|NCT00280917|473211302|FG003|Overall Study|Noncompliance|0|||
131433305|NCT01276639|473211315|FG000|Week 0 to 16|Death|1|||
131433306|NCT01276639|473211316|FG001|Week 0 to 16|Death|0|||
131433307|NCT01276639|473211317|FG002|Week 0 to 16|Death|0|||
131433308|NCT01276639|473211318|FG003|Week 0 to 16|Death|0|||
131433309|NCT01276639|473211319|FG004|Week 0 to 16|Death|0|||
131433310|NCT01276639|473211315|FG000|Week 0 to 16|Adverse Event|11|||
131433311|NCT01276639|473211316|FG001|Week 0 to 16|Adverse Event|8|||
131433312|NCT01276639|473211317|FG002|Week 0 to 16|Adverse Event|11|||
131433313|NCT01276639|473211318|FG003|Week 0 to 16|Adverse Event|0|||
131433314|NCT01276639|473211319|FG004|Week 0 to 16|Adverse Event|0|||
131433315|NCT01276639|473211315|FG000|Week 0 to 16|Lack of Efficacy|20|||
131433316|NCT01276639|473211316|FG001|Week 0 to 16|Lack of Efficacy|15|||
131433317|NCT01276639|473211317|FG002|Week 0 to 16|Lack of Efficacy|25|||
131433318|NCT01276639|473211318|FG003|Week 0 to 16|Lack of Efficacy|0|||
131433319|NCT01276639|473211319|FG004|Week 0 to 16|Lack of Efficacy|0|||
131433320|NCT01276639|473211315|FG000|Week 0 to 16|Lost to Follow-up|3|||
131433321|NCT01276639|473211316|FG001|Week 0 to 16|Lost to Follow-up|5|||
131433322|NCT01276639|473211317|FG002|Week 0 to 16|Lost to Follow-up|3|||
131433323|NCT01276639|473211318|FG003|Week 0 to 16|Lost to Follow-up|0|||
131433324|NCT01276639|473211319|FG004|Week 0 to 16|Lost to Follow-up|0|||
131433325|NCT01276639|473211315|FG000|Week 0 to 16|Withdrawal by Subject|8|||
131433326|NCT01276639|473211316|FG001|Week 0 to 16|Withdrawal by Subject|5|||
131433327|NCT01276639|473211317|FG002|Week 0 to 16|Withdrawal by Subject|4|||
131433328|NCT01276639|473211318|FG003|Week 0 to 16|Withdrawal by Subject|0|||
131433329|NCT01276639|473211319|FG004|Week 0 to 16|Withdrawal by Subject|0|||
131433330|NCT01276639|473211315|FG000|Week 0 to 16|Other|7|||
131433331|NCT01276639|473211316|FG001|Week 0 to 16|Other|7|||
131433332|NCT01276639|473211317|FG002|Week 0 to 16|Other|2|||
131433333|NCT01276639|473211318|FG003|Week 0 to 16|Other|0|||
131433334|NCT01276639|473211319|FG004|Week 0 to 16|Other|0|||
131433335|NCT01276639|473211315|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
131433336|NCT01276639|473211316|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
131433337|NCT01276639|473211317|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
131433338|NCT01276639|473211318|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
131433339|NCT01276639|473211319|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
131433340|NCT01276639|473211315|FG000|Week 16 to 52|Death|1|||
131433341|NCT01276639|473211316|FG001|Week 16 to 52|Death|0|||
131433342|NCT01276639|473211317|FG002|Week 16 to 52|Death|0|||
131433343|NCT01276639|473211318|FG003|Week 16 to 52|Death|0|||
131433344|NCT01276639|473211319|FG004|Week 16 to 52|Death|0|||
131433345|NCT01276639|473211315|FG000|Week 16 to 52|Adverse Event|10|||
131433346|NCT01276639|473211316|FG001|Week 16 to 52|Adverse Event|13|||
131433347|NCT01276639|473211317|FG002|Week 16 to 52|Adverse Event|0|||
131433348|NCT01276639|473211318|FG003|Week 16 to 52|Adverse Event|1|||
131433349|NCT01276639|473211319|FG004|Week 16 to 52|Adverse Event|3|||
131433350|NCT01276639|473211315|FG000|Week 16 to 52|Lack of Efficacy|99|||
131433351|NCT01276639|473211316|FG001|Week 16 to 52|Lack of Efficacy|71|||
131433352|NCT01276639|473211317|FG002|Week 16 to 52|Lack of Efficacy|0|||
131433353|NCT01276639|473211318|FG003|Week 16 to 52|Lack of Efficacy|14|||
131433354|NCT01276639|473211319|FG004|Week 16 to 52|Lack of Efficacy|13|||
131433355|NCT01276639|473211315|FG000|Week 16 to 52|Lost to Follow-up|3|||
131458887|NCT02779556|473311739|FG000|Baseline|Partial baseline interview completed|1|||
131433356|NCT01276639|473211316|FG001|Week 16 to 52|Lost to Follow-up|1|||
131433357|NCT01276639|473211317|FG002|Week 16 to 52|Lost to Follow-up|0|||
131433358|NCT01276639|473211318|FG003|Week 16 to 52|Lost to Follow-up|0|||
131433359|NCT01276639|473211319|FG004|Week 16 to 52|Lost to Follow-up|1|||
131433360|NCT01276639|473211315|FG000|Week 16 to 52|Withdrawal by Subject|4|||
131433361|NCT01276639|473211316|FG001|Week 16 to 52|Withdrawal by Subject|4|||
131433362|NCT01276639|473211317|FG002|Week 16 to 52|Withdrawal by Subject|0|||
131433363|NCT01276639|473211318|FG003|Week 16 to 52|Withdrawal by Subject|0|||
131433364|NCT01276639|473211319|FG004|Week 16 to 52|Withdrawal by Subject|1|||
131433365|NCT01276639|473211315|FG000|Week 16 to 52|Other|10|||
131433366|NCT01276639|473211316|FG001|Week 16 to 52|Other|12|||
131433367|NCT01276639|473211317|FG002|Week 16 to 52|Other|0|||
131433368|NCT01276639|473211318|FG003|Week 16 to 52|Other|1|||
131433369|NCT01276639|473211319|FG004|Week 16 to 52|Other|3|||
131433370|NCT01544920|473211326|FG000|Overall Study|Adverse Event|0|||
131433371|NCT01544920|473211327|FG001|Overall Study|Adverse Event|3|||
131433372|NCT01544920|473211326|FG000|Overall Study|Death|0|||
131433373|NCT01544920|473211327|FG001|Overall Study|Death|1|||
131433374|NCT01544920|473211326|FG000|Overall Study|Lost to Follow-up|11|||
131433375|NCT01544920|473211327|FG001|Overall Study|Lost to Follow-up|12|||
131433376|NCT01544920|473211326|FG000|Overall Study|Protocol Violation|0|||
131433377|NCT01544920|473211327|FG001|Overall Study|Protocol Violation|2|||
131433378|NCT01544920|473211326|FG000|Overall Study|Physician Decision|4|||
131433379|NCT01544920|473211327|FG001|Overall Study|Physician Decision|1|||
131433380|NCT01544920|473211326|FG000|Overall Study|Withdrawal by Subject|4|||
131433381|NCT01544920|473211327|FG001|Overall Study|Withdrawal by Subject|4|||
131433382|NCT00466440|473211328|FG000|Overall Study|Adverse Event|0|||
131433383|NCT00466440|473211329|FG001|Overall Study|Adverse Event|3|||
131433384|NCT00466440|473211330|FG002|Overall Study|Adverse Event|1|||
131433385|NCT00466440|473211328|FG000|Overall Study|Death|1|||
131433386|NCT00466440|473211329|FG001|Overall Study|Death|1|||
131433387|NCT00466440|473211330|FG002|Overall Study|Death|0|||
131433388|NCT00466440|473211328|FG000|Overall Study|Progressive disease|13|||
131433389|NCT00466440|473211329|FG001|Overall Study|Progressive disease|5|||
131433390|NCT00466440|473211330|FG002|Overall Study|Progressive disease|4|||
131433391|NCT00466440|473211328|FG000|Overall Study|Lost to Follow-up|0|||
131433392|NCT00466440|473211329|FG001|Overall Study|Lost to Follow-up|1|||
131433393|NCT00466440|473211330|FG002|Overall Study|Lost to Follow-up|0|||
131433394|NCT00466440|473211328|FG000|Overall Study|Physician Decision|0|||
131433395|NCT00466440|473211329|FG001|Overall Study|Physician Decision|1|||
131433396|NCT00466440|473211330|FG002|Overall Study|Physician Decision|2|||
131433397|NCT00466440|473211328|FG000|Overall Study|Protocol entry criteria not met|0|||
131433398|NCT00466440|473211329|FG001|Overall Study|Protocol entry criteria not met|0|||
131433399|NCT00466440|473211330|FG002|Overall Study|Protocol entry criteria not met|4|||
131433400|NCT00466440|473211328|FG000|Overall Study|Withdrawal by Subject|0|||
131433401|NCT00466440|473211329|FG001|Overall Study|Withdrawal by Subject|1|||
131433402|NCT00466440|473211330|FG002|Overall Study|Withdrawal by Subject|0|||
131433403|NCT00466440|473211328|FG000|Overall Study|Sponsor decision|0|||
131433404|NCT00466440|473211329|FG001|Overall Study|Sponsor decision|0|||
131433405|NCT00466440|473211330|FG002|Overall Study|Sponsor decision|1|||
131433406|NCT00965081|473211331|FG000|Overall Study|Adverse Event|14|||
131433407|NCT00965081|473211332|FG001|Overall Study|Adverse Event|9|||
131433408|NCT00965081|473211331|FG000|Overall Study|Lack of Efficacy|2|||
131433409|NCT00965081|473211332|FG001|Overall Study|Lack of Efficacy|5|||
131433410|NCT00965081|473211331|FG000|Overall Study|Lost to Follow-up|4|||
131433411|NCT00965081|473211332|FG001|Overall Study|Lost to Follow-up|5|||
131433412|NCT00965081|473211331|FG000|Overall Study|Physician Decision|2|||
131433413|NCT00965081|473211332|FG001|Overall Study|Physician Decision|0|||
131433414|NCT00965081|473211331|FG000|Overall Study|Protocol Violation|2|||
131433415|NCT00965081|473211332|FG001|Overall Study|Protocol Violation|5|||
131433416|NCT00965081|473211331|FG000|Overall Study|Sponsor Decision|1|||
131433417|NCT00965081|473211332|FG001|Overall Study|Sponsor Decision|0|||
131433418|NCT00965081|473211331|FG000|Overall Study|Withdrawal by Subject|4|||
131433419|NCT00965081|473211332|FG001|Overall Study|Withdrawal by Subject|7|||
131433420|NCT00965081|473211331|FG000|Overall Study|Switched to Rescue Arm|5|||
131433421|NCT00965081|473211332|FG001|Overall Study|Switched to Rescue Arm|12|||
131433422|NCT00796666|473211335|FG000|Overall Study|Death|2|||
131433423|NCT00796666|473211336|FG001|Overall Study|Death|4|||
131433424|NCT00796666|473211335|FG000|Overall Study|Withdrawal by Subject|2|||
131433425|NCT00796666|473211336|FG001|Overall Study|Withdrawal by Subject|0|||
131433426|NCT00796666|473211335|FG000|Overall Study|Adverse Event|7|||
131433427|NCT00796666|473211336|FG001|Overall Study|Adverse Event|5|||
131433428|NCT00796666|473211335|FG000|Overall Study|Protocol Violation|1|||
131433429|NCT00796666|473211336|FG001|Overall Study|Protocol Violation|0|||
131433430|NCT00796666|473211335|FG000|Overall Study|Other|1|||
131433431|NCT00796666|473211336|FG001|Overall Study|Other|0|||
131433432|NCT00796666|473211335|FG000|Overall Study|Terminated by sponsor|53|||
131433433|NCT00796666|473211336|FG001|Overall Study|Terminated by sponsor|55|||
131433434|NCT00796666|473211335|FG000|Overall Study|Randomized and not treated|1|||
131433435|NCT00796666|473211336|FG001|Overall Study|Randomized and not treated|0|||
131433436|NCT00474955|473211337|FG000|Overall Study|Adverse Event|2|||
131433437|NCT00474955|473211337|FG000|Overall Study|Drug unavailability|1|||
131433438|NCT00474955|473211337|FG000|Overall Study|Personal reasons|5|||
131433439|NCT00256724|473211342|FG000|Overall Study|Physician Decision|2|||
131433440|NCT00256724|473211343|FG001|Overall Study|Physician Decision|5|||
131433441|NCT00256724|473211342|FG000|Overall Study|Protocol Violation|3|||
131433442|NCT00256724|473211343|FG001|Overall Study|Protocol Violation|3|||
131433443|NCT01217463|473211344|FG000|Overall Study|Adverse Event|8|||
131433444|NCT01217463|473211345|FG001|Overall Study|Adverse Event|5|||
131433445|NCT01217463|473211344|FG000|Overall Study|Physician Decision|0|||
131433446|NCT01217463|473211345|FG001|Overall Study|Physician Decision|1|||
131433447|NCT01217463|473211344|FG000|Overall Study|Withdrawal by Subject|3|||
131433448|NCT01217463|473211345|FG001|Overall Study|Withdrawal by Subject|0|||
131433449|NCT01217463|473211344|FG000|Overall Study|Surgery on the Target Limb|0|||
131433450|NCT01217463|473211345|FG001|Overall Study|Surgery on the Target Limb|1|||
131433451|NCT01217463|473211344|FG000|Overall Study|Patient Non-compliant|1|||
131433452|NCT01217463|473211345|FG001|Overall Study|Patient Non-compliant|0|||
131433453|NCT01217463|473211344|FG000|Overall Study|Other|1|||
131433454|NCT01217463|473211345|FG001|Overall Study|Other|1|||
131433455|NCT01569841|473211346|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
131433456|NCT01569841|473211347|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
131433457|NCT00764361|473211351|FG000|Overall Study|Withdrawal by Subject|2|||
131433458|NCT00764361|473211352|FG001|Overall Study|Withdrawal by Subject|3|||
131433459|NCT00764361|473211351|FG000|Overall Study|Adverse Event|0|||
131458888|NCT02779556|473311740|FG001|Baseline|Partial baseline interview completed|0|||
131458889|NCT02779556|473311739|FG000|3 Months|Lost to Follow-up|40|||
131458890|NCT02779556|473311740|FG001|3 Months|Lost to Follow-up|29|||
131458891|NCT02779556|473311739|FG000|3 Months|Missed 3 month clinic visit|27|||
131458892|NCT02779556|473311740|FG001|3 Months|Missed 3 month clinic visit|19|||
131458893|NCT02779556|473311739|FG000|6 Month|Lost to Follow-up|33|||
131458894|NCT02779556|473311740|FG001|6 Month|Lost to Follow-up|39|||
131458895|NCT02779556|473311739|FG000|6 Month HbA1c|No value collected during window|69|||
131458896|NCT02779556|473311740|FG001|6 Month HbA1c|No value collected during window|50|||
131458897|NCT02779556|473311739|FG000|12 Month HbA1c|No value collected during window|138|||
131458898|NCT02779556|473311740|FG001|12 Month HbA1c|No value collected during window|102|||
131458899|NCT03110770|473311744|FG000|Overall Study|Death|1|||
131458900|NCT03110770|473311745|FG001|Overall Study|Death|0|||
131458901|NCT03110770|473311746|FG002|Overall Study|Death|0|||
131458902|NCT03110770|473311747|FG003|Overall Study|Death|1|||
131458903|NCT03110770|473311748|FG004|Overall Study|Death|0|||
131458904|NCT03110770|473311744|FG000|Overall Study|Enrolled but did not receive product|0|||
131458905|NCT03110770|473311745|FG001|Overall Study|Enrolled but did not receive product|0|||
131458906|NCT03110770|473311746|FG002|Overall Study|Enrolled but did not receive product|0|||
131458907|NCT03110770|473311747|FG003|Overall Study|Enrolled but did not receive product|8|||
131458908|NCT03110770|473311748|FG004|Overall Study|Enrolled but did not receive product|7|||
131458909|NCT03110770|473311744|FG000|Overall Study|Lost to Follow-up|0|||
131433460|NCT00764361|473211352|FG001|Overall Study|Adverse Event|1|||
131433461|NCT02090426|473211353|FG000|Overall Study|Lost to Follow-up|12|||
131433462|NCT02090426|473211354|FG001|Overall Study|Lost to Follow-up|6|||
131433463|NCT01141712|473211355|FG000|Overall Study|Disease progression|3|||
131433464|NCT00857285|473211362|FG000|Overall Study|Adverse Event|4|||
131433465|NCT00857285|473211363|FG001|Overall Study|Adverse Event|2|||
131433466|NCT00857285|473211362|FG000|Overall Study|Lack of Efficacy|0|||
131433467|NCT00857285|473211363|FG001|Overall Study|Lack of Efficacy|2|||
131433468|NCT00857285|473211362|FG000|Overall Study|Protocol Violation|3|||
131433469|NCT00857285|473211363|FG001|Overall Study|Protocol Violation|1|||
131433470|NCT00857285|473211362|FG000|Overall Study|Withdrawal by Subject|4|||
131433471|NCT00857285|473211363|FG001|Overall Study|Withdrawal by Subject|0|||
131433472|NCT00857285|473211362|FG000|Overall Study|Randomization criteria not met|1|||
131433473|NCT00857285|473211363|FG001|Overall Study|Randomization criteria not met|1|||
131433474|NCT00430716|473211364|FG000|Double Blind Phase|Death|1|||
131433475|NCT00430716|473211365|FG001|Double Blind Phase|Death|0|||
131433476|NCT00430716|473211366|FG002|Double Blind Phase|Death|0|||
131433477|NCT00430716|473211364|FG000|Double Blind Phase|No longer willing to participate|2|||
131433478|NCT00430716|473211365|FG001|Double Blind Phase|No longer willing to participate|1|||
131433479|NCT00430716|473211366|FG002|Double Blind Phase|No longer willing to participate|1|||
131433480|NCT00430716|473211364|FG000|Double Blind Phase|Other|0|||
131433481|NCT00430716|473211365|FG001|Double Blind Phase|Other|2|||
131433482|NCT00430716|473211366|FG002|Double Blind Phase|Other|0|||
131433483|NCT00430716|473211364|FG000|Double Blind Phase|Study terminated by sponsor|1|||
131433484|NCT00430716|473211365|FG001|Double Blind Phase|Study terminated by sponsor|1|||
131433485|NCT00430716|473211366|FG002|Double Blind Phase|Study terminated by sponsor|2|||
131433486|NCT00430716|473211364|FG000|Double Blind Phase|Adverse Event|1|||
131433487|NCT00430716|473211365|FG001|Double Blind Phase|Adverse Event|1|||
131433488|NCT00430716|473211366|FG002|Double Blind Phase|Adverse Event|3|||
131433489|NCT00430716|473211364|FG000|Double Blind Phase|Not treated|1|||
131433490|NCT00430716|473211365|FG001|Double Blind Phase|Not treated|0|||
131433491|NCT00430716|473211366|FG002|Double Blind Phase|Not treated|0|||
131458910|NCT03110770|473311745|FG001|Overall Study|Lost to Follow-up|0|||
131458911|NCT03110770|473311746|FG002|Overall Study|Lost to Follow-up|0|||
131458912|NCT03110770|473311747|FG003|Overall Study|Lost to Follow-up|53|||
131458913|NCT03110770|473311748|FG004|Overall Study|Lost to Follow-up|45|||
131458914|NCT03110770|473311744|FG000|Overall Study|Investigator Decision|0|||
131458915|NCT03110770|473311745|FG001|Overall Study|Investigator Decision|0|||
131458916|NCT03110770|473311746|FG002|Overall Study|Investigator Decision|0|||
131433492|NCT00430716|473211364|FG000|Open Label Phase|Lost to Follow-up|1|||
131433493|NCT00430716|473211365|FG001|Open Label Phase|Lost to Follow-up|0|||
131433494|NCT00430716|473211366|FG002|Open Label Phase|Lost to Follow-up|1|||
131433495|NCT00430716|473211364|FG000|Open Label Phase|No longer willing to participate|0|||
131433496|NCT00430716|473211365|FG001|Open Label Phase|No longer willing to participate|1|||
131433497|NCT00430716|473211366|FG002|Open Label Phase|No longer willing to participate|1|||
131433498|NCT00430716|473211364|FG000|Open Label Phase|Other|3|||
131433499|NCT00430716|473211365|FG001|Open Label Phase|Other|1|||
131433500|NCT00430716|473211366|FG002|Open Label Phase|Other|1|||
131433501|NCT00430716|473211364|FG000|Open Label Phase|Protocol Violation|1|||
131433502|NCT00430716|473211365|FG001|Open Label Phase|Protocol Violation|0|||
131433503|NCT00430716|473211366|FG002|Open Label Phase|Protocol Violation|0|||
131433504|NCT00430716|473211364|FG000|Open Label Phase|Study terminated by sponsor|4|||
131433505|NCT00430716|473211365|FG001|Open Label Phase|Study terminated by sponsor|5|||
131433506|NCT00430716|473211366|FG002|Open Label Phase|Study terminated by sponsor|4|||
131433507|NCT01329978|473211370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
131433508|NCT01329978|473211371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
131433509|NCT01329978|473211372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
131433510|NCT01329978|473211373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
131433511|NCT01329978|473211374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
131433512|NCT01329978|473211370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
131433513|NCT01329978|473211371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
131433514|NCT01329978|473211372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
131433515|NCT01329978|473211373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
131433516|NCT01329978|473211374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
131433517|NCT01329978|473211370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
131433518|NCT01329978|473211371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
131433519|NCT01329978|473211372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
131433520|NCT01329978|473211373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
131433521|NCT01329978|473211374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
131433522|NCT01329978|473211370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
131433523|NCT01329978|473211371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
131433524|NCT01329978|473211372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
131433525|NCT01329978|473211373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
131433526|NCT01329978|473211374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
131433527|NCT01329978|473211370|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
131433528|NCT01329978|473211371|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
131458917|NCT03110770|473311747|FG003|Overall Study|Investigator Decision|5|||
131458918|NCT03110770|473311748|FG004|Overall Study|Investigator Decision|3|||
131458919|NCT03110770|473311744|FG000|Overall Study|Withdrawal by Subject|0|||
131458920|NCT03110770|473311745|FG001|Overall Study|Withdrawal by Subject|0|||
131458921|NCT03110770|473311746|FG002|Overall Study|Withdrawal by Subject|0|||
131458922|NCT03110770|473311747|FG003|Overall Study|Withdrawal by Subject|24|||
131458923|NCT03110770|473311748|FG004|Overall Study|Withdrawal by Subject|24|||
131433529|NCT01329978|473211372|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
131433530|NCT01329978|473211373|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
131433531|NCT01329978|473211374|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
131433532|NCT01329978|473211370|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
131433533|NCT01329978|473211371|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
131433534|NCT01329978|473211372|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
131433535|NCT01329978|473211373|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
131433536|NCT01329978|473211374|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
131433537|NCT01329978|473211370|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
131458924|NCT03110770|473311744|FG000|Overall Study|Moved from area|5|||
131458925|NCT03110770|473311745|FG001|Overall Study|Moved from area|0|||
131458926|NCT03110770|473311746|FG002|Overall Study|Moved from area|2|||
131433538|NCT01329978|473211371|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
131433539|NCT01329978|473211372|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
131433540|NCT01329978|473211373|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
131433541|NCT01329978|473211374|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
131433542|NCT03087513|473211385|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
131433543|NCT04303559|473211386|FG000|Overall Study|Study closed due to poor enrollment.|1|||
131433544|NCT01987102|473211389|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
131458927|NCT03110770|473311747|FG003|Overall Study|Moved from area|42|||
131433545|NCT01987102|473211390|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
131433546|NCT01987102|473211389|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
131458928|NCT03110770|473311748|FG004|Overall Study|Moved from area|43|||
131433547|NCT01987102|473211390|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
131433548|NCT01987102|473211389|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
131433549|NCT01987102|473211390|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
131433550|NCT01987102|473211389|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
131433551|NCT01987102|473211390|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
131433552|NCT01987102|473211389|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
131433553|NCT01987102|473211390|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
131433554|NCT01987102|473211389|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
131433555|NCT01987102|473211390|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
131433556|NCT01712204|473211409|FG000|Overall Study|Adverse Event|3|||
131433557|NCT01712204|473211410|FG001|Overall Study|Adverse Event|1|||
131433558|NCT01712204|473211409|FG000|Overall Study|Withdrawal by Subject|3|||
131433559|NCT01712204|473211410|FG001|Overall Study|Withdrawal by Subject|3|||
131433560|NCT01712204|473211409|FG000|Overall Study|Lost to Follow-up|1|||
131433561|NCT01712204|473211410|FG001|Overall Study|Lost to Follow-up|0|||
131433562|NCT01712204|473211409|FG000|Overall Study|Protocol Violation|1|||
131433563|NCT01712204|473211410|FG001|Overall Study|Protocol Violation|1|||
131433564|NCT01389882|473213102|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
131433565|NCT01389882|473213103|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
131433566|NCT01389882|473213102|FG000|Overall Study|Withdrawal by Subject|0|||
131433567|NCT01389882|473213103|FG001|Overall Study|Withdrawal by Subject|1|||
131433568|NCT03790111|473213104|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
131433569|NCT02796677|473213111|FG000|Overall Study|Adverse Event|11|||
131433570|NCT02796677|473213112|FG001|Overall Study|Adverse Event|22|||
131433571|NCT02796677|473213113|FG002|Overall Study|Adverse Event|14|||
131433572|NCT02796677|473213114|FG003|Overall Study|Adverse Event|14|||
131433573|NCT02796677|473213111|FG000|Overall Study|Protocol Violation|7|||
131433574|NCT02796677|473213112|FG001|Overall Study|Protocol Violation|5|||
131433575|NCT02796677|473213113|FG002|Overall Study|Protocol Violation|4|||
131433576|NCT02796677|473213114|FG003|Overall Study|Protocol Violation|8|||
131433577|NCT02796677|473213111|FG000|Overall Study|Lost to Follow-up|1|||
131433578|NCT02796677|473213112|FG001|Overall Study|Lost to Follow-up|5|||
131433579|NCT02796677|473213113|FG002|Overall Study|Lost to Follow-up|2|||
131433580|NCT02796677|473213114|FG003|Overall Study|Lost to Follow-up|2|||
131433581|NCT02796677|473213111|FG000|Overall Study|Lack of Efficacy|7|||
131433582|NCT02796677|473213112|FG001|Overall Study|Lack of Efficacy|9|||
131433583|NCT02796677|473213113|FG002|Overall Study|Lack of Efficacy|14|||
131433584|NCT02796677|473213114|FG003|Overall Study|Lack of Efficacy|20|||
131433585|NCT02796677|473213111|FG000|Overall Study|Withdrawal by Subject|4|||
131433586|NCT02796677|473213112|FG001|Overall Study|Withdrawal by Subject|14|||
131433587|NCT02796677|473213113|FG002|Overall Study|Withdrawal by Subject|6|||
131433588|NCT02796677|473213114|FG003|Overall Study|Withdrawal by Subject|7|||
131433589|NCT02796677|473213111|FG000|Overall Study|Progressive disease|6|||
131433590|NCT02796677|473213112|FG001|Overall Study|Progressive disease|15|||
131433591|NCT02796677|473213113|FG002|Overall Study|Progressive disease|13|||
131433592|NCT02796677|473213114|FG003|Overall Study|Progressive disease|18|||
131433593|NCT02796677|473213111|FG000|Overall Study|Reason not mentioned|2|||
131433594|NCT02796677|473213112|FG001|Overall Study|Reason not mentioned|3|||
131433595|NCT02796677|473213113|FG002|Overall Study|Reason not mentioned|0|||
131433596|NCT02796677|473213114|FG003|Overall Study|Reason not mentioned|5|||
131433597|NCT03811340|473213117|FG000|Overall Study|subjects did not complete the survey.|90|||
131433598|NCT01045967|473213118|FG000|Second Intervention|Protocol Violation|0|||
131433599|NCT01045967|473213119|FG001|Second Intervention|Protocol Violation|1|||
131433600|NCT01777308|473213120|FG000|Overall Study|Withdrawal by Subject|5|||
131433601|NCT01777308|473213121|FG001|Overall Study|Withdrawal by Subject|1|||
131433602|NCT01777308|473213120|FG000|Overall Study|Migrated/moved from study area|1|||
131433603|NCT01777308|473213121|FG001|Overall Study|Migrated/moved from study area|0|||
131433604|NCT01777308|473213120|FG000|Overall Study|Lost to Follow-up|7|||
131433605|NCT01777308|473213121|FG001|Overall Study|Lost to Follow-up|2|||
131433606|NCT01777308|473213120|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
131433607|NCT01777308|473213121|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
131458929|NCT03110770|473311744|FG000|Overall Study|Illness/Injury unrelated to product|0|||
131433608|NCT03212326|473213122|FG000|Overall Study|Physician Decision|4|||
131433609|NCT00383786|473213134|FG000|Overall Study|Protocol Violation|2|||
131433610|NCT00383786|473213135|FG001|Overall Study|Protocol Violation|6|||
131433611|NCT00383786|473213134|FG000|Overall Study|Withdrawal by Subject|2|||
131433612|NCT00383786|473213135|FG001|Overall Study|Withdrawal by Subject|5|||
131433613|NCT00383786|473213134|FG000|Overall Study|Physician Decision|0|||
131433614|NCT00383786|473213135|FG001|Overall Study|Physician Decision|1|||
131433615|NCT00985673|473213136|FG000|Overall Study|Lost to Follow-up|6|||
131433616|NCT00985673|473213137|FG001|Overall Study|Lost to Follow-up|7|||
131433617|NCT00985673|473213138|FG002|Overall Study|Lost to Follow-up|6|||
131433618|NCT00985673|473213139|FG003|Overall Study|Lost to Follow-up|10|||
131433619|NCT00985673|473213140|FG004|Overall Study|Lost to Follow-up|5|||
131458930|NCT03110770|473311745|FG001|Overall Study|Illness/Injury unrelated to product|0|||
131458931|NCT03110770|473311746|FG002|Overall Study|Illness/Injury unrelated to product|0|||
131433620|NCT00985673|473213141|FG005|Overall Study|Lost to Follow-up|3|||
131433621|NCT00985673|473213136|FG000|Overall Study|Withdrawal by Subject|0|||
131433622|NCT00985673|473213137|FG001|Overall Study|Withdrawal by Subject|4|||
131433623|NCT00985673|473213138|FG002|Overall Study|Withdrawal by Subject|5|||
131433624|NCT00985673|473213139|FG003|Overall Study|Withdrawal by Subject|2|||
131433625|NCT00985673|473213140|FG004|Overall Study|Withdrawal by Subject|2|||
131433626|NCT00985673|473213141|FG005|Overall Study|Withdrawal by Subject|3|||
131433627|NCT00985673|473213136|FG000|Overall Study|Other|1|||
131458932|NCT03110770|473311747|FG003|Overall Study|Illness/Injury unrelated to product|0|||
131458933|NCT03110770|473311748|FG004|Overall Study|Illness/Injury unrelated to product|1|||
131458934|NCT01767142|473311751|FG000|Overall Study|Lost to Follow-up|3|||
131433628|NCT00985673|473213137|FG001|Overall Study|Other|0|||
131433629|NCT00985673|473213138|FG002|Overall Study|Other|1|||
131433630|NCT00985673|473213139|FG003|Overall Study|Other|0|||
131433631|NCT00985673|473213140|FG004|Overall Study|Other|1|||
131433632|NCT00985673|473213141|FG005|Overall Study|Other|0|||
131433633|NCT02252146|473213142|FG000|Overall Study|Lack of Efficacy|4|||
131433634|NCT02252146|473213142|FG000|Overall Study|Entered hospice care|1|||
131433635|NCT02252146|473213142|FG000|Overall Study|Inability to travel to study site|1|||
131433636|NCT00531284|473213145|FG000|Overall Study|Progressive Disease|1|||
131433637|NCT00531284|473213146|FG001|Overall Study|Progressive Disease|3|||
131433638|NCT00531284|473213147|FG002|Overall Study|Progressive Disease|5|||
131433639|NCT00531284|473213148|FG003|Overall Study|Progressive Disease|42|||
131433640|NCT00531284|473213149|FG004|Overall Study|Progressive Disease|4|||
131433641|NCT00531284|473213150|FG005|Overall Study|Progressive Disease|4|||
131433642|NCT00531284|473213151|FG006|Overall Study|Progressive Disease|3|||
131433643|NCT00531284|473213152|FG007|Overall Study|Progressive Disease|8|||
131433644|NCT00531284|473213153|FG008|Overall Study|Progressive Disease|6|||
131433645|NCT00531284|473213154|FG009|Overall Study|Progressive Disease|3|||
131433646|NCT00531284|473213155|FG010|Overall Study|Progressive Disease|3|||
131433647|NCT00531284|473213156|FG011|Overall Study|Progressive Disease|14|||
131433648|NCT00531284|473213157|FG012|Overall Study|Progressive Disease|2|||
131433649|NCT00531284|473213158|FG013|Overall Study|Progressive Disease|1|||
131433650|NCT00531284|473213159|FG014|Overall Study|Progressive Disease|2|||
131433651|NCT00531284|473213160|FG015|Overall Study|Progressive Disease|11|||
131433652|NCT00531284|473213161|FG016|Overall Study|Progressive Disease|5|||
131433653|NCT00531284|473213145|FG000|Overall Study|Adverse Event|0|||
131433654|NCT00531284|473213146|FG001|Overall Study|Adverse Event|1|||
131433655|NCT00531284|473213147|FG002|Overall Study|Adverse Event|1|||
131433656|NCT00531284|473213148|FG003|Overall Study|Adverse Event|7|||
131433657|NCT00531284|473213149|FG004|Overall Study|Adverse Event|0|||
131433658|NCT00531284|473213150|FG005|Overall Study|Adverse Event|2|||
131433659|NCT00531284|473213151|FG006|Overall Study|Adverse Event|3|||
131433660|NCT00531284|473213152|FG007|Overall Study|Adverse Event|2|||
131433661|NCT00531284|473213153|FG008|Overall Study|Adverse Event|3|||
131433662|NCT00531284|473213154|FG009|Overall Study|Adverse Event|0|||
131433663|NCT00531284|473213155|FG010|Overall Study|Adverse Event|0|||
131433664|NCT00531284|473213156|FG011|Overall Study|Adverse Event|5|||
131433665|NCT00531284|473213157|FG012|Overall Study|Adverse Event|0|||
131433666|NCT00531284|473213158|FG013|Overall Study|Adverse Event|1|||
131433667|NCT00531284|473213159|FG014|Overall Study|Adverse Event|1|||
131433668|NCT00531284|473213160|FG015|Overall Study|Adverse Event|0|||
131433669|NCT00531284|473213161|FG016|Overall Study|Adverse Event|2|||
131433670|NCT00531284|473213145|FG000|Overall Study|Withdrawal by Subject|1|||
131433671|NCT00531284|473213146|FG001|Overall Study|Withdrawal by Subject|0|||
131433672|NCT00531284|473213147|FG002|Overall Study|Withdrawal by Subject|0|||
131433673|NCT00531284|473213148|FG003|Overall Study|Withdrawal by Subject|4|||
131433674|NCT00531284|473213149|FG004|Overall Study|Withdrawal by Subject|0|||
131433675|NCT00531284|473213150|FG005|Overall Study|Withdrawal by Subject|0|||
131433676|NCT00531284|473213151|FG006|Overall Study|Withdrawal by Subject|0|||
131433677|NCT00531284|473213152|FG007|Overall Study|Withdrawal by Subject|0|||
131433678|NCT00531284|473213153|FG008|Overall Study|Withdrawal by Subject|0|||
131433679|NCT00531284|473213154|FG009|Overall Study|Withdrawal by Subject|0|||
131433680|NCT00531284|473213155|FG010|Overall Study|Withdrawal by Subject|0|||
131433681|NCT00531284|473213156|FG011|Overall Study|Withdrawal by Subject|3|||
131433682|NCT00531284|473213157|FG012|Overall Study|Withdrawal by Subject|0|||
131433683|NCT00531284|473213158|FG013|Overall Study|Withdrawal by Subject|1|||
131433684|NCT00531284|473213159|FG014|Overall Study|Withdrawal by Subject|0|||
131433685|NCT00531284|473213160|FG015|Overall Study|Withdrawal by Subject|1|||
131433686|NCT00531284|473213161|FG016|Overall Study|Withdrawal by Subject|1|||
131433687|NCT00531284|473213145|FG000|Overall Study|Other|1|||
131433688|NCT00531284|473213146|FG001|Overall Study|Other|0|||
131433689|NCT00531284|473213147|FG002|Overall Study|Other|0|||
131433690|NCT00531284|473213148|FG003|Overall Study|Other|10|||
131433691|NCT00531284|473213149|FG004|Overall Study|Other|2|||
131433692|NCT00531284|473213150|FG005|Overall Study|Other|1|||
131433693|NCT00531284|473213151|FG006|Overall Study|Other|0|||
131433694|NCT00531284|473213152|FG007|Overall Study|Other|0|||
131433695|NCT00531284|473213153|FG008|Overall Study|Other|2|||
131433696|NCT00531284|473213154|FG009|Overall Study|Other|1|||
131433697|NCT00531284|473213155|FG010|Overall Study|Other|0|||
131433698|NCT00531284|473213156|FG011|Overall Study|Other|2|||
131433699|NCT00531284|473213157|FG012|Overall Study|Other|0|||
131433700|NCT00531284|473213158|FG013|Overall Study|Other|0|||
131433701|NCT00531284|473213159|FG014|Overall Study|Other|1|||
131433702|NCT00531284|473213160|FG015|Overall Study|Other|0|||
131433703|NCT00531284|473213161|FG016|Overall Study|Other|0|||
131433704|NCT02219464|473213163|FG000|Overall Study|Withdrawal by Subject|1|||
131433705|NCT02219464|473213164|FG001|Overall Study|Withdrawal by Subject|0|||
131433706|NCT02219464|473213163|FG000|Overall Study|case cancelled|1|||
131433707|NCT02219464|473213164|FG001|Overall Study|case cancelled|0|||
131433708|NCT02219464|473213163|FG000|Overall Study|catheter malfunction|1|||
131433709|NCT02219464|473213164|FG001|Overall Study|catheter malfunction|0|||
131433710|NCT00984256|473213165|FG000|Overall Study|Withdrawal by Subject|0|||
131433711|NCT00984256|473213166|FG001|Overall Study|Withdrawal by Subject|1|||
131433712|NCT03057496|473213167|FG000|Overall Study|Withdrawal by Subject|8|||
131433713|NCT03057496|473213167|FG000|Overall Study|Lost to Follow-up|5|||
131433714|NCT03057496|473213167|FG000|Overall Study|Did not use device during home trial|3|||
131433715|NCT03057496|473213167|FG000|Overall Study|Device failure|2|||
131433716|NCT02723773|473213175|FG000|Overall Study|Adverse Event|934|||
131433717|NCT02723773|473213176|FG001|Overall Study|Adverse Event|3|||
131433718|NCT02723773|473213177|FG002|Overall Study|Adverse Event|1|||
131433719|NCT02723773|473213178|FG003|Overall Study|Adverse Event|9|||
131433720|NCT02723773|473213175|FG000|Overall Study|Protocol Violation|1|||
131433721|NCT02723773|473213176|FG001|Overall Study|Protocol Violation|0|||
131433722|NCT02723773|473213177|FG002|Overall Study|Protocol Violation|0|||
131433723|NCT02723773|473213178|FG003|Overall Study|Protocol Violation|0|||
131433724|NCT02723773|473213175|FG000|Overall Study|Withdrawal by Subject|360|||
131433725|NCT02723773|473213176|FG001|Overall Study|Withdrawal by Subject|5|||
131433726|NCT02723773|473213177|FG002|Overall Study|Withdrawal by Subject|6|||
131433727|NCT02723773|473213178|FG003|Overall Study|Withdrawal by Subject|10|||
131433728|NCT02723773|473213175|FG000|Overall Study|Migrated/moved from study area|37|||
131433729|NCT02723773|473213176|FG001|Overall Study|Migrated/moved from study area|0|||
131433730|NCT02723773|473213177|FG002|Overall Study|Migrated/moved from study area|0|||
131433731|NCT02723773|473213178|FG003|Overall Study|Migrated/moved from study area|1|||
131433732|NCT02723773|473213175|FG000|Overall Study|Lost to Follow-up|198|||
131433733|NCT02723773|473213176|FG001|Overall Study|Lost to Follow-up|0|||
131433734|NCT02723773|473213177|FG002|Overall Study|Lost to Follow-up|0|||
131433735|NCT02723773|473213178|FG003|Overall Study|Lost to Follow-up|0|||
131433736|NCT02723773|473213175|FG000|Overall Study|Other|189|||
131433737|NCT02723773|473213176|FG001|Overall Study|Other|1|||
131433738|NCT02723773|473213177|FG002|Overall Study|Other|2|||
131433739|NCT02723773|473213178|FG003|Overall Study|Other|2|||
131433740|NCT00354679|473213195|FG000|Overall Study|Patient Not Treated|1|||
131433741|NCT02576639|473213198|FG000|Overall Study|Withdrawal by Subject|1|||
131433742|NCT02576639|473213199|FG001|Overall Study|Withdrawal by Subject|2|||
131433743|NCT02576639|473213200|FG002|Overall Study|Withdrawal by Subject|1|||
131433744|NCT02576639|473213201|FG003|Overall Study|Withdrawal by Subject|0|||
131433745|NCT02576639|473213202|FG004|Overall Study|Withdrawal by Subject|1|||
131433746|NCT02576639|473213198|FG000|Overall Study|Adverse Event|1|||
131433747|NCT02576639|473213199|FG001|Overall Study|Adverse Event|0|||
131433748|NCT02576639|473213200|FG002|Overall Study|Adverse Event|1|||
131433749|NCT02576639|473213201|FG003|Overall Study|Adverse Event|1|||
131433750|NCT02576639|473213202|FG004|Overall Study|Adverse Event|2|||
131433751|NCT02576639|473213198|FG000|Overall Study|Physician Decision|0|||
131433752|NCT02576639|473213199|FG001|Overall Study|Physician Decision|0|||
131433753|NCT02576639|473213200|FG002|Overall Study|Physician Decision|0|||
131433754|NCT02576639|473213201|FG003|Overall Study|Physician Decision|0|||
131433755|NCT02576639|473213202|FG004|Overall Study|Physician Decision|1|||
131433756|NCT01135134|473213203|FG000|Overall Study|Adverse Event|1|||
131433757|NCT01135134|473213204|FG001|Overall Study|Adverse Event|1|||
131458935|NCT03206788|473311755|FG000|Overall Study|Withdrawal by Subject|0|||
131458936|NCT03206788|473311756|FG001|Overall Study|Withdrawal by Subject|1|||
131458937|NCT03206788|473311755|FG000|Overall Study|Adverse Event|0|||
131458938|NCT03206788|473311756|FG001|Overall Study|Adverse Event|1|||
131458939|NCT03206788|473311755|FG000|Overall Study|Physician Decision|0|||
131458940|NCT03206788|473311756|FG001|Overall Study|Physician Decision|1|||
131458941|NCT01625260|473311757|FG000|Overall Study|Adverse Event|3|||
131458942|NCT01625260|473311758|FG001|Overall Study|Adverse Event|0|||
131458943|NCT01625260|473311757|FG000|Overall Study|Study Terminated by Investigator|2|||
131458944|NCT01625260|473311758|FG001|Overall Study|Study Terminated by Investigator|0|||
131433758|NCT01135134|473213203|FG000|Overall Study|Did not meet protocol eligibility|1|||
131433759|NCT01135134|473213204|FG001|Overall Study|Did not meet protocol eligibility|0|||
131433760|NCT00255190|473213205|FG000|Overall Study|Adverse Event|17|||
131433761|NCT00255190|473213206|FG001|Overall Study|Adverse Event|36|||
131433762|NCT00255190|473213205|FG000|Overall Study|Protocol Violation|2|||
131433763|NCT00255190|473213206|FG001|Overall Study|Protocol Violation|2|||
131433764|NCT00255190|473213205|FG000|Overall Study|Lost to Follow-up|10|||
131458945|NCT01625260|473311757|FG000|Overall Study|Disease Progression|2|||
131458946|NCT01625260|473311758|FG001|Overall Study|Disease Progression|0|||
131458947|NCT01625260|473311757|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
131458948|NCT01625260|473311758|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
131458949|NCT03899805|473311759|FG000|Overall Study|Physician Decision|3|||
131458950|NCT03899805|473311760|FG001|Overall Study|Physician Decision|0|||
131458951|NCT03899805|473311761|FG002|Overall Study|Physician Decision|2|||
131458952|NCT03899805|473311759|FG000|Overall Study|Withdrawal by Subject|1|||
131458953|NCT03899805|473311760|FG001|Overall Study|Withdrawal by Subject|0|||
131458954|NCT03899805|473311761|FG002|Overall Study|Withdrawal by Subject|2|||
131458955|NCT03899805|473311759|FG000|Overall Study|Progressive Disease|10|||
131458956|NCT03899805|473311760|FG001|Overall Study|Progressive Disease|18|||
131458957|NCT03899805|473311761|FG002|Overall Study|Progressive Disease|12|||
131458958|NCT03899805|473311759|FG000|Overall Study|Adverse Event|3|||
131458959|NCT03899805|473311760|FG001|Overall Study|Adverse Event|1|||
131458960|NCT03899805|473311761|FG002|Overall Study|Adverse Event|0|||
131458961|NCT03899805|473311759|FG000|Overall Study|Death|2|||
131458962|NCT03899805|473311760|FG001|Overall Study|Death|0|||
131458963|NCT03899805|473311761|FG002|Overall Study|Death|0|||
131458964|NCT03899805|473311759|FG000|Overall Study|Came off for surgery|0|||
131458965|NCT03899805|473311760|FG001|Overall Study|Came off for surgery|0|||
131458966|NCT03899805|473311761|FG002|Overall Study|Came off for surgery|1|||
131458967|NCT03083990|473311764|FG000|Overall Study|Adverse Event|1|||
131458968|NCT03083990|473311765|FG001|Overall Study|Adverse Event|0|||
131458969|NCT01018810|473311766|FG000|Overall Study|Withdrawal by Subject|0|||
131458970|NCT01018810|473311767|FG001|Overall Study|Withdrawal by Subject|1|||
131458971|NCT01018810|473311768|FG002|Overall Study|Withdrawal by Subject|0|||
131458972|NCT01018810|473311769|FG003|Overall Study|Withdrawal by Subject|0|||
131458973|NCT01018810|473311770|FG004|Overall Study|Withdrawal by Subject|0|||
131458974|NCT01018810|473311766|FG000|Overall Study|Sponsor Decision|2|||
131458975|NCT01018810|473311767|FG001|Overall Study|Sponsor Decision|0|||
131458976|NCT01018810|473311768|FG002|Overall Study|Sponsor Decision|1|||
131458977|NCT01018810|473311769|FG003|Overall Study|Sponsor Decision|1|||
131458978|NCT01018810|473311770|FG004|Overall Study|Sponsor Decision|1|||
131458979|NCT03672097|473311771|FG000|Period 1|Withdrawal by Subject|2|||
131458980|NCT03672097|473311771|FG000|Period 1|Adverse Event|1|||
131458981|NCT03672097|473311771|FG000|Period 1|Did not receive treatment|1|||
131458982|NCT03672097|473311771|FG000|Period 2|Withdrawal by Subject|3|||
131458983|NCT03672097|473311771|FG000|Period 2|Other|1|||
131458984|NCT03087617|473311772|FG000|Overall Study|Lost to Follow-up|32|||
131458985|NCT03087617|473311773|FG001|Overall Study|Lost to Follow-up|30|||
131458986|NCT03087617|473311774|FG002|Overall Study|Lost to Follow-up|30|||
131458987|NCT03087617|473311775|FG003|Overall Study|Lost to Follow-up|39|||
131458988|NCT04450381|473311777|FG000|Overall Study|Protocol Violation|4|||
131458989|NCT04450381|473311777|FG000|Overall Study|Wrong device setting|2|||
131458990|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
131458991|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
131458992|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Adverse Event|7|||
131458993|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Adverse Event|6|||
131458994|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
131458995|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
131458996|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Physician Decision|4|||
131458997|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Physician Decision|4|||
131458998|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
131458999|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
131459000|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
131459001|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
131459002|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
131459003|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
131459004|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Non-compliance|1|||
131459005|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Non-compliance|0|||
131459006|NCT00470834|473311778|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
131459007|NCT00470834|473311779|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
131459008|NCT00470834|473311778|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
131459009|NCT00470834|473311779|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
131459010|NCT00470834|473311778|FG000|Extension Period (24 Months)|Adverse Event|3|||
131459011|NCT00470834|473311779|FG001|Extension Period (24 Months)|Adverse Event|4|||
131459012|NCT00470834|473311778|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
131459013|NCT00470834|473311779|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
131459014|NCT00470834|473311778|FG000|Extension Period (24 Months)|Physician Decision|4|||
131459015|NCT00470834|473311779|FG001|Extension Period (24 Months)|Physician Decision|3|||
131459016|NCT00470834|473311778|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
131459017|NCT00470834|473311779|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
131459018|NCT00470834|473311778|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
131459019|NCT00470834|473311779|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
131459020|NCT00470834|473311778|FG000|Extension Period (24 Months)|Non-compliance|0|||
131459021|NCT00470834|473311779|FG001|Extension Period (24 Months)|Non-compliance|1|||
131459022|NCT00470834|473311778|FG000|Extension Period (24 Months)|Disease Progression|0|||
131459023|NCT00470834|473311779|FG001|Extension Period (24 Months)|Disease Progression|1|||
131459024|NCT00862641|473311785|FG000|Overall Study|Randomized, but drug not received|1|||
131459025|NCT00862641|473311786|FG001|Overall Study|Randomized, but drug not received|4|||
131459026|NCT00862641|473311787|FG002|Overall Study|Randomized, but drug not received|1|||
131459027|NCT00862641|473311788|FG003|Overall Study|Randomized, but drug not received|4|||
131459028|NCT02365480|473311789|FG000|Overall Study|Withdrawal by Subject|2|||
131459029|NCT02365480|473311790|FG001|Overall Study|Withdrawal by Subject|0|||
131459030|NCT04534686|473311791|FG000|Baseline Measurement|Lost to Follow-up|4|||
131459031|NCT04534686|473311792|FG001|Baseline Measurement|Lost to Follow-up|6|||
131459032|NCT04534686|473311791|FG000|Baseline Measurement|Withdrawal by Subject|3|||
131459033|NCT04534686|473311792|FG001|Baseline Measurement|Withdrawal by Subject|1|||
131459034|NCT04534686|473311791|FG000|Intervention|Withdrawal by Subject|2|||
131459035|NCT04534686|473311792|FG001|Intervention|Withdrawal by Subject|2|||
131459036|NCT01781299|473311796|FG000|Overall Study|Withdrawal by Subject|0|||
131459037|NCT01781299|473311797|FG001|Overall Study|Withdrawal by Subject|1|||
131459038|NCT01798849|473311801|FG000|Overall Study|Physician Decision|0|||
131459039|NCT01798849|473311802|FG001|Overall Study|Physician Decision|0|||
131459040|NCT01798849|473311803|FG002|Overall Study|Physician Decision|1|||
131459041|NCT02636361|473311804|FG000|Period 4|Physician Decision|0|||
131459042|NCT02636361|473311805|FG001|Period 4|Physician Decision|0|||
131459043|NCT02636361|473311806|FG002|Period 4|Physician Decision|0|||
131459044|NCT02636361|473311807|FG003|Period 4|Physician Decision|1|||
131459045|NCT02636361|473311808|FG004|Period 4|Physician Decision|0|||
131459046|NCT02032238|473311809|FG000|Overall Study|Lost to Follow-up|2|||
131459047|NCT02032238|473311810|FG001|Overall Study|Lost to Follow-up|0|||
131459048|NCT00228553|473311815|FG000|Overall Study|Adverse Event|112|||
131459049|NCT00228553|473311815|FG000|Overall Study|Lack of Efficacy|34|||
131459050|NCT00228553|473311815|FG000|Overall Study|Lost to Follow-up|67|||
131459051|NCT00228553|473311815|FG000|Overall Study|Physician Decision|48|||
131459052|NCT00228553|473311815|FG000|Overall Study|Protocol Violation|6|||
131459053|NCT00228553|473311815|FG000|Overall Study|Withdrawal by Subject|115|||
131459054|NCT00228553|473311815|FG000|Overall Study|Pregnancy|2|||
131459055|NCT00228553|473311815|FG000|Overall Study|Miscellaneous|46|||
131459056|NCT02720042|473311821|FG000|Overall Study|Death|3|||
131459057|NCT02720042|473311821|FG000|Overall Study|Lost to Follow-up|4|||
131459058|NCT02720042|473311821|FG000|Overall Study|Withdrawal by Subject|1|||
131459059|NCT02720042|473311821|FG000|Overall Study|Physician Decision|3|||
131459060|NCT02720042|473311821|FG000|Overall Study|Phasix Mesh explanted|1|||
131459061|NCT02720042|473311821|FG000|Overall Study|unable due to non-study-related illness|3|||
131459062|NCT00246740|473311824|FG000|Initial Enrollment|Death|1|||
131459063|NCT00246740|473311825|FG001|Initial Enrollment|Death|0|||
131459064|NCT00246740|473311824|FG000|Initial Enrollment|Additional surgery scheduled|0|||
131459065|NCT00246740|473311825|FG001|Initial Enrollment|Additional surgery scheduled|2|||
131459066|NCT00246740|473311824|FG000|Initial Enrollment|Surgery schedule change|4|||
131459067|NCT00246740|473311825|FG001|Initial Enrollment|Surgery schedule change|4|||
131459068|NCT00246740|473311824|FG000|Initial Enrollment|Other|1|||
131459069|NCT00246740|473311825|FG001|Initial Enrollment|Other|2|||
131459070|NCT00335764|473311828|FG000|Overall Study|wrong histology|1|||
131459071|NCT00335764|473311829|FG001|Overall Study|wrong histology|0|||
131459072|NCT00335764|473311830|FG002|Overall Study|wrong histology|0|||
131459073|NCT00335764|473311831|FG003|Overall Study|wrong histology|0|||
131459074|NCT00335764|473311832|FG004|Overall Study|wrong histology|1|||
131459075|NCT02466659|473311833|FG000|Overall Study|Lost to Follow-up|5|||
131459076|NCT02466659|473311834|FG001|Overall Study|Lost to Follow-up|2|||
131459077|NCT00929643|473311835|FG000|Overall Study|Protocol Violation|2|||
131459078|NCT01536392|473311838|FG000|Overall Study|Adverse Event|2|||
131459079|NCT01536392|473311839|FG001|Overall Study|Adverse Event|2|||
131459080|NCT01536392|473311838|FG000|Overall Study|Physician Decision|2|||
131459081|NCT01536392|473311839|FG001|Overall Study|Physician Decision|3|||
131459082|NCT01536392|473311838|FG000|Overall Study|Withdrawal by Subject|3|||
131459083|NCT01536392|473311839|FG001|Overall Study|Withdrawal by Subject|6|||
131459084|NCT01536392|473311838|FG000|Overall Study|Non Compliance|3|||
131459085|NCT01536392|473311839|FG001|Overall Study|Non Compliance|4|||
131459086|NCT01536392|473311838|FG000|Overall Study|Completed therapy early|3|||
131459087|NCT01536392|473311839|FG001|Overall Study|Completed therapy early|0|||
131459088|NCT00934440|473311840|FG000|Overall Study|Lost to Follow-up|1|||
131459089|NCT02873429|473311841|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
131459090|NCT02873429|473311842|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
131459091|NCT02873429|473311841|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
131459092|NCT02873429|473311842|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
131459093|NCT02873429|473311841|FG000|16 Weeks|Lost to Follow-up|3|||
131459094|NCT02873429|473311842|FG001|16 Weeks|Lost to Follow-up|0|||
131459095|NCT00744042|473311843|FG000|Overall Study|Withdrawal by Subject|1|||
131459096|NCT02228980|473311849|FG000|Overall Study|Adverse Event|14|||
131459097|NCT02228980|473311850|FG001|Overall Study|Adverse Event|0|||
131459098|NCT02228980|473311851|FG002|Overall Study|Adverse Event|0|||
131459099|NCT02228980|473311852|FG003|Overall Study|Adverse Event|0|||
131459100|NCT02228980|473311849|FG000|Overall Study|Protocol Violation|7|||
131459101|NCT02228980|473311850|FG001|Overall Study|Protocol Violation|0|||
131459102|NCT02228980|473311851|FG002|Overall Study|Protocol Violation|0|||
131459103|NCT02228980|473311852|FG003|Overall Study|Protocol Violation|0|||
131459104|NCT02228980|473311849|FG000|Overall Study|Withdrawal by Subject|3|||
131459105|NCT02228980|473311850|FG001|Overall Study|Withdrawal by Subject|3|||
131459106|NCT02228980|473311851|FG002|Overall Study|Withdrawal by Subject|2|||
131459107|NCT02228980|473311852|FG003|Overall Study|Withdrawal by Subject|3|||
131459108|NCT04629066|473311853|FG000|Overall Study|Lost to Follow-up|3|||
131459109|NCT04629066|473311854|FG001|Overall Study|Lost to Follow-up|2|||
131459110|NCT01808092|473311855|FG000|Overall Study|Death|39|||
131459111|NCT01808092|473311856|FG001|Overall Study|Death|29|||
131459112|NCT01808092|473311855|FG000|Overall Study|Lost to Follow-up|3|||
131459113|NCT01808092|473311856|FG001|Overall Study|Lost to Follow-up|7|||
131459114|NCT01808092|473311855|FG000|Overall Study|Withdrawal by Subject|9|||
131459115|NCT01808092|473311856|FG001|Overall Study|Withdrawal by Subject|4|||
131459116|NCT01808092|473311855|FG000|Overall Study|Other Eligibility criteria|3|||
131459117|NCT01808092|473311856|FG001|Overall Study|Other Eligibility criteria|5|||
131459118|NCT03952039|473311857|FG000|Overall Study|Adverse Event|22|||
131459119|NCT03952039|473311858|FG001|Overall Study|Adverse Event|8|||
131459120|NCT03952039|473311857|FG000|Overall Study|Withdrawal by Participant|17|||
131459121|NCT03952039|473311858|FG001|Overall Study|Withdrawal by Participant|12|||
131459122|NCT03952039|473311857|FG000|Overall Study|Death|13|||
131459123|NCT03952039|473311858|FG001|Overall Study|Death|6|||
131459124|NCT03952039|473311857|FG000|Overall Study|Lack of Efficacy|12|||
131459125|NCT03952039|473311858|FG001|Overall Study|Lack of Efficacy|2|||
131459126|NCT03952039|473311857|FG000|Overall Study|Physician Decision|9|||
131459127|NCT03952039|473311858|FG001|Overall Study|Physician Decision|3|||
131459128|NCT03952039|473311857|FG000|Overall Study|Progressive Disease|6|||
131459129|NCT03952039|473311858|FG001|Overall Study|Progressive Disease|4|||
131459130|NCT03952039|473311857|FG000|Overall Study|Other Reasons|12|||
131459131|NCT03952039|473311858|FG001|Overall Study|Other Reasons|4|||
131459132|NCT05009979|473311861|FG000|Overall Study|Withdrawal by Subject|1|||
131459133|NCT03844945|473314182|FG000|Overall Study|Adverse Event|1|||
131459134|NCT03844945|473314183|FG001|Overall Study|Adverse Event|1|||
131459135|NCT03844945|473314184|FG002|Overall Study|Adverse Event|4|||
131459136|NCT03844945|473314185|FG003|Overall Study|Adverse Event|0|||
131459137|NCT03844945|473314182|FG000|Overall Study|Withdrawal by Subject|0|||
131459138|NCT03844945|473314183|FG001|Overall Study|Withdrawal by Subject|0|||
131459139|NCT03844945|473314184|FG002|Overall Study|Withdrawal by Subject|1|||
131459140|NCT03844945|473314185|FG003|Overall Study|Withdrawal by Subject|0|||
131459141|NCT03844945|473314182|FG000|Overall Study|Lack of Efficacy|0|||
131459142|NCT03844945|473314183|FG001|Overall Study|Lack of Efficacy|0|||
131459143|NCT03844945|473314184|FG002|Overall Study|Lack of Efficacy|0|||
131459144|NCT03844945|473314185|FG003|Overall Study|Lack of Efficacy|1|||
131459145|NCT04473235|473314188|FG000|Overall Study|Lost to Follow-up|6|||
131459146|NCT04473235|473314189|FG001|Overall Study|Lost to Follow-up|5|||
131459147|NCT04473235|473314188|FG000|Overall Study|Declined continuation|2|||
131459148|NCT04473235|473314189|FG001|Overall Study|Declined continuation|0|||
131459149|NCT04473235|473314188|FG000|Overall Study|Physician Decision|1|||
131459150|NCT04473235|473314189|FG001|Overall Study|Physician Decision|1|||
131459151|NCT04473235|473314188|FG000|Overall Study|Protocol Violation|10|||
131459152|NCT04473235|473314189|FG001|Overall Study|Protocol Violation|6|||
131459153|NCT01754402|473314190|FG000|Overall Study|Death|0|||
131459154|NCT01754402|473314191|FG001|Overall Study|Death|0|||
131459155|NCT01754402|473314192|FG002|Overall Study|Death|1|||
131459156|NCT01754402|473314190|FG000|Overall Study|Adverse Event|2|||
131459157|NCT01754402|473314191|FG001|Overall Study|Adverse Event|2|||
131459158|NCT01754402|473314192|FG002|Overall Study|Adverse Event|1|||
131459159|NCT01754402|473314190|FG000|Overall Study|Withdrawal by Subject|0|||
131459160|NCT01754402|473314191|FG001|Overall Study|Withdrawal by Subject|0|||
131459161|NCT01754402|473314192|FG002|Overall Study|Withdrawal by Subject|1|||
131459162|NCT01754402|473314190|FG000|Overall Study|Lack of Efficacy|0|||
131459163|NCT01754402|473314191|FG001|Overall Study|Lack of Efficacy|0|||
131459164|NCT01754402|473314192|FG002|Overall Study|Lack of Efficacy|1|||
131459165|NCT01282463|473314193|FG000|Overall Study|Lost to Follow-up|1|||
131459166|NCT01282463|473314194|FG001|Overall Study|Lost to Follow-up|0|||
131459167|NCT01282463|473314195|FG002|Overall Study|Lost to Follow-up|0|||
131459168|NCT01282463|473314193|FG000|Overall Study|Withdrawal by Subject|6|||
131459169|NCT01282463|473314194|FG001|Overall Study|Withdrawal by Subject|2|||
131459170|NCT01282463|473314195|FG002|Overall Study|Withdrawal by Subject|3|||
131459171|NCT01282463|473314193|FG000|Overall Study|"Never Treated Death"|0|||
131459172|NCT01282463|473314194|FG001|Overall Study|"Never Treated Death"|1|||
131459173|NCT01282463|473314195|FG002|Overall Study|"Never Treated Death"|0|||
131459174|NCT01282463|473314193|FG000|Overall Study|"Never Treated PD"|0|||
131459175|NCT01282463|473314194|FG001|Overall Study|"Never Treated PD"|1|||
131459176|NCT01282463|473314195|FG002|Overall Study|"Never Treated PD"|0|||
131459177|NCT01282463|473314193|FG000|Overall Study|Protocol Violation|0|||
131459178|NCT01282463|473314194|FG001|Overall Study|Protocol Violation|0|||
131459179|NCT01282463|473314195|FG002|Overall Study|Protocol Violation|1|||
131459180|NCT01282463|473314193|FG000|Overall Study|Physician Decision|1|||
131459181|NCT01282463|473314194|FG001|Overall Study|Physician Decision|0|||
131459182|NCT01282463|473314195|FG002|Overall Study|Physician Decision|0|||
131459183|NCT02051933|473314198|FG000|Overall Study|Physician Decision|0|||
131459184|NCT02051933|473314199|FG001|Overall Study|Physician Decision|1|||
131459185|NCT01221285|473314200|FG000|Overall Study|Withdrawal by Subject|1|||
131459186|NCT02123251|473314201|FG000|Overall Study|Death|1|||
131459187|NCT02123251|473314202|FG001|Overall Study|Death|1|||
131459188|NCT02123251|473314201|FG000|Overall Study|Withdrawal by Subject|0|||
131459189|NCT02123251|473314202|FG001|Overall Study|Withdrawal by Subject|3|||
131459190|NCT02123251|473314201|FG000|Overall Study|Lost Medicaid eligibility|29|||
131459191|NCT02123251|473314202|FG001|Overall Study|Lost Medicaid eligibility|22|||
131459192|NCT02123251|473314201|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
131459193|NCT02123251|473314202|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
131459194|NCT00588861|473314203|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
131459195|NCT00588861|473314204|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
131459196|NCT00588861|473314203|FG000|6 Months|Patients did not return for follow-up|98|||
131459197|NCT00588861|473314204|FG001|6 Months|Patients did not return for follow-up|73|||
131459198|NCT00588861|473314203|FG000|1 Year|Patients did not return for follow-up|89|||
131459199|NCT00588861|473314204|FG001|1 Year|Patients did not return for follow-up|82|||
131459200|NCT00588861|473314203|FG000|2 Years|Patients did not return for follow-up|92|||
131459201|NCT00588861|473314204|FG001|2 Years|Patients did not return for follow-up|87|||
131459202|NCT00588861|473314203|FG000|4 Years|Patients did not return for follow-up|91|||
131459203|NCT00588861|473314204|FG001|4 Years|Patients did not return for follow-up|103|||
131459204|NCT00588861|473314203|FG000|6 Years|Patients did not return for follow-up|104|||
131459205|NCT00588861|473314204|FG001|6 Years|Patients did not return for follow-up|109|||
131459206|NCT00588861|473314203|FG000|8 Years|Patients did not return for follow-up|105|||
131459207|NCT00588861|473314204|FG001|8 Years|Patients did not return for follow-up|114|||
131459208|NCT00588861|473314203|FG000|10 Years|Incomplete due to study termination|107|||
131459209|NCT00588861|473314204|FG001|10 Years|Incomplete due to study termination|114|||
131459210|NCT01239992|473314205|FG000|Overall Study|Withdrawal by Subject|2|||
131459211|NCT02848729|473314208|FG000|Overall Study|Withdrawal by Subject|1|||
131459212|NCT02848729|473314209|FG001|Overall Study|Withdrawal by Subject|0|||
131459213|NCT02848729|473314208|FG000|Overall Study|Emesis|15|||
131459214|NCT02848729|473314209|FG001|Overall Study|Emesis|11|||
131459215|NCT00281658|473314216|FG000|Randomized Phase|Adverse Event|0|||
131459216|NCT00281658|473314217|FG001|Randomized Phase|Adverse Event|2|||
131459217|NCT00281658|473314218|FG002|Randomized Phase|Adverse Event|0|||
131459218|NCT00281658|473314219|FG003|Randomized Phase|Adverse Event|0|||
131459219|NCT00281658|473314216|FG000|Randomized Phase|Lost to Follow-up|34|||
131459220|NCT00281658|473314217|FG001|Randomized Phase|Lost to Follow-up|27|||
131459221|NCT00281658|473314218|FG002|Randomized Phase|Lost to Follow-up|0|||
131459222|NCT00281658|473314219|FG003|Randomized Phase|Lost to Follow-up|0|||
131459223|NCT00281658|473314216|FG000|Randomized Phase|Withdrawal by Subject|8|||
131459224|NCT00281658|473314217|FG001|Randomized Phase|Withdrawal by Subject|7|||
131459225|NCT00281658|473314218|FG002|Randomized Phase|Withdrawal by Subject|0|||
131459226|NCT00281658|473314219|FG003|Randomized Phase|Withdrawal by Subject|0|||
131459227|NCT00281658|473314216|FG000|Randomized Phase|Study closed/terminated|1|||
131459228|NCT00281658|473314217|FG001|Randomized Phase|Study closed/terminated|1|||
131459229|NCT00281658|473314218|FG002|Randomized Phase|Study closed/terminated|0|||
131459230|NCT00281658|473314219|FG003|Randomized Phase|Study closed/terminated|0|||
131459231|NCT00281658|473314216|FG000|Randomized Phase|Disease progression|36|||
131459232|NCT00281658|473314217|FG001|Randomized Phase|Disease progression|27|||
131459233|NCT00281658|473314218|FG002|Randomized Phase|Disease progression|0|||
131459234|NCT00281658|473314219|FG003|Randomized Phase|Disease progression|0|||
131459235|NCT00281658|473314216|FG000|Randomized Phase|Physician Decision|1|||
131459236|NCT00281658|473314217|FG001|Randomized Phase|Physician Decision|1|||
131459237|NCT00281658|473314218|FG002|Randomized Phase|Physician Decision|0|||
131459238|NCT00281658|473314219|FG003|Randomized Phase|Physician Decision|0|||
131459239|NCT00281658|473314216|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
131459240|NCT00281658|473314217|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
131459241|NCT00281658|473314218|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
131459242|NCT00281658|473314219|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
131459243|NCT00281658|473314216|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
131459244|NCT00281658|473314217|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
131459245|NCT00281658|473314218|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
131459246|NCT00281658|473314219|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
131459247|NCT00281658|473314216|FG000|Randomized Phase|Treatment ongoing|1|||
131459248|NCT00281658|473314217|FG001|Randomized Phase|Treatment ongoing|0|||
131459249|NCT00281658|473314218|FG002|Randomized Phase|Treatment ongoing|0|||
131459250|NCT00281658|473314219|FG003|Randomized Phase|Treatment ongoing|0|||
131459251|NCT00281658|473314216|FG000|Open Label Phase|Adverse Event|0|||
131459252|NCT00281658|473314217|FG001|Open Label Phase|Adverse Event|0|||
131459253|NCT00281658|473314218|FG002|Open Label Phase|Adverse Event|1|||
131459254|NCT00281658|473314219|FG003|Open Label Phase|Adverse Event|0|||
131459255|NCT00281658|473314216|FG000|Open Label Phase|Lost to Follow-up|0|||
131459256|NCT00281658|473314217|FG001|Open Label Phase|Lost to Follow-up|0|||
131459257|NCT00281658|473314218|FG002|Open Label Phase|Lost to Follow-up|16|||
131459258|NCT00281658|473314219|FG003|Open Label Phase|Lost to Follow-up|2|||
131459259|NCT00281658|473314216|FG000|Open Label Phase|Withdrawal by Subject|0|||
131459260|NCT00281658|473314217|FG001|Open Label Phase|Withdrawal by Subject|0|||
131459261|NCT00281658|473314218|FG002|Open Label Phase|Withdrawal by Subject|3|||
131459262|NCT00281658|473314219|FG003|Open Label Phase|Withdrawal by Subject|2|||
131459263|NCT00281658|473314216|FG000|Open Label Phase|Disease progression|0|||
131459264|NCT00281658|473314217|FG001|Open Label Phase|Disease progression|0|||
131459265|NCT00281658|473314218|FG002|Open Label Phase|Disease progression|18|||
131459266|NCT00281658|473314219|FG003|Open Label Phase|Disease progression|0|||
131459267|NCT00281658|473314216|FG000|Open Label Phase|Physician Decision|0|||
131459268|NCT00281658|473314217|FG001|Open Label Phase|Physician Decision|0|||
131459269|NCT00281658|473314218|FG002|Open Label Phase|Physician Decision|1|||
131459270|NCT00281658|473314219|FG003|Open Label Phase|Physician Decision|0|||
131459271|NCT00281658|473314216|FG000|Open Label Phase|Relocation of patient|0|||
131459272|NCT00281658|473314217|FG001|Open Label Phase|Relocation of patient|0|||
131459273|NCT00281658|473314218|FG002|Open Label Phase|Relocation of patient|1|||
131459274|NCT00281658|473314219|FG003|Open Label Phase|Relocation of patient|0|||
131459275|NCT00281658|473314216|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
131459276|NCT00281658|473314217|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
131459277|NCT00281658|473314218|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
131459278|NCT00281658|473314219|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
131459279|NCT02551991|473314224|FG000|Overall Study|Death|5|||
131459280|NCT02551991|473314225|FG001|Overall Study|Death|7|||
131459281|NCT02551991|473314226|FG002|Overall Study|Death|8|||
131459282|NCT02551991|473314227|FG003|Overall Study|Death|7|||
131459283|NCT02551991|473314228|FG004|Overall Study|Death|17|||
131459284|NCT02551991|473314224|FG000|Overall Study|Withdrawal by Subject|1|||
131459285|NCT02551991|473314225|FG001|Overall Study|Withdrawal by Subject|0|||
131459286|NCT02551991|473314226|FG002|Overall Study|Withdrawal by Subject|0|||
131459287|NCT02551991|473314227|FG003|Overall Study|Withdrawal by Subject|0|||
131459288|NCT02551991|473314228|FG004|Overall Study|Withdrawal by Subject|2|||
131459289|NCT02551991|473314224|FG000|Overall Study|Lost to Follow-up|0|||
131459290|NCT02551991|473314225|FG001|Overall Study|Lost to Follow-up|0|||
131459291|NCT02551991|473314226|FG002|Overall Study|Lost to Follow-up|1|||
131459292|NCT02551991|473314227|FG003|Overall Study|Lost to Follow-up|0|||
131459293|NCT02551991|473314228|FG004|Overall Study|Lost to Follow-up|0|||
131459294|NCT02551991|473314224|FG000|Overall Study|Sponsor Decision|1|||
131459295|NCT02551991|473314225|FG001|Overall Study|Sponsor Decision|0|||
131459296|NCT02551991|473314226|FG002|Overall Study|Sponsor Decision|1|||
131459297|NCT02551991|473314227|FG003|Overall Study|Sponsor Decision|0|||
131459298|NCT02551991|473314228|FG004|Overall Study|Sponsor Decision|5|||
131459299|NCT02551991|473314224|FG000|Overall Study|Other|0|||
131459300|NCT02551991|473314225|FG001|Overall Study|Other|0|||
131459301|NCT02551991|473314226|FG002|Overall Study|Other|0|||
131459302|NCT02551991|473314227|FG003|Overall Study|Other|0|||
131459303|NCT02551991|473314228|FG004|Overall Study|Other|1|||
131459304|NCT00395343|473314229|FG000|Overall Study|Adverse Event|13|||
131459305|NCT00395343|473314230|FG001|Overall Study|Adverse Event|5|||
131459306|NCT00395343|473314229|FG000|Overall Study|Lack of Efficacy|0|||
131459307|NCT00395343|473314230|FG001|Overall Study|Lack of Efficacy|1|||
131459308|NCT00395343|473314229|FG000|Overall Study|Lost to Follow-up|4|||
131459309|NCT00395343|473314230|FG001|Overall Study|Lost to Follow-up|4|||
131459310|NCT00395343|473314229|FG000|Overall Study|Physician Decision|2|||
131459311|NCT00395343|473314230|FG001|Overall Study|Physician Decision|4|||
131459312|NCT00395343|473314229|FG000|Overall Study|Protocol Violation|6|||
131459313|NCT00395343|473314230|FG001|Overall Study|Protocol Violation|8|||
131459314|NCT00395343|473314229|FG000|Overall Study|Withdrawal by Subject|11|||
131459315|NCT00395343|473314230|FG001|Overall Study|Withdrawal by Subject|12|||
131459316|NCT00395343|473314229|FG000|Overall Study|Other|5|||
131459317|NCT00395343|473314230|FG001|Overall Study|Other|2|||
131459318|NCT00387790|473314234|FG000|Overall Study|Adverse Event|5|||
131459319|NCT00387790|473314234|FG000|Overall Study|Lack of Efficacy|2|||
131459320|NCT00387790|473314234|FG000|Overall Study|Physician Decision|2|||
131459321|NCT00387790|473314234|FG000|Overall Study|Withdrawal by Subject|3|||
131459322|NCT00387790|473314234|FG000|Overall Study|Ineligible for study|2|||
131459323|NCT01874340|473314235|FG000|Overall Study|Study terminated by Sponsor|6|||
131459324|NCT01874340|473314236|FG001|Overall Study|Study terminated by Sponsor|8|||
131459325|NCT01874340|473314237|FG002|Overall Study|Study terminated by Sponsor|8|||
131459326|NCT01874340|473314238|FG003|Overall Study|Study terminated by Sponsor|4|||
131459327|NCT01874340|473314235|FG000|Overall Study|Withdrawal by Subject|0|||
131459328|NCT01874340|473314236|FG001|Overall Study|Withdrawal by Subject|0|||
131459329|NCT01874340|473314237|FG002|Overall Study|Withdrawal by Subject|0|||
131459330|NCT01874340|473314238|FG003|Overall Study|Withdrawal by Subject|1|||
131459331|NCT00966875|473314241|FG000|Part A|Adverse Event|2|||
131459332|NCT00966875|473314242|FG001|Part A|Adverse Event|1|||
131459333|NCT00966875|473314243|FG002|Part A|Adverse Event|0|||
131459334|NCT00966875|473314244|FG003|Part A|Adverse Event|1|||
131459335|NCT00966875|473314245|FG004|Part A|Adverse Event|0|||
131459336|NCT00966875|473314246|FG005|Part A|Adverse Event|1|||
131459337|NCT00966875|473314247|FG006|Part A|Adverse Event|0|||
131459338|NCT00966875|473314248|FG007|Part A|Adverse Event|3|||
131459339|NCT00966875|473314249|FG008|Part A|Adverse Event|3|||
131459340|NCT00966875|473314241|FG000|Part A|Entry Criteria|0|||
131459341|NCT00966875|473314242|FG001|Part A|Entry Criteria|0|||
131459342|NCT00966875|473314243|FG002|Part A|Entry Criteria|0|||
131459343|NCT00966875|473314244|FG003|Part A|Entry Criteria|0|||
131459344|NCT00966875|473314245|FG004|Part A|Entry Criteria|0|||
131459345|NCT00966875|473314246|FG005|Part A|Entry Criteria|2|||
131459346|NCT00966875|473314247|FG006|Part A|Entry Criteria|0|||
131459347|NCT00966875|473314248|FG007|Part A|Entry Criteria|0|||
131459348|NCT00966875|473314249|FG008|Part A|Entry Criteria|0|||
131459349|NCT00966875|473314241|FG000|Part A|Lack of Efficacy|0|||
131459350|NCT00966875|473314242|FG001|Part A|Lack of Efficacy|1|||
131459351|NCT00966875|473314243|FG002|Part A|Lack of Efficacy|0|||
131459352|NCT00966875|473314244|FG003|Part A|Lack of Efficacy|0|||
131459353|NCT00966875|473314245|FG004|Part A|Lack of Efficacy|0|||
131459354|NCT00966875|473314246|FG005|Part A|Lack of Efficacy|0|||
131459355|NCT00966875|473314247|FG006|Part A|Lack of Efficacy|4|||
131459356|NCT00966875|473314248|FG007|Part A|Lack of Efficacy|0|||
131459357|NCT00966875|473314249|FG008|Part A|Lack of Efficacy|0|||
131459358|NCT00966875|473314241|FG000|Part A|Lost to Follow-up|2|||
131459359|NCT00966875|473314242|FG001|Part A|Lost to Follow-up|0|||
131459360|NCT00966875|473314243|FG002|Part A|Lost to Follow-up|0|||
131459361|NCT00966875|473314244|FG003|Part A|Lost to Follow-up|0|||
131459362|NCT00966875|473314245|FG004|Part A|Lost to Follow-up|0|||
131459363|NCT00966875|473314246|FG005|Part A|Lost to Follow-up|1|||
131459364|NCT00966875|473314247|FG006|Part A|Lost to Follow-up|0|||
131459365|NCT00966875|473314248|FG007|Part A|Lost to Follow-up|0|||
131459366|NCT00966875|473314249|FG008|Part A|Lost to Follow-up|0|||
131459367|NCT00966875|473314241|FG000|Part A|Parent/Caregiver Decision|0|||
131459368|NCT00966875|473314242|FG001|Part A|Parent/Caregiver Decision|0|||
131459369|NCT00966875|473314243|FG002|Part A|Parent/Caregiver Decision|0|||
131459370|NCT00966875|473314244|FG003|Part A|Parent/Caregiver Decision|1|||
131459371|NCT00966875|473314245|FG004|Part A|Parent/Caregiver Decision|0|||
131459372|NCT00966875|473314246|FG005|Part A|Parent/Caregiver Decision|0|||
131459373|NCT00966875|473314247|FG006|Part A|Parent/Caregiver Decision|0|||
131459374|NCT00966875|473314248|FG007|Part A|Parent/Caregiver Decision|0|||
131459375|NCT00966875|473314249|FG008|Part A|Parent/Caregiver Decision|0|||
131459376|NCT00966875|473314241|FG000|Part A|Physician Decision|0|||
131459377|NCT00966875|473314242|FG001|Part A|Physician Decision|0|||
131459378|NCT00966875|473314243|FG002|Part A|Physician Decision|0|||
131459379|NCT00966875|473314244|FG003|Part A|Physician Decision|0|||
131459380|NCT00966875|473314245|FG004|Part A|Physician Decision|1|||
131459381|NCT00966875|473314246|FG005|Part A|Physician Decision|0|||
131459382|NCT00966875|473314247|FG006|Part A|Physician Decision|1|||
131459383|NCT00966875|473314248|FG007|Part A|Physician Decision|0|||
131459384|NCT00966875|473314249|FG008|Part A|Physician Decision|2|||
131459385|NCT00966875|473314241|FG000|Part A|Sponsor Decision|0|||
131459386|NCT00966875|473314242|FG001|Part A|Sponsor Decision|0|||
131459387|NCT00966875|473314243|FG002|Part A|Sponsor Decision|1|||
131459388|NCT00966875|473314244|FG003|Part A|Sponsor Decision|0|||
131459389|NCT00966875|473314245|FG004|Part A|Sponsor Decision|1|||
131459390|NCT00966875|473314246|FG005|Part A|Sponsor Decision|0|||
131459391|NCT00966875|473314247|FG006|Part A|Sponsor Decision|0|||
131459392|NCT00966875|473314248|FG007|Part A|Sponsor Decision|2|||
131459393|NCT00966875|473314249|FG008|Part A|Sponsor Decision|1|||
131459394|NCT00966875|473314241|FG000|Part A|Withdrawal by Subject|2|||
131459395|NCT00966875|473314242|FG001|Part A|Withdrawal by Subject|2|||
131459396|NCT00966875|473314243|FG002|Part A|Withdrawal by Subject|1|||
131459397|NCT00966875|473314244|FG003|Part A|Withdrawal by Subject|1|||
131459398|NCT00966875|473314245|FG004|Part A|Withdrawal by Subject|3|||
131459399|NCT00966875|473314246|FG005|Part A|Withdrawal by Subject|0|||
131459400|NCT00966875|473314247|FG006|Part A|Withdrawal by Subject|5|||
131459401|NCT00966875|473314248|FG007|Part A|Withdrawal by Subject|1|||
131459402|NCT00966875|473314249|FG008|Part A|Withdrawal by Subject|1|||
131459403|NCT00966875|473314241|FG000|Part A|Protocol Violation|0|||
131459404|NCT00966875|473314242|FG001|Part A|Protocol Violation|0|||
131459405|NCT00966875|473314243|FG002|Part A|Protocol Violation|0|||
131459406|NCT00966875|473314244|FG003|Part A|Protocol Violation|0|||
131459407|NCT00966875|473314245|FG004|Part A|Protocol Violation|0|||
131459408|NCT00966875|473314246|FG005|Part A|Protocol Violation|0|||
131459409|NCT00966875|473314247|FG006|Part A|Protocol Violation|2|||
131459410|NCT00966875|473314248|FG007|Part A|Protocol Violation|1|||
131459411|NCT00966875|473314249|FG008|Part A|Protocol Violation|1|||
131459412|NCT00966875|473314241|FG000|Part B|Adverse Event|0|||
131459413|NCT00966875|473314242|FG001|Part B|Adverse Event|1|||
131459414|NCT00966875|473314243|FG002|Part B|Adverse Event|1|||
131459415|NCT00966875|473314244|FG003|Part B|Adverse Event|0|||
131459416|NCT00966875|473314245|FG004|Part B|Adverse Event|1|||
131459417|NCT00966875|473314246|FG005|Part B|Adverse Event|0|||
131459418|NCT00966875|473314247|FG006|Part B|Adverse Event|5|||
131459419|NCT00966875|473314248|FG007|Part B|Adverse Event|2|||
131459420|NCT00966875|473314249|FG008|Part B|Adverse Event|2|||
131459421|NCT00966875|473314241|FG000|Part B|Death|0|||
131459422|NCT00966875|473314242|FG001|Part B|Death|0|||
131459423|NCT00966875|473314243|FG002|Part B|Death|1|||
131459424|NCT00966875|473314244|FG003|Part B|Death|0|||
131459425|NCT00966875|473314245|FG004|Part B|Death|0|||
131459426|NCT00966875|473314246|FG005|Part B|Death|0|||
131459427|NCT00966875|473314247|FG006|Part B|Death|0|||
131459428|NCT00966875|473314248|FG007|Part B|Death|1|||
131459429|NCT00966875|473314249|FG008|Part B|Death|0|||
131459430|NCT00966875|473314241|FG000|Part B|Lack of Efficacy|2|||
131459431|NCT00966875|473314242|FG001|Part B|Lack of Efficacy|1|||
131459432|NCT00966875|473314243|FG002|Part B|Lack of Efficacy|1|||
131459433|NCT00966875|473314244|FG003|Part B|Lack of Efficacy|1|||
131459434|NCT00966875|473314245|FG004|Part B|Lack of Efficacy|2|||
131459435|NCT00966875|473314246|FG005|Part B|Lack of Efficacy|3|||
131459436|NCT00966875|473314247|FG006|Part B|Lack of Efficacy|12|||
131459437|NCT00966875|473314248|FG007|Part B|Lack of Efficacy|9|||
131459438|NCT00966875|473314249|FG008|Part B|Lack of Efficacy|6|||
131459439|NCT00966875|473314241|FG000|Part B|Lost to Follow-up|0|||
131459440|NCT00966875|473314242|FG001|Part B|Lost to Follow-up|0|||
131459441|NCT00966875|473314243|FG002|Part B|Lost to Follow-up|0|||
131459442|NCT00966875|473314244|FG003|Part B|Lost to Follow-up|1|||
131459443|NCT00966875|473314245|FG004|Part B|Lost to Follow-up|0|||
131459444|NCT00966875|473314246|FG005|Part B|Lost to Follow-up|0|||
131459445|NCT00966875|473314247|FG006|Part B|Lost to Follow-up|0|||
131459446|NCT00966875|473314248|FG007|Part B|Lost to Follow-up|0|||
131459447|NCT00966875|473314249|FG008|Part B|Lost to Follow-up|1|||
131459448|NCT00966875|473314241|FG000|Part B|Physician Decision|0|||
131459449|NCT00966875|473314242|FG001|Part B|Physician Decision|0|||
131459450|NCT00966875|473314243|FG002|Part B|Physician Decision|1|||
131459451|NCT00966875|473314244|FG003|Part B|Physician Decision|0|||
131459452|NCT00966875|473314245|FG004|Part B|Physician Decision|2|||
131459453|NCT00966875|473314246|FG005|Part B|Physician Decision|1|||
131459454|NCT00966875|473314247|FG006|Part B|Physician Decision|0|||
131459455|NCT00966875|473314248|FG007|Part B|Physician Decision|0|||
131459456|NCT00966875|473314249|FG008|Part B|Physician Decision|2|||
131459457|NCT00966875|473314241|FG000|Part B|Sponsor Decision|1|||
131459458|NCT00966875|473314242|FG001|Part B|Sponsor Decision|0|||
131459459|NCT00966875|473314243|FG002|Part B|Sponsor Decision|0|||
131459460|NCT00966875|473314244|FG003|Part B|Sponsor Decision|0|||
131459461|NCT00966875|473314245|FG004|Part B|Sponsor Decision|0|||
131459462|NCT00966875|473314246|FG005|Part B|Sponsor Decision|1|||
131459463|NCT00966875|473314247|FG006|Part B|Sponsor Decision|0|||
131459464|NCT00966875|473314248|FG007|Part B|Sponsor Decision|2|||
131459465|NCT00966875|473314249|FG008|Part B|Sponsor Decision|1|||
131459466|NCT00966875|473314241|FG000|Part B|Withdrawal by Subject|2|||
131459467|NCT00966875|473314242|FG001|Part B|Withdrawal by Subject|1|||
131459468|NCT00966875|473314243|FG002|Part B|Withdrawal by Subject|2|||
131459469|NCT00966875|473314244|FG003|Part B|Withdrawal by Subject|1|||
131459470|NCT00966875|473314245|FG004|Part B|Withdrawal by Subject|2|||
131433765|NCT00255190|473213206|FG001|Overall Study|Lost to Follow-up|27|||
131433766|NCT00255190|473213205|FG000|Overall Study|Withdrew Consent|17|||
131433767|NCT00255190|473213206|FG001|Overall Study|Withdrew Consent|48|||
131433768|NCT00255190|473213205|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
131433769|NCT00255190|473213206|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
131433770|NCT00255190|473213205|FG000|Overall Study|Erosive esophagitis not healed|0|||
131433771|NCT00255190|473213206|FG001|Overall Study|Erosive esophagitis not healed|20|||
131433772|NCT00255190|473213205|FG000|Overall Study|Various|4|||
131433773|NCT00255190|473213206|FG001|Overall Study|Various|23|||
131433774|NCT00057863|473213207|FG000|Overall Study|Death|1|||
131433775|NCT00057863|473213207|FG000|Overall Study|Withdrawal by Subject|2|||
131433776|NCT01308736|473213208|FG000|Overall Study|Did not attend a single session|6|||
131433777|NCT01308736|473213209|FG001|Overall Study|Did not attend a single session|5|||
131433778|NCT01454596|473213210|FG000|Overall Study|Death|0|||
131433779|NCT01454596|473213211|FG001|Overall Study|Death|0|||
131433780|NCT01454596|473213212|FG002|Overall Study|Death|0|||
131433781|NCT01454596|473213213|FG003|Overall Study|Death|0|||
131433782|NCT01454596|473213214|FG004|Overall Study|Death|0|||
131433783|NCT01454596|473213215|FG005|Overall Study|Death|0|||
131433784|NCT01454596|473213216|FG006|Overall Study|Death|0|||
131433785|NCT01454596|473213217|FG007|Overall Study|Death|0|||
131433786|NCT01454596|473213218|FG008|Overall Study|Death|0|||
131433787|NCT01454596|473213219|FG009|Overall Study|Death|1|||
131433788|NCT01454596|473213220|FG010|Overall Study|Death|1|||
131433789|NCT01454596|473213221|FG011|Overall Study|Death|0|||
131433790|NCT02888106|473213222|FG000|Overall Study|Withdrawal by Subject|1|||
131433791|NCT02888106|473213223|FG001|Overall Study|Withdrawal by Subject|2|||
131433792|NCT02888106|473213224|FG002|Overall Study|Withdrawal by Subject|0|||
131433793|NCT02888106|473213225|FG003|Overall Study|Withdrawal by Subject|1|||
131433794|NCT02888106|473213226|FG004|Overall Study|Withdrawal by Subject|0|||
131433795|NCT02888106|473213227|FG005|Overall Study|Withdrawal by Subject|0|||
131433796|NCT02888106|473213222|FG000|Overall Study|Lost to Follow-up|1|||
131433797|NCT02888106|473213223|FG001|Overall Study|Lost to Follow-up|0|||
131433798|NCT02888106|473213224|FG002|Overall Study|Lost to Follow-up|0|||
131433799|NCT02888106|473213225|FG003|Overall Study|Lost to Follow-up|1|||
131433800|NCT02888106|473213226|FG004|Overall Study|Lost to Follow-up|0|||
131433801|NCT02888106|473213227|FG005|Overall Study|Lost to Follow-up|1|||
131433802|NCT02888106|473213222|FG000|Overall Study|Adverse Event|2|||
131433803|NCT02888106|473213223|FG001|Overall Study|Adverse Event|0|||
131433804|NCT02888106|473213224|FG002|Overall Study|Adverse Event|0|||
131433805|NCT02888106|473213225|FG003|Overall Study|Adverse Event|0|||
131433806|NCT02888106|473213226|FG004|Overall Study|Adverse Event|0|||
131433807|NCT02888106|473213227|FG005|Overall Study|Adverse Event|0|||
131433808|NCT02888106|473213222|FG000|Overall Study|Withdrawal of consent|0|||
131433809|NCT02888106|473213223|FG001|Overall Study|Withdrawal of consent|0|||
131433810|NCT02888106|473213224|FG002|Overall Study|Withdrawal of consent|0|||
131433811|NCT02888106|473213225|FG003|Overall Study|Withdrawal of consent|0|||
131433812|NCT02888106|473213226|FG004|Overall Study|Withdrawal of consent|1|||
131433813|NCT02888106|473213227|FG005|Overall Study|Withdrawal of consent|0|||
131433814|NCT02888106|473213222|FG000|Overall Study|Pregnancy|1|||
131433815|NCT02888106|473213223|FG001|Overall Study|Pregnancy|0|||
131433816|NCT02888106|473213224|FG002|Overall Study|Pregnancy|0|||
131433817|NCT02888106|473213225|FG003|Overall Study|Pregnancy|0|||
131433818|NCT02888106|473213226|FG004|Overall Study|Pregnancy|0|||
131433819|NCT02888106|473213227|FG005|Overall Study|Pregnancy|0|||
131433820|NCT01236521|473213230|FG000|Overall Study|Withdrawal by Subject|12|||
131433821|NCT01236521|473213231|FG001|Overall Study|Withdrawal by Subject|17|||
131433822|NCT01236521|473213230|FG000|Overall Study|Death|2|||
131433823|NCT01236521|473213231|FG001|Overall Study|Death|1|||
131433824|NCT01236521|473213230|FG000|Overall Study|Lost to Follow-up|9|||
131433825|NCT01236521|473213231|FG001|Overall Study|Lost to Follow-up|7|||
131433826|NCT03116685|473213236|FG000|Overall Study|Physician Decision|0|||
131433827|NCT03116685|473213237|FG001|Overall Study|Physician Decision|1|||
131433828|NCT04491136|473213242|FG000|Overall Study|Patient withdraw informed consent|9|||
131433829|NCT04491136|473213242|FG000|Overall Study|Adverse Event|2|||
131433830|NCT04491136|473213242|FG000|Overall Study|Death|3|||
131433831|NCT04491136|473213242|FG000|Overall Study|Lost to Follow-up|3|||
131433832|NCT04491136|473213242|FG000|Overall Study|Physician Decision|45|||
131433833|NCT04491136|473213242|FG000|Overall Study|sponsor terminated the study early|16|||
131433834|NCT04491136|473213242|FG000|Overall Study|Patient/guardian's decision|1|||
131433835|NCT01611194|473213243|FG000|Overall Study|Lost to Follow-up|0|||
131433836|NCT01611194|473213244|FG001|Overall Study|Lost to Follow-up|1|||
131433837|NCT01611194|473213243|FG000|Overall Study|Withdrawal by Subject|0|||
131433838|NCT01611194|473213244|FG001|Overall Study|Withdrawal by Subject|1|||
131433839|NCT01611194|473213243|FG000|Overall Study|drug use|0|||
131433840|NCT01611194|473213244|FG001|Overall Study|drug use|1|||
131433841|NCT00348673|473213245|FG000|Stage 1|Randomized but not Treated|0|||
131459471|NCT00966875|473314246|FG005|Part B|Withdrawal by Subject|1|||
131459472|NCT00966875|473314247|FG006|Part B|Withdrawal by Subject|4|||
131459473|NCT00966875|473314248|FG007|Part B|Withdrawal by Subject|5|||
131459474|NCT00966875|473314249|FG008|Part B|Withdrawal by Subject|5|||
131459475|NCT00966875|473314241|FG000|Part B|Entry Criteria|0|||
131459476|NCT00966875|473314242|FG001|Part B|Entry Criteria|0|||
131459477|NCT00966875|473314243|FG002|Part B|Entry Criteria|0|||
131459478|NCT00966875|473314244|FG003|Part B|Entry Criteria|0|||
131459479|NCT00966875|473314245|FG004|Part B|Entry Criteria|0|||
131459480|NCT00966875|473314246|FG005|Part B|Entry Criteria|0|||
131459481|NCT00966875|473314247|FG006|Part B|Entry Criteria|1|||
131459482|NCT00966875|473314248|FG007|Part B|Entry Criteria|0|||
131459483|NCT00966875|473314249|FG008|Part B|Entry Criteria|1|||
131459484|NCT00444678|473314250|FG000|Overall Study|Toxicity|11|||
131459485|NCT00444678|473314250|FG000|Overall Study|Disease Progression|12|||
131459486|NCT00444678|473314250|FG000|Overall Study|Death|3|||
131459487|NCT00444678|473314250|FG000|Overall Study|Physician Decision|3|||
131459488|NCT00444678|473314250|FG000|Overall Study|Withdrawal by Subject|2|||
131459489|NCT01589653|473314251|FG000|Overall Study|Protocol Violation|3|||
131459490|NCT01589653|473314252|FG001|Overall Study|Protocol Violation|1|||
131459491|NCT01589653|473314251|FG000|Overall Study|Withdrawal criteria|4|||
131459492|NCT01589653|473314252|FG001|Overall Study|Withdrawal criteria|7|||
131459493|NCT01589653|473314251|FG000|Overall Study|Unclassified|0|||
131459494|NCT01589653|473314252|FG001|Overall Study|Unclassified|3|||
131459495|NCT04657666|473314253|FG000|Period 1|Withdrawal of participant consent|2|||
131459496|NCT04657666|473314254|FG001|Period 1|Withdrawal of participant consent|1|||
131459497|NCT04657666|473314253|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
131459498|NCT04657666|473314254|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
131459499|NCT04657666|473314253|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
131459500|NCT04657666|473314254|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
131459501|NCT04657666|473314253|FG000|Period 2|Other|2|||
131459502|NCT04657666|473314254|FG001|Period 2|Other|0|||
131459503|NCT04657666|473314253|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
131459504|NCT04657666|473314254|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
131459505|NCT00606905|473314255|FG000|Overall Study|No Pregnancy|9|||
131459506|NCT00606905|473314256|FG001|Overall Study|No Pregnancy|6|||
131459507|NCT00606905|473314255|FG000|Overall Study|Non-Index Pregnancy|1|||
131459508|NCT00606905|473314256|FG001|Overall Study|Non-Index Pregnancy|4|||
131459509|NCT00606905|473314255|FG000|Overall Study|Withdrew|5|||
131459510|NCT00606905|473314256|FG001|Overall Study|Withdrew|5|||
131459511|NCT00870103|473314263|FG000|Overall Study|Physician Decision|2|||
131459512|NCT00870103|473314263|FG000|Overall Study|Lost to Follow-up|2|||
131459513|NCT01086358|473314264|FG000|First Intervention|Lost to Follow-up|9|||
131459514|NCT01086358|473314265|FG001|First Intervention|Lost to Follow-up|4|||
131459515|NCT01086358|473314264|FG000|First Intervention|Withdrawal by Subject|0|||
131459516|NCT01086358|473314265|FG001|First Intervention|Withdrawal by Subject|1|||
131459517|NCT01086358|473314264|FG000|Second Intervention|Lost to Follow-up|4|||
131459518|NCT01086358|473314265|FG001|Second Intervention|Lost to Follow-up|4|||
131459519|NCT03317405|473314266|FG000|Overall Study|Withdrawal by Subject|1|||
131459520|NCT03317405|473314267|FG001|Overall Study|Withdrawal by Subject|0|||
131459521|NCT03317405|473314268|FG002|Overall Study|Withdrawal by Subject|0|||
131459522|NCT03317405|473314266|FG000|Overall Study|Physician Decision|0|||
131459523|NCT03317405|473314267|FG001|Overall Study|Physician Decision|0|||
131459524|NCT03317405|473314268|FG002|Overall Study|Physician Decision|1|||
131459525|NCT03317405|473314266|FG000|Overall Study|Surgery Rescheduled|0|||
131459526|NCT03317405|473314267|FG001|Overall Study|Surgery Rescheduled|1|||
131459527|NCT03317405|473314268|FG002|Overall Study|Surgery Rescheduled|0|||
131459528|NCT01024309|473314271|FG000|Overall Study|Physician Decision|4|||
131459529|NCT01024309|473314272|FG001|Overall Study|Physician Decision|0|||
131459530|NCT01024309|473314271|FG000|Overall Study|Withdrawal by Subject|4|||
131459531|NCT01024309|473314272|FG001|Overall Study|Withdrawal by Subject|4|||
131459532|NCT05194579|473314275|FG000|Overall Study|Lost to Follow-up|2|||
131459533|NCT05194579|473314276|FG001|Overall Study|Lost to Follow-up|3|||
131459534|NCT05194579|473314275|FG000|Overall Study|Withdrawal by Subject|3|||
131459535|NCT05194579|473314276|FG001|Overall Study|Withdrawal by Subject|4|||
131459536|NCT05194579|473314275|FG000|Overall Study|Refused further study procedures|0|||
131459537|NCT05194579|473314276|FG001|Overall Study|Refused further study procedures|1|||
131459538|NCT05194579|473314275|FG000|Overall Study|Protocol deviation|1|||
131459539|NCT05194579|473314276|FG001|Overall Study|Protocol deviation|0|||
131459540|NCT03595228|473314277|FG000|Overall Study|Death|2|||
131459541|NCT03595228|473314277|FG000|Overall Study|Lack of Efficacy|13|||
131459542|NCT03595228|473314277|FG000|Overall Study|Withdrawal by Subject|3|||
131459543|NCT03595228|473314277|FG000|Overall Study|Withdrawal by Sponsor|1|||
131459544|NCT01639729|473314278|FG000|Overall Study|Withdrawal by Subject|1|||
131459545|NCT01639729|473314279|FG001|Overall Study|Withdrawal by Subject|0|||
131459546|NCT01639729|473314280|FG002|Overall Study|Withdrawal by Subject|1|||
131459547|NCT01639729|473314281|FG003|Overall Study|Withdrawal by Subject|1|||
131459548|NCT01639729|473314282|FG004|Overall Study|Withdrawal by Subject|0|||
131459549|NCT01639729|473314283|FG005|Overall Study|Withdrawal by Subject|0|||
131434032|NCT01188772|473214620|FG002|Overall Study|Adverse Event|2|||
131434033|NCT01188772|473214621|FG003|Overall Study|Adverse Event|0|||
131459550|NCT00567255|473314285|FG000|Overall Study|Adverse Event|241|||
131459551|NCT00567255|473314286|FG001|Overall Study|Adverse Event|68|||
131459552|NCT00567255|473314285|FG000|Overall Study|Lost to Follow-up|77|||
131459553|NCT00567255|473314286|FG001|Overall Study|Lost to Follow-up|48|||
131459554|NCT00567255|473314285|FG000|Overall Study|Withdrawal by Subject|75|||
131459555|NCT00567255|473314286|FG001|Overall Study|Withdrawal by Subject|56|||
131459556|NCT00567255|473314285|FG000|Overall Study|Lack of Efficacy|19|||
131459557|NCT00567255|473314286|FG001|Overall Study|Lack of Efficacy|33|||
131459558|NCT00567255|473314285|FG000|Overall Study|Protocol Violation|20|||
131459559|NCT00567255|473314286|FG001|Overall Study|Protocol Violation|8|||
131459560|NCT00567255|473314285|FG000|Overall Study|Pregnancy|6|||
131459561|NCT00567255|473314286|FG001|Overall Study|Pregnancy|0|||
131459562|NCT00567255|473314285|FG000|Overall Study|Drug noncompliance,moved,other|25|||
131459563|NCT00567255|473314286|FG001|Overall Study|Drug noncompliance,moved,other|15|||
131459564|NCT00787267|473314292|FG000|Overall Study|Screen failure/Ineligible|10|||
131459565|NCT00787267|473314292|FG000|Overall Study|No Reason Provided|1|||
131459566|NCT00787267|473314292|FG000|Overall Study|Withdrawal by Subject|1|||
131459567|NCT00865280|473314293|FG000|Overall Study|Withdrawal by Subject|4|||
131459568|NCT00865280|473314294|FG001|Overall Study|Withdrawal by Subject|1|||
131459569|NCT00865280|473314293|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
131459570|NCT00865280|473314294|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
131459571|NCT00865280|473314293|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
131459572|NCT00865280|473314294|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
131459573|NCT00865280|473314293|FG000|Overall Study|Exclusion Condition|1|||
131459574|NCT00865280|473314294|FG001|Overall Study|Exclusion Condition|0|||
131459575|NCT00865280|473314293|FG000|Overall Study|Adverse Event|0|||
131459576|NCT00865280|473314294|FG001|Overall Study|Adverse Event|1|||
131459577|NCT04556383|473314299|FG000|PCP|Lack of Efficacy|28|||
131459578|NCT04556383|473314300|FG001|PCP|Lack of Efficacy|23|||
131459579|NCT04556383|473314301|FG002|PCP|Lack of Efficacy|23|||
131459580|NCT04556383|473314302|FG003|PCP|Lack of Efficacy|0|||
131459581|NCT04556383|473314299|FG000|PCP|Study terminated by sponsor|15|||
131459582|NCT04556383|473314300|FG001|PCP|Study terminated by sponsor|13|||
131459583|NCT04556383|473314301|FG002|PCP|Study terminated by sponsor|16|||
131459584|NCT04556383|473314302|FG003|PCP|Study terminated by sponsor|0|||
131459585|NCT04556383|473314299|FG000|PCP|Withdrawal by Subject|8|||
131459586|NCT04556383|473314300|FG001|PCP|Withdrawal by Subject|6|||
131459587|NCT04556383|473314301|FG002|PCP|Withdrawal by Subject|6|||
131459588|NCT04556383|473314302|FG003|PCP|Withdrawal by Subject|0|||
131459589|NCT04556383|473314299|FG000|PCP|Adverse Event|1|||
131459590|NCT04556383|473314300|FG001|PCP|Adverse Event|7|||
131459591|NCT04556383|473314301|FG002|PCP|Adverse Event|7|||
131459592|NCT04556383|473314302|FG003|PCP|Adverse Event|0|||
131459593|NCT04556383|473314299|FG000|PCP|Other, Not Specified|1|||
131459594|NCT04556383|473314300|FG001|PCP|Other, Not Specified|2|||
131459595|NCT04556383|473314301|FG002|PCP|Other, Not Specified|1|||
131459596|NCT04556383|473314302|FG003|PCP|Other, Not Specified|0|||
131459597|NCT04556383|473314299|FG000|PCP|Protocol Violation|1|||
131459598|NCT04556383|473314300|FG001|PCP|Protocol Violation|0|||
131459599|NCT04556383|473314301|FG002|PCP|Protocol Violation|1|||
131459600|NCT04556383|473314302|FG003|PCP|Protocol Violation|0|||
131459601|NCT04556383|473314299|FG000|PCP|Lost to Follow-up|1|||
131459602|NCT04556383|473314300|FG001|PCP|Lost to Follow-up|0|||
131459603|NCT04556383|473314301|FG002|PCP|Lost to Follow-up|0|||
131459604|NCT04556383|473314302|FG003|PCP|Lost to Follow-up|0|||
131459605|NCT04556383|473314299|FG000|PCP|Physician Decision|0|||
131459606|NCT04556383|473314300|FG001|PCP|Physician Decision|1|||
131459607|NCT04556383|473314301|FG002|PCP|Physician Decision|0|||
131459608|NCT04556383|473314302|FG003|PCP|Physician Decision|0|||
131459609|NCT04556383|473314299|FG000|PCP|Site terminated by sponsor|0|||
131459610|NCT04556383|473314300|FG001|PCP|Site terminated by sponsor|1|||
131459611|NCT04556383|473314301|FG002|PCP|Site terminated by sponsor|0|||
131459612|NCT04556383|473314302|FG003|PCP|Site terminated by sponsor|0|||
131459613|NCT04556383|473314299|FG000|OLE|Study terminated by sponsor|0|||
131459614|NCT04556383|473314300|FG001|OLE|Study terminated by sponsor|0|||
131459615|NCT04556383|473314301|FG002|OLE|Study terminated by sponsor|0|||
131459616|NCT04556383|473314302|FG003|OLE|Study terminated by sponsor|68|||
131459617|NCT04556383|473314299|FG000|OLE|Withdrawal by Subject|0|||
131459618|NCT04556383|473314300|FG001|OLE|Withdrawal by Subject|0|||
131459619|NCT04556383|473314301|FG002|OLE|Withdrawal by Subject|0|||
131459620|NCT04556383|473314302|FG003|OLE|Withdrawal by Subject|10|||
131459621|NCT04556383|473314299|FG000|OLE|Lack of Efficacy|0|||
131459622|NCT04556383|473314300|FG001|OLE|Lack of Efficacy|0|||
131459623|NCT04556383|473314301|FG002|OLE|Lack of Efficacy|0|||
131459624|NCT04556383|473314302|FG003|OLE|Lack of Efficacy|7|||
131459625|NCT04556383|473314299|FG000|OLE|Adverse Event|0|||
131459626|NCT04556383|473314300|FG001|OLE|Adverse Event|0|||
131459627|NCT04556383|473314301|FG002|OLE|Adverse Event|0|||
131459628|NCT04556383|473314302|FG003|OLE|Adverse Event|2|||
131459629|NCT04556383|473314299|FG000|OLE|Other, Not Specified|0|||
131459630|NCT04556383|473314300|FG001|OLE|Other, Not Specified|0|||
131459631|NCT04556383|473314301|FG002|OLE|Other, Not Specified|0|||
131459632|NCT04556383|473314302|FG003|OLE|Other, Not Specified|2|||
131459633|NCT04556383|473314299|FG000|OLE|Death|0|||
131459634|NCT04556383|473314300|FG001|OLE|Death|0|||
131459635|NCT04556383|473314301|FG002|OLE|Death|0|||
131459636|NCT04556383|473314302|FG003|OLE|Death|1|||
131459637|NCT04556383|473314299|FG000|OLE|Lost to Follow-up|0|||
131459638|NCT04556383|473314300|FG001|OLE|Lost to Follow-up|0|||
131459639|NCT04556383|473314301|FG002|OLE|Lost to Follow-up|0|||
131459640|NCT04556383|473314302|FG003|OLE|Lost to Follow-up|1|||
131459641|NCT03158285|473314304|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
131459642|NCT03158285|473314305|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
131459643|NCT03158285|473314306|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
131459644|NCT03158285|473314304|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
131459645|NCT03158285|473314305|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
131459646|NCT03158285|473314306|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
131459647|NCT03158285|473314304|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
131459648|NCT03158285|473314305|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
131459649|NCT03158285|473314306|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
131459650|NCT03158285|473314304|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
131459651|NCT03158285|473314305|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
131459652|NCT03158285|473314306|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
131459653|NCT03158285|473314304|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
131459654|NCT03158285|473314305|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
131459655|NCT03158285|473314306|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
131459656|NCT03158285|473314304|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
131459657|NCT03158285|473314305|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
131459658|NCT03158285|473314306|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
131459659|NCT03158285|473314304|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
131459660|NCT03158285|473314305|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
131459661|NCT03158285|473314306|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
131459662|NCT03158285|473314304|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
131459663|NCT03158285|473314305|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
131459664|NCT03158285|473314306|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
131459665|NCT03158285|473314304|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
131459666|NCT03158285|473314305|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
131459667|NCT03158285|473314306|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
131459668|NCT03158285|473314304|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
131459669|NCT03158285|473314305|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
131459670|NCT03158285|473314306|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
131459671|NCT03158285|473314304|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
131459672|NCT03158285|473314305|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
131459673|NCT03158285|473314306|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
131459674|NCT03158285|473314304|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
131459675|NCT03158285|473314305|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
131459676|NCT03158285|473314306|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
131459677|NCT03158285|473314304|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
131459678|NCT03158285|473314305|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
131459679|NCT03158285|473314306|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
131459680|NCT03158285|473314304|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
131459681|NCT03158285|473314305|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
131459682|NCT03158285|473314306|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
131459683|NCT03158285|473314304|FG000|Active Treatment Period: Week 52-100|Death|1|||
131459684|NCT03158285|473314305|FG001|Active Treatment Period: Week 52-100|Death|0|||
131459685|NCT03158285|473314306|FG002|Active Treatment Period: Week 52-100|Death|0|||
131459686|NCT03158285|473314304|FG000|Active Treatment Period: Week 52-100|Other|4|||
131459687|NCT03158285|473314305|FG001|Active Treatment Period: Week 52-100|Other|1|||
131459688|NCT03158285|473314306|FG002|Active Treatment Period: Week 52-100|Other|0|||
131459689|NCT01642615|473314307|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
131459690|NCT01642615|473314308|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
131459691|NCT01642615|473314309|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
131459692|NCT01642615|473314307|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
131459693|NCT01642615|473314308|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
131459694|NCT01642615|473314309|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
131459695|NCT01642615|473314307|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
131459696|NCT01642615|473314308|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
131459697|NCT01642615|473314309|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
131459698|NCT01642615|473314307|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
131459699|NCT01642615|473314308|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
131459700|NCT01642615|473314309|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
131459701|NCT01642615|473314307|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
131459702|NCT01642615|473314308|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
131459703|NCT01642615|473314309|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
131459704|NCT01642615|473314307|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
131459705|NCT01642615|473314308|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
131459706|NCT01642615|473314309|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
131459707|NCT01642615|473314307|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
131459708|NCT01642615|473314308|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
131459709|NCT01642615|473314309|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
131459710|NCT01642615|473314307|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
131459711|NCT01642615|473314308|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
131459712|NCT01642615|473314309|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
131459713|NCT01642615|473314307|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
131459714|NCT01642615|473314308|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
131459715|NCT01642615|473314309|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
131459716|NCT00750152|473314310|FG000|Overall Study|Adverse Event|2|||
131459717|NCT00750152|473314311|FG001|Overall Study|Adverse Event|1|||
131459718|NCT00750152|473314310|FG000|Overall Study|Lost to Follow-up|8|||
131459719|NCT00750152|473314311|FG001|Overall Study|Lost to Follow-up|13|||
131459720|NCT00750152|473314310|FG000|Overall Study|Withdrawal by Subject|3|||
131459721|NCT00750152|473314311|FG001|Overall Study|Withdrawal by Subject|3|||
131459722|NCT00750152|473314310|FG000|Overall Study|Physician Decision|1|||
131459723|NCT00750152|473314311|FG001|Overall Study|Physician Decision|1|||
131459724|NCT00750152|473314310|FG000|Overall Study|Non-compliance|0|||
131459725|NCT00750152|473314311|FG001|Overall Study|Non-compliance|1|||
131459726|NCT00750152|473314310|FG000|Overall Study|Termination by sponsor|1|||
131459727|NCT00750152|473314311|FG001|Overall Study|Termination by sponsor|0|||
131459728|NCT00750152|473314310|FG000|Overall Study|Other|7|||
131459729|NCT00750152|473314311|FG001|Overall Study|Other|8|||
131459730|NCT01028300|473314314|FG000|Overall Study|Study Terminated|4|||
131459731|NCT02034409|473314315|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
131459732|NCT02034409|473314316|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
131459733|NCT02034409|473314315|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
131459734|NCT02034409|473314316|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
131459735|NCT02034409|473314315|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
131459736|NCT02034409|473314316|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
131459737|NCT02034409|473314315|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
131459738|NCT02034409|473314316|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
131459739|NCT02034409|473314315|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
131459740|NCT02034409|473314316|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
131459741|NCT02034409|473314315|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
131459742|NCT02034409|473314316|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
131459743|NCT01030666|473314317|FG000|Overall Study|Lost to Follow-up|3|||
131459744|NCT01030666|473314318|FG001|Overall Study|Lost to Follow-up|2|||
131459745|NCT01699867|473314319|FG000|Overall Study|Screening Failure|3|||
131459746|NCT00530504|473314322|FG000|Overall Study|Death|54|||
131459747|NCT00530504|473314322|FG000|Overall Study|Lost to Follow-up|26|||
131459748|NCT00530504|473314322|FG000|Overall Study|Withdrawal by Subject|39|||
131459749|NCT00530504|473314322|FG000|Overall Study|Exited study due to other reasons|33|||
131459750|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
131459751|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
131459752|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
131459753|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
131459754|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
131459755|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
131459756|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
131459757|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
131459758|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
131459759|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
131459760|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459761|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
131459762|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459763|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459764|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459765|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459766|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459767|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
131459768|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
131459769|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
131459770|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
131459771|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
131459772|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
131459773|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
131459774|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
131459775|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
131459776|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
131459777|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|Other|0|||
131459778|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|Other|0|||
131459779|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|Other|1|||
131459780|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|Other|1|||
131459781|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|Other|0|||
131459782|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|Other|0|||
131459783|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|Other|0|||
131459784|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|Other|1|||
131459785|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|Other|0|||
131459786|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|Death|0|||
131459787|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|Death|0|||
131459788|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|Death|0|||
131459789|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|Death|0|||
131459790|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|Death|0|||
131459791|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|Death|1|||
131459792|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|Death|0|||
131459793|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|Death|0|||
131459794|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|Death|0|||
131459795|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459796|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459797|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459798|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459799|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459800|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
131459801|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
131459802|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459803|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
131459804|NCT00557856|473314329|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
131459805|NCT00557856|473314330|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459806|NCT00557856|473314331|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459807|NCT00557856|473314332|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459808|NCT00557856|473314333|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459809|NCT00557856|473314334|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459810|NCT00557856|473314335|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459811|NCT00557856|473314336|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459812|NCT00557856|473314337|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
131459813|NCT00557856|473314329|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459814|NCT00557856|473314330|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459815|NCT00557856|473314331|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459816|NCT00557856|473314332|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459817|NCT00557856|473314333|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459818|NCT00557856|473314334|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459819|NCT00557856|473314335|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459820|NCT00557856|473314336|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
131459821|NCT00557856|473314337|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
131459822|NCT00557856|473314329|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459823|NCT00557856|473314330|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459824|NCT00557856|473314331|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459825|NCT00557856|473314332|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459826|NCT00557856|473314333|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459827|NCT00557856|473314334|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459828|NCT00557856|473314335|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459829|NCT00557856|473314336|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131459830|NCT00557856|473314337|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
131459831|NCT00557856|473314329|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
131459832|NCT00557856|473314330|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
131459833|NCT00557856|473314331|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
131459834|NCT00557856|473314332|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
131459835|NCT00557856|473314333|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
131459836|NCT00557856|473314334|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
131459837|NCT00557856|473314335|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
131459838|NCT00557856|473314336|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
131459839|NCT00557856|473314337|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
131459840|NCT00557856|473314329|FG000|Part 2: Exploratory Phase|Other|0|||
131459841|NCT00557856|473314330|FG001|Part 2: Exploratory Phase|Other|0|||
131459842|NCT00557856|473314331|FG002|Part 2: Exploratory Phase|Other|0|||
131459843|NCT00557856|473314332|FG003|Part 2: Exploratory Phase|Other|0|||
131459844|NCT00557856|473314333|FG004|Part 2: Exploratory Phase|Other|0|||
131459845|NCT00557856|473314334|FG005|Part 2: Exploratory Phase|Other|0|||
131459846|NCT00557856|473314335|FG006|Part 2: Exploratory Phase|Other|0|||
131459847|NCT00557856|473314336|FG007|Part 2: Exploratory Phase|Other|0|||
131459848|NCT00557856|473314337|FG008|Part 2: Exploratory Phase|Other|1|||
131459849|NCT00557856|473314329|FG000|Part 2: Exploratory Phase|Death|0|||
131459850|NCT00557856|473314330|FG001|Part 2: Exploratory Phase|Death|0|||
131459851|NCT00557856|473314331|FG002|Part 2: Exploratory Phase|Death|0|||
131459852|NCT00557856|473314332|FG003|Part 2: Exploratory Phase|Death|0|||
131459853|NCT00557856|473314333|FG004|Part 2: Exploratory Phase|Death|0|||
131459854|NCT00557856|473314334|FG005|Part 2: Exploratory Phase|Death|0|||
131459855|NCT00557856|473314335|FG006|Part 2: Exploratory Phase|Death|0|||
131459856|NCT00557856|473314336|FG007|Part 2: Exploratory Phase|Death|0|||
131459857|NCT00557856|473314337|FG008|Part 2: Exploratory Phase|Death|2|||
131459858|NCT00557856|473314329|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459859|NCT00557856|473314330|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459860|NCT00557856|473314331|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459861|NCT00557856|473314332|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459862|NCT00557856|473314333|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459863|NCT00557856|473314334|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459864|NCT00557856|473314335|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459865|NCT00557856|473314336|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
131459866|NCT00557856|473314337|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
131459867|NCT02537015|473314338|FG000|Overall Study|Adverse Event|3|||
131459868|NCT02537015|473314338|FG000|Overall Study|Withdrawal by Subject|2|||
131459869|NCT02537015|473314338|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131459870|NCT03703297|473314339|FG000|Overall Study|Death|115|||
131459871|NCT03703297|473314340|FG001|Overall Study|Death|0|||
131459872|NCT03703297|473314341|FG002|Overall Study|Death|144|||
131459873|NCT03703297|473314339|FG000|Overall Study|Withdrawal by Subject|9|||
131459874|NCT03703297|473314340|FG001|Overall Study|Withdrawal by Subject|0|||
131459875|NCT03703297|473314341|FG002|Overall Study|Withdrawal by Subject|11|||
131459876|NCT03703297|473314339|FG000|Overall Study|Ongoing at the time of DCO|140|||
131459877|NCT03703297|473314340|FG001|Overall Study|Ongoing at the time of DCO|200|||
131459878|NCT03703297|473314341|FG002|Overall Study|Ongoing at the time of DCO|111|||
131459879|NCT01888432|473316592|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
131459880|NCT01888432|473316593|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
131459881|NCT01888432|473316592|FG000|12-month Analysis (FAS)|Physician Decision|1|||
131459882|NCT01888432|473316593|FG001|12-month Analysis (FAS)|Physician Decision|1|||
131459883|NCT01888432|473316592|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
131459884|NCT01888432|473316593|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
131459885|NCT01888432|473316592|FG000|12-month Analysis (FAS)|Death|4|||
131459886|NCT01888432|473316593|FG001|12-month Analysis (FAS)|Death|3|||
131459887|NCT01888432|473316592|FG000|24-month Analysis (FAS)|Graft loss|0|||
131459888|NCT01888432|473316593|FG001|24-month Analysis (FAS)|Graft loss|1|||
131459889|NCT01888432|473316592|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
131459890|NCT01888432|473316593|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
131459891|NCT01888432|473316592|FG000|24-month Analysis (FAS)|Physician Decision|2|||
131459892|NCT01888432|473316593|FG001|24-month Analysis (FAS)|Physician Decision|4|||
131459893|NCT01888432|473316592|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
131459894|NCT01888432|473316593|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
131459895|NCT01888432|473316592|FG000|24-month Analysis (FAS)|Death|8|||
131459896|NCT01888432|473316593|FG001|24-month Analysis (FAS)|Death|4|||
131459897|NCT01888432|473316592|FG000|36-month Analysis (Extension)|Death|1|||
131459898|NCT01888432|473316593|FG001|36-month Analysis (Extension)|Death|0|||
131459899|NCT00130247|473316596|FG000|Overall Study|Pregnancy|1|||
131459900|NCT00130247|473316597|FG001|Overall Study|Pregnancy|0|||
131459901|NCT00130247|473316596|FG000|Overall Study|Post-randomization exclusion|1|||
131459902|NCT00130247|473316597|FG001|Overall Study|Post-randomization exclusion|2|||
131459903|NCT00130247|473316596|FG000|Overall Study|Not compliant with DOT|0|||
131459904|NCT00130247|473316597|FG001|Overall Study|Not compliant with DOT|2|||
131459905|NCT02156271|473316598|FG000|Overall Study|Physician Decision|4|||
131459906|NCT02156271|473316599|FG001|Overall Study|Physician Decision|3|||
131459907|NCT03387111|473316600|FG000|Overall Study|Progressive Disease|3|||
131459908|NCT03387111|473316600|FG000|Overall Study|Other|1|||
131459909|NCT01904773|473316604|FG000|Screen|Screen failure|3|||
131459910|NCT01904773|473316605|FG001|Screen|Screen failure|0|||
131459911|NCT01904773|473316606|FG002|Screen|Screen failure|0|||
131459912|NCT01904773|473316607|FG003|Screen|Screen failure|0|||
131459913|NCT01904773|473316608|FG004|Screen|Screen failure|0|||
131459914|NCT01904773|473316609|FG005|Screen|Screen failure|0|||
131459915|NCT01904773|473316610|FG006|Screen|Screen failure|0|||
131459916|NCT01904773|473316611|FG007|Screen|Screen failure|0|||
131459917|NCT01904773|473316612|FG008|Screen|Screen failure|0|||
131459918|NCT01904773|473316604|FG000|Screen|Withdrawal by Subject|1|||
131459919|NCT01904773|473316605|FG001|Screen|Withdrawal by Subject|0|||
131459920|NCT01904773|473316606|FG002|Screen|Withdrawal by Subject|0|||
131459921|NCT01904773|473316607|FG003|Screen|Withdrawal by Subject|0|||
131459922|NCT01904773|473316608|FG004|Screen|Withdrawal by Subject|0|||
131459923|NCT01904773|473316609|FG005|Screen|Withdrawal by Subject|0|||
131459924|NCT01904773|473316610|FG006|Screen|Withdrawal by Subject|0|||
131459925|NCT01904773|473316611|FG007|Screen|Withdrawal by Subject|0|||
131459926|NCT01904773|473316612|FG008|Screen|Withdrawal by Subject|0|||
131459927|NCT01904773|473316604|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
131459928|NCT01904773|473316605|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459929|NCT01904773|473316606|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459930|NCT01904773|473316607|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459931|NCT01904773|473316608|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459932|NCT01904773|473316609|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459933|NCT01904773|473316610|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459934|NCT01904773|473316611|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459935|NCT01904773|473316612|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
131459936|NCT01904773|473316604|FG000|First Intervention|Adverse Event|0|||
131459937|NCT01904773|473316605|FG001|First Intervention|Adverse Event|0|||
131459938|NCT01904773|473316606|FG002|First Intervention|Adverse Event|0|||
131459939|NCT01904773|473316607|FG003|First Intervention|Adverse Event|0|||
131459940|NCT01904773|473316608|FG004|First Intervention|Adverse Event|0|||
131459941|NCT01904773|473316609|FG005|First Intervention|Adverse Event|0|||
131459942|NCT01904773|473316610|FG006|First Intervention|Adverse Event|1|||
131459943|NCT01904773|473316611|FG007|First Intervention|Adverse Event|0|||
131459944|NCT01904773|473316612|FG008|First Intervention|Adverse Event|0|||
131459945|NCT01904773|473316604|FG000|Placebo Washout First Intervention|Condition worsened|0|||
131459946|NCT01904773|473316605|FG001|Placebo Washout First Intervention|Condition worsened|1|||
131459947|NCT01904773|473316606|FG002|Placebo Washout First Intervention|Condition worsened|0|||
131459948|NCT01904773|473316607|FG003|Placebo Washout First Intervention|Condition worsened|0|||
131459949|NCT01904773|473316608|FG004|Placebo Washout First Intervention|Condition worsened|0|||
131459950|NCT01904773|473316609|FG005|Placebo Washout First Intervention|Condition worsened|0|||
131459951|NCT01904773|473316610|FG006|Placebo Washout First Intervention|Condition worsened|0|||
131459952|NCT01904773|473316611|FG007|Placebo Washout First Intervention|Condition worsened|0|||
131459953|NCT01904773|473316612|FG008|Placebo Washout First Intervention|Condition worsened|0|||
131459954|NCT01904773|473316604|FG000|Fifth Intervention|Adverse Event|0|||
131459955|NCT01904773|473316605|FG001|Fifth Intervention|Adverse Event|0|||
131459956|NCT01904773|473316606|FG002|Fifth Intervention|Adverse Event|0|||
131459957|NCT01904773|473316607|FG003|Fifth Intervention|Adverse Event|0|||
131459958|NCT01904773|473316608|FG004|Fifth Intervention|Adverse Event|0|||
131459959|NCT01904773|473316609|FG005|Fifth Intervention|Adverse Event|0|||
131459960|NCT01904773|473316610|FG006|Fifth Intervention|Adverse Event|0|||
131459961|NCT01904773|473316611|FG007|Fifth Intervention|Adverse Event|1|||
131459962|NCT01904773|473316612|FG008|Fifth Intervention|Adverse Event|0|||
131459963|NCT01904773|473316604|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459964|NCT01904773|473316605|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
131459965|NCT01904773|473316606|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459966|NCT01904773|473316607|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459967|NCT01904773|473316608|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459968|NCT01904773|473316609|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459969|NCT01904773|473316610|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459970|NCT01904773|473316611|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459971|NCT01904773|473316612|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
131459972|NCT02617485|473316613|FG000|Treatment and Observation Period|Adverse Event|9|||
131459973|NCT02617485|473316614|FG001|Treatment and Observation Period|Adverse Event|1|||
131459974|NCT02617485|473316613|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
131459975|NCT02617485|473316614|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
131459976|NCT02617485|473316613|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
131459977|NCT02617485|473316614|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
131459978|NCT02617485|473316613|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
131459979|NCT02617485|473316614|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
131459980|NCT02617485|473316613|FG000|Treatment and Observation Period|Physician Decision|0|||
131459981|NCT02617485|473316614|FG001|Treatment and Observation Period|Physician Decision|1|||
131459982|NCT02617485|473316613|FG000|Follow-up Period|Adverse Event|1|||
131459983|NCT02617485|473316614|FG001|Follow-up Period|Adverse Event|0|||
131459984|NCT02617485|473316613|FG000|Follow-up Period|Withdrawal by Subject|1|||
131459985|NCT02617485|473316614|FG001|Follow-up Period|Withdrawal by Subject|0|||
131459986|NCT02617485|473316613|FG000|Follow-up Period|Disease progression|2|||
131459987|NCT02617485|473316614|FG001|Follow-up Period|Disease progression|1|||
131459988|NCT02617485|473316613|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
131459989|NCT02617485|473316614|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
131459990|NCT02617485|473316613|FG000|Follow-up Period|Patient needed radiotherapy|9|||
131459991|NCT02617485|473316614|FG001|Follow-up Period|Patient needed radiotherapy|5|||
131459992|NCT02617485|473316613|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
131459993|NCT02617485|473316614|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
131459994|NCT00791076|473316618|FG000|Overall Study|Study was terminated,PI left institution|8|||
131459995|NCT02248675|473316619|FG000|Overall Study|Lost to Follow-up|3|||
131459996|NCT02248675|473316620|FG001|Overall Study|Lost to Follow-up|1|||
131459997|NCT03390101|473316621|FG000|Weeks 0-12|Withdrawal by Subject|0|||
131459998|NCT03390101|473316622|FG001|Weeks 0-12|Withdrawal by Subject|1|||
131459999|NCT03390101|473316623|FG002|Weeks 0-12|Withdrawal by Subject|1|||
131460000|NCT03390101|473316621|FG000|Weeks 0-12|Lost to Follow-up|0|||
131460001|NCT03390101|473316622|FG001|Weeks 0-12|Lost to Follow-up|1|||
131460002|NCT03390101|473316623|FG002|Weeks 0-12|Lost to Follow-up|0|||
131460003|NCT03390101|473316621|FG000|Weeks 12-54|Withdrawal by Subject|0|||
131460004|NCT03390101|473316622|FG001|Weeks 12-54|Withdrawal by Subject|3|||
131460005|NCT03390101|473316623|FG002|Weeks 12-54|Withdrawal by Subject|1|||
131460006|NCT03390101|473316621|FG000|Weeks 12-54|Pregnancy|1|||
131460007|NCT03390101|473316622|FG001|Weeks 12-54|Pregnancy|0|||
131460008|NCT03390101|473316623|FG002|Weeks 12-54|Pregnancy|0|||
131460009|NCT03390101|473316621|FG000|Weeks 12-54|Adverse Event|2|||
131460010|NCT03390101|473316622|FG001|Weeks 12-54|Adverse Event|1|||
131460011|NCT03390101|473316623|FG002|Weeks 12-54|Adverse Event|1|||
131460012|NCT02052414|473316625|FG000|Overall Study|Adverse Event|12|||
131460013|NCT02052414|473316625|FG000|Overall Study|Lack of Efficacy|2|||
131460014|NCT02052414|473316625|FG000|Overall Study|Withdrawal by Subject|3|||
131460015|NCT01343693|473316629|FG000|Overall Study|Lost to Follow-up|9|||
131460016|NCT02704143|473316630|FG000|Overall Study|disease progression|10|||
131460017|NCT01235598|473316631|FG000|Overall Study|Adverse Event|0|||
131460018|NCT01235598|473316632|FG001|Overall Study|Adverse Event|3|||
131460019|NCT01235598|473316631|FG000|Overall Study|Lack of Efficacy|0|||
131460020|NCT01235598|473316632|FG001|Overall Study|Lack of Efficacy|1|||
131460021|NCT01235598|473316631|FG000|Overall Study|Withdrawal by Subject|1|||
131460022|NCT01235598|473316632|FG001|Overall Study|Withdrawal by Subject|0|||
131460023|NCT02151773|473316633|FG000|Overall Study|Protocol Deviation|64|||
131460024|NCT04605991|473316635|FG000|Overall Study|Adverse Event|5|||
131460025|NCT04605991|473316635|FG000|Overall Study|Lack of Efficacy|1|||
131460026|NCT04605991|473316635|FG000|Overall Study|Lost to Follow-up|8|||
131460027|NCT04605991|473316635|FG000|Overall Study|Physician Decision|4|||
131460028|NCT04605991|473316635|FG000|Overall Study|Withdrawal by Subject|14|||
131460029|NCT04605991|473316635|FG000|Overall Study|Non-compliance with study|1|||
131460030|NCT03263702|473316636|FG000|Overall Study|Lost to Follow-up|2|||
131460031|NCT03263702|473316637|FG001|Overall Study|Lost to Follow-up|2|||
131460032|NCT03263702|473316636|FG000|Overall Study|Withdrawal by Subject|1|||
131460033|NCT03263702|473316637|FG001|Overall Study|Withdrawal by Subject|2|||
131460034|NCT02386189|473316639|FG000|Overall Study|Lost to Follow-up|2|||
131460035|NCT02386189|473316640|FG001|Overall Study|Lost to Follow-up|3|||
131460036|NCT02386189|473316639|FG000|Overall Study|Withdrawal by Subject|1|||
131460037|NCT02386189|473316640|FG001|Overall Study|Withdrawal by Subject|0|||
131460038|NCT02386189|473316639|FG000|Overall Study|Death|1|||
131460039|NCT02386189|473316640|FG001|Overall Study|Death|0|||
131460040|NCT04250077|473316643|FG000|Overall Study|Withdrawal by Subject|0|||
131460041|NCT04250077|473316644|FG001|Overall Study|Withdrawal by Subject|1|||
131460042|NCT04250077|473316645|FG002|Overall Study|Withdrawal by Subject|0|||
131460043|NCT04250077|473316643|FG000|Overall Study|Lost to Follow-up|2|||
131460044|NCT04250077|473316644|FG001|Overall Study|Lost to Follow-up|3|||
131460045|NCT04250077|473316645|FG002|Overall Study|Lost to Follow-up|0|||
131460046|NCT01022398|473316646|FG000|Overall Study|Study terminated|2|||
131460047|NCT01022398|473316647|FG001|Overall Study|Study terminated|2|||
131460048|NCT03700684|473316648|FG000|Overall Study|COVID-19|0|||
131460049|NCT03700684|473316649|FG001|Overall Study|COVID-19|0|||
131460050|NCT03700684|473316650|FG002|Overall Study|COVID-19|2|||
131460051|NCT03319745|473316652|FG000|Overall Study|Death|1|||
131460052|NCT03319745|473316652|FG000|Overall Study|Toxicity Precluding Surgery|1|||
131460053|NCT01317550|473316653|FG000|Overall Study|Withdrawal by Subject|1|||
131460054|NCT01317550|473316654|FG001|Overall Study|Withdrawal by Subject|0|||
131460055|NCT01317550|473316655|FG002|Overall Study|Withdrawal by Subject|0|||
131460056|NCT01317550|473316656|FG003|Overall Study|Withdrawal by Subject|0|||
131460057|NCT01317550|473316653|FG000|Overall Study|Lack of compliance study med|1|||
131460058|NCT01317550|473316654|FG001|Overall Study|Lack of compliance study med|0|||
131460059|NCT01317550|473316655|FG002|Overall Study|Lack of compliance study med|0|||
131460060|NCT01317550|473316656|FG003|Overall Study|Lack of compliance study med|0|||
131460061|NCT01120782|473316657|FG000|Overall Study|Test article shipping error|11|||
131460062|NCT00640224|473316658|FG000|Overall Study|Lost to Follow-up|5|||
131460063|NCT00640224|473316659|FG001|Overall Study|Lost to Follow-up|2|||
131460064|NCT00640224|473316660|FG002|Overall Study|Lost to Follow-up|0|||
131460065|NCT00640224|473316661|FG003|Overall Study|Lost to Follow-up|0|||
131460066|NCT00640224|473316658|FG000|Overall Study|Withdrawal by Subject|1|||
131460067|NCT00640224|473316659|FG001|Overall Study|Withdrawal by Subject|0|||
131460068|NCT00640224|473316660|FG002|Overall Study|Withdrawal by Subject|0|||
131460069|NCT00640224|473316661|FG003|Overall Study|Withdrawal by Subject|0|||
131460070|NCT00640224|473316658|FG000|Overall Study|Headaches|0|||
131460071|NCT00640224|473316659|FG001|Overall Study|Headaches|1|||
131460072|NCT00640224|473316660|FG002|Overall Study|Headaches|0|||
131460073|NCT00640224|473316661|FG003|Overall Study|Headaches|0|||
131460074|NCT02937584|473316666|FG000|Period 1|Adverse Event|1|||
131460075|NCT02937584|473316667|FG001|Period 1|Adverse Event|2|||
131460076|NCT02937584|473316666|FG000|Washout|Adverse Event|0|||
131460077|NCT02937584|473316667|FG001|Washout|Adverse Event|1|||
131460078|NCT04075734|473316676|FG000|Overall Study|Lost to Follow-up|1|||
131460079|NCT04075734|473316677|FG001|Overall Study|Lost to Follow-up|1|||
131460080|NCT04075734|473316678|FG002|Overall Study|Lost to Follow-up|0|||
131460081|NCT04075734|473316676|FG000|Overall Study|Withdrawal by Subject|3|||
131460082|NCT04075734|473316677|FG001|Overall Study|Withdrawal by Subject|0|||
131460083|NCT04075734|473316678|FG002|Overall Study|Withdrawal by Subject|0|||
131460084|NCT03615040|473316679|FG000|Overall Study|Withdrawal by Subject|2|||
131460085|NCT03615040|473316680|FG001|Overall Study|Withdrawal by Subject|1|||
131460086|NCT03615040|473316679|FG000|Overall Study|Physician Decision|2|||
131460087|NCT03615040|473316680|FG001|Overall Study|Physician Decision|2|||
131460088|NCT03615040|473316679|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
131460089|NCT03615040|473316680|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
131460090|NCT03615040|473316679|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
131460091|NCT03615040|473316680|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
131460092|NCT03615040|473316679|FG000|Overall Study|Death|0|||
131460093|NCT03615040|473316680|FG001|Overall Study|Death|2|||
131460094|NCT01776307|473316681|FG000|Overall Study|Not dosed|0|||
131460095|NCT01776307|473316682|FG001|Overall Study|Not dosed|0|||
131460096|NCT01776307|473316683|FG002|Overall Study|Not dosed|1|||
131460097|NCT04074161|473316691|FG000|Overall Study|Withdrawal by Subject|2|||
131460098|NCT04074161|473316692|FG001|Overall Study|Withdrawal by Subject|4|||
131460099|NCT04074161|473316693|FG002|Overall Study|Withdrawal by Subject|1|||
131460100|NCT04074161|473316691|FG000|Overall Study|Lost to Follow-up|4|||
131460101|NCT04074161|473316692|FG001|Overall Study|Lost to Follow-up|5|||
131460102|NCT04074161|473316693|FG002|Overall Study|Lost to Follow-up|3|||
131460103|NCT03890666|473316700|FG000|Overall Study|Withdrawal by Subject|0|||
131460104|NCT03890666|473316701|FG001|Overall Study|Withdrawal by Subject|1|||
131460105|NCT03890666|473316700|FG000|Overall Study|Protocol deviation|1|||
131460106|NCT03890666|473316701|FG001|Overall Study|Protocol deviation|4|||
131460107|NCT03890666|473316700|FG000|Overall Study|Lost to Follow-up|2|||
131460108|NCT03890666|473316701|FG001|Overall Study|Lost to Follow-up|5|||
131460109|NCT03890666|473316700|FG000|Overall Study|Other than specified|1|||
131460110|NCT03890666|473316701|FG001|Overall Study|Other than specified|8|||
131460111|NCT03232333|473316702|FG000|Overall Study|Infection or Osteomyelitis|9|||
131460112|NCT03232333|473316702|FG000|Overall Study|Lost to Follow-up|4|||
131460113|NCT03232333|473316702|FG000|Overall Study|Withdrawal by Subject|2|||
131460114|NCT03052426|473316703|FG000|Overall Study|Withdrawal by Subject|0|||
131460115|NCT03052426|473316704|FG001|Overall Study|Withdrawal by Subject|1|||
131460116|NCT03052426|473316705|FG002|Overall Study|Withdrawal by Subject|0|||
131460117|NCT03052426|473316703|FG000|Overall Study|Lost to Follow-up|2|||
131460118|NCT03052426|473316704|FG001|Overall Study|Lost to Follow-up|0|||
131460119|NCT03052426|473316705|FG002|Overall Study|Lost to Follow-up|1|||
131460120|NCT01640314|473316707|FG000|Overall Study|Protocol Violation|0|||
131460121|NCT01640314|473316708|FG001|Overall Study|Protocol Violation|1|||
131460122|NCT01290796|473316709|FG000|Overall Study|Lost to Follow-up|21|||
131460123|NCT01290796|473316709|FG000|Overall Study|Withdrawal by Subject|4|||
131460124|NCT01290796|473316709|FG000|Overall Study|Physician Decision|2|||
131460125|NCT01290796|473316709|FG000|Overall Study|Secondary Surgical Intervention|2|||
131460126|NCT01290796|473316709|FG000|Overall Study|Withdrawal by Sponsor|1|||
131460127|NCT01419197|473316713|FG000|Overall Study|Death|247|||
131460128|NCT01419197|473316714|FG001|Overall Study|Death|122|||
131460129|NCT01419197|473316713|FG000|Overall Study|Physician Decision|4|||
131460130|NCT01419197|473316714|FG001|Overall Study|Physician Decision|4|||
131460131|NCT01419197|473316713|FG000|Overall Study|Non-compliance|3|||
131460132|NCT01419197|473316714|FG001|Overall Study|Non-compliance|1|||
131460133|NCT01419197|473316713|FG000|Overall Study|Withdrawal by Subject|33|||
131460134|NCT01419197|473316714|FG001|Overall Study|Withdrawal by Subject|32|||
131460135|NCT01419197|473316713|FG000|Overall Study|Study Completed by Sponsor|103|||
131460136|NCT01419197|473316714|FG001|Overall Study|Study Completed by Sponsor|34|||
131460137|NCT01419197|473316713|FG000|Overall Study|Reason Not Specified|0|||
131460138|NCT01419197|473316714|FG001|Overall Study|Reason Not Specified|1|||
131460139|NCT01419197|473316713|FG000|Overall Study|Lost to Follow-up|14|||
131460140|NCT01419197|473316714|FG001|Overall Study|Lost to Follow-up|4|||
131460141|NCT00146848|473316715|FG000|Pre-randomization|Death|19|||
131460142|NCT00146848|473316716|FG001|Pre-randomization|Death|0|||
131460143|NCT00146848|473316717|FG002|Pre-randomization|Death|0|||
131460144|NCT00146848|473316715|FG000|Pre-randomization|Lost to Follow-up|70|||
131460145|NCT00146848|473316716|FG001|Pre-randomization|Lost to Follow-up|0|||
131460146|NCT00146848|473316717|FG002|Pre-randomization|Lost to Follow-up|0|||
131460147|NCT00146848|473316715|FG000|Pre-randomization|Physician Decision|8|||
131460148|NCT00146848|473316716|FG001|Pre-randomization|Physician Decision|0|||
131460149|NCT00146848|473316717|FG002|Pre-randomization|Physician Decision|0|||
131460150|NCT00146848|473316715|FG000|Pre-randomization|Protocol Violation|172|||
131460151|NCT00146848|473316716|FG001|Pre-randomization|Protocol Violation|0|||
131460152|NCT00146848|473316717|FG002|Pre-randomization|Protocol Violation|0|||
131460153|NCT00146848|473316715|FG000|Pre-randomization|Withdrawal by Subject|40|||
131460154|NCT00146848|473316716|FG001|Pre-randomization|Withdrawal by Subject|0|||
131460155|NCT00146848|473316717|FG002|Pre-randomization|Withdrawal by Subject|0|||
131460156|NCT00146848|473316715|FG000|Post-randomization|Lost to Follow-up|12|||
131460157|NCT00146848|473316716|FG001|Post-randomization|Lost to Follow-up|15|||
131460158|NCT00146848|473316717|FG002|Post-randomization|Lost to Follow-up|12|||
131460159|NCT00146848|473316715|FG000|Post-randomization|Withdrawn|26|||
131460160|NCT00146848|473316716|FG001|Post-randomization|Withdrawn|32|||
131460161|NCT00146848|473316717|FG002|Post-randomization|Withdrawn|27|||
131460162|NCT00119678|473316719|FG000|Double-blind Treatment Period|Death|1|||
131460163|NCT00119678|473316720|FG001|Double-blind Treatment Period|Death|0|||
131460164|NCT00119678|473316719|FG000|Double-blind Treatment Period|Adverse Event|7|||
131460165|NCT00119678|473316720|FG001|Double-blind Treatment Period|Adverse Event|1|||
131460166|NCT00119678|473316719|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
131460167|NCT00119678|473316720|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
131460168|NCT00119678|473316719|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
131460169|NCT00119678|473316720|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
131460170|NCT00119678|473316719|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
131460171|NCT00119678|473316720|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
131460172|NCT00119678|473316719|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
131460173|NCT00119678|473316720|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
131460174|NCT00119678|473316719|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
131460175|NCT00119678|473316720|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
131460176|NCT00119678|473316719|FG000|Double-blind Treatment Period|Pregnancy|0|||
131460177|NCT00119678|473316720|FG001|Double-blind Treatment Period|Pregnancy|2|||
131460178|NCT00119678|473316719|FG000|Double-blind Treatment Period|Not treated|1|||
131460179|NCT00119678|473316720|FG001|Double-blind Treatment Period|Not treated|2|||
131460180|NCT00119678|473316719|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
131460181|NCT00119678|473316720|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
131460182|NCT00119678|473316719|FG000|Open-label Treatment Period|Death|1|||
131460183|NCT00119678|473316720|FG001|Open-label Treatment Period|Death|0|||
131460184|NCT00119678|473316719|FG000|Open-label Treatment Period|Adverse Event|3|||
131460185|NCT00119678|473316720|FG001|Open-label Treatment Period|Adverse Event|0|||
131460186|NCT00119678|473316719|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
131460187|NCT00119678|473316720|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
131460188|NCT00119678|473316719|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
131460189|NCT00119678|473316720|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
131460190|NCT00119678|473316719|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
131460191|NCT00119678|473316720|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
131460192|NCT00119678|473316719|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
131460193|NCT00119678|473316720|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
131460194|NCT00119678|473316719|FG000|Open-label Treatment Period|Pregnancy|1|||
131460195|NCT00119678|473316720|FG001|Open-label Treatment Period|Pregnancy|0|||
131460196|NCT00119678|473316719|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
131460197|NCT00119678|473316720|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
131460198|NCT01761240|473316721|FG000|Overall Study|Progressive disease:radiology assessment|3|||
131460199|NCT01761240|473316722|FG001|Overall Study|Progressive disease:radiology assessment|3|||
131460200|NCT01761240|473316723|FG002|Overall Study|Progressive disease:radiology assessment|0|||
131460201|NCT01761240|473316724|FG003|Overall Study|Progressive disease:radiology assessment|0|||
131460202|NCT01761240|473316725|FG004|Overall Study|Progressive disease:radiology assessment|0|||
131460203|NCT01761240|473316721|FG000|Overall Study|Progressive disease:clinical assessment|0|||
131460204|NCT01761240|473316722|FG001|Overall Study|Progressive disease:clinical assessment|0|||
131460205|NCT01761240|473316723|FG002|Overall Study|Progressive disease:clinical assessment|3|||
131460206|NCT01761240|473316724|FG003|Overall Study|Progressive disease:clinical assessment|1|||
131460207|NCT01761240|473316725|FG004|Overall Study|Progressive disease:clinical assessment|0|||
131460208|NCT01761240|473316721|FG000|Overall Study|Withdrawal by Subject|0|||
131460209|NCT01761240|473316722|FG001|Overall Study|Withdrawal by Subject|0|||
131460210|NCT01761240|473316723|FG002|Overall Study|Withdrawal by Subject|0|||
131460211|NCT01761240|473316724|FG003|Overall Study|Withdrawal by Subject|3|||
131460212|NCT01761240|473316725|FG004|Overall Study|Withdrawal by Subject|1|||
131460213|NCT01761240|473316721|FG000|Overall Study|Adverse Event|0|||
131460214|NCT01761240|473316722|FG001|Overall Study|Adverse Event|0|||
131460215|NCT01761240|473316723|FG002|Overall Study|Adverse Event|0|||
131460216|NCT01761240|473316724|FG003|Overall Study|Adverse Event|1|||
131460217|NCT01761240|473316725|FG004|Overall Study|Adverse Event|6|||
131460218|NCT01761240|473316721|FG000|Overall Study|Death|0|||
131460219|NCT01761240|473316722|FG001|Overall Study|Death|1|||
131460220|NCT01761240|473316723|FG002|Overall Study|Death|1|||
131460221|NCT01761240|473316724|FG003|Overall Study|Death|2|||
131460222|NCT01761240|473316725|FG004|Overall Study|Death|1|||
131460223|NCT01761240|473316721|FG000|Overall Study|Non-compliance|0|||
131460224|NCT01761240|473316722|FG001|Overall Study|Non-compliance|0|||
131460225|NCT01761240|473316723|FG002|Overall Study|Non-compliance|1|||
131460226|NCT01761240|473316724|FG003|Overall Study|Non-compliance|0|||
131460227|NCT01761240|473316725|FG004|Overall Study|Non-compliance|0|||
131460228|NCT00509145|473316726|FG000|Overall Study|Death|0|||
131460229|NCT00509145|473316727|FG001|Overall Study|Death|2|||
131460230|NCT00509145|473316726|FG000|Overall Study|Adverse Event|42|||
131460231|NCT00509145|473316727|FG001|Overall Study|Adverse Event|28|||
131460232|NCT00509145|473316726|FG000|Overall Study|Withdrawal by Subject|32|||
131460233|NCT00509145|473316727|FG001|Overall Study|Withdrawal by Subject|38|||
131460234|NCT00509145|473316726|FG000|Overall Study|Physician Decision|11|||
131460235|NCT00509145|473316727|FG001|Overall Study|Physician Decision|14|||
131460236|NCT00509145|473316726|FG000|Overall Study|Protocol Violation|1|||
131460237|NCT00509145|473316727|FG001|Overall Study|Protocol Violation|6|||
131460238|NCT00509145|473316726|FG000|Overall Study|Pregnancy|3|||
131460239|NCT00509145|473316727|FG001|Overall Study|Pregnancy|8|||
131460240|NCT00509145|473316726|FG000|Overall Study|Lost to Follow-up|6|||
131460241|NCT00509145|473316727|FG001|Overall Study|Lost to Follow-up|5|||
131460242|NCT00509145|473316726|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
131460243|NCT00509145|473316727|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
131460244|NCT00509145|473316726|FG000|Overall Study|Other|6|||
131460245|NCT00509145|473316727|FG001|Overall Study|Other|6|||
131460246|NCT01994889|473316728|FG000|Overall Study|Adverse Event|5|||
131460247|NCT01994889|473316729|FG001|Overall Study|Adverse Event|12|||
131460248|NCT01994889|473316730|FG002|Overall Study|Adverse Event|11|||
131460249|NCT01994889|473316728|FG000|Overall Study|Cardiac Device Implantation|0|||
131460250|NCT01994889|473316729|FG001|Overall Study|Cardiac Device Implantation|2|||
131460251|NCT01994889|473316730|FG002|Overall Study|Cardiac Device Implantation|0|||
131460252|NCT01994889|473316728|FG000|Overall Study|Organ Transplantation|1|||
131460253|NCT01994889|473316729|FG001|Overall Study|Organ Transplantation|5|||
131460254|NCT01994889|473316730|FG002|Overall Study|Organ Transplantation|5|||
131460255|NCT01994889|473316728|FG000|Overall Study|No longer willing to participate|8|||
131460256|NCT01994889|473316729|FG001|Overall Study|No longer willing to participate|17|||
131460257|NCT01994889|473316730|FG002|Overall Study|No longer willing to participate|37|||
131460258|NCT01994889|473316728|FG000|Overall Study|Lost to Follow-up|0|||
131460259|NCT01994889|473316729|FG001|Overall Study|Lost to Follow-up|1|||
131460260|NCT01994889|473316730|FG002|Overall Study|Lost to Follow-up|0|||
131460261|NCT01994889|473316728|FG000|Overall Study|Protocol Violation|0|||
131460262|NCT01994889|473316729|FG001|Overall Study|Protocol Violation|1|||
131460263|NCT01994889|473316730|FG002|Overall Study|Protocol Violation|1|||
131460264|NCT01994889|473316728|FG000|Overall Study|Death|14|||
131460265|NCT01994889|473316729|FG001|Overall Study|Death|25|||
131460266|NCT01994889|473316730|FG002|Overall Study|Death|38|||
131460267|NCT02874144|473316731|FG000|Overall Study|Lost to Follow-up|3|||
131460268|NCT02874144|473316732|FG001|Overall Study|Lost to Follow-up|5|||
131460269|NCT02929498|473316737|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
131460270|NCT02929498|473316738|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
131460271|NCT02929498|473316739|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
131460272|NCT02929498|473316737|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
131460273|NCT02929498|473316738|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
131460274|NCT02929498|473316739|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
131460275|NCT01214395|473316742|FG000|Overall Study|All patients had infection|5|||
131460276|NCT00715910|473316746|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
131460277|NCT00715910|473316747|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
131460278|NCT00715910|473316748|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
131460279|NCT00715910|473316749|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
131460280|NCT00715910|473316750|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
131460281|NCT00715910|473316751|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
131460282|NCT00715910|473316746|FG000|Booster and ESFU Phase|Other|0|||
131460283|NCT00715910|473316747|FG001|Booster and ESFU Phase|Other|0|||
131460284|NCT00715910|473316748|FG002|Booster and ESFU Phase|Other|0|||
131460285|NCT00715910|473316749|FG003|Booster and ESFU Phase|Other|5|||
131460286|NCT00715910|473316750|FG004|Booster and ESFU Phase|Other|1|||
131460287|NCT00715910|473316751|FG005|Booster and ESFU Phase|Other|0|||
131460288|NCT00006289|473316752|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
131460289|NCT00006289|473316753|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
131460290|NCT00006289|473316752|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
131460291|NCT00006289|473316753|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
131460292|NCT04359901|473316758|FG000|Overall Study|Withdrawal by Subject|0|||
131460293|NCT04359901|473316759|FG001|Overall Study|Withdrawal by Subject|1|||
131460294|NCT04359901|473316758|FG000|Overall Study|Death|6|||
131460295|NCT04359901|473316759|FG001|Overall Study|Death|2|||
131460296|NCT00243841|473316762|FG000|Overall Study|Physician Decision|0|||
131460297|NCT00243841|473316763|FG001|Overall Study|Physician Decision|0|||
131460298|NCT00243841|473316764|FG002|Overall Study|Physician Decision|1|||
131460299|NCT00243841|473316765|FG003|Overall Study|Physician Decision|0|||
131460300|NCT00243841|473316766|FG004|Overall Study|Physician Decision|0|||
131460301|NCT00243841|473316767|FG005|Overall Study|Physician Decision|2|||
131460302|NCT01379508|473316768|FG000|Treatment to Week 104|Adverse Event|2|||
131460303|NCT01379508|473316769|FG001|Treatment to Week 104|Adverse Event|0|||
131460304|NCT01379508|473316770|FG002|Treatment to Week 104|Adverse Event|5|||
131460305|NCT01379508|473316771|FG003|Treatment to Week 104|Adverse Event|0|||
131460306|NCT01379508|473316768|FG000|Treatment to Week 104|Abnormal lab value|1|||
131460307|NCT01379508|473316769|FG001|Treatment to Week 104|Abnormal lab value|0|||
131460308|NCT01379508|473316770|FG002|Treatment to Week 104|Abnormal lab value|0|||
131460309|NCT01379508|473316771|FG003|Treatment to Week 104|Abnormal lab value|0|||
131460310|NCT01379508|473316768|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
131460311|NCT01379508|473316769|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
131460312|NCT01379508|473316770|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
131460313|NCT01379508|473316771|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
131460314|NCT01379508|473316768|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
131460315|NCT01379508|473316769|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
131460316|NCT01379508|473316770|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
131460317|NCT01379508|473316771|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
131460318|NCT01379508|473316768|FG000|Treatment to Week 104|Lost to Follow-up|5|||
131460319|NCT01379508|473316769|FG001|Treatment to Week 104|Lost to Follow-up|0|||
131460320|NCT01379508|473316770|FG002|Treatment to Week 104|Lost to Follow-up|3|||
131460321|NCT01379508|473316771|FG003|Treatment to Week 104|Lost to Follow-up|0|||
131460322|NCT01379508|473316768|FG000|Treatment to Week 104|Administrative problems|3|||
131460323|NCT01379508|473316769|FG001|Treatment to Week 104|Administrative problems|1|||
131460324|NCT01379508|473316770|FG002|Treatment to Week 104|Administrative problems|0|||
131460325|NCT01379508|473316771|FG003|Treatment to Week 104|Administrative problems|0|||
131460326|NCT01379508|473316768|FG000|Treatment to Week 104|Protocol Violation|1|||
131460327|NCT01379508|473316769|FG001|Treatment to Week 104|Protocol Violation|1|||
131460328|NCT01379508|473316770|FG002|Treatment to Week 104|Protocol Violation|1|||
131460329|NCT01379508|473316771|FG003|Treatment to Week 104|Protocol Violation|0|||
131460330|NCT01379508|473316768|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
131460331|NCT01379508|473316769|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
131460332|NCT01379508|473316770|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
131460333|NCT01379508|473316771|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
131460334|NCT01379508|473316768|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
131460335|NCT01379508|473316769|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
131460336|NCT01379508|473316770|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
131460337|NCT01379508|473316771|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
131460338|NCT01379508|473316768|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
131460339|NCT01379508|473316769|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
131460340|NCT01379508|473316770|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
131460341|NCT01379508|473316771|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
131460342|NCT01379508|473316768|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
131460343|NCT01379508|473316769|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
131460344|NCT01379508|473316770|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
131460345|NCT01379508|473316771|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
131460346|NCT03320824|473318695|FG000|Overall Study|Withdrawal by Subject|8|||
131460347|NCT03320824|473318696|FG001|Overall Study|Withdrawal by Subject|1|||
131460348|NCT03320824|473318695|FG000|Overall Study|Lost to Follow-up|10|||
131460349|NCT03320824|473318696|FG001|Overall Study|Lost to Follow-up|1|||
131460350|NCT03320824|473318695|FG000|Overall Study|moved out of state|0|||
131460351|NCT03320824|473318696|FG001|Overall Study|moved out of state|1|||
131460352|NCT03320824|473318695|FG000|Overall Study|could not complete final visit|0|||
131460353|NCT03320824|473318696|FG001|Overall Study|could not complete final visit|1|||
131460354|NCT04590248|473318703|FG000|Overall Study|Lost to Follow-up|1|||
131460355|NCT04590248|473318703|FG000|Overall Study|Withdrawal by Subject|16|||
131460356|NCT04590248|473318703|FG000|Overall Study|Other|2|||
131460357|NCT00615901|473318704|FG000|Overall Study|Withdrawal by Subject|2|||
131460358|NCT00615901|473318704|FG000|Overall Study|Adverse Event|7|||
131460359|NCT03598114|473318705|FG000|Overall Study|Staff turnover/left the program|3|||
131460360|NCT03598114|473318706|FG001|Overall Study|Staff turnover/left the program|39|||
131460361|NCT02527200|473318707|FG000|Overall Study|Withdrawal by Subject|3|||
131460362|NCT02527200|473318708|FG001|Overall Study|Withdrawal by Subject|2|||
131460363|NCT02527200|473318709|FG002|Overall Study|Withdrawal by Subject|1|||
131460364|NCT02527200|473318710|FG003|Overall Study|Withdrawal by Subject|0|||
131460365|NCT02527200|473318707|FG000|Overall Study|Unclassified|0|||
131460366|NCT02527200|473318708|FG001|Overall Study|Unclassified|1|||
131460367|NCT02527200|473318709|FG002|Overall Study|Unclassified|0|||
131460368|NCT02527200|473318710|FG003|Overall Study|Unclassified|0|||
131460369|NCT02527200|473318707|FG000|Overall Study|Lost to Follow-up|0|||
131460370|NCT02527200|473318708|FG001|Overall Study|Lost to Follow-up|0|||
131460371|NCT02527200|473318709|FG002|Overall Study|Lost to Follow-up|1|||
131460372|NCT02527200|473318710|FG003|Overall Study|Lost to Follow-up|0|||
131460373|NCT03330002|473318715|FG000|Overall Study|Lost to Follow-up|15|||
131460374|NCT03330002|473318715|FG000|Overall Study|Death|7|||
131460375|NCT00635219|473318716|FG000|Overall Study|Adverse Event|12|||
131460376|NCT00635219|473318717|FG001|Overall Study|Adverse Event|10|||
131460377|NCT00635219|473318718|FG002|Overall Study|Adverse Event|18|||
131460378|NCT00635219|473318719|FG003|Overall Study|Adverse Event|15|||
131460379|NCT00635219|473318720|FG004|Overall Study|Adverse Event|19|||
131460380|NCT00635219|473318716|FG000|Overall Study|Lack of Efficacy|5|||
131460381|NCT00635219|473318717|FG001|Overall Study|Lack of Efficacy|6|||
131460382|NCT00635219|473318718|FG002|Overall Study|Lack of Efficacy|3|||
131460383|NCT00635219|473318719|FG003|Overall Study|Lack of Efficacy|4|||
131460384|NCT00635219|473318720|FG004|Overall Study|Lack of Efficacy|6|||
131460385|NCT00635219|473318716|FG000|Overall Study|Non-compliance With Study Product|0|||
131460386|NCT00635219|473318717|FG001|Overall Study|Non-compliance With Study Product|0|||
131460387|NCT00635219|473318718|FG002|Overall Study|Non-compliance With Study Product|0|||
131460388|NCT00635219|473318719|FG003|Overall Study|Non-compliance With Study Product|2|||
131460389|NCT00635219|473318720|FG004|Overall Study|Non-compliance With Study Product|1|||
131460390|NCT00635219|473318716|FG000|Overall Study|Protocol Violation|0|||
131460391|NCT00635219|473318717|FG001|Overall Study|Protocol Violation|2|||
131460392|NCT00635219|473318718|FG002|Overall Study|Protocol Violation|3|||
131460393|NCT00635219|473318719|FG003|Overall Study|Protocol Violation|2|||
131460394|NCT00635219|473318720|FG004|Overall Study|Protocol Violation|4|||
131460395|NCT00635219|473318716|FG000|Overall Study|Withdrawal of Consent|8|||
131460396|NCT00635219|473318717|FG001|Overall Study|Withdrawal of Consent|6|||
131460397|NCT00635219|473318718|FG002|Overall Study|Withdrawal of Consent|8|||
131460398|NCT00635219|473318719|FG003|Overall Study|Withdrawal of Consent|11|||
131460399|NCT00635219|473318720|FG004|Overall Study|Withdrawal of Consent|8|||
131460400|NCT00635219|473318716|FG000|Overall Study|Lost to Follow-up|0|||
131460401|NCT00635219|473318717|FG001|Overall Study|Lost to Follow-up|0|||
131460402|NCT00635219|473318718|FG002|Overall Study|Lost to Follow-up|2|||
131460403|NCT00635219|473318719|FG003|Overall Study|Lost to Follow-up|0|||
131460404|NCT00635219|473318720|FG004|Overall Study|Lost to Follow-up|3|||
131460405|NCT00635219|473318716|FG000|Overall Study|Administrative or Other Reasons|0|||
131460406|NCT00635219|473318717|FG001|Overall Study|Administrative or Other Reasons|1|||
131460407|NCT00635219|473318718|FG002|Overall Study|Administrative or Other Reasons|1|||
131460408|NCT00635219|473318719|FG003|Overall Study|Administrative or Other Reasons|0|||
131460409|NCT00635219|473318720|FG004|Overall Study|Administrative or Other Reasons|1|||
131460410|NCT01598129|473318721|FG000|Overall Study|Disease progression|6|||
131460411|NCT01598129|473318721|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
131460412|NCT01598129|473318721|FG000|Overall Study|Withdrawal by Subject|1|||
131460413|NCT00505076|473318722|FG000|Overall Study|Adverse Event|1|||
131460414|NCT00505076|473318723|FG001|Overall Study|Adverse Event|0|||
131460415|NCT00505076|473318724|FG002|Overall Study|Adverse Event|1|||
131460416|NCT00505076|473318722|FG000|Overall Study|Protocol Violation|2|||
131460417|NCT00505076|473318723|FG001|Overall Study|Protocol Violation|1|||
131460418|NCT00505076|473318724|FG002|Overall Study|Protocol Violation|2|||
131460419|NCT00505076|473318722|FG000|Overall Study|Withdrawal by Subject|0|||
131460420|NCT00505076|473318723|FG001|Overall Study|Withdrawal by Subject|1|||
131460421|NCT00505076|473318724|FG002|Overall Study|Withdrawal by Subject|2|||
131460422|NCT00591318|473318727|FG000|Overall Study|Lack of Efficacy|2|||
131460423|NCT00591318|473318728|FG001|Overall Study|Lack of Efficacy|0|||
131460424|NCT00591318|473318727|FG000|Overall Study|Adverse Event|2|||
131460425|NCT00591318|473318728|FG001|Overall Study|Adverse Event|0|||
131460426|NCT00233454|473318734|FG000|Overall Study|Death|6|||
131460427|NCT04224688|473318735|FG000|Overall Study|Withdrawal by Subject|1|||
131460428|NCT04224688|473318736|FG001|Overall Study|Withdrawal by Subject|3|||
131460429|NCT04224688|473318735|FG000|Overall Study|Lack of Efficacy|1|||
131460430|NCT04224688|473318736|FG001|Overall Study|Lack of Efficacy|1|||
131460431|NCT04224688|473318735|FG000|Overall Study|Adverse event, not fatal|0|||
131460432|NCT04224688|473318736|FG001|Overall Study|Adverse event, not fatal|2|||
131460433|NCT04224688|473318735|FG000|Overall Study|COVID-19|0|||
131460434|NCT04224688|473318736|FG001|Overall Study|COVID-19|1|||
131460435|NCT02745145|473318737|FG000|Overall Study|Adverse Event|1|||
131460436|NCT02745145|473318738|FG001|Overall Study|Adverse Event|0|||
131460437|NCT02745145|473318739|FG002|Overall Study|Adverse Event|0|||
131460438|NCT02745145|473318737|FG000|Overall Study|Death|0|||
131460439|NCT02745145|473318738|FG001|Overall Study|Death|1|||
131460440|NCT02745145|473318739|FG002|Overall Study|Death|0|||
131460441|NCT02745145|473318737|FG000|Overall Study|Progressive disease|0|||
131460442|NCT02745145|473318738|FG001|Overall Study|Progressive disease|0|||
131460443|NCT02745145|473318739|FG002|Overall Study|Progressive disease|1|||
131460444|NCT02745145|473318737|FG000|Overall Study|Withdrew consent|1|||
131460445|NCT02745145|473318738|FG001|Overall Study|Withdrew consent|1|||
131460446|NCT02745145|473318739|FG002|Overall Study|Withdrew consent|1|||
131460447|NCT02745145|473318737|FG000|Overall Study|Study Termination|8|||
131460448|NCT02745145|473318738|FG001|Overall Study|Study Termination|3|||
131460449|NCT02745145|473318739|FG002|Overall Study|Study Termination|7|||
131460450|NCT00388583|473318740|FG000|Overall Study|Protocol Violation|1|||
131460451|NCT00388583|473318741|FG001|Overall Study|Protocol Violation|0|||
131460452|NCT00388583|473318740|FG000|Overall Study|Withdrawal by Subject|3|||
131460453|NCT00388583|473318741|FG001|Overall Study|Withdrawal by Subject|3|||
131460454|NCT00388583|473318740|FG000|Overall Study|Serious Adverse Event|2|||
131460455|NCT00388583|473318741|FG001|Overall Study|Serious Adverse Event|0|||
131460456|NCT00388583|473318740|FG000|Overall Study|Did not receive vaccine|0|||
131460457|NCT00388583|473318741|FG001|Overall Study|Did not receive vaccine|1|||
131460458|NCT01155011|473318743|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
131460459|NCT01155011|473318744|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
131460460|NCT01155011|473318743|FG000|Baseline to 6 Months|investigator decision, moved|4|||
131460461|NCT01155011|473318744|FG001|Baseline to 6 Months|investigator decision, moved|5|||
131460462|NCT01155011|473318743|FG000|Baseline to 6 Months|Death|0|||
131460463|NCT01155011|473318744|FG001|Baseline to 6 Months|Death|1|||
131460464|NCT01155011|473318743|FG000|6 to 12 Months|Withdrawal by Subject|8|||
131460465|NCT01155011|473318744|FG001|6 to 12 Months|Withdrawal by Subject|5|||
131460466|NCT01155011|473318743|FG000|6 to 12 Months|Death|1|||
131460467|NCT01155011|473318744|FG001|6 to 12 Months|Death|5|||
131460468|NCT01743001|473318745|FG000|Overall Study|Physician Decision|1|||
131460469|NCT01743001|473318746|FG001|Overall Study|Physician Decision|0|||
131460470|NCT01743001|473318745|FG000|Overall Study|Pregnancy|1|||
131460471|NCT01743001|473318746|FG001|Overall Study|Pregnancy|0|||
131460472|NCT01743001|473318745|FG000|Overall Study|Death|1|||
131460473|NCT01743001|473318746|FG001|Overall Study|Death|0|||
131460474|NCT01565343|473318749|FG000|Overall Study|Administrative decision/technical issues|1|||
131460475|NCT01565343|473318750|FG001|Overall Study|Administrative decision/technical issues|0|||
131460476|NCT01565343|473318751|FG002|Overall Study|Administrative decision/technical issues|0|||
131460477|NCT01853839|473318756|FG000|Overall Study|Violated inclusion criteria|2|||
131460478|NCT01853839|473318756|FG000|Overall Study|Not meet ITT population definition|58|||
131460479|NCT01853839|473318756|FG000|Overall Study|End of treatment visit too early|33|||
131460480|NCT01853839|473318756|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
131460481|NCT04145219|473318757|FG000|Overall Study|Adverse Event|18|||
131460482|NCT04145219|473318758|FG001|Overall Study|Adverse Event|6|||
131460483|NCT04145219|473318757|FG000|Overall Study|Lost to Follow-up|2|||
131460484|NCT04145219|473318758|FG001|Overall Study|Lost to Follow-up|3|||
131460485|NCT04145219|473318757|FG000|Overall Study|Physician Decision|0|||
131460486|NCT04145219|473318758|FG001|Overall Study|Physician Decision|2|||
131460487|NCT04145219|473318757|FG000|Overall Study|Withdrawal by Subject|12|||
131460488|NCT04145219|473318758|FG001|Overall Study|Withdrawal by Subject|8|||
131460489|NCT04145219|473318757|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
131460490|NCT04145219|473318758|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
131460491|NCT02709538|473318759|FG000|Overall Study|Adverse Event|13|||
131460492|NCT02709538|473318760|FG001|Overall Study|Adverse Event|2|||
131460493|NCT02709538|473318761|FG002|Overall Study|Adverse Event|3|||
131460494|NCT02709538|473318759|FG000|Overall Study|Lack of Efficacy|1|||
131460495|NCT02709538|473318760|FG001|Overall Study|Lack of Efficacy|0|||
131460496|NCT02709538|473318761|FG002|Overall Study|Lack of Efficacy|0|||
131460497|NCT02709538|473318759|FG000|Overall Study|Lost to Follow-up|24|||
131460498|NCT02709538|473318760|FG001|Overall Study|Lost to Follow-up|8|||
131460499|NCT02709538|473318761|FG002|Overall Study|Lost to Follow-up|4|||
131460500|NCT02709538|473318759|FG000|Overall Study|Physician Decision|1|||
131460501|NCT02709538|473318760|FG001|Overall Study|Physician Decision|0|||
131460502|NCT02709538|473318761|FG002|Overall Study|Physician Decision|0|||
131460503|NCT02709538|473318759|FG000|Overall Study|Withdrawal by Subject|40|||
131460504|NCT02709538|473318760|FG001|Overall Study|Withdrawal by Subject|7|||
131460505|NCT02709538|473318761|FG002|Overall Study|Withdrawal by Subject|4|||
131460506|NCT02709538|473318759|FG000|Overall Study|Non-compliance with study procedures|5|||
131460507|NCT02709538|473318760|FG001|Overall Study|Non-compliance with study procedures|0|||
131460508|NCT02709538|473318761|FG002|Overall Study|Non-compliance with study procedures|0|||
131460509|NCT02709538|473318759|FG000|Overall Study|Non-compliance with study drug|2|||
131460510|NCT02709538|473318760|FG001|Overall Study|Non-compliance with study drug|0|||
131460511|NCT02709538|473318761|FG002|Overall Study|Non-compliance with study drug|0|||
131460512|NCT02709538|473318759|FG000|Overall Study|Protocol deviation|10|||
131460513|NCT02709538|473318760|FG001|Overall Study|Protocol deviation|4|||
131460514|NCT02709538|473318761|FG002|Overall Study|Protocol deviation|4|||
131460515|NCT02709538|473318759|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
131460516|NCT02709538|473318760|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
131460517|NCT02709538|473318761|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
131460518|NCT02709538|473318759|FG000|Overall Study|Other|16|||
131460519|NCT02709538|473318760|FG001|Overall Study|Other|7|||
131460520|NCT02709538|473318761|FG002|Overall Study|Other|5|||
131460521|NCT02059291|473318762|FG000|Epoch 2|Lack of Efficacy|0|||
131460522|NCT02059291|473318763|FG001|Epoch 2|Lack of Efficacy|0|||
131460523|NCT02059291|473318764|FG002|Epoch 2|Lack of Efficacy|0|||
131460524|NCT02059291|473318765|FG003|Epoch 2|Lack of Efficacy|1|||
131460525|NCT02059291|473318766|FG004|Epoch 2|Lack of Efficacy|0|||
131460526|NCT02059291|473318767|FG005|Epoch 2|Lack of Efficacy|1|||
131460527|NCT02059291|473318768|FG006|Epoch 2|Lack of Efficacy|0|||
131460528|NCT02059291|473318769|FG007|Epoch 2|Lack of Efficacy|0|||
131460529|NCT02059291|473318770|FG008|Epoch 2|Lack of Efficacy|0|||
131460530|NCT02059291|473318771|FG009|Epoch 2|Lack of Efficacy|0|||
131460531|NCT02059291|473318772|FG010|Epoch 2|Lack of Efficacy|0|||
131460532|NCT02059291|473318773|FG011|Epoch 2|Lack of Efficacy|0|||
131460533|NCT02059291|473318774|FG012|Epoch 2|Lack of Efficacy|0|||
131460534|NCT02059291|473318775|FG013|Epoch 2|Lack of Efficacy|0|||
131460535|NCT02059291|473318776|FG014|Epoch 2|Lack of Efficacy|0|||
131460536|NCT02059291|473318777|FG015|Epoch 2|Lack of Efficacy|0|||
131460537|NCT02059291|473318778|FG016|Epoch 2|Lack of Efficacy|0|||
131460538|NCT02059291|473318779|FG017|Epoch 2|Lack of Efficacy|0|||
131460539|NCT02059291|473318780|FG018|Epoch 2|Lack of Efficacy|0|||
131460540|NCT02059291|473318781|FG019|Epoch 2|Lack of Efficacy|0|||
131460541|NCT02059291|473318782|FG020|Epoch 2|Lack of Efficacy|0|||
131460542|NCT02059291|473318783|FG021|Epoch 2|Lack of Efficacy|0|||
131460543|NCT02059291|473318784|FG022|Epoch 2|Lack of Efficacy|0|||
131460544|NCT02059291|473318785|FG023|Epoch 2|Lack of Efficacy|0|||
131460545|NCT02059291|473318786|FG024|Epoch 2|Lack of Efficacy|0|||
131460546|NCT02059291|473318762|FG000|Epoch 2|Adverse Event|0|||
131460547|NCT02059291|473318763|FG001|Epoch 2|Adverse Event|0|||
131460548|NCT02059291|473318764|FG002|Epoch 2|Adverse Event|1|||
131460549|NCT02059291|473318765|FG003|Epoch 2|Adverse Event|1|||
131460550|NCT02059291|473318766|FG004|Epoch 2|Adverse Event|0|||
131460551|NCT02059291|473318767|FG005|Epoch 2|Adverse Event|0|||
131460552|NCT02059291|473318768|FG006|Epoch 2|Adverse Event|0|||
131460553|NCT02059291|473318769|FG007|Epoch 2|Adverse Event|1|||
131460554|NCT02059291|473318770|FG008|Epoch 2|Adverse Event|1|||
131460555|NCT02059291|473318771|FG009|Epoch 2|Adverse Event|0|||
131460556|NCT02059291|473318772|FG010|Epoch 2|Adverse Event|0|||
131460557|NCT02059291|473318773|FG011|Epoch 2|Adverse Event|0|||
131460558|NCT02059291|473318774|FG012|Epoch 2|Adverse Event|0|||
131460559|NCT02059291|473318775|FG013|Epoch 2|Adverse Event|0|||
131460560|NCT02059291|473318776|FG014|Epoch 2|Adverse Event|0|||
131460561|NCT02059291|473318777|FG015|Epoch 2|Adverse Event|0|||
131460562|NCT02059291|473318778|FG016|Epoch 2|Adverse Event|0|||
131460563|NCT02059291|473318779|FG017|Epoch 2|Adverse Event|0|||
131460564|NCT02059291|473318780|FG018|Epoch 2|Adverse Event|0|||
131460565|NCT02059291|473318781|FG019|Epoch 2|Adverse Event|0|||
131460566|NCT02059291|473318782|FG020|Epoch 2|Adverse Event|0|||
131460567|NCT02059291|473318783|FG021|Epoch 2|Adverse Event|0|||
131460568|NCT02059291|473318784|FG022|Epoch 2|Adverse Event|0|||
131460569|NCT02059291|473318785|FG023|Epoch 2|Adverse Event|0|||
131460570|NCT02059291|473318786|FG024|Epoch 2|Adverse Event|0|||
131460571|NCT02059291|473318762|FG000|Epoch 2|Withdrawal by Subject|0|||
131460572|NCT02059291|473318763|FG001|Epoch 2|Withdrawal by Subject|1|||
131460573|NCT02059291|473318764|FG002|Epoch 2|Withdrawal by Subject|0|||
131460574|NCT02059291|473318765|FG003|Epoch 2|Withdrawal by Subject|0|||
131460575|NCT02059291|473318766|FG004|Epoch 2|Withdrawal by Subject|0|||
131460576|NCT02059291|473318767|FG005|Epoch 2|Withdrawal by Subject|1|||
131460577|NCT02059291|473318768|FG006|Epoch 2|Withdrawal by Subject|0|||
131460578|NCT02059291|473318769|FG007|Epoch 2|Withdrawal by Subject|0|||
131460579|NCT02059291|473318770|FG008|Epoch 2|Withdrawal by Subject|1|||
131460580|NCT02059291|473318771|FG009|Epoch 2|Withdrawal by Subject|0|||
131460581|NCT02059291|473318772|FG010|Epoch 2|Withdrawal by Subject|0|||
131460582|NCT02059291|473318773|FG011|Epoch 2|Withdrawal by Subject|0|||
131460583|NCT02059291|473318774|FG012|Epoch 2|Withdrawal by Subject|0|||
131460584|NCT02059291|473318775|FG013|Epoch 2|Withdrawal by Subject|0|||
131460585|NCT02059291|473318776|FG014|Epoch 2|Withdrawal by Subject|0|||
131460586|NCT02059291|473318777|FG015|Epoch 2|Withdrawal by Subject|0|||
131460587|NCT02059291|473318778|FG016|Epoch 2|Withdrawal by Subject|0|||
131460588|NCT02059291|473318779|FG017|Epoch 2|Withdrawal by Subject|0|||
131460589|NCT02059291|473318780|FG018|Epoch 2|Withdrawal by Subject|0|||
131460590|NCT02059291|473318781|FG019|Epoch 2|Withdrawal by Subject|0|||
131460591|NCT02059291|473318782|FG020|Epoch 2|Withdrawal by Subject|0|||
131460592|NCT02059291|473318783|FG021|Epoch 2|Withdrawal by Subject|0|||
131460593|NCT02059291|473318784|FG022|Epoch 2|Withdrawal by Subject|0|||
131460594|NCT02059291|473318785|FG023|Epoch 2|Withdrawal by Subject|0|||
131460595|NCT02059291|473318786|FG024|Epoch 2|Withdrawal by Subject|0|||
131460596|NCT02059291|473318762|FG000|Epoch 3|Physician Decision|0|||
131460597|NCT02059291|473318763|FG001|Epoch 3|Physician Decision|0|||
131460598|NCT02059291|473318764|FG002|Epoch 3|Physician Decision|0|||
131460599|NCT02059291|473318765|FG003|Epoch 3|Physician Decision|0|||
131460600|NCT02059291|473318766|FG004|Epoch 3|Physician Decision|0|||
131460601|NCT02059291|473318767|FG005|Epoch 3|Physician Decision|0|||
131460602|NCT02059291|473318768|FG006|Epoch 3|Physician Decision|0|||
131460603|NCT02059291|473318769|FG007|Epoch 3|Physician Decision|0|||
131460604|NCT02059291|473318770|FG008|Epoch 3|Physician Decision|0|||
131460605|NCT02059291|473318771|FG009|Epoch 3|Physician Decision|0|||
131460606|NCT02059291|473318772|FG010|Epoch 3|Physician Decision|0|||
131460607|NCT02059291|473318773|FG011|Epoch 3|Physician Decision|0|||
131460608|NCT02059291|473318774|FG012|Epoch 3|Physician Decision|0|||
131460609|NCT02059291|473318775|FG013|Epoch 3|Physician Decision|1|||
131460610|NCT02059291|473318776|FG014|Epoch 3|Physician Decision|0|||
131460611|NCT02059291|473318777|FG015|Epoch 3|Physician Decision|1|||
131460612|NCT02059291|473318778|FG016|Epoch 3|Physician Decision|0|||
131460613|NCT02059291|473318779|FG017|Epoch 3|Physician Decision|0|||
131460614|NCT02059291|473318780|FG018|Epoch 3|Physician Decision|0|||
131460615|NCT02059291|473318781|FG019|Epoch 3|Physician Decision|0|||
131460616|NCT02059291|473318782|FG020|Epoch 3|Physician Decision|0|||
131460617|NCT02059291|473318783|FG021|Epoch 3|Physician Decision|0|||
131460618|NCT02059291|473318784|FG022|Epoch 3|Physician Decision|0|||
131460619|NCT02059291|473318785|FG023|Epoch 3|Physician Decision|0|||
131460620|NCT02059291|473318786|FG024|Epoch 3|Physician Decision|0|||
131460621|NCT02059291|473318762|FG000|Epoch 3|Adverse Event|0|||
131460622|NCT02059291|473318763|FG001|Epoch 3|Adverse Event|0|||
131460623|NCT02059291|473318764|FG002|Epoch 3|Adverse Event|0|||
131460624|NCT02059291|473318765|FG003|Epoch 3|Adverse Event|0|||
131460625|NCT02059291|473318766|FG004|Epoch 3|Adverse Event|0|||
131460626|NCT02059291|473318767|FG005|Epoch 3|Adverse Event|0|||
131460627|NCT02059291|473318768|FG006|Epoch 3|Adverse Event|0|||
131460628|NCT02059291|473318769|FG007|Epoch 3|Adverse Event|0|||
131460629|NCT02059291|473318770|FG008|Epoch 3|Adverse Event|0|||
131460630|NCT02059291|473318771|FG009|Epoch 3|Adverse Event|0|||
131460631|NCT02059291|473318772|FG010|Epoch 3|Adverse Event|0|||
131460632|NCT02059291|473318773|FG011|Epoch 3|Adverse Event|0|||
131460633|NCT02059291|473318774|FG012|Epoch 3|Adverse Event|0|||
131460634|NCT02059291|473318775|FG013|Epoch 3|Adverse Event|0|||
131460635|NCT02059291|473318776|FG014|Epoch 3|Adverse Event|0|||
131460636|NCT02059291|473318777|FG015|Epoch 3|Adverse Event|1|||
131460637|NCT02059291|473318778|FG016|Epoch 3|Adverse Event|0|||
131460638|NCT02059291|473318779|FG017|Epoch 3|Adverse Event|0|||
131460639|NCT02059291|473318780|FG018|Epoch 3|Adverse Event|0|||
131460640|NCT02059291|473318781|FG019|Epoch 3|Adverse Event|0|||
131460641|NCT02059291|473318782|FG020|Epoch 3|Adverse Event|0|||
131460642|NCT02059291|473318783|FG021|Epoch 3|Adverse Event|0|||
131460643|NCT02059291|473318784|FG022|Epoch 3|Adverse Event|0|||
131460644|NCT02059291|473318785|FG023|Epoch 3|Adverse Event|0|||
131460645|NCT02059291|473318786|FG024|Epoch 3|Adverse Event|0|||
131460646|NCT02059291|473318762|FG000|Epoch 3|Lack of Efficacy|0|||
131460647|NCT02059291|473318763|FG001|Epoch 3|Lack of Efficacy|0|||
131460648|NCT02059291|473318764|FG002|Epoch 3|Lack of Efficacy|0|||
131460649|NCT02059291|473318765|FG003|Epoch 3|Lack of Efficacy|0|||
131460650|NCT02059291|473318766|FG004|Epoch 3|Lack of Efficacy|0|||
131460651|NCT02059291|473318767|FG005|Epoch 3|Lack of Efficacy|0|||
131460652|NCT02059291|473318768|FG006|Epoch 3|Lack of Efficacy|0|||
131460653|NCT02059291|473318769|FG007|Epoch 3|Lack of Efficacy|0|||
131460654|NCT02059291|473318770|FG008|Epoch 3|Lack of Efficacy|0|||
131460655|NCT02059291|473318771|FG009|Epoch 3|Lack of Efficacy|0|||
131460656|NCT02059291|473318772|FG010|Epoch 3|Lack of Efficacy|0|||
131460657|NCT02059291|473318773|FG011|Epoch 3|Lack of Efficacy|0|||
131460658|NCT02059291|473318774|FG012|Epoch 3|Lack of Efficacy|0|||
131460659|NCT02059291|473318775|FG013|Epoch 3|Lack of Efficacy|0|||
131460660|NCT02059291|473318776|FG014|Epoch 3|Lack of Efficacy|0|||
131460661|NCT02059291|473318777|FG015|Epoch 3|Lack of Efficacy|3|||
131460662|NCT02059291|473318778|FG016|Epoch 3|Lack of Efficacy|0|||
131460663|NCT02059291|473318779|FG017|Epoch 3|Lack of Efficacy|0|||
131460664|NCT02059291|473318780|FG018|Epoch 3|Lack of Efficacy|0|||
131460665|NCT02059291|473318781|FG019|Epoch 3|Lack of Efficacy|0|||
131460666|NCT02059291|473318782|FG020|Epoch 3|Lack of Efficacy|0|||
131460667|NCT02059291|473318783|FG021|Epoch 3|Lack of Efficacy|0|||
131460668|NCT02059291|473318784|FG022|Epoch 3|Lack of Efficacy|0|||
131460669|NCT02059291|473318785|FG023|Epoch 3|Lack of Efficacy|0|||
131460670|NCT02059291|473318786|FG024|Epoch 3|Lack of Efficacy|0|||
131460671|NCT02059291|473318762|FG000|Epoch 3|Withdrawal by Subject|0|||
131460672|NCT02059291|473318763|FG001|Epoch 3|Withdrawal by Subject|0|||
131460673|NCT02059291|473318764|FG002|Epoch 3|Withdrawal by Subject|0|||
131460674|NCT02059291|473318765|FG003|Epoch 3|Withdrawal by Subject|0|||
131460675|NCT02059291|473318766|FG004|Epoch 3|Withdrawal by Subject|0|||
131460676|NCT02059291|473318767|FG005|Epoch 3|Withdrawal by Subject|0|||
131460677|NCT02059291|473318768|FG006|Epoch 3|Withdrawal by Subject|0|||
131460678|NCT02059291|473318769|FG007|Epoch 3|Withdrawal by Subject|0|||
131460679|NCT02059291|473318770|FG008|Epoch 3|Withdrawal by Subject|0|||
131460680|NCT02059291|473318771|FG009|Epoch 3|Withdrawal by Subject|0|||
131460681|NCT02059291|473318772|FG010|Epoch 3|Withdrawal by Subject|0|||
131460682|NCT02059291|473318773|FG011|Epoch 3|Withdrawal by Subject|0|||
131460683|NCT02059291|473318774|FG012|Epoch 3|Withdrawal by Subject|0|||
131460684|NCT02059291|473318775|FG013|Epoch 3|Withdrawal by Subject|0|||
131460685|NCT02059291|473318776|FG014|Epoch 3|Withdrawal by Subject|0|||
131460686|NCT02059291|473318777|FG015|Epoch 3|Withdrawal by Subject|1|||
131460687|NCT02059291|473318778|FG016|Epoch 3|Withdrawal by Subject|0|||
131460688|NCT02059291|473318779|FG017|Epoch 3|Withdrawal by Subject|0|||
131460689|NCT02059291|473318780|FG018|Epoch 3|Withdrawal by Subject|0|||
131460690|NCT02059291|473318781|FG019|Epoch 3|Withdrawal by Subject|0|||
131460691|NCT02059291|473318782|FG020|Epoch 3|Withdrawal by Subject|0|||
131460692|NCT02059291|473318783|FG021|Epoch 3|Withdrawal by Subject|0|||
131460693|NCT02059291|473318784|FG022|Epoch 3|Withdrawal by Subject|0|||
131460694|NCT02059291|473318785|FG023|Epoch 3|Withdrawal by Subject|0|||
131460695|NCT02059291|473318786|FG024|Epoch 3|Withdrawal by Subject|0|||
131460696|NCT02059291|473318762|FG000|Epoch 4|Adverse Event|0|||
131460697|NCT02059291|473318763|FG001|Epoch 4|Adverse Event|0|||
131460698|NCT02059291|473318764|FG002|Epoch 4|Adverse Event|0|||
131460699|NCT02059291|473318765|FG003|Epoch 4|Adverse Event|0|||
131460700|NCT02059291|473318766|FG004|Epoch 4|Adverse Event|0|||
131460701|NCT02059291|473318767|FG005|Epoch 4|Adverse Event|0|||
131460702|NCT02059291|473318768|FG006|Epoch 4|Adverse Event|0|||
131460703|NCT02059291|473318769|FG007|Epoch 4|Adverse Event|0|||
131460704|NCT02059291|473318770|FG008|Epoch 4|Adverse Event|0|||
131460705|NCT02059291|473318771|FG009|Epoch 4|Adverse Event|0|||
131460706|NCT02059291|473318772|FG010|Epoch 4|Adverse Event|0|||
131460707|NCT02059291|473318773|FG011|Epoch 4|Adverse Event|0|||
131460708|NCT02059291|473318774|FG012|Epoch 4|Adverse Event|0|||
131460709|NCT02059291|473318775|FG013|Epoch 4|Adverse Event|0|||
131460710|NCT02059291|473318776|FG014|Epoch 4|Adverse Event|0|||
131460711|NCT02059291|473318777|FG015|Epoch 4|Adverse Event|0|||
131460712|NCT02059291|473318778|FG016|Epoch 4|Adverse Event|1|||
131460713|NCT02059291|473318779|FG017|Epoch 4|Adverse Event|0|||
131460714|NCT02059291|473318780|FG018|Epoch 4|Adverse Event|0|||
131460715|NCT02059291|473318781|FG019|Epoch 4|Adverse Event|0|||
131460716|NCT02059291|473318782|FG020|Epoch 4|Adverse Event|0|||
131460717|NCT02059291|473318783|FG021|Epoch 4|Adverse Event|0|||
131460718|NCT02059291|473318784|FG022|Epoch 4|Adverse Event|1|||
131460719|NCT02059291|473318785|FG023|Epoch 4|Adverse Event|0|||
131460720|NCT02059291|473318786|FG024|Epoch 4|Adverse Event|0|||
131460721|NCT02059291|473318762|FG000|Epoch 4|Pregnancy|0|||
131460722|NCT02059291|473318763|FG001|Epoch 4|Pregnancy|0|||
131460723|NCT02059291|473318764|FG002|Epoch 4|Pregnancy|0|||
131460724|NCT02059291|473318765|FG003|Epoch 4|Pregnancy|0|||
131460725|NCT02059291|473318766|FG004|Epoch 4|Pregnancy|0|||
131460726|NCT02059291|473318767|FG005|Epoch 4|Pregnancy|0|||
131460727|NCT02059291|473318768|FG006|Epoch 4|Pregnancy|0|||
131460728|NCT02059291|473318769|FG007|Epoch 4|Pregnancy|0|||
131460729|NCT02059291|473318770|FG008|Epoch 4|Pregnancy|0|||
131460730|NCT02059291|473318771|FG009|Epoch 4|Pregnancy|0|||
131460731|NCT02059291|473318772|FG010|Epoch 4|Pregnancy|0|||
131460732|NCT02059291|473318773|FG011|Epoch 4|Pregnancy|0|||
131460733|NCT02059291|473318774|FG012|Epoch 4|Pregnancy|0|||
131460734|NCT02059291|473318775|FG013|Epoch 4|Pregnancy|0|||
131460735|NCT02059291|473318776|FG014|Epoch 4|Pregnancy|0|||
131460736|NCT02059291|473318777|FG015|Epoch 4|Pregnancy|0|||
131460737|NCT02059291|473318778|FG016|Epoch 4|Pregnancy|1|||
131460738|NCT02059291|473318779|FG017|Epoch 4|Pregnancy|0|||
131460739|NCT02059291|473318780|FG018|Epoch 4|Pregnancy|0|||
131460740|NCT02059291|473318781|FG019|Epoch 4|Pregnancy|0|||
131460741|NCT02059291|473318782|FG020|Epoch 4|Pregnancy|0|||
131460742|NCT02059291|473318783|FG021|Epoch 4|Pregnancy|0|||
131460743|NCT02059291|473318784|FG022|Epoch 4|Pregnancy|0|||
131460744|NCT02059291|473318785|FG023|Epoch 4|Pregnancy|0|||
131460745|NCT02059291|473318786|FG024|Epoch 4|Pregnancy|0|||
131460746|NCT02059291|473318762|FG000|Epoch 4|Withdrawal by Subject|0|||
131460747|NCT02059291|473318763|FG001|Epoch 4|Withdrawal by Subject|0|||
131460748|NCT02059291|473318764|FG002|Epoch 4|Withdrawal by Subject|0|||
131460749|NCT02059291|473318765|FG003|Epoch 4|Withdrawal by Subject|0|||
131460750|NCT02059291|473318766|FG004|Epoch 4|Withdrawal by Subject|0|||
131460751|NCT02059291|473318767|FG005|Epoch 4|Withdrawal by Subject|0|||
131460752|NCT02059291|473318768|FG006|Epoch 4|Withdrawal by Subject|0|||
131460753|NCT02059291|473318769|FG007|Epoch 4|Withdrawal by Subject|0|||
131460754|NCT02059291|473318770|FG008|Epoch 4|Withdrawal by Subject|0|||
131460755|NCT02059291|473318771|FG009|Epoch 4|Withdrawal by Subject|0|||
131460756|NCT02059291|473318772|FG010|Epoch 4|Withdrawal by Subject|0|||
131460757|NCT02059291|473318773|FG011|Epoch 4|Withdrawal by Subject|0|||
131460758|NCT02059291|473318774|FG012|Epoch 4|Withdrawal by Subject|0|||
131460759|NCT02059291|473318775|FG013|Epoch 4|Withdrawal by Subject|0|||
131460760|NCT02059291|473318776|FG014|Epoch 4|Withdrawal by Subject|0|||
131460761|NCT02059291|473318777|FG015|Epoch 4|Withdrawal by Subject|0|||
131460762|NCT02059291|473318778|FG016|Epoch 4|Withdrawal by Subject|0|||
131460763|NCT02059291|473318779|FG017|Epoch 4|Withdrawal by Subject|0|||
131460764|NCT02059291|473318780|FG018|Epoch 4|Withdrawal by Subject|0|||
131460765|NCT02059291|473318781|FG019|Epoch 4|Withdrawal by Subject|0|||
131460766|NCT02059291|473318782|FG020|Epoch 4|Withdrawal by Subject|1|||
131460767|NCT02059291|473318783|FG021|Epoch 4|Withdrawal by Subject|0|||
131460768|NCT02059291|473318784|FG022|Epoch 4|Withdrawal by Subject|0|||
131460769|NCT02059291|473318785|FG023|Epoch 4|Withdrawal by Subject|0|||
131460770|NCT02059291|473318786|FG024|Epoch 4|Withdrawal by Subject|0|||
131460771|NCT02059291|473318762|FG000|Epoch 4|Lack of Efficacy|0|||
131460772|NCT02059291|473318763|FG001|Epoch 4|Lack of Efficacy|0|||
131460773|NCT02059291|473318764|FG002|Epoch 4|Lack of Efficacy|0|||
131460774|NCT02059291|473318765|FG003|Epoch 4|Lack of Efficacy|0|||
131460775|NCT02059291|473318766|FG004|Epoch 4|Lack of Efficacy|0|||
131460776|NCT02059291|473318767|FG005|Epoch 4|Lack of Efficacy|0|||
131460777|NCT02059291|473318768|FG006|Epoch 4|Lack of Efficacy|0|||
131460778|NCT02059291|473318769|FG007|Epoch 4|Lack of Efficacy|0|||
131460779|NCT02059291|473318770|FG008|Epoch 4|Lack of Efficacy|0|||
131460780|NCT02059291|473318771|FG009|Epoch 4|Lack of Efficacy|0|||
131460781|NCT02059291|473318772|FG010|Epoch 4|Lack of Efficacy|0|||
131460782|NCT02059291|473318773|FG011|Epoch 4|Lack of Efficacy|0|||
131460783|NCT02059291|473318774|FG012|Epoch 4|Lack of Efficacy|0|||
131460784|NCT02059291|473318775|FG013|Epoch 4|Lack of Efficacy|0|||
131460785|NCT02059291|473318776|FG014|Epoch 4|Lack of Efficacy|0|||
131460786|NCT02059291|473318777|FG015|Epoch 4|Lack of Efficacy|0|||
131460787|NCT02059291|473318778|FG016|Epoch 4|Lack of Efficacy|0|||
131460788|NCT02059291|473318779|FG017|Epoch 4|Lack of Efficacy|0|||
131460789|NCT02059291|473318780|FG018|Epoch 4|Lack of Efficacy|0|||
131460790|NCT02059291|473318781|FG019|Epoch 4|Lack of Efficacy|0|||
131460791|NCT02059291|473318782|FG020|Epoch 4|Lack of Efficacy|0|||
131460792|NCT02059291|473318783|FG021|Epoch 4|Lack of Efficacy|0|||
131460793|NCT02059291|473318784|FG022|Epoch 4|Lack of Efficacy|0|||
131460794|NCT02059291|473318785|FG023|Epoch 4|Lack of Efficacy|1|||
131460795|NCT02059291|473318786|FG024|Epoch 4|Lack of Efficacy|0|||
131460796|NCT01433289|473318787|FG000|Overall Study|Pregnancy|0|||
131460797|NCT01433289|473318788|FG001|Overall Study|Pregnancy|1|||
131460798|NCT01433289|473318789|FG002|Overall Study|Pregnancy|0|||
131460799|NCT01433289|473318790|FG003|Overall Study|Pregnancy|0|||
131460800|NCT04975438|473318791|FG000|Overall Study|Lost to Follow-up|1|||
131460801|NCT04975438|473318792|FG001|Overall Study|Lost to Follow-up|0|||
131460802|NCT04975438|473318793|FG002|Overall Study|Lost to Follow-up|1|||
131460803|NCT04975438|473318794|FG003|Overall Study|Lost to Follow-up|0|||
131460804|NCT04975438|473318791|FG000|Overall Study|Withdrawal by Subject|1|||
131460805|NCT04975438|473318792|FG001|Overall Study|Withdrawal by Subject|0|||
131460806|NCT04975438|473318793|FG002|Overall Study|Withdrawal by Subject|0|||
131460807|NCT04975438|473318794|FG003|Overall Study|Withdrawal by Subject|0|||
131460808|NCT04343235|473318795|FG000|Overall Study|Lost to Follow-up|3|||
131460809|NCT04343235|473318796|FG001|Overall Study|Lost to Follow-up|2|||
131460810|NCT01763996|473318797|FG000|Treatment Period 2|Adverse Event|0|||
131460811|NCT01763996|473318798|FG001|Treatment Period 2|Adverse Event|1|||
131460812|NCT01950013|473318805|FG000|Overall Study|Withdrawal by Subject|0|||
131460813|NCT01950013|473318806|FG001|Overall Study|Withdrawal by Subject|2|||
131460814|NCT01950013|473318807|FG002|Overall Study|Withdrawal by Subject|0|||
131460815|NCT00275340|473318808|FG000|Overall Study|Lost to Follow-up|2|||
131460816|NCT00275340|473318809|FG001|Overall Study|Lost to Follow-up|4|||
131460817|NCT03091348|473318812|FG000|Overall Study|Lost to Follow-up|2|||
131460818|NCT03091348|473318813|FG001|Overall Study|Lost to Follow-up|1|||
131460819|NCT00706342|473318814|FG000|Overall Study|Adverse Event|3|||
131460820|NCT00706342|473318814|FG000|Overall Study|Not responding to treatment|2|||
131460821|NCT00706342|473318814|FG000|Overall Study|Withdrawn due to failure to respond|1|||
131460822|NCT00706342|473318814|FG000|Overall Study|Death|1|||
131460823|NCT00706342|473318814|FG000|Overall Study|Withdrew from the study on his own.|1|||
131460824|NCT00706342|473318814|FG000|Overall Study|Investigator discretion|2|||
131460825|NCT00706342|473318814|FG000|Overall Study|Non-responder Week 12|1|||
131460826|NCT00706342|473318814|FG000|Overall Study|Ongoing|6|||
131460827|NCT00706342|473318814|FG000|Overall Study|WIthdrawal of consent|1|||
131460828|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
131460829|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
131460830|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
131460831|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
131460832|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
131460833|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
131460834|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
131460835|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
131460836|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
131460837|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
131460838|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
131460839|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
131460840|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
131460841|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
131460842|NCT00612105|473318816|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
131460843|NCT00612105|473318817|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
131460844|NCT00612105|473318816|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
131460845|NCT00612105|473318817|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
131460846|NCT00612105|473318816|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
131460847|NCT00612105|473318817|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
131460848|NCT00612105|473318816|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
131460849|NCT00612105|473318817|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
131460850|NCT00612105|473318816|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
131460851|NCT00612105|473318817|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
131460852|NCT01105767|473318818|FG000|Overall Study|Lost to Follow-up|1160|||
131460853|NCT01105767|473318819|FG001|Overall Study|Lost to Follow-up|1614|||
131460854|NCT01105767|473318820|FG002|Overall Study|Lost to Follow-up|1184|||
131460855|NCT00743106|473318821|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
131460856|NCT00743106|473318822|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
131460857|NCT02674204|473318826|FG000|Overall Study|Adverse Event|1|||
131460858|NCT02674204|473318827|FG001|Overall Study|Adverse Event|0|||
131460859|NCT00486811|473318833|FG000|Overall Study|Adverse Event|28|||
131460860|NCT00486811|473318834|FG001|Overall Study|Adverse Event|60|||
131460861|NCT00486811|473318835|FG002|Overall Study|Adverse Event|135|||
131460862|NCT00486811|473318833|FG000|Overall Study|Lack of Efficacy|34|||
131460863|NCT00486811|473318834|FG001|Overall Study|Lack of Efficacy|14|||
131460864|NCT00486811|473318835|FG002|Overall Study|Lack of Efficacy|7|||
131460865|NCT00486811|473318833|FG000|Overall Study|Lost to Follow-up|4|||
131460866|NCT00486811|473318834|FG001|Overall Study|Lost to Follow-up|6|||
131460867|NCT00486811|473318835|FG002|Overall Study|Lost to Follow-up|4|||
131460868|NCT00486811|473318833|FG000|Overall Study|Withdrawal by Subject|33|||
131460869|NCT00486811|473318834|FG001|Overall Study|Withdrawal by Subject|44|||
131460870|NCT00486811|473318835|FG002|Overall Study|Withdrawal by Subject|58|||
131460871|NCT00486811|473318833|FG000|Overall Study|Study drug non-compliant|5|||
131460872|NCT00486811|473318834|FG001|Overall Study|Study drug non-compliant|6|||
131460873|NCT00486811|473318835|FG002|Overall Study|Study drug non-compliant|3|||
131460874|NCT00486811|473318833|FG000|Overall Study|All other|18|||
131460875|NCT00486811|473318834|FG001|Overall Study|All other|11|||
131460876|NCT00486811|473318835|FG002|Overall Study|All other|7|||
131460877|NCT03753789|473318836|FG000|Overall Study|Withdrawal by Subject|2|||
131460878|NCT01578850|473318838|FG000|Period 1|Insufficient Clinical Response|1|||
131460879|NCT01578850|473318839|FG001|Period 1|Insufficient Clinical Response|0|||
131460880|NCT01578850|473318840|FG002|Period 1|Insufficient Clinical Response|0|||
131460881|NCT01578850|473318838|FG000|Period 1|Adverse Event|11|||
131460882|NCT01578850|473318839|FG001|Period 1|Adverse Event|0|||
131460883|NCT01578850|473318840|FG002|Period 1|Adverse Event|0|||
131460884|NCT01578850|473318838|FG000|Period 1|Death|1|||
131460885|NCT01578850|473318839|FG001|Period 1|Death|0|||
131460886|NCT01578850|473318840|FG002|Period 1|Death|0|||
131460887|NCT01578850|473318838|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
131460888|NCT01578850|473318839|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
131460889|NCT01578850|473318840|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
131460890|NCT01578850|473318838|FG000|Period 1|Withdrawal by Subject|9|||
131460891|NCT01578850|473318839|FG001|Period 1|Withdrawal by Subject|0|||
131460892|NCT01578850|473318840|FG002|Period 1|Withdrawal by Subject|0|||
131460893|NCT01578850|473318838|FG000|Period 1|Study Terminated by Sponsor|3|||
131460894|NCT01578850|473318839|FG001|Period 1|Study Terminated by Sponsor|0|||
131460895|NCT01578850|473318840|FG002|Period 1|Study Terminated by Sponsor|0|||
131460896|NCT01578850|473318838|FG000|Period 2|Insufficient Clinical Response|0|||
131460897|NCT01578850|473318839|FG001|Period 2|Insufficient Clinical Response|1|||
131460898|NCT01578850|473318840|FG002|Period 2|Insufficient Clinical Response|0|||
131460899|NCT01578850|473318838|FG000|Period 2|Adverse Event|0|||
131460900|NCT01578850|473318839|FG001|Period 2|Adverse Event|3|||
131460901|NCT01578850|473318840|FG002|Period 2|Adverse Event|6|||
131460902|NCT01578850|473318838|FG000|Period 2|Lost to Follow-up|0|||
131460903|NCT01578850|473318839|FG001|Period 2|Lost to Follow-up|1|||
131460904|NCT01578850|473318840|FG002|Period 2|Lost to Follow-up|2|||
131460905|NCT01578850|473318838|FG000|Period 2|Withdrawal by Subject|0|||
131460906|NCT01578850|473318839|FG001|Period 2|Withdrawal by Subject|2|||
131460907|NCT01578850|473318840|FG002|Period 2|Withdrawal by Subject|2|||
131460908|NCT01578850|473318838|FG000|Period 2|Study Terminated by Sponsor|0|||
131460909|NCT01578850|473318839|FG001|Period 2|Study Terminated by Sponsor|5|||
131460910|NCT01578850|473318840|FG002|Period 2|Study Terminated by Sponsor|4|||
131460911|NCT01578850|473318838|FG000|Period 2|Unspecified Reasons|0|||
131460912|NCT01578850|473318839|FG001|Period 2|Unspecified Reasons|1|||
131460913|NCT01578850|473318840|FG002|Period 2|Unspecified Reasons|0|||
131460914|NCT01711216|473318843|FG000|Overall Study|Adverse Event|4|||
131460915|NCT01711216|473318843|FG000|Overall Study|Pregnancy|56|||
131460916|NCT01711216|473318843|FG000|Overall Study|Withdrawal by Subject|6|||
131460917|NCT01711216|473318843|FG000|Overall Study|Lost to Follow-up|46|||
131460918|NCT01711216|473318843|FG000|Overall Study|variety of other minor reasons|83|||
131460919|NCT01711216|473318843|FG000|Overall Study|no reason specified|22|||
131460920|NCT00096356|473318844|FG000|Overall Study|Adverse Event|11|||
131460921|NCT00096356|473318845|FG001|Overall Study|Adverse Event|9|||
131460922|NCT00096356|473318844|FG000|Overall Study|Physician Decision|5|||
131460923|NCT00096356|473318845|FG001|Overall Study|Physician Decision|3|||
131460924|NCT00096356|473318844|FG000|Overall Study|Withdrawal by Subject|17|||
131460925|NCT00096356|473318845|FG001|Overall Study|Withdrawal by Subject|23|||
131460926|NCT00096356|473318844|FG000|Overall Study|Lack of Efficacy|1|||
131460927|NCT00096356|473318845|FG001|Overall Study|Lack of Efficacy|0|||
131460928|NCT00096356|473318844|FG000|Overall Study|multiple reasons|10|||
131460929|NCT00096356|473318845|FG001|Overall Study|multiple reasons|18|||
131460930|NCT05092360|473318852|FG000|Overall Study|Withdrawal by Subject|21|||
131460931|NCT05092360|473318853|FG001|Overall Study|Withdrawal by Subject|4|||
131460932|NCT05092360|473318854|FG002|Overall Study|Withdrawal by Subject|9|||
131460933|NCT05092360|473318855|FG003|Overall Study|Withdrawal by Subject|26|||
131460934|NCT05092360|473318852|FG000|Overall Study|Death|97|||
131460935|NCT05092360|473318853|FG001|Overall Study|Death|14|||
131460936|NCT05092360|473318854|FG002|Overall Study|Death|31|||
131460937|NCT05092360|473318855|FG003|Overall Study|Death|101|||
131460938|NCT05092360|473318852|FG000|Overall Study|Lost to Follow-up|1|||
131460939|NCT05092360|473318853|FG001|Overall Study|Lost to Follow-up|2|||
131460940|NCT05092360|473318854|FG002|Overall Study|Lost to Follow-up|2|||
131460941|NCT05092360|473318855|FG003|Overall Study|Lost to Follow-up|2|||
131460942|NCT05092360|473318852|FG000|Overall Study|Study terminated by sponsor|65|||
131460943|NCT05092360|473318853|FG001|Overall Study|Study terminated by sponsor|7|||
131460944|NCT05092360|473318854|FG002|Overall Study|Study terminated by sponsor|13|||
131460945|NCT05092360|473318855|FG003|Overall Study|Study terminated by sponsor|61|||
131460946|NCT01525225|473318856|FG000|Enrollment|No longer met study criteria|1|||
131460947|NCT01525225|473318856|FG000|Enrollment|Other|1|||
131460948|NCT00363545|473318857|FG000|Overall Study|Serious Adverse Event|0|||
131460949|NCT00363545|473318858|FG001|Overall Study|Serious Adverse Event|1|||
131460950|NCT00363545|473318857|FG000|Overall Study|Withdrawal by Subject|12|||
131460951|NCT00363545|473318858|FG001|Overall Study|Withdrawal by Subject|15|||
131460952|NCT00363545|473318857|FG000|Overall Study|Migrated/moved from study area|3|||
131460953|NCT00363545|473318858|FG001|Overall Study|Migrated/moved from study area|6|||
131460954|NCT00363545|473318857|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
131460955|NCT00363545|473318858|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
131460956|NCT00363545|473318857|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
131460957|NCT00363545|473318858|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
131460958|NCT00363545|473318857|FG000|Overall Study|Others|1|||
131460959|NCT00363545|473318858|FG001|Overall Study|Others|0|||
131460960|NCT04236141|473320497|FG000|Overall Study|Death|18|||
131460961|NCT04236141|473320498|FG001|Overall Study|Death|10|||
131460962|NCT04236141|473320497|FG000|Overall Study|Withdrawal by Participant|1|||
131460963|NCT04236141|473320498|FG001|Overall Study|Withdrawal by Participant|0|||
131460964|NCT04236141|473320497|FG000|Overall Study|Reason not Specified|1|||
131460965|NCT04236141|473320498|FG001|Overall Study|Reason not Specified|0|||
131460966|NCT04236141|473320497|FG000|Overall Study|Study terminated by Sponsor|8|||
131768916|NCT01497899|474431897|FG000|Double-Blind Phase|Lack of Efficacy|0|||
131460967|NCT04236141|473320498|FG001|Overall Study|Study terminated by Sponsor|4|||
131460968|NCT01925131|473320499|FG000|Overall Study|Death|0|||
131460969|NCT01925131|473320500|FG001|Overall Study|Death|0|||
131460970|NCT01925131|473320501|FG002|Overall Study|Death|1|||
131460971|NCT01925131|473320502|FG003|Overall Study|Death|0|||
131460972|NCT01925131|473320503|FG004|Overall Study|Death|0|||
131460973|NCT01925131|473320504|FG005|Overall Study|Death|0|||
131460974|NCT01925131|473320499|FG000|Overall Study|Progression/Relapse|1|||
131460975|NCT01925131|473320500|FG001|Overall Study|Progression/Relapse|1|||
131460976|NCT01925131|473320501|FG002|Overall Study|Progression/Relapse|4|||
131460977|NCT01925131|473320502|FG003|Overall Study|Progression/Relapse|0|||
131460978|NCT01925131|473320503|FG004|Overall Study|Progression/Relapse|0|||
131460979|NCT01925131|473320504|FG005|Overall Study|Progression/Relapse|1|||
131460980|NCT01925131|473320499|FG000|Overall Study|Patient Refusal|1|||
131460981|NCT01925131|473320500|FG001|Overall Study|Patient Refusal|0|||
131460982|NCT01925131|473320501|FG002|Overall Study|Patient Refusal|0|||
131460983|NCT01925131|473320502|FG003|Overall Study|Patient Refusal|0|||
131460984|NCT01925131|473320503|FG004|Overall Study|Patient Refusal|0|||
131460985|NCT01925131|473320504|FG005|Overall Study|Patient Refusal|0|||
131460986|NCT01925131|473320499|FG000|Overall Study|Adverse Event|0|||
131460987|NCT01925131|473320500|FG001|Overall Study|Adverse Event|0|||
131460988|NCT01925131|473320501|FG002|Overall Study|Adverse Event|2|||
131460989|NCT01925131|473320502|FG003|Overall Study|Adverse Event|0|||
131460990|NCT01925131|473320503|FG004|Overall Study|Adverse Event|1|||
131460991|NCT01925131|473320504|FG005|Overall Study|Adverse Event|3|||
131460992|NCT01925131|473320499|FG000|Overall Study|Other - Not Protocol Specified|3|||
131460993|NCT01925131|473320500|FG001|Overall Study|Other - Not Protocol Specified|1|||
131460994|NCT01925131|473320501|FG002|Overall Study|Other - Not Protocol Specified|2|||
131460995|NCT01925131|473320502|FG003|Overall Study|Other - Not Protocol Specified|5|||
131460996|NCT01925131|473320503|FG004|Overall Study|Other - Not Protocol Specified|10|||
131460997|NCT01925131|473320504|FG005|Overall Study|Other - Not Protocol Specified|6|||
131460998|NCT01948193|473320505|FG000|Overall Study|Serious event|2|||
131460999|NCT01948193|473320505|FG000|Overall Study|Lost to Follow-up|7|||
131461000|NCT01696929|473320506|FG000|Overall Study|Physician Decision|1|||
131461001|NCT01794338|473320507|FG000|Overall Study|Death|2|||
131461002|NCT01794338|473320508|FG001|Overall Study|Death|0|||
131461003|NCT01794338|473320507|FG000|Overall Study|Lost to Follow-up|6|||
131461004|NCT01794338|473320508|FG001|Overall Study|Lost to Follow-up|9|||
131461005|NCT02522624|473320509|FG000|Overall Study|Technical failure|1|||
131461006|NCT02522624|473320510|FG001|Overall Study|Technical failure|0|||
131461007|NCT01954927|473320511|FG000|Overall Study|Withdrawal by Subject|3|||
131461008|NCT01954927|473320512|FG001|Overall Study|Withdrawal by Subject|1|||
131461009|NCT00955305|473320513|FG000|Overall Study|Disease progression|39|||
131461010|NCT00955305|473320514|FG001|Overall Study|Disease progression|41|||
131461011|NCT00955305|473320513|FG000|Overall Study|Adverse Event|22|||
131461012|NCT00955305|473320514|FG001|Overall Study|Adverse Event|22|||
131461013|NCT00955305|473320513|FG000|Overall Study|Death|2|||
131461014|NCT00955305|473320514|FG001|Overall Study|Death|1|||
131461015|NCT00955305|473320513|FG000|Overall Study|Withdrawal by Subject|5|||
131461016|NCT00955305|473320514|FG001|Overall Study|Withdrawal by Subject|4|||
131461017|NCT00955305|473320513|FG000|Overall Study|Alternative therapy|4|||
131461018|NCT00955305|473320514|FG001|Overall Study|Alternative therapy|0|||
131461019|NCT00955305|473320513|FG000|Overall Study|Other complicating disease|2|||
131461020|NCT00955305|473320514|FG001|Overall Study|Other complicating disease|4|||
131461021|NCT00955305|473320513|FG000|Overall Study|Physician Decision|1|||
131461022|NCT00955305|473320514|FG001|Overall Study|Physician Decision|0|||
131461023|NCT00955305|473320513|FG000|Overall Study|Continued presence of residual disease|0|||
131461024|NCT00955305|473320514|FG001|Overall Study|Continued presence of residual disease|1|||
131461025|NCT00955305|473320513|FG000|Overall Study|Functional decline|2|||
131461026|NCT00955305|473320514|FG001|Overall Study|Functional decline|0|||
131461027|NCT00955305|473320513|FG000|Overall Study|Maximum response achieved|0|||
131461028|NCT00955305|473320514|FG001|Overall Study|Maximum response achieved|1|||
131461029|NCT00955305|473320513|FG000|Overall Study|Lost to Follow-up|0|||
131461030|NCT00955305|473320514|FG001|Overall Study|Lost to Follow-up|1|||
131461031|NCT00955305|473320513|FG000|Overall Study|No off-treatment reason submitted|1|||
131461032|NCT00955305|473320514|FG001|Overall Study|No off-treatment reason submitted|0|||
131461033|NCT00955305|473320513|FG000|Overall Study|Never started protocol treatment|5|||
131461034|NCT00955305|473320514|FG001|Overall Study|Never started protocol treatment|5|||
131461035|NCT00955305|473320513|FG000|Overall Study|Ineligible|5|||
131461036|NCT00955305|473320514|FG001|Overall Study|Ineligible|7|||
131461037|NCT00109590|473320515|FG000|Overall Study|Lost to Follow-up|1|||
131461038|NCT00109590|473320516|FG001|Overall Study|Lost to Follow-up|0|||
131461039|NCT00109590|473320517|FG002|Overall Study|Lost to Follow-up|1|||
131461040|NCT00109590|473320515|FG000|Overall Study|Never Started Treatment|1|||
131461041|NCT00109590|473320516|FG001|Overall Study|Never Started Treatment|2|||
131461042|NCT00109590|473320517|FG002|Overall Study|Never Started Treatment|3|||
131461043|NCT03254108|473320521|FG000|Overall Study|Adverse Event|0|||
131461044|NCT03254108|473320522|FG001|Overall Study|Adverse Event|2|||
131461045|NCT03254108|473320523|FG002|Overall Study|Adverse Event|0|||
131461046|NCT03254108|473320524|FG003|Overall Study|Adverse Event|1|||
131461047|NCT03254108|473320525|FG004|Overall Study|Adverse Event|1|||
131461048|NCT03254108|473320521|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
131461049|NCT03254108|473320522|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
131461050|NCT03254108|473320523|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
131461051|NCT03254108|473320524|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
131461052|NCT03254108|473320525|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
131461053|NCT00409331|473320530|FG000|Overall Study|Physician Decision|1|||
131461054|NCT01511055|473320541|FG000|Overall Study|Withdrawal by Subject|6|||
131461055|NCT00830869|473320542|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
131461056|NCT00830869|473320543|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
131461057|NCT00830869|473320544|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
131461058|NCT00830869|473320545|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
131461059|NCT00830869|473320546|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
131461060|NCT00830869|473320547|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
131461061|NCT00830869|473320548|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
131461062|NCT00830869|473320549|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
131461063|NCT00830869|473320550|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
131461064|NCT00830869|473320551|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
131461065|NCT00830869|473320552|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
131461066|NCT00830869|473320553|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
131461067|NCT00830869|473320542|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
131461068|NCT00830869|473320543|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
131461069|NCT00830869|473320544|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
131461070|NCT00830869|473320545|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
131461071|NCT00830869|473320546|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
131461072|NCT00830869|473320547|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
131461073|NCT00830869|473320548|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
131461074|NCT00830869|473320549|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
131461075|NCT00830869|473320550|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
131461076|NCT00830869|473320551|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
131461077|NCT00830869|473320552|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
131461078|NCT00830869|473320553|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
131461079|NCT00830869|473320542|FG000|Period 1: Part 1|Adverse Event|0|||
131461080|NCT00830869|473320543|FG001|Period 1: Part 1|Adverse Event|0|||
131461081|NCT00830869|473320544|FG002|Period 1: Part 1|Adverse Event|0|||
131461082|NCT00830869|473320545|FG003|Period 1: Part 1|Adverse Event|0|||
131461083|NCT00830869|473320546|FG004|Period 1: Part 1|Adverse Event|0|||
131461084|NCT00830869|473320547|FG005|Period 1: Part 1|Adverse Event|1|||
131461085|NCT00830869|473320548|FG006|Period 1: Part 1|Adverse Event|1|||
131461086|NCT00830869|473320549|FG007|Period 1: Part 1|Adverse Event|0|||
131461087|NCT00830869|473320550|FG008|Period 1: Part 1|Adverse Event|0|||
131461088|NCT00830869|473320551|FG009|Period 1: Part 1|Adverse Event|0|||
131461089|NCT00830869|473320552|FG010|Period 1: Part 1|Adverse Event|0|||
131461090|NCT00830869|473320553|FG011|Period 1: Part 1|Adverse Event|0|||
131461091|NCT00830869|473320542|FG000|Period 1: Part 1|Progressive disease|1|||
131461092|NCT00830869|473320543|FG001|Period 1: Part 1|Progressive disease|0|||
131461093|NCT00830869|473320544|FG002|Period 1: Part 1|Progressive disease|1|||
131461094|NCT00830869|473320545|FG003|Period 1: Part 1|Progressive disease|6|||
131461095|NCT00830869|473320546|FG004|Period 1: Part 1|Progressive disease|4|||
131461096|NCT00830869|473320547|FG005|Period 1: Part 1|Progressive disease|4|||
131461097|NCT00830869|473320548|FG006|Period 1: Part 1|Progressive disease|1|||
131461098|NCT00830869|473320549|FG007|Period 1: Part 1|Progressive disease|0|||
131461099|NCT00830869|473320550|FG008|Period 1: Part 1|Progressive disease|0|||
131461100|NCT00830869|473320551|FG009|Period 1: Part 1|Progressive disease|0|||
131461101|NCT00830869|473320552|FG010|Period 1: Part 1|Progressive disease|0|||
131461102|NCT00830869|473320553|FG011|Period 1: Part 1|Progressive disease|0|||
131461103|NCT00830869|473320542|FG000|Period 2: Part 2|Protocol Violation|0|||
131461104|NCT00830869|473320543|FG001|Period 2: Part 2|Protocol Violation|0|||
131461105|NCT00830869|473320544|FG002|Period 2: Part 2|Protocol Violation|0|||
131461106|NCT00830869|473320545|FG003|Period 2: Part 2|Protocol Violation|0|||
131461107|NCT00830869|473320546|FG004|Period 2: Part 2|Protocol Violation|0|||
131461108|NCT00830869|473320547|FG005|Period 2: Part 2|Protocol Violation|0|||
131461109|NCT00830869|473320548|FG006|Period 2: Part 2|Protocol Violation|0|||
131461110|NCT00830869|473320549|FG007|Period 2: Part 2|Protocol Violation|1|||
131461111|NCT00830869|473320550|FG008|Period 2: Part 2|Protocol Violation|0|||
131461112|NCT00830869|473320551|FG009|Period 2: Part 2|Protocol Violation|1|||
131461113|NCT00830869|473320552|FG010|Period 2: Part 2|Protocol Violation|0|||
131461114|NCT00830869|473320553|FG011|Period 2: Part 2|Protocol Violation|0|||
131461115|NCT00830869|473320542|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
131461116|NCT00830869|473320543|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
131461117|NCT00830869|473320544|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
131461118|NCT00830869|473320545|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
131461119|NCT00830869|473320546|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
131461120|NCT00830869|473320547|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
131461121|NCT00830869|473320548|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
131461122|NCT00830869|473320549|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
131461123|NCT00830869|473320550|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
131461124|NCT00830869|473320551|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
131461125|NCT00830869|473320552|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
131461126|NCT00830869|473320553|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
131461127|NCT00830869|473320542|FG000|Period 2: Part 2|Adverse Event|0|||
131461128|NCT00830869|473320543|FG001|Period 2: Part 2|Adverse Event|0|||
131461129|NCT00830869|473320544|FG002|Period 2: Part 2|Adverse Event|0|||
131461130|NCT00830869|473320545|FG003|Period 2: Part 2|Adverse Event|0|||
131461131|NCT00830869|473320546|FG004|Period 2: Part 2|Adverse Event|0|||
131461132|NCT00830869|473320547|FG005|Period 2: Part 2|Adverse Event|0|||
131461133|NCT00830869|473320548|FG006|Period 2: Part 2|Adverse Event|0|||
131461134|NCT00830869|473320549|FG007|Period 2: Part 2|Adverse Event|4|||
131461135|NCT00830869|473320550|FG008|Period 2: Part 2|Adverse Event|3|||
131461136|NCT00830869|473320551|FG009|Period 2: Part 2|Adverse Event|2|||
131461137|NCT00830869|473320552|FG010|Period 2: Part 2|Adverse Event|2|||
131461138|NCT00830869|473320553|FG011|Period 2: Part 2|Adverse Event|0|||
131461139|NCT00830869|473320542|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
131461140|NCT00830869|473320543|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
131461141|NCT00830869|473320544|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
131461142|NCT00830869|473320545|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
131461143|NCT00830869|473320546|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
131461144|NCT00830869|473320547|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
131461145|NCT00830869|473320548|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
131461146|NCT00830869|473320549|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
131461147|NCT00830869|473320550|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
131461148|NCT00830869|473320551|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
131461149|NCT00830869|473320552|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
131461150|NCT00830869|473320553|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
131461151|NCT00830869|473320542|FG000|Period 2: Part 2|Progressive disease|0|||
131461152|NCT00830869|473320543|FG001|Period 2: Part 2|Progressive disease|0|||
131434034|NCT01188772|473214618|FG000|Overall Study|Lost to Follow-up|4|||
131434035|NCT01188772|473214619|FG001|Overall Study|Lost to Follow-up|1|||
131434036|NCT01188772|473214620|FG002|Overall Study|Lost to Follow-up|1|||
131434037|NCT01188772|473214621|FG003|Overall Study|Lost to Follow-up|1|||
131461153|NCT00830869|473320544|FG002|Period 2: Part 2|Progressive disease|0|||
131461154|NCT00830869|473320545|FG003|Period 2: Part 2|Progressive disease|0|||
131461155|NCT00830869|473320546|FG004|Period 2: Part 2|Progressive disease|0|||
131461156|NCT00830869|473320547|FG005|Period 2: Part 2|Progressive disease|0|||
131461157|NCT00830869|473320548|FG006|Period 2: Part 2|Progressive disease|0|||
131461158|NCT00830869|473320549|FG007|Period 2: Part 2|Progressive disease|14|||
131461159|NCT00830869|473320550|FG008|Period 2: Part 2|Progressive disease|11|||
131461160|NCT00830869|473320551|FG009|Period 2: Part 2|Progressive disease|12|||
131461161|NCT00830869|473320552|FG010|Period 2: Part 2|Progressive disease|8|||
131461162|NCT00830869|473320553|FG011|Period 2: Part 2|Progressive disease|15|||
131461163|NCT00830869|473320542|FG000|Period 2: Part 2|Other|0|||
131461164|NCT00830869|473320543|FG001|Period 2: Part 2|Other|0|||
131461165|NCT00830869|473320544|FG002|Period 2: Part 2|Other|0|||
131461166|NCT00830869|473320545|FG003|Period 2: Part 2|Other|0|||
131461167|NCT00830869|473320546|FG004|Period 2: Part 2|Other|0|||
131461168|NCT00830869|473320547|FG005|Period 2: Part 2|Other|0|||
131461169|NCT00830869|473320548|FG006|Period 2: Part 2|Other|0|||
131461170|NCT00830869|473320549|FG007|Period 2: Part 2|Other|0|||
131461171|NCT00830869|473320550|FG008|Period 2: Part 2|Other|0|||
131461172|NCT00830869|473320551|FG009|Period 2: Part 2|Other|1|||
131461173|NCT00830869|473320552|FG010|Period 2: Part 2|Other|0|||
131461174|NCT00830869|473320553|FG011|Period 2: Part 2|Other|0|||
131461175|NCT00617669|473320554|FG000|Overall Study|Withdrawal by Subject|71|||
131461176|NCT00617669|473320555|FG001|Overall Study|Withdrawal by Subject|77|||
131461177|NCT00617669|473320554|FG000|Overall Study|Lost to Follow-up|3|||
131461178|NCT00617669|473320555|FG001|Overall Study|Lost to Follow-up|2|||
131461179|NCT00617669|473320554|FG000|Overall Study|Adverse Event|87|||
131461180|NCT00617669|473320555|FG001|Overall Study|Adverse Event|76|||
131461181|NCT00617669|473320554|FG000|Overall Study|Protocol Violation|2|||
131434038|NCT01188772|473214618|FG000|Overall Study|Non-responder|0|||
131434039|NCT01188772|473214619|FG001|Overall Study|Non-responder|0|||
131434040|NCT01188772|473214620|FG002|Overall Study|Non-responder|3|||
131434041|NCT01188772|473214621|FG003|Overall Study|Non-responder|0|||
131461182|NCT00617669|473320555|FG001|Overall Study|Protocol Violation|3|||
131461183|NCT00617669|473320554|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
131461184|NCT00617669|473320555|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
131461185|NCT00617669|473320554|FG000|Overall Study|Patients randomized but not treated|2|||
131461186|NCT00617669|473320555|FG001|Overall Study|Patients randomized but not treated|3|||
131461187|NCT03745820|473320556|FG000|Overall Study|Adverse Event|0|||
131461188|NCT03745820|473320557|FG001|Overall Study|Adverse Event|3|||
131461189|NCT03745820|473320558|FG002|Overall Study|Adverse Event|2|||
131461190|NCT03745820|473320556|FG000|Overall Study|Non-Compliance with Study Drug|4|||
131461191|NCT03745820|473320557|FG001|Overall Study|Non-Compliance with Study Drug|3|||
131461192|NCT03745820|473320558|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131461193|NCT03745820|473320556|FG000|Overall Study|Withdrawal by Subject|4|||
131461194|NCT03745820|473320557|FG001|Overall Study|Withdrawal by Subject|4|||
131461195|NCT03745820|473320558|FG002|Overall Study|Withdrawal by Subject|4|||
131461196|NCT03745820|473320556|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
131461197|NCT03745820|473320557|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
131461198|NCT03745820|473320558|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
131461199|NCT03745820|473320556|FG000|Overall Study|Lost to Follow-up|2|||
131461200|NCT03745820|473320557|FG001|Overall Study|Lost to Follow-up|0|||
131461201|NCT03745820|473320558|FG002|Overall Study|Lost to Follow-up|3|||
131461202|NCT03745820|473320556|FG000|Overall Study|Reason not Specified|2|||
131434042|NCT01188772|473214618|FG000|Overall Study|Physician Decision|0|||
131434043|NCT01188772|473214619|FG001|Overall Study|Physician Decision|0|||
131434044|NCT01188772|473214620|FG002|Overall Study|Physician Decision|1|||
131434045|NCT01188772|473214621|FG003|Overall Study|Physician Decision|0|||
131434046|NCT01188772|473214618|FG000|Overall Study|Terminated by Sponsor|0|||
131461203|NCT03745820|473320557|FG001|Overall Study|Reason not Specified|4|||
131461204|NCT03745820|473320558|FG002|Overall Study|Reason not Specified|1|||
131461205|NCT00507728|473320559|FG000|Randomization to Month 3|Lost to Follow-up|15|||
131461206|NCT00507728|473320560|FG001|Randomization to Month 3|Lost to Follow-up|14|||
131461207|NCT00507728|473320561|FG002|Randomization to Month 3|Lost to Follow-up|20|||
131461208|NCT00507728|473320559|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
131461209|NCT00507728|473320560|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
131461210|NCT00507728|473320561|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
131461211|NCT03680742|473320562|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
131461212|NCT01410357|473320563|FG000|Overall Study|Death|2|||
131461213|NCT01410357|473320564|FG001|Overall Study|Death|1|||
131461214|NCT01410357|473320563|FG000|Overall Study|Withdrawal by Subject|1|||
131461215|NCT01410357|473320564|FG001|Overall Study|Withdrawal by Subject|2|||
131461216|NCT01410357|473320563|FG000|Overall Study|Lost to Follow-up|23|||
131461217|NCT01410357|473320564|FG001|Overall Study|Lost to Follow-up|21|||
131461218|NCT00668733|473320565|FG000|Overall Study|Lost to Follow-up|2|||
131461219|NCT00668733|473320566|FG001|Overall Study|Lost to Follow-up|3|||
131461220|NCT00668733|473320565|FG000|Overall Study|Withdrawal by Subject|0|||
131461221|NCT00668733|473320566|FG001|Overall Study|Withdrawal by Subject|4|||
131461222|NCT01909791|473320567|FG000|Overall Study|Death|9|||
131461223|NCT01909791|473320568|FG001|Overall Study|Death|8|||
131461224|NCT01909791|473320569|FG002|Overall Study|Death|4|||
131461225|NCT01909791|473320567|FG000|Overall Study|Withdrawal by Subject|5|||
131461226|NCT01909791|473320568|FG001|Overall Study|Withdrawal by Subject|9|||
131461227|NCT01909791|473320569|FG002|Overall Study|Withdrawal by Subject|13|||
131461228|NCT01909791|473320567|FG000|Overall Study|Lost to Follow-up|5|||
131461229|NCT01909791|473320568|FG001|Overall Study|Lost to Follow-up|11|||
131461230|NCT01909791|473320569|FG002|Overall Study|Lost to Follow-up|10|||
131461231|NCT01909791|473320567|FG000|Overall Study|Missed Visit|2|||
131461232|NCT01909791|473320568|FG001|Overall Study|Missed Visit|0|||
131461233|NCT01909791|473320569|FG002|Overall Study|Missed Visit|1|||
131461234|NCT01659554|473320570|FG000|Overall Study|Study Termination|4|||
131461235|NCT00945906|473320573|FG000|Overall Study|Withdrawal by Subject|1|||
131461236|NCT00945906|473320573|FG000|Overall Study|Did not want to return for last visit|2|||
131461237|NCT00945906|473320573|FG000|Overall Study|Unable to return for last visit|2|||
131461238|NCT00945906|473320573|FG000|Overall Study|Moved to another country|2|||
131461239|NCT03135119|473320575|FG000|Overall Study|Lost to Follow-up|2|||
131461240|NCT03135119|473320576|FG001|Overall Study|Lost to Follow-up|0|||
131461241|NCT03135119|473320575|FG000|Overall Study|Physician Decision|1|||
131461242|NCT03135119|473320576|FG001|Overall Study|Physician Decision|1|||
131461243|NCT03135119|473320575|FG000|Overall Study|COVID-19 Shutdown|2|||
131461244|NCT03135119|473320576|FG001|Overall Study|COVID-19 Shutdown|2|||
131461245|NCT00361634|473320581|FG000|Overall Study|Lost to Follow-up|1|||
131461246|NCT00361634|473320581|FG000|Overall Study|Withdrawal by Subject|1|||
131461247|NCT00833417|473320582|FG000|Overall Study|Adverse Event|5|||
131461248|NCT00833417|473320583|FG001|Overall Study|Adverse Event|16|||
131461249|NCT00833417|473320582|FG000|Overall Study|Death|1|||
131461250|NCT00833417|473320583|FG001|Overall Study|Death|3|||
131461251|NCT00833417|473320582|FG000|Overall Study|Lost to Follow-up|1|||
131461252|NCT00833417|473320583|FG001|Overall Study|Lost to Follow-up|2|||
131461253|NCT00833417|473320582|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
131461254|NCT00833417|473320583|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
131461255|NCT00833417|473320582|FG000|Overall Study|Patient Decision to Withdraw|4|||
131461256|NCT00833417|473320583|FG001|Overall Study|Patient Decision to Withdraw|23|||
131461257|NCT00833417|473320582|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
131461258|NCT00833417|473320583|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
131461259|NCT00833417|473320582|FG000|Overall Study|Disease Progression|18|||
131461260|NCT00833417|473320583|FG001|Overall Study|Disease Progression|17|||
131461261|NCT00833417|473320582|FG000|Overall Study|Reason Not Specified|0|||
131461262|NCT00833417|473320583|FG001|Overall Study|Reason Not Specified|1|||
131461263|NCT05315908|473320584|FG000|Overall Study|Lost to Follow-up|4477|||
131461264|NCT05315908|473320585|FG001|Overall Study|Lost to Follow-up|4606|||
131461265|NCT01561898|473320586|FG000|Overall Study|Withdrawal by Subject|0|||
131461266|NCT01561898|473320587|FG001|Overall Study|Withdrawal by Subject|8|||
131461267|NCT01561898|473320588|FG002|Overall Study|Withdrawal by Subject|12|||
131461268|NCT01561898|473320589|FG003|Overall Study|Withdrawal by Subject|5|||
131461269|NCT01561898|473320586|FG000|Overall Study|Lack of Efficacy|0|||
131461270|NCT01561898|473320587|FG001|Overall Study|Lack of Efficacy|8|||
131461271|NCT01561898|473320588|FG002|Overall Study|Lack of Efficacy|10|||
131461272|NCT01561898|473320589|FG003|Overall Study|Lack of Efficacy|5|||
131461273|NCT01561898|473320586|FG000|Overall Study|Worsening of complications|0|||
131461274|NCT01561898|473320587|FG001|Overall Study|Worsening of complications|1|||
131461275|NCT01561898|473320588|FG002|Overall Study|Worsening of complications|0|||
131461276|NCT01561898|473320589|FG003|Overall Study|Worsening of complications|0|||
131461277|NCT01561898|473320586|FG000|Overall Study|Lost to Follow-up|0|||
131461278|NCT01561898|473320587|FG001|Overall Study|Lost to Follow-up|0|||
131461279|NCT01561898|473320588|FG002|Overall Study|Lost to Follow-up|1|||
131461280|NCT01561898|473320589|FG003|Overall Study|Lost to Follow-up|0|||
131461281|NCT01561898|473320586|FG000|Overall Study|Adverse Event|1|||
131461282|NCT01561898|473320587|FG001|Overall Study|Adverse Event|19|||
131461283|NCT01561898|473320588|FG002|Overall Study|Adverse Event|14|||
131461284|NCT01561898|473320589|FG003|Overall Study|Adverse Event|9|||
131461285|NCT01561898|473320586|FG000|Overall Study|Physician Decision|1|||
131461286|NCT01561898|473320587|FG001|Overall Study|Physician Decision|5|||
131461287|NCT01561898|473320588|FG002|Overall Study|Physician Decision|7|||
131461288|NCT01561898|473320589|FG003|Overall Study|Physician Decision|1|||
131461289|NCT00294762|473320590|FG000|Overall Study|Did not receive study treatment|3|||
131461290|NCT00294762|473320591|FG001|Overall Study|Did not receive study treatment|3|||
131461291|NCT02238080|473320592|FG000|Overall Study|Death|13|||
131461292|NCT02238080|473320592|FG000|Overall Study|Treatment interrupted|6|||
131461293|NCT02238080|473320592|FG000|Overall Study|Withdrawal by Subject|2|||
131461294|NCT02238080|473320592|FG000|Overall Study|Other|4|||
131461295|NCT01738646|473320593|FG000|Overall Study|Still Receiving Treatment|2|||
131461296|NCT04093024|473320594|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
131461297|NCT04093024|473320595|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
131461298|NCT04093024|473320594|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
131461299|NCT04093024|473320595|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
131461300|NCT04093024|473320594|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
131461301|NCT04093024|473320595|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
131461302|NCT04093024|473320594|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
131461303|NCT04093024|473320595|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
131461304|NCT00647270|473320602|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
131461305|NCT00647270|473320603|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
131461306|NCT00647270|473320604|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
131461307|NCT00647270|473320602|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
131461308|NCT00647270|473320603|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
131461309|NCT00647270|473320604|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
131461310|NCT00647270|473320602|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
131461311|NCT00647270|473320603|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
131461312|NCT00647270|473320604|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
131461313|NCT00647270|473320602|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
131461314|NCT00647270|473320603|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
131461315|NCT00647270|473320604|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
131461316|NCT00647270|473320602|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
131461317|NCT00647270|473320603|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
131461318|NCT00647270|473320604|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
131461319|NCT00647270|473320602|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
131461320|NCT00647270|473320603|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
131461321|NCT00647270|473320604|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
131461322|NCT00647270|473320602|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
131461323|NCT00647270|473320603|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
131461324|NCT00647270|473320604|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
131461325|NCT00322621|473320605|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
131461326|NCT00322621|473320606|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
131461327|NCT00322621|473320607|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
131461328|NCT00322621|473320605|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
131461329|NCT00322621|473320606|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
131461330|NCT00322621|473320607|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
131461331|NCT00322621|473320605|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
131461332|NCT00322621|473320606|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
131461333|NCT00322621|473320607|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
131461334|NCT00322621|473320605|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
131461335|NCT00322621|473320606|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
131461336|NCT00322621|473320607|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
131461337|NCT00322621|473320605|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
131461338|NCT00322621|473320606|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
131461339|NCT00322621|473320607|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
131461340|NCT00322621|473320605|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
131461341|NCT00322621|473320606|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
131461342|NCT00322621|473320607|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
131461343|NCT00322621|473320605|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
131461344|NCT00322621|473320606|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
131461345|NCT00322621|473320607|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
131461346|NCT00322621|473320605|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
131461347|NCT00322621|473320606|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
131461348|NCT00322621|473320607|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
131461349|NCT00322621|473320605|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
131461350|NCT00322621|473320606|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
131461351|NCT00322621|473320607|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
131461352|NCT00322621|473320605|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
131461353|NCT00322621|473320606|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
131461354|NCT00322621|473320607|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
131461355|NCT00322621|473320605|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
131461356|NCT00322621|473320606|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
131461357|NCT00322621|473320607|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
131461358|NCT00763698|473320608|FG000|Overall Study|Unsuccessful Implant|5|||
131461359|NCT00763698|473320608|FG000|Overall Study|Death|4|||
131461360|NCT00763698|473320608|FG000|Overall Study|Withdrawal by Subject|1|||
131461361|NCT01960907|473320613|FG000|Overall Study|Death|4|||
131461362|NCT01960907|473320614|FG001|Overall Study|Death|3|||
131461363|NCT01960907|473320613|FG000|Overall Study|Withdrawal by Subject|32|||
131461364|NCT01960907|473320614|FG001|Overall Study|Withdrawal by Subject|42|||
131461365|NCT01788215|473320617|FG000|Overall Study|Withdrawal by Subject|0|||
131461366|NCT01788215|473320618|FG001|Overall Study|Withdrawal by Subject|1|||
131461367|NCT01788215|473320617|FG000|Overall Study|Lost to Follow-up|2|||
131461368|NCT01788215|473320618|FG001|Overall Study|Lost to Follow-up|0|||
131461369|NCT00717236|473320619|FG000|Double-Blind Period|Adverse Event|33|||
131461370|NCT00717236|473320620|FG001|Double-Blind Period|Adverse Event|6|||
131461371|NCT00717236|473320619|FG000|Double-Blind Period|Lack of Efficacy|6|||
131461372|NCT00717236|473320620|FG001|Double-Blind Period|Lack of Efficacy|6|||
131461373|NCT00717236|473320619|FG000|Double-Blind Period|Lost to Follow-up|3|||
131461374|NCT00717236|473320620|FG001|Double-Blind Period|Lost to Follow-up|5|||
131461375|NCT00717236|473320619|FG000|Double-Blind Period|Withdrawal by Subject|10|||
131461376|NCT00717236|473320620|FG001|Double-Blind Period|Withdrawal by Subject|2|||
131461377|NCT00717236|473320619|FG000|Double-Blind Period|Loss of efficacy|3|||
131461378|NCT00717236|473320620|FG001|Double-Blind Period|Loss of efficacy|0|||
131461379|NCT00717236|473320619|FG000|Double-Blind Period|Other: Death|1|||
131461380|NCT00717236|473320620|FG001|Double-Blind Period|Other: Death|0|||
131461381|NCT00717236|473320619|FG000|Double-Blind Period|Other: Pregnancy|1|||
131461382|NCT00717236|473320620|FG001|Double-Blind Period|Other: Pregnancy|0|||
131461383|NCT00717236|473320619|FG000|Double-Blind Period|Other: Protocol Violation|2|||
131461384|NCT00717236|473320620|FG001|Double-Blind Period|Other: Protocol Violation|0|||
131461385|NCT00717236|473320619|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
131461386|NCT00717236|473320620|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
131461387|NCT00717236|473320619|FG000|Double-Blind Period|Other: Site withdrew|2|||
131461388|NCT00717236|473320620|FG001|Double-Blind Period|Other: Site withdrew|0|||
131461389|NCT00717236|473320619|FG000|Double-Blind Period|Other: Screening failure|1|||
131461390|NCT00717236|473320620|FG001|Double-Blind Period|Other: Screening failure|0|||
131461391|NCT00717236|473320619|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
131461392|NCT00717236|473320620|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
131461393|NCT00717236|473320619|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
131461394|NCT00717236|473320620|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
131461395|NCT00717236|473320619|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
131461396|NCT00717236|473320620|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
131461397|NCT00717236|473320619|FG000|Double-Blind Period|Other: History of cancer|1|||
131461398|NCT00717236|473320620|FG001|Double-Blind Period|Other: History of cancer|0|||
131461399|NCT00717236|473320619|FG000|Double-Blind Period|Other: Sponsor request|1|||
131461400|NCT00717236|473320620|FG001|Double-Blind Period|Other: Sponsor request|0|||
131461401|NCT00717236|473320619|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
131461402|NCT00717236|473320620|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
131461403|NCT00717236|473320619|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
131461404|NCT00717236|473320620|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
131461405|NCT00717236|473320619|FG000|Double-Blind Period|Other: Subject moved|1|||
131461406|NCT00717236|473320620|FG001|Double-Blind Period|Other: Subject moved|1|||
131461407|NCT00717236|473320619|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
131461408|NCT00717236|473320620|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
131461409|NCT00717236|473320619|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
131461410|NCT00717236|473320620|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
131461411|NCT00717236|473320619|FG000|Double-Blind Period|Other: Transportation problems|0|||
131461412|NCT00717236|473320620|FG001|Double-Blind Period|Other: Transportation problems|1|||
131461413|NCT00717236|473320619|FG000|Double-Blind Period|Other: Investigator Decision|0|||
131461414|NCT00717236|473320620|FG001|Double-Blind Period|Other: Investigator Decision|1|||
131461415|NCT00717236|473320619|FG000|Open-Label Period|Adverse Event|29|||
131461416|NCT00717236|473320620|FG001|Open-Label Period|Adverse Event|4|||
131461417|NCT00717236|473320619|FG000|Open-Label Period|Lack of Efficacy|30|||
131461418|NCT00717236|473320620|FG001|Open-Label Period|Lack of Efficacy|8|||
131461419|NCT00717236|473320619|FG000|Open-Label Period|Lost to Follow-up|28|||
131461420|NCT00717236|473320620|FG001|Open-Label Period|Lost to Follow-up|4|||
131461421|NCT00717236|473320619|FG000|Open-Label Period|Withdrawal by Subject|20|||
131461422|NCT00717236|473320620|FG001|Open-Label Period|Withdrawal by Subject|2|||
131461423|NCT00717236|473320619|FG000|Open-Label Period|Loss of Efficacy|6|||
131461424|NCT00717236|473320620|FG001|Open-Label Period|Loss of Efficacy|1|||
131461425|NCT00717236|473320619|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
131461426|NCT00717236|473320620|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
131461427|NCT00717236|473320619|FG000|Open-Label Period|Other: Lack of Compliance|1|||
131461428|NCT00717236|473320620|FG001|Open-Label Period|Other: Lack of Compliance|1|||
131461429|NCT00717236|473320619|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
131461430|NCT00717236|473320620|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
131461431|NCT00717236|473320619|FG000|Open-Label Period|Other: Moved|1|||
131461432|NCT00717236|473320620|FG001|Open-Label Period|Other: Moved|0|||
131461433|NCT00717236|473320619|FG000|Open-Label Period|Other: Investigator Decision|1|||
131461434|NCT00717236|473320620|FG001|Open-Label Period|Other: Investigator Decision|0|||
131461435|NCT00717236|473320619|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
131461436|NCT00717236|473320620|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
131461437|NCT00717236|473320619|FG000|Open-Label Period|Other: Sponsor Request|3|||
131461438|NCT00717236|473320620|FG001|Open-Label Period|Other: Sponsor Request|0|||
131461439|NCT00717236|473320619|FG000|Open-Label Period|Other: Cataract Surgery|1|||
131461440|NCT00717236|473320620|FG001|Open-Label Period|Other: Cataract Surgery|0|||
131461441|NCT00717236|473320619|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
131461442|NCT00717236|473320620|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
131461443|NCT00717236|473320619|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
131461444|NCT00717236|473320620|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
131461445|NCT00717236|473320619|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
131461446|NCT00717236|473320620|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
131461447|NCT00271505|473320626|FG000|Overall Study|Screen Failure|3|||
131461448|NCT00271505|473320626|FG000|Overall Study|Adverse Event|1|||
131461449|NCT00271505|473320626|FG000|Overall Study|Death|1|||
131461450|NCT03704636|473320627|FG000|Overall Study|Inadequate Venous Flow|3|||
131461451|NCT00539188|473320630|FG000|Overall Study|Withdrawal by Subject|1|||
131461452|NCT00539188|473320631|FG001|Overall Study|Withdrawal by Subject|0|||
131461453|NCT00539188|473320630|FG000|Overall Study|Lost to Follow-up|2|||
131461454|NCT00539188|473320631|FG001|Overall Study|Lost to Follow-up|1|||
131461455|NCT04784442|473320632|FG000|Overall Study|Adverse Event|1|||
131461456|NCT04784442|473320633|FG001|Overall Study|Adverse Event|0|||
131461457|NCT04784442|473320634|FG002|Overall Study|Adverse Event|2|||
131461458|NCT04784442|473320635|FG003|Overall Study|Adverse Event|1|||
131461459|NCT04784442|473320632|FG000|Overall Study|Protocol Violation|1|||
131461460|NCT04784442|473320633|FG001|Overall Study|Protocol Violation|0|||
131461461|NCT04784442|473320634|FG002|Overall Study|Protocol Violation|0|||
131461462|NCT04784442|473320635|FG003|Overall Study|Protocol Violation|0|||
131461463|NCT04784442|473320632|FG000|Overall Study|Non-compliance with study drug|1|||
131461464|NCT04784442|473320633|FG001|Overall Study|Non-compliance with study drug|0|||
131461465|NCT04784442|473320634|FG002|Overall Study|Non-compliance with study drug|0|||
131461466|NCT04784442|473320635|FG003|Overall Study|Non-compliance with study drug|0|||
131461467|NCT00852371|473320636|FG000|Overall Study|Lost to Follow-up|2|||
131461468|NCT00852371|473320637|FG001|Overall Study|Lost to Follow-up|3|||
131461469|NCT00852371|473320638|FG002|Overall Study|Lost to Follow-up|4|||
131461470|NCT00852371|473320639|FG003|Overall Study|Lost to Follow-up|2|||
131461471|NCT02744040|473320640|FG000|Overall Study|Withdrawal by Subject|3|||
131461472|NCT02744040|473320641|FG001|Overall Study|Withdrawal by Subject|2|||
131461473|NCT02744040|473320642|FG002|Overall Study|Withdrawal by Subject|2|||
131461474|NCT02744040|473320640|FG000|Overall Study|Physician Decision|0|||
131461475|NCT02744040|473320641|FG001|Overall Study|Physician Decision|8|||
131461476|NCT02744040|473320642|FG002|Overall Study|Physician Decision|13|||
131461477|NCT02744040|473320640|FG000|Overall Study|Lost to Follow-up|3|||
131461478|NCT02744040|473320641|FG001|Overall Study|Lost to Follow-up|1|||
131461479|NCT02744040|473320642|FG002|Overall Study|Lost to Follow-up|7|||
131461480|NCT03288142|473320644|FG000|Overall Study|Lost to Follow-up|22|||
131461481|NCT03288142|473320645|FG001|Overall Study|Lost to Follow-up|15|||
131461482|NCT00946153|473320646|FG000|Phase 2|Adverse Event|0|||
131461483|NCT00946153|473320647|FG001|Phase 2|Adverse Event|0|||
131461484|NCT00946153|473320648|FG002|Phase 2|Adverse Event|0|||
131461485|NCT00946153|473320649|FG003|Phase 2|Adverse Event|0|||
131461486|NCT00946153|473320650|FG004|Phase 2|Adverse Event|6|||
131461487|NCT00946153|473320646|FG000|Phase 2|Need more reduction of dose|0|||
131461488|NCT00946153|473320647|FG001|Phase 2|Need more reduction of dose|0|||
131461489|NCT00946153|473320648|FG002|Phase 2|Need more reduction of dose|0|||
131461490|NCT00946153|473320649|FG003|Phase 2|Need more reduction of dose|0|||
131461491|NCT00946153|473320650|FG004|Phase 2|Need more reduction of dose|2|||
131461492|NCT00946153|473320646|FG000|Phase 2|Physician Decision|0|||
131461493|NCT00946153|473320647|FG001|Phase 2|Physician Decision|0|||
131461494|NCT00946153|473320648|FG002|Phase 2|Physician Decision|0|||
131461495|NCT00946153|473320649|FG003|Phase 2|Physician Decision|0|||
131461496|NCT00946153|473320650|FG004|Phase 2|Physician Decision|1|||
131461497|NCT00946153|473320646|FG000|Phase 2|14 days washout for recovery due to AE|0|||
131461498|NCT00946153|473320647|FG001|Phase 2|14 days washout for recovery due to AE|0|||
131461499|NCT00946153|473320648|FG002|Phase 2|14 days washout for recovery due to AE|0|||
131461500|NCT00946153|473320649|FG003|Phase 2|14 days washout for recovery due to AE|0|||
131461501|NCT00946153|473320650|FG004|Phase 2|14 days washout for recovery due to AE|4|||
131461502|NCT04002908|473320653|FG000|Overall Study|Death|41|||
131461503|NCT04002908|473320654|FG001|Overall Study|Death|0|||
131461504|NCT04002908|473320655|FG002|Overall Study|Death|0|||
131461505|NCT04002908|473320656|FG003|Overall Study|Death|0|||
131461506|NCT04002908|473320653|FG000|Overall Study|Withdrawal by Subject|112|||
131461507|NCT04002908|473320654|FG001|Overall Study|Withdrawal by Subject|0|||
131461508|NCT04002908|473320655|FG002|Overall Study|Withdrawal by Subject|0|||
131461509|NCT04002908|473320656|FG003|Overall Study|Withdrawal by Subject|0|||
131461510|NCT04002908|473320653|FG000|Overall Study|Lost to Follow-up|72|||
131461511|NCT04002908|473320654|FG001|Overall Study|Lost to Follow-up|0|||
131461512|NCT04002908|473320655|FG002|Overall Study|Lost to Follow-up|0|||
131461513|NCT04002908|473320656|FG003|Overall Study|Lost to Follow-up|0|||
131461514|NCT04002908|473320653|FG000|Overall Study|Infant died, so mother withdrawn|34|||
131461515|NCT04002908|473320654|FG001|Overall Study|Infant died, so mother withdrawn|0|||
131461516|NCT04002908|473320655|FG002|Overall Study|Infant died, so mother withdrawn|0|||
131461517|NCT04002908|473320656|FG003|Overall Study|Infant died, so mother withdrawn|0|||
131461518|NCT01675167|473320661|FG000|Open-label Titration Phase|Adverse Event|81|||
131461519|NCT01675167|473320662|FG001|Open-label Titration Phase|Adverse Event|0|||
131461520|NCT01675167|473320663|FG002|Open-label Titration Phase|Adverse Event|0|||
131461521|NCT01675167|473320661|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
131461522|NCT01675167|473320662|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
131461523|NCT01675167|473320663|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
131461524|NCT01675167|473320661|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
131461525|NCT01675167|473320662|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
131461526|NCT01675167|473320663|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
131461527|NCT01675167|473320661|FG000|Open-label Titration Phase|Protocol Violation|43|||
131461528|NCT01675167|473320662|FG001|Open-label Titration Phase|Protocol Violation|0|||
131461529|NCT01675167|473320663|FG002|Open-label Titration Phase|Protocol Violation|0|||
131461530|NCT01675167|473320661|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
131461531|NCT01675167|473320662|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
131461532|NCT01675167|473320663|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
131461533|NCT01675167|473320661|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
131461534|NCT01675167|473320662|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
131461535|NCT01675167|473320663|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
131461536|NCT01675167|473320661|FG000|Open-label Titration Phase|Other|55|||
131461537|NCT01675167|473320662|FG001|Open-label Titration Phase|Other|0|||
131461538|NCT01675167|473320663|FG002|Open-label Titration Phase|Other|0|||
131461539|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
131461540|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
131461541|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
131461542|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131461543|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
131461544|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
131461545|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Adverse Event|0|||
131461546|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Adverse Event|5|||
131461547|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Adverse Event|13|||
131461548|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
131461549|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
131461550|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
131461551|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131461552|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
131461553|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
131461554|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
131461555|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
131461556|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
131461557|NCT01675167|473320661|FG000|Double-blind Treatment Phase|Other|0|||
131461558|NCT01675167|473320662|FG001|Double-blind Treatment Phase|Other|7|||
131461559|NCT01675167|473320663|FG002|Double-blind Treatment Phase|Other|5|||
131461560|NCT01182844|473320664|FG000|Overall Study|Withdrawal by Subject|0|||
131461561|NCT01182844|473320665|FG001|Overall Study|Withdrawal by Subject|2|||
131461562|NCT04174365|473320666|FG000|Overall Study|Lost to Follow-up|1|||
131461563|NCT04174365|473320667|FG001|Overall Study|Lost to Follow-up|2|||
131461564|NCT04174365|473320666|FG000|Overall Study|Adverse Event|2|||
131461565|NCT04174365|473320667|FG001|Overall Study|Adverse Event|1|||
131461566|NCT04174365|473320666|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
131461567|NCT04174365|473320667|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
131461568|NCT04174365|473320666|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
131461569|NCT04174365|473320667|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
131461570|NCT04174365|473320666|FG000|Overall Study|Protocol Deviation|1|||
131461571|NCT04174365|473320667|FG001|Overall Study|Protocol Deviation|0|||
131461572|NCT04174365|473320666|FG000|Overall Study|Lack of Efficacy|0|||
131461573|NCT04174365|473320667|FG001|Overall Study|Lack of Efficacy|2|||
131461574|NCT04174365|473320666|FG000|Overall Study|Disease Relapse|1|||
131461575|NCT04174365|473320667|FG001|Overall Study|Disease Relapse|0|||
131461576|NCT04174365|473320666|FG000|Overall Study|Reason Not Specified|0|||
131461577|NCT04174365|473320667|FG001|Overall Study|Reason Not Specified|1|||
131461578|NCT00490529|473322093|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
131461579|NCT00490529|473322093|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
131461580|NCT00490529|473322093|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
131461581|NCT00490529|473322093|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
131461582|NCT00490529|473322093|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
131461583|NCT00490529|473322093|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
131461584|NCT03254459|473322094|FG000|Overall Study|Adverse Event|7|||
131461585|NCT03254459|473322095|FG001|Overall Study|Adverse Event|20|||
131461586|NCT03254459|473322094|FG000|Overall Study|Withdrawal by Subject Consent|3|||
131461587|NCT03254459|473322095|FG001|Overall Study|Withdrawal by Subject Consent|1|||
131461588|NCT03254459|473322094|FG000|Overall Study|Lost to Follow-up|0|||
131461589|NCT03254459|473322095|FG001|Overall Study|Lost to Follow-up|1|||
131461590|NCT03254459|473322094|FG000|Overall Study|Miscellaneous|0|||
131461591|NCT03254459|473322095|FG001|Overall Study|Miscellaneous|1|||
131461592|NCT00727441|473322096|FG000|Overall Study|Disease Progression|11|||
131461593|NCT00727441|473322097|FG001|Overall Study|Disease Progression|14|||
131461594|NCT00727441|473322098|FG002|Overall Study|Disease Progression|17|||
131461595|NCT00727441|473322096|FG000|Overall Study|Eligibility|7|||
131461596|NCT00727441|473322097|FG001|Overall Study|Eligibility|5|||
131461597|NCT00727441|473322098|FG002|Overall Study|Eligibility|7|||
131461598|NCT00727441|473322096|FG000|Overall Study|Death|0|||
131461599|NCT00727441|473322097|FG001|Overall Study|Death|1|||
131461600|NCT00727441|473322098|FG002|Overall Study|Death|1|||
131461601|NCT00727441|473322096|FG000|Overall Study|Physician Decision|0|||
131461602|NCT00727441|473322097|FG001|Overall Study|Physician Decision|1|||
131461603|NCT00727441|473322098|FG002|Overall Study|Physician Decision|0|||
131461604|NCT00727441|473322096|FG000|Overall Study|Withdrawal by Subject|0|||
131461605|NCT00727441|473322097|FG001|Overall Study|Withdrawal by Subject|1|||
131461606|NCT00727441|473322098|FG002|Overall Study|Withdrawal by Subject|0|||
131461607|NCT00535288|473322099|FG000|Overall Study|Adverse Event|20|||
131461608|NCT00535288|473322100|FG001|Overall Study|Adverse Event|19|||
131461609|NCT00535288|473322101|FG002|Overall Study|Adverse Event|25|||
131461610|NCT00535288|473322102|FG003|Overall Study|Adverse Event|20|||
131461611|NCT00535288|473322103|FG004|Overall Study|Adverse Event|30|||
131461612|NCT00535288|473322099|FG000|Overall Study|Lost to Follow-up|0|||
131461613|NCT00535288|473322100|FG001|Overall Study|Lost to Follow-up|3|||
131461614|NCT00535288|473322101|FG002|Overall Study|Lost to Follow-up|0|||
131461615|NCT00535288|473322102|FG003|Overall Study|Lost to Follow-up|0|||
131461616|NCT00535288|473322103|FG004|Overall Study|Lost to Follow-up|0|||
131461617|NCT00535288|473322099|FG000|Overall Study|Lack of Efficacy|26|||
131461618|NCT00535288|473322100|FG001|Overall Study|Lack of Efficacy|3|||
131461619|NCT00535288|473322101|FG002|Overall Study|Lack of Efficacy|4|||
131461620|NCT00535288|473322102|FG003|Overall Study|Lack of Efficacy|4|||
131461621|NCT00535288|473322103|FG004|Overall Study|Lack of Efficacy|7|||
131461622|NCT00535288|473322099|FG000|Overall Study|Unwilling to cooperate|6|||
131461623|NCT00535288|473322100|FG001|Overall Study|Unwilling to cooperate|6|||
131461624|NCT00535288|473322101|FG002|Overall Study|Unwilling to cooperate|3|||
131461625|NCT00535288|473322102|FG003|Overall Study|Unwilling to cooperate|3|||
131461626|NCT00535288|473322103|FG004|Overall Study|Unwilling to cooperate|4|||
131461627|NCT00535288|473322099|FG000|Overall Study|Other|2|||
131461628|NCT00535288|473322100|FG001|Overall Study|Other|1|||
131461629|NCT00535288|473322101|FG002|Overall Study|Other|1|||
131461630|NCT00535288|473322102|FG003|Overall Study|Other|2|||
131461631|NCT00535288|473322103|FG004|Overall Study|Other|1|||
131461632|NCT00745849|473322104|FG000|First Intervention|Withdrawal by Subject|0|||
131461633|NCT00745849|473322105|FG001|First Intervention|Withdrawal by Subject|1|||
131461634|NCT00745849|473322104|FG000|First Intervention|Lost to Follow-up|1|||
131461635|NCT00745849|473322105|FG001|First Intervention|Lost to Follow-up|1|||
131461636|NCT00745849|473322104|FG000|Second Intervention|Lost to Follow-up|2|||
131461637|NCT00745849|473322105|FG001|Second Intervention|Lost to Follow-up|1|||
131461638|NCT01129583|473322111|FG000|Overall Study|Death|1|||
131461639|NCT01129583|473322112|FG001|Overall Study|Death|0|||
131461640|NCT01129583|473322111|FG000|Overall Study|Lost to Follow-up|1|||
131461641|NCT01129583|473322112|FG001|Overall Study|Lost to Follow-up|1|||
131461642|NCT01129583|473322111|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
131461643|NCT01129583|473322112|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
131461644|NCT02855541|473322130|FG000|Overall Study|Change in health status|2|||
131461645|NCT02855541|473322130|FG000|Overall Study|Withdrawal by Subject|2|||
131461646|NCT00422513|473322131|FG000|Overall Study|Lack of Efficacy|4|||
131461647|NCT00422513|473322132|FG001|Overall Study|Lack of Efficacy|5|||
131461648|NCT00422513|473322131|FG000|Overall Study|Protocol Violation|23|||
131461649|NCT00422513|473322132|FG001|Overall Study|Protocol Violation|7|||
131461650|NCT00422513|473322131|FG000|Overall Study|Refused Treatment|4|||
131461651|NCT00422513|473322132|FG001|Overall Study|Refused Treatment|2|||
131461652|NCT00422513|473322131|FG000|Overall Study|Withdrawal by Subject|2|||
131461653|NCT00422513|473322132|FG001|Overall Study|Withdrawal by Subject|1|||
131461654|NCT00422513|473322131|FG000|Overall Study|early termination of the study|67|||
131461655|NCT00422513|473322132|FG001|Overall Study|early termination of the study|80|||
131461656|NCT00422513|473322131|FG000|Overall Study|Adverse Event|4|||
131461657|NCT00422513|473322132|FG001|Overall Study|Adverse Event|4|||
131461658|NCT00422513|473322131|FG000|Overall Study|Death|3|||
131461659|NCT00422513|473322132|FG001|Overall Study|Death|7|||
131461660|NCT04493892|473322137|FG000|Overall Study|Withdrawal by Subject|15|||
131461661|NCT02366091|473322144|FG000|Overall Study|Withdrawal by Subject|3|||
131461662|NCT02366091|473322145|FG001|Overall Study|Withdrawal by Subject|7|||
131461663|NCT02366091|473322146|FG002|Overall Study|Withdrawal by Subject|3|||
131461664|NCT02366091|473322147|FG003|Overall Study|Withdrawal by Subject|1|||
131461665|NCT00422084|473322148|FG000|Overall Study|Adverse Event|21|||
131461666|NCT00422084|473322149|FG001|Overall Study|Adverse Event|7|||
131461667|NCT00422084|473322148|FG000|Overall Study|Withdrawal by Subject|12|||
131461668|NCT00422084|473322149|FG001|Overall Study|Withdrawal by Subject|9|||
131461669|NCT00422084|473322148|FG000|Overall Study|Lost to Follow-up|14|||
131461670|NCT00422084|473322149|FG001|Overall Study|Lost to Follow-up|9|||
131461671|NCT00422084|473322148|FG000|Overall Study|Protocol Violation|4|||
131461672|NCT00422084|473322149|FG001|Overall Study|Protocol Violation|1|||
131461673|NCT00422084|473322148|FG000|Overall Study|Lack of Efficacy|40|||
131461674|NCT00422084|473322149|FG001|Overall Study|Lack of Efficacy|42|||
131461675|NCT00422084|473322148|FG000|Overall Study|P. vivax infection|3|||
131461676|NCT00422084|473322149|FG001|Overall Study|P. vivax infection|6|||
131461677|NCT00422084|473322148|FG000|Overall Study|Cyesis|1|||
131461678|NCT00422084|473322149|FG001|Overall Study|Cyesis|0|||
131461679|NCT00422084|473322148|FG000|Overall Study|Withdrawn from study accidentally|1|||
131461680|NCT00422084|473322149|FG001|Overall Study|Withdrawn from study accidentally|0|||
131461681|NCT00422084|473322148|FG000|Overall Study|Non-compliance|1|||
131461682|NCT00422084|473322149|FG001|Overall Study|Non-compliance|0|||
131461683|NCT00422084|473322148|FG000|Overall Study|Re-location|0|||
131461684|NCT00422084|473322149|FG001|Overall Study|Re-location|1|||
131461685|NCT00422084|473322148|FG000|Overall Study|Not defined|1|||
131461686|NCT00422084|473322149|FG001|Overall Study|Not defined|1|||
131461687|NCT01087736|473322150|FG000|Overall Study|Lost to Follow-up|1|||
131461688|NCT01087736|473322151|FG001|Overall Study|Lost to Follow-up|0|||
131461689|NCT01087736|473322150|FG000|Overall Study|Death|0|||
131461690|NCT01087736|473322151|FG001|Overall Study|Death|1|||
131461691|NCT01087736|473322150|FG000|Overall Study|Withdrawal by Subject|0|||
131461692|NCT01087736|473322151|FG001|Overall Study|Withdrawal by Subject|1|||
131461693|NCT01253811|473322152|FG000|Overall Study|Withdrawal criteria|1|||
131461694|NCT03774823|473322155|FG000|Overall Study|Withdrawal by Subject|1|||
131461695|NCT03774823|473322156|FG001|Overall Study|Withdrawal by Subject|1|||
131461696|NCT00958438|473322160|FG000|Overall Study|Protocol Violation|3|||
131461697|NCT00958438|473322161|FG001|Overall Study|Protocol Violation|2|||
131461698|NCT00958438|473322162|FG002|Overall Study|Protocol Violation|2|||
131461699|NCT00958438|473322160|FG000|Overall Study|Withdrawal by Subject|4|||
131461700|NCT00958438|473322161|FG001|Overall Study|Withdrawal by Subject|2|||
131461701|NCT00958438|473322162|FG002|Overall Study|Withdrawal by Subject|1|||
131461702|NCT00958438|473322160|FG000|Overall Study|Adverse Event|0|||
131461703|NCT00958438|473322161|FG001|Overall Study|Adverse Event|3|||
131461704|NCT00958438|473322162|FG002|Overall Study|Adverse Event|0|||
131461705|NCT00958438|473322160|FG000|Overall Study|Physician Decision|1|||
131461706|NCT00958438|473322161|FG001|Overall Study|Physician Decision|0|||
131461707|NCT00958438|473322162|FG002|Overall Study|Physician Decision|1|||
131461708|NCT00958438|473322160|FG000|Overall Study|Other than specified above|2|||
131461709|NCT00958438|473322161|FG001|Overall Study|Other than specified above|3|||
131461710|NCT00958438|473322162|FG002|Overall Study|Other than specified above|2|||
131461711|NCT00759564|473322163|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
131461712|NCT00759564|473322164|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
131461713|NCT00759564|473322165|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
131461714|NCT00759564|473322166|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
131768917|NCT01497899|474431898|FG001|Double-Blind Phase|Lack of Efficacy|1|||
131768918|NCT01497899|474431899|FG002|Double-Blind Phase|Lack of Efficacy|0|||
131768919|NCT01497899|474431900|FG003|Double-Blind Phase|Lack of Efficacy|0|||
131768920|NCT01497899|474431897|FG000|Double-Blind Phase|Investigator's Discretion|1|||
131768921|NCT01497899|474431898|FG001|Double-Blind Phase|Investigator's Discretion|0|||
131768922|NCT01497899|474431899|FG002|Double-Blind Phase|Investigator's Discretion|0|||
131768923|NCT01497899|474431900|FG003|Double-Blind Phase|Investigator's Discretion|0|||
131768924|NCT01497899|474431897|FG000|Double-Blind Phase|Withdrew Consent|0|||
131768925|NCT01497899|474431898|FG001|Double-Blind Phase|Withdrew Consent|1|||
131768926|NCT01497899|474431899|FG002|Double-Blind Phase|Withdrew Consent|0|||
131768927|NCT01497899|474431900|FG003|Double-Blind Phase|Withdrew Consent|0|||
131768928|NCT01497899|474431897|FG000|Double-Blind Phase|Lost to Follow-up|3|||
131768929|NCT01497899|474431898|FG001|Double-Blind Phase|Lost to Follow-up|2|||
131768930|NCT01497899|474431899|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131768931|NCT01497899|474431900|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131768932|NCT01497899|474431897|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
131768933|NCT01497899|474431898|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
131461715|NCT00759564|473322167|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
131461716|NCT02788279|473322168|FG000|Overall Study|Death|62|||
131461717|NCT02788279|473322169|FG001|Overall Study|Death|136|||
131461718|NCT02788279|473322170|FG002|Overall Study|Death|72|||
131461719|NCT02788279|473322168|FG000|Overall Study|Withdrawal by Subject|10|||
131461720|NCT02788279|473322169|FG001|Overall Study|Withdrawal by Subject|15|||
131461721|NCT02788279|473322170|FG002|Overall Study|Withdrawal by Subject|5|||
131461722|NCT02788279|473322168|FG000|Overall Study|Lost to Follow-up|0|||
131461723|NCT02788279|473322169|FG001|Overall Study|Lost to Follow-up|3|||
131461724|NCT02788279|473322170|FG002|Overall Study|Lost to Follow-up|2|||
131461725|NCT02788279|473322168|FG000|Overall Study|Sponsor decision|18|||
131461726|NCT02788279|473322169|FG001|Overall Study|Sponsor decision|29|||
131461727|NCT02788279|473322170|FG002|Overall Study|Sponsor decision|11|||
131461728|NCT01782469|473322171|FG000|Overall Study|Lost to Follow-up|1|||
131461729|NCT00835211|473322175|FG000|First Intervention|Withdrawal by Subject|0|||
131461730|NCT00835211|473322176|FG001|First Intervention|Withdrawal by Subject|1|||
131461731|NCT00835211|473322175|FG000|Washout: 7 Days|Adverse Event|2|||
131461732|NCT00835211|473322176|FG001|Washout: 7 Days|Adverse Event|1|||
131461733|NCT00835211|473322175|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131461734|NCT00835211|473322176|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
131461735|NCT02343549|473322177|FG000|Overall Study|Death|11|||
131461736|NCT02343549|473322177|FG000|Overall Study|Withdrawal by Subject|2|||
131461737|NCT02160041|473322178|FG000|Overall Study|Adverse Event|11|||
131461738|NCT02160041|473322178|FG000|Overall Study|Death|2|||
131461739|NCT02160041|473322178|FG000|Overall Study|disease progression|57|||
131461740|NCT02160041|473322178|FG000|Overall Study|Protocol Violation|1|||
131461741|NCT02160041|473322178|FG000|Overall Study|non-compliance with study|1|||
131461742|NCT02160041|473322178|FG000|Overall Study|Physician Decision|3|||
131461743|NCT02160041|473322178|FG000|Overall Study|Withdrawal by Subject|8|||
131461744|NCT02160041|473322178|FG000|Overall Study|study terminated by by sponsor|1|||
131461745|NCT01403948|473322179|FG000|Overall Study|Progressive disease|0|||
131461746|NCT01403948|473322180|FG001|Overall Study|Progressive disease|2|||
131461747|NCT01403948|473322181|FG002|Overall Study|Progressive disease|2|||
131461748|NCT01403948|473322182|FG003|Overall Study|Progressive disease|4|||
131461749|NCT01403948|473322183|FG004|Overall Study|Progressive disease|2|||
131461750|NCT01403948|473322184|FG005|Overall Study|Progressive disease|6|||
131461751|NCT01403948|473322185|FG006|Overall Study|Progressive disease|2|||
131461752|NCT01403948|473322186|FG007|Overall Study|Progressive disease|4|||
131461753|NCT01403948|473322187|FG008|Overall Study|Progressive disease|5|||
131461754|NCT01403948|473322188|FG009|Overall Study|Progressive disease|5|||
131461755|NCT01403948|473322179|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461756|NCT01403948|473322180|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461757|NCT01403948|473322181|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461758|NCT01403948|473322182|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461759|NCT01403948|473322183|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
131461760|NCT01403948|473322184|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461761|NCT01403948|473322185|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
131461762|NCT01403948|473322186|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461763|NCT01403948|473322187|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
131461764|NCT01403948|473322188|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
131461765|NCT01403948|473322179|FG000|Overall Study|Lost to Follow-up|0|||
131461766|NCT01403948|473322180|FG001|Overall Study|Lost to Follow-up|0|||
131461767|NCT01403948|473322181|FG002|Overall Study|Lost to Follow-up|0|||
131461768|NCT01403948|473322182|FG003|Overall Study|Lost to Follow-up|0|||
131461769|NCT01403948|473322183|FG004|Overall Study|Lost to Follow-up|0|||
131461770|NCT01403948|473322184|FG005|Overall Study|Lost to Follow-up|0|||
131461771|NCT01403948|473322185|FG006|Overall Study|Lost to Follow-up|0|||
131461772|NCT01403948|473322186|FG007|Overall Study|Lost to Follow-up|0|||
131461773|NCT01403948|473322187|FG008|Overall Study|Lost to Follow-up|0|||
131461774|NCT01403948|473322188|FG009|Overall Study|Lost to Follow-up|1|||
131461775|NCT01403948|473322179|FG000|Overall Study|Refused cont. medication|0|||
131461776|NCT01403948|473322180|FG001|Overall Study|Refused cont. medication|0|||
131461777|NCT01403948|473322181|FG002|Overall Study|Refused cont. medication|0|||
131461778|NCT01403948|473322182|FG003|Overall Study|Refused cont. medication|0|||
131461779|NCT01403948|473322183|FG004|Overall Study|Refused cont. medication|1|||
131461780|NCT01403948|473322184|FG005|Overall Study|Refused cont. medication|0|||
131461781|NCT01403948|473322185|FG006|Overall Study|Refused cont. medication|0|||
131461782|NCT01403948|473322186|FG007|Overall Study|Refused cont. medication|0|||
131461783|NCT01403948|473322187|FG008|Overall Study|Refused cont. medication|0|||
131461784|NCT01403948|473322188|FG009|Overall Study|Refused cont. medication|1|||
131461785|NCT01403948|473322179|FG000|Overall Study|other than above|1|||
131461786|NCT01403948|473322180|FG001|Overall Study|other than above|2|||
131461787|NCT01403948|473322181|FG002|Overall Study|other than above|1|||
131461788|NCT01403948|473322182|FG003|Overall Study|other than above|0|||
131461789|NCT01403948|473322183|FG004|Overall Study|other than above|1|||
131461790|NCT01403948|473322184|FG005|Overall Study|other than above|1|||
131461791|NCT01403948|473322185|FG006|Overall Study|other than above|2|||
131461792|NCT01403948|473322186|FG007|Overall Study|other than above|0|||
131461793|NCT01403948|473322187|FG008|Overall Study|other than above|0|||
131461794|NCT01403948|473322188|FG009|Overall Study|other than above|0|||
131461795|NCT01090323|473322189|FG000|Overall Study|Adverse Event|12|||
131461796|NCT01090323|473322190|FG001|Overall Study|Adverse Event|2|||
131461797|NCT01090323|473322189|FG000|Overall Study|Abnormal Lab Values|3|||
131461798|NCT01090323|473322190|FG001|Overall Study|Abnormal Lab Values|1|||
131461799|NCT01090323|473322189|FG000|Overall Study|Abnormal Test Procedure Results|2|||
131461800|NCT01090323|473322190|FG001|Overall Study|Abnormal Test Procedure Results|0|||
131461801|NCT01090323|473322189|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131461802|NCT01090323|473322190|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131461803|NCT01090323|473322189|FG000|Overall Study|Condition no longer requires drug|5|||
131461804|NCT01090323|473322190|FG001|Overall Study|Condition no longer requires drug|4|||
131461805|NCT01090323|473322189|FG000|Overall Study|Protocol Violation|2|||
131461806|NCT01090323|473322190|FG001|Overall Study|Protocol Violation|1|||
131461807|NCT01090323|473322189|FG000|Overall Study|Withdrew consent|33|||
131461808|NCT01090323|473322190|FG001|Overall Study|Withdrew consent|11|||
131461809|NCT01090323|473322189|FG000|Overall Study|Lost to Follow-up|11|||
131461810|NCT01090323|473322190|FG001|Overall Study|Lost to Follow-up|6|||
131461811|NCT01090323|473322189|FG000|Overall Study|Administrative problems|6|||
131461812|NCT01090323|473322190|FG001|Overall Study|Administrative problems|4|||
131461813|NCT01090323|473322189|FG000|Overall Study|Death|1|||
131461814|NCT01090323|473322190|FG001|Overall Study|Death|2|||
131461815|NCT01090323|473322189|FG000|Overall Study|Stopped end of core|7|||
131461816|NCT01090323|473322190|FG001|Overall Study|Stopped end of core|0|||
131461817|NCT01090323|473322189|FG000|Overall Study|Stopped end of extension 1#|3|||
131461818|NCT01090323|473322190|FG001|Overall Study|Stopped end of extension 1#|1|||
131461819|NCT05498701|473322191|FG000|Period 3|Adverse Event|1|||
131461820|NCT05498701|473322192|FG001|Period 3|Adverse Event|0|||
131461821|NCT01864005|473322193|FG000|Overall Study|Protocol Violation|0|||
131461822|NCT01864005|473322194|FG001|Overall Study|Protocol Violation|1|||
131461823|NCT01864005|473322193|FG000|Overall Study|Withdrawal by Subject|0|||
131461824|NCT01864005|473322194|FG001|Overall Study|Withdrawal by Subject|1|||
131461825|NCT01864005|473322193|FG000|Overall Study|Incorrect enrolment|1|||
131461826|NCT01864005|473322194|FG001|Overall Study|Incorrect enrolment|0|||
131461827|NCT01864005|473322193|FG000|Overall Study|Disease need|1|||
131461828|NCT01864005|473322194|FG001|Overall Study|Disease need|1|||
131461829|NCT01864005|473322193|FG000|Overall Study|Need GP IIb/IIIa|1|||
131461830|NCT01864005|473322194|FG001|Overall Study|Need GP IIb/IIIa|3|||
131461831|NCT02184572|473322198|FG000|Overall Study|Lost to Follow-up|29|||
131461832|NCT02184572|473322199|FG001|Overall Study|Lost to Follow-up|21|||
131461833|NCT02184572|473322198|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
131461834|NCT02184572|473322199|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
131461835|NCT02184572|473322198|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
131461836|NCT02184572|473322199|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
131461837|NCT02184572|473322198|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
131461838|NCT02184572|473322199|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
131461839|NCT02184572|473322198|FG000|Overall Study|Traveling Outside The Country|1|||
131461840|NCT02184572|473322199|FG001|Overall Study|Traveling Outside The Country|0|||
131461841|NCT02184572|473322198|FG000|Overall Study|Withdrawal by Subject|14|||
131461842|NCT02184572|473322199|FG001|Overall Study|Withdrawal by Subject|9|||
131461843|NCT00638183|473322203|FG000|Overall Study|Adverse Event|23|||
131461844|NCT00638183|473322203|FG000|Overall Study|Lack of Efficacy|14|||
131461845|NCT00638183|473322203|FG000|Overall Study|Physician Decision|9|||
131461846|NCT00638183|473322203|FG000|Overall Study|Lost to Follow-up|46|||
131461847|NCT00638183|473322203|FG000|Overall Study|Other reason not defined above|27|||
131461848|NCT00006409|473322204|FG000|Baseline|Protocol Violation|48|||
131461849|NCT00006409|473322205|FG001|Baseline|Protocol Violation|70|||
131461850|NCT00006409|473322206|FG002|Baseline|Protocol Violation|0|||
131461851|NCT00006409|473322207|FG003|Baseline|Protocol Violation|0|||
131461852|NCT00006409|473322208|FG004|Baseline|Protocol Violation|0|||
131461853|NCT00006409|473322209|FG005|Baseline|Protocol Violation|0|||
131461854|NCT00006409|473322204|FG000|Post-2 Year Intervention|Protocol Violation|0|||
131461855|NCT00006409|473322205|FG001|Post-2 Year Intervention|Protocol Violation|0|||
131461856|NCT00006409|473322206|FG002|Post-2 Year Intervention|Protocol Violation|251|||
131461857|NCT00006409|473322207|FG003|Post-2 Year Intervention|Protocol Violation|168|||
131461858|NCT00006409|473322208|FG004|Post-2 Year Intervention|Protocol Violation|0|||
131461859|NCT00006409|473322209|FG005|Post-2 Year Intervention|Protocol Violation|0|||
131461860|NCT00006409|473322204|FG000|Post-3 Year Intervention|Protocol Violation|0|||
131461861|NCT00006409|473322205|FG001|Post-3 Year Intervention|Protocol Violation|0|||
131461862|NCT00006409|473322206|FG002|Post-3 Year Intervention|Protocol Violation|0|||
131461863|NCT00006409|473322207|FG003|Post-3 Year Intervention|Protocol Violation|0|||
131461864|NCT00006409|473322208|FG004|Post-3 Year Intervention|Protocol Violation|62|||
131461865|NCT00006409|473322209|FG005|Post-3 Year Intervention|Protocol Violation|62|||
131461866|NCT04620798|473322210|FG000|Overall Study|Lost to Follow-up|126|||
131461867|NCT04620798|473322211|FG001|Overall Study|Lost to Follow-up|138|||
131461868|NCT00080899|473322212|FG000|Overall Study|Adverse Event|1|||
131461869|NCT01616693|473322213|FG000|Evaluated for Safety|Physician Decision|1|||
131461870|NCT01616693|473322214|FG001|Evaluated for Safety|Physician Decision|0|||
131461871|NCT01616693|473322215|FG002|Evaluated for Safety|Physician Decision|1|||
131461872|NCT01616693|473322216|FG003|Evaluated for Safety|Physician Decision|0|||
131461873|NCT01616693|473322213|FG000|Received Both Vaccines|Adverse Event|2|||
131461874|NCT01616693|473322214|FG001|Received Both Vaccines|Adverse Event|0|||
131461875|NCT01616693|473322215|FG002|Received Both Vaccines|Adverse Event|0|||
131461876|NCT01616693|473322216|FG003|Received Both Vaccines|Adverse Event|0|||
131461877|NCT01616693|473322213|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
131461878|NCT01616693|473322214|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
131461879|NCT01616693|473322215|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
131461880|NCT01616693|473322216|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
131461881|NCT01616693|473322213|FG000|Received Both Vaccines|Lost to Follow-up|4|||
131461882|NCT01616693|473322214|FG001|Received Both Vaccines|Lost to Follow-up|3|||
131461883|NCT01616693|473322215|FG002|Received Both Vaccines|Lost to Follow-up|4|||
131461884|NCT01616693|473322216|FG003|Received Both Vaccines|Lost to Follow-up|4|||
131461885|NCT01616693|473322213|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
131461886|NCT01616693|473322214|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
131461887|NCT01616693|473322215|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
131461888|NCT01616693|473322216|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
131461889|NCT00832624|473322217|FG000|Overall Study|Study Terminated|10|||
131461890|NCT00475982|473322218|FG000|Overall Study|surgery rescheduled|7|||
131461891|NCT00475982|473322219|FG001|Overall Study|surgery rescheduled|3|||
131461892|NCT00783198|473322220|FG000|Overall Study|Adverse Event|15|||
131461893|NCT00783198|473322221|FG001|Overall Study|Adverse Event|19|||
131461894|NCT00783198|473322222|FG002|Overall Study|Adverse Event|3|||
131461895|NCT00783198|473322220|FG000|Overall Study|Lost to Follow-up|11|||
131461896|NCT00783198|473322221|FG001|Overall Study|Lost to Follow-up|1|||
131461897|NCT00783198|473322222|FG002|Overall Study|Lost to Follow-up|7|||
131461898|NCT00783198|473322220|FG000|Overall Study|Withdrawal by Subject|22|||
131461899|NCT00783198|473322221|FG001|Overall Study|Withdrawal by Subject|14|||
131461900|NCT00783198|473322222|FG002|Overall Study|Withdrawal by Subject|20|||
131461901|NCT00783198|473322220|FG000|Overall Study|Noncompliance with protocol|7|||
131461902|NCT00783198|473322221|FG001|Overall Study|Noncompliance with protocol|7|||
131461903|NCT00783198|473322222|FG002|Overall Study|Noncompliance with protocol|10|||
131461904|NCT00783198|473322220|FG000|Overall Study|Did not meet protocol eligibility|0|||
131461905|NCT00783198|473322221|FG001|Overall Study|Did not meet protocol eligibility|1|||
131461906|NCT00783198|473322222|FG002|Overall Study|Did not meet protocol eligibility|0|||
131461907|NCT00783198|473322220|FG000|Overall Study|Administrative|2|||
131461908|NCT00783198|473322221|FG001|Overall Study|Administrative|1|||
131461909|NCT00783198|473322222|FG002|Overall Study|Administrative|2|||
131461910|NCT01546623|473322223|FG000|Overall Study|Adverse Event|2|||
131461911|NCT01546623|473322224|FG001|Overall Study|Adverse Event|3|||
131461912|NCT01546623|473322223|FG000|Overall Study|Major Protocol Deviation|1|||
131461913|NCT01546623|473322224|FG001|Overall Study|Major Protocol Deviation|1|||
131461914|NCT01546623|473322223|FG000|Overall Study|High Prostate specific antigen|2|||
131461915|NCT01546623|473322224|FG001|Overall Study|High Prostate specific antigen|1|||
131461916|NCT01546623|473322223|FG000|Overall Study|Did Not Receive Study Drug|1|||
131461917|NCT01546623|473322224|FG001|Overall Study|Did Not Receive Study Drug|1|||
131461918|NCT01134705|473322225|FG000|Overall Study|Adverse Event|1|||
131461919|NCT01134705|473322226|FG001|Overall Study|Adverse Event|7|||
131461920|NCT01134705|473322225|FG000|Overall Study|Withdrawal by Subject|6|||
131461921|NCT01134705|473322226|FG001|Overall Study|Withdrawal by Subject|6|||
131461922|NCT01134705|473322225|FG000|Overall Study|Pregnancy|1|||
131461923|NCT01134705|473322226|FG001|Overall Study|Pregnancy|0|||
131461924|NCT01134705|473322225|FG000|Overall Study|Lost to Follow-up|5|||
131461925|NCT01134705|473322226|FG001|Overall Study|Lost to Follow-up|2|||
131461926|NCT01134705|473322225|FG000|Overall Study|Protocol Violation|1|||
131461927|NCT01134705|473322226|FG001|Overall Study|Protocol Violation|1|||
131461928|NCT01134705|473322225|FG000|Overall Study|Other|1|||
131461929|NCT01134705|473322226|FG001|Overall Study|Other|6|||
131461930|NCT01590758|473322229|FG000|Overall Study|Withdrawal by Subject|0|||
131461931|NCT01590758|473322230|FG001|Overall Study|Withdrawal by Subject|3|||
131461932|NCT01590758|473322229|FG000|Overall Study|Physician Decision|1|||
131461933|NCT01590758|473322230|FG001|Overall Study|Physician Decision|2|||
131461934|NCT01590758|473322229|FG000|Overall Study|Lost to Follow-up|4|||
131461935|NCT01590758|473322230|FG001|Overall Study|Lost to Follow-up|2|||
131461936|NCT04525885|473322231|FG000|Overall Study|Screen Failure|1|||
131461937|NCT04525885|473322232|FG001|Overall Study|Screen Failure|0|||
131461938|NCT04525885|473322233|FG002|Overall Study|Screen Failure|0|||
131461939|NCT04525885|473322231|FG000|Overall Study|Withdrawal by Subject|14|||
131461940|NCT04525885|473322232|FG001|Overall Study|Withdrawal by Subject|6|||
131461941|NCT04525885|473322233|FG002|Overall Study|Withdrawal by Subject|20|||
131461942|NCT04525885|473322231|FG000|Overall Study|Physician Decision|1|||
131461943|NCT04525885|473322232|FG001|Overall Study|Physician Decision|0|||
131461944|NCT04525885|473322233|FG002|Overall Study|Physician Decision|1|||
131461945|NCT02756806|473322234|FG000|Overall Study|Study terminated early|5|||
131461946|NCT02717832|473322235|FG000|Overall Study|Inability to place IV|3|||
131461947|NCT01008423|473322236|FG000|Overall Study|Adverse Event|13|||
131461948|NCT01008423|473322237|FG001|Overall Study|Adverse Event|6|||
131461949|NCT01008423|473322236|FG000|Overall Study|Withdrawal by Subject|4|||
131461950|NCT01008423|473322237|FG001|Overall Study|Withdrawal by Subject|7|||
131461951|NCT01008423|473322236|FG000|Overall Study|Lost to Follow-up|0|||
131461952|NCT01008423|473322237|FG001|Overall Study|Lost to Follow-up|2|||
131461953|NCT01008423|473322236|FG000|Overall Study|Low Cortisol|0|||
131461954|NCT01008423|473322237|FG001|Overall Study|Low Cortisol|1|||
131461955|NCT01008423|473322236|FG000|Overall Study|Lack of Efficacy|0|||
131461956|NCT01008423|473322237|FG001|Overall Study|Lack of Efficacy|5|||
131461957|NCT01008423|473322236|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
131461958|NCT01008423|473322237|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
131461959|NCT01008423|473322236|FG000|Overall Study|Personal Conflict|1|||
131461960|NCT01008423|473322237|FG001|Overall Study|Personal Conflict|0|||
131461961|NCT01008423|473322236|FG000|Overall Study|Other|0|||
131461962|NCT01008423|473322237|FG001|Overall Study|Other|1|||
131461963|NCT03698591|473322244|FG000|Overall Study|Withdrawal by Subject|2|||
131461964|NCT03698591|473322245|FG001|Overall Study|Withdrawal by Subject|2|||
131461965|NCT03698591|473322244|FG000|Overall Study|Failed drug screen|1|||
131461966|NCT03698591|473322245|FG001|Overall Study|Failed drug screen|1|||
131461967|NCT03698591|473322244|FG000|Overall Study|Failed health screen|0|||
131461968|NCT03698591|473322245|FG001|Overall Study|Failed health screen|1|||
131461969|NCT03698591|473322244|FG000|Overall Study|Ineligible for financial compensation|1|||
131461970|NCT03698591|473322245|FG001|Overall Study|Ineligible for financial compensation|0|||
131461971|NCT03698591|473322244|FG000|Overall Study|Equipment Error|1|||
131461972|NCT03698591|473322245|FG001|Overall Study|Equipment Error|0|||
131461973|NCT03698591|473322244|FG000|Overall Study|Could not establish TMS dosage|0|||
131461974|NCT03698591|473322245|FG001|Overall Study|Could not establish TMS dosage|1|||
131461975|NCT00831493|473322246|FG000|Overall Study|Intractable nausea and vomiting|1|||
131461976|NCT00881868|473322248|FG000|Overall Study|Adverse Event|0|||
131461977|NCT00881868|473322249|FG001|Overall Study|Adverse Event|1|||
131461978|NCT00881868|473322248|FG000|Overall Study|Lost to Follow-up|2|||
131461979|NCT00881868|473322249|FG001|Overall Study|Lost to Follow-up|1|||
131461980|NCT00881868|473322248|FG000|Overall Study|Physician Decision|4|||
131461981|NCT00881868|473322249|FG001|Overall Study|Physician Decision|0|||
131461982|NCT00881868|473322248|FG000|Overall Study|Protocol Violation|2|||
131461983|NCT00881868|473322249|FG001|Overall Study|Protocol Violation|0|||
131461984|NCT03255083|473322250|FG000|Overall Study|Clinical progression|1|||
131461985|NCT03255083|473322251|FG001|Overall Study|Clinical progression|0|||
131461986|NCT03255083|473322252|FG002|Overall Study|Clinical progression|0|||
131461987|NCT03255083|473322253|FG003|Overall Study|Clinical progression|0|||
131461988|NCT03255083|473322250|FG000|Overall Study|Adverse Event|0|||
131461989|NCT03255083|473322251|FG001|Overall Study|Adverse Event|1|||
131461990|NCT03255083|473322252|FG002|Overall Study|Adverse Event|0|||
131461991|NCT03255083|473322253|FG003|Overall Study|Adverse Event|0|||
131461992|NCT03255083|473322250|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
131461993|NCT03255083|473322251|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
131461994|NCT03255083|473322252|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
131461995|NCT03255083|473322253|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
131461996|NCT03255083|473322250|FG000|Overall Study|Withdrawal by Subject|1|||
131461997|NCT03255083|473322251|FG001|Overall Study|Withdrawal by Subject|1|||
131461998|NCT03255083|473322252|FG002|Overall Study|Withdrawal by Subject|1|||
131461999|NCT03255083|473322253|FG003|Overall Study|Withdrawal by Subject|0|||
131462000|NCT01457352|473322254|FG000|Period 1|Adverse Event|2|||
131462001|NCT01457352|473322255|FG001|Period 1|Adverse Event|0|||
131462002|NCT01457352|473322254|FG000|Period 1|Withdrawal by Subject|2|||
131462003|NCT01457352|473322255|FG001|Period 1|Withdrawal by Subject|0|||
131462004|NCT01457352|473322254|FG000|Period 1|Physician Decision|2|||
131462005|NCT01457352|473322255|FG001|Period 1|Physician Decision|0|||
131462006|NCT01457352|473322254|FG000|Period 1|MS related disease progression|1|||
131462007|NCT01457352|473322255|FG001|Period 1|MS related disease progression|0|||
131462008|NCT01457352|473322254|FG000|Period 1|Withdrawn|1|||
131462009|NCT01457352|473322255|FG001|Period 1|Withdrawn|0|||
131462010|NCT01457352|473322254|FG000|Period 1|withdrew per sponsor|1|||
131462011|NCT01457352|473322255|FG001|Period 1|withdrew per sponsor|0|||
131462012|NCT01457352|473322254|FG000|Period 1|Protocol Violation|4|||
131462013|NCT01457352|473322255|FG001|Period 1|Protocol Violation|0|||
131462014|NCT01457352|473322254|FG000|Period 1|Did not meet eligibility criteria|3|||
131462015|NCT01457352|473322255|FG001|Period 1|Did not meet eligibility criteria|0|||
131462016|NCT01457352|473322254|FG000|Period 2|Withdrawal by Subject|23|||
131462017|NCT01457352|473322255|FG001|Period 2|Withdrawal by Subject|0|||
131462018|NCT01457352|473322254|FG000|Period 2|Adverse Event|22|||
131462019|NCT01457352|473322255|FG001|Period 2|Adverse Event|0|||
131462020|NCT01457352|473322254|FG000|Period 2|no analysis|10|||
131462021|NCT01457352|473322255|FG001|Period 2|no analysis|0|||
131462022|NCT01457352|473322254|FG000|Period 2|Lack of Efficacy|8|||
131462023|NCT01457352|473322255|FG001|Period 2|Lack of Efficacy|0|||
131462024|NCT01457352|473322254|FG000|Period 2|Protocol Violation|4|||
131462025|NCT01457352|473322255|FG001|Period 2|Protocol Violation|0|||
131462026|NCT01457352|473322254|FG000|Period 2|Sponsor's withdrawal|7|||
131462027|NCT01457352|473322255|FG001|Period 2|Sponsor's withdrawal|0|||
131462028|NCT01457352|473322254|FG000|Period 2|Lost to Follow-up|1|||
131462029|NCT01457352|473322255|FG001|Period 2|Lost to Follow-up|0|||
131462030|NCT01457352|473322254|FG000|Period 2|dose change|1|||
131462031|NCT01457352|473322255|FG001|Period 2|dose change|0|||
131462032|NCT01457352|473322254|FG000|Period 2|Physician Decision|1|||
131462033|NCT01457352|473322255|FG001|Period 2|Physician Decision|0|||
131462034|NCT01457352|473322254|FG000|Period 2|Did not meet eligibility criteria|3|||
131462035|NCT01457352|473322255|FG001|Period 2|Did not meet eligibility criteria|0|||
131462036|NCT01457352|473322254|FG000|Period 3|Adverse Event|1|||
131462037|NCT01457352|473322255|FG001|Period 3|Adverse Event|1|||
131462038|NCT01457352|473322254|FG000|Period 3|Withdrawal by Subject|0|||
131462039|NCT01457352|473322255|FG001|Period 3|Withdrawal by Subject|2|||
131462040|NCT01457352|473322254|FG000|Period 3|incorrect treatment|0|||
131462041|NCT01457352|473322255|FG001|Period 3|incorrect treatment|1|||
131462042|NCT01457352|473322254|FG000|Period 3|Sponsor's withdrawal|0|||
131462043|NCT01457352|473322255|FG001|Period 3|Sponsor's withdrawal|1|||
131462044|NCT03472547|473322259|FG000|Overall Study|Withdrawal by Subject|30|||
131462045|NCT01031836|473323925|FG000|Stage I|Adverse Event|1|||
131462046|NCT01031836|473323926|FG001|Stage I|Adverse Event|1|||
131462047|NCT01031836|473323927|FG002|Stage I|Adverse Event|0|||
131462048|NCT01031836|473323928|FG003|Stage I|Adverse Event|0|||
131462049|NCT01031836|473323929|FG004|Stage I|Adverse Event|0|||
131462050|NCT01031836|473323930|FG005|Stage I|Adverse Event|0|||
131462051|NCT01031836|473323925|FG000|Stage I|Other|0|||
131462052|NCT01031836|473323926|FG001|Stage I|Other|1|||
131462053|NCT01031836|473323927|FG002|Stage I|Other|0|||
131462054|NCT01031836|473323928|FG003|Stage I|Other|0|||
131462055|NCT01031836|473323929|FG004|Stage I|Other|0|||
131462056|NCT01031836|473323930|FG005|Stage I|Other|1|||
131462057|NCT01031836|473323925|FG000|Stage II|Adverse Event|0|||
131462058|NCT01031836|473323926|FG001|Stage II|Adverse Event|0|||
131462059|NCT01031836|473323927|FG002|Stage II|Adverse Event|2|||
131462060|NCT01031836|473323928|FG003|Stage II|Adverse Event|2|||
131462061|NCT01031836|473323929|FG004|Stage II|Adverse Event|1|||
131462062|NCT01031836|473323930|FG005|Stage II|Adverse Event|1|||
131462063|NCT01031836|473323925|FG000|Stage II|Other|2|||
131462064|NCT01031836|473323926|FG001|Stage II|Other|0|||
131462065|NCT01031836|473323927|FG002|Stage II|Other|0|||
131462066|NCT01031836|473323928|FG003|Stage II|Other|1|||
131462067|NCT01031836|473323929|FG004|Stage II|Other|1|||
131462068|NCT01031836|473323930|FG005|Stage II|Other|0|||
131462069|NCT02600871|473323932|FG000|Overall Study|Lost to Follow-up|13|||
131462070|NCT02600871|473323933|FG001|Overall Study|Lost to Follow-up|10|||
131462071|NCT03859973|473323934|FG000|Overall Study|Other reason than listed|3|||
131462072|NCT03859973|473323935|FG001|Overall Study|Other reason than listed|2|||
131462073|NCT03859973|473323934|FG000|Overall Study|COVID-19 related, not due to AE|3|||
131462074|NCT03859973|473323935|FG001|Overall Study|COVID-19 related, not due to AE|4|||
131462075|NCT03859973|473323934|FG000|Overall Study|Withdrawal by Subject|8|||
131462076|NCT03859973|473323935|FG001|Overall Study|Withdrawal by Subject|9|||
131462077|NCT03859973|473323934|FG000|Overall Study|Lost to Follow-up|2|||
131462078|NCT03859973|473323935|FG001|Overall Study|Lost to Follow-up|3|||
131462079|NCT03859973|473323934|FG000|Overall Study|Protocol Violation|1|||
131462080|NCT03859973|473323935|FG001|Overall Study|Protocol Violation|3|||
131462081|NCT03859973|473323934|FG000|Overall Study|Adverse Event|3|||
131462082|NCT03859973|473323935|FG001|Overall Study|Adverse Event|5|||
131462083|NCT03032380|473323936|FG000|Overall Study|Adverse Event|0|||
131462084|NCT03032380|473323937|FG001|Overall Study|Adverse Event|1|||
131462085|NCT03032380|473323936|FG000|Overall Study|Lack of Efficacy|1|||
131462086|NCT03032380|473323937|FG001|Overall Study|Lack of Efficacy|0|||
131462087|NCT03032380|473323936|FG000|Overall Study|Withdrawal by Subject|2|||
131462088|NCT03032380|473323937|FG001|Overall Study|Withdrawal by Subject|3|||
131462089|NCT03032380|473323936|FG000|Overall Study|Recovery|0|||
131462090|NCT03032380|473323937|FG001|Overall Study|Recovery|1|||
131462091|NCT03032380|473323936|FG000|Overall Study|Death|39|||
131462092|NCT03032380|473323937|FG001|Overall Study|Death|34|||
131462093|NCT03032380|473323936|FG000|Overall Study|Other - Miscellaneous|0|||
131462094|NCT03032380|473323937|FG001|Overall Study|Other - Miscellaneous|1|||
131462095|NCT02267317|473323938|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
131462096|NCT02267317|473323939|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
131462097|NCT02267317|473323940|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
131462098|NCT02267317|473323941|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
131462099|NCT02267317|473323942|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
131462100|NCT02267317|473323943|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
131462101|NCT02267317|473323938|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
131462102|NCT02267317|473323939|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
131462103|NCT02267317|473323940|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
131462104|NCT02267317|473323941|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
131462105|NCT02267317|473323942|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
131462106|NCT02267317|473323943|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
131462107|NCT01128621|473323944|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
131462108|NCT01128621|473323945|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
131462109|NCT00796445|473323948|FG000|Overall Study|Protocol Violation|5|||
131462110|NCT00796445|473323949|FG001|Overall Study|Protocol Violation|3|||
131462111|NCT00796445|473323948|FG000|Overall Study|Adverse event, serious fatal|10|||
131462112|NCT00796445|473323949|FG001|Overall Study|Adverse event, serious fatal|5|||
131462113|NCT00796445|473323948|FG000|Overall Study|Adverse event, non-fatal|4|||
131462114|NCT00796445|473323949|FG001|Overall Study|Adverse event, non-fatal|0|||
131462115|NCT00796445|473323948|FG000|Overall Study|Disease progression/recurrence|537|||
131462116|NCT00796445|473323949|FG001|Overall Study|Disease progression/recurrence|268|||
131462117|NCT00796445|473323948|FG000|Overall Study|Other|10|||
131462118|NCT00796445|473323949|FG001|Overall Study|Other|7|||
131462119|NCT00796445|473323948|FG000|Overall Study|Withdrawal by Subject|18|||
131462120|NCT00796445|473323949|FG001|Overall Study|Withdrawal by Subject|9|||
131462121|NCT00796445|473323948|FG000|Overall Study|Invalid Informed Consent Form|1|||
131462122|NCT00796445|473323949|FG001|Overall Study|Invalid Informed Consent Form|0|||
131462123|NCT02208063|473323950|FG000|Overall Study|Death|3|||
131462124|NCT02208063|473323951|FG001|Overall Study|Death|5|||
131462125|NCT02208063|473323950|FG000|Overall Study|Not Specified in report|3|||
131462126|NCT02208063|473323951|FG001|Overall Study|Not Specified in report|4|||
131462127|NCT02208063|473323950|FG000|Overall Study|Withdrawal by Subject|5|||
131462128|NCT02208063|473323951|FG001|Overall Study|Withdrawal by Subject|2|||
131462129|NCT02208063|473323950|FG000|Overall Study|Lost to Follow-up|1|||
131462130|NCT02208063|473323951|FG001|Overall Study|Lost to Follow-up|0|||
131462131|NCT00913458|473323952|FG000|Phase 1|Non-Responder|54|||
131462132|NCT00913458|473323953|FG001|Phase 1|Non-Responder|0|||
131462133|NCT00913458|473323954|FG002|Phase 1|Non-Responder|0|||
131462134|NCT00913458|473323955|FG003|Phase 1|Non-Responder|0|||
131462135|NCT00913458|473323956|FG004|Phase 1|Non-Responder|0|||
131462136|NCT00913458|473323957|FG005|Phase 1|Non-Responder|0|||
131462137|NCT00913458|473323958|FG006|Phase 1|Non-Responder|0|||
131462138|NCT00913458|473323952|FG000|Phase 1|Subject Request|17|||
131462139|NCT00913458|473323953|FG001|Phase 1|Subject Request|0|||
131462140|NCT00913458|473323954|FG002|Phase 1|Subject Request|0|||
131462141|NCT00913458|473323955|FG003|Phase 1|Subject Request|0|||
131462142|NCT00913458|473323956|FG004|Phase 1|Subject Request|0|||
131462143|NCT00913458|473323957|FG005|Phase 1|Subject Request|0|||
131462144|NCT00913458|473323958|FG006|Phase 1|Subject Request|0|||
131462145|NCT00913458|473323952|FG000|Phase 1|Adverse Event|20|||
131462146|NCT00913458|473323953|FG001|Phase 1|Adverse Event|0|||
131462147|NCT00913458|473323954|FG002|Phase 1|Adverse Event|0|||
131462148|NCT00913458|473323955|FG003|Phase 1|Adverse Event|0|||
131462149|NCT00913458|473323956|FG004|Phase 1|Adverse Event|0|||
131462150|NCT00913458|473323957|FG005|Phase 1|Adverse Event|0|||
131462151|NCT00913458|473323958|FG006|Phase 1|Adverse Event|0|||
131462152|NCT00913458|473323952|FG000|Phase 1|Lost to Follow-up|2|||
131462153|NCT00913458|473323953|FG001|Phase 1|Lost to Follow-up|0|||
131462154|NCT00913458|473323954|FG002|Phase 1|Lost to Follow-up|0|||
131462155|NCT00913458|473323955|FG003|Phase 1|Lost to Follow-up|0|||
131462156|NCT00913458|473323956|FG004|Phase 1|Lost to Follow-up|0|||
131462157|NCT00913458|473323957|FG005|Phase 1|Lost to Follow-up|0|||
131462158|NCT00913458|473323958|FG006|Phase 1|Lost to Follow-up|0|||
131462159|NCT00913458|473323952|FG000|Phase 1|Protocol Violation|10|||
131462160|NCT00913458|473323953|FG001|Phase 1|Protocol Violation|0|||
131462161|NCT00913458|473323954|FG002|Phase 1|Protocol Violation|0|||
131462162|NCT00913458|473323955|FG003|Phase 1|Protocol Violation|0|||
131462163|NCT00913458|473323956|FG004|Phase 1|Protocol Violation|0|||
131462164|NCT00913458|473323957|FG005|Phase 1|Protocol Violation|0|||
131462165|NCT00913458|473323958|FG006|Phase 1|Protocol Violation|0|||
131462166|NCT00913458|473323952|FG000|Phase 1|Sponsor|2|||
131462167|NCT00913458|473323953|FG001|Phase 1|Sponsor|0|||
131462168|NCT00913458|473323954|FG002|Phase 1|Sponsor|0|||
131462169|NCT00913458|473323955|FG003|Phase 1|Sponsor|0|||
131462170|NCT00913458|473323956|FG004|Phase 1|Sponsor|0|||
131462171|NCT00913458|473323957|FG005|Phase 1|Sponsor|0|||
131462172|NCT00913458|473323958|FG006|Phase 1|Sponsor|0|||
131462173|NCT00913458|473323952|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
131462174|NCT00913458|473323953|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
131462175|NCT00913458|473323954|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
131462176|NCT00913458|473323955|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
131462177|NCT00913458|473323956|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
131462178|NCT00913458|473323957|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
131462179|NCT00913458|473323958|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
131462180|NCT00913458|473323952|FG000|Phase 2|Non-Responder|0|||
131462181|NCT00913458|473323953|FG001|Phase 2|Non-Responder|5|||
131462182|NCT00913458|473323954|FG002|Phase 2|Non-Responder|7|||
131462183|NCT00913458|473323955|FG003|Phase 2|Non-Responder|12|||
131462184|NCT00913458|473323956|FG004|Phase 2|Non-Responder|0|||
131462185|NCT00913458|473323957|FG005|Phase 2|Non-Responder|0|||
131462186|NCT00913458|473323958|FG006|Phase 2|Non-Responder|0|||
131462187|NCT00913458|473323952|FG000|Phase 2|Subject Request|0|||
131462188|NCT00913458|473323953|FG001|Phase 2|Subject Request|0|||
131462189|NCT00913458|473323954|FG002|Phase 2|Subject Request|1|||
131462190|NCT00913458|473323955|FG003|Phase 2|Subject Request|2|||
131462191|NCT00913458|473323956|FG004|Phase 2|Subject Request|0|||
131462192|NCT00913458|473323957|FG005|Phase 2|Subject Request|0|||
131462193|NCT00913458|473323958|FG006|Phase 2|Subject Request|0|||
131462194|NCT00913458|473323952|FG000|Phase 2|Adverse Event|0|||
131462195|NCT00913458|473323953|FG001|Phase 2|Adverse Event|3|||
131462196|NCT00913458|473323954|FG002|Phase 2|Adverse Event|0|||
131462197|NCT00913458|473323955|FG003|Phase 2|Adverse Event|1|||
131462198|NCT00913458|473323956|FG004|Phase 2|Adverse Event|0|||
131462199|NCT00913458|473323957|FG005|Phase 2|Adverse Event|0|||
131462200|NCT00913458|473323958|FG006|Phase 2|Adverse Event|0|||
131462201|NCT00913458|473323952|FG000|Phase 2|Lost to Follow-up|0|||
131462202|NCT00913458|473323953|FG001|Phase 2|Lost to Follow-up|0|||
131462203|NCT00913458|473323954|FG002|Phase 2|Lost to Follow-up|0|||
131462204|NCT00913458|473323955|FG003|Phase 2|Lost to Follow-up|1|||
131462205|NCT00913458|473323956|FG004|Phase 2|Lost to Follow-up|0|||
131462206|NCT00913458|473323957|FG005|Phase 2|Lost to Follow-up|0|||
131462207|NCT00913458|473323958|FG006|Phase 2|Lost to Follow-up|0|||
131462208|NCT00913458|473323952|FG000|Phase 2|Protocol Violation|0|||
131462209|NCT00913458|473323953|FG001|Phase 2|Protocol Violation|2|||
131462210|NCT00913458|473323954|FG002|Phase 2|Protocol Violation|0|||
131462211|NCT00913458|473323955|FG003|Phase 2|Protocol Violation|0|||
131462212|NCT00913458|473323956|FG004|Phase 2|Protocol Violation|0|||
131462213|NCT00913458|473323957|FG005|Phase 2|Protocol Violation|0|||
131462214|NCT00913458|473323958|FG006|Phase 2|Protocol Violation|0|||
131462215|NCT00913458|473323952|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
131462216|NCT00913458|473323953|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
131462217|NCT00913458|473323954|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
131462218|NCT00913458|473323955|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
131462219|NCT00913458|473323956|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
131462220|NCT00913458|473323957|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
131462221|NCT00913458|473323958|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
131462222|NCT00913458|473323952|FG000|Phase 3|Adverse Event|0|||
131462223|NCT00913458|473323953|FG001|Phase 3|Adverse Event|0|||
131462224|NCT00913458|473323954|FG002|Phase 3|Adverse Event|0|||
131462225|NCT00913458|473323955|FG003|Phase 3|Adverse Event|0|||
131462226|NCT00913458|473323956|FG004|Phase 3|Adverse Event|5|||
131462227|NCT00913458|473323957|FG005|Phase 3|Adverse Event|4|||
131462228|NCT00913458|473323958|FG006|Phase 3|Adverse Event|1|||
131462229|NCT00913458|473323952|FG000|Phase 3|Lost to Follow-up|0|||
131462230|NCT00913458|473323953|FG001|Phase 3|Lost to Follow-up|0|||
131462231|NCT00913458|473323954|FG002|Phase 3|Lost to Follow-up|0|||
131462232|NCT00913458|473323955|FG003|Phase 3|Lost to Follow-up|0|||
131462233|NCT00913458|473323956|FG004|Phase 3|Lost to Follow-up|2|||
131462234|NCT00913458|473323957|FG005|Phase 3|Lost to Follow-up|0|||
131462235|NCT00913458|473323958|FG006|Phase 3|Lost to Follow-up|0|||
131462236|NCT00913458|473323952|FG000|Phase 3|Non-Responder|0|||
131462237|NCT00913458|473323953|FG001|Phase 3|Non-Responder|0|||
131462238|NCT00913458|473323954|FG002|Phase 3|Non-Responder|0|||
131462239|NCT00913458|473323955|FG003|Phase 3|Non-Responder|0|||
131462240|NCT00913458|473323956|FG004|Phase 3|Non-Responder|0|||
131462241|NCT00913458|473323957|FG005|Phase 3|Non-Responder|1|||
131462242|NCT00913458|473323958|FG006|Phase 3|Non-Responder|3|||
131462243|NCT00913458|473323952|FG000|Phase 3|Withdrawal by Subject|0|||
131462244|NCT00913458|473323953|FG001|Phase 3|Withdrawal by Subject|0|||
131462245|NCT00913458|473323954|FG002|Phase 3|Withdrawal by Subject|0|||
131462246|NCT00913458|473323955|FG003|Phase 3|Withdrawal by Subject|0|||
131462247|NCT00913458|473323956|FG004|Phase 3|Withdrawal by Subject|1|||
131462248|NCT00913458|473323957|FG005|Phase 3|Withdrawal by Subject|2|||
131462249|NCT00913458|473323958|FG006|Phase 3|Withdrawal by Subject|0|||
131462250|NCT00913458|473323952|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
131462251|NCT00913458|473323953|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
131462252|NCT00913458|473323954|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
131462253|NCT00913458|473323955|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
131462254|NCT00913458|473323956|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
131462255|NCT00913458|473323957|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
131462256|NCT00913458|473323958|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
131462257|NCT00917644|473323959|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
131462258|NCT00917644|473323960|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
131462259|NCT00917644|473323959|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
131462260|NCT00917644|473323960|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
131462261|NCT00917644|473323959|FG000|Period 2: Second Intervention|family emergency|1|||
131462262|NCT00917644|473323960|FG001|Period 2: Second Intervention|family emergency|0|||
131462263|NCT00329849|473323968|FG000|Overall Study|Withdrawal by Subject|6|||
131462264|NCT00329849|473323969|FG001|Overall Study|Withdrawal by Subject|4|||
131462265|NCT00653432|473323970|FG000|Overall Study|Adverse Event|4|||
131462266|NCT00653432|473323971|FG001|Overall Study|Adverse Event|1|||
131462267|NCT00653432|473323970|FG000|Overall Study|Withdrawal by Subject|4|||
131462268|NCT00653432|473323971|FG001|Overall Study|Withdrawal by Subject|5|||
131462269|NCT00653432|473323970|FG000|Overall Study|Lost to Follow-up|7|||
131462270|NCT00653432|473323971|FG001|Overall Study|Lost to Follow-up|6|||
131462271|NCT00653432|473323970|FG000|Overall Study|Use/Need of Con Therapy|2|||
131462272|NCT00653432|473323971|FG001|Overall Study|Use/Need of Con Therapy|1|||
131462273|NCT00653432|473323970|FG000|Overall Study|Other - Reason Not Provided|5|||
131462274|NCT00653432|473323971|FG001|Overall Study|Other - Reason Not Provided|3|||
131462275|NCT00357760|473323972|FG000|Overall Study|Disease progression|44|||
131462276|NCT00357760|473323973|FG001|Overall Study|Disease progression|17|||
131462277|NCT00357760|473323972|FG000|Overall Study|Adverse Event|10|||
131462278|NCT00357760|473323973|FG001|Overall Study|Adverse Event|7|||
131462279|NCT00357760|473323972|FG000|Overall Study|Death|0|||
131462280|NCT00357760|473323973|FG001|Overall Study|Death|3|||
131462281|NCT00357760|473323972|FG000|Overall Study|Alternative therapy|1|||
131462282|NCT00357760|473323973|FG001|Overall Study|Alternative therapy|0|||
131462283|NCT00357760|473323972|FG000|Overall Study|Withdrawal by Subject|0|||
131462284|NCT00357760|473323973|FG001|Overall Study|Withdrawal by Subject|2|||
131462285|NCT00357760|473323972|FG000|Overall Study|Never started treatment|2|||
131462286|NCT00357760|473323973|FG001|Overall Study|Never started treatment|1|||
131462287|NCT00357760|473323972|FG000|Overall Study|Ineligible|0|||
131462288|NCT00357760|473323973|FG001|Overall Study|Ineligible|2|||
131462289|NCT00357760|473323972|FG000|Overall Study|Physician Decision|2|||
131462290|NCT00357760|473323973|FG001|Overall Study|Physician Decision|1|||
131462291|NCT00357760|473323972|FG000|Overall Study|Protocol Violation|0|||
131462292|NCT00357760|473323973|FG001|Overall Study|Protocol Violation|1|||
131462293|NCT00357760|473323972|FG000|Overall Study|To receive hospice care|0|||
131462294|NCT00357760|473323973|FG001|Overall Study|To receive hospice care|1|||
131462295|NCT04136444|473323974|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
131462296|NCT04136444|473323975|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
131462297|NCT02238067|473323976|FG000|Overall Study|Not completed survey at Month 6|45|||
131462298|NCT00869778|473323977|FG000|Overall Study|Adverse Event|2|||
131462299|NCT00869778|473323978|FG001|Overall Study|Adverse Event|0|||
131462300|NCT00869778|473323979|FG002|Overall Study|Adverse Event|0|||
131462301|NCT00869778|473323977|FG000|Overall Study|Withdrawal by Subject|3|||
131462302|NCT00869778|473323978|FG001|Overall Study|Withdrawal by Subject|4|||
131462303|NCT00869778|473323979|FG002|Overall Study|Withdrawal by Subject|5|||
131462304|NCT00869778|473323977|FG000|Overall Study|Pregnancy|1|||
131462305|NCT00869778|473323978|FG001|Overall Study|Pregnancy|0|||
131462306|NCT00869778|473323979|FG002|Overall Study|Pregnancy|0|||
131462307|NCT00869778|473323977|FG000|Overall Study|Protocol Violation|5|||
131462308|NCT00869778|473323978|FG001|Overall Study|Protocol Violation|3|||
131462309|NCT00869778|473323979|FG002|Overall Study|Protocol Violation|5|||
131462310|NCT00869778|473323977|FG000|Overall Study|Unblinding|1|||
131462311|NCT00869778|473323978|FG001|Overall Study|Unblinding|0|||
131462312|NCT00869778|473323979|FG002|Overall Study|Unblinding|0|||
131462313|NCT02350764|473323982|FG000|Overall Study|Adverse Event|4|||
131462314|NCT02350764|473323982|FG000|Overall Study|Death|3|||
131462315|NCT02350764|473323982|FG000|Overall Study|Physician Decision|2|||
131462316|NCT02350764|473323982|FG000|Overall Study|Withdrawal by Subject|2|||
131462317|NCT03726996|473323983|FG000|Overall Study|Parent's decision|2|||
131462318|NCT03726996|473323983|FG000|Overall Study|Study early termination|2|||
131462319|NCT01328444|473323984|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131462320|NCT01328444|473323985|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131462321|NCT01328444|473323986|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131462322|NCT01328444|473323987|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131462323|NCT01328444|473323988|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
131462324|NCT01328444|473323989|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
131462325|NCT01328444|473323984|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
131462326|NCT01328444|473323985|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
131462327|NCT01328444|473323986|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
131462328|NCT01328444|473323987|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
131462329|NCT01328444|473323988|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
131462330|NCT01328444|473323989|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
131462331|NCT01328444|473323984|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
131462332|NCT01328444|473323985|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
131462333|NCT01328444|473323986|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
131462334|NCT01328444|473323987|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131462335|NCT01328444|473323988|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
131462336|NCT01328444|473323989|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131462337|NCT01328444|473323984|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
131462338|NCT01328444|473323985|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
131462339|NCT01328444|473323986|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
131462340|NCT01328444|473323987|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
131462341|NCT01328444|473323988|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
131462342|NCT01328444|473323989|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
131462343|NCT01328444|473323984|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
131462344|NCT01328444|473323985|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131462345|NCT01328444|473323986|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131462346|NCT01328444|473323987|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131462347|NCT01328444|473323988|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131462348|NCT01328444|473323989|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131462349|NCT01328444|473323984|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131462350|NCT01328444|473323985|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
131462351|NCT01328444|473323986|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131462352|NCT01328444|473323987|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
131462353|NCT01328444|473323988|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131462354|NCT01328444|473323989|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131462355|NCT01328444|473323984|FG000|Washout Period (14 Days)|Adverse Event|1|||
131462356|NCT01328444|473323985|FG001|Washout Period (14 Days)|Adverse Event|1|||
131462357|NCT01328444|473323986|FG002|Washout Period (14 Days)|Adverse Event|0|||
131462358|NCT01328444|473323987|FG003|Washout Period (14 Days)|Adverse Event|1|||
131462359|NCT01328444|473323988|FG004|Washout Period (14 Days)|Adverse Event|1|||
131462360|NCT01328444|473323989|FG005|Washout Period (14 Days)|Adverse Event|2|||
131462361|NCT01328444|473323984|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
131462362|NCT01328444|473323985|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
131462363|NCT01328444|473323986|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
131462364|NCT01328444|473323987|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
131462365|NCT01328444|473323988|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
131462366|NCT01328444|473323989|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
131462367|NCT01328444|473323984|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
131462368|NCT01328444|473323985|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
131462369|NCT01328444|473323986|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
131462370|NCT01328444|473323987|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
131462371|NCT01328444|473323988|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
131462372|NCT01328444|473323989|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
131462373|NCT01328444|473323984|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
131462374|NCT01328444|473323985|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131462375|NCT01328444|473323986|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131462376|NCT01328444|473323987|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131462377|NCT01328444|473323988|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131462378|NCT01328444|473323989|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131462379|NCT01328444|473323984|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
131462380|NCT01328444|473323985|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131462381|NCT01328444|473323986|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131462382|NCT01328444|473323987|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
131462383|NCT01328444|473323988|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
131462384|NCT01328444|473323989|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
131462385|NCT01328444|473323984|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
131462386|NCT01328444|473323985|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
131462387|NCT01328444|473323986|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
131462388|NCT01328444|473323987|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
131462389|NCT01328444|473323988|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
131462390|NCT01328444|473323989|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
131462391|NCT01328444|473323984|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
131462392|NCT01328444|473323985|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
131462393|NCT01328444|473323986|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
131462394|NCT01328444|473323987|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
131462395|NCT01328444|473323988|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
131462396|NCT01328444|473323989|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
131462397|NCT01328444|473323984|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131462398|NCT01328444|473323985|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131462399|NCT01328444|473323986|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131462400|NCT01328444|473323987|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131462401|NCT01328444|473323988|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131462402|NCT01328444|473323989|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
131462403|NCT01328444|473323984|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131462404|NCT01328444|473323985|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131462405|NCT01328444|473323986|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131462406|NCT01328444|473323987|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131462407|NCT01328444|473323988|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131462408|NCT01328444|473323989|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131462409|NCT03180619|473323990|FG000|Overall Study|Withdrew Consent|5|||
131462410|NCT03180619|473323991|FG001|Overall Study|Withdrew Consent|0|||
131462411|NCT03180619|473323992|FG002|Overall Study|Withdrew Consent|2|||
131462412|NCT03180619|473323990|FG000|Overall Study|Death|2|||
131462413|NCT03180619|473323991|FG001|Overall Study|Death|1|||
131462414|NCT03180619|473323992|FG002|Overall Study|Death|2|||
131462415|NCT03180619|473323990|FG000|Overall Study|Adverse Event|2|||
131462416|NCT03180619|473323991|FG001|Overall Study|Adverse Event|0|||
131462417|NCT03180619|473323992|FG002|Overall Study|Adverse Event|1|||
131462418|NCT03180619|473323990|FG000|Overall Study|Investigator's discretion|2|||
131462419|NCT03180619|473323991|FG001|Overall Study|Investigator's discretion|0|||
131462420|NCT03180619|473323992|FG002|Overall Study|Investigator's discretion|1|||
131462421|NCT03531632|473323993|FG000|Overall Study|Adverse Event|0|||
131462422|NCT03531632|473323994|FG001|Overall Study|Adverse Event|0|||
131462423|NCT03531632|473323995|FG002|Overall Study|Adverse Event|1|||
131462424|NCT03531632|473323993|FG000|Overall Study|Death|4|||
131462425|NCT03531632|473323994|FG001|Overall Study|Death|0|||
131462426|NCT03531632|473323995|FG002|Overall Study|Death|14|||
131462427|NCT03531632|473323993|FG000|Overall Study|Study Terminated|1|||
131462428|NCT03531632|473323994|FG001|Overall Study|Study Terminated|3|||
131462429|NCT03531632|473323995|FG002|Overall Study|Study Terminated|11|||
131462430|NCT02743611|473323996|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
131462431|NCT02743611|473323997|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
131462432|NCT02743611|473323998|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
131462433|NCT02743611|473323999|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
131462434|NCT00600119|473324000|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
131462435|NCT00600119|473324001|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
131462436|NCT00600119|473324002|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
131462437|NCT00600119|473324003|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
131462438|NCT00600119|473324004|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
131462439|NCT00600119|473324005|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
131462440|NCT00600119|473324000|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131462441|NCT00600119|473324001|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
131462442|NCT00600119|473324002|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
131462443|NCT00600119|473324003|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131462444|NCT00600119|473324004|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131462445|NCT00600119|473324005|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
131462446|NCT00600119|473324000|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
131462447|NCT00600119|473324001|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
131462448|NCT00600119|473324002|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
131462449|NCT00600119|473324003|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
131462450|NCT00600119|473324004|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
131462451|NCT00600119|473324005|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
131462452|NCT00600119|473324000|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
131462453|NCT00600119|473324001|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
131462454|NCT00600119|473324002|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
131462455|NCT00600119|473324003|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
131462456|NCT00600119|473324004|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
131462457|NCT00600119|473324005|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
131462458|NCT00600119|473324000|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
131462459|NCT00600119|473324001|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
131462460|NCT00600119|473324002|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
131462461|NCT00600119|473324003|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
131462462|NCT00600119|473324004|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
131462463|NCT00600119|473324005|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
131462464|NCT00600119|473324000|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
131462465|NCT00600119|473324001|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
131462466|NCT00600119|473324002|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
131462467|NCT00600119|473324003|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
131462468|NCT00600119|473324004|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
131462469|NCT00600119|473324005|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
131462470|NCT00600119|473324000|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
131462471|NCT00600119|473324001|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131462472|NCT00600119|473324002|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131462473|NCT00600119|473324003|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
131462474|NCT00600119|473324004|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
131462475|NCT00600119|473324005|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
131462476|NCT00600119|473324000|FG000|Double-blind Treatment Period|Other|0|||
131462477|NCT00600119|473324001|FG001|Double-blind Treatment Period|Other|0|||
131462478|NCT00600119|473324002|FG002|Double-blind Treatment Period|Other|0|||
131462479|NCT00600119|473324003|FG003|Double-blind Treatment Period|Other|0|||
131462480|NCT00600119|473324004|FG004|Double-blind Treatment Period|Other|2|||
131462481|NCT00600119|473324005|FG005|Double-blind Treatment Period|Other|1|||
131462482|NCT00600119|473324000|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
131462483|NCT00600119|473324001|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
131462484|NCT00600119|473324002|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
131462485|NCT00600119|473324003|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
131462486|NCT00600119|473324004|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
131462487|NCT00600119|473324005|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
131462488|NCT00600119|473324000|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
131462489|NCT00600119|473324001|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
131462490|NCT00600119|473324002|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
131462491|NCT00600119|473324003|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
131462492|NCT00600119|473324004|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
131462493|NCT00600119|473324005|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
131462494|NCT00600119|473324000|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
131462495|NCT00600119|473324001|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
131462496|NCT00600119|473324002|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
131462497|NCT00600119|473324003|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
131462498|NCT00600119|473324004|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
131462499|NCT00600119|473324005|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
131462500|NCT00600119|473324000|FG000|Double-blind Treatment Period|Physician Decision|2|||
131462501|NCT00600119|473324001|FG001|Double-blind Treatment Period|Physician Decision|0|||
131462502|NCT00600119|473324002|FG002|Double-blind Treatment Period|Physician Decision|0|||
131462503|NCT00600119|473324003|FG003|Double-blind Treatment Period|Physician Decision|0|||
131462504|NCT00600119|473324004|FG004|Double-blind Treatment Period|Physician Decision|0|||
131462505|NCT00600119|473324005|FG005|Double-blind Treatment Period|Physician Decision|0|||
131462506|NCT00600119|473324000|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131462507|NCT00600119|473324001|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
131462508|NCT00600119|473324002|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131462509|NCT00600119|473324003|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131462510|NCT00600119|473324004|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
131462511|NCT00600119|473324005|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
131462512|NCT00600119|473324000|FG000|Double-blind Treatment Period|Adverse Event|1|||
131462513|NCT00600119|473324001|FG001|Double-blind Treatment Period|Adverse Event|1|||
131462514|NCT00600119|473324002|FG002|Double-blind Treatment Period|Adverse Event|0|||
131462515|NCT00600119|473324003|FG003|Double-blind Treatment Period|Adverse Event|1|||
131462516|NCT00600119|473324004|FG004|Double-blind Treatment Period|Adverse Event|2|||
131462517|NCT00600119|473324005|FG005|Double-blind Treatment Period|Adverse Event|10|||
131462518|NCT00600119|473324000|FG000|Follow-up Period|Adverse Event|0|||
131462519|NCT00600119|473324001|FG001|Follow-up Period|Adverse Event|0|||
131462520|NCT00600119|473324002|FG002|Follow-up Period|Adverse Event|0|||
131462521|NCT00600119|473324003|FG003|Follow-up Period|Adverse Event|0|||
131462522|NCT00600119|473324004|FG004|Follow-up Period|Adverse Event|0|||
131462523|NCT00600119|473324005|FG005|Follow-up Period|Adverse Event|1|||
131462524|NCT00600119|473324000|FG000|Follow-up Period|Other|1|||
131462525|NCT00600119|473324001|FG001|Follow-up Period|Other|0|||
131462526|NCT00600119|473324002|FG002|Follow-up Period|Other|0|||
131462527|NCT00600119|473324003|FG003|Follow-up Period|Other|0|||
131462528|NCT00600119|473324004|FG004|Follow-up Period|Other|0|||
131462529|NCT00600119|473324005|FG005|Follow-up Period|Other|0|||
131462530|NCT03241368|473324006|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
131462531|NCT03241368|473324006|FG000|Overall Study|Lost to Follow-up|1|||
131462532|NCT03241368|473324006|FG000|Overall Study|Physician Decision|6|||
131462533|NCT03241368|473324006|FG000|Overall Study|Withdrawal by Subject|6|||
131462534|NCT03241368|473324006|FG000|Overall Study|Protocol Violation|1|||
131462535|NCT00729469|473324007|FG000|Overall Study|Adverse Event|14|||
131462536|NCT00729469|473324008|FG001|Overall Study|Adverse Event|25|||
131462537|NCT00729469|473324007|FG000|Overall Study|Lost to Follow-up|9|||
131462538|NCT00729469|473324008|FG001|Overall Study|Lost to Follow-up|9|||
131462539|NCT00729469|473324007|FG000|Overall Study|Protocol Violation|2|||
131462540|NCT00729469|473324008|FG001|Overall Study|Protocol Violation|1|||
131462541|NCT00729469|473324007|FG000|Overall Study|Withdrawal by Subject|19|||
131462542|NCT00729469|473324008|FG001|Overall Study|Withdrawal by Subject|8|||
131462543|NCT00729469|473324007|FG000|Overall Study|Other-Not mentioned|9|||
131462544|NCT00729469|473324008|FG001|Overall Study|Other-Not mentioned|4|||
131462545|NCT01270802|473324011|FG000|Overall Study|Withdrawal by Subject|1|||
131462546|NCT01270802|473324012|FG001|Overall Study|Withdrawal by Subject|0|||
131462547|NCT01270802|473324011|FG000|Overall Study|Adverse Event|1|||
131462548|NCT01270802|473324012|FG001|Overall Study|Adverse Event|0|||
131462549|NCT01270802|473324011|FG000|Overall Study|Lost to Follow-up|0|||
131462550|NCT01270802|473324012|FG001|Overall Study|Lost to Follow-up|1|||
131462551|NCT01566214|473324015|FG000|Overall Study|Lost to Follow-up|3|||
131462552|NCT01566214|473324016|FG001|Overall Study|Lost to Follow-up|0|||
131462553|NCT00561977|473324017|FG000|Overall Study|Withdrawal by Subject|0|||
131462554|NCT00561977|473324018|FG001|Overall Study|Withdrawal by Subject|2|||
131462555|NCT00561977|473324019|FG002|Overall Study|Withdrawal by Subject|1|||
131462556|NCT00561977|473324017|FG000|Overall Study|Pregnancy|0|||
131462557|NCT00561977|473324018|FG001|Overall Study|Pregnancy|1|||
131462558|NCT00561977|473324019|FG002|Overall Study|Pregnancy|1|||
131462559|NCT00653939|473324028|FG000|Overall Study|Adverse Event|1|||
131462560|NCT00653939|473324029|FG001|Overall Study|Adverse Event|3|||
131462561|NCT00653939|473324028|FG000|Overall Study|Withdrawal by Subject|3|||
131462562|NCT00653939|473324029|FG001|Overall Study|Withdrawal by Subject|3|||
131462563|NCT00653939|473324028|FG000|Overall Study|Physician Decision|4|||
131462564|NCT00653939|473324029|FG001|Overall Study|Physician Decision|0|||
131462565|NCT00653939|473324028|FG000|Overall Study|Disease Progression|2|||
131462566|NCT00653939|473324029|FG001|Overall Study|Disease Progression|3|||
131462567|NCT00653939|473324028|FG000|Overall Study|Other|2|||
131462568|NCT00653939|473324029|FG001|Overall Study|Other|6|||
131462569|NCT00402740|473324040|FG000|Overall Study|Withdrawal by Subject|18|||
131462570|NCT00402740|473324040|FG000|Overall Study|Death|50|||
131462571|NCT00402740|473324040|FG000|Overall Study|Lost to Follow-up|6|||
131462572|NCT00402740|473324040|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
131462573|NCT00402740|473324040|FG000|Overall Study|Subject disposition unknown.|1|||
131462574|NCT00934843|473324041|FG000|Overall Study|Protocol Violation|0|||
131462575|NCT00934843|473324042|FG001|Overall Study|Protocol Violation|1|||
131462576|NCT01144299|473324045|FG000|Overall Study|Lost to Follow-up|1|||
131462577|NCT01144299|473324046|FG001|Overall Study|Lost to Follow-up|0|||
131462578|NCT01144299|473324045|FG000|Overall Study|Withdrawal by Subject|1|||
131462579|NCT01144299|473324046|FG001|Overall Study|Withdrawal by Subject|0|||
131462580|NCT01375075|473324049|FG000|Overall Study|Adverse Event|0|||
131462581|NCT01375075|473324050|FG001|Overall Study|Adverse Event|0|||
131462582|NCT01375075|473324051|FG002|Overall Study|Adverse Event|3|||
131462583|NCT01375075|473324052|FG003|Overall Study|Adverse Event|1|||
131462584|NCT01375075|473324053|FG004|Overall Study|Adverse Event|0|||
131462585|NCT01375075|473324054|FG005|Overall Study|Adverse Event|1|||
131462586|NCT01375075|473324049|FG000|Overall Study|Entry Criterion Not Met|1|||
131462587|NCT01375075|473324050|FG001|Overall Study|Entry Criterion Not Met|0|||
131462588|NCT01375075|473324051|FG002|Overall Study|Entry Criterion Not Met|0|||
131462589|NCT01375075|473324052|FG003|Overall Study|Entry Criterion Not Met|0|||
131462590|NCT01375075|473324053|FG004|Overall Study|Entry Criterion Not Met|0|||
131462591|NCT01375075|473324054|FG005|Overall Study|Entry Criterion Not Met|1|||
131462592|NCT01375075|473324049|FG000|Overall Study|Withdrawal by Subject|0|||
131462593|NCT01375075|473324050|FG001|Overall Study|Withdrawal by Subject|1|||
131462594|NCT01375075|473324051|FG002|Overall Study|Withdrawal by Subject|0|||
131462595|NCT01375075|473324052|FG003|Overall Study|Withdrawal by Subject|0|||
131462596|NCT01375075|473324053|FG004|Overall Study|Withdrawal by Subject|0|||
131462597|NCT01375075|473324054|FG005|Overall Study|Withdrawal by Subject|1|||
131462598|NCT01011309|473324056|FG000|Overall Study|Adverse Event|2|||
131462599|NCT01011309|473324057|FG001|Overall Study|Adverse Event|1|||
131462600|NCT01011309|473324058|FG002|Overall Study|Adverse Event|2|||
131462601|NCT01011309|473324056|FG000|Overall Study|Lack of Efficacy|0|||
131462602|NCT01011309|473324057|FG001|Overall Study|Lack of Efficacy|1|||
131462603|NCT01011309|473324058|FG002|Overall Study|Lack of Efficacy|0|||
131462604|NCT01011309|473324056|FG000|Overall Study|Protocol Violation|0|||
131462605|NCT01011309|473324057|FG001|Overall Study|Protocol Violation|1|||
131462606|NCT01011309|473324058|FG002|Overall Study|Protocol Violation|3|||
131462607|NCT03976648|473324073|FG000|Overall Study|Adverse Event|0|||
131462608|NCT03976648|473324074|FG001|Overall Study|Adverse Event|2|||
131462609|NCT03976648|473324073|FG000|Overall Study|Study terminated by sponsor|21|||
131462610|NCT03976648|473324074|FG001|Overall Study|Study terminated by sponsor|8|||
131462611|NCT01981551|473324075|FG000|Overall Study|Refused further treatment|8|||
131462612|NCT01981551|473324075|FG000|Overall Study|Adverse Event|1|||
131462613|NCT02043899|473325832|FG000|Overall Study|Adverse Event|3|||
131462614|NCT02043899|473325832|FG000|Overall Study|Physician Decision|1|||
131462615|NCT02043899|473325832|FG000|Overall Study|Withdrawal by Subject|2|||
131462616|NCT02043899|473325832|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
131462617|NCT02043899|473325832|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
131462618|NCT02043899|473325832|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
131462619|NCT02043899|473325832|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
131462620|NCT02043899|473325832|FG000|Overall Study|Treatment delayed|1|||
131462621|NCT01325337|473325833|FG000|Overall Study|Adverse Event|0|||
131462622|NCT01325337|473325834|FG001|Overall Study|Adverse Event|2|||
131462623|NCT01325337|473325835|FG002|Overall Study|Adverse Event|2|||
131462624|NCT01325337|473325836|FG003|Overall Study|Adverse Event|1|||
131462625|NCT01325337|473325837|FG004|Overall Study|Adverse Event|2|||
131462626|NCT01325337|473325833|FG000|Overall Study|Lost to Follow-up|2|||
131462627|NCT01325337|473325834|FG001|Overall Study|Lost to Follow-up|2|||
131462628|NCT01325337|473325835|FG002|Overall Study|Lost to Follow-up|2|||
131462629|NCT01325337|473325836|FG003|Overall Study|Lost to Follow-up|1|||
131462630|NCT01325337|473325837|FG004|Overall Study|Lost to Follow-up|2|||
131462631|NCT01325337|473325833|FG000|Overall Study|Personal Reasons|2|||
131462632|NCT01325337|473325834|FG001|Overall Study|Personal Reasons|5|||
131462633|NCT01325337|473325835|FG002|Overall Study|Personal Reasons|4|||
131462634|NCT01325337|473325836|FG003|Overall Study|Personal Reasons|8|||
131462635|NCT01325337|473325837|FG004|Overall Study|Personal Reasons|3|||
131462636|NCT01325337|473325833|FG000|Overall Study|Withdrawal by Subject|1|||
131462637|NCT01325337|473325834|FG001|Overall Study|Withdrawal by Subject|0|||
131462638|NCT01325337|473325835|FG002|Overall Study|Withdrawal by Subject|1|||
131462639|NCT01325337|473325836|FG003|Overall Study|Withdrawal by Subject|0|||
131462640|NCT01325337|473325837|FG004|Overall Study|Withdrawal by Subject|1|||
131462641|NCT00843778|473325845|FG000|Overall Study|Adverse Event|15|||
131462642|NCT00843778|473325845|FG000|Overall Study|Lack of Efficacy|14|||
131462643|NCT00843778|473325845|FG000|Overall Study|Loss of efficacy|2|||
131462644|NCT00843778|473325845|FG000|Overall Study|Withdrawal by Subject|4|||
131462645|NCT00369629|473325846|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
131462646|NCT00369629|473325847|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
131462647|NCT00369629|473325848|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
131462648|NCT00369629|473325849|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
131462649|NCT00369629|473325846|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
131462650|NCT00369629|473325847|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
131462651|NCT00369629|473325848|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
131462652|NCT00369629|473325849|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
131462653|NCT00369629|473325846|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
131462654|NCT00369629|473325847|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
131462655|NCT00369629|473325848|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
131462656|NCT00369629|473325849|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
131462657|NCT00369629|473325846|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
131462658|NCT00369629|473325847|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
131462659|NCT00369629|473325848|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
131462660|NCT00369629|473325849|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
131462661|NCT00369629|473325846|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
131462662|NCT00369629|473325847|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
131462663|NCT00369629|473325848|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
131462664|NCT00369629|473325849|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
131462665|NCT00369629|473325846|FG000|Completed 4 More Cycles|Progressive disease|2|||
131462666|NCT00369629|473325847|FG001|Completed 4 More Cycles|Progressive disease|1|||
131462667|NCT00369629|473325848|FG002|Completed 4 More Cycles|Progressive disease|2|||
131462668|NCT00369629|473325849|FG003|Completed 4 More Cycles|Progressive disease|0|||
131462669|NCT00369629|473325846|FG000|Follow up for 1 Year|Death|2|||
131462670|NCT00369629|473325847|FG001|Follow up for 1 Year|Death|1|||
131462671|NCT00369629|473325848|FG002|Follow up for 1 Year|Death|1|||
131462672|NCT00369629|473325849|FG003|Follow up for 1 Year|Death|0|||
131462673|NCT00369629|473325846|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
131462674|NCT00369629|473325847|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
131462675|NCT00369629|473325848|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
131462676|NCT00369629|473325849|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
131462677|NCT00369629|473325846|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
131462678|NCT00369629|473325847|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
131462679|NCT00369629|473325848|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
131462680|NCT00369629|473325849|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
131462681|NCT02184455|473325850|FG000|Overall Study|Lost to Follow-up|1|||
131462682|NCT01347580|473325851|FG000|Overall Study|Withdrawal by Subject|13|||
131462683|NCT01347580|473325852|FG001|Overall Study|Withdrawal by Subject|23|||
131462684|NCT01347580|473325851|FG000|Overall Study|Death|30|||
131462685|NCT01347580|473325852|FG001|Overall Study|Death|19|||
131462686|NCT01347580|473325851|FG000|Overall Study|Protocol Violation|10|||
131462687|NCT01347580|473325852|FG001|Overall Study|Protocol Violation|7|||
131462688|NCT01347580|473325851|FG000|Overall Study|Lost to Follow-up|3|||
131462689|NCT01347580|473325852|FG001|Overall Study|Lost to Follow-up|1|||
131462690|NCT01347580|473325851|FG000|Overall Study|Had other reason|9|||
131462691|NCT01347580|473325852|FG001|Overall Study|Had other reason|6|||
131462692|NCT01964755|473325855|FG000|Overall Study|Death|2|||
131462693|NCT02894502|473325856|FG000|Baseline|Withdrawal by Subject|24|||
131462694|NCT02894502|473325857|FG001|Baseline|Withdrawal by Subject|31|||
131462695|NCT02894502|473325858|FG002|Baseline|Withdrawal by Subject|36|||
131462696|NCT02894502|473325856|FG000|Baseline|Death|3|||
131462697|NCT02894502|473325857|FG001|Baseline|Death|1|||
131462698|NCT02894502|473325858|FG002|Baseline|Death|9|||
131462699|NCT02894502|473325856|FG000|First Follow up|Withdrawal by Subject|32|||
131462700|NCT02894502|473325857|FG001|First Follow up|Withdrawal by Subject|29|||
131462701|NCT02894502|473325858|FG002|First Follow up|Withdrawal by Subject|37|||
131462702|NCT02894502|473325856|FG000|First Follow up|Death|2|||
131462703|NCT02894502|473325857|FG001|First Follow up|Death|2|||
131462704|NCT02894502|473325858|FG002|First Follow up|Death|3|||
131462705|NCT02894502|473325856|FG000|Second Follow up|Withdrawal by Subject|13|||
131462706|NCT02894502|473325857|FG001|Second Follow up|Withdrawal by Subject|15|||
131462707|NCT02894502|473325858|FG002|Second Follow up|Withdrawal by Subject|13|||
131462708|NCT02894502|473325856|FG000|Second Follow up|Death|2|||
131462709|NCT02894502|473325857|FG001|Second Follow up|Death|3|||
131462710|NCT02894502|473325858|FG002|Second Follow up|Death|1|||
131462711|NCT02894502|473325856|FG000|Third Follow up|Withdrawal by Subject|5|||
131462712|NCT02894502|473325857|FG001|Third Follow up|Withdrawal by Subject|6|||
131462713|NCT02894502|473325858|FG002|Third Follow up|Withdrawal by Subject|3|||
131462714|NCT02894502|473325856|FG000|Third Follow up|Death|1|||
131462715|NCT02894502|473325857|FG001|Third Follow up|Death|1|||
131462716|NCT02894502|473325858|FG002|Third Follow up|Death|0|||
131462717|NCT01332799|473325862|FG000|Overall Study|Insufficient funding|10|||
131462718|NCT01332799|473325863|FG001|Overall Study|Insufficient funding|10|||
131462719|NCT02168387|473325866|FG000|Overall Study|Planned exubation|6|||
131462720|NCT02168387|473325867|FG001|Overall Study|Planned exubation|3|||
131462721|NCT02168387|473325866|FG000|Overall Study|Death|1|||
131462722|NCT02168387|473325867|FG001|Overall Study|Death|0|||
131462723|NCT03467152|473325868|FG000|Overall Study|Adverse Event|4|||
131462724|NCT03467152|473325869|FG001|Overall Study|Adverse Event|5|||
131462725|NCT03467152|473325870|FG002|Overall Study|Adverse Event|0|||
131462726|NCT03467152|473325868|FG000|Overall Study|Subject Choice|1|||
131462727|NCT03467152|473325869|FG001|Overall Study|Subject Choice|3|||
131462728|NCT03467152|473325870|FG002|Overall Study|Subject Choice|0|||
131462729|NCT03467152|473325868|FG000|Overall Study|Lost to Follow-up|1|||
131462730|NCT03467152|473325869|FG001|Overall Study|Lost to Follow-up|0|||
131462731|NCT03467152|473325870|FG002|Overall Study|Lost to Follow-up|0|||
131462732|NCT03467152|473325868|FG000|Overall Study|Withdrawal by Subject|4|||
131462733|NCT03467152|473325869|FG001|Overall Study|Withdrawal by Subject|2|||
131462734|NCT03467152|473325870|FG002|Overall Study|Withdrawal by Subject|0|||
131462735|NCT03467152|473325868|FG000|Overall Study|Others|3|||
131462736|NCT03467152|473325869|FG001|Overall Study|Others|0|||
131462737|NCT03467152|473325870|FG002|Overall Study|Others|0|||
131462738|NCT03467152|473325868|FG000|Overall Study|Not treated|3|||
131462739|NCT03467152|473325869|FG001|Overall Study|Not treated|1|||
131462740|NCT03467152|473325870|FG002|Overall Study|Not treated|6|||
131462741|NCT01236547|473325871|FG000|Overall Study|Protocol Violation|0|||
131462742|NCT01236547|473325872|FG001|Overall Study|Protocol Violation|1|||
131462743|NCT01236547|473325873|FG002|Overall Study|Protocol Violation|1|||
131462744|NCT01236547|473325874|FG003|Overall Study|Protocol Violation|6|||
131462745|NCT01236547|473325875|FG004|Overall Study|Protocol Violation|12|||
131462746|NCT00910624|473325877|FG000|Treatment Phase|Adverse Event|2|||
131462747|NCT00910624|473325878|FG001|Treatment Phase|Adverse Event|6|||
131462748|NCT00910624|473325879|FG002|Treatment Phase|Adverse Event|6|||
131462749|NCT00910624|473325880|FG003|Treatment Phase|Adverse Event|0|||
131462750|NCT00910624|473325877|FG000|Treatment Phase|Treatment Failure|23|||
131462751|NCT00910624|473325878|FG001|Treatment Phase|Treatment Failure|10|||
131462752|NCT00910624|473325879|FG002|Treatment Phase|Treatment Failure|0|||
131462753|NCT00910624|473325880|FG003|Treatment Phase|Treatment Failure|0|||
131462754|NCT00910624|473325877|FG000|Treatment Phase|Lost to Follow-up|0|||
131462755|NCT00910624|473325878|FG001|Treatment Phase|Lost to Follow-up|0|||
131462756|NCT00910624|473325879|FG002|Treatment Phase|Lost to Follow-up|1|||
131462757|NCT00910624|473325880|FG003|Treatment Phase|Lost to Follow-up|0|||
131462758|NCT00910624|473325877|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
131462759|NCT00910624|473325878|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
131462760|NCT00910624|473325879|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
131462761|NCT00910624|473325880|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
131462762|NCT00910624|473325877|FG000|Treatment Phase|Withdrawal by Subject|2|||
131462763|NCT00910624|473325878|FG001|Treatment Phase|Withdrawal by Subject|1|||
131462764|NCT00910624|473325879|FG002|Treatment Phase|Withdrawal by Subject|0|||
131462765|NCT00910624|473325880|FG003|Treatment Phase|Withdrawal by Subject|0|||
131462766|NCT00910624|473325877|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
131462767|NCT00910624|473325878|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
131462768|NCT00910624|473325879|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
131462769|NCT00910624|473325880|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
131462770|NCT00910624|473325877|FG000|Follow-Up Phase|Adverse Event|0|||
131462771|NCT00910624|473325878|FG001|Follow-Up Phase|Adverse Event|0|||
131462772|NCT00910624|473325879|FG002|Follow-Up Phase|Adverse Event|1|||
131462773|NCT00910624|473325880|FG003|Follow-Up Phase|Adverse Event|0|||
131462774|NCT00910624|473325877|FG000|Follow-Up Phase|Lost to Follow-up|3|||
131462775|NCT00910624|473325878|FG001|Follow-Up Phase|Lost to Follow-up|1|||
131462776|NCT00910624|473325879|FG002|Follow-Up Phase|Lost to Follow-up|2|||
131462777|NCT00910624|473325880|FG003|Follow-Up Phase|Lost to Follow-up|0|||
131462778|NCT00910624|473325877|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
131462779|NCT00910624|473325878|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
131462780|NCT00910624|473325879|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
131462781|NCT00910624|473325880|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
131462782|NCT00910624|473325877|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
131462783|NCT00910624|473325878|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
131462784|NCT00910624|473325879|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
131462785|NCT00910624|473325880|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
131462786|NCT00910624|473325877|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
131462787|NCT00910624|473325878|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
131462788|NCT00910624|473325879|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
131462789|NCT00910624|473325880|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
131462790|NCT00910624|473325877|FG000|Follow-Up Phase|Administrative|0|||
131462791|NCT00910624|473325878|FG001|Follow-Up Phase|Administrative|1|||
131462792|NCT00910624|473325879|FG002|Follow-Up Phase|Administrative|1|||
131462793|NCT00910624|473325880|FG003|Follow-Up Phase|Administrative|0|||
131462794|NCT03005873|473325881|FG000|Overall Study|Prohibited medication use post radnomization|1|||
131462795|NCT03005873|473325882|FG001|Overall Study|Prohibited medication use post radnomization|1|||
131462796|NCT03005873|473325883|FG002|Overall Study|Prohibited medication use post radnomization|1|||
131462797|NCT03005873|473325881|FG000|Overall Study|Withdrew consent|0|||
131462798|NCT03005873|473325882|FG001|Overall Study|Withdrew consent|1|||
131462799|NCT03005873|473325883|FG002|Overall Study|Withdrew consent|2|||
131462800|NCT03005873|473325881|FG000|Overall Study|Lost to Follow-up|0|||
131462801|NCT03005873|473325882|FG001|Overall Study|Lost to Follow-up|1|||
131462802|NCT03005873|473325883|FG002|Overall Study|Lost to Follow-up|0|||
131462803|NCT03005873|473325881|FG000|Overall Study|Ineligible post randomization|0|||
131462804|NCT03005873|473325882|FG001|Overall Study|Ineligible post randomization|0|||
131462805|NCT03005873|473325883|FG002|Overall Study|Ineligible post randomization|1|||
131462806|NCT04140227|473325884|FG000|Overall Study|Withdrawal by Subject|26|||
131462807|NCT04140227|473325884|FG000|Overall Study|Lost to Follow-up|8|||
131462808|NCT04140227|473325884|FG000|Overall Study|Adverse Event|8|||
131462809|NCT04140227|473325884|FG000|Overall Study|Death|1|||
131462810|NCT04140227|473325884|FG000|Overall Study|Other|3|||
131462811|NCT04140227|473325884|FG000|Overall Study|Protocol Violation|2|||
131462812|NCT01713933|473325885|FG000|Overall Study|Lost to Follow-up|2|||
131462813|NCT01713933|473325885|FG000|Overall Study|Withdrawal by Subject|3|||
131462814|NCT01713933|473325885|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
131462815|NCT00412373|473325888|FG000|Overall Study|Adverse Event|8|||
131462816|NCT00412373|473325889|FG001|Overall Study|Adverse Event|13|||
131462817|NCT00412373|473325888|FG000|Overall Study|Lack of Efficacy|16|||
131462818|NCT00412373|473325889|FG001|Overall Study|Lack of Efficacy|22|||
131462819|NCT00412373|473325888|FG000|Overall Study|Lost to Follow-up|7|||
131462820|NCT00412373|473325889|FG001|Overall Study|Lost to Follow-up|13|||
131462821|NCT00412373|473325888|FG000|Overall Study|Withdrawal by Subject|8|||
131462822|NCT00412373|473325889|FG001|Overall Study|Withdrawal by Subject|27|||
131462823|NCT00412373|473325888|FG000|Overall Study|Other|2|||
131462824|NCT00412373|473325889|FG001|Overall Study|Other|2|||
131462825|NCT00538785|473325893|FG000|Overall Study|Death|9|||
131462826|NCT00538785|473325894|FG001|Overall Study|Death|10|||
131462827|NCT00538785|473325893|FG000|Overall Study|Withdrawal of consent|9|||
131462828|NCT00538785|473325894|FG001|Overall Study|Withdrawal of consent|7|||
131462829|NCT00538785|473325893|FG000|Overall Study|Lost to Follow-up|1|||
131462830|NCT00538785|473325894|FG001|Overall Study|Lost to Follow-up|0|||
131462831|NCT01009840|473325895|FG000|Overall Study|Lost to Follow-up|1|||
131462832|NCT01009840|473325895|FG000|Overall Study|Adverse Event|4|||
131462833|NCT01009840|473325895|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
131462834|NCT01009840|473325895|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
131462835|NCT01009840|473325895|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
131462836|NCT04022733|473325896|FG000|Overall Study|conversion to open surgery|3|||
131462837|NCT04022733|473325897|FG001|Overall Study|conversion to open surgery|2|||
131462838|NCT04022733|473325896|FG000|Overall Study|bradycardia|0|||
131462839|NCT04022733|473325897|FG001|Overall Study|bradycardia|1|||
131462840|NCT01104376|473325900|FG000|Overall Study|Withdrawal by Subject|15|||
131462841|NCT01104376|473325900|FG000|Overall Study|Consented but excluded after labs|13|||
131462842|NCT00797966|473325901|FG000|Phase A|Lost to Follow-up|0|||
131462843|NCT00797966|473325902|FG001|Phase A|Lost to Follow-up|0|||
131462844|NCT00797966|473325903|FG002|Phase A|Lost to Follow-up|0|||
131462845|NCT00797966|473325904|FG003|Phase A|Lost to Follow-up|0|||
131462846|NCT00797966|473325905|FG004|Phase A|Lost to Follow-up|33|||
131462847|NCT00797966|473325906|FG005|Phase A|Lost to Follow-up|0|||
131462848|NCT00797966|473325901|FG000|Phase A|Adverse Event|0|||
131462849|NCT00797966|473325902|FG001|Phase A|Adverse Event|0|||
131462850|NCT00797966|473325903|FG002|Phase A|Adverse Event|0|||
131462851|NCT00797966|473325904|FG003|Phase A|Adverse Event|0|||
131462852|NCT00797966|473325905|FG004|Phase A|Adverse Event|46|||
131462853|NCT00797966|473325906|FG005|Phase A|Adverse Event|0|||
131462854|NCT00797966|473325901|FG000|Phase A|Met withdrawal criteria|0|||
131462855|NCT00797966|473325902|FG001|Phase A|Met withdrawal criteria|0|||
131462856|NCT00797966|473325903|FG002|Phase A|Met withdrawal criteria|0|||
131462857|NCT00797966|473325904|FG003|Phase A|Met withdrawal criteria|0|||
131462858|NCT00797966|473325905|FG004|Phase A|Met withdrawal criteria|4|||
131462859|NCT00797966|473325906|FG005|Phase A|Met withdrawal criteria|0|||
131462860|NCT00797966|473325901|FG000|Phase A|Physician Decision|0|||
131462861|NCT00797966|473325902|FG001|Phase A|Physician Decision|0|||
131462862|NCT00797966|473325903|FG002|Phase A|Physician Decision|0|||
131462863|NCT00797966|473325904|FG003|Phase A|Physician Decision|0|||
131462864|NCT00797966|473325905|FG004|Phase A|Physician Decision|13|||
131462865|NCT00797966|473325906|FG005|Phase A|Physician Decision|0|||
131462866|NCT00797966|473325901|FG000|Phase A|Withdrawal by Subject|0|||
131462867|NCT00797966|473325902|FG001|Phase A|Withdrawal by Subject|0|||
131462868|NCT00797966|473325903|FG002|Phase A|Withdrawal by Subject|0|||
131462869|NCT00797966|473325904|FG003|Phase A|Withdrawal by Subject|0|||
131462870|NCT00797966|473325905|FG004|Phase A|Withdrawal by Subject|33|||
131462871|NCT00797966|473325906|FG005|Phase A|Withdrawal by Subject|0|||
131462872|NCT00797966|473325901|FG000|Phase A|Protocol deviation|0|||
131462873|NCT00797966|473325902|FG001|Phase A|Protocol deviation|0|||
131462874|NCT00797966|473325903|FG002|Phase A|Protocol deviation|0|||
131462875|NCT00797966|473325904|FG003|Phase A|Protocol deviation|0|||
131462876|NCT00797966|473325905|FG004|Phase A|Protocol deviation|56|||
131462877|NCT00797966|473325906|FG005|Phase A|Protocol deviation|0|||
131462878|NCT00797966|473325901|FG000|Phase B|Lost to Follow-up|0|||
131462879|NCT00797966|473325902|FG001|Phase B|Lost to Follow-up|1|||
131462880|NCT00797966|473325903|FG002|Phase B|Lost to Follow-up|3|||
131462881|NCT00797966|473325904|FG003|Phase B|Lost to Follow-up|0|||
131462882|NCT00797966|473325905|FG004|Phase B|Lost to Follow-up|0|||
131462883|NCT00797966|473325906|FG005|Phase B|Lost to Follow-up|0|||
131462884|NCT00797966|473325901|FG000|Phase B|Adverse Event|2|||
131462885|NCT00797966|473325902|FG001|Phase B|Adverse Event|1|||
131462886|NCT00797966|473325903|FG002|Phase B|Adverse Event|3|||
131462887|NCT00797966|473325904|FG003|Phase B|Adverse Event|1|||
131462888|NCT00797966|473325905|FG004|Phase B|Adverse Event|0|||
131462889|NCT00797966|473325906|FG005|Phase B|Adverse Event|0|||
131462890|NCT00797966|473325901|FG000|Phase B|Met Withdrawal Criteria|3|||
131462891|NCT00797966|473325902|FG001|Phase B|Met Withdrawal Criteria|3|||
131462892|NCT00797966|473325903|FG002|Phase B|Met Withdrawal Criteria|6|||
131462893|NCT00797966|473325904|FG003|Phase B|Met Withdrawal Criteria|1|||
131462894|NCT00797966|473325905|FG004|Phase B|Met Withdrawal Criteria|0|||
131462895|NCT00797966|473325906|FG005|Phase B|Met Withdrawal Criteria|0|||
131462896|NCT00797966|473325901|FG000|Phase B|Physician Decision|1|||
131462897|NCT00797966|473325902|FG001|Phase B|Physician Decision|0|||
131462898|NCT00797966|473325903|FG002|Phase B|Physician Decision|3|||
131462899|NCT00797966|473325904|FG003|Phase B|Physician Decision|1|||
131462900|NCT00797966|473325905|FG004|Phase B|Physician Decision|0|||
131462901|NCT00797966|473325906|FG005|Phase B|Physician Decision|0|||
131462902|NCT00797966|473325901|FG000|Phase B|Withdrawal by Subject|1|||
131462903|NCT00797966|473325902|FG001|Phase B|Withdrawal by Subject|4|||
131462904|NCT00797966|473325903|FG002|Phase B|Withdrawal by Subject|3|||
131462905|NCT00797966|473325904|FG003|Phase B|Withdrawal by Subject|3|||
131462906|NCT00797966|473325905|FG004|Phase B|Withdrawal by Subject|0|||
131462907|NCT00797966|473325906|FG005|Phase B|Withdrawal by Subject|0|||
131462908|NCT00797966|473325901|FG000|Phase B|Protocol Deviation|4|||
131462909|NCT00797966|473325902|FG001|Phase B|Protocol Deviation|8|||
131462910|NCT00797966|473325903|FG002|Phase B|Protocol Deviation|2|||
131462911|NCT00797966|473325904|FG003|Phase B|Protocol Deviation|6|||
131462912|NCT00797966|473325905|FG004|Phase B|Protocol Deviation|0|||
131462913|NCT00797966|473325906|FG005|Phase B|Protocol Deviation|0|||
131462914|NCT00797966|473325901|FG000|Phase B|Lack of Efficacy|0|||
131462915|NCT00797966|473325902|FG001|Phase B|Lack of Efficacy|1|||
131462916|NCT00797966|473325903|FG002|Phase B|Lack of Efficacy|1|||
131462917|NCT00797966|473325904|FG003|Phase B|Lack of Efficacy|4|||
131462918|NCT00797966|473325905|FG004|Phase B|Lack of Efficacy|0|||
131462919|NCT00797966|473325906|FG005|Phase B|Lack of Efficacy|0|||
131462920|NCT00797966|473325901|FG000|Phase A+|Lost to Follow-up|0|||
131462921|NCT00797966|473325902|FG001|Phase A+|Lost to Follow-up|0|||
131462922|NCT00797966|473325903|FG002|Phase A+|Lost to Follow-up|0|||
131462923|NCT00797966|473325904|FG003|Phase A+|Lost to Follow-up|0|||
131462924|NCT00797966|473325905|FG004|Phase A+|Lost to Follow-up|0|||
131462925|NCT00797966|473325906|FG005|Phase A+|Lost to Follow-up|9|||
131462926|NCT00797966|473325901|FG000|Phase A+|Met withdrawal criteria|0|||
131462927|NCT00797966|473325902|FG001|Phase A+|Met withdrawal criteria|0|||
131462928|NCT00797966|473325903|FG002|Phase A+|Met withdrawal criteria|0|||
131462929|NCT00797966|473325904|FG003|Phase A+|Met withdrawal criteria|0|||
131462930|NCT00797966|473325905|FG004|Phase A+|Met withdrawal criteria|0|||
131462931|NCT00797966|473325906|FG005|Phase A+|Met withdrawal criteria|5|||
131462932|NCT00797966|473325901|FG000|Phase A+|Withdrawal by Subject|0|||
131462933|NCT00797966|473325902|FG001|Phase A+|Withdrawal by Subject|0|||
131462934|NCT00797966|473325903|FG002|Phase A+|Withdrawal by Subject|0|||
131462935|NCT00797966|473325904|FG003|Phase A+|Withdrawal by Subject|0|||
131462936|NCT00797966|473325905|FG004|Phase A+|Withdrawal by Subject|0|||
131462937|NCT00797966|473325906|FG005|Phase A+|Withdrawal by Subject|6|||
131462938|NCT00797966|473325901|FG000|Phase A+|Adverse Event|0|||
131462939|NCT00797966|473325902|FG001|Phase A+|Adverse Event|0|||
131462940|NCT00797966|473325903|FG002|Phase A+|Adverse Event|0|||
131462941|NCT00797966|473325904|FG003|Phase A+|Adverse Event|0|||
131462942|NCT00797966|473325905|FG004|Phase A+|Adverse Event|0|||
131462943|NCT00797966|473325906|FG005|Phase A+|Adverse Event|4|||
131462944|NCT00797966|473325901|FG000|Phase A+|Protocol deviation|0|||
131462945|NCT00797966|473325902|FG001|Phase A+|Protocol deviation|0|||
131462946|NCT00797966|473325903|FG002|Phase A+|Protocol deviation|0|||
131462947|NCT00797966|473325904|FG003|Phase A+|Protocol deviation|0|||
131462948|NCT00797966|473325905|FG004|Phase A+|Protocol deviation|0|||
131462949|NCT00797966|473325906|FG005|Phase A+|Protocol deviation|4|||
131462950|NCT01478048|473325914|FG000|Overall Study|Disease Progression|52|||
131462951|NCT01478048|473325915|FG001|Overall Study|Disease Progression|35|||
131462952|NCT01478048|473325914|FG000|Overall Study|study drug toxicity|11|||
131462953|NCT01478048|473325915|FG001|Overall Study|study drug toxicity|14|||
131462954|NCT01478048|473325914|FG000|Overall Study|Adverse Event|2|||
131462955|NCT01478048|473325915|FG001|Overall Study|Adverse Event|11|||
131462956|NCT01478048|473325914|FG000|Overall Study|subject request to discontinue treatment|3|||
131462957|NCT01478048|473325915|FG001|Overall Study|subject request to discontinue treatment|5|||
131462958|NCT01478048|473325914|FG000|Overall Study|Withdrawal by Subject|2|||
131462959|NCT01478048|473325915|FG001|Overall Study|Withdrawal by Subject|5|||
131462960|NCT01478048|473325914|FG000|Overall Study|non-specified|6|||
131462961|NCT01478048|473325915|FG001|Overall Study|non-specified|4|||
131462962|NCT01478048|473325914|FG000|Overall Study|poor/non-compliance|0|||
131462963|NCT01478048|473325915|FG001|Overall Study|poor/non-compliance|1|||
131462964|NCT01478048|473325914|FG000|Overall Study|no longer meets study criteria|1|||
131462965|NCT01478048|473325915|FG001|Overall Study|no longer meets study criteria|0|||
131462966|NCT01883453|473325920|FG000|Overall Study|No episode of common cold|25|||
131462967|NCT01883453|473325921|FG001|Overall Study|No episode of common cold|23|||
131462968|NCT01541397|473325925|FG000|Overall Study|Study ended prior to data collection|4|||
131462969|NCT01541397|473325926|FG001|Overall Study|Study ended prior to data collection|2|||
131462970|NCT02577887|473325927|FG000|Overall Study|Death|93|||
131462971|NCT02577887|473325927|FG000|Overall Study|Protocol Violation|125|||
131462972|NCT02577887|473325927|FG000|Overall Study|Withdrawal by Subject|80|||
131462973|NCT03560518|473325928|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
131462974|NCT03560518|473325929|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
131462975|NCT03560518|473325930|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
131462976|NCT03560518|473325928|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
131462977|NCT03560518|473325929|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
131462978|NCT03560518|473325930|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
131462979|NCT03560518|473325928|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131462980|NCT03560518|473325929|FG001|Double Blind Treatment Period|Protocol Violation|2|||
131462981|NCT03560518|473325930|FG002|Double Blind Treatment Period|Protocol Violation|0|||
131462982|NCT03560518|473325928|FG000|Double Blind Treatment Period|Pregnancy|0|||
131462983|NCT03560518|473325929|FG001|Double Blind Treatment Period|Pregnancy|2|||
131462984|NCT03560518|473325930|FG002|Double Blind Treatment Period|Pregnancy|0|||
131462985|NCT03560518|473325928|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
131462986|NCT03560518|473325929|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
131462987|NCT03560518|473325930|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
131462988|NCT03560518|473325928|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
131462989|NCT03560518|473325929|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
131462990|NCT03560518|473325930|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
131462991|NCT03560518|473325928|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
131462992|NCT03560518|473325929|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
131462993|NCT03560518|473325930|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
131462994|NCT03560518|473325928|FG000|Double Blind Treatment Period|Adverse Event|0|||
131462995|NCT03560518|473325929|FG001|Double Blind Treatment Period|Adverse Event|3|||
131462996|NCT03560518|473325930|FG002|Double Blind Treatment Period|Adverse Event|1|||
131462997|NCT01689532|473325931|FG000|Overall Study|Adverse Event|9|||
131462998|NCT01689532|473325932|FG001|Overall Study|Adverse Event|5|||
131462999|NCT01689532|473325931|FG000|Overall Study|Lack of Efficacy|2|||
131463000|NCT01689532|473325932|FG001|Overall Study|Lack of Efficacy|2|||
131463001|NCT01689532|473325931|FG000|Overall Study|Withdrawal by Subject|1|||
131463002|NCT01689532|473325932|FG001|Overall Study|Withdrawal by Subject|2|||
131463003|NCT01689532|473325931|FG000|Overall Study|Physician Decision|2|||
131463004|NCT01689532|473325932|FG001|Overall Study|Physician Decision|0|||
131463005|NCT01363349|473325933|FG000|Overall Study|Adverse Event|6|||
131463006|NCT01363349|473325934|FG001|Overall Study|Adverse Event|7|||
131463007|NCT01363349|473325933|FG000|Overall Study|Lack of Efficacy|3|||
131463008|NCT01363349|473325934|FG001|Overall Study|Lack of Efficacy|10|||
131463009|NCT01363349|473325933|FG000|Overall Study|Non compliance/Protocol deviations|2|||
131463010|NCT01363349|473325934|FG001|Overall Study|Non compliance/Protocol deviations|2|||
131463011|NCT01363349|473325933|FG000|Overall Study|Withdrawal by Subject|14|||
131463012|NCT01363349|473325934|FG001|Overall Study|Withdrawal by Subject|6|||
131463013|NCT01363349|473325933|FG000|Overall Study|Lost to Follow-up|5|||
131463014|NCT01363349|473325934|FG001|Overall Study|Lost to Follow-up|6|||
131463015|NCT01363349|473325933|FG000|Overall Study|Not reported|36|||
131463016|NCT01363349|473325934|FG001|Overall Study|Not reported|37|||
131463017|NCT01363349|473325933|FG000|Overall Study|missing|1|||
131463018|NCT01363349|473325934|FG001|Overall Study|missing|2|||
131463019|NCT01958489|473325935|FG000|Period 2|Adverse Event|0|||
131463020|NCT01958489|473325936|FG001|Period 2|Adverse Event|1|||
131463021|NCT03595618|473325937|FG000|Overall Study|Adverse Event|16|||
131463022|NCT03595618|473325938|FG001|Overall Study|Adverse Event|17|||
131463023|NCT03595618|473325939|FG002|Overall Study|Adverse Event|20|||
131463024|NCT03595618|473325940|FG003|Overall Study|Adverse Event|8|||
131463025|NCT03595618|473325937|FG000|Overall Study|Withdrawal by Subject|12|||
131463026|NCT03595618|473325938|FG001|Overall Study|Withdrawal by Subject|14|||
131463027|NCT03595618|473325939|FG002|Overall Study|Withdrawal by Subject|14|||
131463028|NCT03595618|473325940|FG003|Overall Study|Withdrawal by Subject|10|||
131463029|NCT03595618|473325937|FG000|Overall Study|Lost to Follow-up|6|||
131463030|NCT03595618|473325938|FG001|Overall Study|Lost to Follow-up|4|||
131463031|NCT03595618|473325939|FG002|Overall Study|Lost to Follow-up|5|||
131463032|NCT03595618|473325940|FG003|Overall Study|Lost to Follow-up|6|||
131463033|NCT03595618|473325937|FG000|Overall Study|Protocol Violation|2|||
131463034|NCT03595618|473325938|FG001|Overall Study|Protocol Violation|0|||
131463035|NCT03595618|473325939|FG002|Overall Study|Protocol Violation|6|||
131463036|NCT03595618|473325940|FG003|Overall Study|Protocol Violation|2|||
131463037|NCT03595618|473325937|FG000|Overall Study|Physician Decision|0|||
131463038|NCT03595618|473325938|FG001|Overall Study|Physician Decision|0|||
131463039|NCT03595618|473325939|FG002|Overall Study|Physician Decision|1|||
131463040|NCT03595618|473325940|FG003|Overall Study|Physician Decision|2|||
131463041|NCT03595618|473325937|FG000|Overall Study|Miscellaneous|7|||
131463042|NCT03595618|473325938|FG001|Overall Study|Miscellaneous|5|||
131463043|NCT03595618|473325939|FG002|Overall Study|Miscellaneous|10|||
131463044|NCT03595618|473325940|FG003|Overall Study|Miscellaneous|6|||
131463045|NCT02338232|473325941|FG000|Overall Study|Screen Failure|3|||
131463046|NCT02338232|473325941|FG000|Overall Study|Withdrawal by Subject|6|||
131463047|NCT02338232|473325941|FG000|Overall Study|Adverse Event|2|||
131463048|NCT02279407|473325942|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
131463049|NCT02279407|473325943|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
131463050|NCT02279407|473325944|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
131463051|NCT02279407|473325945|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
131463052|NCT02279407|473325942|FG000|Overall Study|Withdrawal by Subject|1|||
131463053|NCT02279407|473325943|FG001|Overall Study|Withdrawal by Subject|0|||
131463054|NCT02279407|473325944|FG002|Overall Study|Withdrawal by Subject|1|||
131463055|NCT02279407|473325945|FG003|Overall Study|Withdrawal by Subject|1|||
131463056|NCT02279407|473325942|FG000|Overall Study|Adverse Event|1|||
131463057|NCT02279407|473325943|FG001|Overall Study|Adverse Event|1|||
131463058|NCT02279407|473325944|FG002|Overall Study|Adverse Event|2|||
131463059|NCT02279407|473325945|FG003|Overall Study|Adverse Event|0|||
131463060|NCT02500056|473325946|FG000|Overall Study|Lost to Follow-up|3|||
131463061|NCT02500056|473325947|FG001|Overall Study|Lost to Follow-up|7|||
131463062|NCT02500056|473325946|FG000|Overall Study|Recurrence|1|||
131463063|NCT02500056|473325947|FG001|Overall Study|Recurrence|0|||
131463064|NCT02500056|473325946|FG000|Overall Study|Death|3|||
131463065|NCT02500056|473325947|FG001|Overall Study|Death|1|||
131463066|NCT00864916|473325948|FG000|Overall Study|Lost to Follow-up|4|||
131463067|NCT00864916|473325949|FG001|Overall Study|Lost to Follow-up|4|||
131463068|NCT00864916|473325948|FG000|Overall Study|Protocol Violation|1|||
131463069|NCT00864916|473325949|FG001|Overall Study|Protocol Violation|0|||
131463070|NCT00864916|473325948|FG000|Overall Study|Withdrawal by Subject|1|||
131463071|NCT00864916|473325949|FG001|Overall Study|Withdrawal by Subject|0|||
131463072|NCT03996369|473325950|FG000|Overall Study|Protocol deviation|1|||
131463073|NCT03996369|473325951|FG001|Overall Study|Protocol deviation|1|||
131463074|NCT03996369|473325950|FG000|Overall Study|Physician Decision|4|||
131463075|NCT03996369|473325951|FG001|Overall Study|Physician Decision|2|||
131463076|NCT03996369|473325950|FG000|Overall Study|Participant decision|0|||
131463077|NCT03996369|473325951|FG001|Overall Study|Participant decision|1|||
131463078|NCT03996369|473325950|FG000|Overall Study|Lack of Efficacy|4|||
131463079|NCT03996369|473325951|FG001|Overall Study|Lack of Efficacy|0|||
131463080|NCT03996369|473325950|FG000|Overall Study|Adverse Event|9|||
131463081|NCT03996369|473325951|FG001|Overall Study|Adverse Event|0|||
131463082|NCT03996369|473325950|FG000|Overall Study|Withdrawal by Subject|6|||
131463083|NCT03996369|473325951|FG001|Overall Study|Withdrawal by Subject|8|||
131463084|NCT03996369|473325950|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
131463085|NCT03996369|473325951|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
131463086|NCT03996369|473325950|FG000|Overall Study|Lost to Follow-up|0|||
131463087|NCT03996369|473325951|FG001|Overall Study|Lost to Follow-up|1|||
131463088|NCT01185301|473325953|FG000|Overall Study|Adverse Event|3|||
131463089|NCT01185301|473325954|FG001|Overall Study|Adverse Event|0|||
131463090|NCT01185301|473325955|FG002|Overall Study|Adverse Event|2|||
131463091|NCT01185301|473325956|FG003|Overall Study|Adverse Event|3|||
131463092|NCT01185301|473325953|FG000|Overall Study|Withdrawal by Subject|7|||
131463093|NCT01185301|473325954|FG001|Overall Study|Withdrawal by Subject|5|||
131463094|NCT01185301|473325955|FG002|Overall Study|Withdrawal by Subject|2|||
131463095|NCT01185301|473325956|FG003|Overall Study|Withdrawal by Subject|3|||
131463096|NCT01185301|473325953|FG000|Overall Study|Lost to Follow-up|2|||
131463097|NCT01185301|473325954|FG001|Overall Study|Lost to Follow-up|0|||
131463098|NCT01185301|473325955|FG002|Overall Study|Lost to Follow-up|0|||
131463099|NCT01185301|473325956|FG003|Overall Study|Lost to Follow-up|1|||
131463100|NCT01185301|473325953|FG000|Overall Study|Other Reason|3|||
131463101|NCT01185301|473325954|FG001|Overall Study|Other Reason|2|||
131463102|NCT01185301|473325955|FG002|Overall Study|Other Reason|2|||
131463103|NCT01185301|473325956|FG003|Overall Study|Other Reason|2|||
131463104|NCT02395172|473325961|FG000|Overall Study|Participants randomized but not treated|3|||
131463105|NCT02395172|473325962|FG001|Overall Study|Participants randomized but not treated|31|||
131463106|NCT03678870|473325966|FG000|Overall Study|prescribed non- protocol medications|10|||
131463107|NCT03678870|473325967|FG001|Overall Study|prescribed non- protocol medications|6|||
131463108|NCT03678870|473325966|FG000|Overall Study|Lost to Follow-up|3|||
131463109|NCT03678870|473325967|FG001|Overall Study|Lost to Follow-up|2|||
131463110|NCT03104816|473325969|FG000|Overall Study|Lack of Efficacy|0|||
131463111|NCT03104816|473325970|FG001|Overall Study|Lack of Efficacy|2|||
131463112|NCT03104816|473325971|FG002|Overall Study|Lack of Efficacy|0|||
131463113|NCT03104816|473325969|FG000|Overall Study|Protocol Violation|2|||
131463114|NCT03104816|473325970|FG001|Overall Study|Protocol Violation|0|||
131463115|NCT03104816|473325971|FG002|Overall Study|Protocol Violation|2|||
131463116|NCT01159431|473325973|FG000|Overall Study|Adverse Event|1|||
131463117|NCT01159431|473325974|FG001|Overall Study|Adverse Event|2|||
131463118|NCT01159431|473325973|FG000|Overall Study|non-compliance|1|||
131463119|NCT01159431|473325974|FG001|Overall Study|non-compliance|1|||
131463120|NCT01159431|473325973|FG000|Overall Study|Lack of Efficacy|0|||
131463121|NCT01159431|473325974|FG001|Overall Study|Lack of Efficacy|3|||
131463122|NCT01227629|473325975|FG000|Overall Study|Adverse Event|2|||
131463123|NCT01227629|473325976|FG001|Overall Study|Adverse Event|2|||
131463124|NCT01227629|473325977|FG002|Overall Study|Adverse Event|1|||
131463125|NCT01227629|473325978|FG003|Overall Study|Adverse Event|6|||
131463126|NCT01227629|473325979|FG004|Overall Study|Adverse Event|1|||
131463127|NCT01227629|473325980|FG005|Overall Study|Adverse Event|1|||
131463128|NCT01227629|473325981|FG006|Overall Study|Adverse Event|6|||
131463129|NCT01227629|473325982|FG007|Overall Study|Adverse Event|6|||
131463130|NCT01227629|473325983|FG008|Overall Study|Adverse Event|4|||
131463131|NCT01227629|473325984|FG009|Overall Study|Adverse Event|0|||
131463132|NCT01227629|473325975|FG000|Overall Study|Protocol Violation|0|||
131463133|NCT01227629|473325976|FG001|Overall Study|Protocol Violation|0|||
131463134|NCT01227629|473325977|FG002|Overall Study|Protocol Violation|0|||
131463135|NCT01227629|473325978|FG003|Overall Study|Protocol Violation|1|||
131463136|NCT01227629|473325979|FG004|Overall Study|Protocol Violation|0|||
131463137|NCT01227629|473325980|FG005|Overall Study|Protocol Violation|0|||
131463138|NCT01227629|473325981|FG006|Overall Study|Protocol Violation|0|||
131463139|NCT01227629|473325982|FG007|Overall Study|Protocol Violation|0|||
131463140|NCT01227629|473325983|FG008|Overall Study|Protocol Violation|0|||
131463141|NCT01227629|473325984|FG009|Overall Study|Protocol Violation|0|||
131463142|NCT01227629|473325975|FG000|Overall Study|Lost to Follow-up|0|||
131463143|NCT01227629|473325976|FG001|Overall Study|Lost to Follow-up|0|||
131463144|NCT01227629|473325977|FG002|Overall Study|Lost to Follow-up|0|||
131463145|NCT01227629|473325978|FG003|Overall Study|Lost to Follow-up|0|||
131463146|NCT01227629|473325979|FG004|Overall Study|Lost to Follow-up|1|||
131463147|NCT01227629|473325980|FG005|Overall Study|Lost to Follow-up|0|||
131463148|NCT01227629|473325981|FG006|Overall Study|Lost to Follow-up|0|||
131463149|NCT01227629|473325982|FG007|Overall Study|Lost to Follow-up|0|||
131463150|NCT01227629|473325983|FG008|Overall Study|Lost to Follow-up|0|||
131463151|NCT01227629|473325984|FG009|Overall Study|Lost to Follow-up|0|||
131463152|NCT01227629|473325975|FG000|Overall Study|Withdrawal by Subject|0|||
131463153|NCT01227629|473325976|FG001|Overall Study|Withdrawal by Subject|0|||
131463154|NCT01227629|473325977|FG002|Overall Study|Withdrawal by Subject|0|||
131463155|NCT01227629|473325978|FG003|Overall Study|Withdrawal by Subject|0|||
131463156|NCT01227629|473325979|FG004|Overall Study|Withdrawal by Subject|0|||
131463157|NCT01227629|473325980|FG005|Overall Study|Withdrawal by Subject|0|||
131463158|NCT01227629|473325981|FG006|Overall Study|Withdrawal by Subject|2|||
131463159|NCT01227629|473325982|FG007|Overall Study|Withdrawal by Subject|0|||
131463160|NCT01227629|473325983|FG008|Overall Study|Withdrawal by Subject|0|||
131463161|NCT01227629|473325984|FG009|Overall Study|Withdrawal by Subject|1|||
131463162|NCT01227629|473325975|FG000|Overall Study|Other|0|||
131463163|NCT01227629|473325976|FG001|Overall Study|Other|0|||
131463164|NCT01227629|473325977|FG002|Overall Study|Other|0|||
131463165|NCT01227629|473325978|FG003|Overall Study|Other|1|||
131463166|NCT01227629|473325979|FG004|Overall Study|Other|0|||
131463167|NCT01227629|473325980|FG005|Overall Study|Other|0|||
131463168|NCT01227629|473325981|FG006|Overall Study|Other|0|||
131463169|NCT01227629|473325982|FG007|Overall Study|Other|0|||
131463170|NCT01227629|473325983|FG008|Overall Study|Other|2|||
131463171|NCT01227629|473325984|FG009|Overall Study|Other|1|||
131463172|NCT00534599|473325985|FG000|Overall Study|Adverse Event|25|||
131463173|NCT00534599|473325986|FG001|Overall Study|Adverse Event|4|||
131463174|NCT00534599|473325985|FG000|Overall Study|Incorrect enrollment|2|||
131463175|NCT00534599|473325986|FG001|Overall Study|Incorrect enrollment|1|||
131463176|NCT00534599|473325985|FG000|Overall Study|Mis-randomization|2|||
131463177|NCT00534599|473325986|FG001|Overall Study|Mis-randomization|2|||
131463178|NCT00534599|473325985|FG000|Overall Study|Developed study-specific d/c criteria|5|||
131463179|NCT00534599|473325986|FG001|Overall Study|Developed study-specific d/c criteria|0|||
131463180|NCT00534599|473325985|FG000|Overall Study|Lack of Efficacy|0|||
131463181|NCT00534599|473325986|FG001|Overall Study|Lack of Efficacy|1|||
131463182|NCT00534599|473325985|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
131463183|NCT00534599|473325986|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
131463184|NCT00534599|473325985|FG000|Overall Study|Protocol Violation|1|||
131463185|NCT00534599|473325986|FG001|Overall Study|Protocol Violation|3|||
131463186|NCT00534599|473325985|FG000|Overall Study|Lost to Follow-up|11|||
131463187|NCT00534599|473325986|FG001|Overall Study|Lost to Follow-up|14|||
131463188|NCT00534599|473325985|FG000|Overall Study|Withdrawal by Subject|4|||
131463189|NCT00534599|473325986|FG001|Overall Study|Withdrawal by Subject|6|||
131463190|NCT00534599|473325985|FG000|Overall Study|Other|7|||
131463191|NCT00534599|473325986|FG001|Overall Study|Other|0|||
131463192|NCT03645434|473325987|FG000|Period 1|Adverse Event|0|||
131463193|NCT03645434|473325988|FG001|Period 1|Adverse Event|0|||
131463194|NCT03645434|473325989|FG002|Period 1|Adverse Event|0|||
131463195|NCT03645434|473325990|FG003|Period 1|Adverse Event|1|||
131463196|NCT03645434|473325991|FG004|Period 1|Adverse Event|0|||
131463197|NCT03645434|473325992|FG005|Period 1|Adverse Event|0|||
131463198|NCT03645434|473325987|FG000|Period 1|COPD exacerbation|0|||
131463199|NCT03645434|473325988|FG001|Period 1|COPD exacerbation|0|||
131463200|NCT03645434|473325989|FG002|Period 1|COPD exacerbation|0|||
131463201|NCT03645434|473325990|FG003|Period 1|COPD exacerbation|0|||
131463202|NCT03645434|473325991|FG004|Period 1|COPD exacerbation|1|||
131463203|NCT03645434|473325992|FG005|Period 1|COPD exacerbation|0|||
131463204|NCT00960570|473325993|FG000|21 Day Washout Period|Adverse Event|1|||
131463205|NCT00960570|473325993|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
131463206|NCT00960570|473325993|FG000|1 Day Period Between Dosing|Adverse Event|2|||
131463207|NCT00960570|473325993|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
131463208|NCT01451437|473325994|FG000|Overall Study|Adverse Event|0|||
131463209|NCT01451437|473325995|FG001|Overall Study|Adverse Event|0|||
131463210|NCT01451437|473325996|FG002|Overall Study|Adverse Event|0|||
131463211|NCT01451437|473325997|FG003|Overall Study|Adverse Event|0|||
131463212|NCT01451437|473325998|FG004|Overall Study|Adverse Event|0|||
131463213|NCT01451437|473325999|FG005|Overall Study|Adverse Event|1|||
131463214|NCT01451437|473326000|FG006|Overall Study|Adverse Event|1|||
131463215|NCT01451437|473326001|FG007|Overall Study|Adverse Event|2|||
131463216|NCT01451437|473326002|FG008|Overall Study|Adverse Event|1|||
131463217|NCT01451437|473325994|FG000|Overall Study|Physician Decision|1|||
131463218|NCT01451437|473325995|FG001|Overall Study|Physician Decision|1|||
131463219|NCT01451437|473325996|FG002|Overall Study|Physician Decision|2|||
131463220|NCT01451437|473325997|FG003|Overall Study|Physician Decision|0|||
131463221|NCT01451437|473325998|FG004|Overall Study|Physician Decision|0|||
131463222|NCT01451437|473325999|FG005|Overall Study|Physician Decision|0|||
131463223|NCT01451437|473326000|FG006|Overall Study|Physician Decision|0|||
131463224|NCT01451437|473326001|FG007|Overall Study|Physician Decision|0|||
131463225|NCT01451437|473326002|FG008|Overall Study|Physician Decision|0|||
131463226|NCT01451437|473325994|FG000|Overall Study|Disease Progression|0|||
131463227|NCT01451437|473325995|FG001|Overall Study|Disease Progression|0|||
131463228|NCT01451437|473325996|FG002|Overall Study|Disease Progression|1|||
131463229|NCT01451437|473325997|FG003|Overall Study|Disease Progression|1|||
131463230|NCT01451437|473325998|FG004|Overall Study|Disease Progression|3|||
131463231|NCT01451437|473325999|FG005|Overall Study|Disease Progression|2|||
131463232|NCT01451437|473326000|FG006|Overall Study|Disease Progression|3|||
131463233|NCT01451437|473326001|FG007|Overall Study|Disease Progression|1|||
131463234|NCT01451437|473326002|FG008|Overall Study|Disease Progression|3|||
131463235|NCT01451437|473325994|FG000|Overall Study|Protocol Violation|0|||
131463236|NCT01451437|473325995|FG001|Overall Study|Protocol Violation|0|||
131463237|NCT01451437|473325996|FG002|Overall Study|Protocol Violation|0|||
131463238|NCT01451437|473325997|FG003|Overall Study|Protocol Violation|0|||
131463239|NCT01451437|473325998|FG004|Overall Study|Protocol Violation|0|||
131463240|NCT01451437|473325999|FG005|Overall Study|Protocol Violation|0|||
131463241|NCT01451437|473326000|FG006|Overall Study|Protocol Violation|1|||
131463242|NCT01451437|473326001|FG007|Overall Study|Protocol Violation|0|||
131463243|NCT01451437|473326002|FG008|Overall Study|Protocol Violation|0|||
131463244|NCT01451437|473325994|FG000|Overall Study|Withdrawal by Subject|0|||
131463245|NCT01451437|473325995|FG001|Overall Study|Withdrawal by Subject|0|||
131463246|NCT01451437|473325996|FG002|Overall Study|Withdrawal by Subject|0|||
131463247|NCT01451437|473325997|FG003|Overall Study|Withdrawal by Subject|0|||
131463248|NCT01451437|473325998|FG004|Overall Study|Withdrawal by Subject|1|||
131463249|NCT01451437|473325999|FG005|Overall Study|Withdrawal by Subject|0|||
131463250|NCT01451437|473326000|FG006|Overall Study|Withdrawal by Subject|1|||
131463251|NCT01451437|473326001|FG007|Overall Study|Withdrawal by Subject|0|||
131463252|NCT01451437|473326002|FG008|Overall Study|Withdrawal by Subject|0|||
131496728|NCT02289690|473446366|FG007|Overall Study|Sponsor Discontinued Study|9|||
131496729|NCT02289690|473446367|FG008|Overall Study|Sponsor Discontinued Study|7|||
131496730|NCT02289690|473446368|FG009|Overall Study|Sponsor Discontinued Study|15|||
131496731|NCT02289690|473446359|FG000|Overall Study|Other|0|||
131496732|NCT02289690|473446360|FG001|Overall Study|Other|0|||
131496733|NCT02289690|473446361|FG002|Overall Study|Other|0|||
131496734|NCT02289690|473446362|FG003|Overall Study|Other|1|||
131496735|NCT02289690|473446363|FG004|Overall Study|Other|1|||
131496736|NCT02289690|473446364|FG005|Overall Study|Other|0|||
131496737|NCT02289690|473446365|FG006|Overall Study|Other|1|||
131496738|NCT02289690|473446366|FG007|Overall Study|Other|2|||
131496739|NCT02289690|473446367|FG008|Overall Study|Other|3|||
131496740|NCT02289690|473446368|FG009|Overall Study|Other|1|||
131496741|NCT02692703|473446369|FG000|Overall Study|Lost to Follow-up|1|||
131496742|NCT02692703|473446369|FG000|Overall Study|Other|1|||
131496743|NCT04118166|473446370|FG000|Overall Study|Adverse Event|1|||
131496744|NCT00885105|473446371|FG000|Overall Study|Withdrawal by Subject|0|||
131496745|NCT00885105|473446372|FG001|Overall Study|Withdrawal by Subject|8|||
131496746|NCT00885105|473446371|FG000|Overall Study|Adverse Event|1|||
131496747|NCT00885105|473446372|FG001|Overall Study|Adverse Event|0|||
131496748|NCT00885105|473446371|FG000|Overall Study|Protocol Violation|0|||
131496749|NCT00885105|473446372|FG001|Overall Study|Protocol Violation|2|||
131496750|NCT03519932|473446373|FG000|First Intervention|Adverse Event|1|||
131496751|NCT03519932|473446374|FG001|First Intervention|Adverse Event|3|||
131496752|NCT02254486|473446375|FG000|Overall Study|Adverse Event|1|||
131496753|NCT02254486|473446376|FG001|Overall Study|Adverse Event|1|||
131496754|NCT02254486|473446375|FG000|Overall Study|Lack of Efficacy|1|||
131496755|NCT02254486|473446376|FG001|Overall Study|Lack of Efficacy|0|||
131496756|NCT02254486|473446375|FG000|Overall Study|Lost to Follow-up|2|||
131496757|NCT02254486|473446376|FG001|Overall Study|Lost to Follow-up|4|||
131496758|NCT02254486|473446375|FG000|Overall Study|Protocol Violation|1|||
131496759|NCT02254486|473446376|FG001|Overall Study|Protocol Violation|2|||
131496760|NCT02254486|473446375|FG000|Overall Study|Withdrawal by Subject|17|||
131496761|NCT02254486|473446376|FG001|Overall Study|Withdrawal by Subject|15|||
131496762|NCT02254486|473446375|FG000|Overall Study|GFR<60mL/min|16|||
131496763|NCT02254486|473446376|FG001|Overall Study|GFR<60mL/min|21|||
131496764|NCT02254486|473446375|FG000|Overall Study|Various|12|||
131496765|NCT02254486|473446376|FG001|Overall Study|Various|12|||
131496766|NCT01350414|473446383|FG000|Overall Study|Lost to Follow-up|13|||
131496767|NCT01350414|473446383|FG000|Overall Study|Withdrawal by Subject|4|||
131496768|NCT01350414|473446383|FG000|Overall Study|Physician Decision|2|||
131496769|NCT04166435|473446384|FG000|Overall Study|2 patients ineligible for response|2|||
131496770|NCT02743520|473446388|FG000|Overall Study|Withdrawal by Subject|1|||
131496771|NCT01749514|473446389|FG000|Overall Study|Lost to Follow-up|0|||
131496772|NCT01749514|473446390|FG001|Overall Study|Lost to Follow-up|0|||
131496773|NCT01749514|473446391|FG002|Overall Study|Lost to Follow-up|0|||
131496774|NCT01749514|473446392|FG003|Overall Study|Lost to Follow-up|0|||
131496775|NCT01749514|473446393|FG004|Overall Study|Lost to Follow-up|0|||
131496776|NCT01749514|473446394|FG005|Overall Study|Lost to Follow-up|0|||
131496777|NCT01749514|473446395|FG006|Overall Study|Lost to Follow-up|0|||
131496778|NCT01749514|473446396|FG007|Overall Study|Lost to Follow-up|1|||
131496779|NCT01749514|473446389|FG000|Overall Study|Withdrawal by Subject|0|||
131496780|NCT01749514|473446390|FG001|Overall Study|Withdrawal by Subject|0|||
131496781|NCT01749514|473446391|FG002|Overall Study|Withdrawal by Subject|0|||
131496782|NCT01749514|473446392|FG003|Overall Study|Withdrawal by Subject|0|||
131496783|NCT01749514|473446393|FG004|Overall Study|Withdrawal by Subject|0|||
131496784|NCT01749514|473446394|FG005|Overall Study|Withdrawal by Subject|1|||
131496785|NCT01749514|473446395|FG006|Overall Study|Withdrawal by Subject|0|||
131496786|NCT01749514|473446396|FG007|Overall Study|Withdrawal by Subject|1|||
131496787|NCT01749514|473446389|FG000|Overall Study|Not Reported|0|||
131496788|NCT01749514|473446390|FG001|Overall Study|Not Reported|0|||
131496789|NCT01749514|473446391|FG002|Overall Study|Not Reported|0|||
131496790|NCT01749514|473446392|FG003|Overall Study|Not Reported|0|||
131496791|NCT01749514|473446393|FG004|Overall Study|Not Reported|0|||
131496792|NCT01749514|473446394|FG005|Overall Study|Not Reported|0|||
131463253|NCT03865316|473328084|FG000|Overall Study|Procedure Cancelled|4|||
131463254|NCT03865316|473328084|FG000|Overall Study|Equipment failure|4|||
131463255|NCT03137069|473328089|FG000|Overall Study|Withdrawal by Subject|1|||
131463256|NCT03137069|473328090|FG001|Overall Study|Withdrawal by Subject|2|||
131463257|NCT03137069|473328091|FG002|Overall Study|Withdrawal by Subject|2|||
131463258|NCT03137069|473328092|FG003|Overall Study|Withdrawal by Subject|2|||
131463259|NCT03137069|473328093|FG004|Overall Study|Withdrawal by Subject|0|||
131463260|NCT03137069|473328094|FG005|Overall Study|Withdrawal by Subject|0|||
131463261|NCT03137069|473328089|FG000|Overall Study|Adverse Event|0|||
131463262|NCT03137069|473328090|FG001|Overall Study|Adverse Event|3|||
131463263|NCT03137069|473328091|FG002|Overall Study|Adverse Event|1|||
131463264|NCT03137069|473328092|FG003|Overall Study|Adverse Event|1|||
131463265|NCT03137069|473328093|FG004|Overall Study|Adverse Event|0|||
131463266|NCT03137069|473328094|FG005|Overall Study|Adverse Event|1|||
131463267|NCT03137069|473328089|FG000|Overall Study|Protocol Violation|0|||
131463268|NCT03137069|473328090|FG001|Overall Study|Protocol Violation|1|||
131463269|NCT03137069|473328091|FG002|Overall Study|Protocol Violation|0|||
131463270|NCT03137069|473328092|FG003|Overall Study|Protocol Violation|1|||
131463271|NCT03137069|473328093|FG004|Overall Study|Protocol Violation|1|||
131463272|NCT03137069|473328094|FG005|Overall Study|Protocol Violation|1|||
131463273|NCT03137069|473328089|FG000|Overall Study|Physician Decision|0|||
131463274|NCT03137069|473328090|FG001|Overall Study|Physician Decision|0|||
131463275|NCT03137069|473328091|FG002|Overall Study|Physician Decision|0|||
131463276|NCT03137069|473328092|FG003|Overall Study|Physician Decision|1|||
131463277|NCT03137069|473328093|FG004|Overall Study|Physician Decision|0|||
131463278|NCT03137069|473328094|FG005|Overall Study|Physician Decision|0|||
131463279|NCT03137069|473328089|FG000|Overall Study|Study Terminated by Sponsor|0|||
131463280|NCT03137069|473328090|FG001|Overall Study|Study Terminated by Sponsor|0|||
131463281|NCT03137069|473328091|FG002|Overall Study|Study Terminated by Sponsor|0|||
131463282|NCT03137069|473328092|FG003|Overall Study|Study Terminated by Sponsor|0|||
131463283|NCT03137069|473328093|FG004|Overall Study|Study Terminated by Sponsor|1|||
131463284|NCT03137069|473328094|FG005|Overall Study|Study Terminated by Sponsor|0|||
131463285|NCT03137069|473328089|FG000|Overall Study|Data Entry Error|0|||
131463286|NCT03137069|473328090|FG001|Overall Study|Data Entry Error|0|||
131463287|NCT03137069|473328091|FG002|Overall Study|Data Entry Error|0|||
131463288|NCT03137069|473328092|FG003|Overall Study|Data Entry Error|1|||
131463289|NCT03137069|473328093|FG004|Overall Study|Data Entry Error|0|||
131463290|NCT03137069|473328094|FG005|Overall Study|Data Entry Error|0|||
131463291|NCT00336856|473328095|FG000|Overall Study|Withdrawal by Subject|3|||
131463292|NCT00336856|473328095|FG000|Overall Study|Found ineligible at time of analysis|1|||
131463293|NCT00362180|473328097|FG000|Treated Period|Withdrawal by Subject|1|||
131463294|NCT00362180|473328098|FG001|Treated Period|Withdrawal by Subject|0|||
131463295|NCT00362180|473328099|FG002|Treated Period|Withdrawal by Subject|0|||
131463296|NCT00362180|473328100|FG003|Treated Period|Withdrawal by Subject|0|||
131463297|NCT00362180|473328101|FG004|Treated Period|Withdrawal by Subject|0|||
131463298|NCT00362180|473328102|FG005|Treated Period|Withdrawal by Subject|0|||
131463299|NCT00362180|473328103|FG006|Treated Period|Withdrawal by Subject|0|||
131463300|NCT00362180|473328104|FG007|Treated Period|Withdrawal by Subject|0|||
131463301|NCT00362180|473328105|FG008|Treated Period|Withdrawal by Subject|0|||
131463302|NCT00362180|473328097|FG000|Treated Period|Adverse Event|0|||
131463303|NCT00362180|473328098|FG001|Treated Period|Adverse Event|0|||
131463304|NCT00362180|473328099|FG002|Treated Period|Adverse Event|0|||
131463305|NCT00362180|473328100|FG003|Treated Period|Adverse Event|0|||
131463306|NCT00362180|473328101|FG004|Treated Period|Adverse Event|0|||
131463307|NCT00362180|473328102|FG005|Treated Period|Adverse Event|1|||
131463308|NCT00362180|473328103|FG006|Treated Period|Adverse Event|0|||
131463309|NCT00362180|473328104|FG007|Treated Period|Adverse Event|1|||
131463310|NCT00362180|473328105|FG008|Treated Period|Adverse Event|0|||
131463311|NCT02434471|473328108|FG000|Overall Study|Physician Decision|9|||
131463312|NCT03338959|473328109|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
131463313|NCT03338959|473328109|FG000|Overall Study|Physician Decision|1|||
131463314|NCT01604278|473328110|FG000|Overall Study|Lack of Efficacy|0|||
131463315|NCT01604278|473328111|FG001|Overall Study|Lack of Efficacy|1|||
131463316|NCT01604278|473328110|FG000|Overall Study|Lost to Follow-up|1|||
131463317|NCT01604278|473328111|FG001|Overall Study|Lost to Follow-up|0|||
131463318|NCT01604278|473328110|FG000|Overall Study|Administrative problems|2|||
131463319|NCT01604278|473328111|FG001|Overall Study|Administrative problems|1|||
131463320|NCT01604278|473328110|FG000|Overall Study|Withdrawal by Subject|3|||
131463321|NCT01604278|473328111|FG001|Overall Study|Withdrawal by Subject|3|||
131463322|NCT01604278|473328110|FG000|Overall Study|Adverse Event|3|||
131463323|NCT01604278|473328111|FG001|Overall Study|Adverse Event|5|||
131463324|NCT01604278|473328110|FG000|Overall Study|Protocol Deviation|5|||
131463325|NCT01604278|473328111|FG001|Overall Study|Protocol Deviation|3|||
131463326|NCT00874939|473328116|FG000|Overall Study|Study terminated|4|||
131463327|NCT02870933|473328117|FG000|Overall Study|Death|2|||
131463328|NCT02870933|473328118|FG001|Overall Study|Death|1|||
131463329|NCT02870933|473328117|FG000|Overall Study|Withdrawal by Subject|0|||
131463330|NCT02870933|473328118|FG001|Overall Study|Withdrawal by Subject|1|||
131463331|NCT01250496|473328119|FG000|Overall Study|Study terminated|124|||
131463332|NCT01250496|473328120|FG001|Overall Study|Study terminated|124|||
131463333|NCT03642132|473328121|FG000|Chemotherapy Period|Adverse Event|1|||
131463334|NCT03642132|473328122|FG001|Chemotherapy Period|Adverse Event|1|||
131463335|NCT03642132|473328123|FG002|Chemotherapy Period|Adverse Event|0|||
131463336|NCT03642132|473328121|FG000|Chemotherapy Period|Physician's decision|4|||
131463337|NCT03642132|473328122|FG001|Chemotherapy Period|Physician's decision|1|||
131463338|NCT03642132|473328123|FG002|Chemotherapy Period|Physician's decision|0|||
131463339|NCT03642132|473328121|FG000|Chemotherapy Period|Progressive disease|0|||
131463340|NCT03642132|473328122|FG001|Chemotherapy Period|Progressive disease|0|||
131463341|NCT03642132|473328123|FG002|Chemotherapy Period|Progressive disease|1|||
131463342|NCT03642132|473328121|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
131463343|NCT03642132|473328122|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
131463344|NCT03642132|473328123|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
131463345|NCT03642132|473328121|FG000|Chemotherapy Period|Other|1|||
131463346|NCT03642132|473328122|FG001|Chemotherapy Period|Other|0|||
131463347|NCT03642132|473328123|FG002|Chemotherapy Period|Other|2|||
131463348|NCT03642132|473328121|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
131463349|NCT03642132|473328122|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
131463350|NCT03642132|473328123|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
131463351|NCT03642132|473328121|FG000|Maintenance Period|Adverse Event|1|||
131463352|NCT03642132|473328122|FG001|Maintenance Period|Adverse Event|2|||
131463353|NCT03642132|473328123|FG002|Maintenance Period|Adverse Event|0|||
131463354|NCT03642132|473328121|FG000|Maintenance Period|Non-compliance with study drug|0|||
131463355|NCT03642132|473328122|FG001|Maintenance Period|Non-compliance with study drug|0|||
131463356|NCT03642132|473328123|FG002|Maintenance Period|Non-compliance with study drug|1|||
131463357|NCT03642132|473328121|FG000|Maintenance Period|Physician's decision|2|||
131463358|NCT03642132|473328122|FG001|Maintenance Period|Physician's decision|2|||
131463359|NCT03642132|473328123|FG002|Maintenance Period|Physician's decision|2|||
131463360|NCT03642132|473328121|FG000|Maintenance Period|Progressive disease|9|||
131463361|NCT03642132|473328122|FG001|Maintenance Period|Progressive disease|3|||
131463362|NCT03642132|473328123|FG002|Maintenance Period|Progressive disease|6|||
131463363|NCT03642132|473328121|FG000|Maintenance Period|Other|0|||
131463364|NCT03642132|473328122|FG001|Maintenance Period|Other|0|||
131463365|NCT03642132|473328123|FG002|Maintenance Period|Other|3|||
131463366|NCT03642132|473328121|FG000|Maintenance Period|Withdrawal by Subject|1|||
131463367|NCT03642132|473328122|FG001|Maintenance Period|Withdrawal by Subject|1|||
131463368|NCT03642132|473328123|FG002|Maintenance Period|Withdrawal by Subject|2|||
131463369|NCT03642132|473328121|FG000|Follow-up Period|Other|0|||
131463370|NCT03642132|473328122|FG001|Follow-up Period|Other|0|||
131463371|NCT03642132|473328123|FG002|Follow-up Period|Other|1|||
131463372|NCT03642132|473328121|FG000|Follow-up Period|Withdrawal by Subject|1|||
131463373|NCT03642132|473328122|FG001|Follow-up Period|Withdrawal by Subject|2|||
131463374|NCT03642132|473328123|FG002|Follow-up Period|Withdrawal by Subject|0|||
131463375|NCT03642132|473328121|FG000|Follow-up Period|Study terminated by sponsor|1|||
131463376|NCT03642132|473328122|FG001|Follow-up Period|Study terminated by sponsor|0|||
131463377|NCT03642132|473328123|FG002|Follow-up Period|Study terminated by sponsor|1|||
131463378|NCT03642132|473328121|FG000|Follow-up Period|Lack of Efficacy|1|||
131463379|NCT03642132|473328122|FG001|Follow-up Period|Lack of Efficacy|0|||
131463380|NCT03642132|473328123|FG002|Follow-up Period|Lack of Efficacy|0|||
131463381|NCT03642132|473328121|FG000|Follow-up Period|Death|1|||
131463382|NCT03642132|473328122|FG001|Follow-up Period|Death|0|||
131463383|NCT03642132|473328123|FG002|Follow-up Period|Death|2|||
131463384|NCT03642132|473328121|FG000|Follow-up Period|Adverse Event|1|||
131463385|NCT03642132|473328122|FG001|Follow-up Period|Adverse Event|0|||
131463386|NCT03642132|473328123|FG002|Follow-up Period|Adverse Event|0|||
131463387|NCT03337490|473328124|FG000|Overall Study|Withdrawal by Subject|1|||
131463388|NCT03337490|473328125|FG001|Overall Study|Withdrawal by Subject|0|||
131463389|NCT03337490|473328126|FG002|Overall Study|Withdrawal by Subject|0|||
131463390|NCT03337490|473328124|FG000|Overall Study|Lack of Efficacy|10|||
131463391|NCT03337490|473328125|FG001|Overall Study|Lack of Efficacy|12|||
131463392|NCT03337490|473328126|FG002|Overall Study|Lack of Efficacy|35|||
131463393|NCT03337490|473328124|FG000|Overall Study|Physician Decision|0|||
131463394|NCT03337490|473328125|FG001|Overall Study|Physician Decision|1|||
131463395|NCT03337490|473328126|FG002|Overall Study|Physician Decision|0|||
131463396|NCT03337490|473328124|FG000|Overall Study|Lost to Follow-up|0|||
131463397|NCT03337490|473328125|FG001|Overall Study|Lost to Follow-up|1|||
131463398|NCT03337490|473328126|FG002|Overall Study|Lost to Follow-up|0|||
131463399|NCT01579812|473328129|FG000|Overall Study|Ineligible after treatment start|40|||
131463400|NCT01579812|473328129|FG000|Overall Study|Patient choice|3|||
131463401|NCT01579812|473328129|FG000|Overall Study|Noncompliance|3|||
131463402|NCT01579812|473328129|FG000|Overall Study|Withdrawal by Subject|6|||
131463403|NCT01133990|473328132|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
131463404|NCT01133990|473328133|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131463405|NCT01133990|473328134|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131463406|NCT01133990|473328135|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131463407|NCT01133990|473328136|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131463408|NCT01133990|473328137|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131496793|NCT01749514|473446395|FG006|Overall Study|Not Reported|0|||
131463409|NCT01133990|473328132|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
131463410|NCT01133990|473328133|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
131463411|NCT01133990|473328134|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
131463412|NCT01133990|473328135|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
131463413|NCT01133990|473328136|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
131463414|NCT01133990|473328137|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
131463415|NCT01133990|473328132|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
131463416|NCT01133990|473328133|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131463417|NCT01133990|473328134|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131463418|NCT01133990|473328135|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131463419|NCT01133990|473328136|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131463420|NCT01133990|473328137|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131463421|NCT01133990|473328132|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
131463422|NCT01133990|473328133|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
131463423|NCT01133990|473328134|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
131463424|NCT01133990|473328135|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
131463425|NCT01133990|473328136|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
131463426|NCT01133990|473328137|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
131463427|NCT05277337|473328138|FG000|Overall Study|Lost to Follow-up|2|||
131463428|NCT05277337|473328139|FG001|Overall Study|Lost to Follow-up|0|||
131463429|NCT05277337|473328138|FG000|Overall Study|Withdrawal by Subject|1|||
131463430|NCT05277337|473328139|FG001|Overall Study|Withdrawal by Subject|0|||
131463431|NCT04905498|473328140|FG000|Overall Study|Lost to Follow-up|0|||
131463432|NCT04905498|473328141|FG001|Overall Study|Lost to Follow-up|2|||
131463433|NCT04905498|473328140|FG000|Overall Study|COVID lockdown|1|||
131463434|NCT04905498|473328141|FG001|Overall Study|COVID lockdown|0|||
131463435|NCT03077087|473328142|FG000|Overall Study|Physician Decision|2|||
131463436|NCT01989468|473328143|FG000|Overall Study|Adverse Event|10|||
131463437|NCT01989468|473328144|FG001|Overall Study|Adverse Event|15|||
131463438|NCT01989468|473328145|FG002|Overall Study|Adverse Event|4|||
131463439|NCT01989468|473328146|FG003|Overall Study|Adverse Event|5|||
131463440|NCT01989468|473328147|FG004|Overall Study|Adverse Event|4|||
131463441|NCT01989468|473328143|FG000|Overall Study|Lack of Efficacy|11|||
131463442|NCT01989468|473328144|FG001|Overall Study|Lack of Efficacy|11|||
131463443|NCT01989468|473328145|FG002|Overall Study|Lack of Efficacy|7|||
131463444|NCT01989468|473328146|FG003|Overall Study|Lack of Efficacy|4|||
131463445|NCT01989468|473328147|FG004|Overall Study|Lack of Efficacy|2|||
131463446|NCT01989468|473328143|FG000|Overall Study|Lost to Follow-up|5|||
131463447|NCT01989468|473328144|FG001|Overall Study|Lost to Follow-up|2|||
131463448|NCT01989468|473328145|FG002|Overall Study|Lost to Follow-up|0|||
131463449|NCT01989468|473328146|FG003|Overall Study|Lost to Follow-up|1|||
131463450|NCT01989468|473328147|FG004|Overall Study|Lost to Follow-up|1|||
131463451|NCT01989468|473328143|FG000|Overall Study|Physician Decision|4|||
131463452|NCT01989468|473328144|FG001|Overall Study|Physician Decision|1|||
131463453|NCT01989468|473328145|FG002|Overall Study|Physician Decision|0|||
131463454|NCT01989468|473328146|FG003|Overall Study|Physician Decision|1|||
131463455|NCT01989468|473328147|FG004|Overall Study|Physician Decision|0|||
131463456|NCT01989468|473328143|FG000|Overall Study|Pregnancy|0|||
131463457|NCT01989468|473328144|FG001|Overall Study|Pregnancy|1|||
131463458|NCT01989468|473328145|FG002|Overall Study|Pregnancy|0|||
131463459|NCT01989468|473328146|FG003|Overall Study|Pregnancy|0|||
131463460|NCT01989468|473328147|FG004|Overall Study|Pregnancy|0|||
131463461|NCT01989468|473328143|FG000|Overall Study|Technical Problems|3|||
131463462|NCT01989468|473328144|FG001|Overall Study|Technical Problems|1|||
131463463|NCT01989468|473328145|FG002|Overall Study|Technical Problems|3|||
131463464|NCT01989468|473328146|FG003|Overall Study|Technical Problems|1|||
131463465|NCT01989468|473328147|FG004|Overall Study|Technical Problems|0|||
131463466|NCT01989468|473328143|FG000|Overall Study|Subject Guardian Decision|11|||
131463467|NCT01989468|473328144|FG001|Overall Study|Subject Guardian Decision|6|||
131463468|NCT01989468|473328145|FG002|Overall Study|Subject Guardian Decision|4|||
131463469|NCT01989468|473328146|FG003|Overall Study|Subject Guardian Decision|4|||
131463470|NCT01989468|473328147|FG004|Overall Study|Subject Guardian Decision|1|||
131463471|NCT01989468|473328143|FG000|Overall Study|Death|3|||
131463472|NCT01989468|473328144|FG001|Overall Study|Death|0|||
131463473|NCT01989468|473328145|FG002|Overall Study|Death|1|||
131463474|NCT01989468|473328146|FG003|Overall Study|Death|0|||
131463475|NCT01989468|473328147|FG004|Overall Study|Death|0|||
131463476|NCT01224782|473328155|FG000|Overall Study|Lost to Follow-up|177|||
131463477|NCT01224782|473328155|FG000|Overall Study|Withdrawal by Subject|16|||
131463478|NCT01224782|473328155|FG000|Overall Study|Death|14|||
131463479|NCT01224782|473328155|FG000|Overall Study|Improvement|13|||
131463480|NCT01224782|473328155|FG000|Overall Study|Adverse Event|12|||
131463481|NCT01224782|473328155|FG000|Overall Study|Adverse Reaction|11|||
131463482|NCT01224782|473328155|FG000|Overall Study|Noncompliance|10|||
131463483|NCT01224782|473328155|FG000|Overall Study|Other|4|||
131463484|NCT01224782|473328155|FG000|Overall Study|Start of Dialysis|3|||
131463485|NCT01224782|473328155|FG000|Overall Study|Change of Treatment|1|||
131463486|NCT01224782|473328155|FG000|Overall Study|Financial Reasons|1|||
131463487|NCT01224782|473328155|FG000|Overall Study|Deterioration|1|||
131463488|NCT01224782|473328155|FG000|Overall Study|Transplantation|1|||
131463489|NCT02112045|473328156|FG000|Overall Study|Withdrawal by Subject|1|||
131463490|NCT02112045|473328157|FG001|Overall Study|Withdrawal by Subject|0|||
131463491|NCT00065429|473328158|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
131463492|NCT00065429|473328159|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
131463493|NCT00065429|473328160|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
131463494|NCT00065429|473328161|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
131463495|NCT00065429|473328162|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
131463496|NCT00065429|473328163|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
131463497|NCT00065429|473328164|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
131463498|NCT00065429|473328158|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131463499|NCT00065429|473328159|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131463500|NCT00065429|473328160|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
131463501|NCT00065429|473328161|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131463502|NCT00065429|473328162|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131463503|NCT00065429|473328163|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131463504|NCT00065429|473328164|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131463505|NCT00065429|473328158|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
131463506|NCT00065429|473328159|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
131463507|NCT00065429|473328160|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
131463508|NCT00065429|473328161|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
131463509|NCT00065429|473328162|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
131463510|NCT00065429|473328163|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
131463511|NCT00065429|473328164|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
131463512|NCT00065429|473328158|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
131463513|NCT00065429|473328159|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
131463514|NCT00065429|473328160|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
131463515|NCT00065429|473328161|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
131463516|NCT00065429|473328162|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
131463517|NCT00065429|473328163|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
131463518|NCT00065429|473328164|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
131463519|NCT00065429|473328158|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
131463520|NCT00065429|473328159|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
131463521|NCT00065429|473328160|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
131463522|NCT00065429|473328161|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
131463523|NCT00065429|473328162|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
131463524|NCT00065429|473328163|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
131463525|NCT00065429|473328164|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
131463526|NCT00065429|473328158|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
131463527|NCT00065429|473328159|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
131463528|NCT00065429|473328160|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
131463529|NCT00065429|473328161|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
131463530|NCT00065429|473328162|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
131463531|NCT00065429|473328163|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
131463532|NCT00065429|473328164|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
131463533|NCT00065429|473328158|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
131463534|NCT00065429|473328159|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
131463535|NCT00065429|473328160|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
131463536|NCT00065429|473328161|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
131463537|NCT00065429|473328162|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
131463538|NCT00065429|473328163|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
131463539|NCT00065429|473328164|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
131463540|NCT00977080|473328166|FG000|Overall Study|Adverse Event|2|||
131463541|NCT00977080|473328167|FG001|Overall Study|Adverse Event|7|||
131463542|NCT00977080|473328168|FG002|Overall Study|Adverse Event|7|||
131463543|NCT00977080|473328169|FG003|Overall Study|Adverse Event|7|||
131463544|NCT00977080|473328166|FG000|Overall Study|Withdrawal by Subject|1|||
131463545|NCT00977080|473328167|FG001|Overall Study|Withdrawal by Subject|5|||
131463546|NCT00977080|473328168|FG002|Overall Study|Withdrawal by Subject|1|||
131463547|NCT00977080|473328169|FG003|Overall Study|Withdrawal by Subject|5|||
131463548|NCT00977080|473328166|FG000|Overall Study|Protocol Violation|7|||
131463549|NCT00977080|473328167|FG001|Overall Study|Protocol Violation|3|||
131463550|NCT00977080|473328168|FG002|Overall Study|Protocol Violation|4|||
131463551|NCT00977080|473328169|FG003|Overall Study|Protocol Violation|3|||
131463552|NCT00977080|473328166|FG000|Overall Study|Noncompliance|0|||
131463553|NCT00977080|473328167|FG001|Overall Study|Noncompliance|2|||
131463554|NCT00977080|473328168|FG002|Overall Study|Noncompliance|1|||
131463555|NCT00977080|473328169|FG003|Overall Study|Noncompliance|0|||
131463556|NCT00977080|473328166|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
131463557|NCT00977080|473328167|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
131463558|NCT00977080|473328168|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
131463559|NCT00977080|473328169|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
131463560|NCT00977080|473328166|FG000|Overall Study|Required kidney transplantation|1|||
131463561|NCT00977080|473328167|FG001|Overall Study|Required kidney transplantation|3|||
131463562|NCT00977080|473328168|FG002|Overall Study|Required kidney transplantation|3|||
131463563|NCT00977080|473328169|FG003|Overall Study|Required kidney transplantation|1|||
131463564|NCT00977080|473328166|FG000|Overall Study|Travel for family reasons|1|||
131463565|NCT00977080|473328167|FG001|Overall Study|Travel for family reasons|0|||
131463566|NCT00977080|473328168|FG002|Overall Study|Travel for family reasons|0|||
131463567|NCT00977080|473328169|FG003|Overall Study|Travel for family reasons|0|||
131463568|NCT00441116|473328172|FG000|Overall Study|Adverse Event|1|||
131463569|NCT00441116|473328173|FG001|Overall Study|Adverse Event|1|||
131463570|NCT00441116|473328172|FG000|Overall Study|Withdrawal by Subject|1|||
131463571|NCT00441116|473328173|FG001|Overall Study|Withdrawal by Subject|0|||
131463572|NCT00441116|473328172|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
131463573|NCT00441116|473328173|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
131463574|NCT02509117|473328177|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463575|NCT02509117|473328178|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
131463576|NCT02509117|473328179|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463577|NCT02509117|473328180|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463578|NCT02509117|473328181|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463579|NCT02509117|473328182|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463580|NCT02509117|473328183|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463581|NCT02509117|473328184|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463582|NCT02509117|473328185|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463583|NCT02509117|473328186|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
131463584|NCT02509117|473328177|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463585|NCT02509117|473328178|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463586|NCT02509117|473328179|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463587|NCT02509117|473328180|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463588|NCT02509117|473328181|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463589|NCT02509117|473328182|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463590|NCT02509117|473328183|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463591|NCT02509117|473328184|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463592|NCT02509117|473328185|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131463593|NCT02509117|473328186|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
131463594|NCT02509117|473328177|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463595|NCT02509117|473328178|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463596|NCT02509117|473328179|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463597|NCT02509117|473328180|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463598|NCT02509117|473328181|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463599|NCT02509117|473328182|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463600|NCT02509117|473328183|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463601|NCT02509117|473328184|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463602|NCT02509117|473328185|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131463603|NCT02509117|473328186|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
131463604|NCT00548184|473328189|FG000|Overall Study|Adverse Event|3|||
131463605|NCT00548184|473328189|FG000|Overall Study|took other drug|1|||
131463606|NCT00548184|473328189|FG000|Overall Study|Found Her2 negative|1|||
131463607|NCT01765218|473328198|FG000|Overall Study|Protocol Violation|1|||
131463608|NCT01765218|473328199|FG001|Overall Study|Protocol Violation|2|||
131463609|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
131463610|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
131463611|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
131463612|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
131463613|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
131463614|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
131463615|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
131463616|NCT00946985|473328200|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
131463617|NCT00946985|473328200|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
131463618|NCT03148691|473328201|FG000|Overall Study|Protocol Violation|1|||
131463619|NCT03148691|473328202|FG001|Overall Study|Protocol Violation|2|||
131463620|NCT03148691|473328203|FG002|Overall Study|Protocol Violation|7|||
131463621|NCT03148691|473328201|FG000|Overall Study|Lost to Follow-up|0|||
131463622|NCT03148691|473328202|FG001|Overall Study|Lost to Follow-up|0|||
131463623|NCT03148691|473328203|FG002|Overall Study|Lost to Follow-up|1|||
131463624|NCT03148691|473328201|FG000|Overall Study|Other|1|||
131463625|NCT03148691|473328202|FG001|Overall Study|Other|0|||
131463626|NCT03148691|473328203|FG002|Overall Study|Other|0|||
131463627|NCT03148691|473328201|FG000|Overall Study|Withdrawal by Subject|1|||
131463628|NCT03148691|473328202|FG001|Overall Study|Withdrawal by Subject|0|||
131463629|NCT03148691|473328203|FG002|Overall Study|Withdrawal by Subject|0|||
131463630|NCT00171834|473328204|FG000|Overall Study|Adverse Event|2|||
131463631|NCT00171834|473328205|FG001|Overall Study|Adverse Event|1|||
131463632|NCT00171834|473328206|FG002|Overall Study|Adverse Event|3|||
131463633|NCT00171834|473328207|FG003|Overall Study|Adverse Event|2|||
131463634|NCT00171834|473328208|FG004|Overall Study|Adverse Event|2|||
131463635|NCT00171834|473328209|FG005|Overall Study|Adverse Event|15|||
131463636|NCT00171834|473328210|FG006|Overall Study|Adverse Event|1|||
131463637|NCT00171834|473328204|FG000|Overall Study|Withdrawal by Subject|0|||
131463638|NCT00171834|473328205|FG001|Overall Study|Withdrawal by Subject|2|||
131463639|NCT00171834|473328206|FG002|Overall Study|Withdrawal by Subject|0|||
131463640|NCT00171834|473328207|FG003|Overall Study|Withdrawal by Subject|1|||
131463641|NCT00171834|473328208|FG004|Overall Study|Withdrawal by Subject|1|||
131463642|NCT00171834|473328209|FG005|Overall Study|Withdrawal by Subject|1|||
131463643|NCT00171834|473328210|FG006|Overall Study|Withdrawal by Subject|0|||
131463644|NCT00171834|473328204|FG000|Overall Study|Death from study indication|0|||
131463645|NCT00171834|473328205|FG001|Overall Study|Death from study indication|1|||
131463646|NCT00171834|473328206|FG002|Overall Study|Death from study indication|0|||
131463647|NCT00171834|473328207|FG003|Overall Study|Death from study indication|0|||
131463648|NCT00171834|473328208|FG004|Overall Study|Death from study indication|1|||
131463649|NCT00171834|473328209|FG005|Overall Study|Death from study indication|0|||
131463650|NCT00171834|473328210|FG006|Overall Study|Death from study indication|0|||
131463651|NCT00171834|473328204|FG000|Overall Study|Disease Progression|4|||
131463652|NCT00171834|473328205|FG001|Overall Study|Disease Progression|8|||
131463653|NCT00171834|473328206|FG002|Overall Study|Disease Progression|8|||
131463654|NCT00171834|473328207|FG003|Overall Study|Disease Progression|9|||
131463655|NCT00171834|473328208|FG004|Overall Study|Disease Progression|2|||
131463656|NCT00171834|473328209|FG005|Overall Study|Disease Progression|18|||
131463657|NCT00171834|473328210|FG006|Overall Study|Disease Progression|3|||
131463658|NCT00171834|473328204|FG000|Overall Study|Treatment Duration Completed|0|||
131463659|NCT00171834|473328205|FG001|Overall Study|Treatment Duration Completed|0|||
131463660|NCT00171834|473328206|FG002|Overall Study|Treatment Duration Completed|1|||
131463661|NCT00171834|473328207|FG003|Overall Study|Treatment Duration Completed|0|||
131463662|NCT00171834|473328208|FG004|Overall Study|Treatment Duration Completed|2|||
131463663|NCT00171834|473328209|FG005|Overall Study|Treatment Duration Completed|1|||
131463664|NCT00171834|473328210|FG006|Overall Study|Treatment Duration Completed|0|||
131463665|NCT04345367|473328211|FG000|Overall Study|Other|3|||
131463666|NCT04345367|473328212|FG001|Overall Study|Other|4|||
131463667|NCT04345367|473328211|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
131463668|NCT04345367|473328212|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
131463669|NCT04345367|473328211|FG000|Overall Study|Withdrawal by Subject|11|||
131463670|NCT04345367|473328212|FG001|Overall Study|Withdrawal by Subject|11|||
131463671|NCT04345367|473328211|FG000|Overall Study|Protocol Violation|4|||
131463672|NCT04345367|473328212|FG001|Overall Study|Protocol Violation|3|||
131463673|NCT04345367|473328211|FG000|Overall Study|Lost to Follow-up|2|||
131463674|NCT04345367|473328212|FG001|Overall Study|Lost to Follow-up|4|||
131463675|NCT04345367|473328211|FG000|Overall Study|Lack of Efficacy|2|||
131463676|NCT04345367|473328212|FG001|Overall Study|Lack of Efficacy|0|||
131463677|NCT04345367|473328211|FG000|Overall Study|Death|2|||
131463678|NCT04345367|473328212|FG001|Overall Study|Death|0|||
131463679|NCT04345367|473328211|FG000|Overall Study|Adverse Event|10|||
131463680|NCT04345367|473328212|FG001|Overall Study|Adverse Event|9|||
131463681|NCT00796523|473328213|FG000|Overall Study|Lost to Follow-up|9|||
131463682|NCT00796523|473328214|FG001|Overall Study|Lost to Follow-up|7|||
131463683|NCT02431260|473328216|FG000|Overall Study|Subject Decision|0|||
131463684|NCT02431260|473328217|FG001|Overall Study|Subject Decision|1|||
131463685|NCT02431260|473328218|FG002|Overall Study|Subject Decision|1|||
131463686|NCT02431260|473328219|FG003|Overall Study|Subject Decision|0|||
131463687|NCT02431260|473328220|FG004|Overall Study|Subject Decision|0|||
131463688|NCT02431260|473328221|FG005|Overall Study|Subject Decision|0|||
131463689|NCT02431260|473328222|FG006|Overall Study|Subject Decision|0|||
131463690|NCT02431260|473328223|FG007|Overall Study|Subject Decision|0|||
131463691|NCT02431260|473328224|FG008|Overall Study|Subject Decision|1|||
131463692|NCT02431260|473328225|FG009|Overall Study|Subject Decision|1|||
131463693|NCT02431260|473328226|FG010|Overall Study|Subject Decision|0|||
131463694|NCT02431260|473328227|FG011|Overall Study|Subject Decision|1|||
131463695|NCT02431260|473328228|FG012|Overall Study|Subject Decision|0|||
131463696|NCT02431260|473328229|FG013|Overall Study|Subject Decision|0|||
131463697|NCT02431260|473328216|FG000|Overall Study|Death|4|||
131463698|NCT02431260|473328217|FG001|Overall Study|Death|4|||
131463699|NCT02431260|473328218|FG002|Overall Study|Death|3|||
131463700|NCT02431260|473328219|FG003|Overall Study|Death|4|||
131463701|NCT02431260|473328220|FG004|Overall Study|Death|2|||
131463702|NCT02431260|473328221|FG005|Overall Study|Death|2|||
131463703|NCT02431260|473328222|FG006|Overall Study|Death|3|||
131463704|NCT02431260|473328223|FG007|Overall Study|Death|1|||
131463705|NCT02431260|473328224|FG008|Overall Study|Death|6|||
131463706|NCT02431260|473328225|FG009|Overall Study|Death|6|||
131463707|NCT02431260|473328226|FG010|Overall Study|Death|3|||
131463708|NCT02431260|473328227|FG011|Overall Study|Death|2|||
131463709|NCT02431260|473328228|FG012|Overall Study|Death|5|||
131463710|NCT02431260|473328229|FG013|Overall Study|Death|1|||
131463711|NCT02431260|473328216|FG000|Overall Study|Lost to Follow-up|0|||
131463712|NCT02431260|473328217|FG001|Overall Study|Lost to Follow-up|0|||
131463713|NCT02431260|473328218|FG002|Overall Study|Lost to Follow-up|0|||
131463714|NCT02431260|473328219|FG003|Overall Study|Lost to Follow-up|0|||
131463715|NCT02431260|473328220|FG004|Overall Study|Lost to Follow-up|0|||
131463716|NCT02431260|473328221|FG005|Overall Study|Lost to Follow-up|1|||
131463717|NCT02431260|473328222|FG006|Overall Study|Lost to Follow-up|0|||
131463718|NCT02431260|473328223|FG007|Overall Study|Lost to Follow-up|0|||
131463719|NCT02431260|473328224|FG008|Overall Study|Lost to Follow-up|0|||
131463720|NCT02431260|473328225|FG009|Overall Study|Lost to Follow-up|0|||
131463721|NCT02431260|473328226|FG010|Overall Study|Lost to Follow-up|0|||
131463722|NCT02431260|473328227|FG011|Overall Study|Lost to Follow-up|0|||
131463723|NCT02431260|473328228|FG012|Overall Study|Lost to Follow-up|0|||
131463724|NCT02431260|473328229|FG013|Overall Study|Lost to Follow-up|0|||
131463725|NCT02431260|473328216|FG000|Overall Study|Study Terminated by the Sponsor|0|||
131463726|NCT02431260|473328217|FG001|Overall Study|Study Terminated by the Sponsor|0|||
131463727|NCT02431260|473328218|FG002|Overall Study|Study Terminated by the Sponsor|2|||
131463728|NCT02431260|473328219|FG003|Overall Study|Study Terminated by the Sponsor|1|||
131463729|NCT02431260|473328220|FG004|Overall Study|Study Terminated by the Sponsor|1|||
131463730|NCT02431260|473328221|FG005|Overall Study|Study Terminated by the Sponsor|0|||
131463731|NCT02431260|473328222|FG006|Overall Study|Study Terminated by the Sponsor|1|||
131463732|NCT02431260|473328223|FG007|Overall Study|Study Terminated by the Sponsor|2|||
131463733|NCT02431260|473328224|FG008|Overall Study|Study Terminated by the Sponsor|1|||
131463734|NCT02431260|473328225|FG009|Overall Study|Study Terminated by the Sponsor|1|||
131463735|NCT02431260|473328226|FG010|Overall Study|Study Terminated by the Sponsor|1|||
131463736|NCT02431260|473328227|FG011|Overall Study|Study Terminated by the Sponsor|0|||
131463737|NCT02431260|473328228|FG012|Overall Study|Study Terminated by the Sponsor|4|||
131463738|NCT02431260|473328229|FG013|Overall Study|Study Terminated by the Sponsor|0|||
131463739|NCT02431260|473328216|FG000|Overall Study|Physician Decision|0|||
131463740|NCT02431260|473328217|FG001|Overall Study|Physician Decision|0|||
131463741|NCT02431260|473328218|FG002|Overall Study|Physician Decision|0|||
131463742|NCT02431260|473328219|FG003|Overall Study|Physician Decision|0|||
131463743|NCT02431260|473328220|FG004|Overall Study|Physician Decision|0|||
131463744|NCT02431260|473328221|FG005|Overall Study|Physician Decision|1|||
131463745|NCT02431260|473328222|FG006|Overall Study|Physician Decision|0|||
131463746|NCT02431260|473328223|FG007|Overall Study|Physician Decision|0|||
131463747|NCT02431260|473328224|FG008|Overall Study|Physician Decision|0|||
131463748|NCT02431260|473328225|FG009|Overall Study|Physician Decision|0|||
131463749|NCT02431260|473328226|FG010|Overall Study|Physician Decision|0|||
131463750|NCT02431260|473328227|FG011|Overall Study|Physician Decision|0|||
131463751|NCT02431260|473328228|FG012|Overall Study|Physician Decision|0|||
131463752|NCT02431260|473328229|FG013|Overall Study|Physician Decision|0|||
131463753|NCT02431260|473328216|FG000|Overall Study|Other Unspecified|0|||
131463754|NCT02431260|473328217|FG001|Overall Study|Other Unspecified|0|||
131463755|NCT02431260|473328218|FG002|Overall Study|Other Unspecified|0|||
131463756|NCT02431260|473328219|FG003|Overall Study|Other Unspecified|0|||
131463757|NCT02431260|473328220|FG004|Overall Study|Other Unspecified|0|||
131463758|NCT02431260|473328221|FG005|Overall Study|Other Unspecified|0|||
131463759|NCT02431260|473328222|FG006|Overall Study|Other Unspecified|0|||
131463760|NCT02431260|473328223|FG007|Overall Study|Other Unspecified|0|||
131463761|NCT02431260|473328224|FG008|Overall Study|Other Unspecified|0|||
131463762|NCT02431260|473328225|FG009|Overall Study|Other Unspecified|0|||
131463763|NCT02431260|473328226|FG010|Overall Study|Other Unspecified|0|||
131463764|NCT02431260|473328227|FG011|Overall Study|Other Unspecified|1|||
131463765|NCT02431260|473328228|FG012|Overall Study|Other Unspecified|1|||
131463766|NCT02431260|473328229|FG013|Overall Study|Other Unspecified|0|||
131463767|NCT00439738|473328233|FG000|Overall Study|Withdrawal by Subject|16|||
131463768|NCT00439738|473328234|FG001|Overall Study|Withdrawal by Subject|13|||
131463769|NCT00439738|473328233|FG000|Overall Study|Adverse Event|6|||
131463770|NCT00439738|473328234|FG001|Overall Study|Adverse Event|4|||
131463771|NCT00439738|473328233|FG000|Overall Study|Lost to Follow-up|5|||
131463772|NCT00439738|473328234|FG001|Overall Study|Lost to Follow-up|6|||
131463773|NCT00439738|473328233|FG000|Overall Study|Protocol Violation|6|||
131463774|NCT00439738|473328234|FG001|Overall Study|Protocol Violation|3|||
131463775|NCT00439738|473328233|FG000|Overall Study|Lack of Efficacy|2|||
131463776|NCT00439738|473328234|FG001|Overall Study|Lack of Efficacy|2|||
131463777|NCT00439738|473328233|FG000|Overall Study|Abnormal Lab Values|1|||
131463778|NCT00439738|473328234|FG001|Overall Study|Abnormal Lab Values|0|||
131463779|NCT00978757|473328235|FG000|Overall Study|Physician Decision|1|||
131463780|NCT00978757|473328236|FG001|Overall Study|Physician Decision|3|||
131463781|NCT00781885|473328237|FG000|Overall Study|Physician Decision|1|||
131463782|NCT01755026|473328238|FG000|Overall Study|Adverse Event|1|||
131463783|NCT01755026|473328239|FG001|Overall Study|Adverse Event|0|||
131463784|NCT01755026|473328238|FG000|Overall Study|Withdrawal by Subject|1|||
131463785|NCT01755026|473328239|FG001|Overall Study|Withdrawal by Subject|1|||
131463786|NCT01700387|473328245|FG000|Overall Study|Withdrawal by Subject|1|||
131463787|NCT01700387|473328246|FG001|Overall Study|Withdrawal by Subject|2|||
131463788|NCT01700387|473328245|FG000|Overall Study|Adverse Event|1|||
131463789|NCT01700387|473328246|FG001|Overall Study|Adverse Event|1|||
131463790|NCT01700387|473328245|FG000|Overall Study|Lost to Follow-up|2|||
131463791|NCT01700387|473328246|FG001|Overall Study|Lost to Follow-up|1|||
131463792|NCT01185353|473328249|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
131463793|NCT01185353|473328250|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
131463794|NCT01185353|473328251|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
131463795|NCT01185353|473328252|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
131463796|NCT01185353|473328253|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
131463797|NCT01185353|473328254|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
131463798|NCT01185353|473328255|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
131463799|NCT01185353|473328256|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
131463800|NCT01185353|473328257|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
131463801|NCT01185353|473328258|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
131463802|NCT01185353|473328249|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463803|NCT01185353|473328250|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463804|NCT01185353|473328251|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463805|NCT01185353|473328252|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463806|NCT01185353|473328253|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
131463807|NCT01185353|473328254|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463808|NCT01185353|473328255|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463809|NCT01185353|473328256|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463810|NCT01185353|473328257|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463811|NCT01185353|473328258|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
131463812|NCT01185353|473328249|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
131463813|NCT01185353|473328250|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463814|NCT01185353|473328251|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463815|NCT01185353|473328252|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463816|NCT01185353|473328253|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
131463817|NCT01185353|473328254|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463818|NCT01185353|473328255|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463819|NCT01185353|473328256|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463820|NCT01185353|473328257|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463821|NCT01185353|473328258|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131463822|NCT01185353|473328249|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463823|NCT01185353|473328250|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463824|NCT01185353|473328251|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
131463825|NCT01185353|473328252|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463826|NCT01185353|473328253|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
131463827|NCT01185353|473328254|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463828|NCT01185353|473328255|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463829|NCT01185353|473328256|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463830|NCT01185353|473328257|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463831|NCT01185353|473328258|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131463832|NCT01185353|473328249|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463833|NCT01185353|473328250|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463834|NCT01185353|473328251|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463835|NCT01185353|473328252|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463836|NCT01185353|473328253|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
131463837|NCT01185353|473328254|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463838|NCT01185353|473328255|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463839|NCT01185353|473328256|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463840|NCT01185353|473328257|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463841|NCT01185353|473328258|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
131463842|NCT01185353|473328249|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
131463843|NCT01185353|473328250|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463844|NCT01185353|473328251|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463845|NCT01185353|473328252|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463846|NCT01185353|473328253|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
131463847|NCT01185353|473328254|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463848|NCT01185353|473328255|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463849|NCT01185353|473328256|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463850|NCT01185353|473328257|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463851|NCT01185353|473328258|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
131463852|NCT01185353|473328249|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463853|NCT01185353|473328250|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463854|NCT01185353|473328251|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
131463855|NCT01185353|473328252|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463856|NCT01185353|473328253|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463857|NCT01185353|473328254|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
131463858|NCT01185353|473328255|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463859|NCT01185353|473328256|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463860|NCT01185353|473328257|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463861|NCT01185353|473328258|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
131463862|NCT01185353|473328249|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463863|NCT01185353|473328250|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
131463864|NCT01185353|473328251|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463865|NCT01185353|473328252|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
131463866|NCT01185353|473328253|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463867|NCT01185353|473328254|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463868|NCT01185353|473328255|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463869|NCT01185353|473328256|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463870|NCT01185353|473328257|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463871|NCT01185353|473328258|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
131463872|NCT01185353|473328249|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463873|NCT01185353|473328250|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463874|NCT01185353|473328251|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463875|NCT01185353|473328252|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
131463876|NCT01185353|473328253|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463877|NCT01185353|473328254|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463878|NCT01185353|473328255|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
131463879|NCT01185353|473328256|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463880|NCT01185353|473328257|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463881|NCT01185353|473328258|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
131463882|NCT01185353|473328249|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
131463883|NCT01185353|473328250|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
131463884|NCT01185353|473328251|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
131463885|NCT01185353|473328252|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
131463886|NCT01185353|473328253|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
131463887|NCT01185353|473328254|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
131463888|NCT01185353|473328255|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
131463889|NCT01185353|473328256|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
131463890|NCT01185353|473328257|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
131463891|NCT01185353|473328258|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
131463892|NCT01185353|473328249|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463893|NCT01185353|473328250|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463894|NCT01185353|473328251|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463895|NCT01185353|473328252|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463896|NCT01185353|473328253|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463897|NCT01185353|473328254|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463898|NCT01185353|473328255|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
131463899|NCT01185353|473328256|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463900|NCT01185353|473328257|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463901|NCT01185353|473328258|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131463902|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463903|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463904|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463905|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463906|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463907|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463908|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
131463909|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
131463910|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
131463911|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
131463912|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463913|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463914|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463915|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463916|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463917|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463918|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
131463919|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
131463920|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
131463921|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
131463922|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463923|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463924|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463925|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463926|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463927|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463928|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
131463929|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
131463930|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
131463931|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
131463932|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463933|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463934|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463935|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463936|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463937|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463938|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463939|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463940|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
131463941|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131463942|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Death|0|||
131463943|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Death|0|||
131463944|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Death|0|||
131463945|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Death|0|||
131463946|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Death|0|||
131463947|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Death|0|||
131463948|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Death|0|||
131463949|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Death|0|||
131463950|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Death|0|||
131463951|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Death|1|||
131463952|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463953|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463954|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463955|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463956|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463957|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463958|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463959|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463960|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
131463961|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
131463962|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463963|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463964|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463965|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463966|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463967|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463968|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463969|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463970|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
131463971|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
131463972|NCT01185353|473328249|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463973|NCT01185353|473328250|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463974|NCT01185353|473328251|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463975|NCT01185353|473328252|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463976|NCT01185353|473328253|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463977|NCT01185353|473328254|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463978|NCT01185353|473328255|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463979|NCT01185353|473328256|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463980|NCT01185353|473328257|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
131463981|NCT01185353|473328258|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
131463982|NCT01185353|473328249|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131496794|NCT01749514|473446396|FG007|Overall Study|Not Reported|5|||
131463983|NCT01185353|473328250|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463984|NCT01185353|473328251|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463985|NCT01185353|473328252|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463986|NCT01185353|473328253|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463987|NCT01185353|473328254|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463988|NCT01185353|473328255|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463989|NCT01185353|473328256|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
131463990|NCT01185353|473328257|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
131463991|NCT01185353|473328258|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
131463992|NCT01185353|473328249|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463993|NCT01185353|473328250|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463994|NCT01185353|473328251|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463995|NCT01185353|473328252|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463996|NCT01185353|473328253|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463997|NCT01185353|473328254|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463998|NCT01185353|473328255|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
131463999|NCT01185353|473328256|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
131464000|NCT01185353|473328257|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
131464001|NCT01185353|473328258|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
131464002|NCT01185353|473328249|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464003|NCT01185353|473328250|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464004|NCT01185353|473328251|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464005|NCT01185353|473328252|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464006|NCT01185353|473328253|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464007|NCT01185353|473328254|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464008|NCT01185353|473328255|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464009|NCT01185353|473328256|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
131464010|NCT01185353|473328257|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
131464011|NCT01185353|473328258|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
131464012|NCT02270944|473328259|FG000|Overall Study|Lost to Follow-up|9|||
131464013|NCT02270944|473328260|FG001|Overall Study|Lost to Follow-up|4|||
131464014|NCT02270944|473328259|FG000|Overall Study|Withdrawal by Subject|2|||
131464015|NCT02270944|473328260|FG001|Overall Study|Withdrawal by Subject|1|||
131464016|NCT01978938|473328261|FG000|Overall Study|Lost to Follow-up|12|||
131464017|NCT01978938|473328262|FG001|Overall Study|Lost to Follow-up|6|||
131464018|NCT01978938|473328261|FG000|Overall Study|Withdrawal by Subject|8|||
131464019|NCT01978938|473328262|FG001|Overall Study|Withdrawal by Subject|4|||
131464020|NCT01978938|473328261|FG000|Overall Study|Adverse Event, non-fatal|2|||
131464021|NCT01978938|473328262|FG001|Overall Study|Adverse Event, non-fatal|1|||
131464022|NCT01978938|473328261|FG000|Overall Study|Participant noncompliance|1|||
131464023|NCT01978938|473328262|FG001|Overall Study|Participant noncompliance|1|||
131464024|NCT01978938|473328261|FG000|Overall Study|Did not meet inclusion criteria|0|||
131464025|NCT01978938|473328262|FG001|Overall Study|Did not meet inclusion criteria|1|||
131464026|NCT01978938|473328261|FG000|Overall Study|Previously scheduled procedure|0|||
131464027|NCT01978938|473328262|FG001|Overall Study|Previously scheduled procedure|1|||
131464028|NCT00095147|473328263|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
131464029|NCT00095147|473328264|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
131464030|NCT00095147|473328265|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
131464031|NCT00095147|473328266|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
131464032|NCT00095147|473328267|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
131464033|NCT00095147|473328263|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
131464034|NCT00095147|473328264|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
131464035|NCT00095147|473328265|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
131464036|NCT00095147|473328266|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
131464037|NCT00095147|473328267|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
131464038|NCT00095147|473328263|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
131464039|NCT00095147|473328264|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
131464040|NCT00095147|473328265|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
131464041|NCT00095147|473328266|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
131464042|NCT00095147|473328267|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
131464043|NCT00095147|473328263|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
131464044|NCT00095147|473328264|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
131464045|NCT00095147|473328265|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
131464046|NCT00095147|473328266|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
131464047|NCT00095147|473328267|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
131464048|NCT00095147|473328263|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
131464049|NCT00095147|473328264|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
131464050|NCT00095147|473328265|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
131464051|NCT00095147|473328266|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
131464052|NCT00095147|473328267|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
131464053|NCT00095147|473328263|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
131464054|NCT00095147|473328264|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
131464055|NCT00095147|473328265|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
131464056|NCT00095147|473328266|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
131464057|NCT00095147|473328267|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
131464058|NCT00095147|473328263|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
131464059|NCT00095147|473328264|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
131464060|NCT00095147|473328265|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
131464061|NCT00095147|473328266|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
131464062|NCT00095147|473328267|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
131464063|NCT00095147|473328263|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
131464064|NCT00095147|473328264|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
131464065|NCT00095147|473328265|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
131464066|NCT00095147|473328266|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
131464067|NCT00095147|473328267|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
131464068|NCT00095147|473328263|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
131464069|NCT00095147|473328264|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
131464070|NCT00095147|473328265|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
131464071|NCT00095147|473328266|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
131464072|NCT00095147|473328267|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
131464073|NCT00095147|473328263|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
131464074|NCT00095147|473328264|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
131464075|NCT00095147|473328265|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
131464076|NCT00095147|473328266|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
131464077|NCT00095147|473328267|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
131464078|NCT00095147|473328263|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
131464079|NCT00095147|473328264|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
131464080|NCT00095147|473328265|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
131464081|NCT00095147|473328266|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
131464082|NCT00095147|473328267|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
131464083|NCT00095147|473328263|FG000|Long-term Extension Period|Death|0|||
131464084|NCT00095147|473328264|FG001|Long-term Extension Period|Death|0|||
131464085|NCT00095147|473328265|FG002|Long-term Extension Period|Death|0|||
131464086|NCT00095147|473328266|FG003|Long-term Extension Period|Death|0|||
131464087|NCT00095147|473328267|FG004|Long-term Extension Period|Death|3|||
131464088|NCT00095147|473328263|FG000|Long-term Extension Period|Adverse Event|0|||
131464089|NCT00095147|473328264|FG001|Long-term Extension Period|Adverse Event|0|||
131464090|NCT00095147|473328265|FG002|Long-term Extension Period|Adverse Event|0|||
131464091|NCT00095147|473328266|FG003|Long-term Extension Period|Adverse Event|0|||
131464092|NCT00095147|473328267|FG004|Long-term Extension Period|Adverse Event|11|||
131464093|NCT00095147|473328263|FG000|Long-term Extension Period|Lack of Efficacy|0|||
131464094|NCT00095147|473328264|FG001|Long-term Extension Period|Lack of Efficacy|0|||
131464095|NCT00095147|473328265|FG002|Long-term Extension Period|Lack of Efficacy|0|||
131464096|NCT00095147|473328266|FG003|Long-term Extension Period|Lack of Efficacy|0|||
131464097|NCT00095147|473328267|FG004|Long-term Extension Period|Lack of Efficacy|9|||
131464098|NCT00095147|473328263|FG000|Long-term Extension Period|Lost to Follow-up|0|||
131464099|NCT00095147|473328264|FG001|Long-term Extension Period|Lost to Follow-up|0|||
131464100|NCT00095147|473328265|FG002|Long-term Extension Period|Lost to Follow-up|0|||
131464101|NCT00095147|473328266|FG003|Long-term Extension Period|Lost to Follow-up|0|||
131464102|NCT00095147|473328267|FG004|Long-term Extension Period|Lost to Follow-up|6|||
131464103|NCT00095147|473328263|FG000|Long-term Extension Period|Withdrawal of consent|0|||
131464104|NCT00095147|473328264|FG001|Long-term Extension Period|Withdrawal of consent|0|||
131464105|NCT00095147|473328265|FG002|Long-term Extension Period|Withdrawal of consent|0|||
131464106|NCT00095147|473328266|FG003|Long-term Extension Period|Withdrawal of consent|0|||
131464107|NCT00095147|473328267|FG004|Long-term Extension Period|Withdrawal of consent|12|||
131464108|NCT00095147|473328263|FG000|Long-term Extension Period|Pregnancy|0|||
131464109|NCT00095147|473328264|FG001|Long-term Extension Period|Pregnancy|0|||
131464110|NCT00095147|473328265|FG002|Long-term Extension Period|Pregnancy|0|||
131464111|NCT00095147|473328266|FG003|Long-term Extension Period|Pregnancy|0|||
131464112|NCT00095147|473328267|FG004|Long-term Extension Period|Pregnancy|1|||
131464113|NCT00095147|473328263|FG000|Long-term Extension Period|No longer meets study criteria|0|||
131464114|NCT00095147|473328264|FG001|Long-term Extension Period|No longer meets study criteria|0|||
131464115|NCT00095147|473328265|FG002|Long-term Extension Period|No longer meets study criteria|0|||
131464116|NCT00095147|473328266|FG003|Long-term Extension Period|No longer meets study criteria|0|||
131464117|NCT00095147|473328267|FG004|Long-term Extension Period|No longer meets study criteria|1|||
131464118|NCT00095147|473328263|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
131464119|NCT00095147|473328264|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
131464120|NCT00095147|473328265|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
131464121|NCT00095147|473328266|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
131464122|NCT00095147|473328267|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
131464123|NCT00095147|473328263|FG000|Long-term Extension Period|Leaving country|0|||
131464124|NCT00095147|473328264|FG001|Long-term Extension Period|Leaving country|0|||
131464125|NCT00095147|473328265|FG002|Long-term Extension Period|Leaving country|0|||
131464126|NCT00095147|473328266|FG003|Long-term Extension Period|Leaving country|0|||
131464127|NCT00095147|473328267|FG004|Long-term Extension Period|Leaving country|1|||
131464128|NCT02342418|473328268|FG000|Overall Study|Adverse Event|0|||
131464129|NCT02342418|473328269|FG001|Overall Study|Adverse Event|1|||
131464130|NCT04255394|473328270|FG000|Overall Study|Death|35|||
131464131|NCT04255394|473328271|FG001|Overall Study|Death|25|||
131464132|NCT04255394|473328270|FG000|Overall Study|Device removed|2|||
131464133|NCT04255394|473328271|FG001|Overall Study|Device removed|10|||
131464134|NCT04255394|473328270|FG000|Overall Study|Withdrawal by Subject|9|||
131464135|NCT04255394|473328271|FG001|Overall Study|Withdrawal by Subject|8|||
131464136|NCT04255394|473328270|FG000|Overall Study|Screen Failure/Not treated|12|||
131464137|NCT04255394|473328271|FG001|Overall Study|Screen Failure/Not treated|8|||
131464138|NCT04255394|473328270|FG000|Overall Study|Lost to Follow-up|123|||
131464139|NCT04255394|473328271|FG001|Overall Study|Lost to Follow-up|265|||
131464140|NCT04255394|473328270|FG000|Overall Study|Adverse Event|1|||
131464141|NCT04255394|473328271|FG001|Overall Study|Adverse Event|3|||
131464142|NCT01806662|473328272|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
131464143|NCT01806662|473328273|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
131464144|NCT01806662|473328272|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
131464145|NCT01806662|473328273|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
131464146|NCT01806662|473328272|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
131464147|NCT01806662|473328273|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
131464148|NCT01806662|473328272|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
131464149|NCT01806662|473328273|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
131464150|NCT01917656|473328279|FG000|Overall Study|Adverse Event|11|||
131464151|NCT01917656|473328280|FG001|Overall Study|Adverse Event|0|||
131464152|NCT01917656|473328279|FG000|Overall Study|Withdrawal criteria|8|||
131464153|NCT01917656|473328280|FG001|Overall Study|Withdrawal criteria|14|||
131464154|NCT01917656|473328279|FG000|Overall Study|Unclassified|0|||
131464155|NCT01917656|473328280|FG001|Overall Study|Unclassified|3|||
131464156|NCT01917656|473328279|FG000|Overall Study|Withdrawal by Subject|4|||
131464157|NCT01917656|473328280|FG001|Overall Study|Withdrawal by Subject|3|||
131464158|NCT01917656|473328279|FG000|Overall Study|Lost to Follow-up|3|||
131464159|NCT01917656|473328280|FG001|Overall Study|Lost to Follow-up|4|||
131464160|NCT02081859|473328281|FG000|Overall Study|No fertilization|2|||
131464161|NCT02081859|473328282|FG001|Overall Study|No fertilization|2|||
131464162|NCT02081859|473328281|FG000|Overall Study|No sperm|1|||
131464163|NCT02081859|473328282|FG001|Overall Study|No sperm|0|||
131464164|NCT02081859|473328281|FG000|Overall Study|Unanticipated freeze all cycle|2|||
131464165|NCT02081859|473328282|FG001|Overall Study|Unanticipated freeze all cycle|6|||
131464166|NCT02081859|473328281|FG000|Overall Study|< 4 embryos|27|||
131464167|NCT02081859|473328282|FG001|Overall Study|< 4 embryos|23|||
131464168|NCT02081859|473328281|FG000|Overall Study|Other reasons|2|||
131464169|NCT02081859|473328282|FG001|Overall Study|Other reasons|0|||
131464170|NCT02015221|473328283|FG000|Overall Study|Withdrawal by Subject|8|||
131464171|NCT02015221|473328284|FG001|Overall Study|Withdrawal by Subject|6|||
131464172|NCT02015221|473328283|FG000|Overall Study|Lost to Follow-up|1|||
131464173|NCT02015221|473328284|FG001|Overall Study|Lost to Follow-up|0|||
131464174|NCT01870076|473328291|FG000|Overall Study|Withdrawal by Subject|1|||
131464175|NCT01870076|473328292|FG001|Overall Study|Withdrawal by Subject|0|||
131464176|NCT01870076|473328293|FG002|Overall Study|Withdrawal by Subject|1|||
131464177|NCT01870076|473328294|FG003|Overall Study|Withdrawal by Subject|0|||
131464178|NCT00492063|473328295|FG000|Overall Study|Death|0|||
131464179|NCT00492063|473328296|FG001|Overall Study|Death|0|||
131464180|NCT00492063|473328297|FG002|Overall Study|Death|1|||
131464181|NCT00492063|473328298|FG003|Overall Study|Death|2|||
131464182|NCT00492063|473328295|FG000|Overall Study|Withdrawal by Subject|4|||
131464183|NCT00492063|473328296|FG001|Overall Study|Withdrawal by Subject|3|||
131464184|NCT00492063|473328297|FG002|Overall Study|Withdrawal by Subject|5|||
131464185|NCT00492063|473328298|FG003|Overall Study|Withdrawal by Subject|4|||
131464186|NCT00492063|473328295|FG000|Overall Study|Lost to Follow-up|6|||
131464187|NCT00492063|473328296|FG001|Overall Study|Lost to Follow-up|11|||
131464188|NCT00492063|473328297|FG002|Overall Study|Lost to Follow-up|5|||
131464189|NCT00492063|473328298|FG003|Overall Study|Lost to Follow-up|3|||
131464190|NCT00492063|473328295|FG000|Overall Study|Protocol Violation|0|||
131464191|NCT00492063|473328296|FG001|Overall Study|Protocol Violation|0|||
131464192|NCT00492063|473328297|FG002|Overall Study|Protocol Violation|0|||
131464193|NCT00492063|473328298|FG003|Overall Study|Protocol Violation|1|||
131464194|NCT03041129|473328301|FG000|Overall Study|Withdrawal by Subject|2|||
131464195|NCT03041129|473328302|FG001|Overall Study|Withdrawal by Subject|0|||
131464196|NCT03041129|473328303|FG002|Overall Study|Withdrawal by Subject|0|||
131464197|NCT03041129|473328304|FG003|Overall Study|Withdrawal by Subject|0|||
131464198|NCT00510653|473328305|FG000|Overall Study|Withdrawal by Subject|8|||
131464199|NCT00510653|473328305|FG000|Overall Study|Monetary|3|||
131464200|NCT00821509|473328306|FG000|Overall Study|Withdrawal by Subject|12|||
131464201|NCT00821509|473328307|FG001|Overall Study|Withdrawal by Subject|11|||
131464202|NCT00821509|473328308|FG002|Overall Study|Withdrawal by Subject|34|||
131464203|NCT01425463|473330134|FG000|Overall Study|Adverse Event|5|||
131464204|NCT01425463|473330135|FG001|Overall Study|Adverse Event|7|||
131464205|NCT01425463|473330134|FG000|Overall Study|Lack of Efficacy|1|||
131464206|NCT01425463|473330135|FG001|Overall Study|Lack of Efficacy|1|||
131464207|NCT01425463|473330134|FG000|Overall Study|Protocol Violation|2|||
131464208|NCT01425463|473330135|FG001|Overall Study|Protocol Violation|2|||
131464209|NCT01425463|473330134|FG000|Overall Study|Lost to Follow-up|5|||
131464210|NCT01425463|473330135|FG001|Overall Study|Lost to Follow-up|2|||
131464211|NCT01425463|473330134|FG000|Overall Study|Withdrawal by Subject|7|||
131464212|NCT01425463|473330135|FG001|Overall Study|Withdrawal by Subject|5|||
131464213|NCT01425463|473330134|FG000|Overall Study|Unknown Reason|4|||
131464214|NCT01425463|473330135|FG001|Overall Study|Unknown Reason|7|||
131464215|NCT01444092|473330143|FG000|Overall Study|Adverse Event|8|||
131464216|NCT01444092|473330143|FG000|Overall Study|Protocol Violation|1|||
131464217|NCT01444092|473330143|FG000|Overall Study|Withdrawal by Subject|1|||
131464218|NCT01444092|473330143|FG000|Overall Study|Other Eligibility criteria|7|||
131464219|NCT01328366|473330144|FG000|Overall Study|Death|1|||
131464220|NCT01328366|473330144|FG000|Overall Study|Withdrawal by Subject|2|||
131464221|NCT01328366|473330144|FG000|Overall Study|Lost to Follow-up|7|||
131464222|NCT01122264|473330148|FG000|Overall Study|Adverse Event|6|||
131464223|NCT01122264|473330149|FG001|Overall Study|Adverse Event|5|||
131464224|NCT01122264|473330150|FG002|Overall Study|Adverse Event|7|||
131464225|NCT01122264|473330148|FG000|Overall Study|Death|1|||
131464226|NCT01122264|473330149|FG001|Overall Study|Death|0|||
131464227|NCT01122264|473330150|FG002|Overall Study|Death|0|||
131464228|NCT01122264|473330148|FG000|Overall Study|Lost to Follow-up|5|||
131464229|NCT01122264|473330149|FG001|Overall Study|Lost to Follow-up|9|||
131464230|NCT01122264|473330150|FG002|Overall Study|Lost to Follow-up|13|||
131464231|NCT01122264|473330148|FG000|Overall Study|Entry Criteria Not Met|1|||
131464232|NCT01122264|473330149|FG001|Overall Study|Entry Criteria Not Met|0|||
131464233|NCT01122264|473330150|FG002|Overall Study|Entry Criteria Not Met|0|||
131464234|NCT01122264|473330148|FG000|Overall Study|Protocol Violation|7|||
131464235|NCT01122264|473330149|FG001|Overall Study|Protocol Violation|7|||
131464236|NCT01122264|473330150|FG002|Overall Study|Protocol Violation|9|||
131464237|NCT01122264|473330148|FG000|Overall Study|Withdrawal by Subject|6|||
131464238|NCT01122264|473330149|FG001|Overall Study|Withdrawal by Subject|6|||
131464239|NCT01122264|473330150|FG002|Overall Study|Withdrawal by Subject|16|||
131464240|NCT01122264|473330148|FG000|Overall Study|Physician Decision|3|||
131464241|NCT01122264|473330149|FG001|Overall Study|Physician Decision|1|||
131464242|NCT01122264|473330150|FG002|Overall Study|Physician Decision|1|||
131464243|NCT01122264|473330148|FG000|Overall Study|Lack of Efficacy|3|||
131464244|NCT01122264|473330149|FG001|Overall Study|Lack of Efficacy|1|||
131464245|NCT01122264|473330150|FG002|Overall Study|Lack of Efficacy|1|||
131464246|NCT04585009|473330159|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
131464247|NCT04585009|473330160|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464248|NCT04585009|473330161|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464249|NCT04585009|473330162|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464250|NCT04585009|473330163|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464251|NCT04585009|473330164|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464252|NCT04585009|473330165|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464253|NCT04585009|473330166|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464254|NCT04585009|473330167|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464255|NCT04585009|473330168|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464256|NCT04585009|473330169|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464257|NCT04585009|473330170|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
131464258|NCT04585009|473330159|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
131464259|NCT04585009|473330160|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464260|NCT04585009|473330161|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464261|NCT04585009|473330162|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464262|NCT04585009|473330163|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464263|NCT04585009|473330164|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464264|NCT04585009|473330165|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464265|NCT04585009|473330166|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464266|NCT04585009|473330167|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464267|NCT04585009|473330168|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464268|NCT04585009|473330169|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464269|NCT04585009|473330170|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
131464270|NCT04585009|473330159|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464271|NCT04585009|473330160|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464272|NCT04585009|473330161|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464273|NCT04585009|473330162|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464274|NCT04585009|473330163|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464275|NCT04585009|473330164|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464276|NCT04585009|473330165|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464277|NCT04585009|473330166|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
131464278|NCT04585009|473330167|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464279|NCT04585009|473330168|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464280|NCT04585009|473330169|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464281|NCT04585009|473330170|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
131464282|NCT04585009|473330159|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464283|NCT04585009|473330160|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464284|NCT04585009|473330161|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464285|NCT04585009|473330162|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464286|NCT04585009|473330163|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
131464287|NCT04585009|473330164|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464288|NCT04585009|473330165|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464289|NCT04585009|473330166|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464290|NCT04585009|473330167|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464291|NCT04585009|473330168|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464292|NCT04585009|473330169|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464293|NCT04585009|473330170|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131464294|NCT04585009|473330159|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464295|NCT04585009|473330160|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464296|NCT04585009|473330161|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464297|NCT04585009|473330162|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464298|NCT04585009|473330163|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464299|NCT04585009|473330164|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464300|NCT04585009|473330165|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464301|NCT04585009|473330166|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464302|NCT04585009|473330167|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464303|NCT04585009|473330168|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
131464304|NCT04585009|473330169|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464305|NCT04585009|473330170|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
131464306|NCT04585009|473330159|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464307|NCT04585009|473330160|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464308|NCT04585009|473330161|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464309|NCT04585009|473330162|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464310|NCT04585009|473330163|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464311|NCT04585009|473330164|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464312|NCT04585009|473330165|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464313|NCT04585009|473330166|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464314|NCT04585009|473330167|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464315|NCT04585009|473330168|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464316|NCT04585009|473330169|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
131464317|NCT04585009|473330170|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
131464318|NCT00097981|473330171|FG000|Overall Study|Adverse Event|31|||
131464319|NCT00097981|473330172|FG001|Overall Study|Adverse Event|44|||
131464320|NCT00097981|473330171|FG000|Overall Study|Withdrawal by Subject|10|||
131464321|NCT00097981|473330172|FG001|Overall Study|Withdrawal by Subject|8|||
131464322|NCT00097981|473330171|FG000|Overall Study|Protocol Violation|1|||
131464323|NCT00097981|473330172|FG001|Overall Study|Protocol Violation|1|||
131464324|NCT00097981|473330171|FG000|Overall Study|Death|2|||
131464325|NCT00097981|473330172|FG001|Overall Study|Death|4|||
131464326|NCT00097981|473330171|FG000|Overall Study|Physician Decision|7|||
131464327|NCT00097981|473330172|FG001|Overall Study|Physician Decision|1|||
131464328|NCT00097981|473330171|FG000|Overall Study|Disease Progression|8|||
131464329|NCT00097981|473330172|FG001|Overall Study|Disease Progression|2|||
131464330|NCT00097981|473330171|FG000|Overall Study|Transplant planned|28|||
131464331|NCT00097981|473330172|FG001|Overall Study|Transplant planned|27|||
131464332|NCT00097981|473330171|FG000|Overall Study|Other|19|||
131464333|NCT00097981|473330172|FG001|Overall Study|Other|13|||
131464334|NCT01002820|473330175|FG000|Overall Study|Adverse Event|1|||
131464335|NCT01002820|473330175|FG000|Overall Study|Withdrawal by Subject|2|||
131464336|NCT01002820|473330175|FG000|Overall Study|Lack of Efficacy|1|||
131464337|NCT01673347|473330177|FG000|Overall Study|failure of allograft|7|||
131464338|NCT00895011|473330181|FG000|Overall Study|Withdrawal by Subject|14|||
131464339|NCT00895011|473330182|FG001|Overall Study|Withdrawal by Subject|7|||
131464340|NCT00895011|473330183|FG002|Overall Study|Withdrawal by Subject|2|||
131464341|NCT00895011|473330181|FG000|Overall Study|Lost to Follow-up|5|||
131464342|NCT00895011|473330182|FG001|Overall Study|Lost to Follow-up|4|||
131464343|NCT00895011|473330183|FG002|Overall Study|Lost to Follow-up|1|||
131464344|NCT00895011|473330181|FG000|Overall Study|Protocol Violation|3|||
131464345|NCT00895011|473330182|FG001|Overall Study|Protocol Violation|1|||
131464346|NCT00895011|473330183|FG002|Overall Study|Protocol Violation|3|||
131464347|NCT00895011|473330181|FG000|Overall Study|Adverse Event|1|||
131464348|NCT00895011|473330182|FG001|Overall Study|Adverse Event|2|||
131464349|NCT00895011|473330183|FG002|Overall Study|Adverse Event|2|||
131464350|NCT00895011|473330181|FG000|Overall Study|schedule conflict|1|||
131464351|NCT00895011|473330182|FG001|Overall Study|schedule conflict|0|||
131464352|NCT00895011|473330183|FG002|Overall Study|schedule conflict|0|||
131464353|NCT02661178|473330184|FG000|Part 1|Protocol Violation|1|||
131464354|NCT02661178|473330185|FG001|Part 1|Protocol Violation|0|||
131464355|NCT02661178|473330186|FG002|Part 1|Protocol Violation|0|||
131464356|NCT02661178|473330187|FG003|Part 1|Protocol Violation|0|||
131464357|NCT02661178|473330188|FG004|Part 1|Protocol Violation|0|||
131464358|NCT02661178|473330189|FG005|Part 1|Protocol Violation|0|||
131464359|NCT02661178|473330190|FG006|Part 1|Protocol Violation|0|||
131464360|NCT02661178|473330191|FG007|Part 1|Protocol Violation|0|||
131464361|NCT02661178|473330192|FG008|Part 1|Protocol Violation|0|||
131464362|NCT02661178|473330193|FG009|Part 1|Protocol Violation|0|||
131464363|NCT02661178|473330194|FG010|Part 1|Protocol Violation|0|||
131464364|NCT02661178|473330195|FG011|Part 1|Protocol Violation|0|||
131464365|NCT02661178|473330196|FG012|Part 1|Protocol Violation|0|||
131464366|NCT02661178|473330197|FG013|Part 1|Protocol Violation|0|||
131464367|NCT02661178|473330198|FG014|Part 1|Protocol Violation|0|||
131464368|NCT01369329|473330202|FG000|Overall Study|Withdrawal by Subject|8|||
131464369|NCT01369329|473330203|FG001|Overall Study|Withdrawal by Subject|6|||
131464370|NCT01369329|473330204|FG002|Overall Study|Withdrawal by Subject|10|||
131464371|NCT01369329|473330202|FG000|Overall Study|Lost to Follow-up|2|||
131464372|NCT01369329|473330203|FG001|Overall Study|Lost to Follow-up|2|||
131464373|NCT01369329|473330204|FG002|Overall Study|Lost to Follow-up|2|||
131464374|NCT01369329|473330202|FG000|Overall Study|Other|2|||
131464375|NCT01369329|473330203|FG001|Overall Study|Other|3|||
131464376|NCT01369329|473330204|FG002|Overall Study|Other|2|||
131464377|NCT01252667|473330205|FG000|Overall Study|Transplant aborted post-conditioning|0|||
131464378|NCT01252667|473330206|FG001|Overall Study|Transplant aborted post-conditioning|0|||
131464379|NCT01252667|473330207|FG002|Overall Study|Transplant aborted post-conditioning|0|||
131464380|NCT01252667|473330208|FG003|Overall Study|Transplant aborted post-conditioning|0|||
131464381|NCT01252667|473330209|FG004|Overall Study|Transplant aborted post-conditioning|0|||
131464382|NCT01252667|473330210|FG005|Overall Study|Transplant aborted post-conditioning|1|||
131464383|NCT01836276|473330211|FG000|Overall Study|Lost to Follow-up|28|||
131464384|NCT01836276|473330212|FG001|Overall Study|Lost to Follow-up|51|||
131464385|NCT00331552|473330215|FG000|Period 3: Phase II|Neurological Symptoms|1|||
131464386|NCT00331552|473330216|FG001|Period 3: Phase II|Neurological Symptoms|0|||
131464387|NCT00331552|473330215|FG000|Period 3: Phase II|Severe Nausea|1|||
131464388|NCT00331552|473330216|FG001|Period 3: Phase II|Severe Nausea|0|||
131464389|NCT01445548|473330217|FG000|Overall Study|Adverse Event|1|||
131464390|NCT01101308|473330222|FG000|Period 1|Adverse Event|2|||
131464391|NCT01101308|473330223|FG001|Period 1|Adverse Event|1|||
131464392|NCT01101308|473330222|FG000|Period 1|Positive for cotinine|1|||
131464393|NCT01101308|473330223|FG001|Period 1|Positive for cotinine|0|||
131464394|NCT02282345|473330225|FG000|Overall Study|Progression|0|||
131464395|NCT02282345|473330226|FG001|Overall Study|Progression|1|||
131464396|NCT02683746|473330227|FG000|Overall Study|Adverse Event|3|||
131464397|NCT02683746|473330228|FG001|Overall Study|Adverse Event|2|||
131464398|NCT02683746|473330227|FG000|Overall Study|Lost to Follow-up|5|||
131464399|NCT02683746|473330228|FG001|Overall Study|Lost to Follow-up|6|||
131464400|NCT02683746|473330227|FG000|Overall Study|Withdrawal by Subject|6|||
131464401|NCT02683746|473330228|FG001|Overall Study|Withdrawal by Subject|5|||
131464402|NCT02683746|473330227|FG000|Overall Study|Physician Decision|2|||
131464403|NCT02683746|473330228|FG001|Overall Study|Physician Decision|1|||
131464404|NCT04987944|473330233|FG000|Overall Study|Adverse Event|0|||
131464405|NCT04987944|473330234|FG001|Overall Study|Adverse Event|1|||
131464406|NCT04987944|473330233|FG000|Overall Study|Withdrawal by Subject|0|||
131464407|NCT04987944|473330234|FG001|Overall Study|Withdrawal by Subject|1|||
131464408|NCT01038869|473330237|FG000|Overall Study|Withdrawal by Subject|1|||
131464409|NCT01038869|473330237|FG000|Overall Study|Lost to Follow-up|6|||
131464410|NCT02412488|473330241|FG000|Overall Study|Lost to Follow-up|10|||
131464411|NCT02412488|473330241|FG000|Overall Study|Withdrawal by Subject|5|||
131464412|NCT02412488|473330241|FG000|Overall Study|Physician Decision|1|||
131464413|NCT02412488|473330241|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
131464414|NCT02412488|473330241|FG000|Overall Study|Reveal LINQ explant|1|||
131464415|NCT03222492|473330242|FG000|Overall Study|Withdrawal by Subject|0|||
131464416|NCT03222492|473330243|FG001|Overall Study|Withdrawal by Subject|0|||
131464417|NCT03222492|473330244|FG002|Overall Study|Withdrawal by Subject|1|||
131464418|NCT03222492|473330245|FG003|Overall Study|Withdrawal by Subject|0|||
131464419|NCT03222492|473330242|FG000|Overall Study|COVID-19 related|0|||
131464420|NCT03222492|473330243|FG001|Overall Study|COVID-19 related|0|||
131464421|NCT03222492|473330244|FG002|Overall Study|COVID-19 related|1|||
131464422|NCT03222492|473330245|FG003|Overall Study|COVID-19 related|0|||
131464423|NCT00029146|473330250|FG000|Overall Study|Lost to Follow-up|2|||
131464424|NCT00029146|473330251|FG001|Overall Study|Lost to Follow-up|1|||
131464425|NCT00313781|473330252|FG000|Before Crossover|Death|22|||
131464426|NCT00313781|473330253|FG001|Before Crossover|Death|8|||
131464427|NCT00313781|473330254|FG002|Before Crossover|Death|0|||
131464428|NCT00313781|473330252|FG000|Before Crossover|Lost to Follow-up|0|||
131464429|NCT00313781|473330253|FG001|Before Crossover|Lost to Follow-up|3|||
131464430|NCT00313781|473330254|FG002|Before Crossover|Lost to Follow-up|0|||
131464431|NCT00313781|473330252|FG000|Before Crossover|Withdrawal by Subject|3|||
131464432|NCT00313781|473330253|FG001|Before Crossover|Withdrawal by Subject|1|||
131464433|NCT00313781|473330254|FG002|Before Crossover|Withdrawal by Subject|0|||
131464434|NCT00313781|473330252|FG000|Before Crossover|Other|45|||
131464435|NCT00313781|473330253|FG001|Before Crossover|Other|30|||
131464436|NCT00313781|473330254|FG002|Before Crossover|Other|0|||
131464437|NCT00313781|473330252|FG000|Before Crossover|Crossover|0|||
131464438|NCT00313781|473330253|FG001|Before Crossover|Crossover|37|||
131464439|NCT00313781|473330254|FG002|Before Crossover|Crossover|0|||
131464440|NCT00313781|473330252|FG000|Before Crossover|Randomized, not treated|5|||
131464441|NCT00313781|473330253|FG001|Before Crossover|Randomized, not treated|0|||
131464442|NCT00313781|473330254|FG002|Before Crossover|Randomized, not treated|0|||
131464443|NCT00313781|473330252|FG000|After Crossover|Death|0|||
131464444|NCT00313781|473330253|FG001|After Crossover|Death|0|||
131464445|NCT00313781|473330254|FG002|After Crossover|Death|6|||
131464446|NCT00313781|473330252|FG000|After Crossover|Withdrawal by Subject|0|||
131464447|NCT00313781|473330253|FG001|After Crossover|Withdrawal by Subject|0|||
131464448|NCT00313781|473330254|FG002|After Crossover|Withdrawal by Subject|3|||
131464449|NCT00313781|473330252|FG000|After Crossover|Other|0|||
131464450|NCT00313781|473330253|FG001|After Crossover|Other|0|||
131464451|NCT00313781|473330254|FG002|After Crossover|Other|18|||
131464452|NCT00834080|473330255|FG000|Overall Study|Adverse Event|7|||
131464453|NCT00834080|473330255|FG000|Overall Study|Lost to Follow-up|7|||
131464454|NCT00834080|473330255|FG000|Overall Study|Withdrawal by Subject|5|||
131464455|NCT00834080|473330255|FG000|Overall Study|Other - Pregnancy|1|||
131464456|NCT00834080|473330255|FG000|Overall Study|Other - False positive tests of the UDS|1|||
131464457|NCT00834080|473330255|FG000|Overall Study|Physician Decision|1|||
131464458|NCT00834080|473330255|FG000|Overall Study|Subject Relocated|1|||
131464459|NCT02285062|473330266|FG000|Pre-Treatment Period|Protocol Violation|0|||
131464460|NCT02285062|473330267|FG001|Pre-Treatment Period|Protocol Violation|2|||
131464461|NCT02285062|473330266|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
131464462|NCT02285062|473330267|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131464463|NCT01947855|473330268|FG000|Overall Study|Withdrawal by Subject|1|||
131464464|NCT01947855|473330269|FG001|Overall Study|Withdrawal by Subject|0|||
131464465|NCT01947855|473330270|FG002|Overall Study|Withdrawal by Subject|0|||
131464466|NCT03011892|473330271|FG000|Double Blind (DB) Period|Adverse Event|0|||
131464467|NCT03011892|473330272|FG001|Double Blind (DB) Period|Adverse Event|1|||
131464468|NCT03011892|473330273|FG002|Double Blind (DB) Period|Adverse Event|1|||
131464469|NCT03011892|473330274|FG003|Double Blind (DB) Period|Adverse Event|0|||
131464470|NCT03011892|473330275|FG004|Double Blind (DB) Period|Adverse Event|0|||
131464471|NCT03011892|473330276|FG005|Double Blind (DB) Period|Adverse Event|0|||
131464472|NCT03011892|473330277|FG006|Double Blind (DB) Period|Adverse Event|0|||
131464473|NCT03011892|473330278|FG007|Double Blind (DB) Period|Adverse Event|0|||
131464474|NCT03011892|473330279|FG008|Double Blind (DB) Period|Adverse Event|0|||
131464475|NCT03011892|473330280|FG009|Double Blind (DB) Period|Adverse Event|0|||
131464476|NCT03011892|473330281|FG010|Double Blind (DB) Period|Adverse Event|0|||
131464477|NCT03011892|473330282|FG011|Double Blind (DB) Period|Adverse Event|0|||
131464478|NCT03011892|473330271|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
131464479|NCT03011892|473330272|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
131464480|NCT03011892|473330273|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
131464481|NCT03011892|473330274|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
131464482|NCT03011892|473330275|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
131464483|NCT03011892|473330276|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
131464484|NCT03011892|473330277|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
131464485|NCT03011892|473330278|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
131464486|NCT03011892|473330279|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
131464487|NCT03011892|473330280|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
131464488|NCT03011892|473330281|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
131464489|NCT03011892|473330282|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
131464490|NCT03011892|473330271|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
131464491|NCT03011892|473330272|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
131464492|NCT03011892|473330273|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
131464493|NCT03011892|473330274|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
131464494|NCT03011892|473330275|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
131464495|NCT03011892|473330276|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
131464496|NCT03011892|473330277|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
131464497|NCT03011892|473330278|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
131464498|NCT03011892|473330279|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
131464499|NCT03011892|473330280|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
131464500|NCT03011892|473330281|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
131464501|NCT03011892|473330282|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
131464502|NCT03011892|473330271|FG000|Double Blind (DB) Period|Other|1|||
131464503|NCT03011892|473330272|FG001|Double Blind (DB) Period|Other|1|||
131464504|NCT03011892|473330273|FG002|Double Blind (DB) Period|Other|1|||
131464505|NCT03011892|473330274|FG003|Double Blind (DB) Period|Other|0|||
131464506|NCT03011892|473330275|FG004|Double Blind (DB) Period|Other|1|||
131464507|NCT03011892|473330276|FG005|Double Blind (DB) Period|Other|0|||
131464508|NCT03011892|473330277|FG006|Double Blind (DB) Period|Other|0|||
131464509|NCT03011892|473330278|FG007|Double Blind (DB) Period|Other|0|||
131464510|NCT03011892|473330279|FG008|Double Blind (DB) Period|Other|0|||
131464511|NCT03011892|473330280|FG009|Double Blind (DB) Period|Other|0|||
131464512|NCT03011892|473330281|FG010|Double Blind (DB) Period|Other|0|||
131464513|NCT03011892|473330282|FG011|Double Blind (DB) Period|Other|0|||
131464514|NCT03011892|473330271|FG000|Double Blind (DB) Period|Physician Decision|1|||
131464515|NCT03011892|473330272|FG001|Double Blind (DB) Period|Physician Decision|0|||
131464516|NCT03011892|473330273|FG002|Double Blind (DB) Period|Physician Decision|1|||
131464517|NCT03011892|473330274|FG003|Double Blind (DB) Period|Physician Decision|0|||
131464518|NCT03011892|473330275|FG004|Double Blind (DB) Period|Physician Decision|0|||
131464519|NCT03011892|473330276|FG005|Double Blind (DB) Period|Physician Decision|0|||
131464520|NCT03011892|473330277|FG006|Double Blind (DB) Period|Physician Decision|0|||
131464521|NCT03011892|473330278|FG007|Double Blind (DB) Period|Physician Decision|0|||
131464522|NCT03011892|473330279|FG008|Double Blind (DB) Period|Physician Decision|0|||
131464523|NCT03011892|473330280|FG009|Double Blind (DB) Period|Physician Decision|0|||
131464524|NCT03011892|473330281|FG010|Double Blind (DB) Period|Physician Decision|0|||
131464525|NCT03011892|473330282|FG011|Double Blind (DB) Period|Physician Decision|0|||
131464526|NCT03011892|473330271|FG000|Double Blind (DB) Period|Pregnancy|0|||
131464527|NCT03011892|473330272|FG001|Double Blind (DB) Period|Pregnancy|0|||
131464528|NCT03011892|473330273|FG002|Double Blind (DB) Period|Pregnancy|0|||
131464529|NCT03011892|473330274|FG003|Double Blind (DB) Period|Pregnancy|0|||
131464530|NCT03011892|473330275|FG004|Double Blind (DB) Period|Pregnancy|1|||
131464531|NCT03011892|473330276|FG005|Double Blind (DB) Period|Pregnancy|0|||
131464532|NCT03011892|473330277|FG006|Double Blind (DB) Period|Pregnancy|0|||
131464533|NCT03011892|473330278|FG007|Double Blind (DB) Period|Pregnancy|0|||
131464534|NCT03011892|473330279|FG008|Double Blind (DB) Period|Pregnancy|0|||
131464535|NCT03011892|473330280|FG009|Double Blind (DB) Period|Pregnancy|0|||
131464536|NCT03011892|473330281|FG010|Double Blind (DB) Period|Pregnancy|0|||
131464537|NCT03011892|473330282|FG011|Double Blind (DB) Period|Pregnancy|0|||
131464538|NCT03011892|473330271|FG000|Double Blind (DB) Period|Protocol Violation|1|||
131464539|NCT03011892|473330272|FG001|Double Blind (DB) Period|Protocol Violation|0|||
131464540|NCT03011892|473330273|FG002|Double Blind (DB) Period|Protocol Violation|0|||
131464541|NCT03011892|473330274|FG003|Double Blind (DB) Period|Protocol Violation|0|||
131464542|NCT03011892|473330275|FG004|Double Blind (DB) Period|Protocol Violation|0|||
131464543|NCT03011892|473330276|FG005|Double Blind (DB) Period|Protocol Violation|0|||
131464544|NCT03011892|473330277|FG006|Double Blind (DB) Period|Protocol Violation|0|||
131464545|NCT03011892|473330278|FG007|Double Blind (DB) Period|Protocol Violation|0|||
131464546|NCT03011892|473330279|FG008|Double Blind (DB) Period|Protocol Violation|0|||
131464547|NCT03011892|473330280|FG009|Double Blind (DB) Period|Protocol Violation|0|||
131464548|NCT03011892|473330281|FG010|Double Blind (DB) Period|Protocol Violation|0|||
131464549|NCT03011892|473330282|FG011|Double Blind (DB) Period|Protocol Violation|0|||
131464550|NCT03011892|473330271|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
131464551|NCT03011892|473330272|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
131464552|NCT03011892|473330273|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
131464553|NCT03011892|473330274|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
131464554|NCT03011892|473330275|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
131464555|NCT03011892|473330276|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
131464556|NCT03011892|473330277|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
131464557|NCT03011892|473330278|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
131464558|NCT03011892|473330279|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
131464559|NCT03011892|473330280|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
131464560|NCT03011892|473330281|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
131464561|NCT03011892|473330282|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
131464562|NCT03011892|473330271|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
131464563|NCT03011892|473330272|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
131464564|NCT03011892|473330273|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
131464565|NCT03011892|473330274|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
131464566|NCT03011892|473330275|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
131464567|NCT03011892|473330276|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
131464568|NCT03011892|473330277|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
131464569|NCT03011892|473330278|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
131464570|NCT03011892|473330279|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
131464571|NCT03011892|473330280|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
131464572|NCT03011892|473330281|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
131464573|NCT03011892|473330282|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
131464574|NCT03011892|473330271|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
131464575|NCT03011892|473330272|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
131464576|NCT03011892|473330273|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
131464577|NCT03011892|473330274|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
131464578|NCT03011892|473330275|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
131464579|NCT03011892|473330276|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
131464580|NCT03011892|473330277|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
131464581|NCT03011892|473330278|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
131464582|NCT03011892|473330279|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
131464583|NCT03011892|473330280|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
131464584|NCT03011892|473330281|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
131464585|NCT03011892|473330282|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
131464586|NCT03011892|473330271|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
131464587|NCT03011892|473330272|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
131464588|NCT03011892|473330273|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
131464589|NCT03011892|473330274|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
131464590|NCT03011892|473330275|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
131464591|NCT03011892|473330276|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
131464592|NCT03011892|473330277|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
131464593|NCT03011892|473330278|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
131464594|NCT03011892|473330279|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
131464595|NCT03011892|473330280|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
131464596|NCT03011892|473330281|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
131464597|NCT03011892|473330282|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
131464598|NCT03011892|473330271|FG000|Open Label (OL) Period|Reason not specified|0|||
131464599|NCT03011892|473330272|FG001|Open Label (OL) Period|Reason not specified|0|||
131464600|NCT03011892|473330273|FG002|Open Label (OL) Period|Reason not specified|0|||
131464601|NCT03011892|473330274|FG003|Open Label (OL) Period|Reason not specified|0|||
131464602|NCT03011892|473330275|FG004|Open Label (OL) Period|Reason not specified|0|||
131464603|NCT03011892|473330276|FG005|Open Label (OL) Period|Reason not specified|0|||
131464604|NCT03011892|473330277|FG006|Open Label (OL) Period|Reason not specified|0|||
131464605|NCT03011892|473330278|FG007|Open Label (OL) Period|Reason not specified|1|||
131464606|NCT03011892|473330279|FG008|Open Label (OL) Period|Reason not specified|0|||
131464607|NCT03011892|473330280|FG009|Open Label (OL) Period|Reason not specified|0|||
131464608|NCT03011892|473330281|FG010|Open Label (OL) Period|Reason not specified|0|||
131464609|NCT03011892|473330282|FG011|Open Label (OL) Period|Reason not specified|0|||
131464610|NCT00608569|473330283|FG000|Overall Study|Death|4|||
131464611|NCT00608569|473330284|FG001|Overall Study|Death|3|||
131464612|NCT00608569|473330283|FG000|Overall Study|Lost to Follow-up|4|||
131464613|NCT00608569|473330284|FG001|Overall Study|Lost to Follow-up|5|||
131464614|NCT00608569|473330283|FG000|Overall Study|Withdrawal by Subject|1|||
131464615|NCT00608569|473330284|FG001|Overall Study|Withdrawal by Subject|0|||
131464616|NCT00608569|473330283|FG000|Overall Study|Adverse Event|1|||
131464617|NCT00608569|473330284|FG001|Overall Study|Adverse Event|0|||
131464618|NCT00608569|473330283|FG000|Overall Study|Unable to adhere with study requirements|0|||
131464619|NCT00608569|473330284|FG001|Overall Study|Unable to adhere with study requirements|1|||
131464620|NCT02282293|473330285|FG000|Overall Study|Lost to Follow-up|2|||
131464621|NCT02282293|473330286|FG001|Overall Study|Lost to Follow-up|2|||
131464622|NCT02282293|473330285|FG000|Overall Study|Unable to comply with study procedures|1|||
131464623|NCT02282293|473330286|FG001|Overall Study|Unable to comply with study procedures|0|||
131464624|NCT02282293|473330285|FG000|Overall Study|Moved out of study area|0|||
131464625|NCT02282293|473330286|FG001|Overall Study|Moved out of study area|1|||
131464626|NCT02312687|473330288|FG000|Overall Study|Other, Not Specified|1|||
131464627|NCT03720652|473330289|FG000|Overall Study|Withdrawal by Subject|2|||
131464628|NCT03720652|473330290|FG001|Overall Study|Withdrawal by Subject|7|||
131464629|NCT03720652|473330289|FG000|Overall Study|Lost to Follow-up|0|||
131464630|NCT03720652|473330290|FG001|Overall Study|Lost to Follow-up|4|||
131464631|NCT00348881|473330295|FG000|Overall Study|Lost to Follow-up|12|||
131464632|NCT00348881|473330296|FG001|Overall Study|Lost to Follow-up|6|||
131464633|NCT00348881|473330295|FG000|Overall Study|Withdrawal by Subject|3|||
131464634|NCT00348881|473330296|FG001|Overall Study|Withdrawal by Subject|4|||
131464635|NCT00348881|473330295|FG000|Overall Study|Adverse Event|2|||
131464636|NCT00348881|473330296|FG001|Overall Study|Adverse Event|0|||
131464637|NCT00348881|473330295|FG000|Overall Study|Serious Adverse Event|0|||
131464638|NCT00348881|473330296|FG001|Overall Study|Serious Adverse Event|2|||
131464639|NCT03658876|473332151|FG000|Overall Study|Protocol Violation|3|||
131464640|NCT03658876|473332152|FG001|Overall Study|Protocol Violation|2|||
131464641|NCT03658876|473332151|FG000|Overall Study|Withdrawal by Subject|2|||
131464642|NCT03658876|473332152|FG001|Overall Study|Withdrawal by Subject|0|||
131464643|NCT03658876|473332151|FG000|Overall Study|Death|0|||
131464644|NCT03658876|473332152|FG001|Overall Study|Death|1|||
131464645|NCT03658876|473332151|FG000|Overall Study|Intercurrent illness|6|||
131464646|NCT03658876|473332152|FG001|Overall Study|Intercurrent illness|4|||
131464647|NCT03658876|473332151|FG000|Overall Study|Transplantation/other operation|1|||
131464648|NCT03658876|473332152|FG001|Overall Study|Transplantation/other operation|5|||
131464649|NCT01330017|473332153|FG000|Overall Study|Adverse Event|0|||
131464650|NCT01330017|473332154|FG001|Overall Study|Adverse Event|1|||
131464651|NCT01330017|473332155|FG002|Overall Study|Adverse Event|1|||
131464652|NCT01330017|473332156|FG003|Overall Study|Adverse Event|4|||
131464653|NCT01330017|473332157|FG004|Overall Study|Adverse Event|0|||
131464654|NCT01330017|473332153|FG000|Overall Study|Withdrawal by Subject|0|||
131464655|NCT01330017|473332154|FG001|Overall Study|Withdrawal by Subject|0|||
131464656|NCT01330017|473332155|FG002|Overall Study|Withdrawal by Subject|1|||
131464657|NCT01330017|473332156|FG003|Overall Study|Withdrawal by Subject|0|||
131464658|NCT01330017|473332157|FG004|Overall Study|Withdrawal by Subject|1|||
131464659|NCT01330017|473332153|FG000|Overall Study|Lost to Follow-up|0|||
131464660|NCT01330017|473332154|FG001|Overall Study|Lost to Follow-up|0|||
131464661|NCT01330017|473332155|FG002|Overall Study|Lost to Follow-up|1|||
131464662|NCT01330017|473332156|FG003|Overall Study|Lost to Follow-up|0|||
131464663|NCT01330017|473332157|FG004|Overall Study|Lost to Follow-up|0|||
131464664|NCT01330017|473332153|FG000|Overall Study|Protocol Violation|0|||
131464665|NCT01330017|473332154|FG001|Overall Study|Protocol Violation|0|||
131464666|NCT01330017|473332155|FG002|Overall Study|Protocol Violation|0|||
131464667|NCT01330017|473332156|FG003|Overall Study|Protocol Violation|1|||
131464668|NCT01330017|473332157|FG004|Overall Study|Protocol Violation|0|||
131464669|NCT01330017|473332153|FG000|Overall Study|Unknown Reason|5|||
131464670|NCT01330017|473332154|FG001|Overall Study|Unknown Reason|3|||
131464671|NCT01330017|473332155|FG002|Overall Study|Unknown Reason|5|||
131464672|NCT01330017|473332156|FG003|Overall Study|Unknown Reason|7|||
131464673|NCT01330017|473332157|FG004|Overall Study|Unknown Reason|2|||
131464674|NCT01246466|473332165|FG000|Overall Study|Death|1|||
131464675|NCT01246466|473332165|FG000|Overall Study|Withdrawal by Subject|1|||
131464676|NCT00877773|473332166|FG000|Overall Study|Disease Progression|44|||
131464677|NCT03328182|473332169|FG000|Overall Study|Withdrawal by Subject|1|||
131464678|NCT03328182|473332169|FG000|Overall Study|Protocol Violation|2|||
131464679|NCT03328182|473332169|FG000|Overall Study|No Product Evaluated|1|||
131464680|NCT00730028|473332171|FG000|Overall Study|Adverse Event|23|||
131464681|NCT00730028|473332172|FG001|Overall Study|Adverse Event|26|||
131464682|NCT00730028|473332173|FG002|Overall Study|Adverse Event|16|||
131464683|NCT00730028|473332174|FG003|Overall Study|Adverse Event|20|||
131464684|NCT00730028|473332175|FG004|Overall Study|Adverse Event|43|||
131464685|NCT00730028|473332171|FG000|Overall Study|Lost to Follow-up|13|||
131464686|NCT00730028|473332172|FG001|Overall Study|Lost to Follow-up|26|||
131464687|NCT00730028|473332173|FG002|Overall Study|Lost to Follow-up|22|||
131464688|NCT00730028|473332174|FG003|Overall Study|Lost to Follow-up|26|||
131464689|NCT00730028|473332175|FG004|Overall Study|Lost to Follow-up|25|||
131464690|NCT00730028|473332171|FG000|Overall Study|Protocol Violation|6|||
131464691|NCT00730028|473332172|FG001|Overall Study|Protocol Violation|1|||
131464692|NCT00730028|473332173|FG002|Overall Study|Protocol Violation|1|||
131464693|NCT00730028|473332174|FG003|Overall Study|Protocol Violation|2|||
131464694|NCT00730028|473332175|FG004|Overall Study|Protocol Violation|0|||
131464695|NCT00730028|473332171|FG000|Overall Study|Withdrawal by Subject|9|||
131464696|NCT00730028|473332172|FG001|Overall Study|Withdrawal by Subject|5|||
131464697|NCT00730028|473332173|FG002|Overall Study|Withdrawal by Subject|4|||
131464698|NCT00730028|473332174|FG003|Overall Study|Withdrawal by Subject|5|||
131464699|NCT00730028|473332175|FG004|Overall Study|Withdrawal by Subject|9|||
131464700|NCT00730028|473332171|FG000|Overall Study|Physician Decision|3|||
131464701|NCT00730028|473332172|FG001|Overall Study|Physician Decision|3|||
131464702|NCT00730028|473332173|FG002|Overall Study|Physician Decision|2|||
131464703|NCT00730028|473332174|FG003|Overall Study|Physician Decision|3|||
131464704|NCT00730028|473332175|FG004|Overall Study|Physician Decision|2|||
131464705|NCT00730028|473332171|FG000|Overall Study|Treatment Failure|5|||
131464706|NCT00730028|473332172|FG001|Overall Study|Treatment Failure|5|||
131464707|NCT00730028|473332173|FG002|Overall Study|Treatment Failure|0|||
131464708|NCT00730028|473332174|FG003|Overall Study|Treatment Failure|0|||
131464709|NCT00730028|473332175|FG004|Overall Study|Treatment Failure|1|||
131464710|NCT00730028|473332171|FG000|Overall Study|Randomization Error|1|||
131464711|NCT00730028|473332172|FG001|Overall Study|Randomization Error|0|||
131464712|NCT00730028|473332173|FG002|Overall Study|Randomization Error|0|||
131464713|NCT00730028|473332174|FG003|Overall Study|Randomization Error|0|||
131464714|NCT00730028|473332175|FG004|Overall Study|Randomization Error|2|||
131464715|NCT01012219|473332176|FG000|Period 1|Withdrawal by Subject|1|||
131464716|NCT01012219|473332176|FG000|Period 2|Withdrawal by Subject|1|||
131464717|NCT00003590|473332179|FG000|Overall Study|Ineligible Patient|1|||
131464718|NCT00003590|473332179|FG000|Overall Study|Adverse Event|7|||
131464719|NCT00003590|473332179|FG000|Overall Study|Withdrawal by Subject|1|||
131464720|NCT00003590|473332179|FG000|Overall Study|Lack of Efficacy|11|||
131464721|NCT00003590|473332179|FG000|Overall Study|Death|1|||
131464722|NCT00003590|473332179|FG000|Overall Study|Physician Decision|1|||
131464723|NCT00883688|473332180|FG000|Overall Study|Ineligible|2|||
131464724|NCT01350544|473332181|FG000|Overall Study|Administrative Withdrawal|0|||
131464725|NCT01350544|473332182|FG001|Overall Study|Administrative Withdrawal|1|||
131464726|NCT01350544|473332181|FG000|Overall Study|Death|1|||
131464727|NCT01350544|473332182|FG001|Overall Study|Death|2|||
131464728|NCT01350544|473332181|FG000|Overall Study|Moved out of LA County|2|||
131464729|NCT01350544|473332182|FG001|Overall Study|Moved out of LA County|2|||
131464730|NCT01350544|473332181|FG000|Overall Study|Medical Issues|1|||
131464731|NCT01350544|473332182|FG001|Overall Study|Medical Issues|1|||
131464732|NCT01350544|473332181|FG000|Overall Study|Withdrawal by Subject|0|||
131464733|NCT01350544|473332182|FG001|Overall Study|Withdrawal by Subject|1|||
131464734|NCT01350544|473332181|FG000|Overall Study|Incarceration|1|||
131464735|NCT01350544|473332182|FG001|Overall Study|Incarceration|0|||
131464736|NCT01350544|473332181|FG000|Overall Study|Lost to Follow-up|18|||
131464737|NCT01350544|473332182|FG001|Overall Study|Lost to Follow-up|15|||
131464738|NCT03085914|473332183|FG000|Overall Study|Death|6|||
131464739|NCT03085914|473332184|FG001|Overall Study|Death|6|||
131464740|NCT03085914|473332185|FG002|Overall Study|Death|4|||
131464741|NCT03085914|473332186|FG003|Overall Study|Death|1|||
131464742|NCT03085914|473332187|FG004|Overall Study|Death|5|||
131464743|NCT03085914|473332188|FG005|Overall Study|Death|2|||
131464744|NCT03085914|473332189|FG006|Overall Study|Death|2|||
131464745|NCT03085914|473332183|FG000|Overall Study|Withdrawal by Subject|1|||
131464746|NCT03085914|473332184|FG001|Overall Study|Withdrawal by Subject|1|||
131464747|NCT03085914|473332185|FG002|Overall Study|Withdrawal by Subject|2|||
131464748|NCT03085914|473332186|FG003|Overall Study|Withdrawal by Subject|2|||
131464749|NCT03085914|473332187|FG004|Overall Study|Withdrawal by Subject|2|||
131464750|NCT03085914|473332188|FG005|Overall Study|Withdrawal by Subject|0|||
131464751|NCT03085914|473332189|FG006|Overall Study|Withdrawal by Subject|1|||
131464752|NCT03085914|473332183|FG000|Overall Study|Lost to Follow-up|0|||
131464753|NCT03085914|473332184|FG001|Overall Study|Lost to Follow-up|0|||
131464754|NCT03085914|473332185|FG002|Overall Study|Lost to Follow-up|1|||
131464755|NCT03085914|473332186|FG003|Overall Study|Lost to Follow-up|0|||
131464756|NCT03085914|473332187|FG004|Overall Study|Lost to Follow-up|0|||
131464757|NCT03085914|473332188|FG005|Overall Study|Lost to Follow-up|1|||
131464758|NCT03085914|473332189|FG006|Overall Study|Lost to Follow-up|1|||
131464759|NCT03085914|473332183|FG000|Overall Study|Reason was not specified,|2|||
131464760|NCT03085914|473332184|FG001|Overall Study|Reason was not specified,|2|||
131464761|NCT03085914|473332185|FG002|Overall Study|Reason was not specified,|2|||
131464762|NCT03085914|473332186|FG003|Overall Study|Reason was not specified,|3|||
131464763|NCT03085914|473332187|FG004|Overall Study|Reason was not specified,|3|||
131464764|NCT03085914|473332188|FG005|Overall Study|Reason was not specified,|3|||
131464765|NCT03085914|473332189|FG006|Overall Study|Reason was not specified,|6|||
131464766|NCT03085914|473332183|FG000|Overall Study|Progressive Disease|0|||
131464767|NCT03085914|473332184|FG001|Overall Study|Progressive Disease|0|||
131464768|NCT03085914|473332185|FG002|Overall Study|Progressive Disease|2|||
131464769|NCT03085914|473332186|FG003|Overall Study|Progressive Disease|2|||
131464770|NCT03085914|473332187|FG004|Overall Study|Progressive Disease|1|||
131464771|NCT03085914|473332188|FG005|Overall Study|Progressive Disease|1|||
131464772|NCT03085914|473332189|FG006|Overall Study|Progressive Disease|1|||
131464773|NCT03085914|473332183|FG000|Overall Study|Study Terminated by the Sponsor|0|||
131464774|NCT03085914|473332184|FG001|Overall Study|Study Terminated by the Sponsor|0|||
131464775|NCT03085914|473332185|FG002|Overall Study|Study Terminated by the Sponsor|0|||
131464776|NCT03085914|473332186|FG003|Overall Study|Study Terminated by the Sponsor|1|||
131464777|NCT03085914|473332187|FG004|Overall Study|Study Terminated by the Sponsor|2|||
131464778|NCT03085914|473332188|FG005|Overall Study|Study Terminated by the Sponsor|1|||
131464779|NCT03085914|473332189|FG006|Overall Study|Study Terminated by the Sponsor|0|||
131464780|NCT01242813|473332190|FG000|Overall Study|Lost to Follow-up|2|||
131464781|NCT04644315|473332191|FG000|Overall Study|Subject withdrawal of consent|1|||
131464782|NCT02353143|473332199|FG000|Overall Study|Withdrawal by Subject|1|||
131464783|NCT02353143|473332200|FG001|Overall Study|Withdrawal by Subject|0|||
131464784|NCT02353143|473332201|FG002|Overall Study|Withdrawal by Subject|0|||
131464785|NCT02353143|473332202|FG003|Overall Study|Withdrawal by Subject|0|||
131464786|NCT02353143|473332203|FG004|Overall Study|Withdrawal by Subject|1|||
131464787|NCT02353143|473332204|FG005|Overall Study|Withdrawal by Subject|0|||
131464788|NCT02353143|473332205|FG006|Overall Study|Withdrawal by Subject|0|||
131464789|NCT02353143|473332206|FG007|Overall Study|Withdrawal by Subject|1|||
131464790|NCT02353143|473332207|FG008|Overall Study|Withdrawal by Subject|1|||
131464791|NCT02353143|473332199|FG000|Overall Study|Lack of Efficacy|2|||
131464792|NCT02353143|473332200|FG001|Overall Study|Lack of Efficacy|1|||
131464793|NCT02353143|473332201|FG002|Overall Study|Lack of Efficacy|2|||
131464794|NCT02353143|473332202|FG003|Overall Study|Lack of Efficacy|4|||
131464795|NCT02353143|473332203|FG004|Overall Study|Lack of Efficacy|13|||
131464796|NCT02353143|473332204|FG005|Overall Study|Lack of Efficacy|2|||
131464797|NCT02353143|473332205|FG006|Overall Study|Lack of Efficacy|2|||
131464798|NCT02353143|473332206|FG007|Overall Study|Lack of Efficacy|2|||
131464799|NCT02353143|473332207|FG008|Overall Study|Lack of Efficacy|1|||
131464800|NCT02353143|473332199|FG000|Overall Study|reason not specified|1|||
131464801|NCT02353143|473332200|FG001|Overall Study|reason not specified|2|||
131464802|NCT02353143|473332201|FG002|Overall Study|reason not specified|0|||
131464803|NCT02353143|473332202|FG003|Overall Study|reason not specified|0|||
131464804|NCT02353143|473332203|FG004|Overall Study|reason not specified|6|||
131464805|NCT02353143|473332204|FG005|Overall Study|reason not specified|1|||
131464806|NCT02353143|473332205|FG006|Overall Study|reason not specified|0|||
131464807|NCT02353143|473332206|FG007|Overall Study|reason not specified|3|||
131464808|NCT02353143|473332207|FG008|Overall Study|reason not specified|1|||
131464809|NCT02353143|473332199|FG000|Overall Study|Physician Decision|0|||
131464810|NCT02353143|473332200|FG001|Overall Study|Physician Decision|4|||
131464811|NCT02353143|473332201|FG002|Overall Study|Physician Decision|2|||
131464812|NCT02353143|473332202|FG003|Overall Study|Physician Decision|3|||
131464813|NCT02353143|473332203|FG004|Overall Study|Physician Decision|4|||
131464814|NCT02353143|473332204|FG005|Overall Study|Physician Decision|0|||
131464815|NCT02353143|473332205|FG006|Overall Study|Physician Decision|1|||
131464816|NCT02353143|473332206|FG007|Overall Study|Physician Decision|2|||
131464817|NCT02353143|473332207|FG008|Overall Study|Physician Decision|0|||
131464818|NCT02353143|473332199|FG000|Overall Study|Adverse Event|0|||
131464819|NCT02353143|473332200|FG001|Overall Study|Adverse Event|0|||
131464820|NCT02353143|473332201|FG002|Overall Study|Adverse Event|1|||
131464821|NCT02353143|473332202|FG003|Overall Study|Adverse Event|0|||
131464822|NCT02353143|473332203|FG004|Overall Study|Adverse Event|1|||
131464823|NCT02353143|473332204|FG005|Overall Study|Adverse Event|1|||
131464824|NCT02353143|473332205|FG006|Overall Study|Adverse Event|0|||
131464825|NCT02353143|473332206|FG007|Overall Study|Adverse Event|0|||
131464826|NCT02353143|473332207|FG008|Overall Study|Adverse Event|0|||
131464827|NCT02353143|473332199|FG000|Overall Study|patient receiving other treatment for AML|0|||
131464828|NCT02353143|473332200|FG001|Overall Study|patient receiving other treatment for AML|0|||
131464829|NCT02353143|473332201|FG002|Overall Study|patient receiving other treatment for AML|1|||
131464830|NCT02353143|473332202|FG003|Overall Study|patient receiving other treatment for AML|0|||
131464831|NCT02353143|473332203|FG004|Overall Study|patient receiving other treatment for AML|0|||
131464832|NCT02353143|473332204|FG005|Overall Study|patient receiving other treatment for AML|0|||
131464833|NCT02353143|473332205|FG006|Overall Study|patient receiving other treatment for AML|0|||
131464834|NCT02353143|473332206|FG007|Overall Study|patient receiving other treatment for AML|0|||
131464835|NCT02353143|473332207|FG008|Overall Study|patient receiving other treatment for AML|0|||
131464836|NCT02353143|473332199|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
131464837|NCT02353143|473332200|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
131464838|NCT02353143|473332201|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
131464839|NCT02353143|473332202|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
131464840|NCT02353143|473332203|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
131464841|NCT02353143|473332204|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
131464842|NCT02353143|473332205|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
131464843|NCT02353143|473332206|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
131464844|NCT02353143|473332207|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
131464845|NCT02946931|473332216|FG000|Overall Study|Did not require collection of CRFs|588|||
131464846|NCT02946931|473332216|FG000|Overall Study|Other than listed|37|||
131464847|NCT02946931|473332216|FG000|Overall Study|Discharge from hospital|118|||
131464848|NCT02946931|473332216|FG000|Overall Study|Adverse Event|81|||
131464849|NCT02946931|473332216|FG000|Overall Study|CRFs not valid|1|||
131464850|NCT02946931|473332216|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
131464851|NCT03339297|473332217|FG000|Overall Study|Relapse of Hematologic Disease|1|||
131464852|NCT03339297|473332218|FG001|Overall Study|Relapse of Hematologic Disease|0|||
131464853|NCT03339297|473332217|FG000|Overall Study|Death|10|||
131464854|NCT03339297|473332218|FG001|Overall Study|Death|7|||
131464855|NCT03339297|473332217|FG000|Overall Study|Hepatic Candidosis|1|||
131464856|NCT03339297|473332218|FG001|Overall Study|Hepatic Candidosis|0|||
131464857|NCT03339297|473332217|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
131464858|NCT03339297|473332218|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
131464859|NCT03339297|473332217|FG000|Overall Study|Consent Withdrawn by Participant|3|||
131464860|NCT03339297|473332218|FG001|Overall Study|Consent Withdrawn by Participant|3|||
131464861|NCT03339297|473332217|FG000|Overall Study|Disease Relapse|2|||
131464862|NCT03339297|473332218|FG001|Overall Study|Disease Relapse|0|||
131464863|NCT03339297|473332217|FG000|Overall Study|Physician Decision|1|||
131464864|NCT03339297|473332218|FG001|Overall Study|Physician Decision|1|||
131464865|NCT03339297|473332217|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
131464866|NCT03339297|473332218|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
131464867|NCT03339297|473332217|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
131464868|NCT03339297|473332218|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
131464869|NCT03339297|473332217|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
131464870|NCT03339297|473332218|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
131464871|NCT03339297|473332217|FG000|Overall Study|Adverse Event, Non-fatal|1|||
131464872|NCT03339297|473332218|FG001|Overall Study|Adverse Event, Non-fatal|0|||
131464873|NCT03339297|473332217|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
131464874|NCT03339297|473332218|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
131464875|NCT03339297|473332217|FG000|Overall Study|Patient Was Not Eligible|1|||
131464876|NCT03339297|473332218|FG001|Overall Study|Patient Was Not Eligible|0|||
131464877|NCT02213133|473332222|FG000|Overall Study|Participant discontinued study therapy|2|||
131464878|NCT02213133|473332223|FG001|Overall Study|Participant discontinued study therapy|0|||
131464879|NCT02213133|473332224|FG002|Overall Study|Participant discontinued study therapy|0|||
131464880|NCT02213133|473332222|FG000|Overall Study|Participant withdrew informed consent|2|||
131464881|NCT02213133|473332223|FG001|Overall Study|Participant withdrew informed consent|1|||
131464882|NCT02213133|473332224|FG002|Overall Study|Participant withdrew informed consent|2|||
131464883|NCT02213133|473332222|FG000|Overall Study|Disease progression|11|||
131464884|NCT02213133|473332223|FG001|Overall Study|Disease progression|2|||
131464885|NCT02213133|473332224|FG002|Overall Study|Disease progression|0|||
131464886|NCT02213133|473332222|FG000|Overall Study|Adverse Event (AE)|1|||
131464887|NCT02213133|473332223|FG001|Overall Study|Adverse Event (AE)|0|||
131464888|NCT02213133|473332224|FG002|Overall Study|Adverse Event (AE)|0|||
131464889|NCT02213133|473332222|FG000|Overall Study|Death|16|||
131464890|NCT02213133|473332223|FG001|Overall Study|Death|2|||
131464891|NCT02213133|473332224|FG002|Overall Study|Death|1|||
131464892|NCT02213133|473332222|FG000|Overall Study|Other|5|||
131464893|NCT02213133|473332223|FG001|Overall Study|Other|0|||
131464894|NCT02213133|473332224|FG002|Overall Study|Other|0|||
131464895|NCT03316911|473332227|FG000|Overall Study|Lost to Follow-up|33|||
131464896|NCT03316911|473332228|FG001|Overall Study|Lost to Follow-up|29|||
131464897|NCT01119937|473332229|FG000|Overall Study|Adverse Event|11|||
131464898|NCT01119937|473332230|FG001|Overall Study|Adverse Event|5|||
131464899|NCT01119937|473332229|FG000|Overall Study|Protocol deviation|3|||
131464900|NCT01119937|473332230|FG001|Overall Study|Protocol deviation|1|||
131464901|NCT01119937|473332229|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
131464902|NCT01119937|473332230|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131464903|NCT01119937|473332229|FG000|Overall Study|Withdrawal by Subject|2|||
131464904|NCT01119937|473332230|FG001|Overall Study|Withdrawal by Subject|1|||
131464905|NCT04740905|473332233|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
131464906|NCT04740905|473332234|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
131464907|NCT04740905|473332233|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
131464908|NCT04740905|473332234|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
131464909|NCT04740905|473332233|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
131464910|NCT04740905|473332234|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
131464911|NCT04740905|473332233|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
131464912|NCT04740905|473332234|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
131464913|NCT04740905|473332233|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
131464914|NCT04740905|473332234|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
131464915|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
131464916|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
131464917|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
131464918|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
131464919|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
131464920|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
131464921|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
131464922|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
131464923|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
131464924|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
131464925|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
131464926|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
131464927|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
131464928|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
131464929|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
131464930|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
131464931|NCT04740905|473332233|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
131464932|NCT04740905|473332234|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
131464933|NCT03051620|473332235|FG000|Overall Study|Lost to Follow-up|6|||
131464934|NCT03051620|473332235|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
131464935|NCT00393510|473332236|FG000|Overall Study|Physician Decision|3|||
131464936|NCT00393510|473332237|FG001|Overall Study|Physician Decision|9|||
131464937|NCT00770146|473332240|FG000|Treatment Period|Withdrawal by Subject|6|||
131464938|NCT00770146|473332241|FG001|Treatment Period|Withdrawal by Subject|13|||
131464939|NCT00770146|473332240|FG000|Treatment Period|Adverse Event|2|||
131464940|NCT00770146|473332241|FG001|Treatment Period|Adverse Event|26|||
131464941|NCT00770146|473332240|FG000|Treatment Period|Other|1|||
131464942|NCT00770146|473332241|FG001|Treatment Period|Other|5|||
131464943|NCT00770146|473332240|FG000|Treatment Period|Protocol non-compliance|0|||
131464944|NCT00770146|473332241|FG001|Treatment Period|Protocol non-compliance|1|||
131464945|NCT00770146|473332240|FG000|Follow-up Period|Withdrawal by Subject|7|||
131464946|NCT00770146|473332241|FG001|Follow-up Period|Withdrawal by Subject|13|||
131464947|NCT00770146|473332240|FG000|Follow-up Period|Adverse Event|0|||
131464948|NCT00770146|473332241|FG001|Follow-up Period|Adverse Event|2|||
131464949|NCT00770146|473332240|FG000|Follow-up Period|Other|4|||
131464950|NCT00770146|473332241|FG001|Follow-up Period|Other|5|||
131464951|NCT00816023|473332245|FG000|Overall Study|Lost to Follow-up|1|||
131464952|NCT00816023|473332246|FG001|Overall Study|Lost to Follow-up|1|||
131464953|NCT00816023|473332247|FG002|Overall Study|Lost to Follow-up|0|||
131464954|NCT00816023|473332248|FG003|Overall Study|Lost to Follow-up|0|||
131464955|NCT00816023|473332245|FG000|Overall Study|Withdrawal by Subject|1|||
131464956|NCT00816023|473332246|FG001|Overall Study|Withdrawal by Subject|0|||
131464957|NCT00816023|473332247|FG002|Overall Study|Withdrawal by Subject|0|||
131464958|NCT00816023|473332248|FG003|Overall Study|Withdrawal by Subject|0|||
131464959|NCT00816023|473332245|FG000|Overall Study|Physician Decision|0|||
131464960|NCT00816023|473332246|FG001|Overall Study|Physician Decision|0|||
131464961|NCT00816023|473332247|FG002|Overall Study|Physician Decision|1|||
131464962|NCT00816023|473332248|FG003|Overall Study|Physician Decision|0|||
131464963|NCT00816023|473332245|FG000|Overall Study|assessments complete prior to window|1|||
131464964|NCT00816023|473332246|FG001|Overall Study|assessments complete prior to window|1|||
131464965|NCT00816023|473332247|FG002|Overall Study|assessments complete prior to window|2|||
131464966|NCT00816023|473332248|FG003|Overall Study|assessments complete prior to window|1|||
131464967|NCT00816023|473332245|FG000|Overall Study|Randomized Not Treated|6|||
131464968|NCT00816023|473332246|FG001|Overall Study|Randomized Not Treated|4|||
131464969|NCT00816023|473332247|FG002|Overall Study|Randomized Not Treated|6|||
131464970|NCT00816023|473332248|FG003|Overall Study|Randomized Not Treated|11|||
131464971|NCT01525901|473332249|FG000|Period 2: 12 Weeks|Adverse Event|0|||
131464972|NCT01525901|473332250|FG001|Period 2: 12 Weeks|Adverse Event|1|||
131464973|NCT01525901|473332251|FG002|Period 2: 12 Weeks|Adverse Event|0|||
131464974|NCT01525901|473332252|FG003|Period 2: 12 Weeks|Adverse Event|0|||
131464975|NCT05027971|473332257|FG000|Overall Study|Physician Decision|7|||
131464976|NCT05027971|473332258|FG001|Overall Study|Physician Decision|3|||
131464977|NCT05027971|473332257|FG000|Overall Study|Lost to Follow-up|1|||
131464978|NCT05027971|473332258|FG001|Overall Study|Lost to Follow-up|1|||
131464979|NCT05027971|473332257|FG000|Overall Study|Withdrawal by Subject|0|||
131464980|NCT05027971|473332258|FG001|Overall Study|Withdrawal by Subject|2|||
131464981|NCT05027971|473332257|FG000|Overall Study|Non-study fiber used.|0|||
131464982|NCT05027971|473332258|FG001|Overall Study|Non-study fiber used.|1|||
131464983|NCT05027971|473332257|FG000|Overall Study|Protocol Violation|0|||
131464984|NCT05027971|473332258|FG001|Overall Study|Protocol Violation|2|||
131464985|NCT02486627|473332259|FG000|Overall Study|Death|1|||
131464986|NCT02486627|473332260|FG001|Overall Study|Death|0|||
131464987|NCT02486627|473332259|FG000|Overall Study|Other Unspecified|0|||
131464988|NCT02486627|473332260|FG001|Overall Study|Other Unspecified|2|||
131464989|NCT02486627|473332259|FG000|Overall Study|Consent Withdrawn by Participant|4|||
131464990|NCT02486627|473332260|FG001|Overall Study|Consent Withdrawn by Participant|3|||
131464991|NCT02486627|473332259|FG000|Overall Study|Significant Participant Noncompliance|1|||
131464992|NCT02486627|473332260|FG001|Overall Study|Significant Participant Noncompliance|1|||
131464993|NCT02486627|473332259|FG000|Overall Study|Lost to Follow-up|1|||
131464994|NCT02486627|473332260|FG001|Overall Study|Lost to Follow-up|3|||
131464995|NCT01073462|473332262|FG000|Overall Study|Death|14|||
131464996|NCT01073462|473332262|FG000|Overall Study|Kidney transplant|10|||
131464997|NCT01073462|473332262|FG000|Overall Study|Low parathyroid hormone levels|8|||
131464998|NCT01073462|473332262|FG000|Overall Study|Serious adverse event|2|||
131464999|NCT01073462|473332262|FG000|Overall Study|Lost to Follow-up|7|||
131465000|NCT01238588|473332265|FG000|Overall Study|Withdrawal by Subject|1|||
131465001|NCT01238588|473332265|FG000|Overall Study|Physician Decision|2|||
131465002|NCT05395091|473332266|FG000|Baseline to Month 12|Adverse Event|7|||
131465003|NCT05395091|473332267|FG001|Baseline to Month 12|Adverse Event|2|||
131465004|NCT05395091|473332268|FG002|Baseline to Month 12|Adverse Event|0|||
131465005|NCT05395091|473332266|FG000|Baseline to Month 12|Death|3|||
131465006|NCT05395091|473332267|FG001|Baseline to Month 12|Death|1|||
131465007|NCT05395091|473332268|FG002|Baseline to Month 12|Death|0|||
131465008|NCT05395091|473332266|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
131465009|NCT05395091|473332267|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
131465010|NCT05395091|473332268|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
131465011|NCT05395091|473332266|FG000|Baseline to Month 12|Protocol Violation|2|||
131465012|NCT05395091|473332267|FG001|Baseline to Month 12|Protocol Violation|3|||
131465013|NCT05395091|473332268|FG002|Baseline to Month 12|Protocol Violation|0|||
131465014|NCT05395091|473332266|FG000|Baseline to Month 12|Physician Decision|1|||
131465015|NCT05395091|473332267|FG001|Baseline to Month 12|Physician Decision|0|||
131465016|NCT05395091|473332268|FG002|Baseline to Month 12|Physician Decision|0|||
131465017|NCT05395091|473332266|FG000|Month 12 to Month 18|Death|1|||
131465018|NCT05395091|473332267|FG001|Month 12 to Month 18|Death|0|||
131465019|NCT05395091|473332268|FG002|Month 12 to Month 18|Death|0|||
131465020|NCT05395091|473332266|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
131465021|NCT05395091|473332267|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
131465022|NCT05395091|473332268|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
131465023|NCT05395091|473332266|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
131465024|NCT05395091|473332267|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
131465025|NCT05395091|473332268|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
131465026|NCT05395091|473332266|FG000|Month 12 to Month 18|Other reasons|0|||
131465027|NCT05395091|473332267|FG001|Month 12 to Month 18|Other reasons|0|||
131465028|NCT05395091|473332268|FG002|Month 12 to Month 18|Other reasons|1|||
131465029|NCT03554486|473332269|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
131465030|NCT03554486|473332270|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
131465031|NCT03554486|473332271|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
131465032|NCT03554486|473332269|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
131465033|NCT03554486|473332270|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
131465034|NCT03554486|473332271|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
131465035|NCT03554486|473332269|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131465036|NCT03554486|473332270|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
131465037|NCT03554486|473332271|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
131465038|NCT01509053|473332272|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
131465039|NCT01509053|473332272|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
131465040|NCT01509053|473332272|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
131465041|NCT01509053|473332272|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
131465042|NCT01509053|473332272|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
131465043|NCT01509053|473332272|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
131465044|NCT01915303|473332273|FG000|Core Phase|Adverse Event|7|||
131465045|NCT01915303|473332273|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
131465046|NCT01915303|473332273|FG000|Core Phase|Death|2|||
131465047|NCT01915303|473332273|FG000|Core Phase|Protocol Violation|2|||
131465048|NCT01915303|473332273|FG000|Core Phase|Abnormal lab value|1|||
131465049|NCT01915303|473332273|FG000|Core Phase|Withdrawal by Subject|1|||
131465050|NCT01915303|473332273|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
131465051|NCT01915303|473332273|FG000|Extension Phase|Withdrawal by Subject|4|||
131465052|NCT01915303|473332273|FG000|Extension Phase|Adverse Event|3|||
131465053|NCT01915303|473332273|FG000|Extension Phase|Death|1|||
131465054|NCT01915303|473332273|FG000|Extension Phase|Protocol Violation|1|||
131465055|NCT02925338|473332274|FG000|Overall Study|Death|0|||
131465056|NCT02925338|473332275|FG001|Overall Study|Death|2|||
131465057|NCT02925338|473332276|FG002|Overall Study|Death|1|||
131465058|NCT02925338|473332277|FG003|Overall Study|Death|0|||
131465059|NCT02925338|473332278|FG004|Overall Study|Death|0|||
131465060|NCT02925338|473332274|FG000|Overall Study|Lost to Follow-up|30|||
131465061|NCT02925338|473332275|FG001|Overall Study|Lost to Follow-up|10|||
131465062|NCT02925338|473332276|FG002|Overall Study|Lost to Follow-up|1|||
131465063|NCT02925338|473332277|FG003|Overall Study|Lost to Follow-up|16|||
131465064|NCT02925338|473332278|FG004|Overall Study|Lost to Follow-up|3|||
131465065|NCT02925338|473332274|FG000|Overall Study|Withdrawal by Subject|3|||
131465066|NCT02925338|473332275|FG001|Overall Study|Withdrawal by Subject|0|||
131465067|NCT02925338|473332276|FG002|Overall Study|Withdrawal by Subject|3|||
131465068|NCT02925338|473332277|FG003|Overall Study|Withdrawal by Subject|2|||
131465069|NCT02925338|473332278|FG004|Overall Study|Withdrawal by Subject|2|||
131465070|NCT02925338|473332274|FG000|Overall Study|Missing|38|||
131465071|NCT02925338|473332275|FG001|Overall Study|Missing|27|||
131465072|NCT02925338|473332276|FG002|Overall Study|Missing|0|||
131465073|NCT02925338|473332277|FG003|Overall Study|Missing|3|||
131465074|NCT02925338|473332278|FG004|Overall Study|Missing|2|||
131465075|NCT02925338|473332274|FG000|Overall Study|Participant's Decision|11|||
131465076|NCT02925338|473332275|FG001|Overall Study|Participant's Decision|7|||
131465077|NCT02925338|473332276|FG002|Overall Study|Participant's Decision|3|||
131465078|NCT02925338|473332277|FG003|Overall Study|Participant's Decision|8|||
131465079|NCT02925338|473332278|FG004|Overall Study|Participant's Decision|1|||
131465080|NCT02925338|473332274|FG000|Overall Study|Treatment Discontinuation|144|||
131465081|NCT02925338|473332275|FG001|Overall Study|Treatment Discontinuation|65|||
131465082|NCT02925338|473332276|FG002|Overall Study|Treatment Discontinuation|56|||
131465083|NCT02925338|473332277|FG003|Overall Study|Treatment Discontinuation|131|||
131465084|NCT02925338|473332278|FG004|Overall Study|Treatment Discontinuation|22|||
131465085|NCT00636363|473332279|FG000|Overall Study|Conjunctivitis|0|||
131465086|NCT00636363|473332280|FG001|Overall Study|Conjunctivitis|0|||
131465087|NCT00636363|473332281|FG002|Overall Study|Conjunctivitis|1|||
131465088|NCT00636363|473332279|FG000|Overall Study|Adverse Event|0|||
131465089|NCT00636363|473332280|FG001|Overall Study|Adverse Event|0|||
131465090|NCT00636363|473332281|FG002|Overall Study|Adverse Event|1|||
131465091|NCT00636363|473332279|FG000|Overall Study|Positive slit lamp finding|0|||
131465092|NCT00636363|473332280|FG001|Overall Study|Positive slit lamp finding|2|||
131465093|NCT00636363|473332281|FG002|Overall Study|Positive slit lamp finding|1|||
131465094|NCT00636363|473332279|FG000|Overall Study|Study related symptoms/complaints|8|||
131465095|NCT00636363|473332280|FG001|Overall Study|Study related symptoms/complaints|7|||
131465096|NCT00636363|473332281|FG002|Overall Study|Study related symptoms/complaints|4|||
131465097|NCT00636363|473332279|FG000|Overall Study|Met ineligibility criteria|0|||
131465098|NCT00636363|473332280|FG001|Overall Study|Met ineligibility criteria|0|||
131465099|NCT00636363|473332281|FG002|Overall Study|Met ineligibility criteria|3|||
131465100|NCT00636363|473332279|FG000|Overall Study|Missed > 1 visit|0|||
131465101|NCT00636363|473332280|FG001|Overall Study|Missed > 1 visit|1|||
131465102|NCT00636363|473332281|FG002|Overall Study|Missed > 1 visit|3|||
131465103|NCT00636363|473332279|FG000|Overall Study|Lack of motivation|1|||
131465104|NCT00636363|473332280|FG001|Overall Study|Lack of motivation|0|||
131465105|NCT00636363|473332281|FG002|Overall Study|Lack of motivation|1|||
131465106|NCT00636363|473332279|FG000|Overall Study|Protocol Violation|0|||
131465107|NCT00636363|473332280|FG001|Overall Study|Protocol Violation|3|||
131465108|NCT00636363|473332281|FG002|Overall Study|Protocol Violation|0|||
131465109|NCT00636363|473332279|FG000|Overall Study|Lost to Follow-up|3|||
131465110|NCT00636363|473332280|FG001|Overall Study|Lost to Follow-up|4|||
131465111|NCT00636363|473332281|FG002|Overall Study|Lost to Follow-up|2|||
131465112|NCT00636363|473332279|FG000|Overall Study|Withdrawal by Subject|1|||
131465113|NCT00636363|473332280|FG001|Overall Study|Withdrawal by Subject|3|||
131465114|NCT00636363|473332281|FG002|Overall Study|Withdrawal by Subject|2|||
131465115|NCT00796991|473332282|FG000|Overall Study|Adverse Event|0|||
131465116|NCT00796991|473332283|FG001|Overall Study|Adverse Event|0|||
131465117|NCT00796991|473332284|FG002|Overall Study|Adverse Event|1|||
131465118|NCT00796991|473332282|FG000|Overall Study|Death|2|||
131465119|NCT00796991|473332283|FG001|Overall Study|Death|0|||
131465120|NCT00796991|473332284|FG002|Overall Study|Death|0|||
131465121|NCT00796991|473332282|FG000|Overall Study|Disease Progression|10|||
131465122|NCT00796991|473332283|FG001|Overall Study|Disease Progression|9|||
131465123|NCT00796991|473332284|FG002|Overall Study|Disease Progression|7|||
131465124|NCT00796991|473332282|FG000|Overall Study|Study Drug Toxicity|3|||
131465125|NCT00796991|473332283|FG001|Overall Study|Study Drug Toxicity|3|||
131465126|NCT00796991|473332284|FG002|Overall Study|Study Drug Toxicity|5|||
131465127|NCT00796991|473332282|FG000|Overall Study|Withdrawal by Subject|0|||
131465128|NCT00796991|473332283|FG001|Overall Study|Withdrawal by Subject|0|||
131465129|NCT00796991|473332284|FG002|Overall Study|Withdrawal by Subject|1|||
131465130|NCT00280748|473332285|FG000|Overall Study|Decline in performance|3|||
131465131|NCT00280748|473332285|FG000|Overall Study|Extra-cranial disease progression|1|||
131465132|NCT03567343|473332286|FG000|Overall Study|Lost to Follow-up|2|||
131465133|NCT03567343|473332287|FG001|Overall Study|Lost to Follow-up|1|||
131465134|NCT03567343|473332286|FG000|Overall Study|No longer eligible|2|||
131465135|NCT03567343|473332287|FG001|Overall Study|No longer eligible|1|||
131465136|NCT03567343|473332286|FG000|Overall Study|Adverse Event|1|||
131465137|NCT03567343|473332287|FG001|Overall Study|Adverse Event|0|||
131465138|NCT03567343|473332286|FG000|Overall Study|Protocol Violation|1|||
131465139|NCT03567343|473332287|FG001|Overall Study|Protocol Violation|1|||
131465140|NCT01433250|473332288|FG000|Overall Study|Protocol Violation|0|||
131465141|NCT01433250|473332289|FG001|Overall Study|Protocol Violation|1|||
131465142|NCT01433250|473332288|FG000|Overall Study|Withdrawal by Subject|3|||
131465143|NCT01433250|473332289|FG001|Overall Study|Withdrawal by Subject|2|||
131465144|NCT00321646|473332292|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
131465145|NCT00321646|473332292|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
131465146|NCT00321646|473332292|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
131465147|NCT00392379|473332293|FG000|Overall Study|Withdrawal by Subject|17|||
131465148|NCT00392379|473332294|FG001|Overall Study|Withdrawal by Subject|28|||
131465149|NCT00392379|473332293|FG000|Overall Study|Lost to Follow-up|4|||
131465150|NCT00392379|473332294|FG001|Overall Study|Lost to Follow-up|9|||
131465151|NCT00392379|473332293|FG000|Overall Study|Adverse Event|1|||
131465152|NCT00392379|473332294|FG001|Overall Study|Adverse Event|1|||
131465153|NCT02730793|473332295|FG000|Overall Study|Physician Decision|0|||
131465154|NCT02730793|473332296|FG001|Overall Study|Physician Decision|1|||
131465155|NCT02730793|473332295|FG000|Overall Study|Withdrawal by Subject|0|||
131465156|NCT02730793|473332296|FG001|Overall Study|Withdrawal by Subject|1|||
131465157|NCT02365233|473332297|FG000|Overall Study|IRB withheld the data|1|||
131465158|NCT02365233|473332298|FG001|Overall Study|IRB withheld the data|2|||
131465159|NCT02365233|473332299|FG002|Overall Study|IRB withheld the data|2|||
131465160|NCT00534313|473332301|FG000|Short-term Period|Adverse Event|1|||
131465161|NCT00534313|473332302|FG001|Short-term Period|Adverse Event|2|||
131465162|NCT00534313|473332303|FG002|Short-term Period|Adverse Event|1|||
131465163|NCT00534313|473332304|FG003|Short-term Period|Adverse Event|3|||
131465164|NCT00534313|473332301|FG000|Short-term Period|Lack of Efficacy|3|||
131465165|NCT00534313|473332302|FG001|Short-term Period|Lack of Efficacy|4|||
131465166|NCT00534313|473332303|FG002|Short-term Period|Lack of Efficacy|0|||
131465167|NCT00534313|473332304|FG003|Short-term Period|Lack of Efficacy|3|||
131465168|NCT00534313|473332301|FG000|Short-term Period|Participant not meeting study criteria|0|||
131465169|NCT00534313|473332302|FG001|Short-term Period|Participant not meeting study criteria|0|||
131465170|NCT00534313|473332303|FG002|Short-term Period|Participant not meeting study criteria|0|||
131465171|NCT00534313|473332304|FG003|Short-term Period|Participant not meeting study criteria|1|||
131465172|NCT00534313|473332301|FG000|Short-term Period|Participant withdrew consent|2|||
131465173|NCT00534313|473332302|FG001|Short-term Period|Participant withdrew consent|0|||
131465174|NCT00534313|473332303|FG002|Short-term Period|Participant withdrew consent|0|||
131465175|NCT00534313|473332304|FG003|Short-term Period|Participant withdrew consent|2|||
131465176|NCT00534313|473332301|FG000|Short-term Period|Pregnancy|0|||
131465177|NCT00534313|473332302|FG001|Short-term Period|Pregnancy|0|||
131465178|NCT00534313|473332303|FG002|Short-term Period|Pregnancy|1|||
131465179|NCT00534313|473332304|FG003|Short-term Period|Pregnancy|0|||
131465180|NCT00534313|473332301|FG000|Long-term Period|Adverse Event|2|||
131465181|NCT00534313|473332302|FG001|Long-term Period|Adverse Event|1|||
131465182|NCT00534313|473332303|FG002|Long-term Period|Adverse Event|0|||
131465183|NCT00534313|473332304|FG003|Long-term Period|Adverse Event|1|||
131465184|NCT00534313|473332301|FG000|Long-term Period|Lack of Efficacy|14|||
131465185|NCT00534313|473332302|FG001|Long-term Period|Lack of Efficacy|10|||
131465186|NCT00534313|473332303|FG002|Long-term Period|Lack of Efficacy|14|||
131465187|NCT00534313|473332304|FG003|Long-term Period|Lack of Efficacy|12|||
131465188|NCT00534313|473332301|FG000|Long-term Period|Lost to Follow-up|1|||
131465189|NCT00534313|473332302|FG001|Long-term Period|Lost to Follow-up|2|||
131465190|NCT00534313|473332303|FG002|Long-term Period|Lost to Follow-up|0|||
131465191|NCT00534313|473332304|FG003|Long-term Period|Lost to Follow-up|0|||
131465192|NCT00534313|473332301|FG000|Long-term Period|Withdrawal by Subject|2|||
131465193|NCT00534313|473332302|FG001|Long-term Period|Withdrawal by Subject|2|||
131465194|NCT00534313|473332303|FG002|Long-term Period|Withdrawal by Subject|0|||
131465195|NCT00534313|473332304|FG003|Long-term Period|Withdrawal by Subject|0|||
131465196|NCT00534313|473332301|FG000|Long-term Period|No longer meets study criteria|0|||
131465197|NCT00534313|473332302|FG001|Long-term Period|No longer meets study criteria|1|||
131465198|NCT00534313|473332303|FG002|Long-term Period|No longer meets study criteria|0|||
131465199|NCT00534313|473332304|FG003|Long-term Period|No longer meets study criteria|0|||
131465200|NCT00534313|473332301|FG000|Long-term Period|Poor compliance/noncompliance|0|||
131465201|NCT00534313|473332302|FG001|Long-term Period|Poor compliance/noncompliance|1|||
131465202|NCT00534313|473332303|FG002|Long-term Period|Poor compliance/noncompliance|1|||
131465203|NCT00534313|473332304|FG003|Long-term Period|Poor compliance/noncompliance|0|||
131465204|NCT00534313|473332301|FG000|Long-term Period|Administrative reason by sponsor|17|||
131465205|NCT00534313|473332302|FG001|Long-term Period|Administrative reason by sponsor|15|||
131465206|NCT00534313|473332303|FG002|Long-term Period|Administrative reason by sponsor|26|||
131465207|NCT00534313|473332304|FG003|Long-term Period|Administrative reason by sponsor|18|||
131465208|NCT00534313|473332301|FG000|Long-term Period|Other|1|||
131465209|NCT00534313|473332302|FG001|Long-term Period|Other|2|||
131465210|NCT00534313|473332303|FG002|Long-term Period|Other|2|||
131465211|NCT00534313|473332304|FG003|Long-term Period|Other|2|||
131465212|NCT00384111|473332305|FG000|Overall Study|Disease Progression|3|||
131465213|NCT00384111|473332305|FG000|Overall Study|Adverse Event|1|||
131465214|NCT00384111|473332305|FG000|Overall Study|Investigator Decision|3|||
131465215|NCT00384111|473332305|FG000|Overall Study|Study Terminated by the Sponsor|19|||
131465216|NCT01454778|473332306|FG000|Overall Study|Lost to Follow-up|2|||
131465217|NCT01454778|473332306|FG000|Overall Study|Death|1|||
131465218|NCT02880956|473332309|FG000|Overall Study|Adverse Event|3|||
131465219|NCT02880956|473332310|FG001|Overall Study|Adverse Event|6|||
131465220|NCT02880956|473332311|FG002|Overall Study|Adverse Event|5|||
131465221|NCT02880956|473332312|FG003|Overall Study|Adverse Event|4|||
131465222|NCT02880956|473332309|FG000|Overall Study|Withdrawal by Subject|9|||
131465223|NCT02880956|473332310|FG001|Overall Study|Withdrawal by Subject|4|||
131465224|NCT02880956|473332311|FG002|Overall Study|Withdrawal by Subject|6|||
131465225|NCT02880956|473332312|FG003|Overall Study|Withdrawal by Subject|11|||
131465226|NCT02880956|473332309|FG000|Overall Study|Lost to Follow-up|0|||
131465227|NCT02880956|473332310|FG001|Overall Study|Lost to Follow-up|1|||
131465228|NCT02880956|473332311|FG002|Overall Study|Lost to Follow-up|0|||
131465229|NCT02880956|473332312|FG003|Overall Study|Lost to Follow-up|0|||
131465230|NCT02880956|473332309|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
131465231|NCT02880956|473332310|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
131465232|NCT02880956|473332311|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
131465233|NCT02880956|473332312|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
131465234|NCT02880956|473332309|FG000|Overall Study|Other, Not Specified|4|||
131465235|NCT02880956|473332310|FG001|Overall Study|Other, Not Specified|2|||
131465236|NCT02880956|473332311|FG002|Overall Study|Other, Not Specified|0|||
131465237|NCT02880956|473332312|FG003|Overall Study|Other, Not Specified|3|||
131465238|NCT00576420|473334501|FG000|Overall Study|Death|0|||
131465239|NCT00576420|473334502|FG001|Overall Study|Death|0|||
131465240|NCT00576420|473334503|FG002|Overall Study|Death|1|||
131465241|NCT02616146|473334504|FG000|Overall Study|Adverse Event|64|||
131465242|NCT02616146|473334505|FG001|Overall Study|Adverse Event|24|||
131465243|NCT02616146|473334504|FG000|Overall Study|Lost to Follow-up|23|||
131465244|NCT02616146|473334505|FG001|Overall Study|Lost to Follow-up|13|||
131465245|NCT02616146|473334504|FG000|Overall Study|Non-compliance with study protocol|2|||
131465246|NCT02616146|473334505|FG001|Overall Study|Non-compliance with study protocol|0|||
131465247|NCT02616146|473334504|FG000|Overall Study|Non-compliance with study drug|4|||
131465248|NCT02616146|473334505|FG001|Overall Study|Non-compliance with study drug|2|||
131465249|NCT02616146|473334504|FG000|Overall Study|Pregnancy|2|||
131465250|NCT02616146|473334505|FG001|Overall Study|Pregnancy|2|||
131465251|NCT02616146|473334504|FG000|Overall Study|Pregnancy wish|3|||
131465252|NCT02616146|473334505|FG001|Overall Study|Pregnancy wish|0|||
131465253|NCT02616146|473334504|FG000|Overall Study|Protocol Violation|6|||
131465254|NCT02616146|473334505|FG001|Overall Study|Protocol Violation|3|||
131465255|NCT02616146|473334504|FG000|Overall Study|Study terminated by sponsor|1372|||
131465256|NCT02616146|473334505|FG001|Overall Study|Study terminated by sponsor|432|||
131465257|NCT02616146|473334504|FG000|Overall Study|Participant moved|4|||
131465258|NCT02616146|473334505|FG001|Overall Study|Participant moved|3|||
131465259|NCT02616146|473334504|FG000|Overall Study|Withdrawal by Subject|30|||
131465260|NCT02616146|473334505|FG001|Overall Study|Withdrawal by Subject|24|||
131465261|NCT02616146|473334504|FG000|Overall Study|Physician Decision|2|||
131465262|NCT02616146|473334505|FG001|Overall Study|Physician Decision|1|||
131465263|NCT01221272|473334507|FG000|Period 1|Adverse Event|2|||
131465264|NCT01221272|473334508|FG001|Period 1|Adverse Event|0|||
131465265|NCT01221272|473334507|FG000|Period 1|Consent Withdrawal|0|||
131465266|NCT01221272|473334508|FG001|Period 1|Consent Withdrawal|1|||
131465267|NCT01221272|473334507|FG000|Period 1|Significant Dosing Noncompliance|0|||
131465268|NCT01221272|473334508|FG001|Period 1|Significant Dosing Noncompliance|1|||
131465269|NCT01221272|473334507|FG000|Period 2|Adverse Event|0|||
131465270|NCT01221272|473334508|FG001|Period 2|Adverse Event|2|||
131465271|NCT01340872|473334509|FG000|Double-blind Phase|Adverse Event|6|||
131465272|NCT01340872|473334510|FG001|Double-blind Phase|Adverse Event|4|||
131465273|NCT01340872|473334511|FG002|Double-blind Phase|Adverse Event|0|||
131465274|NCT01340872|473334512|FG003|Double-blind Phase|Adverse Event|0|||
131465275|NCT01340872|473334509|FG000|Double-blind Phase|Withdrawal by Subject|3|||
131465276|NCT01340872|473334510|FG001|Double-blind Phase|Withdrawal by Subject|5|||
131465277|NCT01340872|473334511|FG002|Double-blind Phase|Withdrawal by Subject|0|||
131465278|NCT01340872|473334512|FG003|Double-blind Phase|Withdrawal by Subject|0|||
131465279|NCT01340872|473334509|FG000|Double-blind Phase|Lost to Follow-up|0|||
131465280|NCT01340872|473334510|FG001|Double-blind Phase|Lost to Follow-up|1|||
131465281|NCT01340872|473334511|FG002|Double-blind Phase|Lost to Follow-up|0|||
131465282|NCT01340872|473334512|FG003|Double-blind Phase|Lost to Follow-up|0|||
131465283|NCT01340872|473334509|FG000|Double-blind Phase|Protocol Violation|0|||
131465284|NCT01340872|473334510|FG001|Double-blind Phase|Protocol Violation|1|||
131465285|NCT01340872|473334511|FG002|Double-blind Phase|Protocol Violation|0|||
131465286|NCT01340872|473334512|FG003|Double-blind Phase|Protocol Violation|0|||
131465287|NCT01340872|473334509|FG000|Open-label Phase|Physician Decision|0|||
131465288|NCT01340872|473334510|FG001|Open-label Phase|Physician Decision|0|||
131465289|NCT01340872|473334511|FG002|Open-label Phase|Physician Decision|2|||
131465290|NCT01340872|473334512|FG003|Open-label Phase|Physician Decision|1|||
131465291|NCT01340872|473334509|FG000|Open-label Phase|Pregnancy|0|||
131465292|NCT01340872|473334510|FG001|Open-label Phase|Pregnancy|0|||
131465293|NCT01340872|473334511|FG002|Open-label Phase|Pregnancy|1|||
131465294|NCT01340872|473334512|FG003|Open-label Phase|Pregnancy|0|||
131465295|NCT01340872|473334509|FG000|Open-label Phase|Adverse Event|0|||
131465296|NCT01340872|473334510|FG001|Open-label Phase|Adverse Event|0|||
131465297|NCT01340872|473334511|FG002|Open-label Phase|Adverse Event|8|||
131465298|NCT01340872|473334512|FG003|Open-label Phase|Adverse Event|4|||
131465299|NCT01340872|473334509|FG000|Open-label Phase|Withdrawal by Subject|0|||
131465300|NCT01340872|473334510|FG001|Open-label Phase|Withdrawal by Subject|0|||
131465301|NCT01340872|473334511|FG002|Open-label Phase|Withdrawal by Subject|1|||
131465302|NCT01340872|473334512|FG003|Open-label Phase|Withdrawal by Subject|6|||
131465303|NCT01340872|473334509|FG000|Open-label Phase|Worsening of IBD|0|||
131465304|NCT01340872|473334510|FG001|Open-label Phase|Worsening of IBD|0|||
131465305|NCT01340872|473334511|FG002|Open-label Phase|Worsening of IBD|1|||
131465306|NCT01340872|473334512|FG003|Open-label Phase|Worsening of IBD|0|||
131465307|NCT01771809|473334515|FG000|Overall Study|Adverse Event|4|||
131465308|NCT01771809|473334516|FG001|Overall Study|Adverse Event|12|||
131465309|NCT01771809|473334515|FG000|Overall Study|Protocol Violation|0|||
131465310|NCT01771809|473334516|FG001|Overall Study|Protocol Violation|1|||
131465311|NCT01771809|473334515|FG000|Overall Study|Withdrawal by Subject|34|||
131465312|NCT01771809|473334516|FG001|Overall Study|Withdrawal by Subject|42|||
131465313|NCT01771809|473334515|FG000|Overall Study|Lost to Follow-up|1|||
131465314|NCT01771809|473334516|FG001|Overall Study|Lost to Follow-up|3|||
131465315|NCT01771809|473334515|FG000|Overall Study|Other (Insufficient clinical response)|22|||
131465316|NCT01771809|473334516|FG001|Overall Study|Other (Insufficient clinical response)|20|||
131465317|NCT01771809|473334515|FG000|Overall Study|Death|1|||
131465318|NCT01771809|473334516|FG001|Overall Study|Death|0|||
131465319|NCT01771809|473334515|FG000|Overall Study|Other (other)|9|||
131465320|NCT01771809|473334516|FG001|Overall Study|Other (other)|5|||
131465321|NCT01106092|473334517|FG000|Overall Study|Withdrawal by Subject|0|||
131465322|NCT01106092|473334518|FG001|Overall Study|Withdrawal by Subject|0|||
131465323|NCT01106092|473334519|FG002|Overall Study|Withdrawal by Subject|0|||
131465324|NCT01106092|473334520|FG003|Overall Study|Withdrawal by Subject|1|||
131465325|NCT04839562|473334523|FG000|Overall Study|Withdrawal by Subject|0|||
131465326|NCT04839562|473334524|FG001|Overall Study|Withdrawal by Subject|1|||
131465327|NCT04839562|473334523|FG000|Overall Study|Physician Decision|0|||
131465328|NCT04839562|473334524|FG001|Overall Study|Physician Decision|1|||
131465329|NCT01142089|473334536|FG000|Overall Study|Physician Decision|1|||
131465330|NCT01142089|473334537|FG001|Overall Study|Physician Decision|0|||
131465331|NCT01142089|473334536|FG000|Overall Study|Withdrawal by Subject|1|||
131465332|NCT01142089|473334537|FG001|Overall Study|Withdrawal by Subject|2|||
131465333|NCT01142089|473334536|FG000|Overall Study|Use of prohibited medications|0|||
131465334|NCT01142089|473334537|FG001|Overall Study|Use of prohibited medications|1|||
131465335|NCT01142089|473334536|FG000|Overall Study|Noncompliance with study procedures|2|||
131465336|NCT01142089|473334537|FG001|Overall Study|Noncompliance with study procedures|1|||
131465337|NCT01142089|473334536|FG000|Overall Study|Patient required rescue medication|8|||
131465338|NCT01142089|473334537|FG001|Overall Study|Patient required rescue medication|17|||
131465339|NCT02907892|473334542|FG000|Overall Study|Lost to Follow-up|27|||
131465340|NCT02907892|473334543|FG001|Overall Study|Lost to Follow-up|40|||
131465341|NCT00003472|473334547|FG000|Overall Study|Not evaluable|3|||
131465342|NCT00528970|473334548|FG000|Overall Study|Adverse Event|6|||
131465343|NCT00528970|473334549|FG001|Overall Study|Adverse Event|8|||
131465344|NCT00528970|473334550|FG002|Overall Study|Adverse Event|5|||
131465345|NCT00528970|473334548|FG000|Overall Study|Lost to Follow-up|0|||
131465346|NCT00528970|473334549|FG001|Overall Study|Lost to Follow-up|0|||
131465347|NCT00528970|473334550|FG002|Overall Study|Lost to Follow-up|1|||
131465348|NCT00528970|473334548|FG000|Overall Study|Other than specified|2|||
131465349|NCT00528970|473334549|FG001|Overall Study|Other than specified|3|||
131465350|NCT00528970|473334550|FG002|Overall Study|Other than specified|3|||
131465351|NCT00528970|473334548|FG000|Overall Study|Protocol Violation|2|||
131465352|NCT00528970|473334549|FG001|Overall Study|Protocol Violation|1|||
131465353|NCT00528970|473334550|FG002|Overall Study|Protocol Violation|4|||
131465354|NCT00528970|473334548|FG000|Overall Study|Lack of Efficacy|0|||
131465355|NCT00528970|473334549|FG001|Overall Study|Lack of Efficacy|0|||
131465356|NCT00528970|473334550|FG002|Overall Study|Lack of Efficacy|1|||
131465357|NCT00528970|473334548|FG000|Overall Study|Withdrawal by Subject|4|||
131465358|NCT00528970|473334549|FG001|Overall Study|Withdrawal by Subject|3|||
131465359|NCT00528970|473334550|FG002|Overall Study|Withdrawal by Subject|5|||
131465360|NCT00528970|473334548|FG000|Overall Study|Randomized but not treated|0|||
131465361|NCT00528970|473334549|FG001|Overall Study|Randomized but not treated|0|||
131465362|NCT00528970|473334550|FG002|Overall Study|Randomized but not treated|1|||
131465363|NCT03860935|473334551|FG000|Overall Study|Withdrawal of Consent|15|||
131465364|NCT03860935|473334552|FG001|Overall Study|Withdrawal of Consent|6|||
131465365|NCT03860935|473334551|FG000|Overall Study|Death|75|||
131465366|NCT03860935|473334552|FG001|Overall Study|Death|51|||
131465367|NCT03086967|473334553|FG000|Overall Study|Screen Failure|2|||
131465368|NCT03086967|473334554|FG001|Overall Study|Screen Failure|2|||
131465369|NCT01430754|473334557|FG000|Run-In Phase|Circadian Period Ineligible|24|||
131465370|NCT01430754|473334558|FG001|Run-In Phase|Circadian Period Ineligible|0|||
131465371|NCT01430754|473334557|FG000|Run-In Phase|Protocol Violation|6|||
131465372|NCT01430754|473334558|FG001|Run-In Phase|Protocol Violation|0|||
131465373|NCT01430754|473334557|FG000|Run-In Phase|Adverse Event|2|||
131465374|NCT01430754|473334558|FG001|Run-In Phase|Adverse Event|0|||
131465375|NCT01430754|473334557|FG000|Run-In Phase|Other|2|||
131465376|NCT01430754|473334558|FG001|Run-In Phase|Other|0|||
131465377|NCT01430754|473334557|FG000|Run-In Phase|Withdrawal by Subject|2|||
131465378|NCT01430754|473334558|FG001|Run-In Phase|Withdrawal by Subject|0|||
131465379|NCT01430754|473334557|FG000|Run-In Phase|Lost to Follow-up|1|||
131465380|NCT01430754|473334558|FG001|Run-In Phase|Lost to Follow-up|0|||
131465381|NCT02230527|473334560|FG000|Overall Study|Withdrawal by Subject|1|||
131465382|NCT02230527|473334561|FG001|Overall Study|Withdrawal by Subject|1|||
131465383|NCT02230527|473334560|FG000|Overall Study|Death|1|||
131465384|NCT02230527|473334561|FG001|Overall Study|Death|0|||
131465385|NCT02230527|473334560|FG000|Overall Study|Lost to Follow-up|2|||
131465386|NCT02230527|473334561|FG001|Overall Study|Lost to Follow-up|1|||
131465387|NCT02230527|473334560|FG000|Overall Study|Other|1|||
131465388|NCT02230527|473334561|FG001|Overall Study|Other|0|||
131465389|NCT02122783|473334562|FG000|Overall Study|Adverse Event|0|||
131465390|NCT02122783|473334563|FG001|Overall Study|Adverse Event|1|||
131465391|NCT04575597|473334566|FG000|Overall Study|Death|0|||
131465392|NCT04575597|473334567|FG001|Overall Study|Death|0|||
131465393|NCT04575597|473334568|FG002|Overall Study|Death|0|||
131465394|NCT04575597|473334569|FG003|Overall Study|Death|1|||
131465395|NCT04575597|473334570|FG004|Overall Study|Death|3|||
131465396|NCT04575597|473334571|FG005|Overall Study|Death|14|||
131465397|NCT04575597|473334566|FG000|Overall Study|Lost to Follow-up|2|||
131465398|NCT04575597|473334567|FG001|Overall Study|Lost to Follow-up|1|||
131465399|NCT04575597|473334568|FG002|Overall Study|Lost to Follow-up|1|||
131465400|NCT04575597|473334569|FG003|Overall Study|Lost to Follow-up|2|||
131465401|NCT04575597|473334570|FG004|Overall Study|Lost to Follow-up|10|||
131465402|NCT04575597|473334571|FG005|Overall Study|Lost to Follow-up|8|||
131465403|NCT04575597|473334566|FG000|Overall Study|Withdrawal by Subject|2|||
131465404|NCT04575597|473334567|FG001|Overall Study|Withdrawal by Subject|2|||
131465405|NCT04575597|473334568|FG002|Overall Study|Withdrawal by Subject|4|||
131465406|NCT04575597|473334569|FG003|Overall Study|Withdrawal by Subject|2|||
131465407|NCT04575597|473334570|FG004|Overall Study|Withdrawal by Subject|25|||
131465408|NCT04575597|473334571|FG005|Overall Study|Withdrawal by Subject|28|||
131465409|NCT04575597|473334566|FG000|Overall Study|Not Recorded|0|||
131465410|NCT04575597|473334567|FG001|Overall Study|Not Recorded|0|||
131465411|NCT04575597|473334568|FG002|Overall Study|Not Recorded|0|||
131465412|NCT04575597|473334569|FG003|Overall Study|Not Recorded|0|||
131465413|NCT04575597|473334570|FG004|Overall Study|Not Recorded|0|||
131465414|NCT04575597|473334571|FG005|Overall Study|Not Recorded|2|||
131465415|NCT04575597|473334566|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131465416|NCT04575597|473334567|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131465417|NCT04575597|473334568|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131465418|NCT04575597|473334569|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131465419|NCT04575597|473334570|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
131465420|NCT04575597|473334571|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
131465421|NCT02694757|473334587|FG000|Overall Study|Lack of Efficacy|3|||
131465422|NCT02650921|473334588|FG000|Overall Study|Withdrawal by Subject|4|||
131465423|NCT02650921|473334588|FG000|Overall Study|Lost to Follow-up|2|||
131465424|NCT02650921|473334588|FG000|Overall Study|Adverse Event|1|||
131465425|NCT02650921|473334588|FG000|Overall Study|Due to Medical Condition|1|||
131465426|NCT00783302|473334589|FG000|Overall Study|Lost to Follow-up|17|||
131465427|NCT00783302|473334589|FG000|Overall Study|Technical Problems|11|||
131465428|NCT00783302|473334589|FG000|Overall Study|Protocol Violation|3|||
131465429|NCT00783302|473334589|FG000|Overall Study|Physician Decision|1|||
131465430|NCT00783302|473334589|FG000|Overall Study|Withdrawal by Subject|3|||
131465431|NCT04604132|473334590|FG000|Overall Study|Adverse Event|2|||
131465432|NCT04604132|473334591|FG001|Overall Study|Adverse Event|0|||
131465433|NCT04604132|473334592|FG002|Overall Study|Adverse Event|0|||
131465434|NCT04604132|473334593|FG003|Overall Study|Adverse Event|1|||
131465435|NCT04604132|473334594|FG004|Overall Study|Adverse Event|2|||
131465436|NCT04604132|473334590|FG000|Overall Study|Study terminated by sponsor|0|||
131465437|NCT04604132|473334591|FG001|Overall Study|Study terminated by sponsor|0|||
131465438|NCT04604132|473334592|FG002|Overall Study|Study terminated by sponsor|0|||
131465439|NCT04604132|473334593|FG003|Overall Study|Study terminated by sponsor|0|||
131465440|NCT04604132|473334594|FG004|Overall Study|Study terminated by sponsor|1|||
131465441|NCT04604132|473334590|FG000|Overall Study|Progressive disease: Clinical progression|0|||
131465442|NCT04604132|473334591|FG001|Overall Study|Progressive disease: Clinical progression|0|||
131465443|NCT04604132|473334592|FG002|Overall Study|Progressive disease: Clinical progression|1|||
131465444|NCT04604132|473334593|FG003|Overall Study|Progressive disease: Clinical progression|0|||
131465445|NCT04604132|473334594|FG004|Overall Study|Progressive disease: Clinical progression|0|||
131465446|NCT04604132|473334590|FG000|Overall Study|Progressive disease: Radiological progression|8|||
131465447|NCT04604132|473334591|FG001|Overall Study|Progressive disease: Radiological progression|7|||
131465448|NCT04604132|473334592|FG002|Overall Study|Progressive disease: Radiological progression|10|||
131465449|NCT04604132|473334593|FG003|Overall Study|Progressive disease: Radiological progression|4|||
131465450|NCT04604132|473334594|FG004|Overall Study|Progressive disease: Radiological progression|3|||
131465451|NCT04604132|473334590|FG000|Overall Study|Death|3|||
131465452|NCT04604132|473334591|FG001|Overall Study|Death|1|||
131465453|NCT04604132|473334592|FG002|Overall Study|Death|2|||
131465454|NCT04604132|473334593|FG003|Overall Study|Death|1|||
131465455|NCT04604132|473334594|FG004|Overall Study|Death|0|||
131465456|NCT00952380|473334595|FG000|Overall Study|Other|0|||
131465457|NCT00952380|473334596|FG001|Overall Study|Other|0|||
131465458|NCT00952380|473334597|FG002|Overall Study|Other|0|||
131465459|NCT00952380|473334598|FG003|Overall Study|Other|0|||
131465460|NCT00952380|473334599|FG004|Overall Study|Other|1|||
131465461|NCT00952380|473334595|FG000|Overall Study|Withdrawal by Subject|0|||
131465462|NCT00952380|473334596|FG001|Overall Study|Withdrawal by Subject|0|||
131465463|NCT00952380|473334597|FG002|Overall Study|Withdrawal by Subject|1|||
131465464|NCT00952380|473334598|FG003|Overall Study|Withdrawal by Subject|0|||
131465465|NCT00952380|473334599|FG004|Overall Study|Withdrawal by Subject|2|||
131465466|NCT00952380|473334595|FG000|Overall Study|Adverse Event|0|||
131465467|NCT00952380|473334596|FG001|Overall Study|Adverse Event|1|||
131465468|NCT00952380|473334597|FG002|Overall Study|Adverse Event|0|||
131465469|NCT00952380|473334598|FG003|Overall Study|Adverse Event|0|||
131465470|NCT00952380|473334599|FG004|Overall Study|Adverse Event|3|||
131465471|NCT00952380|473334595|FG000|Overall Study|Physician Decision|0|||
131465472|NCT00952380|473334596|FG001|Overall Study|Physician Decision|0|||
131465473|NCT00952380|473334597|FG002|Overall Study|Physician Decision|1|||
131465474|NCT00952380|473334598|FG003|Overall Study|Physician Decision|2|||
131465475|NCT00952380|473334599|FG004|Overall Study|Physician Decision|0|||
131465476|NCT00952380|473334595|FG000|Overall Study|Non-compliant to protocol|0|||
131465477|NCT00952380|473334596|FG001|Overall Study|Non-compliant to protocol|0|||
131465478|NCT00952380|473334597|FG002|Overall Study|Non-compliant to protocol|0|||
131465479|NCT00952380|473334598|FG003|Overall Study|Non-compliant to protocol|1|||
131465480|NCT00952380|473334599|FG004|Overall Study|Non-compliant to protocol|0|||
131465481|NCT03400956|473334600|FG000|Treatment Period 1|Adverse Event|0|||
131465482|NCT03400956|473334601|FG001|Treatment Period 1|Adverse Event|1|||
131465483|NCT03400956|473334602|FG002|Treatment Period 1|Adverse Event|0|||
131465484|NCT03400956|473334600|FG000|Treatment Period 1|Lost to Follow-up|0|||
131465485|NCT03400956|473334601|FG001|Treatment Period 1|Lost to Follow-up|0|||
131465486|NCT03400956|473334602|FG002|Treatment Period 1|Lost to Follow-up|1|||
131465487|NCT03400956|473334600|FG000|Treatment Period 1|Protocol Violation|0|||
131465488|NCT03400956|473334601|FG001|Treatment Period 1|Protocol Violation|2|||
131465489|NCT03400956|473334602|FG002|Treatment Period 1|Protocol Violation|0|||
131465490|NCT03400956|473334600|FG000|Treatment Period 1|Study terminated by sponsor|3|||
131465491|NCT03400956|473334601|FG001|Treatment Period 1|Study terminated by sponsor|1|||
131465492|NCT03400956|473334602|FG002|Treatment Period 1|Study terminated by sponsor|1|||
131465493|NCT03400956|473334600|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131465494|NCT03400956|473334601|FG001|Treatment Period 1|Withdrawal by Subject|2|||
131465495|NCT03400956|473334602|FG002|Treatment Period 1|Withdrawal by Subject|4|||
131465496|NCT03400956|473334600|FG000|Treatment Period 1|Other|1|||
131465497|NCT03400956|473334601|FG001|Treatment Period 1|Other|2|||
131465498|NCT03400956|473334602|FG002|Treatment Period 1|Other|3|||
131465499|NCT03400956|473334600|FG000|Post-treatment Period 1|Adverse Event|0|||
131465500|NCT03400956|473334601|FG001|Post-treatment Period 1|Adverse Event|0|||
131465501|NCT03400956|473334602|FG002|Post-treatment Period 1|Adverse Event|1|||
131465502|NCT03400956|473334600|FG000|Post-treatment Period 1|Physician Decision|2|||
131465503|NCT03400956|473334601|FG001|Post-treatment Period 1|Physician Decision|3|||
131465504|NCT03400956|473334602|FG002|Post-treatment Period 1|Physician Decision|0|||
131465505|NCT03400956|473334600|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
131465506|NCT03400956|473334601|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
131465507|NCT03400956|473334602|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
131465508|NCT03400956|473334600|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
131465509|NCT03400956|473334601|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
131465510|NCT03400956|473334602|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
131465511|NCT03400956|473334600|FG000|Post-treatment Period 1|Other|4|||
131465512|NCT03400956|473334601|FG001|Post-treatment Period 1|Other|3|||
131465513|NCT03400956|473334602|FG002|Post-treatment Period 1|Other|4|||
131465514|NCT03400956|473334600|FG000|Treatment Period 2|Adverse Event|2|||
131465515|NCT03400956|473334601|FG001|Treatment Period 2|Adverse Event|1|||
131465516|NCT03400956|473334602|FG002|Treatment Period 2|Adverse Event|1|||
131465517|NCT03400956|473334600|FG000|Treatment Period 2|Lost to Follow-up|1|||
131465518|NCT03400956|473334601|FG001|Treatment Period 2|Lost to Follow-up|1|||
131465519|NCT03400956|473334602|FG002|Treatment Period 2|Lost to Follow-up|0|||
131465520|NCT03400956|473334600|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131465521|NCT03400956|473334601|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131465522|NCT03400956|473334602|FG002|Treatment Period 2|Withdrawal by Subject|3|||
131465523|NCT03400956|473334600|FG000|Treatment Period 2|Other|1|||
131465524|NCT03400956|473334601|FG001|Treatment Period 2|Other|1|||
131465525|NCT03400956|473334602|FG002|Treatment Period 2|Other|0|||
131465526|NCT03400956|473334600|FG000|Follow-up Period|Withdrawal by Subject|0|||
131465527|NCT03400956|473334601|FG001|Follow-up Period|Withdrawal by Subject|0|||
131465528|NCT03400956|473334602|FG002|Follow-up Period|Withdrawal by Subject|1|||
131465529|NCT03400956|473334600|FG000|Follow-up Period|Other|0|||
131465530|NCT03400956|473334601|FG001|Follow-up Period|Other|0|||
131465531|NCT03400956|473334602|FG002|Follow-up Period|Other|1|||
131465532|NCT00160667|473334603|FG000|Overall Study|Adverse Event|3|||
131465533|NCT00160667|473334604|FG001|Overall Study|Adverse Event|1|||
131465534|NCT00160667|473334605|FG002|Overall Study|Adverse Event|4|||
131465535|NCT00160667|473334603|FG000|Overall Study|Withdrawal by Subject|2|||
131465536|NCT00160667|473334604|FG001|Overall Study|Withdrawal by Subject|0|||
131465537|NCT00160667|473334605|FG002|Overall Study|Withdrawal by Subject|1|||
131465538|NCT00160667|473334603|FG000|Overall Study|Lack of Efficacy|0|||
131465539|NCT00160667|473334604|FG001|Overall Study|Lack of Efficacy|1|||
131465540|NCT00160667|473334605|FG002|Overall Study|Lack of Efficacy|0|||
131465541|NCT00160667|473334603|FG000|Overall Study|Protocol Violation|0|||
131465542|NCT00160667|473334604|FG001|Overall Study|Protocol Violation|1|||
131465543|NCT00160667|473334605|FG002|Overall Study|Protocol Violation|0|||
131465544|NCT00160667|473334603|FG000|Overall Study|Patient decision|0|||
131465545|NCT00160667|473334604|FG001|Overall Study|Patient decision|0|||
131465546|NCT00160667|473334605|FG002|Overall Study|Patient decision|1|||
131465547|NCT00927940|473334611|FG000|Overall Study|Death|1|||
131465548|NCT03007888|473334612|FG000|First Intervention (14 Days)|Adverse Event|1|||
131465549|NCT03007888|473334613|FG001|First Intervention (14 Days)|Adverse Event|0|||
131465550|NCT00043550|473334617|FG000|Overall Study|Withdrawal by Subject|22|||
131465551|NCT00043550|473334618|FG001|Overall Study|Withdrawal by Subject|12|||
131465552|NCT00043550|473334619|FG002|Overall Study|Withdrawal by Subject|20|||
131465553|NCT00827931|473334620|FG000|Overall Study|Death|3|||
131465554|NCT00827931|473334621|FG001|Overall Study|Death|5|||
131465555|NCT00827931|473334620|FG000|Overall Study|Adverse Event|1|||
131465556|NCT00827931|473334621|FG001|Overall Study|Adverse Event|0|||
131465557|NCT00827931|473334620|FG000|Overall Study|Lost to Follow-up|1|||
131465558|NCT00827931|473334621|FG001|Overall Study|Lost to Follow-up|0|||
131465559|NCT00827931|473334620|FG000|Overall Study|Withdrawal by Subject|0|||
131465560|NCT00827931|473334621|FG001|Overall Study|Withdrawal by Subject|1|||
131465561|NCT00827931|473334620|FG000|Overall Study|Other|1|||
131465562|NCT00827931|473334621|FG001|Overall Study|Other|0|||
131465563|NCT01306929|473334622|FG000|Overall Study|Withdrawal by Subject|23|||
131465564|NCT01306929|473334622|FG000|Overall Study|Adverse Event|21|||
131465565|NCT01306929|473334622|FG000|Overall Study|Physician Decision|13|||
131465566|NCT01306929|473334622|FG000|Overall Study|Death|8|||
131465567|NCT01306929|473334622|FG000|Overall Study|Withdrawal by parent/guardian|5|||
131465568|NCT01306929|473334622|FG000|Overall Study|Protocol Violation|3|||
131465569|NCT01306929|473334622|FG000|Overall Study|Non-compliance with study drug|2|||
131465570|NCT01306929|473334622|FG000|Overall Study|Lost to Follow-up|2|||
131465571|NCT01306929|473334622|FG000|Overall Study|Various|17|||
131465572|NCT00995566|473334623|FG000|Overall Study|Adverse Event|2|||
131465573|NCT00995566|473334623|FG000|Overall Study|Early study termination|52|||
131465574|NCT03709576|473334624|FG000|Overall Study|progression prior to enrollment|1|||
131465575|NCT00890045|473334630|FG000|Overall Study|Death|0|||
131465576|NCT00890045|473334631|FG001|Overall Study|Death|1|||
131465577|NCT00890045|473334630|FG000|Overall Study|Did not receive HeRO Graft|0|||
131465578|NCT00890045|473334631|FG001|Overall Study|Did not receive HeRO Graft|2|||
131465579|NCT00890045|473334630|FG000|Overall Study|Lost to Follow-up|5|||
131465580|NCT00890045|473334631|FG001|Overall Study|Lost to Follow-up|7|||
131465581|NCT00483756|473334632|FG000|Overall Study|Death|2|||
131465582|NCT00483756|473334633|FG001|Overall Study|Death|0|||
131465583|NCT00483756|473334634|FG002|Overall Study|Death|1|||
131465584|NCT00483756|473334632|FG000|Overall Study|Adverse Event|19|||
131465585|NCT00483756|473334633|FG001|Overall Study|Adverse Event|38|||
131465586|NCT00483756|473334634|FG002|Overall Study|Adverse Event|40|||
131465587|NCT00483756|473334632|FG000|Overall Study|Lack of Efficacy|1|||
131465588|NCT00483756|473334633|FG001|Overall Study|Lack of Efficacy|0|||
131465589|NCT00483756|473334634|FG002|Overall Study|Lack of Efficacy|0|||
131465590|NCT00483756|473334632|FG000|Overall Study|Lost to Follow-up|3|||
131465591|NCT00483756|473334633|FG001|Overall Study|Lost to Follow-up|1|||
131465592|NCT00483756|473334634|FG002|Overall Study|Lost to Follow-up|0|||
131465593|NCT00483756|473334632|FG000|Overall Study|Withdrawal by Subject|5|||
131465594|NCT00483756|473334633|FG001|Overall Study|Withdrawal by Subject|3|||
131465595|NCT00483756|473334634|FG002|Overall Study|Withdrawal by Subject|4|||
131465596|NCT00483756|473334632|FG000|Overall Study|Other|2|||
131465597|NCT00483756|473334633|FG001|Overall Study|Other|4|||
131465598|NCT00483756|473334634|FG002|Overall Study|Other|3|||
131465599|NCT00483756|473334632|FG000|Overall Study|Randomized, Not Treated|1|||
131465600|NCT00483756|473334633|FG001|Overall Study|Randomized, Not Treated|4|||
131465601|NCT00483756|473334634|FG002|Overall Study|Randomized, Not Treated|4|||
131465602|NCT00436501|473334635|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
131465603|NCT00436501|473334636|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
131465604|NCT00436501|473334635|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
131465605|NCT00436501|473334636|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
131465606|NCT03612856|473334640|FG000|Pre-dose Period|Physician Decision|0|||
131465607|NCT03612856|473334641|FG001|Pre-dose Period|Physician Decision|1|||
131465608|NCT03612856|473334642|FG002|Pre-dose Period|Physician Decision|1|||
131465609|NCT03612856|473334640|FG000|Pre-dose Period|Withdrawal by Subject|0|||
131465610|NCT03612856|473334641|FG001|Pre-dose Period|Withdrawal by Subject|1|||
131465611|NCT03612856|473334642|FG002|Pre-dose Period|Withdrawal by Subject|0|||
131465612|NCT01576159|473334643|FG000|Overall Study|Withdrawal by Subject|0|||
131465613|NCT01576159|473334644|FG001|Overall Study|Withdrawal by Subject|1|||
131465614|NCT01576159|473334645|FG002|Overall Study|Withdrawal by Subject|0|||
131465615|NCT01576159|473334646|FG003|Overall Study|Withdrawal by Subject|0|||
131465616|NCT01576159|473334643|FG000|Overall Study|Physician Decision|0|||
131465617|NCT01576159|473334644|FG001|Overall Study|Physician Decision|0|||
131465618|NCT01576159|473334645|FG002|Overall Study|Physician Decision|1|||
131465619|NCT01576159|473334646|FG003|Overall Study|Physician Decision|0|||
131465620|NCT01576159|473334643|FG000|Overall Study|Lost to Follow-up|0|||
131465621|NCT01576159|473334644|FG001|Overall Study|Lost to Follow-up|0|||
131465622|NCT01576159|473334645|FG002|Overall Study|Lost to Follow-up|0|||
131465623|NCT01576159|473334646|FG003|Overall Study|Lost to Follow-up|1|||
131465624|NCT01576159|473334643|FG000|Overall Study|Protocol Violation|1|||
131465625|NCT01576159|473334644|FG001|Overall Study|Protocol Violation|0|||
131465626|NCT01576159|473334645|FG002|Overall Study|Protocol Violation|0|||
131465627|NCT01576159|473334646|FG003|Overall Study|Protocol Violation|0|||
131465628|NCT00169442|473334647|FG000|Overall Study|Withdrawal by Subject|0|||
131465629|NCT00169442|473334648|FG001|Overall Study|Withdrawal by Subject|0|||
131465630|NCT00169442|473334649|FG002|Overall Study|Withdrawal by Subject|1|||
131465631|NCT00169442|473334650|FG003|Overall Study|Withdrawal by Subject|0|||
131465632|NCT00169442|473334651|FG004|Overall Study|Withdrawal by Subject|0|||
131465633|NCT00169442|473334652|FG005|Overall Study|Withdrawal by Subject|0|||
131465634|NCT00169442|473334647|FG000|Overall Study|Migrated/moved from study area|0|||
131465635|NCT00169442|473334648|FG001|Overall Study|Migrated/moved from study area|0|||
131465636|NCT00169442|473334649|FG002|Overall Study|Migrated/moved from study area|0|||
131465637|NCT00169442|473334650|FG003|Overall Study|Migrated/moved from study area|0|||
131465638|NCT00169442|473334651|FG004|Overall Study|Migrated/moved from study area|0|||
131465639|NCT00169442|473334652|FG005|Overall Study|Migrated/moved from study area|2|||
131465640|NCT00169442|473334647|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131465641|NCT00169442|473334648|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131465642|NCT00169442|473334649|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131465643|NCT00169442|473334650|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131465644|NCT00169442|473334651|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
131465645|NCT00169442|473334652|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131465646|NCT00169442|473334647|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
131465647|NCT00169442|473334648|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
131465648|NCT00169442|473334649|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
131465649|NCT00169442|473334650|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
131465650|NCT00169442|473334651|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
131465651|NCT00169442|473334652|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
131465652|NCT01181986|473334655|FG000|Phase 1|Lost to Follow-up|0|||
131465653|NCT01181986|473334656|FG001|Phase 1|Lost to Follow-up|1|||
131465654|NCT01181986|473334657|FG002|Phase 1|Lost to Follow-up|1|||
131465655|NCT01181986|473334655|FG000|Phase 1|Adverse Event|0|||
131465656|NCT01181986|473334656|FG001|Phase 1|Adverse Event|0|||
131465657|NCT01181986|473334657|FG002|Phase 1|Adverse Event|1|||
131465658|NCT01181986|473334655|FG000|Phase 1|Protocol Violation|1|||
131465659|NCT01181986|473334656|FG001|Phase 1|Protocol Violation|0|||
131465660|NCT01181986|473334657|FG002|Phase 1|Protocol Violation|0|||
131465661|NCT01181986|473334655|FG000|Phase 2|Adverse Event|0|||
131465662|NCT01181986|473334656|FG001|Phase 2|Adverse Event|3|||
131465663|NCT01181986|473334657|FG002|Phase 2|Adverse Event|0|||
131465664|NCT01181986|473334655|FG000|Phase 2|Medical condition|0|||
131465665|NCT01181986|473334656|FG001|Phase 2|Medical condition|1|||
131465666|NCT01181986|473334657|FG002|Phase 2|Medical condition|0|||
131465667|NCT00311584|473334658|FG000|Overall Study|Death|1|||
131465668|NCT00311584|473334659|FG001|Overall Study|Death|0|||
131465669|NCT00311584|473334658|FG000|Overall Study|Lack of Efficacy|12|||
131465670|NCT00311584|473334659|FG001|Overall Study|Lack of Efficacy|15|||
131465671|NCT00311584|473334658|FG000|Overall Study|Physician Decision|4|||
131465672|NCT00311584|473334659|FG001|Overall Study|Physician Decision|5|||
131465673|NCT00311584|473334658|FG000|Overall Study|Withdrawal by Subject|1|||
131465674|NCT00311584|473334659|FG001|Overall Study|Withdrawal by Subject|1|||
131465675|NCT00311584|473334658|FG000|Overall Study|ineligible|2|||
131465676|NCT00311584|473334659|FG001|Overall Study|ineligible|2|||
131465677|NCT03073733|473334660|FG000|Overall Study|Lost to Follow-up|1|||
131465678|NCT03073733|473334661|FG001|Overall Study|Lost to Follow-up|0|||
131465679|NCT03073733|473334662|FG002|Overall Study|Lost to Follow-up|0|||
131465680|NCT03073733|473334660|FG000|Overall Study|Physician Decision|0|||
131465681|NCT03073733|473334661|FG001|Overall Study|Physician Decision|1|||
131465682|NCT03073733|473334662|FG002|Overall Study|Physician Decision|0|||
131465683|NCT03073733|473334660|FG000|Overall Study|Withdrawal by Subject|0|||
131465684|NCT03073733|473334661|FG001|Overall Study|Withdrawal by Subject|0|||
131465685|NCT03073733|473334662|FG002|Overall Study|Withdrawal by Subject|1|||
131465686|NCT00835731|473334663|FG000|Overall Study|Withdrawal by Subject|1|||
131465687|NCT00835731|473334664|FG001|Overall Study|Withdrawal by Subject|0|||
131465688|NCT00835731|473334663|FG000|Overall Study|Physician Decision|1|||
131465689|NCT00835731|473334664|FG001|Overall Study|Physician Decision|1|||
131465690|NCT01155167|473334665|FG000|Overall Study|Insufficient ultrasound data|2|||
131465691|NCT01155167|473334666|FG001|Overall Study|Insufficient ultrasound data|0|||
131465692|NCT01155167|473334665|FG000|Overall Study|Access site changed to femoral artery|1|||
131465693|NCT01155167|473334666|FG001|Overall Study|Access site changed to femoral artery|0|||
131465694|NCT00167778|473334667|FG000|Overall Study|Withdrawal by Subject|1|||
131465695|NCT02654717|473334668|FG000|Overall Study|Adverse Event|2|||
131465696|NCT02654717|473334669|FG001|Overall Study|Adverse Event|2|||
131465697|NCT02654717|473334668|FG000|Overall Study|Protocol Violation|1|||
131465698|NCT02654717|473334669|FG001|Overall Study|Protocol Violation|2|||
131465699|NCT02654717|473334668|FG000|Overall Study|Withdrawal by Subject|0|||
131465700|NCT02654717|473334669|FG001|Overall Study|Withdrawal by Subject|1|||
131465701|NCT02654717|473334668|FG000|Overall Study|Non-permitted medication|3|||
131465702|NCT02654717|473334669|FG001|Overall Study|Non-permitted medication|0|||
131465703|NCT01974765|473336536|FG000|Overall Study|Withdrawal by Subject|1|||
131465704|NCT01974765|473336536|FG000|Overall Study|Death|1|||
131465705|NCT01974765|473336536|FG000|Overall Study|Adverse Event|2|||
131465706|NCT04461600|473336537|FG000|Overall Study|Death|6|||
131465707|NCT04461600|473336538|FG001|Overall Study|Death|5|||
131465708|NCT04461600|473336537|FG000|Overall Study|Withdrawal by Subject|0|||
131465709|NCT04461600|473336538|FG001|Overall Study|Withdrawal by Subject|1|||
131465710|NCT00775203|473336544|FG000|Overall Study|Adverse Event|25|||
131465711|NCT00775203|473336545|FG001|Overall Study|Adverse Event|6|||
131465712|NCT00775203|473336544|FG000|Overall Study|Lack of Efficacy|8|||
131465713|NCT00775203|473336545|FG001|Overall Study|Lack of Efficacy|9|||
131465714|NCT00775203|473336544|FG000|Overall Study|Withdrawal by Subject|11|||
131465715|NCT00775203|473336545|FG001|Overall Study|Withdrawal by Subject|9|||
131465716|NCT00775203|473336544|FG000|Overall Study|Lost to Follow-up|11|||
131465717|NCT00775203|473336545|FG001|Overall Study|Lost to Follow-up|15|||
131465718|NCT00775203|473336544|FG000|Overall Study|Administrative reason|2|||
131465719|NCT00775203|473336545|FG001|Overall Study|Administrative reason|0|||
131465720|NCT00775203|473336544|FG000|Overall Study|Noncompliance|4|||
131465721|NCT00775203|473336545|FG001|Overall Study|Noncompliance|2|||
131465722|NCT00775203|473336544|FG000|Overall Study|Protocol Violation|0|||
131465723|NCT00775203|473336545|FG001|Overall Study|Protocol Violation|1|||
131465724|NCT00775203|473336544|FG000|Overall Study|Entered other study|1|||
131465725|NCT00775203|473336545|FG001|Overall Study|Entered other study|0|||
131465726|NCT00775203|473336544|FG000|Overall Study|Physician Decision|0|||
131465727|NCT00775203|473336545|FG001|Overall Study|Physician Decision|1|||
131465728|NCT00704522|473336546|FG000|Overall Study|Lack of Efficacy|65|||
131465729|NCT00704522|473336547|FG001|Overall Study|Lack of Efficacy|17|||
131465730|NCT00704522|473336546|FG000|Overall Study|Failure to appear again at hospital|56|||
131465731|NCT00704522|473336547|FG001|Overall Study|Failure to appear again at hospital|10|||
131465732|NCT00704522|473336546|FG000|Overall Study|Withdrawal by Subject|17|||
131465733|NCT00704522|473336547|FG001|Overall Study|Withdrawal by Subject|8|||
131465734|NCT00704522|473336546|FG000|Overall Study|Adverse Event|9|||
131465735|NCT00704522|473336547|FG001|Overall Study|Adverse Event|1|||
131465736|NCT00704522|473336546|FG000|Overall Study|Undefined causes|9|||
131465737|NCT00704522|473336547|FG001|Overall Study|Undefined causes|7|||
131465738|NCT00704522|473336546|FG000|Overall Study|No information on therapy end|27|||
131465739|NCT00704522|473336547|FG001|Overall Study|No information on therapy end|2|||
131465740|NCT00701662|473336548|FG000|Overall Study|Lack of Efficacy|1|||
131465741|NCT00635024|473336549|FG000|Overall Study|Adverse Event|1|||
131465742|NCT01105065|473336550|FG000|Overall Study|Adverse Event|5|||
131465743|NCT01105065|473336550|FG000|Overall Study|Technical Problems|1|||
131465744|NCT02984943|473336553|FG000|Overall Study|Withdrawal by Subject|3|||
131465745|NCT02984943|473336553|FG000|Overall Study|Physician Decision|1|||
131465746|NCT00711516|473336554|FG000|Overall Study|Adverse Event|1|||
131465747|NCT00711516|473336555|FG001|Overall Study|Adverse Event|1|||
131465748|NCT00711516|473336554|FG000|Overall Study|Withdrawal by Subject|0|||
131465749|NCT00711516|473336555|FG001|Overall Study|Withdrawal by Subject|1|||
131465750|NCT00711516|473336554|FG000|Overall Study|Protocol Violation|0|||
131465751|NCT00711516|473336555|FG001|Overall Study|Protocol Violation|1|||
131465752|NCT01029405|473336558|FG000|Overall Study|Withdrawal by Subject|0|||
131465753|NCT01029405|473336559|FG001|Overall Study|Withdrawal by Subject|1|||
131465754|NCT01029405|473336560|FG002|Overall Study|Withdrawal by Subject|2|||
131465755|NCT01029405|473336561|FG003|Overall Study|Withdrawal by Subject|0|||
131465756|NCT01029405|473336558|FG000|Overall Study|Protocol Violation|0|||
131465757|NCT01029405|473336559|FG001|Overall Study|Protocol Violation|0|||
131465758|NCT01029405|473336560|FG002|Overall Study|Protocol Violation|0|||
131465759|NCT01029405|473336561|FG003|Overall Study|Protocol Violation|1|||
131465760|NCT01029405|473336558|FG000|Overall Study|Adverse Event|0|||
131465761|NCT01029405|473336559|FG001|Overall Study|Adverse Event|0|||
131465762|NCT01029405|473336560|FG002|Overall Study|Adverse Event|1|||
131465763|NCT01029405|473336561|FG003|Overall Study|Adverse Event|1|||
131465764|NCT01029405|473336558|FG000|Overall Study|Lost to Follow-up|2|||
131465765|NCT01029405|473336559|FG001|Overall Study|Lost to Follow-up|1|||
131465766|NCT01029405|473336560|FG002|Overall Study|Lost to Follow-up|1|||
131465767|NCT01029405|473336561|FG003|Overall Study|Lost to Follow-up|2|||
131465768|NCT01029405|473336558|FG000|Overall Study|Other|0|||
131465769|NCT01029405|473336559|FG001|Overall Study|Other|1|||
131465770|NCT01029405|473336560|FG002|Overall Study|Other|0|||
131465771|NCT01029405|473336561|FG003|Overall Study|Other|1|||
131465772|NCT01534182|473336565|FG000|Overall Study|Administrative problems|1|||
131465773|NCT01534182|473336566|FG001|Overall Study|Administrative problems|0|||
131465774|NCT01534182|473336565|FG000|Overall Study|Withdrawal by Subject|4|||
131465775|NCT01534182|473336566|FG001|Overall Study|Withdrawal by Subject|7|||
131465776|NCT01534182|473336565|FG000|Overall Study|Adverse Event|7|||
131465777|NCT01534182|473336566|FG001|Overall Study|Adverse Event|3|||
131465778|NCT02536404|473336567|FG000|Overall Study|Adverse Event|5|||
131465779|NCT02536404|473336568|FG001|Overall Study|Adverse Event|0|||
131465780|NCT02536404|473336567|FG000|Overall Study|Withdrawal by Subject|4|||
131465781|NCT02536404|473336568|FG001|Overall Study|Withdrawal by Subject|1|||
131465782|NCT02536404|473336567|FG000|Overall Study|Physician Decision|10|||
131465783|NCT02536404|473336568|FG001|Overall Study|Physician Decision|0|||
131465784|NCT02536404|473336567|FG000|Overall Study|Sponsor decision|1|||
131465785|NCT02536404|473336568|FG001|Overall Study|Sponsor decision|0|||
131465786|NCT00924170|473336574|FG000|Overall Study|Refused further treatment|0|||
131465787|NCT00924170|473336575|FG001|Overall Study|Refused further treatment|1|||
131465788|NCT00924170|473336574|FG000|Overall Study|Physician Decision|0|||
131465789|NCT00924170|473336575|FG001|Overall Study|Physician Decision|1|||
131465790|NCT00924170|473336574|FG000|Overall Study|Progressive disease|3|||
131465791|NCT00924170|473336575|FG001|Overall Study|Progressive disease|6|||
131465792|NCT00924170|473336574|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
131465793|NCT00924170|473336575|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
131465794|NCT00924170|473336574|FG000|Overall Study|Death|1|||
131465795|NCT00924170|473336575|FG001|Overall Study|Death|0|||
131465796|NCT04449029|473336578|FG000|Overall Study|Adverse Event|0|||
131465797|NCT04449029|473336579|FG001|Overall Study|Adverse Event|1|||
131465798|NCT04449029|473336580|FG002|Overall Study|Adverse Event|1|||
131465799|NCT04449029|473336581|FG003|Overall Study|Adverse Event|0|||
131465800|NCT04449029|473336582|FG004|Overall Study|Adverse Event|1|||
131465801|NCT04449029|473336583|FG005|Overall Study|Adverse Event|0|||
131465802|NCT04449029|473336584|FG006|Overall Study|Adverse Event|1|||
131465803|NCT04449029|473336585|FG007|Overall Study|Adverse Event|0|||
131465804|NCT04449029|473336578|FG000|Overall Study|Lost to Follow-up|0|||
131465805|NCT04449029|473336579|FG001|Overall Study|Lost to Follow-up|1|||
131465806|NCT04449029|473336580|FG002|Overall Study|Lost to Follow-up|0|||
131465807|NCT04449029|473336581|FG003|Overall Study|Lost to Follow-up|0|||
131465808|NCT04449029|473336582|FG004|Overall Study|Lost to Follow-up|0|||
131465809|NCT04449029|473336583|FG005|Overall Study|Lost to Follow-up|0|||
131465810|NCT04449029|473336584|FG006|Overall Study|Lost to Follow-up|0|||
131465811|NCT04449029|473336585|FG007|Overall Study|Lost to Follow-up|0|||
131465812|NCT04449029|473336578|FG000|Overall Study|Protocol Violation|0|||
131465813|NCT04449029|473336579|FG001|Overall Study|Protocol Violation|1|||
131465814|NCT04449029|473336580|FG002|Overall Study|Protocol Violation|0|||
131465815|NCT04449029|473336581|FG003|Overall Study|Protocol Violation|0|||
131465816|NCT04449029|473336582|FG004|Overall Study|Protocol Violation|0|||
131465817|NCT04449029|473336583|FG005|Overall Study|Protocol Violation|0|||
131465818|NCT04449029|473336584|FG006|Overall Study|Protocol Violation|0|||
131465819|NCT04449029|473336585|FG007|Overall Study|Protocol Violation|0|||
131465820|NCT04449029|473336578|FG000|Overall Study|Physician Decision|0|||
131465821|NCT04449029|473336579|FG001|Overall Study|Physician Decision|0|||
131465822|NCT04449029|473336580|FG002|Overall Study|Physician Decision|0|||
131465823|NCT04449029|473336581|FG003|Overall Study|Physician Decision|0|||
131465824|NCT04449029|473336582|FG004|Overall Study|Physician Decision|0|||
131465825|NCT04449029|473336583|FG005|Overall Study|Physician Decision|1|||
131465826|NCT04449029|473336584|FG006|Overall Study|Physician Decision|0|||
131465827|NCT04449029|473336585|FG007|Overall Study|Physician Decision|0|||
131465828|NCT04449029|473336578|FG000|Overall Study|Withdrawal by Subject|3|||
131465829|NCT04449029|473336579|FG001|Overall Study|Withdrawal by Subject|0|||
131465830|NCT04449029|473336580|FG002|Overall Study|Withdrawal by Subject|1|||
131465831|NCT04449029|473336581|FG003|Overall Study|Withdrawal by Subject|1|||
131465832|NCT04449029|473336582|FG004|Overall Study|Withdrawal by Subject|5|||
131465833|NCT04449029|473336583|FG005|Overall Study|Withdrawal by Subject|1|||
131465834|NCT04449029|473336584|FG006|Overall Study|Withdrawal by Subject|4|||
131465835|NCT04449029|473336585|FG007|Overall Study|Withdrawal by Subject|0|||
131465836|NCT02025556|473336587|FG000|Overall Study|Adverse Event|0|||
131465837|NCT02025556|473336588|FG001|Overall Study|Adverse Event|4|||
131465838|NCT02025556|473336589|FG002|Overall Study|Adverse Event|2|||
131465839|NCT02025556|473336587|FG000|Overall Study|Lack of Efficacy|2|||
131465840|NCT02025556|473336588|FG001|Overall Study|Lack of Efficacy|1|||
131465841|NCT02025556|473336589|FG002|Overall Study|Lack of Efficacy|0|||
131465842|NCT02025556|473336587|FG000|Overall Study|Protocol Violation|2|||
131465843|NCT02025556|473336588|FG001|Overall Study|Protocol Violation|1|||
131465844|NCT02025556|473336589|FG002|Overall Study|Protocol Violation|0|||
131465845|NCT02025556|473336587|FG000|Overall Study|Withdrawal by Subject|0|||
131465846|NCT02025556|473336588|FG001|Overall Study|Withdrawal by Subject|3|||
131465847|NCT02025556|473336589|FG002|Overall Study|Withdrawal by Subject|6|||
131465848|NCT02025556|473336587|FG000|Overall Study|Lost to Follow-up|2|||
131465849|NCT02025556|473336588|FG001|Overall Study|Lost to Follow-up|4|||
131465850|NCT02025556|473336589|FG002|Overall Study|Lost to Follow-up|0|||
131465851|NCT02025556|473336587|FG000|Overall Study|Reason not reported|0|||
131465852|NCT02025556|473336588|FG001|Overall Study|Reason not reported|0|||
131465853|NCT02025556|473336589|FG002|Overall Study|Reason not reported|1|||
131465854|NCT00627445|473336590|FG000|Overall Study|Adverse Event|3|||
131465855|NCT00627445|473336591|FG001|Overall Study|Adverse Event|3|||
131465856|NCT00627445|473336590|FG000|Overall Study|Lack of Efficacy|0|||
131465857|NCT00627445|473336591|FG001|Overall Study|Lack of Efficacy|1|||
131465858|NCT00627445|473336590|FG000|Overall Study|Other|6|||
131465859|NCT00627445|473336591|FG001|Overall Study|Other|8|||
131465860|NCT04098224|473336592|FG000|Overall Study|Adverse Event|1|||
131465861|NCT04098224|473336593|FG001|Overall Study|Adverse Event|0|||
131465862|NCT04098224|473336592|FG000|Overall Study|Physician Decision|1|||
131465863|NCT04098224|473336593|FG001|Overall Study|Physician Decision|0|||
131465864|NCT04098224|473336592|FG000|Overall Study|Patient not required enteral feeding|1|||
131465865|NCT04098224|473336593|FG001|Overall Study|Patient not required enteral feeding|0|||
131465866|NCT04098224|473336592|FG000|Overall Study|Patient failure nasogastric tube|1|||
131465867|NCT04098224|473336593|FG001|Overall Study|Patient failure nasogastric tube|0|||
131465868|NCT04098224|473336592|FG000|Overall Study|Patient early extubation|1|||
131465869|NCT04098224|473336593|FG001|Overall Study|Patient early extubation|3|||
131465870|NCT01203852|473336597|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
131465871|NCT01203852|473336597|FG000|Washout 2 Weeks|Physician Decision|46|||
131465872|NCT00247611|473336603|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
131465873|NCT00247611|473336604|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
131465874|NCT00247611|473336603|FG000|Baselined|Completed baseline only|9|||
131465875|NCT00247611|473336604|FG001|Baselined|Completed baseline only|8|||
131465876|NCT01587898|473336607|FG000|Overall Study|Adverse Event|1|||
131465877|NCT01587898|473336608|FG001|Overall Study|Adverse Event|1|||
131465878|NCT01587898|473336609|FG002|Overall Study|Adverse Event|0|||
131465879|NCT01587898|473336610|FG003|Overall Study|Adverse Event|0|||
131465880|NCT01587898|473336607|FG000|Overall Study|Protocol Violation|0|||
131465881|NCT01587898|473336608|FG001|Overall Study|Protocol Violation|2|||
131465882|NCT01587898|473336609|FG002|Overall Study|Protocol Violation|1|||
131465883|NCT01587898|473336610|FG003|Overall Study|Protocol Violation|1|||
131465884|NCT01587898|473336607|FG000|Overall Study|Lost to Follow-up|0|||
131465885|NCT01587898|473336608|FG001|Overall Study|Lost to Follow-up|0|||
131465886|NCT01587898|473336609|FG002|Overall Study|Lost to Follow-up|0|||
131465887|NCT01587898|473336610|FG003|Overall Study|Lost to Follow-up|1|||
131465888|NCT01587898|473336607|FG000|Overall Study|Withdrawal by Subject|2|||
131465889|NCT01587898|473336608|FG001|Overall Study|Withdrawal by Subject|1|||
131465890|NCT01587898|473336609|FG002|Overall Study|Withdrawal by Subject|0|||
131465891|NCT01587898|473336610|FG003|Overall Study|Withdrawal by Subject|0|||
131465892|NCT01587898|473336607|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
131465893|NCT01587898|473336608|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
131465894|NCT01587898|473336609|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
131465895|NCT01587898|473336610|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
131465896|NCT01738477|473336611|FG000|Overall Study|Lost to Follow-up|1|||
131465897|NCT01738477|473336612|FG001|Overall Study|Lost to Follow-up|4|||
131465898|NCT02576145|473336619|FG000|Overall Study|Adverse Event|1|||
131465899|NCT02576145|473336620|FG001|Overall Study|Adverse Event|0|||
131465900|NCT02576145|473336619|FG000|Overall Study|Withdrawal by Subject|1|||
131465901|NCT02576145|473336620|FG001|Overall Study|Withdrawal by Subject|0|||
131465902|NCT02576145|473336619|FG000|Overall Study|Acute rejection|1|||
131465903|NCT02576145|473336620|FG001|Overall Study|Acute rejection|0|||
131465904|NCT02576145|473336619|FG000|Overall Study|Tetanus Titers Decreased|0|||
131465905|NCT02576145|473336620|FG001|Overall Study|Tetanus Titers Decreased|1|||
131465906|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
131465907|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
131465908|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
131465909|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
131465910|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
131465911|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
131465912|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
131465913|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
131465914|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
131465915|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
131465916|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
131465917|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
131465918|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
131465919|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
131465920|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
131465921|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
131465922|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
131465923|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
131465924|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
131465925|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
131465926|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
131465927|NCT01227824|473336621|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
131465928|NCT01227824|473336622|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
131465929|NCT01227824|473336623|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
131465930|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
131465931|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
131465932|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
131465933|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
131465934|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
131465935|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
131465936|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
131465937|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
131465938|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
131465939|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
131465940|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
131465941|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
131465942|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
131465943|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
131465944|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
131465945|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
131465946|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
131465947|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
131465948|NCT01227824|473336621|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
131465949|NCT01227824|473336622|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
131465950|NCT01227824|473336623|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
131465951|NCT02660138|473336624|FG000|Overall Study|Adverse Event|0|||
131465952|NCT02660138|473336625|FG001|Overall Study|Adverse Event|3|||
131465953|NCT02660138|473336626|FG002|Overall Study|Adverse Event|2|||
131465954|NCT02660138|473336624|FG000|Overall Study|Lack of Efficacy|1|||
131465955|NCT02660138|473336625|FG001|Overall Study|Lack of Efficacy|2|||
131465956|NCT02660138|473336626|FG002|Overall Study|Lack of Efficacy|1|||
131465957|NCT02660138|473336624|FG000|Overall Study|Withdrawal by Subject|7|||
131465958|NCT02660138|473336625|FG001|Overall Study|Withdrawal by Subject|6|||
131465959|NCT02660138|473336626|FG002|Overall Study|Withdrawal by Subject|6|||
131465960|NCT02660138|473336624|FG000|Overall Study|Lost to Follow-up|4|||
131465961|NCT02660138|473336625|FG001|Overall Study|Lost to Follow-up|4|||
131465962|NCT02660138|473336626|FG002|Overall Study|Lost to Follow-up|1|||
131465963|NCT02660138|473336624|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
131465964|NCT02660138|473336625|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
131465965|NCT02660138|473336626|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
131465966|NCT02660138|473336624|FG000|Overall Study|Other|1|||
131465967|NCT02660138|473336625|FG001|Overall Study|Other|1|||
131465968|NCT02660138|473336626|FG002|Overall Study|Other|0|||
131465969|NCT02660138|473336624|FG000|Overall Study|Not treated|0|||
131465970|NCT02660138|473336625|FG001|Overall Study|Not treated|1|||
131465971|NCT02660138|473336626|FG002|Overall Study|Not treated|0|||
131465972|NCT02395302|473336630|FG000|Overall Study|Screen Failure|3|||
131465973|NCT02395302|473336630|FG000|Overall Study|Run In Failure|7|||
131465974|NCT02395302|473336630|FG000|Overall Study|Withdrawal by Subject|2|||
131465975|NCT02395302|473336630|FG000|Overall Study|Physician Decision|2|||
131465976|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
131465977|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
131465978|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
131465979|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
131465980|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
131465981|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
131465982|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
131465983|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
131465984|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
131465985|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
131465986|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
131465987|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
131465988|NCT01087788|473336631|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
131465989|NCT01087788|473336632|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
131465990|NCT01087788|473336633|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
131465991|NCT01087788|473336631|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
131465992|NCT01087788|473336632|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
131465993|NCT01087788|473336633|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
131465994|NCT01087788|473336631|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
131465995|NCT01087788|473336632|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
131465996|NCT01087788|473336633|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
131465997|NCT01087788|473336631|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
131465998|NCT01087788|473336632|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
131465999|NCT01087788|473336633|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
131466000|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
131466001|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
131466002|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
131466003|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
131466004|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
131466005|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
131466006|NCT01087788|473336631|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
131466007|NCT01087788|473336632|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
131466008|NCT01087788|473336633|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
131466009|NCT01087788|473336631|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
131466010|NCT01087788|473336632|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
131466011|NCT01087788|473336633|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
131466012|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
131466013|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
131466014|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
131466015|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
131466016|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
131466017|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
131466018|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
131466019|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
131466020|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
131466021|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
131466022|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
131466023|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
131466024|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
131466025|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
131466026|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
131466027|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
131466028|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
131466029|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
131466030|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
131466031|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
131466032|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
131466033|NCT01087788|473336631|FG000|24-weeks Dose-blind Period|Patient moved|0|||
131466034|NCT01087788|473336632|FG001|24-weeks Dose-blind Period|Patient moved|0|||
131466035|NCT01087788|473336633|FG002|24-weeks Dose-blind Period|Patient moved|1|||
131466036|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
131466037|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
131466038|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
131466039|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
131466040|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
131466041|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
131466042|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
131466043|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
131466044|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
131466045|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
131466046|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
131466047|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
131466048|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
131466049|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
131466050|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
131466051|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
131466052|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
131466053|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
131466054|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
131466055|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
131466056|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
131466057|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
131466058|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
131466059|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
131466060|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
131466061|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
131466062|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
131466063|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
131466064|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
131466065|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
131466066|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
131466067|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
131466068|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
131466069|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
131466070|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
131466071|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
131466072|NCT01087788|473336631|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
131466073|NCT01087788|473336632|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
131466074|NCT01087788|473336633|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
131466075|NCT03044574|473336641|FG000|Overall Study|Lost to Follow-up|37|||
131466076|NCT03044574|473336642|FG001|Overall Study|Lost to Follow-up|45|||
131466077|NCT00710762|473336649|FG000|Overall Study|Progressive disease|27|||
131466078|NCT00710762|473336650|FG001|Overall Study|Progressive disease|30|||
131466079|NCT00710762|473336649|FG000|Overall Study|Adverse Event other disease worsening|2|||
131466080|NCT00710762|473336650|FG001|Overall Study|Adverse Event other disease worsening|1|||
131466081|NCT00710762|473336649|FG000|Overall Study|Other Adverse Event|7|||
131466082|NCT00710762|473336650|FG001|Overall Study|Other Adverse Event|7|||
131466083|NCT00710762|473336649|FG000|Overall Study|Lost to Follow-up|1|||
131466084|NCT00710762|473336650|FG001|Overall Study|Lost to Follow-up|0|||
131466085|NCT00710762|473336649|FG000|Overall Study|Reason other than listed above|2|||
131466086|NCT00710762|473336650|FG001|Overall Study|Reason other than listed above|2|||
131466087|NCT01700439|473336652|FG000|Overall Study|Lost to Follow-up|47|||
131466088|NCT01700439|473336652|FG000|Overall Study|Withdrawal by Subject|183|||
131466089|NCT01700439|473336652|FG000|Overall Study|Death|186|||
131466090|NCT00621621|473336661|FG000|Overall Study|Subjects were exited at EP study|30|||
131466091|NCT00621621|473336662|FG001|Overall Study|Subjects were exited at EP study|0|||
131466092|NCT01077375|473336675|FG000|Overall Study|Adverse Event|2|||
131466093|NCT01077375|473336676|FG001|Overall Study|Adverse Event|15|||
131466094|NCT01077375|473336675|FG000|Overall Study|Lack of Efficacy|6|||
131466095|NCT01077375|473336676|FG001|Overall Study|Lack of Efficacy|8|||
131466096|NCT01077375|473336675|FG000|Overall Study|Withdrawal by Subject|0|||
131466097|NCT01077375|473336676|FG001|Overall Study|Withdrawal by Subject|6|||
131466098|NCT01077375|473336675|FG000|Overall Study|Lost to Follow-up|2|||
131466099|NCT01077375|473336676|FG001|Overall Study|Lost to Follow-up|5|||
131466100|NCT01077375|473336675|FG000|Overall Study|Other Reason|0|||
131466101|NCT01077375|473336676|FG001|Overall Study|Other Reason|1|||
131466102|NCT01924429|473336679|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
131466103|NCT01924429|473336680|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
131466104|NCT00906971|473336681|FG000|Overall Study|Withdrawal by Subject|8|||
131466105|NCT00906971|473336682|FG001|Overall Study|Withdrawal by Subject|2|||
131466106|NCT00906971|473336681|FG000|Overall Study|Lost to Follow-up|0|||
131466107|NCT00906971|473336682|FG001|Overall Study|Lost to Follow-up|1|||
131466108|NCT00545129|473336683|FG000|Overall Study|Lack of Efficacy|2|||
131466109|NCT00545129|473336684|FG001|Overall Study|Lack of Efficacy|5|||
131466110|NCT00545129|473336683|FG000|Overall Study|Death|2|||
131466111|NCT00545129|473336684|FG001|Overall Study|Death|1|||
131466112|NCT00545129|473336683|FG000|Overall Study|Adverse Event|1|||
131466113|NCT00545129|473336684|FG001|Overall Study|Adverse Event|1|||
131466114|NCT00545129|473336683|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
131466115|NCT00545129|473336684|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
131466116|NCT00545129|473336683|FG000|Overall Study|Other|3|||
131466117|NCT00545129|473336684|FG001|Overall Study|Other|3|||
131466118|NCT01894568|473336685|FG000|Overall Study|Adverse Event|2|||
131466119|NCT01894568|473336686|FG001|Overall Study|Adverse Event|3|||
131466120|NCT01894568|473336685|FG000|Overall Study|Protocol required discontinuation|2|||
131466121|NCT01894568|473336686|FG001|Overall Study|Protocol required discontinuation|1|||
131466122|NCT01894568|473336685|FG000|Overall Study|Withdrawal by Subject|5|||
131466123|NCT01894568|473336686|FG001|Overall Study|Withdrawal by Subject|5|||
131466124|NCT01894568|473336685|FG000|Overall Study|Physician Decision|1|||
131466125|NCT01894568|473336686|FG001|Overall Study|Physician Decision|0|||
131466126|NCT01894568|473336685|FG000|Overall Study|Lost to Follow-up|0|||
131466127|NCT01894568|473336686|FG001|Overall Study|Lost to Follow-up|1|||
131466128|NCT00807573|473336687|FG000|Overall Study|Withdrawal by Subject|1|||
131466129|NCT00807573|473336687|FG000|Overall Study|Adverse Event|1|||
131466130|NCT00217464|473336688|FG000|Overall Study|Progression|15|||
131466131|NCT00217464|473336688|FG000|Overall Study|Other|2|||
131466132|NCT01089361|473336689|FG000|Overall Study|Death|1|||
131466133|NCT01089361|473336690|FG001|Overall Study|Death|0|||
131466134|NCT01426789|473336691|FG000|Part 1|Protocol deviation|0|||
131466135|NCT01426789|473336692|FG001|Part 1|Protocol deviation|1|||
131466136|NCT01426789|473336693|FG002|Part 1|Protocol deviation|0|||
131466137|NCT01426789|473336694|FG003|Part 1|Protocol deviation|0|||
131466138|NCT01426789|473336695|FG004|Part 1|Protocol deviation|0|||
131466139|NCT01426789|473336696|FG005|Part 1|Protocol deviation|0|||
131466140|NCT01426789|473336691|FG000|Part 1|Lost to Follow-up|1|||
131466141|NCT01426789|473336692|FG001|Part 1|Lost to Follow-up|2|||
131466142|NCT01426789|473336693|FG002|Part 1|Lost to Follow-up|0|||
131466143|NCT01426789|473336694|FG003|Part 1|Lost to Follow-up|0|||
131466144|NCT01426789|473336695|FG004|Part 1|Lost to Follow-up|0|||
131466145|NCT01426789|473336696|FG005|Part 1|Lost to Follow-up|0|||
131466146|NCT01426789|473336691|FG000|Part 1|Lack of Efficacy|2|||
131466147|NCT01426789|473336692|FG001|Part 1|Lack of Efficacy|1|||
131466148|NCT01426789|473336693|FG002|Part 1|Lack of Efficacy|0|||
131466149|NCT01426789|473336694|FG003|Part 1|Lack of Efficacy|0|||
131466150|NCT01426789|473336695|FG004|Part 1|Lack of Efficacy|0|||
131466151|NCT01426789|473336696|FG005|Part 1|Lack of Efficacy|0|||
131466152|NCT01426789|473336691|FG000|Part 1|Adverse Event|3|||
131466153|NCT01426789|473336692|FG001|Part 1|Adverse Event|0|||
131466154|NCT01426789|473336693|FG002|Part 1|Adverse Event|0|||
131466155|NCT01426789|473336694|FG003|Part 1|Adverse Event|0|||
131466156|NCT01426789|473336695|FG004|Part 1|Adverse Event|0|||
131466157|NCT01426789|473336696|FG005|Part 1|Adverse Event|0|||
131466158|NCT01426789|473336691|FG000|Part 2|Protocol deviation|0|||
131466159|NCT01426789|473336692|FG001|Part 2|Protocol deviation|0|||
131466160|NCT01426789|473336693|FG002|Part 2|Protocol deviation|1|||
131466161|NCT01426789|473336694|FG003|Part 2|Protocol deviation|0|||
131466162|NCT01426789|473336695|FG004|Part 2|Protocol deviation|0|||
131466163|NCT01426789|473336696|FG005|Part 2|Protocol deviation|0|||
131466164|NCT01426789|473336691|FG000|Part 2|Death|0|||
131466165|NCT01426789|473336692|FG001|Part 2|Death|0|||
131466166|NCT01426789|473336693|FG002|Part 2|Death|1|||
131466167|NCT01426789|473336694|FG003|Part 2|Death|0|||
131466168|NCT01426789|473336695|FG004|Part 2|Death|1|||
131466169|NCT01426789|473336696|FG005|Part 2|Death|0|||
131466170|NCT01426789|473336691|FG000|Part 2|Administrative problems|0|||
131466171|NCT01426789|473336692|FG001|Part 2|Administrative problems|0|||
131466172|NCT01426789|473336693|FG002|Part 2|Administrative problems|2|||
131466173|NCT01426789|473336694|FG003|Part 2|Administrative problems|0|||
131466174|NCT01426789|473336695|FG004|Part 2|Administrative problems|1|||
131466175|NCT01426789|473336696|FG005|Part 2|Administrative problems|0|||
131466176|NCT01426789|473336691|FG000|Part 2|Lost to Follow-up|0|||
131466177|NCT01426789|473336692|FG001|Part 2|Lost to Follow-up|0|||
131466178|NCT01426789|473336693|FG002|Part 2|Lost to Follow-up|4|||
131466179|NCT01426789|473336694|FG003|Part 2|Lost to Follow-up|0|||
131466180|NCT01426789|473336695|FG004|Part 2|Lost to Follow-up|1|||
131466181|NCT01426789|473336696|FG005|Part 2|Lost to Follow-up|0|||
131466182|NCT01426789|473336691|FG000|Part 2|Withdrawal by Subject|0|||
131466183|NCT01426789|473336692|FG001|Part 2|Withdrawal by Subject|0|||
131466184|NCT01426789|473336693|FG002|Part 2|Withdrawal by Subject|0|||
131466185|NCT01426789|473336694|FG003|Part 2|Withdrawal by Subject|1|||
131466186|NCT01426789|473336695|FG004|Part 2|Withdrawal by Subject|2|||
131466187|NCT01426789|473336696|FG005|Part 2|Withdrawal by Subject|0|||
131466188|NCT01426789|473336691|FG000|Part 2|Lack of Efficacy|0|||
131466189|NCT01426789|473336692|FG001|Part 2|Lack of Efficacy|0|||
131466190|NCT01426789|473336693|FG002|Part 2|Lack of Efficacy|5|||
131466191|NCT01426789|473336694|FG003|Part 2|Lack of Efficacy|0|||
131466192|NCT01426789|473336695|FG004|Part 2|Lack of Efficacy|2|||
131466193|NCT01426789|473336696|FG005|Part 2|Lack of Efficacy|0|||
131466194|NCT01426789|473336691|FG000|Part 2|Adverse Event|0|||
131466195|NCT01426789|473336692|FG001|Part 2|Adverse Event|0|||
131466196|NCT01426789|473336693|FG002|Part 2|Adverse Event|2|||
131466197|NCT01426789|473336694|FG003|Part 2|Adverse Event|0|||
131466198|NCT01426789|473336695|FG004|Part 2|Adverse Event|1|||
131466199|NCT01426789|473336696|FG005|Part 2|Adverse Event|0|||
131466200|NCT04463069|473336697|FG000|Overall Study|Withdrawal by Subject|2|||
131466201|NCT04463069|473336698|FG001|Overall Study|Withdrawal by Subject|10|||
131466202|NCT04463069|473336697|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
131466203|NCT04463069|473336698|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
131466204|NCT04966910|473338005|FG000|Baseline|Participant did not complete measure|0|||
131466205|NCT04966910|473338006|FG001|Baseline|Participant did not complete measure|0|||
131466206|NCT04966910|473338007|FG002|Baseline|Participant did not complete measure|1|||
131466207|NCT04966910|473338008|FG003|Baseline|Participant did not complete measure|0|||
131466208|NCT04966910|473338005|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
131466209|NCT04966910|473338006|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
131466210|NCT04966910|473338007|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
131466211|NCT04966910|473338008|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
131466212|NCT04966910|473338005|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
131466213|NCT04966910|473338006|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
131466214|NCT04966910|473338007|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
131466215|NCT04966910|473338008|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
131466216|NCT04966910|473338005|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
131466217|NCT04966910|473338006|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
131466218|NCT04966910|473338007|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
131466219|NCT04966910|473338008|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
131466220|NCT02276027|473338010|FG000|Overall Study|Death|1|||
131466221|NCT02276027|473338011|FG001|Overall Study|Death|0|||
131466222|NCT02276027|473338012|FG002|Overall Study|Death|0|||
131466223|NCT02276027|473338013|FG003|Overall Study|Death|2|||
131466224|NCT02276027|473338010|FG000|Overall Study|Physician Decision|0|||
131466225|NCT02276027|473338011|FG001|Overall Study|Physician Decision|0|||
131466226|NCT02276027|473338012|FG002|Overall Study|Physician Decision|0|||
131466227|NCT02276027|473338013|FG003|Overall Study|Physician Decision|1|||
131466228|NCT02276027|473338010|FG000|Overall Study|Progressive disease|1|||
131466229|NCT02276027|473338011|FG001|Overall Study|Progressive disease|13|||
131466230|NCT02276027|473338012|FG002|Overall Study|Progressive disease|12|||
131466231|NCT02276027|473338013|FG003|Overall Study|Progressive disease|14|||
131466232|NCT02276027|473338010|FG000|Overall Study|Subject/guardian decision|0|||
131466233|NCT02276027|473338011|FG001|Overall Study|Subject/guardian decision|1|||
131466234|NCT02276027|473338012|FG002|Overall Study|Subject/guardian decision|0|||
131466235|NCT02276027|473338013|FG003|Overall Study|Subject/guardian decision|3|||
131466236|NCT02276027|473338010|FG000|Overall Study|Adverse Event|0|||
131466237|NCT02276027|473338011|FG001|Overall Study|Adverse Event|2|||
131466238|NCT02276027|473338012|FG002|Overall Study|Adverse Event|8|||
131466239|NCT02276027|473338013|FG003|Overall Study|Adverse Event|2|||
131466240|NCT02446171|473338017|FG000|Overall Study|Withdrawal by Subject|0|||
131466241|NCT02446171|473338018|FG001|Overall Study|Withdrawal by Subject|0|||
131466242|NCT02446171|473338019|FG002|Overall Study|Withdrawal by Subject|2|||
131466243|NCT02446171|473338020|FG003|Overall Study|Withdrawal by Subject|0|||
131466244|NCT04531462|473338021|FG000|Overall Study|Withdrawal by Subject|3|||
131466245|NCT04531462|473338022|FG001|Overall Study|Withdrawal by Subject|1|||
131466246|NCT04531462|473338021|FG000|Overall Study|Adverse Event|3|||
131466247|NCT04531462|473338022|FG001|Overall Study|Adverse Event|3|||
131466248|NCT00504582|473338023|FG000|Overall Study|Lost to Follow-up|1|||
131466249|NCT00504582|473338024|FG001|Overall Study|Lost to Follow-up|0|||
131466250|NCT00504582|473338025|FG002|Overall Study|Lost to Follow-up|0|||
131466251|NCT00348933|473338028|FG000|Overall Study|Withdrawal by Subject|10|||
131466252|NCT00348933|473338028|FG000|Overall Study|Lost to Follow-up|6|||
131466253|NCT00348933|473338028|FG000|Overall Study|Protocol Violation|2|||
131466254|NCT00348933|473338028|FG000|Overall Study|Adverse Event|7|||
131466255|NCT01489111|473338029|FG000|Overall Study|Withdrawal criterion|1|||
131466256|NCT03811093|473338031|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
131466257|NCT03811093|473338032|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
131466258|NCT03811093|473338031|FG000|Overall Study|Unable to measure body fat percentage|2|||
131466259|NCT03811093|473338032|FG001|Overall Study|Unable to measure body fat percentage|0|||
131466260|NCT04456673|473338036|FG000|Overall Study|Adverse Event|7|||
131466261|NCT04456673|473338037|FG001|Overall Study|Adverse Event|14|||
131466262|NCT04456673|473338036|FG000|Overall Study|Poor compliance to protocol|1|||
131466263|NCT04456673|473338037|FG001|Overall Study|Poor compliance to protocol|0|||
131466264|NCT04456673|473338036|FG000|Overall Study|Withdrawal by Subject|31|||
131466265|NCT04456673|473338037|FG001|Overall Study|Withdrawal by Subject|23|||
131466266|NCT04456673|473338036|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
131466267|NCT04456673|473338037|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
131466268|NCT04391049|473338038|FG000|Overall Study|Protocol Violation|1|||
131466269|NCT03874429|473338039|FG000|Overall Study|Adverse Event|2|||
131466270|NCT03874429|473338040|FG001|Overall Study|Adverse Event|2|||
131466271|NCT03874429|473338039|FG000|Overall Study|Lack of Efficacy|0|||
131466272|NCT03874429|473338040|FG001|Overall Study|Lack of Efficacy|1|||
131466273|NCT03874429|473338039|FG000|Overall Study|Covid-19 pandemic|4|||
131466274|NCT03874429|473338040|FG001|Overall Study|Covid-19 pandemic|2|||
131466275|NCT00992589|473338044|FG000|Open-Label Phase|Adverse Event|4|||
131466276|NCT00992589|473338045|FG001|Open-Label Phase|Adverse Event|0|||
131466277|NCT00992589|473338046|FG002|Open-Label Phase|Adverse Event|0|||
131466278|NCT00992589|473338047|FG003|Open-Label Phase|Adverse Event|0|||
131466279|NCT00992589|473338044|FG000|Open-Label Phase|Withdrawal by Subject|20|||
131466280|NCT00992589|473338045|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131466281|NCT00992589|473338046|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131466282|NCT00992589|473338047|FG003|Open-Label Phase|Withdrawal by Subject|0|||
131466283|NCT00992589|473338044|FG000|Open-Label Phase|Lost to Follow-up|1|||
131466284|NCT00992589|473338045|FG001|Open-Label Phase|Lost to Follow-up|0|||
131466285|NCT00992589|473338046|FG002|Open-Label Phase|Lost to Follow-up|0|||
131466286|NCT00992589|473338047|FG003|Open-Label Phase|Lost to Follow-up|0|||
131466287|NCT00992589|473338044|FG000|Open-Label Phase|Protocol Violation|3|||
131466288|NCT00992589|473338045|FG001|Open-Label Phase|Protocol Violation|0|||
131466289|NCT00992589|473338046|FG002|Open-Label Phase|Protocol Violation|0|||
131466290|NCT00992589|473338047|FG003|Open-Label Phase|Protocol Violation|0|||
131466291|NCT00992589|473338044|FG000|Open-Label Phase|Physician Decision|4|||
131466292|NCT00992589|473338045|FG001|Open-Label Phase|Physician Decision|0|||
131466293|NCT00992589|473338046|FG002|Open-Label Phase|Physician Decision|0|||
131466294|NCT00992589|473338047|FG003|Open-Label Phase|Physician Decision|0|||
131466295|NCT00992589|473338044|FG000|Open-Label Phase|Other|45|||
131466296|NCT00992589|473338045|FG001|Open-Label Phase|Other|0|||
131466297|NCT00992589|473338046|FG002|Open-Label Phase|Other|0|||
131466298|NCT00992589|473338047|FG003|Open-Label Phase|Other|0|||
131466299|NCT00992589|473338044|FG000|Double-Blind Phase|Adverse Event|0|||
131466300|NCT00992589|473338045|FG001|Double-Blind Phase|Adverse Event|6|||
131466301|NCT00992589|473338046|FG002|Double-Blind Phase|Adverse Event|2|||
131466302|NCT00992589|473338047|FG003|Double-Blind Phase|Adverse Event|3|||
131466303|NCT00992589|473338044|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131466304|NCT00992589|473338045|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
131466305|NCT00992589|473338046|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
131466306|NCT00992589|473338047|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
131466307|NCT00992589|473338044|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131466308|NCT00992589|473338045|FG001|Double-Blind Phase|Lost to Follow-up|0|||
131466309|NCT00992589|473338046|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131466310|NCT00992589|473338047|FG003|Double-Blind Phase|Lost to Follow-up|2|||
131466311|NCT00992589|473338044|FG000|Double-Blind Phase|Other|0|||
131466312|NCT00992589|473338045|FG001|Double-Blind Phase|Other|1|||
131466313|NCT00992589|473338046|FG002|Double-Blind Phase|Other|6|||
131466314|NCT00992589|473338047|FG003|Double-Blind Phase|Other|3|||
131466315|NCT01215916|473338048|FG000|Overall Study|Progressive Disease|0|||
131466316|NCT01215916|473338049|FG001|Overall Study|Progressive Disease|2|||
131466317|NCT01215916|473338050|FG002|Overall Study|Progressive Disease|1|||
131466318|NCT01215916|473338051|FG003|Overall Study|Progressive Disease|2|||
131466319|NCT01215916|473338052|FG004|Overall Study|Progressive Disease|5|||
131466320|NCT01215916|473338053|FG005|Overall Study|Progressive Disease|4|||
131466321|NCT01215916|473338054|FG006|Overall Study|Progressive Disease|5|||
131466322|NCT01215916|473338055|FG007|Overall Study|Progressive Disease|3|||
131466323|NCT01215916|473338056|FG008|Overall Study|Progressive Disease|1|||
131466324|NCT01215916|473338048|FG000|Overall Study|Adverse Event|1|||
131466325|NCT01215916|473338049|FG001|Overall Study|Adverse Event|1|||
131466326|NCT01215916|473338050|FG002|Overall Study|Adverse Event|0|||
131466327|NCT01215916|473338051|FG003|Overall Study|Adverse Event|1|||
131466328|NCT01215916|473338052|FG004|Overall Study|Adverse Event|0|||
131466329|NCT01215916|473338053|FG005|Overall Study|Adverse Event|0|||
131466330|NCT01215916|473338054|FG006|Overall Study|Adverse Event|3|||
131466331|NCT01215916|473338055|FG007|Overall Study|Adverse Event|0|||
131466332|NCT01215916|473338056|FG008|Overall Study|Adverse Event|0|||
131466333|NCT01215916|473338048|FG000|Overall Study|Withdrawal by Subject|0|||
131466334|NCT01215916|473338049|FG001|Overall Study|Withdrawal by Subject|1|||
131466335|NCT01215916|473338050|FG002|Overall Study|Withdrawal by Subject|1|||
131466336|NCT01215916|473338051|FG003|Overall Study|Withdrawal by Subject|2|||
131466337|NCT01215916|473338052|FG004|Overall Study|Withdrawal by Subject|0|||
131466338|NCT01215916|473338053|FG005|Overall Study|Withdrawal by Subject|0|||
131466339|NCT01215916|473338054|FG006|Overall Study|Withdrawal by Subject|1|||
131466340|NCT01215916|473338055|FG007|Overall Study|Withdrawal by Subject|0|||
131466341|NCT01215916|473338056|FG008|Overall Study|Withdrawal by Subject|0|||
131466342|NCT01215916|473338048|FG000|Overall Study|Death|0|||
131466343|NCT01215916|473338049|FG001|Overall Study|Death|1|||
131466344|NCT01215916|473338050|FG002|Overall Study|Death|0|||
131466345|NCT01215916|473338051|FG003|Overall Study|Death|0|||
131466346|NCT01215916|473338052|FG004|Overall Study|Death|1|||
131466347|NCT01215916|473338053|FG005|Overall Study|Death|0|||
131466348|NCT01215916|473338054|FG006|Overall Study|Death|0|||
131466349|NCT01215916|473338055|FG007|Overall Study|Death|0|||
131466350|NCT01215916|473338056|FG008|Overall Study|Death|1|||
131466351|NCT01215916|473338048|FG000|Overall Study|Physician Decision|0|||
131466352|NCT01215916|473338049|FG001|Overall Study|Physician Decision|0|||
131466353|NCT01215916|473338050|FG002|Overall Study|Physician Decision|1|||
131466354|NCT01215916|473338051|FG003|Overall Study|Physician Decision|1|||
131466355|NCT01215916|473338052|FG004|Overall Study|Physician Decision|0|||
131466356|NCT01215916|473338053|FG005|Overall Study|Physician Decision|0|||
131466357|NCT01215916|473338054|FG006|Overall Study|Physician Decision|0|||
131466358|NCT01215916|473338055|FG007|Overall Study|Physician Decision|0|||
131466359|NCT01215916|473338056|FG008|Overall Study|Physician Decision|0|||
131466360|NCT00045942|473338057|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
131466361|NCT00045942|473338058|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466362|NCT00045942|473338059|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466363|NCT00045942|473338060|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466364|NCT00045942|473338061|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466365|NCT00045942|473338062|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466366|NCT00045942|473338063|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466367|NCT00045942|473338064|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466368|NCT00045942|473338065|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
131466369|NCT00045942|473338057|FG000|PKC412A2104 (Core)|Adverse Event|5|||
131466370|NCT00045942|473338058|FG001|PKC412A2104 (Core)|Adverse Event|0|||
131466371|NCT00045942|473338059|FG002|PKC412A2104 (Core)|Adverse Event|0|||
131466372|NCT00045942|473338060|FG003|PKC412A2104 (Core)|Adverse Event|0|||
131466373|NCT00045942|473338061|FG004|PKC412A2104 (Core)|Adverse Event|0|||
131466374|NCT00045942|473338062|FG005|PKC412A2104 (Core)|Adverse Event|0|||
131466375|NCT00045942|473338063|FG006|PKC412A2104 (Core)|Adverse Event|0|||
131466376|NCT00045942|473338064|FG007|PKC412A2104 (Core)|Adverse Event|0|||
131466377|NCT00045942|473338065|FG008|PKC412A2104 (Core)|Adverse Event|0|||
131466378|NCT00045942|473338057|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
131466379|NCT00045942|473338058|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466380|NCT00045942|473338059|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466381|NCT00045942|473338060|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466382|NCT00045942|473338061|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466383|NCT00045942|473338062|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466384|NCT00045942|473338063|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466385|NCT00045942|473338064|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466386|NCT00045942|473338065|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
131466387|NCT00045942|473338057|FG000|PKC412A2104 (Core)|Death|1|||
131466388|NCT00045942|473338058|FG001|PKC412A2104 (Core)|Death|0|||
131466389|NCT00045942|473338059|FG002|PKC412A2104 (Core)|Death|0|||
131466390|NCT00045942|473338060|FG003|PKC412A2104 (Core)|Death|0|||
131466391|NCT00045942|473338061|FG004|PKC412A2104 (Core)|Death|0|||
131466392|NCT00045942|473338062|FG005|PKC412A2104 (Core)|Death|0|||
131466393|NCT00045942|473338063|FG006|PKC412A2104 (Core)|Death|0|||
131466394|NCT00045942|473338064|FG007|PKC412A2104 (Core)|Death|0|||
131466395|NCT00045942|473338065|FG008|PKC412A2104 (Core)|Death|0|||
131466396|NCT00045942|473338057|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
131466397|NCT00045942|473338058|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
131466398|NCT00045942|473338059|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
131466399|NCT00045942|473338060|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
131466400|NCT00045942|473338061|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
131466401|NCT00045942|473338062|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
131466402|NCT00045942|473338063|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
131466403|NCT00045942|473338064|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
131466404|NCT00045942|473338065|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
131466405|NCT00045942|473338057|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
131466406|NCT00045942|473338058|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
131466407|NCT00045942|473338059|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
131466408|NCT00045942|473338060|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
131466409|NCT00045942|473338061|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
131466410|NCT00045942|473338062|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
131466411|NCT00045942|473338063|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
131466412|NCT00045942|473338064|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
131466413|NCT00045942|473338065|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
131466414|NCT00045942|473338057|FG000|PKC412A2104E1|Lack of Efficacy|0|||
131466415|NCT00045942|473338058|FG001|PKC412A2104E1|Lack of Efficacy|11|||
131466416|NCT00045942|473338059|FG002|PKC412A2104E1|Lack of Efficacy|11|||
131466417|NCT00045942|473338060|FG003|PKC412A2104E1|Lack of Efficacy|23|||
131466418|NCT00045942|473338061|FG004|PKC412A2104E1|Lack of Efficacy|17|||
131466419|NCT00045942|473338062|FG005|PKC412A2104E1|Lack of Efficacy|0|||
131466420|NCT00045942|473338063|FG006|PKC412A2104E1|Lack of Efficacy|0|||
131466421|NCT00045942|473338064|FG007|PKC412A2104E1|Lack of Efficacy|0|||
131466422|NCT00045942|473338065|FG008|PKC412A2104E1|Lack of Efficacy|0|||
131466423|NCT00045942|473338057|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
131466424|NCT00045942|473338058|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
131466425|NCT00045942|473338059|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
131466426|NCT00045942|473338060|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
131466427|NCT00045942|473338061|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
131466428|NCT00045942|473338062|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
131466429|NCT00045942|473338063|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
131466430|NCT00045942|473338064|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
131466431|NCT00045942|473338065|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
131466432|NCT00045942|473338057|FG000|PKC412A2104E1|Adverse Event|0|||
131466433|NCT00045942|473338058|FG001|PKC412A2104E1|Adverse Event|1|||
131466434|NCT00045942|473338059|FG002|PKC412A2104E1|Adverse Event|1|||
131466435|NCT00045942|473338060|FG003|PKC412A2104E1|Adverse Event|3|||
131466436|NCT00045942|473338061|FG004|PKC412A2104E1|Adverse Event|6|||
131466437|NCT00045942|473338062|FG005|PKC412A2104E1|Adverse Event|0|||
131466438|NCT00045942|473338063|FG006|PKC412A2104E1|Adverse Event|0|||
131466439|NCT00045942|473338064|FG007|PKC412A2104E1|Adverse Event|0|||
131466440|NCT00045942|473338065|FG008|PKC412A2104E1|Adverse Event|0|||
131466441|NCT00045942|473338057|FG000|PKC412A2104E1|Death|0|||
131466442|NCT00045942|473338058|FG001|PKC412A2104E1|Death|4|||
131466443|NCT00045942|473338059|FG002|PKC412A2104E1|Death|1|||
131466444|NCT00045942|473338060|FG003|PKC412A2104E1|Death|1|||
131466445|NCT00045942|473338061|FG004|PKC412A2104E1|Death|1|||
131466446|NCT00045942|473338062|FG005|PKC412A2104E1|Death|0|||
131466447|NCT00045942|473338063|FG006|PKC412A2104E1|Death|0|||
131466448|NCT00045942|473338064|FG007|PKC412A2104E1|Death|0|||
131466449|NCT00045942|473338065|FG008|PKC412A2104E1|Death|0|||
131466450|NCT00045942|473338057|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466451|NCT00045942|473338058|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466452|NCT00045942|473338059|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
131466453|NCT00045942|473338060|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
131466454|NCT00045942|473338061|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466455|NCT00045942|473338062|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466456|NCT00045942|473338063|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466457|NCT00045942|473338064|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466458|NCT00045942|473338065|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
131466459|NCT00045942|473338057|FG000|PKC412A2104E2|Lost to Follow-up|0|||
131466460|NCT00045942|473338058|FG001|PKC412A2104E2|Lost to Follow-up|0|||
131466461|NCT00045942|473338059|FG002|PKC412A2104E2|Lost to Follow-up|0|||
131466462|NCT00045942|473338060|FG003|PKC412A2104E2|Lost to Follow-up|0|||
131466463|NCT00045942|473338061|FG004|PKC412A2104E2|Lost to Follow-up|0|||
131466464|NCT00045942|473338062|FG005|PKC412A2104E2|Lost to Follow-up|0|||
131466465|NCT00045942|473338063|FG006|PKC412A2104E2|Lost to Follow-up|0|||
131466466|NCT00045942|473338064|FG007|PKC412A2104E2|Lost to Follow-up|3|||
131466467|NCT00045942|473338065|FG008|PKC412A2104E2|Lost to Follow-up|0|||
131466468|NCT00045942|473338057|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
131466469|NCT00045942|473338058|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
131466470|NCT00045942|473338059|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
131466471|NCT00045942|473338060|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
131466472|NCT00045942|473338061|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
131466473|NCT00045942|473338062|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
131466474|NCT00045942|473338063|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
131466475|NCT00045942|473338064|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
131466476|NCT00045942|473338065|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
131466477|NCT00045942|473338057|FG000|PKC412A2104E2|Lack of Efficacy|0|||
131466478|NCT00045942|473338058|FG001|PKC412A2104E2|Lack of Efficacy|0|||
131466479|NCT00045942|473338059|FG002|PKC412A2104E2|Lack of Efficacy|0|||
131466480|NCT00045942|473338060|FG003|PKC412A2104E2|Lack of Efficacy|0|||
131466481|NCT00045942|473338061|FG004|PKC412A2104E2|Lack of Efficacy|0|||
131466482|NCT00045942|473338062|FG005|PKC412A2104E2|Lack of Efficacy|3|||
131466483|NCT00045942|473338063|FG006|PKC412A2104E2|Lack of Efficacy|2|||
131466484|NCT00045942|473338064|FG007|PKC412A2104E2|Lack of Efficacy|2|||
131466485|NCT00045942|473338065|FG008|PKC412A2104E2|Lack of Efficacy|6|||
131466486|NCT00045942|473338057|FG000|PKC412A2104E2|Adverse Event|0|||
131466487|NCT00045942|473338058|FG001|PKC412A2104E2|Adverse Event|0|||
131466488|NCT00045942|473338059|FG002|PKC412A2104E2|Adverse Event|0|||
131466489|NCT00045942|473338060|FG003|PKC412A2104E2|Adverse Event|0|||
131466490|NCT00045942|473338061|FG004|PKC412A2104E2|Adverse Event|0|||
131466491|NCT00045942|473338062|FG005|PKC412A2104E2|Adverse Event|4|||
131466492|NCT00045942|473338063|FG006|PKC412A2104E2|Adverse Event|3|||
131466493|NCT00045942|473338064|FG007|PKC412A2104E2|Adverse Event|1|||
131466494|NCT00045942|473338065|FG008|PKC412A2104E2|Adverse Event|0|||
131466495|NCT00045942|473338057|FG000|PKC412A2104E2|Death|0|||
131466496|NCT00045942|473338058|FG001|PKC412A2104E2|Death|0|||
131466497|NCT00045942|473338059|FG002|PKC412A2104E2|Death|0|||
131466498|NCT00045942|473338060|FG003|PKC412A2104E2|Death|0|||
131466499|NCT00045942|473338061|FG004|PKC412A2104E2|Death|0|||
131466500|NCT00045942|473338062|FG005|PKC412A2104E2|Death|1|||
131466501|NCT00045942|473338063|FG006|PKC412A2104E2|Death|2|||
131466502|NCT00045942|473338064|FG007|PKC412A2104E2|Death|0|||
131466503|NCT00045942|473338065|FG008|PKC412A2104E2|Death|0|||
131466504|NCT02586506|473338067|FG000|Overall Study|Protocol Violation|6|||
131466505|NCT02586506|473338067|FG000|Overall Study|Lost to Follow-up|1|||
131466506|NCT02586506|473338067|FG000|Overall Study|Other Reason|2|||
131466507|NCT00674154|473338068|FG000|Overall Study|Withdrawal by Subject|3|||
131466508|NCT00674154|473338069|FG001|Overall Study|Withdrawal by Subject|1|||
131466509|NCT00674154|473338068|FG000|Overall Study|Did not want parathyroidectomy|0|||
131466510|NCT00674154|473338069|FG001|Overall Study|Did not want parathyroidectomy|2|||
131466511|NCT05093790|473338070|FG000|Overall Study|Failure to meet continuation criteria|0|||
131466512|NCT05093790|473338071|FG001|Overall Study|Failure to meet continuation criteria|0|||
131466513|NCT05093790|473338072|FG002|Overall Study|Failure to meet continuation criteria|1|||
131466514|NCT05093790|473338073|FG003|Overall Study|Failure to meet continuation criteria|0|||
131466515|NCT05093790|473338070|FG000|Overall Study|Adverse Event|1|||
131466516|NCT05093790|473338071|FG001|Overall Study|Adverse Event|0|||
131466517|NCT05093790|473338072|FG002|Overall Study|Adverse Event|0|||
131466518|NCT05093790|473338073|FG003|Overall Study|Adverse Event|0|||
131466519|NCT01903252|473338075|FG000|Double-Blind Induction|Adverse Event|20|||
131466520|NCT01903252|473338076|FG001|Double-Blind Induction|Adverse Event|18|||
131466521|NCT01903252|473338077|FG002|Double-Blind Induction|Adverse Event|0|||
131466522|NCT01903252|473338078|FG003|Double-Blind Induction|Adverse Event|0|||
131466523|NCT01903252|473338079|FG004|Double-Blind Induction|Adverse Event|0|||
131466524|NCT01903252|473338080|FG005|Double-Blind Induction|Adverse Event|0|||
131466525|NCT01903252|473338075|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
131466526|NCT01903252|473338076|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
131466527|NCT01903252|473338077|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
131466528|NCT01903252|473338078|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
131466529|NCT01903252|473338079|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
131466530|NCT01903252|473338080|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
131466531|NCT01903252|473338075|FG000|Double-Blind Induction|Physician Decision|2|||
131466532|NCT01903252|473338076|FG001|Double-Blind Induction|Physician Decision|3|||
131466533|NCT01903252|473338077|FG002|Double-Blind Induction|Physician Decision|0|||
131466534|NCT01903252|473338078|FG003|Double-Blind Induction|Physician Decision|0|||
131466535|NCT01903252|473338079|FG004|Double-Blind Induction|Physician Decision|0|||
131466536|NCT01903252|473338080|FG005|Double-Blind Induction|Physician Decision|0|||
131466537|NCT01903252|473338075|FG000|Double-Blind Induction|non-compliance,|7|||
131466538|NCT01903252|473338076|FG001|Double-Blind Induction|non-compliance,|7|||
131466539|NCT01903252|473338077|FG002|Double-Blind Induction|non-compliance,|0|||
131466540|NCT01903252|473338078|FG003|Double-Blind Induction|non-compliance,|0|||
131466541|NCT01903252|473338079|FG004|Double-Blind Induction|non-compliance,|0|||
131466542|NCT01903252|473338080|FG005|Double-Blind Induction|non-compliance,|0|||
131466543|NCT01903252|473338075|FG000|Extended Induction, Open-Label|Adverse Event|0|||
131466544|NCT01903252|473338076|FG001|Extended Induction, Open-Label|Adverse Event|0|||
131466545|NCT01903252|473338077|FG002|Extended Induction, Open-Label|Adverse Event|17|||
131466546|NCT01903252|473338078|FG003|Extended Induction, Open-Label|Adverse Event|0|||
131466547|NCT01903252|473338079|FG004|Extended Induction, Open-Label|Adverse Event|0|||
131466548|NCT01903252|473338080|FG005|Extended Induction, Open-Label|Adverse Event|0|||
131466549|NCT01903252|473338075|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
131466550|NCT01903252|473338076|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
131466551|NCT01903252|473338077|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
131466552|NCT01903252|473338078|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
131466553|NCT01903252|473338079|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
131466554|NCT01903252|473338080|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
131466555|NCT01903252|473338075|FG000|Extended Induction, Open-Label|Physician Decision|0|||
131466556|NCT01903252|473338076|FG001|Extended Induction, Open-Label|Physician Decision|0|||
131466557|NCT01903252|473338077|FG002|Extended Induction, Open-Label|Physician Decision|1|||
131466558|NCT01903252|473338078|FG003|Extended Induction, Open-Label|Physician Decision|0|||
131466559|NCT01903252|473338079|FG004|Extended Induction, Open-Label|Physician Decision|0|||
131466560|NCT01903252|473338080|FG005|Extended Induction, Open-Label|Physician Decision|0|||
131466561|NCT01903252|473338075|FG000|Maintenance, Open-Label|Adverse Event|0|||
131466562|NCT01903252|473338076|FG001|Maintenance, Open-Label|Adverse Event|0|||
131466563|NCT01903252|473338077|FG002|Maintenance, Open-Label|Adverse Event|0|||
131466564|NCT01903252|473338078|FG003|Maintenance, Open-Label|Adverse Event|3|||
131466565|NCT01903252|473338079|FG004|Maintenance, Open-Label|Adverse Event|9|||
131466566|NCT01903252|473338080|FG005|Maintenance, Open-Label|Adverse Event|14|||
131466567|NCT01903252|473338075|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
131466568|NCT01903252|473338076|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
131466569|NCT01903252|473338077|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
131466570|NCT01903252|473338078|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
131466571|NCT01903252|473338079|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
131466572|NCT01903252|473338080|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
131466573|NCT01903252|473338075|FG000|Maintenance, Open-Label|Other|0|||
131466574|NCT01903252|473338076|FG001|Maintenance, Open-Label|Other|0|||
131466575|NCT01903252|473338077|FG002|Maintenance, Open-Label|Other|0|||
131466576|NCT01903252|473338078|FG003|Maintenance, Open-Label|Other|2|||
131466577|NCT01903252|473338079|FG004|Maintenance, Open-Label|Other|6|||
131466578|NCT01903252|473338080|FG005|Maintenance, Open-Label|Other|2|||
131466579|NCT02437110|473338081|FG000|Screening|Lost to Follow-up|3|||
131466580|NCT02437110|473338081|FG000|Screening|Physician Decision|1|||
131466581|NCT02437110|473338081|FG000|ART|Adverse Event|3|||
131466582|NCT02437110|473338081|FG000|ART|Protocol Violation|3|||
131466583|NCT02437110|473338081|FG000|ART|Withdrawal by Subject|4|||
131466584|NCT02437110|473338081|FG000|ART|Lost to follow-up prior to start of intervention|1|||
131466585|NCT02437110|473338081|FG000|ART|Physician decision prior to start of intervention|2|||
131466586|NCT02437110|473338081|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
131466587|NCT02437110|473338081|FG000|Post-ART|Lost to Follow-up|3|||
131466588|NCT02437110|473338081|FG000|Post-ART|Protocol Violation|4|||
131466589|NCT02437110|473338081|FG000|Post-ART|Withdrawal by Subject|3|||
131466590|NCT01381562|473338083|FG000|Overall Study|Adverse Event|0|||
131466591|NCT01381562|473338084|FG001|Overall Study|Adverse Event|1|||
131466592|NCT01381562|473338085|FG002|Overall Study|Adverse Event|0|||
131466593|NCT01642732|473338089|FG000|Overall Study|Withdrawal by Subject|1|||
131466594|NCT00308581|473338090|FG000|Induction Phase|Adverse Event|0|||
131466595|NCT00308581|473338091|FG001|Induction Phase|Adverse Event|0|||
131466596|NCT00308581|473338092|FG002|Induction Phase|Adverse Event|37|||
131466597|NCT00308581|473338090|FG000|Induction Phase|Lack of Efficacy|0|||
131466598|NCT00308581|473338091|FG001|Induction Phase|Lack of Efficacy|0|||
131466599|NCT00308581|473338092|FG002|Induction Phase|Lack of Efficacy|121|||
131466600|NCT00308581|473338090|FG000|Induction Phase|Withdrawal by Subject|0|||
131466601|NCT00308581|473338091|FG001|Induction Phase|Withdrawal by Subject|0|||
131466602|NCT00308581|473338092|FG002|Induction Phase|Withdrawal by Subject|5|||
131466603|NCT00308581|473338090|FG000|Induction Phase|Unknown reason|0|||
131466604|NCT00308581|473338091|FG001|Induction Phase|Unknown reason|0|||
131466605|NCT00308581|473338092|FG002|Induction Phase|Unknown reason|3|||
131466606|NCT00308581|473338090|FG000|Randomized Maintenance Phase|Adverse Event|10|||
131466607|NCT00308581|473338091|FG001|Randomized Maintenance Phase|Adverse Event|17|||
131466608|NCT00308581|473338092|FG002|Randomized Maintenance Phase|Adverse Event|0|||
131466609|NCT00308581|473338090|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
131466610|NCT00308581|473338091|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
131466611|NCT00308581|473338092|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
131466612|NCT00308581|473338090|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
131466613|NCT00308581|473338091|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
131466614|NCT00308581|473338092|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
131466615|NCT00308581|473338090|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
131466616|NCT00308581|473338091|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
131466617|NCT00308581|473338092|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
131466618|NCT00308581|473338090|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
131466619|NCT00308581|473338091|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
131466620|NCT00308581|473338092|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
131466621|NCT00308581|473338090|FG000|Randomized Maintenance Phase|Unknown reason|3|||
131466622|NCT00308581|473338091|FG001|Randomized Maintenance Phase|Unknown reason|0|||
131466623|NCT00308581|473338092|FG002|Randomized Maintenance Phase|Unknown reason|0|||
131466624|NCT00899353|473338093|FG000|Overall Study|Adverse Event|2|||
131466625|NCT00899353|473338093|FG000|Overall Study|Lost to Follow-up|1|||
131466626|NCT00899353|473338093|FG000|Overall Study|Withdrawal by Subject|2|||
131466627|NCT01284491|473338102|FG000|Overall Study|Study termination|13|||
131466628|NCT00495040|473338105|FG000|Overall Study|Withdrawal by Subject|3|||
131466629|NCT01514370|473338110|FG000|Overall Study|Protocol Violation|2|||
131466630|NCT01514370|473338111|FG001|Overall Study|Protocol Violation|3|||
131466631|NCT01514370|473338110|FG000|Overall Study|Lost to Follow-up|0|||
131466632|NCT01514370|473338111|FG001|Overall Study|Lost to Follow-up|2|||
131466633|NCT01514370|473338110|FG000|Overall Study|Withdrawal by Subject|2|||
131466634|NCT01514370|473338111|FG001|Overall Study|Withdrawal by Subject|1|||
131466635|NCT01514370|473338110|FG000|Overall Study|Adverse Event|1|||
131466636|NCT01514370|473338111|FG001|Overall Study|Adverse Event|3|||
131466637|NCT01514370|473338110|FG000|Overall Study|Other|6|||
131466638|NCT01514370|473338111|FG001|Overall Study|Other|7|||
131466639|NCT01551420|473338112|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
131466640|NCT01551420|473338113|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
131466641|NCT01551420|473338112|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
131466642|NCT01551420|473338113|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
131466643|NCT01551420|473338112|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
131466644|NCT01551420|473338113|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
131466645|NCT01551420|473338112|FG000|Screened for Part B Eligibility|Declined participation|8|||
131466646|NCT01551420|473338113|FG001|Screened for Part B Eligibility|Declined participation|1|||
131466647|NCT01551420|473338112|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
131466648|NCT01551420|473338113|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
131466649|NCT01551420|473338112|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
131466650|NCT01551420|473338113|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
131466651|NCT01551420|473338112|FG000|Home Use (Part B)|Withdrawal by staff|0|||
131466652|NCT01551420|473338113|FG001|Home Use (Part B)|Withdrawal by staff|1|||
131466653|NCT04054947|473338114|FG000|Overall Study|Withdrawal by Subject|1|||
131466654|NCT04054947|473338115|FG001|Overall Study|Withdrawal by Subject|0|||
131466655|NCT04054947|473338114|FG000|Overall Study|Lost to Follow-up|2|||
131466656|NCT04054947|473338115|FG001|Overall Study|Lost to Follow-up|5|||
131466657|NCT00853970|473338124|FG000|Overall Study|Withdrawal by Subject|2|||
131466658|NCT00853970|473338125|FG001|Overall Study|Withdrawal by Subject|1|||
131466659|NCT00853970|473338124|FG000|Overall Study|Cancelled surgery|4|||
131466660|NCT00853970|473338125|FG001|Overall Study|Cancelled surgery|2|||
131466661|NCT02055365|473339531|FG000|Overall Study|Prematurely Withdrawn|1|||
131466662|NCT03039621|473339532|FG000|Overall Study|Violation of inclusion criteria|3|||
131466663|NCT03039621|473339533|FG001|Overall Study|Violation of inclusion criteria|2|||
131466664|NCT03039621|473339532|FG000|Overall Study|Non-compliance with protocol requirement|4|||
131466665|NCT03039621|473339533|FG001|Overall Study|Non-compliance with protocol requirement|5|||
131466666|NCT03039621|473339532|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
131466667|NCT03039621|473339533|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
131466668|NCT03039621|473339532|FG000|Overall Study|Violation of non-inclusion criteria|1|||
131466669|NCT03039621|473339533|FG001|Overall Study|Violation of non-inclusion criteria|2|||
131466670|NCT03603509|473339534|FG000|Overall Study|Lost to Follow-up|3|||
131466671|NCT03603509|473339535|FG001|Overall Study|Lost to Follow-up|4|||
131466672|NCT02656680|473339538|FG000|Overall Study|Lost to Follow-up|0|||
131466673|NCT02656680|473339539|FG001|Overall Study|Lost to Follow-up|1|||
131466674|NCT02656680|473339540|FG002|Overall Study|Lost to Follow-up|7|||
131466675|NCT01258998|473339541|FG000|Overall Study|Ineligible|1|||
131466676|NCT01143389|473339544|FG000|Overall Study|Lost to Follow-up|26|||
131466677|NCT01143389|473339545|FG001|Overall Study|Lost to Follow-up|25|||
131466678|NCT00002931|473339548|FG000|Overall Study|rapidly progressing disease during|2|||
131466679|NCT03224598|473339549|FG000|Overall Study|Lost to Follow-up|0|||
131466680|NCT03224598|473339550|FG001|Overall Study|Lost to Follow-up|2|||
131466681|NCT03224598|473339551|FG002|Overall Study|Lost to Follow-up|0|||
131466682|NCT03224598|473339549|FG000|Overall Study|Other|0|||
131466683|NCT03224598|473339550|FG001|Overall Study|Other|1|||
131466684|NCT03224598|473339551|FG002|Overall Study|Other|0|||
131466685|NCT00464490|473339552|FG000|Overall Study|Physician Decision|11|||
131466686|NCT00464490|473339553|FG001|Overall Study|Physician Decision|11|||
131466687|NCT03188042|473339554|FG000|Overall Study|Withdrawal by Subject|1|||
131466688|NCT03188042|473339555|FG001|Overall Study|Withdrawal by Subject|1|||
131466689|NCT00603590|473339556|FG000|Overall Study|Did not attend study clinic|39|||
131466690|NCT00603590|473339557|FG001|Overall Study|Did not attend study clinic|30|||
131466691|NCT00603590|473339556|FG000|Overall Study|Refused blood test|5|||
131466692|NCT00603590|473339557|FG001|Overall Study|Refused blood test|1|||
131466693|NCT00603590|473339556|FG000|Overall Study|Patient discontinued study drug|22|||
131466694|NCT00603590|473339557|FG001|Overall Study|Patient discontinued study drug|15|||
131466695|NCT00603590|473339556|FG000|Overall Study|Adverse Event|2|||
131466696|NCT00603590|473339557|FG001|Overall Study|Adverse Event|0|||
131466697|NCT00603590|473339556|FG000|Overall Study|Lost to Follow-up|8|||
131466698|NCT00603590|473339557|FG001|Overall Study|Lost to Follow-up|4|||
131466699|NCT00603590|473339556|FG000|Overall Study|Cardiovascular event|0|||
131466700|NCT00603590|473339557|FG001|Overall Study|Cardiovascular event|1|||
131466701|NCT03565367|473339558|FG000|Overall Study|No scan due to technical issues|4|||
131466702|NCT03565367|473339559|FG001|Overall Study|No scan due to technical issues|0|||
131466703|NCT00137839|473339562|FG000|Overall Study|Adverse Event|7|||
131466704|NCT00137839|473339562|FG000|Overall Study|Physician Decision|7|||
131466705|NCT00137839|473339562|FG000|Overall Study|Death|8|||
131466706|NCT00137839|473339562|FG000|Overall Study|Disease Progression|60|||
131466707|NCT00137839|473339562|FG000|Overall Study|Not Start Treatment|1|||
131466708|NCT00137839|473339562|FG000|Overall Study|Prolonged Treatment Delay|1|||
131466709|NCT02882152|473339563|FG000|Overall Study|Lost to Follow-up|1|||
131466710|NCT02882152|473339564|FG001|Overall Study|Lost to Follow-up|0|||
131466711|NCT01475071|473339570|FG000|Overall Study|Physician Decision|1|||
131466712|NCT01475071|473339570|FG000|Overall Study|Withdrawal by Subject|6|||
131466713|NCT01475071|473339570|FG000|Overall Study|Lost to Follow-up|1|||
131466714|NCT01343823|473339571|FG000|Overall Study|Study Terminated|1|||
131466715|NCT01343823|473339572|FG001|Overall Study|Study Terminated|0|||
131466716|NCT01343823|473339573|FG002|Overall Study|Study Terminated|0|||
131466717|NCT01343823|473339574|FG003|Overall Study|Study Terminated|1|||
131466718|NCT01343823|473339571|FG000|Overall Study|Withdrawal by Subject|1|||
131466719|NCT01343823|473339572|FG001|Overall Study|Withdrawal by Subject|0|||
131466720|NCT01343823|473339573|FG002|Overall Study|Withdrawal by Subject|0|||
131466721|NCT01343823|473339574|FG003|Overall Study|Withdrawal by Subject|0|||
131466722|NCT00923364|473339575|FG000|Overall Study|Death|3|||
131466723|NCT00923364|473339576|FG001|Overall Study|Death|0|||
131466724|NCT00923364|473339575|FG000|Overall Study|Did not go to transplant|1|||
131466725|NCT00923364|473339576|FG001|Overall Study|Did not go to transplant|0|||
131466726|NCT01011478|473339577|FG000|Overall Study|No follow up data|12|||
131466727|NCT01011478|473339578|FG001|Overall Study|No follow up data|7|||
131466728|NCT04352127|473339580|FG000|Overall Study|Unable to obtain readings|4|||
131466729|NCT04352127|473339581|FG001|Overall Study|Unable to obtain readings|1|||
131466730|NCT03468543|473339582|FG000|Overall Study|Protocol stopping rules met|3|||
131466731|NCT01437995|473339583|FG000|Overall Study|Lost to Follow-up|11|||
131466732|NCT01437995|473339584|FG001|Overall Study|Lost to Follow-up|18|||
131466733|NCT01437995|473339585|FG002|Overall Study|Lost to Follow-up|20|||
131466734|NCT05338671|473339586|FG000|Overall Study|Lost to Follow-up|2|||
131466735|NCT05338671|473339587|FG001|Overall Study|Lost to Follow-up|2|||
131466736|NCT05338671|473339586|FG000|Overall Study|Root canal completed in a single visit|1|||
131466737|NCT05338671|473339587|FG001|Overall Study|Root canal completed in a single visit|0|||
131466738|NCT00159822|473339588|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
131466739|NCT00159822|473339588|FG000|Voriconazole Treatment Period|Adverse Event|9|||
131466740|NCT00159822|473339588|FG000|Voriconazole Treatment Period|Death|4|||
131466741|NCT00159822|473339588|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
131466742|NCT00159822|473339588|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
131466743|NCT00159822|473339588|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
131466744|NCT00159822|473339588|FG000|Post-treatment Follow-up Period|Death|1|||
131466745|NCT00159822|473339588|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
131466746|NCT00159822|473339588|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
131466747|NCT00275821|473339590|FG000|Overall Study|Adverse Event|4|||
131466748|NCT00275821|473339591|FG001|Overall Study|Adverse Event|12|||
131466749|NCT00275821|473339592|FG002|Overall Study|Adverse Event|5|||
131466750|NCT00275821|473339590|FG000|Overall Study|Administrative problems|3|||
131466751|NCT00275821|473339591|FG001|Overall Study|Administrative problems|4|||
131466752|NCT00275821|473339592|FG002|Overall Study|Administrative problems|4|||
131466753|NCT00275821|473339590|FG000|Overall Study|Withdrawal by Subject|0|||
131466754|NCT00275821|473339591|FG001|Overall Study|Withdrawal by Subject|2|||
131466755|NCT00275821|473339592|FG002|Overall Study|Withdrawal by Subject|1|||
131466756|NCT00275821|473339590|FG000|Overall Study|Lost to Follow-up|0|||
131466757|NCT00275821|473339591|FG001|Overall Study|Lost to Follow-up|1|||
131466758|NCT00275821|473339592|FG002|Overall Study|Lost to Follow-up|1|||
131466759|NCT00275821|473339590|FG000|Overall Study|Death|0|||
131466760|NCT00275821|473339591|FG001|Overall Study|Death|2|||
131466761|NCT00275821|473339592|FG002|Overall Study|Death|1|||
131466762|NCT00275821|473339590|FG000|Overall Study|Lack of Efficacy|2|||
131466763|NCT00275821|473339591|FG001|Overall Study|Lack of Efficacy|1|||
131466764|NCT00275821|473339592|FG002|Overall Study|Lack of Efficacy|0|||
131466765|NCT00275821|473339590|FG000|Overall Study|Protocol Violation|5|||
131466766|NCT00275821|473339591|FG001|Overall Study|Protocol Violation|1|||
131466767|NCT00275821|473339592|FG002|Overall Study|Protocol Violation|0|||
131466768|NCT00329901|473339593|FG000|Overall Study|Withdrawal by Subject|4|||
131466769|NCT00329901|473339594|FG001|Overall Study|Withdrawal by Subject|3|||
131466770|NCT00329901|473339595|FG002|Overall Study|Withdrawal by Subject|2|||
131466771|NCT00329901|473339593|FG000|Overall Study|Lost to Follow-up|2|||
131466772|NCT00329901|473339594|FG001|Overall Study|Lost to Follow-up|0|||
131466773|NCT00329901|473339595|FG002|Overall Study|Lost to Follow-up|1|||
131466774|NCT00329901|473339593|FG000|Overall Study|Protocol Violation|1|||
131466775|NCT00329901|473339594|FG001|Overall Study|Protocol Violation|0|||
131466776|NCT00329901|473339595|FG002|Overall Study|Protocol Violation|1|||
131466777|NCT00329901|473339593|FG000|Overall Study|Unable to classify|2|||
131466778|NCT00329901|473339594|FG001|Overall Study|Unable to classify|2|||
131466779|NCT00329901|473339595|FG002|Overall Study|Unable to classify|0|||
131466780|NCT02142387|473339596|FG000|Overall Study|<19 years old|49|||
131466781|NCT02142387|473339597|FG001|Overall Study|<19 years old|326|||
131466782|NCT02142387|473339596|FG000|Overall Study|non-cardiac etiology|504|||
131466783|NCT02142387|473339597|FG001|Overall Study|non-cardiac etiology|3431|||
131466784|NCT02142387|473339596|FG000|Overall Study|CPR not performed|74|||
131466785|NCT02142387|473339597|FG001|Overall Study|CPR not performed|473|||
131466786|NCT02142387|473339596|FG000|Overall Study|witnessed by paramedic|139|||
131466787|NCT02142387|473339597|FG001|Overall Study|witnessed by paramedic|917|||
131466788|NCT02142387|473339596|FG000|Overall Study|incomplete data|1|||
131466789|NCT02142387|473339597|FG001|Overall Study|incomplete data|9|||
131466790|NCT02142387|473339596|FG000|Overall Study|occurred not at home|298|||
131466791|NCT02142387|473339597|FG001|Overall Study|occurred not at home|2474|||
131466792|NCT05028361|473339598|FG000|Overall Study|Withdrawal by Subject|1|||
131466793|NCT05028361|473339599|FG001|Overall Study|Withdrawal by Subject|0|||
131466794|NCT00779259|473339600|FG000|Quinine Alone|Adverse Event|2|||
131466795|NCT02047318|473339604|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
131466796|NCT02047318|473339604|FG000|Core Study Period|Adverse Event|1|||
131466797|NCT02047318|473339604|FG000|Core Study Period|Withdrawal by caregiver|3|||
131466798|NCT02047318|473339604|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
131466799|NCT02296138|473339605|FG000|Overall Study|Adverse Event|348|||
131466800|NCT02296138|473339606|FG001|Overall Study|Adverse Event|259|||
131466801|NCT02296138|473339605|FG000|Overall Study|Lack of Efficacy|59|||
131466802|NCT02296138|473339606|FG001|Overall Study|Lack of Efficacy|37|||
131466803|NCT02296138|473339605|FG000|Overall Study|Protocol Violation|35|||
131466804|NCT02296138|473339606|FG001|Overall Study|Protocol Violation|36|||
131466805|NCT02296138|473339605|FG000|Overall Study|Lost to Follow-up|9|||
131466806|NCT02296138|473339606|FG001|Overall Study|Lost to Follow-up|12|||
131466807|NCT02296138|473339605|FG000|Overall Study|Withdrawal by Subject|184|||
131466808|NCT02296138|473339606|FG001|Overall Study|Withdrawal by Subject|131|||
131466809|NCT02296138|473339605|FG000|Overall Study|Not Treated|1|||
131466810|NCT02296138|473339606|FG001|Overall Study|Not Treated|1|||
131466811|NCT02296138|473339605|FG000|Overall Study|Patients with data irregularities|10|||
131466812|NCT02296138|473339606|FG001|Overall Study|Patients with data irregularities|11|||
131466813|NCT02296138|473339605|FG000|Overall Study|Other than specified|15|||
131466814|NCT02296138|473339606|FG001|Overall Study|Other than specified|13|||
131466815|NCT02095132|473339607|FG000|Overall Study|Adverse Event|0|||
131466816|NCT02095132|473339608|FG001|Overall Study|Adverse Event|0|||
131466817|NCT02095132|473339609|FG002|Overall Study|Adverse Event|0|||
131466818|NCT02095132|473339610|FG003|Overall Study|Adverse Event|0|||
131466819|NCT02095132|473339611|FG004|Overall Study|Adverse Event|1|||
131466820|NCT02095132|473339612|FG005|Overall Study|Adverse Event|0|||
131466821|NCT02095132|473339613|FG006|Overall Study|Adverse Event|1|||
131466822|NCT02095132|473339614|FG007|Overall Study|Adverse Event|0|||
131466823|NCT02095132|473339615|FG008|Overall Study|Adverse Event|0|||
131466824|NCT02095132|473339607|FG000|Overall Study|Death|0|||
131466825|NCT02095132|473339608|FG001|Overall Study|Death|0|||
131466826|NCT02095132|473339609|FG002|Overall Study|Death|0|||
131466827|NCT02095132|473339610|FG003|Overall Study|Death|0|||
131466828|NCT02095132|473339611|FG004|Overall Study|Death|0|||
131466829|NCT02095132|473339612|FG005|Overall Study|Death|0|||
131466830|NCT02095132|473339613|FG006|Overall Study|Death|1|||
131466831|NCT02095132|473339614|FG007|Overall Study|Death|0|||
131466832|NCT02095132|473339615|FG008|Overall Study|Death|0|||
131466833|NCT02095132|473339607|FG000|Overall Study|Lack of Efficacy|3|||
131466834|NCT02095132|473339608|FG001|Overall Study|Lack of Efficacy|5|||
131466835|NCT02095132|473339609|FG002|Overall Study|Lack of Efficacy|2|||
131466836|NCT02095132|473339610|FG003|Overall Study|Lack of Efficacy|8|||
131466837|NCT02095132|473339611|FG004|Overall Study|Lack of Efficacy|3|||
131466838|NCT02095132|473339612|FG005|Overall Study|Lack of Efficacy|6|||
131466839|NCT02095132|473339613|FG006|Overall Study|Lack of Efficacy|10|||
131466840|NCT02095132|473339614|FG007|Overall Study|Lack of Efficacy|9|||
131466841|NCT02095132|473339615|FG008|Overall Study|Lack of Efficacy|8|||
131466842|NCT02095132|473339607|FG000|Overall Study|Physician Decision|1|||
131466843|NCT02095132|473339608|FG001|Overall Study|Physician Decision|0|||
131466844|NCT02095132|473339609|FG002|Overall Study|Physician Decision|0|||
131466845|NCT02095132|473339610|FG003|Overall Study|Physician Decision|0|||
131466846|NCT02095132|473339611|FG004|Overall Study|Physician Decision|0|||
131466847|NCT02095132|473339612|FG005|Overall Study|Physician Decision|0|||
131466848|NCT02095132|473339613|FG006|Overall Study|Physician Decision|1|||
131466849|NCT02095132|473339614|FG007|Overall Study|Physician Decision|0|||
131466850|NCT02095132|473339615|FG008|Overall Study|Physician Decision|2|||
131466851|NCT02095132|473339607|FG000|Overall Study|Withdrawal by Subject|0|||
131466852|NCT02095132|473339608|FG001|Overall Study|Withdrawal by Subject|0|||
131466853|NCT02095132|473339609|FG002|Overall Study|Withdrawal by Subject|2|||
131466854|NCT02095132|473339610|FG003|Overall Study|Withdrawal by Subject|2|||
131466855|NCT02095132|473339611|FG004|Overall Study|Withdrawal by Subject|3|||
131466856|NCT02095132|473339612|FG005|Overall Study|Withdrawal by Subject|0|||
131466857|NCT02095132|473339613|FG006|Overall Study|Withdrawal by Subject|5|||
131466858|NCT02095132|473339614|FG007|Overall Study|Withdrawal by Subject|0|||
131466859|NCT02095132|473339615|FG008|Overall Study|Withdrawal by Subject|0|||
131466860|NCT00409175|473339616|FG000|Overall Study|Adverse Event|4|||
131466861|NCT00409175|473339617|FG001|Overall Study|Adverse Event|3|||
131466862|NCT00409175|473339616|FG000|Overall Study|Withdrawal by Subject|1|||
131466863|NCT00409175|473339617|FG001|Overall Study|Withdrawal by Subject|2|||
131466864|NCT00409175|473339616|FG000|Overall Study|Negative genotype|0|||
131466865|NCT00409175|473339617|FG001|Overall Study|Negative genotype|1|||
131466866|NCT00409175|473339616|FG000|Overall Study|Liver transplantation|13|||
131466867|NCT00409175|473339617|FG001|Overall Study|Liver transplantation|13|||
131466868|NCT02108262|473339620|FG000|Overall Study|Non-compliance|0|||
131466869|NCT02108262|473339621|FG001|Overall Study|Non-compliance|2|||
131466870|NCT02108262|473339622|FG002|Overall Study|Non-compliance|1|||
131466871|NCT02108262|473339623|FG003|Overall Study|Non-compliance|1|||
131466872|NCT02108262|473339620|FG000|Overall Study|Randomized by error/screen failure|0|||
131466873|NCT02108262|473339621|FG001|Overall Study|Randomized by error/screen failure|0|||
131466874|NCT02108262|473339622|FG002|Overall Study|Randomized by error/screen failure|1|||
131466875|NCT02108262|473339623|FG003|Overall Study|Randomized by error/screen failure|0|||
131466876|NCT02108262|473339620|FG000|Overall Study|Distance to center|0|||
131466877|NCT02108262|473339621|FG001|Overall Study|Distance to center|1|||
131466878|NCT02108262|473339622|FG002|Overall Study|Distance to center|1|||
131466879|NCT02108262|473339623|FG003|Overall Study|Distance to center|0|||
131466880|NCT02108262|473339620|FG000|Overall Study|Adverse Event|0|||
131466881|NCT02108262|473339621|FG001|Overall Study|Adverse Event|11|||
131466882|NCT02108262|473339622|FG002|Overall Study|Adverse Event|6|||
131466883|NCT02108262|473339623|FG003|Overall Study|Adverse Event|12|||
131466884|NCT02108262|473339620|FG000|Overall Study|Death|0|||
131466885|NCT02108262|473339621|FG001|Overall Study|Death|2|||
131466886|NCT02108262|473339622|FG002|Overall Study|Death|2|||
131466887|NCT02108262|473339623|FG003|Overall Study|Death|1|||
131466888|NCT02108262|473339620|FG000|Overall Study|Lost to Follow-up|0|||
131466889|NCT02108262|473339621|FG001|Overall Study|Lost to Follow-up|0|||
131466890|NCT02108262|473339622|FG002|Overall Study|Lost to Follow-up|1|||
131466891|NCT02108262|473339623|FG003|Overall Study|Lost to Follow-up|0|||
131466892|NCT02108262|473339620|FG000|Overall Study|Physician Decision|0|||
131466893|NCT02108262|473339621|FG001|Overall Study|Physician Decision|0|||
131466894|NCT02108262|473339622|FG002|Overall Study|Physician Decision|2|||
131466895|NCT02108262|473339623|FG003|Overall Study|Physician Decision|0|||
131466896|NCT02108262|473339620|FG000|Overall Study|Withdrawal by Subject|0|||
131466897|NCT02108262|473339621|FG001|Overall Study|Withdrawal by Subject|7|||
131466898|NCT02108262|473339622|FG002|Overall Study|Withdrawal by Subject|3|||
131466899|NCT02108262|473339623|FG003|Overall Study|Withdrawal by Subject|4|||
131466900|NCT02108262|473339620|FG000|Overall Study|Due to key hepatic values|0|||
131466901|NCT02108262|473339621|FG001|Overall Study|Due to key hepatic values|1|||
131466902|NCT02108262|473339622|FG002|Overall Study|Due to key hepatic values|0|||
131466903|NCT02108262|473339623|FG003|Overall Study|Due to key hepatic values|0|||
131466904|NCT02108262|473339620|FG000|Overall Study|Unable to contact patient|0|||
131466905|NCT02108262|473339621|FG001|Overall Study|Unable to contact patient|3|||
131466906|NCT02108262|473339622|FG002|Overall Study|Unable to contact patient|1|||
131466907|NCT02108262|473339623|FG003|Overall Study|Unable to contact patient|2|||
131466908|NCT02108262|473339620|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
131466909|NCT02108262|473339621|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
131466910|NCT02108262|473339622|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
131466911|NCT02108262|473339623|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
131466912|NCT02108262|473339620|FG000|Overall Study|Patient did not want another infusion|0|||
131466913|NCT02108262|473339621|FG001|Overall Study|Patient did not want another infusion|3|||
131466914|NCT02108262|473339622|FG002|Overall Study|Patient did not want another infusion|3|||
131466915|NCT02108262|473339623|FG003|Overall Study|Patient did not want another infusion|2|||
131466916|NCT02108262|473339620|FG000|Overall Study|Vacation|0|||
131466917|NCT02108262|473339621|FG001|Overall Study|Vacation|1|||
131466918|NCT02108262|473339622|FG002|Overall Study|Vacation|0|||
131466919|NCT02108262|473339623|FG003|Overall Study|Vacation|0|||
131466920|NCT02108262|473339620|FG000|Overall Study|Patient decision|0|||
131466921|NCT02108262|473339621|FG001|Overall Study|Patient decision|7|||
131466922|NCT02108262|473339622|FG002|Overall Study|Patient decision|9|||
131466923|NCT02108262|473339623|FG003|Overall Study|Patient decision|14|||
131466924|NCT02108262|473339620|FG000|Overall Study|Missed IV due to pharmacy error|0|||
131466925|NCT02108262|473339621|FG001|Overall Study|Missed IV due to pharmacy error|0|||
131466926|NCT02108262|473339622|FG002|Overall Study|Missed IV due to pharmacy error|1|||
131466927|NCT02108262|473339623|FG003|Overall Study|Missed IV due to pharmacy error|0|||
131466928|NCT01895361|473339627|FG000|Overall Study|Adverse Event|1|||
131466929|NCT01895361|473339628|FG001|Overall Study|Adverse Event|1|||
131466930|NCT01895361|473339629|FG002|Overall Study|Adverse Event|3|||
131466931|NCT01895361|473339627|FG000|Overall Study|Death|2|||
131466932|NCT01895361|473339628|FG001|Overall Study|Death|1|||
131466933|NCT01895361|473339629|FG002|Overall Study|Death|2|||
131466934|NCT01895361|473339627|FG000|Overall Study|Lost to Follow-up|4|||
131466935|NCT01895361|473339628|FG001|Overall Study|Lost to Follow-up|4|||
131466936|NCT01895361|473339629|FG002|Overall Study|Lost to Follow-up|6|||
131466937|NCT01895361|473339627|FG000|Overall Study|Non-compliance with study|1|||
131466938|NCT01895361|473339628|FG001|Overall Study|Non-compliance with study|3|||
131466939|NCT01895361|473339629|FG002|Overall Study|Non-compliance with study|1|||
131466940|NCT01895361|473339627|FG000|Overall Study|Physician Decision|2|||
131466941|NCT01895361|473339628|FG001|Overall Study|Physician Decision|2|||
131466942|NCT01895361|473339629|FG002|Overall Study|Physician Decision|2|||
131466943|NCT01895361|473339627|FG000|Overall Study|Withdrawal by Subject|7|||
131466944|NCT01895361|473339628|FG001|Overall Study|Withdrawal by Subject|6|||
131466945|NCT01895361|473339629|FG002|Overall Study|Withdrawal by Subject|6|||
131466946|NCT01895361|473339627|FG000|Overall Study|Lack of Efficacy|0|||
131466947|NCT01895361|473339628|FG001|Overall Study|Lack of Efficacy|1|||
131466948|NCT01895361|473339629|FG002|Overall Study|Lack of Efficacy|0|||
131466949|NCT01895361|473339627|FG000|Overall Study|Reasons different from categories above|7|||
131466950|NCT01895361|473339628|FG001|Overall Study|Reasons different from categories above|3|||
131466951|NCT01895361|473339629|FG002|Overall Study|Reasons different from categories above|4|||
131466952|NCT01944839|473339630|FG000|Overall Study|Physician Decision|2|||
131466953|NCT01944839|473339631|FG001|Overall Study|Physician Decision|2|||
131466954|NCT01944839|473339630|FG000|Overall Study|Protocol Violation|0|||
131466955|NCT01944839|473339631|FG001|Overall Study|Protocol Violation|1|||
131466956|NCT01944839|473339630|FG000|Overall Study|Adverse Event|10|||
131466957|NCT01944839|473339631|FG001|Overall Study|Adverse Event|5|||
131466958|NCT01944839|473339630|FG000|Overall Study|Withdrawal by Subject|9|||
131466959|NCT01944839|473339631|FG001|Overall Study|Withdrawal by Subject|17|||
131466960|NCT01944839|473339630|FG000|Overall Study|Lost to Follow-up|1|||
131466961|NCT01944839|473339631|FG001|Overall Study|Lost to Follow-up|0|||
131466962|NCT01944839|473339630|FG000|Overall Study|Subject non-compliance|0|||
131466963|NCT01944839|473339631|FG001|Overall Study|Subject non-compliance|3|||
131466964|NCT01892384|473339638|FG000|Overall Study|Withdrawal by Subject|1|||
131768934|NCT01497899|474431899|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
131768935|NCT01497899|474431900|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
131768936|NCT01497899|474431897|FG000|Open-Label Extension Phase|Adverse Event|1|||
131768937|NCT01497899|474431898|FG001|Open-Label Extension Phase|Adverse Event|0|||
131768938|NCT01497899|474431899|FG002|Open-Label Extension Phase|Adverse Event|0|||
131768939|NCT01497899|474431900|FG003|Open-Label Extension Phase|Adverse Event|0|||
131768940|NCT01497899|474431897|FG000|Open-Label Extension Phase|Death|1|||
131768941|NCT01497899|474431898|FG001|Open-Label Extension Phase|Death|0|||
131768942|NCT01497899|474431899|FG002|Open-Label Extension Phase|Death|0|||
131768943|NCT01497899|474431900|FG003|Open-Label Extension Phase|Death|0|||
131768944|NCT01497899|474431897|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
131768945|NCT01497899|474431898|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
131768946|NCT01497899|474431899|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
131768947|NCT01497899|474431900|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
131768948|NCT01497899|474431897|FG000|Open-Label Extension Phase|Pregnancy|0|||
131768949|NCT01497899|474431898|FG001|Open-Label Extension Phase|Pregnancy|1|||
131768950|NCT01497899|474431899|FG002|Open-Label Extension Phase|Pregnancy|1|||
131768951|NCT01497899|474431900|FG003|Open-Label Extension Phase|Pregnancy|0|||
131768952|NCT01497899|474431897|FG000|Open-Label Extension Phase|Protocol Violation|0|||
131768953|NCT01497899|474431898|FG001|Open-Label Extension Phase|Protocol Violation|0|||
131768954|NCT01497899|474431899|FG002|Open-Label Extension Phase|Protocol Violation|1|||
131466965|NCT01892384|473339639|FG001|Overall Study|Withdrawal by Subject|1|||
131466966|NCT01892384|473339640|FG002|Overall Study|Withdrawal by Subject|0|||
131466967|NCT01892384|473339641|FG003|Overall Study|Withdrawal by Subject|0|||
131466968|NCT00592774|473339642|FG000|Overall Study|Adverse Event|5|||
131768955|NCT01497899|474431900|FG003|Open-Label Extension Phase|Protocol Violation|0|||
131768956|NCT01497899|474431897|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
131768957|NCT01497899|474431898|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
131768958|NCT01497899|474431899|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
131768959|NCT01497899|474431900|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
131768960|NCT05047601|474431901|FG000|Overall Study|Lost to Follow-up|9|||
131768961|NCT05047601|474431902|FG001|Overall Study|Lost to Follow-up|11|||
131768962|NCT05047601|474431903|FG002|Overall Study|Lost to Follow-up|7|||
131768963|NCT05047601|474431901|FG000|Overall Study|Withdrawal by Subject|25|||
131768964|NCT05047601|474431902|FG001|Overall Study|Withdrawal by Subject|36|||
131768965|NCT05047601|474431903|FG002|Overall Study|Withdrawal by Subject|23|||
131768966|NCT05047601|474431901|FG000|Overall Study|Other|10|||
131768967|NCT05047601|474431902|FG001|Overall Study|Other|6|||
131768968|NCT05047601|474431903|FG002|Overall Study|Other|5|||
131466969|NCT00592774|473339643|FG001|Overall Study|Adverse Event|19|||
131768969|NCT00286234|474431904|FG000|Overall Study|Protocol Violation|1|||
131768970|NCT00286234|474431905|FG001|Overall Study|Protocol Violation|2|||
131768971|NCT00286234|474431906|FG002|Overall Study|Protocol Violation|0|||
131768972|NCT00286234|474431907|FG003|Overall Study|Protocol Violation|1|||
131768973|NCT00286234|474431904|FG000|Overall Study|Physician Decision|1|||
131768974|NCT00286234|474431905|FG001|Overall Study|Physician Decision|0|||
131768975|NCT00286234|474431906|FG002|Overall Study|Physician Decision|0|||
131768976|NCT00286234|474431907|FG003|Overall Study|Physician Decision|1|||
131768977|NCT00286234|474431904|FG000|Overall Study|Adverse Event|0|||
131768978|NCT00286234|474431905|FG001|Overall Study|Adverse Event|0|||
131768979|NCT00286234|474431906|FG002|Overall Study|Adverse Event|0|||
131768980|NCT00286234|474431907|FG003|Overall Study|Adverse Event|1|||
131768981|NCT00286234|474431904|FG000|Overall Study|Adverse Event|0|||
131768982|NCT00286234|474431905|FG001|Overall Study|Adverse Event|0|||
131768983|NCT00286234|474431906|FG002|Overall Study|Adverse Event|0|||
131768984|NCT00286234|474431907|FG003|Overall Study|Adverse Event|1|||
131768985|NCT01843933|474431911|FG000|Overall Study|Data lost|6|||
131768986|NCT01843933|474431912|FG001|Overall Study|Data lost|4|||
131768987|NCT01535638|474431913|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
131768988|NCT01535638|474431914|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
131768989|NCT01535638|474431915|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
131768990|NCT01535638|474431916|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
131768991|NCT01535638|474431917|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
131768992|NCT01535638|474431918|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
131768993|NCT01535638|474431913|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
131768994|NCT01535638|474431914|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
131768995|NCT01535638|474431915|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
131768996|NCT01535638|474431916|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
131768997|NCT01535638|474431917|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
131768998|NCT01535638|474431918|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
131768999|NCT01482598|474431919|FG000|Overall Study|Death|7|||
131769000|NCT01482598|474431920|FG001|Overall Study|Death|10|||
131769001|NCT01482598|474431919|FG000|Overall Study|Physician Decision|0|||
131769002|NCT01482598|474431920|FG001|Overall Study|Physician Decision|3|||
131769003|NCT01482598|474431919|FG000|Overall Study|Withdrawal by Subject|4|||
131769004|NCT01482598|474431920|FG001|Overall Study|Withdrawal by Subject|5|||
131769005|NCT01482598|474431919|FG000|Overall Study|Lost to Follow-up|5|||
131769006|NCT01482598|474431920|FG001|Overall Study|Lost to Follow-up|4|||
131769007|NCT01373294|474431921|FG000|Overall Study|Adverse Event|1|||
131769008|NCT01373294|474431922|FG001|Overall Study|Adverse Event|0|||
131769009|NCT02694562|474431923|FG000|Overall Study|Death|8|||
131769010|NCT02694562|474431923|FG000|Overall Study|Protocol Violation|4|||
131769011|NCT02694562|474431923|FG000|Overall Study|Lost to Follow-up|3|||
131769012|NCT02694562|474431923|FG000|Overall Study|Screen Failure|2|||
131769013|NCT02694562|474431923|FG000|Overall Study|Physician Decision|1|||
131466970|NCT00592774|473339644|FG002|Overall Study|Adverse Event|2|||
131466971|NCT00592774|473339645|FG003|Overall Study|Adverse Event|14|||
131466972|NCT00592774|473339646|FG004|Overall Study|Adverse Event|8|||
131466973|NCT00592774|473339642|FG000|Overall Study|Protocol Violation|0|||
131769014|NCT01333865|474431924|FG000|Overall Study|Adverse Event|2|||
131769015|NCT00620815|474431927|FG000|Overall Study|Adverse Event|1|||
131769016|NCT00620815|474431928|FG001|Overall Study|Adverse Event|1|||
131769017|NCT00620815|474431929|FG002|Overall Study|Adverse Event|2|||
131769018|NCT00620815|474431927|FG000|Overall Study|Withdrawal by Subject|1|||
131466974|NCT00592774|473339643|FG001|Overall Study|Protocol Violation|1|||
131769019|NCT00620815|474431928|FG001|Overall Study|Withdrawal by Subject|2|||
131769020|NCT00620815|474431929|FG002|Overall Study|Withdrawal by Subject|0|||
131769021|NCT00620815|474431927|FG000|Overall Study|Lost to Follow-up|1|||
131769022|NCT00620815|474431928|FG001|Overall Study|Lost to Follow-up|6|||
131769023|NCT00620815|474431929|FG002|Overall Study|Lost to Follow-up|3|||
131769024|NCT00620815|474431927|FG000|Overall Study|Inappropriate enrolment|0|||
131769025|NCT00620815|474431928|FG001|Overall Study|Inappropriate enrolment|0|||
131769026|NCT00620815|474431929|FG002|Overall Study|Inappropriate enrolment|1|||
131769027|NCT00620815|474431927|FG000|Overall Study|Protocol Violation|1|||
131769028|NCT00620815|474431928|FG001|Overall Study|Protocol Violation|2|||
131769029|NCT00620815|474431929|FG002|Overall Study|Protocol Violation|1|||
131769030|NCT00877929|474431931|FG000|Overall Study|Adverse Event|11|||
131769031|NCT00877929|474431932|FG001|Overall Study|Adverse Event|20|||
131769032|NCT00877929|474431931|FG000|Overall Study|Protocol Violation|3|||
131769033|NCT00877929|474431932|FG001|Overall Study|Protocol Violation|3|||
131466975|NCT00592774|473339644|FG002|Overall Study|Protocol Violation|0|||
131466976|NCT00592774|473339645|FG003|Overall Study|Protocol Violation|0|||
131466977|NCT00592774|473339646|FG004|Overall Study|Protocol Violation|1|||
131466978|NCT00592774|473339642|FG000|Overall Study|Withdrawal by Subject|3|||
131466979|NCT00592774|473339643|FG001|Overall Study|Withdrawal by Subject|7|||
131466980|NCT00592774|473339644|FG002|Overall Study|Withdrawal by Subject|0|||
131466981|NCT00592774|473339645|FG003|Overall Study|Withdrawal by Subject|0|||
131466982|NCT00592774|473339646|FG004|Overall Study|Withdrawal by Subject|0|||
131466983|NCT00592774|473339642|FG000|Overall Study|Lack of Efficacy|3|||
131466984|NCT00592774|473339643|FG001|Overall Study|Lack of Efficacy|3|||
131466985|NCT00592774|473339644|FG002|Overall Study|Lack of Efficacy|0|||
131466986|NCT00592774|473339645|FG003|Overall Study|Lack of Efficacy|0|||
131466987|NCT00592774|473339646|FG004|Overall Study|Lack of Efficacy|2|||
131466988|NCT00592774|473339642|FG000|Overall Study|Physician Decision|0|||
131466989|NCT00592774|473339643|FG001|Overall Study|Physician Decision|1|||
131466990|NCT00592774|473339644|FG002|Overall Study|Physician Decision|1|||
131466991|NCT00592774|473339645|FG003|Overall Study|Physician Decision|0|||
131466992|NCT00592774|473339646|FG004|Overall Study|Physician Decision|1|||
131466993|NCT00592774|473339642|FG000|Overall Study|Other|0|||
131466994|NCT00592774|473339643|FG001|Overall Study|Other|1|||
131466995|NCT00592774|473339644|FG002|Overall Study|Other|1|||
131466996|NCT00592774|473339645|FG003|Overall Study|Other|0|||
131466997|NCT00592774|473339646|FG004|Overall Study|Other|2|||
131466998|NCT01829243|473339649|FG000|First Intervention|Screen Failure|4|||
131466999|NCT01829243|473339650|FG001|First Intervention|Screen Failure|2|||
131467000|NCT00053898|473339660|FG000|Overall Study|No follow-up data from any source|9|||
131467001|NCT00053898|473339661|FG001|Overall Study|No follow-up data from any source|12|||
131467002|NCT00053898|473339660|FG000|Overall Study|Follow-up from telephone contact only|5|||
131467003|NCT00053898|473339661|FG001|Overall Study|Follow-up from telephone contact only|1|||
131467004|NCT01606878|473339669|FG000|Overall Study|Adverse Event|1|||
131467005|NCT01606878|473339670|FG001|Overall Study|Adverse Event|1|||
131467006|NCT01606878|473339671|FG002|Overall Study|Adverse Event|0|||
131467007|NCT01606878|473339672|FG003|Overall Study|Adverse Event|0|||
131467008|NCT01606878|473339673|FG004|Overall Study|Adverse Event|0|||
131467009|NCT01606878|473339674|FG005|Overall Study|Adverse Event|0|||
131467010|NCT01606878|473339675|FG006|Overall Study|Adverse Event|1|||
131467011|NCT01606878|473339676|FG007|Overall Study|Adverse Event|0|||
131467012|NCT01606878|473339677|FG008|Overall Study|Adverse Event|1|||
131467013|NCT01606878|473339678|FG009|Overall Study|Adverse Event|3|||
131467014|NCT01606878|473339679|FG010|Overall Study|Adverse Event|0|||
131467015|NCT01606878|473339669|FG000|Overall Study|Lack of Efficacy|1|||
131467016|NCT01606878|473339670|FG001|Overall Study|Lack of Efficacy|1|||
131467017|NCT01606878|473339671|FG002|Overall Study|Lack of Efficacy|1|||
131467018|NCT01606878|473339672|FG003|Overall Study|Lack of Efficacy|2|||
131467019|NCT01606878|473339673|FG004|Overall Study|Lack of Efficacy|1|||
131467020|NCT01606878|473339674|FG005|Overall Study|Lack of Efficacy|2|||
131467021|NCT01606878|473339675|FG006|Overall Study|Lack of Efficacy|1|||
131467022|NCT01606878|473339676|FG007|Overall Study|Lack of Efficacy|2|||
131467023|NCT01606878|473339677|FG008|Overall Study|Lack of Efficacy|2|||
131467024|NCT01606878|473339678|FG009|Overall Study|Lack of Efficacy|0|||
131467025|NCT01606878|473339679|FG010|Overall Study|Lack of Efficacy|1|||
131467026|NCT01606878|473339669|FG000|Overall Study|Physician Decision|1|||
131467027|NCT01606878|473339670|FG001|Overall Study|Physician Decision|0|||
131467028|NCT01606878|473339671|FG002|Overall Study|Physician Decision|2|||
131467029|NCT01606878|473339672|FG003|Overall Study|Physician Decision|1|||
131467030|NCT01606878|473339673|FG004|Overall Study|Physician Decision|1|||
131467031|NCT01606878|473339674|FG005|Overall Study|Physician Decision|1|||
131467032|NCT01606878|473339675|FG006|Overall Study|Physician Decision|2|||
131467033|NCT01606878|473339676|FG007|Overall Study|Physician Decision|0|||
131467034|NCT01606878|473339677|FG008|Overall Study|Physician Decision|1|||
131769034|NCT00877929|474431931|FG000|Overall Study|Lost to Follow-up|0|||
131769035|NCT00877929|474431932|FG001|Overall Study|Lost to Follow-up|1|||
131467035|NCT01606878|473339678|FG009|Overall Study|Physician Decision|0|||
131467036|NCT01606878|473339679|FG010|Overall Study|Physician Decision|0|||
131467037|NCT01606878|473339669|FG000|Overall Study|Withdrawal by Subject|3|||
131467038|NCT01606878|473339670|FG001|Overall Study|Withdrawal by Subject|2|||
131467039|NCT01606878|473339671|FG002|Overall Study|Withdrawal by Subject|2|||
131467040|NCT01606878|473339672|FG003|Overall Study|Withdrawal by Subject|0|||
131467041|NCT01606878|473339673|FG004|Overall Study|Withdrawal by Subject|1|||
131467042|NCT01606878|473339674|FG005|Overall Study|Withdrawal by Subject|1|||
131769036|NCT00877929|474431931|FG000|Overall Study|Withdrawal by Subject|4|||
131467043|NCT01606878|473339675|FG006|Overall Study|Withdrawal by Subject|2|||
131467044|NCT01606878|473339676|FG007|Overall Study|Withdrawal by Subject|1|||
131467045|NCT01606878|473339677|FG008|Overall Study|Withdrawal by Subject|2|||
131467046|NCT01606878|473339678|FG009|Overall Study|Withdrawal by Subject|0|||
131467047|NCT01606878|473339679|FG010|Overall Study|Withdrawal by Subject|2|||
131467048|NCT03353740|473339683|FG000|Overall Study|Images for these participants not viable|52|||
131467049|NCT01395784|473339684|FG000|Overall Study|Lost to Follow-up|7|||
131467050|NCT01395784|473339684|FG000|Overall Study|Withdrawal by Subject|3|||
131467051|NCT01395784|473339684|FG000|Overall Study|Physician Decision|5|||
131467052|NCT01527357|473341230|FG000|Overall Study|Death|8|||
131467053|NCT01527357|473341231|FG001|Overall Study|Death|2|||
131467054|NCT01527357|473341230|FG000|Overall Study|Lost to Follow-up|6|||
131467055|NCT01527357|473341231|FG001|Overall Study|Lost to Follow-up|4|||
131467056|NCT01527357|473341230|FG000|Overall Study|Withdrew Consent|1|||
131467057|NCT01527357|473341231|FG001|Overall Study|Withdrew Consent|1|||
131467058|NCT01527357|473341230|FG000|Overall Study|Non-compliance|0|||
131467059|NCT01527357|473341231|FG001|Overall Study|Non-compliance|1|||
131467060|NCT01527357|473341230|FG000|Overall Study|No Day 29 Visit|0|||
131467061|NCT01527357|473341231|FG001|Overall Study|No Day 29 Visit|1|||
131467062|NCT01527357|473341230|FG000|Overall Study|Did Not Receive Treatment|2|||
131467063|NCT01527357|473341231|FG001|Overall Study|Did Not Receive Treatment|0|||
131467064|NCT01879579|473341232|FG000|Overall Study|Phone incompatible with texting platform|3|||
131467065|NCT01879579|473341233|FG001|Overall Study|Phone incompatible with texting platform|0|||
131467066|NCT01879579|473341232|FG000|Overall Study|Did not enroll in texting platform|1|||
131467067|NCT01879579|473341233|FG001|Overall Study|Did not enroll in texting platform|0|||
131467068|NCT01879579|473341232|FG000|Overall Study|Did not initiate insulin treatment|1|||
131467069|NCT01879579|473341233|FG001|Overall Study|Did not initiate insulin treatment|0|||
131467070|NCT01879579|473341232|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
131467071|NCT01879579|473341233|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
131467072|NCT01879579|473341232|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
131467073|NCT01879579|473341233|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
131467074|NCT02292784|473341234|FG000|Overall Study|Lost to Follow-up|1|||
131467075|NCT02292784|473341235|FG001|Overall Study|Lost to Follow-up|17|||
131467076|NCT02292784|473341236|FG002|Overall Study|Lost to Follow-up|18|||
131467077|NCT02292784|473341234|FG000|Overall Study|Withdrawal by Subject|0|||
131467078|NCT02292784|473341235|FG001|Overall Study|Withdrawal by Subject|3|||
131467079|NCT02292784|473341236|FG002|Overall Study|Withdrawal by Subject|3|||
131467080|NCT01264081|473341237|FG000|Participants Screened|Screening failures|30|||
131467081|NCT01264081|473341237|FG000|Started Treatment|Withdrawal by Subject|1|||
131467082|NCT01264081|473341237|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
131467083|NCT00134784|473341238|FG000|Overall Study|Withdrawal by Subject|2|||
131467084|NCT00134784|473341239|FG001|Overall Study|Withdrawal by Subject|2|||
131467085|NCT00134784|473341240|FG002|Overall Study|Withdrawal by Subject|2|||
131467086|NCT00134784|473341241|FG003|Overall Study|Withdrawal by Subject|1|||
131467087|NCT02716896|473341242|FG000|Overall Study|Physician Decision|0|||
131467088|NCT02716896|473341243|FG001|Overall Study|Physician Decision|1|||
131467089|NCT02519855|473341246|FG000|Overall Study|Adverse Event|0|||
131467090|NCT02519855|473341247|FG001|Overall Study|Adverse Event|1|||
131467091|NCT02519855|473341246|FG000|Overall Study|Lost to Follow-up|3|||
131467092|NCT02519855|473341247|FG001|Overall Study|Lost to Follow-up|3|||
131467093|NCT00003830|473341261|FG000|Overall Study|No follow up data|3|||
131467094|NCT00003830|473341262|FG001|Overall Study|No follow up data|0|||
131769037|NCT00877929|474431932|FG001|Overall Study|Withdrawal by Subject|4|||
131769038|NCT00877929|474431931|FG000|Overall Study|Lack of Efficacy|0|||
131467095|NCT00003830|473341261|FG000|Overall Study|Sentinel node positive patients|829|||
131467096|NCT00003830|473341262|FG001|Overall Study|Sentinel node positive patients|793|||
131467097|NCT03699475|473341269|FG000|Overall Study|Death|1|||
131467098|NCT04896229|473341278|FG000|Overall Study|Lost to Follow-up|113|||
131467099|NCT04896229|473341279|FG001|Overall Study|Lost to Follow-up|113|||
131467100|NCT01209832|473341283|FG000|Period 1|Sponsor Decision and was not dosed|1|||
131467101|NCT01209832|473341283|FG000|Period 2|Sponsor Decision|1|||
131467102|NCT01268579|473341284|FG000|Overall Study|Adverse Event|1|||
131467103|NCT01268579|473341284|FG000|Overall Study|Withdrawal by Subject|2|||
131467104|NCT02480712|473341285|FG000|Overall Study|Enrolled but Never Treated|1|||
131467105|NCT02480712|473341285|FG000|Overall Study|Lost to Follow-up|5|||
131467106|NCT02480712|473341285|FG000|Overall Study|Withdrew Consent|3|||
131467107|NCT02480712|473341285|FG000|Overall Study|Death|1|||
131467108|NCT02480712|473341285|FG000|Overall Study|Lack of Efficacy|1|||
131467109|NCT01860846|473341286|FG000|Overall Study|Lost to Follow-up|33|||
131467110|NCT05463198|473341287|FG000|Overall Study|Withdrawal by Subject|19|||
131467111|NCT05463198|473341287|FG000|Overall Study|Procedure Notes Missing|18|||
131467112|NCT02239120|473341290|FG000|Overall Study|Death|56|||
131467113|NCT02239120|473341291|FG001|Overall Study|Death|58|||
131467114|NCT02239120|473341290|FG000|Overall Study|Lost to Follow-up|19|||
131467115|NCT02239120|473341291|FG001|Overall Study|Lost to Follow-up|14|||
131467116|NCT00466687|473341292|FG000|Overall Study|Adverse Event|1|||
131467117|NCT00466687|473341292|FG000|Overall Study|Other complicating illness|3|||
131467118|NCT00466687|473341292|FG000|Overall Study|Withdrawal by Subject|1|||
131467119|NCT00466687|473341292|FG000|Overall Study|Disease progression|29|||
131467120|NCT01925989|473341293|FG000|Period 1|Sponsor Decision|1|||
131467121|NCT01925989|473341294|FG001|Period 1|Sponsor Decision|1|||
131467122|NCT01925989|473341295|FG002|Period 1|Sponsor Decision|0|||
131467123|NCT01925989|473341293|FG000|Period 1|Withdrawal by Subject|0|||
131467124|NCT01925989|473341294|FG001|Period 1|Withdrawal by Subject|1|||
131467125|NCT01925989|473341295|FG002|Period 1|Withdrawal by Subject|0|||
131467126|NCT00868517|473341300|FG000|Overall Study|Withdrawal by Subject|3|||
131467127|NCT00868517|473341301|FG001|Overall Study|Withdrawal by Subject|3|||
131467128|NCT00868517|473341302|FG002|Overall Study|Withdrawal by Subject|2|||
131467129|NCT00868517|473341300|FG000|Overall Study|Protocol Violation|1|||
131467130|NCT00868517|473341301|FG001|Overall Study|Protocol Violation|1|||
131467131|NCT00868517|473341302|FG002|Overall Study|Protocol Violation|0|||
131467132|NCT00046891|473341303|FG000|Overall Study|Cancels|5|||
131467133|NCT00046891|473341304|FG001|Overall Study|Cancels|9|||
131467134|NCT00046891|473341303|FG000|Overall Study|Ineligible|1|||
131467135|NCT00046891|473341304|FG001|Overall Study|Ineligible|1|||
131467136|NCT00046891|473341303|FG000|Overall Study|Withdrawal by Subject|18|||
131467137|NCT00046891|473341304|FG001|Overall Study|Withdrawal by Subject|15|||
131467138|NCT00046891|473341303|FG000|Overall Study|Adverse Event|5|||
131467139|NCT00046891|473341304|FG001|Overall Study|Adverse Event|5|||
131467140|NCT02496676|473341308|FG000|Phase 1 - Period 1|Adverse Event|0|||
131467141|NCT02496676|473341309|FG001|Phase 1 - Period 1|Adverse Event|1|||
131467142|NCT02496676|473341308|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
131467143|NCT02496676|473341309|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
131467144|NCT00420641|473341310|FG000|Overall Study|Adverse Event|3|||
131467145|NCT00420641|473341311|FG001|Overall Study|Adverse Event|25|||
131467146|NCT00420641|473341312|FG002|Overall Study|Adverse Event|10|||
131467147|NCT00420641|473341310|FG000|Overall Study|Lost to Follow-up|2|||
131467148|NCT00420641|473341311|FG001|Overall Study|Lost to Follow-up|4|||
131467149|NCT00420641|473341312|FG002|Overall Study|Lost to Follow-up|2|||
131467150|NCT00420641|473341310|FG000|Overall Study|Protocol Violation|8|||
131467151|NCT00420641|473341311|FG001|Overall Study|Protocol Violation|8|||
131467152|NCT00420641|473341312|FG002|Overall Study|Protocol Violation|7|||
131467153|NCT00420641|473341310|FG000|Overall Study|Withdrawal by Subject|15|||
131467154|NCT00420641|473341311|FG001|Overall Study|Withdrawal by Subject|21|||
131467155|NCT00420641|473341312|FG002|Overall Study|Withdrawal by Subject|14|||
131467156|NCT00420641|473341310|FG000|Overall Study|Lack of Efficacy|6|||
131467157|NCT00420641|473341311|FG001|Overall Study|Lack of Efficacy|5|||
131467158|NCT00420641|473341312|FG002|Overall Study|Lack of Efficacy|4|||
131467159|NCT00420641|473341310|FG000|Overall Study|Non-compliance|7|||
131467160|NCT00420641|473341311|FG001|Overall Study|Non-compliance|5|||
131467161|NCT00420641|473341312|FG002|Overall Study|Non-compliance|4|||
131467162|NCT00420641|473341310|FG000|Overall Study|Other|4|||
131467163|NCT00420641|473341311|FG001|Overall Study|Other|4|||
131467164|NCT00420641|473341312|FG002|Overall Study|Other|3|||
131467165|NCT03459690|473341319|FG000|Overall Study|Lost to Follow-up|0|||
131467166|NCT03459690|473341320|FG001|Overall Study|Lost to Follow-up|1|||
131467167|NCT03459690|473341319|FG000|Overall Study|Withdrawal by Subject|1|||
131467168|NCT03459690|473341320|FG001|Overall Study|Withdrawal by Subject|1|||
131467169|NCT02815280|473341324|FG000|Double-Blind Phase|Adverse Event|1|||
131467170|NCT02815280|473341325|FG001|Double-Blind Phase|Adverse Event|1|||
131467171|NCT02815280|473341324|FG000|Double-Blind Phase|Lost to Follow-up|10|||
131467172|NCT02815280|473341325|FG001|Double-Blind Phase|Lost to Follow-up|9|||
131467173|NCT02815280|473341324|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
131467174|NCT02815280|473341325|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
131467175|NCT02815280|473341324|FG000|Double-Blind Phase|Protocol Violation|2|||
131467176|NCT02815280|473341325|FG001|Double-Blind Phase|Protocol Violation|2|||
131467177|NCT02815280|473341324|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
131467178|NCT02815280|473341325|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
131467179|NCT02815280|473341324|FG000|Open-Label Phase|Adverse Event|2|||
131467180|NCT02815280|473341325|FG001|Open-Label Phase|Adverse Event|3|||
131467181|NCT02815280|473341324|FG000|Open-Label Phase|Lost to Follow-up|18|||
131467182|NCT02815280|473341325|FG001|Open-Label Phase|Lost to Follow-up|9|||
131467183|NCT02815280|473341324|FG000|Open-Label Phase|Withdrawal by Subject|33|||
131467184|NCT02815280|473341325|FG001|Open-Label Phase|Withdrawal by Subject|18|||
131467185|NCT02815280|473341324|FG000|Open-Label Phase|Protocol Violation|3|||
131467186|NCT02815280|473341325|FG001|Open-Label Phase|Protocol Violation|0|||
131467187|NCT02815280|473341324|FG000|Open-Label Phase|Administrative|26|||
131467188|NCT02815280|473341325|FG001|Open-Label Phase|Administrative|12|||
131467189|NCT02815280|473341324|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
131467190|NCT02815280|473341325|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
131467191|NCT02514473|473341342|FG000|Overall Study|Adverse Event|0|||
131467192|NCT02514473|473341343|FG001|Overall Study|Adverse Event|2|||
131467193|NCT02514473|473341342|FG000|Overall Study|Withdrawal by Subject|2|||
131467194|NCT02514473|473341343|FG001|Overall Study|Withdrawal by Subject|1|||
131467195|NCT02514473|473341342|FG000|Overall Study|Lost to Follow-up|0|||
131467196|NCT02514473|473341343|FG001|Overall Study|Lost to Follow-up|1|||
131467197|NCT02514473|473341342|FG000|Overall Study|Other|1|||
131467198|NCT02514473|473341343|FG001|Overall Study|Other|1|||
131467199|NCT02158364|473341344|FG000|Overall Study|Case report forms uncollected|10|||
131467200|NCT02158364|473341344|FG000|Overall Study|Protocol Deviation|50|||
131467201|NCT04381988|473341345|FG000|Overall Study|The study was terminated|4|||
131467202|NCT04381988|473341346|FG001|Overall Study|The study was terminated|0|||
131467203|NCT01107379|473341347|FG000|Overall Study|Withdrawal by Subject|18|||
131467204|NCT01107379|473341347|FG000|Overall Study|Lost to Follow-up|3|||
131467205|NCT00609362|473341348|FG000|Overall Study|Withdrawal by Subject|2|||
131467206|NCT00609362|473341349|FG001|Overall Study|Withdrawal by Subject|1|||
131467207|NCT00609362|473341348|FG000|Overall Study|Adverse Event|1|||
131467208|NCT00609362|473341349|FG001|Overall Study|Adverse Event|0|||
131467209|NCT04559529|473341350|FG000|First Intervention (1 Day)|Adverse Event|0|||
131467210|NCT04559529|473341351|FG001|First Intervention (1 Day)|Adverse Event|0|||
131467211|NCT04559529|473341352|FG002|First Intervention (1 Day)|Adverse Event|0|||
131467212|NCT04559529|473341353|FG003|First Intervention (1 Day)|Adverse Event|1|||
131467213|NCT04559529|473341350|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
131467214|NCT04559529|473341351|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
131467215|NCT04559529|473341352|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
131467216|NCT04559529|473341353|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
131467217|NCT04559529|473341350|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
131467218|NCT04559529|473341351|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
131467219|NCT04559529|473341352|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
131467220|NCT04559529|473341353|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
131467221|NCT01009281|473341354|FG000|Overall Study|Administrative problems|7|||
131467222|NCT00548405|473341355|FG000|Overall Study|Adverse Event|6|||
131467223|NCT00548405|473341356|FG001|Overall Study|Adverse Event|2|||
131467224|NCT00548405|473341357|FG002|Overall Study|Adverse Event|0|||
131467225|NCT00548405|473341355|FG000|Overall Study|Lack of Efficacy|6|||
131467226|NCT00548405|473341356|FG001|Overall Study|Lack of Efficacy|0|||
131467227|NCT00548405|473341357|FG002|Overall Study|Lack of Efficacy|0|||
131467228|NCT00548405|473341355|FG000|Overall Study|Physician Decision|3|||
131467229|NCT00548405|473341356|FG001|Overall Study|Physician Decision|4|||
131467230|NCT00548405|473341357|FG002|Overall Study|Physician Decision|1|||
131467231|NCT00548405|473341355|FG000|Overall Study|Pregnancy|1|||
131467232|NCT00548405|473341356|FG001|Overall Study|Pregnancy|0|||
131467233|NCT00548405|473341357|FG002|Overall Study|Pregnancy|0|||
131467234|NCT00548405|473341355|FG000|Overall Study|Protocol Violation|1|||
131467235|NCT00548405|473341356|FG001|Overall Study|Protocol Violation|0|||
131467236|NCT00548405|473341357|FG002|Overall Study|Protocol Violation|0|||
131467237|NCT00548405|473341355|FG000|Overall Study|Withdrawal by Subject|36|||
131467238|NCT00548405|473341356|FG001|Overall Study|Withdrawal by Subject|12|||
131467239|NCT00548405|473341357|FG002|Overall Study|Withdrawal by Subject|5|||
131467240|NCT00548405|473341355|FG000|Overall Study|Lost to Follow-up|1|||
131467241|NCT00548405|473341356|FG001|Overall Study|Lost to Follow-up|1|||
131467242|NCT00548405|473341357|FG002|Overall Study|Lost to Follow-up|2|||
131467243|NCT00548405|473341355|FG000|Overall Study|Death|0|||
131467244|NCT00548405|473341356|FG001|Overall Study|Death|1|||
131467245|NCT00548405|473341357|FG002|Overall Study|Death|1|||
131467246|NCT00548405|473341355|FG000|Overall Study|Sponsor decision|1|||
131467247|NCT00548405|473341356|FG001|Overall Study|Sponsor decision|0|||
131467248|NCT00548405|473341357|FG002|Overall Study|Sponsor decision|0|||
131467249|NCT00548405|473341355|FG000|Overall Study|Randomized but not treated|1|||
131467250|NCT00548405|473341356|FG001|Overall Study|Randomized but not treated|0|||
131467251|NCT00548405|473341357|FG002|Overall Study|Randomized but not treated|0|||
131467252|NCT02217527|473341359|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
131467253|NCT02217527|473341360|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
131467254|NCT02217527|473341359|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
131467255|NCT02217527|473341360|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
131467256|NCT01878149|473341361|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
131467257|NCT01878149|473341362|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
131467258|NCT00502203|473341370|FG000|Overall Study|Inevaluable|1|||
131467259|NCT02241889|473341373|FG000|Overall Study|device issues|0|||
131467260|NCT02241889|473341374|FG001|Overall Study|device issues|0|||
131467261|NCT02241889|473341375|FG002|Overall Study|device issues|1|||
131467262|NCT02241889|473341376|FG003|Overall Study|device issues|0|||
131467263|NCT02241889|473341377|FG004|Overall Study|device issues|0|||
131467264|NCT02241889|473341378|FG005|Overall Study|device issues|0|||
131467265|NCT02241889|473341373|FG000|Overall Study|Withdrawal by Subject|0|||
131467266|NCT02241889|473341374|FG001|Overall Study|Withdrawal by Subject|0|||
131467267|NCT02241889|473341375|FG002|Overall Study|Withdrawal by Subject|0|||
131467268|NCT02241889|473341376|FG003|Overall Study|Withdrawal by Subject|0|||
131467269|NCT02241889|473341377|FG004|Overall Study|Withdrawal by Subject|0|||
131467270|NCT02241889|473341378|FG005|Overall Study|Withdrawal by Subject|1|||
131467271|NCT03836001|473341379|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
131467272|NCT03836001|473341380|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
131467273|NCT03836001|473341381|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
131467274|NCT03836001|473341379|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
131467275|NCT03836001|473341380|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
131467276|NCT03836001|473341381|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
131467277|NCT03836001|473341379|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
131467278|NCT03836001|473341380|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
131467279|NCT03836001|473341381|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
131467280|NCT03836001|473341379|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
131467281|NCT03836001|473341380|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
131467282|NCT03836001|473341381|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
131467283|NCT04658940|473341382|FG000|Overall Study|Withdrawal by Subject|1|||
131467284|NCT03579602|473341383|FG000|Overall Study|Subject unable to receive study drug|0|||
131467285|NCT03579602|473341384|FG001|Overall Study|Subject unable to receive study drug|2|||
131467286|NCT03579602|473341383|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
131467287|NCT03579602|473341384|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
131467288|NCT02518464|473341385|FG000|Overall Study|Adverse Event|2|||
131467289|NCT01120067|473341386|FG000|Overall Study|Lost to Follow-up|3|||
131467290|NCT01120067|473341387|FG001|Overall Study|Lost to Follow-up|1|||
131467291|NCT01120067|473341386|FG000|Overall Study|fail to engage >3 sessions|2|||
131467292|NCT01120067|473341387|FG001|Overall Study|fail to engage >3 sessions|0|||
131467293|NCT00266877|473341388|FG000|Overall Study|Death|1|||
131467294|NCT00266877|473341389|FG001|Overall Study|Death|1|||
131467295|NCT00266877|473341390|FG002|Overall Study|Death|1|||
131467296|NCT00266877|473341388|FG000|Overall Study|Adverse Event|6|||
131467297|NCT00266877|473341389|FG001|Overall Study|Adverse Event|4|||
131467298|NCT00266877|473341390|FG002|Overall Study|Adverse Event|1|||
131467299|NCT00266877|473341388|FG000|Overall Study|Physician Decision|2|||
131467300|NCT00266877|473341389|FG001|Overall Study|Physician Decision|1|||
131467301|NCT00266877|473341390|FG002|Overall Study|Physician Decision|1|||
131467302|NCT00266877|473341388|FG000|Overall Study|Withdrawal by Subject|3|||
131467303|NCT00266877|473341389|FG001|Overall Study|Withdrawal by Subject|1|||
131467304|NCT00266877|473341390|FG002|Overall Study|Withdrawal by Subject|1|||
131467305|NCT00266877|473341388|FG000|Overall Study|Disease Progression|72|||
131467306|NCT00266877|473341389|FG001|Overall Study|Disease Progression|37|||
131467307|NCT00266877|473341390|FG002|Overall Study|Disease Progression|23|||
131467308|NCT00266877|473341388|FG000|Overall Study|Symptomatic Deterioration|6|||
131467309|NCT00266877|473341389|FG001|Overall Study|Symptomatic Deterioration|3|||
131467310|NCT00266877|473341390|FG002|Overall Study|Symptomatic Deterioration|1|||
131467311|NCT00266877|473341388|FG000|Overall Study|Hospitalization|1|||
131467312|NCT00266877|473341389|FG001|Overall Study|Hospitalization|0|||
131467313|NCT00266877|473341390|FG002|Overall Study|Hospitalization|0|||
131467314|NCT00266877|473341388|FG000|Overall Study|Concomitant Radiotherapy|0|||
131467315|NCT00266877|473341389|FG001|Overall Study|Concomitant Radiotherapy|1|||
131467316|NCT00266877|473341390|FG002|Overall Study|Concomitant Radiotherapy|0|||
131467317|NCT03985878|473341392|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
131467318|NCT03985878|473341392|FG000|Overall Study|Study Terminated by Sponsor|12|||
131467319|NCT03985878|473341392|FG000|Overall Study|Withdrawal by Subject|1|||
131467320|NCT04268823|473341395|FG000|Overall Study|Adverse Event|1|||
131467321|NCT04268823|473341396|FG001|Overall Study|Adverse Event|0|||
131467322|NCT04268823|473341395|FG000|Overall Study|Participant Decision|1|||
131467323|NCT04268823|473341396|FG001|Overall Study|Participant Decision|0|||
131467324|NCT00336583|473342718|FG000|Overall Study|Lost to Follow-up|1|||
131467325|NCT00336583|473342718|FG000|Overall Study|Death|1|||
131467326|NCT00910247|473342719|FG000|Overall Study|Adverse Event|15|||
131467327|NCT00910247|473342719|FG000|Overall Study|Death|2|||
131467328|NCT00910247|473342719|FG000|Overall Study|Lost to Follow-up|10|||
131467329|NCT00910247|473342719|FG000|Overall Study|Physician Decision|3|||
131467330|NCT00910247|473342719|FG000|Overall Study|Protocol Violation|10|||
131467331|NCT00910247|473342719|FG000|Overall Study|Withdrawal by Subject|25|||
131467332|NCT00910247|473342719|FG000|Overall Study|Not collected|4|||
131467333|NCT02927067|473342720|FG000|Overall Study|Withdrawn Consent|20|||
131467334|NCT02927067|473342721|FG001|Overall Study|Withdrawn Consent|12|||
131467335|NCT02927067|473342720|FG000|Overall Study|Death|18|||
131467336|NCT02927067|473342721|FG001|Overall Study|Death|31|||
131467337|NCT02927067|473342720|FG000|Overall Study|Adverse Event|13|||
131467338|NCT02927067|473342721|FG001|Overall Study|Adverse Event|10|||
131467339|NCT02927067|473342720|FG000|Overall Study|Noncompliance|5|||
131467340|NCT02927067|473342721|FG001|Overall Study|Noncompliance|2|||
131467341|NCT02927067|473342720|FG000|Overall Study|Reason not Specified|4|||
131467342|NCT02927067|473342721|FG001|Overall Study|Reason not Specified|6|||
131467343|NCT01727700|473342724|FG000|Overall Study|Adverse Event|0|||
131467344|NCT01727700|473342725|FG001|Overall Study|Adverse Event|7|||
131467345|NCT01727700|473342726|FG002|Overall Study|Adverse Event|1|||
131467346|NCT01727700|473342724|FG000|Overall Study|Particpant withdrew consent|0|||
131467347|NCT01727700|473342725|FG001|Overall Study|Particpant withdrew consent|3|||
131467348|NCT01727700|473342726|FG002|Overall Study|Particpant withdrew consent|1|||
131467349|NCT01727700|473342724|FG000|Overall Study|Protocol Violation|2|||
131467350|NCT01727700|473342725|FG001|Overall Study|Protocol Violation|0|||
131467351|NCT01727700|473342726|FG002|Overall Study|Protocol Violation|0|||
131769039|NCT00877929|474431932|FG001|Overall Study|Lack of Efficacy|1|||
131467352|NCT01757691|473342730|FG000|Overall Study|Administrative problems|2|||
131467353|NCT01757691|473342731|FG001|Overall Study|Administrative problems|0|||
131467354|NCT02054481|473342734|FG000|Overall Study|Adverse Event|1|||
131467355|NCT02054481|473342735|FG001|Overall Study|Adverse Event|1|||
131467356|NCT02054481|473342736|FG002|Overall Study|Adverse Event|0|||
131467357|NCT02054481|473342737|FG003|Overall Study|Adverse Event|1|||
131467358|NCT02054481|473342734|FG000|Overall Study|Lost to Follow-up|1|||
131467359|NCT02054481|473342735|FG001|Overall Study|Lost to Follow-up|0|||
131467360|NCT02054481|473342736|FG002|Overall Study|Lost to Follow-up|0|||
131467361|NCT02054481|473342737|FG003|Overall Study|Lost to Follow-up|0|||
131467362|NCT02054481|473342734|FG000|Overall Study|Other reason|2|||
131467363|NCT02054481|473342735|FG001|Overall Study|Other reason|1|||
131467364|NCT02054481|473342736|FG002|Overall Study|Other reason|2|||
131467365|NCT02054481|473342737|FG003|Overall Study|Other reason|0|||
131467366|NCT03739242|473342739|FG000|Overall Study|Withdrawal by Subject|1|||
131467367|NCT03739242|473342740|FG001|Overall Study|Withdrawal by Subject|1|||
131467368|NCT03739242|473342739|FG000|Overall Study|Protocol Violation|0|||
131467369|NCT03739242|473342740|FG001|Overall Study|Protocol Violation|1|||
131467370|NCT03361176|473342741|FG000|Overall Study|Lost to Follow-up|1|||
131467371|NCT03361176|473342742|FG001|Overall Study|Lost to Follow-up|2|||
131467372|NCT03361176|473342741|FG000|Overall Study|Adverse Event|0|||
131467373|NCT03361176|473342742|FG001|Overall Study|Adverse Event|2|||
131467374|NCT03361176|473342741|FG000|Overall Study|Withdrawal by Subject|0|||
131467375|NCT03361176|473342742|FG001|Overall Study|Withdrawal by Subject|1|||
131467376|NCT03718299|473342743|FG000|Overall Study|Adverse Event|1|||
131467377|NCT03718299|473342743|FG000|Overall Study|Withdrawal by Subject|6|||
131467378|NCT03718299|473342743|FG000|Overall Study|Physician Decision|2|||
131467379|NCT03718299|473342743|FG000|Overall Study|Lost to Follow-up|1|||
131467380|NCT01752036|473342744|FG000|Overall Study|Death|2|||
131467381|NCT01992159|473342746|FG000|Overall Study|Withdrawal by Subject|4|||
131467382|NCT01992159|473342747|FG001|Overall Study|Withdrawal by Subject|7|||
131467383|NCT01992159|473342748|FG002|Overall Study|Withdrawal by Subject|0|||
131467384|NCT01992159|473342749|FG003|Overall Study|Withdrawal by Subject|3|||
131467385|NCT01992159|473342746|FG000|Overall Study|Adverse Event|0|||
131467386|NCT01992159|473342747|FG001|Overall Study|Adverse Event|1|||
131467387|NCT01992159|473342748|FG002|Overall Study|Adverse Event|0|||
131467388|NCT01992159|473342749|FG003|Overall Study|Adverse Event|1|||
131467389|NCT01992159|473342746|FG000|Overall Study|Death|0|||
131467390|NCT01992159|473342747|FG001|Overall Study|Death|0|||
131467391|NCT01992159|473342748|FG002|Overall Study|Death|1|||
131467392|NCT01992159|473342749|FG003|Overall Study|Death|0|||
131467393|NCT02278471|473342752|FG000|Overall Study|Lost to Follow-up|6|||
131467394|NCT02278471|473342753|FG001|Overall Study|Lost to Follow-up|15|||
131467395|NCT02278471|473342752|FG000|Overall Study|Death|2|||
131467396|NCT02278471|473342753|FG001|Overall Study|Death|2|||
131467397|NCT02278471|473342752|FG000|Overall Study|Withdrawal by Subject|0|||
131467398|NCT02278471|473342753|FG001|Overall Study|Withdrawal by Subject|3|||
131467399|NCT00640835|473342754|FG000|Overall Study|Adverse Event|5|||
131467400|NCT00640835|473342755|FG001|Overall Study|Adverse Event|3|||
131467401|NCT00640835|473342754|FG000|Overall Study|Withdrawal by Subject|12|||
131467402|NCT00640835|473342755|FG001|Overall Study|Withdrawal by Subject|14|||
131467403|NCT00640835|473342754|FG000|Overall Study|Physician Decision|10|||
131467404|NCT00640835|473342755|FG001|Overall Study|Physician Decision|14|||
131467405|NCT00640835|473342754|FG000|Overall Study|Sponsor's Decision|11|||
131467406|NCT00640835|473342755|FG001|Overall Study|Sponsor's Decision|7|||
131467407|NCT00640835|473342754|FG000|Overall Study|Protocol Violation|2|||
131467408|NCT00640835|473342755|FG001|Overall Study|Protocol Violation|2|||
131467409|NCT00640835|473342754|FG000|Overall Study|Lost to Follow-up|17|||
131467410|NCT00640835|473342755|FG001|Overall Study|Lost to Follow-up|13|||
131467411|NCT00640835|473342754|FG000|Overall Study|Other Reason|19|||
131467412|NCT00640835|473342755|FG001|Overall Study|Other Reason|4|||
131467413|NCT04535167|473342757|FG000|Treatment|Adverse Event|0|||
131467414|NCT04535167|473342758|FG001|Treatment|Adverse Event|0|||
131467415|NCT04535167|473342759|FG002|Treatment|Adverse Event|0|||
131467416|NCT04535167|473342760|FG003|Treatment|Adverse Event|0|||
131467417|NCT04535167|473342761|FG004|Treatment|Adverse Event|0|||
131467418|NCT04535167|473342762|FG005|Treatment|Adverse Event|0|||
131467419|NCT04535167|473342763|FG006|Treatment|Adverse Event|1|||
131467420|NCT04535167|473342757|FG000|Follow-Up|Death|0|||
131467421|NCT04535167|473342758|FG001|Follow-Up|Death|0|||
131467422|NCT04535167|473342759|FG002|Follow-Up|Death|0|||
131467423|NCT04535167|473342760|FG003|Follow-Up|Death|0|||
131467424|NCT04535167|473342761|FG004|Follow-Up|Death|0|||
131467425|NCT04535167|473342762|FG005|Follow-Up|Death|0|||
131467426|NCT04535167|473342763|FG006|Follow-Up|Death|1|||
131467427|NCT04535167|473342757|FG000|Follow-Up|Lost to Follow-up|0|||
131467428|NCT04535167|473342758|FG001|Follow-Up|Lost to Follow-up|0|||
131467429|NCT04535167|473342759|FG002|Follow-Up|Lost to Follow-up|0|||
131467430|NCT04535167|473342760|FG003|Follow-Up|Lost to Follow-up|1|||
131467431|NCT04535167|473342761|FG004|Follow-Up|Lost to Follow-up|0|||
131467432|NCT04535167|473342762|FG005|Follow-Up|Lost to Follow-up|0|||
131467433|NCT04535167|473342763|FG006|Follow-Up|Lost to Follow-up|0|||
131467434|NCT00978432|473342764|FG000|Overall Study|Withdrawal by Subject|0|||
131467435|NCT00978432|473342765|FG001|Overall Study|Withdrawal by Subject|0|||
131467436|NCT00978432|473342766|FG002|Overall Study|Withdrawal by Subject|1|||
131467437|NCT00978432|473342764|FG000|Overall Study|Lack of Efficacy|1|||
131467438|NCT00978432|473342765|FG001|Overall Study|Lack of Efficacy|1|||
131467439|NCT00978432|473342766|FG002|Overall Study|Lack of Efficacy|3|||
131467440|NCT00978432|473342764|FG000|Overall Study|Adverse Event|2|||
131467441|NCT00978432|473342765|FG001|Overall Study|Adverse Event|0|||
131467442|NCT00978432|473342766|FG002|Overall Study|Adverse Event|1|||
131467443|NCT04618770|473342767|FG000|Overall Study|Censored from Analysis|12|||
131467444|NCT04618770|473342767|FG000|Overall Study|Early Termination|25|||
131467445|NCT04972630|473342768|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
131467446|NCT04972630|473342769|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
131467447|NCT04972630|473342770|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
131467448|NCT00075270|473342773|FG000|Overall Study|Withdrawal by Subject|28|||
131467449|NCT00075270|473342774|FG001|Overall Study|Withdrawal by Subject|21|||
131467450|NCT00075270|473342773|FG000|Overall Study|Lost to Follow-up|25|||
131467451|NCT00075270|473342774|FG001|Overall Study|Lost to Follow-up|28|||
131467452|NCT00075270|473342773|FG000|Overall Study|Protocol Violation|0|||
131467453|NCT00075270|473342774|FG001|Overall Study|Protocol Violation|2|||
131467454|NCT00075270|473342773|FG000|Overall Study|Death|198|||
131467455|NCT00075270|473342774|FG001|Overall Study|Death|215|||
131467456|NCT00075270|473342773|FG000|Overall Study|Other/Unknown|9|||
131467457|NCT00075270|473342774|FG001|Overall Study|Other/Unknown|5|||
131467458|NCT00075270|473342773|FG000|Overall Study|Missing|26|||
131467459|NCT00075270|473342774|FG001|Overall Study|Missing|13|||
131467460|NCT02160002|473342775|FG000|Overall Study|Withdrawal by Subject|2|||
131467461|NCT02160002|473342776|FG001|Overall Study|Withdrawal by Subject|1|||
131467462|NCT04418661|473342777|FG000|Overall Study|Adverse Event|0|||
131467463|NCT04418661|473342778|FG001|Overall Study|Adverse Event|1|||
131467464|NCT04418661|473342779|FG002|Overall Study|Adverse Event|5|||
131467465|NCT04418661|473342780|FG003|Overall Study|Adverse Event|3|||
131467466|NCT04418661|473342781|FG004|Overall Study|Adverse Event|0|||
131467467|NCT04418661|473342782|FG005|Overall Study|Adverse Event|2|||
131467468|NCT04418661|473342777|FG000|Overall Study|Progressive disease|4|||
131467469|NCT04418661|473342778|FG001|Overall Study|Progressive disease|11|||
131467470|NCT04418661|473342779|FG002|Overall Study|Progressive disease|6|||
131467471|NCT04418661|473342780|FG003|Overall Study|Progressive disease|11|||
131467472|NCT04418661|473342781|FG004|Overall Study|Progressive disease|1|||
131467473|NCT04418661|473342782|FG005|Overall Study|Progressive disease|12|||
131467474|NCT04418661|473342777|FG000|Overall Study|Withdrawal by Subject|0|||
131467475|NCT04418661|473342778|FG001|Overall Study|Withdrawal by Subject|1|||
131467476|NCT04418661|473342779|FG002|Overall Study|Withdrawal by Subject|0|||
131467477|NCT04418661|473342780|FG003|Overall Study|Withdrawal by Subject|1|||
131467478|NCT04418661|473342781|FG004|Overall Study|Withdrawal by Subject|0|||
131467479|NCT04418661|473342782|FG005|Overall Study|Withdrawal by Subject|0|||
131467480|NCT04418661|473342777|FG000|Overall Study|Other|0|||
131467481|NCT04418661|473342778|FG001|Overall Study|Other|0|||
131467482|NCT04418661|473342779|FG002|Overall Study|Other|1|||
131467483|NCT04418661|473342780|FG003|Overall Study|Other|3|||
131467484|NCT04418661|473342781|FG004|Overall Study|Other|0|||
131467485|NCT04418661|473342782|FG005|Overall Study|Other|1|||
131467486|NCT00713310|473342786|FG000|Overall Study|Adverse Event|5|||
131467487|NCT00713310|473342787|FG001|Overall Study|Adverse Event|2|||
131467488|NCT00713310|473342786|FG000|Overall Study|Lack of Efficacy|0|||
131467489|NCT00713310|473342787|FG001|Overall Study|Lack of Efficacy|2|||
131467490|NCT00713310|473342786|FG000|Overall Study|Withdrawal by Subject|0|||
131467491|NCT00713310|473342787|FG001|Overall Study|Withdrawal by Subject|2|||
131467492|NCT00686634|473342794|FG000|Overall Study|Protocol Violation|6|||
131467493|NCT02361580|473342797|FG000|Overall Study|Lost to Follow-up|6|||
131467494|NCT02361580|473342798|FG001|Overall Study|Lost to Follow-up|3|||
131467495|NCT00761150|473342799|FG000|Open-label Period|Adverse Event|36|||
131467496|NCT00761150|473342800|FG001|Open-label Period|Adverse Event|0|||
131467497|NCT00761150|473342801|FG002|Open-label Period|Adverse Event|0|||
131467498|NCT00761150|473342799|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
131467499|NCT00761150|473342800|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
131467500|NCT00761150|473342801|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
131467501|NCT00761150|473342799|FG000|Open-label Period|Lost to Follow-up|7|||
131467502|NCT00761150|473342800|FG001|Open-label Period|Lost to Follow-up|0|||
131467503|NCT00761150|473342801|FG002|Open-label Period|Lost to Follow-up|0|||
131467504|NCT00761150|473342799|FG000|Open-label Period|Lack of Efficacy|4|||
131467505|NCT00761150|473342800|FG001|Open-label Period|Lack of Efficacy|0|||
131467506|NCT00761150|473342801|FG002|Open-label Period|Lack of Efficacy|0|||
131467507|NCT00761150|473342799|FG000|Open-label Period|Withdrawal by Subject|5|||
131467508|NCT00761150|473342800|FG001|Open-label Period|Withdrawal by Subject|0|||
131467509|NCT00761150|473342801|FG002|Open-label Period|Withdrawal by Subject|0|||
131467510|NCT00761150|473342799|FG000|Open-label Period|Noncompliance|2|||
131467511|NCT00761150|473342800|FG001|Open-label Period|Noncompliance|0|||
131467512|NCT00761150|473342801|FG002|Open-label Period|Noncompliance|0|||
131467513|NCT00761150|473342799|FG000|Open-label Period|Other|5|||
131467514|NCT00761150|473342800|FG001|Open-label Period|Other|0|||
131467515|NCT00761150|473342801|FG002|Open-label Period|Other|0|||
131467516|NCT00761150|473342799|FG000|Double-blind Period|Lack of Efficacy|0|||
131467517|NCT00761150|473342800|FG001|Double-blind Period|Lack of Efficacy|2|||
131467518|NCT00761150|473342801|FG002|Double-blind Period|Lack of Efficacy|19|||
131467519|NCT00761150|473342799|FG000|Double-blind Period|Adverse Event|0|||
131467520|NCT00761150|473342800|FG001|Double-blind Period|Adverse Event|3|||
131467521|NCT00761150|473342801|FG002|Double-blind Period|Adverse Event|3|||
131467522|NCT00761150|473342799|FG000|Double-blind Period|Withdrawal by Subject|0|||
131467523|NCT00761150|473342800|FG001|Double-blind Period|Withdrawal by Subject|3|||
131467524|NCT00761150|473342801|FG002|Double-blind Period|Withdrawal by Subject|2|||
131467525|NCT00761150|473342799|FG000|Double-blind Period|Lost to Follow-up|0|||
131467526|NCT00761150|473342800|FG001|Double-blind Period|Lost to Follow-up|2|||
131467527|NCT00761150|473342801|FG002|Double-blind Period|Lost to Follow-up|1|||
131467528|NCT00761150|473342799|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
131467529|NCT00761150|473342800|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
131467530|NCT00761150|473342801|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
131467531|NCT00761150|473342799|FG000|Double-blind Period|Noncompliance|0|||
131467532|NCT00761150|473342800|FG001|Double-blind Period|Noncompliance|1|||
131467533|NCT00761150|473342801|FG002|Double-blind Period|Noncompliance|0|||
131467534|NCT00761150|473342799|FG000|Double-blind Period|Other|0|||
131467535|NCT00761150|473342800|FG001|Double-blind Period|Other|3|||
131467536|NCT00761150|473342801|FG002|Double-blind Period|Other|3|||
131467537|NCT02692651|473342802|FG000|Study Treatment|Death|7|||
131467538|NCT02692651|473342803|FG001|Study Treatment|Death|3|||
131467539|NCT02692651|473342802|FG000|Study Treatment|comfort care|1|||
131467540|NCT02692651|473342803|FG001|Study Treatment|comfort care|1|||
131467541|NCT02692651|473342802|FG000|Study Treatment|Protocol violation per treating team preference|8|||
131467542|NCT02692651|473342803|FG001|Study Treatment|Protocol violation per treating team preference|6|||
131467543|NCT02692651|473342802|FG000|Post Study Treatment Follow-up|Death|4|||
131467544|NCT02692651|473342803|FG001|Post Study Treatment Follow-up|Death|4|||
131467545|NCT00475423|473342804|FG000|Overall Study|Protocol Violation|5|||
131467546|NCT00475423|473342804|FG000|Overall Study|Adverse Event|4|||
131467547|NCT00475423|473342804|FG000|Overall Study|Withdrawal by Subject|6|||
131467548|NCT00475423|473342804|FG000|Overall Study|Lack of Efficacy|8|||
131467549|NCT00475423|473342804|FG000|Overall Study|Death|1|||
131467550|NCT00475423|473342804|FG000|Overall Study|Reason not specified|1|||
131467551|NCT00475423|473342804|FG000|Overall Study|Lost to Follow-up|7|||
131467552|NCT02582684|473342805|FG000|Overall Study|Unable to contact subject/parent|4|||
131467553|NCT02582684|473342805|FG000|Overall Study|Subject not able to get to clinic|10|||
131467554|NCT02582684|473342805|FG000|Overall Study|Subject withdrew consent|1|||
131467555|NCT02582684|473342805|FG000|Overall Study|Found to be ineligible after enrollment|2|||
131467556|NCT03025035|473342806|FG000|Overall Study|Death|2|||
131467557|NCT03025035|473342806|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
131467558|NCT00899392|473342807|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
131467559|NCT00899392|473342808|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
131467560|NCT01431638|473342815|FG000|Overall Study|Adverse Event|1|||
131467561|NCT01431638|473342816|FG001|Overall Study|Adverse Event|3|||
131467562|NCT01431638|473342817|FG002|Overall Study|Adverse Event|1|||
131467563|NCT01431638|473342815|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131467564|NCT01431638|473342816|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131467565|NCT01431638|473342817|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
131467566|NCT01431638|473342815|FG000|Overall Study|Participants condition no longer requires study drug|0|||
131467567|NCT01431638|473342816|FG001|Overall Study|Participants condition no longer requires study drug|1|||
131467568|NCT01431638|473342817|FG002|Overall Study|Participants condition no longer requires study drug|0|||
131467569|NCT01431638|473342815|FG000|Overall Study|Participant withdrew consent|14|||
131467570|NCT01431638|473342816|FG001|Overall Study|Participant withdrew consent|5|||
131467571|NCT01431638|473342817|FG002|Overall Study|Participant withdrew consent|8|||
131467572|NCT01431638|473342815|FG000|Overall Study|Lost to Follow-up|7|||
131467573|NCT01431638|473342816|FG001|Overall Study|Lost to Follow-up|9|||
131467574|NCT01431638|473342817|FG002|Overall Study|Lost to Follow-up|7|||
131467575|NCT01431638|473342815|FG000|Overall Study|Administrative problems|1|||
131467576|NCT01431638|473342816|FG001|Overall Study|Administrative problems|4|||
131467577|NCT01431638|473342817|FG002|Overall Study|Administrative problems|6|||
131467578|NCT01431638|473342815|FG000|Overall Study|Death|1|||
131467579|NCT01431638|473342816|FG001|Overall Study|Death|0|||
131467580|NCT01431638|473342817|FG002|Overall Study|Death|0|||
131467581|NCT01431638|473342815|FG000|Overall Study|Protocol deviation|1|||
131467582|NCT01431638|473342816|FG001|Overall Study|Protocol deviation|1|||
131467583|NCT01431638|473342817|FG002|Overall Study|Protocol deviation|4|||
131467584|NCT01431638|473342815|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
131467585|NCT01431638|473342816|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
131467586|NCT01431638|473342817|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
131467587|NCT01239732|473342818|FG000|Overall Study|Termination of study per protocol|667|||
131467588|NCT01239732|473342818|FG000|Overall Study|Death|226|||
131467589|NCT01239732|473342818|FG000|Overall Study|Withdrawal by Subject|87|||
131467590|NCT01239732|473342818|FG000|Overall Study|Adverse Event|6|||
131467591|NCT01239732|473342818|FG000|Overall Study|Protocol Violation|3|||
131467592|NCT01239732|473342818|FG000|Overall Study|Participant non compliance|5|||
131467593|NCT01239732|473342818|FG000|Overall Study|Study termination by sponsor|2|||
131467594|NCT01239732|473342818|FG000|Overall Study|Investigator's decision|4|||
131467595|NCT01239732|473342818|FG000|Overall Study|Treatment failure|2|||
131467596|NCT01239732|473342818|FG000|Overall Study|Other|19|||
131467597|NCT02048241|473342819|FG000|Overall Study|Withdrawal by Subject|0|||
131467598|NCT02048241|473342820|FG001|Overall Study|Withdrawal by Subject|1|||
131467599|NCT00402233|473342821|FG000|Overall Study|Adverse Event|1|||
131467600|NCT00402233|473342822|FG001|Overall Study|Adverse Event|7|||
131467601|NCT00402233|473342823|FG002|Overall Study|Adverse Event|9|||
131467602|NCT00402233|473342824|FG003|Overall Study|Adverse Event|9|||
131467603|NCT00402233|473342821|FG000|Overall Study|Protocol Violation|0|||
131467604|NCT00402233|473342822|FG001|Overall Study|Protocol Violation|1|||
131467605|NCT00402233|473342823|FG002|Overall Study|Protocol Violation|0|||
131467606|NCT00402233|473342824|FG003|Overall Study|Protocol Violation|0|||
131467607|NCT00402233|473342821|FG000|Overall Study|Withdrawal by Subject|2|||
131467608|NCT00402233|473342822|FG001|Overall Study|Withdrawal by Subject|1|||
131467609|NCT00402233|473342823|FG002|Overall Study|Withdrawal by Subject|2|||
131467610|NCT00402233|473342824|FG003|Overall Study|Withdrawal by Subject|2|||
131467611|NCT00402233|473342821|FG000|Overall Study|Worsening of disease under study|2|||
131467612|NCT00402233|473342822|FG001|Overall Study|Worsening of disease under study|0|||
131467613|NCT00402233|473342823|FG002|Overall Study|Worsening of disease under study|0|||
131467614|NCT00402233|473342824|FG003|Overall Study|Worsening of disease under study|0|||
131467615|NCT00402233|473342821|FG000|Overall Study|Worsening of other pre-existing disease|0|||
131467616|NCT00402233|473342822|FG001|Overall Study|Worsening of other pre-existing disease|1|||
131467617|NCT00402233|473342823|FG002|Overall Study|Worsening of other pre-existing disease|0|||
131467618|NCT00402233|473342824|FG003|Overall Study|Worsening of other pre-existing disease|0|||
131467619|NCT00278915|473342830|FG000|Overall Study|Disease progression|1|||
131467620|NCT02520089|473342831|FG000|Overall Study|Lost to Follow-up|3|||
131467621|NCT02520089|473342832|FG001|Overall Study|Lost to Follow-up|4|||
131467622|NCT03473548|473342835|FG000|Overall Study|Did not attempt HST testing|3|||
131467623|NCT03473548|473342836|FG001|Overall Study|Did not attempt HST testing|0|||
131467624|NCT00129311|473342838|FG000|Overall Study|Withdrawal by Subject|12|||
131467625|NCT00129311|473342839|FG001|Overall Study|Withdrawal by Subject|19|||
131467626|NCT02232880|473342840|FG000|Overall Study|study stopped prior to randomization|1|||
131467627|NCT00604214|473342845|FG000|Baseline to Day 28|Death|223|||
131467628|NCT00604214|473342846|FG001|Baseline to Day 28|Death|202|||
131467629|NCT00604214|473342845|FG000|Baseline to Day 28|Lost to Follow-up|2|||
131467630|NCT00604214|473342846|FG001|Baseline to Day 28|Lost to Follow-up|4|||
131467631|NCT00604214|473342845|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
131467632|NCT00604214|473342846|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
131467633|NCT00604214|473342845|FG000|Day 29 to Day 90|Death|64|||
131467634|NCT00604214|473342846|FG001|Day 29 to Day 90|Death|67|||
131467635|NCT00604214|473342845|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
131467636|NCT00604214|473342846|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
131467637|NCT00604214|473342845|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
131467638|NCT00604214|473342846|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
131467639|NCT00604214|473342845|FG000|Day 91 to Day 180|Death|19|||
131467640|NCT00604214|473342846|FG001|Day 91 to Day 180|Death|23|||
131467641|NCT00604214|473342845|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
131467642|NCT00604214|473342846|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
131467643|NCT00604214|473342845|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
131467644|NCT00604214|473342846|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
131467645|NCT02545543|473342847|FG000|Overall Study|Lost to Follow-up|67|||
131467646|NCT02545543|473342848|FG001|Overall Study|Lost to Follow-up|25|||
131467647|NCT02545543|473342847|FG000|Overall Study|Physician Decision|3|||
131467648|NCT02545543|473342848|FG001|Overall Study|Physician Decision|0|||
131467649|NCT02545543|473342847|FG000|Overall Study|Withdrawal by Subject|9|||
131467650|NCT02545543|473342848|FG001|Overall Study|Withdrawal by Subject|8|||
131467651|NCT02545543|473342847|FG000|Overall Study|Noncomplaince|1|||
131467652|NCT02545543|473342848|FG001|Overall Study|Noncomplaince|0|||
131467653|NCT02545543|473342847|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
131467654|NCT02545543|473342848|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
131467655|NCT02829944|473342852|FG000|Overall Study|Physician Decision|0|||
131467656|NCT02829944|473342853|FG001|Overall Study|Physician Decision|1|||
131467657|NCT02829944|473342852|FG000|Overall Study|Screen Failure|2|||
131467658|NCT02829944|473342853|FG001|Overall Study|Screen Failure|2|||
131467659|NCT02829944|473342852|FG000|Overall Study|Inadequate Neuraxial Block|1|||
131467660|NCT02829944|473342853|FG001|Overall Study|Inadequate Neuraxial Block|1|||
131467661|NCT02829944|473342852|FG000|Overall Study|Withdrawal by Subject|2|||
131467662|NCT02829944|473342853|FG001|Overall Study|Withdrawal by Subject|1|||
131467663|NCT02829944|473342852|FG000|Overall Study|Catheter Displacement|1|||
131467664|NCT02829944|473342853|FG001|Overall Study|Catheter Displacement|0|||
131467665|NCT02829944|473342852|FG000|Overall Study|Catheter broke|0|||
131467666|NCT02829944|473342853|FG001|Overall Study|Catheter broke|1|||
131467667|NCT02829944|473342852|FG000|Overall Study|Staff unavailable|0|||
131467668|NCT02829944|473342853|FG001|Overall Study|Staff unavailable|1|||
131467669|NCT02320903|473344453|FG000|Overall Study|Withdrawal by Subject|0|||
131467670|NCT02320903|473344454|FG001|Overall Study|Withdrawal by Subject|9|||
131467671|NCT02320903|473344455|FG002|Overall Study|Withdrawal by Subject|9|||
131467672|NCT02320903|473344453|FG000|Overall Study|Exited therapy; no longer eligible|8|||
131467673|NCT02320903|473344454|FG001|Overall Study|Exited therapy; no longer eligible|2|||
131467674|NCT02320903|473344455|FG002|Overall Study|Exited therapy; no longer eligible|2|||
131467675|NCT02320903|473344453|FG000|Overall Study|Lost to Follow-up|0|||
131467676|NCT02320903|473344454|FG001|Overall Study|Lost to Follow-up|5|||
131467677|NCT02320903|473344455|FG002|Overall Study|Lost to Follow-up|5|||
131467678|NCT01122394|473344463|FG000|Overall Study|Withdrawal by Subject|1|||
131467679|NCT01122394|473344464|FG001|Overall Study|Withdrawal by Subject|1|||
131467680|NCT01122394|473344463|FG000|Overall Study|Lost to Follow-up|2|||
131467681|NCT01122394|473344464|FG001|Overall Study|Lost to Follow-up|2|||
131467682|NCT01122394|473344463|FG000|Overall Study|Adverse Event|0|||
131467683|NCT01122394|473344464|FG001|Overall Study|Adverse Event|1|||
131467684|NCT02446743|473344465|FG000|Overall Study|Withdrawal by Subject|1|||
131467685|NCT02446743|473344466|FG001|Overall Study|Withdrawal by Subject|1|||
131467686|NCT02446743|473344465|FG000|Overall Study|Lost to Follow-up|1|||
131467687|NCT02446743|473344466|FG001|Overall Study|Lost to Follow-up|0|||
131467688|NCT02446743|473344465|FG000|Overall Study|Adverse Event|1|||
131467689|NCT02446743|473344466|FG001|Overall Study|Adverse Event|1|||
131467690|NCT02446743|473344465|FG000|Overall Study|Other|2|||
131467691|NCT02446743|473344466|FG001|Overall Study|Other|3|||
131467692|NCT04389970|473344467|FG000|Overall Study|Lost to Follow-up|1|||
131467693|NCT01931670|473344469|FG000|Treatment Period|Exclusionary Medication Received|1|||
131467694|NCT01931670|473344470|FG001|Treatment Period|Exclusionary Medication Received|1|||
131467695|NCT01931670|473344471|FG002|Treatment Period|Exclusionary Medication Received|1|||
131467696|NCT01931670|473344469|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
131467697|NCT01931670|473344470|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
131467698|NCT01931670|473344471|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
131467699|NCT01931670|473344469|FG000|Treatment Period|Subject Noncompliant|4|||
131467700|NCT01931670|473344470|FG001|Treatment Period|Subject Noncompliant|9|||
131467701|NCT01931670|473344471|FG002|Treatment Period|Subject Noncompliant|5|||
131467702|NCT01931670|473344469|FG000|Treatment Period|Adverse Event|19|||
131467703|NCT01931670|473344470|FG001|Treatment Period|Adverse Event|8|||
131467704|NCT01931670|473344471|FG002|Treatment Period|Adverse Event|21|||
131467705|NCT01931670|473344469|FG000|Treatment Period|Lack of Efficacy|11|||
131467706|NCT01931670|473344470|FG001|Treatment Period|Lack of Efficacy|2|||
131467707|NCT01931670|473344471|FG002|Treatment Period|Lack of Efficacy|2|||
131467708|NCT01931670|473344469|FG000|Treatment Period|Pregnancy|7|||
131467709|NCT01931670|473344470|FG001|Treatment Period|Pregnancy|2|||
131467710|NCT01931670|473344471|FG002|Treatment Period|Pregnancy|0|||
131467711|NCT01931670|473344469|FG000|Treatment Period|Other|8|||
131467712|NCT01931670|473344470|FG001|Treatment Period|Other|7|||
131467713|NCT01931670|473344471|FG002|Treatment Period|Other|2|||
131467714|NCT01931670|473344469|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
131467715|NCT01931670|473344470|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
131467716|NCT01931670|473344471|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
131467717|NCT01931670|473344469|FG000|Treatment Period|Lost to Follow-up|19|||
131467718|NCT01931670|473344470|FG001|Treatment Period|Lost to Follow-up|5|||
131467719|NCT01931670|473344471|FG002|Treatment Period|Lost to Follow-up|7|||
131467720|NCT01931670|473344469|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
131467721|NCT01931670|473344470|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
131467722|NCT01931670|473344471|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
131467723|NCT01931670|473344469|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
131467724|NCT01931670|473344470|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
131467725|NCT01931670|473344471|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
131467726|NCT01931670|473344469|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
131467727|NCT01931670|473344470|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
131467728|NCT01931670|473344471|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
131467729|NCT01931670|473344469|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
131467730|NCT01931670|473344470|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
131467731|NCT01931670|473344471|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
131467732|NCT01931670|473344469|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
131467733|NCT01931670|473344470|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
131467734|NCT01931670|473344471|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
131467735|NCT01931670|473344469|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
131467736|NCT01931670|473344470|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
131467737|NCT01931670|473344471|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
131467738|NCT00976508|473344472|FG000|Overall Study|Death|7|||
131467739|NCT00976508|473344473|FG001|Overall Study|Death|1|||
131467740|NCT00976508|473344472|FG000|Overall Study|Lost to Follow-up|1|||
131467741|NCT00976508|473344473|FG001|Overall Study|Lost to Follow-up|0|||
131467742|NCT00976508|473344472|FG000|Overall Study|Withdrawal by Subject|1|||
131467743|NCT00976508|473344473|FG001|Overall Study|Withdrawal by Subject|0|||
131467744|NCT00976508|473344472|FG000|Overall Study|Disease Progression|4|||
131467745|NCT00976508|473344473|FG001|Overall Study|Disease Progression|4|||
131467746|NCT00976508|473344472|FG000|Overall Study|Subject Enrolled in Hospice|1|||
131467747|NCT00976508|473344473|FG001|Overall Study|Subject Enrolled in Hospice|0|||
131467748|NCT00976508|473344472|FG000|Overall Study|Terminated by the Sponsor|0|||
131467749|NCT00976508|473344473|FG001|Overall Study|Terminated by the Sponsor|1|||
131467750|NCT03023046|473344474|FG000|Overall Study|Withdrawal by Subject|1|||
131467751|NCT01205581|473344475|FG000|Overall Study|Withdrawal by Subject|1|||
131467752|NCT01205581|473344476|FG001|Overall Study|Withdrawal by Subject|0|||
131467753|NCT01205581|473344477|FG002|Overall Study|Withdrawal by Subject|0|||
131467754|NCT01205581|473344478|FG003|Overall Study|Withdrawal by Subject|0|||
131467755|NCT01205581|473344479|FG004|Overall Study|Withdrawal by Subject|0|||
131467756|NCT01205581|473344480|FG005|Overall Study|Withdrawal by Subject|0|||
131467757|NCT02455557|473344483|FG000|Overall Study|Withdrawal by Subject|2|||
131467758|NCT00807027|473344484|FG000|Overall Study|Withdrawal by Subject|13|||
131467759|NCT00807027|473344485|FG001|Overall Study|Withdrawal by Subject|14|||
131467760|NCT00807027|473344484|FG000|Overall Study|Protocol Violation|1|||
131467761|NCT00807027|473344485|FG001|Overall Study|Protocol Violation|1|||
131467762|NCT00807027|473344484|FG000|Overall Study|Adverse Event|2|||
131467763|NCT00807027|473344485|FG001|Overall Study|Adverse Event|2|||
131467764|NCT05508074|473344489|FG000|Overall Study|Death|2|||
131467765|NCT05508074|473344490|FG001|Overall Study|Death|5|||
131467766|NCT05508074|473344489|FG000|Overall Study|Withdrawal by Subject|1|||
131467767|NCT05508074|473344490|FG001|Overall Study|Withdrawal by Subject|2|||
131467768|NCT05508074|473344489|FG000|Overall Study|Adverse Event|0|||
131467769|NCT05508074|473344490|FG001|Overall Study|Adverse Event|1|||
131467770|NCT05508074|473344489|FG000|Overall Study|Physician Decision|0|||
131467771|NCT05508074|473344490|FG001|Overall Study|Physician Decision|1|||
131467772|NCT05508074|473344489|FG000|Overall Study|wrongly randomized|0|||
131467773|NCT05508074|473344490|FG001|Overall Study|wrongly randomized|1|||
131467774|NCT05508074|473344489|FG000|Overall Study|non-compliance|0|||
131467775|NCT05508074|473344490|FG001|Overall Study|non-compliance|1|||
131467776|NCT00924781|473344491|FG000|Overall Study|Study terminated by sponsor|12|||
131467777|NCT00924781|473344492|FG001|Overall Study|Study terminated by sponsor|10|||
131467778|NCT00708201|473344493|FG000|Overall Study|Adverse Event|4|||
131467779|NCT00708201|473344494|FG001|Overall Study|Adverse Event|4|||
131467780|NCT00708201|473344493|FG000|Overall Study|Withdrawal by Subject|1|||
131467781|NCT00708201|473344494|FG001|Overall Study|Withdrawal by Subject|1|||
131467782|NCT00708201|473344493|FG000|Overall Study|Lost to Follow-up|2|||
131467783|NCT00708201|473344494|FG001|Overall Study|Lost to Follow-up|0|||
131467784|NCT00708201|473344493|FG000|Overall Study|Protocol Violation|0|||
131467785|NCT00708201|473344494|FG001|Overall Study|Protocol Violation|1|||
131467786|NCT01653132|473344495|FG000|First Intervention|Protocol Violation|1|||
131467787|NCT01653132|473344496|FG001|First Intervention|Protocol Violation|0|||
131467788|NCT00761748|473344497|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
131467789|NCT00761748|473344498|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
131467790|NCT00761748|473344497|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
131467791|NCT00761748|473344498|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
131467792|NCT03312751|473344499|FG000|Overall Study|Death|7|||
131467793|NCT03312751|473344500|FG001|Overall Study|Death|9|||
131467794|NCT03312751|473344499|FG000|Overall Study|Study discontinuation due to other reason|0|||
131467795|NCT03312751|473344500|FG001|Overall Study|Study discontinuation due to other reason|1|||
131467796|NCT03490981|473344501|FG000|Overall Study|Lost to Follow-up|1|||
131467797|NCT03490981|473344502|FG001|Overall Study|Lost to Follow-up|2|||
131467798|NCT00282464|473344509|FG000|Overall Study|Adverse Event|26|||
131467799|NCT00282464|473344510|FG001|Overall Study|Adverse Event|20|||
131467800|NCT00282464|473344509|FG000|Overall Study|Lack of Efficacy|8|||
131467801|NCT00282464|473344510|FG001|Overall Study|Lack of Efficacy|8|||
131467802|NCT00282464|473344509|FG000|Overall Study|Lost to Follow-up|10|||
131467803|NCT00282464|473344510|FG001|Overall Study|Lost to Follow-up|10|||
131467804|NCT00282464|473344509|FG000|Overall Study|Withdrawal by Subject|24|||
131467805|NCT00282464|473344510|FG001|Overall Study|Withdrawal by Subject|10|||
131467806|NCT00282464|473344509|FG000|Overall Study|laboratory abnormality|1|||
131467807|NCT00282464|473344510|FG001|Overall Study|laboratory abnormality|2|||
131467808|NCT00282464|473344509|FG000|Overall Study|Protocol Violation|0|||
131467809|NCT00282464|473344510|FG001|Overall Study|Protocol Violation|7|||
131467810|NCT00282464|473344509|FG000|Overall Study|Patient moved|1|||
131467811|NCT00282464|473344510|FG001|Overall Study|Patient moved|0|||
131467812|NCT00282464|473344509|FG000|Overall Study|patient non-compliant|3|||
131467813|NCT00282464|473344510|FG001|Overall Study|patient non-compliant|0|||
131467814|NCT00282464|473344509|FG000|Overall Study|patient no show|0|||
131467815|NCT00282464|473344510|FG001|Overall Study|patient no show|1|||
131467816|NCT00282464|473344509|FG000|Overall Study|patient incarcerated|0|||
131467817|NCT00282464|473344510|FG001|Overall Study|patient incarcerated|1|||
131467818|NCT00282464|473344509|FG000|Overall Study|family crisis|0|||
131467819|NCT00282464|473344510|FG001|Overall Study|family crisis|1|||
131467820|NCT00282464|473344509|FG000|Overall Study|dispensed wrong kit|0|||
131467821|NCT00282464|473344510|FG001|Overall Study|dispensed wrong kit|1|||
131467822|NCT00282464|473344509|FG000|Overall Study|dropped due to missed visits|0|||
131467823|NCT00282464|473344510|FG001|Overall Study|dropped due to missed visits|1|||
131467824|NCT01624870|473344511|FG000|Overall Study|Death|19|||
131467825|NCT01624870|473344511|FG000|Overall Study|Withdrawal by Subject|1|||
131467826|NCT01624870|473344511|FG000|Overall Study|CoreValve not implanted|6|||
131467827|NCT01624870|473344511|FG000|Overall Study|Lost to follow up|1|||
131467828|NCT04672252|473344518|FG000|Overall Study|Protocol Violation|1|||
131467829|NCT04672252|473344519|FG001|Overall Study|Protocol Violation|0|||
131467830|NCT04391569|473344520|FG000|Overall Study|Death|15|||
131467831|NCT04391569|473344521|FG001|Overall Study|Death|10|||
131467832|NCT04391569|473344520|FG000|Overall Study|Withdrawal by Subject|1|||
131467833|NCT04391569|473344521|FG001|Overall Study|Withdrawal by Subject|0|||
131467834|NCT04391569|473344520|FG000|Overall Study|Lost to Follow-up|3|||
131467835|NCT04391569|473344521|FG001|Overall Study|Lost to Follow-up|2|||
131467836|NCT04391569|473344520|FG000|Overall Study|Lack of Efficacy|0|||
131467837|NCT04391569|473344521|FG001|Overall Study|Lack of Efficacy|1|||
131467838|NCT04391569|473344520|FG000|Overall Study|Participant discharged to hospice facility|0|||
131467839|NCT04391569|473344521|FG001|Overall Study|Participant discharged to hospice facility|1|||
131467840|NCT04391569|473344520|FG000|Overall Study|Participant family decision|1|||
131467841|NCT04391569|473344521|FG001|Overall Study|Participant family decision|0|||
131467842|NCT04391569|473344520|FG000|Overall Study|Participant discharged prematurely|1|||
131467843|NCT04391569|473344521|FG001|Overall Study|Participant discharged prematurely|0|||
131467844|NCT01302834|473344525|FG000|Overall Study|Protocol Violation|17|||
131467845|NCT01302834|473344526|FG001|Overall Study|Protocol Violation|23|||
131467846|NCT01302834|473344525|FG000|Overall Study|HIV positive|1|||
131467847|NCT01302834|473344526|FG001|Overall Study|HIV positive|3|||
131467848|NCT02486718|473344529|FG000|Enrollment Phase|Death|19|||
131467849|NCT02486718|473344530|FG001|Enrollment Phase|Death|0|||
131467850|NCT02486718|473344531|FG002|Enrollment Phase|Death|0|||
131467851|NCT02486718|473344529|FG000|Enrollment Phase|Symptomatic deterioration|1|||
131467852|NCT02486718|473344530|FG001|Enrollment Phase|Symptomatic deterioration|0|||
131467853|NCT02486718|473344531|FG002|Enrollment Phase|Symptomatic deterioration|0|||
131467854|NCT02486718|473344529|FG000|Enrollment Phase|Withdrawal by Subject|86|||
131467855|NCT02486718|473344530|FG001|Enrollment Phase|Withdrawal by Subject|0|||
131467856|NCT02486718|473344531|FG002|Enrollment Phase|Withdrawal by Subject|0|||
131467857|NCT02486718|473344529|FG000|Enrollment Phase|Protocol Violation|18|||
131467858|NCT02486718|473344530|FG001|Enrollment Phase|Protocol Violation|0|||
131467859|NCT02486718|473344531|FG002|Enrollment Phase|Protocol Violation|0|||
131467860|NCT02486718|473344529|FG000|Enrollment Phase|Physician Decision|18|||
131467861|NCT02486718|473344530|FG001|Enrollment Phase|Physician Decision|0|||
131467862|NCT02486718|473344531|FG002|Enrollment Phase|Physician Decision|0|||
131467863|NCT02486718|473344529|FG000|Enrollment Phase|Reason not provided|41|||
131467864|NCT02486718|473344530|FG001|Enrollment Phase|Reason not provided|0|||
131467865|NCT02486718|473344531|FG002|Enrollment Phase|Reason not provided|0|||
131467866|NCT02486718|473344529|FG000|Enrollment Phase|Disease relapse|54|||
131467867|NCT02486718|473344530|FG001|Enrollment Phase|Disease relapse|0|||
131467868|NCT02486718|473344531|FG002|Enrollment Phase|Disease relapse|0|||
131467869|NCT02486718|473344529|FG000|Enrollment Phase|Lost to Follow-up|4|||
131467870|NCT02486718|473344530|FG001|Enrollment Phase|Lost to Follow-up|0|||
131467871|NCT02486718|473344531|FG002|Enrollment Phase|Lost to Follow-up|0|||
131467872|NCT02486718|473344529|FG000|Enrollment Phase|Adverse Event|34|||
131467873|NCT02486718|473344530|FG001|Enrollment Phase|Adverse Event|0|||
131467874|NCT02486718|473344531|FG002|Enrollment Phase|Adverse Event|0|||
131467875|NCT02486718|473344529|FG000|Randomized Phase|Withdrawal by Subject|0|||
131467876|NCT02486718|473344530|FG001|Randomized Phase|Withdrawal by Subject|44|||
131467877|NCT02486718|473344531|FG002|Randomized Phase|Withdrawal by Subject|47|||
131467878|NCT02486718|473344529|FG000|Randomized Phase|Protocol Violation|0|||
131467879|NCT02486718|473344530|FG001|Randomized Phase|Protocol Violation|2|||
131467880|NCT02486718|473344531|FG002|Randomized Phase|Protocol Violation|0|||
131467881|NCT02486718|473344529|FG000|Randomized Phase|Physician Decision|0|||
131467882|NCT02486718|473344530|FG001|Randomized Phase|Physician Decision|0|||
131467883|NCT02486718|473344531|FG002|Randomized Phase|Physician Decision|3|||
131467884|NCT02486718|473344529|FG000|Randomized Phase|Lost to Follow-up|0|||
131467885|NCT02486718|473344530|FG001|Randomized Phase|Lost to Follow-up|5|||
131467886|NCT02486718|473344531|FG002|Randomized Phase|Lost to Follow-up|11|||
131467887|NCT02486718|473344529|FG000|Randomized Phase|Disease Relapse|0|||
131467888|NCT02486718|473344530|FG001|Randomized Phase|Disease Relapse|1|||
131467889|NCT02486718|473344531|FG002|Randomized Phase|Disease Relapse|0|||
131467890|NCT02486718|473344529|FG000|Randomized Phase|Death|0|||
131467891|NCT02486718|473344530|FG001|Randomized Phase|Death|154|||
131467892|NCT02486718|473344531|FG002|Randomized Phase|Death|155|||
131467893|NCT02486718|473344529|FG000|Randomized Phase|Ongoing|0|||
131467894|NCT02486718|473344530|FG001|Randomized Phase|Ongoing|301|||
131467895|NCT02486718|473344531|FG002|Randomized Phase|Ongoing|282|||
131467896|NCT02216812|473344542|FG000|Overall Study|Lost to Follow-up|10|||
131467897|NCT02216812|473344543|FG001|Overall Study|Lost to Follow-up|5|||
131467898|NCT00527488|473344548|FG000|Overall Study|Withdrawn prior to dosing|0|||
131467899|NCT00527488|473344549|FG001|Overall Study|Withdrawn prior to dosing|1|||
131467900|NCT00527488|473344550|FG002|Overall Study|Withdrawn prior to dosing|1|||
131467901|NCT00527488|473344551|FG003|Overall Study|Withdrawn prior to dosing|0|||
131467902|NCT04803214|473344552|FG000|Overall Study|Adverse Event|1|||
131467903|NCT04803214|473344553|FG001|Overall Study|Adverse Event|0|||
131467904|NCT04803214|473344552|FG000|Overall Study|Withdrawal by Subject|1|||
131467905|NCT04803214|473344553|FG001|Overall Study|Withdrawal by Subject|2|||
131467906|NCT04803214|473344552|FG000|Overall Study|Lost to Follow-up|2|||
131467907|NCT04803214|473344553|FG001|Overall Study|Lost to Follow-up|4|||
131467908|NCT04803214|473344552|FG000|Overall Study|Physician Decision|1|||
131467909|NCT04803214|473344553|FG001|Overall Study|Physician Decision|1|||
131467910|NCT04803214|473344552|FG000|Overall Study|Missed 12 month visit|0|||
131467911|NCT04803214|473344553|FG001|Overall Study|Missed 12 month visit|3|||
131467912|NCT04675151|473344554|FG000|Overall Study|Protocol Violation|1|||
131467913|NCT04675151|473344555|FG001|Overall Study|Protocol Violation|0|||
131467914|NCT04675151|473344556|FG002|Overall Study|Protocol Violation|0|||
131467915|NCT04675151|473344557|FG003|Overall Study|Protocol Violation|1|||
131467916|NCT04035486|473344558|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
131467917|NCT04035486|473344559|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
131467918|NCT04035486|473344560|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
131467919|NCT04035486|473344561|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
131467920|NCT04035486|473344558|FG000|Overall Study|Death|6|||
131467921|NCT04035486|473344559|FG001|Overall Study|Death|3|||
131467922|NCT04035486|473344560|FG002|Overall Study|Death|70|||
131467923|NCT04035486|473344561|FG003|Overall Study|Death|77|||
131467924|NCT04035486|473344558|FG000|Overall Study|Screen Failure|0|||
131467925|NCT04035486|473344559|FG001|Overall Study|Screen Failure|0|||
131467926|NCT04035486|473344560|FG002|Overall Study|Screen Failure|1|||
131769040|NCT00877929|474431931|FG000|Overall Study|Other reason (not specified)|2|||
131769041|NCT00877929|474431932|FG001|Overall Study|Other reason (not specified)|6|||
131769042|NCT00689728|474431933|FG000|Double-Blind Treatment|Adverse Event|1|||
131769043|NCT00689728|474431934|FG001|Double-Blind Treatment|Adverse Event|0|||
131769044|NCT00689728|474431935|FG002|Double-Blind Treatment|Adverse Event|0|||
131769045|NCT00689728|474431933|FG000|Double-Blind Treatment|Protocol Violation|0|||
131769046|NCT00689728|474431934|FG001|Double-Blind Treatment|Protocol Violation|0|||
131769047|NCT00689728|474431935|FG002|Double-Blind Treatment|Protocol Violation|1|||
131769048|NCT00689728|474431933|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
131769049|NCT00689728|474431934|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
131769050|NCT00689728|474431935|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
131769051|NCT00689728|474431933|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
131769052|NCT00689728|474431934|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
131769053|NCT00689728|474431935|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
131769054|NCT00689728|474431933|FG000|Rescue|Adverse Event|0|||
131769055|NCT00689728|474431934|FG001|Rescue|Adverse Event|1|||
131769056|NCT00689728|474431935|FG002|Rescue|Adverse Event|0|||
131769057|NCT00689728|474431933|FG000|Rescue|Withdrawal by Subject|1|||
131769058|NCT00689728|474431934|FG001|Rescue|Withdrawal by Subject|1|||
131769059|NCT00689728|474431935|FG002|Rescue|Withdrawal by Subject|1|||
131769060|NCT00689728|474431933|FG000|Optional Follow-Up|Adverse Event|1|||
131769061|NCT00689728|474431934|FG001|Optional Follow-Up|Adverse Event|0|||
131467927|NCT04035486|473344561|FG003|Overall Study|Screen Failure|1|||
131467928|NCT04035486|473344558|FG000|Overall Study|Withdrawal by Subject|1|||
131467929|NCT04035486|473344559|FG001|Overall Study|Withdrawal by Subject|1|||
131467930|NCT04035486|473344560|FG002|Overall Study|Withdrawal by Subject|11|||
131467931|NCT04035486|473344561|FG003|Overall Study|Withdrawal by Subject|9|||
131467932|NCT01730937|473344562|FG000|Overall Study|Protocol Violation|5|||
131467933|NCT01730937|473344563|FG001|Overall Study|Protocol Violation|11|||
131467934|NCT03947684|473344566|FG000|Overall Study|Lost to Follow-up|13|||
131467935|NCT03947684|473344567|FG001|Overall Study|Lost to Follow-up|5|||
131467936|NCT03947684|473344568|FG002|Overall Study|Lost to Follow-up|1|||
131467937|NCT03947684|473344566|FG000|Overall Study|Withdrawal by Subject|11|||
131467938|NCT03947684|473344567|FG001|Overall Study|Withdrawal by Subject|4|||
131769062|NCT00689728|474431935|FG002|Optional Follow-Up|Adverse Event|0|||
131769063|NCT00689728|474431933|FG000|Optional Follow-Up|Lack of Efficacy|0|||
131467939|NCT03947684|473344568|FG002|Overall Study|Withdrawal by Subject|0|||
131467940|NCT03947684|473344566|FG000|Overall Study|Physician Decision|1|||
131467941|NCT03947684|473344567|FG001|Overall Study|Physician Decision|0|||
131467942|NCT03947684|473344568|FG002|Overall Study|Physician Decision|0|||
131467943|NCT03947684|473344566|FG000|Overall Study|Lack of adherence to study protocol|2|||
131467944|NCT03947684|473344567|FG001|Overall Study|Lack of adherence to study protocol|0|||
131467945|NCT03947684|473344568|FG002|Overall Study|Lack of adherence to study protocol|0|||
131467946|NCT03875235|473344569|FG000|Overall Study|Ongoing study treatment|63|||
131467947|NCT03875235|473344570|FG001|Overall Study|Ongoing study treatment|20|||
131467948|NCT03875235|473344569|FG000|Overall Study|Off treatment|77|||
131467949|NCT03875235|473344570|FG001|Overall Study|Off treatment|91|||
131467950|NCT03875235|473344569|FG000|Overall Study|Withdrawal by Subject|3|||
131467951|NCT03875235|473344570|FG001|Overall Study|Withdrawal by Subject|10|||
131467952|NCT03875235|473344569|FG000|Overall Study|Death|198|||
131467953|NCT03875235|473344570|FG001|Overall Study|Death|223|||
131467954|NCT04526665|473344571|FG000|Overall Study|Withdrawal by Subject|6|||
131467955|NCT04526665|473344572|FG001|Overall Study|Withdrawal by Subject|3|||
131467956|NCT04526665|473344571|FG000|Overall Study|Adverse Event|4|||
131467957|NCT04526665|473344572|FG001|Overall Study|Adverse Event|1|||
131467958|NCT04526665|473344571|FG000|Overall Study|Physician Decision|2|||
131467959|NCT04526665|473344572|FG001|Overall Study|Physician Decision|2|||
131467960|NCT04526665|473344571|FG000|Overall Study|Death|2|||
131467961|NCT04526665|473344572|FG001|Overall Study|Death|0|||
131467962|NCT04526665|473344571|FG000|Overall Study|Other|0|||
131467963|NCT04526665|473344572|FG001|Overall Study|Other|1|||
131467964|NCT03595124|473345513|FG000|Overall Study|Physician Decision|1|||
131467965|NCT03595124|473345514|FG001|Overall Study|Physician Decision|1|||
131467966|NCT03595124|473345515|FG002|Overall Study|Physician Decision|1|||
131467967|NCT03595124|473345513|FG000|Overall Study|Ineligible|1|||
131467968|NCT03595124|473345514|FG001|Overall Study|Ineligible|1|||
131467969|NCT03595124|473345515|FG002|Overall Study|Ineligible|0|||
131467970|NCT03595124|473345513|FG000|Overall Study|Disease Progression|4|||
131467971|NCT03595124|473345514|FG001|Overall Study|Disease Progression|1|||
131467972|NCT03595124|473345515|FG002|Overall Study|Disease Progression|4|||
131467973|NCT01095094|473345518|FG000|Overall Study|Withdrawal by Subject|1|||
131467974|NCT01095094|473345518|FG000|Overall Study|Death|1|||
131467975|NCT01095094|473345518|FG000|Overall Study|Physician Decision|1|||
131467976|NCT05347147|473345519|FG000|Overall Study|Lost to Follow-up|0|||
131467977|NCT05347147|473345520|FG001|Overall Study|Lost to Follow-up|1|||
131467978|NCT05347147|473345519|FG000|Overall Study|Sponsor request|3|||
131467979|NCT05347147|473345520|FG001|Overall Study|Sponsor request|3|||
131467980|NCT05347147|473345519|FG000|Overall Study|Study termination|2|||
131467981|NCT05347147|473345520|FG001|Overall Study|Study termination|1|||
131467982|NCT03404960|473345522|FG000|Overall Study|Adverse Event|0|||
131467983|NCT03404960|473345523|FG001|Overall Study|Adverse Event|2|||
131467984|NCT03404960|473345522|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
131467985|NCT03404960|473345523|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
131467986|NCT03404960|473345522|FG000|Overall Study|Bowel obstruction|0|||
131467987|NCT03404960|473345523|FG001|Overall Study|Bowel obstruction|1|||
131467988|NCT03404960|473345522|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
131467989|NCT03404960|473345523|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
131467990|NCT00246571|473345524|FG000|Overall Study|Adverse Event|7|||
131467991|NCT00246571|473345525|FG001|Overall Study|Adverse Event|0|||
131467992|NCT00246571|473345524|FG000|Overall Study|Protocol Violation|0|||
131467993|NCT00246571|473345525|FG001|Overall Study|Protocol Violation|1|||
131467994|NCT00246571|473345524|FG000|Overall Study|Withdrawal by Subject|2|||
131467995|NCT00246571|473345525|FG001|Overall Study|Withdrawal by Subject|3|||
131467996|NCT00246571|473345524|FG000|Overall Study|Lack of Efficacy|84|||
131467997|NCT00246571|473345525|FG001|Overall Study|Lack of Efficacy|21|||
131467998|NCT00246571|473345524|FG000|Overall Study|Death|17|||
131467999|NCT00246571|473345525|FG001|Overall Study|Death|3|||
131468000|NCT00246571|473345524|FG000|Overall Study|Sponsor|0|||
131468001|NCT00246571|473345525|FG001|Overall Study|Sponsor|1|||
131468002|NCT00246571|473345524|FG000|Overall Study|Did not meet entrance criteria|2|||
131468003|NCT00246571|473345525|FG001|Overall Study|Did not meet entrance criteria|1|||
131468004|NCT00246571|473345524|FG000|Overall Study|Laboratory abnormalities|1|||
131468005|NCT00246571|473345525|FG001|Overall Study|Laboratory abnormalities|0|||
131468006|NCT00246571|473345524|FG000|Overall Study|Crossover participants|0|||
131468007|NCT00246571|473345525|FG001|Overall Study|Crossover participants|74|||
131468008|NCT04395001|473345529|FG000|Overall Study|Lost to Follow-up|8|||
131468009|NCT04395001|473345530|FG001|Overall Study|Lost to Follow-up|9|||
131468010|NCT04395001|473345531|FG002|Overall Study|Lost to Follow-up|5|||
131468011|NCT04395001|473345529|FG000|Overall Study|Withdrawal by Subject|3|||
131468012|NCT04395001|473345530|FG001|Overall Study|Withdrawal by Subject|1|||
131468013|NCT04395001|473345531|FG002|Overall Study|Withdrawal by Subject|3|||
131468014|NCT04395001|473345529|FG000|Overall Study|missed appointment|7|||
131468015|NCT04395001|473345530|FG001|Overall Study|missed appointment|4|||
131468016|NCT04395001|473345531|FG002|Overall Study|missed appointment|1|||
131468017|NCT04251156|473345532|FG000|Overall Study|Lost to Follow-up|1|||
131468018|NCT04251156|473345533|FG001|Overall Study|Lost to Follow-up|1|||
131468019|NCT04251156|473345532|FG000|Overall Study|Withdrawal by Subject|4|||
131468020|NCT04251156|473345533|FG001|Overall Study|Withdrawal by Subject|4|||
131468021|NCT01129024|473345534|FG000|Overall Study|Physician Decision|5|||
131468022|NCT01129024|473345534|FG000|Overall Study|Study Terminated by Sponsor|8|||
131468023|NCT01129024|473345534|FG000|Overall Study|Withdrawal by Subject|2|||
131468024|NCT01129024|473345534|FG000|Overall Study|Lack of Efficacy|3|||
131468025|NCT01129024|473345534|FG000|Overall Study|Needed a Platelet Transfusion|1|||
131468026|NCT01993836|473345535|FG000|Overall Study|Surgery Cancelled|3|||
131468027|NCT01993836|473345536|FG001|Overall Study|Surgery Cancelled|0|||
131468028|NCT01993836|473345537|FG002|Overall Study|Surgery Cancelled|0|||
131468029|NCT01993836|473345535|FG000|Overall Study|Physician Decision|2|||
131468030|NCT01993836|473345536|FG001|Overall Study|Physician Decision|1|||
131468031|NCT01993836|473345537|FG002|Overall Study|Physician Decision|0|||
131468032|NCT01993836|473345535|FG000|Overall Study|Death|0|||
131468033|NCT01993836|473345536|FG001|Overall Study|Death|2|||
131468034|NCT01993836|473345537|FG002|Overall Study|Death|0|||
131468035|NCT01993836|473345535|FG000|Overall Study|Withdrawal by Subject|12|||
131468036|NCT01993836|473345536|FG001|Overall Study|Withdrawal by Subject|10|||
131468037|NCT01993836|473345537|FG002|Overall Study|Withdrawal by Subject|5|||
131468038|NCT02195687|473345539|FG000|Overall Study|Personal Reasons|1|||
131468039|NCT02195687|473345540|FG001|Overall Study|Personal Reasons|1|||
131468040|NCT02195687|473345539|FG000|Overall Study|Lost to Follow-up|4|||
131468041|NCT02195687|473345540|FG001|Overall Study|Lost to Follow-up|1|||
131468042|NCT02677324|473345543|FG000|Overall Study|Disease Progression|6|||
131468043|NCT02677324|473345543|FG000|Overall Study|Inability to Swallow pills|1|||
131468044|NCT02677324|473345543|FG000|Overall Study|Non-compliance|1|||
131468045|NCT02677324|473345543|FG000|Overall Study|Lack of Efficacy|1|||
131468046|NCT02677324|473345543|FG000|Overall Study|Medical insurance coverage|1|||
131468047|NCT02677324|473345543|FG000|Overall Study|Adverse Event|1|||
131468048|NCT02677324|473345543|FG000|Overall Study|IgM Myeloma diagnosis|1|||
131468049|NCT02106923|473345544|FG000|Overall Study|Protocol Violation|0|||
131468050|NCT02106923|473345545|FG001|Overall Study|Protocol Violation|0|||
131468051|NCT02106923|473345546|FG002|Overall Study|Protocol Violation|0|||
131468052|NCT02106923|473345547|FG003|Overall Study|Protocol Violation|0|||
131468053|NCT02106923|473345548|FG004|Overall Study|Protocol Violation|0|||
131468054|NCT02106923|473345549|FG005|Overall Study|Protocol Violation|1|||
131468055|NCT03485495|473345550|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
131468056|NCT03485495|473345551|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
131468057|NCT05040971|473345553|FG000|Overall Study|Withdrawal by Subject|0|||
131468058|NCT05040971|473345554|FG001|Overall Study|Withdrawal by Subject|2|||
131468059|NCT05040971|473345553|FG000|Overall Study|Lost to Follow-up|8|||
131468060|NCT05040971|473345554|FG001|Overall Study|Lost to Follow-up|3|||
131468061|NCT05040971|473345553|FG000|Overall Study|Death|2|||
131468062|NCT05040971|473345554|FG001|Overall Study|Death|0|||
131468063|NCT02720094|473345558|FG000|Overall Study|Ongoing|2210|||
131468064|NCT02720094|473345559|FG001|Overall Study|Ongoing|2203|||
131468065|NCT02720094|473345558|FG000|Overall Study|Scheduled exit visit/end of study|2|||
131468066|NCT02720094|473345559|FG001|Overall Study|Scheduled exit visit/end of study|1|||
131468067|NCT02720094|473345558|FG000|Overall Study|Death|4|||
131468068|NCT02720094|473345559|FG001|Overall Study|Death|7|||
131468069|NCT02720094|473345558|FG000|Overall Study|Withdrawal by Subject|55|||
131468070|NCT02720094|473345559|FG001|Overall Study|Withdrawal by Subject|56|||
131468071|NCT02720094|473345558|FG000|Overall Study|Lost to Follow-up|2|||
131468072|NCT02720094|473345559|FG001|Overall Study|Lost to Follow-up|7|||
131468073|NCT02720094|473345558|FG000|Overall Study|Physician Decision|1|||
131468074|NCT02720094|473345559|FG001|Overall Study|Physician Decision|3|||
131468075|NCT02720094|473345558|FG000|Overall Study|Inappropriate enrollment|1|||
131468076|NCT02720094|473345559|FG001|Overall Study|Inappropriate enrollment|3|||
131468077|NCT02720094|473345558|FG000|Overall Study|Relocation|1|||
131468078|NCT02720094|473345559|FG001|Overall Study|Relocation|1|||
131468079|NCT03735238|473345560|FG000|Overall Study|Did not want to participate in research|3|||
131468080|NCT03735238|473345560|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
131468081|NCT01261780|473345561|FG000|Overall Study|Withdrawal by Subject|1|||
131468082|NCT01261780|473345562|FG001|Overall Study|Withdrawal by Subject|0|||
131468083|NCT01261780|473345561|FG000|Overall Study|Event not related to subject|1|||
131468084|NCT01261780|473345562|FG001|Overall Study|Event not related to subject|2|||
131468085|NCT03562767|473345563|FG000|Overall Study|Physician Decision|2|||
131468086|NCT03562767|473345564|FG001|Overall Study|Physician Decision|0|||
131468087|NCT03562767|473345565|FG002|Overall Study|Physician Decision|0|||
131468088|NCT03562767|473345563|FG000|Overall Study|Logistic Reason|1|||
131468089|NCT03562767|473345564|FG001|Overall Study|Logistic Reason|3|||
131468090|NCT03562767|473345565|FG002|Overall Study|Logistic Reason|0|||
131468091|NCT00938886|473345568|FG000|Overall Study|Death|0|||
131468092|NCT00938886|473345569|FG001|Overall Study|Death|1|||
131468093|NCT00938886|473345568|FG000|Overall Study|Withdrawal by Subject|4|||
131468094|NCT00938886|473345569|FG001|Overall Study|Withdrawal by Subject|7|||
131468095|NCT00938886|473345568|FG000|Overall Study|Lost to Follow-up|3|||
131468096|NCT00938886|473345569|FG001|Overall Study|Lost to Follow-up|2|||
131468097|NCT00913692|473345574|FG000|Screening (4 Months)|Physician Decision|3|||
131468098|NCT00913692|473345574|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
131468099|NCT00913692|473345574|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
131468100|NCT04231981|473345577|FG000|Overall Study|Adverse Event|1|||
131468101|NCT04231981|473345577|FG000|Overall Study|Death|16|||
131468102|NCT04231981|473345577|FG000|Overall Study|Lost to Follow-up|1|||
131468103|NCT02889562|473345578|FG000|Overall Study|Physician Decision|0|||
131468104|NCT02889562|473345579|FG001|Overall Study|Physician Decision|1|||
131468105|NCT02889562|473345578|FG000|Overall Study|Withdrawal by Subject|0|||
131468106|NCT02889562|473345579|FG001|Overall Study|Withdrawal by Subject|1|||
131468107|NCT01470989|473345582|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
131468108|NCT01470989|473345583|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
131468109|NCT01470989|473345582|FG000|Overall Study|Adverse Event|2|||
131468110|NCT01470989|473345583|FG001|Overall Study|Adverse Event|5|||
131468111|NCT01470989|473345582|FG000|Overall Study|Abnormal laboratory value|1|||
131468112|NCT01470989|473345583|FG001|Overall Study|Abnormal laboratory value|1|||
131468113|NCT01470989|473345582|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131468114|NCT01470989|473345583|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131468115|NCT01470989|473345582|FG000|Overall Study|Withdrawal by Subject|19|||
131468116|NCT01470989|473345583|FG001|Overall Study|Withdrawal by Subject|17|||
131468117|NCT01470989|473345582|FG000|Overall Study|Lost to Follow-up|18|||
131468118|NCT01470989|473345583|FG001|Overall Study|Lost to Follow-up|13|||
131468119|NCT01470989|473345582|FG000|Overall Study|Administrative problems|2|||
131468120|NCT01470989|473345583|FG001|Overall Study|Administrative problems|4|||
131468121|NCT01470989|473345582|FG000|Overall Study|Death|2|||
131468122|NCT01470989|473345583|FG001|Overall Study|Death|2|||
131468123|NCT01470989|473345582|FG000|Overall Study|Protocol deviation|1|||
131468124|NCT01470989|473345583|FG001|Overall Study|Protocol deviation|2|||
131468125|NCT00969280|473345584|FG000|Overall Study|Protocol Violation|2|||
131468126|NCT00969280|473345585|FG001|Overall Study|Protocol Violation|1|||
131468127|NCT00969280|473345584|FG000|Overall Study|Withdrawal by Subject|0|||
131468128|NCT00969280|473345585|FG001|Overall Study|Withdrawal by Subject|1|||
131468129|NCT00969280|473345584|FG000|Overall Study|infection of influenza A(H1N1)|0|||
131468130|NCT00969280|473345585|FG001|Overall Study|infection of influenza A(H1N1)|1|||
131468131|NCT05214573|473345586|FG000|Overall Study|Physician Decision|5924|||
131468132|NCT05214573|473345587|FG001|Overall Study|Physician Decision|0|||
131468133|NCT01958827|473345588|FG000|Overall Study|Adverse Event|3|||
131468134|NCT01958827|473345588|FG000|Overall Study|Lack of Efficacy|6|||
131468135|NCT01958827|473345588|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
131769064|NCT00689728|474431934|FG001|Optional Follow-Up|Lack of Efficacy|1|||
131769065|NCT00689728|474431935|FG002|Optional Follow-Up|Lack of Efficacy|1|||
131769066|NCT00689728|474431933|FG000|Optional Follow-Up|Lost to Follow-up|0|||
131769067|NCT00689728|474431934|FG001|Optional Follow-Up|Lost to Follow-up|1|||
131769068|NCT00689728|474431935|FG002|Optional Follow-Up|Lost to Follow-up|1|||
131769069|NCT00689728|474431933|FG000|Optional Follow-Up|Protocol Violation|0|||
131769070|NCT00689728|474431934|FG001|Optional Follow-Up|Protocol Violation|0|||
131769071|NCT00689728|474431935|FG002|Optional Follow-Up|Protocol Violation|1|||
131769072|NCT00689728|474431933|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
131769073|NCT00689728|474431934|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
131769074|NCT00689728|474431935|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
131769075|NCT03590613|474431937|FG000|Period 2, 4 Days|Physician Decision|0|||
131769076|NCT03590613|474431938|FG001|Period 2, 4 Days|Physician Decision|0|||
131769077|NCT03590613|474431939|FG002|Period 2, 4 Days|Physician Decision|0|||
131769078|NCT03590613|474431940|FG003|Period 2, 4 Days|Physician Decision|1|||
131769079|NCT04369742|474431941|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
131769080|NCT04369742|474431942|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
131769081|NCT04369742|474431941|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
131769082|NCT04369742|474431942|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
131468136|NCT05985980|473345589|FG000|Overall Study|Withdrawal by Subject|1|||
131468137|NCT05985980|473345589|FG000|Overall Study|Withdrawal by Subject|1|||
131468138|NCT05985980|473345589|FG000|Overall Study|Withdrawal by Subject|1|||
131468139|NCT05985980|473345589|FG000|Overall Study|Withdrawal by Subject|1|||
131468140|NCT03370276|473345590|FG000|Overall Study|Death|0|||
131769083|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Death|2|||
131769084|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Death|0|||
131468141|NCT03370276|473345591|FG001|Overall Study|Death|2|||
131468142|NCT03370276|473345592|FG002|Overall Study|Death|5|||
131468143|NCT03587727|473345595|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
131468144|NCT03587727|473345595|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
131468145|NCT04085367|473346717|FG000|Overall Study|Adverse Event|1|||
131468146|NCT04085367|473346718|FG001|Overall Study|Adverse Event|1|||
131468147|NCT04085367|473346717|FG000|Overall Study|Withdrawal by Subject|13|||
131468148|NCT04085367|473346718|FG001|Overall Study|Withdrawal by Subject|4|||
131769085|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Adverse Event|33|||
131769086|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Adverse Event|31|||
131769087|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
131769088|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
131769089|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
131769090|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
131769091|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
131769092|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
131769093|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Other|7|||
131769094|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Other|8|||
131769095|NCT00280059|474431943|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
131769096|NCT00280059|474431944|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
131769097|NCT01130831|474431949|FG000|Overall Study|Withdrawal by Subject|7|||
131769098|NCT01130831|474431949|FG000|Overall Study|Death|4|||
131769099|NCT01130831|474431949|FG000|Overall Study|Information was missing|3|||
131769100|NCT00951912|474431950|FG000|Overall Study|Lack of Efficacy|1|||
131769101|NCT00951912|474431951|FG001|Overall Study|Lack of Efficacy|0|||
131769102|NCT00951912|474431952|FG002|Overall Study|Lack of Efficacy|0|||
131769103|NCT00951912|474431950|FG000|Overall Study|Adverse Event|0|||
131769104|NCT00951912|474431951|FG001|Overall Study|Adverse Event|1|||
131769105|NCT00951912|474431952|FG002|Overall Study|Adverse Event|1|||
131769106|NCT00951912|474431950|FG000|Overall Study|Lost to Follow-up|2|||
131769107|NCT00951912|474431951|FG001|Overall Study|Lost to Follow-up|2|||
131769108|NCT00951912|474431952|FG002|Overall Study|Lost to Follow-up|0|||
131769109|NCT00951912|474431950|FG000|Overall Study|Physician Decision|1|||
131769110|NCT00951912|474431951|FG001|Overall Study|Physician Decision|0|||
131769111|NCT00951912|474431952|FG002|Overall Study|Physician Decision|1|||
131769112|NCT00951912|474431950|FG000|Overall Study|Withdrawal by Subject|1|||
131769113|NCT00951912|474431951|FG001|Overall Study|Withdrawal by Subject|1|||
131769114|NCT00951912|474431952|FG002|Overall Study|Withdrawal by Subject|0|||
131769115|NCT00951912|474431950|FG000|Overall Study|Other:Depression|1|||
131769116|NCT00951912|474431951|FG001|Overall Study|Other:Depression|0|||
131769117|NCT00951912|474431952|FG002|Overall Study|Other:Depression|0|||
131769118|NCT00951912|474431950|FG000|Overall Study|Other: Colon cancer|1|||
131769119|NCT00951912|474431951|FG001|Overall Study|Other: Colon cancer|0|||
131769120|NCT00951912|474431952|FG002|Overall Study|Other: Colon cancer|0|||
131769121|NCT00951912|474431950|FG000|Overall Study|Other: Stroke|0|||
131769122|NCT00951912|474431951|FG001|Overall Study|Other: Stroke|1|||
131769123|NCT00951912|474431952|FG002|Overall Study|Other: Stroke|0|||
131769124|NCT03417999|474431953|FG000|Overall Study|Withdrawal by Subject|1|||
131769125|NCT03417999|474431954|FG001|Overall Study|Withdrawal by Subject|0|||
131769126|NCT03417999|474431955|FG002|Overall Study|Withdrawal by Subject|0|||
131769127|NCT03417999|474431953|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
131769128|NCT03417999|474431954|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
131769129|NCT03417999|474431955|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
131769130|NCT03417999|474431953|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
131769131|NCT03417999|474431954|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
131769132|NCT03417999|474431955|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
131769133|NCT03417999|474431953|FG000|Overall Study|Inadequate study staff available to process samples|0|||
131769134|NCT03417999|474431954|FG001|Overall Study|Inadequate study staff available to process samples|0|||
131769135|NCT03417999|474431955|FG002|Overall Study|Inadequate study staff available to process samples|1|||
131769136|NCT00422942|474431961|FG000|Overall Study|Study terminated by Sponsor|3|||
131769137|NCT02612194|474431962|FG000|Overall Study|Death|5|||
131769138|NCT02612194|474431963|FG001|Overall Study|Death|0|||
131769139|NCT02612194|474431964|FG002|Overall Study|Death|2|||
131769140|NCT02612194|474431962|FG000|Overall Study|Early Study Termination|1|||
131769141|NCT02612194|474431963|FG001|Overall Study|Early Study Termination|0|||
131769142|NCT02612194|474431964|FG002|Overall Study|Early Study Termination|0|||
131769143|NCT00372905|474431967|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
131769144|NCT00372905|474431968|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
131769145|NCT00372905|474431969|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
131769146|NCT00372905|474431970|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
131468149|NCT04085367|473346717|FG000|Overall Study|Lost to Follow-up|3|||
131769147|NCT00372905|474431967|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
131769148|NCT00372905|474431968|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
131769149|NCT00372905|474431969|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
131769150|NCT00372905|474431970|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
131769151|NCT00372905|474431967|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
131769152|NCT00372905|474431968|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
131769153|NCT00372905|474431969|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
131769154|NCT00372905|474431970|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
131769155|NCT00372905|474431967|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
131769156|NCT00372905|474431968|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
131769157|NCT00372905|474431969|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
131769158|NCT00372905|474431970|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
131769159|NCT00372905|474431967|FG000|Follow up Until Relapse or Progression|Study closed|0|||
131769160|NCT00372905|474431968|FG001|Follow up Until Relapse or Progression|Study closed|0|||
131769161|NCT00372905|474431969|FG002|Follow up Until Relapse or Progression|Study closed|0|||
131769162|NCT00372905|474431970|FG003|Follow up Until Relapse or Progression|Study closed|3|||
131769163|NCT00372905|474431967|FG000|Follow up Until Relapse or Progression|Other|0|||
131769164|NCT00372905|474431968|FG001|Follow up Until Relapse or Progression|Other|1|||
131769165|NCT00372905|474431969|FG002|Follow up Until Relapse or Progression|Other|0|||
131769166|NCT00372905|474431970|FG003|Follow up Until Relapse or Progression|Other|0|||
131769167|NCT02312934|474431971|FG000|Overall Study|Lost to Follow-up|1|||
131769168|NCT02312934|474431972|FG001|Overall Study|Lost to Follow-up|0|||
131769169|NCT02312934|474431971|FG000|Overall Study|Physician Decision|1|||
131769170|NCT02312934|474431972|FG001|Overall Study|Physician Decision|0|||
131769171|NCT00689299|474431974|FG000|Overall Study|Adverse Event|2|||
131769172|NCT00689299|474431975|FG001|Overall Study|Adverse Event|1|||
131769173|NCT00689299|474431976|FG002|Overall Study|Adverse Event|1|||
131769174|NCT00689299|474431974|FG000|Overall Study|Lost to Follow-up|0|||
131769175|NCT00689299|474431975|FG001|Overall Study|Lost to Follow-up|1|||
131769176|NCT00689299|474431976|FG002|Overall Study|Lost to Follow-up|1|||
131769177|NCT00689299|474431974|FG000|Overall Study|Withdrawal by Subject|4|||
131769178|NCT00689299|474431975|FG001|Overall Study|Withdrawal by Subject|1|||
131769179|NCT00689299|474431976|FG002|Overall Study|Withdrawal by Subject|3|||
131769180|NCT00689299|474431974|FG000|Overall Study|Protocol Violation|1|||
131769181|NCT00689299|474431975|FG001|Overall Study|Protocol Violation|0|||
131769182|NCT00689299|474431976|FG002|Overall Study|Protocol Violation|0|||
131769183|NCT02613910|474431979|FG000|Overall Study|Termination of study|1|||
131769184|NCT02098733|474431980|FG000|Overall Study|Data Not Available|5|||
131769185|NCT02098733|474431980|FG000|Overall Study|Lost to Follow-up|5|||
131769186|NCT03395704|474431981|FG000|Overall Study|Adverse Event|2|||
131769187|NCT03395704|474431982|FG001|Overall Study|Adverse Event|1|||
131769188|NCT03395704|474431981|FG000|Overall Study|Withdrawal by Subject|2|||
131769189|NCT03395704|474431982|FG001|Overall Study|Withdrawal by Subject|1|||
131769190|NCT03395704|474431981|FG000|Overall Study|Physician Decision|0|||
131769191|NCT03395704|474431982|FG001|Overall Study|Physician Decision|1|||
131769192|NCT00434876|474431985|FG000|Overall Study|Lost to Follow-up|1|||
131769193|NCT00434876|474431986|FG001|Overall Study|Lost to Follow-up|1|||
131769194|NCT03044730|474431987|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
131769195|NCT03044730|474431987|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
131769196|NCT03044730|474431987|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
131769197|NCT03044730|474431987|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
131769198|NCT03044730|474431987|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
131769199|NCT03044730|474431987|FG000|Cycles 4 and Beyond|Adverse Event|1|||
131769200|NCT03044730|474431987|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
131769201|NCT03044730|474431987|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
131769202|NCT03044730|474431987|FG000|On Follow-up for 2 Years|Death|17|||
131769203|NCT00690612|474433928|FG000|Overall Study|Adverse Event|1|||
131769204|NCT00690612|474433928|FG000|Overall Study|Withdrawal by Subject|2|||
131769205|NCT01233076|474433929|FG000|Period 2, One Week|Lost to Follow-up|1|||
131769206|NCT01233076|474433930|FG001|Period 2, One Week|Lost to Follow-up|0|||
131769207|NCT04120116|474433932|FG000|Overall Study|Lost to Follow-up|0|||
131769208|NCT04120116|474433933|FG001|Overall Study|Lost to Follow-up|1|||
131769209|NCT04120116|474433934|FG002|Overall Study|Lost to Follow-up|0|||
131769210|NCT04120116|474433935|FG003|Overall Study|Lost to Follow-up|2|||
131769211|NCT04120116|474433932|FG000|Overall Study|Withdrawal by Subject|1|||
131769212|NCT04120116|474433933|FG001|Overall Study|Withdrawal by Subject|0|||
131468150|NCT04085367|473346718|FG001|Overall Study|Lost to Follow-up|1|||
131769213|NCT04120116|474433934|FG002|Overall Study|Withdrawal by Subject|1|||
131769214|NCT04120116|474433935|FG003|Overall Study|Withdrawal by Subject|1|||
131769215|NCT04120116|474433932|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
131769216|NCT04120116|474433933|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
131769217|NCT04120116|474433934|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
131769218|NCT04120116|474433935|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
131769219|NCT05637515|474433936|FG000|Overall Study|Withdrawal by Subject|17|||
131769220|NCT05637515|474433937|FG001|Overall Study|Withdrawal by Subject|17|||
131769221|NCT02087085|474433939|FG000|Overall Study|Adverse Event|10|||
131769222|NCT02087085|474433940|FG001|Overall Study|Adverse Event|14|||
131769223|NCT02087085|474433939|FG000|Overall Study|Lack of Efficacy|4|||
131769224|NCT02087085|474433940|FG001|Overall Study|Lack of Efficacy|3|||
131769225|NCT02087085|474433939|FG000|Overall Study|Lost to Follow-up|6|||
131769226|NCT02087085|474433940|FG001|Overall Study|Lost to Follow-up|4|||
131769227|NCT02087085|474433939|FG000|Overall Study|Withdrawal by Subject|9|||
131769228|NCT02087085|474433940|FG001|Overall Study|Withdrawal by Subject|11|||
131769229|NCT02087085|474433939|FG000|Overall Study|Protocol Violation|1|||
131769230|NCT02087085|474433940|FG001|Overall Study|Protocol Violation|0|||
131769231|NCT02087085|474433939|FG000|Overall Study|Study Terminated by Sponsor|87|||
131769232|NCT02087085|474433940|FG001|Overall Study|Study Terminated by Sponsor|80|||
131769233|NCT02087085|474433939|FG000|Overall Study|Other Miscellaneous Reasons|3|||
131769234|NCT02087085|474433940|FG001|Overall Study|Other Miscellaneous Reasons|4|||
131769235|NCT02505945|474433941|FG000|Overall Study|Withdrawal by Subject|13|||
131769236|NCT02505945|474433942|FG001|Overall Study|Withdrawal by Subject|2|||
131769237|NCT02505945|474433941|FG000|Overall Study|Adverse Event|1|||
131769238|NCT02505945|474433942|FG001|Overall Study|Adverse Event|0|||
131769239|NCT02505945|474433941|FG000|Overall Study|Physician Decision|2|||
131769240|NCT02505945|474433942|FG001|Overall Study|Physician Decision|1|||
131769241|NCT02505945|474433941|FG000|Overall Study|Lost to Follow-up|6|||
131769242|NCT02505945|474433942|FG001|Overall Study|Lost to Follow-up|1|||
131769243|NCT00635804|474433943|FG000|Overall Study|Adverse Event|0|||
131769244|NCT00635804|474433944|FG001|Overall Study|Adverse Event|0|||
131769245|NCT00635804|474433945|FG002|Overall Study|Adverse Event|0|||
131769246|NCT00635804|474433946|FG003|Overall Study|Adverse Event|0|||
131769247|NCT00635804|474433947|FG004|Overall Study|Adverse Event|0|||
131769248|NCT00635804|474433948|FG005|Overall Study|Adverse Event|1|||
131769249|NCT00635804|474433949|FG006|Overall Study|Adverse Event|0|||
131769250|NCT00635804|474433950|FG007|Overall Study|Adverse Event|0|||
131769251|NCT00635804|474433943|FG000|Overall Study|Withdrawal by Subject|1|||
131769252|NCT00635804|474433944|FG001|Overall Study|Withdrawal by Subject|0|||
131769253|NCT00635804|474433945|FG002|Overall Study|Withdrawal by Subject|0|||
131769254|NCT00635804|474433946|FG003|Overall Study|Withdrawal by Subject|0|||
131769255|NCT00635804|474433947|FG004|Overall Study|Withdrawal by Subject|0|||
131769256|NCT00635804|474433948|FG005|Overall Study|Withdrawal by Subject|0|||
131769257|NCT00635804|474433949|FG006|Overall Study|Withdrawal by Subject|0|||
131769258|NCT00635804|474433950|FG007|Overall Study|Withdrawal by Subject|0|||
131769259|NCT02718131|474433957|FG000|Overall Study|Withdrawal by Subject|1|||
131769260|NCT02718131|474433958|FG001|Overall Study|Withdrawal by Subject|0|||
131769261|NCT02718131|474433957|FG000|Overall Study|Adverse Event|1|||
131769262|NCT02718131|474433958|FG001|Overall Study|Adverse Event|0|||
131769263|NCT02718131|474433957|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
131468151|NCT04085367|473346717|FG000|Overall Study|Other unspecified|2|||
131468152|NCT04085367|473346718|FG001|Overall Study|Other unspecified|1|||
131468153|NCT04085367|473346717|FG000|Overall Study|Status Unknown|1|||
131468154|NCT04085367|473346718|FG001|Overall Study|Status Unknown|1|||
131468155|NCT00130442|473346721|FG000|Overall Study|Withdrawal by Subject|0|||
131468156|NCT00130442|473346722|FG001|Overall Study|Withdrawal by Subject|1|||
131468157|NCT00130442|473346721|FG000|Overall Study|did not meet criteria|1|||
131468158|NCT00130442|473346722|FG001|Overall Study|did not meet criteria|1|||
131468159|NCT00814333|473346723|FG000|Enrollment|Lost to Follow-up|1|||
131769264|NCT02718131|474433958|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
131769265|NCT01097057|474433960|FG000|Overall Study|Physician Decision|3|||
131769266|NCT01101321|474433961|FG000|Period 1|Withdrawal by Subject|1|||
131769267|NCT01101321|474433962|FG001|Period 1|Withdrawal by Subject|1|||
131769268|NCT01101321|474433961|FG000|Period 1|Adverse Event|3|||
131769269|NCT01101321|474433962|FG001|Period 1|Adverse Event|3|||
131769270|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
131769271|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
131769272|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
131769273|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
131468160|NCT00814333|473346724|FG001|Enrollment|Lost to Follow-up|0|||
131769274|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
131769275|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
131769276|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
131769277|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
131769278|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
131769279|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
131769280|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
131769281|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
131769282|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
131769283|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
131769284|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
131769285|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|Other|6|||
131769286|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|Other|6|||
131769287|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|Other|7|||
131769288|NCT02681094|474433963|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
131769289|NCT02681094|474433964|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
131769290|NCT02681094|474433965|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
131769291|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|Participant decision|7|||
131769292|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|Participant decision|10|||
131769293|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|Participant decision|9|||
131769294|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
131769295|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
131769296|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
131769297|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
131769298|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
131769299|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
131769300|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
131769301|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
131769302|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
131769303|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
131468161|NCT02233946|473346727|FG000|Baseline|Withdrawal by Subject|2|||
131468162|NCT02233946|473346728|FG001|Baseline|Withdrawal by Subject|0|||
131468163|NCT02233946|473346727|FG000|3-months Follow-up|Lost to Follow-up|53|||
131468164|NCT02233946|473346728|FG001|3-months Follow-up|Lost to Follow-up|29|||
131468165|NCT02233946|473346727|FG000|6-months Follow-up|Lost to Follow-up|21|||
131468166|NCT02233946|473346728|FG001|6-months Follow-up|Lost to Follow-up|2|||
131468167|NCT02233946|473346727|FG000|9-month Follow-up|Lost to Follow-up|20|||
131468168|NCT02233946|473346728|FG001|9-month Follow-up|Lost to Follow-up|11|||
131468169|NCT02233946|473346727|FG000|12-month Follow-up|Lost to Follow-up|28|||
131769304|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
131769305|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
131769306|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|Other|6|||
131468170|NCT02233946|473346728|FG001|12-month Follow-up|Lost to Follow-up|11|||
131468171|NCT00773383|473346729|FG000|Overall Study|Adverse Event|4|||
131468172|NCT00773383|473346729|FG000|Overall Study|Death|1|||
131468173|NCT00773383|473346729|FG000|Overall Study|Progression of Disease|23|||
131468174|NCT00773383|473346729|FG000|Overall Study|Other|2|||
131468175|NCT00773383|473346729|FG000|Overall Study|No study dose received|1|||
131468176|NCT03384693|473346730|FG000|Overall Study|Adverse Event|3|||
131468177|NCT02093351|473346731|FG000|Part A|Adverse Event|0|||
131468178|NCT02093351|473346732|FG001|Part A|Adverse Event|1|||
131468179|NCT02093351|473346733|FG002|Part A|Adverse Event|1|||
131468180|NCT02093351|473346734|FG003|Part A|Adverse Event|0|||
131468181|NCT02093351|473346731|FG000|Part A|Condition under investigation worsened|2|||
131468182|NCT02093351|473346732|FG001|Part A|Condition under investigation worsened|0|||
131468183|NCT02093351|473346733|FG002|Part A|Condition under investigation worsened|2|||
131468184|NCT02093351|473346734|FG003|Part A|Condition under investigation worsened|0|||
131468185|NCT02093351|473346731|FG000|Part A|Death|0|||
131468186|NCT02093351|473346732|FG001|Part A|Death|1|||
131468187|NCT02093351|473346733|FG002|Part A|Death|0|||
131468188|NCT02093351|473346734|FG003|Part A|Death|0|||
131468189|NCT02093351|473346731|FG000|Part B|Patient decision|0|||
131468190|NCT02093351|473346732|FG001|Part B|Patient decision|0|||
131468191|NCT02093351|473346733|FG002|Part B|Patient decision|0|||
131468192|NCT02093351|473346734|FG003|Part B|Patient decision|3|||
131468193|NCT02093351|473346731|FG000|Part B|Disease progression|0|||
131468194|NCT02093351|473346732|FG001|Part B|Disease progression|0|||
131468195|NCT02093351|473346733|FG002|Part B|Disease progression|0|||
131468196|NCT02093351|473346734|FG003|Part B|Disease progression|4|||
131468197|NCT02093351|473346731|FG000|Part B|Complete response|0|||
131468198|NCT02093351|473346732|FG001|Part B|Complete response|0|||
131468199|NCT02093351|473346733|FG002|Part B|Complete response|0|||
131468200|NCT02093351|473346734|FG003|Part B|Complete response|1|||
131468201|NCT02093351|473346731|FG000|Part B|Adverse event + disease progression|0|||
131468202|NCT02093351|473346732|FG001|Part B|Adverse event + disease progression|0|||
131468203|NCT02093351|473346733|FG002|Part B|Adverse event + disease progression|0|||
131468204|NCT02093351|473346734|FG003|Part B|Adverse event + disease progression|1|||
131468205|NCT02093351|473346731|FG000|Part B|Lack of therapeutic response|0|||
131468206|NCT02093351|473346732|FG001|Part B|Lack of therapeutic response|0|||
131468207|NCT02093351|473346733|FG002|Part B|Lack of therapeutic response|0|||
131468208|NCT02093351|473346734|FG003|Part B|Lack of therapeutic response|12|||
131468209|NCT02093351|473346731|FG000|Part B|Condition under investigation worsened|0|||
131468210|NCT02093351|473346732|FG001|Part B|Condition under investigation worsened|0|||
131468211|NCT02093351|473346733|FG002|Part B|Condition under investigation worsened|0|||
131468212|NCT02093351|473346734|FG003|Part B|Condition under investigation worsened|39|||
131468213|NCT02093351|473346731|FG000|Part B|Adverse Event|0|||
131468214|NCT02093351|473346732|FG001|Part B|Adverse Event|0|||
131468215|NCT02093351|473346733|FG002|Part B|Adverse Event|0|||
131468216|NCT02093351|473346734|FG003|Part B|Adverse Event|2|||
131468217|NCT02093351|473346731|FG000|Part B|Death|0|||
131468218|NCT02093351|473346732|FG001|Part B|Death|0|||
131468219|NCT02093351|473346733|FG002|Part B|Death|0|||
131468220|NCT02093351|473346734|FG003|Part B|Death|1|||
131468221|NCT01099709|473346735|FG000|Period 1|Withdrawal by Subject|0|||
131468222|NCT01099709|473346736|FG001|Period 1|Withdrawal by Subject|1|||
131468223|NCT01099709|473346735|FG000|Period 1|Positive cotinine test|0|||
131468224|NCT01099709|473346736|FG001|Period 1|Positive cotinine test|1|||
131468225|NCT01099709|473346735|FG000|Period 1|Adverse Event|1|||
131468226|NCT01099709|473346736|FG001|Period 1|Adverse Event|0|||
131468227|NCT00706849|473346737|FG000|Treatment Period|Adverse Event|0|||
131468228|NCT00706849|473346738|FG001|Treatment Period|Adverse Event|9|||
131468229|NCT00706849|473346737|FG000|Treatment Period|Other|0|||
131468230|NCT00706849|473346738|FG001|Treatment Period|Other|1|||
131468231|NCT00706849|473346737|FG000|Follow-up Period|Withdrawal by Subject|0|||
131468232|NCT00706849|473346738|FG001|Follow-up Period|Withdrawal by Subject|2|||
131468233|NCT00706849|473346737|FG000|Follow-up Period|Protocol non-compliance|0|||
131468234|NCT00706849|473346738|FG001|Follow-up Period|Protocol non-compliance|1|||
131468235|NCT01611454|473346740|FG000|Overall Study|Lack of Efficacy|18|||
131468236|NCT01611454|473346741|FG001|Overall Study|Lack of Efficacy|10|||
131468237|NCT03269552|473346742|FG000|Overall Study|Adverse Event|2|||
131468238|NCT00920907|473346743|FG000|Induction Period|Adverse Event|0|||
131468239|NCT00920907|473346744|FG001|Induction Period|Adverse Event|2|||
131468240|NCT00920907|473346743|FG000|Induction Period|Death|1|||
131468241|NCT00920907|473346744|FG001|Induction Period|Death|1|||
131468242|NCT00920907|473346743|FG000|Induction Period|Disease Progression|12|||
131468243|NCT00920907|473346744|FG001|Induction Period|Disease Progression|11|||
131468244|NCT00920907|473346743|FG000|Induction Period|Study Drug Toxicity|8|||
131468245|NCT00920907|473346744|FG001|Induction Period|Study Drug Toxicity|6|||
131468246|NCT00920907|473346743|FG000|Induction Period|No longer meets study criteria|0|||
131468247|NCT00920907|473346744|FG001|Induction Period|No longer meets study criteria|1|||
131468248|NCT00920907|473346743|FG000|Induction Period|Withdrawal by Subject|1|||
131468249|NCT00920907|473346744|FG001|Induction Period|Withdrawal by Subject|1|||
131468250|NCT00920907|473346743|FG000|Maintenance Period|Disease Progression|3|||
131468251|NCT00920907|473346744|FG001|Maintenance Period|Disease Progression|7|||
131468252|NCT00920907|473346743|FG000|Maintenance Period|Administrative (study closure)|7|||
131468253|NCT00920907|473346744|FG001|Maintenance Period|Administrative (study closure)|2|||
131468254|NCT00920907|473346743|FG000|Maintenance Period|Study Drug Toxicity|0|||
131468255|NCT00920907|473346744|FG001|Maintenance Period|Study Drug Toxicity|2|||
131468256|NCT00920907|473346743|FG000|Maintenance Period|Death|1|||
131468257|NCT00920907|473346744|FG001|Maintenance Period|Death|1|||
131468258|NCT00920907|473346743|FG000|Maintenance Period|Withdrawal by Subject|1|||
131468259|NCT00920907|473346744|FG001|Maintenance Period|Withdrawal by Subject|0|||
131468260|NCT00920907|473346743|FG000|Maintenance Period|Adverse Event|0|||
131468261|NCT00920907|473346744|FG001|Maintenance Period|Adverse Event|1|||
131468262|NCT02616601|473346745|FG000|Overall Study|Withdrawal by Subject|4|||
131468263|NCT02616601|473346746|FG001|Overall Study|Withdrawal by Subject|4|||
131468264|NCT02616601|473346747|FG002|Overall Study|Withdrawal by Subject|3|||
131468265|NCT02616601|473346745|FG000|Overall Study|Adverse Event|2|||
131468266|NCT02616601|473346746|FG001|Overall Study|Adverse Event|0|||
131468267|NCT02616601|473346747|FG002|Overall Study|Adverse Event|2|||
131468268|NCT02616601|473346745|FG000|Overall Study|Death|1|||
131468269|NCT02616601|473346746|FG001|Overall Study|Death|0|||
131468270|NCT02616601|473346747|FG002|Overall Study|Death|0|||
131468271|NCT02616601|473346745|FG000|Overall Study|Lost to Follow-up|1|||
131468272|NCT02616601|473346746|FG001|Overall Study|Lost to Follow-up|0|||
131468273|NCT02616601|473346747|FG002|Overall Study|Lost to Follow-up|1|||
131468274|NCT02616601|473346745|FG000|Overall Study|Non-Compliance with Test Article|1|||
131468275|NCT02616601|473346746|FG001|Overall Study|Non-Compliance with Test Article|0|||
131468276|NCT02616601|473346747|FG002|Overall Study|Non-Compliance with Test Article|1|||
131468277|NCT01397825|473346753|FG000|Overall Study|Progressive Disease|10|||
131468278|NCT01397825|473346754|FG001|Overall Study|Progressive Disease|3|||
131468279|NCT01397825|473346755|FG002|Overall Study|Progressive Disease|11|||
131468280|NCT01397825|473346756|FG003|Overall Study|Progressive Disease|1|||
131468281|NCT01397825|473346757|FG004|Overall Study|Progressive Disease|0|||
131468282|NCT01397825|473346753|FG000|Overall Study|Symptomatic Deterioration|2|||
131468283|NCT01397825|473346754|FG001|Overall Study|Symptomatic Deterioration|0|||
131468284|NCT01397825|473346755|FG002|Overall Study|Symptomatic Deterioration|4|||
131468285|NCT01397825|473346756|FG003|Overall Study|Symptomatic Deterioration|0|||
131468286|NCT01397825|473346757|FG004|Overall Study|Symptomatic Deterioration|0|||
131468287|NCT01397825|473346753|FG000|Overall Study|Adverse Event|0|||
131468288|NCT01397825|473346754|FG001|Overall Study|Adverse Event|1|||
131468289|NCT01397825|473346755|FG002|Overall Study|Adverse Event|5|||
131468290|NCT01397825|473346756|FG003|Overall Study|Adverse Event|1|||
131468291|NCT01397825|473346757|FG004|Overall Study|Adverse Event|0|||
131468292|NCT01397825|473346753|FG000|Overall Study|Withdrawal by Subject|1|||
131468293|NCT01397825|473346754|FG001|Overall Study|Withdrawal by Subject|0|||
131468294|NCT01397825|473346755|FG002|Overall Study|Withdrawal by Subject|5|||
131468295|NCT01397825|473346756|FG003|Overall Study|Withdrawal by Subject|1|||
131468296|NCT01397825|473346757|FG004|Overall Study|Withdrawal by Subject|0|||
131468297|NCT00815516|473346758|FG000|Overall Study|Death|3|||
131468298|NCT00815516|473346759|FG001|Overall Study|Death|1|||
131468299|NCT00815516|473346758|FG000|Overall Study|Physician Decision|1|||
131468300|NCT00815516|473346759|FG001|Overall Study|Physician Decision|0|||
131468301|NCT01741012|473346766|FG000|Overall Study|Lost to Follow-up|1|||
131468302|NCT01741012|473346766|FG000|Overall Study|Withdrawal by Subject|2|||
131468303|NCT00470158|473346767|FG000|Overall Study|Death|0|||
131468304|NCT00470158|473346768|FG001|Overall Study|Death|0|||
131468305|NCT00470158|473346769|FG002|Overall Study|Death|0|||
131468306|NCT00470158|473346770|FG003|Overall Study|Death|0|||
131468307|NCT00470158|473346771|FG004|Overall Study|Death|2|||
131468308|NCT00470158|473346767|FG000|Overall Study|Lost to Follow-up|7|||
131468309|NCT00470158|473346768|FG001|Overall Study|Lost to Follow-up|8|||
131468310|NCT00470158|473346769|FG002|Overall Study|Lost to Follow-up|8|||
131468311|NCT00470158|473346770|FG003|Overall Study|Lost to Follow-up|5|||
131468312|NCT00470158|473346771|FG004|Overall Study|Lost to Follow-up|4|||
131468313|NCT00470158|473346767|FG000|Overall Study|Protocol Violation|1|||
131468314|NCT00470158|473346768|FG001|Overall Study|Protocol Violation|0|||
131468315|NCT00470158|473346769|FG002|Overall Study|Protocol Violation|0|||
131468316|NCT00470158|473346770|FG003|Overall Study|Protocol Violation|0|||
131468317|NCT00470158|473346771|FG004|Overall Study|Protocol Violation|0|||
131468318|NCT00880685|473346772|FG000|Memantine 10mg|Lost to Follow-up|2|||
131468319|NCT00880685|473346772|FG000|Memantine 20mg|Withdrawal by Subject|1|||
131468320|NCT01249118|473346773|FG000|First Washout Period|Physician Decision|0|||
131468321|NCT01249118|473346774|FG001|First Washout Period|Physician Decision|1|||
131468322|NCT01249118|473346775|FG002|First Washout Period|Physician Decision|0|||
131468323|NCT04179890|473346776|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
131468324|NCT04179890|473346777|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
131468325|NCT04179890|473346776|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
131468326|NCT04179890|473346777|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
131468327|NCT04179890|473346776|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
131468328|NCT04179890|473346777|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
131468329|NCT04179890|473346776|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
131468330|NCT04179890|473346777|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
131468331|NCT04179890|473346776|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
131468332|NCT04179890|473346777|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
131468333|NCT04179890|473346776|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
131468334|NCT04179890|473346777|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
131468335|NCT04179890|473346776|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
131468336|NCT04179890|473346777|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
131468337|NCT04179890|473346776|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
131468338|NCT04179890|473346777|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
131468339|NCT04179890|473346776|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
131468340|NCT04179890|473346777|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
131468341|NCT01236118|473346778|FG000|Overall Study|Adverse Event|2|||
131468342|NCT01236118|473346779|FG001|Overall Study|Adverse Event|0|||
131468343|NCT01236118|473346780|FG002|Overall Study|Adverse Event|2|||
131468344|NCT01236118|473346778|FG000|Overall Study|Physician Decision|0|||
131468345|NCT01236118|473346779|FG001|Overall Study|Physician Decision|1|||
131468346|NCT01236118|473346780|FG002|Overall Study|Physician Decision|0|||
131468347|NCT01236118|473346778|FG000|Overall Study|Withdrawal by Subject|0|||
131468348|NCT01236118|473346779|FG001|Overall Study|Withdrawal by Subject|0|||
131468349|NCT01236118|473346780|FG002|Overall Study|Withdrawal by Subject|1|||
131468350|NCT02915874|473346785|FG000|Overall Study|Lost to Follow-up|5|||
131468351|NCT02915874|473346786|FG001|Overall Study|Lost to Follow-up|4|||
131468352|NCT02915874|473346785|FG000|Overall Study|Withdrawal by Subject|1|||
131468353|NCT02915874|473346786|FG001|Overall Study|Withdrawal by Subject|1|||
131468354|NCT02915874|473346785|FG000|Overall Study|Started New Anxiety Medication|0|||
131468355|NCT02915874|473346786|FG001|Overall Study|Started New Anxiety Medication|1|||
131468356|NCT01056380|473346788|FG000|Overall Study|Lost to Follow-up|2|||
131468357|NCT01056380|473346789|FG001|Overall Study|Lost to Follow-up|3|||
131468358|NCT03901456|473346790|FG000|Overall Study|Withdrawal by Subject|0|||
131468359|NCT03901456|473346791|FG001|Overall Study|Withdrawal by Subject|0|||
131468360|NCT03901456|473346792|FG002|Overall Study|Withdrawal by Subject|1|||
131468361|NCT03901456|473346790|FG000|Overall Study|Lost to Follow-up|0|||
131468362|NCT03901456|473346791|FG001|Overall Study|Lost to Follow-up|1|||
131468363|NCT03901456|473346792|FG002|Overall Study|Lost to Follow-up|0|||
131468364|NCT00773838|473346793|FG000|Overall Study|Adverse Event|29|||
131468365|NCT00773838|473346793|FG000|Overall Study|Lost to Follow-up|1|||
131468366|NCT00773838|473346793|FG000|Overall Study|Physician Decision|8|||
131468367|NCT00773838|473346793|FG000|Overall Study|Progressive Disease|82|||
131468368|NCT00773838|473346793|FG000|Overall Study|Protocol Violation|2|||
131468369|NCT00773838|473346793|FG000|Overall Study|Withdrawal by Subject|21|||
131468370|NCT01658813|473346796|FG000|Overall Study|Disease progression|3|||
131468371|NCT04738318|473346797|FG000|Overall Study|Protocol Violation|1|||
131468372|NCT04738318|473346798|FG001|Overall Study|Protocol Violation|0|||
131468373|NCT02290431|473346799|FG000|Overall Study|Adverse Event|20|||
131468374|NCT02290431|473346799|FG000|Overall Study|Progressive disease|4|||
131468375|NCT02290431|473346799|FG000|Overall Study|Study terminated by Sponsor|1|||
131468376|NCT02290431|473346799|FG000|Overall Study|Physician Decision|2|||
131468377|NCT00821327|473346800|FG000|Overall Study|Adverse Event|13|||
131468378|NCT00821327|473346800|FG000|Overall Study|Patient Request|1|||
131468379|NCT00821327|473346800|FG000|Overall Study|Investigator Request|2|||
131468380|NCT00821327|473346800|FG000|Overall Study|Sponsor Request|1|||
131468381|NCT00821327|473346800|FG000|Overall Study|Disease Progression|13|||
131468382|NCT00821327|473346800|FG000|Overall Study|Other/Unknown|5|||
131468383|NCT02119676|473346801|FG000|Overall Study|Adverse Event|9|||
131468384|NCT02119676|473346802|FG001|Overall Study|Adverse Event|17|||
131468385|NCT02119676|473346803|FG002|Overall Study|Adverse Event|10|||
131468386|NCT02119676|473346804|FG003|Overall Study|Adverse Event|10|||
131468387|NCT02119676|473346801|FG000|Overall Study|Disease progression|53|||
131468388|NCT02119676|473346802|FG001|Overall Study|Disease progression|55|||
131468389|NCT02119676|473346803|FG002|Overall Study|Disease progression|68|||
131468390|NCT02119676|473346804|FG003|Overall Study|Disease progression|73|||
131468391|NCT02119676|473346801|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
131468392|NCT02119676|473346802|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
131468393|NCT02119676|473346803|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
131468394|NCT02119676|473346804|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
131468395|NCT02119676|473346801|FG000|Overall Study|Physician Decision|4|||
131468396|NCT02119676|473346802|FG001|Overall Study|Physician Decision|2|||
131468397|NCT02119676|473346803|FG002|Overall Study|Physician Decision|3|||
131468398|NCT02119676|473346804|FG003|Overall Study|Physician Decision|2|||
131468399|NCT02119676|473346801|FG000|Overall Study|Death|9|||
131468400|NCT02119676|473346802|FG001|Overall Study|Death|3|||
131468401|NCT02119676|473346803|FG002|Overall Study|Death|2|||
131468402|NCT02119676|473346804|FG003|Overall Study|Death|1|||
131468403|NCT02119676|473346801|FG000|Overall Study|Noncompliance|0|||
131468404|NCT02119676|473346802|FG001|Overall Study|Noncompliance|1|||
131468405|NCT02119676|473346803|FG002|Overall Study|Noncompliance|0|||
131468406|NCT02119676|473346804|FG003|Overall Study|Noncompliance|0|||
131468407|NCT02119676|473346801|FG000|Overall Study|Lost to Follow-up|0|||
131468408|NCT02119676|473346802|FG001|Overall Study|Lost to Follow-up|0|||
131468409|NCT02119676|473346803|FG002|Overall Study|Lost to Follow-up|1|||
131468410|NCT02119676|473346804|FG003|Overall Study|Lost to Follow-up|0|||
131468411|NCT02119676|473346801|FG000|Overall Study|Protocol deviation|0|||
131468412|NCT02119676|473346802|FG001|Overall Study|Protocol deviation|0|||
131468413|NCT02119676|473346803|FG002|Overall Study|Protocol deviation|1|||
131468414|NCT02119676|473346804|FG003|Overall Study|Protocol deviation|0|||
131468415|NCT02119676|473346801|FG000|Overall Study|Other, unspecified|2|||
131468416|NCT02119676|473346802|FG001|Overall Study|Other, unspecified|1|||
131468417|NCT02119676|473346803|FG002|Overall Study|Other, unspecified|3|||
131468418|NCT02119676|473346804|FG003|Overall Study|Other, unspecified|4|||
131468419|NCT02119676|473346801|FG000|Overall Study|Did not receive study med|2|||
131468420|NCT02119676|473346802|FG001|Overall Study|Did not receive study med|2|||
131468421|NCT02119676|473346803|FG002|Overall Study|Did not receive study med|4|||
131468422|NCT02119676|473346804|FG003|Overall Study|Did not receive study med|5|||
131468423|NCT00219544|473346805|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
131468424|NCT00219544|473346806|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
131468425|NCT00219544|473346805|FG000|Single Blind Treatment Period|Adverse Event|9|||
131468426|NCT00219544|473346806|FG001|Single Blind Treatment Period|Adverse Event|0|||
131468427|NCT00219544|473346805|FG000|Single Blind Treatment Period|Protocol Violation|4|||
131468428|NCT00219544|473346806|FG001|Single Blind Treatment Period|Protocol Violation|0|||
131468429|NCT00219544|473346805|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
131468430|NCT00219544|473346806|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
131468431|NCT00219544|473346805|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
131468432|NCT00219544|473346806|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
131468433|NCT00219544|473346805|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
131468434|NCT00219544|473346806|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
131468435|NCT01007253|473346809|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
131468436|NCT01007253|473346810|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
131468437|NCT01007253|473346811|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
131468438|NCT01007253|473346812|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
131468439|NCT00814801|473346813|FG000|Overall Study|Adverse Event|15|||
131468440|NCT00814801|473346814|FG001|Overall Study|Adverse Event|16|||
131468441|NCT00814801|473346815|FG002|Overall Study|Adverse Event|19|||
131468442|NCT00814801|473346813|FG000|Overall Study|Withdrawal by Subject|9|||
131468443|NCT00814801|473346814|FG001|Overall Study|Withdrawal by Subject|11|||
131468444|NCT00814801|473346815|FG002|Overall Study|Withdrawal by Subject|14|||
131468445|NCT00814801|473346813|FG000|Overall Study|Inappropriate as a subject|1|||
131468446|NCT00814801|473346814|FG001|Overall Study|Inappropriate as a subject|1|||
131468447|NCT00814801|473346815|FG002|Overall Study|Inappropriate as a subject|1|||
131468448|NCT00814801|473346813|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
131468449|NCT00814801|473346814|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
131468450|NCT00814801|473346815|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
131468451|NCT00814801|473346813|FG000|Overall Study|Missing or change of caregiver|6|||
131468452|NCT00814801|473346814|FG001|Overall Study|Missing or change of caregiver|2|||
131468453|NCT00814801|473346815|FG002|Overall Study|Missing or change of caregiver|4|||
131468454|NCT00814801|473346813|FG000|Overall Study|Non-compliance|0|||
131468455|NCT00814801|473346814|FG001|Overall Study|Non-compliance|1|||
131468456|NCT00814801|473346815|FG002|Overall Study|Non-compliance|1|||
131468457|NCT00814801|473346813|FG000|Overall Study|Other|2|||
131468458|NCT00814801|473346814|FG001|Overall Study|Other|6|||
131468459|NCT00814801|473346815|FG002|Overall Study|Other|4|||
131468460|NCT00586664|473346816|FG000|Overall Study|Withdrawal by Subject|3|||
131468461|NCT00586664|473346817|FG001|Overall Study|Withdrawal by Subject|7|||
131468462|NCT00586664|473346818|FG002|Overall Study|Withdrawal by Subject|1|||
131468463|NCT00586664|473346816|FG000|Overall Study|Exclusion criteria met|2|||
131468464|NCT00586664|473346817|FG001|Overall Study|Exclusion criteria met|0|||
131468465|NCT00586664|473346818|FG002|Overall Study|Exclusion criteria met|0|||
131468466|NCT02751931|473346819|FG000|Overall Study|Adverse Event|3|||
131769307|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|Other|6|||
131769308|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|Other|7|||
131769309|NCT02681094|474433963|FG000|2 - Enrolled Participants Set|No treatment given|0|||
131769310|NCT02681094|474433964|FG001|2 - Enrolled Participants Set|No treatment given|1|||
131769311|NCT02681094|474433965|FG002|2 - Enrolled Participants Set|No treatment given|1|||
131769312|NCT01270139|474433968|FG000|Overall Study|Adverse Event|8|||
131769313|NCT01270139|474433969|FG001|Overall Study|Adverse Event|17|||
131769314|NCT01270139|474433970|FG002|Overall Study|Adverse Event|18|||
131769315|NCT01270139|474433968|FG000|Overall Study|Lost to Follow-up|10|||
131769316|NCT01270139|474433969|FG001|Overall Study|Lost to Follow-up|9|||
131769317|NCT01270139|474433970|FG002|Overall Study|Lost to Follow-up|2|||
131769318|NCT00134563|474433971|FG000|Overall Study|Not treated due to protocol violation|0|||
131769319|NCT00134563|474433972|FG001|Overall Study|Not treated due to protocol violation|1|||
131468467|NCT02751931|473346820|FG001|Overall Study|Adverse Event|0|||
131468468|NCT02751931|473346819|FG000|Overall Study|Other: Miscelleneous|10|||
131468469|NCT02751931|473346820|FG001|Overall Study|Other: Miscelleneous|8|||
131769320|NCT00134563|474433973|FG002|Overall Study|Not treated due to protocol violation|1|||
131769321|NCT00134563|474433971|FG000|Overall Study|Adverse Event|29|||
131468470|NCT01037088|473346821|FG000|Overall Study|Withdrawal by Subject|3|||
131468471|NCT04102189|473346824|FG000|Overall Study|Withdrawal by Subject|1|||
131769322|NCT00134563|474433972|FG001|Overall Study|Adverse Event|37|||
131769323|NCT00134563|474433973|FG002|Overall Study|Adverse Event|38|||
131769324|NCT00134563|474433971|FG000|Overall Study|Lack of Efficacy|24|||
131769325|NCT00134563|474433972|FG001|Overall Study|Lack of Efficacy|14|||
131769326|NCT00134563|474433973|FG002|Overall Study|Lack of Efficacy|17|||
131769327|NCT00134563|474433971|FG000|Overall Study|Protocol Violation|3|||
131769328|NCT00134563|474433972|FG001|Overall Study|Protocol Violation|2|||
131769329|NCT00134563|474433973|FG002|Overall Study|Protocol Violation|5|||
131769330|NCT00134563|474433971|FG000|Overall Study|Lost to Follow-up|4|||
131769331|NCT00134563|474433972|FG001|Overall Study|Lost to Follow-up|0|||
131769332|NCT00134563|474433973|FG002|Overall Study|Lost to Follow-up|2|||
131769333|NCT00134563|474433971|FG000|Overall Study|progressive disease|11|||
131769334|NCT00134563|474433972|FG001|Overall Study|progressive disease|4|||
131769335|NCT00134563|474433973|FG002|Overall Study|progressive disease|2|||
131769336|NCT00134563|474433971|FG000|Overall Study|did not wish to continue|33|||
131769337|NCT00134563|474433972|FG001|Overall Study|did not wish to continue|32|||
131769338|NCT00134563|474433973|FG002|Overall Study|did not wish to continue|26|||
131769339|NCT00134563|474433971|FG000|Overall Study|Reason other than above|0|||
131769340|NCT00134563|474433972|FG001|Overall Study|Reason other than above|2|||
131769341|NCT00134563|474433973|FG002|Overall Study|Reason other than above|5|||
131769342|NCT03382639|474433974|FG000|Overall Study|Adverse Event|2|||
131769343|NCT03382639|474433975|FG001|Overall Study|Adverse Event|0|||
131769344|NCT03382639|474433976|FG002|Overall Study|Adverse Event|1|||
131769345|NCT03382639|474433977|FG003|Overall Study|Adverse Event|1|||
131769346|NCT03382639|474433974|FG000|Overall Study|Lost to Follow-up|1|||
131468472|NCT04102189|473346825|FG001|Overall Study|Withdrawal by Subject|2|||
131468473|NCT04102189|473346824|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131468474|NCT04102189|473346825|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131468475|NCT04102189|473346824|FG000|Overall Study|Lost to Follow-up|1|||
131769347|NCT03382639|474433975|FG001|Overall Study|Lost to Follow-up|0|||
131769348|NCT03382639|474433976|FG002|Overall Study|Lost to Follow-up|0|||
131769349|NCT03382639|474433977|FG003|Overall Study|Lost to Follow-up|0|||
131769350|NCT03382639|474433974|FG000|Overall Study|Withdrawal by Subject|4|||
131769351|NCT03382639|474433975|FG001|Overall Study|Withdrawal by Subject|3|||
131769352|NCT03382639|474433976|FG002|Overall Study|Withdrawal by Subject|2|||
131769353|NCT03382639|474433977|FG003|Overall Study|Withdrawal by Subject|3|||
131769354|NCT03382639|474433974|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
131769355|NCT03382639|474433975|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
131769356|NCT03382639|474433976|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
131769357|NCT03382639|474433977|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
131769358|NCT03382639|474433974|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
131769359|NCT03382639|474433975|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
131769360|NCT03382639|474433976|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
131769361|NCT03382639|474433977|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
131769362|NCT03382639|474433974|FG000|Overall Study|Other|2|||
131769363|NCT03382639|474433975|FG001|Overall Study|Other|0|||
131769364|NCT03382639|474433976|FG002|Overall Study|Other|0|||
131769365|NCT03382639|474433977|FG003|Overall Study|Other|3|||
131769366|NCT02477215|474433980|FG000|Dose Escalation Phase|Physician Decision|1|||
131468476|NCT04102189|473346825|FG001|Overall Study|Lost to Follow-up|0|||
131468477|NCT03576274|473346827|FG000|Overall Study|Lost to Follow-up|3|||
131468478|NCT03576274|473346828|FG001|Overall Study|Lost to Follow-up|2|||
131468479|NCT03576274|473346829|FG002|Overall Study|Lost to Follow-up|3|||
131468480|NCT03576274|473346830|FG003|Overall Study|Lost to Follow-up|1|||
131468481|NCT03576274|473346831|FG004|Overall Study|Lost to Follow-up|3|||
131468482|NCT03576274|473346827|FG000|Overall Study|Withdrawal by Subject|5|||
131468483|NCT03576274|473346828|FG001|Overall Study|Withdrawal by Subject|3|||
131468484|NCT03576274|473346829|FG002|Overall Study|Withdrawal by Subject|2|||
131468485|NCT03576274|473346830|FG003|Overall Study|Withdrawal by Subject|8|||
131468486|NCT03576274|473346831|FG004|Overall Study|Withdrawal by Subject|6|||
131468487|NCT03976323|473346832|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
131468488|NCT03976323|473346833|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
131468489|NCT03976323|473346834|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
131468490|NCT03976323|473346832|FG000|Induction Phase|Death|80|||
131468491|NCT03976323|473346833|FG001|Induction Phase|Death|0|||
131468492|NCT03976323|473346834|FG002|Induction Phase|Death|0|||
131769367|NCT02477215|474433981|FG001|Dose Escalation Phase|Physician Decision|2|||
131769368|NCT02477215|474433982|FG002|Dose Escalation Phase|Physician Decision|0|||
131769369|NCT02477215|474433980|FG000|Fixed Dose Phase|Physician Decision|0|||
131769370|NCT02477215|474433981|FG001|Fixed Dose Phase|Physician Decision|7|||
131769371|NCT02477215|474433982|FG002|Fixed Dose Phase|Physician Decision|0|||
131769372|NCT01911546|474433985|FG000|Overall Study|Lost to Follow-up|1|||
131769373|NCT01911546|474433985|FG000|Overall Study|Everolimus was discontinued|5|||
131769374|NCT02210559|474433986|FG000|Overall Study|Progressive Disease|3|||
131468493|NCT03976323|473346832|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
131769375|NCT02210559|474433987|FG001|Overall Study|Progressive Disease|2|||
131769376|NCT02210559|474433986|FG000|Overall Study|Adverse Event|2|||
131769377|NCT02210559|474433987|FG001|Overall Study|Adverse Event|2|||
131769378|NCT02210559|474433986|FG000|Overall Study|Physician Decision|1|||
131468494|NCT03976323|473346833|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
131468495|NCT03976323|473346834|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
131468496|NCT03976323|473346832|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131468497|NCT03976323|473346833|FG001|Maintenance Phase|Withdrawal by Subject|9|||
131468498|NCT03976323|473346834|FG002|Maintenance Phase|Withdrawal by Subject|3|||
131468499|NCT03976323|473346832|FG000|Maintenance Phase|Physician Decision|0|||
131468500|NCT03976323|473346833|FG001|Maintenance Phase|Physician Decision|0|||
131468501|NCT03976323|473346834|FG002|Maintenance Phase|Physician Decision|1|||
131468502|NCT03976323|473346832|FG000|Maintenance Phase|Death|0|||
131468503|NCT03976323|473346833|FG001|Maintenance Phase|Death|228|||
131468504|NCT03976323|473346834|FG002|Maintenance Phase|Death|234|||
131468505|NCT02919969|473348382|FG000|Overall Study|Lack of Efficacy|22|||
131468506|NCT02919969|473348382|FG000|Overall Study|Death|4|||
131468507|NCT02919969|473348382|FG000|Overall Study|Physician Decision|3|||
131468508|NCT02919969|473348382|FG000|Overall Study|Withdrawal by Subject|2|||
131468509|NCT03621475|473348383|FG000|Overall Study|No longer required restraints at initiation|0|||
131468510|NCT03621475|473348384|FG001|Overall Study|No longer required restraints at initiation|1|||
131468511|NCT01842633|473348385|FG000|Overall Study|Screen Failure|1|||
131468512|NCT01842633|473348386|FG001|Overall Study|Screen Failure|0|||
131468513|NCT01842633|473348387|FG002|Overall Study|Screen Failure|0|||
131468514|NCT01842633|473348385|FG000|Overall Study|Adverse Event|1|||
131468515|NCT01842633|473348386|FG001|Overall Study|Adverse Event|1|||
131468516|NCT01842633|473348387|FG002|Overall Study|Adverse Event|0|||
131468517|NCT01842633|473348385|FG000|Overall Study|Withdrawal by Subject|0|||
131468518|NCT01842633|473348386|FG001|Overall Study|Withdrawal by Subject|1|||
131468519|NCT01842633|473348387|FG002|Overall Study|Withdrawal by Subject|0|||
131468520|NCT01842633|473348385|FG000|Overall Study|Technical issues|1|||
131468521|NCT01842633|473348386|FG001|Overall Study|Technical issues|0|||
131468522|NCT01842633|473348387|FG002|Overall Study|Technical issues|0|||
131468523|NCT00039871|473348394|FG000|Overall Study|Adverse Event|165|||
131468524|NCT00039871|473348394|FG000|Overall Study|Lost to Follow-up|18|||
131468525|NCT00039871|473348394|FG000|Overall Study|Protocol Violation|24|||
131468526|NCT00039871|473348394|FG000|Overall Study|Withdrawal by Subject|97|||
131468527|NCT00039871|473348394|FG000|Overall Study|Did not meet eligibility criteria|11|||
131468528|NCT00039871|473348394|FG000|Overall Study|Administrative|1|||
131468529|NCT00039871|473348394|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
131468530|NCT00039871|473348394|FG000|Overall Study|Never entered follow-up|7|||
131468531|NCT02186301|473348395|FG000|Overall Study|Progressive Disease|7|||
131468532|NCT02186301|473348396|FG001|Overall Study|Progressive Disease|22|||
131468533|NCT02186301|473348397|FG002|Overall Study|Progressive Disease|27|||
131468534|NCT02186301|473348395|FG000|Overall Study|Adverse Event|5|||
131468535|NCT02186301|473348396|FG001|Overall Study|Adverse Event|5|||
131468536|NCT02186301|473348397|FG002|Overall Study|Adverse Event|5|||
131468537|NCT02186301|473348395|FG000|Overall Study|Death|1|||
131468538|NCT02186301|473348396|FG001|Overall Study|Death|0|||
131468539|NCT02186301|473348397|FG002|Overall Study|Death|0|||
131468540|NCT02186301|473348395|FG000|Overall Study|Withdrawal by Subject|5|||
131468541|NCT02186301|473348396|FG001|Overall Study|Withdrawal by Subject|1|||
131468542|NCT02186301|473348397|FG002|Overall Study|Withdrawal by Subject|3|||
131468543|NCT02186301|473348395|FG000|Overall Study|Physician Decision|1|||
131468544|NCT02186301|473348396|FG001|Overall Study|Physician Decision|0|||
131468545|NCT02186301|473348397|FG002|Overall Study|Physician Decision|1|||
131468546|NCT02186301|473348395|FG000|Overall Study|Study Terminated by Sponsor|1|||
131468547|NCT02186301|473348396|FG001|Overall Study|Study Terminated by Sponsor|0|||
131468548|NCT02186301|473348397|FG002|Overall Study|Study Terminated by Sponsor|11|||
131468549|NCT02186301|473348395|FG000|Overall Study|Protocol Deviation|0|||
131468550|NCT02186301|473348396|FG001|Overall Study|Protocol Deviation|2|||
131468551|NCT02186301|473348397|FG002|Overall Study|Protocol Deviation|0|||
131468552|NCT02186301|473348395|FG000|Overall Study|Missing|0|||
131468553|NCT02186301|473348396|FG001|Overall Study|Missing|0|||
131468554|NCT02186301|473348397|FG002|Overall Study|Missing|2|||
131468555|NCT02186301|473348395|FG000|Overall Study|Other|0|||
131468556|NCT02186301|473348396|FG001|Overall Study|Other|0|||
131468557|NCT02186301|473348397|FG002|Overall Study|Other|1|||
131468558|NCT01275339|473348399|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
131468559|NCT01275339|473348400|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
131468560|NCT01275339|473348401|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
131468561|NCT01275339|473348402|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
131468562|NCT01275339|473348399|FG000|Overall Study|Withdrawal by Subject|0|||
131468563|NCT01275339|473348400|FG001|Overall Study|Withdrawal by Subject|0|||
131468564|NCT01275339|473348401|FG002|Overall Study|Withdrawal by Subject|1|||
131468565|NCT01275339|473348402|FG003|Overall Study|Withdrawal by Subject|0|||
131468566|NCT03560739|473348403|FG000|Overall Study|Adverse Event|0|||
131468567|NCT03560739|473348404|FG001|Overall Study|Adverse Event|1|||
131468568|NCT03560739|473348405|FG002|Overall Study|Adverse Event|0|||
131468569|NCT03560739|473348406|FG003|Overall Study|Adverse Event|0|||
131468570|NCT02478398|473348407|FG000|Overall Study|Adverse Event|20|||
131769379|NCT02210559|474433987|FG001|Overall Study|Physician Decision|0|||
131769380|NCT02210559|474433986|FG000|Overall Study|Withdrawal by Subject|0|||
131769381|NCT02210559|474433987|FG001|Overall Study|Withdrawal by Subject|1|||
131769382|NCT02210559|474433986|FG000|Overall Study|Other than specified|0|||
131769383|NCT02210559|474433987|FG001|Overall Study|Other than specified|1|||
131769384|NCT00310440|474433988|FG000|Overall Study|Lost to Follow-up|17|||
131769385|NCT00310440|474433989|FG001|Overall Study|Lost to Follow-up|8|||
131769386|NCT00310440|474433988|FG000|Overall Study|Withdrawal by Subject|2|||
131769387|NCT00310440|474433989|FG001|Overall Study|Withdrawal by Subject|1|||
131769388|NCT00310440|474433988|FG000|Overall Study|Missed 12 Month Visit|7|||
131769389|NCT00310440|474433989|FG001|Overall Study|Missed 12 Month Visit|4|||
131468571|NCT02478398|473348408|FG001|Overall Study|Adverse Event|5|||
131468572|NCT02478398|473348407|FG000|Overall Study|Lost to Follow-up|5|||
131468573|NCT02478398|473348408|FG001|Overall Study|Lost to Follow-up|4|||
131468574|NCT02478398|473348407|FG000|Overall Study|Non-Compliance With Study Drug|5|||
131468575|NCT02478398|473348408|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131468576|NCT02478398|473348407|FG000|Overall Study|Protocol Violation|3|||
131468577|NCT02478398|473348408|FG001|Overall Study|Protocol Violation|1|||
131468578|NCT02478398|473348407|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
131468579|NCT02478398|473348408|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
131468580|NCT02478398|473348407|FG000|Overall Study|Withdrawal By Participant|10|||
131468581|NCT02478398|473348408|FG001|Overall Study|Withdrawal By Participant|4|||
131769390|NCT01474291|474433990|FG000|Overall Study|Not Evaluable for Efficacy|26|||
131769391|NCT01474291|474433990|FG000|Overall Study|Lack of Treatment Efficacy|88|||
131769392|NCT01474291|474433990|FG000|Overall Study|Adverse Event|53|||
131769393|NCT01474291|474433990|FG000|Overall Study|Lost to Follow-up|29|||
131769394|NCT01474291|474433990|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
131769395|NCT01474291|474433990|FG000|Overall Study|No Reason Reported|10|||
131769396|NCT01474291|474433990|FG000|Overall Study|Death|2|||
131769397|NCT01287403|474433991|FG000|1st Intervention (1 Day)|Adverse Event|1|||
131769398|NCT00148109|474433992|FG000|Overall Study|Lack of Efficacy|10|||
131769399|NCT00148109|474433993|FG001|Overall Study|Lack of Efficacy|18|||
131769400|NCT00148109|474433992|FG000|Overall Study|Adverse Event|0|||
131769401|NCT00148109|474433993|FG001|Overall Study|Adverse Event|2|||
131769402|NCT00148109|474433992|FG000|Overall Study|Withdrawal by Subject|2|||
131769403|NCT00148109|474433993|FG001|Overall Study|Withdrawal by Subject|0|||
131769404|NCT03137433|474433995|FG000|Overall Study|Withdrawal by Subject|11|||
131769405|NCT03137433|474433996|FG001|Overall Study|Withdrawal by Subject|11|||
131769406|NCT03137433|474433995|FG000|Overall Study|Lost to Follow-up|5|||
131769407|NCT03137433|474433996|FG001|Overall Study|Lost to Follow-up|6|||
131769408|NCT03137433|474433995|FG000|Overall Study|Physician Decision|2|||
131769409|NCT03137433|474433996|FG001|Overall Study|Physician Decision|0|||
131769410|NCT03137433|474433995|FG000|Overall Study|Moved out of study area|1|||
131769411|NCT03137433|474433996|FG001|Overall Study|Moved out of study area|0|||
131769412|NCT03137433|474433995|FG000|Overall Study|Too far out of window due to COVID|0|||
131769413|NCT03137433|474433996|FG001|Overall Study|Too far out of window due to COVID|1|||
131769414|NCT00083616|474433997|FG000|Overall Study|Disease Progression|16|||
131769415|NCT00083616|474433997|FG000|Overall Study|Lost to Follow-up|1|||
131769416|NCT00083616|474433997|FG000|Overall Study|Physician Decision|2|||
131769417|NCT00083616|474433997|FG000|Overall Study|Withdrawal by Subject|3|||
131769418|NCT00083616|474433997|FG000|Overall Study|Ineligibility determined|2|||
131769419|NCT00083616|474433997|FG000|Overall Study|Non-compliance|1|||
131769420|NCT00083616|474433997|FG000|Overall Study|Other|6|||
131769421|NCT01853397|474433998|FG000|Overall Study|Withdrawal by Subject|0|||
131769422|NCT01853397|474433999|FG001|Overall Study|Withdrawal by Subject|0|||
131468582|NCT03123185|473348409|FG000|Overall Study|Withdrawal by Subject|0|||
131468583|NCT03123185|473348410|FG001|Overall Study|Withdrawal by Subject|0|||
131468584|NCT03123185|473348411|FG002|Overall Study|Withdrawal by Subject|0|||
131769423|NCT01853397|474434000|FG002|Overall Study|Withdrawal by Subject|0|||
131769424|NCT01853397|474434001|FG003|Overall Study|Withdrawal by Subject|1|||
131769425|NCT01853397|474433998|FG000|Overall Study|Subject Noncompliance|0|||
131769426|NCT01853397|474433999|FG001|Overall Study|Subject Noncompliance|0|||
131769427|NCT01853397|474434000|FG002|Overall Study|Subject Noncompliance|0|||
131468585|NCT03123185|473348412|FG003|Overall Study|Withdrawal by Subject|0|||
131769428|NCT01853397|474434001|FG003|Overall Study|Subject Noncompliance|1|||
131769429|NCT03258710|474434002|FG000|Overall Study|Adverse Event|1|||
131769430|NCT03258710|474434002|FG000|Overall Study|Protocol-defined stopping criteria|1|||
131769431|NCT03258710|474434002|FG000|Overall Study|Physician Decision|1|||
131468586|NCT03123185|473348413|FG004|Overall Study|Withdrawal by Subject|0|||
131468587|NCT03123185|473348414|FG005|Overall Study|Withdrawal by Subject|0|||
131769432|NCT02452892|474434005|FG000|Week 1 Initial Randommization|Adverse Event|1|||
131769433|NCT02452892|474434006|FG001|Week 1 Initial Randommization|Adverse Event|0|||
131769434|NCT02452892|474434007|FG002|Week 1 Initial Randommization|Adverse Event|0|||
131769435|NCT02452892|474434008|FG003|Week 1 Initial Randommization|Adverse Event|0|||
131769436|NCT02452892|474434005|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
131769437|NCT02452892|474434006|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
131769438|NCT02452892|474434007|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
131769439|NCT02452892|474434008|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
131769440|NCT02452892|474434005|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
131769441|NCT02452892|474434006|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
131769442|NCT02452892|474434007|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
131769443|NCT02452892|474434008|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
131769444|NCT02452892|474434005|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
131769445|NCT02452892|474434006|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
131468588|NCT03123185|473348415|FG006|Overall Study|Withdrawal by Subject|0|||
131468589|NCT03123185|473348416|FG007|Overall Study|Withdrawal by Subject|0|||
131468590|NCT03123185|473348417|FG008|Overall Study|Withdrawal by Subject|0|||
131468591|NCT03123185|473348418|FG009|Overall Study|Withdrawal by Subject|0|||
131468592|NCT03123185|473348419|FG010|Overall Study|Withdrawal by Subject|0|||
131468593|NCT03123185|473348420|FG011|Overall Study|Withdrawal by Subject|0|||
131468594|NCT03123185|473348421|FG012|Overall Study|Withdrawal by Subject|1|||
131468595|NCT03123185|473348422|FG013|Overall Study|Withdrawal by Subject|0|||
131468596|NCT00718081|473348425|FG000|Overall Study|Adverse Event|0|||
131468597|NCT00718081|473348426|FG001|Overall Study|Adverse Event|1|||
131468598|NCT00718081|473348427|FG002|Overall Study|Adverse Event|0|||
131468599|NCT00718081|473348425|FG000|Overall Study|Lack of Efficacy|7|||
131468600|NCT00718081|473348426|FG001|Overall Study|Lack of Efficacy|3|||
131468601|NCT00718081|473348427|FG002|Overall Study|Lack of Efficacy|21|||
131468602|NCT03754972|473348428|FG000|Overall Study|Protocol Violation|25|||
131468603|NCT02311582|473348429|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
131468604|NCT02311582|473348430|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
131468605|NCT02311582|473348431|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
131468606|NCT02311582|473348432|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
131468607|NCT02311582|473348433|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
131468608|NCT03422627|473348434|FG000|Overall Study|Protocol-specified Criteria|1|||
131468609|NCT03422627|473348435|FG001|Overall Study|Protocol-specified Criteria|1|||
131468610|NCT03422627|473348436|FG002|Overall Study|Protocol-specified Criteria|0|||
131468611|NCT03422627|473348437|FG003|Overall Study|Protocol-specified Criteria|0|||
131468612|NCT03422627|473348438|FG004|Overall Study|Protocol-specified Criteria|2|||
131468613|NCT03422627|473348434|FG000|Overall Study|Requirement for Alternative Therapy|1|||
131468614|NCT03422627|473348435|FG001|Overall Study|Requirement for Alternative Therapy|1|||
131468615|NCT03422627|473348436|FG002|Overall Study|Requirement for Alternative Therapy|2|||
131468616|NCT03422627|473348437|FG003|Overall Study|Requirement for Alternative Therapy|0|||
131468617|NCT03422627|473348438|FG004|Overall Study|Requirement for Alternative Therapy|0|||
131468618|NCT03422627|473348434|FG000|Overall Study|Disease Progression|1|||
131468619|NCT03422627|473348435|FG001|Overall Study|Disease Progression|0|||
131468620|NCT03422627|473348436|FG002|Overall Study|Disease Progression|1|||
131468621|NCT03422627|473348437|FG003|Overall Study|Disease Progression|2|||
131468622|NCT03422627|473348438|FG004|Overall Study|Disease Progression|0|||
131468623|NCT03422627|473348434|FG000|Overall Study|Adverse Event|2|||
131468624|NCT03422627|473348435|FG001|Overall Study|Adverse Event|1|||
131468625|NCT03422627|473348436|FG002|Overall Study|Adverse Event|0|||
131468626|NCT03422627|473348437|FG003|Overall Study|Adverse Event|0|||
131468627|NCT03422627|473348438|FG004|Overall Study|Adverse Event|2|||
131468628|NCT03422627|473348434|FG000|Overall Study|Ineligibility Determined|0|||
131468629|NCT03422627|473348435|FG001|Overall Study|Ineligibility Determined|1|||
131468630|NCT03422627|473348436|FG002|Overall Study|Ineligibility Determined|0|||
131468631|NCT03422627|473348437|FG003|Overall Study|Ineligibility Determined|0|||
131468632|NCT03422627|473348438|FG004|Overall Study|Ineligibility Determined|0|||
131468633|NCT03422627|473348434|FG000|Overall Study|Death|0|||
131468634|NCT03422627|473348435|FG001|Overall Study|Death|1|||
131468635|NCT03422627|473348436|FG002|Overall Study|Death|1|||
131468636|NCT03422627|473348437|FG003|Overall Study|Death|0|||
131468637|NCT03422627|473348438|FG004|Overall Study|Death|0|||
131468638|NCT03422627|473348434|FG000|Overall Study|Withdrawal by Subject|0|||
131468639|NCT03422627|473348435|FG001|Overall Study|Withdrawal by Subject|0|||
131468640|NCT03422627|473348436|FG002|Overall Study|Withdrawal by Subject|0|||
131468641|NCT03422627|473348437|FG003|Overall Study|Withdrawal by Subject|1|||
131468642|NCT03422627|473348438|FG004|Overall Study|Withdrawal by Subject|0|||
131468643|NCT00934648|473348441|FG000|Overall Study|Failure to return|8|||
131468644|NCT00934648|473348441|FG000|Overall Study|Withdrawal by Subject|1|||
131468645|NCT04369924|473348442|FG000|Overall Study|Lost to Follow-up|302|||
131468646|NCT04369924|473348443|FG001|Overall Study|Lost to Follow-up|339|||
131468647|NCT03828370|473348444|FG000|3 Month Follow-up|Lost to Follow-up|4|||
131468648|NCT03828370|473348445|FG001|3 Month Follow-up|Lost to Follow-up|12|||
131468649|NCT03828370|473348444|FG000|9 Month Follow up|Lost to Follow-up|12|||
131468650|NCT03828370|473348445|FG001|9 Month Follow up|Lost to Follow-up|20|||
131468651|NCT02554279|473348448|FG000|Overall Study|Adverse Event|2|||
131769446|NCT02452892|474434007|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
131769447|NCT02452892|474434008|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
131769448|NCT02452892|474434005|FG000|Follow-up|Withdrawal by Subject|0|||
131769449|NCT02452892|474434006|FG001|Follow-up|Withdrawal by Subject|0|||
131769450|NCT02452892|474434007|FG002|Follow-up|Withdrawal by Subject|0|||
131769451|NCT02452892|474434008|FG003|Follow-up|Withdrawal by Subject|1|||
131769452|NCT02452892|474434005|FG000|Follow-up|Subject left town on Day 42|1|||
131769453|NCT02452892|474434006|FG001|Follow-up|Subject left town on Day 42|0|||
131769454|NCT02452892|474434007|FG002|Follow-up|Subject left town on Day 42|0|||
131769455|NCT02452892|474434008|FG003|Follow-up|Subject left town on Day 42|0|||
131769456|NCT02813681|474434009|FG000|Overall Study|Physician Decision|5|||
131769457|NCT02813681|474434010|FG001|Overall Study|Physician Decision|5|||
131769458|NCT02813681|474434011|FG002|Overall Study|Physician Decision|0|||
131769459|NCT02813681|474434009|FG000|Overall Study|Lost to Follow-up|0|||
131769460|NCT02813681|474434010|FG001|Overall Study|Lost to Follow-up|1|||
131769461|NCT02813681|474434011|FG002|Overall Study|Lost to Follow-up|0|||
131769462|NCT01874288|474434019|FG000|Overall Study|Withdrawal by Subject|1|||
131769463|NCT01874288|474434020|FG001|Overall Study|Withdrawal by Subject|0|||
131769464|NCT01874288|474434021|FG002|Overall Study|Withdrawal by Subject|2|||
131769465|NCT01874288|474434022|FG003|Overall Study|Withdrawal by Subject|1|||
131769466|NCT01874288|474434023|FG004|Overall Study|Withdrawal by Subject|1|||
131769467|NCT01874288|474434019|FG000|Overall Study|Physician Decision|0|||
131769468|NCT01874288|474434020|FG001|Overall Study|Physician Decision|0|||
131769469|NCT01874288|474434021|FG002|Overall Study|Physician Decision|0|||
131769470|NCT01874288|474434022|FG003|Overall Study|Physician Decision|1|||
131769471|NCT01874288|474434023|FG004|Overall Study|Physician Decision|0|||
131769472|NCT01874288|474434019|FG000|Overall Study|Progressive disease|2|||
131769473|NCT01874288|474434020|FG001|Overall Study|Progressive disease|0|||
131769474|NCT01874288|474434021|FG002|Overall Study|Progressive disease|3|||
131468652|NCT02554279|473348449|FG001|Overall Study|Adverse Event|5|||
131468653|NCT02554279|473348448|FG000|Overall Study|Lost to Follow-up|3|||
131468654|NCT02554279|473348449|FG001|Overall Study|Lost to Follow-up|2|||
131468655|NCT02554279|473348448|FG000|Overall Study|Withdrawal by Subject|6|||
131468656|NCT02554279|473348449|FG001|Overall Study|Withdrawal by Subject|4|||
131468657|NCT02554279|473348448|FG000|Overall Study|Protocol Violation|2|||
131468658|NCT02554279|473348449|FG001|Overall Study|Protocol Violation|1|||
131468659|NCT02554279|473348448|FG000|Overall Study|Other reason|19|||
131468660|NCT02554279|473348449|FG001|Overall Study|Other reason|6|||
131769475|NCT01874288|474434022|FG003|Overall Study|Progressive disease|5|||
131468661|NCT00812487|473348450|FG000|Overall Study|Lost to Follow-up|2|||
131769476|NCT01874288|474434023|FG004|Overall Study|Progressive disease|1|||
131769477|NCT00283062|474434024|FG000|Overall Study|Did not receive any study medication|5|||
131468662|NCT00812487|473348451|FG001|Overall Study|Lost to Follow-up|0|||
131468663|NCT00812487|473348450|FG000|Overall Study|Withdrawal by Subject|3|||
131468664|NCT00812487|473348451|FG001|Overall Study|Withdrawal by Subject|2|||
131468665|NCT00812487|473348450|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
131468666|NCT00812487|473348451|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
131769478|NCT00283062|474434025|FG001|Overall Study|Did not receive any study medication|4|||
131769479|NCT00283062|474434026|FG002|Overall Study|Did not receive any study medication|36|||
131769480|NCT00283062|474434027|FG003|Overall Study|Did not receive any study medication|45|||
131769481|NCT00283062|474434024|FG000|Overall Study|Adverse Event|2|||
131769482|NCT00283062|474434025|FG001|Overall Study|Adverse Event|0|||
131769483|NCT00283062|474434026|FG002|Overall Study|Adverse Event|1|||
131769484|NCT00283062|474434027|FG003|Overall Study|Adverse Event|0|||
131769485|NCT00283062|474434024|FG000|Overall Study|Lost to Follow-up|1|||
131468667|NCT00812487|473348450|FG000|Overall Study|Protocol Violation|0|||
131468668|NCT00812487|473348451|FG001|Overall Study|Protocol Violation|1|||
131468669|NCT02360605|473348452|FG000|Overall Study|Withdrawal by Subject|4|||
131468670|NCT02360605|473348453|FG001|Overall Study|Withdrawal by Subject|9|||
131468671|NCT02360605|473348452|FG000|Overall Study|Lost to Follow-up|7|||
131468672|NCT02360605|473348453|FG001|Overall Study|Lost to Follow-up|8|||
131468673|NCT02360605|473348452|FG000|Overall Study|Death|0|||
131468674|NCT02360605|473348453|FG001|Overall Study|Death|1|||
131468675|NCT00998764|473348454|FG000|Overall Study|Lack of Efficacy|3|||
131468676|NCT00998764|473348455|FG001|Overall Study|Lack of Efficacy|6|||
131769486|NCT00283062|474434025|FG001|Overall Study|Lost to Follow-up|0|||
131769487|NCT00283062|474434026|FG002|Overall Study|Lost to Follow-up|1|||
131769488|NCT00283062|474434027|FG003|Overall Study|Lost to Follow-up|0|||
131769489|NCT00283062|474434024|FG000|Overall Study|Progressive disease|0|||
131769490|NCT00283062|474434025|FG001|Overall Study|Progressive disease|0|||
131769491|NCT00283062|474434026|FG002|Overall Study|Progressive disease|1|||
131769492|NCT00283062|474434027|FG003|Overall Study|Progressive disease|0|||
131769493|NCT00283062|474434024|FG000|Overall Study|Participant did not wish to continue|3|||
131769494|NCT00283062|474434025|FG001|Overall Study|Participant did not wish to continue|2|||
131769495|NCT00283062|474434026|FG002|Overall Study|Participant did not wish to continue|1|||
131769496|NCT00283062|474434027|FG003|Overall Study|Participant did not wish to continue|0|||
131769497|NCT00283062|474434024|FG000|Overall Study|Undefined|0|||
131769498|NCT00283062|474434025|FG001|Overall Study|Undefined|1|||
131769499|NCT00283062|474434026|FG002|Overall Study|Undefined|1|||
131769500|NCT00283062|474434027|FG003|Overall Study|Undefined|4|||
131769501|NCT00283062|474434024|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
131769502|NCT00283062|474434025|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
131769503|NCT00283062|474434026|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
131769504|NCT00283062|474434027|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
131769505|NCT03137173|474434028|FG000|Overall Study|Withdrawal by Subject|8|||
131769506|NCT03137173|474434029|FG001|Overall Study|Withdrawal by Subject|13|||
131769507|NCT03137173|474434028|FG000|Overall Study|Death|1|||
131769508|NCT03137173|474434029|FG001|Overall Study|Death|3|||
131769509|NCT03137173|474434028|FG000|Overall Study|Physician Decision|1|||
131769510|NCT03137173|474434029|FG001|Overall Study|Physician Decision|0|||
131769511|NCT03137173|474434028|FG000|Overall Study|Lost to Follow-up|13|||
131468677|NCT00998764|473348454|FG000|Overall Study|Adverse Event|17|||
131468678|NCT00998764|473348455|FG001|Overall Study|Adverse Event|12|||
131769512|NCT03137173|474434029|FG001|Overall Study|Lost to Follow-up|18|||
131769513|NCT03137173|474434028|FG000|Overall Study|Other reasons|3|||
131769514|NCT03137173|474434029|FG001|Overall Study|Other reasons|2|||
131769515|NCT01365468|474434030|FG000|Overall Study|Physician Decision|1|||
131769516|NCT01365468|474434031|FG001|Overall Study|Physician Decision|0|||
131769517|NCT01365468|474434030|FG000|Overall Study|Disease progression|1|||
131769518|NCT01365468|474434031|FG001|Overall Study|Disease progression|0|||
131769519|NCT01365468|474434030|FG000|Overall Study|Lost to Follow-up|2|||
131769520|NCT01365468|474434031|FG001|Overall Study|Lost to Follow-up|0|||
131769521|NCT03524664|474434032|FG000|Overall Study|Withdrawal by Subject|1|||
131769522|NCT03524664|474434033|FG001|Overall Study|Withdrawal by Subject|2|||
131769523|NCT03524664|474434032|FG000|Overall Study|Lost to Follow-up|4|||
131769524|NCT03524664|474434033|FG001|Overall Study|Lost to Follow-up|13|||
131769525|NCT00423267|474434034|FG000|Period A|Withdrawal by Subject|0|||
131769526|NCT00423267|474434035|FG001|Period A|Withdrawal by Subject|1|||
131769527|NCT00423267|474434034|FG000|Period A|Non-compliance with protocol|1|||
131769528|NCT00423267|474434035|FG001|Period A|Non-compliance with protocol|0|||
131468679|NCT00998764|473348454|FG000|Overall Study|Withdrawal by Subject|19|||
131468680|NCT00998764|473348455|FG001|Overall Study|Withdrawal by Subject|25|||
131468681|NCT00998764|473348454|FG000|Overall Study|Physician Decision|3|||
131468682|NCT00998764|473348455|FG001|Overall Study|Physician Decision|3|||
131468683|NCT00998764|473348454|FG000|Overall Study|Death|3|||
131468684|NCT00998764|473348455|FG001|Overall Study|Death|1|||
131769529|NCT00423267|474434034|FG000|Period A|Administrative|1|||
131769530|NCT00423267|474434035|FG001|Period A|Administrative|0|||
131769531|NCT00827112|474434036|FG000|Overall Study|Adverse Event|2|||
131769532|NCT00827112|474434037|FG001|Overall Study|Adverse Event|0|||
131769533|NCT00827112|474434036|FG000|Overall Study|Lack of Efficacy|2|||
131769534|NCT00827112|474434037|FG001|Overall Study|Lack of Efficacy|0|||
131769535|NCT00827112|474434036|FG000|Overall Study|Lost to Follow-up|3|||
131769536|NCT00827112|474434037|FG001|Overall Study|Lost to Follow-up|2|||
131769537|NCT00827112|474434036|FG000|Overall Study|Pregnancy|0|||
131769538|NCT00827112|474434037|FG001|Overall Study|Pregnancy|1|||
131769539|NCT00827112|474434036|FG000|Overall Study|Protocol Violation|0|||
131769540|NCT00827112|474434037|FG001|Overall Study|Protocol Violation|2|||
131769541|NCT00827112|474434036|FG000|Overall Study|Withdrawal by Subject|2|||
131769542|NCT00827112|474434037|FG001|Overall Study|Withdrawal by Subject|1|||
131769543|NCT00827112|474434036|FG000|Overall Study|Randomized but not treated|5|||
131769544|NCT00827112|474434037|FG001|Overall Study|Randomized but not treated|3|||
131769545|NCT00827112|474434036|FG000|Overall Study|Other|1|||
131769546|NCT00827112|474434037|FG001|Overall Study|Other|3|||
131769547|NCT00591786|474434042|FG000|Overall Study|Withdrawal of Informed Consent|0|||
131769548|NCT00591786|474434043|FG001|Overall Study|Withdrawal of Informed Consent|0|||
131769549|NCT00591786|474434044|FG002|Overall Study|Withdrawal of Informed Consent|1|||
131769550|NCT00591786|474434045|FG003|Overall Study|Withdrawal of Informed Consent|0|||
131769551|NCT00591786|474434046|FG004|Overall Study|Withdrawal of Informed Consent|0|||
131769552|NCT00591786|474434047|FG005|Overall Study|Withdrawal of Informed Consent|0|||
131769553|NCT00591786|474434048|FG006|Overall Study|Withdrawal of Informed Consent|0|||
131769554|NCT00591786|474434049|FG007|Overall Study|Withdrawal of Informed Consent|0|||
131769555|NCT00591786|474434050|FG008|Overall Study|Withdrawal of Informed Consent|0|||
131769556|NCT00591786|474434051|FG009|Overall Study|Withdrawal of Informed Consent|0|||
131769557|NCT01920061|474434052|FG000|Overall Study|Death|1|||
131769558|NCT01920061|474434053|FG001|Overall Study|Death|1|||
131468685|NCT00998764|473348454|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
131468686|NCT00998764|473348455|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
131468687|NCT00998764|473348454|FG000|Overall Study|Protocol Violation|0|||
131468688|NCT00998764|473348455|FG001|Overall Study|Protocol Violation|1|||
131468689|NCT00998764|473348454|FG000|Overall Study|Failed to Return|1|||
131468690|NCT00998764|473348455|FG001|Overall Study|Failed to Return|1|||
131769559|NCT01920061|474434054|FG002|Overall Study|Death|0|||
131769560|NCT01920061|474434055|FG003|Overall Study|Death|1|||
131769561|NCT01920061|474434056|FG004|Overall Study|Death|1|||
131769562|NCT01920061|474434057|FG005|Overall Study|Death|0|||
131769563|NCT01920061|474434058|FG006|Overall Study|Death|0|||
131769564|NCT01920061|474434059|FG007|Overall Study|Death|1|||
131468691|NCT00998764|473348454|FG000|Overall Study|Lost to Follow-up|1|||
131468692|NCT00998764|473348455|FG001|Overall Study|Lost to Follow-up|1|||
131769565|NCT01920061|474434060|FG008|Overall Study|Death|0|||
131769566|NCT01920061|474434061|FG009|Overall Study|Death|1|||
131468693|NCT00998764|473348454|FG000|Overall Study|Loss of Caregiver|0|||
131769567|NCT01920061|474434062|FG010|Overall Study|Death|0|||
131769568|NCT01920061|474434063|FG011|Overall Study|Death|1|||
131769569|NCT01920061|474434064|FG012|Overall Study|Death|0|||
131769570|NCT01920061|474434065|FG013|Overall Study|Death|2|||
131769571|NCT01920061|474434066|FG014|Overall Study|Death|0|||
131769572|NCT01920061|474434067|FG015|Overall Study|Death|0|||
131769573|NCT01920061|474434068|FG016|Overall Study|Death|0|||
131769574|NCT01920061|474434069|FG017|Overall Study|Death|0|||
131769575|NCT01920061|474434070|FG018|Overall Study|Death|1|||
131769576|NCT01920061|474434071|FG019|Overall Study|Death|0|||
131769577|NCT01920061|474434052|FG000|Overall Study|Lost to Follow-up|0|||
131769578|NCT01920061|474434053|FG001|Overall Study|Lost to Follow-up|2|||
131769579|NCT01920061|474434054|FG002|Overall Study|Lost to Follow-up|0|||
131769580|NCT01920061|474434055|FG003|Overall Study|Lost to Follow-up|0|||
131769581|NCT01920061|474434056|FG004|Overall Study|Lost to Follow-up|0|||
131769582|NCT01920061|474434057|FG005|Overall Study|Lost to Follow-up|0|||
131769583|NCT01920061|474434058|FG006|Overall Study|Lost to Follow-up|1|||
131769584|NCT01920061|474434059|FG007|Overall Study|Lost to Follow-up|0|||
131769585|NCT01920061|474434060|FG008|Overall Study|Lost to Follow-up|0|||
131769586|NCT01920061|474434061|FG009|Overall Study|Lost to Follow-up|0|||
131769587|NCT01920061|474434062|FG010|Overall Study|Lost to Follow-up|3|||
131769588|NCT01920061|474434063|FG011|Overall Study|Lost to Follow-up|0|||
131468694|NCT00998764|473348455|FG001|Overall Study|Loss of Caregiver|3|||
131468695|NCT00998764|473348454|FG000|Overall Study|Other|4|||
131468696|NCT00998764|473348455|FG001|Overall Study|Other|4|||
131468697|NCT00998764|473348454|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
131769589|NCT01920061|474434064|FG012|Overall Study|Lost to Follow-up|0|||
131769590|NCT01920061|474434065|FG013|Overall Study|Lost to Follow-up|0|||
131769591|NCT01920061|474434066|FG014|Overall Study|Lost to Follow-up|0|||
131769592|NCT01920061|474434067|FG015|Overall Study|Lost to Follow-up|0|||
131769593|NCT01920061|474434068|FG016|Overall Study|Lost to Follow-up|0|||
131769594|NCT01920061|474434069|FG017|Overall Study|Lost to Follow-up|1|||
131769595|NCT01920061|474434070|FG018|Overall Study|Lost to Follow-up|4|||
131769596|NCT01920061|474434071|FG019|Overall Study|Lost to Follow-up|3|||
131468698|NCT00998764|473348455|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
131468699|NCT01214174|473348458|FG000|Overall Study|Withdrawal by Subject|0|||
131468700|NCT01214174|473348459|FG001|Overall Study|Withdrawal by Subject|0|||
131468701|NCT01214174|473348460|FG002|Overall Study|Withdrawal by Subject|1|||
131468702|NCT00290407|473348461|FG000|Overall Study|Physician Decision|2|||
131468703|NCT01933789|473348470|FG000|Overall Study|Death|0|||
131468704|NCT01933789|473348471|FG001|Overall Study|Death|0|||
131468705|NCT01933789|473348472|FG002|Overall Study|Death|0|||
131468706|NCT01933789|473348473|FG003|Overall Study|Death|0|||
131468707|NCT01933789|473348474|FG004|Overall Study|Death|21|||
131468708|NCT01933789|473348475|FG005|Overall Study|Death|32|||
131468709|NCT01933789|473348476|FG006|Overall Study|Death|0|||
131468710|NCT01933789|473348477|FG007|Overall Study|Death|0|||
131468711|NCT01933789|473348478|FG008|Overall Study|Death|0|||
131468712|NCT01933789|473348470|FG000|Overall Study|Lost to Follow-up|0|||
131468713|NCT01933789|473348471|FG001|Overall Study|Lost to Follow-up|0|||
131769597|NCT01920061|474434052|FG000|Overall Study|Other|1|||
131769598|NCT01920061|474434053|FG001|Overall Study|Other|1|||
131769599|NCT01920061|474434054|FG002|Overall Study|Other|2|||
131769600|NCT01920061|474434055|FG003|Overall Study|Other|1|||
131468714|NCT01933789|473348472|FG002|Overall Study|Lost to Follow-up|0|||
131468715|NCT01933789|473348473|FG003|Overall Study|Lost to Follow-up|1|||
131769601|NCT01920061|474434056|FG004|Overall Study|Other|0|||
131769602|NCT01920061|474434057|FG005|Overall Study|Other|1|||
131769603|NCT01920061|474434058|FG006|Overall Study|Other|0|||
131769604|NCT01920061|474434059|FG007|Overall Study|Other|0|||
131769605|NCT01920061|474434060|FG008|Overall Study|Other|0|||
131769606|NCT01920061|474434061|FG009|Overall Study|Other|1|||
131468716|NCT01933789|473348474|FG004|Overall Study|Lost to Follow-up|8|||
131468717|NCT01933789|473348475|FG005|Overall Study|Lost to Follow-up|9|||
131468718|NCT01933789|473348476|FG006|Overall Study|Lost to Follow-up|1|||
131468719|NCT01933789|473348477|FG007|Overall Study|Lost to Follow-up|4|||
131468720|NCT01933789|473348478|FG008|Overall Study|Lost to Follow-up|0|||
131468721|NCT01933789|473348470|FG000|Overall Study|Withdrawal by Subject|2|||
131468722|NCT01933789|473348471|FG001|Overall Study|Withdrawal by Subject|1|||
131468723|NCT01933789|473348472|FG002|Overall Study|Withdrawal by Subject|0|||
131468724|NCT01933789|473348473|FG003|Overall Study|Withdrawal by Subject|0|||
131769607|NCT01920061|474434062|FG010|Overall Study|Other|1|||
131769608|NCT01920061|474434063|FG011|Overall Study|Other|2|||
131769609|NCT01920061|474434064|FG012|Overall Study|Other|1|||
131769610|NCT01920061|474434065|FG013|Overall Study|Other|4|||
131769611|NCT01920061|474434066|FG014|Overall Study|Other|0|||
131769612|NCT01920061|474434067|FG015|Overall Study|Other|1|||
131769613|NCT01920061|474434068|FG016|Overall Study|Other|1|||
131769614|NCT01920061|474434069|FG017|Overall Study|Other|0|||
131769615|NCT01920061|474434070|FG018|Overall Study|Other|1|||
131769616|NCT01920061|474434071|FG019|Overall Study|Other|1|||
131769617|NCT01920061|474434052|FG000|Overall Study|Participant refused further follow-up|0|||
131769618|NCT01920061|474434053|FG001|Overall Study|Participant refused further follow-up|0|||
131769619|NCT01920061|474434054|FG002|Overall Study|Participant refused further follow-up|0|||
131769620|NCT01920061|474434055|FG003|Overall Study|Participant refused further follow-up|0|||
131769621|NCT01920061|474434056|FG004|Overall Study|Participant refused further follow-up|1|||
131769622|NCT01920061|474434057|FG005|Overall Study|Participant refused further follow-up|1|||
131769623|NCT01920061|474434058|FG006|Overall Study|Participant refused further follow-up|0|||
131769624|NCT01920061|474434059|FG007|Overall Study|Participant refused further follow-up|0|||
131769625|NCT01920061|474434060|FG008|Overall Study|Participant refused further follow-up|1|||
131769626|NCT01920061|474434061|FG009|Overall Study|Participant refused further follow-up|0|||
131769627|NCT01920061|474434062|FG010|Overall Study|Participant refused further follow-up|1|||
131769628|NCT01920061|474434063|FG011|Overall Study|Participant refused further follow-up|0|||
131769629|NCT01920061|474434064|FG012|Overall Study|Participant refused further follow-up|1|||
131769630|NCT01920061|474434065|FG013|Overall Study|Participant refused further follow-up|0|||
131769631|NCT01920061|474434066|FG014|Overall Study|Participant refused further follow-up|1|||
131769632|NCT01920061|474434067|FG015|Overall Study|Participant refused further follow-up|2|||
131769633|NCT01920061|474434068|FG016|Overall Study|Participant refused further follow-up|1|||
131769634|NCT01920061|474434069|FG017|Overall Study|Participant refused further follow-up|1|||
131769635|NCT01920061|474434070|FG018|Overall Study|Participant refused further follow-up|0|||
131769636|NCT01920061|474434071|FG019|Overall Study|Participant refused further follow-up|0|||
131769637|NCT00554229|474434072|FG000|Overall Study|Lost to Follow-up|3|||
131769638|NCT00554229|474434073|FG001|Overall Study|Lost to Follow-up|6|||
131769639|NCT00554229|474434072|FG000|Overall Study|Withdrawal by Subject|29|||
131769640|NCT00554229|474434073|FG001|Overall Study|Withdrawal by Subject|37|||
131769641|NCT00554229|474434072|FG000|Overall Study|Adverse Event|71|||
131769642|NCT00554229|474434073|FG001|Overall Study|Adverse Event|39|||
131769643|NCT00554229|474434072|FG000|Overall Study|Protocol Violation|3|||
131769644|NCT00554229|474434073|FG001|Overall Study|Protocol Violation|3|||
131769645|NCT00554229|474434072|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
131769646|NCT00554229|474434073|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
131769647|NCT00554229|474434072|FG000|Overall Study|Randomised but no treatment received|1|||
131769648|NCT00554229|474434073|FG001|Overall Study|Randomised but no treatment received|0|||
131769649|NCT01140646|474434074|FG000|Overall Study|Adverse Event|4|||
131769650|NCT01140646|474434074|FG000|Overall Study|Refused Further Treatment|5|||
131769651|NCT00842829|474434080|FG000|Dose Titration Period|Adverse Event|11|||
131769652|NCT00842829|474434081|FG001|Dose Titration Period|Adverse Event|10|||
131769653|NCT00842829|474434082|FG002|Dose Titration Period|Adverse Event|0|||
131769654|NCT00842829|474434080|FG000|Dose Titration Period|Lack of Efficacy|4|||
131769655|NCT00842829|474434081|FG001|Dose Titration Period|Lack of Efficacy|1|||
131769656|NCT00842829|474434082|FG002|Dose Titration Period|Lack of Efficacy|0|||
131769657|NCT00842829|474434080|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
131769658|NCT00842829|474434081|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
131769659|NCT00842829|474434082|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
131769660|NCT00842829|474434080|FG000|Dose Titration Period|Withdrawal by Subject|2|||
131769661|NCT00842829|474434081|FG001|Dose Titration Period|Withdrawal by Subject|6|||
131769662|NCT00842829|474434082|FG002|Dose Titration Period|Withdrawal by Subject|0|||
131769663|NCT00842829|474434080|FG000|Dose Titration Period|Other|5|||
131769664|NCT00842829|474434081|FG001|Dose Titration Period|Other|4|||
131769665|NCT00842829|474434082|FG002|Dose Titration Period|Other|0|||
131769666|NCT00842829|474434080|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
131769667|NCT00842829|474434081|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
131769668|NCT00842829|474434082|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
131769669|NCT00842829|474434080|FG000|Dose Titration Period|Non-compliance to study drug|2|||
131769670|NCT00842829|474434081|FG001|Dose Titration Period|Non-compliance to study drug|1|||
131769671|NCT00842829|474434082|FG002|Dose Titration Period|Non-compliance to study drug|0|||
131769672|NCT00842829|474434080|FG000|Treatment Period|Adverse Event|0|||
131769673|NCT00842829|474434081|FG001|Treatment Period|Adverse Event|0|||
131769674|NCT00842829|474434082|FG002|Treatment Period|Adverse Event|15|||
131769675|NCT00842829|474434080|FG000|Treatment Period|Lack of Efficacy|0|||
131769676|NCT00842829|474434081|FG001|Treatment Period|Lack of Efficacy|0|||
131769677|NCT00842829|474434082|FG002|Treatment Period|Lack of Efficacy|6|||
131769678|NCT00842829|474434080|FG000|Treatment Period|Unstable persistent cancer pain|0|||
131769679|NCT00842829|474434081|FG001|Treatment Period|Unstable persistent cancer pain|0|||
131769680|NCT00842829|474434082|FG002|Treatment Period|Unstable persistent cancer pain|5|||
131769681|NCT00842829|474434080|FG000|Treatment Period|Withdrawal by Subject|0|||
131769682|NCT00842829|474434081|FG001|Treatment Period|Withdrawal by Subject|0|||
131769683|NCT00842829|474434082|FG002|Treatment Period|Withdrawal by Subject|11|||
131769684|NCT00842829|474434080|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
131769685|NCT00842829|474434081|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
131769686|NCT00842829|474434082|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
131769687|NCT00842829|474434080|FG000|Treatment Period|Protocol Violation|0|||
131769688|NCT00842829|474434081|FG001|Treatment Period|Protocol Violation|0|||
131769689|NCT00842829|474434082|FG002|Treatment Period|Protocol Violation|2|||
131769690|NCT00842829|474434080|FG000|Treatment Period|Other|0|||
131769691|NCT00842829|474434081|FG001|Treatment Period|Other|0|||
131769692|NCT00842829|474434082|FG002|Treatment Period|Other|18|||
131769693|NCT00842829|474434080|FG000|Treatment Period|Non-compliance to study procedures|0|||
131769694|NCT00842829|474434081|FG001|Treatment Period|Non-compliance to study procedures|0|||
131769695|NCT00842829|474434082|FG002|Treatment Period|Non-compliance to study procedures|4|||
131769696|NCT00842829|474434080|FG000|Treatment Period|Unclear completion status|0|||
131769697|NCT00842829|474434081|FG001|Treatment Period|Unclear completion status|0|||
131769698|NCT00842829|474434082|FG002|Treatment Period|Unclear completion status|1|||
131769699|NCT00842829|474434080|FG000|Continuation Period|Adverse Event|0|||
131468725|NCT01933789|473348474|FG004|Overall Study|Withdrawal by Subject|17|||
131468726|NCT01933789|473348475|FG005|Overall Study|Withdrawal by Subject|16|||
131769700|NCT00842829|474434081|FG001|Continuation Period|Adverse Event|0|||
131769701|NCT00842829|474434082|FG002|Continuation Period|Adverse Event|32|||
131769702|NCT00842829|474434080|FG000|Continuation Period|Lack of Efficacy|0|||
131769703|NCT00842829|474434081|FG001|Continuation Period|Lack of Efficacy|0|||
131769704|NCT00842829|474434082|FG002|Continuation Period|Lack of Efficacy|6|||
131769705|NCT00842829|474434080|FG000|Continuation Period|Unstable persistent cancer pain|0|||
131769706|NCT00842829|474434081|FG001|Continuation Period|Unstable persistent cancer pain|0|||
131769707|NCT00842829|474434082|FG002|Continuation Period|Unstable persistent cancer pain|3|||
131769708|NCT00842829|474434080|FG000|Continuation Period|Withdrawal by Subject|0|||
131769709|NCT00842829|474434081|FG001|Continuation Period|Withdrawal by Subject|0|||
131769710|NCT00842829|474434082|FG002|Continuation Period|Withdrawal by Subject|10|||
131769711|NCT00842829|474434080|FG000|Continuation Period|Other|0|||
131769712|NCT00842829|474434081|FG001|Continuation Period|Other|0|||
131769713|NCT00842829|474434082|FG002|Continuation Period|Other|7|||
131769714|NCT00842829|474434080|FG000|Continuation Period|Non-compliance to study procedures|0|||
131769715|NCT00842829|474434081|FG001|Continuation Period|Non-compliance to study procedures|0|||
131769716|NCT00842829|474434082|FG002|Continuation Period|Non-compliance to study procedures|2|||
131769717|NCT00842829|474434080|FG000|Continuation Period|Non-compliance to study drug|0|||
131769718|NCT00842829|474434081|FG001|Continuation Period|Non-compliance to study drug|0|||
131769719|NCT00842829|474434082|FG002|Continuation Period|Non-compliance to study drug|1|||
131769720|NCT00784836|474434085|FG000|Overall Study|Early Study Termination|3|||
131769721|NCT00660829|474434086|FG000|Overall Study|Adverse Event|3|||
131769722|NCT00660829|474434087|FG001|Overall Study|Adverse Event|4|||
131769723|NCT00660829|474434086|FG000|Overall Study|Lack of Efficacy|2|||
131769724|NCT00660829|474434087|FG001|Overall Study|Lack of Efficacy|3|||
131769725|NCT00660829|474434086|FG000|Overall Study|Non-Compliance|0|||
131769726|NCT00660829|474434087|FG001|Overall Study|Non-Compliance|4|||
131769727|NCT00660829|474434086|FG000|Overall Study|Withdrawal by Subject|1|||
131769728|NCT00660829|474434087|FG001|Overall Study|Withdrawal by Subject|2|||
131769729|NCT00660829|474434086|FG000|Overall Study|Lost to Follow-up|3|||
131769730|NCT00660829|474434087|FG001|Overall Study|Lost to Follow-up|2|||
131769731|NCT00660829|474434086|FG000|Overall Study|Other|9|||
131769732|NCT00660829|474434087|FG001|Overall Study|Other|4|||
131769733|NCT02127931|474434088|FG000|Overall Study|Glitch in Game|1|||
131769734|NCT02926833|474435991|FG000|Overall Study|Death|1|||
131769735|NCT02926833|474435992|FG001|Overall Study|Death|1|||
131769736|NCT02926833|474435993|FG002|Overall Study|Death|2|||
131769737|NCT02926833|474435994|FG003|Overall Study|Death|13|||
131769738|NCT02926833|474435991|FG000|Overall Study|Lost to Follow-up|1|||
131468727|NCT01933789|473348476|FG006|Overall Study|Withdrawal by Subject|1|||
131769739|NCT02926833|474435992|FG001|Overall Study|Lost to Follow-up|2|||
131468728|NCT01933789|473348477|FG007|Overall Study|Withdrawal by Subject|4|||
131468729|NCT01933789|473348478|FG008|Overall Study|Withdrawal by Subject|0|||
131468730|NCT01933789|473348470|FG000|Overall Study|Became Ineligible|4|||
131769740|NCT02926833|474435993|FG002|Overall Study|Lost to Follow-up|0|||
131468731|NCT01933789|473348471|FG001|Overall Study|Became Ineligible|0|||
131468732|NCT01933789|473348472|FG002|Overall Study|Became Ineligible|0|||
131468733|NCT01933789|473348473|FG003|Overall Study|Became Ineligible|0|||
131468734|NCT01933789|473348474|FG004|Overall Study|Became Ineligible|13|||
131769741|NCT02926833|474435994|FG003|Overall Study|Lost to Follow-up|3|||
131769742|NCT02926833|474435991|FG000|Overall Study|Full Consent Withdrawal|0|||
131769743|NCT02926833|474435992|FG001|Overall Study|Full Consent Withdrawal|0|||
131468735|NCT01933789|473348475|FG005|Overall Study|Became Ineligible|10|||
131468736|NCT01933789|473348476|FG006|Overall Study|Became Ineligible|13|||
131468737|NCT01933789|473348477|FG007|Overall Study|Became Ineligible|6|||
131769744|NCT02926833|474435993|FG002|Overall Study|Full Consent Withdrawal|0|||
131769745|NCT02926833|474435994|FG003|Overall Study|Full Consent Withdrawal|2|||
131769746|NCT02926833|474435991|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
131769747|NCT02926833|474435992|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
131769748|NCT02926833|474435993|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
131769749|NCT02926833|474435994|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
131769750|NCT02926833|474435991|FG000|Overall Study|Investigator Decision|0|||
131769751|NCT02926833|474435992|FG001|Overall Study|Investigator Decision|1|||
131769752|NCT02926833|474435993|FG002|Overall Study|Investigator Decision|0|||
131769753|NCT02926833|474435994|FG003|Overall Study|Investigator Decision|0|||
131769754|NCT02926833|474435991|FG000|Overall Study|Adverse Event|0|||
131769755|NCT02926833|474435992|FG001|Overall Study|Adverse Event|0|||
131769756|NCT02926833|474435993|FG002|Overall Study|Adverse Event|1|||
131769757|NCT02926833|474435994|FG003|Overall Study|Adverse Event|0|||
131769758|NCT02926833|474435991|FG000|Overall Study|Partial Withdrawal of Consent|0|||
131769759|NCT02926833|474435992|FG001|Overall Study|Partial Withdrawal of Consent|0|||
131769760|NCT02926833|474435993|FG002|Overall Study|Partial Withdrawal of Consent|0|||
131769761|NCT02926833|474435994|FG003|Overall Study|Partial Withdrawal of Consent|1|||
131769762|NCT01189201|474436001|FG000|Overall Study|Adverse Event|1|||
131769763|NCT01277757|474436002|FG000|Overall Study|Disease Progression|1|||
131769764|NCT01277757|474436002|FG000|Overall Study|Withdrawal by Subject|1|||
131769765|NCT00911508|474436003|FG000|Overall Study|Lost to Follow-up|27|||
131769766|NCT00911508|474436004|FG001|Overall Study|Lost to Follow-up|18|||
131769767|NCT00911508|474436003|FG000|Overall Study|Withdrawal by Subject|79|||
131769768|NCT00911508|474436004|FG001|Overall Study|Withdrawal by Subject|112|||
131769769|NCT01409382|474436005|FG000|Overall Study|Lost to Follow-up|1|||
131769770|NCT01409382|474436006|FG001|Overall Study|Lost to Follow-up|1|||
131769771|NCT01409382|474436005|FG000|Overall Study|Protocol Violation|0|||
131769772|NCT01409382|474436006|FG001|Overall Study|Protocol Violation|3|||
131769773|NCT01409382|474436005|FG000|Overall Study|Multiple pregnancy|2|||
131769774|NCT01409382|474436006|FG001|Overall Study|Multiple pregnancy|4|||
131769775|NCT01409382|474436005|FG000|Overall Study|Still pregnant when study ended|13|||
131769776|NCT01409382|474436006|FG001|Overall Study|Still pregnant when study ended|2|||
131769777|NCT01409382|474436005|FG000|Overall Study|Did not manage to get pregnant|64|||
131769778|NCT01409382|474436006|FG001|Overall Study|Did not manage to get pregnant|70|||
131769779|NCT01409382|474436005|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
131769780|NCT01409382|474436006|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
131769781|NCT04308668|474436007|FG000|Overall Study|Lost to Follow-up|32|||
131769782|NCT04308668|474436008|FG001|Overall Study|Lost to Follow-up|38|||
131769783|NCT04308668|474436007|FG000|Overall Study|Withdrawal by Subject|4|||
131769784|NCT04308668|474436008|FG001|Overall Study|Withdrawal by Subject|4|||
131769785|NCT01336647|474436009|FG000|Overall Study|Lost to Follow-up|4|||
131769786|NCT01336647|474436010|FG001|Overall Study|Lost to Follow-up|1|||
131769787|NCT01336647|474436011|FG002|Overall Study|Lost to Follow-up|3|||
131769788|NCT03808298|474436012|FG000|Overall Study|Adverse Event|3|||
131769789|NCT03808298|474436012|FG000|Overall Study|Physician Decision|1|||
131769790|NCT03808298|474436012|FG000|Overall Study|Withdrawal by Subject|1|||
131769791|NCT03808298|474436012|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
131769792|NCT01004822|474436013|FG000|Overall Study|Objective progression or relapse|3|||
131769793|NCT01004822|474436014|FG001|Overall Study|Objective progression or relapse|3|||
131769794|NCT01004822|474436015|FG002|Overall Study|Objective progression or relapse|0|||
131769795|NCT01004822|474436016|FG003|Overall Study|Objective progression or relapse|1|||
131769796|NCT01004822|474436017|FG004|Overall Study|Objective progression or relapse|2|||
131769797|NCT01004822|474436018|FG005|Overall Study|Objective progression or relapse|2|||
131769798|NCT01004822|474436019|FG006|Overall Study|Objective progression or relapse|1|||
131769799|NCT01004822|474436020|FG007|Overall Study|Objective progression or relapse|4|||
131769800|NCT01004822|474436013|FG000|Overall Study|Global deterioration of health status|0|||
131769801|NCT01004822|474436014|FG001|Overall Study|Global deterioration of health status|0|||
131769802|NCT01004822|474436015|FG002|Overall Study|Global deterioration of health status|0|||
131769803|NCT01004822|474436016|FG003|Overall Study|Global deterioration of health status|1|||
131769804|NCT01004822|474436017|FG004|Overall Study|Global deterioration of health status|0|||
131769805|NCT01004822|474436018|FG005|Overall Study|Global deterioration of health status|0|||
131769806|NCT01004822|474436019|FG006|Overall Study|Global deterioration of health status|1|||
131769807|NCT01004822|474436020|FG007|Overall Study|Global deterioration of health status|0|||
131769808|NCT01004822|474436013|FG000|Overall Study|No longer willing to continue|0|||
131769809|NCT01004822|474436014|FG001|Overall Study|No longer willing to continue|0|||
131769810|NCT01004822|474436015|FG002|Overall Study|No longer willing to continue|0|||
131769811|NCT01004822|474436016|FG003|Overall Study|No longer willing to continue|1|||
131769812|NCT01004822|474436017|FG004|Overall Study|No longer willing to continue|2|||
131769813|NCT01004822|474436018|FG005|Overall Study|No longer willing to continue|1|||
131769814|NCT01004822|474436019|FG006|Overall Study|No longer willing to continue|1|||
131769815|NCT01004822|474436020|FG007|Overall Study|No longer willing to continue|0|||
131769816|NCT01004822|474436013|FG000|Overall Study|Adverse Event|0|||
131769817|NCT01004822|474436014|FG001|Overall Study|Adverse Event|0|||
131769818|NCT01004822|474436015|FG002|Overall Study|Adverse Event|0|||
131769819|NCT01004822|474436016|FG003|Overall Study|Adverse Event|0|||
131769820|NCT01004822|474436017|FG004|Overall Study|Adverse Event|0|||
131769821|NCT01004822|474436018|FG005|Overall Study|Adverse Event|0|||
131769822|NCT01004822|474436019|FG006|Overall Study|Adverse Event|1|||
131769823|NCT01004822|474436020|FG007|Overall Study|Adverse Event|1|||
131769824|NCT01004822|474436013|FG000|Overall Study|Other|0|||
131769825|NCT01004822|474436014|FG001|Overall Study|Other|0|||
131769826|NCT01004822|474436015|FG002|Overall Study|Other|4|||
131769827|NCT01004822|474436016|FG003|Overall Study|Other|1|||
131769828|NCT01004822|474436017|FG004|Overall Study|Other|0|||
131769829|NCT01004822|474436018|FG005|Overall Study|Other|1|||
131769830|NCT01004822|474436019|FG006|Overall Study|Other|0|||
131769831|NCT01004822|474436020|FG007|Overall Study|Other|0|||
131769832|NCT01858701|474436021|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
131769833|NCT01858701|474436022|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
131769834|NCT01858701|474436021|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
131769835|NCT01858701|474436022|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
131769836|NCT01858701|474436021|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
131769837|NCT01858701|474436022|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
131769838|NCT01858701|474436021|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
131769839|NCT01858701|474436022|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
131769840|NCT01801475|474436023|FG000|Overall Study|Withdrawal by Subject|0|||
131769841|NCT01801475|474436024|FG001|Overall Study|Withdrawal by Subject|0|||
131769842|NCT01801475|474436025|FG002|Overall Study|Withdrawal by Subject|0|||
131769843|NCT01801475|474436026|FG003|Overall Study|Withdrawal by Subject|0|||
131769844|NCT01801475|474436027|FG004|Overall Study|Withdrawal by Subject|1|||
131769845|NCT00421928|474436028|FG000|Overall Study|Adverse Event|61|||
131769846|NCT00421928|474436029|FG001|Overall Study|Adverse Event|140|||
131769847|NCT00421928|474436030|FG002|Overall Study|Adverse Event|22|||
131769848|NCT00421928|474436028|FG000|Overall Study|Lost to Follow-up|5|||
131769849|NCT00421928|474436029|FG001|Overall Study|Lost to Follow-up|0|||
131769850|NCT00421928|474436030|FG002|Overall Study|Lost to Follow-up|3|||
131769851|NCT00421928|474436028|FG000|Overall Study|Withdrawal by Subject|50|||
131769852|NCT00421928|474436029|FG001|Overall Study|Withdrawal by Subject|48|||
131769853|NCT00421928|474436030|FG002|Overall Study|Withdrawal by Subject|43|||
131769854|NCT00421928|474436028|FG000|Overall Study|Lack of Efficacy|15|||
131769855|NCT00421928|474436029|FG001|Overall Study|Lack of Efficacy|7|||
131769856|NCT00421928|474436030|FG002|Overall Study|Lack of Efficacy|35|||
131769857|NCT00421928|474436028|FG000|Overall Study|Study drug non-compliant|6|||
131769858|NCT00421928|474436029|FG001|Overall Study|Study drug non-compliant|7|||
131769859|NCT00421928|474436030|FG002|Overall Study|Study drug non-compliant|4|||
131769860|NCT00421928|474436028|FG000|Overall Study|All other|26|||
131769861|NCT00421928|474436029|FG001|Overall Study|All other|21|||
131769862|NCT00421928|474436030|FG002|Overall Study|All other|27|||
131769863|NCT00421928|474436028|FG000|Overall Study|Death|0|||
131769864|NCT00421928|474436029|FG001|Overall Study|Death|1|||
131769865|NCT00421928|474436030|FG002|Overall Study|Death|0|||
131769866|NCT01789476|474436049|FG000|Overall Study|Lack of Efficacy|6|||
131769867|NCT01789476|474436050|FG001|Overall Study|Lack of Efficacy|2|||
131769868|NCT01789476|474436049|FG000|Overall Study|Adverse Event|1|||
131769869|NCT01789476|474436050|FG001|Overall Study|Adverse Event|0|||
131769870|NCT01789476|474436049|FG000|Overall Study|Unable to get IV access|1|||
131769871|NCT01789476|474436050|FG001|Overall Study|Unable to get IV access|0|||
131769872|NCT00965458|474436051|FG000|Overall Study|Adverse Event|1|||
131769873|NCT00965458|474436052|FG001|Overall Study|Adverse Event|0|||
131468738|NCT01933789|473348478|FG008|Overall Study|Became Ineligible|0|||
131468739|NCT01117792|473348484|FG000|Overall Study|Death|1|||
131468740|NCT01117792|473348484|FG000|Overall Study|Adverse Event|3|||
131468741|NCT00274924|473348487|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
131468742|NCT00274924|473348488|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
131468743|NCT00274924|473348489|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
131468744|NCT00274924|473348487|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
131468745|NCT00274924|473348488|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
131468746|NCT00274924|473348489|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
131468747|NCT00274924|473348487|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
131468748|NCT00274924|473348488|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
131468749|NCT00274924|473348489|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
131468750|NCT00274924|473348487|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
131468751|NCT00274924|473348488|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
131468752|NCT00274924|473348489|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
131468753|NCT00274924|473348487|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
131468754|NCT00274924|473348488|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
131468755|NCT00274924|473348489|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
131769874|NCT00965458|474436051|FG000|Overall Study|Lost to Follow-up|1|||
131769875|NCT00965458|474436052|FG001|Overall Study|Lost to Follow-up|3|||
131769876|NCT00965458|474436051|FG000|Overall Study|Withdrawal by Subject|0|||
131769877|NCT00965458|474436052|FG001|Overall Study|Withdrawal by Subject|1|||
131769878|NCT00594958|474436054|FG000|Overall Study|Withdrawal by Subject|1|||
131769879|NCT00594958|474436055|FG001|Overall Study|Withdrawal by Subject|0|||
131769880|NCT00594958|474436056|FG002|Overall Study|Withdrawal by Subject|1|||
131769881|NCT00594958|474436054|FG000|Overall Study|Adverse Event|4|||
131769882|NCT00594958|474436055|FG001|Overall Study|Adverse Event|1|||
131769883|NCT00594958|474436056|FG002|Overall Study|Adverse Event|2|||
131769884|NCT00594958|474436054|FG000|Overall Study|Pregnancy|0|||
131468756|NCT00274924|473348487|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
131468757|NCT00274924|473348488|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
131468758|NCT00274924|473348489|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
131468759|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
131468760|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
131468761|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
131468762|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
131468763|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
131468764|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
131468765|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
131468766|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
131468767|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
131468768|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
131468769|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
131468770|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
131468771|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
131468772|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
131468773|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
131468774|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
131468775|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
131468776|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
131468777|NCT00274924|473348487|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
131468778|NCT00274924|473348488|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
131468779|NCT00274924|473348489|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
131468780|NCT00740051|473348490|FG000|Overall Study|Lack of Efficacy|2|||
131468781|NCT00740051|473348491|FG001|Overall Study|Lack of Efficacy|5|||
131468782|NCT00740051|473348490|FG000|Overall Study|Adverse Event|1|||
131468783|NCT00740051|473348491|FG001|Overall Study|Adverse Event|4|||
131468784|NCT00740051|473348490|FG000|Overall Study|Protocol Violation|2|||
131468785|NCT00740051|473348491|FG001|Overall Study|Protocol Violation|6|||
131468786|NCT00740051|473348490|FG000|Overall Study|Lost to Follow-up|3|||
131468787|NCT00740051|473348491|FG001|Overall Study|Lost to Follow-up|8|||
131468788|NCT00740051|473348490|FG000|Overall Study|Withdrawal by Subject|6|||
131468789|NCT00740051|473348491|FG001|Overall Study|Withdrawal by Subject|8|||
131468790|NCT00740051|473348490|FG000|Overall Study|Other reason (not specified)|4|||
131468791|NCT00740051|473348491|FG001|Overall Study|Other reason (not specified)|1|||
131468792|NCT01055496|473348493|FG000|Overall Study|Withdrawal by Subject|2|||
131468793|NCT01055496|473348494|FG001|Overall Study|Withdrawal by Subject|4|||
131468794|NCT01055496|473348493|FG000|Overall Study|Death|13|||
131468795|NCT01055496|473348494|FG001|Overall Study|Death|23|||
131468796|NCT01055496|473348493|FG000|Overall Study|Lost to Follow-up|0|||
131468797|NCT01055496|473348494|FG001|Overall Study|Lost to Follow-up|2|||
131468798|NCT01055496|473348493|FG000|Overall Study|Other - Unspecified|0|||
131468799|NCT01055496|473348494|FG001|Overall Study|Other - Unspecified|1|||
131468800|NCT01966432|473348495|FG000|Overall Study|Lost to Follow-up|3|||
131468801|NCT01966432|473348496|FG001|Overall Study|Lost to Follow-up|2|||
131468802|NCT01966432|473348497|FG002|Overall Study|Lost to Follow-up|5|||
131468803|NCT01966432|473348495|FG000|Overall Study|Withdrawal by Subject|1|||
131468804|NCT01966432|473348496|FG001|Overall Study|Withdrawal by Subject|3|||
131468805|NCT01966432|473348497|FG002|Overall Study|Withdrawal by Subject|0|||
131468806|NCT01966432|473348495|FG000|Overall Study|Subject Incarcerated|0|||
131468807|NCT01966432|473348496|FG001|Overall Study|Subject Incarcerated|0|||
131468808|NCT01966432|473348497|FG002|Overall Study|Subject Incarcerated|1|||
131468809|NCT01966432|473348495|FG000|Overall Study|SBIRT program ended|1|||
131468810|NCT01966432|473348496|FG001|Overall Study|SBIRT program ended|8|||
131468811|NCT01966432|473348497|FG002|Overall Study|SBIRT program ended|20|||
131468812|NCT00584740|473348500|FG000|Overall Study|Adverse Event|1|||
131468813|NCT00584740|473348501|FG001|Overall Study|Adverse Event|1|||
131468814|NCT00584740|473348500|FG000|Overall Study|Lack of Efficacy|8|||
131468815|NCT00584740|473348501|FG001|Overall Study|Lack of Efficacy|2|||
131468816|NCT00584740|473348500|FG000|Overall Study|Withdrawal by Subject|3|||
131468817|NCT00584740|473348501|FG001|Overall Study|Withdrawal by Subject|2|||
131468818|NCT00584740|473348500|FG000|Overall Study|Lost to Follow-up|0|||
131468819|NCT00584740|473348501|FG001|Overall Study|Lost to Follow-up|1|||
131468820|NCT01903525|473348502|FG000|Overall Study|Lost to Follow-up|5|||
131468821|NCT01903525|473348503|FG001|Overall Study|Lost to Follow-up|9|||
131468822|NCT01903525|473348502|FG000|Overall Study|Adverse Event|0|||
131468823|NCT01903525|473348503|FG001|Overall Study|Adverse Event|1|||
131468824|NCT00930982|473348505|FG000|Overall Study|Adverse Event|19|||
131769885|NCT00594958|474436055|FG001|Overall Study|Pregnancy|2|||
131769886|NCT00594958|474436056|FG002|Overall Study|Pregnancy|0|||
131468825|NCT00930982|473348506|FG001|Overall Study|Adverse Event|23|||
131468826|NCT00930982|473348505|FG000|Overall Study|Protocol Violation|1|||
131769887|NCT00594958|474436054|FG000|Overall Study|Protocol Violation|1|||
131468827|NCT00930982|473348506|FG001|Overall Study|Protocol Violation|5|||
131468828|NCT00930982|473348505|FG000|Overall Study|Withdrawal by Subject|1|||
131468829|NCT00930982|473348506|FG001|Overall Study|Withdrawal by Subject|1|||
131769888|NCT00594958|474436055|FG001|Overall Study|Protocol Violation|0|||
131769889|NCT00594958|474436056|FG002|Overall Study|Protocol Violation|2|||
131769890|NCT00594958|474436054|FG000|Overall Study|Lost to Follow-up|5|||
131769891|NCT00594958|474436055|FG001|Overall Study|Lost to Follow-up|0|||
131769892|NCT00594958|474436056|FG002|Overall Study|Lost to Follow-up|3|||
131769893|NCT00594958|474436054|FG000|Overall Study|administrative|3|||
131769894|NCT00594958|474436055|FG001|Overall Study|administrative|0|||
131769895|NCT00594958|474436056|FG002|Overall Study|administrative|2|||
131769896|NCT04516291|474436057|FG000|Treatment Period (24 Weeks)|Other|1|||
131769897|NCT04516291|474436058|FG001|Treatment Period (24 Weeks)|Other|0|||
131769898|NCT04516291|474436059|FG002|Treatment Period (24 Weeks)|Other|0|||
131769899|NCT04516291|474436060|FG003|Treatment Period (24 Weeks)|Other|2|||
131769900|NCT04516291|474436061|FG004|Treatment Period (24 Weeks)|Other|2|||
131769901|NCT04516291|474436062|FG005|Treatment Period (24 Weeks)|Other|4|||
131769902|NCT04516291|474436063|FG006|Treatment Period (24 Weeks)|Other|2|||
131769903|NCT04516291|474436064|FG007|Treatment Period (24 Weeks)|Other|0|||
131769904|NCT04516291|474436057|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131769905|NCT04516291|474436058|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131769906|NCT04516291|474436059|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131769907|NCT04516291|474436060|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131769908|NCT04516291|474436061|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131769909|NCT04516291|474436062|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131769910|NCT04516291|474436063|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131769911|NCT04516291|474436064|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131769912|NCT04516291|474436057|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769913|NCT04516291|474436058|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769914|NCT04516291|474436059|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769915|NCT04516291|474436060|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
131769916|NCT04516291|474436061|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769917|NCT04516291|474436062|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769918|NCT04516291|474436063|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769919|NCT04516291|474436064|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
131769920|NCT04516291|474436057|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131769921|NCT04516291|474436058|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131769922|NCT04516291|474436059|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131769923|NCT04516291|474436060|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131769924|NCT04516291|474436061|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131769925|NCT04516291|474436062|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131468830|NCT01673282|473348511|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
131468831|NCT01673282|473348512|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
131468832|NCT01673282|473348511|FG000|Overall Study|Lack of Efficacy|9|||
131468833|NCT01673282|473348512|FG001|Overall Study|Lack of Efficacy|2|||
131468834|NCT01673282|473348511|FG000|Overall Study|Lost to Follow-up|11|||
131468835|NCT01673282|473348512|FG001|Overall Study|Lost to Follow-up|10|||
131468836|NCT01673282|473348511|FG000|Overall Study|Withdrawal by Subject|3|||
131468837|NCT01673282|473348512|FG001|Overall Study|Withdrawal by Subject|3|||
131468838|NCT01673282|473348511|FG000|Overall Study|Other|1|||
131468839|NCT01673282|473348512|FG001|Overall Study|Other|6|||
131468840|NCT01323920|473348515|FG000|Overall Study|Death|5|||
131468841|NCT01323920|473348515|FG000|Overall Study|Withdrawal by Subject|1|||
131468842|NCT03915860|473348516|FG000|Overall Study|Adverse Event|3|||
131468843|NCT03915860|473348516|FG000|Overall Study|Withdrawal by Subject|6|||
131468844|NCT03915860|473348516|FG000|Overall Study|Lost to Follow-up|2|||
131468845|NCT03915860|473348516|FG000|Overall Study|Other than specified|3|||
131468846|NCT02195011|473348517|FG000|Overall Study|Adverse Event|4|||
131468847|NCT02195011|473348518|FG001|Overall Study|Adverse Event|0|||
131468848|NCT02195011|473348517|FG000|Overall Study|Progressive Disease|18|||
131468849|NCT02195011|473348518|FG001|Overall Study|Progressive Disease|1|||
131468850|NCT02195011|473348517|FG000|Overall Study|Withdrawal by Subject|3|||
131468851|NCT02195011|473348518|FG001|Overall Study|Withdrawal by Subject|0|||
131468852|NCT00732940|473348519|FG000|Overall Study|Withdrawal by Subject|1|||
131468853|NCT00732940|473348520|FG001|Overall Study|Withdrawal by Subject|2|||
131468854|NCT00732940|473348519|FG000|Overall Study|Adverse Event|0|||
131468855|NCT00732940|473348520|FG001|Overall Study|Adverse Event|1|||
131468856|NCT00732940|473348519|FG000|Overall Study|Lost to Follow-up|1|||
131468857|NCT00732940|473348520|FG001|Overall Study|Lost to Follow-up|0|||
131769926|NCT04516291|474436063|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131769927|NCT04516291|474436064|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131769928|NCT04516291|474436057|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
131769929|NCT04516291|474436058|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
131769930|NCT04516291|474436059|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
131769931|NCT04516291|474436060|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
131769932|NCT04516291|474436061|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
131468858|NCT00509262|473348524|FG000|Overall Study|Adverse Event|16|||
131468859|NCT00509262|473348525|FG001|Overall Study|Adverse Event|18|||
131468860|NCT00509262|473348524|FG000|Overall Study|Other|2|||
131468861|NCT00509262|473348525|FG001|Overall Study|Other|2|||
131468862|NCT00509262|473348524|FG000|Overall Study|Lack of Efficacy|1|||
131468863|NCT00509262|473348525|FG001|Overall Study|Lack of Efficacy|0|||
131468864|NCT00509262|473348524|FG000|Overall Study|Lost to Follow-up|1|||
131468865|NCT00509262|473348525|FG001|Overall Study|Lost to Follow-up|6|||
131468866|NCT00509262|473348524|FG000|Overall Study|Physician Decision|1|||
131468867|NCT00509262|473348525|FG001|Overall Study|Physician Decision|3|||
131468868|NCT00509262|473348524|FG000|Overall Study|Protocol Violation|2|||
131468869|NCT00509262|473348525|FG001|Overall Study|Protocol Violation|2|||
131468870|NCT00509262|473348524|FG000|Overall Study|Withdrawal by Subject|24|||
131468871|NCT00509262|473348525|FG001|Overall Study|Withdrawal by Subject|11|||
131468872|NCT01589770|473348526|FG000|Overall Study|EGFR <60ml/min|6|||
131468873|NCT01589770|473348527|FG001|Overall Study|EGFR <60ml/min|4|||
131468874|NCT01589770|473348526|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
131468875|NCT01589770|473348527|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
131468876|NCT02674854|473348532|FG000|Overall Study|Adverse Event|17|||
131468877|NCT02674854|473348533|FG001|Overall Study|Adverse Event|15|||
131468878|NCT02674854|473348534|FG002|Overall Study|Adverse Event|5|||
131468879|NCT02674854|473348532|FG000|Overall Study|Withdrawal by Subject|1|||
131468880|NCT02674854|473348533|FG001|Overall Study|Withdrawal by Subject|5|||
131468881|NCT02674854|473348534|FG002|Overall Study|Withdrawal by Subject|4|||
131468882|NCT02674854|473348532|FG000|Overall Study|No-compliant subject|1|||
131468883|NCT02674854|473348533|FG001|Overall Study|No-compliant subject|0|||
131468884|NCT02674854|473348534|FG002|Overall Study|No-compliant subject|1|||
131468885|NCT02674854|473348532|FG000|Overall Study|Lost to Follow-up|1|||
131468886|NCT02674854|473348533|FG001|Overall Study|Lost to Follow-up|0|||
131468887|NCT02674854|473348534|FG002|Overall Study|Lost to Follow-up|2|||
131468888|NCT02674854|473348532|FG000|Overall Study|Lack of Efficacy|0|||
131468889|NCT02674854|473348533|FG001|Overall Study|Lack of Efficacy|3|||
131468890|NCT02674854|473348534|FG002|Overall Study|Lack of Efficacy|0|||
131468891|NCT02674854|473348532|FG000|Overall Study|Disallowed Concurrent Medication|2|||
131468892|NCT02674854|473348533|FG001|Overall Study|Disallowed Concurrent Medication|2|||
131468893|NCT02674854|473348534|FG002|Overall Study|Disallowed Concurrent Medication|0|||
131468894|NCT02674854|473348532|FG000|Overall Study|Protocol Violation|1|||
131468895|NCT02674854|473348533|FG001|Overall Study|Protocol Violation|1|||
131468896|NCT02674854|473348534|FG002|Overall Study|Protocol Violation|2|||
131468897|NCT02674854|473348532|FG000|Overall Study|Death|0|||
131468898|NCT02674854|473348533|FG001|Overall Study|Death|1|||
131468899|NCT02674854|473348534|FG002|Overall Study|Death|0|||
131468900|NCT02674854|473348532|FG000|Overall Study|Subject missed V6.2|1|||
131468901|NCT02674854|473348533|FG001|Overall Study|Subject missed V6.2|0|||
131468902|NCT02674854|473348534|FG002|Overall Study|Subject missed V6.2|0|||
131468903|NCT01585584|473348535|FG000|Overall Study|Lack of Efficacy|1|||
131468904|NCT01585584|473348535|FG000|Overall Study|Withdrawal by Subject|1|||
131468905|NCT01585584|473348535|FG000|Overall Study|Physician Decision|2|||
131468906|NCT01077154|473348536|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
131468907|NCT01077154|473348537|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
131468908|NCT01077154|473348536|FG000|Overall Study|Withdrawal by Subject|369|||
131468909|NCT01077154|473348537|FG001|Overall Study|Withdrawal by Subject|385|||
131468910|NCT01077154|473348536|FG000|Overall Study|Death|215|||
131468911|NCT01077154|473348537|FG001|Overall Study|Death|214|||
131468912|NCT01077154|473348536|FG000|Overall Study|Lost to Follow-up|43|||
131468913|NCT01077154|473348537|FG001|Overall Study|Lost to Follow-up|35|||
131468914|NCT01077154|473348536|FG000|Overall Study|Noncompliance|22|||
131468915|NCT01077154|473348537|FG001|Overall Study|Noncompliance|20|||
131468916|NCT01077154|473348536|FG000|Overall Study|Disease Progression|18|||
131468917|NCT01077154|473348537|FG001|Overall Study|Disease Progression|20|||
131468918|NCT01077154|473348536|FG000|Overall Study|Ineligibility Determined|10|||
131468919|NCT01077154|473348537|FG001|Overall Study|Ineligibility Determined|14|||
131468920|NCT01077154|473348536|FG000|Overall Study|Other|14|||
131468921|NCT01077154|473348537|FG001|Overall Study|Other|11|||
131468922|NCT01077154|473348536|FG000|Overall Study|Adverse Event|9|||
131468923|NCT01077154|473348537|FG001|Overall Study|Adverse Event|9|||
131468924|NCT01077154|473348536|FG000|Overall Study|Administrative Decision|1|||
131468925|NCT01077154|473348537|FG001|Overall Study|Administrative Decision|6|||
131468926|NCT01077154|473348536|FG000|Overall Study|Protocol Deviation|1|||
131468927|NCT01077154|473348537|FG001|Overall Study|Protocol Deviation|0|||
131468928|NCT00686998|473348538|FG000|Overall Study|Adverse Event|3|||
131468929|NCT00686998|473348539|FG001|Overall Study|Adverse Event|2|||
131468930|NCT00686998|473348540|FG002|Overall Study|Adverse Event|1|||
131468931|NCT00686998|473348538|FG000|Overall Study|Withdrawal by Subject|2|||
131468932|NCT00686998|473348539|FG001|Overall Study|Withdrawal by Subject|1|||
131468933|NCT00686998|473348540|FG002|Overall Study|Withdrawal by Subject|2|||
131468934|NCT00686998|473348538|FG000|Overall Study|Lack of Efficacy|7|||
131468935|NCT00686998|473348539|FG001|Overall Study|Lack of Efficacy|5|||
131468936|NCT00686998|473348540|FG002|Overall Study|Lack of Efficacy|0|||
131468937|NCT00686998|473348538|FG000|Overall Study|Other|0|||
131468938|NCT00686998|473348539|FG001|Overall Study|Other|0|||
131468939|NCT00686998|473348540|FG002|Overall Study|Other|1|||
131468940|NCT00686998|473348538|FG000|Overall Study|Safety Reasons|1|||
131468941|NCT00686998|473348539|FG001|Overall Study|Safety Reasons|0|||
131468942|NCT00686998|473348540|FG002|Overall Study|Safety Reasons|0|||
131468943|NCT02361346|473348546|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468944|NCT02361346|473348547|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468945|NCT02361346|473348548|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468946|NCT02361346|473348549|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
131468947|NCT02361346|473348550|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468948|NCT02361346|473348551|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468949|NCT02361346|473348552|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468950|NCT02361346|473348553|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468951|NCT02361346|473348554|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
131468952|NCT02361346|473348546|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468953|NCT02361346|473348547|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468954|NCT02361346|473348548|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468955|NCT02361346|473348549|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468956|NCT02361346|473348550|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
131468957|NCT02361346|473348551|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468958|NCT02361346|473348552|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468959|NCT02361346|473348553|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468960|NCT02361346|473348554|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
131468961|NCT02361346|473348546|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
131468962|NCT02361346|473348547|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
131468963|NCT02361346|473348548|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
131468964|NCT02361346|473348549|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
131468965|NCT02361346|473348550|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
131468966|NCT02361346|473348551|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
131468967|NCT02361346|473348552|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
131468968|NCT02361346|473348553|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
131468969|NCT02361346|473348554|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
131468970|NCT02361346|473348546|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468971|NCT02361346|473348547|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468972|NCT02361346|473348548|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468973|NCT02361346|473348549|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468974|NCT02361346|473348550|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468975|NCT02361346|473348551|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468976|NCT02361346|473348552|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468977|NCT02361346|473348553|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
131468978|NCT02361346|473348554|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
131468979|NCT02361346|473348546|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468980|NCT02361346|473348547|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468981|NCT02361346|473348548|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468982|NCT02361346|473348549|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468983|NCT02361346|473348550|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468984|NCT02361346|473348551|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468985|NCT02361346|473348552|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468986|NCT02361346|473348553|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
131468987|NCT02361346|473348554|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
131468988|NCT02361346|473348546|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468989|NCT02361346|473348547|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468990|NCT02361346|473348548|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468991|NCT02361346|473348549|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468992|NCT02361346|473348550|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468993|NCT02361346|473348551|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468994|NCT02361346|473348552|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468995|NCT02361346|473348553|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
131468996|NCT02361346|473348554|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
131468997|NCT01163318|473348555|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
131468998|NCT01163318|473348555|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
131468999|NCT01163318|473348555|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
131469000|NCT01163318|473348555|FG000|Overall Study|Participants Without Case Report Form|7|||
131469001|NCT01163318|473348555|FG000|Overall Study|Multiple Reasons Per Participant|224|||
131469002|NCT01006603|473348560|FG000|Overall Study|Withdrawal by Subject|17|||
131469003|NCT01006603|473348561|FG001|Overall Study|Withdrawal by Subject|19|||
131469004|NCT01006603|473348560|FG000|Overall Study|Lost to Follow-up|0|||
131469005|NCT01006603|473348561|FG001|Overall Study|Lost to Follow-up|1|||
131469006|NCT01006603|473348560|FG000|Overall Study|Safety reason|1|||
131469007|NCT01006603|473348561|FG001|Overall Study|Safety reason|1|||
131469008|NCT01006603|473348560|FG000|Overall Study|Protocol Violation|1|||
131469009|NCT01006603|473348561|FG001|Overall Study|Protocol Violation|3|||
131469010|NCT01006603|473348560|FG000|Overall Study|Incorrect enrolment|0|||
131469011|NCT01006603|473348561|FG001|Overall Study|Incorrect enrolment|2|||
131469012|NCT01006603|473348560|FG000|Overall Study|Adverse Event|15|||
131469013|NCT01006603|473348561|FG001|Overall Study|Adverse Event|7|||
131469014|NCT01006603|473348560|FG000|Overall Study|Death|1|||
131469015|NCT01006603|473348561|FG001|Overall Study|Death|1|||
131469016|NCT01006603|473348560|FG000|Overall Study|Study specific discontinuation criteria|33|||
131469017|NCT01006603|473348561|FG001|Overall Study|Study specific discontinuation criteria|34|||
131469018|NCT01006603|473348560|FG000|Overall Study|Other|3|||
131469019|NCT01006603|473348561|FG001|Overall Study|Other|7|||
131469020|NCT00622739|473350187|FG000|Overall Study|Physician Decision|1|||
131469021|NCT00622739|473350188|FG001|Overall Study|Physician Decision|0|||
131469022|NCT00622739|473350187|FG000|Overall Study|Adverse Event|1|||
131469023|NCT00622739|473350188|FG001|Overall Study|Adverse Event|2|||
131469024|NCT00622739|473350187|FG000|Overall Study|Lack of Efficacy|0|||
131469025|NCT00622739|473350188|FG001|Overall Study|Lack of Efficacy|2|||
131469026|NCT00622739|473350187|FG000|Overall Study|Withdrawal by Subject|0|||
131469027|NCT00622739|473350188|FG001|Overall Study|Withdrawal by Subject|1|||
131469028|NCT00622739|473350187|FG000|Overall Study|Lost to Follow-up|0|||
131469029|NCT00622739|473350188|FG001|Overall Study|Lost to Follow-up|1|||
131469030|NCT03387150|473350189|FG000|Overall Study|Withdrawal by Subject|3|||
131469031|NCT03387150|473350190|FG001|Overall Study|Withdrawal by Subject|0|||
131469032|NCT03387150|473350191|FG002|Overall Study|Withdrawal by Subject|3|||
131469033|NCT03387150|473350192|FG003|Overall Study|Withdrawal by Subject|4|||
131469034|NCT03387150|473350193|FG004|Overall Study|Withdrawal by Subject|1|||
131469035|NCT03387150|473350194|FG005|Overall Study|Withdrawal by Subject|2|||
131469036|NCT03387150|473350195|FG006|Overall Study|Withdrawal by Subject|0|||
131469037|NCT03387150|473350189|FG000|Overall Study|Lost to Follow-up|3|||
131469038|NCT03387150|473350190|FG001|Overall Study|Lost to Follow-up|2|||
131469039|NCT03387150|473350191|FG002|Overall Study|Lost to Follow-up|2|||
131469040|NCT03387150|473350192|FG003|Overall Study|Lost to Follow-up|3|||
131469041|NCT03387150|473350193|FG004|Overall Study|Lost to Follow-up|3|||
131469042|NCT03387150|473350194|FG005|Overall Study|Lost to Follow-up|3|||
131469043|NCT03387150|473350195|FG006|Overall Study|Lost to Follow-up|0|||
131469044|NCT03387150|473350189|FG000|Overall Study|Participant unable to adhere to visit|0|||
131469045|NCT03387150|473350190|FG001|Overall Study|Participant unable to adhere to visit|1|||
131469046|NCT03387150|473350191|FG002|Overall Study|Participant unable to adhere to visit|0|||
131469047|NCT03387150|473350192|FG003|Overall Study|Participant unable to adhere to visit|0|||
131469048|NCT03387150|473350193|FG004|Overall Study|Participant unable to adhere to visit|2|||
131469049|NCT03387150|473350194|FG005|Overall Study|Participant unable to adhere to visit|2|||
131469050|NCT03387150|473350195|FG006|Overall Study|Participant unable to adhere to visit|0|||
131469051|NCT00371761|473350196|FG000|Overall Study|Adverse Event|1|||
131469052|NCT00371761|473350197|FG001|Overall Study|Adverse Event|1|||
131469053|NCT00371761|473350196|FG000|Overall Study|Withdrawal by Subject|1|||
131469054|NCT00371761|473350197|FG001|Overall Study|Withdrawal by Subject|3|||
131469055|NCT00371761|473350196|FG000|Overall Study|Investigator Judgment|2|||
131469056|NCT00371761|473350197|FG001|Overall Study|Investigator Judgment|3|||
131469057|NCT00371761|473350196|FG000|Overall Study|Study termination|4|||
131469058|NCT00371761|473350197|FG001|Overall Study|Study termination|3|||
131469059|NCT02448680|473350199|FG000|Overall Study|Physician Decision|1|||
131469060|NCT02448680|473350200|FG001|Overall Study|Physician Decision|1|||
131469061|NCT02448680|473350199|FG000|Overall Study|Withdrawal by Subject|0|||
131469062|NCT02448680|473350200|FG001|Overall Study|Withdrawal by Subject|2|||
131469063|NCT01736657|473350207|FG000|Overall Study|insufficient vascular access|1|||
131469064|NCT00997438|473350218|FG000|Overall Study|Blood draw difficulty|2|||
131469065|NCT00997438|473350219|FG001|Overall Study|Blood draw difficulty|0|||
131469066|NCT00997438|473350220|FG002|Overall Study|Blood draw difficulty|1|||
131469067|NCT00997438|473350218|FG000|Overall Study|Withdrawal by Subject|1|||
131469068|NCT00997438|473350219|FG001|Overall Study|Withdrawal by Subject|1|||
131469069|NCT00997438|473350220|FG002|Overall Study|Withdrawal by Subject|0|||
131469070|NCT00997438|473350218|FG000|Overall Study|Exclusion criteria at visit 1|2|||
131469071|NCT00997438|473350219|FG001|Overall Study|Exclusion criteria at visit 1|2|||
131469072|NCT00997438|473350220|FG002|Overall Study|Exclusion criteria at visit 1|3|||
131469073|NCT00095238|473350221|FG000|Overall Study|Lack of Efficacy|9|||
131469074|NCT00095238|473350222|FG001|Overall Study|Lack of Efficacy|9|||
131469075|NCT00095238|473350221|FG000|Overall Study|Adverse Event|331|||
131469076|NCT00095238|473350222|FG001|Overall Study|Adverse Event|287|||
131469077|NCT00095238|473350221|FG000|Overall Study|Subject Withdrew Consent|208|||
131469078|NCT00095238|473350222|FG001|Overall Study|Subject Withdrew Consent|223|||
131469079|NCT00095238|473350221|FG000|Overall Study|Death|154|||
131469080|NCT00095238|473350222|FG001|Overall Study|Death|170|||
131469081|NCT00095238|473350221|FG000|Overall Study|Lost to Follow-up|19|||
131469082|NCT00095238|473350222|FG001|Overall Study|Lost to Follow-up|24|||
131469083|NCT00095238|473350221|FG000|Overall Study|Noncompliance|44|||
131469084|NCT00095238|473350222|FG001|Overall Study|Noncompliance|45|||
131469085|NCT00095238|473350221|FG000|Overall Study|No longer met study criteria|4|||
131469086|NCT00095238|473350222|FG001|Overall Study|No longer met study criteria|5|||
131469087|NCT00095238|473350221|FG000|Overall Study|Study terminated by sponsor|0|||
131469088|NCT00095238|473350222|FG001|Overall Study|Study terminated by sponsor|1|||
131469089|NCT00095238|473350221|FG000|Overall Study|Missing|1|||
131469090|NCT00095238|473350222|FG001|Overall Study|Missing|0|||
131469091|NCT00095238|473350221|FG000|Overall Study|Other Reasons|87|||
131469092|NCT00095238|473350222|FG001|Overall Study|Other Reasons|88|||
131469093|NCT03505671|473350223|FG000|Overall Study|Withdrawal by Subject|2|||
131469094|NCT03505671|473350224|FG001|Overall Study|Withdrawal by Subject|1|||
131469095|NCT03505671|473350223|FG000|Overall Study|Lost to Follow-up|1|||
131469096|NCT03505671|473350224|FG001|Overall Study|Lost to Follow-up|0|||
131469097|NCT02038829|473350227|FG000|Washout Period 1|Death|0|||
131469098|NCT02038829|473350228|FG001|Washout Period 1|Death|0|||
131469099|NCT02038829|473350229|FG002|Washout Period 1|Death|0|||
131469100|NCT02038829|473350230|FG003|Washout Period 1|Death|0|||
131469101|NCT02038829|473350231|FG004|Washout Period 1|Death|1|||
131469102|NCT02038829|473350232|FG005|Washout Period 1|Death|0|||
131469103|NCT02038829|473350233|FG006|Washout Period 1|Death|0|||
131469104|NCT02038829|473350234|FG007|Washout Period 1|Death|0|||
131469105|NCT02038829|473350235|FG008|Washout Period 1|Death|0|||
131469106|NCT02038829|473350236|FG009|Washout Period 1|Death|0|||
131469107|NCT02038829|473350237|FG010|Washout Period 1|Death|0|||
131469108|NCT02038829|473350238|FG011|Washout Period 1|Death|0|||
131469109|NCT02038829|473350227|FG000|Treatment Period 2|Adverse Event|0|||
131469110|NCT02038829|473350228|FG001|Treatment Period 2|Adverse Event|0|||
131469111|NCT02038829|473350229|FG002|Treatment Period 2|Adverse Event|0|||
131469112|NCT02038829|473350230|FG003|Treatment Period 2|Adverse Event|0|||
131469113|NCT02038829|473350231|FG004|Treatment Period 2|Adverse Event|0|||
131469114|NCT02038829|473350232|FG005|Treatment Period 2|Adverse Event|0|||
131469115|NCT02038829|473350233|FG006|Treatment Period 2|Adverse Event|0|||
131469116|NCT02038829|473350234|FG007|Treatment Period 2|Adverse Event|0|||
131469117|NCT02038829|473350235|FG008|Treatment Period 2|Adverse Event|0|||
131469118|NCT02038829|473350236|FG009|Treatment Period 2|Adverse Event|0|||
131469119|NCT02038829|473350237|FG010|Treatment Period 2|Adverse Event|1|||
131469120|NCT02038829|473350238|FG011|Treatment Period 2|Adverse Event|0|||
131469121|NCT02038829|473350227|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131469122|NCT02038829|473350228|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131469123|NCT02038829|473350229|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131469124|NCT02038829|473350230|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131469125|NCT02038829|473350231|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131469126|NCT02038829|473350232|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131469127|NCT02038829|473350233|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131469128|NCT02038829|473350234|FG007|Treatment Period 2|Withdrawal by Subject|0|||
131769933|NCT04516291|474436062|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
131469129|NCT02038829|473350235|FG008|Treatment Period 2|Withdrawal by Subject|0|||
131469130|NCT02038829|473350236|FG009|Treatment Period 2|Withdrawal by Subject|0|||
131469131|NCT02038829|473350237|FG010|Treatment Period 2|Withdrawal by Subject|0|||
131469132|NCT02038829|473350238|FG011|Treatment Period 2|Withdrawal by Subject|0|||
131469133|NCT02038829|473350227|FG000|Washout Period 2|Adverse Event|0|||
131469134|NCT02038829|473350228|FG001|Washout Period 2|Adverse Event|0|||
131469135|NCT02038829|473350229|FG002|Washout Period 2|Adverse Event|0|||
131469136|NCT02038829|473350230|FG003|Washout Period 2|Adverse Event|0|||
131469137|NCT02038829|473350231|FG004|Washout Period 2|Adverse Event|0|||
131469138|NCT02038829|473350232|FG005|Washout Period 2|Adverse Event|0|||
131469139|NCT02038829|473350233|FG006|Washout Period 2|Adverse Event|0|||
131469140|NCT02038829|473350234|FG007|Washout Period 2|Adverse Event|0|||
131469141|NCT02038829|473350235|FG008|Washout Period 2|Adverse Event|1|||
131469142|NCT02038829|473350236|FG009|Washout Period 2|Adverse Event|0|||
131469143|NCT02038829|473350237|FG010|Washout Period 2|Adverse Event|0|||
131469144|NCT02038829|473350238|FG011|Washout Period 2|Adverse Event|0|||
131469145|NCT02038829|473350227|FG000|Washout Period 2|Withdrawal by Subject|0|||
131469146|NCT02038829|473350228|FG001|Washout Period 2|Withdrawal by Subject|0|||
131469147|NCT02038829|473350229|FG002|Washout Period 2|Withdrawal by Subject|0|||
131469148|NCT02038829|473350230|FG003|Washout Period 2|Withdrawal by Subject|0|||
131469149|NCT02038829|473350231|FG004|Washout Period 2|Withdrawal by Subject|0|||
131469150|NCT02038829|473350232|FG005|Washout Period 2|Withdrawal by Subject|1|||
131469151|NCT02038829|473350233|FG006|Washout Period 2|Withdrawal by Subject|0|||
131469152|NCT02038829|473350234|FG007|Washout Period 2|Withdrawal by Subject|0|||
131469153|NCT02038829|473350235|FG008|Washout Period 2|Withdrawal by Subject|0|||
131469154|NCT02038829|473350236|FG009|Washout Period 2|Withdrawal by Subject|0|||
131469155|NCT02038829|473350237|FG010|Washout Period 2|Withdrawal by Subject|0|||
131469156|NCT02038829|473350238|FG011|Washout Period 2|Withdrawal by Subject|0|||
131469157|NCT02038829|473350227|FG000|Treatment Period 4|Adverse Event|0|||
131469158|NCT02038829|473350228|FG001|Treatment Period 4|Adverse Event|1|||
131469159|NCT02038829|473350229|FG002|Treatment Period 4|Adverse Event|0|||
131469160|NCT02038829|473350230|FG003|Treatment Period 4|Adverse Event|0|||
131469161|NCT02038829|473350231|FG004|Treatment Period 4|Adverse Event|0|||
131769934|NCT04516291|474436063|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
131469162|NCT02038829|473350232|FG005|Treatment Period 4|Adverse Event|0|||
131469163|NCT02038829|473350233|FG006|Treatment Period 4|Adverse Event|0|||
131469164|NCT02038829|473350234|FG007|Treatment Period 4|Adverse Event|0|||
131469165|NCT02038829|473350235|FG008|Treatment Period 4|Adverse Event|0|||
131469166|NCT02038829|473350236|FG009|Treatment Period 4|Adverse Event|0|||
131469167|NCT02038829|473350237|FG010|Treatment Period 4|Adverse Event|0|||
131469168|NCT02038829|473350238|FG011|Treatment Period 4|Adverse Event|0|||
131469169|NCT02038829|473350227|FG000|Washout Period 4|Adverse Event|0|||
131469170|NCT02038829|473350228|FG001|Washout Period 4|Adverse Event|0|||
131469171|NCT02038829|473350229|FG002|Washout Period 4|Adverse Event|0|||
131469172|NCT02038829|473350230|FG003|Washout Period 4|Adverse Event|0|||
131469173|NCT02038829|473350231|FG004|Washout Period 4|Adverse Event|0|||
131469174|NCT02038829|473350232|FG005|Washout Period 4|Adverse Event|0|||
131469175|NCT02038829|473350233|FG006|Washout Period 4|Adverse Event|1|||
131469176|NCT02038829|473350234|FG007|Washout Period 4|Adverse Event|0|||
131469177|NCT02038829|473350235|FG008|Washout Period 4|Adverse Event|0|||
131469178|NCT02038829|473350236|FG009|Washout Period 4|Adverse Event|0|||
131469179|NCT02038829|473350237|FG010|Washout Period 4|Adverse Event|0|||
131469180|NCT02038829|473350238|FG011|Washout Period 4|Adverse Event|0|||
131469181|NCT02038829|473350227|FG000|Treatment Period 6|Adverse Event|0|||
131469182|NCT02038829|473350228|FG001|Treatment Period 6|Adverse Event|0|||
131469183|NCT02038829|473350229|FG002|Treatment Period 6|Adverse Event|1|||
131469184|NCT02038829|473350230|FG003|Treatment Period 6|Adverse Event|0|||
131469185|NCT02038829|473350231|FG004|Treatment Period 6|Adverse Event|0|||
131469186|NCT02038829|473350232|FG005|Treatment Period 6|Adverse Event|0|||
131469187|NCT02038829|473350233|FG006|Treatment Period 6|Adverse Event|0|||
131469188|NCT02038829|473350234|FG007|Treatment Period 6|Adverse Event|0|||
131469189|NCT02038829|473350235|FG008|Treatment Period 6|Adverse Event|0|||
131469190|NCT02038829|473350236|FG009|Treatment Period 6|Adverse Event|0|||
131469191|NCT02038829|473350237|FG010|Treatment Period 6|Adverse Event|0|||
131469192|NCT02038829|473350238|FG011|Treatment Period 6|Adverse Event|0|||
131769935|NCT04516291|474436064|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
131769936|NCT04516291|474436057|FG000|Follow-up Period (12 Weeks)|Other|0|||
131769937|NCT04516291|474436058|FG001|Follow-up Period (12 Weeks)|Other|1|||
131469193|NCT02579928|473350239|FG000|Overall Study|Withdrawal by Subject|1|||
131469194|NCT02579928|473350240|FG001|Overall Study|Withdrawal by Subject|0|||
131769938|NCT04516291|474436059|FG002|Follow-up Period (12 Weeks)|Other|0|||
131769939|NCT04516291|474436060|FG003|Follow-up Period (12 Weeks)|Other|2|||
131469195|NCT04393298|473350243|FG000|Overall Study|Adverse Event|0|||
131469196|NCT04393298|473350244|FG001|Overall Study|Adverse Event|0|||
131469197|NCT04393298|473350245|FG002|Overall Study|Adverse Event|0|||
131469198|NCT04393298|473350246|FG003|Overall Study|Adverse Event|0|||
131469199|NCT04393298|473350247|FG004|Overall Study|Adverse Event|1|||
131469200|NCT04393298|473350248|FG005|Overall Study|Adverse Event|0|||
131469201|NCT04393298|473350249|FG006|Overall Study|Adverse Event|0|||
131769940|NCT04516291|474436061|FG004|Follow-up Period (12 Weeks)|Other|0|||
131469202|NCT04393298|473350250|FG007|Overall Study|Adverse Event|0|||
131469203|NCT04393298|473350251|FG008|Overall Study|Adverse Event|2|||
131469204|NCT04393298|473350252|FG009|Overall Study|Adverse Event|0|||
131469205|NCT04393298|473350253|FG010|Overall Study|Adverse Event|0|||
131469206|NCT04393298|473350254|FG011|Overall Study|Adverse Event|0|||
131469207|NCT04393298|473350255|FG012|Overall Study|Adverse Event|1|||
131469208|NCT04393298|473350256|FG013|Overall Study|Adverse Event|1|||
131469209|NCT04393298|473350257|FG014|Overall Study|Adverse Event|0|||
131469210|NCT04393298|473350243|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469211|NCT04393298|473350244|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469212|NCT04393298|473350245|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
131469213|NCT04393298|473350246|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469214|NCT04393298|473350247|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469215|NCT04393298|473350248|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469216|NCT04393298|473350249|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469217|NCT04393298|473350250|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469218|NCT04393298|473350251|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469219|NCT04393298|473350252|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469220|NCT04393298|473350253|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469221|NCT04393298|473350254|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469222|NCT04393298|473350255|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469223|NCT04393298|473350256|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
131469224|NCT04393298|473350257|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
131769941|NCT04516291|474436062|FG005|Follow-up Period (12 Weeks)|Other|0|||
131769942|NCT04516291|474436063|FG006|Follow-up Period (12 Weeks)|Other|0|||
131469225|NCT04393298|473350243|FG000|Overall Study|Lack of Efficacy|0|||
131469226|NCT04393298|473350244|FG001|Overall Study|Lack of Efficacy|0|||
131469227|NCT04393298|473350245|FG002|Overall Study|Lack of Efficacy|0|||
131469228|NCT04393298|473350246|FG003|Overall Study|Lack of Efficacy|0|||
131469229|NCT04393298|473350247|FG004|Overall Study|Lack of Efficacy|0|||
131469230|NCT04393298|473350248|FG005|Overall Study|Lack of Efficacy|0|||
131469231|NCT04393298|473350249|FG006|Overall Study|Lack of Efficacy|0|||
131469232|NCT04393298|473350250|FG007|Overall Study|Lack of Efficacy|0|||
131469233|NCT04393298|473350251|FG008|Overall Study|Lack of Efficacy|0|||
131469234|NCT04393298|473350252|FG009|Overall Study|Lack of Efficacy|0|||
131469235|NCT04393298|473350253|FG010|Overall Study|Lack of Efficacy|0|||
131469236|NCT04393298|473350254|FG011|Overall Study|Lack of Efficacy|0|||
131469237|NCT04393298|473350255|FG012|Overall Study|Lack of Efficacy|0|||
131469238|NCT04393298|473350256|FG013|Overall Study|Lack of Efficacy|0|||
131469239|NCT04393298|473350257|FG014|Overall Study|Lack of Efficacy|1|||
131469240|NCT04393298|473350243|FG000|Overall Study|Progression|1|||
131469241|NCT04393298|473350244|FG001|Overall Study|Progression|0|||
131469242|NCT04393298|473350245|FG002|Overall Study|Progression|0|||
131469243|NCT04393298|473350246|FG003|Overall Study|Progression|0|||
131469244|NCT04393298|473350247|FG004|Overall Study|Progression|0|||
131469245|NCT04393298|473350248|FG005|Overall Study|Progression|0|||
131469246|NCT04393298|473350249|FG006|Overall Study|Progression|0|||
131469247|NCT04393298|473350250|FG007|Overall Study|Progression|0|||
131469248|NCT04393298|473350251|FG008|Overall Study|Progression|0|||
131469249|NCT04393298|473350252|FG009|Overall Study|Progression|0|||
131469250|NCT04393298|473350253|FG010|Overall Study|Progression|1|||
131469251|NCT04393298|473350254|FG011|Overall Study|Progression|1|||
131469252|NCT04393298|473350255|FG012|Overall Study|Progression|0|||
131469253|NCT04393298|473350256|FG013|Overall Study|Progression|0|||
131769943|NCT04516291|474436064|FG007|Follow-up Period (12 Weeks)|Other|0|||
131769944|NCT04516291|474436057|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131469254|NCT04393298|473350257|FG014|Overall Study|Progression|0|||
131469255|NCT04393298|473350243|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
131469256|NCT04393298|473350244|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469257|NCT04393298|473350245|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469258|NCT04393298|473350246|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469259|NCT04393298|473350247|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469260|NCT04393298|473350248|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469261|NCT04393298|473350249|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469262|NCT04393298|473350250|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469263|NCT04393298|473350251|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469264|NCT04393298|473350252|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469265|NCT04393298|473350253|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469266|NCT04393298|473350254|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469267|NCT04393298|473350255|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469268|NCT04393298|473350256|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469269|NCT04393298|473350257|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
131469270|NCT04393298|473350243|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131769945|NCT04516291|474436058|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131469271|NCT04393298|473350244|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
131469272|NCT04393298|473350245|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469273|NCT04393298|473350246|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469274|NCT04393298|473350247|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469275|NCT04393298|473350248|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469276|NCT04393298|473350249|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469277|NCT04393298|473350250|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469278|NCT04393298|473350251|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469279|NCT04393298|473350252|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469280|NCT04393298|473350253|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469281|NCT04393298|473350254|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469282|NCT04393298|473350255|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469283|NCT04393298|473350256|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469284|NCT04393298|473350257|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131469285|NCT04393298|473350243|FG000|Overall Study|Clinical Progression|0|||
131469286|NCT04393298|473350244|FG001|Overall Study|Clinical Progression|2|||
131469287|NCT04393298|473350245|FG002|Overall Study|Clinical Progression|0|||
131469288|NCT04393298|473350246|FG003|Overall Study|Clinical Progression|0|||
131469289|NCT04393298|473350247|FG004|Overall Study|Clinical Progression|0|||
131469290|NCT04393298|473350248|FG005|Overall Study|Clinical Progression|0|||
131469291|NCT04393298|473350249|FG006|Overall Study|Clinical Progression|0|||
131469292|NCT04393298|473350250|FG007|Overall Study|Clinical Progression|0|||
131469293|NCT04393298|473350251|FG008|Overall Study|Clinical Progression|0|||
131469294|NCT04393298|473350252|FG009|Overall Study|Clinical Progression|0|||
131469295|NCT04393298|473350253|FG010|Overall Study|Clinical Progression|0|||
131469296|NCT04393298|473350254|FG011|Overall Study|Clinical Progression|0|||
131469297|NCT04393298|473350255|FG012|Overall Study|Clinical Progression|0|||
131469298|NCT04393298|473350256|FG013|Overall Study|Clinical Progression|0|||
131469299|NCT04393298|473350257|FG014|Overall Study|Clinical Progression|0|||
131469300|NCT04393298|473350243|FG000|Overall Study|Disease Progression|0|||
131469301|NCT04393298|473350244|FG001|Overall Study|Disease Progression|1|||
131469302|NCT04393298|473350245|FG002|Overall Study|Disease Progression|0|||
131469303|NCT04393298|473350246|FG003|Overall Study|Disease Progression|0|||
131469304|NCT04393298|473350247|FG004|Overall Study|Disease Progression|0|||
131469305|NCT04393298|473350248|FG005|Overall Study|Disease Progression|3|||
131469306|NCT04393298|473350249|FG006|Overall Study|Disease Progression|2|||
131469307|NCT04393298|473350250|FG007|Overall Study|Disease Progression|1|||
131469308|NCT04393298|473350251|FG008|Overall Study|Disease Progression|2|||
131469309|NCT04393298|473350252|FG009|Overall Study|Disease Progression|1|||
131469310|NCT04393298|473350253|FG010|Overall Study|Disease Progression|0|||
131469311|NCT04393298|473350254|FG011|Overall Study|Disease Progression|3|||
131469312|NCT04393298|473350255|FG012|Overall Study|Disease Progression|0|||
131469313|NCT04393298|473350256|FG013|Overall Study|Disease Progression|0|||
131469314|NCT04393298|473350257|FG014|Overall Study|Disease Progression|1|||
131469315|NCT04393298|473350243|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469316|NCT04393298|473350244|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469317|NCT04393298|473350245|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
131469318|NCT04393298|473350246|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469319|NCT04393298|473350247|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469320|NCT04393298|473350248|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469321|NCT04393298|473350249|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469322|NCT04393298|473350250|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469323|NCT04393298|473350251|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469324|NCT04393298|473350252|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469325|NCT04393298|473350253|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469326|NCT04393298|473350254|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469327|NCT04393298|473350255|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469328|NCT04393298|473350256|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469329|NCT04393298|473350257|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
131469330|NCT04393298|473350243|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469331|NCT04393298|473350244|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469332|NCT04393298|473350245|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
131469333|NCT04393298|473350246|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469334|NCT04393298|473350247|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469335|NCT04393298|473350248|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469336|NCT04393298|473350249|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469337|NCT04393298|473350250|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469338|NCT04393298|473350251|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469339|NCT04393298|473350252|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469340|NCT04393298|473350253|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469341|NCT04393298|473350254|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469342|NCT04393298|473350255|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469343|NCT04393298|473350256|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469344|NCT04393298|473350257|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
131469345|NCT04393298|473350243|FG000|Overall Study|Progressive Disease (PD)|0|||
131469346|NCT04393298|473350244|FG001|Overall Study|Progressive Disease (PD)|0|||
131469347|NCT04393298|473350245|FG002|Overall Study|Progressive Disease (PD)|0|||
131469348|NCT04393298|473350246|FG003|Overall Study|Progressive Disease (PD)|3|||
131469349|NCT04393298|473350247|FG004|Overall Study|Progressive Disease (PD)|0|||
131469350|NCT04393298|473350248|FG005|Overall Study|Progressive Disease (PD)|0|||
131469351|NCT04393298|473350249|FG006|Overall Study|Progressive Disease (PD)|0|||
131469352|NCT04393298|473350250|FG007|Overall Study|Progressive Disease (PD)|0|||
131469353|NCT04393298|473350251|FG008|Overall Study|Progressive Disease (PD)|0|||
131469354|NCT04393298|473350252|FG009|Overall Study|Progressive Disease (PD)|0|||
131469355|NCT04393298|473350253|FG010|Overall Study|Progressive Disease (PD)|0|||
131469356|NCT04393298|473350254|FG011|Overall Study|Progressive Disease (PD)|0|||
131469357|NCT04393298|473350255|FG012|Overall Study|Progressive Disease (PD)|0|||
131469358|NCT04393298|473350256|FG013|Overall Study|Progressive Disease (PD)|0|||
131469359|NCT04393298|473350257|FG014|Overall Study|Progressive Disease (PD)|0|||
131469360|NCT04393298|473350243|FG000|Overall Study|Started a New Cancer Treatment|0|||
131469361|NCT04393298|473350244|FG001|Overall Study|Started a New Cancer Treatment|0|||
131469362|NCT04393298|473350245|FG002|Overall Study|Started a New Cancer Treatment|0|||
131469363|NCT04393298|473350246|FG003|Overall Study|Started a New Cancer Treatment|0|||
131469364|NCT04393298|473350247|FG004|Overall Study|Started a New Cancer Treatment|1|||
131469365|NCT04393298|473350248|FG005|Overall Study|Started a New Cancer Treatment|0|||
131469366|NCT04393298|473350249|FG006|Overall Study|Started a New Cancer Treatment|0|||
131469367|NCT04393298|473350250|FG007|Overall Study|Started a New Cancer Treatment|0|||
131469368|NCT04393298|473350251|FG008|Overall Study|Started a New Cancer Treatment|0|||
131469369|NCT04393298|473350252|FG009|Overall Study|Started a New Cancer Treatment|0|||
131469370|NCT04393298|473350253|FG010|Overall Study|Started a New Cancer Treatment|0|||
131469371|NCT04393298|473350254|FG011|Overall Study|Started a New Cancer Treatment|0|||
131469372|NCT04393298|473350255|FG012|Overall Study|Started a New Cancer Treatment|0|||
131469373|NCT04393298|473350256|FG013|Overall Study|Started a New Cancer Treatment|0|||
131469374|NCT04393298|473350257|FG014|Overall Study|Started a New Cancer Treatment|0|||
131469375|NCT04393298|473350243|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469376|NCT04393298|473350244|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469377|NCT04393298|473350245|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469378|NCT04393298|473350246|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469379|NCT04393298|473350247|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
131469380|NCT04393298|473350248|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469381|NCT04393298|473350249|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469382|NCT04393298|473350250|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469383|NCT04393298|473350251|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469384|NCT04393298|473350252|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469385|NCT04393298|473350253|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469386|NCT04393298|473350254|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469387|NCT04393298|473350255|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469388|NCT04393298|473350256|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469389|NCT04393298|473350257|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
131469390|NCT04393298|473350243|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469391|NCT04393298|473350244|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469392|NCT04393298|473350245|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469393|NCT04393298|473350246|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469394|NCT04393298|473350247|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469395|NCT04393298|473350248|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
131469396|NCT04393298|473350249|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469397|NCT04393298|473350250|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469398|NCT04393298|473350251|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469399|NCT04393298|473350252|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469400|NCT04393298|473350253|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469401|NCT04393298|473350254|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131769946|NCT04516291|474436059|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131769947|NCT04516291|474436060|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131469402|NCT04393298|473350255|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469403|NCT04393298|473350256|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469404|NCT04393298|473350257|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
131469405|NCT04393298|473350243|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469406|NCT04393298|473350244|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469407|NCT04393298|473350245|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469408|NCT04393298|473350246|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469409|NCT04393298|473350247|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469410|NCT04393298|473350248|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
131469411|NCT04393298|473350249|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469412|NCT04393298|473350250|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469413|NCT04393298|473350251|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469414|NCT04393298|473350252|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469415|NCT04393298|473350253|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469416|NCT04393298|473350254|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469417|NCT04393298|473350255|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469418|NCT04393298|473350256|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
131469419|NCT04393298|473350257|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
131469420|NCT04393298|473350243|FG000|Overall Study|Death|0|||
131469421|NCT04393298|473350244|FG001|Overall Study|Death|0|||
131469422|NCT04393298|473350245|FG002|Overall Study|Death|0|||
131469423|NCT04393298|473350246|FG003|Overall Study|Death|0|||
131469424|NCT04393298|473350247|FG004|Overall Study|Death|0|||
131469425|NCT04393298|473350248|FG005|Overall Study|Death|1|||
131469426|NCT04393298|473350249|FG006|Overall Study|Death|1|||
131469427|NCT04393298|473350250|FG007|Overall Study|Death|0|||
131469428|NCT04393298|473350251|FG008|Overall Study|Death|1|||
131469429|NCT04393298|473350252|FG009|Overall Study|Death|1|||
131469430|NCT04393298|473350253|FG010|Overall Study|Death|0|||
131469431|NCT04393298|473350254|FG011|Overall Study|Death|1|||
131469432|NCT04393298|473350255|FG012|Overall Study|Death|1|||
131469433|NCT04393298|473350256|FG013|Overall Study|Death|0|||
131469434|NCT04393298|473350257|FG014|Overall Study|Death|1|||
131469435|NCT04393298|473350243|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469436|NCT04393298|473350244|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469437|NCT04393298|473350245|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469438|NCT04393298|473350246|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469439|NCT04393298|473350247|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469440|NCT04393298|473350248|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
131469441|NCT04393298|473350249|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469442|NCT04393298|473350250|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469443|NCT04393298|473350251|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469444|NCT04393298|473350252|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469445|NCT04393298|473350253|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469446|NCT04393298|473350254|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469447|NCT04393298|473350255|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469448|NCT04393298|473350256|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469449|NCT04393298|473350257|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
131469450|NCT04393298|473350243|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
131469451|NCT04393298|473350244|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
131469452|NCT04393298|473350245|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
131469453|NCT04393298|473350246|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
131469454|NCT04393298|473350247|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
131469455|NCT04393298|473350248|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
131469456|NCT04393298|473350249|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
131469457|NCT04393298|473350250|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
131469458|NCT04393298|473350251|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
131469459|NCT04393298|473350252|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
131469460|NCT04393298|473350253|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
131769948|NCT04516291|474436061|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
131769949|NCT04516291|474436062|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131769950|NCT04516291|474436063|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131469461|NCT04393298|473350254|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
131469462|NCT04393298|473350255|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
131469463|NCT04393298|473350256|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
131469464|NCT04393298|473350257|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
131469465|NCT04393298|473350243|FG000|Overall Study|Patient Passed Away|0|||
131469466|NCT04393298|473350244|FG001|Overall Study|Patient Passed Away|0|||
131469467|NCT04393298|473350245|FG002|Overall Study|Patient Passed Away|0|||
131469468|NCT04393298|473350246|FG003|Overall Study|Patient Passed Away|0|||
131469469|NCT04393298|473350247|FG004|Overall Study|Patient Passed Away|0|||
131469470|NCT04393298|473350248|FG005|Overall Study|Patient Passed Away|0|||
131469471|NCT04393298|473350249|FG006|Overall Study|Patient Passed Away|0|||
131469472|NCT04393298|473350250|FG007|Overall Study|Patient Passed Away|1|||
131469473|NCT04393298|473350251|FG008|Overall Study|Patient Passed Away|0|||
131469474|NCT04393298|473350252|FG009|Overall Study|Patient Passed Away|0|||
131469475|NCT04393298|473350253|FG010|Overall Study|Patient Passed Away|0|||
131469476|NCT04393298|473350254|FG011|Overall Study|Patient Passed Away|0|||
131469477|NCT04393298|473350255|FG012|Overall Study|Patient Passed Away|0|||
131469478|NCT04393298|473350256|FG013|Overall Study|Patient Passed Away|0|||
131469479|NCT04393298|473350257|FG014|Overall Study|Patient Passed Away|0|||
131469480|NCT04393298|473350243|FG000|Overall Study|Patient Deceased|0|||
131469481|NCT04393298|473350244|FG001|Overall Study|Patient Deceased|0|||
131469482|NCT04393298|473350245|FG002|Overall Study|Patient Deceased|0|||
131469483|NCT04393298|473350246|FG003|Overall Study|Patient Deceased|0|||
131469484|NCT04393298|473350247|FG004|Overall Study|Patient Deceased|0|||
131469485|NCT04393298|473350248|FG005|Overall Study|Patient Deceased|0|||
131469486|NCT04393298|473350249|FG006|Overall Study|Patient Deceased|0|||
131469487|NCT04393298|473350250|FG007|Overall Study|Patient Deceased|1|||
131469488|NCT04393298|473350251|FG008|Overall Study|Patient Deceased|0|||
131469489|NCT04393298|473350252|FG009|Overall Study|Patient Deceased|0|||
131469490|NCT04393298|473350253|FG010|Overall Study|Patient Deceased|0|||
131469491|NCT04393298|473350254|FG011|Overall Study|Patient Deceased|0|||
131469492|NCT04393298|473350255|FG012|Overall Study|Patient Deceased|0|||
131469493|NCT04393298|473350256|FG013|Overall Study|Patient Deceased|0|||
131469494|NCT04393298|473350257|FG014|Overall Study|Patient Deceased|0|||
131469495|NCT04393298|473350243|FG000|Overall Study|Patient Discharged to Hospice|0|||
131469496|NCT04393298|473350244|FG001|Overall Study|Patient Discharged to Hospice|0|||
131469497|NCT04393298|473350245|FG002|Overall Study|Patient Discharged to Hospice|0|||
131469498|NCT04393298|473350246|FG003|Overall Study|Patient Discharged to Hospice|0|||
131469499|NCT04393298|473350247|FG004|Overall Study|Patient Discharged to Hospice|0|||
131469500|NCT04393298|473350248|FG005|Overall Study|Patient Discharged to Hospice|0|||
131469501|NCT04393298|473350249|FG006|Overall Study|Patient Discharged to Hospice|0|||
131469502|NCT04393298|473350250|FG007|Overall Study|Patient Discharged to Hospice|0|||
131469503|NCT04393298|473350251|FG008|Overall Study|Patient Discharged to Hospice|1|||
131469504|NCT04393298|473350252|FG009|Overall Study|Patient Discharged to Hospice|0|||
131469505|NCT04393298|473350253|FG010|Overall Study|Patient Discharged to Hospice|0|||
131469506|NCT04393298|473350254|FG011|Overall Study|Patient Discharged to Hospice|0|||
131469507|NCT04393298|473350255|FG012|Overall Study|Patient Discharged to Hospice|0|||
131469508|NCT04393298|473350256|FG013|Overall Study|Patient Discharged to Hospice|0|||
131469509|NCT04393298|473350257|FG014|Overall Study|Patient Discharged to Hospice|0|||
131469510|NCT04393298|473350243|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469511|NCT04393298|473350244|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469512|NCT04393298|473350245|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469513|NCT04393298|473350246|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469514|NCT04393298|473350247|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469515|NCT04393298|473350248|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469516|NCT04393298|473350249|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469517|NCT04393298|473350250|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469518|NCT04393298|473350251|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469519|NCT04393298|473350252|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
131469520|NCT04393298|473350253|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469521|NCT04393298|473350254|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469522|NCT04393298|473350255|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469523|NCT04393298|473350256|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469524|NCT04393298|473350257|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
131469525|NCT04393298|473350243|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
131469526|NCT04393298|473350244|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
131469527|NCT04393298|473350245|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
131469528|NCT04393298|473350246|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
131469529|NCT04393298|473350247|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
131469530|NCT04393298|473350248|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
131469531|NCT04393298|473350249|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
131469532|NCT04393298|473350250|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
131469533|NCT04393298|473350251|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
131469534|NCT04393298|473350252|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
131469535|NCT04393298|473350253|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
131469536|NCT04393298|473350254|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
131469537|NCT04393298|473350255|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
131469538|NCT04393298|473350256|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
131469539|NCT04393298|473350257|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
131469540|NCT04656275|473350260|FG000|Overall Study|Study terminated by sponsor|2|||
131469541|NCT04656275|473350261|FG001|Overall Study|Study terminated by sponsor|4|||
131469542|NCT01857310|473350262|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
131469543|NCT01857310|473350263|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
131469544|NCT04761627|473350264|FG000|Run-in Period|Death|1|||
131469545|NCT04761627|473350265|FG001|Run-in Period|Death|0|||
131469546|NCT04761627|473350266|FG002|Run-in Period|Death|0|||
131469547|NCT04761627|473350264|FG000|Run-in Period|Required alternative therapy|2|||
131469548|NCT04761627|473350265|FG001|Run-in Period|Required alternative therapy|0|||
131469549|NCT04761627|473350266|FG002|Run-in Period|Required alternative therapy|0|||
131469550|NCT04761627|473350264|FG000|Run-in Period|Lost to Follow-up|2|||
131469551|NCT04761627|473350265|FG001|Run-in Period|Lost to Follow-up|0|||
131469552|NCT04761627|473350266|FG002|Run-in Period|Lost to Follow-up|0|||
131469553|NCT04761627|473350264|FG000|Run-in Period|Protocol Violation|3|||
131469554|NCT04761627|473350265|FG001|Run-in Period|Protocol Violation|0|||
131469555|NCT04761627|473350266|FG002|Run-in Period|Protocol Violation|0|||
131469556|NCT04761627|473350264|FG000|Run-in Period|Abnormal liver function|1|||
131469557|NCT04761627|473350265|FG001|Run-in Period|Abnormal liver function|0|||
131469558|NCT04761627|473350266|FG002|Run-in Period|Abnormal liver function|0|||
131469559|NCT04761627|473350264|FG000|Run-in Period|Adverse Event|6|||
131469560|NCT04761627|473350265|FG001|Run-in Period|Adverse Event|0|||
131469561|NCT04761627|473350266|FG002|Run-in Period|Adverse Event|0|||
131469562|NCT04761627|473350264|FG000|Run-in Period|Withdrawal by Subject|7|||
131469563|NCT04761627|473350265|FG001|Run-in Period|Withdrawal by Subject|0|||
131469564|NCT04761627|473350266|FG002|Run-in Period|Withdrawal by Subject|0|||
131469565|NCT04761627|473350264|FG000|Run-in Period|Did not meet PASI 50|15|||
131469566|NCT04761627|473350265|FG001|Run-in Period|Did not meet PASI 50|0|||
131469567|NCT04761627|473350266|FG002|Run-in Period|Did not meet PASI 50|0|||
131469568|NCT04761627|473350264|FG000|Run-in Period|Study site closure|2|||
131469569|NCT04761627|473350265|FG001|Run-in Period|Study site closure|0|||
131469570|NCT04761627|473350266|FG002|Run-in Period|Study site closure|0|||
131469571|NCT04761627|473350264|FG000|Run-in Period|Pregnancy|2|||
131469572|NCT04761627|473350265|FG001|Run-in Period|Pregnancy|0|||
131469573|NCT04761627|473350266|FG002|Run-in Period|Pregnancy|0|||
131469574|NCT04761627|473350264|FG000|Post-randomization Period|Military service|0|||
131469575|NCT04761627|473350265|FG001|Post-randomization Period|Military service|1|||
131469576|NCT04761627|473350266|FG002|Post-randomization Period|Military service|0|||
131469577|NCT04761627|473350264|FG000|Post-randomization Period|Adverse Event|0|||
131469578|NCT04761627|473350265|FG001|Post-randomization Period|Adverse Event|4|||
131469579|NCT04761627|473350266|FG002|Post-randomization Period|Adverse Event|2|||
131469580|NCT04761627|473350264|FG000|Post-randomization Period|Lost to Follow-up|0|||
131469581|NCT04761627|473350265|FG001|Post-randomization Period|Lost to Follow-up|6|||
131469582|NCT04761627|473350266|FG002|Post-randomization Period|Lost to Follow-up|6|||
131469583|NCT04761627|473350264|FG000|Post-randomization Period|Withdrawal by Subject|0|||
131469584|NCT04761627|473350265|FG001|Post-randomization Period|Withdrawal by Subject|7|||
131469585|NCT04761627|473350266|FG002|Post-randomization Period|Withdrawal by Subject|6|||
131469586|NCT04761627|473350264|FG000|Post-randomization Period|Pregnancy|0|||
131469587|NCT04761627|473350265|FG001|Post-randomization Period|Pregnancy|0|||
131469588|NCT04761627|473350266|FG002|Post-randomization Period|Pregnancy|1|||
131469589|NCT04761627|473350264|FG000|Post-randomization Period|Study site closure|0|||
131469590|NCT04761627|473350265|FG001|Post-randomization Period|Study site closure|0|||
131469591|NCT04761627|473350266|FG002|Post-randomization Period|Study site closure|1|||
131469592|NCT04761627|473350264|FG000|Post-randomization Period|Family planning|0|||
131469593|NCT04761627|473350265|FG001|Post-randomization Period|Family planning|1|||
131469594|NCT04761627|473350266|FG002|Post-randomization Period|Family planning|0|||
131469595|NCT05867342|473350267|FG000|Overall Study|Investigator Decision|3|||
131469596|NCT05867342|473350268|FG001|Overall Study|Investigator Decision|3|||
131469597|NCT00723203|473350269|FG000|Overall Study|Withdrawal by Subject|3|||
131469598|NCT01721577|473350270|FG000|Overall Study|Lack of Efficacy|1|||
131469599|NCT01721577|473350271|FG001|Overall Study|Lack of Efficacy|0|||
131469600|NCT01721577|473350270|FG000|Overall Study|Death|1|||
131469601|NCT01721577|473350271|FG001|Overall Study|Death|0|||
131469602|NCT01721577|473350270|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
131469603|NCT01721577|473350271|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
131469604|NCT01721577|473350270|FG000|Overall Study|Adverse Event|0|||
131469605|NCT01721577|473350271|FG001|Overall Study|Adverse Event|2|||
131469606|NCT02497976|473350272|FG000|Overall Study|Withdrawal by Subject|2|||
131469607|NCT02497976|473350273|FG001|Overall Study|Withdrawal by Subject|0|||
131469608|NCT02497976|473350272|FG000|Overall Study|Moved out of area|0|||
131469609|NCT02497976|473350273|FG001|Overall Study|Moved out of area|1|||
131469610|NCT01609478|473350280|FG000|Overall Study|Adverse Event|3|||
131469611|NCT01609478|473350281|FG001|Overall Study|Adverse Event|1|||
131469612|NCT01609478|473350282|FG002|Overall Study|Adverse Event|5|||
131469613|NCT01609478|473350280|FG000|Overall Study|Protocol Deviation|0|||
131469614|NCT01609478|473350281|FG001|Overall Study|Protocol Deviation|1|||
131469615|NCT01609478|473350282|FG002|Overall Study|Protocol Deviation|1|||
131469616|NCT01609478|473350280|FG000|Overall Study|Non-Compliance with study treatment|1|||
131469617|NCT01609478|473350281|FG001|Overall Study|Non-Compliance with study treatment|0|||
131469618|NCT01609478|473350282|FG002|Overall Study|Non-Compliance with study treatment|0|||
131469619|NCT01609478|473350280|FG000|Overall Study|Physician Decision|1|||
131469620|NCT01609478|473350281|FG001|Overall Study|Physician Decision|0|||
131469621|NCT01609478|473350282|FG002|Overall Study|Physician Decision|1|||
131469622|NCT01609478|473350280|FG000|Overall Study|Withdrawal by Subject|2|||
131469623|NCT01609478|473350281|FG001|Overall Study|Withdrawal by Subject|0|||
131469624|NCT01609478|473350282|FG002|Overall Study|Withdrawal by Subject|2|||
131469625|NCT04966741|473350283|FG000|Overall Study|Lost to Follow-up|1|||
131469626|NCT04966741|473350284|FG001|Overall Study|Lost to Follow-up|0|||
131469627|NCT01853618|473350286|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
131469628|NCT01853618|473350287|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
131469629|NCT01853618|473350288|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
131469630|NCT01853618|473350289|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
131469631|NCT01853618|473350290|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
131469632|NCT01853618|473350286|FG000|Overall Study|Progressive disease|1|||
131469633|NCT01853618|473350287|FG001|Overall Study|Progressive disease|1|||
131469634|NCT01853618|473350288|FG002|Overall Study|Progressive disease|1|||
131469635|NCT01853618|473350289|FG003|Overall Study|Progressive disease|1|||
131469636|NCT01853618|473350290|FG004|Overall Study|Progressive disease|2|||
131469637|NCT01853618|473350286|FG000|Overall Study|Physician Decision|0|||
131469638|NCT01853618|473350287|FG001|Overall Study|Physician Decision|1|||
131469639|NCT01853618|473350288|FG002|Overall Study|Physician Decision|1|||
131469640|NCT01853618|473350289|FG003|Overall Study|Physician Decision|0|||
131469641|NCT01853618|473350290|FG004|Overall Study|Physician Decision|0|||
131469642|NCT01853618|473350286|FG000|Overall Study|Refused further treatment|0|||
131469643|NCT01853618|473350287|FG001|Overall Study|Refused further treatment|0|||
131469644|NCT01853618|473350288|FG002|Overall Study|Refused further treatment|0|||
131469645|NCT01853618|473350289|FG003|Overall Study|Refused further treatment|0|||
131469646|NCT01853618|473350290|FG004|Overall Study|Refused further treatment|1|||
131469647|NCT01146860|473350291|FG000|Overall Study|Withdrawal by Subject|0|||
131469648|NCT01146860|473350292|FG001|Overall Study|Withdrawal by Subject|1|||
131469649|NCT01075191|473350293|FG000|Overall Study|Death|1|||
131469650|NCT01075191|473350293|FG000|Overall Study|Intensification|3|||
131469651|NCT01075191|473350293|FG000|Overall Study|Co-morbidities|1|||
131469652|NCT01075191|473350293|FG000|Overall Study|Adverse Event|4|||
131469653|NCT01075191|473350293|FG000|Overall Study|Noncompliance|3|||
131469654|NCT01075191|473350293|FG000|Overall Study|Therapy Break|3|||
131469655|NCT01075191|473350293|FG000|Overall Study|Patient's Wish|2|||
131469656|NCT01075191|473350293|FG000|Overall Study|Unknown Reasons|1|||
131469657|NCT02635646|473350299|FG000|Overall Study|Lost to Follow-up|24|||
131469658|NCT02635646|473350300|FG001|Overall Study|Lost to Follow-up|25|||
131469659|NCT02635646|473350299|FG000|Overall Study|Pregnancy|1|||
131469660|NCT02635646|473350300|FG001|Overall Study|Pregnancy|1|||
131469661|NCT00645788|473350305|FG000|Overall Study|Did not receive study drug|1|||
131469662|NCT00645788|473350306|FG001|Overall Study|Did not receive study drug|1|||
131469663|NCT00645788|473350307|FG002|Overall Study|Did not receive study drug|0|||
131469664|NCT00645788|473350308|FG003|Overall Study|Did not receive study drug|0|||
131469665|NCT00645788|473350305|FG000|Overall Study|Adverse Event|4|||
131469666|NCT00645788|473350306|FG001|Overall Study|Adverse Event|9|||
131469667|NCT00645788|473350307|FG002|Overall Study|Adverse Event|5|||
131469668|NCT00645788|473350308|FG003|Overall Study|Adverse Event|3|||
131469669|NCT00645788|473350305|FG000|Overall Study|Lost to Follow-up|1|||
131469670|NCT00645788|473350306|FG001|Overall Study|Lost to Follow-up|0|||
131469671|NCT00645788|473350307|FG002|Overall Study|Lost to Follow-up|0|||
131469672|NCT00645788|473350308|FG003|Overall Study|Lost to Follow-up|0|||
131469673|NCT00645788|473350305|FG000|Overall Study|Protocol Violation|1|||
131469674|NCT00645788|473350306|FG001|Overall Study|Protocol Violation|0|||
131469675|NCT00645788|473350307|FG002|Overall Study|Protocol Violation|2|||
131469676|NCT00645788|473350308|FG003|Overall Study|Protocol Violation|0|||
131469677|NCT00645788|473350305|FG000|Overall Study|Withdrawal by Subject|0|||
131469678|NCT00645788|473350306|FG001|Overall Study|Withdrawal by Subject|1|||
131469679|NCT00645788|473350307|FG002|Overall Study|Withdrawal by Subject|0|||
131469680|NCT00645788|473350308|FG003|Overall Study|Withdrawal by Subject|2|||
131469681|NCT00645788|473350305|FG000|Overall Study|Pulmonary exacerbation|13|||
131469682|NCT00645788|473350306|FG001|Overall Study|Pulmonary exacerbation|16|||
131469683|NCT00645788|473350307|FG002|Overall Study|Pulmonary exacerbation|11|||
131469684|NCT00645788|473350308|FG003|Overall Study|Pulmonary exacerbation|9|||
131469685|NCT03149848|473350310|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
131469686|NCT03149848|473350310|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
131469687|NCT02581943|473350312|FG000|Overall Study|Death|5|||
131469688|NCT02581943|473350313|FG001|Overall Study|Death|2|||
131469689|NCT02581943|473350312|FG000|Overall Study|Disease Progression|12|||
131469690|NCT02581943|473350313|FG001|Overall Study|Disease Progression|15|||
131469691|NCT02581943|473350312|FG000|Overall Study|Withdrawal by Subject|1|||
131469692|NCT02581943|473350313|FG001|Overall Study|Withdrawal by Subject|2|||
131469693|NCT03021564|473350314|FG000|Overall Study|Death|84|||
131469694|NCT03021564|473350315|FG001|Overall Study|Death|466|||
131469695|NCT03021564|473350314|FG000|Overall Study|Lost to Follow-up|0|||
131469696|NCT03021564|473350315|FG001|Overall Study|Lost to Follow-up|2|||
131469697|NCT00459979|473350320|FG000|Overall Study|Withdrawal by Subject|1|||
131469698|NCT00459979|473350320|FG000|Overall Study|Protocol Violation|1|||
131469699|NCT00745615|473350325|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
131469700|NCT00745615|473350326|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
131469701|NCT00745615|473350327|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
131469702|NCT00745615|473350328|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
131469703|NCT00745615|473350329|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
131469704|NCT00745615|473350330|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
131469705|NCT00745615|473350325|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
131469706|NCT00745615|473350326|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
131469707|NCT00745615|473350327|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
131469708|NCT00745615|473350328|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
131469709|NCT00745615|473350329|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
131469710|NCT00745615|473350330|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
131469711|NCT00745615|473350325|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
131469712|NCT00745615|473350326|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
131469713|NCT00745615|473350327|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
131469714|NCT00745615|473350328|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
131469715|NCT00745615|473350329|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
131469716|NCT00745615|473350330|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
131469717|NCT00745615|473350325|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131469718|NCT00745615|473350326|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
131469719|NCT00745615|473350327|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131469720|NCT00745615|473350328|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131469721|NCT00745615|473350329|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131469722|NCT00745615|473350330|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131469723|NCT00745615|473350325|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
131469724|NCT00745615|473350326|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
131469725|NCT00745615|473350327|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
131469726|NCT00745615|473350328|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
131469727|NCT00745615|473350329|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
131469728|NCT00745615|473350330|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
131469729|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
131469730|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
131469731|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
131469732|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
131469733|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
131469734|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
131469735|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
131469736|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
131469737|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
131469738|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
131469739|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
131469740|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
131469741|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
131469742|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
131469743|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
131469744|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
131469745|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
131469746|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
131469747|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
131469748|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
131469749|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
131469750|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
131469751|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
131469752|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
131469753|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
131469754|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
131469755|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
131469756|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
131469757|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
131769951|NCT04516291|474436064|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131769952|NCT04516291|474436057|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
131769953|NCT04516291|474436058|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
131769954|NCT04516291|474436059|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
131769955|NCT04516291|474436060|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
131469758|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
131469759|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
131469760|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
131469761|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
131469762|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
131469763|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
131469764|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
131469765|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
131469766|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
131469767|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
131469768|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
131469769|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
131469770|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
131469771|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
131469772|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
131469773|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
131469774|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
131469775|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
131469776|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
131469777|NCT00745615|473350325|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
131469778|NCT00745615|473350326|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
131469779|NCT00745615|473350327|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
131469780|NCT00745615|473350328|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
131469781|NCT00745615|473350329|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
131469782|NCT00745615|473350330|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
131469783|NCT00570232|473350333|FG000|Overall Study|Adverse Event|10|||
131469784|NCT00570232|473350333|FG000|Overall Study|discontinued due to medical condition|3|||
131469785|NCT00570232|473350333|FG000|Overall Study|discontinued due to recurrence|8|||
131469786|NCT00570232|473350333|FG000|Overall Study|discontinued due to noncompliance|2|||
131469787|NCT00266864|473350334|FG000|Overall Study|Lost to Follow-up|4|||
131469788|NCT00266864|473350335|FG001|Overall Study|Lost to Follow-up|1|||
131469789|NCT00266864|473350334|FG000|Overall Study|Withdrawal by Subject|1|||
131469790|NCT00266864|473350335|FG001|Overall Study|Withdrawal by Subject|1|||
131469791|NCT03036800|473350336|FG000|Overall Study|Protocol Violation|1|||
131469792|NCT03036800|473350337|FG001|Overall Study|Protocol Violation|0|||
131469793|NCT03036800|473350336|FG000|Overall Study|Non-compliance|1|||
131469794|NCT03036800|473350337|FG001|Overall Study|Non-compliance|0|||
131469795|NCT03036800|473350336|FG000|Overall Study|Lost to Follow-up|1|||
131469796|NCT03036800|473350337|FG001|Overall Study|Lost to Follow-up|0|||
131469797|NCT03036800|473350336|FG000|Overall Study|Death|1|||
131469798|NCT03036800|473350337|FG001|Overall Study|Death|0|||
131469799|NCT03036800|473350336|FG000|Overall Study|Tolerance|5|||
131469800|NCT03036800|473350337|FG001|Overall Study|Tolerance|0|||
131469801|NCT03036800|473350336|FG000|Overall Study|Unknown/no reason given|50|||
131469802|NCT03036800|473350337|FG001|Overall Study|Unknown/no reason given|39|||
131469803|NCT02207946|473350341|FG000|Overall Study|Lost to Follow-up|1|||
131469804|NCT02207946|473350342|FG001|Overall Study|Lost to Follow-up|0|||
131469805|NCT02207946|473350341|FG000|Overall Study|Adverse Event|0|||
131469806|NCT02207946|473350342|FG001|Overall Study|Adverse Event|1|||
131469807|NCT00811642|473350343|FG000|Overall Study|Adverse Event|3|||
131469808|NCT00811642|473350343|FG000|Overall Study|Protocol Violation|1|||
131469809|NCT00811642|473350343|FG000|Overall Study|Death|2|||
131469810|NCT00811642|473350343|FG000|Overall Study|Withdrawal by Subject|7|||
131469811|NCT00811642|473350343|FG000|Overall Study|Cumulative use of antifungal agent|2|||
131469812|NCT01155479|473352045|FG000|Part I|Adverse Event|13|||
131469813|NCT01155479|473352046|FG001|Part I|Adverse Event|8|||
131469814|NCT01155479|473352047|FG002|Part I|Adverse Event|18|||
131469815|NCT01155479|473352048|FG003|Part I|Adverse Event|7|||
131469816|NCT01155479|473352049|FG004|Part I|Adverse Event|6|||
131469817|NCT01155479|473352045|FG000|Part I|Administrative|2|||
131469818|NCT01155479|473352046|FG001|Part I|Administrative|2|||
131469819|NCT01155479|473352047|FG002|Part I|Administrative|2|||
131469820|NCT01155479|473352048|FG003|Part I|Administrative|0|||
131469821|NCT01155479|473352049|FG004|Part I|Administrative|0|||
131469822|NCT01155479|473352045|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
131469823|NCT01155479|473352046|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
131469824|NCT01155479|473352047|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
131469825|NCT01155479|473352048|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
131469826|NCT01155479|473352049|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
131469827|NCT01155479|473352045|FG000|Part I|Withdrawal by Subject|11|||
131469828|NCT01155479|473352046|FG001|Part I|Withdrawal by Subject|13|||
131469829|NCT01155479|473352047|FG002|Part I|Withdrawal by Subject|8|||
131469830|NCT01155479|473352048|FG003|Part I|Withdrawal by Subject|8|||
131469831|NCT01155479|473352049|FG004|Part I|Withdrawal by Subject|9|||
131469832|NCT01155479|473352045|FG000|Part I|Lost to Follow-up|0|||
131469833|NCT01155479|473352046|FG001|Part I|Lost to Follow-up|0|||
131469834|NCT01155479|473352047|FG002|Part I|Lost to Follow-up|1|||
131469835|NCT01155479|473352048|FG003|Part I|Lost to Follow-up|1|||
131469836|NCT01155479|473352049|FG004|Part I|Lost to Follow-up|0|||
131469837|NCT01155479|473352045|FG000|Part I|Treatment Failure|3|||
131469838|NCT01155479|473352046|FG001|Part I|Treatment Failure|0|||
131469839|NCT01155479|473352047|FG002|Part I|Treatment Failure|3|||
131469840|NCT01155479|473352048|FG003|Part I|Treatment Failure|1|||
131469841|NCT01155479|473352049|FG004|Part I|Treatment Failure|2|||
131469842|NCT01155479|473352045|FG000|Part I|Did Not Receive Treatment|4|||
131469843|NCT01155479|473352046|FG001|Part I|Did Not Receive Treatment|2|||
131469844|NCT01155479|473352047|FG002|Part I|Did Not Receive Treatment|2|||
131469845|NCT01155479|473352048|FG003|Part I|Did Not Receive Treatment|6|||
131469846|NCT01155479|473352049|FG004|Part I|Did Not Receive Treatment|1|||
131469847|NCT01155479|473352045|FG000|Part I|Non-Compliance with Protocol|2|||
131469848|NCT01155479|473352046|FG001|Part I|Non-Compliance with Protocol|1|||
131469849|NCT01155479|473352047|FG002|Part I|Non-Compliance with Protocol|3|||
131469850|NCT01155479|473352048|FG003|Part I|Non-Compliance with Protocol|3|||
131469851|NCT01155479|473352049|FG004|Part I|Non-Compliance with Protocol|2|||
131469852|NCT01155479|473352045|FG000|Part II|Adverse Event|7|||
131469853|NCT01155479|473352046|FG001|Part II|Adverse Event|6|||
131469854|NCT01155479|473352047|FG002|Part II|Adverse Event|8|||
131469855|NCT01155479|473352048|FG003|Part II|Adverse Event|3|||
131469856|NCT01155479|473352049|FG004|Part II|Adverse Event|4|||
131469857|NCT01155479|473352045|FG000|Part II|Administrative|43|||
131469858|NCT01155479|473352046|FG001|Part II|Administrative|49|||
131469859|NCT01155479|473352047|FG002|Part II|Administrative|36|||
131469860|NCT01155479|473352048|FG003|Part II|Administrative|38|||
131469861|NCT01155479|473352049|FG004|Part II|Administrative|46|||
131469862|NCT01155479|473352045|FG000|Part II|Withdrawal by Subject|8|||
131469863|NCT01155479|473352046|FG001|Part II|Withdrawal by Subject|4|||
131469864|NCT01155479|473352047|FG002|Part II|Withdrawal by Subject|12|||
131469865|NCT01155479|473352048|FG003|Part II|Withdrawal by Subject|7|||
131469866|NCT01155479|473352049|FG004|Part II|Withdrawal by Subject|3|||
131469867|NCT01155479|473352045|FG000|Part II|Lost to Follow-up|1|||
131469868|NCT01155479|473352046|FG001|Part II|Lost to Follow-up|0|||
131469869|NCT01155479|473352047|FG002|Part II|Lost to Follow-up|0|||
131469870|NCT01155479|473352048|FG003|Part II|Lost to Follow-up|0|||
131469871|NCT01155479|473352049|FG004|Part II|Lost to Follow-up|1|||
131469872|NCT01155479|473352045|FG000|Part II|Treatment Failure|0|||
131469873|NCT01155479|473352046|FG001|Part II|Treatment Failure|1|||
131469874|NCT01155479|473352047|FG002|Part II|Treatment Failure|2|||
131469875|NCT01155479|473352048|FG003|Part II|Treatment Failure|0|||
131469876|NCT01155479|473352049|FG004|Part II|Treatment Failure|1|||
131469877|NCT01155479|473352045|FG000|Part II|Non-Compliance with Protocol|0|||
131469878|NCT01155479|473352046|FG001|Part II|Non-Compliance with Protocol|1|||
131469879|NCT01155479|473352047|FG002|Part II|Non-Compliance with Protocol|0|||
131469880|NCT01155479|473352048|FG003|Part II|Non-Compliance with Protocol|2|||
131469881|NCT01155479|473352049|FG004|Part II|Non-Compliance with Protocol|0|||
131469882|NCT01634178|473352052|FG000|Treatment Period 1|Adverse Event|0|||
131469883|NCT01634178|473352053|FG001|Treatment Period 1|Adverse Event|1|||
131469884|NCT01634178|473352052|FG000|Treatment Period 2|Adverse Event|1|||
131469885|NCT01634178|473352053|FG001|Treatment Period 2|Adverse Event|0|||
131469886|NCT00991952|473352054|FG000|Overall Study|Adverse Event|0|||
131469887|NCT00991952|473352055|FG001|Overall Study|Adverse Event|1|||
131469888|NCT00582816|473352056|FG000|Overall Study|Engraftment Failure|3|||
131469889|NCT00768469|473352059|FG000|Overall Study|Adverse Event|0|||
131469890|NCT00768469|473352060|FG001|Overall Study|Adverse Event|2|||
131469891|NCT00768469|473352059|FG000|Overall Study|Disease Progression|3|||
131469892|NCT00768469|473352060|FG001|Overall Study|Disease Progression|4|||
131469893|NCT00768469|473352059|FG000|Overall Study|Withdrawal by Subject|0|||
131469894|NCT00768469|473352060|FG001|Overall Study|Withdrawal by Subject|1|||
131469895|NCT02953509|473352067|FG000|Overall Study|Death|1|||
131469896|NCT02953509|473352068|FG001|Overall Study|Death|3|||
131469897|NCT02953509|473352069|FG002|Overall Study|Death|3|||
131469898|NCT02953509|473352070|FG003|Overall Study|Death|4|||
131469899|NCT02953509|473352071|FG004|Overall Study|Death|12|||
131469900|NCT02953509|473352072|FG005|Overall Study|Death|3|||
131469901|NCT02953509|473352073|FG006|Overall Study|Death|25|||
131469902|NCT02953509|473352074|FG007|Overall Study|Death|10|||
131469903|NCT02953509|473352075|FG008|Overall Study|Death|21|||
131469904|NCT02953509|473352076|FG009|Overall Study|Death|20|||
131469905|NCT02953509|473352067|FG000|Overall Study|Reason Not Specified|0|||
131469906|NCT02953509|473352068|FG001|Overall Study|Reason Not Specified|2|||
131469907|NCT02953509|473352069|FG002|Overall Study|Reason Not Specified|8|||
131469908|NCT02953509|473352070|FG003|Overall Study|Reason Not Specified|2|||
131469909|NCT02953509|473352071|FG004|Overall Study|Reason Not Specified|11|||
131469910|NCT02953509|473352072|FG005|Overall Study|Reason Not Specified|4|||
131469911|NCT02953509|473352073|FG006|Overall Study|Reason Not Specified|12|||
131469912|NCT02953509|473352074|FG007|Overall Study|Reason Not Specified|2|||
131469913|NCT02953509|473352075|FG008|Overall Study|Reason Not Specified|7|||
131469914|NCT02953509|473352076|FG009|Overall Study|Reason Not Specified|2|||
131469915|NCT02953509|473352067|FG000|Overall Study|Consent Withdrawn|1|||
131469916|NCT02953509|473352068|FG001|Overall Study|Consent Withdrawn|1|||
131469917|NCT02953509|473352069|FG002|Overall Study|Consent Withdrawn|2|||
131469918|NCT02953509|473352070|FG003|Overall Study|Consent Withdrawn|1|||
131469919|NCT02953509|473352071|FG004|Overall Study|Consent Withdrawn|3|||
131469920|NCT02953509|473352072|FG005|Overall Study|Consent Withdrawn|0|||
131469921|NCT02953509|473352073|FG006|Overall Study|Consent Withdrawn|4|||
131469922|NCT02953509|473352074|FG007|Overall Study|Consent Withdrawn|1|||
131469923|NCT02953509|473352075|FG008|Overall Study|Consent Withdrawn|1|||
131469924|NCT02953509|473352076|FG009|Overall Study|Consent Withdrawn|4|||
131469925|NCT02953509|473352067|FG000|Overall Study|Lost to Follow-up|0|||
131469926|NCT02953509|473352068|FG001|Overall Study|Lost to Follow-up|0|||
131469927|NCT02953509|473352069|FG002|Overall Study|Lost to Follow-up|0|||
131469928|NCT02953509|473352070|FG003|Overall Study|Lost to Follow-up|0|||
131469929|NCT02953509|473352071|FG004|Overall Study|Lost to Follow-up|0|||
131469930|NCT02953509|473352072|FG005|Overall Study|Lost to Follow-up|0|||
131469931|NCT02953509|473352073|FG006|Overall Study|Lost to Follow-up|1|||
131469932|NCT02953509|473352074|FG007|Overall Study|Lost to Follow-up|1|||
131469933|NCT02953509|473352075|FG008|Overall Study|Lost to Follow-up|1|||
131469934|NCT02953509|473352076|FG009|Overall Study|Lost to Follow-up|1|||
131469935|NCT02953509|473352067|FG000|Overall Study|Study terminated by sponsor|1|||
131469936|NCT02953509|473352068|FG001|Overall Study|Study terminated by sponsor|0|||
131469937|NCT02953509|473352069|FG002|Overall Study|Study terminated by sponsor|0|||
131469938|NCT02953509|473352070|FG003|Overall Study|Study terminated by sponsor|0|||
131469939|NCT02953509|473352071|FG004|Overall Study|Study terminated by sponsor|0|||
131469940|NCT02953509|473352072|FG005|Overall Study|Study terminated by sponsor|0|||
131469941|NCT02953509|473352073|FG006|Overall Study|Study terminated by sponsor|1|||
131469942|NCT02953509|473352074|FG007|Overall Study|Study terminated by sponsor|0|||
131469943|NCT02953509|473352075|FG008|Overall Study|Study terminated by sponsor|1|||
131469944|NCT02953509|473352076|FG009|Overall Study|Study terminated by sponsor|1|||
131469945|NCT02522871|473352077|FG000|Overall Study|Protocol Violation|1|||
131469946|NCT02522871|473352078|FG001|Overall Study|Protocol Violation|4|||
131469947|NCT02522871|473352077|FG000|Overall Study|Treated without randomization|1|||
131469948|NCT02522871|473352078|FG001|Overall Study|Treated without randomization|0|||
131469949|NCT02522871|473352077|FG000|Overall Study|Death|9|||
131469950|NCT02522871|473352078|FG001|Overall Study|Death|9|||
131469951|NCT02522871|473352077|FG000|Overall Study|Died in operating room prior to transplant|0|||
131469952|NCT02522871|473352078|FG001|Overall Study|Died in operating room prior to transplant|1|||
131469953|NCT00725842|473352079|FG000|Overall Study|Lost to Follow-up|19|||
131469954|NCT00725842|473352079|FG000|Overall Study|Death|1|||
131469955|NCT00725842|473352079|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
131469956|NCT00725842|473352079|FG000|Overall Study|Consent date prior to study start date|5|||
131469957|NCT00725842|473352079|FG000|Overall Study|Inclusion criterion not met|1|||
131469958|NCT00725842|473352079|FG000|Overall Study|No Visit 1 data|1|||
131469959|NCT01715129|473352080|FG000|Overall Study|Adverse Event, fatal|1|||
131469960|NCT01715129|473352080|FG000|Overall Study|Lack of Efficacy|3|||
131469961|NCT01715129|473352080|FG000|Overall Study|Protocol Violation|1|||
131469962|NCT01715129|473352080|FG000|Overall Study|Consent Withdrawn|2|||
131469963|NCT01715129|473352080|FG000|Overall Study|Lost to Follow-up|1|||
131469964|NCT01715129|473352080|FG000|Overall Study|Other|1|||
131469965|NCT02793622|473352081|FG000|Overall Study|Lost to Follow-up|31|||
131469966|NCT02793622|473352082|FG001|Overall Study|Lost to Follow-up|19|||
131469967|NCT02793622|473352081|FG000|Overall Study|Withdrawal by Subject|21|||
131469968|NCT02793622|473352082|FG001|Overall Study|Withdrawal by Subject|17|||
131469969|NCT02793622|473352081|FG000|Overall Study|Adverse Event|0|||
131469970|NCT02793622|473352082|FG001|Overall Study|Adverse Event|1|||
131469971|NCT02793622|473352081|FG000|Overall Study|Protocol Violation|1|||
131469972|NCT02793622|473352082|FG001|Overall Study|Protocol Violation|5|||
131469973|NCT01092832|473352083|FG000|Overall Study|Other|1|||
131469974|NCT01092832|473352084|FG001|Overall Study|Other|0|||
131469975|NCT00722371|473352085|FG000|Overall Study|Adverse Event|6|||
131469976|NCT00722371|473352086|FG001|Overall Study|Adverse Event|13|||
131469977|NCT00722371|473352087|FG002|Overall Study|Adverse Event|9|||
131469978|NCT00722371|473352088|FG003|Overall Study|Adverse Event|10|||
131469979|NCT00722371|473352089|FG004|Overall Study|Adverse Event|6|||
131469980|NCT00722371|473352090|FG005|Overall Study|Adverse Event|8|||
131469981|NCT00722371|473352091|FG006|Overall Study|Adverse Event|4|||
131469982|NCT00722371|473352085|FG000|Overall Study|Contraindication|0|||
131469983|NCT00722371|473352086|FG001|Overall Study|Contraindication|0|||
131469984|NCT00722371|473352087|FG002|Overall Study|Contraindication|1|||
131469985|NCT00722371|473352088|FG003|Overall Study|Contraindication|0|||
131469986|NCT00722371|473352089|FG004|Overall Study|Contraindication|0|||
131469987|NCT00722371|473352090|FG005|Overall Study|Contraindication|0|||
131469988|NCT00722371|473352091|FG006|Overall Study|Contraindication|0|||
131469989|NCT00722371|473352085|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
131469990|NCT00722371|473352086|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
131469991|NCT00722371|473352087|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
131469992|NCT00722371|473352088|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
131469993|NCT00722371|473352089|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
131769956|NCT04516291|474436061|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
131769957|NCT04516291|474436062|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
131769958|NCT04516291|474436063|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
131769959|NCT04516291|474436064|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
131769960|NCT03039686|474436065|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
131769961|NCT03039686|474436066|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
131469994|NCT00722371|473352090|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
131469995|NCT00722371|473352091|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
131469996|NCT00722371|473352085|FG000|Overall Study|Excluded medication|0|||
131469997|NCT00722371|473352086|FG001|Overall Study|Excluded medication|1|||
131469998|NCT00722371|473352087|FG002|Overall Study|Excluded medication|1|||
131469999|NCT00722371|473352088|FG003|Overall Study|Excluded medication|0|||
131470000|NCT00722371|473352089|FG004|Overall Study|Excluded medication|0|||
131470001|NCT00722371|473352090|FG005|Overall Study|Excluded medication|0|||
131470002|NCT00722371|473352091|FG006|Overall Study|Excluded medication|1|||
131470003|NCT00722371|473352085|FG000|Overall Study|Hyperglycemia|2|||
131470004|NCT00722371|473352086|FG001|Overall Study|Hyperglycemia|6|||
131470005|NCT00722371|473352087|FG002|Overall Study|Hyperglycemia|4|||
131470006|NCT00722371|473352088|FG003|Overall Study|Hyperglycemia|2|||
131470007|NCT00722371|473352089|FG004|Overall Study|Hyperglycemia|5|||
131470008|NCT00722371|473352090|FG005|Overall Study|Hyperglycemia|1|||
131470009|NCT00722371|473352091|FG006|Overall Study|Hyperglycemia|1|||
131470010|NCT00722371|473352085|FG000|Overall Study|Hypoglycemia|1|||
131470011|NCT00722371|473352086|FG001|Overall Study|Hypoglycemia|0|||
131470012|NCT00722371|473352087|FG002|Overall Study|Hypoglycemia|0|||
131470013|NCT00722371|473352088|FG003|Overall Study|Hypoglycemia|0|||
131470014|NCT00722371|473352089|FG004|Overall Study|Hypoglycemia|0|||
131470015|NCT00722371|473352090|FG005|Overall Study|Hypoglycemia|0|||
131470016|NCT00722371|473352091|FG006|Overall Study|Hypoglycemia|0|||
131470017|NCT00722371|473352085|FG000|Overall Study|Lack of Efficacy|4|||
131470018|NCT00722371|473352086|FG001|Overall Study|Lack of Efficacy|6|||
131470019|NCT00722371|473352087|FG002|Overall Study|Lack of Efficacy|6|||
131470020|NCT00722371|473352088|FG003|Overall Study|Lack of Efficacy|6|||
131470021|NCT00722371|473352089|FG004|Overall Study|Lack of Efficacy|2|||
131470022|NCT00722371|473352090|FG005|Overall Study|Lack of Efficacy|3|||
131470023|NCT00722371|473352091|FG006|Overall Study|Lack of Efficacy|0|||
131470024|NCT00722371|473352085|FG000|Overall Study|Lost to Follow-up|11|||
131470025|NCT00722371|473352086|FG001|Overall Study|Lost to Follow-up|14|||
131470026|NCT00722371|473352087|FG002|Overall Study|Lost to Follow-up|21|||
131470027|NCT00722371|473352088|FG003|Overall Study|Lost to Follow-up|13|||
131470028|NCT00722371|473352089|FG004|Overall Study|Lost to Follow-up|8|||
131470029|NCT00722371|473352090|FG005|Overall Study|Lost to Follow-up|16|||
131470030|NCT00722371|473352091|FG006|Overall Study|Lost to Follow-up|13|||
131470031|NCT00722371|473352085|FG000|Overall Study|Physician Decision|5|||
131470032|NCT00722371|473352086|FG001|Overall Study|Physician Decision|2|||
131470033|NCT00722371|473352087|FG002|Overall Study|Physician Decision|2|||
131470034|NCT00722371|473352088|FG003|Overall Study|Physician Decision|5|||
131470035|NCT00722371|473352089|FG004|Overall Study|Physician Decision|2|||
131470036|NCT00722371|473352090|FG005|Overall Study|Physician Decision|3|||
131470037|NCT00722371|473352091|FG006|Overall Study|Physician Decision|4|||
131470038|NCT00722371|473352085|FG000|Overall Study|Pregnancy|1|||
131470039|NCT00722371|473352086|FG001|Overall Study|Pregnancy|1|||
131470040|NCT00722371|473352087|FG002|Overall Study|Pregnancy|0|||
131470041|NCT00722371|473352088|FG003|Overall Study|Pregnancy|0|||
131470042|NCT00722371|473352089|FG004|Overall Study|Pregnancy|0|||
131470043|NCT00722371|473352090|FG005|Overall Study|Pregnancy|1|||
131470044|NCT00722371|473352091|FG006|Overall Study|Pregnancy|0|||
131470045|NCT00722371|473352085|FG000|Overall Study|Protocol Violation|6|||
131470046|NCT00722371|473352086|FG001|Overall Study|Protocol Violation|1|||
131470047|NCT00722371|473352087|FG002|Overall Study|Protocol Violation|0|||
131470048|NCT00722371|473352088|FG003|Overall Study|Protocol Violation|1|||
131470049|NCT00722371|473352089|FG004|Overall Study|Protocol Violation|4|||
131470050|NCT00722371|473352090|FG005|Overall Study|Protocol Violation|2|||
131470051|NCT00722371|473352091|FG006|Overall Study|Protocol Violation|1|||
131470052|NCT00722371|473352085|FG000|Overall Study|Withdrawal by Subject|18|||
131470053|NCT00722371|473352086|FG001|Overall Study|Withdrawal by Subject|27|||
131470054|NCT00722371|473352087|FG002|Overall Study|Withdrawal by Subject|19|||
131470055|NCT00722371|473352088|FG003|Overall Study|Withdrawal by Subject|23|||
131470056|NCT00722371|473352089|FG004|Overall Study|Withdrawal by Subject|19|||
131470057|NCT00722371|473352090|FG005|Overall Study|Withdrawal by Subject|18|||
131470058|NCT00722371|473352091|FG006|Overall Study|Withdrawal by Subject|26|||
131470059|NCT02068768|473352092|FG000|Overall Study|Lost to Follow-up|5|||
131470060|NCT02068768|473352092|FG000|Overall Study|Early Termination by Sponsor|2|||
131470061|NCT00555425|473352093|FG000|Overall Study|Missed Medication > 1 wk|34|||
131470062|NCT00555425|473352094|FG001|Overall Study|Missed Medication > 1 wk|15|||
131470063|NCT00555425|473352093|FG000|Overall Study|Missed 3 physician management visits|1|||
131470064|NCT00555425|473352094|FG001|Overall Study|Missed 3 physician management visits|0|||
131470065|NCT00555425|473352093|FG000|Overall Study|Met criteria for protective transfer|16|||
131470066|NCT00555425|473352094|FG001|Overall Study|Met criteria for protective transfer|3|||
131470067|NCT00555425|473352093|FG000|Overall Study|Became pregnant and transferred care|0|||
131470068|NCT00555425|473352094|FG001|Overall Study|Became pregnant and transferred care|1|||
131470069|NCT03761797|473352095|FG000|Overall Study|Changing hospital|11|||
131470070|NCT03761797|473352095|FG000|Overall Study|Improvement/remission|6|||
131470071|NCT03761797|473352095|FG000|Overall Study|Withdrawal by Subject|19|||
131470072|NCT03761797|473352095|FG000|Overall Study|Lost to Follow-up|33|||
131470073|NCT03761797|473352095|FG000|Overall Study|Adverse Event|37|||
131470074|NCT03761797|473352095|FG000|Overall Study|Case report form (CRF) not collected|5|||
131470075|NCT03761797|473352095|FG000|Overall Study|No patient visit after entry|13|||
131470076|NCT03761797|473352095|FG000|Overall Study|Switch to other diabetes medication|10|||
131470077|NCT03761797|473352095|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
131470078|NCT03761797|473352095|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
131470079|NCT03761797|473352095|FG000|Overall Study|Insufficient effectives|2|||
131470080|NCT03761797|473352095|FG000|Overall Study|Excessive alcohol intake|1|||
131470081|NCT01244490|473352099|FG000|Overall Study|Lack of Efficacy|14|||
131470082|NCT01244490|473352100|FG001|Overall Study|Lack of Efficacy|5|||
131470083|NCT01244490|473352101|FG002|Overall Study|Lack of Efficacy|5|||
131470084|NCT01244490|473352099|FG000|Overall Study|Withdrawal by Subject|4|||
131470085|NCT01244490|473352100|FG001|Overall Study|Withdrawal by Subject|4|||
131470086|NCT01244490|473352101|FG002|Overall Study|Withdrawal by Subject|9|||
131470087|NCT01244490|473352099|FG000|Overall Study|Adverse Event|1|||
131470088|NCT01244490|473352100|FG001|Overall Study|Adverse Event|9|||
131470089|NCT01244490|473352101|FG002|Overall Study|Adverse Event|5|||
131470090|NCT01244490|473352099|FG000|Overall Study|Lost to Follow-up|0|||
131470091|NCT01244490|473352100|FG001|Overall Study|Lost to Follow-up|6|||
131470092|NCT01244490|473352101|FG002|Overall Study|Lost to Follow-up|3|||
131470093|NCT01244490|473352099|FG000|Overall Study|Other|0|||
131470094|NCT01244490|473352100|FG001|Overall Study|Other|0|||
131470095|NCT01244490|473352101|FG002|Overall Study|Other|1|||
131470096|NCT00400153|473352102|FG000|Overall Study|AE due to study disease worsening|14|||
131470097|NCT00400153|473352103|FG001|Overall Study|AE due to study disease worsening|19|||
131470098|NCT00400153|473352104|FG002|Overall Study|AE due to study disease worsening|20|||
131470099|NCT00400153|473352102|FG000|Overall Study|AE due to other disease worsening|2|||
131470100|NCT00400153|473352103|FG001|Overall Study|AE due to other disease worsening|1|||
131470101|NCT00400153|473352104|FG002|Overall Study|AE due to other disease worsening|0|||
131470102|NCT00400153|473352102|FG000|Overall Study|AE due to other condition|3|||
131470103|NCT00400153|473352103|FG001|Overall Study|AE due to other condition|14|||
131470104|NCT00400153|473352104|FG002|Overall Study|AE due to other condition|15|||
131470105|NCT00400153|473352102|FG000|Overall Study|Protocol Violation|7|||
131470106|NCT00400153|473352103|FG001|Overall Study|Protocol Violation|4|||
131470107|NCT00400153|473352104|FG002|Overall Study|Protocol Violation|9|||
131470108|NCT00400153|473352102|FG000|Overall Study|Lost to Follow-up|2|||
131470109|NCT00400153|473352103|FG001|Overall Study|Lost to Follow-up|1|||
131470110|NCT00400153|473352104|FG002|Overall Study|Lost to Follow-up|4|||
131470111|NCT00400153|473352102|FG000|Overall Study|Withdrawal by Subject|12|||
131470112|NCT00400153|473352103|FG001|Overall Study|Withdrawal by Subject|11|||
131470113|NCT00400153|473352104|FG002|Overall Study|Withdrawal by Subject|10|||
131470114|NCT00400153|473352102|FG000|Overall Study|Other reasons - not mentioned above|8|||
131470115|NCT00400153|473352103|FG001|Overall Study|Other reasons - not mentioned above|5|||
131470116|NCT00400153|473352104|FG002|Overall Study|Other reasons - not mentioned above|3|||
131470117|NCT00393042|473352107|FG000|First Intervention|Withdrawal by Subject|1|||
131470118|NCT00393042|473352108|FG001|First Intervention|Withdrawal by Subject|2|||
131470119|NCT00393042|473352107|FG000|First Intervention|Lost to Follow-up|3|||
131470120|NCT00393042|473352108|FG001|First Intervention|Lost to Follow-up|3|||
131470121|NCT00393042|473352107|FG000|First Intervention|Protocol Violation|1|||
131470122|NCT00393042|473352108|FG001|First Intervention|Protocol Violation|0|||
131470123|NCT00393042|473352107|FG000|First Intervention|Adverse Event|0|||
131470124|NCT00393042|473352108|FG001|First Intervention|Adverse Event|1|||
131769962|NCT03039686|474436067|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
131769963|NCT03039686|474436065|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
131769964|NCT03039686|474436066|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
131470125|NCT00393042|473352107|FG000|Second Intervetion|Adverse Event|0|||
131470126|NCT00393042|473352108|FG001|Second Intervetion|Adverse Event|3|||
131470127|NCT00393042|473352107|FG000|Second Intervetion|Withdrawal by Subject|0|||
131470128|NCT00393042|473352108|FG001|Second Intervetion|Withdrawal by Subject|2|||
131470129|NCT00393042|473352107|FG000|Second Intervetion|Lack of Efficacy|1|||
131470130|NCT00393042|473352108|FG001|Second Intervetion|Lack of Efficacy|0|||
131470131|NCT00393042|473352107|FG000|Second Intervetion|Lost to Follow-up|0|||
131769965|NCT03039686|474436067|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
131470132|NCT00393042|473352108|FG001|Second Intervetion|Lost to Follow-up|2|||
131470133|NCT00393042|473352107|FG000|Second Intervetion|Protocol Violation|1|||
131470134|NCT00393042|473352108|FG001|Second Intervetion|Protocol Violation|1|||
131769966|NCT03039686|474436065|FG000|Double-blind Period|Withdrawal by Subject|2|||
131470135|NCT01150474|473352113|FG000|Overall Study|Withdrawal by Subject|5|||
131470136|NCT01150474|473352114|FG001|Overall Study|Withdrawal by Subject|2|||
131470137|NCT01150474|473352113|FG000|Overall Study|Cancer found|1|||
131470138|NCT01150474|473352114|FG001|Overall Study|Cancer found|0|||
131470139|NCT01150474|473352113|FG000|Overall Study|Multiple Studies|0|||
131470140|NCT01150474|473352114|FG001|Overall Study|Multiple Studies|1|||
131470141|NCT01150474|473352113|FG000|Overall Study|Rectotomy|1|||
131470142|NCT01150474|473352114|FG001|Overall Study|Rectotomy|0|||
131470143|NCT01150474|473352113|FG000|Overall Study|Drug did not arrive in time|1|||
131470144|NCT01150474|473352114|FG001|Overall Study|Drug did not arrive in time|0|||
131470145|NCT01150474|473352113|FG000|Overall Study|Drug not administered|1|||
131470146|NCT01150474|473352114|FG001|Overall Study|Drug not administered|0|||
131470147|NCT01150474|473352113|FG000|Overall Study|Surgery Changed|1|||
131470148|NCT01150474|473352114|FG001|Overall Study|Surgery Changed|0|||
131470149|NCT00327470|473352117|FG000|Overall Study|Randomized, but not treated|0|||
131470150|NCT00327470|473352118|FG001|Overall Study|Randomized, but not treated|2|||
131470151|NCT00327470|473352117|FG000|Overall Study|Adverse Event|9|||
131470152|NCT00327470|473352118|FG001|Overall Study|Adverse Event|14|||
131470153|NCT00327470|473352117|FG000|Overall Study|Lack of Efficacy|7|||
131470154|NCT00327470|473352118|FG001|Overall Study|Lack of Efficacy|19|||
131470155|NCT00327470|473352117|FG000|Overall Study|Other|5|||
131470156|NCT00327470|473352118|FG001|Overall Study|Other|9|||
131470157|NCT00327470|473352117|FG000|Overall Study|Lost to Follow-up|1|||
131470158|NCT00327470|473352118|FG001|Overall Study|Lost to Follow-up|3|||
131470159|NCT00327470|473352117|FG000|Overall Study|Withdrawal by Subject|6|||
131470160|NCT00327470|473352118|FG001|Overall Study|Withdrawal by Subject|12|||
131470161|NCT00327470|473352117|FG000|Overall Study|Death|1|||
131470162|NCT00327470|473352118|FG001|Overall Study|Death|4|||
131470163|NCT01163032|473352122|FG000|Randomization Phase|Withdrawal by Subject|2|||
131470164|NCT01163032|473352123|FG001|Randomization Phase|Withdrawal by Subject|3|||
131470165|NCT01163032|473352124|FG002|Randomization Phase|Withdrawal by Subject|0|||
131470166|NCT01163032|473352122|FG000|Randomization Phase|Adverse Event|3|||
131470167|NCT01163032|473352123|FG001|Randomization Phase|Adverse Event|3|||
131470168|NCT01163032|473352124|FG002|Randomization Phase|Adverse Event|0|||
131470169|NCT01163032|473352122|FG000|Randomization Phase|Protocol Violation|0|||
131470170|NCT01163032|473352123|FG001|Randomization Phase|Protocol Violation|1|||
131470171|NCT01163032|473352124|FG002|Randomization Phase|Protocol Violation|0|||
131470172|NCT01163032|473352122|FG000|Randomization Phase|Various*|5|||
131470173|NCT01163032|473352123|FG001|Randomization Phase|Various*|4|||
131470174|NCT01163032|473352124|FG002|Randomization Phase|Various*|0|||
131470175|NCT01163032|473352122|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
131470176|NCT01163032|473352123|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
131470177|NCT01163032|473352124|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
131470178|NCT01163032|473352122|FG000|Open Label Extension Phase|Adverse Event|0|||
131470179|NCT01163032|473352123|FG001|Open Label Extension Phase|Adverse Event|0|||
131470180|NCT01163032|473352124|FG002|Open Label Extension Phase|Adverse Event|3|||
131470181|NCT01163032|473352122|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
131470182|NCT01163032|473352123|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
131470183|NCT01163032|473352124|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
131470184|NCT01163032|473352122|FG000|Open Label Extension Phase|Protocol Violation|0|||
131470185|NCT01163032|473352123|FG001|Open Label Extension Phase|Protocol Violation|0|||
131470186|NCT01163032|473352124|FG002|Open Label Extension Phase|Protocol Violation|1|||
131470187|NCT01163032|473352122|FG000|Open Label Extension Phase|Study Termination|0|||
131470188|NCT01163032|473352123|FG001|Open Label Extension Phase|Study Termination|0|||
131470189|NCT01163032|473352124|FG002|Open Label Extension Phase|Study Termination|7|||
131470190|NCT01163032|473352122|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
131470191|NCT01163032|473352123|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
131470192|NCT01163032|473352124|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
131470193|NCT01307020|473352127|FG000|Overall Study|Lost to Follow-up|0|||
131470194|NCT01307020|473352128|FG001|Overall Study|Lost to Follow-up|0|||
131470195|NCT01307020|473352129|FG002|Overall Study|Lost to Follow-up|1|||
131470196|NCT01307020|473352130|FG003|Overall Study|Lost to Follow-up|1|||
131470197|NCT01307020|473352131|FG004|Overall Study|Lost to Follow-up|0|||
131470198|NCT01307020|473352132|FG005|Overall Study|Lost to Follow-up|0|||
131470199|NCT01307020|473352133|FG006|Overall Study|Lost to Follow-up|1|||
131470200|NCT01307020|473352134|FG007|Overall Study|Lost to Follow-up|0|||
131470201|NCT01307020|473352135|FG008|Overall Study|Lost to Follow-up|0|||
131470202|NCT01307020|473352136|FG009|Overall Study|Lost to Follow-up|0|||
131470203|NCT01307020|473352127|FG000|Overall Study|Electronic data capture failure|0|||
131470204|NCT01307020|473352128|FG001|Overall Study|Electronic data capture failure|1|||
131470205|NCT01307020|473352129|FG002|Overall Study|Electronic data capture failure|0|||
131470206|NCT01307020|473352130|FG003|Overall Study|Electronic data capture failure|0|||
131470207|NCT01307020|473352131|FG004|Overall Study|Electronic data capture failure|0|||
131470208|NCT01307020|473352132|FG005|Overall Study|Electronic data capture failure|0|||
131470209|NCT01307020|473352133|FG006|Overall Study|Electronic data capture failure|0|||
131470210|NCT01307020|473352134|FG007|Overall Study|Electronic data capture failure|0|||
131470211|NCT01307020|473352135|FG008|Overall Study|Electronic data capture failure|0|||
131470212|NCT01307020|473352136|FG009|Overall Study|Electronic data capture failure|0|||
131470213|NCT02380690|473352137|FG000|Overall Study|Lost to Follow-up|14|||
131470214|NCT02380690|473352138|FG001|Overall Study|Lost to Follow-up|4|||
131470215|NCT02380690|473352137|FG000|Overall Study|Withdrawal by Subject|20|||
131470216|NCT02380690|473352138|FG001|Overall Study|Withdrawal by Subject|8|||
131470217|NCT00727532|473352139|FG000|Overall Study|Adverse Event|1|||
131470218|NCT00727532|473352139|FG000|Overall Study|Withdrawal by Subject|1|||
131470219|NCT00829933|473352140|FG000|Overall Study|Adverse Event|2|||
131470220|NCT00829933|473352141|FG001|Overall Study|Adverse Event|3|||
131470221|NCT00829933|473352142|FG002|Overall Study|Adverse Event|2|||
131470222|NCT00829933|473352143|FG003|Overall Study|Adverse Event|1|||
131470223|NCT00829933|473352140|FG000|Overall Study|Death|0|||
131470224|NCT00829933|473352141|FG001|Overall Study|Death|0|||
131470225|NCT00829933|473352142|FG002|Overall Study|Death|1|||
131470226|NCT00829933|473352143|FG003|Overall Study|Death|1|||
131470227|NCT00829933|473352140|FG000|Overall Study|Lack of Efficacy|0|||
131470228|NCT00829933|473352141|FG001|Overall Study|Lack of Efficacy|1|||
131470229|NCT00829933|473352142|FG002|Overall Study|Lack of Efficacy|0|||
131470230|NCT00829933|473352143|FG003|Overall Study|Lack of Efficacy|0|||
131470231|NCT00829933|473352140|FG000|Overall Study|Physician Decision|5|||
131470232|NCT00829933|473352141|FG001|Overall Study|Physician Decision|7|||
131470233|NCT00829933|473352142|FG002|Overall Study|Physician Decision|8|||
131470234|NCT00829933|473352143|FG003|Overall Study|Physician Decision|1|||
131470235|NCT00829933|473352140|FG000|Overall Study|Pregnancy|0|||
131470236|NCT00829933|473352141|FG001|Overall Study|Pregnancy|0|||
131470237|NCT00829933|473352142|FG002|Overall Study|Pregnancy|0|||
131470238|NCT00829933|473352143|FG003|Overall Study|Pregnancy|2|||
131470239|NCT00829933|473352140|FG000|Overall Study|Protocol Violation|2|||
131470240|NCT00829933|473352141|FG001|Overall Study|Protocol Violation|1|||
131470241|NCT00829933|473352142|FG002|Overall Study|Protocol Violation|0|||
131470242|NCT00829933|473352143|FG003|Overall Study|Protocol Violation|0|||
131470243|NCT00829933|473352140|FG000|Overall Study|withdrew before treatment started|5|||
131470244|NCT00829933|473352141|FG001|Overall Study|withdrew before treatment started|1|||
131470245|NCT00829933|473352142|FG002|Overall Study|withdrew before treatment started|2|||
131470246|NCT00829933|473352143|FG003|Overall Study|withdrew before treatment started|9|||
131470247|NCT01986933|473352148|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
131470248|NCT01986933|473352149|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
131470249|NCT01986933|473352150|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
131470250|NCT01986933|473352151|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
131470251|NCT01986933|473352152|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
131470252|NCT01986933|473352148|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
131470253|NCT01986933|473352149|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
131470254|NCT01986933|473352150|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
131470255|NCT01986933|473352151|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
131470256|NCT01986933|473352152|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
131470257|NCT01986933|473352148|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
131470258|NCT01986933|473352149|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
131470259|NCT01986933|473352150|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
131470260|NCT01986933|473352151|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
131470261|NCT01986933|473352152|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
131470262|NCT01986933|473352148|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
131470263|NCT01986933|473352149|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
131470264|NCT01986933|473352150|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
131470265|NCT01986933|473352151|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
131470266|NCT01986933|473352152|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
131470267|NCT01986933|473352148|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
131470268|NCT01986933|473352149|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
131470269|NCT01986933|473352150|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
131470270|NCT01986933|473352151|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
131470271|NCT01986933|473352152|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
131470272|NCT01986933|473352148|FG000|Active-to-active (Part B)|Adverse Event|0|||
131470273|NCT01986933|473352149|FG001|Active-to-active (Part B)|Adverse Event|2|||
131470274|NCT01986933|473352150|FG002|Active-to-active (Part B)|Adverse Event|0|||
131470275|NCT01986933|473352151|FG003|Active-to-active (Part B)|Adverse Event|1|||
131470276|NCT01986933|473352152|FG004|Active-to-active (Part B)|Adverse Event|3|||
131470277|NCT01986933|473352148|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
131470278|NCT01986933|473352149|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
131470279|NCT01986933|473352150|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
131470280|NCT01986933|473352151|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
131470281|NCT01986933|473352152|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
131470282|NCT01986933|473352148|FG000|Active-to-active (Part B)|Pregnancy|0|||
131470283|NCT01986933|473352149|FG001|Active-to-active (Part B)|Pregnancy|0|||
131470284|NCT01986933|473352150|FG002|Active-to-active (Part B)|Pregnancy|0|||
131470285|NCT01986933|473352151|FG003|Active-to-active (Part B)|Pregnancy|0|||
131470286|NCT01986933|473352152|FG004|Active-to-active (Part B)|Pregnancy|1|||
131470287|NCT01986933|473352148|FG000|Active-to-active (Part B)|Physician Decision|0|||
131470288|NCT01986933|473352149|FG001|Active-to-active (Part B)|Physician Decision|0|||
131470289|NCT01986933|473352150|FG002|Active-to-active (Part B)|Physician Decision|1|||
131470290|NCT01986933|473352151|FG003|Active-to-active (Part B)|Physician Decision|1|||
131470291|NCT01986933|473352152|FG004|Active-to-active (Part B)|Physician Decision|0|||
131470292|NCT01986933|473352148|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
131470293|NCT01986933|473352149|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
131470294|NCT01986933|473352150|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
131470295|NCT01986933|473352151|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
131470296|NCT01986933|473352152|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
131470297|NCT01986933|473352148|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
131470298|NCT01986933|473352149|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
131470299|NCT01986933|473352150|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
131470300|NCT01986933|473352151|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
131470301|NCT01986933|473352152|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
131470302|NCT01986933|473352148|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
131470303|NCT01986933|473352149|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
131470304|NCT01986933|473352150|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
131470305|NCT01986933|473352151|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
131470306|NCT01986933|473352152|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
131470307|NCT01986933|473352148|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
131470308|NCT01986933|473352149|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
131470309|NCT01986933|473352150|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
131470310|NCT01986933|473352151|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
131470311|NCT01986933|473352152|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
131470312|NCT01986933|473352148|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
131470313|NCT01986933|473352149|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
131470314|NCT01986933|473352150|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
131470315|NCT01986933|473352151|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
131470316|NCT01986933|473352152|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
131470317|NCT01986933|473352148|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
131470318|NCT01986933|473352149|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
131470319|NCT01986933|473352150|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
131470320|NCT01986933|473352151|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
131470321|NCT01986933|473352152|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
131470322|NCT01986933|473352148|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
131470323|NCT01986933|473352149|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
131470324|NCT01986933|473352150|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
131470325|NCT01986933|473352151|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
131470326|NCT01986933|473352152|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
131470327|NCT01986933|473352148|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
131470328|NCT01986933|473352149|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
131470329|NCT01986933|473352150|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
131470330|NCT01986933|473352151|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
131470331|NCT01986933|473352152|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
131470332|NCT03119701|473352153|FG000|6-day Dosing|Death|4|||
131470333|NCT03119701|473352154|FG001|6-day Dosing|Death|1|||
131470334|NCT03119701|473352153|FG000|6-day Dosing|Adverse Event|3|||
131470335|NCT03119701|473352154|FG001|6-day Dosing|Adverse Event|0|||
131470336|NCT03119701|473352153|FG000|6-day Dosing|Physician Decision|0|||
131470337|NCT03119701|473352154|FG001|6-day Dosing|Physician Decision|1|||
131470338|NCT03119701|473352153|FG000|6-day Dosing|Withdrawal by Subject|0|||
131470339|NCT03119701|473352154|FG001|6-day Dosing|Withdrawal by Subject|1|||
131470340|NCT03119701|473352153|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
131470341|NCT03119701|473352154|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
131470342|NCT00782795|473352163|FG000|Overall Study|Withdrawal by Subject|1|||
131470343|NCT00782795|473352164|FG001|Overall Study|Withdrawal by Subject|2|||
131470344|NCT05772702|473352172|FG000|Overall Study|Adverse Event|1|||
131470345|NCT00884377|473353726|FG000|Overall Study|Withdrawal by Subject|1|||
131470346|NCT00884377|473353727|FG001|Overall Study|Withdrawal by Subject|0|||
131769967|NCT03039686|474436066|FG001|Double-blind Period|Withdrawal by Subject|2|||
131470347|NCT00884377|473353726|FG000|Overall Study|Could not confirm diagnosis|1|||
131470348|NCT00884377|473353727|FG001|Overall Study|Could not confirm diagnosis|0|||
131470349|NCT00884377|473353726|FG000|Overall Study|Physician Decision|0|||
131470350|NCT00884377|473353727|FG001|Overall Study|Physician Decision|1|||
131470351|NCT02003365|473353728|FG000|Overall Study|Lost to Follow-up|0|||
131470352|NCT02003365|473353729|FG001|Overall Study|Lost to Follow-up|0|||
131470353|NCT02003365|473353730|FG002|Overall Study|Lost to Follow-up|1|||
131470354|NCT04854642|473353731|FG000|Overall Study|Adverse Event|1|||
131470355|NCT04854642|473353732|FG001|Overall Study|Adverse Event|2|||
131470356|NCT04854642|473353731|FG000|Overall Study|Withdrawal by Subject|0|||
131769968|NCT03039686|474436067|FG002|Double-blind Period|Withdrawal by Subject|1|||
131769969|NCT03039686|474436065|FG000|Double-blind Period|Death|0|||
131769970|NCT03039686|474436066|FG001|Double-blind Period|Death|0|||
131470357|NCT04854642|473353732|FG001|Overall Study|Withdrawal by Subject|1|||
131470358|NCT00562627|473353733|FG000|Overall Study|Protocol Violation|1|||
131470359|NCT00562627|473353734|FG001|Overall Study|Protocol Violation|1|||
131470360|NCT00562627|473353735|FG002|Overall Study|Protocol Violation|1|||
131470361|NCT00625742|473353736|FG000|Overall Study|Disease Progression|2|||
131470362|NCT00625742|473353736|FG000|Overall Study|Withdrawal by Subject|1|||
131470363|NCT00625742|473353736|FG000|Overall Study|Adverse Event|4|||
131470364|NCT00625742|473353736|FG000|Overall Study|Lost to Follow-up|4|||
131470365|NCT00625742|473353736|FG000|Overall Study|Ineligible|1|||
131470366|NCT01709578|473353737|FG000|Overall Study|Rescued and entered in long term safety|63|||
131470367|NCT01709578|473353738|FG001|Overall Study|Rescued and entered in long term safety|25|||
131470368|NCT01709578|473353739|FG002|Overall Study|Rescued and entered in long term safety|26|||
131470369|NCT01709578|473353737|FG000|Overall Study|Adverse Event|9|||
131470370|NCT01709578|473353738|FG001|Overall Study|Adverse Event|18|||
131470371|NCT01709578|473353739|FG002|Overall Study|Adverse Event|17|||
131470372|NCT01709578|473353737|FG000|Overall Study|Lack of Efficacy|5|||
131470373|NCT01709578|473353738|FG001|Overall Study|Lack of Efficacy|4|||
131470374|NCT01709578|473353739|FG002|Overall Study|Lack of Efficacy|2|||
131470375|NCT01709578|473353737|FG000|Overall Study|Poor compliance to protocol|1|||
131470376|NCT01709578|473353738|FG001|Overall Study|Poor compliance to protocol|2|||
131470377|NCT01709578|473353739|FG002|Overall Study|Poor compliance to protocol|1|||
131470378|NCT01709578|473353737|FG000|Overall Study|Other, not related to safety or efficacy|2|||
131470379|NCT01709578|473353738|FG001|Overall Study|Other, not related to safety or efficacy|7|||
131470380|NCT01709578|473353739|FG002|Overall Study|Other, not related to safety or efficacy|5|||
131470381|NCT04050371|473353740|FG000|Overall Study|Withdrawal by Subject|1|||
131470382|NCT04050371|473353741|FG001|Overall Study|Withdrawal by Subject|0|||
131470383|NCT01107418|473353742|FG000|Overall Study|Disease Progression|45|||
131470384|NCT01107418|473353742|FG000|Overall Study|Adverse Event|3|||
131470385|NCT01107418|473353742|FG000|Overall Study|Withdrawal by Subject|1|||
131470386|NCT01107418|473353742|FG000|Overall Study|Study Closing|1|||
131470387|NCT01107418|473353742|FG000|Overall Study|Started Other Therapy|1|||
131470388|NCT01107418|473353742|FG000|Overall Study|Entered Extension Study|1|||
131470389|NCT00597701|473353743|FG000|Overall Study|Withdrawal by Subject|5|||
131470390|NCT00597701|473353744|FG001|Overall Study|Withdrawal by Subject|5|||
131470391|NCT00597701|473353743|FG000|Overall Study|Death|0|||
131470392|NCT00597701|473353744|FG001|Overall Study|Death|1|||
131470393|NCT00597701|473353743|FG000|Overall Study|Physician Decision|2|||
131470394|NCT00597701|473353744|FG001|Overall Study|Physician Decision|0|||
131470395|NCT00597701|473353743|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
131470396|NCT00597701|473353744|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
131470397|NCT00301821|473353751|FG000|Overall Study|Ineligible|25|||
131470398|NCT00301821|473353751|FG000|Overall Study|Cancel|1|||
131470399|NCT01314911|473353753|FG000|Overall Study|Lost to Follow-up|3|||
131470400|NCT01314911|473353754|FG001|Overall Study|Lost to Follow-up|2|||
131470401|NCT01314911|473353753|FG000|Overall Study|Withdrawal by Subject|1|||
131470402|NCT01314911|473353754|FG001|Overall Study|Withdrawal by Subject|3|||
131470403|NCT01314911|473353753|FG000|Overall Study|Received Non-randomized Study Drug|0|||
131470404|NCT01314911|473353754|FG001|Overall Study|Received Non-randomized Study Drug|1|||
131470405|NCT01314911|473353753|FG000|Overall Study|Never Started Treatment|1|||
131470406|NCT01314911|473353754|FG001|Overall Study|Never Started Treatment|0|||
131470407|NCT03410823|473353764|FG000|Overall Study|Death|1|||
131470408|NCT03410823|473353764|FG000|Overall Study|Withdrawal by Subject|2|||
131769971|NCT03039686|474436067|FG002|Double-blind Period|Death|1|||
131769972|NCT03039686|474436065|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
131769973|NCT03039686|474436066|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
131769974|NCT03039686|474436067|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
131769975|NCT03039686|474436065|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
131769976|NCT03039686|474436066|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
131769977|NCT03039686|474436067|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
131769978|NCT03039686|474436065|FG000|Open Label Period|Withdrawal by Subject|0|||
131769979|NCT03039686|474436066|FG001|Open Label Period|Withdrawal by Subject|3|||
131769980|NCT03039686|474436067|FG002|Open Label Period|Withdrawal by Subject|1|||
131769981|NCT02546193|474436074|FG000|Overall Study|Withdrawal by Subject|2|||
131769982|NCT02546193|474436075|FG001|Overall Study|Withdrawal by Subject|0|||
131769983|NCT02546193|474436076|FG002|Overall Study|Withdrawal by Subject|1|||
131769984|NCT02546193|474436077|FG003|Overall Study|Withdrawal by Subject|0|||
131769985|NCT02546193|474436074|FG000|Overall Study|Not eligible at time of induction|4|||
131769986|NCT02546193|474436075|FG001|Overall Study|Not eligible at time of induction|6|||
131769987|NCT02546193|474436076|FG002|Overall Study|Not eligible at time of induction|1|||
131769988|NCT02546193|474436077|FG003|Overall Study|Not eligible at time of induction|0|||
131769989|NCT01098266|474436078|FG000|Overall Study|Physician Decision|1|||
131769990|NCT01098266|474436079|FG001|Overall Study|Physician Decision|0|||
131769991|NCT01098266|474436078|FG000|Overall Study|Death|3|||
131769992|NCT01098266|474436079|FG001|Overall Study|Death|2|||
131769993|NCT01098266|474436078|FG000|Overall Study|Withdrawal by Subject|3|||
131433842|NCT00348673|473213246|FG001|Stage 1|Randomized but not Treated|0|||
131433843|NCT00348673|473213247|FG002|Stage 1|Randomized but not Treated|1|||
131433844|NCT00348673|473213248|FG003|Stage 1|Randomized but not Treated|0|||
131433845|NCT00348673|473213249|FG004|Stage 1|Randomized but not Treated|0|||
131433846|NCT00348673|473213250|FG005|Stage 1|Randomized but not Treated|0|||
131433847|NCT00348673|473213251|FG006|Stage 1|Randomized but not Treated|0|||
131433848|NCT00348673|473213252|FG007|Stage 1|Randomized but not Treated|0|||
131433849|NCT00348673|473213253|FG008|Stage 1|Randomized but not Treated|0|||
131433850|NCT01943591|473213257|FG000|Overall Study|Lost to Follow-up|3|||
131433851|NCT01943591|473213258|FG001|Overall Study|Lost to Follow-up|4|||
131433852|NCT01943591|473213257|FG000|Overall Study|Death|2|||
131433853|NCT01943591|473213258|FG001|Overall Study|Death|7|||
131433854|NCT02719171|473214523|FG000|Overall Study|Adverse Event|1|||
131433855|NCT02719171|473214524|FG001|Overall Study|Adverse Event|2|||
131433856|NCT02719171|473214525|FG002|Overall Study|Adverse Event|0|||
131433857|NCT02719171|473214526|FG003|Overall Study|Adverse Event|0|||
131433858|NCT02719171|473214527|FG004|Overall Study|Adverse Event|2|||
131433859|NCT02719171|473214523|FG000|Overall Study|Lost to Follow-up|0|||
131433860|NCT02719171|473214524|FG001|Overall Study|Lost to Follow-up|0|||
131433861|NCT02719171|473214525|FG002|Overall Study|Lost to Follow-up|1|||
131433862|NCT02719171|473214526|FG003|Overall Study|Lost to Follow-up|0|||
131433863|NCT02719171|473214527|FG004|Overall Study|Lost to Follow-up|0|||
131433864|NCT02719171|473214523|FG000|Overall Study|Subject Withdrawal|0|||
131433865|NCT02719171|473214524|FG001|Overall Study|Subject Withdrawal|2|||
131433866|NCT02719171|473214525|FG002|Overall Study|Subject Withdrawal|2|||
131433867|NCT02719171|473214526|FG003|Overall Study|Subject Withdrawal|1|||
131433868|NCT02719171|473214527|FG004|Overall Study|Subject Withdrawal|0|||
131433869|NCT02719171|473214523|FG000|Overall Study|Other|0|||
131433870|NCT02719171|473214524|FG001|Overall Study|Other|0|||
131470409|NCT03410823|473353764|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
131470410|NCT05128929|473353766|FG000|Overall Study|Adverse Event|0|||
131470411|NCT05128929|473353767|FG001|Overall Study|Adverse Event|1|||
131470412|NCT03553836|473353768|FG000|Overall Study|Ongoing in Study|460|||
131470413|NCT03553836|473353769|FG001|Overall Study|Ongoing in Study|459|||
131470414|NCT03553836|473353768|FG000|Overall Study|Withdrawal by Subject|9|||
131470415|NCT03553836|473353769|FG001|Overall Study|Withdrawal by Subject|10|||
131470416|NCT03553836|473353768|FG000|Overall Study|Lost to Follow-up|1|||
131470417|NCT03553836|473353769|FG001|Overall Study|Lost to Follow-up|3|||
131470418|NCT03553836|473353768|FG000|Overall Study|Death|17|||
131470419|NCT03553836|473353769|FG001|Overall Study|Death|17|||
131470420|NCT03220438|473353770|FG000|Overall Study|Lost to Follow-up|0|||
131470421|NCT03220438|473353771|FG001|Overall Study|Lost to Follow-up|0|||
131470422|NCT03220438|473353772|FG002|Overall Study|Lost to Follow-up|1|||
131470423|NCT03220438|473353773|FG003|Overall Study|Lost to Follow-up|0|||
131470424|NCT04062123|473353774|FG000|Overall Study|Withdrawal by Subject|0|||
131470425|NCT04062123|473353775|FG001|Overall Study|Withdrawal by Subject|1|||
131470426|NCT04062123|473353776|FG002|Overall Study|Withdrawal by Subject|0|||
131470427|NCT01850602|473353779|FG000|Overall Study|Adverse Event|7|||
131470428|NCT01850602|473353780|FG001|Overall Study|Adverse Event|10|||
131470429|NCT01850602|473353779|FG000|Overall Study|Physician Decision|2|||
131470430|NCT01850602|473353780|FG001|Overall Study|Physician Decision|1|||
131470431|NCT01850602|473353779|FG000|Overall Study|Withdrawal by Subject|2|||
131470432|NCT01850602|473353780|FG001|Overall Study|Withdrawal by Subject|4|||
131470433|NCT01850602|473353779|FG000|Overall Study|Decrease in serum calcium|2|||
131470434|NCT01850602|473353780|FG001|Overall Study|Decrease in serum calcium|3|||
131470435|NCT01850602|473353779|FG000|Overall Study|Increase in serum ferritin|1|||
131470436|NCT01850602|473353780|FG001|Overall Study|Increase in serum ferritin|0|||
131470437|NCT00367770|473353781|FG000|Overall Study|Adverse Event|1|||
131470438|NCT00367770|473353781|FG000|Overall Study|Withdrawal by Subject|1|||
131470439|NCT00470184|473353782|FG000|Overall Study|Not Treated(became ineligible)|4|||
131470440|NCT00470184|473353782|FG000|Overall Study|Not treated (other)|1|||
131470441|NCT00470184|473353782|FG000|Overall Study|disease Progression|4|||
131470442|NCT00470184|473353782|FG000|Overall Study|Adverse Event|3|||
131470443|NCT00470184|473353782|FG000|Overall Study|Withdrawal by Subject|4|||
131470444|NCT00470184|473353782|FG000|Overall Study|other|5|||
131470445|NCT00470184|473353782|FG000|Overall Study|recurrence|1|||
131470446|NCT03823378|473353783|FG000|Overall Study|Adverse Event|2|||
131470447|NCT03823378|473353784|FG001|Overall Study|Adverse Event|2|||
131470448|NCT03823378|473353785|FG002|Overall Study|Adverse Event|0|||
131470449|NCT03823378|473353786|FG003|Overall Study|Adverse Event|0|||
131470450|NCT03823378|473353787|FG004|Overall Study|Adverse Event|0|||
131433871|NCT02719171|473214525|FG002|Overall Study|Other|0|||
131433872|NCT02719171|473214526|FG003|Overall Study|Other|1|||
131433873|NCT02719171|473214527|FG004|Overall Study|Other|0|||
131433874|NCT02614729|473214528|FG000|Overall Study|Withdrawal by Subject|1|||
131433875|NCT02614729|473214529|FG001|Overall Study|Withdrawal by Subject|0|||
131433876|NCT02539797|473214532|FG000|Overall Study|Lost to Follow-up|0|||
131470451|NCT03823378|473353788|FG005|Overall Study|Adverse Event|0|||
131470452|NCT03823378|473353783|FG000|Overall Study|Lost to Follow-up|0|||
131470453|NCT03823378|473353784|FG001|Overall Study|Lost to Follow-up|1|||
131433877|NCT02539797|473214533|FG001|Overall Study|Lost to Follow-up|1|||
131433878|NCT02539797|473214534|FG002|Overall Study|Lost to Follow-up|0|||
131433879|NCT03798717|473214536|FG000|Overall Study|Failed Screening|0|||
131433880|NCT03798717|473214537|FG001|Overall Study|Failed Screening|0|||
131433881|NCT03798717|473214538|FG002|Overall Study|Failed Screening|0|||
131433882|NCT03798717|473214539|FG003|Overall Study|Failed Screening|0|||
131433883|NCT03798717|473214540|FG004|Overall Study|Failed Screening|0|||
131433884|NCT03798717|473214541|FG005|Overall Study|Failed Screening|1|||
131433885|NCT03798717|473214536|FG000|Overall Study|Physician Decision|1|||
131433886|NCT03798717|473214537|FG001|Overall Study|Physician Decision|0|||
131433887|NCT03798717|473214538|FG002|Overall Study|Physician Decision|1|||
131433888|NCT03798717|473214539|FG003|Overall Study|Physician Decision|0|||
131433889|NCT03798717|473214540|FG004|Overall Study|Physician Decision|0|||
131470454|NCT03823378|473353785|FG002|Overall Study|Lost to Follow-up|0|||
131470455|NCT03823378|473353786|FG003|Overall Study|Lost to Follow-up|0|||
131470456|NCT03823378|473353787|FG004|Overall Study|Lost to Follow-up|1|||
131470457|NCT03823378|473353788|FG005|Overall Study|Lost to Follow-up|0|||
131470458|NCT03823378|473353783|FG000|Overall Study|Withdrawal by Subject|0|||
131470459|NCT03823378|473353784|FG001|Overall Study|Withdrawal by Subject|1|||
131470460|NCT03823378|473353785|FG002|Overall Study|Withdrawal by Subject|4|||
131470461|NCT03823378|473353786|FG003|Overall Study|Withdrawal by Subject|2|||
131470462|NCT03823378|473353787|FG004|Overall Study|Withdrawal by Subject|0|||
131470463|NCT03823378|473353788|FG005|Overall Study|Withdrawal by Subject|1|||
131470464|NCT03823378|473353783|FG000|Overall Study|Other, not specified|19|||
131470465|NCT03823378|473353784|FG001|Overall Study|Other, not specified|12|||
131470466|NCT03823378|473353785|FG002|Overall Study|Other, not specified|6|||
131470467|NCT03823378|473353786|FG003|Overall Study|Other, not specified|8|||
131470468|NCT03823378|473353787|FG004|Overall Study|Other, not specified|17|||
131470469|NCT03823378|473353788|FG005|Overall Study|Other, not specified|7|||
131470470|NCT01282203|473353789|FG000|Overall Study|Adverse Event|1|||
131470471|NCT00058539|473353792|FG000|Overall Study|Disease progression|24|||
131470472|NCT00058539|473353792|FG000|Overall Study|Adverse Event|3|||
131470473|NCT00058539|473353792|FG000|Overall Study|Withdrawal by Subject|5|||
131470474|NCT00058539|473353792|FG000|Overall Study|Physician Decision|9|||
131470475|NCT00058539|473353792|FG000|Overall Study|Death|1|||
131470476|NCT02963831|473353793|FG000|Overall Study|Progressive Disease|3|||
131470477|NCT02963831|473353794|FG001|Overall Study|Progressive Disease|3|||
131470478|NCT02963831|473353795|FG002|Overall Study|Progressive Disease|16|||
131470479|NCT02963831|473353796|FG003|Overall Study|Progressive Disease|27|||
131470480|NCT02963831|473353793|FG000|Overall Study|Withdrawal by Subject|1|||
131470481|NCT02963831|473353794|FG001|Overall Study|Withdrawal by Subject|0|||
131470482|NCT02963831|473353795|FG002|Overall Study|Withdrawal by Subject|2|||
131470483|NCT02963831|473353796|FG003|Overall Study|Withdrawal by Subject|4|||
131470484|NCT02963831|473353793|FG000|Overall Study|Adverse Event|0|||
131470485|NCT02963831|473353794|FG001|Overall Study|Adverse Event|1|||
131470486|NCT02963831|473353795|FG002|Overall Study|Adverse Event|1|||
131470487|NCT02963831|473353796|FG003|Overall Study|Adverse Event|2|||
131470488|NCT02963831|473353793|FG000|Overall Study|Death|0|||
131470489|NCT02963831|473353794|FG001|Overall Study|Death|0|||
131470490|NCT02963831|473353795|FG002|Overall Study|Death|0|||
131470491|NCT02963831|473353796|FG003|Overall Study|Death|2|||
131470492|NCT03977454|473353797|FG000|Overall Study|immediate postoperative revision|2|||
131470493|NCT03977454|473353798|FG001|Overall Study|immediate postoperative revision|2|||
131470494|NCT02483533|473353800|FG000|Overall Study|Lack of Efficacy|50|||
131470495|NCT02483533|473353801|FG001|Overall Study|Lack of Efficacy|50|||
131470496|NCT04365257|473353802|FG000|Overall Study|Physician Decision|1|||
131470497|NCT04365257|473353803|FG001|Overall Study|Physician Decision|0|||
131470498|NCT04365257|473353802|FG000|Overall Study|Patient Noncompliance|1|||
131470499|NCT04365257|473353803|FG001|Overall Study|Patient Noncompliance|0|||
131470500|NCT04365257|473353802|FG000|Overall Study|Withdrawal by Subject|0|||
131470501|NCT04365257|473353803|FG001|Overall Study|Withdrawal by Subject|1|||
131470502|NCT03452527|473353804|FG000|Overall Study|Withdrawal by Subject|1|||
131470503|NCT03452527|473353805|FG001|Overall Study|Withdrawal by Subject|1|||
131470504|NCT03452527|473353804|FG000|Overall Study|Study Terminated|2|||
131470505|NCT03452527|473353805|FG001|Overall Study|Study Terminated|3|||
131470506|NCT02129777|473353806|FG000|Double-Blind Period|Adverse Event|0|||
131470507|NCT02129777|473353807|FG001|Double-Blind Period|Adverse Event|0|||
131470508|NCT02129777|473353808|FG002|Double-Blind Period|Adverse Event|0|||
131470509|NCT02129777|473353809|FG003|Double-Blind Period|Adverse Event|0|||
131470510|NCT02129777|473353810|FG004|Double-Blind Period|Adverse Event|1|||
131470511|NCT02129777|473353811|FG005|Double-Blind Period|Adverse Event|0|||
131470512|NCT02129777|473353812|FG006|Double-Blind Period|Adverse Event|0|||
131470513|NCT02129777|473353806|FG000|Double-Blind Period|Lost to Follow-up|1|||
131470514|NCT02129777|473353807|FG001|Double-Blind Period|Lost to Follow-up|1|||
131470515|NCT02129777|473353808|FG002|Double-Blind Period|Lost to Follow-up|1|||
131470516|NCT02129777|473353809|FG003|Double-Blind Period|Lost to Follow-up|2|||
131470517|NCT02129777|473353810|FG004|Double-Blind Period|Lost to Follow-up|0|||
131433890|NCT03798717|473214541|FG005|Overall Study|Physician Decision|0|||
131433891|NCT03798717|473214536|FG000|Overall Study|Withdrawal by Subject|0|||
131769994|NCT01098266|474436079|FG001|Overall Study|Withdrawal by Subject|5|||
131769995|NCT00649220|474436083|FG000|Overall Study|Adverse Event|2|||
131769996|NCT00649220|474436083|FG000|Overall Study|Withdrawal by Subject|1|||
131769997|NCT00525499|474436084|FG000|Overall Study|Lost to Follow-up|2|||
131769998|NCT00525499|474436085|FG001|Overall Study|Lost to Follow-up|4|||
131769999|NCT00525499|474436086|FG002|Overall Study|Lost to Follow-up|1|||
131770000|NCT00525499|474436087|FG003|Overall Study|Lost to Follow-up|4|||
131770001|NCT00525499|474436084|FG000|Overall Study|Adverse Event|0|||
131770002|NCT00525499|474436085|FG001|Overall Study|Adverse Event|1|||
131470518|NCT02129777|473353811|FG005|Double-Blind Period|Lost to Follow-up|0|||
131470519|NCT02129777|473353812|FG006|Double-Blind Period|Lost to Follow-up|0|||
131470520|NCT02129777|473353806|FG000|Double-Blind Period|Withdrawal by Subject|2|||
131470521|NCT02129777|473353807|FG001|Double-Blind Period|Withdrawal by Subject|4|||
131470522|NCT02129777|473353808|FG002|Double-Blind Period|Withdrawal by Subject|3|||
131470523|NCT02129777|473353809|FG003|Double-Blind Period|Withdrawal by Subject|2|||
131470524|NCT02129777|473353810|FG004|Double-Blind Period|Withdrawal by Subject|3|||
131470525|NCT02129777|473353811|FG005|Double-Blind Period|Withdrawal by Subject|0|||
131470526|NCT02129777|473353812|FG006|Double-Blind Period|Withdrawal by Subject|0|||
131470527|NCT02129777|473353806|FG000|Double-Blind Period|Pregnancy|0|||
131470528|NCT02129777|473353807|FG001|Double-Blind Period|Pregnancy|0|||
131470529|NCT02129777|473353808|FG002|Double-Blind Period|Pregnancy|0|||
131470530|NCT02129777|473353809|FG003|Double-Blind Period|Pregnancy|0|||
131470531|NCT02129777|473353810|FG004|Double-Blind Period|Pregnancy|1|||
131470532|NCT02129777|473353811|FG005|Double-Blind Period|Pregnancy|0|||
131470533|NCT02129777|473353812|FG006|Double-Blind Period|Pregnancy|0|||
131470534|NCT02129777|473353806|FG000|Double-Blind Period|Lack of Efficacy|3|||
131470535|NCT02129777|473353807|FG001|Double-Blind Period|Lack of Efficacy|1|||
131470536|NCT02129777|473353808|FG002|Double-Blind Period|Lack of Efficacy|0|||
131470537|NCT02129777|473353809|FG003|Double-Blind Period|Lack of Efficacy|3|||
131470538|NCT02129777|473353810|FG004|Double-Blind Period|Lack of Efficacy|2|||
131470539|NCT02129777|473353811|FG005|Double-Blind Period|Lack of Efficacy|0|||
131470540|NCT02129777|473353812|FG006|Double-Blind Period|Lack of Efficacy|0|||
131470541|NCT02129777|473353806|FG000|Double-Blind Period|Other|1|||
131470542|NCT02129777|473353807|FG001|Double-Blind Period|Other|2|||
131470543|NCT02129777|473353808|FG002|Double-Blind Period|Other|0|||
131470544|NCT02129777|473353809|FG003|Double-Blind Period|Other|0|||
131470545|NCT02129777|473353810|FG004|Double-Blind Period|Other|0|||
131470546|NCT02129777|473353811|FG005|Double-Blind Period|Other|0|||
131470547|NCT02129777|473353812|FG006|Double-Blind Period|Other|0|||
131470548|NCT02129777|473353806|FG000|Open-Label Period|Lack of Efficacy|0|||
131470549|NCT02129777|473353807|FG001|Open-Label Period|Lack of Efficacy|0|||
131470550|NCT02129777|473353808|FG002|Open-Label Period|Lack of Efficacy|0|||
131470551|NCT02129777|473353809|FG003|Open-Label Period|Lack of Efficacy|0|||
131470552|NCT02129777|473353810|FG004|Open-Label Period|Lack of Efficacy|0|||
131470553|NCT02129777|473353811|FG005|Open-Label Period|Lack of Efficacy|0|||
131470554|NCT02129777|473353812|FG006|Open-Label Period|Lack of Efficacy|5|||
131470555|NCT02129777|473353806|FG000|Open-Label Period|Lost to Follow-up|0|||
131470556|NCT02129777|473353807|FG001|Open-Label Period|Lost to Follow-up|0|||
131470557|NCT02129777|473353808|FG002|Open-Label Period|Lost to Follow-up|0|||
131470558|NCT02129777|473353809|FG003|Open-Label Period|Lost to Follow-up|0|||
131470559|NCT02129777|473353810|FG004|Open-Label Period|Lost to Follow-up|0|||
131470560|NCT02129777|473353811|FG005|Open-Label Period|Lost to Follow-up|1|||
131470561|NCT02129777|473353812|FG006|Open-Label Period|Lost to Follow-up|1|||
131470562|NCT02129777|473353806|FG000|Open-Label Period|Withdrawal by Subject|0|||
131470563|NCT02129777|473353807|FG001|Open-Label Period|Withdrawal by Subject|0|||
131470564|NCT02129777|473353808|FG002|Open-Label Period|Withdrawal by Subject|0|||
131470565|NCT02129777|473353809|FG003|Open-Label Period|Withdrawal by Subject|0|||
131470566|NCT02129777|473353810|FG004|Open-Label Period|Withdrawal by Subject|0|||
131470567|NCT02129777|473353811|FG005|Open-Label Period|Withdrawal by Subject|1|||
131470568|NCT02129777|473353812|FG006|Open-Label Period|Withdrawal by Subject|3|||
131470569|NCT02129777|473353806|FG000|Open-Label Period|Study Termination|0|||
131470570|NCT02129777|473353807|FG001|Open-Label Period|Study Termination|0|||
131470571|NCT02129777|473353808|FG002|Open-Label Period|Study Termination|0|||
131470572|NCT02129777|473353809|FG003|Open-Label Period|Study Termination|0|||
131470573|NCT02129777|473353810|FG004|Open-Label Period|Study Termination|0|||
131470574|NCT02129777|473353811|FG005|Open-Label Period|Study Termination|10|||
131470575|NCT02129777|473353812|FG006|Open-Label Period|Study Termination|39|||
131470576|NCT01001299|473353813|FG000|Overall Study|Insufficient Therapeutic Response|20|||
131470577|NCT01001299|473353813|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
131470578|NCT01001299|473353813|FG000|Overall Study|Death|1|||
131470579|NCT01001299|473353813|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
131470580|NCT01001299|473353813|FG000|Overall Study|Withdrew Consent|1|||
131470581|NCT01565499|473353814|FG000|Overall Study|Physician Decision|1|||
131470582|NCT01565499|473353814|FG000|Overall Study|Adverse Event|5|||
131470583|NCT01565499|473353814|FG000|Overall Study|Withdrawal by Subject|2|||
131470584|NCT03116347|473353815|FG000|Overall Study|Withdrawal by Subject|1|||
131470585|NCT03116347|473353816|FG001|Overall Study|Withdrawal by Subject|2|||
131770003|NCT00525499|474436086|FG002|Overall Study|Adverse Event|0|||
131770004|NCT00525499|474436087|FG003|Overall Study|Adverse Event|1|||
131770005|NCT00525499|474436084|FG000|Overall Study|Withdrawal by Subject|5|||
131770006|NCT00525499|474436085|FG001|Overall Study|Withdrawal by Subject|1|||
131770007|NCT00525499|474436086|FG002|Overall Study|Withdrawal by Subject|5|||
131770008|NCT00525499|474436087|FG003|Overall Study|Withdrawal by Subject|2|||
131770009|NCT00525499|474436084|FG000|Overall Study|Protocol Violation|0|||
131770010|NCT00525499|474436085|FG001|Overall Study|Protocol Violation|1|||
131770011|NCT00525499|474436086|FG002|Overall Study|Protocol Violation|1|||
131770012|NCT00525499|474436087|FG003|Overall Study|Protocol Violation|0|||
131770013|NCT00438815|474436088|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
131770014|NCT00438815|474436088|FG000|Overall Study|3-month follow-up no longer required|12|||
131770015|NCT00438815|474436088|FG000|Overall Study|Noncompliance with protocol requirements|9|||
131770016|NCT00438815|474436088|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
131470586|NCT01255787|473353817|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
131470587|NCT01255787|473353818|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
131470588|NCT01255787|473353819|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
131470589|NCT01255787|473353820|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
131470590|NCT01255787|473353817|FG000|Overall Study|Major Protocol Deviation|1|||
131470591|NCT01255787|473353818|FG001|Overall Study|Major Protocol Deviation|1|||
131470592|NCT01255787|473353819|FG002|Overall Study|Major Protocol Deviation|0|||
131470593|NCT01255787|473353820|FG003|Overall Study|Major Protocol Deviation|4|||
131470594|NCT01255787|473353817|FG000|Overall Study|Lost to Follow-up|1|||
131470595|NCT01255787|473353818|FG001|Overall Study|Lost to Follow-up|2|||
131470596|NCT01255787|473353819|FG002|Overall Study|Lost to Follow-up|4|||
131470597|NCT01255787|473353820|FG003|Overall Study|Lost to Follow-up|2|||
131470598|NCT01255787|473353817|FG000|Overall Study|Withdrawal of Consent|3|||
131470599|NCT01255787|473353818|FG001|Overall Study|Withdrawal of Consent|9|||
131470600|NCT01255787|473353819|FG002|Overall Study|Withdrawal of Consent|3|||
131470601|NCT01255787|473353820|FG003|Overall Study|Withdrawal of Consent|4|||
131470602|NCT01255787|473353817|FG000|Overall Study|Pregnancy|0|||
131470603|NCT01255787|473353818|FG001|Overall Study|Pregnancy|0|||
131470604|NCT01255787|473353819|FG002|Overall Study|Pregnancy|0|||
131470605|NCT01255787|473353820|FG003|Overall Study|Pregnancy|1|||
131470606|NCT01255787|473353817|FG000|Overall Study|Lack of Efficacy|2|||
131470607|NCT01255787|473353818|FG001|Overall Study|Lack of Efficacy|2|||
131470608|NCT01255787|473353819|FG002|Overall Study|Lack of Efficacy|2|||
131470609|NCT01255787|473353820|FG003|Overall Study|Lack of Efficacy|2|||
131470610|NCT01255787|473353817|FG000|Overall Study|Noncompliance with Study Drug|3|||
131470611|NCT01255787|473353818|FG001|Overall Study|Noncompliance with Study Drug|1|||
131470612|NCT01255787|473353819|FG002|Overall Study|Noncompliance with Study Drug|0|||
131470613|NCT01255787|473353820|FG003|Overall Study|Noncompliance with Study Drug|0|||
131470614|NCT00476047|473353821|FG000|Overall Study|Lost to Follow-up|1|||
131470615|NCT03170232|473353822|FG000|Overall Study|Adverse Event|0|||
131470616|NCT03170232|473353823|FG001|Overall Study|Adverse Event|1|||
131470617|NCT03170232|473353822|FG000|Overall Study|Protocol Violation|0|||
131470618|NCT03170232|473353823|FG001|Overall Study|Protocol Violation|1|||
131470619|NCT03170232|473353822|FG000|Overall Study|Lack of Efficacy|0|||
131470620|NCT03170232|473353823|FG001|Overall Study|Lack of Efficacy|1|||
131470621|NCT03170232|473353822|FG000|Overall Study|Study closed/terminated|26|||
131470622|NCT03170232|473353823|FG001|Overall Study|Study closed/terminated|23|||
131470623|NCT03170232|473353822|FG000|Overall Study|Lost to Follow-up|1|||
131470624|NCT03170232|473353823|FG001|Overall Study|Lost to Follow-up|0|||
131470625|NCT03170232|473353822|FG000|Overall Study|Withdrawal by Subject|0|||
131470626|NCT03170232|473353823|FG001|Overall Study|Withdrawal by Subject|1|||
131470627|NCT00586326|473353824|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
131470628|NCT00586326|473353824|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
131470629|NCT00586326|473353824|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
131470630|NCT00586326|473353824|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
131470631|NCT00586326|473353824|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
131470632|NCT00586326|473353824|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
131470633|NCT00586326|473353824|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
131470634|NCT00586326|473353824|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
131470635|NCT00586326|473353824|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
131470636|NCT00586326|473353824|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
131470637|NCT00586326|473353824|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
131470638|NCT00586326|473353824|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
131470639|NCT00586326|473353824|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
131470640|NCT00586326|473353824|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
131470641|NCT00586326|473353824|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
131470642|NCT00586326|473353824|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
131470643|NCT00586326|473353824|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
131470644|NCT03882008|473353825|FG000|Overall Study|Withdrawal by Subject|1|||
131470645|NCT03882008|473353825|FG000|Overall Study|Lost to Follow-up|1|||
131470646|NCT00484185|473353829|FG000|Overall Study|Lost to Follow-up|44|||
131470647|NCT00484185|473353829|FG000|Overall Study|Other|20|||
131470648|NCT00484185|473353829|FG000|Overall Study|Randomized but not treated|5|||
131470649|NCT00484185|473353829|FG000|Overall Study|Death|2|||
131470650|NCT00459056|473353830|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
131470651|NCT00459056|473353831|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
131470652|NCT02283177|473353832|FG000|Overall Study|Withdrawal by Subject|1|||
131470653|NCT02283177|473353833|FG001|Overall Study|Withdrawal by Subject|1|||
131470654|NCT01101191|473353834|FG000|Period 1|Withdrawal by Subject|1|||
131470655|NCT01101191|473353835|FG001|Period 1|Withdrawal by Subject|0|||
131470656|NCT01101191|473353834|FG000|Period 1|Adverse Event|1|||
131470657|NCT01101191|473353835|FG001|Period 1|Adverse Event|2|||
131470658|NCT00879879|473353836|FG000|Overall Study|Death|1|||
131470659|NCT00879879|473353836|FG000|Overall Study|Withdrawal by Subject|1|||
131470660|NCT00879879|473353836|FG000|Overall Study|Physician Decision|1|||
131470661|NCT01423604|473353837|FG000|Safety Run-In|Adverse Event|3|||
131470662|NCT01423604|473353838|FG001|Safety Run-In|Adverse Event|0|||
131470663|NCT01423604|473353837|FG000|Safety Run-In|Death|1|||
131470664|NCT01423604|473353838|FG001|Safety Run-In|Death|0|||
131470665|NCT01423604|473353837|FG000|Safety Run-In|Physician Decision|1|||
131470666|NCT01423604|473353838|FG001|Safety Run-In|Physician Decision|0|||
131470667|NCT01423604|473353837|FG000|Safety Run-In|Disease progression|3|||
131470668|NCT01423604|473353838|FG001|Safety Run-In|Disease progression|0|||
131470669|NCT01423604|473353837|FG000|Safety Run-In|Patient decision|1|||
131470670|NCT01423604|473353838|FG001|Safety Run-In|Patient decision|0|||
131470671|NCT01423604|473353837|FG000|Randomized|Adverse Event|4|||
131470672|NCT01423604|473353838|FG001|Randomized|Adverse Event|10|||
131470673|NCT01423604|473353837|FG000|Randomized|Death|1|||
131470674|NCT01423604|473353838|FG001|Randomized|Death|0|||
131470675|NCT01423604|473353837|FG000|Randomized|Physician Decision|16|||
131470676|NCT01423604|473353838|FG001|Randomized|Physician Decision|13|||
131470677|NCT01423604|473353837|FG000|Randomized|Other - unspecified|37|||
131470678|NCT01423604|473353838|FG001|Randomized|Other - unspecified|31|||
131470679|NCT01423604|473353837|FG000|Randomized|Patient decision|5|||
131470680|NCT01423604|473353838|FG001|Randomized|Patient decision|9|||
131470681|NCT00424255|473353839|FG000|Overall Study|Death|115|||
131470682|NCT00424255|473353840|FG001|Overall Study|Death|111|||
131470683|NCT00424255|473353839|FG000|Overall Study|Lost to Follow-up|26|||
131470684|NCT00424255|473353840|FG001|Overall Study|Lost to Follow-up|20|||
131470685|NCT00424255|473353839|FG000|Overall Study|Protocol Violation|0|||
131470686|NCT00424255|473353840|FG001|Overall Study|Protocol Violation|1|||
131470687|NCT00424255|473353839|FG000|Overall Study|Withdrawal by Subject|34|||
131470688|NCT00424255|473353840|FG001|Overall Study|Withdrawal by Subject|38|||
131470689|NCT00424255|473353839|FG000|Overall Study|Physician Decision|3|||
131470690|NCT00424255|473353840|FG001|Overall Study|Physician Decision|7|||
131470691|NCT00424255|473353839|FG000|Overall Study|Cognitive Disturbance|1|||
131470692|NCT00424255|473353840|FG001|Overall Study|Cognitive Disturbance|0|||
131470693|NCT00424255|473353839|FG000|Overall Study|Non-compliance by Participants|1|||
131470694|NCT00424255|473353840|FG001|Overall Study|Non-compliance by Participants|0|||
131470695|NCT00424255|473353839|FG000|Overall Study|Fatigue|1|||
131470696|NCT00424255|473353840|FG001|Overall Study|Fatigue|0|||
131470697|NCT00424255|473353839|FG000|Overall Study|Disease Progression|0|||
131470698|NCT00424255|473353840|FG001|Overall Study|Disease Progression|2|||
131470699|NCT00424255|473353839|FG000|Overall Study|Sponsor Terminated Study|161|||
131470700|NCT00424255|473353840|FG001|Overall Study|Sponsor Terminated Study|167|||
131470701|NCT01226121|473353841|FG000|Overall Study|Lost to Follow-up|2|||
131470702|NCT01226121|473353842|FG001|Overall Study|Lost to Follow-up|0|||
131470703|NCT01226121|473353843|FG002|Overall Study|Lost to Follow-up|1|||
131470704|NCT00989573|473353844|FG000|Overall Study|Adverse Event|8|||
131470705|NCT00989573|473353845|FG001|Overall Study|Adverse Event|12|||
131470706|NCT00989573|473353846|FG002|Overall Study|Adverse Event|4|||
131470707|NCT00989573|473353844|FG000|Overall Study|Physician Decision|0|||
131470708|NCT00989573|473353845|FG001|Overall Study|Physician Decision|2|||
131470709|NCT00989573|473353846|FG002|Overall Study|Physician Decision|0|||
131470710|NCT00989573|473353844|FG000|Overall Study|Protocol Violation|1|||
131470711|NCT00989573|473353845|FG001|Overall Study|Protocol Violation|1|||
131470712|NCT00989573|473353846|FG002|Overall Study|Protocol Violation|1|||
131470713|NCT00989573|473353844|FG000|Overall Study|Withdrawal by Subject|4|||
131470714|NCT00989573|473353845|FG001|Overall Study|Withdrawal by Subject|7|||
131470715|NCT00989573|473353846|FG002|Overall Study|Withdrawal by Subject|3|||
131470716|NCT03687970|473353848|FG000|Overall Study|visit scheduling conflicts|2|||
131470717|NCT03687970|473353849|FG001|Overall Study|visit scheduling conflicts|0|||
131470718|NCT00596362|473353850|FG000|Overall Study|Progressive Disease|1|||
131470719|NCT00817479|473353851|FG000|Overall Study|Physician Decision|1|||
131470720|NCT00817479|473353852|FG001|Overall Study|Physician Decision|1|||
131470721|NCT04030026|473353854|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
131470722|NCT04030026|473353855|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
131470723|NCT04030026|473353854|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
131470724|NCT04030026|473353855|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
131470725|NCT04030026|473353854|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
131470726|NCT04030026|473353855|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
131470727|NCT04030026|473353854|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
131470728|NCT04030026|473353855|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
131470729|NCT04030026|473353854|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
131470730|NCT04030026|473353855|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
131470731|NCT04030026|473353854|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
131470732|NCT04030026|473353855|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
131470733|NCT04030026|473353854|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
131470734|NCT04030026|473353855|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
131470735|NCT00523367|473353856|FG000|Overall Study|19 screen failures|19|||
131470736|NCT00523367|473353856|FG000|Overall Study|4 Withdrawn by PI|4|||
131470737|NCT04480424|473353857|FG000|Overall Study|Withdrawal by Subject|0|||
131470738|NCT04480424|473353858|FG001|Overall Study|Withdrawal by Subject|2|||
131470739|NCT04480424|473353857|FG000|Overall Study|Lost to Follow-up|3|||
131470740|NCT04480424|473353858|FG001|Overall Study|Lost to Follow-up|3|||
131470741|NCT04480424|473353857|FG000|Overall Study|Death|14|||
131470742|NCT04480424|473353858|FG001|Overall Study|Death|16|||
131470743|NCT04480424|473353857|FG000|Overall Study|Reason not Specified|5|||
131470744|NCT04480424|473353858|FG001|Overall Study|Reason not Specified|5|||
131470745|NCT02782923|473353859|FG000|Overall Study|Lost to Follow-up|15|||
131470746|NCT02418156|473353860|FG000|Overall Study|Lost to Follow-up|12|||
131470747|NCT02418156|473353860|FG000|Overall Study|Death|2|||
131470748|NCT02418156|473353860|FG000|Overall Study|Physician Decision|1|||
131470749|NCT02418156|473353860|FG000|Overall Study|Withdrawal by Subject|1|||
131470750|NCT02418156|473353860|FG000|Overall Study|Subject refused to return|1|||
131470751|NCT03150485|473355417|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
131470752|NCT03150485|473355418|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
131470753|NCT03150485|473355419|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
131470754|NCT03150485|473355420|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
131470755|NCT03150485|473355421|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
131470756|NCT03150485|473355422|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
131470757|NCT01394718|473355426|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
131470758|NCT01394718|473355427|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
131470759|NCT04078178|473355428|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
131470760|NCT04078178|473355429|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
131470761|NCT04078178|473355428|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
131470762|NCT04078178|473355429|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
131470763|NCT04078178|473355428|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
131470764|NCT04078178|473355429|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
131470765|NCT04078178|473355428|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
131470766|NCT04078178|473355429|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
131470767|NCT04078178|473355428|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
131470768|NCT04078178|473355429|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
131470769|NCT04617795|473355430|FG000|Main Study|Lost to Follow-up|1|||
131470770|NCT04617795|473355431|FG001|Main Study|Lost to Follow-up|0|||
131470771|NCT00472459|473355432|FG000|Overall Study|Adverse Event|13|||
131470772|NCT00472459|473355433|FG001|Overall Study|Adverse Event|13|||
131470773|NCT00472459|473355432|FG000|Overall Study|Withdrawal by Subject|5|||
131470774|NCT00472459|473355433|FG001|Overall Study|Withdrawal by Subject|5|||
131470775|NCT00472459|473355432|FG000|Overall Study|Protocol Violation|3|||
131470776|NCT00472459|473355433|FG001|Overall Study|Protocol Violation|3|||
131470777|NCT00472459|473355432|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
131470778|NCT00472459|473355433|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
131470779|NCT00472459|473355432|FG000|Overall Study|Lost to Follow-up|1|||
131470780|NCT00472459|473355433|FG001|Overall Study|Lost to Follow-up|1|||
131470781|NCT04850313|473355434|FG000|Overall Study|Withdrawal by Subject|0|||
131470782|NCT04850313|473355435|FG001|Overall Study|Withdrawal by Subject|1|||
131470783|NCT01547780|473355436|FG000|Baseline PET Scan|Physician Decision|1|||
131470784|NCT01547780|473355437|FG001|Baseline PET Scan|Physician Decision|0|||
131470785|NCT01547780|473355438|FG002|Baseline PET Scan|Physician Decision|1|||
131470786|NCT01547780|473355439|FG003|Baseline PET Scan|Physician Decision|0|||
131470787|NCT01547780|473355436|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
131470788|NCT01547780|473355437|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
131470789|NCT01547780|473355438|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
131470790|NCT01547780|473355439|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
131470791|NCT00814879|473355440|FG000|By Week 24|Cancer Diagnosis|1|||
131470792|NCT00814879|473355441|FG001|By Week 24|Cancer Diagnosis|0|||
131470793|NCT00814879|473355440|FG000|By Week 24|Incarceration|0|||
131470794|NCT00814879|473355441|FG001|By Week 24|Incarceration|1|||
131470795|NCT00814879|473355440|FG000|By Week 48|Lost to Follow-up|2|||
131470796|NCT00814879|473355441|FG001|By Week 48|Lost to Follow-up|2|||
131470797|NCT00814879|473355440|FG000|By Week 48|Death|0|||
131470798|NCT00814879|473355441|FG001|By Week 48|Death|1|||
131470799|NCT00588952|473355442|FG000|Overall Study|Adverse Event|0|||
131470800|NCT00588952|473355443|FG001|Overall Study|Adverse Event|2|||
131470801|NCT00588952|473355442|FG000|Overall Study|Withdrawal by Subject|3|||
131470802|NCT00588952|473355443|FG001|Overall Study|Withdrawal by Subject|5|||
131470803|NCT01461057|473355444|FG000|Overall Study|Death|10|||
131470804|NCT01461057|473355445|FG001|Overall Study|Death|9|||
131470805|NCT01461057|473355444|FG000|Overall Study|Withdrawal by Subject|2|||
131470806|NCT01461057|473355445|FG001|Overall Study|Withdrawal by Subject|3|||
131470807|NCT01461057|473355444|FG000|Overall Study|Physician Decision|0|||
131470808|NCT01461057|473355445|FG001|Overall Study|Physician Decision|2|||
131470809|NCT01461057|473355444|FG000|Overall Study|Adverse Event|0|||
131470810|NCT01461057|473355445|FG001|Overall Study|Adverse Event|1|||
131470811|NCT01461057|473355444|FG000|Overall Study|Progression of Disease|1|||
131470812|NCT01461057|473355445|FG001|Overall Study|Progression of Disease|0|||
131470813|NCT01461057|473355444|FG000|Overall Study|Study Terminated by Sponsor|2|||
131470814|NCT01461057|473355445|FG001|Overall Study|Study Terminated by Sponsor|0|||
131470815|NCT01288976|473355446|FG000|Overall Study|Withdrawal by Subject|58|||
131470816|NCT01288976|473355447|FG001|Overall Study|Withdrawal by Subject|12|||
131470817|NCT01288976|473355448|FG002|Overall Study|Withdrawal by Subject|9|||
131470818|NCT01288976|473355446|FG000|Overall Study|Death|98|||
131470819|NCT01288976|473355447|FG001|Overall Study|Death|6|||
131470820|NCT01288976|473355448|FG002|Overall Study|Death|4|||
131470821|NCT01288976|473355446|FG000|Overall Study|Data unavailable|22|||
131470822|NCT01288976|473355447|FG001|Overall Study|Data unavailable|9|||
131470823|NCT01288976|473355448|FG002|Overall Study|Data unavailable|7|||
131470824|NCT01362595|473355451|FG000|Overall Study|Screen failure|10|||
131470825|NCT01362595|473355451|FG000|Overall Study|Withdrawal by Subject|2|||
131470826|NCT00959374|473355452|FG000|Overall Study|Withdrawal by Subject|2|||
131470827|NCT00959374|473355452|FG000|Overall Study|Lost to Follow-up|14|||
131470828|NCT00959374|473355452|FG000|Overall Study|Death|1|||
131470829|NCT00959374|473355452|FG000|Overall Study|Protocol Violation|1|||
131470830|NCT00959374|473355452|FG000|Overall Study|Implant Removed/Not Replaced|4|||
131470831|NCT00959374|473355452|FG000|Overall Study|Physician Decision|1|||
131470832|NCT02469038|473355453|FG000|Overall Study|Physician Decision|4|||
131470833|NCT02469038|473355454|FG001|Overall Study|Physician Decision|5|||
131470834|NCT00636987|473355455|FG000|Overall Study|Death|44|||
131470835|NCT00636987|473355455|FG000|Overall Study|Explanted|13|||
131470836|NCT00636987|473355455|FG000|Overall Study|Lost to Follow-up|63|||
131470837|NCT00636987|473355455|FG000|Overall Study|5 year visit window not complete|69|||
131470838|NCT01251146|473355456|FG000|Overall Study|Lost to Follow-up|3|||
131470839|NCT01251146|473355457|FG001|Overall Study|Lost to Follow-up|10|||
131470840|NCT01739400|473355458|FG000|Overall Study|Physician Decision|3|||
131470841|NCT01739400|473355459|FG001|Overall Study|Physician Decision|0|||
131470842|NCT01739400|473355458|FG000|Overall Study|Lost to Follow-up|2|||
131470843|NCT01739400|473355459|FG001|Overall Study|Lost to Follow-up|0|||
131470844|NCT01739400|473355458|FG000|Overall Study|Death|5|||
131470845|NCT01739400|473355459|FG001|Overall Study|Death|2|||
131470846|NCT01739400|473355458|FG000|Overall Study|Withdrawal by Subject|7|||
131470847|NCT01739400|473355459|FG001|Overall Study|Withdrawal by Subject|7|||
131470848|NCT03350984|473355460|FG000|Overall Study|Death|1|||
131470849|NCT03350984|473355461|FG001|Overall Study|Death|0|||
131470850|NCT03350984|473355460|FG000|Overall Study|Lost to Follow-up|5|||
131470851|NCT03350984|473355461|FG001|Overall Study|Lost to Follow-up|6|||
131470852|NCT03350984|473355460|FG000|Overall Study|Protocol Violation|1|||
131470853|NCT03350984|473355461|FG001|Overall Study|Protocol Violation|2|||
131470854|NCT03350984|473355460|FG000|Overall Study|Physician Decision|1|||
131470855|NCT03350984|473355461|FG001|Overall Study|Physician Decision|0|||
131470856|NCT00642473|473355462|FG000|Overall Study|Withdrawal by Subject|0|||
131470857|NCT00642473|473355463|FG001|Overall Study|Withdrawal by Subject|5|||
131470858|NCT00642473|473355462|FG000|Overall Study|Progression or death|2|||
131470859|NCT00642473|473355463|FG001|Overall Study|Progression or death|4|||
131470860|NCT00642473|473355462|FG000|Overall Study|Other|2|||
131470861|NCT00642473|473355463|FG001|Overall Study|Other|2|||
131470862|NCT02284178|473355465|FG000|Overall Study|Met exclusion criteria|49|||
131470863|NCT02284178|473355466|FG001|Overall Study|Met exclusion criteria|54|||
131470864|NCT00737464|473355473|FG000|Overall Study|Adverse Event|1|||
131470865|NCT00737464|473355473|FG000|Overall Study|Death|6|||
131470866|NCT00737464|473355473|FG000|Overall Study|Other - Failure to Return|1|||
131470867|NCT00737464|473355473|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
131470868|NCT00737464|473355473|FG000|Overall Study|Other reasons|4|||
131470869|NCT01083173|473355479|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
131470870|NCT01083173|473355480|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
131470871|NCT01083173|473355479|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
131470872|NCT01083173|473355480|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
131470873|NCT01083173|473355479|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
131470874|NCT01083173|473355480|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
131470875|NCT01083173|473355479|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
131470876|NCT01083173|473355480|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
131470877|NCT01083173|473355479|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
131470878|NCT01083173|473355480|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
131470879|NCT01083173|473355479|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
131470880|NCT01083173|473355480|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
131470881|NCT01083173|473355479|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
131470882|NCT01083173|473355480|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
131470883|NCT01083173|473355479|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
131470884|NCT01083173|473355480|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
131470885|NCT01083173|473355479|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
131470886|NCT01083173|473355480|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
131470887|NCT01083173|473355479|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
131470888|NCT01083173|473355480|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
131470889|NCT01083173|473355479|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
131470890|NCT01083173|473355480|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
131470891|NCT02742246|473355481|FG000|Overall Study|Never initiated treatment|5|||
131470892|NCT02742246|473355482|FG001|Overall Study|Never initiated treatment|3|||
131470893|NCT02742246|473355483|FG002|Overall Study|Never initiated treatment|1|||
131470894|NCT02742246|473355481|FG000|Overall Study|dropped out during treatment|7|||
131470895|NCT02742246|473355482|FG001|Overall Study|dropped out during treatment|13|||
131470896|NCT02742246|473355483|FG002|Overall Study|dropped out during treatment|10|||
131470897|NCT02742246|473355481|FG000|Overall Study|Death|1|||
131470898|NCT02742246|473355482|FG001|Overall Study|Death|0|||
131470899|NCT02742246|473355483|FG002|Overall Study|Death|0|||
131470900|NCT02987660|473355489|FG000|Overall Study|Study terminated by sponsor|10|||
131470901|NCT02987660|473355490|FG001|Overall Study|Study terminated by sponsor|10|||
131470902|NCT03707184|473355491|FG000|Overall Study|Withdrawal by Subject|2|||
131470903|NCT01041495|473355493|FG000|Overall Study|Withdrawal by Subject|2|||
131470904|NCT01041495|473355494|FG001|Overall Study|Withdrawal by Subject|5|||
131470905|NCT01041495|473355493|FG000|Overall Study|Adverse Event|2|||
131470906|NCT01041495|473355494|FG001|Overall Study|Adverse Event|1|||
131470907|NCT01041495|473355493|FG000|Overall Study|Lost to Follow-up|0|||
131470908|NCT01041495|473355494|FG001|Overall Study|Lost to Follow-up|1|||
131470909|NCT03584373|473355497|FG000|Overall Study|Lost to Follow-up|7|||
131470910|NCT03584373|473355498|FG001|Overall Study|Lost to Follow-up|8|||
131470911|NCT01487577|473355499|FG000|Overall Study|Became ineligible after signing consent|1|||
131470912|NCT03780400|473355503|FG000|Overall Study|Lost to Follow-up|5|||
131470913|NCT03780400|473355503|FG000|Overall Study|Withdrawal by Subject|2|||
131470914|NCT01479985|473355504|FG000|Overall Study|Tablet malfunction, no data saved|1|||
131470915|NCT01479985|473355505|FG001|Overall Study|Tablet malfunction, no data saved|1|||
131470916|NCT01479985|473355504|FG000|Overall Study|No decisional conflict scale responses|0|||
131470917|NCT01479985|473355505|FG001|Overall Study|No decisional conflict scale responses|2|||
131470918|NCT01479985|473355504|FG000|Overall Study|No post-visit survey|5|||
131470919|NCT01479985|473355505|FG001|Overall Study|No post-visit survey|3|||
131470920|NCT01653782|473355506|FG000|Overall Study|Withdrawal by Subject|9|||
131470921|NCT01653782|473355507|FG001|Overall Study|Withdrawal by Subject|15|||
131470922|NCT01653782|473355508|FG002|Overall Study|Withdrawal by Subject|4|||
131470923|NCT01653782|473355506|FG000|Overall Study|Lost to Follow-up|7|||
131470924|NCT01653782|473355507|FG001|Overall Study|Lost to Follow-up|3|||
131470925|NCT01653782|473355508|FG002|Overall Study|Lost to Follow-up|2|||
131470926|NCT00662532|473355512|FG000|Overall Study|Adverse Event|0|||
131470927|NCT00662532|473355513|FG001|Overall Study|Adverse Event|1|||
131470928|NCT00662532|473355512|FG000|Overall Study|Lost to Follow-up|0|||
131470929|NCT00662532|473355513|FG001|Overall Study|Lost to Follow-up|1|||
131470930|NCT05442775|473355516|FG000|Overall Study|Trial terminated|61|||
131470931|NCT05442775|473355516|FG000|Overall Study|Lack of Efficacy|4|||
131470932|NCT05442775|473355516|FG000|Overall Study|Withdrawal by Subject|4|||
131470933|NCT05442775|473355516|FG000|Overall Study|Death|1|||
131470934|NCT05442775|473355516|FG000|Overall Study|Participant removed at Sponsor request|1|||
131470935|NCT01606254|473355517|FG000|Overall Study|Withdrawal by Subject|1|||
131470936|NCT01606254|473355518|FG001|Overall Study|Withdrawal by Subject|3|||
131470937|NCT01606254|473355519|FG002|Overall Study|Withdrawal by Subject|0|||
131470938|NCT01606254|473355520|FG003|Overall Study|Withdrawal by Subject|2|||
131470939|NCT01606254|473355517|FG000|Overall Study|Adverse Event|1|||
131470940|NCT01606254|473355518|FG001|Overall Study|Adverse Event|1|||
131470941|NCT01606254|473355519|FG002|Overall Study|Adverse Event|0|||
131470942|NCT01606254|473355520|FG003|Overall Study|Adverse Event|1|||
131470943|NCT04543409|473355521|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131470944|NCT04543409|473355522|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131470945|NCT04543409|473355521|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
131470946|NCT04543409|473355522|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
131470947|NCT04543409|473355521|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
131470948|NCT04543409|473355522|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
131470949|NCT04543409|473355521|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
131470950|NCT04543409|473355522|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
131470951|NCT04543409|473355521|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
131470952|NCT04543409|473355522|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
131470953|NCT04543409|473355521|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
131470954|NCT04543409|473355522|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
131470955|NCT04543409|473355521|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
131470956|NCT04543409|473355522|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
131470957|NCT04543409|473355521|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
131470958|NCT04543409|473355522|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
131470959|NCT04543409|473355521|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
131470960|NCT04543409|473355522|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
131470961|NCT04543409|473355521|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
131470962|NCT04543409|473355522|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
131470963|NCT04543409|473355521|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
131470964|NCT04543409|473355522|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
131470965|NCT02093026|473355523|FG000|Overall Study|Adverse Event|26|||
131470966|NCT02093026|473355523|FG000|Overall Study|Death|10|||
131470967|NCT02093026|473355523|FG000|Overall Study|Other|157|||
131470968|NCT00518973|473355524|FG000|Overall Study|Withdrawal by Subject|3|||
131470969|NCT00518973|473355525|FG001|Overall Study|Withdrawal by Subject|2|||
131470970|NCT00174291|473355536|FG000|Overall Study|Lost to Follow-up|1|||
131470971|NCT00174291|473355537|FG001|Overall Study|Lost to Follow-up|1|||
131470972|NCT00174291|473355536|FG000|Overall Study|Protocol Violation|0|||
131470973|NCT00174291|473355537|FG001|Overall Study|Protocol Violation|2|||
131470974|NCT00174291|473355536|FG000|Overall Study|Study terminated by sponsor|1|||
131470975|NCT00174291|473355537|FG001|Overall Study|Study terminated by sponsor|0|||
131470976|NCT00174291|473355536|FG000|Overall Study|Withdrawal by Subject|3|||
131470977|NCT00174291|473355537|FG001|Overall Study|Withdrawal by Subject|3|||
131470978|NCT01923168|473355540|FG000|Overall Study|Protocol Violation|1|||
131470979|NCT01923168|473355541|FG001|Overall Study|Protocol Violation|1|||
131470980|NCT01923168|473355542|FG002|Overall Study|Protocol Violation|0|||
131470981|NCT01923168|473355540|FG000|Overall Study|Subject/guardian decision|14|||
131470982|NCT01923168|473355541|FG001|Overall Study|Subject/guardian decision|14|||
131470983|NCT01923168|473355542|FG002|Overall Study|Subject/guardian decision|4|||
131470984|NCT01923168|473355540|FG000|Overall Study|Adverse Event|12|||
131470985|NCT01923168|473355541|FG001|Overall Study|Adverse Event|12|||
131470986|NCT01923168|473355542|FG002|Overall Study|Adverse Event|0|||
131470987|NCT01923168|473355540|FG000|Overall Study|Physician Decision|6|||
131470988|NCT01923168|473355541|FG001|Overall Study|Physician Decision|9|||
131470989|NCT01923168|473355542|FG002|Overall Study|Physician Decision|5|||
131470990|NCT01923168|473355540|FG000|Overall Study|Progressive disease|4|||
131470991|NCT01923168|473355541|FG001|Overall Study|Progressive disease|3|||
131470992|NCT01923168|473355542|FG002|Overall Study|Progressive disease|7|||
131470993|NCT01923168|473355540|FG000|Overall Study|Death|0|||
131470994|NCT01923168|473355541|FG001|Overall Study|Death|0|||
131470995|NCT01923168|473355542|FG002|Overall Study|Death|1|||
131470996|NCT03418571|473355543|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
131470997|NCT03418571|473355544|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
131470998|NCT02009384|473355546|FG000|Overall Study|Death|2|||
131470999|NCT00718237|473355548|FG000|Overall Study|Adverse Event|1|||
131471000|NCT00718237|473355549|FG001|Overall Study|Adverse Event|3|||
131471001|NCT00718237|473355548|FG000|Overall Study|Lost to Follow-up|2|||
131471002|NCT00718237|473355549|FG001|Overall Study|Lost to Follow-up|2|||
131471003|NCT00718237|473355548|FG000|Overall Study|Physician Decision|1|||
131471004|NCT00718237|473355549|FG001|Overall Study|Physician Decision|0|||
131471005|NCT00718237|473355548|FG000|Overall Study|Withdrawal by Subject|9|||
131471006|NCT00718237|473355549|FG001|Overall Study|Withdrawal by Subject|10|||
131471007|NCT03189381|473355550|FG000|Overall Study|Death|1|||
131471008|NCT03189381|473355551|FG001|Overall Study|Death|0|||
131471009|NCT00251004|473355552|FG000|Overall Study|Withdrawal by Subject|23|||
131471010|NCT00251004|473355553|FG001|Overall Study|Withdrawal by Subject|16|||
131471011|NCT00251004|473355554|FG002|Overall Study|Withdrawal by Subject|14|||
131471012|NCT00251004|473355552|FG000|Overall Study|Death|9|||
131471013|NCT00251004|473355553|FG001|Overall Study|Death|10|||
131471014|NCT00251004|473355554|FG002|Overall Study|Death|8|||
131471015|NCT00251004|473355552|FG000|Overall Study|Lost to Follow-up|1|||
131471016|NCT00251004|473355553|FG001|Overall Study|Lost to Follow-up|2|||
131471017|NCT00251004|473355554|FG002|Overall Study|Lost to Follow-up|1|||
131471018|NCT00251004|473355552|FG000|Overall Study|Graft Loss|12|||
131471019|NCT00251004|473355553|FG001|Overall Study|Graft Loss|13|||
131471020|NCT00251004|473355554|FG002|Overall Study|Graft Loss|8|||
131471021|NCT03945175|473355556|FG000|Overall Study|Did not meet inclusion criteria|31|||
131471022|NCT03945175|473355556|FG000|Overall Study|Withdrew consent|2|||
131471023|NCT03945175|473355556|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
131471024|NCT03945175|473355556|FG000|Overall Study|Early termination during Mydayis treatment|1|||
131471025|NCT00378079|473355557|FG000|Overall Study|Lost to Follow-up|6|||
131471026|NCT00378079|473355558|FG001|Overall Study|Lost to Follow-up|1|||
131471027|NCT00378079|473355559|FG002|Overall Study|Lost to Follow-up|0|||
131471028|NCT03455764|473355563|FG000|Overall Study|Adverse Event|1|||
131471029|NCT03455764|473355564|FG001|Overall Study|Adverse Event|0|||
131471030|NCT03455764|473355565|FG002|Overall Study|Adverse Event|0|||
131471031|NCT03455764|473355566|FG003|Overall Study|Adverse Event|0|||
131471032|NCT03455764|473355567|FG004|Overall Study|Adverse Event|0|||
131471033|NCT03455764|473355563|FG000|Overall Study|Disease Progression|4|||
131471034|NCT03455764|473355564|FG001|Overall Study|Disease Progression|0|||
131471035|NCT03455764|473355565|FG002|Overall Study|Disease Progression|0|||
131471036|NCT03455764|473355566|FG003|Overall Study|Disease Progression|0|||
131471037|NCT03455764|473355567|FG004|Overall Study|Disease Progression|0|||
131471038|NCT03455764|473355563|FG000|Overall Study|On Treatment|1|||
131471039|NCT03455764|473355564|FG001|Overall Study|On Treatment|0|||
131471040|NCT03455764|473355565|FG002|Overall Study|On Treatment|0|||
131471041|NCT03455764|473355566|FG003|Overall Study|On Treatment|0|||
131471042|NCT03455764|473355567|FG004|Overall Study|On Treatment|0|||
131471043|NCT00282347|473355569|FG000|Treatment Period|Death|2|||
131471044|NCT00282347|473355570|FG001|Treatment Period|Death|0|||
131471045|NCT00282347|473355569|FG000|Treatment Period|Lost to Follow-up|2|||
131471046|NCT00282347|473355570|FG001|Treatment Period|Lost to Follow-up|5|||
131471047|NCT00282347|473355569|FG000|Treatment Period|Withdrawal by Subject|1|||
131471048|NCT00282347|473355570|FG001|Treatment Period|Withdrawal by Subject|3|||
131471049|NCT00282347|473355569|FG000|Treatment Period|Physician Decision|0|||
131471050|NCT00282347|473355570|FG001|Treatment Period|Physician Decision|1|||
131471051|NCT00282347|473355569|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
131471052|NCT00282347|473355570|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
131471053|NCT00282347|473355569|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
131471054|NCT00282347|473355570|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
131471055|NCT00282347|473355569|FG000|Safety Follow-up Period|Physician Decision|1|||
131471056|NCT00282347|473355570|FG001|Safety Follow-up Period|Physician Decision|1|||
131471057|NCT00282347|473355569|FG000|Safety Follow-up Period|Protocol Deviation|0|||
131471058|NCT00282347|473355570|FG001|Safety Follow-up Period|Protocol Deviation|2|||
131471059|NCT00282347|473355569|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
131471060|NCT00282347|473355570|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
131471061|NCT00282347|473355569|FG000|B Cell Follow-up Period|Physician Decision|1|||
131471062|NCT00282347|473355570|FG001|B Cell Follow-up Period|Physician Decision|0|||
131471063|NCT00282347|473355569|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
131471064|NCT00282347|473355570|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
131471065|NCT00356122|473355571|FG000|TREATMENT|Lack of Efficacy|26|||
131471066|NCT00356122|473355571|FG000|TREATMENT|Adverse Event|10|||
131471067|NCT00356122|473355571|FG000|TREATMENT|Subject's request|4|||
131471068|NCT00356122|473355571|FG000|TREATMENT|Other|4|||
131471069|NCT00356122|473355571|FG000|TREATMENT|Did not receive study medication|1|||
131471070|NCT00356122|473355571|FG000|FOLLOW-UP|Death|37|||
131471071|NCT00356122|473355571|FG000|FOLLOW-UP|Lost to Follow-up|2|||
131471072|NCT00356122|473355571|FG000|FOLLOW-UP|Other|2|||
131471073|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
131471074|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
131471075|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
131471076|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
131471077|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
131471078|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
131471079|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
131471080|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
131471081|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
131471082|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
131471083|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
131471084|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
131471085|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
131471086|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
131471087|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
131471088|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
131471089|NCT00491556|473355572|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
131471090|NCT00491556|473355573|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
131471091|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
131471092|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
131471093|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
131471094|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
131471095|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
131471096|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
131471097|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
131471098|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
131471099|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
131471100|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
131471101|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
131471102|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
131471103|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
131471104|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
131471105|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
131471106|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
131471107|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
131471108|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
131471109|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
131471110|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
131471111|NCT00491556|473355572|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
131471112|NCT00491556|473355573|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
131471113|NCT00993044|473355574|FG000|Irinotecan 50 mg|Physician Decision|1|||
131471114|NCT00734747|473355575|FG000|SRS Procedure|No staples placed|3|||
131471115|NCT00734747|473355575|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
131471116|NCT01909453|473355578|FG000|Overall Study|Ongoing|118|||
131471117|NCT01909453|473355579|FG001|Overall Study|Ongoing|103|||
131471118|NCT01909453|473355580|FG002|Overall Study|Ongoing|83|||
131471119|NCT01909453|473355581|FG003|Overall Study|Ongoing|164|||
131471120|NCT01909453|473355582|FG004|Overall Study|Ongoing|50|||
131471121|NCT01909453|473355578|FG000|Overall Study|Death|69|||
131471122|NCT01909453|473355579|FG001|Overall Study|Death|74|||
131471123|NCT01909453|473355580|FG002|Overall Study|Death|88|||
131471124|NCT01909453|473355581|FG003|Overall Study|Death|86|||
131471125|NCT01909453|473355582|FG004|Overall Study|Death|29|||
131471126|NCT01909453|473355578|FG000|Overall Study|Lost to Follow-up|3|||
131471127|NCT01909453|473355579|FG001|Overall Study|Lost to Follow-up|4|||
131471128|NCT01909453|473355580|FG002|Overall Study|Lost to Follow-up|4|||
131471129|NCT01909453|473355581|FG003|Overall Study|Lost to Follow-up|3|||
131471130|NCT01909453|473355582|FG004|Overall Study|Lost to Follow-up|3|||
131471131|NCT01909453|473355578|FG000|Overall Study|Withdrawal by Subject|2|||
131471132|NCT01909453|473355579|FG001|Overall Study|Withdrawal by Subject|13|||
131471133|NCT01909453|473355580|FG002|Overall Study|Withdrawal by Subject|16|||
131471134|NCT01909453|473355581|FG003|Overall Study|Withdrawal by Subject|5|||
131471135|NCT01909453|473355582|FG004|Overall Study|Withdrawal by Subject|4|||
131471136|NCT04006119|473357163|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
131471137|NCT04006119|473357163|FG000|End of Treatment Veledimex|Adverse Event|2|||
131471138|NCT04006119|473357163|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
131471139|NCT04006119|473357163|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
131471140|NCT04006119|473357163|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
131471141|NCT04006119|473357163|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
131471142|NCT03442764|473357164|FG000|Overall Study|Adverse Event|1|||
131471143|NCT03442764|473357165|FG001|Overall Study|Adverse Event|0|||
131471144|NCT03442764|473357166|FG002|Overall Study|Adverse Event|0|||
131471145|NCT02395016|473357167|FG000|Overall Study|Adverse Event|4|||
131471146|NCT02395016|473357168|FG001|Overall Study|Adverse Event|3|||
131471147|NCT02395016|473357167|FG000|Overall Study|Withdrawal by Subject|9|||
131471148|NCT02395016|473357168|FG001|Overall Study|Withdrawal by Subject|6|||
131471149|NCT02395016|473357167|FG000|Overall Study|Protocol Violation|2|||
131471150|NCT02395016|473357168|FG001|Overall Study|Protocol Violation|3|||
131471151|NCT01277042|473357170|FG000|Overall Study|Adverse Event|4|||
131471152|NCT01277042|473357171|FG001|Overall Study|Adverse Event|3|||
131471153|NCT01277042|473357170|FG000|Overall Study|Lost to Follow-up|2|||
131471154|NCT01277042|473357171|FG001|Overall Study|Lost to Follow-up|2|||
131471155|NCT01277042|473357170|FG000|Overall Study|Withdrawal by Subject|2|||
131471156|NCT01277042|473357171|FG001|Overall Study|Withdrawal by Subject|0|||
131471157|NCT01483690|473357174|FG000|Overall Study|Adverse Event|1|||
131471158|NCT01483690|473357175|FG001|Overall Study|Adverse Event|2|||
131471159|NCT01483690|473357174|FG000|Overall Study|clinical deterioration|1|||
131471160|NCT01483690|473357175|FG001|Overall Study|clinical deterioration|0|||
131471161|NCT01483690|473357174|FG000|Overall Study|Physician Decision|0|||
131471162|NCT01483690|473357175|FG001|Overall Study|Physician Decision|2|||
131471163|NCT01483690|473357174|FG000|Overall Study|exclusionary procedure|0|||
131433892|NCT03798717|473214537|FG001|Overall Study|Withdrawal by Subject|0|||
131433893|NCT03798717|473214538|FG002|Overall Study|Withdrawal by Subject|0|||
131433894|NCT03798717|473214539|FG003|Overall Study|Withdrawal by Subject|1|||
131433895|NCT03798717|473214540|FG004|Overall Study|Withdrawal by Subject|0|||
131433896|NCT03798717|473214541|FG005|Overall Study|Withdrawal by Subject|0|||
131433897|NCT03798717|473214536|FG000|Overall Study|Lost to Follow-up|1|||
131471164|NCT01483690|473357175|FG001|Overall Study|exclusionary procedure|1|||
131471165|NCT00478881|473357176|FG000|Overall Study|Adverse Event|31|||
131471166|NCT00478881|473357177|FG001|Overall Study|Adverse Event|12|||
131471167|NCT00478881|473357176|FG000|Overall Study|Lack of Efficacy|0|||
131471168|NCT00478881|473357177|FG001|Overall Study|Lack of Efficacy|3|||
131471169|NCT00478881|473357176|FG000|Overall Study|Lost to Follow-up|0|||
131471170|NCT00478881|473357177|FG001|Overall Study|Lost to Follow-up|1|||
131471171|NCT00478881|473357176|FG000|Overall Study|Protocol Violation|2|||
131471172|NCT00478881|473357177|FG001|Overall Study|Protocol Violation|2|||
131471173|NCT00478881|473357176|FG000|Overall Study|Withdrawal by Subject|6|||
131471174|NCT00478881|473357177|FG001|Overall Study|Withdrawal by Subject|2|||
131471175|NCT00478881|473357176|FG000|Overall Study|Non-Compliance with Study Medication|0|||
131471176|NCT00478881|473357177|FG001|Overall Study|Non-Compliance with Study Medication|2|||
131471177|NCT03981822|473357183|FG000|Overall Study|Lost to Follow-up|0|||
131471178|NCT03981822|473357184|FG001|Overall Study|Lost to Follow-up|1|||
131471179|NCT03981822|473357185|FG002|Overall Study|Lost to Follow-up|1|||
131471180|NCT03981822|473357186|FG003|Overall Study|Lost to Follow-up|0|||
131471181|NCT03981822|473357187|FG004|Overall Study|Lost to Follow-up|6|||
131471182|NCT03981822|473357188|FG005|Overall Study|Lost to Follow-up|4|||
131471183|NCT03981822|473357189|FG006|Overall Study|Lost to Follow-up|4|||
131471184|NCT03981822|473357190|FG007|Overall Study|Lost to Follow-up|2|||
131471185|NCT03981822|473357183|FG000|Overall Study|Withdrawal by Subject|0|||
131471186|NCT03981822|473357184|FG001|Overall Study|Withdrawal by Subject|1|||
131433898|NCT03798717|473214537|FG001|Overall Study|Lost to Follow-up|0|||
131433899|NCT03798717|473214538|FG002|Overall Study|Lost to Follow-up|0|||
131471187|NCT03981822|473357185|FG002|Overall Study|Withdrawal by Subject|0|||
131471188|NCT03981822|473357186|FG003|Overall Study|Withdrawal by Subject|0|||
131471189|NCT03981822|473357187|FG004|Overall Study|Withdrawal by Subject|0|||
131471190|NCT03981822|473357188|FG005|Overall Study|Withdrawal by Subject|1|||
131471191|NCT03981822|473357189|FG006|Overall Study|Withdrawal by Subject|0|||
131471192|NCT03981822|473357190|FG007|Overall Study|Withdrawal by Subject|2|||
131471193|NCT03981822|473357183|FG000|Overall Study|COVID-19 Related|0|||
131471194|NCT03981822|473357184|FG001|Overall Study|COVID-19 Related|0|||
131471195|NCT03981822|473357185|FG002|Overall Study|COVID-19 Related|0|||
131471196|NCT03981822|473357186|FG003|Overall Study|COVID-19 Related|0|||
131471197|NCT03981822|473357187|FG004|Overall Study|COVID-19 Related|2|||
131471198|NCT03981822|473357188|FG005|Overall Study|COVID-19 Related|1|||
131471199|NCT03981822|473357189|FG006|Overall Study|COVID-19 Related|2|||
131471200|NCT03981822|473357190|FG007|Overall Study|COVID-19 Related|1|||
131471201|NCT06460493|473357191|FG000|Overall Study|Withdrawal by Subject|2|||
131471202|NCT04704154|473357192|FG000|Overall Study|Adverse Event|3|||
131471203|NCT04704154|473357193|FG001|Overall Study|Adverse Event|2|||
131471204|NCT04704154|473357194|FG002|Overall Study|Adverse Event|4|||
131471205|NCT04704154|473357195|FG003|Overall Study|Adverse Event|2|||
131471206|NCT04704154|473357196|FG004|Overall Study|Adverse Event|3|||
131471207|NCT04704154|473357197|FG005|Overall Study|Adverse Event|0|||
131471208|NCT04704154|473357192|FG000|Overall Study|Death|3|||
131471209|NCT04704154|473357193|FG001|Overall Study|Death|0|||
131471210|NCT04704154|473357194|FG002|Overall Study|Death|0|||
131471211|NCT04704154|473357195|FG003|Overall Study|Death|0|||
131471212|NCT04704154|473357196|FG004|Overall Study|Death|3|||
131471213|NCT04704154|473357197|FG005|Overall Study|Death|0|||
131471214|NCT04704154|473357192|FG000|Overall Study|Physician Decision|1|||
131471215|NCT04704154|473357193|FG001|Overall Study|Physician Decision|0|||
131471216|NCT04704154|473357194|FG002|Overall Study|Physician Decision|1|||
131471217|NCT04704154|473357195|FG003|Overall Study|Physician Decision|0|||
131471218|NCT04704154|473357196|FG004|Overall Study|Physician Decision|2|||
131471219|NCT04704154|473357197|FG005|Overall Study|Physician Decision|0|||
131471220|NCT04704154|473357192|FG000|Overall Study|Participant Decision|1|||
131471221|NCT04704154|473357193|FG001|Overall Study|Participant Decision|1|||
131471222|NCT04704154|473357194|FG002|Overall Study|Participant Decision|0|||
131471223|NCT04704154|473357195|FG003|Overall Study|Participant Decision|0|||
131471224|NCT04704154|473357196|FG004|Overall Study|Participant Decision|0|||
131471225|NCT04704154|473357197|FG005|Overall Study|Participant Decision|0|||
131471226|NCT04704154|473357192|FG000|Overall Study|Progressive Disease|19|||
131471227|NCT04704154|473357193|FG001|Overall Study|Progressive Disease|17|||
131471228|NCT04704154|473357194|FG002|Overall Study|Progressive Disease|20|||
131471229|NCT04704154|473357195|FG003|Overall Study|Progressive Disease|18|||
131471230|NCT04704154|473357196|FG004|Overall Study|Progressive Disease|36|||
131471231|NCT04704154|473357197|FG005|Overall Study|Progressive Disease|30|||
131471232|NCT04704154|473357192|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
131471233|NCT04704154|473357193|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
131471234|NCT04704154|473357194|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
131471235|NCT04704154|473357195|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
131471236|NCT04704154|473357196|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
131471237|NCT04704154|473357197|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
131471238|NCT04704154|473357192|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
131471239|NCT04704154|473357193|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
131471240|NCT04704154|473357194|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
131471241|NCT04704154|473357195|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
131471242|NCT04704154|473357196|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
131471243|NCT04704154|473357197|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
131471244|NCT02278341|473357198|FG000|Overall Study|Randomized but never received study drug|1|||
131471245|NCT02278341|473357199|FG001|Overall Study|Randomized but never received study drug|1|||
131471246|NCT02278341|473357198|FG000|Overall Study|Adverse Event|3|||
131471247|NCT02278341|473357199|FG001|Overall Study|Adverse Event|0|||
131471248|NCT02278341|473357198|FG000|Overall Study|Death|68|||
131471249|NCT02278341|473357199|FG001|Overall Study|Death|56|||
131471250|NCT02278341|473357198|FG000|Overall Study|Withdrawal by Subject|30|||
131471251|NCT02278341|473357199|FG001|Overall Study|Withdrawal by Subject|19|||
131471252|NCT02278341|473357198|FG000|Overall Study|Lost to Follow-up|0|||
131471253|NCT02278341|473357199|FG001|Overall Study|Lost to Follow-up|1|||
131471254|NCT02278341|473357198|FG000|Overall Study|Physician Decision|1|||
131471255|NCT02278341|473357199|FG001|Overall Study|Physician Decision|1|||
131471256|NCT02278341|473357198|FG000|Overall Study|Miscellaneous|15|||
131471257|NCT02278341|473357199|FG001|Overall Study|Miscellaneous|14|||
131471258|NCT04902326|473357200|FG000|Overall Study|Withdrawal by Subject|1|||
131471259|NCT04902326|473357201|FG001|Overall Study|Withdrawal by Subject|3|||
131471260|NCT04902326|473357202|FG002|Overall Study|Withdrawal by Subject|0|||
131471261|NCT04902326|473357203|FG003|Overall Study|Withdrawal by Subject|1|||
131471262|NCT04902326|473357200|FG000|Overall Study|Lost to Follow-up|14|||
131471263|NCT04902326|473357201|FG001|Overall Study|Lost to Follow-up|14|||
131471264|NCT04902326|473357202|FG002|Overall Study|Lost to Follow-up|14|||
131471265|NCT04902326|473357203|FG003|Overall Study|Lost to Follow-up|6|||
131471266|NCT02604017|473357204|FG000|Overall Study|Withdrew Consent|0|||
131471267|NCT02604017|473357205|FG001|Overall Study|Withdrew Consent|2|||
131471268|NCT02604017|473357204|FG000|Overall Study|Lost to Follow-up|5|||
131471269|NCT02604017|473357205|FG001|Overall Study|Lost to Follow-up|6|||
131471270|NCT02604017|473357204|FG000|Overall Study|Other|1|||
131471271|NCT02604017|473357205|FG001|Overall Study|Other|0|||
131471272|NCT00740246|473357206|FG000|Overall Study|Received Blood Transfusion|0|||
131471273|NCT00740246|473357207|FG001|Overall Study|Received Blood Transfusion|1|||
131770017|NCT00438815|474436088|FG000|Overall Study|Lost to Follow-up|6|||
131471274|NCT00740246|473357206|FG000|Overall Study|Adverse Event|1|||
131471275|NCT00740246|473357207|FG001|Overall Study|Adverse Event|2|||
131471276|NCT00740246|473357206|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
131471277|NCT00740246|473357207|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
131471278|NCT00740246|473357206|FG000|Overall Study|Lost to Follow-up|2|||
131471279|NCT00740246|473357207|FG001|Overall Study|Lost to Follow-up|2|||
131471280|NCT00740246|473357206|FG000|Overall Study|Withdrawal by Subject|4|||
131471281|NCT00740246|473357207|FG001|Overall Study|Withdrawal by Subject|3|||
131471282|NCT00740246|473357206|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
131471283|NCT00740246|473357207|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
131471284|NCT00740246|473357206|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
131471285|NCT00740246|473357207|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
131471286|NCT00740246|473357206|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
131471287|NCT00740246|473357207|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
131471288|NCT00740246|473357206|FG000|Overall Study|Unable To Comply With Study Visits|2|||
131471289|NCT00740246|473357207|FG001|Overall Study|Unable To Comply With Study Visits|0|||
131471290|NCT00740246|473357206|FG000|Overall Study|Unable to Access Vein|0|||
131471291|NCT00740246|473357207|FG001|Overall Study|Unable to Access Vein|2|||
131471292|NCT00740246|473357206|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
131471293|NCT00740246|473357207|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
131471294|NCT00589784|473357210|FG000|Overall Study|Withdrawal by Subject|0|||
131471295|NCT00589784|473357211|FG001|Overall Study|Withdrawal by Subject|6|||
131471296|NCT00589784|473357210|FG000|Overall Study|Patient inevaluable|1|||
131471297|NCT00589784|473357211|FG001|Overall Study|Patient inevaluable|0|||
131471298|NCT00589784|473357210|FG000|Overall Study|Adverse Event|0|||
131471299|NCT00589784|473357211|FG001|Overall Study|Adverse Event|4|||
131471300|NCT02376829|473357221|FG000|Overall Study|Withdrawal by Subject|27|||
131471301|NCT02376829|473357222|FG001|Overall Study|Withdrawal by Subject|44|||
131471302|NCT01439347|473357223|FG000|Overall Study|Death|10|||
131471303|NCT01439347|473357224|FG001|Overall Study|Death|9|||
131471304|NCT01439347|473357223|FG000|Overall Study|Withdrawal by Subject|0|||
131471305|NCT01439347|473357224|FG001|Overall Study|Withdrawal by Subject|1|||
131471306|NCT01439347|473357223|FG000|Overall Study|Physician Decision|1|||
131471307|NCT01439347|473357224|FG001|Overall Study|Physician Decision|0|||
131471308|NCT01439347|473357223|FG000|Overall Study|Sponsor Terminated Study|2|||
131471309|NCT01439347|473357224|FG001|Overall Study|Sponsor Terminated Study|3|||
131471310|NCT04341662|473357225|FG000|Overall Study|Did not have source-verified blood loss data|423|||
131471311|NCT04341662|473357226|FG001|Overall Study|Did not have source-verified blood loss data|514|||
131471312|NCT01582854|473357227|FG000|Overall Study|Death|8|||
131471313|NCT01582854|473357228|FG001|Overall Study|Death|5|||
131471314|NCT01582854|473357227|FG000|Overall Study|Adverse Event|2|||
131471315|NCT01582854|473357228|FG001|Overall Study|Adverse Event|3|||
131471316|NCT01582854|473357227|FG000|Overall Study|Withdrawal by Participant|8|||
131471317|NCT01582854|473357228|FG001|Overall Study|Withdrawal by Participant|11|||
131471318|NCT01582854|473357227|FG000|Overall Study|Lost to Follow-up|1|||
131471319|NCT01582854|473357228|FG001|Overall Study|Lost to Follow-up|2|||
131471320|NCT01582854|473357227|FG000|Overall Study|Physician Decision|0|||
131471321|NCT01582854|473357228|FG001|Overall Study|Physician Decision|1|||
131471322|NCT01582854|473357227|FG000|Overall Study|Recurrent Stroke|13|||
131471323|NCT01582854|473357228|FG001|Overall Study|Recurrent Stroke|8|||
131471324|NCT01582854|473357227|FG000|Overall Study|Disallowed Concomitant Medication|3|||
131471325|NCT01582854|473357228|FG001|Overall Study|Disallowed Concomitant Medication|2|||
131471326|NCT01582854|473357227|FG000|Overall Study|Carotid or Neurosurgery|0|||
131471327|NCT01582854|473357228|FG001|Overall Study|Carotid or Neurosurgery|1|||
131471328|NCT01582854|473357227|FG000|Overall Study|General Anaesthesia|0|||
131471329|NCT01582854|473357228|FG001|Overall Study|General Anaesthesia|1|||
131471330|NCT01582854|473357227|FG000|Overall Study|Other Miscellaneous Reason|1|||
131471331|NCT01582854|473357228|FG001|Overall Study|Other Miscellaneous Reason|0|||
131471332|NCT03101267|473357229|FG000|Primary Study Period|Withdrawal by Subject|1|||
131471333|NCT03101267|473357230|FG001|Primary Study Period|Withdrawal by Subject|2|||
131471334|NCT03101267|473357231|FG002|Primary Study Period|Withdrawal by Subject|3|||
131471335|NCT03101267|473357229|FG000|Primary Study Period|Miscellaneous|2|||
131471336|NCT03101267|473357230|FG001|Primary Study Period|Miscellaneous|0|||
131471337|NCT03101267|473357231|FG002|Primary Study Period|Miscellaneous|0|||
131471338|NCT04068896|473357232|FG000|Overall Study|Adverse Event|2|||
131471339|NCT04068896|473357233|FG001|Overall Study|Adverse Event|0|||
131770018|NCT00438815|474436088|FG000|Overall Study|Withdrawal by Subject|6|||
131471340|NCT04068896|473357234|FG002|Overall Study|Adverse Event|1|||
131471341|NCT04068896|473357235|FG003|Overall Study|Adverse Event|0|||
131471342|NCT04068896|473357236|FG004|Overall Study|Adverse Event|0|||
131471343|NCT04068896|473357237|FG005|Overall Study|Adverse Event|0|||
131471344|NCT04068896|473357232|FG000|Overall Study|Death|3|||
131471345|NCT04068896|473357233|FG001|Overall Study|Death|1|||
131471346|NCT04068896|473357234|FG002|Overall Study|Death|3|||
131471347|NCT04068896|473357235|FG003|Overall Study|Death|19|||
131471348|NCT04068896|473357236|FG004|Overall Study|Death|17|||
131471349|NCT04068896|473357237|FG005|Overall Study|Death|0|||
131471350|NCT04068896|473357232|FG000|Overall Study|Physician Decision|0|||
131471351|NCT04068896|473357233|FG001|Overall Study|Physician Decision|0|||
131471352|NCT04068896|473357234|FG002|Overall Study|Physician Decision|0|||
131471353|NCT04068896|473357235|FG003|Overall Study|Physician Decision|1|||
131471354|NCT04068896|473357236|FG004|Overall Study|Physician Decision|0|||
131471355|NCT04068896|473357237|FG005|Overall Study|Physician Decision|0|||
131471356|NCT04068896|473357232|FG000|Overall Study|progressive disease|3|||
131471357|NCT04068896|473357233|FG001|Overall Study|progressive disease|5|||
131471358|NCT04068896|473357234|FG002|Overall Study|progressive disease|3|||
131471359|NCT04068896|473357235|FG003|Overall Study|progressive disease|2|||
131471360|NCT04068896|473357236|FG004|Overall Study|progressive disease|1|||
131471361|NCT04068896|473357237|FG005|Overall Study|progressive disease|2|||
131471362|NCT04068896|473357232|FG000|Overall Study|Study terminated by sponsor|0|||
131471363|NCT04068896|473357233|FG001|Overall Study|Study terminated by sponsor|0|||
131471364|NCT04068896|473357234|FG002|Overall Study|Study terminated by sponsor|1|||
131471365|NCT04068896|473357235|FG003|Overall Study|Study terminated by sponsor|2|||
131471366|NCT04068896|473357236|FG004|Overall Study|Study terminated by sponsor|1|||
131471367|NCT04068896|473357237|FG005|Overall Study|Study terminated by sponsor|4|||
131471368|NCT04068896|473357232|FG000|Overall Study|Protocol Violation|0|||
131471369|NCT04068896|473357233|FG001|Overall Study|Protocol Violation|0|||
131471370|NCT04068896|473357234|FG002|Overall Study|Protocol Violation|0|||
131471371|NCT04068896|473357235|FG003|Overall Study|Protocol Violation|1|||
131471372|NCT04068896|473357236|FG004|Overall Study|Protocol Violation|0|||
131471373|NCT04068896|473357237|FG005|Overall Study|Protocol Violation|0|||
131471374|NCT04068896|473357232|FG000|Overall Study|Withdrawal by Subject|0|||
131471375|NCT04068896|473357233|FG001|Overall Study|Withdrawal by Subject|3|||
131471376|NCT04068896|473357234|FG002|Overall Study|Withdrawal by Subject|0|||
131471377|NCT04068896|473357235|FG003|Overall Study|Withdrawal by Subject|2|||
131471378|NCT04068896|473357236|FG004|Overall Study|Withdrawal by Subject|1|||
131471379|NCT04068896|473357237|FG005|Overall Study|Withdrawal by Subject|0|||
131471380|NCT04068896|473357232|FG000|Overall Study|Symptomatic deterioration|2|||
131471381|NCT04068896|473357233|FG001|Overall Study|Symptomatic deterioration|0|||
131471382|NCT04068896|473357234|FG002|Overall Study|Symptomatic deterioration|0|||
131471383|NCT04068896|473357235|FG003|Overall Study|Symptomatic deterioration|0|||
131471384|NCT04068896|473357236|FG004|Overall Study|Symptomatic deterioration|0|||
131471385|NCT04068896|473357237|FG005|Overall Study|Symptomatic deterioration|0|||
131471386|NCT02398227|473357238|FG000|Overall Study|Lost to Follow-up|21|||
131471387|NCT02398227|473357239|FG001|Overall Study|Lost to Follow-up|12|||
131471388|NCT02398227|473357238|FG000|Overall Study|Withdrawal by Subject|5|||
131471389|NCT02398227|473357239|FG001|Overall Study|Withdrawal by Subject|6|||
131471390|NCT02398227|473357238|FG000|Overall Study|Removed from treatment and dropped out|1|||
131471391|NCT02398227|473357239|FG001|Overall Study|Removed from treatment and dropped out|0|||
131471392|NCT00107952|473357240|FG000|Overall Study|Death|75|||
131471393|NCT00107952|473357241|FG001|Overall Study|Death|61|||
131471394|NCT00107952|473357240|FG000|Overall Study|Lost to Follow-up|0|||
131471395|NCT00107952|473357241|FG001|Overall Study|Lost to Follow-up|3|||
131471396|NCT00107952|473357240|FG000|Overall Study|Withdrawal by Subject|9|||
131471397|NCT00107952|473357241|FG001|Overall Study|Withdrawal by Subject|6|||
131471398|NCT00107952|473357240|FG000|Overall Study|Other|2|||
131471399|NCT00107952|473357241|FG001|Overall Study|Other|5|||
131471400|NCT00107952|473357240|FG000|Overall Study|Never received study treatment|9|||
131471401|NCT00107952|473357241|FG001|Overall Study|Never received study treatment|6|||
131471402|NCT01975831|473357242|FG000|Overall Study|Adverse Event|1|||
131471403|NCT01975831|473357243|FG001|Overall Study|Adverse Event|2|||
131471404|NCT01975831|473357244|FG002|Overall Study|Adverse Event|2|||
131471405|NCT01975831|473357245|FG003|Overall Study|Adverse Event|0|||
131471406|NCT01975831|473357246|FG004|Overall Study|Adverse Event|1|||
131471407|NCT01975831|473357247|FG005|Overall Study|Adverse Event|1|||
131471408|NCT01975831|473357248|FG006|Overall Study|Adverse Event|3|||
131471409|NCT01975831|473357249|FG007|Overall Study|Adverse Event|4|||
131471410|NCT01975831|473357250|FG008|Overall Study|Adverse Event|1|||
131471411|NCT01975831|473357242|FG000|Overall Study|Death|1|||
131471412|NCT01975831|473357243|FG001|Overall Study|Death|1|||
131471413|NCT01975831|473357244|FG002|Overall Study|Death|0|||
131471414|NCT01975831|473357245|FG003|Overall Study|Death|0|||
131471415|NCT01975831|473357246|FG004|Overall Study|Death|1|||
131471416|NCT01975831|473357247|FG005|Overall Study|Death|0|||
131471417|NCT01975831|473357248|FG006|Overall Study|Death|1|||
131471418|NCT01975831|473357249|FG007|Overall Study|Death|0|||
131471419|NCT01975831|473357250|FG008|Overall Study|Death|0|||
131471420|NCT01975831|473357242|FG000|Overall Study|Progressive Disease|1|||
131471421|NCT01975831|473357243|FG001|Overall Study|Progressive Disease|3|||
131471422|NCT01975831|473357244|FG002|Overall Study|Progressive Disease|2|||
131471423|NCT01975831|473357245|FG003|Overall Study|Progressive Disease|4|||
131471424|NCT01975831|473357246|FG004|Overall Study|Progressive Disease|13|||
131471425|NCT01975831|473357247|FG005|Overall Study|Progressive Disease|9|||
131471426|NCT01975831|473357248|FG006|Overall Study|Progressive Disease|10|||
131471427|NCT01975831|473357249|FG007|Overall Study|Progressive Disease|8|||
131471428|NCT01975831|473357250|FG008|Overall Study|Progressive Disease|10|||
131471429|NCT01975831|473357242|FG000|Overall Study|Withdrawal by Subject|0|||
131471430|NCT01975831|473357243|FG001|Overall Study|Withdrawal by Subject|3|||
131471431|NCT01975831|473357244|FG002|Overall Study|Withdrawal by Subject|0|||
131471432|NCT01975831|473357245|FG003|Overall Study|Withdrawal by Subject|0|||
131471433|NCT01975831|473357246|FG004|Overall Study|Withdrawal by Subject|3|||
131471434|NCT01975831|473357247|FG005|Overall Study|Withdrawal by Subject|1|||
131471435|NCT01975831|473357248|FG006|Overall Study|Withdrawal by Subject|1|||
131471436|NCT01975831|473357249|FG007|Overall Study|Withdrawal by Subject|0|||
131471437|NCT01975831|473357250|FG008|Overall Study|Withdrawal by Subject|0|||
131471438|NCT01975831|473357242|FG000|Overall Study|Physician Decision|0|||
131471439|NCT01975831|473357243|FG001|Overall Study|Physician Decision|0|||
131471440|NCT01975831|473357244|FG002|Overall Study|Physician Decision|0|||
131471441|NCT01975831|473357245|FG003|Overall Study|Physician Decision|0|||
131471442|NCT01975831|473357246|FG004|Overall Study|Physician Decision|0|||
131471443|NCT01975831|473357247|FG005|Overall Study|Physician Decision|1|||
131471444|NCT01975831|473357248|FG006|Overall Study|Physician Decision|0|||
131471445|NCT01975831|473357249|FG007|Overall Study|Physician Decision|1|||
131471446|NCT01975831|473357250|FG008|Overall Study|Physician Decision|0|||
131471447|NCT01975831|473357242|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
131471448|NCT01975831|473357243|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
131471449|NCT01975831|473357244|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
131471450|NCT01975831|473357245|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
131471451|NCT01975831|473357246|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
131471452|NCT01975831|473357247|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
131471453|NCT01975831|473357248|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
131471454|NCT01975831|473357249|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
131471455|NCT01975831|473357250|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
131471456|NCT01975831|473357242|FG000|Overall Study|Entered Hospice|0|||
131770019|NCT00438815|474436088|FG000|Overall Study|Death|1|||
131770020|NCT03380091|474436091|FG000|Overall Study|Withdrawal by Subject|2|||
131770021|NCT03380091|474436092|FG001|Overall Study|Withdrawal by Subject|1|||
131770022|NCT05602818|474436093|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
131770023|NCT05602818|474436094|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
131770024|NCT05602818|474436095|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
131770025|NCT05602818|474436096|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
131770026|NCT05602818|474436097|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
131770027|NCT05602818|474436098|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
131770028|NCT05602818|474436099|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
131770029|NCT05602818|474436100|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
131471457|NCT01975831|473357243|FG001|Overall Study|Entered Hospice|0|||
131471458|NCT01975831|473357244|FG002|Overall Study|Entered Hospice|0|||
131471459|NCT01975831|473357245|FG003|Overall Study|Entered Hospice|0|||
131471460|NCT01975831|473357246|FG004|Overall Study|Entered Hospice|0|||
131471461|NCT01975831|473357247|FG005|Overall Study|Entered Hospice|1|||
131471462|NCT01975831|473357248|FG006|Overall Study|Entered Hospice|0|||
131471463|NCT01975831|473357249|FG007|Overall Study|Entered Hospice|0|||
131471464|NCT01975831|473357250|FG008|Overall Study|Entered Hospice|0|||
131770030|NCT05602818|474436101|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
131770031|NCT05602818|474436102|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
131770032|NCT05602818|474436103|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
131770033|NCT05602818|474436104|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
131770034|NCT05602818|474436093|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
131770035|NCT05602818|474436094|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
131770036|NCT05602818|474436095|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770037|NCT05602818|474436096|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770038|NCT05602818|474436097|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770039|NCT05602818|474436098|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770040|NCT05602818|474436099|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770041|NCT05602818|474436100|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770042|NCT05602818|474436101|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770043|NCT05602818|474436102|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770044|NCT05602818|474436103|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770045|NCT05602818|474436104|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131770046|NCT05602818|474436093|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
131770047|NCT05602818|474436094|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770048|NCT05602818|474436095|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770049|NCT05602818|474436096|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770050|NCT05602818|474436097|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770051|NCT05602818|474436098|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770052|NCT05602818|474436099|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770053|NCT05602818|474436100|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770054|NCT05602818|474436101|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770055|NCT05602818|474436102|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770056|NCT05602818|474436103|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770057|NCT05602818|474436104|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131770058|NCT05602818|474436093|FG000|Qualification Phase (3 Days)|Other|1|||
131770059|NCT05602818|474436094|FG001|Qualification Phase (3 Days)|Other|0|||
131770060|NCT05602818|474436095|FG002|Qualification Phase (3 Days)|Other|0|||
131770061|NCT05602818|474436096|FG003|Qualification Phase (3 Days)|Other|0|||
131770062|NCT05602818|474436097|FG004|Qualification Phase (3 Days)|Other|0|||
131770063|NCT05602818|474436098|FG005|Qualification Phase (3 Days)|Other|0|||
131770064|NCT05602818|474436099|FG006|Qualification Phase (3 Days)|Other|0|||
131770065|NCT05602818|474436100|FG007|Qualification Phase (3 Days)|Other|0|||
131770066|NCT05602818|474436101|FG008|Qualification Phase (3 Days)|Other|0|||
131770067|NCT05602818|474436102|FG009|Qualification Phase (3 Days)|Other|0|||
131471465|NCT01975831|473357242|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471466|NCT01975831|473357243|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471467|NCT01975831|473357244|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471468|NCT01975831|473357245|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471469|NCT01975831|473357246|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471470|NCT01975831|473357247|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471471|NCT01975831|473357248|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
131471472|NCT01975831|473357249|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
131471473|NCT01975831|473357250|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
131471474|NCT01401959|473357251|FG000|Enrolled|Withdrawal by Subject|1|||
131471475|NCT01401959|473357252|FG001|Enrolled|Withdrawal by Subject|0|||
131471476|NCT01401959|473357253|FG002|Enrolled|Withdrawal by Subject|0|||
131471477|NCT01401959|473357251|FG000|Treated|Disease Progression|2|||
131471478|NCT01401959|473357252|FG001|Treated|Disease Progression|2|||
131471479|NCT01401959|473357253|FG002|Treated|Disease Progression|1|||
131471480|NCT01401959|473357251|FG000|Treated|Adverse Event|4|||
131471481|NCT01401959|473357252|FG001|Treated|Adverse Event|3|||
131471482|NCT01401959|473357253|FG002|Treated|Adverse Event|2|||
131471483|NCT01401959|473357251|FG000|Treated|Withdrawal by Subject|1|||
131471484|NCT01401959|473357252|FG001|Treated|Withdrawal by Subject|2|||
131471485|NCT01401959|473357253|FG002|Treated|Withdrawal by Subject|2|||
131471486|NCT01401959|473357251|FG000|Treated|Protocol Violation|0|||
131471487|NCT01401959|473357252|FG001|Treated|Protocol Violation|1|||
131471488|NCT01401959|473357253|FG002|Treated|Protocol Violation|0|||
131471489|NCT00256282|473357254|FG000|Overall Study|Disease progression, relapse during acti|12|||
131471490|NCT00256282|473357254|FG000|Overall Study|Adverse Event|3|||
131471491|NCT00256282|473357254|FG000|Overall Study|Physician Decision|1|||
131471492|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
131471493|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
131471494|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Other|2|||
131471495|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Other|2|||
131471496|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Personal reasons|2|||
131471497|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Personal reasons|2|||
131471498|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
131471499|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
131471500|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
131471501|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
131471502|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
131471503|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
131471504|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
131471505|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
131471506|NCT00667446|473357255|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
131471507|NCT00667446|473357256|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
131471508|NCT00667446|473357255|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
131471509|NCT00667446|473357256|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
131471510|NCT00322153|473357259|FG000|Overall Study|Adverse Event|21|||
131471511|NCT00322153|473357260|FG001|Overall Study|Adverse Event|34|||
131471512|NCT00322153|473357259|FG000|Overall Study|Protocol Violation|6|||
131471513|NCT00322153|473357260|FG001|Overall Study|Protocol Violation|14|||
131471514|NCT00322153|473357259|FG000|Overall Study|Withdrawal by Subject|18|||
131471515|NCT00322153|473357260|FG001|Overall Study|Withdrawal by Subject|10|||
131471516|NCT00322153|473357259|FG000|Overall Study|Lack of Efficacy|8|||
131471517|NCT00322153|473357260|FG001|Overall Study|Lack of Efficacy|3|||
131471518|NCT00322153|473357259|FG000|Overall Study|Lost to Follow-up|5|||
131471519|NCT00322153|473357260|FG001|Overall Study|Lost to Follow-up|4|||
131471520|NCT00322153|473357259|FG000|Overall Study|Withdrawn for other reasons|5|||
131471521|NCT00322153|473357260|FG001|Overall Study|Withdrawn for other reasons|4|||
131471522|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
131471523|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
131471524|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
131471525|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
131471526|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
131471527|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
131471528|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
131471529|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
131471530|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
131471531|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
131471532|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
131471533|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
131471534|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
131471535|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
131471536|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
131471537|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
131471538|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
131471539|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
131471540|NCT00591578|473357262|FG000|Double-Blind Treatment Phase|Other|4|||
131471541|NCT00591578|473357263|FG001|Double-Blind Treatment Phase|Other|9|||
131471542|NCT00591578|473357264|FG002|Double-Blind Treatment Phase|Other|4|||
131471543|NCT00591578|473357262|FG000|Open-Label Extension Phase|Adverse Event|3|||
131471544|NCT00591578|473357263|FG001|Open-Label Extension Phase|Adverse Event|5|||
131471545|NCT00591578|473357264|FG002|Open-Label Extension Phase|Adverse Event|0|||
131471546|NCT00591578|473357262|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
131471547|NCT00591578|473357263|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
131471548|NCT00591578|473357264|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
131471549|NCT00591578|473357262|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
131770068|NCT05602818|474436103|FG010|Qualification Phase (3 Days)|Other|0|||
131770069|NCT05602818|474436104|FG011|Qualification Phase (3 Days)|Other|0|||
131770070|NCT05602818|474436093|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770071|NCT05602818|474436094|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
131770072|NCT05602818|474436095|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770073|NCT05602818|474436096|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770074|NCT05602818|474436097|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770075|NCT05602818|474436098|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770076|NCT05602818|474436099|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770077|NCT05602818|474436100|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770078|NCT05602818|474436101|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770079|NCT05602818|474436102|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770080|NCT05602818|474436103|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131471550|NCT00591578|473357263|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
131471551|NCT00591578|473357264|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
131471552|NCT00591578|473357262|FG000|Open-Label Extension Phase|Other|1|||
131471553|NCT00591578|473357263|FG001|Open-Label Extension Phase|Other|0|||
131471554|NCT00591578|473357264|FG002|Open-Label Extension Phase|Other|0|||
131471555|NCT02632838|473357265|FG000|Overall Study|Withdrawal by Subject|3|||
131471556|NCT02632838|473357266|FG001|Overall Study|Withdrawal by Subject|0|||
131471557|NCT02632838|473357265|FG000|Overall Study|Lost to Follow-up|0|||
131471558|NCT02632838|473357266|FG001|Overall Study|Lost to Follow-up|2|||
131471559|NCT01233687|473357272|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
131471560|NCT01233687|473357272|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
131471561|NCT01233687|473357272|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
131471562|NCT03324581|473357273|FG000|Overall Study|Adverse Event|18|||
131471563|NCT03324581|473357274|FG001|Overall Study|Adverse Event|11|||
131471564|NCT03324581|473357275|FG002|Overall Study|Adverse Event|7|||
131471565|NCT03324581|473357273|FG000|Overall Study|Lack of Efficacy|0|||
131471566|NCT03324581|473357274|FG001|Overall Study|Lack of Efficacy|1|||
131471567|NCT03324581|473357275|FG002|Overall Study|Lack of Efficacy|0|||
131471568|NCT03324581|473357273|FG000|Overall Study|Lost to Follow-up|5|||
131471569|NCT03324581|473357274|FG001|Overall Study|Lost to Follow-up|3|||
131471570|NCT03324581|473357275|FG002|Overall Study|Lost to Follow-up|6|||
131471571|NCT03324581|473357273|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
131471572|NCT03324581|473357274|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
131471573|NCT03324581|473357275|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
131471574|NCT03324581|473357273|FG000|Overall Study|Physician Decision|0|||
131471575|NCT03324581|473357274|FG001|Overall Study|Physician Decision|1|||
131471576|NCT03324581|473357275|FG002|Overall Study|Physician Decision|2|||
131471577|NCT03324581|473357273|FG000|Overall Study|Protocol Deviation|8|||
131471578|NCT03324581|473357274|FG001|Overall Study|Protocol Deviation|9|||
131471579|NCT03324581|473357275|FG002|Overall Study|Protocol Deviation|4|||
131471580|NCT03324581|473357273|FG000|Overall Study|Withdrawal by Subject|6|||
131471581|NCT03324581|473357274|FG001|Overall Study|Withdrawal by Subject|8|||
131471582|NCT03324581|473357275|FG002|Overall Study|Withdrawal by Subject|6|||
131471583|NCT03324581|473357273|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
131471584|NCT03324581|473357274|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
131471585|NCT03324581|473357275|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
131471586|NCT03783702|473357276|FG000|Overall Study|Lost to Follow-up|6|||
131471587|NCT03783702|473357277|FG001|Overall Study|Lost to Follow-up|8|||
131471588|NCT03783702|473357276|FG000|Overall Study|Protocol Violation|1|||
131471589|NCT03783702|473357277|FG001|Overall Study|Protocol Violation|3|||
131471590|NCT02274038|473357278|FG000|Overall Study|Death|1|||
131471591|NCT04473482|473357279|FG000|Overall Study|Death|0|||
131471592|NCT04473482|473357280|FG001|Overall Study|Death|3|||
131471593|NCT04473482|473357279|FG000|Overall Study|Lost to Follow-up|9|||
131471594|NCT04473482|473357280|FG001|Overall Study|Lost to Follow-up|7|||
131471595|NCT04473482|473357279|FG000|Overall Study|Withdrawal by Subject|2|||
131471596|NCT04473482|473357280|FG001|Overall Study|Withdrawal by Subject|1|||
131471597|NCT00321893|473357282|FG000|Overall Study|Non-Compliance/Refusal|16|||
131471598|NCT00321893|473357283|FG001|Overall Study|Non-Compliance/Refusal|10|||
131471599|NCT00321893|473357282|FG000|Overall Study|Lost to Follow-up|2|||
131471600|NCT00321893|473357283|FG001|Overall Study|Lost to Follow-up|1|||
131471601|NCT00321893|473357282|FG000|Overall Study|Adverse Event|6|||
131471602|NCT00321893|473357283|FG001|Overall Study|Adverse Event|3|||
131471603|NCT00769483|473357284|FG000|Overall Study|Withdrawal by Subject|0|||
131471604|NCT00769483|473357285|FG001|Overall Study|Withdrawal by Subject|1|||
131471605|NCT00769483|473357286|FG002|Overall Study|Withdrawal by Subject|0|||
131471606|NCT00769483|473357287|FG003|Overall Study|Withdrawal by Subject|0|||
131471607|NCT00769483|473357288|FG004|Overall Study|Withdrawal by Subject|1|||
131471608|NCT00769483|473357289|FG005|Overall Study|Withdrawal by Subject|0|||
131471609|NCT01306877|473357290|FG000|Overall Study|Lost to Follow-up|3|||
131471610|NCT01306877|473357291|FG001|Overall Study|Lost to Follow-up|3|||
131471611|NCT01306877|473357290|FG000|Overall Study|Physician Decision|0|||
131471612|NCT01306877|473357291|FG001|Overall Study|Physician Decision|1|||
131471613|NCT00006389|473357292|FG000|Overall Study|Adverse Event|1|||
131471614|NCT00999921|473357297|FG000|Overall Study|Lost to Follow-up|10|||
131471615|NCT00999921|473357298|FG001|Overall Study|Lost to Follow-up|19|||
131471616|NCT01076075|473357303|FG000|Overall Study|Adverse Event|3|||
131471617|NCT01076075|473357304|FG001|Overall Study|Adverse Event|9|||
131471618|NCT01076075|473357303|FG000|Overall Study|Lack of Efficacy|5|||
131471619|NCT01076075|473357304|FG001|Overall Study|Lack of Efficacy|4|||
131471620|NCT01076075|473357303|FG000|Overall Study|Lost to Follow-up|6|||
131471621|NCT01076075|473357304|FG001|Overall Study|Lost to Follow-up|5|||
131471622|NCT01076075|473357303|FG000|Overall Study|other|19|||
131471623|NCT01076075|473357304|FG001|Overall Study|other|9|||
131471624|NCT01076075|473357303|FG000|Overall Study|Protocol Violation|0|||
131471625|NCT01076075|473357304|FG001|Overall Study|Protocol Violation|1|||
131471626|NCT01076075|473357303|FG000|Overall Study|Withdrawal by Subject|8|||
131471627|NCT01076075|473357304|FG001|Overall Study|Withdrawal by Subject|19|||
131471628|NCT01445886|473357309|FG000|Overall Study|Lost to Follow-up|2|||
131471629|NCT01445886|473357309|FG000|Overall Study|Protocol Violation|3|||
131471630|NCT00976573|473357312|FG000|Overall Study|Ineligible|0|||
131471631|NCT00976573|473357313|FG001|Overall Study|Ineligible|1|||
131471632|NCT00976573|473357312|FG000|Overall Study|Cancel prior to receiving treatment|4|||
131471633|NCT00976573|473357313|FG001|Overall Study|Cancel prior to receiving treatment|2|||
131471634|NCT00995865|473357316|FG000|Overall Study|Protocol Violation|2|||
131471635|NCT00995865|473357317|FG001|Overall Study|Protocol Violation|0|||
131471636|NCT00995865|473357318|FG002|Overall Study|Protocol Violation|0|||
131471637|NCT00995865|473357316|FG000|Overall Study|Lost to Follow-up|0|||
131471638|NCT00995865|473357317|FG001|Overall Study|Lost to Follow-up|0|||
131471639|NCT00995865|473357318|FG002|Overall Study|Lost to Follow-up|1|||
131471640|NCT05080660|473357320|FG000|Overall Study|Adverse Event|4|||
131471641|NCT05080660|473357321|FG001|Overall Study|Adverse Event|0|||
131471642|NCT05080660|473357320|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
131471643|NCT05080660|473357321|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
131471644|NCT05080660|473357320|FG000|Overall Study|Physician Decision|1|||
131471645|NCT05080660|473357321|FG001|Overall Study|Physician Decision|0|||
131471646|NCT05080660|473357320|FG000|Overall Study|Protocol Deviation|2|||
131471647|NCT05080660|473357321|FG001|Overall Study|Protocol Deviation|0|||
131471648|NCT05080660|473357320|FG000|Overall Study|Withdrawal by Subject|5|||
131471649|NCT05080660|473357321|FG001|Overall Study|Withdrawal by Subject|2|||
131471650|NCT04221230|473357331|FG000|Overall Study|Lost to Follow-up|12|||
131471651|NCT04221230|473357332|FG001|Overall Study|Lost to Follow-up|12|||
131471652|NCT04221230|473357331|FG000|Overall Study|Protocol Violation|2|||
131471653|NCT04221230|473357332|FG001|Overall Study|Protocol Violation|2|||
131471654|NCT04221230|473357331|FG000|Overall Study|Adverse Event|0|||
131471655|NCT04221230|473357332|FG001|Overall Study|Adverse Event|8|||
131471656|NCT04221230|473357331|FG000|Overall Study|Physician Decision|1|||
131471657|NCT04221230|473357332|FG001|Overall Study|Physician Decision|0|||
131471658|NCT04221230|473357331|FG000|Overall Study|Withdrawal by Subject|13|||
131471659|NCT04221230|473357332|FG001|Overall Study|Withdrawal by Subject|11|||
131471660|NCT04221230|473357331|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131471661|NCT04221230|473357332|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131471662|NCT04221230|473357331|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131471663|NCT04221230|473357332|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131471664|NCT04221230|473357331|FG000|Overall Study|Pregnancy|0|||
131471665|NCT04221230|473357332|FG001|Overall Study|Pregnancy|1|||
131471666|NCT04221230|473357331|FG000|Overall Study|Other|1|||
131471667|NCT04221230|473357332|FG001|Overall Study|Other|2|||
131471668|NCT02021656|473357333|FG000|Overall Study|Adverse Event|1|||
131471669|NCT02021656|473357333|FG000|Overall Study|Lack of Efficacy|2|||
131471670|NCT02021656|473357333|FG000|Overall Study|Lost to Follow-up|1|||
131471671|NCT02021656|473357333|FG000|Overall Study|Withdrew Consent|2|||
131471672|NCT03670836|473357336|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
131471673|NCT03670836|473357337|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
131471674|NCT03670836|473357336|FG000|Per Protocol Population (PP)|Physician Decision|9|||
131471675|NCT03670836|473357337|FG001|Per Protocol Population (PP)|Physician Decision|10|||
131471676|NCT03670836|473357336|FG000|Per Protocol Population (PP)|Physician Decision|4|||
131471677|NCT03670836|473357337|FG001|Per Protocol Population (PP)|Physician Decision|6|||
131471678|NCT03670836|473357336|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
131471679|NCT03670836|473357337|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
131471680|NCT01683019|473359026|FG000|Overall Study|Withdrawal by Subject|2|||
131471681|NCT01683019|473359027|FG001|Overall Study|Withdrawal by Subject|1|||
131471682|NCT01683019|473359028|FG002|Overall Study|Withdrawal by Subject|4|||
131471683|NCT04285580|473359031|FG000|Overall Study|Protocol Violation|0|||
131471684|NCT04285580|473359032|FG001|Overall Study|Protocol Violation|1|||
131471685|NCT00076024|473359034|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
131471686|NCT00076024|473359035|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
131471687|NCT00076024|473359036|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
131471688|NCT00076024|473359037|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
131471689|NCT00076024|473359034|FG000|Phase 1, Lead-in|Adverse Event|1|||
131471690|NCT00076024|473359035|FG001|Phase 1, Lead-in|Adverse Event|0|||
131471691|NCT00076024|473359036|FG002|Phase 1, Lead-in|Adverse Event|0|||
131471692|NCT00076024|473359037|FG003|Phase 1, Lead-in|Adverse Event|0|||
131471693|NCT00076024|473359034|FG000|Phase 1, Lead-in|Clinical progression|1|||
131471694|NCT00076024|473359035|FG001|Phase 1, Lead-in|Clinical progression|0|||
131471695|NCT00076024|473359036|FG002|Phase 1, Lead-in|Clinical progression|0|||
131471696|NCT00076024|473359037|FG003|Phase 1, Lead-in|Clinical progression|0|||
131471697|NCT00076024|473359034|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
131471698|NCT00076024|473359035|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
131471699|NCT00076024|473359036|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
131471700|NCT00076024|473359037|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
131471701|NCT00076024|473359034|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
131471702|NCT00076024|473359035|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
131471703|NCT00076024|473359036|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
131471704|NCT00076024|473359037|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
131471705|NCT00076024|473359034|FG000|Phase 2, Double-blind|Adverse Event|0|||
131471706|NCT00076024|473359035|FG001|Phase 2, Double-blind|Adverse Event|25|||
131471707|NCT00076024|473359036|FG002|Phase 2, Double-blind|Adverse Event|6|||
131471708|NCT00076024|473359037|FG003|Phase 2, Double-blind|Adverse Event|0|||
131471709|NCT00076024|473359034|FG000|Phase 2, Double-blind|Un-specified|0|||
131471710|NCT00076024|473359035|FG001|Phase 2, Double-blind|Un-specified|14|||
131471711|NCT00076024|473359036|FG002|Phase 2, Double-blind|Un-specified|6|||
131471712|NCT00076024|473359037|FG003|Phase 2, Double-blind|Un-specified|0|||
131471713|NCT00076024|473359034|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
131471714|NCT00076024|473359035|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
131471715|NCT00076024|473359036|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
131471716|NCT00076024|473359037|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
131471717|NCT00076024|473359034|FG000|Phase 2, Open-label|Adverse Event|0|||
131471718|NCT00076024|473359035|FG001|Phase 2, Open-label|Adverse Event|0|||
131770081|NCT05602818|474436104|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131770082|NCT05602818|474436093|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
131770083|NCT05602818|474436094|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
131770084|NCT05602818|474436095|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
131770085|NCT05602818|474436096|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
131471719|NCT00076024|473359036|FG002|Phase 2, Open-label|Adverse Event|0|||
131471720|NCT00076024|473359037|FG003|Phase 2, Open-label|Adverse Event|2|||
131471721|NCT00076024|473359034|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
131471722|NCT00076024|473359035|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
131471723|NCT00076024|473359036|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
131471724|NCT00076024|473359037|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
131471725|NCT00076024|473359034|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
131471726|NCT00076024|473359035|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
131471727|NCT00076024|473359036|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
131471728|NCT00076024|473359037|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
131471729|NCT00076024|473359034|FG000|Phase 2, Open-label|Other|0|||
131471730|NCT00076024|473359035|FG001|Phase 2, Open-label|Other|0|||
131471731|NCT00076024|473359036|FG002|Phase 2, Open-label|Other|0|||
131471732|NCT00076024|473359037|FG003|Phase 2, Open-label|Other|2|||
131471733|NCT01155219|473359038|FG000|Overall Study|Adverse Event|3|||
131471734|NCT01155219|473359039|FG001|Overall Study|Adverse Event|1|||
131471735|NCT01155219|473359038|FG000|Overall Study|non-medical reason|1|||
131471736|NCT01155219|473359039|FG001|Overall Study|non-medical reason|2|||
131471737|NCT00719264|473359040|FG000|Overall Study|Adverse Event|41|||
131471738|NCT00719264|473359041|FG001|Overall Study|Adverse Event|49|||
131471739|NCT00719264|473359040|FG000|Overall Study|Death|13|||
131471740|NCT00719264|473359041|FG001|Overall Study|Death|10|||
131471741|NCT00719264|473359040|FG000|Overall Study|Administrative Problems|6|||
131471742|NCT00719264|473359041|FG001|Overall Study|Administrative Problems|4|||
131471743|NCT00719264|473359040|FG000|Overall Study|Lost to Follow-up|1|||
131471744|NCT00719264|473359041|FG001|Overall Study|Lost to Follow-up|1|||
131471745|NCT00719264|473359040|FG000|Overall Study|Withdrawal by Subject|12|||
131471746|NCT00719264|473359041|FG001|Overall Study|Withdrawal by Subject|7|||
131471747|NCT00719264|473359040|FG000|Overall Study|Protocol Deviation|1|||
131471748|NCT00719264|473359041|FG001|Overall Study|Protocol Deviation|3|||
131471749|NCT00719264|473359040|FG000|Overall Study|New Cancer Therapy|4|||
131471750|NCT00719264|473359041|FG001|Overall Study|New Cancer Therapy|2|||
131471751|NCT00719264|473359040|FG000|Overall Study|Disease Progression|104|||
131471752|NCT00719264|473359041|FG001|Overall Study|Disease Progression|107|||
131471753|NCT04626310|473359042|FG000|Overall Study|4-miss from treatment|6|||
131471754|NCT04626310|473359043|FG001|Overall Study|4-miss from treatment|5|||
131471755|NCT04626310|473359044|FG002|Overall Study|4-miss from treatment|5|||
131471756|NCT04626310|473359042|FG000|Overall Study|Withdrawal by Subject|1|||
131471757|NCT04626310|473359043|FG001|Overall Study|Withdrawal by Subject|0|||
131471758|NCT04626310|473359044|FG002|Overall Study|Withdrawal by Subject|3|||
131471759|NCT01117051|473359045|FG000|Overall Study|Withdrawal by Subject|5|||
131471760|NCT01117051|473359046|FG001|Overall Study|Withdrawal by Subject|3|||
131471761|NCT01117051|473359045|FG000|Overall Study|Adverse Event|4|||
131471762|NCT01117051|473359046|FG001|Overall Study|Adverse Event|3|||
131471763|NCT01117051|473359045|FG000|Overall Study|Lost to Follow-up|0|||
131471764|NCT01117051|473359046|FG001|Overall Study|Lost to Follow-up|1|||
131471765|NCT01117051|473359045|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
131471766|NCT01117051|473359046|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
131471767|NCT01117051|473359045|FG000|Overall Study|Sponsor's decision|3|||
131471768|NCT01117051|473359046|FG001|Overall Study|Sponsor's decision|1|||
131471769|NCT01117051|473359045|FG000|Overall Study|Surgical procedure|0|||
131471770|NCT01117051|473359046|FG001|Overall Study|Surgical procedure|1|||
131471771|NCT01117051|473359045|FG000|Overall Study|Randomized by mistake|0|||
131471772|NCT01117051|473359046|FG001|Overall Study|Randomized by mistake|1|||
131471773|NCT01117051|473359045|FG000|Overall Study|Convenience issue|1|||
131471774|NCT01117051|473359046|FG001|Overall Study|Convenience issue|0|||
131471775|NCT01142128|473359047|FG000|Overall Study|Physician Decision|1|||
131471776|NCT01142128|473359047|FG000|Overall Study|Lost to Follow-up|1|||
131471777|NCT01142128|473359047|FG000|Overall Study|Withdrawal by Subject|2|||
131471778|NCT00366340|473359048|FG000|Infant Series|Protocol Violation|3|||
131471779|NCT00366340|473359049|FG001|Infant Series|Protocol Violation|4|||
131471780|NCT00366340|473359048|FG000|Infant Series|Withdrawal by Subject|3|||
131471781|NCT00366340|473359049|FG001|Infant Series|Withdrawal by Subject|3|||
131471782|NCT00366340|473359048|FG000|Infant Series|Adverse Event|0|||
131471783|NCT00366340|473359049|FG001|Infant Series|Adverse Event|2|||
131471784|NCT00366340|473359048|FG000|Infant Series|Lost to Follow-up|1|||
131471785|NCT00366340|473359049|FG001|Infant Series|Lost to Follow-up|1|||
131471786|NCT00366340|473359048|FG000|Infant Series|Failure to return|1|||
131471787|NCT00366340|473359049|FG001|Infant Series|Failure to return|0|||
131471788|NCT00366340|473359048|FG000|After the Infant Series|Parent/legal guardian request|1|||
131471789|NCT00366340|473359049|FG001|After the Infant Series|Parent/legal guardian request|1|||
131471790|NCT00366340|473359048|FG000|After the Infant Series|Failed to return|0|||
131471791|NCT00366340|473359049|FG001|After the Infant Series|Failed to return|1|||
131471792|NCT00366340|473359048|FG000|After the Infant Series|Protocol Violation|2|||
131471793|NCT00366340|473359049|FG001|After the Infant Series|Protocol Violation|2|||
131471794|NCT00366340|473359048|FG000|After the Infant Series|Adverse Event|0|||
131471795|NCT00366340|473359049|FG001|After the Infant Series|Adverse Event|1|||
131471796|NCT00366340|473359048|FG000|After the Infant Series|Lost to Follow-up|0|||
131471797|NCT00366340|473359049|FG001|After the Infant Series|Lost to Follow-up|1|||
131471798|NCT00366340|473359048|FG000|Toddler Dose|Failed to return|1|||
131471799|NCT00366340|473359049|FG001|Toddler Dose|Failed to return|0|||
131471800|NCT00366340|473359048|FG000|Toddler Dose|Parent/legal guardian request|0|||
131471801|NCT00366340|473359049|FG001|Toddler Dose|Parent/legal guardian request|1|||
131471802|NCT01315236|473359053|FG000|Double-blind Phase|Death|1|||
131471803|NCT01315236|473359054|FG001|Double-blind Phase|Death|0|||
131471804|NCT01315236|473359053|FG000|Double-blind Phase|Adverse Event|1|||
131471805|NCT01315236|473359054|FG001|Double-blind Phase|Adverse Event|0|||
131471806|NCT01315236|473359053|FG000|Double-blind Phase|Withdrawal of Consent|1|||
131471807|NCT01315236|473359054|FG001|Double-blind Phase|Withdrawal of Consent|0|||
131471808|NCT01315236|473359053|FG000|Double-blind Phase|Lost to Follow-up|1|||
131471809|NCT01315236|473359054|FG001|Double-blind Phase|Lost to Follow-up|0|||
131471810|NCT01315236|473359053|FG000|Open-label Phase|Death|1|||
131471811|NCT01315236|473359054|FG001|Open-label Phase|Death|0|||
131471812|NCT01315236|473359053|FG000|Open-label Phase|Adverse Event|0|||
131471813|NCT01315236|473359054|FG001|Open-label Phase|Adverse Event|1|||
131471814|NCT01315236|473359053|FG000|Open-label Phase|Other|0|||
131471815|NCT01315236|473359054|FG001|Open-label Phase|Other|1|||
131471816|NCT01315236|473359053|FG000|12-Month Follow-up Period|Death|0|||
131471817|NCT01315236|473359054|FG001|12-Month Follow-up Period|Death|1|||
131471818|NCT01315236|473359053|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
131471819|NCT01315236|473359054|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
131471820|NCT00442468|473359055|FG000|Overall Study|Adverse Event|4|||
131471821|NCT00442468|473359055|FG000|Overall Study|Withdrawal by Subject|91|||
131471822|NCT00442468|473359055|FG000|Overall Study|Did not complete all study procedures|88|||
131471823|NCT00287079|473359056|FG000|Overall Study|Qualifying relapse|12|||
131471824|NCT00287079|473359057|FG001|Overall Study|Qualifying relapse|1|||
131471825|NCT00287079|473359056|FG000|Overall Study|Non-qualifying relapse|1|||
131471826|NCT00287079|473359057|FG001|Overall Study|Non-qualifying relapse|0|||
131471827|NCT00287079|473359056|FG000|Overall Study|Adverse Event|5|||
131770086|NCT05602818|474436097|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
131770087|NCT05602818|474436098|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
131471828|NCT00287079|473359057|FG001|Overall Study|Adverse Event|0|||
131471829|NCT00287079|473359056|FG000|Overall Study|Protocol Violation|1|||
131471830|NCT00287079|473359057|FG001|Overall Study|Protocol Violation|0|||
131471831|NCT00287079|473359056|FG000|Overall Study|Other|3|||
131471832|NCT00287079|473359057|FG001|Overall Study|Other|0|||
131471833|NCT01222403|473359060|FG000|Overall Study|Inappropriate enrollment|0|||
131471834|NCT01222403|473359061|FG001|Overall Study|Inappropriate enrollment|2|||
131471835|NCT01028378|473359062|FG000|Overall Study|Lost to Follow-up|12|||
131471836|NCT01028378|473359062|FG000|Overall Study|Withdrawal by Subject|1|||
131471837|NCT01028378|473359062|FG000|Overall Study|Adminstrative Reasons|4|||
131471838|NCT01262352|473359063|FG000|Period 1|Illness after randomization|1|||
131471839|NCT01262352|473359064|FG001|Period 1|Illness after randomization|0|||
131471840|NCT01262352|473359063|FG000|Washout|Adverse Event|1|||
131471841|NCT01262352|473359064|FG001|Washout|Adverse Event|1|||
131471842|NCT01262352|473359063|FG000|Washout|Extended Washout|0|||
131471843|NCT01262352|473359064|FG001|Washout|Extended Washout|1|||
131471844|NCT01185834|473359068|FG000|Overall Study|Lost to Follow-up|2|||
131471845|NCT01185834|473359068|FG000|Overall Study|Discomfort|4|||
131471846|NCT01185834|473359068|FG000|Overall Study|Biomicroscopy|4|||
131471847|NCT01185834|473359068|FG000|Overall Study|Time/Job Conflict|2|||
131471848|NCT01185834|473359068|FG000|Overall Study|Early exit - Site error|2|||
131471849|NCT00887744|473359077|FG000|Overall Study|Adverse Event|3|||
131471850|NCT00887744|473359077|FG000|Overall Study|Death|1|||
131471851|NCT00887744|473359077|FG000|Overall Study|Lost to Follow-up|3|||
131471852|NCT00887744|473359077|FG000|Overall Study|Withdrawal by Subject|18|||
131471853|NCT00887744|473359077|FG000|Overall Study|Various reasons|9|||
131471854|NCT02694718|473359082|FG000|Overall Study|Death|1|||
131471855|NCT02694718|473359082|FG000|Overall Study|Withdrawal by Subject|1|||
131471856|NCT02925793|473359083|FG000|Overall Study|Adverse Event|3|||
131471857|NCT02925793|473359084|FG001|Overall Study|Adverse Event|3|||
131471858|NCT02925793|473359085|FG002|Overall Study|Adverse Event|6|||
131471859|NCT02925793|473359083|FG000|Overall Study|Withdrawal by Subject|16|||
131471860|NCT02925793|473359084|FG001|Overall Study|Withdrawal by Subject|15|||
131471861|NCT02925793|473359085|FG002|Overall Study|Withdrawal by Subject|13|||
131471862|NCT02925793|473359083|FG000|Overall Study|Investigator Discretion|0|||
131471863|NCT02925793|473359084|FG001|Overall Study|Investigator Discretion|1|||
131471864|NCT02925793|473359085|FG002|Overall Study|Investigator Discretion|1|||
131471865|NCT02925793|473359083|FG000|Overall Study|Lost to Follow-up|2|||
131471866|NCT02925793|473359084|FG001|Overall Study|Lost to Follow-up|3|||
131471867|NCT02925793|473359085|FG002|Overall Study|Lost to Follow-up|1|||
131471868|NCT02925793|473359083|FG000|Overall Study|Lack of Efficacy|2|||
131471869|NCT02925793|473359084|FG001|Overall Study|Lack of Efficacy|6|||
131471870|NCT02925793|473359085|FG002|Overall Study|Lack of Efficacy|4|||
131471871|NCT02925793|473359083|FG000|Overall Study|Other:|2|||
131471872|NCT02925793|473359084|FG001|Overall Study|Other:|1|||
131471873|NCT02925793|473359085|FG002|Overall Study|Other:|3|||
131471874|NCT02045303|473359088|FG000|Overall Study|Protocol Violation|2|||
131471875|NCT02045303|473359089|FG001|Overall Study|Protocol Violation|1|||
131471876|NCT02045303|473359090|FG002|Overall Study|Protocol Violation|0|||
131770088|NCT05602818|474436099|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
131770089|NCT05602818|474436100|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
131471877|NCT02045303|473359088|FG000|Overall Study|Withdrawal by Subject|0|||
131471878|NCT02045303|473359089|FG001|Overall Study|Withdrawal by Subject|2|||
131471879|NCT02045303|473359090|FG002|Overall Study|Withdrawal by Subject|0|||
131471880|NCT03063203|473359091|FG000|Overall Study|Chose alternative therapy|3|||
131471881|NCT03063203|473359091|FG000|Overall Study|Death|2|||
131471882|NCT03063203|473359091|FG000|Overall Study|Disease progression|4|||
131471883|NCT03063203|473359091|FG000|Overall Study|Physician Decision|5|||
131471884|NCT01856023|473359092|FG000|Overall Study|Death|1|||
131471885|NCT01856023|473359093|FG001|Overall Study|Death|2|||
131770090|NCT05602818|474436101|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
131770091|NCT05602818|474436102|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
131770092|NCT05602818|474436103|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
131770093|NCT05602818|474436104|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
131770094|NCT05602818|474436093|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770095|NCT05602818|474436094|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770096|NCT05602818|474436095|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770097|NCT05602818|474436096|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770098|NCT05602818|474436097|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770099|NCT05602818|474436098|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770100|NCT05602818|474436099|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770101|NCT05602818|474436100|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770102|NCT05602818|474436101|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770103|NCT05602818|474436102|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131770104|NCT05602818|474436103|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
131770105|NCT05602818|474436104|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
131770106|NCT05602818|474436093|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
131770107|NCT05602818|474436094|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
131471886|NCT01856023|473359092|FG000|Overall Study|Adverse Event|2|||
131471887|NCT01856023|473359093|FG001|Overall Study|Adverse Event|1|||
131471888|NCT01856023|473359092|FG000|Overall Study|Lack of Efficacy|5|||
131471889|NCT01856023|473359093|FG001|Overall Study|Lack of Efficacy|5|||
131471890|NCT01856023|473359092|FG000|Overall Study|non compliance, study closure|1|||
131471891|NCT01856023|473359093|FG001|Overall Study|non compliance, study closure|3|||
131471892|NCT01856023|473359092|FG000|Overall Study|Withdrawal by Subject|1|||
131471893|NCT01856023|473359093|FG001|Overall Study|Withdrawal by Subject|1|||
131770108|NCT05602818|474436095|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
131770109|NCT05602818|474436096|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
131471894|NCT00245583|473359096|FG000|Overall Study|Lost to Follow-up|1|||
131471895|NCT00245583|473359097|FG001|Overall Study|Lost to Follow-up|5|||
131471896|NCT00245583|473359096|FG000|Overall Study|Adverse Event|2|||
131770110|NCT05602818|474436097|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
131770111|NCT05602818|474436098|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
131770112|NCT05602818|474436099|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
131471897|NCT00245583|473359097|FG001|Overall Study|Adverse Event|1|||
131471898|NCT00245583|473359096|FG000|Overall Study|Lack of Efficacy|1|||
131471899|NCT00245583|473359097|FG001|Overall Study|Lack of Efficacy|0|||
131471900|NCT00245583|473359096|FG000|Overall Study|Withdrawal by Subject|2|||
131471901|NCT00245583|473359097|FG001|Overall Study|Withdrawal by Subject|3|||
131471902|NCT00829283|473359098|FG000|Overall Study|Lost to Follow-up|7|||
131471903|NCT00829283|473359099|FG001|Overall Study|Lost to Follow-up|25|||
131471904|NCT04718103|473359100|FG000|Overall Study|Adverse Event|1|||
131471905|NCT04718103|473359101|FG001|Overall Study|Adverse Event|1|||
131471906|NCT04718103|473359100|FG000|Overall Study|Lack of Efficacy|4|||
131471907|NCT04718103|473359101|FG001|Overall Study|Lack of Efficacy|1|||
131471908|NCT04718103|473359100|FG000|Overall Study|Lost to Follow-up|2|||
131471909|NCT04718103|473359101|FG001|Overall Study|Lost to Follow-up|2|||
131471910|NCT04718103|473359100|FG000|Overall Study|Physician Decision|2|||
131471911|NCT04718103|473359101|FG001|Overall Study|Physician Decision|0|||
131471912|NCT04718103|473359100|FG000|Overall Study|Pregnancy|0|||
131471913|NCT04718103|473359101|FG001|Overall Study|Pregnancy|1|||
131471914|NCT04718103|473359100|FG000|Overall Study|Withdrawal by Subject|10|||
131471915|NCT04718103|473359101|FG001|Overall Study|Withdrawal by Subject|6|||
131471916|NCT04718103|473359100|FG000|Overall Study|Randomized, not treated|4|||
131471917|NCT04718103|473359101|FG001|Overall Study|Randomized, not treated|1|||
131471918|NCT04718103|473359100|FG000|Overall Study|GCP violations|7|||
131471919|NCT04718103|473359101|FG001|Overall Study|GCP violations|5|||
131471920|NCT00136604|473359102|FG000|Overall Study|Lost to Follow-up|1|||
131471921|NCT00136604|473359103|FG001|Overall Study|Lost to Follow-up|0|||
131471922|NCT00136604|473359104|FG002|Overall Study|Lost to Follow-up|0|||
131471923|NCT00136604|473359105|FG003|Overall Study|Lost to Follow-up|0|||
131471924|NCT00136604|473359106|FG004|Overall Study|Lost to Follow-up|1|||
131471925|NCT00136604|473359102|FG000|Overall Study|Migrated/moved from study area|0|||
131471926|NCT00136604|473359103|FG001|Overall Study|Migrated/moved from study area|1|||
131471927|NCT00136604|473359104|FG002|Overall Study|Migrated/moved from study area|0|||
131471928|NCT00136604|473359105|FG003|Overall Study|Migrated/moved from study area|0|||
131471929|NCT00136604|473359106|FG004|Overall Study|Migrated/moved from study area|0|||
131471930|NCT01309893|473359107|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
131471931|NCT01309893|473359108|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
131471932|NCT01309893|473359107|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
131471933|NCT01309893|473359108|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
131471934|NCT02414139|473359110|FG000|Treatment Period|Adverse Event|11|||
131471935|NCT02414139|473359111|FG001|Treatment Period|Adverse Event|6|||
131471936|NCT02414139|473359112|FG002|Treatment Period|Adverse Event|8|||
131471937|NCT02414139|473359113|FG003|Treatment Period|Adverse Event|5|||
131471938|NCT02414139|473359114|FG004|Treatment Period|Adverse Event|14|||
131471939|NCT02414139|473359115|FG005|Treatment Period|Adverse Event|3|||
131471940|NCT02414139|473359116|FG006|Treatment Period|Adverse Event|6|||
131471941|NCT02414139|473359117|FG007|Treatment Period|Adverse Event|1|||
131471942|NCT02414139|473359118|FG008|Treatment Period|Adverse Event|6|||
131471943|NCT02414139|473359119|FG009|Treatment Period|Adverse Event|8|||
131471944|NCT02414139|473359110|FG000|Treatment Period|Death|0|||
131471945|NCT02414139|473359111|FG001|Treatment Period|Death|0|||
131471946|NCT02414139|473359112|FG002|Treatment Period|Death|1|||
131471947|NCT02414139|473359113|FG003|Treatment Period|Death|1|||
131471948|NCT02414139|473359114|FG004|Treatment Period|Death|0|||
131471949|NCT02414139|473359115|FG005|Treatment Period|Death|0|||
131471950|NCT02414139|473359116|FG006|Treatment Period|Death|0|||
131471951|NCT02414139|473359117|FG007|Treatment Period|Death|0|||
131471952|NCT02414139|473359118|FG008|Treatment Period|Death|0|||
131471953|NCT02414139|473359119|FG009|Treatment Period|Death|1|||
131471954|NCT02414139|473359110|FG000|Treatment Period|Physician Decision|5|||
131471955|NCT02414139|473359111|FG001|Treatment Period|Physician Decision|4|||
131471956|NCT02414139|473359112|FG002|Treatment Period|Physician Decision|6|||
131471957|NCT02414139|473359113|FG003|Treatment Period|Physician Decision|1|||
131471958|NCT02414139|473359114|FG004|Treatment Period|Physician Decision|4|||
131471959|NCT02414139|473359115|FG005|Treatment Period|Physician Decision|0|||
131471960|NCT02414139|473359116|FG006|Treatment Period|Physician Decision|2|||
131471961|NCT02414139|473359117|FG007|Treatment Period|Physician Decision|0|||
131471962|NCT02414139|473359118|FG008|Treatment Period|Physician Decision|1|||
131471963|NCT02414139|473359119|FG009|Treatment Period|Physician Decision|4|||
131471964|NCT02414139|473359110|FG000|Treatment Period|Progressive disease|48|||
131471965|NCT02414139|473359111|FG001|Treatment Period|Progressive disease|31|||
131471966|NCT02414139|473359112|FG002|Treatment Period|Progressive disease|37|||
131471967|NCT02414139|473359113|FG003|Treatment Period|Progressive disease|21|||
131471968|NCT02414139|473359114|FG004|Treatment Period|Progressive disease|43|||
131471969|NCT02414139|473359115|FG005|Treatment Period|Progressive disease|12|||
131471970|NCT02414139|473359116|FG006|Treatment Period|Progressive disease|16|||
131770113|NCT05602818|474436100|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
131770114|NCT05602818|474436101|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
131770115|NCT05602818|474436102|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
131770116|NCT05602818|474436103|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
131770117|NCT05602818|474436104|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
131770118|NCT00679354|474436111|FG000|Overall Study|Death|3|||
131770119|NCT00679354|474436111|FG000|Overall Study|Lack of Efficacy|22|||
131770120|NCT00679354|474436111|FG000|Overall Study|Physician Decision|4|||
131770121|NCT00679354|474436111|FG000|Overall Study|Ineligible|1|||
131770122|NCT00535262|474436116|FG000|Overall Study|No funding|3|||
131770123|NCT02898662|474436117|FG000|Overall Study|Adverse Event|1|||
131770124|NCT02898662|474436118|FG001|Overall Study|Adverse Event|0|||
131770125|NCT02898662|474436117|FG000|Overall Study|Loss of asthma control|23|||
131770126|NCT02898662|474436118|FG001|Overall Study|Loss of asthma control|24|||
131770127|NCT02898662|474436117|FG000|Overall Study|Withdrawal by Subject|4|||
131770128|NCT02898662|474436118|FG001|Overall Study|Withdrawal by Subject|1|||
131770129|NCT02898662|474436117|FG000|Overall Study|Technical issue|0|||
131770130|NCT02898662|474436118|FG001|Overall Study|Technical issue|1|||
131770131|NCT02898662|474436117|FG000|Overall Study|Randomized in error|0|||
131770132|NCT02898662|474436118|FG001|Overall Study|Randomized in error|1|||
131770133|NCT02898662|474436117|FG000|Overall Study|Subject decision|1|||
131770134|NCT02898662|474436118|FG001|Overall Study|Subject decision|0|||
131770135|NCT02898662|474436117|FG000|Overall Study|Other|0|||
131770136|NCT02898662|474436118|FG001|Overall Study|Other|1|||
131770137|NCT03802331|474436119|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
131770138|NCT03802331|474436120|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
131770139|NCT00917553|474436121|FG000|Overall Study|Lost to Follow-up|2|||
131770140|NCT00917553|474436122|FG001|Overall Study|Lost to Follow-up|1|||
131770141|NCT01616173|474436123|FG000|Overall Study|Lost to Follow-up|0|||
131770142|NCT01616173|474436124|FG001|Overall Study|Lost to Follow-up|2|||
131770143|NCT01616173|474436125|FG002|Overall Study|Lost to Follow-up|0|||
131770144|NCT04382066|474436128|FG000|Overall Study|Adverse Event|1|||
131770145|NCT04382066|474436129|FG001|Overall Study|Adverse Event|0|||
131770146|NCT04382066|474436130|FG002|Overall Study|Adverse Event|0|||
131770147|NCT04382066|474436128|FG000|Overall Study|Death|1|||
131770148|NCT04382066|474436129|FG001|Overall Study|Death|0|||
131770149|NCT04382066|474436130|FG002|Overall Study|Death|1|||
131770150|NCT00504595|474436131|FG000|Overall Study|Lack of Efficacy|1|||
131770151|NCT00504595|474436132|FG001|Overall Study|Lack of Efficacy|0|||
131770152|NCT00504595|474436133|FG002|Overall Study|Lack of Efficacy|0|||
131770153|NCT00504595|474436134|FG003|Overall Study|Lack of Efficacy|0|||
131770154|NCT00504595|474436131|FG000|Overall Study|Other|0|||
131770155|NCT00504595|474436132|FG001|Overall Study|Other|0|||
131770156|NCT00504595|474436133|FG002|Overall Study|Other|2|||
131770157|NCT00504595|474436134|FG003|Overall Study|Other|0|||
131770158|NCT03326323|474436135|FG000|Overall Study|Unable to receive ANH protocol|3|||
131770159|NCT04225026|474436136|FG000|Overall Study|Withdrawal by Subject|4|||
131471971|NCT02414139|473359117|FG007|Treatment Period|Progressive disease|2|||
131471972|NCT02414139|473359118|FG008|Treatment Period|Progressive disease|20|||
131471973|NCT02414139|473359119|FG009|Treatment Period|Progressive disease|14|||
131471974|NCT02414139|473359110|FG000|Treatment Period|Protocol deviation|0|||
131471975|NCT02414139|473359111|FG001|Treatment Period|Protocol deviation|0|||
131471976|NCT02414139|473359112|FG002|Treatment Period|Protocol deviation|1|||
131471977|NCT02414139|473359113|FG003|Treatment Period|Protocol deviation|0|||
131471978|NCT02414139|473359114|FG004|Treatment Period|Protocol deviation|0|||
131471979|NCT02414139|473359115|FG005|Treatment Period|Protocol deviation|0|||
131471980|NCT02414139|473359116|FG006|Treatment Period|Protocol deviation|0|||
131471981|NCT02414139|473359117|FG007|Treatment Period|Protocol deviation|0|||
131471982|NCT02414139|473359118|FG008|Treatment Period|Protocol deviation|0|||
131471983|NCT02414139|473359119|FG009|Treatment Period|Protocol deviation|0|||
131471984|NCT02414139|473359110|FG000|Treatment Period|Subject/Guardian decision|5|||
131471985|NCT02414139|473359111|FG001|Treatment Period|Subject/Guardian decision|1|||
131471986|NCT02414139|473359112|FG002|Treatment Period|Subject/Guardian decision|1|||
131471987|NCT02414139|473359113|FG003|Treatment Period|Subject/Guardian decision|2|||
131471988|NCT02414139|473359114|FG004|Treatment Period|Subject/Guardian decision|5|||
131471989|NCT02414139|473359115|FG005|Treatment Period|Subject/Guardian decision|0|||
131471990|NCT02414139|473359116|FG006|Treatment Period|Subject/Guardian decision|2|||
131471991|NCT02414139|473359117|FG007|Treatment Period|Subject/Guardian decision|0|||
131471992|NCT02414139|473359118|FG008|Treatment Period|Subject/Guardian decision|1|||
131471993|NCT02414139|473359119|FG009|Treatment Period|Subject/Guardian decision|1|||
131471994|NCT02414139|473359110|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
131471995|NCT02414139|473359111|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
131471996|NCT02414139|473359112|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
131770160|NCT04225026|474436136|FG000|Overall Study|Adverse Event|1|||
131770161|NCT04225026|474436136|FG000|Overall Study|Other|1|||
131770162|NCT04225026|474436136|FG000|Overall Study|Death|11|||
131770163|NCT04225026|474436136|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
131770164|NCT03604159|474436139|FG000|Overall Study|Lost to Follow-up|6|||
131471997|NCT02414139|473359113|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
131471998|NCT02414139|473359114|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
131471999|NCT02414139|473359115|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
131472000|NCT02414139|473359116|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
131472001|NCT02414139|473359117|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
131472002|NCT02414139|473359118|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
131472003|NCT02414139|473359119|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
131472004|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131472005|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472006|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472007|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472008|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
131472009|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472010|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472011|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472012|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472013|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131472014|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Death|0|||
131472015|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Death|1|||
131472016|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Death|0|||
131472017|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Death|0|||
131472018|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Death|1|||
131472019|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Death|0|||
131472020|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Death|0|||
131472021|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Death|0|||
131472022|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Death|0|||
131472023|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Death|1|||
131472024|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
131472025|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472026|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472027|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472028|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472029|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472030|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472031|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472032|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472033|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131472034|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
131472035|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131472036|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
131472037|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131472038|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
131472039|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
131472040|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131472041|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
131472042|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
131472043|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131472044|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
131472045|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
131472046|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
131472047|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
131472048|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
131472049|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
131472050|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
131472051|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
131472052|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
131472053|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
131472054|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472055|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
131472056|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472057|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472058|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472059|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472060|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472061|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472062|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
131472063|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
131472064|NCT02414139|473359110|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
131472065|NCT02414139|473359111|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
131472066|NCT02414139|473359112|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
131472067|NCT02414139|473359113|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
131472068|NCT02414139|473359114|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
131472069|NCT02414139|473359115|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
131472070|NCT02414139|473359116|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
131472071|NCT02414139|473359117|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
131472072|NCT02414139|473359118|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
131472073|NCT02414139|473359119|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
131472074|NCT03631355|473359120|FG000|Overall Study|Lost to Follow-up|1|||
131472075|NCT03631355|473359121|FG001|Overall Study|Lost to Follow-up|2|||
131472076|NCT01343901|473359122|FG000|Overall Study|Death|85|||
131472077|NCT01343901|473359122|FG000|Overall Study|Physician Decision|4|||
131472078|NCT01343901|473359122|FG000|Overall Study|Lost to Follow-up|12|||
131472079|NCT01343901|473359122|FG000|Overall Study|Management by another medical team|11|||
131472080|NCT01343901|473359122|FG000|Overall Study|Participant decision|1|||
131472081|NCT02810340|473359123|FG000|Overall Study|Withdrawal by Subject|1|||
131472082|NCT02810340|473359124|FG001|Overall Study|Withdrawal by Subject|0|||
131472083|NCT02810340|473359125|FG002|Overall Study|Withdrawal by Subject|0|||
131472084|NCT02810340|473359123|FG000|Overall Study|Incarceration|0|||
131472085|NCT02810340|473359124|FG001|Overall Study|Incarceration|1|||
131472086|NCT02810340|473359125|FG002|Overall Study|Incarceration|0|||
131472087|NCT02810340|473359123|FG000|Overall Study|Lost to Follow-up|0|||
131472088|NCT02810340|473359124|FG001|Overall Study|Lost to Follow-up|0|||
131472089|NCT02810340|473359125|FG002|Overall Study|Lost to Follow-up|1|||
131472090|NCT00870233|473359130|FG000|Overall Study|Withdrawal by Subject|18|||
131472091|NCT00870233|473359130|FG000|Overall Study|Did not undergo laparotomy|3|||
131472092|NCT00870233|473359130|FG000|Overall Study|Incompatible internet browser|2|||
131472093|NCT00870233|473359130|FG000|Overall Study|Death|1|||
131472094|NCT01369485|473359131|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
131472095|NCT01369485|473359132|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
131472096|NCT01369485|473359131|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
131472097|NCT01369485|473359132|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
131472098|NCT01369485|473359131|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
131472099|NCT01369485|473359132|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
131472100|NCT01369485|473359131|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
131472101|NCT01369485|473359132|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
131472102|NCT01369485|473359131|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
131472103|NCT01369485|473359132|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
131472104|NCT01369485|473359131|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
131472105|NCT01369485|473359132|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
131472106|NCT01369485|473359131|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
131472107|NCT01369485|473359132|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
131472108|NCT01369485|473359131|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
131472109|NCT01369485|473359132|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
131472110|NCT01369485|473359131|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
131472111|NCT01369485|473359132|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
131472112|NCT01369485|473359131|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
131472113|NCT01369485|473359132|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
131472114|NCT03500679|473359136|FG000|Overall Study|Lost to Follow-up|6|||
131472115|NCT03500679|473359137|FG001|Overall Study|Lost to Follow-up|3|||
131472116|NCT03500679|473359136|FG000|Overall Study|Withdrawal by Subject|3|||
131472117|NCT03500679|473359137|FG001|Overall Study|Withdrawal by Subject|0|||
131472118|NCT01962922|473359138|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
131472119|NCT01962922|473359139|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
131472120|NCT01962922|473359138|FG000|PK Portion Day 7|non-compliance|1|||
131472121|NCT01962922|473359139|FG001|PK Portion Day 7|non-compliance|0|||
131472122|NCT01962922|473359138|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
131770165|NCT03604159|474436140|FG001|Overall Study|Lost to Follow-up|7|||
131770166|NCT00851721|474436141|FG000|Overall Study|planned surgery|1|||
131472123|NCT01962922|473359139|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
131472124|NCT01962922|473359138|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
131472125|NCT01962922|473359139|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
131472126|NCT00495131|473359140|FG000|Overall Study|Adverse Event|6|||
131472127|NCT00495131|473359141|FG001|Overall Study|Adverse Event|2|||
131472128|NCT00495131|473359140|FG000|Overall Study|Lack of Efficacy|0|||
131770167|NCT00851721|474436142|FG001|Overall Study|planned surgery|0|||
131770168|NCT00851721|474436141|FG000|Overall Study|Death|1|||
131472129|NCT00495131|473359141|FG001|Overall Study|Lack of Efficacy|2|||
131472130|NCT00495131|473359140|FG000|Overall Study|Lost to Follow-up|0|||
131472131|NCT00495131|473359141|FG001|Overall Study|Lost to Follow-up|2|||
131472132|NCT00495131|473359140|FG000|Overall Study|Withdrawal by Subject|1|||
131472133|NCT00495131|473359141|FG001|Overall Study|Withdrawal by Subject|0|||
131472134|NCT03224546|473359142|FG000|Overall Study|Lost to Follow-up|9|||
131472135|NCT03224546|473359143|FG001|Overall Study|Lost to Follow-up|8|||
131472136|NCT03224546|473359144|FG002|Overall Study|Lost to Follow-up|3|||
131472137|NCT03224546|473359142|FG000|Overall Study|Withdrawal by Subject|7|||
131472138|NCT03224546|473359143|FG001|Overall Study|Withdrawal by Subject|14|||
131472139|NCT03224546|473359144|FG002|Overall Study|Withdrawal by Subject|12|||
131472140|NCT00744471|473359145|FG000|Overall Study|Randomized but not treated|1|||
131472141|NCT00744471|473359146|FG001|Overall Study|Randomized but not treated|1|||
131472142|NCT00744471|473359147|FG002|Overall Study|Randomized but not treated|4|||
131472143|NCT00744471|473359148|FG003|Overall Study|Randomized but not treated|0|||
131472144|NCT00744471|473359145|FG000|Overall Study|Death|0|||
131472145|NCT00744471|473359146|FG001|Overall Study|Death|0|||
131472146|NCT00744471|473359147|FG002|Overall Study|Death|0|||
131472147|NCT00744471|473359148|FG003|Overall Study|Death|1|||
131472148|NCT00744471|473359145|FG000|Overall Study|Adverse Event|6|||
131472149|NCT00744471|473359146|FG001|Overall Study|Adverse Event|7|||
131472150|NCT00744471|473359147|FG002|Overall Study|Adverse Event|5|||
131472151|NCT00744471|473359148|FG003|Overall Study|Adverse Event|9|||
131472152|NCT00744471|473359145|FG000|Overall Study|Withdrawal by Subject|9|||
131472153|NCT00744471|473359146|FG001|Overall Study|Withdrawal by Subject|9|||
131472154|NCT00744471|473359147|FG002|Overall Study|Withdrawal by Subject|15|||
131472155|NCT00744471|473359148|FG003|Overall Study|Withdrawal by Subject|12|||
131472156|NCT00744471|473359145|FG000|Overall Study|Protocol Violation|1|||
131472157|NCT00744471|473359146|FG001|Overall Study|Protocol Violation|4|||
131472158|NCT00744471|473359147|FG002|Overall Study|Protocol Violation|1|||
131472159|NCT00744471|473359148|FG003|Overall Study|Protocol Violation|2|||
131472160|NCT00744471|473359145|FG000|Overall Study|Entered extension study|41|||
131472161|NCT00744471|473359146|FG001|Overall Study|Entered extension study|84|||
131472162|NCT00744471|473359147|FG002|Overall Study|Entered extension study|100|||
131472163|NCT00744471|473359148|FG003|Overall Study|Entered extension study|91|||
131472164|NCT00744471|473359145|FG000|Overall Study|Other|2|||
131472165|NCT00744471|473359146|FG001|Overall Study|Other|3|||
131472166|NCT00744471|473359147|FG002|Overall Study|Other|6|||
131472167|NCT00744471|473359148|FG003|Overall Study|Other|2|||
131472168|NCT00744471|473359145|FG000|Overall Study|Lack of Efficacy|83|||
131472169|NCT00744471|473359146|FG001|Overall Study|Lack of Efficacy|37|||
131472170|NCT00744471|473359147|FG002|Overall Study|Lack of Efficacy|19|||
131472171|NCT00744471|473359148|FG003|Overall Study|Lack of Efficacy|31|||
131472172|NCT00744471|473359145|FG000|Overall Study|Lost to Follow-up|0|||
131472173|NCT00744471|473359146|FG001|Overall Study|Lost to Follow-up|0|||
131472174|NCT00744471|473359147|FG002|Overall Study|Lost to Follow-up|2|||
131472175|NCT00744471|473359148|FG003|Overall Study|Lost to Follow-up|0|||
131472176|NCT04706416|473359153|FG000|Overall Study|Lost to Follow-up|2|||
131472177|NCT04706416|473359154|FG001|Overall Study|Lost to Follow-up|0|||
131472178|NCT02117427|473359162|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
131472179|NCT02117427|473359163|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
131472180|NCT02117427|473359164|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
131472181|NCT02117427|473359162|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
131472182|NCT02117427|473359163|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
131472183|NCT02117427|473359164|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
131472184|NCT02117427|473359162|FG000|Overall Study|Physician Decision|0|||
131472185|NCT02117427|473359163|FG001|Overall Study|Physician Decision|2|||
131472186|NCT02117427|473359164|FG002|Overall Study|Physician Decision|0|||
131472187|NCT02117427|473359162|FG000|Overall Study|No longer meets inclusion criteria|0|||
131472188|NCT02117427|473359163|FG001|Overall Study|No longer meets inclusion criteria|1|||
131472189|NCT02117427|473359164|FG002|Overall Study|No longer meets inclusion criteria|0|||
131472190|NCT02117427|473359162|FG000|Overall Study|Death|0|||
131472191|NCT02117427|473359163|FG001|Overall Study|Death|1|||
131472192|NCT02117427|473359164|FG002|Overall Study|Death|0|||
131472193|NCT02730208|473359165|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131472194|NCT02730208|473359166|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
131472195|NCT00510952|473359167|FG000|Overall Study|Adverse Event|1|||
131472196|NCT00510952|473359168|FG001|Overall Study|Adverse Event|0|||
131472197|NCT00510952|473359167|FG000|Overall Study|Entry Criteria Not Met|3|||
131472198|NCT00510952|473359168|FG001|Overall Study|Entry Criteria Not Met|1|||
131472199|NCT00510952|473359167|FG000|Overall Study|Lost to Follow-up|5|||
131472200|NCT00510952|473359168|FG001|Overall Study|Lost to Follow-up|3|||
131472201|NCT00510952|473359167|FG000|Overall Study|Physician Decision|1|||
131472202|NCT00510952|473359168|FG001|Overall Study|Physician Decision|1|||
131472203|NCT00510952|473359167|FG000|Overall Study|Protocol Violation|7|||
131472204|NCT00510952|473359168|FG001|Overall Study|Protocol Violation|4|||
131472205|NCT00510952|473359167|FG000|Overall Study|Sponsor Decision|1|||
131472206|NCT00510952|473359168|FG001|Overall Study|Sponsor Decision|0|||
131472207|NCT00510952|473359167|FG000|Overall Study|Withdrawal by Subject|6|||
131472208|NCT00510952|473359168|FG001|Overall Study|Withdrawal by Subject|7|||
131472209|NCT00510952|473359167|FG000|Overall Study|Did Not Receive Study Drug|2|||
131472210|NCT00510952|473359168|FG001|Overall Study|Did Not Receive Study Drug|0|||
131472211|NCT02793128|473359173|FG000|Overall Study|Death|4|||
131472212|NCT02793128|473359173|FG000|Overall Study|Withdrawal by Subject|2|||
131472213|NCT02793128|473359173|FG000|Overall Study|Physician Decision|1|||
131472214|NCT02793128|473359173|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
131472215|NCT02793128|473359173|FG000|Overall Study|Patient elected nephroureterectomy|1|||
131472216|NCT00055471|473359174|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
131472217|NCT00055471|473359175|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
131472218|NCT00055471|473359176|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
131472219|NCT00055471|473359174|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
131472220|NCT00055471|473359175|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
131472221|NCT00055471|473359176|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
131472222|NCT00055471|473359174|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
131472223|NCT00055471|473359175|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
131472224|NCT00055471|473359176|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
131472225|NCT04340063|473359177|FG000|Overall Study|Withdrawal by Subject|1|||
131472226|NCT04340063|473359178|FG001|Overall Study|Withdrawal by Subject|2|||
131472227|NCT04340063|473359177|FG000|Overall Study|Lost to Follow-up|3|||
131472228|NCT04340063|473359178|FG001|Overall Study|Lost to Follow-up|1|||
131472229|NCT04340063|473359177|FG000|Overall Study|Protocol Violation|0|||
131472230|NCT04340063|473359178|FG001|Overall Study|Protocol Violation|1|||
131472231|NCT01876810|473359179|FG000|Overall Study|Physician Decision|0|||
131472232|NCT01876810|473359180|FG001|Overall Study|Physician Decision|1|||
131472233|NCT00543855|473360606|FG000|Overall Study|Adverse Event|3|||
131472234|NCT00543855|473360607|FG001|Overall Study|Adverse Event|1|||
131472235|NCT00543855|473360608|FG002|Overall Study|Adverse Event|3|||
131472236|NCT00543855|473360609|FG003|Overall Study|Adverse Event|4|||
131472237|NCT00543855|473360606|FG000|Overall Study|Lost to Follow-up|0|||
131472238|NCT00543855|473360607|FG001|Overall Study|Lost to Follow-up|0|||
131472239|NCT00543855|473360608|FG002|Overall Study|Lost to Follow-up|1|||
131472240|NCT00543855|473360609|FG003|Overall Study|Lost to Follow-up|0|||
131472241|NCT00543855|473360606|FG000|Overall Study|Withdrawal by Subject|0|||
131472242|NCT00543855|473360607|FG001|Overall Study|Withdrawal by Subject|1|||
131472243|NCT00543855|473360608|FG002|Overall Study|Withdrawal by Subject|2|||
131472244|NCT00543855|473360609|FG003|Overall Study|Withdrawal by Subject|0|||
131472245|NCT00543855|473360606|FG000|Overall Study|Protocol Violation|1|||
131472246|NCT00543855|473360607|FG001|Overall Study|Protocol Violation|0|||
131472247|NCT00543855|473360608|FG002|Overall Study|Protocol Violation|0|||
131472248|NCT00543855|473360609|FG003|Overall Study|Protocol Violation|0|||
131472249|NCT05828095|473360610|FG000|Overall Study|Lost to Follow-up|1|||
131472250|NCT05828095|473360611|FG001|Overall Study|Lost to Follow-up|0|||
131472251|NCT05828095|473360610|FG000|Overall Study|Reactogenicity symptom|0|||
131472252|NCT05828095|473360611|FG001|Overall Study|Reactogenicity symptom|1|||
131472253|NCT03332771|473360612|FG000|Overall Study|Adverse Event|6|||
131472254|NCT03332771|473360613|FG001|Overall Study|Adverse Event|4|||
131472255|NCT03332771|473360614|FG002|Overall Study|Adverse Event|1|||
131472256|NCT03332771|473360615|FG003|Overall Study|Adverse Event|3|||
131472257|NCT03332771|473360612|FG000|Overall Study|Poor Compliance to Protocol|0|||
131472258|NCT03332771|473360613|FG001|Overall Study|Poor Compliance to Protocol|1|||
131472259|NCT03332771|473360614|FG002|Overall Study|Poor Compliance to Protocol|0|||
131472260|NCT03332771|473360615|FG003|Overall Study|Poor Compliance to Protocol|1|||
131472261|NCT03332771|473360612|FG000|Overall Study|Lost to Follow-up|2|||
131472262|NCT03332771|473360613|FG001|Overall Study|Lost to Follow-up|2|||
131472263|NCT03332771|473360614|FG002|Overall Study|Lost to Follow-up|1|||
131472264|NCT03332771|473360615|FG003|Overall Study|Lost to Follow-up|2|||
131472265|NCT03332771|473360612|FG000|Overall Study|At the Participant's own request|20|||
131472266|NCT03332771|473360613|FG001|Overall Study|At the Participant's own request|26|||
131472267|NCT03332771|473360614|FG002|Overall Study|At the Participant's own request|14|||
131472268|NCT03332771|473360615|FG003|Overall Study|At the Participant's own request|23|||
131472269|NCT03332771|473360612|FG000|Overall Study|Reason Not Specified|6|||
131472270|NCT03332771|473360613|FG001|Overall Study|Reason Not Specified|18|||
131472271|NCT03332771|473360614|FG002|Overall Study|Reason Not Specified|16|||
131472272|NCT03332771|473360615|FG003|Overall Study|Reason Not Specified|19|||
131472273|NCT00096954|473360616|FG000|Overall Study|Adverse Event|3|||
131472274|NCT00096954|473360617|FG001|Overall Study|Adverse Event|1|||
131472275|NCT00096954|473360616|FG000|Overall Study|Withdrawal by Subject|9|||
131472276|NCT00096954|473360617|FG001|Overall Study|Withdrawal by Subject|8|||
131472277|NCT00096954|473360616|FG000|Overall Study|Physician Decision|1|||
131472278|NCT00096954|473360617|FG001|Overall Study|Physician Decision|1|||
131472279|NCT00096954|473360616|FG000|Overall Study|Sponsors Decision|1|||
131472280|NCT00096954|473360617|FG001|Overall Study|Sponsors Decision|1|||
131472281|NCT00096954|473360616|FG000|Overall Study|Pregnancy|1|||
131472282|NCT00096954|473360617|FG001|Overall Study|Pregnancy|1|||
131472283|NCT00096954|473360616|FG000|Overall Study|Initiation of immunotherapy|1|||
131472284|NCT00096954|473360617|FG001|Overall Study|Initiation of immunotherapy|0|||
131472285|NCT00096954|473360616|FG000|Overall Study|Non-compliance|0|||
131472286|NCT00096954|473360617|FG001|Overall Study|Non-compliance|3|||
131472287|NCT00096954|473360616|FG000|Overall Study|Lost to Follow-up|8|||
131472288|NCT00096954|473360617|FG001|Overall Study|Lost to Follow-up|5|||
131472289|NCT03034200|473360619|FG000|Overall Study|Disease progression|8|||
131472290|NCT03034200|473360620|FG001|Overall Study|Disease progression|10|||
131472291|NCT03034200|473360621|FG002|Overall Study|Disease progression|4|||
131472292|NCT03034200|473360619|FG000|Overall Study|Physician Decision|2|||
131472293|NCT03034200|473360620|FG001|Overall Study|Physician Decision|0|||
131472294|NCT03034200|473360621|FG002|Overall Study|Physician Decision|3|||
131472295|NCT03034200|473360619|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
131472296|NCT03034200|473360620|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
131472297|NCT03034200|473360621|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
131472298|NCT03034200|473360619|FG000|Overall Study|Adjuvant Therapy|0|||
131472299|NCT03034200|473360620|FG001|Overall Study|Adjuvant Therapy|0|||
131472300|NCT03034200|473360621|FG002|Overall Study|Adjuvant Therapy|1|||
131472301|NCT04533880|473360622|FG000|Overall Study|Lost to Follow-up|0|||
131472302|NCT04533880|473360623|FG001|Overall Study|Lost to Follow-up|1|||
131472303|NCT04533880|473360624|FG002|Overall Study|Lost to Follow-up|1|||
131472304|NCT01711879|473360630|FG000|Overall Study|Death|1|||
131472305|NCT01711879|473360631|FG001|Overall Study|Death|0|||
131472306|NCT01466179|473360632|FG000|Overall Study|Ongoing in core study|2|||
131472307|NCT01466179|473360632|FG000|Overall Study|Physician Decision|46|||
131472308|NCT01466179|473360632|FG000|Overall Study|Progressive disease|43|||
131472309|NCT01466179|473360632|FG000|Overall Study|Adverse Event|32|||
131472310|NCT01466179|473360632|FG000|Overall Study|Disease relapse|23|||
131472311|NCT01466179|473360632|FG000|Overall Study|Lack of Efficacy|14|||
131472312|NCT01466179|473360632|FG000|Overall Study|Death|7|||
131472313|NCT01466179|473360632|FG000|Overall Study|Withdrawal by Subject|7|||
131472314|NCT01466179|473360632|FG000|Overall Study|Protocol Violation|2|||
131472315|NCT01466179|473360632|FG000|Overall Study|Other|3|||
131472316|NCT00749580|473360633|FG000|Overall Study|Lost to Follow-up|4|||
131472317|NCT00749580|473360634|FG001|Overall Study|Lost to Follow-up|8|||
131472318|NCT00749580|473360633|FG000|Overall Study|Adverse Event|0|||
131472319|NCT00749580|473360634|FG001|Overall Study|Adverse Event|1|||
131472320|NCT03489551|473360638|FG000|Overall Study|Withdrawal by Subject|2|||
131472321|NCT00054717|473360639|FG000|Overall Study|Randomized but not treated|2|||
131472322|NCT00054717|473360640|FG001|Overall Study|Randomized but not treated|8|||
131472323|NCT00054717|473360639|FG000|Overall Study|Adverse Event|70|||
131472324|NCT00054717|473360640|FG001|Overall Study|Adverse Event|22|||
131472325|NCT00054717|473360639|FG000|Overall Study|Protocol Violation|18|||
131472326|NCT00054717|473360640|FG001|Overall Study|Protocol Violation|19|||
131472327|NCT00054717|473360639|FG000|Overall Study|Lost to Follow-up|23|||
131472328|NCT00054717|473360640|FG001|Overall Study|Lost to Follow-up|13|||
131472329|NCT00054717|473360639|FG000|Overall Study|Withdrawal by Subject|32|||
131472330|NCT00054717|473360640|FG001|Overall Study|Withdrawal by Subject|20|||
131472331|NCT00054717|473360639|FG000|Overall Study|Other reason not defined above|117|||
131472332|NCT00054717|473360640|FG001|Overall Study|Other reason not defined above|217|||
131472333|NCT00433511|473360641|FG000|Step 1|Adverse Event|50|||
131472334|NCT00433511|473360642|FG001|Step 1|Adverse Event|157|||
131472335|NCT00433511|473360643|FG002|Step 1|Adverse Event|153|||
131472336|NCT00433511|473360641|FG000|Step 1|Withdrawal by Subject|45|||
131472337|NCT00433511|473360642|FG001|Step 1|Withdrawal by Subject|143|||
131472338|NCT00433511|473360643|FG002|Step 1|Withdrawal by Subject|154|||
131472339|NCT00433511|473360641|FG000|Step 1|Death|3|||
131472340|NCT00433511|473360642|FG001|Step 1|Death|1|||
131472341|NCT00433511|473360643|FG002|Step 1|Death|1|||
131770169|NCT00851721|474436142|FG001|Overall Study|Death|0|||
131770170|NCT00851721|474436141|FG000|Overall Study|Adverse Event|0|||
131770171|NCT00851721|474436142|FG001|Overall Study|Adverse Event|1|||
131770172|NCT04533204|474436145|FG000|Overall Study|Unable to understand training instructions|1|||
131770173|NCT04533204|474436146|FG001|Overall Study|Unable to understand training instructions|1|||
131472342|NCT00433511|473360641|FG000|Step 1|Physician Decision|1|||
131472343|NCT00433511|473360642|FG001|Step 1|Physician Decision|4|||
131472344|NCT00433511|473360643|FG002|Step 1|Physician Decision|3|||
131472345|NCT00433511|473360641|FG000|Step 1|Never started protocol therapy|28|||
131472346|NCT00433511|473360642|FG001|Step 1|Never started protocol therapy|64|||
131770174|NCT00697255|474436147|FG000|Stage 1a|Insufficient ovarian response|1|||
131770175|NCT00697255|474436148|FG001|Stage 1a|Insufficient ovarian response|0|||
131472347|NCT00433511|473360643|FG002|Step 1|Never started protocol therapy|66|||
131770176|NCT00697255|474436147|FG000|Stage 1a|Multifollicular growth|1|||
131472348|NCT00433511|473360641|FG000|Step 1|Alternative therapy|2|||
131472349|NCT00433511|473360642|FG001|Step 1|Alternative therapy|1|||
131472350|NCT00433511|473360643|FG002|Step 1|Alternative therapy|3|||
131472351|NCT00433511|473360641|FG000|Step 1|Disease progression, relapse|5|||
131472352|NCT00433511|473360642|FG001|Step 1|Disease progression, relapse|3|||
131472353|NCT00433511|473360643|FG002|Step 1|Disease progression, relapse|3|||
131472354|NCT00433511|473360641|FG000|Step 1|Other complicating disease|2|||
131472355|NCT00433511|473360642|FG001|Step 1|Other complicating disease|6|||
131472356|NCT00433511|473360643|FG002|Step 1|Other complicating disease|3|||
131472357|NCT00433511|473360641|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
131472358|NCT00433511|473360642|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
131472359|NCT00433511|473360643|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
131472360|NCT00433511|473360641|FG000|Step 1|Suspected recurrence|0|||
131472361|NCT00433511|473360642|FG001|Step 1|Suspected recurrence|1|||
131472362|NCT00433511|473360643|FG002|Step 1|Suspected recurrence|0|||
131472363|NCT00433511|473360641|FG000|Step 1|Insurance/drug distribution issues|0|||
131472364|NCT00433511|473360642|FG001|Step 1|Insurance/drug distribution issues|1|||
131472365|NCT00433511|473360643|FG002|Step 1|Insurance/drug distribution issues|2|||
131472366|NCT00433511|473360641|FG000|Step 1|Patient moved|0|||
131472367|NCT00433511|473360642|FG001|Step 1|Patient moved|0|||
131472368|NCT00433511|473360643|FG002|Step 1|Patient moved|1|||
131472369|NCT00433511|473360641|FG000|Step 2 (Arm D)|Adverse Event|0|||
131472370|NCT00433511|473360642|FG001|Step 2 (Arm D)|Adverse Event|0|||
131472371|NCT00433511|473360643|FG002|Step 2 (Arm D)|Adverse Event|135|||
131472372|NCT00433511|473360641|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
131472373|NCT00433511|473360642|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
131472374|NCT00433511|473360643|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
131472375|NCT00433511|473360641|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
131472376|NCT00433511|473360642|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
131472377|NCT00433511|473360643|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
131472378|NCT00433511|473360641|FG000|Step 2 (Arm D)|Physician Decision|0|||
131472379|NCT00433511|473360642|FG001|Step 2 (Arm D)|Physician Decision|0|||
131472380|NCT00433511|473360643|FG002|Step 2 (Arm D)|Physician Decision|9|||
131472381|NCT00433511|473360641|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
131472382|NCT00433511|473360642|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
131472383|NCT00433511|473360643|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
131472384|NCT00433511|473360641|FG000|Step 2 (Arm D)|Other complicating disease|0|||
131472385|NCT00433511|473360642|FG001|Step 2 (Arm D)|Other complicating disease|0|||
131472386|NCT00433511|473360643|FG002|Step 2 (Arm D)|Other complicating disease|3|||
131472387|NCT00433511|473360641|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
131472388|NCT00433511|473360642|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
131472389|NCT00433511|473360643|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
131472390|NCT00433511|473360641|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
131472391|NCT00433511|473360642|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
131472392|NCT00433511|473360643|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
131472393|NCT00433511|473360641|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
131472394|NCT00433511|473360642|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
131472395|NCT00433511|473360643|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
131472396|NCT00433511|473360641|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
131472397|NCT00433511|473360642|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
131472398|NCT00433511|473360643|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
131472399|NCT04565236|473360644|FG000|Overall Study|Patient/Guardian Decision|0|||
131472400|NCT04565236|473360645|FG001|Overall Study|Patient/Guardian Decision|0|||
131472401|NCT04565236|473360646|FG002|Overall Study|Patient/Guardian Decision|1|||
131472402|NCT04565236|473360647|FG003|Overall Study|Patient/Guardian Decision|0|||
131472403|NCT04209426|473360651|FG000|Overall Study|Lost to Follow-up|3|||
131472404|NCT04209426|473360652|FG001|Overall Study|Lost to Follow-up|2|||
131472405|NCT04423939|473360653|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
131770177|NCT00697255|474436148|FG001|Stage 1a|Multifollicular growth|0|||
131770178|NCT00697255|474436147|FG000|Stage 1a|Not growing of dominant follicle|1|||
131770179|NCT00697255|474436148|FG001|Stage 1a|Not growing of dominant follicle|0|||
131770180|NCT00697255|474436147|FG000|Stage 1b|Not growing of dominant follicle|0|||
131770181|NCT00697255|474436148|FG001|Stage 1b|Not growing of dominant follicle|1|||
131472406|NCT04423939|473360654|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
131472407|NCT04423939|473360653|FG000|Overall Study|Death|3|||
131472408|NCT04423939|473360654|FG001|Overall Study|Death|0|||
131472409|NCT04423939|473360653|FG000|Overall Study|Withdrawal by Subject|3|||
131472410|NCT04423939|473360654|FG001|Overall Study|Withdrawal by Subject|0|||
131472411|NCT04423939|473360653|FG000|Overall Study|Caregiver to patient who died|0|||
131472412|NCT04423939|473360654|FG001|Overall Study|Caregiver to patient who died|3|||
131472413|NCT04423939|473360653|FG000|Overall Study|Caregiver to patient who withdrew|0|||
131472414|NCT04423939|473360654|FG001|Overall Study|Caregiver to patient who withdrew|3|||
131472415|NCT00521001|473360658|FG000|Overall Study|Ineligible|1|||
131472416|NCT02821910|473360659|FG000|Overall Study|Withdrawal by Subject|0|||
131770182|NCT00697255|474436147|FG000|Stage 1b|Insufficient ovarian response|0|||
131770183|NCT00697255|474436148|FG001|Stage 1b|Insufficient ovarian response|1|||
131770184|NCT01218477|474436149|FG000|Overall Study|Disease progression|2|||
131770185|NCT01218477|474436150|FG001|Overall Study|Disease progression|3|||
131770186|NCT01218477|474436151|FG002|Overall Study|Disease progression|6|||
131472417|NCT02821910|473360660|FG001|Overall Study|Withdrawal by Subject|0|||
131472418|NCT02821910|473360661|FG002|Overall Study|Withdrawal by Subject|1|||
131770187|NCT01218477|474436152|FG003|Overall Study|Disease progression|2|||
131770188|NCT01218477|474436149|FG000|Overall Study|Study drug toxicity|0|||
131770189|NCT01218477|474436150|FG001|Overall Study|Study drug toxicity|2|||
131770190|NCT01218477|474436151|FG002|Overall Study|Study drug toxicity|5|||
131770191|NCT01218477|474436152|FG003|Overall Study|Study drug toxicity|0|||
131770192|NCT01218477|474436149|FG000|Overall Study|No longer meets study criteria|1|||
131770193|NCT01218477|474436150|FG001|Overall Study|No longer meets study criteria|0|||
131770194|NCT01218477|474436151|FG002|Overall Study|No longer meets study criteria|0|||
131770195|NCT01218477|474436152|FG003|Overall Study|No longer meets study criteria|0|||
131770196|NCT01218477|474436149|FG000|Overall Study|Withdrawal by Subject|0|||
131770197|NCT01218477|474436150|FG001|Overall Study|Withdrawal by Subject|0|||
131770198|NCT01218477|474436151|FG002|Overall Study|Withdrawal by Subject|1|||
131770199|NCT01218477|474436152|FG003|Overall Study|Withdrawal by Subject|0|||
131770200|NCT01218477|474436149|FG000|Overall Study|Prepared for cell transplantation|0|||
131770201|NCT01218477|474436150|FG001|Overall Study|Prepared for cell transplantation|1|||
131770202|NCT01218477|474436151|FG002|Overall Study|Prepared for cell transplantation|1|||
131770203|NCT01218477|474436152|FG003|Overall Study|Prepared for cell transplantation|0|||
131770204|NCT01218477|474436149|FG000|Overall Study|Administrative reason by sponsor|0|||
131770205|NCT01218477|474436150|FG001|Overall Study|Administrative reason by sponsor|0|||
131770206|NCT01218477|474436151|FG002|Overall Study|Administrative reason by sponsor|1|||
131770207|NCT01218477|474436152|FG003|Overall Study|Administrative reason by sponsor|0|||
131770208|NCT01218477|474436149|FG000|Overall Study|Maximum clinical benefit|0|||
131770209|NCT01218477|474436150|FG001|Overall Study|Maximum clinical benefit|2|||
131770210|NCT01218477|474436151|FG002|Overall Study|Maximum clinical benefit|0|||
131770211|NCT01218477|474436152|FG003|Overall Study|Maximum clinical benefit|0|||
131770212|NCT01303159|474436156|FG000|Overall Study|Death|16|||
131770213|NCT01303159|474436156|FG000|Overall Study|Study Termination|7|||
131472419|NCT02821910|473360662|FG003|Overall Study|Withdrawal by Subject|0|||
131472420|NCT02821910|473360663|FG004|Overall Study|Withdrawal by Subject|0|||
131472421|NCT02821910|473360664|FG005|Overall Study|Withdrawal by Subject|1|||
131472422|NCT02821910|473360659|FG000|Overall Study|Other than specified|1|||
131472423|NCT02821910|473360660|FG001|Overall Study|Other than specified|0|||
131472424|NCT02821910|473360661|FG002|Overall Study|Other than specified|1|||
131472425|NCT02821910|473360662|FG003|Overall Study|Other than specified|0|||
131472426|NCT02821910|473360663|FG004|Overall Study|Other than specified|0|||
131472427|NCT02821910|473360664|FG005|Overall Study|Other than specified|0|||
131472428|NCT00423670|473360665|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
131472429|NCT00423670|473360666|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472430|NCT00423670|473360667|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472431|NCT00423670|473360668|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472432|NCT00423670|473360669|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472433|NCT00423670|473360670|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472434|NCT00423670|473360671|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472435|NCT00423670|473360672|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
131472436|NCT00423670|473360665|FG000|Treatment Period|Adverse Event|8|||
131472437|NCT00423670|473360666|FG001|Treatment Period|Adverse Event|12|||
131472438|NCT00423670|473360667|FG002|Treatment Period|Adverse Event|15|||
131472439|NCT00423670|473360668|FG003|Treatment Period|Adverse Event|20|||
131472440|NCT00423670|473360669|FG004|Treatment Period|Adverse Event|9|||
131472441|NCT00423670|473360670|FG005|Treatment Period|Adverse Event|4|||
131472442|NCT00423670|473360671|FG006|Treatment Period|Adverse Event|7|||
131472443|NCT00423670|473360672|FG007|Treatment Period|Adverse Event|2|||
131472444|NCT00423670|473360665|FG000|Treatment Period|Protocol-defined clinical event|0|||
131472445|NCT00423670|473360666|FG001|Treatment Period|Protocol-defined clinical event|7|||
131472446|NCT00423670|473360667|FG002|Treatment Period|Protocol-defined clinical event|4|||
131472447|NCT00423670|473360668|FG003|Treatment Period|Protocol-defined clinical event|12|||
131472448|NCT00423670|473360669|FG004|Treatment Period|Protocol-defined clinical event|5|||
131472449|NCT00423670|473360670|FG005|Treatment Period|Protocol-defined clinical event|4|||
131472450|NCT00423670|473360671|FG006|Treatment Period|Protocol-defined clinical event|16|||
131472451|NCT00423670|473360672|FG007|Treatment Period|Protocol-defined clinical event|15|||
131472452|NCT00423670|473360665|FG000|Treatment Period|Lost to Follow-up|2|||
131472453|NCT00423670|473360666|FG001|Treatment Period|Lost to Follow-up|1|||
131472454|NCT00423670|473360667|FG002|Treatment Period|Lost to Follow-up|3|||
131472455|NCT00423670|473360668|FG003|Treatment Period|Lost to Follow-up|1|||
131472456|NCT00423670|473360669|FG004|Treatment Period|Lost to Follow-up|6|||
131472457|NCT00423670|473360670|FG005|Treatment Period|Lost to Follow-up|0|||
131472458|NCT00423670|473360671|FG006|Treatment Period|Lost to Follow-up|3|||
131472459|NCT00423670|473360672|FG007|Treatment Period|Lost to Follow-up|1|||
131472460|NCT00423670|473360665|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
131472461|NCT00423670|473360666|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
131472462|NCT00423670|473360667|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
131770214|NCT00760994|474436159|FG000|Overall Study|Lost to Follow-up|4|||
131770215|NCT00760994|474436160|FG001|Overall Study|Lost to Follow-up|4|||
131770216|NCT00760994|474436161|FG002|Overall Study|Lost to Follow-up|3|||
131770217|NCT02132312|474436162|FG000|Overall Study|Adverse Event|2|||
131472463|NCT00423670|473360668|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
131472464|NCT00423670|473360669|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
131472465|NCT00423670|473360670|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
131472466|NCT00423670|473360671|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
131472467|NCT00423670|473360672|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
131472468|NCT00423670|473360665|FG000|Treatment Period|Investigator decision|0|||
131472469|NCT00423670|473360666|FG001|Treatment Period|Investigator decision|0|||
131472470|NCT00423670|473360667|FG002|Treatment Period|Investigator decision|0|||
131472471|NCT00423670|473360668|FG003|Treatment Period|Investigator decision|0|||
131472472|NCT00423670|473360669|FG004|Treatment Period|Investigator decision|0|||
131472473|NCT00423670|473360670|FG005|Treatment Period|Investigator decision|0|||
131472474|NCT00423670|473360671|FG006|Treatment Period|Investigator decision|0|||
131472475|NCT00423670|473360672|FG007|Treatment Period|Investigator decision|1|||
131472476|NCT00423670|473360665|FG000|Treatment Period|Non-compliance with protocol|3|||
131472477|NCT00423670|473360666|FG001|Treatment Period|Non-compliance with protocol|1|||
131472478|NCT00423670|473360667|FG002|Treatment Period|Non-compliance with protocol|1|||
131472479|NCT00423670|473360668|FG003|Treatment Period|Non-compliance with protocol|3|||
131472480|NCT00423670|473360669|FG004|Treatment Period|Non-compliance with protocol|2|||
131472481|NCT00423670|473360670|FG005|Treatment Period|Non-compliance with protocol|0|||
131472482|NCT00423670|473360671|FG006|Treatment Period|Non-compliance with protocol|2|||
131472483|NCT00423670|473360672|FG007|Treatment Period|Non-compliance with protocol|2|||
131472484|NCT00423670|473360665|FG000|Follow-up Period|Lost to Follow-up|0|||
131472485|NCT00423670|473360666|FG001|Follow-up Period|Lost to Follow-up|12|||
131472486|NCT00423670|473360667|FG002|Follow-up Period|Lost to Follow-up|8|||
131472487|NCT00423670|473360668|FG003|Follow-up Period|Lost to Follow-up|3|||
131472488|NCT00423670|473360669|FG004|Follow-up Period|Lost to Follow-up|1|||
131472489|NCT00423670|473360670|FG005|Follow-up Period|Lost to Follow-up|0|||
131472490|NCT00423670|473360671|FG006|Follow-up Period|Lost to Follow-up|5|||
131472491|NCT00423670|473360672|FG007|Follow-up Period|Lost to Follow-up|0|||
131472492|NCT00423670|473360665|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
131472493|NCT00423670|473360666|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
131472494|NCT00423670|473360667|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
131472495|NCT00423670|473360668|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
131472496|NCT00423670|473360669|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
131472497|NCT00423670|473360670|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
131472498|NCT00423670|473360671|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
131472499|NCT00423670|473360672|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
131472500|NCT00423670|473360665|FG000|Follow-up Period|Non-compliance with protocol|2|||
131472501|NCT00423670|473360666|FG001|Follow-up Period|Non-compliance with protocol|0|||
131472502|NCT00423670|473360667|FG002|Follow-up Period|Non-compliance with protocol|1|||
131472503|NCT00423670|473360668|FG003|Follow-up Period|Non-compliance with protocol|1|||
131472504|NCT00423670|473360669|FG004|Follow-up Period|Non-compliance with protocol|0|||
131472505|NCT00423670|473360670|FG005|Follow-up Period|Non-compliance with protocol|0|||
131472506|NCT00423670|473360671|FG006|Follow-up Period|Non-compliance with protocol|3|||
131472507|NCT00423670|473360672|FG007|Follow-up Period|Non-compliance with protocol|2|||
131472508|NCT01082640|473360673|FG000|Overall Study|Adverse Event|9|||
131472509|NCT01082640|473360674|FG001|Overall Study|Adverse Event|5|||
131472510|NCT01082640|473360675|FG002|Overall Study|Adverse Event|3|||
131472511|NCT01082640|473360673|FG000|Overall Study|Withdrawal by Subject|3|||
131472512|NCT01082640|473360674|FG001|Overall Study|Withdrawal by Subject|3|||
131472513|NCT01082640|473360675|FG002|Overall Study|Withdrawal by Subject|2|||
131472514|NCT01082640|473360673|FG000|Overall Study|Major protocol deviation|3|||
131472515|NCT01082640|473360674|FG001|Overall Study|Major protocol deviation|3|||
131472516|NCT01082640|473360675|FG002|Overall Study|Major protocol deviation|0|||
131472517|NCT01082640|473360673|FG000|Overall Study|Lost to Follow-up|0|||
131472518|NCT01082640|473360674|FG001|Overall Study|Lost to Follow-up|3|||
131472519|NCT01082640|473360675|FG002|Overall Study|Lost to Follow-up|0|||
131472520|NCT01082640|473360673|FG000|Overall Study|Other|2|||
131770218|NCT02132312|474436163|FG001|Overall Study|Adverse Event|0|||
131770219|NCT02132312|474436162|FG000|Overall Study|Physician Decision|1|||
131472521|NCT01082640|473360674|FG001|Overall Study|Other|1|||
131472522|NCT01082640|473360675|FG002|Overall Study|Other|3|||
131472523|NCT02011893|473360677|FG000|Enrollment to Randomization|Adverse Event|2|||
131472524|NCT02011893|473360678|FG001|Enrollment to Randomization|Adverse Event|0|||
131472525|NCT02011893|473360679|FG002|Enrollment to Randomization|Adverse Event|0|||
131472526|NCT02011893|473360677|FG000|Enrollment to Randomization|Physician Decision|10|||
131472527|NCT02011893|473360678|FG001|Enrollment to Randomization|Physician Decision|0|||
131472528|NCT02011893|473360679|FG002|Enrollment to Randomization|Physician Decision|0|||
131472529|NCT02011893|473360677|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
131472530|NCT02011893|473360678|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
131472531|NCT02011893|473360679|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
131472532|NCT02011893|473360677|FG000|Enrollment to Randomization|Screening Failure|29|||
131770220|NCT02132312|474436163|FG001|Overall Study|Physician Decision|1|||
131472533|NCT02011893|473360678|FG001|Enrollment to Randomization|Screening Failure|0|||
131472534|NCT02011893|473360679|FG002|Enrollment to Randomization|Screening Failure|0|||
131472535|NCT02011893|473360677|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
131472536|NCT02011893|473360678|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
131472537|NCT02011893|473360679|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
131472538|NCT02011893|473360677|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
131472539|NCT02011893|473360678|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
131472540|NCT02011893|473360679|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
131472541|NCT02011893|473360677|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
131472542|NCT02011893|473360678|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
131472543|NCT02011893|473360679|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
131472544|NCT02011893|473360677|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
131472545|NCT02011893|473360678|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
131472546|NCT02011893|473360679|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
131472547|NCT02011893|473360677|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
131472548|NCT02011893|473360678|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
131472549|NCT02011893|473360679|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
131472550|NCT01289782|473360680|FG000|Overall Study|Lost to Follow-up|14|||
131472551|NCT01289782|473360681|FG001|Overall Study|Lost to Follow-up|7|||
131472552|NCT01289782|473360680|FG000|Overall Study|Protocol Violation|1|||
131472553|NCT01289782|473360681|FG001|Overall Study|Protocol Violation|1|||
131472554|NCT01289782|473360680|FG000|Overall Study|Withdrawal by Subject|8|||
131472555|NCT01289782|473360681|FG001|Overall Study|Withdrawal by Subject|2|||
131472556|NCT01289782|473360680|FG000|Overall Study|Sponsor's Decision|1|||
131472557|NCT01289782|473360681|FG001|Overall Study|Sponsor's Decision|0|||
131472558|NCT01289782|473360680|FG000|Overall Study|Reason not specified|1|||
131472559|NCT01289782|473360681|FG001|Overall Study|Reason not specified|2|||
131472560|NCT01241240|473360682|FG000|Overall Study|Adverse Event|5|||
131472561|NCT01241240|473360683|FG001|Overall Study|Adverse Event|4|||
131472562|NCT01241240|473360682|FG000|Overall Study|Lost to Follow-up|2|||
131472563|NCT01241240|473360683|FG001|Overall Study|Lost to Follow-up|4|||
131472564|NCT01241240|473360682|FG000|Overall Study|Personal Reasons|1|||
131472565|NCT01241240|473360683|FG001|Overall Study|Personal Reasons|1|||
131472566|NCT01025154|473360687|FG000|Overall Study|Lost to Follow-up|1|||
131472567|NCT01025154|473360687|FG000|Overall Study|Withdrawal by Subject|1|||
131472568|NCT00450112|473360692|FG000|Overall Study|Other Treatment Required|5|||
131472569|NCT00450112|473360693|FG001|Overall Study|Other Treatment Required|1|||
131472570|NCT00450112|473360692|FG000|Overall Study|Withdrawal by Subject|4|||
131472571|NCT00450112|473360693|FG001|Overall Study|Withdrawal by Subject|1|||
131472572|NCT00450112|473360692|FG000|Overall Study|Lost to Follow-up|2|||
131472573|NCT00450112|473360693|FG001|Overall Study|Lost to Follow-up|1|||
131472574|NCT00450112|473360692|FG000|Overall Study|Others|2|||
131472575|NCT00450112|473360693|FG001|Overall Study|Others|3|||
131472576|NCT00542451|473360694|FG000|Overall Study|Adverse Event|31|||
131472577|NCT00542451|473360694|FG000|Overall Study|Withdrawal by Subject|30|||
131472578|NCT00542451|473360694|FG000|Overall Study|Physician Decision|4|||
131472579|NCT00542451|473360694|FG000|Overall Study|Recurrent disease|1|||
131472580|NCT00542451|473360694|FG000|Overall Study|unknown reason|1|||
131472581|NCT00542451|473360694|FG000|Overall Study|Death|2|||
131472582|NCT00542451|473360694|FG000|Overall Study|Lost to Follow-up|10|||
131472583|NCT03519386|473360695|FG000|Overall Study|Withdrawal by Subject|4|||
131472584|NCT03519386|473360696|FG001|Overall Study|Withdrawal by Subject|1|||
131472585|NCT03519386|473360697|FG002|Overall Study|Withdrawal by Subject|2|||
131472586|NCT03519386|473360695|FG000|Overall Study|Physician Decision|1|||
131472587|NCT03519386|473360696|FG001|Overall Study|Physician Decision|1|||
131472588|NCT03519386|473360697|FG002|Overall Study|Physician Decision|1|||
131472589|NCT03519386|473360695|FG000|Overall Study|Lost to Follow-up|0|||
131472590|NCT03519386|473360696|FG001|Overall Study|Lost to Follow-up|1|||
131472591|NCT03519386|473360697|FG002|Overall Study|Lost to Follow-up|1|||
131472592|NCT03519386|473360695|FG000|Overall Study|Death|1|||
131472593|NCT03519386|473360696|FG001|Overall Study|Death|0|||
131472594|NCT03519386|473360697|FG002|Overall Study|Death|4|||
131472595|NCT03519386|473360695|FG000|Overall Study|Adverse Event|2|||
131472596|NCT03519386|473360696|FG001|Overall Study|Adverse Event|1|||
131472597|NCT03519386|473360697|FG002|Overall Study|Adverse Event|2|||
131472598|NCT03519386|473360695|FG000|Overall Study|Explanted|2|||
131472599|NCT03519386|473360696|FG001|Overall Study|Explanted|1|||
131472600|NCT03519386|473360697|FG002|Overall Study|Explanted|0|||
131472601|NCT03519386|473360695|FG000|Overall Study|Ongoing in study|190|||
131472602|NCT03519386|473360696|FG001|Overall Study|Ongoing in study|192|||
131472603|NCT03519386|473360697|FG002|Overall Study|Ongoing in study|183|||
131472604|NCT00450385|473360699|FG000|Overall Study|Death|3|||
131472605|NCT00450385|473360699|FG000|Overall Study|Protocol Violation|1|||
131472606|NCT00450385|473360699|FG000|Overall Study|Withdrawal by Subject|2|||
131472607|NCT00450385|473360699|FG000|Overall Study|Lack of Efficacy|2|||
131472608|NCT00450385|473360699|FG000|Overall Study|Adverse Event|1|||
131472609|NCT00450385|473360699|FG000|Overall Study|Physician Decision|1|||
131472610|NCT00450385|473360699|FG000|Overall Study|Other|3|||
131472611|NCT01390220|473360705|FG000|Test Dose Phase|Adverse Event|17|||
131472612|NCT01390220|473360706|FG001|Test Dose Phase|Adverse Event|0|||
131472613|NCT01390220|473360707|FG002|Test Dose Phase|Adverse Event|0|||
131472614|NCT01390220|473360705|FG000|Test Dose Phase|Withdrawal by Subject|8|||
131472615|NCT01390220|473360706|FG001|Test Dose Phase|Withdrawal by Subject|0|||
131472616|NCT01390220|473360707|FG002|Test Dose Phase|Withdrawal by Subject|0|||
131472617|NCT01390220|473360705|FG000|Test Dose Phase|Lost to Follow-up|2|||
131472618|NCT01390220|473360706|FG001|Test Dose Phase|Lost to Follow-up|0|||
131472619|NCT01390220|473360707|FG002|Test Dose Phase|Lost to Follow-up|0|||
131472620|NCT01390220|473360705|FG000|Test Dose Phase|Protocol Violation|8|||
131472621|NCT01390220|473360706|FG001|Test Dose Phase|Protocol Violation|0|||
131472622|NCT01390220|473360707|FG002|Test Dose Phase|Protocol Violation|0|||
131472623|NCT01390220|473360705|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
131472624|NCT01390220|473360706|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
131472625|NCT01390220|473360707|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
131472626|NCT01390220|473360705|FG000|Test Dose Phase|Study/Site closure|6|||
131472627|NCT01390220|473360706|FG001|Test Dose Phase|Study/Site closure|0|||
131472628|NCT01390220|473360707|FG002|Test Dose Phase|Study/Site closure|0|||
131472629|NCT01390220|473360705|FG000|Test Dose Phase|Caregiver no longer available|5|||
131472630|NCT01390220|473360706|FG001|Test Dose Phase|Caregiver no longer available|0|||
131472631|NCT01390220|473360707|FG002|Test Dose Phase|Caregiver no longer available|0|||
131472632|NCT01390220|473360705|FG000|Test Dose Phase|Noncompliance|2|||
131472633|NCT01390220|473360706|FG001|Test Dose Phase|Noncompliance|0|||
131472634|NCT01390220|473360707|FG002|Test Dose Phase|Noncompliance|0|||
131472635|NCT01390220|473360705|FG000|Test Dose Phase|Logistical|6|||
131472636|NCT01390220|473360706|FG001|Test Dose Phase|Logistical|0|||
131472637|NCT01390220|473360707|FG002|Test Dose Phase|Logistical|0|||
131472638|NCT01390220|473360705|FG000|Comparative Phase|Withdrawal by Subject|0|||
131472639|NCT01390220|473360706|FG001|Comparative Phase|Withdrawal by Subject|1|||
131472640|NCT01390220|473360707|FG002|Comparative Phase|Withdrawal by Subject|0|||
131472641|NCT03533686|473360708|FG000|Overall Study|Withdrawal by Subject|1|||
131472642|NCT03533686|473360709|FG001|Overall Study|Withdrawal by Subject|0|||
131472643|NCT03533686|473360710|FG002|Overall Study|Withdrawal by Subject|0|||
131472644|NCT03533686|473360711|FG003|Overall Study|Withdrawal by Subject|3|||
131472645|NCT03533686|473360712|FG004|Overall Study|Withdrawal by Subject|5|||
131472646|NCT03533686|473360713|FG005|Overall Study|Withdrawal by Subject|1|||
131472647|NCT03533686|473360708|FG000|Overall Study|Lost to Follow-up|0|||
131472648|NCT03533686|473360709|FG001|Overall Study|Lost to Follow-up|1|||
131472649|NCT03533686|473360710|FG002|Overall Study|Lost to Follow-up|0|||
131472650|NCT03533686|473360711|FG003|Overall Study|Lost to Follow-up|0|||
131472651|NCT03533686|473360712|FG004|Overall Study|Lost to Follow-up|2|||
131472652|NCT03533686|473360713|FG005|Overall Study|Lost to Follow-up|0|||
131472653|NCT03533686|473360708|FG000|Overall Study|Screen Failure|0|||
131472654|NCT03533686|473360709|FG001|Overall Study|Screen Failure|0|||
131472655|NCT03533686|473360710|FG002|Overall Study|Screen Failure|0|||
131472656|NCT03533686|473360711|FG003|Overall Study|Screen Failure|2|||
131472657|NCT03533686|473360712|FG004|Overall Study|Screen Failure|0|||
131472658|NCT03533686|473360713|FG005|Overall Study|Screen Failure|0|||
131472659|NCT00772070|473360714|FG000|Overall Study|Lost to Follow-up|0|||
131472660|NCT00772070|473360715|FG001|Overall Study|Lost to Follow-up|8|||
131472661|NCT00772070|473360714|FG000|Overall Study|Withdrawal by Subject|0|||
131472662|NCT00772070|473360715|FG001|Overall Study|Withdrawal by Subject|2|||
131472663|NCT00772070|473360714|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
131472664|NCT00772070|473360715|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
131472665|NCT01309308|473360716|FG000|Overall Study|Lost to Follow-up|6|||
131472666|NCT01309308|473360717|FG001|Overall Study|Lost to Follow-up|4|||
131472667|NCT01017575|473360718|FG000|Overall Study|Lack of Efficacy|0|||
131472668|NCT01017575|473360719|FG001|Overall Study|Lack of Efficacy|1|||
131472669|NCT01017575|473360720|FG002|Overall Study|Lack of Efficacy|0|||
131472670|NCT01017575|473360721|FG003|Overall Study|Lack of Efficacy|1|||
131472671|NCT01017575|473360722|FG004|Overall Study|Lack of Efficacy|1|||
131472672|NCT01017575|473360718|FG000|Overall Study|Adverse Event|0|||
131472673|NCT01017575|473360719|FG001|Overall Study|Adverse Event|1|||
131472674|NCT01017575|473360720|FG002|Overall Study|Adverse Event|0|||
131472675|NCT01017575|473360721|FG003|Overall Study|Adverse Event|0|||
131472676|NCT01017575|473360722|FG004|Overall Study|Adverse Event|2|||
131472677|NCT01017575|473360718|FG000|Overall Study|Withdrawal by Subject|1|||
131472678|NCT01017575|473360719|FG001|Overall Study|Withdrawal by Subject|0|||
131472679|NCT01017575|473360720|FG002|Overall Study|Withdrawal by Subject|0|||
131472680|NCT01017575|473360721|FG003|Overall Study|Withdrawal by Subject|0|||
131472681|NCT01017575|473360722|FG004|Overall Study|Withdrawal by Subject|0|||
131472682|NCT04271280|473360723|FG000|Overall Study|Lost to Follow-up|300|||
131472683|NCT04271280|473360723|FG000|Overall Study|Death|153|||
131472684|NCT04271280|473360723|FG000|Overall Study|Withdrawal of consent by patient|59|||
131472685|NCT04271280|473360723|FG000|Overall Study|Other|51|||
131472686|NCT04271280|473360723|FG000|Overall Study|No end of study information|42|||
131472687|NCT02359851|473360729|FG000|Overall Study|Death|1|||
131472688|NCT02359851|473360729|FG000|Overall Study|Disease progression|1|||
131472689|NCT01888003|473360730|FG000|Overall Study|Study Terminated|5|||
131472690|NCT01888003|473360731|FG001|Overall Study|Study Terminated|6|||
131472691|NCT01888003|473360732|FG002|Overall Study|Study Terminated|40|||
131472692|NCT01854944|473360733|FG000|Overall Study|Withdrawal by Subject|0|||
131472693|NCT01854944|473360734|FG001|Overall Study|Withdrawal by Subject|0|||
131472694|NCT01854944|473360735|FG002|Overall Study|Withdrawal by Subject|1|||
131472695|NCT02101112|473360736|FG000|Overall Study|Adverse Event|0|||
131472696|NCT02101112|473360737|FG001|Overall Study|Adverse Event|0|||
131472697|NCT02101112|473360738|FG002|Overall Study|Adverse Event|1|||
131472698|NCT02101112|473360739|FG003|Overall Study|Adverse Event|0|||
131472699|NCT02101112|473360740|FG004|Overall Study|Adverse Event|0|||
131472700|NCT02101112|473360741|FG005|Overall Study|Adverse Event|0|||
131472701|NCT02101112|473360736|FG000|Overall Study|Withdrawal by Subject|0|||
131472702|NCT02101112|473360737|FG001|Overall Study|Withdrawal by Subject|0|||
131472703|NCT02101112|473360738|FG002|Overall Study|Withdrawal by Subject|0|||
131472704|NCT02101112|473360739|FG003|Overall Study|Withdrawal by Subject|0|||
131472705|NCT02101112|473360740|FG004|Overall Study|Withdrawal by Subject|1|||
131472706|NCT02101112|473360741|FG005|Overall Study|Withdrawal by Subject|0|||
131472707|NCT02125604|473360742|FG000|Overall Study|Other|4|||
131472708|NCT02125604|473360742|FG000|Overall Study|Investigator Decision|1|||
131472709|NCT02125604|473360742|FG000|Overall Study|Lost to Follow-up|2|||
131472710|NCT02125604|473360742|FG000|Overall Study|Consent Withdrawn|4|||
131472711|NCT02125604|473360742|FG000|Overall Study|Adverse Event|20|||
131472712|NCT01857583|473360745|FG000|Overall Study|Adverse Event|0|||
131472713|NCT01857583|473360746|FG001|Overall Study|Adverse Event|0|||
131472714|NCT01857583|473360747|FG002|Overall Study|Adverse Event|1|||
131472715|NCT01857583|473360748|FG003|Overall Study|Adverse Event|1|||
131472716|NCT01857583|473360745|FG000|Overall Study|Death|0|||
131472717|NCT01857583|473360746|FG001|Overall Study|Death|1|||
131472718|NCT01857583|473360747|FG002|Overall Study|Death|1|||
131472719|NCT01857583|473360748|FG003|Overall Study|Death|0|||
131472720|NCT01857583|473360745|FG000|Overall Study|Physician Decision|0|||
131472721|NCT01857583|473360746|FG001|Overall Study|Physician Decision|0|||
131472722|NCT01857583|473360747|FG002|Overall Study|Physician Decision|0|||
131472723|NCT01857583|473360748|FG003|Overall Study|Physician Decision|1|||
131472724|NCT01857583|473360745|FG000|Overall Study|Withdrawal by Subject|1|||
131472725|NCT01857583|473360746|FG001|Overall Study|Withdrawal by Subject|0|||
131472726|NCT01857583|473360747|FG002|Overall Study|Withdrawal by Subject|1|||
131472727|NCT01857583|473360748|FG003|Overall Study|Withdrawal by Subject|2|||
131472728|NCT00458536|473360751|FG000|Overall Study|Disease progression prior to treatment|7|||
131472729|NCT00458536|473360751|FG000|Overall Study|Unable to make vaccine|3|||
131472730|NCT00458536|473360751|FG000|Overall Study|No measurable disease after surgery|2|||
131472731|NCT00458536|473360751|FG000|Overall Study|Did not have renal cell carcinoma|2|||
131472732|NCT00458536|473360751|FG000|Overall Study|Patient did not have surgery|1|||
131472733|NCT00458536|473360751|FG000|Overall Study|Ineligible due to toxicity|1|||
131472734|NCT00458536|473360751|FG000|Overall Study|Withdrawal by Subject|1|||
131472735|NCT00458536|473360751|FG000|Overall Study|Progressive disease during treatment|2|||
131472736|NCT03287635|473360754|FG000|Overall Study|Lost to Follow-up|5|||
131472737|NCT03287635|473360754|FG000|Overall Study|Withdrawal by Subject|1|||
131472738|NCT03287635|473360754|FG000|Overall Study|Physician Decision|1|||
131472739|NCT00323869|473360755|FG000|Overall Study|Death|1|||
131472740|NCT02582255|473362600|FG000|Overall Study|Protocol Violation|0|||
131472741|NCT02582255|473362601|FG001|Overall Study|Protocol Violation|3|||
131472742|NCT02294773|473362606|FG000|Overall Study|Withdrawal by Subject|0|||
131472743|NCT02294773|473362607|FG001|Overall Study|Withdrawal by Subject|2|||
131472744|NCT03052764|473362608|FG000|Double-Blind Treatment Period|Adverse Event|2|||
131472745|NCT03052764|473362609|FG001|Double-Blind Treatment Period|Adverse Event|0|||
131472746|NCT03052764|473362608|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
131472747|NCT03052764|473362609|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
131472748|NCT03052764|473362608|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
131472749|NCT03052764|473362609|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
131472750|NCT03052764|473362608|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
131472751|NCT03052764|473362609|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131472752|NCT03052764|473362608|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
131472753|NCT03052764|473362609|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
131472754|NCT03206073|473362610|FG000|Overall Study|Participant Noncompliance|0|||
131472755|NCT03206073|473362611|FG001|Overall Study|Participant Noncompliance|1|||
131472756|NCT03206073|473362612|FG002|Overall Study|Participant Noncompliance|0|||
131472757|NCT03206073|473362613|FG003|Overall Study|Participant Noncompliance|0|||
131472758|NCT03206073|473362610|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
131472759|NCT03206073|473362611|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
131472760|NCT03206073|473362612|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
131472761|NCT03206073|473362613|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
131472762|NCT03206073|473362610|FG000|Overall Study|Death|0|||
131472763|NCT03206073|473362611|FG001|Overall Study|Death|0|||
131472764|NCT03206073|473362612|FG002|Overall Study|Death|1|||
131472765|NCT03206073|473362613|FG003|Overall Study|Death|0|||
131472766|NCT03206073|473362610|FG000|Overall Study|Taken off active treatment|0|||
131472767|NCT03206073|473362611|FG001|Overall Study|Taken off active treatment|0|||
131472768|NCT03206073|473362612|FG002|Overall Study|Taken off active treatment|3|||
131472769|NCT03206073|473362613|FG003|Overall Study|Taken off active treatment|0|||
131472770|NCT04478123|473362614|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
131472771|NCT04478123|473362614|FG000|Overall Study|NE|1|||
131472772|NCT04444895|473362615|FG000|Overall Study|Adverse Event|2|||
131472773|NCT04444895|473362615|FG000|Overall Study|Lost to Follow-up|2|||
131472774|NCT04444895|473362615|FG000|Overall Study|Withdrawal by Subject|5|||
131472775|NCT03435640|473362618|FG000|Overall Study|Withdrawal by Subject|0|||
131472776|NCT03435640|473362619|FG001|Overall Study|Withdrawal by Subject|1|||
131472777|NCT03435640|473362620|FG002|Overall Study|Withdrawal by Subject|0|||
131472778|NCT03435640|473362621|FG003|Overall Study|Withdrawal by Subject|2|||
131472779|NCT03435640|473362622|FG004|Overall Study|Withdrawal by Subject|0|||
131472780|NCT03435640|473362623|FG005|Overall Study|Withdrawal by Subject|0|||
131472781|NCT03435640|473362624|FG006|Overall Study|Withdrawal by Subject|3|||
131472782|NCT03435640|473362625|FG007|Overall Study|Withdrawal by Subject|0|||
131472783|NCT03435640|473362626|FG008|Overall Study|Withdrawal by Subject|0|||
131472784|NCT03435640|473362627|FG009|Overall Study|Withdrawal by Subject|2|||
131472785|NCT03435640|473362628|FG010|Overall Study|Withdrawal by Subject|3|||
131472786|NCT03435640|473362618|FG000|Overall Study|Lost to Follow-up|0|||
131472787|NCT03435640|473362619|FG001|Overall Study|Lost to Follow-up|0|||
131472788|NCT03435640|473362620|FG002|Overall Study|Lost to Follow-up|1|||
131472789|NCT03435640|473362621|FG003|Overall Study|Lost to Follow-up|0|||
131472790|NCT03435640|473362622|FG004|Overall Study|Lost to Follow-up|0|||
131472791|NCT03435640|473362623|FG005|Overall Study|Lost to Follow-up|0|||
131472792|NCT03435640|473362624|FG006|Overall Study|Lost to Follow-up|0|||
131472793|NCT03435640|473362625|FG007|Overall Study|Lost to Follow-up|0|||
131472794|NCT03435640|473362626|FG008|Overall Study|Lost to Follow-up|0|||
131472795|NCT03435640|473362627|FG009|Overall Study|Lost to Follow-up|0|||
131472796|NCT03435640|473362628|FG010|Overall Study|Lost to Follow-up|0|||
131472797|NCT01347307|473362629|FG000|Overall Study|Death|0|||
131472798|NCT01347307|473362630|FG001|Overall Study|Death|4|||
131472799|NCT01347307|473362629|FG000|Overall Study|Physician Decision|0|||
131472800|NCT01347307|473362630|FG001|Overall Study|Physician Decision|1|||
131472801|NCT00920829|473362634|FG000|Allocation|No post randomization data|3|||
131472802|NCT00920829|473362635|FG001|Allocation|No post randomization data|1|||
131472803|NCT00920829|473362636|FG002|Allocation|No post randomization data|0|||
131472804|NCT00920829|473362637|FG003|Allocation|No post randomization data|2|||
131472805|NCT00920829|473362634|FG000|Available for Analysis|Withdrawal by Subject|6|||
131472806|NCT00920829|473362635|FG001|Available for Analysis|Withdrawal by Subject|6|||
131472807|NCT00920829|473362636|FG002|Available for Analysis|Withdrawal by Subject|6|||
131472808|NCT00920829|473362637|FG003|Available for Analysis|Withdrawal by Subject|10|||
131472809|NCT00920829|473362634|FG000|Available for Analysis|Required Medical Treatment|0|||
131472810|NCT00920829|473362635|FG001|Available for Analysis|Required Medical Treatment|1|||
131472811|NCT00920829|473362636|FG002|Available for Analysis|Required Medical Treatment|2|||
131472812|NCT00920829|473362637|FG003|Available for Analysis|Required Medical Treatment|0|||
131472813|NCT00920829|473362634|FG000|Available for Analysis|Adverse Event|1|||
131472814|NCT00920829|473362635|FG001|Available for Analysis|Adverse Event|2|||
131472815|NCT00920829|473362636|FG002|Available for Analysis|Adverse Event|1|||
131472816|NCT00920829|473362637|FG003|Available for Analysis|Adverse Event|0|||
131472817|NCT00920829|473362634|FG000|Available for Analysis|Death|1|||
131472818|NCT00920829|473362635|FG001|Available for Analysis|Death|0|||
131472819|NCT00920829|473362636|FG002|Available for Analysis|Death|0|||
131472820|NCT00920829|473362637|FG003|Available for Analysis|Death|0|||
131472821|NCT00920829|473362634|FG000|Available for Analysis|Protocol Violation|0|||
131472822|NCT00920829|473362635|FG001|Available for Analysis|Protocol Violation|0|||
131472823|NCT00920829|473362636|FG002|Available for Analysis|Protocol Violation|1|||
131472824|NCT00920829|473362637|FG003|Available for Analysis|Protocol Violation|0|||
131472825|NCT00920829|473362634|FG000|Available for Analysis|Required more treatment|0|||
131472826|NCT00920829|473362635|FG001|Available for Analysis|Required more treatment|2|||
131472827|NCT00920829|473362636|FG002|Available for Analysis|Required more treatment|0|||
131472828|NCT00920829|473362637|FG003|Available for Analysis|Required more treatment|1|||
131472829|NCT04123665|473362638|FG000|Overall Study|Withdrawal by Subject|7|||
131472830|NCT04123665|473362639|FG001|Overall Study|Withdrawal by Subject|0|||
131472831|NCT04123665|473362638|FG000|Overall Study|Lost to Follow-up|1|||
131472832|NCT04123665|473362639|FG001|Overall Study|Lost to Follow-up|0|||
131472833|NCT02239224|473362642|FG000|Overall Study|Administrative|0|||
131472834|NCT02239224|473362643|FG001|Overall Study|Administrative|0|||
131472835|NCT02239224|473362644|FG002|Overall Study|Administrative|3|||
131472836|NCT02239224|473362645|FG003|Overall Study|Administrative|1|||
131472837|NCT00721123|473362646|FG000|Overall Study|Adverse Event|96|||
131472838|NCT00721123|473362646|FG000|Overall Study|Death|10|||
131433900|NCT03798717|473214539|FG003|Overall Study|Lost to Follow-up|1|||
131433901|NCT03798717|473214540|FG004|Overall Study|Lost to Follow-up|0|||
131433902|NCT03798717|473214541|FG005|Overall Study|Lost to Follow-up|0|||
131433903|NCT03798717|473214536|FG000|Overall Study|Adverse Event|0|||
131433904|NCT03798717|473214537|FG001|Overall Study|Adverse Event|1|||
131433905|NCT03798717|473214538|FG002|Overall Study|Adverse Event|0|||
131433906|NCT03798717|473214539|FG003|Overall Study|Adverse Event|0|||
131433907|NCT03798717|473214540|FG004|Overall Study|Adverse Event|0|||
131433908|NCT03798717|473214541|FG005|Overall Study|Adverse Event|0|||
131433909|NCT03798717|473214536|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
131433910|NCT03798717|473214537|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
131433911|NCT03798717|473214538|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
131433912|NCT03798717|473214539|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
131433913|NCT03798717|473214540|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
131433914|NCT03798717|473214541|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
131433915|NCT04002960|473214543|FG000|Overall Study|Withdrawn prior to Completion|2|||
131433916|NCT01132807|473214548|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
131433917|NCT01132807|473214549|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
131433918|NCT01132807|473214550|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
131433919|NCT01132807|473214548|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
131433920|NCT01132807|473214549|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
131433921|NCT01132807|473214550|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
131433922|NCT02322281|473214553|FG000|Overall Study|Progressive Disease|42|||
131433923|NCT02322281|473214554|FG001|Overall Study|Progressive Disease|14|||
131433924|NCT02322281|473214555|FG002|Overall Study|Progressive Disease|49|||
131433925|NCT02322281|473214553|FG000|Overall Study|Adverse Event|3|||
131433926|NCT02322281|473214554|FG001|Overall Study|Adverse Event|4|||
131433927|NCT02322281|473214555|FG002|Overall Study|Adverse Event|6|||
131433928|NCT02322281|473214553|FG000|Overall Study|Death|3|||
131433929|NCT02322281|473214554|FG001|Overall Study|Death|3|||
131433930|NCT02322281|473214555|FG002|Overall Study|Death|3|||
131433931|NCT02322281|473214553|FG000|Overall Study|Withdrawal by Subject|1|||
131433932|NCT02322281|473214554|FG001|Overall Study|Withdrawal by Subject|1|||
131433933|NCT02322281|473214555|FG002|Overall Study|Withdrawal by Subject|6|||
131433934|NCT02322281|473214553|FG000|Overall Study|Physician Decision|2|||
131433935|NCT02322281|473214554|FG001|Overall Study|Physician Decision|0|||
131433936|NCT02322281|473214555|FG002|Overall Study|Physician Decision|5|||
131433937|NCT02322281|473214553|FG000|Overall Study|Study Terminated by Sponsor|2|||
131433938|NCT02322281|473214554|FG001|Overall Study|Study Terminated by Sponsor|0|||
131433939|NCT02322281|473214555|FG002|Overall Study|Study Terminated by Sponsor|0|||
131433940|NCT02322281|473214553|FG000|Overall Study|Missing|0|||
131433941|NCT02322281|473214554|FG001|Overall Study|Missing|0|||
131433942|NCT02322281|473214555|FG002|Overall Study|Missing|1|||
131433943|NCT02322281|473214553|FG000|Overall Study|Miscellaneous|0|||
131433944|NCT02322281|473214554|FG001|Overall Study|Miscellaneous|0|||
131433945|NCT02322281|473214555|FG002|Overall Study|Miscellaneous|4|||
131433946|NCT02420093|473214556|FG000|Overall Study|Withdrawal by Subject|1|||
131433947|NCT02420093|473214557|FG001|Overall Study|Withdrawal by Subject|1|||
131433948|NCT00628030|473214560|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
131433949|NCT00628030|473214561|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
131433950|NCT00628030|473214560|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
131433951|NCT00628030|473214561|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
131433952|NCT00628030|473214560|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
131433953|NCT00628030|473214561|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
131433954|NCT01156480|473214562|FG000|Overall Study|change in diagnosis|0|||
131433955|NCT01156480|473214563|FG001|Overall Study|change in diagnosis|1|||
131433956|NCT03367858|473214564|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
131433957|NCT03367858|473214565|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
131433958|NCT03367858|473214564|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
131433959|NCT03367858|473214565|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
131433960|NCT03367858|473214564|FG000|3 Month Follow Up|Lost to Follow-up|8|||
131433961|NCT03367858|473214565|FG001|3 Month Follow Up|Lost to Follow-up|3|||
131433962|NCT03367858|473214564|FG000|3 Month Follow Up|Moved out of study area|2|||
131433963|NCT03367858|473214565|FG001|3 Month Follow Up|Moved out of study area|6|||
131433964|NCT03367858|473214564|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
131433965|NCT03367858|473214565|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
131433966|NCT03367858|473214564|FG000|3 Month Follow Up|MRI contraindication|2|||
131433967|NCT03367858|473214565|FG001|3 Month Follow Up|MRI contraindication|1|||
131433968|NCT03367858|473214564|FG000|3 Month Follow Up|Incarcerated|0|||
131433969|NCT03367858|473214565|FG001|3 Month Follow Up|Incarcerated|1|||
131433970|NCT03367858|473214564|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
131433971|NCT03367858|473214565|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
131472839|NCT00721123|473362646|FG000|Overall Study|Insufficient Therapeutic Response|21|||
131472840|NCT00721123|473362646|FG000|Overall Study|Protocol Violation|1|||
131472841|NCT00721123|473362646|FG000|Overall Study|Refused Treatment|41|||
131472842|NCT00721123|473362646|FG000|Overall Study|Failure to Return|9|||
131472843|NCT00721123|473362646|FG000|Overall Study|Withdrawal by Subject|5|||
131472844|NCT03954041|473362652|FG000|Overall Study|Lost to Follow-up|3|||
131472845|NCT03954041|473362653|FG001|Overall Study|Lost to Follow-up|3|||
131472846|NCT03954041|473362654|FG002|Overall Study|Lost to Follow-up|6|||
131472847|NCT03954041|473362652|FG000|Overall Study|Death|4|||
131472848|NCT03954041|473362653|FG001|Overall Study|Death|0|||
131472849|NCT03954041|473362654|FG002|Overall Study|Death|1|||
131472850|NCT03954041|473362652|FG000|Overall Study|Death by neurologic criteria|0|||
131472851|NCT03954041|473362653|FG001|Overall Study|Death by neurologic criteria|0|||
131472852|NCT03954041|473362654|FG002|Overall Study|Death by neurologic criteria|1|||
131472853|NCT03954041|473362652|FG000|Overall Study|Reason not specified|7|||
131472854|NCT03954041|473362653|FG001|Overall Study|Reason not specified|4|||
131472855|NCT03954041|473362654|FG002|Overall Study|Reason not specified|2|||
131472856|NCT03954041|473362652|FG000|Overall Study|Withdrew prior to dosing|4|||
131472857|NCT03954041|473362653|FG001|Overall Study|Withdrew prior to dosing|2|||
131472858|NCT03954041|473362654|FG002|Overall Study|Withdrew prior to dosing|0|||
131472859|NCT03868124|473362655|FG000|Overall Study|Withdrawal by Subject|4|||
131472860|NCT03868124|473362656|FG001|Overall Study|Withdrawal by Subject|0|||
131472861|NCT03868124|473362657|FG002|Overall Study|Withdrawal by Subject|1|||
131472862|NCT03868124|473362655|FG000|Overall Study|Physician Decision|1|||
131472863|NCT03868124|473362656|FG001|Overall Study|Physician Decision|0|||
131472864|NCT03868124|473362657|FG002|Overall Study|Physician Decision|1|||
131472865|NCT03868124|473362655|FG000|Overall Study|Lost to Follow-up|1|||
131472866|NCT03868124|473362656|FG001|Overall Study|Lost to Follow-up|1|||
131472867|NCT03868124|473362657|FG002|Overall Study|Lost to Follow-up|2|||
131472868|NCT03868124|473362655|FG000|Overall Study|Death|1|||
131472869|NCT03868124|473362656|FG001|Overall Study|Death|1|||
131472870|NCT03868124|473362657|FG002|Overall Study|Death|2|||
131472871|NCT03868124|473362655|FG000|Overall Study|Adverse Event|0|||
131472872|NCT03868124|473362656|FG001|Overall Study|Adverse Event|0|||
131472873|NCT03868124|473362657|FG002|Overall Study|Adverse Event|3|||
131472874|NCT03868124|473362655|FG000|Overall Study|Explanted|2|||
131472875|NCT03868124|473362656|FG001|Overall Study|Explanted|1|||
131472876|NCT03868124|473362657|FG002|Overall Study|Explanted|0|||
131472877|NCT03868124|473362655|FG000|Overall Study|Ongoing in study|176|||
131472878|NCT03868124|473362656|FG001|Overall Study|Ongoing in study|180|||
131472879|NCT03868124|473362657|FG002|Overall Study|Ongoing in study|183|||
131472880|NCT04177355|473362658|FG000|Overall Study|Lost to Follow-up|0|||
131472881|NCT04177355|473362659|FG001|Overall Study|Lost to Follow-up|2|||
131472882|NCT04177355|473362660|FG002|Overall Study|Lost to Follow-up|0|||
131472883|NCT04177355|473362661|FG003|Overall Study|Lost to Follow-up|1|||
131472884|NCT04177355|473362662|FG004|Overall Study|Lost to Follow-up|2|||
131472885|NCT04177355|473362663|FG005|Overall Study|Lost to Follow-up|0|||
131472886|NCT04177355|473362664|FG006|Overall Study|Lost to Follow-up|1|||
131472887|NCT04177355|473362665|FG007|Overall Study|Lost to Follow-up|0|||
131472888|NCT04177355|473362666|FG008|Overall Study|Lost to Follow-up|0|||
131472889|NCT04177355|473362667|FG009|Overall Study|Lost to Follow-up|0|||
131472890|NCT04177355|473362668|FG010|Overall Study|Lost to Follow-up|0|||
131472891|NCT04177355|473362658|FG000|Overall Study|Withdrawal by Subject|0|||
131472892|NCT04177355|473362659|FG001|Overall Study|Withdrawal by Subject|0|||
131472893|NCT04177355|473362660|FG002|Overall Study|Withdrawal by Subject|0|||
131472894|NCT04177355|473362661|FG003|Overall Study|Withdrawal by Subject|1|||
131472895|NCT04177355|473362662|FG004|Overall Study|Withdrawal by Subject|1|||
131472896|NCT04177355|473362663|FG005|Overall Study|Withdrawal by Subject|0|||
131472897|NCT04177355|473362664|FG006|Overall Study|Withdrawal by Subject|0|||
131472898|NCT04177355|473362665|FG007|Overall Study|Withdrawal by Subject|0|||
131472899|NCT04177355|473362666|FG008|Overall Study|Withdrawal by Subject|1|||
131472900|NCT04177355|473362667|FG009|Overall Study|Withdrawal by Subject|0|||
131472901|NCT04177355|473362668|FG010|Overall Study|Withdrawal by Subject|0|||
131472902|NCT02806973|473362670|FG000|Period 1|Withdrawal by Subject|0|||
131472903|NCT02806973|473362671|FG001|Period 1|Withdrawal by Subject|2|||
131472904|NCT02806973|473362672|FG002|Period 1|Withdrawal by Subject|1|||
131472905|NCT02806973|473362673|FG003|Period 1|Withdrawal by Subject|1|||
131472906|NCT02806973|473362670|FG000|Period 1|Adverse Event|0|||
131472907|NCT02806973|473362671|FG001|Period 1|Adverse Event|0|||
131472908|NCT02806973|473362672|FG002|Period 1|Adverse Event|0|||
131472909|NCT02806973|473362673|FG003|Period 1|Adverse Event|1|||
131472910|NCT02806973|473362670|FG000|Period 3|Withdrawal by Subject|0|||
131770221|NCT02132312|474436162|FG000|Overall Study|Protocol Violation|0|||
131472911|NCT02806973|473362671|FG001|Period 3|Withdrawal by Subject|0|||
131472912|NCT02806973|473362672|FG002|Period 3|Withdrawal by Subject|0|||
131472913|NCT02806973|473362673|FG003|Period 3|Withdrawal by Subject|3|||
131472914|NCT02806973|473362670|FG000|Period 3|Adverse Event|0|||
131472915|NCT02806973|473362671|FG001|Period 3|Adverse Event|0|||
131472916|NCT02806973|473362672|FG002|Period 3|Adverse Event|1|||
131472917|NCT02806973|473362673|FG003|Period 3|Adverse Event|0|||
131472918|NCT00206076|473362679|FG000|Overall Study|Physician Decision|2|||
131472919|NCT00206076|473362680|FG001|Overall Study|Physician Decision|0|||
131472920|NCT00206076|473362679|FG000|Overall Study|Withdrawal by Subject|1|||
131472921|NCT00206076|473362680|FG001|Overall Study|Withdrawal by Subject|1|||
131472922|NCT03355664|473362681|FG000|Overall Study|Adverse Event|1|||
131472923|NCT03355664|473362682|FG001|Overall Study|Adverse Event|2|||
131472924|NCT03355664|473362681|FG000|Overall Study|Lost to Follow-up|11|||
131472925|NCT03355664|473362682|FG001|Overall Study|Lost to Follow-up|7|||
131472926|NCT03355664|473362681|FG000|Overall Study|Protocol Violation|1|||
131472927|NCT03355664|473362682|FG001|Overall Study|Protocol Violation|2|||
131472928|NCT03355664|473362681|FG000|Overall Study|Withdrawal by Subject|2|||
131472929|NCT03355664|473362682|FG001|Overall Study|Withdrawal by Subject|1|||
131472930|NCT01751802|473362685|FG000|Overall Study|Adverse Event|4|||
131472931|NCT01751802|473362686|FG001|Overall Study|Adverse Event|2|||
131472932|NCT03190369|473362691|FG000|Overall Study|Poor compliance to protocol|0|||
131472933|NCT03190369|473362692|FG001|Overall Study|Poor compliance to protocol|1|||
131472934|NCT03190369|473362691|FG000|Overall Study|Withdraw before treatment|1|||
131472935|NCT03190369|473362692|FG001|Overall Study|Withdraw before treatment|5|||
131472936|NCT03190369|473362691|FG000|Overall Study|Randomized but not treated|0|||
131472937|NCT03190369|473362692|FG001|Overall Study|Randomized but not treated|2|||
131472938|NCT05153473|473362694|FG000|Overall Study|Death|46|||
131472939|NCT05153473|473362694|FG000|Overall Study|Lost to Follow-up|3|||
131472940|NCT02962765|473362695|FG000|Overall Study|Protocol Violation|9|||
131472941|NCT02962765|473362695|FG000|Overall Study|Withdrawal by Subject|3|||
131472942|NCT02962765|473362695|FG000|Overall Study|Lost to Follow-up|1|||
131472943|NCT02962765|473362695|FG000|Overall Study|Death|1|||
131472944|NCT02962765|473362695|FG000|Overall Study|Limited access to study medication|3|||
131472945|NCT00750880|473362696|FG000|Overall Study|Adverse Event|76|||
131472946|NCT00750880|473362696|FG000|Overall Study|Death|4|||
131472947|NCT00750880|473362696|FG000|Overall Study|Lack of Efficacy|46|||
131472948|NCT00750880|473362696|FG000|Overall Study|Lost to Follow-up|10|||
131472949|NCT00750880|473362696|FG000|Overall Study|Protocol Violation|15|||
131472950|NCT00750880|473362696|FG000|Overall Study|Withdrawal by Subject|33|||
131472951|NCT00750880|473362696|FG000|Overall Study|Physician Decision|20|||
131472952|NCT00750880|473362696|FG000|Overall Study|Administrative|11|||
131472953|NCT02964507|473362702|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
131472954|NCT02964507|473362703|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
131472955|NCT02964507|473362704|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
131472956|NCT02964507|473362705|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
131472957|NCT02964507|473362706|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
131472958|NCT02964507|473362707|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
131472959|NCT02964507|473362708|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
131472960|NCT02964507|473362709|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
131472961|NCT02964507|473362702|FG000|Overall Study|Study terminated by Sponsor|9|||
131472962|NCT02964507|473362703|FG001|Overall Study|Study terminated by Sponsor|1|||
131472963|NCT02964507|473362704|FG002|Overall Study|Study terminated by Sponsor|9|||
131472964|NCT02964507|473362705|FG003|Overall Study|Study terminated by Sponsor|3|||
131472965|NCT02964507|473362706|FG004|Overall Study|Study terminated by Sponsor|3|||
131472966|NCT02964507|473362707|FG005|Overall Study|Study terminated by Sponsor|2|||
131472967|NCT02964507|473362708|FG006|Overall Study|Study terminated by Sponsor|0|||
131472968|NCT02964507|473362709|FG007|Overall Study|Study terminated by Sponsor|0|||
131472969|NCT02964507|473362702|FG000|Overall Study|Other|3|||
131472970|NCT02964507|473362703|FG001|Overall Study|Other|0|||
131472971|NCT02964507|473362704|FG002|Overall Study|Other|0|||
131472972|NCT02964507|473362705|FG003|Overall Study|Other|0|||
131472973|NCT02964507|473362706|FG004|Overall Study|Other|1|||
131472974|NCT02964507|473362707|FG005|Overall Study|Other|0|||
131472975|NCT02964507|473362708|FG006|Overall Study|Other|0|||
131472976|NCT02964507|473362709|FG007|Overall Study|Other|0|||
131472977|NCT02964507|473362702|FG000|Overall Study|Death|11|||
131472978|NCT02964507|473362703|FG001|Overall Study|Death|9|||
131472979|NCT02964507|473362704|FG002|Overall Study|Death|12|||
131472980|NCT02964507|473362705|FG003|Overall Study|Death|2|||
131472981|NCT02964507|473362706|FG004|Overall Study|Death|10|||
131472982|NCT02964507|473362707|FG005|Overall Study|Death|5|||
131472983|NCT02964507|473362708|FG006|Overall Study|Death|0|||
131472984|NCT02964507|473362709|FG007|Overall Study|Death|0|||
131472985|NCT02964507|473362702|FG000|Overall Study|Withdrawal by Subject|1|||
131472986|NCT02964507|473362703|FG001|Overall Study|Withdrawal by Subject|0|||
131472987|NCT02964507|473362704|FG002|Overall Study|Withdrawal by Subject|1|||
131472988|NCT02964507|473362705|FG003|Overall Study|Withdrawal by Subject|1|||
131472989|NCT02964507|473362706|FG004|Overall Study|Withdrawal by Subject|0|||
131472990|NCT02964507|473362707|FG005|Overall Study|Withdrawal by Subject|1|||
131472991|NCT02964507|473362708|FG006|Overall Study|Withdrawal by Subject|0|||
131472992|NCT02964507|473362709|FG007|Overall Study|Withdrawal by Subject|0|||
131472993|NCT02964507|473362702|FG000|Overall Study|Physician Decision|2|||
131472994|NCT02964507|473362703|FG001|Overall Study|Physician Decision|0|||
131472995|NCT02964507|473362704|FG002|Overall Study|Physician Decision|3|||
131472996|NCT02964507|473362705|FG003|Overall Study|Physician Decision|0|||
131472997|NCT02964507|473362706|FG004|Overall Study|Physician Decision|1|||
131472998|NCT02964507|473362707|FG005|Overall Study|Physician Decision|0|||
131472999|NCT02964507|473362708|FG006|Overall Study|Physician Decision|0|||
131473000|NCT02964507|473362709|FG007|Overall Study|Physician Decision|0|||
131473001|NCT02495233|473362710|FG000|Overall Study|Miscellaneous|0|||
131473002|NCT02495233|473362711|FG001|Overall Study|Miscellaneous|1|||
131473003|NCT03880461|473362712|FG000|Overall Study|Determined ineligible after enrollment|45|||
131473004|NCT03880461|473362713|FG001|Overall Study|Determined ineligible after enrollment|44|||
131473005|NCT03880461|473362712|FG000|Overall Study|No weight measurement after enrollment|24|||
131473006|NCT03880461|473362713|FG001|Overall Study|No weight measurement after enrollment|17|||
131473007|NCT02652767|473362719|FG000|Overall Study|Death|2|||
131473008|NCT02652767|473362719|FG000|Overall Study|Lost to Follow-up|1|||
131473009|NCT02652767|473362719|FG000|Overall Study|Withdrawal by Subject|1|||
131473010|NCT01115803|473362721|FG000|Overall Study|Withdrawal by Subject|0|||
131473011|NCT01115803|473362722|FG001|Overall Study|Withdrawal by Subject|0|||
131473012|NCT01115803|473362723|FG002|Overall Study|Withdrawal by Subject|0|||
131473013|NCT01115803|473362724|FG003|Overall Study|Withdrawal by Subject|0|||
131473014|NCT01115803|473362725|FG004|Overall Study|Withdrawal by Subject|0|||
131473015|NCT01115803|473362726|FG005|Overall Study|Withdrawal by Subject|0|||
131473016|NCT01115803|473362727|FG006|Overall Study|Withdrawal by Subject|1|||
131473017|NCT01115803|473362721|FG000|Overall Study|Lost to Follow-up|0|||
131473018|NCT01115803|473362722|FG001|Overall Study|Lost to Follow-up|0|||
131473019|NCT01115803|473362723|FG002|Overall Study|Lost to Follow-up|1|||
131473020|NCT01115803|473362724|FG003|Overall Study|Lost to Follow-up|0|||
131473021|NCT01115803|473362725|FG004|Overall Study|Lost to Follow-up|0|||
131473022|NCT01115803|473362726|FG005|Overall Study|Lost to Follow-up|0|||
131473023|NCT01115803|473362727|FG006|Overall Study|Lost to Follow-up|0|||
131473024|NCT01115803|473362721|FG000|Overall Study|Progressive Disease during Cycle1|0|||
131473025|NCT01115803|473362722|FG001|Overall Study|Progressive Disease during Cycle1|0|||
131473026|NCT01115803|473362723|FG002|Overall Study|Progressive Disease during Cycle1|0|||
131770222|NCT02132312|474436163|FG001|Overall Study|Protocol Violation|1|||
131770223|NCT02132312|474436162|FG000|Overall Study|Withdrawal by Subject|1|||
131770224|NCT02132312|474436163|FG001|Overall Study|Withdrawal by Subject|0|||
131770225|NCT02132312|474436162|FG000|Overall Study|Lost to Follow-up|2|||
131770226|NCT02132312|474436163|FG001|Overall Study|Lost to Follow-up|1|||
131770227|NCT02431559|474436164|FG000|Overall Study|Adverse Event|0|||
131770228|NCT02431559|474436165|FG001|Overall Study|Adverse Event|1|||
131770229|NCT02431559|474436166|FG002|Overall Study|Adverse Event|0|||
131473027|NCT01115803|473362724|FG003|Overall Study|Progressive Disease during Cycle1|0|||
131473028|NCT01115803|473362725|FG004|Overall Study|Progressive Disease during Cycle1|0|||
131473029|NCT01115803|473362726|FG005|Overall Study|Progressive Disease during Cycle1|0|||
131473030|NCT01115803|473362727|FG006|Overall Study|Progressive Disease during Cycle1|1|||
131473031|NCT00064298|473362728|FG000|Overall Study|Withdrawal by Subject|2|||
131473032|NCT00064298|473362729|FG001|Overall Study|Withdrawal by Subject|1|||
131473033|NCT00064298|473362728|FG000|Overall Study|Lost to Follow-up|2|||
131473034|NCT00064298|473362729|FG001|Overall Study|Lost to Follow-up|2|||
131473035|NCT00064298|473362728|FG000|Overall Study|Death|0|||
131473036|NCT00064298|473362729|FG001|Overall Study|Death|1|||
131473037|NCT00064298|473362728|FG000|Overall Study|Disease Progression|2|||
131473038|NCT00064298|473362729|FG001|Overall Study|Disease Progression|1|||
131473039|NCT03614975|473362730|FG000|Overall Study|Physician Decision|7|||
131473040|NCT03614975|473362731|FG001|Overall Study|Physician Decision|5|||
131473041|NCT03614975|473362730|FG000|Overall Study|Withdrawal by Subject|2|||
131473042|NCT03614975|473362731|FG001|Overall Study|Withdrawal by Subject|2|||
131473043|NCT03614975|473362730|FG000|Overall Study|Specimens not in lab batch shipment|1|||
131473044|NCT03614975|473362731|FG001|Overall Study|Specimens not in lab batch shipment|1|||
131770230|NCT02431559|474436167|FG003|Overall Study|Adverse Event|4|||
131770231|NCT02431559|474436164|FG000|Overall Study|Progressive disease|2|||
131770232|NCT02431559|474436165|FG001|Overall Study|Progressive disease|1|||
131770233|NCT02431559|474436166|FG002|Overall Study|Progressive disease|4|||
131770234|NCT02431559|474436167|FG003|Overall Study|Progressive disease|22|||
131473045|NCT01569464|473362732|FG000|Overall Study|Adverse Event|4|||
131473046|NCT01569464|473362733|FG001|Overall Study|Adverse Event|0|||
131473047|NCT01569464|473362732|FG000|Overall Study|Lack of Efficacy|1|||
131473048|NCT01569464|473362733|FG001|Overall Study|Lack of Efficacy|0|||
131473049|NCT01569464|473362732|FG000|Overall Study|Protocol Violation|1|||
131473050|NCT01569464|473362733|FG001|Overall Study|Protocol Violation|0|||
131473051|NCT01569464|473362732|FG000|Overall Study|Lost to Follow-up|2|||
131473052|NCT01569464|473362733|FG001|Overall Study|Lost to Follow-up|3|||
131473053|NCT01569464|473362732|FG000|Overall Study|Withdrawal by Subject|1|||
131473054|NCT01569464|473362733|FG001|Overall Study|Withdrawal by Subject|1|||
131473055|NCT01569464|473362732|FG000|Overall Study|Other|1|||
131473056|NCT01569464|473362733|FG001|Overall Study|Other|1|||
131473057|NCT03475875|473362734|FG000|Period 1|Lost to Follow-up|1|||
131770235|NCT02431559|474436164|FG000|Overall Study|Withdrawal by Subject|0|||
131770236|NCT02431559|474436165|FG001|Overall Study|Withdrawal by Subject|1|||
131770237|NCT02431559|474436166|FG002|Overall Study|Withdrawal by Subject|0|||
131473058|NCT03475875|473362735|FG001|Period 1|Lost to Follow-up|0|||
131473059|NCT03475875|473362734|FG000|Period 1|Adverse Event|2|||
131473060|NCT03475875|473362735|FG001|Period 1|Adverse Event|1|||
131473061|NCT03475875|473362734|FG000|Period 2|Adverse Event|3|||
131473062|NCT03475875|473362735|FG001|Period 2|Adverse Event|0|||
131473063|NCT03475875|473362734|FG000|Period 2|Protocol Violation|0|||
131473064|NCT03475875|473362735|FG001|Period 2|Protocol Violation|1|||
131473065|NCT01642407|473362736|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
131473066|NCT01642407|473362736|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
131473067|NCT01642407|473362736|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
131473068|NCT04025710|473362737|FG000|Overall Study|Death|3|||
131473069|NCT04025710|473362737|FG000|Overall Study|Lost to Follow-up|5|||
131473070|NCT04025710|473362737|FG000|Overall Study|Withdrawal by Subject|1|||
131473071|NCT04025710|473362737|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
131473072|NCT04025710|473362737|FG000|Overall Study|Drop-out according to protocol|34|||
131473073|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
131473074|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
131473075|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
131473076|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
131473077|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
131473078|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
131473079|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
131473080|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
131473081|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
131473082|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
131473083|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
131473084|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
131473085|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
131473086|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
131473087|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
131473088|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
131473089|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
131473090|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
131473091|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
131473092|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
131473093|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
131473094|NCT02431247|473362738|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
131473095|NCT02431247|473362739|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
131473096|NCT02431247|473362740|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
131473097|NCT02431247|473362738|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
131473098|NCT02431247|473362739|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
131473099|NCT02431247|473362740|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
131473100|NCT02431247|473362738|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
131473101|NCT02431247|473362739|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
131473102|NCT02431247|473362740|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
131473103|NCT02431247|473362738|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
131473104|NCT02431247|473362739|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
131473105|NCT02431247|473362740|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
131473106|NCT02431247|473362738|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
131473107|NCT02431247|473362739|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
131473108|NCT02431247|473362740|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
131473109|NCT02431247|473362738|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
131473110|NCT02431247|473362739|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
131473111|NCT02431247|473362740|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
131473112|NCT02431247|473362738|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
131473113|NCT02431247|473362739|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
131473114|NCT02431247|473362740|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
131473115|NCT01562873|473362741|FG000|Overall Study|Disease Progression per RECIST|10|||
131473116|NCT01562873|473362742|FG001|Overall Study|Disease Progression per RECIST|0|||
131473117|NCT01562873|473362741|FG000|Overall Study|Adverse Event|1|||
131473118|NCT01562873|473362742|FG001|Overall Study|Adverse Event|0|||
131473119|NCT01562873|473362741|FG000|Overall Study|Clinical Disease Progression|9|||
131770238|NCT02431559|474436167|FG003|Overall Study|Withdrawal by Subject|4|||
131770239|NCT02431559|474436164|FG000|Overall Study|Physician Decision|0|||
131473120|NCT01562873|473362742|FG001|Overall Study|Clinical Disease Progression|0|||
131473121|NCT01562873|473362741|FG000|Overall Study|Clinical PD and adverse event|1|||
131473122|NCT01562873|473362742|FG001|Overall Study|Clinical PD and adverse event|0|||
131473123|NCT01484938|473362743|FG000|Overall Study|Adverse Event|2|||
131473124|NCT01484938|473362743|FG000|Overall Study|Lost to Follow-up|1|||
131770240|NCT02431559|474436165|FG001|Overall Study|Physician Decision|0|||
131473125|NCT01484938|473362743|FG000|Overall Study|Noncompliance|1|||
131473126|NCT02942576|473362745|FG000|Overall Study|Adverse Event|28|||
131473127|NCT02942576|473362746|FG001|Overall Study|Adverse Event|6|||
131473128|NCT02942576|473362745|FG000|Overall Study|Withdrawal by Subject|7|||
131473129|NCT02942576|473362746|FG001|Overall Study|Withdrawal by Subject|5|||
131473130|NCT02942576|473362745|FG000|Overall Study|Physician Decision|1|||
131473131|NCT02942576|473362746|FG001|Overall Study|Physician Decision|4|||
131473132|NCT02942576|473362745|FG000|Overall Study|Other|10|||
131473133|NCT02942576|473362746|FG001|Overall Study|Other|8|||
131473134|NCT00938964|473362747|FG000|Overall Study|Death|3|||
131473135|NCT00938964|473362748|FG001|Overall Study|Death|3|||
131473136|NCT00938964|473362747|FG000|Overall Study|Lost to Follow-up|2|||
131473137|NCT00938964|473362748|FG001|Overall Study|Lost to Follow-up|3|||
131473138|NCT00938964|473362747|FG000|Overall Study|Withdrawal by Subject|22|||
131473139|NCT00938964|473362748|FG001|Overall Study|Withdrawal by Subject|18|||
131473140|NCT00938964|473362747|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
131473141|NCT00938964|473362748|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
131473142|NCT01858636|473362749|FG000|Overall Study|No Device Deployment Attempted|24|||
131473143|NCT01858636|473362749|FG000|Overall Study|Physician Decision|1|||
131473144|NCT01858636|473362749|FG000|Overall Study|Death|1|||
131473145|NCT01858636|473362749|FG000|Overall Study|Lost to Follow-up|1|||
131473146|NCT01858636|473362749|FG000|Overall Study|Withdrawal by Subject|1|||
131473147|NCT03523000|473362753|FG000|Overall Study|Withdrawal by Subject|3|||
131473148|NCT03523000|473362754|FG001|Overall Study|Withdrawal by Subject|0|||
131473149|NCT03523000|473362753|FG000|Overall Study|Unsuccessful trial|2|||
131473150|NCT03523000|473362754|FG001|Overall Study|Unsuccessful trial|0|||
131473151|NCT01227564|473362760|FG000|Overall Study|No Longer Willing to Participate|4|||
131473152|NCT01227564|473362761|FG001|Overall Study|No Longer Willing to Participate|2|||
131473153|NCT01227564|473362762|FG002|Overall Study|No Longer Willing to Participate|5|||
131473154|NCT01227564|473362760|FG000|Overall Study|Participant moved to another town|0|||
131473155|NCT01227564|473362761|FG001|Overall Study|Participant moved to another town|0|||
131473156|NCT01227564|473362762|FG002|Overall Study|Participant moved to another town|1|||
131473157|NCT02862600|473362768|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
131473158|NCT02862600|473362768|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
131473159|NCT02862600|473362768|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
131473160|NCT02862600|473362768|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
131473161|NCT00194675|473362783|FG000|Overall Study|Lost to Follow-up|1|||
131473162|NCT00194675|473362784|FG001|Overall Study|Lost to Follow-up|1|||
131473163|NCT00194675|473362783|FG000|Overall Study|lack of interest|1|||
131473164|NCT00194675|473362784|FG001|Overall Study|lack of interest|1|||
131473165|NCT00194675|473362783|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
131473166|NCT00194675|473362784|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
131473167|NCT00194675|473362783|FG000|Overall Study|Protocol Violation|1|||
131473168|NCT00194675|473362784|FG001|Overall Study|Protocol Violation|0|||
131473169|NCT00194675|473362783|FG000|Overall Study|Death|1|||
131473170|NCT00194675|473362784|FG001|Overall Study|Death|0|||
131473171|NCT00704808|473362785|FG000|Overall Study|Discontinued prior to starting treatment|14|||
131473172|NCT00704808|473362785|FG000|Overall Study|Death|7|||
131473173|NCT00704808|473362785|FG000|Overall Study|Tumor progression|80|||
131473174|NCT00704808|473362785|FG000|Overall Study|Patient's decision|11|||
131473175|NCT00704808|473362785|FG000|Overall Study|Early therapy discontinuation|16|||
131473176|NCT00704808|473362785|FG000|Overall Study|Adverse Event|1|||
131473177|NCT00704808|473362785|FG000|Overall Study|Lost to Follow-up|1|||
131473178|NCT00704808|473362785|FG000|Overall Study|Treatment change|1|||
131473179|NCT01539317|473362793|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
131473180|NCT01539317|473362794|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
131473181|NCT01994590|473364051|FG000|Overall Study|Adverse Event|1|||
131473182|NCT01994590|473364051|FG000|Overall Study|Trial Terminated|1|||
131473183|NCT03581786|473364052|FG000|Overall Study|Death|67|||
131473184|NCT03581786|473364053|FG001|Overall Study|Death|47|||
131473185|NCT03581786|473364052|FG000|Overall Study|Withdrawal by Subject|2|||
131473186|NCT03581786|473364053|FG001|Overall Study|Withdrawal by Subject|5|||
131473187|NCT03581786|473364052|FG000|Overall Study|Lost to Follow-up|7|||
131473188|NCT03581786|473364053|FG001|Overall Study|Lost to Follow-up|4|||
131473189|NCT03581786|473364052|FG000|Overall Study|reason other than specified above|0|||
131473190|NCT03581786|473364053|FG001|Overall Study|reason other than specified above|1|||
131473191|NCT05523323|473364054|FG000|Overall Study|Death|26|||
131473192|NCT05523323|473364055|FG001|Overall Study|Death|21|||
131473193|NCT05523323|473364054|FG000|Overall Study|Ongoing participants|35|||
131473194|NCT05523323|473364055|FG001|Overall Study|Ongoing participants|30|||
131473195|NCT02237911|473364064|FG000|Overall Study|Withdrawal by Subject|4|||
131473196|NCT02237911|473364065|FG001|Overall Study|Withdrawal by Subject|7|||
131473197|NCT02237911|473364066|FG002|Overall Study|Withdrawal by Subject|2|||
131473198|NCT02237911|473364064|FG000|Overall Study|Lost to Follow-up|3|||
131473199|NCT02237911|473364065|FG001|Overall Study|Lost to Follow-up|1|||
131473200|NCT02237911|473364066|FG002|Overall Study|Lost to Follow-up|1|||
131473201|NCT00053365|473364067|FG000|Overall Study|Incorrect cell type|1|||
131473202|NCT00053365|473364067|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
131473203|NCT00053365|473364067|FG000|Overall Study|Never treated|4|||
131473204|NCT00958789|473364072|FG000|Overall Study|Death|5|||
131473205|NCT00958789|473364072|FG000|Overall Study|Lost to Follow-up|14|||
131473206|NCT00958789|473364072|FG000|Overall Study|Withdrawal by Subject|17|||
131473207|NCT00958789|473364072|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
131473208|NCT00958789|473364072|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
131473209|NCT00958789|473364072|FG000|Overall Study|Subject terminated|2|||
131473210|NCT00958789|473364072|FG000|Overall Study|Revision|7|||
131473211|NCT03183778|473364076|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
131473212|NCT05007717|473364081|FG000|Overall Study|Death|3|||
131473213|NCT05007717|473364082|FG001|Overall Study|Death|2|||
131473214|NCT00427960|473364086|FG000|Overall Study|Adverse Event|2|||
131473215|NCT00427960|473364087|FG001|Overall Study|Adverse Event|0|||
131473216|NCT00427960|473364086|FG000|Overall Study|Withdrawal by Subject|0|||
131473217|NCT00427960|473364087|FG001|Overall Study|Withdrawal by Subject|3|||
131473218|NCT00427960|473364086|FG000|Overall Study|Other|0|||
131473219|NCT00427960|473364087|FG001|Overall Study|Other|1|||
131473220|NCT03282565|473364090|FG000|Overall Study|COVID-19 Research Shutdown|0|||
131473221|NCT03282565|473364091|FG001|Overall Study|COVID-19 Research Shutdown|2|||
131473222|NCT03282565|473364092|FG002|Overall Study|COVID-19 Research Shutdown|2|||
131473223|NCT01869725|473364093|FG000|Overall Study|ineligible after registration|1|||
131473224|NCT01869725|473364093|FG000|Overall Study|Death|1|||
131473225|NCT01869725|473364093|FG000|Overall Study|Lost to Follow-up|2|||
131473226|NCT01143207|473364094|FG000|Overall Study|Lost to Follow-up|2|||
131473227|NCT04163718|473364097|FG000|Overall Study|Study terminated|12|||
131473228|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
131473229|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
131473230|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
131473231|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
131473232|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
131473233|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
131473234|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
131473235|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
131473236|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
131473237|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
131473238|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
131473239|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
131473240|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
131473241|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
131473242|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
131473243|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
131473244|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Program Termination|3|||
131473245|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Program Termination|0|||
131473246|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Program Termination|1|||
131473247|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Program Termination|1|||
131473248|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
131473249|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
131473250|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
131473251|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
131473252|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
131473253|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
131473254|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
131473255|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
131473256|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
131473257|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
131473258|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
131473259|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
131473260|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
131473261|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
131473262|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
131473263|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
131770241|NCT02431559|474436166|FG002|Overall Study|Physician Decision|0|||
131770242|NCT02431559|474436167|FG003|Overall Study|Physician Decision|1|||
131770243|NCT02543918|474436168|FG000|Overall Study|Never treated|0|||
131770244|NCT02543918|474436169|FG001|Overall Study|Never treated|1|||
131770245|NCT02543918|474436168|FG000|Overall Study|Lost to Follow-up|1|||
131770246|NCT02543918|474436169|FG001|Overall Study|Lost to Follow-up|1|||
131770247|NCT02543918|474436168|FG000|Overall Study|Withdrawal by Subject|1|||
131473264|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
131473265|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
131770248|NCT02543918|474436169|FG001|Overall Study|Withdrawal by Subject|1|||
131770249|NCT02543918|474436168|FG000|Overall Study|Adverse Event|1|||
131473266|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
131473267|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
131473268|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
131473269|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
131473270|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
131473271|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
131473272|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
131473273|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
131473274|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
131473275|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
131473276|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
131473277|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
131473278|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
131473279|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
131473280|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
131473281|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
131473282|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
131473283|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
131473284|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
131473285|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
131473286|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
131473287|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
131473288|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
131473289|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
131473290|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
131473291|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
131473292|NCT03739840|473364102|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
131473293|NCT03739840|473364103|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
131473294|NCT03739840|473364104|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
131473295|NCT03739840|473364105|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
131473296|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
131473297|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
131473298|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
131473299|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
131473300|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
131473301|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
131473302|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
131473303|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
131473304|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
131473305|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
131473306|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
131473307|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
131473308|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
131473309|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
131473310|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
131473311|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
131473312|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
131473313|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
131473314|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
131473315|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
131473316|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
131473317|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
131473318|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
131473319|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
131473320|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
131473321|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
131473322|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
131473323|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
131473324|NCT03739840|473364102|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
131473325|NCT03739840|473364103|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
131473326|NCT03739840|473364104|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
131473327|NCT03739840|473364105|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
131473328|NCT01058265|473364108|FG000|Overall Study|Lost to Follow-up|11|||
131473329|NCT01058265|473364109|FG001|Overall Study|Lost to Follow-up|12|||
131473330|NCT00873860|473364110|FG000|Overall Study|Lost to Follow-up|1|||
131473331|NCT00873860|473364111|FG001|Overall Study|Lost to Follow-up|0|||
131473332|NCT00873860|473364112|FG002|Overall Study|Lost to Follow-up|0|||
131473333|NCT00873860|473364113|FG003|Overall Study|Lost to Follow-up|1|||
131473334|NCT00873860|473364110|FG000|Overall Study|Withdrawal by Subject|1|||
131473335|NCT00873860|473364111|FG001|Overall Study|Withdrawal by Subject|0|||
131473336|NCT00873860|473364112|FG002|Overall Study|Withdrawal by Subject|2|||
131473337|NCT00873860|473364113|FG003|Overall Study|Withdrawal by Subject|0|||
131473338|NCT00873860|473364110|FG000|Overall Study|Death|1|||
131473339|NCT00873860|473364111|FG001|Overall Study|Death|0|||
131473340|NCT00873860|473364112|FG002|Overall Study|Death|0|||
131473341|NCT00873860|473364113|FG003|Overall Study|Death|0|||
131473342|NCT00873860|473364110|FG000|Overall Study|Other|1|||
131473343|NCT00873860|473364111|FG001|Overall Study|Other|0|||
131473344|NCT00873860|473364112|FG002|Overall Study|Other|1|||
131473345|NCT00873860|473364113|FG003|Overall Study|Other|0|||
131473346|NCT01285960|473364130|FG000|Overall Study|Withdrawal by Subject|2|||
131473347|NCT01285960|473364130|FG000|Overall Study|Lost to Follow-up|2|||
131473348|NCT01285960|473364130|FG000|Overall Study|2 subjects received less 10 sonications|2|||
131473349|NCT01476644|473364134|FG000|Overall Study|Death|5|||
131473350|NCT01476644|473364134|FG000|Overall Study|moved to another state|2|||
131473351|NCT01476644|473364134|FG000|Overall Study|Lost to Follow-up|19|||
131473352|NCT01476644|473364134|FG000|Overall Study|Withdrawal by Subject|13|||
131473353|NCT00095628|473364135|FG000|Overall Study|Disease progression prior to treatment|1|||
131473354|NCT02280473|473364136|FG000|Overall Study|Adverse Event|1|||
131473355|NCT02280473|473364137|FG001|Overall Study|Adverse Event|1|||
131473356|NCT02280473|473364136|FG000|Overall Study|Lack of Efficacy|0|||
131473357|NCT02280473|473364137|FG001|Overall Study|Lack of Efficacy|1|||
131473358|NCT02280473|473364136|FG000|Overall Study|Lost to Follow-up|0|||
131473359|NCT02280473|473364137|FG001|Overall Study|Lost to Follow-up|1|||
131473360|NCT01484054|473364138|FG000|Period 1|Withdrawal by Subject|0|||
131473361|NCT01484054|473364139|FG001|Period 1|Withdrawal by Subject|1|||
131473362|NCT01610271|473364140|FG000|Overall Study|Surgery not complete|0|||
131473363|NCT01610271|473364141|FG001|Overall Study|Surgery not complete|1|||
131473364|NCT01610271|473364140|FG000|Overall Study|Prosthesis not implanted|2|||
131473365|NCT01610271|473364141|FG001|Overall Study|Prosthesis not implanted|3|||
131473366|NCT00364130|473364142|FG000|Intervention Period|Lost to Follow-up|4|||
131473367|NCT00364130|473364143|FG001|Intervention Period|Lost to Follow-up|3|||
131473368|NCT00364130|473364142|FG000|Intervention Period|Pregnancy|1|||
131473369|NCT00364130|473364143|FG001|Intervention Period|Pregnancy|0|||
131473370|NCT00364130|473364142|FG000|Intervention Period|Withdrawal by Subject|4|||
131473371|NCT00364130|473364143|FG001|Intervention Period|Withdrawal by Subject|5|||
131473372|NCT00364130|473364142|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
131473373|NCT00364130|473364143|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
131473374|NCT05281601|473364149|FG000|Overall Study|Physician Decision|2|||
131473375|NCT05281601|473364150|FG001|Overall Study|Physician Decision|0|||
131473376|NCT05281601|473364149|FG000|Overall Study|Lost to Follow-up|2|||
131473377|NCT05281601|473364150|FG001|Overall Study|Lost to Follow-up|0|||
131473378|NCT05281601|473364149|FG000|Overall Study|Death|1|||
131473379|NCT05281601|473364150|FG001|Overall Study|Death|0|||
131473380|NCT05281601|473364149|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131473381|NCT05281601|473364150|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131473382|NCT00586846|473364151|FG000|Overall Study|Physician Decision|1|||
131473383|NCT00586846|473364151|FG000|Overall Study|Death|1|||
131473384|NCT00586846|473364151|FG000|Overall Study|Evaluable for Toxicity Only|4|||
131473385|NCT03194490|473364167|FG000|Overall Study|Lost to Follow-up|1|||
131473386|NCT03194490|473364168|FG001|Overall Study|Lost to Follow-up|3|||
131473387|NCT03194490|473364167|FG000|Overall Study|participant developed specific neck pain|1|||
131473388|NCT03194490|473364168|FG001|Overall Study|participant developed specific neck pain|0|||
131473389|NCT01758289|473364169|FG000|Overall Study|Premature Study Termination|44|||
131473390|NCT01758289|473364169|FG000|Overall Study|Adverse Event|9|||
131473391|NCT01574079|473364170|FG000|Overall Study|Physician Decision|0|||
131473392|NCT01574079|473364171|FG001|Overall Study|Physician Decision|2|||
131473393|NCT01574079|473364170|FG000|Overall Study|Lost to Follow-up|1|||
131473394|NCT01574079|473364171|FG001|Overall Study|Lost to Follow-up|0|||
131473395|NCT03640559|473364175|FG000|Overall Study|Physician Decision|1|||
131473396|NCT03640559|473364176|FG001|Overall Study|Physician Decision|1|||
131473397|NCT03640559|473364175|FG000|Overall Study|Withdrawal by Subject|1|||
131473398|NCT03640559|473364176|FG001|Overall Study|Withdrawal by Subject|0|||
131473399|NCT01436162|473364177|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
131473400|NCT01436162|473364178|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
131473401|NCT01436162|473364179|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
131473402|NCT01436162|473364177|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
131473403|NCT01436162|473364178|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
131473404|NCT01436162|473364179|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
131473405|NCT01436162|473364177|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
131473406|NCT01436162|473364178|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
131473407|NCT01436162|473364179|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
131473408|NCT01436162|473364177|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
131473409|NCT01436162|473364178|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
131473410|NCT01436162|473364179|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
131473411|NCT01436162|473364177|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
131473412|NCT01436162|473364178|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131473413|NCT01436162|473364179|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
131473414|NCT01436162|473364177|FG000|Single-blind Lead-in Phase|Other|107|||
131473415|NCT01436162|473364178|FG001|Single-blind Lead-in Phase|Other|0|||
131473416|NCT01436162|473364179|FG002|Single-blind Lead-in Phase|Other|0|||
131473417|NCT01436162|473364177|FG000|Randomized Phase|Adverse Event|1|||
131473418|NCT01436162|473364178|FG001|Randomized Phase|Adverse Event|5|||
131473419|NCT01436162|473364179|FG002|Randomized Phase|Adverse Event|6|||
131473420|NCT01436162|473364177|FG000|Randomized Phase|Protocol Violation|4|||
131473421|NCT01436162|473364178|FG001|Randomized Phase|Protocol Violation|4|||
131473422|NCT01436162|473364179|FG002|Randomized Phase|Protocol Violation|2|||
131473423|NCT01436162|473364177|FG000|Randomized Phase|Withdrawal by Subject|16|||
131473424|NCT01436162|473364178|FG001|Randomized Phase|Withdrawal by Subject|9|||
131473425|NCT01436162|473364179|FG002|Randomized Phase|Withdrawal by Subject|8|||
131473426|NCT01436162|473364177|FG000|Randomized Phase|Lost to Follow-up|17|||
131473427|NCT01436162|473364178|FG001|Randomized Phase|Lost to Follow-up|5|||
131473428|NCT01436162|473364179|FG002|Randomized Phase|Lost to Follow-up|4|||
131473429|NCT01436162|473364177|FG000|Randomized Phase|Lack of Efficacy|0|||
131473430|NCT01436162|473364178|FG001|Randomized Phase|Lack of Efficacy|1|||
131473431|NCT01436162|473364179|FG002|Randomized Phase|Lack of Efficacy|1|||
131473432|NCT01436162|473364177|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
131473433|NCT01436162|473364178|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
131473434|NCT01436162|473364179|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
131473435|NCT01436162|473364177|FG000|Randomized Phase|Other|2|||
131473436|NCT01436162|473364178|FG001|Randomized Phase|Other|5|||
131473437|NCT01436162|473364179|FG002|Randomized Phase|Other|4|||
131473438|NCT01931202|473364180|FG000|Overall Study|Withdrawal by Subject|0|||
131473439|NCT01931202|473364181|FG001|Overall Study|Withdrawal by Subject|0|||
131473440|NCT01931202|473364182|FG002|Overall Study|Withdrawal by Subject|2|||
131473441|NCT01931202|473364180|FG000|Overall Study|Lost to Follow-up|0|||
131473442|NCT01931202|473364181|FG001|Overall Study|Lost to Follow-up|5|||
131473443|NCT01931202|473364182|FG002|Overall Study|Lost to Follow-up|2|||
131473444|NCT04521777|473365871|FG000|Overall Study|Death|2|||
131473445|NCT04521777|473365871|FG000|Overall Study|Withdrawal by Subject|2|||
131473446|NCT03139604|473365874|FG000|Overall Study|Other|7|||
131473447|NCT03139604|473365875|FG001|Overall Study|Other|3|||
131473448|NCT03139604|473365874|FG000|Overall Study|Withdrawal by Subject|16|||
131473449|NCT03139604|473365875|FG001|Overall Study|Withdrawal by Subject|17|||
131473450|NCT03139604|473365874|FG000|Overall Study|Physician Decision|1|||
131473451|NCT03139604|473365875|FG001|Overall Study|Physician Decision|2|||
131473452|NCT03139604|473365874|FG000|Overall Study|Lost to Follow-up|3|||
131473453|NCT03139604|473365875|FG001|Overall Study|Lost to Follow-up|1|||
131473454|NCT03139604|473365874|FG000|Overall Study|Death|65|||
131473455|NCT03139604|473365875|FG001|Overall Study|Death|67|||
131473456|NCT03139604|473365874|FG000|Overall Study|Study Terminated by Sponsor|122|||
131473457|NCT03139604|473365875|FG001|Overall Study|Study Terminated by Sponsor|127|||
131473458|NCT03139604|473365874|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
131473459|NCT03139604|473365875|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
131473460|NCT00900601|473365880|FG000|Overall Study|Physician Decision|1|||
131473461|NCT03026088|473365881|FG000|Overall Study|Study termination|20|||
131473462|NCT01052844|473365889|FG000|Overall Study|Adverse Event|0|||
131473463|NCT01052844|473365890|FG001|Overall Study|Adverse Event|1|||
131473464|NCT03463031|473365891|FG000|Overall Study|Withdrawal by Subject|4|||
131473465|NCT03463031|473365892|FG001|Overall Study|Withdrawal by Subject|2|||
131473466|NCT03463031|473365891|FG000|Overall Study|Investigator/Sponsor Decision|0|||
131473467|NCT03463031|473365892|FG001|Overall Study|Investigator/Sponsor Decision|1|||
131473468|NCT03463031|473365891|FG000|Overall Study|Lost to Follow-up|1|||
131473469|NCT03463031|473365892|FG001|Overall Study|Lost to Follow-up|1|||
131473470|NCT03463031|473365891|FG000|Overall Study|Adverse Event|4|||
131473471|NCT03463031|473365892|FG001|Overall Study|Adverse Event|1|||
131473472|NCT03463031|473365891|FG000|Overall Study|Use of prohibited medication by subject|1|||
131473473|NCT03463031|473365892|FG001|Overall Study|Use of prohibited medication by subject|0|||
131473474|NCT02131532|473365893|FG000|Overall Study|Withdrawal by Subject|1|||
131473475|NCT02131532|473365893|FG000|Overall Study|Physician Decision|1|||
131473476|NCT02131532|473365893|FG000|Overall Study|Other health conditions|2|||
131473477|NCT03583164|473365899|FG000|Overall Study|Death in Main Phase|35|||
131473478|NCT03583164|473365899|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
131473479|NCT03583164|473365899|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
131473480|NCT03583164|473365899|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
131473481|NCT03583164|473365899|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
131473482|NCT03583164|473365899|FG000|Overall Study|Physician decision in Main Phase|1|||
131473483|NCT03583164|473365899|FG000|Overall Study|Physician decision in Extended Phase|2|||
131473484|NCT03583164|473365899|FG000|Overall Study|Death in Extended Phase|13|||
131473485|NCT03583164|473365899|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
131473486|NCT03583164|473365899|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
131473487|NCT03583164|473365899|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
131473488|NCT03583164|473365899|FG000|Overall Study|Treatment failure in Main Phase|2|||
131473489|NCT03583164|473365899|FG000|Overall Study|Treatment failure in Extended Phase|4|||
131473490|NCT03583164|473365899|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
131473491|NCT03583164|473365899|FG000|Overall Study|Other not specified reason in Main Phase|2|||
131473492|NCT01466595|473365900|FG000|Overall Study|Withdrawal by Subject|0|||
131473493|NCT01466595|473365901|FG001|Overall Study|Withdrawal by Subject|1|||
131473494|NCT00057954|473365902|FG000|Overall Study|Death|1|||
131473495|NCT00057954|473365902|FG000|Overall Study|Disease progression|1|||
131473496|NCT00559754|473365903|FG000|Overall Study|Disease progression|1|||
131473497|NCT00559754|473365903|FG000|Overall Study|Adverse Event|5|||
131473498|NCT00559754|473365903|FG000|Overall Study|Protocol Violation|1|||
131473499|NCT00559754|473365903|FG000|Overall Study|Investigator criteria|2|||
131473500|NCT00559754|473365903|FG000|Overall Study|Withdrawal by Subject|2|||
131473501|NCT01264016|473365904|FG000|Overall Study|Withdrawal by Subject|1|||
131473502|NCT01264016|473365904|FG000|Overall Study|Felt faint at sight of blood|1|||
131473503|NCT02147184|473365905|FG000|Overall Study|Lost to Follow-up|28|||
131473504|NCT02147184|473365906|FG001|Overall Study|Lost to Follow-up|15|||
131473505|NCT02147184|473365905|FG000|Overall Study|Study Burden|11|||
131473506|NCT02147184|473365906|FG001|Overall Study|Study Burden|7|||
131473507|NCT02147184|473365905|FG000|Overall Study|Pregnancy|6|||
131473508|NCT02147184|473365906|FG001|Overall Study|Pregnancy|0|||
131473509|NCT02147184|473365905|FG000|Overall Study|Moved out of state|3|||
131473510|NCT02147184|473365906|FG001|Overall Study|Moved out of state|3|||
131473511|NCT02147184|473365905|FG000|Overall Study|Physician Decision|0|||
131473512|NCT02147184|473365906|FG001|Overall Study|Physician Decision|2|||
131473513|NCT02147184|473365905|FG000|Overall Study|Other|1|||
131473514|NCT02147184|473365906|FG001|Overall Study|Other|0|||
131473515|NCT02117414|473365907|FG000|Overall Study|Death|5|||
131473516|NCT02117414|473365908|FG001|Overall Study|Death|2|||
131473517|NCT02117414|473365907|FG000|Overall Study|Withdrawal by Subject|10|||
131473518|NCT02117414|473365908|FG001|Overall Study|Withdrawal by Subject|4|||
131473519|NCT02537574|473365910|FG000|Overall Study|Adverse Event|1|||
131473520|NCT02537574|473365911|FG001|Overall Study|Adverse Event|3|||
131473521|NCT02537574|473365912|FG002|Overall Study|Adverse Event|2|||
131473522|NCT02537574|473365910|FG000|Overall Study|Lost to Follow-up|40|||
131473523|NCT02537574|473365911|FG001|Overall Study|Lost to Follow-up|51|||
131473524|NCT02537574|473365912|FG002|Overall Study|Lost to Follow-up|55|||
131473525|NCT02537574|473365910|FG000|Overall Study|Noncompliance with study drug|0|||
131473526|NCT02537574|473365911|FG001|Overall Study|Noncompliance with study drug|1|||
131473527|NCT02537574|473365912|FG002|Overall Study|Noncompliance with study drug|1|||
131473528|NCT02537574|473365910|FG000|Overall Study|Physician Decision|2|||
131473529|NCT02537574|473365911|FG001|Overall Study|Physician Decision|0|||
131473530|NCT02537574|473365912|FG002|Overall Study|Physician Decision|0|||
131473531|NCT02537574|473365910|FG000|Overall Study|Protocol Violation|4|||
131473532|NCT02537574|473365911|FG001|Overall Study|Protocol Violation|2|||
131473533|NCT02537574|473365912|FG002|Overall Study|Protocol Violation|3|||
131473534|NCT02537574|473365910|FG000|Overall Study|Withdrawal by Subject|37|||
131473535|NCT02537574|473365911|FG001|Overall Study|Withdrawal by Subject|27|||
131473536|NCT02537574|473365912|FG002|Overall Study|Withdrawal by Subject|29|||
131473537|NCT02537574|473365910|FG000|Overall Study|Lack of Efficacy|14|||
131473538|NCT02537574|473365911|FG001|Overall Study|Lack of Efficacy|16|||
131473539|NCT02537574|473365912|FG002|Overall Study|Lack of Efficacy|15|||
131473540|NCT02537574|473365910|FG000|Overall Study|Duplicate Patient|1|||
131473541|NCT02537574|473365911|FG001|Overall Study|Duplicate Patient|0|||
131473542|NCT02537574|473365912|FG002|Overall Study|Duplicate Patient|0|||
131473543|NCT02537574|473365910|FG000|Overall Study|Patient not Stable|0|||
131473544|NCT02537574|473365911|FG001|Overall Study|Patient not Stable|1|||
131473545|NCT02537574|473365912|FG002|Overall Study|Patient not Stable|0|||
131473546|NCT02537574|473365910|FG000|Overall Study|Incarceration|0|||
131473547|NCT02537574|473365911|FG001|Overall Study|Incarceration|1|||
131473548|NCT02537574|473365912|FG002|Overall Study|Incarceration|0|||
131473549|NCT02537574|473365910|FG000|Overall Study|Failed Naloxone Challenge|0|||
131473550|NCT02537574|473365911|FG001|Overall Study|Failed Naloxone Challenge|1|||
131473551|NCT02537574|473365912|FG002|Overall Study|Failed Naloxone Challenge|0|||
131473552|NCT02537574|473365910|FG000|Overall Study|Transportation Issues|0|||
131473553|NCT02537574|473365911|FG001|Overall Study|Transportation Issues|0|||
131473554|NCT02537574|473365912|FG002|Overall Study|Transportation Issues|1|||
131473555|NCT02537574|473365910|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
131473556|NCT02537574|473365911|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
131473557|NCT02537574|473365912|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
131473558|NCT02537574|473365910|FG000|Overall Study|Noncompliance with Protocol|0|||
131473559|NCT02537574|473365911|FG001|Overall Study|Noncompliance with Protocol|0|||
131473560|NCT02537574|473365912|FG002|Overall Study|Noncompliance with Protocol|1|||
131473561|NCT02663687|473365913|FG000|Overall Study|Adverse Event|1|||
131473562|NCT02663687|473365914|FG001|Overall Study|Adverse Event|0|||
131473563|NCT02663687|473365915|FG002|Overall Study|Adverse Event|0|||
131473564|NCT02663687|473365916|FG003|Overall Study|Adverse Event|0|||
131473565|NCT02663687|473365917|FG004|Overall Study|Adverse Event|0|||
131473566|NCT02663687|473365913|FG000|Overall Study|Other|1|||
131473567|NCT02663687|473365914|FG001|Overall Study|Other|0|||
131473568|NCT02663687|473365915|FG002|Overall Study|Other|1|||
131473569|NCT02663687|473365916|FG003|Overall Study|Other|0|||
131473570|NCT02663687|473365917|FG004|Overall Study|Other|0|||
131473571|NCT00417482|473365918|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
131473572|NCT00417482|473365919|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
131473573|NCT00417482|473365920|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
131473574|NCT00417482|473365918|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
131473575|NCT00417482|473365919|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
131473576|NCT00417482|473365920|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
131473577|NCT00417482|473365918|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
131473578|NCT00417482|473365919|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
131473579|NCT00417482|473365920|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
131473580|NCT00417482|473365918|FG000|Phase B 1st 16 Weeks|Death|1|||
131473581|NCT00417482|473365919|FG001|Phase B 1st 16 Weeks|Death|0|||
131473582|NCT00417482|473365920|FG002|Phase B 1st 16 Weeks|Death|0|||
131473583|NCT00417482|473365918|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
131473584|NCT00417482|473365919|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
131473585|NCT00417482|473365920|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
131473586|NCT00417482|473365918|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
131473587|NCT00417482|473365919|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
131473588|NCT00417482|473365920|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
131473589|NCT00417482|473365918|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
131473590|NCT00417482|473365919|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
131473591|NCT00417482|473365920|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
131473592|NCT00417482|473365918|FG000|Phase B 2nd 16 Weeks|Death|1|||
131473593|NCT00417482|473365919|FG001|Phase B 2nd 16 Weeks|Death|1|||
131473594|NCT00417482|473365920|FG002|Phase B 2nd 16 Weeks|Death|0|||
131473595|NCT06400979|473365923|FG000|Overall Study|Lost to Follow-up|29|||
131473596|NCT06400979|473365923|FG000|Overall Study|Withdrawal by Subject|1|||
131473597|NCT00117286|473365924|FG000|Overall Study|Adverse Event|12|||
131473598|NCT00117286|473365925|FG001|Overall Study|Adverse Event|6|||
131473599|NCT00117286|473365924|FG000|Overall Study|Lost to Follow-up|2|||
131473600|NCT00117286|473365925|FG001|Overall Study|Lost to Follow-up|0|||
131473601|NCT00117286|473365924|FG000|Overall Study|Protocol Violation|3|||
131473602|NCT00117286|473365925|FG001|Overall Study|Protocol Violation|3|||
131473603|NCT00117286|473365924|FG000|Overall Study|Withdrawal by Subject|6|||
131473604|NCT00117286|473365925|FG001|Overall Study|Withdrawal by Subject|2|||
131473605|NCT00117286|473365924|FG000|Overall Study|Physician Decision|3|||
131473606|NCT00117286|473365925|FG001|Overall Study|Physician Decision|7|||
131473607|NCT00117286|473365924|FG000|Overall Study|Lack of Efficacy|2|||
131770250|NCT02543918|474436169|FG001|Overall Study|Adverse Event|1|||
131770251|NCT00486720|474436170|FG000|Overall Study|Adverse Event|1|||
131770252|NCT00486720|474436171|FG001|Overall Study|Adverse Event|2|||
131770253|NCT00486720|474436170|FG000|Overall Study|Lack of Efficacy|4|||
131770254|NCT00486720|474436171|FG001|Overall Study|Lack of Efficacy|6|||
131770255|NCT00486720|474436170|FG000|Overall Study|Physician Decision|1|||
131770256|NCT00486720|474436171|FG001|Overall Study|Physician Decision|2|||
131770257|NCT00486720|474436170|FG000|Overall Study|Protocol Violation|1|||
131770258|NCT00486720|474436171|FG001|Overall Study|Protocol Violation|0|||
131770259|NCT00486720|474436170|FG000|Overall Study|Withdrawal by Subject|3|||
131770260|NCT00486720|474436171|FG001|Overall Study|Withdrawal by Subject|1|||
131770261|NCT00486720|474436170|FG000|Overall Study|Progressive Disease|0|||
131770262|NCT00486720|474436171|FG001|Overall Study|Progressive Disease|1|||
131770263|NCT00955682|474436174|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
131770264|NCT00955682|474436175|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
131770265|NCT02117024|474436176|FG000|Overall Study|Progressive Disease|26|||
131770266|NCT02117024|474436177|FG001|Overall Study|Progressive Disease|9|||
131473608|NCT00117286|473365925|FG001|Overall Study|Lack of Efficacy|1|||
131473609|NCT00117286|473365924|FG000|Overall Study|Research site closing|0|||
131473610|NCT00117286|473365925|FG001|Overall Study|Research site closing|2|||
131473611|NCT00048061|473365926|FG000|Overall Study|Adverse Event|41|||
131473612|NCT00048061|473365927|FG001|Overall Study|Adverse Event|32|||
131473613|NCT00048061|473365928|FG002|Overall Study|Adverse Event|44|||
131473614|NCT00048061|473365929|FG003|Overall Study|Adverse Event|37|||
131473615|NCT00048061|473365926|FG000|Overall Study|Lost to Follow-up|3|||
131473616|NCT00048061|473365927|FG001|Overall Study|Lost to Follow-up|2|||
131473617|NCT00048061|473365928|FG002|Overall Study|Lost to Follow-up|4|||
131473618|NCT00048061|473365929|FG003|Overall Study|Lost to Follow-up|5|||
131770267|NCT02117024|474436176|FG000|Overall Study|Significant Clinical Progression|7|||
131770268|NCT02117024|474436177|FG001|Overall Study|Significant Clinical Progression|4|||
131770269|NCT02117024|474436176|FG000|Overall Study|Death|5|||
131770270|NCT02117024|474436177|FG001|Overall Study|Death|0|||
131770271|NCT02117024|474436176|FG000|Overall Study|Withdrawal by Subject|3|||
131770272|NCT02117024|474436177|FG001|Overall Study|Withdrawal by Subject|1|||
131770273|NCT02117024|474436176|FG000|Overall Study|Protocol Violation|1|||
131770274|NCT02117024|474436177|FG001|Overall Study|Protocol Violation|0|||
131770275|NCT02117024|474436176|FG000|Overall Study|Adverse Event|1|||
131770276|NCT02117024|474436177|FG001|Overall Study|Adverse Event|2|||
131770277|NCT02117024|474436176|FG000|Overall Study|Randomized in Error|1|||
131770278|NCT02117024|474436177|FG001|Overall Study|Randomized in Error|0|||
131770279|NCT02117024|474436176|FG000|Overall Study|Patient returned to primary oncologist|0|||
131770280|NCT02117024|474436177|FG001|Overall Study|Patient returned to primary oncologist|1|||
131770281|NCT02117024|474436176|FG000|Overall Study|Patient took treatment break|0|||
131770282|NCT02117024|474436177|FG001|Overall Study|Patient took treatment break|1|||
131770283|NCT02117024|474436176|FG000|Overall Study|Physician Decision|0|||
131473619|NCT00048061|473365926|FG000|Overall Study|Withdrawal by Subject|20|||
131473620|NCT00048061|473365927|FG001|Overall Study|Withdrawal by Subject|29|||
131473621|NCT00048061|473365928|FG002|Overall Study|Withdrawal by Subject|29|||
131473622|NCT00048061|473365929|FG003|Overall Study|Withdrawal by Subject|32|||
131473623|NCT00048061|473365926|FG000|Overall Study|Did not follow-up|5|||
131473624|NCT00048061|473365927|FG001|Overall Study|Did not follow-up|5|||
131473625|NCT00048061|473365928|FG002|Overall Study|Did not follow-up|4|||
131473626|NCT00048061|473365929|FG003|Overall Study|Did not follow-up|5|||
131473627|NCT00048061|473365926|FG000|Overall Study|Early improvement|6|||
131473628|NCT00048061|473365927|FG001|Overall Study|Early improvement|5|||
131473629|NCT00048061|473365928|FG002|Overall Study|Early improvement|3|||
131473630|NCT00048061|473365929|FG003|Overall Study|Early improvement|0|||
131473631|NCT03555435|473365930|FG000|Overall Study|Lost to Follow-up|17|||
131473632|NCT03555435|473365931|FG001|Overall Study|Lost to Follow-up|19|||
131770284|NCT02117024|474436177|FG001|Overall Study|Physician Decision|2|||
131473633|NCT03555435|473365932|FG002|Overall Study|Lost to Follow-up|8|||
131473634|NCT01323946|473365933|FG000|Overall Study|Lost to Follow-up|0|||
131473635|NCT01323946|473365934|FG001|Overall Study|Lost to Follow-up|1|||
131473636|NCT01323946|473365935|FG002|Overall Study|Lost to Follow-up|0|||
131473637|NCT01323946|473365933|FG000|Overall Study|Parents refused the last blood draw|1|||
131473638|NCT01323946|473365934|FG001|Overall Study|Parents refused the last blood draw|0|||
131473639|NCT01323946|473365935|FG002|Overall Study|Parents refused the last blood draw|0|||
131473640|NCT01323946|473365933|FG000|Overall Study|Withdrawal by Subject|2|||
131473641|NCT01323946|473365934|FG001|Overall Study|Withdrawal by Subject|2|||
131473642|NCT01323946|473365935|FG002|Overall Study|Withdrawal by Subject|0|||
131473643|NCT01272661|473365938|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
131473644|NCT01272661|473365939|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
131473645|NCT01272661|473365940|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
131473646|NCT02869438|473365941|FG000|Overall Study|Lost to Follow-up|1|||
131473647|NCT02869438|473365942|FG001|Overall Study|Lost to Follow-up|0|||
131473648|NCT02869438|473365941|FG000|Overall Study|Adverse Event|1|||
131473649|NCT02869438|473365942|FG001|Overall Study|Adverse Event|0|||
131473650|NCT02869438|473365941|FG000|Overall Study|Withdrawal by Subject|1|||
131473651|NCT02869438|473365942|FG001|Overall Study|Withdrawal by Subject|2|||
131473652|NCT01367119|473365943|FG000|Overall Study|Adverse Event|1|||
131473653|NCT01367119|473365944|FG001|Overall Study|Adverse Event|0|||
131473654|NCT01367119|473365943|FG000|Overall Study|Withdrawal by Subject|1|||
131473655|NCT01367119|473365944|FG001|Overall Study|Withdrawal by Subject|1|||
131473656|NCT03180684|473365945|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
131473657|NCT03180684|473365946|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
131473658|NCT03180684|473365945|FG000|Overall Study|Physician Decision|1|||
131473659|NCT03180684|473365946|FG001|Overall Study|Physician Decision|0|||
131473660|NCT03180684|473365945|FG000|Overall Study|Lost to Follow-up|1|||
131473661|NCT03180684|473365946|FG001|Overall Study|Lost to Follow-up|0|||
131473662|NCT03180684|473365945|FG000|Overall Study|Progressive Disease|1|||
131473663|NCT03180684|473365946|FG001|Overall Study|Progressive Disease|0|||
131473664|NCT00410202|473365948|FG000|On-Treatment|Continuing treatment|69|||
131473665|NCT00410202|473365949|FG001|On-Treatment|Continuing treatment|71|||
131473666|NCT00410202|473365950|FG002|On-Treatment|Continuing treatment|66|||
131473667|NCT00410202|473365948|FG000|On-Treatment|Adverse Event|1|||
131473668|NCT00410202|473365949|FG001|On-Treatment|Adverse Event|3|||
131473669|NCT00410202|473365950|FG002|On-Treatment|Adverse Event|2|||
131473670|NCT00410202|473365948|FG000|On-Treatment|Death|1|||
131473671|NCT00410202|473365949|FG001|On-Treatment|Death|0|||
131473672|NCT00410202|473365950|FG002|On-Treatment|Death|0|||
131473673|NCT00410202|473365948|FG000|On-Treatment|Lost to Follow-up|1|||
131473674|NCT00410202|473365949|FG001|On-Treatment|Lost to Follow-up|0|||
131473675|NCT00410202|473365950|FG002|On-Treatment|Lost to Follow-up|1|||
131473676|NCT00410202|473365948|FG000|On-Treatment|Lack of Efficacy|1|||
131473677|NCT00410202|473365949|FG001|On-Treatment|Lack of Efficacy|4|||
131473678|NCT00410202|473365950|FG002|On-Treatment|Lack of Efficacy|0|||
131770285|NCT01475214|474436183|FG000|Overall Study|Lost to Follow-up|1|||
131770286|NCT01475214|474436184|FG001|Overall Study|Lost to Follow-up|0|||
131770287|NCT01475214|474436185|FG002|Overall Study|Lost to Follow-up|1|||
131770288|NCT01475214|474436183|FG000|Overall Study|Physician Decision|2|||
131473679|NCT00410202|473365948|FG000|On-Treatment|Withdrawal by Subject|2|||
131473680|NCT00410202|473365949|FG001|On-Treatment|Withdrawal by Subject|1|||
131473681|NCT00410202|473365950|FG002|On-Treatment|Withdrawal by Subject|1|||
131473682|NCT00410202|473365948|FG000|On-Treatment|Other Reason|0|||
131473683|NCT00410202|473365949|FG001|On-Treatment|Other Reason|0|||
131473684|NCT00410202|473365950|FG002|On-Treatment|Other Reason|1|||
131473685|NCT00410202|473365948|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
131473686|NCT00410202|473365949|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
131473687|NCT00410202|473365950|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
131473688|NCT00410202|473365948|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
131473689|NCT00410202|473365949|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
131473690|NCT00410202|473365950|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
131473691|NCT00410202|473365948|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
131473692|NCT00410202|473365949|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
131473693|NCT00410202|473365950|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
131473694|NCT00144027|473365952|FG000|Overall Study|Lost to Follow-up|1|||
131473695|NCT00144027|473365953|FG001|Overall Study|Lost to Follow-up|3|||
131473696|NCT00144027|473365952|FG000|Overall Study|Withdrawal by Subject|2|||
131473697|NCT00144027|473365953|FG001|Overall Study|Withdrawal by Subject|2|||
131473698|NCT00144027|473365952|FG000|Overall Study|did not complete baseline assessment|0|||
131473699|NCT00144027|473365953|FG001|Overall Study|did not complete baseline assessment|6|||
131473700|NCT00937391|473365954|FG000|Stage 2|Withdrawal by Subject|1|||
131473701|NCT04597918|473365960|FG000|Overall Study|Withdrawal by Subject|6|||
131473702|NCT04597918|473365960|FG000|Overall Study|Lost to Follow-up|3|||
131473703|NCT04597918|473365960|FG000|Overall Study|Death|1|||
131473704|NCT00395538|473365961|FG000|Overall Study|Did not re-consent to revised protocol|1|||
131473705|NCT00395538|473365962|FG001|Overall Study|Did not re-consent to revised protocol|10|||
131473706|NCT00395538|473365963|FG002|Overall Study|Did not re-consent to revised protocol|0|||
131473707|NCT00395538|473365961|FG000|Overall Study|FDA partial hold on PTH|0|||
131473708|NCT00395538|473365962|FG001|Overall Study|FDA partial hold on PTH|0|||
131473709|NCT00395538|473365963|FG002|Overall Study|FDA partial hold on PTH|11|||
131473710|NCT00395538|473365961|FG000|Overall Study|Failed screening|0|||
131473711|NCT00395538|473365962|FG001|Overall Study|Failed screening|0|||
131473712|NCT00395538|473365963|FG002|Overall Study|Failed screening|4|||
131473713|NCT00395538|473365961|FG000|Overall Study|Switch to Natpara|0|||
131473714|NCT00395538|473365962|FG001|Overall Study|Switch to Natpara|0|||
131473715|NCT00395538|473365963|FG002|Overall Study|Switch to Natpara|3|||
131473716|NCT00395538|473365961|FG000|Overall Study|Adverse Event|1|||
131473717|NCT00395538|473365962|FG001|Overall Study|Adverse Event|0|||
131473718|NCT00395538|473365963|FG002|Overall Study|Adverse Event|2|||
131473719|NCT00395538|473365961|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
131473720|NCT00395538|473365962|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
131473721|NCT00395538|473365963|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
131473722|NCT00395538|473365961|FG000|Overall Study|Non-compliance with study protocol|0|||
131473723|NCT00395538|473365962|FG001|Overall Study|Non-compliance with study protocol|1|||
131473724|NCT00395538|473365963|FG002|Overall Study|Non-compliance with study protocol|0|||
131473725|NCT00395538|473365961|FG000|Overall Study|PTH resistance|0|||
131473726|NCT00395538|473365962|FG001|Overall Study|PTH resistance|0|||
131473727|NCT00395538|473365963|FG002|Overall Study|PTH resistance|1|||
131473728|NCT00395538|473365961|FG000|Overall Study|Pregnancy|1|||
131473729|NCT00395538|473365962|FG001|Overall Study|Pregnancy|0|||
131473730|NCT00395538|473365963|FG002|Overall Study|Pregnancy|0|||
131473731|NCT00395538|473365961|FG000|Overall Study|Partial recovery of parathyroid function|0|||
131473732|NCT00395538|473365962|FG001|Overall Study|Partial recovery of parathyroid function|0|||
131473733|NCT00395538|473365963|FG002|Overall Study|Partial recovery of parathyroid function|1|||
131473734|NCT00395538|473365961|FG000|Overall Study|Participant elected to discontinue|0|||
131473735|NCT00395538|473365962|FG001|Overall Study|Participant elected to discontinue|0|||
131473736|NCT00395538|473365963|FG002|Overall Study|Participant elected to discontinue|1|||
131473737|NCT02211638|473365966|FG000|Overall Study|Case Report Forms Uncollected|291|||
131473738|NCT02211638|473365966|FG000|Overall Study|Protocol Violation|692|||
131473739|NCT04041700|473365969|FG000|Overall Study|Pregnancy|1|||
131473740|NCT04041700|473365969|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
131473741|NCT02775903|473365970|FG000|Overall Study|Death|7|||
131473742|NCT02775903|473365971|FG001|Overall Study|Death|11|||
131473743|NCT02775903|473365972|FG002|Overall Study|Death|12|||
131473744|NCT02775903|473365973|FG003|Overall Study|Death|11|||
131473745|NCT02775903|473365970|FG000|Overall Study|Adverse Event|0|||
131473746|NCT02775903|473365971|FG001|Overall Study|Adverse Event|1|||
131473747|NCT02775903|473365972|FG002|Overall Study|Adverse Event|12|||
131473748|NCT02775903|473365973|FG003|Overall Study|Adverse Event|3|||
131473749|NCT02775903|473365970|FG000|Overall Study|Progressive disease|15|||
131473750|NCT02775903|473365971|FG001|Overall Study|Progressive disease|14|||
131473751|NCT02775903|473365972|FG002|Overall Study|Progressive disease|30|||
131770289|NCT01475214|474436184|FG001|Overall Study|Physician Decision|0|||
131770290|NCT01475214|474436185|FG002|Overall Study|Physician Decision|0|||
131473752|NCT02775903|473365973|FG003|Overall Study|Progressive disease|20|||
131473753|NCT02775903|473365970|FG000|Overall Study|Lack of Efficacy|2|||
131473754|NCT02775903|473365971|FG001|Overall Study|Lack of Efficacy|2|||
131473755|NCT02775903|473365972|FG002|Overall Study|Lack of Efficacy|2|||
131473756|NCT02775903|473365973|FG003|Overall Study|Lack of Efficacy|6|||
131473757|NCT02775903|473365970|FG000|Overall Study|Withdrawal by Subject|7|||
131473758|NCT02775903|473365971|FG001|Overall Study|Withdrawal by Subject|5|||
131473759|NCT02775903|473365972|FG002|Overall Study|Withdrawal by Subject|5|||
131473760|NCT02775903|473365973|FG003|Overall Study|Withdrawal by Subject|8|||
131473761|NCT02775903|473365970|FG000|Overall Study|Other reasons|7|||
131473762|NCT02775903|473365971|FG001|Overall Study|Other reasons|8|||
131473763|NCT02775903|473365972|FG002|Overall Study|Other reasons|2|||
131473764|NCT02775903|473365973|FG003|Overall Study|Other reasons|12|||
131473765|NCT00285207|473365976|FG000|Overall Study|Lost to Follow-up|3|||
131473766|NCT00285207|473365977|FG001|Overall Study|Lost to Follow-up|2|||
131473767|NCT00285207|473365976|FG000|Overall Study|Withdrawal by Subject|5|||
131473768|NCT00285207|473365977|FG001|Overall Study|Withdrawal by Subject|2|||
131473769|NCT00285207|473365976|FG000|Overall Study|Pregnancy|1|||
131473770|NCT00285207|473365977|FG001|Overall Study|Pregnancy|1|||
131473771|NCT00285207|473365976|FG000|Overall Study|non-compliance|0|||
131473772|NCT00285207|473365977|FG001|Overall Study|non-compliance|1|||
131473773|NCT04571515|473365978|FG000|Overall Study|Physician Decision|0|||
131473774|NCT04571515|473365979|FG001|Overall Study|Physician Decision|0|||
131473775|NCT04571515|473365980|FG002|Overall Study|Physician Decision|0|||
131473776|NCT04571515|473365981|FG003|Overall Study|Physician Decision|0|||
131473777|NCT04571515|473365982|FG004|Overall Study|Physician Decision|1|||
131473778|NCT04571515|473365978|FG000|Overall Study|Withdrawal by Subject|0|||
131473779|NCT04571515|473365979|FG001|Overall Study|Withdrawal by Subject|0|||
131473780|NCT04571515|473365980|FG002|Overall Study|Withdrawal by Subject|0|||
131473781|NCT04571515|473365981|FG003|Overall Study|Withdrawal by Subject|0|||
131473782|NCT04571515|473365982|FG004|Overall Study|Withdrawal by Subject|1|||
131473783|NCT04571515|473365978|FG000|Overall Study|insufficient pain|1|||
131473784|NCT04571515|473365979|FG001|Overall Study|insufficient pain|0|||
131473785|NCT04571515|473365980|FG002|Overall Study|insufficient pain|0|||
131473786|NCT04571515|473365981|FG003|Overall Study|insufficient pain|0|||
131473787|NCT04571515|473365982|FG004|Overall Study|insufficient pain|1|||
131473788|NCT05140382|473365983|FG000|Overall Study|Death|3|||
131473789|NCT05140382|473365984|FG001|Overall Study|Death|0|||
131473790|NCT05140382|473365985|FG002|Overall Study|Death|0|||
131473791|NCT05140382|473365983|FG000|Overall Study|Investigator decision|1|||
131473792|NCT05140382|473365984|FG001|Overall Study|Investigator decision|0|||
131473793|NCT05140382|473365985|FG002|Overall Study|Investigator decision|0|||
131473794|NCT05140382|473365983|FG000|Overall Study|Other|4|||
131473795|NCT05140382|473365984|FG001|Overall Study|Other|0|||
131473796|NCT05140382|473365985|FG002|Overall Study|Other|1|||
131473797|NCT05140382|473365983|FG000|Overall Study|Progressive disease|20|||
131473798|NCT05140382|473365984|FG001|Overall Study|Progressive disease|1|||
131473799|NCT05140382|473365985|FG002|Overall Study|Progressive disease|12|||
131473800|NCT05140382|473365983|FG000|Overall Study|Subjective disease progression|2|||
131473801|NCT05140382|473365984|FG001|Overall Study|Subjective disease progression|1|||
131473802|NCT05140382|473365985|FG002|Overall Study|Subjective disease progression|0|||
131473803|NCT05140382|473365983|FG000|Overall Study|Unknown at data cut-off|0|||
131473804|NCT05140382|473365984|FG001|Overall Study|Unknown at data cut-off|0|||
131473805|NCT05140382|473365985|FG002|Overall Study|Unknown at data cut-off|1|||
131473806|NCT05140382|473365983|FG000|Overall Study|Withdrawal by Subject|1|||
131473807|NCT05140382|473365984|FG001|Overall Study|Withdrawal by Subject|0|||
131473808|NCT05140382|473365985|FG002|Overall Study|Withdrawal by Subject|4|||
131473809|NCT05140382|473365983|FG000|Overall Study|Withdrawal of consent|0|||
131473810|NCT05140382|473365984|FG001|Overall Study|Withdrawal of consent|0|||
131473811|NCT05140382|473365985|FG002|Overall Study|Withdrawal of consent|1|||
131473812|NCT05063318|473365990|FG000|Overall Study|Progressive disease|2|||
131473813|NCT05063318|473365991|FG001|Overall Study|Progressive disease|0|||
131473814|NCT05063318|473365992|FG002|Overall Study|Progressive disease|3|||
131473815|NCT05063318|473365990|FG000|Overall Study|Compassionate use|1|||
131473816|NCT05063318|473365991|FG001|Overall Study|Compassionate use|3|||
131473817|NCT05063318|473365992|FG002|Overall Study|Compassionate use|3|||
131473818|NCT05063318|473365990|FG000|Overall Study|Adverse Event|0|||
131473819|NCT05063318|473365991|FG001|Overall Study|Adverse Event|1|||
131473820|NCT05063318|473365992|FG002|Overall Study|Adverse Event|0|||
131473821|NCT05063318|473365990|FG000|Overall Study|Withdrawal by Subject|0|||
131473822|NCT05063318|473365991|FG001|Overall Study|Withdrawal by Subject|1|||
131473823|NCT05063318|473365992|FG002|Overall Study|Withdrawal by Subject|0|||
131473824|NCT03607422|473367578|FG000|Overall Study|Adverse Event|7|||
131473825|NCT03607422|473367579|FG001|Overall Study|Adverse Event|3|||
131473826|NCT03607422|473367580|FG002|Overall Study|Adverse Event|2|||
131473827|NCT03607422|473367581|FG003|Overall Study|Adverse Event|0|||
131473828|NCT03607422|473367582|FG004|Overall Study|Adverse Event|2|||
131473829|NCT03607422|473367583|FG005|Overall Study|Adverse Event|0|||
131473830|NCT03607422|473367578|FG000|Overall Study|Withdrawal by Subject|11|||
131473831|NCT03607422|473367579|FG001|Overall Study|Withdrawal by Subject|3|||
131473832|NCT03607422|473367580|FG002|Overall Study|Withdrawal by Subject|6|||
131473833|NCT03607422|473367581|FG003|Overall Study|Withdrawal by Subject|2|||
131473834|NCT03607422|473367582|FG004|Overall Study|Withdrawal by Subject|0|||
131473835|NCT03607422|473367583|FG005|Overall Study|Withdrawal by Subject|0|||
131473836|NCT03607422|473367578|FG000|Overall Study|Lost to Follow-up|0|||
131473837|NCT03607422|473367579|FG001|Overall Study|Lost to Follow-up|0|||
131473838|NCT03607422|473367580|FG002|Overall Study|Lost to Follow-up|1|||
131473839|NCT03607422|473367581|FG003|Overall Study|Lost to Follow-up|0|||
131473840|NCT03607422|473367582|FG004|Overall Study|Lost to Follow-up|0|||
131473841|NCT03607422|473367583|FG005|Overall Study|Lost to Follow-up|0|||
131473842|NCT03607422|473367578|FG000|Overall Study|Other|12|||
131473843|NCT03607422|473367579|FG001|Overall Study|Other|4|||
131473844|NCT03607422|473367580|FG002|Overall Study|Other|1|||
131473845|NCT03607422|473367581|FG003|Overall Study|Other|2|||
131473846|NCT03607422|473367582|FG004|Overall Study|Other|0|||
131473847|NCT03607422|473367583|FG005|Overall Study|Other|2|||
131473848|NCT03607422|473367578|FG000|Overall Study|Ongoing at Time of Analysis|8|||
131473849|NCT03607422|473367579|FG001|Overall Study|Ongoing at Time of Analysis|0|||
131473850|NCT03607422|473367580|FG002|Overall Study|Ongoing at Time of Analysis|2|||
131473851|NCT03607422|473367581|FG003|Overall Study|Ongoing at Time of Analysis|1|||
131473852|NCT03607422|473367582|FG004|Overall Study|Ongoing at Time of Analysis|1|||
131473853|NCT03607422|473367583|FG005|Overall Study|Ongoing at Time of Analysis|1|||
131473854|NCT03228420|473367590|FG000|Overall Study|Lost to Follow-up|5|||
131473855|NCT03228420|473367591|FG001|Overall Study|Lost to Follow-up|3|||
131473856|NCT03228420|473367590|FG000|Overall Study|Withdrawal by Subject|10|||
131473857|NCT03228420|473367591|FG001|Overall Study|Withdrawal by Subject|0|||
131473858|NCT03228420|473367590|FG000|Overall Study|Adverse Event|5|||
131473859|NCT03228420|473367591|FG001|Overall Study|Adverse Event|2|||
131473860|NCT02428608|473367592|FG000|Overall Study|Pregnancy|2|||
131473861|NCT02428608|473367592|FG000|Overall Study|Lost to Follow-up|37|||
131473862|NCT02428608|473367592|FG000|Overall Study|Withdrawal by Subject|2|||
131473863|NCT02428608|473367592|FG000|Overall Study|scheduling conflicts|15|||
131473864|NCT02428608|473367592|FG000|Overall Study|moved away|10|||
131473865|NCT02428608|473367592|FG000|Overall Study|Death|1|||
131473866|NCT02428608|473367592|FG000|Overall Study|various|16|||
131473867|NCT03468985|473367593|FG000|Overall Study|Adverse Event|0|||
131473868|NCT03468985|473367594|FG001|Overall Study|Adverse Event|2|||
131473869|NCT03468985|473367595|FG002|Overall Study|Adverse Event|0|||
131473870|NCT03468985|473367596|FG003|Overall Study|Adverse Event|0|||
131473871|NCT03468985|473367593|FG000|Overall Study|Withdrawal by Subject|0|||
131473872|NCT03468985|473367594|FG001|Overall Study|Withdrawal by Subject|0|||
131473873|NCT03468985|473367595|FG002|Overall Study|Withdrawal by Subject|0|||
131473874|NCT03468985|473367596|FG003|Overall Study|Withdrawal by Subject|1|||
131473875|NCT00085709|473367597|FG000|Overall Study|Adverse Event|8|||
131473876|NCT00085709|473367598|FG001|Overall Study|Adverse Event|0|||
131473877|NCT00085709|473367597|FG000|Overall Study|Death|8|||
131473878|NCT00085709|473367598|FG001|Overall Study|Death|2|||
131473879|NCT00085709|473367597|FG000|Overall Study|Refusal unrelated to adverse events|1|||
131473880|NCT00085709|473367598|FG001|Overall Study|Refusal unrelated to adverse events|2|||
131473881|NCT00085709|473367597|FG000|Overall Study|Progression|3|||
131473882|NCT00085709|473367598|FG001|Overall Study|Progression|4|||
131473883|NCT00085709|473367597|FG000|Overall Study|Not protocol specified|12|||
131473884|NCT00085709|473367598|FG001|Overall Study|Not protocol specified|22|||
131473885|NCT00085709|473367597|FG000|Overall Study|Not eligible|19|||
131473886|NCT00085709|473367598|FG001|Overall Study|Not eligible|19|||
131473887|NCT00085709|473367597|FG000|Overall Study|Withdrawal by Subject|2|||
131473888|NCT00085709|473367598|FG001|Overall Study|Withdrawal by Subject|1|||
131473889|NCT00397943|473367599|FG000|Overall Study|Unspecified reasons|12|||
131473890|NCT00397943|473367600|FG001|Overall Study|Unspecified reasons|9|||
131473891|NCT00397943|473367601|FG002|Overall Study|Unspecified reasons|0|||
131473892|NCT00397943|473367602|FG003|Overall Study|Unspecified reasons|0|||
131473893|NCT00397943|473367603|FG004|Overall Study|Unspecified reasons|0|||
131473894|NCT04950608|473367604|FG000|Overall Study|Withdrawal by Subject|2|||
131473895|NCT04950608|473367604|FG000|Overall Study|Physician Decision|3|||
131473896|NCT04060862|473367605|FG000|Overall Study|Symptomatic Deterioration|1|||
131473897|NCT04060862|473367605|FG000|Overall Study|Un-specified|6|||
131473898|NCT04060862|473367605|FG000|Overall Study|Progressive disease|12|||
131473899|NCT04060862|473367605|FG000|Overall Study|Physician Decision|1|||
131473900|NCT02007512|473367606|FG000|Double Blind Treatment Period|Adverse Event|4|||
131473901|NCT02007512|473367607|FG001|Double Blind Treatment Period|Adverse Event|6|||
131473902|NCT02007512|473367608|FG002|Double Blind Treatment Period|Adverse Event|2|||
131473903|NCT02007512|473367609|FG003|Double Blind Treatment Period|Adverse Event|2|||
131473904|NCT02007512|473367606|FG000|Double Blind Treatment Period|Death|1|||
131473905|NCT02007512|473367607|FG001|Double Blind Treatment Period|Death|0|||
131473906|NCT02007512|473367608|FG002|Double Blind Treatment Period|Death|0|||
131473907|NCT02007512|473367609|FG003|Double Blind Treatment Period|Death|0|||
131473908|NCT02007512|473367606|FG000|Double Blind Treatment Period|Disease progression|51|||
131473909|NCT02007512|473367607|FG001|Double Blind Treatment Period|Disease progression|50|||
131473910|NCT02007512|473367608|FG002|Double Blind Treatment Period|Disease progression|57|||
131473911|NCT02007512|473367609|FG003|Double Blind Treatment Period|Disease progression|52|||
131473912|NCT02007512|473367606|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
131473913|NCT02007512|473367607|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
131473914|NCT02007512|473367608|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
131473915|NCT02007512|473367609|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
131473916|NCT02007512|473367606|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131473917|NCT02007512|473367607|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131473918|NCT02007512|473367608|FG002|Double Blind Treatment Period|Protocol Violation|0|||
131473919|NCT02007512|473367609|FG003|Double Blind Treatment Period|Protocol Violation|1|||
131473920|NCT02007512|473367606|FG000|Double Blind Treatment Period|Other|2|||
131473921|NCT02007512|473367607|FG001|Double Blind Treatment Period|Other|1|||
131473922|NCT02007512|473367608|FG002|Double Blind Treatment Period|Other|1|||
131473923|NCT02007512|473367609|FG003|Double Blind Treatment Period|Other|2|||
131473924|NCT02007512|473367606|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
131473925|NCT02007512|473367607|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
131473926|NCT02007512|473367608|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
131473927|NCT02007512|473367609|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
131473928|NCT02007512|473367606|FG000|Open Label Treatment Period|Adverse Event|1|||
131473929|NCT02007512|473367607|FG001|Open Label Treatment Period|Adverse Event|0|||
131473930|NCT02007512|473367608|FG002|Open Label Treatment Period|Adverse Event|0|||
131473931|NCT02007512|473367609|FG003|Open Label Treatment Period|Adverse Event|0|||
131473932|NCT02007512|473367606|FG000|Open Label Treatment Period|Other|1|||
131473933|NCT02007512|473367607|FG001|Open Label Treatment Period|Other|1|||
131473934|NCT02007512|473367608|FG002|Open Label Treatment Period|Other|0|||
131473935|NCT02007512|473367609|FG003|Open Label Treatment Period|Other|0|||
131473936|NCT02007512|473367606|FG000|Open Label Treatment Period|Disease progression|23|||
131473937|NCT02007512|473367607|FG001|Open Label Treatment Period|Disease progression|11|||
131473938|NCT02007512|473367608|FG002|Open Label Treatment Period|Disease progression|0|||
131473939|NCT02007512|473367609|FG003|Open Label Treatment Period|Disease progression|0|||
131473940|NCT00608543|473367614|FG000|Overall Study|Adverse Event|4|||
131473941|NCT03416374|473367615|FG000|Between Treatment Period I and II|Other|0|||
131473942|NCT03416374|473367616|FG001|Between Treatment Period I and II|Other|9|||
131473943|NCT03416374|473367615|FG000|Treatment Period II|Lack of Efficacy|3|||
131473944|NCT03416374|473367616|FG001|Treatment Period II|Lack of Efficacy|11|||
131473945|NCT03416374|473367615|FG000|Treatment Period II|Adverse Event|1|||
131473946|NCT03416374|473367616|FG001|Treatment Period II|Adverse Event|4|||
131473947|NCT03416374|473367615|FG000|Treatment Period II|Death|0|||
131473948|NCT03416374|473367616|FG001|Treatment Period II|Death|1|||
131473949|NCT03416374|473367615|FG000|Treatment Period II|Other|0|||
131473950|NCT03416374|473367616|FG001|Treatment Period II|Other|2|||
131473951|NCT00214500|473367624|FG000|Treatment Period|Adverse Event|1|||
131473952|NCT00214500|473367624|FG000|Extension Period|Withdrawal by Subject|2|||
131473953|NCT00147251|473367625|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
131473954|NCT00147251|473367626|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
131473955|NCT01629706|473367627|FG000|Phase 1 PureVision|Screen Failure|4|||
131473956|NCT01629706|473367627|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
131473957|NCT01629706|473367627|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
131473958|NCT01629706|473367627|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
131473959|NCT01629706|473367627|FG000|Phase 2 Habitual|Screen Failure|6|||
131473960|NCT01629706|473367627|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
131473961|NCT01629706|473367627|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
131473962|NCT01629706|473367627|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
131473963|NCT01629706|473367627|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
131473964|NCT03595774|473367628|FG000|Overall Study|Adverse Event|1|||
131473965|NCT03595774|473367629|FG001|Overall Study|Adverse Event|0|||
131473966|NCT03595774|473367630|FG002|Overall Study|Adverse Event|1|||
131473967|NCT03595774|473367631|FG003|Overall Study|Adverse Event|0|||
131473968|NCT03595774|473367628|FG000|Overall Study|screen failure|0|||
131473969|NCT03595774|473367629|FG001|Overall Study|screen failure|1|||
131473970|NCT03595774|473367630|FG002|Overall Study|screen failure|0|||
131473971|NCT03595774|473367631|FG003|Overall Study|screen failure|1|||
131473972|NCT01151098|473367632|FG000|Overall Study|Adverse Event|82|||
131473973|NCT01151098|473367632|FG000|Overall Study|Lost to Follow-up|6|||
131473974|NCT01151098|473367632|FG000|Overall Study|Lack of Efficacy|15|||
131473975|NCT01151098|473367632|FG000|Overall Study|Protocol Violation|1|||
131473976|NCT01151098|473367632|FG000|Overall Study|Miscellaneous|13|||
131473977|NCT03343067|473367639|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
131473978|NCT03343067|473367640|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
131473979|NCT03343067|473367641|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
131473980|NCT00116168|473367642|FG000|Overall Study|Lost to Follow-up|6|||
131473981|NCT00116168|473367643|FG001|Overall Study|Lost to Follow-up|5|||
131473982|NCT00116168|473367644|FG002|Overall Study|Lost to Follow-up|0|||
131473983|NCT00116168|473367645|FG003|Overall Study|Lost to Follow-up|0|||
131473984|NCT02788474|473367646|FG000|Double Blind Treatment Period|Not treated|1|||
131473985|NCT02788474|473367647|FG001|Double Blind Treatment Period|Not treated|0|||
131473986|NCT02788474|473367646|FG000|Double Blind Treatment Period|Patient's refusal|3|||
131473987|NCT02788474|473367647|FG001|Double Blind Treatment Period|Patient's refusal|0|||
131473988|NCT02788474|473367646|FG000|Double Blind Treatment Period|Adverse Event|6|||
131473989|NCT02788474|473367647|FG001|Double Blind Treatment Period|Adverse Event|4|||
131473990|NCT02788474|473367646|FG000|Open Label Treatment Period|Adverse Event|29|||
131473991|NCT02788474|473367647|FG001|Open Label Treatment Period|Adverse Event|9|||
131473992|NCT02788474|473367646|FG000|Open Label Treatment Period|Other than reason specified|1|||
131473993|NCT02788474|473367647|FG001|Open Label Treatment Period|Other than reason specified|0|||
131473994|NCT02788474|473367646|FG000|Open Label Treatment Period|Patient's refusal|1|||
131473995|NCT02788474|473367647|FG001|Open Label Treatment Period|Patient's refusal|3|||
131473996|NCT02788474|473367646|FG000|Open Label Treatment Period|Non-compliance|1|||
131473997|NCT02788474|473367647|FG001|Open Label Treatment Period|Non-compliance|0|||
131473998|NCT01243671|473367649|FG000|Overall Study|Adverse Event|3|||
131473999|NCT01243671|473367649|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
131474000|NCT01243671|473367649|FG000|Overall Study|Other|1|||
131474001|NCT02169284|473367657|FG000|Overall Study|Physician Decision|0|||
131474002|NCT02169284|473367658|FG001|Overall Study|Physician Decision|1|||
131474003|NCT00984568|473367659|FG000|Overall Study|Withdrawal by Subject|1|||
131474004|NCT00984568|473367660|FG001|Overall Study|Withdrawal by Subject|2|||
131474005|NCT00984568|473367659|FG000|Overall Study|Lack of Efficacy|2|||
131474006|NCT00984568|473367660|FG001|Overall Study|Lack of Efficacy|0|||
131474007|NCT00984568|473367659|FG000|Overall Study|Adverse Event|2|||
131474008|NCT00984568|473367660|FG001|Overall Study|Adverse Event|0|||
131474009|NCT00984568|473367659|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
131474010|NCT00984568|473367660|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
131474011|NCT00984568|473367659|FG000|Overall Study|Lost to Follow-up|0|||
131474012|NCT00984568|473367660|FG001|Overall Study|Lost to Follow-up|1|||
131474013|NCT00984568|473367659|FG000|Overall Study|Opportunistic Infection|1|||
131474014|NCT00984568|473367660|FG001|Overall Study|Opportunistic Infection|0|||
131474015|NCT00984568|473367659|FG000|Overall Study|Unknown Reason|1|||
131474016|NCT00984568|473367660|FG001|Overall Study|Unknown Reason|3|||
131474017|NCT00573248|473367661|FG000|Overall Study|scheduling conflicts|15|||
131770291|NCT01475214|474436183|FG000|Overall Study|Withdrawal by Subject|2|||
131770292|NCT01475214|474436184|FG001|Overall Study|Withdrawal by Subject|4|||
131770293|NCT01475214|474436185|FG002|Overall Study|Withdrawal by Subject|1|||
131882083|NCT03045276|474849337|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
131882084|NCT03045276|474849334|FG000|Follow-Up Phase|Lost to Follow-up|0|||
131474018|NCT00573248|473367662|FG001|Overall Study|scheduling conflicts|11|||
131474019|NCT03583073|473367663|FG000|Overall Study|Lost to Follow-up|8|||
131474020|NCT03583073|473367664|FG001|Overall Study|Lost to Follow-up|12|||
131474021|NCT05342532|473367665|FG000|Overall Study|Adverse Event|5|||
131474022|NCT05342532|473367666|FG001|Overall Study|Adverse Event|20|||
131474023|NCT05342532|473367665|FG000|Overall Study|Lost to Follow-up|10|||
131474024|NCT05342532|473367666|FG001|Overall Study|Lost to Follow-up|15|||
131474025|NCT02675231|473367667|FG000|Overall Study|Withdrawal by Subject|2|||
131474026|NCT02675231|473367668|FG001|Overall Study|Withdrawal by Subject|4|||
131474027|NCT02675231|473367669|FG002|Overall Study|Withdrawal by Subject|2|||
131474028|NCT02675231|473367667|FG000|Overall Study|Lost to Follow-up|3|||
131474029|NCT02675231|473367668|FG001|Overall Study|Lost to Follow-up|4|||
131474030|NCT02675231|473367669|FG002|Overall Study|Lost to Follow-up|3|||
131474031|NCT02273739|473367673|FG000|Overall Study|Progression of Disease|3|||
131474032|NCT02273739|473367674|FG001|Overall Study|Progression of Disease|4|||
131474033|NCT02273739|473367675|FG002|Overall Study|Progression of Disease|5|||
131474034|NCT02273739|473367676|FG003|Overall Study|Progression of Disease|2|||
131474035|NCT02273739|473367673|FG000|Overall Study|Death|0|||
131474036|NCT02273739|473367674|FG001|Overall Study|Death|0|||
131474037|NCT02273739|473367675|FG002|Overall Study|Death|0|||
131474038|NCT02273739|473367676|FG003|Overall Study|Death|2|||
131474039|NCT02273739|473367673|FG000|Overall Study|Adverse Event|0|||
131882085|NCT03045276|474849335|FG001|Follow-Up Phase|Lost to Follow-up|1|||
131882086|NCT03045276|474849336|FG002|Follow-Up Phase|Lost to Follow-up|0|||
131474040|NCT02273739|473367674|FG001|Overall Study|Adverse Event|0|||
131474041|NCT02273739|473367675|FG002|Overall Study|Adverse Event|0|||
131474042|NCT02273739|473367676|FG003|Overall Study|Adverse Event|1|||
131474043|NCT02273739|473367673|FG000|Overall Study|Withdrawal by Subject|0|||
131474044|NCT02273739|473367674|FG001|Overall Study|Withdrawal by Subject|0|||
131474045|NCT02273739|473367675|FG002|Overall Study|Withdrawal by Subject|2|||
131474046|NCT02273739|473367676|FG003|Overall Study|Withdrawal by Subject|1|||
131474047|NCT02273739|473367673|FG000|Overall Study|Physician Decision|0|||
131474048|NCT02273739|473367674|FG001|Overall Study|Physician Decision|0|||
131474049|NCT02273739|473367675|FG002|Overall Study|Physician Decision|0|||
131474050|NCT02273739|473367676|FG003|Overall Study|Physician Decision|1|||
131882087|NCT03045276|474849337|FG003|Follow-Up Phase|Lost to Follow-up|1|||
131882088|NCT03045276|474849334|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
131882089|NCT03045276|474849335|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
131474051|NCT02536833|473367677|FG000|Overall Study|Discontinued Before Treatment|0|||
131474052|NCT02536833|473367678|FG001|Overall Study|Discontinued Before Treatment|0|||
131474053|NCT02536833|473367679|FG002|Overall Study|Discontinued Before Treatment|1|||
131474054|NCT02536833|473367680|FG003|Overall Study|Discontinued Before Treatment|2|||
131474055|NCT02536833|473367677|FG000|Overall Study|Adverse Event|1|||
131474056|NCT02536833|473367678|FG001|Overall Study|Adverse Event|3|||
131474057|NCT02536833|473367679|FG002|Overall Study|Adverse Event|4|||
131474058|NCT02536833|473367680|FG003|Overall Study|Adverse Event|1|||
131474059|NCT02536833|473367677|FG000|Overall Study|Lost to Follow-up|2|||
131474060|NCT02536833|473367678|FG001|Overall Study|Lost to Follow-up|1|||
131474061|NCT02536833|473367679|FG002|Overall Study|Lost to Follow-up|2|||
131474062|NCT02536833|473367680|FG003|Overall Study|Lost to Follow-up|2|||
131474063|NCT02536833|473367677|FG000|Overall Study|Physician Decision|0|||
131474064|NCT02536833|473367678|FG001|Overall Study|Physician Decision|0|||
131474065|NCT02536833|473367679|FG002|Overall Study|Physician Decision|0|||
131474066|NCT02536833|473367680|FG003|Overall Study|Physician Decision|1|||
131474067|NCT02536833|473367677|FG000|Overall Study|Site Terminated by Sponsor|2|||
131474068|NCT02536833|473367678|FG001|Overall Study|Site Terminated by Sponsor|2|||
131474069|NCT02536833|473367679|FG002|Overall Study|Site Terminated by Sponsor|2|||
131474070|NCT02536833|473367680|FG003|Overall Study|Site Terminated by Sponsor|2|||
131474071|NCT02536833|473367677|FG000|Overall Study|Subject Non-Compliance|0|||
131474072|NCT02536833|473367678|FG001|Overall Study|Subject Non-Compliance|1|||
131474073|NCT02536833|473367679|FG002|Overall Study|Subject Non-Compliance|1|||
131474074|NCT02536833|473367680|FG003|Overall Study|Subject Non-Compliance|0|||
131474075|NCT02536833|473367677|FG000|Overall Study|Withdrawal by Subject|4|||
131474076|NCT02536833|473367678|FG001|Overall Study|Withdrawal by Subject|3|||
131474077|NCT02536833|473367679|FG002|Overall Study|Withdrawal by Subject|5|||
131474078|NCT02536833|473367680|FG003|Overall Study|Withdrawal by Subject|11|||
131474079|NCT03370289|473367681|FG000|Overall Study|Screen Failure|1|||
131474080|NCT03370289|473367681|FG000|Overall Study|Sample Size Sufficient|4|||
131474081|NCT02220998|473367683|FG000|Overall Study|Randomized but Never Treated|1|||
131474082|NCT02220998|473367684|FG001|Overall Study|Randomized but Never Treated|2|||
131474083|NCT02220998|473367683|FG000|Overall Study|Death|2|||
131474084|NCT02220998|473367684|FG001|Overall Study|Death|0|||
131474085|NCT02220998|473367683|FG000|Overall Study|Lack of Efficacy|0|||
131474086|NCT02220998|473367684|FG001|Overall Study|Lack of Efficacy|5|||
131474087|NCT02220998|473367683|FG000|Overall Study|Lost to Follow-up|4|||
131474088|NCT02220998|473367684|FG001|Overall Study|Lost to Follow-up|4|||
131474089|NCT02314143|473367685|FG000|Overall Study|Adverse Event|0|||
131474090|NCT02314143|473367686|FG001|Overall Study|Adverse Event|6|||
131474091|NCT02314143|473367687|FG002|Overall Study|Adverse Event|4|||
131474092|NCT02314143|473367685|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
131474093|NCT02314143|473367686|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
131474094|NCT02314143|473367687|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
131474095|NCT02314143|473367685|FG000|Overall Study|Physician Decision|2|||
131474096|NCT02314143|473367686|FG001|Overall Study|Physician Decision|1|||
131474097|NCT02314143|473367687|FG002|Overall Study|Physician Decision|0|||
131474098|NCT02314143|473367685|FG000|Overall Study|Withdrawal by Subject|1|||
131474099|NCT02314143|473367686|FG001|Overall Study|Withdrawal by Subject|0|||
131474100|NCT02314143|473367687|FG002|Overall Study|Withdrawal by Subject|1|||
131474101|NCT02764190|473367688|FG000|Overall Study|Lost to Follow-up|17|||
131474102|NCT02764190|473367689|FG001|Overall Study|Lost to Follow-up|13|||
131474103|NCT04223232|473367696|FG000|Overall Study|Withdrawal by Subject|1|||
131474104|NCT02393690|473367697|FG000|Overall Study|Ineligible|0|||
131474105|NCT02393690|473367698|FG001|Overall Study|Ineligible|1|||
131474106|NCT03187756|473367699|FG000|Overall Study|Termination of study|4|||
131474107|NCT03172910|473369361|FG000|Overall Study|Adverse Event|0|||
131474108|NCT03172910|473369362|FG001|Overall Study|Adverse Event|0|||
131474109|NCT03172910|473369363|FG002|Overall Study|Adverse Event|0|||
131474110|NCT03172910|473369364|FG003|Overall Study|Adverse Event|0|||
131474111|NCT03172910|473369365|FG004|Overall Study|Adverse Event|1|||
131474112|NCT01659658|473369368|FG000|Overall Study|Withdrawal by Patient|18|||
131474113|NCT01659658|473369369|FG001|Overall Study|Withdrawal by Patient|4|||
131474114|NCT01659658|473369370|FG002|Overall Study|Withdrawal by Patient|2|||
131474115|NCT01659658|473369371|FG003|Overall Study|Withdrawal by Patient|0|||
131474116|NCT01659658|473369372|FG004|Overall Study|Withdrawal by Patient|11|||
131474117|NCT01659658|473369368|FG000|Overall Study|Study Terminated by Sponsor|9|||
131474118|NCT01659658|473369369|FG001|Overall Study|Study Terminated by Sponsor|7|||
131474119|NCT01659658|473369370|FG002|Overall Study|Study Terminated by Sponsor|0|||
131474120|NCT01659658|473369371|FG003|Overall Study|Study Terminated by Sponsor|1|||
131474121|NCT01659658|473369372|FG004|Overall Study|Study Terminated by Sponsor|4|||
131474122|NCT01659658|473369368|FG000|Overall Study|Reason not Specified|61|||
131474123|NCT01659658|473369369|FG001|Overall Study|Reason not Specified|15|||
131474124|NCT01659658|473369370|FG002|Overall Study|Reason not Specified|8|||
131474125|NCT01659658|473369371|FG003|Overall Study|Reason not Specified|1|||
131474126|NCT01659658|473369372|FG004|Overall Study|Reason not Specified|34|||
131474127|NCT01659658|473369368|FG000|Overall Study|Lost to Follow-up|2|||
131474128|NCT01659658|473369369|FG001|Overall Study|Lost to Follow-up|0|||
131474129|NCT01659658|473369370|FG002|Overall Study|Lost to Follow-up|0|||
131474130|NCT01659658|473369371|FG003|Overall Study|Lost to Follow-up|0|||
131474131|NCT01659658|473369372|FG004|Overall Study|Lost to Follow-up|0|||
131474132|NCT01927341|473369374|FG000|Phase 1b|Lost to Follow-up|1|||
131474133|NCT01927341|473369375|FG001|Phase 1b|Lost to Follow-up|0|||
131474134|NCT01927341|473369376|FG002|Phase 1b|Lost to Follow-up|0|||
131474135|NCT01927341|473369377|FG003|Phase 1b|Lost to Follow-up|0|||
131474136|NCT01927341|473369378|FG004|Phase 1b|Lost to Follow-up|0|||
131474137|NCT01927341|473369374|FG000|Phase 1b|Death|2|||
131474138|NCT01927341|473369375|FG001|Phase 1b|Death|0|||
131474139|NCT01927341|473369376|FG002|Phase 1b|Death|0|||
131474140|NCT01927341|473369377|FG003|Phase 1b|Death|0|||
131474141|NCT01927341|473369378|FG004|Phase 1b|Death|0|||
131474142|NCT01927341|473369374|FG000|Phase 1b|Follow-up completed|7|||
131474143|NCT01927341|473369375|FG001|Phase 1b|Follow-up completed|0|||
131474144|NCT01927341|473369376|FG002|Phase 1b|Follow-up completed|0|||
131474145|NCT01927341|473369377|FG003|Phase 1b|Follow-up completed|0|||
131474146|NCT01927341|473369378|FG004|Phase 1b|Follow-up completed|0|||
131474147|NCT01927341|473369374|FG000|Phase 2|Lost to Follow-up|0|||
131474148|NCT01927341|473369375|FG001|Phase 2|Lost to Follow-up|1|||
131474149|NCT01927341|473369376|FG002|Phase 2|Lost to Follow-up|0|||
131474150|NCT01927341|473369377|FG003|Phase 2|Lost to Follow-up|0|||
131474151|NCT01927341|473369378|FG004|Phase 2|Lost to Follow-up|0|||
131474152|NCT01927341|473369374|FG000|Phase 2|Participant withdrew consent|0|||
131474153|NCT01927341|473369375|FG001|Phase 2|Participant withdrew consent|2|||
131474154|NCT01927341|473369376|FG002|Phase 2|Participant withdrew consent|1|||
131474155|NCT01927341|473369377|FG003|Phase 2|Participant withdrew consent|2|||
131474156|NCT01927341|473369378|FG004|Phase 2|Participant withdrew consent|3|||
131474157|NCT01927341|473369374|FG000|Phase 2|Death|0|||
131474158|NCT01927341|473369375|FG001|Phase 2|Death|4|||
131474159|NCT01927341|473369376|FG002|Phase 2|Death|0|||
131474160|NCT01927341|473369377|FG003|Phase 2|Death|3|||
131474161|NCT01927341|473369378|FG004|Phase 2|Death|2|||
131474162|NCT01927341|473369374|FG000|Phase 2|New cancer therapy|0|||
131474163|NCT01927341|473369375|FG001|Phase 2|New cancer therapy|1|||
131474164|NCT01927341|473369376|FG002|Phase 2|New cancer therapy|0|||
131474165|NCT01927341|473369377|FG003|Phase 2|New cancer therapy|4|||
131474166|NCT01927341|473369378|FG004|Phase 2|New cancer therapy|1|||
131474167|NCT01927341|473369374|FG000|Phase 2|Disease progression|0|||
131474168|NCT01927341|473369375|FG001|Phase 2|Disease progression|1|||
131474169|NCT01927341|473369376|FG002|Phase 2|Disease progression|1|||
131474170|NCT01927341|473369377|FG003|Phase 2|Disease progression|1|||
131474171|NCT01927341|473369378|FG004|Phase 2|Disease progression|0|||
131474172|NCT01927341|473369374|FG000|Phase 2|Follow-up completed|0|||
131474173|NCT01927341|473369375|FG001|Phase 2|Follow-up completed|6|||
131474174|NCT01927341|473369376|FG002|Phase 2|Follow-up completed|3|||
131474175|NCT01927341|473369377|FG003|Phase 2|Follow-up completed|5|||
131474176|NCT01927341|473369378|FG004|Phase 2|Follow-up completed|2|||
131474177|NCT01397201|473369379|FG000|Overall Study|Not treated|0|||
131474178|NCT01397201|473369380|FG001|Overall Study|Not treated|0|||
131474179|NCT01397201|473369381|FG002|Overall Study|Not treated|1|||
131474180|NCT01397201|473369382|FG003|Overall Study|Not treated|0|||
131474181|NCT01397201|473369383|FG004|Overall Study|Not treated|0|||
131474182|NCT01397201|473369379|FG000|Overall Study|Not yet defined|3|||
131474183|NCT01397201|473369380|FG001|Overall Study|Not yet defined|6|||
131474184|NCT01397201|473369381|FG002|Overall Study|Not yet defined|5|||
131474185|NCT01397201|473369382|FG003|Overall Study|Not yet defined|5|||
131474186|NCT01397201|473369383|FG004|Overall Study|Not yet defined|4|||
131474187|NCT01397201|473369379|FG000|Overall Study|Adverse Event|2|||
131474188|NCT01397201|473369380|FG001|Overall Study|Adverse Event|0|||
131474189|NCT01397201|473369381|FG002|Overall Study|Adverse Event|0|||
131474190|NCT01397201|473369382|FG003|Overall Study|Adverse Event|0|||
131474191|NCT01397201|473369383|FG004|Overall Study|Adverse Event|0|||
131474192|NCT00215683|473369384|FG000|Overall Study|Adverse Event|15|||
131474193|NCT00215683|473369385|FG001|Overall Study|Adverse Event|16|||
131474194|NCT00215683|473369386|FG002|Overall Study|Adverse Event|15|||
131474195|NCT00215683|473369384|FG000|Overall Study|Lack of Efficacy|5|||
131474196|NCT00215683|473369385|FG001|Overall Study|Lack of Efficacy|1|||
131474197|NCT00215683|473369386|FG002|Overall Study|Lack of Efficacy|2|||
131474198|NCT00215683|473369384|FG000|Overall Study|Lost to Follow-up|0|||
131474199|NCT00215683|473369385|FG001|Overall Study|Lost to Follow-up|2|||
131474200|NCT00215683|473369386|FG002|Overall Study|Lost to Follow-up|1|||
131474201|NCT00215683|473369384|FG000|Overall Study|Withdrawal by Subject|9|||
131474202|NCT00215683|473369385|FG001|Overall Study|Withdrawal by Subject|4|||
131474203|NCT00215683|473369386|FG002|Overall Study|Withdrawal by Subject|13|||
131474204|NCT00215683|473369384|FG000|Overall Study|Physician Decision|0|||
131474205|NCT00215683|473369385|FG001|Overall Study|Physician Decision|0|||
131474206|NCT00215683|473369386|FG002|Overall Study|Physician Decision|1|||
131474207|NCT00215683|473369384|FG000|Overall Study|Difficult to attend visits|0|||
131474208|NCT00215683|473369385|FG001|Overall Study|Difficult to attend visits|1|||
131474209|NCT00215683|473369386|FG002|Overall Study|Difficult to attend visits|0|||
131474210|NCT00215683|473369384|FG000|Overall Study|No study drug available|0|||
131474211|NCT00215683|473369385|FG001|Overall Study|No study drug available|1|||
131474212|NCT00215683|473369386|FG002|Overall Study|No study drug available|0|||
131474213|NCT00215683|473369384|FG000|Overall Study|Intermittent therapy required|0|||
131474214|NCT00215683|473369385|FG001|Overall Study|Intermittent therapy required|1|||
131474215|NCT00215683|473369386|FG002|Overall Study|Intermittent therapy required|0|||
131474216|NCT01083485|473369387|FG000|Overall Study|Adverse Event|0|||
131474217|NCT01083485|473369388|FG001|Overall Study|Adverse Event|1|||
131474218|NCT01083485|473369387|FG000|Overall Study|Protocol Violation|1|||
131474219|NCT01083485|473369388|FG001|Overall Study|Protocol Violation|0|||
131474220|NCT01083485|473369387|FG000|Overall Study|Withdrawal by Subject|5|||
131474221|NCT01083485|473369388|FG001|Overall Study|Withdrawal by Subject|2|||
131474222|NCT01083485|473369387|FG000|Overall Study|Other|1|||
131474223|NCT01083485|473369388|FG001|Overall Study|Other|0|||
131474224|NCT04493333|473369395|FG000|Overall Study|Withdrawal by Subject|1|||
131474225|NCT04493333|473369396|FG001|Overall Study|Withdrawal by Subject|1|||
131474226|NCT04493333|473369395|FG000|Overall Study|Ineligible|0|||
131474227|NCT04493333|473369396|FG001|Overall Study|Ineligible|1|||
131474228|NCT04493333|473369395|FG000|Overall Study|Noncompliance|2|||
131474229|NCT04493333|473369396|FG001|Overall Study|Noncompliance|1|||
131474230|NCT00451451|473369399|FG000|Overall Study|Adverse Event|11|||
131474231|NCT00451451|473369400|FG001|Overall Study|Adverse Event|21|||
131474232|NCT00451451|473369401|FG002|Overall Study|Adverse Event|26|||
131474233|NCT00451451|473369402|FG003|Overall Study|Adverse Event|10|||
131474234|NCT00451451|473369399|FG000|Overall Study|Lost to Follow-up|11|||
131474235|NCT00451451|473369400|FG001|Overall Study|Lost to Follow-up|9|||
131474236|NCT00451451|473369401|FG002|Overall Study|Lost to Follow-up|8|||
131474237|NCT00451451|473369402|FG003|Overall Study|Lost to Follow-up|11|||
131474238|NCT00451451|473369399|FG000|Overall Study|Consent Withdrawn|14|||
131474239|NCT00451451|473369400|FG001|Overall Study|Consent Withdrawn|9|||
131474240|NCT00451451|473369401|FG002|Overall Study|Consent Withdrawn|17|||
131474241|NCT00451451|473369402|FG003|Overall Study|Consent Withdrawn|17|||
131474242|NCT00451451|473369399|FG000|Overall Study|Investigator Decision|6|||
131474243|NCT00451451|473369400|FG001|Overall Study|Investigator Decision|2|||
131474244|NCT00451451|473369401|FG002|Overall Study|Investigator Decision|1|||
131474245|NCT00451451|473369402|FG003|Overall Study|Investigator Decision|2|||
131474246|NCT00451451|473369399|FG000|Overall Study|Subject Non-Compliance|8|||
131474247|NCT00451451|473369400|FG001|Overall Study|Subject Non-Compliance|4|||
131474248|NCT00451451|473369401|FG002|Overall Study|Subject Non-Compliance|3|||
131474249|NCT00451451|473369402|FG003|Overall Study|Subject Non-Compliance|3|||
131474250|NCT00451451|473369399|FG000|Overall Study|Death|1|||
131474251|NCT00451451|473369400|FG001|Overall Study|Death|0|||
131474252|NCT00451451|473369401|FG002|Overall Study|Death|0|||
131474253|NCT00451451|473369402|FG003|Overall Study|Death|1|||
131474254|NCT00451451|473369399|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
131474255|NCT00451451|473369400|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
131474256|NCT00451451|473369401|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
131474257|NCT00451451|473369402|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
131474258|NCT00084838|473369403|FG000|Overall Study|Death|1|||
131474259|NCT00084838|473369403|FG000|Overall Study|Adverse Event|2|||
131474260|NCT00084838|473369403|FG000|Overall Study|Withdrawal by Subject|1|||
131474261|NCT00084838|473369403|FG000|Overall Study|Progressive Disease|4|||
131474262|NCT00084838|473369403|FG000|Overall Study|Pt Non-Compliance|1|||
131474263|NCT00084838|473369403|FG000|Overall Study|Ineligible|4|||
131474264|NCT00122278|473369404|FG000|Overall Study|Lost to Follow-up|2|||
131474265|NCT00122278|473369405|FG001|Overall Study|Lost to Follow-up|0|||
131474266|NCT01002482|473369406|FG000|Overall Study|Withdrawal by Subject|14|||
131474267|NCT01002482|473369407|FG001|Overall Study|Withdrawal by Subject|21|||
131474268|NCT01002482|473369406|FG000|Overall Study|Included twice|1|||
131474269|NCT01002482|473369407|FG001|Overall Study|Included twice|0|||
131474270|NCT01865084|473369408|FG000|Double Blind Period (DB)|Adverse Event|2|||
131474271|NCT01865084|473369409|FG001|Double Blind Period (DB)|Adverse Event|2|||
131474272|NCT01865084|473369410|FG002|Double Blind Period (DB)|Adverse Event|1|||
131474273|NCT01865084|473369408|FG000|Double Blind Period (DB)|Protocol Violation|0|||
131474274|NCT01865084|473369409|FG001|Double Blind Period (DB)|Protocol Violation|0|||
131474275|NCT01865084|473369410|FG002|Double Blind Period (DB)|Protocol Violation|1|||
131474276|NCT01865084|473369408|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
131474277|NCT01865084|473369409|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
131474278|NCT01865084|473369410|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
131474279|NCT01865084|473369408|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
131474280|NCT01865084|473369409|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
131474281|NCT01865084|473369410|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
131474282|NCT01865084|473369408|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
131474283|NCT01865084|473369409|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
131474284|NCT01865084|473369410|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
131474285|NCT01865084|473369408|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
131474286|NCT01865084|473369409|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
131474287|NCT01865084|473369410|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
131474288|NCT01865084|473369408|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
131474289|NCT01865084|473369409|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
131474290|NCT01865084|473369410|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
131474291|NCT01865084|473369408|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
131474292|NCT01865084|473369409|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
131474293|NCT01865084|473369410|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
131474294|NCT01865084|473369408|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
131474295|NCT01865084|473369409|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
131474296|NCT01865084|473369410|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
131474297|NCT01801072|473369411|FG000|Overall Study|Lost to Follow-up|17|||
131474298|NCT01801072|473369412|FG001|Overall Study|Lost to Follow-up|14|||
131474299|NCT01801072|473369411|FG000|Overall Study|Physician Decision|2|||
131474300|NCT01801072|473369412|FG001|Overall Study|Physician Decision|3|||
131474301|NCT01801072|473369411|FG000|Overall Study|Withdrawal by Subject|1|||
131474302|NCT01801072|473369412|FG001|Overall Study|Withdrawal by Subject|0|||
131474303|NCT01801072|473369411|FG000|Overall Study|Protocol Violation|2|||
131474304|NCT01801072|473369412|FG001|Overall Study|Protocol Violation|0|||
131474305|NCT01801072|473369411|FG000|Overall Study|Death|7|||
131474306|NCT01801072|473369412|FG001|Overall Study|Death|8|||
131474307|NCT03693170|473369413|FG000|Overall Study|Disease Progression|48|||
131474308|NCT03693170|473369413|FG000|Overall Study|Adverse Event|16|||
131474309|NCT03693170|473369413|FG000|Overall Study|Physician Decision|6|||
131474310|NCT03693170|473369413|FG000|Overall Study|Protocol Violation|2|||
131474311|NCT03693170|473369413|FG000|Overall Study|Death|1|||
131474312|NCT03693170|473369413|FG000|Overall Study|Non compliance with study drug|1|||
131474313|NCT03693170|473369413|FG000|Overall Study|Withdrawal by Subject|1|||
131474314|NCT02247531|473369414|FG000|Overall Study|Adverse Event|3|||
131474315|NCT02247531|473369415|FG001|Overall Study|Adverse Event|4|||
131474316|NCT02247531|473369416|FG002|Overall Study|Adverse Event|9|||
131474317|NCT02247531|473369414|FG000|Overall Study|Death|8|||
131474318|NCT02247531|473369415|FG001|Overall Study|Death|9|||
131474319|NCT02247531|473369416|FG002|Overall Study|Death|5|||
131474320|NCT02247531|473369414|FG000|Overall Study|Lost to Follow-up|1|||
131474321|NCT02247531|473369415|FG001|Overall Study|Lost to Follow-up|8|||
131474322|NCT02247531|473369416|FG002|Overall Study|Lost to Follow-up|3|||
131474323|NCT02247531|473369414|FG000|Overall Study|Non-compliance|2|||
131474324|NCT02247531|473369415|FG001|Overall Study|Non-compliance|2|||
131474325|NCT02247531|473369416|FG002|Overall Study|Non-compliance|0|||
131474326|NCT02247531|473369414|FG000|Overall Study|Withdrawal by Subject|26|||
131474327|NCT02247531|473369415|FG001|Overall Study|Withdrawal by Subject|31|||
131474328|NCT02247531|473369416|FG002|Overall Study|Withdrawal by Subject|25|||
131474329|NCT02247531|473369414|FG000|Overall Study|Study Terminated by Sponsor|64|||
131474330|NCT02247531|473369415|FG001|Overall Study|Study Terminated by Sponsor|66|||
131474331|NCT02247531|473369416|FG002|Overall Study|Study Terminated by Sponsor|62|||
131474332|NCT02247531|473369414|FG000|Overall Study|Physician Decision|0|||
131474333|NCT02247531|473369415|FG001|Overall Study|Physician Decision|2|||
131474334|NCT02247531|473369416|FG002|Overall Study|Physician Decision|2|||
131474335|NCT02247531|473369414|FG000|Overall Study|Unspecified Reason|2|||
131474336|NCT02247531|473369415|FG001|Overall Study|Unspecified Reason|3|||
131474337|NCT02247531|473369416|FG002|Overall Study|Unspecified Reason|4|||
131474338|NCT01442038|473369419|FG000|Overall Study|Death|35|||
131474339|NCT01442038|473369420|FG001|Overall Study|Death|29|||
131474340|NCT01442038|473369419|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
131474341|NCT01442038|473369420|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
131474342|NCT01442038|473369419|FG000|Overall Study|Participant Withdrew Consent|137|||
131474343|NCT01442038|473369420|FG001|Overall Study|Participant Withdrew Consent|102|||
131474344|NCT01442038|473369419|FG000|Overall Study|Lost to Follow-up|37|||
131474345|NCT01442038|473369420|FG001|Overall Study|Lost to Follow-up|51|||
131474346|NCT01442038|473369419|FG000|Overall Study|Adverse Event|26|||
131474347|NCT01442038|473369420|FG001|Overall Study|Adverse Event|15|||
131474348|NCT01442038|473369419|FG000|Overall Study|Protocol Deviation|9|||
131474349|NCT01442038|473369420|FG001|Overall Study|Protocol Deviation|20|||
131474350|NCT01442038|473369419|FG000|Overall Study|Investigator's Discretion|13|||
131474351|NCT01442038|473369420|FG001|Overall Study|Investigator's Discretion|16|||
131474352|NCT01442038|473369419|FG000|Overall Study|Study Terminated By Sponsor|2|||
131474353|NCT01442038|473369420|FG001|Overall Study|Study Terminated By Sponsor|3|||
131474354|NCT00089284|473369421|FG000|Overall Study|Adverse event before starting treatment|0|||
131474355|NCT00089284|473369422|FG001|Overall Study|Adverse event before starting treatment|0|||
131474356|NCT00089284|473369423|FG002|Overall Study|Adverse event before starting treatment|0|||
131474357|NCT00089284|473369424|FG003|Overall Study|Adverse event before starting treatment|0|||
131474358|NCT00089284|473369425|FG004|Overall Study|Adverse event before starting treatment|0|||
131474359|NCT00089284|473369426|FG005|Overall Study|Adverse event before starting treatment|0|||
131474360|NCT00089284|473369427|FG006|Overall Study|Adverse event before starting treatment|1|||
131474361|NCT02423109|473369436|FG000|Lens 1|Adverse Event|1|||
131474362|NCT02423109|473369437|FG001|Lens 1|Adverse Event|0|||
131474363|NCT03646643|473369438|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
131474364|NCT03646643|473369439|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
131474365|NCT03646643|473369438|FG000|Overall Study|Lost to Follow-up|0|||
131474366|NCT03646643|473369439|FG001|Overall Study|Lost to Follow-up|1|||
131474367|NCT04131556|473369440|FG000|Overall Study|Adverse Event|1|||
131474368|NCT04131556|473369440|FG000|Overall Study|Withdrawal by Subject|1|||
131474369|NCT01229397|473369443|FG000|Overall Study|Withdrawal by Subject|3|||
131474370|NCT01229397|473369444|FG001|Overall Study|Withdrawal by Subject|3|||
131474371|NCT01229397|473369443|FG000|Overall Study|Lost to Follow-up|7|||
131474372|NCT01229397|473369444|FG001|Overall Study|Lost to Follow-up|6|||
131474373|NCT01229397|473369443|FG000|Overall Study|Migrated/moved from study area|1|||
131474374|NCT01229397|473369444|FG001|Overall Study|Migrated/moved from study area|0|||
131474375|NCT02545075|473369445|FG000|Randomization|Lost to Follow-up|0|||
131474376|NCT02545075|473369446|FG001|Randomization|Lost to Follow-up|1|||
131474377|NCT02545075|473369445|FG000|Randomization|Withdrawal by Subject|0|||
131474378|NCT02545075|473369446|FG001|Randomization|Withdrawal by Subject|6|||
131474379|NCT02545075|473369445|FG000|Treatment|Disease progression|71|||
131474380|NCT02545075|473369446|FG001|Treatment|Disease progression|32|||
131474381|NCT02545075|473369445|FG000|Treatment|Participant dicontinued study treatment|7|||
131474382|NCT02545075|473369446|FG001|Treatment|Participant dicontinued study treatment|9|||
131474383|NCT02545075|473369445|FG000|Treatment|Withdrawal by Subject|1|||
131474384|NCT02545075|473369446|FG001|Treatment|Withdrawal by Subject|0|||
131474385|NCT02545075|473369445|FG000|Treatment|Adverse event not related to study drug|1|||
131474386|NCT02545075|473369446|FG001|Treatment|Adverse event not related to study drug|0|||
131474387|NCT02545075|473369445|FG000|Treatment|Death|1|||
131474388|NCT02545075|473369446|FG001|Treatment|Death|0|||
131474389|NCT02545075|473369445|FG000|Treatment|Participant drug toxicity|1|||
131474390|NCT02545075|473369446|FG001|Treatment|Participant drug toxicity|0|||
131474391|NCT02545075|473369445|FG000|Treatment|Completed treatment|40|||
131474392|NCT02545075|473369446|FG001|Treatment|Completed treatment|12|||
131474393|NCT01810432|473369449|FG000|Washout|Protocol Violation|0|||
131474394|NCT01810432|473369450|FG001|Washout|Protocol Violation|1|||
131474395|NCT01810432|473369449|FG000|Washout|Adverse Event|1|||
131474396|NCT01810432|473369450|FG001|Washout|Adverse Event|0|||
131474397|NCT01810432|473369449|FG000|Period 2|Withdrawal by Subject|2|||
131474398|NCT01810432|473369450|FG001|Period 2|Withdrawal by Subject|1|||
131474399|NCT01810432|473369449|FG000|Period 2|Physician Decision|1|||
131474400|NCT01810432|473369450|FG001|Period 2|Physician Decision|0|||
131474401|NCT01810432|473369449|FG000|Period 2|Lost to Follow-up|1|||
131474402|NCT01810432|473369450|FG001|Period 2|Lost to Follow-up|1|||
131474403|NCT00736879|473369451|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
131474404|NCT00736879|473369452|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
131474405|NCT00736879|473369453|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
131474406|NCT00736879|473369454|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
131474407|NCT00736879|473369451|FG000|Double Blind Treatment Period|Adverse Event|0|||
131474408|NCT00736879|473369452|FG001|Double Blind Treatment Period|Adverse Event|1|||
131474409|NCT00736879|473369453|FG002|Double Blind Treatment Period|Adverse Event|1|||
131474410|NCT00736879|473369454|FG003|Double Blind Treatment Period|Adverse Event|0|||
131474411|NCT00736879|473369451|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
131474412|NCT00736879|473369452|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
131474413|NCT00736879|473369453|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
131474414|NCT00736879|473369454|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
131474415|NCT00736879|473369451|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
131474416|NCT00736879|473369452|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131474417|NCT00736879|473369453|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
131474418|NCT00736879|473369454|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
131474419|NCT00736879|473369451|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
131474420|NCT00736879|473369452|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
131474421|NCT00736879|473369453|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
131474422|NCT00736879|473369454|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
131474423|NCT00736879|473369451|FG000|Double Blind Treatment Period|No longer met criteria|0|||
131474424|NCT00736879|473369452|FG001|Double Blind Treatment Period|No longer met criteria|1|||
131474425|NCT00736879|473369453|FG002|Double Blind Treatment Period|No longer met criteria|0|||
131474426|NCT00736879|473369454|FG003|Double Blind Treatment Period|No longer met criteria|0|||
131474427|NCT00736879|473369451|FG000|Double Blind Treatment Period|non-specified|0|||
131474428|NCT00736879|473369452|FG001|Double Blind Treatment Period|non-specified|1|||
131474429|NCT00736879|473369453|FG002|Double Blind Treatment Period|non-specified|0|||
131474430|NCT00736879|473369454|FG003|Double Blind Treatment Period|non-specified|0|||
131474431|NCT00736879|473369451|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
131474432|NCT00736879|473369452|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
131474433|NCT00736879|473369453|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
131474434|NCT00736879|473369454|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
131474435|NCT00736879|473369451|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
131474436|NCT00736879|473369452|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
131474437|NCT00736879|473369453|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
131474438|NCT00736879|473369454|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
131474439|NCT02360111|473369455|FG000|Overall Study|Death|2|||
131474440|NCT02057393|473369458|FG000|Overall Study|Withdrawal by Subject|1|||
131474441|NCT02057393|473369458|FG000|Overall Study|Patient did not meet criteria|1|||
131474442|NCT01298193|473369459|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
131474443|NCT01298193|473369459|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
131474444|NCT01298193|473369459|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
131474445|NCT01298193|473369459|FG000|Efficacy Phase (Second Cycle)|Death|1|||
131474446|NCT02017171|473369460|FG000|Overall Study|Death|10|||
131474447|NCT02017171|473369461|FG001|Overall Study|Death|4|||
131474448|NCT02017171|473369460|FG000|Overall Study|Withdrawal by Subject|23|||
131474449|NCT02017171|473369461|FG001|Overall Study|Withdrawal by Subject|17|||
131474450|NCT02017171|473369460|FG000|Overall Study|Lost to Follow-up|21|||
131474451|NCT02017171|473369461|FG001|Overall Study|Lost to Follow-up|20|||
131474452|NCT02017171|473369460|FG000|Overall Study|ESKD|6|||
131474453|NCT02017171|473369461|FG001|Overall Study|ESKD|2|||
131474454|NCT02017171|473369460|FG000|Overall Study|Miscellaneous|2|||
131474455|NCT02017171|473369461|FG001|Overall Study|Miscellaneous|3|||
131474456|NCT03091777|473369463|FG000|Overall Study|Pregnancy|2|||
131474457|NCT03091777|473369464|FG001|Overall Study|Pregnancy|1|||
131474458|NCT03091777|473369465|FG002|Overall Study|Pregnancy|0|||
131474459|NCT03091777|473369463|FG000|Overall Study|Adverse Event|2|||
131474460|NCT03091777|473369464|FG001|Overall Study|Adverse Event|1|||
131474461|NCT03091777|473369465|FG002|Overall Study|Adverse Event|4|||
131474462|NCT03091777|473369463|FG000|Overall Study|Withdrawal by Subject|4|||
131474463|NCT03091777|473369464|FG001|Overall Study|Withdrawal by Subject|2|||
131474464|NCT03091777|473369465|FG002|Overall Study|Withdrawal by Subject|6|||
131474465|NCT03091777|473369463|FG000|Overall Study|Protocol Violation|2|||
131474466|NCT03091777|473369464|FG001|Overall Study|Protocol Violation|1|||
131474467|NCT03091777|473369465|FG002|Overall Study|Protocol Violation|1|||
131474468|NCT03091777|473369463|FG000|Overall Study|Lost to Follow-up|12|||
131474469|NCT03091777|473369464|FG001|Overall Study|Lost to Follow-up|14|||
131474470|NCT03091777|473369465|FG002|Overall Study|Lost to Follow-up|7|||
131474471|NCT03091777|473369463|FG000|Overall Study|Lack of Efficacy|0|||
131474472|NCT03091777|473369464|FG001|Overall Study|Lack of Efficacy|0|||
131474473|NCT03091777|473369465|FG002|Overall Study|Lack of Efficacy|5|||
131474474|NCT03091777|473369463|FG000|Overall Study|Noncompliance with study drug|2|||
131474475|NCT03091777|473369464|FG001|Overall Study|Noncompliance with study drug|3|||
131474476|NCT03091777|473369465|FG002|Overall Study|Noncompliance with study drug|1|||
131474477|NCT03091777|473369463|FG000|Overall Study|Physician Decision|1|||
131474478|NCT03091777|473369464|FG001|Overall Study|Physician Decision|0|||
131474479|NCT03091777|473369465|FG002|Overall Study|Physician Decision|1|||
131474480|NCT03091777|473369463|FG000|Overall Study|Abnormal Laboratory Value|7|||
131474481|NCT03091777|473369464|FG001|Overall Study|Abnormal Laboratory Value|11|||
131474482|NCT03091777|473369465|FG002|Overall Study|Abnormal Laboratory Value|12|||
131474483|NCT02140775|473369467|FG000|Overall Study|Withdrawal by Subject|30|||
131474484|NCT02140775|473369468|FG001|Overall Study|Withdrawal by Subject|7|||
131474485|NCT01172275|473369469|FG000|Overall Study|Lost to Follow-up|1|||
131474486|NCT01172275|473369470|FG001|Overall Study|Lost to Follow-up|0|||
131474487|NCT01172275|473369469|FG000|Overall Study|Protocol Violation|1|||
131474488|NCT01172275|473369470|FG001|Overall Study|Protocol Violation|0|||
131474489|NCT04650854|473369471|FG000|Overall Study|Adverse Event|1|||
131474490|NCT04650854|473369472|FG001|Overall Study|Adverse Event|12|||
131474491|NCT04650854|473369473|FG002|Overall Study|Adverse Event|14|||
131474492|NCT04650854|473369471|FG000|Overall Study|Lack of Efficacy|1|||
131474493|NCT04650854|473369472|FG001|Overall Study|Lack of Efficacy|3|||
131474494|NCT04650854|473369473|FG002|Overall Study|Lack of Efficacy|6|||
131474495|NCT04650854|473369471|FG000|Overall Study|Lost to Follow-up|1|||
131474496|NCT04650854|473369472|FG001|Overall Study|Lost to Follow-up|1|||
131474497|NCT04650854|473369473|FG002|Overall Study|Lost to Follow-up|0|||
131474498|NCT04650854|473369471|FG000|Overall Study|Withdrawal by Subject|2|||
131474499|NCT04650854|473369472|FG001|Overall Study|Withdrawal by Subject|17|||
131474500|NCT04650854|473369473|FG002|Overall Study|Withdrawal by Subject|9|||
131474501|NCT04650854|473369471|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
131474502|NCT04650854|473369472|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
131474503|NCT04650854|473369473|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
131474504|NCT04650854|473369471|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
131474505|NCT04650854|473369472|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
131474506|NCT04650854|473369473|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
131474507|NCT04650854|473369471|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
131474508|NCT04650854|473369472|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
131474509|NCT04650854|473369473|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
131474510|NCT04650854|473369471|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
131474511|NCT04650854|473369472|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
131474512|NCT04650854|473369473|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
131474513|NCT04650854|473369471|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
131474514|NCT04650854|473369472|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
131474515|NCT04650854|473369473|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
131474516|NCT04650854|473369471|FG000|Overall Study|Use of Rescue Medication|0|||
131474517|NCT04650854|473369472|FG001|Overall Study|Use of Rescue Medication|0|||
131474518|NCT04650854|473369473|FG002|Overall Study|Use of Rescue Medication|1|||
131474519|NCT04650854|473369471|FG000|Overall Study|Last Treatment Per Sponsor|0|||
131474520|NCT04650854|473369472|FG001|Overall Study|Last Treatment Per Sponsor|0|||
131474521|NCT04650854|473369473|FG002|Overall Study|Last Treatment Per Sponsor|2|||
131474522|NCT04650854|473369471|FG000|Overall Study|Rescue Medication|0|||
131474523|NCT04650854|473369472|FG001|Overall Study|Rescue Medication|0|||
131474524|NCT04650854|473369473|FG002|Overall Study|Rescue Medication|1|||
131474525|NCT04650854|473369471|FG000|Overall Study|Participant Want to Start a Family|0|||
131474526|NCT04650854|473369472|FG001|Overall Study|Participant Want to Start a Family|0|||
131474527|NCT04650854|473369473|FG002|Overall Study|Participant Want to Start a Family|1|||
131474528|NCT04650854|473369471|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
131474529|NCT04650854|473369472|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
131474530|NCT04650854|473369473|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
131474531|NCT04650854|473369471|FG000|Overall Study|Participant Screened For MG0020|0|||
131474532|NCT04650854|473369472|FG001|Overall Study|Participant Screened For MG0020|2|||
131474533|NCT04650854|473369473|FG002|Overall Study|Participant Screened For MG0020|3|||
131474534|NCT04650854|473369471|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
131474535|NCT04650854|473369472|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
131474536|NCT04650854|473369473|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
131474537|NCT04650854|473369471|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
131474538|NCT04650854|473369472|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
131474539|NCT04650854|473369473|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
131474540|NCT04650854|473369471|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
131474541|NCT04650854|473369472|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
131474542|NCT04650854|473369473|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
131474543|NCT04650854|473369471|FG000|Overall Study|End Of Study|0|||
131474544|NCT04650854|473369472|FG001|Overall Study|End Of Study|2|||
131474545|NCT04650854|473369473|FG002|Overall Study|End Of Study|1|||
131474546|NCT04650854|473369471|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
131474547|NCT04650854|473369472|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
131474548|NCT04650854|473369473|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
131474549|NCT04650854|473369471|FG000|Overall Study|Participant Received Rescue Medication|0|||
131474550|NCT04650854|473369472|FG001|Overall Study|Participant Received Rescue Medication|1|||
131474551|NCT04650854|473369473|FG002|Overall Study|Participant Received Rescue Medication|0|||
131474552|NCT04650854|473369471|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
131474553|NCT04650854|473369472|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
131474554|NCT04650854|473369473|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
131474555|NCT04650854|473369471|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
131474556|NCT04650854|473369472|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
131474557|NCT04650854|473369473|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
131474558|NCT04650854|473369471|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
131474559|NCT04650854|473369472|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
131474560|NCT04650854|473369473|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
131474561|NCT04650854|473369471|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
131474562|NCT04650854|473369472|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
131474563|NCT04650854|473369473|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
131474564|NCT04650854|473369471|FG000|Overall Study|Enrollment Cup|0|||
131474565|NCT04650854|473369472|FG001|Overall Study|Enrollment Cup|0|||
131474566|NCT04650854|473369473|FG002|Overall Study|Enrollment Cup|1|||
131474567|NCT05308290|473369474|FG000|Overall Study|Death|1|||
131474568|NCT05308290|473369475|FG001|Overall Study|Death|0|||
131474569|NCT05308290|473369474|FG000|Overall Study|Lost to Follow-up|2|||
131474570|NCT05308290|473369475|FG001|Overall Study|Lost to Follow-up|1|||
131474571|NCT05308290|473369474|FG000|Overall Study|still in study followup|0|||
131474572|NCT05308290|473369475|FG001|Overall Study|still in study followup|1|||
131474573|NCT00667420|473369476|FG000|Overall Study|Adverse Event|2|||
131474574|NCT00667420|473369476|FG000|Overall Study|Lack of Efficacy|5|||
131474575|NCT00667420|473369476|FG000|Overall Study|Physician Decision|1|||
131474576|NCT00667420|473369476|FG000|Overall Study|Withdrawal by Subject|2|||
131474577|NCT04437368|473369477|FG000|Overall Study|Death|3|||
131474578|NCT04437368|473369478|FG001|Overall Study|Death|0|||
131474579|NCT04437368|473369479|FG002|Overall Study|Death|2|||
131474580|NCT04437368|473369477|FG000|Overall Study|Study terminated by sponsor|16|||
131474581|NCT04437368|473369478|FG001|Overall Study|Study terminated by sponsor|1|||
131474582|NCT04437368|473369479|FG002|Overall Study|Study terminated by sponsor|25|||
131474583|NCT04437368|473369477|FG000|Overall Study|Withdrawal by Subject|4|||
131474584|NCT04437368|473369478|FG001|Overall Study|Withdrawal by Subject|0|||
131474585|NCT04437368|473369479|FG002|Overall Study|Withdrawal by Subject|3|||
131474586|NCT04437368|473369477|FG000|Overall Study|Sponsor instructions|23|||
131474587|NCT04437368|473369478|FG001|Overall Study|Sponsor instructions|0|||
131474588|NCT04437368|473369479|FG002|Overall Study|Sponsor instructions|0|||
131474589|NCT01982331|473369480|FG000|Received Vaccination 2|Adverse Event|1|||
131474590|NCT01982331|473369481|FG001|Received Vaccination 2|Adverse Event|2|||
131474591|NCT01982331|473369480|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
131474592|NCT01982331|473369481|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
131474593|NCT01982331|473369480|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
131474594|NCT01982331|473369481|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
131474595|NCT01280955|473369485|FG000|Overall Study|Death|2|||
131474596|NCT01280955|473369485|FG000|Overall Study|Withdrawal by Subject|1|||
131474597|NCT00901927|473369487|FG000|Overall Study|Lack of Efficacy|1|||
131474598|NCT00901927|473369487|FG000|Overall Study|Protocol Violation|3|||
131474599|NCT00901927|473369487|FG000|Overall Study|Withdrawal by Subject|2|||
131474600|NCT01674634|473369488|FG000|Overall Study|Withdrawal by Subject|3|||
131474601|NCT01674634|473369488|FG000|Overall Study|Lost to Follow-up|3|||
131474602|NCT01721070|473369489|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
131474603|NCT01226043|473369499|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
131474604|NCT01226043|473369500|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
131474605|NCT01226043|473369501|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
131474606|NCT01226043|473369502|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
131474607|NCT01226043|473369499|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
131474608|NCT01226043|473369500|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
131474609|NCT01226043|473369501|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
131474610|NCT01226043|473369502|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
131474611|NCT01226043|473369499|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
131474612|NCT01226043|473369500|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
131474613|NCT01226043|473369501|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
131474614|NCT01226043|473369502|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
131474615|NCT01226043|473369499|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
131474616|NCT01226043|473369500|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
131474617|NCT01226043|473369501|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
131474618|NCT01226043|473369502|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
131474619|NCT01226043|473369499|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
131474620|NCT01226043|473369500|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
131474621|NCT01226043|473369501|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
131474622|NCT01226043|473369502|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
131474623|NCT01226043|473369499|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
131474624|NCT01226043|473369500|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
131474625|NCT01226043|473369501|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
131474626|NCT01226043|473369502|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
131474627|NCT01226043|473369499|FG000|6-week Re-randomization Phase|Adverse Event|0|||
131474628|NCT01226043|473369500|FG001|6-week Re-randomization Phase|Adverse Event|0|||
131474629|NCT01226043|473369501|FG002|6-week Re-randomization Phase|Adverse Event|1|||
131474630|NCT01226043|473369502|FG003|6-week Re-randomization Phase|Adverse Event|1|||
131474631|NCT01226043|473369499|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
131474632|NCT01226043|473369500|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
131474633|NCT01226043|473369501|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
131474634|NCT01226043|473369502|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
131474635|NCT01226043|473369499|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
131474636|NCT01226043|473369500|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
131474637|NCT01226043|473369501|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
131474638|NCT01226043|473369502|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
131474639|NCT01226043|473369499|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
131474640|NCT01226043|473369500|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
131474641|NCT01226043|473369501|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
131474642|NCT01226043|473369502|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
131474643|NCT01226043|473369499|FG000|6-week Re-randomization Phase|Physician Decision|0|||
131474644|NCT01226043|473369500|FG001|6-week Re-randomization Phase|Physician Decision|0|||
131474645|NCT01226043|473369501|FG002|6-week Re-randomization Phase|Physician Decision|3|||
131474646|NCT01226043|473369502|FG003|6-week Re-randomization Phase|Physician Decision|2|||
131474647|NCT01226043|473369499|FG000|6-week Re-randomization Phase|completed in error|0|||
131474648|NCT01226043|473369500|FG001|6-week Re-randomization Phase|completed in error|0|||
131474649|NCT01226043|473369501|FG002|6-week Re-randomization Phase|completed in error|0|||
131474650|NCT01226043|473369502|FG003|6-week Re-randomization Phase|completed in error|1|||
131474651|NCT01226043|473369499|FG000|30-week Observational Phase|Adverse Event|0|||
131474652|NCT01226043|473369500|FG001|30-week Observational Phase|Adverse Event|0|||
131474653|NCT01226043|473369501|FG002|30-week Observational Phase|Adverse Event|1|||
131474654|NCT01226043|473369502|FG003|30-week Observational Phase|Adverse Event|1|||
131474655|NCT01226043|473369499|FG000|30-week Observational Phase|Protocol Violation|0|||
131474656|NCT01226043|473369500|FG001|30-week Observational Phase|Protocol Violation|0|||
131474657|NCT01226043|473369501|FG002|30-week Observational Phase|Protocol Violation|0|||
131474658|NCT01226043|473369502|FG003|30-week Observational Phase|Protocol Violation|1|||
131474659|NCT01226043|473369499|FG000|30-week Observational Phase|Lost to Follow-up|0|||
131474660|NCT01226043|473369500|FG001|30-week Observational Phase|Lost to Follow-up|0|||
131474661|NCT01226043|473369501|FG002|30-week Observational Phase|Lost to Follow-up|2|||
131474662|NCT01226043|473369502|FG003|30-week Observational Phase|Lost to Follow-up|2|||
131474663|NCT01226043|473369499|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
131474664|NCT01226043|473369500|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
131474665|NCT01226043|473369501|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
131474666|NCT01226043|473369502|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
131474667|NCT01226043|473369499|FG000|30-week Observational Phase|Physician Decision|0|||
131474668|NCT01226043|473369500|FG001|30-week Observational Phase|Physician Decision|0|||
131474669|NCT01226043|473369501|FG002|30-week Observational Phase|Physician Decision|2|||
131474670|NCT01226043|473369502|FG003|30-week Observational Phase|Physician Decision|2|||
131474671|NCT03004443|473369503|FG000|Overall Study|Pregnancy|0|||
131474672|NCT03004443|473369504|FG001|Overall Study|Pregnancy|1|||
131474673|NCT00191646|473369505|FG000|Overall Study|Toxicity|26|||
131474674|NCT00191646|473369506|FG001|Overall Study|Toxicity|37|||
131474675|NCT00191646|473369505|FG000|Overall Study|Disease Progression|5|||
131474676|NCT00191646|473369506|FG001|Overall Study|Disease Progression|6|||
131474677|NCT00191646|473369505|FG000|Overall Study|Physician Decision|20|||
131474678|NCT00191646|473369506|FG001|Overall Study|Physician Decision|11|||
131474679|NCT00191646|473369505|FG000|Overall Study|Withdrawal by Subject|58|||
131474680|NCT00191646|473369506|FG001|Overall Study|Withdrawal by Subject|39|||
131474681|NCT00191646|473369505|FG000|Overall Study|Protocol Violation|5|||
131474682|NCT00191646|473369506|FG001|Overall Study|Protocol Violation|7|||
131474683|NCT00191646|473369505|FG000|Overall Study|Death|6|||
131474684|NCT00191646|473369506|FG001|Overall Study|Death|8|||
131474685|NCT00191646|473369505|FG000|Overall Study|Other|33|||
131474686|NCT00191646|473369506|FG001|Overall Study|Other|34|||
131474687|NCT00191646|473369505|FG000|Overall Study|Missing Data|18|||
131474688|NCT00191646|473369506|FG001|Overall Study|Missing Data|11|||
131474689|NCT05211284|473369511|FG000|Overall Study|Study Terminated|3|||
131474690|NCT05211284|473369512|FG001|Overall Study|Study Terminated|1|||
131474691|NCT03911843|473369513|FG000|Overall Study|Adverse Event|2|||
131474692|NCT03911843|473369514|FG001|Overall Study|Adverse Event|0|||
131474693|NCT03911843|473369513|FG000|Overall Study|Protocol Violation|2|||
131474694|NCT03911843|473369514|FG001|Overall Study|Protocol Violation|0|||
131474695|NCT03911843|473369513|FG000|Overall Study|Lost to Follow-up|0|||
131474696|NCT03911843|473369514|FG001|Overall Study|Lost to Follow-up|1|||
131474697|NCT01907100|473369515|FG000|Overall Study|PD based on modified RECIST criteria|31|||
131474698|NCT01907100|473369516|FG001|Overall Study|PD based on modified RECIST criteria|32|||
131474699|NCT01907100|473369517|FG002|Overall Study|PD based on modified RECIST criteria|95|||
131474700|NCT01907100|473369518|FG003|Overall Study|PD based on modified RECIST criteria|92|||
131474701|NCT01907100|473369515|FG000|Overall Study|Withdrawal by Subject|2|||
131474702|NCT01907100|473369516|FG001|Overall Study|Withdrawal by Subject|5|||
131474703|NCT01907100|473369517|FG002|Overall Study|Withdrawal by Subject|10|||
131474704|NCT01907100|473369518|FG003|Overall Study|Withdrawal by Subject|13|||
131474705|NCT01907100|473369515|FG000|Overall Study|Protocol Violation|0|||
131474706|NCT01907100|473369516|FG001|Overall Study|Protocol Violation|0|||
131474707|NCT01907100|473369517|FG002|Overall Study|Protocol Violation|1|||
131474708|NCT01907100|473369518|FG003|Overall Study|Protocol Violation|1|||
131474709|NCT01907100|473369515|FG000|Overall Study|Lost to Follow-up|0|||
131474710|NCT01907100|473369516|FG001|Overall Study|Lost to Follow-up|0|||
131474711|NCT01907100|473369517|FG002|Overall Study|Lost to Follow-up|0|||
131474712|NCT01907100|473369518|FG003|Overall Study|Lost to Follow-up|1|||
131474713|NCT01907100|473369515|FG000|Overall Study|Not treated|2|||
131474714|NCT01907100|473369516|FG001|Overall Study|Not treated|0|||
131474715|NCT01907100|473369517|FG002|Overall Study|Not treated|1|||
131474716|NCT01907100|473369518|FG003|Overall Study|Not treated|2|||
131474717|NCT01907100|473369515|FG000|Overall Study|Other than reasons specified|1|||
131474718|NCT01907100|473369516|FG001|Overall Study|Other than reasons specified|0|||
131474719|NCT01907100|473369517|FG002|Overall Study|Other than reasons specified|10|||
131474720|NCT01907100|473369518|FG003|Overall Study|Other than reasons specified|6|||
131474721|NCT01907100|473369515|FG000|Overall Study|Adverse event (AE)|6|||
131474722|NCT01907100|473369516|FG001|Overall Study|Adverse event (AE)|3|||
131474723|NCT01907100|473369517|FG002|Overall Study|Adverse event (AE)|22|||
131474724|NCT01907100|473369518|FG003|Overall Study|Adverse event (AE)|23|||
131474725|NCT01907100|473369515|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
131474726|NCT01907100|473369516|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
131474727|NCT01907100|473369517|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
131474728|NCT01907100|473369518|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
131474729|NCT00644228|473369519|FG000|Randomization & Eligibility|Ineligible|31|||
131474730|NCT00644228|473369520|FG001|Randomization & Eligibility|Ineligible|21|||
131474731|NCT00644228|473369519|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
131474732|NCT00644228|473369520|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
131474733|NCT00644228|473369519|FG000|Randomization & Eligibility|Invalid Consent|0|||
131474734|NCT00644228|473369520|FG001|Randomization & Eligibility|Invalid Consent|1|||
131474735|NCT00644228|473369519|FG000|Induction Therapy|Adverse Event|22|||
131474736|NCT00644228|473369520|FG001|Induction Therapy|Adverse Event|55|||
131474737|NCT00644228|473369519|FG000|Induction Therapy|Withdrawal by Subject|10|||
131474738|NCT00644228|473369520|FG001|Induction Therapy|Withdrawal by Subject|3|||
131474739|NCT00644228|473369519|FG000|Induction Therapy|Progression/Relapse|24|||
131474740|NCT00644228|473369520|FG001|Induction Therapy|Progression/Relapse|12|||
131474741|NCT00644228|473369519|FG000|Induction Therapy|Death|3|||
131474742|NCT00644228|473369520|FG001|Induction Therapy|Death|7|||
131474743|NCT00644228|473369519|FG000|Induction Therapy|Not Protocol-Specified|24|||
131474744|NCT00644228|473369520|FG001|Induction Therapy|Not Protocol-Specified|28|||
131474745|NCT00644228|473369519|FG000|Maintenance|Adverse Event|27|||
131474746|NCT00644228|473369520|FG001|Maintenance|Adverse Event|31|||
131474747|NCT00644228|473369519|FG000|Maintenance|Withdrawal by Subject|6|||
131474748|NCT00644228|473369520|FG001|Maintenance|Withdrawal by Subject|4|||
131474749|NCT00644228|473369519|FG000|Maintenance|Progression/Relapse|67|||
131474750|NCT00644228|473369520|FG001|Maintenance|Progression/Relapse|42|||
131474751|NCT00644228|473369519|FG000|Maintenance|Death|3|||
131474752|NCT00644228|473369520|FG001|Maintenance|Death|3|||
131474753|NCT00644228|473369519|FG000|Maintenance|Not Protocol-Specified|14|||
131474754|NCT00644228|473369520|FG001|Maintenance|Not Protocol-Specified|15|||
131474755|NCT00644228|473369519|FG000|Maintenance|On Treatment|26|||
131474756|NCT00644228|473369520|FG001|Maintenance|On Treatment|40|||
131474757|NCT00760084|473369521|FG000|Overall Study|Physician Decision|5|||
131474758|NCT00760084|473369521|FG000|Overall Study|Withdrawal by Subject|2|||
131474759|NCT00760084|473369521|FG000|Overall Study|Progressive Disease|3|||
131474760|NCT02567552|473369522|FG000|Overall Study|Adverse Event|0|||
131474761|NCT02567552|473369523|FG001|Overall Study|Adverse Event|1|||
131474762|NCT01074047|473369524|FG000|Treatment Phase|Adverse Event|89|||
131474763|NCT01074047|473369525|FG001|Treatment Phase|Adverse Event|66|||
131474764|NCT01074047|473369524|FG000|Treatment Phase|Disease Progression|16|||
131474765|NCT01074047|473369525|FG001|Treatment Phase|Disease Progression|21|||
131474766|NCT01074047|473369524|FG000|Treatment Phase|Withdrawal by Subject|27|||
131474767|NCT01074047|473369525|FG001|Treatment Phase|Withdrawal by Subject|48|||
131474768|NCT01074047|473369524|FG000|Treatment Phase|Death|53|||
131474769|NCT01074047|473369525|FG001|Treatment Phase|Death|58|||
131474770|NCT01074047|473369524|FG000|Treatment Phase|Lost to Follow-up|0|||
131474771|NCT01074047|473369525|FG001|Treatment Phase|Lost to Follow-up|1|||
131474772|NCT01074047|473369524|FG000|Treatment Phase|Protocol Violation|0|||
131474773|NCT01074047|473369525|FG001|Treatment Phase|Protocol Violation|1|||
131474774|NCT01074047|473369524|FG000|Treatment Phase|Miscellaneous|32|||
131474775|NCT01074047|473369525|FG001|Treatment Phase|Miscellaneous|39|||
131474776|NCT01074047|473369524|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
131474777|NCT01074047|473369525|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
131474778|NCT01074047|473369524|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
131474779|NCT01074047|473369525|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
131474780|NCT01074047|473369524|FG000|Survival Follow-Up Phase|Death|116|||
131474781|NCT01074047|473369525|FG001|Survival Follow-Up Phase|Death|124|||
131474782|NCT01074047|473369524|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
131474783|NCT01074047|473369525|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
131474784|NCT01074047|473369524|FG000|Extension Phase|Physician Decision|1|||
131474785|NCT01074047|473369525|FG001|Extension Phase|Physician Decision|0|||
131474786|NCT01074047|473369524|FG000|Extension Phase|Adverse Event|5|||
131474787|NCT01074047|473369525|FG001|Extension Phase|Adverse Event|0|||
131474788|NCT01074047|473369524|FG000|Extension Phase|Disease Progression|9|||
131474789|NCT01074047|473369525|FG001|Extension Phase|Disease Progression|0|||
131474790|NCT01074047|473369524|FG000|Extension Phase|Withdrawal by Subject|2|||
131474791|NCT01074047|473369525|FG001|Extension Phase|Withdrawal by Subject|0|||
131474792|NCT01074047|473369524|FG000|Extension Phase|Death|5|||
131474793|NCT01074047|473369525|FG001|Extension Phase|Death|0|||
131474794|NCT05419908|473369527|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
131474795|NCT05419908|473369528|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
131474796|NCT05419908|473369527|FG000|Overall Study|Serious Adverse Event|0|||
131474797|NCT05419908|473369528|FG001|Overall Study|Serious Adverse Event|2|||
131474798|NCT05419908|473369527|FG000|Overall Study|Withdrawal by Subject|2|||
131474799|NCT05419908|473369528|FG001|Overall Study|Withdrawal by Subject|0|||
131474800|NCT05419908|473369527|FG000|Overall Study|Miscellaneous|1|||
131474801|NCT05419908|473369528|FG001|Overall Study|Miscellaneous|1|||
131474802|NCT01933217|473371020|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
131474803|NCT01933217|473371021|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
131474804|NCT01933217|473371020|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
131474805|NCT01933217|473371021|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
131474806|NCT03923738|473371022|FG000|Period 1|Adverse Event|1|||
131474807|NCT03923738|473371022|FG000|Period 1|Withdrawal by Subject|1|||
131474808|NCT01068652|473371026|FG000|Overall Study|Adverse Event|4|||
131474809|NCT01068652|473371027|FG001|Overall Study|Adverse Event|0|||
131474810|NCT01068652|473371026|FG000|Overall Study|Lack of Efficacy|0|||
131474811|NCT01068652|473371027|FG001|Overall Study|Lack of Efficacy|2|||
131474812|NCT01068652|473371026|FG000|Overall Study|Lost to Follow-up|2|||
131474813|NCT01068652|473371027|FG001|Overall Study|Lost to Follow-up|1|||
131474814|NCT01068652|473371026|FG000|Overall Study|Protocol Violation|3|||
131474815|NCT01068652|473371027|FG001|Overall Study|Protocol Violation|6|||
131474816|NCT01068652|473371026|FG000|Overall Study|Withdrawal criteria|1|||
131474817|NCT01068652|473371027|FG001|Overall Study|Withdrawal criteria|2|||
131474818|NCT01068652|473371026|FG000|Overall Study|Patient was not eligible|1|||
131474819|NCT01068652|473371027|FG001|Overall Study|Patient was not eligible|0|||
131474820|NCT01068652|473371026|FG000|Overall Study|Unclassified|7|||
131474821|NCT01068652|473371027|FG001|Overall Study|Unclassified|4|||
131474822|NCT04505540|473371028|FG000|Baseline|Protocol Violation|10|||
131474823|NCT04505540|473371028|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
131474824|NCT04505540|473371028|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
131474825|NCT04505540|473371028|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
131474826|NCT04505540|473371028|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
131474827|NCT04505540|473371028|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
131474828|NCT04505540|473371028|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
131474829|NCT04505540|473371028|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
131474830|NCT04505540|473371028|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
131474831|NCT04505540|473371028|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
131474832|NCT04505540|473371028|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
131474833|NCT04505540|473371028|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
131474834|NCT04505540|473371028|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
131474835|NCT05323656|473371031|FG000|Overall Study|Still On-Treatment|6|||
131474836|NCT05323656|473371032|FG001|Overall Study|Still On-Treatment|6|||
131474837|NCT05323656|473371031|FG000|Overall Study|Progressive Disease|15|||
131474838|NCT05323656|473371032|FG001|Overall Study|Progressive Disease|14|||
131474839|NCT05323656|473371031|FG000|Overall Study|Adverse Event|2|||
131474840|NCT05323656|473371032|FG001|Overall Study|Adverse Event|3|||
131474841|NCT05323656|473371031|FG000|Overall Study|Death|1|||
131474842|NCT05323656|473371032|FG001|Overall Study|Death|2|||
131474843|NCT05323656|473371031|FG000|Overall Study|Withdrawal by Subject|1|||
131474844|NCT05323656|473371032|FG001|Overall Study|Withdrawal by Subject|0|||
131474845|NCT05323656|473371031|FG000|Overall Study|Clinical disease progression|0|||
131474846|NCT05323656|473371032|FG001|Overall Study|Clinical disease progression|1|||
131474847|NCT05323656|473371031|FG000|Overall Study|Patient and Investigator decision|1|||
131474848|NCT05323656|473371032|FG001|Overall Study|Patient and Investigator decision|0|||
131474849|NCT05323656|473371031|FG000|Overall Study|Physician Decision|0|||
131474850|NCT05323656|473371032|FG001|Overall Study|Physician Decision|1|||
131474851|NCT02325791|473371034|FG000|Overall Study|Adverse Event|0|||
131474852|NCT02325791|473371035|FG001|Overall Study|Adverse Event|1|||
131474853|NCT02325791|473371036|FG002|Overall Study|Adverse Event|1|||
131474854|NCT02325791|473371037|FG003|Overall Study|Adverse Event|0|||
131474855|NCT02325791|473371034|FG000|Overall Study|Death|0|||
131474856|NCT02325791|473371035|FG001|Overall Study|Death|3|||
131474857|NCT02325791|473371036|FG002|Overall Study|Death|0|||
131474858|NCT02325791|473371037|FG003|Overall Study|Death|1|||
131474859|NCT02325791|473371034|FG000|Overall Study|Lost to Follow-up|0|||
131474860|NCT02325791|473371035|FG001|Overall Study|Lost to Follow-up|15|||
131474861|NCT02325791|473371036|FG002|Overall Study|Lost to Follow-up|14|||
131474862|NCT02325791|473371037|FG003|Overall Study|Lost to Follow-up|9|||
131474863|NCT02325791|473371034|FG000|Overall Study|Physician Decision|0|||
131474864|NCT02325791|473371035|FG001|Overall Study|Physician Decision|1|||
131474865|NCT02325791|473371036|FG002|Overall Study|Physician Decision|1|||
131474866|NCT02325791|473371037|FG003|Overall Study|Physician Decision|0|||
131474867|NCT02325791|473371034|FG000|Overall Study|Protocol Violation|0|||
131474868|NCT02325791|473371035|FG001|Overall Study|Protocol Violation|0|||
131474869|NCT02325791|473371036|FG002|Overall Study|Protocol Violation|1|||
131474870|NCT02325791|473371037|FG003|Overall Study|Protocol Violation|0|||
131474871|NCT02325791|473371034|FG000|Overall Study|Withdrawal by Subject|0|||
131474872|NCT02325791|473371035|FG001|Overall Study|Withdrawal by Subject|5|||
131474873|NCT02325791|473371036|FG002|Overall Study|Withdrawal by Subject|8|||
131474874|NCT02325791|473371037|FG003|Overall Study|Withdrawal by Subject|16|||
131474875|NCT03953183|473371038|FG000|Overall Study|Physician Decision|0|||
131474876|NCT03953183|473371039|FG001|Overall Study|Physician Decision|1|||
131474877|NCT03953183|473371038|FG000|Overall Study|Withdrawal by Subject|0|||
131474878|NCT03953183|473371039|FG001|Overall Study|Withdrawal by Subject|1|||
131474879|NCT04508140|473371040|FG000|Overall Study|Adverse Event|2|||
131474880|NCT04508140|473371041|FG001|Overall Study|Adverse Event|2|||
131474881|NCT04508140|473371040|FG000|Overall Study|Withdrawal by Subject|0|||
131474882|NCT04508140|473371041|FG001|Overall Study|Withdrawal by Subject|2|||
131474883|NCT04508140|473371040|FG000|Overall Study|progressive disease|9|||
131474884|NCT04508140|473371041|FG001|Overall Study|progressive disease|3|||
131474885|NCT04010539|473371042|FG000|Overall Study|Withdrawal by Subject|4|||
131474886|NCT04010539|473371043|FG001|Overall Study|Withdrawal by Subject|1|||
131474887|NCT04010539|473371042|FG000|Overall Study|Physician Decision|0|||
131474888|NCT04010539|473371043|FG001|Overall Study|Physician Decision|2|||
131474889|NCT04010539|473371042|FG000|Overall Study|Lost to Follow-up|10|||
131474890|NCT04010539|473371043|FG001|Overall Study|Lost to Follow-up|14|||
131474891|NCT04010539|473371042|FG000|Overall Study|Adverse Event|3|||
131474892|NCT04010539|473371043|FG001|Overall Study|Adverse Event|0|||
131474893|NCT04010539|473371042|FG000|Overall Study|Participant Did Not Receive IP|0|||
131474894|NCT04010539|473371043|FG001|Overall Study|Participant Did Not Receive IP|1|||
131474895|NCT04010539|473371042|FG000|Overall Study|Protocol Deviation|0|||
131474896|NCT04010539|473371043|FG001|Overall Study|Protocol Deviation|1|||
131474897|NCT04010539|473371042|FG000|Overall Study|Randomized in Error/ Mistake|2|||
131474898|NCT04010539|473371043|FG001|Overall Study|Randomized in Error/ Mistake|0|||
131474899|NCT04010539|473371042|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
131474900|NCT04010539|473371043|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
131474901|NCT00249288|473371044|FG000|Overall Study|Lost to Follow-up|3|||
131474902|NCT00249288|473371045|FG001|Overall Study|Lost to Follow-up|3|||
131474903|NCT00249288|473371044|FG000|Overall Study|Withdrawal by Subject|2|||
131474904|NCT00249288|473371045|FG001|Overall Study|Withdrawal by Subject|2|||
131474905|NCT03059446|473371046|FG000|Overall Study|Adverse Event|11|||
131474906|NCT03059446|473371046|FG000|Overall Study|Withdrawal of Consent|16|||
131474907|NCT03059446|473371046|FG000|Overall Study|Lost to Follow-up|3|||
131474908|NCT03059446|473371046|FG000|Overall Study|Protocol Violation|1|||
131474909|NCT03059446|473371046|FG000|Overall Study|Study Terminated by Sponsor|131|||
131474910|NCT03059446|473371046|FG000|Overall Study|Reason not Specified|5|||
131474911|NCT04795622|473371047|FG000|Overall Study|Adverse Event|1|||
131474912|NCT04795622|473371048|FG001|Overall Study|Adverse Event|0|||
131474913|NCT04795622|473371047|FG000|Overall Study|Withdrawal by Subject|3|||
131474914|NCT04795622|473371048|FG001|Overall Study|Withdrawal by Subject|3|||
131474915|NCT04795622|473371047|FG000|Overall Study|Protocol Violation|0|||
131474916|NCT04795622|473371048|FG001|Overall Study|Protocol Violation|2|||
131474917|NCT04795622|473371047|FG000|Overall Study|Lost to Follow-up|2|||
131474918|NCT04795622|473371048|FG001|Overall Study|Lost to Follow-up|3|||
131474919|NCT04795622|473371047|FG000|Overall Study|Other|7|||
131474920|NCT04795622|473371048|FG001|Overall Study|Other|8|||
131474921|NCT03309046|473371051|FG000|Overall Study|Withdrawal by Subject|4|||
131474922|NCT03309046|473371052|FG001|Overall Study|Withdrawal by Subject|17|||
131474923|NCT00089674|473371054|FG000|Overall Study|Physician Decision|4|||
131474924|NCT00089674|473371055|FG001|Overall Study|Physician Decision|2|||
131474925|NCT00089674|473371054|FG000|Overall Study|Adverse Event|23|||
131474926|NCT00089674|473371055|FG001|Overall Study|Adverse Event|29|||
131474927|NCT00089674|473371054|FG000|Overall Study|Withdrawal by Subject|143|||
131474928|NCT00089674|473371055|FG001|Overall Study|Withdrawal by Subject|127|||
131474929|NCT00089674|473371054|FG000|Overall Study|Death|43|||
131474930|NCT00089674|473371055|FG001|Overall Study|Death|43|||
131474931|NCT00089674|473371054|FG000|Overall Study|Disease progression|21|||
131474932|NCT00089674|473371055|FG001|Overall Study|Disease progression|23|||
131474933|NCT00089674|473371054|FG000|Overall Study|Ineligibility determined|8|||
131474934|NCT00089674|473371055|FG001|Overall Study|Ineligibility determined|10|||
131474935|NCT00089674|473371054|FG000|Overall Study|Lost to Follow-up|21|||
131474936|NCT00089674|473371055|FG001|Overall Study|Lost to Follow-up|17|||
131474937|NCT00089674|473371054|FG000|Overall Study|Noncompliance|7|||
131474938|NCT00089674|473371055|FG001|Overall Study|Noncompliance|3|||
131474939|NCT00089674|473371054|FG000|Overall Study|Other|5|||
131474940|NCT00089674|473371055|FG001|Overall Study|Other|9|||
131474941|NCT00089674|473371054|FG000|Overall Study|Requirement for alternative therapy|14|||
131474942|NCT00089674|473371055|FG001|Overall Study|Requirement for alternative therapy|4|||
131474943|NCT03963401|473371056|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
131474944|NCT03963401|473371057|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
131474945|NCT03963401|473371058|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
131474946|NCT03963401|473371059|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
131474947|NCT03963401|473371060|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
131474948|NCT03963401|473371061|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
131474949|NCT03963401|473371056|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
131474950|NCT03963401|473371057|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
131474951|NCT03963401|473371058|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
131474952|NCT03963401|473371059|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
131474953|NCT03963401|473371060|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
131474954|NCT03963401|473371061|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
131474955|NCT03963401|473371056|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
131474956|NCT03963401|473371057|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
131474957|NCT03963401|473371058|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
131474958|NCT03963401|473371059|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
131474959|NCT03963401|473371060|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
131474960|NCT03963401|473371061|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
131474961|NCT03963401|473371056|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
131474962|NCT03963401|473371057|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
131474963|NCT03963401|473371058|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
131474964|NCT03963401|473371059|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
131474965|NCT03963401|473371060|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
131474966|NCT03963401|473371061|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
131474967|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
131474968|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
131474969|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
131474970|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
131474971|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
131474972|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
131474973|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
131474974|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
131474975|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
131474976|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
131474977|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
131474978|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
131474979|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
131474980|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
131474981|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
131474982|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
131474983|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
131474984|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
131474985|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
131474986|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
131474987|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
131474988|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
131474989|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
131474990|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
131474991|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
131474992|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
131474993|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
131474994|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
131474995|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
131474996|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
131474997|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
131474998|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
131474999|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
131475000|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
131475001|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
131475002|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
131475003|NCT03963401|473371056|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
131475004|NCT03963401|473371057|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
131475005|NCT03963401|473371058|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
131475006|NCT03963401|473371059|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
131475007|NCT03963401|473371060|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
131475008|NCT03963401|473371061|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
131475009|NCT01437878|473371066|FG000|Overall Study|Withdrawal by Subject|1|||
131475010|NCT01437878|473371067|FG001|Overall Study|Withdrawal by Subject|0|||
131475011|NCT01070043|473371069|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
131475012|NCT01070043|473371070|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
131475013|NCT01070043|473371071|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
131475014|NCT01070043|473371069|FG000|Double-Blind Treatment|Adverse Event|0|||
131475015|NCT01070043|473371070|FG001|Double-Blind Treatment|Adverse Event|0|||
131475016|NCT01070043|473371071|FG002|Double-Blind Treatment|Adverse Event|2|||
131475017|NCT00473746|473371072|FG000|Period 1 (Phase 1)|Adverse Event|1|||
131475018|NCT00473746|473371073|FG001|Period 1 (Phase 1)|Adverse Event|0|||
131475019|NCT00473746|473371074|FG002|Period 1 (Phase 1)|Adverse Event|0|||
131475020|NCT00473746|473371075|FG003|Period 1 (Phase 1)|Adverse Event|0|||
131475021|NCT00473746|473371076|FG004|Period 1 (Phase 1)|Adverse Event|0|||
131475022|NCT00473746|473371072|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
131475023|NCT00473746|473371073|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
131475024|NCT00473746|473371074|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
131475025|NCT00473746|473371075|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
131475026|NCT00473746|473371076|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
131475027|NCT00473746|473371072|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
131475028|NCT00473746|473371073|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
131475029|NCT00473746|473371074|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
131475030|NCT00473746|473371075|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
131475031|NCT00473746|473371076|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
131475032|NCT00473746|473371072|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
131475033|NCT00473746|473371073|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
131475034|NCT00473746|473371074|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
131475035|NCT00473746|473371075|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
131475036|NCT00473746|473371076|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
131475037|NCT00473746|473371072|FG000|Period 1 (Phase 1)|Reason not specified|0|||
131475038|NCT00473746|473371073|FG001|Period 1 (Phase 1)|Reason not specified|1|||
131475039|NCT00473746|473371074|FG002|Period 1 (Phase 1)|Reason not specified|0|||
131475040|NCT00473746|473371075|FG003|Period 1 (Phase 1)|Reason not specified|0|||
131475041|NCT00473746|473371076|FG004|Period 1 (Phase 1)|Reason not specified|0|||
131475042|NCT00473746|473371072|FG000|Period 2 (Phase 2)|Adverse Event|0|||
131475043|NCT00473746|473371073|FG001|Period 2 (Phase 2)|Adverse Event|0|||
131475044|NCT00473746|473371074|FG002|Period 2 (Phase 2)|Adverse Event|0|||
131475045|NCT00473746|473371075|FG003|Period 2 (Phase 2)|Adverse Event|0|||
131475046|NCT00473746|473371076|FG004|Period 2 (Phase 2)|Adverse Event|3|||
131475047|NCT00473746|473371072|FG000|Period 2 (Phase 2)|Death|0|||
131475048|NCT00473746|473371073|FG001|Period 2 (Phase 2)|Death|0|||
131475049|NCT00473746|473371074|FG002|Period 2 (Phase 2)|Death|0|||
131475050|NCT00473746|473371075|FG003|Period 2 (Phase 2)|Death|0|||
131475051|NCT00473746|473371076|FG004|Period 2 (Phase 2)|Death|1|||
131475052|NCT00473746|473371072|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
131475053|NCT00473746|473371073|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
131475054|NCT00473746|473371074|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
131475055|NCT00473746|473371075|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
131475056|NCT00473746|473371076|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
131475057|NCT00473746|473371072|FG000|Period 2 (Phase 2)|Reason not specified|0|||
131475058|NCT00473746|473371073|FG001|Period 2 (Phase 2)|Reason not specified|0|||
131475059|NCT00473746|473371074|FG002|Period 2 (Phase 2)|Reason not specified|0|||
131475060|NCT00473746|473371075|FG003|Period 2 (Phase 2)|Reason not specified|0|||
131475061|NCT00473746|473371076|FG004|Period 2 (Phase 2)|Reason not specified|3|||
131475062|NCT02961218|473371080|FG000|Overall Study|Lost to Follow-up|0|||
131475063|NCT02961218|473371081|FG001|Overall Study|Lost to Follow-up|2|||
131475064|NCT02961218|473371080|FG000|Overall Study|Physician Decision|0|||
131475065|NCT02961218|473371081|FG001|Overall Study|Physician Decision|2|||
131475066|NCT02961218|473371080|FG000|Overall Study|Subject/Guardian Decision|3|||
131475067|NCT02961218|473371081|FG001|Overall Study|Subject/Guardian Decision|1|||
131475068|NCT00591266|473371084|FG000|Overall Study|Adverse Event|2|||
131475069|NCT00591266|473371085|FG001|Overall Study|Adverse Event|2|||
131475070|NCT00591266|473371086|FG002|Overall Study|Adverse Event|3|||
131475071|NCT00591266|473371084|FG000|Overall Study|Lost to Follow-up|0|||
131475072|NCT00591266|473371085|FG001|Overall Study|Lost to Follow-up|1|||
131475073|NCT00591266|473371086|FG002|Overall Study|Lost to Follow-up|0|||
131475074|NCT00591266|473371084|FG000|Overall Study|Protocol Violation|0|||
131475075|NCT00591266|473371085|FG001|Overall Study|Protocol Violation|0|||
131475076|NCT00591266|473371086|FG002|Overall Study|Protocol Violation|1|||
131475077|NCT00591266|473371084|FG000|Overall Study|Withdrawal by Subject|6|||
131475078|NCT00591266|473371085|FG001|Overall Study|Withdrawal by Subject|2|||
131475079|NCT00591266|473371086|FG002|Overall Study|Withdrawal by Subject|5|||
131475080|NCT00591266|473371084|FG000|Overall Study|Lack of Efficacy|0|||
131475081|NCT00591266|473371085|FG001|Overall Study|Lack of Efficacy|2|||
131475082|NCT00591266|473371086|FG002|Overall Study|Lack of Efficacy|0|||
131475083|NCT00591266|473371084|FG000|Overall Study|Other|1|||
131475084|NCT00591266|473371085|FG001|Overall Study|Other|4|||
131475085|NCT00591266|473371086|FG002|Overall Study|Other|5|||
131475086|NCT03488927|473371087|FG000|Overall Study|Withdrawal by Subject|44|||
131475087|NCT03488927|473371088|FG001|Overall Study|Withdrawal by Subject|118|||
131475088|NCT03488927|473371089|FG002|Overall Study|Withdrawal by Subject|217|||
131475089|NCT05298306|473371095|FG000|Overall Study|Physician Decision|0|||
131475090|NCT05298306|473371096|FG001|Overall Study|Physician Decision|0|||
131475091|NCT05298306|473371097|FG002|Overall Study|Physician Decision|0|||
131475092|NCT05298306|473371098|FG003|Overall Study|Physician Decision|1|||
131475093|NCT05298306|473371099|FG004|Overall Study|Physician Decision|0|||
131475094|NCT05298306|473371100|FG005|Overall Study|Physician Decision|0|||
131475095|NCT00586066|473371101|FG000|Overall Study|Lost to Follow-up|6|||
131475096|NCT00586066|473371102|FG001|Overall Study|Lost to Follow-up|3|||
131475097|NCT00586066|473371101|FG000|Overall Study|Lack of Efficacy|5|||
131475098|NCT00586066|473371102|FG001|Overall Study|Lack of Efficacy|3|||
131475099|NCT00586066|473371101|FG000|Overall Study|Adverse Event|2|||
131475100|NCT00586066|473371102|FG001|Overall Study|Adverse Event|2|||
131475101|NCT00586066|473371101|FG000|Overall Study|Physician Decision|1|||
131475102|NCT00586066|473371102|FG001|Overall Study|Physician Decision|0|||
131475103|NCT00586066|473371101|FG000|Overall Study|Withdrawal of consent|4|||
131475104|NCT00586066|473371102|FG001|Overall Study|Withdrawal of consent|2|||
131475105|NCT02676466|473371105|FG000|Overall Study|Death|0|||
131475106|NCT02676466|473371106|FG001|Overall Study|Death|2|||
131475107|NCT02676466|473371107|FG002|Overall Study|Death|1|||
131475108|NCT02676466|473371108|FG003|Overall Study|Death|0|||
131475109|NCT02676466|473371109|FG004|Overall Study|Death|0|||
131475110|NCT02676466|473371110|FG005|Overall Study|Death|0|||
131475111|NCT02676466|473371111|FG006|Overall Study|Death|0|||
131475112|NCT02676466|473371112|FG007|Overall Study|Death|0|||
131475113|NCT02676466|473371105|FG000|Overall Study|Withdrawal by Subject|4|||
131475114|NCT02676466|473371106|FG001|Overall Study|Withdrawal by Subject|3|||
131475115|NCT02676466|473371107|FG002|Overall Study|Withdrawal by Subject|1|||
131475116|NCT02676466|473371108|FG003|Overall Study|Withdrawal by Subject|0|||
131475117|NCT02676466|473371109|FG004|Overall Study|Withdrawal by Subject|3|||
131475118|NCT02676466|473371110|FG005|Overall Study|Withdrawal by Subject|1|||
131475119|NCT02676466|473371111|FG006|Overall Study|Withdrawal by Subject|1|||
131475120|NCT02676466|473371112|FG007|Overall Study|Withdrawal by Subject|1|||
131475121|NCT01178073|473371114|FG000|Overall Study|Adverse Event|34|||
131475122|NCT01178073|473371115|FG001|Overall Study|Adverse Event|27|||
131475123|NCT01178073|473371116|FG002|Overall Study|Adverse Event|24|||
131475124|NCT01178073|473371114|FG000|Overall Study|Protocol Violation|1|||
131475125|NCT01178073|473371115|FG001|Overall Study|Protocol Violation|1|||
131475126|NCT01178073|473371116|FG002|Overall Study|Protocol Violation|1|||
131475127|NCT01178073|473371114|FG000|Overall Study|Lost to Follow-up|2|||
131475128|NCT01178073|473371115|FG001|Overall Study|Lost to Follow-up|0|||
131475129|NCT01178073|473371116|FG002|Overall Study|Lost to Follow-up|3|||
131475130|NCT01178073|473371114|FG000|Overall Study|Physician Decision|14|||
131475131|NCT01178073|473371115|FG001|Overall Study|Physician Decision|10|||
131475132|NCT01178073|473371116|FG002|Overall Study|Physician Decision|10|||
131475133|NCT01178073|473371114|FG000|Overall Study|Withdrawal by Subject|10|||
131475134|NCT01178073|473371115|FG001|Overall Study|Withdrawal by Subject|6|||
131475135|NCT01178073|473371116|FG002|Overall Study|Withdrawal by Subject|8|||
131475136|NCT01178073|473371114|FG000|Overall Study|Missing Completion Status|1|||
131475137|NCT01178073|473371115|FG001|Overall Study|Missing Completion Status|0|||
131475138|NCT01178073|473371116|FG002|Overall Study|Missing Completion Status|0|||
131475139|NCT03497676|473371119|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
131475140|NCT03497676|473371120|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
131475141|NCT03497676|473371121|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
131475142|NCT03497676|473371122|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
131475143|NCT03497676|473371119|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
131475144|NCT03497676|473371120|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
131475145|NCT03497676|473371121|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
131475146|NCT03497676|473371122|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
131475147|NCT03497676|473371119|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
131475148|NCT03497676|473371120|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
131475149|NCT03497676|473371121|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
131475150|NCT03497676|473371122|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
131475151|NCT03497676|473371119|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
131475152|NCT03497676|473371120|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
131475153|NCT03497676|473371121|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
131475154|NCT03497676|473371122|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
131475155|NCT03497676|473371119|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
131475156|NCT03497676|473371120|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
131475157|NCT03497676|473371121|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
131475158|NCT03497676|473371122|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
131475159|NCT03497676|473371119|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
131475160|NCT03497676|473371120|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
131475161|NCT03497676|473371121|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
131475162|NCT03497676|473371122|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
131475163|NCT03497676|473371119|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
131475164|NCT03497676|473371120|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
131475165|NCT03497676|473371121|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
131475166|NCT03497676|473371122|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
131475167|NCT03497676|473371119|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
131475168|NCT03497676|473371120|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
131475169|NCT03497676|473371121|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
131475170|NCT03497676|473371122|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
131475171|NCT02204007|473371123|FG000|Overall Study|Surgery Canceled|1|||
131475172|NCT02204007|473371124|FG001|Overall Study|Surgery Canceled|1|||
131475173|NCT00910988|473371125|FG000|Overall Study|Lost to Follow-up|2|||
131475174|NCT00910988|473371126|FG001|Overall Study|Lost to Follow-up|4|||
131475175|NCT00910988|473371127|FG002|Overall Study|Lost to Follow-up|3|||
131475176|NCT00910988|473371128|FG003|Overall Study|Lost to Follow-up|0|||
131475177|NCT00828854|473371129|FG000|Overall Study|Disease Progression|17|||
131475178|NCT00828854|473371129|FG000|Overall Study|Adverse Event|9|||
131475179|NCT00828854|473371129|FG000|Overall Study|Reason not Specified|1|||
131475180|NCT01505647|473371136|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
131475181|NCT01505647|473371137|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
131475182|NCT01505647|473371136|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
131475183|NCT01505647|473371137|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
131475184|NCT01505647|473371136|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
131475185|NCT01505647|473371137|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
131475186|NCT01505647|473371136|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
131475187|NCT01505647|473371137|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
131475188|NCT01505647|473371136|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
131475189|NCT01505647|473371137|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
131475190|NCT02059005|473371138|FG000|Overall Study|Death|1|||
131475191|NCT02059005|473371139|FG001|Overall Study|Death|3|||
131475192|NCT02059005|473371138|FG000|Overall Study|Lost to Follow-up|19|||
131475193|NCT02059005|473371139|FG001|Overall Study|Lost to Follow-up|19|||
131475194|NCT02059005|473371138|FG000|Overall Study|Incarceration|0|||
131475195|NCT02059005|473371139|FG001|Overall Study|Incarceration|1|||
131475196|NCT02059005|473371138|FG000|Overall Study|Inpatient|0|||
131475197|NCT02059005|473371139|FG001|Overall Study|Inpatient|1|||
131475198|NCT00908011|473371144|FG000|Overall Study|Withdrawal by Subject|2|||
131475199|NCT00908011|473371145|FG001|Overall Study|Withdrawal by Subject|2|||
131475200|NCT00739596|473371146|FG000|Overall Study|Adverse Event|12|||
131475201|NCT00739596|473371147|FG001|Overall Study|Adverse Event|6|||
131475202|NCT00739596|473371146|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
131475203|NCT00739596|473371147|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131475204|NCT00739596|473371146|FG000|Overall Study|Patient Withdrew Consent|8|||
131475205|NCT00739596|473371147|FG001|Overall Study|Patient Withdrew Consent|8|||
131475206|NCT00739596|473371146|FG000|Overall Study|Lost to Follow-up|0|||
131475207|NCT00739596|473371147|FG001|Overall Study|Lost to Follow-up|2|||
131475208|NCT00739596|473371146|FG000|Overall Study|Protocol Deviation|1|||
131475209|NCT00739596|473371147|FG001|Overall Study|Protocol Deviation|1|||
131475210|NCT04669535|473371148|FG000|Overall Study|Death|1|||
131475211|NCT04669535|473371149|FG001|Overall Study|Death|1|||
131475212|NCT04669535|473371150|FG002|Overall Study|Death|0|||
131475213|NCT04669535|473371151|FG003|Overall Study|Death|0|||
131475214|NCT02477696|473371152|FG000|Overall Study|Death|89|||
131475215|NCT02477696|473371153|FG001|Overall Study|Death|106|||
131475216|NCT02477696|473371152|FG000|Overall Study|Lost to Follow-up|7|||
131475217|NCT02477696|473371153|FG001|Overall Study|Lost to Follow-up|5|||
131475218|NCT02477696|473371152|FG000|Overall Study|Withdrawal by Subject|37|||
131475219|NCT02477696|473371153|FG001|Overall Study|Withdrawal by Subject|34|||
131475220|NCT02477696|473371152|FG000|Overall Study|Physician Decision|7|||
131475221|NCT02477696|473371153|FG001|Overall Study|Physician Decision|9|||
131475222|NCT02477696|473371152|FG000|Overall Study|Study terminated by sponsor|103|||
131475223|NCT02477696|473371153|FG001|Overall Study|Study terminated by sponsor|99|||
131475224|NCT02477696|473371152|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
131475225|NCT02477696|473371153|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
131475226|NCT02477696|473371152|FG000|Overall Study|Missing/Unknown|2|||
131475227|NCT02477696|473371153|FG001|Overall Study|Missing/Unknown|0|||
131475228|NCT00401531|473372658|FG000|Overall Study|Adverse Event|2|||
131475229|NCT00401531|473372659|FG001|Overall Study|Adverse Event|0|||
131475230|NCT00401531|473372658|FG000|Overall Study|Protocol Violation|3|||
131475231|NCT00401531|473372659|FG001|Overall Study|Protocol Violation|7|||
131475232|NCT00401531|473372658|FG000|Overall Study|Lost to Follow-up|1|||
131475233|NCT00401531|473372659|FG001|Overall Study|Lost to Follow-up|1|||
131475234|NCT00401531|473372658|FG000|Overall Study|Withdrawal by Subject|3|||
131475235|NCT00401531|473372659|FG001|Overall Study|Withdrawal by Subject|2|||
131475236|NCT03906461|473372660|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
131475237|NCT03906461|473372660|FG000|Completed 12-month Follow-up|Missed Visit|6|||
131475238|NCT00510874|473372661|FG000|Overall Study|Withdrawal by Subject|1|||
131475239|NCT00510874|473372662|FG001|Overall Study|Withdrawal by Subject|1|||
131475240|NCT00510874|473372663|FG002|Overall Study|Withdrawal by Subject|0|||
131475241|NCT00510874|473372664|FG003|Overall Study|Withdrawal by Subject|0|||
131475242|NCT00510874|473372665|FG004|Overall Study|Withdrawal by Subject|3|||
131475243|NCT00510874|473372666|FG005|Overall Study|Withdrawal by Subject|0|||
131475244|NCT00510874|473372667|FG006|Overall Study|Withdrawal by Subject|0|||
131475245|NCT00510874|473372661|FG000|Overall Study|Lost to Follow-up|2|||
131475246|NCT00510874|473372662|FG001|Overall Study|Lost to Follow-up|3|||
131475247|NCT00510874|473372663|FG002|Overall Study|Lost to Follow-up|1|||
131475248|NCT00510874|473372664|FG003|Overall Study|Lost to Follow-up|3|||
131475249|NCT00510874|473372665|FG004|Overall Study|Lost to Follow-up|4|||
131475250|NCT00510874|473372666|FG005|Overall Study|Lost to Follow-up|0|||
131475251|NCT00510874|473372667|FG006|Overall Study|Lost to Follow-up|1|||
131475252|NCT03956056|473372670|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
131475253|NCT03956056|473372670|FG000|Overall Study|Lack of Efficacy|1|||
131475254|NCT02360995|473372671|FG000|Overall Study|Lost to Follow-up|2|||
131475255|NCT02360995|473372672|FG001|Overall Study|Lost to Follow-up|0|||
131475256|NCT02360995|473372673|FG002|Overall Study|Lost to Follow-up|2|||
131475257|NCT02360995|473372671|FG000|Overall Study|Withdrawal by Subject|0|||
131475258|NCT02360995|473372672|FG001|Overall Study|Withdrawal by Subject|1|||
131475259|NCT02360995|473372673|FG002|Overall Study|Withdrawal by Subject|0|||
131475260|NCT02395666|473372674|FG000|Overall Study|Physician Decision|3|||
131475261|NCT02395666|473372675|FG001|Overall Study|Physician Decision|0|||
131475262|NCT02395666|473372674|FG000|Overall Study|Lost to Follow-up|1|||
131475263|NCT02395666|473372675|FG001|Overall Study|Lost to Follow-up|0|||
131475264|NCT02395666|473372674|FG000|Overall Study|Withdrawal by Subject|2|||
131475265|NCT02395666|473372675|FG001|Overall Study|Withdrawal by Subject|1|||
131475266|NCT01409434|473372676|FG000|Overall Study|Protocol Violation|4|||
131475267|NCT04622735|473372677|FG000|Overall Study|Lost to Follow-up|1|||
131475268|NCT04622735|473372678|FG001|Overall Study|Lost to Follow-up|2|||
131475269|NCT04622735|473372679|FG002|Overall Study|Lost to Follow-up|1|||
131475270|NCT04622735|473372677|FG000|Overall Study|Adverse Event|0|||
131475271|NCT04622735|473372678|FG001|Overall Study|Adverse Event|0|||
131475272|NCT04622735|473372679|FG002|Overall Study|Adverse Event|1|||
131475273|NCT04622735|473372677|FG000|Overall Study|Protocol Violation|1|||
131475274|NCT04622735|473372678|FG001|Overall Study|Protocol Violation|0|||
131475275|NCT04622735|473372679|FG002|Overall Study|Protocol Violation|0|||
131475276|NCT04629508|473372680|FG000|Overall Study|Adverse Event|1|||
131475277|NCT04629508|473372680|FG000|Overall Study|Death|2|||
131475278|NCT04629508|473372680|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
131475279|NCT04073368|473372681|FG000|Overall Study|Adverse Event|2|||
131475280|NCT04073368|473372682|FG001|Overall Study|Adverse Event|0|||
131475281|NCT04073368|473372683|FG002|Overall Study|Adverse Event|1|||
131475282|NCT04073368|473372684|FG003|Overall Study|Adverse Event|1|||
131475283|NCT04073368|473372681|FG000|Overall Study|Withdrawal by Subject|2|||
131475284|NCT04073368|473372682|FG001|Overall Study|Withdrawal by Subject|2|||
131475285|NCT04073368|473372683|FG002|Overall Study|Withdrawal by Subject|1|||
131475286|NCT04073368|473372684|FG003|Overall Study|Withdrawal by Subject|1|||
131475287|NCT04073368|473372681|FG000|Overall Study|Lost to Follow-up|1|||
131475288|NCT04073368|473372682|FG001|Overall Study|Lost to Follow-up|1|||
131475289|NCT04073368|473372683|FG002|Overall Study|Lost to Follow-up|1|||
131475290|NCT04073368|473372684|FG003|Overall Study|Lost to Follow-up|0|||
131475291|NCT04073368|473372681|FG000|Overall Study|Protocol Violation|0|||
131475292|NCT04073368|473372682|FG001|Overall Study|Protocol Violation|1|||
131475293|NCT04073368|473372683|FG002|Overall Study|Protocol Violation|0|||
131475294|NCT04073368|473372684|FG003|Overall Study|Protocol Violation|0|||
131475295|NCT04073368|473372681|FG000|Overall Study|Subject noncompliance|7|||
131475296|NCT04073368|473372682|FG001|Overall Study|Subject noncompliance|4|||
131475297|NCT04073368|473372683|FG002|Overall Study|Subject noncompliance|0|||
131475298|NCT04073368|473372684|FG003|Overall Study|Subject noncompliance|0|||
131475299|NCT03960554|473372693|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
131475300|NCT03960554|473372694|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
131475301|NCT00735254|473372695|FG000|Overall Study|Protocol Violation|1|||
131475302|NCT00735254|473372696|FG001|Overall Study|Protocol Violation|1|||
131475303|NCT00735254|473372697|FG002|Overall Study|Protocol Violation|1|||
131475304|NCT00735254|473372698|FG003|Overall Study|Protocol Violation|0|||
131475305|NCT01251744|473372699|FG000|Overall Study|Lost to Follow-up|1|||
131475306|NCT01251744|473372700|FG001|Overall Study|Lost to Follow-up|0|||
131475307|NCT00751621|473372701|FG000|Overall Study|Adverse Event|1|||
131475308|NCT00751621|473372701|FG000|Overall Study|Withdrawal by Subject|1|||
131475309|NCT00751621|473372701|FG000|Overall Study|Subject moved to another country|1|||
131475310|NCT00751621|473372701|FG000|Overall Study|Poor adherence to asthma treatment|1|||
131475311|NCT02694523|473372702|FG000|Part A|Adverse Event|7|||
131475312|NCT02694523|473372703|FG001|Part A|Adverse Event|3|||
131475313|NCT02694523|473372704|FG002|Part A|Adverse Event|0|||
131475314|NCT02694523|473372705|FG003|Part A|Adverse Event|0|||
131475315|NCT02694523|473372706|FG004|Part A|Adverse Event|0|||
131475316|NCT02694523|473372707|FG005|Part A|Adverse Event|0|||
131475317|NCT02694523|473372708|FG006|Part A|Adverse Event|0|||
131475318|NCT02694523|473372702|FG000|Part A|Protocol Violation|1|||
131475319|NCT02694523|473372703|FG001|Part A|Protocol Violation|0|||
131475320|NCT02694523|473372704|FG002|Part A|Protocol Violation|0|||
131475321|NCT02694523|473372705|FG003|Part A|Protocol Violation|0|||
131475322|NCT02694523|473372706|FG004|Part A|Protocol Violation|0|||
131475323|NCT02694523|473372707|FG005|Part A|Protocol Violation|0|||
131475324|NCT02694523|473372708|FG006|Part A|Protocol Violation|0|||
131475325|NCT02694523|473372702|FG000|Part A|Lost to Follow-up|1|||
131475326|NCT02694523|473372703|FG001|Part A|Lost to Follow-up|2|||
131475327|NCT02694523|473372704|FG002|Part A|Lost to Follow-up|0|||
131475328|NCT02694523|473372705|FG003|Part A|Lost to Follow-up|0|||
131475329|NCT02694523|473372706|FG004|Part A|Lost to Follow-up|0|||
131475330|NCT02694523|473372707|FG005|Part A|Lost to Follow-up|0|||
131475331|NCT02694523|473372708|FG006|Part A|Lost to Follow-up|0|||
131475332|NCT02694523|473372702|FG000|Part A|Withdrawal by Subject|3|||
131475333|NCT02694523|473372703|FG001|Part A|Withdrawal by Subject|1|||
131475334|NCT02694523|473372704|FG002|Part A|Withdrawal by Subject|0|||
131475335|NCT02694523|473372705|FG003|Part A|Withdrawal by Subject|0|||
131475336|NCT02694523|473372706|FG004|Part A|Withdrawal by Subject|0|||
131475337|NCT02694523|473372707|FG005|Part A|Withdrawal by Subject|0|||
131475338|NCT02694523|473372708|FG006|Part A|Withdrawal by Subject|0|||
131475339|NCT02694523|473372702|FG000|Part A|Other|1|||
131475340|NCT02694523|473372703|FG001|Part A|Other|1|||
131475341|NCT02694523|473372704|FG002|Part A|Other|0|||
131475342|NCT02694523|473372705|FG003|Part A|Other|0|||
131475343|NCT02694523|473372706|FG004|Part A|Other|0|||
131475344|NCT02694523|473372707|FG005|Part A|Other|0|||
131475345|NCT02694523|473372708|FG006|Part A|Other|0|||
131475346|NCT02694523|473372702|FG000|Part B|Adverse Event|0|||
131475347|NCT02694523|473372703|FG001|Part B|Adverse Event|0|||
131475348|NCT02694523|473372704|FG002|Part B|Adverse Event|7|||
131475349|NCT02694523|473372705|FG003|Part B|Adverse Event|1|||
131475350|NCT02694523|473372706|FG004|Part B|Adverse Event|1|||
131475351|NCT02694523|473372707|FG005|Part B|Adverse Event|2|||
131475352|NCT02694523|473372708|FG006|Part B|Adverse Event|0|||
131475353|NCT02694523|473372702|FG000|Part B|Protocol Violation|0|||
131475354|NCT02694523|473372703|FG001|Part B|Protocol Violation|0|||
131475355|NCT02694523|473372704|FG002|Part B|Protocol Violation|1|||
131475356|NCT02694523|473372705|FG003|Part B|Protocol Violation|0|||
131475357|NCT02694523|473372706|FG004|Part B|Protocol Violation|0|||
131475358|NCT02694523|473372707|FG005|Part B|Protocol Violation|0|||
131475359|NCT02694523|473372708|FG006|Part B|Protocol Violation|0|||
131475360|NCT02694523|473372702|FG000|Part B|Lost to Follow-up|0|||
131475361|NCT02694523|473372703|FG001|Part B|Lost to Follow-up|0|||
131475362|NCT02694523|473372704|FG002|Part B|Lost to Follow-up|2|||
131475363|NCT02694523|473372705|FG003|Part B|Lost to Follow-up|3|||
131475364|NCT02694523|473372706|FG004|Part B|Lost to Follow-up|2|||
131475365|NCT02694523|473372707|FG005|Part B|Lost to Follow-up|0|||
131475366|NCT02694523|473372708|FG006|Part B|Lost to Follow-up|1|||
131475367|NCT02694523|473372702|FG000|Part B|Withdrawal by Subject|0|||
131475368|NCT02694523|473372703|FG001|Part B|Withdrawal by Subject|0|||
131475369|NCT02694523|473372704|FG002|Part B|Withdrawal by Subject|9|||
131475370|NCT02694523|473372705|FG003|Part B|Withdrawal by Subject|0|||
131475371|NCT02694523|473372706|FG004|Part B|Withdrawal by Subject|1|||
131475372|NCT02694523|473372707|FG005|Part B|Withdrawal by Subject|3|||
131475373|NCT02694523|473372708|FG006|Part B|Withdrawal by Subject|0|||
131475374|NCT02694523|473372702|FG000|Part B|Other|0|||
131475375|NCT02694523|473372703|FG001|Part B|Other|0|||
131475376|NCT02694523|473372704|FG002|Part B|Other|1|||
131475377|NCT02694523|473372705|FG003|Part B|Other|0|||
131475378|NCT02694523|473372706|FG004|Part B|Other|0|||
131475379|NCT02694523|473372707|FG005|Part B|Other|0|||
131475380|NCT02694523|473372708|FG006|Part B|Other|1|||
131475381|NCT02791594|473372711|FG000|Overall Study|Physician Decision|2|||
131475382|NCT02310321|473372712|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
131475383|NCT02310321|473372713|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
131475384|NCT02310321|473372714|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
131475385|NCT02310321|473372712|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
131475386|NCT02310321|473372713|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
131475387|NCT02310321|473372714|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
131475388|NCT02310321|473372712|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
131475389|NCT02310321|473372713|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
131475390|NCT02310321|473372714|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
131475391|NCT02310321|473372712|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
131475392|NCT02310321|473372713|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
131475393|NCT02310321|473372714|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
131475394|NCT02310321|473372712|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
131475395|NCT02310321|473372713|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
131475396|NCT02310321|473372714|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
131475397|NCT02310321|473372712|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
131475398|NCT02310321|473372713|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
131475399|NCT02310321|473372714|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
131475400|NCT02310321|473372712|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
131475401|NCT02310321|473372713|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
131475402|NCT02310321|473372714|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
131475403|NCT02310321|473372712|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
131475404|NCT02310321|473372713|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
131475405|NCT02310321|473372714|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
131475406|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
131475407|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
131475408|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
131475409|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
131475410|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
131475411|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
131475412|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
131475413|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
131475414|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
131475415|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
131475416|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
131475417|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
131475418|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
131475419|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
131475420|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
131475421|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
131475422|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
131475423|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
131475424|NCT02310321|473372712|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
131475425|NCT02310321|473372713|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
131475426|NCT02310321|473372714|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
131475427|NCT02310321|473372712|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
131475428|NCT02310321|473372713|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
131475429|NCT02310321|473372714|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
131475430|NCT02310321|473372712|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
131475431|NCT02310321|473372713|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
131475432|NCT02310321|473372714|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
131475433|NCT02310321|473372712|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
131475434|NCT02310321|473372713|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
131475435|NCT02310321|473372714|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
131475436|NCT02310321|473372712|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
131475437|NCT02310321|473372713|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
131475438|NCT02310321|473372714|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
131475439|NCT02310321|473372712|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
131475440|NCT02310321|473372713|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
131475441|NCT02310321|473372714|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
131475442|NCT02310321|473372712|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
131475443|NCT02310321|473372713|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
131475444|NCT02310321|473372714|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
131475445|NCT02310321|473372712|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
131475446|NCT02310321|473372713|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
131475447|NCT02310321|473372714|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
131475448|NCT02310321|473372712|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
131475449|NCT02310321|473372713|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
131475450|NCT02310321|473372714|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
131475451|NCT01698905|473372715|FG000|Overall Study|Adverse Event|4|||
131475452|NCT01698905|473372715|FG000|Overall Study|Physician Decision|2|||
131475453|NCT01698905|473372715|FG000|Overall Study|Pregnancy|1|||
131475454|NCT01698905|473372715|FG000|Overall Study|Protocol Violation|1|||
131475455|NCT01698905|473372715|FG000|Overall Study|Subject/guardian decision|2|||
131475456|NCT01698905|473372715|FG000|Overall Study|Death|1|||
131475457|NCT05896748|473372716|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
131475458|NCT05896748|473372716|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
131475459|NCT05896748|473372716|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
131475460|NCT05896748|473372716|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
131475461|NCT05896748|473372716|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
131475462|NCT01528215|473372718|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
131475463|NCT01528215|473372719|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
131475464|NCT01528215|473372718|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
131475465|NCT01528215|473372719|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
131882090|NCT03045276|474849336|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
131882091|NCT03045276|474849337|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
131882092|NCT03379753|474849338|FG000|Overall Study|Withdrawal by Subject|2|||
131882093|NCT03379753|474849339|FG001|Overall Study|Withdrawal by Subject|1|||
131882094|NCT03379753|474849338|FG000|Overall Study|not having correct procedure|1|||
131882095|NCT03379753|474849339|FG001|Overall Study|not having correct procedure|2|||
131882096|NCT03379753|474849338|FG000|Overall Study|No primary outcome|12|||
131882097|NCT03379753|474849339|FG001|Overall Study|No primary outcome|22|||
131882098|NCT01597375|474849340|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
131882099|NCT01597375|474849341|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
131882100|NCT01597375|474849340|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
131882101|NCT01597375|474849341|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
131882102|NCT01597375|474849340|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131882103|NCT01597375|474849341|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
131882104|NCT01597375|474849340|FG000|Washout (2 Weeks)|Adverse Event|1|||
131882105|NCT01597375|474849341|FG001|Washout (2 Weeks)|Adverse Event|0|||
131882106|NCT01597375|474849340|FG000|Second Intervention|Failed to react at both Aspirin|1|||
131882107|NCT01597375|474849341|FG001|Second Intervention|Failed to react at both Aspirin|1|||
131882108|NCT02225366|474849346|FG000|Overall Study|Lack of Efficacy|1|||
131882109|NCT02225366|474849347|FG001|Overall Study|Lack of Efficacy|0|||
131882110|NCT04713592|474849350|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
131882111|NCT04713592|474849351|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
131882112|NCT04713592|474849352|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
131882113|NCT04713592|474849353|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
131882114|NCT04713592|474849350|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
131882115|NCT04713592|474849351|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
131882116|NCT04713592|474849352|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
131882117|NCT04713592|474849353|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
131882118|NCT04713592|474849350|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
131882119|NCT04713592|474849351|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
131475466|NCT01528215|473372718|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
131475467|NCT01528215|473372719|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
131475468|NCT01528215|473372718|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
131475469|NCT01528215|473372719|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
131475470|NCT01462227|473372721|FG000|Second Assignment|Lost to Follow-up|1|||
131475471|NCT01462227|473372722|FG001|Second Assignment|Lost to Follow-up|0|||
131475472|NCT01462227|473372723|FG002|Second Assignment|Lost to Follow-up|0|||
131475473|NCT01462227|473372724|FG003|Second Assignment|Lost to Follow-up|0|||
131475474|NCT01462227|473372721|FG000|Second Assignment|Protocol Violation|0|||
131475475|NCT01462227|473372722|FG001|Second Assignment|Protocol Violation|1|||
131475476|NCT01462227|473372723|FG002|Second Assignment|Protocol Violation|1|||
131475477|NCT01462227|473372724|FG003|Second Assignment|Protocol Violation|0|||
131475478|NCT00237185|473372730|FG000|Core|Adverse Event|3|||
131475479|NCT00237185|473372731|FG001|Core|Adverse Event|4|||
131475480|NCT00237185|473372730|FG000|Core|Abnormal laboratory value|0|||
131475481|NCT00237185|473372731|FG001|Core|Abnormal laboratory value|4|||
131475482|NCT00237185|473372730|FG000|Core|Abnormal test procedure results|1|||
131475483|NCT00237185|473372731|FG001|Core|Abnormal test procedure results|0|||
131475484|NCT00237185|473372730|FG000|Core|Lack of Efficacy|30|||
131475485|NCT00237185|473372731|FG001|Core|Lack of Efficacy|23|||
131475486|NCT00237185|473372730|FG000|Core|Protocol Violation|1|||
131475487|NCT00237185|473372731|FG001|Core|Protocol Violation|1|||
131475488|NCT00237185|473372730|FG000|Core|Withdrawal by Subject|4|||
131475489|NCT00237185|473372731|FG001|Core|Withdrawal by Subject|4|||
131475490|NCT00237185|473372730|FG000|Core|Administrative problems|0|||
131475491|NCT00237185|473372731|FG001|Core|Administrative problems|1|||
131475492|NCT00237185|473372730|FG000|Core|Death|4|||
131475493|NCT00237185|473372731|FG001|Core|Death|0|||
131475494|NCT00237185|473372730|FG000|Core|Determined ineligible post randomization|1|||
131475495|NCT00237185|473372731|FG001|Core|Determined ineligible post randomization|0|||
131475496|NCT00237185|473372730|FG000|Extension|Adverse Event|1|||
131475497|NCT00237185|473372731|FG001|Extension|Adverse Event|0|||
131475498|NCT00237185|473372730|FG000|Extension|Abnormal laboratory value|0|||
131475499|NCT00237185|473372731|FG001|Extension|Abnormal laboratory value|1|||
131475500|NCT00237185|473372730|FG000|Extension|Lack of Efficacy|9|||
131475501|NCT00237185|473372731|FG001|Extension|Lack of Efficacy|14|||
131475502|NCT00237185|473372730|FG000|Extension|Condition no longer required study drug|0|||
131475503|NCT00237185|473372731|FG001|Extension|Condition no longer required study drug|1|||
131475504|NCT00237185|473372730|FG000|Extension|Withdrawal by Subject|3|||
131475505|NCT00237185|473372731|FG001|Extension|Withdrawal by Subject|2|||
131475506|NCT00237185|473372730|FG000|Extension|Lost to Follow-up|1|||
131475507|NCT00237185|473372731|FG001|Extension|Lost to Follow-up|0|||
131475508|NCT00237185|473372730|FG000|Extension|Administrative problems|1|||
131475509|NCT00237185|473372731|FG001|Extension|Administrative problems|0|||
131475510|NCT00237185|473372730|FG000|Extension|Death|1|||
131475511|NCT00237185|473372731|FG001|Extension|Death|1|||
131475512|NCT02035475|473372732|FG000|Overall Study|Withdrawal by Subject|4|||
131475513|NCT02035475|473372732|FG000|Overall Study|Physician Decision|1|||
131475514|NCT02035475|473372732|FG000|Overall Study|Equipment Error|1|||
131475515|NCT01702571|473372733|FG000|Overall Study|Death|1067|||
131475516|NCT01702571|473372734|FG001|Overall Study|Death|76|||
131475517|NCT01702571|473372733|FG000|Overall Study|Lost to Follow-up|144|||
131475518|NCT01702571|473372734|FG001|Overall Study|Lost to Follow-up|10|||
131475519|NCT01702571|473372733|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
131475520|NCT01702571|473372734|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
131475521|NCT01702571|473372733|FG000|Overall Study|Investigator Decision|5|||
131475522|NCT01702571|473372734|FG001|Overall Study|Investigator Decision|0|||
131475523|NCT01702571|473372733|FG000|Overall Study|Not Classifiable|1|||
131475524|NCT01702571|473372734|FG001|Overall Study|Not Classifiable|0|||
131475525|NCT01702571|473372733|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
131475526|NCT01702571|473372734|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
131475527|NCT01702571|473372733|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
131475528|NCT01702571|473372734|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
131475529|NCT01702571|473372733|FG000|Overall Study|Progressive Disease|3|||
131475530|NCT01702571|473372734|FG001|Overall Study|Progressive Disease|0|||
131475531|NCT01702571|473372733|FG000|Overall Study|Protocol Violation|2|||
131475532|NCT01702571|473372734|FG001|Overall Study|Protocol Violation|0|||
131475533|NCT01702571|473372733|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
131475534|NCT01702571|473372734|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
131475535|NCT01702571|473372733|FG000|Overall Study|Termination By Sponsor|4|||
131475536|NCT01702571|473372734|FG001|Overall Study|Termination By Sponsor|0|||
131475537|NCT01702571|473372733|FG000|Overall Study|Withdrawal by Subject|177|||
131475538|NCT01702571|473372734|FG001|Overall Study|Withdrawal by Subject|29|||
131475539|NCT02047227|473372735|FG000|Overall Study|Adverse Event|2|||
131475540|NCT02047227|473372736|FG001|Overall Study|Adverse Event|4|||
131475541|NCT02047227|473372735|FG000|Overall Study|Lost to Follow-up|0|||
131475542|NCT02047227|473372736|FG001|Overall Study|Lost to Follow-up|3|||
131475543|NCT02047227|473372735|FG000|Overall Study|Protocol Violation|1|||
131475544|NCT02047227|473372736|FG001|Overall Study|Protocol Violation|0|||
131475545|NCT02047227|473372735|FG000|Overall Study|Spontaneous pregnancy|1|||
131475546|NCT02047227|473372736|FG001|Overall Study|Spontaneous pregnancy|0|||
131475547|NCT02047227|473372735|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
131475548|NCT02047227|473372736|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
131475549|NCT02047227|473372735|FG000|Overall Study|No oocytes retrieved|21|||
131475550|NCT02047227|473372736|FG001|Overall Study|No oocytes retrieved|20|||
131475551|NCT02047227|473372735|FG000|Overall Study|No fertilization|61|||
131475552|NCT02047227|473372736|FG001|Overall Study|No fertilization|51|||
131475553|NCT02047227|473372735|FG000|Overall Study|Intention to freeze all embryos|1|||
131475554|NCT02047227|473372736|FG001|Overall Study|Intention to freeze all embryos|0|||
131475555|NCT02047227|473372735|FG000|Overall Study|All embryos discarded|12|||
131475556|NCT02047227|473372736|FG001|Overall Study|All embryos discarded|11|||
131475557|NCT02047227|473372735|FG000|Overall Study|Other|10|||
131475558|NCT02047227|473372736|FG001|Overall Study|Other|9|||
131475559|NCT01977937|473372745|FG000|Overall Study|Withdrawal by Subject|2|||
131475560|NCT01977937|473372746|FG001|Overall Study|Withdrawal by Subject|1|||
131475561|NCT01977937|473372745|FG000|Overall Study|Adverse Event|1|||
131475562|NCT01977937|473372746|FG001|Overall Study|Adverse Event|0|||
131475563|NCT01977937|473372745|FG000|Overall Study|Physician Decision|0|||
131475564|NCT01977937|473372746|FG001|Overall Study|Physician Decision|1|||
131475565|NCT00915356|473372747|FG000|Overall Study|Withdrawal by Subject|1|||
131475566|NCT00915356|473372748|FG001|Overall Study|Withdrawal by Subject|0|||
131475567|NCT00915356|473372749|FG002|Overall Study|Withdrawal by Subject|0|||
131475568|NCT00915356|473372750|FG003|Overall Study|Withdrawal by Subject|0|||
131475569|NCT00915356|473372751|FG004|Overall Study|Withdrawal by Subject|0|||
131475570|NCT02819518|473372757|FG000|Overall Study|Death|9|||
131475571|NCT02819518|473372758|FG001|Overall Study|Death|12|||
131475572|NCT02819518|473372759|FG002|Overall Study|Death|9|||
131475573|NCT02819518|473372760|FG003|Overall Study|Death|475|||
131475574|NCT02819518|473372761|FG004|Overall Study|Death|244|||
131475575|NCT02819518|473372757|FG000|Overall Study|Withdrawal by Subject|0|||
131475576|NCT02819518|473372758|FG001|Overall Study|Withdrawal by Subject|0|||
131475577|NCT02819518|473372759|FG002|Overall Study|Withdrawal by Subject|0|||
131475578|NCT02819518|473372760|FG003|Overall Study|Withdrawal by Subject|25|||
131475579|NCT02819518|473372761|FG004|Overall Study|Withdrawal by Subject|8|||
131475580|NCT02819518|473372757|FG000|Overall Study|Lost to Follow-up|0|||
131475581|NCT02819518|473372758|FG001|Overall Study|Lost to Follow-up|0|||
131475582|NCT02819518|473372759|FG002|Overall Study|Lost to Follow-up|0|||
131475583|NCT02819518|473372760|FG003|Overall Study|Lost to Follow-up|0|||
131475584|NCT02819518|473372761|FG004|Overall Study|Lost to Follow-up|1|||
131475585|NCT02819518|473372757|FG000|Overall Study|Sponsor Decision|1|||
131475586|NCT02819518|473372758|FG001|Overall Study|Sponsor Decision|1|||
131475587|NCT02819518|473372759|FG002|Overall Study|Sponsor Decision|0|||
131475588|NCT02819518|473372760|FG003|Overall Study|Sponsor Decision|34|||
131475589|NCT02819518|473372761|FG004|Overall Study|Sponsor Decision|17|||
131475590|NCT02819518|473372757|FG000|Overall Study|Transferred to extension study|1|||
131475591|NCT02819518|473372758|FG001|Overall Study|Transferred to extension study|1|||
131475592|NCT02819518|473372759|FG002|Overall Study|Transferred to extension study|1|||
131475593|NCT02819518|473372760|FG003|Overall Study|Transferred to extension study|32|||
131475594|NCT02819518|473372761|FG004|Overall Study|Transferred to extension study|11|||
131475595|NCT00880165|473372762|FG000|Overall Study|Withdrawal by Subject|27|||
131475596|NCT00880165|473372763|FG001|Overall Study|Withdrawal by Subject|23|||
131475597|NCT00880165|473372762|FG000|Overall Study|Not diagnosed with OSA|14|||
131475598|NCT00880165|473372763|FG001|Overall Study|Not diagnosed with OSA|8|||
131475599|NCT00880165|473372762|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
131475600|NCT00880165|473372763|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
131475601|NCT00880165|473372762|FG000|Overall Study|Lost to follow|9|||
131475602|NCT00880165|473372763|FG001|Overall Study|Lost to follow|15|||
131475603|NCT00667602|473372764|FG000|Overall Study|Withdrawal by Subject|4|||
131475604|NCT00667602|473372765|FG001|Overall Study|Withdrawal by Subject|9|||
131475605|NCT00667602|473372766|FG002|Overall Study|Withdrawal by Subject|10|||
131475606|NCT00667602|473372764|FG000|Overall Study|Lost to Follow-up|4|||
131475607|NCT00667602|473372765|FG001|Overall Study|Lost to Follow-up|5|||
131475608|NCT00667602|473372766|FG002|Overall Study|Lost to Follow-up|6|||
131475609|NCT00667602|473372764|FG000|Overall Study|Administrative reason|0|||
131475610|NCT00667602|473372765|FG001|Overall Study|Administrative reason|0|||
131475611|NCT00667602|473372766|FG002|Overall Study|Administrative reason|2|||
131475612|NCT00667602|473372764|FG000|Overall Study|Protocol Violation|0|||
131475613|NCT00667602|473372765|FG001|Overall Study|Protocol Violation|1|||
131475614|NCT00667602|473372766|FG002|Overall Study|Protocol Violation|0|||
131475615|NCT02750943|473372774|FG000|Overall Study|Lost to Follow-up|1|||
131475616|NCT02750943|473372775|FG001|Overall Study|Lost to Follow-up|2|||
131475617|NCT02750943|473372774|FG000|Overall Study|Withdrawal by Subject|5|||
131475618|NCT02750943|473372775|FG001|Overall Study|Withdrawal by Subject|7|||
131475619|NCT00171054|473372776|FG000|Overall Study|Protocol Violation|1|||
131475620|NCT00171054|473372777|FG001|Overall Study|Protocol Violation|2|||
131475621|NCT00171054|473372776|FG000|Overall Study|Patient withdrew consent|1|||
131475622|NCT00171054|473372777|FG001|Overall Study|Patient withdrew consent|0|||
131882120|NCT04713592|474849352|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
131882121|NCT04713592|474849353|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
131882122|NCT04713592|474849350|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131882123|NCT04713592|474849351|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
131475623|NCT00171054|473372776|FG000|Overall Study|Lost to Follow-up|0|||
131475624|NCT00171054|473372777|FG001|Overall Study|Lost to Follow-up|1|||
131475625|NCT00171054|473372776|FG000|Overall Study|Adverse Event|8|||
131475626|NCT00171054|473372777|FG001|Overall Study|Adverse Event|8|||
131475627|NCT00171054|473372776|FG000|Overall Study|Condition no longer required study drug|0|||
131475628|NCT00171054|473372777|FG001|Overall Study|Condition no longer required study drug|1|||
131475629|NCT03635788|473372781|FG000|Step 1|Death|1|||
131475630|NCT03635788|473372782|FG001|Step 1|Death|0|||
131475631|NCT03635788|473372783|FG002|Step 1|Death|0|||
131475632|NCT03635788|473372781|FG000|Step 1|Lost to Follow-up|31|||
131475633|NCT03635788|473372782|FG001|Step 1|Lost to Follow-up|0|||
131475634|NCT03635788|473372783|FG002|Step 1|Lost to Follow-up|0|||
131475635|NCT03635788|473372781|FG000|Step 1|Pregnancy|1|||
131475636|NCT03635788|473372782|FG001|Step 1|Pregnancy|0|||
131475637|NCT03635788|473372783|FG002|Step 1|Pregnancy|0|||
131475638|NCT03635788|473372781|FG000|Step 1|Protocol Violation|8|||
131475639|NCT03635788|473372782|FG001|Step 1|Protocol Violation|0|||
131475640|NCT03635788|473372783|FG002|Step 1|Protocol Violation|0|||
131475641|NCT03635788|473372781|FG000|Step 1|Withdrawal by Subject|13|||
131475642|NCT03635788|473372782|FG001|Step 1|Withdrawal by Subject|0|||
131475643|NCT03635788|473372783|FG002|Step 1|Withdrawal by Subject|0|||
131475644|NCT03635788|473372781|FG000|Step 1|Other reasons|12|||
131475645|NCT03635788|473372782|FG001|Step 1|Other reasons|0|||
131475646|NCT03635788|473372783|FG002|Step 1|Other reasons|0|||
131475647|NCT03635788|473372781|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
131475648|NCT03635788|473372782|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
131475649|NCT03635788|473372783|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
131475650|NCT03635788|473372781|FG000|Step 2|Lost to Follow-up|0|||
131475651|NCT03635788|473372782|FG001|Step 2|Lost to Follow-up|8|||
131475652|NCT03635788|473372783|FG002|Step 2|Lost to Follow-up|15|||
131475653|NCT03635788|473372781|FG000|Step 2|Withdrawal by Subject|0|||
131475654|NCT03635788|473372782|FG001|Step 2|Withdrawal by Subject|6|||
131475655|NCT03635788|473372783|FG002|Step 2|Withdrawal by Subject|6|||
131475656|NCT03635788|473372781|FG000|Step 2|Death|0|||
131475657|NCT03635788|473372782|FG001|Step 2|Death|2|||
131882124|NCT04713592|474849352|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
131882125|NCT04713592|474849353|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
131882126|NCT04713592|474849350|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
131882127|NCT04713592|474849351|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
131882128|NCT04713592|474849352|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
131882129|NCT04713592|474849353|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
131882130|NCT04713592|474849350|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131882131|NCT04713592|474849351|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131882132|NCT04713592|474849352|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
131882133|NCT04713592|474849353|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
131475658|NCT03635788|473372783|FG002|Step 2|Death|0|||
131475659|NCT03635788|473372781|FG000|Step 2|Incarceration|0|||
131475660|NCT03635788|473372782|FG001|Step 2|Incarceration|2|||
131475661|NCT03635788|473372783|FG002|Step 2|Incarceration|0|||
131475662|NCT03635788|473372781|FG000|Step 2|Non-Compliance With Study Requirements|0|||
131475663|NCT03635788|473372782|FG001|Step 2|Non-Compliance With Study Requirements|1|||
131475664|NCT03635788|473372783|FG002|Step 2|Non-Compliance With Study Requirements|1|||
131475665|NCT03635788|473372781|FG000|Step 2|Confounding Medical Condition|0|||
131475666|NCT03635788|473372782|FG001|Step 2|Confounding Medical Condition|0|||
131475667|NCT03635788|473372783|FG002|Step 2|Confounding Medical Condition|1|||
131475668|NCT03635788|473372781|FG000|Step 2|Out Of State With No Plan To Return|0|||
131475669|NCT03635788|473372782|FG001|Step 2|Out Of State With No Plan To Return|1|||
131475670|NCT03635788|473372783|FG002|Step 2|Out Of State With No Plan To Return|0|||
131475671|NCT03635788|473372781|FG000|Step 2|Switched To Injectables|0|||
131475672|NCT03635788|473372782|FG001|Step 2|Switched To Injectables|0|||
131475673|NCT03635788|473372783|FG002|Step 2|Switched To Injectables|1|||
131475674|NCT03635788|473372781|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
131475675|NCT03635788|473372782|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
131475676|NCT03635788|473372783|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
131475677|NCT02142803|473372784|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
131475678|NCT02142803|473372785|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
131475679|NCT02142803|473372786|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
131475680|NCT02142803|473372787|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
131475681|NCT05169567|473372788|FG000|Overall Study|On study treatment|116|||
131475682|NCT05169567|473372789|FG001|Overall Study|On study treatment|128|||
131475683|NCT05169567|473372788|FG000|Overall Study|Lost to Follow-up|1|||
131475684|NCT05169567|473372789|FG001|Overall Study|Lost to Follow-up|0|||
131475685|NCT05169567|473372788|FG000|Overall Study|Withdrawal by Subject|25|||
131475686|NCT05169567|473372789|FG001|Overall Study|Withdrawal by Subject|21|||
131475687|NCT04382755|473372790|FG000|Overall Study|Withdrawal by Subject|1|||
131475688|NCT04382755|473372791|FG001|Overall Study|Withdrawal by Subject|0|||
131475689|NCT04382755|473372790|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
131475690|NCT04382755|473372791|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
131475691|NCT04382755|473372790|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
131475692|NCT04382755|473372791|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
131475693|NCT02718300|473372797|FG000|Overall Study|Death|4|||
131475694|NCT02718300|473372798|FG001|Overall Study|Death|5|||
131475695|NCT02718300|473372799|FG002|Overall Study|Death|17|||
131475696|NCT02718300|473372797|FG000|Overall Study|Lost to Follow-up|1|||
131475697|NCT02718300|473372798|FG001|Overall Study|Lost to Follow-up|0|||
131475698|NCT02718300|473372799|FG002|Overall Study|Lost to Follow-up|2|||
131475699|NCT02718300|473372797|FG000|Overall Study|Physician Decision|1|||
131475700|NCT02718300|473372798|FG001|Overall Study|Physician Decision|0|||
131475701|NCT02718300|473372799|FG002|Overall Study|Physician Decision|2|||
131475702|NCT02718300|473372797|FG000|Overall Study|Study Terminated by Sponsor|6|||
131475703|NCT02718300|473372798|FG001|Overall Study|Study Terminated by Sponsor|3|||
131475704|NCT02718300|473372799|FG002|Overall Study|Study Terminated by Sponsor|4|||
131475705|NCT02718300|473372797|FG000|Overall Study|Withdrawal by Subject|0|||
131475706|NCT02718300|473372798|FG001|Overall Study|Withdrawal by Subject|4|||
131475707|NCT02718300|473372799|FG002|Overall Study|Withdrawal by Subject|3|||
131475708|NCT02718300|473372797|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
131475709|NCT02718300|473372798|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
131475710|NCT02718300|473372799|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
131475711|NCT02452697|473372800|FG000|Overall Study|Physician Decision|4|||
131475712|NCT02452697|473372801|FG001|Overall Study|Physician Decision|4|||
131475713|NCT02452697|473372802|FG002|Overall Study|Physician Decision|3|||
131475714|NCT02452697|473372803|FG003|Overall Study|Physician Decision|2|||
131475715|NCT02452697|473372800|FG000|Overall Study|Withdrawal by Subject|1|||
131475716|NCT02452697|473372801|FG001|Overall Study|Withdrawal by Subject|0|||
131475717|NCT02452697|473372802|FG002|Overall Study|Withdrawal by Subject|0|||
131475718|NCT02452697|473372803|FG003|Overall Study|Withdrawal by Subject|0|||
131475719|NCT02452697|473372800|FG000|Overall Study|still in follow-up|2|||
131475720|NCT02452697|473372801|FG001|Overall Study|still in follow-up|2|||
131475721|NCT02452697|473372802|FG002|Overall Study|still in follow-up|1|||
131475722|NCT02452697|473372803|FG003|Overall Study|still in follow-up|3|||
131475723|NCT03552965|473372805|FG000|Overall Study|Death|1|||
131475724|NCT03552965|473372806|FG001|Overall Study|Death|1|||
131475725|NCT03552965|473372805|FG000|Overall Study|Lost to Follow-up|1|||
131475726|NCT03552965|473372806|FG001|Overall Study|Lost to Follow-up|1|||
131475727|NCT03552965|473372805|FG000|Overall Study|Physician Decision|1|||
131475728|NCT03552965|473372806|FG001|Overall Study|Physician Decision|1|||
131475729|NCT03552965|473372805|FG000|Overall Study|Withdrawal by Subject|0|||
131475730|NCT03552965|473372806|FG001|Overall Study|Withdrawal by Subject|2|||
131475731|NCT03552965|473372805|FG000|Overall Study|Continuation not in patient best interest|1|||
131475732|NCT03552965|473372806|FG001|Overall Study|Continuation not in patient best interest|0|||
131475733|NCT03552965|473372805|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
131475734|NCT03552965|473372806|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
131475735|NCT03120624|473372807|FG000|Overall Study|Withdrawal by Subject|0|||
131475736|NCT03120624|473372808|FG001|Overall Study|Withdrawal by Subject|1|||
131475737|NCT03120624|473372809|FG002|Overall Study|Withdrawal by Subject|0|||
131475738|NCT03120624|473372810|FG003|Overall Study|Withdrawal by Subject|0|||
131475739|NCT03120624|473372811|FG004|Overall Study|Withdrawal by Subject|0|||
131475740|NCT03120624|473372812|FG005|Overall Study|Withdrawal by Subject|0|||
131475741|NCT03120624|473372813|FG006|Overall Study|Withdrawal by Subject|0|||
131475742|NCT03120624|473372814|FG007|Overall Study|Withdrawal by Subject|0|||
131475743|NCT03437512|473374099|FG000|Randomized|Withdrawal by Subject|0|||
131475744|NCT03437512|473374100|FG001|Randomized|Withdrawal by Subject|2|||
131475745|NCT03437512|473374099|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
131475746|NCT03437512|473374100|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
131475747|NCT05036369|473374101|FG000|Overall Study|Run In non compliance|1|||
131475748|NCT05036369|473374102|FG001|Overall Study|Run In non compliance|2|||
131475749|NCT05036369|473374101|FG000|Overall Study|Change in eligibility criteria|0|||
131475750|NCT05036369|473374102|FG001|Overall Study|Change in eligibility criteria|1|||
131475751|NCT01795638|473374107|FG000|Overall Study|Death|0|||
131475752|NCT01795638|473374108|FG001|Overall Study|Death|3|||
131475753|NCT01795638|473374107|FG000|Overall Study|transferred to quaternary hospital|2|||
131475754|NCT01795638|473374108|FG001|Overall Study|transferred to quaternary hospital|3|||
131475755|NCT01795638|473374107|FG000|Overall Study|Protocol Violation|3|||
131475756|NCT01795638|473374108|FG001|Overall Study|Protocol Violation|0|||
131475757|NCT01795638|473374107|FG000|Overall Study|discharged from hospital|7|||
131475758|NCT01795638|473374108|FG001|Overall Study|discharged from hospital|5|||
131475759|NCT01795638|473374107|FG000|Overall Study|Withdrawal by Subject|1|||
131475760|NCT01795638|473374108|FG001|Overall Study|Withdrawal by Subject|0|||
131475761|NCT03403374|473374109|FG000|Overall Study|Lost to Follow-up|1|||
131475762|NCT01298531|473374110|FG000|Overall Study|Lack of Efficacy|0|||
131475763|NCT01298531|473374111|FG001|Overall Study|Lack of Efficacy|1|||
131475764|NCT01298531|473374110|FG000|Overall Study|Lost to Follow-up|2|||
131475765|NCT01298531|473374111|FG001|Overall Study|Lost to Follow-up|0|||
131475766|NCT01298531|473374110|FG000|Overall Study|Protocol Violation|1|||
131475767|NCT01298531|473374111|FG001|Overall Study|Protocol Violation|1|||
131475768|NCT01298531|473374110|FG000|Overall Study|Adverse Event|4|||
131475769|NCT01298531|473374111|FG001|Overall Study|Adverse Event|3|||
131475770|NCT01298531|473374110|FG000|Overall Study|Does not meet entrance criteria|0|||
131475771|NCT01298531|473374111|FG001|Overall Study|Does not meet entrance criteria|1|||
131475772|NCT01298531|473374110|FG000|Overall Study|Other|2|||
131475773|NCT01298531|473374111|FG001|Overall Study|Other|1|||
131475774|NCT02213042|473374114|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
131475775|NCT02213042|473374115|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
131475776|NCT02213042|473374116|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
131475777|NCT02213042|473374114|FG000|Overall Study|Adverse Event|2|||
131475778|NCT02213042|473374115|FG001|Overall Study|Adverse Event|1|||
131475779|NCT02213042|473374116|FG002|Overall Study|Adverse Event|0|||
131475780|NCT02213042|473374114|FG000|Overall Study|Withdrawal by Subject|0|||
131475781|NCT02213042|473374115|FG001|Overall Study|Withdrawal by Subject|1|||
131475782|NCT02213042|473374116|FG002|Overall Study|Withdrawal by Subject|1|||
131475783|NCT02213042|473374114|FG000|Overall Study|Protocol Violation|1|||
131475784|NCT02213042|473374115|FG001|Overall Study|Protocol Violation|0|||
131475785|NCT02213042|473374116|FG002|Overall Study|Protocol Violation|0|||
131475786|NCT02213042|473374114|FG000|Overall Study|Investigator discretion|0|||
131475787|NCT02213042|473374115|FG001|Overall Study|Investigator discretion|0|||
131475788|NCT02213042|473374116|FG002|Overall Study|Investigator discretion|1|||
131475789|NCT05314478|473374117|FG000|Overall Study|Physician Decision|1|||
131475790|NCT02476422|473374118|FG000|Overall Study|Subject/guardian decision|0|||
131882134|NCT04713592|474849350|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
131882135|NCT04713592|474849351|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
131882136|NCT04713592|474849352|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
131882137|NCT04713592|474849353|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
131475791|NCT02476422|473374119|FG001|Overall Study|Subject/guardian decision|1|||
131475792|NCT00760214|473374121|FG000|Overall Study|Adverse Event|8|||
131475793|NCT00760214|473374122|FG001|Overall Study|Adverse Event|9|||
131475794|NCT00760214|473374123|FG002|Overall Study|Adverse Event|12|||
131475795|NCT00760214|473374121|FG000|Overall Study|Protocol Violation|3|||
131475796|NCT00760214|473374122|FG001|Overall Study|Protocol Violation|0|||
131475797|NCT00760214|473374123|FG002|Overall Study|Protocol Violation|3|||
131475798|NCT00760214|473374121|FG000|Overall Study|Lost to Follow-up|0|||
131475799|NCT00760214|473374122|FG001|Overall Study|Lost to Follow-up|0|||
131475800|NCT00760214|473374123|FG002|Overall Study|Lost to Follow-up|1|||
131475801|NCT00760214|473374121|FG000|Overall Study|Withdrawal by Subject|12|||
131475802|NCT00760214|473374122|FG001|Overall Study|Withdrawal by Subject|14|||
131475803|NCT00760214|473374123|FG002|Overall Study|Withdrawal by Subject|13|||
131475804|NCT00760214|473374121|FG000|Overall Study|Lack of Efficacy|3|||
131475805|NCT00760214|473374122|FG001|Overall Study|Lack of Efficacy|2|||
131475806|NCT00760214|473374123|FG002|Overall Study|Lack of Efficacy|4|||
131475807|NCT00760214|473374121|FG000|Overall Study|Pregnancy|0|||
131475808|NCT00760214|473374122|FG001|Overall Study|Pregnancy|0|||
131475809|NCT00760214|473374123|FG002|Overall Study|Pregnancy|1|||
131475810|NCT00760214|473374121|FG000|Overall Study|Physician Decision|1|||
131475811|NCT00760214|473374122|FG001|Overall Study|Physician Decision|1|||
131475812|NCT00760214|473374123|FG002|Overall Study|Physician Decision|1|||
131475813|NCT00760214|473374121|FG000|Overall Study|Other|3|||
131475814|NCT00760214|473374122|FG001|Overall Study|Other|4|||
131475815|NCT00760214|473374123|FG002|Overall Study|Other|6|||
131475816|NCT01134315|473374125|FG000|Overall Study|Adverse Event|1|||
131475817|NCT01134315|473374126|FG001|Overall Study|Adverse Event|2|||
131475818|NCT01134315|473374125|FG000|Overall Study|Other Reason|8|||
131882138|NCT03782298|474849356|FG000|Overall Study|Protocol Deviation|4|||
131882139|NCT01797081|474849357|FG000|Overall Study|Adverse Event|1|||
131882140|NCT01797081|474849358|FG001|Overall Study|Adverse Event|0|||
131882141|NCT01797081|474849359|FG002|Overall Study|Adverse Event|1|||
131475819|NCT01134315|473374126|FG001|Overall Study|Other Reason|17|||
131475820|NCT01086423|473374127|FG000|Overall Study|Protocol Violation|0|||
131475821|NCT01086423|473374128|FG001|Overall Study|Protocol Violation|0|||
131475822|NCT01086423|473374129|FG002|Overall Study|Protocol Violation|1|||
131475823|NCT01086423|473374127|FG000|Overall Study|Migrated/moved from study area|2|||
131475824|NCT01086423|473374128|FG001|Overall Study|Migrated/moved from study area|0|||
131475825|NCT01086423|473374129|FG002|Overall Study|Migrated/moved from study area|4|||
131882142|NCT01797081|474849360|FG003|Overall Study|Adverse Event|0|||
131475826|NCT01086423|473374127|FG000|Overall Study|Adverse event, fatal|1|||
131475827|NCT01086423|473374128|FG001|Overall Study|Adverse event, fatal|1|||
131475828|NCT01086423|473374129|FG002|Overall Study|Adverse event, fatal|0|||
131475829|NCT01086423|473374127|FG000|Overall Study|Adverse event, non-fatal|2|||
131475830|NCT01086423|473374128|FG001|Overall Study|Adverse event, non-fatal|1|||
131475831|NCT01086423|473374129|FG002|Overall Study|Adverse event, non-fatal|0|||
131475832|NCT01086423|473374127|FG000|Overall Study|Withdrawal by Subject|5|||
131475833|NCT01086423|473374128|FG001|Overall Study|Withdrawal by Subject|1|||
131475834|NCT01086423|473374129|FG002|Overall Study|Withdrawal by Subject|3|||
131475835|NCT01086423|473374127|FG000|Overall Study|Lost to Follow-up|0|||
131475836|NCT01086423|473374128|FG001|Overall Study|Lost to Follow-up|0|||
131475837|NCT01086423|473374129|FG002|Overall Study|Lost to Follow-up|1|||
131475838|NCT04950166|473374140|FG000|Overall Study|Withdrawal by Subject|1|||
131475839|NCT00857415|473374141|FG000|Overall Study|Image acquisition failure|2|||
131475840|NCT00857415|473374142|FG001|Overall Study|Image acquisition failure|0|||
131475841|NCT00857415|473374141|FG000|Overall Study|Invalid image or not imaged|3|||
131475842|NCT00857415|473374142|FG001|Overall Study|Invalid image or not imaged|0|||
131475843|NCT00857415|473374141|FG000|Overall Study|Subject still living at end of study|110|||
131475844|NCT00857415|473374142|FG001|Overall Study|Subject still living at end of study|0|||
131475845|NCT00857415|473374141|FG000|Overall Study|Deceased with no autopsy|2|||
131475846|NCT00857415|473374142|FG001|Overall Study|Deceased with no autopsy|0|||
131475847|NCT01130103|473374145|FG000|Randomized Treatment|Adverse Event|1|||
131475848|NCT01130103|473374146|FG001|Randomized Treatment|Adverse Event|1|||
131475849|NCT01130103|473374145|FG000|Randomized Treatment|Lost to Follow-up|1|||
131475850|NCT01130103|473374146|FG001|Randomized Treatment|Lost to Follow-up|0|||
131475851|NCT01130103|473374145|FG000|Randomized Treatment|Protocol Violation|3|||
131475852|NCT01130103|473374146|FG001|Randomized Treatment|Protocol Violation|2|||
131475853|NCT01130103|473374145|FG000|Randomized Treatment|Withdrawal by Subject|1|||
131475854|NCT01130103|473374146|FG001|Randomized Treatment|Withdrawal by Subject|2|||
131475855|NCT01130103|473374145|FG000|Maintenance Treatment|Lack of Efficacy|0|||
131475856|NCT01130103|473374146|FG001|Maintenance Treatment|Lack of Efficacy|1|||
131475857|NCT01130103|473374145|FG000|Maintenance Treatment|Lost to Follow-up|1|||
131475858|NCT01130103|473374146|FG001|Maintenance Treatment|Lost to Follow-up|1|||
131475859|NCT01130103|473374145|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
131475860|NCT01130103|473374146|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
131475861|NCT01822678|473374149|FG000|Overall Study|Withdrawal by Subject|5|||
131475862|NCT01822678|473374150|FG001|Overall Study|Withdrawal by Subject|4|||
131475863|NCT01822678|473374151|FG002|Overall Study|Withdrawal by Subject|4|||
131475864|NCT01822678|473374149|FG000|Overall Study|Adverse Event|4|||
131475865|NCT01822678|473374150|FG001|Overall Study|Adverse Event|3|||
131475866|NCT01822678|473374151|FG002|Overall Study|Adverse Event|1|||
131475867|NCT01822678|473374149|FG000|Overall Study|Lack of Efficacy|3|||
131475868|NCT01822678|473374150|FG001|Overall Study|Lack of Efficacy|6|||
131475869|NCT01822678|473374151|FG002|Overall Study|Lack of Efficacy|5|||
131475870|NCT01822678|473374149|FG000|Overall Study|Lost to Follow-up|0|||
131475871|NCT01822678|473374150|FG001|Overall Study|Lost to Follow-up|2|||
131475872|NCT01822678|473374151|FG002|Overall Study|Lost to Follow-up|1|||
131475873|NCT00764504|473374152|FG000|Overall Study|Death|12|||
131475874|NCT00764504|473374153|FG001|Overall Study|Death|6|||
131475875|NCT00764504|473374154|FG002|Overall Study|Death|13|||
131475876|NCT00764504|473374152|FG000|Overall Study|Revision of Device|12|||
131475877|NCT00764504|473374153|FG001|Overall Study|Revision of Device|23|||
131475878|NCT00764504|473374154|FG002|Overall Study|Revision of Device|14|||
131475879|NCT00764504|473374152|FG000|Overall Study|Physician Decision|1|||
131475880|NCT00764504|473374153|FG001|Overall Study|Physician Decision|0|||
131475881|NCT00764504|473374154|FG002|Overall Study|Physician Decision|0|||
131475882|NCT00764504|473374152|FG000|Overall Study|Withdrawal by Subject|1|||
131475883|NCT00764504|473374153|FG001|Overall Study|Withdrawal by Subject|7|||
131475884|NCT00764504|473374154|FG002|Overall Study|Withdrawal by Subject|4|||
131475885|NCT00764504|473374152|FG000|Overall Study|Lost to Follow-up|40|||
131475886|NCT00764504|473374153|FG001|Overall Study|Lost to Follow-up|34|||
131475887|NCT00764504|473374154|FG002|Overall Study|Lost to Follow-up|72|||
131475888|NCT01465191|473374158|FG000|Overall Study|Protocol Violation|6|||
131475889|NCT01465191|473374159|FG001|Overall Study|Protocol Violation|3|||
131475890|NCT01465191|473374160|FG002|Overall Study|Protocol Violation|3|||
131475891|NCT01465191|473374158|FG000|Overall Study|Lost to Follow-up|3|||
131882143|NCT01797081|474849357|FG000|Overall Study|Pregnancy|1|||
131882144|NCT01797081|474849358|FG001|Overall Study|Pregnancy|0|||
131882145|NCT01797081|474849359|FG002|Overall Study|Pregnancy|0|||
131475892|NCT01465191|473374159|FG001|Overall Study|Lost to Follow-up|6|||
131475893|NCT01465191|473374160|FG002|Overall Study|Lost to Follow-up|4|||
131475894|NCT02992132|473374161|FG000|Overall Study|Adverse Event|4|||
131475895|NCT02992132|473374162|FG001|Overall Study|Adverse Event|1|||
131475896|NCT02992132|473374163|FG002|Overall Study|Adverse Event|3|||
131475897|NCT02992132|473374161|FG000|Overall Study|Lack of Efficacy|2|||
131475898|NCT02992132|473374162|FG001|Overall Study|Lack of Efficacy|0|||
131475899|NCT02992132|473374163|FG002|Overall Study|Lack of Efficacy|0|||
131475900|NCT02992132|473374161|FG000|Overall Study|Non-compliance with study drug|2|||
131475901|NCT02992132|473374162|FG001|Overall Study|Non-compliance with study drug|0|||
131475902|NCT02992132|473374163|FG002|Overall Study|Non-compliance with study drug|0|||
131475903|NCT02992132|473374161|FG000|Overall Study|Progressive disease|1|||
131882146|NCT01797081|474849360|FG003|Overall Study|Pregnancy|0|||
131475904|NCT02992132|473374162|FG001|Overall Study|Progressive disease|0|||
131475905|NCT02992132|473374163|FG002|Overall Study|Progressive disease|0|||
131475906|NCT02992132|473374161|FG000|Overall Study|Protocol Violation|2|||
131475907|NCT02992132|473374162|FG001|Overall Study|Protocol Violation|2|||
131475908|NCT02992132|473374163|FG002|Overall Study|Protocol Violation|0|||
131475909|NCT02992132|473374161|FG000|Overall Study|Caregiver withdrew consent|2|||
131475910|NCT02992132|473374162|FG001|Overall Study|Caregiver withdrew consent|3|||
131475911|NCT02992132|473374163|FG002|Overall Study|Caregiver withdrew consent|2|||
131475912|NCT02992132|473374161|FG000|Overall Study|Withdrawal by Subject|0|||
131475913|NCT02992132|473374162|FG001|Overall Study|Withdrawal by Subject|2|||
131475914|NCT02992132|473374163|FG002|Overall Study|Withdrawal by Subject|1|||
131475915|NCT02992132|473374161|FG000|Overall Study|Physician Decision|0|||
131475916|NCT02992132|473374162|FG001|Overall Study|Physician Decision|0|||
131475917|NCT02992132|473374163|FG002|Overall Study|Physician Decision|1|||
131475918|NCT00620464|473374171|FG000|Overall Study|Adverse Event|15|||
131475919|NCT00620464|473374172|FG001|Overall Study|Adverse Event|17|||
131475920|NCT00620464|473374171|FG000|Overall Study|Lost to Follow-up|1|||
131475921|NCT00620464|473374172|FG001|Overall Study|Lost to Follow-up|1|||
131475922|NCT00620464|473374171|FG000|Overall Study|Planning Pregnancy|1|||
131475923|NCT00620464|473374172|FG001|Overall Study|Planning Pregnancy|4|||
131475924|NCT00620464|473374171|FG000|Overall Study|Personal|2|||
131475925|NCT00620464|473374172|FG001|Overall Study|Personal|2|||
131475926|NCT00620464|473374171|FG000|Overall Study|Used prohibited medication|1|||
131475927|NCT00620464|473374172|FG001|Overall Study|Used prohibited medication|0|||
131475928|NCT00467610|473374173|FG000|Overall Study|Withdrawal by Subject|1|||
131475929|NCT01369615|473374174|FG000|Overall Study|Withdrawal by Subject|0|||
131475930|NCT01369615|473374175|FG001|Overall Study|Withdrawal by Subject|1|||
131475931|NCT01369615|473374174|FG000|Overall Study|Lost to Follow-up|0|||
131475932|NCT01369615|473374175|FG001|Overall Study|Lost to Follow-up|1|||
131475933|NCT04263454|473374176|FG000|Overall Study|Adverse Event|0|||
131475934|NCT04263454|473374177|FG001|Overall Study|Adverse Event|2|||
131475935|NCT04263454|473374176|FG000|Overall Study|Physician Decision|3|||
131475936|NCT04263454|473374177|FG001|Overall Study|Physician Decision|5|||
131475937|NCT04263454|473374176|FG000|Overall Study|Poor Data Quality|0|||
131475938|NCT04263454|473374177|FG001|Overall Study|Poor Data Quality|1|||
131475939|NCT00986479|473374178|FG000|Period 1|Improved mood|1|||
131475940|NCT00986479|473374179|FG001|Period 1|Improved mood|0|||
131475941|NCT00986479|473374178|FG000|Period 1|Administrative reasons|1|||
131475942|NCT00986479|473374179|FG001|Period 1|Administrative reasons|0|||
131475943|NCT01231347|473374180|FG000|Overall Study|Full Consent withdrawn|19|||
131475944|NCT01231347|473374181|FG001|Overall Study|Full Consent withdrawn|19|||
131475945|NCT01231347|473374182|FG002|Overall Study|Full Consent withdrawn|11|||
131475946|NCT01231347|473374180|FG000|Overall Study|Lost to Follow-up|4|||
131475947|NCT01231347|473374181|FG001|Overall Study|Lost to Follow-up|2|||
131475948|NCT01231347|473374182|FG002|Overall Study|Lost to Follow-up|2|||
131475949|NCT01231347|473374180|FG000|Overall Study|Death|202|||
131475950|NCT01231347|473374181|FG001|Overall Study|Death|210|||
131475951|NCT01231347|473374182|FG002|Overall Study|Death|101|||
131475952|NCT01231347|473374180|FG000|Overall Study|other event|7|||
131475953|NCT01231347|473374181|FG001|Overall Study|other event|9|||
131475954|NCT01231347|473374182|FG002|Overall Study|other event|3|||
131475955|NCT02322021|473374183|FG000|Core Phase|Adverse Event|1|||
131475956|NCT02322021|473374184|FG001|Core Phase|Adverse Event|3|||
131475957|NCT02322021|473374185|FG002|Core Phase|Adverse Event|4|||
131475958|NCT02322021|473374186|FG003|Core Phase|Adverse Event|2|||
131475959|NCT02322021|473374187|FG004|Core Phase|Adverse Event|0|||
131475960|NCT02322021|473374183|FG000|Core Phase|Participant Choice|4|||
131475961|NCT02322021|473374184|FG001|Core Phase|Participant Choice|5|||
131475962|NCT02322021|473374185|FG002|Core Phase|Participant Choice|4|||
131475963|NCT02322021|473374186|FG003|Core Phase|Participant Choice|2|||
131475964|NCT02322021|473374187|FG004|Core Phase|Participant Choice|0|||
131475965|NCT02322021|473374183|FG000|Core Phase|Lost to Follow-up|0|||
131475966|NCT02322021|473374184|FG001|Core Phase|Lost to Follow-up|0|||
131882147|NCT01797081|474849357|FG000|Overall Study|Personal Reasons|12|||
131882148|NCT01797081|474849358|FG001|Overall Study|Personal Reasons|4|||
131882149|NCT01797081|474849359|FG002|Overall Study|Personal Reasons|4|||
131475967|NCT02322021|473374185|FG002|Core Phase|Lost to Follow-up|0|||
131475968|NCT02322021|473374186|FG003|Core Phase|Lost to Follow-up|1|||
131475969|NCT02322021|473374187|FG004|Core Phase|Lost to Follow-up|0|||
131475970|NCT02322021|473374183|FG000|Core Phase|Other|0|||
131475971|NCT02322021|473374184|FG001|Core Phase|Other|0|||
131475972|NCT02322021|473374185|FG002|Core Phase|Other|1|||
131475973|NCT02322021|473374186|FG003|Core Phase|Other|0|||
131475974|NCT02322021|473374187|FG004|Core Phase|Other|0|||
131475975|NCT02322021|473374183|FG000|Extension Phase|Adverse Event|0|||
131475976|NCT02322021|473374184|FG001|Extension Phase|Adverse Event|0|||
131475977|NCT02322021|473374185|FG002|Extension Phase|Adverse Event|0|||
131475978|NCT02322021|473374186|FG003|Extension Phase|Adverse Event|0|||
131475979|NCT02322021|473374187|FG004|Extension Phase|Adverse Event|3|||
131475980|NCT02322021|473374183|FG000|Extension Phase|Participant Choice|0|||
131475981|NCT02322021|473374184|FG001|Extension Phase|Participant Choice|0|||
131475982|NCT02322021|473374185|FG002|Extension Phase|Participant Choice|0|||
131475983|NCT02322021|473374186|FG003|Extension Phase|Participant Choice|0|||
131882150|NCT01797081|474849360|FG003|Overall Study|Personal Reasons|8|||
131475984|NCT02322021|473374187|FG004|Extension Phase|Participant Choice|6|||
131882151|NCT01797081|474849357|FG000|Overall Study|Protocol Violation|0|||
131882152|NCT01797081|474849358|FG001|Overall Study|Protocol Violation|0|||
131882153|NCT01797081|474849359|FG002|Overall Study|Protocol Violation|0|||
131882154|NCT01797081|474849360|FG003|Overall Study|Protocol Violation|1|||
131882155|NCT02484651|474849367|FG000|Overall Study|Patients' data files were corrupted.|1|||
131882156|NCT02484651|474849368|FG001|Overall Study|Patients' data files were corrupted.|1|||
131882157|NCT02484651|474849367|FG000|Overall Study|BIS monitoring failed.|1|||
131882158|NCT02484651|474849368|FG001|Overall Study|BIS monitoring failed.|1|||
131882159|NCT02484651|474849367|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
131882160|NCT02484651|474849368|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
131882161|NCT02375555|474849369|FG000|Induction Period|Adverse Event|7|||
131882162|NCT02375555|474849369|FG000|Induction Period|Withdrawal by Subject|2|||
131882163|NCT02375555|474849369|FG000|Induction Period|Other|1|||
131882164|NCT02375555|474849369|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
131882165|NCT02375555|474849369|FG000|Maintenance Period|Adverse Event|2|||
131882166|NCT02375555|474849369|FG000|Maintenance Period|Withdrawal by Subject|4|||
131882167|NCT02375555|474849369|FG000|Maintenance Period|Death|1|||
131882168|NCT02375555|474849369|FG000|Maintenance Period|Disease Progression|5|||
131882169|NCT02375555|474849369|FG000|Maintenance Period|Patient Non-compliance|1|||
131882170|NCT02375555|474849369|FG000|Maintenance Period|Still on maintenance|16|||
131882171|NCT01744184|474849378|FG000|Overall Study|Adverse Event|1|||
131882172|NCT01744184|474849379|FG001|Overall Study|Adverse Event|0|||
131882173|NCT01744184|474849378|FG000|Overall Study|Withdrawal by Subject|0|||
131882174|NCT01744184|474849379|FG001|Overall Study|Withdrawal by Subject|1|||
131882175|NCT01095978|474849388|FG000|Overall Study|Did not take Klacid SR|2|||
131882176|NCT01095978|474849388|FG000|Overall Study|Adverse Event|1|||
131882177|NCT02009397|474849391|FG000|Overall Study|Protocol Violation|6|||
131882178|NCT02009397|474849391|FG000|Overall Study|Death|8|||
131475985|NCT02322021|473374183|FG000|Extension Phase|Other|0|||
131475986|NCT02322021|473374184|FG001|Extension Phase|Other|0|||
131475987|NCT02322021|473374185|FG002|Extension Phase|Other|0|||
131475988|NCT02322021|473374186|FG003|Extension Phase|Other|0|||
131475989|NCT02322021|473374187|FG004|Extension Phase|Other|3|||
131475990|NCT02322021|473374183|FG000|Extension Phase|Lost to Follow-up|0|||
131475991|NCT02322021|473374184|FG001|Extension Phase|Lost to Follow-up|0|||
131475992|NCT02322021|473374185|FG002|Extension Phase|Lost to Follow-up|0|||
131475993|NCT02322021|473374186|FG003|Extension Phase|Lost to Follow-up|0|||
131475994|NCT02322021|473374187|FG004|Extension Phase|Lost to Follow-up|1|||
131475995|NCT02322021|473374183|FG000|Extension Phase|Study terminated by sponsor|0|||
131475996|NCT02322021|473374184|FG001|Extension Phase|Study terminated by sponsor|0|||
131475997|NCT02322021|473374185|FG002|Extension Phase|Study terminated by sponsor|0|||
131475998|NCT02322021|473374186|FG003|Extension Phase|Study terminated by sponsor|0|||
131475999|NCT02322021|473374187|FG004|Extension Phase|Study terminated by sponsor|28|||
131476000|NCT00973349|473374188|FG000|Overall Study|Adverse Event|0|||
131476001|NCT00973349|473374189|FG001|Overall Study|Adverse Event|0|||
131476002|NCT00973349|473374190|FG002|Overall Study|Adverse Event|0|||
131476003|NCT00973349|473374191|FG003|Overall Study|Adverse Event|0|||
131476004|NCT00973349|473374192|FG004|Overall Study|Adverse Event|1|||
131476005|NCT00973349|473374193|FG005|Overall Study|Adverse Event|0|||
131476006|NCT00973349|473374194|FG006|Overall Study|Adverse Event|0|||
131476007|NCT00973349|473374195|FG007|Overall Study|Adverse Event|0|||
131476008|NCT00973349|473374196|FG008|Overall Study|Adverse Event|1|||
131476009|NCT00973349|473374197|FG009|Overall Study|Adverse Event|0|||
131476010|NCT00973349|473374198|FG010|Overall Study|Adverse Event|0|||
131476011|NCT00973349|473374199|FG011|Overall Study|Adverse Event|0|||
131476012|NCT00973349|473374200|FG012|Overall Study|Adverse Event|0|||
131476013|NCT00973349|473374201|FG013|Overall Study|Adverse Event|0|||
131476014|NCT00973349|473374202|FG014|Overall Study|Adverse Event|1|||
131476015|NCT00973349|473374203|FG015|Overall Study|Adverse Event|0|||
131476016|NCT00973349|473374188|FG000|Overall Study|Withdrawal by Subject|1|||
131476017|NCT00973349|473374189|FG001|Overall Study|Withdrawal by Subject|2|||
131882179|NCT02009397|474849391|FG000|Overall Study|Lost to Follow-up|6|||
131882180|NCT01790828|474849397|FG000|Overall Study|Other|34|||
131882181|NCT01390428|474851112|FG000|Overall Study|Elective Surgery|0|||
131882182|NCT01390428|474851113|FG001|Overall Study|Elective Surgery|0|||
131882183|NCT01390428|474851114|FG002|Overall Study|Elective Surgery|0|||
131882184|NCT01390428|474851115|FG003|Overall Study|Elective Surgery|0|||
131882185|NCT01390428|474851116|FG004|Overall Study|Elective Surgery|1|||
131882186|NCT01390428|474851117|FG005|Overall Study|Elective Surgery|0|||
131882187|NCT01390428|474851112|FG000|Overall Study|Withdrawal by Subject|0|||
131882188|NCT01390428|474851113|FG001|Overall Study|Withdrawal by Subject|0|||
131882189|NCT01390428|474851114|FG002|Overall Study|Withdrawal by Subject|1|||
131882190|NCT01390428|474851115|FG003|Overall Study|Withdrawal by Subject|0|||
131882191|NCT01390428|474851116|FG004|Overall Study|Withdrawal by Subject|0|||
131882192|NCT01390428|474851117|FG005|Overall Study|Withdrawal by Subject|0|||
131882193|NCT05897827|474851118|FG000|Overall Study|Lost to Follow-up|33|||
131882194|NCT05897827|474851119|FG001|Overall Study|Lost to Follow-up|14|||
131476018|NCT00973349|473374190|FG002|Overall Study|Withdrawal by Subject|2|||
131476019|NCT00973349|473374191|FG003|Overall Study|Withdrawal by Subject|3|||
131476020|NCT00973349|473374192|FG004|Overall Study|Withdrawal by Subject|2|||
131476021|NCT00973349|473374193|FG005|Overall Study|Withdrawal by Subject|0|||
131476022|NCT00973349|473374194|FG006|Overall Study|Withdrawal by Subject|2|||
131476023|NCT00973349|473374195|FG007|Overall Study|Withdrawal by Subject|2|||
131476024|NCT00973349|473374196|FG008|Overall Study|Withdrawal by Subject|0|||
131476025|NCT00973349|473374197|FG009|Overall Study|Withdrawal by Subject|2|||
131476026|NCT00973349|473374198|FG010|Overall Study|Withdrawal by Subject|0|||
131476027|NCT00973349|473374199|FG011|Overall Study|Withdrawal by Subject|1|||
131476028|NCT00973349|473374200|FG012|Overall Study|Withdrawal by Subject|0|||
131476029|NCT00973349|473374201|FG013|Overall Study|Withdrawal by Subject|0|||
131476030|NCT00973349|473374202|FG014|Overall Study|Withdrawal by Subject|0|||
131476031|NCT00973349|473374203|FG015|Overall Study|Withdrawal by Subject|0|||
131476032|NCT00973349|473374188|FG000|Overall Study|Lost to Follow-up|3|||
131476033|NCT00973349|473374189|FG001|Overall Study|Lost to Follow-up|1|||
131476034|NCT00973349|473374190|FG002|Overall Study|Lost to Follow-up|2|||
131476035|NCT00973349|473374191|FG003|Overall Study|Lost to Follow-up|2|||
131476036|NCT00973349|473374192|FG004|Overall Study|Lost to Follow-up|1|||
131476037|NCT00973349|473374193|FG005|Overall Study|Lost to Follow-up|3|||
131476038|NCT00973349|473374194|FG006|Overall Study|Lost to Follow-up|0|||
131476039|NCT00973349|473374195|FG007|Overall Study|Lost to Follow-up|1|||
131476040|NCT00973349|473374196|FG008|Overall Study|Lost to Follow-up|2|||
131476041|NCT00973349|473374197|FG009|Overall Study|Lost to Follow-up|1|||
131476042|NCT00973349|473374198|FG010|Overall Study|Lost to Follow-up|0|||
131476043|NCT00973349|473374199|FG011|Overall Study|Lost to Follow-up|1|||
131476044|NCT00973349|473374200|FG012|Overall Study|Lost to Follow-up|0|||
131476045|NCT00973349|473374201|FG013|Overall Study|Lost to Follow-up|0|||
131476046|NCT00973349|473374202|FG014|Overall Study|Lost to Follow-up|0|||
131476047|NCT00973349|473374203|FG015|Overall Study|Lost to Follow-up|1|||
131476048|NCT00973349|473374188|FG000|Overall Study|Inappropriate enrolment|0|||
131476049|NCT00973349|473374189|FG001|Overall Study|Inappropriate enrolment|0|||
131476050|NCT00973349|473374190|FG002|Overall Study|Inappropriate enrolment|1|||
131476051|NCT00973349|473374191|FG003|Overall Study|Inappropriate enrolment|0|||
131476052|NCT00973349|473374192|FG004|Overall Study|Inappropriate enrolment|0|||
131476053|NCT00973349|473374193|FG005|Overall Study|Inappropriate enrolment|0|||
131476054|NCT00973349|473374194|FG006|Overall Study|Inappropriate enrolment|0|||
131476055|NCT00973349|473374195|FG007|Overall Study|Inappropriate enrolment|0|||
131476056|NCT00973349|473374196|FG008|Overall Study|Inappropriate enrolment|0|||
131476057|NCT00973349|473374197|FG009|Overall Study|Inappropriate enrolment|2|||
131476058|NCT00973349|473374198|FG010|Overall Study|Inappropriate enrolment|0|||
131476059|NCT00973349|473374199|FG011|Overall Study|Inappropriate enrolment|0|||
131476060|NCT00973349|473374200|FG012|Overall Study|Inappropriate enrolment|1|||
131476061|NCT00973349|473374201|FG013|Overall Study|Inappropriate enrolment|0|||
131476062|NCT00973349|473374202|FG014|Overall Study|Inappropriate enrolment|1|||
131476063|NCT00973349|473374203|FG015|Overall Study|Inappropriate enrolment|1|||
131476064|NCT00973349|473374188|FG000|Overall Study|Protocol Violation|0|||
131476065|NCT00973349|473374189|FG001|Overall Study|Protocol Violation|0|||
131476066|NCT00973349|473374190|FG002|Overall Study|Protocol Violation|0|||
131476067|NCT00973349|473374191|FG003|Overall Study|Protocol Violation|0|||
131476068|NCT00973349|473374192|FG004|Overall Study|Protocol Violation|0|||
131476069|NCT00973349|473374193|FG005|Overall Study|Protocol Violation|0|||
131476070|NCT00973349|473374194|FG006|Overall Study|Protocol Violation|0|||
131476071|NCT00973349|473374195|FG007|Overall Study|Protocol Violation|0|||
131476072|NCT00973349|473374196|FG008|Overall Study|Protocol Violation|1|||
131476073|NCT00973349|473374197|FG009|Overall Study|Protocol Violation|0|||
131476074|NCT00973349|473374198|FG010|Overall Study|Protocol Violation|0|||
131476075|NCT00973349|473374199|FG011|Overall Study|Protocol Violation|0|||
131476076|NCT00973349|473374200|FG012|Overall Study|Protocol Violation|0|||
131476077|NCT00973349|473374201|FG013|Overall Study|Protocol Violation|0|||
131476078|NCT00973349|473374202|FG014|Overall Study|Protocol Violation|0|||
131476079|NCT00973349|473374203|FG015|Overall Study|Protocol Violation|0|||
131476080|NCT00973349|473374188|FG000|Overall Study|Unable to classify|0|||
131476081|NCT00973349|473374189|FG001|Overall Study|Unable to classify|0|||
131476082|NCT00973349|473374190|FG002|Overall Study|Unable to classify|0|||
131476083|NCT00973349|473374191|FG003|Overall Study|Unable to classify|0|||
131476084|NCT00973349|473374192|FG004|Overall Study|Unable to classify|1|||
131476085|NCT00973349|473374193|FG005|Overall Study|Unable to classify|1|||
131476086|NCT00973349|473374194|FG006|Overall Study|Unable to classify|0|||
131476087|NCT00973349|473374195|FG007|Overall Study|Unable to classify|0|||
131476088|NCT00973349|473374196|FG008|Overall Study|Unable to classify|0|||
131476089|NCT00973349|473374197|FG009|Overall Study|Unable to classify|1|||
131476090|NCT00973349|473374198|FG010|Overall Study|Unable to classify|0|||
131476091|NCT00973349|473374199|FG011|Overall Study|Unable to classify|0|||
131476092|NCT00973349|473374200|FG012|Overall Study|Unable to classify|0|||
131476093|NCT00973349|473374201|FG013|Overall Study|Unable to classify|0|||
131476094|NCT00973349|473374202|FG014|Overall Study|Unable to classify|0|||
131476095|NCT00973349|473374203|FG015|Overall Study|Unable to classify|0|||
131476096|NCT02898116|473374208|FG000|Overall Study|Adverse Event|1|||
131882195|NCT05897827|474851118|FG000|Overall Study|Withdrawal by Subject|1|||
131882196|NCT05897827|474851119|FG001|Overall Study|Withdrawal by Subject|1|||
131882197|NCT04542499|474851122|FG000|Overall Study|Adverse Event|23|||
131882198|NCT04542499|474851123|FG001|Overall Study|Adverse Event|43|||
131882199|NCT04542499|474851122|FG000|Overall Study|Lack of Efficacy|5|||
131476097|NCT02898116|473374208|FG000|Overall Study|Progressive disease|1|||
131476098|NCT02301988|473374209|FG000|Overall Study|Withdrawal by Subject|2|||
131476099|NCT02301988|473374210|FG001|Overall Study|Withdrawal by Subject|1|||
131476100|NCT02301988|473374209|FG000|Overall Study|Physician Decision|2|||
131476101|NCT02301988|473374210|FG001|Overall Study|Physician Decision|2|||
131476102|NCT02301988|473374209|FG000|Overall Study|Unknown Reason|1|||
131476103|NCT02301988|473374210|FG001|Overall Study|Unknown Reason|3|||
131476104|NCT02301988|473374209|FG000|Overall Study|Lack of Efficacy|3|||
131476105|NCT02301988|473374210|FG001|Overall Study|Lack of Efficacy|2|||
131476106|NCT02301988|473374209|FG000|Overall Study|Death|1|||
131476107|NCT02301988|473374210|FG001|Overall Study|Death|0|||
131476108|NCT02301988|473374209|FG000|Overall Study|Adverse Event|1|||
131476109|NCT02301988|473374210|FG001|Overall Study|Adverse Event|1|||
131476110|NCT04755283|473374213|FG000|Overall Study|Withdrawal by Subject|14|||
131476111|NCT04755283|473374214|FG001|Overall Study|Withdrawal by Subject|3|||
131476112|NCT04755283|473374215|FG002|Overall Study|Withdrawal by Subject|6|||
131476113|NCT04755283|473374213|FG000|Overall Study|Lost to Follow-up|0|||
131476114|NCT04755283|473374214|FG001|Overall Study|Lost to Follow-up|0|||
131476115|NCT04755283|473374215|FG002|Overall Study|Lost to Follow-up|1|||
131476116|NCT04755283|473374213|FG000|Overall Study|Death|31|||
131476117|NCT04755283|473374214|FG001|Overall Study|Death|36|||
131476118|NCT04755283|473374215|FG002|Overall Study|Death|34|||
131476119|NCT01015131|473374217|FG000|Overall Study|Physician Decision|1|||
131476120|NCT01015131|473374217|FG000|Overall Study|Protocol Violation|1|||
131476121|NCT01015131|473374217|FG000|Overall Study|Withdrawal by Subject|2|||
131476122|NCT01015131|473374217|FG000|Overall Study|Other Protocol Specified Criteria|4|||
131476123|NCT05430022|473374218|FG000|Overall Study|Withdrawal by Subject|4|||
131476124|NCT05430022|473374219|FG001|Overall Study|Withdrawal by Subject|4|||
131476125|NCT05069259|473374229|FG000|Overall Study|Withdrawal by Subject|1|||
131476126|NCT05069259|473374229|FG000|Overall Study|Sponsor decision|1|||
131476127|NCT03148275|473374230|FG000|Overall Study|Death|6|||
131476128|NCT03148275|473374230|FG000|Overall Study|Adverse Event|3|||
131476129|NCT03148275|473374230|FG000|Overall Study|Liver transplant|2|||
131476130|NCT03148275|473374230|FG000|Overall Study|Patient decision|5|||
131476131|NCT03148275|473374230|FG000|Overall Study|transition to commercial drug|1|||
131476132|NCT03148275|473374230|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
131476133|NCT05098938|473374231|FG000|Overall Study|Adverse Event|4|||
131476134|NCT05098938|473374232|FG001|Overall Study|Adverse Event|3|||
131476135|NCT05098938|473374231|FG000|Overall Study|inclusion/exclusion criteria change|11|||
131476136|NCT05098938|473374232|FG001|Overall Study|inclusion/exclusion criteria change|5|||
131476137|NCT05098938|473374231|FG000|Overall Study|lack of compliance|26|||
131476138|NCT05098938|473374232|FG001|Overall Study|lack of compliance|19|||
131476139|NCT05098938|473374231|FG000|Overall Study|Lost to Follow-up|37|||
131476140|NCT05098938|473374232|FG001|Overall Study|Lost to Follow-up|40|||
131476141|NCT05098938|473374231|FG000|Overall Study|Lost in treatment period|17|||
131476142|NCT05098938|473374232|FG001|Overall Study|Lost in treatment period|13|||
131476143|NCT05098938|473374231|FG000|Overall Study|Met an exclusion criterion|0|||
131476144|NCT05098938|473374232|FG001|Overall Study|Met an exclusion criterion|3|||
131476145|NCT05098938|473374231|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
131476146|NCT05098938|473374232|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
131476147|NCT05098938|473374231|FG000|Overall Study|Physician Decision|25|||
131476148|NCT05098938|473374232|FG001|Overall Study|Physician Decision|32|||
131476149|NCT05098938|473374231|FG000|Overall Study|Run in failure in treatment phase|1|||
131476150|NCT05098938|473374232|FG001|Overall Study|Run in failure in treatment phase|1|||
131476151|NCT05098938|473374231|FG000|Overall Study|Withdrawal by Subject|0|||
131476152|NCT05098938|473374232|FG001|Overall Study|Withdrawal by Subject|3|||
131476153|NCT05098938|473374231|FG000|Overall Study|Run-in Failure in early study|505|||
131476154|NCT05098938|473374232|FG001|Overall Study|Run-in Failure in early study|514|||
131476155|NCT05098938|473374231|FG000|Overall Study|IMP delivery missed|1|||
131476156|NCT05098938|473374232|FG001|Overall Study|IMP delivery missed|5|||
131476157|NCT05098938|473374231|FG000|Overall Study|6 months visit was missed|2|||
131476158|NCT05098938|473374232|FG001|Overall Study|6 months visit was missed|0|||
131476159|NCT05098938|473374231|FG000|Overall Study|fit for use was not completed within window|3|||
131476160|NCT05098938|473374232|FG001|Overall Study|fit for use was not completed within window|0|||
131476161|NCT05098938|473374231|FG000|Overall Study|V2 visit was not completed within window|0|||
131882200|NCT04542499|474851123|FG001|Overall Study|Lack of Efficacy|2|||
131882201|NCT04542499|474851122|FG000|Overall Study|Lost to Follow-up|3|||
131882202|NCT04542499|474851123|FG001|Overall Study|Lost to Follow-up|4|||
131882203|NCT04542499|474851122|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
131882204|NCT04542499|474851123|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
131882205|NCT04542499|474851122|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
131476162|NCT05098938|473374232|FG001|Overall Study|V2 visit was not completed within window|1|||
131476163|NCT05098938|473374231|FG000|Overall Study|exclusionary medication use|1|||
131476164|NCT05098938|473374232|FG001|Overall Study|exclusionary medication use|2|||
131476165|NCT05098938|473374231|FG000|Overall Study|change in medication|1|||
131476166|NCT05098938|473374232|FG001|Overall Study|change in medication|0|||
131476167|NCT05098938|473374231|FG000|Overall Study|treatment failure|2|||
131476168|NCT05098938|473374232|FG001|Overall Study|treatment failure|1|||
131476169|NCT01828320|473374233|FG000|Overall Study|Lost to Follow-up|1|||
131476170|NCT01828320|473374234|FG001|Overall Study|Lost to Follow-up|3|||
131476171|NCT01828320|473374233|FG000|Overall Study|Withdrawal by Subject|7|||
131476172|NCT01828320|473374234|FG001|Overall Study|Withdrawal by Subject|2|||
131476173|NCT02160782|473375704|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
131476174|NCT02160782|473375705|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
131476175|NCT02160782|473375706|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
131476176|NCT02160782|473375707|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
131476177|NCT02160782|473375708|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
131476178|NCT02160782|473375704|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
131476179|NCT02160782|473375705|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
131476180|NCT02160782|473375706|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
131476181|NCT02160782|473375707|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
131476182|NCT02160782|473375708|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
131476183|NCT02160782|473375704|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
131476184|NCT02160782|473375705|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
131476185|NCT02160782|473375706|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
131476186|NCT02160782|473375707|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
131476187|NCT02160782|473375708|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
131476188|NCT02160782|473375704|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
131476189|NCT02160782|473375705|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
131476190|NCT02160782|473375706|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
131476191|NCT02160782|473375707|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
131476192|NCT02160782|473375708|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
131476193|NCT02160782|473375704|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
131476194|NCT02160782|473375705|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
131476195|NCT02160782|473375706|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
131476196|NCT02160782|473375707|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
131476197|NCT02160782|473375708|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
131476198|NCT02160782|473375704|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
131476199|NCT02160782|473375705|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
131476200|NCT02160782|473375706|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
131476201|NCT02160782|473375707|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
131476202|NCT02160782|473375708|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
131476203|NCT02160782|473375704|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
131476204|NCT02160782|473375705|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
131476205|NCT02160782|473375706|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
131476206|NCT02160782|473375707|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
131476207|NCT02160782|473375708|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
131476208|NCT01104701|473375711|FG000|Overall Study|Withdrawal by Subject|0|||
131476209|NCT01104701|473375712|FG001|Overall Study|Withdrawal by Subject|1|||
131476210|NCT01104701|473375713|FG002|Overall Study|Withdrawal by Subject|2|||
131476211|NCT01104701|473375714|FG003|Overall Study|Withdrawal by Subject|1|||
131476212|NCT01104701|473375711|FG000|Overall Study|Adverse Event|0|||
131476213|NCT01104701|473375712|FG001|Overall Study|Adverse Event|0|||
131476214|NCT01104701|473375713|FG002|Overall Study|Adverse Event|0|||
131476215|NCT01104701|473375714|FG003|Overall Study|Adverse Event|1|||
131476216|NCT01104701|473375711|FG000|Overall Study|Physician Decision|0|||
131476217|NCT01104701|473375712|FG001|Overall Study|Physician Decision|2|||
131476218|NCT01104701|473375713|FG002|Overall Study|Physician Decision|0|||
131476219|NCT01104701|473375714|FG003|Overall Study|Physician Decision|0|||
131476220|NCT00674973|473375715|FG000|Overall Study|Insufficient Therapeutic Response|77|||
131476221|NCT00674973|473375716|FG001|Overall Study|Insufficient Therapeutic Response|72|||
131476222|NCT00674973|473375715|FG000|Overall Study|Refused Treatment|1|||
131476223|NCT00674973|473375716|FG001|Overall Study|Refused Treatment|5|||
131476224|NCT00674973|473375715|FG000|Overall Study|Failure to Return|1|||
131882206|NCT04542499|474851123|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
131882207|NCT04542499|474851122|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131476225|NCT00674973|473375716|FG001|Overall Study|Failure to Return|0|||
131476226|NCT00674973|473375715|FG000|Overall Study|Adverse Event|2|||
131882208|NCT04542499|474851123|FG001|Overall Study|Non-Compliance with Study Drug|2|||
131882209|NCT04542499|474851122|FG000|Overall Study|Physician Decision|0|||
131882210|NCT04542499|474851123|FG001|Overall Study|Physician Decision|1|||
131882211|NCT04542499|474851122|FG000|Overall Study|Site Terminated by Sponsor|3|||
131882212|NCT04542499|474851123|FG001|Overall Study|Site Terminated by Sponsor|5|||
131882213|NCT04542499|474851122|FG000|Overall Study|Withdrawal by Subject|12|||
131882214|NCT04542499|474851123|FG001|Overall Study|Withdrawal by Subject|33|||
131882215|NCT04542499|474851122|FG000|Overall Study|Other|2|||
131882216|NCT04542499|474851123|FG001|Overall Study|Other|2|||
131882217|NCT03617861|474851130|FG000|Second Intervention (1 Day)|Adverse Event|0|||
131882218|NCT03617861|474851131|FG001|Second Intervention (1 Day)|Adverse Event|0|||
131882219|NCT03617861|474851132|FG002|Second Intervention (1 Day)|Adverse Event|1|||
131882220|NCT03617861|474851133|FG003|Second Intervention (1 Day)|Adverse Event|0|||
131882221|NCT01846221|474851141|FG000|Overall Study|Catheter Failure|2|||
131882222|NCT01846221|474851142|FG001|Overall Study|Catheter Failure|0|||
131476227|NCT00674973|473375716|FG001|Overall Study|Adverse Event|9|||
131476228|NCT00674973|473375715|FG000|Overall Study|Death|19|||
131476229|NCT00674973|473375716|FG001|Overall Study|Death|15|||
131476230|NCT00674973|473375715|FG000|Overall Study|Protocol Violation|0|||
131476231|NCT00674973|473375716|FG001|Overall Study|Protocol Violation|1|||
131476232|NCT01397162|473375721|FG000|Overall Study|Adverse Event|4|||
131476233|NCT01397162|473375722|FG001|Overall Study|Adverse Event|0|||
131476234|NCT01397162|473375723|FG002|Overall Study|Adverse Event|0|||
131476235|NCT01397162|473375724|FG003|Overall Study|Adverse Event|0|||
131476236|NCT01397162|473375725|FG004|Overall Study|Adverse Event|0|||
131476237|NCT01397162|473375721|FG000|Overall Study|Not yet defined|3|||
131476238|NCT01397162|473375722|FG001|Overall Study|Not yet defined|4|||
131476239|NCT01397162|473375723|FG002|Overall Study|Not yet defined|3|||
131476240|NCT01397162|473375724|FG003|Overall Study|Not yet defined|5|||
131476241|NCT01397162|473375725|FG004|Overall Study|Not yet defined|3|||
131476242|NCT03875118|473375726|FG000|Overall Study|Withdrawal by Subject|4|||
131476243|NCT03875118|473375727|FG001|Overall Study|Withdrawal by Subject|4|||
131476244|NCT02437513|473375728|FG000|Overall Study|Withdrawal by Subject|2|||
131476245|NCT00422097|473375729|FG000|Dose Level 2|Still on treatment|0|||
131476246|NCT00422097|473375730|FG001|Dose Level 2|Still on treatment|1|||
131476247|NCT00422097|473375731|FG002|Dose Level 2|Still on treatment|0|||
131476248|NCT00422097|473375732|FG003|Dose Level 2|Still on treatment|0|||
131476249|NCT00422097|473375733|FG004|Dose Level 2|Still on treatment|0|||
131476250|NCT00422097|473375734|FG005|Dose Level 2|Still on treatment|0|||
131476251|NCT00422097|473375735|FG006|Dose Level 2|Still on treatment|0|||
131476252|NCT00422097|473375736|FG007|Dose Level 2|Still on treatment|0|||
131476253|NCT00736957|473375737|FG000|Overall Study|Adverse Event|43|||
131476254|NCT00736957|473375737|FG000|Overall Study|Withdrawal by Subject|49|||
131476255|NCT00736957|473375737|FG000|Overall Study|violation of eligibility criteria|2|||
131476256|NCT00736957|473375737|FG000|Overall Study|did not attend hospital appointments|1|||
131476257|NCT00736957|473375737|FG000|Overall Study|not eligible for Treatment Period I|22|||
131476258|NCT00736957|473375737|FG000|Overall Study|Physician Decision|5|||
131476259|NCT00331864|473375738|FG000|Overall Study|Adverse Event|30|||
131476260|NCT00331864|473375739|FG001|Overall Study|Adverse Event|1|||
131476261|NCT00331864|473375738|FG000|Overall Study|Lack of Efficacy|4|||
131476262|NCT00331864|473375739|FG001|Overall Study|Lack of Efficacy|0|||
131476263|NCT00331864|473375738|FG000|Overall Study|Protocol Violation|3|||
131476264|NCT00331864|473375739|FG001|Overall Study|Protocol Violation|0|||
131476265|NCT00331864|473375738|FG000|Overall Study|Withdrawal by Subject|10|||
131476266|NCT00331864|473375739|FG001|Overall Study|Withdrawal by Subject|0|||
131476267|NCT00331864|473375738|FG000|Overall Study|Lost to Follow-up|4|||
131476268|NCT00331864|473375739|FG001|Overall Study|Lost to Follow-up|3|||
131476269|NCT00331864|473375738|FG000|Overall Study|Administrative Problems|1|||
131476270|NCT00331864|473375739|FG001|Overall Study|Administrative Problems|0|||
131476271|NCT00331864|473375738|FG000|Overall Study|Death|6|||
131476272|NCT00331864|473375739|FG001|Overall Study|Death|0|||
131476273|NCT02611960|473375740|FG000|Overall Study|Adverse Event|7|||
131476274|NCT02611960|473375741|FG001|Overall Study|Adverse Event|8|||
131476275|NCT02611960|473375740|FG000|Overall Study|Death|98|||
131476276|NCT02611960|473375741|FG001|Overall Study|Death|92|||
131476277|NCT02611960|473375740|FG000|Overall Study|Withdrawal by Subject|1|||
131476278|NCT02611960|473375741|FG001|Overall Study|Withdrawal by Subject|5|||
131476279|NCT02611960|473375740|FG000|Overall Study|Sponsor Decision|11|||
131476280|NCT02611960|473375741|FG001|Overall Study|Sponsor Decision|11|||
131476281|NCT01092507|473375742|FG000|Overall Study|Withdrawal by Subject|2|||
131476282|NCT01092507|473375743|FG001|Overall Study|Withdrawal by Subject|0|||
131476283|NCT00293215|473375754|FG000|Overall Study|Progressive disease|3|||
131476284|NCT00293215|473375755|FG001|Overall Study|Progressive disease|1|||
131476285|NCT00293215|473375754|FG000|Overall Study|Adverse Event|2|||
131476286|NCT00293215|473375755|FG001|Overall Study|Adverse Event|2|||
131476287|NCT01229371|473375756|FG000|Overall Study|Withdrawal by Subject|0|||
131476288|NCT01229371|473375757|FG001|Overall Study|Withdrawal by Subject|1|||
131476289|NCT01229371|473375758|FG002|Overall Study|Withdrawal by Subject|0|||
131476290|NCT01229371|473375759|FG003|Overall Study|Withdrawal by Subject|0|||
131476291|NCT00145600|473375760|FG000|Overall Study|Death|1|||
131476292|NCT00145600|473375761|FG001|Overall Study|Death|2|||
131476293|NCT00145600|473375762|FG002|Overall Study|Death|2|||
131476294|NCT00145600|473375763|FG003|Overall Study|Death|6|||
131476295|NCT00145600|473375760|FG000|Overall Study|Ineligible|3|||
131476296|NCT00145600|473375761|FG001|Overall Study|Ineligible|0|||
131476297|NCT00145600|473375762|FG002|Overall Study|Ineligible|1|||
131476298|NCT00145600|473375763|FG003|Overall Study|Ineligible|5|||
131476299|NCT00145600|473375760|FG000|Overall Study|Lost to Follow-up|2|||
131476300|NCT00145600|473375761|FG001|Overall Study|Lost to Follow-up|6|||
131476301|NCT00145600|473375762|FG002|Overall Study|Lost to Follow-up|2|||
131476302|NCT00145600|473375763|FG003|Overall Study|Lost to Follow-up|4|||
131476303|NCT00145600|473375760|FG000|Overall Study|Noncompliance|1|||
131476304|NCT00145600|473375761|FG001|Overall Study|Noncompliance|0|||
131476305|NCT00145600|473375762|FG002|Overall Study|Noncompliance|0|||
131476306|NCT00145600|473375763|FG003|Overall Study|Noncompliance|0|||
131476307|NCT00145600|473375760|FG000|Overall Study|Withdrawal by Subject|1|||
131476308|NCT00145600|473375761|FG001|Overall Study|Withdrawal by Subject|2|||
131476309|NCT00145600|473375762|FG002|Overall Study|Withdrawal by Subject|0|||
131476310|NCT00145600|473375763|FG003|Overall Study|Withdrawal by Subject|1|||
131476311|NCT01539642|473375765|FG000|Overall Study|Lack of Efficacy|20|||
131476312|NCT01539642|473375766|FG001|Overall Study|Lack of Efficacy|18|||
131476313|NCT01539642|473375765|FG000|Overall Study|Patient ready for early discharge|8|||
131476314|NCT01539642|473375766|FG001|Overall Study|Patient ready for early discharge|7|||
131476315|NCT01539642|473375765|FG000|Overall Study|Adverse Event|6|||
131476316|NCT01539642|473375766|FG001|Overall Study|Adverse Event|4|||
131476317|NCT01539642|473375765|FG000|Overall Study|Withdrawal by Subject|2|||
131476318|NCT01539642|473375766|FG001|Overall Study|Withdrawal by Subject|2|||
131476319|NCT00761579|473375767|FG000|Overall Study|Adverse Event|10|||
131476320|NCT00761579|473375767|FG000|Overall Study|Death|2|||
131476321|NCT00761579|473375767|FG000|Overall Study|Lack of Efficacy|21|||
131476322|NCT00761579|473375767|FG000|Overall Study|Lost to Follow-up|16|||
131476323|NCT00761579|473375767|FG000|Overall Study|Pregnancy|1|||
131476324|NCT00761579|473375767|FG000|Overall Study|Withdrawal by Subject|34|||
131476325|NCT00761579|473375767|FG000|Overall Study|Lack of compliance|2|||
131476326|NCT00761579|473375767|FG000|Overall Study|Protocol deviation|1|||
131476327|NCT00761579|473375767|FG000|Overall Study|Drug overdose|1|||
131476328|NCT00761579|473375767|FG000|Overall Study|Aggravation of depression|1|||
131476329|NCT00761579|473375767|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
131476330|NCT00761579|473375767|FG000|Overall Study|Lost survey form|1|||
131476331|NCT00761579|473375767|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
131476332|NCT03611010|473375768|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
131476333|NCT03611010|473375769|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
131476334|NCT03611010|473375770|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
131476335|NCT03611010|473375771|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
131476336|NCT00950911|473375772|FG000|Overall Study|Adverse Event|0|||
131476337|NCT00950911|473375773|FG001|Overall Study|Adverse Event|2|||
131476338|NCT00950911|473375772|FG000|Overall Study|Death|4|||
131476339|NCT00950911|473375773|FG001|Overall Study|Death|6|||
131476340|NCT00950911|473375772|FG000|Overall Study|Disease progression|2|||
131476341|NCT00950911|473375773|FG001|Overall Study|Disease progression|2|||
131476342|NCT00950911|473375772|FG000|Overall Study|Consent withdrawn|1|||
131476343|NCT00950911|473375773|FG001|Overall Study|Consent withdrawn|3|||
131476344|NCT00950911|473375772|FG000|Overall Study|Administrative decision|3|||
131476345|NCT00950911|473375773|FG001|Overall Study|Administrative decision|1|||
131476346|NCT00950911|473375772|FG000|Overall Study|Ineligibility determined|1|||
131476347|NCT00950911|473375773|FG001|Overall Study|Ineligibility determined|0|||
131476348|NCT00950911|473375772|FG000|Overall Study|Noncompliance|1|||
131476349|NCT00950911|473375773|FG001|Overall Study|Noncompliance|0|||
131476350|NCT00950911|473375772|FG000|Overall Study|Poor performance status|0|||
131476351|NCT00950911|473375773|FG001|Overall Study|Poor performance status|1|||
131476352|NCT02600351|473375776|FG000|Overall Study|Lack of Efficacy|3|||
131476353|NCT02600351|473375777|FG001|Overall Study|Lack of Efficacy|0|||
131476354|NCT02600351|473375778|FG002|Overall Study|Lack of Efficacy|5|||
131476355|NCT02600351|473375779|FG003|Overall Study|Lack of Efficacy|2|||
131476356|NCT02600351|473375776|FG000|Overall Study|Lost to Follow-up|1|||
131476357|NCT02600351|473375777|FG001|Overall Study|Lost to Follow-up|0|||
131476358|NCT02600351|473375778|FG002|Overall Study|Lost to Follow-up|0|||
131476359|NCT02600351|473375779|FG003|Overall Study|Lost to Follow-up|0|||
131476360|NCT02600351|473375776|FG000|Overall Study|Randomized but Not Treated|1|||
131476361|NCT02600351|473375777|FG001|Overall Study|Randomized but Not Treated|0|||
131476362|NCT02600351|473375778|FG002|Overall Study|Randomized but Not Treated|1|||
131476363|NCT02600351|473375779|FG003|Overall Study|Randomized but Not Treated|3|||
131476364|NCT02063880|473375780|FG000|Overall Study|Death|21|||
131476365|NCT02063880|473375781|FG001|Overall Study|Death|18|||
131476366|NCT02063880|473375780|FG000|Overall Study|Lost to Follow-up|7|||
131476367|NCT02063880|473375781|FG001|Overall Study|Lost to Follow-up|7|||
131476368|NCT02063880|473375780|FG000|Overall Study|Ineligible|0|||
131476369|NCT02063880|473375781|FG001|Overall Study|Ineligible|2|||
131476370|NCT00567593|473375782|FG000|Overall Study|Adverse Event|1|||
131476371|NCT00567593|473375782|FG000|Overall Study|Physician Decision|1|||
131476372|NCT04087213|473375785|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
131476373|NCT04087213|473375785|FG000|In-Facility Introduction|Adverse Event|1|||
131476374|NCT04087213|473375785|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
131476375|NCT04087213|473375785|FG000|Assisted Evaluable Period|Personal reasons|3|||
131882223|NCT01846221|474851141|FG000|Overall Study|Age Exclusion|1|||
131882224|NCT01846221|474851142|FG001|Overall Study|Age Exclusion|0|||
131882225|NCT01668966|474851143|FG000|Overall Study|Withdrawal by Subject|1|||
131882226|NCT01668966|474851143|FG000|Overall Study|Death|1|||
131882227|NCT01668966|474851143|FG000|Overall Study|Not treated|2|||
131882228|NCT02879994|474851144|FG000|Overall Study|off treatment early|7|||
131882229|NCT02879994|474851144|FG000|Overall Study|Adverse Event|2|||
131882230|NCT02879994|474851144|FG000|Overall Study|Death|2|||
131476376|NCT04087213|473375785|FG000|Transition Period B|Renal Transplantation|1|||
131476377|NCT01859143|473375786|FG000|Overall Study|Lost to Follow-up|2|||
131476378|NCT01859143|473375787|FG001|Overall Study|Lost to Follow-up|0|||
131476379|NCT02413372|473375791|FG000|Treatment|Lost to Follow-up|0|||
131476380|NCT02413372|473375792|FG001|Treatment|Lost to Follow-up|2|||
131476381|NCT02413372|473375793|FG002|Treatment|Lost to Follow-up|1|||
131476382|NCT02413372|473375791|FG000|Treatment|Withdrawal by Subject|1|||
131476383|NCT02413372|473375792|FG001|Treatment|Withdrawal by Subject|0|||
131476384|NCT02413372|473375793|FG002|Treatment|Withdrawal by Subject|0|||
131476385|NCT02413372|473375791|FG000|Follow-up|Lost to Follow-up|1|||
131476386|NCT02413372|473375792|FG001|Follow-up|Lost to Follow-up|1|||
131476387|NCT02413372|473375793|FG002|Follow-up|Lost to Follow-up|0|||
131476388|NCT02413372|473375791|FG000|Follow-up|Subject Withdrew Consent|1|||
131476389|NCT02413372|473375792|FG001|Follow-up|Subject Withdrew Consent|0|||
131476390|NCT02413372|473375793|FG002|Follow-up|Subject Withdrew Consent|1|||
131476391|NCT02413372|473375791|FG000|Follow-up|Subject unable to return for visit|0|||
131476392|NCT02413372|473375792|FG001|Follow-up|Subject unable to return for visit|0|||
131476393|NCT02413372|473375793|FG002|Follow-up|Subject unable to return for visit|1|||
131476394|NCT04587271|473375800|FG000|Overall Study|Lost to Follow-up|2|||
131476395|NCT04587271|473375801|FG001|Overall Study|Lost to Follow-up|2|||
131476396|NCT04587271|473375802|FG002|Overall Study|Lost to Follow-up|0|||
131476397|NCT04587271|473375803|FG003|Overall Study|Lost to Follow-up|2|||
131476398|NCT04587271|473375804|FG004|Overall Study|Lost to Follow-up|2|||
131476399|NCT04587271|473375805|FG005|Overall Study|Lost to Follow-up|0|||
131882231|NCT00552032|474851145|FG000|Overall Study|Withdrawal by Subject|2|||
131882232|NCT00552032|474851146|FG001|Overall Study|Withdrawal by Subject|2|||
131882233|NCT00552032|474851145|FG000|Overall Study|Protocol Violation|7|||
131882234|NCT00552032|474851146|FG001|Overall Study|Protocol Violation|12|||
131882235|NCT00552032|474851145|FG000|Overall Study|Lost to Follow-up|8|||
131882236|NCT00552032|474851146|FG001|Overall Study|Lost to Follow-up|5|||
131882237|NCT01643798|474851147|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
131882238|NCT01643798|474851148|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
131882239|NCT03602391|474851158|FG000|Overall Study|COVID-19|7|||
131882240|NCT03602391|474851159|FG001|Overall Study|COVID-19|6|||
131882241|NCT02035748|474851162|FG000|Overall Study|Adverse Event|5|||
131882242|NCT02035748|474851162|FG000|Overall Study|Death|3|||
131476400|NCT04587271|473375800|FG000|Overall Study|Caregiver brought child to visits|0|||
131476401|NCT04587271|473375801|FG001|Overall Study|Caregiver brought child to visits|0|||
131476402|NCT04587271|473375802|FG002|Overall Study|Caregiver brought child to visits|0|||
131476403|NCT04587271|473375803|FG003|Overall Study|Caregiver brought child to visits|1|||
131476404|NCT04587271|473375804|FG004|Overall Study|Caregiver brought child to visits|0|||
131476405|NCT04587271|473375805|FG005|Overall Study|Caregiver brought child to visits|0|||
131476406|NCT02180165|473375807|FG000|Overall Study|Not Treated|0|||
131476407|NCT02180165|473375808|FG001|Overall Study|Not Treated|0|||
131476408|NCT02180165|473375809|FG002|Overall Study|Not Treated|1|||
131476409|NCT02180165|473375810|FG003|Overall Study|Not Treated|0|||
131476410|NCT02180165|473375807|FG000|Overall Study|Adverse Event|7|||
131476411|NCT02180165|473375808|FG001|Overall Study|Adverse Event|0|||
131476412|NCT02180165|473375809|FG002|Overall Study|Adverse Event|18|||
131476413|NCT02180165|473375810|FG003|Overall Study|Adverse Event|3|||
131476414|NCT02180165|473375807|FG000|Overall Study|Lack of Efficacy|0|||
131476415|NCT02180165|473375808|FG001|Overall Study|Lack of Efficacy|1|||
131476416|NCT02180165|473375809|FG002|Overall Study|Lack of Efficacy|3|||
131476417|NCT02180165|473375810|FG003|Overall Study|Lack of Efficacy|2|||
131476418|NCT02180165|473375807|FG000|Overall Study|Physician Decision|1|||
131476419|NCT02180165|473375808|FG001|Overall Study|Physician Decision|0|||
131476420|NCT02180165|473375809|FG002|Overall Study|Physician Decision|5|||
131476421|NCT02180165|473375810|FG003|Overall Study|Physician Decision|0|||
131476422|NCT02180165|473375807|FG000|Overall Study|Withdrawal by Subject|3|||
131476423|NCT02180165|473375808|FG001|Overall Study|Withdrawal by Subject|0|||
131476424|NCT02180165|473375809|FG002|Overall Study|Withdrawal by Subject|2|||
131476425|NCT02180165|473375810|FG003|Overall Study|Withdrawal by Subject|1|||
131476426|NCT02943460|473375812|FG000|Blinded Study Phase|Adverse Event|3|||
131476427|NCT02943460|473375813|FG001|Blinded Study Phase|Adverse Event|0|||
131476428|NCT02943460|473375814|FG002|Blinded Study Phase|Adverse Event|0|||
131476429|NCT02943460|473375812|FG000|Blinded Study Phase|Withdrew Consent|0|||
131476430|NCT02943460|473375813|FG001|Blinded Study Phase|Withdrew Consent|1|||
131882243|NCT02035748|474851162|FG000|Overall Study|Lost to Follow-up|2|||
131882244|NCT02035748|474851162|FG000|Overall Study|Physician Decision|3|||
131476431|NCT02943460|473375814|FG002|Blinded Study Phase|Withdrew Consent|0|||
131476432|NCT02943460|473375812|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
131476433|NCT02943460|473375813|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
131476434|NCT02943460|473375814|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
131476435|NCT02943460|473375812|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
131476436|NCT02943460|473375813|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
131476437|NCT02943460|473375814|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
131476438|NCT02943460|473375812|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
131476439|NCT02943460|473375813|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
131882245|NCT02035748|474851162|FG000|Overall Study|Withdrawal by Subject|6|||
131476440|NCT02943460|473375814|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
131476441|NCT01031381|473375815|FG000|Overall Study|Physician Decision|3|||
131476442|NCT01031381|473375815|FG000|Overall Study|Withdrawal by Subject|6|||
131476443|NCT00723398|473375816|FG000|Overall Study|Withdrawal by Subject|2|||
131476444|NCT00723398|473375817|FG001|Overall Study|Withdrawal by Subject|6|||
131476445|NCT00723398|473375818|FG002|Overall Study|Withdrawal by Subject|4|||
131476446|NCT00723398|473375819|FG003|Overall Study|Withdrawal by Subject|4|||
131476447|NCT00723398|473375820|FG004|Overall Study|Withdrawal by Subject|4|||
131476448|NCT00723398|473375816|FG000|Overall Study|Protocol Violation|2|||
131476449|NCT00723398|473375817|FG001|Overall Study|Protocol Violation|1|||
131476450|NCT00723398|473375818|FG002|Overall Study|Protocol Violation|5|||
131476451|NCT00723398|473375819|FG003|Overall Study|Protocol Violation|0|||
131476452|NCT00723398|473375820|FG004|Overall Study|Protocol Violation|0|||
131476453|NCT00723398|473375816|FG000|Overall Study|Physician Decision|2|||
131476454|NCT00723398|473375817|FG001|Overall Study|Physician Decision|2|||
131476455|NCT00723398|473375818|FG002|Overall Study|Physician Decision|5|||
131476456|NCT00723398|473375819|FG003|Overall Study|Physician Decision|0|||
131476457|NCT00723398|473375820|FG004|Overall Study|Physician Decision|1|||
131476458|NCT00723398|473375816|FG000|Overall Study|Adverse Event|0|||
131476459|NCT00723398|473375817|FG001|Overall Study|Adverse Event|5|||
131476460|NCT00723398|473375818|FG002|Overall Study|Adverse Event|3|||
131476461|NCT00723398|473375819|FG003|Overall Study|Adverse Event|1|||
131476462|NCT00723398|473375820|FG004|Overall Study|Adverse Event|4|||
131476463|NCT00723398|473375816|FG000|Overall Study|Lost to Follow-up|0|||
131476464|NCT00723398|473375817|FG001|Overall Study|Lost to Follow-up|1|||
131476465|NCT00723398|473375818|FG002|Overall Study|Lost to Follow-up|0|||
131476466|NCT00723398|473375819|FG003|Overall Study|Lost to Follow-up|0|||
131476467|NCT00723398|473375820|FG004|Overall Study|Lost to Follow-up|0|||
131476468|NCT00122109|473375822|FG000|Overall Study|Did not meet criteria|6|||
131476469|NCT00122109|473375823|FG001|Overall Study|Did not meet criteria|7|||
131476470|NCT00267189|473375828|FG000|Overall Study|Patient withdrew consent|1|||
131476471|NCT00267189|473375829|FG001|Overall Study|Patient withdrew consent|1|||
131476472|NCT00267189|473375828|FG000|Overall Study|Death|1|||
131476473|NCT00267189|473375829|FG001|Overall Study|Death|0|||
131476474|NCT00267189|473375828|FG000|Overall Study|Missing|3|||
131476475|NCT00267189|473375829|FG001|Overall Study|Missing|0|||
131476476|NCT01578330|473375834|FG000|Overall Study|Adverse Event|2|||
131476477|NCT01578330|473375834|FG000|Overall Study|Protocol Violation|5|||
131476478|NCT01638819|473375842|FG000|Overall Study|Lost to Follow-up|1|||
131476479|NCT01638819|473375843|FG001|Overall Study|Lost to Follow-up|0|||
131476480|NCT03538431|473375844|FG000|Overall Study|Physician Decision|0|||
131476481|NCT03538431|473375845|FG001|Overall Study|Physician Decision|1|||
131476482|NCT03538431|473375844|FG000|Overall Study|Withdrawal by Subject|1|||
131476483|NCT03538431|473375845|FG001|Overall Study|Withdrawal by Subject|0|||
131476484|NCT00406718|473375849|FG000|Overall Study|Withdrawal by Subject|2|||
131476485|NCT00406718|473375850|FG001|Overall Study|Withdrawal by Subject|9|||
131476486|NCT00406718|473375851|FG002|Overall Study|Withdrawal by Subject|4|||
131476487|NCT00406718|473375849|FG000|Overall Study|Lost to Follow-up|2|||
131476488|NCT00406718|473375850|FG001|Overall Study|Lost to Follow-up|5|||
131476489|NCT00406718|473375851|FG002|Overall Study|Lost to Follow-up|4|||
131476490|NCT02891161|473375852|FG000|Study Treatment|Disease Progression|2|||
131476491|NCT02891161|473375853|FG001|Study Treatment|Disease Progression|4|||
131476492|NCT02891161|473375852|FG000|Study Treatment|AE/Side Effects/Complications|1|||
131476493|NCT02891161|473375853|FG001|Study Treatment|AE/Side Effects/Complications|5|||
131476494|NCT02891161|473375852|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
131476495|NCT02891161|473375853|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
131476496|NCT02891161|473375852|FG000|Follow up|Death|4|||
131476497|NCT02891161|473375853|FG001|Follow up|Death|8|||
131476498|NCT02891161|473375852|FG000|Follow up|Refused to Follow up|0|||
131476499|NCT02891161|473375853|FG001|Follow up|Refused to Follow up|2|||
131476500|NCT02891161|473375852|FG000|Follow up|Symptomatic deterioration|0|||
131476501|NCT02891161|473375853|FG001|Follow up|Symptomatic deterioration|1|||
131476502|NCT02891161|473375852|FG000|Follow up|Study terminated|0|||
131476503|NCT02891161|473375853|FG001|Follow up|Study terminated|6|||
131476504|NCT05597020|473375860|FG000|Washout|Forbidden medication|2|||
131476505|NCT05597020|473375861|FG001|Washout|Forbidden medication|0|||
131476506|NCT05597020|473375860|FG000|Treatment Period II|Advice from primary care physician|1|||
131476507|NCT05597020|473375861|FG001|Treatment Period II|Advice from primary care physician|0|||
131476508|NCT05597020|473375860|FG000|Treatment Period II|Subject lost investigational product|1|||
131476509|NCT05597020|473375861|FG001|Treatment Period II|Subject lost investigational product|0|||
131476510|NCT05597020|473375860|FG000|Treatment Period II|Private reasons|0|||
131476511|NCT05597020|473375861|FG001|Treatment Period II|Private reasons|1|||
131476512|NCT00560885|473375870|FG000|Overall Study|Death|7|||
131476513|NCT00560885|473375870|FG000|Overall Study|Withdrawal by Subject|1|||
131476514|NCT02445391|473375871|FG000|Overall Study|No active protocol treatment|3|||
131476515|NCT02445391|473375872|FG001|Overall Study|No active protocol treatment|0|||
131476516|NCT02445391|473375873|FG002|Overall Study|No active protocol treatment|0|||
131476517|NCT02445391|473375871|FG000|Overall Study|Adverse Event|0|||
131476518|NCT02445391|473375872|FG001|Overall Study|Adverse Event|21|||
131476519|NCT02445391|473375873|FG002|Overall Study|Adverse Event|12|||
131476520|NCT02445391|473375871|FG000|Overall Study|Alternative therapy|0|||
131476521|NCT02445391|473375872|FG001|Overall Study|Alternative therapy|0|||
131476522|NCT02445391|473375873|FG002|Overall Study|Alternative therapy|1|||
131476523|NCT02445391|473375871|FG000|Overall Study|Disease progression|0|||
131476524|NCT02445391|473375872|FG001|Overall Study|Disease progression|7|||
131476525|NCT02445391|473375873|FG002|Overall Study|Disease progression|22|||
131476526|NCT02445391|473375871|FG000|Overall Study|Complicating disease|0|||
131476527|NCT02445391|473375872|FG001|Overall Study|Complicating disease|2|||
131476528|NCT02445391|473375873|FG002|Overall Study|Complicating disease|1|||
131476529|NCT02445391|473375871|FG000|Overall Study|Withdrawal by Subject|0|||
131476530|NCT02445391|473375872|FG001|Overall Study|Withdrawal by Subject|4|||
131476531|NCT02445391|473375873|FG002|Overall Study|Withdrawal by Subject|9|||
131476532|NCT02445391|473375871|FG000|Overall Study|Financial issue|0|||
131476533|NCT02445391|473375872|FG001|Overall Study|Financial issue|0|||
131476534|NCT02445391|473375873|FG002|Overall Study|Financial issue|2|||
131476535|NCT02445391|473375871|FG000|Overall Study|Still on treatment|0|||
131476536|NCT02445391|473375872|FG001|Overall Study|Still on treatment|7|||
131476537|NCT02445391|473375873|FG002|Overall Study|Still on treatment|16|||
131476538|NCT02445391|473375871|FG000|Overall Study|Not start protocol therapy|0|||
131476539|NCT02445391|473375872|FG001|Overall Study|Not start protocol therapy|12|||
131476540|NCT02445391|473375873|FG002|Overall Study|Not start protocol therapy|9|||
131476541|NCT03803683|473375875|FG000|Overall Study|Lost to Follow-up|41|||
131476542|NCT03803683|473375876|FG001|Overall Study|Lost to Follow-up|18|||
131476543|NCT03803683|473375877|FG002|Overall Study|Lost to Follow-up|12|||
131476544|NCT03803683|473375875|FG000|Overall Study|Withdrawal by Subject|9|||
131476545|NCT03803683|473375876|FG001|Overall Study|Withdrawal by Subject|1|||
131476546|NCT03803683|473375877|FG002|Overall Study|Withdrawal by Subject|4|||
131476547|NCT00492050|473375878|FG000|Overall Study|Adverse Event|1|||
131476548|NCT00492050|473375878|FG000|Overall Study|Lack of Efficacy|1|||
131476549|NCT00492050|473375878|FG000|Overall Study|Withdrawal by Subject|3|||
131476550|NCT00492050|473375878|FG000|Overall Study|Unable to collect SCT|2|||
131476551|NCT00492050|473375878|FG000|Overall Study|Progressive Disease|2|||
131476552|NCT01897714|473377240|FG000|Phase I (Dose Escalation)|Disease progression|3|||
131476553|NCT01897714|473377241|FG001|Phase I (Dose Escalation)|Disease progression|5|||
131476554|NCT01897714|473377242|FG002|Phase I (Dose Escalation)|Disease progression|1|||
131476555|NCT01897714|473377243|FG003|Phase I (Dose Escalation)|Disease progression|3|||
131476556|NCT01897714|473377244|FG004|Phase I (Dose Escalation)|Disease progression|0|||
131476557|NCT01897714|473377245|FG005|Phase I (Dose Escalation)|Disease progression|0|||
131476558|NCT01897714|473377240|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
131476559|NCT01897714|473377241|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
131476560|NCT01897714|473377242|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
131476561|NCT01897714|473377243|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
131476562|NCT01897714|473377244|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
131476563|NCT01897714|473377245|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
131476564|NCT01897714|473377240|FG000|Phase I (Dose Escalation)|Other|0|||
131476565|NCT01897714|473377241|FG001|Phase I (Dose Escalation)|Other|1|||
131476566|NCT01897714|473377242|FG002|Phase I (Dose Escalation)|Other|0|||
131476567|NCT01897714|473377243|FG003|Phase I (Dose Escalation)|Other|0|||
131476568|NCT01897714|473377244|FG004|Phase I (Dose Escalation)|Other|0|||
131476569|NCT01897714|473377245|FG005|Phase I (Dose Escalation)|Other|0|||
131476570|NCT01897714|473377240|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
131476571|NCT01897714|473377241|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
131476572|NCT01897714|473377242|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
131476573|NCT01897714|473377243|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
131476574|NCT01897714|473377244|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
131476575|NCT01897714|473377245|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
131476576|NCT01897714|473377240|FG000|Phase II (MTD)|Lost to Follow-up|0|||
131476577|NCT01897714|473377241|FG001|Phase II (MTD)|Lost to Follow-up|0|||
131476578|NCT01897714|473377242|FG002|Phase II (MTD)|Lost to Follow-up|0|||
131476579|NCT01897714|473377243|FG003|Phase II (MTD)|Lost to Follow-up|0|||
131476580|NCT01897714|473377244|FG004|Phase II (MTD)|Lost to Follow-up|1|||
131476581|NCT01897714|473377245|FG005|Phase II (MTD)|Lost to Follow-up|0|||
131476582|NCT01897714|473377240|FG000|Phase II (MTD)|Death|0|||
131476583|NCT01897714|473377241|FG001|Phase II (MTD)|Death|0|||
131476584|NCT01897714|473377242|FG002|Phase II (MTD)|Death|0|||
131476585|NCT01897714|473377243|FG003|Phase II (MTD)|Death|0|||
131476586|NCT01897714|473377244|FG004|Phase II (MTD)|Death|25|||
131476587|NCT01897714|473377245|FG005|Phase II (MTD)|Death|10|||
131476588|NCT01897714|473377240|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
131476589|NCT01897714|473377241|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
131476590|NCT01897714|473377242|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
131476591|NCT01897714|473377243|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
131476592|NCT01897714|473377244|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
131476593|NCT01897714|473377245|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
131476594|NCT01897714|473377240|FG000|Phase II (MTD)|Other|0|||
131476595|NCT01897714|473377241|FG001|Phase II (MTD)|Other|0|||
131476596|NCT01897714|473377242|FG002|Phase II (MTD)|Other|0|||
131476597|NCT01897714|473377243|FG003|Phase II (MTD)|Other|0|||
131476598|NCT01897714|473377244|FG004|Phase II (MTD)|Other|3|||
131476599|NCT01897714|473377245|FG005|Phase II (MTD)|Other|0|||
131476600|NCT00423722|473377246|FG000|Overall Study|Death|4|||
131476601|NCT00423722|473377247|FG001|Overall Study|Death|4|||
131476602|NCT00423722|473377246|FG000|Overall Study|Declined to participate|2|||
131476603|NCT00423722|473377247|FG001|Overall Study|Declined to participate|3|||
131476604|NCT00423722|473377246|FG000|Overall Study|Unable to complete questionnaires|4|||
131476605|NCT00423722|473377247|FG001|Overall Study|Unable to complete questionnaires|4|||
131476606|NCT00423722|473377246|FG000|Overall Study|Withdrawal by Subject|4|||
131476607|NCT00423722|473377247|FG001|Overall Study|Withdrawal by Subject|2|||
131476608|NCT00518687|473377249|FG000|Overall Study|Adverse Event|201|||
131476609|NCT00518687|473377250|FG001|Overall Study|Adverse Event|177|||
131476610|NCT00518687|473377249|FG000|Overall Study|Lost to Follow-up|144|||
131476611|NCT00518687|473377250|FG001|Overall Study|Lost to Follow-up|155|||
131476612|NCT00518687|473377249|FG000|Overall Study|Physician Decision|42|||
131476613|NCT00518687|473377250|FG001|Overall Study|Physician Decision|48|||
131476614|NCT00518687|473377249|FG000|Overall Study|Progressive disease|2|||
131476615|NCT00518687|473377250|FG001|Overall Study|Progressive disease|2|||
131476616|NCT00518687|473377249|FG000|Overall Study|Protocol Violation|8|||
131476617|NCT00518687|473377250|FG001|Overall Study|Protocol Violation|10|||
131476618|NCT00518687|473377249|FG000|Overall Study|Study terminated by sponsor|930|||
131476619|NCT00518687|473377250|FG001|Overall Study|Study terminated by sponsor|918|||
131476620|NCT00518687|473377249|FG000|Overall Study|Withdrawal by Subject|110|||
131476621|NCT00518687|473377250|FG001|Overall Study|Withdrawal by Subject|110|||
131476622|NCT05108922|473377251|FG000|Overall Study|Adverse Event|2|||
131476623|NCT05108922|473377252|FG001|Overall Study|Adverse Event|3|||
131476624|NCT05108922|473377251|FG000|Overall Study|Lost to Follow-up|2|||
131476625|NCT05108922|473377252|FG001|Overall Study|Lost to Follow-up|1|||
131476626|NCT05108922|473377251|FG000|Overall Study|Inadvertent enrollment|0|||
131476627|NCT05108922|473377252|FG001|Overall Study|Inadvertent enrollment|1|||
131476628|NCT05108922|473377251|FG000|Overall Study|Physician Decision|2|||
131476629|NCT05108922|473377252|FG001|Overall Study|Physician Decision|3|||
131476630|NCT05108922|473377251|FG000|Overall Study|Protocol deviation|1|||
131476631|NCT05108922|473377252|FG001|Overall Study|Protocol deviation|0|||
131476632|NCT05108922|473377251|FG000|Overall Study|Screen failure|1|||
131476633|NCT05108922|473377252|FG001|Overall Study|Screen failure|0|||
131476634|NCT05108922|473377251|FG000|Overall Study|Withdrawal by Subject|11|||
131476635|NCT05108922|473377252|FG001|Overall Study|Withdrawal by Subject|8|||
131476636|NCT01846104|473377257|FG000|Overall Study|Withdrawal by Subject|1|||
131476637|NCT00851630|473377261|FG000|Overall Study|Death|2|||
131476638|NCT00851630|473377262|FG001|Overall Study|Death|1|||
131476639|NCT00851630|473377261|FG000|Overall Study|Clinical failure|0|||
131476640|NCT00851630|473377262|FG001|Overall Study|Clinical failure|1|||
131476641|NCT02349061|473377264|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
131476642|NCT02349061|473377265|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
131476643|NCT02349061|473377266|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
131476644|NCT02349061|473377264|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
131476645|NCT02349061|473377265|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
131476646|NCT02349061|473377266|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
131476647|NCT02349061|473377264|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
131476648|NCT02349061|473377265|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
131476649|NCT02349061|473377266|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
131476650|NCT02349061|473377264|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
131476651|NCT02349061|473377265|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
131476652|NCT02349061|473377266|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
131476653|NCT02349061|473377264|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
131476654|NCT02349061|473377265|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
131476655|NCT02349061|473377266|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
131476656|NCT02349061|473377264|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
131476657|NCT02349061|473377265|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
131476658|NCT02349061|473377266|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
131476659|NCT02349061|473377264|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
131476660|NCT02349061|473377265|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
131476661|NCT02349061|473377266|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
131476662|NCT02349061|473377264|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
131476663|NCT02349061|473377265|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
131476664|NCT02349061|473377266|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
131476665|NCT02349061|473377264|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
131476666|NCT02349061|473377265|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
131476667|NCT02349061|473377266|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
131476668|NCT02349061|473377264|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
131476669|NCT02349061|473377265|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
131476670|NCT02349061|473377266|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
131476671|NCT02349061|473377264|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
131476672|NCT02349061|473377265|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
131476673|NCT02349061|473377266|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
131476674|NCT02349061|473377264|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
131476675|NCT02349061|473377265|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
131476676|NCT02349061|473377266|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
131476677|NCT02349061|473377264|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
131476678|NCT02349061|473377265|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
131476679|NCT02349061|473377266|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
131476680|NCT00398411|473377267|FG000|Overall Study|Death|0|||
131476681|NCT00398411|473377268|FG001|Overall Study|Death|1|||
131476682|NCT02095223|473377269|FG000|Overall Study|Withdrawal by Subject|1|||
131476683|NCT02095223|473377270|FG001|Overall Study|Withdrawal by Subject|0|||
131476684|NCT02339285|473377271|FG000|Overall Study|Withdrawal by Subject|0|||
131476685|NCT02339285|473377272|FG001|Overall Study|Withdrawal by Subject|1|||
131476686|NCT02339285|473377273|FG002|Overall Study|Withdrawal by Subject|1|||
131476687|NCT02339285|473377271|FG000|Overall Study|Lost to Follow-up|1|||
131476688|NCT02339285|473377272|FG001|Overall Study|Lost to Follow-up|1|||
131476689|NCT02339285|473377273|FG002|Overall Study|Lost to Follow-up|1|||
131476690|NCT02339285|473377271|FG000|Overall Study|Protocol Deviation|0|||
131476691|NCT02339285|473377272|FG001|Overall Study|Protocol Deviation|1|||
131476692|NCT02339285|473377273|FG002|Overall Study|Protocol Deviation|0|||
131476693|NCT00282412|473377274|FG000|Overall Study|Death|2|||
131476694|NCT01507298|473377275|FG000|Overall Study|Protocol Violation|0|||
131476695|NCT01507298|473377276|FG001|Overall Study|Protocol Violation|6|||
131476696|NCT00537238|473377277|FG000|Overall Study|Death|1|||
131476697|NCT00537238|473377278|FG001|Overall Study|Death|2|||
131476698|NCT00537238|473377277|FG000|Overall Study|Adverse Event|31|||
131476699|NCT00537238|473377278|FG001|Overall Study|Adverse Event|22|||
131476700|NCT00537238|473377277|FG000|Overall Study|Lack of Efficacy|20|||
131476701|NCT00537238|473377278|FG001|Overall Study|Lack of Efficacy|21|||
131476702|NCT00537238|473377277|FG000|Overall Study|Lost to Follow-up|12|||
131476703|NCT00537238|473377278|FG001|Overall Study|Lost to Follow-up|8|||
131476704|NCT00537238|473377277|FG000|Overall Study|Withdrawal by Subject|51|||
131476705|NCT00537238|473377278|FG001|Overall Study|Withdrawal by Subject|47|||
131476706|NCT00537238|473377277|FG000|Overall Study|Protocol Violation|15|||
131476707|NCT00537238|473377278|FG001|Overall Study|Protocol Violation|19|||
131476708|NCT00537238|473377277|FG000|Overall Study|Does not meet entrance criteria|0|||
131476709|NCT00537238|473377278|FG001|Overall Study|Does not meet entrance criteria|2|||
131476710|NCT00537238|473377277|FG000|Overall Study|Other|44|||
131476711|NCT00537238|473377278|FG001|Overall Study|Other|52|||
131476712|NCT00426231|473377281|FG000|Overall Study|Withdrawal by Subject|9|||
131476713|NCT00426231|473377282|FG001|Overall Study|Withdrawal by Subject|12|||
131476714|NCT03061097|473377283|FG000|Overall Study|Withdrawal by Subject|0|||
131476715|NCT03061097|473377284|FG001|Overall Study|Withdrawal by Subject|3|||
131476716|NCT03911713|473377285|FG000|Overall Study|Lost to Follow-up|0|||
131476717|NCT03911713|473377286|FG001|Overall Study|Lost to Follow-up|2|||
131476718|NCT03911713|473377287|FG002|Overall Study|Lost to Follow-up|0|||
131476719|NCT03911713|473377288|FG003|Overall Study|Lost to Follow-up|0|||
131476720|NCT03911713|473377289|FG004|Overall Study|Lost to Follow-up|0|||
131476721|NCT03911713|473377285|FG000|Overall Study|Other|0|||
131476722|NCT03911713|473377286|FG001|Overall Study|Other|0|||
131476723|NCT03911713|473377287|FG002|Overall Study|Other|0|||
131476724|NCT03911713|473377288|FG003|Overall Study|Other|1|||
131476725|NCT03911713|473377289|FG004|Overall Study|Other|0|||
131476726|NCT03911713|473377285|FG000|Overall Study|Randomized, Never Dosed|1|||
131476727|NCT03911713|473377286|FG001|Overall Study|Randomized, Never Dosed|0|||
131476728|NCT03911713|473377287|FG002|Overall Study|Randomized, Never Dosed|0|||
131476729|NCT03911713|473377288|FG003|Overall Study|Randomized, Never Dosed|1|||
131476730|NCT03911713|473377289|FG004|Overall Study|Randomized, Never Dosed|0|||
131476731|NCT01614600|473377290|FG000|Overall Study|Unacceptable fit|1|||
131476732|NCT01614600|473377290|FG000|Overall Study|Discomfort|1|||
131476733|NCT01614600|473377290|FG000|Overall Study|Unable to remove lens at the end of day|1|||
131476734|NCT01614600|473377290|FG000|Overall Study|Protocol deviation|1|||
131476735|NCT03347188|473377291|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
131476736|NCT03347188|473377292|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
131476737|NCT03347188|473377291|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
131476738|NCT03347188|473377292|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
131476739|NCT03347188|473377291|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
131476740|NCT03347188|473377292|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
131882246|NCT02035748|474851162|FG000|Overall Study|Progressive Disease|1|||
131476741|NCT03347188|473377291|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
131476742|NCT03347188|473377292|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
131476743|NCT03347188|473377291|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
131476744|NCT03347188|473377292|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
131476745|NCT03347188|473377291|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
131476746|NCT03347188|473377292|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
131476747|NCT03347188|473377291|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
131476748|NCT03347188|473377292|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
131476749|NCT03347188|473377291|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
131476750|NCT03347188|473377292|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
131476751|NCT01845818|473377293|FG000|Overall Study|Withdrawal by Subject|0|||
131476752|NCT01845818|473377294|FG001|Overall Study|Withdrawal by Subject|1|||
131476753|NCT01845818|473377293|FG000|Overall Study|Lost to Follow-up|7|||
131476754|NCT01845818|473377294|FG001|Overall Study|Lost to Follow-up|5|||
131476755|NCT01845818|473377293|FG000|Overall Study|Administrative Reasons|3|||
131476756|NCT01845818|473377294|FG001|Overall Study|Administrative Reasons|1|||
131476757|NCT01845818|473377293|FG000|Overall Study|Serious Adverse Event|1|||
131476758|NCT01845818|473377294|FG001|Overall Study|Serious Adverse Event|1|||
131476759|NCT01845818|473377293|FG000|Overall Study|Other|25|||
131476760|NCT01845818|473377294|FG001|Overall Study|Other|8|||
131476761|NCT01845818|473377293|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
131476762|NCT01845818|473377294|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
131476763|NCT01845818|473377293|FG000|Overall Study|No Follow-Up Data Available|4|||
131476764|NCT01845818|473377294|FG001|Overall Study|No Follow-Up Data Available|1|||
131476765|NCT02186873|473377295|FG000|Overall Study|Adverse Event|1|||
131476766|NCT02186873|473377296|FG001|Overall Study|Adverse Event|3|||
131476767|NCT02186873|473377295|FG000|Overall Study|Lack of Efficacy|0|||
131476768|NCT02186873|473377296|FG001|Overall Study|Lack of Efficacy|1|||
131476769|NCT02186873|473377295|FG000|Overall Study|Lost to Follow-up|1|||
131476770|NCT02186873|473377296|FG001|Overall Study|Lost to Follow-up|2|||
131476771|NCT02186873|473377295|FG000|Overall Study|Withdrawal by Subject|7|||
131476772|NCT02186873|473377296|FG001|Overall Study|Withdrawal by Subject|2|||
131476773|NCT00107783|473377297|FG000|Overall Study|Adverse Event|0|||
131476774|NCT00107783|473377298|FG001|Overall Study|Adverse Event|2|||
131476775|NCT00107783|473377297|FG000|Overall Study|Death|0|||
131476776|NCT00107783|473377298|FG001|Overall Study|Death|1|||
131476777|NCT00107783|473377297|FG000|Overall Study|Withdrawal by Subject|2|||
131476778|NCT00107783|473377298|FG001|Overall Study|Withdrawal by Subject|0|||
131476779|NCT00107783|473377297|FG000|Overall Study|Second hip replacement|1|||
131476780|NCT00107783|473377298|FG001|Overall Study|Second hip replacement|1|||
131476781|NCT01051466|473377299|FG000|Overall Study|Adverse Event|1|||
131476782|NCT01051466|473377300|FG001|Overall Study|Adverse Event|0|||
131476783|NCT01051466|473377299|FG000|Overall Study|Lost to Follow-up|1|||
131476784|NCT01051466|473377300|FG001|Overall Study|Lost to Follow-up|1|||
131476785|NCT01051466|473377299|FG000|Overall Study|Withdrawal by Subject|5|||
131476786|NCT01051466|473377300|FG001|Overall Study|Withdrawal by Subject|1|||
131476787|NCT01051466|473377299|FG000|Overall Study|Entry Criteria Not Met|0|||
131476788|NCT01051466|473377300|FG001|Overall Study|Entry Criteria Not Met|3|||
131476789|NCT01051466|473377299|FG000|Overall Study|Physician Decision|1|||
131476790|NCT01051466|473377300|FG001|Overall Study|Physician Decision|0|||
131476791|NCT02231918|473377301|FG000|Overall Study|Withdrawal by Subject|0|||
131476792|NCT02231918|473377302|FG001|Overall Study|Withdrawal by Subject|1|||
131476793|NCT02231918|473377303|FG002|Overall Study|Withdrawal by Subject|0|||
131476794|NCT02231918|473377301|FG000|Overall Study|Adverse Event|0|||
131476795|NCT02231918|473377302|FG001|Overall Study|Adverse Event|0|||
131476796|NCT02231918|473377303|FG002|Overall Study|Adverse Event|1|||
131476797|NCT05061966|473377305|FG000|Overall Study|Lost to Follow-up|13|||
131476798|NCT05061966|473377306|FG001|Overall Study|Lost to Follow-up|13|||
131476799|NCT05246397|473377313|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
131476800|NCT03114488|473377314|FG000|Time Period 2|Withdrawal by Subject|1|||
131476801|NCT03114488|473377315|FG001|Time Period 2|Withdrawal by Subject|3|||
131476802|NCT04137224|473377316|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
131476803|NCT04137224|473377317|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
131476804|NCT04137224|473377316|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
131476805|NCT04137224|473377317|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
131476806|NCT04137224|473377316|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
131476807|NCT04137224|473377317|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
131476808|NCT01225887|473377318|FG000|Overall Study|Ineligible:required test not done|2|||
131476809|NCT01225887|473377318|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
131476810|NCT01225887|473377318|FG000|Overall Study|Ineligible:inadequate pathology|2|||
131476811|NCT01669928|473377319|FG000|First Intervention|Withdrawal by Subject|3|||
131476812|NCT01669928|473377320|FG001|First Intervention|Withdrawal by Subject|5|||
131476813|NCT00566501|473377323|FG000|Overall Study|Adverse Event|68|||
131476814|NCT00566501|473377324|FG001|Overall Study|Adverse Event|59|||
131476815|NCT00566501|473377323|FG000|Overall Study|Medication Non-compliance|5|||
131476816|NCT00566501|473377324|FG001|Overall Study|Medication Non-compliance|0|||
131476817|NCT00566501|473377323|FG000|Overall Study|Protocol Violation|2|||
131476818|NCT00566501|473377324|FG001|Overall Study|Protocol Violation|2|||
131476819|NCT00566501|473377323|FG000|Overall Study|Request of Investigator or Sponsor|6|||
131476820|NCT00566501|473377324|FG001|Overall Study|Request of Investigator or Sponsor|7|||
131476821|NCT00566501|473377323|FG000|Overall Study|Withdrawal by Subject|33|||
131476822|NCT00566501|473377324|FG001|Overall Study|Withdrawal by Subject|30|||
131476823|NCT00566501|473377323|FG000|Overall Study|Lack of Efficacy|8|||
131476824|NCT00566501|473377324|FG001|Overall Study|Lack of Efficacy|3|||
131476825|NCT00566501|473377323|FG000|Overall Study|Other|25|||
131476826|NCT00566501|473377324|FG001|Overall Study|Other|21|||
131476827|NCT00679055|473377327|FG000|Overall Study|Adverse Event|0|||
131476828|NCT00679055|473377328|FG001|Overall Study|Adverse Event|1|||
131476829|NCT00679055|473377327|FG000|Overall Study|Other|0|||
131476830|NCT00679055|473377328|FG001|Overall Study|Other|3|||
131476831|NCT00679055|473377327|FG000|Overall Study|Study Terminated|2|||
131476832|NCT00679055|473377328|FG001|Overall Study|Study Terminated|1|||
131476833|NCT00925990|473377329|FG000|Overall Study|Adverse Event|1|||
131476834|NCT00925990|473377330|FG001|Overall Study|Adverse Event|3|||
131476835|NCT00925990|473377329|FG000|Overall Study|Withdrawal by Subject|2|||
131476836|NCT00925990|473377330|FG001|Overall Study|Withdrawal by Subject|2|||
131476837|NCT00925990|473377329|FG000|Overall Study|Lost to Follow-up|1|||
131476838|NCT00925990|473377330|FG001|Overall Study|Lost to Follow-up|3|||
131476839|NCT00925990|473377329|FG000|Overall Study|Physician Decision|1|||
131476840|NCT00925990|473377330|FG001|Overall Study|Physician Decision|1|||
131476841|NCT00925990|473377329|FG000|Overall Study|moved out of state, missed medication|0|||
131476842|NCT00925990|473377330|FG001|Overall Study|moved out of state, missed medication|2|||
131476843|NCT01368432|473377333|FG000|Overall Study|Lost to Follow-up|0|||
131476844|NCT01368432|473377334|FG001|Overall Study|Lost to Follow-up|1|||
131476845|NCT01008150|473377335|FG000|Overall Study|did not receive study drug|1|||
131476846|NCT01008150|473377336|FG001|Overall Study|did not receive study drug|1|||
131476847|NCT01008150|473377337|FG002|Overall Study|did not receive study drug|1|||
131476848|NCT01008150|473377338|FG003|Overall Study|did not receive study drug|0|||
131476849|NCT00737438|473377339|FG000|Overall Study|Withdrawal by Subject|2|||
131476850|NCT00737438|473377339|FG000|Overall Study|Patient ineligible|1|||
131476851|NCT03845543|473377341|FG000|Overall Study|Death|25|||
131476852|NCT03845543|473377341|FG000|Overall Study|Withdrawal by Subject|2|||
131476853|NCT03845543|473377341|FG000|Overall Study|Lost to Follow-up|12|||
131476854|NCT03845543|473377341|FG000|Overall Study|Adverse Event|17|||
131476855|NCT01400815|473377342|FG000|Overall Study|Adverse Event|3|||
131476856|NCT01400815|473377343|FG001|Overall Study|Adverse Event|0|||
131476857|NCT01400815|473377342|FG000|Overall Study|Death|0|||
131476858|NCT01400815|473377343|FG001|Overall Study|Death|1|||
131476859|NCT01400815|473377342|FG000|Overall Study|Lost to Follow-up|18|||
131476860|NCT01400815|473377343|FG001|Overall Study|Lost to Follow-up|11|||
131476861|NCT01400815|473377342|FG000|Overall Study|Protocol Violation|0|||
131476862|NCT01400815|473377343|FG001|Overall Study|Protocol Violation|1|||
131476863|NCT01400815|473377342|FG000|Overall Study|Physician Decision|1|||
131476864|NCT01400815|473377343|FG001|Overall Study|Physician Decision|0|||
131476865|NCT01400815|473377342|FG000|Overall Study|Withdrawal by Subject|15|||
131476866|NCT01400815|473377343|FG001|Overall Study|Withdrawal by Subject|8|||
131476867|NCT01400815|473377342|FG000|Overall Study|Subject in jail|1|||
131476868|NCT01400815|473377343|FG001|Overall Study|Subject in jail|0|||
131476869|NCT01123850|473377344|FG000|Overall Study|Slow enrollment|45|||
131476870|NCT02448810|473377346|FG000|Overall Study|Adverse Event|0|||
131476871|NCT02448810|473377347|FG001|Overall Study|Adverse Event|0|||
131476872|NCT02448810|473377348|FG002|Overall Study|Adverse Event|1|||
131476873|NCT02448810|473377349|FG003|Overall Study|Adverse Event|0|||
131476874|NCT02448810|473377350|FG004|Overall Study|Adverse Event|0|||
131476875|NCT02448810|473377351|FG005|Overall Study|Adverse Event|0|||
131476876|NCT02448810|473377352|FG006|Overall Study|Adverse Event|0|||
131476877|NCT02448810|473377353|FG007|Overall Study|Adverse Event|0|||
131476878|NCT02448810|473377346|FG000|Overall Study|Withdrawal by Subject|0|||
131476879|NCT02448810|473377347|FG001|Overall Study|Withdrawal by Subject|0|||
131476880|NCT02448810|473377348|FG002|Overall Study|Withdrawal by Subject|1|||
131476881|NCT02448810|473377349|FG003|Overall Study|Withdrawal by Subject|0|||
131476882|NCT02448810|473377350|FG004|Overall Study|Withdrawal by Subject|3|||
131476883|NCT02448810|473377351|FG005|Overall Study|Withdrawal by Subject|5|||
131476884|NCT02448810|473377352|FG006|Overall Study|Withdrawal by Subject|0|||
131476885|NCT02448810|473377353|FG007|Overall Study|Withdrawal by Subject|2|||
131476886|NCT02448810|473377346|FG000|Overall Study|Other (study terminated by sponsor)|0|||
131476887|NCT02448810|473377347|FG001|Overall Study|Other (study terminated by sponsor)|0|||
131476888|NCT02448810|473377348|FG002|Overall Study|Other (study terminated by sponsor)|0|||
131476889|NCT02448810|473377349|FG003|Overall Study|Other (study terminated by sponsor)|0|||
131476890|NCT02448810|473377350|FG004|Overall Study|Other (study terminated by sponsor)|4|||
131476891|NCT02448810|473377351|FG005|Overall Study|Other (study terminated by sponsor)|2|||
131476892|NCT02448810|473377352|FG006|Overall Study|Other (study terminated by sponsor)|2|||
131476893|NCT02448810|473377353|FG007|Overall Study|Other (study terminated by sponsor)|1|||
131476894|NCT02448810|473377346|FG000|Overall Study|Death|1|||
131476895|NCT02448810|473377347|FG001|Overall Study|Death|0|||
131476896|NCT02448810|473377348|FG002|Overall Study|Death|1|||
131476897|NCT02448810|473377349|FG003|Overall Study|Death|0|||
131476898|NCT02448810|473377350|FG004|Overall Study|Death|1|||
131476899|NCT02448810|473377351|FG005|Overall Study|Death|0|||
131476900|NCT02448810|473377352|FG006|Overall Study|Death|0|||
131476901|NCT02448810|473377353|FG007|Overall Study|Death|0|||
131476902|NCT02448810|473377346|FG000|Overall Study|Other (Progressive disease)|2|||
131476903|NCT02448810|473377347|FG001|Overall Study|Other (Progressive disease)|2|||
131476904|NCT02448810|473377348|FG002|Overall Study|Other (Progressive disease)|0|||
131476905|NCT02448810|473377349|FG003|Overall Study|Other (Progressive disease)|3|||
131476906|NCT02448810|473377350|FG004|Overall Study|Other (Progressive disease)|23|||
131476907|NCT02448810|473377351|FG005|Overall Study|Other (Progressive disease)|9|||
131476908|NCT02448810|473377352|FG006|Overall Study|Other (Progressive disease)|14|||
131476909|NCT02448810|473377353|FG007|Overall Study|Other (Progressive disease)|5|||
131476910|NCT02448810|473377346|FG000|Overall Study|Lost to Follow-up|0|||
131476911|NCT02448810|473377347|FG001|Overall Study|Lost to Follow-up|1|||
131476912|NCT02448810|473377348|FG002|Overall Study|Lost to Follow-up|0|||
131476913|NCT02448810|473377349|FG003|Overall Study|Lost to Follow-up|0|||
131476914|NCT02448810|473377350|FG004|Overall Study|Lost to Follow-up|0|||
131476915|NCT02448810|473377351|FG005|Overall Study|Lost to Follow-up|0|||
131476916|NCT02448810|473377352|FG006|Overall Study|Lost to Follow-up|0|||
131476917|NCT02448810|473377353|FG007|Overall Study|Lost to Follow-up|0|||
131476918|NCT02448810|473377346|FG000|Overall Study|Other (unspecified)|0|||
131476919|NCT02448810|473377347|FG001|Overall Study|Other (unspecified)|0|||
131476920|NCT02448810|473377348|FG002|Overall Study|Other (unspecified)|0|||
131476921|NCT02448810|473377349|FG003|Overall Study|Other (unspecified)|0|||
131476922|NCT02448810|473377350|FG004|Overall Study|Other (unspecified)|0|||
131476923|NCT02448810|473377351|FG005|Overall Study|Other (unspecified)|0|||
131476924|NCT02448810|473377352|FG006|Overall Study|Other (unspecified)|2|||
131476925|NCT02448810|473377353|FG007|Overall Study|Other (unspecified)|0|||
131476926|NCT00470847|473377356|FG000|Overall Study|Pt still receiving treatment|1|||
131476927|NCT00381381|473377362|FG000|Overall Study|Adverse Event|3|||
131476928|NCT00381381|473377362|FG000|Overall Study|Lost to Follow-up|52|||
131882247|NCT02231879|474851163|FG000|Overall Study|Adverse Event|2|||
131882248|NCT02231879|474851164|FG001|Overall Study|Adverse Event|1|||
131882249|NCT02231879|474851163|FG000|Overall Study|Lack of Efficacy|0|||
131882250|NCT02231879|474851164|FG001|Overall Study|Lack of Efficacy|1|||
131882251|NCT02052596|474851165|FG000|Active Phase|Adverse Event|3|||
131882252|NCT02052596|474851166|FG001|Active Phase|Adverse Event|2|||
131882253|NCT02052596|474851165|FG000|Active Phase|Lost to Follow-up|8|||
131882254|NCT02052596|474851166|FG001|Active Phase|Lost to Follow-up|11|||
131882255|NCT02052596|474851165|FG000|Active Phase|Protocol Violation|1|||
131882256|NCT02052596|474851166|FG001|Active Phase|Protocol Violation|2|||
131882257|NCT02052596|474851165|FG000|Active Phase|Withdrawal by Subject|3|||
131882258|NCT02052596|474851166|FG001|Active Phase|Withdrawal by Subject|4|||
131882259|NCT02052596|474851165|FG000|Active Phase|Enrolled in error|1|||
131476929|NCT00381381|473377362|FG000|Overall Study|Withdrawal by Subject|9|||
131476930|NCT01147172|473377365|FG000|Overall Study|Withdrawal by Subject|2|||
131476931|NCT01147172|473377365|FG000|Overall Study|Lost to Follow-up|2|||
131476932|NCT02787551|473377366|FG000|Core Period: 26 Weeks|Adverse Event|10|||
131476933|NCT02787551|473377367|FG001|Core Period: 26 Weeks|Adverse Event|0|||
131476934|NCT02787551|473377366|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
131476935|NCT02787551|473377367|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
131476936|NCT02787551|473377366|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
131476937|NCT02787551|473377367|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
131476938|NCT02787551|473377366|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
131476939|NCT02787551|473377367|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
131476940|NCT02787551|473377366|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
131476941|NCT02787551|473377367|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
131476942|NCT02787551|473377366|FG000|Core Period: 26 Weeks|Other than specified|3|||
131476943|NCT02787551|473377367|FG001|Core Period: 26 Weeks|Other than specified|1|||
131476944|NCT02787551|473377366|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
131476945|NCT02787551|473377367|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
131476946|NCT02787551|473377366|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
131476947|NCT02787551|473377367|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
131476948|NCT02787551|473377366|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
131476949|NCT02787551|473377367|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
131476950|NCT03911154|473377368|FG000|Overall Study|Withdrawal by Subject|1|||
131476951|NCT02001181|473377371|FG000|Overall Study|Adverse Event|0|||
131476952|NCT02001181|473377372|FG001|Overall Study|Adverse Event|2|||
131476953|NCT02001181|473377371|FG000|Overall Study|Lost to Follow-up|1|||
131476954|NCT02001181|473377372|FG001|Overall Study|Lost to Follow-up|0|||
131476955|NCT02001181|473377371|FG000|Overall Study|Withdrawal by Subject|0|||
131476956|NCT02001181|473377372|FG001|Overall Study|Withdrawal by Subject|1|||
131476957|NCT00292318|473377374|FG000|Overall Study|Study terminated by officials|2|||
131476958|NCT00292318|473377375|FG001|Overall Study|Study terminated by officials|1|||
131476959|NCT00771316|473377376|FG000|Overall Study|Adverse Event|0|||
131476960|NCT00771316|473377377|FG001|Overall Study|Adverse Event|1|||
131476961|NCT00771316|473377376|FG000|Overall Study|Patient withdrew consent|1|||
131476962|NCT00771316|473377377|FG001|Overall Study|Patient withdrew consent|0|||
131476963|NCT00771316|473377376|FG000|Overall Study|Discontinued due to early termination|1|||
131476964|NCT00771316|473377377|FG001|Overall Study|Discontinued due to early termination|0|||
131476965|NCT02027376|473377378|FG000|Overall Study|Death|1|||
131476966|NCT02027376|473377379|FG001|Overall Study|Death|0|||
131476967|NCT02027376|473377380|FG002|Overall Study|Death|0|||
131476968|NCT01278160|473377381|FG000|Overall Study|Adverse Event|1|||
131476969|NCT01278160|473377382|FG001|Overall Study|Adverse Event|1|||
131882260|NCT02052596|474851166|FG001|Active Phase|Enrolled in error|0|||
131882261|NCT02052596|474851165|FG000|Active Phase|Lost due to Crohn's disease|0|||
131882262|NCT02052596|474851166|FG001|Active Phase|Lost due to Crohn's disease|1|||
131882263|NCT02052596|474851165|FG000|Safety Phase|Adverse Event|6|||
131882264|NCT02052596|474851166|FG001|Safety Phase|Adverse Event|3|||
131882265|NCT02052596|474851165|FG000|Safety Phase|Lost to Follow-up|11|||
131882266|NCT02052596|474851166|FG001|Safety Phase|Lost to Follow-up|18|||
131476970|NCT01278160|473377381|FG000|Overall Study|Lost to Follow-up|0|||
131476971|NCT01278160|473377382|FG001|Overall Study|Lost to Follow-up|1|||
131476972|NCT01278160|473377381|FG000|Overall Study|Withdrawal by Subject|3|||
131476973|NCT01278160|473377382|FG001|Overall Study|Withdrawal by Subject|2|||
131476974|NCT01278160|473377381|FG000|Overall Study|Unclassified|1|||
131476975|NCT01278160|473377382|FG001|Overall Study|Unclassified|2|||
131476976|NCT00843726|473377385|FG000|Overall Study|Death|1|||
131476977|NCT00843726|473377386|FG001|Overall Study|Death|0|||
131476978|NCT00843726|473377385|FG000|Overall Study|Withdrawal by Subject|0|||
131882267|NCT02052596|474851165|FG000|Safety Phase|Protocol Violation|1|||
131882268|NCT02052596|474851166|FG001|Safety Phase|Protocol Violation|2|||
131882269|NCT02052596|474851165|FG000|Safety Phase|Withdrawal by Subject|8|||
131882270|NCT02052596|474851166|FG001|Safety Phase|Withdrawal by Subject|11|||
131882271|NCT02052596|474851165|FG000|Safety Phase|Enrolled in error|1|||
131882272|NCT02052596|474851166|FG001|Safety Phase|Enrolled in error|0|||
131882273|NCT02052596|474851165|FG000|Safety Phase|Lost due to Crohn's disease|0|||
131882274|NCT02052596|474851166|FG001|Safety Phase|Lost due to Crohn's disease|1|||
131882275|NCT00558896|474851167|FG000|Overall Study|Adverse Event|1|||
131882276|NCT00558896|474851168|FG001|Overall Study|Adverse Event|1|||
131882277|NCT00558896|474851169|FG002|Overall Study|Adverse Event|1|||
131882278|NCT00558896|474851170|FG003|Overall Study|Adverse Event|3|||
131882279|NCT00558896|474851171|FG004|Overall Study|Adverse Event|4|||
131882280|NCT00558896|474851172|FG005|Overall Study|Adverse Event|10|||
131882281|NCT00558896|474851173|FG006|Overall Study|Adverse Event|3|||
131882282|NCT00558896|474851167|FG000|Overall Study|Death|3|||
131882283|NCT00558896|474851168|FG001|Overall Study|Death|0|||
131882284|NCT00558896|474851169|FG002|Overall Study|Death|2|||
131882285|NCT00558896|474851170|FG003|Overall Study|Death|3|||
131882286|NCT00558896|474851171|FG004|Overall Study|Death|2|||
131882287|NCT00558896|474851172|FG005|Overall Study|Death|2|||
131882288|NCT00558896|474851173|FG006|Overall Study|Death|6|||
131882289|NCT00558896|474851167|FG000|Overall Study|Withdrawal by Subject|2|||
131882290|NCT00558896|474851168|FG001|Overall Study|Withdrawal by Subject|1|||
131882291|NCT00558896|474851169|FG002|Overall Study|Withdrawal by Subject|1|||
131882292|NCT00558896|474851170|FG003|Overall Study|Withdrawal by Subject|1|||
131882293|NCT00558896|474851171|FG004|Overall Study|Withdrawal by Subject|1|||
131882294|NCT00558896|474851172|FG005|Overall Study|Withdrawal by Subject|5|||
131882295|NCT00558896|474851173|FG006|Overall Study|Withdrawal by Subject|5|||
131882296|NCT00558896|474851167|FG000|Overall Study|Alternative Treatment|2|||
131882297|NCT00558896|474851168|FG001|Overall Study|Alternative Treatment|2|||
131882298|NCT00558896|474851169|FG002|Overall Study|Alternative Treatment|0|||
131882299|NCT00558896|474851170|FG003|Overall Study|Alternative Treatment|2|||
131882300|NCT00558896|474851171|FG004|Overall Study|Alternative Treatment|6|||
131882301|NCT00558896|474851172|FG005|Overall Study|Alternative Treatment|7|||
131882302|NCT00558896|474851173|FG006|Overall Study|Alternative Treatment|1|||
131882303|NCT00558896|474851167|FG000|Overall Study|Physician discretion|3|||
131882304|NCT00558896|474851168|FG001|Overall Study|Physician discretion|2|||
131882305|NCT00558896|474851169|FG002|Overall Study|Physician discretion|1|||
131882306|NCT00558896|474851170|FG003|Overall Study|Physician discretion|2|||
131882307|NCT00558896|474851171|FG004|Overall Study|Physician discretion|1|||
131882308|NCT00558896|474851172|FG005|Overall Study|Physician discretion|3|||
131882309|NCT00558896|474851173|FG006|Overall Study|Physician discretion|3|||
131882310|NCT00558896|474851167|FG000|Overall Study|Continues on treatment|10|||
131882311|NCT00558896|474851168|FG001|Overall Study|Continues on treatment|1|||
131882312|NCT00558896|474851169|FG002|Overall Study|Continues on treatment|0|||
131882313|NCT00558896|474851170|FG003|Overall Study|Continues on treatment|1|||
131882314|NCT00558896|474851171|FG004|Overall Study|Continues on treatment|9|||
131882315|NCT00558896|474851172|FG005|Overall Study|Continues on treatment|25|||
131882316|NCT00558896|474851173|FG006|Overall Study|Continues on treatment|6|||
131882317|NCT00705718|474851174|FG000|Overall Study|Death|6|||
131882318|NCT00705718|474851175|FG001|Overall Study|Death|6|||
131882319|NCT00705718|474851174|FG000|Overall Study|Not due for Visit|0|||
131476979|NCT00843726|473377386|FG001|Overall Study|Withdrawal by Subject|1|||
131476980|NCT05521906|473377388|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
131476981|NCT05521906|473377389|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
131476982|NCT02598960|473379381|FG000|Treatment Period|Disease Progression|4|||
131476983|NCT02598960|473379382|FG001|Treatment Period|Disease Progression|4|||
131476984|NCT02598960|473379383|FG002|Treatment Period|Disease Progression|4|||
131476985|NCT02598960|473379384|FG003|Treatment Period|Disease Progression|6|||
131476986|NCT02598960|473379385|FG004|Treatment Period|Disease Progression|8|||
131476987|NCT02598960|473379386|FG005|Treatment Period|Disease Progression|2|||
131476988|NCT02598960|473379387|FG006|Treatment Period|Disease Progression|2|||
131476989|NCT02598960|473379388|FG007|Treatment Period|Disease Progression|3|||
131476990|NCT02598960|473379389|FG008|Treatment Period|Disease Progression|7|||
131476991|NCT02598960|473379390|FG009|Treatment Period|Disease Progression|9|||
131882320|NCT00705718|474851175|FG001|Overall Study|Not due for Visit|12|||
131882321|NCT00705718|474851174|FG000|Overall Study|Follow up not done|1|||
131882322|NCT00705718|474851175|FG001|Overall Study|Follow up not done|4|||
131882323|NCT06137703|474851176|FG000|Overall Study|Other|0|||
131882324|NCT06137703|474851177|FG001|Overall Study|Other|1|||
131882325|NCT06137703|474851178|FG002|Overall Study|Other|0|||
131882326|NCT06137703|474851179|FG003|Overall Study|Other|0|||
131882327|NCT06137703|474851176|FG000|Overall Study|Adverse Event|0|||
131882328|NCT06137703|474851177|FG001|Overall Study|Adverse Event|0|||
131476992|NCT02598960|473379391|FG010|Treatment Period|Disease Progression|7|||
131476993|NCT02598960|473379392|FG011|Treatment Period|Disease Progression|143|||
131476994|NCT02598960|473379393|FG012|Treatment Period|Disease Progression|23|||
131476995|NCT02598960|473379381|FG000|Treatment Period|Study drug toxicity|0|||
131882329|NCT06137703|474851178|FG002|Overall Study|Adverse Event|1|||
131882330|NCT06137703|474851179|FG003|Overall Study|Adverse Event|0|||
131476996|NCT02598960|473379382|FG001|Treatment Period|Study drug toxicity|0|||
131476997|NCT02598960|473379383|FG002|Treatment Period|Study drug toxicity|0|||
131476998|NCT02598960|473379384|FG003|Treatment Period|Study drug toxicity|0|||
131476999|NCT02598960|473379385|FG004|Treatment Period|Study drug toxicity|0|||
131477000|NCT02598960|473379386|FG005|Treatment Period|Study drug toxicity|0|||
131477001|NCT02598960|473379387|FG006|Treatment Period|Study drug toxicity|0|||
131477002|NCT02598960|473379388|FG007|Treatment Period|Study drug toxicity|0|||
131477003|NCT02598960|473379389|FG008|Treatment Period|Study drug toxicity|0|||
131477004|NCT02598960|473379390|FG009|Treatment Period|Study drug toxicity|1|||
131477005|NCT02598960|473379391|FG010|Treatment Period|Study drug toxicity|0|||
131477006|NCT02598960|473379392|FG011|Treatment Period|Study drug toxicity|3|||
131477007|NCT02598960|473379393|FG012|Treatment Period|Study drug toxicity|0|||
131477008|NCT02598960|473379381|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
131477009|NCT02598960|473379382|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
131477010|NCT02598960|473379383|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
131477011|NCT02598960|473379384|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
131477012|NCT02598960|473379385|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
131477013|NCT02598960|473379386|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
131477014|NCT02598960|473379387|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
131477015|NCT02598960|473379388|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
131477016|NCT02598960|473379389|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
131477017|NCT02598960|473379390|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
131477018|NCT02598960|473379391|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
131477019|NCT02598960|473379392|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
131477020|NCT02598960|473379393|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
131477021|NCT02598960|473379381|FG000|Treatment Period|participant request to discontinue|0|||
131477022|NCT02598960|473379382|FG001|Treatment Period|participant request to discontinue|1|||
131477023|NCT02598960|473379383|FG002|Treatment Period|participant request to discontinue|0|||
131477024|NCT02598960|473379384|FG003|Treatment Period|participant request to discontinue|0|||
131477025|NCT02598960|473379385|FG004|Treatment Period|participant request to discontinue|1|||
131477026|NCT02598960|473379386|FG005|Treatment Period|participant request to discontinue|0|||
131477027|NCT02598960|473379387|FG006|Treatment Period|participant request to discontinue|0|||
131477028|NCT02598960|473379388|FG007|Treatment Period|participant request to discontinue|0|||
131477029|NCT02598960|473379389|FG008|Treatment Period|participant request to discontinue|0|||
131477030|NCT02598960|473379390|FG009|Treatment Period|participant request to discontinue|0|||
131477031|NCT02598960|473379391|FG010|Treatment Period|participant request to discontinue|1|||
131477032|NCT02598960|473379392|FG011|Treatment Period|participant request to discontinue|4|||
131477033|NCT02598960|473379393|FG012|Treatment Period|participant request to discontinue|0|||
131477034|NCT02598960|473379381|FG000|Treatment Period|participant withdrew consent|0|||
131477035|NCT02598960|473379382|FG001|Treatment Period|participant withdrew consent|0|||
131477036|NCT02598960|473379383|FG002|Treatment Period|participant withdrew consent|0|||
131477037|NCT02598960|473379384|FG003|Treatment Period|participant withdrew consent|0|||
131477038|NCT02598960|473379385|FG004|Treatment Period|participant withdrew consent|0|||
131477039|NCT02598960|473379386|FG005|Treatment Period|participant withdrew consent|0|||
131477040|NCT02598960|473379387|FG006|Treatment Period|participant withdrew consent|0|||
131882331|NCT04329091|474851182|FG000|Overall Study|Physician Decision|5|||
131882332|NCT00741091|474851185|FG000|Overall Study|Death|13|||
131882333|NCT00741091|474851185|FG000|Overall Study|Lost to Follow-up|16|||
131882334|NCT00741091|474851185|FG000|Overall Study|Withdrawal by Subject|6|||
131477041|NCT02598960|473379388|FG007|Treatment Period|participant withdrew consent|0|||
131477042|NCT02598960|473379389|FG008|Treatment Period|participant withdrew consent|0|||
131477043|NCT02598960|473379390|FG009|Treatment Period|participant withdrew consent|0|||
131477044|NCT02598960|473379391|FG010|Treatment Period|participant withdrew consent|0|||
131882335|NCT00741091|474851185|FG000|Overall Study|Missed Visit|22|||
131882336|NCT01527487|474851186|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
131882337|NCT01527487|474851187|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
131882338|NCT01527487|474851186|FG000|Overall Study|Disease Progression|4|||
131882339|NCT01527487|474851187|FG001|Overall Study|Disease Progression|1|||
131882340|NCT01527487|474851186|FG000|Overall Study|Adverse Event|1|||
131882341|NCT01527487|474851187|FG001|Overall Study|Adverse Event|1|||
131882342|NCT01527487|474851186|FG000|Overall Study|Death|0|||
131882343|NCT01527487|474851187|FG001|Overall Study|Death|1|||
131882344|NCT00723190|474851189|FG000|Overall Study|Withdrawal by Subject|45|||
131882345|NCT00723190|474851189|FG000|Overall Study|Lost to Follow-up|37|||
131882346|NCT00723190|474851189|FG000|Overall Study|Adverse Event|18|||
131477045|NCT02598960|473379392|FG011|Treatment Period|participant withdrew consent|3|||
131477046|NCT02598960|473379393|FG012|Treatment Period|participant withdrew consent|0|||
131477047|NCT02598960|473379381|FG000|Treatment Period|No longer meets study criteria|0|||
131477048|NCT02598960|473379382|FG001|Treatment Period|No longer meets study criteria|0|||
131477049|NCT02598960|473379383|FG002|Treatment Period|No longer meets study criteria|0|||
131477050|NCT02598960|473379384|FG003|Treatment Period|No longer meets study criteria|0|||
131477051|NCT02598960|473379385|FG004|Treatment Period|No longer meets study criteria|0|||
131477052|NCT02598960|473379386|FG005|Treatment Period|No longer meets study criteria|0|||
131477053|NCT02598960|473379387|FG006|Treatment Period|No longer meets study criteria|0|||
131477054|NCT02598960|473379388|FG007|Treatment Period|No longer meets study criteria|0|||
131477055|NCT02598960|473379389|FG008|Treatment Period|No longer meets study criteria|0|||
131477056|NCT02598960|473379390|FG009|Treatment Period|No longer meets study criteria|0|||
131477057|NCT02598960|473379391|FG010|Treatment Period|No longer meets study criteria|0|||
131477058|NCT02598960|473379392|FG011|Treatment Period|No longer meets study criteria|1|||
131477059|NCT02598960|473379393|FG012|Treatment Period|No longer meets study criteria|0|||
131477060|NCT02598960|473379381|FG000|Treatment Period|Other Reasons|0|||
131477061|NCT02598960|473379382|FG001|Treatment Period|Other Reasons|0|||
131477062|NCT02598960|473379383|FG002|Treatment Period|Other Reasons|0|||
131477063|NCT02598960|473379384|FG003|Treatment Period|Other Reasons|0|||
131477064|NCT02598960|473379385|FG004|Treatment Period|Other Reasons|0|||
131477065|NCT02598960|473379386|FG005|Treatment Period|Other Reasons|0|||
131477066|NCT02598960|473379387|FG006|Treatment Period|Other Reasons|0|||
131477067|NCT02598960|473379388|FG007|Treatment Period|Other Reasons|0|||
131477068|NCT02598960|473379389|FG008|Treatment Period|Other Reasons|0|||
131477069|NCT02598960|473379390|FG009|Treatment Period|Other Reasons|0|||
131477070|NCT02598960|473379391|FG010|Treatment Period|Other Reasons|0|||
131477071|NCT02598960|473379392|FG011|Treatment Period|Other Reasons|0|||
131477072|NCT02598960|473379393|FG012|Treatment Period|Other Reasons|1|||
131477073|NCT02598960|473379381|FG000|Participants Entering Follow Up Period|Death|1|||
131477074|NCT02598960|473379382|FG001|Participants Entering Follow Up Period|Death|0|||
131477075|NCT02598960|473379383|FG002|Participants Entering Follow Up Period|Death|0|||
131477076|NCT02598960|473379384|FG003|Participants Entering Follow Up Period|Death|0|||
131477077|NCT02598960|473379385|FG004|Participants Entering Follow Up Period|Death|0|||
131477078|NCT02598960|473379386|FG005|Participants Entering Follow Up Period|Death|0|||
131477079|NCT02598960|473379387|FG006|Participants Entering Follow Up Period|Death|0|||
131477080|NCT02598960|473379388|FG007|Participants Entering Follow Up Period|Death|0|||
131477081|NCT02598960|473379389|FG008|Participants Entering Follow Up Period|Death|0|||
131477082|NCT02598960|473379390|FG009|Participants Entering Follow Up Period|Death|1|||
131477083|NCT02598960|473379391|FG010|Participants Entering Follow Up Period|Death|0|||
131477084|NCT02598960|473379392|FG011|Participants Entering Follow Up Period|Death|11|||
131477085|NCT02598960|473379393|FG012|Participants Entering Follow Up Period|Death|2|||
131477086|NCT02598960|473379381|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477087|NCT02598960|473379382|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477088|NCT02598960|473379383|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477089|NCT02598960|473379384|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477090|NCT02598960|473379385|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477091|NCT02598960|473379386|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477092|NCT02598960|473379387|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477093|NCT02598960|473379388|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477094|NCT02598960|473379389|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477095|NCT02598960|473379390|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477096|NCT02598960|473379391|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477097|NCT02598960|473379392|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
131477098|NCT02598960|473379393|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
131477099|NCT02598960|473379381|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
131477100|NCT02598960|473379382|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
131477101|NCT02598960|473379383|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
131477102|NCT02598960|473379384|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
131477103|NCT02598960|473379385|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
131477104|NCT02598960|473379386|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
131477105|NCT02598960|473379387|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
131477106|NCT02598960|473379388|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
131477107|NCT02598960|473379389|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
131477108|NCT02598960|473379390|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
131477109|NCT02598960|473379391|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
131477110|NCT02598960|473379392|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
131477111|NCT02598960|473379393|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
131477112|NCT02598960|473379381|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477113|NCT02598960|473379382|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477114|NCT02598960|473379383|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477115|NCT02598960|473379384|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477116|NCT02598960|473379385|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477117|NCT02598960|473379386|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477118|NCT02598960|473379387|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477119|NCT02598960|473379388|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477120|NCT02598960|473379389|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477121|NCT02598960|473379390|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477122|NCT02598960|473379391|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477123|NCT02598960|473379392|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
131477124|NCT02598960|473379393|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
131477125|NCT02598960|473379381|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
131477126|NCT02598960|473379382|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
131477127|NCT02598960|473379383|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
131477128|NCT02598960|473379384|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
131477129|NCT02598960|473379385|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
131477130|NCT02598960|473379386|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
131477131|NCT02598960|473379387|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
131477132|NCT02598960|473379388|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
131477133|NCT02598960|473379389|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
131477134|NCT02598960|473379390|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
131477135|NCT02598960|473379391|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
131477136|NCT02598960|473379392|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
131477137|NCT02598960|473379393|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
131477138|NCT01193660|473379396|FG000|Overall Study|Withdrawal by Subject|2|||
131477139|NCT01193660|473379397|FG001|Overall Study|Withdrawal by Subject|3|||
131477140|NCT01193660|473379398|FG002|Overall Study|Withdrawal by Subject|1|||
131477141|NCT01193660|473379396|FG000|Overall Study|Death|1|||
131477142|NCT01193660|473379397|FG001|Overall Study|Death|0|||
131477143|NCT01193660|473379398|FG002|Overall Study|Death|0|||
131477144|NCT01193660|473379396|FG000|Overall Study|Physician Decision|1|||
131477145|NCT01193660|473379397|FG001|Overall Study|Physician Decision|0|||
131477146|NCT01193660|473379398|FG002|Overall Study|Physician Decision|1|||
131477147|NCT01680965|473379399|FG000|Overall Study|Death|0|||
131477148|NCT01680965|473379400|FG001|Overall Study|Death|0|||
131477149|NCT01680965|473379401|FG002|Overall Study|Death|0|||
131477150|NCT01680965|473379402|FG003|Overall Study|Death|6|||
131477151|NCT00195273|473379403|FG000|Overall Study|Adverse Event|9|||
131477152|NCT00195273|473379404|FG001|Overall Study|Adverse Event|9|||
131477153|NCT00195273|473379403|FG000|Overall Study|Protocol deviation|0|||
131477154|NCT00195273|473379404|FG001|Overall Study|Protocol deviation|1|||
131477155|NCT00195273|473379403|FG000|Overall Study|Lack of Efficacy|3|||
131477156|NCT00195273|473379404|FG001|Overall Study|Lack of Efficacy|1|||
131477157|NCT00195273|473379403|FG000|Overall Study|Procedural complications|9|||
131477158|NCT00195273|473379404|FG001|Overall Study|Procedural complications|3|||
131477159|NCT00595465|473379405|FG000|Overall Study|Adverse Event|4|||
131477160|NCT00595465|473379406|FG001|Overall Study|Adverse Event|3|||
131477161|NCT00595465|473379407|FG002|Overall Study|Adverse Event|3|||
131477162|NCT00595465|473379405|FG000|Overall Study|Pregnancy|0|||
131477163|NCT00595465|473379406|FG001|Overall Study|Pregnancy|0|||
131477164|NCT00595465|473379407|FG002|Overall Study|Pregnancy|1|||
131477165|NCT00595465|473379405|FG000|Overall Study|Protocol Violation|2|||
131477166|NCT00595465|473379406|FG001|Overall Study|Protocol Violation|1|||
131477167|NCT00595465|473379407|FG002|Overall Study|Protocol Violation|0|||
131477168|NCT00595465|473379405|FG000|Overall Study|Lost to Follow-up|0|||
131477169|NCT00595465|473379406|FG001|Overall Study|Lost to Follow-up|0|||
131477170|NCT00595465|473379407|FG002|Overall Study|Lost to Follow-up|2|||
131477171|NCT00595465|473379405|FG000|Overall Study|administrative reason|0|||
131477172|NCT00595465|473379406|FG001|Overall Study|administrative reason|0|||
131477173|NCT00595465|473379407|FG002|Overall Study|administrative reason|1|||
131477174|NCT02595970|473379408|FG000|Overall Study|Withdrawal by Subject|2|||
131477175|NCT02595970|473379408|FG000|Overall Study|Physician Decision|2|||
131477176|NCT02595970|473379408|FG000|Overall Study|Protocol Violation|4|||
131477177|NCT02595970|473379408|FG000|Overall Study|Adverse Event|5|||
131477178|NCT02595970|473379408|FG000|Overall Study|Lack of Efficacy|7|||
131477179|NCT04879225|473379409|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
131477180|NCT04879225|473379409|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
131477181|NCT02367131|473379412|FG000|Overall Study|Adverse Event|64|||
131477182|NCT02367131|473379412|FG000|Overall Study|No visit since the first visit|3|||
131477183|NCT02367131|473379412|FG000|Overall Study|Request by patient|53|||
131477184|NCT02367131|473379412|FG000|Overall Study|Improvement/remission|2|||
131477185|NCT02367131|473379412|FG000|Overall Study|No change/progressive disease|78|||
131477186|NCT02367131|473379412|FG000|Overall Study|Other than stated above|20|||
131477187|NCT02367131|473379412|FG000|Overall Study|Not treated|2|||
131477188|NCT00810108|473379413|FG000|Overall Study|Withdrawal by Subject|1|||
131477189|NCT00810108|473379414|FG001|Overall Study|Withdrawal by Subject|0|||
131477190|NCT02923427|473379417|FG000|Overall Study|convert to laparatomy|2|||
131477191|NCT02923427|473379418|FG001|Overall Study|convert to laparatomy|2|||
131477192|NCT02923427|473379417|FG000|Overall Study|destaturation|1|||
131477193|NCT02923427|473379418|FG001|Overall Study|destaturation|0|||
131477194|NCT02923427|473379417|FG000|Overall Study|can not replace LMA|1|||
131477195|NCT02923427|473379418|FG001|Overall Study|can not replace LMA|0|||
131477196|NCT01325623|473379419|FG000|Overall Study|Withdrawal by Subject|3|||
131477197|NCT02106910|473379420|FG000|Overall Study|Lost to Follow-up|1|||
131477198|NCT02106910|473379421|FG001|Overall Study|Lost to Follow-up|1|||
131477199|NCT02556203|473379422|FG000|Overall Study|Withdrawal by Subject|21|||
131477200|NCT02556203|473379423|FG001|Overall Study|Withdrawal by Subject|21|||
131477201|NCT02556203|473379422|FG000|Overall Study|Lost to Follow-up|5|||
131477202|NCT02556203|473379423|FG001|Overall Study|Lost to Follow-up|5|||
131477203|NCT02556203|473379422|FG000|Overall Study|Adverse Event|1|||
131477204|NCT02556203|473379423|FG001|Overall Study|Adverse Event|0|||
131477205|NCT03875768|473379431|FG000|Overall Study|Lost to Follow-up|16|||
131477206|NCT03875768|473379432|FG001|Overall Study|Lost to Follow-up|13|||
131477207|NCT03875768|473379431|FG000|Overall Study|Withdrawal by Subject|10|||
131477208|NCT03875768|473379432|FG001|Overall Study|Withdrawal by Subject|21|||
131477209|NCT03875768|473379431|FG000|Overall Study|Did not complete assessment|21|||
131477210|NCT03875768|473379432|FG001|Overall Study|Did not complete assessment|12|||
131477211|NCT03875768|473379431|FG000|Overall Study|Became ineligible|1|||
131477212|NCT03875768|473379432|FG001|Overall Study|Became ineligible|0|||
131477213|NCT01925274|473379433|FG000|Overall Study|Death|1|||
131477214|NCT01925274|473379434|FG001|Overall Study|Death|0|||
131477215|NCT01925274|473379435|FG002|Overall Study|Death|0|||
131477216|NCT01925274|473379433|FG000|Overall Study|Lost to Follow-up|0|||
131477217|NCT01925274|473379434|FG001|Overall Study|Lost to Follow-up|1|||
131477218|NCT01925274|473379435|FG002|Overall Study|Lost to Follow-up|0|||
131477219|NCT01925274|473379433|FG000|Overall Study|Withdrawal by Subject|1|||
131477220|NCT01925274|473379434|FG001|Overall Study|Withdrawal by Subject|2|||
131477221|NCT01925274|473379435|FG002|Overall Study|Withdrawal by Subject|0|||
131477222|NCT01925274|473379433|FG000|Overall Study|Study terminated by sponsor|4|||
131477223|NCT01925274|473379434|FG001|Overall Study|Study terminated by sponsor|0|||
131477224|NCT01925274|473379435|FG002|Overall Study|Study terminated by sponsor|0|||
131477225|NCT01925274|473379433|FG000|Overall Study|Protocol amendment|1|||
131477226|NCT01925274|473379434|FG001|Overall Study|Protocol amendment|3|||
131477227|NCT01925274|473379435|FG002|Overall Study|Protocol amendment|6|||
131477228|NCT01461980|473379438|FG000|Overall Study|Other|9|||
131477229|NCT01461980|473379439|FG001|Overall Study|Other|8|||
131477230|NCT01461980|473379440|FG002|Overall Study|Other|6|||
131477231|NCT01461980|473379438|FG000|Overall Study|Medication error|7|||
131477232|NCT01461980|473379439|FG001|Overall Study|Medication error|5|||
131477233|NCT01461980|473379440|FG002|Overall Study|Medication error|6|||
131477234|NCT01461980|473379438|FG000|Overall Study|Adverse Event|12|||
131477235|NCT01461980|473379439|FG001|Overall Study|Adverse Event|5|||
131477236|NCT01461980|473379440|FG002|Overall Study|Adverse Event|6|||
131477237|NCT01461980|473379438|FG000|Overall Study|Protocol Violation|12|||
131477238|NCT01461980|473379439|FG001|Overall Study|Protocol Violation|19|||
131477239|NCT01461980|473379440|FG002|Overall Study|Protocol Violation|16|||
131477240|NCT01461980|473379438|FG000|Overall Study|No longer meets eligibility criteria|18|||
131477241|NCT01461980|473379439|FG001|Overall Study|No longer meets eligibility criteria|9|||
131477242|NCT01461980|473379440|FG002|Overall Study|No longer meets eligibility criteria|19|||
131477243|NCT01461980|473379438|FG000|Overall Study|Lost to Follow-up|52|||
131477244|NCT01461980|473379439|FG001|Overall Study|Lost to Follow-up|53|||
131477245|NCT01461980|473379440|FG002|Overall Study|Lost to Follow-up|51|||
131477246|NCT01461980|473379438|FG000|Overall Study|No longer willing to participate|52|||
131477247|NCT01461980|473379439|FG001|Overall Study|No longer willing to participate|38|||
131882347|NCT00723190|474851189|FG000|Overall Study|Lack of Efficacy|16|||
131882348|NCT00723190|474851189|FG000|Overall Study|Protocol Violation|15|||
131477248|NCT01461980|473379440|FG002|Overall Study|No longer willing to participate|54|||
131477249|NCT01461980|473379438|FG000|Overall Study|Randomized but not vaccinated|4|||
131477250|NCT01461980|473379439|FG001|Overall Study|Randomized but not vaccinated|8|||
131477251|NCT01461980|473379440|FG002|Overall Study|Randomized but not vaccinated|7|||
131477252|NCT04171765|473379441|FG000|Overall Study|Adverse Event|2|||
131477253|NCT04171765|473379442|FG001|Overall Study|Adverse Event|0|||
131477254|NCT04171765|473379443|FG002|Overall Study|Adverse Event|1|||
131477255|NCT04171765|473379444|FG003|Overall Study|Adverse Event|0|||
131477256|NCT04171765|473379441|FG000|Overall Study|Lost to Follow-up|0|||
131477257|NCT04171765|473379442|FG001|Overall Study|Lost to Follow-up|2|||
131477258|NCT04171765|473379443|FG002|Overall Study|Lost to Follow-up|2|||
131477259|NCT04171765|473379444|FG003|Overall Study|Lost to Follow-up|2|||
131477260|NCT04171765|473379441|FG000|Overall Study|Week 58 visit missed|0|||
131477261|NCT04171765|473379442|FG001|Overall Study|Week 58 visit missed|0|||
131477262|NCT04171765|473379443|FG002|Overall Study|Week 58 visit missed|1|||
131477263|NCT04171765|473379444|FG003|Overall Study|Week 58 visit missed|0|||
131477264|NCT04171765|473379441|FG000|Overall Study|Study terminated by sponsor|2|||
131477265|NCT04171765|473379442|FG001|Overall Study|Study terminated by sponsor|0|||
131477266|NCT04171765|473379443|FG002|Overall Study|Study terminated by sponsor|0|||
131477267|NCT04171765|473379444|FG003|Overall Study|Study terminated by sponsor|0|||
131477268|NCT04171765|473379441|FG000|Overall Study|Withdrawal by Subject|1|||
131477269|NCT04171765|473379442|FG001|Overall Study|Withdrawal by Subject|0|||
131477270|NCT04171765|473379443|FG002|Overall Study|Withdrawal by Subject|0|||
131477271|NCT04171765|473379444|FG003|Overall Study|Withdrawal by Subject|3|||
131477272|NCT00809354|473379447|FG000|Overall Study|Adverse Event|32|||
131477273|NCT00809354|473379448|FG001|Overall Study|Adverse Event|45|||
131477274|NCT00809354|473379449|FG002|Overall Study|Adverse Event|37|||
131477275|NCT00809354|473379450|FG003|Overall Study|Adverse Event|53|||
131477276|NCT00809354|473379451|FG004|Overall Study|Adverse Event|26|||
131477277|NCT00809354|473379452|FG005|Overall Study|Adverse Event|33|||
131477278|NCT00809354|473379453|FG006|Overall Study|Adverse Event|44|||
131882349|NCT00723190|474851189|FG000|Overall Study|Other-Premature Discontinuation|9|||
131477279|NCT00809354|473379454|FG007|Overall Study|Adverse Event|40|||
131477280|NCT00809354|473379455|FG008|Overall Study|Adverse Event|46|||
131477281|NCT00809354|473379456|FG009|Overall Study|Adverse Event|26|||
131477282|NCT00809354|473379447|FG000|Overall Study|Lack of Efficacy|23|||
131477283|NCT00809354|473379448|FG001|Overall Study|Lack of Efficacy|23|||
131477284|NCT00809354|473379449|FG002|Overall Study|Lack of Efficacy|22|||
131477285|NCT00809354|473379450|FG003|Overall Study|Lack of Efficacy|15|||
131477286|NCT00809354|473379451|FG004|Overall Study|Lack of Efficacy|40|||
131477287|NCT00809354|473379452|FG005|Overall Study|Lack of Efficacy|19|||
131477288|NCT00809354|473379453|FG006|Overall Study|Lack of Efficacy|21|||
131477289|NCT00809354|473379454|FG007|Overall Study|Lack of Efficacy|15|||
131477290|NCT00809354|473379455|FG008|Overall Study|Lack of Efficacy|18|||
131477291|NCT00809354|473379456|FG009|Overall Study|Lack of Efficacy|38|||
131477292|NCT00809354|473379447|FG000|Overall Study|Lost to Follow-up|10|||
131477293|NCT00809354|473379448|FG001|Overall Study|Lost to Follow-up|11|||
131477294|NCT00809354|473379449|FG002|Overall Study|Lost to Follow-up|8|||
131477295|NCT00809354|473379450|FG003|Overall Study|Lost to Follow-up|13|||
131477296|NCT00809354|473379451|FG004|Overall Study|Lost to Follow-up|6|||
131477297|NCT00809354|473379452|FG005|Overall Study|Lost to Follow-up|2|||
131477298|NCT00809354|473379453|FG006|Overall Study|Lost to Follow-up|0|||
131477299|NCT00809354|473379454|FG007|Overall Study|Lost to Follow-up|5|||
131477300|NCT00809354|473379455|FG008|Overall Study|Lost to Follow-up|4|||
131477301|NCT00809354|473379456|FG009|Overall Study|Lost to Follow-up|0|||
131477302|NCT00809354|473379447|FG000|Overall Study|Protocol Violation|7|||
131477303|NCT00809354|473379448|FG001|Overall Study|Protocol Violation|14|||
131477304|NCT00809354|473379449|FG002|Overall Study|Protocol Violation|14|||
131477305|NCT00809354|473379450|FG003|Overall Study|Protocol Violation|12|||
131477306|NCT00809354|473379451|FG004|Overall Study|Protocol Violation|14|||
131477307|NCT00809354|473379452|FG005|Overall Study|Protocol Violation|6|||
131477308|NCT00809354|473379453|FG006|Overall Study|Protocol Violation|4|||
131477309|NCT00809354|473379454|FG007|Overall Study|Protocol Violation|6|||
131477310|NCT00809354|473379455|FG008|Overall Study|Protocol Violation|9|||
131477311|NCT00809354|473379456|FG009|Overall Study|Protocol Violation|3|||
131477312|NCT00809354|473379447|FG000|Overall Study|Withdrawal by Subject|32|||
131477313|NCT00809354|473379448|FG001|Overall Study|Withdrawal by Subject|27|||
131477314|NCT00809354|473379449|FG002|Overall Study|Withdrawal by Subject|31|||
131477315|NCT00809354|473379450|FG003|Overall Study|Withdrawal by Subject|33|||
131477316|NCT00809354|473379451|FG004|Overall Study|Withdrawal by Subject|34|||
131477317|NCT00809354|473379452|FG005|Overall Study|Withdrawal by Subject|29|||
131477318|NCT00809354|473379453|FG006|Overall Study|Withdrawal by Subject|27|||
131477319|NCT00809354|473379454|FG007|Overall Study|Withdrawal by Subject|19|||
131477320|NCT00809354|473379455|FG008|Overall Study|Withdrawal by Subject|18|||
131477321|NCT00809354|473379456|FG009|Overall Study|Withdrawal by Subject|20|||
131477322|NCT00809354|473379447|FG000|Overall Study|Other|10|||
131477323|NCT00809354|473379448|FG001|Overall Study|Other|2|||
131477324|NCT00809354|473379449|FG002|Overall Study|Other|7|||
131477325|NCT00809354|473379450|FG003|Overall Study|Other|10|||
131477326|NCT00809354|473379451|FG004|Overall Study|Other|5|||
131477327|NCT00809354|473379452|FG005|Overall Study|Other|3|||
131882350|NCT00723190|474851189|FG000|Overall Study|Other-Not included in safety population|2|||
131477328|NCT00809354|473379453|FG006|Overall Study|Other|2|||
131477329|NCT00809354|473379454|FG007|Overall Study|Other|3|||
131477330|NCT00809354|473379455|FG008|Overall Study|Other|4|||
131477331|NCT00809354|473379456|FG009|Overall Study|Other|3|||
131477332|NCT00809354|473379447|FG000|Overall Study|Study terminated by sponsor|138|||
131477333|NCT00809354|473379448|FG001|Overall Study|Study terminated by sponsor|134|||
131477334|NCT00809354|473379449|FG002|Overall Study|Study terminated by sponsor|129|||
131477335|NCT00809354|473379450|FG003|Overall Study|Study terminated by sponsor|120|||
131477336|NCT00809354|473379451|FG004|Overall Study|Study terminated by sponsor|126|||
131477337|NCT00809354|473379452|FG005|Overall Study|Study terminated by sponsor|133|||
131882351|NCT00454818|474851190|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
131882352|NCT00454818|474851191|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
131882353|NCT00454818|474851192|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
131882354|NCT00454818|474851193|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
131882355|NCT00454818|474851194|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
131882356|NCT00454818|474851190|FG000|Phase I: Open-label Dose-escalation|Death|0|||
131882357|NCT00454818|474851191|FG001|Phase I: Open-label Dose-escalation|Death|1|||
131882358|NCT00454818|474851192|FG002|Phase I: Open-label Dose-escalation|Death|0|||
131882359|NCT00454818|474851193|FG003|Phase I: Open-label Dose-escalation|Death|0|||
131882360|NCT00454818|474851194|FG004|Phase I: Open-label Dose-escalation|Death|0|||
131882361|NCT00454818|474851190|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
131882362|NCT00454818|474851191|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
131882363|NCT00454818|474851192|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
131882364|NCT00454818|474851193|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
131882365|NCT00454818|474851194|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
131882366|NCT00454818|474851190|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
131882367|NCT00454818|474851191|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
131882368|NCT00454818|474851192|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
131882369|NCT00454818|474851193|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
131882370|NCT00454818|474851194|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
131882371|NCT00454818|474851190|FG000|Phase 2: Randomized Double-blind|Death|0|||
131882372|NCT00454818|474851191|FG001|Phase 2: Randomized Double-blind|Death|1|||
131882373|NCT00454818|474851192|FG002|Phase 2: Randomized Double-blind|Death|0|||
131477338|NCT00809354|473379453|FG006|Overall Study|Study terminated by sponsor|124|||
131477339|NCT00809354|473379454|FG007|Overall Study|Study terminated by sponsor|148|||
131477340|NCT00809354|473379455|FG008|Overall Study|Study terminated by sponsor|127|||
131477341|NCT00809354|473379456|FG009|Overall Study|Study terminated by sponsor|135|||
131477342|NCT00809354|473379447|FG000|Overall Study|Withdrawn due to pregnancy|0|||
131477343|NCT00809354|473379448|FG001|Overall Study|Withdrawn due to pregnancy|1|||
131477344|NCT00809354|473379449|FG002|Overall Study|Withdrawn due to pregnancy|0|||
131477345|NCT00809354|473379450|FG003|Overall Study|Withdrawn due to pregnancy|0|||
131477346|NCT00809354|473379451|FG004|Overall Study|Withdrawn due to pregnancy|0|||
131477347|NCT00809354|473379452|FG005|Overall Study|Withdrawn due to pregnancy|0|||
131477348|NCT00809354|473379453|FG006|Overall Study|Withdrawn due to pregnancy|0|||
131477349|NCT00809354|473379454|FG007|Overall Study|Withdrawn due to pregnancy|0|||
131477350|NCT00809354|473379455|FG008|Overall Study|Withdrawn due to pregnancy|0|||
131477351|NCT00809354|473379456|FG009|Overall Study|Withdrawn due to pregnancy|0|||
131477352|NCT00809354|473379447|FG000|Overall Study|Randomized but not Treated|3|||
131477353|NCT00809354|473379448|FG001|Overall Study|Randomized but not Treated|1|||
131477354|NCT00809354|473379449|FG002|Overall Study|Randomized but not Treated|6|||
131477355|NCT00809354|473379450|FG003|Overall Study|Randomized but not Treated|0|||
131477356|NCT00809354|473379451|FG004|Overall Study|Randomized but not Treated|5|||
131477357|NCT00809354|473379452|FG005|Overall Study|Randomized but not Treated|0|||
131477358|NCT00809354|473379453|FG006|Overall Study|Randomized but not Treated|1|||
131477359|NCT00809354|473379454|FG007|Overall Study|Randomized but not Treated|1|||
131477360|NCT00809354|473379455|FG008|Overall Study|Randomized but not Treated|2|||
131477361|NCT00809354|473379456|FG009|Overall Study|Randomized but not Treated|1|||
131477362|NCT00809354|473379447|FG000|Overall Study|Death|0|||
131477363|NCT00809354|473379448|FG001|Overall Study|Death|0|||
131477364|NCT00809354|473379449|FG002|Overall Study|Death|0|||
131477365|NCT00809354|473379450|FG003|Overall Study|Death|0|||
131477366|NCT00809354|473379451|FG004|Overall Study|Death|0|||
131477367|NCT00809354|473379452|FG005|Overall Study|Death|0|||
131477368|NCT00809354|473379453|FG006|Overall Study|Death|0|||
131477369|NCT00809354|473379454|FG007|Overall Study|Death|1|||
131477370|NCT00809354|473379455|FG008|Overall Study|Death|0|||
131477371|NCT00809354|473379456|FG009|Overall Study|Death|0|||
131477372|NCT00777205|473379459|FG000|Overall Study|Lost to Follow-up|25|||
131477373|NCT00777205|473379460|FG001|Overall Study|Lost to Follow-up|9|||
131477374|NCT00777205|473379459|FG000|Overall Study|Withdrawal by Subject|6|||
131477375|NCT00777205|473379460|FG001|Overall Study|Withdrawal by Subject|4|||
131477376|NCT00777205|473379459|FG000|Overall Study|Death|0|||
131477377|NCT00777205|473379460|FG001|Overall Study|Death|2|||
131477378|NCT00777205|473379459|FG000|Overall Study|Protocol Violation|0|||
131477379|NCT00777205|473379460|FG001|Overall Study|Protocol Violation|56|||
131477380|NCT00100178|473379461|FG000|Overall Study|Lost to Follow-up|0|||
131477381|NCT00100178|473379462|FG001|Overall Study|Lost to Follow-up|6|||
131477382|NCT00100178|473379463|FG002|Overall Study|Lost to Follow-up|5|||
131477383|NCT00100178|473379461|FG000|Overall Study|Adverse Event|2|||
131477384|NCT00100178|473379462|FG001|Overall Study|Adverse Event|2|||
131477385|NCT00100178|473379463|FG002|Overall Study|Adverse Event|1|||
131477386|NCT00100178|473379461|FG000|Overall Study|Withdrawal by Subject|1|||
131477387|NCT00100178|473379462|FG001|Overall Study|Withdrawal by Subject|1|||
131882374|NCT00454818|474851193|FG003|Phase 2: Randomized Double-blind|Death|0|||
131882375|NCT00454818|474851194|FG004|Phase 2: Randomized Double-blind|Death|1|||
131882376|NCT00454818|474851190|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
131882377|NCT00454818|474851191|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
131477388|NCT00100178|473379463|FG002|Overall Study|Withdrawal by Subject|1|||
131477389|NCT00100178|473379461|FG000|Overall Study|Physician Decision|6|||
131477390|NCT00100178|473379462|FG001|Overall Study|Physician Decision|1|||
131477391|NCT00100178|473379463|FG002|Overall Study|Physician Decision|3|||
131477392|NCT03257371|473379464|FG000|Overall Study|Lost to Follow-up|1|||
131477393|NCT02477839|473379469|FG000|Overall Study|Adverse Event|0|||
131477394|NCT02477839|473379470|FG001|Overall Study|Adverse Event|1|||
131477395|NCT02477839|473379469|FG000|Overall Study|Protocol Violation|0|||
131477396|NCT02477839|473379470|FG001|Overall Study|Protocol Violation|2|||
131477397|NCT02477839|473379469|FG000|Overall Study|Withdrawal by Subject|3|||
131477398|NCT02477839|473379470|FG001|Overall Study|Withdrawal by Subject|3|||
131477399|NCT02477839|473379469|FG000|Overall Study|Participant had PGS during V6|0|||
131477400|NCT02477839|473379470|FG001|Overall Study|Participant had PGS during V6|1|||
131477401|NCT02477839|473379469|FG000|Overall Study|Parents decided to stop medication|0|||
131477402|NCT02477839|473379470|FG001|Overall Study|Parents decided to stop medication|1|||
131477403|NCT02477839|473379469|FG000|Overall Study|Lack of tolerability|0|||
131477404|NCT02477839|473379470|FG001|Overall Study|Lack of tolerability|1|||
131477405|NCT02477839|473379469|FG000|Overall Study|Exclusion criterion|0|||
131477406|NCT02477839|473379470|FG001|Overall Study|Exclusion criterion|1|||
131477407|NCT00631696|473379475|FG000|Overall Study|Entered, not randomized to treatment|1|||
131477408|NCT00631696|473379476|FG001|Overall Study|Entered, not randomized to treatment|1|||
131477409|NCT00631696|473379475|FG000|Overall Study|Discontinued after database release date|1|||
131477410|NCT00631696|473379476|FG001|Overall Study|Discontinued after database release date|0|||
131477411|NCT00631696|473379475|FG000|Overall Study|Follow up after database release date|1|||
131477412|NCT00631696|473379476|FG001|Overall Study|Follow up after database release date|0|||
131477413|NCT00631696|473379475|FG000|Overall Study|Lost to Follow-up|7|||
131477414|NCT00631696|473379476|FG001|Overall Study|Lost to Follow-up|10|||
131477415|NCT00631696|473379475|FG000|Overall Study|Withdrawal by Subject|2|||
131477416|NCT00631696|473379476|FG001|Overall Study|Withdrawal by Subject|9|||
131477417|NCT00631696|473379475|FG000|Overall Study|Other|8|||
131477418|NCT00631696|473379476|FG001|Overall Study|Other|8|||
131477419|NCT00631696|473379475|FG000|Overall Study|Protocol Violation|9|||
131477420|NCT00631696|473379476|FG001|Overall Study|Protocol Violation|9|||
131477421|NCT00631696|473379475|FG000|Overall Study|Study terminated by sponsor|3|||
131477422|NCT00631696|473379476|FG001|Overall Study|Study terminated by sponsor|3|||
131477423|NCT00631696|473379475|FG000|Overall Study|Adverse Event|5|||
131477424|NCT00631696|473379476|FG001|Overall Study|Adverse Event|0|||
131477425|NCT01439568|473379478|FG000|Overall Study|Lost to Follow-up|1|||
131477426|NCT01439568|473379479|FG001|Overall Study|Lost to Follow-up|0|||
131477427|NCT01439568|473379478|FG000|Overall Study|Withdrawal by Subject|2|||
131477428|NCT01439568|473379479|FG001|Overall Study|Withdrawal by Subject|2|||
131477429|NCT03198078|473379482|FG000|Overall Study|Adverse Event|0|||
131477430|NCT03198078|473379483|FG001|Overall Study|Adverse Event|1|||
131477431|NCT03198078|473379484|FG002|Overall Study|Adverse Event|2|||
131477432|NCT03198078|473379482|FG000|Overall Study|Lack of Efficacy|0|||
131477433|NCT03198078|473379483|FG001|Overall Study|Lack of Efficacy|0|||
131477434|NCT03198078|473379484|FG002|Overall Study|Lack of Efficacy|3|||
131477435|NCT03198078|473379482|FG000|Overall Study|Lost to Follow-up|1|||
131477436|NCT03198078|473379483|FG001|Overall Study|Lost to Follow-up|0|||
131477437|NCT03198078|473379484|FG002|Overall Study|Lost to Follow-up|0|||
131477438|NCT03198078|473379482|FG000|Overall Study|Pregnancy|0|||
131477439|NCT03198078|473379483|FG001|Overall Study|Pregnancy|1|||
131477440|NCT03198078|473379484|FG002|Overall Study|Pregnancy|0|||
131477441|NCT03198078|473379482|FG000|Overall Study|Withdrawal by Subject|1|||
131477442|NCT03198078|473379483|FG001|Overall Study|Withdrawal by Subject|0|||
131477443|NCT03198078|473379484|FG002|Overall Study|Withdrawal by Subject|2|||
131477444|NCT03198078|473379482|FG000|Overall Study|Withdrawal by Caregiver|1|||
131477445|NCT03198078|473379483|FG001|Overall Study|Withdrawal by Caregiver|3|||
131477446|NCT03198078|473379484|FG002|Overall Study|Withdrawal by Caregiver|5|||
131477447|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
131477448|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
131477449|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
131477450|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
131477451|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
131477452|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
131477453|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
131477454|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
131477455|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
131477456|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
131477457|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
131882378|NCT00454818|474851192|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
131477458|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
131477459|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
131477460|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
131477461|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
131477462|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
131477463|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
131477464|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
131477465|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
131477466|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
131477467|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
131477468|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
131882379|NCT00454818|474851193|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
131882380|NCT00454818|474851194|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
131882381|NCT00454818|474851190|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
131882382|NCT00454818|474851191|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
131882383|NCT00454818|474851192|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
131882384|NCT00454818|474851193|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
131882385|NCT00454818|474851194|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
131882386|NCT03181503|474851195|FG000|Overall Study|Adverse Event|2|||
131882387|NCT03181503|474851196|FG001|Overall Study|Adverse Event|2|||
131882388|NCT03181503|474851195|FG000|Overall Study|Protocol Violation|1|||
131882389|NCT03181503|474851196|FG001|Overall Study|Protocol Violation|0|||
131882390|NCT03181503|474851195|FG000|Overall Study|Withdrawal by Subject|3|||
131882391|NCT03181503|474851196|FG001|Overall Study|Withdrawal by Subject|0|||
131882392|NCT03181503|474851195|FG000|Overall Study|Lost to Follow-up|1|||
131882393|NCT03181503|474851196|FG001|Overall Study|Lost to Follow-up|1|||
131882394|NCT02505334|474851202|FG000|Main Treatment Period|Adverse Event|3|||
131882395|NCT02505334|474851203|FG001|Main Treatment Period|Adverse Event|3|||
131882396|NCT02505334|474851202|FG000|Main Treatment Period|Lack of Efficacy|7|||
131882397|NCT02505334|474851203|FG001|Main Treatment Period|Lack of Efficacy|17|||
131882398|NCT02505334|474851202|FG000|Main Treatment Period|Protocol Violation|0|||
131882399|NCT02505334|474851203|FG001|Main Treatment Period|Protocol Violation|1|||
131882400|NCT02505334|474851202|FG000|Main Treatment Period|Withdrawal by Subject|1|||
131477469|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
131477470|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
131477471|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Death|2|||
131477472|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Death|1|||
131477473|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Death|0|||
131477474|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Death|0|||
131477475|NCT02607930|473379485|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
131477476|NCT02607930|473379486|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
131477477|NCT02607930|473379487|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
131477478|NCT02607930|473379488|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
131477479|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
131477480|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
131477481|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
131477482|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
131477483|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
131477484|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
131477485|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
131477486|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
131477487|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
131477488|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
131477489|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
131477490|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
131477491|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
131477492|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
131477493|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
131882401|NCT02505334|474851203|FG001|Main Treatment Period|Withdrawal by Subject|8|||
131882402|NCT02505334|474851202|FG000|Main Treatment Period|Unclassified|4|||
131882403|NCT02505334|474851203|FG001|Main Treatment Period|Unclassified|10|||
131882404|NCT02505334|474851202|FG000|Extension Treatment Period|Adverse Event|5|||
131477494|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
131477495|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
131882405|NCT02505334|474851203|FG001|Extension Treatment Period|Adverse Event|0|||
131882406|NCT02505334|474851202|FG000|Extension Treatment Period|Lack of Efficacy|4|||
131882407|NCT02505334|474851203|FG001|Extension Treatment Period|Lack of Efficacy|0|||
131882408|NCT02505334|474851202|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
131477496|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
131477497|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
131477498|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
131477499|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
131477500|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
131477501|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
131477502|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
131477503|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
131882409|NCT02505334|474851203|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131882410|NCT02505334|474851202|FG000|Extension Treatment Period|Unclassified|3|||
131882411|NCT02505334|474851203|FG001|Extension Treatment Period|Unclassified|0|||
131882412|NCT00597506|474851204|FG000|Overall Study|Subject is being followed for survival|1|||
131882413|NCT03199612|474851205|FG000|Overall Study|Adverse Event|1|||
131882414|NCT03199612|474851206|FG001|Overall Study|Adverse Event|0|||
131882415|NCT00081731|474851213|FG000|Overall Study|scientific integrity issue|8|||
131882416|NCT00081731|474851214|FG001|Overall Study|scientific integrity issue|8|||
131882417|NCT02386345|474851215|FG000|Overall Study|Not treated|14|||
131882418|NCT02386345|474851215|FG000|Overall Study|Lost to Follow-up|1|||
131882419|NCT02386345|474851215|FG000|Overall Study|Adverse Event|5|||
131882420|NCT02386345|474851215|FG000|Overall Study|Repeat Procedure|10|||
131882421|NCT02386345|474851215|FG000|Overall Study|Did not complete 12-month follow-up|72|||
131882422|NCT02258542|474851216|FG000|Overall Study|eg. not made to the visit|7|||
131882423|NCT02258542|474851217|FG001|Overall Study|eg. not made to the visit|4|||
131882424|NCT02258542|474851218|FG002|Overall Study|eg. not made to the visit|0|||
131882425|NCT02258542|474851219|FG003|Overall Study|eg. not made to the visit|1|||
131882426|NCT02258542|474851216|FG000|Overall Study|study specific discount. criteria|1|||
131882427|NCT02258542|474851217|FG001|Overall Study|study specific discount. criteria|1|||
131882428|NCT02258542|474851218|FG002|Overall Study|study specific discount. criteria|0|||
131882429|NCT02258542|474851219|FG003|Overall Study|study specific discount. criteria|0|||
131882430|NCT02258542|474851216|FG000|Overall Study|Withdrawal by Subject|20|||
131882431|NCT02258542|474851217|FG001|Overall Study|Withdrawal by Subject|20|||
131882432|NCT02258542|474851218|FG002|Overall Study|Withdrawal by Subject|7|||
131882433|NCT02258542|474851219|FG003|Overall Study|Withdrawal by Subject|1|||
131882434|NCT02258542|474851216|FG000|Overall Study|Lost to Follow-up|5|||
131882435|NCT02258542|474851217|FG001|Overall Study|Lost to Follow-up|12|||
131882436|NCT02258542|474851218|FG002|Overall Study|Lost to Follow-up|1|||
131882437|NCT02258542|474851219|FG003|Overall Study|Lost to Follow-up|2|||
131882438|NCT02258542|474851216|FG000|Overall Study|Death|5|||
131882439|NCT02258542|474851217|FG001|Overall Study|Death|4|||
131882440|NCT02258542|474851218|FG002|Overall Study|Death|0|||
131882441|NCT02258542|474851219|FG003|Overall Study|Death|1|||
131882442|NCT02258542|474851216|FG000|Overall Study|Adverse Event|3|||
131882443|NCT02258542|474851217|FG001|Overall Study|Adverse Event|4|||
131882444|NCT02258542|474851218|FG002|Overall Study|Adverse Event|0|||
131882445|NCT02258542|474851219|FG003|Overall Study|Adverse Event|0|||
131882446|NCT02258542|474851216|FG000|Overall Study|Protocol Violation|1|||
131882447|NCT02258542|474851217|FG001|Overall Study|Protocol Violation|2|||
131882448|NCT02258542|474851218|FG002|Overall Study|Protocol Violation|0|||
131882449|NCT02258542|474851219|FG003|Overall Study|Protocol Violation|0|||
131882450|NCT02258542|474851216|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131882451|NCT02258542|474851217|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
131882452|NCT02258542|474851218|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
131882453|NCT02258542|474851219|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
131882454|NCT00581542|474851220|FG000|Overall Study|they met an exclusion criteria|2|||
131882455|NCT00581542|474851221|FG001|Overall Study|they met an exclusion criteria|2|||
131882456|NCT00581542|474851220|FG000|Overall Study|Lost to Follow-up|9|||
131882457|NCT00581542|474851221|FG001|Overall Study|Lost to Follow-up|21|||
131882458|NCT00656851|474851222|FG000|Overall Study|Withdrawal by Subject|0|||
131882459|NCT00656851|474851223|FG001|Overall Study|Withdrawal by Subject|4|||
131882460|NCT02291601|474851224|FG000|Abdomen|Did not qualify|333|||
131882461|NCT02291601|474851225|FG001|Abdomen|Did not qualify|54|||
131882462|NCT02291601|474851226|FG002|Abdomen|Did not qualify|339|||
131882463|NCT02291601|474851224|FG000|Groin|Did not qualify|183|||
131882464|NCT02291601|474851225|FG001|Groin|Did not qualify|30|||
131882465|NCT02291601|474851226|FG002|Groin|Did not qualify|177|||
131882466|NCT01032239|474851227|FG000|Overall Study|Lost to Follow-up|3|||
131882467|NCT01032239|474851228|FG001|Overall Study|Lost to Follow-up|2|||
131882468|NCT01032239|474851227|FG000|Overall Study|Withdrawal by Subject|2|||
131882469|NCT01032239|474851228|FG001|Overall Study|Withdrawal by Subject|3|||
131882470|NCT01032239|474851227|FG000|Overall Study|Death|1|||
131882471|NCT01032239|474851228|FG001|Overall Study|Death|0|||
131882472|NCT01032239|474851227|FG000|Overall Study|Protocol Violation|1|||
131882473|NCT01032239|474851228|FG001|Overall Study|Protocol Violation|0|||
131882474|NCT01940900|474851231|FG000|Overall Study|Physician Decision|4|||
131882475|NCT01940900|474851232|FG001|Overall Study|Physician Decision|0|||
131882476|NCT01940900|474851231|FG000|Overall Study|Adverse Event|10|||
131882477|NCT01940900|474851232|FG001|Overall Study|Adverse Event|15|||
131477504|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
131477505|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
131477506|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
131477507|NCT02607930|473379485|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
131477508|NCT02607930|473379486|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
131477509|NCT02607930|473379487|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
131477510|NCT02607930|473379488|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
131477511|NCT01676727|473379489|FG000|Overall Study|Death|18|||
131882478|NCT01940900|474851231|FG000|Overall Study|Withdrawal by Subject|11|||
131882479|NCT01940900|474851232|FG001|Overall Study|Withdrawal by Subject|15|||
131882480|NCT01940900|474851231|FG000|Overall Study|Lost to Follow-up|1|||
131882481|NCT01940900|474851232|FG001|Overall Study|Lost to Follow-up|0|||
131882482|NCT01940900|474851231|FG000|Overall Study|Sponsor Decision|1|||
131882483|NCT01940900|474851232|FG001|Overall Study|Sponsor Decision|0|||
131882484|NCT01940900|474851231|FG000|Overall Study|subject non-compliance|1|||
131882485|NCT01940900|474851232|FG001|Overall Study|subject non-compliance|1|||
131882486|NCT01940900|474851231|FG000|Overall Study|other|1|||
131882487|NCT01940900|474851232|FG001|Overall Study|other|0|||
131882488|NCT04972968|474851233|FG000|Overall Study|Adverse Event|3|||
131882489|NCT04972968|474851234|FG001|Overall Study|Adverse Event|1|||
131882490|NCT04972968|474851235|FG002|Overall Study|Adverse Event|1|||
131882491|NCT04972968|474851236|FG003|Overall Study|Adverse Event|7|||
131882492|NCT04972968|474851233|FG000|Overall Study|Lack of Efficacy|2|||
131882493|NCT04972968|474851234|FG001|Overall Study|Lack of Efficacy|1|||
131882494|NCT04972968|474851235|FG002|Overall Study|Lack of Efficacy|0|||
131882495|NCT04972968|474851236|FG003|Overall Study|Lack of Efficacy|0|||
131882496|NCT04972968|474851233|FG000|Overall Study|Withdrawal by Subject|7|||
131882497|NCT04972968|474851234|FG001|Overall Study|Withdrawal by Subject|4|||
131882498|NCT04972968|474851235|FG002|Overall Study|Withdrawal by Subject|3|||
131882499|NCT04972968|474851236|FG003|Overall Study|Withdrawal by Subject|2|||
131882500|NCT04972968|474851233|FG000|Overall Study|Study Terminated by Sponsor|25|||
131882501|NCT04972968|474851234|FG001|Overall Study|Study Terminated by Sponsor|28|||
131882502|NCT04972968|474851235|FG002|Overall Study|Study Terminated by Sponsor|32|||
131882503|NCT04972968|474851236|FG003|Overall Study|Study Terminated by Sponsor|27|||
131882504|NCT04972968|474851233|FG000|Overall Study|Other|1|||
131882505|NCT04972968|474851234|FG001|Overall Study|Other|0|||
131882506|NCT04972968|474851235|FG002|Overall Study|Other|1|||
131882507|NCT04972968|474851236|FG003|Overall Study|Other|1|||
131882508|NCT01698879|474851237|FG000|Overall Study|Withdrawal by Subject|1|||
131882509|NCT01698879|474851238|FG001|Overall Study|Withdrawal by Subject|0|||
131882510|NCT01698879|474851239|FG002|Overall Study|Withdrawal by Subject|0|||
131882511|NCT02419612|474851240|FG000|Short-term Treatment Period|Adverse Event|1|||
131882512|NCT02419612|474851241|FG001|Short-term Treatment Period|Adverse Event|1|||
131882513|NCT02419612|474851240|FG000|Short-term Treatment Period|Death|0|||
131882514|NCT02419612|474851241|FG001|Short-term Treatment Period|Death|2|||
131882515|NCT02419612|474851240|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
131477512|NCT01676727|473379489|FG000|Overall Study|Withdrawal by Subject|6|||
131477513|NCT01676727|473379489|FG000|Overall Study|Screening failure|5|||
131477514|NCT01676727|473379489|FG000|Overall Study|Not willing to attend 1-year visit|2|||
131477515|NCT01676727|473379489|FG000|Overall Study|Valve explanted|1|||
131477516|NCT01050543|473379490|FG000|Overall Study|Withdrawal by Subject|0|||
131477517|NCT01050543|473379491|FG001|Overall Study|Withdrawal by Subject|2|||
131477518|NCT01050543|473379490|FG000|Overall Study|Protocol Violation|0|||
131477519|NCT01050543|473379491|FG001|Overall Study|Protocol Violation|1|||
131477520|NCT01050543|473379490|FG000|Overall Study|Administrative|4|||
131477521|NCT01050543|473379491|FG001|Overall Study|Administrative|1|||
131477522|NCT03053271|473379492|FG000|Overall Study|Did not meet randomization criteria|3|||
131477523|NCT03053271|473379492|FG000|Overall Study|Withdrawal by Subject|1|||
131477524|NCT00580970|473379493|FG000|Pre-treatment|Non-compliance|1|||
131477525|NCT00580970|473379493|FG000|Treatment (Lovastatin)|Non-compliance|6|||
131882516|NCT02419612|474851241|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
131882517|NCT02419612|474851240|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
131882518|NCT02419612|474851241|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
131882519|NCT02419612|474851240|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
131882520|NCT02419612|474851241|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
131882521|NCT02419612|474851240|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
131477526|NCT00580970|473379493|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
131477527|NCT00580970|473379493|FG000|Treatment (Lovastatin)|Physician Decision|4|||
131477528|NCT00580970|473379493|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
131477529|NCT00580970|473379493|FG000|Treatment (Lovastatin)|Death|1|||
131477530|NCT00570765|473379494|FG000|DB Phase|Withdrawal by Subject|1|||
131477531|NCT00570765|473379495|FG001|DB Phase|Withdrawal by Subject|0|||
131477532|NCT00570765|473379496|FG002|DB Phase|Withdrawal by Subject|0|||
131477533|NCT00570765|473379497|FG003|DB Phase|Withdrawal by Subject|0|||
131882522|NCT02419612|474851241|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
131882523|NCT02419612|474851240|FG000|Short-term Treatment Period|Worsening of liver function|0|||
131882524|NCT02419612|474851241|FG001|Short-term Treatment Period|Worsening of liver function|1|||
131477534|NCT00570765|473379494|FG000|DB Phase|Protocol Violation|0|||
131477535|NCT00570765|473379495|FG001|DB Phase|Protocol Violation|1|||
131477536|NCT00570765|473379496|FG002|DB Phase|Protocol Violation|0|||
131477537|NCT00570765|473379497|FG003|DB Phase|Protocol Violation|0|||
131477538|NCT00570765|473379494|FG000|DB Phase|Adverse Event|3|||
131477539|NCT00570765|473379495|FG001|DB Phase|Adverse Event|6|||
131477540|NCT00570765|473379496|FG002|DB Phase|Adverse Event|0|||
131477541|NCT00570765|473379497|FG003|DB Phase|Adverse Event|0|||
131477542|NCT00570765|473379494|FG000|DB Phase|Did Not Receive Study Drug|0|||
131477543|NCT00570765|473379495|FG001|DB Phase|Did Not Receive Study Drug|0|||
131477544|NCT00570765|473379496|FG002|DB Phase|Did Not Receive Study Drug|1|||
131477545|NCT00570765|473379497|FG003|DB Phase|Did Not Receive Study Drug|0|||
131477546|NCT00570765|473379494|FG000|LTSE Phase|Withdrawal by Subject|0|||
131477547|NCT00570765|473379495|FG001|LTSE Phase|Withdrawal by Subject|0|||
131477548|NCT00570765|473379496|FG002|LTSE Phase|Withdrawal by Subject|0|||
131477549|NCT00570765|473379497|FG003|LTSE Phase|Withdrawal by Subject|1|||
131477550|NCT00570765|473379494|FG000|LTSE Phase|Adverse Event|0|||
131477551|NCT00570765|473379495|FG001|LTSE Phase|Adverse Event|0|||
131477552|NCT00570765|473379496|FG002|LTSE Phase|Adverse Event|0|||
131477553|NCT00570765|473379497|FG003|LTSE Phase|Adverse Event|7|||
131477554|NCT00570765|473379494|FG000|LTSE Phase|Physician Decision|0|||
131477555|NCT00570765|473379495|FG001|LTSE Phase|Physician Decision|0|||
131477556|NCT00570765|473379496|FG002|LTSE Phase|Physician Decision|0|||
131477557|NCT00570765|473379497|FG003|LTSE Phase|Physician Decision|4|||
131477558|NCT03711266|473379499|FG000|Overall Study|Lost to Follow-up|10|||
131477559|NCT00057876|473379500|FG000|Overall Study|Adverse Event|8|||
131477560|NCT00057876|473379501|FG001|Overall Study|Adverse Event|8|||
131477561|NCT00057876|473379500|FG000|Overall Study|Death|2|||
131477562|NCT00057876|473379501|FG001|Overall Study|Death|1|||
131477563|NCT00057876|473379500|FG000|Overall Study|Withdrawal by Subject|5|||
131477564|NCT00057876|473379501|FG001|Overall Study|Withdrawal by Subject|6|||
131477565|NCT00057876|473379500|FG000|Overall Study|Lack of Efficacy|10|||
131477566|NCT00057876|473379501|FG001|Overall Study|Lack of Efficacy|8|||
131477567|NCT00057876|473379500|FG000|Overall Study|Ineligible|1|||
131477568|NCT00057876|473379501|FG001|Overall Study|Ineligible|2|||
131477569|NCT00057876|473379500|FG000|Overall Study|other reason|2|||
131477570|NCT00057876|473379501|FG001|Overall Study|other reason|2|||
131477571|NCT00057876|473379500|FG000|Overall Study|other complicating disease|1|||
131477572|NCT00057876|473379501|FG001|Overall Study|other complicating disease|0|||
131477573|NCT00437320|473379504|FG000|Overall Study|Participant request|2|||
131477574|NCT00437320|473379505|FG001|Overall Study|Participant request|1|||
131477575|NCT00437320|473379506|FG002|Overall Study|Participant request|4|||
131477576|NCT01938573|473379507|FG000|Overall Study|Lack of Efficacy|1|||
131477577|NCT01938573|473379508|FG001|Overall Study|Lack of Efficacy|0|||
131477578|NCT01938573|473379507|FG000|Overall Study|Operation at other hospital|1|||
131477579|NCT01938573|473379508|FG001|Overall Study|Operation at other hospital|0|||
131477580|NCT01649804|473379517|FG000|Overall Study|Administrative/Other|8|||
131477581|NCT01199731|473379519|FG000|Overall Study|Adverse Event|0|||
131477582|NCT01199731|473379520|FG001|Overall Study|Adverse Event|1|||
131477583|NCT01199731|473379521|FG002|Overall Study|Adverse Event|0|||
131477584|NCT01199731|473379519|FG000|Overall Study|Study closed/terminated|7|||
131477585|NCT01199731|473379520|FG001|Overall Study|Study closed/terminated|9|||
131477586|NCT01199731|473379521|FG002|Overall Study|Study closed/terminated|7|||
131477587|NCT01199731|473379519|FG000|Overall Study|Lost to Follow-up|0|||
131477588|NCT01199731|473379520|FG001|Overall Study|Lost to Follow-up|0|||
131477589|NCT01199731|473379521|FG002|Overall Study|Lost to Follow-up|2|||
131477590|NCT01199731|473379519|FG000|Overall Study|Physician Decision|0|||
131477591|NCT01199731|473379520|FG001|Overall Study|Physician Decision|1|||
131477592|NCT01199731|473379521|FG002|Overall Study|Physician Decision|1|||
131477593|NCT01199731|473379519|FG000|Overall Study|Withdrawal by Subject|2|||
131882525|NCT02419612|474851240|FG000|Short-term Treatment Period|Subject moved out of state|0|||
131882526|NCT02419612|474851241|FG001|Short-term Treatment Period|Subject moved out of state|1|||
131882527|NCT02419612|474851240|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
131882528|NCT02419612|474851241|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
131477594|NCT01199731|473379520|FG001|Overall Study|Withdrawal by Subject|0|||
131477595|NCT01199731|473379521|FG002|Overall Study|Withdrawal by Subject|0|||
131477596|NCT02456103|473379522|FG000|Overall Study|Study Closure|207|||
131477597|NCT02456103|473379522|FG000|Overall Study|Physician Decision|1|||
131477598|NCT02456103|473379522|FG000|Overall Study|Required prohibited medications|5|||
131477599|NCT02456103|473379522|FG000|Overall Study|Protocol Violation|1|||
131477600|NCT02456103|473379522|FG000|Overall Study|Adverse Event|5|||
131477601|NCT02456103|473379522|FG000|Overall Study|Abnormal Laboratory Value|2|||
131477602|NCT02456103|473379522|FG000|Overall Study|Lost to Follow-up|1|||
131477603|NCT02456103|473379522|FG000|Overall Study|Withdrawal by Subject|24|||
131477604|NCT00943124|473379523|FG000|Period 1|Withdrawal by Subject|1|||
131477605|NCT00943124|473379524|FG001|Period 1|Withdrawal by Subject|1|||
131882529|NCT02419612|474851240|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
131882530|NCT02419612|474851241|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
131882531|NCT02419612|474851240|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
131882532|NCT02419612|474851241|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
131882533|NCT02419612|474851240|FG000|Long-term Treatment Period|Death|0|||
131882534|NCT02419612|474851241|FG001|Long-term Treatment Period|Death|1|||
131882535|NCT02419612|474851240|FG000|Long-term Treatment Period|Adverse Event|0|||
131882536|NCT02419612|474851241|FG001|Long-term Treatment Period|Adverse Event|5|||
131882537|NCT02419612|474851240|FG000|Long-term Treatment Period|Other|4|||
131882538|NCT02419612|474851241|FG001|Long-term Treatment Period|Other|4|||
131882539|NCT02419612|474851240|FG000|Long-term Treatment Period|Subject Decision|2|||
131882540|NCT02419612|474851241|FG001|Long-term Treatment Period|Subject Decision|4|||
131882541|NCT02419612|474851240|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
131882542|NCT02419612|474851241|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
131882543|NCT00474045|474851248|FG000|Overall Study|Adverse Event|18|||
131477606|NCT00943124|473379523|FG000|Period 1|Did Not Follow Study Procedures|1|||
131477607|NCT00943124|473379524|FG001|Period 1|Did Not Follow Study Procedures|0|||
131477608|NCT00943124|473379523|FG000|Period 1|Personal Reasons|0|||
131477609|NCT00943124|473379524|FG001|Period 1|Personal Reasons|1|||
131477610|NCT01912963|473379532|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
131882544|NCT00474045|474851249|FG001|Overall Study|Adverse Event|8|||
131882545|NCT00474045|474851248|FG000|Overall Study|Unclassified|1|||
131882546|NCT00474045|474851249|FG001|Overall Study|Unclassified|3|||
131882547|NCT00474045|474851248|FG000|Overall Study|Lack of Efficacy|0|||
131882548|NCT00474045|474851249|FG001|Overall Study|Lack of Efficacy|9|||
131882549|NCT00474045|474851248|FG000|Overall Study|Lost to Follow-up|1|||
131882550|NCT00474045|474851249|FG001|Overall Study|Lost to Follow-up|1|||
131882551|NCT00474045|474851248|FG000|Overall Study|Protocol Violation|10|||
131882552|NCT00474045|474851249|FG001|Overall Study|Protocol Violation|12|||
131882553|NCT00474045|474851248|FG000|Overall Study|Withdrawal by Subject|16|||
131882554|NCT00474045|474851249|FG001|Overall Study|Withdrawal by Subject|18|||
131882555|NCT00474045|474851248|FG000|Overall Study|Withdrawal criteria|60|||
131882556|NCT00474045|474851249|FG001|Overall Study|Withdrawal criteria|50|||
131477611|NCT01912963|473379533|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
131477612|NCT01912963|473379534|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
131477613|NCT01912963|473379532|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
131477614|NCT01912963|473379533|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
131477615|NCT01912963|473379534|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
131477616|NCT01912963|473379532|FG000|Overall Study|Adverse Event|0|||
131477617|NCT01912963|473379533|FG001|Overall Study|Adverse Event|1|||
131477618|NCT01912963|473379534|FG002|Overall Study|Adverse Event|1|||
131477619|NCT01912963|473379532|FG000|Overall Study|Withdrawal by Subject|0|||
131477620|NCT01912963|473379533|FG001|Overall Study|Withdrawal by Subject|1|||
131477621|NCT01912963|473379534|FG002|Overall Study|Withdrawal by Subject|0|||
131477622|NCT01912963|473379532|FG000|Overall Study|Sought treatment locally|0|||
131477623|NCT01912963|473379533|FG001|Overall Study|Sought treatment locally|1|||
131477624|NCT01912963|473379534|FG002|Overall Study|Sought treatment locally|0|||
131477625|NCT03112590|473379539|FG000|Overall Study|Adverse Event|0|||
131477626|NCT03112590|473379540|FG001|Overall Study|Adverse Event|1|||
131477627|NCT03112590|473379541|FG002|Overall Study|Adverse Event|0|||
131477628|NCT05156073|473379542|FG000|Overall Study|Patient canceled appointment with PCP|1|||
131477629|NCT02734433|473379543|FG000|Overall Study|Disease progression|1|||
131477630|NCT02734433|473379544|FG001|Overall Study|Disease progression|5|||
131477631|NCT02734433|473379543|FG000|Overall Study|Clinical progression|0|||
131477632|NCT02734433|473379544|FG001|Overall Study|Clinical progression|1|||
131477633|NCT02734433|473379543|FG000|Overall Study|Withdrawal by Subject|1|||
131477634|NCT02734433|473379544|FG001|Overall Study|Withdrawal by Subject|2|||
131477635|NCT03805646|473379545|FG000|Overall Study|Death|40|||
131477636|NCT03805646|473379546|FG001|Overall Study|Death|49|||
131477637|NCT03805646|473379545|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
131477638|NCT03805646|473379546|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
131477639|NCT00891462|473381197|FG000|Overall Study|Withdrawal by Subject|9|||
131477640|NCT00891462|473381198|FG001|Overall Study|Withdrawal by Subject|6|||
131477641|NCT00891462|473381199|FG002|Overall Study|Withdrawal by Subject|7|||
131477642|NCT00891462|473381197|FG000|Overall Study|Adverse Event|7|||
131477643|NCT00891462|473381198|FG001|Overall Study|Adverse Event|8|||
131477644|NCT00891462|473381199|FG002|Overall Study|Adverse Event|7|||
131477645|NCT00891462|473381197|FG000|Overall Study|Lack of Efficacy|10|||
131477646|NCT00891462|473381198|FG001|Overall Study|Lack of Efficacy|5|||
131477647|NCT00891462|473381199|FG002|Overall Study|Lack of Efficacy|1|||
131477648|NCT00891462|473381197|FG000|Overall Study|COPD exacerbation|7|||
131477649|NCT00891462|473381198|FG001|Overall Study|COPD exacerbation|4|||
131477650|NCT00891462|473381199|FG002|Overall Study|COPD exacerbation|1|||
131882557|NCT02278120|474851252|FG000|Treatment Period|Progressive disease|234|||
131882558|NCT02278120|474851253|FG001|Treatment Period|Progressive disease|260|||
131882559|NCT02278120|474851252|FG000|Treatment Period|Subject/guardian decision|23|||
131882560|NCT02278120|474851253|FG001|Treatment Period|Subject/guardian decision|20|||
131477651|NCT00891462|473381197|FG000|Overall Study|Other Reason|2|||
131477652|NCT00891462|473381198|FG001|Overall Study|Other Reason|5|||
131477653|NCT00891462|473381199|FG002|Overall Study|Other Reason|3|||
131477654|NCT00891462|473381197|FG000|Overall Study|Protocol Violation|2|||
131477655|NCT00891462|473381198|FG001|Overall Study|Protocol Violation|1|||
131477656|NCT00891462|473381199|FG002|Overall Study|Protocol Violation|3|||
131477657|NCT00891462|473381197|FG000|Overall Study|Inclusion/exclusion criteria|0|||
131477658|NCT00891462|473381198|FG001|Overall Study|Inclusion/exclusion criteria|2|||
131477659|NCT00891462|473381199|FG002|Overall Study|Inclusion/exclusion criteria|2|||
131477660|NCT00891462|473381197|FG000|Overall Study|Lost to Follow-up|0|||
131477661|NCT00891462|473381198|FG001|Overall Study|Lost to Follow-up|2|||
131477662|NCT00891462|473381199|FG002|Overall Study|Lost to Follow-up|0|||
131477663|NCT00257608|473381202|FG000|Chemotherapy Phase|Adverse Event|138|||
131477664|NCT00257608|473381203|FG001|Chemotherapy Phase|Adverse Event|0|||
131477665|NCT00257608|473381204|FG002|Chemotherapy Phase|Adverse Event|0|||
131477666|NCT00257608|473381202|FG000|Chemotherapy Phase|Disease progression|139|||
131882561|NCT02278120|474851252|FG000|Treatment Period|Adverse Event|16|||
131882562|NCT02278120|474851253|FG001|Treatment Period|Adverse Event|14|||
131882563|NCT02278120|474851252|FG000|Treatment Period|Physician Decision|14|||
131882564|NCT02278120|474851253|FG001|Treatment Period|Physician Decision|27|||
131882565|NCT02278120|474851252|FG000|Treatment Period|Death|3|||
131882566|NCT02278120|474851253|FG001|Treatment Period|Death|3|||
131882567|NCT02278120|474851252|FG000|Treatment Period|Lost to Follow-up|2|||
131882568|NCT02278120|474851253|FG001|Treatment Period|Lost to Follow-up|0|||
131882569|NCT02278120|474851252|FG000|Treatment Period|Protocol deviation|0|||
131882570|NCT02278120|474851253|FG001|Treatment Period|Protocol deviation|2|||
131882571|NCT02278120|474851252|FG000|Treatment Period|Study terminated as per protocol|43|||
131882572|NCT02278120|474851253|FG001|Treatment Period|Study terminated as per protocol|11|||
131882573|NCT02278120|474851252|FG000|Post-treatment Efficacy Follow-up|Death|0|||
131882574|NCT02278120|474851253|FG001|Post-treatment Efficacy Follow-up|Death|1|||
131882575|NCT02278120|474851252|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
131882576|NCT02278120|474851253|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
131882577|NCT02278120|474851252|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
131477667|NCT00257608|473381203|FG001|Chemotherapy Phase|Disease progression|0|||
131477668|NCT00257608|473381204|FG002|Chemotherapy Phase|Disease progression|0|||
131477669|NCT00257608|473381202|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
131882578|NCT02278120|474851253|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
131882579|NCT02278120|474851252|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
131882580|NCT02278120|474851253|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
131882581|NCT02278120|474851252|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131882582|NCT02278120|474851253|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131882583|NCT01966068|474851257|FG000|Overall Study|Withdrawal by Subject|57|||
131882584|NCT01966068|474851257|FG000|Overall Study|Lost to Follow-up|81|||
131882585|NCT00808639|474851258|FG000|Overall Study|Disease progression before surgery.|1|||
131882586|NCT00102531|474851259|FG000|Overall Study|Adverse Event|0|||
131882587|NCT00102531|474851260|FG001|Overall Study|Adverse Event|1|||
131882588|NCT00102531|474851259|FG000|Overall Study|Disease Progression|5|||
131882589|NCT00102531|474851260|FG001|Overall Study|Disease Progression|9|||
131882590|NCT00102531|474851259|FG000|Overall Study|Physician Decision|0|||
131882591|NCT00102531|474851260|FG001|Overall Study|Physician Decision|1|||
131882592|NCT00514904|474851264|FG000|Overall Study|Withdrawal by Subject|3|||
131882593|NCT00514904|474851265|FG001|Overall Study|Withdrawal by Subject|2|||
131882594|NCT00514904|474851264|FG000|Overall Study|Lost to Follow-up|21|||
131882595|NCT00514904|474851265|FG001|Overall Study|Lost to Follow-up|3|||
131882596|NCT03026530|474851267|FG000|Overall Study|Lost to Follow-up|19|||
131882597|NCT03026530|474851268|FG001|Overall Study|Lost to Follow-up|24|||
131882598|NCT03026530|474851267|FG000|Overall Study|Protocol Violation|2|||
131882599|NCT03026530|474851268|FG001|Overall Study|Protocol Violation|5|||
131477670|NCT00257608|473381203|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
131477671|NCT00257608|473381204|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
131477672|NCT00257608|473381202|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
131477673|NCT00257608|473381203|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
131477674|NCT00257608|473381204|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
131477675|NCT00257608|473381202|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
131477676|NCT00257608|473381203|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
131477677|NCT00257608|473381204|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
131477678|NCT00257608|473381202|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
131477679|NCT00257608|473381203|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
131477680|NCT00257608|473381204|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
131477681|NCT00257608|473381202|FG000|Chemotherapy Phase|Physician Decision|28|||
131477682|NCT00257608|473381203|FG001|Chemotherapy Phase|Physician Decision|0|||
131477683|NCT00257608|473381204|FG002|Chemotherapy Phase|Physician Decision|0|||
131477684|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Adverse Event|0|||
131477685|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Adverse Event|34|||
131477686|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Adverse Event|38|||
131477687|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Disease progression|0|||
131477688|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Disease progression|204|||
131477689|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Disease progression|168|||
131477690|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
131477691|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
131477692|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
131477693|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
131477694|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
131477695|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
131477696|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
131477697|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
131477698|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
131477699|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
131477700|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
131477701|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
131477702|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
131477703|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
131477704|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
131477705|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Physician Decision|0|||
131477706|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Physician Decision|8|||
131477707|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Physician Decision|11|||
131477708|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
131477709|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
131477710|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
131477711|NCT00257608|473381202|FG000|Post Chemotherapy Phase|Not treated|0|||
131477712|NCT00257608|473381203|FG001|Post Chemotherapy Phase|Not treated|4|||
131477713|NCT00257608|473381204|FG002|Post Chemotherapy Phase|Not treated|7|||
131477714|NCT02171065|473381205|FG000|Overall Study|Withdrawal by Subject|1|||
131477715|NCT02171065|473381206|FG001|Overall Study|Withdrawal by Subject|0|||
131477716|NCT02171065|473381207|FG002|Overall Study|Withdrawal by Subject|0|||
131477717|NCT02171065|473381205|FG000|Overall Study|Lost to Follow-up|0|||
131477718|NCT02171065|473381206|FG001|Overall Study|Lost to Follow-up|0|||
131477719|NCT02171065|473381207|FG002|Overall Study|Lost to Follow-up|1|||
131477720|NCT01920555|473381212|FG000|Overall Study|Physician Decision|1|||
131477721|NCT01920555|473381213|FG001|Overall Study|Physician Decision|2|||
131477722|NCT01920555|473381214|FG002|Overall Study|Physician Decision|1|||
131477723|NCT01920555|473381215|FG003|Overall Study|Physician Decision|2|||
131477724|NCT01920555|473381216|FG004|Overall Study|Physician Decision|0|||
131477725|NCT01920555|473381212|FG000|Overall Study|Lack of Efficacy|2|||
131477726|NCT01920555|473381213|FG001|Overall Study|Lack of Efficacy|0|||
131477727|NCT01920555|473381214|FG002|Overall Study|Lack of Efficacy|0|||
131477728|NCT01920555|473381215|FG003|Overall Study|Lack of Efficacy|0|||
131477729|NCT01920555|473381216|FG004|Overall Study|Lack of Efficacy|0|||
131477730|NCT01920555|473381212|FG000|Overall Study|Travel Difficulties|1|||
131477731|NCT01920555|473381213|FG001|Overall Study|Travel Difficulties|1|||
131477732|NCT01920555|473381214|FG002|Overall Study|Travel Difficulties|0|||
131477733|NCT01920555|473381215|FG003|Overall Study|Travel Difficulties|0|||
131477734|NCT01920555|473381216|FG004|Overall Study|Travel Difficulties|1|||
131477735|NCT01920555|473381212|FG000|Overall Study|Lost to Follow-up|0|||
131477736|NCT01920555|473381213|FG001|Overall Study|Lost to Follow-up|1|||
131477737|NCT01920555|473381214|FG002|Overall Study|Lost to Follow-up|0|||
131477738|NCT01920555|473381215|FG003|Overall Study|Lost to Follow-up|1|||
131477739|NCT01920555|473381216|FG004|Overall Study|Lost to Follow-up|0|||
131477740|NCT03265665|473381217|FG000|24-week Data Collection|Withdrawal by Subject|2|||
131477741|NCT03265665|473381218|FG001|24-week Data Collection|Withdrawal by Subject|2|||
131477742|NCT03265665|473381217|FG000|24-week Data Collection|Lost to Follow-up|4|||
131477743|NCT03265665|473381218|FG001|24-week Data Collection|Lost to Follow-up|5|||
131477744|NCT03265665|473381217|FG000|36-week Data Collection|Lost to Follow-up|6|||
131477745|NCT03265665|473381218|FG001|36-week Data Collection|Lost to Follow-up|8|||
131477746|NCT02572388|473381219|FG000|Overall Study|Withdrawal by Subject|1|||
131477747|NCT02572388|473381220|FG001|Overall Study|Withdrawal by Subject|1|||
131477748|NCT02572388|473381221|FG002|Overall Study|Withdrawal by Subject|2|||
131477749|NCT02572388|473381222|FG003|Overall Study|Withdrawal by Subject|2|||
131477750|NCT01973569|473381226|FG000|Overall Study|Adverse Event|9|||
131477751|NCT01973569|473381227|FG001|Overall Study|Adverse Event|2|||
131477752|NCT01973569|473381228|FG002|Overall Study|Adverse Event|4|||
131477753|NCT01973569|473381226|FG000|Overall Study|Protocol Violation|2|||
131477754|NCT01973569|473381227|FG001|Overall Study|Protocol Violation|1|||
131477755|NCT01973569|473381228|FG002|Overall Study|Protocol Violation|3|||
131477756|NCT01973569|473381226|FG000|Overall Study|Withdrawal by Subject|7|||
131477757|NCT01973569|473381227|FG001|Overall Study|Withdrawal by Subject|5|||
131477758|NCT01973569|473381228|FG002|Overall Study|Withdrawal by Subject|2|||
131477759|NCT01973569|473381226|FG000|Overall Study|Invasive dental treatment|3|||
131477760|NCT01973569|473381227|FG001|Overall Study|Invasive dental treatment|5|||
131477761|NCT01973569|473381228|FG002|Overall Study|Invasive dental treatment|6|||
131477762|NCT01973569|473381226|FG000|Overall Study|Prohibited concomitant d|1|||
131477763|NCT01973569|473381227|FG001|Overall Study|Prohibited concomitant d|5|||
131477764|NCT01973569|473381228|FG002|Overall Study|Prohibited concomitant d|0|||
131477765|NCT01973569|473381226|FG000|Overall Study|Disease progression|0|||
131477766|NCT01973569|473381227|FG001|Overall Study|Disease progression|3|||
131477767|NCT01973569|473381228|FG002|Overall Study|Disease progression|0|||
131477768|NCT01973569|473381226|FG000|Overall Study|Other|1|||
131477769|NCT01973569|473381227|FG001|Overall Study|Other|1|||
131477770|NCT01973569|473381228|FG002|Overall Study|Other|0|||
131477771|NCT01973569|473381226|FG000|Overall Study|Did not receive study drug|6|||
131477772|NCT01973569|473381227|FG001|Overall Study|Did not receive study drug|3|||
131477773|NCT01973569|473381228|FG002|Overall Study|Did not receive study drug|3|||
131477774|NCT00137631|473381234|FG000|Overall Study|Lost to Follow-up|37|||
131477775|NCT00137631|473381235|FG001|Overall Study|Lost to Follow-up|41|||
131477776|NCT02486302|473381237|FG000|Overall Study|Discontinued prematurely|410|||
131477777|NCT02486302|473381237|FG000|Overall Study|Documentation not completed|255|||
131477778|NCT02486302|473381237|FG000|Overall Study|Excluded due to legal reasons|8|||
131477779|NCT02486302|473381237|FG000|Overall Study|Not treated|3|||
131477780|NCT01871142|473381238|FG000|Overall Study|Adverse Event|1|||
131477781|NCT00598702|473381247|FG000|Overall Study|Other|0|||
131477782|NCT00598702|473381248|FG001|Overall Study|Other|2|||
131477783|NCT00598702|473381249|FG002|Overall Study|Other|0|||
131477784|NCT00598702|473381250|FG003|Overall Study|Other|0|||
131477785|NCT00598702|473381251|FG004|Overall Study|Other|0|||
131477786|NCT00598702|473381252|FG005|Overall Study|Other|1|||
131477787|NCT00598702|473381253|FG006|Overall Study|Other|0|||
131477788|NCT00598702|473381254|FG007|Overall Study|Other|0|||
131477789|NCT00598702|473381247|FG000|Overall Study|Early discharge from hospital|0|||
131477790|NCT00598702|473381248|FG001|Overall Study|Early discharge from hospital|0|||
131477791|NCT00598702|473381249|FG002|Overall Study|Early discharge from hospital|2|||
131477792|NCT00598702|473381250|FG003|Overall Study|Early discharge from hospital|5|||
131477793|NCT00598702|473381251|FG004|Overall Study|Early discharge from hospital|0|||
131477794|NCT00598702|473381252|FG005|Overall Study|Early discharge from hospital|10|||
131477795|NCT00598702|473381253|FG006|Overall Study|Early discharge from hospital|1|||
131477796|NCT00598702|473381254|FG007|Overall Study|Early discharge from hospital|0|||
131477797|NCT00598702|473381247|FG000|Overall Study|Adverse Event|0|||
131477798|NCT00598702|473381248|FG001|Overall Study|Adverse Event|0|||
131477799|NCT00598702|473381249|FG002|Overall Study|Adverse Event|0|||
131477800|NCT00598702|473381250|FG003|Overall Study|Adverse Event|1|||
131477801|NCT00598702|473381251|FG004|Overall Study|Adverse Event|0|||
131477802|NCT00598702|473381252|FG005|Overall Study|Adverse Event|0|||
131477803|NCT00598702|473381253|FG006|Overall Study|Adverse Event|0|||
131477804|NCT00598702|473381254|FG007|Overall Study|Adverse Event|0|||
131477805|NCT00598702|473381247|FG000|Overall Study|Withdrawal by Subject|0|||
131477806|NCT00598702|473381248|FG001|Overall Study|Withdrawal by Subject|0|||
131477807|NCT00598702|473381249|FG002|Overall Study|Withdrawal by Subject|0|||
131477808|NCT00598702|473381250|FG003|Overall Study|Withdrawal by Subject|1|||
131477809|NCT00598702|473381251|FG004|Overall Study|Withdrawal by Subject|1|||
131477810|NCT00598702|473381252|FG005|Overall Study|Withdrawal by Subject|0|||
131477811|NCT00598702|473381253|FG006|Overall Study|Withdrawal by Subject|0|||
131477812|NCT00598702|473381254|FG007|Overall Study|Withdrawal by Subject|0|||
131477813|NCT00598702|473381247|FG000|Overall Study|Physician Decision|0|||
131477814|NCT00598702|473381248|FG001|Overall Study|Physician Decision|0|||
131477815|NCT00598702|473381249|FG002|Overall Study|Physician Decision|0|||
131477816|NCT00598702|473381250|FG003|Overall Study|Physician Decision|0|||
131477817|NCT00598702|473381251|FG004|Overall Study|Physician Decision|1|||
131477818|NCT00598702|473381252|FG005|Overall Study|Physician Decision|0|||
131477819|NCT00598702|473381253|FG006|Overall Study|Physician Decision|0|||
131477820|NCT00598702|473381254|FG007|Overall Study|Physician Decision|0|||
131477821|NCT00598702|473381247|FG000|Overall Study|Dose limiting toxicity|0|||
131477822|NCT00598702|473381248|FG001|Overall Study|Dose limiting toxicity|0|||
131477823|NCT00598702|473381249|FG002|Overall Study|Dose limiting toxicity|0|||
131477824|NCT00598702|473381250|FG003|Overall Study|Dose limiting toxicity|1|||
131477825|NCT00598702|473381251|FG004|Overall Study|Dose limiting toxicity|1|||
131477826|NCT00598702|473381252|FG005|Overall Study|Dose limiting toxicity|1|||
131477827|NCT00598702|473381253|FG006|Overall Study|Dose limiting toxicity|0|||
131477828|NCT00598702|473381254|FG007|Overall Study|Dose limiting toxicity|0|||
131477829|NCT01675427|473381257|FG000|Overall Study|Withdrawal by Subject|7|||
131477830|NCT01675427|473381257|FG000|Overall Study|Participant Refused Sample Collection|18|||
131477831|NCT01675427|473381257|FG000|Overall Study|Sample not Collected by Mistake|2|||
131477832|NCT01675427|473381257|FG000|Overall Study|Lost to Follow-up|5|||
131477833|NCT01675427|473381257|FG000|Overall Study|Other|2|||
131477834|NCT00700570|473381258|FG000|Overall Study|Adverse Event|2|||
131477835|NCT00700570|473381259|FG001|Overall Study|Adverse Event|6|||
131477836|NCT00700570|473381258|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
131477837|NCT00700570|473381259|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
131477838|NCT00700570|473381258|FG000|Overall Study|Disease Progression|8|||
131477839|NCT00700570|473381259|FG001|Overall Study|Disease Progression|11|||
131477840|NCT00700570|473381258|FG000|Overall Study|Withdrawal by Subject|1|||
131477841|NCT00700570|473381259|FG001|Overall Study|Withdrawal by Subject|6|||
131477842|NCT00611533|473381260|FG000|First Intervention (6 Weeks)|Never started study|0|||
131477843|NCT00611533|473381261|FG001|First Intervention (6 Weeks)|Never started study|1|||
131477844|NCT00611533|473381260|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
131477845|NCT00611533|473381261|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
131477846|NCT00611533|473381260|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
131477847|NCT00611533|473381261|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
131477848|NCT04327674|473381266|FG000|Overall Study|Protocol Violation|19|||
131477849|NCT05447897|473381267|FG000|Overall Study|Did not participate in survey|2|||
131477850|NCT02028871|473381270|FG000|Overall Study|Positive urine drug screen|1|||
131477851|NCT02028871|473381271|FG001|Overall Study|Positive urine drug screen|1|||
131477852|NCT02028871|473381270|FG000|Overall Study|Withdrawal by Subject|1|||
131477853|NCT02028871|473381271|FG001|Overall Study|Withdrawal by Subject|2|||
131477854|NCT02028871|473381270|FG000|Overall Study|IV placement difficulty|1|||
131477855|NCT02028871|473381271|FG001|Overall Study|IV placement difficulty|0|||
131477856|NCT02028871|473381270|FG000|Overall Study|Current Illness|1|||
131477857|NCT02028871|473381271|FG001|Overall Study|Current Illness|0|||
131477858|NCT01916967|473381277|FG000|Overall Study|Adverse Event|0|||
131477859|NCT01916967|473381278|FG001|Overall Study|Adverse Event|0|||
131477860|NCT01916967|473381279|FG002|Overall Study|Adverse Event|2|||
131477861|NCT01916967|473381277|FG000|Overall Study|Lack of Efficacy|0|||
131477862|NCT01916967|473381278|FG001|Overall Study|Lack of Efficacy|0|||
131477863|NCT01916967|473381279|FG002|Overall Study|Lack of Efficacy|6|||
131477864|NCT01916967|473381277|FG000|Overall Study|Physician Decision|0|||
131477865|NCT01916967|473381278|FG001|Overall Study|Physician Decision|0|||
131477866|NCT01916967|473381279|FG002|Overall Study|Physician Decision|1|||
131477867|NCT01916967|473381277|FG000|Overall Study|Protocol Violation|0|||
131477868|NCT01916967|473381278|FG001|Overall Study|Protocol Violation|1|||
131477869|NCT01916967|473381279|FG002|Overall Study|Protocol Violation|0|||
131477870|NCT01104155|473381280|FG000|Overall Study|Adverse Event|15|||
131477871|NCT01104155|473381281|FG001|Overall Study|Adverse Event|8|||
131477872|NCT01104155|473381280|FG000|Overall Study|Participant choice|6|||
131477873|NCT01104155|473381281|FG001|Overall Study|Participant choice|5|||
131477874|NCT01104155|473381280|FG000|Overall Study|Withdrawal of consent|1|||
131477875|NCT01104155|473381281|FG001|Overall Study|Withdrawal of consent|1|||
131477876|NCT01104155|473381280|FG000|Overall Study|Other|3|||
131477877|NCT01104155|473381281|FG001|Overall Study|Other|4|||
131477878|NCT01484132|473381287|FG000|Overall Study|Lost to Follow-up|8|||
131477879|NCT01484132|473381287|FG000|Overall Study|Difficulty with time commitment|2|||
131477880|NCT01484132|473381287|FG000|Overall Study|Ineligible|1|||
131477881|NCT01484132|473381287|FG000|Overall Study|No pre-treatment urine sample collected|1|||
131477882|NCT01484132|473381287|FG000|Overall Study|No post-treatment urine sample collected|10|||
131477883|NCT00568685|473381288|FG000|Overall Study|Adverse Event|2|||
131477884|NCT00568685|473381289|FG001|Overall Study|Adverse Event|3|||
131477885|NCT00568685|473381290|FG002|Overall Study|Adverse Event|3|||
131477886|NCT00568685|473381288|FG000|Overall Study|Withdrawal by Subject|7|||
131477887|NCT00568685|473381289|FG001|Overall Study|Withdrawal by Subject|2|||
131477888|NCT00568685|473381290|FG002|Overall Study|Withdrawal by Subject|2|||
131477889|NCT00568685|473381288|FG000|Overall Study|Protocol Violation|1|||
131477890|NCT00568685|473381289|FG001|Overall Study|Protocol Violation|0|||
131477891|NCT00568685|473381290|FG002|Overall Study|Protocol Violation|0|||
131477892|NCT02038452|473381291|FG000|Overall Study|Withdrawal by Subject|7|||
131477893|NCT02038452|473381292|FG001|Overall Study|Withdrawal by Subject|9|||
131477894|NCT02038452|473381291|FG000|Overall Study|Lost to Follow-up|31|||
131477895|NCT02038452|473381292|FG001|Overall Study|Lost to Follow-up|28|||
131477896|NCT01090973|473381297|FG000|Overall Study|Disease progression|1|||
131477897|NCT01626495|473381299|FG000|Overall Study|Adverse Event|3|||
131477898|NCT01626495|473381299|FG000|Overall Study|Disease progression|27|||
131477899|NCT01626495|473381299|FG000|Overall Study|Withdrawal by Subject|1|||
131477900|NCT01626495|473381299|FG000|Overall Study|Administrative problem|1|||
131477901|NCT01626495|473381299|FG000|Overall Study|Death|2|||
131477902|NCT01626495|473381299|FG000|Overall Study|Physician Decision|1|||
131477903|NCT01626495|473381299|FG000|Overall Study|New cancer therapy|16|||
131477904|NCT01626495|473381299|FG000|Overall Study|Manufacturing failure|1|||
131477905|NCT01934972|473381300|FG000|Overall Study|Withdrawal by Subject|9|||
131477906|NCT01934972|473381301|FG001|Overall Study|Withdrawal by Subject|6|||
131477907|NCT03131453|473381302|FG000|Overall Study|Study terminated by Sponsor|424|||
131477908|NCT03131453|473381303|FG001|Overall Study|Study terminated by Sponsor|222|||
131477909|NCT03131453|473381304|FG002|Overall Study|Study terminated by Sponsor|438|||
131477910|NCT03131453|473381302|FG000|Overall Study|Withdrawal by Subject|18|||
131477911|NCT03131453|473381303|FG001|Overall Study|Withdrawal by Subject|7|||
131477912|NCT03131453|473381304|FG002|Overall Study|Withdrawal by Subject|13|||
131477913|NCT03131453|473381302|FG000|Overall Study|Adverse Event|10|||
131477914|NCT03131453|473381303|FG001|Overall Study|Adverse Event|3|||
131477915|NCT03131453|473381304|FG002|Overall Study|Adverse Event|3|||
131477916|NCT03131453|473381302|FG000|Overall Study|Lost to Follow-up|1|||
131477917|NCT03131453|473381303|FG001|Overall Study|Lost to Follow-up|0|||
131477918|NCT03131453|473381304|FG002|Overall Study|Lost to Follow-up|1|||
131477919|NCT03131453|473381302|FG000|Overall Study|Physician Decision|1|||
131477920|NCT03131453|473381303|FG001|Overall Study|Physician Decision|0|||
131477921|NCT03131453|473381304|FG002|Overall Study|Physician Decision|1|||
131477922|NCT03131453|473381302|FG000|Overall Study|Non-compliance with study treatment|1|||
131477923|NCT03131453|473381303|FG001|Overall Study|Non-compliance with study treatment|0|||
131477924|NCT03131453|473381304|FG002|Overall Study|Non-compliance with study treatment|0|||
131477925|NCT03131453|473381302|FG000|Overall Study|Technical problems|1|||
131477926|NCT03131453|473381303|FG001|Overall Study|Technical problems|0|||
131477927|NCT03131453|473381304|FG002|Overall Study|Technical problems|0|||
131477928|NCT03131453|473381302|FG000|Overall Study|Protocol deviation|0|||
131477929|NCT03131453|473381303|FG001|Overall Study|Protocol deviation|1|||
131477930|NCT03131453|473381304|FG002|Overall Study|Protocol deviation|0|||
131477931|NCT00445978|473381307|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
131477932|NCT00445978|473381307|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
131477933|NCT00445978|473381307|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
131477934|NCT00445978|473381307|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
131477935|NCT00445978|473381307|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
131477936|NCT00445978|473381307|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
131477937|NCT00445978|473381307|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
131477938|NCT00445978|473381307|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
131477939|NCT00445978|473381307|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
131477940|NCT01822496|473381310|FG000|Overall Study|Protocol Violation|2|||
131477941|NCT01822496|473381311|FG001|Overall Study|Protocol Violation|2|||
131477942|NCT01822496|473381312|FG002|Overall Study|Protocol Violation|0|||
131477943|NCT01822496|473381313|FG003|Overall Study|Protocol Violation|1|||
131477944|NCT01822496|473381310|FG000|Overall Study|Withdrawal by Subject|0|||
131477945|NCT01822496|473381311|FG001|Overall Study|Withdrawal by Subject|0|||
131477946|NCT01822496|473381312|FG002|Overall Study|Withdrawal by Subject|0|||
131477947|NCT01822496|473381313|FG003|Overall Study|Withdrawal by Subject|3|||
131477948|NCT00304239|473381314|FG000|Overall Study|Protocol Deviations/Violations|15|||
131477949|NCT00304239|473381315|FG001|Overall Study|Protocol Deviations/Violations|0|||
131477950|NCT00304239|473381314|FG000|Overall Study|Adverse Event|2|||
131477951|NCT00304239|473381315|FG001|Overall Study|Adverse Event|0|||
131477952|NCT02979197|473381316|FG000|Overall Study|Adverse Event|4|||
131477953|NCT02979197|473381317|FG001|Overall Study|Adverse Event|2|||
131477954|NCT02979197|473381318|FG002|Overall Study|Adverse Event|0|||
131477955|NCT02979197|473381316|FG000|Overall Study|Protocol Violation|0|||
131477956|NCT02979197|473381317|FG001|Overall Study|Protocol Violation|1|||
131477957|NCT02979197|473381318|FG002|Overall Study|Protocol Violation|0|||
131477958|NCT02979197|473381316|FG000|Overall Study|Subject unable to commit to study dates|0|||
131477959|NCT02979197|473381317|FG001|Overall Study|Subject unable to commit to study dates|1|||
131477960|NCT02979197|473381318|FG002|Overall Study|Subject unable to commit to study dates|0|||
131477961|NCT03643159|473381319|FG000|Overall Study|Adverse Event|1|||
131477962|NCT03643159|473381319|FG000|Overall Study|Withdrawal by Subject|1|||
131477963|NCT03438383|473381320|FG000|Overall Study|Protocol Violation|9|||
131477964|NCT03438383|473381321|FG001|Overall Study|Protocol Violation|3|||
131477965|NCT02766465|473381322|FG000|Overall Study|Withdrawal by Subject|0|||
131477966|NCT02766465|473381323|FG001|Overall Study|Withdrawal by Subject|10|||
131477967|NCT01631812|473381324|FG000|Overall Study|Adverse Event|25|||
131477968|NCT01631812|473381324|FG000|Overall Study|Lack of Efficacy|5|||
131477969|NCT01631812|473381324|FG000|Overall Study|Withdrawal by Subject|4|||
131477970|NCT01631812|473381324|FG000|Overall Study|Physician Decision|3|||
131477971|NCT02435069|473381325|FG000|Dose Response - First Intervention|Adverse Event|0|||
131477972|NCT02435069|473381326|FG001|Dose Response - First Intervention|Adverse Event|1|||
131477973|NCT02435069|473381327|FG002|Dose Response - First Intervention|Adverse Event|1|||
131477974|NCT02435069|473381328|FG003|Dose Response - First Intervention|Adverse Event|0|||
131477975|NCT02435069|473381329|FG004|Dose Response - First Intervention|Adverse Event|0|||
131477976|NCT02435069|473381325|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
131477977|NCT02435069|473381326|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
131477978|NCT02435069|473381327|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
131477979|NCT02435069|473381328|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
131477980|NCT02435069|473381329|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
131477981|NCT01528033|473381330|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
131477982|NCT01528033|473381331|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
131477983|NCT01528033|473381330|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
131477984|NCT01528033|473381331|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
131477985|NCT01528033|473381330|FG000|Primary Endpoint Assessment ITT|Death|2|||
131477986|NCT01528033|473381331|FG001|Primary Endpoint Assessment ITT|Death|2|||
131477987|NCT01528033|473381330|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
131477988|NCT01528033|473381331|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
131477989|NCT01528033|473381330|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
131477990|NCT01528033|473381331|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
131477991|NCT01528033|473381330|FG000|Follow Up|No data available|46|||
131477992|NCT01528033|473381331|FG001|Follow Up|No data available|44|||
131477993|NCT03387683|473382703|FG000|Overall Study|In receipt of disallowed medication|1|||
131477994|NCT03387683|473382704|FG001|Overall Study|In receipt of disallowed medication|0|||
131477995|NCT03387683|473382703|FG000|Overall Study|Did not receive treatment|1|||
131477996|NCT03387683|473382704|FG001|Overall Study|Did not receive treatment|0|||
131477997|NCT01954342|473382705|FG000|Overall Study|Missing data from 13-16week study visit|0|||
131477998|NCT01954342|473382706|FG001|Overall Study|Missing data from 13-16week study visit|0|||
131477999|NCT01954342|473382707|FG002|Overall Study|Missing data from 13-16week study visit|0|||
131478000|NCT01954342|473382708|FG003|Overall Study|Missing data from 13-16week study visit|1|||
131478001|NCT01954342|473382705|FG000|Overall Study|Miscarriage|0|||
131478002|NCT01954342|473382706|FG001|Overall Study|Miscarriage|0|||
131478003|NCT01954342|473382707|FG002|Overall Study|Miscarriage|0|||
131478004|NCT01954342|473382708|FG003|Overall Study|Miscarriage|3|||
131478005|NCT01954342|473382705|FG000|Overall Study|Lost to Follow-up|0|||
131478006|NCT01954342|473382706|FG001|Overall Study|Lost to Follow-up|0|||
131478007|NCT01954342|473382707|FG002|Overall Study|Lost to Follow-up|0|||
131478008|NCT01954342|473382708|FG003|Overall Study|Lost to Follow-up|5|||
131478009|NCT01954342|473382705|FG000|Overall Study|Preterm delivery|0|||
131478010|NCT01954342|473382706|FG001|Overall Study|Preterm delivery|0|||
131478011|NCT01954342|473382707|FG002|Overall Study|Preterm delivery|0|||
131478012|NCT01954342|473382708|FG003|Overall Study|Preterm delivery|3|||
131478013|NCT01954342|473382705|FG000|Overall Study|Pre-eclampsia|0|||
131478014|NCT01954342|473382706|FG001|Overall Study|Pre-eclampsia|0|||
131478015|NCT01954342|473382707|FG002|Overall Study|Pre-eclampsia|0|||
131478016|NCT01954342|473382708|FG003|Overall Study|Pre-eclampsia|4|||
131478017|NCT01954342|473382705|FG000|Overall Study|Unreliable Data|0|||
131478018|NCT01954342|473382706|FG001|Overall Study|Unreliable Data|0|||
131478019|NCT01954342|473382707|FG002|Overall Study|Unreliable Data|0|||
131478020|NCT01954342|473382708|FG003|Overall Study|Unreliable Data|2|||
131478021|NCT01646073|473382709|FG000|Period A (12 Weeks)|Adverse Event|0|||
131478022|NCT01646073|473382710|FG001|Period A (12 Weeks)|Adverse Event|2|||
131478023|NCT01646073|473382709|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
131478024|NCT01646073|473382710|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
131478025|NCT01646073|473382709|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
131478026|NCT01646073|473382710|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
131478027|NCT01646073|473382709|FG000|Period A (12 Weeks)|Protocol Violation|0|||
131478028|NCT01646073|473382710|FG001|Period A (12 Weeks)|Protocol Violation|1|||
131478029|NCT01646073|473382709|FG000|Period A (12 Weeks)|Other|0|||
131478030|NCT01646073|473382710|FG001|Period A (12 Weeks)|Other|1|||
131478031|NCT01646073|473382709|FG000|Period B (12 Weeks)|Adverse Event|0|||
131478032|NCT01646073|473382710|FG001|Period B (12 Weeks)|Adverse Event|7|||
131478033|NCT01646073|473382709|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
131478034|NCT01646073|473382710|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
131478035|NCT01646073|473382709|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
131478036|NCT01646073|473382710|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
131478037|NCT01999114|473382711|FG000|Overall Study|Adverse Event|8|||
131478038|NCT01999114|473382712|FG001|Overall Study|Adverse Event|7|||
131478039|NCT01999114|473382713|FG002|Overall Study|Adverse Event|2|||
131478040|NCT01999114|473382714|FG003|Overall Study|Adverse Event|2|||
131478041|NCT01999114|473382715|FG004|Overall Study|Adverse Event|1|||
131478042|NCT01999114|473382711|FG000|Overall Study|Withdrawal by Subject|0|||
131478043|NCT01999114|473382712|FG001|Overall Study|Withdrawal by Subject|0|||
131478044|NCT01999114|473382713|FG002|Overall Study|Withdrawal by Subject|1|||
131478045|NCT01999114|473382714|FG003|Overall Study|Withdrawal by Subject|0|||
131478046|NCT01999114|473382715|FG004|Overall Study|Withdrawal by Subject|1|||
131478047|NCT01999114|473382711|FG000|Overall Study|Lost to Follow-up|0|||
131478048|NCT01999114|473382712|FG001|Overall Study|Lost to Follow-up|0|||
131478049|NCT01999114|473382713|FG002|Overall Study|Lost to Follow-up|1|||
131478050|NCT01999114|473382714|FG003|Overall Study|Lost to Follow-up|0|||
131478051|NCT01999114|473382715|FG004|Overall Study|Lost to Follow-up|0|||
131478052|NCT01999114|473382711|FG000|Overall Study|Administrative|0|||
131478053|NCT01999114|473382712|FG001|Overall Study|Administrative|0|||
131478054|NCT01999114|473382713|FG002|Overall Study|Administrative|1|||
131478055|NCT01999114|473382714|FG003|Overall Study|Administrative|1|||
131478056|NCT01999114|473382715|FG004|Overall Study|Administrative|2|||
131478057|NCT01497275|473382718|FG000|Overall Study|Death|1|||
131478058|NCT01497275|473382718|FG000|Overall Study|Adverse Event|1|||
131478059|NCT01950169|473382719|FG000|Overall Study|Withdrawal by Subject|2|||
131478060|NCT01950169|473382720|FG001|Overall Study|Withdrawal by Subject|8|||
131478061|NCT01950169|473382721|FG002|Overall Study|Withdrawal by Subject|1|||
131478062|NCT01950169|473382719|FG000|Overall Study|Death|1|||
131478063|NCT01950169|473382720|FG001|Overall Study|Death|0|||
131478064|NCT01950169|473382721|FG002|Overall Study|Death|0|||
131478065|NCT02410551|473382724|FG000|Overall Study|Adverse Event|1|||
131478066|NCT02410551|473382724|FG000|Overall Study|Withdrawal by Subject|1|||
131478067|NCT02410551|473382724|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
131478068|NCT01739309|473382725|FG000|Overall Study|Adverse Event|1|||
131478069|NCT01739309|473382725|FG000|Overall Study|Withdrawal by Subject|1|||
131478070|NCT01495975|473382726|FG000|Overall Study|Lost to Follow-up|1|||
131478071|NCT01495975|473382727|FG001|Overall Study|Lost to Follow-up|0|||
131478072|NCT02083081|473382732|FG000|Overall Study|Lost to Follow-up|31|||
131478073|NCT02083081|473382733|FG001|Overall Study|Lost to Follow-up|9|||
131478074|NCT03799211|473382734|FG000|Overall Study|Lost to Follow-up|2|||
131478075|NCT03799211|473382735|FG001|Overall Study|Lost to Follow-up|13|||
131478076|NCT03799211|473382734|FG000|Overall Study|Withdrawal by Subject|2|||
131478077|NCT03799211|473382735|FG001|Overall Study|Withdrawal by Subject|0|||
131478078|NCT00764491|473382736|FG000|Overall Study|Lost to Follow-up|35|||
131478079|NCT00764491|473382737|FG001|Overall Study|Lost to Follow-up|17|||
131478080|NCT03139279|473382740|FG000|Overall Study|Physician Decision|2|||
131478081|NCT03139279|473382741|FG001|Overall Study|Physician Decision|0|||
131478082|NCT03139279|473382740|FG000|Overall Study|Protocol Violation|5|||
131478083|NCT03139279|473382741|FG001|Overall Study|Protocol Violation|4|||
131478084|NCT03139279|473382740|FG000|Overall Study|Withdrawal by Subject|0|||
131478085|NCT03139279|473382741|FG001|Overall Study|Withdrawal by Subject|2|||
131478086|NCT01336569|473382742|FG000|Overall Study|Lost to Follow-up|4|||
131478087|NCT02337738|473382743|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
131478088|NCT02337738|473382744|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
131478089|NCT02337738|473382745|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
131478090|NCT02337738|473382743|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
131478091|NCT02337738|473382744|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
131478092|NCT02337738|473382745|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
131478093|NCT02337738|473382743|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
131478094|NCT02337738|473382744|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
131478095|NCT02337738|473382745|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
131478096|NCT02337738|473382743|FG000|Overall Study|Voluntary Withdrawal|10|||
131478097|NCT02337738|473382744|FG001|Overall Study|Voluntary Withdrawal|5|||
131478098|NCT02337738|473382745|FG002|Overall Study|Voluntary Withdrawal|2|||
131478099|NCT02337738|473382743|FG000|Overall Study|Lack of Efficacy|2|||
131478100|NCT02337738|473382744|FG001|Overall Study|Lack of Efficacy|4|||
131478101|NCT02337738|473382745|FG002|Overall Study|Lack of Efficacy|0|||
131478102|NCT02337738|473382743|FG000|Overall Study|Investigator's Judgment|1|||
131478103|NCT02337738|473382744|FG001|Overall Study|Investigator's Judgment|1|||
131478104|NCT02337738|473382745|FG002|Overall Study|Investigator's Judgment|3|||
131478105|NCT00406354|473382746|FG000|All Randomized Patients|Protocol Violation|0|||
131478106|NCT00406354|473382747|FG001|All Randomized Patients|Protocol Violation|0|||
131478107|NCT00406354|473382748|FG002|All Randomized Patients|Protocol Violation|1|||
131478108|NCT00406354|473382746|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
131478109|NCT00406354|473382747|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
131478110|NCT00406354|473382748|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
131478111|NCT00406354|473382746|FG000|All Randomized and Treated Patients|Adverse Event|6|||
131478112|NCT00406354|473382747|FG001|All Randomized and Treated Patients|Adverse Event|2|||
131478113|NCT00406354|473382748|FG002|All Randomized and Treated Patients|Adverse Event|1|||
131478114|NCT00406354|473382746|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
131478115|NCT00406354|473382747|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
131478116|NCT00406354|473382748|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
131478117|NCT00406354|473382746|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
131478118|NCT00406354|473382747|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
131478119|NCT00406354|473382748|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
131478120|NCT00406354|473382746|FG000|All Randomized and Treated Patients|Physician Decision|0|||
131478121|NCT00406354|473382747|FG001|All Randomized and Treated Patients|Physician Decision|0|||
131478122|NCT00406354|473382748|FG002|All Randomized and Treated Patients|Physician Decision|1|||
131478123|NCT00747461|473382749|FG000|Overall Study|study terminated by sponsor|5|||
131478124|NCT00299182|473382764|FG000|Overall Study|Withdrawal by Subject|0|||
131478125|NCT00299182|473382765|FG001|Overall Study|Withdrawal by Subject|0|||
131478126|NCT00299182|473382766|FG002|Overall Study|Withdrawal by Subject|1|||
131478127|NCT00299182|473382767|FG003|Overall Study|Withdrawal by Subject|0|||
131478128|NCT00299182|473382768|FG004|Overall Study|Withdrawal by Subject|1|||
131478129|NCT00299182|473382769|FG005|Overall Study|Withdrawal by Subject|2|||
131478130|NCT00299182|473382770|FG006|Overall Study|Withdrawal by Subject|0|||
131478131|NCT00299182|473382764|FG000|Overall Study|Chemotherapy Changed|0|||
131478132|NCT00299182|473382765|FG001|Overall Study|Chemotherapy Changed|0|||
131478133|NCT00299182|473382766|FG002|Overall Study|Chemotherapy Changed|1|||
131478134|NCT00299182|473382767|FG003|Overall Study|Chemotherapy Changed|0|||
131478135|NCT00299182|473382768|FG004|Overall Study|Chemotherapy Changed|1|||
131478136|NCT00299182|473382769|FG005|Overall Study|Chemotherapy Changed|0|||
131478137|NCT00299182|473382770|FG006|Overall Study|Chemotherapy Changed|1|||
131478138|NCT00299182|473382764|FG000|Overall Study|Adverse Event|0|||
131478139|NCT00299182|473382765|FG001|Overall Study|Adverse Event|0|||
131478140|NCT00299182|473382766|FG002|Overall Study|Adverse Event|0|||
131478141|NCT00299182|473382767|FG003|Overall Study|Adverse Event|0|||
131478142|NCT00299182|473382768|FG004|Overall Study|Adverse Event|0|||
131478143|NCT00299182|473382769|FG005|Overall Study|Adverse Event|1|||
131478144|NCT00299182|473382770|FG006|Overall Study|Adverse Event|0|||
131478145|NCT00299182|473382764|FG000|Overall Study|Not Eligible|0|||
131478146|NCT00299182|473382765|FG001|Overall Study|Not Eligible|0|||
131478147|NCT00299182|473382766|FG002|Overall Study|Not Eligible|0|||
131478148|NCT00299182|473382767|FG003|Overall Study|Not Eligible|0|||
131478149|NCT00299182|473382768|FG004|Overall Study|Not Eligible|1|||
131478150|NCT00299182|473382769|FG005|Overall Study|Not Eligible|0|||
131478151|NCT00299182|473382770|FG006|Overall Study|Not Eligible|0|||
131478152|NCT02436681|473382777|FG000|Overall Study|Lost to Follow-up|10|||
131478153|NCT02436681|473382777|FG000|Overall Study|Withdrawal by Subject|2|||
131478154|NCT02436681|473382777|FG000|Overall Study|Death|2|||
131478155|NCT02030938|473382778|FG000|Overall Study|Lost to Follow-up|4|||
131478156|NCT02030938|473382778|FG000|Overall Study|Withdrawal by Subject|1|||
131478157|NCT02520661|473382782|FG000|Overall Study|Lost to Follow-up|7|||
131478158|NCT02520661|473382783|FG001|Overall Study|Lost to Follow-up|3|||
131478159|NCT02520661|473382782|FG000|Overall Study|Admitted from ED|49|||
131478160|NCT02520661|473382783|FG001|Overall Study|Admitted from ED|48|||
131478161|NCT02520661|473382782|FG000|Overall Study|ED greater than 24 hours|29|||
131478162|NCT02520661|473382783|FG001|Overall Study|ED greater than 24 hours|38|||
131478163|NCT02520661|473382782|FG000|Overall Study|other ineligibility|14|||
131478164|NCT02520661|473382783|FG001|Overall Study|other ineligibility|22|||
131478165|NCT02520661|473382782|FG000|Overall Study|Withdrawal by Subject|7|||
131478166|NCT02520661|473382783|FG001|Overall Study|Withdrawal by Subject|16|||
131478167|NCT03954132|473382784|FG000|Overall Study|Adverse Event|2|||
131478168|NCT03954132|473382785|FG001|Overall Study|Adverse Event|0|||
131478169|NCT03954132|473382784|FG000|Overall Study|Patient's wish|5|||
131478170|NCT03954132|473382785|FG001|Overall Study|Patient's wish|0|||
131478171|NCT03954132|473382784|FG000|Overall Study|Lost to Follow-up|10|||
131478172|NCT03954132|473382785|FG001|Overall Study|Lost to Follow-up|0|||
131478173|NCT03954132|473382784|FG000|Overall Study|Screening failure|0|||
131478174|NCT03954132|473382785|FG001|Overall Study|Screening failure|1|||
131478175|NCT03954132|473382784|FG000|Overall Study|No registration after Visit 1|5|||
131478176|NCT03954132|473382785|FG001|Overall Study|No registration after Visit 1|2|||
131478177|NCT03954132|473382784|FG000|Overall Study|Other reason than listed|2|||
131478178|NCT03954132|473382785|FG001|Overall Study|Other reason than listed|2|||
131478179|NCT03954132|473382784|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
131478180|NCT03954132|473382785|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
131478181|NCT03954132|473382784|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
131478182|NCT03954132|473382785|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
131478183|NCT00072176|473382788|FG000|Overall Study|Withdrawal by Subject|1|||
131478184|NCT00072176|473382789|FG001|Overall Study|Withdrawal by Subject|0|||
131478185|NCT00072176|473382788|FG000|Overall Study|Protocol Violation|0|||
131478186|NCT00072176|473382789|FG001|Overall Study|Protocol Violation|1|||
131478187|NCT04502979|473382795|FG000|Overall Study|Lost to Follow-up|1|||
131478188|NCT04502979|473382796|FG001|Overall Study|Lost to Follow-up|3|||
131478189|NCT04502979|473382795|FG000|Overall Study|Withdrawal by Subject|2|||
131478190|NCT04502979|473382796|FG001|Overall Study|Withdrawal by Subject|1|||
131478191|NCT00932737|473382804|FG000|Overall Study|Not treated in second episode|1|||
131478192|NCT00932737|473382805|FG001|Overall Study|Not treated in second episode|0|||
131478193|NCT00932737|473382804|FG000|Overall Study|Adverse Event|0|||
131478194|NCT00932737|473382805|FG001|Overall Study|Adverse Event|1|||
131478195|NCT02906332|473382810|FG000|Overall Study|Withdrawal by Subject|1|||
131478196|NCT02949700|473382811|FG000|Phase I|Withdrawal by Subject|1|||
131478197|NCT02949700|473382812|FG001|Phase I|Withdrawal by Subject|1|||
131478198|NCT02949700|473382813|FG002|Phase I|Withdrawal by Subject|0|||
131478199|NCT02949700|473382814|FG003|Phase I|Withdrawal by Subject|0|||
131478200|NCT02949700|473382811|FG000|Phase I|Protocol Violation|1|||
131478201|NCT02949700|473382812|FG001|Phase I|Protocol Violation|0|||
131478202|NCT02949700|473382813|FG002|Phase I|Protocol Violation|0|||
131478203|NCT02949700|473382814|FG003|Phase I|Protocol Violation|0|||
131478204|NCT02949700|473382811|FG000|Phase II|Withdrawal by Subject|0|||
131478205|NCT02949700|473382812|FG001|Phase II|Withdrawal by Subject|0|||
131478206|NCT02949700|473382813|FG002|Phase II|Withdrawal by Subject|0|||
131478207|NCT02949700|473382814|FG003|Phase II|Withdrawal by Subject|2|||
131478208|NCT02949700|473382811|FG000|Phase II|Protocol Violation|0|||
131478209|NCT02949700|473382812|FG001|Phase II|Protocol Violation|0|||
131478210|NCT02949700|473382813|FG002|Phase II|Protocol Violation|1|||
131478211|NCT02949700|473382814|FG003|Phase II|Protocol Violation|3|||
131478212|NCT02628769|473382829|FG000|First Intervention|Adverse Event|1|||
131478213|NCT02628769|473382830|FG001|First Intervention|Adverse Event|0|||
131478214|NCT02628769|473382829|FG000|First Intervention|Withdrawal by Subject|0|||
131478215|NCT02628769|473382830|FG001|First Intervention|Withdrawal by Subject|1|||
131478216|NCT02628769|473382829|FG000|Second Intervention|Adverse Event|2|||
131478217|NCT02628769|473382830|FG001|Second Intervention|Adverse Event|0|||
131478218|NCT02628769|473382829|FG000|Second Intervention|Physician Decision|0|||
131478219|NCT02628769|473382830|FG001|Second Intervention|Physician Decision|1|||
131478220|NCT02024555|473382831|FG000|Overall Study|Lost to Follow-up|1|||
131478221|NCT02024555|473382832|FG001|Overall Study|Lost to Follow-up|1|||
131478222|NCT02024555|473382831|FG000|Overall Study|Withdrawal by Subject|5|||
131478223|NCT02024555|473382832|FG001|Overall Study|Withdrawal by Subject|1|||
131478224|NCT02719327|473382837|FG000|Overall Study|Withdrawal by Subject|11|||
131478225|NCT02719327|473382838|FG001|Overall Study|Withdrawal by Subject|8|||
131478226|NCT03350620|473382839|FG000|Stage 2|Adverse Event|0|||
131478227|NCT03350620|473382840|FG001|Stage 2|Adverse Event|1|||
131478228|NCT03350620|473382841|FG002|Stage 2|Adverse Event|1|||
131478229|NCT03350620|473382839|FG000|Stage 2|Lack of Efficacy|0|||
131478230|NCT03350620|473382840|FG001|Stage 2|Lack of Efficacy|2|||
131478231|NCT03350620|473382841|FG002|Stage 2|Lack of Efficacy|0|||
131478232|NCT03350620|473382839|FG000|Stage 2|Lost to Follow-up|1|||
131478233|NCT03350620|473382840|FG001|Stage 2|Lost to Follow-up|2|||
131478234|NCT03350620|473382841|FG002|Stage 2|Lost to Follow-up|2|||
131478235|NCT03350620|473382839|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
131478236|NCT03350620|473382840|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
131478237|NCT03350620|473382841|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
131478238|NCT01066000|473382844|FG000|Overall Study|Protocol Violation|4|||
131478239|NCT01066000|473382844|FG000|Overall Study|Death|3|||
131478240|NCT01066000|473382844|FG000|Overall Study|Withdrawal by Subject|1|||
131478241|NCT01066000|473382844|FG000|Overall Study|Adverse Event|1|||
131478242|NCT05268055|473382845|FG000|Overall Study|Lost to Follow-up|68|||
131478243|NCT05268055|473382846|FG001|Overall Study|Lost to Follow-up|68|||
131478244|NCT05268055|473382845|FG000|Overall Study|Withdrawal by Subject|12|||
131478245|NCT05268055|473382846|FG001|Overall Study|Withdrawal by Subject|8|||
131478246|NCT02887859|473382847|FG000|Overall Study|Ongoing|6|||
131478247|NCT02887859|473382847|FG000|Overall Study|Adverse Event|7|||
131478248|NCT02887859|473382847|FG000|Overall Study|Death|1|||
131478249|NCT02887859|473382847|FG000|Overall Study|Physician Decision|1|||
131478250|NCT01854658|473384837|FG000|Overall Study|Protocol Violation|6|||
131478251|NCT01854658|473384838|FG001|Overall Study|Protocol Violation|2|||
131478252|NCT01854658|473384839|FG002|Overall Study|Protocol Violation|2|||
131478253|NCT01854658|473384840|FG003|Overall Study|Protocol Violation|1|||
131478254|NCT01854658|473384837|FG000|Overall Study|Physician Decision|7|||
131478255|NCT01854658|473384838|FG001|Overall Study|Physician Decision|5|||
131478256|NCT01854658|473384839|FG002|Overall Study|Physician Decision|2|||
131478257|NCT01854658|473384840|FG003|Overall Study|Physician Decision|4|||
131478258|NCT01854658|473384837|FG000|Overall Study|Lost to Follow-up|8|||
131478259|NCT01854658|473384838|FG001|Overall Study|Lost to Follow-up|9|||
131478260|NCT01854658|473384839|FG002|Overall Study|Lost to Follow-up|8|||
131478261|NCT01854658|473384840|FG003|Overall Study|Lost to Follow-up|4|||
131478262|NCT01854658|473384837|FG000|Overall Study|Withdrawal by Subject|28|||
131478263|NCT01854658|473384838|FG001|Overall Study|Withdrawal by Subject|21|||
131478264|NCT01854658|473384839|FG002|Overall Study|Withdrawal by Subject|29|||
131478265|NCT01854658|473384840|FG003|Overall Study|Withdrawal by Subject|15|||
131478266|NCT01854658|473384837|FG000|Overall Study|Protocol-specified criteria|15|||
131478267|NCT01854658|473384838|FG001|Overall Study|Protocol-specified criteria|15|||
131478268|NCT01854658|473384839|FG002|Overall Study|Protocol-specified criteria|10|||
131478269|NCT01854658|473384840|FG003|Overall Study|Protocol-specified criteria|7|||
131478270|NCT01854658|473384837|FG000|Overall Study|Lack of Efficacy|3|||
131478271|NCT01854658|473384838|FG001|Overall Study|Lack of Efficacy|8|||
131478272|NCT01854658|473384839|FG002|Overall Study|Lack of Efficacy|4|||
131478273|NCT01854658|473384840|FG003|Overall Study|Lack of Efficacy|7|||
131478274|NCT01854658|473384837|FG000|Overall Study|Adverse Event|21|||
131478275|NCT01854658|473384838|FG001|Overall Study|Adverse Event|14|||
131478276|NCT01854658|473384839|FG002|Overall Study|Adverse Event|23|||
131478277|NCT01854658|473384840|FG003|Overall Study|Adverse Event|19|||
131478278|NCT01854658|473384837|FG000|Overall Study|Administrative reasons|5|||
131478279|NCT01854658|473384838|FG001|Overall Study|Administrative reasons|1|||
131478280|NCT01854658|473384839|FG002|Overall Study|Administrative reasons|2|||
131478281|NCT01854658|473384840|FG003|Overall Study|Administrative reasons|2|||
131478282|NCT00697073|473384841|FG000|Overall Study|Withdrawal by Subject|2|||
131478283|NCT00697073|473384841|FG000|Overall Study|Pregnancy|1|||
131478284|NCT00697073|473384841|FG000|Overall Study|non compliance and other|6|||
131478285|NCT01858376|473384842|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
131478286|NCT02203071|473384845|FG000|Overall Study|Lost to Follow-up|3|||
131478287|NCT02203071|473384846|FG001|Overall Study|Lost to Follow-up|1|||
131478288|NCT01886716|473384849|FG000|Week 1|Lost to Follow-up|0|||
131478289|NCT01886716|473384850|FG001|Week 1|Lost to Follow-up|0|||
131478290|NCT01886716|473384851|FG002|Week 1|Lost to Follow-up|2|||
131478291|NCT01886716|473384852|FG003|Week 1|Lost to Follow-up|2|||
131478292|NCT01886716|473384849|FG000|Week 2|Lost to Follow-up|3|||
131478293|NCT01886716|473384850|FG001|Week 2|Lost to Follow-up|2|||
131478294|NCT01886716|473384851|FG002|Week 2|Lost to Follow-up|1|||
131478295|NCT01886716|473384852|FG003|Week 2|Lost to Follow-up|3|||
131478296|NCT01886716|473384849|FG000|Week 3|Lost to Follow-up|1|||
131478297|NCT01886716|473384850|FG001|Week 3|Lost to Follow-up|1|||
131478298|NCT01886716|473384851|FG002|Week 3|Lost to Follow-up|0|||
131478299|NCT01886716|473384852|FG003|Week 3|Lost to Follow-up|1|||
131478300|NCT03894046|473384853|FG000|Overall Study|Protocol Violation|1|||
131478301|NCT03894046|473384854|FG001|Overall Study|Protocol Violation|0|||
131478302|NCT03894046|473384855|FG002|Overall Study|Protocol Violation|0|||
131478303|NCT03894046|473384853|FG000|Overall Study|Adverse Event|0|||
131478304|NCT03894046|473384854|FG001|Overall Study|Adverse Event|1|||
131478305|NCT03894046|473384855|FG002|Overall Study|Adverse Event|0|||
131478306|NCT03894046|473384853|FG000|Overall Study|Withdrawal by Subject|2|||
131478307|NCT03894046|473384854|FG001|Overall Study|Withdrawal by Subject|3|||
131478308|NCT03894046|473384855|FG002|Overall Study|Withdrawal by Subject|1|||
131478309|NCT03894046|473384853|FG000|Overall Study|Death|15|||
131478310|NCT03894046|473384854|FG001|Overall Study|Death|21|||
131478311|NCT03894046|473384855|FG002|Overall Study|Death|4|||
131478312|NCT03894046|473384853|FG000|Overall Study|No growth of ABC|2|||
131478313|NCT03894046|473384854|FG001|Overall Study|No growth of ABC|1|||
131478314|NCT03894046|473384855|FG002|Overall Study|No growth of ABC|0|||
131478315|NCT03894046|473384853|FG000|Overall Study|Physician Decision|1|||
131478316|NCT03894046|473384854|FG001|Overall Study|Physician Decision|1|||
131478317|NCT03894046|473384855|FG002|Overall Study|Physician Decision|1|||
131478318|NCT03894046|473384853|FG000|Overall Study|Prohibited concomitant medication|1|||
131478319|NCT03894046|473384854|FG001|Overall Study|Prohibited concomitant medication|0|||
131478320|NCT03894046|473384855|FG002|Overall Study|Prohibited concomitant medication|0|||
131478321|NCT03894046|473384853|FG000|Overall Study|Transferred to other arm/group|1|||
131478322|NCT03894046|473384854|FG001|Overall Study|Transferred to other arm/group|1|||
131478323|NCT03894046|473384855|FG002|Overall Study|Transferred to other arm/group|0|||
131478324|NCT02570074|473384866|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
131478325|NCT02570074|473384867|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
131478326|NCT02436304|473384868|FG000|Overall Study|Lost to Follow-up|0|||
131478327|NCT02436304|473384869|FG001|Overall Study|Lost to Follow-up|1|||
131478328|NCT02436304|473384870|FG002|Overall Study|Lost to Follow-up|0|||
131478329|NCT02436304|473384868|FG000|Overall Study|Withdrawal by Subject|0|||
131478330|NCT02436304|473384869|FG001|Overall Study|Withdrawal by Subject|1|||
131478331|NCT02436304|473384870|FG002|Overall Study|Withdrawal by Subject|0|||
131478332|NCT02436304|473384868|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
131478333|NCT02436304|473384869|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
131478334|NCT02436304|473384870|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
131478335|NCT03793556|473384871|FG000|Overall Study|Withdrawal by Subject|12|||
131478336|NCT03793556|473384872|FG001|Overall Study|Withdrawal by Subject|1|||
131478337|NCT03793556|473384871|FG000|Overall Study|Lost to Follow-up|1|||
131478338|NCT03793556|473384872|FG001|Overall Study|Lost to Follow-up|1|||
131478339|NCT04416633|473384873|FG000|Overall Study|Death|1|||
131478340|NCT04416633|473384873|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
131478341|NCT04416633|473384873|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
131478342|NCT04416633|473384873|FG000|Overall Study|Adverse Event|6|||
131478343|NCT04416633|473384873|FG000|Overall Study|Withdrawal by Subject|6|||
131478344|NCT04612790|473384874|FG000|DB Period (Up to 36 Weeks)|Death|1|||
131478345|NCT04612790|473384875|FG001|DB Period (Up to 36 Weeks)|Death|1|||
131478346|NCT04612790|473384876|FG002|DB Period (Up to 36 Weeks)|Death|0|||
131478347|NCT04612790|473384877|FG003|DB Period (Up to 36 Weeks)|Death|0|||
131478348|NCT04612790|473384874|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
131478349|NCT04612790|473384875|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
131478350|NCT04612790|473384876|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
131478351|NCT04612790|473384877|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
131478352|NCT04612790|473384874|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
131478353|NCT04612790|473384875|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
131478354|NCT04612790|473384876|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
131478355|NCT04612790|473384877|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
131478356|NCT04612790|473384874|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
131478357|NCT04612790|473384875|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
131478358|NCT04612790|473384876|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
131478359|NCT04612790|473384877|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
131478360|NCT04612790|473384874|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
131478361|NCT04612790|473384875|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
131478362|NCT04612790|473384876|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
131478363|NCT04612790|473384877|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
131478364|NCT04612790|473384874|FG000|DB Period (Up to 36 Weeks)|Other|1|||
131478365|NCT04612790|473384875|FG001|DB Period (Up to 36 Weeks)|Other|0|||
131478366|NCT04612790|473384876|FG002|DB Period (Up to 36 Weeks)|Other|0|||
131478367|NCT04612790|473384877|FG003|DB Period (Up to 36 Weeks)|Other|0|||
131478368|NCT04612790|473384874|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
131478369|NCT04612790|473384875|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
131478370|NCT04612790|473384876|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
131478371|NCT04612790|473384877|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
131478372|NCT04612790|473384874|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
131478373|NCT04612790|473384875|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
131478374|NCT04612790|473384876|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
131478375|NCT04612790|473384877|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
131478376|NCT04612790|473384874|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
131478377|NCT04612790|473384875|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
131478378|NCT04612790|473384876|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
131478379|NCT04612790|473384877|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
131478380|NCT04612790|473384874|FG000|OLE Period (Up to 1 Year)|Other|0|||
131478381|NCT04612790|473384875|FG001|OLE Period (Up to 1 Year)|Other|0|||
131478382|NCT04612790|473384876|FG002|OLE Period (Up to 1 Year)|Other|0|||
131478383|NCT04612790|473384877|FG003|OLE Period (Up to 1 Year)|Other|1|||
131478384|NCT00785928|473384878|FG000|Treatment Phase|Adverse Event|1|||
131478385|NCT00785928|473384879|FG001|Treatment Phase|Adverse Event|1|||
131478386|NCT00785928|473384880|FG002|Treatment Phase|Adverse Event|2|||
131478387|NCT00785928|473384881|FG003|Treatment Phase|Adverse Event|0|||
131478388|NCT00785928|473384882|FG004|Treatment Phase|Adverse Event|0|||
131478389|NCT00785928|473384883|FG005|Treatment Phase|Adverse Event|0|||
131478390|NCT00785928|473384884|FG006|Treatment Phase|Adverse Event|2|||
131478391|NCT00785928|473384878|FG000|Treatment Phase|Inadequate Response|0|||
131478392|NCT00785928|473384879|FG001|Treatment Phase|Inadequate Response|1|||
131478393|NCT00785928|473384880|FG002|Treatment Phase|Inadequate Response|0|||
131478394|NCT00785928|473384881|FG003|Treatment Phase|Inadequate Response|0|||
131478395|NCT00785928|473384882|FG004|Treatment Phase|Inadequate Response|0|||
131478396|NCT00785928|473384883|FG005|Treatment Phase|Inadequate Response|0|||
131478397|NCT00785928|473384884|FG006|Treatment Phase|Inadequate Response|0|||
131478398|NCT00785928|473384878|FG000|Treatment Phase|Lack of Efficacy|0|||
131478399|NCT00785928|473384879|FG001|Treatment Phase|Lack of Efficacy|1|||
131478400|NCT00785928|473384880|FG002|Treatment Phase|Lack of Efficacy|1|||
131478401|NCT00785928|473384881|FG003|Treatment Phase|Lack of Efficacy|0|||
131478402|NCT00785928|473384882|FG004|Treatment Phase|Lack of Efficacy|0|||
131478403|NCT00785928|473384883|FG005|Treatment Phase|Lack of Efficacy|0|||
131478404|NCT00785928|473384884|FG006|Treatment Phase|Lack of Efficacy|0|||
131478405|NCT00785928|473384878|FG000|Treatment Phase|Physician Decision|0|||
131478406|NCT00785928|473384879|FG001|Treatment Phase|Physician Decision|0|||
131478407|NCT00785928|473384880|FG002|Treatment Phase|Physician Decision|0|||
131478408|NCT00785928|473384881|FG003|Treatment Phase|Physician Decision|0|||
131478409|NCT00785928|473384882|FG004|Treatment Phase|Physician Decision|1|||
131478410|NCT00785928|473384883|FG005|Treatment Phase|Physician Decision|0|||
131478411|NCT00785928|473384884|FG006|Treatment Phase|Physician Decision|0|||
131478412|NCT00785928|473384878|FG000|Treatment Phase|Sponsor Decision|1|||
131478413|NCT00785928|473384879|FG001|Treatment Phase|Sponsor Decision|0|||
131478414|NCT00785928|473384880|FG002|Treatment Phase|Sponsor Decision|0|||
131478415|NCT00785928|473384881|FG003|Treatment Phase|Sponsor Decision|0|||
131478416|NCT00785928|473384882|FG004|Treatment Phase|Sponsor Decision|0|||
131478417|NCT00785928|473384883|FG005|Treatment Phase|Sponsor Decision|0|||
131478418|NCT00785928|473384884|FG006|Treatment Phase|Sponsor Decision|1|||
131478419|NCT00785928|473384878|FG000|Treatment Phase|Withdrawal by Subject|1|||
131478420|NCT00785928|473384879|FG001|Treatment Phase|Withdrawal by Subject|2|||
131478421|NCT00785928|473384880|FG002|Treatment Phase|Withdrawal by Subject|0|||
131478422|NCT00785928|473384881|FG003|Treatment Phase|Withdrawal by Subject|0|||
131478423|NCT00785928|473384882|FG004|Treatment Phase|Withdrawal by Subject|1|||
131478424|NCT00785928|473384883|FG005|Treatment Phase|Withdrawal by Subject|0|||
131478425|NCT00785928|473384884|FG006|Treatment Phase|Withdrawal by Subject|0|||
131478426|NCT05021081|473384889|FG000|Phase 2|Subject enrolled in error|1|||
131478427|NCT05021081|473384890|FG001|Phase 2|Subject enrolled in error|1|||
131478428|NCT05021081|473384891|FG002|Phase 2|Subject enrolled in error|0|||
131478429|NCT00369122|473384892|FG000|Overall Study|Ineligible|10|||
131478430|NCT00369122|473384892|FG000|Overall Study|No protocol treatment|1|||
131478431|NCT00004635|473384893|FG000|Period One|refused|2|||
131478432|NCT00004635|473384894|FG001|Period One|refused|1|||
131478433|NCT00004635|473384893|FG000|Period One|Withdrawal by Subject|1|||
131478434|NCT00004635|473384894|FG001|Period One|Withdrawal by Subject|1|||
131478435|NCT00004635|473384893|FG000|Period One|Protocol Violation|1|||
131478436|NCT00004635|473384894|FG001|Period One|Protocol Violation|0|||
131478437|NCT00004635|473384893|FG000|Period One|PSA did not go <5 ng/mL|1|||
131478438|NCT00004635|473384894|FG001|Period One|PSA did not go <5 ng/mL|0|||
131478439|NCT00004635|473384893|FG000|Period One|second malignancy|1|||
131478440|NCT00004635|473384894|FG001|Period One|second malignancy|0|||
131478441|NCT00004635|473384893|FG000|Period One|progressed|0|||
131478442|NCT00004635|473384894|FG001|Period One|progressed|2|||
131478443|NCT00004635|473384893|FG000|Period One|health problem|0|||
131478444|NCT00004635|473384894|FG001|Period One|health problem|1|||
131478445|NCT00004635|473384893|FG000|Period One|discrepancy in data entry|0|||
131478446|NCT00004635|473384894|FG001|Period One|discrepancy in data entry|1|||
131478447|NCT00004635|473384893|FG000|Period Two|progression|2|||
131478448|NCT00004635|473384894|FG001|Period Two|progression|3|||
131478449|NCT00004635|473384893|FG000|Period Two|Adverse Event|1|||
131478450|NCT00004635|473384894|FG001|Period Two|Adverse Event|0|||
131478451|NCT00004635|473384893|FG000|Period Two|refused|0|||
131478452|NCT00004635|473384894|FG001|Period Two|refused|2|||
131478453|NCT00004635|473384893|FG000|Period Two|health problem|1|||
131478454|NCT00004635|473384894|FG001|Period Two|health problem|1|||
131478455|NCT00004635|473384893|FG000|Period Two|travel issues|0|||
131478456|NCT00004635|473384894|FG001|Period Two|travel issues|1|||
131478457|NCT00004635|473384893|FG000|Period Two|secondary malignancy|1|||
131478458|NCT00004635|473384894|FG001|Period Two|secondary malignancy|1|||
131478459|NCT00004635|473384893|FG000|Period Two|Lost to Follow-up|1|||
131478460|NCT00004635|473384894|FG001|Period Two|Lost to Follow-up|0|||
131478461|NCT00004635|473384893|FG000|Period Two|discrepancy in data entry|0|||
131478462|NCT00004635|473384894|FG001|Period Two|discrepancy in data entry|1|||
131478463|NCT00408629|473384895|FG000|Overall Study|Adverse Event|13|||
131478464|NCT00408629|473384896|FG001|Overall Study|Adverse Event|27|||
131478465|NCT00408629|473384895|FG000|Overall Study|Withdrawal by Subject|8|||
131478466|NCT00408629|473384896|FG001|Overall Study|Withdrawal by Subject|4|||
131478467|NCT00408629|473384895|FG000|Overall Study|Lost to Follow-up|1|||
131478468|NCT00408629|473384896|FG001|Overall Study|Lost to Follow-up|1|||
131478469|NCT00408629|473384895|FG000|Overall Study|Lack of Efficacy|63|||
131478470|NCT00408629|473384896|FG001|Overall Study|Lack of Efficacy|73|||
131478471|NCT00408629|473384895|FG000|Overall Study|Protocol Violation|1|||
131478472|NCT00408629|473384896|FG001|Overall Study|Protocol Violation|5|||
131478473|NCT00408629|473384895|FG000|Overall Study|Miscellaneous|11|||
131478474|NCT00408629|473384896|FG001|Overall Study|Miscellaneous|15|||
131478475|NCT00191906|473384897|FG000|Study Period II|Adverse Event|0|||
131478476|NCT00191906|473384898|FG001|Study Period II|Adverse Event|1|||
131478477|NCT00191906|473384899|FG002|Study Period II|Adverse Event|0|||
131478478|NCT00191906|473384900|FG003|Study Period II|Adverse Event|0|||
131478479|NCT00191906|473384897|FG000|Study Period II|Withdrawal by Subject|0|||
131478480|NCT00191906|473384898|FG001|Study Period II|Withdrawal by Subject|3|||
131478481|NCT00191906|473384899|FG002|Study Period II|Withdrawal by Subject|0|||
131478482|NCT00191906|473384900|FG003|Study Period II|Withdrawal by Subject|0|||
131478483|NCT00191906|473384897|FG000|Study Period II|Parent/Caregiver Decision|0|||
131478484|NCT00191906|473384898|FG001|Study Period II|Parent/Caregiver Decision|1|||
131478485|NCT00191906|473384899|FG002|Study Period II|Parent/Caregiver Decision|0|||
131478486|NCT00191906|473384900|FG003|Study Period II|Parent/Caregiver Decision|0|||
131478487|NCT00191906|473384897|FG000|Study Period II|Entry Criteria Exclusion|0|||
131478488|NCT00191906|473384898|FG001|Study Period II|Entry Criteria Exclusion|0|||
131478489|NCT00191906|473384899|FG002|Study Period II|Entry Criteria Exclusion|1|||
131478490|NCT00191906|473384900|FG003|Study Period II|Entry Criteria Exclusion|0|||
131478491|NCT00191906|473384897|FG000|Study Period III|Adverse Event|1|||
131478492|NCT00191906|473384898|FG001|Study Period III|Adverse Event|0|||
131478493|NCT00191906|473384899|FG002|Study Period III|Adverse Event|0|||
131478494|NCT00191906|473384900|FG003|Study Period III|Adverse Event|0|||
131478495|NCT00191906|473384897|FG000|Study Period III|Lost to Follow-up|0|||
131478496|NCT00191906|473384898|FG001|Study Period III|Lost to Follow-up|1|||
131478497|NCT00191906|473384899|FG002|Study Period III|Lost to Follow-up|0|||
131478498|NCT00191906|473384900|FG003|Study Period III|Lost to Follow-up|0|||
131478499|NCT00191906|473384897|FG000|Study Period III|Parent/Caregiver Decision|1|||
131478500|NCT00191906|473384898|FG001|Study Period III|Parent/Caregiver Decision|0|||
131478501|NCT00191906|473384899|FG002|Study Period III|Parent/Caregiver Decision|0|||
131478502|NCT00191906|473384900|FG003|Study Period III|Parent/Caregiver Decision|0|||
131478503|NCT00191906|473384897|FG000|Study Period III|Lack of Efficacy|3|||
131478504|NCT00191906|473384898|FG001|Study Period III|Lack of Efficacy|3|||
131478505|NCT00191906|473384899|FG002|Study Period III|Lack of Efficacy|0|||
131478506|NCT00191906|473384900|FG003|Study Period III|Lack of Efficacy|0|||
131478507|NCT00573937|473384901|FG000|Overall Study|Study Terminated|0|||
131478508|NCT00573937|473384902|FG001|Overall Study|Study Terminated|1|||
131478509|NCT00333801|473384903|FG000|Overall Study|Moved to another state|5|||
131478510|NCT00333801|473384904|FG001|Overall Study|Moved to another state|3|||
131478511|NCT00333801|473384903|FG000|Overall Study|Lost to Follow-up|2|||
131478512|NCT00333801|473384904|FG001|Overall Study|Lost to Follow-up|0|||
131478513|NCT00333801|473384903|FG000|Overall Study|Incarcerated|1|||
131478514|NCT00333801|473384904|FG001|Overall Study|Incarcerated|2|||
131478515|NCT00333801|473384903|FG000|Overall Study|Withdrawal by Subject|0|||
131478516|NCT00333801|473384904|FG001|Overall Study|Withdrawal by Subject|1|||
131478517|NCT03633617|473384905|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
131478518|NCT03633617|473384906|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
131478519|NCT03633617|473384907|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478520|NCT03633617|473384908|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478521|NCT03633617|473384909|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478522|NCT03633617|473384910|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478523|NCT03633617|473384911|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478524|NCT03633617|473384912|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478525|NCT03633617|473384913|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478526|NCT03633617|473384914|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478527|NCT03633617|473384915|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
131478528|NCT03633617|473384905|FG000|Part A|Unconfirmed early termination visit|1|||
131478529|NCT03633617|473384906|FG001|Part A|Unconfirmed early termination visit|0|||
131478530|NCT03633617|473384907|FG002|Part A|Unconfirmed early termination visit|0|||
131478531|NCT03633617|473384908|FG003|Part A|Unconfirmed early termination visit|0|||
131478532|NCT03633617|473384909|FG004|Part A|Unconfirmed early termination visit|0|||
131478533|NCT03633617|473384910|FG005|Part A|Unconfirmed early termination visit|0|||
131478534|NCT03633617|473384911|FG006|Part A|Unconfirmed early termination visit|0|||
131478535|NCT03633617|473384912|FG007|Part A|Unconfirmed early termination visit|0|||
131478536|NCT03633617|473384913|FG008|Part A|Unconfirmed early termination visit|0|||
131478537|NCT03633617|473384914|FG009|Part A|Unconfirmed early termination visit|0|||
131478538|NCT03633617|473384915|FG010|Part A|Unconfirmed early termination visit|0|||
131478539|NCT03633617|473384905|FG000|Part A|Adverse Event|0|||
131478540|NCT03633617|473384906|FG001|Part A|Adverse Event|1|||
131478541|NCT03633617|473384907|FG002|Part A|Adverse Event|0|||
131478542|NCT03633617|473384908|FG003|Part A|Adverse Event|0|||
131478543|NCT03633617|473384909|FG004|Part A|Adverse Event|0|||
131478544|NCT03633617|473384910|FG005|Part A|Adverse Event|0|||
131478545|NCT03633617|473384911|FG006|Part A|Adverse Event|0|||
131478546|NCT03633617|473384912|FG007|Part A|Adverse Event|0|||
131478547|NCT03633617|473384913|FG008|Part A|Adverse Event|0|||
131478548|NCT03633617|473384914|FG009|Part A|Adverse Event|0|||
131478549|NCT03633617|473384915|FG010|Part A|Adverse Event|0|||
131478550|NCT03633617|473384905|FG000|Part A|Pregnancy|1|||
131478551|NCT03633617|473384906|FG001|Part A|Pregnancy|0|||
131478552|NCT03633617|473384907|FG002|Part A|Pregnancy|0|||
131478553|NCT03633617|473384908|FG003|Part A|Pregnancy|0|||
131478554|NCT03633617|473384909|FG004|Part A|Pregnancy|0|||
131478555|NCT03633617|473384910|FG005|Part A|Pregnancy|0|||
131478556|NCT03633617|473384911|FG006|Part A|Pregnancy|0|||
131478557|NCT03633617|473384912|FG007|Part A|Pregnancy|0|||
131478558|NCT03633617|473384913|FG008|Part A|Pregnancy|0|||
131478559|NCT03633617|473384914|FG009|Part A|Pregnancy|0|||
131478560|NCT03633617|473384915|FG010|Part A|Pregnancy|0|||
131478561|NCT03633617|473384905|FG000|Part A|Withdrawal by Subject|0|||
131478562|NCT03633617|473384906|FG001|Part A|Withdrawal by Subject|1|||
131478563|NCT03633617|473384907|FG002|Part A|Withdrawal by Subject|0|||
131478564|NCT03633617|473384908|FG003|Part A|Withdrawal by Subject|0|||
131478565|NCT03633617|473384909|FG004|Part A|Withdrawal by Subject|0|||
131478566|NCT03633617|473384910|FG005|Part A|Withdrawal by Subject|0|||
131478567|NCT03633617|473384911|FG006|Part A|Withdrawal by Subject|0|||
131478568|NCT03633617|473384912|FG007|Part A|Withdrawal by Subject|0|||
131478569|NCT03633617|473384913|FG008|Part A|Withdrawal by Subject|0|||
131478570|NCT03633617|473384914|FG009|Part A|Withdrawal by Subject|0|||
131478571|NCT03633617|473384915|FG010|Part A|Withdrawal by Subject|0|||
131478572|NCT03633617|473384905|FG000|Part B|Adverse Event|0|||
131478573|NCT03633617|473384906|FG001|Part B|Adverse Event|0|||
131478574|NCT03633617|473384907|FG002|Part B|Adverse Event|2|||
131478575|NCT03633617|473384908|FG003|Part B|Adverse Event|2|||
131478576|NCT03633617|473384909|FG004|Part B|Adverse Event|1|||
131478577|NCT03633617|473384910|FG005|Part B|Adverse Event|0|||
131478578|NCT03633617|473384911|FG006|Part B|Adverse Event|0|||
131478579|NCT03633617|473384912|FG007|Part B|Adverse Event|0|||
131478580|NCT03633617|473384913|FG008|Part B|Adverse Event|0|||
131478581|NCT03633617|473384914|FG009|Part B|Adverse Event|0|||
131478582|NCT03633617|473384915|FG010|Part B|Adverse Event|0|||
131478583|NCT03633617|473384905|FG000|Part B|Withdrawal by Subject|0|||
131478584|NCT03633617|473384906|FG001|Part B|Withdrawal by Subject|0|||
131478585|NCT03633617|473384907|FG002|Part B|Withdrawal by Subject|1|||
131478586|NCT03633617|473384908|FG003|Part B|Withdrawal by Subject|0|||
131478587|NCT03633617|473384909|FG004|Part B|Withdrawal by Subject|2|||
131478588|NCT03633617|473384910|FG005|Part B|Withdrawal by Subject|0|||
131478589|NCT03633617|473384911|FG006|Part B|Withdrawal by Subject|0|||
131478590|NCT03633617|473384912|FG007|Part B|Withdrawal by Subject|0|||
131478591|NCT03633617|473384913|FG008|Part B|Withdrawal by Subject|0|||
131478592|NCT03633617|473384914|FG009|Part B|Withdrawal by Subject|0|||
131478593|NCT03633617|473384915|FG010|Part B|Withdrawal by Subject|0|||
131478594|NCT03633617|473384905|FG000|Part B|Lost to Follow-up|0|||
131478595|NCT03633617|473384906|FG001|Part B|Lost to Follow-up|0|||
131478596|NCT03633617|473384907|FG002|Part B|Lost to Follow-up|0|||
131478597|NCT03633617|473384908|FG003|Part B|Lost to Follow-up|0|||
131478598|NCT03633617|473384909|FG004|Part B|Lost to Follow-up|1|||
131478599|NCT03633617|473384910|FG005|Part B|Lost to Follow-up|0|||
131478600|NCT03633617|473384911|FG006|Part B|Lost to Follow-up|0|||
131478601|NCT03633617|473384912|FG007|Part B|Lost to Follow-up|0|||
131478602|NCT03633617|473384913|FG008|Part B|Lost to Follow-up|0|||
131478603|NCT03633617|473384914|FG009|Part B|Lost to Follow-up|0|||
131478604|NCT03633617|473384915|FG010|Part B|Lost to Follow-up|0|||
131478605|NCT03633617|473384905|FG000|Part B|Physician Decision|0|||
131478606|NCT03633617|473384906|FG001|Part B|Physician Decision|0|||
131478607|NCT03633617|473384907|FG002|Part B|Physician Decision|0|||
131478608|NCT03633617|473384908|FG003|Part B|Physician Decision|0|||
131478609|NCT03633617|473384909|FG004|Part B|Physician Decision|1|||
131478610|NCT03633617|473384910|FG005|Part B|Physician Decision|0|||
131478611|NCT03633617|473384911|FG006|Part B|Physician Decision|0|||
131478612|NCT03633617|473384912|FG007|Part B|Physician Decision|0|||
131478613|NCT03633617|473384913|FG008|Part B|Physician Decision|0|||
131478614|NCT03633617|473384914|FG009|Part B|Physician Decision|0|||
131478615|NCT03633617|473384915|FG010|Part B|Physician Decision|0|||
131478616|NCT03633617|473384905|FG000|Part B|COVID-19 Restrictions|0|||
131478617|NCT03633617|473384906|FG001|Part B|COVID-19 Restrictions|0|||
131478618|NCT03633617|473384907|FG002|Part B|COVID-19 Restrictions|1|||
131478619|NCT03633617|473384908|FG003|Part B|COVID-19 Restrictions|0|||
131478620|NCT03633617|473384909|FG004|Part B|COVID-19 Restrictions|0|||
131478621|NCT03633617|473384910|FG005|Part B|COVID-19 Restrictions|0|||
131478622|NCT03633617|473384911|FG006|Part B|COVID-19 Restrictions|0|||
131478623|NCT03633617|473384912|FG007|Part B|COVID-19 Restrictions|0|||
131478624|NCT03633617|473384913|FG008|Part B|COVID-19 Restrictions|0|||
131478625|NCT03633617|473384914|FG009|Part B|COVID-19 Restrictions|0|||
131478626|NCT03633617|473384915|FG010|Part B|COVID-19 Restrictions|0|||
131478627|NCT03633617|473384905|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478628|NCT03633617|473384906|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478629|NCT03633617|473384907|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
131478630|NCT03633617|473384908|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478631|NCT03633617|473384909|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478632|NCT03633617|473384910|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478633|NCT03633617|473384911|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478634|NCT03633617|473384912|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478635|NCT03633617|473384913|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478636|NCT03633617|473384914|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478637|NCT03633617|473384915|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
131478638|NCT03633617|473384905|FG000|Part C (& Follow-up)|Adverse Event|0|||
131478639|NCT03633617|473384906|FG001|Part C (& Follow-up)|Adverse Event|0|||
131478640|NCT03633617|473384907|FG002|Part C (& Follow-up)|Adverse Event|0|||
131478641|NCT03633617|473384908|FG003|Part C (& Follow-up)|Adverse Event|0|||
131478642|NCT03633617|473384909|FG004|Part C (& Follow-up)|Adverse Event|0|||
131478643|NCT03633617|473384910|FG005|Part C (& Follow-up)|Adverse Event|1|||
131478644|NCT03633617|473384911|FG006|Part C (& Follow-up)|Adverse Event|0|||
131478645|NCT03633617|473384912|FG007|Part C (& Follow-up)|Adverse Event|1|||
131478646|NCT03633617|473384913|FG008|Part C (& Follow-up)|Adverse Event|0|||
131478647|NCT03633617|473384914|FG009|Part C (& Follow-up)|Adverse Event|0|||
131478648|NCT03633617|473384915|FG010|Part C (& Follow-up)|Adverse Event|0|||
131478649|NCT03633617|473384905|FG000|Part C (& Follow-up)|Pregnancy|0|||
131478650|NCT03633617|473384906|FG001|Part C (& Follow-up)|Pregnancy|0|||
131478651|NCT03633617|473384907|FG002|Part C (& Follow-up)|Pregnancy|0|||
131478652|NCT03633617|473384908|FG003|Part C (& Follow-up)|Pregnancy|0|||
131478653|NCT03633617|473384909|FG004|Part C (& Follow-up)|Pregnancy|0|||
131478654|NCT03633617|473384910|FG005|Part C (& Follow-up)|Pregnancy|0|||
131478655|NCT03633617|473384911|FG006|Part C (& Follow-up)|Pregnancy|0|||
131478656|NCT03633617|473384912|FG007|Part C (& Follow-up)|Pregnancy|0|||
131478657|NCT03633617|473384913|FG008|Part C (& Follow-up)|Pregnancy|0|||
131478658|NCT03633617|473384914|FG009|Part C (& Follow-up)|Pregnancy|1|||
131478659|NCT03633617|473384915|FG010|Part C (& Follow-up)|Pregnancy|0|||
131478660|NCT03633617|473384905|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
131478661|NCT03633617|473384906|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
131478662|NCT03633617|473384907|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
131478663|NCT03633617|473384908|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
131478664|NCT03633617|473384909|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
131478665|NCT03633617|473384910|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
131478666|NCT03633617|473384911|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
131478667|NCT03633617|473384912|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
131478668|NCT03633617|473384913|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
131478669|NCT03633617|473384914|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
131478670|NCT03633617|473384915|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
131478671|NCT03633617|473384905|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
131478672|NCT03633617|473384906|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
131478673|NCT03633617|473384907|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
131478674|NCT03633617|473384908|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
131478675|NCT03633617|473384909|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
131478676|NCT03633617|473384910|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
131478677|NCT03633617|473384911|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
131478678|NCT03633617|473384912|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
131478679|NCT03633617|473384913|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
131478680|NCT03633617|473384914|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
131478681|NCT03633617|473384915|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
131478682|NCT03633617|473384905|FG000|Part C (& Follow-up)|Physician Decision|0|||
131478683|NCT03633617|473384906|FG001|Part C (& Follow-up)|Physician Decision|0|||
131478684|NCT03633617|473384907|FG002|Part C (& Follow-up)|Physician Decision|0|||
131478685|NCT03633617|473384908|FG003|Part C (& Follow-up)|Physician Decision|0|||
131478686|NCT03633617|473384909|FG004|Part C (& Follow-up)|Physician Decision|0|||
131478687|NCT03633617|473384910|FG005|Part C (& Follow-up)|Physician Decision|0|||
131478688|NCT03633617|473384911|FG006|Part C (& Follow-up)|Physician Decision|0|||
131478689|NCT03633617|473384912|FG007|Part C (& Follow-up)|Physician Decision|1|||
131478690|NCT03633617|473384913|FG008|Part C (& Follow-up)|Physician Decision|0|||
131478691|NCT03633617|473384914|FG009|Part C (& Follow-up)|Physician Decision|0|||
131478692|NCT03633617|473384915|FG010|Part C (& Follow-up)|Physician Decision|1|||
131478693|NCT03633617|473384905|FG000|Part C (& Follow-up)|COVID-19 related|0|||
131478694|NCT03633617|473384906|FG001|Part C (& Follow-up)|COVID-19 related|0|||
131478695|NCT03633617|473384907|FG002|Part C (& Follow-up)|COVID-19 related|0|||
131478696|NCT03633617|473384908|FG003|Part C (& Follow-up)|COVID-19 related|0|||
131478697|NCT03633617|473384909|FG004|Part C (& Follow-up)|COVID-19 related|0|||
131478698|NCT03633617|473384910|FG005|Part C (& Follow-up)|COVID-19 related|1|||
131478699|NCT03633617|473384911|FG006|Part C (& Follow-up)|COVID-19 related|0|||
131478700|NCT03633617|473384912|FG007|Part C (& Follow-up)|COVID-19 related|0|||
131478701|NCT03633617|473384913|FG008|Part C (& Follow-up)|COVID-19 related|0|||
131478702|NCT03633617|473384914|FG009|Part C (& Follow-up)|COVID-19 related|0|||
131478703|NCT03633617|473384915|FG010|Part C (& Follow-up)|COVID-19 related|0|||
131478704|NCT03633617|473384905|FG000|Part C (& Follow-up)|Protocol Violation|0|||
131478705|NCT03633617|473384906|FG001|Part C (& Follow-up)|Protocol Violation|0|||
131478706|NCT03633617|473384907|FG002|Part C (& Follow-up)|Protocol Violation|0|||
131478707|NCT03633617|473384908|FG003|Part C (& Follow-up)|Protocol Violation|0|||
131478708|NCT03633617|473384909|FG004|Part C (& Follow-up)|Protocol Violation|0|||
131478709|NCT03633617|473384910|FG005|Part C (& Follow-up)|Protocol Violation|0|||
131478710|NCT03633617|473384911|FG006|Part C (& Follow-up)|Protocol Violation|0|||
131478711|NCT03633617|473384912|FG007|Part C (& Follow-up)|Protocol Violation|0|||
131478712|NCT03633617|473384913|FG008|Part C (& Follow-up)|Protocol Violation|0|||
131478713|NCT03633617|473384914|FG009|Part C (& Follow-up)|Protocol Violation|3|||
131478714|NCT03633617|473384915|FG010|Part C (& Follow-up)|Protocol Violation|1|||
131478715|NCT03633617|473384905|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
131478716|NCT03633617|473384906|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
131478717|NCT03633617|473384907|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
131478718|NCT03633617|473384908|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
131478719|NCT03633617|473384909|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
131478720|NCT03633617|473384910|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
131478721|NCT03633617|473384911|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
131478722|NCT03633617|473384912|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
131478723|NCT03633617|473384913|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
131478724|NCT03633617|473384914|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
131478725|NCT03633617|473384915|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
131478726|NCT00629772|473384922|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
131478727|NCT00629772|473384923|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
131478728|NCT00629772|473384922|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
131478729|NCT00629772|473384923|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
131478730|NCT01393301|473384924|FG000|Overall Study|Lost to Follow-up|5|||
131478731|NCT01393301|473384925|FG001|Overall Study|Lost to Follow-up|3|||
131478732|NCT01393301|473384924|FG000|Overall Study|Withdrawal by Subject|2|||
131478733|NCT01393301|473384925|FG001|Overall Study|Withdrawal by Subject|0|||
131478734|NCT01393301|473384924|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
131478735|NCT01393301|473384925|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
131478736|NCT02758171|473384926|FG000|Wash-out|Withdrawal by Subject|1|||
131478737|NCT02758171|473384927|FG001|Wash-out|Withdrawal by Subject|0|||
131478738|NCT02758171|473384926|FG000|Wash-out|Other reason|1|||
131478739|NCT02758171|473384927|FG001|Wash-out|Other reason|0|||
131478740|NCT00853073|473384928|FG000|Overall Study|Withdrawal by Subject|3|||
131478741|NCT00853073|473384929|FG001|Overall Study|Withdrawal by Subject|2|||
131478742|NCT00722423|473384930|FG000|Overall Study|Protocol Violation|0|||
131478743|NCT00722423|473384931|FG001|Overall Study|Protocol Violation|1|||
131478744|NCT01309165|473384932|FG000|Overall Study|Lost to Follow-up|4|||
131478745|NCT01309165|473384933|FG001|Overall Study|Lost to Follow-up|3|||
131478746|NCT01309165|473384932|FG000|Overall Study|Return to work|1|||
131478747|NCT01309165|473384933|FG001|Overall Study|Return to work|2|||
131478748|NCT01309165|473384932|FG000|Overall Study|Left country|0|||
131478749|NCT01309165|473384933|FG001|Overall Study|Left country|1|||
131478750|NCT01309165|473384932|FG000|Overall Study|No transportation|0|||
131478751|NCT01309165|473384933|FG001|Overall Study|No transportation|1|||
131478752|NCT01309165|473384932|FG000|Overall Study|Admitted to hospital for second stroke|1|||
131478753|NCT01309165|473384933|FG001|Overall Study|Admitted to hospital for second stroke|0|||
131478754|NCT05085730|473384935|FG000|Overall Study|Withdrawal by Subject|4|||
131478755|NCT05085730|473384935|FG000|Overall Study|Physician Decision|1|||
131478756|NCT02038881|473384936|FG000|Overall Study|Withdrawal by Subject|0|||
131478757|NCT02038881|473384937|FG001|Overall Study|Withdrawal by Subject|0|||
131478758|NCT02038881|473384938|FG002|Overall Study|Withdrawal by Subject|1|||
131478759|NCT02038881|473384936|FG000|Overall Study|Lost to Follow-up|2|||
131478760|NCT02038881|473384937|FG001|Overall Study|Lost to Follow-up|0|||
131478761|NCT02038881|473384938|FG002|Overall Study|Lost to Follow-up|0|||
131478762|NCT02038881|473384936|FG000|Overall Study|incarcerated|1|||
131478763|NCT02038881|473384937|FG001|Overall Study|incarcerated|0|||
131478764|NCT02038881|473384938|FG002|Overall Study|incarcerated|0|||
131478765|NCT00333840|473384939|FG000|First-line Treatment Period|Adverse Event|38|||
131478766|NCT00333840|473384940|FG001|First-line Treatment Period|Adverse Event|37|||
131478767|NCT00333840|473384941|FG002|First-line Treatment Period|Adverse Event|0|||
131478768|NCT00333840|473384942|FG003|First-line Treatment Period|Adverse Event|0|||
131478769|NCT00333840|473384939|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
131478770|NCT00333840|473384940|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
131478771|NCT00333840|473384941|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
131478772|NCT00333840|473384942|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
131478773|NCT00333840|473384939|FG000|First-line Treatment Period|Abnormal procedure|2|||
131478774|NCT00333840|473384940|FG001|First-line Treatment Period|Abnormal procedure|0|||
131478775|NCT00333840|473384941|FG002|First-line Treatment Period|Abnormal procedure|0|||
131478776|NCT00333840|473384942|FG003|First-line Treatment Period|Abnormal procedure|0|||
131478777|NCT00333840|473384939|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
131478778|NCT00333840|473384940|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
131478779|NCT00333840|473384941|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
131478780|NCT00333840|473384942|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
131478781|NCT00333840|473384939|FG000|First-line Treatment Period|No longer required study drug|21|||
131478782|NCT00333840|473384940|FG001|First-line Treatment Period|No longer required study drug|8|||
131478783|NCT00333840|473384941|FG002|First-line Treatment Period|No longer required study drug|0|||
131478784|NCT00333840|473384942|FG003|First-line Treatment Period|No longer required study drug|0|||
131478785|NCT00333840|473384939|FG000|First-line Treatment Period|Protocol Violation|17|||
131478786|NCT00333840|473384940|FG001|First-line Treatment Period|Protocol Violation|17|||
131478787|NCT00333840|473384941|FG002|First-line Treatment Period|Protocol Violation|0|||
131478788|NCT00333840|473384942|FG003|First-line Treatment Period|Protocol Violation|0|||
131478789|NCT00333840|473384939|FG000|First-line Treatment Period|Subject withdrew consent|57|||
131478790|NCT00333840|473384940|FG001|First-line Treatment Period|Subject withdrew consent|77|||
131478791|NCT00333840|473384941|FG002|First-line Treatment Period|Subject withdrew consent|0|||
131478792|NCT00333840|473384942|FG003|First-line Treatment Period|Subject withdrew consent|0|||
131478793|NCT00333840|473384939|FG000|First-line Treatment Period|Lost to Follow-up|15|||
131478794|NCT00333840|473384940|FG001|First-line Treatment Period|Lost to Follow-up|6|||
131478795|NCT00333840|473384941|FG002|First-line Treatment Period|Lost to Follow-up|0|||
131478796|NCT00333840|473384942|FG003|First-line Treatment Period|Lost to Follow-up|0|||
131478797|NCT00333840|473384939|FG000|First-line Treatment Period|Administrative problems|12|||
131478798|NCT00333840|473384940|FG001|First-line Treatment Period|Administrative problems|6|||
131478799|NCT00333840|473384941|FG002|First-line Treatment Period|Administrative problems|0|||
131478800|NCT00333840|473384942|FG003|First-line Treatment Period|Administrative problems|0|||
131478801|NCT00333840|473384939|FG000|First-line Treatment Period|Death|19|||
131478802|NCT00333840|473384940|FG001|First-line Treatment Period|Death|2|||
131478803|NCT00333840|473384941|FG002|First-line Treatment Period|Death|0|||
131478804|NCT00333840|473384942|FG003|First-line Treatment Period|Death|0|||
131478805|NCT00333840|473384939|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
131478806|NCT00333840|473384940|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
131478807|NCT00333840|473384941|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
131478808|NCT00333840|473384942|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
131478809|NCT00333840|473384939|FG000|Second-line Treatment Period|Adverse Event|0|||
131478810|NCT00333840|473384940|FG001|Second-line Treatment Period|Adverse Event|0|||
131478811|NCT00333840|473384941|FG002|Second-line Treatment Period|Adverse Event|3|||
131478812|NCT00333840|473384942|FG003|Second-line Treatment Period|Adverse Event|34|||
131478813|NCT00333840|473384939|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
131478814|NCT00333840|473384940|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
131478815|NCT00333840|473384941|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
131478816|NCT00333840|473384942|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
131478817|NCT00333840|473384939|FG000|Second-line Treatment Period|Abnormal procedure|0|||
131478818|NCT00333840|473384940|FG001|Second-line Treatment Period|Abnormal procedure|0|||
131478819|NCT00333840|473384941|FG002|Second-line Treatment Period|Abnormal procedure|0|||
131478820|NCT00333840|473384942|FG003|Second-line Treatment Period|Abnormal procedure|1|||
131478821|NCT00333840|473384939|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
131478822|NCT00333840|473384940|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
131478823|NCT00333840|473384941|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
131478824|NCT00333840|473384942|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
131478825|NCT00333840|473384939|FG000|Second-line Treatment Period|No longer required study drug|0|||
131478826|NCT00333840|473384940|FG001|Second-line Treatment Period|No longer required study drug|0|||
131478827|NCT00333840|473384941|FG002|Second-line Treatment Period|No longer required study drug|1|||
131478828|NCT00333840|473384942|FG003|Second-line Treatment Period|No longer required study drug|14|||
131478829|NCT00333840|473384939|FG000|Second-line Treatment Period|Protocol Violation|0|||
131478830|NCT00333840|473384940|FG001|Second-line Treatment Period|Protocol Violation|0|||
131478831|NCT00333840|473384941|FG002|Second-line Treatment Period|Protocol Violation|1|||
131478832|NCT00333840|473384942|FG003|Second-line Treatment Period|Protocol Violation|10|||
131478833|NCT00333840|473384939|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
131478834|NCT00333840|473384940|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
131478835|NCT00333840|473384941|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
131478836|NCT00333840|473384942|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
131478837|NCT00333840|473384939|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
131478838|NCT00333840|473384940|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
131478839|NCT00333840|473384941|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
131478840|NCT00333840|473384942|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
131478841|NCT00333840|473384939|FG000|Second-line Treatment Period|Administrative problems|0|||
131478842|NCT00333840|473384940|FG001|Second-line Treatment Period|Administrative problems|0|||
131478843|NCT00333840|473384941|FG002|Second-line Treatment Period|Administrative problems|0|||
131478844|NCT00333840|473384942|FG003|Second-line Treatment Period|Administrative problems|7|||
131478845|NCT00333840|473384939|FG000|Second-line Treatment Period|Death|0|||
131478846|NCT00333840|473384940|FG001|Second-line Treatment Period|Death|0|||
131478847|NCT00333840|473384941|FG002|Second-line Treatment Period|Death|0|||
131478848|NCT00333840|473384942|FG003|Second-line Treatment Period|Death|9|||
131478849|NCT01453725|473384943|FG000|Overall Study|Adverse Event|3|||
131478850|NCT01453725|473384944|FG001|Overall Study|Adverse Event|3|||
131478851|NCT01453725|473384943|FG000|Overall Study|Lost to Follow-up|4|||
131478852|NCT01453725|473384944|FG001|Overall Study|Lost to Follow-up|0|||
131478853|NCT01453725|473384943|FG000|Overall Study|Non-compliance With Protocol|1|||
131478854|NCT01453725|473384944|FG001|Overall Study|Non-compliance With Protocol|2|||
131478855|NCT01453725|473384943|FG000|Overall Study|Protocol Violation|1|||
131478856|NCT01453725|473384944|FG001|Overall Study|Protocol Violation|0|||
131478857|NCT01453725|473384943|FG000|Overall Study|Withdrawal by Subject|2|||
131478858|NCT01453725|473384944|FG001|Overall Study|Withdrawal by Subject|3|||
131478859|NCT01453725|473384943|FG000|Overall Study|Pregnancy Wish|0|||
131478860|NCT01453725|473384944|FG001|Overall Study|Pregnancy Wish|2|||
131478861|NCT01453725|473384943|FG000|Overall Study|Pregnancy|1|||
131478862|NCT01453725|473384944|FG001|Overall Study|Pregnancy|0|||
131478863|NCT01453725|473384943|FG000|Overall Study|Physician Decision|1|||
131478864|NCT01453725|473384944|FG001|Overall Study|Physician Decision|1|||
131478865|NCT00875979|473384953|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
131478866|NCT00875979|473384954|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
131478867|NCT00875979|473384953|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
131478868|NCT00875979|473384954|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
131478869|NCT00875979|473384953|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
131478870|NCT00875979|473384954|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
131478871|NCT00875979|473384953|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
131478872|NCT00875979|473384954|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
131478873|NCT00875979|473384953|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
131478874|NCT00875979|473384954|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
131478875|NCT00875979|473384953|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
131478876|NCT00875979|473384954|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
131478877|NCT00875979|473384953|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
131478878|NCT00875979|473384954|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
131478879|NCT00875979|473384953|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
131478880|NCT00875979|473384954|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
131478881|NCT00875979|473384953|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
131478882|NCT00875979|473384954|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
131478883|NCT03719586|473384955|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
131478884|NCT03719586|473384956|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
131478885|NCT03719586|473384957|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
131478886|NCT03719586|473384958|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
131478887|NCT00178633|473384959|FG000|Overall Study|Lost to Follow-up|6|||
131478888|NCT04810481|473384963|FG000|Overall Study|Disqualified data sets|10|||
131478889|NCT04810481|473384964|FG001|Overall Study|Disqualified data sets|28|||
131478890|NCT01254292|473384965|FG000|Comparative Phase|Adverse Event|25|||
131478891|NCT01254292|473384966|FG001|Comparative Phase|Adverse Event|25|||
131478892|NCT01254292|473384965|FG000|Comparative Phase|Lost to Follow-up|3|||
131478893|NCT01254292|473384966|FG001|Comparative Phase|Lost to Follow-up|21|||
131478894|NCT01254292|473384965|FG000|Comparative Phase|Pregnancy|2|||
131478895|NCT01254292|473384966|FG001|Comparative Phase|Pregnancy|6|||
131478896|NCT01254292|473384965|FG000|Comparative Phase|Withdrawal by Subject|20|||
131478897|NCT01254292|473384966|FG001|Comparative Phase|Withdrawal by Subject|21|||
131478898|NCT01254292|473384965|FG000|Comparative Phase|Protocol Violation|1|||
131478899|NCT01254292|473384966|FG001|Comparative Phase|Protocol Violation|2|||
131478900|NCT01254292|473384965|FG000|Comparative Phase|Wish for pregnancy|4|||
131478901|NCT01254292|473384966|FG001|Comparative Phase|Wish for pregnancy|6|||
131478902|NCT01254292|473384965|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
131478903|NCT01254292|473384966|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
131478904|NCT01254292|473384965|FG000|LCS12 Extension Phase|Adverse Event|9|||
131478905|NCT01254292|473384966|FG001|LCS12 Extension Phase|Adverse Event|0|||
131478906|NCT01254292|473384965|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
131478907|NCT01254292|473384966|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
131478908|NCT01254292|473384965|FG000|LCS12 Extension Phase|Other unknown|4|||
131478909|NCT01254292|473384966|FG001|LCS12 Extension Phase|Other unknown|0|||
131478910|NCT01254292|473384965|FG000|LCS12 Extension Phase|Pregnancy|2|||
131478911|NCT01254292|473384966|FG001|LCS12 Extension Phase|Pregnancy|0|||
131478912|NCT01254292|473384965|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
131478913|NCT01254292|473384966|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
131478914|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
131478915|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
131478916|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Death|1|||
131478917|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Death|0|||
131478918|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
131496795|NCT01979016|473446397|FG000|Overall Study|Withdrawal by Subject|2|||
131478919|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
131478920|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
131478921|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
131478922|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
131478923|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
131478924|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
131478925|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
131478926|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
131478927|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
131478928|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
131478929|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
131478930|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
131478931|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
131478932|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
131478933|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
131478934|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
131478935|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
131478936|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
131478937|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
131478938|NCT02927262|473384967|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
131478939|NCT02927262|473384968|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
131478940|NCT02927262|473384967|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
131478941|NCT02927262|473384968|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
131478942|NCT02927262|473384967|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
131478943|NCT02927262|473384968|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
131478944|NCT02927262|473384967|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
131478945|NCT02927262|473384968|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
131478946|NCT00923936|473384969|FG000|Overall Study|progressive disease on study|2|||
131478947|NCT00923936|473384970|FG001|Overall Study|progressive disease on study|1|||
131478948|NCT00923936|473384969|FG000|Overall Study|Adverse Event|2|||
131478949|NCT00923936|473384970|FG001|Overall Study|Adverse Event|1|||
131478950|NCT00923936|473384969|FG000|Overall Study|Lost to follow up|2|||
131478951|NCT00923936|473384970|FG001|Overall Study|Lost to follow up|0|||
131478952|NCT00923936|473384969|FG000|Overall Study|Continuing in follow up period|2|||
131478953|NCT00923936|473384970|FG001|Overall Study|Continuing in follow up period|1|||
131478954|NCT01697358|473384971|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
131478955|NCT01697358|473384972|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
131478956|NCT01697358|473384971|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
131478957|NCT01697358|473384972|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
131478958|NCT01697358|473384971|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
131478959|NCT01697358|473384972|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
131478960|NCT01697358|473384971|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
131478961|NCT01697358|473384972|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
131478962|NCT01697358|473384971|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
131478963|NCT01697358|473384972|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
131478964|NCT01697358|473384971|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
131478965|NCT01697358|473384972|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
131478966|NCT01697358|473384971|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
131478967|NCT01697358|473384972|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
131478968|NCT01697358|473384971|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
131478969|NCT01697358|473384972|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
131478970|NCT01697358|473384971|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
131478971|NCT01697358|473384972|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
131478972|NCT01697358|473384971|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
131478973|NCT01697358|473384972|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
131478974|NCT00471146|473384973|FG000|Overall Study|Adverse Event|32|||
131478975|NCT00471146|473384974|FG001|Overall Study|Adverse Event|33|||
131478976|NCT00471146|473384973|FG000|Overall Study|Withdrawal by Subject|14|||
131478977|NCT00471146|473384974|FG001|Overall Study|Withdrawal by Subject|11|||
131478978|NCT00471146|473384973|FG000|Overall Study|Death|11|||
131478979|NCT00471146|473384974|FG001|Overall Study|Death|12|||
131478980|NCT00471146|473384973|FG000|Overall Study|Lost to Follow-up|4|||
131478981|NCT00471146|473384974|FG001|Overall Study|Lost to Follow-up|2|||
131478982|NCT00471146|473384973|FG000|Overall Study|Protocol Violation|2|||
131478983|NCT00471146|473384974|FG001|Overall Study|Protocol Violation|2|||
131478984|NCT00471146|473384973|FG000|Overall Study|Objective progression or relapse|84|||
131478985|NCT00471146|473384974|FG001|Overall Study|Objective progression or relapse|87|||
131478986|NCT00471146|473384973|FG000|Overall Study|Global deterioration of health status|12|||
131478987|NCT00471146|473384974|FG001|Overall Study|Global deterioration of health status|14|||
131478988|NCT00471146|473384973|FG000|Overall Study|Randomized but not treated|9|||
131478989|NCT00471146|473384974|FG001|Overall Study|Randomized but not treated|8|||
131478990|NCT00471146|473384973|FG000|Overall Study|Other|4|||
131478991|NCT00471146|473384974|FG001|Overall Study|Other|5|||
131478992|NCT05394350|473384975|FG000|Overall Study|Death|2|||
131478993|NCT05394350|473384976|FG001|Overall Study|Death|2|||
131478994|NCT05394350|473384977|FG002|Overall Study|Death|4|||
131478995|NCT05394350|473384978|FG003|Overall Study|Death|0|||
131478996|NCT05394350|473384979|FG004|Overall Study|Death|1|||
131478997|NCT05394350|473384980|FG005|Overall Study|Death|0|||
131478998|NCT05394350|473384975|FG000|Overall Study|Study terminated by sponsor|1|||
131478999|NCT05394350|473384976|FG001|Overall Study|Study terminated by sponsor|1|||
131479000|NCT05394350|473384977|FG002|Overall Study|Study terminated by sponsor|7|||
131479001|NCT05394350|473384978|FG003|Overall Study|Study terminated by sponsor|3|||
131479002|NCT05394350|473384979|FG004|Overall Study|Study terminated by sponsor|2|||
131479003|NCT05394350|473384980|FG005|Overall Study|Study terminated by sponsor|4|||
131479004|NCT02963935|473384983|FG000|Overall Study|Adverse Event|12|||
131479005|NCT02963935|473384984|FG001|Overall Study|Adverse Event|6|||
131479006|NCT02963935|473384983|FG000|Overall Study|Protocol Violation|2|||
131479007|NCT02963935|473384984|FG001|Overall Study|Protocol Violation|1|||
131479008|NCT02963935|473384983|FG000|Overall Study|Lack of Efficacy|0|||
131479009|NCT02963935|473384984|FG001|Overall Study|Lack of Efficacy|2|||
131479010|NCT02963935|473384983|FG000|Overall Study|Lost to Follow-up|1|||
131479011|NCT02963935|473384984|FG001|Overall Study|Lost to Follow-up|6|||
131479012|NCT02963935|473384983|FG000|Overall Study|Unclassified|13|||
131479013|NCT02963935|473384984|FG001|Overall Study|Unclassified|22|||
131479014|NCT00464269|473384985|FG000|Overall Study|Lack of Efficacy|1|||
131479015|NCT00464269|473384986|FG001|Overall Study|Lack of Efficacy|0|||
131479016|NCT00464269|473384987|FG002|Overall Study|Lack of Efficacy|0|||
131479017|NCT00464269|473384988|FG003|Overall Study|Lack of Efficacy|0|||
131479018|NCT00464269|473384985|FG000|Overall Study|Lost to Follow-up|0|||
131479019|NCT00464269|473384986|FG001|Overall Study|Lost to Follow-up|4|||
131479020|NCT00464269|473384987|FG002|Overall Study|Lost to Follow-up|0|||
131479021|NCT00464269|473384988|FG003|Overall Study|Lost to Follow-up|1|||
131479022|NCT00464269|473384985|FG000|Overall Study|Withdrawal by Subject|0|||
131479023|NCT00464269|473384986|FG001|Overall Study|Withdrawal by Subject|2|||
131479024|NCT00464269|473384987|FG002|Overall Study|Withdrawal by Subject|1|||
131479025|NCT00464269|473384988|FG003|Overall Study|Withdrawal by Subject|1|||
131479026|NCT00464269|473384985|FG000|Overall Study|Other reason|3|||
131479027|NCT00464269|473384986|FG001|Overall Study|Other reason|3|||
131479028|NCT00464269|473384987|FG002|Overall Study|Other reason|1|||
131479029|NCT00464269|473384988|FG003|Overall Study|Other reason|1|||
131479030|NCT00464269|473384985|FG000|Overall Study|AE, serious fatal|0|||
131479031|NCT00464269|473384986|FG001|Overall Study|AE, serious fatal|0|||
131479032|NCT00464269|473384987|FG002|Overall Study|AE, serious fatal|1|||
131479033|NCT00464269|473384988|FG003|Overall Study|AE, serious fatal|1|||
131479034|NCT00464269|473384985|FG000|Overall Study|SAE, non-fatal|0|||
131479035|NCT00464269|473384986|FG001|Overall Study|SAE, non-fatal|0|||
131479036|NCT00464269|473384987|FG002|Overall Study|SAE, non-fatal|0|||
131479037|NCT00464269|473384988|FG003|Overall Study|SAE, non-fatal|1|||
131479038|NCT00464269|473384985|FG000|Overall Study|AE, non-serious non-fatal|2|||
131479039|NCT00464269|473384986|FG001|Overall Study|AE, non-serious non-fatal|8|||
131479040|NCT00464269|473384987|FG002|Overall Study|AE, non-serious non-fatal|3|||
131479041|NCT00464269|473384988|FG003|Overall Study|AE, non-serious non-fatal|4|||
131479042|NCT00464269|473384985|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131479043|NCT00464269|473384986|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131479044|NCT00464269|473384987|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
131479045|NCT00464269|473384988|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131479046|NCT01898208|473384991|FG000|Overall Study|Positive blood culture|17|||
131479047|NCT01898208|473384992|FG001|Overall Study|Positive blood culture|23|||
131479048|NCT01898208|473384993|FG002|Overall Study|Positive blood culture|15|||
131479049|NCT01898208|473384991|FG000|Overall Study|Death/comfort care within 24 hours|10|||
131479050|NCT01898208|473384992|FG001|Overall Study|Death/comfort care within 24 hours|9|||
131479051|NCT01898208|473384993|FG002|Overall Study|Death/comfort care within 24 hours|8|||
131479052|NCT01898208|473384991|FG000|Overall Study|Negative Gram Stain|6|||
131479053|NCT01898208|473384992|FG001|Overall Study|Negative Gram Stain|9|||
131479054|NCT01898208|473384993|FG002|Overall Study|Negative Gram Stain|6|||
131479055|NCT01898208|473384991|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
131479056|NCT01898208|473384992|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
131479057|NCT01898208|473384993|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
131479058|NCT01898208|473384991|FG000|Overall Study|System/Technical Error|1|||
131479059|NCT01898208|473384992|FG001|Overall Study|System/Technical Error|2|||
131479060|NCT01898208|473384993|FG002|Overall Study|System/Technical Error|3|||
131479061|NCT01898208|473384991|FG000|Overall Study|Lost to Follow-up|3|||
131479062|NCT01898208|473384992|FG001|Overall Study|Lost to Follow-up|1|||
131479063|NCT01898208|473384993|FG002|Overall Study|Lost to Follow-up|1|||
131479064|NCT03001882|473384995|FG000|Overall Study|Death|1|||
131479065|NCT03001882|473384996|FG001|Overall Study|Death|0|||
131479066|NCT03001882|473384997|FG002|Overall Study|Death|0|||
131479067|NCT03001882|473384998|FG003|Overall Study|Death|3|||
131479068|NCT03001882|473384995|FG000|Overall Study|Participant withdrew consent|0|||
131479069|NCT03001882|473384996|FG001|Overall Study|Participant withdrew consent|1|||
131479070|NCT03001882|473384997|FG002|Overall Study|Participant withdrew consent|0|||
131479071|NCT03001882|473384998|FG003|Overall Study|Participant withdrew consent|5|||
131479072|NCT03001882|473384995|FG000|Overall Study|Other reasons|1|||
131479073|NCT03001882|473384996|FG001|Overall Study|Other reasons|2|||
131479074|NCT03001882|473384997|FG002|Overall Study|Other reasons|0|||
131479075|NCT03001882|473384998|FG003|Overall Study|Other reasons|5|||
131479076|NCT03001882|473384995|FG000|Overall Study|Administrative reason by sponsor|0|||
131479077|NCT03001882|473384996|FG001|Overall Study|Administrative reason by sponsor|0|||
131479078|NCT03001882|473384997|FG002|Overall Study|Administrative reason by sponsor|0|||
131479079|NCT03001882|473384998|FG003|Overall Study|Administrative reason by sponsor|1|||
131479080|NCT03001882|473384995|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
131479081|NCT03001882|473384996|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
131479082|NCT03001882|473384997|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
131479083|NCT03001882|473384998|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
131479084|NCT03001882|473384995|FG000|Overall Study|Not reported|0|||
131479085|NCT03001882|473384996|FG001|Overall Study|Not reported|0|||
131479086|NCT03001882|473384997|FG002|Overall Study|Not reported|0|||
131479087|NCT03001882|473384998|FG003|Overall Study|Not reported|6|||
131479088|NCT03001882|473384995|FG000|Overall Study|Maximum clinical benefit|2|||
131479089|NCT03001882|473384996|FG001|Overall Study|Maximum clinical benefit|3|||
131479090|NCT03001882|473384997|FG002|Overall Study|Maximum clinical benefit|0|||
131479091|NCT03001882|473384998|FG003|Overall Study|Maximum clinical benefit|10|||
131479092|NCT03001882|473384995|FG000|Overall Study|AE unrelated to study drug|3|||
131479093|NCT03001882|473384996|FG001|Overall Study|AE unrelated to study drug|3|||
131479094|NCT03001882|473384997|FG002|Overall Study|AE unrelated to study drug|0|||
131479095|NCT03001882|473384998|FG003|Overall Study|AE unrelated to study drug|11|||
131479096|NCT03001882|473384995|FG000|Overall Study|Study Drug Toxicity|8|||
131479097|NCT03001882|473384996|FG001|Overall Study|Study Drug Toxicity|5|||
131479098|NCT03001882|473384997|FG002|Overall Study|Study Drug Toxicity|0|||
131479099|NCT03001882|473384998|FG003|Overall Study|Study Drug Toxicity|37|||
131479100|NCT03001882|473384995|FG000|Overall Study|Disease progression|16|||
131479101|NCT03001882|473384996|FG001|Overall Study|Disease progression|14|||
131479102|NCT03001882|473384997|FG002|Overall Study|Disease progression|1|||
131479103|NCT03001882|473384998|FG003|Overall Study|Disease progression|90|||
131479104|NCT02651467|473386513|FG000|Overall Study|Withdrawal by Subject|0|||
131479105|NCT02651467|473386514|FG001|Overall Study|Withdrawal by Subject|0|||
131479106|NCT02651467|473386515|FG002|Overall Study|Withdrawal by Subject|2|||
131479107|NCT02651467|473386513|FG000|Overall Study|Other (Not specified)|1|||
131479108|NCT02651467|473386514|FG001|Overall Study|Other (Not specified)|0|||
131479109|NCT02651467|473386515|FG002|Overall Study|Other (Not specified)|2|||
131479110|NCT02024529|473386516|FG000|Overall Study|Withdrawal by Subject|11|||
131479111|NCT02024529|473386517|FG001|Overall Study|Withdrawal by Subject|21|||
131479112|NCT02024529|473386516|FG000|Overall Study|Lost to Follow-up|2|||
131479113|NCT02024529|473386517|FG001|Overall Study|Lost to Follow-up|4|||
131479114|NCT00354614|473386518|FG000|Overall Study|Lack of Efficacy|28|||
131479115|NCT02124161|473386519|FG000|Overall Study|Other unspecified|0|||
131479116|NCT02124161|473386520|FG001|Overall Study|Other unspecified|1|||
131479117|NCT02124161|473386519|FG000|Overall Study|Death|1|||
131479118|NCT02124161|473386520|FG001|Overall Study|Death|0|||
131479119|NCT02124161|473386519|FG000|Overall Study|Protocol Violation|2|||
131479120|NCT02124161|473386520|FG001|Overall Study|Protocol Violation|1|||
131479121|NCT02124161|473386519|FG000|Overall Study|Withdrawal by Subject|1|||
131479122|NCT02124161|473386520|FG001|Overall Study|Withdrawal by Subject|2|||
131479123|NCT02124161|473386519|FG000|Overall Study|Adverse Event|2|||
131479124|NCT02124161|473386520|FG001|Overall Study|Adverse Event|0|||
131479125|NCT02124161|473386519|FG000|Overall Study|Does not meet entrance criteria|2|||
131479126|NCT02124161|473386520|FG001|Overall Study|Does not meet entrance criteria|3|||
131479127|NCT02124161|473386519|FG000|Overall Study|No longer meets eligibility criteria|5|||
131479128|NCT02124161|473386520|FG001|Overall Study|No longer meets eligibility criteria|4|||
131479129|NCT02124161|473386519|FG000|Overall Study|Lost to Follow-up|3|||
131479130|NCT02124161|473386520|FG001|Overall Study|Lost to Follow-up|4|||
131479131|NCT02517866|473386521|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
131479132|NCT02517866|473386522|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
131479133|NCT02517866|473386523|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131479134|NCT02517866|473386521|FG000|Overall Study|Significant Protocol Deviation|4|||
131479135|NCT02517866|473386522|FG001|Overall Study|Significant Protocol Deviation|1|||
131479136|NCT02517866|473386523|FG002|Overall Study|Significant Protocol Deviation|0|||
131479137|NCT02517866|473386521|FG000|Overall Study|Lost to Follow-up|1|||
131479138|NCT02517866|473386522|FG001|Overall Study|Lost to Follow-up|0|||
131479139|NCT02517866|473386523|FG002|Overall Study|Lost to Follow-up|0|||
131479140|NCT02517866|473386521|FG000|Overall Study|Voluntary Withdrawal|2|||
131479141|NCT02517866|473386522|FG001|Overall Study|Voluntary Withdrawal|2|||
131479142|NCT02517866|473386523|FG002|Overall Study|Voluntary Withdrawal|0|||
131479143|NCT02517866|473386521|FG000|Overall Study|Investigator Decision|2|||
131479144|NCT02517866|473386522|FG001|Overall Study|Investigator Decision|1|||
131479145|NCT02517866|473386523|FG002|Overall Study|Investigator Decision|0|||
131479146|NCT02517866|473386521|FG000|Overall Study|Reason not specified|2|||
131479147|NCT02517866|473386522|FG001|Overall Study|Reason not specified|0|||
131479148|NCT02517866|473386523|FG002|Overall Study|Reason not specified|0|||
131479149|NCT04674644|473386531|FG000|Overall Study|with missing data|37|||
131479150|NCT01230710|473386537|FG000|Overall Study|Disease Progression|41|||
131479151|NCT01230710|473386537|FG000|Overall Study|Lost to Follow-up|3|||
131479152|NCT01230710|473386537|FG000|Overall Study|Death|4|||
131479153|NCT01230710|473386537|FG000|Overall Study|Withdrawal of Consent|1|||
131479154|NCT00747812|473386538|FG000|Overall Study|Research Site Staff Relocation|5|||
131479155|NCT00747812|473386539|FG001|Overall Study|Research Site Staff Relocation|3|||
131479156|NCT01708161|473386540|FG000|Overall Study|Adverse Event|1|||
131479157|NCT01708161|473386541|FG001|Overall Study|Adverse Event|3|||
131479158|NCT01708161|473386542|FG002|Overall Study|Adverse Event|4|||
131479159|NCT01708161|473386543|FG003|Overall Study|Adverse Event|2|||
131479160|NCT01708161|473386544|FG004|Overall Study|Adverse Event|3|||
131479161|NCT01708161|473386545|FG005|Overall Study|Adverse Event|0|||
131479162|NCT01708161|473386540|FG000|Overall Study|Death|0|||
131479163|NCT01708161|473386541|FG001|Overall Study|Death|0|||
131479164|NCT01708161|473386542|FG002|Overall Study|Death|0|||
131479165|NCT01708161|473386543|FG003|Overall Study|Death|1|||
131479166|NCT01708161|473386544|FG004|Overall Study|Death|0|||
131479167|NCT01708161|473386545|FG005|Overall Study|Death|1|||
131479168|NCT01708161|473386540|FG000|Overall Study|Withdrawal by Subject|0|||
131479169|NCT01708161|473386541|FG001|Overall Study|Withdrawal by Subject|1|||
131479170|NCT01708161|473386542|FG002|Overall Study|Withdrawal by Subject|1|||
131479171|NCT01708161|473386543|FG003|Overall Study|Withdrawal by Subject|0|||
131479172|NCT01708161|473386544|FG004|Overall Study|Withdrawal by Subject|0|||
131479173|NCT01708161|473386545|FG005|Overall Study|Withdrawal by Subject|0|||
131479174|NCT01708161|473386540|FG000|Overall Study|Administrative problems|0|||
131479175|NCT01708161|473386541|FG001|Overall Study|Administrative problems|1|||
131479176|NCT01708161|473386542|FG002|Overall Study|Administrative problems|0|||
131479177|NCT01708161|473386543|FG003|Overall Study|Administrative problems|0|||
131479178|NCT01708161|473386544|FG004|Overall Study|Administrative problems|0|||
131479179|NCT01708161|473386545|FG005|Overall Study|Administrative problems|0|||
131479180|NCT01708161|473386540|FG000|Overall Study|Disease progression|3|||
131479181|NCT01708161|473386541|FG001|Overall Study|Disease progression|5|||
131479182|NCT01708161|473386542|FG002|Overall Study|Disease progression|5|||
131479183|NCT01708161|473386543|FG003|Overall Study|Disease progression|13|||
131479184|NCT01708161|473386544|FG004|Overall Study|Disease progression|3|||
131479185|NCT01708161|473386545|FG005|Overall Study|Disease progression|0|||
131479186|NCT02019277|473386546|FG000|Overall Study|Withdrawal by Subject|3|||
131479187|NCT02019277|473386546|FG000|Overall Study|Death|7|||
131479188|NCT02019277|473386546|FG000|Overall Study|Did no Cooperate|1|||
131479189|NCT02019277|473386546|FG000|Overall Study|Adverse Event|1|||
131479190|NCT02633501|473386548|FG000|Overall Study|Adverse Event|0|||
131479191|NCT02633501|473386549|FG001|Overall Study|Adverse Event|0|||
131479192|NCT02633501|473386550|FG002|Overall Study|Adverse Event|1|||
131479193|NCT02633501|473386551|FG003|Overall Study|Adverse Event|0|||
131479194|NCT02633501|473386552|FG004|Overall Study|Adverse Event|1|||
131479195|NCT02633501|473386553|FG005|Overall Study|Adverse Event|1|||
131479196|NCT02633501|473386548|FG000|Overall Study|Withdrawal by Subject|2|||
131479197|NCT02633501|473386549|FG001|Overall Study|Withdrawal by Subject|1|||
131479198|NCT02633501|473386550|FG002|Overall Study|Withdrawal by Subject|2|||
131479199|NCT02633501|473386551|FG003|Overall Study|Withdrawal by Subject|2|||
131479200|NCT02633501|473386552|FG004|Overall Study|Withdrawal by Subject|1|||
131479201|NCT02633501|473386553|FG005|Overall Study|Withdrawal by Subject|3|||
131479202|NCT02633501|473386548|FG000|Overall Study|Various other reasons|0|||
131479203|NCT02633501|473386549|FG001|Overall Study|Various other reasons|2|||
131479204|NCT02633501|473386550|FG002|Overall Study|Various other reasons|4|||
131479205|NCT02633501|473386551|FG003|Overall Study|Various other reasons|1|||
131479206|NCT02633501|473386552|FG004|Overall Study|Various other reasons|7|||
131479207|NCT02633501|473386553|FG005|Overall Study|Various other reasons|11|||
131479208|NCT02633501|473386548|FG000|Overall Study|Lost to Follow-up|0|||
131479209|NCT02633501|473386549|FG001|Overall Study|Lost to Follow-up|0|||
131479210|NCT02633501|473386550|FG002|Overall Study|Lost to Follow-up|0|||
131479211|NCT02633501|473386551|FG003|Overall Study|Lost to Follow-up|1|||
131479212|NCT02633501|473386552|FG004|Overall Study|Lost to Follow-up|2|||
131479213|NCT02633501|473386553|FG005|Overall Study|Lost to Follow-up|0|||
131479214|NCT01986140|473386555|FG000|Overall Study|Withdrawal by Subject|31|||
131479215|NCT01986140|473386556|FG001|Overall Study|Withdrawal by Subject|25|||
131479216|NCT01986140|473386555|FG000|Overall Study|alternative treatment|1|||
131479217|NCT01986140|473386556|FG001|Overall Study|alternative treatment|1|||
131479218|NCT01986140|473386555|FG000|Overall Study|found not eligible|3|||
131479219|NCT01986140|473386556|FG001|Overall Study|found not eligible|0|||
131479220|NCT01986140|473386555|FG000|Overall Study|Adverse Event|0|||
131479221|NCT01986140|473386556|FG001|Overall Study|Adverse Event|1|||
131479222|NCT01986140|473386555|FG000|Overall Study|progression disease|0|||
131479223|NCT01986140|473386556|FG001|Overall Study|progression disease|1|||
131479224|NCT01069627|473386562|FG000|Overall Study|Disease progression|7|||
131479225|NCT01069627|473386562|FG000|Overall Study|Adverse Event|12|||
131479226|NCT01069627|473386562|FG000|Overall Study|Protocol Violation|1|||
131479227|NCT02939079|473386566|FG000|Overall Study|Adverse Event|2|||
131479228|NCT02939079|473386567|FG001|Overall Study|Adverse Event|1|||
131479229|NCT02939079|473386566|FG000|Overall Study|Lost to Follow-up|0|||
131479230|NCT02939079|473386567|FG001|Overall Study|Lost to Follow-up|2|||
131479231|NCT02939079|473386566|FG000|Overall Study|Protocol Violation|1|||
131479232|NCT02939079|473386567|FG001|Overall Study|Protocol Violation|0|||
131479233|NCT02939079|473386566|FG000|Overall Study|Withdrawal by Subject|0|||
131479234|NCT02939079|473386567|FG001|Overall Study|Withdrawal by Subject|1|||
131479235|NCT02939079|473386566|FG000|Overall Study|relapse during the study|1|||
131479236|NCT02939079|473386567|FG001|Overall Study|relapse during the study|1|||
131479237|NCT04209348|473386568|FG000|Overall Study|Lost to Follow-up|1|||
131479238|NCT04209348|473386569|FG001|Overall Study|Lost to Follow-up|0|||
131479239|NCT05055128|473386572|FG000|Overall Study|Adverse Event|0|||
131479240|NCT05055128|473386573|FG001|Overall Study|Adverse Event|0|||
131479241|NCT05055128|473386574|FG002|Overall Study|Adverse Event|0|||
131479242|NCT05055128|473386575|FG003|Overall Study|Adverse Event|1|||
131479243|NCT05055128|473386576|FG004|Overall Study|Adverse Event|1|||
131479244|NCT05055128|473386572|FG000|Overall Study|Protocol Violation|0|||
131479245|NCT05055128|473386573|FG001|Overall Study|Protocol Violation|0|||
131479246|NCT05055128|473386574|FG002|Overall Study|Protocol Violation|0|||
131479247|NCT05055128|473386575|FG003|Overall Study|Protocol Violation|1|||
131479248|NCT05055128|473386576|FG004|Overall Study|Protocol Violation|0|||
131479249|NCT05055128|473386572|FG000|Overall Study|Withdrawal by Subject|5|||
131479250|NCT05055128|473386573|FG001|Overall Study|Withdrawal by Subject|2|||
131479251|NCT05055128|473386574|FG002|Overall Study|Withdrawal by Subject|2|||
131479252|NCT05055128|473386575|FG003|Overall Study|Withdrawal by Subject|4|||
131479253|NCT05055128|473386576|FG004|Overall Study|Withdrawal by Subject|2|||
131479254|NCT05055128|473386572|FG000|Overall Study|Randomized By Mistake|0|||
131479255|NCT05055128|473386573|FG001|Overall Study|Randomized By Mistake|1|||
131479256|NCT05055128|473386574|FG002|Overall Study|Randomized By Mistake|0|||
131479257|NCT05055128|473386575|FG003|Overall Study|Randomized By Mistake|0|||
131479258|NCT05055128|473386576|FG004|Overall Study|Randomized By Mistake|0|||
131479259|NCT05055128|473386572|FG000|Overall Study|Other|1|||
131479260|NCT05055128|473386573|FG001|Overall Study|Other|0|||
131479261|NCT05055128|473386574|FG002|Overall Study|Other|0|||
131479262|NCT05055128|473386575|FG003|Overall Study|Other|0|||
131479263|NCT05055128|473386576|FG004|Overall Study|Other|0|||
131479264|NCT01460368|473386577|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
131479265|NCT01460368|473386578|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
131479266|NCT01460368|473386579|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
131479267|NCT01460368|473386580|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
131479268|NCT01460368|473386581|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
131479269|NCT01460368|473386582|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
131479270|NCT01460368|473386583|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
131479271|NCT01460368|473386577|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
131479272|NCT01460368|473386578|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
131479273|NCT01460368|473386579|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
131479274|NCT01460368|473386580|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
131479275|NCT01460368|473386581|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
131479276|NCT01460368|473386582|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
131479277|NCT01460368|473386583|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
131479278|NCT01460368|473386577|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
131479279|NCT01460368|473386578|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
131479280|NCT01460368|473386579|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
131479281|NCT01460368|473386580|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
131479282|NCT01460368|473386581|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
131479283|NCT01460368|473386582|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
131479284|NCT01460368|473386583|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
131479285|NCT01460368|473386577|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
131479286|NCT01460368|473386578|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
131479287|NCT01460368|473386579|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
131479288|NCT01460368|473386580|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
131479289|NCT01460368|473386581|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
131479290|NCT01460368|473386582|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
131479291|NCT01460368|473386583|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
131479292|NCT01460368|473386577|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
131479293|NCT01460368|473386578|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
131479294|NCT01460368|473386579|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
131479295|NCT01460368|473386580|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
131479296|NCT01460368|473386581|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
131479297|NCT01460368|473386582|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
131479298|NCT01460368|473386583|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
131479299|NCT02149875|473386590|FG000|Overall Study|Lost to Follow-up|3|||
131479300|NCT02149875|473386591|FG001|Overall Study|Lost to Follow-up|4|||
131479301|NCT02149875|473386592|FG002|Overall Study|Lost to Follow-up|5|||
131479302|NCT02149875|473386590|FG000|Overall Study|Withdrawal by Subject|3|||
131479303|NCT02149875|473386591|FG001|Overall Study|Withdrawal by Subject|2|||
131479304|NCT02149875|473386592|FG002|Overall Study|Withdrawal by Subject|2|||
131479305|NCT02149875|473386590|FG000|Overall Study|Physician Decision|1|||
131479306|NCT02149875|473386591|FG001|Overall Study|Physician Decision|2|||
131479307|NCT02149875|473386592|FG002|Overall Study|Physician Decision|2|||
131479308|NCT01385371|473386593|FG000|Overall Study|Adverse Event|54|||
131479309|NCT01385371|473386594|FG001|Overall Study|Adverse Event|19|||
131479310|NCT01385371|473386593|FG000|Overall Study|Lost to Follow-up|16|||
131479311|NCT01385371|473386594|FG001|Overall Study|Lost to Follow-up|16|||
131479312|NCT01385371|473386593|FG000|Overall Study|Withdrawal by Subject|52|||
131479313|NCT01385371|473386594|FG001|Overall Study|Withdrawal by Subject|39|||
131479314|NCT01385371|473386593|FG000|Overall Study|Protocol Violation|25|||
131479315|NCT01385371|473386594|FG001|Overall Study|Protocol Violation|21|||
131479316|NCT01385371|473386593|FG000|Overall Study|Administrative|2|||
131479317|NCT01385371|473386594|FG001|Overall Study|Administrative|2|||
131479318|NCT02478372|473386595|FG000|Overall Study|Protocol Violation|12|||
131479319|NCT02478372|473386596|FG001|Overall Study|Protocol Violation|8|||
131479320|NCT02478372|473386595|FG000|Overall Study|Lost to Follow-up|1|||
131479321|NCT02478372|473386596|FG001|Overall Study|Lost to Follow-up|4|||
131479322|NCT02478372|473386595|FG000|Overall Study|Death|0|||
131479323|NCT02478372|473386596|FG001|Overall Study|Death|2|||
131479324|NCT01565642|473386598|FG000|Overall Study|Withdrawal by Subject|2|||
131479325|NCT01565642|473386599|FG001|Overall Study|Withdrawal by Subject|1|||
131479326|NCT02955797|473386600|FG000|Overall Study|Protocol Violation|1|||
131479327|NCT02955797|473386601|FG001|Overall Study|Protocol Violation|0|||
131479328|NCT02955797|473386602|FG002|Overall Study|Protocol Violation|0|||
131479329|NCT02955797|473386603|FG003|Overall Study|Protocol Violation|1|||
131479330|NCT02955797|473386600|FG000|Overall Study|Withdrawal by Subject|2|||
131479331|NCT02955797|473386601|FG001|Overall Study|Withdrawal by Subject|2|||
131479332|NCT02955797|473386602|FG002|Overall Study|Withdrawal by Subject|0|||
131479333|NCT02955797|473386603|FG003|Overall Study|Withdrawal by Subject|1|||
131479334|NCT02955797|473386600|FG000|Overall Study|Lost to Follow-up|0|||
131479335|NCT02955797|473386601|FG001|Overall Study|Lost to Follow-up|1|||
131479336|NCT02955797|473386602|FG002|Overall Study|Lost to Follow-up|0|||
131479337|NCT02955797|473386603|FG003|Overall Study|Lost to Follow-up|0|||
131479338|NCT00961649|473386605|FG000|Overall Study|Adverse Event|4|||
131479339|NCT00961649|473386606|FG001|Overall Study|Adverse Event|0|||
131479340|NCT00961649|473386607|FG002|Overall Study|Adverse Event|0|||
131479341|NCT00961649|473386608|FG003|Overall Study|Adverse Event|2|||
131479342|NCT00961649|473386605|FG000|Overall Study|Inadequate control of IOP|0|||
131479343|NCT00961649|473386606|FG001|Overall Study|Inadequate control of IOP|0|||
131479344|NCT00961649|473386607|FG002|Overall Study|Inadequate control of IOP|0|||
131479345|NCT00961649|473386608|FG003|Overall Study|Inadequate control of IOP|1|||
131479346|NCT00961649|473386605|FG000|Overall Study|Patient has travel plans during holidays|0|||
131479347|NCT00961649|473386606|FG001|Overall Study|Patient has travel plans during holidays|0|||
131479348|NCT00961649|473386607|FG002|Overall Study|Patient has travel plans during holidays|1|||
131479349|NCT00961649|473386608|FG003|Overall Study|Patient has travel plans during holidays|0|||
131479350|NCT00961649|473386605|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
131479351|NCT00961649|473386606|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
131479352|NCT00961649|473386607|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
131479353|NCT00961649|473386608|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
131479354|NCT00961649|473386605|FG000|Overall Study|Study terminated by sponsor|4|||
131479355|NCT00961649|473386606|FG001|Overall Study|Study terminated by sponsor|4|||
131479356|NCT00961649|473386607|FG002|Overall Study|Study terminated by sponsor|4|||
131479357|NCT00961649|473386608|FG003|Overall Study|Study terminated by sponsor|1|||
131479358|NCT02711345|473386609|FG000|Overall Study|Adverse Event|0|||
131479359|NCT02711345|473386610|FG001|Overall Study|Adverse Event|0|||
131479360|NCT02711345|473386611|FG002|Overall Study|Adverse Event|0|||
131479361|NCT02711345|473386612|FG003|Overall Study|Adverse Event|1|||
131479362|NCT02711345|473386613|FG004|Overall Study|Adverse Event|1|||
131479363|NCT02711345|473386614|FG005|Overall Study|Adverse Event|2|||
131479364|NCT02711345|473386615|FG006|Overall Study|Adverse Event|1|||
131479365|NCT02711345|473386616|FG007|Overall Study|Adverse Event|0|||
131479366|NCT02711345|473386617|FG008|Overall Study|Adverse Event|0|||
131479367|NCT02711345|473386618|FG009|Overall Study|Adverse Event|2|||
131479368|NCT02711345|473386609|FG000|Overall Study|Physician Decision|0|||
131479369|NCT02711345|473386610|FG001|Overall Study|Physician Decision|0|||
131479370|NCT02711345|473386611|FG002|Overall Study|Physician Decision|1|||
131479371|NCT02711345|473386612|FG003|Overall Study|Physician Decision|0|||
131479372|NCT02711345|473386613|FG004|Overall Study|Physician Decision|0|||
131479373|NCT02711345|473386614|FG005|Overall Study|Physician Decision|0|||
131479374|NCT02711345|473386615|FG006|Overall Study|Physician Decision|0|||
131479375|NCT02711345|473386616|FG007|Overall Study|Physician Decision|0|||
131479376|NCT02711345|473386617|FG008|Overall Study|Physician Decision|1|||
131479377|NCT02711345|473386618|FG009|Overall Study|Physician Decision|0|||
131479378|NCT02711345|473386609|FG000|Overall Study|Progressive disease|1|||
131479379|NCT02711345|473386610|FG001|Overall Study|Progressive disease|3|||
131479380|NCT02711345|473386611|FG002|Overall Study|Progressive disease|5|||
131479381|NCT02711345|473386612|FG003|Overall Study|Progressive disease|3|||
131479382|NCT02711345|473386613|FG004|Overall Study|Progressive disease|7|||
131479383|NCT02711345|473386614|FG005|Overall Study|Progressive disease|2|||
131479384|NCT02711345|473386615|FG006|Overall Study|Progressive disease|8|||
131479385|NCT02711345|473386616|FG007|Overall Study|Progressive disease|4|||
131479386|NCT02711345|473386617|FG008|Overall Study|Progressive disease|5|||
131479387|NCT02711345|473386618|FG009|Overall Study|Progressive disease|6|||
131479388|NCT02711345|473386609|FG000|Overall Study|Subject/guardian decision|0|||
131479389|NCT02711345|473386610|FG001|Overall Study|Subject/guardian decision|0|||
131479390|NCT02711345|473386611|FG002|Overall Study|Subject/guardian decision|0|||
131479391|NCT02711345|473386612|FG003|Overall Study|Subject/guardian decision|0|||
131479392|NCT02711345|473386613|FG004|Overall Study|Subject/guardian decision|0|||
131479393|NCT02711345|473386614|FG005|Overall Study|Subject/guardian decision|2|||
131479394|NCT02711345|473386615|FG006|Overall Study|Subject/guardian decision|3|||
131479395|NCT02711345|473386616|FG007|Overall Study|Subject/guardian decision|1|||
131479396|NCT02711345|473386617|FG008|Overall Study|Subject/guardian decision|0|||
131479397|NCT02711345|473386618|FG009|Overall Study|Subject/guardian decision|4|||
131479398|NCT02711345|473386609|FG000|Overall Study|Death|1|||
131479399|NCT02711345|473386610|FG001|Overall Study|Death|0|||
131479400|NCT02711345|473386611|FG002|Overall Study|Death|0|||
131479401|NCT02711345|473386612|FG003|Overall Study|Death|0|||
131479402|NCT02711345|473386613|FG004|Overall Study|Death|0|||
131479403|NCT02711345|473386614|FG005|Overall Study|Death|0|||
131479404|NCT02711345|473386615|FG006|Overall Study|Death|0|||
131479405|NCT02711345|473386616|FG007|Overall Study|Death|1|||
131479406|NCT02711345|473386617|FG008|Overall Study|Death|0|||
131479407|NCT02711345|473386618|FG009|Overall Study|Death|0|||
131479408|NCT00543543|473386621|FG000|Base Study|Adverse Event|1|||
131479409|NCT00543543|473386622|FG001|Base Study|Adverse Event|11|||
131479410|NCT00543543|473386623|FG002|Base Study|Adverse Event|0|||
131479411|NCT00543543|473386624|FG003|Base Study|Adverse Event|5|||
131479412|NCT00543543|473386621|FG000|Base Study|Lost to Follow-up|12|||
131479413|NCT00543543|473386622|FG001|Base Study|Lost to Follow-up|749|||
131479414|NCT00543543|473386623|FG002|Base Study|Lost to Follow-up|9|||
131479415|NCT00543543|473386624|FG003|Base Study|Lost to Follow-up|701|||
131479416|NCT00543543|473386621|FG000|Base Study|Physician Decision|0|||
131479417|NCT00543543|473386622|FG001|Base Study|Physician Decision|4|||
131479418|NCT00543543|473386623|FG002|Base Study|Physician Decision|0|||
131479419|NCT00543543|473386624|FG003|Base Study|Physician Decision|7|||
131479420|NCT00543543|473386621|FG000|Base Study|Protocol Violation|0|||
131479421|NCT00543543|473386622|FG001|Base Study|Protocol Violation|6|||
131479422|NCT00543543|473386623|FG002|Base Study|Protocol Violation|0|||
131479423|NCT00543543|473386624|FG003|Base Study|Protocol Violation|6|||
131479424|NCT00543543|473386621|FG000|Base Study|Withdrawal by Subject|7|||
131479425|NCT00543543|473386622|FG001|Base Study|Withdrawal by Subject|482|||
131479426|NCT00543543|473386623|FG002|Base Study|Withdrawal by Subject|5|||
131479427|NCT00543543|473386624|FG003|Base Study|Withdrawal by Subject|503|||
131479428|NCT00543543|473386621|FG000|Extension Study|Adverse Event|0|||
131479429|NCT00543543|473386622|FG001|Extension Study|Adverse Event|0|||
131479430|NCT00543543|473386623|FG002|Extension Study|Adverse Event|0|||
131479431|NCT00543543|473386624|FG003|Extension Study|Adverse Event|5|||
131479432|NCT00543543|473386621|FG000|Extension Study|Lost to Follow-up|0|||
131479433|NCT00543543|473386622|FG001|Extension Study|Lost to Follow-up|0|||
131479434|NCT00543543|473386623|FG002|Extension Study|Lost to Follow-up|0|||
131479435|NCT00543543|473386624|FG003|Extension Study|Lost to Follow-up|77|||
131479436|NCT00543543|473386621|FG000|Extension Study|Physician Decision|0|||
131479437|NCT00543543|473386622|FG001|Extension Study|Physician Decision|0|||
131479438|NCT00543543|473386623|FG002|Extension Study|Physician Decision|0|||
131479439|NCT00543543|473386624|FG003|Extension Study|Physician Decision|7|||
131479440|NCT00543543|473386621|FG000|Extension Study|Pregnancy|0|||
131479441|NCT00543543|473386622|FG001|Extension Study|Pregnancy|0|||
131479442|NCT00543543|473386623|FG002|Extension Study|Pregnancy|0|||
131479443|NCT00543543|473386624|FG003|Extension Study|Pregnancy|6|||
131479444|NCT00543543|473386621|FG000|Extension Study|Protocol Violation|0|||
131479445|NCT00543543|473386622|FG001|Extension Study|Protocol Violation|0|||
131479446|NCT00543543|473386623|FG002|Extension Study|Protocol Violation|0|||
131479447|NCT00543543|473386624|FG003|Extension Study|Protocol Violation|11|||
131479448|NCT00543543|473386621|FG000|Extension Study|Withdrawal by Subject|0|||
131479449|NCT00543543|473386622|FG001|Extension Study|Withdrawal by Subject|0|||
131479450|NCT00543543|473386623|FG002|Extension Study|Withdrawal by Subject|0|||
131479451|NCT00543543|473386624|FG003|Extension Study|Withdrawal by Subject|120|||
131479452|NCT02919696|473386625|FG000|Overall Study|Adverse Event|1|||
131479453|NCT02919696|473386626|FG001|Overall Study|Adverse Event|2|||
131479454|NCT02919696|473386625|FG000|Overall Study|Withdrawal by Subject|2|||
131479455|NCT02919696|473386626|FG001|Overall Study|Withdrawal by Subject|1|||
131479456|NCT02919696|473386625|FG000|Overall Study|Sponsor Decision|1|||
131479457|NCT02919696|473386626|FG001|Overall Study|Sponsor Decision|1|||
131479458|NCT02919696|473386625|FG000|Overall Study|Never Treated|0|||
131479459|NCT02919696|473386626|FG001|Overall Study|Never Treated|1|||
131479460|NCT04308304|473386627|FG000|Overall Study|Withdrawal by Subject|4|||
131479461|NCT04308304|473386628|FG001|Overall Study|Withdrawal by Subject|0|||
131479462|NCT04308304|473386627|FG000|Overall Study|Protocol Violation|1|||
131479463|NCT04308304|473386628|FG001|Overall Study|Protocol Violation|0|||
131479464|NCT00484094|473386629|FG000|Overall Study|Discontinued|39|||
131479465|NCT00484094|473386629|FG000|Overall Study|Other|3|||
131479466|NCT01686828|473386630|FG000|Overall Study|Physician Decision|1|||
131479467|NCT01686828|473386631|FG001|Overall Study|Physician Decision|0|||
131479468|NCT01686828|473386632|FG002|Overall Study|Physician Decision|0|||
131479469|NCT01686828|473386633|FG003|Overall Study|Physician Decision|0|||
131479470|NCT01686828|473386630|FG000|Overall Study|New Job|0|||
131479471|NCT01686828|473386631|FG001|Overall Study|New Job|1|||
131479472|NCT01686828|473386632|FG002|Overall Study|New Job|0|||
131479473|NCT01686828|473386633|FG003|Overall Study|New Job|0|||
131479474|NCT01686828|473386630|FG000|Overall Study|Weight Loss|0|||
131479475|NCT01686828|473386631|FG001|Overall Study|Weight Loss|0|||
131479476|NCT01686828|473386632|FG002|Overall Study|Weight Loss|1|||
131479477|NCT01686828|473386633|FG003|Overall Study|Weight Loss|0|||
131479478|NCT01558739|473386636|FG000|Overall Study|Adverse Event|7|||
131479479|NCT01558739|473386636|FG000|Overall Study|Withdrawal by Subject|2|||
131479480|NCT01558739|473386636|FG000|Overall Study|Death|3|||
131479481|NCT01558739|473386636|FG000|Overall Study|Disease Progression|4|||
131479482|NCT01558739|473386636|FG000|Overall Study|Protocol Violation|1|||
131479483|NCT04176705|473386637|FG000|Overall Study|Withdrawal by Subject|4|||
131479484|NCT04176705|473386638|FG001|Overall Study|Withdrawal by Subject|4|||
131479485|NCT04176705|473386637|FG000|Overall Study|Death|1|||
131479486|NCT04176705|473386638|FG001|Overall Study|Death|1|||
131479487|NCT04176705|473386637|FG000|Overall Study|Lost to Follow-up|3|||
131479488|NCT04176705|473386638|FG001|Overall Study|Lost to Follow-up|3|||
131479489|NCT03698331|473386640|FG000|Overall Study|Adverse Event|2|||
131479490|NCT03698331|473386641|FG001|Overall Study|Adverse Event|3|||
131479491|NCT03698331|473386640|FG000|Overall Study|Withdrawal by Subject|1|||
131479492|NCT03698331|473386641|FG001|Overall Study|Withdrawal by Subject|1|||
131479493|NCT03698331|473386640|FG000|Overall Study|Lost to Follow-up|0|||
131479494|NCT03698331|473386641|FG001|Overall Study|Lost to Follow-up|2|||
131479495|NCT03698331|473386640|FG000|Overall Study|Non-compliance with study drug|1|||
131479496|NCT03698331|473386641|FG001|Overall Study|Non-compliance with study drug|0|||
131479497|NCT02130024|473386643|FG000|Overall Study|Adverse Event|10|||
131479498|NCT02130024|473386644|FG001|Overall Study|Adverse Event|11|||
131479499|NCT02130024|473386643|FG000|Overall Study|Death|2|||
131479500|NCT02130024|473386644|FG001|Overall Study|Death|2|||
131479501|NCT02130024|473386643|FG000|Overall Study|Lost to Follow-up|1|||
131479502|NCT02130024|473386644|FG001|Overall Study|Lost to Follow-up|1|||
131479503|NCT02130024|473386643|FG000|Overall Study|Physician Decision|1|||
131479504|NCT02130024|473386644|FG001|Overall Study|Physician Decision|3|||
131479505|NCT02130024|473386643|FG000|Overall Study|Protocol Deviation|4|||
131479506|NCT02130024|473386644|FG001|Overall Study|Protocol Deviation|0|||
131479507|NCT02130024|473386643|FG000|Overall Study|Site Administration Problems|1|||
131479508|NCT02130024|473386644|FG001|Overall Study|Site Administration Problems|0|||
131479509|NCT02130024|473386643|FG000|Overall Study|Subject Withdrew Consent|6|||
131479510|NCT02130024|473386644|FG001|Overall Study|Subject Withdrew Consent|14|||
131479511|NCT03672643|473386657|FG000|Overall Study|Adverse Event|3|||
131479512|NCT03672643|473386657|FG000|Overall Study|Death|2|||
131479513|NCT03672643|473386657|FG000|Overall Study|Withdrawal by Subject|1|||
131479514|NCT03672643|473386657|FG000|Overall Study|Progressive disease|11|||
131479515|NCT03672643|473386657|FG000|Overall Study|Global deterioration of health status|1|||
131479516|NCT03672643|473386657|FG000|Overall Study|Refused further treatment|7|||
131479517|NCT03672643|473386657|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
131479518|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
131479519|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
131479520|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
131479521|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
131479522|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
131479523|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
131479524|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
131479525|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
131479526|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
131479527|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
131479528|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
131479529|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
131479530|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
131479531|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
131479532|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
131479533|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
131479534|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
131479535|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
131479536|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
131479537|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
131479538|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
131479539|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
131479540|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
131479541|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
131479542|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
131479543|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
131479544|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
131479545|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
131479546|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
131479547|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
131479548|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
131479549|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
131479550|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
131479551|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
131479552|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
131479553|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
131479554|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
131479555|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
131479556|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
131479557|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
131479558|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
131479559|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
131479560|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
131479561|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
131479562|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
131479563|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
131479564|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
131479565|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
131479566|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
131479567|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
131479568|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
131479569|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
131479570|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
131479571|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
131479572|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
131479573|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
131479574|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
131479575|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
131479576|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
131479577|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
131479578|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
131479579|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
131479580|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
131479581|NCT04526509|473386658|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
131479582|NCT04526509|473386659|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
131479583|NCT04526509|473386660|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
131479584|NCT04526509|473386661|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
131479585|NCT04526509|473386662|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
131479586|NCT04526509|473386663|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
131479587|NCT04526509|473386664|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
131479588|NCT04526509|473386658|FG000|Enrolled|Study Terminated by Sponsor|0|||
131479589|NCT04526509|473386659|FG001|Enrolled|Study Terminated by Sponsor|0|||
131479590|NCT04526509|473386660|FG002|Enrolled|Study Terminated by Sponsor|0|||
131479591|NCT04526509|473386661|FG003|Enrolled|Study Terminated by Sponsor|0|||
131479592|NCT04526509|473386662|FG004|Enrolled|Study Terminated by Sponsor|0|||
131479593|NCT04526509|473386663|FG005|Enrolled|Study Terminated by Sponsor|0|||
131479594|NCT04526509|473386664|FG006|Enrolled|Study Terminated by Sponsor|1|||
131479595|NCT04526509|473386658|FG000|Enrolled|Death prior to lymphodepletion|0|||
131479596|NCT04526509|473386659|FG001|Enrolled|Death prior to lymphodepletion|0|||
131479597|NCT04526509|473386660|FG002|Enrolled|Death prior to lymphodepletion|0|||
131479598|NCT04526509|473386661|FG003|Enrolled|Death prior to lymphodepletion|1|||
131479599|NCT04526509|473386662|FG004|Enrolled|Death prior to lymphodepletion|0|||
131479600|NCT04526509|473386663|FG005|Enrolled|Death prior to lymphodepletion|0|||
131479601|NCT04526509|473386664|FG006|Enrolled|Death prior to lymphodepletion|0|||
131479602|NCT04526509|473386658|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
131479603|NCT04526509|473386659|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
131479604|NCT04526509|473386660|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
131479605|NCT04526509|473386661|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
131479606|NCT04526509|473386662|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
131479607|NCT04526509|473386663|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
131479608|NCT04526509|473386664|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
131479609|NCT04526509|473386658|FG000|Enrolled|Physician Decision|0|||
131479610|NCT04526509|473386659|FG001|Enrolled|Physician Decision|1|||
131479611|NCT04526509|473386660|FG002|Enrolled|Physician Decision|0|||
131479612|NCT04526509|473386661|FG003|Enrolled|Physician Decision|0|||
131479613|NCT04526509|473386662|FG004|Enrolled|Physician Decision|0|||
131479614|NCT04526509|473386663|FG005|Enrolled|Physician Decision|0|||
131479615|NCT04526509|473386664|FG006|Enrolled|Physician Decision|0|||
131479616|NCT01386008|473386666|FG000|Overall Study|exited w/o incident /study discontinued|17|||
131479617|NCT01386008|473386666|FG000|Overall Study|Adverse Event|3|||
131479618|NCT01067976|473386667|FG000|Overall Study|Study drug never administered|20|||
131479619|NCT01067976|473386667|FG000|Overall Study|Study prematurely discontinued|2|||
131479620|NCT00589290|473386668|FG000|Overall Study|Withdrawal by Subject|1|||
131479621|NCT00566111|473386669|FG000|Overall Study|Adverse Event|0|||
131479622|NCT00566111|473386670|FG001|Overall Study|Adverse Event|2|||
131479623|NCT04449861|473386671|FG000|Overall Study|Withdrawal by Subject|4|||
131479624|NCT04449861|473386671|FG000|Overall Study|Lost to Follow-up|5|||
131479625|NCT04449861|473386671|FG000|Overall Study|Death|112|||
131479626|NCT00976677|473386672|FG000|Overall Study|Adverse Event|1|||
131479627|NCT00976677|473386673|FG001|Overall Study|Adverse Event|0|||
131479628|NCT00976677|473386672|FG000|Overall Study|Withdrawal by Subject|0|||
131479629|NCT00976677|473386673|FG001|Overall Study|Withdrawal by Subject|2|||
131479630|NCT00976677|473386672|FG000|Overall Study|Disease progression|1|||
131479631|NCT00976677|473386673|FG001|Overall Study|Disease progression|1|||
131479632|NCT00976677|473386672|FG000|Overall Study|Trial unblinded|2|||
131479633|NCT00976677|473386673|FG001|Overall Study|Trial unblinded|2|||
131479634|NCT00976677|473386672|FG000|Overall Study|Unknown/Missing|1|||
131479635|NCT00976677|473386673|FG001|Overall Study|Unknown/Missing|0|||
131479636|NCT03507400|473386674|FG000|Overall Study|discontinued|5|||
131479637|NCT03507400|473386675|FG001|Overall Study|discontinued|1|||
131479638|NCT03507400|473386674|FG000|Overall Study|Lost to Follow-up|8|||
131479639|NCT03507400|473386675|FG001|Overall Study|Lost to Follow-up|6|||
131479640|NCT03507400|473386674|FG000|Overall Study|Protocol Violation|0|||
131479641|NCT03507400|473386675|FG001|Overall Study|Protocol Violation|1|||
131479642|NCT01555983|473386680|FG000|Overall Study|Withdrawal by Subject|1|||
131479643|NCT01555983|473386681|FG001|Overall Study|Withdrawal by Subject|0|||
131479644|NCT01555983|473386682|FG002|Overall Study|Withdrawal by Subject|0|||
131479645|NCT01555983|473386683|FG003|Overall Study|Withdrawal by Subject|0|||
131479646|NCT01555983|473386684|FG004|Overall Study|Withdrawal by Subject|1|||
131479647|NCT01555983|473386685|FG005|Overall Study|Withdrawal by Subject|1|||
131479648|NCT01554397|473386688|FG000|Overall Study|Withdrawal by Subject|1|||
131479649|NCT01554397|473386689|FG001|Overall Study|Withdrawal by Subject|0|||
131479650|NCT01554397|473386688|FG000|Overall Study|Ineligible|7|||
131479651|NCT01554397|473386689|FG001|Overall Study|Ineligible|0|||
131479652|NCT00108433|473388900|FG000|Overall Study|Lack of Efficacy|1|||
131479653|NCT00108433|473388901|FG001|Overall Study|Lack of Efficacy|2|||
131479654|NCT00108433|473388900|FG000|Overall Study|Death|3|||
131479655|NCT00108433|473388901|FG001|Overall Study|Death|0|||
131479656|NCT00108433|473388900|FG000|Overall Study|Adverse Event|3|||
131479657|NCT00108433|473388901|FG001|Overall Study|Adverse Event|1|||
131479658|NCT00108433|473388900|FG000|Overall Study|Other|14|||
131479659|NCT00108433|473388901|FG001|Overall Study|Other|14|||
131479660|NCT04806503|473388904|FG000|Overall Study|Lost to Follow-up|0|||
131479661|NCT04806503|473388905|FG001|Overall Study|Lost to Follow-up|0|||
131479662|NCT04806503|473388906|FG002|Overall Study|Lost to Follow-up|1|||
131479663|NCT04806503|473388907|FG003|Overall Study|Lost to Follow-up|0|||
131479664|NCT04806503|473388908|FG004|Overall Study|Lost to Follow-up|0|||
131479665|NCT04806503|473388904|FG000|Overall Study|Withdrawal by Subject|1|||
131479666|NCT04806503|473388905|FG001|Overall Study|Withdrawal by Subject|0|||
131479667|NCT04806503|473388906|FG002|Overall Study|Withdrawal by Subject|1|||
131479668|NCT04806503|473388907|FG003|Overall Study|Withdrawal by Subject|1|||
131479669|NCT04806503|473388908|FG004|Overall Study|Withdrawal by Subject|1|||
131479670|NCT04806503|473388904|FG000|Overall Study|Adverse Event|1|||
131479671|NCT04806503|473388905|FG001|Overall Study|Adverse Event|1|||
131479672|NCT04806503|473388906|FG002|Overall Study|Adverse Event|0|||
131479673|NCT04806503|473388907|FG003|Overall Study|Adverse Event|1|||
131479674|NCT04806503|473388908|FG004|Overall Study|Adverse Event|0|||
131479675|NCT00734474|473388916|FG000|Overall Study|Entry Criteria Not Met|0|||
131479676|NCT00734474|473388917|FG001|Overall Study|Entry Criteria Not Met|0|||
131479677|NCT00734474|473388918|FG002|Overall Study|Entry Criteria Not Met|5|||
131479678|NCT00734474|473388919|FG003|Overall Study|Entry Criteria Not Met|0|||
131479679|NCT00734474|473388920|FG004|Overall Study|Entry Criteria Not Met|3|||
131479680|NCT00734474|473388921|FG005|Overall Study|Entry Criteria Not Met|1|||
131479681|NCT00734474|473388922|FG006|Overall Study|Entry Criteria Not Met|0|||
131479682|NCT00734474|473388923|FG007|Overall Study|Entry Criteria Not Met|1|||
131479683|NCT00734474|473388924|FG008|Overall Study|Entry Criteria Not Met|1|||
131479684|NCT00734474|473388916|FG000|Overall Study|Lost to Follow-up|1|||
131479685|NCT00734474|473388917|FG001|Overall Study|Lost to Follow-up|0|||
131479686|NCT00734474|473388918|FG002|Overall Study|Lost to Follow-up|13|||
131479687|NCT00734474|473388919|FG003|Overall Study|Lost to Follow-up|0|||
131479688|NCT00734474|473388920|FG004|Overall Study|Lost to Follow-up|11|||
131479689|NCT00734474|473388921|FG005|Overall Study|Lost to Follow-up|1|||
131479690|NCT00734474|473388922|FG006|Overall Study|Lost to Follow-up|0|||
131479691|NCT00734474|473388923|FG007|Overall Study|Lost to Follow-up|9|||
131479692|NCT00734474|473388924|FG008|Overall Study|Lost to Follow-up|4|||
131479693|NCT00734474|473388916|FG000|Overall Study|Withdrawal by Subject|2|||
131479694|NCT00734474|473388917|FG001|Overall Study|Withdrawal by Subject|1|||
131479695|NCT00734474|473388918|FG002|Overall Study|Withdrawal by Subject|18|||
131479696|NCT00734474|473388919|FG003|Overall Study|Withdrawal by Subject|0|||
131479697|NCT00734474|473388920|FG004|Overall Study|Withdrawal by Subject|24|||
131479698|NCT00734474|473388921|FG005|Overall Study|Withdrawal by Subject|2|||
131479699|NCT00734474|473388922|FG006|Overall Study|Withdrawal by Subject|0|||
131479700|NCT00734474|473388923|FG007|Overall Study|Withdrawal by Subject|36|||
131479701|NCT00734474|473388924|FG008|Overall Study|Withdrawal by Subject|21|||
131479702|NCT00734474|473388916|FG000|Overall Study|Physician Decision|0|||
131479703|NCT00734474|473388917|FG001|Overall Study|Physician Decision|0|||
131479704|NCT00734474|473388918|FG002|Overall Study|Physician Decision|4|||
131479705|NCT00734474|473388919|FG003|Overall Study|Physician Decision|1|||
131479706|NCT00734474|473388920|FG004|Overall Study|Physician Decision|11|||
131479707|NCT00734474|473388921|FG005|Overall Study|Physician Decision|0|||
131479708|NCT00734474|473388922|FG006|Overall Study|Physician Decision|0|||
131479709|NCT00734474|473388923|FG007|Overall Study|Physician Decision|9|||
131479710|NCT00734474|473388924|FG008|Overall Study|Physician Decision|9|||
131479711|NCT00734474|473388916|FG000|Overall Study|Adverse Event|4|||
131479712|NCT00734474|473388917|FG001|Overall Study|Adverse Event|4|||
131479713|NCT00734474|473388918|FG002|Overall Study|Adverse Event|63|||
131479714|NCT00734474|473388919|FG003|Overall Study|Adverse Event|1|||
131479715|NCT00734474|473388920|FG004|Overall Study|Adverse Event|64|||
131479716|NCT00734474|473388921|FG005|Overall Study|Adverse Event|0|||
131479717|NCT00734474|473388922|FG006|Overall Study|Adverse Event|1|||
131479718|NCT00734474|473388923|FG007|Overall Study|Adverse Event|65|||
131479719|NCT00734474|473388924|FG008|Overall Study|Adverse Event|39|||
131479720|NCT00734474|473388916|FG000|Overall Study|Protocol Violation|0|||
131479721|NCT00734474|473388917|FG001|Overall Study|Protocol Violation|0|||
131479722|NCT00734474|473388918|FG002|Overall Study|Protocol Violation|4|||
131479723|NCT00734474|473388919|FG003|Overall Study|Protocol Violation|0|||
131479724|NCT00734474|473388920|FG004|Overall Study|Protocol Violation|3|||
131479725|NCT00734474|473388921|FG005|Overall Study|Protocol Violation|0|||
131479726|NCT00734474|473388922|FG006|Overall Study|Protocol Violation|0|||
131479727|NCT00734474|473388923|FG007|Overall Study|Protocol Violation|3|||
131479728|NCT00734474|473388924|FG008|Overall Study|Protocol Violation|1|||
131479729|NCT00734474|473388916|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
131479730|NCT00734474|473388917|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
131479731|NCT00734474|473388918|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
131479732|NCT00734474|473388919|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
131479733|NCT00734474|473388920|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
131479734|NCT00734474|473388921|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
131479735|NCT00734474|473388922|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
131479736|NCT00734474|473388923|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
131479737|NCT00734474|473388924|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
131479738|NCT00734474|473388916|FG000|Overall Study|Sponsor Decision|0|||
131479739|NCT00734474|473388917|FG001|Overall Study|Sponsor Decision|0|||
131479740|NCT00734474|473388918|FG002|Overall Study|Sponsor Decision|0|||
131479741|NCT00734474|473388919|FG003|Overall Study|Sponsor Decision|0|||
131479742|NCT00734474|473388920|FG004|Overall Study|Sponsor Decision|2|||
131479743|NCT00734474|473388921|FG005|Overall Study|Sponsor Decision|0|||
131479744|NCT00734474|473388922|FG006|Overall Study|Sponsor Decision|0|||
131479745|NCT00734474|473388923|FG007|Overall Study|Sponsor Decision|0|||
131479746|NCT00734474|473388924|FG008|Overall Study|Sponsor Decision|0|||
131479747|NCT00734474|473388916|FG000|Overall Study|Death|0|||
131479748|NCT00734474|473388917|FG001|Overall Study|Death|0|||
131479749|NCT00734474|473388918|FG002|Overall Study|Death|1|||
131479750|NCT00734474|473388919|FG003|Overall Study|Death|0|||
131479751|NCT00734474|473388920|FG004|Overall Study|Death|0|||
131479752|NCT00734474|473388921|FG005|Overall Study|Death|0|||
131479753|NCT00734474|473388922|FG006|Overall Study|Death|0|||
131479754|NCT00734474|473388923|FG007|Overall Study|Death|2|||
131479755|NCT00734474|473388924|FG008|Overall Study|Death|1|||
131479756|NCT00734474|473388916|FG000|Overall Study|Lack of Efficacy|0|||
131479757|NCT00734474|473388917|FG001|Overall Study|Lack of Efficacy|0|||
131479758|NCT00734474|473388918|FG002|Overall Study|Lack of Efficacy|4|||
131479759|NCT00734474|473388919|FG003|Overall Study|Lack of Efficacy|0|||
131479760|NCT00734474|473388920|FG004|Overall Study|Lack of Efficacy|0|||
131479761|NCT00734474|473388921|FG005|Overall Study|Lack of Efficacy|0|||
131479762|NCT00734474|473388922|FG006|Overall Study|Lack of Efficacy|0|||
131479763|NCT00734474|473388923|FG007|Overall Study|Lack of Efficacy|4|||
131479764|NCT00734474|473388924|FG008|Overall Study|Lack of Efficacy|6|||
131479765|NCT02497612|473388933|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
131479766|NCT02497612|473388934|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
131479767|NCT02497612|473388935|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
131479768|NCT02497612|473388936|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
131479769|NCT02497612|473388933|FG000|Overall Study|Participant's request|2|||
131479770|NCT02497612|473388934|FG001|Overall Study|Participant's request|3|||
131479771|NCT02497612|473388935|FG002|Overall Study|Participant's request|4|||
131479772|NCT02497612|473388936|FG003|Overall Study|Participant's request|1|||
131479773|NCT02497612|473388933|FG000|Overall Study|Investigator's judgement|1|||
131479774|NCT02497612|473388934|FG001|Overall Study|Investigator's judgement|0|||
131479775|NCT02497612|473388935|FG002|Overall Study|Investigator's judgement|0|||
131479776|NCT02497612|473388936|FG003|Overall Study|Investigator's judgement|2|||
131479777|NCT02497612|473388933|FG000|Overall Study|Adverse Event|3|||
131479778|NCT02497612|473388934|FG001|Overall Study|Adverse Event|1|||
131479779|NCT02497612|473388935|FG002|Overall Study|Adverse Event|4|||
131479780|NCT02497612|473388936|FG003|Overall Study|Adverse Event|1|||
131479781|NCT02497612|473388933|FG000|Overall Study|Lost to Follow-up|1|||
131479782|NCT02497612|473388934|FG001|Overall Study|Lost to Follow-up|1|||
131479783|NCT02497612|473388935|FG002|Overall Study|Lost to Follow-up|0|||
131479784|NCT02497612|473388936|FG003|Overall Study|Lost to Follow-up|1|||
131479785|NCT02497612|473388933|FG000|Overall Study|Other unspecified|1|||
131479786|NCT02497612|473388934|FG001|Overall Study|Other unspecified|1|||
131479787|NCT02497612|473388935|FG002|Overall Study|Other unspecified|2|||
131479788|NCT02497612|473388936|FG003|Overall Study|Other unspecified|0|||
131479789|NCT02497612|473388933|FG000|Overall Study|Not eligible|1|||
131479790|NCT02497612|473388934|FG001|Overall Study|Not eligible|0|||
131479791|NCT02497612|473388935|FG002|Overall Study|Not eligible|0|||
131479792|NCT02497612|473388936|FG003|Overall Study|Not eligible|1|||
131479793|NCT01890746|473388937|FG000|Overall Study|Death|39|||
131479794|NCT01890746|473388938|FG001|Overall Study|Death|30|||
131479795|NCT01890746|473388937|FG000|Overall Study|Adverse Event|1|||
131479796|NCT01890746|473388938|FG001|Overall Study|Adverse Event|0|||
131479797|NCT01890746|473388937|FG000|Overall Study|Lost to Follow-up|4|||
131479798|NCT01890746|473388938|FG001|Overall Study|Lost to Follow-up|1|||
131479799|NCT01890746|473388937|FG000|Overall Study|Physician Decision|3|||
131479800|NCT01890746|473388938|FG001|Overall Study|Physician Decision|2|||
131479801|NCT01890746|473388937|FG000|Overall Study|Withdrawal by Subject|5|||
131479802|NCT01890746|473388938|FG001|Overall Study|Withdrawal by Subject|8|||
131479803|NCT02642029|473388939|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
131479804|NCT02642029|473388940|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
131479805|NCT02642029|473388941|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
131479806|NCT02642029|473388942|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
131479807|NCT02642029|473388943|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
131479808|NCT02642029|473388944|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
131479809|NCT02642029|473388939|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
131479810|NCT02642029|473388940|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
131479811|NCT02642029|473388941|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
131479812|NCT02642029|473388942|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
131479813|NCT02642029|473388943|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
131479814|NCT02642029|473388944|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
131479815|NCT02642029|473388939|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
131479816|NCT02642029|473388940|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
131479817|NCT02642029|473388941|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
131479818|NCT02642029|473388942|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
131479819|NCT02642029|473388943|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
131479820|NCT02642029|473388944|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
131479821|NCT02642029|473388939|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
131479822|NCT02642029|473388940|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
131479823|NCT02642029|473388941|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
131479824|NCT02642029|473388942|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
131479825|NCT02642029|473388943|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
131479826|NCT02642029|473388944|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
131479827|NCT02642029|473388939|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
131479828|NCT02642029|473388940|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
131479829|NCT02642029|473388941|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
131479830|NCT02642029|473388942|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
131479831|NCT02642029|473388943|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
131479832|NCT02642029|473388944|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
131479833|NCT02642029|473388939|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
131479834|NCT02642029|473388940|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
131479835|NCT02642029|473388941|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
131479836|NCT02642029|473388942|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
131479837|NCT02642029|473388943|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
131479838|NCT02642029|473388944|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
131479839|NCT01134731|473388946|FG000|Overall Study|Adverse Event|3|||
131479840|NCT01134731|473388947|FG001|Overall Study|Adverse Event|2|||
131479841|NCT01134731|473388948|FG002|Overall Study|Adverse Event|1|||
131479842|NCT01134731|473388946|FG000|Overall Study|Physician Decision|2|||
131479843|NCT01134731|473388947|FG001|Overall Study|Physician Decision|2|||
131479844|NCT01134731|473388948|FG002|Overall Study|Physician Decision|2|||
131479845|NCT01134731|473388946|FG000|Overall Study|Lack of Efficacy|0|||
131479846|NCT01134731|473388947|FG001|Overall Study|Lack of Efficacy|0|||
131479847|NCT01134731|473388948|FG002|Overall Study|Lack of Efficacy|1|||
131479848|NCT01134731|473388946|FG000|Overall Study|Withdrawal by Subject|3|||
131479849|NCT01134731|473388947|FG001|Overall Study|Withdrawal by Subject|3|||
131479850|NCT01134731|473388948|FG002|Overall Study|Withdrawal by Subject|1|||
131479851|NCT01134731|473388946|FG000|Overall Study|Lost to Follow-up|5|||
131479852|NCT01134731|473388947|FG001|Overall Study|Lost to Follow-up|4|||
131479853|NCT01134731|473388948|FG002|Overall Study|Lost to Follow-up|3|||
131479854|NCT00676338|473388949|FG000|Overall Study|Adverse Event|6|||
131479855|NCT00676338|473388950|FG001|Overall Study|Adverse Event|6|||
131479856|NCT00676338|473388951|FG002|Overall Study|Adverse Event|5|||
131479857|NCT00676338|473388952|FG003|Overall Study|Adverse Event|1|||
131479858|NCT00676338|473388949|FG000|Overall Study|Lost to Follow-up|4|||
131479859|NCT00676338|473388950|FG001|Overall Study|Lost to Follow-up|1|||
131479860|NCT00676338|473388951|FG002|Overall Study|Lost to Follow-up|3|||
131479861|NCT00676338|473388952|FG003|Overall Study|Lost to Follow-up|4|||
131479862|NCT00676338|473388949|FG000|Overall Study|Physician Decision|3|||
131479863|NCT00676338|473388950|FG001|Overall Study|Physician Decision|3|||
131479864|NCT00676338|473388951|FG002|Overall Study|Physician Decision|2|||
131479865|NCT00676338|473388952|FG003|Overall Study|Physician Decision|3|||
131479866|NCT00676338|473388949|FG000|Overall Study|Protocol Violation|5|||
131479867|NCT00676338|473388950|FG001|Overall Study|Protocol Violation|9|||
131479868|NCT00676338|473388951|FG002|Overall Study|Protocol Violation|2|||
131479869|NCT00676338|473388952|FG003|Overall Study|Protocol Violation|5|||
131479870|NCT00676338|473388949|FG000|Overall Study|Withdrawal by Subject|17|||
131479871|NCT00676338|473388950|FG001|Overall Study|Withdrawal by Subject|9|||
131479872|NCT00676338|473388951|FG002|Overall Study|Withdrawal by Subject|12|||
131479873|NCT00676338|473388952|FG003|Overall Study|Withdrawal by Subject|6|||
131479874|NCT00676338|473388949|FG000|Overall Study|Entry Criteria Not Met|0|||
131479875|NCT00676338|473388950|FG001|Overall Study|Entry Criteria Not Met|2|||
131479876|NCT00676338|473388951|FG002|Overall Study|Entry Criteria Not Met|1|||
131479877|NCT00676338|473388952|FG003|Overall Study|Entry Criteria Not Met|1|||
131479878|NCT00676338|473388949|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
131479879|NCT00676338|473388950|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
131479880|NCT00676338|473388951|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
131479881|NCT00676338|473388952|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
131479882|NCT02122458|473388953|FG000|Overall Study|Withdrawal by Subject|0|||
131479883|NCT02122458|473388954|FG001|Overall Study|Withdrawal by Subject|0|||
131479884|NCT02122458|473388955|FG002|Overall Study|Withdrawal by Subject|0|||
131479885|NCT02122458|473388956|FG003|Overall Study|Withdrawal by Subject|4|||
131479886|NCT02122458|473388957|FG004|Overall Study|Withdrawal by Subject|4|||
131479887|NCT02122458|473388958|FG005|Overall Study|Withdrawal by Subject|4|||
131479888|NCT02122458|473388959|FG006|Overall Study|Withdrawal by Subject|0|||
131479889|NCT02122458|473388953|FG000|Overall Study|Lost to Follow-up|1|||
131479890|NCT02122458|473388954|FG001|Overall Study|Lost to Follow-up|3|||
131479891|NCT02122458|473388955|FG002|Overall Study|Lost to Follow-up|0|||
131479892|NCT02122458|473388956|FG003|Overall Study|Lost to Follow-up|7|||
131479893|NCT02122458|473388957|FG004|Overall Study|Lost to Follow-up|5|||
131479894|NCT02122458|473388958|FG005|Overall Study|Lost to Follow-up|15|||
131479895|NCT02122458|473388959|FG006|Overall Study|Lost to Follow-up|1|||
131479896|NCT02122458|473388953|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
131479897|NCT02122458|473388954|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
131479898|NCT02122458|473388955|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
131479899|NCT02122458|473388956|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
131479900|NCT02122458|473388957|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
131479901|NCT02122458|473388958|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
131479902|NCT02122458|473388959|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
131479903|NCT02122458|473388953|FG000|Overall Study|Adverse Event|1|||
131479904|NCT02122458|473388954|FG001|Overall Study|Adverse Event|0|||
131479905|NCT02122458|473388955|FG002|Overall Study|Adverse Event|0|||
131479906|NCT02122458|473388956|FG003|Overall Study|Adverse Event|0|||
131479907|NCT02122458|473388957|FG004|Overall Study|Adverse Event|0|||
131479908|NCT02122458|473388958|FG005|Overall Study|Adverse Event|0|||
131479909|NCT02122458|473388959|FG006|Overall Study|Adverse Event|0|||
131479910|NCT02122458|473388953|FG000|Overall Study|Experimental Error|0|||
131479911|NCT02122458|473388954|FG001|Overall Study|Experimental Error|0|||
131479912|NCT02122458|473388955|FG002|Overall Study|Experimental Error|0|||
131479913|NCT02122458|473388956|FG003|Overall Study|Experimental Error|0|||
131479914|NCT02122458|473388957|FG004|Overall Study|Experimental Error|3|||
131479915|NCT02122458|473388958|FG005|Overall Study|Experimental Error|0|||
131479916|NCT02122458|473388959|FG006|Overall Study|Experimental Error|0|||
131479917|NCT02122458|473388953|FG000|Overall Study|Deployed or Moved|0|||
131479918|NCT02122458|473388954|FG001|Overall Study|Deployed or Moved|0|||
131479919|NCT02122458|473388955|FG002|Overall Study|Deployed or Moved|0|||
131479920|NCT02122458|473388956|FG003|Overall Study|Deployed or Moved|0|||
131479921|NCT02122458|473388957|FG004|Overall Study|Deployed or Moved|1|||
131479922|NCT02122458|473388958|FG005|Overall Study|Deployed or Moved|0|||
131479923|NCT02122458|473388959|FG006|Overall Study|Deployed or Moved|0|||
131479924|NCT02122458|473388953|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
131479925|NCT02122458|473388954|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
131479926|NCT02122458|473388955|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
131479927|NCT02122458|473388956|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
131479928|NCT02122458|473388957|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
131479929|NCT02122458|473388958|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
131479930|NCT02122458|473388959|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
131479931|NCT02122458|473388953|FG000|Overall Study|Noncompliance|0|||
131479932|NCT02122458|473388954|FG001|Overall Study|Noncompliance|1|||
131479933|NCT02122458|473388955|FG002|Overall Study|Noncompliance|0|||
131479934|NCT02122458|473388956|FG003|Overall Study|Noncompliance|0|||
131479935|NCT02122458|473388957|FG004|Overall Study|Noncompliance|0|||
131479936|NCT02122458|473388958|FG005|Overall Study|Noncompliance|0|||
131479937|NCT02122458|473388959|FG006|Overall Study|Noncompliance|0|||
131479938|NCT00412542|473388960|FG000|Overall Study|Withdrawal by Subject|0|||
131479939|NCT00412542|473388961|FG001|Overall Study|Withdrawal by Subject|2|||
131479940|NCT00412542|473388960|FG000|Overall Study|Not Eligible|0|||
131479941|NCT00412542|473388961|FG001|Overall Study|Not Eligible|1|||
131479942|NCT03161093|473388962|FG000|Overall Study|Protocol Violation|11|||
131479943|NCT03161093|473388963|FG001|Overall Study|Protocol Violation|14|||
131479944|NCT03161093|473388964|FG002|Overall Study|Protocol Violation|6|||
131479945|NCT03161093|473388965|FG003|Overall Study|Protocol Violation|13|||
131479946|NCT03161093|473388966|FG004|Overall Study|Protocol Violation|1|||
131479947|NCT03161093|473388967|FG005|Overall Study|Protocol Violation|0|||
131479948|NCT03161093|473388962|FG000|Overall Study|Adverse Event|5|||
131479949|NCT03161093|473388963|FG001|Overall Study|Adverse Event|21|||
131479950|NCT03161093|473388964|FG002|Overall Study|Adverse Event|16|||
131479951|NCT03161093|473388965|FG003|Overall Study|Adverse Event|35|||
131479952|NCT03161093|473388966|FG004|Overall Study|Adverse Event|2|||
131479953|NCT03161093|473388967|FG005|Overall Study|Adverse Event|1|||
131479954|NCT03161093|473388962|FG000|Overall Study|Lack of Efficacy|9|||
131479955|NCT03161093|473388963|FG001|Overall Study|Lack of Efficacy|13|||
131479956|NCT03161093|473388964|FG002|Overall Study|Lack of Efficacy|9|||
131479957|NCT03161093|473388965|FG003|Overall Study|Lack of Efficacy|24|||
131479958|NCT03161093|473388966|FG004|Overall Study|Lack of Efficacy|4|||
131479959|NCT03161093|473388967|FG005|Overall Study|Lack of Efficacy|1|||
131479960|NCT03161093|473388962|FG000|Overall Study|Physician Decision|0|||
131479961|NCT03161093|473388963|FG001|Overall Study|Physician Decision|1|||
131479962|NCT03161093|473388964|FG002|Overall Study|Physician Decision|0|||
131479963|NCT03161093|473388965|FG003|Overall Study|Physician Decision|2|||
131479964|NCT03161093|473388966|FG004|Overall Study|Physician Decision|17|||
131479965|NCT03161093|473388967|FG005|Overall Study|Physician Decision|15|||
131479966|NCT03161093|473388962|FG000|Overall Study|Withdrawal by Subject|24|||
131479967|NCT03161093|473388963|FG001|Overall Study|Withdrawal by Subject|73|||
131479968|NCT03161093|473388964|FG002|Overall Study|Withdrawal by Subject|44|||
131479969|NCT03161093|473388965|FG003|Overall Study|Withdrawal by Subject|97|||
131479970|NCT03161093|473388966|FG004|Overall Study|Withdrawal by Subject|11|||
131479971|NCT03161093|473388967|FG005|Overall Study|Withdrawal by Subject|10|||
131479972|NCT03161093|473388962|FG000|Overall Study|Lost to Follow-up|3|||
131479973|NCT03161093|473388963|FG001|Overall Study|Lost to Follow-up|12|||
131479974|NCT03161093|473388964|FG002|Overall Study|Lost to Follow-up|4|||
131479975|NCT03161093|473388965|FG003|Overall Study|Lost to Follow-up|7|||
131479976|NCT03161093|473388966|FG004|Overall Study|Lost to Follow-up|8|||
131479977|NCT03161093|473388967|FG005|Overall Study|Lost to Follow-up|13|||
131479978|NCT03161093|473388962|FG000|Overall Study|Death|3|||
131479979|NCT03161093|473388963|FG001|Overall Study|Death|9|||
131479980|NCT03161093|473388964|FG002|Overall Study|Death|7|||
131479981|NCT03161093|473388965|FG003|Overall Study|Death|9|||
131479982|NCT03161093|473388966|FG004|Overall Study|Death|0|||
131479983|NCT03161093|473388967|FG005|Overall Study|Death|0|||
131479984|NCT03161093|473388962|FG000|Overall Study|Unknown - Not reported|0|||
131479985|NCT03161093|473388963|FG001|Overall Study|Unknown - Not reported|1|||
131479986|NCT03161093|473388964|FG002|Overall Study|Unknown - Not reported|0|||
131479987|NCT03161093|473388965|FG003|Overall Study|Unknown - Not reported|0|||
131479988|NCT03161093|473388966|FG004|Overall Study|Unknown - Not reported|0|||
131479989|NCT03161093|473388967|FG005|Overall Study|Unknown - Not reported|1|||
131479990|NCT01031706|473388968|FG000|Overall Study|Adverse Event|1|||
131479991|NCT01031706|473388969|FG001|Overall Study|Adverse Event|0|||
131479992|NCT01031706|473388968|FG000|Overall Study|Withdrawal by Subject|1|||
131479993|NCT01031706|473388969|FG001|Overall Study|Withdrawal by Subject|1|||
131479994|NCT01147640|473388972|FG000|Overall Study|Adverse Event|2|||
131479995|NCT01147640|473388973|FG001|Overall Study|Adverse Event|0|||
131479996|NCT01147640|473388972|FG000|Overall Study|Physician Decision|1|||
131479997|NCT01147640|473388973|FG001|Overall Study|Physician Decision|0|||
131479998|NCT01147640|473388972|FG000|Overall Study|Withdrawal by Subject|1|||
131479999|NCT01147640|473388973|FG001|Overall Study|Withdrawal by Subject|0|||
131480000|NCT01147640|473388972|FG000|Overall Study|Lost to Follow-up|0|||
131480001|NCT01147640|473388973|FG001|Overall Study|Lost to Follow-up|1|||
131480002|NCT01147640|473388972|FG000|Overall Study|Didn't meet eligibility criteria|1|||
131480003|NCT01147640|473388973|FG001|Overall Study|Didn't meet eligibility criteria|0|||
131480004|NCT05095454|473388978|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
131480005|NCT05095454|473388979|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
131480006|NCT03342963|473388980|FG000|Overall Study|Adverse Event|1|||
131480007|NCT03342963|473388981|FG001|Overall Study|Adverse Event|2|||
131480008|NCT03342963|473388982|FG002|Overall Study|Adverse Event|0|||
131480009|NCT03342963|473388983|FG003|Overall Study|Adverse Event|0|||
131480010|NCT03342963|473388980|FG000|Overall Study|Withdrawal by Subject|1|||
131480011|NCT03342963|473388981|FG001|Overall Study|Withdrawal by Subject|0|||
131480012|NCT03342963|473388982|FG002|Overall Study|Withdrawal by Subject|0|||
131480013|NCT03342963|473388983|FG003|Overall Study|Withdrawal by Subject|0|||
131480014|NCT00986830|473388984|FG000|Overall Study|Death|1|||
131480015|NCT00986830|473388984|FG000|Overall Study|Lost to Follow-up|1|||
131480016|NCT00986830|473388984|FG000|Overall Study|Lack of Efficacy|1|||
131480017|NCT00986830|473388984|FG000|Overall Study|Unable to access sinus with device|5|||
131480018|NCT01332331|473388986|FG000|Overall Study|Lost to Follow-up|0|||
131480019|NCT01332331|473388987|FG001|Overall Study|Lost to Follow-up|1|||
131480020|NCT01332331|473388986|FG000|Overall Study|Adverse Event|1|||
131480021|NCT01332331|473388987|FG001|Overall Study|Adverse Event|1|||
131480022|NCT01332331|473388986|FG000|Overall Study|Physician Decision|1|||
131480023|NCT01332331|473388987|FG001|Overall Study|Physician Decision|0|||
131480024|NCT00369707|473388993|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
131480025|NCT00369707|473388993|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
131480026|NCT00369707|473388993|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
131480027|NCT00369707|473388993|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
131480028|NCT00369707|473388993|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
131480029|NCT00369707|473388993|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
131480030|NCT00369707|473388993|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
131480031|NCT00369707|473388993|FG000|Follow up for 2 Years After Treatment|Death|1|||
131480032|NCT00369707|473388993|FG000|Follow up for 2 Years After Treatment|Other|2|||
131480033|NCT03605212|473388997|FG000|Treatment Period|Adverse Event|1|||
131480034|NCT03605212|473388998|FG001|Treatment Period|Adverse Event|0|||
131480035|NCT03605212|473388999|FG002|Treatment Period|Adverse Event|0|||
131480036|NCT03605212|473389000|FG003|Treatment Period|Adverse Event|0|||
131480037|NCT03605212|473389001|FG004|Treatment Period|Adverse Event|0|||
131480038|NCT03605212|473388997|FG000|Treatment Period|Physician Decision|0|||
131480039|NCT03605212|473388998|FG001|Treatment Period|Physician Decision|0|||
131480040|NCT03605212|473388999|FG002|Treatment Period|Physician Decision|0|||
131480041|NCT03605212|473389000|FG003|Treatment Period|Physician Decision|0|||
131480042|NCT03605212|473389001|FG004|Treatment Period|Physician Decision|1|||
131480043|NCT01756053|473389002|FG000|Period 1 (10 Days)|Protocol Violation|1|||
131480044|NCT01756053|473389003|FG001|Period 1 (10 Days)|Protocol Violation|1|||
131480045|NCT01756053|473389002|FG000|Period 2 (10 Days)|Protocol Violation|0|||
131480046|NCT01756053|473389003|FG001|Period 2 (10 Days)|Protocol Violation|2|||
131480047|NCT00285818|473389004|FG000|Overall Study|Withdrawal by Subject|3|||
131480048|NCT00285818|473389005|FG001|Overall Study|Withdrawal by Subject|2|||
131480049|NCT00285818|473389004|FG000|Overall Study|Lost to Follow-up|1|||
131480050|NCT00285818|473389005|FG001|Overall Study|Lost to Follow-up|0|||
131480051|NCT04041375|473389006|FG000|Intervention Phase|Withdrawal by Subject|2|||
131480052|NCT04041375|473389007|FG001|Intervention Phase|Withdrawal by Subject|2|||
131480053|NCT04041375|473389006|FG000|Follow-up Phase|Death|2|||
131480054|NCT04041375|473389007|FG001|Follow-up Phase|Death|0|||
131480055|NCT04041375|473389006|FG000|Follow-up Phase|Lost to Follow-up|2|||
131480056|NCT04041375|473389007|FG001|Follow-up Phase|Lost to Follow-up|1|||
131480057|NCT04041375|473389006|FG000|Follow-up Phase|Too ill|3|||
131480058|NCT04041375|473389007|FG001|Follow-up Phase|Too ill|0|||
131480059|NCT03277690|473389010|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
131480060|NCT03277690|473389011|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
131480061|NCT03277690|473389010|FG000|Dose Titration and Maintenance|Physician Decision|1|||
131480062|NCT03277690|473389011|FG001|Dose Titration and Maintenance|Physician Decision|0|||
131480063|NCT03277690|473389010|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
131480064|NCT03277690|473389011|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
131480065|NCT03277690|473389010|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
131480066|NCT03277690|473389011|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
131480067|NCT03277690|473389010|FG000|Dose Titration and Maintenance|Adverse Event|15|||
131480068|NCT03277690|473389011|FG001|Dose Titration and Maintenance|Adverse Event|0|||
131480069|NCT03277690|473389010|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
131480070|NCT03277690|473389011|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
131480071|NCT03277690|473389010|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
131480072|NCT03277690|473389011|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
131480073|NCT01691898|473389012|FG000|Overall Study|Death|34|||
131480074|NCT01691898|473389013|FG001|Overall Study|Death|32|||
131480075|NCT01691898|473389014|FG002|Overall Study|Death|6|||
131480076|NCT01691898|473389015|FG003|Overall Study|Death|3|||
131480077|NCT01691898|473389016|FG004|Overall Study|Death|8|||
131480078|NCT01691898|473389017|FG005|Overall Study|Death|31|||
131480079|NCT01691898|473389012|FG000|Overall Study|Adverse Event|0|||
131480080|NCT01691898|473389013|FG001|Overall Study|Adverse Event|1|||
131480081|NCT01691898|473389014|FG002|Overall Study|Adverse Event|0|||
131480082|NCT01691898|473389015|FG003|Overall Study|Adverse Event|1|||
131480083|NCT01691898|473389016|FG004|Overall Study|Adverse Event|1|||
131480084|NCT01691898|473389017|FG005|Overall Study|Adverse Event|0|||
131480085|NCT01691898|473389012|FG000|Overall Study|Progression of Disease|1|||
131480086|NCT01691898|473389013|FG001|Overall Study|Progression of Disease|2|||
131480087|NCT01691898|473389014|FG002|Overall Study|Progression of Disease|1|||
131480088|NCT01691898|473389015|FG003|Overall Study|Progression of Disease|0|||
131480089|NCT01691898|473389016|FG004|Overall Study|Progression of Disease|0|||
131480090|NCT01691898|473389017|FG005|Overall Study|Progression of Disease|1|||
131480091|NCT01691898|473389012|FG000|Overall Study|Lost to Follow-up|3|||
131480092|NCT01691898|473389013|FG001|Overall Study|Lost to Follow-up|1|||
131480093|NCT01691898|473389014|FG002|Overall Study|Lost to Follow-up|0|||
131480094|NCT01691898|473389015|FG003|Overall Study|Lost to Follow-up|0|||
131480095|NCT01691898|473389016|FG004|Overall Study|Lost to Follow-up|1|||
131480096|NCT01691898|473389017|FG005|Overall Study|Lost to Follow-up|0|||
131480097|NCT01691898|473389012|FG000|Overall Study|Withdrawal by Subject|9|||
131480098|NCT01691898|473389013|FG001|Overall Study|Withdrawal by Subject|8|||
131480099|NCT01691898|473389014|FG002|Overall Study|Withdrawal by Subject|2|||
131480100|NCT01691898|473389015|FG003|Overall Study|Withdrawal by Subject|1|||
131480101|NCT01691898|473389016|FG004|Overall Study|Withdrawal by Subject|3|||
131480102|NCT01691898|473389017|FG005|Overall Study|Withdrawal by Subject|3|||
131480103|NCT01691898|473389012|FG000|Overall Study|Non-Compliance|0|||
131480104|NCT01691898|473389013|FG001|Overall Study|Non-Compliance|0|||
131480105|NCT01691898|473389014|FG002|Overall Study|Non-Compliance|0|||
131480106|NCT01691898|473389015|FG003|Overall Study|Non-Compliance|0|||
131480107|NCT01691898|473389016|FG004|Overall Study|Non-Compliance|1|||
131480108|NCT01691898|473389017|FG005|Overall Study|Non-Compliance|0|||
131480109|NCT02808650|473389020|FG000|Overall Study|Death|0|||
131480110|NCT02808650|473389021|FG001|Overall Study|Death|0|||
131480111|NCT02808650|473389022|FG002|Overall Study|Death|0|||
131480112|NCT02808650|473389023|FG003|Overall Study|Death|0|||
131480113|NCT02808650|473389024|FG004|Overall Study|Death|1|||
131480114|NCT02808650|473389020|FG000|Overall Study|Lack of Efficacy|5|||
131480115|NCT02808650|473389021|FG001|Overall Study|Lack of Efficacy|5|||
131480116|NCT02808650|473389022|FG002|Overall Study|Lack of Efficacy|6|||
131480117|NCT02808650|473389023|FG003|Overall Study|Lack of Efficacy|5|||
131480118|NCT02808650|473389024|FG004|Overall Study|Lack of Efficacy|4|||
131480119|NCT02808650|473389020|FG000|Overall Study|Physician Decision|1|||
131480120|NCT02808650|473389021|FG001|Overall Study|Physician Decision|1|||
131480121|NCT02808650|473389022|FG002|Overall Study|Physician Decision|0|||
131480122|NCT02808650|473389023|FG003|Overall Study|Physician Decision|0|||
131480123|NCT02808650|473389024|FG004|Overall Study|Physician Decision|0|||
131480124|NCT02808650|473389020|FG000|Overall Study|Withdrawal by Subject|0|||
131480125|NCT02808650|473389021|FG001|Overall Study|Withdrawal by Subject|0|||
131480126|NCT02808650|473389022|FG002|Overall Study|Withdrawal by Subject|0|||
131480127|NCT02808650|473389023|FG003|Overall Study|Withdrawal by Subject|1|||
131480128|NCT02808650|473389024|FG004|Overall Study|Withdrawal by Subject|1|||
131480129|NCT04093414|473389027|FG000|3 Month Follow up|Physician Decision|0|||
131480130|NCT04093414|473389028|FG001|3 Month Follow up|Physician Decision|1|||
131480131|NCT04093414|473389027|FG000|6month Follow up|Physician Decision|1|||
131480132|NCT04093414|473389028|FG001|6month Follow up|Physician Decision|3|||
131480133|NCT00936611|473389029|FG000|Overall Study|Progressive Disease|3|||
131480134|NCT00936611|473389029|FG000|Overall Study|New Systemic Therapy|22|||
131480135|NCT00936611|473389029|FG000|Overall Study|Lost to Follow-up|1|||
131480136|NCT00936611|473389029|FG000|Overall Study|Withdrawal by Subject|2|||
131480137|NCT00936611|473389029|FG000|Overall Study|Still on Follow-up|1|||
131480138|NCT00936611|473389029|FG000|Overall Study|Still on Active Therapy|7|||
131480139|NCT00936611|473389029|FG000|Overall Study|Ineligible for Study Drug|3|||
131480140|NCT02081183|473389031|FG000|Overall Study|Lost to Follow-up|0|||
131480141|NCT02081183|473389032|FG001|Overall Study|Lost to Follow-up|1|||
131480142|NCT02081183|473389031|FG000|Overall Study|Protocol Violation|1|||
131480143|NCT02081183|473389032|FG001|Overall Study|Protocol Violation|0|||
131480144|NCT02081183|473389031|FG000|Overall Study|Other|3|||
131480145|NCT02081183|473389032|FG001|Overall Study|Other|3|||
131480146|NCT00910273|473389037|FG000|Overall Study|Lack of Efficacy|6|||
131480147|NCT00910273|473389038|FG001|Overall Study|Lack of Efficacy|9|||
131480148|NCT00910273|473389037|FG000|Overall Study|Adverse Event|1|||
131480149|NCT00910273|473389038|FG001|Overall Study|Adverse Event|1|||
131480150|NCT00910273|473389037|FG000|Overall Study|Withdrawal by Subject|1|||
131480151|NCT00910273|473389038|FG001|Overall Study|Withdrawal by Subject|0|||
131480152|NCT00910273|473389037|FG000|Overall Study|Discontinuation of study by sponsor|8|||
131480153|NCT00910273|473389038|FG001|Overall Study|Discontinuation of study by sponsor|2|||
131480154|NCT00910273|473389037|FG000|Overall Study|Protocol Violation|1|||
131480155|NCT00910273|473389038|FG001|Overall Study|Protocol Violation|0|||
131480156|NCT00910273|473389037|FG000|Overall Study|Lost to Follow-up|1|||
131480157|NCT00910273|473389038|FG001|Overall Study|Lost to Follow-up|1|||
131480158|NCT04043728|473389039|FG000|Overall Study|Lost to Follow-up|1|||
131480159|NCT04043728|473389040|FG001|Overall Study|Lost to Follow-up|2|||
131480160|NCT04043728|473389041|FG002|Overall Study|Lost to Follow-up|0|||
131480161|NCT01033851|473389042|FG000|Overall Study|Withdrawal by Subject|3|||
131480162|NCT01033851|473389043|FG001|Overall Study|Withdrawal by Subject|7|||
131480163|NCT02349542|473389044|FG000|Overall Study|Withdrawal by Subject|5|||
131480164|NCT01011738|473389045|FG000|Overall Study|Death|12|||
131480165|NCT01011738|473389046|FG001|Overall Study|Death|3|||
131480166|NCT01011738|473389047|FG002|Overall Study|Death|0|||
131480167|NCT01011738|473389045|FG000|Overall Study|Unknown reasons|312|||
131480168|NCT01011738|473389046|FG001|Overall Study|Unknown reasons|291|||
131480169|NCT01011738|473389047|FG002|Overall Study|Unknown reasons|17|||
131480170|NCT03841448|473389048|FG000|Double-blind Treatment (DBT) Period|Death|1|||
131480171|NCT03841448|473389049|FG001|Double-blind Treatment (DBT) Period|Death|1|||
131480172|NCT03841448|473389050|FG002|Double-blind Treatment (DBT) Period|Death|0|||
131480173|NCT03841448|473389051|FG003|Double-blind Treatment (DBT) Period|Death|0|||
131480174|NCT03841448|473389048|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
131480175|NCT03841448|473389049|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
131480176|NCT03841448|473389050|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
131480177|NCT03841448|473389051|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
131480178|NCT03841448|473389048|FG000|Open-Label Extension (OLE) Period|Death|0|||
131480179|NCT03841448|473389049|FG001|Open-Label Extension (OLE) Period|Death|0|||
131480180|NCT03841448|473389050|FG002|Open-Label Extension (OLE) Period|Death|0|||
131480181|NCT03841448|473389051|FG003|Open-Label Extension (OLE) Period|Death|1|||
131480182|NCT03841448|473389048|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
131480183|NCT03841448|473389049|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
131480184|NCT03841448|473389050|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
131480185|NCT03841448|473389051|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
131480186|NCT03841448|473389048|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
131480187|NCT03841448|473389049|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
131480188|NCT03841448|473389050|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
131480189|NCT03841448|473389051|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
131480190|NCT03841448|473389048|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
131480191|NCT03841448|473389049|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
131480192|NCT03841448|473389050|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
131480193|NCT03841448|473389051|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
131480194|NCT00945555|473389052|FG000|Overall Study|Referred to another hospital|5|||
131480195|NCT00945555|473389052|FG000|Overall Study|Worsening condition, intensive care unit|1|||
131480196|NCT00945555|473389052|FG000|Overall Study|Withdrawal by Subject|2|||
131480197|NCT00945555|473389052|FG000|Overall Study|Participant continued treatment at home|1|||
131480198|NCT00945555|473389052|FG000|Overall Study|Death|18|||
131480199|NCT00945555|473389052|FG000|Overall Study|Other|1|||
131480200|NCT00586625|473389053|FG000|Overall Study|Adverse Event|6|||
131480201|NCT00586625|473389054|FG001|Overall Study|Adverse Event|6|||
131480202|NCT00586625|473389053|FG000|Overall Study|Protocol Violation|3|||
131480203|NCT00586625|473389054|FG001|Overall Study|Protocol Violation|0|||
131480204|NCT00586625|473389053|FG000|Overall Study|Withdrawal by Subject|32|||
131480205|NCT00586625|473389054|FG001|Overall Study|Withdrawal by Subject|10|||
131480206|NCT00586625|473389053|FG000|Overall Study|Subject non-compliance|0|||
131480207|NCT00586625|473389054|FG001|Overall Study|Subject non-compliance|1|||
131480208|NCT00586625|473389053|FG000|Overall Study|Subject unable to return for visit|2|||
131480209|NCT00586625|473389054|FG001|Overall Study|Subject unable to return for visit|0|||
131480210|NCT02728596|473389055|FG000|Overall Study|Refusal unrelated to adverse event|3|||
131480211|NCT02728596|473389056|FG001|Overall Study|Refusal unrelated to adverse event|6|||
131480212|NCT02728596|473389057|FG002|Overall Study|Refusal unrelated to adverse event|7|||
131480213|NCT02728596|473389058|FG003|Overall Study|Refusal unrelated to adverse event|7|||
131480214|NCT02728596|473389055|FG000|Overall Study|Death|44|||
131480215|NCT02728596|473389056|FG001|Overall Study|Death|42|||
131480216|NCT02728596|473389057|FG002|Overall Study|Death|123|||
131480217|NCT02728596|473389058|FG003|Overall Study|Death|68|||
131480218|NCT01193842|473389063|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
131480219|NCT01193842|473389064|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
131480220|NCT01193842|473389065|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
131480221|NCT01193842|473389066|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
131480222|NCT01193842|473389067|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
131480223|NCT01193842|473389063|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
131480224|NCT01193842|473389064|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
131480225|NCT01193842|473389065|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
131480226|NCT01193842|473389066|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
131480227|NCT01193842|473389067|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
131480228|NCT01193842|473389063|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
131480229|NCT01193842|473389064|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
131480230|NCT01193842|473389065|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
131480231|NCT01193842|473389066|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
131480232|NCT01193842|473389067|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
131480233|NCT01193842|473389063|FG000|Phase II: Randomized Groups|Death|0|||
131480234|NCT01193842|473389064|FG001|Phase II: Randomized Groups|Death|0|||
131480235|NCT01193842|473389065|FG002|Phase II: Randomized Groups|Death|0|||
131480236|NCT01193842|473389066|FG003|Phase II: Randomized Groups|Death|1|||
131480237|NCT01193842|473389067|FG004|Phase II: Randomized Groups|Death|1|||
131480238|NCT01193842|473389063|FG000|Phase II: Randomized Groups|Adverse Event|0|||
131480239|NCT01193842|473389064|FG001|Phase II: Randomized Groups|Adverse Event|0|||
131480240|NCT01193842|473389065|FG002|Phase II: Randomized Groups|Adverse Event|0|||
131480241|NCT01193842|473389066|FG003|Phase II: Randomized Groups|Adverse Event|5|||
131480242|NCT01193842|473389067|FG004|Phase II: Randomized Groups|Adverse Event|3|||
131480243|NCT01193842|473389063|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
131480244|NCT01193842|473389064|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
131480245|NCT01193842|473389065|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
131480246|NCT01193842|473389066|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
131480247|NCT01193842|473389067|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
131480248|NCT01193842|473389063|FG000|Phase II: Randomized Groups|Ineligible|0|||
131480249|NCT01193842|473389064|FG001|Phase II: Randomized Groups|Ineligible|0|||
131480250|NCT01193842|473389065|FG002|Phase II: Randomized Groups|Ineligible|0|||
131480251|NCT01193842|473389066|FG003|Phase II: Randomized Groups|Ineligible|0|||
131480252|NCT01193842|473389067|FG004|Phase II: Randomized Groups|Ineligible|1|||
131480253|NCT01193842|473389063|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
131480254|NCT01193842|473389064|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
131480255|NCT01193842|473389065|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
131480256|NCT01193842|473389066|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
131480257|NCT01193842|473389067|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
131480258|NCT01467583|473389069|FG000|Overall Study|Death|1|||
131480259|NCT01467583|473389070|FG001|Overall Study|Death|1|||
131480260|NCT01467583|473389071|FG002|Overall Study|Death|0|||
131480261|NCT01467583|473389069|FG000|Overall Study|Withdrawal by Subject|1|||
131480262|NCT01467583|473389070|FG001|Overall Study|Withdrawal by Subject|0|||
131480263|NCT01467583|473389071|FG002|Overall Study|Withdrawal by Subject|0|||
131480264|NCT01467583|473389069|FG000|Overall Study|Protocol Violation|0|||
131480265|NCT01467583|473389070|FG001|Overall Study|Protocol Violation|0|||
131480266|NCT01467583|473389071|FG002|Overall Study|Protocol Violation|2|||
131480267|NCT05274165|473389072|FG000|Overall Study|Withdrawal by Subject|3|||
131480268|NCT05274165|473389073|FG001|Overall Study|Withdrawal by Subject|3|||
131480269|NCT02484690|473389074|FG000|Overall Study|Adverse Event|1|||
131480270|NCT02484690|473389075|FG001|Overall Study|Adverse Event|3|||
131480271|NCT02484690|473389076|FG002|Overall Study|Adverse Event|0|||
131480272|NCT02484690|473389077|FG003|Overall Study|Adverse Event|0|||
131480273|NCT02484690|473389078|FG004|Overall Study|Adverse Event|5|||
131480274|NCT02484690|473389074|FG000|Overall Study|Death|0|||
131480275|NCT02484690|473389075|FG001|Overall Study|Death|0|||
131480276|NCT02484690|473389076|FG002|Overall Study|Death|0|||
131480277|NCT02484690|473389077|FG003|Overall Study|Death|0|||
131480278|NCT02484690|473389078|FG004|Overall Study|Death|1|||
131480279|NCT02484690|473389074|FG000|Overall Study|Withdrawal by Subject|1|||
131480280|NCT02484690|473389075|FG001|Overall Study|Withdrawal by Subject|3|||
131480281|NCT02484690|473389076|FG002|Overall Study|Withdrawal by Subject|1|||
131480282|NCT02484690|473389077|FG003|Overall Study|Withdrawal by Subject|2|||
131480283|NCT02484690|473389078|FG004|Overall Study|Withdrawal by Subject|0|||
131480284|NCT02484690|473389074|FG000|Overall Study|Physician Decision|2|||
131480285|NCT02484690|473389075|FG001|Overall Study|Physician Decision|0|||
131480286|NCT02484690|473389076|FG002|Overall Study|Physician Decision|1|||
131480287|NCT02484690|473389077|FG003|Overall Study|Physician Decision|0|||
131480288|NCT02484690|473389078|FG004|Overall Study|Physician Decision|0|||
131480289|NCT02484690|473389074|FG000|Overall Study|Lost to Follow-up|0|||
131480290|NCT02484690|473389075|FG001|Overall Study|Lost to Follow-up|0|||
131480291|NCT02484690|473389076|FG002|Overall Study|Lost to Follow-up|1|||
131480292|NCT02484690|473389077|FG003|Overall Study|Lost to Follow-up|0|||
131480293|NCT02484690|473389078|FG004|Overall Study|Lost to Follow-up|0|||
131480294|NCT04916769|473389082|FG000|Period 1|Physician Decision|0|||
131480295|NCT04916769|473389083|FG001|Period 1|Physician Decision|0|||
131480296|NCT04916769|473389084|FG002|Period 1|Physician Decision|0|||
131480297|NCT04916769|473389085|FG003|Period 1|Physician Decision|0|||
131480298|NCT04916769|473389086|FG004|Period 1|Physician Decision|0|||
131480299|NCT04916769|473389087|FG005|Period 1|Physician Decision|1|||
131480300|NCT04916769|473389082|FG000|Period 2|Physician Decision|0|||
131480301|NCT04916769|473389083|FG001|Period 2|Physician Decision|1|||
131480302|NCT04916769|473389084|FG002|Period 2|Physician Decision|0|||
131480303|NCT04916769|473389085|FG003|Period 2|Physician Decision|0|||
131480304|NCT04916769|473389086|FG004|Period 2|Physician Decision|0|||
131480305|NCT04916769|473389087|FG005|Period 2|Physician Decision|0|||
131480306|NCT04340193|473389088|FG000|Overall Study|Other reason|0|||
131480307|NCT04340193|473389089|FG001|Overall Study|Other reason|0|||
131480308|NCT04340193|473389090|FG002|Overall Study|Other reason|1|||
131480309|NCT04340193|473389088|FG000|Overall Study|Disease recurrence|0|||
131480310|NCT04340193|473389089|FG001|Overall Study|Disease recurrence|1|||
131480311|NCT04340193|473389090|FG002|Overall Study|Disease recurrence|0|||
131480312|NCT04340193|473389088|FG000|Overall Study|Study drug toxicity|1|||
131480313|NCT04340193|473389089|FG001|Overall Study|Study drug toxicity|0|||
131480314|NCT04340193|473389090|FG002|Overall Study|Study drug toxicity|0|||
131480315|NCT04340193|473389088|FG000|Overall Study|Disease progression|1|||
131480316|NCT04340193|473389089|FG001|Overall Study|Disease progression|2|||
131480317|NCT04340193|473389090|FG002|Overall Study|Disease progression|3|||
131480318|NCT04340193|473389088|FG000|Overall Study|Administrative reasons by sponsor|0|||
131480319|NCT04340193|473389089|FG001|Overall Study|Administrative reasons by sponsor|1|||
131480320|NCT04340193|473389090|FG002|Overall Study|Administrative reasons by sponsor|0|||
131480321|NCT04340193|473389088|FG000|Overall Study|Adverse Event|1|||
131480322|NCT04340193|473389089|FG001|Overall Study|Adverse Event|1|||
131480323|NCT04340193|473389090|FG002|Overall Study|Adverse Event|0|||
131480324|NCT03589469|473390447|FG000|Overall Study|Withdrawal by Subject|8|||
131480325|NCT03589469|473390447|FG000|Overall Study|Physician Decision|20|||
131480326|NCT03589469|473390447|FG000|Overall Study|Death|97|||
131480327|NCT03589469|473390447|FG000|Overall Study|Lost to Follow-up|8|||
131480328|NCT03589469|473390447|FG000|Overall Study|Miscellaneous|1|||
131480329|NCT00371826|473390448|FG000|Core Phase (12 Months)|Adverse Event|15|||
131480330|NCT00371826|473390449|FG001|Core Phase (12 Months)|Adverse Event|4|||
131480331|NCT00371826|473390450|FG002|Core Phase (12 Months)|Adverse Event|9|||
131480332|NCT00371826|473390448|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
131480333|NCT00371826|473390449|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
131480334|NCT00371826|473390450|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
131480335|NCT00371826|473390448|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
131480336|NCT00371826|473390449|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
131480337|NCT00371826|473390450|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
131480338|NCT00371826|473390448|FG000|Core Phase (12 Months)|Protocol Violation|1|||
131480339|NCT00371826|473390449|FG001|Core Phase (12 Months)|Protocol Violation|0|||
131480340|NCT00371826|473390450|FG002|Core Phase (12 Months)|Protocol Violation|1|||
131480341|NCT00371826|473390448|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
131480342|NCT00371826|473390449|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
131480343|NCT00371826|473390450|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
131480344|NCT00371826|473390448|FG000|Core Phase (12 Months)|Administrative problems|1|||
131480345|NCT00371826|473390449|FG001|Core Phase (12 Months)|Administrative problems|0|||
131480346|NCT00371826|473390450|FG002|Core Phase (12 Months)|Administrative problems|8|||
131480347|NCT00371826|473390448|FG000|Core Phase (12 Months)|Graft Loss|0|||
131480348|NCT00371826|473390449|FG001|Core Phase (12 Months)|Graft Loss|1|||
131480349|NCT00371826|473390450|FG002|Core Phase (12 Months)|Graft Loss|0|||
131480350|NCT00371826|473390448|FG000|Extension Phase (24 Months)|Adverse Event|4|||
131480351|NCT00371826|473390449|FG001|Extension Phase (24 Months)|Adverse Event|5|||
131480352|NCT00371826|473390450|FG002|Extension Phase (24 Months)|Adverse Event|0|||
131480353|NCT00371826|473390448|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
131480354|NCT00371826|473390449|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
131480355|NCT00371826|473390450|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
131480356|NCT00371826|473390448|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
131480357|NCT00371826|473390449|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
131480358|NCT00371826|473390450|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
131480359|NCT00371826|473390448|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
131480360|NCT00371826|473390449|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
131480361|NCT00371826|473390450|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
131480362|NCT00371826|473390448|FG000|Extension Phase (24 Months)|Administrative problems|0|||
131480363|NCT00371826|473390449|FG001|Extension Phase (24 Months)|Administrative problems|0|||
131480364|NCT00371826|473390450|FG002|Extension Phase (24 Months)|Administrative problems|2|||
131480365|NCT00385762|473390451|FG000|Overall Study|Adverse Event|1|||
131480366|NCT00385762|473390451|FG000|Overall Study|Lost to Follow-up|1|||
131480367|NCT00573183|473390452|FG000|Overall Study|Lost to Follow-up|52|||
131480368|NCT00573183|473390453|FG001|Overall Study|Lost to Follow-up|50|||
131480369|NCT00573183|473390452|FG000|Overall Study|Withdrawal by Subject|8|||
131480370|NCT00573183|473390453|FG001|Overall Study|Withdrawal by Subject|2|||
131480371|NCT00573183|473390452|FG000|Overall Study|Death|0|||
131480372|NCT00573183|473390453|FG001|Overall Study|Death|1|||
131480373|NCT00573183|473390452|FG000|Overall Study|Adverse Event|2|||
131480374|NCT00573183|473390453|FG001|Overall Study|Adverse Event|0|||
131480375|NCT00573183|473390452|FG000|Overall Study|Incarceration|5|||
131480376|NCT00573183|473390453|FG001|Overall Study|Incarceration|8|||
131480377|NCT00573183|473390452|FG000|Overall Study|Other|5|||
131480378|NCT00573183|473390453|FG001|Overall Study|Other|2|||
131480379|NCT00231842|473390454|FG000|Overall Study|Withdrawal by Subject|3|||
131480380|NCT00231842|473390454|FG000|Overall Study|Did not complete the last 3 cycle|8|||
131480381|NCT02422303|473390455|FG000|Overall Study|Lost to Follow-up|1|||
131480382|NCT02422303|473390456|FG001|Overall Study|Lost to Follow-up|1|||
131480383|NCT00428792|473390459|FG000|Overall Study|Lack of Efficacy|1|||
131480384|NCT00428792|473390460|FG001|Overall Study|Lack of Efficacy|3|||
131480385|NCT00428792|473390459|FG000|Overall Study|Lost to Follow-up|0|||
131480386|NCT00428792|473390460|FG001|Overall Study|Lost to Follow-up|1|||
131480387|NCT00639678|473390461|FG000|Overall Study|Withdrawal by Subject|3|||
131480388|NCT00639678|473390462|FG001|Overall Study|Withdrawal by Subject|0|||
131480389|NCT00639678|473390463|FG002|Overall Study|Withdrawal by Subject|4|||
131480390|NCT00639678|473390464|FG003|Overall Study|Withdrawal by Subject|0|||
131480391|NCT00639678|473390461|FG000|Overall Study|Lost to Follow-up|1|||
131480392|NCT00639678|473390462|FG001|Overall Study|Lost to Follow-up|0|||
131480393|NCT00639678|473390463|FG002|Overall Study|Lost to Follow-up|6|||
131480394|NCT00639678|473390464|FG003|Overall Study|Lost to Follow-up|0|||
131480395|NCT00639678|473390461|FG000|Overall Study|Adverse Event|0|||
131480396|NCT00639678|473390462|FG001|Overall Study|Adverse Event|1|||
131480397|NCT00639678|473390463|FG002|Overall Study|Adverse Event|0|||
131480398|NCT00639678|473390464|FG003|Overall Study|Adverse Event|0|||
131480399|NCT00639678|473390461|FG000|Overall Study|Lack of Compliance|0|||
131480400|NCT00639678|473390462|FG001|Overall Study|Lack of Compliance|0|||
131480401|NCT00639678|473390463|FG002|Overall Study|Lack of Compliance|1|||
131480402|NCT00639678|473390464|FG003|Overall Study|Lack of Compliance|0|||
131480403|NCT01926015|473390465|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131480404|NCT01926015|473390466|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131480405|NCT01926015|473390465|FG000|Overall Study|Randomized not treated|2|||
131480406|NCT01926015|473390466|FG001|Overall Study|Randomized not treated|0|||
131480407|NCT01364649|473390467|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
131480408|NCT01364649|473390468|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
131480409|NCT01364649|473390467|FG000|Overall Study|Lack of Efficacy|6|||
131480410|NCT01364649|473390468|FG001|Overall Study|Lack of Efficacy|0|||
131480411|NCT01364649|473390467|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
131480412|NCT01364649|473390468|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
131480413|NCT01364649|473390467|FG000|Overall Study|Protocol Deviations|4|||
131480414|NCT01364649|473390468|FG001|Overall Study|Protocol Deviations|8|||
131480415|NCT01364649|473390467|FG000|Overall Study|Withdrawal of Consent|9|||
131480416|NCT01364649|473390468|FG001|Overall Study|Withdrawal of Consent|7|||
131480417|NCT01364649|473390467|FG000|Overall Study|Lost to Follow-up|12|||
131480418|NCT01364649|473390468|FG001|Overall Study|Lost to Follow-up|13|||
131480419|NCT01364649|473390467|FG000|Overall Study|Other|4|||
131480420|NCT01364649|473390468|FG001|Overall Study|Other|1|||
131480421|NCT03270644|473390487|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
131480422|NCT03270644|473390487|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
131480423|NCT01426438|473390493|FG000|Overall Study|Lost to Follow-up|1|||
131480424|NCT01426438|473390494|FG001|Overall Study|Lost to Follow-up|3|||
131480425|NCT01426438|473390493|FG000|Overall Study|Off study Treatment|9|||
131480426|NCT01426438|473390494|FG001|Overall Study|Off study Treatment|3|||
131480427|NCT01426438|473390493|FG000|Overall Study|Poor scan quality|3|||
131480428|NCT01426438|473390494|FG001|Overall Study|Poor scan quality|2|||
131480429|NCT01426438|473390493|FG000|Overall Study|Missed Scan|2|||
131480430|NCT01426438|473390494|FG001|Overall Study|Missed Scan|2|||
131480431|NCT01500031|473390497|FG000|Overall Study|Death|1|||
131480432|NCT01500031|473390497|FG000|Overall Study|Withdrawal by Subject|4|||
131480433|NCT01797731|473390498|FG000|Overall Study|Didn't have proper radiographs required|3|||
131480434|NCT01797731|473390499|FG001|Overall Study|Didn't have proper radiographs required|3|||
131480435|NCT00091442|473390501|FG000|Overall Study|Progressive Disease|220|||
131480436|NCT00091442|473390502|FG001|Overall Study|Progressive Disease|189|||
131480437|NCT00091442|473390501|FG000|Overall Study|Physician Decision|61|||
131480438|NCT00091442|473390502|FG001|Overall Study|Physician Decision|58|||
131480439|NCT00091442|473390501|FG000|Overall Study|Withdrawal by Subject|38|||
131480440|NCT00091442|473390502|FG001|Overall Study|Withdrawal by Subject|46|||
131480441|NCT00091442|473390501|FG000|Overall Study|Adverse Event|29|||
131480442|NCT00091442|473390502|FG001|Overall Study|Adverse Event|48|||
131480443|NCT00091442|473390501|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
131480444|NCT00091442|473390502|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
131480445|NCT00091442|473390501|FG000|Overall Study|Death|9|||
131480446|NCT00091442|473390502|FG001|Overall Study|Death|7|||
131480447|NCT00091442|473390501|FG000|Overall Study|Lost to Follow-up|1|||
131480448|NCT00091442|473390502|FG001|Overall Study|Lost to Follow-up|3|||
131480449|NCT00091442|473390501|FG000|Overall Study|Other|2|||
131480450|NCT00091442|473390502|FG001|Overall Study|Other|6|||
131480451|NCT03643575|473390503|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
131480452|NCT03643575|473390504|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
131480453|NCT03643575|473390505|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
131480454|NCT03643575|473390506|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
131480455|NCT03643575|473390507|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
131480456|NCT03643575|473390508|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
131480457|NCT03643575|473390503|FG000|Washout: 7 Days|Adverse Event|1|||
131480458|NCT03643575|473390504|FG001|Washout: 7 Days|Adverse Event|0|||
131480459|NCT03643575|473390505|FG002|Washout: 7 Days|Adverse Event|0|||
131480460|NCT03643575|473390506|FG003|Washout: 7 Days|Adverse Event|0|||
131480461|NCT03643575|473390507|FG004|Washout: 7 Days|Adverse Event|0|||
131480462|NCT03643575|473390508|FG005|Washout: 7 Days|Adverse Event|0|||
131480463|NCT03643575|473390503|FG000|Washout: 7 Days|Non compliance check in|0|||
131480464|NCT03643575|473390504|FG001|Washout: 7 Days|Non compliance check in|1|||
131480465|NCT03643575|473390505|FG002|Washout: 7 Days|Non compliance check in|0|||
131480466|NCT03643575|473390506|FG003|Washout: 7 Days|Non compliance check in|0|||
131480467|NCT03643575|473390507|FG004|Washout: 7 Days|Non compliance check in|0|||
131480468|NCT03643575|473390508|FG005|Washout: 7 Days|Non compliance check in|0|||
131480469|NCT03945214|473390509|FG000|Overall Study|Lost to Follow-up|3|||
131480470|NCT03945214|473390510|FG001|Overall Study|Lost to Follow-up|4|||
131480471|NCT03945214|473390511|FG002|Overall Study|Lost to Follow-up|7|||
131480472|NCT03945214|473390512|FG003|Overall Study|Lost to Follow-up|4|||
131480473|NCT01772160|473390514|FG000|Overall Study|Death|3|||
131480474|NCT01772160|473390514|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
131480475|NCT01772160|473390514|FG000|Overall Study|Consent withdrawal|3|||
131480476|NCT01772160|473390514|FG000|Overall Study|Migrated / moved from the study area|4|||
131480477|NCT01772160|473390514|FG000|Overall Study|Lost to Follow-up|30|||
131480478|NCT01772160|473390514|FG000|Overall Study|Other|5|||
131480479|NCT00538291|473390515|FG000|Overall Study|Adverse Event|2|||
131480480|NCT00538291|473390515|FG000|Overall Study|Withdrawal by Subject|1|||
131480481|NCT01672736|473390518|FG000|Overall Study|Available drug expired on 31 May 16|3|||
131480482|NCT01262573|473390519|FG000|Overall Study|Withdrawal by Subject|0|||
131480483|NCT01262573|473390520|FG001|Overall Study|Withdrawal by Subject|1|||
131480484|NCT03800173|473390527|FG000|Overall Study|Lost to Follow-up|0|||
131480485|NCT03800173|473390528|FG001|Overall Study|Lost to Follow-up|0|||
131480486|NCT03800173|473390529|FG002|Overall Study|Lost to Follow-up|0|||
131480487|NCT03800173|473390530|FG003|Overall Study|Lost to Follow-up|0|||
131480488|NCT03800173|473390531|FG004|Overall Study|Lost to Follow-up|1|||
131480489|NCT02507973|473390532|FG000|Overall Study|Adverse Event|1|||
131480490|NCT00331422|473390533|FG000|Overall Study|Did not receive entire study regimen|5|||
131480491|NCT01163266|473390534|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
131480492|NCT01163266|473390535|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
131480493|NCT01163266|473390536|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
131480494|NCT01163266|473390534|FG000|Overall Study|Lack of Efficacy|1|||
131480495|NCT01163266|473390535|FG001|Overall Study|Lack of Efficacy|3|||
131480496|NCT01163266|473390536|FG002|Overall Study|Lack of Efficacy|1|||
131480497|NCT01163266|473390534|FG000|Overall Study|Noncompliance with Study Drug|0|||
131480498|NCT01163266|473390535|FG001|Overall Study|Noncompliance with Study Drug|2|||
131480499|NCT01163266|473390536|FG002|Overall Study|Noncompliance with Study Drug|0|||
131480500|NCT01163266|473390534|FG000|Overall Study|Protocol Deviations|2|||
131480501|NCT01163266|473390535|FG001|Overall Study|Protocol Deviations|2|||
131480502|NCT01163266|473390536|FG002|Overall Study|Protocol Deviations|5|||
131480503|NCT01163266|473390534|FG000|Overall Study|Withdrawal of Consent|5|||
131480504|NCT01163266|473390535|FG001|Overall Study|Withdrawal of Consent|7|||
131480505|NCT01163266|473390536|FG002|Overall Study|Withdrawal of Consent|3|||
131480506|NCT01163266|473390534|FG000|Overall Study|Lost to Follow-up|7|||
131480507|NCT01163266|473390535|FG001|Overall Study|Lost to Follow-up|7|||
131480508|NCT01163266|473390536|FG002|Overall Study|Lost to Follow-up|10|||
131480509|NCT01163266|473390534|FG000|Overall Study|Other|1|||
131480510|NCT01163266|473390535|FG001|Overall Study|Other|1|||
131480511|NCT01163266|473390536|FG002|Overall Study|Other|2|||
131480512|NCT02586064|473390537|FG000|Overall Study|Other Obligations|6|||
131480513|NCT02586064|473390538|FG001|Overall Study|Other Obligations|6|||
131480514|NCT02586064|473390537|FG000|Overall Study|Other|3|||
131480515|NCT02586064|473390538|FG001|Overall Study|Other|7|||
131480516|NCT02586064|473390537|FG000|Overall Study|Never Started|3|||
131480517|NCT02586064|473390538|FG001|Overall Study|Never Started|3|||
131480518|NCT02586064|473390537|FG000|Overall Study|Lost Interest|1|||
131480519|NCT02586064|473390538|FG001|Overall Study|Lost Interest|4|||
131480520|NCT02586064|473390537|FG000|Overall Study|Miscellaneous Life Issues|0|||
131480521|NCT02586064|473390538|FG001|Overall Study|Miscellaneous Life Issues|5|||
131480522|NCT02586064|473390537|FG000|Overall Study|Infrequent Attendance|2|||
131480523|NCT02586064|473390538|FG001|Overall Study|Infrequent Attendance|1|||
131480524|NCT02586064|473390537|FG000|Overall Study|Timed Out|2|||
131480525|NCT02586064|473390538|FG001|Overall Study|Timed Out|0|||
131480526|NCT02586064|473390537|FG000|Overall Study|AUD relapse|0|||
131480527|NCT02586064|473390538|FG001|Overall Study|AUD relapse|2|||
131480528|NCT02586064|473390537|FG000|Overall Study|Legal Issue|1|||
131480529|NCT02586064|473390538|FG001|Overall Study|Legal Issue|0|||
131480530|NCT03181893|473390539|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480531|NCT03181893|473390540|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
131480532|NCT03181893|473390541|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480533|NCT03181893|473390542|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480534|NCT03181893|473390543|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480535|NCT03181893|473390544|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480536|NCT03181893|473390545|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480537|NCT03181893|473390546|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480538|NCT03181893|473390547|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480539|NCT03181893|473390548|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480540|NCT03181893|473390549|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
131480541|NCT03181893|473390539|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
131480542|NCT03181893|473390540|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
131480543|NCT03181893|473390541|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480544|NCT03181893|473390542|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480545|NCT03181893|473390543|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480546|NCT03181893|473390544|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480547|NCT03181893|473390545|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480548|NCT03181893|473390546|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480549|NCT03181893|473390547|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480550|NCT03181893|473390548|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480551|NCT03181893|473390549|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131480552|NCT03181893|473390539|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480553|NCT03181893|473390540|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480554|NCT03181893|473390541|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480555|NCT03181893|473390542|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480556|NCT03181893|473390543|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480557|NCT03181893|473390544|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480558|NCT03181893|473390545|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480559|NCT03181893|473390546|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
131480560|NCT03181893|473390547|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
131480561|NCT03181893|473390548|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480562|NCT03181893|473390549|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131480563|NCT03181893|473390539|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480564|NCT03181893|473390540|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480565|NCT03181893|473390541|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480566|NCT03181893|473390542|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480567|NCT03181893|473390543|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480568|NCT03181893|473390544|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480569|NCT03181893|473390545|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480570|NCT03181893|473390546|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480571|NCT03181893|473390547|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480572|NCT03181893|473390548|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
131480573|NCT03181893|473390549|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
131480574|NCT03181893|473390539|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480575|NCT03181893|473390540|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480576|NCT03181893|473390541|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480577|NCT03181893|473390542|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480578|NCT03181893|473390543|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480579|NCT03181893|473390544|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480580|NCT03181893|473390545|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480581|NCT03181893|473390546|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480582|NCT03181893|473390547|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480583|NCT03181893|473390548|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
131480584|NCT03181893|473390549|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
131480585|NCT04128371|473390550|FG000|Overall Study|Lack of Efficacy|1|||
131480586|NCT00968864|473390552|FG000|Overall Study|Protocol exception/ not evaluable|1|||
131480587|NCT04815031|473390553|FG000|Overall Study|No adverse event information (missing information)|33|||
131480588|NCT04032652|473390559|FG000|Overall Study|The study was terminated and the PI has|1|||
131480589|NCT04032652|473390560|FG001|Overall Study|The study was terminated and the PI has|1|||
131480590|NCT00165984|473390561|FG000|Overall Study|Death|15|||
131480591|NCT01414608|473390562|FG000|Overall Study|Ineligible|5|||
131480592|NCT01414608|473390563|FG001|Overall Study|Ineligible|2|||
131480593|NCT03945266|473390564|FG000|Overall Study|Withdrawal by Subject|1|||
131480594|NCT03945266|473390565|FG001|Overall Study|Withdrawal by Subject|0|||
131480595|NCT03945266|473390564|FG000|Overall Study|Miscarriage|0|||
131480596|NCT03945266|473390565|FG001|Overall Study|Miscarriage|2|||
131480597|NCT03945266|473390564|FG000|Overall Study|Lost to Follow-up|1|||
131480598|NCT03945266|473390565|FG001|Overall Study|Lost to Follow-up|0|||
131480599|NCT01736124|473390568|FG000|Post-intervention Assessment|Death|2|||
131480600|NCT01736124|473390569|FG001|Post-intervention Assessment|Death|2|||
131480601|NCT01736124|473390568|FG000|Post-intervention Assessment|lost computer access|1|||
131480602|NCT01736124|473390569|FG001|Post-intervention Assessment|lost computer access|1|||
131480603|NCT01736124|473390568|FG000|Post-intervention Assessment|Moved away|3|||
131480604|NCT01736124|473390569|FG001|Post-intervention Assessment|Moved away|1|||
131480605|NCT01736124|473390568|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
131480606|NCT01736124|473390569|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
131480607|NCT01736124|473390568|FG000|Post-intervention Assessment|Illness|3|||
131480608|NCT01736124|473390569|FG001|Post-intervention Assessment|Illness|2|||
131480609|NCT01736124|473390568|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
131480610|NCT01736124|473390569|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
131480611|NCT01736124|473390568|FG000|Post-intervention Assessment|Temporarily away|3|||
131480612|NCT01736124|473390569|FG001|Post-intervention Assessment|Temporarily away|1|||
131480613|NCT01736124|473390568|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
131480614|NCT01736124|473390569|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
131480615|NCT01736124|473390568|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
131480616|NCT01736124|473390569|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
131480617|NCT01736124|473390568|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
131480618|NCT01736124|473390569|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
131480619|NCT01736124|473390568|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
131480620|NCT01736124|473390569|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
131480621|NCT01736124|473390568|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
131480622|NCT01736124|473390569|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
131480623|NCT01736124|473390568|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
131480624|NCT01736124|473390569|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
131480625|NCT01736124|473390568|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
131480626|NCT01736124|473390569|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
131480627|NCT01736124|473390568|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
131480628|NCT01736124|473390569|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
131480629|NCT01736124|473390568|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
131480630|NCT01736124|473390569|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
131480631|NCT03553927|473390570|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
131480632|NCT03553927|473390571|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
131480633|NCT03553927|473390570|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
131480634|NCT03553927|473390571|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
131480635|NCT02423772|473390572|FG000|Overall Study|Lost to Follow-up|3|||
131480636|NCT02423772|473390573|FG001|Overall Study|Lost to Follow-up|3|||
131480637|NCT02423772|473390572|FG000|Overall Study|Did not begin intervention|2|||
131480638|NCT02423772|473390573|FG001|Overall Study|Did not begin intervention|5|||
131480639|NCT01759511|473390579|FG000|Overall Study|Adverse Event|4|||
131480640|NCT01759511|473390579|FG000|Overall Study|Death|2|||
131480641|NCT01759511|473390579|FG000|Overall Study|Lack of Efficacy|2|||
131480642|NCT01759511|473390579|FG000|Overall Study|Physician Decision|1|||
131480643|NCT01759511|473390579|FG000|Overall Study|Progressive Disease|5|||
131480644|NCT01759511|473390579|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
131480645|NCT01759511|473390579|FG000|Overall Study|Study Terminated by Sponsor|13|||
131480646|NCT01759511|473390579|FG000|Overall Study|Withdrawal by Subject|3|||
131480647|NCT05736224|473390580|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
131480648|NCT03673046|473392361|FG000|Overall Study|Adverse Event|1|||
131480649|NCT03673046|473392362|FG001|Overall Study|Adverse Event|1|||
131480650|NCT03673046|473392361|FG000|Overall Study|Withdrawal by Subject|8|||
131480651|NCT03673046|473392362|FG001|Overall Study|Withdrawal by Subject|2|||
131480652|NCT03693300|473392363|FG000|Overall Study|Withdrawal by Subject|6|||
131480653|NCT03693300|473392364|FG001|Overall Study|Withdrawal by Subject|0|||
131480654|NCT03693300|473392363|FG000|Overall Study|Death|50|||
131480655|NCT03693300|473392364|FG001|Overall Study|Death|2|||
131480656|NCT03693300|473392363|FG000|Overall Study|Lost to Follow-up|2|||
131480657|NCT03693300|473392364|FG001|Overall Study|Lost to Follow-up|0|||
131480658|NCT02206048|473392365|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
131480659|NCT00866788|473392366|FG000|Overall Study|Adverse Event|0|||
131480660|NCT00866788|473392367|FG001|Overall Study|Adverse Event|2|||
131480661|NCT00866788|473392368|FG002|Overall Study|Adverse Event|0|||
131480662|NCT00866788|473392369|FG003|Overall Study|Adverse Event|1|||
131480663|NCT00866788|473392366|FG000|Overall Study|Lost to Follow-up|1|||
131480664|NCT00866788|473392367|FG001|Overall Study|Lost to Follow-up|1|||
131480665|NCT00866788|473392368|FG002|Overall Study|Lost to Follow-up|0|||
131480666|NCT00866788|473392369|FG003|Overall Study|Lost to Follow-up|2|||
131480667|NCT00866788|473392366|FG000|Overall Study|Withdrawal by Subject|2|||
131480668|NCT00866788|473392367|FG001|Overall Study|Withdrawal by Subject|1|||
131480669|NCT00866788|473392368|FG002|Overall Study|Withdrawal by Subject|0|||
131480670|NCT00866788|473392369|FG003|Overall Study|Withdrawal by Subject|1|||
131480671|NCT00866788|473392366|FG000|Overall Study|Pregnancy|0|||
131480672|NCT00866788|473392367|FG001|Overall Study|Pregnancy|1|||
131480673|NCT00866788|473392368|FG002|Overall Study|Pregnancy|0|||
131480674|NCT00866788|473392369|FG003|Overall Study|Pregnancy|0|||
131480675|NCT00866788|473392366|FG000|Overall Study|Disease progression|3|||
131480676|NCT00866788|473392367|FG001|Overall Study|Disease progression|1|||
131480677|NCT00866788|473392368|FG002|Overall Study|Disease progression|1|||
131480678|NCT00866788|473392369|FG003|Overall Study|Disease progression|0|||
131480679|NCT00866788|473392366|FG000|Overall Study|Physician Decision|0|||
131480680|NCT00866788|473392367|FG001|Overall Study|Physician Decision|0|||
131480681|NCT00866788|473392368|FG002|Overall Study|Physician Decision|1|||
131480682|NCT00866788|473392369|FG003|Overall Study|Physician Decision|1|||
131480683|NCT02742441|473392370|FG000|Overall Study|Lost to Follow-up|4|||
131480684|NCT02742441|473392371|FG001|Overall Study|Lost to Follow-up|4|||
131480685|NCT02742441|473392370|FG000|Overall Study|Withdrawal by Subject|2|||
131480686|NCT02742441|473392371|FG001|Overall Study|Withdrawal by Subject|2|||
131480687|NCT02742441|473392370|FG000|Overall Study|Adverse Event|0|||
131480688|NCT02742441|473392371|FG001|Overall Study|Adverse Event|2|||
131480689|NCT02202837|473392375|FG000|Overall Study|Enbrel treatment discontinued|36|||
131480690|NCT02202837|473392376|FG001|Overall Study|Enbrel treatment discontinued|4|||
131480691|NCT02202837|473392375|FG000|Overall Study|Other|10|||
131480692|NCT02202837|473392376|FG001|Overall Study|Other|0|||
131480693|NCT02202837|473392375|FG000|Overall Study|Lost to Follow-up|7|||
131480694|NCT02202837|473392376|FG001|Overall Study|Lost to Follow-up|1|||
131480695|NCT04195906|473392377|FG000|Part 1|Adverse Event|3|||
131480696|NCT04195906|473392378|FG001|Part 1|Adverse Event|7|||
131480697|NCT04195906|473392377|FG000|Part 1|Withdrawal by Subject|0|||
131480698|NCT04195906|473392378|FG001|Part 1|Withdrawal by Subject|1|||
131480699|NCT04195906|473392377|FG000|Part 2|Adverse Event|1|||
131480700|NCT04195906|473392378|FG001|Part 2|Adverse Event|1|||
131480701|NCT04195906|473392377|FG000|Part 2|Withdrawal by Subject|0|||
131480702|NCT04195906|473392378|FG001|Part 2|Withdrawal by Subject|3|||
131480703|NCT04195906|473392377|FG000|Part 2|Other|1|||
131480704|NCT04195906|473392378|FG001|Part 2|Other|3|||
131480705|NCT02008318|473392379|FG000|Overall Study|Adverse Event|4|||
131480706|NCT02008318|473392380|FG001|Overall Study|Adverse Event|0|||
131480707|NCT02008318|473392379|FG000|Overall Study|Physician Decision|2|||
131480708|NCT02008318|473392380|FG001|Overall Study|Physician Decision|0|||
131480709|NCT02008318|473392379|FG000|Overall Study|Progressive Disease|2|||
131480710|NCT02008318|473392380|FG001|Overall Study|Progressive Disease|0|||
131480711|NCT02008318|473392379|FG000|Overall Study|Protocol Violation|1|||
131480712|NCT02008318|473392380|FG001|Overall Study|Protocol Violation|1|||
131480713|NCT02008318|473392379|FG000|Overall Study|Withdrawal by Subject|3|||
131480714|NCT02008318|473392380|FG001|Overall Study|Withdrawal by Subject|0|||
131480715|NCT02281773|473392381|FG000|Overall Study|Adverse Event|6|||
131480716|NCT02281773|473392382|FG001|Overall Study|Adverse Event|1|||
131480717|NCT02281773|473392383|FG002|Overall Study|Adverse Event|4|||
131480718|NCT02281773|473392384|FG003|Overall Study|Adverse Event|8|||
131480719|NCT02281773|473392385|FG004|Overall Study|Adverse Event|9|||
131480720|NCT02281773|473392381|FG000|Overall Study|Protocol Violation|1|||
131480721|NCT02281773|473392382|FG001|Overall Study|Protocol Violation|0|||
131480722|NCT02281773|473392383|FG002|Overall Study|Protocol Violation|0|||
131480723|NCT02281773|473392384|FG003|Overall Study|Protocol Violation|2|||
131480724|NCT02281773|473392385|FG004|Overall Study|Protocol Violation|2|||
131480725|NCT02281773|473392381|FG000|Overall Study|Lost to Follow-up|2|||
131480726|NCT02281773|473392382|FG001|Overall Study|Lost to Follow-up|2|||
131480727|NCT02281773|473392383|FG002|Overall Study|Lost to Follow-up|6|||
131480728|NCT02281773|473392384|FG003|Overall Study|Lost to Follow-up|2|||
131480729|NCT02281773|473392385|FG004|Overall Study|Lost to Follow-up|10|||
131480730|NCT02281773|473392381|FG000|Overall Study|Withdrawal by Subject|2|||
131480731|NCT02281773|473392382|FG001|Overall Study|Withdrawal by Subject|8|||
131480732|NCT02281773|473392383|FG002|Overall Study|Withdrawal by Subject|6|||
131480733|NCT02281773|473392384|FG003|Overall Study|Withdrawal by Subject|6|||
131480734|NCT02281773|473392385|FG004|Overall Study|Withdrawal by Subject|8|||
131480735|NCT02281773|473392381|FG000|Overall Study|Other Reason|0|||
131480736|NCT02281773|473392382|FG001|Overall Study|Other Reason|4|||
131480737|NCT02281773|473392383|FG002|Overall Study|Other Reason|2|||
131480738|NCT02281773|473392384|FG003|Overall Study|Other Reason|3|||
131480739|NCT02281773|473392385|FG004|Overall Study|Other Reason|1|||
131480740|NCT00902668|473392396|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
131480741|NCT01914757|473392397|FG000|Overall Study|Severe non-compliance to protocol|3|||
131480742|NCT01914757|473392398|FG001|Overall Study|Severe non-compliance to protocol|1|||
131480743|NCT01914757|473392399|FG002|Overall Study|Severe non-compliance to protocol|2|||
131480744|NCT01914757|473392397|FG000|Overall Study|Lost to Follow-up|5|||
131480745|NCT01914757|473392398|FG001|Overall Study|Lost to Follow-up|8|||
131480746|NCT01914757|473392399|FG002|Overall Study|Lost to Follow-up|6|||
131480747|NCT01914757|473392397|FG000|Overall Study|Withdrawal by Subject|15|||
131480748|NCT01914757|473392398|FG001|Overall Study|Withdrawal by Subject|27|||
131480749|NCT01914757|473392399|FG002|Overall Study|Withdrawal by Subject|19|||
131480750|NCT01914757|473392397|FG000|Overall Study|Death|2|||
131480751|NCT01914757|473392398|FG001|Overall Study|Death|2|||
131480752|NCT01914757|473392399|FG002|Overall Study|Death|1|||
131480753|NCT01914757|473392397|FG000|Overall Study|Adverse Event|4|||
131480754|NCT01914757|473392398|FG001|Overall Study|Adverse Event|3|||
131480755|NCT01914757|473392399|FG002|Overall Study|Adverse Event|4|||
131480756|NCT01914757|473392397|FG000|Overall Study|Study specific withdrawal criteria|0|||
131480757|NCT01914757|473392398|FG001|Overall Study|Study specific withdrawal criteria|1|||
131480758|NCT01914757|473392399|FG002|Overall Study|Study specific withdrawal criteria|0|||
131480759|NCT01914757|473392397|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131480760|NCT01914757|473392398|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131480761|NCT01914757|473392399|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
131480762|NCT01914757|473392397|FG000|Overall Study|Other reasons|5|||
131480763|NCT01914757|473392398|FG001|Overall Study|Other reasons|9|||
131480764|NCT01914757|473392399|FG002|Overall Study|Other reasons|4|||
131480765|NCT00615108|473392400|FG000|Overall Study|Adverse Event|122|||
131480766|NCT00615108|473392400|FG000|Overall Study|Other|370|||
131480767|NCT00615108|473392400|FG000|Overall Study|Lost to Follow-up|15|||
131480768|NCT02833350|473392405|FG000|Overall Study|Adverse Event|0|||
131480769|NCT02833350|473392406|FG001|Overall Study|Adverse Event|3|||
131480770|NCT02833350|473392407|FG002|Overall Study|Adverse Event|4|||
131480771|NCT02833350|473392408|FG003|Overall Study|Adverse Event|4|||
131480772|NCT02833350|473392409|FG004|Overall Study|Adverse Event|1|||
131480773|NCT02833350|473392410|FG005|Overall Study|Adverse Event|0|||
131480774|NCT02833350|473392411|FG006|Overall Study|Adverse Event|1|||
131480775|NCT02833350|473392405|FG000|Overall Study|Death|0|||
131480776|NCT02833350|473392406|FG001|Overall Study|Death|0|||
131480777|NCT02833350|473392407|FG002|Overall Study|Death|1|||
131480778|NCT02833350|473392408|FG003|Overall Study|Death|0|||
131480779|NCT02833350|473392409|FG004|Overall Study|Death|0|||
131480780|NCT02833350|473392410|FG005|Overall Study|Death|0|||
131480781|NCT02833350|473392411|FG006|Overall Study|Death|0|||
131480782|NCT02833350|473392405|FG000|Overall Study|Lack of Efficacy|0|||
131480783|NCT02833350|473392406|FG001|Overall Study|Lack of Efficacy|2|||
131480784|NCT02833350|473392407|FG002|Overall Study|Lack of Efficacy|1|||
131480785|NCT02833350|473392408|FG003|Overall Study|Lack of Efficacy|4|||
131480786|NCT02833350|473392409|FG004|Overall Study|Lack of Efficacy|0|||
131480787|NCT02833350|473392410|FG005|Overall Study|Lack of Efficacy|1|||
131480788|NCT02833350|473392411|FG006|Overall Study|Lack of Efficacy|1|||
131480789|NCT02833350|473392405|FG000|Overall Study|Lost to Follow-up|0|||
131480790|NCT02833350|473392406|FG001|Overall Study|Lost to Follow-up|1|||
131480791|NCT02833350|473392407|FG002|Overall Study|Lost to Follow-up|0|||
131480792|NCT02833350|473392408|FG003|Overall Study|Lost to Follow-up|0|||
131480793|NCT02833350|473392409|FG004|Overall Study|Lost to Follow-up|0|||
131480794|NCT02833350|473392410|FG005|Overall Study|Lost to Follow-up|0|||
131480795|NCT02833350|473392411|FG006|Overall Study|Lost to Follow-up|1|||
131480796|NCT02833350|473392405|FG000|Overall Study|Withdrawal by Subject|3|||
131480797|NCT02833350|473392406|FG001|Overall Study|Withdrawal by Subject|3|||
131480798|NCT02833350|473392407|FG002|Overall Study|Withdrawal by Subject|2|||
131480799|NCT02833350|473392408|FG003|Overall Study|Withdrawal by Subject|0|||
131480800|NCT02833350|473392409|FG004|Overall Study|Withdrawal by Subject|2|||
131480801|NCT02833350|473392410|FG005|Overall Study|Withdrawal by Subject|0|||
131480802|NCT02833350|473392411|FG006|Overall Study|Withdrawal by Subject|2|||
131480803|NCT01856907|473392414|FG000|Overall Study|Pregnancy|0|||
131480804|NCT01856907|473392415|FG001|Overall Study|Pregnancy|1|||
131480805|NCT01856907|473392416|FG002|Overall Study|Pregnancy|0|||
131480806|NCT01856907|473392414|FG000|Overall Study|Pregnancy|0|||
131480807|NCT01856907|473392415|FG001|Overall Study|Pregnancy|1|||
131480808|NCT01856907|473392416|FG002|Overall Study|Pregnancy|0|||
131480809|NCT01856907|473392414|FG000|Overall Study|Withdrawal by Subject|0|||
131480810|NCT01856907|473392415|FG001|Overall Study|Withdrawal by Subject|1|||
131480811|NCT01856907|473392416|FG002|Overall Study|Withdrawal by Subject|0|||
131480812|NCT00917501|473392417|FG000|Overall Study|Lost to Follow-up|4|||
131480813|NCT00917501|473392418|FG001|Overall Study|Lost to Follow-up|1|||
131480814|NCT00917501|473392417|FG000|Overall Study|Withdrawal by Subject|3|||
131480815|NCT00917501|473392418|FG001|Overall Study|Withdrawal by Subject|1|||
131480816|NCT00917501|473392417|FG000|Overall Study|Lack of Efficacy|1|||
131480817|NCT00917501|473392418|FG001|Overall Study|Lack of Efficacy|2|||
131480818|NCT00917501|473392417|FG000|Overall Study|trouble swollowing capsules|0|||
131480819|NCT00917501|473392418|FG001|Overall Study|trouble swollowing capsules|1|||
131480820|NCT01189604|473392419|FG000|Overall Study|Impossible to visit|0|||
131480821|NCT01189604|473392420|FG001|Overall Study|Impossible to visit|0|||
131480822|NCT01189604|473392421|FG002|Overall Study|Impossible to visit|0|||
131480823|NCT01189604|473392422|FG003|Overall Study|Impossible to visit|0|||
131480824|NCT01189604|473392423|FG004|Overall Study|Impossible to visit|0|||
131480825|NCT01189604|473392424|FG005|Overall Study|Impossible to visit|1|||
131480826|NCT01189604|473392425|FG006|Overall Study|Impossible to visit|0|||
131480827|NCT01189604|473392419|FG000|Overall Study|Adverse Event|0|||
131480828|NCT01189604|473392420|FG001|Overall Study|Adverse Event|1|||
131480829|NCT01189604|473392421|FG002|Overall Study|Adverse Event|0|||
131480830|NCT01189604|473392422|FG003|Overall Study|Adverse Event|0|||
131480831|NCT01189604|473392423|FG004|Overall Study|Adverse Event|2|||
131480832|NCT01189604|473392424|FG005|Overall Study|Adverse Event|0|||
131480833|NCT01189604|473392425|FG006|Overall Study|Adverse Event|1|||
131480834|NCT01189604|473392419|FG000|Overall Study|Withdrawal by Subject|1|||
131480835|NCT01189604|473392420|FG001|Overall Study|Withdrawal by Subject|0|||
131480836|NCT01189604|473392421|FG002|Overall Study|Withdrawal by Subject|0|||
131480837|NCT01189604|473392422|FG003|Overall Study|Withdrawal by Subject|0|||
131480838|NCT01189604|473392423|FG004|Overall Study|Withdrawal by Subject|0|||
131480839|NCT01189604|473392424|FG005|Overall Study|Withdrawal by Subject|0|||
131480840|NCT01189604|473392425|FG006|Overall Study|Withdrawal by Subject|0|||
131480841|NCT03626168|473392426|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131480842|NCT03626168|473392427|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131480843|NCT03626168|473392426|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
131480844|NCT03626168|473392427|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
131480845|NCT03626168|473392426|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
131480846|NCT03626168|473392427|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
131480847|NCT00808483|473392430|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
131480848|NCT00808483|473392431|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
131480849|NCT00808483|473392430|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
131480850|NCT00808483|473392431|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
131480851|NCT00808483|473392430|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
131480852|NCT00808483|473392431|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
131480853|NCT04553679|473392432|FG000|Overall Study|Withdrawal by Subject|2|||
131480854|NCT04553679|473392433|FG001|Overall Study|Withdrawal by Subject|0|||
131480855|NCT04553679|473392432|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
131480856|NCT04553679|473392433|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
131480857|NCT02357979|473392434|FG000|Overall Study|Lost to Follow-up|5|||
131480858|NCT02357979|473392435|FG001|Overall Study|Lost to Follow-up|5|||
131480859|NCT00850070|473392439|FG000|Overall Study|Lack of Efficacy|1|||
131480860|NCT00850070|473392440|FG001|Overall Study|Lack of Efficacy|1|||
131480861|NCT00850070|473392439|FG000|Overall Study|Adverse Event|2|||
131480862|NCT00850070|473392440|FG001|Overall Study|Adverse Event|0|||
131480863|NCT05047770|473392441|FG000|Overall Study|Withdrawal by Subject|15|||
131480864|NCT05047770|473392442|FG001|Overall Study|Withdrawal by Subject|10|||
131480865|NCT05047770|473392443|FG002|Overall Study|Withdrawal by Subject|6|||
131480866|NCT05047770|473392444|FG003|Overall Study|Withdrawal by Subject|12|||
131480867|NCT05047770|473392441|FG000|Overall Study|Lost to Follow-up|7|||
131480868|NCT05047770|473392442|FG001|Overall Study|Lost to Follow-up|5|||
131480869|NCT05047770|473392443|FG002|Overall Study|Lost to Follow-up|12|||
131480870|NCT05047770|473392444|FG003|Overall Study|Lost to Follow-up|13|||
131480871|NCT05047770|473392441|FG000|Overall Study|Other|1|||
131480872|NCT05047770|473392442|FG001|Overall Study|Other|0|||
131480873|NCT05047770|473392443|FG002|Overall Study|Other|1|||
131480874|NCT05047770|473392444|FG003|Overall Study|Other|0|||
131480875|NCT00074984|473392447|FG000|Overall Study|Death|1|||
131480876|NCT00074984|473392448|FG001|Overall Study|Death|2|||
131480877|NCT00074984|473392447|FG000|Overall Study|Withdrawal by Subject|2|||
131480878|NCT00074984|473392448|FG001|Overall Study|Withdrawal by Subject|3|||
131480879|NCT00074984|473392447|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
131480880|NCT00074984|473392448|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
131480881|NCT01522248|473392451|FG000|Overall Study|Lost to Follow-up|1|||
131480882|NCT01522248|473392452|FG001|Overall Study|Lost to Follow-up|0|||
131480883|NCT00591344|473392457|FG000|Overall Study|Transportation issues|1|||
131480884|NCT00591344|473392458|FG001|Overall Study|Transportation issues|0|||
131480885|NCT00591344|473392457|FG000|Overall Study|Moved out of state|1|||
131480886|NCT00591344|473392458|FG001|Overall Study|Moved out of state|0|||
131480887|NCT00591344|473392457|FG000|Overall Study|Medical complications|1|||
131480888|NCT00591344|473392458|FG001|Overall Study|Medical complications|3|||
131480889|NCT00591344|473392457|FG000|Overall Study|Underwent DBS|2|||
131480890|NCT00591344|473392458|FG001|Overall Study|Underwent DBS|2|||
131480891|NCT00591344|473392457|FG000|Overall Study|Death|0|||
131480892|NCT00591344|473392458|FG001|Overall Study|Death|1|||
131480893|NCT00591344|473392457|FG000|Overall Study|Lost to Follow-up|0|||
131480894|NCT00591344|473392458|FG001|Overall Study|Lost to Follow-up|1|||
131480895|NCT00591344|473392457|FG000|Overall Study|Did not want to come off medication|0|||
131480896|NCT00591344|473392458|FG001|Overall Study|Did not want to come off medication|1|||
131480897|NCT00694707|473392459|FG000|Overall Study|Did Not Receive Treatment|0|||
131480898|NCT00694707|473392460|FG001|Overall Study|Did Not Receive Treatment|0|||
131480899|NCT00694707|473392461|FG002|Overall Study|Did Not Receive Treatment|1|||
131480900|NCT00694707|473392462|FG003|Overall Study|Did Not Receive Treatment|1|||
131480901|NCT00694707|473392463|FG004|Overall Study|Did Not Receive Treatment|1|||
131480902|NCT00694707|473392459|FG000|Overall Study|Adverse Event|22|||
131480903|NCT00694707|473392460|FG001|Overall Study|Adverse Event|14|||
131480904|NCT00694707|473392461|FG002|Overall Study|Adverse Event|8|||
131480905|NCT00694707|473392462|FG003|Overall Study|Adverse Event|12|||
131480906|NCT00694707|473392463|FG004|Overall Study|Adverse Event|13|||
131480907|NCT00694707|473392459|FG000|Overall Study|Insufficient Therapeutic Response|33|||
131480908|NCT00694707|473392460|FG001|Overall Study|Insufficient Therapeutic Response|18|||
131480909|NCT00694707|473392461|FG002|Overall Study|Insufficient Therapeutic Response|17|||
131480910|NCT00694707|473392462|FG003|Overall Study|Insufficient Therapeutic Response|15|||
131480911|NCT00694707|473392463|FG004|Overall Study|Insufficient Therapeutic Response|10|||
131480912|NCT00694707|473392459|FG000|Overall Study|Protocol Violation|1|||
131480913|NCT00694707|473392460|FG001|Overall Study|Protocol Violation|2|||
131480914|NCT00694707|473392461|FG002|Overall Study|Protocol Violation|1|||
131480915|NCT00694707|473392462|FG003|Overall Study|Protocol Violation|3|||
131480916|NCT00694707|473392463|FG004|Overall Study|Protocol Violation|1|||
131480917|NCT00694707|473392459|FG000|Overall Study|Withdrawal of Consent|14|||
131480918|NCT00694707|473392460|FG001|Overall Study|Withdrawal of Consent|18|||
131480919|NCT00694707|473392461|FG002|Overall Study|Withdrawal of Consent|22|||
131480920|NCT00694707|473392462|FG003|Overall Study|Withdrawal of Consent|16|||
131480921|NCT00694707|473392463|FG004|Overall Study|Withdrawal of Consent|15|||
131480922|NCT00694707|473392459|FG000|Overall Study|Lost to Follow-up|0|||
131480923|NCT00694707|473392460|FG001|Overall Study|Lost to Follow-up|1|||
131480924|NCT00694707|473392461|FG002|Overall Study|Lost to Follow-up|2|||
131480925|NCT00694707|473392462|FG003|Overall Study|Lost to Follow-up|0|||
131480926|NCT00694707|473392463|FG004|Overall Study|Lost to Follow-up|0|||
131480927|NCT00694707|473392459|FG000|Overall Study|Jeopardizing Parole Status|1|||
131480928|NCT00694707|473392460|FG001|Overall Study|Jeopardizing Parole Status|0|||
131480929|NCT00694707|473392461|FG002|Overall Study|Jeopardizing Parole Status|0|||
131480930|NCT00694707|473392462|FG003|Overall Study|Jeopardizing Parole Status|0|||
131480931|NCT00694707|473392463|FG004|Overall Study|Jeopardizing Parole Status|0|||
131480932|NCT00694707|473392459|FG000|Overall Study|Death in the Family|1|||
131480933|NCT00694707|473392460|FG001|Overall Study|Death in the Family|0|||
131480934|NCT00694707|473392461|FG002|Overall Study|Death in the Family|0|||
131480935|NCT00694707|473392462|FG003|Overall Study|Death in the Family|0|||
131480936|NCT00694707|473392463|FG004|Overall Study|Death in the Family|0|||
131480937|NCT00694707|473392459|FG000|Overall Study|Arrest by Police|0|||
131480938|NCT00694707|473392460|FG001|Overall Study|Arrest by Police|1|||
131480939|NCT00694707|473392461|FG002|Overall Study|Arrest by Police|0|||
131480940|NCT00694707|473392462|FG003|Overall Study|Arrest by Police|0|||
131480941|NCT00694707|473392463|FG004|Overall Study|Arrest by Police|0|||
131480942|NCT00694707|473392459|FG000|Overall Study|Administrative Reasons|0|||
131480943|NCT00694707|473392460|FG001|Overall Study|Administrative Reasons|1|||
131480944|NCT00694707|473392461|FG002|Overall Study|Administrative Reasons|0|||
131480945|NCT00694707|473392462|FG003|Overall Study|Administrative Reasons|2|||
131480946|NCT00694707|473392463|FG004|Overall Study|Administrative Reasons|0|||
131480947|NCT00694707|473392459|FG000|Overall Study|Notification of Past Head Injury|0|||
131480948|NCT00694707|473392460|FG001|Overall Study|Notification of Past Head Injury|0|||
131480949|NCT00694707|473392461|FG002|Overall Study|Notification of Past Head Injury|0|||
131480950|NCT00694707|473392462|FG003|Overall Study|Notification of Past Head Injury|1|||
131480951|NCT00694707|473392463|FG004|Overall Study|Notification of Past Head Injury|0|||
131480952|NCT01904058|473392468|FG000|Overall Study|Adverse Event|2|||
131480953|NCT01904058|473392469|FG001|Overall Study|Adverse Event|0|||
131480954|NCT01904058|473392470|FG002|Overall Study|Adverse Event|0|||
131480955|NCT01904058|473392471|FG003|Overall Study|Adverse Event|0|||
131480956|NCT01904058|473392468|FG000|Overall Study|Withdrawal by Subject|1|||
131480957|NCT01904058|473392469|FG001|Overall Study|Withdrawal by Subject|0|||
131480958|NCT01904058|473392470|FG002|Overall Study|Withdrawal by Subject|1|||
131480959|NCT01904058|473392471|FG003|Overall Study|Withdrawal by Subject|0|||
131480960|NCT01904058|473392468|FG000|Overall Study|Pregnancy|0|||
131480961|NCT01904058|473392469|FG001|Overall Study|Pregnancy|0|||
131480962|NCT01904058|473392470|FG002|Overall Study|Pregnancy|0|||
131480963|NCT01904058|473392471|FG003|Overall Study|Pregnancy|1|||
131480964|NCT03096483|473392473|FG000|Overall Study|Withdrawal by site|1|||
131480965|NCT00199875|473392477|FG000|Overall Study|Withdrawal by Subject|0|||
131480966|NCT00199875|473392478|FG001|Overall Study|Withdrawal by Subject|0|||
131480967|NCT00199875|473392479|FG002|Overall Study|Withdrawal by Subject|0|||
131480968|NCT00199875|473392480|FG003|Overall Study|Withdrawal by Subject|0|||
131480969|NCT00199875|473392481|FG004|Overall Study|Withdrawal by Subject|1|||
131480970|NCT01024231|473392484|FG000|Overall Study|Other Reasons|1|||
131480971|NCT01024231|473392485|FG001|Overall Study|Other Reasons|2|||
131480972|NCT01024231|473392486|FG002|Overall Study|Other Reasons|0|||
131480973|NCT01024231|473392487|FG003|Overall Study|Other Reasons|0|||
131480974|NCT01024231|473392488|FG004|Overall Study|Other Reasons|2|||
131480975|NCT01024231|473392489|FG005|Overall Study|Other Reasons|0|||
131480976|NCT01024231|473392490|FG006|Overall Study|Other Reasons|1|||
131480977|NCT01024231|473392484|FG000|Overall Study|Maximum Clinical Benefit|1|||
131480978|NCT01024231|473392485|FG001|Overall Study|Maximum Clinical Benefit|2|||
131480979|NCT01024231|473392486|FG002|Overall Study|Maximum Clinical Benefit|0|||
131480980|NCT01024231|473392487|FG003|Overall Study|Maximum Clinical Benefit|1|||
131480981|NCT01024231|473392488|FG004|Overall Study|Maximum Clinical Benefit|1|||
131480982|NCT01024231|473392489|FG005|Overall Study|Maximum Clinical Benefit|0|||
131480983|NCT01024231|473392490|FG006|Overall Study|Maximum Clinical Benefit|0|||
131480984|NCT01024231|473392484|FG000|Overall Study|Disease Progression|3|||
131480985|NCT01024231|473392485|FG001|Overall Study|Disease Progression|1|||
131480986|NCT01024231|473392486|FG002|Overall Study|Disease Progression|3|||
131480987|NCT01024231|473392487|FG003|Overall Study|Disease Progression|0|||
131480988|NCT01024231|473392488|FG004|Overall Study|Disease Progression|4|||
131480989|NCT01024231|473392489|FG005|Overall Study|Disease Progression|11|||
131480990|NCT01024231|473392490|FG006|Overall Study|Disease Progression|6|||
131480991|NCT01024231|473392484|FG000|Overall Study|AE unrelated to Study Drug|0|||
131480992|NCT01024231|473392485|FG001|Overall Study|AE unrelated to Study Drug|1|||
131480993|NCT01024231|473392486|FG002|Overall Study|AE unrelated to Study Drug|0|||
131480994|NCT01024231|473392487|FG003|Overall Study|AE unrelated to Study Drug|0|||
131480995|NCT01024231|473392488|FG004|Overall Study|AE unrelated to Study Drug|0|||
131480996|NCT01024231|473392489|FG005|Overall Study|AE unrelated to Study Drug|0|||
131480997|NCT01024231|473392490|FG006|Overall Study|AE unrelated to Study Drug|0|||
131480998|NCT01024231|473392484|FG000|Overall Study|No longer meets criteria|0|||
131480999|NCT01024231|473392485|FG001|Overall Study|No longer meets criteria|0|||
131481000|NCT01024231|473392486|FG002|Overall Study|No longer meets criteria|0|||
131481001|NCT01024231|473392487|FG003|Overall Study|No longer meets criteria|0|||
131481002|NCT01024231|473392488|FG004|Overall Study|No longer meets criteria|1|||
131481003|NCT01024231|473392489|FG005|Overall Study|No longer meets criteria|0|||
131481004|NCT01024231|473392490|FG006|Overall Study|No longer meets criteria|1|||
131481005|NCT01024231|473392484|FG000|Overall Study|Study Drug Toxicity|1|||
131481006|NCT01024231|473392485|FG001|Overall Study|Study Drug Toxicity|6|||
131481007|NCT01024231|473392486|FG002|Overall Study|Study Drug Toxicity|6|||
131481008|NCT01024231|473392487|FG003|Overall Study|Study Drug Toxicity|4|||
131481009|NCT01024231|473392488|FG004|Overall Study|Study Drug Toxicity|2|||
131481010|NCT01024231|473392489|FG005|Overall Study|Study Drug Toxicity|0|||
131481011|NCT01024231|473392490|FG006|Overall Study|Study Drug Toxicity|7|||
131481012|NCT01024231|473392484|FG000|Overall Study|Death|6|||
131481013|NCT01024231|473392485|FG001|Overall Study|Death|2|||
131481014|NCT01024231|473392486|FG002|Overall Study|Death|1|||
131481015|NCT01024231|473392487|FG003|Overall Study|Death|0|||
131481016|NCT01024231|473392488|FG004|Overall Study|Death|4|||
131481017|NCT01024231|473392489|FG005|Overall Study|Death|3|||
131481018|NCT01024231|473392490|FG006|Overall Study|Death|5|||
131481019|NCT01024231|473392484|FG000|Overall Study|Lost to Follow-up|0|||
131481020|NCT01024231|473392485|FG001|Overall Study|Lost to Follow-up|0|||
131481021|NCT01024231|473392486|FG002|Overall Study|Lost to Follow-up|0|||
131481022|NCT01024231|473392487|FG003|Overall Study|Lost to Follow-up|0|||
131481023|NCT01024231|473392488|FG004|Overall Study|Lost to Follow-up|0|||
131481024|NCT01024231|473392489|FG005|Overall Study|Lost to Follow-up|0|||
131481025|NCT01024231|473392490|FG006|Overall Study|Lost to Follow-up|1|||
131481026|NCT01024231|473392484|FG000|Overall Study|Withdrew Consent|0|||
131481027|NCT01024231|473392485|FG001|Overall Study|Withdrew Consent|1|||
131481028|NCT01024231|473392486|FG002|Overall Study|Withdrew Consent|0|||
131481029|NCT01024231|473392487|FG003|Overall Study|Withdrew Consent|0|||
131481030|NCT01024231|473392488|FG004|Overall Study|Withdrew Consent|0|||
131481031|NCT01024231|473392489|FG005|Overall Study|Withdrew Consent|0|||
131481032|NCT01024231|473392490|FG006|Overall Study|Withdrew Consent|0|||
131481033|NCT01024231|473392484|FG000|Overall Study|Continuing on Treatment|0|||
131481034|NCT01024231|473392485|FG001|Overall Study|Continuing on Treatment|0|||
131481035|NCT01024231|473392486|FG002|Overall Study|Continuing on Treatment|0|||
131481036|NCT01024231|473392487|FG003|Overall Study|Continuing on Treatment|0|||
131481037|NCT01024231|473392488|FG004|Overall Study|Continuing on Treatment|3|||
131481038|NCT01024231|473392489|FG005|Overall Study|Continuing on Treatment|2|||
131481039|NCT01024231|473392490|FG006|Overall Study|Continuing on Treatment|0|||
131481040|NCT04738734|473392491|FG000|Overall Study|Withdrawal by Subject|2|||
131481041|NCT04738734|473392492|FG001|Overall Study|Withdrawal by Subject|4|||
131481042|NCT04738734|473392491|FG000|Overall Study|Lost to Follow-up|5|||
131481043|NCT04738734|473392492|FG001|Overall Study|Lost to Follow-up|2|||
131481044|NCT04738734|473392491|FG000|Overall Study|Physician Decision|0|||
131481045|NCT04738734|473392492|FG001|Overall Study|Physician Decision|1|||
131481046|NCT04738734|473392491|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
131481047|NCT04738734|473392492|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
131481048|NCT02435147|473392496|FG000|Overall Study|non-evaluable DXA scan|11|||
131481049|NCT03452228|473392497|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131481050|NCT03452228|473392498|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
131481051|NCT03452228|473392499|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131481052|NCT03452228|473392497|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131481053|NCT03452228|473392498|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131481054|NCT03452228|473392499|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131481055|NCT03452228|473392497|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
131481056|NCT03452228|473392498|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
131481057|NCT03452228|473392499|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
131481058|NCT03452228|473392497|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131481059|NCT03452228|473392498|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131481060|NCT03452228|473392499|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
131481061|NCT04251273|473392500|FG000|Overall Study|Lost to Follow-up|331|||
131481062|NCT04251273|473392501|FG001|Overall Study|Lost to Follow-up|290|||
131481063|NCT00810693|473392502|FG000|Treatment Period|Adverse Event|8|||
131481064|NCT00810693|473392503|FG001|Treatment Period|Adverse Event|1|||
131481065|NCT00810693|473392504|FG002|Treatment Period|Adverse Event|7|||
131481066|NCT00810693|473392502|FG000|Treatment Period|Death|0|||
131481067|NCT00810693|473392503|FG001|Treatment Period|Death|1|||
131481068|NCT00810693|473392504|FG002|Treatment Period|Death|2|||
131481069|NCT00810693|473392502|FG000|Treatment Period|Lack of Efficacy|0|||
131481070|NCT00810693|473392503|FG001|Treatment Period|Lack of Efficacy|0|||
131481071|NCT00810693|473392504|FG002|Treatment Period|Lack of Efficacy|1|||
131481072|NCT00810693|473392502|FG000|Treatment Period|Lost to Follow-up|1|||
131481073|NCT00810693|473392503|FG001|Treatment Period|Lost to Follow-up|0|||
131481074|NCT00810693|473392504|FG002|Treatment Period|Lost to Follow-up|0|||
131481075|NCT00810693|473392502|FG000|Treatment Period|Non-compliance|1|||
131481076|NCT00810693|473392503|FG001|Treatment Period|Non-compliance|0|||
131481077|NCT00810693|473392504|FG002|Treatment Period|Non-compliance|0|||
131481078|NCT00810693|473392502|FG000|Treatment Period|Protocol Violation|1|||
131481079|NCT00810693|473392503|FG001|Treatment Period|Protocol Violation|2|||
131481080|NCT00810693|473392504|FG002|Treatment Period|Protocol Violation|2|||
131481081|NCT00810693|473392502|FG000|Treatment Period|Withdrawal by Subject|6|||
131481082|NCT00810693|473392503|FG001|Treatment Period|Withdrawal by Subject|2|||
131481083|NCT00810693|473392504|FG002|Treatment Period|Withdrawal by Subject|3|||
131481084|NCT00810693|473392502|FG000|Treatment Period|Not treated|0|||
131481085|NCT00810693|473392503|FG001|Treatment Period|Not treated|1|||
131481086|NCT00810693|473392504|FG002|Treatment Period|Not treated|1|||
131481087|NCT00810693|473392502|FG000|Follow-up Period (FUP)|Adverse Event|3|||
131481088|NCT00810693|473392503|FG001|Follow-up Period (FUP)|Adverse Event|1|||
131481089|NCT00810693|473392504|FG002|Follow-up Period (FUP)|Adverse Event|1|||
131481090|NCT00810693|473392502|FG000|Follow-up Period (FUP)|Death|2|||
131481091|NCT00810693|473392503|FG001|Follow-up Period (FUP)|Death|0|||
131481092|NCT00810693|473392504|FG002|Follow-up Period (FUP)|Death|1|||
131481093|NCT00810693|473392502|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
131481094|NCT00810693|473392503|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
131481095|NCT00810693|473392504|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
131481096|NCT00810693|473392502|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
131481097|NCT00810693|473392503|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
131481098|NCT00810693|473392504|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
131481099|NCT00810693|473392502|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
131481100|NCT00810693|473392503|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
131481101|NCT00810693|473392504|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
131481102|NCT03212690|473392505|FG000|Overall Study|Protocol Violation|1|||
131481103|NCT01297920|473392506|FG000|Overall Study|Adverse Event|42|||
131481104|NCT01297920|473392507|FG001|Overall Study|Adverse Event|10|||
131481105|NCT01297920|473392508|FG002|Overall Study|Adverse Event|38|||
131481106|NCT01297920|473392506|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
131481107|NCT01297920|473392507|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
131481108|NCT01297920|473392508|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
131481109|NCT01297920|473392506|FG000|Overall Study|Noncompliance|1|||
131481110|NCT01297920|473392507|FG001|Overall Study|Noncompliance|0|||
131481111|NCT01297920|473392508|FG002|Overall Study|Noncompliance|0|||
131481112|NCT01297920|473392506|FG000|Overall Study|Protocol Violation|1|||
131481113|NCT01297920|473392507|FG001|Overall Study|Protocol Violation|3|||
131481114|NCT01297920|473392508|FG002|Overall Study|Protocol Violation|0|||
131481115|NCT01297920|473392506|FG000|Overall Study|Inadequate Control of IOP|7|||
131481116|NCT01297920|473392507|FG001|Overall Study|Inadequate Control of IOP|9|||
131481117|NCT01297920|473392508|FG002|Overall Study|Inadequate Control of IOP|17|||
131481118|NCT01297920|473392506|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
131481119|NCT01297920|473392507|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
131481120|NCT01297920|473392508|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
131481121|NCT00474760|473392509|FG000|Overall Study|Death|0|||
131481122|NCT00474760|473392510|FG001|Overall Study|Death|0|||
131481123|NCT00474760|473392511|FG002|Overall Study|Death|0|||
131481124|NCT00474760|473392512|FG003|Overall Study|Death|0|||
131481125|NCT00474760|473392513|FG004|Overall Study|Death|2|||
131481126|NCT00474760|473392514|FG005|Overall Study|Death|0|||
131481127|NCT00474760|473392515|FG006|Overall Study|Death|0|||
131481128|NCT00474760|473392509|FG000|Overall Study|Adverse Event|0|||
131481129|NCT00474760|473392510|FG001|Overall Study|Adverse Event|0|||
131481130|NCT00474760|473392511|FG002|Overall Study|Adverse Event|0|||
131481131|NCT00474760|473392512|FG003|Overall Study|Adverse Event|0|||
131481132|NCT00474760|473392513|FG004|Overall Study|Adverse Event|1|||
131481133|NCT00474760|473392514|FG005|Overall Study|Adverse Event|7|||
131481134|NCT00474760|473392515|FG006|Overall Study|Adverse Event|0|||
131481135|NCT00474760|473392509|FG000|Overall Study|Laboratory abnormality|0|||
131481136|NCT00474760|473392510|FG001|Overall Study|Laboratory abnormality|0|||
131481137|NCT00474760|473392511|FG002|Overall Study|Laboratory abnormality|0|||
131481138|NCT00474760|473392512|FG003|Overall Study|Laboratory abnormality|0|||
131481139|NCT00474760|473392513|FG004|Overall Study|Laboratory abnormality|0|||
131481140|NCT00474760|473392514|FG005|Overall Study|Laboratory abnormality|1|||
131481141|NCT00474760|473392515|FG006|Overall Study|Laboratory abnormality|0|||
131481142|NCT00474760|473392509|FG000|Overall Study|Withdrawal by Subject|0|||
131481143|NCT00474760|473392510|FG001|Overall Study|Withdrawal by Subject|0|||
131481144|NCT00474760|473392511|FG002|Overall Study|Withdrawal by Subject|0|||
131481145|NCT00474760|473392512|FG003|Overall Study|Withdrawal by Subject|1|||
131481146|NCT00474760|473392513|FG004|Overall Study|Withdrawal by Subject|0|||
131481147|NCT00474760|473392514|FG005|Overall Study|Withdrawal by Subject|1|||
131481148|NCT00474760|473392515|FG006|Overall Study|Withdrawal by Subject|1|||
131481149|NCT00474760|473392509|FG000|Overall Study|Other|0|||
131481150|NCT00474760|473392510|FG001|Overall Study|Other|1|||
131481151|NCT00474760|473392511|FG002|Overall Study|Other|0|||
131481152|NCT00474760|473392512|FG003|Overall Study|Other|0|||
131481153|NCT00474760|473392513|FG004|Overall Study|Other|1|||
131481154|NCT00474760|473392514|FG005|Overall Study|Other|0|||
131481155|NCT00474760|473392515|FG006|Overall Study|Other|0|||
131481156|NCT00474760|473392509|FG000|Overall Study|Progressive disease|3|||
131481157|NCT00474760|473392510|FG001|Overall Study|Progressive disease|2|||
131481158|NCT00474760|473392511|FG002|Overall Study|Progressive disease|3|||
131481159|NCT00474760|473392512|FG003|Overall Study|Progressive disease|2|||
131481160|NCT00474760|473392513|FG004|Overall Study|Progressive disease|8|||
131481161|NCT00474760|473392514|FG005|Overall Study|Progressive disease|20|||
131481162|NCT00474760|473392515|FG006|Overall Study|Progressive disease|7|||
131481163|NCT00474760|473392509|FG000|Overall Study|Terminated by sponsor|0|||
131481164|NCT00474760|473392510|FG001|Overall Study|Terminated by sponsor|0|||
131481165|NCT00474760|473392511|FG002|Overall Study|Terminated by sponsor|0|||
131481166|NCT00474760|473392512|FG003|Overall Study|Terminated by sponsor|0|||
131481167|NCT00474760|473392513|FG004|Overall Study|Terminated by sponsor|0|||
131481168|NCT00474760|473392514|FG005|Overall Study|Terminated by sponsor|0|||
131481169|NCT00474760|473392515|FG006|Overall Study|Terminated by sponsor|2|||
131481170|NCT02345226|473392516|FG000|Double-Blind Phase|Adverse Event|5|||
131481171|NCT02345226|473392517|FG001|Double-Blind Phase|Adverse Event|6|||
131481172|NCT02345226|473392516|FG000|Double-Blind Phase|Death|3|||
131481173|NCT02345226|473392517|FG001|Double-Blind Phase|Death|0|||
131481174|NCT02345226|473392516|FG000|Double-Blind Phase|Pregnancy|0|||
131481175|NCT02345226|473392517|FG001|Double-Blind Phase|Pregnancy|1|||
131481176|NCT02345226|473392516|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131481177|NCT02345226|473392517|FG001|Double-Blind Phase|Lack of Efficacy|0|||
131481178|NCT02345226|473392516|FG000|Double-Blind Phase|Investigator's Discretion|4|||
131481179|NCT02345226|473392517|FG001|Double-Blind Phase|Investigator's Discretion|3|||
131481180|NCT02345226|473392516|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
131481181|NCT02345226|473392517|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
131481182|NCT02345226|473392516|FG000|Double-Blind Phase|Withdrew Consent|41|||
131481183|NCT02345226|473392517|FG001|Double-Blind Phase|Withdrew Consent|39|||
131481184|NCT02345226|473392516|FG000|Double-Blind Phase|Lost to Follow-up|12|||
131481185|NCT02345226|473392517|FG001|Double-Blind Phase|Lost to Follow-up|16|||
131481186|NCT02345226|473392516|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
131481187|NCT02345226|473392517|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
131481188|NCT02345226|473392516|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
131481189|NCT02345226|473392517|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
131481190|NCT01710046|473392520|FG000|Overall Study|Lost to Follow-up|1|||
131481191|NCT01710046|473392521|FG001|Overall Study|Lost to Follow-up|0|||
131481192|NCT02282358|473392522|FG000|Overall Study|Nonevaluable|1|||
131481193|NCT02158975|473392525|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
131481194|NCT01346969|473392526|FG000|Overall Study|Withdrawal by Subject|0|||
131481195|NCT01346969|473392527|FG001|Overall Study|Withdrawal by Subject|0|||
131481196|NCT01346969|473392528|FG002|Overall Study|Withdrawal by Subject|1|||
131481197|NCT01346969|473392529|FG003|Overall Study|Withdrawal by Subject|0|||
131481198|NCT01346969|473392526|FG000|Overall Study|Lost to Follow-up|1|||
131481199|NCT01346969|473392527|FG001|Overall Study|Lost to Follow-up|0|||
131481200|NCT01346969|473392528|FG002|Overall Study|Lost to Follow-up|2|||
131481201|NCT01346969|473392529|FG003|Overall Study|Lost to Follow-up|0|||
131481202|NCT01346969|473392526|FG000|Overall Study|Physician Decision|0|||
131481203|NCT01346969|473392527|FG001|Overall Study|Physician Decision|0|||
131481204|NCT01346969|473392528|FG002|Overall Study|Physician Decision|0|||
131481205|NCT01346969|473392529|FG003|Overall Study|Physician Decision|1|||
131481206|NCT01346969|473392526|FG000|Overall Study|Randomized but not treated|1|||
131481207|NCT01346969|473392527|FG001|Overall Study|Randomized but not treated|0|||
131481208|NCT01346969|473392528|FG002|Overall Study|Randomized but not treated|0|||
131481209|NCT01346969|473392529|FG003|Overall Study|Randomized but not treated|0|||
131481210|NCT03360747|473392530|FG000|Overall Study|Voluntary Withdrawal|1|||
131481211|NCT02557295|473392531|FG000|Overall Study|Withdrawal by Subject|9|||
131481212|NCT02557295|473392532|FG001|Overall Study|Withdrawal by Subject|2|||
131481213|NCT02557295|473392533|FG002|Overall Study|Withdrawal by Subject|4|||
131481214|NCT02557295|473392534|FG003|Overall Study|Withdrawal by Subject|0|||
131481215|NCT02557295|473392535|FG004|Overall Study|Withdrawal by Subject|0|||
131481216|NCT02557295|473392536|FG005|Overall Study|Withdrawal by Subject|0|||
131481217|NCT02557295|473392537|FG006|Overall Study|Withdrawal by Subject|15|||
131481218|NCT02557295|473392538|FG007|Overall Study|Withdrawal by Subject|1|||
131481219|NCT02557295|473392539|FG008|Overall Study|Withdrawal by Subject|3|||
131481220|NCT02557295|473392531|FG000|Overall Study|Disease Progression|0|||
131481221|NCT02557295|473392532|FG001|Overall Study|Disease Progression|0|||
131481222|NCT02557295|473392533|FG002|Overall Study|Disease Progression|0|||
131481223|NCT02557295|473392534|FG003|Overall Study|Disease Progression|0|||
131481224|NCT02557295|473392535|FG004|Overall Study|Disease Progression|0|||
131481225|NCT02557295|473392536|FG005|Overall Study|Disease Progression|0|||
131481226|NCT02557295|473392537|FG006|Overall Study|Disease Progression|1|||
131481227|NCT02557295|473392538|FG007|Overall Study|Disease Progression|0|||
131481228|NCT02557295|473392539|FG008|Overall Study|Disease Progression|0|||
131481229|NCT02557295|473392531|FG000|Overall Study|Lack of Efficacy|24|||
131481230|NCT02557295|473392532|FG001|Overall Study|Lack of Efficacy|1|||
131481231|NCT02557295|473392533|FG002|Overall Study|Lack of Efficacy|3|||
131481232|NCT02557295|473392534|FG003|Overall Study|Lack of Efficacy|0|||
131481233|NCT02557295|473392535|FG004|Overall Study|Lack of Efficacy|0|||
131481234|NCT02557295|473392536|FG005|Overall Study|Lack of Efficacy|0|||
131481235|NCT02557295|473392537|FG006|Overall Study|Lack of Efficacy|12|||
131481236|NCT02557295|473392538|FG007|Overall Study|Lack of Efficacy|1|||
131481237|NCT02557295|473392539|FG008|Overall Study|Lack of Efficacy|0|||
131481238|NCT02557295|473392531|FG000|Overall Study|Adverse Event|16|||
131481239|NCT02557295|473392532|FG001|Overall Study|Adverse Event|2|||
131481240|NCT02557295|473392533|FG002|Overall Study|Adverse Event|3|||
131481241|NCT02557295|473392534|FG003|Overall Study|Adverse Event|0|||
131481242|NCT02557295|473392535|FG004|Overall Study|Adverse Event|0|||
131481243|NCT02557295|473392536|FG005|Overall Study|Adverse Event|0|||
131481244|NCT02557295|473392537|FG006|Overall Study|Adverse Event|2|||
131481245|NCT02557295|473392538|FG007|Overall Study|Adverse Event|1|||
131481246|NCT02557295|473392539|FG008|Overall Study|Adverse Event|1|||
131481247|NCT02557295|473392531|FG000|Overall Study|Lost to Follow-up|4|||
131481248|NCT02557295|473392532|FG001|Overall Study|Lost to Follow-up|0|||
131481249|NCT02557295|473392533|FG002|Overall Study|Lost to Follow-up|0|||
131481250|NCT02557295|473392534|FG003|Overall Study|Lost to Follow-up|0|||
131481251|NCT02557295|473392535|FG004|Overall Study|Lost to Follow-up|0|||
131481252|NCT02557295|473392536|FG005|Overall Study|Lost to Follow-up|0|||
131481253|NCT02557295|473392537|FG006|Overall Study|Lost to Follow-up|9|||
131481254|NCT02557295|473392538|FG007|Overall Study|Lost to Follow-up|0|||
131481255|NCT02557295|473392539|FG008|Overall Study|Lost to Follow-up|0|||
131481256|NCT02557295|473392531|FG000|Overall Study|Study Close|54|||
131481257|NCT02557295|473392532|FG001|Overall Study|Study Close|3|||
131481258|NCT02557295|473392533|FG002|Overall Study|Study Close|5|||
131481259|NCT02557295|473392534|FG003|Overall Study|Study Close|3|||
131481260|NCT02557295|473392535|FG004|Overall Study|Study Close|0|||
131481261|NCT02557295|473392536|FG005|Overall Study|Study Close|0|||
131481262|NCT02557295|473392537|FG006|Overall Study|Study Close|37|||
131481263|NCT02557295|473392538|FG007|Overall Study|Study Close|3|||
131481264|NCT02557295|473392539|FG008|Overall Study|Study Close|19|||
131481265|NCT02557295|473392531|FG000|Overall Study|except for study close|4|||
131481266|NCT02557295|473392532|FG001|Overall Study|except for study close|0|||
131481267|NCT02557295|473392533|FG002|Overall Study|except for study close|0|||
131481268|NCT02557295|473392534|FG003|Overall Study|except for study close|0|||
131481269|NCT02557295|473392535|FG004|Overall Study|except for study close|0|||
131481270|NCT02557295|473392536|FG005|Overall Study|except for study close|0|||
131481271|NCT02557295|473392537|FG006|Overall Study|except for study close|5|||
131481272|NCT02557295|473392538|FG007|Overall Study|except for study close|1|||
131481273|NCT02557295|473392539|FG008|Overall Study|except for study close|0|||
131481274|NCT03817879|473394078|FG000|Overall Study|Drop out|5|||
131481275|NCT03817879|473394079|FG001|Overall Study|Drop out|12|||
131481276|NCT03817879|473394078|FG000|Overall Study|Withdrawal by Subject|0|||
131481277|NCT03817879|473394079|FG001|Overall Study|Withdrawal by Subject|1|||
131481278|NCT01896050|473394082|FG000|Overall Study|Adverse Event|37|||
131481279|NCT01896050|473394083|FG001|Overall Study|Adverse Event|2|||
131481280|NCT01896050|473394082|FG000|Overall Study|Death|1|||
131481281|NCT01896050|473394083|FG001|Overall Study|Death|0|||
131481282|NCT00392015|473394084|FG000|Overall Study|Lost to Follow-up|2|||
131481283|NCT00392015|473394085|FG001|Overall Study|Lost to Follow-up|0|||
131481284|NCT00392015|473394086|FG002|Overall Study|Lost to Follow-up|2|||
131481285|NCT00392015|473394087|FG003|Overall Study|Lost to Follow-up|1|||
131481286|NCT00392015|473394088|FG004|Overall Study|Lost to Follow-up|1|||
131481287|NCT00392015|473394089|FG005|Overall Study|Lost to Follow-up|0|||
131481288|NCT00392015|473394084|FG000|Overall Study|Withdrawal by Subject|0|||
131481289|NCT00392015|473394085|FG001|Overall Study|Withdrawal by Subject|0|||
131481290|NCT00392015|473394086|FG002|Overall Study|Withdrawal by Subject|2|||
131481291|NCT00392015|473394087|FG003|Overall Study|Withdrawal by Subject|0|||
131481292|NCT00392015|473394088|FG004|Overall Study|Withdrawal by Subject|0|||
131481293|NCT00392015|473394089|FG005|Overall Study|Withdrawal by Subject|0|||
131481294|NCT00392015|473394084|FG000|Overall Study|Adverse Event|0|||
131481295|NCT00392015|473394085|FG001|Overall Study|Adverse Event|0|||
131481296|NCT00392015|473394086|FG002|Overall Study|Adverse Event|0|||
131481297|NCT00392015|473394087|FG003|Overall Study|Adverse Event|0|||
131481298|NCT00392015|473394088|FG004|Overall Study|Adverse Event|1|||
131481299|NCT00392015|473394089|FG005|Overall Study|Adverse Event|0|||
131481300|NCT00392015|473394084|FG000|Overall Study|Previous trial recipient|0|||
131481301|NCT00392015|473394085|FG001|Overall Study|Previous trial recipient|0|||
131481302|NCT00392015|473394086|FG002|Overall Study|Previous trial recipient|0|||
131481303|NCT00392015|473394087|FG003|Overall Study|Previous trial recipient|0|||
131481304|NCT00392015|473394088|FG004|Overall Study|Previous trial recipient|1|||
131481305|NCT00392015|473394089|FG005|Overall Study|Previous trial recipient|0|||
131481306|NCT01863953|473394090|FG000|Overall Study|Adverse Event|0|||
131481307|NCT01863953|473394091|FG001|Overall Study|Adverse Event|0|||
131481308|NCT01863953|473394092|FG002|Overall Study|Adverse Event|1|||
131481309|NCT01824342|473394094|FG000|Overall Study|Withdrawal by Subject|0|||
131481310|NCT01824342|473394095|FG001|Overall Study|Withdrawal by Subject|3|||
131481311|NCT01824342|473394094|FG000|Overall Study|Adverse Event|1|||
131481312|NCT01824342|473394095|FG001|Overall Study|Adverse Event|1|||
131481313|NCT01824342|473394094|FG000|Overall Study|Disease Progression|1|||
131481314|NCT01824342|473394095|FG001|Overall Study|Disease Progression|1|||
131481315|NCT01824342|473394094|FG000|Overall Study|Physician Decision|5|||
131481316|NCT01824342|473394095|FG001|Overall Study|Physician Decision|0|||
131481317|NCT01824342|473394094|FG000|Overall Study|Death|2|||
131481318|NCT01824342|473394095|FG001|Overall Study|Death|0|||
131481319|NCT02104752|473394096|FG000|Overall Study|Withdrawal by Subject|1|||
131481320|NCT02104752|473394097|FG001|Overall Study|Withdrawal by Subject|0|||
131481321|NCT02104752|473394096|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
131481322|NCT02104752|473394097|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
131481323|NCT05439941|473394098|FG000|Overall Study|Lack of Efficacy|8|||
131481324|NCT05439941|473394099|FG001|Overall Study|Lack of Efficacy|5|||
131481325|NCT05439941|473394100|FG002|Overall Study|Lack of Efficacy|3|||
131481326|NCT05439941|473394098|FG000|Overall Study|Treatment Failure|0|||
131481327|NCT05439941|473394099|FG001|Overall Study|Treatment Failure|1|||
131481328|NCT05439941|473394100|FG002|Overall Study|Treatment Failure|0|||
131481329|NCT05439941|473394098|FG000|Overall Study|Adverse Event|1|||
131481330|NCT05439941|473394099|FG001|Overall Study|Adverse Event|3|||
131481331|NCT05439941|473394100|FG002|Overall Study|Adverse Event|0|||
131481332|NCT05439941|473394098|FG000|Overall Study|Adverse Event - Parent Study|1|||
131481333|NCT05439941|473394099|FG001|Overall Study|Adverse Event - Parent Study|0|||
131481334|NCT05439941|473394100|FG002|Overall Study|Adverse Event - Parent Study|0|||
131481335|NCT05439941|473394098|FG000|Overall Study|Pregnancy|1|||
131481336|NCT05439941|473394099|FG001|Overall Study|Pregnancy|0|||
131481337|NCT05439941|473394100|FG002|Overall Study|Pregnancy|0|||
131481338|NCT05439941|473394098|FG000|Overall Study|Withdrawal by Subject|9|||
131481339|NCT05439941|473394099|FG001|Overall Study|Withdrawal by Subject|6|||
131481340|NCT05439941|473394100|FG002|Overall Study|Withdrawal by Subject|10|||
131481341|NCT05439941|473394098|FG000|Overall Study|Non-Compliance|1|||
131481342|NCT05439941|473394099|FG001|Overall Study|Non-Compliance|1|||
131481343|NCT05439941|473394100|FG002|Overall Study|Non-Compliance|1|||
131481344|NCT05439941|473394098|FG000|Overall Study|Lost to Follow-up|2|||
131481345|NCT05439941|473394099|FG001|Overall Study|Lost to Follow-up|2|||
131481346|NCT05439941|473394100|FG002|Overall Study|Lost to Follow-up|0|||
131481347|NCT05439941|473394098|FG000|Overall Study|Physician Decision|1|||
131481348|NCT05439941|473394099|FG001|Overall Study|Physician Decision|0|||
131481349|NCT05439941|473394100|FG002|Overall Study|Physician Decision|0|||
131481350|NCT05439941|473394098|FG000|Overall Study|Trial Termination by Sponsor|78|||
131481351|NCT05439941|473394099|FG001|Overall Study|Trial Termination by Sponsor|83|||
131481352|NCT05439941|473394100|FG002|Overall Study|Trial Termination by Sponsor|65|||
131481353|NCT05439941|473394098|FG000|Overall Study|Other than Reasons Listed|2|||
131481354|NCT05439941|473394099|FG001|Overall Study|Other than Reasons Listed|1|||
131481355|NCT05439941|473394100|FG002|Overall Study|Other than Reasons Listed|0|||
131481356|NCT02336373|473394101|FG000|Overall Study|Protocol closed early|4|||
131481357|NCT02336373|473394101|FG000|Overall Study|Physician Decision|14|||
131481358|NCT01604408|473394116|FG000|Treatment Period 1|Protocol Violation|0|||
131481359|NCT01604408|473394117|FG001|Treatment Period 1|Protocol Violation|1|||
131481360|NCT01604408|473394116|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131481361|NCT01604408|473394117|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131481362|NCT01604408|473394116|FG000|Treatment Period 2|Protocol Violation|1|||
131481363|NCT01604408|473394117|FG001|Treatment Period 2|Protocol Violation|0|||
131481364|NCT01604408|473394116|FG000|Treatment Period 2|Adverse Event|0|||
131481365|NCT01604408|473394117|FG001|Treatment Period 2|Adverse Event|1|||
131481366|NCT01604408|473394116|FG000|Treatment Period 3|Protocol Violation|1|||
131481367|NCT01604408|473394117|FG001|Treatment Period 3|Protocol Violation|1|||
131481368|NCT01604408|473394116|FG000|Treatment Period 3|Adverse Event|0|||
131481369|NCT01604408|473394117|FG001|Treatment Period 3|Adverse Event|3|||
131481370|NCT01604408|473394116|FG000|Treatment Period 3|Withdrawal by Subject|3|||
131481371|NCT01604408|473394117|FG001|Treatment Period 3|Withdrawal by Subject|1|||
131481372|NCT01604408|473394116|FG000|Treatment Period 3|Sponsor Decision|1|||
131481373|NCT01604408|473394117|FG001|Treatment Period 3|Sponsor Decision|0|||
131481374|NCT01604408|473394116|FG000|Treatment Period 4|Death|1|||
131481375|NCT01604408|473394117|FG001|Treatment Period 4|Death|0|||
131481376|NCT01604408|473394116|FG000|Treatment Period 4|Withdrawal by Subject|2|||
131481377|NCT01604408|473394117|FG001|Treatment Period 4|Withdrawal by Subject|1|||
131481378|NCT01604408|473394116|FG000|Treatment Period 4|Adverse Event|0|||
131481379|NCT01604408|473394117|FG001|Treatment Period 4|Adverse Event|1|||
131481380|NCT01604408|473394116|FG000|Treatment Period 5|Adverse Event|4|||
131481381|NCT01604408|473394117|FG001|Treatment Period 5|Adverse Event|0|||
131481382|NCT01604408|473394116|FG000|Treatment Period 6|Lost to Follow-up|0|||
131481383|NCT01604408|473394117|FG001|Treatment Period 6|Lost to Follow-up|1|||
131481384|NCT01604408|473394116|FG000|Treatment Period 6|Adverse Event|2|||
131481385|NCT01604408|473394117|FG001|Treatment Period 6|Adverse Event|0|||
131481386|NCT01604408|473394116|FG000|Treatment Period 6|Sponsor decision|0|||
131481387|NCT01604408|473394117|FG001|Treatment Period 6|Sponsor decision|1|||
131481388|NCT01604408|473394116|FG000|Observation Period|Adverse Event|1|||
131481389|NCT01604408|473394117|FG001|Observation Period|Adverse Event|1|||
131481390|NCT01604408|473394116|FG000|Observation Period|Withdrawal by Subject|0|||
131481391|NCT01604408|473394117|FG001|Observation Period|Withdrawal by Subject|2|||
131481392|NCT02046733|473394118|FG000|Overall Study|never initiated 'treatment visits'|6|||
131481393|NCT02046733|473394119|FG001|Overall Study|never initiated 'treatment visits'|0|||
131481394|NCT01013350|473394126|FG000|Overall Study|Lost to Follow-up|15|||
131481395|NCT01013350|473394127|FG001|Overall Study|Lost to Follow-up|95|||
131481396|NCT01013350|473394126|FG000|Overall Study|Adverse Event|0|||
131481397|NCT01013350|473394127|FG001|Overall Study|Adverse Event|1|||
131481398|NCT01013350|473394126|FG000|Overall Study|Physician Decision|4|||
131481399|NCT01013350|473394127|FG001|Overall Study|Physician Decision|20|||
131481400|NCT01013350|473394126|FG000|Overall Study|Withdrawal by Subject|15|||
131481401|NCT01013350|473394127|FG001|Overall Study|Withdrawal by Subject|38|||
131481402|NCT01013350|473394126|FG000|Overall Study|Death|3|||
131481403|NCT01013350|473394127|FG001|Overall Study|Death|5|||
131481404|NCT01013350|473394126|FG000|Overall Study|Participant entered interventional study|0|||
131481405|NCT01013350|473394127|FG001|Overall Study|Participant entered interventional study|8|||
131481406|NCT01013350|473394126|FG000|Overall Study|Other|1|||
131481407|NCT01013350|473394127|FG001|Overall Study|Other|25|||
131481408|NCT01268150|473394128|FG000|Treatment Phase|Progression of disease|18|||
131481409|NCT01268150|473394128|FG000|Treatment Phase|Adverse Event|3|||
131481410|NCT01268150|473394128|FG000|Treatment Phase|Withdrawal by Subject|3|||
131481411|NCT01268150|473394128|FG000|Treatment Phase|Other|4|||
131481412|NCT01268150|473394128|FG000|Extension Phase|Adverse Event|3|||
131481413|NCT01268150|473394128|FG000|Extension Phase|Disease progression|18|||
131481414|NCT01268150|473394128|FG000|Extension Phase|Other|6|||
131481415|NCT00395733|473394129|FG000|Period 2|Withdrawal by Subject|1|||
131481416|NCT00395733|473394130|FG001|Period 2|Withdrawal by Subject|2|||
131481417|NCT00395733|473394129|FG000|Period 2|Protocol Violation|0|||
131481418|NCT00395733|473394130|FG001|Period 2|Protocol Violation|1|||
131481419|NCT00395733|473394129|FG000|Period 2|Adverse Event|0|||
131481420|NCT00395733|473394130|FG001|Period 2|Adverse Event|2|||
131481421|NCT00395733|473394129|FG000|Period 2|Technical problems|1|||
131481422|NCT00395733|473394130|FG001|Period 2|Technical problems|0|||
131481423|NCT03725852|473394131|FG000|Overall Study|Death|1|||
131481424|NCT03725852|473394132|FG001|Overall Study|Death|0|||
131481425|NCT03725852|473394131|FG000|Overall Study|Withdrawal by Subject|1|||
131481426|NCT03725852|473394132|FG001|Overall Study|Withdrawal by Subject|0|||
131481427|NCT03725852|473394131|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
131481428|NCT03725852|473394132|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
131481429|NCT04402060|473394137|FG000|Overall Study|Death|1|||
131481430|NCT04402060|473394138|FG001|Overall Study|Death|12|||
131481431|NCT04402060|473394139|FG002|Overall Study|Death|7|||
131481432|NCT04402060|473394137|FG000|Overall Study|Adverse Event|0|||
131481433|NCT04402060|473394138|FG001|Overall Study|Adverse Event|0|||
131481434|NCT04402060|473394139|FG002|Overall Study|Adverse Event|1|||
131481435|NCT04402060|473394137|FG000|Overall Study|Withdrawal by Subject|0|||
131481436|NCT04402060|473394138|FG001|Overall Study|Withdrawal by Subject|1|||
131481437|NCT04402060|473394139|FG002|Overall Study|Withdrawal by Subject|2|||
131481438|NCT04402060|473394137|FG000|Overall Study|Sponsor Request|0|||
131481439|NCT04402060|473394138|FG001|Overall Study|Sponsor Request|2|||
131481440|NCT04402060|473394139|FG002|Overall Study|Sponsor Request|0|||
131481441|NCT04402060|473394137|FG000|Overall Study|Physician Decision|0|||
131481442|NCT04402060|473394138|FG001|Overall Study|Physician Decision|0|||
131481443|NCT04402060|473394139|FG002|Overall Study|Physician Decision|1|||
131481444|NCT04402060|473394137|FG000|Overall Study|Other|0|||
131481445|NCT04402060|473394138|FG001|Overall Study|Other|1|||
131481446|NCT04402060|473394139|FG002|Overall Study|Other|0|||
131481447|NCT04357782|473394153|FG000|Overall Study|Discharged from hospital|1|||
131481448|NCT04357782|473394154|FG001|Overall Study|Discharged from hospital|0|||
131481449|NCT04357782|473394153|FG000|Overall Study|Death|0|||
131481450|NCT04357782|473394154|FG001|Overall Study|Death|2|||
131481451|NCT01786148|473394155|FG000|Overall Study|Lost to Follow-up|21|||
131481452|NCT01786148|473394156|FG001|Overall Study|Lost to Follow-up|13|||
131481453|NCT01786148|473394155|FG000|Overall Study|Death|0|||
131481454|NCT01786148|473394156|FG001|Overall Study|Death|1|||
131481455|NCT01786148|473394155|FG000|Overall Study|Withdrawal by Subject|0|||
131481456|NCT01786148|473394156|FG001|Overall Study|Withdrawal by Subject|7|||
131481457|NCT01786148|473394155|FG000|Overall Study|Incarceration|1|||
131481458|NCT01786148|473394156|FG001|Overall Study|Incarceration|1|||
131481459|NCT03780543|473394158|FG000|Overall Study|Adverse Event|1|||
131481460|NCT03780543|473394159|FG001|Overall Study|Adverse Event|0|||
131481461|NCT03780543|473394160|FG002|Overall Study|Adverse Event|2|||
131481462|NCT03780543|473394158|FG000|Overall Study|Lost to Follow-up|2|||
131481463|NCT03780543|473394159|FG001|Overall Study|Lost to Follow-up|0|||
131481464|NCT03780543|473394160|FG002|Overall Study|Lost to Follow-up|1|||
131481465|NCT03780543|473394158|FG000|Overall Study|Study terminated by Sponsor|8|||
131481466|NCT03780543|473394159|FG001|Overall Study|Study terminated by Sponsor|7|||
131481467|NCT03780543|473394160|FG002|Overall Study|Study terminated by Sponsor|13|||
131481468|NCT03780543|473394158|FG000|Overall Study|Withdrawal by Subject|1|||
131481469|NCT03780543|473394159|FG001|Overall Study|Withdrawal by Subject|8|||
131481470|NCT03780543|473394160|FG002|Overall Study|Withdrawal by Subject|1|||
131481471|NCT03780543|473394158|FG000|Overall Study|Noncompliance with study drug|1|||
131481472|NCT03780543|473394159|FG001|Overall Study|Noncompliance with study drug|0|||
131481473|NCT03780543|473394160|FG002|Overall Study|Noncompliance with study drug|0|||
131481474|NCT01811225|473394161|FG000|Treatment Period 1|Adverse Event|2|||
131481475|NCT01811225|473394162|FG001|Treatment Period 1|Adverse Event|3|||
131481476|NCT01811225|473394161|FG000|Treatment Period 1|Lost to Follow-up|12|||
131481477|NCT01811225|473394162|FG001|Treatment Period 1|Lost to Follow-up|8|||
131481478|NCT01811225|473394161|FG000|Treatment Period 1|transporation|1|||
131481479|NCT01811225|473394162|FG001|Treatment Period 1|transporation|0|||
131481480|NCT01811225|473394161|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
131481481|NCT01811225|473394162|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
131481482|NCT01811225|473394161|FG000|Treatment Period 2|Lost to Follow-up|1|||
131481483|NCT01811225|473394162|FG001|Treatment Period 2|Lost to Follow-up|2|||
131481484|NCT01811225|473394161|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
131481485|NCT01811225|473394162|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
131481486|NCT00287365|473394163|FG000|Overall Study|sample not acquired|13|||
131481487|NCT03000569|473394164|FG000|Overall Study|Withdrawal by Subject|1|||
131481488|NCT03000569|473394165|FG001|Overall Study|Withdrawal by Subject|0|||
131481489|NCT02298023|473394168|FG000|Overall Study|Withdrawal by Subject|1|||
131481490|NCT02298023|473394169|FG001|Overall Study|Withdrawal by Subject|0|||
131481491|NCT02298023|473394170|FG002|Overall Study|Withdrawal by Subject|0|||
131481492|NCT01967173|473394171|FG000|Overall Study|Lost to Follow-up|5|||
131481493|NCT01967173|473394172|FG001|Overall Study|Lost to Follow-up|3|||
131481494|NCT01967173|473394173|FG002|Overall Study|Lost to Follow-up|2|||
131481495|NCT01967173|473394174|FG003|Overall Study|Lost to Follow-up|4|||
131481496|NCT01967173|473394175|FG004|Overall Study|Lost to Follow-up|8|||
131481497|NCT01967173|473394176|FG005|Overall Study|Lost to Follow-up|12|||
131481498|NCT01967173|473394177|FG006|Overall Study|Lost to Follow-up|6|||
131481499|NCT01967173|473394178|FG007|Overall Study|Lost to Follow-up|8|||
131481500|NCT01967173|473394171|FG000|Overall Study|Physician Decision|2|||
131481501|NCT01967173|473394172|FG001|Overall Study|Physician Decision|0|||
131481502|NCT01967173|473394173|FG002|Overall Study|Physician Decision|2|||
131481503|NCT01967173|473394174|FG003|Overall Study|Physician Decision|1|||
131481504|NCT01967173|473394175|FG004|Overall Study|Physician Decision|1|||
131481505|NCT01967173|473394176|FG005|Overall Study|Physician Decision|1|||
131481506|NCT01967173|473394177|FG006|Overall Study|Physician Decision|1|||
131481507|NCT01967173|473394178|FG007|Overall Study|Physician Decision|0|||
131481508|NCT01967173|473394171|FG000|Overall Study|Lack of Efficacy|2|||
131481509|NCT01967173|473394172|FG001|Overall Study|Lack of Efficacy|0|||
131481510|NCT01967173|473394173|FG002|Overall Study|Lack of Efficacy|2|||
131481511|NCT01967173|473394174|FG003|Overall Study|Lack of Efficacy|2|||
131481512|NCT01967173|473394175|FG004|Overall Study|Lack of Efficacy|0|||
131481513|NCT01967173|473394176|FG005|Overall Study|Lack of Efficacy|1|||
131481514|NCT01967173|473394177|FG006|Overall Study|Lack of Efficacy|0|||
131481515|NCT01967173|473394178|FG007|Overall Study|Lack of Efficacy|2|||
131481516|NCT01967173|473394171|FG000|Overall Study|Pregnancy|0|||
131481517|NCT01967173|473394172|FG001|Overall Study|Pregnancy|0|||
131481518|NCT01967173|473394173|FG002|Overall Study|Pregnancy|0|||
131481519|NCT01967173|473394174|FG003|Overall Study|Pregnancy|0|||
131481520|NCT01967173|473394175|FG004|Overall Study|Pregnancy|0|||
131481521|NCT01967173|473394176|FG005|Overall Study|Pregnancy|0|||
131481522|NCT01967173|473394177|FG006|Overall Study|Pregnancy|1|||
131481523|NCT01967173|473394178|FG007|Overall Study|Pregnancy|1|||
131481524|NCT01967173|473394171|FG000|Overall Study|Adverse Event|0|||
131481525|NCT01967173|473394172|FG001|Overall Study|Adverse Event|0|||
131481526|NCT01967173|473394173|FG002|Overall Study|Adverse Event|0|||
131481527|NCT01967173|473394174|FG003|Overall Study|Adverse Event|0|||
131481528|NCT01967173|473394175|FG004|Overall Study|Adverse Event|0|||
131481529|NCT01967173|473394176|FG005|Overall Study|Adverse Event|0|||
131481530|NCT01967173|473394177|FG006|Overall Study|Adverse Event|0|||
131481531|NCT01967173|473394178|FG007|Overall Study|Adverse Event|1|||
131481532|NCT01967173|473394171|FG000|Overall Study|Withdrawal by Subject|15|||
131481533|NCT01967173|473394172|FG001|Overall Study|Withdrawal by Subject|14|||
131481534|NCT01967173|473394173|FG002|Overall Study|Withdrawal by Subject|10|||
131481535|NCT01967173|473394174|FG003|Overall Study|Withdrawal by Subject|7|||
131481536|NCT01967173|473394175|FG004|Overall Study|Withdrawal by Subject|8|||
131481537|NCT01967173|473394176|FG005|Overall Study|Withdrawal by Subject|9|||
131481538|NCT01967173|473394177|FG006|Overall Study|Withdrawal by Subject|10|||
131481539|NCT01967173|473394178|FG007|Overall Study|Withdrawal by Subject|12|||
131481540|NCT04122534|473394184|FG000|Overall Study|Lost to Follow-up|4|||
131481541|NCT00397215|473394192|FG000|Month 0 (Day 0)|Adverse Event|0|||
131481542|NCT00397215|473394193|FG001|Month 0 (Day 0)|Adverse Event|1|||
131481543|NCT00397215|473394194|FG002|Month 0 (Day 0)|Adverse Event|0|||
131481544|NCT00397215|473394195|FG003|Month 0 (Day 0)|Adverse Event|0|||
131481545|NCT00397215|473394192|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
131481546|NCT00397215|473394193|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
131481547|NCT00397215|473394194|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
131481548|NCT00397215|473394195|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
131481549|NCT00397215|473394192|FG000|Month 0 (Day 0)|Other|4|||
131481550|NCT00397215|473394193|FG001|Month 0 (Day 0)|Other|1|||
131481551|NCT00397215|473394194|FG002|Month 0 (Day 0)|Other|3|||
131481552|NCT00397215|473394195|FG003|Month 0 (Day 0)|Other|3|||
131481553|NCT00397215|473394192|FG000|Month 6 (Day 180)|Adverse Event|0|||
131481554|NCT00397215|473394193|FG001|Month 6 (Day 180)|Adverse Event|3|||
131481555|NCT00397215|473394194|FG002|Month 6 (Day 180)|Adverse Event|2|||
131481556|NCT00397215|473394195|FG003|Month 6 (Day 180)|Adverse Event|0|||
131481557|NCT00397215|473394192|FG000|Month 6 (Day 180)|Other|2|||
131481558|NCT00397215|473394193|FG001|Month 6 (Day 180)|Other|0|||
131481559|NCT00397215|473394194|FG002|Month 6 (Day 180)|Other|3|||
131481560|NCT00397215|473394195|FG003|Month 6 (Day 180)|Other|0|||
131481561|NCT02128932|473394196|FG000|Overall Study|Withdrawal by Subject|11|||
131481562|NCT02128932|473394197|FG001|Overall Study|Withdrawal by Subject|7|||
131481563|NCT02128932|473394198|FG002|Overall Study|Withdrawal by Subject|8|||
131481564|NCT02128932|473394196|FG000|Overall Study|Death|2|||
131481565|NCT02128932|473394197|FG001|Overall Study|Death|0|||
131481566|NCT02128932|473394198|FG002|Overall Study|Death|2|||
131481567|NCT02128932|473394196|FG000|Overall Study|Lost to Follow-up|2|||
131481568|NCT02128932|473394197|FG001|Overall Study|Lost to Follow-up|1|||
131481569|NCT02128932|473394198|FG002|Overall Study|Lost to Follow-up|1|||
131481570|NCT02128932|473394196|FG000|Overall Study|No reason for withdrawal|12|||
131481571|NCT02128932|473394197|FG001|Overall Study|No reason for withdrawal|11|||
131481572|NCT02128932|473394198|FG002|Overall Study|No reason for withdrawal|7|||
131481573|NCT01361568|473394203|FG000|Overall Study|Adverse Event|0|||
131481574|NCT01361568|473394204|FG001|Overall Study|Adverse Event|0|||
131481575|NCT01361568|473394205|FG002|Overall Study|Adverse Event|0|||
131481576|NCT01361568|473394206|FG003|Overall Study|Adverse Event|0|||
131481577|NCT01361568|473394207|FG004|Overall Study|Adverse Event|1|||
131481578|NCT01361568|473394208|FG005|Overall Study|Adverse Event|0|||
131481579|NCT01361568|473394203|FG000|Overall Study|Physician Decision|0|||
131481580|NCT01361568|473394204|FG001|Overall Study|Physician Decision|0|||
131481581|NCT01361568|473394205|FG002|Overall Study|Physician Decision|0|||
131481582|NCT01361568|473394206|FG003|Overall Study|Physician Decision|0|||
131481583|NCT01361568|473394207|FG004|Overall Study|Physician Decision|0|||
131481584|NCT01361568|473394208|FG005|Overall Study|Physician Decision|1|||
131481585|NCT01361568|473394203|FG000|Overall Study|Withdrawal by Subject|2|||
131481586|NCT01361568|473394204|FG001|Overall Study|Withdrawal by Subject|1|||
131481587|NCT01361568|473394205|FG002|Overall Study|Withdrawal by Subject|0|||
131481588|NCT01361568|473394206|FG003|Overall Study|Withdrawal by Subject|0|||
131481589|NCT01361568|473394207|FG004|Overall Study|Withdrawal by Subject|0|||
131481590|NCT01361568|473394208|FG005|Overall Study|Withdrawal by Subject|1|||
131481591|NCT00657358|473394209|FG000|Overall Study|Lack of Efficacy|6|||
131481592|NCT02959983|473394210|FG000|Overall Study|Protocol Violation|0|||
131481593|NCT02959983|473394211|FG001|Overall Study|Protocol Violation|1|||
131481594|NCT02959983|473394210|FG000|Overall Study|Lack of Efficacy|0|||
131481595|NCT02959983|473394211|FG001|Overall Study|Lack of Efficacy|1|||
131481596|NCT02959983|473394210|FG000|Overall Study|Lost to Follow-up|12|||
131481597|NCT02959983|473394211|FG001|Overall Study|Lost to Follow-up|9|||
131481598|NCT02959983|473394210|FG000|Overall Study|Other|1|||
131481599|NCT02959983|473394211|FG001|Overall Study|Other|1|||
131481600|NCT02959983|473394210|FG000|Overall Study|Physician Decision|1|||
131481601|NCT02959983|473394211|FG001|Overall Study|Physician Decision|0|||
131481602|NCT02959983|473394210|FG000|Overall Study|Adverse Event|5|||
131481603|NCT02959983|473394211|FG001|Overall Study|Adverse Event|1|||
131481604|NCT02959983|473394210|FG000|Overall Study|Withdrawal by Subject|7|||
131481605|NCT02959983|473394211|FG001|Overall Study|Withdrawal by Subject|12|||
131481606|NCT01254630|473394212|FG000|Overall Study|Adverse Event|36|||
131481607|NCT01254630|473394213|FG001|Overall Study|Adverse Event|15|||
131481608|NCT01254630|473394214|FG002|Overall Study|Adverse Event|40|||
131481609|NCT01254630|473394215|FG003|Overall Study|Adverse Event|8|||
131481610|NCT01254630|473394212|FG000|Overall Study|Death|461|||
131481611|NCT01254630|473394213|FG001|Overall Study|Death|151|||
131481612|NCT01254630|473394214|FG002|Overall Study|Death|478|||
131481613|NCT01254630|473394215|FG003|Overall Study|Death|139|||
131481614|NCT01254630|473394212|FG000|Overall Study|Lost to Follow-up|80|||
131481615|NCT01254630|473394213|FG001|Overall Study|Lost to Follow-up|26|||
131481616|NCT01254630|473394214|FG002|Overall Study|Lost to Follow-up|89|||
131481617|NCT01254630|473394215|FG003|Overall Study|Lost to Follow-up|32|||
131481618|NCT01254630|473394212|FG000|Overall Study|Physician Decision|24|||
131481619|NCT01254630|473394213|FG001|Overall Study|Physician Decision|8|||
131481620|NCT01254630|473394214|FG002|Overall Study|Physician Decision|16|||
131481621|NCT01254630|473394215|FG003|Overall Study|Physician Decision|7|||
131481622|NCT01254630|473394212|FG000|Overall Study|Withdrawal by Subject|201|||
131481623|NCT01254630|473394213|FG001|Overall Study|Withdrawal by Subject|94|||
131481624|NCT01254630|473394214|FG002|Overall Study|Withdrawal by Subject|188|||
131481625|NCT01254630|473394215|FG003|Overall Study|Withdrawal by Subject|89|||
131481626|NCT01254630|473394212|FG000|Overall Study|Study terminated by sponsor|0|||
131481627|NCT01254630|473394213|FG001|Overall Study|Study terminated by sponsor|994|||
131481628|NCT01254630|473394214|FG002|Overall Study|Study terminated by sponsor|0|||
131481629|NCT01254630|473394215|FG003|Overall Study|Study terminated by sponsor|1010|||
131481630|NCT01254630|473394212|FG000|Overall Study|Status not recorded|0|||
131481631|NCT01254630|473394213|FG001|Overall Study|Status not recorded|0|||
131481632|NCT01254630|473394214|FG002|Overall Study|Status not recorded|1|||
131481633|NCT01254630|473394215|FG003|Overall Study|Status not recorded|0|||
131481634|NCT02020577|473394216|FG000|Overall Study|Progressive disease|3|||
131481635|NCT02020577|473394217|FG001|Overall Study|Progressive disease|38|||
131481636|NCT02020577|473394216|FG000|Overall Study|Other AE or clinical progression|0|||
131481637|NCT02020577|473394217|FG001|Overall Study|Other AE or clinical progression|15|||
131481638|NCT02020577|473394216|FG000|Overall Study|Withdrawal by Subject|0|||
131481639|NCT02020577|473394217|FG001|Overall Study|Withdrawal by Subject|1|||
131481640|NCT02020577|473394216|FG000|Overall Study|Other than stated above|0|||
131481641|NCT02020577|473394217|FG001|Overall Study|Other than stated above|1|||
131481642|NCT00241358|473394218|FG000|Overall Study|Determined to be not ineligible|0|||
131481643|NCT00241358|473394219|FG001|Overall Study|Determined to be not ineligible|1|||
131481644|NCT00241358|473394220|FG002|Overall Study|Determined to be not ineligible|1|||
131481645|NCT02663908|473394221|FG000|Overall Study|Withdrawal by Subject|8|||
131481646|NCT02663908|473394222|FG001|Overall Study|Withdrawal by Subject|5|||
131481647|NCT02663908|473394221|FG000|Overall Study|Lost to Follow-up|1|||
131481648|NCT02663908|473394222|FG001|Overall Study|Lost to Follow-up|5|||
131481649|NCT02663908|473394221|FG000|Overall Study|Adverse Event|13|||
131481650|NCT02663908|473394222|FG001|Overall Study|Adverse Event|11|||
131481651|NCT02663908|473394221|FG000|Overall Study|Protocol Violation|1|||
131481652|NCT02663908|473394222|FG001|Overall Study|Protocol Violation|2|||
131481653|NCT02663908|473394221|FG000|Overall Study|Lack of therapeutic response|2|||
131481654|NCT02663908|473394222|FG001|Overall Study|Lack of therapeutic response|0|||
131481655|NCT02663908|473394221|FG000|Overall Study|COVID-19|1|||
131481656|NCT02663908|473394222|FG001|Overall Study|COVID-19|0|||
131481657|NCT02663908|473394221|FG000|Overall Study|Site closed|1|||
131481658|NCT02663908|473394222|FG001|Overall Study|Site closed|0|||
131481659|NCT02663908|473394221|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
131481660|NCT02663908|473394222|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
131481661|NCT02663908|473394221|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
131481662|NCT02663908|473394222|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
131481663|NCT02663908|473394221|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
131481664|NCT02663908|473394222|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
131481665|NCT02663908|473394221|FG000|Overall Study|Death|1|||
131481666|NCT02663908|473394222|FG001|Overall Study|Death|0|||
131481667|NCT02663908|473394221|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
131481668|NCT02663908|473394222|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
131481669|NCT02663908|473394221|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
131481670|NCT02663908|473394222|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
131481671|NCT03308786|473394223|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
131481672|NCT06238362|473394224|FG000|Overall Study|Insufficient total sleep time|1|||
131481673|NCT06238362|473394225|FG001|Overall Study|Insufficient total sleep time|0|||
131481674|NCT06238362|473394224|FG000|Overall Study|Inadequate signal quality|1|||
131481675|NCT06238362|473394225|FG001|Overall Study|Inadequate signal quality|0|||
131481676|NCT05136690|473394226|FG000|Period 1|Withdrawal by Subject|0|||
131481677|NCT05136690|473394227|FG001|Period 1|Withdrawal by Subject|1|||
131481678|NCT05136690|473394226|FG000|Period 2|Lost to Follow-up|0|||
131481679|NCT05136690|473394227|FG001|Period 2|Lost to Follow-up|3|||
131481680|NCT05136690|473394226|FG000|Period 2|Withdrawal by Subject|0|||
131481681|NCT05136690|473394227|FG001|Period 2|Withdrawal by Subject|1|||
131481682|NCT02925923|473395896|FG000|Overall Study|blood samples hemolyzed|0|||
131481683|NCT02925923|473395897|FG001|Overall Study|blood samples hemolyzed|2|||
131481684|NCT01313858|473395906|FG000|Overall Study|Premature Treatment Termination|251|||
131481685|NCT01313858|473395907|FG001|Overall Study|Premature Treatment Termination|219|||
131481686|NCT01313858|473395908|FG002|Overall Study|Premature Treatment Termination|191|||
131481687|NCT01313858|473395906|FG000|Overall Study|Lost to Follow-up|35|||
131481688|NCT01313858|473395907|FG001|Overall Study|Lost to Follow-up|51|||
131481689|NCT01313858|473395908|FG002|Overall Study|Lost to Follow-up|47|||
131481690|NCT02899299|473395909|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
131481691|NCT02899299|473395910|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
131481692|NCT02899299|473395909|FG000|Pre-treatment|Participant withdrew consent|1|||
131481693|NCT02899299|473395910|FG001|Pre-treatment|Participant withdrew consent|11|||
131481694|NCT02899299|473395909|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
131481695|NCT02899299|473395910|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
131481696|NCT02899299|473395909|FG000|Pre-treatment|Not reported|0|||
131481697|NCT02899299|473395910|FG001|Pre-treatment|Not reported|1|||
131481698|NCT02899299|473395909|FG000|Treatment|Disease Progression|182|||
131481699|NCT02899299|473395910|FG001|Treatment|Disease Progression|43|||
131481700|NCT02899299|473395909|FG000|Treatment|Study Drug Toxicity|60|||
131481701|NCT02899299|473395910|FG001|Treatment|Study Drug Toxicity|24|||
131481702|NCT02899299|473395909|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
131481703|NCT02899299|473395910|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
131481704|NCT02899299|473395909|FG000|Treatment|Participant request to discontinue Study treatment|4|||
131481705|NCT02899299|473395910|FG001|Treatment|Participant request to discontinue Study treatment|10|||
131481706|NCT02899299|473395909|FG000|Treatment|Participant withdrew consent|6|||
131481707|NCT02899299|473395910|FG001|Treatment|Participant withdrew consent|3|||
131481708|NCT02899299|473395909|FG000|Treatment|Lost to Follow-up|0|||
131481709|NCT02899299|473395910|FG001|Treatment|Lost to Follow-up|2|||
131481710|NCT02899299|473395909|FG000|Treatment|Maximum Clinical Benefit|11|||
131481711|NCT02899299|473395910|FG001|Treatment|Maximum Clinical Benefit|2|||
131481712|NCT02899299|473395909|FG000|Treatment|Poor/Non-compliance|1|||
131481713|NCT02899299|473395910|FG001|Treatment|Poor/Non-compliance|0|||
131481714|NCT02899299|473395909|FG000|Treatment|Participant no longer meets Study criteria|4|||
131481715|NCT02899299|473395910|FG001|Treatment|Participant no longer meets Study criteria|0|||
131481716|NCT02899299|473395909|FG000|Treatment|Administrative reason by Sponsor|2|||
131481717|NCT02899299|473395910|FG001|Treatment|Administrative reason by Sponsor|0|||
131481718|NCT02899299|473395909|FG000|Treatment|Other reasons|12|||
131481719|NCT02899299|473395910|FG001|Treatment|Other reasons|2|||
131481720|NCT02899299|473395909|FG000|Treatment|Not reported|7|||
131481721|NCT02899299|473395910|FG001|Treatment|Not reported|0|||
131481722|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
131481723|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
131481724|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
131481725|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
131481726|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
131481727|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
131481728|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
131481729|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
131481730|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
131481731|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
131481732|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
131481733|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
131481734|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
131481735|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
131481736|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
131481737|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
131481738|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
131481739|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
131481740|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
131481741|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
131481742|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
131481743|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
131481744|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
131481745|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
131481746|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
131481747|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
131481748|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
131481749|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
131481750|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
131481751|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
131481752|NCT00313300|473395912|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
131481753|NCT00313300|473395913|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
131481754|NCT00313300|473395914|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
131481755|NCT00313300|473395915|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
131481756|NCT00313300|473395916|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
131481757|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
131481758|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
131481759|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
131481760|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
131481761|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
131481762|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
131481763|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
131481764|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
131481765|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
131481766|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
131481767|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
131481768|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
131481769|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
131481770|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
131481771|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
131481772|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
131481773|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
131481774|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
131481775|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
131481776|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
131481777|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
131481778|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
131481779|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
131481780|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
131481781|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
131481782|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
131481783|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
131481784|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
131481785|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
131481786|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
131481787|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
131481788|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
131481789|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
131481790|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
131481791|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
131481792|NCT00313300|473395912|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
131481793|NCT00313300|473395913|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
131481794|NCT00313300|473395914|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
131481795|NCT00313300|473395915|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
131481796|NCT00313300|473395916|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
131481797|NCT00313300|473395912|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
131481798|NCT00313300|473395913|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
131481799|NCT00313300|473395914|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
131481800|NCT00313300|473395915|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
131481801|NCT00313300|473395916|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
131481802|NCT00313300|473395912|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
131481803|NCT00313300|473395913|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
131481804|NCT00313300|473395914|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
131481805|NCT00313300|473395915|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
131481806|NCT00313300|473395916|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
131481807|NCT00313300|473395912|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
131481808|NCT00313300|473395913|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
131481809|NCT00313300|473395914|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
131481810|NCT00313300|473395915|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
131481811|NCT00313300|473395916|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
131481812|NCT00313300|473395912|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
131481813|NCT00313300|473395913|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
131481814|NCT00313300|473395914|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
131481815|NCT00313300|473395915|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
131481816|NCT00313300|473395916|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
131481817|NCT00313300|473395912|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
131481818|NCT00313300|473395913|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
131481819|NCT00313300|473395914|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
131481820|NCT00313300|473395915|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
131481821|NCT00313300|473395916|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
131481822|NCT00313300|473395912|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
131481823|NCT00313300|473395913|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
131481824|NCT00313300|473395914|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
131481825|NCT00313300|473395915|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
131481826|NCT00313300|473395916|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
131481827|NCT00850343|473395917|FG000|Overall Study|Withdrawal by Subject|11|||
131481828|NCT00850343|473395918|FG001|Overall Study|Withdrawal by Subject|0|||
131481829|NCT00850343|473395919|FG002|Overall Study|Withdrawal by Subject|3|||
131481830|NCT00850343|473395920|FG003|Overall Study|Withdrawal by Subject|2|||
131481831|NCT00850343|473395917|FG000|Overall Study|Adverse Event|15|||
131481832|NCT00850343|473395918|FG001|Overall Study|Adverse Event|2|||
131481833|NCT00850343|473395919|FG002|Overall Study|Adverse Event|6|||
131481834|NCT00850343|473395920|FG003|Overall Study|Adverse Event|6|||
131481835|NCT00850343|473395917|FG000|Overall Study|Pregnancy|0|||
131481836|NCT00850343|473395918|FG001|Overall Study|Pregnancy|0|||
131481837|NCT00850343|473395919|FG002|Overall Study|Pregnancy|0|||
131481838|NCT00850343|473395920|FG003|Overall Study|Pregnancy|1|||
131481839|NCT00850343|473395917|FG000|Overall Study|Lack of Efficacy|17|||
131481840|NCT00850343|473395918|FG001|Overall Study|Lack of Efficacy|0|||
131481841|NCT00850343|473395919|FG002|Overall Study|Lack of Efficacy|3|||
131481842|NCT00850343|473395920|FG003|Overall Study|Lack of Efficacy|2|||
131481843|NCT00850343|473395917|FG000|Overall Study|Non-compliance with Study Procedures|1|||
131481844|NCT00850343|473395918|FG001|Overall Study|Non-compliance with Study Procedures|0|||
131481845|NCT00850343|473395919|FG002|Overall Study|Non-compliance with Study Procedures|1|||
131481846|NCT00850343|473395920|FG003|Overall Study|Non-compliance with Study Procedures|1|||
131481847|NCT00850343|473395917|FG000|Overall Study|Physician Decision|2|||
131481848|NCT00850343|473395918|FG001|Overall Study|Physician Decision|1|||
131481849|NCT00850343|473395919|FG002|Overall Study|Physician Decision|1|||
131481850|NCT00850343|473395920|FG003|Overall Study|Physician Decision|1|||
131481851|NCT02468232|473395922|FG000|Core Part of Study|Adverse Event|0|||
131481852|NCT02468232|473395923|FG001|Core Part of Study|Adverse Event|1|||
131481853|NCT02468232|473395924|FG002|Core Part of Study|Adverse Event|0|||
131481854|NCT02468232|473395925|FG003|Core Part of Study|Adverse Event|0|||
131481855|NCT02468232|473395922|FG000|Core Part of Study|Death|20|||
131481856|NCT02468232|473395923|FG001|Core Part of Study|Death|17|||
131481857|NCT02468232|473395924|FG002|Core Part of Study|Death|0|||
131481858|NCT02468232|473395925|FG003|Core Part of Study|Death|0|||
131481859|NCT02468232|473395922|FG000|Core Part of Study|Technical Problems|1|||
131481860|NCT02468232|473395923|FG001|Core Part of Study|Technical Problems|1|||
131481861|NCT02468232|473395924|FG002|Core Part of Study|Technical Problems|0|||
131481862|NCT02468232|473395925|FG003|Core Part of Study|Technical Problems|0|||
131481863|NCT02468232|473395922|FG000|OLE Part of Study|Adverse Event|0|||
131481864|NCT02468232|473395923|FG001|OLE Part of Study|Adverse Event|0|||
131481865|NCT02468232|473395924|FG002|OLE Part of Study|Adverse Event|4|||
131481866|NCT02468232|473395925|FG003|OLE Part of Study|Adverse Event|5|||
131481867|NCT02468232|473395922|FG000|OLE Part of Study|Death|0|||
131481868|NCT02468232|473395923|FG001|OLE Part of Study|Death|0|||
131481869|NCT02468232|473395924|FG002|OLE Part of Study|Death|4|||
131481870|NCT02468232|473395925|FG003|OLE Part of Study|Death|2|||
131481871|NCT02468232|473395922|FG000|OLE Part of Study|Physician Decision|0|||
131481872|NCT02468232|473395923|FG001|OLE Part of Study|Physician Decision|0|||
131481873|NCT02468232|473395924|FG002|OLE Part of Study|Physician Decision|4|||
131481874|NCT02468232|473395925|FG003|OLE Part of Study|Physician Decision|0|||
131481875|NCT02468232|473395922|FG000|OLE Part of Study|Subject/Guardian decision|0|||
131481876|NCT02468232|473395923|FG001|OLE Part of Study|Subject/Guardian decision|0|||
131481877|NCT02468232|473395924|FG002|OLE Part of Study|Subject/Guardian decision|2|||
131481878|NCT02468232|473395925|FG003|OLE Part of Study|Subject/Guardian decision|5|||
131481879|NCT02764333|473395927|FG000|Overall Study|Ineligible|1|||
131481880|NCT01788046|473395930|FG000|Overall Study|Withdrawal by Subject|12|||
131481881|NCT01788046|473395931|FG001|Overall Study|Withdrawal by Subject|12|||
131481882|NCT01788046|473395930|FG000|Overall Study|Lost to Follow-up|12|||
131481883|NCT01788046|473395931|FG001|Overall Study|Lost to Follow-up|19|||
131481884|NCT01788046|473395930|FG000|Overall Study|Death|7|||
131481885|NCT01788046|473395931|FG001|Overall Study|Death|5|||
131481886|NCT01788046|473395930|FG000|Overall Study|Protocol Specified Criteria|25|||
131481887|NCT01788046|473395931|FG001|Overall Study|Protocol Specified Criteria|1|||
131481888|NCT00075218|473395935|FG000|Double-Blind Treatment|Adverse Event|23|||
131481889|NCT00075218|473395936|FG001|Double-Blind Treatment|Adverse Event|4|||
131481890|NCT00075218|473395937|FG002|Double-Blind Treatment|Adverse Event|0|||
131481891|NCT00075218|473395935|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
131481892|NCT00075218|473395936|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
131481893|NCT00075218|473395937|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
131481894|NCT00075218|473395935|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
131481895|NCT00075218|473395936|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
131481896|NCT00075218|473395937|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
131481897|NCT00075218|473395935|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
131481898|NCT00075218|473395936|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
131481899|NCT00075218|473395937|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
131481900|NCT00075218|473395935|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
131481901|NCT00075218|473395936|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
131481902|NCT00075218|473395937|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
131481903|NCT00075218|473395935|FG000|Double-Blind Treatment|No study medication taken|2|||
131481904|NCT00075218|473395936|FG001|Double-Blind Treatment|No study medication taken|0|||
131481905|NCT00075218|473395937|FG002|Double-Blind Treatment|No study medication taken|0|||
131481906|NCT00075218|473395935|FG000|Open-Label Treatment|Lack of Efficacy|0|||
131481907|NCT00075218|473395936|FG001|Open-Label Treatment|Lack of Efficacy|0|||
131481908|NCT00075218|473395937|FG002|Open-Label Treatment|Lack of Efficacy|174|||
131481909|NCT00075218|473395935|FG000|Open-Label Treatment|Adverse Event|0|||
131481910|NCT00075218|473395936|FG001|Open-Label Treatment|Adverse Event|0|||
131481911|NCT00075218|473395937|FG002|Open-Label Treatment|Adverse Event|51|||
131481912|NCT00075218|473395935|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
131481913|NCT00075218|473395936|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
131481914|NCT00075218|473395937|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
131481915|NCT00075218|473395935|FG000|Open-Label Treatment|Decision of Sponsor|0|||
131481916|NCT00075218|473395936|FG001|Open-Label Treatment|Decision of Sponsor|0|||
131481917|NCT00075218|473395937|FG002|Open-Label Treatment|Decision of Sponsor|8|||
131481918|NCT00075218|473395935|FG000|Open-Label Treatment|Protocol Violation|0|||
131481919|NCT00075218|473395936|FG001|Open-Label Treatment|Protocol Violation|0|||
131481920|NCT00075218|473395937|FG002|Open-Label Treatment|Protocol Violation|1|||
131481921|NCT00075218|473395935|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
131481922|NCT00075218|473395936|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
131481923|NCT00075218|473395937|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
131481924|NCT00131508|473395942|FG000|Overall Study|Disease progression|0|||
131481925|NCT00131508|473395943|FG001|Overall Study|Disease progression|2|||
131481926|NCT00131508|473395942|FG000|Overall Study|Non-Compliance|2|||
131481927|NCT00131508|473395943|FG001|Overall Study|Non-Compliance|4|||
131481928|NCT00131508|473395942|FG000|Overall Study|Withdrawal by Subject|1|||
131481929|NCT00131508|473395943|FG001|Overall Study|Withdrawal by Subject|2|||
131481930|NCT03758443|473395944|FG000|Induction Period|Adverse Event|2|||
131481931|NCT03758443|473395945|FG001|Induction Period|Adverse Event|4|||
131481932|NCT03758443|473395946|FG002|Induction Period|Adverse Event|2|||
131481933|NCT03758443|473395947|FG003|Induction Period|Adverse Event|3|||
131481934|NCT03758443|473395944|FG000|Induction Period|Physician Decision|1|||
131481935|NCT03758443|473395945|FG001|Induction Period|Physician Decision|1|||
131481936|NCT03758443|473395946|FG002|Induction Period|Physician Decision|3|||
131481937|NCT03758443|473395947|FG003|Induction Period|Physician Decision|0|||
131481938|NCT03758443|473395944|FG000|Induction Period|Protocol Violation|0|||
131481939|NCT03758443|473395945|FG001|Induction Period|Protocol Violation|0|||
131481940|NCT03758443|473395946|FG002|Induction Period|Protocol Violation|0|||
131481941|NCT03758443|473395947|FG003|Induction Period|Protocol Violation|1|||
131481942|NCT03758443|473395944|FG000|Induction Period|Withdrawal by Subject|3|||
131481943|NCT03758443|473395945|FG001|Induction Period|Withdrawal by Subject|2|||
131481944|NCT03758443|473395946|FG002|Induction Period|Withdrawal by Subject|2|||
131481945|NCT03758443|473395947|FG003|Induction Period|Withdrawal by Subject|4|||
131481946|NCT03758443|473395944|FG000|Extended Induction Period|Adverse Event|1|||
131481947|NCT03758443|473395945|FG001|Extended Induction Period|Adverse Event|1|||
131481948|NCT03758443|473395946|FG002|Extended Induction Period|Adverse Event|0|||
131481949|NCT03758443|473395947|FG003|Extended Induction Period|Adverse Event|1|||
131481950|NCT03758443|473395944|FG000|Extended Induction Period|Lost to Follow-up|1|||
131481951|NCT03758443|473395945|FG001|Extended Induction Period|Lost to Follow-up|0|||
131481952|NCT03758443|473395946|FG002|Extended Induction Period|Lost to Follow-up|0|||
131481953|NCT03758443|473395947|FG003|Extended Induction Period|Lost to Follow-up|0|||
131481954|NCT03758443|473395944|FG000|Extended Induction Period|Physician Decision|2|||
131481955|NCT03758443|473395945|FG001|Extended Induction Period|Physician Decision|1|||
131481956|NCT03758443|473395946|FG002|Extended Induction Period|Physician Decision|2|||
131481957|NCT03758443|473395947|FG003|Extended Induction Period|Physician Decision|2|||
131481958|NCT03758443|473395944|FG000|Extended Induction Period|Protocol Violation|0|||
131481959|NCT03758443|473395945|FG001|Extended Induction Period|Protocol Violation|0|||
131481960|NCT03758443|473395946|FG002|Extended Induction Period|Protocol Violation|0|||
131481961|NCT03758443|473395947|FG003|Extended Induction Period|Protocol Violation|1|||
131481962|NCT03758443|473395944|FG000|Extended Induction Period|Withdrawal by Subject|8|||
131481963|NCT03758443|473395945|FG001|Extended Induction Period|Withdrawal by Subject|1|||
131481964|NCT03758443|473395946|FG002|Extended Induction Period|Withdrawal by Subject|7|||
131481965|NCT03758443|473395947|FG003|Extended Induction Period|Withdrawal by Subject|3|||
131481966|NCT03758443|473395944|FG000|Extended Induction Period|Miscellaneous|1|||
131481967|NCT03758443|473395945|FG001|Extended Induction Period|Miscellaneous|0|||
131481968|NCT03758443|473395946|FG002|Extended Induction Period|Miscellaneous|0|||
131481969|NCT03758443|473395947|FG003|Extended Induction Period|Miscellaneous|0|||
131481970|NCT03758443|473395944|FG000|Maintenance Period|Adverse Event|1|||
131481971|NCT03758443|473395945|FG001|Maintenance Period|Adverse Event|2|||
131481972|NCT03758443|473395946|FG002|Maintenance Period|Adverse Event|0|||
131481973|NCT03758443|473395947|FG003|Maintenance Period|Adverse Event|0|||
131481974|NCT03758443|473395944|FG000|Maintenance Period|Lost to Follow-up|0|||
131481975|NCT03758443|473395945|FG001|Maintenance Period|Lost to Follow-up|0|||
131481976|NCT03758443|473395946|FG002|Maintenance Period|Lost to Follow-up|0|||
131481977|NCT03758443|473395947|FG003|Maintenance Period|Lost to Follow-up|1|||
131481978|NCT03758443|473395944|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
131481979|NCT03758443|473395945|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
131481980|NCT03758443|473395946|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
131481981|NCT03758443|473395947|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
131481982|NCT03758443|473395944|FG000|Maintenance Period|Protocol Violation|0|||
131481983|NCT03758443|473395945|FG001|Maintenance Period|Protocol Violation|1|||
131481984|NCT03758443|473395946|FG002|Maintenance Period|Protocol Violation|0|||
131481985|NCT03758443|473395947|FG003|Maintenance Period|Protocol Violation|0|||
131481986|NCT03758443|473395944|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
131481987|NCT03758443|473395945|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
131481988|NCT03758443|473395946|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
131481989|NCT03758443|473395947|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
131481990|NCT03758443|473395944|FG000|Maintenance Period|Withdrawal by Subject|1|||
131481991|NCT03758443|473395945|FG001|Maintenance Period|Withdrawal by Subject|0|||
131481992|NCT03758443|473395946|FG002|Maintenance Period|Withdrawal by Subject|1|||
131481993|NCT03758443|473395947|FG003|Maintenance Period|Withdrawal by Subject|1|||
131481994|NCT03758443|473395944|FG000|Maintenance Period|Miscellaneous|0|||
131481995|NCT03758443|473395945|FG001|Maintenance Period|Miscellaneous|0|||
131481996|NCT03758443|473395946|FG002|Maintenance Period|Miscellaneous|1|||
131481997|NCT03758443|473395947|FG003|Maintenance Period|Miscellaneous|0|||
131481998|NCT03080454|473395948|FG000|Baseline|Adverse Event|2|||
131481999|NCT03080454|473395948|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
131482000|NCT03080454|473395948|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
131482001|NCT01436396|473395949|FG000|Overall Study|Protocol Violation|7|||
131482002|NCT01436396|473395950|FG001|Overall Study|Protocol Violation|5|||
131482003|NCT01436396|473395949|FG000|Overall Study|Adverse Event|1|||
131482004|NCT01436396|473395950|FG001|Overall Study|Adverse Event|2|||
131482005|NCT01436396|473395949|FG000|Overall Study|Withdrawal by Subject|19|||
131482006|NCT01436396|473395950|FG001|Overall Study|Withdrawal by Subject|29|||
131482007|NCT01436396|473395949|FG000|Overall Study|Serious adverse event|2|||
131482008|NCT01436396|473395950|FG001|Overall Study|Serious adverse event|3|||
131482009|NCT01436396|473395949|FG000|Overall Study|Lost to Follow-up|3|||
131482010|NCT01436396|473395950|FG001|Overall Study|Lost to Follow-up|3|||
131482011|NCT00216476|473395951|FG000|Overall Study|Withdrawal by Subject|59|||
131482012|NCT00216476|473395952|FG001|Overall Study|Withdrawal by Subject|72|||
131482013|NCT00216476|473395953|FG002|Overall Study|Withdrawal by Subject|9|||
131482014|NCT00216476|473395951|FG000|Overall Study|Lost to Follow-up|10|||
131482015|NCT00216476|473395952|FG001|Overall Study|Lost to Follow-up|9|||
131482016|NCT00216476|473395953|FG002|Overall Study|Lost to Follow-up|1|||
131482017|NCT00216476|473395951|FG000|Overall Study|Adverse Event|6|||
131482018|NCT00216476|473395952|FG001|Overall Study|Adverse Event|10|||
131482019|NCT00216476|473395953|FG002|Overall Study|Adverse Event|1|||
131482020|NCT00216476|473395951|FG000|Overall Study|Lack of Efficacy|4|||
131482021|NCT00216476|473395952|FG001|Overall Study|Lack of Efficacy|3|||
131482022|NCT00216476|473395953|FG002|Overall Study|Lack of Efficacy|0|||
131482023|NCT00216476|473395951|FG000|Overall Study|Death|2|||
131482024|NCT00216476|473395952|FG001|Overall Study|Death|0|||
131482025|NCT00216476|473395953|FG002|Overall Study|Death|0|||
131482026|NCT00216476|473395951|FG000|Overall Study|Pregnancy|0|||
131482027|NCT00216476|473395952|FG001|Overall Study|Pregnancy|1|||
131482028|NCT00216476|473395953|FG002|Overall Study|Pregnancy|1|||
131482029|NCT00216476|473395951|FG000|Overall Study|Other|0|||
131482030|NCT00216476|473395952|FG001|Overall Study|Other|0|||
131482031|NCT00216476|473395953|FG002|Overall Study|Other|1|||
131482032|NCT00216476|473395951|FG000|Overall Study|Refuses Injection|11|||
131482033|NCT00216476|473395952|FG001|Overall Study|Refuses Injection|0|||
131482034|NCT00216476|473395953|FG002|Overall Study|Refuses Injection|0|||
131482035|NCT00216476|473395951|FG000|Overall Study|No Further Need for Treatment|3|||
131482036|NCT00216476|473395952|FG001|Overall Study|No Further Need for Treatment|4|||
131482037|NCT00216476|473395953|FG002|Overall Study|No Further Need for Treatment|1|||
131482038|NCT00216476|473395951|FG000|Overall Study|Non-compliance|0|||
131482039|NCT00216476|473395952|FG001|Overall Study|Non-compliance|4|||
131482040|NCT00216476|473395953|FG002|Overall Study|Non-compliance|1|||
131482041|NCT00216476|473395951|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
131482042|NCT00216476|473395952|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
131482043|NCT00216476|473395953|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
131482044|NCT00216476|473395951|FG000|Overall Study|Administrative Reasons|1|||
131482045|NCT00216476|473395952|FG001|Overall Study|Administrative Reasons|1|||
131482046|NCT00216476|473395953|FG002|Overall Study|Administrative Reasons|0|||
131482047|NCT00216476|473395951|FG000|Overall Study|Protocol Deviation|5|||
131482048|NCT00216476|473395952|FG001|Overall Study|Protocol Deviation|1|||
131482049|NCT00216476|473395953|FG002|Overall Study|Protocol Deviation|0|||
131482050|NCT00216476|473395951|FG000|Overall Study|Patient Moved|2|||
131482051|NCT00216476|473395952|FG001|Overall Study|Patient Moved|2|||
131482052|NCT00216476|473395953|FG002|Overall Study|Patient Moved|0|||
131482053|NCT02191137|473395954|FG000|Treatment|Death|4|||
131482054|NCT02191137|473395954|FG000|Treatment|Withdrawal by Subject|3|||
131482055|NCT02191137|473395954|FG000|Treatment|Adverse Event|2|||
131482056|NCT02191137|473395954|FG000|Treatment|Other|1|||
131482057|NCT02191137|473395954|FG000|Follow-up|Lost to Follow-up|2|||
131482058|NCT02191137|473395954|FG000|Follow-up|Ongoing/unknown|2|||
131482059|NCT02191137|473395954|FG000|Follow-up|Adverse Event|1|||
131482060|NCT00696800|473395955|FG000|Overall Study|Adverse Event|16|||
131482061|NCT00696800|473395956|FG001|Overall Study|Adverse Event|3|||
131482062|NCT00696800|473395955|FG000|Overall Study|Insufficient compliance with medication|2|||
131482063|NCT00696800|473395956|FG001|Overall Study|Insufficient compliance with medication|1|||
131482064|NCT00696800|473395955|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
131482065|NCT00696800|473395956|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
131482066|NCT00696800|473395955|FG000|Overall Study|Insufficient ovarian response|4|||
131482067|NCT00696800|473395956|FG001|Overall Study|Insufficient ovarian response|1|||
131482068|NCT00696800|473395955|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
131482069|NCT00696800|473395956|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
131482070|NCT00696800|473395955|FG000|Overall Study|Too high ovarian response|6|||
131482071|NCT00696800|473395956|FG001|Overall Study|Too high ovarian response|1|||
131482072|NCT00696800|473395955|FG000|Overall Study|No/too few/bad quality oocytes|4|||
131482073|NCT00696800|473395956|FG001|Overall Study|No/too few/bad quality oocytes|3|||
131482074|NCT00696800|473395955|FG000|Overall Study|No/abnormal fertilization|11|||
131482075|NCT00696800|473395956|FG001|Overall Study|No/abnormal fertilization|13|||
131482076|NCT00696800|473395955|FG000|Overall Study|No/too few/bad quality embryos|24|||
131482077|NCT00696800|473395956|FG001|Overall Study|No/too few/bad quality embryos|18|||
131482078|NCT00696800|473395955|FG000|Overall Study|Other Reasons|5|||
131482079|NCT00696800|473395956|FG001|Overall Study|Other Reasons|3|||
131482080|NCT00696800|473395955|FG000|Overall Study|Not treated|1|||
131482081|NCT00696800|473395956|FG001|Overall Study|Not treated|2|||
131482082|NCT05224141|473395957|FG000|Overall Study|Ongoing|75|||
131482083|NCT05224141|473395958|FG001|Overall Study|Ongoing|88|||
131482084|NCT05224141|473395957|FG000|Overall Study|Withdrawal by Subject|2|||
131482085|NCT05224141|473395958|FG001|Overall Study|Withdrawal by Subject|4|||
131482086|NCT05224141|473395957|FG000|Overall Study|Death|153|||
131482087|NCT05224141|473395958|FG001|Overall Study|Death|138|||
131482088|NCT03469934|473395963|FG000|Overall Study|Withdrawal by Subject|0|||
131482089|NCT03469934|473395964|FG001|Overall Study|Withdrawal by Subject|1|||
131482090|NCT04889222|473395966|FG000|Overall Study|Did not meet eligibility criteria|8|||
131482091|NCT04889222|473395966|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
131482092|NCT04889222|473395966|FG000|Overall Study|Did not proceed due to time constraints|5|||
131482093|NCT02853344|473395975|FG000|Overall Study|Lost to Follow-up|1|||
131482094|NCT02853344|473395976|FG001|Overall Study|Lost to Follow-up|1|||
131482095|NCT02853344|473395975|FG000|Overall Study|Withdrawal by Subject|2|||
131482096|NCT02853344|473395976|FG001|Overall Study|Withdrawal by Subject|4|||
131482097|NCT02853344|473395975|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
131482098|NCT02853344|473395976|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
131482099|NCT02853344|473395975|FG000|Overall Study|Death|70|||
131482100|NCT02853344|473395976|FG001|Overall Study|Death|112|||
131482101|NCT02913612|473395977|FG000|Overall Study|Lost to Follow-up|6|||
131482102|NCT02913612|473395978|FG001|Overall Study|Lost to Follow-up|5|||
131482103|NCT02913612|473395979|FG002|Overall Study|Lost to Follow-up|2|||
131482104|NCT02913612|473395980|FG003|Overall Study|Lost to Follow-up|0|||
131482105|NCT02913612|473395977|FG000|Overall Study|Physician Decision|1|||
131482106|NCT02913612|473395978|FG001|Overall Study|Physician Decision|4|||
131482107|NCT02913612|473395979|FG002|Overall Study|Physician Decision|1|||
131482108|NCT02913612|473395980|FG003|Overall Study|Physician Decision|0|||
131482109|NCT02913612|473395977|FG000|Overall Study|Withdrawal by Subject|2|||
131482110|NCT02913612|473395978|FG001|Overall Study|Withdrawal by Subject|4|||
131482111|NCT02913612|473395979|FG002|Overall Study|Withdrawal by Subject|0|||
131482112|NCT02913612|473395980|FG003|Overall Study|Withdrawal by Subject|0|||
131482113|NCT02913612|473395977|FG000|Overall Study|Hemangioma resolved|1|||
131482114|NCT02913612|473395978|FG001|Overall Study|Hemangioma resolved|0|||
131482115|NCT02913612|473395979|FG002|Overall Study|Hemangioma resolved|0|||
131482116|NCT02913612|473395980|FG003|Overall Study|Hemangioma resolved|0|||
131482117|NCT02913612|473395977|FG000|Overall Study|Local IRB decision|1|||
131482118|NCT02913612|473395978|FG001|Overall Study|Local IRB decision|0|||
131482119|NCT02913612|473395979|FG002|Overall Study|Local IRB decision|0|||
131482120|NCT02913612|473395980|FG003|Overall Study|Local IRB decision|0|||
131482121|NCT02913612|473395977|FG000|Overall Study|Study drug non-compliance|1|||
131482122|NCT02913612|473395978|FG001|Overall Study|Study drug non-compliance|1|||
131482123|NCT02913612|473395979|FG002|Overall Study|Study drug non-compliance|0|||
131482124|NCT02913612|473395980|FG003|Overall Study|Study drug non-compliance|0|||
131482125|NCT02913612|473395977|FG000|Overall Study|Insurance issues|0|||
131482126|NCT02913612|473395978|FG001|Overall Study|Insurance issues|1|||
131482127|NCT02913612|473395979|FG002|Overall Study|Insurance issues|0|||
131482128|NCT02913612|473395980|FG003|Overall Study|Insurance issues|0|||
131482129|NCT02913612|473395977|FG000|Overall Study|Needed to treat second hemangioma|0|||
131482130|NCT02913612|473395978|FG001|Overall Study|Needed to treat second hemangioma|1|||
131482131|NCT02913612|473395979|FG002|Overall Study|Needed to treat second hemangioma|0|||
131482132|NCT02913612|473395980|FG003|Overall Study|Needed to treat second hemangioma|0|||
131482133|NCT02913612|473395977|FG000|Overall Study|Study completion criteria not met|0|||
131482134|NCT02913612|473395978|FG001|Overall Study|Study completion criteria not met|1|||
131482135|NCT02913612|473395979|FG002|Overall Study|Study completion criteria not met|0|||
131482136|NCT02913612|473395980|FG003|Overall Study|Study completion criteria not met|0|||
131482137|NCT02913612|473395977|FG000|Overall Study|Ineligible|0|||
131482138|NCT02913612|473395978|FG001|Overall Study|Ineligible|1|||
131482139|NCT02913612|473395979|FG002|Overall Study|Ineligible|0|||
131482140|NCT02913612|473395980|FG003|Overall Study|Ineligible|0|||
131482141|NCT00973674|473395983|FG000|Overall Study|Protocol Violation|2|||
131482142|NCT00973674|473395984|FG001|Overall Study|Protocol Violation|0|||
131482143|NCT00071396|473395985|FG000|Overall Study|Withdrawal by Subject|1|||
131482144|NCT00071396|473395985|FG000|Overall Study|Physician Decision|2|||
131482145|NCT02639546|473395986|FG000|Overall Study|Death|2|||
131482146|NCT02639546|473395987|FG001|Overall Study|Death|2|||
131482147|NCT02639546|473395988|FG002|Overall Study|Death|1|||
131482148|NCT02639546|473395989|FG003|Overall Study|Death|2|||
131482149|NCT02639546|473395990|FG004|Overall Study|Death|2|||
131482150|NCT02639546|473395991|FG005|Overall Study|Death|2|||
131482151|NCT02639546|473395992|FG006|Overall Study|Death|0|||
131482152|NCT02639546|473395993|FG007|Overall Study|Death|0|||
131482153|NCT02639546|473395986|FG000|Overall Study|Lost to Follow-up|0|||
131482154|NCT02639546|473395987|FG001|Overall Study|Lost to Follow-up|0|||
131482155|NCT02639546|473395988|FG002|Overall Study|Lost to Follow-up|1|||
131482156|NCT02639546|473395989|FG003|Overall Study|Lost to Follow-up|0|||
131482157|NCT02639546|473395990|FG004|Overall Study|Lost to Follow-up|1|||
131482158|NCT02639546|473395991|FG005|Overall Study|Lost to Follow-up|1|||
131482159|NCT02639546|473395992|FG006|Overall Study|Lost to Follow-up|0|||
131482160|NCT02639546|473395993|FG007|Overall Study|Lost to Follow-up|1|||
131482161|NCT02639546|473395986|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
131482162|NCT02639546|473395987|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
131482163|NCT02639546|473395988|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
131482164|NCT02639546|473395989|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
131482165|NCT02639546|473395990|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
131482166|NCT02639546|473395991|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
131482167|NCT02639546|473395992|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
131482168|NCT02639546|473395993|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
131482169|NCT02639546|473395986|FG000|Overall Study|Study Terminated By Sponsor|0|||
131482170|NCT02639546|473395987|FG001|Overall Study|Study Terminated By Sponsor|2|||
131482171|NCT02639546|473395988|FG002|Overall Study|Study Terminated By Sponsor|3|||
131482172|NCT02639546|473395989|FG003|Overall Study|Study Terminated By Sponsor|4|||
131482173|NCT02639546|473395990|FG004|Overall Study|Study Terminated By Sponsor|4|||
131482174|NCT02639546|473395991|FG005|Overall Study|Study Terminated By Sponsor|3|||
131482175|NCT02639546|473395992|FG006|Overall Study|Study Terminated By Sponsor|3|||
131482176|NCT02639546|473395993|FG007|Overall Study|Study Terminated By Sponsor|9|||
131482177|NCT02639546|473395986|FG000|Overall Study|Withdrawal by Subject|2|||
131482178|NCT02639546|473395987|FG001|Overall Study|Withdrawal by Subject|2|||
131482179|NCT02639546|473395988|FG002|Overall Study|Withdrawal by Subject|1|||
131482180|NCT02639546|473395989|FG003|Overall Study|Withdrawal by Subject|0|||
131482181|NCT02639546|473395990|FG004|Overall Study|Withdrawal by Subject|0|||
131482182|NCT02639546|473395991|FG005|Overall Study|Withdrawal by Subject|1|||
131482183|NCT02639546|473395992|FG006|Overall Study|Withdrawal by Subject|2|||
131482184|NCT02639546|473395993|FG007|Overall Study|Withdrawal by Subject|1|||
131482185|NCT00116428|473395994|FG000|Overall Study|Withdrawal by Subject|2|||
131482186|NCT00116428|473395995|FG001|Overall Study|Withdrawal by Subject|5|||
131482187|NCT00116428|473395994|FG000|Overall Study|Did not meet inclusion criteria|1|||
131482188|NCT00116428|473395995|FG001|Overall Study|Did not meet inclusion criteria|0|||
131482189|NCT00113087|473395996|FG000|Overall Study|Death or Transplant|14|||
131482190|NCT00113087|473395997|FG001|Overall Study|Death or Transplant|16|||
131482191|NCT00113087|473395996|FG000|Overall Study|Family or MD withdrew subject|10|||
131482192|NCT00113087|473395997|FG001|Overall Study|Family or MD withdrew subject|5|||
131482193|NCT02713204|473395998|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
131482194|NCT02713204|473395999|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
131482195|NCT02713204|473396000|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
131482196|NCT02713204|473396001|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
131482197|NCT02713204|473396002|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
131482198|NCT02713204|473396003|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
131482199|NCT02713204|473396004|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
131482200|NCT02713204|473396005|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
131482201|NCT02713204|473395998|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482202|NCT02713204|473395999|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482203|NCT02713204|473396000|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
131482204|NCT02713204|473396001|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482205|NCT02713204|473396002|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482206|NCT02713204|473396003|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482207|NCT02713204|473396004|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482208|NCT02713204|473396005|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131482209|NCT02713204|473395998|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482210|NCT02713204|473395999|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
131482211|NCT02713204|473396000|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482212|NCT02713204|473396001|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482213|NCT02713204|473396002|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482214|NCT02713204|473396003|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482215|NCT02713204|473396004|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482216|NCT02713204|473396005|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131482217|NCT02713204|473395998|FG000|From Week 12 up to Week 36|Adverse Event|1|||
131482218|NCT02713204|473395999|FG001|From Week 12 up to Week 36|Adverse Event|0|||
131482219|NCT02713204|473396000|FG002|From Week 12 up to Week 36|Adverse Event|0|||
131482220|NCT02713204|473396001|FG003|From Week 12 up to Week 36|Adverse Event|1|||
131482221|NCT02713204|473396002|FG004|From Week 12 up to Week 36|Adverse Event|1|||
131482222|NCT02713204|473396003|FG005|From Week 12 up to Week 36|Adverse Event|0|||
131482223|NCT02713204|473396004|FG006|From Week 12 up to Week 36|Adverse Event|2|||
131482224|NCT02713204|473396005|FG007|From Week 12 up to Week 36|Adverse Event|1|||
131482225|NCT02713204|473395998|FG000|From Week 12 up to Week 36|Death|0|||
131482226|NCT02713204|473395999|FG001|From Week 12 up to Week 36|Death|0|||
131482227|NCT02713204|473396000|FG002|From Week 12 up to Week 36|Death|0|||
131482228|NCT02713204|473396001|FG003|From Week 12 up to Week 36|Death|1|||
131482229|NCT02713204|473396002|FG004|From Week 12 up to Week 36|Death|0|||
131482230|NCT02713204|473396003|FG005|From Week 12 up to Week 36|Death|1|||
131482231|NCT02713204|473396004|FG006|From Week 12 up to Week 36|Death|0|||
131482232|NCT02713204|473396005|FG007|From Week 12 up to Week 36|Death|3|||
131482233|NCT02713204|473395998|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482234|NCT02713204|473395999|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482235|NCT02713204|473396000|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482236|NCT02713204|473396001|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
131482237|NCT02713204|473396002|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482238|NCT02713204|473396003|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482239|NCT02713204|473396004|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482240|NCT02713204|473396005|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
131482241|NCT02713204|473395998|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
131482242|NCT02713204|473395999|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
131482243|NCT02713204|473396000|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
131482244|NCT02713204|473396001|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
131482245|NCT02713204|473396002|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
131482246|NCT02713204|473396003|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
131482247|NCT02713204|473396004|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
131482248|NCT02713204|473396005|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
131482249|NCT00669396|473396006|FG000|Overall Study|Lost to Follow-up|10|||
131482250|NCT00669396|473396007|FG001|Overall Study|Lost to Follow-up|12|||
131482251|NCT03386474|473396008|FG000|Overall Study|Death|1|||
131482252|NCT03386474|473396009|FG001|Overall Study|Death|0|||
131482253|NCT03386474|473396008|FG000|Overall Study|Adverse Event|0|||
131482254|NCT03386474|473396009|FG001|Overall Study|Adverse Event|1|||
131482255|NCT02155881|473396010|FG000|Overall Study|Withdrawal by Subject|0|||
131482256|NCT02155881|473396011|FG001|Overall Study|Withdrawal by Subject|2|||
131482257|NCT02155881|473396010|FG000|Overall Study|Inappropriately randomized|2|||
131482258|NCT02155881|473396011|FG001|Overall Study|Inappropriately randomized|2|||
131482259|NCT00066729|473396017|FG000|Overall Study|Lost to Follow-up|1|||
131482260|NCT00066729|473396017|FG000|Overall Study|Disease progression|1|||
131482261|NCT02215096|473396020|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
131482262|NCT02215096|473396021|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
131482263|NCT02215096|473396022|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
131482264|NCT02215096|473396023|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
131482265|NCT02215096|473396024|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
131482266|NCT02215096|473396020|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
131482267|NCT02215096|473396021|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
131482268|NCT02215096|473396022|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
131482269|NCT02215096|473396023|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
131482270|NCT02215096|473396024|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
131482271|NCT02215096|473396020|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
131482272|NCT02215096|473396021|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
131482273|NCT02215096|473396022|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
131482274|NCT02215096|473396023|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
131482275|NCT02215096|473396024|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
131482276|NCT02215096|473396020|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
131482277|NCT02215096|473396021|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
131482278|NCT02215096|473396022|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
131482279|NCT02215096|473396023|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
131482280|NCT02215096|473396024|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
131482281|NCT03896165|473396025|FG000|Overall Study|Withdrawal by Subject|2|||
131482282|NCT02840721|473396026|FG000|Treatment Period|Adverse Event|1|||
131482283|NCT02840721|473396026|FG000|Follow-Up|Lack of Efficacy|1|||
131482284|NCT02840721|473396026|FG000|Follow-Up|Withdrawal by Subject|4|||
131482285|NCT02840721|473396026|FG000|Follow-Up|Withdrawal of Consent|2|||
131482286|NCT03685123|473396027|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
131482287|NCT03685123|473396028|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
131482288|NCT03685123|473396029|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
131482289|NCT03685123|473396027|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
131482290|NCT03685123|473396028|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
131482291|NCT03685123|473396029|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
131482292|NCT03685123|473396027|FG000|Weight Loss Phase|Lost to Follow-up|1|||
131482293|NCT03685123|473396028|FG001|Weight Loss Phase|Lost to Follow-up|0|||
131482294|NCT03685123|473396029|FG002|Weight Loss Phase|Lost to Follow-up|0|||
131482295|NCT03685123|473396027|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
131482296|NCT03685123|473396028|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
131482297|NCT03685123|473396029|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
131482298|NCT03685123|473396027|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
131482299|NCT03685123|473396028|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
131482300|NCT03685123|473396029|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
131482301|NCT03685123|473396027|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
131482302|NCT03685123|473396028|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
131482303|NCT03685123|473396029|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
131482304|NCT01402011|473396032|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
131482305|NCT01402011|473396033|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
131482306|NCT01402011|473396034|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
131482307|NCT01402011|473396032|FG000|Active Treatment Period|Withdrawal by Subject|1|||
131482308|NCT01402011|473396033|FG001|Active Treatment Period|Withdrawal by Subject|3|||
131482309|NCT01402011|473396034|FG002|Active Treatment Period|Withdrawal by Subject|0|||
131482310|NCT01402011|473396032|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
131482311|NCT01402011|473396033|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
131482312|NCT01402011|473396034|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
131482313|NCT00717093|473398039|FG000|Overall Study|Adverse Event|19|||
131482314|NCT00717093|473398040|FG001|Overall Study|Adverse Event|9|||
131482315|NCT00717093|473398039|FG000|Overall Study|Lack of Efficacy|3|||
131482316|NCT00717093|473398040|FG001|Overall Study|Lack of Efficacy|13|||
131482317|NCT00717093|473398039|FG000|Overall Study|Lost to Follow-up|9|||
131482318|NCT00717093|473398040|FG001|Overall Study|Lost to Follow-up|6|||
131482319|NCT00717093|473398039|FG000|Overall Study|Withdrawal by Subject|12|||
131482320|NCT00717093|473398040|FG001|Overall Study|Withdrawal by Subject|19|||
131482321|NCT00717093|473398039|FG000|Overall Study|Other|0|||
131482322|NCT00717093|473398040|FG001|Overall Study|Other|1|||
131482323|NCT00717093|473398039|FG000|Overall Study|Randomized but not treated|1|||
131482324|NCT00717093|473398040|FG001|Overall Study|Randomized but not treated|0|||
131482325|NCT00531934|473398041|FG000|Overall Study|Adverse Event|4|||
131482326|NCT00531934|473398042|FG001|Overall Study|Adverse Event|8|||
131482327|NCT00531934|473398041|FG000|Overall Study|Progression|52|||
131482328|NCT00531934|473398042|FG001|Overall Study|Progression|42|||
131482329|NCT00531934|473398041|FG000|Overall Study|Death|7|||
131482330|NCT00531934|473398042|FG001|Overall Study|Death|10|||
131482331|NCT00531934|473398041|FG000|Overall Study|Withdrawal by Subject|1|||
131482332|NCT00531934|473398042|FG001|Overall Study|Withdrawal by Subject|1|||
131482333|NCT00531934|473398041|FG000|Overall Study|Other|2|||
131482334|NCT00531934|473398042|FG001|Overall Study|Other|2|||
131482335|NCT01543698|473398047|FG000|Phase 1b|Disease progression|2|||
131482336|NCT01543698|473398048|FG001|Phase 1b|Disease progression|4|||
131482337|NCT01543698|473398049|FG002|Phase 1b|Disease progression|3|||
131482338|NCT01543698|473398050|FG003|Phase 1b|Disease progression|2|||
131482339|NCT01543698|473398051|FG004|Phase 1b|Disease progression|10|||
131482340|NCT01543698|473398052|FG005|Phase 1b|Disease progression|6|||
131482341|NCT01543698|473398053|FG006|Phase 1b|Disease progression|5|||
131482342|NCT01543698|473398054|FG007|Phase 1b|Disease progression|3|||
131482343|NCT01543698|473398055|FG008|Phase 1b|Disease progression|4|||
131482344|NCT01543698|473398056|FG009|Phase 1b|Disease progression|5|||
131482345|NCT01543698|473398057|FG010|Phase 1b|Disease progression|1|||
131482346|NCT01543698|473398058|FG011|Phase 1b|Disease progression|0|||
131482347|NCT01543698|473398059|FG012|Phase 1b|Disease progression|0|||
131482348|NCT01543698|473398060|FG013|Phase 1b|Disease progression|0|||
131482349|NCT01543698|473398061|FG014|Phase 1b|Disease progression|0|||
131482350|NCT01543698|473398047|FG000|Phase 1b|Death|0|||
131482351|NCT01543698|473398048|FG001|Phase 1b|Death|0|||
131482352|NCT01543698|473398049|FG002|Phase 1b|Death|1|||
131482353|NCT01543698|473398050|FG003|Phase 1b|Death|1|||
131482354|NCT01543698|473398051|FG004|Phase 1b|Death|0|||
131482355|NCT01543698|473398052|FG005|Phase 1b|Death|0|||
131482356|NCT01543698|473398053|FG006|Phase 1b|Death|0|||
131482357|NCT01543698|473398054|FG007|Phase 1b|Death|0|||
131482358|NCT01543698|473398055|FG008|Phase 1b|Death|0|||
131482359|NCT01543698|473398056|FG009|Phase 1b|Death|0|||
131482360|NCT01543698|473398057|FG010|Phase 1b|Death|1|||
131482361|NCT01543698|473398058|FG011|Phase 1b|Death|0|||
131482362|NCT01543698|473398059|FG012|Phase 1b|Death|0|||
131482363|NCT01543698|473398060|FG013|Phase 1b|Death|0|||
131482364|NCT01543698|473398061|FG014|Phase 1b|Death|0|||
131482365|NCT01543698|473398047|FG000|Phase 1b|Withdrawal by Subject|0|||
131482366|NCT01543698|473398048|FG001|Phase 1b|Withdrawal by Subject|1|||
131482367|NCT01543698|473398049|FG002|Phase 1b|Withdrawal by Subject|0|||
131482368|NCT01543698|473398050|FG003|Phase 1b|Withdrawal by Subject|1|||
131482369|NCT01543698|473398051|FG004|Phase 1b|Withdrawal by Subject|0|||
131482370|NCT01543698|473398052|FG005|Phase 1b|Withdrawal by Subject|0|||
131482371|NCT01543698|473398053|FG006|Phase 1b|Withdrawal by Subject|1|||
131482372|NCT01543698|473398054|FG007|Phase 1b|Withdrawal by Subject|0|||
131482373|NCT01543698|473398055|FG008|Phase 1b|Withdrawal by Subject|0|||
131482374|NCT01543698|473398056|FG009|Phase 1b|Withdrawal by Subject|0|||
131482375|NCT01543698|473398057|FG010|Phase 1b|Withdrawal by Subject|0|||
131482376|NCT01543698|473398058|FG011|Phase 1b|Withdrawal by Subject|0|||
131482377|NCT01543698|473398059|FG012|Phase 1b|Withdrawal by Subject|0|||
131482378|NCT01543698|473398060|FG013|Phase 1b|Withdrawal by Subject|0|||
131482379|NCT01543698|473398061|FG014|Phase 1b|Withdrawal by Subject|0|||
131482380|NCT01543698|473398047|FG000|Phase 1b|Adverse Event|1|||
131482381|NCT01543698|473398048|FG001|Phase 1b|Adverse Event|0|||
131482382|NCT01543698|473398049|FG002|Phase 1b|Adverse Event|0|||
131482383|NCT01543698|473398050|FG003|Phase 1b|Adverse Event|1|||
131482384|NCT01543698|473398051|FG004|Phase 1b|Adverse Event|2|||
131482385|NCT01543698|473398052|FG005|Phase 1b|Adverse Event|2|||
131482386|NCT01543698|473398053|FG006|Phase 1b|Adverse Event|0|||
131482387|NCT01543698|473398054|FG007|Phase 1b|Adverse Event|0|||
131482388|NCT01543698|473398055|FG008|Phase 1b|Adverse Event|1|||
131482389|NCT01543698|473398056|FG009|Phase 1b|Adverse Event|1|||
131482390|NCT01543698|473398057|FG010|Phase 1b|Adverse Event|2|||
131482391|NCT01543698|473398058|FG011|Phase 1b|Adverse Event|0|||
131482392|NCT01543698|473398059|FG012|Phase 1b|Adverse Event|0|||
131482393|NCT01543698|473398060|FG013|Phase 1b|Adverse Event|0|||
131482394|NCT01543698|473398061|FG014|Phase 1b|Adverse Event|0|||
131482395|NCT01543698|473398047|FG000|Phase 1b|Administrative problems|1|||
131482396|NCT01543698|473398048|FG001|Phase 1b|Administrative problems|0|||
131482397|NCT01543698|473398049|FG002|Phase 1b|Administrative problems|0|||
131482398|NCT01543698|473398050|FG003|Phase 1b|Administrative problems|0|||
131482399|NCT01543698|473398051|FG004|Phase 1b|Administrative problems|1|||
131482400|NCT01543698|473398052|FG005|Phase 1b|Administrative problems|0|||
131482401|NCT01543698|473398053|FG006|Phase 1b|Administrative problems|0|||
131482402|NCT01543698|473398054|FG007|Phase 1b|Administrative problems|1|||
131482403|NCT01543698|473398055|FG008|Phase 1b|Administrative problems|0|||
131482404|NCT01543698|473398056|FG009|Phase 1b|Administrative problems|0|||
131482405|NCT01543698|473398057|FG010|Phase 1b|Administrative problems|2|||
131482406|NCT01543698|473398058|FG011|Phase 1b|Administrative problems|0|||
131482407|NCT01543698|473398059|FG012|Phase 1b|Administrative problems|0|||
131482408|NCT01543698|473398060|FG013|Phase 1b|Administrative problems|0|||
131482409|NCT01543698|473398061|FG014|Phase 1b|Administrative problems|0|||
131482410|NCT01543698|473398047|FG000|Phase 1b|Protocol Violation|2|||
131482411|NCT01543698|473398048|FG001|Phase 1b|Protocol Violation|0|||
131482412|NCT01543698|473398049|FG002|Phase 1b|Protocol Violation|0|||
131482413|NCT01543698|473398050|FG003|Phase 1b|Protocol Violation|0|||
131482414|NCT01543698|473398051|FG004|Phase 1b|Protocol Violation|0|||
131482415|NCT01543698|473398052|FG005|Phase 1b|Protocol Violation|0|||
131482416|NCT01543698|473398053|FG006|Phase 1b|Protocol Violation|0|||
131482417|NCT01543698|473398054|FG007|Phase 1b|Protocol Violation|0|||
131482418|NCT01543698|473398055|FG008|Phase 1b|Protocol Violation|0|||
131482419|NCT01543698|473398056|FG009|Phase 1b|Protocol Violation|0|||
131482420|NCT01543698|473398057|FG010|Phase 1b|Protocol Violation|0|||
131482421|NCT01543698|473398058|FG011|Phase 1b|Protocol Violation|0|||
131482422|NCT01543698|473398059|FG012|Phase 1b|Protocol Violation|0|||
131482423|NCT01543698|473398060|FG013|Phase 1b|Protocol Violation|0|||
131482424|NCT01543698|473398061|FG014|Phase 1b|Protocol Violation|0|||
131482425|NCT01543698|473398047|FG000|Phase 2|Protocol Violation|0|||
131482426|NCT01543698|473398048|FG001|Phase 2|Protocol Violation|0|||
131482427|NCT01543698|473398049|FG002|Phase 2|Protocol Violation|0|||
131482428|NCT01543698|473398050|FG003|Phase 2|Protocol Violation|0|||
131482429|NCT01543698|473398051|FG004|Phase 2|Protocol Violation|0|||
131482430|NCT01543698|473398052|FG005|Phase 2|Protocol Violation|0|||
131482431|NCT01543698|473398053|FG006|Phase 2|Protocol Violation|0|||
131482432|NCT01543698|473398054|FG007|Phase 2|Protocol Violation|0|||
131482433|NCT01543698|473398055|FG008|Phase 2|Protocol Violation|0|||
131482434|NCT01543698|473398056|FG009|Phase 2|Protocol Violation|0|||
131482435|NCT01543698|473398057|FG010|Phase 2|Protocol Violation|0|||
131482436|NCT01543698|473398058|FG011|Phase 2|Protocol Violation|0|||
131482437|NCT01543698|473398059|FG012|Phase 2|Protocol Violation|1|||
131482438|NCT01543698|473398060|FG013|Phase 2|Protocol Violation|0|||
131482439|NCT01543698|473398061|FG014|Phase 2|Protocol Violation|0|||
131482440|NCT01543698|473398047|FG000|Phase 2|Disease progression|0|||
131482441|NCT01543698|473398048|FG001|Phase 2|Disease progression|0|||
131482442|NCT01543698|473398049|FG002|Phase 2|Disease progression|0|||
131482443|NCT01543698|473398050|FG003|Phase 2|Disease progression|0|||
131482444|NCT01543698|473398051|FG004|Phase 2|Disease progression|0|||
131482445|NCT01543698|473398052|FG005|Phase 2|Disease progression|0|||
131482446|NCT01543698|473398053|FG006|Phase 2|Disease progression|0|||
131482447|NCT01543698|473398054|FG007|Phase 2|Disease progression|0|||
131482448|NCT01543698|473398055|FG008|Phase 2|Disease progression|0|||
131482449|NCT01543698|473398056|FG009|Phase 2|Disease progression|0|||
131482450|NCT01543698|473398057|FG010|Phase 2|Disease progression|0|||
131482451|NCT01543698|473398058|FG011|Phase 2|Disease progression|10|||
131482452|NCT01543698|473398059|FG012|Phase 2|Disease progression|21|||
131482453|NCT01543698|473398060|FG013|Phase 2|Disease progression|30|||
131482454|NCT01543698|473398061|FG014|Phase 2|Disease progression|25|||
131482455|NCT01543698|473398047|FG000|Phase 2|Death|0|||
131482456|NCT01543698|473398048|FG001|Phase 2|Death|0|||
131482457|NCT01543698|473398049|FG002|Phase 2|Death|0|||
131482458|NCT01543698|473398050|FG003|Phase 2|Death|0|||
131482459|NCT01543698|473398051|FG004|Phase 2|Death|0|||
131482460|NCT01543698|473398052|FG005|Phase 2|Death|0|||
131482461|NCT01543698|473398053|FG006|Phase 2|Death|0|||
131482462|NCT01543698|473398054|FG007|Phase 2|Death|0|||
131482463|NCT01543698|473398055|FG008|Phase 2|Death|0|||
131482464|NCT01543698|473398056|FG009|Phase 2|Death|0|||
131482465|NCT01543698|473398057|FG010|Phase 2|Death|0|||
131482466|NCT01543698|473398058|FG011|Phase 2|Death|0|||
131482467|NCT01543698|473398059|FG012|Phase 2|Death|1|||
131482468|NCT01543698|473398060|FG013|Phase 2|Death|1|||
131482469|NCT01543698|473398061|FG014|Phase 2|Death|1|||
131482470|NCT01543698|473398047|FG000|Phase 2|Administrative problems|0|||
131482471|NCT01543698|473398048|FG001|Phase 2|Administrative problems|0|||
131482472|NCT01543698|473398049|FG002|Phase 2|Administrative problems|0|||
131482473|NCT01543698|473398050|FG003|Phase 2|Administrative problems|0|||
131482474|NCT01543698|473398051|FG004|Phase 2|Administrative problems|0|||
131482475|NCT01543698|473398052|FG005|Phase 2|Administrative problems|0|||
131482476|NCT01543698|473398053|FG006|Phase 2|Administrative problems|0|||
131482477|NCT01543698|473398054|FG007|Phase 2|Administrative problems|0|||
131482478|NCT01543698|473398055|FG008|Phase 2|Administrative problems|0|||
131482479|NCT01543698|473398056|FG009|Phase 2|Administrative problems|0|||
131482480|NCT01543698|473398057|FG010|Phase 2|Administrative problems|0|||
131482481|NCT01543698|473398058|FG011|Phase 2|Administrative problems|0|||
131482482|NCT01543698|473398059|FG012|Phase 2|Administrative problems|0|||
131482483|NCT01543698|473398060|FG013|Phase 2|Administrative problems|3|||
131482484|NCT01543698|473398061|FG014|Phase 2|Administrative problems|1|||
131482485|NCT01543698|473398047|FG000|Phase 2|Withdrawal by Subject|0|||
131482486|NCT01543698|473398048|FG001|Phase 2|Withdrawal by Subject|0|||
131482487|NCT01543698|473398049|FG002|Phase 2|Withdrawal by Subject|0|||
131482488|NCT01543698|473398050|FG003|Phase 2|Withdrawal by Subject|0|||
131482489|NCT01543698|473398051|FG004|Phase 2|Withdrawal by Subject|0|||
131482490|NCT01543698|473398052|FG005|Phase 2|Withdrawal by Subject|0|||
131482491|NCT01543698|473398053|FG006|Phase 2|Withdrawal by Subject|0|||
131482492|NCT01543698|473398054|FG007|Phase 2|Withdrawal by Subject|0|||
131482493|NCT01543698|473398055|FG008|Phase 2|Withdrawal by Subject|0|||
131482494|NCT01543698|473398056|FG009|Phase 2|Withdrawal by Subject|0|||
131482495|NCT01543698|473398057|FG010|Phase 2|Withdrawal by Subject|0|||
131482496|NCT01543698|473398058|FG011|Phase 2|Withdrawal by Subject|0|||
131482497|NCT01543698|473398059|FG012|Phase 2|Withdrawal by Subject|0|||
131482498|NCT01543698|473398060|FG013|Phase 2|Withdrawal by Subject|3|||
131482499|NCT01543698|473398061|FG014|Phase 2|Withdrawal by Subject|1|||
131482500|NCT01543698|473398047|FG000|Phase 2|Adverse Event|0|||
131482501|NCT01543698|473398048|FG001|Phase 2|Adverse Event|0|||
131482502|NCT01543698|473398049|FG002|Phase 2|Adverse Event|0|||
131482503|NCT01543698|473398050|FG003|Phase 2|Adverse Event|0|||
131482504|NCT01543698|473398051|FG004|Phase 2|Adverse Event|0|||
131482505|NCT01543698|473398052|FG005|Phase 2|Adverse Event|0|||
131482506|NCT01543698|473398053|FG006|Phase 2|Adverse Event|0|||
131482507|NCT01543698|473398054|FG007|Phase 2|Adverse Event|0|||
131482508|NCT01543698|473398055|FG008|Phase 2|Adverse Event|0|||
131482509|NCT01543698|473398056|FG009|Phase 2|Adverse Event|0|||
131482510|NCT01543698|473398057|FG010|Phase 2|Adverse Event|0|||
131482511|NCT01543698|473398058|FG011|Phase 2|Adverse Event|1|||
131482512|NCT01543698|473398059|FG012|Phase 2|Adverse Event|3|||
131482513|NCT01543698|473398060|FG013|Phase 2|Adverse Event|5|||
131482514|NCT01543698|473398061|FG014|Phase 2|Adverse Event|14|||
131482515|NCT00217620|473398062|FG000|Overall Study|Adverse Event|2|||
131482516|NCT00217620|473398062|FG000|Overall Study|Progression|31|||
131482517|NCT00217620|473398062|FG000|Overall Study|Not Protocol Specified|4|||
131482518|NCT00217620|473398062|FG000|Overall Study|Ineligible|13|||
131482519|NCT00217620|473398062|FG000|Overall Study|Never received treatment|1|||
131482520|NCT00150709|473398063|FG000|Overall Study|Protocol Violation|7|||
131482521|NCT00150709|473398064|FG001|Overall Study|Protocol Violation|8|||
131482522|NCT00150709|473398065|FG002|Overall Study|Protocol Violation|3|||
131482523|NCT00150709|473398066|FG003|Overall Study|Protocol Violation|1|||
131482524|NCT00150709|473398063|FG000|Overall Study|Adverse Event|8|||
131482525|NCT00150709|473398064|FG001|Overall Study|Adverse Event|2|||
131482526|NCT00150709|473398065|FG002|Overall Study|Adverse Event|2|||
131482527|NCT00150709|473398066|FG003|Overall Study|Adverse Event|3|||
131482528|NCT00150709|473398063|FG000|Overall Study|Lack of Efficacy|6|||
131482529|NCT00150709|473398064|FG001|Overall Study|Lack of Efficacy|11|||
131482530|NCT00150709|473398065|FG002|Overall Study|Lack of Efficacy|9|||
131482531|NCT00150709|473398066|FG003|Overall Study|Lack of Efficacy|0|||
131482532|NCT00150709|473398063|FG000|Overall Study|Withdrawal by Subject|7|||
131482533|NCT00150709|473398064|FG001|Overall Study|Withdrawal by Subject|10|||
131482534|NCT00150709|473398065|FG002|Overall Study|Withdrawal by Subject|5|||
131482535|NCT00150709|473398066|FG003|Overall Study|Withdrawal by Subject|0|||
131482536|NCT00150709|473398063|FG000|Overall Study|Lost to Follow-up|3|||
131482537|NCT00150709|473398064|FG001|Overall Study|Lost to Follow-up|2|||
131482538|NCT00150709|473398065|FG002|Overall Study|Lost to Follow-up|0|||
131482539|NCT00150709|473398066|FG003|Overall Study|Lost to Follow-up|0|||
131482540|NCT00150709|473398063|FG000|Overall Study|Sponsor decision|0|||
131482541|NCT00150709|473398064|FG001|Overall Study|Sponsor decision|0|||
131482542|NCT00150709|473398065|FG002|Overall Study|Sponsor decision|0|||
131482543|NCT00150709|473398066|FG003|Overall Study|Sponsor decision|1|||
131482544|NCT00150709|473398063|FG000|Overall Study|Site/Investigator discontinued the study|5|||
131482545|NCT00150709|473398064|FG001|Overall Study|Site/Investigator discontinued the study|5|||
131482546|NCT00150709|473398065|FG002|Overall Study|Site/Investigator discontinued the study|2|||
131482547|NCT00150709|473398066|FG003|Overall Study|Site/Investigator discontinued the study|0|||
131482548|NCT00150709|473398063|FG000|Overall Study|Decision of parent(s)|1|||
131482549|NCT00150709|473398064|FG001|Overall Study|Decision of parent(s)|2|||
131482550|NCT00150709|473398065|FG002|Overall Study|Decision of parent(s)|0|||
131482551|NCT00150709|473398066|FG003|Overall Study|Decision of parent(s)|0|||
131482552|NCT00150709|473398063|FG000|Overall Study|Decision of parent(s) and investigator|3|||
131482553|NCT00150709|473398064|FG001|Overall Study|Decision of parent(s) and investigator|0|||
131482554|NCT00150709|473398065|FG002|Overall Study|Decision of parent(s) and investigator|0|||
131482555|NCT00150709|473398066|FG003|Overall Study|Decision of parent(s) and investigator|0|||
131482556|NCT00150709|473398063|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
131482557|NCT00150709|473398064|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
131482558|NCT00150709|473398065|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
131482559|NCT00150709|473398066|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
131482560|NCT00150709|473398063|FG000|Overall Study|Investigator decision|1|||
131482561|NCT00150709|473398064|FG001|Overall Study|Investigator decision|0|||
131482562|NCT00150709|473398065|FG002|Overall Study|Investigator decision|0|||
131482563|NCT00150709|473398066|FG003|Overall Study|Investigator decision|1|||
131482564|NCT00150709|473398063|FG000|Overall Study|Subject relocated|2|||
131482565|NCT00150709|473398064|FG001|Overall Study|Subject relocated|2|||
131482566|NCT00150709|473398065|FG002|Overall Study|Subject relocated|1|||
131482567|NCT00150709|473398066|FG003|Overall Study|Subject relocated|0|||
131482568|NCT00150709|473398063|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
131482569|NCT00150709|473398064|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
131482570|NCT00150709|473398065|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
131482571|NCT00150709|473398066|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
131482572|NCT00150709|473398063|FG000|Overall Study|Convenience|0|||
131482573|NCT00150709|473398064|FG001|Overall Study|Convenience|1|||
131482574|NCT00150709|473398065|FG002|Overall Study|Convenience|0|||
131482575|NCT00150709|473398066|FG003|Overall Study|Convenience|0|||
131482576|NCT00150709|473398063|FG000|Overall Study|Subject entered new drug study|0|||
131482577|NCT00150709|473398064|FG001|Overall Study|Subject entered new drug study|1|||
131482578|NCT00150709|473398065|FG002|Overall Study|Subject entered new drug study|0|||
131482579|NCT00150709|473398066|FG003|Overall Study|Subject entered new drug study|0|||
131482580|NCT00150709|473398063|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
131482581|NCT00150709|473398064|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
131482582|NCT00150709|473398065|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
131482583|NCT00150709|473398066|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
131482584|NCT00150709|473398063|FG000|Overall Study|Lack of ease of swallowing|0|||
131482585|NCT00150709|473398064|FG001|Overall Study|Lack of ease of swallowing|1|||
131482586|NCT00150709|473398065|FG002|Overall Study|Lack of ease of swallowing|0|||
131482587|NCT00150709|473398066|FG003|Overall Study|Lack of ease of swallowing|0|||
131482588|NCT01626456|473398082|FG000|Overall Study|Withdrawal by Subject|21|||
131482589|NCT01626456|473398083|FG001|Overall Study|Withdrawal by Subject|46|||
131482590|NCT01626456|473398082|FG000|Overall Study|Adverse Event|2|||
131482591|NCT01626456|473398083|FG001|Overall Study|Adverse Event|27|||
131482592|NCT01626456|473398082|FG000|Overall Study|Lost to Follow-up|2|||
131482593|NCT01626456|473398083|FG001|Overall Study|Lost to Follow-up|27|||
131482594|NCT01626456|473398082|FG000|Overall Study|Lack of Efficacy|6|||
131482595|NCT01626456|473398083|FG001|Overall Study|Lack of Efficacy|7|||
131482596|NCT01626456|473398082|FG000|Overall Study|Physician Decision|1|||
131482597|NCT01626456|473398083|FG001|Overall Study|Physician Decision|4|||
131482598|NCT01626456|473398082|FG000|Overall Study|Protocol Violation|1|||
131482599|NCT01626456|473398083|FG001|Overall Study|Protocol Violation|1|||
131482600|NCT01626456|473398082|FG000|Overall Study|Site Closure|2|||
131482601|NCT01626456|473398083|FG001|Overall Study|Site Closure|3|||
131482602|NCT01626456|473398082|FG000|Overall Study|Incarceration|0|||
131482603|NCT01626456|473398083|FG001|Overall Study|Incarceration|2|||
131482604|NCT00506662|473398084|FG000|Overall Study|Adverse Event|0|||
131482605|NCT00506662|473398085|FG001|Overall Study|Adverse Event|2|||
131482606|NCT00506662|473398084|FG000|Overall Study|Lack of Efficacy|1|||
131482607|NCT00506662|473398085|FG001|Overall Study|Lack of Efficacy|0|||
131482608|NCT00506662|473398084|FG000|Overall Study|Protocol Violation|2|||
131482609|NCT00506662|473398085|FG001|Overall Study|Protocol Violation|4|||
131482610|NCT00506662|473398084|FG000|Overall Study|Trial terminated|10|||
131482611|NCT00506662|473398085|FG001|Overall Study|Trial terminated|16|||
131482612|NCT00506662|473398084|FG000|Overall Study|Not recorded|4|||
131482613|NCT00506662|473398085|FG001|Overall Study|Not recorded|6|||
131482614|NCT04015336|473398086|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
131482615|NCT00246753|473398090|FG000|Overall Study|Withdrawal by Subject|2|||
131482616|NCT00246753|473398090|FG000|Overall Study|Physician Decision|2|||
131482617|NCT00246753|473398090|FG000|Overall Study|Adverse Event|2|||
131482618|NCT00246753|473398090|FG000|Overall Study|Unacceptable toxicity|2|||
131482619|NCT01816074|473398092|FG000|Phase 1|Time commitment issues|0|||
131482620|NCT01816074|473398093|FG001|Phase 1|Time commitment issues|0|||
131482621|NCT01816074|473398094|FG002|Phase 1|Time commitment issues|1|||
131482622|NCT01816074|473398095|FG003|Phase 1|Time commitment issues|0|||
131482623|NCT01816074|473398092|FG000|Phase 2|Time commitment Issues|0|||
131482624|NCT01816074|473398093|FG001|Phase 2|Time commitment Issues|2|||
131482625|NCT01816074|473398094|FG002|Phase 2|Time commitment Issues|0|||
131482626|NCT01816074|473398095|FG003|Phase 2|Time commitment Issues|0|||
131482627|NCT01816074|473398092|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
131482628|NCT01816074|473398093|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
131482629|NCT01816074|473398094|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
131482630|NCT01816074|473398095|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
131482631|NCT01816074|473398092|FG000|Phase 2|Physician Decision|0|||
131482632|NCT01816074|473398093|FG001|Phase 2|Physician Decision|0|||
131482633|NCT01816074|473398094|FG002|Phase 2|Physician Decision|0|||
131482634|NCT01816074|473398095|FG003|Phase 2|Physician Decision|1|||
131482635|NCT01816074|473398092|FG000|Phase 2|Withdrawal by Subject|1|||
131482636|NCT01816074|473398093|FG001|Phase 2|Withdrawal by Subject|0|||
131482637|NCT01816074|473398094|FG002|Phase 2|Withdrawal by Subject|0|||
131482638|NCT01816074|473398095|FG003|Phase 2|Withdrawal by Subject|0|||
131482639|NCT00617851|473398098|FG000|Overall Study|Death|0|||
131482640|NCT00617851|473398099|FG001|Overall Study|Death|0|||
131482641|NCT00617851|473398100|FG002|Overall Study|Death|0|||
131482642|NCT00617851|473398101|FG003|Overall Study|Death|1|||
131482643|NCT00617851|473398098|FG000|Overall Study|Withdrawal by Subject|14|||
131482644|NCT00617851|473398099|FG001|Overall Study|Withdrawal by Subject|7|||
131482645|NCT00617851|473398100|FG002|Overall Study|Withdrawal by Subject|12|||
131482646|NCT00617851|473398101|FG003|Overall Study|Withdrawal by Subject|4|||
131482647|NCT00617851|473398098|FG000|Overall Study|Lost to Follow-up|27|||
131482648|NCT00617851|473398099|FG001|Overall Study|Lost to Follow-up|29|||
131482649|NCT00617851|473398100|FG002|Overall Study|Lost to Follow-up|31|||
131482650|NCT00617851|473398101|FG003|Overall Study|Lost to Follow-up|19|||
131482651|NCT00617851|473398098|FG000|Overall Study|Inappropriate Enrollment|5|||
131482652|NCT00617851|473398099|FG001|Overall Study|Inappropriate Enrollment|4|||
131482653|NCT00617851|473398100|FG002|Overall Study|Inappropriate Enrollment|1|||
131482654|NCT00617851|473398101|FG003|Overall Study|Inappropriate Enrollment|1|||
131482655|NCT00617851|473398098|FG000|Overall Study|Unable to classify|1|||
131482656|NCT00617851|473398099|FG001|Overall Study|Unable to classify|0|||
131482657|NCT00617851|473398100|FG002|Overall Study|Unable to classify|1|||
131482658|NCT00617851|473398101|FG003|Overall Study|Unable to classify|0|||
131482659|NCT01200524|473398102|FG000|Overall Study|Withdrawal by Subject|1|||
131482660|NCT01200524|473398103|FG001|Overall Study|Withdrawal by Subject|1|||
131482661|NCT01200524|473398104|FG002|Overall Study|Withdrawal by Subject|3|||
131482662|NCT01200524|473398102|FG000|Overall Study|Adverse Event|1|||
131482663|NCT01200524|473398103|FG001|Overall Study|Adverse Event|0|||
131482664|NCT01200524|473398104|FG002|Overall Study|Adverse Event|0|||
131482665|NCT01200524|473398102|FG000|Overall Study|Non availability of study nurse|0|||
131482666|NCT01200524|473398103|FG001|Overall Study|Non availability of study nurse|0|||
131482667|NCT01200524|473398104|FG002|Overall Study|Non availability of study nurse|1|||
131482668|NCT01303861|473398105|FG000|Overall Study|Lost to Follow-up|34|||
131482669|NCT01303861|473398106|FG001|Overall Study|Lost to Follow-up|14|||
131482670|NCT01303861|473398107|FG002|Overall Study|Lost to Follow-up|27|||
131482671|NCT01303861|473398108|FG003|Overall Study|Lost to Follow-up|31|||
131482672|NCT01303861|473398105|FG000|Overall Study|Lack of Efficacy|3|||
131482673|NCT01303861|473398106|FG001|Overall Study|Lack of Efficacy|2|||
131482674|NCT01303861|473398107|FG002|Overall Study|Lack of Efficacy|1|||
131482675|NCT01303861|473398108|FG003|Overall Study|Lack of Efficacy|0|||
131482676|NCT01303861|473398105|FG000|Overall Study|Withdrawal by Subject|16|||
131482677|NCT01303861|473398106|FG001|Overall Study|Withdrawal by Subject|8|||
131482678|NCT01303861|473398107|FG002|Overall Study|Withdrawal by Subject|8|||
131482679|NCT01303861|473398108|FG003|Overall Study|Withdrawal by Subject|23|||
131482680|NCT01303861|473398105|FG000|Overall Study|Adverse Event|4|||
131482681|NCT01303861|473398106|FG001|Overall Study|Adverse Event|1|||
131482682|NCT01303861|473398107|FG002|Overall Study|Adverse Event|0|||
131482683|NCT01303861|473398108|FG003|Overall Study|Adverse Event|5|||
131482684|NCT01303861|473398105|FG000|Overall Study|Pregnancy|1|||
131482685|NCT01303861|473398106|FG001|Overall Study|Pregnancy|0|||
131482686|NCT01303861|473398107|FG002|Overall Study|Pregnancy|0|||
131482687|NCT01303861|473398108|FG003|Overall Study|Pregnancy|0|||
131482688|NCT01868503|473398109|FG000|Overall Study|Withdrawal by Subject|1|||
131482689|NCT01868503|473398109|FG000|Overall Study|Protocol Violation|1|||
131482690|NCT02476201|473398110|FG000|Overall Study|Unable to program MPP|9|||
131482691|NCT02476201|473398110|FG000|Overall Study|Study echo not performed|5|||
131482692|NCT02476201|473398110|FG000|Overall Study|Adverse Event|4|||
131482693|NCT02476201|473398110|FG000|Overall Study|Death|2|||
131482694|NCT02476201|473398110|FG000|Overall Study|Lost to Follow-up|2|||
131482695|NCT02476201|473398110|FG000|Overall Study|MPP programmed to OFF|2|||
131482696|NCT02476201|473398110|FG000|Overall Study|Withdrawal by Subject|1|||
131482697|NCT02476201|473398110|FG000|Overall Study|Unsuccessful implant|1|||
131482698|NCT03650556|473398111|FG000|Overall Study|Death|2|||
131482699|NCT03650556|473398111|FG000|Overall Study|Withdrawal by Subject|20|||
131482700|NCT03650556|473398111|FG000|Overall Study|Physician Decision|2|||
131482701|NCT03650556|473398111|FG000|Overall Study|Lost to Follow-up|8|||
131482702|NCT03650556|473398111|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
131482703|NCT03650556|473398111|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
131482704|NCT00691301|473398112|FG000|Overall Study|Adverse Event|10|||
131482705|NCT00691301|473398112|FG000|Overall Study|Death|2|||
131482706|NCT00691301|473398112|FG000|Overall Study|Lack of Efficacy|32|||
131482707|NCT00691301|473398112|FG000|Overall Study|Withdrawal by Subject|4|||
131482708|NCT00691301|473398112|FG000|Overall Study|Concurrent illness|2|||
131482709|NCT00691301|473398112|FG000|Overall Study|other reason|3|||
131482710|NCT00691301|473398112|FG000|Overall Study|Did not initiate study treatment|1|||
131482711|NCT01823146|473398113|FG000|Overall Study|Withdrawal by Subject|0|||
131482712|NCT01823146|473398114|FG001|Overall Study|Withdrawal by Subject|1|||
131482713|NCT01823146|473398113|FG000|Overall Study|Lost to Follow-up|2|||
131482714|NCT01823146|473398114|FG001|Overall Study|Lost to Follow-up|1|||
131482715|NCT00463580|473398115|FG000|Overall Study|Lost to Follow-up|1|||
131482716|NCT00463580|473398116|FG001|Overall Study|Lost to Follow-up|0|||
131482717|NCT00463580|473398115|FG000|Overall Study|Schedule conflict|2|||
131482718|NCT00463580|473398116|FG001|Overall Study|Schedule conflict|0|||
131482719|NCT00463580|473398115|FG000|Overall Study|Medical/psychiatric complications|0|||
131482720|NCT00463580|473398116|FG001|Overall Study|Medical/psychiatric complications|2|||
131482721|NCT03917459|473398118|FG000|Overall Study|Adverse Event|1|||
131482722|NCT03917459|473398119|FG001|Overall Study|Adverse Event|0|||
131482723|NCT03917459|473398118|FG000|Overall Study|Withdrawal by Subject|0|||
131482724|NCT03917459|473398119|FG001|Overall Study|Withdrawal by Subject|1|||
131482725|NCT00491764|473398120|FG000|Overall Study|Adverse Event|1|||
131482726|NCT00491764|473398121|FG001|Overall Study|Adverse Event|2|||
131482727|NCT00491764|473398122|FG002|Overall Study|Adverse Event|4|||
131482728|NCT00491764|473398123|FG003|Overall Study|Adverse Event|4|||
131482729|NCT00491764|473398124|FG004|Overall Study|Adverse Event|0|||
131482730|NCT00491764|473398125|FG005|Overall Study|Adverse Event|1|||
131482731|NCT00491764|473398120|FG000|Overall Study|Lost to Follow-up|0|||
131482732|NCT00491764|473398121|FG001|Overall Study|Lost to Follow-up|1|||
131482733|NCT00491764|473398122|FG002|Overall Study|Lost to Follow-up|0|||
131482734|NCT00491764|473398123|FG003|Overall Study|Lost to Follow-up|1|||
131482735|NCT00491764|473398124|FG004|Overall Study|Lost to Follow-up|0|||
131482736|NCT00491764|473398125|FG005|Overall Study|Lost to Follow-up|3|||
131482737|NCT00491764|473398120|FG000|Overall Study|Withdrawal by Subject|2|||
131482738|NCT00491764|473398121|FG001|Overall Study|Withdrawal by Subject|3|||
131482739|NCT00491764|473398122|FG002|Overall Study|Withdrawal by Subject|1|||
131482740|NCT00491764|473398123|FG003|Overall Study|Withdrawal by Subject|2|||
131482741|NCT00491764|473398124|FG004|Overall Study|Withdrawal by Subject|2|||
131482742|NCT00491764|473398125|FG005|Overall Study|Withdrawal by Subject|4|||
131482743|NCT00491764|473398120|FG000|Overall Study|Non Compliance with the Protocol|1|||
131482744|NCT00491764|473398121|FG001|Overall Study|Non Compliance with the Protocol|0|||
131482745|NCT00491764|473398122|FG002|Overall Study|Non Compliance with the Protocol|0|||
131482746|NCT00491764|473398123|FG003|Overall Study|Non Compliance with the Protocol|0|||
131482747|NCT00491764|473398124|FG004|Overall Study|Non Compliance with the Protocol|0|||
131482748|NCT00491764|473398125|FG005|Overall Study|Non Compliance with the Protocol|0|||
131482749|NCT00491764|473398120|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
131482750|NCT00491764|473398121|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
131482751|NCT00491764|473398122|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
131482752|NCT00491764|473398123|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
131482753|NCT00491764|473398124|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
131482754|NCT00491764|473398125|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
131482755|NCT00491764|473398120|FG000|Overall Study|Administrative|1|||
131482756|NCT00491764|473398121|FG001|Overall Study|Administrative|0|||
131482757|NCT00491764|473398122|FG002|Overall Study|Administrative|2|||
131482758|NCT00491764|473398123|FG003|Overall Study|Administrative|1|||
131482759|NCT00491764|473398124|FG004|Overall Study|Administrative|0|||
131482760|NCT00491764|473398125|FG005|Overall Study|Administrative|0|||
131482761|NCT00697788|473398130|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482762|NCT00697788|473398131|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
131482763|NCT00697788|473398132|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482764|NCT00697788|473398133|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482765|NCT00697788|473398134|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482766|NCT00697788|473398135|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482767|NCT00697788|473398136|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482768|NCT00697788|473398137|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
131482769|NCT00697788|473398130|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482770|NCT00697788|473398131|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482771|NCT00697788|473398132|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482772|NCT00697788|473398133|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482773|NCT00697788|473398134|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
131482774|NCT00697788|473398135|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482775|NCT00697788|473398136|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482776|NCT00697788|473398137|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
131482777|NCT03228433|473398139|FG000|Overall Study|Lost to Follow-up|1|||
131482778|NCT03228433|473398140|FG001|Overall Study|Lost to Follow-up|0|||
131482779|NCT03228433|473398141|FG002|Overall Study|Lost to Follow-up|0|||
131482780|NCT03228433|473398142|FG003|Overall Study|Lost to Follow-up|0|||
131482781|NCT03228433|473398143|FG004|Overall Study|Lost to Follow-up|0|||
131482782|NCT03228433|473398144|FG005|Overall Study|Lost to Follow-up|0|||
131482783|NCT03228433|473398139|FG000|Overall Study|Positive alcohol test|0|||
131482784|NCT03228433|473398140|FG001|Overall Study|Positive alcohol test|0|||
131482785|NCT03228433|473398141|FG002|Overall Study|Positive alcohol test|0|||
131482786|NCT03228433|473398142|FG003|Overall Study|Positive alcohol test|1|||
131482787|NCT03228433|473398143|FG004|Overall Study|Positive alcohol test|0|||
131482788|NCT03228433|473398144|FG005|Overall Study|Positive alcohol test|0|||
131482789|NCT01030536|473398149|FG000|Overall Study|Withdrawal by Subject|0|||
131482790|NCT01030536|473398150|FG001|Overall Study|Withdrawal by Subject|0|||
131482791|NCT01030536|473398151|FG002|Overall Study|Withdrawal by Subject|1|||
131482792|NCT01030536|473398152|FG003|Overall Study|Withdrawal by Subject|0|||
131482793|NCT01030536|473398153|FG004|Overall Study|Withdrawal by Subject|0|||
131482794|NCT01030536|473398149|FG000|Overall Study|undefined|1|||
131482795|NCT01030536|473398150|FG001|Overall Study|undefined|0|||
131482796|NCT01030536|473398151|FG002|Overall Study|undefined|1|||
131482797|NCT01030536|473398152|FG003|Overall Study|undefined|1|||
131482798|NCT01030536|473398153|FG004|Overall Study|undefined|0|||
131482799|NCT01030536|473398149|FG000|Overall Study|Adverse Event|0|||
131482800|NCT01030536|473398150|FG001|Overall Study|Adverse Event|3|||
131482801|NCT01030536|473398151|FG002|Overall Study|Adverse Event|1|||
131482802|NCT01030536|473398152|FG003|Overall Study|Adverse Event|0|||
131482803|NCT01030536|473398153|FG004|Overall Study|Adverse Event|1|||
131482804|NCT01030536|473398149|FG000|Overall Study|Progressive disease|6|||
131482805|NCT01030536|473398150|FG001|Overall Study|Progressive disease|2|||
131482806|NCT01030536|473398151|FG002|Overall Study|Progressive disease|3|||
131482807|NCT01030536|473398152|FG003|Overall Study|Progressive disease|2|||
131482808|NCT01030536|473398153|FG004|Overall Study|Progressive disease|0|||
131482809|NCT01030536|473398149|FG000|Overall Study|Death|0|||
131482810|NCT01030536|473398150|FG001|Overall Study|Death|1|||
131482811|NCT01030536|473398151|FG002|Overall Study|Death|0|||
131482812|NCT01030536|473398152|FG003|Overall Study|Death|0|||
131482813|NCT01030536|473398153|FG004|Overall Study|Death|0|||
131482814|NCT03840174|473398158|FG000|Overall Study|Withdrawal by Subject|1|||
131482815|NCT03840174|473398159|FG001|Overall Study|Withdrawal by Subject|0|||
131482816|NCT03840174|473398160|FG002|Overall Study|Withdrawal by Subject|0|||
131482817|NCT03840174|473398161|FG003|Overall Study|Withdrawal by Subject|0|||
131482818|NCT02248701|473398163|FG000|Overall Study|Withdrawal by Subject|2|||
131482819|NCT02248701|473398164|FG001|Overall Study|Withdrawal by Subject|1|||
131482820|NCT02248701|473398163|FG000|Overall Study|Physician Decision|0|||
131482821|NCT02248701|473398164|FG001|Overall Study|Physician Decision|1|||
131482822|NCT02248701|473398163|FG000|Overall Study|Adverse Event|1|||
131482823|NCT02248701|473398164|FG001|Overall Study|Adverse Event|0|||
131482824|NCT02248701|473398163|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
131482825|NCT02248701|473398164|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
131482826|NCT00845858|473398165|FG000|Overall Study|Withdrawal by Subject|5|||
131482827|NCT00845858|473398166|FG001|Overall Study|Withdrawal by Subject|1|||
131482828|NCT00845858|473398167|FG002|Overall Study|Withdrawal by Subject|1|||
131482829|NCT00845858|473398165|FG000|Overall Study|Adverse Event|3|||
131482830|NCT00845858|473398166|FG001|Overall Study|Adverse Event|8|||
131482831|NCT00845858|473398167|FG002|Overall Study|Adverse Event|4|||
131482832|NCT00845858|473398165|FG000|Overall Study|Protocol Violation|0|||
131482833|NCT00845858|473398166|FG001|Overall Study|Protocol Violation|0|||
131482834|NCT00845858|473398167|FG002|Overall Study|Protocol Violation|1|||
131482835|NCT00845858|473398165|FG000|Overall Study|not eligible|0|||
131482836|NCT00845858|473398166|FG001|Overall Study|not eligible|3|||
131482837|NCT00845858|473398167|FG002|Overall Study|not eligible|2|||
131482838|NCT00880542|473398168|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
131482839|NCT00880542|473398168|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
131482840|NCT00880542|473398168|FG000|REP: Surgical Resection|progressive disease|1|||
131482841|NCT04289623|473398169|FG000|Wave 1 Emails|Email was not delivered|268|||
131482842|NCT04289623|473398170|FG001|Wave 1 Emails|Email was not delivered|257|||
131482843|NCT04289623|473398171|FG002|Wave 1 Emails|Email was not delivered|0|||
131482844|NCT04289623|473398172|FG003|Wave 1 Emails|Email was not delivered|0|||
131482845|NCT04289623|473398173|FG004|Wave 1 Emails|Email was not delivered|0|||
131482846|NCT04289623|473398174|FG005|Wave 1 Emails|Email was not delivered|0|||
131482847|NCT03666624|473398177|FG000|Overall Study|participant grieving over recent death of parent|1|||
131482848|NCT03666624|473398178|FG001|Overall Study|participant grieving over recent death of parent|0|||
131482849|NCT03021304|473398183|FG000|Overall Study|Lack of Efficacy|1|||
131482850|NCT00569270|473398185|FG000|Period: First Intervention|Protocol Violation|0|||
131482851|NCT00569270|473398186|FG001|Period: First Intervention|Protocol Violation|1|||
131482852|NCT00492531|473398187|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
131482853|NCT00492531|473398188|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
131482854|NCT00423514|473398190|FG000|Overall Study|Ineligible|1|||
131482855|NCT00423514|473398191|FG001|Overall Study|Ineligible|0|||
131482856|NCT02628938|473398192|FG000|Overall Study|Did not attend the follow up recall|2|||
131482857|NCT02628938|473398193|FG001|Overall Study|Did not attend the follow up recall|2|||
131482858|NCT02628938|473398194|FG002|Overall Study|Did not attend the follow up recall|1|||
131482859|NCT02628938|473398192|FG000|Overall Study|Failure to comply with the instructions|3|||
131482860|NCT02628938|473398193|FG001|Overall Study|Failure to comply with the instructions|0|||
131482861|NCT02628938|473398194|FG002|Overall Study|Failure to comply with the instructions|3|||
131482862|NCT03113916|473398197|FG000|Overall Study|Withdrawal by Subject|9|||
131482863|NCT03113916|473398198|FG001|Overall Study|Withdrawal by Subject|7|||
131482864|NCT03113916|473398197|FG000|Overall Study|Pregnancy|1|||
131482865|NCT03113916|473398198|FG001|Overall Study|Pregnancy|3|||
131482866|NCT03113916|473398197|FG000|Overall Study|Lost to Follow-up|1|||
131482867|NCT03113916|473398198|FG001|Overall Study|Lost to Follow-up|2|||
131482868|NCT00843856|473398199|FG000|Overall Study|Lost to Follow-up|1|||
131482869|NCT00843856|473398200|FG001|Overall Study|Lost to Follow-up|2|||
131482870|NCT04729621|473398201|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
131482871|NCT04729621|473398202|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
131482872|NCT04729621|473398203|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
131482873|NCT04729621|473398204|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
131482874|NCT04729621|473398205|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
131482875|NCT04729621|473398201|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
131482876|NCT04729621|473398202|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
131482877|NCT04729621|473398203|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
131482878|NCT04729621|473398204|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
131482879|NCT04729621|473398205|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
131482880|NCT04729621|473398201|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
131482881|NCT04729621|473398202|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
131482882|NCT04729621|473398203|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
131482883|NCT04729621|473398204|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
131482884|NCT04729621|473398205|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
131482885|NCT04729621|473398201|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131482886|NCT04729621|473398202|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131482887|NCT04729621|473398203|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
131482888|NCT04729621|473398204|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
131482889|NCT04729621|473398205|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
131482890|NCT04729621|473398201|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
131482891|NCT04729621|473398202|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
131482892|NCT04729621|473398203|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
131482893|NCT04729621|473398204|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
131482894|NCT04729621|473398205|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
131482895|NCT04729621|473398201|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
131482896|NCT04729621|473398202|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
131482897|NCT04729621|473398203|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
131482898|NCT04729621|473398204|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
131482899|NCT04729621|473398205|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
131482900|NCT03439657|473398206|FG000|Overall Study|Adverse Event|2|||
131482901|NCT03439657|473398207|FG001|Overall Study|Adverse Event|3|||
131482902|NCT03439657|473398206|FG000|Overall Study|Lost to Follow-up|1|||
131482903|NCT03439657|473398207|FG001|Overall Study|Lost to Follow-up|0|||
131482904|NCT03439657|473398206|FG000|Overall Study|Protocol Violation|1|||
131482905|NCT03439657|473398207|FG001|Overall Study|Protocol Violation|1|||
131482906|NCT03439657|473398206|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
131482907|NCT03439657|473398207|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
131482908|NCT00370071|473398209|FG000|Overall Study|Withdrawal by Subject|2|||
131482909|NCT00761631|473398210|FG000|Overall Study|Parent/legal guardian request|8|||
131482910|NCT00761631|473398211|FG001|Overall Study|Parent/legal guardian request|3|||
131482911|NCT00761631|473398212|FG002|Overall Study|Parent/legal guardian request|8|||
131482912|NCT00761631|473398213|FG003|Overall Study|Parent/legal guardian request|0|||
131482913|NCT00761631|473398214|FG004|Overall Study|Parent/legal guardian request|5|||
131482914|NCT00761631|473398215|FG005|Overall Study|Parent/legal guardian request|0|||
131482915|NCT00761631|473398210|FG000|Overall Study|Lost to Follow-up|2|||
131482916|NCT00761631|473398211|FG001|Overall Study|Lost to Follow-up|4|||
131482917|NCT00761631|473398212|FG002|Overall Study|Lost to Follow-up|7|||
131482918|NCT00761631|473398213|FG003|Overall Study|Lost to Follow-up|1|||
131482919|NCT00761631|473398214|FG004|Overall Study|Lost to Follow-up|6|||
131482920|NCT00761631|473398215|FG005|Overall Study|Lost to Follow-up|1|||
131482921|NCT00761631|473398210|FG000|Overall Study|Protocol Violation|2|||
131482922|NCT00761631|473398211|FG001|Overall Study|Protocol Violation|0|||
131482923|NCT00761631|473398212|FG002|Overall Study|Protocol Violation|0|||
131482924|NCT00761631|473398213|FG003|Overall Study|Protocol Violation|1|||
131482925|NCT00761631|473398214|FG004|Overall Study|Protocol Violation|5|||
131482926|NCT00761631|473398215|FG005|Overall Study|Protocol Violation|1|||
131482927|NCT00761631|473398210|FG000|Overall Study|Randomized, not treated|1|||
131482928|NCT00761631|473398211|FG001|Overall Study|Randomized, not treated|0|||
131482929|NCT00761631|473398212|FG002|Overall Study|Randomized, not treated|0|||
131482930|NCT00761631|473398213|FG003|Overall Study|Randomized, not treated|0|||
131482931|NCT00761631|473398214|FG004|Overall Study|Randomized, not treated|0|||
131482932|NCT00761631|473398215|FG005|Overall Study|Randomized, not treated|0|||
131482933|NCT00761631|473398210|FG000|Overall Study|Failed to return|1|||
131482934|NCT00761631|473398211|FG001|Overall Study|Failed to return|0|||
131482935|NCT00761631|473398212|FG002|Overall Study|Failed to return|1|||
131482936|NCT00761631|473398213|FG003|Overall Study|Failed to return|1|||
131482937|NCT00761631|473398214|FG004|Overall Study|Failed to return|5|||
131482938|NCT00761631|473398215|FG005|Overall Study|Failed to return|2|||
131482939|NCT00761631|473398210|FG000|Overall Study|Physician Decision|1|||
131482940|NCT00761631|473398211|FG001|Overall Study|Physician Decision|0|||
131482941|NCT00761631|473398212|FG002|Overall Study|Physician Decision|0|||
131482942|NCT00761631|473398213|FG003|Overall Study|Physician Decision|0|||
131482943|NCT00761631|473398214|FG004|Overall Study|Physician Decision|0|||
131482944|NCT00761631|473398215|FG005|Overall Study|Physician Decision|0|||
131482945|NCT00761631|473398210|FG000|Overall Study|Other|0|||
131482946|NCT00761631|473398211|FG001|Overall Study|Other|0|||
131482947|NCT00761631|473398212|FG002|Overall Study|Other|0|||
131482948|NCT00761631|473398213|FG003|Overall Study|Other|0|||
131482949|NCT00761631|473398214|FG004|Overall Study|Other|1|||
131482950|NCT00761631|473398215|FG005|Overall Study|Other|1|||
131482951|NCT01999868|473398216|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
131482952|NCT01999868|473398217|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
131482953|NCT01999868|473398218|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
131482954|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
131482955|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
131482956|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
131482957|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
131482958|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
131482959|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
131482960|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
131482961|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
131482962|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
131482963|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
131482964|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
131482965|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
131482966|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
131482967|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
131482968|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
131482969|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
131482970|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
131482971|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
131482972|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
131482973|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
131482974|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
131482975|NCT01999868|473398216|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
131482976|NCT01999868|473398217|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
131482977|NCT01999868|473398218|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
131482978|NCT01999868|473398216|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
131482979|NCT01999868|473398217|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
131482980|NCT01999868|473398218|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
131482981|NCT01999868|473398216|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
131482982|NCT01999868|473398217|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
131482983|NCT01999868|473398218|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
131482984|NCT01999868|473398216|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
131482985|NCT01999868|473398217|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
131482986|NCT01999868|473398218|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
131482987|NCT01999868|473398216|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
131482988|NCT01999868|473398217|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
131482989|NCT01999868|473398218|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
131482990|NCT01999868|473398216|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
131482991|NCT01999868|473398217|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
131482992|NCT01999868|473398218|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
131482993|NCT01999868|473398216|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
131482994|NCT01999868|473398217|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
131482995|NCT01999868|473398218|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
131482996|NCT03487549|473398223|FG000|Overall Study|Protocol Violation|0|||
131482997|NCT03487549|473398224|FG001|Overall Study|Protocol Violation|1|||
131482998|NCT03487549|473398223|FG000|Overall Study|Lost to Follow-up|2|||
131482999|NCT03487549|473398224|FG001|Overall Study|Lost to Follow-up|1|||
131483000|NCT03487549|473398223|FG000|Overall Study|Withdrawal by Subject|2|||
131483001|NCT03487549|473398224|FG001|Overall Study|Withdrawal by Subject|0|||
131483002|NCT01392443|473399754|FG000|Overall Study|Disease progression|30|||
131483003|NCT01392443|473399754|FG000|Overall Study|Adverse Event|24|||
131483004|NCT01392443|473399754|FG000|Overall Study|Death|7|||
131483005|NCT01392443|473399754|FG000|Overall Study|Withdrawal by Subject|5|||
131483006|NCT01392443|473399754|FG000|Overall Study|Lost to Follow-up|1|||
131483007|NCT01392443|473399754|FG000|Overall Study|Protocol Violation|1|||
131483008|NCT00533897|473399756|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
131483009|NCT00533897|473399757|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
131483010|NCT00533897|473399758|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
131483011|NCT00533897|473399759|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
131483012|NCT00533897|473399760|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
131483013|NCT00533897|473399761|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
131483014|NCT00533897|473399762|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
131483015|NCT00533897|473399763|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
131483016|NCT00533897|473399756|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
131483017|NCT00533897|473399757|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483018|NCT00533897|473399758|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483019|NCT00533897|473399759|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483020|NCT00533897|473399760|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483021|NCT00533897|473399761|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483022|NCT00533897|473399762|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483023|NCT00533897|473399763|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
131483024|NCT00533897|473399756|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
131483025|NCT00533897|473399757|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483026|NCT00533897|473399758|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483027|NCT00533897|473399759|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483028|NCT00533897|473399760|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483029|NCT00533897|473399761|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483030|NCT00533897|473399762|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483031|NCT00533897|473399763|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
131483032|NCT00533897|473399756|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
131483033|NCT00533897|473399757|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483034|NCT00533897|473399758|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483035|NCT00533897|473399759|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483036|NCT00533897|473399760|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483037|NCT00533897|473399761|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483038|NCT00533897|473399762|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483039|NCT00533897|473399763|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
131483040|NCT00533897|473399756|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
131483041|NCT00533897|473399757|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483042|NCT00533897|473399758|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483043|NCT00533897|473399759|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483044|NCT00533897|473399760|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483045|NCT00533897|473399761|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483046|NCT00533897|473399762|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483047|NCT00533897|473399763|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
131483048|NCT00533897|473399756|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
131483049|NCT00533897|473399757|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483050|NCT00533897|473399758|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483051|NCT00533897|473399759|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483052|NCT00533897|473399760|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483053|NCT00533897|473399761|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483054|NCT00533897|473399762|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483055|NCT00533897|473399763|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
131483056|NCT00533897|473399756|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
131483057|NCT00533897|473399757|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
131483058|NCT00533897|473399758|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
131483059|NCT00533897|473399759|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
131483060|NCT00533897|473399760|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
131483061|NCT00533897|473399761|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
131483062|NCT00533897|473399762|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
131483063|NCT00533897|473399763|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
131483064|NCT00533897|473399756|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483065|NCT00533897|473399757|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483066|NCT00533897|473399758|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
131483067|NCT00533897|473399759|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483068|NCT00533897|473399760|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483069|NCT00533897|473399761|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483070|NCT00533897|473399762|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483071|NCT00533897|473399763|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
131483072|NCT00533897|473399756|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483073|NCT00533897|473399757|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483074|NCT00533897|473399758|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483075|NCT00533897|473399759|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483076|NCT00533897|473399760|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483077|NCT00533897|473399761|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
131483078|NCT00533897|473399762|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483079|NCT00533897|473399763|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
131483080|NCT00533897|473399756|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483081|NCT00533897|473399757|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483082|NCT00533897|473399758|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483083|NCT00533897|473399759|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483084|NCT00533897|473399760|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483085|NCT00533897|473399761|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
131483086|NCT00533897|473399762|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483087|NCT00533897|473399763|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131483088|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
131483089|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
131483090|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
131483091|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
131483092|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
131483093|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
131483094|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
131483095|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
131483096|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Death|0|||
131483097|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Death|0|||
131483098|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Death|0|||
131483099|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Death|0|||
131483100|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Death|0|||
131483101|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Death|0|||
131483102|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Death|1|||
131483103|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Death|3|||
131483104|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
131483105|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
131483106|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
131483107|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
131483108|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
131483109|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
131483110|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
131483111|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
131483112|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483113|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483114|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483115|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483116|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483117|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483118|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
131483119|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
131483120|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Adverse Event|0|||
131483121|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Adverse Event|0|||
131483122|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Adverse Event|0|||
131483123|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Adverse Event|0|||
131483124|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Adverse Event|0|||
131483125|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Adverse Event|0|||
131483126|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Adverse Event|2|||
131483127|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Adverse Event|5|||
131483128|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Pregnancy|0|||
131483129|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Pregnancy|0|||
131483130|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Pregnancy|0|||
131483131|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Pregnancy|0|||
131483132|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Pregnancy|0|||
131483133|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Pregnancy|0|||
131483134|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Pregnancy|0|||
131483135|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Pregnancy|2|||
131483136|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
131483137|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
131483138|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
131483139|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
131483140|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
131483141|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
131483142|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
131483143|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
131483144|NCT00533897|473399756|FG000|Long Term Extension (LTE)|Other|0|||
131483145|NCT00533897|473399757|FG001|Long Term Extension (LTE)|Other|0|||
131483146|NCT00533897|473399758|FG002|Long Term Extension (LTE)|Other|0|||
131483147|NCT00533897|473399759|FG003|Long Term Extension (LTE)|Other|0|||
131483148|NCT00533897|473399760|FG004|Long Term Extension (LTE)|Other|0|||
131483149|NCT00533897|473399761|FG005|Long Term Extension (LTE)|Other|0|||
131483150|NCT00533897|473399762|FG006|Long Term Extension (LTE)|Other|1|||
131483151|NCT00533897|473399763|FG007|Long Term Extension (LTE)|Other|6|||
131483152|NCT02110238|473399764|FG000|12 Week Pivotal Phase|Adverse Event|3|||
131483153|NCT02110238|473399765|FG001|12 Week Pivotal Phase|Adverse Event|0|||
131483154|NCT02110238|473399764|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
131483155|NCT02110238|473399765|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
131483156|NCT02110238|473399764|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
131483157|NCT02110238|473399765|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
131483158|NCT02110238|473399764|FG000|12 Week Pivotal Phase|Physician Decision|0|||
131483159|NCT02110238|473399765|FG001|12 Week Pivotal Phase|Physician Decision|2|||
131483160|NCT02110238|473399764|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
131483161|NCT02110238|473399765|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
131483162|NCT02110238|473399764|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
131483163|NCT02110238|473399765|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
131483164|NCT02110238|473399764|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
131483165|NCT02110238|473399765|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
131483166|NCT02110238|473399764|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
131483167|NCT02110238|473399765|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
131483168|NCT02110238|473399764|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
131483169|NCT02110238|473399765|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
131483170|NCT02110238|473399764|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
131483171|NCT02110238|473399765|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
131483172|NCT02110238|473399764|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
131483173|NCT02110238|473399765|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
131483174|NCT00142935|473399768|FG000|Overall Study|Other reason|1|||
131483175|NCT00142935|473399769|FG001|Overall Study|Other reason|1|||
131483176|NCT00142935|473399770|FG002|Overall Study|Other reason|1|||
131483177|NCT00142935|473399768|FG000|Overall Study|Lost to Follow-up|2|||
131483178|NCT00142935|473399769|FG001|Overall Study|Lost to Follow-up|5|||
131483179|NCT00142935|473399770|FG002|Overall Study|Lost to Follow-up|5|||
131483180|NCT00142935|473399768|FG000|Overall Study|Death|0|||
131483181|NCT00142935|473399769|FG001|Overall Study|Death|2|||
131483182|NCT00142935|473399770|FG002|Overall Study|Death|1|||
131483183|NCT01330030|473399773|FG000|Overall Study|Lost to Follow-up|16|||
131483184|NCT01330030|473399774|FG001|Overall Study|Lost to Follow-up|17|||
131483185|NCT01419626|473399775|FG000|Overall Study|Protocol Violation|3|||
131483186|NCT01419626|473399776|FG001|Overall Study|Protocol Violation|2|||
131483187|NCT01419626|473399777|FG002|Overall Study|Protocol Violation|2|||
131483188|NCT01419626|473399775|FG000|Overall Study|Withdrawal by Subject|1|||
131483189|NCT01419626|473399776|FG001|Overall Study|Withdrawal by Subject|0|||
131483190|NCT01419626|473399777|FG002|Overall Study|Withdrawal by Subject|0|||
131483191|NCT01419626|473399775|FG000|Overall Study|Lost to Follow-up|0|||
131483192|NCT01419626|473399776|FG001|Overall Study|Lost to Follow-up|1|||
131483193|NCT01419626|473399777|FG002|Overall Study|Lost to Follow-up|1|||
131483194|NCT01365052|473399778|FG000|Overall Study|Adverse Event|4|||
131483195|NCT01365052|473399779|FG001|Overall Study|Adverse Event|4|||
131483196|NCT01146912|473399780|FG000|Overall Study|Already received influenza vaccination|817|||
131483197|NCT01146912|473399781|FG001|Overall Study|Already received influenza vaccination|822|||
131483198|NCT01146912|473399782|FG002|Overall Study|Already received influenza vaccination|13|||
131483199|NCT01146912|473399783|FG003|Overall Study|Already received influenza vaccination|15|||
131483200|NCT01146912|473399784|FG004|Overall Study|Already received influenza vaccination|41|||
131483201|NCT01146912|473399785|FG005|Overall Study|Already received influenza vaccination|61|||
131483202|NCT01146912|473399786|FG006|Overall Study|Already received influenza vaccination|56|||
131483203|NCT01146912|473399787|FG007|Overall Study|Already received influenza vaccination|0|||
131483204|NCT01146912|473399780|FG000|Overall Study|< 14 weeks gestational age|0|||
131483205|NCT01146912|473399781|FG001|Overall Study|< 14 weeks gestational age|0|||
131483206|NCT01146912|473399782|FG002|Overall Study|< 14 weeks gestational age|3|||
131483207|NCT01146912|473399783|FG003|Overall Study|< 14 weeks gestational age|2|||
131483208|NCT01146912|473399784|FG004|Overall Study|< 14 weeks gestational age|0|||
131483209|NCT01146912|473399785|FG005|Overall Study|< 14 weeks gestational age|0|||
131483210|NCT01146912|473399786|FG006|Overall Study|< 14 weeks gestational age|0|||
131483211|NCT01146912|473399787|FG007|Overall Study|< 14 weeks gestational age|0|||
131483212|NCT01146912|473399780|FG000|Overall Study|Duplicate patient|0|||
131483213|NCT01146912|473399781|FG001|Overall Study|Duplicate patient|0|||
131483214|NCT01146912|473399782|FG002|Overall Study|Duplicate patient|1|||
131483215|NCT01146912|473399783|FG003|Overall Study|Duplicate patient|0|||
131483216|NCT01146912|473399784|FG004|Overall Study|Duplicate patient|0|||
131483217|NCT01146912|473399785|FG005|Overall Study|Duplicate patient|0|||
131483218|NCT01146912|473399786|FG006|Overall Study|Duplicate patient|0|||
131483219|NCT01146912|473399787|FG007|Overall Study|Duplicate patient|0|||
131483220|NCT01145625|473399790|FG000|Overall Study|Lost to Follow-up|8|||
131483221|NCT01145625|473399791|FG001|Overall Study|Lost to Follow-up|9|||
131483222|NCT01145625|473399790|FG000|Overall Study|Adverse Event|6|||
131483223|NCT01145625|473399791|FG001|Overall Study|Adverse Event|4|||
131483224|NCT01145625|473399790|FG000|Overall Study|Protocol Violation|3|||
131483225|NCT01145625|473399791|FG001|Overall Study|Protocol Violation|1|||
131483226|NCT01145625|473399790|FG000|Overall Study|Withdrawal by Subject|7|||
131483227|NCT01145625|473399791|FG001|Overall Study|Withdrawal by Subject|16|||
131483228|NCT01145625|473399790|FG000|Overall Study|Pregnancy|0|||
131483229|NCT01145625|473399791|FG001|Overall Study|Pregnancy|1|||
131483230|NCT02980783|473399792|FG000|Overall Study|Lost to Follow-up|1|||
131483231|NCT02202980|473399795|FG000|Overall Study|Lack of Efficacy|1|||
131483232|NCT02202980|473399796|FG001|Overall Study|Lack of Efficacy|0|||
131483233|NCT02202980|473399797|FG002|Overall Study|Lack of Efficacy|7|||
131483234|NCT02202980|473399798|FG003|Overall Study|Lack of Efficacy|0|||
131483235|NCT02202980|473399799|FG004|Overall Study|Lack of Efficacy|3|||
131483236|NCT02202980|473399800|FG005|Overall Study|Lack of Efficacy|1|||
131483237|NCT02202980|473399801|FG006|Overall Study|Lack of Efficacy|11|||
131483238|NCT02202980|473399802|FG007|Overall Study|Lack of Efficacy|2|||
131483239|NCT02202980|473399803|FG008|Overall Study|Lack of Efficacy|2|||
131483240|NCT02202980|473399804|FG009|Overall Study|Lack of Efficacy|0|||
131483241|NCT02202980|473399805|FG010|Overall Study|Lack of Efficacy|0|||
131483242|NCT02202980|473399806|FG011|Overall Study|Lack of Efficacy|3|||
131483243|NCT02202980|473399807|FG012|Overall Study|Lack of Efficacy|10|||
131483244|NCT02202980|473399808|FG013|Overall Study|Lack of Efficacy|0|||
131483245|NCT02202980|473399795|FG000|Overall Study|Protocol Violation|0|||
131483246|NCT02202980|473399796|FG001|Overall Study|Protocol Violation|0|||
131483247|NCT02202980|473399797|FG002|Overall Study|Protocol Violation|0|||
131483248|NCT02202980|473399798|FG003|Overall Study|Protocol Violation|3|||
131483249|NCT02202980|473399799|FG004|Overall Study|Protocol Violation|3|||
131483250|NCT02202980|473399800|FG005|Overall Study|Protocol Violation|0|||
131483251|NCT02202980|473399801|FG006|Overall Study|Protocol Violation|0|||
131483252|NCT02202980|473399802|FG007|Overall Study|Protocol Violation|0|||
131483253|NCT02202980|473399803|FG008|Overall Study|Protocol Violation|0|||
131483254|NCT02202980|473399804|FG009|Overall Study|Protocol Violation|0|||
131483255|NCT02202980|473399805|FG010|Overall Study|Protocol Violation|0|||
131483256|NCT02202980|473399806|FG011|Overall Study|Protocol Violation|0|||
131483257|NCT02202980|473399807|FG012|Overall Study|Protocol Violation|0|||
131483258|NCT02202980|473399808|FG013|Overall Study|Protocol Violation|0|||
131483259|NCT02202980|473399795|FG000|Overall Study|Lost to Follow-up|0|||
131483260|NCT02202980|473399796|FG001|Overall Study|Lost to Follow-up|1|||
131483261|NCT02202980|473399797|FG002|Overall Study|Lost to Follow-up|1|||
131483262|NCT02202980|473399798|FG003|Overall Study|Lost to Follow-up|1|||
131483263|NCT02202980|473399799|FG004|Overall Study|Lost to Follow-up|0|||
131483264|NCT02202980|473399800|FG005|Overall Study|Lost to Follow-up|0|||
131483265|NCT02202980|473399801|FG006|Overall Study|Lost to Follow-up|0|||
131483266|NCT02202980|473399802|FG007|Overall Study|Lost to Follow-up|1|||
131483267|NCT02202980|473399803|FG008|Overall Study|Lost to Follow-up|1|||
131483268|NCT02202980|473399804|FG009|Overall Study|Lost to Follow-up|0|||
131483269|NCT02202980|473399805|FG010|Overall Study|Lost to Follow-up|0|||
131483270|NCT02202980|473399806|FG011|Overall Study|Lost to Follow-up|0|||
131483271|NCT02202980|473399807|FG012|Overall Study|Lost to Follow-up|1|||
131483272|NCT02202980|473399808|FG013|Overall Study|Lost to Follow-up|0|||
131483273|NCT02202980|473399795|FG000|Overall Study|Withdrew Consent|0|||
131483274|NCT02202980|473399796|FG001|Overall Study|Withdrew Consent|1|||
131483275|NCT02202980|473399797|FG002|Overall Study|Withdrew Consent|2|||
131483276|NCT02202980|473399798|FG003|Overall Study|Withdrew Consent|0|||
131483277|NCT02202980|473399799|FG004|Overall Study|Withdrew Consent|0|||
131483278|NCT02202980|473399800|FG005|Overall Study|Withdrew Consent|0|||
131483279|NCT02202980|473399801|FG006|Overall Study|Withdrew Consent|0|||
131483280|NCT02202980|473399802|FG007|Overall Study|Withdrew Consent|0|||
131483281|NCT02202980|473399803|FG008|Overall Study|Withdrew Consent|1|||
131483282|NCT02202980|473399804|FG009|Overall Study|Withdrew Consent|0|||
131483283|NCT02202980|473399805|FG010|Overall Study|Withdrew Consent|0|||
131483284|NCT02202980|473399806|FG011|Overall Study|Withdrew Consent|0|||
131483285|NCT02202980|473399807|FG012|Overall Study|Withdrew Consent|0|||
131483286|NCT02202980|473399808|FG013|Overall Study|Withdrew Consent|0|||
131483287|NCT02130570|473399810|FG000|Overall Study|Death|3|||
131483288|NCT02130570|473399811|FG001|Overall Study|Death|5|||
131483289|NCT02130570|473399810|FG000|Overall Study|Withdrawal by Subject|6|||
131483290|NCT02130570|473399811|FG001|Overall Study|Withdrawal by Subject|3|||
131483291|NCT02130570|473399810|FG000|Overall Study|Part of practice that discontinued study|0|||
131483292|NCT02130570|473399811|FG001|Overall Study|Part of practice that discontinued study|5|||
131483293|NCT01696695|473399814|FG000|Overall Study|Disease progression|373|||
131483294|NCT01696695|473399814|FG000|Overall Study|Death|29|||
131483295|NCT01696695|473399814|FG000|Overall Study|Adverse Event|74|||
131483296|NCT01696695|473399814|FG000|Overall Study|Withdrawal by Subject|92|||
131483297|NCT01696695|473399814|FG000|Overall Study|Lost to Follow-up|48|||
131483298|NCT01696695|473399814|FG000|Overall Study|Other|74|||
131483299|NCT01696695|473399814|FG000|Overall Study|Major Protocol Violation|192|||
131483300|NCT01781975|473399830|FG000|Overall Study|Death|1|||
131483301|NCT01781975|473399831|FG001|Overall Study|Death|0|||
131483302|NCT01781975|473399830|FG000|Overall Study|Withdrawal by Subject|1|||
131483303|NCT01781975|473399831|FG001|Overall Study|Withdrawal by Subject|1|||
131483304|NCT02404220|473399832|FG000|Overall Study|Adverse Event|0|||
131483305|NCT02404220|473399833|FG001|Overall Study|Adverse Event|0|||
131483306|NCT02404220|473399834|FG002|Overall Study|Adverse Event|1|||
131483307|NCT02404220|473399835|FG003|Overall Study|Adverse Event|0|||
131483308|NCT02404220|473399832|FG000|Overall Study|Death|5|||
131483309|NCT02404220|473399833|FG001|Overall Study|Death|5|||
131483310|NCT02404220|473399834|FG002|Overall Study|Death|3|||
131483311|NCT02404220|473399835|FG003|Overall Study|Death|8|||
131483312|NCT02404220|473399832|FG000|Overall Study|Progressive Disease|0|||
131483313|NCT02404220|473399833|FG001|Overall Study|Progressive Disease|0|||
131483314|NCT02404220|473399834|FG002|Overall Study|Progressive Disease|1|||
131483315|NCT02404220|473399835|FG003|Overall Study|Progressive Disease|1|||
131483316|NCT02404220|473399832|FG000|Overall Study|Study Terminated by Sponsor|0|||
131483317|NCT02404220|473399833|FG001|Overall Study|Study Terminated by Sponsor|0|||
131483318|NCT02404220|473399834|FG002|Overall Study|Study Terminated by Sponsor|2|||
131483319|NCT02404220|473399835|FG003|Overall Study|Study Terminated by Sponsor|1|||
131483320|NCT02404220|473399832|FG000|Overall Study|Withdrawal by Subject|0|||
131483321|NCT02404220|473399833|FG001|Overall Study|Withdrawal by Subject|1|||
131483322|NCT02404220|473399834|FG002|Overall Study|Withdrawal by Subject|0|||
131483323|NCT02404220|473399835|FG003|Overall Study|Withdrawal by Subject|0|||
131483324|NCT02404220|473399832|FG000|Overall Study|Enrolled but Never Treated|0|||
131483325|NCT02404220|473399833|FG001|Overall Study|Enrolled but Never Treated|2|||
131483326|NCT02404220|473399834|FG002|Overall Study|Enrolled but Never Treated|0|||
131483327|NCT02404220|473399835|FG003|Overall Study|Enrolled but Never Treated|0|||
131483328|NCT02905149|473399836|FG000|Overall Study|Lost to Follow-up|2|||
131483329|NCT02905149|473399837|FG001|Overall Study|Lost to Follow-up|0|||
131483330|NCT01180647|473399846|FG000|Overall Study|Lost to Follow-up|5|||
131483331|NCT01180647|473399847|FG001|Overall Study|Lost to Follow-up|6|||
131483332|NCT00386607|473399848|FG000|Core|Adverse Event|40|||
131483333|NCT00386607|473399849|FG001|Core|Adverse Event|0|||
131483334|NCT00386607|473399848|FG000|Core|Abnormal laboratory value(s)|3|||
131483335|NCT00386607|473399849|FG001|Core|Abnormal laboratory value(s)|0|||
131483336|NCT00386607|473399848|FG000|Core|Unsatisfactory therapeutic effect|23|||
131483337|NCT00386607|473399849|FG001|Core|Unsatisfactory therapeutic effect|0|||
131483338|NCT00386607|473399848|FG000|Core|Condition no longer requires study drug|4|||
131483339|NCT00386607|473399849|FG001|Core|Condition no longer requires study drug|0|||
131483340|NCT00386607|473399848|FG000|Core|Patient withdrew consent|15|||
131483341|NCT00386607|473399849|FG001|Core|Patient withdrew consent|0|||
131483342|NCT00386607|473399848|FG000|Core|Lost to Follow-up|23|||
131483343|NCT00386607|473399849|FG001|Core|Lost to Follow-up|0|||
131483344|NCT00386607|473399848|FG000|Core|Administrative problems|1|||
131483345|NCT00386607|473399849|FG001|Core|Administrative problems|0|||
131483346|NCT00386607|473399848|FG000|Core|Protocol Deviation|6|||
131483347|NCT00386607|473399849|FG001|Core|Protocol Deviation|0|||
131483348|NCT00386607|473399848|FG000|Extension|Adverse Event|0|||
131483349|NCT00386607|473399849|FG001|Extension|Adverse Event|6|||
131483350|NCT00386607|473399848|FG000|Extension|Abnormal laboratory value(s)|0|||
131483351|NCT00386607|473399849|FG001|Extension|Abnormal laboratory value(s)|1|||
131483352|NCT00386607|473399848|FG000|Extension|Administrative problems|0|||
131483353|NCT00386607|473399849|FG001|Extension|Administrative problems|1|||
131483354|NCT00386607|473399848|FG000|Extension|Lost to Follow-up|0|||
131483355|NCT00386607|473399849|FG001|Extension|Lost to Follow-up|3|||
131483356|NCT00386607|473399848|FG000|Extension|Patient withdrew consent|0|||
131483357|NCT00386607|473399849|FG001|Extension|Patient withdrew consent|5|||
131483358|NCT00386607|473399848|FG000|Extension|Unsatisfactory therapeutic effect|0|||
131483359|NCT00386607|473399849|FG001|Extension|Unsatisfactory therapeutic effect|1|||
131483360|NCT01927627|473399851|FG000|Overall Study|Adverse Event|3|||
131483361|NCT01927627|473399851|FG000|Overall Study|Lack of Efficacy|1|||
131483362|NCT01927627|473399851|FG000|Overall Study|Financial Concerns|1|||
131483363|NCT00467857|473399852|FG000|Overall Study|Adverse Event|1|||
131483364|NCT00467857|473399853|FG001|Overall Study|Adverse Event|0|||
131483365|NCT00467857|473399852|FG000|Overall Study|Withdrew consent|2|||
131483366|NCT00467857|473399853|FG001|Overall Study|Withdrew consent|0|||
131483367|NCT00467857|473399852|FG000|Overall Study|Death|0|||
131483368|NCT00467857|473399853|FG001|Overall Study|Death|1|||
131483369|NCT00467857|473399852|FG000|Overall Study|Discharged from court service|0|||
131483370|NCT00467857|473399853|FG001|Overall Study|Discharged from court service|1|||
131483371|NCT00467857|473399852|FG000|Overall Study|Emergency care required|0|||
131483372|NCT00467857|473399853|FG001|Overall Study|Emergency care required|1|||
131483373|NCT00467857|473399852|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
131483374|NCT00467857|473399853|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
131483375|NCT00467857|473399852|FG000|Overall Study|Discontinuation reason missing|0|||
131483376|NCT00467857|473399853|FG001|Overall Study|Discontinuation reason missing|3|||
131483377|NCT03208127|473399856|FG000|Overall Study|Death|1|||
131483378|NCT00579098|473399861|FG000|Overall Study|Lost to Follow-up|2|||
131483379|NCT00579098|473399862|FG001|Overall Study|Lost to Follow-up|0|||
131483380|NCT00579098|473399861|FG000|Overall Study|Adverse Event|2|||
131483381|NCT00579098|473399862|FG001|Overall Study|Adverse Event|3|||
131483382|NCT00579098|473399861|FG000|Overall Study|Withdrawal by Subject|2|||
131483383|NCT00579098|473399862|FG001|Overall Study|Withdrawal by Subject|3|||
131483384|NCT00579098|473399861|FG000|Overall Study|AF returned after ablation|3|||
131483385|NCT00579098|473399862|FG001|Overall Study|AF returned after ablation|2|||
131483386|NCT02121522|473399863|FG000|Overall Study|Adverse Event|1|||
131483387|NCT00338104|473399866|FG000|Overall Study|Protocol Violation|2|||
131483388|NCT00338104|473399867|FG001|Overall Study|Protocol Violation|1|||
131483389|NCT00338104|473399868|FG002|Overall Study|Protocol Violation|3|||
131483390|NCT00633750|473399869|FG000|Overall Study|Adverse Event|2|||
131483391|NCT00633750|473399869|FG000|Overall Study|Withdrawal by Subject|3|||
131483392|NCT03822182|473399871|FG000|Overall Study|Protocol Violation|0|||
131483393|NCT03822182|473399872|FG001|Overall Study|Protocol Violation|1|||
131483394|NCT03822182|473399873|FG002|Overall Study|Protocol Violation|1|||
131483395|NCT00810355|473399874|FG000|Overall Study|Lost to Follow-up|13|||
131483396|NCT00810355|473399875|FG001|Overall Study|Lost to Follow-up|17|||
131483397|NCT00810355|473399876|FG002|Overall Study|Lost to Follow-up|11|||
131483398|NCT00810355|473399874|FG000|Overall Study|Withdrawal by Subject|1|||
131483399|NCT00810355|473399875|FG001|Overall Study|Withdrawal by Subject|0|||
131483400|NCT00810355|473399876|FG002|Overall Study|Withdrawal by Subject|0|||
131483401|NCT00400764|473399877|FG000|Phase Ib|Adverse Event|1|||
131483402|NCT00400764|473399878|FG001|Phase Ib|Adverse Event|0|||
131483403|NCT00400764|473399879|FG002|Phase Ib|Adverse Event|0|||
131483404|NCT00400764|473399880|FG003|Phase Ib|Adverse Event|0|||
131483405|NCT00400764|473399881|FG004|Phase Ib|Adverse Event|0|||
131483406|NCT00400764|473399877|FG000|Phase Ib|Death|1|||
131483407|NCT00400764|473399878|FG001|Phase Ib|Death|0|||
131483408|NCT00400764|473399879|FG002|Phase Ib|Death|0|||
131483409|NCT00400764|473399880|FG003|Phase Ib|Death|0|||
131483410|NCT00400764|473399881|FG004|Phase Ib|Death|0|||
131483411|NCT00400764|473399877|FG000|Phase Ib|Disease Progression|4|||
131483412|NCT00400764|473399878|FG001|Phase Ib|Disease Progression|4|||
131483413|NCT00400764|473399879|FG002|Phase Ib|Disease Progression|0|||
131483414|NCT00400764|473399880|FG003|Phase Ib|Disease Progression|0|||
131483415|NCT00400764|473399881|FG004|Phase Ib|Disease Progression|0|||
131483416|NCT00400764|473399877|FG000|Phase II|Death|0|||
131483417|NCT00400764|473399878|FG001|Phase II|Death|0|||
131483418|NCT00400764|473399879|FG002|Phase II|Death|1|||
131483419|NCT00400764|473399880|FG003|Phase II|Death|2|||
131483420|NCT00400764|473399881|FG004|Phase II|Death|0|||
131483421|NCT00400764|473399877|FG000|Phase II|Lost to Follow-up|0|||
131483422|NCT00400764|473399878|FG001|Phase II|Lost to Follow-up|0|||
131483423|NCT00400764|473399879|FG002|Phase II|Lost to Follow-up|1|||
131483424|NCT00400764|473399880|FG003|Phase II|Lost to Follow-up|0|||
131483425|NCT00400764|473399881|FG004|Phase II|Lost to Follow-up|0|||
131483426|NCT00400764|473399877|FG000|Phase II|Physician Decision|0|||
131483427|NCT00400764|473399878|FG001|Phase II|Physician Decision|0|||
131483428|NCT00400764|473399879|FG002|Phase II|Physician Decision|1|||
131483429|NCT00400764|473399880|FG003|Phase II|Physician Decision|1|||
131483430|NCT00400764|473399881|FG004|Phase II|Physician Decision|0|||
131483431|NCT00400764|473399877|FG000|Phase II|Sponsor's decision to terminate|0|||
131483432|NCT00400764|473399878|FG001|Phase II|Sponsor's decision to terminate|0|||
131483433|NCT00400764|473399879|FG002|Phase II|Sponsor's decision to terminate|18|||
131483434|NCT00400764|473399880|FG003|Phase II|Sponsor's decision to terminate|22|||
131483435|NCT00400764|473399881|FG004|Phase II|Sponsor's decision to terminate|11|||
131483436|NCT00400764|473399877|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
131483437|NCT00400764|473399878|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
131483438|NCT00400764|473399879|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
131483439|NCT00400764|473399880|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
131483440|NCT00400764|473399881|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
131483441|NCT00400764|473399877|FG000|Phase II|Withdrawal by Subject|0|||
131483442|NCT00400764|473399878|FG001|Phase II|Withdrawal by Subject|0|||
131483443|NCT00400764|473399879|FG002|Phase II|Withdrawal by Subject|1|||
131483444|NCT00400764|473399880|FG003|Phase II|Withdrawal by Subject|1|||
131483445|NCT00400764|473399881|FG004|Phase II|Withdrawal by Subject|0|||
131483446|NCT01893203|473399883|FG000|Overall Study|Withdrawal by Subject|1|||
131483447|NCT00621959|473399884|FG000|Overall Study|Adverse Event|4|||
131483448|NCT00621959|473399885|FG001|Overall Study|Adverse Event|2|||
131483449|NCT00621959|473399884|FG000|Overall Study|Lack of Efficacy|1|||
131483450|NCT00621959|473399885|FG001|Overall Study|Lack of Efficacy|1|||
131483451|NCT00621959|473399884|FG000|Overall Study|Lost to Follow-up|0|||
131483452|NCT00621959|473399885|FG001|Overall Study|Lost to Follow-up|2|||
131483453|NCT00621959|473399884|FG000|Overall Study|Withdrawal by Subject|1|||
131483454|NCT00621959|473399885|FG001|Overall Study|Withdrawal by Subject|1|||
131483455|NCT00621959|473399884|FG000|Overall Study|Other|1|||
131483456|NCT00621959|473399885|FG001|Overall Study|Other|3|||
131483457|NCT01758523|473399886|FG000|Overall Study|Adverse Event|2|||
131483458|NCT01758523|473399887|FG001|Overall Study|Adverse Event|1|||
131483459|NCT01758523|473399886|FG000|Overall Study|Lack of Efficacy|4|||
131483460|NCT01758523|473399887|FG001|Overall Study|Lack of Efficacy|2|||
131483461|NCT01758523|473399886|FG000|Overall Study|Lost to Follow-up|3|||
131483462|NCT01758523|473399887|FG001|Overall Study|Lost to Follow-up|4|||
131483463|NCT01758523|473399886|FG000|Overall Study|Withdrawal by Subject|12|||
131483464|NCT01758523|473399887|FG001|Overall Study|Withdrawal by Subject|7|||
131483465|NCT00590135|473399888|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
131483466|NCT02004522|473399893|FG000|Overall Study|Adverse Event|55|||
131483467|NCT02004522|473399894|FG001|Overall Study|Adverse Event|6|||
131483468|NCT02004522|473399893|FG000|Overall Study|Withdrawal by Subject|13|||
131483469|NCT02004522|473399894|FG001|Overall Study|Withdrawal by Subject|7|||
131483470|NCT02004522|473399893|FG000|Overall Study|Death|12|||
131483471|NCT02004522|473399894|FG001|Overall Study|Death|3|||
131483472|NCT02004522|473399893|FG000|Overall Study|Physician Decision|3|||
131483473|NCT02004522|473399894|FG001|Overall Study|Physician Decision|4|||
131483474|NCT02004522|473399893|FG000|Overall Study|Protocol Violation|1|||
131483475|NCT02004522|473399894|FG001|Overall Study|Protocol Violation|0|||
131483476|NCT02004522|473399893|FG000|Overall Study|Other is reason listed by PI|4|||
131483477|NCT02004522|473399894|FG001|Overall Study|Other is reason listed by PI|1|||
131483478|NCT02004522|473399893|FG000|Overall Study|Never Dosed|2|||
131483479|NCT02004522|473399894|FG001|Overall Study|Never Dosed|4|||
131483480|NCT02004522|473399893|FG000|Overall Study|Disease Progression|35|||
131483481|NCT02004522|473399894|FG001|Overall Study|Disease Progression|31|||
131483482|NCT02004522|473399893|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
131483483|NCT02004522|473399894|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
131483484|NCT01787331|473399896|FG000|Overall Study|Physician Decision|1|||
131483485|NCT01787331|473399896|FG000|Overall Study|Withdrawal by Subject|1|||
131483486|NCT00289016|473399897|FG000|Overall Study|Disease Progression|29|||
131483487|NCT00289016|473399897|FG000|Overall Study|Death|2|||
131483488|NCT00289016|473399897|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
131483489|NCT00289016|473399897|FG000|Overall Study|Withdrawal by Subject|2|||
131483490|NCT00289016|473399897|FG000|Overall Study|Adverse Event|1|||
131483491|NCT00289016|473399897|FG000|Overall Study|Other|1|||
131483492|NCT00319501|473399898|FG000|Double-blind Period|Withdrawal by Subject|0|||
131483493|NCT00319501|473399899|FG001|Double-blind Period|Withdrawal by Subject|3|||
131483494|NCT00319501|473399898|FG000|Double-blind Period|Sponsor Request|1|||
131483495|NCT00319501|473399899|FG001|Double-blind Period|Sponsor Request|0|||
131483496|NCT00319501|473399898|FG000|Double-blind Period|Did not receive treatment|42|||
131483497|NCT00319501|473399899|FG001|Double-blind Period|Did not receive treatment|29|||
131483498|NCT00319501|473399898|FG000|Open-label Period|Adverse Event|5|||
131483499|NCT00319501|473399899|FG001|Open-label Period|Adverse Event|0|||
131483500|NCT00319501|473399898|FG000|Open-label Period|Protocol Violation|6|||
131483501|NCT00319501|473399899|FG001|Open-label Period|Protocol Violation|0|||
131483502|NCT00319501|473399898|FG000|Open-label Period|Withdrawal by Subject|38|||
131483503|NCT00319501|473399899|FG001|Open-label Period|Withdrawal by Subject|0|||
131483504|NCT00319501|473399898|FG000|Open-label Period|Principal Investigator decision|6|||
131483505|NCT00319501|473399899|FG001|Open-label Period|Principal Investigator decision|0|||
131483506|NCT00319501|473399898|FG000|Open-label Period|Sponsor request|12|||
131483507|NCT00319501|473399899|FG001|Open-label Period|Sponsor request|0|||
131483508|NCT00319501|473399898|FG000|Open-label Period|Lost to Follow-up|5|||
131483509|NCT00319501|473399899|FG001|Open-label Period|Lost to Follow-up|0|||
131483510|NCT00319501|473399898|FG000|Open-label Period|Did not receive treatment|33|||
131483511|NCT00319501|473399899|FG001|Open-label Period|Did not receive treatment|0|||
131483512|NCT00319501|473399898|FG000|Open-label Period|Other|11|||
131483513|NCT00319501|473399899|FG001|Open-label Period|Other|0|||
131483514|NCT00319501|473399898|FG000|Open-label Extension Period|Adverse Event|2|||
131483515|NCT00319501|473399899|FG001|Open-label Extension Period|Adverse Event|0|||
131483516|NCT00319501|473399898|FG000|Open-label Extension Period|Did not receive treatment|18|||
131483517|NCT00319501|473399899|FG001|Open-label Extension Period|Did not receive treatment|0|||
131483518|NCT00319501|473399898|FG000|Open-label Extension Period|Other|1|||
131483519|NCT00319501|473399899|FG001|Open-label Extension Period|Other|0|||
131483520|NCT00319501|473399898|FG000|Open-label Extension Period|Principal investigator decision|2|||
131483521|NCT00319501|473399899|FG001|Open-label Extension Period|Principal investigator decision|0|||
131483522|NCT00319501|473399898|FG000|Open-label Extension Period|Sponsor request|26|||
131483523|NCT00319501|473399899|FG001|Open-label Extension Period|Sponsor request|0|||
131483524|NCT00319501|473399898|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
131483525|NCT00319501|473399899|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
131483526|NCT00667875|473399901|FG000|Overall Study|Adverse Event|0|||
131483527|NCT00667875|473399902|FG001|Overall Study|Adverse Event|2|||
131483528|NCT00667875|473399903|FG002|Overall Study|Adverse Event|6|||
131483529|NCT00667875|473399901|FG000|Overall Study|Withdrawal by Subject|10|||
131483530|NCT00667875|473399902|FG001|Overall Study|Withdrawal by Subject|9|||
131483531|NCT00667875|473399903|FG002|Overall Study|Withdrawal by Subject|7|||
131483532|NCT00450255|473399904|FG000|Overall Study|Prior RFA ablation of liver|1|||
131483533|NCT01696071|473399910|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
131483534|NCT01696071|473399911|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
131483535|NCT02764697|473399912|FG000|Overall Study|Lack of Efficacy|3|||
131483536|NCT00302107|473399913|FG000|Overall Study|Lost to Follow-up|6|||
131483537|NCT00302107|473399914|FG001|Overall Study|Lost to Follow-up|5|||
131483538|NCT00302107|473399913|FG000|Overall Study|Protocol Violation|1|||
131483539|NCT00302107|473399914|FG001|Overall Study|Protocol Violation|0|||
131483540|NCT00302107|473399913|FG000|Overall Study|Relocation|0|||
131483541|NCT00302107|473399914|FG001|Overall Study|Relocation|1|||
131483542|NCT00302107|473399913|FG000|Overall Study|Withdrawal by Subject|0|||
131483543|NCT00302107|473399914|FG001|Overall Study|Withdrawal by Subject|3|||
131483544|NCT00302107|473399913|FG000|Overall Study|Adverse Event|1|||
131483545|NCT00302107|473399914|FG001|Overall Study|Adverse Event|0|||
131483546|NCT01790932|473399915|FG000|Overall Study|Disease Progression|41|||
131483547|NCT01790932|473399915|FG000|Overall Study|Adverse Event|7|||
131483548|NCT01790932|473399915|FG000|Overall Study|Physician Decision|1|||
131483549|NCT01790932|473399915|FG000|Overall Study|Withdrawal by Subject|1|||
131483550|NCT04223973|473399916|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
131483551|NCT04223973|473399917|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
131483552|NCT04223973|473399916|FG000|Overall Study|Adverse Event|4|||
131483553|NCT04223973|473399917|FG001|Overall Study|Adverse Event|0|||
131483554|NCT04223973|473399916|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
131483555|NCT04223973|473399917|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
131483556|NCT04223973|473399916|FG000|Overall Study|Physician Decision|1|||
131483557|NCT04223973|473399917|FG001|Overall Study|Physician Decision|1|||
131483558|NCT04223973|473399916|FG000|Overall Study|Withdrawal by Subject|0|||
131483559|NCT04223973|473399917|FG001|Overall Study|Withdrawal by Subject|1|||
131483560|NCT01441180|473399923|FG000|Overall Study|Lost to Follow-up|1|||
131483561|NCT01441180|473399924|FG001|Overall Study|Lost to Follow-up|1|||
131483562|NCT01441180|473399925|FG002|Overall Study|Lost to Follow-up|1|||
131483563|NCT01441180|473399923|FG000|Overall Study|Discontinued|0|||
131483564|NCT01441180|473399924|FG001|Overall Study|Discontinued|0|||
131483565|NCT01441180|473399925|FG002|Overall Study|Discontinued|2|||
131483566|NCT02569671|473399928|FG000|Overall Study|Lost to Follow-up|2|||
131483567|NCT02569671|473399929|FG001|Overall Study|Lost to Follow-up|1|||
131483568|NCT02569671|473399928|FG000|Overall Study|Withdrawal by Subject|1|||
131483569|NCT02569671|473399929|FG001|Overall Study|Withdrawal by Subject|3|||
131483570|NCT02612129|473399930|FG000|Single Dose Treatment Period|Screening Failure|1|||
131483571|NCT02612129|473399931|FG001|Single Dose Treatment Period|Screening Failure|0|||
131483572|NCT02612129|473399932|FG002|Single Dose Treatment Period|Screening Failure|0|||
131483573|NCT02612129|473399930|FG000|Continuous Treatment Period|Early Escape|0|||
131483574|NCT02612129|473399931|FG001|Continuous Treatment Period|Early Escape|2|||
131483575|NCT02612129|473399932|FG002|Continuous Treatment Period|Early Escape|0|||
131483576|NCT02612129|473399930|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
131483577|NCT02612129|473399931|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
131483578|NCT02612129|473399932|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
131483579|NCT02612129|473399930|FG000|Continuous Treatment Period|Safety Reasons|0|||
131483580|NCT02612129|473399931|FG001|Continuous Treatment Period|Safety Reasons|3|||
131483581|NCT02612129|473399932|FG002|Continuous Treatment Period|Safety Reasons|0|||
131483582|NCT02612129|473399930|FG000|Continuous Treatment Period|Death|0|||
131483583|NCT02612129|473399931|FG001|Continuous Treatment Period|Death|1|||
131483584|NCT02612129|473399932|FG002|Continuous Treatment Period|Death|0|||
131483585|NCT02612129|473399930|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
131483586|NCT02612129|473399931|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
131496796|NCT01979016|473446398|FG001|Overall Study|Withdrawal by Subject|0|||
131483587|NCT02612129|473399932|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
131483588|NCT01757535|473399933|FG000|Overall Study|Disease Relapse|151|||
131483589|NCT01757535|473399934|FG001|Overall Study|Disease Relapse|181|||
131483590|NCT01757535|473399933|FG000|Overall Study|Other Reasons|28|||
131483591|NCT01757535|473399934|FG001|Overall Study|Other Reasons|27|||
131483592|NCT01757535|473399933|FG000|Overall Study|Adverse Event|31|||
131483593|NCT01757535|473399934|FG001|Overall Study|Adverse Event|11|||
131483594|NCT01757535|473399933|FG000|Overall Study|Withdrew Consent|19|||
131483595|NCT01757535|473399934|FG001|Overall Study|Withdrew Consent|13|||
131483596|NCT01757535|473399933|FG000|Overall Study|Physician Decision|7|||
131483597|NCT01757535|473399934|FG001|Overall Study|Physician Decision|0|||
131483598|NCT01757535|473399933|FG000|Overall Study|Death|2|||
131483599|NCT01757535|473399934|FG001|Overall Study|Death|2|||
131483600|NCT00825682|473401533|FG000|Overall Study|personal reasons/ inconvenience|13|||
131483601|NCT00825682|473401534|FG001|Overall Study|personal reasons/ inconvenience|5|||
131483602|NCT01644565|473401535|FG000|Overall Study|Undisclosed Medical History|1|||
131483603|NCT01644565|473401536|FG001|Overall Study|Undisclosed Medical History|0|||
131483604|NCT01644565|473401537|FG002|Overall Study|Undisclosed Medical History|0|||
131483605|NCT01644565|473401538|FG003|Overall Study|Undisclosed Medical History|0|||
131483606|NCT01644565|473401539|FG004|Overall Study|Undisclosed Medical History|0|||
131483607|NCT01644565|473401540|FG005|Overall Study|Undisclosed Medical History|0|||
131483608|NCT01644565|473401541|FG006|Overall Study|Undisclosed Medical History|0|||
131483609|NCT01644565|473401542|FG007|Overall Study|Undisclosed Medical History|0|||
131483610|NCT01644565|473401543|FG008|Overall Study|Undisclosed Medical History|0|||
131483611|NCT01644565|473401535|FG000|Overall Study|Lost to Follow-up|0|||
131483612|NCT01644565|473401536|FG001|Overall Study|Lost to Follow-up|0|||
131483613|NCT01644565|473401537|FG002|Overall Study|Lost to Follow-up|0|||
131483614|NCT01644565|473401538|FG003|Overall Study|Lost to Follow-up|1|||
131483615|NCT01644565|473401539|FG004|Overall Study|Lost to Follow-up|0|||
131483616|NCT01644565|473401540|FG005|Overall Study|Lost to Follow-up|0|||
131483617|NCT01644565|473401541|FG006|Overall Study|Lost to Follow-up|0|||
131483618|NCT01644565|473401542|FG007|Overall Study|Lost to Follow-up|2|||
131483619|NCT01644565|473401543|FG008|Overall Study|Lost to Follow-up|0|||
131483620|NCT01644565|473401535|FG000|Overall Study|Family emergency|0|||
131483621|NCT01644565|473401536|FG001|Overall Study|Family emergency|0|||
131483622|NCT01644565|473401537|FG002|Overall Study|Family emergency|0|||
131483623|NCT01644565|473401538|FG003|Overall Study|Family emergency|0|||
131483624|NCT01644565|473401539|FG004|Overall Study|Family emergency|1|||
131483625|NCT01644565|473401540|FG005|Overall Study|Family emergency|0|||
131483626|NCT01644565|473401541|FG006|Overall Study|Family emergency|0|||
131483627|NCT01644565|473401542|FG007|Overall Study|Family emergency|0|||
131483628|NCT01644565|473401543|FG008|Overall Study|Family emergency|0|||
131483629|NCT01644565|473401535|FG000|Overall Study|Relocation|0|||
131483630|NCT01644565|473401536|FG001|Overall Study|Relocation|0|||
131483631|NCT01644565|473401537|FG002|Overall Study|Relocation|0|||
131483632|NCT01644565|473401538|FG003|Overall Study|Relocation|0|||
131483633|NCT01644565|473401539|FG004|Overall Study|Relocation|0|||
131483634|NCT01644565|473401540|FG005|Overall Study|Relocation|0|||
131483635|NCT01644565|473401541|FG006|Overall Study|Relocation|0|||
131483636|NCT01644565|473401542|FG007|Overall Study|Relocation|0|||
131483637|NCT01644565|473401543|FG008|Overall Study|Relocation|1|||
131483638|NCT01550289|473401544|FG000|Overall Study|Protocol Violation|1|||
131483639|NCT01550289|473401545|FG001|Overall Study|Protocol Violation|0|||
131483640|NCT01550289|473401544|FG000|Overall Study|Lost to Follow-up|1|||
131483641|NCT01550289|473401545|FG001|Overall Study|Lost to Follow-up|1|||
131483642|NCT01550289|473401544|FG000|Overall Study|Withdrawal by Subject|11|||
131483643|NCT01550289|473401545|FG001|Overall Study|Withdrawal by Subject|3|||
131483644|NCT02975336|473401546|FG000|DBPC (52 Weeks)|Adverse Event|16|||
131483645|NCT02975336|473401547|FG001|DBPC (52 Weeks)|Adverse Event|17|||
131483646|NCT02975336|473401548|FG002|DBPC (52 Weeks)|Adverse Event|13|||
131483647|NCT02975336|473401549|FG003|DBPC (52 Weeks)|Adverse Event|18|||
131483648|NCT02975336|473401550|FG004|DBPC (52 Weeks)|Adverse Event|0|||
131483649|NCT02975336|473401551|FG005|DBPC (52 Weeks)|Adverse Event|0|||
131483650|NCT02975336|473401552|FG006|DBPC (52 Weeks)|Adverse Event|0|||
131483651|NCT02975336|473401553|FG007|DBPC (52 Weeks)|Adverse Event|0|||
131483652|NCT02975336|473401546|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
131483653|NCT02975336|473401547|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
131483654|NCT02975336|473401548|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
131483655|NCT02975336|473401549|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
131483656|NCT02975336|473401550|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
131483657|NCT02975336|473401551|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
131483658|NCT02975336|473401552|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
131483659|NCT02975336|473401553|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
131483660|NCT02975336|473401546|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
131483661|NCT02975336|473401547|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
131483662|NCT02975336|473401548|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
131483663|NCT02975336|473401549|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
131483664|NCT02975336|473401550|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
131483665|NCT02975336|473401551|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
131496797|NCT01979016|473446397|FG000|Overall Study|Adverse Event|0|||
131483666|NCT02975336|473401552|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
131483667|NCT02975336|473401553|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
131483668|NCT02975336|473401546|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
131483669|NCT02975336|473401547|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
131483670|NCT02975336|473401548|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
131483671|NCT02975336|473401549|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
131483672|NCT02975336|473401550|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
131483673|NCT02975336|473401551|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
131483674|NCT02975336|473401552|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
131483675|NCT02975336|473401553|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
131483676|NCT02975336|473401546|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
131483677|NCT02975336|473401547|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
131483678|NCT02975336|473401548|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
131483679|NCT02975336|473401549|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
131483680|NCT02975336|473401550|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
131483681|NCT02975336|473401551|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
131483682|NCT02975336|473401552|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
131483683|NCT02975336|473401553|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
131483684|NCT02975336|473401546|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
131483685|NCT02975336|473401547|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
131483686|NCT02975336|473401548|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
131483687|NCT02975336|473401549|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
131483688|NCT02975336|473401550|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
131483689|NCT02975336|473401551|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
131483690|NCT02975336|473401552|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
131483691|NCT02975336|473401553|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
131483692|NCT02975336|473401546|FG000|LTE (104 Weeks)|Adverse Event|0|||
131483693|NCT02975336|473401547|FG001|LTE (104 Weeks)|Adverse Event|0|||
131483694|NCT02975336|473401548|FG002|LTE (104 Weeks)|Adverse Event|0|||
131483695|NCT02975336|473401549|FG003|LTE (104 Weeks)|Adverse Event|0|||
131483696|NCT02975336|473401550|FG004|LTE (104 Weeks)|Adverse Event|7|||
131483697|NCT02975336|473401551|FG005|LTE (104 Weeks)|Adverse Event|4|||
131483698|NCT02975336|473401552|FG006|LTE (104 Weeks)|Adverse Event|2|||
131483699|NCT02975336|473401553|FG007|LTE (104 Weeks)|Adverse Event|0|||
131483700|NCT02975336|473401546|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
131483701|NCT02975336|473401547|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
131483702|NCT02975336|473401548|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
131483703|NCT02975336|473401549|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
131483704|NCT02975336|473401550|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
131483705|NCT02975336|473401551|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
131483706|NCT02975336|473401552|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
131483707|NCT02975336|473401553|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
131483708|NCT02975336|473401546|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
131483709|NCT02975336|473401547|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
131483710|NCT02975336|473401548|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
131483711|NCT02975336|473401549|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
131483712|NCT02975336|473401550|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
131483713|NCT02975336|473401551|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
131483714|NCT02975336|473401552|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
131483715|NCT02975336|473401553|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
131483716|NCT02975336|473401546|FG000|LTE (104 Weeks)|Other|0|||
131483717|NCT02975336|473401547|FG001|LTE (104 Weeks)|Other|0|||
131483718|NCT02975336|473401548|FG002|LTE (104 Weeks)|Other|0|||
131483719|NCT02975336|473401549|FG003|LTE (104 Weeks)|Other|0|||
131483720|NCT02975336|473401550|FG004|LTE (104 Weeks)|Other|55|||
131483721|NCT02975336|473401551|FG005|LTE (104 Weeks)|Other|63|||
131483722|NCT02975336|473401552|FG006|LTE (104 Weeks)|Other|76|||
131483723|NCT02975336|473401553|FG007|LTE (104 Weeks)|Other|72|||
131483724|NCT01897454|473401554|FG000|Overall Study|Withdrawal by Subject|1|||
131483725|NCT00094172|473401557|FG000|Overall Study|Adverse Event|0|||
131483726|NCT00094172|473401558|FG001|Overall Study|Adverse Event|1|||
131483727|NCT00094172|473401557|FG000|Overall Study|Lost to Follow-up|2|||
131483728|NCT00094172|473401558|FG001|Overall Study|Lost to Follow-up|0|||
131483729|NCT00094172|473401557|FG000|Overall Study|Protocol Violation|0|||
131483730|NCT00094172|473401558|FG001|Overall Study|Protocol Violation|1|||
131483731|NCT00094172|473401557|FG000|Overall Study|Withdrawal by Subject|10|||
131483732|NCT00094172|473401558|FG001|Overall Study|Withdrawal by Subject|5|||
131483733|NCT00094172|473401557|FG000|Overall Study|Primary endpoint met.|1|||
131483734|NCT00094172|473401558|FG001|Overall Study|Primary endpoint met.|0|||
131483735|NCT00094172|473401557|FG000|Overall Study|Started other MS therapy due to disease|1|||
131483736|NCT00094172|473401558|FG001|Overall Study|Started other MS therapy due to disease|0|||
131483737|NCT01977794|473401563|FG000|Overall Study|Adverse Event|2|||
131483738|NCT01977794|473401564|FG001|Overall Study|Adverse Event|2|||
131483739|NCT01977794|473401563|FG000|Overall Study|Lost to Follow-up|2|||
131483740|NCT01977794|473401564|FG001|Overall Study|Lost to Follow-up|1|||
131483741|NCT01977794|473401563|FG000|Overall Study|Protocol Violation|1|||
131483742|NCT01977794|473401564|FG001|Overall Study|Protocol Violation|0|||
131483743|NCT01977794|473401563|FG000|Overall Study|Death|1|||
131483744|NCT01977794|473401564|FG001|Overall Study|Death|1|||
131483745|NCT01977794|473401563|FG000|Overall Study|Withdrew consent|2|||
131483746|NCT01977794|473401564|FG001|Overall Study|Withdrew consent|1|||
131483747|NCT01977794|473401563|FG000|Overall Study|Other|0|||
131483748|NCT01977794|473401564|FG001|Overall Study|Other|1|||
131483749|NCT00827502|473401567|FG000|Overall Study|randomized but not treated|11|||
131483750|NCT00827502|473401567|FG000|Overall Study|Adverse Event|1|||
131483751|NCT00827502|473401567|FG000|Overall Study|Lost to Follow-up|4|||
131483752|NCT00827502|473401567|FG000|Overall Study|Withdrawal by Subject|5|||
131483753|NCT02478632|473401568|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
131483754|NCT02478632|473401569|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
131483755|NCT02478632|473401568|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
131483756|NCT02478632|473401569|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
131483757|NCT02478632|473401568|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
131483758|NCT02478632|473401569|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
131483759|NCT03019185|473401570|FG000|Overall Study|Lost to Follow-up|3|||
131483760|NCT03019185|473401571|FG001|Overall Study|Lost to Follow-up|0|||
131483761|NCT03019185|473401572|FG002|Overall Study|Lost to Follow-up|2|||
131483762|NCT03019185|473401570|FG000|Overall Study|Withdrawal by Subject|1|||
131483763|NCT03019185|473401571|FG001|Overall Study|Withdrawal by Subject|1|||
131483764|NCT03019185|473401572|FG002|Overall Study|Withdrawal by Subject|0|||
131483765|NCT03019185|473401570|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
131483766|NCT03019185|473401571|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
131483767|NCT03019185|473401572|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
131483768|NCT03019185|473401570|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
131483769|NCT03019185|473401571|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
131483770|NCT03019185|473401572|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
131483771|NCT03355365|473401573|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
131483772|NCT03355365|473401574|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
131483773|NCT03355365|473401573|FG000|Year 1, First Intervention|Protocol Violation|1|||
131483774|NCT03355365|473401574|FG001|Year 1, First Intervention|Protocol Violation|0|||
131483775|NCT03355365|473401573|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
131483776|NCT03355365|473401574|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
131483777|NCT03355365|473401573|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
131483778|NCT03355365|473401574|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
131483779|NCT03355365|473401573|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
131483780|NCT03355365|473401574|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
131483781|NCT03355365|473401573|FG000|Year 2, Crossover Intervention|severe COVID|0|||
131483782|NCT03355365|473401574|FG001|Year 2, Crossover Intervention|severe COVID|1|||
131483783|NCT03355365|473401573|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
131483784|NCT03355365|473401574|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
131483785|NCT04622306|473401575|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
131483786|NCT04622306|473401576|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
131483787|NCT04622306|473401577|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
131483788|NCT04622306|473401578|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
131483789|NCT04622306|473401579|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
131483790|NCT04622306|473401580|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
131483791|NCT04622306|473401575|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
131483792|NCT04622306|473401576|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
131483793|NCT04622306|473401577|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
131483794|NCT04622306|473401578|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
131483795|NCT04622306|473401579|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
131483796|NCT04622306|473401580|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
131483797|NCT00736944|473401581|FG000|Induction|Death|1|||
131483798|NCT00736944|473401581|FG000|Definitive Treatment|Physician Decision|1|||
131483799|NCT01601132|473401582|FG000|Overall Study|Patient withdrew consent|1|||
131483800|NCT01601132|473401582|FG000|Overall Study|Protocol deviation|1|||
131483801|NCT01952145|473401590|FG000|Overall Study|Protocol Violation|2|||
131483802|NCT01952145|473401591|FG001|Overall Study|Protocol Violation|1|||
131483803|NCT01952145|473401590|FG000|Overall Study|Death|0|||
131483804|NCT01952145|473401591|FG001|Overall Study|Death|1|||
131483805|NCT01952145|473401590|FG000|Overall Study|Adverse Event|9|||
131483806|NCT01952145|473401591|FG001|Overall Study|Adverse Event|0|||
131483807|NCT01952145|473401590|FG000|Overall Study|Withdrawal Criteria|16|||
131483808|NCT01952145|473401591|FG001|Overall Study|Withdrawal Criteria|11|||
131483809|NCT01952145|473401590|FG000|Overall Study|Unclassified|1|||
131483810|NCT01952145|473401591|FG001|Overall Study|Unclassified|1|||
131483811|NCT04138810|473401595|FG000|Overall Study|Withdrawal by Subject|0|||
131483812|NCT04138810|473401596|FG001|Overall Study|Withdrawal by Subject|1|||
131483813|NCT04138810|473401595|FG000|Overall Study|Subject cancelled surgery|1|||
131483814|NCT04138810|473401596|FG001|Overall Study|Subject cancelled surgery|0|||
131483815|NCT01622231|473401599|FG000|Overall Study|Physician Decision|1|||
131483816|NCT01622231|473401599|FG000|Overall Study|Withdrawal by Subject|1|||
131483817|NCT02329080|473401601|FG000|Overall Study|Adverse Event|1|||
131483818|NCT02329080|473401601|FG000|Overall Study|Death|4|||
131483819|NCT02329080|473401601|FG000|Overall Study|Lack of Efficacy|22|||
131483820|NCT02329080|473401601|FG000|Overall Study|Lost to Follow-up|1|||
131483821|NCT02329080|473401601|FG000|Overall Study|Physician Decision|2|||
131483822|NCT02329080|473401601|FG000|Overall Study|Partial response|4|||
131483823|NCT02329080|473401601|FG000|Overall Study|Complete response|4|||
131483824|NCT04545060|473401602|FG000|Overall Study|Adverse Event|0|||
131483825|NCT04545060|473401603|FG001|Overall Study|Adverse Event|1|||
131483826|NCT04545060|473401602|FG000|Overall Study|Death|0|||
131483827|NCT04545060|473401603|FG001|Overall Study|Death|5|||
131483828|NCT04545060|473401602|FG000|Overall Study|Lost to Follow-up|10|||
131483829|NCT04545060|473401603|FG001|Overall Study|Lost to Follow-up|13|||
131483830|NCT04545060|473401602|FG000|Overall Study|Physician Decision|3|||
131483831|NCT04545060|473401603|FG001|Overall Study|Physician Decision|0|||
131483832|NCT04545060|473401602|FG000|Overall Study|Withdrawal by Subject|17|||
131483833|NCT04545060|473401603|FG001|Overall Study|Withdrawal by Subject|22|||
131483834|NCT00619177|473401606|FG000|Overall Study|Adverse Event|18|||
131483835|NCT00619177|473401606|FG000|Overall Study|Lost to Follow-up|2|||
131483836|NCT00619177|473401606|FG000|Overall Study|Lack of Efficacy|1|||
131483837|NCT00619177|473401606|FG000|Overall Study|Missing termination information|481|||
131483838|NCT00619177|473401606|FG000|Overall Study|Not specified reasons|6|||
131483839|NCT01609231|473401607|FG000|Overall Study|Adverse Event|1|||
131483840|NCT01609231|473401608|FG001|Overall Study|Adverse Event|3|||
131483841|NCT01609231|473401607|FG000|Overall Study|Physician Decision|1|||
131483842|NCT01609231|473401608|FG001|Overall Study|Physician Decision|0|||
131483843|NCT01609231|473401607|FG000|Overall Study|Withdrawal by Subject|1|||
131483844|NCT01609231|473401608|FG001|Overall Study|Withdrawal by Subject|0|||
131483845|NCT03082261|473401611|FG000|Overall Study|Death|4|||
131483846|NCT03082261|473401611|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
131483847|NCT03082261|473401611|FG000|Overall Study|Insurance denial|1|||
131483848|NCT03082261|473401611|FG000|Overall Study|Peripheral lead added|1|||
131483849|NCT03082261|473401611|FG000|Overall Study|Withdrawal by Subject|40|||
131483850|NCT03082261|473401611|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
131483851|NCT03082261|473401611|FG000|Overall Study|Subject implanted with device other than study device|1|||
131483852|NCT03082261|473401611|FG000|Overall Study|Lost to Follow-up|14|||
131483853|NCT03082261|473401611|FG000|Overall Study|Subject moved to a different state|1|||
131483854|NCT03082261|473401611|FG000|Overall Study|Subject non-compliance|2|||
131483855|NCT03082261|473401611|FG000|Overall Study|Subject participation terminated by investigator|9|||
131483856|NCT03082261|473401611|FG000|Overall Study|Subject participation terminated by sponsor|4|||
131483857|NCT03082261|473401611|FG000|Overall Study|System explant|19|||
131483858|NCT03082261|473401611|FG000|Overall Study|Unable to place lead(s)|2|||
131483859|NCT03082261|473401611|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
131483860|NCT00702689|473401612|FG000|Overall Study|Withdrawal by Subject|4|||
131483861|NCT00702689|473401612|FG000|Overall Study|Recurrent malignancy|1|||
131483862|NCT00702689|473401612|FG000|Overall Study|Adverse Event|1|||
131483863|NCT01281137|473401615|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
131483864|NCT01281137|473401616|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
131483865|NCT01281137|473401615|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
131483866|NCT01281137|473401616|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
131483867|NCT01281137|473401615|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
131483868|NCT01281137|473401616|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
131483869|NCT01281137|473401615|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
131483870|NCT01281137|473401616|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
131483871|NCT01281137|473401615|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
131483872|NCT01281137|473401616|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
131483873|NCT03576495|473401626|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
131483874|NCT03576495|473401627|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
131483875|NCT03608254|473401629|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
131483876|NCT03608254|473401629|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
131483877|NCT04203797|473401630|FG000|Overall Study|Adverse Event|1|||
131483878|NCT04203797|473401631|FG001|Overall Study|Adverse Event|0|||
131483879|NCT04203797|473401630|FG000|Overall Study|Did not complete End of Study follow-up|1|||
131483880|NCT04203797|473401631|FG001|Overall Study|Did not complete End of Study follow-up|0|||
131483881|NCT01903031|473401632|FG000|Overall Study|Not Able to Attend Clinic|1|||
131483882|NCT01903031|473401633|FG001|Overall Study|Not Able to Attend Clinic|1|||
131483883|NCT01903031|473401634|FG002|Overall Study|Not Able to Attend Clinic|0|||
131483884|NCT01903031|473401632|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
131483885|NCT01903031|473401633|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
131483886|NCT01903031|473401634|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
131483887|NCT01903031|473401632|FG000|Overall Study|Adverse Event|0|||
131483888|NCT01903031|473401633|FG001|Overall Study|Adverse Event|1|||
131483889|NCT01903031|473401634|FG002|Overall Study|Adverse Event|0|||
131483890|NCT01903031|473401632|FG000|Overall Study|Withdrawal by Subject|0|||
131483891|NCT01903031|473401633|FG001|Overall Study|Withdrawal by Subject|1|||
131483892|NCT01903031|473401634|FG002|Overall Study|Withdrawal by Subject|1|||
131483893|NCT01903031|473401632|FG000|Overall Study|Protocol Violation|0|||
131483894|NCT01903031|473401633|FG001|Overall Study|Protocol Violation|0|||
131483895|NCT01903031|473401634|FG002|Overall Study|Protocol Violation|2|||
131483896|NCT01903031|473401632|FG000|Overall Study|Lost to Follow-up|0|||
131483897|NCT01903031|473401633|FG001|Overall Study|Lost to Follow-up|0|||
131483898|NCT01903031|473401634|FG002|Overall Study|Lost to Follow-up|1|||
131483899|NCT01903031|473401632|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
131483900|NCT01903031|473401633|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
131483901|NCT01903031|473401634|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
131483902|NCT03540030|473401635|FG000|Overall Study|Withdrawal by Subject|2|||
131483903|NCT03540030|473401636|FG001|Overall Study|Withdrawal by Subject|1|||
131483904|NCT03540030|473401635|FG000|Overall Study|screen fail|7|||
131483905|NCT03540030|473401636|FG001|Overall Study|screen fail|1|||
131483906|NCT03540030|473401635|FG000|Overall Study|never had surgery after signing consent|9|||
131483907|NCT03540030|473401636|FG001|Overall Study|never had surgery after signing consent|1|||
131483908|NCT01484275|473401640|FG000|Overall Study|Study terminated by sponsor|28|||
131483909|NCT01484275|473401641|FG001|Overall Study|Study terminated by sponsor|32|||
131483910|NCT01484275|473401640|FG000|Overall Study|Other|10|||
131483911|NCT01484275|473401641|FG001|Overall Study|Other|0|||
131483912|NCT01484275|473401640|FG000|Overall Study|Death|3|||
131483913|NCT01484275|473401641|FG001|Overall Study|Death|4|||
131483914|NCT01484275|473401640|FG000|Overall Study|Withdrawal by Subject|1|||
131483915|NCT01484275|473401641|FG001|Overall Study|Withdrawal by Subject|5|||
131483916|NCT01484275|473401640|FG000|Overall Study|Lost to Follow-up|1|||
131483917|NCT01484275|473401641|FG001|Overall Study|Lost to Follow-up|1|||
131483918|NCT03855228|473401644|FG000|Overall Study|Adverse Event|2|||
131483919|NCT03855228|473401645|FG001|Overall Study|Adverse Event|4|||
131483920|NCT03855228|473401646|FG002|Overall Study|Adverse Event|4|||
131483921|NCT03855228|473401647|FG003|Overall Study|Adverse Event|8|||
131483922|NCT03855228|473401644|FG000|Overall Study|Treatment Failure|1|||
131483923|NCT03855228|473401645|FG001|Overall Study|Treatment Failure|2|||
131483924|NCT03855228|473401646|FG002|Overall Study|Treatment Failure|1|||
131483925|NCT03855228|473401647|FG003|Overall Study|Treatment Failure|8|||
131483926|NCT03855228|473401644|FG000|Overall Study|Lost to Follow-up|0|||
131483927|NCT03855228|473401645|FG001|Overall Study|Lost to Follow-up|0|||
131483928|NCT03855228|473401646|FG002|Overall Study|Lost to Follow-up|0|||
131483929|NCT03855228|473401647|FG003|Overall Study|Lost to Follow-up|1|||
131483930|NCT03855228|473401644|FG000|Overall Study|Protocol Violation|0|||
131483931|NCT03855228|473401645|FG001|Overall Study|Protocol Violation|1|||
131483932|NCT03855228|473401646|FG002|Overall Study|Protocol Violation|2|||
131483933|NCT03855228|473401647|FG003|Overall Study|Protocol Violation|1|||
131483934|NCT03855228|473401644|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
131483935|NCT03855228|473401645|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
131483936|NCT03855228|473401646|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
131483937|NCT03855228|473401647|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
131483938|NCT00722800|473401648|FG000|Overall Study|Withdrawal by Subject|1|||
131483939|NCT00722800|473401649|FG001|Overall Study|Withdrawal by Subject|0|||
131483940|NCT00722800|473401648|FG000|Overall Study|Physician Decision|1|||
131483941|NCT00722800|473401649|FG001|Overall Study|Physician Decision|0|||
131483942|NCT02130297|473401653|FG000|Overall Study|Lost to Follow-up|4|||
131483943|NCT00913380|473401654|FG000|Clinical Outcomes|Lost to Follow-up|6|||
131483944|NCT00913380|473401655|FG001|Clinical Outcomes|Lost to Follow-up|6|||
131483945|NCT00806351|473401656|FG000|Overall Study|Death|5|||
131483946|NCT00806351|473401657|FG001|Overall Study|Death|4|||
131483947|NCT00142298|473401661|FG000|Overall Study|Adverse Event|10|||
131483948|NCT00142298|473401662|FG001|Overall Study|Adverse Event|10|||
131483949|NCT00142298|473401663|FG002|Overall Study|Adverse Event|1|||
131483950|NCT00142298|473401664|FG003|Overall Study|Adverse Event|5|||
131483951|NCT00142298|473401665|FG004|Overall Study|Adverse Event|2|||
131483952|NCT00142298|473401666|FG005|Overall Study|Adverse Event|2|||
131483953|NCT00142298|473401667|FG006|Overall Study|Adverse Event|0|||
131483954|NCT00142298|473401668|FG007|Overall Study|Adverse Event|0|||
131483955|NCT00142298|473401669|FG008|Overall Study|Adverse Event|0|||
131483956|NCT00142298|473401670|FG009|Overall Study|Adverse Event|0|||
131483957|NCT00142298|473401661|FG000|Overall Study|Clinical disease progression|1|||
131483958|NCT00142298|473401662|FG001|Overall Study|Clinical disease progression|0|||
131483959|NCT00142298|473401663|FG002|Overall Study|Clinical disease progression|0|||
131483960|NCT00142298|473401664|FG003|Overall Study|Clinical disease progression|0|||
131483961|NCT00142298|473401665|FG004|Overall Study|Clinical disease progression|0|||
131483962|NCT00142298|473401666|FG005|Overall Study|Clinical disease progression|0|||
131483963|NCT00142298|473401667|FG006|Overall Study|Clinical disease progression|0|||
131483964|NCT00142298|473401668|FG007|Overall Study|Clinical disease progression|0|||
131483965|NCT00142298|473401669|FG008|Overall Study|Clinical disease progression|0|||
131483966|NCT00142298|473401670|FG009|Overall Study|Clinical disease progression|0|||
131483967|NCT00142298|473401661|FG000|Overall Study|Death|1|||
131483968|NCT00142298|473401662|FG001|Overall Study|Death|1|||
131483969|NCT00142298|473401663|FG002|Overall Study|Death|1|||
131483970|NCT00142298|473401664|FG003|Overall Study|Death|0|||
131483971|NCT00142298|473401665|FG004|Overall Study|Death|0|||
131483972|NCT00142298|473401666|FG005|Overall Study|Death|6|||
131483973|NCT00142298|473401667|FG006|Overall Study|Death|0|||
131483974|NCT00142298|473401668|FG007|Overall Study|Death|0|||
131483975|NCT00142298|473401669|FG008|Overall Study|Death|0|||
131483976|NCT00142298|473401670|FG009|Overall Study|Death|0|||
131483977|NCT00142298|473401661|FG000|Overall Study|Lack of Efficacy|44|||
131483978|NCT00142298|473401662|FG001|Overall Study|Lack of Efficacy|62|||
131483979|NCT00142298|473401663|FG002|Overall Study|Lack of Efficacy|9|||
131483980|NCT00142298|473401664|FG003|Overall Study|Lack of Efficacy|12|||
131483981|NCT00142298|473401665|FG004|Overall Study|Lack of Efficacy|1|||
131483982|NCT00142298|473401666|FG005|Overall Study|Lack of Efficacy|0|||
131483983|NCT00142298|473401667|FG006|Overall Study|Lack of Efficacy|0|||
131483984|NCT00142298|473401668|FG007|Overall Study|Lack of Efficacy|1|||
131483985|NCT00142298|473401669|FG008|Overall Study|Lack of Efficacy|0|||
131483986|NCT00142298|473401670|FG009|Overall Study|Lack of Efficacy|0|||
131483987|NCT00142298|473401661|FG000|Overall Study|Non-compliance|15|||
131483988|NCT00142298|473401662|FG001|Overall Study|Non-compliance|13|||
131483989|NCT00142298|473401663|FG002|Overall Study|Non-compliance|0|||
131483990|NCT00142298|473401664|FG003|Overall Study|Non-compliance|6|||
131483991|NCT00142298|473401665|FG004|Overall Study|Non-compliance|1|||
131483992|NCT00142298|473401666|FG005|Overall Study|Non-compliance|0|||
131483993|NCT00142298|473401667|FG006|Overall Study|Non-compliance|0|||
131483994|NCT00142298|473401668|FG007|Overall Study|Non-compliance|3|||
131483995|NCT00142298|473401669|FG008|Overall Study|Non-compliance|3|||
131483996|NCT00142298|473401670|FG009|Overall Study|Non-compliance|0|||
131483997|NCT00142298|473401661|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
131483998|NCT00142298|473401662|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
131483999|NCT00142298|473401663|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
131484000|NCT00142298|473401664|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
131484001|NCT00142298|473401665|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
131484002|NCT00142298|473401666|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
131484003|NCT00142298|473401667|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
131484004|NCT00142298|473401668|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
131484005|NCT00142298|473401669|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
131484006|NCT00142298|473401670|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
131484007|NCT00142298|473401661|FG000|Overall Study|Pregnancy|4|||
131484008|NCT00142298|473401662|FG001|Overall Study|Pregnancy|4|||
131484009|NCT00142298|473401663|FG002|Overall Study|Pregnancy|2|||
131484010|NCT00142298|473401664|FG003|Overall Study|Pregnancy|3|||
131484011|NCT00142298|473401665|FG004|Overall Study|Pregnancy|0|||
131484012|NCT00142298|473401666|FG005|Overall Study|Pregnancy|0|||
131484013|NCT00142298|473401667|FG006|Overall Study|Pregnancy|0|||
131484014|NCT00142298|473401668|FG007|Overall Study|Pregnancy|0|||
131484015|NCT00142298|473401669|FG008|Overall Study|Pregnancy|1|||
131484016|NCT00142298|473401670|FG009|Overall Study|Pregnancy|0|||
131484017|NCT00142298|473401661|FG000|Overall Study|Virologic breakthrough|19|||
131484018|NCT00142298|473401662|FG001|Overall Study|Virologic breakthrough|23|||
131484019|NCT00142298|473401663|FG002|Overall Study|Virologic breakthrough|9|||
131484020|NCT00142298|473401664|FG003|Overall Study|Virologic breakthrough|7|||
131484021|NCT00142298|473401665|FG004|Overall Study|Virologic breakthrough|2|||
131484022|NCT00142298|473401666|FG005|Overall Study|Virologic breakthrough|3|||
131484023|NCT00142298|473401667|FG006|Overall Study|Virologic breakthrough|3|||
131484024|NCT00142298|473401668|FG007|Overall Study|Virologic breakthrough|0|||
131484025|NCT00142298|473401669|FG008|Overall Study|Virologic breakthrough|0|||
131484026|NCT00142298|473401670|FG009|Overall Study|Virologic breakthrough|0|||
131484027|NCT00142298|473401661|FG000|Overall Study|Other- not specified|0|||
131484028|NCT00142298|473401662|FG001|Overall Study|Other- not specified|3|||
131484029|NCT00142298|473401663|FG002|Overall Study|Other- not specified|0|||
131484030|NCT00142298|473401664|FG003|Overall Study|Other- not specified|1|||
131484031|NCT00142298|473401665|FG004|Overall Study|Other- not specified|0|||
131484032|NCT00142298|473401666|FG005|Overall Study|Other- not specified|0|||
131484033|NCT00142298|473401667|FG006|Overall Study|Other- not specified|0|||
131484034|NCT00142298|473401668|FG007|Overall Study|Other- not specified|0|||
131484035|NCT00142298|473401669|FG008|Overall Study|Other- not specified|0|||
131484036|NCT00142298|473401670|FG009|Overall Study|Other- not specified|0|||
131484037|NCT00142298|473401661|FG000|Overall Study|Lost to Follow-up|0|||
131484038|NCT00142298|473401662|FG001|Overall Study|Lost to Follow-up|0|||
131484039|NCT00142298|473401663|FG002|Overall Study|Lost to Follow-up|0|||
131484040|NCT00142298|473401664|FG003|Overall Study|Lost to Follow-up|0|||
131484041|NCT00142298|473401665|FG004|Overall Study|Lost to Follow-up|0|||
131484042|NCT00142298|473401666|FG005|Overall Study|Lost to Follow-up|0|||
131484043|NCT00142298|473401667|FG006|Overall Study|Lost to Follow-up|2|||
131484044|NCT00142298|473401668|FG007|Overall Study|Lost to Follow-up|0|||
131484045|NCT00142298|473401669|FG008|Overall Study|Lost to Follow-up|0|||
131484046|NCT00142298|473401670|FG009|Overall Study|Lost to Follow-up|0|||
131484047|NCT00142298|473401661|FG000|Overall Study|Treatment Failure|0|||
131484048|NCT00142298|473401662|FG001|Overall Study|Treatment Failure|0|||
131484049|NCT00142298|473401663|FG002|Overall Study|Treatment Failure|0|||
131484050|NCT00142298|473401664|FG003|Overall Study|Treatment Failure|0|||
131484051|NCT00142298|473401665|FG004|Overall Study|Treatment Failure|0|||
131484052|NCT00142298|473401666|FG005|Overall Study|Treatment Failure|2|||
131484053|NCT00142298|473401667|FG006|Overall Study|Treatment Failure|2|||
131484054|NCT00142298|473401668|FG007|Overall Study|Treatment Failure|0|||
131484055|NCT00142298|473401669|FG008|Overall Study|Treatment Failure|0|||
131484056|NCT00142298|473401670|FG009|Overall Study|Treatment Failure|0|||
131484057|NCT05147428|473401671|FG000|Overall Study|Removed prior to mailing|289|||
131484058|NCT05147428|473401672|FG001|Overall Study|Removed prior to mailing|306|||
131484059|NCT05147428|473401673|FG002|Overall Study|Removed prior to mailing|270|||
131484060|NCT05147428|473401671|FG000|Overall Study|Died or disenrolled during blackout period|239|||
131484061|NCT05147428|473401672|FG001|Overall Study|Died or disenrolled during blackout period|278|||
131484062|NCT05147428|473401673|FG002|Overall Study|Died or disenrolled during blackout period|273|||
131484063|NCT02280304|473402806|FG000|Overall Study|Lost to Follow-up|7|||
131484064|NCT02280304|473402807|FG001|Overall Study|Lost to Follow-up|8|||
131484065|NCT03689530|473402815|FG000|Overall Study|Withdrawal by Subject|53|||
131484066|NCT03689530|473402816|FG001|Overall Study|Withdrawal by Subject|16|||
131484067|NCT01546207|473402819|FG000|Overall Study|Death|1|||
131484068|NCT00713323|473402820|FG000|Overall Study|Adverse Event|75|||
131484069|NCT00713323|473402820|FG000|Overall Study|Withdrawal by Subject|15|||
131484070|NCT00713323|473402820|FG000|Overall Study|Lost to Follow-up|11|||
131484071|NCT00713323|473402820|FG000|Overall Study|Lack of Efficacy|36|||
131484072|NCT00713323|473402820|FG000|Overall Study|Low creatine clearance at screening|1|||
131484073|NCT00713323|473402820|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
131484074|NCT00713323|473402820|FG000|Overall Study|Surgery cured allodynic pain|1|||
131484075|NCT00713323|473402820|FG000|Overall Study|Pain free|1|||
131484076|NCT00713323|473402820|FG000|Overall Study|Non-compliance|1|||
131484077|NCT00713323|473402820|FG000|Overall Study|Pain resolved|1|||
131484078|NCT00713323|473402820|FG000|Overall Study|Subject travelling to USA|1|||
131484079|NCT00713323|473402820|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
131484080|NCT00713323|473402820|FG000|Overall Study|Treatment that may interact with Sativex|1|||
131484081|NCT01826604|473402822|FG000|Overall Study|Lost to Follow-up|8|||
131484082|NCT01826604|473402823|FG001|Overall Study|Lost to Follow-up|9|||
131484083|NCT00491075|473402824|FG000|Overall Study|Withdrawal by Subject|1|||
131484084|NCT00491075|473402824|FG000|Overall Study|Physician Decision|1|||
131484085|NCT01603355|473402825|FG000|Overall Study|Lack of Efficacy|2|||
131484086|NCT02589405|473402828|FG000|Overall Study|Adverse Event|3|||
131484087|NCT02589405|473402828|FG000|Overall Study|Withdrawal by Subject|1|||
131484088|NCT01032174|473402831|FG000|Overall Study|Adverse Event|0|||
131484089|NCT01032174|473402832|FG001|Overall Study|Adverse Event|1|||
131484090|NCT02761733|473402836|FG000|Overall Study|Death|3|||
131484091|NCT02761733|473402837|FG001|Overall Study|Death|5|||
131484092|NCT02761733|473402838|FG002|Overall Study|Death|1|||
131484093|NCT02761733|473402839|FG003|Overall Study|Death|1|||
131484094|NCT02761733|473402836|FG000|Overall Study|Lost to Follow-up|6|||
131484095|NCT02761733|473402837|FG001|Overall Study|Lost to Follow-up|7|||
131484096|NCT02761733|473402838|FG002|Overall Study|Lost to Follow-up|0|||
131484097|NCT02761733|473402839|FG003|Overall Study|Lost to Follow-up|3|||
131484098|NCT02761733|473402836|FG000|Overall Study|Physician Decision|4|||
131484099|NCT02761733|473402837|FG001|Overall Study|Physician Decision|0|||
131484100|NCT02761733|473402838|FG002|Overall Study|Physician Decision|0|||
131484101|NCT02761733|473402839|FG003|Overall Study|Physician Decision|0|||
131484102|NCT02761733|473402836|FG000|Overall Study|Withdrawal by Subject|2|||
131484103|NCT02761733|473402837|FG001|Overall Study|Withdrawal by Subject|0|||
131484104|NCT02761733|473402838|FG002|Overall Study|Withdrawal by Subject|0|||
131484105|NCT02761733|473402839|FG003|Overall Study|Withdrawal by Subject|0|||
131484106|NCT02761733|473402836|FG000|Overall Study|Discharged from Study Site|10|||
131484107|NCT02761733|473402837|FG001|Overall Study|Discharged from Study Site|9|||
131484108|NCT02761733|473402838|FG002|Overall Study|Discharged from Study Site|25|||
131484109|NCT02761733|473402839|FG003|Overall Study|Discharged from Study Site|11|||
131484110|NCT02761733|473402836|FG000|Overall Study|Cognitive Impairment|5|||
131484111|NCT02761733|473402837|FG001|Overall Study|Cognitive Impairment|0|||
131484112|NCT02761733|473402838|FG002|Overall Study|Cognitive Impairment|1|||
131484113|NCT02761733|473402839|FG003|Overall Study|Cognitive Impairment|0|||
131484114|NCT01986907|473402842|FG000|Overall Study|Adverse Event|11|||
131484115|NCT01986907|473402842|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
131484116|NCT01986907|473402842|FG000|Overall Study|Protocol Violation|4|||
131484117|NCT01986907|473402842|FG000|Overall Study|Withdrawal by Subject|76|||
131484118|NCT01986907|473402842|FG000|Overall Study|Lost to Follow-up|38|||
131484119|NCT01986907|473402842|FG000|Overall Study|Death|9|||
131484120|NCT04295772|473402846|FG000|Overall Study|Protocol Violation|1|||
131484121|NCT04295772|473402847|FG001|Overall Study|Protocol Violation|0|||
131484122|NCT04295772|473402846|FG000|Overall Study|Ongoing for safety monitoring|14|||
131484123|NCT04295772|473402847|FG001|Overall Study|Ongoing for safety monitoring|1|||
131484124|NCT04295772|473402846|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
131484125|NCT04295772|473402847|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
131484126|NCT02846324|473402848|FG000|Overall Study|Other|1|||
131484127|NCT02846324|473402849|FG001|Overall Study|Other|0|||
131484128|NCT02846324|473402850|FG002|Overall Study|Other|0|||
131484129|NCT02846324|473402851|FG003|Overall Study|Other|0|||
131484130|NCT02846324|473402848|FG000|Overall Study|Withdrawal by Subject|1|||
131484131|NCT02846324|473402849|FG001|Overall Study|Withdrawal by Subject|0|||
131484132|NCT02846324|473402850|FG002|Overall Study|Withdrawal by Subject|4|||
131484133|NCT02846324|473402851|FG003|Overall Study|Withdrawal by Subject|0|||
131484134|NCT02635776|473402859|FG000|Overall Study|Physician Decision|1|||
131484135|NCT02635776|473402860|FG001|Overall Study|Physician Decision|0|||
131484136|NCT02635776|473402859|FG000|Overall Study|Adverse Event|51|||
131484137|NCT02635776|473402860|FG001|Overall Study|Adverse Event|3|||
131484138|NCT02635776|473402859|FG000|Overall Study|Withdrawal by Subject|41|||
131484139|NCT02635776|473402860|FG001|Overall Study|Withdrawal by Subject|7|||
131484140|NCT02635776|473402859|FG000|Overall Study|Lost to Follow-up|4|||
131484141|NCT02635776|473402860|FG001|Overall Study|Lost to Follow-up|0|||
131484142|NCT02635776|473402859|FG000|Overall Study|Other reasons|5|||
131484143|NCT02635776|473402860|FG001|Overall Study|Other reasons|1|||
131484144|NCT00239590|473402861|FG000|Randomized|Lost to Follow-up|0|||
131484145|NCT00239590|473402862|FG001|Randomized|Lost to Follow-up|1|||
131484146|NCT00239590|473402861|FG000|Randomized|Withdrawal by Subject|0|||
131484147|NCT00239590|473402862|FG001|Randomized|Withdrawal by Subject|1|||
131484148|NCT00239590|473402861|FG000|Completed Study Protocol|Adverse Event|1|||
131484149|NCT00239590|473402862|FG001|Completed Study Protocol|Adverse Event|1|||
131484150|NCT00239590|473402861|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
131484151|NCT00239590|473402862|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
131484152|NCT00516074|473402863|FG000|Overall Study|Adverse Event|0|||
131484153|NCT00516074|473402864|FG001|Overall Study|Adverse Event|1|||
131484154|NCT00516074|473402863|FG000|Overall Study|Subject Decision|4|||
131484155|NCT00516074|473402864|FG001|Overall Study|Subject Decision|2|||
131484156|NCT00516074|473402863|FG000|Overall Study|Loss of Glucose Control|2|||
131484157|NCT00516074|473402864|FG001|Overall Study|Loss of Glucose Control|0|||
131484158|NCT02362269|473402865|FG000|Overall Study|Moved|1|||
131484159|NCT02362269|473402866|FG001|Overall Study|Moved|0|||
131484160|NCT02362269|473402865|FG000|Overall Study|Lost to Follow-up|0|||
131484161|NCT02362269|473402866|FG001|Overall Study|Lost to Follow-up|6|||
131484162|NCT00447005|473402868|FG000|Overall Study|Adverse Event|1|||
131484163|NCT00447005|473402868|FG000|Overall Study|Lack of Efficacy|11|||
131484164|NCT00003487|473402869|FG000|Overall Study|Not evaluable|2|||
131484165|NCT02058693|473402876|FG000|Phase 1|Withdrawal by Subject|3|||
131484166|NCT02058693|473402877|FG001|Phase 1|Withdrawal by Subject|2|||
131484167|NCT02058693|473402876|FG000|Phase 1|Adverse Event|0|||
131484168|NCT02058693|473402877|FG001|Phase 1|Adverse Event|1|||
131484169|NCT02058693|473402876|FG000|Phase 1|Lack of Efficacy|1|||
131484170|NCT02058693|473402877|FG001|Phase 1|Lack of Efficacy|0|||
131484171|NCT02058693|473402876|FG000|Phase 1|Physician Decision|1|||
131484172|NCT02058693|473402877|FG001|Phase 1|Physician Decision|1|||
131484173|NCT02058693|473402876|FG000|Phase 2|Withdrawal by Subject|0|||
131484174|NCT02058693|473402877|FG001|Phase 2|Withdrawal by Subject|2|||
131484175|NCT00347360|473402889|FG000|Overall Study|Adverse Event|1|||
131484176|NCT00347360|473402890|FG001|Overall Study|Adverse Event|2|||
131484177|NCT00347360|473402891|FG002|Overall Study|Adverse Event|0|||
131484178|NCT00347360|473402892|FG003|Overall Study|Adverse Event|4|||
131484179|NCT00347360|473402893|FG004|Overall Study|Adverse Event|1|||
131484180|NCT00347360|473402894|FG005|Overall Study|Adverse Event|2|||
131484181|NCT00347360|473402895|FG006|Overall Study|Adverse Event|2|||
131484182|NCT00347360|473402896|FG007|Overall Study|Adverse Event|0|||
131484183|NCT00347360|473402897|FG008|Overall Study|Adverse Event|2|||
131484184|NCT00347360|473402898|FG009|Overall Study|Adverse Event|3|||
131484185|NCT00347360|473402899|FG010|Overall Study|Adverse Event|3|||
131484186|NCT00347360|473402900|FG011|Overall Study|Adverse Event|1|||
131484187|NCT00347360|473402901|FG012|Overall Study|Adverse Event|3|||
131484188|NCT00347360|473402902|FG013|Overall Study|Adverse Event|2|||
131484189|NCT00347360|473402903|FG014|Overall Study|Adverse Event|2|||
131484190|NCT00347360|473402889|FG000|Overall Study|Lost to Follow-up|0|||
131484191|NCT00347360|473402890|FG001|Overall Study|Lost to Follow-up|0|||
131484192|NCT00347360|473402891|FG002|Overall Study|Lost to Follow-up|0|||
131484193|NCT00347360|473402892|FG003|Overall Study|Lost to Follow-up|2|||
131484194|NCT00347360|473402893|FG004|Overall Study|Lost to Follow-up|1|||
131484195|NCT00347360|473402894|FG005|Overall Study|Lost to Follow-up|1|||
131484196|NCT00347360|473402895|FG006|Overall Study|Lost to Follow-up|0|||
131484197|NCT00347360|473402896|FG007|Overall Study|Lost to Follow-up|1|||
131484198|NCT00347360|473402897|FG008|Overall Study|Lost to Follow-up|1|||
131484199|NCT00347360|473402898|FG009|Overall Study|Lost to Follow-up|2|||
131484200|NCT00347360|473402899|FG010|Overall Study|Lost to Follow-up|0|||
131484201|NCT00347360|473402900|FG011|Overall Study|Lost to Follow-up|0|||
131484202|NCT00347360|473402901|FG012|Overall Study|Lost to Follow-up|1|||
131484203|NCT00347360|473402902|FG013|Overall Study|Lost to Follow-up|0|||
131484204|NCT00347360|473402903|FG014|Overall Study|Lost to Follow-up|0|||
131484205|NCT00347360|473402889|FG000|Overall Study|Protocol Violation|2|||
131484206|NCT00347360|473402890|FG001|Overall Study|Protocol Violation|3|||
131484207|NCT00347360|473402891|FG002|Overall Study|Protocol Violation|1|||
131484208|NCT00347360|473402892|FG003|Overall Study|Protocol Violation|2|||
131484209|NCT00347360|473402893|FG004|Overall Study|Protocol Violation|1|||
131484210|NCT00347360|473402894|FG005|Overall Study|Protocol Violation|2|||
131484211|NCT00347360|473402895|FG006|Overall Study|Protocol Violation|0|||
131484212|NCT00347360|473402896|FG007|Overall Study|Protocol Violation|0|||
131484213|NCT00347360|473402897|FG008|Overall Study|Protocol Violation|1|||
131484214|NCT00347360|473402898|FG009|Overall Study|Protocol Violation|2|||
131484215|NCT00347360|473402899|FG010|Overall Study|Protocol Violation|0|||
131484216|NCT00347360|473402900|FG011|Overall Study|Protocol Violation|0|||
131484217|NCT00347360|473402901|FG012|Overall Study|Protocol Violation|0|||
131484218|NCT00347360|473402902|FG013|Overall Study|Protocol Violation|1|||
131484219|NCT00347360|473402903|FG014|Overall Study|Protocol Violation|0|||
131484220|NCT00347360|473402889|FG000|Overall Study|Withdrawal by Subject|0|||
131484221|NCT00347360|473402890|FG001|Overall Study|Withdrawal by Subject|1|||
131484222|NCT00347360|473402891|FG002|Overall Study|Withdrawal by Subject|2|||
131484223|NCT00347360|473402892|FG003|Overall Study|Withdrawal by Subject|4|||
131484224|NCT00347360|473402893|FG004|Overall Study|Withdrawal by Subject|1|||
131484225|NCT00347360|473402894|FG005|Overall Study|Withdrawal by Subject|2|||
131484226|NCT00347360|473402895|FG006|Overall Study|Withdrawal by Subject|1|||
131484227|NCT00347360|473402896|FG007|Overall Study|Withdrawal by Subject|1|||
131484228|NCT00347360|473402897|FG008|Overall Study|Withdrawal by Subject|1|||
131484229|NCT00347360|473402898|FG009|Overall Study|Withdrawal by Subject|1|||
131484230|NCT00347360|473402899|FG010|Overall Study|Withdrawal by Subject|0|||
131484231|NCT00347360|473402900|FG011|Overall Study|Withdrawal by Subject|3|||
131484232|NCT00347360|473402901|FG012|Overall Study|Withdrawal by Subject|4|||
131484233|NCT00347360|473402902|FG013|Overall Study|Withdrawal by Subject|2|||
131484234|NCT00347360|473402903|FG014|Overall Study|Withdrawal by Subject|1|||
131484235|NCT00347360|473402889|FG000|Overall Study|Lack of Efficacy|1|||
131484236|NCT00347360|473402890|FG001|Overall Study|Lack of Efficacy|1|||
131484237|NCT00347360|473402891|FG002|Overall Study|Lack of Efficacy|3|||
131484238|NCT00347360|473402892|FG003|Overall Study|Lack of Efficacy|1|||
131484239|NCT00347360|473402893|FG004|Overall Study|Lack of Efficacy|0|||
131484240|NCT00347360|473402894|FG005|Overall Study|Lack of Efficacy|1|||
131484241|NCT00347360|473402895|FG006|Overall Study|Lack of Efficacy|0|||
131484242|NCT00347360|473402896|FG007|Overall Study|Lack of Efficacy|1|||
131484243|NCT00347360|473402897|FG008|Overall Study|Lack of Efficacy|1|||
131484244|NCT00347360|473402898|FG009|Overall Study|Lack of Efficacy|0|||
131484245|NCT00347360|473402899|FG010|Overall Study|Lack of Efficacy|0|||
131484246|NCT00347360|473402900|FG011|Overall Study|Lack of Efficacy|0|||
131484247|NCT00347360|473402901|FG012|Overall Study|Lack of Efficacy|0|||
131484248|NCT00347360|473402902|FG013|Overall Study|Lack of Efficacy|0|||
131484249|NCT00347360|473402903|FG014|Overall Study|Lack of Efficacy|0|||
131484250|NCT00347360|473402889|FG000|Overall Study|Reason not listed/blank|1|||
131484251|NCT00347360|473402890|FG001|Overall Study|Reason not listed/blank|0|||
131484252|NCT00347360|473402891|FG002|Overall Study|Reason not listed/blank|0|||
131484253|NCT00347360|473402892|FG003|Overall Study|Reason not listed/blank|0|||
131484254|NCT00347360|473402893|FG004|Overall Study|Reason not listed/blank|0|||
131484255|NCT00347360|473402894|FG005|Overall Study|Reason not listed/blank|0|||
131484256|NCT00347360|473402895|FG006|Overall Study|Reason not listed/blank|1|||
131484257|NCT00347360|473402896|FG007|Overall Study|Reason not listed/blank|0|||
131484258|NCT00347360|473402897|FG008|Overall Study|Reason not listed/blank|0|||
131484259|NCT00347360|473402898|FG009|Overall Study|Reason not listed/blank|0|||
131484260|NCT00347360|473402899|FG010|Overall Study|Reason not listed/blank|0|||
131484261|NCT00347360|473402900|FG011|Overall Study|Reason not listed/blank|0|||
131484262|NCT00347360|473402901|FG012|Overall Study|Reason not listed/blank|0|||
131484263|NCT00347360|473402902|FG013|Overall Study|Reason not listed/blank|1|||
131484264|NCT00347360|473402903|FG014|Overall Study|Reason not listed/blank|0|||
131484265|NCT00347360|473402889|FG000|Overall Study|Per sponsors instruction|0|||
131484266|NCT00347360|473402890|FG001|Overall Study|Per sponsors instruction|1|||
131484267|NCT00347360|473402891|FG002|Overall Study|Per sponsors instruction|0|||
131484268|NCT00347360|473402892|FG003|Overall Study|Per sponsors instruction|0|||
131484269|NCT00347360|473402893|FG004|Overall Study|Per sponsors instruction|0|||
131484270|NCT00347360|473402894|FG005|Overall Study|Per sponsors instruction|0|||
131484271|NCT00347360|473402895|FG006|Overall Study|Per sponsors instruction|0|||
131484272|NCT00347360|473402896|FG007|Overall Study|Per sponsors instruction|0|||
131484273|NCT00347360|473402897|FG008|Overall Study|Per sponsors instruction|0|||
131484274|NCT00347360|473402898|FG009|Overall Study|Per sponsors instruction|0|||
131484275|NCT00347360|473402899|FG010|Overall Study|Per sponsors instruction|0|||
131484276|NCT00347360|473402900|FG011|Overall Study|Per sponsors instruction|0|||
131484277|NCT00347360|473402901|FG012|Overall Study|Per sponsors instruction|0|||
131484278|NCT00347360|473402902|FG013|Overall Study|Per sponsors instruction|0|||
131484279|NCT00347360|473402903|FG014|Overall Study|Per sponsors instruction|0|||
131484280|NCT00347360|473402889|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
131484281|NCT00347360|473402890|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
131484282|NCT00347360|473402891|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
131484283|NCT00347360|473402892|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
131484284|NCT00347360|473402893|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
131484285|NCT00347360|473402894|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
131484286|NCT00347360|473402895|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
131484287|NCT00347360|473402896|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
131484288|NCT00347360|473402897|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
131484289|NCT00347360|473402898|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
131484290|NCT00347360|473402899|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
131484291|NCT00347360|473402900|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
131484292|NCT00347360|473402901|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
131484293|NCT00347360|473402902|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
131484294|NCT00347360|473402903|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
131484295|NCT00347360|473402889|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
131484296|NCT00347360|473402890|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
131484297|NCT00347360|473402891|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
131484298|NCT00347360|473402892|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
131484299|NCT00347360|473402893|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
131484300|NCT00347360|473402894|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
131484301|NCT00347360|473402895|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
131484302|NCT00347360|473402896|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
131484303|NCT00347360|473402897|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
131484304|NCT00347360|473402898|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
131484305|NCT00347360|473402899|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
131484306|NCT00347360|473402900|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
131484307|NCT00347360|473402901|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
131484308|NCT00347360|473402902|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
131484309|NCT00347360|473402903|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
131484310|NCT00347360|473402889|FG000|Overall Study|Abnormal lab values|0|||
131484311|NCT00347360|473402890|FG001|Overall Study|Abnormal lab values|0|||
131484312|NCT00347360|473402891|FG002|Overall Study|Abnormal lab values|0|||
131484313|NCT00347360|473402892|FG003|Overall Study|Abnormal lab values|0|||
131484314|NCT00347360|473402893|FG004|Overall Study|Abnormal lab values|0|||
131484315|NCT00347360|473402894|FG005|Overall Study|Abnormal lab values|0|||
131484316|NCT00347360|473402895|FG006|Overall Study|Abnormal lab values|1|||
131484317|NCT00347360|473402896|FG007|Overall Study|Abnormal lab values|0|||
131484318|NCT00347360|473402897|FG008|Overall Study|Abnormal lab values|0|||
131484319|NCT00347360|473402898|FG009|Overall Study|Abnormal lab values|0|||
131484320|NCT00347360|473402899|FG010|Overall Study|Abnormal lab values|0|||
131484321|NCT00347360|473402900|FG011|Overall Study|Abnormal lab values|0|||
131484322|NCT00347360|473402901|FG012|Overall Study|Abnormal lab values|0|||
131484323|NCT00347360|473402902|FG013|Overall Study|Abnormal lab values|0|||
131484324|NCT00347360|473402903|FG014|Overall Study|Abnormal lab values|0|||
131484325|NCT00347360|473402889|FG000|Overall Study|PI recommended early withdrawal|0|||
131484326|NCT00347360|473402890|FG001|Overall Study|PI recommended early withdrawal|0|||
131484327|NCT00347360|473402891|FG002|Overall Study|PI recommended early withdrawal|0|||
131484328|NCT00347360|473402892|FG003|Overall Study|PI recommended early withdrawal|0|||
131484329|NCT00347360|473402893|FG004|Overall Study|PI recommended early withdrawal|0|||
131484330|NCT00347360|473402894|FG005|Overall Study|PI recommended early withdrawal|0|||
131484331|NCT00347360|473402895|FG006|Overall Study|PI recommended early withdrawal|0|||
131484332|NCT00347360|473402896|FG007|Overall Study|PI recommended early withdrawal|0|||
131484333|NCT00347360|473402897|FG008|Overall Study|PI recommended early withdrawal|0|||
131484334|NCT00347360|473402898|FG009|Overall Study|PI recommended early withdrawal|1|||
131484335|NCT00347360|473402899|FG010|Overall Study|PI recommended early withdrawal|0|||
131484336|NCT00347360|473402900|FG011|Overall Study|PI recommended early withdrawal|0|||
131484337|NCT00347360|473402901|FG012|Overall Study|PI recommended early withdrawal|0|||
131484338|NCT00347360|473402902|FG013|Overall Study|PI recommended early withdrawal|0|||
131484339|NCT00347360|473402903|FG014|Overall Study|PI recommended early withdrawal|0|||
131484340|NCT00347360|473402889|FG000|Overall Study|Did not meet criteria before ABPM|0|||
131484341|NCT00347360|473402890|FG001|Overall Study|Did not meet criteria before ABPM|0|||
131484342|NCT00347360|473402891|FG002|Overall Study|Did not meet criteria before ABPM|0|||
131484343|NCT00347360|473402892|FG003|Overall Study|Did not meet criteria before ABPM|0|||
131484344|NCT00347360|473402893|FG004|Overall Study|Did not meet criteria before ABPM|0|||
131484345|NCT00347360|473402894|FG005|Overall Study|Did not meet criteria before ABPM|0|||
131484346|NCT00347360|473402895|FG006|Overall Study|Did not meet criteria before ABPM|0|||
131484347|NCT00347360|473402896|FG007|Overall Study|Did not meet criteria before ABPM|0|||
131484348|NCT00347360|473402897|FG008|Overall Study|Did not meet criteria before ABPM|0|||
131484349|NCT00347360|473402898|FG009|Overall Study|Did not meet criteria before ABPM|0|||
131484350|NCT00347360|473402899|FG010|Overall Study|Did not meet criteria before ABPM|1|||
131484351|NCT00347360|473402900|FG011|Overall Study|Did not meet criteria before ABPM|0|||
131484352|NCT00347360|473402901|FG012|Overall Study|Did not meet criteria before ABPM|0|||
131484353|NCT00347360|473402902|FG013|Overall Study|Did not meet criteria before ABPM|0|||
131484354|NCT00347360|473402903|FG014|Overall Study|Did not meet criteria before ABPM|0|||
131484355|NCT00347360|473402889|FG000|Overall Study|Randomized in error|0|||
131484356|NCT00347360|473402890|FG001|Overall Study|Randomized in error|0|||
131484357|NCT00347360|473402891|FG002|Overall Study|Randomized in error|0|||
131484358|NCT00347360|473402892|FG003|Overall Study|Randomized in error|0|||
131484359|NCT00347360|473402893|FG004|Overall Study|Randomized in error|0|||
131484360|NCT00347360|473402894|FG005|Overall Study|Randomized in error|0|||
131484361|NCT00347360|473402895|FG006|Overall Study|Randomized in error|0|||
131484362|NCT00347360|473402896|FG007|Overall Study|Randomized in error|0|||
131484363|NCT00347360|473402897|FG008|Overall Study|Randomized in error|0|||
131484364|NCT00347360|473402898|FG009|Overall Study|Randomized in error|0|||
131484365|NCT00347360|473402899|FG010|Overall Study|Randomized in error|0|||
131484366|NCT00347360|473402900|FG011|Overall Study|Randomized in error|1|||
131484367|NCT00347360|473402901|FG012|Overall Study|Randomized in error|0|||
131484368|NCT00347360|473402902|FG013|Overall Study|Randomized in error|0|||
131484369|NCT00347360|473402903|FG014|Overall Study|Randomized in error|0|||
131484370|NCT00347360|473402889|FG000|Overall Study|Failed inclusion criteria #4|0|||
131484371|NCT00347360|473402890|FG001|Overall Study|Failed inclusion criteria #4|0|||
131484372|NCT00347360|473402891|FG002|Overall Study|Failed inclusion criteria #4|0|||
131484373|NCT00347360|473402892|FG003|Overall Study|Failed inclusion criteria #4|0|||
131484374|NCT00347360|473402893|FG004|Overall Study|Failed inclusion criteria #4|0|||
131484375|NCT00347360|473402894|FG005|Overall Study|Failed inclusion criteria #4|0|||
131484376|NCT00347360|473402895|FG006|Overall Study|Failed inclusion criteria #4|0|||
131484377|NCT00347360|473402896|FG007|Overall Study|Failed inclusion criteria #4|0|||
131484378|NCT00347360|473402897|FG008|Overall Study|Failed inclusion criteria #4|0|||
131484379|NCT00347360|473402898|FG009|Overall Study|Failed inclusion criteria #4|0|||
131484380|NCT00347360|473402899|FG010|Overall Study|Failed inclusion criteria #4|0|||
131484381|NCT00347360|473402900|FG011|Overall Study|Failed inclusion criteria #4|1|||
131484382|NCT00347360|473402901|FG012|Overall Study|Failed inclusion criteria #4|0|||
131484383|NCT00347360|473402902|FG013|Overall Study|Failed inclusion criteria #4|0|||
131484384|NCT00347360|473402903|FG014|Overall Study|Failed inclusion criteria #4|0|||
131484385|NCT00347360|473402889|FG000|Overall Study|Prolonged duration between visits|0|||
131484386|NCT00347360|473402890|FG001|Overall Study|Prolonged duration between visits|0|||
131484387|NCT00347360|473402891|FG002|Overall Study|Prolonged duration between visits|0|||
131484388|NCT00347360|473402892|FG003|Overall Study|Prolonged duration between visits|0|||
131484389|NCT00347360|473402893|FG004|Overall Study|Prolonged duration between visits|0|||
131484390|NCT00347360|473402894|FG005|Overall Study|Prolonged duration between visits|0|||
131484391|NCT00347360|473402895|FG006|Overall Study|Prolonged duration between visits|0|||
131484392|NCT00347360|473402896|FG007|Overall Study|Prolonged duration between visits|0|||
131484393|NCT00347360|473402897|FG008|Overall Study|Prolonged duration between visits|0|||
131484394|NCT00347360|473402898|FG009|Overall Study|Prolonged duration between visits|0|||
131484395|NCT00347360|473402899|FG010|Overall Study|Prolonged duration between visits|0|||
131484396|NCT00347360|473402900|FG011|Overall Study|Prolonged duration between visits|0|||
131484397|NCT00347360|473402901|FG012|Overall Study|Prolonged duration between visits|1|||
131484398|NCT00347360|473402902|FG013|Overall Study|Prolonged duration between visits|0|||
131484399|NCT00347360|473402903|FG014|Overall Study|Prolonged duration between visits|0|||
131484400|NCT00347360|473402889|FG000|Overall Study|Subject left town, ran out of study drug|0|||
131484401|NCT00347360|473402890|FG001|Overall Study|Subject left town, ran out of study drug|0|||
131484402|NCT00347360|473402891|FG002|Overall Study|Subject left town, ran out of study drug|0|||
131484403|NCT00347360|473402892|FG003|Overall Study|Subject left town, ran out of study drug|0|||
131484404|NCT00347360|473402893|FG004|Overall Study|Subject left town, ran out of study drug|0|||
131484405|NCT00347360|473402894|FG005|Overall Study|Subject left town, ran out of study drug|0|||
131484406|NCT00347360|473402895|FG006|Overall Study|Subject left town, ran out of study drug|0|||
131484407|NCT00347360|473402896|FG007|Overall Study|Subject left town, ran out of study drug|0|||
131484408|NCT00347360|473402897|FG008|Overall Study|Subject left town, ran out of study drug|0|||
131484409|NCT00347360|473402898|FG009|Overall Study|Subject left town, ran out of study drug|0|||
131484410|NCT00347360|473402899|FG010|Overall Study|Subject left town, ran out of study drug|0|||
131484411|NCT00347360|473402900|FG011|Overall Study|Subject left town, ran out of study drug|0|||
131484412|NCT00347360|473402901|FG012|Overall Study|Subject left town, ran out of study drug|0|||
131484413|NCT00347360|473402902|FG013|Overall Study|Subject left town, ran out of study drug|1|||
131484414|NCT00347360|473402903|FG014|Overall Study|Subject left town, ran out of study drug|0|||
131484415|NCT00347360|473402889|FG000|Overall Study|Subject refuse to sign updated consent|0|||
131484416|NCT00347360|473402890|FG001|Overall Study|Subject refuse to sign updated consent|0|||
131484417|NCT00347360|473402891|FG002|Overall Study|Subject refuse to sign updated consent|0|||
131484418|NCT00347360|473402892|FG003|Overall Study|Subject refuse to sign updated consent|0|||
131484419|NCT00347360|473402893|FG004|Overall Study|Subject refuse to sign updated consent|0|||
131484420|NCT00347360|473402894|FG005|Overall Study|Subject refuse to sign updated consent|0|||
131484421|NCT00347360|473402895|FG006|Overall Study|Subject refuse to sign updated consent|0|||
131484422|NCT00347360|473402896|FG007|Overall Study|Subject refuse to sign updated consent|0|||
131484423|NCT00347360|473402897|FG008|Overall Study|Subject refuse to sign updated consent|0|||
131484424|NCT00347360|473402898|FG009|Overall Study|Subject refuse to sign updated consent|0|||
131484425|NCT00347360|473402899|FG010|Overall Study|Subject refuse to sign updated consent|0|||
131484426|NCT00347360|473402900|FG011|Overall Study|Subject refuse to sign updated consent|0|||
131484427|NCT00347360|473402901|FG012|Overall Study|Subject refuse to sign updated consent|0|||
131484428|NCT00347360|473402902|FG013|Overall Study|Subject refuse to sign updated consent|0|||
131484429|NCT00347360|473402903|FG014|Overall Study|Subject refuse to sign updated consent|1|||
131484430|NCT00347360|473402889|FG000|Overall Study|Visits conflicted with new job|0|||
131484431|NCT00347360|473402890|FG001|Overall Study|Visits conflicted with new job|0|||
131484432|NCT00347360|473402891|FG002|Overall Study|Visits conflicted with new job|0|||
131484433|NCT00347360|473402892|FG003|Overall Study|Visits conflicted with new job|0|||
131484434|NCT00347360|473402893|FG004|Overall Study|Visits conflicted with new job|0|||
131484435|NCT00347360|473402894|FG005|Overall Study|Visits conflicted with new job|0|||
131484436|NCT00347360|473402895|FG006|Overall Study|Visits conflicted with new job|1|||
131484437|NCT00347360|473402896|FG007|Overall Study|Visits conflicted with new job|0|||
131484438|NCT00347360|473402897|FG008|Overall Study|Visits conflicted with new job|0|||
131484439|NCT00347360|473402898|FG009|Overall Study|Visits conflicted with new job|0|||
131484440|NCT00347360|473402899|FG010|Overall Study|Visits conflicted with new job|0|||
131484441|NCT00347360|473402900|FG011|Overall Study|Visits conflicted with new job|0|||
131484442|NCT00347360|473402901|FG012|Overall Study|Visits conflicted with new job|0|||
131484443|NCT00347360|473402902|FG013|Overall Study|Visits conflicted with new job|0|||
131484444|NCT00347360|473402903|FG014|Overall Study|Visits conflicted with new job|0|||
131484445|NCT01387789|473402904|FG000|Overall Study|Adverse Event|5|||
131484446|NCT01387789|473402904|FG000|Overall Study|Lack of Efficacy|2|||
131484447|NCT01387789|473402904|FG000|Overall Study|Lost to Follow-up|1|||
131484448|NCT00508755|473402913|FG000|Overall Study|Withdrawal by Subject|1|||
131484449|NCT00945893|473402914|FG000|Overall Study|Lost to Follow-up|2|||
131484450|NCT00945893|473402915|FG001|Overall Study|Lost to Follow-up|8|||
131484451|NCT00945893|473402914|FG000|Overall Study|Withdrawal of consent|1|||
131484452|NCT00945893|473402915|FG001|Overall Study|Withdrawal of consent|2|||
131484453|NCT03113071|473402916|FG000|Overall Study|Withdrawal by Subject|1|||
131484454|NCT03113071|473402917|FG001|Overall Study|Withdrawal by Subject|0|||
131484455|NCT01602120|473402918|FG000|Overall Study|Adverse Event|3|||
131484456|NCT01602120|473402919|FG001|Overall Study|Adverse Event|6|||
131484457|NCT01602120|473402920|FG002|Overall Study|Adverse Event|0|||
131484458|NCT01602120|473402921|FG003|Overall Study|Adverse Event|2|||
131484459|NCT01602120|473402918|FG000|Overall Study|Death|0|||
131484460|NCT01602120|473402919|FG001|Overall Study|Death|4|||
131484461|NCT01602120|473402920|FG002|Overall Study|Death|0|||
131484462|NCT01602120|473402921|FG003|Overall Study|Death|0|||
131484463|NCT01602120|473402918|FG000|Overall Study|Lost to Follow-up|0|||
131484464|NCT01602120|473402919|FG001|Overall Study|Lost to Follow-up|1|||
131484465|NCT01602120|473402920|FG002|Overall Study|Lost to Follow-up|0|||
131484466|NCT01602120|473402921|FG003|Overall Study|Lost to Follow-up|1|||
131484467|NCT01602120|473402918|FG000|Overall Study|Protocol Violation|1|||
131484468|NCT01602120|473402919|FG001|Overall Study|Protocol Violation|1|||
131484469|NCT01602120|473402920|FG002|Overall Study|Protocol Violation|0|||
131484470|NCT01602120|473402921|FG003|Overall Study|Protocol Violation|0|||
131484471|NCT01602120|473402918|FG000|Overall Study|Non-compliance|0|||
131484472|NCT01602120|473402919|FG001|Overall Study|Non-compliance|3|||
131484473|NCT01602120|473402920|FG002|Overall Study|Non-compliance|0|||
131484474|NCT01602120|473402921|FG003|Overall Study|Non-compliance|1|||
131484475|NCT01602120|473402918|FG000|Overall Study|Withdrawal by Subject|8|||
131484476|NCT01602120|473402919|FG001|Overall Study|Withdrawal by Subject|17|||
131484477|NCT01602120|473402920|FG002|Overall Study|Withdrawal by Subject|0|||
131484478|NCT01602120|473402921|FG003|Overall Study|Withdrawal by Subject|3|||
131484479|NCT01602120|473402918|FG000|Overall Study|Study Terminated by Sponsor|12|||
131484480|NCT01602120|473402919|FG001|Overall Study|Study Terminated by Sponsor|24|||
131484481|NCT01602120|473402920|FG002|Overall Study|Study Terminated by Sponsor|17|||
131484482|NCT01602120|473402921|FG003|Overall Study|Study Terminated by Sponsor|44|||
131484483|NCT01602120|473402918|FG000|Overall Study|Physician Decision|2|||
131484484|NCT01602120|473402919|FG001|Overall Study|Physician Decision|3|||
131484485|NCT01602120|473402920|FG002|Overall Study|Physician Decision|0|||
131484486|NCT01602120|473402921|FG003|Overall Study|Physician Decision|0|||
131484487|NCT01602120|473402918|FG000|Overall Study|Unspecified Reason|3|||
131484488|NCT01602120|473402919|FG001|Overall Study|Unspecified Reason|1|||
131484489|NCT01602120|473402920|FG002|Overall Study|Unspecified Reason|0|||
131484490|NCT01602120|473402921|FG003|Overall Study|Unspecified Reason|2|||
131484491|NCT01187433|473402932|FG000|Overall Study|Protocol Violation|6|||
131484492|NCT01187433|473402933|FG001|Overall Study|Protocol Violation|2|||
131484493|NCT01187433|473402932|FG000|Overall Study|Withdrawal by Subject|5|||
131484494|NCT01187433|473402933|FG001|Overall Study|Withdrawal by Subject|2|||
131484495|NCT00437983|473402935|FG000|Overall Study|Adverse Event|6|||
131484496|NCT00437983|473402936|FG001|Overall Study|Adverse Event|6|||
131484497|NCT00437983|473402935|FG000|Overall Study|Protocol Violation|2|||
131484498|NCT00437983|473402936|FG001|Overall Study|Protocol Violation|1|||
131484499|NCT00437983|473402935|FG000|Overall Study|Withdrawal by Subject|5|||
131484500|NCT00437983|473402936|FG001|Overall Study|Withdrawal by Subject|6|||
131484501|NCT00672646|473402939|FG000|Overall Study|Lost to Follow-up|0|||
131484502|NCT00672646|473402940|FG001|Overall Study|Lost to Follow-up|1|||
131484503|NCT00672646|473402941|FG002|Overall Study|Lost to Follow-up|2|||
131484504|NCT00672646|473402939|FG000|Overall Study|Withdrawal by Subject|0|||
131484505|NCT00672646|473402940|FG001|Overall Study|Withdrawal by Subject|0|||
131484506|NCT00672646|473402941|FG002|Overall Study|Withdrawal by Subject|1|||
131484507|NCT00300274|473402942|FG000|Overall Study|Withdrawal by Subject|12|||
131484508|NCT00300274|473402943|FG001|Overall Study|Withdrawal by Subject|3|||
131484509|NCT00300274|473402944|FG002|Overall Study|Withdrawal by Subject|14|||
131484510|NCT00300274|473402942|FG000|Overall Study|Lost to Follow-up|3|||
131484511|NCT00300274|473402943|FG001|Overall Study|Lost to Follow-up|4|||
131484512|NCT00300274|473402944|FG002|Overall Study|Lost to Follow-up|5|||
131484513|NCT00300274|473402942|FG000|Overall Study|Death|31|||
131484514|NCT00300274|473402943|FG001|Overall Study|Death|20|||
131484515|NCT00300274|473402944|FG002|Overall Study|Death|25|||
131484516|NCT00300274|473402942|FG000|Overall Study|Re-transplant|0|||
131484517|NCT00300274|473402943|FG001|Overall Study|Re-transplant|0|||
131484518|NCT00300274|473402944|FG002|Overall Study|Re-transplant|1|||
131484519|NCT00242216|473402945|FG000|Overall Study|Lost to Follow-up|12|||
131484520|NCT00242216|473402946|FG001|Overall Study|Lost to Follow-up|17|||
131484521|NCT00242216|473402945|FG000|Overall Study|Death|4|||
131484522|NCT00242216|473402946|FG001|Overall Study|Death|2|||
131484523|NCT00242216|473402945|FG000|Overall Study|Lack of Efficacy|1|||
131484524|NCT00242216|473402946|FG001|Overall Study|Lack of Efficacy|2|||
131484525|NCT00242216|473402945|FG000|Overall Study|no medicaiton dispensed|1|||
131484526|NCT00242216|473402946|FG001|Overall Study|no medicaiton dispensed|1|||
131484527|NCT00678080|473402947|FG000|Overall Study|Physician Decision|2|||
131484528|NCT00678080|473402948|FG001|Overall Study|Physician Decision|0|||
131484529|NCT00678080|473402947|FG000|Overall Study|Lost to Follow-up|1|||
131484530|NCT00678080|473402948|FG001|Overall Study|Lost to Follow-up|0|||
131484531|NCT00678080|473402947|FG000|Overall Study|Withdrawal by Subject|0|||
131484532|NCT00678080|473402948|FG001|Overall Study|Withdrawal by Subject|1|||
131484533|NCT04439201|473402949|FG000|Overall Study|Ineligible|2|||
131484534|NCT04439201|473402949|FG000|Overall Study|Never start protocol therapy|1|||
131484535|NCT04439201|473402949|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
131484536|NCT04439201|473402949|FG000|Overall Study|Mutation status not confirmed|4|||
131484537|NCT04439201|473402949|FG000|Overall Study|Adverse Event|1|||
131484538|NCT04439201|473402949|FG000|Overall Study|Death|7|||
131484539|NCT04439201|473402949|FG000|Overall Study|Withdrawal by Subject|2|||
131484540|NCT04439201|473402949|FG000|Overall Study|Disease progression|20|||
131484541|NCT04439201|473402949|FG000|Overall Study|Alternative therapy|1|||
131484542|NCT04439201|473402949|FG000|Overall Study|Physician Decision|1|||
131484543|NCT03730012|473402952|FG000|Overall Study|Adverse Event|0|||
131484544|NCT03730012|473402953|FG001|Overall Study|Adverse Event|1|||
131484545|NCT03730012|473402952|FG000|Overall Study|Lack of Efficacy|1|||
131484546|NCT03730012|473402953|FG001|Overall Study|Lack of Efficacy|5|||
131484547|NCT03730012|473402952|FG000|Overall Study|Withdrawal by Subject|0|||
131484548|NCT03730012|473402953|FG001|Overall Study|Withdrawal by Subject|1|||
131484549|NCT03730012|473402952|FG000|Overall Study|Miscellaneous|2|||
131484550|NCT03730012|473402953|FG001|Overall Study|Miscellaneous|1|||
131484551|NCT04680052|473404784|FG000|Overall Study|Ongoing|244|||
131484552|NCT04680052|473404785|FG001|Overall Study|Ongoing|229|||
131484553|NCT04680052|473404786|FG002|Overall Study|Ongoing|39|||
131484554|NCT04680052|473404787|FG003|Overall Study|Ongoing|46|||
131484555|NCT04680052|473404784|FG000|Overall Study|Death|15|||
131484556|NCT04680052|473404785|FG001|Overall Study|Death|22|||
131484557|NCT04680052|473404786|FG002|Overall Study|Death|7|||
131484558|NCT04680052|473404787|FG003|Overall Study|Death|1|||
131484559|NCT04680052|473404784|FG000|Overall Study|Lost to Follow-up|3|||
131484560|NCT04680052|473404785|FG001|Overall Study|Lost to Follow-up|2|||
131484561|NCT04680052|473404786|FG002|Overall Study|Lost to Follow-up|0|||
131484562|NCT04680052|473404787|FG003|Overall Study|Lost to Follow-up|1|||
131484563|NCT04680052|473404784|FG000|Overall Study|Withdrawal by Subject|11|||
131484564|NCT04680052|473404785|FG001|Overall Study|Withdrawal by Subject|19|||
131484565|NCT04680052|473404786|FG002|Overall Study|Withdrawal by Subject|7|||
131484566|NCT04680052|473404787|FG003|Overall Study|Withdrawal by Subject|5|||
131484567|NCT04680052|473404784|FG000|Overall Study|Missing|0|||
131484568|NCT04680052|473404785|FG001|Overall Study|Missing|1|||
131484569|NCT04680052|473404786|FG002|Overall Study|Missing|0|||
131484570|NCT04680052|473404787|FG003|Overall Study|Missing|0|||
131484571|NCT04680052|473404784|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
131484572|NCT04680052|473404785|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
131484573|NCT04680052|473404786|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
131484574|NCT04680052|473404787|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
131484575|NCT04680052|473404784|FG000|Overall Study|Physician Decision|0|||
131484576|NCT04680052|473404785|FG001|Overall Study|Physician Decision|1|||
131484577|NCT04680052|473404786|FG002|Overall Study|Physician Decision|0|||
131484578|NCT04680052|473404787|FG003|Overall Study|Physician Decision|0|||
131484579|NCT01367002|473404788|FG000|Overall Study|Withdrawal by Subject|1|||
131484580|NCT01367002|473404789|FG001|Overall Study|Withdrawal by Subject|0|||
131484581|NCT01367002|473404788|FG000|Overall Study|Physician Decision|0|||
131484582|NCT01367002|473404789|FG001|Overall Study|Physician Decision|2|||
131484583|NCT00316719|473404792|FG000|Overall Study|Adverse Event|0|||
131484584|NCT00316719|473404793|FG001|Overall Study|Adverse Event|6|||
131484585|NCT00316719|473404792|FG000|Overall Study|Consent withdrawn|2|||
131484586|NCT00316719|473404793|FG001|Overall Study|Consent withdrawn|0|||
131484587|NCT02468674|473404794|FG000|Overall Study|Adverse Event|0|||
131484588|NCT02468674|473404795|FG001|Overall Study|Adverse Event|0|||
131484589|NCT02468674|473404796|FG002|Overall Study|Adverse Event|0|||
131484590|NCT02468674|473404797|FG003|Overall Study|Adverse Event|1|||
131484591|NCT02468674|473404798|FG004|Overall Study|Adverse Event|0|||
131484592|NCT02468674|473404799|FG005|Overall Study|Adverse Event|1|||
131484593|NCT02468674|473404800|FG006|Overall Study|Adverse Event|0|||
131484594|NCT02468674|473404801|FG007|Overall Study|Adverse Event|0|||
131484595|NCT02468674|473404802|FG008|Overall Study|Adverse Event|0|||
131484596|NCT02468674|473404794|FG000|Overall Study|Lost to Follow-up|1|||
131484597|NCT02468674|473404795|FG001|Overall Study|Lost to Follow-up|0|||
131484598|NCT02468674|473404796|FG002|Overall Study|Lost to Follow-up|0|||
131484599|NCT02468674|473404797|FG003|Overall Study|Lost to Follow-up|0|||
131484600|NCT02468674|473404798|FG004|Overall Study|Lost to Follow-up|0|||
131484601|NCT02468674|473404799|FG005|Overall Study|Lost to Follow-up|0|||
131484602|NCT02468674|473404800|FG006|Overall Study|Lost to Follow-up|0|||
131484603|NCT02468674|473404801|FG007|Overall Study|Lost to Follow-up|1|||
131484604|NCT02468674|473404802|FG008|Overall Study|Lost to Follow-up|1|||
131484605|NCT02468674|473404794|FG000|Overall Study|Physician Decision|0|||
131484606|NCT02468674|473404795|FG001|Overall Study|Physician Decision|0|||
131484607|NCT02468674|473404796|FG002|Overall Study|Physician Decision|0|||
131484608|NCT02468674|473404797|FG003|Overall Study|Physician Decision|0|||
131484609|NCT02468674|473404798|FG004|Overall Study|Physician Decision|0|||
131484610|NCT02468674|473404799|FG005|Overall Study|Physician Decision|0|||
131484611|NCT02468674|473404800|FG006|Overall Study|Physician Decision|1|||
131484612|NCT02468674|473404801|FG007|Overall Study|Physician Decision|0|||
131484613|NCT02468674|473404802|FG008|Overall Study|Physician Decision|0|||
131484614|NCT02468674|473404794|FG000|Overall Study|Patient/Guardian Decision|0|||
131484615|NCT02468674|473404795|FG001|Overall Study|Patient/Guardian Decision|0|||
131484616|NCT02468674|473404796|FG002|Overall Study|Patient/Guardian Decision|0|||
131484617|NCT02468674|473404797|FG003|Overall Study|Patient/Guardian Decision|0|||
131484618|NCT02468674|473404798|FG004|Overall Study|Patient/Guardian Decision|1|||
131484619|NCT02468674|473404799|FG005|Overall Study|Patient/Guardian Decision|0|||
131484620|NCT02468674|473404800|FG006|Overall Study|Patient/Guardian Decision|0|||
131484621|NCT02468674|473404801|FG007|Overall Study|Patient/Guardian Decision|2|||
131484622|NCT02468674|473404802|FG008|Overall Study|Patient/Guardian Decision|1|||
131484623|NCT02468674|473404794|FG000|Overall Study|Protocol Deviation|0|||
131484624|NCT02468674|473404795|FG001|Overall Study|Protocol Deviation|0|||
131484625|NCT02468674|473404796|FG002|Overall Study|Protocol Deviation|0|||
131484626|NCT02468674|473404797|FG003|Overall Study|Protocol Deviation|0|||
131484627|NCT02468674|473404798|FG004|Overall Study|Protocol Deviation|0|||
131484628|NCT02468674|473404799|FG005|Overall Study|Protocol Deviation|0|||
131484629|NCT02468674|473404800|FG006|Overall Study|Protocol Deviation|0|||
131484630|NCT02468674|473404801|FG007|Overall Study|Protocol Deviation|1|||
131484631|NCT02468674|473404802|FG008|Overall Study|Protocol Deviation|1|||
131484632|NCT00934089|473404804|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
131484633|NCT00934089|473404805|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
131484634|NCT00934089|473404804|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
131484635|NCT00934089|473404805|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
131484636|NCT01947582|473404811|FG000|Overall Study|Withdrawal by Subject|1|||
131484637|NCT05350410|473404818|FG000|Overall Study|Withdrawal by Subject|1|||
131484638|NCT00705289|473404819|FG000|Overall Study|Subject or treating physician's choice|131|||
131484639|NCT02609828|473404820|FG000|Overall Study|Adverse Event|8|||
131484640|NCT02609828|473404821|FG001|Overall Study|Adverse Event|1|||
131484641|NCT02609828|473404822|FG002|Overall Study|Adverse Event|0|||
131484642|NCT02609828|473404823|FG003|Overall Study|Adverse Event|6|||
131484643|NCT02609828|473404820|FG000|Overall Study|Death|15|||
131484644|NCT02609828|473404821|FG001|Overall Study|Death|1|||
131484645|NCT02609828|473404822|FG002|Overall Study|Death|1|||
131484646|NCT02609828|473404823|FG003|Overall Study|Death|19|||
131484647|NCT02609828|473404820|FG000|Overall Study|Insufficient clinical response|2|||
131484648|NCT02609828|473404821|FG001|Overall Study|Insufficient clinical response|1|||
131484649|NCT02609828|473404822|FG002|Overall Study|Insufficient clinical response|0|||
131484650|NCT02609828|473404823|FG003|Overall Study|Insufficient clinical response|0|||
131484651|NCT02609828|473404820|FG000|Overall Study|Lost to Follow-up|0|||
131484652|NCT02609828|473404821|FG001|Overall Study|Lost to Follow-up|0|||
131484653|NCT02609828|473404822|FG002|Overall Study|Lost to Follow-up|0|||
131484654|NCT02609828|473404823|FG003|Overall Study|Lost to Follow-up|1|||
131484655|NCT02609828|473404820|FG000|Overall Study|Protocol Violation|2|||
131484656|NCT02609828|473404821|FG001|Overall Study|Protocol Violation|0|||
131484657|NCT02609828|473404822|FG002|Overall Study|Protocol Violation|0|||
131484658|NCT02609828|473404823|FG003|Overall Study|Protocol Violation|1|||
131484659|NCT02609828|473404820|FG000|Overall Study|Withdrawal by Subject|12|||
131484660|NCT02609828|473404821|FG001|Overall Study|Withdrawal by Subject|1|||
131484661|NCT02609828|473404822|FG002|Overall Study|Withdrawal by Subject|0|||
131484662|NCT02609828|473404823|FG003|Overall Study|Withdrawal by Subject|10|||
131484663|NCT02609828|473404820|FG000|Overall Study|Other|3|||
131484664|NCT02609828|473404821|FG001|Overall Study|Other|0|||
131484665|NCT02609828|473404822|FG002|Overall Study|Other|0|||
131484666|NCT02609828|473404823|FG003|Overall Study|Other|6|||
131484667|NCT02609828|473404820|FG000|Overall Study|Randomized but not treated|1|||
131484668|NCT02609828|473404821|FG001|Overall Study|Randomized but not treated|0|||
131484669|NCT02609828|473404822|FG002|Overall Study|Randomized but not treated|0|||
131484670|NCT02609828|473404823|FG003|Overall Study|Randomized but not treated|0|||
131484671|NCT03758066|473404824|FG000|Overall Study|Lost to Follow-up|14|||
131484672|NCT01540838|473404825|FG000|Overall Study|Open nasogastric tube|9|||
131484673|NCT01540838|473404826|FG001|Overall Study|Open nasogastric tube|7|||
131484674|NCT01540838|473404825|FG000|Overall Study|Treatment doses missing|8|||
131484675|NCT01540838|473404826|FG001|Overall Study|Treatment doses missing|12|||
131484676|NCT01540838|473404825|FG000|Overall Study|Additional antibiotic treatment|1|||
131484677|NCT01540838|473404826|FG001|Overall Study|Additional antibiotic treatment|2|||
131484678|NCT01540838|473404825|FG000|Overall Study|Died before treatment initiation|1|||
131484679|NCT01540838|473404826|FG001|Overall Study|Died before treatment initiation|1|||
131484680|NCT01540838|473404825|FG000|Overall Study|Not BM. Other treatment|3|||
131484681|NCT01540838|473404826|FG001|Overall Study|Not BM. Other treatment|1|||
131484682|NCT03641339|473404827|FG000|Overall Study|Physician Decision|1|||
131484683|NCT03641339|473404828|FG001|Overall Study|Physician Decision|0|||
131484684|NCT03641339|473404829|FG002|Overall Study|Physician Decision|0|||
131484685|NCT03641339|473404830|FG003|Overall Study|Physician Decision|0|||
131484686|NCT03641339|473404831|FG004|Overall Study|Physician Decision|0|||
131484687|NCT03641339|473404832|FG005|Overall Study|Physician Decision|0|||
131484688|NCT03641339|473404827|FG000|Overall Study|Withdrawal by Subject|0|||
131484689|NCT03641339|473404828|FG001|Overall Study|Withdrawal by Subject|2|||
131484690|NCT03641339|473404829|FG002|Overall Study|Withdrawal by Subject|0|||
131484691|NCT03641339|473404830|FG003|Overall Study|Withdrawal by Subject|2|||
131484692|NCT03641339|473404831|FG004|Overall Study|Withdrawal by Subject|0|||
131484693|NCT03641339|473404832|FG005|Overall Study|Withdrawal by Subject|1|||
131484694|NCT00413244|473404836|FG000|Overall Study|Withdrawal by Subject|10|||
131484695|NCT00413244|473404837|FG001|Overall Study|Withdrawal by Subject|1|||
131484696|NCT00446251|473404838|FG000|Overall Study|On-study Transplants|2|||
131484697|NCT00446251|473404838|FG000|Overall Study|Rituximab Infusion Reaction|2|||
131484698|NCT00446251|473404838|FG000|Overall Study|Lost to Follow-up|1|||
131484699|NCT01058655|473404840|FG000|Overall Study|Withdrawal by Subject|1|||
131484700|NCT01058655|473404841|FG001|Overall Study|Withdrawal by Subject|0|||
131484701|NCT01058655|473404842|FG002|Overall Study|Withdrawal by Subject|3|||
131484702|NCT01058655|473404843|FG003|Overall Study|Withdrawal by Subject|4|||
131484703|NCT01058655|473404840|FG000|Overall Study|Prolonged Treatment Delay|0|||
131484704|NCT01058655|473404841|FG001|Overall Study|Prolonged Treatment Delay|0|||
131484705|NCT01058655|473404842|FG002|Overall Study|Prolonged Treatment Delay|0|||
131484706|NCT01058655|473404843|FG003|Overall Study|Prolonged Treatment Delay|2|||
131484707|NCT01058655|473404840|FG000|Overall Study|Symptomatic Deterioration|0|||
131484708|NCT01058655|473404841|FG001|Overall Study|Symptomatic Deterioration|0|||
131484709|NCT01058655|473404842|FG002|Overall Study|Symptomatic Deterioration|0|||
131484710|NCT01058655|473404843|FG003|Overall Study|Symptomatic Deterioration|1|||
131484711|NCT01058655|473404840|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
131484712|NCT01058655|473404841|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
131484713|NCT01058655|473404842|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
131484714|NCT01058655|473404843|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
131484715|NCT01058655|473404840|FG000|Overall Study|Death|0|||
131484716|NCT01058655|473404841|FG001|Overall Study|Death|1|||
131484717|NCT01058655|473404842|FG002|Overall Study|Death|1|||
131484718|NCT01058655|473404843|FG003|Overall Study|Death|0|||
131484719|NCT01058655|473404840|FG000|Overall Study|Disease Progression|1|||
131484720|NCT01058655|473404841|FG001|Overall Study|Disease Progression|2|||
131484721|NCT01058655|473404842|FG002|Overall Study|Disease Progression|4|||
131484722|NCT01058655|473404843|FG003|Overall Study|Disease Progression|24|||
131484723|NCT01058655|473404840|FG000|Overall Study|Other|0|||
131484724|NCT01058655|473404841|FG001|Overall Study|Other|0|||
131484725|NCT01058655|473404842|FG002|Overall Study|Other|0|||
131484726|NCT01058655|473404843|FG003|Overall Study|Other|4|||
131484727|NCT00494299|473404848|FG000|Overall Study|Adverse Event|93|||
131484728|NCT00494299|473404849|FG001|Overall Study|Adverse Event|13|||
131484729|NCT00494299|473404848|FG000|Overall Study|Lost to Follow-up|1|||
131484730|NCT00494299|473404849|FG001|Overall Study|Lost to Follow-up|0|||
131484731|NCT00494299|473404848|FG000|Overall Study|Physician Decision|0|||
131484732|NCT00494299|473404849|FG001|Overall Study|Physician Decision|2|||
131484733|NCT00494299|473404848|FG000|Overall Study|Protocol Violation|1|||
131484734|NCT00494299|473404849|FG001|Overall Study|Protocol Violation|2|||
131484735|NCT00494299|473404848|FG000|Overall Study|Withdrawal by Subject|8|||
131484736|NCT00494299|473404849|FG001|Overall Study|Withdrawal by Subject|3|||
131484737|NCT00494299|473404848|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
131484738|NCT00494299|473404849|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
131484739|NCT00494299|473404848|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
131484740|NCT00494299|473404849|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
131484741|NCT00494299|473404848|FG000|Overall Study|Site Closed by Sponsor|6|||
131484742|NCT00494299|473404849|FG001|Overall Study|Site Closed by Sponsor|0|||
131484743|NCT00494299|473404848|FG000|Overall Study|Protocol Driven Decision Point|11|||
131484744|NCT00494299|473404849|FG001|Overall Study|Protocol Driven Decision Point|22|||
131484745|NCT02805972|473404850|FG000|Washout Period|Lost to Follow-up|3|||
131484746|NCT02805972|473404851|FG001|Washout Period|Lost to Follow-up|0|||
131484747|NCT02716805|473404852|FG000|Overall Study|Progressive disease|2|||
131484748|NCT02716805|473404853|FG001|Overall Study|Progressive disease|0|||
131484749|NCT02716805|473404854|FG002|Overall Study|Progressive disease|0|||
131484750|NCT02716805|473404855|FG003|Overall Study|Progressive disease|0|||
131484751|NCT00066365|473404856|FG000|Overall Study|Adverse Event|1|||
131484752|NCT00066365|473404857|FG001|Overall Study|Adverse Event|0|||
131484753|NCT00066365|473404856|FG000|Overall Study|Lack of Efficacy|15|||
131484754|NCT00066365|473404857|FG001|Overall Study|Lack of Efficacy|12|||
131484755|NCT00066365|473404856|FG000|Overall Study|Physician Decision|1|||
131484756|NCT00066365|473404857|FG001|Overall Study|Physician Decision|0|||
131484757|NCT00066365|473404856|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
131484758|NCT00066365|473404857|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
131484759|NCT00066365|473404856|FG000|Overall Study|Ineligible|4|||
131484760|NCT00066365|473404857|FG001|Overall Study|Ineligible|2|||
131484761|NCT00788073|473404862|FG000|STX209 Then Placebo|Adverse Event|1|||
131484762|NCT00788073|473404863|FG001|STX209 Then Placebo|Adverse Event|0|||
131484763|NCT00788073|473404862|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
131484764|NCT00788073|473404863|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
131484765|NCT00788073|473404862|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
131484766|NCT00788073|473404863|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
131484767|NCT00788073|473404862|FG000|STX209 Then Placebo|unable to return due to travel|0|||
131484768|NCT00788073|473404863|FG001|STX209 Then Placebo|unable to return due to travel|1|||
131484769|NCT00788073|473404862|FG000|Placebo Then STX209|Adverse Event|2|||
131484770|NCT00788073|473404863|FG001|Placebo Then STX209|Adverse Event|0|||
131484771|NCT00788073|473404862|FG000|Placebo Then STX209|Protocol Violation|0|||
131484772|NCT00788073|473404863|FG001|Placebo Then STX209|Protocol Violation|1|||
131484773|NCT00660673|473404865|FG000|Overall Study|Adverse Event|84|||
131484774|NCT00660673|473404865|FG000|Overall Study|Lack of Efficacy|7|||
131484775|NCT00660673|473404865|FG000|Overall Study|Withdrawal by Subject|22|||
131484776|NCT00660673|473404865|FG000|Overall Study|Administrative|2|||
131484777|NCT00660673|473404865|FG000|Overall Study|Protocol Violation|2|||
131484778|NCT00415168|473404871|FG000|Overall Study|Death|26|||
131484779|NCT00415168|473404871|FG000|Overall Study|Lost to Follow-up|3|||
131484780|NCT00415168|473404871|FG000|Overall Study|Physician Decision|13|||
131484781|NCT00415168|473404871|FG000|Overall Study|Sponsor Decision|4|||
131484782|NCT00415168|473404871|FG000|Overall Study|Withdrawal by Subject|6|||
131484783|NCT04154930|473404874|FG000|Overall Study|Withdrawal by Subject|15|||
131484784|NCT04154930|473404875|FG001|Overall Study|Withdrawal by Subject|6|||
131484785|NCT04154930|473404874|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
131484786|NCT04154930|473404875|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
131484787|NCT04154930|473404874|FG000|Overall Study|Lost to Follow-up|14|||
131484788|NCT04154930|473404875|FG001|Overall Study|Lost to Follow-up|6|||
131484789|NCT04154930|473404874|FG000|Overall Study|Other|6|||
131484790|NCT04154930|473404875|FG001|Overall Study|Other|0|||
131484791|NCT02925117|473404878|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
131484792|NCT02925117|473404879|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
131484793|NCT02925117|473404880|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
131484794|NCT02925117|473404881|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
131484795|NCT02925117|473404882|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484796|NCT02925117|473404883|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484797|NCT02925117|473404884|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484798|NCT02925117|473404885|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484799|NCT02925117|473404886|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484800|NCT02925117|473404887|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484801|NCT02925117|473404888|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484802|NCT02925117|473404889|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
131484803|NCT02925117|473404878|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
131484804|NCT02925117|473404879|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
131484805|NCT02925117|473404880|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
131484806|NCT02925117|473404881|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484807|NCT02925117|473404882|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484808|NCT02925117|473404883|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484809|NCT02925117|473404884|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484810|NCT02925117|473404885|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484811|NCT02925117|473404886|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484812|NCT02925117|473404887|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484813|NCT02925117|473404888|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484814|NCT02925117|473404889|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
131484815|NCT02925117|473404878|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
131484816|NCT02925117|473404879|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
131484817|NCT02925117|473404880|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484818|NCT02925117|473404881|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484819|NCT02925117|473404882|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484820|NCT02925117|473404883|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484821|NCT02925117|473404884|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484822|NCT02925117|473404885|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484823|NCT02925117|473404886|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484824|NCT02925117|473404887|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484825|NCT02925117|473404888|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484826|NCT02925117|473404889|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
131484827|NCT02925117|473404878|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
131484828|NCT02925117|473404879|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
131484829|NCT02925117|473404880|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
131484830|NCT02925117|473404881|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
131484831|NCT02925117|473404882|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
131484832|NCT02925117|473404883|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
131484833|NCT02925117|473404884|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
131484834|NCT02925117|473404885|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
131484835|NCT02925117|473404886|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
131484836|NCT02925117|473404887|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
131484837|NCT02925117|473404888|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
131484838|NCT02925117|473404889|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
131484839|NCT02925117|473404878|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484840|NCT02925117|473404879|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484841|NCT02925117|473404880|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484842|NCT02925117|473404881|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484843|NCT02925117|473404882|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484844|NCT02925117|473404883|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
131484845|NCT02925117|473404884|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484846|NCT02925117|473404885|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484847|NCT02925117|473404886|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484848|NCT02925117|473404887|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131484849|NCT02925117|473404888|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
131484850|NCT02925117|473404889|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
131484851|NCT02925117|473404878|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
131484852|NCT02925117|473404879|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
131484853|NCT02925117|473404880|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
131484854|NCT02925117|473404881|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
131484855|NCT02925117|473404882|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
131484856|NCT02925117|473404883|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
131484857|NCT02925117|473404884|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
131484858|NCT02925117|473404885|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
131484859|NCT02925117|473404886|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
131484860|NCT02925117|473404887|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
131484861|NCT02925117|473404888|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
131484862|NCT02925117|473404889|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
131484863|NCT02925117|473404878|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
131484864|NCT02925117|473404879|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
131484865|NCT02925117|473404880|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
131484866|NCT02925117|473404881|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
131484867|NCT02925117|473404882|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
131484868|NCT02925117|473404883|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
131484869|NCT02925117|473404884|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
131484870|NCT02925117|473404885|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
131484871|NCT02925117|473404886|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
131484872|NCT02925117|473404887|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
131484873|NCT02925117|473404888|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
131484874|NCT02925117|473404889|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
131484875|NCT02925117|473404878|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
131484876|NCT02925117|473404879|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
131484877|NCT02925117|473404880|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
131484878|NCT02925117|473404881|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
131484879|NCT02925117|473404882|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
131484880|NCT02925117|473404883|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
131484881|NCT02925117|473404884|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
131484882|NCT02925117|473404885|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
131484883|NCT02925117|473404886|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
131484884|NCT02925117|473404887|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
131484885|NCT02925117|473404888|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
131484886|NCT02925117|473404889|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
131484887|NCT01449539|473404894|FG000|Overall Study|Withdrawal by Subject|3|||
131484888|NCT01449539|473404894|FG000|Overall Study|Toxicity not study related|1|||
131484889|NCT02187744|473404897|FG000|Study|Participant refused further follow-up|1|||
131484890|NCT02187744|473404898|FG001|Study|Participant refused further follow-up|0|||
131484891|NCT02187744|473404897|FG000|Study|Other|2|||
131484892|NCT02187744|473404898|FG001|Study|Other|1|||
131484893|NCT02187744|473404897|FG000|Study|Lost to Follow-up|0|||
131484894|NCT02187744|473404898|FG001|Study|Lost to Follow-up|2|||
131484895|NCT02187744|473404897|FG000|Study|Related adverse event, not serious|0|||
131484896|NCT02187744|473404898|FG001|Study|Related adverse event, not serious|2|||
131484897|NCT02187744|473404897|FG000|Study|Death|1|||
131484898|NCT02187744|473404898|FG001|Study|Death|0|||
131484899|NCT02187744|473404897|FG000|Study|Related adverse event, serious non-fatal|0|||
131484900|NCT02187744|473404898|FG001|Study|Related adverse event, serious non-fatal|1|||
131484901|NCT02187744|473404897|FG000|Treatment|Death|1|||
131484902|NCT02187744|473404898|FG001|Treatment|Death|0|||
131484903|NCT02187744|473404897|FG000|Treatment|Related adverse event, serious non-fatal|0|||
131484904|NCT02187744|473404898|FG001|Treatment|Related adverse event, serious non-fatal|1|||
131484905|NCT02187744|473404897|FG000|Treatment|Related adverse event, not serious|0|||
131484906|NCT02187744|473404898|FG001|Treatment|Related adverse event, not serious|2|||
131484907|NCT02187744|473404897|FG000|Treatment|Lost to Follow-up|0|||
131484908|NCT02187744|473404898|FG001|Treatment|Lost to Follow-up|1|||
131484909|NCT02187744|473404897|FG000|Treatment|Other|2|||
131484910|NCT02187744|473404898|FG001|Treatment|Other|0|||
131484911|NCT02187744|473404897|FG000|Treatment|Participant refused continued treatment|1|||
131484912|NCT02187744|473404898|FG001|Treatment|Participant refused continued treatment|1|||
131484913|NCT01972568|473404899|FG000|Overall Study|Other events|3|||
131484914|NCT01972568|473404900|FG001|Overall Study|Other events|0|||
131484915|NCT01972568|473404901|FG002|Overall Study|Other events|0|||
131484916|NCT01972568|473404899|FG000|Overall Study|Lack of Efficacy|0|||
131484917|NCT01972568|473404900|FG001|Overall Study|Lack of Efficacy|1|||
131484918|NCT01972568|473404901|FG002|Overall Study|Lack of Efficacy|2|||
131484919|NCT01972568|473404899|FG000|Overall Study|Protocol Violation|1|||
131484920|NCT01972568|473404900|FG001|Overall Study|Protocol Violation|2|||
131484921|NCT01972568|473404901|FG002|Overall Study|Protocol Violation|2|||
131484922|NCT01972568|473404899|FG000|Overall Study|Withdrawal by Subject|6|||
131484923|NCT01972568|473404900|FG001|Overall Study|Withdrawal by Subject|3|||
131484924|NCT01972568|473404901|FG002|Overall Study|Withdrawal by Subject|7|||
131484925|NCT01972568|473404899|FG000|Overall Study|Lost to Follow-up|1|||
131484926|NCT01972568|473404900|FG001|Overall Study|Lost to Follow-up|0|||
131484927|NCT01972568|473404901|FG002|Overall Study|Lost to Follow-up|0|||
131484928|NCT01972568|473404899|FG000|Overall Study|Adverse Event|5|||
131484929|NCT01972568|473404900|FG001|Overall Study|Adverse Event|6|||
131484930|NCT01972568|473404901|FG002|Overall Study|Adverse Event|5|||
131484931|NCT02572401|473404904|FG000|Overall Study|Lost to Follow-up|5|||
131484932|NCT02572401|473404905|FG001|Overall Study|Lost to Follow-up|8|||
131484933|NCT02572401|473404906|FG002|Overall Study|Lost to Follow-up|9|||
131484934|NCT02572401|473404907|FG003|Overall Study|Lost to Follow-up|9|||
131484935|NCT02572401|473404904|FG000|Overall Study|Death|0|||
131484936|NCT02572401|473404905|FG001|Overall Study|Death|0|||
131484937|NCT02572401|473404906|FG002|Overall Study|Death|0|||
131484938|NCT02572401|473404907|FG003|Overall Study|Death|1|||
131484939|NCT00306189|473404908|FG000|Overall Study|Physician Decision|0|||
131484940|NCT00306189|473404909|FG001|Overall Study|Physician Decision|0|||
131484941|NCT00306189|473404910|FG002|Overall Study|Physician Decision|0|||
131484942|NCT00306189|473404911|FG003|Overall Study|Physician Decision|1|||
131484943|NCT00306189|473404908|FG000|Overall Study|Adverse Event|3|||
131484944|NCT00306189|473404909|FG001|Overall Study|Adverse Event|3|||
131484945|NCT00306189|473404910|FG002|Overall Study|Adverse Event|2|||
131484946|NCT00306189|473404911|FG003|Overall Study|Adverse Event|2|||
131484947|NCT00306189|473404908|FG000|Overall Study|Withdrawal by Subject|4|||
131484948|NCT00306189|473404909|FG001|Overall Study|Withdrawal by Subject|2|||
131484949|NCT00306189|473404910|FG002|Overall Study|Withdrawal by Subject|8|||
131484950|NCT00306189|473404911|FG003|Overall Study|Withdrawal by Subject|1|||
131484951|NCT00306189|473404908|FG000|Overall Study|Ineligibility determined|1|||
131484952|NCT00306189|473404909|FG001|Overall Study|Ineligibility determined|1|||
131484953|NCT00306189|473404910|FG002|Overall Study|Ineligibility determined|1|||
131484954|NCT00306189|473404911|FG003|Overall Study|Ineligibility determined|1|||
131484955|NCT00306189|473404908|FG000|Overall Study|Other|1|||
131484956|NCT00306189|473404909|FG001|Overall Study|Other|0|||
131484957|NCT00306189|473404910|FG002|Overall Study|Other|0|||
131484958|NCT00306189|473404911|FG003|Overall Study|Other|0|||
131484959|NCT02059408|473404912|FG000|Overall Study|Did not get tested|0|||
131484960|NCT02059408|473404913|FG001|Overall Study|Did not get tested|330|||
131484961|NCT02059408|473404914|FG002|Overall Study|Did not get tested|358|||
131484962|NCT02993757|473404915|FG000|Overall Study|Non compliance with the protocol|155|||
131484963|NCT02993757|473404916|FG001|Overall Study|Non compliance with the protocol|170|||
131484964|NCT02993757|473404915|FG000|Overall Study|Lost to Follow-up|1|||
131484965|NCT02993757|473404916|FG001|Overall Study|Lost to Follow-up|0|||
131484966|NCT02993757|473404915|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
131484967|NCT02993757|473404916|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
131484968|NCT00957580|473404919|FG000|Overall Study|Ongoing at data cut-off|0|||
131484969|NCT00957580|473404920|FG001|Overall Study|Ongoing at data cut-off|1|||
131484970|NCT00957580|473404921|FG002|Overall Study|Ongoing at data cut-off|0|||
131484971|NCT00957580|473404919|FG000|Overall Study|Enrolled but not treated|0|||
131484972|NCT00957580|473404920|FG001|Overall Study|Enrolled but not treated|1|||
131484973|NCT00957580|473404921|FG002|Overall Study|Enrolled but not treated|0|||
131484974|NCT01090492|473404922|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
131484975|NCT01090492|473404923|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
131484976|NCT01090492|473404924|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
131484977|NCT01090492|473404925|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
131484978|NCT01090492|473404926|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
131484979|NCT01090492|473404927|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
131484980|NCT01090492|473404928|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
131484981|NCT01090492|473404929|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
131484982|NCT01090492|473404922|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
131484983|NCT01090492|473404923|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
131484984|NCT01090492|473404924|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
131484985|NCT01090492|473404925|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
131484986|NCT01090492|473404926|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
131484987|NCT01090492|473404927|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
131484988|NCT01090492|473404928|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
131484989|NCT01090492|473404929|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
131484990|NCT01090492|473404922|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484991|NCT01090492|473404923|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484992|NCT01090492|473404924|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
131484993|NCT01090492|473404925|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484994|NCT01090492|473404926|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484995|NCT01090492|473404927|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484996|NCT01090492|473404928|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484997|NCT01090492|473404929|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131484998|NCT01090492|473404922|FG000|First Intervention Period (4 Weeks)|Other|0|||
131484999|NCT01090492|473404923|FG001|First Intervention Period (4 Weeks)|Other|0|||
131485000|NCT01090492|473404924|FG002|First Intervention Period (4 Weeks)|Other|1|||
131485001|NCT01090492|473404925|FG003|First Intervention Period (4 Weeks)|Other|1|||
131485002|NCT01090492|473404926|FG004|First Intervention Period (4 Weeks)|Other|2|||
131485003|NCT01090492|473404927|FG005|First Intervention Period (4 Weeks)|Other|0|||
131485004|NCT01090492|473404928|FG006|First Intervention Period (4 Weeks)|Other|0|||
131485005|NCT01090492|473404929|FG007|First Intervention Period (4 Weeks)|Other|0|||
131485006|NCT01090492|473404922|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485007|NCT01090492|473404923|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485008|NCT01090492|473404924|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485009|NCT01090492|473404925|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485010|NCT01090492|473404926|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
131485011|NCT01090492|473404927|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485012|NCT01090492|473404928|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485013|NCT01090492|473404929|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
131485014|NCT01090492|473404922|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
131485015|NCT01090492|473404923|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
131485016|NCT01090492|473404924|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
131485017|NCT01090492|473404925|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
131485018|NCT01090492|473404926|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
131485019|NCT01090492|473404927|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
131485020|NCT01090492|473404928|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
131485021|NCT01090492|473404929|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
131485022|NCT01090492|473404922|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
131485023|NCT01090492|473404923|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
131485024|NCT01090492|473404924|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
131485025|NCT01090492|473404925|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
131485026|NCT01090492|473404926|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
131485027|NCT01090492|473404927|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
131485028|NCT01090492|473404928|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
131485029|NCT01090492|473404929|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
131485030|NCT01090492|473404922|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485031|NCT01090492|473404923|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
131485032|NCT01090492|473404924|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485033|NCT01090492|473404925|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485034|NCT01090492|473404926|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485035|NCT01090492|473404927|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485036|NCT01090492|473404928|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485037|NCT01090492|473404929|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
131485038|NCT01090492|473404922|FG000|Second Intervention Period (4 Weeks)|Other|0|||
131485039|NCT01090492|473404923|FG001|Second Intervention Period (4 Weeks)|Other|1|||
131485040|NCT01090492|473404924|FG002|Second Intervention Period (4 Weeks)|Other|1|||
131485041|NCT01090492|473404925|FG003|Second Intervention Period (4 Weeks)|Other|0|||
131485042|NCT01090492|473404926|FG004|Second Intervention Period (4 Weeks)|Other|0|||
131485043|NCT01090492|473404927|FG005|Second Intervention Period (4 Weeks)|Other|0|||
131485044|NCT01090492|473404928|FG006|Second Intervention Period (4 Weeks)|Other|0|||
131485045|NCT01090492|473404929|FG007|Second Intervention Period (4 Weeks)|Other|0|||
131485046|NCT01090492|473404922|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
131485047|NCT01090492|473404923|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
131485048|NCT01090492|473404924|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
131485049|NCT01090492|473404925|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
131485050|NCT01090492|473404926|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
131485051|NCT01090492|473404927|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
131485052|NCT01090492|473404928|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
131485053|NCT01090492|473404929|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
131485054|NCT01090492|473404922|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485055|NCT01090492|473404923|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485056|NCT01090492|473404924|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485057|NCT01090492|473404925|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485058|NCT01090492|473404926|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485059|NCT01090492|473404927|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485060|NCT01090492|473404928|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
131485061|NCT01090492|473404929|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131485062|NCT01681472|473404930|FG000|Overall Study|Adverse Event|0|||
131485063|NCT01681472|473404931|FG001|Overall Study|Adverse Event|1|||
131485064|NCT01681472|473404932|FG002|Overall Study|Adverse Event|0|||
131485065|NCT01681472|473404933|FG003|Overall Study|Adverse Event|0|||
131485066|NCT01999179|473404944|FG000|Overall Study|Adverse Event|1|||
131485067|NCT01999179|473404944|FG000|Overall Study|Lost to Follow-up|1|||
131485068|NCT01999179|473404944|FG000|Overall Study|Change in Therapy|3|||
131485069|NCT01999179|473404944|FG000|Overall Study|New catheter|2|||
131485070|NCT03128411|473404948|FG000|Treatment Phase|Adverse Event|21|||
131485071|NCT03128411|473404948|FG000|Treatment Phase|Physician Decision|1|||
131485072|NCT03128411|473404948|FG000|Treatment Phase|Other|2|||
131485073|NCT03128411|473404948|FG000|Long Term Follow-up Phase|Death|2|||
131485074|NCT02900976|473404953|FG000|Overall Study|Adverse Event|0|||
131485075|NCT02900976|473404954|FG001|Overall Study|Adverse Event|1|||
131485076|NCT02900976|473404953|FG000|Overall Study|Physician Decision|0|||
131485077|NCT02900976|473404954|FG001|Overall Study|Physician Decision|2|||
131485078|NCT02900976|473404953|FG000|Overall Study|Progressive disease|0|||
131485079|NCT02900976|473404954|FG001|Overall Study|Progressive disease|6|||
131485080|NCT06934993|473404955|FG000|Overall Study|Withdrawal by Subject|29|||
131485081|NCT06934993|473404955|FG000|Overall Study|elevated postoperative creatinine level|11|||
131485082|NCT06934993|473404955|FG000|Overall Study|Death|3|||
131485083|NCT03320057|473406426|FG000|Overall Study|Lost to Follow-up|4|||
131485084|NCT03320057|473406427|FG001|Overall Study|Lost to Follow-up|17|||
131485085|NCT03320057|473406426|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
131485086|NCT03320057|473406427|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
131485087|NCT06956170|473406428|FG000|Overall Study|Death|2|||
131485088|NCT06956170|473406429|FG001|Overall Study|Death|1|||
131485089|NCT06956170|473406428|FG000|Overall Study|Withdrawal by Subject|1|||
131485090|NCT06956170|473406429|FG001|Overall Study|Withdrawal by Subject|0|||
131485091|NCT06956170|473406428|FG000|Overall Study|Ongoing|7|||
131485092|NCT06956170|473406429|FG001|Overall Study|Ongoing|10|||
131485093|NCT01516437|473406430|FG000|Overall Study|Reason not specified|0|||
131485094|NCT01516437|473406431|FG001|Overall Study|Reason not specified|0|||
131485095|NCT01516437|473406432|FG002|Overall Study|Reason not specified|1|||
131485096|NCT01516437|473406433|FG003|Overall Study|Reason not specified|1|||
131485097|NCT02400333|473406436|FG000|Overall Study|Withdrawal by Subject|0|||
131485098|NCT02400333|473406437|FG001|Overall Study|Withdrawal by Subject|1|||
131485099|NCT02400333|473406438|FG002|Overall Study|Withdrawal by Subject|0|||
131485100|NCT02400333|473406439|FG003|Overall Study|Withdrawal by Subject|1|||
131485101|NCT02400333|473406436|FG000|Overall Study|Protocol Violation|1|||
131485102|NCT02400333|473406437|FG001|Overall Study|Protocol Violation|0|||
131485103|NCT02400333|473406438|FG002|Overall Study|Protocol Violation|2|||
131485104|NCT02400333|473406439|FG003|Overall Study|Protocol Violation|1|||
131485105|NCT01890473|473406443|FG000|Overall Study|Lost to Follow-up|1|||
131485106|NCT01890473|473406444|FG001|Overall Study|Lost to Follow-up|0|||
131485107|NCT01890473|473406443|FG000|Overall Study|Poor/non-compliance|1|||
131485108|NCT01890473|473406444|FG001|Overall Study|Poor/non-compliance|0|||
131485109|NCT00003473|473406445|FG000|Overall Study|Three patients were not evaluable.|3|||
131485110|NCT05154578|473406450|FG000|Overall Study|Withdrawal by Subject|2|||
131485111|NCT05154578|473406451|FG001|Overall Study|Withdrawal by Subject|3|||
131485112|NCT05154578|473406452|FG002|Overall Study|Withdrawal by Subject|2|||
131485113|NCT05154578|473406453|FG003|Overall Study|Withdrawal by Subject|4|||
131485114|NCT05154578|473406454|FG004|Overall Study|Withdrawal by Subject|0|||
131485115|NCT05154578|473406450|FG000|Overall Study|Lost to Follow-up|0|||
131485116|NCT05154578|473406451|FG001|Overall Study|Lost to Follow-up|1|||
131485117|NCT05154578|473406452|FG002|Overall Study|Lost to Follow-up|0|||
131485118|NCT05154578|473406453|FG003|Overall Study|Lost to Follow-up|3|||
131485119|NCT05154578|473406454|FG004|Overall Study|Lost to Follow-up|0|||
131485120|NCT05154578|473406450|FG000|Overall Study|Adverse Event|0|||
131485121|NCT05154578|473406451|FG001|Overall Study|Adverse Event|0|||
131485122|NCT05154578|473406452|FG002|Overall Study|Adverse Event|0|||
131485123|NCT05154578|473406453|FG003|Overall Study|Adverse Event|1|||
131485124|NCT05154578|473406454|FG004|Overall Study|Adverse Event|0|||
131485125|NCT05154578|473406450|FG000|Overall Study|Relocated to another province|0|||
131485126|NCT05154578|473406451|FG001|Overall Study|Relocated to another province|0|||
131485127|NCT05154578|473406452|FG002|Overall Study|Relocated to another province|1|||
131485128|NCT05154578|473406453|FG003|Overall Study|Relocated to another province|0|||
131485129|NCT05154578|473406454|FG004|Overall Study|Relocated to another province|1|||
131485130|NCT05154578|473406450|FG000|Overall Study|Baby loss|0|||
131485131|NCT05154578|473406451|FG001|Overall Study|Baby loss|1|||
131485132|NCT05154578|473406452|FG002|Overall Study|Baby loss|0|||
131485133|NCT05154578|473406453|FG003|Overall Study|Baby loss|0|||
131485134|NCT05154578|473406454|FG004|Overall Study|Baby loss|0|||
131485135|NCT03750955|473406456|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
131485136|NCT03750955|473406457|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
131485137|NCT03750955|473406456|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
131485138|NCT03750955|473406457|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
131485139|NCT01705730|473406458|FG000|Overall Study|Lack of Efficacy|1|||
131485140|NCT01705730|473406458|FG000|Overall Study|Adverse Event|3|||
131485141|NCT01705730|473406458|FG000|Overall Study|Lost to Follow-up|1|||
131485142|NCT01705730|473406458|FG000|Overall Study|Reason not Specified|4|||
131485143|NCT01773733|473406461|FG000|Overall Study|Adverse Event|3286|||
131485144|NCT01773733|473406462|FG001|Overall Study|Adverse Event|540|||
131485145|NCT01773733|473406461|FG000|Overall Study|Pregnancy|28|||
131485146|NCT01773733|473406462|FG001|Overall Study|Pregnancy|0|||
131485147|NCT01773733|473406461|FG000|Overall Study|Other different categories of not compl|55415|||
131485148|NCT01773733|473406462|FG001|Overall Study|Other different categories of not compl|7781|||
131485149|NCT01180985|473406463|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
131485150|NCT01180985|473406464|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
131485151|NCT00129272|473406469|FG000|Overall Study|Lost to Follow-up|12|||
131485152|NCT00129272|473406470|FG001|Overall Study|Lost to Follow-up|11|||
131485153|NCT00129272|473406469|FG000|Overall Study|Withdrawal by Subject|5|||
131485154|NCT00129272|473406470|FG001|Overall Study|Withdrawal by Subject|11|||
131485155|NCT03345914|473406471|FG000|Overall Study|Transition to another study at week 16|80|||
131485156|NCT03345914|473406472|FG001|Overall Study|Transition to another study at week 16|86|||
131485157|NCT03345914|473406473|FG002|Overall Study|Transition to another study at week 16|78|||
131485158|NCT03345914|473406471|FG000|Overall Study|Transition to OLE during follow-up|37|||
131485159|NCT03345914|473406472|FG001|Overall Study|Transition to OLE during follow-up|33|||
131485160|NCT03345914|473406473|FG002|Overall Study|Transition to OLE during follow-up|39|||
131485161|NCT03345914|473406471|FG000|Overall Study|Physician Decision|0|||
131485162|NCT03345914|473406472|FG001|Overall Study|Physician Decision|1|||
131485163|NCT03345914|473406473|FG002|Overall Study|Physician Decision|1|||
131485164|NCT03345914|473406471|FG000|Overall Study|Withdrawal by Subject|5|||
131485165|NCT03345914|473406472|FG001|Overall Study|Withdrawal by Subject|1|||
131485166|NCT03345914|473406473|FG002|Overall Study|Withdrawal by Subject|2|||
131485167|NCT03345914|473406471|FG000|Overall Study|Other|1|||
131485168|NCT03345914|473406472|FG001|Overall Study|Other|1|||
131485169|NCT03345914|473406473|FG002|Overall Study|Other|1|||
131485170|NCT03345914|473406471|FG000|Overall Study|Ongoing|0|||
131485171|NCT03345914|473406472|FG001|Overall Study|Ongoing|0|||
131485172|NCT03345914|473406473|FG002|Overall Study|Ongoing|1|||
131485173|NCT02601027|473406475|FG000|Registration to Surgery|Withdrawal by Subject|20|||
131485174|NCT02601027|473406476|FG001|Registration to Surgery|Withdrawal by Subject|10|||
131485175|NCT00885846|473406478|FG000|Overall Study|Withdrawal by Subject|2|||
131485176|NCT00885846|473406479|FG001|Overall Study|Withdrawal by Subject|5|||
131485177|NCT00885846|473406480|FG002|Overall Study|Withdrawal by Subject|2|||
131485178|NCT00762385|473406484|FG000|First Intervention|Lens Issue|1|||
131485179|NCT00762385|473406485|FG001|First Intervention|Lens Issue|1|||
131485180|NCT00762385|473406484|FG000|First Intervention|Lost to Follow-up|0|||
131485181|NCT00762385|473406485|FG001|First Intervention|Lost to Follow-up|2|||
131485182|NCT00762385|473406484|FG000|First Intervention|Ineligible|1|||
131485183|NCT00762385|473406485|FG001|First Intervention|Ineligible|0|||
131485184|NCT00762385|473406484|FG000|First Intervention|Protocol Violation|0|||
131485185|NCT00762385|473406485|FG001|First Intervention|Protocol Violation|1|||
131485186|NCT00762385|473406484|FG000|Second Intervention|Protocol Violation|3|||
131485187|NCT00762385|473406485|FG001|Second Intervention|Protocol Violation|3|||
131485188|NCT04891978|473406486|FG000|Baseline|Protocol Violation|2|||
131485189|NCT04891978|473406487|FG001|Baseline|Protocol Violation|1|||
131485190|NCT04891978|473406488|FG002|Baseline|Protocol Violation|0|||
131485191|NCT04891978|473406486|FG000|Baseline|Missing AIRQ|1|||
131485192|NCT04891978|473406487|FG001|Baseline|Missing AIRQ|0|||
131485193|NCT04891978|473406488|FG002|Baseline|Missing AIRQ|0|||
131485194|NCT04891978|473406486|FG000|Baseline|Did not attend a baseline visit|0|||
131485195|NCT04891978|473406487|FG001|Baseline|Did not attend a baseline visit|0|||
131485196|NCT04891978|473406488|FG002|Baseline|Did not attend a baseline visit|9|||
131485197|NCT00493025|473406489|FG000|Overall Study|Physician Decision|19|||
131485198|NCT03863197|473406490|FG000|Overall Study|Lost to Follow-up|2|||
131485199|NCT03863197|473406491|FG001|Overall Study|Lost to Follow-up|3|||
131485200|NCT03863197|473406490|FG000|Overall Study|Withdrawal by Subject|4|||
131485201|NCT03863197|473406491|FG001|Overall Study|Withdrawal by Subject|0|||
131485202|NCT03863197|473406490|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
131485203|NCT03863197|473406491|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
131485204|NCT01065597|473406492|FG000|Overall Study|Adverse Event|1|||
131485205|NCT04515394|473406493|FG000|Overall Study|Participant did not receive treatment|1|||
131485206|NCT02264639|473406496|FG000|Overall Study|Death (after completing single-dose phase)|1|||
131485207|NCT02264639|473406497|FG001|Overall Study|Death (after completing single-dose phase)|0|||
131485208|NCT02264639|473406498|FG002|Overall Study|Death (after completing single-dose phase)|0|||
131485209|NCT02264639|473406499|FG003|Overall Study|Death (after completing single-dose phase)|0|||
131485210|NCT02264639|473406500|FG004|Overall Study|Death (after completing single-dose phase)|0|||
131485211|NCT02264639|473406496|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
131485212|NCT02264639|473406497|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
131485213|NCT02264639|473406498|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
131485214|NCT02264639|473406499|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
131485215|NCT02264639|473406500|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
131485216|NCT02264639|473406496|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
131485217|NCT02264639|473406497|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
131485218|NCT02264639|473406498|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
131485219|NCT02264639|473406499|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
131485220|NCT02264639|473406500|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
131485221|NCT02264639|473406496|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
131485222|NCT02264639|473406497|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
131485223|NCT02264639|473406498|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
131485224|NCT02264639|473406499|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
131485225|NCT02264639|473406500|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
131485226|NCT04472429|473406501|FG000|Randomized Period|Ongoing|90|||
131485227|NCT04472429|473406502|FG001|Randomized Period|Ongoing|40|||
131485228|NCT04472429|473406503|FG002|Randomized Period|Ongoing|0|||
131485229|NCT04472429|473406501|FG000|Randomized Period|Death|52|||
131485230|NCT04472429|473406502|FG001|Randomized Period|Death|37|||
131485231|NCT04472429|473406503|FG002|Randomized Period|Death|0|||
131485232|NCT04472429|473406501|FG000|Randomized Period|Lost to Follow-up|4|||
131485233|NCT04472429|473406502|FG001|Randomized Period|Lost to Follow-up|0|||
131485234|NCT04472429|473406503|FG002|Randomized Period|Lost to Follow-up|0|||
131485235|NCT04472429|473406501|FG000|Randomized Period|Physician Decision|1|||
131485236|NCT04472429|473406502|FG001|Randomized Period|Physician Decision|2|||
131485237|NCT04472429|473406503|FG002|Randomized Period|Physician Decision|0|||
131485238|NCT04472429|473406501|FG000|Randomized Period|Withdrawal by Subject|6|||
131485239|NCT04472429|473406502|FG001|Randomized Period|Withdrawal by Subject|5|||
131485240|NCT04472429|473406503|FG002|Randomized Period|Withdrawal by Subject|0|||
131485241|NCT04472429|473406501|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
131485242|NCT04472429|473406502|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
131485243|NCT04472429|473406503|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
131485244|NCT04472429|473406501|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
131485245|NCT04472429|473406502|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
131485246|NCT04472429|473406503|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
131485247|NCT04472429|473406501|FG000|Open-label Monotherapy Period|Ongoing|0|||
131485248|NCT04472429|473406502|FG001|Open-label Monotherapy Period|Ongoing|0|||
131485249|NCT04472429|473406503|FG002|Open-label Monotherapy Period|Ongoing|32|||
131485250|NCT04472429|473406501|FG000|Open-label Monotherapy Period|Death|0|||
131485251|NCT04472429|473406502|FG001|Open-label Monotherapy Period|Death|0|||
131485252|NCT04472429|473406503|FG002|Open-label Monotherapy Period|Death|35|||
131485253|NCT04472429|473406501|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
131485254|NCT04472429|473406502|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
131485255|NCT04472429|473406503|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
131485256|NCT01416272|473406504|FG000|Overall Study|Unacceptable distance visual acuity|2|||
131485257|NCT01416272|473406504|FG000|Overall Study|Lost to Follow-up|1|||
131485258|NCT01416272|473406504|FG000|Overall Study|Study related complaints|1|||
131485259|NCT02319837|473406505|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
131485260|NCT02319837|473406506|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
131485261|NCT02319837|473406507|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
131485262|NCT02319837|473406505|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
131485263|NCT02319837|473406506|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
131485264|NCT02319837|473406507|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
131485265|NCT02319837|473406505|FG000|Study Treatment Phase|Adverse Event|73|||
131485266|NCT02319837|473406506|FG001|Study Treatment Phase|Adverse Event|36|||
131485267|NCT02319837|473406507|FG002|Study Treatment Phase|Adverse Event|63|||
131485268|NCT02319837|473406505|FG000|Study Treatment Phase|Development of castration resistance|0|||
131485269|NCT02319837|473406506|FG001|Study Treatment Phase|Development of castration resistance|2|||
131485270|NCT02319837|473406507|FG002|Study Treatment Phase|Development of castration resistance|0|||
131485271|NCT02319837|473406505|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
131485272|NCT02319837|473406506|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
131485273|NCT02319837|473406507|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
131485274|NCT02319837|473406505|FG000|Study Treatment Phase|Protocol Violation|2|||
131485275|NCT02319837|473406506|FG001|Study Treatment Phase|Protocol Violation|2|||
131485276|NCT02319837|473406507|FG002|Study Treatment Phase|Protocol Violation|1|||
131485277|NCT02319837|473406505|FG000|Study Treatment Phase|Lost to Follow-up|0|||
131485278|NCT02319837|473406506|FG001|Study Treatment Phase|Lost to Follow-up|1|||
131485279|NCT02319837|473406507|FG002|Study Treatment Phase|Lost to Follow-up|0|||
131485280|NCT02319837|473406505|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
131485281|NCT02319837|473406506|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
131485282|NCT02319837|473406507|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
131485283|NCT02319837|473406505|FG000|Study Treatment Phase|Other|0|||
131485284|NCT02319837|473406506|FG001|Study Treatment Phase|Other|1|||
131485285|NCT02319837|473406507|FG002|Study Treatment Phase|Other|0|||
131485286|NCT02319837|473406505|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
131485287|NCT02319837|473406506|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
131485288|NCT02319837|473406507|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
131485289|NCT02319837|473406505|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
131485290|NCT02319837|473406506|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
131485291|NCT02319837|473406507|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
131485292|NCT02319837|473406505|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
131485293|NCT02319837|473406506|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
131496798|NCT01979016|473446398|FG001|Overall Study|Adverse Event|1|||
131485294|NCT02319837|473406507|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
131485295|NCT02319837|473406505|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
131485296|NCT02319837|473406506|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
131485297|NCT02319837|473406507|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
131485298|NCT02319837|473406505|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
131485299|NCT02319837|473406506|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
131485300|NCT02319837|473406507|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
131485301|NCT02319837|473406505|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
131485302|NCT02319837|473406506|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
131485303|NCT02319837|473406507|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
131485304|NCT02319837|473406505|FG000|Long-Term Follow-Up Phase|Death|33|||
131485305|NCT02319837|473406506|FG001|Long-Term Follow-Up Phase|Death|54|||
131485306|NCT02319837|473406507|FG002|Long-Term Follow-Up Phase|Death|42|||
131485307|NCT00753766|473406508|FG000|Overall Study|Physician Decision|1|||
131485308|NCT00753766|473406509|FG001|Overall Study|Physician Decision|0|||
131485309|NCT00839852|473406514|FG000|Overall Study|Adverse Event|10|||
131485310|NCT00839852|473406514|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131485311|NCT00839852|473406514|FG000|Overall Study|Protocol Violation|9|||
131485312|NCT00839852|473406514|FG000|Overall Study|Withdrawal of Consent|16|||
131485313|NCT00839852|473406514|FG000|Overall Study|Lost to Follow-up|7|||
131485314|NCT00839852|473406514|FG000|Overall Study|Lack of Compliance While in Jail|1|||
131485315|NCT00839852|473406514|FG000|Overall Study|Pregnancy|1|||
131485316|NCT04545554|473406515|FG000|Overall Study|Withdrawal by Subject|0|||
131485317|NCT04545554|473406516|FG001|Overall Study|Withdrawal by Subject|0|||
131485318|NCT04545554|473406517|FG002|Overall Study|Withdrawal by Subject|0|||
131485319|NCT04545554|473406518|FG003|Overall Study|Withdrawal by Subject|1|||
131485320|NCT04545554|473406519|FG004|Overall Study|Withdrawal by Subject|0|||
131485321|NCT04545554|473406520|FG005|Overall Study|Withdrawal by Subject|0|||
131485322|NCT01313312|473406523|FG000|Overall Study|Adverse Event|5|||
131485323|NCT01313312|473406523|FG000|Overall Study|Withdrawal by Subject|18|||
131485324|NCT01313312|473406523|FG000|Overall Study|Lack of Efficacy|3|||
131485325|NCT01313312|473406523|FG000|Overall Study|Investigator Decision|1|||
131485326|NCT01313312|473406523|FG000|Overall Study|Observational Phase|1|||
131485327|NCT01313312|473406523|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
131485328|NCT01313312|473406523|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
131485329|NCT01206166|473406527|FG000|Overall Study|No evaluable data|2|||
131485330|NCT01206166|473406528|FG001|Overall Study|No evaluable data|3|||
131485331|NCT00932126|473406529|FG000|Overall Study|Adverse Event|0|||
131485332|NCT00932126|473406530|FG001|Overall Study|Adverse Event|0|||
131485333|NCT00932126|473406531|FG002|Overall Study|Adverse Event|0|||
131485334|NCT00932126|473406532|FG003|Overall Study|Adverse Event|0|||
131485335|NCT00932126|473406533|FG004|Overall Study|Adverse Event|0|||
131485336|NCT00932126|473406534|FG005|Overall Study|Adverse Event|0|||
131485337|NCT00932126|473406535|FG006|Overall Study|Adverse Event|1|||
131485338|NCT00932126|473406536|FG007|Overall Study|Adverse Event|2|||
131485339|NCT00932126|473406529|FG000|Overall Study|Protocol Violation|0|||
131485340|NCT00932126|473406530|FG001|Overall Study|Protocol Violation|0|||
131485341|NCT00932126|473406531|FG002|Overall Study|Protocol Violation|0|||
131485342|NCT00932126|473406532|FG003|Overall Study|Protocol Violation|0|||
131485343|NCT00932126|473406533|FG004|Overall Study|Protocol Violation|1|||
131485344|NCT00932126|473406534|FG005|Overall Study|Protocol Violation|0|||
131485345|NCT00932126|473406535|FG006|Overall Study|Protocol Violation|0|||
131485346|NCT00932126|473406536|FG007|Overall Study|Protocol Violation|0|||
131485347|NCT00932126|473406529|FG000|Overall Study|Withdrawal by Subject|0|||
131485348|NCT00932126|473406530|FG001|Overall Study|Withdrawal by Subject|0|||
131485349|NCT00932126|473406531|FG002|Overall Study|Withdrawal by Subject|1|||
131485350|NCT00932126|473406532|FG003|Overall Study|Withdrawal by Subject|0|||
131485351|NCT00932126|473406533|FG004|Overall Study|Withdrawal by Subject|0|||
131485352|NCT00932126|473406534|FG005|Overall Study|Withdrawal by Subject|0|||
131485353|NCT00932126|473406535|FG006|Overall Study|Withdrawal by Subject|0|||
131485354|NCT00932126|473406536|FG007|Overall Study|Withdrawal by Subject|1|||
131485355|NCT00932126|473406529|FG000|Overall Study|Objective progression or relapse|3|||
131485356|NCT00932126|473406530|FG001|Overall Study|Objective progression or relapse|3|||
131485357|NCT00932126|473406531|FG002|Overall Study|Objective progression or relapse|2|||
131485358|NCT00932126|473406532|FG003|Overall Study|Objective progression or relapse|3|||
131485359|NCT00932126|473406533|FG004|Overall Study|Objective progression or relapse|3|||
131485360|NCT00932126|473406534|FG005|Overall Study|Objective progression or relapse|3|||
131485361|NCT00932126|473406535|FG006|Overall Study|Objective progression or relapse|3|||
131485362|NCT00932126|473406536|FG007|Overall Study|Objective progression or relapse|5|||
131485363|NCT00932126|473406529|FG000|Overall Study|Other|0|||
131485364|NCT00932126|473406530|FG001|Overall Study|Other|0|||
131485365|NCT00932126|473406531|FG002|Overall Study|Other|0|||
131485366|NCT00932126|473406532|FG003|Overall Study|Other|0|||
131485367|NCT00932126|473406533|FG004|Overall Study|Other|1|||
131485368|NCT00932126|473406534|FG005|Overall Study|Other|0|||
131485369|NCT00932126|473406535|FG006|Overall Study|Other|1|||
131485370|NCT00932126|473406536|FG007|Overall Study|Other|2|||
131485371|NCT01254331|473406538|FG000|Initial Phase|Adverse Event|3|||
131485372|NCT01254331|473406538|FG000|Initial Phase|Withdrawal by Subject|1|||
131485373|NCT01254331|473406538|FG000|Initial Phase|Pregnancy|1|||
131485374|NCT01254331|473406538|FG000|Extension Phase|Lack of Efficacy|1|||
131485375|NCT01254331|473406538|FG000|Extension Phase|Lost to Follow-up|3|||
131485376|NCT00892047|473406540|FG000|Overall Study|Adverse Event|2|||
131485377|NCT00892047|473406541|FG001|Overall Study|Adverse Event|2|||
131485378|NCT00892047|473406540|FG000|Overall Study|subject burden|2|||
131485379|NCT00892047|473406541|FG001|Overall Study|subject burden|3|||
131485380|NCT00892047|473406540|FG000|Overall Study|Lack of Efficacy|0|||
131485381|NCT00892047|473406541|FG001|Overall Study|Lack of Efficacy|2|||
131485382|NCT05306977|473406542|FG000|Overall Study|Withdrawal by Subject|1|||
131485383|NCT05213481|473406547|FG000|Overall Study|Adverse Event|3|||
131485384|NCT05213481|473406547|FG000|Overall Study|Lost to Follow-up|1|||
131485385|NCT01612858|473406548|FG000|Overall Study|Withdrawal by Subject|5|||
131485386|NCT01612858|473406549|FG001|Overall Study|Withdrawal by Subject|1|||
131485387|NCT00660699|473406554|FG000|Overall Study|Withdrawal by Subject|2|||
131485388|NCT01752985|473406555|FG000|Treatment Period|Subject request to discontinue treatment|1|||
131485389|NCT01752985|473406556|FG001|Treatment Period|Subject request to discontinue treatment|0|||
131485390|NCT01752985|473406557|FG002|Treatment Period|Subject request to discontinue treatment|1|||
131485391|NCT01752985|473406555|FG000|Treatment Period|Subject no longer meets study criteria|0|||
131485392|NCT01752985|473406556|FG001|Treatment Period|Subject no longer meets study criteria|1|||
131485393|NCT01752985|473406557|FG002|Treatment Period|Subject no longer meets study criteria|1|||
131485394|NCT01752985|473406555|FG000|Treatment Period|Adverse Event|2|||
131485395|NCT01752985|473406556|FG001|Treatment Period|Adverse Event|1|||
131485396|NCT01752985|473406557|FG002|Treatment Period|Adverse Event|2|||
131485397|NCT01752985|473406555|FG000|Treatment Period|Withdrawal by Subject|1|||
131485398|NCT01752985|473406556|FG001|Treatment Period|Withdrawal by Subject|1|||
131485399|NCT01752985|473406557|FG002|Treatment Period|Withdrawal by Subject|0|||
131485400|NCT01752985|473406555|FG000|Treatment Period|Lost to Follow-up|0|||
131485401|NCT01752985|473406556|FG001|Treatment Period|Lost to Follow-up|0|||
131485402|NCT01752985|473406557|FG002|Treatment Period|Lost to Follow-up|1|||
131485403|NCT03128047|473406558|FG000|Overall Study|Withdrawal by Subject|1|||
131485404|NCT01995825|473407838|FG000|Overall Study|Withdrawal by Subject|1|||
131485405|NCT01995825|473407839|FG001|Overall Study|Withdrawal by Subject|0|||
131485406|NCT01385566|473407840|FG000|Overall Study|Lost to Follow-up|1|||
131485407|NCT01385566|473407841|FG001|Overall Study|Lost to Follow-up|0|||
131485408|NCT01385566|473407842|FG002|Overall Study|Lost to Follow-up|0|||
131485409|NCT01385566|473407843|FG003|Overall Study|Lost to Follow-up|0|||
131485410|NCT01385566|473407844|FG004|Overall Study|Lost to Follow-up|0|||
131485411|NCT01385566|473407845|FG005|Overall Study|Lost to Follow-up|0|||
131485412|NCT01385566|473407840|FG000|Overall Study|Withdrawal by Subject|0|||
131485413|NCT01385566|473407841|FG001|Overall Study|Withdrawal by Subject|0|||
131485414|NCT01385566|473407842|FG002|Overall Study|Withdrawal by Subject|0|||
131485415|NCT01385566|473407843|FG003|Overall Study|Withdrawal by Subject|1|||
131485416|NCT01385566|473407844|FG004|Overall Study|Withdrawal by Subject|0|||
131485417|NCT01385566|473407845|FG005|Overall Study|Withdrawal by Subject|0|||
131485418|NCT00403234|473407848|FG000|Overall Study|Withdrawal by Subject|0|||
131485419|NCT00403234|473407849|FG001|Overall Study|Withdrawal by Subject|1|||
131485420|NCT00403234|473407850|FG002|Overall Study|Withdrawal by Subject|0|||
131485421|NCT00403234|473407851|FG003|Overall Study|Withdrawal by Subject|0|||
131485422|NCT00403234|473407848|FG000|Overall Study|Adverse Event|1|||
131485423|NCT00403234|473407849|FG001|Overall Study|Adverse Event|0|||
131485424|NCT00403234|473407850|FG002|Overall Study|Adverse Event|1|||
131485425|NCT00403234|473407851|FG003|Overall Study|Adverse Event|0|||
131485426|NCT04092582|473407852|FG000|Overall Study|Death|1|||
131485427|NCT04092582|473407853|FG001|Overall Study|Death|1|||
131485428|NCT04092582|473407852|FG000|Overall Study|Withdrawal by Subject|4|||
131485429|NCT04092582|473407853|FG001|Overall Study|Withdrawal by Subject|1|||
131485430|NCT04092582|473407852|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
131485431|NCT04092582|473407853|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
131485432|NCT02025621|473407860|FG000|Overall Study|Withdrawal by Subject|1|||
131485433|NCT02025621|473407861|FG001|Overall Study|Withdrawal by Subject|0|||
131485434|NCT02025621|473407860|FG000|Overall Study|Death|0|||
131485435|NCT02025621|473407861|FG001|Overall Study|Death|1|||
131485436|NCT02025621|473407860|FG000|Overall Study|No longer eligible|10|||
131485437|NCT02025621|473407861|FG001|Overall Study|No longer eligible|15|||
131485438|NCT02025621|473407860|FG000|Overall Study|Surgery initiated before infusion|3|||
131485439|NCT02025621|473407861|FG001|Overall Study|Surgery initiated before infusion|3|||
131485440|NCT00739674|473407862|FG000|Overall Study|Screening failures|19|||
131485441|NCT00739674|473407863|FG001|Overall Study|Screening failures|17|||
131485442|NCT00739674|473407862|FG000|Overall Study|Site 212 removal|19|||
131485443|NCT00739674|473407863|FG001|Overall Study|Site 212 removal|13|||
131485444|NCT00739674|473407862|FG000|Overall Study|No follow-up data|33|||
131485445|NCT00739674|473407863|FG001|Overall Study|No follow-up data|18|||
131485446|NCT00739674|473407862|FG000|Overall Study|Dietician consultation >30 days|1|||
131485447|NCT00739674|473407863|FG001|Overall Study|Dietician consultation >30 days|9|||
131485448|NCT00739674|473407862|FG000|Overall Study|Adverse Event|22|||
131485449|NCT00739674|473407863|FG001|Overall Study|Adverse Event|13|||
131485450|NCT00739674|473407862|FG000|Overall Study|Death|1|||
131485451|NCT00739674|473407863|FG001|Overall Study|Death|0|||
131485452|NCT00739674|473407862|FG000|Overall Study|Lack of Efficacy|1|||
131485453|NCT00739674|473407863|FG001|Overall Study|Lack of Efficacy|0|||
131485454|NCT00739674|473407862|FG000|Overall Study|Lost to Follow-up|52|||
131485455|NCT00739674|473407863|FG001|Overall Study|Lost to Follow-up|30|||
131485456|NCT00739674|473407862|FG000|Overall Study|Protocol Violation|5|||
131485457|NCT00739674|473407863|FG001|Overall Study|Protocol Violation|5|||
131485458|NCT00739674|473407862|FG000|Overall Study|Withdrawal by Subject|9|||
131485459|NCT00739674|473407863|FG001|Overall Study|Withdrawal by Subject|9|||
131485460|NCT00739674|473407862|FG000|Overall Study|Reason missing|2|||
131485461|NCT00739674|473407863|FG001|Overall Study|Reason missing|0|||
131485462|NCT00739674|473407862|FG000|Overall Study|Clinic closed|6|||
131485463|NCT00739674|473407863|FG001|Overall Study|Clinic closed|4|||
131485464|NCT00739674|473407862|FG000|Overall Study|Patient moved|3|||
131485465|NCT00739674|473407863|FG001|Overall Study|Patient moved|2|||
131485466|NCT00739674|473407862|FG000|Overall Study|Non compliant|4|||
131485467|NCT00739674|473407863|FG001|Overall Study|Non compliant|0|||
131485468|NCT00739674|473407862|FG000|Overall Study|Unable to attend visit|3|||
131485469|NCT00739674|473407863|FG001|Overall Study|Unable to attend visit|1|||
131485470|NCT00739674|473407862|FG000|Overall Study|Home monitoring off meds|1|||
131485471|NCT00739674|473407863|FG001|Overall Study|Home monitoring off meds|0|||
131485472|NCT00739674|473407862|FG000|Overall Study|Erectile dysfunction|0|||
131485473|NCT00739674|473407863|FG001|Overall Study|Erectile dysfunction|1|||
131485474|NCT01594281|473407864|FG000|Interventional Core Phase|Protocol Deviation|1|||
131485475|NCT01594281|473407865|FG001|Interventional Core Phase|Protocol Deviation|0|||
131485476|NCT01594281|473407866|FG002|Interventional Core Phase|Protocol Deviation|0|||
131485477|NCT01594281|473407864|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
131485478|NCT01594281|473407865|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
131485479|NCT01594281|473407866|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
131485480|NCT01594281|473407864|FG000|Interventional Core Phase|Death|1|||
131485481|NCT01594281|473407865|FG001|Interventional Core Phase|Death|1|||
131485482|NCT01594281|473407866|FG002|Interventional Core Phase|Death|2|||
131485483|NCT01594281|473407864|FG000|Interventional Core Phase|Lost to Follow-up|1|||
131485484|NCT01594281|473407865|FG001|Interventional Core Phase|Lost to Follow-up|4|||
131485485|NCT01594281|473407866|FG002|Interventional Core Phase|Lost to Follow-up|1|||
131485486|NCT01594281|473407864|FG000|Interventional Core Phase|Adverse Event|4|||
131485487|NCT01594281|473407865|FG001|Interventional Core Phase|Adverse Event|4|||
131485488|NCT01594281|473407866|FG002|Interventional Core Phase|Adverse Event|4|||
131485489|NCT01594281|473407864|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
131485490|NCT01594281|473407865|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
131485491|NCT01594281|473407866|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
131485492|NCT01594281|473407864|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
131485493|NCT01594281|473407865|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
131485494|NCT01594281|473407866|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
131485495|NCT01594281|473407864|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
131485496|NCT01594281|473407865|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
131485497|NCT01594281|473407866|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
131485498|NCT04805541|473407868|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
131485499|NCT00283400|473407872|FG000|Overall Study|Withdrawal by Subject|1|||
131485500|NCT00283400|473407873|FG001|Overall Study|Withdrawal by Subject|1|||
131485501|NCT00283400|473407874|FG002|Overall Study|Withdrawal by Subject|0|||
131485502|NCT00283400|473407875|FG003|Overall Study|Withdrawal by Subject|0|||
131485503|NCT00283400|473407872|FG000|Overall Study|Death|1|||
131485504|NCT00283400|473407873|FG001|Overall Study|Death|0|||
131485505|NCT00283400|473407874|FG002|Overall Study|Death|1|||
131485506|NCT00283400|473407875|FG003|Overall Study|Death|0|||
131485507|NCT02195583|473407877|FG000|Overall Study|Lost to Follow-up|1|||
131485508|NCT02195583|473407877|FG000|Overall Study|Withdrawal by Subject|4|||
131485509|NCT02195583|473407877|FG000|Overall Study|Adverse Event|2|||
131485510|NCT02195583|473407877|FG000|Overall Study|Other Reason|2|||
131485511|NCT01034631|473407878|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
131485512|NCT01034631|473407879|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
131485513|NCT01034631|473407880|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
131485514|NCT01034631|473407878|FG000|Phase II|Not Evaluable per protocol|0|||
131485515|NCT01034631|473407879|FG001|Phase II|Not Evaluable per protocol|0|||
131485516|NCT01034631|473407880|FG002|Phase II|Not Evaluable per protocol|2|||
131485517|NCT01034631|473407878|FG000|Phase II|Determined Ineligible per protocol|0|||
131485518|NCT01034631|473407879|FG001|Phase II|Determined Ineligible per protocol|1|||
131485519|NCT01034631|473407880|FG002|Phase II|Determined Ineligible per protocol|0|||
131485520|NCT04218695|473407881|FG000|Overall Study|Adverse Event|1|||
131485521|NCT04218695|473407882|FG001|Overall Study|Adverse Event|0|||
131485522|NCT04019288|473407883|FG000|Overall Study|Death|1|||
131485523|NCT04019288|473407884|FG001|Overall Study|Death|0|||
131485524|NCT04019288|473407885|FG002|Overall Study|Death|0|||
131485525|NCT03166735|473407886|FG000|Overall Study|Not Treated|1|||
131485526|NCT03166735|473407887|FG001|Overall Study|Not Treated|0|||
131485527|NCT03166735|473407888|FG002|Overall Study|Not Treated|0|||
131485528|NCT03166735|473407889|FG003|Overall Study|Not Treated|0|||
131485529|NCT03166735|473407890|FG004|Overall Study|Not Treated|0|||
131485530|NCT03166735|473407886|FG000|Overall Study|follow-up not completed as planned|0|||
131485531|NCT03166735|473407887|FG001|Overall Study|follow-up not completed as planned|1|||
131485532|NCT03166735|473407888|FG002|Overall Study|follow-up not completed as planned|1|||
131485533|NCT03166735|473407889|FG003|Overall Study|follow-up not completed as planned|0|||
131485534|NCT03166735|473407890|FG004|Overall Study|follow-up not completed as planned|1|||
131485535|NCT03166735|473407886|FG000|Overall Study|Withdrawal by Subject|0|||
131485536|NCT03166735|473407887|FG001|Overall Study|Withdrawal by Subject|0|||
131485537|NCT03166735|473407888|FG002|Overall Study|Withdrawal by Subject|1|||
131485538|NCT03166735|473407889|FG003|Overall Study|Withdrawal by Subject|1|||
131485539|NCT03166735|473407890|FG004|Overall Study|Withdrawal by Subject|2|||
131485540|NCT03166735|473407886|FG000|Overall Study|Lost to Follow-up|0|||
131485541|NCT03166735|473407887|FG001|Overall Study|Lost to Follow-up|2|||
131485542|NCT03166735|473407888|FG002|Overall Study|Lost to Follow-up|1|||
131485543|NCT03166735|473407889|FG003|Overall Study|Lost to Follow-up|0|||
131485544|NCT03166735|473407890|FG004|Overall Study|Lost to Follow-up|1|||
131485545|NCT01543958|473407891|FG000|Overall Study|Loss to follow-up|3|||
131485546|NCT01543958|473407891|FG000|Overall Study|ART initiation|1|||
131485547|NCT04401423|473407892|FG000|Overall Study|Withdrawal by Subject|3|||
131485548|NCT04401423|473407893|FG001|Overall Study|Withdrawal by Subject|1|||
131485549|NCT04401423|473407892|FG000|Overall Study|Physician Decision|2|||
131485550|NCT04401423|473407893|FG001|Overall Study|Physician Decision|1|||
131485551|NCT01020981|473407896|FG000|Overall Study|Did not return mailed survey|74|||
131485552|NCT01020981|473407897|FG001|Overall Study|Did not return mailed survey|58|||
131485553|NCT01020981|473407896|FG000|Overall Study|Survey returned undeliverable|8|||
131485554|NCT01020981|473407897|FG001|Overall Study|Survey returned undeliverable|32|||
131485555|NCT01020981|473407896|FG000|Overall Study|Participant declined to complete survey|2|||
131485556|NCT01020981|473407897|FG001|Overall Study|Participant declined to complete survey|0|||
131485557|NCT03372096|473407901|FG000|Overall Study|Study Closed|8|||
131485558|NCT00680017|473407902|FG000|Overall Study|Adverse Event|13|||
131485559|NCT00680017|473407903|FG001|Overall Study|Adverse Event|7|||
131485560|NCT00680017|473407902|FG000|Overall Study|Withdrawal by Subject|2|||
131485561|NCT00680017|473407903|FG001|Overall Study|Withdrawal by Subject|5|||
131485562|NCT00680017|473407902|FG000|Overall Study|Lost to Follow-up|2|||
131485563|NCT00680017|473407903|FG001|Overall Study|Lost to Follow-up|0|||
131485564|NCT02555683|473407904|FG000|Overall Study|Physician Decision|1|||
131485565|NCT02555683|473407905|FG001|Overall Study|Physician Decision|0|||
131485566|NCT02555683|473407906|FG002|Overall Study|Physician Decision|2|||
131485567|NCT02555683|473407904|FG000|Overall Study|Lost to Follow-up|2|||
131485568|NCT02555683|473407905|FG001|Overall Study|Lost to Follow-up|1|||
131485569|NCT02555683|473407906|FG002|Overall Study|Lost to Follow-up|2|||
131485570|NCT02555683|473407904|FG000|Overall Study|Technical Problems|1|||
131485571|NCT02555683|473407905|FG001|Overall Study|Technical Problems|1|||
131485572|NCT02555683|473407906|FG002|Overall Study|Technical Problems|0|||
131485573|NCT02555683|473407904|FG000|Overall Study|Protocol deviation|0|||
131485574|NCT02555683|473407905|FG001|Overall Study|Protocol deviation|1|||
131485575|NCT02555683|473407906|FG002|Overall Study|Protocol deviation|0|||
131485576|NCT02555683|473407904|FG000|Overall Study|Lack of Efficacy|2|||
131485577|NCT02555683|473407905|FG001|Overall Study|Lack of Efficacy|0|||
131485578|NCT02555683|473407906|FG002|Overall Study|Lack of Efficacy|0|||
131485579|NCT02555683|473407904|FG000|Overall Study|Death|0|||
131485580|NCT02555683|473407905|FG001|Overall Study|Death|1|||
131485581|NCT02555683|473407906|FG002|Overall Study|Death|2|||
131485582|NCT02555683|473407904|FG000|Overall Study|Adverse Event|1|||
131485583|NCT02555683|473407905|FG001|Overall Study|Adverse Event|0|||
131485584|NCT02555683|473407906|FG002|Overall Study|Adverse Event|1|||
131485585|NCT02555683|473407904|FG000|Overall Study|Subject/guardian decision|12|||
131485586|NCT02555683|473407905|FG001|Overall Study|Subject/guardian decision|12|||
131485587|NCT02555683|473407906|FG002|Overall Study|Subject/guardian decision|22|||
131485588|NCT02555683|473407904|FG000|Overall Study|Death post Treatment/safety period|0|||
131485589|NCT02555683|473407905|FG001|Overall Study|Death post Treatment/safety period|1|||
131485590|NCT02555683|473407906|FG002|Overall Study|Death post Treatment/safety period|0|||
131485591|NCT05074667|473407907|FG000|Overall Study|Death|1|||
131485592|NCT05074667|473407907|FG000|Overall Study|Withdrawal by Subject|4|||
131485593|NCT05074667|473407907|FG000|Overall Study|Lost to Follow-up|10|||
131485594|NCT00434954|473407913|FG000|Overall Study|Adverse Event|17|||
131485595|NCT00434954|473407914|FG001|Overall Study|Adverse Event|2|||
131485596|NCT00434954|473407913|FG000|Overall Study|Entry criteria not met|14|||
131485597|NCT00434954|473407914|FG001|Overall Study|Entry criteria not met|16|||
131485598|NCT00434954|473407913|FG000|Overall Study|Lost to Follow-up|0|||
131485599|NCT00434954|473407914|FG001|Overall Study|Lost to Follow-up|1|||
131485600|NCT00434954|473407913|FG000|Overall Study|Physician Decision|6|||
131485601|NCT00434954|473407914|FG001|Overall Study|Physician Decision|3|||
131485602|NCT00434954|473407913|FG000|Overall Study|Protocol Violation|36|||
131485603|NCT00434954|473407914|FG001|Overall Study|Protocol Violation|27|||
131485604|NCT00434954|473407913|FG000|Overall Study|Sponsor decision|1|||
131485605|NCT00434954|473407914|FG001|Overall Study|Sponsor decision|0|||
131485606|NCT00434954|473407913|FG000|Overall Study|Subject decision|8|||
131485607|NCT00434954|473407914|FG001|Overall Study|Subject decision|22|||
131485608|NCT00864721|473407915|FG000|Overall Study|Patient request|11|||
131485609|NCT00864721|473407915|FG000|Overall Study|Hospitalized|1|||
131485610|NCT00864721|473407915|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
131485611|NCT00864721|473407915|FG000|Overall Study|Adverse Event|21|||
131485612|NCT03478657|473407924|FG000|Overall Study|Withdrawal by Subject|0|||
131485613|NCT03478657|473407925|FG001|Overall Study|Withdrawal by Subject|1|||
131485614|NCT03570697|473407926|FG000|Overall Study|Lost to Follow-up|0|||
131485615|NCT03570697|473407927|FG001|Overall Study|Lost to Follow-up|1|||
131485616|NCT03570697|473407926|FG000|Overall Study|Death|2|||
131485617|NCT03570697|473407927|FG001|Overall Study|Death|0|||
131485618|NCT03570697|473407926|FG000|Overall Study|Withdrawal by Subject|4|||
131485619|NCT03570697|473407927|FG001|Overall Study|Withdrawal by Subject|2|||
131485620|NCT01776840|473407928|FG000|Overall Study|Lost to Follow-up|12|||
131485621|NCT01776840|473407929|FG001|Overall Study|Lost to Follow-up|7|||
131485622|NCT01776840|473407928|FG000|Overall Study|Withdrawal by Subject|32|||
131485623|NCT01776840|473407929|FG001|Overall Study|Withdrawal by Subject|48|||
131485624|NCT01776840|473407928|FG000|Overall Study|Sponsor decision|89|||
131485625|NCT01776840|473407929|FG001|Overall Study|Sponsor decision|87|||
131485626|NCT03068455|473407931|FG000|Pre-treatment Period|Disease progression|0|||
131485627|NCT03068455|473407932|FG001|Pre-treatment Period|Disease progression|1|||
131485628|NCT03068455|473407931|FG000|Pre-treatment Period|Participant withdrew consent|1|||
131485629|NCT03068455|473407932|FG001|Pre-treatment Period|Participant withdrew consent|1|||
131485630|NCT03068455|473407931|FG000|Pre-treatment Period|Poor/non-compliance|0|||
131485631|NCT03068455|473407932|FG001|Pre-treatment Period|Poor/non-compliance|1|||
131485632|NCT03068455|473407931|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
131485633|NCT03068455|473407932|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
131485634|NCT03068455|473407931|FG000|Pre-treatment Period|Not reported|2|||
131485635|NCT03068455|473407932|FG001|Pre-treatment Period|Not reported|1|||
131485636|NCT03068455|473407931|FG000|Treatment Period|Disease progression|166|||
131485637|NCT03068455|473407932|FG001|Treatment Period|Disease progression|208|||
131485638|NCT03068455|473407931|FG000|Treatment Period|Study drug toxicity|317|||
131485639|NCT03068455|473407932|FG001|Treatment Period|Study drug toxicity|104|||
131485640|NCT03068455|473407931|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
131485641|NCT03068455|473407932|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
131485642|NCT03068455|473407931|FG000|Treatment Period|Participant request to stop therapy|33|||
131485643|NCT03068455|473407932|FG001|Treatment Period|Participant request to stop therapy|20|||
131485644|NCT03068455|473407931|FG000|Treatment Period|Participant withdrew consent|5|||
131485645|NCT03068455|473407932|FG001|Treatment Period|Participant withdrew consent|10|||
131485646|NCT03068455|473407931|FG000|Treatment Period|Poor/non-compliance|3|||
131485647|NCT03068455|473407932|FG001|Treatment Period|Poor/non-compliance|0|||
131485648|NCT03068455|473407931|FG000|Treatment Period|Participant no longer meets study criteria|1|||
131485649|NCT03068455|473407932|FG001|Treatment Period|Participant no longer meets study criteria|3|||
131485650|NCT03068455|473407931|FG000|Treatment Period|Other reasons|12|||
131485651|NCT03068455|473407932|FG001|Treatment Period|Other reasons|4|||
131485652|NCT03173313|473407936|FG000|Overall Study|Lost to Follow-up|2|||
131485653|NCT03173313|473407937|FG001|Overall Study|Lost to Follow-up|3|||
131485654|NCT03173313|473407936|FG000|Overall Study|Withdrawal by Subject|0|||
131485655|NCT03173313|473407937|FG001|Overall Study|Withdrawal by Subject|1|||
131485656|NCT03173313|473407936|FG000|Overall Study|Death|5|||
131485657|NCT03173313|473407937|FG001|Overall Study|Death|0|||
131485658|NCT03173313|473407936|FG000|Overall Study|Physician Decision|1|||
131485659|NCT03173313|473407937|FG001|Overall Study|Physician Decision|0|||
131485660|NCT03173313|473407936|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
131485661|NCT03173313|473407937|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
131485662|NCT03173313|473407936|FG000|Overall Study|Bone Fracture|1|||
131485663|NCT03173313|473407937|FG001|Overall Study|Bone Fracture|0|||
131485664|NCT01876420|473407938|FG000|Overall Study|Missed 30 day visit|1|||
131485665|NCT05338216|473407939|FG000|Overall Study|Withdrawal by Subject|1|||
131485666|NCT05338216|473407940|FG001|Overall Study|Withdrawal by Subject|1|||
131485667|NCT01042678|473407944|FG000|Overall Study|Physician Decision|1|||
131485668|NCT01042678|473407945|FG001|Overall Study|Physician Decision|0|||
131485669|NCT01042678|473407946|FG002|Overall Study|Physician Decision|0|||
131485670|NCT01042678|473407947|FG003|Overall Study|Physician Decision|0|||
131485671|NCT01042678|473407948|FG004|Overall Study|Physician Decision|0|||
131485672|NCT01042678|473407949|FG005|Overall Study|Physician Decision|0|||
131485673|NCT01788228|473407957|FG000|Overall Study|Migrated/moved from study area|1|||
131485674|NCT01788228|473407958|FG001|Overall Study|Migrated/moved from study area|0|||
131485675|NCT00259610|473407959|FG000|Overall Study|Withdrawal by Subject|33|||
131485676|NCT00259610|473407960|FG001|Overall Study|Withdrawal by Subject|25|||
131485677|NCT00259610|473407961|FG002|Overall Study|Withdrawal by Subject|29|||
131485678|NCT00259610|473407962|FG003|Overall Study|Withdrawal by Subject|19|||
131485679|NCT00259610|473407959|FG000|Overall Study|Lost to Follow-up|19|||
131485680|NCT00259610|473407960|FG001|Overall Study|Lost to Follow-up|8|||
131485681|NCT00259610|473407961|FG002|Overall Study|Lost to Follow-up|18|||
131485682|NCT00259610|473407962|FG003|Overall Study|Lost to Follow-up|15|||
131485683|NCT00259610|473407959|FG000|Overall Study|Physician Decision|6|||
131485684|NCT00259610|473407960|FG001|Overall Study|Physician Decision|4|||
131485685|NCT00259610|473407961|FG002|Overall Study|Physician Decision|7|||
131485686|NCT00259610|473407962|FG003|Overall Study|Physician Decision|2|||
131485687|NCT00259610|473407959|FG000|Overall Study|Death|1|||
131485688|NCT00259610|473407960|FG001|Overall Study|Death|1|||
131485689|NCT00259610|473407961|FG002|Overall Study|Death|2|||
131485690|NCT00259610|473407962|FG003|Overall Study|Death|0|||
131485691|NCT00259610|473407959|FG000|Overall Study|non medical reason|6|||
131485692|NCT00259610|473407960|FG001|Overall Study|non medical reason|2|||
131485693|NCT00259610|473407961|FG002|Overall Study|non medical reason|10|||
131485694|NCT00259610|473407962|FG003|Overall Study|non medical reason|3|||
131485695|NCT00259610|473407959|FG000|Overall Study|Adverse Event|3|||
131485696|NCT00259610|473407960|FG001|Overall Study|Adverse Event|4|||
131485697|NCT00259610|473407961|FG002|Overall Study|Adverse Event|5|||
131485698|NCT00259610|473407962|FG003|Overall Study|Adverse Event|2|||
131485699|NCT00259610|473407959|FG000|Overall Study|Serious Adverse Event|8|||
131485700|NCT00259610|473407960|FG001|Overall Study|Serious Adverse Event|2|||
131485701|NCT00259610|473407961|FG002|Overall Study|Serious Adverse Event|2|||
131485702|NCT00259610|473407962|FG003|Overall Study|Serious Adverse Event|2|||
131485703|NCT03344796|473407963|FG000|Overall Study|Lost to Follow-up|0|||
131485704|NCT03344796|473407964|FG001|Overall Study|Lost to Follow-up|0|||
131485705|NCT03344796|473407965|FG002|Overall Study|Lost to Follow-up|0|||
131485706|NCT03344796|473407966|FG003|Overall Study|Lost to Follow-up|0|||
131485707|NCT03344796|473407967|FG004|Overall Study|Lost to Follow-up|0|||
131485708|NCT03344796|473407968|FG005|Overall Study|Lost to Follow-up|2|||
131485709|NCT00289783|473407971|FG000|Primary Phase|Adverse Event|10|||
131485710|NCT00289783|473407972|FG001|Primary Phase|Adverse Event|1|||
131485711|NCT00289783|473407971|FG000|Primary Phase|Protocol Violation|27|||
131485712|NCT00289783|473407972|FG001|Primary Phase|Protocol Violation|6|||
131485713|NCT00289783|473407971|FG000|Primary Phase|Withdrawal by Subject|93|||
131485714|NCT00289783|473407972|FG001|Primary Phase|Withdrawal by Subject|40|||
131485715|NCT00289783|473407971|FG000|Primary Phase|Lost to Follow-up|60|||
131485716|NCT00289783|473407972|FG001|Primary Phase|Lost to Follow-up|14|||
131485717|NCT00289783|473407971|FG000|Primary Phase|Migration from the study area|26|||
131485718|NCT00289783|473407972|FG001|Primary Phase|Migration from the study area|10|||
131485719|NCT00289783|473407971|FG000|Primary Phase|Other|32|||
131485720|NCT00289783|473407972|FG001|Primary Phase|Other|12|||
131485721|NCT00289783|473407971|FG000|Fourth Dose Phase|Adverse Event|1|||
131485722|NCT00289783|473407972|FG001|Fourth Dose Phase|Adverse Event|0|||
131485723|NCT00289783|473407971|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
131485724|NCT00289783|473407972|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
131485725|NCT00289783|473407971|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
131485726|NCT00289783|473407972|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
131485727|NCT00289783|473407971|FG000|Fourth Dose Phase|Migration from the study area|1|||
131485728|NCT00289783|473407972|FG001|Fourth Dose Phase|Migration from the study area|1|||
131485729|NCT00289783|473407971|FG000|Fourth Dose Phase|Other|22|||
131485730|NCT00289783|473407972|FG001|Fourth Dose Phase|Other|10|||
131485731|NCT01453361|473407980|FG000|Overall Study|Disease Progression|6|||
131485732|NCT01453361|473407980|FG000|Overall Study|Screen-Failures|10|||
131485733|NCT01798004|473410117|FG000|Overall Study|Death|2|||
131485734|NCT01798004|473410117|FG000|Overall Study|Lack of Efficacy|8|||
131485735|NCT01798004|473410117|FG000|Overall Study|Physician Decision|25|||
131485736|NCT01798004|473410117|FG000|Overall Study|Withdrawal by Subject|4|||
131485737|NCT01798004|473410117|FG000|Overall Study|Ineligible|4|||
131485738|NCT01798004|473410117|FG000|Overall Study|Patient/parent refusal|7|||
131485739|NCT01798004|473410117|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
131485740|NCT01798004|473410117|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
131485741|NCT02323113|473410121|FG000|Overall Study|Adverse Event|3|||
131485742|NCT02323113|473410122|FG001|Overall Study|Adverse Event|3|||
131485743|NCT02323113|473410123|FG002|Overall Study|Adverse Event|2|||
131485744|NCT02323113|473410124|FG003|Overall Study|Adverse Event|5|||
131485745|NCT02323113|473410125|FG004|Overall Study|Adverse Event|8|||
131485746|NCT02323113|473410126|FG005|Overall Study|Adverse Event|3|||
131485747|NCT02323113|473410127|FG006|Overall Study|Adverse Event|6|||
131485748|NCT02323113|473410128|FG007|Overall Study|Adverse Event|0|||
131485749|NCT02323113|473410121|FG000|Overall Study|Progressive Disease|0|||
131485750|NCT02323113|473410122|FG001|Overall Study|Progressive Disease|1|||
131485751|NCT02323113|473410123|FG002|Overall Study|Progressive Disease|1|||
131485752|NCT02323113|473410124|FG003|Overall Study|Progressive Disease|0|||
131485753|NCT02323113|473410125|FG004|Overall Study|Progressive Disease|0|||
131485754|NCT02323113|473410126|FG005|Overall Study|Progressive Disease|3|||
131485755|NCT02323113|473410127|FG006|Overall Study|Progressive Disease|0|||
131485756|NCT02323113|473410128|FG007|Overall Study|Progressive Disease|0|||
131485757|NCT02323113|473410121|FG000|Overall Study|Symptomatic Deterioration|0|||
131485758|NCT02323113|473410122|FG001|Overall Study|Symptomatic Deterioration|0|||
131485759|NCT02323113|473410123|FG002|Overall Study|Symptomatic Deterioration|1|||
131485760|NCT02323113|473410124|FG003|Overall Study|Symptomatic Deterioration|0|||
131485761|NCT02323113|473410125|FG004|Overall Study|Symptomatic Deterioration|1|||
131485762|NCT02323113|473410126|FG005|Overall Study|Symptomatic Deterioration|0|||
131485763|NCT02323113|473410127|FG006|Overall Study|Symptomatic Deterioration|0|||
131485764|NCT02323113|473410128|FG007|Overall Study|Symptomatic Deterioration|0|||
131485765|NCT02323113|473410121|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
131485766|NCT02323113|473410122|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
131485767|NCT02323113|473410123|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
131485768|NCT02323113|473410124|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
131485769|NCT02323113|473410125|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
131485770|NCT02323113|473410126|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
131485771|NCT02323113|473410127|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
131485772|NCT02323113|473410128|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
131485773|NCT02323113|473410121|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485774|NCT02323113|473410122|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
131485775|NCT02323113|473410123|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485776|NCT02323113|473410124|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485777|NCT02323113|473410125|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485778|NCT02323113|473410126|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485779|NCT02323113|473410127|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485780|NCT02323113|473410128|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131485781|NCT00560105|473410135|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
131485782|NCT00560105|473410136|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
131485783|NCT01663532|473410137|FG000|Overall Study|Lost to Follow-up|9|||
131485784|NCT01663532|473410138|FG001|Overall Study|Lost to Follow-up|10|||
131485785|NCT01663532|473410137|FG000|Overall Study|Adverse Event|7|||
131485786|NCT01663532|473410138|FG001|Overall Study|Adverse Event|13|||
131485787|NCT01663532|473410137|FG000|Overall Study|Met Withdrawal Criteria|7|||
131485788|NCT01663532|473410138|FG001|Overall Study|Met Withdrawal Criteria|6|||
131485789|NCT01663532|473410137|FG000|Overall Study|Physician Decision|1|||
131485790|NCT01663532|473410138|FG001|Overall Study|Physician Decision|1|||
131485791|NCT01663532|473410137|FG000|Overall Study|Withdrawal by Subject|35|||
131485792|NCT01663532|473410138|FG001|Overall Study|Withdrawal by Subject|17|||
131485793|NCT01663532|473410137|FG000|Overall Study|Lack of Efficacy|15|||
131485794|NCT01663532|473410138|FG001|Overall Study|Lack of Efficacy|60|||
131485795|NCT01871532|473410146|FG000|Overall Study|Withdrawal by Subject|1|||
131485796|NCT01871532|473410147|FG001|Overall Study|Withdrawal by Subject|2|||
131485797|NCT01673867|473410149|FG000|Randomization|Adverse event unrelated to study drug|1|||
131485798|NCT01673867|473410150|FG001|Randomization|Adverse event unrelated to study drug|0|||
131485799|NCT01673867|473410149|FG000|Randomization|Participant request to discontinue study treatment|0|||
131485800|NCT01673867|473410150|FG001|Randomization|Participant request to discontinue study treatment|4|||
131485801|NCT01673867|473410149|FG000|Randomization|Withdrawal by participant|0|||
131485802|NCT01673867|473410150|FG001|Randomization|Withdrawal by participant|12|||
131485803|NCT01673867|473410149|FG000|Randomization|Lost to Follow-up|0|||
131485804|NCT01673867|473410150|FG001|Randomization|Lost to Follow-up|1|||
131485805|NCT01673867|473410149|FG000|Randomization|Participant no longer meets study criteria|4|||
131485806|NCT01673867|473410150|FG001|Randomization|Participant no longer meets study criteria|5|||
131485807|NCT01673867|473410149|FG000|Treatment|Disease Progression|208|||
131485808|NCT01673867|473410150|FG001|Treatment|Disease Progression|178|||
131485809|NCT01673867|473410149|FG000|Treatment|Study Drug Toxicity|23|||
131485810|NCT01673867|473410150|FG001|Treatment|Study Drug Toxicity|43|||
131485811|NCT01673867|473410149|FG000|Treatment|Death|2|||
131485812|NCT01673867|473410150|FG001|Treatment|Death|3|||
131485813|NCT01673867|473410149|FG000|Treatment|Adverse event unrelated to study drug|23|||
131485814|NCT01673867|473410150|FG001|Treatment|Adverse event unrelated to study drug|10|||
131485815|NCT01673867|473410149|FG000|Treatment|Participant request to discontinue study treatment|7|||
131485816|NCT01673867|473410150|FG001|Treatment|Participant request to discontinue study treatment|17|||
131485817|NCT01673867|473410149|FG000|Treatment|Withdrawal by participant|5|||
131485818|NCT01673867|473410150|FG001|Treatment|Withdrawal by participant|5|||
131485819|NCT01673867|473410149|FG000|Treatment|Maximum clinical benefit|1|||
131485820|NCT01673867|473410150|FG001|Treatment|Maximum clinical benefit|10|||
131485821|NCT01673867|473410149|FG000|Treatment|Participant no longer meets study criteria|2|||
131485822|NCT01673867|473410150|FG001|Treatment|Participant no longer meets study criteria|0|||
131485823|NCT01673867|473410149|FG000|Treatment|Administrative reason by sponsor|3|||
131485824|NCT01673867|473410150|FG001|Treatment|Administrative reason by sponsor|0|||
131485825|NCT01673867|473410149|FG000|Treatment|Other reason|11|||
131485826|NCT01673867|473410150|FG001|Treatment|Other reason|2|||
131485827|NCT01709513|473410151|FG000|Overall Study|Randomized but not treated|0|||
131485828|NCT01709513|473410152|FG001|Overall Study|Randomized but not treated|1|||
131485829|NCT01709513|473410153|FG002|Overall Study|Randomized but not treated|0|||
131485830|NCT01709513|473410151|FG000|Overall Study|Adverse Event|16|||
131485831|NCT01709513|473410152|FG001|Overall Study|Adverse Event|31|||
131485832|NCT01709513|473410153|FG002|Overall Study|Adverse Event|23|||
131485833|NCT01709513|473410151|FG000|Overall Study|Poor compliance to protocol|2|||
131485834|NCT01709513|473410152|FG001|Overall Study|Poor compliance to protocol|0|||
131485835|NCT01709513|473410153|FG002|Overall Study|Poor compliance to protocol|0|||
131485836|NCT01709513|473410151|FG000|Overall Study|Other|3|||
131485837|NCT01709513|473410152|FG001|Overall Study|Other|11|||
131485838|NCT01709513|473410153|FG002|Overall Study|Other|7|||
131485839|NCT01560403|473410154|FG000|Overall Study|Lost to Follow-up|0|||
131485840|NCT01560403|473410155|FG001|Overall Study|Lost to Follow-up|1|||
131485841|NCT00983437|473410156|FG000|Overall Study|Adverse Event|9|||
131485842|NCT00983437|473410156|FG000|Overall Study|Lack of Efficacy|1|||
131485843|NCT00983437|473410156|FG000|Overall Study|Withdrawal by Subject|8|||
131485844|NCT00983437|473410156|FG000|Overall Study|Noncompliance to Study Procedures|1|||
131485845|NCT00983437|473410156|FG000|Overall Study|Lost to Follow-up|2|||
131485846|NCT00983437|473410156|FG000|Overall Study|Other Reason|26|||
131485847|NCT01945281|473410157|FG000|Overall Study|Adverse Event|1|||
131485848|NCT01945281|473410158|FG001|Overall Study|Adverse Event|0|||
131485849|NCT01945281|473410157|FG000|Overall Study|Death|3|||
131485850|NCT01945281|473410158|FG001|Overall Study|Death|3|||
131485851|NCT01945281|473410157|FG000|Overall Study|Physician Decision|1|||
131485852|NCT01945281|473410158|FG001|Overall Study|Physician Decision|1|||
131485853|NCT01945281|473410157|FG000|Overall Study|Technical Problems|1|||
131485854|NCT01945281|473410158|FG001|Overall Study|Technical Problems|0|||
131485855|NCT00040365|473410160|FG000|Overall Study|Death|1|||
131485856|NCT00040365|473410160|FG000|Overall Study|Progressive disease|7|||
131485857|NCT00040365|473410160|FG000|Overall Study|Lost to Follow-up|3|||
131485858|NCT00541931|473410161|FG000|Overall Study|Adverse Event|1|||
131485859|NCT00541931|473410162|FG001|Overall Study|Adverse Event|0|||
131485860|NCT00541931|473410161|FG000|Overall Study|Lost to Follow-up|3|||
131485861|NCT00541931|473410162|FG001|Overall Study|Lost to Follow-up|3|||
131485862|NCT00541931|473410161|FG000|Overall Study|Withdrawal by Subject|1|||
131485863|NCT00541931|473410162|FG001|Overall Study|Withdrawal by Subject|0|||
131485864|NCT00541931|473410161|FG000|Overall Study|Transportation Issue|0|||
131485865|NCT00541931|473410162|FG001|Overall Study|Transportation Issue|1|||
131485866|NCT02165215|473410163|FG000|Induction Phase|Adverse Event|1|||
131485867|NCT02165215|473410164|FG001|Induction Phase|Adverse Event|0|||
131485868|NCT02165215|473410165|FG002|Induction Phase|Adverse Event|0|||
131485869|NCT02165215|473410163|FG000|Induction Phase|Withdrawal by Subject|10|||
131485870|NCT02165215|473410164|FG001|Induction Phase|Withdrawal by Subject|0|||
131485871|NCT02165215|473410165|FG002|Induction Phase|Withdrawal by Subject|0|||
131485872|NCT02165215|473410163|FG000|Induction Phase|Protocol Violation|1|||
131485873|NCT02165215|473410164|FG001|Induction Phase|Protocol Violation|0|||
131485874|NCT02165215|473410165|FG002|Induction Phase|Protocol Violation|0|||
131485875|NCT02165215|473410163|FG000|Induction Phase|Physician Decision|1|||
131485876|NCT02165215|473410164|FG001|Induction Phase|Physician Decision|0|||
131485877|NCT02165215|473410165|FG002|Induction Phase|Physician Decision|0|||
131485878|NCT02165215|473410163|FG000|Induction Phase|Lack of Efficacy|2|||
131485879|NCT02165215|473410164|FG001|Induction Phase|Lack of Efficacy|0|||
131485880|NCT02165215|473410165|FG002|Induction Phase|Lack of Efficacy|0|||
131485881|NCT02165215|473410163|FG000|Induction Phase|Non-Compliance|2|||
131485882|NCT02165215|473410164|FG001|Induction Phase|Non-Compliance|0|||
131485883|NCT02165215|473410165|FG002|Induction Phase|Non-Compliance|0|||
131485884|NCT02165215|473410163|FG000|Induction Phase|Lost to Follow-up|6|||
131485885|NCT02165215|473410164|FG001|Induction Phase|Lost to Follow-up|0|||
131485886|NCT02165215|473410165|FG002|Induction Phase|Lost to Follow-up|0|||
131485887|NCT02165215|473410163|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131485888|NCT02165215|473410164|FG001|Maintenance Phase|Withdrawal by Subject|7|||
131485889|NCT02165215|473410165|FG002|Maintenance Phase|Withdrawal by Subject|3|||
131485890|NCT02165215|473410163|FG000|Maintenance Phase|Multiple reasons|0|||
131485891|NCT02165215|473410164|FG001|Maintenance Phase|Multiple reasons|2|||
131485892|NCT02165215|473410165|FG002|Maintenance Phase|Multiple reasons|1|||
131485893|NCT02165215|473410163|FG000|Maintenance Phase|Lost to Follow-up|0|||
131485894|NCT02165215|473410164|FG001|Maintenance Phase|Lost to Follow-up|2|||
131485895|NCT02165215|473410165|FG002|Maintenance Phase|Lost to Follow-up|0|||
131485896|NCT02165215|473410163|FG000|Maintenance Phase|Adverse Event|0|||
131485897|NCT02165215|473410164|FG001|Maintenance Phase|Adverse Event|1|||
131485898|NCT02165215|473410165|FG002|Maintenance Phase|Adverse Event|1|||
131485899|NCT01086033|473410166|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
131485900|NCT01086033|473410166|FG000|Overall Study|Lost to Follow-up|86|||
131485901|NCT01086033|473410166|FG000|Overall Study|Adverse Event|42|||
131485902|NCT01086033|473410166|FG000|Overall Study|Withdrawal by Subject|41|||
131485903|NCT01086033|473410166|FG000|Overall Study|Other|14|||
131485904|NCT01086033|473410166|FG000|Overall Study|Other|13|||
131485905|NCT01086033|473410166|FG000|Overall Study|AE and Withdrew Consent|5|||
131485906|NCT01086033|473410166|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
131485907|NCT01086033|473410166|FG000|Overall Study|Withdrew consent and Other Reason|4|||
131485908|NCT01086033|473410166|FG000|Overall Study|AE and Lack of Efficacy|4|||
131485909|NCT01086033|473410166|FG000|Overall Study|Death|1|||
131485910|NCT01086033|473410166|FG000|Overall Study|AE and Lost to Follow-up|1|||
131485911|NCT01086033|473410166|FG000|Overall Study|AE and Other Reason|1|||
131485912|NCT01086033|473410166|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
131485913|NCT04572633|473410167|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
131485914|NCT02924571|473410168|FG000|Overall Study|Lost to Follow-up|1|||
131485915|NCT02924571|473410169|FG001|Overall Study|Lost to Follow-up|1|||
131485916|NCT02924571|473410170|FG002|Overall Study|Lost to Follow-up|0|||
131485917|NCT00894166|473410171|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
131485918|NCT00894166|473410172|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
131485919|NCT00894166|473410173|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
131485920|NCT00894166|473410174|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
131485921|NCT00894166|473410175|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
131485922|NCT00894166|473410176|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
131485923|NCT00894166|473410177|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
131485924|NCT00894166|473410178|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
131485925|NCT00894166|473410171|FG000|Overall Study|Death|0|||
131485926|NCT00894166|473410172|FG001|Overall Study|Death|0|||
131485927|NCT00894166|473410173|FG002|Overall Study|Death|0|||
131485928|NCT00894166|473410174|FG003|Overall Study|Death|1|||
131485929|NCT00894166|473410175|FG004|Overall Study|Death|0|||
131485930|NCT00894166|473410176|FG005|Overall Study|Death|0|||
131485931|NCT00894166|473410177|FG006|Overall Study|Death|0|||
131485932|NCT00894166|473410178|FG007|Overall Study|Death|0|||
131485933|NCT00319553|473410184|FG000|Overall Study|Protocol Violation|1|||
131485934|NCT00319553|473410185|FG001|Overall Study|Protocol Violation|2|||
131485935|NCT00319553|473410184|FG000|Overall Study|Lost to Follow-up|2|||
131485936|NCT00319553|473410185|FG001|Overall Study|Lost to Follow-up|1|||
131485937|NCT00319553|473410184|FG000|Overall Study|Withdrawal by Subject|1|||
131485938|NCT00319553|473410185|FG001|Overall Study|Withdrawal by Subject|1|||
131485939|NCT01281865|473410189|FG000|Overall Study|Adverse Event|1|||
131485940|NCT01281865|473410190|FG001|Overall Study|Adverse Event|1|||
131485941|NCT01281865|473410189|FG000|Overall Study|Withdrawal by Subject|1|||
131485942|NCT01281865|473410190|FG001|Overall Study|Withdrawal by Subject|0|||
131485943|NCT01281865|473410189|FG000|Overall Study|Lack of Efficacy|1|||
131485944|NCT01281865|473410190|FG001|Overall Study|Lack of Efficacy|0|||
131485945|NCT02747875|473410191|FG000|Overall Study|Physician Decision|1|||
131485946|NCT02747875|473410192|FG001|Overall Study|Physician Decision|0|||
131485947|NCT02747875|473410191|FG000|Overall Study|Adverse Event|0|||
131485948|NCT02747875|473410192|FG001|Overall Study|Adverse Event|1|||
131485949|NCT01786668|473410194|FG000|Overall Study|Adverse Event|0|||
131485950|NCT01786668|473410195|FG001|Overall Study|Adverse Event|1|||
131485951|NCT01786668|473410196|FG002|Overall Study|Adverse Event|1|||
131485952|NCT01786668|473410197|FG003|Overall Study|Adverse Event|2|||
131485953|NCT01786668|473410194|FG000|Overall Study|Withdrawal by Subject|0|||
131485954|NCT01786668|473410195|FG001|Overall Study|Withdrawal by Subject|0|||
131485955|NCT01786668|473410196|FG002|Overall Study|Withdrawal by Subject|3|||
131485956|NCT01786668|473410197|FG003|Overall Study|Withdrawal by Subject|1|||
131485957|NCT01786668|473410194|FG000|Overall Study|Pregnancy|0|||
131485958|NCT01786668|473410195|FG001|Overall Study|Pregnancy|0|||
131485959|NCT01786668|473410196|FG002|Overall Study|Pregnancy|0|||
131485960|NCT01786668|473410197|FG003|Overall Study|Pregnancy|1|||
131485961|NCT01786668|473410194|FG000|Overall Study|Lost to Follow-up|1|||
131485962|NCT01786668|473410195|FG001|Overall Study|Lost to Follow-up|0|||
131485963|NCT01786668|473410196|FG002|Overall Study|Lost to Follow-up|1|||
131485964|NCT01786668|473410197|FG003|Overall Study|Lost to Follow-up|0|||
131485965|NCT01702805|473410198|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
131485966|NCT01702805|473410199|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
131485967|NCT01702805|473410198|FG000|Overall Study|Incomplete Follow-up|18|||
131485968|NCT01702805|473410199|FG001|Overall Study|Incomplete Follow-up|15|||
131485969|NCT01702805|473410198|FG000|Overall Study|Vital Status Assessment Only|40|||
131485970|NCT01702805|473410199|FG001|Overall Study|Vital Status Assessment Only|39|||
131485971|NCT01702805|473410198|FG000|Overall Study|Lost to Follow-up|5|||
131485972|NCT01702805|473410199|FG001|Overall Study|Lost to Follow-up|5|||
131485973|NCT01849783|473410200|FG000|Overall Study|Adverse Event|5|||
131485974|NCT01849783|473410200|FG000|Overall Study|Death|2|||
131485975|NCT01849783|473410200|FG000|Overall Study|Physician Decision|1|||
131485976|NCT01849783|473410200|FG000|Overall Study|Withdrawal by Subject|1|||
131485977|NCT01849783|473410200|FG000|Overall Study|Unable to comply|2|||
131485978|NCT01849783|473410200|FG000|Overall Study|Disease progression|11|||
131485979|NCT03948581|473410201|FG000|Overall Study|Lost to Follow-up|0|||
131485980|NCT03948581|473410202|FG001|Overall Study|Lost to Follow-up|1|||
131485981|NCT04457336|473410203|FG000|Period 2: Part A|Withdrawal by Subject|0|||
131485982|NCT04457336|473410204|FG001|Period 2: Part A|Withdrawal by Subject|1|||
131485983|NCT04457336|473410205|FG002|Period 2: Part A|Withdrawal by Subject|1|||
131485984|NCT04457336|473410206|FG003|Period 2: Part A|Withdrawal by Subject|1|||
131485985|NCT04457336|473410207|FG004|Period 2: Part A|Withdrawal by Subject|0|||
131485986|NCT04457336|473410208|FG005|Period 2: Part A|Withdrawal by Subject|0|||
131485987|NCT04457336|473410209|FG006|Period 2: Part A|Withdrawal by Subject|0|||
131485988|NCT04457336|473410210|FG007|Period 2: Part A|Withdrawal by Subject|0|||
131485989|NCT04457336|473410203|FG000|Period 2: Part A|Adverse Event|0|||
131485990|NCT04457336|473410204|FG001|Period 2: Part A|Adverse Event|0|||
131485991|NCT04457336|473410205|FG002|Period 2: Part A|Adverse Event|1|||
131485992|NCT04457336|473410206|FG003|Period 2: Part A|Adverse Event|1|||
131485993|NCT04457336|473410207|FG004|Period 2: Part A|Adverse Event|0|||
131485994|NCT04457336|473410208|FG005|Period 2: Part A|Adverse Event|0|||
131485995|NCT04457336|473410209|FG006|Period 2: Part A|Adverse Event|0|||
131485996|NCT04457336|473410210|FG007|Period 2: Part A|Adverse Event|0|||
131485997|NCT04457336|473410203|FG000|Period 2: Part A|Study Terminated|0|||
131485998|NCT04457336|473410204|FG001|Period 2: Part A|Study Terminated|0|||
131485999|NCT04457336|473410205|FG002|Period 2: Part A|Study Terminated|1|||
131486000|NCT04457336|473410206|FG003|Period 2: Part A|Study Terminated|0|||
131486001|NCT04457336|473410207|FG004|Period 2: Part A|Study Terminated|0|||
131486002|NCT04457336|473410208|FG005|Period 2: Part A|Study Terminated|0|||
131486003|NCT04457336|473410209|FG006|Period 2: Part A|Study Terminated|0|||
131486004|NCT04457336|473410210|FG007|Period 2: Part A|Study Terminated|0|||
131486005|NCT04457336|473410203|FG000|Period 2: Part A|Protocol Violation|0|||
131486006|NCT04457336|473410204|FG001|Period 2: Part A|Protocol Violation|1|||
131486007|NCT04457336|473410205|FG002|Period 2: Part A|Protocol Violation|0|||
131486008|NCT04457336|473410206|FG003|Period 2: Part A|Protocol Violation|0|||
131486009|NCT04457336|473410207|FG004|Period 2: Part A|Protocol Violation|0|||
131486010|NCT04457336|473410208|FG005|Period 2: Part A|Protocol Violation|0|||
131486011|NCT04457336|473410209|FG006|Period 2: Part A|Protocol Violation|0|||
131486012|NCT04457336|473410210|FG007|Period 2: Part A|Protocol Violation|0|||
131486013|NCT04457336|473410203|FG000|Period 2: Part A|Lost to Follow-up|0|||
131486014|NCT04457336|473410204|FG001|Period 2: Part A|Lost to Follow-up|1|||
131486015|NCT04457336|473410205|FG002|Period 2: Part A|Lost to Follow-up|0|||
131486016|NCT04457336|473410206|FG003|Period 2: Part A|Lost to Follow-up|0|||
131486017|NCT04457336|473410207|FG004|Period 2: Part A|Lost to Follow-up|0|||
131486018|NCT04457336|473410208|FG005|Period 2: Part A|Lost to Follow-up|0|||
131486019|NCT04457336|473410209|FG006|Period 2: Part A|Lost to Follow-up|0|||
131486020|NCT04457336|473410210|FG007|Period 2: Part A|Lost to Follow-up|0|||
131486021|NCT04457336|473410203|FG000|Period 2: Part A|Other|0|||
131486022|NCT04457336|473410204|FG001|Period 2: Part A|Other|1|||
131486023|NCT04457336|473410205|FG002|Period 2: Part A|Other|0|||
131486024|NCT04457336|473410206|FG003|Period 2: Part A|Other|0|||
131486025|NCT04457336|473410207|FG004|Period 2: Part A|Other|0|||
131486026|NCT04457336|473410208|FG005|Period 2: Part A|Other|0|||
131486027|NCT04457336|473410209|FG006|Period 2: Part A|Other|0|||
131486028|NCT04457336|473410210|FG007|Period 2: Part A|Other|0|||
131486029|NCT04457336|473410203|FG000|Period 2: Part A|Physician Decision|0|||
131486030|NCT04457336|473410204|FG001|Period 2: Part A|Physician Decision|0|||
131486031|NCT04457336|473410205|FG002|Period 2: Part A|Physician Decision|0|||
131486032|NCT04457336|473410206|FG003|Period 2: Part A|Physician Decision|1|||
131486033|NCT04457336|473410207|FG004|Period 2: Part A|Physician Decision|0|||
131486034|NCT04457336|473410208|FG005|Period 2: Part A|Physician Decision|0|||
131486035|NCT04457336|473410209|FG006|Period 2: Part A|Physician Decision|0|||
131486036|NCT04457336|473410210|FG007|Period 2: Part A|Physician Decision|0|||
131486037|NCT04457336|473410203|FG000|Period 3: Part B|Study Terminated|0|||
131486038|NCT04457336|473410204|FG001|Period 3: Part B|Study Terminated|0|||
131486039|NCT04457336|473410205|FG002|Period 3: Part B|Study Terminated|0|||
131486040|NCT04457336|473410206|FG003|Period 3: Part B|Study Terminated|0|||
131486041|NCT04457336|473410207|FG004|Period 3: Part B|Study Terminated|1|||
131486042|NCT04457336|473410208|FG005|Period 3: Part B|Study Terminated|10|||
131486043|NCT04457336|473410209|FG006|Period 3: Part B|Study Terminated|13|||
131486044|NCT04457336|473410210|FG007|Period 3: Part B|Study Terminated|0|||
131486045|NCT04457336|473410203|FG000|Period 3: Part B|Withdrawal by Subject|0|||
131486046|NCT04457336|473410204|FG001|Period 3: Part B|Withdrawal by Subject|0|||
131486047|NCT04457336|473410205|FG002|Period 3: Part B|Withdrawal by Subject|0|||
131486048|NCT04457336|473410206|FG003|Period 3: Part B|Withdrawal by Subject|0|||
131486049|NCT04457336|473410207|FG004|Period 3: Part B|Withdrawal by Subject|0|||
131486050|NCT04457336|473410208|FG005|Period 3: Part B|Withdrawal by Subject|1|||
131486051|NCT04457336|473410209|FG006|Period 3: Part B|Withdrawal by Subject|2|||
131486052|NCT04457336|473410210|FG007|Period 3: Part B|Withdrawal by Subject|0|||
131486053|NCT04457336|473410203|FG000|Period 4: Part C|Study Terminated|0|||
131486054|NCT04457336|473410204|FG001|Period 4: Part C|Study Terminated|0|||
131486055|NCT04457336|473410205|FG002|Period 4: Part C|Study Terminated|0|||
131486056|NCT04457336|473410206|FG003|Period 4: Part C|Study Terminated|0|||
131486057|NCT04457336|473410207|FG004|Period 4: Part C|Study Terminated|0|||
131486058|NCT04457336|473410208|FG005|Period 4: Part C|Study Terminated|0|||
131486059|NCT04457336|473410209|FG006|Period 4: Part C|Study Terminated|0|||
131486060|NCT04457336|473410210|FG007|Period 4: Part C|Study Terminated|30|||
131486061|NCT04457336|473410203|FG000|Period 4: Part C|Adverse Event|0|||
131486062|NCT04457336|473410204|FG001|Period 4: Part C|Adverse Event|0|||
131486063|NCT04457336|473410205|FG002|Period 4: Part C|Adverse Event|0|||
131486064|NCT04457336|473410206|FG003|Period 4: Part C|Adverse Event|0|||
131486065|NCT04457336|473410207|FG004|Period 4: Part C|Adverse Event|0|||
131486066|NCT04457336|473410208|FG005|Period 4: Part C|Adverse Event|0|||
131486067|NCT04457336|473410209|FG006|Period 4: Part C|Adverse Event|0|||
131486068|NCT04457336|473410210|FG007|Period 4: Part C|Adverse Event|2|||
131486069|NCT04457336|473410203|FG000|Period 4: Part C|Site Terminated|0|||
131486070|NCT04457336|473410204|FG001|Period 4: Part C|Site Terminated|0|||
131486071|NCT04457336|473410205|FG002|Period 4: Part C|Site Terminated|0|||
131486072|NCT04457336|473410206|FG003|Period 4: Part C|Site Terminated|0|||
131486073|NCT04457336|473410207|FG004|Period 4: Part C|Site Terminated|0|||
131486074|NCT04457336|473410208|FG005|Period 4: Part C|Site Terminated|0|||
131486075|NCT04457336|473410209|FG006|Period 4: Part C|Site Terminated|0|||
131486076|NCT04457336|473410210|FG007|Period 4: Part C|Site Terminated|1|||
131486077|NCT04457336|473410203|FG000|Period 4: Part C|Other|0|||
131486078|NCT04457336|473410204|FG001|Period 4: Part C|Other|0|||
131486079|NCT04457336|473410205|FG002|Period 4: Part C|Other|0|||
131486080|NCT04457336|473410206|FG003|Period 4: Part C|Other|0|||
131486081|NCT04457336|473410207|FG004|Period 4: Part C|Other|0|||
131486082|NCT04457336|473410208|FG005|Period 4: Part C|Other|0|||
131486083|NCT04457336|473410209|FG006|Period 4: Part C|Other|0|||
131486084|NCT04457336|473410210|FG007|Period 4: Part C|Other|2|||
131486085|NCT04457336|473410203|FG000|Period 4: Part C|Withdrawal by Subject|0|||
131486086|NCT04457336|473410204|FG001|Period 4: Part C|Withdrawal by Subject|0|||
131486087|NCT04457336|473410205|FG002|Period 4: Part C|Withdrawal by Subject|0|||
131486088|NCT04457336|473410206|FG003|Period 4: Part C|Withdrawal by Subject|0|||
131486089|NCT04457336|473410207|FG004|Period 4: Part C|Withdrawal by Subject|0|||
131486090|NCT04457336|473410208|FG005|Period 4: Part C|Withdrawal by Subject|0|||
131486091|NCT04457336|473410209|FG006|Period 4: Part C|Withdrawal by Subject|0|||
131486092|NCT04457336|473410210|FG007|Period 4: Part C|Withdrawal by Subject|3|||
131486093|NCT03330288|473410217|FG000|Overall Study|Other reason|1|||
131486094|NCT03330288|473410218|FG001|Overall Study|Other reason|1|||
131486095|NCT03330288|473410217|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
131486096|NCT03330288|473410218|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
131486097|NCT03330288|473410217|FG000|Overall Study|Adverse Event|1|||
131486098|NCT03330288|473410218|FG001|Overall Study|Adverse Event|0|||
131486099|NCT03330288|473410217|FG000|Overall Study|Withdrawal by Subject|1|||
131486100|NCT03330288|473410218|FG001|Overall Study|Withdrawal by Subject|0|||
131486101|NCT03330288|473410217|FG000|Overall Study|Lost to Follow-up|26|||
131486102|NCT03330288|473410218|FG001|Overall Study|Lost to Follow-up|7|||
131486103|NCT02693119|473410222|FG000|Open-Label Period|Withdrawal by Subject|0|||
131486104|NCT02693119|473410223|FG001|Open-Label Period|Withdrawal by Subject|1|||
131486105|NCT01719783|473410226|FG000|Dose 2|Physician Decision|1|||
131486106|NCT01719783|473410227|FG001|Dose 2|Physician Decision|0|||
131486107|NCT01350492|473410228|FG000|Intervention|Lost to Follow-up|2|||
131486108|NCT01350492|473410229|FG001|Intervention|Lost to Follow-up|5|||
131486109|NCT01350492|473410228|FG000|Intervention|Withdrawal by Subject|3|||
131486110|NCT01350492|473410229|FG001|Intervention|Withdrawal by Subject|1|||
131486111|NCT01350492|473410228|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
131486112|NCT01350492|473410229|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
131486113|NCT01350492|473410228|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
131486114|NCT01350492|473410229|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
131486115|NCT00939640|473410230|FG000|Overall Study|Physician Decision|1|||
131486116|NCT03988088|473410235|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
131486117|NCT03988088|473410236|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
131486118|NCT03988088|473410237|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
131486119|NCT03988088|473410238|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
131486120|NCT03988088|473410235|FG000|Open-Label Addendum|Lost to Follow-up|0|||
131486121|NCT03988088|473410236|FG001|Open-Label Addendum|Lost to Follow-up|0|||
131486122|NCT03988088|473410237|FG002|Open-Label Addendum|Lost to Follow-up|1|||
131486123|NCT03988088|473410238|FG003|Open-Label Addendum|Lost to Follow-up|0|||
131486124|NCT00181155|473410239|FG000|Overall Study|Physician Decision|1|||
131486125|NCT00181155|473410240|FG001|Overall Study|Physician Decision|0|||
131486126|NCT00181155|473410239|FG000|Overall Study|Withdrawal by Subject|1|||
131486127|NCT00181155|473410240|FG001|Overall Study|Withdrawal by Subject|0|||
131486128|NCT01548287|473410244|FG000|Screening|No reason provided|0|||
131486129|NCT01548287|473410245|FG001|Screening|No reason provided|0|||
131486130|NCT01548287|473410246|FG002|Screening|No reason provided|0|||
131486131|NCT01548287|473410247|FG003|Screening|No reason provided|0|||
131486132|NCT01548287|473410248|FG004|Screening|No reason provided|9|||
131486133|NCT01548287|473410244|FG000|Screening|Did not meet eligibility criteria|0|||
131486134|NCT01548287|473410245|FG001|Screening|Did not meet eligibility criteria|0|||
131486135|NCT01548287|473410246|FG002|Screening|Did not meet eligibility criteria|0|||
131486136|NCT01548287|473410247|FG003|Screening|Did not meet eligibility criteria|0|||
131486137|NCT01548287|473410248|FG004|Screening|Did not meet eligibility criteria|74|||
131486138|NCT01548287|473410244|FG000|Randomized Period|Did not meet inclusion criteria|0|||
131486139|NCT01548287|473410245|FG001|Randomized Period|Did not meet inclusion criteria|0|||
131486140|NCT01548287|473410246|FG002|Randomized Period|Did not meet inclusion criteria|2|||
131486141|NCT01548287|473410247|FG003|Randomized Period|Did not meet inclusion criteria|0|||
131486142|NCT01548287|473410248|FG004|Randomized Period|Did not meet inclusion criteria|0|||
131486143|NCT01548287|473410244|FG000|Randomized Period|Adverse Event|0|||
131486144|NCT01548287|473410245|FG001|Randomized Period|Adverse Event|2|||
131486145|NCT01548287|473410246|FG002|Randomized Period|Adverse Event|5|||
131486146|NCT01548287|473410247|FG003|Randomized Period|Adverse Event|0|||
131486147|NCT01548287|473410248|FG004|Randomized Period|Adverse Event|0|||
131486148|NCT02762578|473410249|FG000|Overall Study|Adverse Event|1|||
131486149|NCT02762578|473410250|FG001|Overall Study|Adverse Event|6|||
131486150|NCT02762578|473410249|FG000|Overall Study|Protocol Violation|4|||
131486151|NCT02762578|473410250|FG001|Overall Study|Protocol Violation|2|||
131486152|NCT02762578|473410249|FG000|Overall Study|Withdrawal by Subject|4|||
131486153|NCT02762578|473410250|FG001|Overall Study|Withdrawal by Subject|2|||
131486154|NCT02762578|473410249|FG000|Overall Study|Unclassified|6|||
131486155|NCT02762578|473410250|FG001|Overall Study|Unclassified|0|||
131486156|NCT02083965|473410253|FG000|Treatment Period|Other|1|||
131486157|NCT02083965|473410254|FG001|Treatment Period|Other|0|||
131486158|NCT01611155|473410255|FG000|Overall Study|Adverse Event|1|||
131486159|NCT01611155|473410256|FG001|Overall Study|Adverse Event|1|||
131486160|NCT01611155|473410255|FG000|Overall Study|Refused further treatment|6|||
131486161|NCT01611155|473410256|FG001|Overall Study|Refused further treatment|4|||
131486162|NCT01611155|473410255|FG000|Overall Study|Disease progression|1|||
131486163|NCT01611155|473410256|FG001|Overall Study|Disease progression|0|||
131486164|NCT01611155|473410255|FG000|Overall Study|Withdrawal by Subject|1|||
131486165|NCT01611155|473410256|FG001|Overall Study|Withdrawal by Subject|0|||
131486166|NCT01611155|473410255|FG000|Overall Study|Alternative treatment|0|||
131486167|NCT01611155|473410256|FG001|Overall Study|Alternative treatment|1|||
131486168|NCT01611155|473410255|FG000|Overall Study|Ineligible patient|0|||
131486169|NCT01611155|473410256|FG001|Overall Study|Ineligible patient|1|||
131486170|NCT04502433|473410259|FG000|Overall Study|Death|2|||
131486171|NCT04502433|473410260|FG001|Overall Study|Death|4|||
131486172|NCT04502433|473410259|FG000|Overall Study|Lost to Follow-up|1|||
131486173|NCT04502433|473410260|FG001|Overall Study|Lost to Follow-up|0|||
131486174|NCT04502433|473410259|FG000|Overall Study|Physician Decision|0|||
131486175|NCT04502433|473410260|FG001|Overall Study|Physician Decision|1|||
131486176|NCT02699593|473410261|FG000|Period 1|Unsatisfactory Visual Response|0|||
131486177|NCT02699593|473410262|FG001|Period 1|Unsatisfactory Visual Response|1|||
131486178|NCT02699593|473410261|FG000|Period 1|Torn Contact Len|4|||
131486179|NCT02699593|473410262|FG001|Period 1|Torn Contact Len|3|||
131486180|NCT02699593|473410261|FG000|Period 1|Protocol Violation|0|||
131486181|NCT02699593|473410262|FG001|Period 1|Protocol Violation|1|||
131486182|NCT02699593|473410261|FG000|Period 1|Withdrawal by Subject|0|||
131486183|NCT02699593|473410262|FG001|Period 1|Withdrawal by Subject|1|||
131486184|NCT02699593|473410261|FG000|Period 1|Adverse Event|1|||
131486185|NCT02699593|473410262|FG001|Period 1|Adverse Event|1|||
131486186|NCT02699593|473410261|FG000|Period 2|Adverse Event|1|||
131486187|NCT02699593|473410262|FG001|Period 2|Adverse Event|1|||
131486188|NCT02699593|473410261|FG000|Period 2|Lost Contact Lens|0|||
131486189|NCT02699593|473410262|FG001|Period 2|Lost Contact Lens|1|||
131486190|NCT02699593|473410261|FG000|Period 2|Torn Contact Lens|1|||
131486191|NCT02699593|473410262|FG001|Period 2|Torn Contact Lens|0|||
131486192|NCT00868608|473410263|FG000|Overall Study|Withdrawal by Subject|3|||
131486193|NCT00868608|473410264|FG001|Overall Study|Withdrawal by Subject|1|||
131486194|NCT00868608|473410265|FG002|Overall Study|Withdrawal by Subject|0|||
131486195|NCT00868608|473410263|FG000|Overall Study|Lost to Follow-up|3|||
131486196|NCT00868608|473410264|FG001|Overall Study|Lost to Follow-up|0|||
131486197|NCT00868608|473410265|FG002|Overall Study|Lost to Follow-up|1|||
131486198|NCT00868608|473410263|FG000|Overall Study|Death|16|||
131486199|NCT00868608|473410264|FG001|Overall Study|Death|2|||
131486200|NCT00868608|473410265|FG002|Overall Study|Death|4|||
131486201|NCT00868608|473410263|FG000|Overall Study|Other - Unspecified|1|||
131486202|NCT00868608|473410264|FG001|Overall Study|Other - Unspecified|0|||
131486203|NCT00868608|473410265|FG002|Overall Study|Other - Unspecified|0|||
131486204|NCT02935842|473410266|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
131486205|NCT02935842|473410267|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
131486206|NCT02935842|473410268|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
131486207|NCT02935842|473410269|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
131486208|NCT02935842|473410266|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
131486209|NCT02935842|473410267|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
131486210|NCT02935842|473410268|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
131486211|NCT02935842|473410269|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
131486212|NCT02935842|473410266|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
131486213|NCT02935842|473410267|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
131486214|NCT02935842|473410268|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
131486215|NCT02935842|473410269|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
131486216|NCT02935842|473410266|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
131486217|NCT02935842|473410267|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
131486218|NCT02935842|473410268|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
131486219|NCT02935842|473410269|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
131486220|NCT02935842|473410266|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
131486221|NCT02935842|473410267|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
131486222|NCT02935842|473410268|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
131486223|NCT02935842|473410269|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
131486224|NCT00911547|473410270|FG000|Overall Study|Adverse Event|8|||
131486225|NCT00911547|473410271|FG001|Overall Study|Adverse Event|27|||
131486226|NCT00911547|473410272|FG002|Overall Study|Adverse Event|11|||
131486227|NCT00911547|473410273|FG003|Overall Study|Adverse Event|6|||
131486228|NCT00911547|473410270|FG000|Overall Study|Lost to Follow-up|0|||
131486229|NCT00911547|473410271|FG001|Overall Study|Lost to Follow-up|0|||
131486230|NCT00911547|473410272|FG002|Overall Study|Lost to Follow-up|2|||
131486231|NCT00911547|473410273|FG003|Overall Study|Lost to Follow-up|1|||
131486232|NCT00911547|473410270|FG000|Overall Study|Protocol Violation|0|||
131486233|NCT00911547|473410271|FG001|Overall Study|Protocol Violation|5|||
131486234|NCT00911547|473410272|FG002|Overall Study|Protocol Violation|5|||
131486235|NCT00911547|473410273|FG003|Overall Study|Protocol Violation|1|||
131486236|NCT00911547|473410270|FG000|Overall Study|Withdrawal by Subject|3|||
131486237|NCT00911547|473410271|FG001|Overall Study|Withdrawal by Subject|10|||
131486238|NCT00911547|473410272|FG002|Overall Study|Withdrawal by Subject|4|||
131486239|NCT00911547|473410273|FG003|Overall Study|Withdrawal by Subject|8|||
131486240|NCT01201785|473410274|FG000|Overall Study|Lost to Follow-up|16|||
131486241|NCT02151110|473410275|FG000|Overall Study|Withdrawal by Subject|0|||
131486242|NCT02151110|473410276|FG001|Overall Study|Withdrawal by Subject|0|||
131486243|NCT02151110|473410277|FG002|Overall Study|Withdrawal by Subject|0|||
131486244|NCT02151110|473410278|FG003|Overall Study|Withdrawal by Subject|0|||
131486245|NCT02151110|473410279|FG004|Overall Study|Withdrawal by Subject|0|||
131486246|NCT02151110|473410280|FG005|Overall Study|Withdrawal by Subject|0|||
131486247|NCT02151110|473410281|FG006|Overall Study|Withdrawal by Subject|0|||
131486248|NCT02151110|473410282|FG007|Overall Study|Withdrawal by Subject|1|||
131486249|NCT02151110|473410275|FG000|Overall Study|Lost to Follow-up|0|||
131486250|NCT02151110|473410276|FG001|Overall Study|Lost to Follow-up|0|||
131486251|NCT02151110|473410277|FG002|Overall Study|Lost to Follow-up|0|||
131486252|NCT02151110|473410278|FG003|Overall Study|Lost to Follow-up|0|||
131486253|NCT02151110|473410279|FG004|Overall Study|Lost to Follow-up|0|||
131486254|NCT02151110|473410280|FG005|Overall Study|Lost to Follow-up|0|||
131486255|NCT02151110|473410281|FG006|Overall Study|Lost to Follow-up|0|||
131486256|NCT02151110|473410282|FG007|Overall Study|Lost to Follow-up|2|||
131486257|NCT03298867|473410292|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
131486258|NCT03298867|473410293|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
131486259|NCT03298867|473410292|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
131486260|NCT03298867|473410293|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
131486261|NCT03298867|473410292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
131486262|NCT03298867|473410293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
131486263|NCT03298867|473410292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
131486264|NCT03298867|473410293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
131486265|NCT03298867|473410292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
131486266|NCT03298867|473410293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
131486267|NCT03298867|473410292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
131486268|NCT03298867|473410293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
131486269|NCT03298867|473410292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
131486270|NCT03298867|473410293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
131486271|NCT03298867|473410292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
131486272|NCT03298867|473410293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
131486273|NCT03298867|473410292|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
131486274|NCT03298867|473410293|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
131486275|NCT03281577|473412015|FG000|Overall Study|Adverse Event|0|||
131486276|NCT03281577|473412016|FG001|Overall Study|Adverse Event|0|||
131486277|NCT03281577|473412017|FG002|Overall Study|Adverse Event|0|||
131486278|NCT03281577|473412018|FG003|Overall Study|Adverse Event|1|||
131486279|NCT03281577|473412015|FG000|Overall Study|Withdrawal by Subject|1|||
131486280|NCT03281577|473412016|FG001|Overall Study|Withdrawal by Subject|0|||
131486281|NCT03281577|473412017|FG002|Overall Study|Withdrawal by Subject|0|||
131486282|NCT03281577|473412018|FG003|Overall Study|Withdrawal by Subject|0|||
131486283|NCT00443261|473412019|FG000|Overall Study|Death|1|||
131486284|NCT01433991|473412023|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
131486285|NCT01433991|473412024|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
131486286|NCT01433991|473412025|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
131486287|NCT01433991|473412026|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
131486288|NCT01433991|473412023|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
131486289|NCT01433991|473412024|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
131486290|NCT01433991|473412025|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
131486291|NCT01433991|473412026|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
131486292|NCT01433991|473412023|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
131486293|NCT01433991|473412024|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
131486294|NCT01433991|473412025|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
131486295|NCT01433991|473412026|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
131486296|NCT01433991|473412023|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
131486297|NCT01433991|473412024|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
131486298|NCT01433991|473412025|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
131486299|NCT01433991|473412026|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
131486300|NCT01433991|473412023|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
131486301|NCT01433991|473412024|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
131486302|NCT01433991|473412025|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
131486303|NCT01433991|473412026|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
131486304|NCT01433991|473412023|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
131486305|NCT01433991|473412024|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
131486306|NCT01433991|473412025|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
131486307|NCT01433991|473412026|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
131486308|NCT01433991|473412023|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
131486309|NCT01433991|473412024|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
131486310|NCT01433991|473412025|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
131486311|NCT01433991|473412026|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
131486312|NCT03539081|473412028|FG000|Overall Study|Withdrawal by Subject|2|||
131486313|NCT03539081|473412029|FG001|Overall Study|Withdrawal by Subject|3|||
131486314|NCT03539081|473412030|FG002|Overall Study|Withdrawal by Subject|0|||
131486315|NCT03539081|473412028|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
131486316|NCT03539081|473412029|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
131486317|NCT03539081|473412030|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
131486318|NCT02550106|473412036|FG000|Overall Study|Adverse Event|1|||
131486319|NCT02550106|473412036|FG000|Overall Study|Lack of Efficacy|3|||
131486320|NCT02550106|473412036|FG000|Overall Study|Protocol Violation|6|||
131486321|NCT02550106|473412036|FG000|Overall Study|Withdrawal by Subject|2|||
131486322|NCT01193530|473412037|FG000|Overall Study|Withdrawal by Subject|2|||
131486323|NCT01193530|473412038|FG001|Overall Study|Withdrawal by Subject|2|||
131486324|NCT01193530|473412037|FG000|Overall Study|Began Contraindicated Therapy|1|||
131486325|NCT01193530|473412038|FG001|Overall Study|Began Contraindicated Therapy|0|||
131486326|NCT01193530|473412037|FG000|Overall Study|Lost Light Box|0|||
131486327|NCT01193530|473412038|FG001|Overall Study|Lost Light Box|1|||
131486328|NCT01193530|473412037|FG000|Overall Study|Returned home - out of state|0|||
131486329|NCT01193530|473412038|FG001|Overall Study|Returned home - out of state|1|||
131486330|NCT01193530|473412037|FG000|Overall Study|Non-Compliance|0|||
131486331|NCT01193530|473412038|FG001|Overall Study|Non-Compliance|1|||
131486332|NCT00799383|473412041|FG000|Overall Study|Protocol Violation|1|||
131486333|NCT00799383|473412042|FG001|Overall Study|Protocol Violation|1|||
131486334|NCT00799383|473412041|FG000|Overall Study|Adverse Event|0|||
131486335|NCT00799383|473412042|FG001|Overall Study|Adverse Event|1|||
131486336|NCT00799383|473412041|FG000|Overall Study|Lost to Follow-up|1|||
131486337|NCT00799383|473412042|FG001|Overall Study|Lost to Follow-up|2|||
131486338|NCT00799383|473412041|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
131486339|NCT00799383|473412042|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
131486340|NCT00799383|473412041|FG000|Overall Study|Withdrawal by Subject|0|||
131486341|NCT00799383|473412042|FG001|Overall Study|Withdrawal by Subject|1|||
131486342|NCT00064337|473412054|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
131486343|NCT00064337|473412054|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
131486344|NCT00064337|473412054|FG000|PBSCC or Induction/PBSCC|Progression|3|||
131486345|NCT00064337|473412054|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
131486346|NCT00064337|473412054|FG000|PBSCC or Induction/PBSCC|Death|2|||
131486347|NCT00064337|473412054|FG000|Transplant|Adverse Event|9|||
131486348|NCT00064337|473412054|FG000|Transplant|Not protocol-specified|5|||
131486349|NCT00064337|473412054|FG000|Transplant|Death|3|||
131486350|NCT00064337|473412054|FG000|Transplant|Patient Refusal|2|||
131486351|NCT00064337|473412054|FG000|Transplant|Progression|2|||
131486352|NCT00064337|473412054|FG000|Maintenance|Adverse Event|3|||
131486353|NCT00064337|473412054|FG000|Maintenance|Progression|2|||
131486354|NCT00064337|473412054|FG000|Maintenance|On treatment at time of analysis|2|||
131486355|NCT00064337|473412054|FG000|Maintenance|Not protocol-specified|2|||
131486356|NCT00064337|473412054|FG000|Maintenance|Death|1|||
131486357|NCT00612040|473412055|FG000|Overall Study|Adverse Event|0|||
131486358|NCT00612040|473412056|FG001|Overall Study|Adverse Event|2|||
131486359|NCT00612040|473412057|FG002|Overall Study|Adverse Event|1|||
131486360|NCT00612040|473412055|FG000|Overall Study|Protocol Violation|1|||
131486361|NCT00612040|473412056|FG001|Overall Study|Protocol Violation|2|||
131486362|NCT00612040|473412057|FG002|Overall Study|Protocol Violation|1|||
131486363|NCT00612040|473412055|FG000|Overall Study|Lack of Efficacy|2|||
131486364|NCT00612040|473412056|FG001|Overall Study|Lack of Efficacy|1|||
131486365|NCT00612040|473412057|FG002|Overall Study|Lack of Efficacy|0|||
131486366|NCT00612040|473412055|FG000|Overall Study|Unclassified|2|||
131486367|NCT00612040|473412056|FG001|Overall Study|Unclassified|2|||
131486368|NCT00612040|473412057|FG002|Overall Study|Unclassified|5|||
131486369|NCT01397890|473412058|FG000|Overall Study|Withdrawal by Subject|7|||
131486370|NCT01397890|473412059|FG001|Overall Study|Withdrawal by Subject|11|||
131486371|NCT01397890|473412058|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
131486372|NCT01397890|473412059|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
131486373|NCT01397890|473412058|FG000|Overall Study|Death|2|||
131486374|NCT01397890|473412059|FG001|Overall Study|Death|3|||
131486375|NCT01397890|473412058|FG000|Overall Study|Lost to Follow-up|1|||
131486376|NCT01397890|473412059|FG001|Overall Study|Lost to Follow-up|4|||
131486377|NCT01397890|473412058|FG000|Overall Study|Condition under Investigation Worsened|1|||
131486378|NCT01397890|473412059|FG001|Overall Study|Condition under Investigation Worsened|3|||
131486379|NCT01397890|473412058|FG000|Overall Study|Adverse Event|1|||
131486380|NCT01397890|473412059|FG001|Overall Study|Adverse Event|2|||
131486381|NCT01397890|473412058|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
131486382|NCT01397890|473412059|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
131486383|NCT01397890|473412058|FG000|Overall Study|Others|2|||
131486384|NCT01397890|473412059|FG001|Overall Study|Others|1|||
131486385|NCT00002651|473412060|FG000|Induction|Adverse Event|44|||
131486386|NCT00002651|473412061|FG001|Induction|Adverse Event|0|||
131486387|NCT00002651|473412062|FG002|Induction|Adverse Event|0|||
131486388|NCT00002651|473412060|FG000|Induction|Refusal unrelated to adverse event|50|||
131486389|NCT00002651|473412061|FG001|Induction|Refusal unrelated to adverse event|0|||
131486390|NCT00002651|473412062|FG002|Induction|Refusal unrelated to adverse event|0|||
131486391|NCT00002651|473412060|FG000|Induction|Progression/relapse|274|||
131486392|NCT00002651|473412061|FG001|Induction|Progression/relapse|0|||
131486393|NCT00002651|473412062|FG002|Induction|Progression/relapse|0|||
131486394|NCT00002651|473412060|FG000|Induction|Death|62|||
131486395|NCT00002651|473412061|FG001|Induction|Death|0|||
131486396|NCT00002651|473412062|FG002|Induction|Death|0|||
131486397|NCT00002651|473412060|FG000|Induction|Other|823|||
131486398|NCT00002651|473412061|FG001|Induction|Other|0|||
131486399|NCT00002651|473412062|FG002|Induction|Other|0|||
131486400|NCT00002651|473412060|FG000|Induction|not eligible|90|||
131486401|NCT00002651|473412061|FG001|Induction|not eligible|0|||
131486402|NCT00002651|473412062|FG002|Induction|not eligible|0|||
131486403|NCT00002651|473412060|FG000|Consolidation and Randomization|Adverse Event|0|||
131486404|NCT00002651|473412061|FG001|Consolidation and Randomization|Adverse Event|36|||
131486405|NCT00002651|473412062|FG002|Consolidation and Randomization|Adverse Event|14|||
131486406|NCT00002651|473412060|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
131486407|NCT00002651|473412061|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
131486408|NCT00002651|473412062|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
131486409|NCT00002651|473412060|FG000|Consolidation and Randomization|Progression/relapse|0|||
131486410|NCT00002651|473412061|FG001|Consolidation and Randomization|Progression/relapse|295|||
131486411|NCT00002651|473412062|FG002|Consolidation and Randomization|Progression/relapse|298|||
131486412|NCT00002651|473412060|FG000|Consolidation and Randomization|Death|0|||
131486413|NCT00002651|473412061|FG001|Consolidation and Randomization|Death|38|||
131486414|NCT00002651|473412062|FG002|Consolidation and Randomization|Death|48|||
131486415|NCT00002651|473412060|FG000|Consolidation and Randomization|Other|0|||
131486416|NCT00002651|473412061|FG001|Consolidation and Randomization|Other|314|||
131486417|NCT00002651|473412062|FG002|Consolidation and Randomization|Other|313|||
131486418|NCT00002651|473412060|FG000|Consolidation and Randomization|not eligible|0|||
131486419|NCT00002651|473412061|FG001|Consolidation and Randomization|not eligible|102|||
131486420|NCT00002651|473412062|FG002|Consolidation and Randomization|not eligible|112|||
131486421|NCT02763462|473412063|FG000|Overall Study|Protocol Violation|6|||
131486422|NCT03417219|473412064|FG000|Overall Study|Lost to Follow-up|0|||
131486423|NCT03417219|473412065|FG001|Overall Study|Lost to Follow-up|3|||
131486424|NCT00261807|473412066|FG000|Overall Study|Lost to Follow-up|2|||
131486425|NCT00261807|473412066|FG000|Overall Study|Adverse Event|2|||
131486426|NCT00261807|473412066|FG000|Overall Study|Death|1|||
131486427|NCT00261807|473412066|FG000|Overall Study|Protocol Violation|2|||
131486428|NCT05209360|473412069|FG000|Overall Study|Withdrawal by Subject|0|||
131486429|NCT05209360|473412070|FG001|Overall Study|Withdrawal by Subject|0|||
131486430|NCT05209360|473412071|FG002|Overall Study|Withdrawal by Subject|1|||
131486431|NCT05209360|473412072|FG003|Overall Study|Withdrawal by Subject|0|||
131486432|NCT05209360|473412073|FG004|Overall Study|Withdrawal by Subject|0|||
131486433|NCT05209360|473412074|FG005|Overall Study|Withdrawal by Subject|0|||
131486434|NCT02527161|473412075|FG000|Overall Study|Failed MRI|52|||
131486435|NCT02527161|473412075|FG000|Overall Study|Withdrawal by Subject|19|||
131486436|NCT02527161|473412075|FG000|Overall Study|Delay in or unfit for surgery|16|||
131486437|NCT02527161|473412075|FG000|Overall Study|MRI contraindication|6|||
131486438|NCT02527161|473412075|FG000|Overall Study|Consent violation|4|||
131486439|NCT02527161|473412075|FG000|Overall Study|Only Recruited to Part A|27|||
131486440|NCT02527161|473412075|FG000|Overall Study|Physician Decision|1|||
131486441|NCT02527161|473412075|FG000|Overall Study|Adverse Event|1|||
131486442|NCT02527161|473412075|FG000|Overall Study|Lost to Follow-up|6|||
131486443|NCT02100514|473412076|FG000|Treatment Period|Adverse Event|0|||
131486444|NCT02100514|473412077|FG001|Treatment Period|Adverse Event|5|||
131486445|NCT02100514|473412078|FG002|Treatment Period|Adverse Event|0|||
131486446|NCT02100514|473412079|FG003|Treatment Period|Adverse Event|0|||
131486447|NCT02100514|473412080|FG004|Treatment Period|Adverse Event|0|||
131486448|NCT02100514|473412076|FG000|Treatment Period|Death|2|||
131486449|NCT02100514|473412077|FG001|Treatment Period|Death|2|||
131486450|NCT02100514|473412078|FG002|Treatment Period|Death|0|||
131486451|NCT02100514|473412079|FG003|Treatment Period|Death|0|||
131486452|NCT02100514|473412080|FG004|Treatment Period|Death|0|||
131486453|NCT02100514|473412076|FG000|Treatment Period|Lost to Follow-up|5|||
131486454|NCT02100514|473412077|FG001|Treatment Period|Lost to Follow-up|17|||
131486455|NCT02100514|473412078|FG002|Treatment Period|Lost to Follow-up|0|||
131486456|NCT02100514|473412079|FG003|Treatment Period|Lost to Follow-up|0|||
131486457|NCT02100514|473412080|FG004|Treatment Period|Lost to Follow-up|0|||
131486458|NCT02100514|473412076|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
131486459|NCT02100514|473412077|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
131486460|NCT02100514|473412078|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
131486461|NCT02100514|473412079|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
131486462|NCT02100514|473412080|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
131486463|NCT02100514|473412076|FG000|Treatment Period|Protocol Violation|1|||
131486464|NCT02100514|473412077|FG001|Treatment Period|Protocol Violation|1|||
131486465|NCT02100514|473412078|FG002|Treatment Period|Protocol Violation|0|||
131486466|NCT02100514|473412079|FG003|Treatment Period|Protocol Violation|0|||
131486467|NCT02100514|473412080|FG004|Treatment Period|Protocol Violation|0|||
131486468|NCT02100514|473412076|FG000|Treatment Period|Withdrawal by Subject|12|||
131486469|NCT02100514|473412077|FG001|Treatment Period|Withdrawal by Subject|37|||
131486470|NCT02100514|473412078|FG002|Treatment Period|Withdrawal by Subject|0|||
131486471|NCT02100514|473412079|FG003|Treatment Period|Withdrawal by Subject|0|||
131486472|NCT02100514|473412080|FG004|Treatment Period|Withdrawal by Subject|0|||
131486473|NCT02100514|473412076|FG000|Treatment Period|Other|9|||
131486474|NCT02100514|473412077|FG001|Treatment Period|Other|11|||
131486475|NCT02100514|473412078|FG002|Treatment Period|Other|0|||
131486476|NCT02100514|473412079|FG003|Treatment Period|Other|0|||
131486477|NCT02100514|473412080|FG004|Treatment Period|Other|0|||
131486478|NCT02100514|473412076|FG000|Extension Period|Withdrew consent|0|||
131486479|NCT02100514|473412077|FG001|Extension Period|Withdrew consent|0|||
131486480|NCT02100514|473412078|FG002|Extension Period|Withdrew consent|2|||
131486481|NCT02100514|473412079|FG003|Extension Period|Withdrew consent|0|||
131486482|NCT02100514|473412080|FG004|Extension Period|Withdrew consent|0|||
131486483|NCT00724932|473412081|FG000|Overall Study|Lost to Follow-up|1|||
131486484|NCT00724932|473412082|FG001|Overall Study|Lost to Follow-up|0|||
131486485|NCT00724932|473412081|FG000|Overall Study|Not treated|4|||
131486486|NCT00724932|473412082|FG001|Overall Study|Not treated|3|||
131486487|NCT02021331|473412083|FG000|Overall Study|Adverse Event|0|||
131486488|NCT02021331|473412084|FG001|Overall Study|Adverse Event|2|||
131486489|NCT00762229|473412085|FG000|Overall Study|Lost to Follow-up|1|||
131486490|NCT00762229|473412086|FG001|Overall Study|Lost to Follow-up|1|||
131486491|NCT00762229|473412085|FG000|Overall Study|did not recveive intervention|0|||
131486492|NCT00762229|473412086|FG001|Overall Study|did not recveive intervention|1|||
131486493|NCT01896102|473412089|FG000|Overall Study|Death|1|||
131486494|NCT01896102|473412089|FG000|Overall Study|Participant to receive allogenic transplant|2|||
131486495|NCT01443078|473412093|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
131486496|NCT01443078|473412093|FG000|Overall Study|Withdrawal by Subject|1|||
131486497|NCT01443078|473412093|FG000|Overall Study|Patient had brain mets|1|||
131486498|NCT00389597|473412094|FG000|Overall Study|Lost to Follow-up|8|||
131486499|NCT00389597|473412095|FG001|Overall Study|Lost to Follow-up|6|||
131486500|NCT00389597|473412096|FG002|Overall Study|Lost to Follow-up|4|||
131486501|NCT00389597|473412097|FG003|Overall Study|Lost to Follow-up|6|||
131486502|NCT02106975|473412098|FG000|Overall Study|Death|25|||
131486503|NCT02106975|473412099|FG001|Overall Study|Death|39|||
131486504|NCT00005044|473412100|FG000|Overall Study|Protocol Violation|37|||
131486505|NCT00005044|473412101|FG001|Overall Study|Protocol Violation|46|||
131486506|NCT00005044|473412100|FG000|Overall Study|Withdrawal by Subject|1|||
131486507|NCT00005044|473412101|FG001|Overall Study|Withdrawal by Subject|5|||
131486508|NCT00005044|473412100|FG000|Overall Study|No protocol treatment|0|||
131486509|NCT00005044|473412101|FG001|Overall Study|No protocol treatment|1|||
131486510|NCT00087607|473412102|FG000|Overall Study|Adverse Event|14|||
131486511|NCT00087607|473412103|FG001|Overall Study|Adverse Event|24|||
131486512|NCT00087607|473412102|FG000|Overall Study|Death|0|||
131486513|NCT00087607|473412103|FG001|Overall Study|Death|1|||
131486514|NCT00087607|473412102|FG000|Overall Study|Insufficient Therapeutic Response|53|||
131486515|NCT00087607|473412103|FG001|Overall Study|Insufficient Therapeutic Response|42|||
131486516|NCT00087607|473412102|FG000|Overall Study|Failure to return|21|||
131486517|NCT00087607|473412103|FG001|Overall Study|Failure to return|17|||
131486518|NCT00087607|473412102|FG000|Overall Study|Withdrew Consent|12|||
131486519|NCT00087607|473412103|FG001|Overall Study|Withdrew Consent|16|||
131486520|NCT00087607|473412102|FG000|Overall Study|Administrative|12|||
131486521|NCT00087607|473412103|FG001|Overall Study|Administrative|12|||
131486522|NCT00087607|473412102|FG000|Overall Study|Refused Treatment|5|||
131486523|NCT00087607|473412103|FG001|Overall Study|Refused Treatment|7|||
131486524|NCT00087607|473412102|FG000|Overall Study|Other Protocol Violation|5|||
131486525|NCT00087607|473412103|FG001|Overall Study|Other Protocol Violation|2|||
131486526|NCT00087607|473412102|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
131486527|NCT00087607|473412103|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131486528|NCT00915278|473412104|FG000|Overall Study|Death|1|||
131486529|NCT00915278|473412105|FG001|Overall Study|Death|0|||
131486530|NCT00915278|473412106|FG002|Overall Study|Death|0|||
131486531|NCT00915278|473412107|FG003|Overall Study|Death|0|||
131486532|NCT00915278|473412108|FG004|Overall Study|Death|0|||
131486533|NCT00915278|473412109|FG005|Overall Study|Death|0|||
131486534|NCT00915278|473412104|FG000|Overall Study|Lost to Follow-up|0|||
131486535|NCT00915278|473412105|FG001|Overall Study|Lost to Follow-up|1|||
131486536|NCT00915278|473412106|FG002|Overall Study|Lost to Follow-up|0|||
131486537|NCT00915278|473412107|FG003|Overall Study|Lost to Follow-up|0|||
131486538|NCT00915278|473412108|FG004|Overall Study|Lost to Follow-up|0|||
131486539|NCT00915278|473412109|FG005|Overall Study|Lost to Follow-up|0|||
131486540|NCT00915278|473412104|FG000|Overall Study|Withdrawal by Subject|0|||
131486541|NCT00915278|473412105|FG001|Overall Study|Withdrawal by Subject|1|||
131486542|NCT00915278|473412106|FG002|Overall Study|Withdrawal by Subject|0|||
131486543|NCT00915278|473412107|FG003|Overall Study|Withdrawal by Subject|0|||
131486544|NCT00915278|473412108|FG004|Overall Study|Withdrawal by Subject|1|||
131486545|NCT00915278|473412109|FG005|Overall Study|Withdrawal by Subject|4|||
131486546|NCT00915278|473412104|FG000|Overall Study|Adverse Event|4|||
131486547|NCT00915278|473412105|FG001|Overall Study|Adverse Event|1|||
131486548|NCT00915278|473412106|FG002|Overall Study|Adverse Event|0|||
131486549|NCT00915278|473412107|FG003|Overall Study|Adverse Event|0|||
131486550|NCT00915278|473412108|FG004|Overall Study|Adverse Event|0|||
131486551|NCT00915278|473412109|FG005|Overall Study|Adverse Event|0|||
131486552|NCT00915278|473412104|FG000|Overall Study|Progressive disease/clinical progression|0|||
131486553|NCT00915278|473412105|FG001|Overall Study|Progressive disease/clinical progression|0|||
131486554|NCT00915278|473412106|FG002|Overall Study|Progressive disease/clinical progression|0|||
131486555|NCT00915278|473412107|FG003|Overall Study|Progressive disease/clinical progression|3|||
131486556|NCT00915278|473412108|FG004|Overall Study|Progressive disease/clinical progression|1|||
131486557|NCT00915278|473412109|FG005|Overall Study|Progressive disease/clinical progression|2|||
131486558|NCT00915278|473412104|FG000|Overall Study|Infusion related AEs|0|||
131486559|NCT00915278|473412105|FG001|Overall Study|Infusion related AEs|0|||
131486560|NCT00915278|473412106|FG002|Overall Study|Infusion related AEs|0|||
131486561|NCT00915278|473412107|FG003|Overall Study|Infusion related AEs|0|||
131486562|NCT00915278|473412108|FG004|Overall Study|Infusion related AEs|0|||
131486563|NCT00915278|473412109|FG005|Overall Study|Infusion related AEs|2|||
131486564|NCT00915278|473412104|FG000|Overall Study|Admission to hospice|0|||
131486565|NCT00915278|473412105|FG001|Overall Study|Admission to hospice|0|||
131486566|NCT00915278|473412106|FG002|Overall Study|Admission to hospice|1|||
131486567|NCT00915278|473412107|FG003|Overall Study|Admission to hospice|0|||
131486568|NCT00915278|473412108|FG004|Overall Study|Admission to hospice|0|||
131486569|NCT00915278|473412109|FG005|Overall Study|Admission to hospice|0|||
131486570|NCT02369016|473412110|FG000|Overall Study|AE associated with clinical disease progression|2|||
131486571|NCT02369016|473412111|FG001|Overall Study|AE associated with clinical disease progression|1|||
131486572|NCT02369016|473412110|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
131486573|NCT02369016|473412111|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
131486574|NCT02369016|473412110|FG000|Overall Study|Progressive disease - clinical progression|1|||
131486575|NCT02369016|473412111|FG001|Overall Study|Progressive disease - clinical progression|4|||
131486576|NCT02369016|473412110|FG000|Overall Study|withdrawal by patient|4|||
131486577|NCT02369016|473412111|FG001|Overall Study|withdrawal by patient|0|||
131486578|NCT02369016|473412110|FG000|Overall Study|Progressive disease - radiological progression|6|||
131486579|NCT02369016|473412111|FG001|Overall Study|Progressive disease - radiological progression|2|||
131486580|NCT02229383|473412112|FG000|Overall Study|Adverse Event|7|||
131486581|NCT02229383|473412113|FG001|Overall Study|Adverse Event|4|||
131486582|NCT02229383|473412112|FG000|Overall Study|Death|0|||
131486583|NCT02229383|473412113|FG001|Overall Study|Death|1|||
131486584|NCT02229383|473412112|FG000|Overall Study|Lost to Follow-up|5|||
131486585|NCT02229383|473412113|FG001|Overall Study|Lost to Follow-up|3|||
131486586|NCT02229383|473412112|FG000|Overall Study|Withdrawal by Subject|4|||
131486587|NCT02229383|473412113|FG001|Overall Study|Withdrawal by Subject|6|||
131486588|NCT02229383|473412112|FG000|Overall Study|Did not receive treatment|1|||
131486589|NCT02229383|473412113|FG001|Overall Study|Did not receive treatment|0|||
131486590|NCT02229383|473412112|FG000|Overall Study|Other|3|||
131486591|NCT02229383|473412113|FG001|Overall Study|Other|8|||
131486592|NCT01201850|473412118|FG000|Overall Study|Tumor progression|4|||
131486593|NCT00939770|473412119|FG000|Overall Study|Adverse Event|1|||
131486594|NCT00939770|473412120|FG001|Overall Study|Adverse Event|1|||
131486595|NCT00939770|473412121|FG002|Overall Study|Adverse Event|0|||
131486596|NCT00939770|473412122|FG003|Overall Study|Adverse Event|0|||
131486597|NCT00939770|473412123|FG004|Overall Study|Adverse Event|6|||
131486598|NCT00939770|473412124|FG005|Overall Study|Adverse Event|2|||
131486599|NCT00939770|473412125|FG006|Overall Study|Adverse Event|1|||
131486600|NCT00939770|473412126|FG007|Overall Study|Adverse Event|1|||
131486601|NCT00939770|473412119|FG000|Overall Study|Lack of Efficacy|4|||
131486602|NCT00939770|473412120|FG001|Overall Study|Lack of Efficacy|6|||
131486603|NCT00939770|473412121|FG002|Overall Study|Lack of Efficacy|13|||
131486604|NCT00939770|473412122|FG003|Overall Study|Lack of Efficacy|9|||
131486605|NCT00939770|473412123|FG004|Overall Study|Lack of Efficacy|16|||
131486606|NCT00939770|473412124|FG005|Overall Study|Lack of Efficacy|8|||
131486607|NCT00939770|473412125|FG006|Overall Study|Lack of Efficacy|11|||
131486608|NCT00939770|473412126|FG007|Overall Study|Lack of Efficacy|1|||
131486609|NCT00939770|473412119|FG000|Overall Study|Lost to Follow-up|0|||
131486610|NCT00939770|473412120|FG001|Overall Study|Lost to Follow-up|0|||
131486611|NCT00939770|473412121|FG002|Overall Study|Lost to Follow-up|0|||
131486612|NCT00939770|473412122|FG003|Overall Study|Lost to Follow-up|0|||
131486613|NCT00939770|473412123|FG004|Overall Study|Lost to Follow-up|1|||
131486614|NCT00939770|473412124|FG005|Overall Study|Lost to Follow-up|0|||
131486615|NCT00939770|473412125|FG006|Overall Study|Lost to Follow-up|0|||
131486616|NCT00939770|473412126|FG007|Overall Study|Lost to Follow-up|0|||
131486617|NCT00939770|473412119|FG000|Overall Study|Physician Decision|0|||
131486618|NCT00939770|473412120|FG001|Overall Study|Physician Decision|0|||
131486619|NCT00939770|473412121|FG002|Overall Study|Physician Decision|2|||
131486620|NCT00939770|473412122|FG003|Overall Study|Physician Decision|0|||
131486621|NCT00939770|473412123|FG004|Overall Study|Physician Decision|7|||
131486622|NCT00939770|473412124|FG005|Overall Study|Physician Decision|1|||
131486623|NCT00939770|473412125|FG006|Overall Study|Physician Decision|0|||
131486624|NCT00939770|473412126|FG007|Overall Study|Physician Decision|6|||
131486625|NCT00939770|473412119|FG000|Overall Study|Protocol Violation|0|||
131486626|NCT00939770|473412120|FG001|Overall Study|Protocol Violation|0|||
131486627|NCT00939770|473412121|FG002|Overall Study|Protocol Violation|0|||
131486628|NCT00939770|473412122|FG003|Overall Study|Protocol Violation|0|||
131486629|NCT00939770|473412123|FG004|Overall Study|Protocol Violation|1|||
131486630|NCT00939770|473412124|FG005|Overall Study|Protocol Violation|0|||
131486631|NCT00939770|473412125|FG006|Overall Study|Protocol Violation|0|||
131486632|NCT00939770|473412126|FG007|Overall Study|Protocol Violation|0|||
131486633|NCT00939770|473412119|FG000|Overall Study|Withdrawal by Subject|0|||
131486634|NCT00939770|473412120|FG001|Overall Study|Withdrawal by Subject|1|||
131486635|NCT00939770|473412121|FG002|Overall Study|Withdrawal by Subject|5|||
131486636|NCT00939770|473412122|FG003|Overall Study|Withdrawal by Subject|2|||
131486637|NCT00939770|473412123|FG004|Overall Study|Withdrawal by Subject|6|||
131486638|NCT00939770|473412124|FG005|Overall Study|Withdrawal by Subject|0|||
131486639|NCT00939770|473412125|FG006|Overall Study|Withdrawal by Subject|2|||
131486640|NCT00939770|473412126|FG007|Overall Study|Withdrawal by Subject|2|||
131486641|NCT02564796|473412131|FG000|Overall Study|Physician Decision|2|||
131486642|NCT02564796|473412132|FG001|Overall Study|Physician Decision|2|||
131486643|NCT00453063|473412133|FG000|Overall Study|Adverse Event|1|||
131486644|NCT00453063|473412134|FG001|Overall Study|Adverse Event|2|||
131486645|NCT00453063|473412133|FG000|Overall Study|Withdrawal by Subject|1|||
131486646|NCT00453063|473412134|FG001|Overall Study|Withdrawal by Subject|1|||
131486647|NCT00453063|473412133|FG000|Overall Study|Protocol Violation|1|||
131486648|NCT00453063|473412134|FG001|Overall Study|Protocol Violation|0|||
131486649|NCT00566995|473412136|FG000|Overall Study|Toxicity|4|||
131486650|NCT00566995|473412136|FG000|Overall Study|Withdrew consent|3|||
131486651|NCT00404235|473412137|FG000|Overall Study|Withdrawal by Subject|1|||
131486652|NCT00404235|473412138|FG001|Overall Study|Withdrawal by Subject|2|||
131486653|NCT00594659|473412139|FG000|Overall Study|Lost to Follow-up|13|||
131486654|NCT00594659|473412140|FG001|Overall Study|Lost to Follow-up|9|||
131486655|NCT00594659|473412141|FG002|Overall Study|Lost to Follow-up|7|||
131486656|NCT00228384|473412142|FG000|Overall Study|Death|9|||
131486657|NCT00228384|473412143|FG001|Overall Study|Death|3|||
131486658|NCT00228384|473412142|FG000|Overall Study|Lost to Follow-up|6|||
131486659|NCT00228384|473412143|FG001|Overall Study|Lost to Follow-up|10|||
131486660|NCT00228384|473412142|FG000|Overall Study|Surgical Intervention (bypass)|5|||
131486661|NCT00228384|473412143|FG001|Overall Study|Surgical Intervention (bypass)|5|||
131486662|NCT00228384|473412142|FG000|Overall Study|Withdrawal by Subject|9|||
131486663|NCT00228384|473412143|FG001|Overall Study|Withdrawal by Subject|10|||
131486664|NCT00228384|473412142|FG000|Overall Study|Physician Decision|0|||
131486665|NCT00228384|473412143|FG001|Overall Study|Physician Decision|1|||
131486666|NCT01785069|473412149|FG000|Overall Study|Implanted with nonstudy device|1|||
131486667|NCT01785069|473412150|FG001|Overall Study|Implanted with nonstudy device|2|||
131486668|NCT01785069|473412151|FG002|Overall Study|Implanted with nonstudy device|1|||
131486669|NCT01785069|473412152|FG003|Overall Study|Implanted with nonstudy device|0|||
131486670|NCT01785069|473412149|FG000|Overall Study|Death|0|||
131486671|NCT01785069|473412150|FG001|Overall Study|Death|0|||
131486672|NCT01785069|473412151|FG002|Overall Study|Death|2|||
131486673|NCT01785069|473412152|FG003|Overall Study|Death|0|||
131486674|NCT01785069|473412149|FG000|Overall Study|Subject choice|2|||
131486675|NCT01785069|473412150|FG001|Overall Study|Subject choice|2|||
131486676|NCT01785069|473412151|FG002|Overall Study|Subject choice|0|||
131486677|NCT01785069|473412152|FG003|Overall Study|Subject choice|1|||
131486678|NCT01785069|473412149|FG000|Overall Study|Lost to Follow-up|1|||
131486679|NCT01785069|473412150|FG001|Overall Study|Lost to Follow-up|2|||
131486680|NCT01785069|473412151|FG002|Overall Study|Lost to Follow-up|4|||
131486681|NCT01785069|473412152|FG003|Overall Study|Lost to Follow-up|1|||
131486682|NCT01785069|473412149|FG000|Overall Study|Reason not Specified|1|||
131486683|NCT01785069|473412150|FG001|Overall Study|Reason not Specified|2|||
131486684|NCT01785069|473412151|FG002|Overall Study|Reason not Specified|1|||
131486685|NCT01785069|473412152|FG003|Overall Study|Reason not Specified|4|||
131486686|NCT01785069|473412149|FG000|Overall Study|Not evaluable|7|||
131486687|NCT01785069|473412150|FG001|Overall Study|Not evaluable|4|||
131486688|NCT01785069|473412151|FG002|Overall Study|Not evaluable|5|||
131486689|NCT01785069|473412152|FG003|Overall Study|Not evaluable|8|||
131486690|NCT05695209|473412155|FG000|3-months|Withdrawal by Subject|2|||
131486691|NCT05695209|473412156|FG001|3-months|Withdrawal by Subject|0|||
131486692|NCT05695209|473412155|FG000|3-months|Unable to contact for 3-month data collection|0|||
131486693|NCT05695209|473412156|FG001|3-months|Unable to contact for 3-month data collection|1|||
131486694|NCT05695209|473412155|FG000|6-months|Lost to Follow-up|1|||
131486695|NCT05695209|473412156|FG001|6-months|Lost to Follow-up|1|||
131486696|NCT05358444|473412157|FG000|Overall Study|Withdrawal by Subject|0|||
131486697|NCT05358444|473412158|FG001|Overall Study|Withdrawal by Subject|1|||
131486698|NCT05358444|473412157|FG000|Overall Study|Lost to Follow-up|0|||
131486699|NCT05358444|473412158|FG001|Overall Study|Lost to Follow-up|3|||
131486700|NCT04997304|473412159|FG000|Overall Study|Lost to Follow-up|11|||
131486701|NCT04997304|473412159|FG000|Overall Study|Death|1|||
131486702|NCT04997304|473412159|FG000|Overall Study|Withdrawal by Subject|14|||
131486703|NCT04560998|473412160|FG000|Overall Study|Withdrawal by Subject|18|||
131486704|NCT04560998|473412161|FG001|Overall Study|Withdrawal by Subject|12|||
131486705|NCT04560998|473412160|FG000|Overall Study|Lost to Follow-up|8|||
131486706|NCT04560998|473412161|FG001|Overall Study|Lost to Follow-up|5|||
131486707|NCT04560998|473412160|FG000|Overall Study|Physician Decision|4|||
131486708|NCT04560998|473412161|FG001|Overall Study|Physician Decision|0|||
131486709|NCT00354744|473413881|FG000|Overall Study|Adverse Event|2|||
131486710|NCT00354744|473413881|FG000|Overall Study|Death|2|||
131486711|NCT00354744|473413881|FG000|Overall Study|Lack of Efficacy|11|||
131486712|NCT00354744|473413881|FG000|Overall Study|Lost to Follow-up|2|||
131486713|NCT00354744|473413881|FG000|Overall Study|Physician Decision|11|||
131486714|NCT00354744|473413881|FG000|Overall Study|Withdrawal by Subject|14|||
131486715|NCT00926328|473413882|FG000|Overall Study|Lost to Follow-up|12|||
131486716|NCT00926328|473413883|FG001|Overall Study|Lost to Follow-up|14|||
131486717|NCT00726986|473413886|FG000|Induction Phase|Adverse Event|4|||
131486718|NCT00726986|473413886|FG000|Induction Phase|Withdrawal by Subject|2|||
131486719|NCT00726986|473413886|FG000|Induction Phase|Death|2|||
131486720|NCT00726986|473413886|FG000|Induction Phase|Lack of Efficacy|5|||
131486721|NCT00726986|473413886|FG000|Induction Phase|Secondary Disease|2|||
131486722|NCT00726986|473413886|FG000|Maintenance Phase|Adverse Event|1|||
131486723|NCT00726986|473413886|FG000|Maintenance Phase|Lack of Efficacy|2|||
131486724|NCT00289133|473413887|FG000|Overall Study|Non-study device implanted|12|||
131486725|NCT00289133|473413888|FG001|Overall Study|Non-study device implanted|0|||
131486726|NCT00289133|473413887|FG000|Overall Study|Protocol Violation|32|||
131486727|NCT00289133|473413888|FG001|Overall Study|Protocol Violation|38|||
131486728|NCT00289133|473413887|FG000|Overall Study|Withdrawal by Subject|9|||
131486729|NCT00289133|473413888|FG001|Overall Study|Withdrawal by Subject|10|||
131486730|NCT00289133|473413887|FG000|Overall Study|Death|5|||
131486731|NCT00289133|473413888|FG001|Overall Study|Death|10|||
131486732|NCT00289133|473413887|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
131486733|NCT00289133|473413888|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
131486734|NCT00289133|473413887|FG000|Overall Study|Physician Decision|41|||
131486735|NCT00289133|473413888|FG001|Overall Study|Physician Decision|45|||
131486736|NCT00289133|473413887|FG000|Overall Study|Revision|8|||
131486737|NCT00289133|473413888|FG001|Overall Study|Revision|6|||
131486738|NCT00289133|473413887|FG000|Overall Study|Lost to Follow-up|92|||
131486739|NCT00289133|473413888|FG001|Overall Study|Lost to Follow-up|115|||
131486740|NCT01513343|473413891|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
131486741|NCT01513343|473413892|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
131486742|NCT01513343|473413891|FG000|Post Data Collection|Dropped/withdrew from study|7|||
131486743|NCT01513343|473413892|FG001|Post Data Collection|Dropped/withdrew from study|1|||
131486744|NCT01513343|473413891|FG000|Post Data Collection|Lost to Follow-up|10|||
131486745|NCT01513343|473413892|FG001|Post Data Collection|Lost to Follow-up|23|||
131486746|NCT01513343|473413891|FG000|6-month Follow-up|Lost to Follow-up|28|||
131486747|NCT01513343|473413892|FG001|6-month Follow-up|Lost to Follow-up|17|||
131486748|NCT01513343|473413891|FG000|12-month Follow-up|Lost to Follow-up|10|||
131486749|NCT01513343|473413892|FG001|12-month Follow-up|Lost to Follow-up|3|||
131486750|NCT02279420|473413893|FG000|Overall Study|Lost to Follow-up|23|||
131486751|NCT01153347|473413896|FG000|Overall Study|Withdrawal by Subject|7|||
131486752|NCT01153347|473413897|FG001|Overall Study|Withdrawal by Subject|7|||
131486753|NCT01153347|473413898|FG002|Overall Study|Withdrawal by Subject|7|||
131486754|NCT01153347|473413899|FG003|Overall Study|Withdrawal by Subject|7|||
131486755|NCT01153347|473413896|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131486756|NCT01153347|473413897|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131486757|NCT01153347|473413898|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
131486758|NCT01153347|473413899|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
131486759|NCT01153347|473413896|FG000|Overall Study|Adverse Event|3|||
131486760|NCT01153347|473413897|FG001|Overall Study|Adverse Event|9|||
131486761|NCT01153347|473413898|FG002|Overall Study|Adverse Event|21|||
131486762|NCT01153347|473413899|FG003|Overall Study|Adverse Event|7|||
131486763|NCT01153347|473413896|FG000|Overall Study|Severe non-compliance to protocol|6|||
131486764|NCT01153347|473413897|FG001|Overall Study|Severe non-compliance to protocol|7|||
131486765|NCT01153347|473413898|FG002|Overall Study|Severe non-compliance to protocol|4|||
131486766|NCT01153347|473413899|FG003|Overall Study|Severe non-compliance to protocol|3|||
131486767|NCT01153347|473413896|FG000|Overall Study|Condition under investigation worsened|1|||
131486768|NCT01153347|473413897|FG001|Overall Study|Condition under investigation worsened|1|||
131486769|NCT01153347|473413898|FG002|Overall Study|Condition under investigation worsened|0|||
131486770|NCT01153347|473413899|FG003|Overall Study|Condition under investigation worsened|0|||
131486771|NCT01153347|473413896|FG000|Overall Study|Lack of Efficacy|2|||
131486772|NCT01153347|473413897|FG001|Overall Study|Lack of Efficacy|2|||
131486773|NCT01153347|473413898|FG002|Overall Study|Lack of Efficacy|0|||
131486774|NCT01153347|473413899|FG003|Overall Study|Lack of Efficacy|4|||
131486775|NCT01153347|473413896|FG000|Overall Study|Study-specific withdrawal criteria|4|||
131486776|NCT01153347|473413897|FG001|Overall Study|Study-specific withdrawal criteria|3|||
131486777|NCT01153347|473413898|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131486778|NCT01153347|473413899|FG003|Overall Study|Study-specific withdrawal criteria|2|||
131486779|NCT01153347|473413896|FG000|Overall Study|Lost to Follow-up|4|||
131486780|NCT01153347|473413897|FG001|Overall Study|Lost to Follow-up|9|||
131486781|NCT01153347|473413898|FG002|Overall Study|Lost to Follow-up|11|||
131486782|NCT01153347|473413899|FG003|Overall Study|Lost to Follow-up|8|||
131486783|NCT01153347|473413896|FG000|Overall Study|Other|5|||
131486784|NCT01153347|473413897|FG001|Overall Study|Other|5|||
131486785|NCT01153347|473413898|FG002|Overall Study|Other|4|||
131486786|NCT01153347|473413899|FG003|Overall Study|Other|0|||
131486787|NCT01153347|473413896|FG000|Overall Study|Death|1|||
131486788|NCT01153347|473413897|FG001|Overall Study|Death|0|||
131486789|NCT01153347|473413898|FG002|Overall Study|Death|0|||
131486790|NCT01153347|473413899|FG003|Overall Study|Death|0|||
131486791|NCT00297830|473413900|FG000|6 Month Visit|Death|1|||
131486792|NCT00297830|473413901|FG001|6 Month Visit|Death|0|||
131486793|NCT00297830|473413902|FG002|6 Month Visit|Death|2|||
131486794|NCT00297830|473413900|FG000|6 Month Visit|Withdrawal by Subject|2|||
131486795|NCT00297830|473413901|FG001|6 Month Visit|Withdrawal by Subject|1|||
131486796|NCT00297830|473413902|FG002|6 Month Visit|Withdrawal by Subject|1|||
131486797|NCT00297830|473413900|FG000|6 Month Visit|Adverse Event|0|||
131486798|NCT00297830|473413901|FG001|6 Month Visit|Adverse Event|1|||
131486799|NCT00297830|473413902|FG002|6 Month Visit|Adverse Event|0|||
131486800|NCT00297830|473413900|FG000|12 Month Visit|Lost to Follow-up|1|||
131486801|NCT00297830|473413901|FG001|12 Month Visit|Lost to Follow-up|0|||
131486802|NCT00297830|473413902|FG002|12 Month Visit|Lost to Follow-up|0|||
131486803|NCT00297830|473413900|FG000|12 Month Visit|Adverse Event|0|||
131486804|NCT00297830|473413901|FG001|12 Month Visit|Adverse Event|3|||
131486805|NCT00297830|473413902|FG002|12 Month Visit|Adverse Event|0|||
131486806|NCT00297830|473413900|FG000|12 Month Visit|Withdrawal by Subject|0|||
131486807|NCT00297830|473413901|FG001|12 Month Visit|Withdrawal by Subject|3|||
131486808|NCT00297830|473413902|FG002|12 Month Visit|Withdrawal by Subject|0|||
131486809|NCT05096221|473413905|FG000|Part 2|Physician Decision|0|||
131486810|NCT05096221|473413906|FG001|Part 2|Physician Decision|1|||
131486811|NCT04678661|473413908|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
131486812|NCT04678661|473413909|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
131486813|NCT04678661|473413908|FG000|Overall Study|Protocol Violation|2|||
131486814|NCT04678661|473413909|FG001|Overall Study|Protocol Violation|0|||
131486815|NCT04678661|473413908|FG000|Overall Study|Withdrawal by Subject|1|||
131486816|NCT04678661|473413909|FG001|Overall Study|Withdrawal by Subject|0|||
131486817|NCT04678661|473413908|FG000|Overall Study|Lost to Follow-up|2|||
131486818|NCT04678661|473413909|FG001|Overall Study|Lost to Follow-up|0|||
131486819|NCT04678661|473413908|FG000|Overall Study|Death|2|||
131486820|NCT04678661|473413909|FG001|Overall Study|Death|0|||
131486821|NCT03094169|473413910|FG000|Overall Study|Lack of Efficacy|0|||
131486822|NCT03094169|473413911|FG001|Overall Study|Lack of Efficacy|0|||
131486823|NCT03094169|473413912|FG002|Overall Study|Lack of Efficacy|0|||
131486824|NCT03094169|473413913|FG003|Overall Study|Lack of Efficacy|0|||
131486825|NCT03094169|473413914|FG004|Overall Study|Lack of Efficacy|0|||
131486826|NCT03094169|473413915|FG005|Overall Study|Lack of Efficacy|0|||
131486827|NCT03094169|473413916|FG006|Overall Study|Lack of Efficacy|0|||
131486828|NCT03094169|473413917|FG007|Overall Study|Lack of Efficacy|21|||
131486829|NCT03094169|473413910|FG000|Overall Study|Adverse Event|0|||
131486830|NCT03094169|473413911|FG001|Overall Study|Adverse Event|0|||
131486831|NCT03094169|473413912|FG002|Overall Study|Adverse Event|0|||
131486832|NCT03094169|473413913|FG003|Overall Study|Adverse Event|0|||
131486833|NCT03094169|473413914|FG004|Overall Study|Adverse Event|0|||
131486834|NCT03094169|473413915|FG005|Overall Study|Adverse Event|0|||
131486835|NCT03094169|473413916|FG006|Overall Study|Adverse Event|0|||
131486836|NCT03094169|473413917|FG007|Overall Study|Adverse Event|2|||
131486837|NCT03094169|473413910|FG000|Overall Study|Withdrawal by Subject|0|||
131486838|NCT03094169|473413911|FG001|Overall Study|Withdrawal by Subject|0|||
131486839|NCT03094169|473413912|FG002|Overall Study|Withdrawal by Subject|0|||
131486840|NCT03094169|473413913|FG003|Overall Study|Withdrawal by Subject|0|||
131486841|NCT03094169|473413914|FG004|Overall Study|Withdrawal by Subject|0|||
131486842|NCT03094169|473413915|FG005|Overall Study|Withdrawal by Subject|0|||
131486843|NCT03094169|473413916|FG006|Overall Study|Withdrawal by Subject|1|||
131486844|NCT03094169|473413917|FG007|Overall Study|Withdrawal by Subject|1|||
131486845|NCT03094169|473413910|FG000|Overall Study|Trial Termination|0|||
131486846|NCT03094169|473413911|FG001|Overall Study|Trial Termination|0|||
131486847|NCT03094169|473413912|FG002|Overall Study|Trial Termination|0|||
131486848|NCT03094169|473413913|FG003|Overall Study|Trial Termination|0|||
131486849|NCT03094169|473413914|FG004|Overall Study|Trial Termination|0|||
131486850|NCT03094169|473413915|FG005|Overall Study|Trial Termination|0|||
131486851|NCT03094169|473413916|FG006|Overall Study|Trial Termination|0|||
131486852|NCT03094169|473413917|FG007|Overall Study|Trial Termination|1|||
131486853|NCT04645953|473413918|FG000|Overall Study|Lost to Follow-up|2|||
131486854|NCT04645953|473413919|FG001|Overall Study|Lost to Follow-up|1|||
131486855|NCT04645953|473413920|FG002|Overall Study|Lost to Follow-up|1|||
131486856|NCT04645953|473413918|FG000|Overall Study|Withdrawal by Subject|0|||
131486857|NCT04645953|473413919|FG001|Overall Study|Withdrawal by Subject|1|||
131486858|NCT04645953|473413920|FG002|Overall Study|Withdrawal by Subject|0|||
131486859|NCT04645953|473413918|FG000|Overall Study|Physician Decision|0|||
131486860|NCT04645953|473413919|FG001|Overall Study|Physician Decision|1|||
131486861|NCT04645953|473413920|FG002|Overall Study|Physician Decision|0|||
131486862|NCT04645953|473413918|FG000|Overall Study|Discontinued Prior to Dosing|0|||
131486863|NCT04645953|473413919|FG001|Overall Study|Discontinued Prior to Dosing|0|||
131486864|NCT04645953|473413920|FG002|Overall Study|Discontinued Prior to Dosing|2|||
131486865|NCT04613375|473413921|FG000|Overall Study|Death|198|||
131486866|NCT04613375|473413921|FG000|Overall Study|Withdrawal by Subject|3|||
131486867|NCT02590003|473413928|FG000|Overall Study|Death|1|||
131486868|NCT02590003|473413929|FG001|Overall Study|Death|2|||
131486869|NCT00518284|473413930|FG000|Overall Study|Adverse Event|0|||
131486870|NCT00518284|473413931|FG001|Overall Study|Adverse Event|1|||
131486871|NCT00518284|473413932|FG002|Overall Study|Adverse Event|0|||
131486872|NCT00518284|473413933|FG003|Overall Study|Adverse Event|0|||
131486873|NCT00518284|473413930|FG000|Overall Study|Study Termination|0|||
131486874|NCT00518284|473413931|FG001|Overall Study|Study Termination|2|||
131486875|NCT00518284|473413932|FG002|Overall Study|Study Termination|1|||
131486876|NCT00518284|473413933|FG003|Overall Study|Study Termination|2|||
131486877|NCT00205881|473413934|FG000|Overall Study|Withdrawal by Subject|16|||
131486878|NCT01235689|473413939|FG000|Overall Study|Adverse Event|12|||
131486879|NCT01235689|473413940|FG001|Overall Study|Adverse Event|16|||
131486880|NCT01235689|473413939|FG000|Overall Study|Lack of Efficacy|12|||
131486881|NCT01235689|473413940|FG001|Overall Study|Lack of Efficacy|5|||
131486882|NCT01235689|473413939|FG000|Overall Study|Withdrawal by Subject|3|||
131486883|NCT01235689|473413940|FG001|Overall Study|Withdrawal by Subject|4|||
131486884|NCT01235689|473413939|FG000|Overall Study|Lost to Follow-up|1|||
131486885|NCT01235689|473413940|FG001|Overall Study|Lost to Follow-up|2|||
131486886|NCT01235689|473413939|FG000|Overall Study|Miscellaneous|1|||
131486887|NCT01235689|473413940|FG001|Overall Study|Miscellaneous|5|||
131486888|NCT04431453|473413947|FG000|Overall Study|Withdrew Consent|0|||
131486889|NCT04431453|473413948|FG001|Overall Study|Withdrew Consent|1|||
131486890|NCT04431453|473413949|FG002|Overall Study|Withdrew Consent|0|||
131486891|NCT04431453|473413950|FG003|Overall Study|Withdrew Consent|2|||
131486892|NCT04431453|473413951|FG004|Overall Study|Withdrew Consent|0|||
131486893|NCT04431453|473413952|FG005|Overall Study|Withdrew Consent|0|||
131486894|NCT04431453|473413953|FG006|Overall Study|Withdrew Consent|0|||
131486895|NCT04431453|473413954|FG007|Overall Study|Withdrew Consent|0|||
131486896|NCT04431453|473413947|FG000|Overall Study|Death|1|||
131486897|NCT04431453|473413948|FG001|Overall Study|Death|0|||
131486898|NCT04431453|473413949|FG002|Overall Study|Death|0|||
131486899|NCT04431453|473413950|FG003|Overall Study|Death|0|||
131486900|NCT04431453|473413951|FG004|Overall Study|Death|0|||
131486901|NCT04431453|473413952|FG005|Overall Study|Death|0|||
131486902|NCT04431453|473413953|FG006|Overall Study|Death|0|||
131486903|NCT04431453|473413954|FG007|Overall Study|Death|1|||
131486904|NCT04431453|473413947|FG000|Overall Study|Lost to Follow-up|0|||
131486905|NCT04431453|473413948|FG001|Overall Study|Lost to Follow-up|0|||
131486906|NCT04431453|473413949|FG002|Overall Study|Lost to Follow-up|1|||
131486907|NCT04431453|473413950|FG003|Overall Study|Lost to Follow-up|1|||
131486908|NCT04431453|473413951|FG004|Overall Study|Lost to Follow-up|0|||
131486909|NCT04431453|473413952|FG005|Overall Study|Lost to Follow-up|0|||
131486910|NCT04431453|473413953|FG006|Overall Study|Lost to Follow-up|0|||
131486911|NCT04431453|473413954|FG007|Overall Study|Lost to Follow-up|0|||
131486912|NCT04431453|473413947|FG000|Overall Study|Enrolled but Never Treated|0|||
131486913|NCT04431453|473413948|FG001|Overall Study|Enrolled but Never Treated|0|||
131486914|NCT04431453|473413949|FG002|Overall Study|Enrolled but Never Treated|0|||
131486915|NCT04431453|473413950|FG003|Overall Study|Enrolled but Never Treated|0|||
131486916|NCT04431453|473413951|FG004|Overall Study|Enrolled but Never Treated|1|||
131486917|NCT04431453|473413952|FG005|Overall Study|Enrolled but Never Treated|0|||
131486918|NCT04431453|473413953|FG006|Overall Study|Enrolled but Never Treated|0|||
131486919|NCT04431453|473413954|FG007|Overall Study|Enrolled but Never Treated|0|||
131486920|NCT00622401|473413955|FG000|Overall Study|Disease progression prior to treatment|3|||
131486921|NCT00622401|473413956|FG001|Overall Study|Disease progression prior to treatment|2|||
131486922|NCT00622401|473413957|FG002|Overall Study|Disease progression prior to treatment|0|||
131486923|NCT03546062|473413961|FG000|Overall Study|Adverse Event|6|||
131486924|NCT03546062|473413962|FG001|Overall Study|Adverse Event|5|||
131486925|NCT03546062|473413963|FG002|Overall Study|Adverse Event|8|||
131486926|NCT01768286|473413965|FG000|Overall Study|Randomized But Not Treated|0|||
131486927|NCT01768286|473413966|FG001|Overall Study|Randomized But Not Treated|0|||
131486928|NCT01768286|473413967|FG002|Overall Study|Randomized But Not Treated|1|||
131486929|NCT01768286|473413968|FG003|Overall Study|Randomized But Not Treated|0|||
131486930|NCT01768286|473413965|FG000|Overall Study|Lack of Efficacy|7|||
131486931|NCT01768286|473413966|FG001|Overall Study|Lack of Efficacy|4|||
131486932|NCT01768286|473413967|FG002|Overall Study|Lack of Efficacy|0|||
131486933|NCT01768286|473413968|FG003|Overall Study|Lack of Efficacy|1|||
131486934|NCT01768286|473413965|FG000|Overall Study|Withdrew Consent|0|||
131486935|NCT01768286|473413966|FG001|Overall Study|Withdrew Consent|0|||
131486936|NCT01768286|473413967|FG002|Overall Study|Withdrew Consent|1|||
131486937|NCT01768286|473413968|FG003|Overall Study|Withdrew Consent|0|||
131486938|NCT00190671|473413969|FG000|Overall Study|Satisfactory Response|4|||
131486939|NCT00190671|473413970|FG001|Overall Study|Satisfactory Response|7|||
131486940|NCT00190671|473413969|FG000|Overall Study|Lack of Efficacy|19|||
131486941|NCT00190671|473413970|FG001|Overall Study|Lack of Efficacy|24|||
131486942|NCT00190671|473413969|FG000|Overall Study|Death from Study Disease|1|||
131486943|NCT00190671|473413970|FG001|Overall Study|Death from Study Disease|1|||
131486944|NCT00190671|473413969|FG000|Overall Study|Adverse Event|3|||
131486945|NCT00190671|473413970|FG001|Overall Study|Adverse Event|2|||
131486946|NCT00190671|473413969|FG000|Overall Study|Clinical Relapse|0|||
131486947|NCT00190671|473413970|FG001|Overall Study|Clinical Relapse|1|||
131486948|NCT00190671|473413969|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
131486949|NCT00190671|473413970|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
131486950|NCT00190671|473413969|FG000|Overall Study|Death from Other Causes|0|||
131486951|NCT00190671|473413970|FG001|Overall Study|Death from Other Causes|2|||
131486952|NCT00190671|473413969|FG000|Overall Study|Protocol Violation|0|||
131486953|NCT00190671|473413970|FG001|Overall Study|Protocol Violation|1|||
131486954|NCT00190671|473413969|FG000|Overall Study|Withdrawal by Subject|0|||
131486955|NCT00190671|473413970|FG001|Overall Study|Withdrawal by Subject|2|||
131486956|NCT04545385|473413973|FG000|Overall Study|Withdrawal by Subject|2|||
131486957|NCT04545385|473413974|FG001|Overall Study|Withdrawal by Subject|0|||
131486958|NCT04545385|473413973|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
131486959|NCT04545385|473413974|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
131486960|NCT04545385|473413973|FG000|Overall Study|Study termination|10|||
131486961|NCT04545385|473413974|FG001|Overall Study|Study termination|10|||
131486962|NCT04545385|473413973|FG000|Overall Study|Sponsor decision|2|||
131486963|NCT04545385|473413974|FG001|Overall Study|Sponsor decision|2|||
131486964|NCT04545385|473413973|FG000|Overall Study|Other than specified|1|||
131486965|NCT04545385|473413974|FG001|Overall Study|Other than specified|0|||
131486966|NCT02015754|473413975|FG000|Overall Study|Disease progression|5|||
131486967|NCT02015754|473413975|FG000|Overall Study|Change in treatment modality|5|||
131486968|NCT02015754|473413975|FG000|Overall Study|Lost to Follow-up|1|||
131486969|NCT03137537|473413981|FG000|Overall Study|Adverse Event|0|||
131486970|NCT03137537|473413982|FG001|Overall Study|Adverse Event|1|||
131486971|NCT00191139|473413983|FG000|Overall Study|Adverse Event|2|||
131486972|NCT00191139|473413984|FG001|Overall Study|Adverse Event|6|||
131486973|NCT00191139|473413983|FG000|Overall Study|Death|2|||
131486974|NCT00191139|473413984|FG001|Overall Study|Death|0|||
131486975|NCT00191139|473413983|FG000|Overall Study|Withdrawal by Subject|0|||
131486976|NCT00191139|473413984|FG001|Overall Study|Withdrawal by Subject|3|||
131486977|NCT00191139|473413983|FG000|Overall Study|Disease Progression|0|||
131486978|NCT00191139|473413984|FG001|Overall Study|Disease Progression|1|||
131486979|NCT00191139|473413983|FG000|Overall Study|Other|1|||
131486980|NCT00191139|473413984|FG001|Overall Study|Other|2|||
131486981|NCT03338010|473413985|FG000|Overall Study|Withdrawal by Subject|14|||
131486982|NCT03338010|473413986|FG001|Overall Study|Withdrawal by Subject|8|||
131486983|NCT03338010|473413985|FG000|Overall Study|Lost to Follow-up|4|||
131486984|NCT03338010|473413986|FG001|Overall Study|Lost to Follow-up|2|||
131486985|NCT03338010|473413985|FG000|Overall Study|Adverse Event|3|||
131486986|NCT03338010|473413986|FG001|Overall Study|Adverse Event|2|||
131486987|NCT03338010|473413985|FG000|Overall Study|Physician Decision|2|||
131486988|NCT03338010|473413986|FG001|Overall Study|Physician Decision|2|||
131486989|NCT03338010|473413985|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131486990|NCT03338010|473413986|FG001|Overall Study|Non-Compliance with Study Drug|3|||
131486991|NCT03338010|473413985|FG000|Overall Study|Protocol Violation|0|||
131486992|NCT03338010|473413986|FG001|Overall Study|Protocol Violation|1|||
131486993|NCT01146665|473413987|FG000|Overall Study|Withdrawal by Subject|10|||
131486994|NCT01146665|473413988|FG001|Overall Study|Withdrawal by Subject|16|||
131486995|NCT02465515|473413989|FG000|Overall Study|Investigator site closed|4|||
131486996|NCT02465515|473413990|FG001|Overall Study|Investigator site closed|5|||
131486997|NCT02465515|473413989|FG000|Overall Study|Withdrawal by Subject|74|||
131486998|NCT02465515|473413990|FG001|Overall Study|Withdrawal by Subject|43|||
131486999|NCT02465515|473413989|FG000|Overall Study|Physician Decision|8|||
131487000|NCT02465515|473413990|FG001|Overall Study|Physician Decision|12|||
131487001|NCT02465515|473413989|FG000|Overall Study|Lost to Follow-up|68|||
131487002|NCT02465515|473413990|FG001|Overall Study|Lost to Follow-up|51|||
131487003|NCT00816595|473413991|FG000|Overall Study|Withdrawal by Subject|2|||
131487004|NCT00816595|473413992|FG001|Overall Study|Withdrawal by Subject|0|||
131487005|NCT00293033|473413993|FG000|Open-label Titration Period|Adverse Event|10|||
131487006|NCT00293033|473413993|FG000|Open-label Titration Period|Death|3|||
131487007|NCT00293033|473413993|FG000|Open-label Titration Period|Lack of Efficacy|5|||
131487008|NCT00293033|473413993|FG000|Open-label Titration Period|Protocol Violation|2|||
131487009|NCT00293033|473413993|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
131487010|NCT00293033|473413993|FG000|Open-label Titration Period|Noncompliance and other|27|||
131487011|NCT00293033|473413993|FG000|Double-blind Treatment Period|Adverse Event|3|||
131487012|NCT00293033|473413993|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
131487013|NCT00293033|473413993|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
131487014|NCT00293033|473413993|FG000|Double-blind Treatment Period|Noncompliance|4|||
131487015|NCT00365508|473413997|FG000|Overall Study|Lost to Follow-up|139|||
131487016|NCT00365508|473413998|FG001|Overall Study|Lost to Follow-up|154|||
131487017|NCT00751933|473413999|FG000|Overall Study|Withdrawal by Subject|0|||
131487018|NCT00751933|473414000|FG001|Overall Study|Withdrawal by Subject|1|||
131487019|NCT00751933|473414001|FG002|Overall Study|Withdrawal by Subject|0|||
131487020|NCT00751933|473414002|FG003|Overall Study|Withdrawal by Subject|0|||
131487021|NCT00751933|473413999|FG000|Overall Study|Physician Decision|0|||
131487022|NCT00751933|473414000|FG001|Overall Study|Physician Decision|0|||
131487023|NCT00751933|473414001|FG002|Overall Study|Physician Decision|1|||
131487024|NCT00751933|473414002|FG003|Overall Study|Physician Decision|1|||
131487025|NCT01817530|473414004|FG000|Overall Study|Exclusionary Medication Received|0|||
131487026|NCT01817530|473414005|FG001|Overall Study|Exclusionary Medication Received|0|||
131487027|NCT01817530|473414006|FG002|Overall Study|Exclusionary Medication Received|0|||
131487028|NCT01817530|473414007|FG003|Overall Study|Exclusionary Medication Received|0|||
131487029|NCT01817530|473414008|FG004|Overall Study|Exclusionary Medication Received|1|||
131487030|NCT01817530|473414009|FG005|Overall Study|Exclusionary Medication Received|0|||
131487031|NCT01817530|473414010|FG006|Overall Study|Exclusionary Medication Received|0|||
131487032|NCT01817530|473414011|FG007|Overall Study|Exclusionary Medication Received|0|||
131487033|NCT01817530|473414004|FG000|Overall Study|Adverse Event|6|||
131487034|NCT01817530|473414005|FG001|Overall Study|Adverse Event|3|||
131487035|NCT01817530|473414006|FG002|Overall Study|Adverse Event|2|||
131487036|NCT01817530|473414007|FG003|Overall Study|Adverse Event|5|||
131487037|NCT01817530|473414008|FG004|Overall Study|Adverse Event|0|||
131487038|NCT01817530|473414009|FG005|Overall Study|Adverse Event|10|||
131487039|NCT01817530|473414010|FG006|Overall Study|Adverse Event|5|||
131487040|NCT01817530|473414011|FG007|Overall Study|Adverse Event|8|||
131487041|NCT01817530|473414004|FG000|Overall Study|Subject Noncompliant|3|||
131487042|NCT01817530|473414005|FG001|Overall Study|Subject Noncompliant|1|||
131487043|NCT01817530|473414006|FG002|Overall Study|Subject Noncompliant|0|||
131487044|NCT01817530|473414007|FG003|Overall Study|Subject Noncompliant|4|||
131487045|NCT01817530|473414008|FG004|Overall Study|Subject Noncompliant|0|||
131487046|NCT01817530|473414009|FG005|Overall Study|Subject Noncompliant|1|||
131487047|NCT01817530|473414010|FG006|Overall Study|Subject Noncompliant|1|||
131487048|NCT01817530|473414011|FG007|Overall Study|Subject Noncompliant|1|||
131487049|NCT01817530|473414004|FG000|Overall Study|Lack of Efficacy|1|||
131487050|NCT01817530|473414005|FG001|Overall Study|Lack of Efficacy|0|||
131487051|NCT01817530|473414006|FG002|Overall Study|Lack of Efficacy|0|||
131487052|NCT01817530|473414007|FG003|Overall Study|Lack of Efficacy|0|||
131487053|NCT01817530|473414008|FG004|Overall Study|Lack of Efficacy|0|||
131487054|NCT01817530|473414009|FG005|Overall Study|Lack of Efficacy|1|||
131487055|NCT01817530|473414010|FG006|Overall Study|Lack of Efficacy|0|||
131487056|NCT01817530|473414011|FG007|Overall Study|Lack of Efficacy|1|||
131487057|NCT01817530|473414004|FG000|Overall Study|Pregnancy|0|||
131487058|NCT01817530|473414005|FG001|Overall Study|Pregnancy|0|||
131487059|NCT01817530|473414006|FG002|Overall Study|Pregnancy|0|||
131487060|NCT01817530|473414007|FG003|Overall Study|Pregnancy|0|||
131487061|NCT01817530|473414008|FG004|Overall Study|Pregnancy|0|||
131487062|NCT01817530|473414009|FG005|Overall Study|Pregnancy|1|||
131487063|NCT01817530|473414010|FG006|Overall Study|Pregnancy|0|||
131487064|NCT01817530|473414011|FG007|Overall Study|Pregnancy|0|||
131487065|NCT01817530|473414004|FG000|Overall Study|Other|0|||
131487066|NCT01817530|473414005|FG001|Overall Study|Other|1|||
131487067|NCT01817530|473414006|FG002|Overall Study|Other|0|||
131487068|NCT01817530|473414007|FG003|Overall Study|Other|0|||
131487069|NCT01817530|473414008|FG004|Overall Study|Other|1|||
131487070|NCT01817530|473414009|FG005|Overall Study|Other|0|||
131487071|NCT01817530|473414010|FG006|Overall Study|Other|5|||
131487072|NCT01817530|473414011|FG007|Overall Study|Other|0|||
131487073|NCT01817530|473414004|FG000|Overall Study|Surgery or Invasive Intervention|1|||
131487074|NCT01817530|473414005|FG001|Overall Study|Surgery or Invasive Intervention|0|||
131487075|NCT01817530|473414006|FG002|Overall Study|Surgery or Invasive Intervention|0|||
131487076|NCT01817530|473414007|FG003|Overall Study|Surgery or Invasive Intervention|0|||
131487077|NCT01817530|473414008|FG004|Overall Study|Surgery or Invasive Intervention|1|||
131487078|NCT01817530|473414009|FG005|Overall Study|Surgery or Invasive Intervention|1|||
131487079|NCT01817530|473414010|FG006|Overall Study|Surgery or Invasive Intervention|1|||
131487080|NCT01817530|473414011|FG007|Overall Study|Surgery or Invasive Intervention|0|||
131487081|NCT01817530|473414004|FG000|Overall Study|Consent Withdrawn by Subject|3|||
131487082|NCT01817530|473414005|FG001|Overall Study|Consent Withdrawn by Subject|4|||
131487083|NCT01817530|473414006|FG002|Overall Study|Consent Withdrawn by Subject|7|||
131487084|NCT01817530|473414007|FG003|Overall Study|Consent Withdrawn by Subject|3|||
131487085|NCT01817530|473414008|FG004|Overall Study|Consent Withdrawn by Subject|5|||
131487086|NCT01817530|473414009|FG005|Overall Study|Consent Withdrawn by Subject|3|||
131487087|NCT01817530|473414010|FG006|Overall Study|Consent Withdrawn by Subject|3|||
131487088|NCT01817530|473414011|FG007|Overall Study|Consent Withdrawn by Subject|10|||
131487089|NCT01817530|473414004|FG000|Overall Study|Lost to Follow-up|1|||
131487090|NCT01817530|473414005|FG001|Overall Study|Lost to Follow-up|4|||
131487091|NCT01817530|473414006|FG002|Overall Study|Lost to Follow-up|2|||
131487092|NCT01817530|473414007|FG003|Overall Study|Lost to Follow-up|1|||
131487093|NCT01817530|473414008|FG004|Overall Study|Lost to Follow-up|3|||
131487094|NCT01817530|473414009|FG005|Overall Study|Lost to Follow-up|2|||
131487095|NCT01817530|473414010|FG006|Overall Study|Lost to Follow-up|8|||
131487096|NCT01817530|473414011|FG007|Overall Study|Lost to Follow-up|4|||
131487097|NCT03846804|473414012|FG000|Overall Study|Refused blood draw|1|||
131487098|NCT03846804|473414012|FG000|Overall Study|Protocol Violation|1|||
131487099|NCT00345839|473414014|FG000|Overall Study|Withdrawal by Subject|91|||
131487100|NCT00345839|473414015|FG001|Overall Study|Withdrawal by Subject|98|||
131487101|NCT00345839|473414014|FG000|Overall Study|Lost to Follow-up|58|||
131487102|NCT00345839|473414015|FG001|Overall Study|Lost to Follow-up|61|||
131487103|NCT00743483|473414025|FG000|Baseline Period|Physician Decision|1|||
131487104|NCT00743483|473414025|FG000|Treatment Period|Adverse Event|1|||
131487105|NCT00873912|473414027|FG000|Overall Study|Withdrawal by Subject|1|||
131487106|NCT00873912|473414028|FG001|Overall Study|Withdrawal by Subject|0|||
131487107|NCT00873912|473414027|FG000|Overall Study|Lost to Follow-up|2|||
131487108|NCT00873912|473414028|FG001|Overall Study|Lost to Follow-up|0|||
131487109|NCT01466153|473414029|FG000|Overall Study|Disease Progression|2|||
131487110|NCT01466153|473414030|FG001|Overall Study|Disease Progression|2|||
131487111|NCT01466153|473414031|FG002|Overall Study|Disease Progression|0|||
131487112|NCT01466153|473414029|FG000|Overall Study|Adverse Event|14|||
131487113|NCT01466153|473414030|FG001|Overall Study|Adverse Event|13|||
131487114|NCT01466153|473414031|FG002|Overall Study|Adverse Event|17|||
131487115|NCT01466153|473414029|FG000|Overall Study|Withdrawal of Consent|2|||
131487116|NCT01466153|473414030|FG001|Overall Study|Withdrawal of Consent|0|||
131487117|NCT01466153|473414031|FG002|Overall Study|Withdrawal of Consent|0|||
131487118|NCT01466153|473414029|FG000|Overall Study|Investigator Discretion|3|||
131487119|NCT01466153|473414030|FG001|Overall Study|Investigator Discretion|2|||
131487120|NCT01466153|473414031|FG002|Overall Study|Investigator Discretion|2|||
131487121|NCT01466153|473414029|FG000|Overall Study|Randomized-Not Treated|2|||
131487122|NCT01466153|473414030|FG001|Overall Study|Randomized-Not Treated|3|||
131487123|NCT01466153|473414031|FG002|Overall Study|Randomized-Not Treated|4|||
131487124|NCT01466153|473414029|FG000|Overall Study|Other-Unspecified|6|||
131487125|NCT01466153|473414030|FG001|Overall Study|Other-Unspecified|4|||
131487126|NCT01466153|473414031|FG002|Overall Study|Other-Unspecified|2|||
131487127|NCT01088997|473414036|FG000|Overall Study|Physician Decision|1|||
131487128|NCT01088997|473414037|FG001|Overall Study|Physician Decision|1|||
131487129|NCT01088997|473414036|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
131487130|NCT01088997|473414037|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
131487131|NCT01088997|473414036|FG000|Overall Study|Excluded prior to receiving drug|1|||
131487132|NCT01088997|473414037|FG001|Overall Study|Excluded prior to receiving drug|1|||
131487133|NCT03749447|473415477|FG000|Overall Study|Adverse Event|11|||
131487134|NCT03749447|473415478|FG001|Overall Study|Adverse Event|3|||
131487135|NCT03749447|473415477|FG000|Overall Study|Death|1|||
131487136|NCT03749447|473415478|FG001|Overall Study|Death|1|||
131487137|NCT03749447|473415477|FG000|Overall Study|Lost to Follow-up|2|||
131487138|NCT03749447|473415478|FG001|Overall Study|Lost to Follow-up|2|||
131487139|NCT03749447|473415477|FG000|Overall Study|Reason Not Specified|0|||
131487140|NCT03749447|473415478|FG001|Overall Study|Reason Not Specified|3|||
131487141|NCT03749447|473415477|FG000|Overall Study|Physician Decision|4|||
131487142|NCT03749447|473415478|FG001|Overall Study|Physician Decision|3|||
131487143|NCT03749447|473415477|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
131487144|NCT03749447|473415478|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
131487145|NCT03749447|473415477|FG000|Overall Study|Study Terminated By Sponsor|112|||
131487146|NCT03749447|473415478|FG001|Overall Study|Study Terminated By Sponsor|105|||
131487147|NCT03749447|473415477|FG000|Overall Study|Withdrawal by Subject|12|||
131487148|NCT03749447|473415478|FG001|Overall Study|Withdrawal by Subject|6|||
131487149|NCT03749447|473415477|FG000|Overall Study|Non-compliance With Study Drug|0|||
131487150|NCT03749447|473415478|FG001|Overall Study|Non-compliance With Study Drug|1|||
131487151|NCT01218113|473415479|FG000|Overall Study|Withdrawal by Subject|1|||
131487152|NCT01218113|473415480|FG001|Overall Study|Withdrawal by Subject|0|||
131487153|NCT01218113|473415481|FG002|Overall Study|Withdrawal by Subject|1|||
131487154|NCT01218113|473415479|FG000|Overall Study|Lost to Follow-up|4|||
131487155|NCT01218113|473415480|FG001|Overall Study|Lost to Follow-up|1|||
131487156|NCT01218113|473415481|FG002|Overall Study|Lost to Follow-up|4|||
131487157|NCT01218113|473415479|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
131487158|NCT01218113|473415480|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
131487159|NCT01218113|473415481|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
131487160|NCT00787891|473415482|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
131487161|NCT00787891|473415483|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
131487162|NCT00787891|473415482|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
131487163|NCT00787891|473415483|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
131487164|NCT00787891|473415482|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
131487165|NCT00787891|473415483|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
131487166|NCT00787891|473415482|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
131487167|NCT00787891|473415483|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
131487168|NCT00787891|473415482|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
131487169|NCT00787891|473415483|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
131487170|NCT00787891|473415482|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
131487171|NCT00787891|473415483|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
131487172|NCT00787891|473415482|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
131487173|NCT00787891|473415483|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
131487174|NCT00787891|473415482|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
131487175|NCT00787891|473415483|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
131487176|NCT00787891|473415482|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
131487177|NCT00787891|473415483|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
131487178|NCT00787891|473415482|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
131487179|NCT00787891|473415483|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
131487180|NCT03486223|473415494|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
131487181|NCT03486223|473415495|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
131487182|NCT01819831|473415498|FG000|Overall Study|Withdrawal by Subject|1|||
131487183|NCT01434667|473415499|FG000|Overall Study|Lost to Follow-up|5|||
131487184|NCT01434667|473415500|FG001|Overall Study|Lost to Follow-up|10|||
131487185|NCT02034110|473415509|FG000|Overall Study|Physician Decision|0|||
131487186|NCT02034110|473415510|FG001|Overall Study|Physician Decision|0|||
131487187|NCT02034110|473415511|FG002|Overall Study|Physician Decision|0|||
131487188|NCT02034110|473415512|FG003|Overall Study|Physician Decision|0|||
131487189|NCT02034110|473415513|FG004|Overall Study|Physician Decision|2|||
131487190|NCT02034110|473415514|FG005|Overall Study|Physician Decision|0|||
131487191|NCT02034110|473415515|FG006|Overall Study|Physician Decision|1|||
131487192|NCT02034110|473415516|FG007|Overall Study|Physician Decision|0|||
131487193|NCT02034110|473415509|FG000|Overall Study|Lost to Follow-up|1|||
131487194|NCT02034110|473415510|FG001|Overall Study|Lost to Follow-up|0|||
131487195|NCT02034110|473415511|FG002|Overall Study|Lost to Follow-up|0|||
131487196|NCT02034110|473415512|FG003|Overall Study|Lost to Follow-up|0|||
131487197|NCT02034110|473415513|FG004|Overall Study|Lost to Follow-up|1|||
131487198|NCT02034110|473415514|FG005|Overall Study|Lost to Follow-up|0|||
131487199|NCT02034110|473415515|FG006|Overall Study|Lost to Follow-up|1|||
131487200|NCT02034110|473415516|FG007|Overall Study|Lost to Follow-up|0|||
131487201|NCT02034110|473415509|FG000|Overall Study|Withdrawal by Subject|5|||
131487202|NCT02034110|473415510|FG001|Overall Study|Withdrawal by Subject|7|||
131487203|NCT02034110|473415511|FG002|Overall Study|Withdrawal by Subject|0|||
131487204|NCT02034110|473415512|FG003|Overall Study|Withdrawal by Subject|3|||
131487205|NCT02034110|473415513|FG004|Overall Study|Withdrawal by Subject|7|||
131487206|NCT02034110|473415514|FG005|Overall Study|Withdrawal by Subject|0|||
131487207|NCT02034110|473415515|FG006|Overall Study|Withdrawal by Subject|3|||
131487208|NCT02034110|473415516|FG007|Overall Study|Withdrawal by Subject|1|||
131487209|NCT02034110|473415509|FG000|Overall Study|Study closed by sponsor|6|||
131487210|NCT02034110|473415510|FG001|Overall Study|Study closed by sponsor|2|||
131487211|NCT02034110|473415511|FG002|Overall Study|Study closed by sponsor|0|||
131487212|NCT02034110|473415512|FG003|Overall Study|Study closed by sponsor|6|||
131487213|NCT02034110|473415513|FG004|Overall Study|Study closed by sponsor|7|||
131487214|NCT02034110|473415514|FG005|Overall Study|Study closed by sponsor|0|||
131487215|NCT02034110|473415515|FG006|Overall Study|Study closed by sponsor|42|||
131487216|NCT02034110|473415516|FG007|Overall Study|Study closed by sponsor|0|||
131487217|NCT02835820|473415519|FG000|Overall Study|Baseline Screen Failure|0|||
131487218|NCT02835820|473415520|FG001|Overall Study|Baseline Screen Failure|3|||
131487219|NCT01867424|473415524|FG000|Overall Study|Patient noncompliance|2|||
131487220|NCT01867424|473415525|FG001|Overall Study|Patient noncompliance|1|||
131487221|NCT01056653|473415526|FG000|Overall Study|Lost to Follow-up|0|||
131487222|NCT01056653|473415527|FG001|Overall Study|Lost to Follow-up|0|||
131487223|NCT01056653|473415528|FG002|Overall Study|Lost to Follow-up|2|||
131487224|NCT01921387|473415529|FG000|Overall Study|Adverse Event|1|||
131487225|NCT03741062|473415530|FG000|Overall Study|Protocol Violation|1|||
131487226|NCT03741062|473415531|FG001|Overall Study|Protocol Violation|0|||
131487227|NCT01706146|473415534|FG000|Overall Study|Withdrawal by Subject|1|||
131487228|NCT01706146|473415534|FG000|Overall Study|Adverse Event|3|||
131487229|NCT01706146|473415534|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
131487230|NCT00675948|473415535|FG000|Overall Study|Adverse Event|23|||
131487231|NCT00675948|473415536|FG001|Overall Study|Adverse Event|1|||
131487232|NCT00675948|473415535|FG000|Overall Study|Lack of Efficacy|3|||
131487233|NCT00675948|473415536|FG001|Overall Study|Lack of Efficacy|0|||
131487234|NCT00675948|473415535|FG000|Overall Study|Withdrawal by Subject|7|||
131487235|NCT00675948|473415536|FG001|Overall Study|Withdrawal by Subject|0|||
131487236|NCT00675948|473415535|FG000|Overall Study|Lost to Follow-up|2|||
131487237|NCT00675948|473415536|FG001|Overall Study|Lost to Follow-up|0|||
131487238|NCT00675948|473415535|FG000|Overall Study|Protocol Violation|1|||
131487239|NCT00675948|473415536|FG001|Overall Study|Protocol Violation|0|||
131487240|NCT00675948|473415535|FG000|Overall Study|Pain under control|1|||
131487241|NCT00675948|473415536|FG001|Overall Study|Pain under control|0|||
131487242|NCT00675948|473415535|FG000|Overall Study|Sponsor decision|0|||
131487243|NCT00675948|473415536|FG001|Overall Study|Sponsor decision|1|||
131487244|NCT00675948|473415535|FG000|Overall Study|Patient died|1|||
131487245|NCT00675948|473415536|FG001|Overall Study|Patient died|0|||
131487246|NCT00675948|473415535|FG000|Overall Study|Patient unable to comply with diaries|1|||
131487247|NCT00675948|473415536|FG001|Overall Study|Patient unable to comply with diaries|0|||
131487248|NCT00675948|473415535|FG000|Overall Study|Patient feels unable to take medication|0|||
131487249|NCT00675948|473415536|FG001|Overall Study|Patient feels unable to take medication|1|||
131487250|NCT02582983|473415537|FG000|Overall Study|Death|3|||
131487251|NCT02582983|473415537|FG000|Overall Study|Withdrawal by Subject|2|||
131487252|NCT02582983|473415537|FG000|Overall Study|Adverse Event|1|||
131487253|NCT01751178|473415538|FG000|Overall Study|Adverse Event|2|||
131487254|NCT01751178|473415539|FG001|Overall Study|Adverse Event|0|||
131487255|NCT01751178|473415540|FG002|Overall Study|Adverse Event|0|||
131487256|NCT01751178|473415538|FG000|Overall Study|Other Reason (unknown)|1|||
131487257|NCT01751178|473415539|FG001|Overall Study|Other Reason (unknown)|0|||
131487258|NCT01751178|473415540|FG002|Overall Study|Other Reason (unknown)|2|||
131487259|NCT01081678|473415546|FG000|Overall Study|Ineligibility Determined|0|||
131487260|NCT01081678|473415547|FG001|Overall Study|Ineligibility Determined|0|||
131487261|NCT01081678|473415548|FG002|Overall Study|Ineligibility Determined|1|||
131487262|NCT01081678|473415549|FG003|Overall Study|Ineligibility Determined|1|||
131487263|NCT01081678|473415546|FG000|Overall Study|Noncompliance|3|||
131487264|NCT01081678|473415547|FG001|Overall Study|Noncompliance|4|||
131487265|NCT01081678|473415548|FG002|Overall Study|Noncompliance|5|||
131487266|NCT01081678|473415549|FG003|Overall Study|Noncompliance|2|||
131487267|NCT01081678|473415546|FG000|Overall Study|Adverse Event|2|||
131487268|NCT01081678|473415547|FG001|Overall Study|Adverse Event|1|||
131487269|NCT01081678|473415548|FG002|Overall Study|Adverse Event|2|||
131487270|NCT01081678|473415549|FG003|Overall Study|Adverse Event|2|||
131487271|NCT01081678|473415546|FG000|Overall Study|Withdrawal by Subject|15|||
131487272|NCT01081678|473415547|FG001|Overall Study|Withdrawal by Subject|7|||
131487273|NCT01081678|473415548|FG002|Overall Study|Withdrawal by Subject|17|||
131487274|NCT01081678|473415549|FG003|Overall Study|Withdrawal by Subject|14|||
131487275|NCT01081678|473415546|FG000|Overall Study|Administrative Decision|1|||
131487276|NCT01081678|473415547|FG001|Overall Study|Administrative Decision|0|||
131487277|NCT01081678|473415548|FG002|Overall Study|Administrative Decision|0|||
131487278|NCT01081678|473415549|FG003|Overall Study|Administrative Decision|1|||
131487279|NCT01081678|473415546|FG000|Overall Study|Lost to Follow-up|4|||
131487280|NCT01081678|473415547|FG001|Overall Study|Lost to Follow-up|1|||
131487281|NCT01081678|473415548|FG002|Overall Study|Lost to Follow-up|4|||
131487282|NCT01081678|473415549|FG003|Overall Study|Lost to Follow-up|3|||
131487283|NCT01081678|473415546|FG000|Overall Study|Death|2|||
131487284|NCT01081678|473415547|FG001|Overall Study|Death|2|||
131487285|NCT01081678|473415548|FG002|Overall Study|Death|2|||
131487286|NCT01081678|473415549|FG003|Overall Study|Death|6|||
131487287|NCT01081678|473415546|FG000|Overall Study|Other|0|||
131487288|NCT01081678|473415547|FG001|Overall Study|Other|1|||
131487289|NCT01081678|473415548|FG002|Overall Study|Other|0|||
131487290|NCT01081678|473415549|FG003|Overall Study|Other|0|||
131487291|NCT00288054|473415550|FG000|Overall Study|Protocol Violation|2|||
131487292|NCT00288054|473415550|FG000|Overall Study|Lack of Efficacy|16|||
131487293|NCT00288054|473415550|FG000|Overall Study|Adverse Event|3|||
131487294|NCT00288054|473415550|FG000|Overall Study|Withdrawal by Subject|1|||
131487295|NCT00288054|473415550|FG000|Overall Study|Not protocol specified|2|||
131487296|NCT02499783|473415560|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
131487297|NCT02499783|473415561|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
131487298|NCT02499783|473415562|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
131487299|NCT02499783|473415560|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
131487300|NCT02499783|473415561|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
131487301|NCT02499783|473415562|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
131487302|NCT02499783|473415560|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
131487303|NCT02499783|473415561|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
131487304|NCT02499783|473415562|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
131487305|NCT02499783|473415560|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
131487306|NCT02499783|473415561|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
131487307|NCT02499783|473415562|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
131487308|NCT02499783|473415560|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
131487309|NCT02499783|473415561|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
131487310|NCT02499783|473415562|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
131487311|NCT02499783|473415560|FG000|DB Period: Weeks 0-8|Other|1|||
131487312|NCT02499783|473415561|FG001|DB Period: Weeks 0-8|Other|1|||
131487313|NCT02499783|473415562|FG002|DB Period: Weeks 0-8|Other|0|||
131487314|NCT02499783|473415560|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
131487315|NCT02499783|473415561|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
131487316|NCT02499783|473415562|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
131487317|NCT02499783|473415560|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
131487318|NCT02499783|473415561|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
131487319|NCT02499783|473415562|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
131487320|NCT02499783|473415560|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
131487321|NCT02499783|473415561|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
131487322|NCT02499783|473415562|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
131487323|NCT02499783|473415560|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
131487324|NCT02499783|473415561|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
131487325|NCT02499783|473415562|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
131487326|NCT00555971|473415563|FG000|Overall Study|Adverse Event|1|||
131487327|NCT00555971|473415564|FG001|Overall Study|Adverse Event|1|||
131487328|NCT00801632|473415565|FG000|Overall Study|Re-transplant|1|||
131487329|NCT04447794|473415569|FG000|Overall Study|Lost to Follow-up|2|||
131487330|NCT04447794|473415570|FG001|Overall Study|Lost to Follow-up|3|||
131487331|NCT04447794|473415571|FG002|Overall Study|Lost to Follow-up|8|||
131487332|NCT04447794|473415569|FG000|Overall Study|Withdrawal by Subject|1|||
131487333|NCT04447794|473415570|FG001|Overall Study|Withdrawal by Subject|1|||
131487334|NCT04447794|473415571|FG002|Overall Study|Withdrawal by Subject|0|||
131487335|NCT00621582|473415572|FG000|Overall Study|Adverse Event|7|||
131487336|NCT00621582|473415572|FG000|Overall Study|Protocol Violation|57|||
131487337|NCT00621582|473415572|FG000|Overall Study|Lost to Follow-up|24|||
131487338|NCT00621582|473415572|FG000|Overall Study|issues not identified by investigators|18|||
131487339|NCT01387932|473415574|FG000|Randomized and Treated|Physician Decision|3|||
131487340|NCT01387932|473415575|FG001|Randomized and Treated|Physician Decision|2|||
131487341|NCT01387932|473415574|FG000|Randomized and Treated|Withdrawal by Subject|4|||
131487342|NCT01387932|473415575|FG001|Randomized and Treated|Withdrawal by Subject|2|||
131487343|NCT01387932|473415574|FG000|Survival Follow-up|Liver Transplant|24|||
131487344|NCT01387932|473415575|FG001|Survival Follow-up|Liver Transplant|28|||
131487345|NCT01387932|473415574|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
131487346|NCT01387932|473415575|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
131487347|NCT01387932|473415574|FG000|Survival Follow-up|Withdrawal by Subject|2|||
131487348|NCT01387932|473415575|FG001|Survival Follow-up|Withdrawal by Subject|4|||
131487349|NCT01387932|473415574|FG000|Survival Follow-up|Lost to Follow-up|6|||
131487350|NCT01387932|473415575|FG001|Survival Follow-up|Lost to Follow-up|5|||
131487351|NCT02571075|473415578|FG000|Overall Study|Lost to Follow-up|20|||
131487352|NCT02571075|473415579|FG001|Overall Study|Lost to Follow-up|24|||
131487353|NCT00963937|473415582|FG000|Overall Study|Protocol Violation|1|||
131487354|NCT00963937|473415583|FG001|Overall Study|Protocol Violation|1|||
131487355|NCT00963937|473415584|FG002|Overall Study|Protocol Violation|0|||
131487356|NCT00963937|473415582|FG000|Overall Study|Physician Decision|18|||
131487357|NCT00963937|473415583|FG001|Overall Study|Physician Decision|10|||
131487358|NCT00963937|473415584|FG002|Overall Study|Physician Decision|4|||
131487359|NCT02197520|473415588|FG000|Period 1|Withdrawal by Subject|1|||
131487360|NCT02197520|473415589|FG001|Period 1|Withdrawal by Subject|0|||
131487361|NCT02197520|473415588|FG000|Period 2|Adverse Event|0|||
131487362|NCT02197520|473415589|FG001|Period 2|Adverse Event|2|||
131487363|NCT02197520|473415588|FG000|Period 2|Withdrawal by Subject|1|||
131487364|NCT02197520|473415589|FG001|Period 2|Withdrawal by Subject|0|||
131487365|NCT04203498|473415590|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
131487366|NCT04203498|473415591|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
131487367|NCT04203498|473415590|FG000|Overall Study|Withdrawal of patient consent|7|||
131487368|NCT04203498|473415591|FG001|Overall Study|Withdrawal of patient consent|2|||
131487369|NCT04203498|473415590|FG000|Overall Study|Adverse Event|4|||
131487370|NCT04203498|473415591|FG001|Overall Study|Adverse Event|1|||
131487371|NCT04203498|473415590|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
131487372|NCT04203498|473415591|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
131487373|NCT04203498|473415590|FG000|Overall Study|Did not receive IMP|2|||
131487374|NCT04203498|473415591|FG001|Overall Study|Did not receive IMP|0|||
131487375|NCT00369824|473415594|FG000|Overall Study|Adverse Event|0|||
131487376|NCT00369824|473415595|FG001|Overall Study|Adverse Event|2|||
131487377|NCT00369824|473415596|FG002|Overall Study|Adverse Event|0|||
131487378|NCT00369824|473415597|FG003|Overall Study|Adverse Event|0|||
131487379|NCT00369824|473415598|FG004|Overall Study|Adverse Event|1|||
131487380|NCT00369824|473415599|FG005|Overall Study|Adverse Event|0|||
131487381|NCT00369824|473415594|FG000|Overall Study|Protocol Violation|0|||
131487382|NCT00369824|473415595|FG001|Overall Study|Protocol Violation|1|||
131487383|NCT00369824|473415596|FG002|Overall Study|Protocol Violation|0|||
131487384|NCT00369824|473415597|FG003|Overall Study|Protocol Violation|1|||
131487385|NCT00369824|473415598|FG004|Overall Study|Protocol Violation|1|||
131487386|NCT00369824|473415599|FG005|Overall Study|Protocol Violation|0|||
131487387|NCT00369824|473415594|FG000|Overall Study|Withdrawal by Subject|9|||
131487388|NCT00369824|473415595|FG001|Overall Study|Withdrawal by Subject|5|||
131487389|NCT00369824|473415596|FG002|Overall Study|Withdrawal by Subject|5|||
131487390|NCT00369824|473415597|FG003|Overall Study|Withdrawal by Subject|4|||
131487391|NCT00369824|473415598|FG004|Overall Study|Withdrawal by Subject|6|||
131487392|NCT00369824|473415599|FG005|Overall Study|Withdrawal by Subject|2|||
131487393|NCT00369824|473415594|FG000|Overall Study|Lost to Follow-up|6|||
131487394|NCT00369824|473415595|FG001|Overall Study|Lost to Follow-up|11|||
131487395|NCT00369824|473415596|FG002|Overall Study|Lost to Follow-up|7|||
131487396|NCT00369824|473415597|FG003|Overall Study|Lost to Follow-up|8|||
131487397|NCT00369824|473415598|FG004|Overall Study|Lost to Follow-up|9|||
131487398|NCT00369824|473415599|FG005|Overall Study|Lost to Follow-up|6|||
131487399|NCT00369824|473415594|FG000|Overall Study|Other|0|||
131487400|NCT00369824|473415595|FG001|Overall Study|Other|0|||
131487401|NCT00369824|473415596|FG002|Overall Study|Other|0|||
131487402|NCT00369824|473415597|FG003|Overall Study|Other|2|||
131487403|NCT00369824|473415598|FG004|Overall Study|Other|1|||
131487404|NCT00369824|473415599|FG005|Overall Study|Other|3|||
131487405|NCT02217878|473415600|FG000|Overall Study|required morphine due to chest pain|1|||
131487406|NCT02217878|473415601|FG001|Overall Study|required morphine due to chest pain|2|||
131487407|NCT02217878|473415600|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
131487408|NCT02217878|473415601|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
131487409|NCT00334958|473415602|FG000|Overall Study|Medication Noncompliance|0|||
131487410|NCT00334958|473415603|FG001|Overall Study|Medication Noncompliance|3|||
131487411|NCT00334958|473415602|FG000|Overall Study|Protocol Violation|2|||
131487412|NCT00334958|473415603|FG001|Overall Study|Protocol Violation|2|||
131487413|NCT00334958|473415602|FG000|Overall Study|Request of the investigator or sponsor|0|||
131487414|NCT00334958|473415603|FG001|Overall Study|Request of the investigator or sponsor|1|||
131487415|NCT00334958|473415602|FG000|Overall Study|Withdrawal by Subject|7|||
131487416|NCT00334958|473415603|FG001|Overall Study|Withdrawal by Subject|4|||
131487417|NCT00334958|473415602|FG000|Overall Study|Adverse Event|27|||
131487418|NCT00334958|473415603|FG001|Overall Study|Adverse Event|12|||
131487419|NCT00334958|473415602|FG000|Overall Study|Other|1|||
131487420|NCT00334958|473415603|FG001|Overall Study|Other|2|||
131487421|NCT05248867|473415611|FG000|Double-blind Period|Lost to Follow-up|0|||
131487422|NCT05248867|473415612|FG001|Double-blind Period|Lost to Follow-up|3|||
131487423|NCT05248867|473415613|FG002|Double-blind Period|Lost to Follow-up|0|||
131487424|NCT05248867|473415614|FG003|Double-blind Period|Lost to Follow-up|0|||
131487425|NCT05248867|473415615|FG004|Double-blind Period|Lost to Follow-up|0|||
131487426|NCT05248867|473415616|FG005|Double-blind Period|Lost to Follow-up|0|||
131487427|NCT05248867|473415611|FG000|Double-blind Period|Withdrawal by Subject|5|||
131487428|NCT05248867|473415612|FG001|Double-blind Period|Withdrawal by Subject|14|||
131487429|NCT05248867|473415613|FG002|Double-blind Period|Withdrawal by Subject|0|||
131487430|NCT05248867|473415614|FG003|Double-blind Period|Withdrawal by Subject|0|||
131487431|NCT05248867|473415615|FG004|Double-blind Period|Withdrawal by Subject|0|||
131487432|NCT05248867|473415616|FG005|Double-blind Period|Withdrawal by Subject|0|||
131487433|NCT05248867|473415611|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
131487434|NCT05248867|473415612|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
131487435|NCT05248867|473415613|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
131487436|NCT05248867|473415614|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
131487437|NCT05248867|473415615|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
131487438|NCT05248867|473415616|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
131487439|NCT05248867|473415611|FG000|Double-blind Period|Other, not specified|3|||
131487440|NCT05248867|473415612|FG001|Double-blind Period|Other, not specified|8|||
131487441|NCT05248867|473415613|FG002|Double-blind Period|Other, not specified|0|||
131487442|NCT05248867|473415614|FG003|Double-blind Period|Other, not specified|0|||
131487443|NCT05248867|473415615|FG004|Double-blind Period|Other, not specified|0|||
131487444|NCT05248867|473415616|FG005|Double-blind Period|Other, not specified|0|||
131487445|NCT05248867|473415611|FG000|Open-label Period|Withdrawal by Subject|0|||
131487446|NCT05248867|473415612|FG001|Open-label Period|Withdrawal by Subject|0|||
131487447|NCT05248867|473415613|FG002|Open-label Period|Withdrawal by Subject|3|||
131487448|NCT05248867|473415614|FG003|Open-label Period|Withdrawal by Subject|1|||
131487449|NCT05248867|473415615|FG004|Open-label Period|Withdrawal by Subject|7|||
131487450|NCT05248867|473415616|FG005|Open-label Period|Withdrawal by Subject|9|||
131487451|NCT05248867|473415611|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
131487452|NCT05248867|473415612|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
131487453|NCT05248867|473415613|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
131487454|NCT05248867|473415614|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
131487455|NCT05248867|473415615|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
131487456|NCT05248867|473415616|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
131487457|NCT05248867|473415611|FG000|Open-label Period|Lost to Follow-up|0|||
131487458|NCT05248867|473415612|FG001|Open-label Period|Lost to Follow-up|0|||
131487459|NCT05248867|473415613|FG002|Open-label Period|Lost to Follow-up|0|||
131487460|NCT05248867|473415614|FG003|Open-label Period|Lost to Follow-up|0|||
131487461|NCT05248867|473415615|FG004|Open-label Period|Lost to Follow-up|5|||
131487462|NCT05248867|473415616|FG005|Open-label Period|Lost to Follow-up|2|||
131487463|NCT05248867|473415611|FG000|Open-label Period|COVID-19 Infection|0|||
131487464|NCT05248867|473415612|FG001|Open-label Period|COVID-19 Infection|0|||
131487465|NCT05248867|473415613|FG002|Open-label Period|COVID-19 Infection|0|||
131487466|NCT05248867|473415614|FG003|Open-label Period|COVID-19 Infection|0|||
131487467|NCT05248867|473415615|FG004|Open-label Period|COVID-19 Infection|1|||
131487468|NCT05248867|473415616|FG005|Open-label Period|COVID-19 Infection|0|||
131487469|NCT05248867|473415611|FG000|Open-label Period|Other, not specified|0|||
131487470|NCT05248867|473415612|FG001|Open-label Period|Other, not specified|0|||
131487471|NCT05248867|473415613|FG002|Open-label Period|Other, not specified|0|||
131487472|NCT05248867|473415614|FG003|Open-label Period|Other, not specified|0|||
131487473|NCT05248867|473415615|FG004|Open-label Period|Other, not specified|4|||
131487474|NCT05248867|473415616|FG005|Open-label Period|Other, not specified|0|||
131487475|NCT01084083|473415618|FG000|Overall Study|Adverse Event|5|||
131487476|NCT01084083|473415618|FG000|Overall Study|Death|1|||
131487477|NCT01084083|473415618|FG000|Overall Study|Withdrawal by Subject|2|||
131487478|NCT01084083|473415618|FG000|Overall Study|Complicating disease|1|||
131487479|NCT01084083|473415618|FG000|Overall Study|Other|2|||
131487480|NCT01084083|473415618|FG000|Overall Study|Never started assigned therapy|1|||
131487481|NCT01970397|473417428|FG000|Overall Study|Adverse Event|0|||
131487482|NCT01970397|473417429|FG001|Overall Study|Adverse Event|1|||
131487483|NCT01970397|473417428|FG000|Overall Study|Lost to Follow-up|0|||
131487484|NCT01970397|473417429|FG001|Overall Study|Lost to Follow-up|1|||
131487485|NCT01970397|473417428|FG000|Overall Study|Personal Reasons|1|||
131487486|NCT01970397|473417429|FG001|Overall Study|Personal Reasons|2|||
131487487|NCT01970397|473417428|FG000|Overall Study|Protocol Violation|1|||
131487488|NCT01970397|473417429|FG001|Overall Study|Protocol Violation|1|||
131487489|NCT03305575|473417440|FG000|Overall Study|Physician Decision|1|||
131487490|NCT03305575|473417441|FG001|Overall Study|Physician Decision|0|||
131487491|NCT01389817|473417442|FG000|Overall Study|Physician Decision|1|||
131487492|NCT01389817|473417443|FG001|Overall Study|Physician Decision|0|||
131487493|NCT01389817|473417442|FG000|Overall Study|Lost to Follow-up|1|||
131487494|NCT01389817|473417443|FG001|Overall Study|Lost to Follow-up|0|||
131487495|NCT01389817|473417442|FG000|Overall Study|Withdrawal by Subject|2|||
131487496|NCT01389817|473417443|FG001|Overall Study|Withdrawal by Subject|0|||
131487497|NCT01877265|473417444|FG000|Treatment Period 1|Sponsor Decision|0|||
131487498|NCT01877265|473417445|FG001|Treatment Period 1|Sponsor Decision|0|||
131487499|NCT01877265|473417446|FG002|Treatment Period 1|Sponsor Decision|1|||
131487500|NCT01877265|473417447|FG003|Treatment Period 1|Sponsor Decision|0|||
131487501|NCT01877265|473417448|FG004|Treatment Period 1|Sponsor Decision|0|||
131487502|NCT01877265|473417449|FG005|Treatment Period 1|Sponsor Decision|0|||
131487503|NCT01877265|473417444|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
131487504|NCT01877265|473417445|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
131487505|NCT01877265|473417446|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
131487506|NCT01877265|473417447|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
131487507|NCT01877265|473417448|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
131487508|NCT01877265|473417449|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
131487509|NCT01877265|473417444|FG000|Treatment Period 3|Lost to Follow-up|1|||
131487510|NCT01877265|473417445|FG001|Treatment Period 3|Lost to Follow-up|0|||
131487511|NCT01877265|473417446|FG002|Treatment Period 3|Lost to Follow-up|0|||
131487512|NCT01877265|473417447|FG003|Treatment Period 3|Lost to Follow-up|0|||
131487513|NCT01877265|473417448|FG004|Treatment Period 3|Lost to Follow-up|0|||
131487514|NCT01877265|473417449|FG005|Treatment Period 3|Lost to Follow-up|0|||
131487515|NCT03535844|473417450|FG000|Overall Study|Withdrawal by Subject|0|||
131487516|NCT03535844|473417451|FG001|Overall Study|Withdrawal by Subject|1|||
131487517|NCT00444912|473417452|FG000|Overall Study|Death|1|||
131487518|NCT00444912|473417453|FG001|Overall Study|Death|2|||
131487519|NCT00444912|473417452|FG000|Overall Study|Lost to Follow-up|1|||
131487520|NCT00444912|473417453|FG001|Overall Study|Lost to Follow-up|0|||
131487521|NCT00444912|473417452|FG000|Overall Study|Participant Failed Mobilization|1|||
131487522|NCT00444912|473417453|FG001|Overall Study|Participant Failed Mobilization|0|||
131487523|NCT01606007|473417454|FG000|Overall Study|Reason 'Other' in the protocol|0|||
131487524|NCT01606007|473417455|FG001|Overall Study|Reason 'Other' in the protocol|1|||
131487525|NCT01606007|473417456|FG002|Overall Study|Reason 'Other' in the protocol|1|||
131487526|NCT01606007|473417454|FG000|Overall Study|Pregnancy|0|||
131487527|NCT01606007|473417455|FG001|Overall Study|Pregnancy|1|||
131487528|NCT01606007|473417456|FG002|Overall Study|Pregnancy|1|||
131487529|NCT01606007|473417454|FG000|Overall Study|Withdrawal by Subject|8|||
131487530|NCT01606007|473417455|FG001|Overall Study|Withdrawal by Subject|6|||
131487531|NCT01606007|473417456|FG002|Overall Study|Withdrawal by Subject|1|||
131487532|NCT01606007|473417454|FG000|Overall Study|Adverse Event|0|||
131487533|NCT01606007|473417455|FG001|Overall Study|Adverse Event|1|||
131487534|NCT01606007|473417456|FG002|Overall Study|Adverse Event|1|||
131487535|NCT01606007|473417454|FG000|Overall Study|discontinue study treatment|0|||
131487536|NCT01606007|473417455|FG001|Overall Study|discontinue study treatment|2|||
131487537|NCT01606007|473417456|FG002|Overall Study|discontinue study treatment|1|||
131487538|NCT01606007|473417454|FG000|Overall Study|Lost to Follow-up|6|||
131487539|NCT01606007|473417455|FG001|Overall Study|Lost to Follow-up|8|||
131487540|NCT01606007|473417456|FG002|Overall Study|Lost to Follow-up|5|||
131487541|NCT01606007|473417454|FG000|Overall Study|Poor/Non-compliance|1|||
131487542|NCT01606007|473417455|FG001|Overall Study|Poor/Non-compliance|0|||
131487543|NCT01606007|473417456|FG002|Overall Study|Poor/Non-compliance|0|||
131487544|NCT01007812|473417459|FG000|Period 1, One Week|Lost to Follow-up|0|||
131487545|NCT01007812|473417460|FG001|Period 1, One Week|Lost to Follow-up|1|||
131487546|NCT01007812|473417459|FG000|Period 1, One Week|Discomfort|1|||
131487547|NCT01007812|473417460|FG001|Period 1, One Week|Discomfort|0|||
131487548|NCT01091974|473417461|FG000|Overall Study|Did not start intervention|3|||
131487549|NCT01091974|473417462|FG001|Overall Study|Did not start intervention|1|||
131487550|NCT01091974|473417463|FG002|Overall Study|Did not start intervention|3|||
131487551|NCT01091974|473417464|FG003|Overall Study|Did not start intervention|1|||
131487552|NCT01091974|473417461|FG000|Overall Study|resumed sleep medication|0|||
131487553|NCT01091974|473417462|FG001|Overall Study|resumed sleep medication|0|||
131487554|NCT01091974|473417463|FG002|Overall Study|resumed sleep medication|1|||
131487555|NCT01091974|473417464|FG003|Overall Study|resumed sleep medication|2|||
131487556|NCT01091974|473417461|FG000|Overall Study|Withdrawal by Subject|1|||
131487557|NCT01091974|473417462|FG001|Overall Study|Withdrawal by Subject|3|||
131487558|NCT01091974|473417463|FG002|Overall Study|Withdrawal by Subject|2|||
131487559|NCT01091974|473417464|FG003|Overall Study|Withdrawal by Subject|2|||
131487560|NCT01091974|473417461|FG000|Overall Study|side-effects|1|||
131487561|NCT01091974|473417462|FG001|Overall Study|side-effects|1|||
131487562|NCT01091974|473417463|FG002|Overall Study|side-effects|0|||
131487563|NCT01091974|473417464|FG003|Overall Study|side-effects|2|||
131487564|NCT01866293|473417465|FG000|Overall Study|Adverse Event|2|||
131487565|NCT03768414|473417467|FG000|Overall Study|Adverse Event or side effects|72|||
131487566|NCT03768414|473417468|FG001|Overall Study|Adverse Event or side effects|28|||
131487567|NCT03768414|473417467|FG000|Overall Study|Refusal unrelated to adverse event|33|||
131487568|NCT03768414|473417468|FG001|Overall Study|Refusal unrelated to adverse event|33|||
131487569|NCT03768414|473417467|FG000|Overall Study|Progression/relapse|132|||
131487570|NCT03768414|473417468|FG001|Overall Study|Progression/relapse|60|||
131487571|NCT03768414|473417467|FG000|Overall Study|Death|9|||
131487572|NCT03768414|473417468|FG001|Overall Study|Death|6|||
131487573|NCT03768414|473417467|FG000|Overall Study|Other - not protocol specified|45|||
131487574|NCT03768414|473417468|FG001|Overall Study|Other - not protocol specified|18|||
131487575|NCT03768414|473417467|FG000|Overall Study|Reason under review|3|||
131487576|NCT03768414|473417468|FG001|Overall Study|Reason under review|2|||
131487577|NCT02571777|473417469|FG000|Overall Study|Subject/guardian decision|34|||
131487578|NCT02571777|473417470|FG001|Overall Study|Subject/guardian decision|26|||
131487579|NCT02571777|473417471|FG002|Overall Study|Subject/guardian decision|26|||
131487580|NCT02571777|473417472|FG003|Overall Study|Subject/guardian decision|25|||
131487581|NCT02571777|473417473|FG004|Overall Study|Subject/guardian decision|27|||
131487582|NCT02571777|473417469|FG000|Overall Study|Protocol Deviation|2|||
131487583|NCT02571777|473417470|FG001|Overall Study|Protocol Deviation|3|||
131487584|NCT02571777|473417471|FG002|Overall Study|Protocol Deviation|4|||
131487585|NCT02571777|473417472|FG003|Overall Study|Protocol Deviation|8|||
131487586|NCT02571777|473417473|FG004|Overall Study|Protocol Deviation|4|||
131487587|NCT02571777|473417469|FG000|Overall Study|Death|1|||
131487588|NCT02571777|473417470|FG001|Overall Study|Death|1|||
131487589|NCT02571777|473417471|FG002|Overall Study|Death|4|||
131487590|NCT02571777|473417472|FG003|Overall Study|Death|0|||
131487591|NCT02571777|473417473|FG004|Overall Study|Death|0|||
131487592|NCT02571777|473417469|FG000|Overall Study|Lost to Follow-up|1|||
131487593|NCT02571777|473417470|FG001|Overall Study|Lost to Follow-up|1|||
131487594|NCT02571777|473417471|FG002|Overall Study|Lost to Follow-up|2|||
131487595|NCT02571777|473417472|FG003|Overall Study|Lost to Follow-up|0|||
131487596|NCT02571777|473417473|FG004|Overall Study|Lost to Follow-up|1|||
131487597|NCT02571777|473417469|FG000|Overall Study|Physician Decision|1|||
131487598|NCT02571777|473417470|FG001|Overall Study|Physician Decision|7|||
131487599|NCT02571777|473417471|FG002|Overall Study|Physician Decision|5|||
131487600|NCT02571777|473417472|FG003|Overall Study|Physician Decision|2|||
131487601|NCT02571777|473417473|FG004|Overall Study|Physician Decision|4|||
131487602|NCT02571777|473417469|FG000|Overall Study|Pregnancy|0|||
131487603|NCT02571777|473417470|FG001|Overall Study|Pregnancy|0|||
131487604|NCT02571777|473417471|FG002|Overall Study|Pregnancy|0|||
131487605|NCT02571777|473417472|FG003|Overall Study|Pregnancy|2|||
131487606|NCT02571777|473417473|FG004|Overall Study|Pregnancy|0|||
131487607|NCT03706079|473417474|FG000|Predecessor Study|Death|0|||
131487608|NCT03706079|473417475|FG001|Predecessor Study|Death|2|||
131487609|NCT03706079|473417476|FG002|Predecessor Study|Death|0|||
131487610|NCT03706079|473417477|FG003|Predecessor Study|Death|1|||
131487611|NCT03706079|473417478|FG004|Predecessor Study|Death|0|||
131487612|NCT03706079|473417479|FG005|Predecessor Study|Death|0|||
131487613|NCT03706079|473417474|FG000|Predecessor Study|Lost to Follow-up|5|||
131487614|NCT03706079|473417475|FG001|Predecessor Study|Lost to Follow-up|2|||
131487615|NCT03706079|473417476|FG002|Predecessor Study|Lost to Follow-up|0|||
131487616|NCT03706079|473417477|FG003|Predecessor Study|Lost to Follow-up|0|||
131487617|NCT03706079|473417478|FG004|Predecessor Study|Lost to Follow-up|1|||
131487618|NCT03706079|473417479|FG005|Predecessor Study|Lost to Follow-up|0|||
131487619|NCT03706079|473417474|FG000|Predecessor Study|Withdrawal by Subject|8|||
131487620|NCT03706079|473417475|FG001|Predecessor Study|Withdrawal by Subject|15|||
131487621|NCT03706079|473417476|FG002|Predecessor Study|Withdrawal by Subject|0|||
131487622|NCT03706079|473417477|FG003|Predecessor Study|Withdrawal by Subject|5|||
131487623|NCT03706079|473417478|FG004|Predecessor Study|Withdrawal by Subject|2|||
131487624|NCT03706079|473417479|FG005|Predecessor Study|Withdrawal by Subject|0|||
131487625|NCT03706079|473417474|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
131487626|NCT03706079|473417475|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
131487627|NCT03706079|473417476|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
131487628|NCT03706079|473417477|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
131487629|NCT03706079|473417478|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
131487630|NCT03706079|473417479|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
131487631|NCT03706079|473417474|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
131487632|NCT03706079|473417475|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
131487633|NCT03706079|473417476|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
131487634|NCT03706079|473417477|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
131487635|NCT03706079|473417478|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
131487636|NCT03706079|473417479|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
131487637|NCT03706079|473417474|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
131487638|NCT03706079|473417475|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
131487639|NCT03706079|473417476|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
131487640|NCT03706079|473417477|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
131487641|NCT03706079|473417478|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
131487642|NCT03706079|473417479|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
131487643|NCT03706079|473417474|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
131487644|NCT03706079|473417475|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
131487645|NCT03706079|473417476|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
131487646|NCT03706079|473417477|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
131487647|NCT03706079|473417478|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
131487648|NCT03706079|473417479|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
131487649|NCT03706079|473417474|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
131487650|NCT03706079|473417475|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
131487651|NCT03706079|473417476|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
131487652|NCT03706079|473417477|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
131487653|NCT03706079|473417478|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
131487654|NCT03706079|473417479|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
131487655|NCT03706079|473417474|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
131487656|NCT03706079|473417475|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
131487657|NCT03706079|473417476|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
131487658|NCT03706079|473417477|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
131487659|NCT03706079|473417478|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
131487660|NCT03706079|473417479|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
131487661|NCT03706079|473417474|FG000|Long Term Extension (DESTINATION)|Death|8|||
131487662|NCT03706079|473417475|FG001|Long Term Extension (DESTINATION)|Death|2|||
131487663|NCT03706079|473417476|FG002|Long Term Extension (DESTINATION)|Death|2|||
131487664|NCT03706079|473417477|FG003|Long Term Extension (DESTINATION)|Death|1|||
131487665|NCT03706079|473417478|FG004|Long Term Extension (DESTINATION)|Death|0|||
131487666|NCT03706079|473417479|FG005|Long Term Extension (DESTINATION)|Death|0|||
131487667|NCT00968513|473417480|FG000|Overall Study|Death|4|||
131487668|NCT00968513|473417481|FG001|Overall Study|Death|10|||
131487669|NCT00968513|473417482|FG002|Overall Study|Death|15|||
131487670|NCT05379231|473417483|FG000|Home Visit|Withdrawal by Subject|2|||
131487671|NCT05379231|473417483|FG000|In-lab Visit|Withdrawal by Subject|2|||
131487672|NCT01203098|473417490|FG000|Overall Study|Adverse Event|3|||
131487673|NCT01203098|473417491|FG001|Overall Study|Adverse Event|1|||
131487674|NCT01203098|473417492|FG002|Overall Study|Adverse Event|7|||
131487675|NCT01203098|473417490|FG000|Overall Study|Lost to Follow-up|0|||
131487676|NCT01203098|473417491|FG001|Overall Study|Lost to Follow-up|0|||
131487677|NCT01203098|473417492|FG002|Overall Study|Lost to Follow-up|1|||
131487678|NCT01203098|473417490|FG000|Overall Study|Physician Decision|2|||
131487679|NCT01203098|473417491|FG001|Overall Study|Physician Decision|2|||
131487680|NCT01203098|473417492|FG002|Overall Study|Physician Decision|0|||
131487681|NCT01203098|473417490|FG000|Overall Study|Withdrawal by Subject|1|||
131487682|NCT01203098|473417491|FG001|Overall Study|Withdrawal by Subject|1|||
131487683|NCT01203098|473417492|FG002|Overall Study|Withdrawal by Subject|3|||
131487684|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
131487685|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
131487686|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
131487687|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
131487688|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
131487689|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
131487690|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
131487691|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
131487692|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
131487693|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
131487694|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
131487695|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
131487696|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
131487697|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
131487698|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
131487699|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
131487700|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
131487701|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
131487702|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
131487703|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
131487704|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
131487705|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
131487706|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
131487707|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
131487708|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
131487709|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
131487710|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
131487711|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
131487712|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
131487713|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
131487714|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
131487715|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
131487716|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
131487717|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
131487718|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
131487719|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
131487720|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
131487721|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
131487722|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
131487723|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
131487724|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
131487725|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
131487726|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
131487727|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
131487728|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
131487729|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
131487730|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
131487731|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
131487732|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
131487733|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
131487734|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
131487735|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
131487736|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
131487737|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
131487738|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
131487739|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
131487740|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
131487741|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
131487742|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
131487743|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
131487744|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
131487745|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
131487746|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
131487747|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
131487748|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
131487749|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
131487750|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
131487751|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
131487752|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
131487753|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
131487754|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Change of location|0|||
131487755|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Change of location|0|||
131487756|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Change of location|0|||
131487757|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Change of location|1|||
131487758|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Change of location|0|||
131487759|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
131487760|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
131487761|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
131487762|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
131487763|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
131487764|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
131487765|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
131487766|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
131487767|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
131487768|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
131487769|NCT00730405|473417493|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
131487770|NCT00730405|473417494|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
131487771|NCT00730405|473417495|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
131487772|NCT00730405|473417496|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
131487773|NCT00730405|473417497|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
131487774|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
131487775|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
131487776|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
131487777|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
131487778|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
131487779|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
131487780|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
131487781|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
131487782|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
131487783|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
131487784|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
131487785|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
131487786|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
131487787|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
131487788|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
131487789|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Death|0|||
131487790|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Death|1|||
131487791|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Death|0|||
131487792|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Death|1|||
131487793|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Death|0|||
131487794|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Change of location|1|||
131487795|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Change of location|1|||
131487796|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Change of location|0|||
131487797|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Change of location|1|||
131487798|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Change of location|0|||
131487799|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
131487800|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
131487801|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
131487802|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
131487803|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
131487804|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
131487805|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
131487806|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
131487807|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
131487808|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
131487809|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
131487810|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
131487811|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
131487812|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
131487813|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
131487814|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
131487815|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
131487816|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
131487817|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
131487818|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
131487819|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
131487820|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
131487821|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
131487822|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
131487823|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
131487824|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
131487825|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
131487826|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
131487827|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
131487828|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
131487829|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
131487830|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
131487831|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
131487832|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
131487833|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
131487834|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
131487835|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
131487836|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
131487837|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
131487838|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
131487839|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
131487840|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
131487841|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
131487842|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
131487843|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
131487844|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
131487845|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
131487846|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
131487847|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
131487848|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
131487849|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Missing|0|||
131487850|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Missing|0|||
131487851|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Missing|2|||
131487852|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Missing|0|||
131487853|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Missing|0|||
131487854|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
131487855|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
131487856|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
131487857|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
131487858|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
131487859|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
131487860|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
131487861|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
131487862|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
131487863|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
131487864|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
131487865|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
131487866|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
131487867|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
131487868|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
131487869|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
131487870|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
131487871|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
131487872|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
131487873|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
131487874|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
131487875|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
131487876|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
131487877|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
131487878|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
131487879|NCT00730405|473417493|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
131487880|NCT00730405|473417494|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
131487881|NCT00730405|473417495|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
131487882|NCT00730405|473417496|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
131487883|NCT00730405|473417497|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
131487884|NCT03851705|473417503|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
131487885|NCT03851705|473417504|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131487886|NCT03851705|473417505|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131487887|NCT03851705|473417506|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131487888|NCT03851705|473417503|FG000|Part 1: Double-Blind Period|Other reason|1|||
131487889|NCT03851705|473417504|FG001|Part 1: Double-Blind Period|Other reason|0|||
131487890|NCT03851705|473417505|FG002|Part 1: Double-Blind Period|Other reason|0|||
131487891|NCT03851705|473417506|FG003|Part 1: Double-Blind Period|Other reason|0|||
131487892|NCT03851705|473417503|FG000|Part 2: Open-Label Period|Other reason|0|||
131487893|NCT03851705|473417504|FG001|Part 2: Open-Label Period|Other reason|0|||
131487894|NCT03851705|473417505|FG002|Part 2: Open-Label Period|Other reason|0|||
131487895|NCT03851705|473417506|FG003|Part 2: Open-Label Period|Other reason|1|||
131487896|NCT03851705|473417503|FG000|Part 2: Open-Label Period|Death|0|||
131487897|NCT03851705|473417504|FG001|Part 2: Open-Label Period|Death|0|||
131487898|NCT03851705|473417505|FG002|Part 2: Open-Label Period|Death|3|||
131487899|NCT03851705|473417506|FG003|Part 2: Open-Label Period|Death|0|||
131487900|NCT03851705|473417503|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
131487901|NCT03851705|473417504|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
131487902|NCT03851705|473417505|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
131487903|NCT03851705|473417506|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
131487904|NCT01496807|473417507|FG000|Overall Study|Progressive Disease|21|||
131487905|NCT01496807|473417507|FG000|Overall Study|Participant preference/toxicity|8|||
131487906|NCT01496807|473417507|FG000|Overall Study|Change in diagnosis|1|||
131487907|NCT03095612|473417514|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
131487908|NCT03095612|473417515|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
131487909|NCT03095612|473417516|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
131487910|NCT03095612|473417517|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
131487911|NCT03095612|473417518|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
131487912|NCT03095612|473417519|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
131487913|NCT03095612|473417520|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
131487914|NCT02591290|473417523|FG000|Overall Study|Withdrawal by Subject|2|||
131487915|NCT01306942|473417524|FG000|Phase I|Adverse Event|2|||
131487916|NCT01306942|473417525|FG001|Phase I|Adverse Event|2|||
131487917|NCT01306942|473417526|FG002|Phase I|Adverse Event|0|||
131487918|NCT01306942|473417527|FG003|Phase I|Adverse Event|0|||
131487919|NCT01306942|473417524|FG000|Phase I|Physician Decision|3|||
131487920|NCT01306942|473417525|FG001|Phase I|Physician Decision|1|||
131487921|NCT01306942|473417526|FG002|Phase I|Physician Decision|0|||
131487922|NCT01306942|473417527|FG003|Phase I|Physician Decision|0|||
131487923|NCT01306942|473417524|FG000|Phase II|Adverse Event|0|||
131487924|NCT01306942|473417525|FG001|Phase II|Adverse Event|0|||
131487925|NCT01306942|473417526|FG002|Phase II|Adverse Event|0|||
131487926|NCT01306942|473417527|FG003|Phase II|Adverse Event|6|||
131487927|NCT01306942|473417524|FG000|Phase II|Physician Decision|2|||
131487928|NCT01306942|473417525|FG001|Phase II|Physician Decision|0|||
131487929|NCT01306942|473417526|FG002|Phase II|Physician Decision|0|||
131487930|NCT01306942|473417527|FG003|Phase II|Physician Decision|5|||
131487931|NCT01306942|473417524|FG000|Phase II|Withdrawal by Subject|0|||
131487932|NCT01306942|473417525|FG001|Phase II|Withdrawal by Subject|0|||
131487933|NCT01306942|473417526|FG002|Phase II|Withdrawal by Subject|0|||
131487934|NCT01306942|473417527|FG003|Phase II|Withdrawal by Subject|2|||
131487935|NCT01306942|473417524|FG000|Phase II|Death|0|||
131487936|NCT01306942|473417525|FG001|Phase II|Death|0|||
131487937|NCT01306942|473417526|FG002|Phase II|Death|0|||
131487938|NCT01306942|473417527|FG003|Phase II|Death|1|||
131487939|NCT01306942|473417524|FG000|Phase II|Not finished treatment|0|||
131487940|NCT01306942|473417525|FG001|Phase II|Not finished treatment|0|||
131487941|NCT01306942|473417526|FG002|Phase II|Not finished treatment|0|||
131487942|NCT01306942|473417527|FG003|Phase II|Not finished treatment|1|||
131487943|NCT01306942|473417524|FG000|Phase II|Protocol Violation|0|||
131487944|NCT01306942|473417525|FG001|Phase II|Protocol Violation|0|||
131487945|NCT01306942|473417526|FG002|Phase II|Protocol Violation|0|||
131487946|NCT01306942|473417527|FG003|Phase II|Protocol Violation|1|||
131487947|NCT01390649|473417528|FG000|Overall Study|Physician Decision|1|||
131487948|NCT00781274|473417529|FG000|Overall Study|Withdrawal by Subject|2|||
131487949|NCT02021773|473417530|FG000|Overall Study|Adverse Event|1|||
131487950|NCT02021773|473417531|FG001|Overall Study|Adverse Event|4|||
131487951|NCT02021773|473417532|FG002|Overall Study|Adverse Event|3|||
131487952|NCT02021773|473417530|FG000|Overall Study|Lack of Efficacy|2|||
131487953|NCT02021773|473417531|FG001|Overall Study|Lack of Efficacy|2|||
131487954|NCT02021773|473417532|FG002|Overall Study|Lack of Efficacy|2|||
131487955|NCT02021773|473417530|FG000|Overall Study|Protocol Violation|2|||
131487956|NCT02021773|473417531|FG001|Overall Study|Protocol Violation|3|||
131487957|NCT02021773|473417532|FG002|Overall Study|Protocol Violation|1|||
131487958|NCT02021773|473417530|FG000|Overall Study|Withdrawal by Subject|3|||
131487959|NCT02021773|473417531|FG001|Overall Study|Withdrawal by Subject|4|||
131487960|NCT02021773|473417532|FG002|Overall Study|Withdrawal by Subject|5|||
131487961|NCT02021773|473417530|FG000|Overall Study|Lost to Follow-up|1|||
131487962|NCT02021773|473417531|FG001|Overall Study|Lost to Follow-up|3|||
131487963|NCT02021773|473417532|FG002|Overall Study|Lost to Follow-up|0|||
131487964|NCT02021773|473417530|FG000|Overall Study|Reason not specified|3|||
131487965|NCT02021773|473417531|FG001|Overall Study|Reason not specified|0|||
131487966|NCT02021773|473417532|FG002|Overall Study|Reason not specified|0|||
131487967|NCT02243696|473417533|FG000|Overall Study|Death|282|||
131487968|NCT02243696|473417533|FG000|Overall Study|Withdrawal by Subject|79|||
131487969|NCT02243696|473417533|FG000|Overall Study|Lost to Follow-up|57|||
131487970|NCT02243696|473417533|FG000|Overall Study|Subject No Longer has Study System|42|||
131487971|NCT02243696|473417533|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
131487972|NCT02243696|473417533|FG000|Overall Study|Study Terminated for EP PASSION|961|||
131487973|NCT01534962|473417534|FG000|Overall Study|Randomized but did not start treatment|2|||
131487974|NCT01534962|473417535|FG001|Overall Study|Randomized but did not start treatment|0|||
131487975|NCT01534962|473417536|FG002|Overall Study|Randomized but did not start treatment|0|||
131487976|NCT01534962|473417537|FG003|Overall Study|Randomized but did not start treatment|1|||
131487977|NCT01534962|473417534|FG000|Overall Study|Discontinued at AF recurrence|35|||
131487978|NCT01534962|473417535|FG001|Overall Study|Discontinued at AF recurrence|26|||
131487979|NCT01534962|473417536|FG002|Overall Study|Discontinued at AF recurrence|24|||
131487980|NCT01534962|473417537|FG003|Overall Study|Discontinued at AF recurrence|31|||
131487981|NCT00191269|473417538|FG000|Overall Study|Protocol Violation|0|||
131487982|NCT00191269|473417539|FG001|Overall Study|Protocol Violation|2|||
131487983|NCT00191269|473417538|FG000|Overall Study|Adverse Event|1|||
131487984|NCT00191269|473417539|FG001|Overall Study|Adverse Event|4|||
131487985|NCT00191269|473417538|FG000|Overall Study|Progression of Disease|4|||
131487986|NCT00191269|473417539|FG001|Overall Study|Progression of Disease|42|||
131487987|NCT00191269|473417538|FG000|Overall Study|Lack of Efficacy|1|||
131487988|NCT00191269|473417539|FG001|Overall Study|Lack of Efficacy|5|||
131487989|NCT00191269|473417538|FG000|Overall Study|Withdrawal by Subject|0|||
131487990|NCT00191269|473417539|FG001|Overall Study|Withdrawal by Subject|1|||
131487991|NCT00191269|473417538|FG000|Overall Study|Pathologic Aggrevation|0|||
131487992|NCT00191269|473417539|FG001|Overall Study|Pathologic Aggrevation|1|||
131487993|NCT00191269|473417538|FG000|Overall Study|Physician Decision|0|||
131487994|NCT00191269|473417539|FG001|Overall Study|Physician Decision|3|||
131487995|NCT04528732|473417551|FG000|Overall Study|Death|1|||
131487996|NCT04528732|473417552|FG001|Overall Study|Death|0|||
131487997|NCT04528732|473417553|FG002|Overall Study|Death|1|||
131487998|NCT04528732|473417551|FG000|Overall Study|Lost to Follow-up|0|||
131487999|NCT04528732|473417552|FG001|Overall Study|Lost to Follow-up|1|||
131488000|NCT04528732|473417553|FG002|Overall Study|Lost to Follow-up|2|||
131488001|NCT02094677|473417554|FG000|Overall Study|Screening|3|||
131488002|NCT02094677|473417555|FG001|Overall Study|Screening|1|||
131488003|NCT03408483|473417556|FG000|Overall Study|Physician Decision|3|||
131488004|NCT03408483|473417557|FG001|Overall Study|Physician Decision|3|||
131488005|NCT03408483|473417556|FG000|Overall Study|Lost to Follow-up|3|||
131488006|NCT03408483|473417557|FG001|Overall Study|Lost to Follow-up|0|||
131488007|NCT05399641|473417558|FG000|Overall Study|Adverse Event|0|||
131488008|NCT05399641|473417559|FG001|Overall Study|Adverse Event|1|||
131488009|NCT05399641|473417560|FG002|Overall Study|Adverse Event|1|||
131488010|NCT05399641|473417558|FG000|Overall Study|Lost to Follow-up|1|||
131488011|NCT05399641|473417559|FG001|Overall Study|Lost to Follow-up|2|||
131488012|NCT05399641|473417560|FG002|Overall Study|Lost to Follow-up|2|||
131488013|NCT05399641|473417558|FG000|Overall Study|Physician Decision|1|||
131488014|NCT05399641|473417559|FG001|Overall Study|Physician Decision|3|||
131488015|NCT05399641|473417560|FG002|Overall Study|Physician Decision|3|||
131488016|NCT05399641|473417558|FG000|Overall Study|Withdrawal by Subject|4|||
131488017|NCT05399641|473417559|FG001|Overall Study|Withdrawal by Subject|11|||
131488018|NCT05399641|473417560|FG002|Overall Study|Withdrawal by Subject|7|||
131488019|NCT05399641|473417558|FG000|Overall Study|Reason not defined|3|||
131488020|NCT05399641|473417559|FG001|Overall Study|Reason not defined|5|||
131488021|NCT05399641|473417560|FG002|Overall Study|Reason not defined|6|||
131488022|NCT01300650|473417561|FG000|Overall Study|Adverse Event|1|||
131488023|NCT01702961|473417562|FG000|Overall Study|Additional treatment|3|||
131488024|NCT01702961|473417562|FG000|Overall Study|Progressive disease|5|||
131488025|NCT01702961|473417562|FG000|Overall Study|Relapse|20|||
131488026|NCT01702961|473417562|FG000|Overall Study|Death|6|||
131488027|NCT01702961|473417562|FG000|Overall Study|Lost to Follow-up|2|||
131488028|NCT01702961|473417562|FG000|Overall Study|Ongoing|11|||
131488029|NCT00668707|473417565|FG000|Overall Study|Cancer Recurrence|58|||
131488030|NCT00668707|473417566|FG001|Overall Study|Cancer Recurrence|58|||
131488031|NCT00668707|473417565|FG000|Overall Study|Withdrawal by Subject|117|||
131488032|NCT00668707|473417566|FG001|Overall Study|Withdrawal by Subject|100|||
131488033|NCT00668707|473417565|FG000|Overall Study|Lost to Follow-up|3|||
131488034|NCT00668707|473417566|FG001|Overall Study|Lost to Follow-up|6|||
131488035|NCT00668707|473417565|FG000|Overall Study|Protocol Violation|10|||
131488036|NCT00668707|473417566|FG001|Overall Study|Protocol Violation|12|||
131488037|NCT00668707|473417565|FG000|Overall Study|Death|11|||
131488038|NCT00668707|473417566|FG001|Overall Study|Death|4|||
131488039|NCT00674362|473417567|FG000|Double Blind|Adverse Event|6|||
131488040|NCT00674362|473417568|FG001|Double Blind|Adverse Event|6|||
131488041|NCT00674362|473417567|FG000|Double Blind|Lack of Efficacy|2|||
131488042|NCT00674362|473417568|FG001|Double Blind|Lack of Efficacy|6|||
131488043|NCT00674362|473417567|FG000|Double Blind|Loss of efficacy|0|||
131488044|NCT00674362|473417568|FG001|Double Blind|Loss of efficacy|1|||
131488045|NCT00674362|473417567|FG000|Double Blind|Withdrawal by Subject|4|||
131488046|NCT00674362|473417568|FG001|Double Blind|Withdrawal by Subject|3|||
131488047|NCT00674362|473417567|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
131488048|NCT00674362|473417568|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
131488049|NCT00674362|473417567|FG000|Double Blind|Other: Surgery|0|||
131488050|NCT00674362|473417568|FG001|Double Blind|Other: Surgery|1|||
131488051|NCT00674362|473417567|FG000|Open Label|Adverse Event|1|||
131488052|NCT00674362|473417568|FG001|Open Label|Adverse Event|0|||
131488053|NCT00674362|473417567|FG000|Open Label|Other: Subject moved to extension study|1|||
131488054|NCT00674362|473417568|FG001|Open Label|Other: Subject moved to extension study|0|||
131488055|NCT00923156|473417569|FG000|Overall Study|Adverse Event|0|||
131488056|NCT00923156|473417570|FG001|Overall Study|Adverse Event|2|||
131488057|NCT00923156|473417571|FG002|Overall Study|Adverse Event|1|||
131488058|NCT00923156|473417569|FG000|Overall Study|Abnormal laboratory values|0|||
131488059|NCT00923156|473417570|FG001|Overall Study|Abnormal laboratory values|0|||
131488060|NCT00923156|473417571|FG002|Overall Study|Abnormal laboratory values|1|||
131488061|NCT00923156|473417569|FG000|Overall Study|Withdrawal by Subject|0|||
131488062|NCT00923156|473417570|FG001|Overall Study|Withdrawal by Subject|1|||
131488063|NCT00923156|473417571|FG002|Overall Study|Withdrawal by Subject|0|||
131488064|NCT00923156|473417569|FG000|Overall Study|Death|0|||
131488065|NCT00923156|473417570|FG001|Overall Study|Death|1|||
131488066|NCT00923156|473417571|FG002|Overall Study|Death|0|||
131488067|NCT00923156|473417569|FG000|Overall Study|Lack of Efficacy|0|||
131488068|NCT00923156|473417570|FG001|Overall Study|Lack of Efficacy|0|||
131488069|NCT00923156|473417571|FG002|Overall Study|Lack of Efficacy|1|||
131488070|NCT04066023|473417574|FG000|Overall Study|Adverse Event|0|||
131488071|NCT04066023|473417575|FG001|Overall Study|Adverse Event|0|||
131488072|NCT04066023|473417576|FG002|Overall Study|Adverse Event|1|||
131488073|NCT04066023|473417574|FG000|Overall Study|Sponsor decision|3|||
131488074|NCT04066023|473417575|FG001|Overall Study|Sponsor decision|6|||
131488075|NCT04066023|473417576|FG002|Overall Study|Sponsor decision|2|||
131488076|NCT04066023|473417574|FG000|Overall Study|Physician Decision|0|||
131488077|NCT04066023|473417575|FG001|Overall Study|Physician Decision|0|||
131488078|NCT04066023|473417576|FG002|Overall Study|Physician Decision|1|||
131488079|NCT04066023|473417574|FG000|Overall Study|Lost to Follow-up|0|||
131488080|NCT04066023|473417575|FG001|Overall Study|Lost to Follow-up|1|||
131488081|NCT04066023|473417576|FG002|Overall Study|Lost to Follow-up|1|||
131488082|NCT04066023|473417574|FG000|Overall Study|Noncompliance|0|||
131488083|NCT04066023|473417575|FG001|Overall Study|Noncompliance|1|||
131488084|NCT04066023|473417576|FG002|Overall Study|Noncompliance|1|||
131488085|NCT03386448|473417577|FG000|Overall Study|Adverse Event|0|||
131488086|NCT03386448|473417578|FG001|Overall Study|Adverse Event|2|||
131488087|NCT03583697|473417579|FG000|Overall Study|Withdrawal by Subject|0|||
131488088|NCT03583697|473417580|FG001|Overall Study|Withdrawal by Subject|0|||
131488089|NCT03583697|473417581|FG002|Overall Study|Withdrawal by Subject|1|||
131488090|NCT03583697|473417579|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
131488091|NCT03583697|473417580|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
131488092|NCT03583697|473417581|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
131488093|NCT00114530|473417582|FG000|Overall Study|Death|3|||
131488094|NCT00114530|473417583|FG001|Overall Study|Death|11|||
131488095|NCT00114530|473417582|FG000|Overall Study|Lost to Follow-up|1|||
131488096|NCT00114530|473417583|FG001|Overall Study|Lost to Follow-up|1|||
131488097|NCT00114530|473417582|FG000|Overall Study|Physician Decision|1|||
131488098|NCT00114530|473417583|FG001|Overall Study|Physician Decision|1|||
131488099|NCT00114530|473417582|FG000|Overall Study|Withdrawal by Subject|2|||
131488100|NCT00114530|473417583|FG001|Overall Study|Withdrawal by Subject|6|||
131488101|NCT00114530|473417582|FG000|Overall Study|Breast Cancer|1|||
131488102|NCT00114530|473417583|FG001|Overall Study|Breast Cancer|0|||
131488103|NCT00114530|473417582|FG000|Overall Study|Subject decision after endpoint failure|0|||
131488104|NCT00114530|473417583|FG001|Overall Study|Subject decision after endpoint failure|1|||
131488105|NCT00114530|473417582|FG000|Overall Study|Ineligible|1|||
131488106|NCT00114530|473417583|FG001|Overall Study|Ineligible|0|||
131488107|NCT02538029|473417584|FG000|Overall Study|unable to complete cognitive assessments|1|||
131488108|NCT02538029|473417585|FG001|Overall Study|unable to complete cognitive assessments|0|||
131488109|NCT02538029|473417586|FG002|Overall Study|unable to complete cognitive assessments|1|||
131488110|NCT01064310|473417587|FG000|Period 1|Adverse Event|7|||
131488111|NCT01064310|473417588|FG001|Period 1|Adverse Event|10|||
131488112|NCT01064310|473417589|FG002|Period 1|Adverse Event|0|||
131488113|NCT01064310|473417587|FG000|Period 1|Physician Decision|1|||
131488114|NCT01064310|473417588|FG001|Period 1|Physician Decision|0|||
131488115|NCT01064310|473417589|FG002|Period 1|Physician Decision|0|||
131488116|NCT01064310|473417587|FG000|Period 1|Withdrawal by Subject|2|||
131488117|NCT01064310|473417588|FG001|Period 1|Withdrawal by Subject|2|||
131488118|NCT01064310|473417589|FG002|Period 1|Withdrawal by Subject|0|||
131488119|NCT01064310|473417587|FG000|Period 1|Lack of Efficacy|3|||
131488120|NCT01064310|473417588|FG001|Period 1|Lack of Efficacy|5|||
131488121|NCT01064310|473417589|FG002|Period 1|Lack of Efficacy|0|||
131488122|NCT01064310|473417587|FG000|Period 1|Entered Open-label Period|1|||
131488123|NCT01064310|473417588|FG001|Period 1|Entered Open-label Period|1|||
131488124|NCT01064310|473417589|FG002|Period 1|Entered Open-label Period|0|||
131488125|NCT01064310|473417587|FG000|Period 2|Adverse Event|2|||
131488126|NCT01064310|473417588|FG001|Period 2|Adverse Event|1|||
131488127|NCT01064310|473417589|FG002|Period 2|Adverse Event|0|||
131488128|NCT01064310|473417587|FG000|Period 2|Physician Decision|0|||
131488129|NCT01064310|473417588|FG001|Period 2|Physician Decision|1|||
131488130|NCT01064310|473417589|FG002|Period 2|Physician Decision|0|||
131488131|NCT01064310|473417587|FG000|Period 2|Entered Open-label Period|1|||
131488132|NCT01064310|473417588|FG001|Period 2|Entered Open-label Period|0|||
131488133|NCT01064310|473417589|FG002|Period 2|Entered Open-label Period|0|||
131488134|NCT01064310|473417587|FG000|Period 2|Lack of Efficacy|1|||
131488135|NCT01064310|473417588|FG001|Period 2|Lack of Efficacy|4|||
131488136|NCT01064310|473417589|FG002|Period 2|Lack of Efficacy|0|||
131488137|NCT01064310|473417587|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
131488138|NCT01064310|473417588|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
131488139|NCT01064310|473417589|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
131488140|NCT01064310|473417587|FG000|Open Label Pazopinib|Adverse Event|0|||
131488141|NCT01064310|473417588|FG001|Open Label Pazopinib|Adverse Event|0|||
131488142|NCT01064310|473417589|FG002|Open Label Pazopinib|Adverse Event|12|||
131488143|NCT01064310|473417587|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
131488144|NCT01064310|473417588|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
131488145|NCT01064310|473417589|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
131488146|NCT01064310|473417587|FG000|Open Label Pazopinib|Physician Decision|0|||
131488147|NCT01064310|473417588|FG001|Open Label Pazopinib|Physician Decision|0|||
131488148|NCT01064310|473417589|FG002|Open Label Pazopinib|Physician Decision|20|||
131488149|NCT00679432|473417590|FG000|Overall Study|Adverse Event|5|||
131488150|NCT00679432|473417591|FG001|Overall Study|Adverse Event|6|||
131488151|NCT00679432|473417592|FG002|Overall Study|Adverse Event|10|||
131488152|NCT00679432|473417593|FG003|Overall Study|Adverse Event|7|||
131488153|NCT00679432|473417590|FG000|Overall Study|Protocol Violation|1|||
131488154|NCT00679432|473417591|FG001|Overall Study|Protocol Violation|1|||
131488155|NCT00679432|473417592|FG002|Overall Study|Protocol Violation|2|||
131488156|NCT00679432|473417593|FG003|Overall Study|Protocol Violation|1|||
131488157|NCT00679432|473417590|FG000|Overall Study|Withdrawal by Subject|8|||
131488158|NCT00679432|473417591|FG001|Overall Study|Withdrawal by Subject|11|||
131488159|NCT00679432|473417592|FG002|Overall Study|Withdrawal by Subject|10|||
131488160|NCT00679432|473417593|FG003|Overall Study|Withdrawal by Subject|9|||
131488161|NCT00679432|473417590|FG000|Overall Study|Lost to Follow-up|1|||
131488162|NCT00679432|473417591|FG001|Overall Study|Lost to Follow-up|5|||
131488163|NCT00679432|473417592|FG002|Overall Study|Lost to Follow-up|4|||
131488164|NCT00679432|473417593|FG003|Overall Study|Lost to Follow-up|2|||
131488165|NCT00679432|473417590|FG000|Overall Study|Physician Decision|3|||
131488166|NCT00679432|473417591|FG001|Overall Study|Physician Decision|2|||
131488167|NCT00679432|473417592|FG002|Overall Study|Physician Decision|2|||
131488168|NCT00679432|473417593|FG003|Overall Study|Physician Decision|2|||
131488169|NCT00679432|473417590|FG000|Overall Study|Sponsor decision|1|||
131488170|NCT00679432|473417591|FG001|Overall Study|Sponsor decision|0|||
131488171|NCT00679432|473417592|FG002|Overall Study|Sponsor decision|0|||
131488172|NCT00679432|473417593|FG003|Overall Study|Sponsor decision|0|||
131488173|NCT00679432|473417590|FG000|Overall Study|Lack of Efficacy|13|||
131488174|NCT00679432|473417591|FG001|Overall Study|Lack of Efficacy|9|||
131488175|NCT00679432|473417592|FG002|Overall Study|Lack of Efficacy|14|||
131488176|NCT00679432|473417593|FG003|Overall Study|Lack of Efficacy|8|||
131488177|NCT00679432|473417590|FG000|Overall Study|Infectious colitis, normal histology|5|||
131488178|NCT00679432|473417591|FG001|Overall Study|Infectious colitis, normal histology|4|||
131488179|NCT00679432|473417592|FG002|Overall Study|Infectious colitis, normal histology|8|||
131488180|NCT00679432|473417593|FG003|Overall Study|Infectious colitis, normal histology|3|||
131488181|NCT00679432|473417590|FG000|Overall Study|Randomization error, return to prior Rx|0|||
131488182|NCT00679432|473417591|FG001|Overall Study|Randomization error, return to prior Rx|0|||
131488183|NCT00679432|473417592|FG002|Overall Study|Randomization error, return to prior Rx|3|||
131488184|NCT00679432|473417593|FG003|Overall Study|Randomization error, return to prior Rx|0|||
131488185|NCT02339584|473417594|FG000|Overall Study|Adverse Event|11|||
131488186|NCT02339584|473417595|FG001|Overall Study|Adverse Event|7|||
131488187|NCT02339584|473417594|FG000|Overall Study|Lack of Efficacy|0|||
131488188|NCT02339584|473417595|FG001|Overall Study|Lack of Efficacy|1|||
131488189|NCT02339584|473417594|FG000|Overall Study|Physician Decision|1|||
131488190|NCT02339584|473417595|FG001|Overall Study|Physician Decision|2|||
131488191|NCT02339584|473417594|FG000|Overall Study|Protocol Violation|1|||
131488192|NCT02339584|473417595|FG001|Overall Study|Protocol Violation|1|||
131488193|NCT02339584|473417594|FG000|Overall Study|Withdrawal by Subject|2|||
131488194|NCT02339584|473417595|FG001|Overall Study|Withdrawal by Subject|4|||
131488195|NCT01980940|473417596|FG000|Overall Study|Protocol Violation|0|||
131488196|NCT01980940|473417597|FG001|Overall Study|Protocol Violation|0|||
131488197|NCT01980940|473417598|FG002|Overall Study|Protocol Violation|0|||
131488198|NCT01980940|473417599|FG003|Overall Study|Protocol Violation|0|||
131488199|NCT01980940|473417600|FG004|Overall Study|Protocol Violation|0|||
131488200|NCT01980940|473417601|FG005|Overall Study|Protocol Violation|2|||
131488201|NCT01980940|473417602|FG006|Overall Study|Protocol Violation|0|||
131488202|NCT01980940|473417603|FG007|Overall Study|Protocol Violation|0|||
131488203|NCT04731363|473417605|FG000|Overall Study|Could not obtain samples|0|||
131488204|NCT04731363|473417606|FG001|Overall Study|Could not obtain samples|1|||
131488205|NCT04731363|473417607|FG002|Overall Study|Could not obtain samples|0|||
131488206|NCT04731363|473417608|FG003|Overall Study|Could not obtain samples|0|||
131488207|NCT04731363|473417605|FG000|Overall Study|Physician Decision|0|||
131488208|NCT04731363|473417606|FG001|Overall Study|Physician Decision|1|||
131488209|NCT04731363|473417607|FG002|Overall Study|Physician Decision|0|||
131488210|NCT04731363|473417608|FG003|Overall Study|Physician Decision|0|||
131488211|NCT05996718|473418940|FG000|Overall Study|Lost to Follow-up|3|||
131488212|NCT01713686|473418941|FG000|Overall Study|Lost to Follow-up|9|||
131488213|NCT01713686|473418941|FG000|Overall Study|Withdrawal by Subject|6|||
131488214|NCT04840615|473418942|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
131488215|NCT04840615|473418943|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
131488216|NCT04840615|473418944|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
131488217|NCT00967668|473418945|FG000|Overall Study|Withdrawal by Subject|13|||
131488218|NCT00967668|473418946|FG001|Overall Study|Withdrawal by Subject|8|||
131488219|NCT00967668|473418947|FG002|Overall Study|Withdrawal by Subject|8|||
131488220|NCT00967668|473418945|FG000|Overall Study|Death|0|||
131488221|NCT00967668|473418946|FG001|Overall Study|Death|2|||
131488222|NCT00967668|473418947|FG002|Overall Study|Death|4|||
131488223|NCT00967668|473418945|FG000|Overall Study|Removed due to behavior|1|||
131488224|NCT00967668|473418946|FG001|Overall Study|Removed due to behavior|1|||
131488225|NCT00967668|473418947|FG002|Overall Study|Removed due to behavior|2|||
131488226|NCT00967668|473418945|FG000|Overall Study|Refused Year 2|11|||
131488227|NCT00967668|473418946|FG001|Overall Study|Refused Year 2|6|||
131488228|NCT00967668|473418947|FG002|Overall Study|Refused Year 2|4|||
131488229|NCT00967668|473418945|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
131488230|NCT00967668|473418946|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
131433972|NCT03367858|473214564|FG000|6 Month Follow Up|Lost to Follow-up|5|||
131433973|NCT03367858|473214565|FG001|6 Month Follow Up|Lost to Follow-up|2|||
131488231|NCT00967668|473418947|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
131488232|NCT00967668|473418945|FG000|Overall Study|Lost to Follow-up|15|||
131488233|NCT00967668|473418946|FG001|Overall Study|Lost to Follow-up|9|||
131488234|NCT00967668|473418947|FG002|Overall Study|Lost to Follow-up|16|||
131488235|NCT00967668|473418945|FG000|Overall Study|Refused 12-mo assessment|3|||
131488236|NCT00967668|473418946|FG001|Overall Study|Refused 12-mo assessment|1|||
131488237|NCT00967668|473418947|FG002|Overall Study|Refused 12-mo assessment|9|||
131488238|NCT00967668|473418945|FG000|Overall Study|Pregnancy|1|||
131488239|NCT00967668|473418946|FG001|Overall Study|Pregnancy|0|||
131488240|NCT00967668|473418947|FG002|Overall Study|Pregnancy|0|||
131488241|NCT00115739|473418949|FG000|Overall Study|Lost to Follow-up|3|||
131488242|NCT00709761|473418952|FG000|Overall Study|Withdrawal by Subject|8|||
131488243|NCT00709761|473418952|FG000|Overall Study|study closed/terminated|17|||
131488244|NCT00709761|473418952|FG000|Overall Study|Lost to Follow-up|2|||
131488245|NCT01918774|473418953|FG000|Overall Study|Lost prior to first CBTw session|4|||
131488246|NCT01918774|473418953|FG000|Overall Study|Lost to Follow-up|1|||
131488247|NCT01606800|473418954|FG000|Overall Study|Adverse Event|3|||
131488248|NCT01606800|473418955|FG001|Overall Study|Adverse Event|1|||
131488249|NCT01606800|473418954|FG000|Overall Study|Participant withdrew consent|0|||
131488250|NCT01606800|473418955|FG001|Overall Study|Participant withdrew consent|1|||
131488251|NCT01606800|473418954|FG000|Overall Study|Missing completion status|2|||
131488252|NCT01606800|473418955|FG001|Overall Study|Missing completion status|0|||
131488253|NCT01687998|473418956|FG000|Overall Study|Withdrawal by Subject|49|||
131488254|NCT01687998|473418957|FG001|Overall Study|Withdrawal by Subject|51|||
131488255|NCT01687998|473418956|FG000|Overall Study|Known to be Alive at Study End|54|||
131488256|NCT01687998|473418957|FG001|Overall Study|Known to be Alive at Study End|62|||
131488257|NCT01687998|473418956|FG000|Overall Study|Lost to Follow-up|9|||
131488258|NCT01687998|473418957|FG001|Overall Study|Lost to Follow-up|7|||
131488259|NCT00717197|473418964|FG000|Overall Study|Unable to purchase study drug|5|||
131488260|NCT00717197|473418964|FG000|Overall Study|Tumor Progression|1|||
131488261|NCT00717197|473418964|FG000|Overall Study|Physician Decision|1|||
131488262|NCT00982137|473418965|FG000|Overall Study|Lost to Follow-up|0|||
131488263|NCT00982137|473418966|FG001|Overall Study|Lost to Follow-up|0|||
131488264|NCT00982137|473418967|FG002|Overall Study|Lost to Follow-up|0|||
131488265|NCT00982137|473418968|FG003|Overall Study|Lost to Follow-up|1|||
131488266|NCT00982137|473418965|FG000|Overall Study|Withdrawal by Subject|0|||
131488267|NCT00982137|473418966|FG001|Overall Study|Withdrawal by Subject|1|||
131488268|NCT00982137|473418967|FG002|Overall Study|Withdrawal by Subject|0|||
131488269|NCT00982137|473418968|FG003|Overall Study|Withdrawal by Subject|0|||
131488270|NCT03003390|473418969|FG000|Overall Study|Physician Decision|2|||
131488271|NCT03003390|473418970|FG001|Overall Study|Physician Decision|0|||
131488272|NCT03003390|473418969|FG000|Overall Study|Parent refused intervention|2|||
131488273|NCT03003390|473418970|FG001|Overall Study|Parent refused intervention|0|||
131488274|NCT01648101|473418971|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
131488275|NCT01648101|473418972|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
131488276|NCT01648101|473418973|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
131488277|NCT01648101|473418971|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
131488278|NCT01648101|473418972|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
131433974|NCT03367858|473214564|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
131433975|NCT03367858|473214565|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
131433976|NCT03367858|473214564|FG000|12 Month Follow Up|Lost to Follow-up|3|||
131433977|NCT03367858|473214565|FG001|12 Month Follow Up|Lost to Follow-up|3|||
131433978|NCT03367858|473214564|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
131433979|NCT03367858|473214565|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
131433980|NCT01859923|473214576|FG000|Overall Study|Adverse Event|0|||
131433981|NCT01859923|473214577|FG001|Overall Study|Adverse Event|0|||
131433982|NCT01859923|473214578|FG002|Overall Study|Adverse Event|1|||
131433983|NCT01859923|473214579|FG003|Overall Study|Adverse Event|1|||
131433984|NCT02079038|473214586|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
131433985|NCT02079038|473214587|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
131433986|NCT02079038|473214586|FG000|Modified Intent to Treat Population|Death|1|||
131433987|NCT02079038|473214587|FG001|Modified Intent to Treat Population|Death|0|||
131433988|NCT02079038|473214586|FG000|Completed 6 Months|Lost to Follow-up|2|||
131433989|NCT02079038|473214587|FG001|Completed 6 Months|Lost to Follow-up|1|||
131433990|NCT03634085|473214588|FG000|Overall Study|Adverse Event|1|||
131433991|NCT03634085|473214589|FG001|Overall Study|Adverse Event|0|||
131433992|NCT03634085|473214588|FG000|Overall Study|Withdrawal by Subject|0|||
131433993|NCT03634085|473214589|FG001|Overall Study|Withdrawal by Subject|2|||
131488279|NCT01648101|473418973|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
131488280|NCT01648101|473418971|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
131488281|NCT01648101|473418972|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
131488282|NCT01648101|473418973|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
131488283|NCT01648101|473418971|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
131488284|NCT01648101|473418972|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
131488285|NCT01648101|473418973|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
131488286|NCT01648101|473418971|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
131488287|NCT01648101|473418972|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
131488288|NCT01648101|473418973|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
131488289|NCT01648101|473418971|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
131488290|NCT01648101|473418972|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
131488291|NCT01648101|473418973|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
131488292|NCT01648101|473418971|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
131488293|NCT01648101|473418972|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
131488294|NCT01648101|473418973|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
131488295|NCT01648101|473418971|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
131488296|NCT01648101|473418972|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
131488297|NCT01648101|473418973|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
131488298|NCT01648101|473418971|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
131488299|NCT01648101|473418972|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
131488300|NCT01648101|473418973|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
131488301|NCT01648101|473418971|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
131488302|NCT01648101|473418972|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
131488303|NCT01648101|473418973|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
131488304|NCT01648101|473418971|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
131488305|NCT01648101|473418972|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
131488306|NCT01648101|473418973|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
131488307|NCT03311724|473418974|FG000|Overall Study|Physician Decision|0|||
131488308|NCT03311724|473418975|FG001|Overall Study|Physician Decision|0|||
131488309|NCT03311724|473418976|FG002|Overall Study|Physician Decision|0|||
131488310|NCT03311724|473418977|FG003|Overall Study|Physician Decision|1|||
131488311|NCT03311724|473418974|FG000|Overall Study|Protocol Violation|1|||
131488312|NCT03311724|473418975|FG001|Overall Study|Protocol Violation|0|||
131488313|NCT03311724|473418976|FG002|Overall Study|Protocol Violation|1|||
131488314|NCT03311724|473418977|FG003|Overall Study|Protocol Violation|0|||
131488315|NCT03311724|473418974|FG000|Overall Study|Withdrawal by Subject|1|||
131488316|NCT03311724|473418975|FG001|Overall Study|Withdrawal by Subject|1|||
131488317|NCT03311724|473418976|FG002|Overall Study|Withdrawal by Subject|0|||
131488318|NCT03311724|473418977|FG003|Overall Study|Withdrawal by Subject|0|||
131488319|NCT03311724|473418974|FG000|Overall Study|Lost to Follow-up|1|||
131488320|NCT03311724|473418975|FG001|Overall Study|Lost to Follow-up|0|||
131488321|NCT03311724|473418976|FG002|Overall Study|Lost to Follow-up|0|||
131488322|NCT03311724|473418977|FG003|Overall Study|Lost to Follow-up|0|||
131488323|NCT03311724|473418974|FG000|Overall Study|Sponsor Decision|0|||
131488324|NCT03311724|473418975|FG001|Overall Study|Sponsor Decision|0|||
131488325|NCT03311724|473418976|FG002|Overall Study|Sponsor Decision|1|||
131488326|NCT03311724|473418977|FG003|Overall Study|Sponsor Decision|0|||
131488327|NCT00395304|473418984|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131488328|NCT00395304|473418985|FG001|Treatment Period 1|Withdrawal by Subject|3|||
131488329|NCT00395304|473418986|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131488330|NCT00395304|473418987|FG003|Treatment Period 1|Withdrawal by Subject|2|||
131488331|NCT00395304|473418988|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131488332|NCT00395304|473418989|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131488333|NCT00395304|473418984|FG000|Treatment Period 1|Lost to Follow-up|1|||
131488334|NCT00395304|473418985|FG001|Treatment Period 1|Lost to Follow-up|0|||
131488335|NCT00395304|473418986|FG002|Treatment Period 1|Lost to Follow-up|0|||
131488336|NCT00395304|473418987|FG003|Treatment Period 1|Lost to Follow-up|1|||
131488337|NCT00395304|473418988|FG004|Treatment Period 1|Lost to Follow-up|0|||
131488338|NCT00395304|473418989|FG005|Treatment Period 1|Lost to Follow-up|1|||
131488339|NCT00395304|473418984|FG000|Treatment Period 1|Physician Decision|0|||
131488340|NCT00395304|473418985|FG001|Treatment Period 1|Physician Decision|1|||
131488341|NCT00395304|473418986|FG002|Treatment Period 1|Physician Decision|0|||
131488342|NCT00395304|473418987|FG003|Treatment Period 1|Physician Decision|0|||
131488343|NCT00395304|473418988|FG004|Treatment Period 1|Physician Decision|0|||
131488344|NCT00395304|473418989|FG005|Treatment Period 1|Physician Decision|0|||
131488345|NCT00395304|473418984|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131488346|NCT00395304|473418985|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131488347|NCT00395304|473418986|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131488348|NCT00395304|473418987|FG003|Treatment Period 2|Withdrawal by Subject|1|||
131488349|NCT00395304|473418988|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131488350|NCT00395304|473418989|FG005|Treatment Period 2|Withdrawal by Subject|2|||
131488351|NCT00395304|473418984|FG000|Treatment Period 2|Lost to Follow-up|0|||
131488352|NCT00395304|473418985|FG001|Treatment Period 2|Lost to Follow-up|3|||
131488353|NCT00395304|473418986|FG002|Treatment Period 2|Lost to Follow-up|0|||
131488354|NCT00395304|473418987|FG003|Treatment Period 2|Lost to Follow-up|0|||
131488355|NCT00395304|473418988|FG004|Treatment Period 2|Lost to Follow-up|0|||
131488356|NCT00395304|473418989|FG005|Treatment Period 2|Lost to Follow-up|0|||
131488357|NCT00395304|473418984|FG000|Treatment Period 2|Physician Decision|0|||
131488358|NCT00395304|473418985|FG001|Treatment Period 2|Physician Decision|0|||
131488359|NCT00395304|473418986|FG002|Treatment Period 2|Physician Decision|1|||
131488360|NCT00395304|473418987|FG003|Treatment Period 2|Physician Decision|0|||
131488361|NCT00395304|473418988|FG004|Treatment Period 2|Physician Decision|0|||
131488362|NCT00395304|473418989|FG005|Treatment Period 2|Physician Decision|0|||
131488363|NCT00395304|473418984|FG000|Treatment Period 2|Other|0|||
131488364|NCT00395304|473418985|FG001|Treatment Period 2|Other|1|||
131488365|NCT00395304|473418986|FG002|Treatment Period 2|Other|0|||
131488366|NCT00395304|473418987|FG003|Treatment Period 2|Other|0|||
131488367|NCT00395304|473418988|FG004|Treatment Period 2|Other|0|||
131488368|NCT00395304|473418989|FG005|Treatment Period 2|Other|0|||
131488369|NCT00395304|473418984|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131488370|NCT00395304|473418985|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131488371|NCT00395304|473418986|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131488372|NCT00395304|473418987|FG003|Treatment Period 3|Withdrawal by Subject|1|||
131488373|NCT00395304|473418988|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131488374|NCT00395304|473418989|FG005|Treatment Period 3|Withdrawal by Subject|1|||
131488375|NCT00395304|473418984|FG000|Treatment Period 3|Lost to Follow-up|1|||
131488376|NCT00395304|473418985|FG001|Treatment Period 3|Lost to Follow-up|1|||
131488377|NCT00395304|473418986|FG002|Treatment Period 3|Lost to Follow-up|0|||
131488378|NCT00395304|473418987|FG003|Treatment Period 3|Lost to Follow-up|0|||
131488379|NCT00395304|473418988|FG004|Treatment Period 3|Lost to Follow-up|0|||
131488380|NCT00395304|473418989|FG005|Treatment Period 3|Lost to Follow-up|0|||
131488381|NCT00395304|473418984|FG000|Treatment Period 3|Physician Decision|0|||
131488382|NCT00395304|473418985|FG001|Treatment Period 3|Physician Decision|1|||
131488383|NCT00395304|473418986|FG002|Treatment Period 3|Physician Decision|0|||
131488384|NCT00395304|473418987|FG003|Treatment Period 3|Physician Decision|0|||
131488385|NCT00395304|473418988|FG004|Treatment Period 3|Physician Decision|0|||
131488386|NCT00395304|473418989|FG005|Treatment Period 3|Physician Decision|0|||
131488387|NCT00395304|473418984|FG000|Treatment Period 3|Other|0|||
131488388|NCT00395304|473418985|FG001|Treatment Period 3|Other|0|||
131488389|NCT00395304|473418986|FG002|Treatment Period 3|Other|0|||
131488390|NCT00395304|473418987|FG003|Treatment Period 3|Other|1|||
131488391|NCT00395304|473418988|FG004|Treatment Period 3|Other|0|||
131488392|NCT00395304|473418989|FG005|Treatment Period 3|Other|0|||
131488393|NCT00691015|473418990|FG000|Overall Study|Refused further treatment|1|||
131488394|NCT04160195|473418991|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
131488395|NCT04160195|473418992|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
131488396|NCT03068130|473418995|FG000|Overall Study|Adverse Event|19|||
131488397|NCT03068130|473418995|FG000|Overall Study|Death|14|||
131488398|NCT03068130|473418995|FG000|Overall Study|Lost to Follow-up|4|||
131488399|NCT03068130|473418995|FG000|Overall Study|Withdrawal by Subject|26|||
131488400|NCT03068130|473418995|FG000|Overall Study|Administrative Reasons|3|||
131488401|NCT03068130|473418995|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
131488402|NCT03068130|473418995|FG000|Overall Study|Study terminated by sponsor|194|||
131488403|NCT03130257|473418996|FG000|Overall Study|Withdrawal by Subject|1|||
131488404|NCT03130257|473418997|FG001|Overall Study|Withdrawal by Subject|0|||
131488405|NCT03130257|473418998|FG002|Overall Study|Withdrawal by Subject|2|||
131488406|NCT00590720|473418999|FG000|Overall Study|Lost to Follow-up|1|||
131488407|NCT00590720|473419000|FG001|Overall Study|Lost to Follow-up|0|||
131488408|NCT00590720|473418999|FG000|Overall Study|Withdrawal by Subject|0|||
131488409|NCT00590720|473419000|FG001|Overall Study|Withdrawal by Subject|1|||
131488410|NCT00160693|473419001|FG000|Overall Study|Adverse Event|97|||
131488411|NCT00160693|473419001|FG000|Overall Study|Lack of Efficacy|30|||
131488412|NCT00160693|473419001|FG000|Overall Study|Protocol Violation|24|||
131488413|NCT00160693|473419001|FG000|Overall Study|Lost to Follow-up|15|||
131488414|NCT00160693|473419001|FG000|Overall Study|Withdrawal by Subject|54|||
131488415|NCT00160693|473419001|FG000|Overall Study|Study terminated by sponsor|15|||
131488416|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
131488417|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
131488418|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
131488419|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
131488420|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488421|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488422|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488423|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488424|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488425|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488426|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
131488427|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
131488428|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
131488429|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
131488430|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
131488431|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488432|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488433|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488434|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488435|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488436|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488437|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
131488438|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
131488439|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
131488440|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
131488441|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
131488442|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488443|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488444|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488445|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488446|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488447|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488448|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
131488449|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488450|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488451|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488452|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
131488453|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488454|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488455|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488456|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488457|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488458|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488459|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131488460|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
131488461|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
131488462|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
131488463|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
131488464|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488465|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488466|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488467|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488468|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488469|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488470|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
131488471|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
131488472|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
131488473|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
131488474|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
131488475|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488476|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488477|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488478|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488479|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488480|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488481|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
131488482|NCT01847274|473419004|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
131488483|NCT01847274|473419005|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
131488484|NCT01847274|473419006|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
131488485|NCT01847274|473419007|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
131488486|NCT01847274|473419008|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488487|NCT01847274|473419009|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488488|NCT01847274|473419010|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488489|NCT01847274|473419011|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488490|NCT01847274|473419012|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488491|NCT01847274|473419013|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488492|NCT01847274|473419014|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
131488493|NCT01847274|473419004|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488494|NCT01847274|473419005|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488495|NCT01847274|473419006|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488496|NCT01847274|473419007|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488497|NCT01847274|473419008|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488498|NCT01847274|473419009|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
131488499|NCT01847274|473419010|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488500|NCT01847274|473419011|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488501|NCT01847274|473419012|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488502|NCT01847274|473419013|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488503|NCT01847274|473419014|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
131488504|NCT01847274|473419004|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488505|NCT01847274|473419005|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488506|NCT01847274|473419006|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488507|NCT01847274|473419007|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488508|NCT01847274|473419008|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
131488509|NCT01847274|473419009|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488510|NCT01847274|473419010|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488511|NCT01847274|473419011|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488512|NCT01847274|473419012|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488513|NCT01847274|473419013|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488514|NCT01847274|473419014|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
131488515|NCT01847274|473419004|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488516|NCT01847274|473419005|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488517|NCT01847274|473419006|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488518|NCT01847274|473419007|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488519|NCT01847274|473419008|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488520|NCT01847274|473419009|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488521|NCT01847274|473419010|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
131488522|NCT01847274|473419011|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488523|NCT01847274|473419012|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488524|NCT01847274|473419013|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488525|NCT01847274|473419014|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131488526|NCT01847274|473419004|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488527|NCT01847274|473419005|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488528|NCT01847274|473419006|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488529|NCT01847274|473419007|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488530|NCT01847274|473419008|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488531|NCT01847274|473419009|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488532|NCT01847274|473419010|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
131488533|NCT01847274|473419011|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488534|NCT01847274|473419012|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488535|NCT01847274|473419013|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488536|NCT01847274|473419014|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
131488537|NCT01847274|473419004|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488538|NCT01847274|473419005|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488539|NCT01847274|473419006|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488540|NCT01847274|473419007|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488541|NCT01847274|473419008|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488542|NCT01847274|473419009|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488543|NCT01847274|473419010|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
131488544|NCT01847274|473419011|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488545|NCT01847274|473419012|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488546|NCT01847274|473419013|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488547|NCT01847274|473419014|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
131488548|NCT01847274|473419004|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488549|NCT01847274|473419005|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488550|NCT01847274|473419006|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488551|NCT01847274|473419007|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488552|NCT01847274|473419008|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488553|NCT01847274|473419009|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488554|NCT01847274|473419010|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
131488555|NCT01847274|473419011|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
131488556|NCT01847274|473419012|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
131488557|NCT01847274|473419013|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
131488558|NCT01847274|473419014|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
131488559|NCT01847274|473419004|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488560|NCT01847274|473419005|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488561|NCT01847274|473419006|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488562|NCT01847274|473419007|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488563|NCT01847274|473419008|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488564|NCT01847274|473419009|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488565|NCT01847274|473419010|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488566|NCT01847274|473419011|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
131488567|NCT01847274|473419012|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488568|NCT01847274|473419013|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
131488569|NCT01847274|473419014|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
131488570|NCT01847274|473419004|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488571|NCT01847274|473419005|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488572|NCT01847274|473419006|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488573|NCT01847274|473419007|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488574|NCT01847274|473419008|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488575|NCT01847274|473419009|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488576|NCT01847274|473419010|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488577|NCT01847274|473419011|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
131488578|NCT01847274|473419012|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131488579|NCT01847274|473419013|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
131488580|NCT01847274|473419014|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
131488581|NCT01847274|473419004|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488582|NCT01847274|473419005|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488583|NCT01847274|473419006|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488584|NCT01847274|473419007|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488585|NCT01847274|473419008|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488586|NCT01847274|473419009|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488587|NCT01847274|473419010|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488588|NCT01847274|473419011|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488589|NCT01847274|473419012|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488590|NCT01847274|473419013|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
131488591|NCT01847274|473419014|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
131488592|NCT03727230|473419015|FG000|Overall Study|Lost to Follow-up|12|||
131488593|NCT04377620|473419017|FG000|Overall Study|Death|42|||
131488594|NCT04377620|473419018|FG001|Overall Study|Death|48|||
131488595|NCT04377620|473419019|FG002|Overall Study|Death|36|||
131488596|NCT04377620|473419017|FG000|Overall Study|Withdrawal by Subject|0|||
131488597|NCT04377620|473419018|FG001|Overall Study|Withdrawal by Subject|2|||
131488598|NCT04377620|473419019|FG002|Overall Study|Withdrawal by Subject|0|||
131488599|NCT02849678|473419020|FG000|Overall Study|Protocol Violation|3|||
131488600|NCT02849678|473419021|FG001|Overall Study|Protocol Violation|6|||
131488601|NCT00289991|473419023|FG000|Overall Study|Death|35|||
131488602|NCT00289991|473419024|FG001|Overall Study|Death|38|||
131488603|NCT00289991|473419023|FG000|Overall Study|Adverse Event|15|||
131488604|NCT00289991|473419024|FG001|Overall Study|Adverse Event|13|||
131488605|NCT00289991|473419023|FG000|Overall Study|Failure of prophylaxis|1|||
131488606|NCT00289991|473419024|FG001|Overall Study|Failure of prophylaxis|1|||
131488607|NCT00289991|473419023|FG000|Overall Study|Fungal breakthrough infection|0|||
131488608|NCT00289991|473419024|FG001|Overall Study|Fungal breakthrough infection|1|||
131488609|NCT00289991|473419023|FG000|Overall Study|Lost to Follow-up|0|||
131488610|NCT00289991|473419024|FG001|Overall Study|Lost to Follow-up|1|||
131488611|NCT00289991|473419023|FG000|Overall Study|Withdrawal by Subject|2|||
131488612|NCT00289991|473419024|FG001|Overall Study|Withdrawal by Subject|12|||
131488613|NCT00289991|473419023|FG000|Overall Study|Other|5|||
131488614|NCT00289991|473419024|FG001|Overall Study|Other|14|||
131488615|NCT03733470|473419030|FG000|Overall Study|PI Decision|1|||
131488616|NCT03733470|473419031|FG001|Overall Study|PI Decision|1|||
131488617|NCT01010061|473419032|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
131488618|NCT01010061|473419033|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
131488619|NCT01010061|473419032|FG000|Overall Study|Disease Progression|2|||
131488620|NCT01010061|473419033|FG001|Overall Study|Disease Progression|8|||
131488621|NCT01010061|473419032|FG000|Overall Study|Withdrew Consent|5|||
131488622|NCT01010061|473419033|FG001|Overall Study|Withdrew Consent|1|||
131488623|NCT01010061|473419032|FG000|Overall Study|Death|3|||
131488624|NCT01010061|473419033|FG001|Overall Study|Death|6|||
131488625|NCT01010061|473419032|FG000|Overall Study|Administrative/Other|0|||
131488626|NCT01010061|473419033|FG001|Overall Study|Administrative/Other|1|||
131488627|NCT01010061|473419032|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
131488628|NCT01010061|473419033|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131488629|NCT01010061|473419032|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131488630|NCT01010061|473419033|FG001|Overall Study|Insufficient Therapeutic Response|5|||
131488631|NCT01010061|473419032|FG000|Overall Study|Violation of Selection Criteria|0|||
131488632|NCT01010061|473419033|FG001|Overall Study|Violation of Selection Criteria|1|||
131488633|NCT01010061|473419032|FG000|Overall Study|Did Not Receive Treatment|2|||
131488634|NCT01010061|473419033|FG001|Overall Study|Did Not Receive Treatment|2|||
131488635|NCT03470441|473419034|FG000|Overall Study|Death|0|||
131488636|NCT03470441|473419035|FG001|Overall Study|Death|1|||
131488637|NCT03470441|473419036|FG002|Overall Study|Death|1|||
131488638|NCT03470441|473419037|FG003|Overall Study|Death|0|||
131488639|NCT03470441|473419034|FG000|Overall Study|Adverse Event|0|||
131488640|NCT03470441|473419035|FG001|Overall Study|Adverse Event|0|||
131488641|NCT03470441|473419036|FG002|Overall Study|Adverse Event|0|||
131488642|NCT03470441|473419037|FG003|Overall Study|Adverse Event|1|||
131488643|NCT03470441|473419034|FG000|Overall Study|Withdrawal by Subject|1|||
131488644|NCT03470441|473419035|FG001|Overall Study|Withdrawal by Subject|4|||
131488645|NCT03470441|473419036|FG002|Overall Study|Withdrawal by Subject|1|||
131488646|NCT03470441|473419037|FG003|Overall Study|Withdrawal by Subject|3|||
131488647|NCT00913497|473419038|FG000|Overall Study|Adverse Event|1|||
131488648|NCT00913497|473419038|FG000|Overall Study|Withdrawal by Subject|2|||
131488649|NCT02002091|473419045|FG000|Screening|Lost to Follow-up|10|||
131488650|NCT02002091|473419046|FG001|Screening|Lost to Follow-up|12|||
131488651|NCT02002091|473419045|FG000|Screening|Death|3|||
131488652|NCT02002091|473419046|FG001|Screening|Death|2|||
131488653|NCT00457301|473419049|FG000|Overall Study|Withdrawal by Subject|3|||
131488654|NCT00457301|473419050|FG001|Overall Study|Withdrawal by Subject|3|||
131488655|NCT00457301|473419049|FG000|Overall Study|Censored out of the study|15|||
131488656|NCT00457301|473419050|FG001|Overall Study|Censored out of the study|14|||
131488657|NCT00457301|473419049|FG000|Overall Study|Death|5|||
131488658|NCT00457301|473419050|FG001|Overall Study|Death|7|||
131488659|NCT01128842|473419053|FG000|Overall Study|Adverse Event|1|||
131488660|NCT01128842|473419053|FG000|Overall Study|Disease Progression|6|||
131488661|NCT00478231|473419054|FG000|Overall Study|Death|7|||
131488662|NCT00478231|473419054|FG000|Overall Study|Lack of Efficacy|47|||
131488663|NCT00478231|473419054|FG000|Overall Study|Lost to Follow-up|7|||
131488664|NCT00478231|473419054|FG000|Overall Study|Withdrawal by Subject|6|||
131488665|NCT00478231|473419054|FG000|Overall Study|Other|9|||
131488666|NCT00478231|473419054|FG000|Overall Study|Adverse Event|5|||
131488667|NCT00478231|473419054|FG000|Overall Study|Randomized, not treated|3|||
131488668|NCT03035409|473419055|FG000|Overall Study|Adverse Event|5|||
131488669|NCT03035409|473419055|FG000|Overall Study|Death|2|||
131488670|NCT03035409|473419055|FG000|Overall Study|Withdrawal by Subject|2|||
131488671|NCT03035409|473419055|FG000|Overall Study|Non compliance|4|||
131488672|NCT03035409|473419055|FG000|Overall Study|Patient was jittery|1|||
131488673|NCT03035409|473419055|FG000|Overall Study|Did not like Questionnaire|1|||
131488674|NCT03035409|473419055|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
131488675|NCT03035409|473419055|FG000|Overall Study|Did not like taking drugs|1|||
131488676|NCT01552694|473419058|FG000|Overall Study|Lost to Follow-up|0|||
131488677|NCT01552694|473419059|FG001|Overall Study|Lost to Follow-up|1|||
131488678|NCT01552694|473419058|FG000|Overall Study|Protocol Violation|0|||
131488679|NCT01552694|473419059|FG001|Overall Study|Protocol Violation|1|||
131488680|NCT03724032|473419061|FG000|Overall Study|Physician Decision|1|||
131488681|NCT03724032|473419062|FG001|Overall Study|Physician Decision|0|||
131488682|NCT03724032|473419063|FG002|Overall Study|Physician Decision|0|||
131488683|NCT03724032|473419061|FG000|Overall Study|Protocol Violation|2|||
131488684|NCT03724032|473419062|FG001|Overall Study|Protocol Violation|2|||
131488685|NCT03724032|473419063|FG002|Overall Study|Protocol Violation|1|||
131488686|NCT00001880|473419064|FG000|Overall Study|Death|14|||
131488687|NCT00824720|473419065|FG000|Overall Study|failed plug insertion|3|||
131488688|NCT00824720|473419066|FG001|Overall Study|failed plug insertion|1|||
131488689|NCT00824720|473419067|FG002|Overall Study|failed plug insertion|0|||
131488690|NCT00824720|473419065|FG000|Overall Study|Protocol Violation|0|||
131488691|NCT00824720|473419066|FG001|Overall Study|Protocol Violation|0|||
131488692|NCT00824720|473419067|FG002|Overall Study|Protocol Violation|1|||
131488693|NCT00873015|473419068|FG000|Overall Study|Withdrawal by Subject|0|||
131488694|NCT00873015|473419069|FG001|Overall Study|Withdrawal by Subject|1|||
131488695|NCT00873015|473419070|FG002|Overall Study|Withdrawal by Subject|0|||
131488696|NCT00873015|473419071|FG003|Overall Study|Withdrawal by Subject|0|||
131488697|NCT04094883|473419072|FG000|Overall Study|Withdrawal by Subject|1|||
131488698|NCT01382212|473419074|FG000|Overall Study|Kidney transplant|1|||
131488699|NCT01382212|473419074|FG000|Overall Study|Withdrew consent|1|||
131488700|NCT01273597|473419075|FG000|Overall Study|Adverse Event|5|||
131488701|NCT01273597|473419075|FG000|Overall Study|Underwent Kidney Transplantation|2|||
131488702|NCT01273597|473419075|FG000|Overall Study|Reason Not Reported|1|||
131488703|NCT02513394|473419088|FG000|Overall Study|Withdrawal by Subject|11|||
131488704|NCT02513394|473419089|FG001|Overall Study|Withdrawal by Subject|23|||
131488705|NCT02513394|473419088|FG000|Overall Study|Ineligible|1|||
131488706|NCT02513394|473419089|FG001|Overall Study|Ineligible|0|||
131488707|NCT00688753|473421541|FG000|Overall Study|Disease progression|55|||
131488708|NCT00688753|473421541|FG000|Overall Study|Missing|1|||
131488709|NCT00688753|473421541|FG000|Overall Study|Death|9|||
131488710|NCT00688753|473421541|FG000|Overall Study|Withdrawal by Subject|3|||
131488711|NCT00688753|473421541|FG000|Overall Study|Adverse Event|20|||
131488712|NCT00688753|473421541|FG000|Overall Study|Protocol Violation|1|||
131488713|NCT00688753|473421541|FG000|Overall Study|Lost to Follow-up|3|||
131488714|NCT00259649|473421546|FG000|Overall Study|Lost to Follow-up|7|||
131488715|NCT00259649|473421546|FG000|Overall Study|irregular menses|3|||
131488716|NCT02200211|473421549|FG000|Overall Study|Lost to Follow-up|7|||
131488717|NCT02200211|473421550|FG001|Overall Study|Lost to Follow-up|7|||
131488718|NCT02200211|473421551|FG002|Overall Study|Lost to Follow-up|1|||
131488719|NCT02200211|473421552|FG003|Overall Study|Lost to Follow-up|2|||
131488720|NCT02200211|473421549|FG000|Overall Study|Withdrawal by Subject|1|||
131488721|NCT02200211|473421550|FG001|Overall Study|Withdrawal by Subject|0|||
131488722|NCT02200211|473421551|FG002|Overall Study|Withdrawal by Subject|0|||
131488723|NCT02200211|473421552|FG003|Overall Study|Withdrawal by Subject|0|||
131488724|NCT00381485|473421553|FG000|Open-Label Run-In Period|Adverse Event|9|||
131488725|NCT00381485|473421554|FG001|Open-Label Run-In Period|Adverse Event|0|||
131488726|NCT00381485|473421555|FG002|Open-Label Run-In Period|Adverse Event|0|||
131488727|NCT00381485|473421556|FG003|Open-Label Run-In Period|Adverse Event|0|||
131488728|NCT00381485|473421553|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
131488729|NCT00381485|473421554|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
131488730|NCT00381485|473421555|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
131488731|NCT00381485|473421556|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
131488732|NCT00381485|473421553|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
131488733|NCT00381485|473421554|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
131488734|NCT00381485|473421555|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
131488735|NCT00381485|473421556|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
131488736|NCT00381485|473421553|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
131488737|NCT00381485|473421554|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
131488738|NCT00381485|473421555|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
131488739|NCT00381485|473421556|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
131488740|NCT00381485|473421553|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
131488741|NCT00381485|473421554|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
131488742|NCT00381485|473421555|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
131488743|NCT00381485|473421556|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
131488744|NCT00381485|473421553|FG000|Open-Label Run-In Period|Treatment failure|1|||
131488745|NCT00381485|473421554|FG001|Open-Label Run-In Period|Treatment failure|0|||
131488746|NCT00381485|473421555|FG002|Open-Label Run-In Period|Treatment failure|0|||
131488747|NCT00381485|473421556|FG003|Open-Label Run-In Period|Treatment failure|0|||
131488748|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131488749|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Adverse Event|2|||
131488750|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Adverse Event|2|||
131488751|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Adverse Event|5|||
131488752|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
131488753|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
131488754|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
131488755|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
131488756|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131488757|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
131488758|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
131488759|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
131488760|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
131488761|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
131488762|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
131488763|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
131488764|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
131488765|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
131488766|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
131488767|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
131488768|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
131488769|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
131488770|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
131488771|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
131488772|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
131488773|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
131488774|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
131488775|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
131488776|NCT00381485|473421553|FG000|Double-Blind Treatment Period|Administrative|0|||
131488777|NCT00381485|473421554|FG001|Double-Blind Treatment Period|Administrative|1|||
131488778|NCT00381485|473421555|FG002|Double-Blind Treatment Period|Administrative|0|||
131488779|NCT00381485|473421556|FG003|Double-Blind Treatment Period|Administrative|1|||
131488780|NCT01235351|473421557|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
131488781|NCT01235351|473421558|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
131488782|NCT00042289|473421559|FG000|Overall Study|Lost to Follow-up|3|||
131488783|NCT00042289|473421560|FG001|Overall Study|Lost to Follow-up|0|||
131488784|NCT00042289|473421561|FG002|Overall Study|Lost to Follow-up|0|||
131488785|NCT00042289|473421562|FG003|Overall Study|Lost to Follow-up|1|||
131488786|NCT00042289|473421563|FG004|Overall Study|Lost to Follow-up|3|||
131488787|NCT00042289|473421564|FG005|Overall Study|Lost to Follow-up|3|||
131488788|NCT00042289|473421565|FG006|Overall Study|Lost to Follow-up|6|||
131488789|NCT00042289|473421566|FG007|Overall Study|Lost to Follow-up|1|||
131488790|NCT00042289|473421567|FG008|Overall Study|Lost to Follow-up|1|||
131488791|NCT00042289|473421568|FG009|Overall Study|Lost to Follow-up|0|||
131488792|NCT00042289|473421569|FG010|Overall Study|Lost to Follow-up|0|||
131488793|NCT00042289|473421570|FG011|Overall Study|Lost to Follow-up|0|||
131488794|NCT00042289|473421571|FG012|Overall Study|Lost to Follow-up|0|||
131488795|NCT00042289|473421572|FG013|Overall Study|Lost to Follow-up|0|||
131488796|NCT00042289|473421573|FG014|Overall Study|Lost to Follow-up|0|||
131488797|NCT00042289|473421574|FG015|Overall Study|Lost to Follow-up|1|||
131488798|NCT00042289|473421575|FG016|Overall Study|Lost to Follow-up|1|||
131488799|NCT00042289|473421576|FG017|Overall Study|Lost to Follow-up|0|||
131488800|NCT00042289|473421577|FG018|Overall Study|Lost to Follow-up|3|||
131488801|NCT00042289|473421578|FG019|Overall Study|Lost to Follow-up|2|||
131488802|NCT00042289|473421579|FG020|Overall Study|Lost to Follow-up|0|||
131488803|NCT00042289|473421580|FG021|Overall Study|Lost to Follow-up|0|||
131488804|NCT00042289|473421581|FG022|Overall Study|Lost to Follow-up|0|||
131488805|NCT00042289|473421582|FG023|Overall Study|Lost to Follow-up|0|||
131488806|NCT00042289|473421583|FG024|Overall Study|Lost to Follow-up|0|||
131488807|NCT00042289|473421584|FG025|Overall Study|Lost to Follow-up|0|||
131488808|NCT00042289|473421585|FG026|Overall Study|Lost to Follow-up|2|||
131488809|NCT00042289|473421586|FG027|Overall Study|Lost to Follow-up|2|||
131488810|NCT00042289|473421587|FG028|Overall Study|Lost to Follow-up|2|||
131488811|NCT00042289|473421588|FG029|Overall Study|Lost to Follow-up|0|||
131488812|NCT00042289|473421589|FG030|Overall Study|Lost to Follow-up|0|||
131488813|NCT00042289|473421590|FG031|Overall Study|Lost to Follow-up|2|||
131488814|NCT00042289|473421591|FG032|Overall Study|Lost to Follow-up|1|||
131488815|NCT00042289|473421592|FG033|Overall Study|Lost to Follow-up|1|||
131488816|NCT00042289|473421593|FG034|Overall Study|Lost to Follow-up|1|||
131488817|NCT00042289|473421594|FG035|Overall Study|Lost to Follow-up|2|||
131488818|NCT00042289|473421595|FG036|Overall Study|Lost to Follow-up|1|||
131488819|NCT00042289|473421596|FG037|Overall Study|Lost to Follow-up|1|||
131488820|NCT00042289|473421597|FG038|Overall Study|Lost to Follow-up|0|||
131488821|NCT00042289|473421598|FG039|Overall Study|Lost to Follow-up|5|||
131488822|NCT00042289|473421599|FG040|Overall Study|Lost to Follow-up|0|||
131488823|NCT00042289|473421600|FG041|Overall Study|Lost to Follow-up|2|||
131488824|NCT00042289|473421601|FG042|Overall Study|Lost to Follow-up|2|||
131488825|NCT00042289|473421602|FG043|Overall Study|Lost to Follow-up|0|||
131488826|NCT00042289|473421603|FG044|Overall Study|Lost to Follow-up|0|||
131488827|NCT00042289|473421604|FG045|Overall Study|Lost to Follow-up|1|||
131488828|NCT00042289|473421605|FG046|Overall Study|Lost to Follow-up|0|||
131488829|NCT00042289|473421559|FG000|Overall Study|Other reason|0|||
131488830|NCT00042289|473421560|FG001|Overall Study|Other reason|0|||
131488831|NCT00042289|473421561|FG002|Overall Study|Other reason|0|||
131488832|NCT00042289|473421562|FG003|Overall Study|Other reason|2|||
131488833|NCT00042289|473421563|FG004|Overall Study|Other reason|0|||
131488834|NCT00042289|473421564|FG005|Overall Study|Other reason|0|||
131488835|NCT00042289|473421565|FG006|Overall Study|Other reason|0|||
131488836|NCT00042289|473421566|FG007|Overall Study|Other reason|0|||
131488837|NCT00042289|473421567|FG008|Overall Study|Other reason|0|||
131488838|NCT00042289|473421568|FG009|Overall Study|Other reason|0|||
131488839|NCT00042289|473421569|FG010|Overall Study|Other reason|0|||
131488840|NCT00042289|473421570|FG011|Overall Study|Other reason|0|||
131488841|NCT00042289|473421571|FG012|Overall Study|Other reason|0|||
131488842|NCT00042289|473421572|FG013|Overall Study|Other reason|0|||
131488843|NCT00042289|473421573|FG014|Overall Study|Other reason|0|||
131488844|NCT00042289|473421574|FG015|Overall Study|Other reason|0|||
131488845|NCT00042289|473421575|FG016|Overall Study|Other reason|0|||
131488846|NCT00042289|473421576|FG017|Overall Study|Other reason|0|||
131488847|NCT00042289|473421577|FG018|Overall Study|Other reason|1|||
131488848|NCT00042289|473421578|FG019|Overall Study|Other reason|0|||
131488849|NCT00042289|473421579|FG020|Overall Study|Other reason|0|||
131488850|NCT00042289|473421580|FG021|Overall Study|Other reason|0|||
131488851|NCT00042289|473421581|FG022|Overall Study|Other reason|0|||
131488852|NCT00042289|473421582|FG023|Overall Study|Other reason|1|||
131488853|NCT00042289|473421583|FG024|Overall Study|Other reason|0|||
131488854|NCT00042289|473421584|FG025|Overall Study|Other reason|0|||
131488855|NCT00042289|473421585|FG026|Overall Study|Other reason|1|||
131488856|NCT00042289|473421586|FG027|Overall Study|Other reason|0|||
131488857|NCT00042289|473421587|FG028|Overall Study|Other reason|3|||
131488858|NCT00042289|473421588|FG029|Overall Study|Other reason|0|||
131488859|NCT00042289|473421589|FG030|Overall Study|Other reason|0|||
131488860|NCT00042289|473421590|FG031|Overall Study|Other reason|1|||
131488861|NCT00042289|473421591|FG032|Overall Study|Other reason|0|||
131488862|NCT00042289|473421592|FG033|Overall Study|Other reason|1|||
131488863|NCT00042289|473421593|FG034|Overall Study|Other reason|0|||
131488864|NCT00042289|473421594|FG035|Overall Study|Other reason|2|||
131488865|NCT00042289|473421595|FG036|Overall Study|Other reason|0|||
131488866|NCT00042289|473421596|FG037|Overall Study|Other reason|0|||
131488867|NCT00042289|473421597|FG038|Overall Study|Other reason|0|||
131488868|NCT00042289|473421598|FG039|Overall Study|Other reason|0|||
131488869|NCT00042289|473421599|FG040|Overall Study|Other reason|0|||
131488870|NCT00042289|473421600|FG041|Overall Study|Other reason|0|||
131488871|NCT00042289|473421601|FG042|Overall Study|Other reason|0|||
131488872|NCT00042289|473421602|FG043|Overall Study|Other reason|1|||
131488873|NCT00042289|473421603|FG044|Overall Study|Other reason|0|||
131488874|NCT00042289|473421604|FG045|Overall Study|Other reason|0|||
131488875|NCT00042289|473421605|FG046|Overall Study|Other reason|0|||
131488876|NCT00042289|473421559|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131488877|NCT00042289|473421560|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131488878|NCT00042289|473421561|FG002|Overall Study|Severe debilitation, unable to continue|0|||
131488879|NCT00042289|473421562|FG003|Overall Study|Severe debilitation, unable to continue|0|||
131488880|NCT00042289|473421563|FG004|Overall Study|Severe debilitation, unable to continue|0|||
131488881|NCT00042289|473421564|FG005|Overall Study|Severe debilitation, unable to continue|0|||
131488882|NCT00042289|473421565|FG006|Overall Study|Severe debilitation, unable to continue|0|||
131488883|NCT00042289|473421566|FG007|Overall Study|Severe debilitation, unable to continue|0|||
131488884|NCT00042289|473421567|FG008|Overall Study|Severe debilitation, unable to continue|0|||
131488885|NCT00042289|473421568|FG009|Overall Study|Severe debilitation, unable to continue|0|||
131488886|NCT00042289|473421569|FG010|Overall Study|Severe debilitation, unable to continue|0|||
131488887|NCT00042289|473421570|FG011|Overall Study|Severe debilitation, unable to continue|0|||
131488888|NCT00042289|473421571|FG012|Overall Study|Severe debilitation, unable to continue|0|||
131488889|NCT00042289|473421572|FG013|Overall Study|Severe debilitation, unable to continue|0|||
131488890|NCT00042289|473421573|FG014|Overall Study|Severe debilitation, unable to continue|0|||
131488891|NCT00042289|473421574|FG015|Overall Study|Severe debilitation, unable to continue|0|||
131488892|NCT00042289|473421575|FG016|Overall Study|Severe debilitation, unable to continue|0|||
131488893|NCT00042289|473421576|FG017|Overall Study|Severe debilitation, unable to continue|0|||
131488894|NCT00042289|473421577|FG018|Overall Study|Severe debilitation, unable to continue|0|||
131488895|NCT00042289|473421578|FG019|Overall Study|Severe debilitation, unable to continue|0|||
131488896|NCT00042289|473421579|FG020|Overall Study|Severe debilitation, unable to continue|0|||
131488897|NCT00042289|473421580|FG021|Overall Study|Severe debilitation, unable to continue|1|||
131488898|NCT00042289|473421581|FG022|Overall Study|Severe debilitation, unable to continue|0|||
131488899|NCT00042289|473421582|FG023|Overall Study|Severe debilitation, unable to continue|1|||
131488900|NCT00042289|473421583|FG024|Overall Study|Severe debilitation, unable to continue|0|||
131488901|NCT00042289|473421584|FG025|Overall Study|Severe debilitation, unable to continue|0|||
131488902|NCT00042289|473421585|FG026|Overall Study|Severe debilitation, unable to continue|0|||
131488903|NCT00042289|473421586|FG027|Overall Study|Severe debilitation, unable to continue|1|||
131488904|NCT00042289|473421587|FG028|Overall Study|Severe debilitation, unable to continue|0|||
131488905|NCT00042289|473421588|FG029|Overall Study|Severe debilitation, unable to continue|0|||
131488906|NCT00042289|473421589|FG030|Overall Study|Severe debilitation, unable to continue|0|||
131488907|NCT00042289|473421590|FG031|Overall Study|Severe debilitation, unable to continue|1|||
131488908|NCT00042289|473421591|FG032|Overall Study|Severe debilitation, unable to continue|1|||
131488909|NCT00042289|473421592|FG033|Overall Study|Severe debilitation, unable to continue|0|||
131488910|NCT00042289|473421593|FG034|Overall Study|Severe debilitation, unable to continue|0|||
131488911|NCT00042289|473421594|FG035|Overall Study|Severe debilitation, unable to continue|0|||
131488912|NCT00042289|473421595|FG036|Overall Study|Severe debilitation, unable to continue|0|||
131488913|NCT00042289|473421596|FG037|Overall Study|Severe debilitation, unable to continue|0|||
131488914|NCT00042289|473421597|FG038|Overall Study|Severe debilitation, unable to continue|0|||
131488915|NCT00042289|473421598|FG039|Overall Study|Severe debilitation, unable to continue|0|||
131488916|NCT00042289|473421599|FG040|Overall Study|Severe debilitation, unable to continue|0|||
131488917|NCT00042289|473421600|FG041|Overall Study|Severe debilitation, unable to continue|0|||
131488918|NCT00042289|473421601|FG042|Overall Study|Severe debilitation, unable to continue|0|||
131488919|NCT00042289|473421602|FG043|Overall Study|Severe debilitation, unable to continue|0|||
131488920|NCT00042289|473421603|FG044|Overall Study|Severe debilitation, unable to continue|0|||
131488921|NCT00042289|473421604|FG045|Overall Study|Severe debilitation, unable to continue|0|||
131488922|NCT00042289|473421605|FG046|Overall Study|Severe debilitation, unable to continue|0|||
131488923|NCT00042289|473421559|FG000|Overall Study|Site closed|0|||
131488924|NCT00042289|473421560|FG001|Overall Study|Site closed|0|||
131488925|NCT00042289|473421561|FG002|Overall Study|Site closed|0|||
131488926|NCT00042289|473421562|FG003|Overall Study|Site closed|0|||
131488927|NCT00042289|473421563|FG004|Overall Study|Site closed|0|||
131488928|NCT00042289|473421564|FG005|Overall Study|Site closed|0|||
131488929|NCT00042289|473421565|FG006|Overall Study|Site closed|0|||
131488930|NCT00042289|473421566|FG007|Overall Study|Site closed|0|||
131488931|NCT00042289|473421567|FG008|Overall Study|Site closed|0|||
131488932|NCT00042289|473421568|FG009|Overall Study|Site closed|0|||
131488933|NCT00042289|473421569|FG010|Overall Study|Site closed|0|||
131488934|NCT00042289|473421570|FG011|Overall Study|Site closed|0|||
131488935|NCT00042289|473421571|FG012|Overall Study|Site closed|0|||
131488936|NCT00042289|473421572|FG013|Overall Study|Site closed|0|||
131488937|NCT00042289|473421573|FG014|Overall Study|Site closed|0|||
131488938|NCT00042289|473421574|FG015|Overall Study|Site closed|0|||
131488939|NCT00042289|473421575|FG016|Overall Study|Site closed|0|||
131488940|NCT00042289|473421576|FG017|Overall Study|Site closed|0|||
131488941|NCT00042289|473421577|FG018|Overall Study|Site closed|0|||
131488942|NCT00042289|473421578|FG019|Overall Study|Site closed|0|||
131488943|NCT00042289|473421579|FG020|Overall Study|Site closed|0|||
131488944|NCT00042289|473421580|FG021|Overall Study|Site closed|0|||
131488945|NCT00042289|473421581|FG022|Overall Study|Site closed|0|||
131488946|NCT00042289|473421582|FG023|Overall Study|Site closed|0|||
131488947|NCT00042289|473421583|FG024|Overall Study|Site closed|0|||
131488948|NCT00042289|473421584|FG025|Overall Study|Site closed|0|||
131488949|NCT00042289|473421585|FG026|Overall Study|Site closed|0|||
131488950|NCT00042289|473421586|FG027|Overall Study|Site closed|0|||
131488951|NCT00042289|473421587|FG028|Overall Study|Site closed|0|||
131488952|NCT00042289|473421588|FG029|Overall Study|Site closed|0|||
131488953|NCT00042289|473421589|FG030|Overall Study|Site closed|0|||
131488954|NCT00042289|473421590|FG031|Overall Study|Site closed|3|||
131488955|NCT00042289|473421591|FG032|Overall Study|Site closed|0|||
131488956|NCT00042289|473421592|FG033|Overall Study|Site closed|0|||
131488957|NCT00042289|473421593|FG034|Overall Study|Site closed|0|||
131488958|NCT00042289|473421594|FG035|Overall Study|Site closed|0|||
131488959|NCT00042289|473421595|FG036|Overall Study|Site closed|1|||
131488960|NCT00042289|473421596|FG037|Overall Study|Site closed|0|||
131488961|NCT00042289|473421597|FG038|Overall Study|Site closed|0|||
131488962|NCT00042289|473421598|FG039|Overall Study|Site closed|0|||
131488963|NCT00042289|473421599|FG040|Overall Study|Site closed|0|||
131488964|NCT00042289|473421600|FG041|Overall Study|Site closed|0|||
131488965|NCT00042289|473421601|FG042|Overall Study|Site closed|1|||
131488966|NCT00042289|473421602|FG043|Overall Study|Site closed|0|||
131488967|NCT00042289|473421603|FG044|Overall Study|Site closed|0|||
131488968|NCT00042289|473421604|FG045|Overall Study|Site closed|0|||
131488969|NCT00042289|473421605|FG046|Overall Study|Site closed|0|||
131488970|NCT00042289|473421559|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
131488971|NCT00042289|473421560|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
131488972|NCT00042289|473421561|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
131488973|NCT00042289|473421562|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
131488974|NCT00042289|473421563|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
131488975|NCT00042289|473421564|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
131488976|NCT00042289|473421565|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
131488977|NCT00042289|473421566|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
131488978|NCT00042289|473421567|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
131488979|NCT00042289|473421568|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
131488980|NCT00042289|473421569|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
131488981|NCT00042289|473421570|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
131488982|NCT00042289|473421571|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
131488983|NCT00042289|473421572|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
131488984|NCT00042289|473421573|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
131488985|NCT00042289|473421574|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
131488986|NCT00042289|473421575|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
131488987|NCT00042289|473421576|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
131488988|NCT00042289|473421577|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
131488989|NCT00042289|473421578|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
131488990|NCT00042289|473421579|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
131488991|NCT00042289|473421580|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
131488992|NCT00042289|473421581|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
131488993|NCT00042289|473421582|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
131488994|NCT00042289|473421583|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
131488995|NCT00042289|473421584|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
131488996|NCT00042289|473421585|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
131488997|NCT00042289|473421586|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
131488998|NCT00042289|473421587|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
131488999|NCT00042289|473421588|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
131489000|NCT00042289|473421589|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
131489001|NCT00042289|473421590|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
131489002|NCT00042289|473421591|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
131489003|NCT00042289|473421592|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
131489004|NCT00042289|473421593|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
131489005|NCT00042289|473421594|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
131489006|NCT00042289|473421595|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
131489007|NCT00042289|473421596|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
131489008|NCT00042289|473421597|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
131489009|NCT00042289|473421598|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
131489010|NCT00042289|473421599|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
131489011|NCT00042289|473421600|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
131489012|NCT00042289|473421601|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
131489013|NCT00042289|473421602|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
131489014|NCT00042289|473421603|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
131489015|NCT00042289|473421604|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
131489016|NCT00042289|473421605|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
131489017|NCT00042289|473421559|FG000|Overall Study|Protocol Violation|0|||
131489018|NCT00042289|473421560|FG001|Overall Study|Protocol Violation|0|||
131489019|NCT00042289|473421561|FG002|Overall Study|Protocol Violation|0|||
131489020|NCT00042289|473421562|FG003|Overall Study|Protocol Violation|0|||
131489021|NCT00042289|473421563|FG004|Overall Study|Protocol Violation|0|||
131489022|NCT00042289|473421564|FG005|Overall Study|Protocol Violation|1|||
131489023|NCT00042289|473421565|FG006|Overall Study|Protocol Violation|0|||
131489024|NCT00042289|473421566|FG007|Overall Study|Protocol Violation|1|||
131489025|NCT00042289|473421567|FG008|Overall Study|Protocol Violation|0|||
131489026|NCT00042289|473421568|FG009|Overall Study|Protocol Violation|0|||
131489027|NCT00042289|473421569|FG010|Overall Study|Protocol Violation|0|||
131489028|NCT00042289|473421570|FG011|Overall Study|Protocol Violation|0|||
131489029|NCT00042289|473421571|FG012|Overall Study|Protocol Violation|0|||
131489030|NCT00042289|473421572|FG013|Overall Study|Protocol Violation|0|||
131489031|NCT00042289|473421573|FG014|Overall Study|Protocol Violation|0|||
131489032|NCT00042289|473421574|FG015|Overall Study|Protocol Violation|0|||
131489033|NCT00042289|473421575|FG016|Overall Study|Protocol Violation|0|||
131489034|NCT00042289|473421576|FG017|Overall Study|Protocol Violation|0|||
131489035|NCT00042289|473421577|FG018|Overall Study|Protocol Violation|0|||
131489036|NCT00042289|473421578|FG019|Overall Study|Protocol Violation|0|||
131489037|NCT00042289|473421579|FG020|Overall Study|Protocol Violation|0|||
131489038|NCT00042289|473421580|FG021|Overall Study|Protocol Violation|0|||
131489039|NCT00042289|473421581|FG022|Overall Study|Protocol Violation|0|||
131489040|NCT00042289|473421582|FG023|Overall Study|Protocol Violation|1|||
131489041|NCT00042289|473421583|FG024|Overall Study|Protocol Violation|1|||
131489042|NCT00042289|473421584|FG025|Overall Study|Protocol Violation|0|||
131489043|NCT00042289|473421585|FG026|Overall Study|Protocol Violation|2|||
131489044|NCT00042289|473421586|FG027|Overall Study|Protocol Violation|0|||
131489045|NCT00042289|473421587|FG028|Overall Study|Protocol Violation|0|||
131489046|NCT00042289|473421588|FG029|Overall Study|Protocol Violation|0|||
131489047|NCT00042289|473421589|FG030|Overall Study|Protocol Violation|1|||
131489048|NCT00042289|473421590|FG031|Overall Study|Protocol Violation|0|||
131489049|NCT00042289|473421591|FG032|Overall Study|Protocol Violation|0|||
131489050|NCT00042289|473421592|FG033|Overall Study|Protocol Violation|0|||
131489051|NCT00042289|473421593|FG034|Overall Study|Protocol Violation|0|||
131489052|NCT00042289|473421594|FG035|Overall Study|Protocol Violation|0|||
131489053|NCT00042289|473421595|FG036|Overall Study|Protocol Violation|0|||
131489054|NCT00042289|473421596|FG037|Overall Study|Protocol Violation|0|||
131489055|NCT00042289|473421597|FG038|Overall Study|Protocol Violation|0|||
131489056|NCT00042289|473421598|FG039|Overall Study|Protocol Violation|0|||
131489057|NCT00042289|473421599|FG040|Overall Study|Protocol Violation|0|||
131489058|NCT00042289|473421600|FG041|Overall Study|Protocol Violation|1|||
131489059|NCT00042289|473421601|FG042|Overall Study|Protocol Violation|1|||
131489060|NCT00042289|473421602|FG043|Overall Study|Protocol Violation|1|||
131489061|NCT00042289|473421603|FG044|Overall Study|Protocol Violation|0|||
131489062|NCT00042289|473421604|FG045|Overall Study|Protocol Violation|0|||
131489063|NCT00042289|473421605|FG046|Overall Study|Protocol Violation|0|||
131489064|NCT00042289|473421559|FG000|Overall Study|Withdrawal by Subject|4|||
131489065|NCT00042289|473421560|FG001|Overall Study|Withdrawal by Subject|1|||
131489066|NCT00042289|473421561|FG002|Overall Study|Withdrawal by Subject|0|||
131489067|NCT00042289|473421562|FG003|Overall Study|Withdrawal by Subject|2|||
131489068|NCT00042289|473421563|FG004|Overall Study|Withdrawal by Subject|0|||
131489069|NCT00042289|473421564|FG005|Overall Study|Withdrawal by Subject|2|||
131489070|NCT00042289|473421565|FG006|Overall Study|Withdrawal by Subject|0|||
131489071|NCT00042289|473421566|FG007|Overall Study|Withdrawal by Subject|0|||
131489072|NCT00042289|473421567|FG008|Overall Study|Withdrawal by Subject|0|||
131489073|NCT00042289|473421568|FG009|Overall Study|Withdrawal by Subject|1|||
131489074|NCT00042289|473421569|FG010|Overall Study|Withdrawal by Subject|0|||
131489075|NCT00042289|473421570|FG011|Overall Study|Withdrawal by Subject|0|||
131489076|NCT00042289|473421571|FG012|Overall Study|Withdrawal by Subject|2|||
131489077|NCT00042289|473421572|FG013|Overall Study|Withdrawal by Subject|0|||
131489078|NCT00042289|473421573|FG014|Overall Study|Withdrawal by Subject|0|||
131489079|NCT00042289|473421574|FG015|Overall Study|Withdrawal by Subject|0|||
131489080|NCT00042289|473421575|FG016|Overall Study|Withdrawal by Subject|0|||
131489081|NCT00042289|473421576|FG017|Overall Study|Withdrawal by Subject|0|||
131489082|NCT00042289|473421577|FG018|Overall Study|Withdrawal by Subject|0|||
131489083|NCT00042289|473421578|FG019|Overall Study|Withdrawal by Subject|0|||
131489084|NCT00042289|473421579|FG020|Overall Study|Withdrawal by Subject|0|||
131489085|NCT00042289|473421580|FG021|Overall Study|Withdrawal by Subject|1|||
131489086|NCT00042289|473421581|FG022|Overall Study|Withdrawal by Subject|1|||
131489087|NCT00042289|473421582|FG023|Overall Study|Withdrawal by Subject|1|||
131489088|NCT00042289|473421583|FG024|Overall Study|Withdrawal by Subject|0|||
131489089|NCT00042289|473421584|FG025|Overall Study|Withdrawal by Subject|0|||
131489090|NCT00042289|473421585|FG026|Overall Study|Withdrawal by Subject|1|||
131489091|NCT00042289|473421586|FG027|Overall Study|Withdrawal by Subject|0|||
131489092|NCT00042289|473421587|FG028|Overall Study|Withdrawal by Subject|2|||
131489093|NCT00042289|473421588|FG029|Overall Study|Withdrawal by Subject|0|||
131489094|NCT00042289|473421589|FG030|Overall Study|Withdrawal by Subject|0|||
131489095|NCT00042289|473421590|FG031|Overall Study|Withdrawal by Subject|1|||
131489096|NCT00042289|473421591|FG032|Overall Study|Withdrawal by Subject|2|||
131489097|NCT00042289|473421592|FG033|Overall Study|Withdrawal by Subject|1|||
131489098|NCT00042289|473421593|FG034|Overall Study|Withdrawal by Subject|0|||
131489099|NCT00042289|473421594|FG035|Overall Study|Withdrawal by Subject|0|||
131489100|NCT00042289|473421595|FG036|Overall Study|Withdrawal by Subject|0|||
131489101|NCT00042289|473421596|FG037|Overall Study|Withdrawal by Subject|1|||
131489102|NCT00042289|473421597|FG038|Overall Study|Withdrawal by Subject|0|||
131489103|NCT00042289|473421598|FG039|Overall Study|Withdrawal by Subject|0|||
131489104|NCT00042289|473421599|FG040|Overall Study|Withdrawal by Subject|0|||
131489105|NCT00042289|473421600|FG041|Overall Study|Withdrawal by Subject|0|||
131489106|NCT00042289|473421601|FG042|Overall Study|Withdrawal by Subject|1|||
131489107|NCT00042289|473421602|FG043|Overall Study|Withdrawal by Subject|0|||
131489108|NCT00042289|473421603|FG044|Overall Study|Withdrawal by Subject|0|||
131489109|NCT00042289|473421604|FG045|Overall Study|Withdrawal by Subject|0|||
131489110|NCT00042289|473421605|FG046|Overall Study|Withdrawal by Subject|0|||
131489111|NCT00745823|473421607|FG000|Overall Study|Adverse Event|5|||
131489112|NCT00745823|473421608|FG001|Overall Study|Adverse Event|3|||
131489113|NCT00745823|473421607|FG000|Overall Study|Lack of Efficacy|20|||
131489114|NCT00745823|473421608|FG001|Overall Study|Lack of Efficacy|6|||
131489115|NCT00745823|473421607|FG000|Overall Study|Lost to Follow-up|10|||
131489116|NCT00745823|473421608|FG001|Overall Study|Lost to Follow-up|11|||
131489117|NCT00745823|473421607|FG000|Overall Study|Physician Decision|10|||
131489118|NCT00745823|473421608|FG001|Overall Study|Physician Decision|5|||
131489119|NCT00745823|473421607|FG000|Overall Study|Pregnancy|0|||
131489120|NCT00745823|473421608|FG001|Overall Study|Pregnancy|4|||
131489121|NCT00745823|473421607|FG000|Overall Study|Withdrawal by Subject|14|||
131489122|NCT00745823|473421608|FG001|Overall Study|Withdrawal by Subject|8|||
131489123|NCT00745823|473421607|FG000|Overall Study|Study Terminated by Sponsor|326|||
131489124|NCT00745823|473421608|FG001|Overall Study|Study Terminated by Sponsor|349|||
131489125|NCT01898806|473421611|FG000|Overall Study|Withdrawal by Subject|2|||
131489126|NCT01898806|473421611|FG000|Overall Study|Physician Decision|1|||
131489127|NCT00126191|473421612|FG000|Overall Study|Physician Decision|0|||
131489128|NCT00126191|473421613|FG001|Overall Study|Physician Decision|1|||
131489129|NCT00126191|473421612|FG000|Overall Study|Death|0|||
131489130|NCT00126191|473421613|FG001|Overall Study|Death|1|||
131489131|NCT00307294|473421629|FG000|Overall Study|Withdrawal by Subject|1|||
131489132|NCT00612690|473421630|FG000|Overall Study|Lost to Follow-up|72|||
131489133|NCT00612690|473421631|FG001|Overall Study|Lost to Follow-up|98|||
131489134|NCT00612690|473421630|FG000|Overall Study|Withdrawal by Subject|32|||
131489135|NCT00612690|473421631|FG001|Overall Study|Withdrawal by Subject|20|||
131489136|NCT00612690|473421630|FG000|Overall Study|Withdrawal by Site|11|||
131489137|NCT00612690|473421631|FG001|Overall Study|Withdrawal by Site|0|||
131489138|NCT02955602|473421633|FG000|Overall Study|Adverse Event|0|||
131489139|NCT02955602|473421634|FG001|Overall Study|Adverse Event|3|||
131489140|NCT02955602|473421635|FG002|Overall Study|Adverse Event|0|||
131489141|NCT02955602|473421633|FG000|Overall Study|Withdrawal of informed consent|1|||
131489142|NCT02955602|473421634|FG001|Overall Study|Withdrawal of informed consent|3|||
131489143|NCT02955602|473421635|FG002|Overall Study|Withdrawal of informed consent|2|||
131489144|NCT02955602|473421633|FG000|Overall Study|Lost to Follow-up|0|||
131489145|NCT02955602|473421634|FG001|Overall Study|Lost to Follow-up|0|||
131489146|NCT02955602|473421635|FG002|Overall Study|Lost to Follow-up|1|||
131489147|NCT02955602|473421633|FG000|Overall Study|Other|0|||
131489148|NCT02955602|473421634|FG001|Overall Study|Other|1|||
131489149|NCT02955602|473421635|FG002|Overall Study|Other|3|||
131489150|NCT02980601|473421636|FG000|Overall Study|Lost to Follow-up|2|||
131489151|NCT02980601|473421637|FG001|Overall Study|Lost to Follow-up|2|||
131489152|NCT02980601|473421636|FG000|Overall Study|Death|0|||
131489153|NCT02980601|473421637|FG001|Overall Study|Death|1|||
131489154|NCT02980601|473421636|FG000|Overall Study|Graft loss|1|||
131489155|NCT02980601|473421637|FG001|Overall Study|Graft loss|0|||
131489156|NCT02980601|473421636|FG000|Overall Study|Failed to sign consent|2|||
131489157|NCT02980601|473421637|FG001|Overall Study|Failed to sign consent|0|||
131489158|NCT01575769|473421638|FG000|Overall Study|Adverse Event|1|||
131489159|NCT01575769|473421638|FG000|Overall Study|Study terminated by sponsor|40|||
131489160|NCT00844831|473421639|FG000|Overall Study|Withdrawal by Subject|4|||
131489161|NCT00844831|473421639|FG000|Overall Study|Adverse Event|1|||
131489162|NCT00844831|473421639|FG000|Overall Study|Physician Decision|1|||
131489163|NCT01749137|473421644|FG000|Overall Study|Adverse Event|4|||
131489164|NCT01749137|473421645|FG001|Overall Study|Adverse Event|4|||
131489165|NCT01749137|473421644|FG000|Overall Study|Lost to Follow-up|2|||
131489166|NCT01749137|473421645|FG001|Overall Study|Lost to Follow-up|3|||
131489167|NCT01749137|473421644|FG000|Overall Study|Physician Decision|1|||
131489168|NCT01749137|473421645|FG001|Overall Study|Physician Decision|0|||
131489169|NCT01749137|473421644|FG000|Overall Study|Withdrawal by Subject|8|||
131489170|NCT01749137|473421645|FG001|Overall Study|Withdrawal by Subject|4|||
131489171|NCT04115839|473421653|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
131489172|NCT04115839|473421654|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
131489173|NCT04115839|473421655|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
131489174|NCT04115839|473421656|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
131489175|NCT04115839|473421657|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
131489176|NCT04115839|473421658|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
131489177|NCT04115839|473421659|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
131489178|NCT04115839|473421653|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
131489179|NCT04115839|473421654|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
131489180|NCT04115839|473421655|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
131489181|NCT04115839|473421656|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
131489182|NCT04115839|473421657|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
131489183|NCT04115839|473421658|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
131489184|NCT04115839|473421659|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
131489185|NCT04115839|473421653|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
131489186|NCT04115839|473421654|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
131489187|NCT04115839|473421655|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
131489188|NCT04115839|473421656|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
131489189|NCT04115839|473421657|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
131489190|NCT04115839|473421658|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
131489191|NCT04115839|473421659|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
131489192|NCT04115839|473421653|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
131489193|NCT04115839|473421654|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
131489194|NCT04115839|473421655|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
131489195|NCT04115839|473421656|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
131489196|NCT04115839|473421657|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
131489197|NCT04115839|473421658|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
131489198|NCT04115839|473421659|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
131489199|NCT04115839|473421653|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
131489200|NCT04115839|473421654|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
131489201|NCT04115839|473421655|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
131489202|NCT04115839|473421656|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
131489203|NCT04115839|473421657|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
131489204|NCT04115839|473421658|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
131489205|NCT04115839|473421659|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
131489206|NCT04115839|473421653|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
131489207|NCT04115839|473421654|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
131489208|NCT04115839|473421655|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
131489209|NCT04115839|473421656|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
131489210|NCT04115839|473421657|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
131489211|NCT04115839|473421658|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
131489212|NCT04115839|473421659|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
131489213|NCT02966028|473421660|FG000|Overall Study|Adverse Event|7|||
131489214|NCT02966028|473421661|FG001|Overall Study|Adverse Event|13|||
131489215|NCT02966028|473421662|FG002|Overall Study|Adverse Event|10|||
131489216|NCT02966028|473421660|FG000|Overall Study|Physician Decision|1|||
131489217|NCT02966028|473421661|FG001|Overall Study|Physician Decision|0|||
131489218|NCT02966028|473421662|FG002|Overall Study|Physician Decision|2|||
131489219|NCT02966028|473421660|FG000|Overall Study|Withdrawal by Subject|7|||
131489220|NCT02966028|473421661|FG001|Overall Study|Withdrawal by Subject|5|||
131489221|NCT02966028|473421662|FG002|Overall Study|Withdrawal by Subject|5|||
131489222|NCT02966028|473421660|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
131489223|NCT02966028|473421661|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
131489224|NCT02966028|473421662|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
131489225|NCT00621985|473421663|FG000|Dexamethasone Admission|Adverse Event|1|||
131489226|NCT02587234|473421666|FG000|Overall Study|Withdrawal by Subject|1|||
131489227|NCT02587234|473421667|FG001|Overall Study|Withdrawal by Subject|1|||
131489228|NCT02587234|473421666|FG000|Overall Study|Lost to Follow-up|0|||
131489229|NCT02587234|473421667|FG001|Overall Study|Lost to Follow-up|2|||
131489230|NCT00684593|473421673|FG000|Overall Study|Adverse Event|0|||
131489231|NCT00684593|473421674|FG001|Overall Study|Adverse Event|2|||
131489232|NCT01001377|473421681|FG000|Overall Study|Ineligibility determined|2|||
131489233|NCT01001377|473421682|FG001|Overall Study|Ineligibility determined|0|||
131489234|NCT01001377|473421681|FG000|Overall Study|Withdrawal by Subject|19|||
131489235|NCT01001377|473421682|FG001|Overall Study|Withdrawal by Subject|20|||
131489236|NCT01001377|473421681|FG000|Overall Study|Lost to Follow-up|14|||
131489237|NCT01001377|473421682|FG001|Overall Study|Lost to Follow-up|17|||
131489238|NCT01001377|473421681|FG000|Overall Study|Death|391|||
131489239|NCT01001377|473421682|FG001|Overall Study|Death|384|||
131489240|NCT03039283|473421686|FG000|Overall Study|Protocol Violation|2|||
131489241|NCT02193867|473421687|FG000|Overall Study|Death|2|||
131489242|NCT02193867|473421687|FG000|Overall Study|Sponsor Study Termination|2|||
131489243|NCT00867568|473421688|FG000|Overall Study|Lack of Efficacy|10|||
131489244|NCT00867568|473421688|FG000|Overall Study|Adverse Event|4|||
131489245|NCT00867568|473421688|FG000|Overall Study|Withdrawal by Subject|1|||
131489246|NCT01619423|473421693|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
131489247|NCT01619423|473421694|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
131489248|NCT01619423|473421695|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
131489249|NCT01619423|473421696|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
131489250|NCT02340975|473421700|FG000|Overall Study|Death|6|||
131489251|NCT02340975|473421701|FG001|Overall Study|Death|23|||
131489252|NCT02340975|473421702|FG002|Overall Study|Death|21|||
131489253|NCT02340975|473421703|FG003|Overall Study|Death|7|||
131489254|NCT02340975|473421704|FG004|Overall Study|Death|21|||
131489255|NCT02340975|473421705|FG005|Overall Study|Death|13|||
131489256|NCT02340975|473421700|FG000|Overall Study|Lost to Follow-up|0|||
131489257|NCT02340975|473421701|FG001|Overall Study|Lost to Follow-up|0|||
131489258|NCT02340975|473421702|FG002|Overall Study|Lost to Follow-up|0|||
131489259|NCT02340975|473421703|FG003|Overall Study|Lost to Follow-up|0|||
131489260|NCT02340975|473421704|FG004|Overall Study|Lost to Follow-up|2|||
131489261|NCT02340975|473421705|FG005|Overall Study|Lost to Follow-up|0|||
131489262|NCT02340975|473421700|FG000|Overall Study|Withdrawal by Subject|0|||
131489263|NCT02340975|473421701|FG001|Overall Study|Withdrawal by Subject|0|||
131489264|NCT02340975|473421702|FG002|Overall Study|Withdrawal by Subject|3|||
131489265|NCT02340975|473421703|FG003|Overall Study|Withdrawal by Subject|3|||
131489266|NCT02340975|473421704|FG004|Overall Study|Withdrawal by Subject|2|||
131489267|NCT02340975|473421705|FG005|Overall Study|Withdrawal by Subject|0|||
131489268|NCT02340975|473421700|FG000|Overall Study|Other|0|||
131489269|NCT02340975|473421701|FG001|Overall Study|Other|4|||
131489270|NCT02340975|473421702|FG002|Overall Study|Other|0|||
131489271|NCT02340975|473421703|FG003|Overall Study|Other|2|||
131489272|NCT02340975|473421704|FG004|Overall Study|Other|0|||
131489273|NCT02340975|473421705|FG005|Overall Study|Other|6|||
131489274|NCT02228460|473421708|FG000|Overall Study|Adverse Event|1|||
131489275|NCT02228460|473421708|FG000|Overall Study|Lost to Follow-up|1|||
131489276|NCT01243892|473421709|FG000|Overall Study|Did not meet eligibility criteria|2|||
131489277|NCT01243892|473421710|FG001|Overall Study|Did not meet eligibility criteria|0|||
131489278|NCT00119106|473421711|FG000|Overall Study|HIV infected at baseline|179|||
131489279|NCT00119106|473421712|FG001|Overall Study|HIV infected at baseline|178|||
131489280|NCT03066804|473421713|FG000|Overall Study|Physician Decision|0|||
131489281|NCT03066804|473421714|FG001|Overall Study|Physician Decision|4|||
131489282|NCT03066804|473421713|FG000|Overall Study|Death|23|||
131489283|NCT03066804|473421714|FG001|Overall Study|Death|17|||
131489284|NCT03066804|473421713|FG000|Overall Study|Withdrawal by Subject|19|||
131489285|NCT03066804|473421714|FG001|Overall Study|Withdrawal by Subject|25|||
131489286|NCT03066804|473421713|FG000|Overall Study|Lost to Follow-up|2|||
131489287|NCT03066804|473421714|FG001|Overall Study|Lost to Follow-up|0|||
131489288|NCT03066804|473421713|FG000|Overall Study|Adverse Event|2|||
131489289|NCT03066804|473421714|FG001|Overall Study|Adverse Event|3|||
131489290|NCT03066804|473421713|FG000|Overall Study|Technical problems|5|||
131489291|NCT03066804|473421714|FG001|Overall Study|Technical problems|1|||
131489292|NCT03982368|473421722|FG000|Overall Study|Adverse Event|6|||
131489293|NCT03982368|473421723|FG001|Overall Study|Adverse Event|4|||
131489294|NCT03982368|473421724|FG002|Overall Study|Adverse Event|3|||
131489295|NCT03982368|473421722|FG000|Overall Study|Lost to Follow-up|2|||
131489296|NCT03982368|473421723|FG001|Overall Study|Lost to Follow-up|1|||
131489297|NCT03982368|473421724|FG002|Overall Study|Lost to Follow-up|0|||
131489298|NCT03982368|473421722|FG000|Overall Study|Withdrawal by Subject|1|||
131489299|NCT03982368|473421723|FG001|Overall Study|Withdrawal by Subject|2|||
131489300|NCT03982368|473421724|FG002|Overall Study|Withdrawal by Subject|0|||
131489301|NCT03982368|473421722|FG000|Overall Study|unknow|4|||
131489302|NCT03982368|473421723|FG001|Overall Study|unknow|0|||
131489303|NCT03982368|473421724|FG002|Overall Study|unknow|2|||
131489304|NCT00329238|473421725|FG000|Overall Study|Adverse Event|147|||
131489305|NCT00329238|473421726|FG001|Overall Study|Adverse Event|129|||
131489306|NCT00329238|473421725|FG000|Overall Study|Protocol Violation|23|||
131489307|NCT00329238|473421726|FG001|Overall Study|Protocol Violation|34|||
131489308|NCT00329238|473421725|FG000|Overall Study|Lost to Follow-up|2|||
131489309|NCT00329238|473421726|FG001|Overall Study|Lost to Follow-up|6|||
131489310|NCT00329238|473421725|FG000|Overall Study|Withdrawal by Subject|64|||
131489311|NCT00329238|473421726|FG001|Overall Study|Withdrawal by Subject|58|||
131489312|NCT00329238|473421725|FG000|Overall Study|Other reason (not specified)|40|||
131489313|NCT00329238|473421726|FG001|Overall Study|Other reason (not specified)|54|||
131489314|NCT03385564|473421730|FG000|Overall Study|Adverse Event|0|||
131489315|NCT03385564|473421731|FG001|Overall Study|Adverse Event|0|||
131489316|NCT03385564|473421732|FG002|Overall Study|Adverse Event|3|||
131489317|NCT03385564|473421733|FG003|Overall Study|Adverse Event|3|||
131489318|NCT03385564|473421730|FG000|Overall Study|Other than listed|0|||
131489319|NCT03385564|473421731|FG001|Overall Study|Other than listed|0|||
131489320|NCT03385564|473421732|FG002|Overall Study|Other than listed|0|||
131489321|NCT03385564|473421733|FG003|Overall Study|Other than listed|5|||
131489322|NCT03385564|473421730|FG000|Overall Study|Withdrawal by Subject|0|||
131489323|NCT03385564|473421731|FG001|Overall Study|Withdrawal by Subject|1|||
131489324|NCT03385564|473421732|FG002|Overall Study|Withdrawal by Subject|1|||
131489325|NCT03385564|473421733|FG003|Overall Study|Withdrawal by Subject|0|||
131489326|NCT03385564|473421730|FG000|Overall Study|Lack of Efficacy|0|||
131489327|NCT03385564|473421731|FG001|Overall Study|Lack of Efficacy|0|||
131489328|NCT03385564|473421732|FG002|Overall Study|Lack of Efficacy|0|||
131489329|NCT03385564|473421733|FG003|Overall Study|Lack of Efficacy|1|||
131489330|NCT03385564|473421730|FG000|Overall Study|Death|0|||
131489331|NCT03385564|473421731|FG001|Overall Study|Death|0|||
131489332|NCT03385564|473421732|FG002|Overall Study|Death|1|||
131489333|NCT03385564|473421733|FG003|Overall Study|Death|0|||
131489334|NCT02083783|473421740|FG000|Overall Study|Withdrawal by Subject|1|||
131489335|NCT02083783|473421741|FG001|Overall Study|Withdrawal by Subject|0|||
131489336|NCT02256631|473421744|FG000|Overall Study|Lost to Follow-up|1|||
131489337|NCT02256631|473421745|FG001|Overall Study|Lost to Follow-up|1|||
131489338|NCT02256631|473421746|FG002|Overall Study|Lost to Follow-up|0|||
131489339|NCT02256631|473421747|FG003|Overall Study|Lost to Follow-up|2|||
131489340|NCT02256631|473421748|FG004|Overall Study|Lost to Follow-up|0|||
131489341|NCT02256631|473421749|FG005|Overall Study|Lost to Follow-up|4|||
131489342|NCT02256631|473421750|FG006|Overall Study|Lost to Follow-up|1|||
131489343|NCT02256631|473421744|FG000|Overall Study|Withdrawal by Subject|0|||
131489344|NCT02256631|473421745|FG001|Overall Study|Withdrawal by Subject|0|||
131489345|NCT02256631|473421746|FG002|Overall Study|Withdrawal by Subject|0|||
131489346|NCT02256631|473421747|FG003|Overall Study|Withdrawal by Subject|1|||
131489347|NCT02256631|473421748|FG004|Overall Study|Withdrawal by Subject|1|||
131489348|NCT02256631|473421749|FG005|Overall Study|Withdrawal by Subject|0|||
131489349|NCT02256631|473421750|FG006|Overall Study|Withdrawal by Subject|1|||
131489350|NCT02256631|473421744|FG000|Overall Study|Unable to get to clinic|0|||
131489351|NCT02256631|473421745|FG001|Overall Study|Unable to get to clinic|2|||
131489352|NCT02256631|473421746|FG002|Overall Study|Unable to get to clinic|0|||
131489353|NCT02256631|473421747|FG003|Overall Study|Unable to get to clinic|1|||
131489354|NCT02256631|473421748|FG004|Overall Study|Unable to get to clinic|0|||
131489355|NCT02256631|473421749|FG005|Overall Study|Unable to get to clinic|1|||
131489356|NCT02256631|473421750|FG006|Overall Study|Unable to get to clinic|2|||
131489357|NCT00282984|473421751|FG000|Overall Study|Death|2|||
131489358|NCT00282984|473421752|FG001|Overall Study|Death|5|||
131489359|NCT00282984|473421751|FG000|Overall Study|Adverse Event|8|||
131489360|NCT00282984|473421752|FG001|Overall Study|Adverse Event|5|||
131489361|NCT00282984|473421751|FG000|Overall Study|Lack of Efficacy|0|||
131489362|NCT00282984|473421752|FG001|Overall Study|Lack of Efficacy|2|||
131489363|NCT00282984|473421751|FG000|Overall Study|Lost to Follow-up|14|||
131489364|NCT00282984|473421752|FG001|Overall Study|Lost to Follow-up|10|||
131489365|NCT00282984|473421751|FG000|Overall Study|Withdrawal by Participant|22|||
131489366|NCT00282984|473421752|FG001|Overall Study|Withdrawal by Participant|34|||
131489367|NCT00282984|473421751|FG000|Overall Study|Participant stopped study medication|2|||
131489368|NCT00282984|473421752|FG001|Overall Study|Participant stopped study medication|2|||
131489369|NCT00282984|473421751|FG000|Overall Study|Participant only allowed phone follow-up|0|||
131489370|NCT00282984|473421752|FG001|Overall Study|Participant only allowed phone follow-up|1|||
131489371|NCT00282984|473421751|FG000|Overall Study|Participant used antipsychosis meds|0|||
131489372|NCT00282984|473421752|FG001|Overall Study|Participant used antipsychosis meds|1|||
131489373|NCT00282984|473421751|FG000|Overall Study|lack of motivation|1|||
131489374|NCT00282984|473421752|FG001|Overall Study|lack of motivation|0|||
131489375|NCT00282984|473421751|FG000|Overall Study|in prison|0|||
131489376|NCT00282984|473421752|FG001|Overall Study|in prison|1|||
131489377|NCT00282984|473421751|FG000|Overall Study|Protocol Violation|2|||
131489378|NCT00282984|473421752|FG001|Overall Study|Protocol Violation|0|||
131489379|NCT02639065|473421758|FG000|Study Treatment|Disease Progression|13|||
131489380|NCT02639065|473421758|FG000|Study Treatment|Adverse Event|9|||
131489381|NCT02639065|473421758|FG000|Study Treatment|Withdrawal by Subject|1|||
131489382|NCT02639065|473421758|FG000|Follow up|Subject refused to follow up|1|||
131489383|NCT02639065|473421758|FG000|Follow up|Symptomatic Deterioration|2|||
131489384|NCT02639065|473421758|FG000|Follow up|Death|2|||
131489385|NCT02639065|473421758|FG000|Follow up|Study Terminated|1|||
131489386|NCT02639065|473421758|FG000|Follow up|Disease Progression|3|||
131489387|NCT00481078|473421759|FG000|Overall Study|Progression of disease|11|||
131489388|NCT00481078|473421760|FG001|Overall Study|Progression of disease|11|||
131489389|NCT00481078|473421759|FG000|Overall Study|Adverse Event|15|||
131489390|NCT00481078|473421760|FG001|Overall Study|Adverse Event|3|||
131489391|NCT00481078|473421759|FG000|Overall Study|Death|5|||
131489392|NCT00481078|473421760|FG001|Overall Study|Death|3|||
131489393|NCT00481078|473421759|FG000|Overall Study|Intercurrent illness|1|||
131489394|NCT00481078|473421760|FG001|Overall Study|Intercurrent illness|0|||
131489395|NCT00481078|473421759|FG000|Overall Study|Withdrawal by Subject|7|||
131489396|NCT00481078|473421760|FG001|Overall Study|Withdrawal by Subject|1|||
131489397|NCT00481078|473421759|FG000|Overall Study|Information not available|1|||
131489398|NCT00481078|473421760|FG001|Overall Study|Information not available|0|||
131489399|NCT00481078|473421759|FG000|Overall Study|Received other treatment|2|||
131489400|NCT00481078|473421760|FG001|Overall Study|Received other treatment|1|||
131489401|NCT00481078|473421759|FG000|Overall Study|Brain metastasis|0|||
131489402|NCT00481078|473421760|FG001|Overall Study|Brain metastasis|1|||
131489403|NCT01558271|473421761|FG000|Overall Study|Adverse Event|6|||
131489404|NCT01558271|473421762|FG001|Overall Study|Adverse Event|3|||
131489405|NCT01558271|473421763|FG002|Overall Study|Adverse Event|4|||
131489406|NCT01558271|473421761|FG000|Overall Study|Lost to Follow-up|1|||
131489407|NCT01558271|473421762|FG001|Overall Study|Lost to Follow-up|0|||
131489408|NCT01558271|473421763|FG002|Overall Study|Lost to Follow-up|0|||
131489409|NCT01558271|473421761|FG000|Overall Study|Protocol Violation|1|||
131489410|NCT01558271|473421762|FG001|Overall Study|Protocol Violation|0|||
131489411|NCT01558271|473421763|FG002|Overall Study|Protocol Violation|0|||
131489412|NCT01558271|473421761|FG000|Overall Study|Withdrawal by Subject|10|||
131489413|NCT01558271|473421762|FG001|Overall Study|Withdrawal by Subject|6|||
131489414|NCT01558271|473421763|FG002|Overall Study|Withdrawal by Subject|12|||
131489415|NCT01558271|473421761|FG000|Overall Study|Physician Decision|0|||
131489416|NCT01558271|473421762|FG001|Overall Study|Physician Decision|2|||
131489417|NCT01558271|473421763|FG002|Overall Study|Physician Decision|1|||
131489418|NCT03329573|473421764|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
131489419|NCT03329573|473421765|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
131489420|NCT03329573|473421766|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
131489421|NCT03329573|473421767|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
131489422|NCT03329573|473421764|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
131489423|NCT03329573|473421765|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
131489424|NCT03329573|473421766|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131489425|NCT03329573|473421767|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131489426|NCT03329573|473421764|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
131489427|NCT03329573|473421765|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
131489428|NCT03329573|473421766|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
131489429|NCT03329573|473421767|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
131489430|NCT03329573|473421764|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
131489431|NCT03329573|473421765|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
131489432|NCT03329573|473421766|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
131489433|NCT03329573|473421767|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
131489434|NCT02777333|473421770|FG000|Overall Study|Withdrawal by Subject|0|||
131489435|NCT02777333|473421771|FG001|Overall Study|Withdrawal by Subject|1|||
131489436|NCT02777333|473421770|FG000|Overall Study|Lost to Follow-up|0|||
131489437|NCT02777333|473421771|FG001|Overall Study|Lost to Follow-up|1|||
131489438|NCT00837811|473421772|FG000|Overall Study|Adverse Event|4|||
131489439|NCT00837811|473421773|FG001|Overall Study|Adverse Event|6|||
131489440|NCT00837811|473421774|FG002|Overall Study|Adverse Event|0|||
131489441|NCT00837811|473421772|FG000|Overall Study|Death|1|||
131489442|NCT00837811|473421773|FG001|Overall Study|Death|1|||
131489443|NCT00837811|473421774|FG002|Overall Study|Death|0|||
131489444|NCT00837811|473421772|FG000|Overall Study|Lack of Efficacy|0|||
131489445|NCT00837811|473421773|FG001|Overall Study|Lack of Efficacy|11|||
131489446|NCT00837811|473421774|FG002|Overall Study|Lack of Efficacy|0|||
131489447|NCT00837811|473421772|FG000|Overall Study|Lost to Follow-up|1|||
131489448|NCT00837811|473421773|FG001|Overall Study|Lost to Follow-up|3|||
131489449|NCT00837811|473421774|FG002|Overall Study|Lost to Follow-up|0|||
131489450|NCT00837811|473421772|FG000|Overall Study|Physician Decision|0|||
131489451|NCT00837811|473421773|FG001|Overall Study|Physician Decision|2|||
131489452|NCT00837811|473421774|FG002|Overall Study|Physician Decision|1|||
131489453|NCT00837811|473421772|FG000|Overall Study|Withdrawal by Subject|1|||
131489454|NCT00837811|473421773|FG001|Overall Study|Withdrawal by Subject|9|||
131489455|NCT00837811|473421774|FG002|Overall Study|Withdrawal by Subject|0|||
131489456|NCT00837811|473421772|FG000|Overall Study|Sponsor Decision|0|||
131489457|NCT00837811|473421773|FG001|Overall Study|Sponsor Decision|2|||
131489458|NCT00837811|473421774|FG002|Overall Study|Sponsor Decision|0|||
131489459|NCT03307967|473421775|FG000|Overall Study|Lost to Follow-up|4|||
131489460|NCT02578316|473421776|FG000|Extension Phase|Progression of disease|6|||
131489461|NCT05372419|473421777|FG000|Overall Study|Protocol Deviation|1|||
131489462|NCT05372419|473421777|FG000|Overall Study|Withdrawal by Subject|5|||
131489463|NCT05372419|473421777|FG000|Overall Study|Lost to Follow-up|7|||
131489464|NCT04362072|473421781|FG000|Treatment|Adverse Event|1|||
131489465|NCT04362072|473421781|FG000|Treatment|Death|9|||
131489466|NCT04362072|473421781|FG000|Treatment|Physician Decision|2|||
131489467|NCT04362072|473421781|FG000|Treatment|Progressive disease|27|||
131489468|NCT04362072|473421781|FG000|Treatment|Withdrawal by Subject|4|||
131489469|NCT04362072|473421781|FG000|Treatment|Global deterioration of health status|1|||
131489470|NCT04362072|473421781|FG000|Treatment|Switched to commercial Lorlatinib|13|||
131489471|NCT04362072|473421781|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
131489472|NCT04362072|473421781|FG000|Treatment|Other|3|||
131489473|NCT04362072|473421781|FG000|Follow up|Death|2|||
131489474|NCT04362072|473421781|FG000|Follow up|Other|2|||
131489475|NCT01133522|473421782|FG000|Overall Study|Withdrawal by Subject|0|||
131489476|NCT01133522|473421783|FG001|Overall Study|Withdrawal by Subject|1|||
131489477|NCT01133522|473421784|FG002|Overall Study|Withdrawal by Subject|0|||
131489478|NCT01133522|473421785|FG003|Overall Study|Withdrawal by Subject|1|||
131489479|NCT01133522|473421786|FG004|Overall Study|Withdrawal by Subject|0|||
131489480|NCT01133522|473421787|FG005|Overall Study|Withdrawal by Subject|0|||
131489481|NCT01133522|473421788|FG006|Overall Study|Withdrawal by Subject|0|||
131489482|NCT01133522|473421789|FG007|Overall Study|Withdrawal by Subject|0|||
131489483|NCT01133522|473421790|FG008|Overall Study|Withdrawal by Subject|0|||
131489484|NCT01133522|473421791|FG009|Overall Study|Withdrawal by Subject|0|||
131489485|NCT01133522|473421782|FG000|Overall Study|Physician Decision|0|||
131489486|NCT01133522|473421783|FG001|Overall Study|Physician Decision|0|||
131489487|NCT01133522|473421784|FG002|Overall Study|Physician Decision|0|||
131489488|NCT01133522|473421785|FG003|Overall Study|Physician Decision|0|||
131489489|NCT01133522|473421786|FG004|Overall Study|Physician Decision|1|||
131489490|NCT01133522|473421787|FG005|Overall Study|Physician Decision|0|||
131489491|NCT01133522|473421788|FG006|Overall Study|Physician Decision|0|||
131489492|NCT01133522|473421789|FG007|Overall Study|Physician Decision|0|||
131489493|NCT01133522|473421790|FG008|Overall Study|Physician Decision|0|||
131489494|NCT01133522|473421791|FG009|Overall Study|Physician Decision|0|||
131489495|NCT04292743|473421792|FG000|Overall Study|Physician Decision|1|||
131489496|NCT04292743|473421793|FG001|Overall Study|Physician Decision|3|||
131489497|NCT04292743|473421794|FG002|Overall Study|Physician Decision|0|||
131489498|NCT04292743|473421795|FG003|Overall Study|Physician Decision|0|||
131489499|NCT04292743|473421792|FG000|Overall Study|Withdrawal by Subject|0|||
131489500|NCT04292743|473421793|FG001|Overall Study|Withdrawal by Subject|5|||
131489501|NCT04292743|473421794|FG002|Overall Study|Withdrawal by Subject|0|||
131489502|NCT04292743|473421795|FG003|Overall Study|Withdrawal by Subject|0|||
131489503|NCT04292743|473421792|FG000|Overall Study|Death|0|||
131489504|NCT04292743|473421793|FG001|Overall Study|Death|1|||
131489505|NCT04292743|473421794|FG002|Overall Study|Death|0|||
131489506|NCT04292743|473421795|FG003|Overall Study|Death|0|||
131489507|NCT04292743|473421792|FG000|Overall Study|Progression of Disease|2|||
131489508|NCT04292743|473421793|FG001|Overall Study|Progression of Disease|5|||
131489509|NCT04292743|473421794|FG002|Overall Study|Progression of Disease|0|||
131489510|NCT04292743|473421795|FG003|Overall Study|Progression of Disease|0|||
131489511|NCT04292743|473421792|FG000|Overall Study|No Treatment per protocol|0|||
131489512|NCT04292743|473421793|FG001|Overall Study|No Treatment per protocol|2|||
131489513|NCT04292743|473421794|FG002|Overall Study|No Treatment per protocol|0|||
131489514|NCT04292743|473421795|FG003|Overall Study|No Treatment per protocol|0|||
131489515|NCT05766423|473421796|FG000|Overall Study|Withdrawal by Subject|1|||
131489516|NCT05766423|473421797|FG001|Overall Study|Withdrawal by Subject|0|||
131489517|NCT05766423|473421796|FG000|Overall Study|Consented, not scheduled|3|||
131489518|NCT05766423|473421797|FG001|Overall Study|Consented, not scheduled|5|||
131489519|NCT03187197|473423291|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
131489520|NCT03187197|473423292|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
131489521|NCT03187197|473423293|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
131489522|NCT03187197|473423291|FG000|Overall Study|Withdrawal by Subject|8|||
131489523|NCT03187197|473423292|FG001|Overall Study|Withdrawal by Subject|63|||
131489524|NCT03187197|473423293|FG002|Overall Study|Withdrawal by Subject|4|||
131489525|NCT03187197|473423291|FG000|Overall Study|Lost to Follow-up|1|||
131489526|NCT03187197|473423292|FG001|Overall Study|Lost to Follow-up|60|||
131489527|NCT03187197|473423293|FG002|Overall Study|Lost to Follow-up|7|||
131489528|NCT03187197|473423291|FG000|Overall Study|Adverse Event|6|||
131489529|NCT03187197|473423292|FG001|Overall Study|Adverse Event|29|||
131489530|NCT03187197|473423293|FG002|Overall Study|Adverse Event|0|||
131489531|NCT03187197|473423291|FG000|Overall Study|Death|0|||
131489532|NCT03187197|473423292|FG001|Overall Study|Death|11|||
131489533|NCT03187197|473423293|FG002|Overall Study|Death|0|||
131489534|NCT03187197|473423291|FG000|Overall Study|Administrative problem|1|||
131489535|NCT03187197|473423292|FG001|Overall Study|Administrative problem|1|||
131489536|NCT03187197|473423293|FG002|Overall Study|Administrative problem|0|||
131489537|NCT03187197|473423291|FG000|Overall Study|Reason not listed|2|||
131489538|NCT03187197|473423292|FG001|Overall Study|Reason not listed|54|||
131489539|NCT03187197|473423293|FG002|Overall Study|Reason not listed|1|||
131489540|NCT03187197|473423291|FG000|Overall Study|Missing|1|||
131489541|NCT03187197|473423292|FG001|Overall Study|Missing|32|||
131489542|NCT03187197|473423293|FG002|Overall Study|Missing|3|||
131489543|NCT03187197|473423291|FG000|Overall Study|Status missing|2|||
131489544|NCT03187197|473423292|FG001|Overall Study|Status missing|33|||
131489545|NCT03187197|473423293|FG002|Overall Study|Status missing|3|||
131489546|NCT03187197|473423291|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
131489547|NCT03187197|473423292|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
131489548|NCT03187197|473423293|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
131489549|NCT02385045|473423294|FG000|Overall Study|Endoscopy could not be completed|4|||
131489550|NCT02469298|473423302|FG000|Overall Study|Protocol Violation|0|||
131489551|NCT02469298|473423303|FG001|Overall Study|Protocol Violation|1|||
131489552|NCT02469298|473423304|FG002|Overall Study|Protocol Violation|1|||
131489553|NCT02469298|473423305|FG003|Overall Study|Protocol Violation|0|||
131489554|NCT02469298|473423302|FG000|Overall Study|Lost to Follow-up|1|||
131489555|NCT02469298|473423303|FG001|Overall Study|Lost to Follow-up|0|||
131489556|NCT02469298|473423304|FG002|Overall Study|Lost to Follow-up|1|||
131489557|NCT02469298|473423305|FG003|Overall Study|Lost to Follow-up|0|||
131489558|NCT02469298|473423302|FG000|Overall Study|Physician Decision|0|||
131489559|NCT02469298|473423303|FG001|Overall Study|Physician Decision|0|||
131489560|NCT02469298|473423304|FG002|Overall Study|Physician Decision|0|||
131489561|NCT02469298|473423305|FG003|Overall Study|Physician Decision|1|||
131489562|NCT02469298|473423302|FG000|Overall Study|Withdrawal by Subject|0|||
131489563|NCT02469298|473423303|FG001|Overall Study|Withdrawal by Subject|0|||
131489564|NCT02469298|473423304|FG002|Overall Study|Withdrawal by Subject|0|||
131489565|NCT02469298|473423305|FG003|Overall Study|Withdrawal by Subject|1|||
131489566|NCT01664533|473423308|FG000|Overall Study|Death|42|||
131489567|NCT01664533|473423308|FG000|Overall Study|Lost to Follow-up|3|||
131489568|NCT01664533|473423308|FG000|Overall Study|Study termination|9|||
131489569|NCT01664533|473423308|FG000|Overall Study|Protocol Violation|3|||
131489570|NCT00290888|473423312|FG000|Overall Study|Physician Decision|3|||
131489571|NCT00290888|473423313|FG001|Overall Study|Physician Decision|1|||
131489572|NCT03000439|473423314|FG000|Open Label Part 1|Adverse Event|6|||
131489573|NCT03000439|473423315|FG001|Open Label Part 1|Adverse Event|0|||
131489574|NCT03000439|473423316|FG002|Open Label Part 1|Adverse Event|0|||
131489575|NCT03000439|473423317|FG003|Open Label Part 1|Adverse Event|0|||
131489576|NCT03000439|473423314|FG000|Open Label Part 1|Other|2|||
131489577|NCT03000439|473423315|FG001|Open Label Part 1|Other|0|||
131489578|NCT03000439|473423316|FG002|Open Label Part 1|Other|0|||
131489579|NCT03000439|473423317|FG003|Open Label Part 1|Other|0|||
131489580|NCT03000439|473423314|FG000|Open Label Part 1|Insufficient clinical response|16|||
131489581|NCT03000439|473423315|FG001|Open Label Part 1|Insufficient clinical response|0|||
131489582|NCT03000439|473423316|FG002|Open Label Part 1|Insufficient clinical response|0|||
131489583|NCT03000439|473423317|FG003|Open Label Part 1|Insufficient clinical response|0|||
131489584|NCT03000439|473423314|FG000|Open Label Part 2|Other|0|||
131489585|NCT03000439|473423315|FG001|Open Label Part 2|Other|5|||
131489586|NCT03000439|473423316|FG002|Open Label Part 2|Other|0|||
131489587|NCT03000439|473423317|FG003|Open Label Part 2|Other|0|||
131489588|NCT03000439|473423314|FG000|Open Label Part 2|Insufficient clinical response|0|||
131489589|NCT03000439|473423315|FG001|Open Label Part 2|Insufficient clinical response|12|||
131489590|NCT03000439|473423316|FG002|Open Label Part 2|Insufficient clinical response|0|||
131489591|NCT03000439|473423317|FG003|Open Label Part 2|Insufficient clinical response|0|||
131489592|NCT03000439|473423314|FG000|Double Blind Phase|Adverse Event|0|||
131489593|NCT03000439|473423315|FG001|Double Blind Phase|Adverse Event|0|||
131489594|NCT03000439|473423316|FG002|Double Blind Phase|Adverse Event|2|||
131489595|NCT03000439|473423317|FG003|Double Blind Phase|Adverse Event|1|||
131489596|NCT03000439|473423314|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
131489597|NCT03000439|473423315|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
131489598|NCT03000439|473423316|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
131489599|NCT03000439|473423317|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
131489600|NCT03000439|473423314|FG000|Double Blind Phase|Other|0|||
131489601|NCT03000439|473423315|FG001|Double Blind Phase|Other|0|||
131489602|NCT03000439|473423316|FG002|Double Blind Phase|Other|10|||
131489603|NCT03000439|473423317|FG003|Double Blind Phase|Other|11|||
131489604|NCT03000439|473423314|FG000|Double Blind Phase|Insufficient clinical response|0|||
131489605|NCT03000439|473423315|FG001|Double Blind Phase|Insufficient clinical response|0|||
131489606|NCT03000439|473423316|FG002|Double Blind Phase|Insufficient clinical response|0|||
131489607|NCT03000439|473423317|FG003|Double Blind Phase|Insufficient clinical response|2|||
131489608|NCT02370160|473423318|FG000|Overall Study|Death|3|||
131489609|NCT02370160|473423319|FG001|Overall Study|Death|4|||
131489610|NCT02370160|473423320|FG002|Overall Study|Death|1|||
131489611|NCT01581931|473423321|FG000|Washout|Adverse Event|0|||
131489612|NCT01581931|473423322|FG001|Washout|Adverse Event|1|||
131489613|NCT03156543|473423327|FG000|Overall Study|Withdrawal by Subject|1|||
131489614|NCT03156543|473423328|FG001|Overall Study|Withdrawal by Subject|0|||
131489615|NCT00674700|473423329|FG000|Year 1|Adverse Event|17|||
131489616|NCT00674700|473423330|FG001|Year 1|Adverse Event|20|||
131489617|NCT00674700|473423331|FG002|Year 1|Adverse Event|5|||
131489618|NCT00674700|473423329|FG000|Year 1|Withdrawal by Subject|7|||
131489619|NCT00674700|473423330|FG001|Year 1|Withdrawal by Subject|7|||
131489620|NCT00674700|473423331|FG002|Year 1|Withdrawal by Subject|6|||
131489621|NCT00674700|473423329|FG000|Year 1|Any other reason not above-mentioned|7|||
131489622|NCT00674700|473423330|FG001|Year 1|Any other reason not above-mentioned|7|||
131489623|NCT00674700|473423331|FG002|Year 1|Any other reason not above-mentioned|6|||
131489624|NCT00674700|473423329|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
131489625|NCT00674700|473423330|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
131489626|NCT00674700|473423331|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
131489627|NCT00674700|473423329|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
131489628|NCT00674700|473423330|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
131489629|NCT00674700|473423331|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
131489630|NCT00674700|473423329|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
131489631|NCT00674700|473423330|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
131489632|NCT00674700|473423331|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
131489633|NCT02954237|473423332|FG000|Overall Study|Withdrawal by Subject|25|||
131489634|NCT02954237|473423332|FG000|Overall Study|Missed visit|16|||
131489635|NCT02954237|473423332|FG000|Overall Study|Death|2|||
131489636|NCT03797014|473423334|FG000|Overall Study|Withdrawal by Subject|1|||
131489637|NCT03797014|473423334|FG000|Overall Study|Lost to Follow-up|1|||
131489638|NCT03797014|473423334|FG000|Overall Study|Protocol Violation|1|||
131489639|NCT02871297|473423335|FG000|Overall Study|Adverse Event|34|||
131489640|NCT02871297|473423335|FG000|Overall Study|Lack of Efficacy|10|||
131489641|NCT02871297|473423335|FG000|Overall Study|Non-compliance with study drug|15|||
131489642|NCT02871297|473423335|FG000|Overall Study|Protocol Violation|3|||
131489643|NCT02871297|473423335|FG000|Overall Study|Withdrawal by Subject|20|||
131489644|NCT02871297|473423335|FG000|Overall Study|Lost to Follow-up|13|||
131489645|NCT02871297|473423335|FG000|Overall Study|Rolled over to 13546A|2|||
131489646|NCT02871297|473423335|FG000|Overall Study|Other than specified|39|||
131489647|NCT00592384|473423340|FG000|Overall Study|Withdrawal by Subject|5|||
131489648|NCT00592384|473423341|FG001|Overall Study|Withdrawal by Subject|6|||
131489649|NCT02151591|473423343|FG000|Overall Study|Lost to Follow-up|6|||
131489650|NCT02151591|473423344|FG001|Overall Study|Lost to Follow-up|3|||
131489651|NCT00964860|473423347|FG000|Overall Study|Withdrawal by Subject|0|||
131489652|NCT00964860|473423348|FG001|Overall Study|Withdrawal by Subject|1|||
131489653|NCT03716024|473423349|FG000|Overall Study|Randomized, not Treated|7|||
131489654|NCT03716024|473423350|FG001|Overall Study|Randomized, not Treated|8|||
131489655|NCT03716024|473423349|FG000|Overall Study|Adverse Event|1|||
131489656|NCT03716024|473423350|FG001|Overall Study|Adverse Event|2|||
131489657|NCT03716024|473423349|FG000|Overall Study|Treatment Failure|1|||
131489658|NCT03716024|473423350|FG001|Overall Study|Treatment Failure|0|||
131489659|NCT03716024|473423349|FG000|Overall Study|Lost to Follow-up|2|||
131489660|NCT03716024|473423350|FG001|Overall Study|Lost to Follow-up|6|||
131489661|NCT03716024|473423349|FG000|Overall Study|Withdrawal by Subject|0|||
131489662|NCT03716024|473423350|FG001|Overall Study|Withdrawal by Subject|1|||
131489663|NCT03716024|473423349|FG000|Overall Study|Missing Reason|0|||
131489664|NCT03716024|473423350|FG001|Overall Study|Missing Reason|1|||
131489665|NCT02585960|473423351|FG000|PK/Safety Assessment Period|Physician Decision|0|||
131489666|NCT02585960|473423352|FG001|PK/Safety Assessment Period|Physician Decision|1|||
131489667|NCT02585960|473423353|FG002|PK/Safety Assessment Period|Physician Decision|0|||
131489668|NCT02585960|473423351|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
131489669|NCT02585960|473423352|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
131489670|NCT02585960|473423353|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
131489671|NCT02585960|473423351|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
131489672|NCT02585960|473423352|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
131489673|NCT02585960|473423353|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
131489674|NCT02585960|473423351|FG000|PK/Safety Assessment Period|Other|4|||
131489675|NCT02585960|473423352|FG001|PK/Safety Assessment Period|Other|4|||
131489676|NCT02585960|473423353|FG002|PK/Safety Assessment Period|Other|0|||
131489677|NCT02585960|473423351|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
131489678|NCT02585960|473423352|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
131489679|NCT02585960|473423353|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
131489680|NCT02585960|473423351|FG000|PK/Safety Assessment Period|Screen Failure|0|||
131489681|NCT02585960|473423352|FG001|PK/Safety Assessment Period|Screen Failure|0|||
131489682|NCT02585960|473423353|FG002|PK/Safety Assessment Period|Screen Failure|1|||
131489683|NCT02585960|473423351|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
131489684|NCT02585960|473423352|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
131489685|NCT02585960|473423353|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
131489686|NCT02585960|473423351|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
131489687|NCT02585960|473423352|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
131489688|NCT02585960|473423353|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
131489689|NCT03639935|473423354|FG000|Overall Study|Death|3|||
131489690|NCT03639935|473423354|FG000|Overall Study|Adverse Event|1|||
131489691|NCT06333613|473423356|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
131489692|NCT03616600|473423358|FG000|Overall Study|Withdrawal by Subject|1|||
131489693|NCT03616600|473423359|FG001|Overall Study|Withdrawal by Subject|0|||
131489694|NCT01651039|473423363|FG000|Overall Study|Non-evaluables|5|||
131489695|NCT01651039|473423363|FG000|Overall Study|Physician Decision|2|||
131489696|NCT01651039|473423363|FG000|Overall Study|Withdrawal by Subject|1|||
131489697|NCT01651039|473423363|FG000|Overall Study|Progressive Disease|22|||
131489698|NCT03600818|473423364|FG000|Overall Study|Adverse Event|4|||
131489699|NCT03600818|473423365|FG001|Overall Study|Adverse Event|7|||
131489700|NCT03600818|473423364|FG000|Overall Study|Lack of Efficacy|9|||
131489701|NCT03600818|473423365|FG001|Overall Study|Lack of Efficacy|4|||
131489702|NCT03600818|473423364|FG000|Overall Study|Withdrawal by Subject|4|||
131489703|NCT03600818|473423365|FG001|Overall Study|Withdrawal by Subject|3|||
131489704|NCT03600818|473423364|FG000|Overall Study|Other-unspecified|5|||
131489705|NCT03600818|473423365|FG001|Overall Study|Other-unspecified|3|||
131489706|NCT03600818|473423364|FG000|Overall Study|Randomized and not treated|0|||
131489707|NCT03600818|473423365|FG001|Overall Study|Randomized and not treated|1|||
131489708|NCT02059395|473423369|FG000|Overall Study|Lost to Follow-up|2|||
131489709|NCT02059395|473423370|FG001|Overall Study|Lost to Follow-up|4|||
131489710|NCT04930965|473423371|FG000|Overall Study|Lost to Follow-up|7|||
131489711|NCT04930965|473423372|FG001|Overall Study|Lost to Follow-up|5|||
131489712|NCT00134082|473423373|FG000|Overall Study|Adverse Event|2|||
131489713|NCT00134082|473423373|FG000|Overall Study|Death|1|||
131489714|NCT01488370|473423374|FG000|Overall Study|Protocol Violation|0|||
131489715|NCT01488370|473423375|FG001|Overall Study|Protocol Violation|1|||
131489716|NCT01488370|473423376|FG002|Overall Study|Protocol Violation|1|||
131489717|NCT01471171|473423377|FG000|Treatment Period 1|Adverse Event|4|||
131489718|NCT01471171|473423378|FG001|Treatment Period 1|Adverse Event|1|||
131489719|NCT01471171|473423377|FG000|Treatment Period 2|Adverse Event|1|||
131489720|NCT01471171|473423378|FG001|Treatment Period 2|Adverse Event|0|||
131489721|NCT04189081|473423379|FG000|Overall Study|Lost to Follow-up|1|||
131489722|NCT04189081|473423380|FG001|Overall Study|Lost to Follow-up|0|||
131489723|NCT04189081|473423381|FG002|Overall Study|Lost to Follow-up|0|||
131489724|NCT04189081|473423379|FG000|Overall Study|Withdrawal by Subject|0|||
131489725|NCT04189081|473423380|FG001|Overall Study|Withdrawal by Subject|0|||
131489726|NCT04189081|473423381|FG002|Overall Study|Withdrawal by Subject|1|||
131489727|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
131489728|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
131489729|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
131489730|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
131489731|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
131489732|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
131489733|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
131489734|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
131489735|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
131489736|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
131489737|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
131489738|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
131489739|NCT00044083|473423382|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
131489740|NCT00044083|473423383|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
131489741|NCT00044083|473423382|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
131489742|NCT00044083|473423383|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
131489743|NCT00044083|473423382|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
131489744|NCT00044083|473423383|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
131489745|NCT00044083|473423382|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
131489746|NCT00044083|473423383|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
131489747|NCT00705484|473423388|FG000|Overall Study|Adverse Event|28|||
131489748|NCT00705484|473423389|FG001|Overall Study|Adverse Event|27|||
131489749|NCT00705484|473423388|FG000|Overall Study|Lost to Follow-up|169|||
131489750|NCT00705484|473423389|FG001|Overall Study|Lost to Follow-up|250|||
131489751|NCT00705484|473423388|FG000|Overall Study|Withdrawal by Subject|96|||
131489752|NCT00705484|473423389|FG001|Overall Study|Withdrawal by Subject|72|||
131489753|NCT00705484|473423388|FG000|Overall Study|Administrative|89|||
131489754|NCT00705484|473423389|FG001|Overall Study|Administrative|59|||
131489755|NCT01253408|473423410|FG000|Overall Study|Adverse Event|0|||
131489756|NCT01253408|473423411|FG001|Overall Study|Adverse Event|1|||
131489757|NCT01253408|473423412|FG002|Overall Study|Adverse Event|0|||
131489758|NCT00629707|473423416|FG000|Overall Study|Withdrawal by Subject|0|||
131489759|NCT00629707|473423417|FG001|Overall Study|Withdrawal by Subject|1|||
131489760|NCT00629707|473423416|FG000|Overall Study|Physician Decision|0|||
131489761|NCT00629707|473423417|FG001|Overall Study|Physician Decision|1|||
131489762|NCT00361569|473423418|FG000|Overall Study|Protocol Violation|3|||
131489763|NCT00361569|473423419|FG001|Overall Study|Protocol Violation|2|||
131489764|NCT00361569|473423420|FG002|Overall Study|Protocol Violation|4|||
131489765|NCT00361569|473423421|FG003|Overall Study|Protocol Violation|2|||
131489766|NCT00361569|473423418|FG000|Overall Study|Withdrawal by Subject|2|||
131489767|NCT00361569|473423419|FG001|Overall Study|Withdrawal by Subject|1|||
131489768|NCT00361569|473423420|FG002|Overall Study|Withdrawal by Subject|9|||
131489769|NCT00361569|473423421|FG003|Overall Study|Withdrawal by Subject|14|||
131489770|NCT00361569|473423418|FG000|Overall Study|Adverse Event|3|||
131489771|NCT00361569|473423419|FG001|Overall Study|Adverse Event|5|||
131489772|NCT00361569|473423420|FG002|Overall Study|Adverse Event|2|||
131489773|NCT00361569|473423421|FG003|Overall Study|Adverse Event|2|||
131489774|NCT00361569|473423418|FG000|Overall Study|Lost to Follow-up|2|||
131489775|NCT00361569|473423419|FG001|Overall Study|Lost to Follow-up|3|||
131489776|NCT00361569|473423420|FG002|Overall Study|Lost to Follow-up|3|||
131489777|NCT00361569|473423421|FG003|Overall Study|Lost to Follow-up|2|||
131489778|NCT00361569|473423418|FG000|Overall Study|Not specified by investigator|2|||
131489779|NCT00361569|473423419|FG001|Overall Study|Not specified by investigator|0|||
131489780|NCT00361569|473423420|FG002|Overall Study|Not specified by investigator|0|||
131489781|NCT00361569|473423421|FG003|Overall Study|Not specified by investigator|1|||
131489782|NCT01845831|473423422|FG000|Inpatient Phase|Withdrawal by Subject|1|||
131489783|NCT01845831|473423423|FG001|Inpatient Phase|Withdrawal by Subject|1|||
131489784|NCT01845831|473423424|FG002|Inpatient Phase|Withdrawal by Subject|0|||
131489785|NCT01845831|473423425|FG003|Inpatient Phase|Withdrawal by Subject|0|||
131489786|NCT01845831|473423426|FG004|Inpatient Phase|Withdrawal by Subject|0|||
131489787|NCT02610725|473423427|FG000|Overall Study|Lost to Follow-up|197|||
131489788|NCT02610725|473423427|FG000|Overall Study|self-reported contraindication|9|||
131489789|NCT00826943|473423428|FG000|Overall Study|Withdrawal by Subject|0|||
131489790|NCT00826943|473423429|FG001|Overall Study|Withdrawal by Subject|0|||
131489791|NCT00826943|473423430|FG002|Overall Study|Withdrawal by Subject|0|||
131489792|NCT00826943|473423431|FG003|Overall Study|Withdrawal by Subject|0|||
131489793|NCT00826943|473423432|FG004|Overall Study|Withdrawal by Subject|1|||
131489794|NCT00826943|473423433|FG005|Overall Study|Withdrawal by Subject|0|||
131489795|NCT05570500|473423434|FG000|Overall Study|Lost to Follow-up|7|||
131489796|NCT05570500|473423435|FG001|Overall Study|Lost to Follow-up|5|||
131489797|NCT02302807|473423436|FG000|Overall Study|Withdrawal by Subject|28|||
131489798|NCT02302807|473423437|FG001|Overall Study|Withdrawal by Subject|11|||
131489799|NCT02302807|473423436|FG000|Overall Study|Lost to Follow-up|4|||
131489800|NCT02302807|473423437|FG001|Overall Study|Lost to Follow-up|6|||
131489801|NCT02302807|473423436|FG000|Overall Study|Death|397|||
131489802|NCT02302807|473423437|FG001|Overall Study|Death|385|||
131489803|NCT02302807|473423436|FG000|Overall Study|Study Terminated By Sponsor|35|||
131489804|NCT02302807|473423437|FG001|Overall Study|Study Terminated By Sponsor|64|||
131489805|NCT02302807|473423436|FG000|Overall Study|Physician Decision|0|||
131489806|NCT02302807|473423437|FG001|Overall Study|Physician Decision|1|||
131489807|NCT03278873|473423438|FG000|Overall Study|Withdrawal by Subject|0|||
131489808|NCT03278873|473423439|FG001|Overall Study|Withdrawal by Subject|1|||
131489809|NCT03278873|473423440|FG002|Overall Study|Withdrawal by Subject|0|||
131489810|NCT03278873|473423441|FG003|Overall Study|Withdrawal by Subject|0|||
131489811|NCT03278873|473423438|FG000|Overall Study|Sponsor's decision|0|||
131489812|NCT03278873|473423439|FG001|Overall Study|Sponsor's decision|1|||
131489813|NCT03278873|473423440|FG002|Overall Study|Sponsor's decision|0|||
131489814|NCT03278873|473423441|FG003|Overall Study|Sponsor's decision|0|||
131489815|NCT03278873|473423438|FG000|Overall Study|Early Termination|2|||
131489816|NCT03278873|473423439|FG001|Overall Study|Early Termination|6|||
131489817|NCT03278873|473423440|FG002|Overall Study|Early Termination|0|||
131489818|NCT03278873|473423441|FG003|Overall Study|Early Termination|4|||
131489819|NCT03278873|473423438|FG000|Overall Study|Lost to Follow-up|0|||
131489820|NCT03278873|473423439|FG001|Overall Study|Lost to Follow-up|0|||
131489821|NCT03278873|473423440|FG002|Overall Study|Lost to Follow-up|2|||
131489822|NCT03278873|473423441|FG003|Overall Study|Lost to Follow-up|0|||
131489823|NCT03278873|473423438|FG000|Overall Study|The patient decided to withdraw via email|1|||
131489824|NCT03278873|473423439|FG001|Overall Study|The patient decided to withdraw via email|0|||
131489825|NCT03278873|473423440|FG002|Overall Study|The patient decided to withdraw via email|0|||
131489826|NCT03278873|473423441|FG003|Overall Study|The patient decided to withdraw via email|0|||
131489827|NCT03278873|473423438|FG000|Overall Study|The patient was unresponsive to contact|0|||
131489828|NCT03278873|473423439|FG001|Overall Study|The patient was unresponsive to contact|0|||
131489829|NCT03278873|473423440|FG002|Overall Study|The patient was unresponsive to contact|0|||
131489830|NCT03278873|473423441|FG003|Overall Study|The patient was unresponsive to contact|4|||
131489831|NCT03278873|473423438|FG000|Overall Study|The patient wished to participate no longer|0|||
131489832|NCT03278873|473423439|FG001|Overall Study|The patient wished to participate no longer|1|||
131489833|NCT03278873|473423440|FG002|Overall Study|The patient wished to participate no longer|0|||
131489834|NCT03278873|473423441|FG003|Overall Study|The patient wished to participate no longer|0|||
131489835|NCT03278873|473423438|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
131489836|NCT03278873|473423439|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
131489837|NCT03278873|473423440|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
131489838|NCT03278873|473423441|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
131489839|NCT00540514|473425439|FG000|Overall Study|Still on treatment|3|||
131489840|NCT00540514|473425440|FG001|Overall Study|Still on treatment|0|||
131489841|NCT00540514|473425439|FG000|Overall Study|Unacceptable Toxicity|61|||
131489842|NCT00540514|473425440|FG001|Overall Study|Unacceptable Toxicity|62|||
131489843|NCT00540514|473425439|FG000|Overall Study|Adverse Event|20|||
131489844|NCT00540514|473425440|FG001|Overall Study|Adverse Event|24|||
131489845|NCT00540514|473425439|FG000|Overall Study|Physician Decision|86|||
131489846|NCT00540514|473425440|FG001|Overall Study|Physician Decision|99|||
131489847|NCT00540514|473425439|FG000|Overall Study|Protocol Deviation|3|||
131489848|NCT00540514|473425440|FG001|Overall Study|Protocol Deviation|4|||
131489849|NCT00540514|473425439|FG000|Overall Study|Lost to Follow-up|1|||
131489850|NCT00540514|473425440|FG001|Overall Study|Lost to Follow-up|1|||
131489851|NCT00540514|473425439|FG000|Overall Study|Withdrawal by Subject|65|||
131489852|NCT00540514|473425440|FG001|Overall Study|Withdrawal by Subject|67|||
131489853|NCT00540514|473425439|FG000|Overall Study|Excluded prior to treatment|7|||
131489854|NCT00540514|473425440|FG001|Overall Study|Excluded prior to treatment|7|||
131489855|NCT00540514|473425439|FG000|Overall Study|Paclitaxel not available|0|||
131489856|NCT00540514|473425440|FG001|Overall Study|Paclitaxel not available|2|||
131489857|NCT02501473|473425443|FG000|Overall Study|Study Terminated|2|||
131489858|NCT02501473|473425444|FG001|Overall Study|Study Terminated|3|||
131489859|NCT02501473|473425445|FG002|Overall Study|Study Terminated|7|||
131489860|NCT02501473|473425446|FG003|Overall Study|Study Terminated|9|||
131489861|NCT02501473|473425447|FG004|Overall Study|Study Terminated|2|||
131489862|NCT02501473|473425448|FG005|Overall Study|Study Terminated|10|||
131489863|NCT02501473|473425449|FG006|Overall Study|Study Terminated|1|||
131489864|NCT02501473|473425450|FG007|Overall Study|Study Terminated|0|||
131489865|NCT02501473|473425443|FG000|Overall Study|Withdrawal by Subject|0|||
131489866|NCT02501473|473425444|FG001|Overall Study|Withdrawal by Subject|0|||
131489867|NCT02501473|473425445|FG002|Overall Study|Withdrawal by Subject|3|||
131489868|NCT02501473|473425446|FG003|Overall Study|Withdrawal by Subject|3|||
131489869|NCT02501473|473425447|FG004|Overall Study|Withdrawal by Subject|2|||
131489870|NCT02501473|473425448|FG005|Overall Study|Withdrawal by Subject|2|||
131489871|NCT02501473|473425449|FG006|Overall Study|Withdrawal by Subject|0|||
131489872|NCT02501473|473425450|FG007|Overall Study|Withdrawal by Subject|0|||
131489873|NCT02501473|473425443|FG000|Overall Study|Death|0|||
131489874|NCT02501473|473425444|FG001|Overall Study|Death|0|||
131489875|NCT02501473|473425445|FG002|Overall Study|Death|1|||
131489876|NCT02501473|473425446|FG003|Overall Study|Death|1|||
131489877|NCT02501473|473425447|FG004|Overall Study|Death|0|||
131489878|NCT02501473|473425448|FG005|Overall Study|Death|1|||
131489879|NCT02501473|473425449|FG006|Overall Study|Death|0|||
131489880|NCT02501473|473425450|FG007|Overall Study|Death|0|||
131489881|NCT02501473|473425443|FG000|Overall Study|Lost to Follow-up|1|||
131489882|NCT02501473|473425444|FG001|Overall Study|Lost to Follow-up|0|||
131489883|NCT02501473|473425445|FG002|Overall Study|Lost to Follow-up|1|||
131489884|NCT02501473|473425446|FG003|Overall Study|Lost to Follow-up|0|||
131489885|NCT02501473|473425447|FG004|Overall Study|Lost to Follow-up|0|||
131489886|NCT02501473|473425448|FG005|Overall Study|Lost to Follow-up|1|||
131489887|NCT02501473|473425449|FG006|Overall Study|Lost to Follow-up|0|||
131489888|NCT02501473|473425450|FG007|Overall Study|Lost to Follow-up|0|||
131489889|NCT02501473|473425443|FG000|Overall Study|Reason not specified|0|||
131489890|NCT02501473|473425444|FG001|Overall Study|Reason not specified|0|||
131489891|NCT02501473|473425445|FG002|Overall Study|Reason not specified|1|||
131489892|NCT02501473|473425446|FG003|Overall Study|Reason not specified|1|||
131489893|NCT02501473|473425447|FG004|Overall Study|Reason not specified|0|||
131489894|NCT02501473|473425448|FG005|Overall Study|Reason not specified|0|||
131489895|NCT02501473|473425449|FG006|Overall Study|Reason not specified|0|||
131489896|NCT02501473|473425450|FG007|Overall Study|Reason not specified|0|||
131489897|NCT04487730|473425451|FG000|Overall Study|Withdrawal by Subject|3|||
131489898|NCT04487730|473425452|FG001|Overall Study|Withdrawal by Subject|1|||
131489899|NCT04487730|473425451|FG000|Overall Study|Lost to Follow-up|0|||
131489900|NCT04487730|473425452|FG001|Overall Study|Lost to Follow-up|1|||
131489901|NCT04487730|473425451|FG000|Overall Study|Physician Decision|0|||
131489902|NCT04487730|473425452|FG001|Overall Study|Physician Decision|1|||
131489903|NCT02397278|473425455|FG000|Overall Study|Withdrawal by Subject|0|||
131489904|NCT02397278|473425456|FG001|Overall Study|Withdrawal by Subject|2|||
131489905|NCT02397278|473425455|FG000|Overall Study|Deemed ineligible following surgery|1|||
131489906|NCT02397278|473425456|FG001|Overall Study|Deemed ineligible following surgery|1|||
131489907|NCT01397084|473425461|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
131489908|NCT01397084|473425461|FG000|Overall Study|Protocol Violation|2|||
131489909|NCT01397084|473425461|FG000|Overall Study|Adverse Event|2|||
131489910|NCT01397084|473425461|FG000|Overall Study|Withdrawal by Subject|1|||
131489911|NCT01397084|473425461|FG000|Overall Study|Lost to Follow-up|1|||
131489912|NCT01397084|473425461|FG000|Overall Study|Used other proton pump inhibitor|1|||
131489913|NCT00618072|473425462|FG000|Overall Study|Lost to Follow-up|2|||
131489914|NCT00618072|473425463|FG001|Overall Study|Lost to Follow-up|0|||
131489915|NCT00618072|473425464|FG002|Overall Study|Lost to Follow-up|3|||
131489916|NCT00618072|473425462|FG000|Overall Study|Physician Decision|0|||
131489917|NCT00618072|473425463|FG001|Overall Study|Physician Decision|1|||
131489918|NCT00618072|473425464|FG002|Overall Study|Physician Decision|1|||
131489919|NCT03292588|473425465|FG000|Overall Study|Death|1|||
131489920|NCT03292588|473425466|FG001|Overall Study|Death|0|||
131489921|NCT03292588|473425465|FG000|Overall Study|Lost to Follow-up|12|||
131489922|NCT03292588|473425466|FG001|Overall Study|Lost to Follow-up|16|||
131489923|NCT03292588|473425465|FG000|Overall Study|Physician Decision|0|||
131489924|NCT03292588|473425466|FG001|Overall Study|Physician Decision|1|||
131489925|NCT03292588|473425465|FG000|Overall Study|Withdrawal by Subject|4|||
131489926|NCT03292588|473425466|FG001|Overall Study|Withdrawal by Subject|4|||
131489927|NCT03292588|473425465|FG000|Overall Study|Move out of town|1|||
131489928|NCT03292588|473425466|FG001|Overall Study|Move out of town|0|||
131489929|NCT03292588|473425465|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
131489930|NCT03292588|473425466|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
131489931|NCT00062374|473425467|FG000|Overall Study|Not treated|12|||
131489932|NCT03633695|473425470|FG000|Overall Study|Lost to Follow-up|4|||
131489933|NCT03633695|473425471|FG001|Overall Study|Lost to Follow-up|5|||
131489934|NCT03633695|473425470|FG000|Overall Study|Discontinued|8|||
131489935|NCT03633695|473425471|FG001|Overall Study|Discontinued|4|||
131489936|NCT00617773|473425472|FG000|Overall Study|Physician Decision|1|||
131489937|NCT00617773|473425472|FG000|Overall Study|Lack of compliance with the protocol|1|||
131489938|NCT00617773|473425472|FG000|Overall Study|Withdrawal by Subject|1|||
131489939|NCT00617773|473425472|FG000|Overall Study|Death|1|||
131489940|NCT00617773|473425472|FG000|Overall Study|Progressive disease|19|||
131489941|NCT00617773|473425472|FG000|Overall Study|Protocol Violation|1|||
131489942|NCT01751867|473425473|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
131489943|NCT01751867|473425474|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
131489944|NCT01751867|473425473|FG000|Overall Study|Diease Progression|4|||
131489945|NCT01751867|473425474|FG001|Overall Study|Diease Progression|18|||
131489946|NCT01751867|473425473|FG000|Overall Study|Adverse Event|8|||
131489947|NCT01751867|473425474|FG001|Overall Study|Adverse Event|15|||
131489948|NCT01751867|473425473|FG000|Overall Study|Poor Compliance|0|||
131489949|NCT01751867|473425474|FG001|Overall Study|Poor Compliance|5|||
131489950|NCT01751867|473425473|FG000|Overall Study|Withdrawal by Subject|3|||
131489951|NCT01751867|473425474|FG001|Overall Study|Withdrawal by Subject|1|||
131489952|NCT01751867|473425473|FG000|Overall Study|Physician Decision|4|||
131489953|NCT01751867|473425474|FG001|Overall Study|Physician Decision|7|||
131489954|NCT01751867|473425473|FG000|Overall Study|Protocol Violation|0|||
131489955|NCT01751867|473425474|FG001|Overall Study|Protocol Violation|2|||
131489956|NCT01751867|473425473|FG000|Overall Study|Death|0|||
131489957|NCT01751867|473425474|FG001|Overall Study|Death|5|||
131489958|NCT01751867|473425473|FG000|Overall Study|Other|11|||
131489959|NCT01751867|473425474|FG001|Overall Study|Other|37|||
131489960|NCT01751867|473425473|FG000|Overall Study|Randomized but not treated.|2|||
131489961|NCT01751867|473425474|FG001|Overall Study|Randomized but not treated.|1|||
131489962|NCT04932096|473425475|FG000|Overall Study|Withdrawal by Subject|1|||
131489963|NCT04932096|473425476|FG001|Overall Study|Withdrawal by Subject|1|||
131489964|NCT04932096|473425475|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
131489965|NCT04932096|473425476|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
131489966|NCT00777608|473425477|FG000|Overall Study|Lost to Follow-up|1|||
131489967|NCT00777608|473425478|FG001|Overall Study|Lost to Follow-up|1|||
131489968|NCT00777608|473425477|FG000|Overall Study|Withdrawal by Subject|1|||
131489969|NCT00777608|473425478|FG001|Overall Study|Withdrawal by Subject|3|||
131489970|NCT00777608|473425477|FG000|Overall Study|Protocol Violation|1|||
131489971|NCT00777608|473425478|FG001|Overall Study|Protocol Violation|0|||
131489972|NCT00777608|473425477|FG000|Overall Study|Investigator Decision|1|||
131489973|NCT00777608|473425478|FG001|Overall Study|Investigator Decision|2|||
131489974|NCT02853604|473425479|FG000|Overall Study|Withdrawal by Subject|12|||
131489975|NCT02853604|473425480|FG001|Overall Study|Withdrawal by Subject|35|||
131489976|NCT02853604|473425479|FG000|Overall Study|Lost to Follow-up|4|||
131489977|NCT02853604|473425480|FG001|Overall Study|Lost to Follow-up|8|||
131489978|NCT02853604|473425479|FG000|Overall Study|Death|1|||
131489979|NCT02853604|473425480|FG001|Overall Study|Death|5|||
131489980|NCT02853604|473425479|FG000|Overall Study|Miscellaneous|11|||
131489981|NCT02853604|473425480|FG001|Overall Study|Miscellaneous|2|||
131489982|NCT02853604|473425479|FG000|Overall Study|Progressive Disease|0|||
131489983|NCT02853604|473425480|FG001|Overall Study|Progressive Disease|2|||
131489984|NCT03766581|473425481|FG000|Randomization|Other reasons|2|||
131489985|NCT03766581|473425482|FG001|Randomization|Other reasons|1|||
131489986|NCT03766581|473425483|FG002|Randomization|Other reasons|0|||
131489987|NCT03766581|473425484|FG003|Randomization|Other reasons|1|||
131489988|NCT03766581|473425485|FG004|Randomization|Other reasons|0|||
131489989|NCT03766581|473425486|FG005|Randomization|Other reasons|0|||
131489990|NCT03766581|473425487|FG006|Randomization|Other reasons|0|||
131489991|NCT03766581|473425488|FG007|Randomization|Other reasons|0|||
131489992|NCT03766581|473425481|FG000|Randomization|Participant no longer meets study criteria|5|||
131489993|NCT03766581|473425482|FG001|Randomization|Participant no longer meets study criteria|3|||
131489994|NCT03766581|473425483|FG002|Randomization|Participant no longer meets study criteria|4|||
131489995|NCT03766581|473425484|FG003|Randomization|Participant no longer meets study criteria|0|||
131489996|NCT03766581|473425485|FG004|Randomization|Participant no longer meets study criteria|2|||
131489997|NCT03766581|473425486|FG005|Randomization|Participant no longer meets study criteria|3|||
131489998|NCT03766581|473425487|FG006|Randomization|Participant no longer meets study criteria|0|||
131489999|NCT03766581|473425488|FG007|Randomization|Participant no longer meets study criteria|1|||
131490000|NCT03766581|473425481|FG000|Randomization|Participant request to discontinue study treatment|1|||
131490001|NCT03766581|473425482|FG001|Randomization|Participant request to discontinue study treatment|0|||
131490002|NCT03766581|473425483|FG002|Randomization|Participant request to discontinue study treatment|0|||
131490003|NCT03766581|473425484|FG003|Randomization|Participant request to discontinue study treatment|0|||
131490004|NCT03766581|473425485|FG004|Randomization|Participant request to discontinue study treatment|1|||
131490005|NCT03766581|473425486|FG005|Randomization|Participant request to discontinue study treatment|2|||
131490006|NCT03766581|473425487|FG006|Randomization|Participant request to discontinue study treatment|0|||
131490007|NCT03766581|473425488|FG007|Randomization|Participant request to discontinue study treatment|0|||
131490008|NCT03766581|473425481|FG000|Randomization|Participant withdrew consent|1|||
131490009|NCT03766581|473425482|FG001|Randomization|Participant withdrew consent|0|||
131490010|NCT03766581|473425483|FG002|Randomization|Participant withdrew consent|1|||
131490011|NCT03766581|473425484|FG003|Randomization|Participant withdrew consent|2|||
131490012|NCT03766581|473425485|FG004|Randomization|Participant withdrew consent|1|||
131490013|NCT03766581|473425486|FG005|Randomization|Participant withdrew consent|1|||
131490014|NCT03766581|473425487|FG006|Randomization|Participant withdrew consent|0|||
131490015|NCT03766581|473425488|FG007|Randomization|Participant withdrew consent|0|||
131490016|NCT03766581|473425481|FG000|Treatment|Adverse Event|82|||
131490017|NCT03766581|473425482|FG001|Treatment|Adverse Event|44|||
131490018|NCT03766581|473425483|FG002|Treatment|Adverse Event|47|||
131490019|NCT03766581|473425484|FG003|Treatment|Adverse Event|46|||
131490020|NCT03766581|473425485|FG004|Treatment|Adverse Event|50|||
131490021|NCT03766581|473425486|FG005|Treatment|Adverse Event|77|||
131490022|NCT03766581|473425487|FG006|Treatment|Adverse Event|5|||
131490023|NCT03766581|473425488|FG007|Treatment|Adverse Event|2|||
131490024|NCT03766581|473425481|FG000|Treatment|Participant request to discontinue treatment|34|||
131490025|NCT03766581|473425482|FG001|Treatment|Participant request to discontinue treatment|6|||
131490026|NCT03766581|473425483|FG002|Treatment|Participant request to discontinue treatment|10|||
131490027|NCT03766581|473425484|FG003|Treatment|Participant request to discontinue treatment|10|||
131490028|NCT03766581|473425485|FG004|Treatment|Participant request to discontinue treatment|14|||
131490029|NCT03766581|473425486|FG005|Treatment|Participant request to discontinue treatment|15|||
131490030|NCT03766581|473425487|FG006|Treatment|Participant request to discontinue treatment|0|||
131490031|NCT03766581|473425488|FG007|Treatment|Participant request to discontinue treatment|1|||
131490032|NCT03766581|473425481|FG000|Treatment|Participant withdrew consent|11|||
131490033|NCT03766581|473425482|FG001|Treatment|Participant withdrew consent|4|||
131490034|NCT03766581|473425483|FG002|Treatment|Participant withdrew consent|5|||
131490035|NCT03766581|473425484|FG003|Treatment|Participant withdrew consent|5|||
131490036|NCT03766581|473425485|FG004|Treatment|Participant withdrew consent|4|||
131490037|NCT03766581|473425486|FG005|Treatment|Participant withdrew consent|4|||
131490038|NCT03766581|473425487|FG006|Treatment|Participant withdrew consent|0|||
131490039|NCT03766581|473425488|FG007|Treatment|Participant withdrew consent|0|||
131490040|NCT03766581|473425481|FG000|Treatment|Death|1|||
131490041|NCT03766581|473425482|FG001|Treatment|Death|0|||
131490042|NCT03766581|473425483|FG002|Treatment|Death|0|||
131490043|NCT03766581|473425484|FG003|Treatment|Death|0|||
131490044|NCT03766581|473425485|FG004|Treatment|Death|0|||
131490045|NCT03766581|473425486|FG005|Treatment|Death|0|||
131490046|NCT03766581|473425487|FG006|Treatment|Death|0|||
131490047|NCT03766581|473425488|FG007|Treatment|Death|0|||
131490048|NCT03766581|473425481|FG000|Treatment|Lost to Follow-up|1|||
131490049|NCT03766581|473425482|FG001|Treatment|Lost to Follow-up|0|||
131490050|NCT03766581|473425483|FG002|Treatment|Lost to Follow-up|0|||
131490051|NCT03766581|473425484|FG003|Treatment|Lost to Follow-up|1|||
131490052|NCT03766581|473425485|FG004|Treatment|Lost to Follow-up|0|||
131490053|NCT03766581|473425486|FG005|Treatment|Lost to Follow-up|0|||
131490054|NCT03766581|473425487|FG006|Treatment|Lost to Follow-up|0|||
131490055|NCT03766581|473425488|FG007|Treatment|Lost to Follow-up|0|||
131490056|NCT03766581|473425481|FG000|Treatment|Poor/Non compliance|2|||
131490057|NCT03766581|473425482|FG001|Treatment|Poor/Non compliance|2|||
131490058|NCT03766581|473425483|FG002|Treatment|Poor/Non compliance|1|||
131490059|NCT03766581|473425484|FG003|Treatment|Poor/Non compliance|1|||
131490060|NCT03766581|473425485|FG004|Treatment|Poor/Non compliance|1|||
131490061|NCT03766581|473425486|FG005|Treatment|Poor/Non compliance|1|||
131490062|NCT03766581|473425487|FG006|Treatment|Poor/Non compliance|0|||
131490063|NCT03766581|473425488|FG007|Treatment|Poor/Non compliance|0|||
131490064|NCT03766581|473425481|FG000|Treatment|Participant no longer meets study criteria|9|||
131490065|NCT03766581|473425482|FG001|Treatment|Participant no longer meets study criteria|1|||
131490066|NCT03766581|473425483|FG002|Treatment|Participant no longer meets study criteria|5|||
131490067|NCT03766581|473425484|FG003|Treatment|Participant no longer meets study criteria|4|||
131490068|NCT03766581|473425485|FG004|Treatment|Participant no longer meets study criteria|4|||
131490069|NCT03766581|473425486|FG005|Treatment|Participant no longer meets study criteria|4|||
131490070|NCT03766581|473425487|FG006|Treatment|Participant no longer meets study criteria|2|||
131490071|NCT03766581|473425488|FG007|Treatment|Participant no longer meets study criteria|0|||
131490072|NCT03766581|473425481|FG000|Treatment|Other reasons|13|||
131490073|NCT03766581|473425482|FG001|Treatment|Other reasons|8|||
131490074|NCT03766581|473425483|FG002|Treatment|Other reasons|3|||
131490075|NCT03766581|473425484|FG003|Treatment|Other reasons|7|||
131490076|NCT03766581|473425485|FG004|Treatment|Other reasons|3|||
131490077|NCT03766581|473425486|FG005|Treatment|Other reasons|3|||
131490078|NCT03766581|473425487|FG006|Treatment|Other reasons|0|||
131490079|NCT03766581|473425488|FG007|Treatment|Other reasons|0|||
131490080|NCT04343261|473425489|FG000|Overall Study|Adverse Event|1|||
131490081|NCT04343261|473425489|FG000|Overall Study|received inadequate amount of antibodies|7|||
131490082|NCT00587054|473425490|FG000|Overall Study|Patient not treated|9|||
131490083|NCT03478930|473425493|FG000|Overall Study|Adverse Event|0|||
131490084|NCT03478930|473425494|FG001|Overall Study|Adverse Event|1|||
131490085|NCT03478930|473425493|FG000|Overall Study|Lack of Efficacy|3|||
131490086|NCT03478930|473425494|FG001|Overall Study|Lack of Efficacy|3|||
131490087|NCT03478930|473425493|FG000|Overall Study|Withdrawal by Subject|6|||
131490088|NCT03478930|473425494|FG001|Overall Study|Withdrawal by Subject|5|||
131490089|NCT05393895|473425496|FG000|Overall Study|Adverse Event|2|||
131490090|NCT05393895|473425497|FG001|Overall Study|Adverse Event|3|||
131490091|NCT05393895|473425496|FG000|Overall Study|Lost to Follow-up|4|||
131490092|NCT05393895|473425497|FG001|Overall Study|Lost to Follow-up|3|||
131490093|NCT05393895|473425496|FG000|Overall Study|Protocol Violation|1|||
131490094|NCT05393895|473425497|FG001|Overall Study|Protocol Violation|0|||
131490095|NCT05393895|473425496|FG000|Overall Study|Withdrawal by Subject|1|||
131490096|NCT05393895|473425497|FG001|Overall Study|Withdrawal by Subject|4|||
131490097|NCT02296320|473425498|FG000|Overall Study|Withdrawal by Subject|4|||
131490098|NCT02296320|473425499|FG001|Overall Study|Withdrawal by Subject|0|||
131490099|NCT02296320|473425500|FG002|Overall Study|Withdrawal by Subject|2|||
131490100|NCT02296320|473425498|FG000|Overall Study|Death|24|||
131490101|NCT02296320|473425499|FG001|Overall Study|Death|3|||
131490102|NCT02296320|473425500|FG002|Overall Study|Death|27|||
131490103|NCT02296320|473425498|FG000|Overall Study|Lost to Follow-up|5|||
131490104|NCT02296320|473425499|FG001|Overall Study|Lost to Follow-up|2|||
131490105|NCT02296320|473425500|FG002|Overall Study|Lost to Follow-up|7|||
131490106|NCT02296320|473425498|FG000|Overall Study|Not treated|2|||
131490107|NCT02296320|473425499|FG001|Overall Study|Not treated|0|||
131490108|NCT02296320|473425500|FG002|Overall Study|Not treated|0|||
131490109|NCT02296320|473425498|FG000|Overall Study|Not - specified|0|||
131490110|NCT02296320|473425499|FG001|Overall Study|Not - specified|0|||
131490111|NCT02296320|473425500|FG002|Overall Study|Not - specified|1|||
131490112|NCT03087643|473425505|FG000|Overall Study|Withdrawal by Subject|2|||
131490113|NCT03087643|473425506|FG001|Overall Study|Withdrawal by Subject|4|||
131490114|NCT03087643|473425505|FG000|Overall Study|Death|2|||
131490115|NCT03087643|473425506|FG001|Overall Study|Death|2|||
131490116|NCT01546883|473425507|FG000|Overall Study|Withdrawal by Subject|3|||
131490117|NCT01546883|473425507|FG000|Overall Study|Adverse Event|4|||
131490118|NCT01546883|473425507|FG000|Overall Study|Lost to Follow-up|2|||
131490119|NCT01546883|473425507|FG000|Overall Study|early closure of study|2|||
131490120|NCT01546883|473425507|FG000|Overall Study|other unrelated illness|1|||
131490121|NCT01427972|473425513|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490122|NCT01427972|473425514|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490123|NCT01427972|473425515|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490124|NCT01427972|473425516|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490125|NCT01427972|473425517|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490126|NCT01427972|473425518|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490127|NCT01427972|473425519|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490128|NCT01427972|473425520|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
131490129|NCT01427972|473425521|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490130|NCT01427972|473425522|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490131|NCT01427972|473425523|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490132|NCT01427972|473425524|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
131490133|NCT01427972|473425513|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490134|NCT01427972|473425514|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490135|NCT01427972|473425515|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490136|NCT01427972|473425516|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490137|NCT01427972|473425517|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490138|NCT01427972|473425518|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
131490139|NCT01427972|473425519|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490140|NCT01427972|473425520|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490141|NCT01427972|473425521|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490142|NCT01427972|473425522|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490143|NCT01427972|473425523|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490144|NCT01427972|473425524|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
131490145|NCT01427972|473425513|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490146|NCT01427972|473425514|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
131490147|NCT01427972|473425515|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490148|NCT01427972|473425516|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490149|NCT01427972|473425517|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490150|NCT01427972|473425518|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490151|NCT01427972|473425519|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490152|NCT01427972|473425520|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490153|NCT01427972|473425521|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490154|NCT01427972|473425522|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490155|NCT01427972|473425523|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490156|NCT01427972|473425524|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
131490157|NCT00799422|473425526|FG000|First Week of Wear|Lost to Follow-up|0|||
131490158|NCT00799422|473425527|FG001|First Week of Wear|Lost to Follow-up|0|||
131490159|NCT00799422|473425528|FG002|First Week of Wear|Lost to Follow-up|1|||
131490160|NCT00799422|473425529|FG003|First Week of Wear|Lost to Follow-up|0|||
131490161|NCT00799422|473425530|FG004|First Week of Wear|Lost to Follow-up|0|||
131490162|NCT00799422|473425531|FG005|First Week of Wear|Lost to Follow-up|0|||
131490163|NCT00799422|473425526|FG000|First Week of Wear|Adverse Event|0|||
131490164|NCT00799422|473425527|FG001|First Week of Wear|Adverse Event|0|||
131490165|NCT00799422|473425528|FG002|First Week of Wear|Adverse Event|0|||
131490166|NCT00799422|473425529|FG003|First Week of Wear|Adverse Event|1|||
131490167|NCT00799422|473425530|FG004|First Week of Wear|Adverse Event|0|||
131490168|NCT00799422|473425531|FG005|First Week of Wear|Adverse Event|0|||
131490169|NCT00530946|473425532|FG000|Overall Study|Adverse Event|1|||
131490170|NCT00530946|473425533|FG001|Overall Study|Adverse Event|2|||
131490171|NCT00530946|473425534|FG002|Overall Study|Adverse Event|1|||
131490172|NCT00530946|473425535|FG003|Overall Study|Adverse Event|1|||
131490173|NCT00530946|473425532|FG000|Overall Study|Protocol Violation|0|||
131490174|NCT00530946|473425533|FG001|Overall Study|Protocol Violation|0|||
131490175|NCT00530946|473425534|FG002|Overall Study|Protocol Violation|0|||
131490176|NCT00530946|473425535|FG003|Overall Study|Protocol Violation|1|||
131490177|NCT00530946|473425532|FG000|Overall Study|Noncompliance|1|||
131490178|NCT00530946|473425533|FG001|Overall Study|Noncompliance|0|||
131490179|NCT00530946|473425534|FG002|Overall Study|Noncompliance|0|||
131490180|NCT00530946|473425535|FG003|Overall Study|Noncompliance|0|||
131490181|NCT00622284|473425536|FG000|Overall Study|Lack of Efficacy|45|||
131490182|NCT00622284|473425537|FG001|Overall Study|Lack of Efficacy|15|||
131490183|NCT00622284|473425536|FG000|Overall Study|Adverse Event|61|||
131490184|NCT00622284|473425537|FG001|Overall Study|Adverse Event|90|||
131490185|NCT00622284|473425536|FG000|Overall Study|Protocol Violation|12|||
131490186|NCT00622284|473425537|FG001|Overall Study|Protocol Violation|5|||
131490187|NCT00622284|473425536|FG000|Overall Study|Lost to Follow-up|11|||
131490188|NCT00622284|473425537|FG001|Overall Study|Lost to Follow-up|13|||
131490189|NCT00622284|473425536|FG000|Overall Study|Withdrawal by Subject|27|||
131490190|NCT00622284|473425537|FG001|Overall Study|Withdrawal by Subject|24|||
131490191|NCT00622284|473425536|FG000|Overall Study|Other reason (not specified)|33|||
131490192|NCT00622284|473425537|FG001|Overall Study|Other reason (not specified)|24|||
131490193|NCT00880009|473425538|FG000|Overall Study|Study terminated by sponsor|14|||
131490194|NCT00880009|473425538|FG000|Overall Study|Withdrawal by Subject|1|||
131490195|NCT00880009|473425538|FG000|Overall Study|Protocol Violation|1|||
131490196|NCT03322631|473425543|FG000|Overall Study|Withdrawal by Subject|0|||
131490197|NCT03322631|473425544|FG001|Overall Study|Withdrawal by Subject|1|||
131490198|NCT03322631|473425545|FG002|Overall Study|Withdrawal by Subject|0|||
131490199|NCT03322631|473425546|FG003|Overall Study|Withdrawal by Subject|0|||
131490200|NCT03322631|473425543|FG000|Overall Study|Adverse Event|0|||
131490201|NCT03322631|473425544|FG001|Overall Study|Adverse Event|0|||
131490202|NCT03322631|473425545|FG002|Overall Study|Adverse Event|1|||
131490203|NCT03322631|473425546|FG003|Overall Study|Adverse Event|0|||
131490204|NCT02412618|473425547|FG000|Overall Study|Withdrawal by Subject|1|||
131490205|NCT02412618|473425548|FG001|Overall Study|Withdrawal by Subject|1|||
131490206|NCT02412618|473425547|FG000|Overall Study|Expulsion|1|||
131490207|NCT02412618|473425548|FG001|Overall Study|Expulsion|1|||
131490208|NCT02378961|473425549|FG000|Overall Study|Lack of Efficacy|4|||
131490209|NCT02378961|473425550|FG001|Overall Study|Lack of Efficacy|2|||
131490210|NCT02378961|473425551|FG002|Overall Study|Lack of Efficacy|0|||
131490211|NCT02378961|473425552|FG003|Overall Study|Lack of Efficacy|1|||
131490212|NCT02378961|473425549|FG000|Overall Study|Death|0|||
131490213|NCT02378961|473425550|FG001|Overall Study|Death|0|||
131490214|NCT02378961|473425551|FG002|Overall Study|Death|1|||
131490215|NCT02378961|473425552|FG003|Overall Study|Death|0|||
131490216|NCT01217801|473425553|FG000|Period 1|Protocol Violation|1|||
131490217|NCT01217801|473425554|FG001|Period 1|Protocol Violation|1|||
131490218|NCT01217801|473425553|FG000|Period 1|Withdrawal by Subject|0|||
131490219|NCT01217801|473425554|FG001|Period 1|Withdrawal by Subject|1|||
131490220|NCT04967443|473425557|FG000|Open Label Treatment|Death|1|||
131490221|NCT04967443|473425558|FG001|Open Label Treatment|Death|0|||
131490222|NCT04967443|473425559|FG002|Open Label Treatment|Death|0|||
131490223|NCT04967443|473425560|FG003|Open Label Treatment|Death|0|||
131490224|NCT04967443|473425561|FG004|Open Label Treatment|Death|0|||
131490225|NCT04967443|473425562|FG005|Open Label Treatment|Death|0|||
131490226|NCT04967443|473425563|FG006|Open Label Treatment|Death|0|||
131490227|NCT04967443|473425564|FG007|Open Label Treatment|Death|0|||
131490228|NCT04967443|473425557|FG000|Open Label Treatment|Lost to Follow-up|0|||
131490229|NCT04967443|473425558|FG001|Open Label Treatment|Lost to Follow-up|0|||
131490230|NCT04967443|473425559|FG002|Open Label Treatment|Lost to Follow-up|1|||
131490231|NCT04967443|473425560|FG003|Open Label Treatment|Lost to Follow-up|0|||
131490232|NCT04967443|473425561|FG004|Open Label Treatment|Lost to Follow-up|0|||
131490233|NCT04967443|473425562|FG005|Open Label Treatment|Lost to Follow-up|0|||
131490234|NCT04967443|473425563|FG006|Open Label Treatment|Lost to Follow-up|0|||
131490235|NCT04967443|473425564|FG007|Open Label Treatment|Lost to Follow-up|0|||
131490236|NCT04967443|473425557|FG000|Open Label Treatment|Withdrawal by Subject|0|||
131490237|NCT04967443|473425558|FG001|Open Label Treatment|Withdrawal by Subject|1|||
131490238|NCT04967443|473425559|FG002|Open Label Treatment|Withdrawal by Subject|0|||
131490239|NCT04967443|473425560|FG003|Open Label Treatment|Withdrawal by Subject|1|||
131490240|NCT04967443|473425561|FG004|Open Label Treatment|Withdrawal by Subject|0|||
131490241|NCT04967443|473425562|FG005|Open Label Treatment|Withdrawal by Subject|1|||
131490242|NCT04967443|473425563|FG006|Open Label Treatment|Withdrawal by Subject|2|||
131490243|NCT04967443|473425564|FG007|Open Label Treatment|Withdrawal by Subject|3|||
131490244|NCT04967443|473425557|FG000|Follow-Up|Death|1|||
131490245|NCT04967443|473425558|FG001|Follow-Up|Death|0|||
131490246|NCT04967443|473425559|FG002|Follow-Up|Death|0|||
131490247|NCT04967443|473425560|FG003|Follow-Up|Death|0|||
131490248|NCT04967443|473425561|FG004|Follow-Up|Death|0|||
131490249|NCT04967443|473425562|FG005|Follow-Up|Death|0|||
131490250|NCT04967443|473425563|FG006|Follow-Up|Death|0|||
131490251|NCT04967443|473425564|FG007|Follow-Up|Death|0|||
131490252|NCT04967443|473425557|FG000|Follow-Up|Lost to Follow-up|0|||
131490253|NCT04967443|473425558|FG001|Follow-Up|Lost to Follow-up|0|||
131490254|NCT04967443|473425559|FG002|Follow-Up|Lost to Follow-up|1|||
131490255|NCT04967443|473425560|FG003|Follow-Up|Lost to Follow-up|1|||
131490256|NCT04967443|473425561|FG004|Follow-Up|Lost to Follow-up|0|||
131490257|NCT04967443|473425562|FG005|Follow-Up|Lost to Follow-up|0|||
131490258|NCT04967443|473425563|FG006|Follow-Up|Lost to Follow-up|0|||
131490259|NCT04967443|473425564|FG007|Follow-Up|Lost to Follow-up|0|||
131490260|NCT04967443|473425557|FG000|Follow-Up|Withdrawal by Subject|0|||
131490261|NCT04967443|473425558|FG001|Follow-Up|Withdrawal by Subject|1|||
131490262|NCT04967443|473425559|FG002|Follow-Up|Withdrawal by Subject|0|||
131490263|NCT04967443|473425560|FG003|Follow-Up|Withdrawal by Subject|1|||
131490264|NCT04967443|473425561|FG004|Follow-Up|Withdrawal by Subject|0|||
131490265|NCT04967443|473425562|FG005|Follow-Up|Withdrawal by Subject|1|||
131490266|NCT04967443|473425563|FG006|Follow-Up|Withdrawal by Subject|2|||
131490267|NCT04967443|473425564|FG007|Follow-Up|Withdrawal by Subject|3|||
131490268|NCT02405780|473425566|FG000|Period I|Adverse Event|8|||
131490269|NCT02405780|473425567|FG001|Period I|Adverse Event|0|||
131490270|NCT02405780|473425568|FG002|Period I|Adverse Event|3|||
131490271|NCT02405780|473425569|FG003|Period I|Adverse Event|7|||
131490272|NCT02405780|473425566|FG000|Period I|Medical reasons|1|||
131490273|NCT02405780|473425567|FG001|Period I|Medical reasons|1|||
131490274|NCT02405780|473425568|FG002|Period I|Medical reasons|0|||
131490275|NCT02405780|473425569|FG003|Period I|Medical reasons|1|||
131490276|NCT02405780|473425566|FG000|Period I|Screening Failure|1|||
131490277|NCT02405780|473425567|FG001|Period I|Screening Failure|0|||
131490278|NCT02405780|473425568|FG002|Period I|Screening Failure|1|||
131490279|NCT02405780|473425569|FG003|Period I|Screening Failure|0|||
131490280|NCT02405780|473425566|FG000|Period I|Withdrawal by Subject|9|||
131490281|NCT02405780|473425567|FG001|Period I|Withdrawal by Subject|1|||
131490282|NCT02405780|473425568|FG002|Period I|Withdrawal by Subject|3|||
131490283|NCT02405780|473425569|FG003|Period I|Withdrawal by Subject|4|||
131490284|NCT02405780|473425566|FG000|Period I|Non-compliance with study procedures|8|||
131490285|NCT02405780|473425567|FG001|Period I|Non-compliance with study procedures|6|||
131490286|NCT02405780|473425568|FG002|Period I|Non-compliance with study procedures|8|||
131490287|NCT02405780|473425569|FG003|Period I|Non-compliance with study procedures|11|||
131490288|NCT02405780|473425566|FG000|Period II|Adverse Event|3|||
131490289|NCT02405780|473425567|FG001|Period II|Adverse Event|5|||
131490290|NCT02405780|473425568|FG002|Period II|Adverse Event|4|||
131490291|NCT02405780|473425569|FG003|Period II|Adverse Event|11|||
131490292|NCT02405780|473425566|FG000|Period II|Medical reason|0|||
131490293|NCT02405780|473425567|FG001|Period II|Medical reason|1|||
131490294|NCT02405780|473425568|FG002|Period II|Medical reason|0|||
131490295|NCT02405780|473425569|FG003|Period II|Medical reason|0|||
131490296|NCT02405780|473425566|FG000|Period II|Pregnancy|0|||
131490297|NCT02405780|473425567|FG001|Period II|Pregnancy|0|||
131490298|NCT02405780|473425568|FG002|Period II|Pregnancy|1|||
131490299|NCT02405780|473425569|FG003|Period II|Pregnancy|0|||
131490300|NCT02405780|473425566|FG000|Period II|Withdrawal by Subject|7|||
131490301|NCT02405780|473425567|FG001|Period II|Withdrawal by Subject|4|||
131490302|NCT02405780|473425568|FG002|Period II|Withdrawal by Subject|0|||
131490303|NCT02405780|473425569|FG003|Period II|Withdrawal by Subject|3|||
131490304|NCT02405780|473425566|FG000|Period II|Non-compliance with study procedures|5|||
131490305|NCT02405780|473425567|FG001|Period II|Non-compliance with study procedures|2|||
131490306|NCT02405780|473425568|FG002|Period II|Non-compliance with study procedures|7|||
131490307|NCT02405780|473425569|FG003|Period II|Non-compliance with study procedures|4|||
131490308|NCT01654536|473425570|FG000|Overall Study|Lost to Follow-up|5|||
131490309|NCT01654536|473425571|FG001|Overall Study|Lost to Follow-up|5|||
131490310|NCT01654536|473425570|FG000|Overall Study|Physician Decision|12|||
131490311|NCT01654536|473425571|FG001|Overall Study|Physician Decision|8|||
131490312|NCT01654536|473425570|FG000|Overall Study|Withdrawal by Subject|27|||
131490313|NCT01654536|473425571|FG001|Overall Study|Withdrawal by Subject|25|||
131490314|NCT04502693|473425572|FG000|Overall Study|Adverse Event|7|||
131490315|NCT04502693|473425573|FG001|Overall Study|Adverse Event|6|||
131490316|NCT04502693|473425574|FG002|Overall Study|Adverse Event|11|||
131490317|NCT04502693|473425575|FG003|Overall Study|Adverse Event|1|||
131490318|NCT04502693|473425572|FG000|Overall Study|Lost to Follow-up|32|||
131490319|NCT04502693|473425573|FG001|Overall Study|Lost to Follow-up|36|||
131490320|NCT04502693|473425574|FG002|Overall Study|Lost to Follow-up|69|||
131490321|NCT04502693|473425575|FG003|Overall Study|Lost to Follow-up|4|||
131490322|NCT04502693|473425572|FG000|Overall Study|Protocol Violation|8|||
131490323|NCT04502693|473425573|FG001|Overall Study|Protocol Violation|8|||
131490324|NCT04502693|473425574|FG002|Overall Study|Protocol Violation|16|||
131490325|NCT04502693|473425575|FG003|Overall Study|Protocol Violation|1|||
131490326|NCT04502693|473425572|FG000|Overall Study|Withdrawal by Subject|46|||
131490327|NCT04502693|473425573|FG001|Overall Study|Withdrawal by Subject|38|||
131490328|NCT04502693|473425574|FG002|Overall Study|Withdrawal by Subject|54|||
131490329|NCT04502693|473425575|FG003|Overall Study|Withdrawal by Subject|7|||
131490330|NCT04502693|473425572|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
131490331|NCT04502693|473425573|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
131490332|NCT04502693|473425574|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
131490333|NCT04502693|473425575|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131490334|NCT04502693|473425572|FG000|Overall Study|Other|1|||
131490335|NCT04502693|473425573|FG001|Overall Study|Other|0|||
131490336|NCT04502693|473425574|FG002|Overall Study|Other|1|||
131490337|NCT04502693|473425575|FG003|Overall Study|Other|1|||
131490338|NCT00602797|473425577|FG000|Overall Study|Adverse Event|1|||
131490339|NCT03943147|473425582|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
131490340|NCT03943147|473425583|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
131490341|NCT03943147|473425582|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
131490342|NCT03943147|473425583|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
131490343|NCT03943147|473425582|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
131490344|NCT03943147|473425583|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
131490345|NCT03943147|473425582|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
131490346|NCT03943147|473425583|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
131490347|NCT03943147|473425582|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
131490348|NCT03943147|473425583|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
131490349|NCT03943147|473425582|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
131490350|NCT03943147|473425583|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
131490351|NCT03736447|473425584|FG000|Overall Study|Adverse Event|5|||
131490352|NCT03736447|473425585|FG001|Overall Study|Adverse Event|1|||
131490353|NCT03736447|473425584|FG000|Overall Study|Withdrawal by Subject|5|||
131490354|NCT03736447|473425585|FG001|Overall Study|Withdrawal by Subject|1|||
131490355|NCT03736447|473425584|FG000|Overall Study|Lost to Follow-up|1|||
131490356|NCT03736447|473425585|FG001|Overall Study|Lost to Follow-up|0|||
131490357|NCT03736447|473425584|FG000|Overall Study|Physician Decision|1|||
131490358|NCT03736447|473425585|FG001|Overall Study|Physician Decision|0|||
131490359|NCT03736447|473425584|FG000|Overall Study|Continued commitment to study treatment|3|||
131490360|NCT03736447|473425585|FG001|Overall Study|Continued commitment to study treatment|0|||
131490361|NCT03736447|473425584|FG000|Overall Study|Taste aversion to study product|0|||
131490362|NCT03736447|473425585|FG001|Overall Study|Taste aversion to study product|1|||
131490363|NCT02619175|473425586|FG000|Overall Study|Withdrawal by Subject|1|||
131490364|NCT02619175|473425587|FG001|Overall Study|Withdrawal by Subject|0|||
131490365|NCT02619175|473425586|FG000|Overall Study|foot pain|1|||
131490366|NCT02619175|473425587|FG001|Overall Study|foot pain|0|||
131490367|NCT02657369|473425588|FG000|Overall Study|Death|27|||
131490368|NCT02657369|473425588|FG000|Overall Study|Study terminated by sponsor|7|||
131490369|NCT00221403|473425589|FG000|Overall Study|Protocol Violation|1|||
131490370|NCT00221403|473425590|FG001|Overall Study|Protocol Violation|0|||
131490371|NCT00221403|473425591|FG002|Overall Study|Protocol Violation|0|||
131490372|NCT00221403|473425589|FG000|Overall Study|Physician Decision|1|||
131490373|NCT00221403|473425590|FG001|Overall Study|Physician Decision|0|||
131490374|NCT00221403|473425591|FG002|Overall Study|Physician Decision|0|||
131490375|NCT00221403|473425589|FG000|Overall Study|Withdrawal by Subject|0|||
131490376|NCT00221403|473425590|FG001|Overall Study|Withdrawal by Subject|3|||
131490377|NCT00221403|473425591|FG002|Overall Study|Withdrawal by Subject|0|||
131490378|NCT00221403|473425589|FG000|Overall Study|Lack of Efficacy|0|||
131490379|NCT00221403|473425590|FG001|Overall Study|Lack of Efficacy|1|||
131490380|NCT00221403|473425591|FG002|Overall Study|Lack of Efficacy|0|||
131490381|NCT00221403|473425589|FG000|Overall Study|Adverse Event|0|||
131490382|NCT00221403|473425590|FG001|Overall Study|Adverse Event|1|||
131490383|NCT00221403|473425591|FG002|Overall Study|Adverse Event|0|||
131490384|NCT01348165|473425592|FG000|Overall Study|Adverse Event|0|||
131490385|NCT01348165|473425593|FG001|Overall Study|Adverse Event|0|||
131490386|NCT01348165|473425594|FG002|Overall Study|Adverse Event|0|||
131490387|NCT01348165|473425595|FG003|Overall Study|Adverse Event|0|||
131490388|NCT01348165|473425596|FG004|Overall Study|Adverse Event|0|||
131490389|NCT01348165|473425597|FG005|Overall Study|Adverse Event|0|||
131490390|NCT01348165|473425598|FG006|Overall Study|Adverse Event|1|||
131490391|NCT00074152|473425599|FG000|Overall Study|Death|21|||
131490392|NCT00074152|473425600|FG001|Overall Study|Death|9|||
131490393|NCT00074152|473425599|FG000|Overall Study|Lack of Efficacy|34|||
131490394|NCT00074152|473425600|FG001|Overall Study|Lack of Efficacy|24|||
131490395|NCT01594762|473425601|FG000|Overall Study|Withdrawal by Subject|1|||
131490396|NCT01594762|473425602|FG001|Overall Study|Withdrawal by Subject|0|||
131490397|NCT01594762|473425601|FG000|Overall Study|Lost to Follow-up|10|||
131490398|NCT01594762|473425602|FG001|Overall Study|Lost to Follow-up|10|||
131490399|NCT03547583|473425603|FG000|Overall Study|Adverse Event|16|||
131490400|NCT03547583|473425604|FG001|Overall Study|Adverse Event|11|||
131490401|NCT03547583|473425605|FG002|Overall Study|Adverse Event|10|||
131490402|NCT03547583|473425603|FG000|Overall Study|Death|11|||
131490403|NCT03547583|473425604|FG001|Overall Study|Death|7|||
131490404|NCT03547583|473425605|FG002|Overall Study|Death|4|||
131490405|NCT03547583|473425603|FG000|Overall Study|Lost to Follow-up|1|||
131490406|NCT03547583|473425604|FG001|Overall Study|Lost to Follow-up|0|||
131490407|NCT03547583|473425605|FG002|Overall Study|Lost to Follow-up|0|||
131490408|NCT03547583|473425603|FG000|Overall Study|Non-compliance with study drug|0|||
131490409|NCT03547583|473425604|FG001|Overall Study|Non-compliance with study drug|0|||
131490410|NCT03547583|473425605|FG002|Overall Study|Non-compliance with study drug|1|||
131490411|NCT03547583|473425603|FG000|Overall Study|Physician Decision|1|||
131490412|NCT03547583|473425604|FG001|Overall Study|Physician Decision|0|||
131490413|NCT03547583|473425605|FG002|Overall Study|Physician Decision|3|||
131490414|NCT03547583|473425603|FG000|Overall Study|Protocol Violation|2|||
131490415|NCT03547583|473425604|FG001|Overall Study|Protocol Violation|1|||
131490416|NCT03547583|473425605|FG002|Overall Study|Protocol Violation|1|||
131490417|NCT03547583|473425603|FG000|Overall Study|Withdrawal by Subject|12|||
131490418|NCT03547583|473425604|FG001|Overall Study|Withdrawal by Subject|19|||
131490419|NCT03547583|473425605|FG002|Overall Study|Withdrawal by Subject|10|||
131490420|NCT03547583|473425603|FG000|Overall Study|Other|2|||
131490421|NCT03547583|473425604|FG001|Overall Study|Other|2|||
131490422|NCT03547583|473425605|FG002|Overall Study|Other|3|||
131490423|NCT00382252|473425606|FG000|Overall Study|Death|4|||
131490424|NCT00382252|473425606|FG000|Overall Study|Protocol Violation|8|||
131490425|NCT00382252|473425606|FG000|Overall Study|Not treated by RFA|1|||
131490426|NCT04706091|473425613|FG000|Treatment 2|Withdrawal by Subject|1|||
131490427|NCT04706091|473425614|FG001|Treatment 2|Withdrawal by Subject|0|||
131490428|NCT02612727|473425615|FG000|Overall Study|Parent request|4|||
131490429|NCT02612727|473425616|FG001|Overall Study|Parent request|1|||
131490430|NCT02612727|473425615|FG000|Overall Study|Needed treatment incompatible with PT|1|||
131490431|NCT02612727|473425616|FG001|Overall Study|Needed treatment incompatible with PT|1|||
131490432|NCT02612727|473425615|FG000|Overall Study|Direct hyperbilirubinemia|0|||
131490433|NCT02612727|473425616|FG001|Overall Study|Direct hyperbilirubinemia|2|||
131490434|NCT01063868|473425617|FG000|Overall Study|Adverse Event|9|||
131490435|NCT01063868|473425618|FG001|Overall Study|Adverse Event|7|||
131490436|NCT01063868|473425617|FG000|Overall Study|Withdrawal by Subject|3|||
131490437|NCT01063868|473425618|FG001|Overall Study|Withdrawal by Subject|1|||
131490438|NCT01063868|473425617|FG000|Overall Study|Study Terminated By Sponsor|23|||
131490439|NCT01063868|473425618|FG001|Overall Study|Study Terminated By Sponsor|4|||
131490440|NCT01446289|473425619|FG000|Overall Study|Withdrawal by Subject|1|||
131490441|NCT01446289|473425620|FG001|Overall Study|Withdrawal by Subject|0|||
131490442|NCT01446289|473425621|FG002|Overall Study|Withdrawal by Subject|1|||
131490443|NCT01446289|473425622|FG003|Overall Study|Withdrawal by Subject|0|||
131490444|NCT05243641|473425626|FG000|Overall Study|Adverse Event|3|||
131490445|NCT05243641|473425627|FG001|Overall Study|Adverse Event|0|||
131490446|NCT05243641|473425628|FG002|Overall Study|Adverse Event|0|||
131490447|NCT05243641|473425629|FG003|Overall Study|Adverse Event|1|||
131490448|NCT05243641|473425630|FG004|Overall Study|Adverse Event|0|||
131490449|NCT05243641|473425631|FG005|Overall Study|Adverse Event|0|||
131490450|NCT05243641|473425626|FG000|Overall Study|Disease progression|4|||
131490451|NCT05243641|473425627|FG001|Overall Study|Disease progression|0|||
131490452|NCT05243641|473425628|FG002|Overall Study|Disease progression|0|||
131490453|NCT05243641|473425629|FG003|Overall Study|Disease progression|2|||
131490454|NCT05243641|473425630|FG004|Overall Study|Disease progression|0|||
131490455|NCT05243641|473425631|FG005|Overall Study|Disease progression|0|||
131490456|NCT04518306|473425632|FG000|Double-Blind Period|Run in failure|0|||
131490457|NCT04518306|473425633|FG001|Double-Blind Period|Run in failure|0|||
131490458|NCT04518306|473425634|FG002|Double-Blind Period|Run in failure|1|||
131490459|NCT04518306|473425632|FG000|Double-Blind Period|Adverse Event|0|||
131490460|NCT04518306|473425633|FG001|Double-Blind Period|Adverse Event|2|||
131490461|NCT04518306|473425634|FG002|Double-Blind Period|Adverse Event|2|||
131490462|NCT04518306|473425632|FG000|Double-Blind Period|Lost to Follow-up|1|||
131490463|NCT04518306|473425633|FG001|Double-Blind Period|Lost to Follow-up|2|||
131490464|NCT04518306|473425634|FG002|Double-Blind Period|Lost to Follow-up|2|||
131490465|NCT04518306|473425632|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
131490466|NCT04518306|473425633|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
131490467|NCT04518306|473425634|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
131490468|NCT04518306|473425632|FG000|Double-Blind Period|Other|0|||
131490469|NCT04518306|473425633|FG001|Double-Blind Period|Other|2|||
131490470|NCT04518306|473425634|FG002|Double-Blind Period|Other|0|||
131490471|NCT04518306|473425632|FG000|Double-Blind Period|Missing|0|||
131490472|NCT04518306|473425633|FG001|Double-Blind Period|Missing|1|||
131490473|NCT04518306|473425634|FG002|Double-Blind Period|Missing|0|||
131490474|NCT02801331|473425635|FG000|Overall Study|Transferred to another hospital|8|||
131490475|NCT02801331|473425636|FG001|Overall Study|Transferred to another hospital|7|||
131490476|NCT02801331|473425635|FG000|Overall Study|Withdrawal by Subject|0|||
131490477|NCT02801331|473425636|FG001|Overall Study|Withdrawal by Subject|4|||
131490478|NCT02801331|473425635|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
131490479|NCT02801331|473425636|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
131490480|NCT04698187|473425643|FG000|Overall Study|Withdrawal by Subject|7|||
131490481|NCT04698187|473425643|FG000|Overall Study|Death|21|||
131490482|NCT04698187|473425643|FG000|Overall Study|Sponsor Decision|15|||
131490483|NCT04698187|473425643|FG000|Overall Study|In-transit Disease|1|||
131490484|NCT03904043|473425644|FG000|Overall Study|Adverse Event|1|||
131490485|NCT03904043|473425645|FG001|Overall Study|Adverse Event|1|||
131490486|NCT03904043|473425644|FG000|Overall Study|Withdrawal by Subject|1|||
131490487|NCT03904043|473425645|FG001|Overall Study|Withdrawal by Subject|0|||
131490488|NCT03904043|473425644|FG000|Overall Study|Non-compliance|1|||
131490489|NCT03904043|473425645|FG001|Overall Study|Non-compliance|0|||
131490490|NCT03904043|473425644|FG000|Overall Study|Did not start treatment|1|||
131490491|NCT03904043|473425645|FG001|Overall Study|Did not start treatment|0|||
131490492|NCT00907777|473427187|FG000|Overall Study|Withdrawal by Subject|0|||
131490493|NCT00907777|473427188|FG001|Overall Study|Withdrawal by Subject|1|||
131490494|NCT01473836|473427189|FG000|Overall Study|Adverse Event|4|||
131490495|NCT01473836|473427189|FG000|Overall Study|Lack of Efficacy|1|||
131490496|NCT01473836|473427189|FG000|Overall Study|Does not meet entrance criteria|1|||
131490497|NCT03291808|473427190|FG000|Overall Study|Lost to Follow-up|6|||
131490498|NCT03291808|473427190|FG000|Overall Study|Research burden|4|||
131490499|NCT03364023|473427191|FG000|Overall Study|Lost to Follow-up|3|||
131490500|NCT03364023|473427191|FG000|Overall Study|Death|14|||
131490501|NCT01892293|473427200|FG000|Overall Study|Apheresed but not treated|4|||
131490502|NCT03602482|473427201|FG000|Overall Study|Withdrawal by Subject|6|||
131490503|NCT03602482|473427202|FG001|Overall Study|Withdrawal by Subject|7|||
131490504|NCT03602482|473427203|FG002|Overall Study|Withdrawal by Subject|0|||
131490505|NCT03602482|473427204|FG003|Overall Study|Withdrawal by Subject|0|||
131490506|NCT00105469|473427207|FG000|Overall Study|Adverse Event|9|||
131490507|NCT00105469|473427208|FG001|Overall Study|Adverse Event|8|||
131490508|NCT00105469|473427207|FG000|Overall Study|Protocol Violation|4|||
131490509|NCT00105469|473427208|FG001|Overall Study|Protocol Violation|0|||
131490510|NCT00105469|473427207|FG000|Overall Study|Withdrawal by Subject|2|||
131490511|NCT00105469|473427208|FG001|Overall Study|Withdrawal by Subject|3|||
131490512|NCT00105469|473427207|FG000|Overall Study|Lost to Follow-up|1|||
131490513|NCT00105469|473427208|FG001|Overall Study|Lost to Follow-up|0|||
131490514|NCT00105469|473427207|FG000|Overall Study|Lack of Efficacy|2|||
131490515|NCT00105469|473427208|FG001|Overall Study|Lack of Efficacy|0|||
131490516|NCT00105469|473427207|FG000|Overall Study|Other Reason|4|||
131490517|NCT00105469|473427208|FG001|Overall Study|Other Reason|0|||
131490518|NCT00599924|473427210|FG000|Overall Study|Lack of Efficacy|3|||
131490519|NCT00599924|473427211|FG001|Overall Study|Lack of Efficacy|5|||
131490520|NCT00599924|473427212|FG002|Overall Study|Lack of Efficacy|1|||
131490521|NCT00599924|473427213|FG003|Overall Study|Lack of Efficacy|2|||
131490522|NCT00599924|473427214|FG004|Overall Study|Lack of Efficacy|3|||
131490523|NCT00599924|473427215|FG005|Overall Study|Lack of Efficacy|2|||
131490524|NCT00599924|473427216|FG006|Overall Study|Lack of Efficacy|0|||
131490525|NCT00599924|473427210|FG000|Overall Study|Adverse Event|0|||
131490526|NCT00599924|473427211|FG001|Overall Study|Adverse Event|0|||
131490527|NCT00599924|473427212|FG002|Overall Study|Adverse Event|0|||
131490528|NCT00599924|473427213|FG003|Overall Study|Adverse Event|2|||
131490529|NCT00599924|473427214|FG004|Overall Study|Adverse Event|0|||
131490530|NCT00599924|473427215|FG005|Overall Study|Adverse Event|0|||
131490531|NCT00599924|473427216|FG006|Overall Study|Adverse Event|2|||
131490532|NCT00599924|473427210|FG000|Overall Study|Death|0|||
131490533|NCT00599924|473427211|FG001|Overall Study|Death|0|||
131490534|NCT00599924|473427212|FG002|Overall Study|Death|0|||
131490535|NCT00599924|473427213|FG003|Overall Study|Death|2|||
131490536|NCT00599924|473427214|FG004|Overall Study|Death|0|||
131490537|NCT00599924|473427215|FG005|Overall Study|Death|2|||
131490538|NCT00599924|473427216|FG006|Overall Study|Death|1|||
131490539|NCT00599924|473427210|FG000|Overall Study|Protocol Violation|0|||
131490540|NCT00599924|473427211|FG001|Overall Study|Protocol Violation|0|||
131490541|NCT00599924|473427212|FG002|Overall Study|Protocol Violation|0|||
131490542|NCT00599924|473427213|FG003|Overall Study|Protocol Violation|1|||
131490543|NCT00599924|473427214|FG004|Overall Study|Protocol Violation|0|||
131490544|NCT00599924|473427215|FG005|Overall Study|Protocol Violation|0|||
131490545|NCT00599924|473427216|FG006|Overall Study|Protocol Violation|0|||
131490546|NCT00599924|473427210|FG000|Overall Study|Withdrawal by Subject|0|||
131490547|NCT00599924|473427211|FG001|Overall Study|Withdrawal by Subject|0|||
131490548|NCT00599924|473427212|FG002|Overall Study|Withdrawal by Subject|1|||
131490549|NCT00599924|473427213|FG003|Overall Study|Withdrawal by Subject|0|||
131490550|NCT00599924|473427214|FG004|Overall Study|Withdrawal by Subject|1|||
131490551|NCT00599924|473427215|FG005|Overall Study|Withdrawal by Subject|0|||
131490552|NCT00599924|473427216|FG006|Overall Study|Withdrawal by Subject|0|||
131490553|NCT00599924|473427210|FG000|Overall Study|Other|0|||
131490554|NCT00599924|473427211|FG001|Overall Study|Other|0|||
131490555|NCT00599924|473427212|FG002|Overall Study|Other|0|||
131490556|NCT00599924|473427213|FG003|Overall Study|Other|1|||
131490557|NCT00599924|473427214|FG004|Overall Study|Other|2|||
131490558|NCT00599924|473427215|FG005|Overall Study|Other|0|||
131490559|NCT00599924|473427216|FG006|Overall Study|Other|2|||
131490560|NCT02601469|473427217|FG000|Overall Study|Enrolled in Error|1|||
131490561|NCT02601469|473427218|FG001|Overall Study|Enrolled in Error|0|||
131490562|NCT01806298|473427219|FG000|Overall Study|Adverse Event|3|||
131490563|NCT01806298|473427219|FG000|Overall Study|Protocol Non-compliance|1|||
131490564|NCT01806298|473427219|FG000|Overall Study|Withdrawal by Subject|1|||
131490565|NCT01806298|473427219|FG000|Overall Study|Other|5|||
131490566|NCT03808545|473427220|FG000|Overall Study|Withdrawal by Subject|1|||
131490567|NCT03808545|473427221|FG001|Overall Study|Withdrawal by Subject|1|||
131490568|NCT04980040|473427226|FG000|Overall Study|Violated the Inclusion Criteria|260|||
131490569|NCT04980040|473427226|FG000|Overall Study|Violated the Administration & Dosage|225|||
131490570|NCT04980040|473427226|FG000|Overall Study|Lost to Safety-Follow-up|4|||
131490571|NCT04980040|473427226|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
131490572|NCT01396148|473427239|FG000|Overall Study|Patient Decision|1|||
131490573|NCT02170298|473427240|FG000|Overall Study|Withdrawal by Subject|0|||
131490574|NCT02170298|473427241|FG001|Overall Study|Withdrawal by Subject|1|||
131490575|NCT02170298|473427240|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
131490576|NCT02170298|473427241|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
131490577|NCT01976338|473427243|FG000|Overall Study|Physician Decision|0|||
131490578|NCT01976338|473427244|FG001|Overall Study|Physician Decision|1|||
131490579|NCT01976338|473427243|FG000|Overall Study|Lost to Follow-up|3|||
131490580|NCT01976338|473427244|FG001|Overall Study|Lost to Follow-up|0|||
131490581|NCT01976338|473427243|FG000|Overall Study|Withdrawal by Subject|5|||
131490582|NCT01976338|473427244|FG001|Overall Study|Withdrawal by Subject|2|||
131490583|NCT01976338|473427243|FG000|Overall Study|Adverse Event|5|||
131490584|NCT01976338|473427244|FG001|Overall Study|Adverse Event|1|||
131490585|NCT04213079|473427245|FG000|Overall Study|Lost to Follow-up|0|||
131490586|NCT04213079|473427246|FG001|Overall Study|Lost to Follow-up|2|||
131490587|NCT02732119|473427248|FG000|Phase I|Adverse Event|1|||
131490588|NCT02732119|473427249|FG001|Phase I|Adverse Event|3|||
131490589|NCT02732119|473427250|FG002|Phase I|Adverse Event|1|||
131490590|NCT02732119|473427251|FG003|Phase I|Adverse Event|0|||
131490591|NCT02732119|473427252|FG004|Phase I|Adverse Event|0|||
131490592|NCT02732119|473427248|FG000|Phase I|Progressive disease|7|||
131490593|NCT02732119|473427249|FG001|Phase I|Progressive disease|3|||
131490594|NCT02732119|473427250|FG002|Phase I|Progressive disease|2|||
131490595|NCT02732119|473427251|FG003|Phase I|Progressive disease|0|||
131490596|NCT02732119|473427252|FG004|Phase I|Progressive disease|0|||
131490597|NCT02732119|473427248|FG000|Phase I|Protocol deviation|0|||
131490598|NCT02732119|473427249|FG001|Phase I|Protocol deviation|1|||
131490599|NCT02732119|473427250|FG002|Phase I|Protocol deviation|0|||
131490600|NCT02732119|473427251|FG003|Phase I|Protocol deviation|0|||
131490601|NCT02732119|473427252|FG004|Phase I|Protocol deviation|0|||
131490602|NCT02732119|473427248|FG000|Phase I|Physician Decision|0|||
131490603|NCT02732119|473427249|FG001|Phase I|Physician Decision|3|||
131490604|NCT02732119|473427250|FG002|Phase I|Physician Decision|4|||
131490605|NCT02732119|473427251|FG003|Phase I|Physician Decision|0|||
131490606|NCT02732119|473427252|FG004|Phase I|Physician Decision|0|||
131490607|NCT02732119|473427248|FG000|Phase II|Adverse Event|0|||
131490608|NCT02732119|473427249|FG001|Phase II|Adverse Event|0|||
131490609|NCT02732119|473427250|FG002|Phase II|Adverse Event|0|||
131490610|NCT02732119|473427251|FG003|Phase II|Adverse Event|3|||
131490611|NCT02732119|473427252|FG004|Phase II|Adverse Event|3|||
131490612|NCT02732119|473427248|FG000|Phase II|Death|0|||
131490613|NCT02732119|473427249|FG001|Phase II|Death|0|||
131490614|NCT02732119|473427250|FG002|Phase II|Death|0|||
131490615|NCT02732119|473427251|FG003|Phase II|Death|1|||
131490616|NCT02732119|473427252|FG004|Phase II|Death|0|||
131490617|NCT02732119|473427248|FG000|Phase II|Progressive dissease|0|||
131490618|NCT02732119|473427249|FG001|Phase II|Progressive dissease|0|||
131490619|NCT02732119|473427250|FG002|Phase II|Progressive dissease|0|||
131490620|NCT02732119|473427251|FG003|Phase II|Progressive dissease|30|||
131490621|NCT02732119|473427252|FG004|Phase II|Progressive dissease|23|||
131490622|NCT02732119|473427248|FG000|Phase II|Study terminated by sponsor|0|||
131490623|NCT02732119|473427249|FG001|Phase II|Study terminated by sponsor|0|||
131490624|NCT02732119|473427250|FG002|Phase II|Study terminated by sponsor|0|||
131490625|NCT02732119|473427251|FG003|Phase II|Study terminated by sponsor|2|||
131490626|NCT02732119|473427252|FG004|Phase II|Study terminated by sponsor|2|||
131490627|NCT02732119|473427248|FG000|Phase II|Other|0|||
131490628|NCT02732119|473427249|FG001|Phase II|Other|0|||
131490629|NCT02732119|473427250|FG002|Phase II|Other|0|||
131490630|NCT02732119|473427251|FG003|Phase II|Other|2|||
131490631|NCT02732119|473427252|FG004|Phase II|Other|0|||
131490632|NCT02732119|473427248|FG000|Phase II|Physician Decision|0|||
131490633|NCT02732119|473427249|FG001|Phase II|Physician Decision|0|||
131490634|NCT02732119|473427250|FG002|Phase II|Physician Decision|0|||
131490635|NCT02732119|473427251|FG003|Phase II|Physician Decision|8|||
131490636|NCT02732119|473427252|FG004|Phase II|Physician Decision|5|||
131490637|NCT00520936|473427253|FG000|Overall Study|Physician Decision|0|||
131490638|NCT00520936|473427254|FG001|Overall Study|Physician Decision|2|||
131490639|NCT00520936|473427255|FG002|Overall Study|Physician Decision|1|||
131490640|NCT00520936|473427256|FG003|Overall Study|Physician Decision|0|||
131490641|NCT00520936|473427257|FG004|Overall Study|Physician Decision|0|||
131490642|NCT00520936|473427258|FG005|Overall Study|Physician Decision|0|||
131490643|NCT00520936|473427259|FG006|Overall Study|Physician Decision|0|||
131490644|NCT00520936|473427260|FG007|Overall Study|Physician Decision|0|||
131490645|NCT00520936|473427253|FG000|Overall Study|Withdrawal by Subject|0|||
131490646|NCT00520936|473427254|FG001|Overall Study|Withdrawal by Subject|0|||
131490647|NCT00520936|473427255|FG002|Overall Study|Withdrawal by Subject|0|||
131490648|NCT00520936|473427256|FG003|Overall Study|Withdrawal by Subject|0|||
131490649|NCT00520936|473427257|FG004|Overall Study|Withdrawal by Subject|0|||
131490650|NCT00520936|473427258|FG005|Overall Study|Withdrawal by Subject|0|||
131490651|NCT00520936|473427259|FG006|Overall Study|Withdrawal by Subject|0|||
131490652|NCT00520936|473427260|FG007|Overall Study|Withdrawal by Subject|1|||
131490653|NCT00520936|473427253|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
131490654|NCT00520936|473427254|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
131490655|NCT00520936|473427255|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
131490656|NCT00520936|473427256|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
131490657|NCT00520936|473427257|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
131490658|NCT00520936|473427258|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
131490659|NCT00520936|473427259|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
131490660|NCT00520936|473427260|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
131490661|NCT00520936|473427253|FG000|Overall Study|Death|0|||
131490662|NCT00520936|473427254|FG001|Overall Study|Death|0|||
131490663|NCT00520936|473427255|FG002|Overall Study|Death|0|||
131490664|NCT00520936|473427256|FG003|Overall Study|Death|0|||
131490665|NCT00520936|473427257|FG004|Overall Study|Death|0|||
131490666|NCT00520936|473427258|FG005|Overall Study|Death|0|||
131490667|NCT00520936|473427259|FG006|Overall Study|Death|1|||
131490668|NCT00520936|473427260|FG007|Overall Study|Death|0|||
131490669|NCT00520936|473427253|FG000|Overall Study|Protocol Violation|0|||
131490670|NCT00520936|473427254|FG001|Overall Study|Protocol Violation|1|||
131490671|NCT00520936|473427255|FG002|Overall Study|Protocol Violation|1|||
131490672|NCT00520936|473427256|FG003|Overall Study|Protocol Violation|0|||
131490673|NCT00520936|473427257|FG004|Overall Study|Protocol Violation|1|||
131490674|NCT00520936|473427258|FG005|Overall Study|Protocol Violation|0|||
131490675|NCT00520936|473427259|FG006|Overall Study|Protocol Violation|1|||
131490676|NCT00520936|473427260|FG007|Overall Study|Protocol Violation|0|||
131490677|NCT05275400|473427264|FG000|Treatment Period|Adverse Event|7|||
131490678|NCT05275400|473427265|FG001|Treatment Period|Adverse Event|1|||
131490679|NCT05275400|473427264|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
131490680|NCT05275400|473427265|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
131490681|NCT05275400|473427264|FG000|Treatment Period|Death|5|||
131490682|NCT05275400|473427265|FG001|Treatment Period|Death|2|||
131490683|NCT05275400|473427264|FG000|Treatment Period|Protocol Violation|1|||
131490684|NCT05275400|473427265|FG001|Treatment Period|Protocol Violation|0|||
131490685|NCT05275400|473427264|FG000|Treatment Period|Physician Decision|5|||
131490686|NCT05275400|473427265|FG001|Treatment Period|Physician Decision|4|||
131490687|NCT05275400|473427264|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
131490688|NCT05275400|473427265|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
131490689|NCT05275400|473427264|FG000|Treatment Period|Withdrawal by Subject|30|||
131490690|NCT05275400|473427265|FG001|Treatment Period|Withdrawal by Subject|12|||
131490691|NCT05275400|473427264|FG000|Treatment Period|Lost to Follow-up|1|||
131490692|NCT05275400|473427265|FG001|Treatment Period|Lost to Follow-up|5|||
131490693|NCT05275400|473427264|FG000|Treatment Period|Lack of Efficacy|1|||
131490694|NCT05275400|473427265|FG001|Treatment Period|Lack of Efficacy|0|||
131490695|NCT05275400|473427264|FG000|Treatment Period|Sponsor Decision|1|||
131490696|NCT05275400|473427265|FG001|Treatment Period|Sponsor Decision|0|||
131490697|NCT05275400|473427264|FG000|Follow-Up Period|Death|2|||
131490698|NCT05275400|473427265|FG001|Follow-Up Period|Death|0|||
131490699|NCT05275400|473427264|FG000|Follow-Up Period|Protocol Violation|1|||
131490700|NCT05275400|473427265|FG001|Follow-Up Period|Protocol Violation|0|||
131490701|NCT05275400|473427264|FG000|Follow-Up Period|Withdrawal by Subject|3|||
131490702|NCT05275400|473427265|FG001|Follow-Up Period|Withdrawal by Subject|0|||
131490703|NCT00553644|473427268|FG000|Overall Study|Adverse Event|17|||
131490704|NCT00553644|473427268|FG000|Overall Study|Withdrawal by Subject|4|||
131490705|NCT00553644|473427268|FG000|Overall Study|Physician Decision|1|||
131490706|NCT00553644|473427268|FG000|Overall Study|Alternative therapy|6|||
131490707|NCT02197247|473427269|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
131490708|NCT02197247|473427269|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
131490709|NCT02197247|473427269|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
131490710|NCT02197247|473427269|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
131490711|NCT02197247|473427269|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
131490712|NCT02197247|473427269|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
131490713|NCT02197247|473427269|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
131490714|NCT02197247|473427269|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
131490715|NCT00851747|473427283|FG000|Overall Study|Physician Decision|6|||
131490716|NCT00851747|473427284|FG001|Overall Study|Physician Decision|6|||
131490717|NCT00851747|473427285|FG002|Overall Study|Physician Decision|6|||
131490718|NCT05537883|473427287|FG000|Overall Study|revisional surgery|4|||
131490719|NCT05537883|473427288|FG001|Overall Study|revisional surgery|2|||
131490720|NCT05537883|473427287|FG000|Overall Study|surgeries were cancelled|0|||
131490721|NCT05537883|473427288|FG001|Overall Study|surgeries were cancelled|2|||
131490722|NCT05537883|473427287|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
131490723|NCT05537883|473427288|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
131490724|NCT01328431|473427289|FG000|Baseline|Protocol Violation|0|||
131490725|NCT01328431|473427290|FG001|Baseline|Protocol Violation|2|||
131490726|NCT01328431|473427289|FG000|1 Month (1M)|Lost to Follow-up|55|||
131490727|NCT01328431|473427290|FG001|1 Month (1M)|Lost to Follow-up|58|||
131490728|NCT01328431|473427289|FG000|3 Month (3M)|Death|2|||
131490729|NCT01328431|473427290|FG001|3 Month (3M)|Death|2|||
131490730|NCT01328431|473427289|FG000|3 Month (3M)|Lost to Follow-up|75|||
131490731|NCT01328431|473427290|FG001|3 Month (3M)|Lost to Follow-up|70|||
131490732|NCT01328431|473427289|FG000|12 Month (12M)|Death|2|||
131490733|NCT01328431|473427290|FG001|12 Month (12M)|Death|6|||
131490734|NCT01328431|473427289|FG000|12 Month (12M)|Lost to Follow-up|82|||
131490735|NCT01328431|473427290|FG001|12 Month (12M)|Lost to Follow-up|91|||
131490736|NCT02099708|473427297|FG000|Overall Study|Data Not Available|30|||
131490737|NCT02099708|473427297|FG000|Overall Study|Lost to Follow-up|141|||
131490738|NCT02099708|473427297|FG000|Overall Study|Other|29|||
131490739|NCT05466682|473427303|FG000|Overall Study|Withdrawal by Subject|0|||
131490740|NCT05466682|473427304|FG001|Overall Study|Withdrawal by Subject|2|||
131490741|NCT05466682|473427303|FG000|Overall Study|Lost to Follow-up|2|||
131490742|NCT05466682|473427304|FG001|Overall Study|Lost to Follow-up|1|||
131490743|NCT01697566|473427305|FG000|Overall Study|Withdrawal by Subject|0|||
131490744|NCT01697566|473427306|FG001|Overall Study|Withdrawal by Subject|0|||
131490745|NCT01697566|473427307|FG002|Overall Study|Withdrawal by Subject|1|||
131490746|NCT01697566|473427308|FG003|Overall Study|Withdrawal by Subject|1|||
131490747|NCT01697566|473427305|FG000|Overall Study|Final biopsy not obtained|0|||
131490748|NCT01697566|473427306|FG001|Overall Study|Final biopsy not obtained|0|||
131490749|NCT01697566|473427307|FG002|Overall Study|Final biopsy not obtained|1|||
131490750|NCT01697566|473427308|FG003|Overall Study|Final biopsy not obtained|0|||
131490751|NCT01930123|473427309|FG000|Overall Study|Adverse Event|1|||
131490752|NCT01930123|473427310|FG001|Overall Study|Adverse Event|0|||
131490753|NCT01930123|473427309|FG000|Overall Study|Physician Decision|21|||
131490754|NCT01930123|473427310|FG001|Overall Study|Physician Decision|8|||
131490755|NCT01930123|473427309|FG000|Overall Study|Withdrawal by Subject|1|||
131490756|NCT01930123|473427310|FG001|Overall Study|Withdrawal by Subject|0|||
131490757|NCT01447433|473427313|FG000|Overall Study|Lost to Follow-up|0|||
131490758|NCT01447433|473427314|FG001|Overall Study|Lost to Follow-up|2|||
131490759|NCT01447433|473427313|FG000|Overall Study|Withdrawal by Subject|3|||
131490760|NCT01447433|473427314|FG001|Overall Study|Withdrawal by Subject|3|||
131490761|NCT01447433|473427313|FG000|Overall Study|Protocol Violation|1|||
131490762|NCT01447433|473427314|FG001|Overall Study|Protocol Violation|1|||
131490763|NCT00036270|473427315|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
131490764|NCT00036270|473427316|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
131490765|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
131490766|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
131490767|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
131490768|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
131490769|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
131490770|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
131490771|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Other|277|||
131490772|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Other|288|||
131490773|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
131490774|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
131490775|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
131490776|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
131490777|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
131490778|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
131490779|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
131490780|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
131490781|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
131490782|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
131490783|NCT00036270|473427315|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
131490784|NCT00036270|473427316|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
131490785|NCT01964430|473427317|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
131490786|NCT01964430|473427318|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
131490787|NCT01964430|473427317|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
131490788|NCT01964430|473427318|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
131490789|NCT01964430|473427317|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
131490790|NCT01964430|473427318|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
131490791|NCT01964430|473427317|FG000|Treatment Period|Adverse Event|71|||
131490792|NCT01964430|473427318|FG001|Treatment Period|Adverse Event|37|||
131490793|NCT01964430|473427317|FG000|Treatment Period|Withdrawal by Subject|36|||
131490794|NCT01964430|473427318|FG001|Treatment Period|Withdrawal by Subject|27|||
131490795|NCT01964430|473427317|FG000|Treatment Period|Death|1|||
131490796|NCT01964430|473427318|FG001|Treatment Period|Death|3|||
131490797|NCT01964430|473427317|FG000|Treatment Period|Protocol Deviation|0|||
131490798|NCT01964430|473427318|FG001|Treatment Period|Protocol Deviation|1|||
131490799|NCT01964430|473427317|FG000|Treatment Period|Physician Decision|5|||
131490800|NCT01964430|473427318|FG001|Treatment Period|Physician Decision|4|||
131490801|NCT01964430|473427317|FG000|Treatment Period|Disease Relapse|28|||
131490802|NCT01964430|473427318|FG001|Treatment Period|Disease Relapse|38|||
131490803|NCT01964430|473427317|FG000|Treatment Period|Other reasons|1|||
131490804|NCT01964430|473427318|FG001|Treatment Period|Other reasons|3|||
131490805|NCT02516163|473427319|FG000|Overall Study|Withdrawal by Subject|1|||
131490806|NCT02516163|473427319|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
131490807|NCT02516163|473427319|FG000|Overall Study|Unfit/delay in surgery|3|||
131490808|NCT02516163|473427319|FG000|Overall Study|Use of incorrect measurement technique|5|||
131490809|NCT02516163|473427319|FG000|Overall Study|Data not recorded|2|||
131490810|NCT02516163|473427319|FG000|Overall Study|MRI contraindication exclusion|6|||
131490811|NCT02801396|473427320|FG000|Period 1|Withdrawal by Subject|0|||
131490812|NCT02801396|473427321|FG001|Period 1|Withdrawal by Subject|0|||
131490813|NCT02801396|473427322|FG002|Period 1|Withdrawal by Subject|0|||
131490814|NCT02801396|473427323|FG003|Period 1|Withdrawal by Subject|0|||
131490815|NCT02801396|473427324|FG004|Period 1|Withdrawal by Subject|1|||
131490816|NCT02801396|473427325|FG005|Period 1|Withdrawal by Subject|0|||
131490817|NCT01658072|473427328|FG000|Overall Study|Protocol Violation|4|||
131490818|NCT01658072|473427329|FG001|Overall Study|Protocol Violation|2|||
131490819|NCT03310021|473427332|FG000|Overall Study|Withdrawal by Subject|0|||
131490820|NCT03310021|473427333|FG001|Overall Study|Withdrawal by Subject|0|||
131490821|NCT03310021|473427334|FG002|Overall Study|Withdrawal by Subject|0|||
131490822|NCT03310021|473427335|FG003|Overall Study|Withdrawal by Subject|0|||
131490823|NCT03310021|473427336|FG004|Overall Study|Withdrawal by Subject|0|||
131490824|NCT03310021|473427337|FG005|Overall Study|Withdrawal by Subject|0|||
131490825|NCT03310021|473427338|FG006|Overall Study|Withdrawal by Subject|1|||
131490826|NCT03310021|473427339|FG007|Overall Study|Withdrawal by Subject|0|||
131490827|NCT03310021|473427340|FG008|Overall Study|Withdrawal by Subject|0|||
131490828|NCT03310021|473427341|FG009|Overall Study|Withdrawal by Subject|0|||
131490829|NCT03310021|473427342|FG010|Overall Study|Withdrawal by Subject|0|||
131490830|NCT03310021|473427343|FG011|Overall Study|Withdrawal by Subject|0|||
131490831|NCT03310021|473427344|FG012|Overall Study|Withdrawal by Subject|0|||
131490832|NCT03310021|473427345|FG013|Overall Study|Withdrawal by Subject|0|||
131490833|NCT03310021|473427346|FG014|Overall Study|Withdrawal by Subject|0|||
131490834|NCT03310021|473427347|FG015|Overall Study|Withdrawal by Subject|0|||
131490835|NCT03310021|473427348|FG016|Overall Study|Withdrawal by Subject|0|||
131490836|NCT03310021|473427349|FG017|Overall Study|Withdrawal by Subject|0|||
131490837|NCT03310021|473427350|FG018|Overall Study|Withdrawal by Subject|0|||
131490838|NCT03310021|473427351|FG019|Overall Study|Withdrawal by Subject|0|||
131490839|NCT03310021|473427332|FG000|Overall Study|Lost to Follow-up|0|||
131490840|NCT03310021|473427333|FG001|Overall Study|Lost to Follow-up|0|||
131490841|NCT03310021|473427334|FG002|Overall Study|Lost to Follow-up|0|||
131490842|NCT03310021|473427335|FG003|Overall Study|Lost to Follow-up|0|||
131490843|NCT03310021|473427336|FG004|Overall Study|Lost to Follow-up|0|||
131490844|NCT03310021|473427337|FG005|Overall Study|Lost to Follow-up|0|||
131490845|NCT03310021|473427338|FG006|Overall Study|Lost to Follow-up|0|||
131490846|NCT03310021|473427339|FG007|Overall Study|Lost to Follow-up|0|||
131490847|NCT03310021|473427340|FG008|Overall Study|Lost to Follow-up|0|||
131490848|NCT03310021|473427341|FG009|Overall Study|Lost to Follow-up|0|||
131490849|NCT03310021|473427342|FG010|Overall Study|Lost to Follow-up|1|||
131490850|NCT03310021|473427343|FG011|Overall Study|Lost to Follow-up|0|||
131490851|NCT03310021|473427344|FG012|Overall Study|Lost to Follow-up|0|||
131490852|NCT03310021|473427345|FG013|Overall Study|Lost to Follow-up|0|||
131490853|NCT03310021|473427346|FG014|Overall Study|Lost to Follow-up|0|||
131490854|NCT03310021|473427347|FG015|Overall Study|Lost to Follow-up|0|||
131490855|NCT03310021|473427348|FG016|Overall Study|Lost to Follow-up|0|||
131490856|NCT03310021|473427349|FG017|Overall Study|Lost to Follow-up|0|||
131490857|NCT03310021|473427350|FG018|Overall Study|Lost to Follow-up|0|||
131490858|NCT03310021|473427351|FG019|Overall Study|Lost to Follow-up|0|||
131490859|NCT01874054|473427352|FG000|Overall Study|Withdrawal by Subject|3|||
131490860|NCT01874054|473427352|FG000|Overall Study|Study Termination by Sponsor|42|||
131490861|NCT01874054|473427352|FG000|Overall Study|Lost to Follow-up|5|||
131490862|NCT01874054|473427352|FG000|Overall Study|Death|5|||
131490863|NCT00702923|473427353|FG000|Overall Study|Adverse Event|1|||
131490864|NCT03953820|473427355|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
131490865|NCT03953820|473427356|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
131490866|NCT03953820|473427357|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
131490867|NCT03953820|473427355|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
131490868|NCT03953820|473427356|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
131490869|NCT03953820|473427357|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
131490870|NCT01318993|473427358|FG000|Overall Study|Adverse Event|53|||
131490871|NCT01318993|473427358|FG000|Overall Study|Lack of Efficacy|121|||
131490872|NCT01318993|473427358|FG000|Overall Study|Protocol Violation|3|||
131490873|NCT01318993|473427358|FG000|Overall Study|Protocol based stopping criteria|6|||
131490874|NCT01318993|473427358|FG000|Overall Study|Study closed or terminated|174|||
131490875|NCT01318993|473427358|FG000|Overall Study|Lost to Follow-up|4|||
131490876|NCT01318993|473427358|FG000|Overall Study|Physician Decision|13|||
131490877|NCT01318993|473427358|FG000|Overall Study|Withdrawal by Subject|24|||
131490878|NCT02784431|473427359|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
131490879|NCT02784431|473427359|FG000|Overall Study|Early Study Termination|19|||
131490880|NCT03715530|473427360|FG000|Overall Study|Lost to Follow-up|3|||
131490881|NCT03715530|473427361|FG001|Overall Study|Lost to Follow-up|1|||
131490882|NCT03715530|473427362|FG002|Overall Study|Lost to Follow-up|2|||
131490883|NCT05255068|473429342|FG000|Overall Study|Lost to Follow-up|0|||
131490884|NCT05255068|473429343|FG001|Overall Study|Lost to Follow-up|1|||
131490885|NCT00980057|473429348|FG000|Overall Study|Death|13|||
131490886|NCT00980057|473429349|FG001|Overall Study|Death|3|||
131490887|NCT00980057|473429348|FG000|Overall Study|Adverse Event|0|||
131490888|NCT00980057|473429349|FG001|Overall Study|Adverse Event|1|||
131490889|NCT00980057|473429348|FG000|Overall Study|Physician Decision|4|||
131490890|NCT00980057|473429349|FG001|Overall Study|Physician Decision|0|||
131490891|NCT00980057|473429348|FG000|Overall Study|Lost to Follow-up|1|||
131490892|NCT00980057|473429349|FG001|Overall Study|Lost to Follow-up|0|||
131490893|NCT00980057|473429348|FG000|Overall Study|Withdrawal by Subject|1|||
131490894|NCT00980057|473429349|FG001|Overall Study|Withdrawal by Subject|1|||
131490895|NCT01315678|473429353|FG000|Overall Study|Withdrawal by Subject|7|||
131490896|NCT01315678|473429354|FG001|Overall Study|Withdrawal by Subject|3|||
131490897|NCT01315678|473429353|FG000|Overall Study|Adverse Event|3|||
131490898|NCT01315678|473429354|FG001|Overall Study|Adverse Event|1|||
131490899|NCT01315678|473429353|FG000|Overall Study|Lost to Follow-up|1|||
131490900|NCT01315678|473429354|FG001|Overall Study|Lost to Follow-up|0|||
131490901|NCT01315678|473429353|FG000|Overall Study|similar reason to those listed above|3|||
131490902|NCT01315678|473429354|FG001|Overall Study|similar reason to those listed above|2|||
131490903|NCT00331682|473429355|FG000|Overall Study|Adverse Event|1|||
131490904|NCT00790023|473429356|FG000|Overall Study|Adverse Event|2|||
131490905|NCT00790023|473429357|FG001|Overall Study|Adverse Event|1|||
131490906|NCT00790023|473429358|FG002|Overall Study|Adverse Event|4|||
131490907|NCT00790023|473429356|FG000|Overall Study|Protocol Violation|2|||
131490908|NCT00790023|473429357|FG001|Overall Study|Protocol Violation|4|||
131490909|NCT00790023|473429358|FG002|Overall Study|Protocol Violation|2|||
131490910|NCT00790023|473429356|FG000|Overall Study|Withdrawal by Subject|2|||
131490911|NCT00790023|473429357|FG001|Overall Study|Withdrawal by Subject|0|||
131490912|NCT00790023|473429358|FG002|Overall Study|Withdrawal by Subject|6|||
131490913|NCT00790023|473429356|FG000|Overall Study|Lost to Follow-up|0|||
131490914|NCT00790023|473429357|FG001|Overall Study|Lost to Follow-up|0|||
131490915|NCT00790023|473429358|FG002|Overall Study|Lost to Follow-up|1|||
131490916|NCT00790023|473429356|FG000|Overall Study|Other|5|||
131490917|NCT00790023|473429357|FG001|Overall Study|Other|5|||
131490918|NCT00790023|473429358|FG002|Overall Study|Other|8|||
131490919|NCT01338792|473429359|FG000|Overall Study|Adverse Event|2|||
131490920|NCT01338792|473429359|FG000|Overall Study|Death|1|||
131490921|NCT01338792|473429359|FG000|Overall Study|Withdrawal by Subject|1|||
131490922|NCT00573469|473429360|FG000|Overall Study|Adverse Event|1|||
131490923|NCT00573469|473429361|FG001|Overall Study|Adverse Event|1|||
131490924|NCT00573469|473429362|FG002|Overall Study|Adverse Event|1|||
131490925|NCT00573469|473429360|FG000|Overall Study|Withdrawal by Subject|0|||
131490926|NCT00573469|473429361|FG001|Overall Study|Withdrawal by Subject|2|||
131490927|NCT00573469|473429362|FG002|Overall Study|Withdrawal by Subject|0|||
131490928|NCT00573469|473429360|FG000|Overall Study|Other|5|||
131490929|NCT00573469|473429361|FG001|Overall Study|Other|1|||
131490930|NCT00573469|473429362|FG002|Overall Study|Other|3|||
131490931|NCT02468414|473429363|FG000|Overall Study|Early Study Termination by Sponsor|1|||
131490932|NCT02468414|473429364|FG001|Overall Study|Early Study Termination by Sponsor|0|||
131490933|NCT02468414|473429363|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
131490934|NCT02468414|473429364|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
131490935|NCT02468414|473429363|FG000|Overall Study|Screen Failure|1|||
131490936|NCT02468414|473429364|FG001|Overall Study|Screen Failure|0|||
131490937|NCT00004978|473429365|FG000|Overall Study|Death|107|||
131490938|NCT00004978|473429366|FG001|Overall Study|Death|116|||
131490939|NCT00004978|473429365|FG000|Overall Study|Lost to Follow-up|101|||
131490940|NCT00004978|473429366|FG001|Overall Study|Lost to Follow-up|108|||
131490941|NCT00004978|473429365|FG000|Overall Study|Withdrawal by Subject|17|||
131490942|NCT00004978|473429366|FG001|Overall Study|Withdrawal by Subject|26|||
131490943|NCT00004978|473429365|FG000|Overall Study|site closure - not in analysis cohort|19|||
131490944|NCT00004978|473429366|FG001|Overall Study|site closure - not in analysis cohort|20|||
131490945|NCT01652703|473429370|FG000|Overall Study|Withdrawal by Subject|0|||
131490946|NCT01652703|473429371|FG001|Overall Study|Withdrawal by Subject|1|||
131490947|NCT01652703|473429372|FG002|Overall Study|Withdrawal by Subject|3|||
131490948|NCT01652703|473429373|FG003|Overall Study|Withdrawal by Subject|1|||
131490949|NCT01652703|473429374|FG004|Overall Study|Withdrawal by Subject|0|||
131490950|NCT01652703|473429375|FG005|Overall Study|Withdrawal by Subject|1|||
131490951|NCT01652703|473429370|FG000|Overall Study|Other|0|||
131490952|NCT01652703|473429371|FG001|Overall Study|Other|0|||
131490953|NCT01652703|473429372|FG002|Overall Study|Other|0|||
131490954|NCT01652703|473429373|FG003|Overall Study|Other|1|||
131490955|NCT01652703|473429374|FG004|Overall Study|Other|1|||
131490956|NCT01652703|473429375|FG005|Overall Study|Other|1|||
131490957|NCT02155608|473429376|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
131490958|NCT02155608|473429377|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
131490959|NCT02155608|473429376|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
131490960|NCT02155608|473429377|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
131490961|NCT03555591|473429378|FG000|Overall Study|Protocol Violation|77|||
131490962|NCT01532414|473429379|FG000|Overall Study|Lost to Follow-up|3|||
131490963|NCT01532414|473429380|FG001|Overall Study|Lost to Follow-up|0|||
131490964|NCT01532414|473429381|FG002|Overall Study|Lost to Follow-up|1|||
131490965|NCT01532414|473429379|FG000|Overall Study|Withdrawal by Subject|3|||
131490966|NCT01532414|473429380|FG001|Overall Study|Withdrawal by Subject|0|||
131490967|NCT01532414|473429381|FG002|Overall Study|Withdrawal by Subject|0|||
131490968|NCT01532414|473429379|FG000|Overall Study|No V6 semen sample|0|||
131490969|NCT01532414|473429380|FG001|Overall Study|No V6 semen sample|1|||
131490970|NCT01532414|473429381|FG002|Overall Study|No V6 semen sample|0|||
131490971|NCT01532414|473429379|FG000|Overall Study|Adverse Event|0|||
131490972|NCT01532414|473429380|FG001|Overall Study|Adverse Event|1|||
131490973|NCT01532414|473429381|FG002|Overall Study|Adverse Event|1|||
131490974|NCT01532414|473429379|FG000|Overall Study|Unable to complete 24 hour PK|0|||
131490975|NCT01532414|473429380|FG001|Overall Study|Unable to complete 24 hour PK|0|||
131490976|NCT01532414|473429381|FG002|Overall Study|Unable to complete 24 hour PK|1|||
131490977|NCT01532414|473429379|FG000|Overall Study|Withdrawn by sponsor|1|||
131490978|NCT01532414|473429380|FG001|Overall Study|Withdrawn by sponsor|0|||
131490979|NCT01532414|473429381|FG002|Overall Study|Withdrawn by sponsor|0|||
131490980|NCT00187486|473429382|FG000|Overall Study|Protocol Violation|1|||
131490981|NCT02380677|473429383|FG000|Overall Study|Adverse Event|0|||
131490982|NCT02380677|473429384|FG001|Overall Study|Adverse Event|0|||
131490983|NCT02380677|473429385|FG002|Overall Study|Adverse Event|0|||
131490984|NCT02380677|473429386|FG003|Overall Study|Adverse Event|1|||
131490985|NCT02380677|473429387|FG004|Overall Study|Adverse Event|1|||
131490986|NCT02380677|473429388|FG005|Overall Study|Adverse Event|4|||
131490987|NCT02380677|473429389|FG006|Overall Study|Adverse Event|2|||
131490988|NCT02380677|473429390|FG007|Overall Study|Adverse Event|2|||
131490989|NCT02380677|473429391|FG008|Overall Study|Adverse Event|2|||
131490990|NCT02380677|473429392|FG009|Overall Study|Adverse Event|1|||
131490991|NCT02380677|473429393|FG010|Overall Study|Adverse Event|2|||
131490992|NCT02380677|473429394|FG011|Overall Study|Adverse Event|1|||
131490993|NCT02380677|473429383|FG000|Overall Study|Physician Decision|1|||
131490994|NCT02380677|473429384|FG001|Overall Study|Physician Decision|0|||
131490995|NCT02380677|473429385|FG002|Overall Study|Physician Decision|1|||
131490996|NCT02380677|473429386|FG003|Overall Study|Physician Decision|1|||
131490997|NCT02380677|473429387|FG004|Overall Study|Physician Decision|0|||
131490998|NCT02380677|473429388|FG005|Overall Study|Physician Decision|0|||
131490999|NCT02380677|473429389|FG006|Overall Study|Physician Decision|0|||
131491000|NCT02380677|473429390|FG007|Overall Study|Physician Decision|0|||
131491001|NCT02380677|473429391|FG008|Overall Study|Physician Decision|0|||
131491002|NCT02380677|473429392|FG009|Overall Study|Physician Decision|0|||
131491003|NCT02380677|473429393|FG010|Overall Study|Physician Decision|0|||
131491004|NCT02380677|473429394|FG011|Overall Study|Physician Decision|0|||
131491005|NCT02380677|473429383|FG000|Overall Study|Lack of Efficacy|0|||
131491006|NCT02380677|473429384|FG001|Overall Study|Lack of Efficacy|1|||
131491007|NCT02380677|473429385|FG002|Overall Study|Lack of Efficacy|2|||
131491008|NCT02380677|473429386|FG003|Overall Study|Lack of Efficacy|0|||
131491009|NCT02380677|473429387|FG004|Overall Study|Lack of Efficacy|4|||
131491010|NCT02380677|473429388|FG005|Overall Study|Lack of Efficacy|1|||
131491011|NCT02380677|473429389|FG006|Overall Study|Lack of Efficacy|1|||
131491012|NCT02380677|473429390|FG007|Overall Study|Lack of Efficacy|2|||
131491013|NCT02380677|473429391|FG008|Overall Study|Lack of Efficacy|2|||
131491014|NCT02380677|473429392|FG009|Overall Study|Lack of Efficacy|0|||
131491015|NCT02380677|473429393|FG010|Overall Study|Lack of Efficacy|2|||
131491016|NCT02380677|473429394|FG011|Overall Study|Lack of Efficacy|1|||
131491017|NCT02380677|473429383|FG000|Overall Study|Withdrawal by Subject|0|||
131491018|NCT02380677|473429384|FG001|Overall Study|Withdrawal by Subject|0|||
131491019|NCT02380677|473429385|FG002|Overall Study|Withdrawal by Subject|0|||
131491020|NCT02380677|473429386|FG003|Overall Study|Withdrawal by Subject|0|||
131491021|NCT02380677|473429387|FG004|Overall Study|Withdrawal by Subject|0|||
131491022|NCT02380677|473429388|FG005|Overall Study|Withdrawal by Subject|0|||
131491023|NCT02380677|473429389|FG006|Overall Study|Withdrawal by Subject|0|||
131491024|NCT02380677|473429390|FG007|Overall Study|Withdrawal by Subject|0|||
131491025|NCT02380677|473429391|FG008|Overall Study|Withdrawal by Subject|0|||
131491026|NCT02380677|473429392|FG009|Overall Study|Withdrawal by Subject|1|||
131491027|NCT02380677|473429393|FG010|Overall Study|Withdrawal by Subject|0|||
131491028|NCT02380677|473429394|FG011|Overall Study|Withdrawal by Subject|3|||
131491029|NCT02380677|473429383|FG000|Overall Study|Other|0|||
131491030|NCT02380677|473429384|FG001|Overall Study|Other|0|||
131491031|NCT02380677|473429385|FG002|Overall Study|Other|0|||
131491032|NCT02380677|473429386|FG003|Overall Study|Other|1|||
131491033|NCT02380677|473429387|FG004|Overall Study|Other|1|||
131491034|NCT02380677|473429388|FG005|Overall Study|Other|1|||
131491035|NCT02380677|473429389|FG006|Overall Study|Other|0|||
131491036|NCT02380677|473429390|FG007|Overall Study|Other|0|||
131491037|NCT02380677|473429391|FG008|Overall Study|Other|0|||
131491038|NCT02380677|473429392|FG009|Overall Study|Other|0|||
131491039|NCT02380677|473429393|FG010|Overall Study|Other|0|||
131491040|NCT02380677|473429394|FG011|Overall Study|Other|0|||
131491041|NCT01029795|473429402|FG000|Overall Study|Entry Criteria Not Met|2|||
131491042|NCT01029795|473429403|FG001|Overall Study|Entry Criteria Not Met|1|||
131491043|NCT01029795|473429402|FG000|Overall Study|Physician Decision|2|||
131491044|NCT01029795|473429403|FG001|Overall Study|Physician Decision|1|||
131491045|NCT01029795|473429402|FG000|Overall Study|Sponsor Decision|11|||
131491046|NCT01029795|473429403|FG001|Overall Study|Sponsor Decision|17|||
131491047|NCT01029795|473429402|FG000|Overall Study|Withdrawal by Subject|1|||
131491048|NCT01029795|473429403|FG001|Overall Study|Withdrawal by Subject|3|||
131491049|NCT03217175|473429404|FG000|Overall Study|Physician Decision|4|||
131491050|NCT03217175|473429405|FG001|Overall Study|Physician Decision|1|||
131491051|NCT05035550|473429414|FG000|Overall Study|Withdrawal by Subject|3|||
131491052|NCT05035550|473429415|FG001|Overall Study|Withdrawal by Subject|0|||
131491053|NCT00003479|473429416|FG000|Overall Study|Not evaluable|3|||
131491054|NCT01844518|473429417|FG000|Overall Study|Adverse Event|7|||
131491055|NCT01844518|473429418|FG001|Overall Study|Adverse Event|1|||
131491056|NCT01844518|473429417|FG000|Overall Study|Lack of Efficacy|17|||
131491057|NCT01844518|473429418|FG001|Overall Study|Lack of Efficacy|5|||
131491058|NCT01844518|473429417|FG000|Overall Study|Participant's request to discontinue|4|||
131491059|NCT01844518|473429418|FG001|Overall Study|Participant's request to discontinue|1|||
131491060|NCT01844518|473429417|FG000|Overall Study|Poor/Non-compliance|1|||
131491061|NCT01844518|473429418|FG001|Overall Study|Poor/Non-compliance|0|||
131491062|NCT01844518|473429417|FG000|Overall Study|No Longer Met Study Criteria|2|||
131491063|NCT01844518|473429418|FG001|Overall Study|No Longer Met Study Criteria|0|||
131491064|NCT01844518|473429417|FG000|Overall Study|Withdrawal by Subject|9|||
131491065|NCT01844518|473429418|FG001|Overall Study|Withdrawal by Subject|0|||
131491066|NCT01844518|473429417|FG000|Overall Study|Pregnancy|1|||
131491067|NCT01844518|473429418|FG001|Overall Study|Pregnancy|0|||
131491068|NCT00291577|473429420|FG000|Overall Study|Adverse Event|1|||
131491069|NCT00291577|473429420|FG000|Overall Study|Other|4|||
131491070|NCT00291577|473429420|FG000|Overall Study|Withdrawal by Subject|2|||
131491071|NCT00291577|473429420|FG000|Overall Study|Lack of Efficacy|14|||
131491072|NCT04584645|473429421|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
131491073|NCT04584645|473429422|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
131491074|NCT00390468|473429423|FG000|Overall Study|Protocol Violation|2|||
131491075|NCT00390468|473429423|FG000|Overall Study|Lack of Efficacy|1|||
131491076|NCT03129100|473429429|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
131491077|NCT03129100|473429430|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
131491078|NCT03129100|473429431|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
131491079|NCT03129100|473429432|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
131491080|NCT03129100|473429433|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
131491081|NCT03129100|473429434|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
131491082|NCT03129100|473429435|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
131491083|NCT03129100|473429436|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
131491084|NCT03129100|473429437|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
131491085|NCT03129100|473429438|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
131491086|NCT03129100|473429439|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
131491087|NCT03129100|473429440|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
131491088|NCT03129100|473429441|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
131491089|NCT03129100|473429442|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
131491090|NCT03129100|473429443|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
131491091|NCT03129100|473429444|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
131491092|NCT03129100|473429445|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
131491093|NCT03129100|473429446|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
131491094|NCT03129100|473429447|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
131491095|NCT03129100|473429448|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
131491096|NCT03129100|473429449|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
131491097|NCT03129100|473429450|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
131491098|NCT03129100|473429451|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
131491099|NCT03129100|473429452|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
131491100|NCT03129100|473429453|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
131491101|NCT03129100|473429454|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
131491102|NCT03129100|473429429|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
131491103|NCT03129100|473429430|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491104|NCT03129100|473429431|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491105|NCT03129100|473429432|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491106|NCT03129100|473429433|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491107|NCT03129100|473429434|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491108|NCT03129100|473429435|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491109|NCT03129100|473429436|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491110|NCT03129100|473429437|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491111|NCT03129100|473429438|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491112|NCT03129100|473429439|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491113|NCT03129100|473429440|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491114|NCT03129100|473429441|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491115|NCT03129100|473429442|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491116|NCT03129100|473429443|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491117|NCT03129100|473429444|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491118|NCT03129100|473429445|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491119|NCT03129100|473429446|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491120|NCT03129100|473429447|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491121|NCT03129100|473429448|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491122|NCT03129100|473429449|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491123|NCT03129100|473429450|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491124|NCT03129100|473429451|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491125|NCT03129100|473429452|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491126|NCT03129100|473429453|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491127|NCT03129100|473429454|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131491128|NCT03129100|473429429|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
131491129|NCT03129100|473429430|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
131491130|NCT03129100|473429431|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491131|NCT03129100|473429432|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491132|NCT03129100|473429433|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491133|NCT03129100|473429434|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491134|NCT03129100|473429435|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491135|NCT03129100|473429436|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491136|NCT03129100|473429437|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491137|NCT03129100|473429438|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491138|NCT03129100|473429439|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491139|NCT03129100|473429440|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491140|NCT03129100|473429441|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491141|NCT03129100|473429442|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491142|NCT03129100|473429443|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491143|NCT03129100|473429444|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491144|NCT03129100|473429445|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491145|NCT03129100|473429446|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491146|NCT03129100|473429447|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491147|NCT03129100|473429448|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491148|NCT03129100|473429449|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491149|NCT03129100|473429450|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491150|NCT03129100|473429451|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491151|NCT03129100|473429452|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491152|NCT03129100|473429453|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491153|NCT03129100|473429454|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
131491154|NCT03129100|473429429|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
131491155|NCT03129100|473429430|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
131491156|NCT03129100|473429431|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491157|NCT03129100|473429432|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491158|NCT03129100|473429433|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491159|NCT03129100|473429434|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491160|NCT03129100|473429435|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491161|NCT03129100|473429436|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491162|NCT03129100|473429437|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491163|NCT03129100|473429438|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491164|NCT03129100|473429439|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491165|NCT03129100|473429440|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491166|NCT03129100|473429441|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491167|NCT03129100|473429442|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491168|NCT03129100|473429443|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491169|NCT03129100|473429444|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491170|NCT03129100|473429445|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491171|NCT03129100|473429446|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491172|NCT03129100|473429447|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491173|NCT03129100|473429448|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491174|NCT03129100|473429449|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491175|NCT03129100|473429450|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491176|NCT03129100|473429451|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491177|NCT03129100|473429452|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491178|NCT03129100|473429453|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491179|NCT03129100|473429454|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
131491180|NCT03129100|473429429|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491181|NCT03129100|473429430|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
131491182|NCT03129100|473429431|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491183|NCT03129100|473429432|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491184|NCT03129100|473429433|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491185|NCT03129100|473429434|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491186|NCT03129100|473429435|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491187|NCT03129100|473429436|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491188|NCT03129100|473429437|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491189|NCT03129100|473429438|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491190|NCT03129100|473429439|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491191|NCT03129100|473429440|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491192|NCT03129100|473429441|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491193|NCT03129100|473429442|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491194|NCT03129100|473429443|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491195|NCT03129100|473429444|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491196|NCT03129100|473429445|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491197|NCT03129100|473429446|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491198|NCT03129100|473429447|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491199|NCT03129100|473429448|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491200|NCT03129100|473429449|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491201|NCT03129100|473429450|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491202|NCT03129100|473429451|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491203|NCT03129100|473429452|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491204|NCT03129100|473429453|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491205|NCT03129100|473429454|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
131491206|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491207|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491208|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
131491209|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
131491210|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491211|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
131491212|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491213|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491214|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491215|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491216|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491217|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491218|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491219|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491220|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491221|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491222|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491223|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491224|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491225|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491226|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491227|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491228|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491229|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491230|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491231|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
131491232|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Death|0|||
131491233|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Death|0|||
131491234|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Death|1|||
131491235|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Death|0|||
131491236|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Death|0|||
131491237|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Death|0|||
131491238|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Death|0|||
131491239|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Death|0|||
131491240|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Death|0|||
131491241|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Death|0|||
131491242|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Death|0|||
131491243|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Death|0|||
131491244|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Death|0|||
131491245|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Death|0|||
131491246|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Death|0|||
131491247|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Death|0|||
131491248|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Death|0|||
131491249|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Death|0|||
131491250|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Death|0|||
131491251|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Death|0|||
131491252|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Death|0|||
131491253|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Death|0|||
131491254|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Death|0|||
131491255|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Death|0|||
131491256|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Death|0|||
131491257|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Death|0|||
131491258|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491259|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491260|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
131491261|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
131491262|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
131491263|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
131491264|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
131491265|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491266|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491267|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491268|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491269|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491270|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491271|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491272|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491273|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491274|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491275|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491276|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491277|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491278|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491279|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491280|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491281|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491282|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491283|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
131491284|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491285|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491286|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
131491287|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491288|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491289|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491290|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491291|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491292|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491293|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491294|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491295|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491296|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491297|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491298|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491299|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491300|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491301|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491302|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491303|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491304|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491305|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491306|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491307|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491308|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491309|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
131491310|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491311|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491312|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
131491313|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491314|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491315|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491316|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491317|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491318|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491319|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491320|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491321|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491322|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491323|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491324|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491325|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491326|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491327|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491328|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491329|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491330|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491331|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491332|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491333|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491334|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491335|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
131491336|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491337|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491338|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
131491339|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491340|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491341|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491342|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491343|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491344|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491345|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491346|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491347|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491348|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491349|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491350|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491351|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491352|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491353|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491354|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491355|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491356|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491357|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491358|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491359|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491360|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491361|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131491362|NCT03129100|473429429|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491363|NCT03129100|473429430|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491364|NCT03129100|473429431|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491365|NCT03129100|473429432|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491366|NCT03129100|473429433|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
131491367|NCT03129100|473429434|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
131491368|NCT03129100|473429435|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
131491369|NCT03129100|473429436|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491370|NCT03129100|473429437|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491371|NCT03129100|473429438|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491372|NCT03129100|473429439|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491373|NCT03129100|473429440|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491374|NCT03129100|473429441|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491375|NCT03129100|473429442|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491376|NCT03129100|473429443|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491377|NCT03129100|473429444|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491378|NCT03129100|473429445|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491379|NCT03129100|473429446|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491380|NCT03129100|473429447|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491381|NCT03129100|473429448|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491382|NCT03129100|473429449|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491383|NCT03129100|473429450|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491384|NCT03129100|473429451|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491385|NCT03129100|473429452|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491386|NCT03129100|473429453|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491387|NCT03129100|473429454|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
131491388|NCT03129100|473429429|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491389|NCT03129100|473429430|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491390|NCT03129100|473429431|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491391|NCT03129100|473429432|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491392|NCT03129100|473429433|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491393|NCT03129100|473429434|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491394|NCT03129100|473429435|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491395|NCT03129100|473429436|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491396|NCT03129100|473429437|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491397|NCT03129100|473429438|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
131491398|NCT03129100|473429439|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491399|NCT03129100|473429440|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491400|NCT03129100|473429441|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491401|NCT03129100|473429442|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491402|NCT03129100|473429443|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491403|NCT03129100|473429444|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491404|NCT03129100|473429445|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491405|NCT03129100|473429446|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491406|NCT03129100|473429447|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491407|NCT03129100|473429448|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491408|NCT03129100|473429449|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491409|NCT03129100|473429450|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491410|NCT03129100|473429451|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491411|NCT03129100|473429452|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491412|NCT03129100|473429453|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491413|NCT03129100|473429454|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
131491414|NCT03129100|473429429|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491415|NCT03129100|473429430|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491416|NCT03129100|473429431|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491417|NCT03129100|473429432|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491418|NCT03129100|473429433|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491419|NCT03129100|473429434|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491420|NCT03129100|473429435|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491421|NCT03129100|473429436|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491422|NCT03129100|473429437|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491423|NCT03129100|473429438|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491424|NCT03129100|473429439|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491425|NCT03129100|473429440|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
131491426|NCT03129100|473429441|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491427|NCT03129100|473429442|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491428|NCT03129100|473429443|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491429|NCT03129100|473429444|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491430|NCT03129100|473429445|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491431|NCT03129100|473429446|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491432|NCT03129100|473429447|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491433|NCT03129100|473429448|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491434|NCT03129100|473429449|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491435|NCT03129100|473429450|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491436|NCT03129100|473429451|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491437|NCT03129100|473429452|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491438|NCT03129100|473429453|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491439|NCT03129100|473429454|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
131491440|NCT03129100|473429429|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491441|NCT03129100|473429430|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491442|NCT03129100|473429431|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491443|NCT03129100|473429432|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491444|NCT03129100|473429433|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491445|NCT03129100|473429434|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491446|NCT03129100|473429435|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491447|NCT03129100|473429436|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491448|NCT03129100|473429437|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491449|NCT03129100|473429438|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491450|NCT03129100|473429439|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491451|NCT03129100|473429440|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
131491452|NCT03129100|473429441|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
131491453|NCT03129100|473429442|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
131491454|NCT03129100|473429443|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
131491455|NCT03129100|473429444|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491456|NCT03129100|473429445|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491457|NCT03129100|473429446|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491458|NCT03129100|473429447|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491459|NCT03129100|473429448|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491460|NCT03129100|473429449|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491461|NCT03129100|473429450|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491462|NCT03129100|473429451|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491463|NCT03129100|473429452|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491464|NCT03129100|473429453|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491465|NCT03129100|473429454|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
131491466|NCT03129100|473429429|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491467|NCT03129100|473429430|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491468|NCT03129100|473429431|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491469|NCT03129100|473429432|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491470|NCT03129100|473429433|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491471|NCT03129100|473429434|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491472|NCT03129100|473429435|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491473|NCT03129100|473429436|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491474|NCT03129100|473429437|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491475|NCT03129100|473429438|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491476|NCT03129100|473429439|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491477|NCT03129100|473429440|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
131491478|NCT03129100|473429441|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491479|NCT03129100|473429442|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
131491480|NCT03129100|473429443|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
131491481|NCT03129100|473429444|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491482|NCT03129100|473429445|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491483|NCT03129100|473429446|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491484|NCT03129100|473429447|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491485|NCT03129100|473429448|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491486|NCT03129100|473429449|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491487|NCT03129100|473429450|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491488|NCT03129100|473429451|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491489|NCT03129100|473429452|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491490|NCT03129100|473429453|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491491|NCT03129100|473429454|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131491492|NCT03129100|473429429|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491493|NCT03129100|473429430|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491494|NCT03129100|473429431|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491495|NCT03129100|473429432|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491496|NCT03129100|473429433|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491497|NCT03129100|473429434|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491498|NCT03129100|473429435|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491499|NCT03129100|473429436|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491500|NCT03129100|473429437|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491501|NCT03129100|473429438|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491502|NCT03129100|473429439|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491503|NCT03129100|473429440|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491504|NCT03129100|473429441|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491505|NCT03129100|473429442|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491506|NCT03129100|473429443|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491507|NCT03129100|473429444|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
131491508|NCT03129100|473429445|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491509|NCT03129100|473429446|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491510|NCT03129100|473429447|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491511|NCT03129100|473429448|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491512|NCT03129100|473429449|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491513|NCT03129100|473429450|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491514|NCT03129100|473429451|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491515|NCT03129100|473429452|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491516|NCT03129100|473429453|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491517|NCT03129100|473429454|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
131491518|NCT03129100|473429429|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491519|NCT03129100|473429430|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491520|NCT03129100|473429431|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491521|NCT03129100|473429432|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491522|NCT03129100|473429433|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491523|NCT03129100|473429434|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491524|NCT03129100|473429435|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491525|NCT03129100|473429436|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491526|NCT03129100|473429437|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491527|NCT03129100|473429438|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491528|NCT03129100|473429439|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491529|NCT03129100|473429440|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491530|NCT03129100|473429441|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
131491531|NCT03129100|473429442|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491532|NCT03129100|473429443|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
131491533|NCT03129100|473429444|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
131491534|NCT03129100|473429445|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491535|NCT03129100|473429446|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491536|NCT03129100|473429447|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491537|NCT03129100|473429448|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491538|NCT03129100|473429449|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491539|NCT03129100|473429450|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491540|NCT03129100|473429451|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491541|NCT03129100|473429452|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491542|NCT03129100|473429453|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491543|NCT03129100|473429454|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
131491544|NCT03129100|473429429|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491545|NCT03129100|473429430|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491546|NCT03129100|473429431|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491547|NCT03129100|473429432|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491548|NCT03129100|473429433|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491549|NCT03129100|473429434|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491550|NCT03129100|473429435|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491551|NCT03129100|473429436|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491552|NCT03129100|473429437|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491553|NCT03129100|473429438|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491554|NCT03129100|473429439|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491555|NCT03129100|473429440|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491556|NCT03129100|473429441|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491557|NCT03129100|473429442|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491558|NCT03129100|473429443|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491559|NCT03129100|473429444|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491560|NCT03129100|473429445|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491561|NCT03129100|473429446|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
131491562|NCT03129100|473429447|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491563|NCT03129100|473429448|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
131491564|NCT03129100|473429449|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491565|NCT03129100|473429450|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491566|NCT03129100|473429451|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491567|NCT03129100|473429452|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491568|NCT03129100|473429453|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491569|NCT03129100|473429454|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
131491570|NCT03129100|473429429|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491571|NCT03129100|473429430|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491572|NCT03129100|473429431|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491573|NCT03129100|473429432|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491574|NCT03129100|473429433|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491575|NCT03129100|473429434|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491576|NCT03129100|473429435|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491577|NCT03129100|473429436|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491578|NCT03129100|473429437|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491579|NCT03129100|473429438|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491580|NCT03129100|473429439|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491581|NCT03129100|473429440|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491582|NCT03129100|473429441|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491583|NCT03129100|473429442|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491584|NCT03129100|473429443|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491585|NCT03129100|473429444|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491586|NCT03129100|473429445|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491587|NCT03129100|473429446|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491588|NCT03129100|473429447|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491589|NCT03129100|473429448|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491590|NCT03129100|473429449|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
131491591|NCT03129100|473429450|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491592|NCT03129100|473429451|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491593|NCT03129100|473429452|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491594|NCT03129100|473429453|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491595|NCT03129100|473429454|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
131491596|NCT03129100|473429429|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
131491597|NCT03129100|473429430|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
131491598|NCT03129100|473429431|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
131491599|NCT03129100|473429432|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
131491600|NCT03129100|473429433|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
131491601|NCT03129100|473429434|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
131491602|NCT03129100|473429435|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
131491603|NCT03129100|473429436|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
131491604|NCT03129100|473429437|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
131491605|NCT03129100|473429438|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
131491606|NCT03129100|473429439|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
131491607|NCT03129100|473429440|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
131491608|NCT03129100|473429441|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
131491609|NCT03129100|473429442|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
131491610|NCT03129100|473429443|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
131491611|NCT03129100|473429444|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
131491612|NCT03129100|473429445|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
131491613|NCT03129100|473429446|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
131491614|NCT03129100|473429447|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
131491615|NCT03129100|473429448|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
131491616|NCT03129100|473429449|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
131491617|NCT03129100|473429450|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
131491618|NCT03129100|473429451|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
131491619|NCT03129100|473429452|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
131491620|NCT03129100|473429453|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
131491621|NCT03129100|473429454|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
131491622|NCT03129100|473429429|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491623|NCT03129100|473429430|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491624|NCT03129100|473429431|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491625|NCT03129100|473429432|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491626|NCT03129100|473429433|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491627|NCT03129100|473429434|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491628|NCT03129100|473429435|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491629|NCT03129100|473429436|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491630|NCT03129100|473429437|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491631|NCT03129100|473429438|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491632|NCT03129100|473429439|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491633|NCT03129100|473429440|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491634|NCT03129100|473429441|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491635|NCT03129100|473429442|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491636|NCT03129100|473429443|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491637|NCT03129100|473429444|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491638|NCT03129100|473429445|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491639|NCT03129100|473429446|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491640|NCT03129100|473429447|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491641|NCT03129100|473429448|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491642|NCT03129100|473429449|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
131491643|NCT03129100|473429450|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491644|NCT03129100|473429451|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491645|NCT03129100|473429452|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491646|NCT03129100|473429453|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491647|NCT03129100|473429454|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
131491648|NCT03129100|473429429|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
131491649|NCT03129100|473429430|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
131491650|NCT03129100|473429431|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
131491651|NCT03129100|473429432|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
131491652|NCT03129100|473429433|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
131491653|NCT03129100|473429434|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
131491654|NCT03129100|473429435|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
131491655|NCT03129100|473429436|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
131491656|NCT03129100|473429437|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
131491657|NCT03129100|473429438|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
131491658|NCT03129100|473429439|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
131491659|NCT03129100|473429440|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
131491660|NCT03129100|473429441|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
131491661|NCT03129100|473429442|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
131491662|NCT03129100|473429443|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
131491663|NCT03129100|473429444|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
131491664|NCT03129100|473429445|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
131491665|NCT03129100|473429446|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
131491666|NCT03129100|473429447|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
131491667|NCT03129100|473429448|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
131491668|NCT03129100|473429449|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
131491669|NCT03129100|473429450|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
131491670|NCT03129100|473429451|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
131491671|NCT03129100|473429452|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
131491672|NCT03129100|473429453|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
131491673|NCT03129100|473429454|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
131491674|NCT03129100|473429429|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491675|NCT03129100|473429430|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491676|NCT03129100|473429431|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491677|NCT03129100|473429432|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491678|NCT03129100|473429433|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491679|NCT03129100|473429434|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491680|NCT03129100|473429435|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491681|NCT03129100|473429436|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491682|NCT03129100|473429437|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491683|NCT03129100|473429438|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491684|NCT03129100|473429439|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491685|NCT03129100|473429440|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491686|NCT03129100|473429441|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491687|NCT03129100|473429442|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491688|NCT03129100|473429443|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491689|NCT03129100|473429444|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491690|NCT03129100|473429445|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491691|NCT03129100|473429446|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491692|NCT03129100|473429447|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491693|NCT03129100|473429448|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491694|NCT03129100|473429449|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491695|NCT03129100|473429450|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491696|NCT03129100|473429451|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491697|NCT03129100|473429452|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
131491698|NCT03129100|473429453|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
131491699|NCT03129100|473429454|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
131491700|NCT03129100|473429429|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491701|NCT03129100|473429430|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491702|NCT03129100|473429431|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491703|NCT03129100|473429432|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491704|NCT03129100|473429433|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491705|NCT03129100|473429434|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491706|NCT03129100|473429435|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491707|NCT03129100|473429436|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491708|NCT03129100|473429437|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491709|NCT03129100|473429438|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491710|NCT03129100|473429439|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491711|NCT03129100|473429440|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491712|NCT03129100|473429441|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491713|NCT03129100|473429442|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491714|NCT03129100|473429443|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491715|NCT03129100|473429444|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491716|NCT03129100|473429445|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491717|NCT03129100|473429446|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491718|NCT03129100|473429447|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491719|NCT03129100|473429448|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491720|NCT03129100|473429449|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491721|NCT03129100|473429450|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491722|NCT03129100|473429451|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
131491723|NCT03129100|473429452|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
131491724|NCT03129100|473429453|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
131491725|NCT03129100|473429454|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
131491726|NCT03129100|473429429|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491727|NCT03129100|473429430|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491728|NCT03129100|473429431|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491729|NCT03129100|473429432|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491730|NCT03129100|473429433|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491731|NCT03129100|473429434|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491732|NCT03129100|473429435|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491733|NCT03129100|473429436|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491734|NCT03129100|473429437|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491735|NCT03129100|473429438|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491736|NCT03129100|473429439|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491737|NCT03129100|473429440|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491738|NCT03129100|473429441|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491739|NCT03129100|473429442|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491740|NCT03129100|473429443|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491741|NCT03129100|473429444|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491742|NCT03129100|473429445|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491743|NCT03129100|473429446|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491744|NCT03129100|473429447|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491745|NCT03129100|473429448|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491746|NCT03129100|473429449|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491747|NCT03129100|473429450|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491748|NCT03129100|473429451|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491749|NCT03129100|473429452|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491750|NCT03129100|473429453|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
131491751|NCT03129100|473429454|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131491752|NCT03129100|473429429|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491753|NCT03129100|473429430|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491754|NCT03129100|473429431|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491755|NCT03129100|473429432|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491756|NCT03129100|473429433|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491757|NCT03129100|473429434|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491758|NCT03129100|473429435|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491759|NCT03129100|473429436|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491760|NCT03129100|473429437|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491761|NCT03129100|473429438|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491762|NCT03129100|473429439|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491763|NCT03129100|473429440|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491764|NCT03129100|473429441|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491765|NCT03129100|473429442|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491766|NCT03129100|473429443|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491767|NCT03129100|473429444|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491768|NCT03129100|473429445|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491769|NCT03129100|473429446|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491770|NCT03129100|473429447|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491771|NCT03129100|473429448|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491772|NCT03129100|473429449|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491773|NCT03129100|473429450|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491774|NCT03129100|473429451|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491775|NCT03129100|473429452|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491776|NCT03129100|473429453|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
131491777|NCT03129100|473429454|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
131491778|NCT03129100|473429429|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
131491779|NCT03129100|473429430|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
131491780|NCT03129100|473429431|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
131491781|NCT03129100|473429432|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
131491782|NCT03129100|473429433|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
131491783|NCT03129100|473429434|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
131491784|NCT03129100|473429435|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
131491785|NCT03129100|473429436|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
131491786|NCT03129100|473429437|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
131491787|NCT03129100|473429438|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
131491788|NCT03129100|473429439|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
131491789|NCT03129100|473429440|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
131491790|NCT03129100|473429441|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
131491791|NCT03129100|473429442|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
131491792|NCT03129100|473429443|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
131491793|NCT03129100|473429444|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
131491794|NCT03129100|473429445|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
131491795|NCT03129100|473429446|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
131491796|NCT03129100|473429447|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
131491797|NCT03129100|473429448|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
131491798|NCT03129100|473429449|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
131491799|NCT03129100|473429450|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
131491800|NCT03129100|473429451|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
131491801|NCT03129100|473429452|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
131491802|NCT03129100|473429453|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
131491803|NCT03129100|473429454|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
131491804|NCT01587001|473429455|FG000|Overall Study|Lost to Follow-up|2|||
131491805|NCT01587001|473429456|FG001|Overall Study|Lost to Follow-up|0|||
131491806|NCT01587001|473429455|FG000|Overall Study|Insufficient samples to complete testing|4|||
131491807|NCT01587001|473429456|FG001|Overall Study|Insufficient samples to complete testing|1|||
131491808|NCT02756013|473429459|FG000|Overall Study|Adverse Event|1|||
131491809|NCT02756013|473429459|FG000|Overall Study|Hypersensitivity|1|||
131491810|NCT03334539|473429460|FG000|Overall Study|Adverse Event|3|||
131491811|NCT03334539|473429461|FG001|Overall Study|Adverse Event|5|||
131491812|NCT03334539|473429462|FG002|Overall Study|Adverse Event|0|||
131491813|NCT03334539|473429460|FG000|Overall Study|Withdrawal by Subject|0|||
131491814|NCT03334539|473429461|FG001|Overall Study|Withdrawal by Subject|1|||
131491815|NCT03334539|473429462|FG002|Overall Study|Withdrawal by Subject|1|||
131491816|NCT03334539|473429460|FG000|Overall Study|Administrative Reasons|1|||
131491817|NCT03334539|473429461|FG001|Overall Study|Administrative Reasons|0|||
131491818|NCT03334539|473429462|FG002|Overall Study|Administrative Reasons|0|||
131491819|NCT03334539|473429460|FG000|Overall Study|Hypertension Not Controlled|0|||
131491820|NCT03334539|473429461|FG001|Overall Study|Hypertension Not Controlled|1|||
131491821|NCT03334539|473429462|FG002|Overall Study|Hypertension Not Controlled|0|||
131491822|NCT00968201|473429463|FG000|Base Study - (Period II)|Adverse Event|8|||
131491823|NCT00968201|473429464|FG001|Base Study - (Period II)|Adverse Event|0|||
131491824|NCT00968201|473429465|FG002|Base Study - (Period II)|Adverse Event|16|||
131491825|NCT00968201|473429463|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
131491826|NCT00968201|473429464|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
131491827|NCT00968201|473429465|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
131491828|NCT00968201|473429463|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
131491829|NCT00968201|473429464|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
131491830|NCT00968201|473429465|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
131491831|NCT00968201|473429463|FG000|Base Study - (Period II)|Protocol Violation|12|||
131491832|NCT00968201|473429464|FG001|Base Study - (Period II)|Protocol Violation|0|||
131491833|NCT00968201|473429465|FG002|Base Study - (Period II)|Protocol Violation|12|||
131491834|NCT00968201|473429463|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
131491835|NCT00968201|473429464|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
131491836|NCT00968201|473429465|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
131491837|NCT00968201|473429463|FG000|Base Study - (Period II)|Site Error|0|||
131491838|NCT00968201|473429464|FG001|Base Study - (Period II)|Site Error|0|||
131491839|NCT00968201|473429465|FG002|Base Study - (Period II)|Site Error|1|||
131491840|NCT00968201|473429463|FG000|Extension Study - (Period III)|Adverse Event|0|||
131491841|NCT00968201|473429464|FG001|Extension Study - (Period III)|Adverse Event|5|||
131491842|NCT00968201|473429465|FG002|Extension Study - (Period III)|Adverse Event|22|||
131491843|NCT00968201|473429463|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
131491844|NCT00968201|473429464|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
131491845|NCT00968201|473429465|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
131491846|NCT00968201|473429463|FG000|Extension Study - (Period III)|Protocol Violation|0|||
131491847|NCT00968201|473429464|FG001|Extension Study - (Period III)|Protocol Violation|17|||
131491848|NCT00968201|473429465|FG002|Extension Study - (Period III)|Protocol Violation|14|||
131491849|NCT00968201|473429463|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
131491850|NCT00968201|473429464|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
131491851|NCT00968201|473429465|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
131491852|NCT00968201|473429463|FG000|Extension Study - (Period III)|Patient Relocated|0|||
131491853|NCT00968201|473429464|FG001|Extension Study - (Period III)|Patient Relocated|1|||
131491854|NCT00968201|473429465|FG002|Extension Study - (Period III)|Patient Relocated|1|||
131491855|NCT00968201|473429463|FG000|Extension Study - (Period III)|Noncompliance|0|||
131491856|NCT00968201|473429464|FG001|Extension Study - (Period III)|Noncompliance|0|||
131491857|NCT00968201|473429465|FG002|Extension Study - (Period III)|Noncompliance|3|||
131491858|NCT00968201|473429463|FG000|Extension Study - (Period III)|Other|0|||
131491859|NCT00968201|473429464|FG001|Extension Study - (Period III)|Other|0|||
131491860|NCT00968201|473429465|FG002|Extension Study - (Period III)|Other|2|||
131491861|NCT00968201|473429463|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
131491862|NCT00968201|473429464|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
131491863|NCT00968201|473429465|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
131491864|NCT04974697|473429467|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
131491865|NCT04974697|473429467|FG000|Overall Study|Lens discomfort|1|||
131491866|NCT03706456|473429469|FG000|Overall Study|Adverse Event|1|||
131491867|NCT03706456|473429469|FG000|Overall Study|Lack of Efficacy|2|||
131491868|NCT03302234|473429470|FG000|Overall Study|Death|191|||
131491869|NCT03302234|473429471|FG001|Overall Study|Death|192|||
131491870|NCT03302234|473429470|FG000|Overall Study|Withdrawal by Subject|2|||
131491871|NCT03302234|473429471|FG001|Overall Study|Withdrawal by Subject|2|||
131491872|NCT03302234|473429470|FG000|Overall Study|Sponsor Decision|90|||
131491873|NCT03302234|473429471|FG001|Overall Study|Sponsor Decision|89|||
131491874|NCT03302234|473429470|FG000|Overall Study|Laryngeal carcinoma|0|||
131491875|NCT03302234|473429471|FG001|Overall Study|Laryngeal carcinoma|1|||
131491876|NCT03302234|473429470|FG000|Overall Study|Not Reported|1|||
131491877|NCT03302234|473429471|FG001|Overall Study|Not Reported|0|||
131491878|NCT02795832|473429472|FG000|Overall Study|Adverse Event|0|||
131491879|NCT02795832|473429473|FG001|Overall Study|Adverse Event|0|||
131491880|NCT02795832|473429474|FG002|Overall Study|Adverse Event|0|||
131491881|NCT02795832|473429475|FG003|Overall Study|Adverse Event|0|||
131491882|NCT02795832|473429476|FG004|Overall Study|Adverse Event|0|||
131491883|NCT02795832|473429477|FG005|Overall Study|Adverse Event|3|||
131491884|NCT00571948|473429478|FG000|Overall Study|Lost to Follow-up|2|||
131491885|NCT00571948|473429479|FG001|Overall Study|Lost to Follow-up|0|||
131491886|NCT00571948|473429478|FG000|Overall Study|Withdrawal by Subject|1|||
131491887|NCT00571948|473429479|FG001|Overall Study|Withdrawal by Subject|2|||
131491888|NCT00571948|473429478|FG000|Overall Study|Protocol Violation|3|||
131491889|NCT00571948|473429479|FG001|Overall Study|Protocol Violation|3|||
131491890|NCT00571948|473429478|FG000|Overall Study|infant refused study meal|3|||
131491891|NCT00571948|473429479|FG001|Overall Study|infant refused study meal|4|||
131491892|NCT00571948|473429478|FG000|Overall Study|Parent were afraid of blood colection|2|||
131491893|NCT00571948|473429479|FG001|Overall Study|Parent were afraid of blood colection|5|||
131491894|NCT02605824|473429480|FG000|Overall Study|Physician Decision|1|||
131491895|NCT02605824|473429481|FG001|Overall Study|Physician Decision|0|||
131491896|NCT04112784|473429482|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
131491897|NCT04112784|473429482|FG000|Overall Study|Screen Failures|4|||
131491898|NCT02010775|473429483|FG000|Overall Study|Adverse Event|0|||
131491899|NCT02010775|473429484|FG001|Overall Study|Adverse Event|0|||
131491900|NCT02010775|473429485|FG002|Overall Study|Adverse Event|0|||
131491901|NCT02010775|473429486|FG003|Overall Study|Adverse Event|0|||
131491902|NCT02010775|473429487|FG004|Overall Study|Adverse Event|1|||
131491903|NCT02010775|473429483|FG000|Overall Study|Pregnancy|0|||
131491904|NCT02010775|473429484|FG001|Overall Study|Pregnancy|0|||
131491905|NCT02010775|473429485|FG002|Overall Study|Pregnancy|2|||
131491906|NCT02010775|473429486|FG003|Overall Study|Pregnancy|0|||
131491907|NCT02010775|473429487|FG004|Overall Study|Pregnancy|0|||
131491908|NCT02010775|473429483|FG000|Overall Study|Lost to Follow-up|2|||
131491909|NCT02010775|473429484|FG001|Overall Study|Lost to Follow-up|0|||
131491910|NCT02010775|473429485|FG002|Overall Study|Lost to Follow-up|0|||
131491911|NCT02010775|473429486|FG003|Overall Study|Lost to Follow-up|1|||
131491912|NCT02010775|473429487|FG004|Overall Study|Lost to Follow-up|1|||
131491913|NCT02010775|473429483|FG000|Overall Study|Personal Reasons|3|||
131491914|NCT02010775|473429484|FG001|Overall Study|Personal Reasons|3|||
131491915|NCT02010775|473429485|FG002|Overall Study|Personal Reasons|1|||
131491916|NCT02010775|473429486|FG003|Overall Study|Personal Reasons|2|||
131491917|NCT02010775|473429487|FG004|Overall Study|Personal Reasons|4|||
131491918|NCT00256750|473429490|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
131491919|NCT00256750|473429491|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
131491920|NCT00256750|473429492|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
131491921|NCT00256750|473429490|FG000|Transplanted Pre-Treatment|Other|2|||
131491922|NCT00256750|473429491|FG001|Transplanted Pre-Treatment|Other|0|||
131491923|NCT00256750|473429492|FG002|Transplanted Pre-Treatment|Other|0|||
131491924|NCT00256750|473429490|FG000|Transplanted Pre-Treatment|Death|1|||
131491925|NCT00256750|473429491|FG001|Transplanted Pre-Treatment|Death|0|||
131491926|NCT00256750|473429492|FG002|Transplanted Pre-Treatment|Death|0|||
131491927|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
131491928|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
131491929|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
131491930|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Death|3|||
131491931|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Death|2|||
131491932|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Death|4|||
131491933|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
131491934|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
131491935|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
131491936|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
131491937|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
131491938|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
131491939|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Other|5|||
131491940|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Other|4|||
131491941|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Other|2|||
131491942|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
131491943|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
131491944|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
131491945|NCT00256750|473429490|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
131491946|NCT00256750|473429491|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
131491947|NCT00256750|473429492|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
131491948|NCT00256750|473429490|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
131491949|NCT00256750|473429491|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
131491950|NCT00256750|473429492|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
131491951|NCT00256750|473429490|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
131491952|NCT00256750|473429491|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
131491953|NCT00256750|473429492|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
131491954|NCT00256750|473429490|FG000|Post-Transplant Treated (24 Months)|Death|3|||
131491955|NCT00256750|473429491|FG001|Post-Transplant Treated (24 Months)|Death|0|||
131491956|NCT00256750|473429492|FG002|Post-Transplant Treated (24 Months)|Death|0|||
131491957|NCT00256750|473429490|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
131491958|NCT00256750|473429491|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
131491959|NCT00256750|473429492|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
131491960|NCT00256750|473429490|FG000|Post-Transplant Treated (24 Months)|Other|2|||
131491961|NCT00256750|473429491|FG001|Post-Transplant Treated (24 Months)|Other|0|||
131491962|NCT00256750|473429492|FG002|Post-Transplant Treated (24 Months)|Other|1|||
131491963|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
131491964|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
131491965|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
131491966|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
131491967|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
131491968|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
131491969|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Death|0|||
131491970|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Death|2|||
131491971|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Death|1|||
131491972|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
131491973|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
131491974|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
131491975|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
131491976|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
131491977|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
131491978|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
131491979|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
131491980|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
131491981|NCT00256750|473429490|FG000|Post-Transplant Treated (36 Months)|Other|0|||
131491982|NCT00256750|473429491|FG001|Post-Transplant Treated (36 Months)|Other|1|||
131491983|NCT00256750|473429492|FG002|Post-Transplant Treated (36 Months)|Other|1|||
131491984|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
131491985|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
131491986|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
131491987|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
131491988|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
131491989|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
131491990|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
131491991|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
131491992|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
131491993|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
131491994|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
131491995|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
131491996|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
131491997|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
131491998|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
131491999|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
131492000|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
131492001|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
131492002|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
131492003|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
131492004|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
131492005|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
131492006|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
131492007|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
131492008|NCT00256750|473429490|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
131492009|NCT00256750|473429491|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
131492010|NCT00256750|473429492|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
131492011|NCT02030041|473429493|FG000|Overall Study|Withdrawal by Subject|2|||
131492012|NCT02030041|473429494|FG001|Overall Study|Withdrawal by Subject|2|||
131492013|NCT02030041|473429495|FG002|Overall Study|Withdrawal by Subject|1|||
131492014|NCT05201703|473429496|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
131492015|NCT05201703|473429497|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
131492016|NCT05201703|473429496|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
131492017|NCT05201703|473429497|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
131492018|NCT01197560|473429498|FG000|Overall Study|Adverse Event|6|||
131492019|NCT01197560|473429499|FG001|Overall Study|Adverse Event|8|||
131492020|NCT01197560|473429498|FG000|Overall Study|Death|3|||
131492021|NCT01197560|473429499|FG001|Overall Study|Death|5|||
131492022|NCT01197560|473429498|FG000|Overall Study|Withdrawal by Subject|1|||
131492023|NCT01197560|473429499|FG001|Overall Study|Withdrawal by Subject|1|||
131492024|NCT01197560|473429498|FG000|Overall Study|Disease progression|40|||
131492025|NCT01197560|473429499|FG001|Overall Study|Disease progression|35|||
131492026|NCT01197560|473429498|FG000|Overall Study|Miscellaneous|4|||
131492027|NCT01197560|473429499|FG001|Overall Study|Miscellaneous|3|||
131492028|NCT01197560|473429498|FG000|Overall Study|Missing|0|||
131492029|NCT01197560|473429499|FG001|Overall Study|Missing|1|||
131492030|NCT02006719|473429500|FG000|Overall Study|Withdrawal by Subject|10|||
131492031|NCT02006719|473429501|FG001|Overall Study|Withdrawal by Subject|2|||
131492032|NCT02006719|473429500|FG000|Overall Study|Lost to Follow-up|5|||
131492033|NCT02006719|473429501|FG001|Overall Study|Lost to Follow-up|1|||
131492034|NCT02006719|473429500|FG000|Overall Study|Protocol Violation|2|||
131492035|NCT02006719|473429501|FG001|Overall Study|Protocol Violation|0|||
131492036|NCT02006719|473429500|FG000|Overall Study|Adverse Event|1|||
131492037|NCT02006719|473429501|FG001|Overall Study|Adverse Event|1|||
131492038|NCT02006719|473429500|FG000|Overall Study|Other/Unknown|0|||
131492039|NCT02006719|473429501|FG001|Overall Study|Other/Unknown|1|||
131492040|NCT00393029|473429502|FG000|Overall Study|Not treated|0|||
131492041|NCT00393029|473429503|FG001|Overall Study|Not treated|1|||
131492042|NCT04659161|473429504|FG000|Overall Study|Adverse Event|10|||
131492043|NCT04659161|473429505|FG001|Overall Study|Adverse Event|6|||
131492044|NCT04659161|473429504|FG000|Overall Study|Withdrawal by Subject|13|||
131492045|NCT04659161|473429505|FG001|Overall Study|Withdrawal by Subject|12|||
131492046|NCT04659161|473429504|FG000|Overall Study|Other|9|||
131492047|NCT04659161|473429505|FG001|Overall Study|Other|8|||
131492048|NCT01929343|473429508|FG000|Overall Study|Physician Decision|0|||
131492049|NCT01929343|473429509|FG001|Overall Study|Physician Decision|2|||
131492050|NCT01929343|473429510|FG002|Overall Study|Physician Decision|0|||
131492051|NCT01929343|473429508|FG000|Overall Study|Withdrawal by Subject|1|||
131492052|NCT01929343|473429509|FG001|Overall Study|Withdrawal by Subject|0|||
131492053|NCT01929343|473429510|FG002|Overall Study|Withdrawal by Subject|0|||
131492054|NCT02197130|473429511|FG000|Overall Study|Adverse Event|13|||
131492055|NCT02197130|473429512|FG001|Overall Study|Adverse Event|4|||
131492056|NCT02197130|473429513|FG002|Overall Study|Adverse Event|23|||
131492057|NCT02197130|473429511|FG000|Overall Study|Death|0|||
131492058|NCT02197130|473429512|FG001|Overall Study|Death|1|||
131492059|NCT02197130|473429513|FG002|Overall Study|Death|0|||
131492060|NCT02197130|473429511|FG000|Overall Study|Lost to Follow-up|2|||
131492061|NCT02197130|473429512|FG001|Overall Study|Lost to Follow-up|0|||
131492062|NCT02197130|473429513|FG002|Overall Study|Lost to Follow-up|1|||
131492063|NCT02197130|473429511|FG000|Overall Study|Does not meet entrance criteria|0|||
131492064|NCT02197130|473429512|FG001|Overall Study|Does not meet entrance criteria|0|||
131492065|NCT02197130|473429513|FG002|Overall Study|Does not meet entrance criteria|1|||
131492066|NCT02197130|473429511|FG000|Overall Study|Withdrawal by Subject|0|||
131492067|NCT02197130|473429512|FG001|Overall Study|Withdrawal by Subject|3|||
131492068|NCT02197130|473429513|FG002|Overall Study|Withdrawal by Subject|4|||
131492069|NCT02197130|473429511|FG000|Overall Study|Other|1|||
131492070|NCT02197130|473429512|FG001|Overall Study|Other|0|||
131492071|NCT02197130|473429513|FG002|Overall Study|Other|3|||
131492072|NCT00211510|473429519|FG000|Overall Study|Physician Decision|3|||
131492073|NCT00211510|473429520|FG001|Overall Study|Physician Decision|1|||
131492074|NCT00211510|473429519|FG000|Overall Study|Withdrawal by Subject|3|||
131492075|NCT00211510|473429520|FG001|Overall Study|Withdrawal by Subject|1|||
131492076|NCT01962896|473429521|FG000|Overall Study|Lack of Efficacy|4|||
131492077|NCT00558558|473429524|FG000|Overall Study|Unable to swallow|1|||
131492078|NCT00558558|473429524|FG000|Overall Study|Withdrawal by Subject|1|||
131492079|NCT00558558|473429524|FG000|Overall Study|Lack of Efficacy|4|||
131492080|NCT02915016|473429525|FG000|Overall Study|Lost to Follow-up|4|||
131492081|NCT02915016|473429526|FG001|Overall Study|Lost to Follow-up|2|||
131492082|NCT02915016|473429527|FG002|Overall Study|Lost to Follow-up|5|||
131492083|NCT02915016|473429528|FG003|Overall Study|Lost to Follow-up|3|||
131492084|NCT02915016|473429529|FG004|Overall Study|Lost to Follow-up|5|||
131492085|NCT02915016|473429530|FG005|Overall Study|Lost to Follow-up|2|||
131492086|NCT02915016|473429531|FG006|Overall Study|Lost to Follow-up|8|||
131492087|NCT02915016|473429532|FG007|Overall Study|Lost to Follow-up|2|||
131492088|NCT02915016|473429525|FG000|Overall Study|Physician Decision|0|||
131492089|NCT02915016|473429526|FG001|Overall Study|Physician Decision|0|||
131492090|NCT02915016|473429527|FG002|Overall Study|Physician Decision|1|||
131492091|NCT02915016|473429528|FG003|Overall Study|Physician Decision|0|||
131492092|NCT02915016|473429529|FG004|Overall Study|Physician Decision|0|||
131492093|NCT02915016|473429530|FG005|Overall Study|Physician Decision|1|||
131492094|NCT02915016|473429531|FG006|Overall Study|Physician Decision|2|||
131492095|NCT02915016|473429532|FG007|Overall Study|Physician Decision|0|||
131492096|NCT02915016|473429525|FG000|Overall Study|Withdrawal by Subject|2|||
131492097|NCT02915016|473429526|FG001|Overall Study|Withdrawal by Subject|0|||
131492098|NCT02915016|473429527|FG002|Overall Study|Withdrawal by Subject|1|||
131492099|NCT02915016|473429528|FG003|Overall Study|Withdrawal by Subject|0|||
131492100|NCT02915016|473429529|FG004|Overall Study|Withdrawal by Subject|1|||
131492101|NCT02915016|473429530|FG005|Overall Study|Withdrawal by Subject|3|||
131492102|NCT02915016|473429531|FG006|Overall Study|Withdrawal by Subject|1|||
131492103|NCT02915016|473429532|FG007|Overall Study|Withdrawal by Subject|1|||
131492104|NCT02915016|473429525|FG000|Overall Study|Elected not to continue|0|||
131492105|NCT02915016|473429526|FG001|Overall Study|Elected not to continue|0|||
131492106|NCT02915016|473429527|FG002|Overall Study|Elected not to continue|0|||
131492107|NCT02915016|473429528|FG003|Overall Study|Elected not to continue|1|||
131492108|NCT02915016|473429529|FG004|Overall Study|Elected not to continue|0|||
131492109|NCT02915016|473429530|FG005|Overall Study|Elected not to continue|0|||
131492110|NCT02915016|473429531|FG006|Overall Study|Elected not to continue|1|||
131492111|NCT02915016|473429532|FG007|Overall Study|Elected not to continue|0|||
131492112|NCT02915016|473429525|FG000|Overall Study|HIV infection|1|||
131492113|NCT02915016|473429526|FG001|Overall Study|HIV infection|1|||
131492114|NCT02915016|473429527|FG002|Overall Study|HIV infection|1|||
131492115|NCT02915016|473429528|FG003|Overall Study|HIV infection|0|||
131492116|NCT02915016|473429529|FG004|Overall Study|HIV infection|1|||
131492117|NCT02915016|473429530|FG005|Overall Study|HIV infection|0|||
131492118|NCT02915016|473429531|FG006|Overall Study|HIV infection|0|||
131492119|NCT02915016|473429532|FG007|Overall Study|HIV infection|0|||
131492120|NCT02915016|473429525|FG000|Overall Study|Participant unable to adhere|0|||
131492121|NCT02915016|473429526|FG001|Overall Study|Participant unable to adhere|0|||
131492122|NCT02915016|473429527|FG002|Overall Study|Participant unable to adhere|0|||
131492123|NCT02915016|473429528|FG003|Overall Study|Participant unable to adhere|0|||
131492124|NCT02915016|473429529|FG004|Overall Study|Participant unable to adhere|0|||
131492125|NCT02915016|473429530|FG005|Overall Study|Participant unable to adhere|0|||
131492126|NCT02915016|473429531|FG006|Overall Study|Participant unable to adhere|0|||
131492127|NCT02915016|473429532|FG007|Overall Study|Participant unable to adhere|1|||
131492128|NCT02166905|473429533|FG000|Overall Study|Withdrawal by Subject|1|||
131492129|NCT02166905|473429534|FG001|Overall Study|Withdrawal by Subject|0|||
131492130|NCT02166905|473429535|FG002|Overall Study|Withdrawal by Subject|0|||
131492131|NCT02166905|473429536|FG003|Overall Study|Withdrawal by Subject|0|||
131492132|NCT02617628|473429537|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
131492133|NCT02617628|473429538|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
131496799|NCT00938639|473446400|FG000|Overall Study|Moved away from study area|0|||
131496800|NCT00938639|473446401|FG001|Overall Study|Moved away from study area|1|||
131496801|NCT00938639|473446400|FG000|Overall Study|Lost to Follow-up|1|||
131496802|NCT00938639|473446401|FG001|Overall Study|Lost to Follow-up|2|||
131496803|NCT00938639|473446400|FG000|Overall Study|Family issues|1|||
131496804|NCT00938639|473446401|FG001|Overall Study|Family issues|1|||
131496805|NCT00938639|473446400|FG000|Overall Study|Participant noncompliance|1|||
131496806|NCT00938639|473446401|FG001|Overall Study|Participant noncompliance|0|||
131496807|NCT02509156|473446402|FG000|Randomized Phase|Death|1|||
131496808|NCT02509156|473446403|FG001|Randomized Phase|Death|0|||
131496809|NCT02509156|473446402|FG000|Randomized Phase|Withdrawal by Subject|1|||
131496810|NCT02509156|473446403|FG001|Randomized Phase|Withdrawal by Subject|1|||
131496811|NCT03042533|473446406|FG000|Overall Study|MD left program|1|||
131496812|NCT03042533|473446407|FG001|Overall Study|MD left program|4|||
131496813|NCT03042533|473446408|FG002|Overall Study|MD left program|1|||
131496814|NCT04326231|473446409|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
131496815|NCT01111149|473446415|FG000|Overall Study|Protocol Violation|1|||
131496816|NCT01111149|473446416|FG001|Overall Study|Protocol Violation|1|||
131496817|NCT01111149|473446417|FG002|Overall Study|Protocol Violation|2|||
131496818|NCT01111149|473446415|FG000|Overall Study|Withdrawal by Subject|1|||
131496819|NCT01111149|473446416|FG001|Overall Study|Withdrawal by Subject|0|||
131496820|NCT01111149|473446417|FG002|Overall Study|Withdrawal by Subject|2|||
131496821|NCT02551731|473446420|FG000|Overall Study|Withdrawal by Subject|2|||
131496822|NCT01678911|473446421|FG000|Second Intervention|Lost to Follow-up|2|||
131496823|NCT01678911|473446422|FG001|Second Intervention|Lost to Follow-up|0|||
131496824|NCT01980992|473446423|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
131496825|NCT01980992|473446424|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
131496826|NCT01980992|473446423|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
131496827|NCT01980992|473446424|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
131496828|NCT01980992|473446423|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
131496829|NCT01980992|473446424|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
131492134|NCT01408485|473431380|FG000|Overall Study|Withdrawal by Subject|21|||
131492135|NCT01806545|473431384|FG000|Overall Study|Adverse Event|2|||
131492136|NCT01806545|473431385|FG001|Overall Study|Adverse Event|3|||
131492137|NCT01806545|473431384|FG000|Overall Study|Lost to Follow-up|1|||
131492138|NCT01806545|473431385|FG001|Overall Study|Lost to Follow-up|0|||
131492139|NCT01806545|473431384|FG000|Overall Study|Withdrawal by Subject|3|||
131492140|NCT01806545|473431385|FG001|Overall Study|Withdrawal by Subject|2|||
131492141|NCT01508650|473431386|FG000|Overall Study|Lost to Follow-up|0|||
131492142|NCT01508650|473431387|FG001|Overall Study|Lost to Follow-up|3|||
131492143|NCT00429273|473431388|FG000|Overall Study|Lost to Follow-up|1|||
131492144|NCT00429273|473431389|FG001|Overall Study|Lost to Follow-up|2|||
131492145|NCT00429273|473431390|FG002|Overall Study|Lost to Follow-up|2|||
131492146|NCT00429273|473431388|FG000|Overall Study|Physician Decision|6|||
131492147|NCT00429273|473431389|FG001|Overall Study|Physician Decision|5|||
131492148|NCT00429273|473431390|FG002|Overall Study|Physician Decision|5|||
131492149|NCT00429273|473431388|FG000|Overall Study|Adverse Event|1|||
131492150|NCT00429273|473431389|FG001|Overall Study|Adverse Event|1|||
131492151|NCT00429273|473431390|FG002|Overall Study|Adverse Event|2|||
131492152|NCT02064894|473431391|FG000|Overall Study|Withdrawal by Subject|43|||
131492153|NCT02064894|473431392|FG001|Overall Study|Withdrawal by Subject|102|||
131492154|NCT02064894|473431393|FG002|Overall Study|Withdrawal by Subject|115|||
131492155|NCT01438957|473431394|FG000|Overall Study|Physician Decision|1|||
131492156|NCT01438957|473431395|FG001|Overall Study|Physician Decision|1|||
131492157|NCT01438957|473431396|FG002|Overall Study|Physician Decision|0|||
131492158|NCT01438957|473431397|FG003|Overall Study|Physician Decision|1|||
131492159|NCT01438957|473431398|FG004|Overall Study|Physician Decision|0|||
131492160|NCT00884312|473431407|FG000|Overall Study|Non-fatal Progressive Disease|0|||
131492161|NCT00884312|473431408|FG001|Overall Study|Non-fatal Progressive Disease|8|||
131492162|NCT00884312|473431407|FG000|Overall Study|Fatal Progressive Disease|0|||
131492163|NCT00884312|473431408|FG001|Overall Study|Fatal Progressive Disease|1|||
131492164|NCT00884312|473431407|FG000|Overall Study|Non-fatal Adverse Event|1|||
131492165|NCT00884312|473431408|FG001|Overall Study|Non-fatal Adverse Event|0|||
131492166|NCT00884312|473431407|FG000|Overall Study|Fatal Adverse Event|1|||
131492167|NCT00884312|473431408|FG001|Overall Study|Fatal Adverse Event|4|||
131492168|NCT00884312|473431407|FG000|Overall Study|Withdrawal by Subject|0|||
131492169|NCT00884312|473431408|FG001|Overall Study|Withdrawal by Subject|6|||
131492170|NCT00884312|473431407|FG000|Overall Study|Physician Decision|0|||
131492171|NCT00884312|473431408|FG001|Overall Study|Physician Decision|1|||
131492172|NCT00884312|473431407|FG000|Overall Study|Other|0|||
131492173|NCT00884312|473431408|FG001|Overall Study|Other|4|||
131492174|NCT00884312|473431407|FG000|Overall Study|Did Not Receive Study Drug|0|||
131492175|NCT00884312|473431408|FG001|Overall Study|Did Not Receive Study Drug|1|||
131492176|NCT00224042|473431409|FG000|Overall Study|Adverse Event|2|||
131492177|NCT00224042|473431410|FG001|Overall Study|Adverse Event|1|||
131492178|NCT00224042|473431409|FG000|Overall Study|Protocol Violation|0|||
131492179|NCT00224042|473431410|FG001|Overall Study|Protocol Violation|1|||
131492180|NCT00224042|473431409|FG000|Overall Study|Physician Decision|0|||
131492181|NCT00224042|473431410|FG001|Overall Study|Physician Decision|1|||
131492182|NCT00224042|473431409|FG000|Overall Study|Did not meet lab incusion criteria|2|||
131492183|NCT00224042|473431410|FG001|Overall Study|Did not meet lab incusion criteria|3|||
131492184|NCT00224042|473431409|FG000|Overall Study|Other|2|||
131492185|NCT00224042|473431410|FG001|Overall Study|Other|0|||
131492186|NCT00840450|473431411|FG000|Overall Study|Adverse Event|1|||
131492187|NCT00840450|473431411|FG000|Overall Study|Lack of Efficacy|2|||
131492188|NCT00617123|473431412|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
131492189|NCT00617123|473431413|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
131492190|NCT00617123|473431412|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
131492191|NCT00617123|473431413|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
131492192|NCT00617123|473431412|FG000|Referral Screening Period|Adverse Event|0|||
131492193|NCT00617123|473431413|FG001|Referral Screening Period|Adverse Event|1|||
131492194|NCT00617123|473431412|FG000|Study Treatment Period|Withdrawal by Subject|8|||
131492195|NCT00617123|473431413|FG001|Study Treatment Period|Withdrawal by Subject|12|||
131492196|NCT00617123|473431412|FG000|Study Treatment Period|Adverse Event|7|||
131492197|NCT00617123|473431413|FG001|Study Treatment Period|Adverse Event|3|||
131492198|NCT00617123|473431412|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
131492199|NCT00617123|473431413|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
131492200|NCT00617123|473431412|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
131492201|NCT00617123|473431413|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
131492202|NCT00133952|473431415|FG000|Overall Study|Adverse Event|1|||
131492203|NCT00133952|473431416|FG001|Overall Study|Adverse Event|2|||
131492204|NCT00133952|473431415|FG000|Overall Study|Death|3|||
131492205|NCT00133952|473431416|FG001|Overall Study|Death|2|||
131492206|NCT00133952|473431415|FG000|Overall Study|Lost to Follow-up|9|||
131492207|NCT00133952|473431416|FG001|Overall Study|Lost to Follow-up|14|||
131492208|NCT00133952|473431415|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
131492209|NCT00133952|473431416|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
131492210|NCT00133952|473431415|FG000|Overall Study|Protocol Violation|1|||
131492211|NCT00133952|473431416|FG001|Overall Study|Protocol Violation|1|||
131492212|NCT00133952|473431415|FG000|Overall Study|Withdrawal by Subject|20|||
131492213|NCT00133952|473431416|FG001|Overall Study|Withdrawal by Subject|4|||
131492214|NCT00133952|473431415|FG000|Overall Study|Physician Decision|4|||
131492215|NCT00133952|473431416|FG001|Overall Study|Physician Decision|3|||
131492216|NCT00133952|473431415|FG000|Overall Study|Sponsor Decision|0|||
131492217|NCT00133952|473431416|FG001|Overall Study|Sponsor Decision|1|||
131492218|NCT03052725|473431417|FG000|Overall Study|Adverse Event|2|||
131492219|NCT03052725|473431418|FG001|Overall Study|Adverse Event|0|||
131492220|NCT03052725|473431417|FG000|Overall Study|Withdrawal by Subject|3|||
131492221|NCT03052725|473431418|FG001|Overall Study|Withdrawal by Subject|4|||
131492222|NCT03052725|473431417|FG000|Overall Study|Pregnancy|0|||
131492223|NCT03052725|473431418|FG001|Overall Study|Pregnancy|1|||
131492224|NCT03052725|473431417|FG000|Overall Study|Site closure|0|||
131492225|NCT03052725|473431418|FG001|Overall Study|Site closure|1|||
131492226|NCT03052725|473431417|FG000|Overall Study|Study terminated by sponsor|143|||
131492227|NCT03052725|473431418|FG001|Overall Study|Study terminated by sponsor|144|||
131492228|NCT00727025|473431424|FG000|Overall Study|Physician Decision|23|||
131492229|NCT02128113|473431425|FG000|Overall Study|Withdrawal by Subject|3|||
131492230|NCT02128113|473431426|FG001|Overall Study|Withdrawal by Subject|1|||
131492231|NCT02128113|473431427|FG002|Overall Study|Withdrawal by Subject|0|||
131492232|NCT02128113|473431425|FG000|Overall Study|Protocol Violation|0|||
131492233|NCT02128113|473431426|FG001|Overall Study|Protocol Violation|1|||
131492234|NCT02128113|473431427|FG002|Overall Study|Protocol Violation|0|||
131492235|NCT02128113|473431425|FG000|Overall Study|Surgery cancelled|0|||
131492236|NCT02128113|473431426|FG001|Overall Study|Surgery cancelled|1|||
131492237|NCT02128113|473431427|FG002|Overall Study|Surgery cancelled|0|||
131492238|NCT02128113|473431425|FG000|Overall Study|Adverse Event|0|||
131492239|NCT02128113|473431426|FG001|Overall Study|Adverse Event|0|||
131492240|NCT02128113|473431427|FG002|Overall Study|Adverse Event|1|||
131492241|NCT01061177|473431428|FG000|Overall Study|Adverse Event|117|||
131492242|NCT01061177|473431428|FG000|Overall Study|Withdrawal by Subject|27|||
131492243|NCT01061177|473431428|FG000|Overall Study|Disease progression|17|||
131492244|NCT01061177|473431428|FG000|Overall Study|Protocol Violation|11|||
131492245|NCT01061177|473431428|FG000|Overall Study|Lost to Follow-up|9|||
131492246|NCT01061177|473431428|FG000|Overall Study|New cancer therapy|9|||
131492247|NCT01061177|473431428|FG000|Overall Study|Abnormal laboratory values|6|||
131492248|NCT01061177|473431428|FG000|Overall Study|Abnormal test procedure results|4|||
131492249|NCT01061177|473431428|FG000|Overall Study|Administratie problems|4|||
131492250|NCT01061177|473431428|FG000|Overall Study|Death|4|||
131492251|NCT00299104|473431429|FG000|Treatment Period|Adverse Event|14|||
131492252|NCT00299104|473431430|FG001|Treatment Period|Adverse Event|9|||
131492253|NCT00299104|473431431|FG002|Treatment Period|Adverse Event|7|||
131492254|NCT00299104|473431429|FG000|Treatment Period|Death|1|||
131492255|NCT00299104|473431430|FG001|Treatment Period|Death|1|||
131492256|NCT00299104|473431431|FG002|Treatment Period|Death|1|||
131492257|NCT00299104|473431429|FG000|Treatment Period|Insufficient therapeutic response|34|||
131492258|NCT00299104|473431430|FG001|Treatment Period|Insufficient therapeutic response|13|||
131492259|NCT00299104|473431431|FG002|Treatment Period|Insufficient therapeutic response|8|||
131492260|NCT00299104|473431429|FG000|Treatment Period|Failure to return|9|||
131492261|NCT00299104|473431430|FG001|Treatment Period|Failure to return|8|||
131492262|NCT00299104|473431431|FG002|Treatment Period|Failure to return|8|||
131492263|NCT00299104|473431429|FG000|Treatment Period|Violation of selection criteria|1|||
131492264|NCT00299104|473431430|FG001|Treatment Period|Violation of selection criteria|2|||
131492265|NCT00299104|473431431|FG002|Treatment Period|Violation of selection criteria|0|||
131492266|NCT00299104|473431429|FG000|Treatment Period|Protocol Violation|1|||
131492267|NCT00299104|473431430|FG001|Treatment Period|Protocol Violation|1|||
131492268|NCT00299104|473431431|FG002|Treatment Period|Protocol Violation|0|||
131492269|NCT00299104|473431429|FG000|Treatment Period|Refused treatment|9|||
131492270|NCT00299104|473431430|FG001|Treatment Period|Refused treatment|2|||
131492271|NCT00299104|473431431|FG002|Treatment Period|Refused treatment|2|||
131492272|NCT00299104|473431429|FG000|Treatment Period|Withdrew consent|14|||
131492273|NCT00299104|473431430|FG001|Treatment Period|Withdrew consent|19|||
131492274|NCT00299104|473431431|FG002|Treatment Period|Withdrew consent|9|||
131492275|NCT00299104|473431429|FG000|Treatment Period|Administrative reasons|106|||
131492276|NCT00299104|473431430|FG001|Treatment Period|Administrative reasons|120|||
131492277|NCT00299104|473431431|FG002|Treatment Period|Administrative reasons|137|||
131492278|NCT00299104|473431429|FG000|Safety Follow-Up (SFU) Period|Death|3|||
131492279|NCT00299104|473431430|FG001|Safety Follow-Up (SFU) Period|Death|2|||
131492280|NCT00299104|473431431|FG002|Safety Follow-Up (SFU) Period|Death|1|||
131492281|NCT00299104|473431429|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
131492282|NCT00299104|473431430|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
131492283|NCT00299104|473431431|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
131492284|NCT00299104|473431429|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
131492285|NCT00299104|473431430|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
131492286|NCT00299104|473431431|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
131492287|NCT00299104|473431429|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
131492288|NCT00299104|473431430|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
131492289|NCT00299104|473431431|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
131492290|NCT00299104|473431429|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
131492291|NCT00299104|473431430|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
131492292|NCT00299104|473431431|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
131492293|NCT00299104|473431429|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
131492294|NCT00299104|473431430|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
131492295|NCT00299104|473431431|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
131492296|NCT00299104|473431429|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
131492297|NCT00299104|473431430|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
131492298|NCT00299104|473431431|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
131492299|NCT00299104|473431429|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
131492300|NCT00299104|473431430|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
131492301|NCT00299104|473431431|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
131492302|NCT00847379|473431444|FG000|Overall Study|Study terminated by Sponsor|59|||
131492303|NCT00847379|473431445|FG001|Overall Study|Study terminated by Sponsor|57|||
131492304|NCT00847379|473431446|FG002|Overall Study|Study terminated by Sponsor|57|||
131492305|NCT03978832|473431447|FG000|Overall Study|Adverse Event|1|||
131492306|NCT03978832|473431447|FG000|Overall Study|Lost to Follow-up|1|||
131492307|NCT03978832|473431447|FG000|Overall Study|Withdrawal by Subject|6|||
131492308|NCT03978832|473431447|FG000|Overall Study|Physician Decision|2|||
131492309|NCT03978832|473431447|FG000|Overall Study|did not pass screening criteria|44|||
131492310|NCT00003499|473431448|FG000|Overall Study|Not evaluable|8|||
131492311|NCT02042183|473431453|FG000|Overall Study|Physician Decision|7|||
131492312|NCT02042183|473431454|FG001|Overall Study|Physician Decision|2|||
131492313|NCT02042183|473431453|FG000|Overall Study|Lack of Efficacy|4|||
131492314|NCT02042183|473431454|FG001|Overall Study|Lack of Efficacy|3|||
131492315|NCT02042183|473431453|FG000|Overall Study|Non-compliance with Study Drug|2|||
131492316|NCT02042183|473431454|FG001|Overall Study|Non-compliance with Study Drug|3|||
131492317|NCT02042183|473431453|FG000|Overall Study|Adverse Event|17|||
131492318|NCT02042183|473431454|FG001|Overall Study|Adverse Event|6|||
131492319|NCT02042183|473431453|FG000|Overall Study|Other|3|||
131492320|NCT02042183|473431454|FG001|Overall Study|Other|3|||
131492321|NCT02042183|473431453|FG000|Overall Study|Withdrawal by Subject|21|||
131492322|NCT02042183|473431454|FG001|Overall Study|Withdrawal by Subject|16|||
131492323|NCT02042183|473431453|FG000|Overall Study|Site Terminated by Sponsor|2|||
131492324|NCT02042183|473431454|FG001|Overall Study|Site Terminated by Sponsor|1|||
131492325|NCT02042183|473431453|FG000|Overall Study|Lost to Follow-up|9|||
131492326|NCT02042183|473431454|FG001|Overall Study|Lost to Follow-up|2|||
131492327|NCT01727297|473431455|FG000|Overall Study|Death|13|||
131492328|NCT01727297|473431456|FG001|Overall Study|Death|0|||
131492329|NCT01727297|473431455|FG000|Overall Study|Protocol Violation|1|||
131492330|NCT01727297|473431456|FG001|Overall Study|Protocol Violation|10|||
131492331|NCT01727297|473431455|FG000|Overall Study|Adverse Event|3|||
131492332|NCT01727297|473431456|FG001|Overall Study|Adverse Event|1|||
131492333|NCT01727297|473431455|FG000|Overall Study|Lost to Follow-up|11|||
131492334|NCT01727297|473431456|FG001|Overall Study|Lost to Follow-up|0|||
131492335|NCT01727297|473431455|FG000|Overall Study|Withdrawal by Subject|26|||
131492336|NCT01727297|473431456|FG001|Overall Study|Withdrawal by Subject|27|||
131492337|NCT01727297|473431455|FG000|Overall Study|Physician Decision|19|||
131492338|NCT01727297|473431456|FG001|Overall Study|Physician Decision|5|||
131492339|NCT01727297|473431455|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
131492340|NCT01727297|473431456|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
131492341|NCT02864498|473431457|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
131492342|NCT02864498|473431458|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
131492343|NCT02864498|473431459|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
131492344|NCT02864498|473431457|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
131492345|NCT02864498|473431458|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
131492346|NCT02864498|473431459|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
131492347|NCT02864498|473431457|FG000|Overall Study|Investigator Discretion|0|||
131492348|NCT02864498|473431458|FG001|Overall Study|Investigator Discretion|2|||
131492349|NCT02864498|473431459|FG002|Overall Study|Investigator Discretion|1|||
131492350|NCT02864498|473431457|FG000|Overall Study|Lost to Follow-up|8|||
131492351|NCT02864498|473431458|FG001|Overall Study|Lost to Follow-up|6|||
131492352|NCT02864498|473431459|FG002|Overall Study|Lost to Follow-up|3|||
131492353|NCT02864498|473431457|FG000|Overall Study|Lack of Efficacy|5|||
131492354|NCT02864498|473431458|FG001|Overall Study|Lack of Efficacy|3|||
131492355|NCT02864498|473431459|FG002|Overall Study|Lack of Efficacy|3|||
131492356|NCT02864498|473431457|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
131492357|NCT02864498|473431458|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
131492358|NCT02864498|473431459|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
131492359|NCT02864498|473431457|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
131492360|NCT02864498|473431458|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
131492361|NCT02864498|473431459|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
131492362|NCT02864498|473431457|FG000|Overall Study|Subject moved out of the country.|0|||
131492363|NCT02864498|473431458|FG001|Overall Study|Subject moved out of the country.|0|||
131492364|NCT02864498|473431459|FG002|Overall Study|Subject moved out of the country.|1|||
131492365|NCT02244606|473431460|FG000|Overall Study|Adverse Event|0|||
131492366|NCT02244606|473431461|FG001|Overall Study|Adverse Event|1|||
131492367|NCT02244606|473431462|FG002|Overall Study|Adverse Event|1|||
131492368|NCT02244606|473431463|FG003|Overall Study|Adverse Event|0|||
131492369|NCT02244606|473431460|FG000|Overall Study|Lost to Follow-up|2|||
131492370|NCT02244606|473431461|FG001|Overall Study|Lost to Follow-up|2|||
131492371|NCT02244606|473431462|FG002|Overall Study|Lost to Follow-up|1|||
131492372|NCT02244606|473431463|FG003|Overall Study|Lost to Follow-up|0|||
131492373|NCT02244606|473431460|FG000|Overall Study|Protocol Violation|0|||
131492374|NCT02244606|473431461|FG001|Overall Study|Protocol Violation|0|||
131492375|NCT02244606|473431462|FG002|Overall Study|Protocol Violation|0|||
131492376|NCT02244606|473431463|FG003|Overall Study|Protocol Violation|1|||
131492377|NCT02244606|473431460|FG000|Overall Study|Withdrawal by Subject|1|||
131492378|NCT02244606|473431461|FG001|Overall Study|Withdrawal by Subject|1|||
131492379|NCT02244606|473431462|FG002|Overall Study|Withdrawal by Subject|0|||
131492380|NCT02244606|473431463|FG003|Overall Study|Withdrawal by Subject|0|||
131492381|NCT02244606|473431460|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
131492382|NCT02244606|473431461|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
131492383|NCT02244606|473431462|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
131492384|NCT02244606|473431463|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
131492385|NCT00378378|473431466|FG000|Overall Study|Withdrawal by Subject|0|||
131492386|NCT00378378|473431467|FG001|Overall Study|Withdrawal by Subject|1|||
131492387|NCT00378378|473431468|FG002|Overall Study|Withdrawal by Subject|0|||
131492388|NCT00378378|473431466|FG000|Overall Study|Treatment Failure|0|||
131492389|NCT00378378|473431467|FG001|Overall Study|Treatment Failure|0|||
131492390|NCT00378378|473431468|FG002|Overall Study|Treatment Failure|1|||
131492391|NCT00378378|473431466|FG000|Overall Study|Non-compliance with protocol|0|||
131492392|NCT00378378|473431467|FG001|Overall Study|Non-compliance with protocol|0|||
131492393|NCT00378378|473431468|FG002|Overall Study|Non-compliance with protocol|1|||
131492394|NCT00407797|473431469|FG000|Overall Study|Lost to Follow-up|2|||
131492395|NCT00407797|473431469|FG000|Overall Study|Adverse Event|6|||
131492396|NCT00407797|473431469|FG000|Overall Study|Other|7|||
131492397|NCT00407797|473431469|FG000|Overall Study|Withdrawal by Subject|3|||
131492398|NCT01812174|473431470|FG000|Overall Study|Death|1|||
131492399|NCT01812174|473431471|FG001|Overall Study|Death|0|||
131492400|NCT01812174|473431470|FG000|Overall Study|Protocol Violation|2|||
131492401|NCT01812174|473431471|FG001|Overall Study|Protocol Violation|0|||
131492402|NCT01854710|473431475|FG000|Overall Study|Withdrawal by Subject|2|||
131492403|NCT01854710|473431476|FG001|Overall Study|Withdrawal by Subject|1|||
131492404|NCT01854710|473431477|FG002|Overall Study|Withdrawal by Subject|0|||
131492405|NCT01854710|473431478|FG003|Overall Study|Withdrawal by Subject|0|||
131492406|NCT01854710|473431479|FG004|Overall Study|Withdrawal by Subject|0|||
131492407|NCT01854710|473431480|FG005|Overall Study|Withdrawal by Subject|0|||
131492408|NCT01854710|473431475|FG000|Overall Study|CRI procedural error|2|||
131492409|NCT01854710|473431476|FG001|Overall Study|CRI procedural error|2|||
131492410|NCT01854710|473431477|FG002|Overall Study|CRI procedural error|2|||
131492411|NCT01854710|473431478|FG003|Overall Study|CRI procedural error|2|||
131492412|NCT01854710|473431479|FG004|Overall Study|CRI procedural error|2|||
131492413|NCT01854710|473431480|FG005|Overall Study|CRI procedural error|2|||
131492414|NCT03132220|473431481|FG000|Overall Study|Lost to Follow-up|17|||
131492415|NCT03132220|473431482|FG001|Overall Study|Lost to Follow-up|8|||
131492416|NCT03132220|473431481|FG000|Overall Study|Withdrawal by Subject|1|||
131492417|NCT03132220|473431482|FG001|Overall Study|Withdrawal by Subject|4|||
131492418|NCT01051323|473431485|FG000|Overall Study|Discontinuation of treatment|103|||
131492419|NCT01051323|473431485|FG000|Overall Study|Transplantation|28|||
131492420|NCT01051323|473431485|FG000|Overall Study|Dialysis dependency|22|||
131492421|NCT01051323|473431485|FG000|Overall Study|Withdrawal by Subject|13|||
131492422|NCT01051323|473431485|FG000|Overall Study|Lost to Follow-up|31|||
131492423|NCT01051323|473431485|FG000|Overall Study|Death|129|||
131492424|NCT01051323|473431485|FG000|Overall Study|Hospitalization|28|||
131492425|NCT01051323|473431485|FG000|Overall Study|Other|148|||
131492426|NCT01051323|473431485|FG000|Overall Study|Missing|37|||
131492427|NCT00601458|473431486|FG000|Overall Study|Dosing Error|1|||
131492428|NCT00601458|473431487|FG001|Overall Study|Dosing Error|0|||
131492429|NCT00601458|473431488|FG002|Overall Study|Dosing Error|0|||
131492430|NCT00601458|473431486|FG000|Overall Study|Incomplete Data|0|||
131492431|NCT00601458|473431487|FG001|Overall Study|Incomplete Data|2|||
131492432|NCT00601458|473431488|FG002|Overall Study|Incomplete Data|0|||
131492433|NCT00601458|473431486|FG000|Overall Study|Protocol Violation|3|||
131492434|NCT00601458|473431487|FG001|Overall Study|Protocol Violation|2|||
131492435|NCT00601458|473431488|FG002|Overall Study|Protocol Violation|1|||
131492436|NCT00601458|473431486|FG000|Overall Study|Early Termination|0|||
131492437|NCT00601458|473431487|FG001|Overall Study|Early Termination|1|||
131492438|NCT00601458|473431488|FG002|Overall Study|Early Termination|1|||
131492439|NCT00370032|473431489|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
131492440|NCT00370032|473431490|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
131492441|NCT00370032|473431489|FG000|Washout Period|Withdrawal by Subject|0|||
131492442|NCT00370032|473431490|FG001|Washout Period|Withdrawal by Subject|1|||
131492443|NCT00370032|473431489|FG000|Washout Period|Lost to Follow-up|0|||
131492444|NCT00370032|473431490|FG001|Washout Period|Lost to Follow-up|1|||
131492445|NCT00370032|473431489|FG000|Washout Period|Adverse Event|1|||
131492446|NCT00370032|473431490|FG001|Washout Period|Adverse Event|0|||
131492447|NCT00370032|473431489|FG000|Follow-up Period|Withdrawal by Subject|1|||
131492448|NCT00370032|473431490|FG001|Follow-up Period|Withdrawal by Subject|0|||
131492449|NCT00518986|473431491|FG000|Overall Study|Adverse Event|12|||
131492450|NCT00518986|473431492|FG001|Overall Study|Adverse Event|7|||
131492451|NCT00518986|473431491|FG000|Overall Study|Lack of Efficacy|0|||
131492452|NCT00518986|473431492|FG001|Overall Study|Lack of Efficacy|2|||
131492453|NCT00518986|473431491|FG000|Overall Study|Lost to Follow-up|3|||
131492454|NCT00518986|473431492|FG001|Overall Study|Lost to Follow-up|2|||
131492455|NCT00518986|473431491|FG000|Overall Study|Physician Decision|0|||
131492456|NCT00518986|473431492|FG001|Overall Study|Physician Decision|3|||
131492457|NCT00518986|473431491|FG000|Overall Study|Protocol Violation|5|||
131492458|NCT00518986|473431492|FG001|Overall Study|Protocol Violation|7|||
131492459|NCT00518986|473431491|FG000|Overall Study|Withdrawal by Subject|4|||
131492460|NCT00518986|473431492|FG001|Overall Study|Withdrawal by Subject|4|||
131492461|NCT00518986|473431491|FG000|Overall Study|Non-Specific|2|||
131492462|NCT00518986|473431492|FG001|Overall Study|Non-Specific|1|||
131492463|NCT05683249|473431493|FG000|Overall Study|Adverse Event|3|||
131492464|NCT05683249|473431494|FG001|Overall Study|Adverse Event|1|||
131492465|NCT05683249|473431493|FG000|Overall Study|Lack of Efficacy|0|||
131492466|NCT05683249|473431494|FG001|Overall Study|Lack of Efficacy|2|||
131492467|NCT05683249|473431493|FG000|Overall Study|Lost to Follow-up|6|||
131492468|NCT05683249|473431494|FG001|Overall Study|Lost to Follow-up|5|||
131492469|NCT05683249|473431493|FG000|Overall Study|Non-compliance with Study Drug|2|||
131492470|NCT05683249|473431494|FG001|Overall Study|Non-compliance with Study Drug|0|||
131492471|NCT05683249|473431493|FG000|Overall Study|Protocol Violation|6|||
131492472|NCT05683249|473431494|FG001|Overall Study|Protocol Violation|3|||
131492473|NCT05683249|473431493|FG000|Overall Study|Withdrawal by Subject|9|||
131492474|NCT05683249|473431494|FG001|Overall Study|Withdrawal by Subject|8|||
131492475|NCT05683249|473431493|FG000|Overall Study|Other|0|||
131492476|NCT05683249|473431494|FG001|Overall Study|Other|2|||
131492477|NCT05229406|473431495|FG000|Overall Study|Withdrawal by Subject|1|||
131492478|NCT05229406|473431496|FG001|Overall Study|Withdrawal by Subject|2|||
131492479|NCT01537393|473431497|FG000|Overall Study|Exclude prior to study|32|||
131492480|NCT01537393|473431498|FG001|Overall Study|Exclude prior to study|44|||
131492481|NCT01537393|473431497|FG000|Overall Study|Death|20|||
131492482|NCT01537393|473431498|FG001|Overall Study|Death|32|||
131492483|NCT01537393|473431497|FG000|Overall Study|Withdrawal by Subject|18|||
131492484|NCT01537393|473431498|FG001|Overall Study|Withdrawal by Subject|17|||
131492485|NCT01537393|473431497|FG000|Overall Study|Lost to Follow-up|53|||
131492486|NCT01537393|473431498|FG001|Overall Study|Lost to Follow-up|48|||
131492487|NCT01537393|473431497|FG000|Overall Study|Failure - Regrafted|28|||
131492488|NCT01537393|473431498|FG001|Overall Study|Failure - Regrafted|43|||
131492489|NCT01537393|473431497|FG000|Overall Study|Failure - Not regrafted|2|||
131492490|NCT01537393|473431498|FG001|Overall Study|Failure - Not regrafted|6|||
131492491|NCT01537393|473431497|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
131492492|NCT01537393|473431498|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
131492493|NCT01578187|473431499|FG000|Usability Phase|Withdrawal by Subject|1|||
131492494|NCT03208244|473431505|FG000|Overall Study|Death|1|||
131492495|NCT01709162|473431506|FG000|Overall Study|Disease progression|3|||
131492496|NCT01709162|473431507|FG001|Overall Study|Disease progression|3|||
131492497|NCT01709162|473431506|FG000|Overall Study|Study drug toxicity|2|||
131492498|NCT01709162|473431507|FG001|Overall Study|Study drug toxicity|0|||
131492499|NCT01709162|473431506|FG000|Overall Study|Administrative reason by sponsor|0|||
131492500|NCT01709162|473431507|FG001|Overall Study|Administrative reason by sponsor|1|||
131492501|NCT01709162|473431506|FG000|Overall Study|Other|1|||
131492502|NCT01709162|473431507|FG001|Overall Study|Other|0|||
131492503|NCT01709162|473431506|FG000|Overall Study|Withdrawal by Subject|0|||
131492504|NCT01709162|473431507|FG001|Overall Study|Withdrawal by Subject|1|||
131492505|NCT01637272|473431511|FG000|Overall Study|Adverse Event|6|||
131492506|NCT01637272|473431511|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131492507|NCT01637272|473431511|FG000|Overall Study|Withdrawal by Subject|3|||
131492508|NCT01637272|473431511|FG000|Overall Study|Lost to Follow-up|2|||
131492509|NCT01637272|473431511|FG000|Overall Study|completed core, did not enter ext. phase|4|||
131492510|NCT01637272|473431511|FG000|Overall Study|Administrative problems|1|||
131492511|NCT01637272|473431511|FG000|Overall Study|Protocol Violation|2|||
131492512|NCT03845985|473431512|FG000|Overall Study|Lost to Follow-up|2|||
131492513|NCT03845985|473431513|FG001|Overall Study|Lost to Follow-up|1|||
131492514|NCT03845985|473431512|FG000|Overall Study|Physician Decision|1|||
131492515|NCT03845985|473431513|FG001|Overall Study|Physician Decision|0|||
131492516|NCT03845985|473431512|FG000|Overall Study|Withdrawal by Subject|4|||
131492517|NCT03845985|473431513|FG001|Overall Study|Withdrawal by Subject|1|||
131492518|NCT04523220|473431519|FG000|Main Treatment Period|Physician Decision|1|||
131492519|NCT04523220|473431520|FG001|Main Treatment Period|Physician Decision|1|||
131492520|NCT04523220|473431521|FG002|Main Treatment Period|Physician Decision|0|||
131492521|NCT04523220|473431519|FG000|Main Treatment Period|Other|5|||
131492522|NCT04523220|473431520|FG001|Main Treatment Period|Other|2|||
131492523|NCT04523220|473431521|FG002|Main Treatment Period|Other|4|||
131492524|NCT04523220|473431519|FG000|Main Treatment Period|Subject Decision|5|||
131492525|NCT04523220|473431520|FG001|Main Treatment Period|Subject Decision|7|||
131492526|NCT04523220|473431521|FG002|Main Treatment Period|Subject Decision|3|||
131492527|NCT04523220|473431519|FG000|Main Treatment Period|Death|5|||
131492528|NCT04523220|473431520|FG001|Main Treatment Period|Death|11|||
131492529|NCT04523220|473431521|FG002|Main Treatment Period|Death|4|||
131492530|NCT04523220|473431519|FG000|Main Treatment Period|Adverse Event|11|||
131492531|NCT04523220|473431520|FG001|Main Treatment Period|Adverse Event|9|||
131492532|NCT04523220|473431521|FG002|Main Treatment Period|Adverse Event|9|||
131492533|NCT04523220|473431519|FG000|Main Treatment Period|Withdrawal by Subject|3|||
131492534|NCT04523220|473431520|FG001|Main Treatment Period|Withdrawal by Subject|3|||
131492535|NCT04523220|473431521|FG002|Main Treatment Period|Withdrawal by Subject|4|||
131492536|NCT04523220|473431519|FG000|Main Treatment Period|Study drug never adminstered|10|||
131492537|NCT04523220|473431520|FG001|Main Treatment Period|Study drug never adminstered|3|||
131492538|NCT04523220|473431521|FG002|Main Treatment Period|Study drug never adminstered|5|||
131492539|NCT04523220|473431519|FG000|Extension Treatment Period|Physician Decision|1|||
131492540|NCT04523220|473431520|FG001|Extension Treatment Period|Physician Decision|0|||
131492541|NCT04523220|473431521|FG002|Extension Treatment Period|Physician Decision|3|||
131492542|NCT04523220|473431519|FG000|Extension Treatment Period|Other|2|||
131492543|NCT04523220|473431520|FG001|Extension Treatment Period|Other|6|||
131492544|NCT04523220|473431521|FG002|Extension Treatment Period|Other|6|||
131492545|NCT04523220|473431519|FG000|Extension Treatment Period|Subject Decision|5|||
131492546|NCT04523220|473431520|FG001|Extension Treatment Period|Subject Decision|2|||
131492547|NCT04523220|473431521|FG002|Extension Treatment Period|Subject Decision|4|||
131492548|NCT04523220|473431519|FG000|Extension Treatment Period|Death|6|||
131492549|NCT04523220|473431520|FG001|Extension Treatment Period|Death|4|||
131492550|NCT04523220|473431521|FG002|Extension Treatment Period|Death|7|||
131492551|NCT04523220|473431519|FG000|Extension Treatment Period|Adverse Event|6|||
131492552|NCT04523220|473431520|FG001|Extension Treatment Period|Adverse Event|7|||
131492553|NCT04523220|473431521|FG002|Extension Treatment Period|Adverse Event|9|||
131492554|NCT04523220|473431519|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
131492555|NCT04523220|473431520|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
131492556|NCT04523220|473431521|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
131492557|NCT04523220|473431519|FG000|Extension Treatment Period|Study drug never administered|0|||
131492558|NCT04523220|473431520|FG001|Extension Treatment Period|Study drug never administered|1|||
131492559|NCT04523220|473431521|FG002|Extension Treatment Period|Study drug never administered|0|||
131492560|NCT01737697|473431522|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492561|NCT01737697|473431523|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
131492562|NCT01737697|473431524|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492563|NCT01737697|473431525|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
131492564|NCT01737697|473431526|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
131492565|NCT01737697|473431527|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492566|NCT01737697|473431528|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492567|NCT01737697|473431529|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492568|NCT01737697|473431530|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492569|NCT01737697|473431531|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492570|NCT01737697|473431532|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492571|NCT01737697|473431533|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492572|NCT01737697|473431534|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492573|NCT01737697|473431535|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492574|NCT01737697|473431536|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
131492575|NCT01737697|473431522|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
131492576|NCT01737697|473431523|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
131492577|NCT01737697|473431524|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
131492578|NCT01737697|473431525|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492579|NCT01737697|473431526|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492580|NCT01737697|473431527|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492581|NCT01737697|473431528|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492582|NCT01737697|473431529|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492583|NCT01737697|473431530|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492584|NCT01737697|473431531|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492585|NCT01737697|473431532|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492586|NCT01737697|473431533|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492587|NCT01737697|473431534|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492588|NCT01737697|473431535|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492589|NCT01737697|473431536|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
131492590|NCT01737697|473431522|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492591|NCT01737697|473431523|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492592|NCT01737697|473431524|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492593|NCT01737697|473431525|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
131492594|NCT01737697|473431526|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492595|NCT01737697|473431527|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492596|NCT01737697|473431528|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492597|NCT01737697|473431529|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492598|NCT01737697|473431530|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492599|NCT01737697|473431531|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492600|NCT01737697|473431532|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492601|NCT01737697|473431533|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492602|NCT01737697|473431534|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492603|NCT01737697|473431535|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492604|NCT01737697|473431536|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
131492605|NCT01737697|473431522|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492606|NCT01737697|473431523|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
131492607|NCT01737697|473431524|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492608|NCT01737697|473431525|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492609|NCT01737697|473431526|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492610|NCT01737697|473431527|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492611|NCT01737697|473431528|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492612|NCT01737697|473431529|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492613|NCT01737697|473431530|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492614|NCT01737697|473431531|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492615|NCT01737697|473431532|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492616|NCT01737697|473431533|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492617|NCT01737697|473431534|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492618|NCT01737697|473431535|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492619|NCT01737697|473431536|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
131492620|NCT01737697|473431522|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492621|NCT01737697|473431523|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492622|NCT01737697|473431524|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492623|NCT01737697|473431525|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492624|NCT01737697|473431526|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
131492625|NCT01737697|473431527|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492626|NCT01737697|473431528|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492627|NCT01737697|473431529|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492628|NCT01737697|473431530|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492629|NCT01737697|473431531|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492630|NCT01737697|473431532|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492631|NCT01737697|473431533|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492632|NCT01737697|473431534|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492633|NCT01737697|473431535|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492634|NCT01737697|473431536|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131492635|NCT01737697|473431522|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492636|NCT01737697|473431523|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
131492637|NCT01737697|473431524|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
131492638|NCT01737697|473431525|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
131492639|NCT01737697|473431526|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
131492640|NCT01737697|473431527|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492641|NCT01737697|473431528|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492642|NCT01737697|473431529|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492643|NCT01737697|473431530|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492644|NCT01737697|473431531|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492645|NCT01737697|473431532|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492646|NCT01737697|473431533|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492647|NCT01737697|473431534|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492648|NCT01737697|473431535|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492649|NCT01737697|473431536|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
131492650|NCT01737697|473431522|FG000|Subacute Phase|Adverse Event|0|||
131492651|NCT01737697|473431523|FG001|Subacute Phase|Adverse Event|0|||
131492652|NCT01737697|473431524|FG002|Subacute Phase|Adverse Event|0|||
131492653|NCT01737697|473431525|FG003|Subacute Phase|Adverse Event|0|||
131492654|NCT01737697|473431526|FG004|Subacute Phase|Adverse Event|0|||
131492655|NCT01737697|473431527|FG005|Subacute Phase|Adverse Event|1|||
131492656|NCT01737697|473431528|FG006|Subacute Phase|Adverse Event|1|||
131492657|NCT01737697|473431529|FG007|Subacute Phase|Adverse Event|1|||
131492658|NCT01737697|473431530|FG008|Subacute Phase|Adverse Event|1|||
131492659|NCT01737697|473431531|FG009|Subacute Phase|Adverse Event|1|||
131492660|NCT01737697|473431532|FG010|Subacute Phase|Adverse Event|4|||
131492661|NCT01737697|473431533|FG011|Subacute Phase|Adverse Event|1|||
131492662|NCT01737697|473431534|FG012|Subacute Phase|Adverse Event|1|||
131492663|NCT01737697|473431535|FG013|Subacute Phase|Adverse Event|0|||
131492664|NCT01737697|473431536|FG014|Subacute Phase|Adverse Event|0|||
131492665|NCT01737697|473431522|FG000|Subacute Phase|Withdrawal by Subject|0|||
131492666|NCT01737697|473431523|FG001|Subacute Phase|Withdrawal by Subject|0|||
131492667|NCT01737697|473431524|FG002|Subacute Phase|Withdrawal by Subject|0|||
131492668|NCT01737697|473431525|FG003|Subacute Phase|Withdrawal by Subject|0|||
131492669|NCT01737697|473431526|FG004|Subacute Phase|Withdrawal by Subject|0|||
131492670|NCT01737697|473431527|FG005|Subacute Phase|Withdrawal by Subject|1|||
131492671|NCT01737697|473431528|FG006|Subacute Phase|Withdrawal by Subject|0|||
131492672|NCT01737697|473431529|FG007|Subacute Phase|Withdrawal by Subject|2|||
131492673|NCT01737697|473431530|FG008|Subacute Phase|Withdrawal by Subject|0|||
131492674|NCT01737697|473431531|FG009|Subacute Phase|Withdrawal by Subject|1|||
131492675|NCT01737697|473431532|FG010|Subacute Phase|Withdrawal by Subject|0|||
131492676|NCT01737697|473431533|FG011|Subacute Phase|Withdrawal by Subject|1|||
131492677|NCT01737697|473431534|FG012|Subacute Phase|Withdrawal by Subject|1|||
131492678|NCT01737697|473431535|FG013|Subacute Phase|Withdrawal by Subject|1|||
131492679|NCT01737697|473431536|FG014|Subacute Phase|Withdrawal by Subject|0|||
131492680|NCT01737697|473431522|FG000|Subacute Phase|Lost to Follow-up|0|||
131492681|NCT01737697|473431523|FG001|Subacute Phase|Lost to Follow-up|0|||
131492682|NCT01737697|473431524|FG002|Subacute Phase|Lost to Follow-up|0|||
131492683|NCT01737697|473431525|FG003|Subacute Phase|Lost to Follow-up|0|||
131492684|NCT01737697|473431526|FG004|Subacute Phase|Lost to Follow-up|0|||
131492685|NCT01737697|473431527|FG005|Subacute Phase|Lost to Follow-up|0|||
131492686|NCT01737697|473431528|FG006|Subacute Phase|Lost to Follow-up|0|||
131492687|NCT01737697|473431529|FG007|Subacute Phase|Lost to Follow-up|0|||
131492688|NCT01737697|473431530|FG008|Subacute Phase|Lost to Follow-up|0|||
131492689|NCT01737697|473431531|FG009|Subacute Phase|Lost to Follow-up|0|||
131492690|NCT01737697|473431532|FG010|Subacute Phase|Lost to Follow-up|0|||
131492691|NCT01737697|473431533|FG011|Subacute Phase|Lost to Follow-up|0|||
131492692|NCT01737697|473431534|FG012|Subacute Phase|Lost to Follow-up|0|||
131492693|NCT01737697|473431535|FG013|Subacute Phase|Lost to Follow-up|0|||
131492694|NCT01737697|473431536|FG014|Subacute Phase|Lost to Follow-up|1|||
131492695|NCT01737697|473431522|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
131492696|NCT01737697|473431523|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
131492697|NCT01737697|473431524|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
131492698|NCT01737697|473431525|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
131492699|NCT01737697|473431526|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
131492700|NCT01737697|473431527|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
131492701|NCT01737697|473431528|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
131492702|NCT01737697|473431529|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
131492703|NCT01737697|473431530|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
131492704|NCT01737697|473431531|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
131492705|NCT01737697|473431532|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
131492706|NCT01737697|473431533|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
131492707|NCT01737697|473431534|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
131492708|NCT01737697|473431535|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
131492709|NCT01737697|473431536|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
131492710|NCT01737697|473431522|FG000|Subacute Phase|Protocol Violation|0|||
131492711|NCT01737697|473431523|FG001|Subacute Phase|Protocol Violation|0|||
131492712|NCT01737697|473431524|FG002|Subacute Phase|Protocol Violation|0|||
131492713|NCT01737697|473431525|FG003|Subacute Phase|Protocol Violation|0|||
131492714|NCT01737697|473431526|FG004|Subacute Phase|Protocol Violation|0|||
131492715|NCT01737697|473431527|FG005|Subacute Phase|Protocol Violation|1|||
131492716|NCT01737697|473431528|FG006|Subacute Phase|Protocol Violation|0|||
131492717|NCT01737697|473431529|FG007|Subacute Phase|Protocol Violation|0|||
131492718|NCT01737697|473431530|FG008|Subacute Phase|Protocol Violation|0|||
131492719|NCT01737697|473431531|FG009|Subacute Phase|Protocol Violation|0|||
131492720|NCT01737697|473431532|FG010|Subacute Phase|Protocol Violation|1|||
131492721|NCT01737697|473431533|FG011|Subacute Phase|Protocol Violation|0|||
131492722|NCT01737697|473431534|FG012|Subacute Phase|Protocol Violation|0|||
131492723|NCT01737697|473431535|FG013|Subacute Phase|Protocol Violation|0|||
131492724|NCT01737697|473431536|FG014|Subacute Phase|Protocol Violation|0|||
131492725|NCT01737697|473431522|FG000|Subacute Phase|Physician Decision|0|||
131492726|NCT01737697|473431523|FG001|Subacute Phase|Physician Decision|0|||
131492727|NCT01737697|473431524|FG002|Subacute Phase|Physician Decision|0|||
131492728|NCT01737697|473431525|FG003|Subacute Phase|Physician Decision|0|||
131492729|NCT01737697|473431526|FG004|Subacute Phase|Physician Decision|0|||
131492730|NCT01737697|473431527|FG005|Subacute Phase|Physician Decision|0|||
131492731|NCT01737697|473431528|FG006|Subacute Phase|Physician Decision|0|||
131492732|NCT01737697|473431529|FG007|Subacute Phase|Physician Decision|0|||
131492733|NCT01737697|473431530|FG008|Subacute Phase|Physician Decision|1|||
131492734|NCT01737697|473431531|FG009|Subacute Phase|Physician Decision|0|||
131492735|NCT01737697|473431532|FG010|Subacute Phase|Physician Decision|0|||
131492736|NCT01737697|473431533|FG011|Subacute Phase|Physician Decision|0|||
131492737|NCT01737697|473431534|FG012|Subacute Phase|Physician Decision|0|||
131492738|NCT01737697|473431535|FG013|Subacute Phase|Physician Decision|0|||
131492739|NCT01737697|473431536|FG014|Subacute Phase|Physician Decision|0|||
131492740|NCT01737697|473431522|FG000|Subacute Phase|Death|0|||
131492741|NCT01737697|473431523|FG001|Subacute Phase|Death|0|||
131492742|NCT01737697|473431524|FG002|Subacute Phase|Death|0|||
131492743|NCT01737697|473431525|FG003|Subacute Phase|Death|0|||
131492744|NCT01737697|473431526|FG004|Subacute Phase|Death|0|||
131492745|NCT01737697|473431527|FG005|Subacute Phase|Death|0|||
131492746|NCT01737697|473431528|FG006|Subacute Phase|Death|0|||
131492747|NCT01737697|473431529|FG007|Subacute Phase|Death|0|||
131492748|NCT01737697|473431530|FG008|Subacute Phase|Death|0|||
131492749|NCT01737697|473431531|FG009|Subacute Phase|Death|0|||
131492750|NCT01737697|473431532|FG010|Subacute Phase|Death|1|||
131492751|NCT01737697|473431533|FG011|Subacute Phase|Death|0|||
131492752|NCT01737697|473431534|FG012|Subacute Phase|Death|0|||
131492753|NCT01737697|473431535|FG013|Subacute Phase|Death|0|||
131492754|NCT01737697|473431536|FG014|Subacute Phase|Death|0|||
131492755|NCT03338998|473431540|FG000|Treatment Period|Withdrawal by Subject|1|||
131492756|NCT03338998|473431541|FG001|Treatment Period|Withdrawal by Subject|1|||
131492757|NCT03338998|473431540|FG000|Treatment Period|Adverse Event|0|||
131492758|NCT03338998|473431541|FG001|Treatment Period|Adverse Event|2|||
131492759|NCT03338998|473431540|FG000|Treatment Period|Protocol deviation|1|||
131492760|NCT03338998|473431541|FG001|Treatment Period|Protocol deviation|0|||
131492761|NCT03338998|473431540|FG000|Treatment Period|Physician Decision|2|||
131492762|NCT03338998|473431541|FG001|Treatment Period|Physician Decision|0|||
131492763|NCT03338998|473431540|FG000|Treatment Period|Subject failed swallow test|4|||
131492764|NCT03338998|473431541|FG001|Treatment Period|Subject failed swallow test|0|||
131492765|NCT03338998|473431540|FG000|Safety Follow-Up Period|Adverse Event|0|||
131492766|NCT03338998|473431541|FG001|Safety Follow-Up Period|Adverse Event|1|||
131492767|NCT03338998|473431540|FG000|Safety Follow-Up Period|Protocol deviation|1|||
131492768|NCT03338998|473431541|FG001|Safety Follow-Up Period|Protocol deviation|0|||
131492769|NCT03338998|473431540|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
131492770|NCT03338998|473431541|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
131492771|NCT03288129|473431542|FG000|Overall Study|Adverse Event|10|||
131492772|NCT03288129|473431542|FG000|Overall Study|Lost to Follow-up|3|||
131492773|NCT03288129|473431542|FG000|Overall Study|Withdrawal by Subject|3|||
131492774|NCT03288129|473431542|FG000|Overall Study|Withdrawal of consent/assent|1|||
131492775|NCT03288129|473431542|FG000|Overall Study|Other|5|||
131492776|NCT01949506|473431547|FG000|Overall Study|Physician Decision|1|||
131492777|NCT02820753|473432838|FG000|2 Month|Withdrawal by Subject|3|||
131492778|NCT02820753|473432839|FG001|2 Month|Withdrawal by Subject|3|||
131492779|NCT02820753|473432838|FG000|2 Month|Lost to Follow-up|24|||
131492780|NCT02820753|473432839|FG001|2 Month|Lost to Follow-up|26|||
131492781|NCT02820753|473432838|FG000|2 Month|Stopped per NIH Hold|51|||
131492782|NCT02820753|473432839|FG001|2 Month|Stopped per NIH Hold|13|||
131492783|NCT02820753|473432838|FG000|6 Month|Withdrawal by Subject|2|||
131492784|NCT02820753|473432839|FG001|6 Month|Withdrawal by Subject|2|||
131492785|NCT02820753|473432838|FG000|6 Month|Lost to Follow-up|20|||
131492786|NCT02820753|473432839|FG001|6 Month|Lost to Follow-up|27|||
131492787|NCT02820753|473432838|FG000|6 Month|Stopped per NIH Hold|81|||
131492788|NCT02820753|473432839|FG001|6 Month|Stopped per NIH Hold|81|||
131492789|NCT02820753|473432838|FG000|6 Month|Death|0|||
131492790|NCT02820753|473432839|FG001|6 Month|Death|1|||
131492791|NCT02161731|473432840|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
131492792|NCT02161731|473432841|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
131492793|NCT02161731|473432840|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
131492794|NCT02161731|473432841|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
131492795|NCT03761277|473432842|FG000|Enrollment to Implant|Screen Failure|17|||
131492796|NCT03761277|473432842|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
131492797|NCT03761277|473432842|FG000|Enrollment to Implant|Physician Decision|2|||
131492798|NCT03761277|473432842|FG000|Enrollment to Implant|Site Closure|3|||
131492799|NCT03761277|473432842|FG000|Enrollment to Implant|Sponsor Request|2|||
131492800|NCT03761277|473432842|FG000|Post-Implant to 6 Months|Adverse Event|2|||
131492801|NCT03761277|473432842|FG000|Post-Implant to 6 Months|Death|1|||
131492802|NCT03761277|473432842|FG000|Post-Implant to 6 Months|Site Closure|2|||
131492803|NCT03761277|473432842|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
131492804|NCT03761277|473432842|FG000|6 Months to 12 Months|Physician Decision|2|||
131492805|NCT03761277|473432842|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
131492806|NCT00903695|473432843|FG000|Overall Study|medical exclusion after 1st testing|1|||
131492807|NCT00903695|473432844|FG001|Overall Study|medical exclusion after 1st testing|0|||
131492808|NCT00903695|473432843|FG000|Overall Study|lung cancer|1|||
131492809|NCT00903695|473432844|FG001|Overall Study|lung cancer|0|||
131492810|NCT00543140|473432845|FG000|Overall Study|Lost to Follow-up|33|||
131492811|NCT00543140|473432845|FG000|Overall Study|Withdrawal by Subject|13|||
131492812|NCT00543140|473432845|FG000|Overall Study|Protocol Violation|10|||
131492813|NCT00543140|473432845|FG000|Overall Study|Insufficient weight loss|10|||
131492814|NCT00543140|473432845|FG000|Overall Study|SAE leading to explant of SAGB|3|||
131492815|NCT00543140|473432845|FG000|Overall Study|Death|1|||
131492816|NCT00543140|473432845|FG000|Overall Study|Subject moved|1|||
131492817|NCT00543140|473432845|FG000|Overall Study|Conversion to different procedure|1|||
131492818|NCT00578812|473432846|FG000|Overall Study|Not treated|6|||
131492819|NCT00578812|473432847|FG001|Overall Study|Not treated|7|||
131492820|NCT04532164|473432848|FG000|Overall Study|Adverse Event|1|||
131492821|NCT04532164|473432848|FG000|Overall Study|Protocol Violation|5|||
131492822|NCT04532164|473432848|FG000|Overall Study|Lost to Follow-up|1|||
131492823|NCT04532164|473432848|FG000|Overall Study|Found to be Ineligible|3|||
131492824|NCT04532164|473432848|FG000|Overall Study|Withdrawal by Subject|14|||
131492825|NCT02269241|473432853|FG000|Overall Study|Lost to Follow-up|269|||
131492826|NCT02269241|473432853|FG000|Overall Study|Withdrawal by Subject|155|||
131492827|NCT02269241|473432853|FG000|Overall Study|Protocol Violation|1|||
131492828|NCT02269241|473432853|FG000|Overall Study|Physician Decision|7|||
131492829|NCT02269241|473432853|FG000|Overall Study|Pregnancy|15|||
131492830|NCT02269241|473432853|FG000|Overall Study|Wish for pregnancy|5|||
131492831|NCT02269241|473432853|FG000|Overall Study|Development of an exclusion criteria|16|||
131492832|NCT02269241|473432853|FG000|Overall Study|Adverse Event|113|||
131492833|NCT02269241|473432853|FG000|Overall Study|At the specific request of the sponsor|20|||
131492834|NCT02269241|473432853|FG000|Overall Study|Several reasons not classified|53|||
131492835|NCT02269241|473432853|FG000|Overall Study|Screening failures|546|||
131492836|NCT00489541|473432864|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
131492837|NCT00489541|473432865|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
131492838|NCT00489541|473432864|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
131492839|NCT00489541|473432865|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
131492840|NCT00489541|473432864|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
131492841|NCT00489541|473432865|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
131492842|NCT00489541|473432864|FG000|12-Month Clinical Follow-up|Death|3|||
131492843|NCT00489541|473432865|FG001|12-Month Clinical Follow-up|Death|2|||
131492844|NCT00489541|473432864|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
131492845|NCT00489541|473432865|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
131492846|NCT00489541|473432864|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
131492847|NCT00489541|473432865|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
131492848|NCT05131646|473432866|FG000|Overall Study|Withdrawal by Subject|1|||
131492849|NCT05131646|473432867|FG001|Overall Study|Withdrawal by Subject|0|||
131492850|NCT05131646|473432868|FG002|Overall Study|Withdrawal by Subject|0|||
131492851|NCT02548650|473432873|FG000|Triple Therapy|Adverse Event|1|||
131492852|NCT02548650|473432874|FG001|Triple Therapy|Adverse Event|0|||
131492853|NCT02548650|473432873|FG000|Triple Therapy|Withdrawal by Subject|0|||
131492854|NCT02548650|473432874|FG001|Triple Therapy|Withdrawal by Subject|4|||
131492855|NCT02548650|473432873|FG000|Double Therapy|Adverse Event|1|||
131492856|NCT02548650|473432874|FG001|Double Therapy|Adverse Event|1|||
131492857|NCT02548650|473432873|FG000|Double Therapy|Withdrawal by Subject|0|||
131492858|NCT02548650|473432874|FG001|Double Therapy|Withdrawal by Subject|1|||
131492859|NCT01909674|473432875|FG000|Overall Study|Withdrawal by Subject|5|||
131492860|NCT01909674|473432876|FG001|Overall Study|Withdrawal by Subject|2|||
131492861|NCT00521014|473432877|FG000|Overall Study|Inevaluable, not treated|1|||
131492862|NCT02969369|473432878|FG000|Study|Adverse Event|1|||
131492863|NCT02969369|473432879|FG001|Study|Adverse Event|6|||
131492864|NCT02969369|473432878|FG000|Study|Lack of Efficacy|0|||
131492865|NCT02969369|473432879|FG001|Study|Lack of Efficacy|1|||
131492866|NCT02969369|473432878|FG000|Study|Lost to Follow-up|0|||
131492867|NCT02969369|473432879|FG001|Study|Lost to Follow-up|1|||
131492868|NCT02969369|473432878|FG000|Study|Withdrawal by Subject|3|||
131492869|NCT02969369|473432879|FG001|Study|Withdrawal by Subject|5|||
131492870|NCT02969369|473432878|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
131492871|NCT02969369|473432879|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
131492872|NCT02969369|473432878|FG000|Double-blind Period|Adverse Event|1|||
131492873|NCT02969369|473432879|FG001|Double-blind Period|Adverse Event|5|||
131492874|NCT02969369|473432878|FG000|Double-blind Period|Lost to Follow-up|0|||
131492875|NCT02969369|473432879|FG001|Double-blind Period|Lost to Follow-up|1|||
131492876|NCT02969369|473432878|FG000|Double-blind Period|Withdrawal by Subject|2|||
131492877|NCT02969369|473432879|FG001|Double-blind Period|Withdrawal by Subject|3|||
131492878|NCT02969369|473432878|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
131492879|NCT02969369|473432879|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
131492880|NCT02969369|473432878|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
131492881|NCT02969369|473432879|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
131492882|NCT02969369|473432878|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
131492883|NCT02969369|473432879|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
131492884|NCT02969369|473432878|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
131492885|NCT02969369|473432879|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
131492886|NCT04390191|473432880|FG000|Overall Study|Withdrawal by Subject|1|||
131492887|NCT04390191|473432881|FG001|Overall Study|Withdrawal by Subject|0|||
131492888|NCT01256008|473432882|FG000|Overall Study|Lost to Follow-up|6|||
131492889|NCT01256008|473432883|FG001|Overall Study|Lost to Follow-up|4|||
131492890|NCT01256008|473432884|FG002|Overall Study|Lost to Follow-up|11|||
131492891|NCT01256008|473432882|FG000|Overall Study|Withdrawal by Subject|2|||
131492892|NCT01256008|473432883|FG001|Overall Study|Withdrawal by Subject|3|||
131492893|NCT01256008|473432884|FG002|Overall Study|Withdrawal by Subject|10|||
131492894|NCT02321800|473432887|FG000|Overall Study|Withdrawal by Subject|3|||
131492895|NCT02321800|473432888|FG001|Overall Study|Withdrawal by Subject|3|||
131492896|NCT02321800|473432887|FG000|Overall Study|Death|1|||
131492897|NCT02321800|473432888|FG001|Overall Study|Death|0|||
131492898|NCT02321800|473432887|FG000|Overall Study|Protocol Violation|1|||
131492899|NCT02321800|473432888|FG001|Overall Study|Protocol Violation|0|||
131492900|NCT02321800|473432887|FG000|Overall Study|Lost to Follow-up|10|||
131492901|NCT02321800|473432888|FG001|Overall Study|Lost to Follow-up|4|||
131492902|NCT02321800|473432887|FG000|Overall Study|Adverse Event|2|||
131492903|NCT02321800|473432888|FG001|Overall Study|Adverse Event|3|||
131492904|NCT02321800|473432887|FG000|Overall Study|Other, Miscellaneous|3|||
131492905|NCT02321800|473432888|FG001|Overall Study|Other, Miscellaneous|1|||
131492906|NCT01626391|473432889|FG000|Overall Study|Physician Decision|1|||
131492907|NCT01626391|473432890|FG001|Overall Study|Physician Decision|0|||
131492908|NCT01626391|473432889|FG000|Overall Study|Withdrawal by Subject|1|||
131492909|NCT01626391|473432890|FG001|Overall Study|Withdrawal by Subject|0|||
131492910|NCT01496612|473432892|FG000|1st Intervention|Adverse Event|1|||
131492911|NCT01496612|473432893|FG001|1st Intervention|Adverse Event|0|||
131492912|NCT01496612|473432892|FG000|1st Intervention|Withdrawal by Subject|1|||
131492913|NCT01496612|473432893|FG001|1st Intervention|Withdrawal by Subject|0|||
131492914|NCT03708328|473432901|FG000|Overall Study|Death|3|||
131492915|NCT03708328|473432902|FG001|Overall Study|Death|3|||
131492916|NCT03708328|473432903|FG002|Overall Study|Death|4|||
131492917|NCT03708328|473432904|FG003|Overall Study|Death|2|||
131492918|NCT03708328|473432905|FG004|Overall Study|Death|2|||
131492919|NCT03708328|473432906|FG005|Overall Study|Death|13|||
131492920|NCT03708328|473432907|FG006|Overall Study|Death|26|||
131492921|NCT03708328|473432908|FG007|Overall Study|Death|18|||
131492922|NCT03708328|473432909|FG008|Overall Study|Death|13|||
131492923|NCT03708328|473432910|FG009|Overall Study|Death|8|||
131492924|NCT03708328|473432901|FG000|Overall Study|Lost to Follow-up|0|||
131492925|NCT03708328|473432902|FG001|Overall Study|Lost to Follow-up|1|||
131492926|NCT03708328|473432903|FG002|Overall Study|Lost to Follow-up|0|||
131492927|NCT03708328|473432904|FG003|Overall Study|Lost to Follow-up|1|||
131492928|NCT03708328|473432905|FG004|Overall Study|Lost to Follow-up|0|||
131492929|NCT03708328|473432906|FG005|Overall Study|Lost to Follow-up|3|||
131492930|NCT03708328|473432907|FG006|Overall Study|Lost to Follow-up|3|||
131492931|NCT03708328|473432908|FG007|Overall Study|Lost to Follow-up|0|||
131492932|NCT03708328|473432909|FG008|Overall Study|Lost to Follow-up|0|||
131492933|NCT03708328|473432910|FG009|Overall Study|Lost to Follow-up|1|||
131492934|NCT03708328|473432901|FG000|Overall Study|Physician Decision|0|||
131492935|NCT03708328|473432902|FG001|Overall Study|Physician Decision|0|||
131492936|NCT03708328|473432903|FG002|Overall Study|Physician Decision|0|||
131492937|NCT03708328|473432904|FG003|Overall Study|Physician Decision|0|||
131492938|NCT03708328|473432905|FG004|Overall Study|Physician Decision|0|||
131492939|NCT03708328|473432906|FG005|Overall Study|Physician Decision|1|||
131492940|NCT03708328|473432907|FG006|Overall Study|Physician Decision|0|||
131492941|NCT03708328|473432908|FG007|Overall Study|Physician Decision|0|||
131492942|NCT03708328|473432909|FG008|Overall Study|Physician Decision|0|||
131492943|NCT03708328|473432910|FG009|Overall Study|Physician Decision|0|||
131492944|NCT03708328|473432901|FG000|Overall Study|Withdrawal by Subject|0|||
131492945|NCT03708328|473432902|FG001|Overall Study|Withdrawal by Subject|0|||
131492946|NCT03708328|473432903|FG002|Overall Study|Withdrawal by Subject|0|||
131492947|NCT03708328|473432904|FG003|Overall Study|Withdrawal by Subject|0|||
131492948|NCT03708328|473432905|FG004|Overall Study|Withdrawal by Subject|1|||
131492949|NCT03708328|473432906|FG005|Overall Study|Withdrawal by Subject|0|||
131492950|NCT03708328|473432907|FG006|Overall Study|Withdrawal by Subject|2|||
131492951|NCT03708328|473432908|FG007|Overall Study|Withdrawal by Subject|4|||
131492952|NCT03708328|473432909|FG008|Overall Study|Withdrawal by Subject|1|||
131492953|NCT03708328|473432910|FG009|Overall Study|Withdrawal by Subject|5|||
131492954|NCT03708328|473432901|FG000|Overall Study|Study Closed Locally|0|||
131492955|NCT03708328|473432902|FG001|Overall Study|Study Closed Locally|0|||
131492956|NCT03708328|473432903|FG002|Overall Study|Study Closed Locally|0|||
131492957|NCT03708328|473432904|FG003|Overall Study|Study Closed Locally|0|||
131492958|NCT03708328|473432905|FG004|Overall Study|Study Closed Locally|0|||
131492959|NCT03708328|473432906|FG005|Overall Study|Study Closed Locally|0|||
131492960|NCT03708328|473432907|FG006|Overall Study|Study Closed Locally|0|||
131492961|NCT03708328|473432908|FG007|Overall Study|Study Closed Locally|1|||
131492962|NCT03708328|473432909|FG008|Overall Study|Study Closed Locally|0|||
131492963|NCT03708328|473432910|FG009|Overall Study|Study Closed Locally|0|||
131492964|NCT03708328|473432901|FG000|Overall Study|Study Ended By Sponsor|0|||
131492965|NCT03708328|473432902|FG001|Overall Study|Study Ended By Sponsor|0|||
131492966|NCT03708328|473432903|FG002|Overall Study|Study Ended By Sponsor|0|||
131492967|NCT03708328|473432904|FG003|Overall Study|Study Ended By Sponsor|0|||
131492968|NCT03708328|473432905|FG004|Overall Study|Study Ended By Sponsor|0|||
131492969|NCT03708328|473432906|FG005|Overall Study|Study Ended By Sponsor|1|||
131492970|NCT03708328|473432907|FG006|Overall Study|Study Ended By Sponsor|0|||
131492971|NCT03708328|473432908|FG007|Overall Study|Study Ended By Sponsor|1|||
131492972|NCT03708328|473432909|FG008|Overall Study|Study Ended By Sponsor|0|||
131492973|NCT03708328|473432910|FG009|Overall Study|Study Ended By Sponsor|0|||
131492974|NCT03708328|473432901|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492975|NCT03708328|473432902|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492976|NCT03708328|473432903|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492977|NCT03708328|473432904|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492978|NCT03708328|473432905|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492979|NCT03708328|473432906|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492980|NCT03708328|473432907|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492981|NCT03708328|473432908|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492982|NCT03708328|473432909|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
131492983|NCT03708328|473432910|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
131492984|NCT02695329|473432913|FG000|Overall Study|Adverse Event|1|||
131492985|NCT02695329|473432914|FG001|Overall Study|Adverse Event|0|||
131492986|NCT02695329|473432913|FG000|Overall Study|Poor X-ray quality for measurement|4|||
131492987|NCT02695329|473432914|FG001|Overall Study|Poor X-ray quality for measurement|5|||
131492988|NCT03727347|473432917|FG000|Overall Study|Withdrawal by Subject|2|||
131492989|NCT03727347|473432917|FG000|Overall Study|Lost to Follow-up|1|||
131492990|NCT01487200|473432918|FG000|Overall Study|Withdrawal by Subject|0|||
131492991|NCT01487200|473432919|FG001|Overall Study|Withdrawal by Subject|1|||
131492992|NCT01487200|473432920|FG002|Overall Study|Withdrawal by Subject|0|||
131492993|NCT01487200|473432921|FG003|Overall Study|Withdrawal by Subject|0|||
131492994|NCT02216591|473432922|FG000|Overall Study|Lost to Follow-up|0|||
131492995|NCT02216591|473432923|FG001|Overall Study|Lost to Follow-up|1|||
131492996|NCT01269463|473432926|FG000|First Intervention|Withdrawal by Subject|1|||
131492997|NCT01269463|473432927|FG001|First Intervention|Withdrawal by Subject|0|||
131492998|NCT01269463|473432926|FG000|First Intervention|Adverse Event|1|||
131492999|NCT01269463|473432927|FG001|First Intervention|Adverse Event|0|||
131493000|NCT01269463|473432926|FG000|First Intervention|Lack of Efficacy|0|||
131493001|NCT01269463|473432927|FG001|First Intervention|Lack of Efficacy|1|||
131493002|NCT01269463|473432926|FG000|First Intervention|Physician Decision|0|||
131493003|NCT01269463|473432927|FG001|First Intervention|Physician Decision|1|||
131493004|NCT00279305|473432928|FG000|Overall Study|Pregnancy|1|||
131493005|NCT00279305|473432929|FG001|Overall Study|Pregnancy|0|||
131493006|NCT00279305|473432928|FG000|Overall Study|Withdrawal by Subject|2|||
131493007|NCT00279305|473432929|FG001|Overall Study|Withdrawal by Subject|0|||
131493008|NCT00279305|473432928|FG000|Overall Study|Dificulting establishing IV|1|||
131493009|NCT00279305|473432929|FG001|Overall Study|Dificulting establishing IV|0|||
131493010|NCT00279305|473432928|FG000|Overall Study|FDA Safety Alert|4|||
131493011|NCT00279305|473432929|FG001|Overall Study|FDA Safety Alert|1|||
131493012|NCT04404361|473432933|FG000|Overall Study|Death|12|||
131493013|NCT04404361|473432934|FG001|Overall Study|Death|12|||
131493014|NCT04404361|473432933|FG000|Overall Study|Withdrawal by Subject|13|||
131493015|NCT04404361|473432934|FG001|Overall Study|Withdrawal by Subject|5|||
131493016|NCT04404361|473432933|FG000|Overall Study|Lost to Follow-up|6|||
131493017|NCT04404361|473432934|FG001|Overall Study|Lost to Follow-up|3|||
131493018|NCT04404361|473432933|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
131493019|NCT04404361|473432934|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
131493020|NCT02549937|473432936|FG000|Overall Study|Death|0|||
131493021|NCT02549937|473432937|FG001|Overall Study|Death|1|||
131493022|NCT02549937|473432938|FG002|Overall Study|Death|0|||
131493023|NCT02549937|473432939|FG003|Overall Study|Death|1|||
131493024|NCT02549937|473432940|FG004|Overall Study|Death|0|||
131493025|NCT02549937|473432941|FG005|Overall Study|Death|8|||
131493026|NCT02549937|473432942|FG006|Overall Study|Death|0|||
131493027|NCT02549937|473432943|FG007|Overall Study|Death|0|||
131493028|NCT02549937|473432944|FG008|Overall Study|Death|19|||
131493029|NCT02549937|473432936|FG000|Overall Study|No follow up required|3|||
131493030|NCT02549937|473432937|FG001|Overall Study|No follow up required|6|||
131493031|NCT02549937|473432938|FG002|Overall Study|No follow up required|3|||
131493032|NCT02549937|473432939|FG003|Overall Study|No follow up required|8|||
131493033|NCT02549937|473432940|FG004|Overall Study|No follow up required|12|||
131493034|NCT02549937|473432941|FG005|Overall Study|No follow up required|21|||
131493035|NCT02549937|473432942|FG006|Overall Study|No follow up required|9|||
131493036|NCT02549937|473432943|FG007|Overall Study|No follow up required|11|||
131493037|NCT02549937|473432944|FG008|Overall Study|No follow up required|0|||
131493038|NCT02549937|473432936|FG000|Overall Study|Other|0|||
131493039|NCT02549937|473432937|FG001|Overall Study|Other|0|||
131493040|NCT02549937|473432938|FG002|Overall Study|Other|0|||
131493041|NCT02549937|473432939|FG003|Overall Study|Other|0|||
131493042|NCT02549937|473432940|FG004|Overall Study|Other|1|||
131493043|NCT02549937|473432941|FG005|Overall Study|Other|0|||
131493044|NCT02549937|473432942|FG006|Overall Study|Other|3|||
131493045|NCT02549937|473432943|FG007|Overall Study|Other|2|||
131493046|NCT02549937|473432944|FG008|Overall Study|Other|3|||
131493047|NCT02549937|473432936|FG000|Overall Study|Lost to Follow-up|0|||
131493048|NCT02549937|473432937|FG001|Overall Study|Lost to Follow-up|0|||
131493049|NCT02549937|473432938|FG002|Overall Study|Lost to Follow-up|0|||
131493050|NCT02549937|473432939|FG003|Overall Study|Lost to Follow-up|0|||
131493051|NCT02549937|473432940|FG004|Overall Study|Lost to Follow-up|0|||
131493052|NCT02549937|473432941|FG005|Overall Study|Lost to Follow-up|0|||
131493053|NCT02549937|473432942|FG006|Overall Study|Lost to Follow-up|0|||
131493054|NCT02549937|473432943|FG007|Overall Study|Lost to Follow-up|0|||
131493055|NCT02549937|473432944|FG008|Overall Study|Lost to Follow-up|3|||
131493056|NCT02549937|473432936|FG000|Overall Study|Withdrawal by Subject|0|||
131493057|NCT02549937|473432937|FG001|Overall Study|Withdrawal by Subject|0|||
131493058|NCT02549937|473432938|FG002|Overall Study|Withdrawal by Subject|0|||
131493059|NCT02549937|473432939|FG003|Overall Study|Withdrawal by Subject|0|||
131493060|NCT02549937|473432940|FG004|Overall Study|Withdrawal by Subject|0|||
131493061|NCT02549937|473432941|FG005|Overall Study|Withdrawal by Subject|1|||
131493062|NCT02549937|473432942|FG006|Overall Study|Withdrawal by Subject|4|||
131493063|NCT02549937|473432943|FG007|Overall Study|Withdrawal by Subject|3|||
131493064|NCT02549937|473432944|FG008|Overall Study|Withdrawal by Subject|2|||
131493065|NCT02549937|473432936|FG000|Overall Study|Sponsor Decision|0|||
131493066|NCT02549937|473432937|FG001|Overall Study|Sponsor Decision|0|||
131493067|NCT02549937|473432938|FG002|Overall Study|Sponsor Decision|0|||
131493068|NCT02549937|473432939|FG003|Overall Study|Sponsor Decision|0|||
131493069|NCT02549937|473432940|FG004|Overall Study|Sponsor Decision|0|||
131493070|NCT02549937|473432941|FG005|Overall Study|Sponsor Decision|0|||
131493071|NCT02549937|473432942|FG006|Overall Study|Sponsor Decision|0|||
131493072|NCT02549937|473432943|FG007|Overall Study|Sponsor Decision|0|||
131493073|NCT02549937|473432944|FG008|Overall Study|Sponsor Decision|6|||
131493074|NCT03930797|473432945|FG000|Overall Study|Lost to Follow-up|3|||
131493075|NCT03930797|473432946|FG001|Overall Study|Lost to Follow-up|10|||
131493076|NCT00662012|473432947|FG000|Overall Study|Lost to Follow-up|85|||
131493077|NCT00662012|473432947|FG000|Overall Study|Death|1|||
131493078|NCT00662012|473432947|FG000|Overall Study|Withdrawal by Subject|1|||
131493079|NCT01744197|473432954|FG000|Overall Study|Received 1 patch|2|||
131493080|NCT01744197|473432955|FG001|Overall Study|Received 1 patch|1|||
131493081|NCT01744197|473432954|FG000|Overall Study|No patch received|2|||
131493082|NCT01744197|473432955|FG001|Overall Study|No patch received|2|||
131493083|NCT00317356|473432958|FG000|Overall Study|Adverse Event|0|||
131493084|NCT00317356|473432959|FG001|Overall Study|Adverse Event|0|||
131493085|NCT00317356|473432960|FG002|Overall Study|Adverse Event|1|||
131493086|NCT00317356|473432961|FG003|Overall Study|Adverse Event|0|||
131493087|NCT00317356|473432958|FG000|Overall Study|Lack of Efficacy|1|||
131493088|NCT00317356|473432959|FG001|Overall Study|Lack of Efficacy|1|||
131493089|NCT00317356|473432960|FG002|Overall Study|Lack of Efficacy|0|||
131493090|NCT00317356|473432961|FG003|Overall Study|Lack of Efficacy|3|||
131493091|NCT00317356|473432958|FG000|Overall Study|Physician Decision|0|||
131493092|NCT00317356|473432959|FG001|Overall Study|Physician Decision|1|||
131493093|NCT00317356|473432960|FG002|Overall Study|Physician Decision|0|||
131493094|NCT00317356|473432961|FG003|Overall Study|Physician Decision|0|||
131493095|NCT04419714|473432967|FG000|Overall Study|Technical Fault|5|||
131493096|NCT04419714|473432967|FG000|Overall Study|Protocol Deviation|2|||
131493097|NCT04419714|473432967|FG000|Overall Study|Withdrawal by Subject|1|||
131493098|NCT05425745|473432970|FG000|Overall Study|Withdrawal of Consent|3|||
131493099|NCT05425745|473432971|FG001|Overall Study|Withdrawal of Consent|3|||
131493100|NCT05425745|473432970|FG000|Overall Study|Death|2|||
131493101|NCT05425745|473432971|FG001|Overall Study|Death|3|||
131493102|NCT05425745|473432970|FG000|Overall Study|Lost to Follow-up|1|||
131493103|NCT05425745|473432971|FG001|Overall Study|Lost to Follow-up|2|||
131493104|NCT05425745|473432970|FG000|Overall Study|Adverse Event|0|||
131493105|NCT05425745|473432971|FG001|Overall Study|Adverse Event|1|||
131493106|NCT05425745|473432970|FG000|Overall Study|Did not return for end of study visit|0|||
131493107|NCT05425745|473432971|FG001|Overall Study|Did not return for end of study visit|1|||
131493108|NCT05425745|473432970|FG000|Overall Study|End of study visit completed by phone|1|||
131493109|NCT05425745|473432971|FG001|Overall Study|End of study visit completed by phone|0|||
131493110|NCT05425745|473432970|FG000|Overall Study|Subject decision|1|||
131493111|NCT05425745|473432971|FG001|Overall Study|Subject decision|0|||
131493112|NCT02674529|473434636|FG000|Overall Study|Lost to Follow-up|1|||
131493113|NCT02674529|473434637|FG001|Overall Study|Lost to Follow-up|2|||
131493114|NCT02674529|473434636|FG000|Overall Study|Withdrawal by Subject|2|||
131493115|NCT02674529|473434637|FG001|Overall Study|Withdrawal by Subject|1|||
131493116|NCT02674529|473434636|FG000|Overall Study|Physician Decision|0|||
131493117|NCT02674529|473434637|FG001|Overall Study|Physician Decision|1|||
131493118|NCT02674529|473434636|FG000|Overall Study|Protocol Violation|0|||
131493119|NCT02674529|473434637|FG001|Overall Study|Protocol Violation|1|||
131493120|NCT02891850|473434638|FG000|Overall Study|Adverse Event|3|||
131493121|NCT02891850|473434639|FG001|Overall Study|Adverse Event|0|||
131493122|NCT02891850|473434638|FG000|Overall Study|Death|0|||
131493123|NCT02891850|473434639|FG001|Overall Study|Death|4|||
131493124|NCT02891850|473434638|FG000|Overall Study|Physician Decision|1|||
131493125|NCT02891850|473434639|FG001|Overall Study|Physician Decision|0|||
131493126|NCT02891850|473434638|FG000|Overall Study|Pregnancy|1|||
131493127|NCT02891850|473434639|FG001|Overall Study|Pregnancy|0|||
131493128|NCT02891850|473434638|FG000|Overall Study|Withdrawal by Subject|2|||
131493129|NCT02891850|473434639|FG001|Overall Study|Withdrawal by Subject|3|||
131493130|NCT00630396|473434641|FG000|Overall Study|Death|4|||
131493131|NCT00630396|473434641|FG000|Overall Study|Lost to Follow-up|3|||
131493132|NCT00056316|473434642|FG000|Overall Study|Withdrawal by Subject|2|||
131493133|NCT00056316|473434643|FG001|Overall Study|Withdrawal by Subject|2|||
131493134|NCT00056316|473434642|FG000|Overall Study|Death/NH placement of pt|1|||
131493135|NCT00056316|473434643|FG001|Overall Study|Death/NH placement of pt|1|||
131493136|NCT02599129|473434650|FG000|Overall Study|Lack of Efficacy|2|||
131493137|NCT02599129|473434651|FG001|Overall Study|Lack of Efficacy|2|||
131493138|NCT02599129|473434650|FG000|Overall Study|Lost to Follow-up|1|||
131493139|NCT02599129|473434651|FG001|Overall Study|Lost to Follow-up|0|||
131493140|NCT02599129|473434650|FG000|Overall Study|Withdrawal by Subject|2|||
131493141|NCT02599129|473434651|FG001|Overall Study|Withdrawal by Subject|1|||
131493142|NCT03489720|473434654|FG000|Overall Study|Withdrawal by Subject|2|||
131493143|NCT03489720|473434655|FG001|Overall Study|Withdrawal by Subject|0|||
131493144|NCT02270957|473434656|FG000|Overall Study|Lack of Efficacy|2|||
131493145|NCT02270957|473434657|FG001|Overall Study|Lack of Efficacy|4|||
131493146|NCT02270957|473434656|FG000|Overall Study|Adverse Event|2|||
131493147|NCT02270957|473434657|FG001|Overall Study|Adverse Event|0|||
131493148|NCT00545168|473434660|FG000|Overall Study|Lost to Follow-up|5|||
131493149|NCT00545168|473434661|FG001|Overall Study|Lost to Follow-up|5|||
131493150|NCT00545168|473434662|FG002|Overall Study|Lost to Follow-up|5|||
131493151|NCT00545168|473434660|FG000|Overall Study|Withdrawal by Subject|9|||
131493152|NCT00545168|473434661|FG001|Overall Study|Withdrawal by Subject|0|||
131493153|NCT00545168|473434662|FG002|Overall Study|Withdrawal by Subject|13|||
131493154|NCT00545168|473434660|FG000|Overall Study|Protocol Violation|1|||
131493155|NCT00545168|473434661|FG001|Overall Study|Protocol Violation|0|||
131493156|NCT00545168|473434662|FG002|Overall Study|Protocol Violation|1|||
131493157|NCT00545168|473434660|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
131493158|NCT00545168|473434661|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
131493159|NCT00545168|473434662|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
131493160|NCT01218204|473434663|FG000|Part B Washout|Adverse Event|0|||
131493161|NCT01218204|473434664|FG001|Part B Washout|Adverse Event|1|||
131493162|NCT01218204|473434665|FG002|Part B Washout|Adverse Event|0|||
131493163|NCT01218204|473434666|FG003|Part B Washout|Adverse Event|0|||
131493164|NCT01218204|473434663|FG000|Part B Washout|Lost to Follow-up|0|||
131493165|NCT01218204|473434664|FG001|Part B Washout|Lost to Follow-up|2|||
131493166|NCT01218204|473434665|FG002|Part B Washout|Lost to Follow-up|0|||
131493167|NCT01218204|473434666|FG003|Part B Washout|Lost to Follow-up|0|||
131493168|NCT01218204|473434663|FG000|Part B Washout|Physician Decision|0|||
131493169|NCT01218204|473434664|FG001|Part B Washout|Physician Decision|14|||
131493170|NCT01218204|473434665|FG002|Part B Washout|Physician Decision|0|||
131493171|NCT01218204|473434666|FG003|Part B Washout|Physician Decision|0|||
131493172|NCT01218204|473434663|FG000|Part B Washout|Withdrawal by Subject|0|||
131493173|NCT01218204|473434664|FG001|Part B Washout|Withdrawal by Subject|14|||
131493174|NCT01218204|473434665|FG002|Part B Washout|Withdrawal by Subject|0|||
131493175|NCT01218204|473434666|FG003|Part B Washout|Withdrawal by Subject|0|||
131493176|NCT01218204|473434663|FG000|Part B Washout|Reached defined stopping criteria|0|||
131493177|NCT01218204|473434664|FG001|Part B Washout|Reached defined stopping criteria|2|||
131493178|NCT01218204|473434665|FG002|Part B Washout|Reached defined stopping criteria|0|||
131493179|NCT01218204|473434666|FG003|Part B Washout|Reached defined stopping criteria|0|||
131493180|NCT01218204|473434663|FG000|Part B Washout|Did not meet continuation criteria|0|||
131493181|NCT01218204|473434664|FG001|Part B Washout|Did not meet continuation criteria|112|||
131493182|NCT01218204|473434665|FG002|Part B Washout|Did not meet continuation criteria|0|||
131493183|NCT01218204|473434666|FG003|Part B Washout|Did not meet continuation criteria|0|||
131493184|NCT01218204|473434663|FG000|Part B Run-in|Adverse Event|0|||
131493185|NCT01218204|473434664|FG001|Part B Run-in|Adverse Event|0|||
131493186|NCT01218204|473434665|FG002|Part B Run-in|Adverse Event|1|||
131493187|NCT01218204|473434666|FG003|Part B Run-in|Adverse Event|0|||
131493188|NCT01218204|473434663|FG000|Part B Run-in|Protocol Violation|0|||
131493189|NCT01218204|473434664|FG001|Part B Run-in|Protocol Violation|0|||
131493190|NCT01218204|473434665|FG002|Part B Run-in|Protocol Violation|2|||
131493191|NCT01218204|473434666|FG003|Part B Run-in|Protocol Violation|0|||
131493192|NCT01218204|473434663|FG000|Part B Run-in|Withdrawal by Subject|0|||
131493193|NCT01218204|473434664|FG001|Part B Run-in|Withdrawal by Subject|0|||
131493194|NCT01218204|473434665|FG002|Part B Run-in|Withdrawal by Subject|3|||
131493195|NCT01218204|473434666|FG003|Part B Run-in|Withdrawal by Subject|0|||
131493196|NCT01218204|473434663|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
131493197|NCT01218204|473434664|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
131493198|NCT01218204|473434665|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
131493199|NCT01218204|473434666|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
131493200|NCT01218204|473434663|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
131493201|NCT01218204|473434664|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
131493202|NCT01218204|473434665|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
131493203|NCT01218204|473434666|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
131493204|NCT01987505|473434667|FG000|Overall Study|Other|9|||
131493205|NCT01987505|473434667|FG000|Overall Study|Withdrawal by Subject|2|||
131493206|NCT01987505|473434667|FG000|Overall Study|Other Reason|2|||
131493207|NCT01987505|473434667|FG000|Overall Study|Lost to Follow-up|15|||
131493208|NCT01987505|473434667|FG000|Overall Study|Investigator Decision|2|||
131493209|NCT01987505|473434667|FG000|Overall Study|Death|4|||
131493210|NCT03266107|473434668|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
131493211|NCT03266107|473434668|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
131493212|NCT03266107|473434668|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
131493213|NCT03266107|473434668|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
131493214|NCT01191801|473434671|FG000|Overall Study|Death|36|||
131493215|NCT01191801|473434672|FG001|Overall Study|Death|12|||
131493216|NCT01191801|473434671|FG000|Overall Study|Lack of Efficacy|176|||
131493217|NCT01191801|473434672|FG001|Overall Study|Lack of Efficacy|258|||
131493218|NCT01191801|473434671|FG000|Overall Study|Adverse Event|9|||
131493219|NCT01191801|473434672|FG001|Overall Study|Adverse Event|8|||
131493220|NCT01191801|473434671|FG000|Overall Study|Protocol Violation|2|||
131493221|NCT01191801|473434672|FG001|Overall Study|Protocol Violation|4|||
131493222|NCT01191801|473434671|FG000|Overall Study|Physician Decision|47|||
131493223|NCT01191801|473434672|FG001|Overall Study|Physician Decision|24|||
131493224|NCT01191801|473434671|FG000|Overall Study|Withdrawal by Subject|1|||
131493225|NCT01191801|473434672|FG001|Overall Study|Withdrawal by Subject|4|||
131493226|NCT01191801|473434671|FG000|Overall Study|Not Provided|45|||
131493227|NCT01191801|473434672|FG001|Overall Study|Not Provided|27|||
131493228|NCT05147350|473434680|FG000|Overall Study|Death|2|||
131493229|NCT05147350|473434681|FG001|Overall Study|Death|3|||
131493230|NCT05147350|473434682|FG002|Overall Study|Death|3|||
131493231|NCT05147350|473434683|FG003|Overall Study|Death|2|||
131493232|NCT05147350|473434684|FG004|Overall Study|Death|2|||
131493233|NCT05147350|473434685|FG005|Overall Study|Death|1|||
131493234|NCT05147350|473434686|FG006|Overall Study|Death|1|||
131493235|NCT05147350|473434687|FG007|Overall Study|Death|3|||
131493236|NCT05147350|473434680|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
131493237|NCT05147350|473434681|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
131493238|NCT05147350|473434682|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
131493239|NCT05147350|473434683|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
131493240|NCT05147350|473434684|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
131493241|NCT05147350|473434685|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
131493242|NCT05147350|473434686|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
131493243|NCT05147350|473434687|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
131493244|NCT05147350|473434680|FG000|Overall Study|Withdrawal by Subject|0|||
131493245|NCT05147350|473434681|FG001|Overall Study|Withdrawal by Subject|0|||
131493246|NCT05147350|473434682|FG002|Overall Study|Withdrawal by Subject|3|||
131493247|NCT05147350|473434683|FG003|Overall Study|Withdrawal by Subject|1|||
131493248|NCT05147350|473434684|FG004|Overall Study|Withdrawal by Subject|1|||
131493249|NCT05147350|473434685|FG005|Overall Study|Withdrawal by Subject|0|||
131493250|NCT05147350|473434686|FG006|Overall Study|Withdrawal by Subject|1|||
131493251|NCT05147350|473434687|FG007|Overall Study|Withdrawal by Subject|0|||
131493252|NCT05147350|473434680|FG000|Overall Study|Other Reasons|0|||
131493253|NCT05147350|473434681|FG001|Overall Study|Other Reasons|0|||
131493254|NCT05147350|473434682|FG002|Overall Study|Other Reasons|2|||
131493255|NCT05147350|473434683|FG003|Overall Study|Other Reasons|0|||
131493256|NCT05147350|473434684|FG004|Overall Study|Other Reasons|0|||
131493257|NCT05147350|473434685|FG005|Overall Study|Other Reasons|2|||
131493258|NCT05147350|473434686|FG006|Overall Study|Other Reasons|1|||
131493259|NCT05147350|473434687|FG007|Overall Study|Other Reasons|1|||
131493260|NCT01539538|473434688|FG000|Overall Study|Adverse Event|13|||
131493261|NCT01539538|473434689|FG001|Overall Study|Adverse Event|18|||
131493262|NCT01539538|473434688|FG000|Overall Study|Lack of Efficacy|13|||
131493263|NCT01539538|473434689|FG001|Overall Study|Lack of Efficacy|16|||
131493264|NCT01539538|473434688|FG000|Overall Study|Withdrawal by Subject|2|||
131493265|NCT01539538|473434689|FG001|Overall Study|Withdrawal by Subject|3|||
131493266|NCT01539538|473434688|FG000|Overall Study|PCA no longer required or PCA problem|3|||
131493267|NCT01539538|473434689|FG001|Overall Study|PCA no longer required or PCA problem|7|||
131493268|NCT02794883|473434690|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
131493269|NCT02794883|473434691|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
131493270|NCT02794883|473434692|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
131493271|NCT02794883|473434690|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
131493272|NCT02794883|473434691|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
131493273|NCT02794883|473434692|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
131493274|NCT02794883|473434690|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
131493275|NCT02794883|473434691|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
131493276|NCT02794883|473434692|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
131493277|NCT02794883|473434690|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
131493278|NCT02794883|473434691|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
131493279|NCT02794883|473434692|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
131493280|NCT02794883|473434690|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
131493281|NCT02794883|473434691|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
131493282|NCT02794883|473434692|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
131493283|NCT02794883|473434690|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
131493284|NCT02794883|473434691|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
131493285|NCT02794883|473434692|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
131493286|NCT02794883|473434690|FG000|Follow-up Period (up to 2 Years)|Death|12|||
131493287|NCT02794883|473434691|FG001|Follow-up Period (up to 2 Years)|Death|10|||
131493288|NCT02794883|473434692|FG002|Follow-up Period (up to 2 Years)|Death|10|||
131493289|NCT01192516|473434697|FG000|Overall Study|Lost to Follow-up|7|||
131493290|NCT01192516|473434698|FG001|Overall Study|Lost to Follow-up|10|||
131493291|NCT01192516|473434699|FG002|Overall Study|Lost to Follow-up|7|||
131493292|NCT01192516|473434697|FG000|Overall Study|Withdrawal by Subject|4|||
131493293|NCT01192516|473434698|FG001|Overall Study|Withdrawal by Subject|4|||
131493294|NCT01192516|473434699|FG002|Overall Study|Withdrawal by Subject|1|||
131493295|NCT01192516|473434697|FG000|Overall Study|started new treatment|5|||
131493296|NCT01192516|473434698|FG001|Overall Study|started new treatment|1|||
131493297|NCT01192516|473434699|FG002|Overall Study|started new treatment|0|||
131493298|NCT01192516|473434697|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
131493299|NCT01192516|473434698|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
131493300|NCT01192516|473434699|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
131493301|NCT05228132|473434703|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
131493302|NCT05228132|473434703|FG000|Overall Study|Adverse Event|3|||
131493303|NCT05228132|473434703|FG000|Overall Study|Lost to Follow-up|1|||
131493304|NCT05228132|473434703|FG000|Overall Study|Arteriovenous-fistula mature|1|||
131493305|NCT01336764|473434704|FG000|Overall Study|Withdrawal by Subject|5|||
131493306|NCT01336764|473434705|FG001|Overall Study|Withdrawal by Subject|5|||
131493307|NCT00730132|473434706|FG000|Overall Study|Protocol Violation|154|||
131493308|NCT00730132|473434706|FG000|Overall Study|Death|1|||
131493309|NCT00420927|473434707|FG000|Period 1|Adverse Event|19|||
131493310|NCT00420927|473434708|FG001|Period 1|Adverse Event|15|||
131493311|NCT00420927|473434709|FG002|Period 1|Adverse Event|0|||
131493312|NCT00420927|473434710|FG003|Period 1|Adverse Event|0|||
131493313|NCT00420927|473434711|FG004|Period 1|Adverse Event|0|||
131493314|NCT00420927|473434712|FG005|Period 1|Adverse Event|0|||
131493315|NCT00420927|473434713|FG006|Period 1|Adverse Event|0|||
131493316|NCT00420927|473434707|FG000|Period 1|Withdrawal by Subject|7|||
131493317|NCT00420927|473434708|FG001|Period 1|Withdrawal by Subject|12|||
131493318|NCT00420927|473434709|FG002|Period 1|Withdrawal by Subject|0|||
131493319|NCT00420927|473434710|FG003|Period 1|Withdrawal by Subject|0|||
131493320|NCT00420927|473434711|FG004|Period 1|Withdrawal by Subject|0|||
131493321|NCT00420927|473434712|FG005|Period 1|Withdrawal by Subject|0|||
131493322|NCT00420927|473434713|FG006|Period 1|Withdrawal by Subject|0|||
131493323|NCT00420927|473434707|FG000|Period 1|Lost to Follow-up|8|||
131493324|NCT00420927|473434708|FG001|Period 1|Lost to Follow-up|6|||
131493325|NCT00420927|473434709|FG002|Period 1|Lost to Follow-up|0|||
131493326|NCT00420927|473434710|FG003|Period 1|Lost to Follow-up|0|||
131493327|NCT00420927|473434711|FG004|Period 1|Lost to Follow-up|0|||
131493328|NCT00420927|473434712|FG005|Period 1|Lost to Follow-up|0|||
131493329|NCT00420927|473434713|FG006|Period 1|Lost to Follow-up|0|||
131493330|NCT00420927|473434707|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
131493331|NCT00420927|473434708|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
131493332|NCT00420927|473434709|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
131493333|NCT00420927|473434710|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
131493334|NCT00420927|473434711|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
131493335|NCT00420927|473434712|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
131493336|NCT00420927|473434713|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
131493337|NCT00420927|473434707|FG000|Period 1|Death|2|||
131493338|NCT00420927|473434708|FG001|Period 1|Death|0|||
131493339|NCT00420927|473434709|FG002|Period 1|Death|0|||
131493340|NCT00420927|473434710|FG003|Period 1|Death|0|||
131493341|NCT00420927|473434711|FG004|Period 1|Death|0|||
131493342|NCT00420927|473434712|FG005|Period 1|Death|0|||
131493343|NCT00420927|473434713|FG006|Period 1|Death|0|||
131493344|NCT00420927|473434707|FG000|Period 1|Subject moved/relocated|0|||
131493345|NCT00420927|473434708|FG001|Period 1|Subject moved/relocated|2|||
131493346|NCT00420927|473434709|FG002|Period 1|Subject moved/relocated|0|||
131493347|NCT00420927|473434710|FG003|Period 1|Subject moved/relocated|0|||
131493348|NCT00420927|473434711|FG004|Period 1|Subject moved/relocated|0|||
131493349|NCT00420927|473434712|FG005|Period 1|Subject moved/relocated|0|||
131493350|NCT00420927|473434713|FG006|Period 1|Subject moved/relocated|0|||
131493351|NCT00420927|473434707|FG000|Period 1|Noncompliant with study drug|1|||
131493352|NCT00420927|473434708|FG001|Period 1|Noncompliant with study drug|1|||
131493353|NCT00420927|473434709|FG002|Period 1|Noncompliant with study drug|0|||
131493354|NCT00420927|473434710|FG003|Period 1|Noncompliant with study drug|0|||
131493355|NCT00420927|473434711|FG004|Period 1|Noncompliant with study drug|0|||
131493356|NCT00420927|473434712|FG005|Period 1|Noncompliant with study drug|0|||
131493357|NCT00420927|473434713|FG006|Period 1|Noncompliant with study drug|0|||
131493358|NCT00420927|473434707|FG000|Period 1|Randomization error|1|||
131493359|NCT00420927|473434708|FG001|Period 1|Randomization error|0|||
131493360|NCT00420927|473434709|FG002|Period 1|Randomization error|0|||
131493361|NCT00420927|473434710|FG003|Period 1|Randomization error|0|||
131493362|NCT00420927|473434711|FG004|Period 1|Randomization error|0|||
131493363|NCT00420927|473434712|FG005|Period 1|Randomization error|0|||
131493364|NCT00420927|473434713|FG006|Period 1|Randomization error|0|||
131493365|NCT00420927|473434707|FG000|Period 1|Suspected tuberculosis/positive test|1|||
131493366|NCT00420927|473434708|FG001|Period 1|Suspected tuberculosis/positive test|1|||
131493367|NCT00420927|473434709|FG002|Period 1|Suspected tuberculosis/positive test|0|||
131493368|NCT00420927|473434710|FG003|Period 1|Suspected tuberculosis/positive test|0|||
131493369|NCT00420927|473434711|FG004|Period 1|Suspected tuberculosis/positive test|0|||
131493370|NCT00420927|473434712|FG005|Period 1|Suspected tuberculosis/positive test|0|||
131493371|NCT00420927|473434713|FG006|Period 1|Suspected tuberculosis/positive test|0|||
131493372|NCT00420927|473434707|FG000|Period 1|Study site closure|0|||
131493373|NCT00420927|473434708|FG001|Period 1|Study site closure|1|||
131493374|NCT00420927|473434709|FG002|Period 1|Study site closure|0|||
131493375|NCT00420927|473434710|FG003|Period 1|Study site closure|0|||
131493376|NCT00420927|473434711|FG004|Period 1|Study site closure|0|||
131493377|NCT00420927|473434712|FG005|Period 1|Study site closure|0|||
131493378|NCT00420927|473434713|FG006|Period 1|Study site closure|0|||
131493379|NCT00420927|473434707|FG000|Period 1|Subject received new diagnosis|0|||
131493380|NCT00420927|473434708|FG001|Period 1|Subject received new diagnosis|2|||
131493381|NCT00420927|473434709|FG002|Period 1|Subject received new diagnosis|0|||
131493382|NCT00420927|473434710|FG003|Period 1|Subject received new diagnosis|0|||
131493383|NCT00420927|473434711|FG004|Period 1|Subject received new diagnosis|0|||
131493384|NCT00420927|473434712|FG005|Period 1|Subject received new diagnosis|0|||
131493385|NCT00420927|473434713|FG006|Period 1|Subject received new diagnosis|0|||
131493386|NCT00420927|473434707|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
131493387|NCT00420927|473434708|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
131493388|NCT00420927|473434709|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
131493389|NCT00420927|473434710|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
131493390|NCT00420927|473434711|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
131493391|NCT00420927|473434712|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
131493392|NCT00420927|473434713|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
131493393|NCT00420927|473434707|FG000|Period 1|Failed to meet entry criteria|8|||
131493394|NCT00420927|473434708|FG001|Period 1|Failed to meet entry criteria|7|||
131493395|NCT00420927|473434709|FG002|Period 1|Failed to meet entry criteria|0|||
131493396|NCT00420927|473434710|FG003|Period 1|Failed to meet entry criteria|0|||
131493397|NCT00420927|473434711|FG004|Period 1|Failed to meet entry criteria|0|||
131493398|NCT00420927|473434712|FG005|Period 1|Failed to meet entry criteria|0|||
131493399|NCT00420927|473434713|FG006|Period 1|Failed to meet entry criteria|0|||
131493400|NCT00420927|473434707|FG000|Period 1|Took prohibited medication|1|||
131493401|NCT00420927|473434708|FG001|Period 1|Took prohibited medication|3|||
131493402|NCT00420927|473434709|FG002|Period 1|Took prohibited medication|0|||
131493403|NCT00420927|473434710|FG003|Period 1|Took prohibited medication|0|||
131493404|NCT00420927|473434711|FG004|Period 1|Took prohibited medication|0|||
131493405|NCT00420927|473434712|FG005|Period 1|Took prohibited medication|0|||
131493406|NCT00420927|473434713|FG006|Period 1|Took prohibited medication|0|||
131493407|NCT00420927|473434707|FG000|Period 2|Adverse Event|0|||
131493408|NCT00420927|473434708|FG001|Period 2|Adverse Event|0|||
131493409|NCT00420927|473434709|FG002|Period 2|Adverse Event|7|||
131493410|NCT00420927|473434710|FG003|Period 2|Adverse Event|3|||
131493411|NCT00420927|473434711|FG004|Period 2|Adverse Event|17|||
131493412|NCT00420927|473434712|FG005|Period 2|Adverse Event|6|||
131493413|NCT00420927|473434713|FG006|Period 2|Adverse Event|20|||
131493414|NCT00420927|473434707|FG000|Period 2|Withdrawal by Subject|0|||
131493415|NCT00420927|473434708|FG001|Period 2|Withdrawal by Subject|0|||
131493416|NCT00420927|473434709|FG002|Period 2|Withdrawal by Subject|1|||
131493417|NCT00420927|473434710|FG003|Period 2|Withdrawal by Subject|3|||
131493418|NCT00420927|473434711|FG004|Period 2|Withdrawal by Subject|11|||
131493419|NCT00420927|473434712|FG005|Period 2|Withdrawal by Subject|2|||
131493420|NCT00420927|473434713|FG006|Period 2|Withdrawal by Subject|12|||
131493421|NCT00420927|473434707|FG000|Period 2|Lost to Follow-up|0|||
131493422|NCT00420927|473434708|FG001|Period 2|Lost to Follow-up|0|||
131493423|NCT00420927|473434709|FG002|Period 2|Lost to Follow-up|2|||
131493424|NCT00420927|473434710|FG003|Period 2|Lost to Follow-up|2|||
131493425|NCT00420927|473434711|FG004|Period 2|Lost to Follow-up|6|||
131493426|NCT00420927|473434712|FG005|Period 2|Lost to Follow-up|3|||
131493427|NCT00420927|473434713|FG006|Period 2|Lost to Follow-up|9|||
131493428|NCT00420927|473434707|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
131493429|NCT00420927|473434708|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
131493430|NCT00420927|473434709|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
131493431|NCT00420927|473434710|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
131493432|NCT00420927|473434711|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
131493433|NCT00420927|473434712|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
131493434|NCT00420927|473434713|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
131493435|NCT00420927|473434707|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
131493436|NCT00420927|473434708|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
131493437|NCT00420927|473434709|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
131493438|NCT00420927|473434710|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
131493439|NCT00420927|473434711|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
131493440|NCT00420927|473434712|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
131493441|NCT00420927|473434713|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
131493442|NCT00420927|473434707|FG000|Period 2|Subject unable to find transportation|0|||
131493443|NCT00420927|473434708|FG001|Period 2|Subject unable to find transportation|0|||
131493444|NCT00420927|473434709|FG002|Period 2|Subject unable to find transportation|0|||
131493445|NCT00420927|473434710|FG003|Period 2|Subject unable to find transportation|0|||
131493446|NCT00420927|473434711|FG004|Period 2|Subject unable to find transportation|0|||
131493447|NCT00420927|473434712|FG005|Period 2|Subject unable to find transportation|0|||
131493448|NCT00420927|473434713|FG006|Period 2|Subject unable to find transportation|1|||
131493449|NCT00420927|473434707|FG000|Period 2|Physician Decision|0|||
131493450|NCT00420927|473434708|FG001|Period 2|Physician Decision|0|||
131493451|NCT00420927|473434709|FG002|Period 2|Physician Decision|0|||
131493452|NCT00420927|473434710|FG003|Period 2|Physician Decision|0|||
131493453|NCT00420927|473434711|FG004|Period 2|Physician Decision|1|||
131493454|NCT00420927|473434712|FG005|Period 2|Physician Decision|1|||
131493455|NCT00420927|473434713|FG006|Period 2|Physician Decision|0|||
131493456|NCT00420927|473434707|FG000|Period 2|Sponsor decision|0|||
131493457|NCT00420927|473434708|FG001|Period 2|Sponsor decision|0|||
131493458|NCT00420927|473434709|FG002|Period 2|Sponsor decision|1|||
131493459|NCT00420927|473434710|FG003|Period 2|Sponsor decision|0|||
131493460|NCT00420927|473434711|FG004|Period 2|Sponsor decision|0|||
131493461|NCT00420927|473434712|FG005|Period 2|Sponsor decision|0|||
131493462|NCT00420927|473434713|FG006|Period 2|Sponsor decision|1|||
131493463|NCT00420927|473434707|FG000|Period 2|Randomization error|0|||
131493464|NCT00420927|473434708|FG001|Period 2|Randomization error|0|||
131493465|NCT00420927|473434709|FG002|Period 2|Randomization error|0|||
131493466|NCT00420927|473434710|FG003|Period 2|Randomization error|0|||
131493467|NCT00420927|473434711|FG004|Period 2|Randomization error|1|||
131493468|NCT00420927|473434712|FG005|Period 2|Randomization error|1|||
131493469|NCT00420927|473434713|FG006|Period 2|Randomization error|0|||
131493470|NCT00420927|473434707|FG000|Period 2|Noncompliant with study drug|0|||
131493471|NCT00420927|473434708|FG001|Period 2|Noncompliant with study drug|0|||
131493472|NCT00420927|473434709|FG002|Period 2|Noncompliant with study drug|0|||
131493473|NCT00420927|473434710|FG003|Period 2|Noncompliant with study drug|1|||
131493474|NCT00420927|473434711|FG004|Period 2|Noncompliant with study drug|0|||
131493475|NCT00420927|473434712|FG005|Period 2|Noncompliant with study drug|0|||
131493476|NCT00420927|473434713|FG006|Period 2|Noncompliant with study drug|2|||
131493477|NCT00420927|473434707|FG000|Period 2|Methotrexate intolerance|0|||
131493478|NCT00420927|473434708|FG001|Period 2|Methotrexate intolerance|0|||
131493479|NCT00420927|473434709|FG002|Period 2|Methotrexate intolerance|0|||
131493480|NCT00420927|473434710|FG003|Period 2|Methotrexate intolerance|0|||
131493481|NCT00420927|473434711|FG004|Period 2|Methotrexate intolerance|0|||
131493482|NCT00420927|473434712|FG005|Period 2|Methotrexate intolerance|0|||
131493483|NCT00420927|473434713|FG006|Period 2|Methotrexate intolerance|1|||
131493484|NCT00420927|473434707|FG000|Period 2|Took prohibited medication|0|||
131493485|NCT00420927|473434708|FG001|Period 2|Took prohibited medication|0|||
131493486|NCT00420927|473434709|FG002|Period 2|Took prohibited medication|0|||
131493487|NCT00420927|473434710|FG003|Period 2|Took prohibited medication|0|||
131493488|NCT00420927|473434711|FG004|Period 2|Took prohibited medication|1|||
131493489|NCT00420927|473434712|FG005|Period 2|Took prohibited medication|0|||
131493490|NCT00420927|473434713|FG006|Period 2|Took prohibited medication|0|||
131493491|NCT00320411|473434714|FG000|Overall Study|No investigational product admin.|4|||
131493492|NCT02088047|473434715|FG000|Overall Study|Withdrawal by Subject|1|||
131493493|NCT02088047|473434716|FG001|Overall Study|Withdrawal by Subject|0|||
131493494|NCT00459953|473434718|FG000|Overall Study|not analyzed-household member in study|1|||
131493495|NCT00459953|473434719|FG001|Overall Study|not analyzed-household member in study|1|||
131493496|NCT00040664|473434720|FG000|Overall Study|Adverse Event|12|||
131493497|NCT00040664|473434721|FG001|Overall Study|Adverse Event|3|||
131493498|NCT00040664|473434722|FG002|Overall Study|Adverse Event|2|||
131493499|NCT00040664|473434723|FG003|Overall Study|Adverse Event|7|||
131493500|NCT00040664|473434720|FG000|Overall Study|Lack of Efficacy|9|||
131493501|NCT00040664|473434721|FG001|Overall Study|Lack of Efficacy|2|||
131493502|NCT00040664|473434722|FG002|Overall Study|Lack of Efficacy|3|||
131493503|NCT00040664|473434723|FG003|Overall Study|Lack of Efficacy|4|||
131493504|NCT00040664|473434720|FG000|Overall Study|Insufficient CD4 response|1|||
131493505|NCT00040664|473434721|FG001|Overall Study|Insufficient CD4 response|0|||
131493506|NCT00040664|473434722|FG002|Overall Study|Insufficient CD4 response|1|||
131493507|NCT00040664|473434723|FG003|Overall Study|Insufficient CD4 response|0|||
131493508|NCT00040664|473434720|FG000|Overall Study|Lost to Follow-up|4|||
131493509|NCT00040664|473434721|FG001|Overall Study|Lost to Follow-up|2|||
131493510|NCT00040664|473434722|FG002|Overall Study|Lost to Follow-up|0|||
131493511|NCT00040664|473434723|FG003|Overall Study|Lost to Follow-up|2|||
131493512|NCT00040664|473434720|FG000|Overall Study|Protocol Violation|2|||
131493513|NCT00040664|473434721|FG001|Overall Study|Protocol Violation|1|||
131493514|NCT00040664|473434722|FG002|Overall Study|Protocol Violation|0|||
131493515|NCT00040664|473434723|FG003|Overall Study|Protocol Violation|1|||
131493516|NCT00040664|473434720|FG000|Overall Study|Withdrawal by Subject|7|||
131493517|NCT00040664|473434721|FG001|Overall Study|Withdrawal by Subject|0|||
131493518|NCT00040664|473434722|FG002|Overall Study|Withdrawal by Subject|3|||
131493519|NCT00040664|473434723|FG003|Overall Study|Withdrawal by Subject|4|||
131493520|NCT00040664|473434720|FG000|Overall Study|Pregnancy|3|||
131493521|NCT00040664|473434721|FG001|Overall Study|Pregnancy|0|||
131493522|NCT00040664|473434722|FG002|Overall Study|Pregnancy|0|||
131493523|NCT00040664|473434723|FG003|Overall Study|Pregnancy|3|||
131493524|NCT00040664|473434720|FG000|Overall Study|Medication adherence/compliance problems|8|||
131493525|NCT00040664|473434721|FG001|Overall Study|Medication adherence/compliance problems|2|||
131493526|NCT00040664|473434722|FG002|Overall Study|Medication adherence/compliance problems|1|||
131493527|NCT00040664|473434723|FG003|Overall Study|Medication adherence/compliance problems|5|||
131493528|NCT00040664|473434720|FG000|Overall Study|Poor taste|2|||
131493529|NCT00040664|473434721|FG001|Overall Study|Poor taste|0|||
131493530|NCT00040664|473434722|FG002|Overall Study|Poor taste|2|||
131493531|NCT00040664|473434723|FG003|Overall Study|Poor taste|0|||
131493532|NCT00040664|473434720|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
131493533|NCT00040664|473434721|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
131493534|NCT00040664|473434722|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
131493535|NCT00040664|473434723|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
131493536|NCT00040664|473434720|FG000|Overall Study|Change of formulation|2|||
131493537|NCT00040664|473434721|FG001|Overall Study|Change of formulation|2|||
131493538|NCT00040664|473434722|FG002|Overall Study|Change of formulation|0|||
131493539|NCT00040664|473434723|FG003|Overall Study|Change of formulation|0|||
131493540|NCT00040664|473434720|FG000|Overall Study|Non-viability of oral suspension|1|||
131493541|NCT00040664|473434721|FG001|Overall Study|Non-viability of oral suspension|0|||
131493542|NCT00040664|473434722|FG002|Overall Study|Non-viability of oral suspension|1|||
131493543|NCT00040664|473434723|FG003|Overall Study|Non-viability of oral suspension|0|||
131493544|NCT01233258|473434725|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
131493545|NCT01233258|473434726|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
131493546|NCT01233258|473434727|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
131493547|NCT01233258|473434728|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
131493548|NCT01233258|473434729|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
131493549|NCT01233258|473434730|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
131493550|NCT01233258|473434725|FG000|First Intervention (6 Months)|Protocol Violation|0|||
131493551|NCT01233258|473434726|FG001|First Intervention (6 Months)|Protocol Violation|0|||
131493552|NCT01233258|473434727|FG002|First Intervention (6 Months)|Protocol Violation|1|||
131493553|NCT01233258|473434728|FG003|First Intervention (6 Months)|Protocol Violation|0|||
131493554|NCT01233258|473434729|FG004|First Intervention (6 Months)|Protocol Violation|0|||
131493555|NCT01233258|473434730|FG005|First Intervention (6 Months)|Protocol Violation|0|||
131493556|NCT01233258|473434725|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
131493557|NCT01233258|473434726|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
131493558|NCT01233258|473434727|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
131493559|NCT01233258|473434728|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
131493560|NCT01233258|473434729|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
131493561|NCT01233258|473434730|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
131493562|NCT01049308|473434731|FG000|Pill Counts|Withdrawal by Subject|83|||
131493563|NCT03926169|473434736|FG000|Period A|Adverse Event|2|||
131493564|NCT03926169|473434737|FG001|Period A|Adverse Event|2|||
131493565|NCT03926169|473434738|FG002|Period A|Adverse Event|1|||
131493566|NCT03926169|473434736|FG000|Period A|Withdrawal by Subject|2|||
131493567|NCT03926169|473434737|FG001|Period A|Withdrawal by Subject|2|||
131493568|NCT03926169|473434738|FG002|Period A|Withdrawal by Subject|2|||
131493569|NCT03926169|473434736|FG000|Period A|Lost to Follow-up|3|||
131493570|NCT03926169|473434737|FG001|Period A|Lost to Follow-up|1|||
131493571|NCT03926169|473434738|FG002|Period A|Lost to Follow-up|0|||
131493572|NCT03926169|473434736|FG000|Period A|Lack of Efficacy|0|||
131493573|NCT03926169|473434737|FG001|Period A|Lack of Efficacy|2|||
131493574|NCT03926169|473434738|FG002|Period A|Lack of Efficacy|2|||
131493575|NCT03926169|473434736|FG000|Period A|COVID-19 Infection|0|||
131493576|NCT03926169|473434737|FG001|Period A|COVID-19 Infection|1|||
131493577|NCT03926169|473434738|FG002|Period A|COVID-19 Infection|0|||
131493578|NCT03926169|473434736|FG000|Period A|COVID-19 Logistical Restrictions|0|||
131493579|NCT03926169|473434737|FG001|Period A|COVID-19 Logistical Restrictions|2|||
131493580|NCT03926169|473434738|FG002|Period A|COVID-19 Logistical Restrictions|1|||
131493581|NCT03926169|473434736|FG000|Period A|Other, Not Specified|1|||
131493582|NCT03926169|473434737|FG001|Period A|Other, Not Specified|0|||
131493583|NCT03926169|473434738|FG002|Period A|Other, Not Specified|0|||
131493584|NCT03926169|473434736|FG000|Period B|Adverse Event|3|||
131493585|NCT03926169|473434737|FG001|Period B|Adverse Event|1|||
131493586|NCT03926169|473434738|FG002|Period B|Adverse Event|1|||
131493587|NCT03926169|473434736|FG000|Period B|Withdrawal by Subject|1|||
131493588|NCT03926169|473434737|FG001|Period B|Withdrawal by Subject|3|||
131493589|NCT03926169|473434738|FG002|Period B|Withdrawal by Subject|0|||
131493590|NCT03926169|473434736|FG000|Period B|Lack of Efficacy|3|||
131493591|NCT03926169|473434737|FG001|Period B|Lack of Efficacy|1|||
131493592|NCT03926169|473434738|FG002|Period B|Lack of Efficacy|1|||
131493593|NCT03926169|473434736|FG000|Period B|Lost to Follow-up|1|||
131493594|NCT03926169|473434737|FG001|Period B|Lost to Follow-up|1|||
131493595|NCT03926169|473434738|FG002|Period B|Lost to Follow-up|4|||
131493596|NCT03926169|473434736|FG000|Period B|Other, Not Specified|62|||
131493597|NCT03926169|473434737|FG001|Period B|Other, Not Specified|57|||
131493598|NCT03926169|473434738|FG002|Period B|Other, Not Specified|65|||
131493599|NCT01032837|473434739|FG000|Overall Study|Adverse event/internal illness|0|||
131493600|NCT01032837|473434740|FG001|Overall Study|Adverse event/internal illness|1|||
131493601|NCT01032837|473434741|FG002|Overall Study|Adverse event/internal illness|0|||
131493602|NCT01032837|473434742|FG003|Overall Study|Adverse event/internal illness|1|||
131493603|NCT01032837|473434739|FG000|Overall Study|Withdrew consent|0|||
131493604|NCT01032837|473434740|FG001|Overall Study|Withdrew consent|2|||
131493605|NCT01032837|473434741|FG002|Overall Study|Withdrew consent|0|||
131493606|NCT01032837|473434742|FG003|Overall Study|Withdrew consent|1|||
131493607|NCT01032837|473434739|FG000|Overall Study|Failed to return|0|||
131493608|NCT01032837|473434740|FG001|Overall Study|Failed to return|0|||
131493609|NCT01032837|473434741|FG002|Overall Study|Failed to return|1|||
131493610|NCT01032837|473434742|FG003|Overall Study|Failed to return|0|||
131493611|NCT01032837|473434739|FG000|Overall Study|Refused treatment|0|||
131493612|NCT01032837|473434740|FG001|Overall Study|Refused treatment|0|||
131493613|NCT01032837|473434741|FG002|Overall Study|Refused treatment|0|||
131493614|NCT01032837|473434742|FG003|Overall Study|Refused treatment|1|||
131493615|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
131493616|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
131493617|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
131493618|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
131493619|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
131493620|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
131493621|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
131493622|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
131493623|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
131493624|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
131493625|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
131493626|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
131493627|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
131493628|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
131493629|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
131493630|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
131493631|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
131493632|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
131493633|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
131493634|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
131493635|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
131493636|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
131493637|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
131493638|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
131493639|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
131493640|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
131493641|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
131493642|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
131493643|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
131493644|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
131493645|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
131493646|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
131493647|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
131493648|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
131493649|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
131493650|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
131493651|NCT00843024|473434743|FG000|Single-blind Placebo Run-In Phase|Other|0|||
131493652|NCT00843024|473434744|FG001|Single-blind Placebo Run-In Phase|Other|1|||
131493653|NCT00843024|473434745|FG002|Single-blind Placebo Run-In Phase|Other|0|||
131493654|NCT00843024|473434746|FG003|Single-blind Placebo Run-In Phase|Other|0|||
131493655|NCT00843024|473434747|FG004|Single-blind Placebo Run-In Phase|Other|0|||
131493656|NCT00843024|473434748|FG005|Single-blind Placebo Run-In Phase|Other|0|||
131493657|NCT00843024|473434743|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
131493658|NCT00843024|473434744|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
131493659|NCT00843024|473434745|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
131493660|NCT00843024|473434746|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
131493661|NCT00843024|473434747|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
131493662|NCT00843024|473434748|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
131493663|NCT00843024|473434743|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131493664|NCT00843024|473434744|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
131493665|NCT00843024|473434745|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
131493666|NCT00843024|473434746|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
131493667|NCT00843024|473434747|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
131493668|NCT00843024|473434748|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
131493669|NCT00843024|473434743|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131493670|NCT00843024|473434744|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131493671|NCT00843024|473434745|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131493672|NCT00843024|473434746|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
131493673|NCT00843024|473434747|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131493674|NCT00843024|473434748|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
131493675|NCT00843024|473434743|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
131493676|NCT00843024|473434744|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
131493677|NCT00843024|473434745|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
131493678|NCT00843024|473434746|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
131493679|NCT00843024|473434747|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
131493680|NCT00843024|473434748|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
131493681|NCT00843024|473434743|FG000|Double-blind Treatment Phase|Physician Decision|0|||
131493682|NCT00843024|473434744|FG001|Double-blind Treatment Phase|Physician Decision|0|||
131493683|NCT00843024|473434745|FG002|Double-blind Treatment Phase|Physician Decision|0|||
131493684|NCT00843024|473434746|FG003|Double-blind Treatment Phase|Physician Decision|3|||
131493685|NCT00843024|473434747|FG004|Double-blind Treatment Phase|Physician Decision|1|||
131493686|NCT00843024|473434748|FG005|Double-blind Treatment Phase|Physician Decision|1|||
131493687|NCT00843024|473434743|FG000|Double-blind Treatment Phase|Adverse Event|0|||
131493688|NCT00843024|473434744|FG001|Double-blind Treatment Phase|Adverse Event|0|||
131493689|NCT00843024|473434745|FG002|Double-blind Treatment Phase|Adverse Event|0|||
131493690|NCT00843024|473434746|FG003|Double-blind Treatment Phase|Adverse Event|0|||
131493691|NCT00843024|473434747|FG004|Double-blind Treatment Phase|Adverse Event|1|||
131493692|NCT00843024|473434748|FG005|Double-blind Treatment Phase|Adverse Event|1|||
131493693|NCT00843024|473434743|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
131493694|NCT00843024|473434744|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
131493695|NCT00843024|473434745|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
131493696|NCT00843024|473434746|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
131493697|NCT00843024|473434747|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
131493698|NCT00843024|473434748|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
131493699|NCT02439138|473434750|FG000|Overall Study|Adverse Event|1|||
131493700|NCT02439138|473434750|FG000|Overall Study|PI decision to terminate the study|2|||
131493701|NCT02615145|473434755|FG000|Overall Study|Did Not Start Treatment|0|||
131493702|NCT02615145|473434756|FG001|Overall Study|Did Not Start Treatment|0|||
131493703|NCT02615145|473434757|FG002|Overall Study|Did Not Start Treatment|1|||
131493704|NCT02615145|473434758|FG003|Overall Study|Did Not Start Treatment|1|||
131493705|NCT02615145|473434755|FG000|Overall Study|Failure to Return|20|||
131493706|NCT02615145|473434756|FG001|Overall Study|Failure to Return|10|||
131493707|NCT02615145|473434757|FG002|Overall Study|Failure to Return|7|||
131493708|NCT02615145|473434758|FG003|Overall Study|Failure to Return|0|||
131493709|NCT02615145|473434755|FG000|Overall Study|Death|2|||
131493710|NCT02615145|473434756|FG001|Overall Study|Death|3|||
131493711|NCT02615145|473434757|FG002|Overall Study|Death|0|||
131493712|NCT02615145|473434758|FG003|Overall Study|Death|0|||
131493713|NCT02615145|473434755|FG000|Overall Study|Other, Not Specified|5|||
131493714|NCT02615145|473434756|FG001|Overall Study|Other, Not Specified|2|||
131493715|NCT02615145|473434757|FG002|Overall Study|Other, Not Specified|0|||
131493716|NCT02615145|473434758|FG003|Overall Study|Other, Not Specified|0|||
131493717|NCT00006237|473434761|FG000|Overall Study|Adverse Event|39|||
131493718|NCT00006237|473434762|FG001|Overall Study|Adverse Event|29|||
131493719|NCT00006237|473434761|FG000|Overall Study|Death|1|||
131493720|NCT00006237|473434762|FG001|Overall Study|Death|0|||
131493721|NCT00006237|473434761|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
131493722|NCT00006237|473434762|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
131493723|NCT00006237|473434761|FG000|Overall Study|Progression/relapse|54|||
131493724|NCT00006237|473434762|FG001|Overall Study|Progression/relapse|2|||
131493725|NCT00006237|473434761|FG000|Overall Study|Not eligible|9|||
131493726|NCT00006237|473434762|FG001|Overall Study|Not eligible|20|||
131493727|NCT00006237|473434761|FG000|Overall Study|Withdrawal by Subject|0|||
131493728|NCT00006237|473434762|FG001|Overall Study|Withdrawal by Subject|1|||
131493729|NCT00006237|473434761|FG000|Overall Study|Not protocol specified|14|||
131493730|NCT00006237|473434762|FG001|Overall Study|Not protocol specified|5|||
131493731|NCT01846416|473434765|FG000|Treatment Phase|Death|2|||
131493732|NCT01846416|473434766|FG001|Treatment Phase|Death|9|||
131493733|NCT01846416|473434767|FG002|Treatment Phase|Death|1|||
131493734|NCT01846416|473434765|FG000|Treatment Phase|Withdrawal by Subject|2|||
131493735|NCT01846416|473434766|FG001|Treatment Phase|Withdrawal by Subject|4|||
131493736|NCT01846416|473434767|FG002|Treatment Phase|Withdrawal by Subject|2|||
131493737|NCT01846416|473434765|FG000|Treatment Phase|Other|1|||
131493738|NCT01846416|473434766|FG001|Treatment Phase|Other|5|||
131493739|NCT01846416|473434767|FG002|Treatment Phase|Other|1|||
131493740|NCT01846416|473434765|FG000|Treatment Phase|Physician Decision|1|||
131493741|NCT01846416|473434766|FG001|Treatment Phase|Physician Decision|2|||
131493742|NCT01846416|473434767|FG002|Treatment Phase|Physician Decision|0|||
131493743|NCT01846416|473434765|FG000|Treatment Phase|Adverse Event|3|||
131493744|NCT01846416|473434766|FG001|Treatment Phase|Adverse Event|4|||
131493745|NCT01846416|473434767|FG002|Treatment Phase|Adverse Event|0|||
131493746|NCT01846416|473434765|FG000|Treatment Phase|Non-compliance|0|||
131493747|NCT01846416|473434766|FG001|Treatment Phase|Non-compliance|2|||
131493748|NCT01846416|473434767|FG002|Treatment Phase|Non-compliance|0|||
131493749|NCT01846416|473434765|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
131493750|NCT01846416|473434766|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
131493751|NCT01846416|473434767|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
131493752|NCT01846416|473434765|FG000|Treatment Phase|Progressive Disease|21|||
131493753|NCT01846416|473434766|FG001|Treatment Phase|Progressive Disease|63|||
131493754|NCT01846416|473434767|FG002|Treatment Phase|Progressive Disease|9|||
131493755|NCT01846416|473434765|FG000|Survival Follow-up|Death|21|||
131493756|NCT01846416|473434766|FG001|Survival Follow-up|Death|62|||
131493757|NCT01846416|473434767|FG002|Survival Follow-up|Death|9|||
131493758|NCT01846416|473434765|FG000|Survival Follow-up|Lost to Follow-up|0|||
131493759|NCT01846416|473434766|FG001|Survival Follow-up|Lost to Follow-up|2|||
131493760|NCT01846416|473434767|FG002|Survival Follow-up|Lost to Follow-up|2|||
131493761|NCT01846416|473434765|FG000|Survival Follow-up|Withdrawal by Subject|2|||
131493762|NCT01846416|473434766|FG001|Survival Follow-up|Withdrawal by Subject|7|||
131493763|NCT01846416|473434767|FG002|Survival Follow-up|Withdrawal by Subject|0|||
131493764|NCT01846416|473434765|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
131493765|NCT01846416|473434766|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
131493766|NCT01846416|473434767|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
131493767|NCT01846416|473434765|FG000|Survival Follow-up|Other|3|||
131493768|NCT01846416|473434766|FG001|Survival Follow-up|Other|1|||
131493769|NCT01846416|473434767|FG002|Survival Follow-up|Other|1|||
131493770|NCT02837783|473434770|FG000|Overall Study|Adverse Event|1|||
131493771|NCT02837783|473434771|FG001|Overall Study|Adverse Event|0|||
131493772|NCT02837783|473434770|FG000|Overall Study|Other, Not Specified|1|||
131493773|NCT02837783|473434771|FG001|Overall Study|Other, Not Specified|2|||
131493774|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
131493775|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
131493776|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
131493777|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493778|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493779|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493780|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493781|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493782|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493783|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493784|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
131493785|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
131493786|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493787|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
131493788|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493789|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493790|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493791|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493792|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493793|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493794|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493795|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
131493796|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
131493797|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
131493798|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
131493799|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493800|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493801|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493802|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493803|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493804|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493805|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493806|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131493807|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
131493808|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
131493809|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493810|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493811|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493812|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493813|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493814|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493815|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493816|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493817|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
131493818|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
131493819|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
131493820|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
131493821|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493822|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493823|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493824|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493825|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493826|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493827|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493828|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
131493829|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493830|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
131493831|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
131493832|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493833|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493834|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493835|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493836|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493837|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493838|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493839|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
131493840|NCT02207244|473434772|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493841|NCT02207244|473434773|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
131493842|NCT02207244|473434774|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493843|NCT02207244|473434775|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493844|NCT02207244|473434776|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493845|NCT02207244|473434777|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493846|NCT02207244|473434778|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493847|NCT02207244|473434779|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493848|NCT02207244|473434780|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493849|NCT02207244|473434781|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493850|NCT02207244|473434782|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
131493851|NCT02207244|473434772|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493852|NCT02207244|473434773|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493853|NCT02207244|473434774|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493854|NCT02207244|473434775|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493855|NCT02207244|473434776|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
131493856|NCT02207244|473434777|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
131493857|NCT02207244|473434778|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493858|NCT02207244|473434779|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493859|NCT02207244|473434780|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493860|NCT02207244|473434781|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493861|NCT02207244|473434782|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
131493862|NCT02207244|473434772|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493863|NCT02207244|473434773|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493864|NCT02207244|473434774|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493865|NCT02207244|473434775|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493866|NCT02207244|473434776|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493867|NCT02207244|473434777|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
131493868|NCT02207244|473434778|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493869|NCT02207244|473434779|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493870|NCT02207244|473434780|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493871|NCT02207244|473434781|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493872|NCT02207244|473434782|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131493873|NCT02207244|473434772|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493874|NCT02207244|473434773|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493875|NCT02207244|473434774|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493876|NCT02207244|473434775|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
131493877|NCT02207244|473434776|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
131493878|NCT02207244|473434777|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
131493879|NCT02207244|473434778|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493880|NCT02207244|473434779|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493881|NCT02207244|473434780|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493882|NCT02207244|473434781|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493883|NCT02207244|473434782|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
131493884|NCT02207244|473434772|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493885|NCT02207244|473434773|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493886|NCT02207244|473434774|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493887|NCT02207244|473434775|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
131493888|NCT02207244|473434776|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
131493889|NCT02207244|473434777|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
131493890|NCT02207244|473434778|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493891|NCT02207244|473434779|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493892|NCT02207244|473434780|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493893|NCT02207244|473434781|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493894|NCT02207244|473434782|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
131493895|NCT02207244|473434772|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493896|NCT02207244|473434773|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493897|NCT02207244|473434774|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493898|NCT02207244|473434775|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
131493899|NCT02207244|473434776|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493900|NCT02207244|473434777|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
131493901|NCT02207244|473434778|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493902|NCT02207244|473434779|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493903|NCT02207244|473434780|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493904|NCT02207244|473434781|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493905|NCT02207244|473434782|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
131493906|NCT02207244|473434772|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493907|NCT02207244|473434773|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493908|NCT02207244|473434774|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493909|NCT02207244|473434775|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
131493910|NCT02207244|473434776|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493911|NCT02207244|473434777|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493912|NCT02207244|473434778|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493913|NCT02207244|473434779|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493914|NCT02207244|473434780|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493915|NCT02207244|473434781|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493916|NCT02207244|473434782|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
131493917|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493918|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493919|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493920|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493921|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493922|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493923|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
131493924|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
131493925|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
131493926|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
131493927|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
131493928|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493929|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493930|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493931|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493932|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493933|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493934|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493935|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
131493936|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493937|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493938|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131493939|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493940|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493941|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493942|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493943|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493944|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493945|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
131493946|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
131493947|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
131493948|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
131493949|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
131493950|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493951|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493952|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493953|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493954|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493955|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493956|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
131493957|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
131493958|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493959|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
131493960|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
131493961|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493962|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493963|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493964|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493965|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493966|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493967|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
131493968|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
131493969|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
131493970|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
131493971|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
131493972|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493973|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493974|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493975|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493976|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493977|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493978|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493979|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
131493980|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
131493981|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493982|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
131493983|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493984|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493985|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493986|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493987|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493988|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493989|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493990|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493991|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
131493992|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493993|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
131493994|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131493995|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131493996|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131493997|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131493998|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131493999|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131494000|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131494001|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
131494002|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131494003|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131494004|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
131494005|NCT02207244|473434772|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494006|NCT02207244|473434773|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494007|NCT02207244|473434774|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494008|NCT02207244|473434775|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494009|NCT02207244|473434776|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494010|NCT02207244|473434777|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494011|NCT02207244|473434778|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
131494012|NCT02207244|473434779|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494013|NCT02207244|473434780|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494014|NCT02207244|473434781|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494015|NCT02207244|473434782|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
131494016|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494017|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494018|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494019|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494020|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494021|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494022|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494023|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494024|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
131494025|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
131494026|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
131494027|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494028|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494029|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494030|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494031|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494032|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494033|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494034|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494035|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
131494036|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
131494037|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
131494038|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494039|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494040|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494041|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494042|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494043|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494044|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494045|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494046|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
131494047|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
131494048|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
131494049|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494050|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494051|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494052|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494053|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494054|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494055|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494056|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494057|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
131494058|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131494059|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
131494060|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
131494061|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
131494062|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
131494063|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
131494064|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
131494065|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
131494066|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
131494067|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
131494068|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
131494069|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
131494070|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
131494071|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
131494072|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
131494073|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
131494074|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
131494075|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
131494076|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
131494077|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
131494078|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
131494079|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
131494080|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
131494081|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
131494082|NCT02207244|473434772|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494083|NCT02207244|473434773|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494084|NCT02207244|473434774|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494085|NCT02207244|473434775|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494086|NCT02207244|473434776|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494087|NCT02207244|473434777|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494088|NCT02207244|473434778|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494089|NCT02207244|473434779|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494090|NCT02207244|473434780|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494091|NCT02207244|473434781|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
131494092|NCT02207244|473434782|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
131494093|NCT00039130|473434783|FG000|Overall Study|Adverse Event|11|||
131494094|NCT00039130|473434783|FG000|Overall Study|Death|9|||
131494095|NCT00039130|473434783|FG000|Overall Study|Withdrawal by Subject|3|||
131494096|NCT00039130|473434783|FG000|Overall Study|Progression|2|||
131494097|NCT00039130|473434783|FG000|Overall Study|Subsequent treatment|2|||
131494098|NCT00039130|473434783|FG000|Overall Study|Physician Decision|3|||
131494099|NCT01950741|473434784|FG000|Overall Study|Lost to Follow-up|1|||
131494100|NCT01950741|473434784|FG000|Overall Study|Death|1|||
131494101|NCT01950741|473434784|FG000|Overall Study|Withdrawal by Subject|1|||
131494102|NCT03648983|473434785|FG000|Overall Study|Study was terminated due to PI departure|95|||
131494103|NCT01866930|473434786|FG000|Treatment Period|Other|1|||
131494104|NCT01866930|473434787|FG001|Treatment Period|Other|0|||
131494105|NCT01866930|473434786|FG000|Treatment Period|Death|0|||
131494106|NCT01866930|473434787|FG001|Treatment Period|Death|2|||
131494107|NCT01866930|473434786|FG000|Treatment Period|Poor/non compliance|0|||
131494108|NCT01866930|473434787|FG001|Treatment Period|Poor/non compliance|2|||
131494109|NCT01866930|473434786|FG000|Treatment Period|No longer meets study criteria|0|||
131494110|NCT01866930|473434787|FG001|Treatment Period|No longer meets study criteria|1|||
131494111|NCT01866930|473434786|FG000|Treatment Period|Withdrawal by Subject|2|||
131494112|NCT01866930|473434787|FG001|Treatment Period|Withdrawal by Subject|8|||
131494113|NCT01866930|473434786|FG000|Treatment Period|Lack of Efficacy|1|||
131494114|NCT01866930|473434787|FG001|Treatment Period|Lack of Efficacy|9|||
131494115|NCT01866930|473434786|FG000|Treatment Period|Adverse Event|4|||
131494116|NCT01866930|473434787|FG001|Treatment Period|Adverse Event|12|||
131494117|NCT01866930|473434786|FG000|Treatment Period|Lost to Follow-up|1|||
131494118|NCT01866930|473434787|FG001|Treatment Period|Lost to Follow-up|1|||
131494119|NCT01866930|473434786|FG000|Follow-up Period|Lost to Follow-up|1|||
131494120|NCT01866930|473434787|FG001|Follow-up Period|Lost to Follow-up|1|||
131494121|NCT01866930|473434786|FG000|Follow-up Period|Other|1|||
131494122|NCT01866930|473434787|FG001|Follow-up Period|Other|5|||
131494123|NCT01866930|473434786|FG000|Follow-up Period|No longer required per protocol|1|||
131494124|NCT01866930|473434787|FG001|Follow-up Period|No longer required per protocol|0|||
131494125|NCT01866930|473434786|FG000|Follow-up Period|Withdrawal by Subject|3|||
131494126|NCT01866930|473434787|FG001|Follow-up Period|Withdrawal by Subject|3|||
131494127|NCT02862171|473434788|FG000|Overall Study|Death|1|||
131494128|NCT02862171|473434788|FG000|Overall Study|Lost to Follow-up|13|||
131494129|NCT02862171|473434788|FG000|Overall Study|Withdrawal by Subject|57|||
131494130|NCT02862171|473434788|FG000|Overall Study|Non-compliance|4|||
131494131|NCT02862171|473434788|FG000|Overall Study|HIV-1 seroconversion|18|||
131494132|NCT02144012|473434789|FG000|Overall Study|Adverse Event|1|||
131494133|NCT02144012|473434790|FG001|Overall Study|Adverse Event|0|||
131494134|NCT02144012|473434789|FG000|Overall Study|Death|1|||
131494135|NCT02144012|473434790|FG001|Overall Study|Death|0|||
131494136|NCT02144012|473434789|FG000|Overall Study|Withdrawal by Subject|11|||
131494137|NCT02144012|473434790|FG001|Overall Study|Withdrawal by Subject|3|||
131494138|NCT02144012|473434789|FG000|Overall Study|Study Terminated by Sponsor|18|||
131494139|NCT02144012|473434790|FG001|Overall Study|Study Terminated by Sponsor|12|||
131494140|NCT02144012|473434789|FG000|Overall Study|Other|3|||
131494141|NCT02144012|473434790|FG001|Overall Study|Other|0|||
131494142|NCT04492618|473436191|FG000|Overall Study|Withdrawal by Subject|1|||
131494143|NCT00127660|473436198|FG000|Overall Study|Protocol Violation|3|||
131494144|NCT00127660|473436199|FG001|Overall Study|Protocol Violation|3|||
131494145|NCT00127660|473436200|FG002|Overall Study|Protocol Violation|5|||
131494146|NCT00127660|473436201|FG003|Overall Study|Protocol Violation|0|||
131494147|NCT00171730|473436203|FG000|Overall Study|Adverse Event|3|||
131494148|NCT00171730|473436203|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
131494149|NCT00171730|473436203|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
131494150|NCT00171730|473436203|FG000|Overall Study|Withdrawal by Subject|3|||
131494151|NCT03018704|473436204|FG000|Overall Study|Lost to Follow-up|1|||
131494152|NCT03018704|473436205|FG001|Overall Study|Lost to Follow-up|1|||
131494153|NCT04448171|473436206|FG000|Overall Study|Procedure Cancelled|1|||
131494154|NCT04448171|473436207|FG001|Overall Study|Procedure Cancelled|0|||
131494155|NCT04448171|473436206|FG000|Overall Study|Protocol Violation|1|||
131494156|NCT04448171|473436207|FG001|Overall Study|Protocol Violation|0|||
131494157|NCT04605484|473436212|FG000|Overall Study|Lost to Follow-up|0|||
131494158|NCT04605484|473436213|FG001|Overall Study|Lost to Follow-up|1|||
131494159|NCT04605484|473436214|FG002|Overall Study|Lost to Follow-up|1|||
131494160|NCT04605484|473436212|FG000|Overall Study|Other|0|||
131494161|NCT04605484|473436213|FG001|Overall Study|Other|1|||
131494162|NCT04605484|473436214|FG002|Overall Study|Other|0|||
131494163|NCT00660309|473436215|FG000|Overall Study|Adverse Event|2|||
131494164|NCT00660309|473436216|FG001|Overall Study|Adverse Event|0|||
131494165|NCT00660309|473436215|FG000|Overall Study|Withdrawal by Subject|0|||
131494166|NCT00660309|473436216|FG001|Overall Study|Withdrawal by Subject|3|||
131494167|NCT02573311|473436219|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
131494168|NCT02573311|473436220|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
131494169|NCT02573311|473436219|FG000|Disposition for Part 2|Physician Decision|25|||
131494170|NCT02573311|473436220|FG001|Disposition for Part 2|Physician Decision|7|||
131494171|NCT02573311|473436219|FG000|Disposition for Part 2|Adverse Event|36|||
131494172|NCT02573311|473436220|FG001|Disposition for Part 2|Adverse Event|5|||
131494173|NCT02573311|473436219|FG000|Disposition for Part 2|Lost to Follow-up|76|||
131494174|NCT02573311|473436220|FG001|Disposition for Part 2|Lost to Follow-up|7|||
131494175|NCT02573311|473436219|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
131494176|NCT02573311|473436220|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
131494177|NCT02573311|473436219|FG000|Disposition for Part 2|Investigator decision|0|||
131494178|NCT02573311|473436220|FG001|Disposition for Part 2|Investigator decision|1|||
131494179|NCT02573311|473436219|FG000|Disposition for Part 2|Other than specified above|13|||
131494180|NCT02573311|473436220|FG001|Disposition for Part 2|Other than specified above|3|||
131494181|NCT04171531|473436222|FG000|Overall Study|Lost to Follow-up|4|||
131494182|NCT04171531|473436223|FG001|Overall Study|Lost to Follow-up|5|||
131494183|NCT04171531|473436222|FG000|Overall Study|Consent only through 6 months|1|||
131494184|NCT04171531|473436223|FG001|Overall Study|Consent only through 6 months|1|||
131494185|NCT04171531|473436222|FG000|Overall Study|Insurance did not cover procedure|0|||
131494186|NCT04171531|473436223|FG001|Overall Study|Insurance did not cover procedure|1|||
131494187|NCT04171531|473436222|FG000|Overall Study|Physician Decision|0|||
131494188|NCT04171531|473436223|FG001|Overall Study|Physician Decision|3|||
131494189|NCT04171531|473436222|FG000|Overall Study|Withdrawal by Subject|1|||
131494190|NCT04171531|473436223|FG001|Overall Study|Withdrawal by Subject|5|||
131494191|NCT04862585|473436226|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
131496830|NCT01980992|473446423|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
131494192|NCT04862585|473436227|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
131494193|NCT04862585|473436226|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
131494194|NCT04862585|473436227|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
131494195|NCT04862585|473436226|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
131494196|NCT04862585|473436227|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
131494197|NCT04862585|473436226|FG000|Overall Study|one withdrew without providing a reason|0|||
131494198|NCT04862585|473436227|FG001|Overall Study|one withdrew without providing a reason|1|||
131494199|NCT03366337|473436228|FG000|Overall Study|Lost to Follow-up|1|||
131494200|NCT03366337|473436229|FG001|Overall Study|Lost to Follow-up|0|||
131494201|NCT03366337|473436230|FG002|Overall Study|Lost to Follow-up|1|||
131494202|NCT03366337|473436231|FG003|Overall Study|Lost to Follow-up|0|||
131494203|NCT03366337|473436228|FG000|Overall Study|Withdrawal by Subject|2|||
131494204|NCT03366337|473436229|FG001|Overall Study|Withdrawal by Subject|0|||
131494205|NCT03366337|473436230|FG002|Overall Study|Withdrawal by Subject|1|||
131494206|NCT03366337|473436231|FG003|Overall Study|Withdrawal by Subject|1|||
131494207|NCT05288062|473436233|FG000|Overall Study|Ineligible|0|||
131494208|NCT05288062|473436234|FG001|Overall Study|Ineligible|0|||
131494209|NCT05288062|473436235|FG002|Overall Study|Ineligible|1|||
131494210|NCT05288062|473436236|FG003|Overall Study|Ineligible|0|||
131494211|NCT05288062|473436233|FG000|Overall Study|Withdrawal by Subject|0|||
131494212|NCT05288062|473436234|FG001|Overall Study|Withdrawal by Subject|0|||
131494213|NCT05288062|473436235|FG002|Overall Study|Withdrawal by Subject|1|||
131494214|NCT05288062|473436236|FG003|Overall Study|Withdrawal by Subject|0|||
131494215|NCT00211809|473436237|FG000|Overall Study|Lack of Efficacy|1|||
131494216|NCT00211809|473436237|FG000|Overall Study|Lost to Follow-up|2|||
131494217|NCT00211809|473436237|FG000|Overall Study|Pregnancy|1|||
131494218|NCT00211809|473436237|FG000|Overall Study|side effects|2|||
131494219|NCT00496470|473436238|FG000|Overall Study|Adverse Event|8|||
131494220|NCT00496470|473436239|FG001|Overall Study|Adverse Event|10|||
131494221|NCT00496470|473436238|FG000|Overall Study|Withdrawal by Subject|5|||
131494222|NCT00496470|473436239|FG001|Overall Study|Withdrawal by Subject|12|||
131494223|NCT00496470|473436238|FG000|Overall Study|Incorrectly enrolled|13|||
131494224|NCT00496470|473436239|FG001|Overall Study|Incorrectly enrolled|5|||
131494225|NCT00496470|473436238|FG000|Overall Study|Other reason|0|||
131494226|NCT00496470|473436239|FG001|Overall Study|Other reason|2|||
131494227|NCT01370356|473436240|FG000|Overall Study|Death|1|||
131494228|NCT01370356|473436241|FG001|Overall Study|Death|0|||
131494229|NCT01370356|473436240|FG000|Overall Study|Lack of Efficacy|6|||
131494230|NCT01370356|473436241|FG001|Overall Study|Lack of Efficacy|28|||
131494231|NCT01370356|473436240|FG000|Overall Study|Lost to Follow-up|76|||
131494232|NCT01370356|473436241|FG001|Overall Study|Lost to Follow-up|81|||
131494233|NCT01370356|473436240|FG000|Overall Study|Withdrawal by Subject|54|||
131494234|NCT01370356|473436241|FG001|Overall Study|Withdrawal by Subject|59|||
131494235|NCT01370356|473436240|FG000|Overall Study|Reason not specified|39|||
131494236|NCT01370356|473436241|FG001|Overall Study|Reason not specified|43|||
131494237|NCT01370356|473436240|FG000|Overall Study|Protocol Violation|3|||
131494238|NCT01370356|473436241|FG001|Overall Study|Protocol Violation|3|||
131494239|NCT01370356|473436240|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
131494240|NCT01370356|473436241|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
131494241|NCT01370356|473436240|FG000|Overall Study|AE Not Related to Study Drug|1|||
131494242|NCT01370356|473436241|FG001|Overall Study|AE Not Related to Study Drug|4|||
131494243|NCT00729651|473436242|FG000|Overall Study|Withdrawal by Subject|5|||
131494244|NCT00729651|473436243|FG001|Overall Study|Withdrawal by Subject|6|||
131494245|NCT00729651|473436242|FG000|Overall Study|Lost to Follow-up|5|||
131494246|NCT00729651|473436243|FG001|Overall Study|Lost to Follow-up|4|||
131494247|NCT00729651|473436242|FG000|Overall Study|Protocol Violation|0|||
131494248|NCT00729651|473436243|FG001|Overall Study|Protocol Violation|1|||
131494249|NCT00729651|473436242|FG000|Overall Study|Adverse Event|7|||
131494250|NCT00729651|473436243|FG001|Overall Study|Adverse Event|3|||
131494251|NCT00729651|473436242|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
131494252|NCT00729651|473436243|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
131494253|NCT00729651|473436242|FG000|Overall Study|Subject's private reason|2|||
131494254|NCT00729651|473436243|FG001|Overall Study|Subject's private reason|0|||
131494255|NCT01218243|473436244|FG000|Overall Study|Lack of Efficacy|1|||
131494256|NCT01218243|473436245|FG001|Overall Study|Lack of Efficacy|1|||
131494257|NCT01218243|473436244|FG000|Overall Study|Lost to Follow-up|3|||
131494258|NCT01218243|473436245|FG001|Overall Study|Lost to Follow-up|3|||
131494259|NCT01218243|473436244|FG000|Overall Study|Protocol Violation|5|||
131494260|NCT01218243|473436245|FG001|Overall Study|Protocol Violation|10|||
131494261|NCT02521870|473436246|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494262|NCT02521870|473436247|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
131494263|NCT02521870|473436248|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494264|NCT02521870|473436249|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494265|NCT02521870|473436250|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494266|NCT02521870|473436251|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494267|NCT02521870|473436252|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494268|NCT02521870|473436253|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494269|NCT02521870|473436254|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494270|NCT02521870|473436255|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494271|NCT02521870|473436256|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494272|NCT02521870|473436257|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131494273|NCT02521870|473436246|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
131494274|NCT02521870|473436247|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
131494275|NCT02521870|473436248|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
131494276|NCT02521870|473436249|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
131494277|NCT02521870|473436250|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
131494278|NCT02521870|473436251|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
131494279|NCT02521870|473436252|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
131494280|NCT02521870|473436253|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
131494281|NCT02521870|473436254|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
131494282|NCT02521870|473436255|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
131494283|NCT02521870|473436256|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
131494284|NCT02521870|473436257|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
131494285|NCT02521870|473436246|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
131494286|NCT02521870|473436247|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
131494287|NCT02521870|473436248|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
131494288|NCT02521870|473436249|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
131494289|NCT02521870|473436250|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
131494290|NCT02521870|473436251|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
131494291|NCT02521870|473436252|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
131494292|NCT02521870|473436253|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
131494293|NCT02521870|473436254|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
131494294|NCT02521870|473436255|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
131494295|NCT02521870|473436256|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
131494296|NCT02521870|473436257|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
131494297|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131494298|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131494299|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131494300|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131494301|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
131494302|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
131494303|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
131494304|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131494305|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
131494306|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
131494307|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
131494308|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131494309|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
131494310|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
131494311|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
131494312|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
131494313|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
131494314|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
131494315|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
131494316|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
131494317|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
131494318|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
131494319|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
131494320|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
131494321|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
131494322|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
131494323|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
131494324|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
131494325|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
131494326|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
131494327|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
131494328|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
131494329|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
131494330|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
131494331|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
131494332|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
131494333|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Death|0|||
131494334|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Death|0|||
131494335|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Death|0|||
131494336|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Death|0|||
131494337|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Death|1|||
131494338|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Death|1|||
131494339|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Death|3|||
131494340|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Death|1|||
131494341|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Death|1|||
131494342|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Death|5|||
131494343|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Death|2|||
131494344|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Death|2|||
131494345|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Other|0|||
131494346|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Other|0|||
131494347|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Other|0|||
131494348|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Other|0|||
131494349|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Other|10|||
131494350|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Other|3|||
131494351|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Other|2|||
131494352|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Other|0|||
131494353|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Other|10|||
131494354|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Other|5|||
131494355|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Other|1|||
131494356|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Other|7|||
131494357|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494358|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494359|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494360|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494361|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
131494362|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494363|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494364|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494365|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494366|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494367|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494368|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131494369|NCT02521870|473436246|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494370|NCT02521870|473436247|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494371|NCT02521870|473436248|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494372|NCT02521870|473436249|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494373|NCT02521870|473436250|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
131494374|NCT02521870|473436251|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494375|NCT02521870|473436252|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494376|NCT02521870|473436253|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494377|NCT02521870|473436254|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494378|NCT02521870|473436255|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494379|NCT02521870|473436256|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494380|NCT02521870|473436257|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
131494381|NCT00519831|473436258|FG000|Overall Study|Adverse Event|3|||
131494382|NCT02854631|473436259|FG000|Overall Study|Adverse Event|1|||
131494383|NCT02854631|473436260|FG001|Overall Study|Adverse Event|2|||
131494384|NCT02854631|473436259|FG000|Overall Study|Withdrew Consent|3|||
131494385|NCT02854631|473436260|FG001|Overall Study|Withdrew Consent|2|||
131494386|NCT02854631|473436259|FG000|Overall Study|Investigator's Discretion|2|||
131494387|NCT02854631|473436260|FG001|Overall Study|Investigator's Discretion|0|||
131494388|NCT02854631|473436259|FG000|Overall Study|Death|12|||
131494389|NCT02854631|473436260|FG001|Overall Study|Death|8|||
131494390|NCT02854631|473436259|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
131494391|NCT02854631|473436260|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
131494392|NCT02854631|473436259|FG000|Overall Study|Protocol Violation|0|||
131494393|NCT02854631|473436260|FG001|Overall Study|Protocol Violation|1|||
131494394|NCT02854631|473436259|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
131494395|NCT02854631|473436260|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
131494396|NCT02854631|473436259|FG000|Overall Study|Lost to Follow-up|4|||
131494397|NCT02854631|473436260|FG001|Overall Study|Lost to Follow-up|2|||
131494398|NCT03200860|473436261|FG000|Overall Study|Withdrawal by Subject|1|||
131494399|NCT03200860|473436262|FG001|Overall Study|Withdrawal by Subject|0|||
131494400|NCT00844896|473436263|FG000|Overall Study|Lost to Follow-up|12|||
131494401|NCT00844896|473436264|FG001|Overall Study|Lost to Follow-up|16|||
131494402|NCT00844896|473436263|FG000|Overall Study|Parents did not have time to complete|0|||
131494403|NCT00844896|473436264|FG001|Overall Study|Parents did not have time to complete|1|||
131494404|NCT02233647|473436268|FG000|Overall Study|Adverse Event|1|||
131494405|NCT04342897|473436269|FG000|Overall Study|Death|7|||
131494406|NCT04342897|473436270|FG001|Overall Study|Death|4|||
131494407|NCT04342897|473436269|FG000|Overall Study|Lost to Follow-up|6|||
131494408|NCT04342897|473436270|FG001|Overall Study|Lost to Follow-up|6|||
131494409|NCT04342897|473436269|FG000|Overall Study|Withdrawal by Subject|1|||
131494410|NCT04342897|473436270|FG001|Overall Study|Withdrawal by Subject|2|||
131494411|NCT00753415|473436276|FG000|Part A|Disease progression|1|||
131494412|NCT00753415|473436277|FG001|Part A|Disease progression|0|||
131494413|NCT00753415|473436278|FG002|Part A|Disease progression|1|||
131494414|NCT00753415|473436279|FG003|Part A|Disease progression|2|||
131494415|NCT00753415|473436280|FG004|Part A|Disease progression|0|||
131494416|NCT00753415|473436281|FG005|Part A|Disease progression|0|||
131494417|NCT00753415|473436282|FG006|Part A|Disease progression|0|||
131494418|NCT00753415|473436283|FG007|Part A|Disease progression|0|||
131494419|NCT00753415|473436284|FG008|Part A|Disease progression|0|||
131494420|NCT00753415|473436285|FG009|Part A|Disease progression|0|||
131494421|NCT00753415|473436276|FG000|Part A|Withdrawal by Subject|0|||
131494422|NCT00753415|473436277|FG001|Part A|Withdrawal by Subject|0|||
131494423|NCT00753415|473436278|FG002|Part A|Withdrawal by Subject|1|||
131494424|NCT00753415|473436279|FG003|Part A|Withdrawal by Subject|0|||
131494425|NCT00753415|473436280|FG004|Part A|Withdrawal by Subject|0|||
131494426|NCT00753415|473436281|FG005|Part A|Withdrawal by Subject|0|||
131494427|NCT00753415|473436282|FG006|Part A|Withdrawal by Subject|0|||
131494428|NCT00753415|473436283|FG007|Part A|Withdrawal by Subject|0|||
131494429|NCT00753415|473436284|FG008|Part A|Withdrawal by Subject|0|||
131494430|NCT00753415|473436285|FG009|Part A|Withdrawal by Subject|0|||
131494431|NCT00753415|473436276|FG000|Part B|Lost to Follow-up|0|||
131494432|NCT00753415|473436277|FG001|Part B|Lost to Follow-up|0|||
131494433|NCT00753415|473436278|FG002|Part B|Lost to Follow-up|0|||
131494434|NCT00753415|473436279|FG003|Part B|Lost to Follow-up|0|||
131494435|NCT00753415|473436280|FG004|Part B|Lost to Follow-up|0|||
131494436|NCT00753415|473436281|FG005|Part B|Lost to Follow-up|0|||
131494437|NCT00753415|473436282|FG006|Part B|Lost to Follow-up|0|||
131494438|NCT00753415|473436283|FG007|Part B|Lost to Follow-up|1|||
131494439|NCT00753415|473436284|FG008|Part B|Lost to Follow-up|1|||
131494440|NCT00753415|473436285|FG009|Part B|Lost to Follow-up|0|||
131494441|NCT00753415|473436276|FG000|Part B|Disease progression|0|||
131494442|NCT00753415|473436277|FG001|Part B|Disease progression|0|||
131494443|NCT00753415|473436278|FG002|Part B|Disease progression|0|||
131494444|NCT00753415|473436279|FG003|Part B|Disease progression|0|||
131494445|NCT00753415|473436280|FG004|Part B|Disease progression|0|||
131494446|NCT00753415|473436281|FG005|Part B|Disease progression|0|||
131494447|NCT00753415|473436282|FG006|Part B|Disease progression|0|||
131494448|NCT00753415|473436283|FG007|Part B|Disease progression|0|||
131494449|NCT00753415|473436284|FG008|Part B|Disease progression|2|||
131494450|NCT00753415|473436285|FG009|Part B|Disease progression|1|||
131494451|NCT00621153|473436286|FG000|Overall Study|Safety Reason|8|||
131494452|NCT00621153|473436287|FG001|Overall Study|Safety Reason|7|||
131494453|NCT00621153|473436286|FG000|Overall Study|Adverse Event|3|||
131494454|NCT00621153|473436287|FG001|Overall Study|Adverse Event|2|||
131494455|NCT00621153|473436286|FG000|Overall Study|Lost to Follow-up|5|||
131494456|NCT00621153|473436287|FG001|Overall Study|Lost to Follow-up|1|||
131494457|NCT00621153|473436286|FG000|Overall Study|Withdrawal by Subject|4|||
131494458|NCT00621153|473436287|FG001|Overall Study|Withdrawal by Subject|5|||
131494459|NCT04212650|473436289|FG000|Overall Study|Withdrawal by Subject|1|||
131494460|NCT04212650|473436290|FG001|Overall Study|Withdrawal by Subject|0|||
131494461|NCT02634320|473436291|FG000|Overall Study|Adverse Event|2|||
131494462|NCT02634320|473436291|FG000|Overall Study|Lost to Follow-up|3|||
131494463|NCT02634320|473436291|FG000|Overall Study|Moved out of area|2|||
131494464|NCT02634320|473436291|FG000|Overall Study|Out of window for study visits|1|||
131494465|NCT02634320|473436291|FG000|Overall Study|Protocol Violation|1|||
131494466|NCT02634320|473436291|FG000|Overall Study|Withdrawal by Subject|5|||
131494467|NCT02634320|473436291|FG000|Overall Study|Lack of Efficacy|2|||
131494468|NCT03919799|473436295|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
131494469|NCT03919799|473436296|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
131494470|NCT03919799|473436297|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
131494471|NCT03919799|473436298|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
131494472|NCT03919799|473436299|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
131494473|NCT03919799|473436295|FG000|DB Period (28 Weeks)|Adverse Event|1|||
131494474|NCT03919799|473436296|FG001|DB Period (28 Weeks)|Adverse Event|1|||
131494475|NCT03919799|473436297|FG002|DB Period (28 Weeks)|Adverse Event|1|||
131494476|NCT03919799|473436298|FG003|DB Period (28 Weeks)|Adverse Event|0|||
131494477|NCT03919799|473436299|FG004|DB Period (28 Weeks)|Adverse Event|0|||
131494478|NCT03919799|473436295|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
131494479|NCT03919799|473436296|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
131494480|NCT03919799|473436297|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
131494481|NCT03919799|473436298|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
131494482|NCT03919799|473436299|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
131494483|NCT03919799|473436295|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
131494484|NCT03919799|473436296|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
131494485|NCT03919799|473436297|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
131494486|NCT03919799|473436298|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
131494487|NCT03919799|473436299|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
131494488|NCT03919799|473436295|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
131494489|NCT03919799|473436296|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
131494490|NCT03919799|473436297|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
131494491|NCT03919799|473436298|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
131494492|NCT03919799|473436299|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
131494493|NCT04656691|473436304|FG000|Overall Study|Adverse Event|1|||
131494494|NCT03199274|473436305|FG000|Overall Study|Withdrawal by Subject|4|||
131494495|NCT03199274|473436306|FG001|Overall Study|Withdrawal by Subject|0|||
131494496|NCT03199274|473436305|FG000|Overall Study|Lost to Follow-up|0|||
131494497|NCT03199274|473436306|FG001|Overall Study|Lost to Follow-up|1|||
131494498|NCT03199274|473436305|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
131494499|NCT03199274|473436306|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
131494500|NCT02846779|473436309|FG000|Overall Study|Lost Enrollment|83|||
131494501|NCT02846779|473436310|FG001|Overall Study|Lost Enrollment|82|||
131494502|NCT02846779|473436311|FG002|Overall Study|Lost Enrollment|86|||
131494503|NCT02846779|473436309|FG000|Overall Study|Less than 31 days of follow-up|56|||
131494504|NCT02846779|473436310|FG001|Overall Study|Less than 31 days of follow-up|45|||
131494505|NCT02846779|473436311|FG002|Overall Study|Less than 31 days of follow-up|52|||
131494506|NCT05980182|473436317|FG000|Overall Study|Lost to Follow-up|10|||
131494507|NCT05475236|473436318|FG000|Overall Study|Withdrawal by Subject|0|||
131494508|NCT05475236|473436319|FG001|Overall Study|Withdrawal by Subject|1|||
131494509|NCT04023526|473438256|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
131494510|NCT04023526|473438257|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
131494511|NCT04023526|473438256|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
131494512|NCT04023526|473438257|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
131494513|NCT02324569|473438266|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
131494514|NCT02324569|473438267|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
131494515|NCT02324569|473438266|FG000|Overall Study|Voluntary Withdrawal|3|||
131494516|NCT02324569|473438267|FG001|Overall Study|Voluntary Withdrawal|6|||
131494517|NCT02324569|473438266|FG000|Overall Study|Lack of Efficacy|2|||
131494518|NCT02324569|473438267|FG001|Overall Study|Lack of Efficacy|3|||
131494519|NCT02324569|473438266|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
131494520|NCT02324569|473438267|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
131494521|NCT02324569|473438266|FG000|Overall Study|Inconvenient Schedule|2|||
131494522|NCT02324569|473438267|FG001|Overall Study|Inconvenient Schedule|0|||
131494523|NCT00638378|473438274|FG000|Overall Study|Death|2|||
131494524|NCT00638378|473438274|FG000|Overall Study|Adverse Event|1|||
131494525|NCT00638378|473438274|FG000|Overall Study|Disease progression|15|||
131494526|NCT00638378|473438274|FG000|Overall Study|Physician Decision|4|||
131494527|NCT01411774|473438292|FG000|Overall Study|Withdrawal by Subject|0|||
131494528|NCT01411774|473438293|FG001|Overall Study|Withdrawal by Subject|3|||
131494529|NCT02990910|473438297|FG000|Overall Study|Lack of Efficacy|6|||
131494530|NCT02990910|473438298|FG001|Overall Study|Lack of Efficacy|10|||
131494531|NCT00684307|473438303|FG000|Overall Study|Adverse Event|11|||
131494532|NCT00684307|473438304|FG001|Overall Study|Adverse Event|6|||
131494533|NCT00684307|473438305|FG002|Overall Study|Adverse Event|15|||
131494534|NCT00684307|473438306|FG003|Overall Study|Adverse Event|16|||
131494535|NCT00684307|473438307|FG004|Overall Study|Adverse Event|8|||
131494536|NCT00684307|473438303|FG000|Overall Study|Development of increasing Liver Function|0|||
131494537|NCT00684307|473438304|FG001|Overall Study|Development of increasing Liver Function|2|||
131494538|NCT00684307|473438305|FG002|Overall Study|Development of increasing Liver Function|0|||
131494539|NCT00684307|473438306|FG003|Overall Study|Development of increasing Liver Function|1|||
131494540|NCT00684307|473438307|FG004|Overall Study|Development of increasing Liver Function|0|||
131494541|NCT00684307|473438303|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
131494542|NCT00684307|473438304|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
131494543|NCT00684307|473438305|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
131494544|NCT00684307|473438306|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
131494545|NCT00684307|473438307|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
131494546|NCT00684307|473438303|FG000|Overall Study|Incorrect enrolment or randomization|4|||
131494547|NCT00684307|473438304|FG001|Overall Study|Incorrect enrolment or randomization|0|||
131494548|NCT00684307|473438305|FG002|Overall Study|Incorrect enrolment or randomization|0|||
131494549|NCT00684307|473438306|FG003|Overall Study|Incorrect enrolment or randomization|0|||
131494550|NCT00684307|473438307|FG004|Overall Study|Incorrect enrolment or randomization|0|||
131494551|NCT00684307|473438303|FG000|Overall Study|Interupted IP for more than 7 days|0|||
131494552|NCT00684307|473438304|FG001|Overall Study|Interupted IP for more than 7 days|4|||
131494553|NCT00684307|473438305|FG002|Overall Study|Interupted IP for more than 7 days|1|||
131494554|NCT00684307|473438306|FG003|Overall Study|Interupted IP for more than 7 days|3|||
131494555|NCT00684307|473438307|FG004|Overall Study|Interupted IP for more than 7 days|3|||
131494556|NCT00684307|473438303|FG000|Overall Study|Severe non compliance to protocol|1|||
131494557|NCT00684307|473438304|FG001|Overall Study|Severe non compliance to protocol|0|||
131494558|NCT00684307|473438305|FG002|Overall Study|Severe non compliance to protocol|0|||
131494559|NCT00684307|473438306|FG003|Overall Study|Severe non compliance to protocol|1|||
131494560|NCT00684307|473438307|FG004|Overall Study|Severe non compliance to protocol|2|||
131494561|NCT00684307|473438303|FG000|Overall Study|Participant not willing to continue|7|||
131494562|NCT00684307|473438304|FG001|Overall Study|Participant not willing to continue|10|||
131494563|NCT00684307|473438305|FG002|Overall Study|Participant not willing to continue|11|||
131494564|NCT00684307|473438306|FG003|Overall Study|Participant not willing to continue|5|||
131494565|NCT00684307|473438307|FG004|Overall Study|Participant not willing to continue|8|||
131494566|NCT00684307|473438303|FG000|Overall Study|Criteria from the CSR|0|||
131494567|NCT00684307|473438304|FG001|Overall Study|Criteria from the CSR|0|||
131494568|NCT00684307|473438305|FG002|Overall Study|Criteria from the CSR|1|||
131494569|NCT00684307|473438306|FG003|Overall Study|Criteria from the CSR|3|||
131494570|NCT00684307|473438307|FG004|Overall Study|Criteria from the CSR|3|||
131494571|NCT02430311|473438308|FG000|Part A|Adverse Event|0|||
131494572|NCT02430311|473438309|FG001|Part A|Adverse Event|1|||
131494573|NCT02430311|473438308|FG000|Part A|Withdrawal by Subject|1|||
131494574|NCT02430311|473438309|FG001|Part A|Withdrawal by Subject|0|||
131494575|NCT02430311|473438308|FG000|Part B|Meet study-specific withdrawal criteria|6|||
131494576|NCT02430311|473438309|FG001|Part B|Meet study-specific withdrawal criteria|6|||
131494577|NCT02430311|473438308|FG000|Part B|Withdrawal by Subject|2|||
131494578|NCT02430311|473438309|FG001|Part B|Withdrawal by Subject|2|||
131494579|NCT02430311|473438308|FG000|Part B|Adverse Event|1|||
131494580|NCT02430311|473438309|FG001|Part B|Adverse Event|0|||
131494581|NCT02430311|473438308|FG000|Part B|Death|1|||
131494582|NCT02430311|473438309|FG001|Part B|Death|0|||
131494583|NCT02483520|473438314|FG000|Overall Study|Lost to Follow-up|3|||
131494584|NCT02483520|473438315|FG001|Overall Study|Lost to Follow-up|4|||
131494585|NCT02483520|473438314|FG000|Overall Study|Withdrawal by Subject|4|||
131494586|NCT02483520|473438315|FG001|Overall Study|Withdrawal by Subject|14|||
131494587|NCT02483520|473438314|FG000|Overall Study|Hospitalized|2|||
131494588|NCT02483520|473438315|FG001|Overall Study|Hospitalized|3|||
131494589|NCT02483520|473438314|FG000|Overall Study|Moved to LTC|2|||
131494590|NCT02483520|473438315|FG001|Overall Study|Moved to LTC|3|||
131494591|NCT01104493|473438316|FG000|Overall Study|Lost to Follow-up|0|||
131494592|NCT01104493|473438317|FG001|Overall Study|Lost to Follow-up|2|||
131494593|NCT01342796|473438319|FG000|Overall Study|Withdrawal by Subject|2|||
131494594|NCT01342796|473438320|FG001|Overall Study|Withdrawal by Subject|0|||
131494595|NCT01342796|473438319|FG000|Overall Study|Lost to Follow-up|0|||
131494596|NCT01342796|473438320|FG001|Overall Study|Lost to Follow-up|3|||
131494597|NCT01342796|473438319|FG000|Overall Study|Inappropriate enrollment|1|||
131494598|NCT01342796|473438320|FG001|Overall Study|Inappropriate enrollment|0|||
131494599|NCT01599234|473438321|FG000|Overall Study|Adverse Event|9|||
131494600|NCT01599234|473438322|FG001|Overall Study|Adverse Event|5|||
131494601|NCT01599234|473438321|FG000|Overall Study|Withdrawal by Subject|2|||
131494602|NCT01599234|473438322|FG001|Overall Study|Withdrawal by Subject|1|||
131494603|NCT01599234|473438321|FG000|Overall Study|Lost to Follow-up|1|||
131494604|NCT01599234|473438322|FG001|Overall Study|Lost to Follow-up|2|||
131494605|NCT01599234|473438321|FG000|Overall Study|Lack of Efficacy|2|||
131494606|NCT01599234|473438322|FG001|Overall Study|Lack of Efficacy|4|||
131494607|NCT01599234|473438321|FG000|Overall Study|Unable to operate spray|1|||
131494608|NCT01599234|473438322|FG001|Overall Study|Unable to operate spray|0|||
131494609|NCT01599234|473438321|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
131494610|NCT01599234|473438322|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
131494611|NCT01599234|473438321|FG000|Overall Study|Death|1|||
131494612|NCT01599234|473438322|FG001|Overall Study|Death|0|||
131494613|NCT01599234|473438321|FG000|Overall Study|Patient would not stop driving|1|||
131494614|NCT01599234|473438322|FG001|Overall Study|Patient would not stop driving|0|||
131494615|NCT01599234|473438321|FG000|Overall Study|Contra-indication discovered|0|||
131494616|NCT01599234|473438322|FG001|Overall Study|Contra-indication discovered|1|||
131494617|NCT01599234|473438321|FG000|Overall Study|Pregnancy|0|||
131494618|NCT01599234|473438322|FG001|Overall Study|Pregnancy|1|||
131494619|NCT03902574|473438340|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
131494620|NCT03902574|473438341|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
131494621|NCT03902574|473438342|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
131494622|NCT02485301|473438345|FG000|Overall Study|Serious Adverse Events|2|||
131494623|NCT02485301|473438346|FG001|Overall Study|Serious Adverse Events|1|||
131494624|NCT02485301|473438345|FG000|Overall Study|Protocol Violation|0|||
131494625|NCT02485301|473438346|FG001|Overall Study|Protocol Violation|1|||
131494626|NCT02485301|473438345|FG000|Overall Study|Withdrawal by Subject|6|||
131494627|NCT02485301|473438346|FG001|Overall Study|Withdrawal by Subject|7|||
131494628|NCT02485301|473438345|FG000|Overall Study|Migrated/moved from study area|10|||
131494629|NCT02485301|473438346|FG001|Overall Study|Migrated/moved from study area|19|||
131494630|NCT02485301|473438345|FG000|Overall Study|Lost to Follow-up|17|||
131494631|NCT02485301|473438346|FG001|Overall Study|Lost to Follow-up|17|||
131494632|NCT02485301|473438345|FG000|Overall Study|Other|3|||
131494633|NCT02485301|473438346|FG001|Overall Study|Other|4|||
131494634|NCT01059825|473438350|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
131494635|NCT01059825|473438351|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
131494636|NCT01059825|473438352|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
131494637|NCT01059825|473438353|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
131494638|NCT01059825|473438354|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
131494639|NCT01059825|473438355|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
131494640|NCT01059825|473438356|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
131494641|NCT01059825|473438350|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
131494642|NCT01059825|473438351|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
131494643|NCT01059825|473438352|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
131494644|NCT01059825|473438353|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
131494645|NCT01059825|473438354|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
131494646|NCT01059825|473438355|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
131494647|NCT01059825|473438356|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
131494648|NCT01059825|473438350|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
131494649|NCT01059825|473438351|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
131494650|NCT01059825|473438352|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
131494651|NCT01059825|473438353|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
131494652|NCT01059825|473438354|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
131494653|NCT01059825|473438355|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
131494654|NCT01059825|473438356|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
131494655|NCT01059825|473438350|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
131494656|NCT01059825|473438351|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
131494657|NCT01059825|473438352|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
131494658|NCT01059825|473438353|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
131494659|NCT01059825|473438354|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
131494660|NCT01059825|473438355|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
131494661|NCT01059825|473438356|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
131494662|NCT01059825|473438350|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
131494663|NCT01059825|473438351|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
131494664|NCT01059825|473438352|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
131494665|NCT01059825|473438353|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
131494666|NCT01059825|473438354|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
131494667|NCT01059825|473438355|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
131494668|NCT01059825|473438356|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
131494669|NCT01059825|473438350|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
131494670|NCT01059825|473438351|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
131494671|NCT01059825|473438352|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
131494672|NCT01059825|473438353|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
131494673|NCT01059825|473438354|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
131494674|NCT01059825|473438355|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
131494675|NCT01059825|473438356|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
131494676|NCT01059825|473438350|FG000|Treatment Period|Lost to Follow-up|2|||
131494677|NCT01059825|473438351|FG001|Treatment Period|Lost to Follow-up|1|||
131494678|NCT01059825|473438352|FG002|Treatment Period|Lost to Follow-up|0|||
131494679|NCT01059825|473438353|FG003|Treatment Period|Lost to Follow-up|1|||
131494680|NCT01059825|473438354|FG004|Treatment Period|Lost to Follow-up|2|||
131494681|NCT01059825|473438355|FG005|Treatment Period|Lost to Follow-up|0|||
131494682|NCT01059825|473438356|FG006|Treatment Period|Lost to Follow-up|0|||
131494683|NCT01059825|473438350|FG000|Treatment Period|Withdrawal by Subject|3|||
131494684|NCT01059825|473438351|FG001|Treatment Period|Withdrawal by Subject|0|||
131494685|NCT01059825|473438352|FG002|Treatment Period|Withdrawal by Subject|1|||
131494686|NCT01059825|473438353|FG003|Treatment Period|Withdrawal by Subject|5|||
131494687|NCT01059825|473438354|FG004|Treatment Period|Withdrawal by Subject|4|||
131494688|NCT01059825|473438355|FG005|Treatment Period|Withdrawal by Subject|1|||
131494689|NCT01059825|473438356|FG006|Treatment Period|Withdrawal by Subject|0|||
131494690|NCT01059825|473438350|FG000|Treatment Period|Other reason not specified|1|||
131494691|NCT01059825|473438351|FG001|Treatment Period|Other reason not specified|2|||
131494692|NCT01059825|473438352|FG002|Treatment Period|Other reason not specified|1|||
131494693|NCT01059825|473438353|FG003|Treatment Period|Other reason not specified|2|||
131494694|NCT01059825|473438354|FG004|Treatment Period|Other reason not specified|0|||
131494695|NCT01059825|473438355|FG005|Treatment Period|Other reason not specified|0|||
131494696|NCT01059825|473438356|FG006|Treatment Period|Other reason not specified|0|||
131494697|NCT01059825|473438350|FG000|Treatment Period|Protocol Violation|0|||
131494698|NCT01059825|473438351|FG001|Treatment Period|Protocol Violation|0|||
131494699|NCT01059825|473438352|FG002|Treatment Period|Protocol Violation|1|||
131494700|NCT01059825|473438353|FG003|Treatment Period|Protocol Violation|1|||
131494701|NCT01059825|473438354|FG004|Treatment Period|Protocol Violation|1|||
131494702|NCT01059825|473438355|FG005|Treatment Period|Protocol Violation|1|||
131494703|NCT01059825|473438356|FG006|Treatment Period|Protocol Violation|0|||
131494704|NCT01059825|473438350|FG000|Treatment Period|Adverse event related to study drug|1|||
131494705|NCT01059825|473438351|FG001|Treatment Period|Adverse event related to study drug|0|||
131494706|NCT01059825|473438352|FG002|Treatment Period|Adverse event related to study drug|1|||
131494707|NCT01059825|473438353|FG003|Treatment Period|Adverse event related to study drug|1|||
131494708|NCT01059825|473438354|FG004|Treatment Period|Adverse event related to study drug|0|||
131494709|NCT01059825|473438355|FG005|Treatment Period|Adverse event related to study drug|0|||
131494710|NCT01059825|473438356|FG006|Treatment Period|Adverse event related to study drug|0|||
131494711|NCT01059825|473438350|FG000|Treatment Period|Insufficient clinical response|3|||
131494712|NCT01059825|473438351|FG001|Treatment Period|Insufficient clinical response|0|||
131494713|NCT01059825|473438352|FG002|Treatment Period|Insufficient clinical response|0|||
131494714|NCT01059825|473438353|FG003|Treatment Period|Insufficient clinical response|0|||
131494715|NCT01059825|473438354|FG004|Treatment Period|Insufficient clinical response|0|||
131494716|NCT01059825|473438355|FG005|Treatment Period|Insufficient clinical response|0|||
131494717|NCT01059825|473438356|FG006|Treatment Period|Insufficient clinical response|0|||
131494718|NCT01059825|473438350|FG000|Treatment Period|Adverse event not related to study drug|0|||
131494719|NCT01059825|473438351|FG001|Treatment Period|Adverse event not related to study drug|1|||
131494720|NCT01059825|473438352|FG002|Treatment Period|Adverse event not related to study drug|2|||
131494721|NCT01059825|473438353|FG003|Treatment Period|Adverse event not related to study drug|1|||
131494722|NCT01059825|473438354|FG004|Treatment Period|Adverse event not related to study drug|1|||
131494723|NCT01059825|473438355|FG005|Treatment Period|Adverse event not related to study drug|1|||
131494724|NCT01059825|473438356|FG006|Treatment Period|Adverse event not related to study drug|0|||
131494725|NCT02101060|473438359|FG000|Overall Study|Adverse Event|1|||
131494726|NCT02101060|473438360|FG001|Overall Study|Adverse Event|0|||
131494727|NCT02101060|473438359|FG000|Overall Study|Withdrawal by Subject|1|||
131494728|NCT02101060|473438360|FG001|Overall Study|Withdrawal by Subject|1|||
131494729|NCT02101060|473438359|FG000|Overall Study|Lost to Follow-up|3|||
131494730|NCT02101060|473438360|FG001|Overall Study|Lost to Follow-up|3|||
131494731|NCT03020160|473438361|FG000|Overall Study|Withdrawal by Subject|1|||
131494732|NCT03020160|473438362|FG001|Overall Study|Withdrawal by Subject|0|||
131494733|NCT01513473|473438363|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
131494734|NCT01513473|473438364|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
131494735|NCT01513473|473438363|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
131494736|NCT01513473|473438364|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
131494737|NCT01513473|473438363|FG000|Main Trial (26 Weeks)|Unclassified|0|||
131494738|NCT01513473|473438364|FG001|Main Trial (26 Weeks)|Unclassified|2|||
131494739|NCT01513473|473438363|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
131494740|NCT01513473|473438364|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
131494741|NCT01513473|473438363|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
131494742|NCT01513473|473438364|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
131494743|NCT03462082|473438367|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
131494744|NCT03462082|473438368|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
131494745|NCT03462082|473438369|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
131494746|NCT03462082|473438370|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
131494747|NCT03462082|473438371|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
131494748|NCT03462082|473438372|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
131494749|NCT03462082|473438373|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
131494750|NCT03462082|473438374|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
131494751|NCT00166114|473438375|FG000|Overall Study|Protocol Violation|2|||
131494752|NCT00166114|473438376|FG001|Overall Study|Protocol Violation|1|||
131494753|NCT00166114|473438375|FG000|Overall Study|Withdrawal by Subject|10|||
131494754|NCT00166114|473438376|FG001|Overall Study|Withdrawal by Subject|4|||
131494755|NCT00166114|473438375|FG000|Overall Study|Adverse Event|2|||
131494756|NCT00166114|473438376|FG001|Overall Study|Adverse Event|1|||
131494757|NCT00743340|473438379|FG000|Overall Study|Study medication non-compliance|1|||
131494758|NCT00743340|473438379|FG000|Overall Study|Lost to Follow-up|1|||
131494759|NCT00743340|473438379|FG000|Overall Study|Withdrawal from the Study|5|||
131494760|NCT00743340|473438379|FG000|Overall Study|Protocol Violation|1|||
131494761|NCT00743340|473438379|FG000|Overall Study|Virologic failure|8|||
131494762|NCT00743340|473438379|FG000|Overall Study|Pregnancy|1|||
131494763|NCT00743340|473438379|FG000|Overall Study|Rolled over to other Gilead Study|23|||
131494764|NCT00743340|473438379|FG000|Overall Study|Participant Relocated|1|||
131494765|NCT01425281|473438382|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
131494766|NCT01425281|473438383|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
131494767|NCT01425281|473438382|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
131494768|NCT01425281|473438383|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
131494769|NCT01425281|473438382|FG000|At 180-day Clinical Follow-up|Death|0|||
131494770|NCT01425281|473438383|FG001|At 180-day Clinical Follow-up|Death|1|||
131494771|NCT01425281|473438382|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
131494772|NCT01425281|473438383|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
131494773|NCT01425281|473438382|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
131494774|NCT01425281|473438383|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
131494775|NCT01425281|473438382|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
131494776|NCT01425281|473438383|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
131494777|NCT01425281|473438382|FG000|At 2-year Clinical Follow-up|Death|2|||
131494778|NCT01425281|473438383|FG001|At 2-year Clinical Follow-up|Death|0|||
131494779|NCT01425281|473438382|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
131494780|NCT01425281|473438383|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
131494781|NCT01425281|473438382|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
131494782|NCT01425281|473438383|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
131494783|NCT01425281|473438382|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
131494784|NCT01425281|473438383|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
131494785|NCT01425281|473438382|FG000|At 3-year Clinical Follow-up|Death|2|||
131494786|NCT01425281|473438383|FG001|At 3-year Clinical Follow-up|Death|3|||
131494787|NCT01425281|473438382|FG000|At 4-year Clinical Follow-up|Death|7|||
131494788|NCT01425281|473438383|FG001|At 4-year Clinical Follow-up|Death|3|||
131494789|NCT01425281|473438382|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
131494790|NCT01425281|473438383|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
131494791|NCT01425281|473438382|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
131494792|NCT01425281|473438383|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
131494793|NCT01425281|473438382|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
131494794|NCT01425281|473438383|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
131494795|NCT01425281|473438382|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
131494796|NCT01425281|473438383|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
131494797|NCT01425281|473438382|FG000|At 5-year Clinical Follow-up|Death|2|||
131494798|NCT01425281|473438383|FG001|At 5-year Clinical Follow-up|Death|0|||
131494799|NCT01425281|473438382|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
131494800|NCT01425281|473438383|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
131494801|NCT01425281|473438382|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
131494802|NCT01425281|473438383|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
131494803|NCT01425281|473438382|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
131494804|NCT01425281|473438383|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
131494805|NCT03454997|473438384|FG000|Overall Study|Staff Coach - Left Oranization|1|||
131494806|NCT03454997|473438385|FG001|Overall Study|Staff Coach - Left Oranization|1|||
131494807|NCT03454997|473438384|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
131494808|NCT03454997|473438385|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
131494809|NCT03454997|473438384|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
131494810|NCT03454997|473438385|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
131494811|NCT03454997|473438384|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
131494812|NCT03454997|473438385|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
131494813|NCT03454997|473438384|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
131494814|NCT03454997|473438385|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
131494815|NCT03454997|473438384|FG000|Overall Study|Client with SMI - Left organization|0|||
131494816|NCT03454997|473438385|FG001|Overall Study|Client with SMI - Left organization|1|||
131494817|NCT03454997|473438384|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
131494818|NCT03454997|473438385|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
131494819|NCT01402492|473438389|FG000|Overall Study|Withdrawal by Subject|17|||
131494820|NCT01402492|473438390|FG001|Overall Study|Withdrawal by Subject|11|||
131494821|NCT01402492|473438391|FG002|Overall Study|Withdrawal by Subject|11|||
131494822|NCT01402492|473438389|FG000|Overall Study|Adverse Event|2|||
131494823|NCT01402492|473438390|FG001|Overall Study|Adverse Event|3|||
131494824|NCT01402492|473438391|FG002|Overall Study|Adverse Event|4|||
131494825|NCT01402492|473438389|FG000|Overall Study|Physician Decision|0|||
131494826|NCT01402492|473438390|FG001|Overall Study|Physician Decision|3|||
131494827|NCT01402492|473438391|FG002|Overall Study|Physician Decision|0|||
131494828|NCT01402492|473438389|FG000|Overall Study|Incarcerated (N=3)|2|||
131494829|NCT01402492|473438390|FG001|Overall Study|Incarcerated (N=3)|0|||
131494830|NCT01402492|473438391|FG002|Overall Study|Incarcerated (N=3)|1|||
131494831|NCT00814164|473438392|FG000|Overall Study|Progression|7|||
131494832|NCT00814164|473438392|FG000|Overall Study|not stated|7|||
131494833|NCT00814164|473438392|FG000|Overall Study|Death|5|||
131494834|NCT01169493|473438398|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
131494835|NCT01169493|473438399|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
131494836|NCT01169493|473438400|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
131494837|NCT01169493|473438401|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
131494838|NCT01169493|473438402|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
131494839|NCT01169493|473438403|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
131494840|NCT01169493|473438398|FG000|Period 3 (6 Months)|Adverse Event|0|||
131494841|NCT01169493|473438399|FG001|Period 3 (6 Months)|Adverse Event|1|||
131494842|NCT01169493|473438400|FG002|Period 3 (6 Months)|Adverse Event|0|||
131494843|NCT01169493|473438401|FG003|Period 3 (6 Months)|Adverse Event|0|||
131494844|NCT01169493|473438402|FG004|Period 3 (6 Months)|Adverse Event|0|||
131494845|NCT01169493|473438403|FG005|Period 3 (6 Months)|Adverse Event|0|||
131494846|NCT01169493|473438398|FG000|Period 3 (6 Months)|Physician Decision|0|||
131494847|NCT01169493|473438399|FG001|Period 3 (6 Months)|Physician Decision|1|||
131494848|NCT01169493|473438400|FG002|Period 3 (6 Months)|Physician Decision|1|||
131494849|NCT01169493|473438401|FG003|Period 3 (6 Months)|Physician Decision|0|||
131494850|NCT01169493|473438402|FG004|Period 3 (6 Months)|Physician Decision|0|||
131494851|NCT01169493|473438403|FG005|Period 3 (6 Months)|Physician Decision|0|||
131494852|NCT01906008|473438407|FG000|Overall Study|Lost to Follow-up|2|||
131494853|NCT01906008|473438408|FG001|Overall Study|Lost to Follow-up|0|||
131494854|NCT01906008|473438407|FG000|Overall Study|Oxaliplatin toxicity|2|||
131494855|NCT01906008|473438408|FG001|Overall Study|Oxaliplatin toxicity|0|||
131494856|NCT01906008|473438407|FG000|Overall Study|Protocol Violation|0|||
131494857|NCT01906008|473438408|FG001|Overall Study|Protocol Violation|1|||
131494858|NCT01906008|473438407|FG000|Overall Study|Withdrawal by Subject|1|||
131494859|NCT01906008|473438408|FG001|Overall Study|Withdrawal by Subject|5|||
131494860|NCT01906008|473438407|FG000|Overall Study|Did not start study med|3|||
131494861|NCT01906008|473438408|FG001|Overall Study|Did not start study med|4|||
131494862|NCT01906008|473438407|FG000|Overall Study|Oxaliplatin stops|10|||
131494863|NCT01906008|473438408|FG001|Overall Study|Oxaliplatin stops|8|||
131494864|NCT01906008|473438407|FG000|Overall Study|Hospice|1|||
131494865|NCT01906008|473438408|FG001|Overall Study|Hospice|0|||
131494866|NCT01906008|473438407|FG000|Overall Study|Physician Decision|3|||
131494867|NCT01906008|473438408|FG001|Overall Study|Physician Decision|3|||
131494868|NCT01906008|473438407|FG000|Overall Study|Lack of compliance of study med|5|||
131494869|NCT01906008|473438408|FG001|Overall Study|Lack of compliance of study med|3|||
131494870|NCT01906008|473438407|FG000|Overall Study|Adverse Event|0|||
131494871|NCT01906008|473438408|FG001|Overall Study|Adverse Event|3|||
131494872|NCT02651922|473438412|FG000|Overall Study|due to exclusion criteria|2|||
131494873|NCT02220205|473438414|FG000|Overall Study|Withdrawal by Subject|1|||
131494874|NCT02220205|473438415|FG001|Overall Study|Withdrawal by Subject|0|||
131494875|NCT02266225|473438416|FG000|Overall Study|Lost to Follow-up|2|||
131494876|NCT02266225|473438416|FG000|Overall Study|Death|1|||
131494877|NCT02266225|473438416|FG000|Overall Study|Withdrawal by Subject|13|||
131494878|NCT01465997|473438417|FG000|Overall Study|Adverse Event|12|||
131494879|NCT01465997|473438418|FG001|Overall Study|Adverse Event|22|||
131494880|NCT01465997|473438417|FG000|Overall Study|Lack of Efficacy|13|||
131494881|NCT01465997|473438418|FG001|Overall Study|Lack of Efficacy|1|||
131494882|NCT01465997|473438417|FG000|Overall Study|Protocol Violation|1|||
131494883|NCT01465997|473438418|FG001|Overall Study|Protocol Violation|4|||
131494884|NCT01465997|473438417|FG000|Overall Study|Lost to Follow-up|6|||
131494885|NCT01465997|473438418|FG001|Overall Study|Lost to Follow-up|9|||
131494886|NCT01465997|473438417|FG000|Overall Study|Withdrawal by Subject|32|||
131494887|NCT01465997|473438418|FG001|Overall Study|Withdrawal by Subject|35|||
131494888|NCT01465997|473438417|FG000|Overall Study|investigator's decision|1|||
131494889|NCT01465997|473438418|FG001|Overall Study|investigator's decision|1|||
131494890|NCT01465997|473438417|FG000|Overall Study|Death|0|||
131494891|NCT01465997|473438418|FG001|Overall Study|Death|1|||
131494892|NCT01465997|473438417|FG000|Overall Study|sponsor's decision|1|||
131494893|NCT01465997|473438418|FG001|Overall Study|sponsor's decision|1|||
131494894|NCT01465997|473438417|FG000|Overall Study|subject withdrew consent|1|||
131494895|NCT01465997|473438418|FG001|Overall Study|subject withdrew consent|0|||
131494896|NCT01465997|473438417|FG000|Overall Study|local lab unblinded site|1|||
131494897|NCT01465997|473438418|FG001|Overall Study|local lab unblinded site|0|||
131494898|NCT01465997|473438417|FG000|Overall Study|withdrew before follow-up|0|||
131494899|NCT01465997|473438418|FG001|Overall Study|withdrew before follow-up|13|||
131494900|NCT01465997|473438417|FG000|Overall Study|decision by site staff|0|||
131494901|NCT01465997|473438418|FG001|Overall Study|decision by site staff|1|||
131494902|NCT01465997|473438417|FG000|Overall Study|subject left participation SP0993|0|||
131494903|NCT01465997|473438418|FG001|Overall Study|subject left participation SP0993|1|||
131494904|NCT02246660|473438419|FG000|Overall Study|Withdrawal by Subject|0|||
131494905|NCT02246660|473438420|FG001|Overall Study|Withdrawal by Subject|1|||
131494906|NCT02246660|473438421|FG002|Overall Study|Withdrawal by Subject|0|||
131494907|NCT02246660|473438419|FG000|Overall Study|Death|0|||
131494908|NCT02246660|473438420|FG001|Overall Study|Death|0|||
131494909|NCT02246660|473438421|FG002|Overall Study|Death|1|||
131494910|NCT00642460|473438424|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
131494911|NCT00642460|473438425|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
131494912|NCT00642460|473438426|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
131494913|NCT00642460|473438427|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
131494914|NCT00642460|473438428|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
131494915|NCT00642460|473438429|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
131494916|NCT00642460|473438424|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
131494917|NCT00642460|473438425|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
131494918|NCT00642460|473438426|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
131494919|NCT00642460|473438427|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
131494920|NCT00642460|473438428|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
131494921|NCT00642460|473438429|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
131494922|NCT00642460|473438424|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
131494923|NCT00642460|473438425|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
131494924|NCT00642460|473438426|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
131494925|NCT00642460|473438427|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
131494926|NCT00642460|473438428|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
131494927|NCT00642460|473438429|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
131494928|NCT00642460|473438424|FG000|Part II: Open-Label Up to Week 92|Death|0|||
131494929|NCT00642460|473438425|FG001|Part II: Open-Label Up to Week 92|Death|1|||
131494930|NCT00642460|473438426|FG002|Part II: Open-Label Up to Week 92|Death|0|||
131494931|NCT00642460|473438427|FG003|Part II: Open-Label Up to Week 92|Death|2|||
131494932|NCT00642460|473438428|FG004|Part II: Open-Label Up to Week 92|Death|0|||
131494933|NCT00642460|473438429|FG005|Part II: Open-Label Up to Week 92|Death|0|||
131494934|NCT00642460|473438424|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
131494935|NCT00642460|473438425|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
131494936|NCT00642460|473438426|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
131494937|NCT00642460|473438427|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
131494938|NCT00642460|473438428|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
131494939|NCT00642460|473438429|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
131494940|NCT00642460|473438424|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
131494941|NCT00642460|473438425|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
131494942|NCT00642460|473438426|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
131494943|NCT00642460|473438427|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
131494944|NCT00642460|473438428|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
131494945|NCT00642460|473438429|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
131494946|NCT00642460|473438424|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
131494947|NCT00642460|473438425|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
131494948|NCT00642460|473438426|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
131494949|NCT00642460|473438427|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
131494950|NCT00642460|473438428|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
131494951|NCT00642460|473438429|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
131494952|NCT00642460|473438424|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
131494953|NCT00642460|473438425|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
131494954|NCT00642460|473438426|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
131494955|NCT00642460|473438427|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
131494956|NCT00642460|473438428|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
131494957|NCT00642460|473438429|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
131494958|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
131494959|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
131494960|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
131494961|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
131494962|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
131494963|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
131494964|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
131494965|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
131494966|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
131494967|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
131494968|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
131494969|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
131494970|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
131494971|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
131494972|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
131494973|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
131494974|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
131494975|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
131494976|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
131494977|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
131494978|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
131494979|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
131494980|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
131494981|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
131494982|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Other|0|||
131494983|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Other|0|||
131494984|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Other|0|||
131494985|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Other|0|||
131494986|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Other|2|||
131494987|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Other|2|||
131494988|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Death|0|||
131494989|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Death|0|||
131494990|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Death|0|||
131494991|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Death|0|||
131494992|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Death|0|||
131494993|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Death|3|||
131494994|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
131494995|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
131494996|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
131494997|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
131494998|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
131494999|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
131495000|NCT00642460|473438424|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
131495001|NCT00642460|473438425|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
131495002|NCT00642460|473438426|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
131495003|NCT00642460|473438427|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
131495004|NCT00642460|473438428|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
131495005|NCT00642460|473438429|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
131495006|NCT02557646|473438432|FG000|Overall Study|Adverse Event|40|||
131495007|NCT02557646|473438432|FG000|Overall Study|Death|1|||
131495008|NCT02557646|473438432|FG000|Overall Study|Lack of Efficacy|186|||
131495009|NCT02557646|473438432|FG000|Overall Study|Withdrawal by Subject|18|||
131495010|NCT02557646|473438432|FG000|Overall Study|Lost to Follow-up|17|||
131495011|NCT02557646|473438432|FG000|Overall Study|Other|14|||
131495012|NCT01217814|473438433|FG000|Overall Study|Adverse Event|1|||
131495013|NCT01217814|473438434|FG001|Overall Study|Adverse Event|1|||
131495014|NCT01217814|473438435|FG002|Overall Study|Adverse Event|0|||
131495015|NCT01217814|473438433|FG000|Overall Study|Lack of Efficacy|0|||
131495016|NCT01217814|473438434|FG001|Overall Study|Lack of Efficacy|0|||
131495017|NCT01217814|473438435|FG002|Overall Study|Lack of Efficacy|1|||
131495018|NCT00496054|473438438|FG000|Overall Study|Adverse Event|1|||
131495019|NCT00496054|473438438|FG000|Overall Study|Lost to Follow-up|7|||
131495020|NCT00471328|473438445|FG000|Core Phase|Adverse Event|18|||
131495021|NCT00471328|473438446|FG001|Core Phase|Adverse Event|6|||
131495022|NCT00471328|473438445|FG000|Core Phase|Death|8|||
131495023|NCT00471328|473438446|FG001|Core Phase|Death|4|||
131495024|NCT00471328|473438445|FG000|Core Phase|Withdrawal by Subject|2|||
131495025|NCT00471328|473438446|FG001|Core Phase|Withdrawal by Subject|2|||
131495026|NCT00471328|473438445|FG000|Core Phase|Abnormal laboratory value|1|||
131495027|NCT00471328|473438446|FG001|Core Phase|Abnormal laboratory value|0|||
131495028|NCT00471328|473438445|FG000|Core Phase|Disease Progression|78|||
131495029|NCT00471328|473438446|FG001|Core Phase|Disease Progression|53|||
131495030|NCT00471328|473438445|FG000|Core Phase|Administrative Problem|0|||
131495031|NCT00471328|473438446|FG001|Core Phase|Administrative Problem|1|||
131495032|NCT00471328|473438445|FG000|Core Phase|Protocol Deviation|0|||
131495033|NCT00471328|473438446|FG001|Core Phase|Protocol Deviation|1|||
131495034|NCT00471328|473438445|FG000|Extension Phase|Adverse Event|3|||
131495035|NCT00471328|473438446|FG001|Extension Phase|Adverse Event|12|||
131495036|NCT00471328|473438445|FG000|Extension Phase|Withdrawal by Subject|0|||
131495037|NCT00471328|473438446|FG001|Extension Phase|Withdrawal by Subject|2|||
131495038|NCT00471328|473438445|FG000|Extension Phase|Death|1|||
131495039|NCT00471328|473438446|FG001|Extension Phase|Death|7|||
131495040|NCT00471328|473438445|FG000|Extension Phase|Protocol Deviation|3|||
131495041|NCT00471328|473438446|FG001|Extension Phase|Protocol Deviation|1|||
131495042|NCT00471328|473438445|FG000|Extension Phase|Treatment duration as per protocol|0|||
131495043|NCT00471328|473438446|FG001|Extension Phase|Treatment duration as per protocol|1|||
131495044|NCT00471328|473438445|FG000|Extension Phase|Disease Progression|32|||
131495045|NCT00471328|473438446|FG001|Extension Phase|Disease Progression|44|||
131495046|NCT00471328|473438445|FG000|Extension Phase|New cancer Therapy|1|||
131495047|NCT00471328|473438446|FG001|Extension Phase|New cancer Therapy|0|||
131495048|NCT00471328|473438445|FG000|Extension Phase|Administrative Problem|1|||
131495049|NCT00471328|473438446|FG001|Extension Phase|Administrative Problem|0|||
131495050|NCT02239978|473439744|FG000|Overall Study|Withdrawal by Subject|2|||
131495051|NCT02239978|473439745|FG001|Overall Study|Withdrawal by Subject|0|||
131495052|NCT01943292|473439749|FG000|Overall Study|Withdrawal by Subject|1|||
131495053|NCT01943292|473439750|FG001|Overall Study|Withdrawal by Subject|0|||
131495054|NCT01943292|473439751|FG002|Overall Study|Withdrawal by Subject|0|||
131495055|NCT00911820|473439752|FG000|Overall Study|RECIST progression|12|||
131495056|NCT00911820|473439753|FG001|Overall Study|RECIST progression|8|||
131495057|NCT00911820|473439752|FG000|Overall Study|Adverse Event|8|||
131495058|NCT00911820|473439753|FG001|Overall Study|Adverse Event|8|||
131495059|NCT00911820|473439752|FG000|Overall Study|Clinical Progression|7|||
131495060|NCT00911820|473439753|FG001|Overall Study|Clinical Progression|5|||
131495061|NCT00911820|473439752|FG000|Overall Study|Physician Decision|5|||
131495062|NCT00911820|473439753|FG001|Overall Study|Physician Decision|9|||
131495063|NCT00911820|473439752|FG000|Overall Study|Decline in Performance Status|4|||
131495064|NCT00911820|473439753|FG001|Overall Study|Decline in Performance Status|2|||
131495065|NCT00911820|473439752|FG000|Overall Study|Withdrawal by Subject|3|||
131495066|NCT00911820|473439753|FG001|Overall Study|Withdrawal by Subject|4|||
131495067|NCT00911820|473439752|FG000|Overall Study|Death|1|||
131495068|NCT00911820|473439753|FG001|Overall Study|Death|2|||
131495069|NCT00911820|473439752|FG000|Overall Study|Pursue surgery|1|||
131495070|NCT00911820|473439753|FG001|Overall Study|Pursue surgery|1|||
131495071|NCT00911820|473439752|FG000|Overall Study|Pursue Radiation|1|||
131495072|NCT00911820|473439753|FG001|Overall Study|Pursue Radiation|0|||
131495073|NCT00911820|473439752|FG000|Overall Study|Still on Therapy|2|||
131495074|NCT00911820|473439753|FG001|Overall Study|Still on Therapy|2|||
131495075|NCT00911820|473439752|FG000|Overall Study|Pathology Not Confirmed|1|||
131495076|NCT00911820|473439753|FG001|Overall Study|Pathology Not Confirmed|0|||
131495077|NCT00911820|473439752|FG000|Overall Study|Withdraw before Receive Treatment|0|||
131495078|NCT00911820|473439753|FG001|Overall Study|Withdraw before Receive Treatment|2|||
131495079|NCT01852110|473439754|FG000|Overall Study|Adverse Event|12|||
131495080|NCT01852110|473439755|FG001|Overall Study|Adverse Event|5|||
131495081|NCT01852110|473439756|FG002|Overall Study|Adverse Event|0|||
131495082|NCT01852110|473439757|FG003|Overall Study|Adverse Event|0|||
131495083|NCT01852110|473439758|FG004|Overall Study|Adverse Event|0|||
131495084|NCT01852110|473439759|FG005|Overall Study|Adverse Event|0|||
131495085|NCT01852110|473439754|FG000|Overall Study|Lost to Follow-up|1|||
131495086|NCT01852110|473439755|FG001|Overall Study|Lost to Follow-up|3|||
131495087|NCT01852110|473439756|FG002|Overall Study|Lost to Follow-up|0|||
131495088|NCT01852110|473439757|FG003|Overall Study|Lost to Follow-up|0|||
131495089|NCT01852110|473439758|FG004|Overall Study|Lost to Follow-up|0|||
131495090|NCT01852110|473439759|FG005|Overall Study|Lost to Follow-up|0|||
131495091|NCT01852110|473439754|FG000|Overall Study|Non-compliance with Study Drug|2|||
131495092|NCT01852110|473439755|FG001|Overall Study|Non-compliance with Study Drug|1|||
131495093|NCT01852110|473439756|FG002|Overall Study|Non-compliance with Study Drug|0|||
131495094|NCT01852110|473439757|FG003|Overall Study|Non-compliance with Study Drug|0|||
131495095|NCT01852110|473439758|FG004|Overall Study|Non-compliance with Study Drug|0|||
131495096|NCT01852110|473439759|FG005|Overall Study|Non-compliance with Study Drug|0|||
131495097|NCT01852110|473439754|FG000|Overall Study|Physician Decision|1|||
131495098|NCT01852110|473439755|FG001|Overall Study|Physician Decision|0|||
131495099|NCT01852110|473439756|FG002|Overall Study|Physician Decision|0|||
131495100|NCT01852110|473439757|FG003|Overall Study|Physician Decision|0|||
131495101|NCT01852110|473439758|FG004|Overall Study|Physician Decision|0|||
131495102|NCT01852110|473439759|FG005|Overall Study|Physician Decision|0|||
131495103|NCT01852110|473439754|FG000|Overall Study|Protocol Violation|0|||
131495104|NCT01852110|473439755|FG001|Overall Study|Protocol Violation|1|||
131495105|NCT01852110|473439756|FG002|Overall Study|Protocol Violation|0|||
131495106|NCT01852110|473439757|FG003|Overall Study|Protocol Violation|0|||
131495107|NCT01852110|473439758|FG004|Overall Study|Protocol Violation|0|||
131495108|NCT01852110|473439759|FG005|Overall Study|Protocol Violation|0|||
131495109|NCT01852110|473439754|FG000|Overall Study|Study Terminated by Sponsor|30|||
131495110|NCT01852110|473439755|FG001|Overall Study|Study Terminated by Sponsor|32|||
131495111|NCT01852110|473439756|FG002|Overall Study|Study Terminated by Sponsor|0|||
131495112|NCT01852110|473439757|FG003|Overall Study|Study Terminated by Sponsor|0|||
131495113|NCT01852110|473439758|FG004|Overall Study|Study Terminated by Sponsor|0|||
131495114|NCT01852110|473439759|FG005|Overall Study|Study Terminated by Sponsor|0|||
131495115|NCT01852110|473439754|FG000|Overall Study|Withdrawal by Subject|4|||
131495116|NCT01852110|473439755|FG001|Overall Study|Withdrawal by Subject|4|||
131495117|NCT01852110|473439756|FG002|Overall Study|Withdrawal by Subject|0|||
131495118|NCT01852110|473439757|FG003|Overall Study|Withdrawal by Subject|0|||
131495119|NCT01852110|473439758|FG004|Overall Study|Withdrawal by Subject|0|||
131495120|NCT01852110|473439759|FG005|Overall Study|Withdrawal by Subject|0|||
131495121|NCT00410046|473439762|FG000|Overall Study|Adverse Event|3|||
131495122|NCT00410046|473439762|FG000|Overall Study|Withdrawal by Subject|1|||
131495123|NCT00410046|473439762|FG000|Overall Study|Lost to Follow-up|1|||
131495124|NCT03098550|473439763|FG000|Overall Study|Disease Progression|30|||
131495125|NCT03098550|473439764|FG001|Overall Study|Disease Progression|19|||
131495126|NCT03098550|473439765|FG002|Overall Study|Disease Progression|41|||
131495127|NCT03098550|473439763|FG000|Overall Study|Study Drug Toxicity|2|||
131495128|NCT03098550|473439764|FG001|Overall Study|Study Drug Toxicity|1|||
131495129|NCT03098550|473439765|FG002|Overall Study|Study Drug Toxicity|0|||
131495130|NCT03098550|473439763|FG000|Overall Study|Death|1|||
131495131|NCT03098550|473439764|FG001|Overall Study|Death|0|||
131495132|NCT03098550|473439765|FG002|Overall Study|Death|0|||
131495133|NCT03098550|473439763|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
131495134|NCT03098550|473439764|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
131495135|NCT03098550|473439765|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
131495136|NCT03098550|473439763|FG000|Overall Study|Administrative reason by sponsor|0|||
131495137|NCT03098550|473439764|FG001|Overall Study|Administrative reason by sponsor|0|||
131495138|NCT03098550|473439765|FG002|Overall Study|Administrative reason by sponsor|1|||
131495139|NCT03098550|473439763|FG000|Overall Study|Other reasons|2|||
131495140|NCT03098550|473439764|FG001|Overall Study|Other reasons|0|||
131495141|NCT03098550|473439765|FG002|Overall Study|Other reasons|0|||
131495142|NCT04160091|473439769|FG000|Overall Study|Terminated by Sponsor|7|||
131495143|NCT04160091|473439770|FG001|Overall Study|Terminated by Sponsor|3|||
131495144|NCT04160091|473439771|FG002|Overall Study|Terminated by Sponsor|5|||
131495145|NCT04160091|473439772|FG003|Overall Study|Terminated by Sponsor|2|||
131495146|NCT04160091|473439769|FG000|Overall Study|Noncompliance|0|||
131495147|NCT04160091|473439770|FG001|Overall Study|Noncompliance|0|||
131495148|NCT04160091|473439771|FG002|Overall Study|Noncompliance|0|||
131495149|NCT04160091|473439772|FG003|Overall Study|Noncompliance|1|||
131495150|NCT04160091|473439769|FG000|Overall Study|Withdrawal by Subject|0|||
131495151|NCT04160091|473439770|FG001|Overall Study|Withdrawal by Subject|0|||
131495152|NCT04160091|473439771|FG002|Overall Study|Withdrawal by Subject|0|||
131495153|NCT04160091|473439772|FG003|Overall Study|Withdrawal by Subject|1|||
131495154|NCT00309387|473439774|FG000|Overall Study|Death|72|||
131495155|NCT00309387|473439775|FG001|Overall Study|Death|73|||
131495156|NCT00309387|473439774|FG000|Overall Study|Lost to Follow-up|70|||
131495157|NCT00309387|473439775|FG001|Overall Study|Lost to Follow-up|86|||
131495158|NCT00381095|473439777|FG000|Overall Study|Death|3|||
131495159|NCT00381095|473439778|FG001|Overall Study|Death|4|||
131495160|NCT00381095|473439777|FG000|Overall Study|Lack of Efficacy|2|||
131495161|NCT00381095|473439778|FG001|Overall Study|Lack of Efficacy|4|||
131495162|NCT00381095|473439777|FG000|Overall Study|Other|2|||
131495163|NCT00381095|473439778|FG001|Overall Study|Other|2|||
131495164|NCT00381095|473439777|FG000|Overall Study|Protocol Violation|1|||
131495165|NCT00381095|473439778|FG001|Overall Study|Protocol Violation|1|||
131495166|NCT00381095|473439777|FG000|Overall Study|Withdrawal by Subject|3|||
131495167|NCT00381095|473439778|FG001|Overall Study|Withdrawal by Subject|3|||
131495168|NCT00381095|473439777|FG000|Overall Study|Adverse Event|2|||
131495169|NCT00381095|473439778|FG001|Overall Study|Adverse Event|7|||
131495170|NCT00411645|473439783|FG000|Overall Study|Consent Withdrawn|13|||
131495171|NCT00411645|473439784|FG001|Overall Study|Consent Withdrawn|22|||
131495172|NCT00411645|473439783|FG000|Overall Study|Death|56|||
131495173|NCT00411645|473439784|FG001|Overall Study|Death|135|||
131495174|NCT00411645|473439783|FG000|Overall Study|Investigator/Sponsor Decision|10|||
131495175|NCT00411645|473439784|FG001|Overall Study|Investigator/Sponsor Decision|7|||
131495176|NCT00411645|473439783|FG000|Overall Study|Lost to Follow-up|2|||
131495177|NCT00411645|473439784|FG001|Overall Study|Lost to Follow-up|0|||
131495178|NCT02495168|473439785|FG000|Overall Study|Other than Specified|18|||
131495179|NCT02495168|473439786|FG001|Overall Study|Other than Specified|22|||
131495180|NCT02495168|473439787|FG002|Overall Study|Other than Specified|5|||
131495181|NCT02495168|473439785|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
131495182|NCT02495168|473439786|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
131495183|NCT02495168|473439787|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
131495184|NCT02495168|473439785|FG000|Overall Study|Physician Decision|1|||
131495185|NCT02495168|473439786|FG001|Overall Study|Physician Decision|1|||
131495186|NCT02495168|473439787|FG002|Overall Study|Physician Decision|0|||
131495187|NCT02495168|473439785|FG000|Overall Study|Lost to Follow-up|10|||
131495188|NCT02495168|473439786|FG001|Overall Study|Lost to Follow-up|6|||
131495189|NCT02495168|473439787|FG002|Overall Study|Lost to Follow-up|1|||
131495190|NCT02495168|473439785|FG000|Overall Study|Withdrawal by Subject|1|||
131495191|NCT02495168|473439786|FG001|Overall Study|Withdrawal by Subject|4|||
131495192|NCT02495168|473439787|FG002|Overall Study|Withdrawal by Subject|2|||
131495193|NCT02495168|473439785|FG000|Overall Study|Protocol Violation|0|||
131495194|NCT02495168|473439786|FG001|Overall Study|Protocol Violation|10|||
131495195|NCT02495168|473439787|FG002|Overall Study|Protocol Violation|1|||
131495196|NCT02495168|473439785|FG000|Overall Study|Adverse Event|4|||
131495197|NCT02495168|473439786|FG001|Overall Study|Adverse Event|8|||
131495198|NCT02495168|473439787|FG002|Overall Study|Adverse Event|3|||
131495199|NCT02495168|473439785|FG000|Overall Study|Lack of Efficacy|0|||
131495200|NCT02495168|473439786|FG001|Overall Study|Lack of Efficacy|0|||
131495201|NCT02495168|473439787|FG002|Overall Study|Lack of Efficacy|3|||
131495202|NCT04626297|473439790|FG000|Overall Study|Adverse Event|5|||
131495203|NCT04626297|473439791|FG001|Overall Study|Adverse Event|3|||
131495204|NCT04626297|473439790|FG000|Overall Study|Lost to Follow-up|7|||
131495205|NCT04626297|473439791|FG001|Overall Study|Lost to Follow-up|3|||
131495206|NCT04626297|473439790|FG000|Overall Study|Protocol Violation|5|||
131495207|NCT04626297|473439791|FG001|Overall Study|Protocol Violation|1|||
131495208|NCT04626297|473439790|FG000|Overall Study|Withdrawal by Subject|20|||
131495209|NCT04626297|473439791|FG001|Overall Study|Withdrawal by Subject|6|||
131495210|NCT04626297|473439790|FG000|Overall Study|Sponsor decision|2|||
131495211|NCT04626297|473439791|FG001|Overall Study|Sponsor decision|1|||
131495212|NCT05048784|473439798|FG000|Period 1|Adverse Event|3|||
131495213|NCT05048784|473439799|FG001|Period 1|Adverse Event|1|||
131495214|NCT05048784|473439800|FG002|Period 1|Adverse Event|0|||
131495215|NCT05048784|473439801|FG003|Period 1|Adverse Event|0|||
131495216|NCT05048784|473439798|FG000|Period 2|Lost to Follow-up|0|||
131495217|NCT05048784|473439799|FG001|Period 2|Lost to Follow-up|1|||
131495218|NCT05048784|473439800|FG002|Period 2|Lost to Follow-up|0|||
131495219|NCT05048784|473439801|FG003|Period 2|Lost to Follow-up|0|||
131495220|NCT03521934|473439802|FG000|Overall Study|Death|65|||
131495221|NCT03521934|473439803|FG001|Overall Study|Death|73|||
131495222|NCT03521934|473439802|FG000|Overall Study|Withdrawal by Subject|18|||
131495223|NCT03521934|473439803|FG001|Overall Study|Withdrawal by Subject|23|||
131495224|NCT03521934|473439802|FG000|Overall Study|Site Terminated by Sponsor|39|||
131495225|NCT03521934|473439803|FG001|Overall Study|Site Terminated by Sponsor|35|||
131495226|NCT03521934|473439802|FG000|Overall Study|Study Terminated by Sponsor|483|||
131495227|NCT03521934|473439803|FG001|Overall Study|Study Terminated by Sponsor|477|||
131495228|NCT03521934|473439802|FG000|Overall Study|Reason not Specified|3|||
131495229|NCT03521934|473439803|FG001|Overall Study|Reason not Specified|6|||
131495230|NCT04016285|473439804|FG000|Overall Study|Did not progress to surgery|2|||
131495231|NCT04016285|473439805|FG001|Overall Study|Did not progress to surgery|5|||
131495232|NCT04016285|473439804|FG000|Overall Study|Failed to collect outcome data|5|||
131495233|NCT04016285|473439805|FG001|Overall Study|Failed to collect outcome data|3|||
131495234|NCT01750242|473439810|FG000|Overall Study|Unreadable Images|3|||
131495235|NCT00299975|473439819|FG000|Overall Study|Adverse Event|1|||
131495236|NCT00299975|473439820|FG001|Overall Study|Adverse Event|0|||
131495237|NCT00299975|473439821|FG002|Overall Study|Adverse Event|2|||
131495238|NCT00299975|473439819|FG000|Overall Study|Pregnancy|0|||
131495239|NCT00299975|473439820|FG001|Overall Study|Pregnancy|0|||
131495240|NCT00299975|473439821|FG002|Overall Study|Pregnancy|1|||
131495241|NCT00299975|473439819|FG000|Overall Study|Lack of Efficacy|1|||
131495242|NCT00299975|473439820|FG001|Overall Study|Lack of Efficacy|0|||
131495243|NCT00299975|473439821|FG002|Overall Study|Lack of Efficacy|1|||
131495244|NCT00299975|473439819|FG000|Overall Study|Lost to Follow-up|1|||
131495245|NCT00299975|473439820|FG001|Overall Study|Lost to Follow-up|0|||
131495246|NCT00299975|473439821|FG002|Overall Study|Lost to Follow-up|0|||
131495247|NCT00299975|473439819|FG000|Overall Study|Withdrawal by Subject|0|||
131495248|NCT00299975|473439820|FG001|Overall Study|Withdrawal by Subject|1|||
131495249|NCT00299975|473439821|FG002|Overall Study|Withdrawal by Subject|3|||
131495250|NCT00299975|473439819|FG000|Overall Study|Physician Decision|0|||
131495251|NCT00299975|473439820|FG001|Overall Study|Physician Decision|0|||
131495252|NCT00299975|473439821|FG002|Overall Study|Physician Decision|1|||
131495253|NCT00982878|473439822|FG000|Overall Study|Physician Decision|1|||
131495254|NCT03167411|473439825|FG000|Overall Study|Adverse Event|0|||
131495255|NCT03167411|473439826|FG001|Overall Study|Adverse Event|1|||
131495256|NCT02627144|473439829|FG000|Overall Study|Serious adverse event|32|||
131495257|NCT02627144|473439829|FG000|Overall Study|Cancer progression|171|||
131495258|NCT02627144|473439829|FG000|Overall Study|Death from cancer|20|||
131495259|NCT02627144|473439829|FG000|Overall Study|Death from other cause|8|||
131495260|NCT02627144|473439829|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
131495261|NCT02627144|473439829|FG000|Overall Study|Administrative reasons|65|||
131495262|NCT02627144|473439829|FG000|Overall Study|Lost to Follow-up|8|||
131495263|NCT02627144|473439829|FG000|Overall Study|Enrolled, not treated|6|||
131495264|NCT02627144|473439829|FG000|Overall Study|Other|17|||
131495265|NCT01025752|473439836|FG000|Overall Study|Lost to Follow-up|7|||
131495266|NCT01025752|473439837|FG001|Overall Study|Lost to Follow-up|10|||
131495267|NCT01025752|473439836|FG000|Overall Study|Physician Decision|1|||
131495268|NCT01025752|473439837|FG001|Overall Study|Physician Decision|3|||
131495269|NCT01417234|473439840|FG000|Overall Study|Subject non-compliant|3|||
131495270|NCT00023764|473439841|FG000|Overall Study|Other|1|||
131495271|NCT00023764|473439841|FG000|Overall Study|Adverse Event|4|||
131495272|NCT00023764|473439841|FG000|Overall Study|Withdrawal by Subject|1|||
131495273|NCT00023764|473439841|FG000|Overall Study|Progression of disease|6|||
131495274|NCT00023764|473439841|FG000|Overall Study|patient received other treatment|1|||
131495275|NCT00023764|473439841|FG000|Overall Study|delay in obtaining staging images|1|||
131495276|NCT04294472|473439842|FG000|Overall Study|Adverse Event|0|||
131495277|NCT04294472|473439843|FG001|Overall Study|Adverse Event|1|||
131495278|NCT04294472|473439844|FG002|Overall Study|Adverse Event|1|||
131495279|NCT04294472|473439842|FG000|Overall Study|Randomized but not treated|0|||
131495280|NCT04294472|473439843|FG001|Overall Study|Randomized but not treated|1|||
131495281|NCT04294472|473439844|FG002|Overall Study|Randomized but not treated|1|||
131495282|NCT00357968|473439851|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
131495283|NCT00357968|473439852|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
131495284|NCT00357968|473439851|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
131495285|NCT00357968|473439852|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
131495286|NCT00439244|473439853|FG000|Overall Study|Adverse Event|5|||
131495287|NCT00439244|473439854|FG001|Overall Study|Adverse Event|2|||
131495288|NCT00439244|473439855|FG002|Overall Study|Adverse Event|3|||
131495289|NCT00439244|473439853|FG000|Overall Study|Withdrawal by Subject|3|||
131495290|NCT00439244|473439854|FG001|Overall Study|Withdrawal by Subject|1|||
131495291|NCT00439244|473439855|FG002|Overall Study|Withdrawal by Subject|2|||
131495292|NCT00439244|473439853|FG000|Overall Study|Lost to Follow-up|2|||
131495293|NCT00439244|473439854|FG001|Overall Study|Lost to Follow-up|1|||
131495294|NCT00439244|473439855|FG002|Overall Study|Lost to Follow-up|2|||
131495295|NCT00439244|473439853|FG000|Overall Study|Death|0|||
131495296|NCT00439244|473439854|FG001|Overall Study|Death|1|||
131495297|NCT00439244|473439855|FG002|Overall Study|Death|0|||
131495298|NCT00439244|473439853|FG000|Overall Study|Protocol Violation|0|||
131495299|NCT00439244|473439854|FG001|Overall Study|Protocol Violation|1|||
131495300|NCT00439244|473439855|FG002|Overall Study|Protocol Violation|0|||
131495301|NCT00439244|473439853|FG000|Overall Study|Administrative problems|1|||
131495302|NCT00439244|473439854|FG001|Overall Study|Administrative problems|0|||
131495303|NCT00439244|473439855|FG002|Overall Study|Administrative problems|0|||
131495304|NCT04102020|473439856|FG000|Overall Study|Adverse Event|1|||
131495305|NCT04102020|473439857|FG001|Overall Study|Adverse Event|0|||
131495306|NCT04102020|473439858|FG002|Overall Study|Adverse Event|0|||
131495307|NCT04102020|473439859|FG003|Overall Study|Adverse Event|1|||
131495308|NCT04102020|473439860|FG004|Overall Study|Adverse Event|0|||
131495309|NCT04102020|473439856|FG000|Overall Study|Withdrawal by Subject|0|||
131495310|NCT04102020|473439857|FG001|Overall Study|Withdrawal by Subject|1|||
131495311|NCT04102020|473439858|FG002|Overall Study|Withdrawal by Subject|1|||
131495312|NCT04102020|473439859|FG003|Overall Study|Withdrawal by Subject|1|||
131495313|NCT04102020|473439860|FG004|Overall Study|Withdrawal by Subject|1|||
131495314|NCT04102020|473439856|FG000|Overall Study|Death|1|||
131495315|NCT04102020|473439857|FG001|Overall Study|Death|4|||
131495316|NCT04102020|473439858|FG002|Overall Study|Death|1|||
131495317|NCT04102020|473439859|FG003|Overall Study|Death|1|||
131495318|NCT04102020|473439860|FG004|Overall Study|Death|0|||
131495319|NCT04102020|473439856|FG000|Overall Study|Physician Decision|1|||
131495320|NCT04102020|473439857|FG001|Overall Study|Physician Decision|2|||
131495321|NCT04102020|473439858|FG002|Overall Study|Physician Decision|2|||
131495322|NCT04102020|473439859|FG003|Overall Study|Physician Decision|0|||
131495323|NCT04102020|473439860|FG004|Overall Study|Physician Decision|1|||
131495324|NCT04102020|473439856|FG000|Overall Study|COVID-19 Infection|1|||
131495325|NCT04102020|473439857|FG001|Overall Study|COVID-19 Infection|0|||
131495326|NCT04102020|473439858|FG002|Overall Study|COVID-19 Infection|0|||
131495327|NCT04102020|473439859|FG003|Overall Study|COVID-19 Infection|0|||
131495328|NCT04102020|473439860|FG004|Overall Study|COVID-19 Infection|0|||
131495329|NCT04102020|473439856|FG000|Overall Study|Not disclosed|5|||
131495330|NCT04102020|473439857|FG001|Overall Study|Not disclosed|3|||
131495331|NCT04102020|473439858|FG002|Overall Study|Not disclosed|8|||
131495332|NCT04102020|473439859|FG003|Overall Study|Not disclosed|0|||
131495333|NCT04102020|473439860|FG004|Overall Study|Not disclosed|1|||
131495334|NCT04102020|473439856|FG000|Overall Study|MIssing|1|||
131495335|NCT04102020|473439857|FG001|Overall Study|MIssing|0|||
131495336|NCT04102020|473439858|FG002|Overall Study|MIssing|1|||
131495337|NCT04102020|473439859|FG003|Overall Study|MIssing|1|||
131495338|NCT04102020|473439860|FG004|Overall Study|MIssing|1|||
131495339|NCT04102020|473439856|FG000|Overall Study|Continuing in ongoing study|13|||
131495340|NCT04102020|473439857|FG001|Overall Study|Continuing in ongoing study|13|||
131495341|NCT04102020|473439858|FG002|Overall Study|Continuing in ongoing study|7|||
131495342|NCT04102020|473439859|FG003|Overall Study|Continuing in ongoing study|26|||
131495343|NCT04102020|473439860|FG004|Overall Study|Continuing in ongoing study|12|||
131495344|NCT04600921|473439863|FG000|Overall Study|Withdrawal by Subject|3|||
131495345|NCT04600921|473439864|FG001|Overall Study|Withdrawal by Subject|5|||
131495346|NCT04600921|473439863|FG000|Overall Study|Death|0|||
131495347|NCT04600921|473439864|FG001|Overall Study|Death|1|||
131495348|NCT02700815|473441685|FG000|Overall Study|Adverse Event|0|||
131495349|NCT02700815|473441686|FG001|Overall Study|Adverse Event|6|||
131495350|NCT02700815|473441687|FG002|Overall Study|Adverse Event|2|||
131495351|NCT02700815|473441688|FG003|Overall Study|Adverse Event|3|||
131495352|NCT02700815|473441685|FG000|Overall Study|Lack of Efficacy|0|||
131495353|NCT02700815|473441686|FG001|Overall Study|Lack of Efficacy|0|||
131495354|NCT02700815|473441687|FG002|Overall Study|Lack of Efficacy|1|||
131495355|NCT02700815|473441688|FG003|Overall Study|Lack of Efficacy|2|||
131495356|NCT02700815|473441685|FG000|Overall Study|Lost to Follow-up|1|||
131495357|NCT02700815|473441686|FG001|Overall Study|Lost to Follow-up|0|||
131495358|NCT02700815|473441687|FG002|Overall Study|Lost to Follow-up|0|||
131495359|NCT02700815|473441688|FG003|Overall Study|Lost to Follow-up|1|||
131495360|NCT02700815|473441685|FG000|Overall Study|Refusal to continue medication|0|||
131495361|NCT02700815|473441686|FG001|Overall Study|Refusal to continue medication|1|||
131495362|NCT02700815|473441687|FG002|Overall Study|Refusal to continue medication|0|||
131495363|NCT02700815|473441688|FG003|Overall Study|Refusal to continue medication|1|||
131495364|NCT02700815|473441685|FG000|Overall Study|Withdrawal by Subject|0|||
131495365|NCT02700815|473441686|FG001|Overall Study|Withdrawal by Subject|0|||
131495366|NCT02700815|473441687|FG002|Overall Study|Withdrawal by Subject|1|||
131495367|NCT02700815|473441688|FG003|Overall Study|Withdrawal by Subject|0|||
131495368|NCT00996216|473441694|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
131495369|NCT00996216|473441694|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
131495370|NCT00996216|473441694|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
131495371|NCT00793403|473441697|FG000|Overall Study|Other|73|||
131495372|NCT00842712|473441698|FG000|Safety Run-in Part|Adverse Event|0|||
131495373|NCT00842712|473441699|FG001|Safety Run-in Part|Adverse Event|1|||
131495374|NCT00842712|473441700|FG002|Safety Run-in Part|Adverse Event|0|||
131495375|NCT00842712|473441701|FG003|Safety Run-in Part|Adverse Event|0|||
131495376|NCT00842712|473441702|FG004|Safety Run-in Part|Adverse Event|0|||
131495377|NCT00842712|473441703|FG005|Safety Run-in Part|Adverse Event|0|||
131495378|NCT00842712|473441704|FG006|Safety Run-in Part|Adverse Event|0|||
131495379|NCT00842712|473441698|FG000|Safety Run-in Part|Progressive disease|3|||
131495380|NCT00842712|473441699|FG001|Safety Run-in Part|Progressive disease|1|||
131495381|NCT00842712|473441700|FG002|Safety Run-in Part|Progressive disease|0|||
131495382|NCT00842712|473441701|FG003|Safety Run-in Part|Progressive disease|1|||
131495383|NCT00842712|473441702|FG004|Safety Run-in Part|Progressive disease|0|||
131495384|NCT00842712|473441703|FG005|Safety Run-in Part|Progressive disease|0|||
131495385|NCT00842712|473441704|FG006|Safety Run-in Part|Progressive disease|0|||
131495386|NCT00842712|473441698|FG000|Randomized Part|Randomized but not treated|0|||
131495387|NCT00842712|473441699|FG001|Randomized Part|Randomized but not treated|0|||
131495388|NCT00842712|473441700|FG002|Randomized Part|Randomized but not treated|0|||
131495389|NCT00842712|473441701|FG003|Randomized Part|Randomized but not treated|0|||
131495390|NCT00842712|473441702|FG004|Randomized Part|Randomized but not treated|0|||
131495391|NCT00842712|473441703|FG005|Randomized Part|Randomized but not treated|1|||
131495392|NCT00842712|473441704|FG006|Randomized Part|Randomized but not treated|4|||
131495393|NCT00842712|473441698|FG000|Randomized Part|Ongoing at cut-off date|0|||
131495394|NCT00842712|473441699|FG001|Randomized Part|Ongoing at cut-off date|0|||
131495395|NCT00842712|473441700|FG002|Randomized Part|Ongoing at cut-off date|0|||
131495396|NCT00842712|473441701|FG003|Randomized Part|Ongoing at cut-off date|0|||
131495397|NCT00842712|473441702|FG004|Randomized Part|Ongoing at cut-off date|0|||
131495398|NCT00842712|473441703|FG005|Randomized Part|Ongoing at cut-off date|0|||
131495399|NCT00842712|473441704|FG006|Randomized Part|Ongoing at cut-off date|2|||
131495400|NCT00963547|473441706|FG000|Overall Study|Adverse Event|0|||
131495401|NCT00963547|473441707|FG001|Overall Study|Adverse Event|1|||
131495402|NCT00963547|473441708|FG002|Overall Study|Adverse Event|0|||
131495403|NCT00963547|473441709|FG003|Overall Study|Adverse Event|1|||
131495404|NCT00963547|473441710|FG004|Overall Study|Adverse Event|0|||
131495405|NCT00963547|473441711|FG005|Overall Study|Adverse Event|0|||
131495406|NCT00963547|473441712|FG006|Overall Study|Adverse Event|0|||
131495407|NCT00963547|473441706|FG000|Overall Study|Physician Decision|1|||
131495408|NCT00963547|473441707|FG001|Overall Study|Physician Decision|1|||
131495409|NCT00963547|473441708|FG002|Overall Study|Physician Decision|0|||
131495410|NCT00963547|473441709|FG003|Overall Study|Physician Decision|0|||
131495411|NCT00963547|473441710|FG004|Overall Study|Physician Decision|0|||
131495412|NCT00963547|473441711|FG005|Overall Study|Physician Decision|0|||
131495413|NCT00963547|473441712|FG006|Overall Study|Physician Decision|0|||
131495414|NCT00963547|473441706|FG000|Overall Study|Progressive Disease|3|||
131495415|NCT00963547|473441707|FG001|Overall Study|Progressive Disease|8|||
131495416|NCT00963547|473441708|FG002|Overall Study|Progressive Disease|9|||
131495417|NCT00963547|473441709|FG003|Overall Study|Progressive Disease|5|||
131495418|NCT00963547|473441710|FG004|Overall Study|Progressive Disease|0|||
131495419|NCT00963547|473441711|FG005|Overall Study|Progressive Disease|0|||
131495420|NCT00963547|473441712|FG006|Overall Study|Progressive Disease|0|||
131495421|NCT00963547|473441706|FG000|Overall Study|Withdrawal by Subject|0|||
131495422|NCT00963547|473441707|FG001|Overall Study|Withdrawal by Subject|0|||
131495423|NCT00963547|473441708|FG002|Overall Study|Withdrawal by Subject|3|||
131495424|NCT00963547|473441709|FG003|Overall Study|Withdrawal by Subject|0|||
131495425|NCT00963547|473441710|FG004|Overall Study|Withdrawal by Subject|0|||
131495426|NCT00963547|473441711|FG005|Overall Study|Withdrawal by Subject|0|||
131495427|NCT00963547|473441712|FG006|Overall Study|Withdrawal by Subject|0|||
131495428|NCT00963547|473441706|FG000|Overall Study|Reason Unknown|0|||
131495429|NCT00963547|473441707|FG001|Overall Study|Reason Unknown|1|||
131495430|NCT00963547|473441708|FG002|Overall Study|Reason Unknown|0|||
131495431|NCT00963547|473441709|FG003|Overall Study|Reason Unknown|0|||
131495432|NCT00963547|473441710|FG004|Overall Study|Reason Unknown|0|||
131495433|NCT00963547|473441711|FG005|Overall Study|Reason Unknown|0|||
131495434|NCT00963547|473441712|FG006|Overall Study|Reason Unknown|0|||
131495435|NCT00482612|473441719|FG000|In-treatment Period|No study medication administered|0|||
131495436|NCT00482612|473441720|FG001|In-treatment Period|No study medication administered|0|||
131495437|NCT00482612|473441721|FG002|In-treatment Period|No study medication administered|1|||
131495438|NCT00482612|473441722|FG003|In-treatment Period|No study medication administered|0|||
131495439|NCT00482612|473441719|FG000|Follow-up Period|Other|4|||
131495440|NCT00482612|473441720|FG001|Follow-up Period|Other|2|||
131495441|NCT00482612|473441721|FG002|Follow-up Period|Other|1|||
131495442|NCT00482612|473441722|FG003|Follow-up Period|Other|2|||
131495443|NCT00482612|473441719|FG000|Follow-up Period|Lack of compliance|0|||
131495444|NCT00482612|473441720|FG001|Follow-up Period|Lack of compliance|0|||
131495445|NCT00482612|473441721|FG002|Follow-up Period|Lack of compliance|1|||
131495446|NCT00482612|473441722|FG003|Follow-up Period|Lack of compliance|0|||
131495447|NCT00482612|473441719|FG000|Follow-up Period|Lost to Follow-up|0|||
131495448|NCT00482612|473441720|FG001|Follow-up Period|Lost to Follow-up|4|||
131495449|NCT00482612|473441721|FG002|Follow-up Period|Lost to Follow-up|2|||
131495450|NCT00482612|473441722|FG003|Follow-up Period|Lost to Follow-up|1|||
131495451|NCT00482612|473441719|FG000|Follow-up Period|Adverse Event|4|||
131495452|NCT00482612|473441720|FG001|Follow-up Period|Adverse Event|7|||
131495453|NCT00482612|473441721|FG002|Follow-up Period|Adverse Event|9|||
131495454|NCT00482612|473441722|FG003|Follow-up Period|Adverse Event|0|||
131495455|NCT00482612|473441719|FG000|Follow-up Period|Lack of Efficacy|2|||
131495456|NCT00482612|473441720|FG001|Follow-up Period|Lack of Efficacy|0|||
131495457|NCT00482612|473441721|FG002|Follow-up Period|Lack of Efficacy|1|||
131495458|NCT00482612|473441722|FG003|Follow-up Period|Lack of Efficacy|0|||
131495459|NCT00482612|473441719|FG000|Follow-up Period|Withdrawal by Subject|3|||
131495460|NCT00482612|473441720|FG001|Follow-up Period|Withdrawal by Subject|5|||
131495461|NCT00482612|473441721|FG002|Follow-up Period|Withdrawal by Subject|7|||
131495462|NCT00482612|473441722|FG003|Follow-up Period|Withdrawal by Subject|2|||
131495463|NCT00482612|473441719|FG000|Follow-up Period|Reasons not related to trial|1|||
131495464|NCT00482612|473441720|FG001|Follow-up Period|Reasons not related to trial|0|||
131495465|NCT00482612|473441721|FG002|Follow-up Period|Reasons not related to trial|1|||
131495466|NCT00482612|473441722|FG003|Follow-up Period|Reasons not related to trial|3|||
131495467|NCT01366521|473441723|FG000|Overall Study|Adverse Event|1|||
131495468|NCT01366521|473441724|FG001|Overall Study|Adverse Event|0|||
131495469|NCT01366521|473441725|FG002|Overall Study|Adverse Event|0|||
131495470|NCT01366521|473441726|FG003|Overall Study|Adverse Event|0|||
131495471|NCT01366521|473441723|FG000|Overall Study|Protocol Violation|0|||
131495472|NCT01366521|473441724|FG001|Overall Study|Protocol Violation|0|||
131495473|NCT01366521|473441725|FG002|Overall Study|Protocol Violation|1|||
131495474|NCT01366521|473441726|FG003|Overall Study|Protocol Violation|0|||
131495475|NCT01366521|473441723|FG000|Overall Study|Physician Decision|0|||
131495476|NCT01366521|473441724|FG001|Overall Study|Physician Decision|0|||
131495477|NCT01366521|473441725|FG002|Overall Study|Physician Decision|1|||
131495478|NCT01366521|473441726|FG003|Overall Study|Physician Decision|0|||
131495479|NCT01366521|473441723|FG000|Overall Study|Withdrawal by Subject|0|||
131495480|NCT01366521|473441724|FG001|Overall Study|Withdrawal by Subject|1|||
131495481|NCT01366521|473441725|FG002|Overall Study|Withdrawal by Subject|0|||
131495482|NCT01366521|473441726|FG003|Overall Study|Withdrawal by Subject|0|||
131495483|NCT00660023|473441727|FG000|Overall Study|Adverse Event|2|||
131495484|NCT00660023|473441727|FG000|Overall Study|Death|8|||
131495485|NCT00660023|473441727|FG000|Overall Study|Blood Transfusion|5|||
131495486|NCT00660023|473441727|FG000|Overall Study|Renal Transplantation|3|||
131495487|NCT00660023|473441727|FG000|Overall Study|Withdrawal by Subject|1|||
131495488|NCT00660023|473441727|FG000|Overall Study|Missed Pregnancy Test|1|||
131495489|NCT00660023|473441727|FG000|Overall Study|Other Screening Failure|9|||
131495490|NCT00759031|473441728|FG000|First Intervention (1 Day)|Physician Decision|1|||
131495491|NCT00759031|473441729|FG001|First Intervention (1 Day)|Physician Decision|0|||
131495492|NCT00759031|473441728|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
131495493|NCT00759031|473441729|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
131495494|NCT00759031|473441728|FG000|First Intervention (1 Day)|Screening failure|1|||
131495495|NCT00759031|473441729|FG001|First Intervention (1 Day)|Screening failure|0|||
131495496|NCT04180488|473441730|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
131495497|NCT04180488|473441731|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
131495498|NCT04180488|473441732|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
131495499|NCT04180488|473441733|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
131495500|NCT04180488|473441734|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
131495501|NCT04180488|473441735|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
131495502|NCT04180488|473441730|FG000|Overall Study|Withdrawal by Subject|8|||
131495503|NCT04180488|473441731|FG001|Overall Study|Withdrawal by Subject|4|||
131495504|NCT04180488|473441732|FG002|Overall Study|Withdrawal by Subject|5|||
131495505|NCT04180488|473441733|FG003|Overall Study|Withdrawal by Subject|2|||
131495506|NCT04180488|473441734|FG004|Overall Study|Withdrawal by Subject|8|||
131495507|NCT04180488|473441735|FG005|Overall Study|Withdrawal by Subject|6|||
131495508|NCT04180488|473441730|FG000|Overall Study|Adverse Event|3|||
131495509|NCT04180488|473441731|FG001|Overall Study|Adverse Event|2|||
131495510|NCT04180488|473441732|FG002|Overall Study|Adverse Event|0|||
131495511|NCT04180488|473441733|FG003|Overall Study|Adverse Event|0|||
131495512|NCT04180488|473441734|FG004|Overall Study|Adverse Event|0|||
131495513|NCT04180488|473441735|FG005|Overall Study|Adverse Event|0|||
131495514|NCT04180488|473441730|FG000|Overall Study|Poor compliance to protocol|0|||
131495515|NCT04180488|473441731|FG001|Overall Study|Poor compliance to protocol|0|||
131495516|NCT04180488|473441732|FG002|Overall Study|Poor compliance to protocol|1|||
131495517|NCT04180488|473441733|FG003|Overall Study|Poor compliance to protocol|0|||
131495518|NCT04180488|473441734|FG004|Overall Study|Poor compliance to protocol|0|||
131495519|NCT04180488|473441735|FG005|Overall Study|Poor compliance to protocol|0|||
131495520|NCT03506815|473441736|FG000|Overall Study|Adverse Event|8|||
131495521|NCT03506815|473441737|FG001|Overall Study|Adverse Event|0|||
131495522|NCT03506815|473441736|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
131495523|NCT03506815|473441737|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
131495524|NCT03506815|473441736|FG000|Overall Study|Protocol Violation|1|||
131495525|NCT03506815|473441737|FG001|Overall Study|Protocol Violation|0|||
131495526|NCT03506815|473441736|FG000|Overall Study|Elective Surgery|1|||
131495527|NCT03506815|473441737|FG001|Overall Study|Elective Surgery|0|||
131495528|NCT01327885|473441739|FG000|Overall Study|Disease progression-according to RECIST|173|||
131495529|NCT01327885|473441740|FG001|Overall Study|Disease progression-according to RECIST|165|||
131495530|NCT01327885|473441739|FG000|Overall Study|Clinical progression|24|||
131495531|NCT01327885|473441740|FG001|Overall Study|Clinical progression|27|||
131495532|NCT01327885|473441739|FG000|Overall Study|Adverse Event|14|||
131495533|NCT01327885|473441740|FG001|Overall Study|Adverse Event|10|||
131495534|NCT01327885|473441739|FG000|Overall Study|Subject choice|5|||
131495535|NCT01327885|473441740|FG001|Overall Study|Subject choice|10|||
131495536|NCT01327885|473441739|FG000|Overall Study|Other|8|||
131495537|NCT01327885|473441740|FG001|Overall Study|Other|6|||
131495538|NCT01327885|473441739|FG000|Overall Study|Withdrawal of consent from study|3|||
131495539|NCT01327885|473441740|FG001|Overall Study|Withdrawal of consent from study|4|||
131495540|NCT01327885|473441739|FG000|Overall Study|Not treated|1|||
131495541|NCT01327885|473441740|FG001|Overall Study|Not treated|1|||
131495542|NCT01327885|473441739|FG000|Overall Study|Administrative decision|0|||
131495543|NCT01327885|473441740|FG001|Overall Study|Administrative decision|1|||
131495544|NCT00085631|473441743|FG000|Overall Study|Missing Data|4|||
131495545|NCT00085631|473441744|FG001|Overall Study|Missing Data|11|||
131495546|NCT00085631|473441745|FG002|Overall Study|Missing Data|7|||
131495547|NCT01833520|473441748|FG000|Overall Study|Lack of Efficacy|3|||
131495548|NCT01833520|473441749|FG001|Overall Study|Lack of Efficacy|3|||
131495549|NCT01833520|473441750|FG002|Overall Study|Lack of Efficacy|8|||
131495550|NCT01833520|473441751|FG003|Overall Study|Lack of Efficacy|3|||
131495551|NCT02547649|473441752|FG000|Overall Study|Lost to Follow-up|3|||
131495552|NCT02547649|473441753|FG001|Overall Study|Lost to Follow-up|1|||
131495553|NCT02547649|473441754|FG002|Overall Study|Lost to Follow-up|1|||
131495554|NCT02547649|473441752|FG000|Overall Study|Not vaccinated|0|||
131495555|NCT02547649|473441753|FG001|Overall Study|Not vaccinated|0|||
131495556|NCT02547649|473441754|FG002|Overall Study|Not vaccinated|1|||
131495557|NCT02547649|473441752|FG000|Overall Study|Withdrawal by Subject|0|||
131495558|NCT02547649|473441753|FG001|Overall Study|Withdrawal by Subject|4|||
131495559|NCT02547649|473441754|FG002|Overall Study|Withdrawal by Subject|2|||
131495560|NCT03765918|473441757|FG000|Overall Study|Death|109|||
131495561|NCT03765918|473441758|FG001|Overall Study|Death|127|||
131495562|NCT03765918|473441757|FG000|Overall Study|Lost to Follow-up|2|||
131495563|NCT03765918|473441758|FG001|Overall Study|Lost to Follow-up|3|||
131495564|NCT03765918|473441757|FG000|Overall Study|Withdrawal by Subject|12|||
131495565|NCT03765918|473441758|FG001|Overall Study|Withdrawal by Subject|16|||
131495566|NCT03765918|473441757|FG000|Overall Study|Participants Ongoing|240|||
131495567|NCT03765918|473441758|FG001|Overall Study|Participants Ongoing|205|||
131495568|NCT01484197|473441761|FG000|Treatment Period 1|Adverse Event|1|||
131495569|NCT01484197|473441762|FG001|Treatment Period 1|Adverse Event|0|||
131495570|NCT01484197|473441763|FG002|Treatment Period 1|Adverse Event|0|||
131495571|NCT01484197|473441764|FG003|Treatment Period 1|Adverse Event|0|||
131495572|NCT01484197|473441761|FG000|Treatment Period 2|Subject withdrew consent|0|||
131495573|NCT01484197|473441762|FG001|Treatment Period 2|Subject withdrew consent|0|||
131495574|NCT01484197|473441763|FG002|Treatment Period 2|Subject withdrew consent|0|||
131495575|NCT01484197|473441764|FG003|Treatment Period 2|Subject withdrew consent|1|||
131495576|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
131495577|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
131495578|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
131495579|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
131495580|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
131495581|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
131495582|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
131495583|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
131495584|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Other|1|||
131495585|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Other|4|||
131495586|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Other|3|||
131495587|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Other|6|||
131495588|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
131495589|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
131495590|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
131495591|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
131495592|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
131495593|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
131495594|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
131495595|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
131495596|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
131495597|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
131495598|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
131495599|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
131495600|NCT02925494|473441766|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
131495601|NCT02925494|473441767|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
131495602|NCT02925494|473441768|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
131495603|NCT02925494|473441769|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
131495604|NCT06149247|473441770|FG000|Overall Study|Adverse Event|0|||
131495605|NCT06149247|473441771|FG001|Overall Study|Adverse Event|1|||
131495606|NCT02289417|473441772|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
131495607|NCT02289417|473441773|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495608|NCT02289417|473441774|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
131495609|NCT02289417|473441775|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495610|NCT02289417|473441776|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495611|NCT02289417|473441777|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495612|NCT02289417|473441778|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495613|NCT02289417|473441779|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495614|NCT02289417|473441780|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
131495615|NCT02289417|473441772|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
131495616|NCT02289417|473441773|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
131495617|NCT02289417|473441774|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
131495618|NCT02289417|473441775|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
131495619|NCT02289417|473441776|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
131495620|NCT02289417|473441777|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
131495621|NCT02289417|473441778|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
131495622|NCT02289417|473441779|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
131495623|NCT02289417|473441780|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
131495624|NCT02289417|473441772|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495625|NCT02289417|473441773|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
131495626|NCT02289417|473441774|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495627|NCT02289417|473441775|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495628|NCT02289417|473441776|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495629|NCT02289417|473441777|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495630|NCT02289417|473441778|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495631|NCT02289417|473441779|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495632|NCT02289417|473441780|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
131495633|NCT02289417|473441772|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
131495634|NCT02289417|473441773|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495635|NCT02289417|473441774|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495636|NCT02289417|473441775|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495637|NCT02289417|473441776|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495638|NCT02289417|473441777|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495639|NCT02289417|473441778|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495640|NCT02289417|473441779|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495641|NCT02289417|473441780|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
131495642|NCT02289417|473441772|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
131495643|NCT02289417|473441773|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
131495644|NCT02289417|473441774|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
131495645|NCT02289417|473441775|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
131495646|NCT02289417|473441776|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
131495647|NCT02289417|473441777|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
131495648|NCT02289417|473441778|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
131495649|NCT02289417|473441779|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
131495650|NCT02289417|473441780|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
131495651|NCT02289417|473441772|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495652|NCT02289417|473441773|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495653|NCT02289417|473441774|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
131495654|NCT02289417|473441775|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495655|NCT02289417|473441776|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495656|NCT02289417|473441777|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495657|NCT02289417|473441778|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495658|NCT02289417|473441779|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495659|NCT02289417|473441780|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
131495660|NCT02289417|473441772|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
131495661|NCT02289417|473441773|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
131495662|NCT02289417|473441774|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
131495663|NCT02289417|473441775|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
131495664|NCT02289417|473441776|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
131495665|NCT02289417|473441777|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
131495666|NCT02289417|473441778|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
131495667|NCT02289417|473441779|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
131495668|NCT02289417|473441780|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
131495669|NCT02289417|473441772|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131495670|NCT02289417|473441773|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131495671|NCT02289417|473441774|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
131495672|NCT02289417|473441775|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131495673|NCT02289417|473441776|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
131495674|NCT02289417|473441777|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
131495675|NCT02289417|473441778|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131495676|NCT02289417|473441779|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131495677|NCT02289417|473441780|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131495678|NCT02289417|473441772|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495679|NCT02289417|473441773|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495680|NCT02289417|473441774|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495681|NCT02289417|473441775|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495682|NCT02289417|473441776|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495683|NCT02289417|473441777|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495684|NCT02289417|473441778|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
131495685|NCT02289417|473441779|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495686|NCT02289417|473441780|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131495687|NCT02289417|473441772|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495688|NCT02289417|473441773|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495689|NCT02289417|473441774|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495690|NCT02289417|473441775|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
131495691|NCT02289417|473441776|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495692|NCT02289417|473441777|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495693|NCT02289417|473441778|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
131495694|NCT02289417|473441779|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495695|NCT02289417|473441780|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
131495696|NCT02289417|473441772|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
131495697|NCT02289417|473441773|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
131495698|NCT02289417|473441774|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
131495699|NCT02289417|473441775|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
131495700|NCT02289417|473441776|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
131495701|NCT02289417|473441777|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
131495702|NCT02289417|473441778|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
131495703|NCT02289417|473441779|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
131495704|NCT02289417|473441780|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
131495705|NCT02289417|473441772|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495706|NCT02289417|473441773|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495707|NCT02289417|473441774|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495708|NCT02289417|473441775|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495709|NCT02289417|473441776|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495710|NCT02289417|473441777|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495711|NCT02289417|473441778|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
131495712|NCT02289417|473441779|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
131495713|NCT02289417|473441780|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
131495714|NCT02289417|473441772|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495715|NCT02289417|473441773|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495716|NCT02289417|473441774|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495717|NCT02289417|473441775|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495718|NCT02289417|473441776|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495719|NCT02289417|473441777|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495720|NCT02289417|473441778|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131495721|NCT02289417|473441779|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
131495722|NCT02289417|473441780|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
131495723|NCT02289417|473441772|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495724|NCT02289417|473441773|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495725|NCT02289417|473441774|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495726|NCT02289417|473441775|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495727|NCT02289417|473441776|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495728|NCT02289417|473441777|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495729|NCT02289417|473441778|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495730|NCT02289417|473441779|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
131495731|NCT02289417|473441780|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
131495732|NCT01782222|473441783|FG000|Overall Study|Adverse Event|4|||
131495733|NCT01782222|473441784|FG001|Overall Study|Adverse Event|5|||
131495734|NCT01782222|473441785|FG002|Overall Study|Adverse Event|3|||
131495735|NCT01782222|473441783|FG000|Overall Study|Lack of Efficacy|2|||
131495736|NCT01782222|473441784|FG001|Overall Study|Lack of Efficacy|1|||
131495737|NCT01782222|473441785|FG002|Overall Study|Lack of Efficacy|0|||
131495738|NCT01782222|473441783|FG000|Overall Study|Protocol Violation|1|||
131495739|NCT01782222|473441784|FG001|Overall Study|Protocol Violation|0|||
131495740|NCT01782222|473441785|FG002|Overall Study|Protocol Violation|0|||
131495741|NCT01782222|473441783|FG000|Overall Study|Withdrawal by Subject|1|||
131495742|NCT01782222|473441784|FG001|Overall Study|Withdrawal by Subject|4|||
131495743|NCT01782222|473441785|FG002|Overall Study|Withdrawal by Subject|1|||
131495744|NCT01782222|473441783|FG000|Overall Study|Moved to other state|0|||
131495745|NCT01782222|473441784|FG001|Overall Study|Moved to other state|1|||
131495746|NCT01782222|473441785|FG002|Overall Study|Moved to other state|0|||
131495747|NCT01756898|473441789|FG000|Overall Study|Adverse Event|7|||
131495748|NCT01756898|473441790|FG001|Overall Study|Adverse Event|1|||
131495749|NCT01756898|473441791|FG002|Overall Study|Adverse Event|0|||
131495750|NCT01756898|473441792|FG003|Overall Study|Adverse Event|0|||
131495751|NCT01756898|473441789|FG000|Overall Study|Lack of Efficacy|4|||
131495752|NCT01756898|473441790|FG001|Overall Study|Lack of Efficacy|7|||
131495753|NCT01756898|473441791|FG002|Overall Study|Lack of Efficacy|6|||
131495754|NCT01756898|473441792|FG003|Overall Study|Lack of Efficacy|6|||
131495755|NCT01756898|473441789|FG000|Overall Study|Lost to Follow-up|2|||
131495756|NCT01756898|473441790|FG001|Overall Study|Lost to Follow-up|4|||
131495757|NCT01756898|473441791|FG002|Overall Study|Lost to Follow-up|2|||
131495758|NCT01756898|473441792|FG003|Overall Study|Lost to Follow-up|3|||
131495759|NCT01756898|473441789|FG000|Overall Study|Protocol Violation|1|||
131495760|NCT01756898|473441790|FG001|Overall Study|Protocol Violation|2|||
131495761|NCT01756898|473441791|FG002|Overall Study|Protocol Violation|2|||
131495762|NCT01756898|473441792|FG003|Overall Study|Protocol Violation|1|||
131495763|NCT01756898|473441789|FG000|Overall Study|Withdrew Consent|5|||
131495764|NCT01756898|473441790|FG001|Overall Study|Withdrew Consent|3|||
131495765|NCT01756898|473441791|FG002|Overall Study|Withdrew Consent|5|||
131495766|NCT01756898|473441792|FG003|Overall Study|Withdrew Consent|6|||
131495767|NCT01756898|473441789|FG000|Overall Study|Other|0|||
131495768|NCT01756898|473441790|FG001|Overall Study|Other|2|||
131495769|NCT01756898|473441791|FG002|Overall Study|Other|2|||
131495770|NCT01756898|473441792|FG003|Overall Study|Other|0|||
131495771|NCT01500694|473441793|FG000|Overall Study|Adverse Event|4|||
131495772|NCT01500694|473441794|FG001|Overall Study|Adverse Event|3|||
131495773|NCT01500694|473441793|FG000|Overall Study|Protocol Violation|0|||
131495774|NCT01500694|473441794|FG001|Overall Study|Protocol Violation|1|||
131495775|NCT01500694|473441793|FG000|Overall Study|Withdrawal by Subject|23|||
131495776|NCT01500694|473441794|FG001|Overall Study|Withdrawal by Subject|14|||
131495777|NCT01500694|473441793|FG000|Overall Study|Lost to Follow-up|2|||
131495778|NCT01500694|473441794|FG001|Overall Study|Lost to Follow-up|3|||
131495779|NCT01500694|473441793|FG000|Overall Study|Lack of Efficacy|14|||
131495780|NCT01500694|473441794|FG001|Overall Study|Lack of Efficacy|5|||
131495781|NCT01500694|473441793|FG000|Overall Study|Other|9|||
131495782|NCT01500694|473441794|FG001|Overall Study|Other|3|||
131495783|NCT00833794|473441797|FG000|Open-label Phase|Adverse Event|225|||
131495784|NCT00833794|473441798|FG001|Open-label Phase|Adverse Event|0|||
131495785|NCT00833794|473441797|FG000|Open-label Phase|Lack of Efficacy|28|||
131495786|NCT00833794|473441798|FG001|Open-label Phase|Lack of Efficacy|0|||
131495787|NCT00833794|473441797|FG000|Open-label Phase|Withdrawal by Subject|48|||
131495788|NCT00833794|473441798|FG001|Open-label Phase|Withdrawal by Subject|0|||
131495789|NCT00833794|473441797|FG000|Open-label Phase|Physician Decision|20|||
131495790|NCT00833794|473441798|FG001|Open-label Phase|Physician Decision|0|||
131495791|NCT00833794|473441797|FG000|Open-label Phase|Administrative reason|1|||
131495792|NCT00833794|473441798|FG001|Open-label Phase|Administrative reason|0|||
131495793|NCT00833794|473441797|FG000|Open-label Phase|Protocol Violation|47|||
131495794|NCT00833794|473441798|FG001|Open-label Phase|Protocol Violation|0|||
131495795|NCT00833794|473441797|FG000|Open-label Phase|Did not complete wash-out period|12|||
131495796|NCT00833794|473441798|FG001|Open-label Phase|Did not complete wash-out period|0|||
131495797|NCT00833794|473441797|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
131495798|NCT00833794|473441798|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
131495799|NCT00833794|473441797|FG000|Double-blind Phase|Adverse Event|44|||
131495800|NCT00833794|473441798|FG001|Double-blind Phase|Adverse Event|11|||
131495801|NCT00833794|473441797|FG000|Double-blind Phase|Lack of Efficacy|34|||
131495802|NCT00833794|473441798|FG001|Double-blind Phase|Lack of Efficacy|22|||
131495803|NCT00833794|473441797|FG000|Double-blind Phase|Withdrawal by Subject|23|||
131495804|NCT00833794|473441798|FG001|Double-blind Phase|Withdrawal by Subject|6|||
131495805|NCT00833794|473441797|FG000|Double-blind Phase|Physician Decision|4|||
131495806|NCT00833794|473441798|FG001|Double-blind Phase|Physician Decision|7|||
131495807|NCT00833794|473441797|FG000|Double-blind Phase|Administrative reason|1|||
131495808|NCT00833794|473441798|FG001|Double-blind Phase|Administrative reason|3|||
131495809|NCT02007109|473441801|FG000|Overall Study|Diary not returned or excluded|102|||
131495810|NCT02007109|473441801|FG000|Overall Study|Excluded - Age<7yo|9|||
131495811|NCT01858389|473441803|FG000|Overall Study|Death|1|||
131495812|NCT01858389|473441804|FG001|Overall Study|Death|3|||
131495813|NCT01858389|473441803|FG000|Overall Study|Study terminated by sponsor|0|||
131495814|NCT01858389|473441804|FG001|Overall Study|Study terminated by sponsor|2|||
131495815|NCT01858389|473441803|FG000|Overall Study|Withdrawal by Subject|0|||
131495816|NCT01858389|473441804|FG001|Overall Study|Withdrawal by Subject|1|||
131495817|NCT01858389|473441803|FG000|Overall Study|Progressive disease|10|||
131495818|NCT01858389|473441804|FG001|Overall Study|Progressive disease|11|||
131495819|NCT01858389|473441803|FG000|Overall Study|Other|2|||
131495820|NCT01858389|473441804|FG001|Overall Study|Other|4|||
131495821|NCT01858389|473441803|FG000|Overall Study|Adverse Event|3|||
131495822|NCT01858389|473441804|FG001|Overall Study|Adverse Event|1|||
131495823|NCT01858389|473441803|FG000|Overall Study|Did not receive treatment|0|||
131495824|NCT01858389|473441804|FG001|Overall Study|Did not receive treatment|3|||
131495825|NCT04051008|473441805|FG000|Overall Study|Withdrawal by Subject|2|||
131495826|NCT04051008|473441806|FG001|Overall Study|Withdrawal by Subject|0|||
131495827|NCT04051008|473441807|FG002|Overall Study|Withdrawal by Subject|1|||
131495828|NCT00458211|473441808|FG000|Overall Study|Lack of Efficacy|12|||
131495829|NCT00458211|473441808|FG000|Overall Study|Withdrawal by Subject|2|||
131495830|NCT00458211|473441808|FG000|Overall Study|Protocol Violation|2|||
131495831|NCT01835587|473441809|FG000|Overall Study|Disease Recurrence or Relapse|0|||
131495832|NCT01835587|473441810|FG001|Overall Study|Disease Recurrence or Relapse|3|||
131495833|NCT01835587|473441811|FG002|Overall Study|Disease Recurrence or Relapse|0|||
131495834|NCT01835587|473441812|FG003|Overall Study|Disease Recurrence or Relapse|3|||
131495835|NCT01835587|473441809|FG000|Overall Study|Withdrawal by Subject|2|||
131495836|NCT01835587|473441810|FG001|Overall Study|Withdrawal by Subject|0|||
131495837|NCT01835587|473441811|FG002|Overall Study|Withdrawal by Subject|0|||
131495838|NCT01835587|473441812|FG003|Overall Study|Withdrawal by Subject|3|||
131495839|NCT01835587|473441809|FG000|Overall Study|Adverse Event|0|||
131495840|NCT01835587|473441810|FG001|Overall Study|Adverse Event|0|||
131495841|NCT01835587|473441811|FG002|Overall Study|Adverse Event|2|||
131495842|NCT01835587|473441812|FG003|Overall Study|Adverse Event|2|||
131495843|NCT01835587|473441809|FG000|Overall Study|Death|0|||
131495844|NCT01835587|473441810|FG001|Overall Study|Death|0|||
131495845|NCT01835587|473441811|FG002|Overall Study|Death|0|||
131495846|NCT01835587|473441812|FG003|Overall Study|Death|1|||
131495847|NCT01835587|473441809|FG000|Overall Study|Miscellaneous|0|||
131495848|NCT01835587|473441810|FG001|Overall Study|Miscellaneous|1|||
131495849|NCT01835587|473441811|FG002|Overall Study|Miscellaneous|0|||
131495850|NCT01835587|473441812|FG003|Overall Study|Miscellaneous|0|||
131495851|NCT02132130|473441816|FG000|Overall Study|Lost to Follow-up|0|||
131495852|NCT02132130|473441817|FG001|Overall Study|Lost to Follow-up|2|||
131495853|NCT02132130|473441818|FG002|Overall Study|Lost to Follow-up|0|||
131495854|NCT02132130|473441819|FG003|Overall Study|Lost to Follow-up|0|||
131495855|NCT02132130|473441816|FG000|Overall Study|Withdrawal by Subject|0|||
131495856|NCT02132130|473441817|FG001|Overall Study|Withdrawal by Subject|0|||
131495857|NCT02132130|473441818|FG002|Overall Study|Withdrawal by Subject|0|||
131495858|NCT02132130|473441819|FG003|Overall Study|Withdrawal by Subject|1|||
131495859|NCT00838578|473441824|FG000|Overall Study|Protocol Violation|2|||
131495860|NCT00600483|473441825|FG000|Overall Study|Lost to Follow-up|26|||
131495861|NCT00600483|473441826|FG001|Overall Study|Lost to Follow-up|47|||
131495862|NCT00600483|473441825|FG000|Overall Study|Randomized but not treated|10|||
131495863|NCT00600483|473441826|FG001|Overall Study|Randomized but not treated|0|||
131495864|NCT01482884|473441834|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
131495865|NCT01482884|473441835|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
131495866|NCT01482884|473441834|FG000|Overall Study|Protocol Violation|1|||
131495867|NCT01482884|473441835|FG001|Overall Study|Protocol Violation|0|||
131495868|NCT01482884|473441834|FG000|Overall Study|Lost to Follow-up|2|||
131495869|NCT01482884|473441835|FG001|Overall Study|Lost to Follow-up|2|||
131495870|NCT01482884|473441834|FG000|Overall Study|Lack of Efficacy|0|||
131495871|NCT01482884|473441835|FG001|Overall Study|Lack of Efficacy|1|||
131495872|NCT01482884|473441834|FG000|Overall Study|Adverse Event|2|||
131495873|NCT01482884|473441835|FG001|Overall Study|Adverse Event|1|||
131495874|NCT01482884|473441834|FG000|Overall Study|Withdrawal by Subject|8|||
131495875|NCT01482884|473441835|FG001|Overall Study|Withdrawal by Subject|13|||
131495876|NCT00580606|473441845|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
131495877|NCT00580606|473441846|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
131495878|NCT00580606|473441845|FG000|Open Label (OL)|Withdrawal by Subject|4|||
131495879|NCT00580606|473441846|FG001|Open Label (OL)|Withdrawal by Subject|6|||
131495880|NCT00580606|473441845|FG000|Open Label (OL)|Dosing Symptoms|0|||
131495881|NCT00580606|473441846|FG001|Open Label (OL)|Dosing Symptoms|1|||
131495882|NCT00580606|473441845|FG000|Open Label (OL)|Lost to Follow-up|0|||
131495883|NCT00580606|473441846|FG001|Open Label (OL)|Lost to Follow-up|1|||
131495884|NCT00580606|473441845|FG000|Open Label (OL)|Pregnancy|0|||
131495885|NCT00580606|473441846|FG001|Open Label (OL)|Pregnancy|1|||
131495886|NCT00580606|473441845|FG000|Open Label (OL)|Non-compliance|2|||
131495887|NCT00580606|473441846|FG001|Open Label (OL)|Non-compliance|0|||
131495888|NCT00580606|473441845|FG000|Open Label (OL)|Physician Decision|1|||
131495889|NCT00580606|473441846|FG001|Open Label (OL)|Physician Decision|1|||
131495890|NCT00580606|473441845|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
131495891|NCT00580606|473441846|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
131495892|NCT03655691|473441849|FG000|Overall Study|Adverse Event|0|||
131495893|NCT03655691|473441850|FG001|Overall Study|Adverse Event|0|||
131495894|NCT03655691|473441851|FG002|Overall Study|Adverse Event|1|||
131495895|NCT03655691|473441849|FG000|Overall Study|Lost to Follow-up|1|||
131495896|NCT03655691|473441850|FG001|Overall Study|Lost to Follow-up|1|||
131495897|NCT03655691|473441851|FG002|Overall Study|Lost to Follow-up|2|||
131495898|NCT03655691|473441849|FG000|Overall Study|Protocol Violation|0|||
131495899|NCT03655691|473441850|FG001|Overall Study|Protocol Violation|1|||
131495900|NCT03655691|473441851|FG002|Overall Study|Protocol Violation|0|||
131495901|NCT03655691|473441849|FG000|Overall Study|Withdrawal by Subject|1|||
131495902|NCT03655691|473441850|FG001|Overall Study|Withdrawal by Subject|1|||
131495903|NCT03655691|473441851|FG002|Overall Study|Withdrawal by Subject|0|||
131495904|NCT01753856|473441854|FG000|Overall Study|Adverse Event|1|||
131495905|NCT01753856|473441855|FG001|Overall Study|Adverse Event|0|||
131495906|NCT01753856|473441854|FG000|Overall Study|Withdrawal by Subject|0|||
131495907|NCT01753856|473441855|FG001|Overall Study|Withdrawal by Subject|2|||
131495908|NCT01753856|473441854|FG000|Overall Study|Sponsor Decision|2|||
131495909|NCT01753856|473441855|FG001|Overall Study|Sponsor Decision|0|||
131495910|NCT01325584|473441856|FG000|Overall Study|Death|1|||
131495911|NCT00887978|473441857|FG000|Overall Study|Adverse Event|18|||
131495912|NCT00887978|473441858|FG001|Overall Study|Adverse Event|5|||
131495913|NCT00887978|473441857|FG000|Overall Study|Clinical Worsening|4|||
131495914|NCT00887978|473441858|FG001|Overall Study|Clinical Worsening|4|||
131495915|NCT00887978|473441857|FG000|Overall Study|Death|2|||
131495916|NCT00887978|473441858|FG001|Overall Study|Death|3|||
131495917|NCT00887978|473441857|FG000|Overall Study|Withdrawal by Subject|1|||
131495918|NCT00887978|473441858|FG001|Overall Study|Withdrawal by Subject|2|||
131495919|NCT00887978|473441857|FG000|Overall Study|Lost to Follow-up|0|||
131495920|NCT00887978|473441858|FG001|Overall Study|Lost to Follow-up|1|||
131495921|NCT05353985|473441865|FG000|Overall Study|Adverse Event|5|||
131495922|NCT05353985|473441866|FG001|Overall Study|Adverse Event|7|||
131495923|NCT05353985|473441865|FG000|Overall Study|Lost to Follow-up|1|||
131495924|NCT05353985|473441866|FG001|Overall Study|Lost to Follow-up|1|||
131495925|NCT05353985|473441865|FG000|Overall Study|Protocol Violation|1|||
131495926|NCT05353985|473441866|FG001|Overall Study|Protocol Violation|0|||
131495927|NCT05353985|473441865|FG000|Overall Study|Withdrawal by Subject|13|||
131495928|NCT05353985|473441866|FG001|Overall Study|Withdrawal by Subject|17|||
131495929|NCT05353985|473441865|FG000|Overall Study|Reason Not Specified|1|||
131495930|NCT05353985|473441866|FG001|Overall Study|Reason Not Specified|0|||
131495931|NCT05353985|473441865|FG000|Overall Study|Randomized in Error & Not Treated|0|||
131495932|NCT05353985|473441866|FG001|Overall Study|Randomized in Error & Not Treated|1|||
131495933|NCT04847557|473441869|FG000|Overall Study|Adverse Event|1|||
131495934|NCT04847557|473441870|FG001|Overall Study|Adverse Event|0|||
131495935|NCT04847557|473441869|FG000|Overall Study|Death|19|||
131495936|NCT04847557|473441870|FG001|Overall Study|Death|15|||
131495937|NCT04847557|473441869|FG000|Overall Study|Lost to Follow-up|3|||
131495938|NCT04847557|473441870|FG001|Overall Study|Lost to Follow-up|6|||
131495939|NCT04847557|473441869|FG000|Overall Study|Physician Decision|1|||
131495940|NCT04847557|473441870|FG001|Overall Study|Physician Decision|0|||
131495941|NCT04847557|473441869|FG000|Overall Study|Protocol Violation|0|||
131495942|NCT04847557|473441870|FG001|Overall Study|Protocol Violation|1|||
131495943|NCT04847557|473441869|FG000|Overall Study|Withdrawal by Subject|8|||
131495944|NCT04847557|473441870|FG001|Overall Study|Withdrawal by Subject|14|||
131495945|NCT02310568|473444075|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
131495946|NCT02310568|473444076|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
131495947|NCT02310568|473444077|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
131495948|NCT02310568|473444078|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
131495949|NCT02310568|473444079|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
131495950|NCT02310568|473444075|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
131495951|NCT02310568|473444076|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
131495952|NCT02310568|473444077|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
131495953|NCT02310568|473444078|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
131495954|NCT02310568|473444079|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
131495955|NCT02310568|473444075|FG000|Stage 1 ( 4 Weeks)|Other|1|||
131495956|NCT02310568|473444076|FG001|Stage 1 ( 4 Weeks)|Other|1|||
131495957|NCT02310568|473444077|FG002|Stage 1 ( 4 Weeks)|Other|0|||
131495958|NCT02310568|473444078|FG003|Stage 1 ( 4 Weeks)|Other|0|||
131495959|NCT02310568|473444079|FG004|Stage 1 ( 4 Weeks)|Other|0|||
131495960|NCT02310568|473444075|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
131495961|NCT02310568|473444076|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
131495962|NCT02310568|473444077|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
131495963|NCT02310568|473444078|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
131495964|NCT02310568|473444079|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
131495965|NCT02310568|473444075|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
131495966|NCT02310568|473444076|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
131495967|NCT02310568|473444077|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
131495968|NCT02310568|473444078|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
131495969|NCT02310568|473444079|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
131495970|NCT02310568|473444075|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
131495971|NCT02310568|473444076|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
131495972|NCT02310568|473444077|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
131495973|NCT02310568|473444078|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
131495974|NCT02310568|473444079|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
131495975|NCT02310568|473444075|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
131495976|NCT02310568|473444076|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
131495977|NCT02310568|473444077|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
131495978|NCT02310568|473444078|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
131495979|NCT02310568|473444079|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
131495980|NCT02310568|473444075|FG000|Stage 2 (4 Weeks)|Other|0|||
131495981|NCT02310568|473444076|FG001|Stage 2 (4 Weeks)|Other|1|||
131495982|NCT02310568|473444077|FG002|Stage 2 (4 Weeks)|Other|1|||
131495983|NCT02310568|473444078|FG003|Stage 2 (4 Weeks)|Other|0|||
131495984|NCT02310568|473444079|FG004|Stage 2 (4 Weeks)|Other|0|||
131495985|NCT02310568|473444075|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
131495986|NCT02310568|473444076|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
131495987|NCT02310568|473444077|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
131495988|NCT02310568|473444078|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
131495989|NCT02310568|473444079|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
131495990|NCT02310568|473444075|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
131495991|NCT02310568|473444076|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
131495992|NCT02310568|473444077|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
131495993|NCT02310568|473444078|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
131495994|NCT02310568|473444079|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
131495995|NCT02310568|473444075|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
131495996|NCT02310568|473444076|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
131495997|NCT02310568|473444077|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
131495998|NCT02310568|473444078|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
131495999|NCT02310568|473444079|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
131496000|NCT02989194|473444084|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
131496001|NCT02989194|473444085|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
131496002|NCT02989194|473444086|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
131496003|NCT02989194|473444084|FG000|Overall Study|Lost to Follow-up|0|||
131496004|NCT02989194|473444085|FG001|Overall Study|Lost to Follow-up|1|||
131496005|NCT02989194|473444086|FG002|Overall Study|Lost to Follow-up|0|||
131496006|NCT02989194|473444084|FG000|Overall Study|Withdrawal by Subject|0|||
131496007|NCT02989194|473444085|FG001|Overall Study|Withdrawal by Subject|1|||
131496008|NCT02989194|473444086|FG002|Overall Study|Withdrawal by Subject|0|||
131496009|NCT02899988|473444089|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
131496010|NCT02899988|473444090|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
131496011|NCT02899988|473444091|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496012|NCT02899988|473444092|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496013|NCT02899988|473444093|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496014|NCT02899988|473444094|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496015|NCT02899988|473444095|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496016|NCT02899988|473444096|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496017|NCT02899988|473444097|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496018|NCT02899988|473444098|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496019|NCT02899988|473444099|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131496020|NCT02899988|473444089|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
131496021|NCT02899988|473444090|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
131496022|NCT02899988|473444091|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
131496023|NCT02899988|473444092|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
131496024|NCT02899988|473444093|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
131496025|NCT02899988|473444094|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
131496026|NCT02899988|473444095|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
131496027|NCT02899988|473444096|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
131496028|NCT02899988|473444097|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
131496029|NCT02899988|473444098|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
131496030|NCT02899988|473444099|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
131496031|NCT02899988|473444089|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
131496032|NCT02899988|473444090|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
131496033|NCT02899988|473444091|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
131496034|NCT02899988|473444092|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
131496035|NCT02899988|473444093|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
131496036|NCT02899988|473444094|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
131496037|NCT02899988|473444095|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
131496038|NCT02899988|473444096|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
131496039|NCT02899988|473444097|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
131496040|NCT02899988|473444098|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
131496041|NCT02899988|473444099|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
131496042|NCT02899988|473444089|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
131496043|NCT02899988|473444090|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
131496044|NCT02899988|473444091|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
131496045|NCT02899988|473444092|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
131496046|NCT02899988|473444093|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
131496047|NCT02899988|473444094|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
131496048|NCT02899988|473444095|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
131496049|NCT02899988|473444096|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
131496050|NCT02899988|473444097|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
131496051|NCT02899988|473444098|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
131496052|NCT02899988|473444099|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
131496053|NCT02899988|473444089|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496054|NCT02899988|473444090|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496055|NCT02899988|473444091|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496056|NCT02899988|473444092|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496057|NCT02899988|473444093|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496058|NCT02899988|473444094|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
131496059|NCT02899988|473444095|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496060|NCT02899988|473444096|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
131496061|NCT02899988|473444097|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496062|NCT02899988|473444098|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496063|NCT02899988|473444099|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
131496064|NCT02899988|473444089|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131496065|NCT02899988|473444090|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131496066|NCT02899988|473444091|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131496067|NCT02899988|473444092|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131496068|NCT02899988|473444093|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
131496069|NCT02899988|473444094|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131496070|NCT02899988|473444095|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
131496071|NCT02899988|473444096|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
131496072|NCT02899988|473444097|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
131496073|NCT02899988|473444098|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131496074|NCT02899988|473444099|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
131496075|NCT01401283|473444101|FG000|Overall Study|surgery cancelled|5|||
131496076|NCT01401283|473444102|FG001|Overall Study|surgery cancelled|8|||
131496077|NCT01401283|473444101|FG000|Overall Study|preoperative arrhythmia|5|||
131496078|NCT01401283|473444102|FG001|Overall Study|preoperative arrhythmia|0|||
131496079|NCT01401283|473444101|FG000|Overall Study|no central venous access|0|||
131496080|NCT01401283|473444102|FG001|Overall Study|no central venous access|1|||
131496081|NCT01401283|473444101|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
131496082|NCT01401283|473444102|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
131496083|NCT02433483|473444103|FG000|Overall Study|Unacceptable toxicity|1|||
131496084|NCT02433483|473444103|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
131496085|NCT03824912|473444108|FG000|Overall Study|Lost to Follow-up|18|||
131496086|NCT03824912|473444109|FG001|Overall Study|Lost to Follow-up|15|||
131496087|NCT03824912|473444110|FG002|Overall Study|Lost to Follow-up|8|||
131496088|NCT03824912|473444108|FG000|Overall Study|Negative Baseline Culture Result|118|||
131496089|NCT03824912|473444109|FG001|Overall Study|Negative Baseline Culture Result|112|||
131496090|NCT03824912|473444110|FG002|Overall Study|Negative Baseline Culture Result|57|||
131496091|NCT03824912|473444108|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131496092|NCT03824912|473444109|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131496093|NCT03824912|473444110|FG002|Overall Study|Non-Compliance with Study Drug|1|||
131496094|NCT03824912|473444108|FG000|Overall Study|Protocol Violation|1|||
131496095|NCT03824912|473444109|FG001|Overall Study|Protocol Violation|4|||
131496096|NCT03824912|473444110|FG002|Overall Study|Protocol Violation|1|||
131496097|NCT03824912|473444108|FG000|Overall Study|Withdrawal by Subject|3|||
131496098|NCT03824912|473444109|FG001|Overall Study|Withdrawal by Subject|2|||
131496099|NCT03824912|473444110|FG002|Overall Study|Withdrawal by Subject|1|||
131496100|NCT03824912|473444108|FG000|Overall Study|Participation in another study|0|||
131496101|NCT03824912|473444109|FG001|Overall Study|Participation in another study|1|||
131496102|NCT03824912|473444110|FG002|Overall Study|Participation in another study|0|||
131496103|NCT02511184|473444111|FG000|Overall Study|Death|1|||
131496104|NCT02511184|473444112|FG001|Overall Study|Death|0|||
131496105|NCT02511184|473444111|FG000|Overall Study|Lost to Follow-up|0|||
131496106|NCT02511184|473444112|FG001|Overall Study|Lost to Follow-up|1|||
131496107|NCT02511184|473444111|FG000|Overall Study|Study terminated by sponsor|1|||
131496108|NCT02511184|473444112|FG001|Overall Study|Study terminated by sponsor|5|||
131496109|NCT02511184|473444111|FG000|Overall Study|Withdrawal by Subject|0|||
131496110|NCT02511184|473444112|FG001|Overall Study|Withdrawal by Subject|1|||
131496111|NCT04271605|473444113|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
131496112|NCT03342690|473444120|FG000|Overall Study|Missing Information|9|||
131496113|NCT03342690|473444120|FG000|Overall Study|Protocol Violation|16|||
131496114|NCT03585504|473444121|FG000|Overall Study|Lost to Follow-up|26|||
131496115|NCT03585504|473444122|FG001|Overall Study|Lost to Follow-up|29|||
131496116|NCT01414114|473444123|FG000|Overall Study|Adverse Event|2|||
131496117|NCT01414114|473444123|FG000|Overall Study|Withdrawal by Subject|1|||
131496118|NCT01414114|473444123|FG000|Overall Study|Other|2|||
131496119|NCT00105482|473444124|FG000|Overall Study|Adverse Event|1|||
131496120|NCT00105482|473444125|FG001|Overall Study|Adverse Event|1|||
131496121|NCT00105482|473444124|FG000|Overall Study|Lost to Follow-up|26|||
131496122|NCT00105482|473444125|FG001|Overall Study|Lost to Follow-up|17|||
131496123|NCT00105482|473444124|FG000|Overall Study|Withdrawal by Subject|0|||
131496124|NCT00105482|473444125|FG001|Overall Study|Withdrawal by Subject|1|||
131496125|NCT00105482|473444124|FG000|Overall Study|Lost Interest|29|||
131496126|NCT00105482|473444125|FG001|Overall Study|Lost Interest|32|||
131496127|NCT00105482|473444124|FG000|Overall Study|Scheduling Conflict|2|||
131496128|NCT00105482|473444125|FG001|Overall Study|Scheduling Conflict|3|||
131496129|NCT00105482|473444124|FG000|Overall Study|Withdrawn by PI|1|||
131496130|NCT00105482|473444125|FG001|Overall Study|Withdrawn by PI|1|||
131496131|NCT02085785|473444130|FG000|Overall Study|Withdrawal by Subject|2|||
131496132|NCT02085785|473444131|FG001|Overall Study|Withdrawal by Subject|1|||
131496133|NCT02085785|473444130|FG000|Overall Study|Lost to Follow-up|0|||
131496134|NCT02085785|473444131|FG001|Overall Study|Lost to Follow-up|1|||
131496135|NCT00779467|473444132|FG000|Overall Study|Lack of Efficacy|11|||
131496136|NCT00779467|473444133|FG001|Overall Study|Lack of Efficacy|2|||
131496137|NCT00779467|473444134|FG002|Overall Study|Lack of Efficacy|6|||
131496138|NCT00779467|473444135|FG003|Overall Study|Lack of Efficacy|11|||
131496139|NCT00779467|473444132|FG000|Overall Study|failed inclusion criteria|3|||
131496140|NCT00779467|473444133|FG001|Overall Study|failed inclusion criteria|3|||
131496141|NCT00779467|473444134|FG002|Overall Study|failed inclusion criteria|1|||
131496142|NCT00779467|473444135|FG003|Overall Study|failed inclusion criteria|2|||
131496143|NCT00779467|473444132|FG000|Overall Study|missing data|1|||
131496144|NCT00779467|473444133|FG001|Overall Study|missing data|0|||
131496145|NCT00779467|473444134|FG002|Overall Study|missing data|1|||
131496146|NCT00779467|473444135|FG003|Overall Study|missing data|4|||
131496147|NCT00779467|473444132|FG000|Overall Study|technical issue|0|||
131496148|NCT00779467|473444133|FG001|Overall Study|technical issue|0|||
131496149|NCT00779467|473444134|FG002|Overall Study|technical issue|2|||
131496150|NCT00779467|473444135|FG003|Overall Study|technical issue|1|||
131496151|NCT00779467|473444132|FG000|Overall Study|unavailable research staff|0|||
131496152|NCT00779467|473444133|FG001|Overall Study|unavailable research staff|0|||
131496153|NCT00779467|473444134|FG002|Overall Study|unavailable research staff|0|||
131496154|NCT00779467|473444135|FG003|Overall Study|unavailable research staff|1|||
131496155|NCT00284050|473444136|FG000|Overall Study|Adverse Event|1|||
131496156|NCT00284050|473444137|FG001|Overall Study|Adverse Event|1|||
131496157|NCT00284050|473444138|FG002|Overall Study|Adverse Event|1|||
131496158|NCT00284050|473444136|FG000|Overall Study|Lack of Efficacy|0|||
131496159|NCT00284050|473444137|FG001|Overall Study|Lack of Efficacy|1|||
131496160|NCT00284050|473444138|FG002|Overall Study|Lack of Efficacy|3|||
131496161|NCT00284050|473444136|FG000|Overall Study|Protocol Violation|0|||
131496162|NCT00284050|473444137|FG001|Overall Study|Protocol Violation|1|||
131496163|NCT00284050|473444138|FG002|Overall Study|Protocol Violation|2|||
131496164|NCT00284050|473444136|FG000|Overall Study|Withdrawal by Subject|2|||
131496165|NCT00284050|473444137|FG001|Overall Study|Withdrawal by Subject|2|||
131496166|NCT00284050|473444138|FG002|Overall Study|Withdrawal by Subject|2|||
131496167|NCT00284050|473444136|FG000|Overall Study|Lost to Follow-up|1|||
131496168|NCT00284050|473444137|FG001|Overall Study|Lost to Follow-up|0|||
131496169|NCT00284050|473444138|FG002|Overall Study|Lost to Follow-up|1|||
131496170|NCT00284050|473444136|FG000|Overall Study|Death|1|||
131496171|NCT00284050|473444137|FG001|Overall Study|Death|0|||
131496172|NCT00284050|473444138|FG002|Overall Study|Death|0|||
131496173|NCT02573350|473444140|FG000|Overall Study|Lost to Follow-up|2|||
131496174|NCT02573350|473444141|FG001|Overall Study|Lost to Follow-up|1|||
131496175|NCT02573350|473444140|FG000|Overall Study|Adverse Event|3|||
131496176|NCT02573350|473444141|FG001|Overall Study|Adverse Event|4|||
131496177|NCT02573350|473444140|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
131496178|NCT02573350|473444141|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
131496179|NCT02573350|473444140|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
131496180|NCT02573350|473444141|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
131496181|NCT02573350|473444140|FG000|Overall Study|Subject withdrew consent to participate|6|||
131496182|NCT02573350|473444141|FG001|Overall Study|Subject withdrew consent to participate|1|||
131496183|NCT02573350|473444140|FG000|Overall Study|Protocol Deviation|1|||
131496184|NCT02573350|473444141|FG001|Overall Study|Protocol Deviation|1|||
131496185|NCT02708121|473444142|FG000|Overall Study|Withdrawn by Study Team|1|||
131496186|NCT02708121|473444143|FG001|Overall Study|Withdrawn by Study Team|1|||
131496187|NCT02708121|473444142|FG000|Overall Study|Withdrawal by Subject|0|||
131496188|NCT02708121|473444143|FG001|Overall Study|Withdrawal by Subject|4|||
131496189|NCT04202965|473444145|FG000|Overall Study|Adverse Event|3|||
131496190|NCT04202965|473444145|FG000|Overall Study|Did not meet inclusion criteria|1|||
131496191|NCT00006903|473444146|FG000|Overall Study|Still receiving treatment|0|||
131496192|NCT00006903|473444147|FG001|Overall Study|Still receiving treatment|0|||
131496193|NCT00006903|473444148|FG002|Overall Study|Still receiving treatment|1|||
131496194|NCT00006903|473444146|FG000|Overall Study|Refused further treatment|0|||
131496195|NCT00006903|473444147|FG001|Overall Study|Refused further treatment|2|||
131496196|NCT00006903|473444148|FG002|Overall Study|Refused further treatment|1|||
131496197|NCT00006903|473444146|FG000|Overall Study|Adverse Event|0|||
131496198|NCT00006903|473444147|FG001|Overall Study|Adverse Event|0|||
131496199|NCT00006903|473444148|FG002|Overall Study|Adverse Event|1|||
131496200|NCT00006903|473444146|FG000|Overall Study|Death|0|||
131496201|NCT00006903|473444147|FG001|Overall Study|Death|1|||
131496202|NCT00006903|473444148|FG002|Overall Study|Death|0|||
131496203|NCT00006903|473444146|FG000|Overall Study|Patient never treated|0|||
131496204|NCT00006903|473444147|FG001|Overall Study|Patient never treated|0|||
131496205|NCT00006903|473444148|FG002|Overall Study|Patient never treated|1|||
131496206|NCT00006903|473444146|FG000|Overall Study|Ineligible|10|||
131496207|NCT00006903|473444147|FG001|Overall Study|Ineligible|1|||
131496208|NCT00006903|473444148|FG002|Overall Study|Ineligible|2|||
131496209|NCT02706691|473444152|FG000|Overall Study|Adverse Event|1|||
131496210|NCT05025241|473444158|FG000|Screening|Failed Screening|5|||
131496211|NCT05025241|473444158|FG000|Treatment and Follow Up|Adverse Event|3|||
131496212|NCT01366209|473444159|FG000|Overall Study|Adverse Event|6|||
131496213|NCT01366209|473444160|FG001|Overall Study|Adverse Event|7|||
131496214|NCT01366209|473444159|FG000|Overall Study|Withdrawal by Subject|4|||
131496215|NCT01366209|473444160|FG001|Overall Study|Withdrawal by Subject|4|||
131496216|NCT01366209|473444159|FG000|Overall Study|Death|12|||
131496217|NCT01366209|473444160|FG001|Overall Study|Death|19|||
131496218|NCT01366209|473444159|FG000|Overall Study|Lung transplantation|6|||
131496219|NCT01366209|473444160|FG001|Overall Study|Lung transplantation|1|||
131496220|NCT01366209|473444159|FG000|Overall Study|Lost to Follow-up|2|||
131496221|NCT01366209|473444160|FG001|Overall Study|Lost to Follow-up|1|||
131496222|NCT01366209|473444159|FG000|Overall Study|Physician Decision|1|||
131496223|NCT01366209|473444160|FG001|Overall Study|Physician Decision|0|||
131496224|NCT01366209|473444159|FG000|Overall Study|Sponsors decision|0|||
131496225|NCT01366209|473444160|FG001|Overall Study|Sponsors decision|1|||
131496226|NCT01366209|473444159|FG000|Overall Study|Withdrew consent|4|||
131496227|NCT01366209|473444160|FG001|Overall Study|Withdrew consent|3|||
131496228|NCT02670837|473444161|FG000|Overall Study|Death|2|||
131496229|NCT02670837|473444162|FG001|Overall Study|Death|0|||
131496230|NCT02670837|473444163|FG002|Overall Study|Death|0|||
131496231|NCT01053221|473444164|FG000|Overall Study|The study was closed prematurely|5|||
131496232|NCT01053221|473444165|FG001|Overall Study|The study was closed prematurely|9|||
131496233|NCT01919723|473444166|FG000|Overall Study|Blood Samples Hemolyzed|2|||
131496234|NCT01919723|473444167|FG001|Overall Study|Blood Samples Hemolyzed|2|||
131496235|NCT00555321|473444168|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
131496236|NCT00555321|473444169|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
131496237|NCT00555321|473444170|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
131496238|NCT00555321|473444171|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
131496239|NCT00555321|473444172|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
131496240|NCT00555321|473444168|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
131496241|NCT00555321|473444169|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
131496242|NCT00555321|473444170|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
131496243|NCT00555321|473444171|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
131496244|NCT00555321|473444172|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
131496245|NCT00555321|473444168|FG000|Treatment Phase up to 12-months|Death|2|||
131496246|NCT00555321|473444169|FG001|Treatment Phase up to 12-months|Death|1|||
131496247|NCT00555321|473444170|FG002|Treatment Phase up to 12-months|Death|4|||
131496248|NCT00555321|473444171|FG003|Treatment Phase up to 12-months|Death|0|||
131496249|NCT00555321|473444172|FG004|Treatment Phase up to 12-months|Death|0|||
131496250|NCT00555321|473444168|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
131496251|NCT00555321|473444169|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
131496252|NCT00555321|473444170|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
131496253|NCT00555321|473444171|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
131496254|NCT00555321|473444172|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
131496255|NCT00555321|473444168|FG000|Treatment Phase up to 12-months|Other Reason|1|||
131496256|NCT00555321|473444169|FG001|Treatment Phase up to 12-months|Other Reason|3|||
131496257|NCT00555321|473444170|FG002|Treatment Phase up to 12-months|Other Reason|2|||
131496258|NCT00555321|473444171|FG003|Treatment Phase up to 12-months|Other Reason|0|||
131496259|NCT00555321|473444172|FG004|Treatment Phase up to 12-months|Other Reason|0|||
131496260|NCT00555321|473444168|FG000|Treatment Phase up to 12-months|Never treated|2|||
131496261|NCT00555321|473444169|FG001|Treatment Phase up to 12-months|Never treated|3|||
131496262|NCT00555321|473444170|FG002|Treatment Phase up to 12-months|Never treated|1|||
131496263|NCT00555321|473444171|FG003|Treatment Phase up to 12-months|Never treated|0|||
131496264|NCT00555321|473444172|FG004|Treatment Phase up to 12-months|Never treated|4|||
131496265|NCT00555321|473444168|FG000|Long-term Extension Phase|Adverse Event|2|||
131496266|NCT00555321|473444169|FG001|Long-term Extension Phase|Adverse Event|5|||
131496267|NCT00555321|473444170|FG002|Long-term Extension Phase|Adverse Event|2|||
131496268|NCT00555321|473444171|FG003|Long-term Extension Phase|Adverse Event|1|||
131496269|NCT00555321|473444172|FG004|Long-term Extension Phase|Adverse Event|0|||
131496270|NCT00555321|473444168|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
131496271|NCT00555321|473444169|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
131496272|NCT00555321|473444170|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
131496273|NCT00555321|473444171|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
131496274|NCT00555321|473444172|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
131496275|NCT00555321|473444168|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
131496276|NCT00555321|473444169|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
131496277|NCT00555321|473444170|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
131496278|NCT00555321|473444171|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
131496279|NCT00555321|473444172|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
131496280|NCT00555321|473444168|FG000|Long-term Extension Phase|Death|2|||
131496281|NCT00555321|473444169|FG001|Long-term Extension Phase|Death|0|||
131496282|NCT00555321|473444170|FG002|Long-term Extension Phase|Death|0|||
131496283|NCT00555321|473444171|FG003|Long-term Extension Phase|Death|3|||
131496284|NCT00555321|473444172|FG004|Long-term Extension Phase|Death|0|||
131496285|NCT00555321|473444168|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
131496286|NCT00555321|473444169|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
131496287|NCT00555321|473444170|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
131496288|NCT00555321|473444171|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
131496289|NCT00555321|473444172|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
131496290|NCT00555321|473444168|FG000|Long-term Extension Phase|Other Reason|1|||
131496291|NCT00555321|473444169|FG001|Long-term Extension Phase|Other Reason|0|||
131496292|NCT00555321|473444170|FG002|Long-term Extension Phase|Other Reason|2|||
131496293|NCT00555321|473444171|FG003|Long-term Extension Phase|Other Reason|0|||
131496294|NCT00555321|473444172|FG004|Long-term Extension Phase|Other Reason|0|||
131496295|NCT00582166|473444175|FG000|Overall Study|Death|1|||
131496296|NCT00582166|473444175|FG000|Overall Study|Ineligible pathology|1|||
131496297|NCT02532972|473444176|FG000|Overall Study|Withdrawal by Subject|1|||
131496298|NCT03944954|473444177|FG000|Overall Study|Withdrawal by Subject|22|||
131496299|NCT03944954|473444178|FG001|Overall Study|Withdrawal by Subject|4|||
131496300|NCT03944954|473444177|FG000|Overall Study|Lost to Follow-up|18|||
131496301|NCT03944954|473444178|FG001|Overall Study|Lost to Follow-up|0|||
131496302|NCT03944954|473444177|FG000|Overall Study|Failed Medical Screening|7|||
131496303|NCT03944954|473444178|FG001|Overall Study|Failed Medical Screening|0|||
131496304|NCT02268084|473444181|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
131496305|NCT02268084|473444182|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
131496306|NCT02268084|473444181|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
131496307|NCT02268084|473444182|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
131496308|NCT05227027|473444183|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
131496309|NCT05227027|473444184|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
131496310|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
131496311|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
131496312|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
131496313|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
131496314|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
131496315|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
131496316|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
131496317|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
131496318|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
131496319|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
131496320|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
131496321|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
131496322|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
131496323|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
131496324|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
131496325|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
131496326|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
131496327|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
131496328|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
131496329|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
131496330|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
131496331|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
131496332|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
131496333|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
131496334|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
131496335|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
131496336|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
131496337|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
131496338|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
131496339|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
131496340|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
131496341|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
131496342|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
131496343|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
131496344|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
131496345|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
131496346|NCT02603419|473444185|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
131496347|NCT02603419|473444186|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
131496348|NCT02603419|473444187|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
131496349|NCT02603419|473444188|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
131496350|NCT02603419|473444189|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
131496351|NCT02603419|473444190|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
131496352|NCT02603419|473444185|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
131496353|NCT02603419|473444186|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
131496354|NCT02603419|473444187|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
131496355|NCT02603419|473444188|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
131496356|NCT02603419|473444189|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
131496357|NCT02603419|473444190|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
131496358|NCT02603419|473444185|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
131496359|NCT02603419|473444186|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
131496360|NCT02603419|473444187|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
131496361|NCT02603419|473444188|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
131496362|NCT02603419|473444189|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
131496363|NCT02603419|473444190|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
131496364|NCT02603419|473444185|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
131496365|NCT02603419|473444186|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
131496366|NCT02603419|473444187|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
131496367|NCT02603419|473444188|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
131496368|NCT02603419|473444189|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
131496369|NCT02603419|473444190|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
131496370|NCT03334448|473444194|FG000|Washout|Personal Reason|0|||
131496371|NCT03334448|473444195|FG001|Washout|Personal Reason|1|||
131496372|NCT03334448|473444196|FG002|Washout|Personal Reason|0|||
131496373|NCT03334448|473444197|FG003|Washout|Personal Reason|0|||
131496374|NCT03334448|473444194|FG000|Washout|Protocol Violation|0|||
131496375|NCT03334448|473444195|FG001|Washout|Protocol Violation|0|||
131496376|NCT03334448|473444196|FG002|Washout|Protocol Violation|0|||
131496377|NCT03334448|473444197|FG003|Washout|Protocol Violation|1|||
131496378|NCT00855920|473444203|FG000|Overall Study|Protocol Violation|0|||
131496379|NCT00855920|473444204|FG001|Overall Study|Protocol Violation|0|||
131496380|NCT00855920|473444205|FG002|Overall Study|Protocol Violation|2|||
131496381|NCT00855920|473444203|FG000|Overall Study|Adverse Event|2|||
131496382|NCT00855920|473444204|FG001|Overall Study|Adverse Event|1|||
131496383|NCT00855920|473444205|FG002|Overall Study|Adverse Event|1|||
131496384|NCT00855920|473444203|FG000|Overall Study|Lack of Efficacy|2|||
131496385|NCT00855920|473444204|FG001|Overall Study|Lack of Efficacy|2|||
131496386|NCT00855920|473444205|FG002|Overall Study|Lack of Efficacy|2|||
131496387|NCT00855920|473444203|FG000|Overall Study|Withdrawal by Subject|2|||
131496388|NCT00855920|473444204|FG001|Overall Study|Withdrawal by Subject|3|||
131496389|NCT00855920|473444205|FG002|Overall Study|Withdrawal by Subject|2|||
131496390|NCT00855920|473444203|FG000|Overall Study|Lost to Follow-up|1|||
131496391|NCT00855920|473444204|FG001|Overall Study|Lost to Follow-up|0|||
131496392|NCT00855920|473444205|FG002|Overall Study|Lost to Follow-up|2|||
131496393|NCT00855920|473444203|FG000|Overall Study|Death|0|||
131496394|NCT00855920|473444204|FG001|Overall Study|Death|1|||
131496395|NCT00855920|473444205|FG002|Overall Study|Death|0|||
131496396|NCT00855920|473444203|FG000|Overall Study|Decision by the sponsor|0|||
131496397|NCT00855920|473444204|FG001|Overall Study|Decision by the sponsor|1|||
131496398|NCT00855920|473444205|FG002|Overall Study|Decision by the sponsor|1|||
131496399|NCT00855920|473444203|FG000|Overall Study|Other than specified above|1|||
131496400|NCT00855920|473444204|FG001|Overall Study|Other than specified above|1|||
131496401|NCT00855920|473444205|FG002|Overall Study|Other than specified above|1|||
131496402|NCT02496611|473444208|FG000|Overall Study|Lost to Follow-up|2|||
131496403|NCT02496611|473444209|FG001|Overall Study|Lost to Follow-up|1|||
131496404|NCT02496611|473444208|FG000|Overall Study|Withdrawal by Subject|5|||
131496405|NCT02496611|473444209|FG001|Overall Study|Withdrawal by Subject|2|||
131496406|NCT02850965|473444210|FG000|Overall Study|Other than listed|3|||
131496407|NCT02850965|473444211|FG001|Overall Study|Other than listed|4|||
131496408|NCT02850965|473444210|FG000|Overall Study|Protocol Violation|0|||
131496409|NCT02850965|473444211|FG001|Overall Study|Protocol Violation|2|||
131496410|NCT02850965|473444210|FG000|Overall Study|Lost to Follow-up|5|||
131496411|NCT02850965|473444211|FG001|Overall Study|Lost to Follow-up|3|||
131496412|NCT02850965|473444210|FG000|Overall Study|Lack of Efficacy|4|||
131496413|NCT02850965|473444211|FG001|Overall Study|Lack of Efficacy|8|||
131496414|NCT02850965|473444210|FG000|Overall Study|Adverse Event|3|||
131496415|NCT02850965|473444211|FG001|Overall Study|Adverse Event|2|||
131496416|NCT02850965|473444210|FG000|Overall Study|Withdrawal by Subject|3|||
131496417|NCT02850965|473444211|FG001|Overall Study|Withdrawal by Subject|4|||
131496418|NCT02850965|473444210|FG000|Overall Study|Physician Decision|0|||
131496419|NCT02850965|473444211|FG001|Overall Study|Physician Decision|1|||
131496420|NCT02850965|473444210|FG000|Overall Study|Randomized but not treated|0|||
131496421|NCT02850965|473444211|FG001|Overall Study|Randomized but not treated|1|||
131496422|NCT02788357|473444215|FG000|Overall Study|Lost to Follow-up|3|||
131496423|NCT02788357|473444216|FG001|Overall Study|Lost to Follow-up|0|||
131496424|NCT01365910|473444217|FG000|Overall Study|Withdrawal by Subject|7|||
131496425|NCT01365910|473444217|FG000|Overall Study|disease progression|18|||
131496426|NCT01365910|473444217|FG000|Overall Study|Adverse Event|3|||
131496427|NCT01365910|473444217|FG000|Overall Study|other complicating disease|1|||
131496428|NCT01365910|473444217|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
131496429|NCT00371137|473444218|FG000|Overall Study|Adverse Event|20|||
131496430|NCT00371137|473444219|FG001|Overall Study|Adverse Event|35|||
131496431|NCT00371137|473444220|FG002|Overall Study|Adverse Event|42|||
131496432|NCT00371137|473444218|FG000|Overall Study|Withdrawal by Subject|11|||
131496433|NCT00371137|473444219|FG001|Overall Study|Withdrawal by Subject|10|||
131496434|NCT00371137|473444220|FG002|Overall Study|Withdrawal by Subject|15|||
131496435|NCT00371137|473444218|FG000|Overall Study|Lost to Follow-up|6|||
131496436|NCT00371137|473444219|FG001|Overall Study|Lost to Follow-up|3|||
131496437|NCT00371137|473444220|FG002|Overall Study|Lost to Follow-up|5|||
131496438|NCT00371137|473444218|FG000|Overall Study|Lack of Efficacy|30|||
131496439|NCT00371137|473444219|FG001|Overall Study|Lack of Efficacy|12|||
131496440|NCT00371137|473444220|FG002|Overall Study|Lack of Efficacy|13|||
131496441|NCT00371137|473444218|FG000|Overall Study|Sponsor Decision|2|||
131496442|NCT00371137|473444219|FG001|Overall Study|Sponsor Decision|1|||
131496443|NCT00371137|473444220|FG002|Overall Study|Sponsor Decision|2|||
131496444|NCT00371137|473444218|FG000|Overall Study|Physician Decision|1|||
131496445|NCT00371137|473444219|FG001|Overall Study|Physician Decision|1|||
131496446|NCT00371137|473444220|FG002|Overall Study|Physician Decision|1|||
131496447|NCT00371137|473444218|FG000|Overall Study|Protocol Violation|2|||
131496448|NCT00371137|473444219|FG001|Overall Study|Protocol Violation|1|||
131496449|NCT00371137|473444220|FG002|Overall Study|Protocol Violation|1|||
131496450|NCT00536198|473444221|FG000|Overall Study|Lost to Follow-up|15|||
131496451|NCT00536198|473444222|FG001|Overall Study|Lost to Follow-up|14|||
131496452|NCT00536198|473444221|FG000|Overall Study|Withdrawal by Subject|16|||
131496453|NCT00536198|473444222|FG001|Overall Study|Withdrawal by Subject|12|||
131496454|NCT00536198|473444221|FG000|Overall Study|Adverse Event|2|||
131496455|NCT00536198|473444222|FG001|Overall Study|Adverse Event|2|||
131496456|NCT00536198|473444221|FG000|Overall Study|Rescue|3|||
131496457|NCT00536198|473444222|FG001|Overall Study|Rescue|9|||
131496458|NCT00536198|473444221|FG000|Overall Study|Pregnancy|1|||
131496459|NCT00536198|473444222|FG001|Overall Study|Pregnancy|1|||
131496460|NCT00536198|473444221|FG000|Overall Study|Protocol Violation|0|||
131496461|NCT00536198|473444222|FG001|Overall Study|Protocol Violation|1|||
131496462|NCT01666782|473444223|FG000|Overall Study|Received 2 doses of vaccine|0|||
131496463|NCT01666782|473444224|FG001|Overall Study|Received 2 doses of vaccine|1|||
131496464|NCT01666782|473444223|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
131496465|NCT01666782|473444224|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
131496466|NCT04786990|473444225|FG000|Overall Study|Withdrawal by Subject|1|||
131496467|NCT04786990|473444225|FG000|Overall Study|Adverse Event|1|||
131496468|NCT04786990|473444225|FG000|Overall Study|Lost to Follow-up|1|||
131496469|NCT04786990|473444225|FG000|Overall Study|Noncompliance|1|||
131496470|NCT04786990|473444225|FG000|Overall Study|Unable to complete site visits|1|||
131496471|NCT04786990|473444225|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
131496472|NCT03572062|473444237|FG000|Overall Study|Adverse Event|0|||
131496473|NCT03572062|473444238|FG001|Overall Study|Adverse Event|0|||
131496474|NCT03572062|473444239|FG002|Overall Study|Adverse Event|0|||
131496475|NCT03572062|473444240|FG003|Overall Study|Adverse Event|0|||
131496476|NCT03572062|473444241|FG004|Overall Study|Adverse Event|0|||
131496477|NCT03572062|473444242|FG005|Overall Study|Adverse Event|0|||
131496478|NCT03572062|473444243|FG006|Overall Study|Adverse Event|0|||
131496479|NCT03572062|473444244|FG007|Overall Study|Adverse Event|0|||
131496480|NCT03572062|473444245|FG008|Overall Study|Adverse Event|1|||
131496481|NCT03572062|473444246|FG009|Overall Study|Adverse Event|3|||
131496482|NCT03572062|473444237|FG000|Overall Study|Death|0|||
131496483|NCT03572062|473444238|FG001|Overall Study|Death|0|||
131496484|NCT03572062|473444239|FG002|Overall Study|Death|0|||
131496485|NCT03572062|473444240|FG003|Overall Study|Death|0|||
131496486|NCT03572062|473444241|FG004|Overall Study|Death|0|||
131496487|NCT03572062|473444242|FG005|Overall Study|Death|1|||
131496488|NCT03572062|473444243|FG006|Overall Study|Death|0|||
131496489|NCT03572062|473444244|FG007|Overall Study|Death|0|||
131496490|NCT03572062|473444245|FG008|Overall Study|Death|0|||
131496491|NCT03572062|473444246|FG009|Overall Study|Death|0|||
131496492|NCT03572062|473444237|FG000|Overall Study|Lost to Follow-up|0|||
131496493|NCT03572062|473444238|FG001|Overall Study|Lost to Follow-up|0|||
131496494|NCT03572062|473444239|FG002|Overall Study|Lost to Follow-up|0|||
131496495|NCT03572062|473444240|FG003|Overall Study|Lost to Follow-up|0|||
131496496|NCT03572062|473444241|FG004|Overall Study|Lost to Follow-up|0|||
131496497|NCT03572062|473444242|FG005|Overall Study|Lost to Follow-up|1|||
131496498|NCT03572062|473444243|FG006|Overall Study|Lost to Follow-up|1|||
131496499|NCT03572062|473444244|FG007|Overall Study|Lost to Follow-up|0|||
131496500|NCT03572062|473444245|FG008|Overall Study|Lost to Follow-up|0|||
131496501|NCT03572062|473444246|FG009|Overall Study|Lost to Follow-up|0|||
131496502|NCT03572062|473444237|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496503|NCT03572062|473444238|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496504|NCT03572062|473444239|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496505|NCT03572062|473444240|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496506|NCT03572062|473444241|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496507|NCT03572062|473444242|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496508|NCT03572062|473444243|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496509|NCT03572062|473444244|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496510|NCT03572062|473444245|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
131496511|NCT03572062|473444246|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
131496512|NCT03572062|473444237|FG000|Overall Study|Study Terminated By Sponsor|0|||
131496513|NCT03572062|473444238|FG001|Overall Study|Study Terminated By Sponsor|0|||
131496514|NCT03572062|473444239|FG002|Overall Study|Study Terminated By Sponsor|0|||
131496515|NCT03572062|473444240|FG003|Overall Study|Study Terminated By Sponsor|0|||
131496516|NCT03572062|473444241|FG004|Overall Study|Study Terminated By Sponsor|0|||
131496517|NCT03572062|473444242|FG005|Overall Study|Study Terminated By Sponsor|0|||
131496518|NCT03572062|473444243|FG006|Overall Study|Study Terminated By Sponsor|0|||
131496519|NCT03572062|473444244|FG007|Overall Study|Study Terminated By Sponsor|0|||
131496520|NCT03572062|473444245|FG008|Overall Study|Study Terminated By Sponsor|29|||
131496521|NCT03572062|473444246|FG009|Overall Study|Study Terminated By Sponsor|27|||
131496522|NCT03572062|473444237|FG000|Overall Study|Physician Decision|0|||
131496523|NCT03572062|473444238|FG001|Overall Study|Physician Decision|0|||
131496524|NCT03572062|473444239|FG002|Overall Study|Physician Decision|0|||
131496525|NCT03572062|473444240|FG003|Overall Study|Physician Decision|0|||
131496526|NCT03572062|473444241|FG004|Overall Study|Physician Decision|0|||
131496527|NCT03572062|473444242|FG005|Overall Study|Physician Decision|0|||
131496528|NCT03572062|473444243|FG006|Overall Study|Physician Decision|0|||
131496529|NCT03572062|473444244|FG007|Overall Study|Physician Decision|0|||
131496530|NCT03572062|473444245|FG008|Overall Study|Physician Decision|1|||
131496531|NCT03572062|473444246|FG009|Overall Study|Physician Decision|0|||
131496532|NCT03572062|473444237|FG000|Overall Study|Withdrawal by Subject|0|||
131496533|NCT03572062|473444238|FG001|Overall Study|Withdrawal by Subject|0|||
131496534|NCT03572062|473444239|FG002|Overall Study|Withdrawal by Subject|0|||
131496535|NCT03572062|473444240|FG003|Overall Study|Withdrawal by Subject|0|||
131496536|NCT03572062|473444241|FG004|Overall Study|Withdrawal by Subject|0|||
131496537|NCT03572062|473444242|FG005|Overall Study|Withdrawal by Subject|0|||
131496538|NCT03572062|473444243|FG006|Overall Study|Withdrawal by Subject|0|||
131496539|NCT03572062|473444244|FG007|Overall Study|Withdrawal by Subject|0|||
131496540|NCT03572062|473444245|FG008|Overall Study|Withdrawal by Subject|0|||
131496541|NCT03572062|473444246|FG009|Overall Study|Withdrawal by Subject|1|||
131496542|NCT03572062|473444237|FG000|Overall Study|Randomized But Not Treated|0|||
131496543|NCT03572062|473444238|FG001|Overall Study|Randomized But Not Treated|0|||
131496544|NCT03572062|473444239|FG002|Overall Study|Randomized But Not Treated|0|||
131496545|NCT03572062|473444240|FG003|Overall Study|Randomized But Not Treated|0|||
131496546|NCT03572062|473444241|FG004|Overall Study|Randomized But Not Treated|1|||
131496547|NCT03572062|473444242|FG005|Overall Study|Randomized But Not Treated|2|||
131496548|NCT03572062|473444243|FG006|Overall Study|Randomized But Not Treated|0|||
131496549|NCT03572062|473444244|FG007|Overall Study|Randomized But Not Treated|1|||
131496550|NCT03572062|473444245|FG008|Overall Study|Randomized But Not Treated|0|||
131496551|NCT03572062|473444246|FG009|Overall Study|Randomized But Not Treated|0|||
131496552|NCT01691781|473444247|FG000|Overall Study|Withdrawal by Subject|4|||
131496553|NCT01691781|473444248|FG001|Overall Study|Withdrawal by Subject|3|||
131496554|NCT01691781|473444247|FG000|Overall Study|Physician Decision|1|||
131496555|NCT01691781|473444248|FG001|Overall Study|Physician Decision|1|||
131496556|NCT01691781|473444247|FG000|Overall Study|Protocol Violation|2|||
131496557|NCT01691781|473444248|FG001|Overall Study|Protocol Violation|2|||
131496558|NCT01691781|473444247|FG000|Overall Study|Adverse Event|0|||
131496559|NCT01691781|473444248|FG001|Overall Study|Adverse Event|1|||
131496560|NCT01605877|473444249|FG000|Overall Study|Withdrawal by Subject|1|||
131496561|NCT01918085|473444252|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
131496562|NCT01918085|473444253|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
131496563|NCT00687323|473444260|FG000|Overall Study|Death|25|||
131496564|NCT00687323|473444260|FG000|Overall Study|Withdrawal by Subject|1|||
131496565|NCT00687323|473444260|FG000|Overall Study|Excluded from efficacy evaluations|6|||
131496566|NCT00687323|473444260|FG000|Overall Study|Screen failure|148|||
131496567|NCT03310775|473444265|FG000|Overall Study|Lost to Follow-up|2|||
131496568|NCT03310775|473444266|FG001|Overall Study|Lost to Follow-up|3|||
131496569|NCT03310775|473444265|FG000|Overall Study|aggravation of depression|0|||
131496570|NCT03310775|473444266|FG001|Overall Study|aggravation of depression|1|||
131496571|NCT00679302|473444267|FG000|Overall Study|Lost to Follow-up|8|||
131496572|NCT00679302|473444268|FG001|Overall Study|Lost to Follow-up|4|||
131496573|NCT00646776|473444269|FG000|Overall Study|Adverse Event|1|||
131496574|NCT00646776|473444270|FG001|Overall Study|Adverse Event|9|||
131496575|NCT00646776|473444269|FG000|Overall Study|Investigator discretion|0|||
131496576|NCT00646776|473444270|FG001|Overall Study|Investigator discretion|4|||
131496577|NCT00126568|473444271|FG000|Overall Study|Death|2|||
131496578|NCT03031678|473444273|FG000|Overall Study|Study closed prior to completion|1|||
131496579|NCT03278613|473444276|FG000|Overall Study|Lost to Follow-up|3|||
131496580|NCT03278613|473444277|FG001|Overall Study|Lost to Follow-up|1|||
131496581|NCT01937559|473444278|FG000|Overall Study|Physician Decision|3|||
131496582|NCT01937559|473444279|FG001|Overall Study|Physician Decision|3|||
131496583|NCT01937559|473444280|FG002|Overall Study|Physician Decision|0|||
131496584|NCT01937559|473444278|FG000|Overall Study|Withdrawal by Subject|6|||
131496585|NCT01937559|473444279|FG001|Overall Study|Withdrawal by Subject|4|||
131496586|NCT01937559|473444280|FG002|Overall Study|Withdrawal by Subject|0|||
131496587|NCT01937559|473444278|FG000|Overall Study|screen fail|2|||
131496588|NCT01937559|473444279|FG001|Overall Study|screen fail|4|||
131496589|NCT01937559|473444280|FG002|Overall Study|screen fail|0|||
131496590|NCT01384760|473446311|FG000|Overall Study|Lost to Follow-up|0|||
131496591|NCT01384760|473446312|FG001|Overall Study|Lost to Follow-up|6|||
131496592|NCT01384760|473446311|FG000|Overall Study|Protocol Violation|16|||
131496593|NCT01384760|473446312|FG001|Overall Study|Protocol Violation|0|||
131496594|NCT01549860|473446318|FG000|Overall Study|Withdrawal by Subject|1|||
131496595|NCT01549860|473446319|FG001|Overall Study|Withdrawal by Subject|0|||
131496596|NCT01549860|473446318|FG000|Overall Study|Physician Decision|1|||
131496597|NCT01549860|473446319|FG001|Overall Study|Physician Decision|1|||
131496598|NCT02041286|473446323|FG000|Overall Study|Adverse Event|1|||
131496599|NCT03138889|473446328|FG000|Overall Study|Withdrawal by Subject|5|||
131496600|NCT03138889|473446329|FG001|Overall Study|Withdrawal by Subject|5|||
131496601|NCT03138889|473446330|FG002|Overall Study|Withdrawal by Subject|0|||
131496602|NCT03138889|473446331|FG003|Overall Study|Withdrawal by Subject|2|||
131496603|NCT03138889|473446332|FG004|Overall Study|Withdrawal by Subject|1|||
131496604|NCT03138889|473446333|FG005|Overall Study|Withdrawal by Subject|3|||
131496605|NCT03138889|473446334|FG006|Overall Study|Withdrawal by Subject|0|||
131496606|NCT03138889|473446335|FG007|Overall Study|Withdrawal by Subject|1|||
131496607|NCT01963403|473446340|FG000|Overall Study|Lost to Follow-up|2|||
131496608|NCT01963403|473446341|FG001|Overall Study|Lost to Follow-up|3|||
131496609|NCT01963403|473446340|FG000|Overall Study|Implant removal|0|||
131496610|NCT01963403|473446341|FG001|Overall Study|Implant removal|1|||
131496611|NCT00549302|473446348|FG000|Double-Blind|Death|2|||
131496612|NCT00549302|473446349|FG001|Double-Blind|Death|9|||
131496613|NCT00549302|473446350|FG002|Double-Blind|Death|0|||
131496614|NCT00549302|473446348|FG000|Double-Blind|Adverse Event|3|||
131496615|NCT00549302|473446349|FG001|Double-Blind|Adverse Event|16|||
131496616|NCT00549302|473446350|FG002|Double-Blind|Adverse Event|0|||
131496617|NCT00549302|473446348|FG000|Double-Blind|Withdrawal by Subject|3|||
131496618|NCT00549302|473446349|FG001|Double-Blind|Withdrawal by Subject|8|||
131496619|NCT00549302|473446350|FG002|Double-Blind|Withdrawal by Subject|0|||
131496620|NCT00549302|473446348|FG000|Double-Blind|Investigator Decision|1|||
131496621|NCT00549302|473446349|FG001|Double-Blind|Investigator Decision|5|||
131496622|NCT00549302|473446350|FG002|Double-Blind|Investigator Decision|0|||
131496623|NCT00549302|473446348|FG000|Double-Blind|Sponsor Decision|0|||
131496624|NCT00549302|473446349|FG001|Double-Blind|Sponsor Decision|1|||
131496625|NCT00549302|473446350|FG002|Double-Blind|Sponsor Decision|0|||
131496626|NCT00549302|473446348|FG000|Double-Blind|Lost to Follow-up|1|||
131496627|NCT00549302|473446349|FG001|Double-Blind|Lost to Follow-up|2|||
131496628|NCT00549302|473446350|FG002|Double-Blind|Lost to Follow-up|0|||
131496629|NCT00549302|473446348|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
131496630|NCT00549302|473446349|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
131496631|NCT00549302|473446350|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
131496632|NCT00549302|473446348|FG000|Double-Blind|New condition or starts new therapy|0|||
131496633|NCT00549302|473446349|FG001|Double-Blind|New condition or starts new therapy|2|||
131496634|NCT00549302|473446350|FG002|Double-Blind|New condition or starts new therapy|0|||
131496635|NCT00549302|473446348|FG000|Open-Label|Adverse Event|0|||
131496636|NCT00549302|473446349|FG001|Open-Label|Adverse Event|0|||
131496637|NCT00549302|473446350|FG002|Open-Label|Adverse Event|11|||
131496638|NCT00549302|473446348|FG000|Open-Label|Death|0|||
131496639|NCT00549302|473446349|FG001|Open-Label|Death|0|||
131496640|NCT00549302|473446350|FG002|Open-Label|Death|40|||
131496641|NCT00549302|473446348|FG000|Open-Label|Investigator Decision|0|||
131496642|NCT00549302|473446349|FG001|Open-Label|Investigator Decision|0|||
131496643|NCT00549302|473446350|FG002|Open-Label|Investigator Decision|5|||
131496644|NCT00549302|473446348|FG000|Open-Label|Lost to Follow-up|0|||
131496645|NCT00549302|473446349|FG001|Open-Label|Lost to Follow-up|0|||
131496646|NCT00549302|473446350|FG002|Open-Label|Lost to Follow-up|2|||
131496647|NCT00549302|473446348|FG000|Open-Label|Other|0|||
131496648|NCT00549302|473446349|FG001|Open-Label|Other|0|||
131496649|NCT00549302|473446350|FG002|Open-Label|Other|3|||
131496650|NCT00549302|473446348|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
131496651|NCT00549302|473446349|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
131496652|NCT00549302|473446350|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
131496653|NCT00549302|473446348|FG000|Open-Label|Withdrawal by Subject|0|||
131496654|NCT00549302|473446349|FG001|Open-Label|Withdrawal by Subject|0|||
131496655|NCT00549302|473446350|FG002|Open-Label|Withdrawal by Subject|6|||
131496656|NCT05620563|473446351|FG000|Overall Study|Adverse Event|3|||
131496657|NCT05620563|473446352|FG001|Overall Study|Adverse Event|1|||
131496658|NCT05620563|473446351|FG000|Overall Study|Lost to Follow-up|0|||
131496659|NCT05620563|473446352|FG001|Overall Study|Lost to Follow-up|2|||
131496660|NCT05620563|473446351|FG000|Overall Study|Protocol Deviation|1|||
131496661|NCT05620563|473446352|FG001|Overall Study|Protocol Deviation|2|||
131496662|NCT05620563|473446351|FG000|Overall Study|Withdrawal by Subject|3|||
131496663|NCT05620563|473446352|FG001|Overall Study|Withdrawal by Subject|3|||
131496664|NCT05620563|473446351|FG000|Overall Study|Physician Decision|0|||
131496665|NCT05620563|473446352|FG001|Overall Study|Physician Decision|1|||
131496666|NCT01349790|473446358|FG000|Overall Study|Investigator Judgement|3|||
131496667|NCT01349790|473446358|FG000|Overall Study|Death|2|||
131496668|NCT01349790|473446358|FG000|Overall Study|Withdrawal by Patient|2|||
131496669|NCT01349790|473446358|FG000|Overall Study|Adverse Event|1|||
131496670|NCT01349790|473446358|FG000|Overall Study|Lost to Follow-up|1|||
131496671|NCT02289690|473446359|FG000|Overall Study|Adverse Event Related to Progression|0|||
131496672|NCT02289690|473446360|FG001|Overall Study|Adverse Event Related to Progression|1|||
131496673|NCT02289690|473446361|FG002|Overall Study|Adverse Event Related to Progression|1|||
131496674|NCT02289690|473446362|FG003|Overall Study|Adverse Event Related to Progression|0|||
131496675|NCT02289690|473446363|FG004|Overall Study|Adverse Event Related to Progression|1|||
131496676|NCT02289690|473446364|FG005|Overall Study|Adverse Event Related to Progression|0|||
131496677|NCT02289690|473446365|FG006|Overall Study|Adverse Event Related to Progression|1|||
131496678|NCT02289690|473446366|FG007|Overall Study|Adverse Event Related to Progression|0|||
131496679|NCT02289690|473446367|FG008|Overall Study|Adverse Event Related to Progression|0|||
131496680|NCT02289690|473446368|FG009|Overall Study|Adverse Event Related to Progression|0|||
131496681|NCT02289690|473446359|FG000|Overall Study|Withdrawal by Subject|1|||
131496682|NCT02289690|473446360|FG001|Overall Study|Withdrawal by Subject|0|||
131496683|NCT02289690|473446361|FG002|Overall Study|Withdrawal by Subject|0|||
131496684|NCT02289690|473446362|FG003|Overall Study|Withdrawal by Subject|0|||
131496685|NCT02289690|473446363|FG004|Overall Study|Withdrawal by Subject|1|||
131496686|NCT02289690|473446364|FG005|Overall Study|Withdrawal by Subject|1|||
131496687|NCT02289690|473446365|FG006|Overall Study|Withdrawal by Subject|0|||
131496688|NCT02289690|473446366|FG007|Overall Study|Withdrawal by Subject|0|||
131496689|NCT02289690|473446367|FG008|Overall Study|Withdrawal by Subject|4|||
131496690|NCT02289690|473446368|FG009|Overall Study|Withdrawal by Subject|2|||
131496691|NCT02289690|473446359|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
131496692|NCT02289690|473446360|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
131496693|NCT02289690|473446361|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
131496694|NCT02289690|473446362|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
131496695|NCT02289690|473446363|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
131496696|NCT02289690|473446364|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
131496697|NCT02289690|473446365|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
131496698|NCT02289690|473446366|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
131496699|NCT02289690|473446367|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
131496700|NCT02289690|473446368|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
131496701|NCT02289690|473446359|FG000|Overall Study|Lost to Follow-up|0|||
131496702|NCT02289690|473446360|FG001|Overall Study|Lost to Follow-up|0|||
131496703|NCT02289690|473446361|FG002|Overall Study|Lost to Follow-up|0|||
131496704|NCT02289690|473446362|FG003|Overall Study|Lost to Follow-up|0|||
131496705|NCT02289690|473446363|FG004|Overall Study|Lost to Follow-up|0|||
131496706|NCT02289690|473446364|FG005|Overall Study|Lost to Follow-up|0|||
131496707|NCT02289690|473446365|FG006|Overall Study|Lost to Follow-up|0|||
131496708|NCT02289690|473446366|FG007|Overall Study|Lost to Follow-up|1|||
131496709|NCT02289690|473446367|FG008|Overall Study|Lost to Follow-up|0|||
131496831|NCT01980992|473446424|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
131496832|NCT01980992|473446423|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
131496833|NCT01980992|473446424|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
131496834|NCT01980992|473446423|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
131496835|NCT01980992|473446424|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
131496836|NCT02725710|473446426|FG000|Overall Study|Lost to Follow-up|1|||
131496837|NCT02725710|473446427|FG001|Overall Study|Lost to Follow-up|0|||
131496838|NCT01927367|473446428|FG000|Overall Study|Withdrawal by Subject|7|||
131496839|NCT01927367|473446429|FG001|Overall Study|Withdrawal by Subject|4|||
131496840|NCT01927367|473446428|FG000|Overall Study|No baseline data|0|||
131496841|NCT01927367|473446429|FG001|Overall Study|No baseline data|1|||
131496842|NCT02142959|473446434|FG000|Overall Study|Adverse Event|1|||
131496843|NCT02142959|473446435|FG001|Overall Study|Adverse Event|0|||
131496844|NCT02142959|473446436|FG002|Overall Study|Adverse Event|0|||
131496845|NCT02142959|473446434|FG000|Overall Study|Death|0|||
131496846|NCT02142959|473446435|FG001|Overall Study|Death|1|||
131496847|NCT02142959|473446436|FG002|Overall Study|Death|0|||
131496848|NCT02142959|473446434|FG000|Overall Study|Withdrawal by Subject|3|||
131496849|NCT02142959|473446435|FG001|Overall Study|Withdrawal by Subject|1|||
131496850|NCT02142959|473446436|FG002|Overall Study|Withdrawal by Subject|3|||
131496851|NCT02142959|473446434|FG000|Overall Study|Administrative Reasons|1|||
131496852|NCT02142959|473446435|FG001|Overall Study|Administrative Reasons|0|||
131496853|NCT02142959|473446436|FG002|Overall Study|Administrative Reasons|1|||
131496854|NCT02142959|473446434|FG000|Overall Study|Missing|0|||
131496855|NCT02142959|473446435|FG001|Overall Study|Missing|1|||
131496856|NCT02142959|473446436|FG002|Overall Study|Missing|0|||
131496857|NCT02142959|473446434|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
131496858|NCT02142959|473446435|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
131496859|NCT02142959|473446436|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
131496860|NCT02142959|473446434|FG000|Overall Study|Patient didn't complete end of study visit|0|||
131496861|NCT02142959|473446435|FG001|Overall Study|Patient didn't complete end of study visit|0|||
131496862|NCT02142959|473446436|FG002|Overall Study|Patient didn't complete end of study visit|1|||
131496863|NCT03547687|473446437|FG000|Overall Study|Withdrawal by Subject|1|||
131496864|NCT03547687|473446437|FG000|Overall Study|Death|1|||
131496865|NCT02547454|473446441|FG000|Overall Study|Due to hemodialysis|53|||
131496866|NCT02547454|473446441|FG000|Overall Study|Due to transplantation|1|||
131496867|NCT02547454|473446441|FG000|Overall Study|Due to no further need to treat|4|||
131496868|NCT02547454|473446441|FG000|Overall Study|Death|38|||
131496869|NCT02547454|473446441|FG000|Overall Study|Lost to Follow-up|26|||
131496870|NCT02547454|473446441|FG000|Overall Study|Other|39|||
131496871|NCT02547454|473446441|FG000|Overall Study|No data|11|||
131496872|NCT03064451|473446443|FG000|Overall Study|Lost to Follow-up|1|||
131496873|NCT03064451|473446443|FG000|Overall Study|Mapping Failure|4|||
131496874|NCT03064451|473446443|FG000|Overall Study|Exited prior to procedure|8|||
131496875|NCT03064451|473446443|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
131496876|NCT00434330|473446448|FG000|Overall Study|Adverse Event|0|||
131496877|NCT00434330|473446449|FG001|Overall Study|Adverse Event|0|||
131496878|NCT00434330|473446450|FG002|Overall Study|Adverse Event|1|||
131496879|NCT00434330|473446451|FG003|Overall Study|Adverse Event|0|||
131496880|NCT00434330|473446452|FG004|Overall Study|Adverse Event|0|||
131496881|NCT00434330|473446453|FG005|Overall Study|Adverse Event|0|||
131496882|NCT00434330|473446448|FG000|Overall Study|Death|1|||
131496883|NCT00434330|473446449|FG001|Overall Study|Death|0|||
131496884|NCT00434330|473446450|FG002|Overall Study|Death|0|||
131496885|NCT00434330|473446451|FG003|Overall Study|Death|0|||
131496886|NCT00434330|473446452|FG004|Overall Study|Death|1|||
131496887|NCT00434330|473446453|FG005|Overall Study|Death|1|||
131496888|NCT00434330|473446448|FG000|Overall Study|Withdrawal by Subject|0|||
131496889|NCT00434330|473446449|FG001|Overall Study|Withdrawal by Subject|0|||
131496890|NCT00434330|473446450|FG002|Overall Study|Withdrawal by Subject|1|||
131496891|NCT00434330|473446451|FG003|Overall Study|Withdrawal by Subject|1|||
131496892|NCT00434330|473446452|FG004|Overall Study|Withdrawal by Subject|0|||
131496893|NCT00434330|473446453|FG005|Overall Study|Withdrawal by Subject|0|||
131496894|NCT00434330|473446448|FG000|Overall Study|Renal transplant|0|||
131496895|NCT00434330|473446449|FG001|Overall Study|Renal transplant|0|||
131496896|NCT00434330|473446450|FG002|Overall Study|Renal transplant|0|||
131496897|NCT00434330|473446451|FG003|Overall Study|Renal transplant|1|||
131496898|NCT00434330|473446452|FG004|Overall Study|Renal transplant|0|||
131496899|NCT00434330|473446453|FG005|Overall Study|Renal transplant|0|||
131496900|NCT00434330|473446448|FG000|Overall Study|Subject Not Compliant With Study|0|||
131496901|NCT00434330|473446449|FG001|Overall Study|Subject Not Compliant With Study|0|||
131496902|NCT00434330|473446450|FG002|Overall Study|Subject Not Compliant With Study|1|||
131496903|NCT00434330|473446451|FG003|Overall Study|Subject Not Compliant With Study|0|||
131496904|NCT00434330|473446452|FG004|Overall Study|Subject Not Compliant With Study|0|||
131496905|NCT00434330|473446453|FG005|Overall Study|Subject Not Compliant With Study|0|||
131496906|NCT05109442|473446454|FG000|Overall Study|Withdrawal by Subject|0|||
131496907|NCT05109442|473446455|FG001|Overall Study|Withdrawal by Subject|0|||
131496908|NCT05109442|473446456|FG002|Overall Study|Withdrawal by Subject|1|||
131496909|NCT05109442|473446457|FG003|Overall Study|Withdrawal by Subject|0|||
131496910|NCT05109442|473446458|FG004|Overall Study|Withdrawal by Subject|0|||
131496911|NCT05109442|473446459|FG005|Overall Study|Withdrawal by Subject|0|||
131496912|NCT05109442|473446454|FG000|Overall Study|Adverse Event|0|||
131496913|NCT05109442|473446455|FG001|Overall Study|Adverse Event|1|||
131496914|NCT05109442|473446456|FG002|Overall Study|Adverse Event|5|||
131496915|NCT05109442|473446457|FG003|Overall Study|Adverse Event|0|||
131496916|NCT05109442|473446458|FG004|Overall Study|Adverse Event|0|||
131496917|NCT05109442|473446459|FG005|Overall Study|Adverse Event|2|||
131496918|NCT05109442|473446454|FG000|Overall Study|Death|0|||
131496919|NCT05109442|473446455|FG001|Overall Study|Death|0|||
131496920|NCT05109442|473446456|FG002|Overall Study|Death|4|||
131496921|NCT05109442|473446457|FG003|Overall Study|Death|0|||
131496922|NCT05109442|473446458|FG004|Overall Study|Death|0|||
131496923|NCT05109442|473446459|FG005|Overall Study|Death|1|||
131496924|NCT05109442|473446454|FG000|Overall Study|Physician Decision|1|||
131496925|NCT05109442|473446455|FG001|Overall Study|Physician Decision|0|||
131496926|NCT05109442|473446456|FG002|Overall Study|Physician Decision|1|||
131496927|NCT05109442|473446457|FG003|Overall Study|Physician Decision|0|||
131496928|NCT05109442|473446458|FG004|Overall Study|Physician Decision|0|||
131496929|NCT05109442|473446459|FG005|Overall Study|Physician Decision|2|||
131496930|NCT05109442|473446454|FG000|Overall Study|Other than listed|0|||
131496931|NCT05109442|473446455|FG001|Overall Study|Other than listed|0|||
131496932|NCT05109442|473446456|FG002|Overall Study|Other than listed|9|||
131496933|NCT05109442|473446457|FG003|Overall Study|Other than listed|2|||
131496934|NCT05109442|473446458|FG004|Overall Study|Other than listed|0|||
131496935|NCT05109442|473446459|FG005|Overall Study|Other than listed|8|||
131496936|NCT05109442|473446454|FG000|Overall Study|Lack of Efficacy|3|||
131496937|NCT05109442|473446455|FG001|Overall Study|Lack of Efficacy|5|||
131496938|NCT05109442|473446456|FG002|Overall Study|Lack of Efficacy|29|||
131496939|NCT05109442|473446457|FG003|Overall Study|Lack of Efficacy|10|||
131496940|NCT05109442|473446458|FG004|Overall Study|Lack of Efficacy|11|||
131496941|NCT05109442|473446459|FG005|Overall Study|Lack of Efficacy|17|||
131496942|NCT04853225|473446460|FG000|Overall Study|Withdrawal by Subject|81|||
131496943|NCT04853225|473446461|FG001|Overall Study|Withdrawal by Subject|4|||
131496944|NCT04853225|473446462|FG002|Overall Study|Withdrawal by Subject|1|||
131496945|NCT04853225|473446460|FG000|Overall Study|Physician Decision|12|||
131496946|NCT04853225|473446461|FG001|Overall Study|Physician Decision|4|||
131496947|NCT04853225|473446462|FG002|Overall Study|Physician Decision|1|||
131496948|NCT04853225|473446460|FG000|Overall Study|Lost to Follow-up|50|||
131496949|NCT04853225|473446461|FG001|Overall Study|Lost to Follow-up|0|||
131496950|NCT04853225|473446462|FG002|Overall Study|Lost to Follow-up|0|||
131496951|NCT04853225|473446460|FG000|Overall Study|Other|102|||
131496952|NCT04853225|473446461|FG001|Overall Study|Other|11|||
131496953|NCT04853225|473446462|FG002|Overall Study|Other|5|||
131496954|NCT04853225|473446460|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
131496955|NCT04853225|473446461|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
131496956|NCT04853225|473446462|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
131496957|NCT04853225|473446460|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
131496958|NCT04853225|473446461|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
131496959|NCT04853225|473446462|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
131496960|NCT03918447|473446463|FG000|Overall Study|Death|1|||
131496961|NCT03918447|473446464|FG001|Overall Study|Death|0|||
131496962|NCT03918447|473446463|FG000|Overall Study|Lost to Follow-up|13|||
131496963|NCT03918447|473446464|FG001|Overall Study|Lost to Follow-up|6|||
131496964|NCT03918447|473446463|FG000|Overall Study|Withdrawal by Subject|19|||
131496965|NCT03918447|473446464|FG001|Overall Study|Withdrawal by Subject|17|||
131496966|NCT03918447|473446463|FG000|Overall Study|Study Terminated by Sponsor|195|||
131496967|NCT03918447|473446464|FG001|Overall Study|Study Terminated by Sponsor|197|||
131496968|NCT03918447|473446463|FG000|Overall Study|Reason not Specified|0|||
131496969|NCT03918447|473446464|FG001|Overall Study|Reason not Specified|1|||
131496970|NCT01405456|473446465|FG000|Overall Study|Lost to Follow-up|2|||
131496971|NCT01405456|473446466|FG001|Overall Study|Lost to Follow-up|1|||
131496972|NCT01405456|473446465|FG000|Overall Study|Physician Decision|1|||
131496973|NCT01405456|473446466|FG001|Overall Study|Physician Decision|0|||
131496974|NCT01774968|473446467|FG000|Overall Study|Adverse Event|4|||
131496975|NCT01774968|473446468|FG001|Overall Study|Adverse Event|4|||
131496976|NCT01774968|473446467|FG000|Overall Study|Death|0|||
131496977|NCT01774968|473446468|FG001|Overall Study|Death|1|||
131496978|NCT01774968|473446467|FG000|Overall Study|Lost to Follow-up|1|||
131496979|NCT01774968|473446468|FG001|Overall Study|Lost to Follow-up|3|||
131496980|NCT01774968|473446467|FG000|Overall Study|Physician Decision|5|||
131496981|NCT01774968|473446468|FG001|Overall Study|Physician Decision|1|||
131496982|NCT01774968|473446467|FG000|Overall Study|Protocol Violation|14|||
131496983|NCT01774968|473446468|FG001|Overall Study|Protocol Violation|13|||
131496984|NCT01774968|473446467|FG000|Overall Study|Sponsor Decision|0|||
131496985|NCT01774968|473446468|FG001|Overall Study|Sponsor Decision|2|||
131496986|NCT01774968|473446467|FG000|Overall Study|Withdrawal by Subject|6|||
131496987|NCT01774968|473446468|FG001|Overall Study|Withdrawal by Subject|11|||
131496988|NCT05355805|473446471|FG000|Overall Study|Lost to Follow-up|6|||
131496989|NCT05355805|473446472|FG001|Overall Study|Lost to Follow-up|11|||
131496990|NCT05355805|473446473|FG002|Overall Study|Lost to Follow-up|10|||
131496991|NCT05355805|473446474|FG003|Overall Study|Lost to Follow-up|6|||
131496992|NCT05355805|473446471|FG000|Overall Study|Decision by Sponsor|0|||
131496993|NCT05355805|473446472|FG001|Overall Study|Decision by Sponsor|0|||
131496994|NCT05355805|473446473|FG002|Overall Study|Decision by Sponsor|1|||
131496995|NCT05355805|473446474|FG003|Overall Study|Decision by Sponsor|0|||
131496996|NCT05355805|473446471|FG000|Overall Study|Withdrawal by Subject|7|||
131496997|NCT05355805|473446472|FG001|Overall Study|Withdrawal by Subject|14|||
131496998|NCT05355805|473446473|FG002|Overall Study|Withdrawal by Subject|15|||
131496999|NCT05355805|473446474|FG003|Overall Study|Withdrawal by Subject|13|||
131497000|NCT02167893|473446475|FG000|Overall Study|Investigator transferred|85|||
131497001|NCT02167893|473446475|FG000|Overall Study|Investigator health reasons|10|||
131497002|NCT02167893|473446475|FG000|Overall Study|Case report forms not collected|68|||
131497003|NCT04818840|473446476|FG000|Overall Study|Lost to Follow-up|0|||
131497004|NCT04818840|473446477|FG001|Overall Study|Lost to Follow-up|5|||
131497005|NCT04818840|473446476|FG000|Overall Study|Physician Decision|1|||
131497006|NCT04818840|473446477|FG001|Overall Study|Physician Decision|0|||
131497007|NCT04818840|473446476|FG000|Overall Study|Site Terminated by Sponsor|0|||
131497008|NCT04818840|473446477|FG001|Overall Study|Site Terminated by Sponsor|3|||
131497009|NCT04818840|473446476|FG000|Overall Study|Study Terminated by Sponsor|43|||
131497010|NCT04818840|473446477|FG001|Overall Study|Study Terminated by Sponsor|7|||
131497011|NCT04818840|473446476|FG000|Overall Study|Withdrawal by Subject|0|||
131497012|NCT04818840|473446477|FG001|Overall Study|Withdrawal by Subject|1|||
131497013|NCT02154490|473448053|FG000|Overall Study|No tissue submitted|23|||
131497014|NCT02154490|473448053|FG000|Overall Study|No biomarker results|167|||
131497015|NCT02154490|473448053|FG000|Overall Study|Not assigned to a sub-study|270|||
131497016|NCT02154490|473448053|FG000|Overall Study|Did not register to a sub-study|749|||
131497017|NCT02961751|473448054|FG000|Overall Study|Lost to Follow-up|11|||
131497018|NCT02961751|473448054|FG000|Overall Study|Physician Decision|2|||
131497019|NCT02961751|473448054|FG000|Overall Study|Not Eligible at Enrollment|1|||
131497020|NCT02961751|473448054|FG000|Overall Study|Protocol Violation|1|||
131497021|NCT03909295|473448056|FG000|Overall Study|Adverse Event|2|||
131497022|NCT03909295|473448056|FG000|Overall Study|Study terminated by sponsor|50|||
131497023|NCT02670083|473448059|FG000|Overall Study|Adverse Event|16|||
131497024|NCT02670083|473448060|FG001|Overall Study|Adverse Event|13|||
131497025|NCT02670083|473448059|FG000|Overall Study|Death|4|||
131497026|NCT02670083|473448060|FG001|Overall Study|Death|6|||
131497027|NCT02670083|473448059|FG000|Overall Study|Lost to Follow-up|2|||
131497028|NCT02670083|473448060|FG001|Overall Study|Lost to Follow-up|2|||
131497029|NCT02670083|473448059|FG000|Overall Study|Multiple Reasons|9|||
131497030|NCT02670083|473448060|FG001|Overall Study|Multiple Reasons|9|||
131497031|NCT02670083|473448059|FG000|Overall Study|Physician Decision|0|||
131497032|NCT02670083|473448060|FG001|Overall Study|Physician Decision|2|||
131497033|NCT02670083|473448059|FG000|Overall Study|Study Terminated By Sponsor|257|||
131497034|NCT02670083|473448060|FG001|Overall Study|Study Terminated By Sponsor|254|||
131497035|NCT02670083|473448059|FG000|Overall Study|Symptomatic Deterioration|0|||
131497036|NCT02670083|473448060|FG001|Overall Study|Symptomatic Deterioration|2|||
131497037|NCT02670083|473448059|FG000|Overall Study|Withdrawal by Subject|32|||
131497038|NCT02670083|473448060|FG001|Overall Study|Withdrawal by Subject|31|||
131497039|NCT02670083|473448059|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131497040|NCT02670083|473448060|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131497041|NCT00720434|473448063|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
131497042|NCT00720434|473448064|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
131497043|NCT00720434|473448065|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
131497044|NCT00720434|473448066|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
131497045|NCT00720434|473448063|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
131497046|NCT00720434|473448064|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
131497047|NCT00720434|473448065|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
131497048|NCT00720434|473448066|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
131497049|NCT00720434|473448063|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
131497050|NCT00720434|473448064|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
131497051|NCT00720434|473448065|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
131497052|NCT00720434|473448066|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
131497053|NCT00720434|473448063|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
131497054|NCT00720434|473448064|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
131497055|NCT00720434|473448065|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
131497056|NCT00720434|473448066|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
131497057|NCT00720434|473448063|FG000|Open-Label Period (Week 5-72)|Other|4|||
131497058|NCT00720434|473448064|FG001|Open-Label Period (Week 5-72)|Other|3|||
131497059|NCT00720434|473448065|FG002|Open-Label Period (Week 5-72)|Other|3|||
131497060|NCT00720434|473448066|FG003|Open-Label Period (Week 5-72)|Other|2|||
131497061|NCT01224431|473448067|FG000|Overall Study|not randomized|0|||
131497062|NCT01224431|473448068|FG001|Overall Study|not randomized|4|||
131497063|NCT01224431|473448067|FG000|Overall Study|no video record|0|||
131497064|NCT01224431|473448068|FG001|Overall Study|no video record|1|||
131497065|NCT02057406|473448069|FG000|Overall Study|Physician Decision|0|||
131497066|NCT02057406|473448070|FG001|Overall Study|Physician Decision|0|||
131497067|NCT02057406|473448071|FG002|Overall Study|Physician Decision|2|||
131497068|NCT02057406|473448069|FG000|Overall Study|Withdrawal by Subject|0|||
131497069|NCT02057406|473448070|FG001|Overall Study|Withdrawal by Subject|2|||
131497070|NCT02057406|473448071|FG002|Overall Study|Withdrawal by Subject|0|||
131497071|NCT02057406|473448069|FG000|Overall Study|Lost to Follow-up|0|||
131497072|NCT02057406|473448070|FG001|Overall Study|Lost to Follow-up|0|||
131497073|NCT02057406|473448071|FG002|Overall Study|Lost to Follow-up|1|||
131497074|NCT02057406|473448069|FG000|Overall Study|Death|1|||
131497075|NCT02057406|473448070|FG001|Overall Study|Death|0|||
131497076|NCT02057406|473448071|FG002|Overall Study|Death|0|||
131497077|NCT02057406|473448069|FG000|Overall Study|Protocol Violation|0|||
131497078|NCT02057406|473448070|FG001|Overall Study|Protocol Violation|1|||
131497079|NCT02057406|473448071|FG002|Overall Study|Protocol Violation|0|||
131497080|NCT02057406|473448069|FG000|Overall Study|Patient transportation issues|0|||
131497081|NCT02057406|473448070|FG001|Overall Study|Patient transportation issues|0|||
131497082|NCT02057406|473448071|FG002|Overall Study|Patient transportation issues|1|||
131497083|NCT02425046|473448072|FG000|Overall Study|Lost to Follow-up|52|||
131497084|NCT02425046|473448073|FG001|Overall Study|Lost to Follow-up|50|||
131497085|NCT02425046|473448074|FG002|Overall Study|Lost to Follow-up|56|||
131497086|NCT02425046|473448072|FG000|Overall Study|Withdrawal by Subject|16|||
131497087|NCT02425046|473448073|FG001|Overall Study|Withdrawal by Subject|12|||
131497088|NCT02425046|473448074|FG002|Overall Study|Withdrawal by Subject|0|||
131497089|NCT03654651|473448075|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131497090|NCT03654651|473448076|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
131497091|NCT00856284|473448081|FG000|Overall Study|Hyperglycemic rescue|231|||
131497092|NCT00856284|473448082|FG001|Overall Study|Hyperglycemic rescue|201|||
131497093|NCT00856284|473448083|FG002|Overall Study|Hyperglycemic rescue|235|||
131497094|NCT00856284|473448081|FG000|Overall Study|Adverse Event|60|||
131497095|NCT00856284|473448082|FG001|Overall Study|Adverse Event|74|||
131497096|NCT00856284|473448083|FG002|Overall Study|Adverse Event|82|||
131497097|NCT00856284|473448081|FG000|Overall Study|Major protocol deviation|24|||
131497098|NCT00856284|473448082|FG001|Overall Study|Major protocol deviation|16|||
131497099|NCT00856284|473448083|FG002|Overall Study|Major protocol deviation|15|||
131497100|NCT00856284|473448081|FG000|Overall Study|Lost to Follow-up|20|||
131497101|NCT00856284|473448082|FG001|Overall Study|Lost to Follow-up|22|||
131497102|NCT00856284|473448083|FG002|Overall Study|Lost to Follow-up|28|||
131497103|NCT00856284|473448081|FG000|Overall Study|Voluntary withdrawal|48|||
131497104|NCT00856284|473448082|FG001|Overall Study|Voluntary withdrawal|52|||
131497105|NCT00856284|473448083|FG002|Overall Study|Voluntary withdrawal|62|||
131497106|NCT00856284|473448081|FG000|Overall Study|Pregnancy|1|||
131497107|NCT00856284|473448082|FG001|Overall Study|Pregnancy|2|||
131497108|NCT00856284|473448083|FG002|Overall Study|Pregnancy|0|||
131497109|NCT00856284|473448081|FG000|Overall Study|Investigator discretion|9|||
131497110|NCT00856284|473448082|FG001|Overall Study|Investigator discretion|8|||
131497111|NCT00856284|473448083|FG002|Overall Study|Investigator discretion|10|||
131497112|NCT00856284|473448081|FG000|Overall Study|Other|15|||
131497113|NCT00856284|473448082|FG001|Overall Study|Other|17|||
131497114|NCT00856284|473448083|FG002|Overall Study|Other|14|||
131497115|NCT00856284|473448081|FG000|Overall Study|Randomized in error|0|||
131497116|NCT00856284|473448082|FG001|Overall Study|Randomized in error|0|||
131497117|NCT00856284|473448083|FG002|Overall Study|Randomized in error|1|||
131497118|NCT00865124|473448093|FG000|Overall Study|Physician Decision|2|||
131497119|NCT00865124|473448094|FG001|Overall Study|Physician Decision|1|||
131497120|NCT00865124|473448095|FG002|Overall Study|Physician Decision|0|||
131497121|NCT00865124|473448093|FG000|Overall Study|Withdrawn consent|2|||
131497122|NCT00865124|473448094|FG001|Overall Study|Withdrawn consent|0|||
131497123|NCT00865124|473448095|FG002|Overall Study|Withdrawn consent|0|||
131497124|NCT00372112|473448099|FG000|Overall Study|Adverse Event|0|||
131497125|NCT00372112|473448100|FG001|Overall Study|Adverse Event|1|||
131497126|NCT00372112|473448101|FG002|Overall Study|Adverse Event|1|||
131497127|NCT00372112|473448102|FG003|Overall Study|Adverse Event|1|||
131497128|NCT00372112|473448099|FG000|Overall Study|Withdrawal by Subject|0|||
131497129|NCT00372112|473448100|FG001|Overall Study|Withdrawal by Subject|0|||
131497130|NCT00372112|473448101|FG002|Overall Study|Withdrawal by Subject|2|||
131497131|NCT00372112|473448102|FG003|Overall Study|Withdrawal by Subject|1|||
131497132|NCT00372112|473448099|FG000|Overall Study|Exacerbation|0|||
131497133|NCT00372112|473448100|FG001|Overall Study|Exacerbation|0|||
131497134|NCT00372112|473448101|FG002|Overall Study|Exacerbation|0|||
131497135|NCT00372112|473448102|FG003|Overall Study|Exacerbation|1|||
131497136|NCT00372112|473448099|FG000|Overall Study|PR >240 at Visit 3|0|||
131497137|NCT00372112|473448100|FG001|Overall Study|PR >240 at Visit 3|0|||
131497138|NCT00372112|473448101|FG002|Overall Study|PR >240 at Visit 3|0|||
131497139|NCT00372112|473448102|FG003|Overall Study|PR >240 at Visit 3|1|||
131497140|NCT00372112|473448099|FG000|Overall Study|Hepatitis B|1|||
131497141|NCT00372112|473448100|FG001|Overall Study|Hepatitis B|0|||
131497142|NCT00372112|473448101|FG002|Overall Study|Hepatitis B|0|||
131497143|NCT00372112|473448102|FG003|Overall Study|Hepatitis B|0|||
131497144|NCT00372112|473448099|FG000|Overall Study|Other-protocol violation|0|||
131497145|NCT00372112|473448100|FG001|Overall Study|Other-protocol violation|0|||
131497146|NCT00372112|473448101|FG002|Overall Study|Other-protocol violation|1|||
131497147|NCT00372112|473448102|FG003|Overall Study|Other-protocol violation|0|||
131497148|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
131497149|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
131497150|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
131497151|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
131497152|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
131497153|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
131497154|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
131497155|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
131497156|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Patient Request|1|||
131497157|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Patient Request|0|||
131497158|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
131497159|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
131497160|NCT04649060|473448103|FG000|Arm A/Arm B Treatment|Other|1|||
131497161|NCT04649060|473448104|FG001|Arm A/Arm B Treatment|Other|0|||
131497162|NCT04649060|473448103|FG000|Crossover (Arm B)|Adverse Event|0|||
131497163|NCT04649060|473448104|FG001|Crossover (Arm B)|Adverse Event|1|||
131497164|NCT04649060|473448103|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
131497165|NCT04649060|473448104|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
131497166|NCT00356369|473448105|FG000|Active Phase|Withdrawal by Subject|2|||
131497167|NCT00356369|473448106|FG001|Active Phase|Withdrawal by Subject|1|||
131497168|NCT02117648|473448109|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
131497169|NCT02117648|473448109|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
131497170|NCT02117648|473448109|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
131497171|NCT02117648|473448109|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
131497172|NCT02117648|473448109|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
131497173|NCT02117648|473448109|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
131497174|NCT02117648|473448109|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
131497175|NCT02117648|473448109|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
131497176|NCT02117648|473448109|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
131497177|NCT02117648|473448109|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
131497178|NCT02117648|473448109|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
131497179|NCT01985867|473448110|FG000|Overall Study|Lost to Follow-up|3|||
131497180|NCT01985867|473448111|FG001|Overall Study|Lost to Follow-up|4|||
131497181|NCT01985867|473448110|FG000|Overall Study|Adverse Event|3|||
131497182|NCT01985867|473448111|FG001|Overall Study|Adverse Event|2|||
131497183|NCT01985867|473448110|FG000|Overall Study|Lack of Efficacy|1|||
131497184|NCT01985867|473448111|FG001|Overall Study|Lack of Efficacy|0|||
131497185|NCT00553514|473448114|FG000|Overall Study|Protocol deviation|0|||
131497186|NCT00553514|473448115|FG001|Overall Study|Protocol deviation|0|||
131497187|NCT00553514|473448116|FG002|Overall Study|Protocol deviation|0|||
131497188|NCT00553514|473448117|FG003|Overall Study|Protocol deviation|1|||
131497189|NCT00553514|473448118|FG004|Overall Study|Protocol deviation|0|||
131497190|NCT00553514|473448114|FG000|Overall Study|Lack of ovarian response|4|||
131497191|NCT00553514|473448115|FG001|Overall Study|Lack of ovarian response|5|||
131497192|NCT00553514|473448116|FG002|Overall Study|Lack of ovarian response|5|||
131497193|NCT00553514|473448117|FG003|Overall Study|Lack of ovarian response|5|||
131497194|NCT00553514|473448118|FG004|Overall Study|Lack of ovarian response|6|||
131497195|NCT00553514|473448114|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
131497196|NCT00553514|473448115|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
131497197|NCT00553514|473448116|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131497198|NCT00553514|473448117|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
131497199|NCT00553514|473448118|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
131497200|NCT00553514|473448114|FG000|Overall Study|Risk of multiple pregnancy|0|||
131497201|NCT00553514|473448115|FG001|Overall Study|Risk of multiple pregnancy|2|||
131658085|NCT04445987|474032996|FG002|Overall Study|Adverse Event|1|||
131497202|NCT00553514|473448116|FG002|Overall Study|Risk of multiple pregnancy|0|||
131497203|NCT00553514|473448117|FG003|Overall Study|Risk of multiple pregnancy|1|||
131497204|NCT00553514|473448118|FG004|Overall Study|Risk of multiple pregnancy|0|||
131497205|NCT00553514|473448114|FG000|Overall Study|Other|1|||
131497206|NCT00553514|473448115|FG001|Overall Study|Other|1|||
131497207|NCT00553514|473448116|FG002|Overall Study|Other|0|||
131497208|NCT00553514|473448117|FG003|Overall Study|Other|0|||
131497209|NCT00553514|473448118|FG004|Overall Study|Other|1|||
131497210|NCT00752232|473448121|FG000|Overall Study|Protocol Violation|0|||
131497211|NCT00752232|473448122|FG001|Overall Study|Protocol Violation|0|||
131497212|NCT00752232|473448123|FG002|Overall Study|Protocol Violation|0|||
131497213|NCT00752232|473448124|FG003|Overall Study|Protocol Violation|0|||
131497214|NCT00752232|473448125|FG004|Overall Study|Protocol Violation|0|||
131497215|NCT00752232|473448126|FG005|Overall Study|Protocol Violation|1|||
131497216|NCT00752232|473448127|FG006|Overall Study|Protocol Violation|0|||
131497217|NCT00752232|473448121|FG000|Overall Study|Caregiver request|2|||
131497218|NCT00752232|473448122|FG001|Overall Study|Caregiver request|0|||
131497219|NCT00752232|473448123|FG002|Overall Study|Caregiver request|0|||
131497220|NCT00752232|473448124|FG003|Overall Study|Caregiver request|0|||
131497221|NCT00752232|473448125|FG004|Overall Study|Caregiver request|1|||
131497222|NCT00752232|473448126|FG005|Overall Study|Caregiver request|0|||
131497223|NCT00752232|473448127|FG006|Overall Study|Caregiver request|0|||
131497224|NCT00752232|473448121|FG000|Overall Study|Investigator request|0|||
131497225|NCT00752232|473448122|FG001|Overall Study|Investigator request|0|||
131497226|NCT00752232|473448123|FG002|Overall Study|Investigator request|0|||
131497227|NCT00752232|473448124|FG003|Overall Study|Investigator request|0|||
131497228|NCT00752232|473448125|FG004|Overall Study|Investigator request|1|||
131497229|NCT00752232|473448126|FG005|Overall Study|Investigator request|0|||
131497230|NCT00752232|473448127|FG006|Overall Study|Investigator request|0|||
131497231|NCT00752232|473448121|FG000|Overall Study|Subject request|0|||
131497232|NCT00752232|473448122|FG001|Overall Study|Subject request|0|||
131497233|NCT00752232|473448123|FG002|Overall Study|Subject request|1|||
131497234|NCT00752232|473448124|FG003|Overall Study|Subject request|0|||
131497235|NCT00752232|473448125|FG004|Overall Study|Subject request|0|||
131497236|NCT00752232|473448126|FG005|Overall Study|Subject request|0|||
131497237|NCT00752232|473448127|FG006|Overall Study|Subject request|0|||
131497238|NCT00752232|473448121|FG000|Overall Study|Group home admission|0|||
131497239|NCT00752232|473448122|FG001|Overall Study|Group home admission|0|||
131497240|NCT00752232|473448123|FG002|Overall Study|Group home admission|0|||
131497241|NCT00752232|473448124|FG003|Overall Study|Group home admission|1|||
131497242|NCT00752232|473448125|FG004|Overall Study|Group home admission|0|||
131497243|NCT00752232|473448126|FG005|Overall Study|Group home admission|0|||
131497244|NCT00752232|473448127|FG006|Overall Study|Group home admission|0|||
131497245|NCT00752232|473448121|FG000|Overall Study|Caregiver could not attend the subject|0|||
131497246|NCT00752232|473448122|FG001|Overall Study|Caregiver could not attend the subject|0|||
131497247|NCT00752232|473448123|FG002|Overall Study|Caregiver could not attend the subject|0|||
131497248|NCT00752232|473448124|FG003|Overall Study|Caregiver could not attend the subject|0|||
131497249|NCT00752232|473448125|FG004|Overall Study|Caregiver could not attend the subject|1|||
131497250|NCT00752232|473448126|FG005|Overall Study|Caregiver could not attend the subject|0|||
131497251|NCT00752232|473448127|FG006|Overall Study|Caregiver could not attend the subject|0|||
131497252|NCT04502589|473448128|FG000|Overall Study|Physician Decision|1|||
131497253|NCT04502589|473448129|FG001|Overall Study|Physician Decision|0|||
131497254|NCT00137046|473448135|FG000|Overall Study|Death|2|||
131497255|NCT00137046|473448136|FG001|Overall Study|Death|1|||
131497256|NCT00137046|473448135|FG000|Overall Study|Adverse Event|16|||
131497257|NCT00137046|473448136|FG001|Overall Study|Adverse Event|5|||
131497258|NCT00137046|473448135|FG000|Overall Study|Laboratory Abnormality|2|||
131497259|NCT00137046|473448136|FG001|Overall Study|Laboratory Abnormality|0|||
131497260|NCT00137046|473448135|FG000|Overall Study|Lack of Efficacy|13|||
131497261|NCT00137046|473448136|FG001|Overall Study|Lack of Efficacy|1|||
131497262|NCT00137046|473448135|FG000|Overall Study|Lost to Follow-up|8|||
131497263|NCT00137046|473448136|FG001|Overall Study|Lost to Follow-up|24|||
131497264|NCT00137046|473448135|FG000|Overall Study|Other|23|||
131497265|NCT00137046|473448136|FG001|Overall Study|Other|19|||
131497266|NCT00137046|473448135|FG000|Overall Study|Withdrawal by Subject|33|||
131497267|NCT00137046|473448136|FG001|Overall Study|Withdrawal by Subject|42|||
131497268|NCT00137046|473448135|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
131497269|NCT00137046|473448136|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
131497270|NCT00137046|473448135|FG000|Overall Study|Withdrew prior to study treatment|1|||
131497271|NCT00137046|473448136|FG001|Overall Study|Withdrew prior to study treatment|1|||
131497272|NCT01606436|473448137|FG000|Overall Study|Withdrawal by Subject|0|||
131497273|NCT01606436|473448138|FG001|Overall Study|Withdrawal by Subject|0|||
131497274|NCT01606436|473448139|FG002|Overall Study|Withdrawal by Subject|1|||
131497275|NCT01606436|473448140|FG003|Overall Study|Withdrawal by Subject|1|||
131497276|NCT01606436|473448141|FG004|Overall Study|Withdrawal by Subject|1|||
131497277|NCT01606436|473448142|FG005|Overall Study|Withdrawal by Subject|0|||
131497278|NCT01606436|473448137|FG000|Overall Study|Adverse Event|0|||
131497279|NCT01606436|473448138|FG001|Overall Study|Adverse Event|0|||
131497280|NCT01606436|473448139|FG002|Overall Study|Adverse Event|1|||
131497281|NCT01606436|473448140|FG003|Overall Study|Adverse Event|0|||
131497282|NCT01606436|473448141|FG004|Overall Study|Adverse Event|0|||
131497283|NCT01606436|473448142|FG005|Overall Study|Adverse Event|0|||
131497284|NCT01606436|473448137|FG000|Overall Study|Sponsor Decision|0|||
131497285|NCT01606436|473448138|FG001|Overall Study|Sponsor Decision|0|||
131497286|NCT01606436|473448139|FG002|Overall Study|Sponsor Decision|0|||
131497287|NCT01606436|473448140|FG003|Overall Study|Sponsor Decision|1|||
131497288|NCT01606436|473448141|FG004|Overall Study|Sponsor Decision|0|||
131497289|NCT01606436|473448142|FG005|Overall Study|Sponsor Decision|0|||
131497290|NCT02859454|473448143|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
131497291|NCT02730455|473448144|FG000|Overall Study|Death|5|||
131497292|NCT02730455|473448145|FG001|Overall Study|Death|6|||
131497293|NCT02730455|473448146|FG002|Overall Study|Death|4|||
131497294|NCT02730455|473448144|FG000|Overall Study|Consent withdrawn|2|||
131497295|NCT02730455|473448145|FG001|Overall Study|Consent withdrawn|4|||
131497296|NCT02730455|473448146|FG002|Overall Study|Consent withdrawn|1|||
131497297|NCT02730455|473448144|FG000|Overall Study|Lost to Follow-up|3|||
131497298|NCT02730455|473448145|FG001|Overall Study|Lost to Follow-up|1|||
131497299|NCT02730455|473448146|FG002|Overall Study|Lost to Follow-up|4|||
131497300|NCT02730455|473448144|FG000|Overall Study|Other|1|||
131497301|NCT02730455|473448145|FG001|Overall Study|Other|1|||
131497302|NCT02730455|473448146|FG002|Overall Study|Other|2|||
131497303|NCT02730455|473448144|FG000|Overall Study|Other|2|||
131497304|NCT02730455|473448145|FG001|Overall Study|Other|2|||
131497305|NCT02730455|473448146|FG002|Overall Study|Other|0|||
131497306|NCT01018186|473448150|FG000|2-week Run-in Period|Protocol Violation|1|||
131497307|NCT01018186|473448151|FG001|2-week Run-in Period|Protocol Violation|0|||
131497308|NCT01018186|473448152|FG002|2-week Run-in Period|Protocol Violation|0|||
131497309|NCT01018186|473448153|FG003|2-week Run-in Period|Protocol Violation|0|||
131497310|NCT01018186|473448150|FG000|2-week Run-in Period|Lost to Follow-up|2|||
131497311|NCT01018186|473448151|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131658086|NCT04445987|474032997|FG003|Overall Study|Adverse Event|0|||
131497312|NCT01018186|473448152|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131497313|NCT01018186|473448153|FG003|2-week Run-in Period|Lost to Follow-up|0|||
131497314|NCT01018186|473448150|FG000|2-week Run-in Period|Physician Decision|3|||
131497315|NCT01018186|473448151|FG001|2-week Run-in Period|Physician Decision|0|||
131497316|NCT01018186|473448152|FG002|2-week Run-in Period|Physician Decision|0|||
131497317|NCT01018186|473448153|FG003|2-week Run-in Period|Physician Decision|0|||
131497318|NCT01018186|473448150|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
131497319|NCT01018186|473448151|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131497320|NCT01018186|473448152|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131497321|NCT01018186|473448153|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
131497322|NCT01018186|473448150|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
131497323|NCT01018186|473448151|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131497324|NCT01018186|473448152|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131497325|NCT01018186|473448153|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131497326|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
131497327|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
131497328|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
131497329|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
131497330|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
131497331|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
131497332|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
131497333|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
131497334|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
131497335|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
131497336|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
131497337|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
131497338|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
131497339|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
131497340|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
131497341|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
131497342|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
131497343|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
131497344|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
131497345|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
131497346|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
131497347|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
131497348|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
131497349|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
131497350|NCT01018186|473448150|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131497351|NCT01018186|473448151|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
131497352|NCT01018186|473448152|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
131497353|NCT01018186|473448153|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
131497354|NCT03552198|473448154|FG000|Overall Study|Lost to Follow-up|42|||
131497355|NCT03552198|473448155|FG001|Overall Study|Lost to Follow-up|48|||
131497356|NCT03552198|473448156|FG002|Overall Study|Lost to Follow-up|15|||
131497357|NCT03552198|473448157|FG003|Overall Study|Lost to Follow-up|19|||
131497358|NCT03552198|473448154|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
131497359|NCT03552198|473448155|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
131497360|NCT03552198|473448156|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
131497361|NCT03552198|473448157|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
131497362|NCT03552198|473448154|FG000|Overall Study|Did not receive air alerts|1|||
131497363|NCT03552198|473448155|FG001|Overall Study|Did not receive air alerts|0|||
131497364|NCT03552198|473448156|FG002|Overall Study|Did not receive air alerts|0|||
131497365|NCT03552198|473448157|FG003|Overall Study|Did not receive air alerts|1|||
131497366|NCT03235154|473448158|FG000|Overall Study|Withdrawal by Subject|1|||
131497367|NCT03235154|473448158|FG000|Overall Study|Adverse Event|1|||
131497368|NCT03235154|473448158|FG000|Overall Study|Lost to Follow-up|2|||
131497369|NCT01683383|473448159|FG000|Overall Study|Infant was not transported|1|||
131497370|NCT01683383|473448160|FG001|Overall Study|Infant was not transported|0|||
131497371|NCT00996307|473448161|FG000|Overall Study|Adverse Event|0|||
131497372|NCT00996307|473448162|FG001|Overall Study|Adverse Event|1|||
131497373|NCT00996307|473448163|FG002|Overall Study|Adverse Event|0|||
131497374|NCT00996307|473448164|FG003|Overall Study|Adverse Event|0|||
131497375|NCT00996307|473448161|FG000|Overall Study|Withdrawal by Subject|3|||
131497376|NCT00996307|473448162|FG001|Overall Study|Withdrawal by Subject|2|||
131497377|NCT00996307|473448163|FG002|Overall Study|Withdrawal by Subject|5|||
131497378|NCT00996307|473448164|FG003|Overall Study|Withdrawal by Subject|5|||
131497379|NCT00996307|473448161|FG000|Overall Study|Lost to Follow-up|13|||
131497380|NCT00996307|473448162|FG001|Overall Study|Lost to Follow-up|13|||
131497381|NCT00996307|473448163|FG002|Overall Study|Lost to Follow-up|7|||
131497382|NCT00996307|473448164|FG003|Overall Study|Lost to Follow-up|15|||
131497383|NCT00996307|473448161|FG000|Overall Study|Administrative reason|0|||
131497384|NCT00996307|473448162|FG001|Overall Study|Administrative reason|1|||
131497385|NCT00996307|473448163|FG002|Overall Study|Administrative reason|0|||
131497386|NCT00996307|473448164|FG003|Overall Study|Administrative reason|0|||
131497387|NCT00996307|473448161|FG000|Overall Study|Unable to classify|4|||
131497388|NCT00996307|473448162|FG001|Overall Study|Unable to classify|0|||
131497389|NCT00996307|473448163|FG002|Overall Study|Unable to classify|2|||
131497390|NCT00996307|473448164|FG003|Overall Study|Unable to classify|1|||
131497391|NCT02013791|473448165|FG000|Period 1|Lost to Follow-up|0|||
131497392|NCT02013791|473448166|FG001|Period 1|Lost to Follow-up|0|||
131497393|NCT02013791|473448167|FG002|Period 1|Lost to Follow-up|0|||
131497394|NCT02013791|473448168|FG003|Period 1|Lost to Follow-up|1|||
131497395|NCT02013791|473448169|FG004|Period 1|Lost to Follow-up|0|||
131497396|NCT02013791|473448170|FG005|Period 1|Lost to Follow-up|0|||
131497397|NCT02013791|473448171|FG006|Period 1|Lost to Follow-up|1|||
131497398|NCT02013791|473448172|FG007|Period 1|Lost to Follow-up|1|||
131497399|NCT02013791|473448173|FG008|Period 1|Lost to Follow-up|0|||
131497400|NCT02013791|473448165|FG000|Period 1|Other Miscellaneous Reasons|0|||
131497401|NCT02013791|473448166|FG001|Period 1|Other Miscellaneous Reasons|2|||
131497402|NCT02013791|473448167|FG002|Period 1|Other Miscellaneous Reasons|0|||
131497403|NCT02013791|473448168|FG003|Period 1|Other Miscellaneous Reasons|0|||
131497404|NCT02013791|473448169|FG004|Period 1|Other Miscellaneous Reasons|0|||
131497405|NCT02013791|473448170|FG005|Period 1|Other Miscellaneous Reasons|0|||
131497406|NCT02013791|473448171|FG006|Period 1|Other Miscellaneous Reasons|0|||
131497407|NCT02013791|473448172|FG007|Period 1|Other Miscellaneous Reasons|0|||
131497408|NCT02013791|473448173|FG008|Period 1|Other Miscellaneous Reasons|0|||
131497409|NCT03798483|473448174|FG000|Overall Study|Lost to Follow-up|2|||
131497410|NCT00276744|473448175|FG000|PART A|Reason unknown|98|||
131497411|NCT00640601|473448180|FG000|Overall Study|Adverse Event|43|||
131497412|NCT00640601|473448180|FG000|Overall Study|Withdrawal by Subject|20|||
131497413|NCT00640601|473448180|FG000|Overall Study|Protocol Violation|6|||
131497414|NCT00640601|473448180|FG000|Overall Study|Lack of Efficacy|16|||
131497415|NCT00640601|473448180|FG000|Overall Study|Lost to Follow-up|9|||
131497416|NCT00640601|473448180|FG000|Overall Study|Physician Decision|8|||
131497417|NCT00640601|473448180|FG000|Overall Study|treatment naive, combination therapy|10|||
131497418|NCT00598832|473448185|FG000|Overall Study|Lack of Efficacy|3|||
131497419|NCT00598832|473448186|FG001|Overall Study|Lack of Efficacy|7|||
131497420|NCT00598832|473448185|FG000|Overall Study|Adverse Event|6|||
131497421|NCT00598832|473448186|FG001|Overall Study|Adverse Event|2|||
131497422|NCT00598832|473448185|FG000|Overall Study|Withdrawal by Subject|25|||
131497423|NCT00598832|473448186|FG001|Overall Study|Withdrawal by Subject|36|||
131497424|NCT00598832|473448185|FG000|Overall Study|Protocol Violation|0|||
131497425|NCT00598832|473448186|FG001|Overall Study|Protocol Violation|2|||
131497426|NCT00598832|473448185|FG000|Overall Study|Lost to Follow-up|24|||
131497427|NCT00598832|473448186|FG001|Overall Study|Lost to Follow-up|29|||
131497428|NCT00598832|473448185|FG000|Overall Study|Pregnancy|2|||
131497429|NCT00598832|473448186|FG001|Overall Study|Pregnancy|2|||
131497430|NCT00598832|473448185|FG000|Overall Study|Physician Decision|1|||
131497431|NCT00598832|473448186|FG001|Overall Study|Physician Decision|4|||
131497432|NCT00598832|473448185|FG000|Overall Study|Non compliance|1|||
131497433|NCT00598832|473448186|FG001|Overall Study|Non compliance|0|||
131497434|NCT02760069|473448187|FG000|Overall Study|Withdrawal by Subject|0|||
131497435|NCT02760069|473448188|FG001|Overall Study|Withdrawal by Subject|1|||
131497436|NCT02760069|473448189|FG002|Overall Study|Withdrawal by Subject|1|||
131497437|NCT01648205|473448195|FG000|Placebo|Pregnancy|1|||
131497438|NCT01648205|473448195|FG000|Placebo|Withdrawal by Subject|1|||
131497439|NCT01648205|473448195|FG000|Placebo|Protocol Violation|2|||
131497440|NCT01648205|473448195|FG000|Ranolazine|Death|1|||
131497441|NCT01648205|473448195|FG000|Ranolazine|Withdrawal by Subject|1|||
131497442|NCT01648205|473448195|FG000|Ranolazine|Protocol Violation|3|||
131497443|NCT03667924|473448198|FG000|Baseline Completed|Lost to Follow-up|0|||
131497444|NCT03667924|473448199|FG001|Baseline Completed|Lost to Follow-up|2|||
131497445|NCT03667924|473448200|FG002|Baseline Completed|Lost to Follow-up|0|||
131497446|NCT03667924|473448198|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
131497447|NCT03667924|473448199|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
131497448|NCT03667924|473448200|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
131497449|NCT03667924|473448198|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
131497450|NCT03667924|473448199|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
131497451|NCT03667924|473448200|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
131497452|NCT03667924|473448198|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
131497453|NCT03667924|473448199|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
131497454|NCT03667924|473448200|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
131497455|NCT03667924|473448198|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
131497456|NCT03667924|473448199|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
131497457|NCT03667924|473448200|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
131497458|NCT03667924|473448198|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
131497459|NCT03667924|473448199|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
131497460|NCT03667924|473448200|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
131497461|NCT03667924|473448198|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
131497462|NCT03667924|473448199|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
131497463|NCT03667924|473448200|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
131497464|NCT04557371|473448206|FG000|Overall Study|Covid-19-related|0|||
131497465|NCT04557371|473448207|FG001|Overall Study|Covid-19-related|1|||
131497466|NCT04557371|473448208|FG002|Overall Study|Covid-19-related|0|||
131497467|NCT04557371|473448206|FG000|Overall Study|Withdrawal by Subject|0|||
131497468|NCT04557371|473448207|FG001|Overall Study|Withdrawal by Subject|1|||
131497469|NCT04557371|473448208|FG002|Overall Study|Withdrawal by Subject|0|||
131497470|NCT04557371|473448206|FG000|Overall Study|Adverse Event|1|||
131497471|NCT04557371|473448207|FG001|Overall Study|Adverse Event|0|||
131497472|NCT04557371|473448208|FG002|Overall Study|Adverse Event|0|||
131497473|NCT03694821|473448209|FG000|Overall Study|Study terminated|4|||
131497474|NCT03694821|473448210|FG001|Overall Study|Study terminated|8|||
131497475|NCT03694821|473448211|FG002|Overall Study|Study terminated|4|||
131497476|NCT00203996|473448212|FG000|Overall Study|Lost to Follow-up|0|||
131497477|NCT00203996|473448213|FG001|Overall Study|Lost to Follow-up|0|||
131497478|NCT00203996|473448214|FG002|Overall Study|Lost to Follow-up|0|||
131497479|NCT00203996|473448215|FG003|Overall Study|Lost to Follow-up|1|||
131497480|NCT00203996|473448216|FG004|Overall Study|Lost to Follow-up|0|||
131497481|NCT00203996|473448217|FG005|Overall Study|Lost to Follow-up|0|||
131497482|NCT00203996|473448218|FG006|Overall Study|Lost to Follow-up|0|||
131497483|NCT00203996|473448219|FG007|Overall Study|Lost to Follow-up|0|||
131497484|NCT00203996|473448220|FG008|Overall Study|Lost to Follow-up|0|||
131497485|NCT00203996|473448221|FG009|Overall Study|Lost to Follow-up|0|||
131497486|NCT00203996|473448212|FG000|Overall Study|Protocol Violation|0|||
131497487|NCT00203996|473448213|FG001|Overall Study|Protocol Violation|0|||
131497488|NCT00203996|473448214|FG002|Overall Study|Protocol Violation|0|||
131497489|NCT00203996|473448215|FG003|Overall Study|Protocol Violation|6|||
131497490|NCT00203996|473448216|FG004|Overall Study|Protocol Violation|1|||
131497491|NCT00203996|473448217|FG005|Overall Study|Protocol Violation|0|||
131497492|NCT00203996|473448218|FG006|Overall Study|Protocol Violation|0|||
131497493|NCT00203996|473448219|FG007|Overall Study|Protocol Violation|0|||
131497494|NCT00203996|473448220|FG008|Overall Study|Protocol Violation|0|||
131497495|NCT00203996|473448221|FG009|Overall Study|Protocol Violation|0|||
131497496|NCT00203996|473448212|FG000|Overall Study|Physician Decision|0|||
131497497|NCT00203996|473448213|FG001|Overall Study|Physician Decision|0|||
131497498|NCT00203996|473448214|FG002|Overall Study|Physician Decision|0|||
131497499|NCT00203996|473448215|FG003|Overall Study|Physician Decision|2|||
131497500|NCT00203996|473448216|FG004|Overall Study|Physician Decision|0|||
131497501|NCT00203996|473448217|FG005|Overall Study|Physician Decision|0|||
131497502|NCT00203996|473448218|FG006|Overall Study|Physician Decision|0|||
131497503|NCT00203996|473448219|FG007|Overall Study|Physician Decision|0|||
131497504|NCT00203996|473448220|FG008|Overall Study|Physician Decision|0|||
131497505|NCT00203996|473448221|FG009|Overall Study|Physician Decision|1|||
131497506|NCT00203996|473448212|FG000|Overall Study|CPAP machine malfunction|0|||
131497507|NCT00203996|473448213|FG001|Overall Study|CPAP machine malfunction|0|||
131497508|NCT00203996|473448214|FG002|Overall Study|CPAP machine malfunction|0|||
131497509|NCT00203996|473448215|FG003|Overall Study|CPAP machine malfunction|1|||
131497510|NCT00203996|473448216|FG004|Overall Study|CPAP machine malfunction|0|||
131497511|NCT00203996|473448217|FG005|Overall Study|CPAP machine malfunction|0|||
131497512|NCT00203996|473448218|FG006|Overall Study|CPAP machine malfunction|0|||
131497513|NCT00203996|473448219|FG007|Overall Study|CPAP machine malfunction|0|||
131497514|NCT00203996|473448220|FG008|Overall Study|CPAP machine malfunction|0|||
131497515|NCT00203996|473448221|FG009|Overall Study|CPAP machine malfunction|0|||
131497516|NCT00203996|473448212|FG000|Overall Study|Scheduling issue|0|||
131497517|NCT00203996|473448213|FG001|Overall Study|Scheduling issue|0|||
131497518|NCT00203996|473448214|FG002|Overall Study|Scheduling issue|0|||
131497519|NCT00203996|473448215|FG003|Overall Study|Scheduling issue|0|||
131497520|NCT00203996|473448216|FG004|Overall Study|Scheduling issue|0|||
131497521|NCT00203996|473448217|FG005|Overall Study|Scheduling issue|0|||
131497522|NCT00203996|473448218|FG006|Overall Study|Scheduling issue|0|||
131497523|NCT00203996|473448219|FG007|Overall Study|Scheduling issue|2|||
131497524|NCT00203996|473448220|FG008|Overall Study|Scheduling issue|0|||
131497525|NCT00203996|473448221|FG009|Overall Study|Scheduling issue|0|||
131497526|NCT00897104|473448224|FG000|Overall Study|Lost to Follow-up|12|||
131497527|NCT00897104|473448225|FG001|Overall Study|Lost to Follow-up|17|||
131497528|NCT00897104|473448226|FG002|Overall Study|Lost to Follow-up|2|||
131497529|NCT00897104|473448224|FG000|Overall Study|Pregnancy|0|||
131497530|NCT00897104|473448225|FG001|Overall Study|Pregnancy|1|||
131497531|NCT00897104|473448226|FG002|Overall Study|Pregnancy|0|||
131497532|NCT00897104|473448224|FG000|Overall Study|Protocol Violation|0|||
131497533|NCT00897104|473448225|FG001|Overall Study|Protocol Violation|1|||
131497534|NCT00897104|473448226|FG002|Overall Study|Protocol Violation|0|||
131497535|NCT00897104|473448224|FG000|Overall Study|Withdrawal by Subject|23|||
131497536|NCT00897104|473448225|FG001|Overall Study|Withdrawal by Subject|27|||
131497537|NCT00897104|473448226|FG002|Overall Study|Withdrawal by Subject|3|||
131497538|NCT00897104|473448224|FG000|Overall Study|Abnormal Prestudy Labs|2|||
131497539|NCT00897104|473448225|FG001|Overall Study|Abnormal Prestudy Labs|0|||
131497540|NCT00897104|473448226|FG002|Overall Study|Abnormal Prestudy Labs|0|||
131497541|NCT00897104|473448224|FG000|Overall Study|Abnormal Baseline ECG|2|||
131497542|NCT00897104|473448225|FG001|Overall Study|Abnormal Baseline ECG|2|||
131497543|NCT00897104|473448226|FG002|Overall Study|Abnormal Baseline ECG|0|||
131497544|NCT00897104|473448224|FG000|Overall Study|Need for Concom. Med.|0|||
131497545|NCT00897104|473448225|FG001|Overall Study|Need for Concom. Med.|1|||
131497546|NCT00897104|473448226|FG002|Overall Study|Need for Concom. Med.|1|||
131497547|NCT00897104|473448224|FG000|Overall Study|Lack of Migraine Attack|20|||
131497548|NCT00897104|473448225|FG001|Overall Study|Lack of Migraine Attack|22|||
131497549|NCT00897104|473448226|FG002|Overall Study|Lack of Migraine Attack|1|||
131497550|NCT00897104|473448224|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131497551|NCT00897104|473448225|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131497552|NCT00897104|473448226|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131497553|NCT00897104|473448224|FG000|Overall Study|Other|3|||
131497554|NCT00897104|473448225|FG001|Overall Study|Other|0|||
131497555|NCT00897104|473448226|FG002|Overall Study|Other|0|||
131497556|NCT00897104|473448224|FG000|Overall Study|Protocol Violation|1|||
131497557|NCT00897104|473448225|FG001|Overall Study|Protocol Violation|0|||
131497558|NCT00897104|473448226|FG002|Overall Study|Protocol Violation|0|||
131497559|NCT00897104|473448224|FG000|Overall Study|Withdrawal by Subject|0|||
131497560|NCT00897104|473448225|FG001|Overall Study|Withdrawal by Subject|0|||
131497561|NCT00897104|473448226|FG002|Overall Study|Withdrawal by Subject|1|||
131497562|NCT00750204|473448227|FG000|Overall Study|study halted prematurely|1|||
131497563|NCT00750204|473448228|FG001|Overall Study|study halted prematurely|1|||
131497564|NCT00850564|473448229|FG000|Overall Study|Withdrawal by Subject|2|||
131497565|NCT00477971|473448230|FG000|Overall Study|Disease progression|6|||
131497566|NCT00477971|473448231|FG001|Overall Study|Disease progression|0|||
131497567|NCT00477971|473448230|FG000|Overall Study|Withdrawal by Subject|3|||
131497568|NCT00477971|473448231|FG001|Overall Study|Withdrawal by Subject|1|||
131497569|NCT00477971|473448230|FG000|Overall Study|Adverse Event|3|||
131497570|NCT00477971|473448231|FG001|Overall Study|Adverse Event|0|||
131497571|NCT00477971|473448230|FG000|Overall Study|Death|2|||
131497572|NCT00477971|473448231|FG001|Overall Study|Death|4|||
131497573|NCT00477971|473448230|FG000|Overall Study|Alternative treatment|3|||
131497574|NCT00477971|473448231|FG001|Overall Study|Alternative treatment|1|||
131497575|NCT00524368|473450309|FG000|Overall Study|Adverse Event|10|||
131497576|NCT00524368|473450310|FG001|Overall Study|Adverse Event|12|||
131497577|NCT00524368|473450309|FG000|Overall Study|Lost to Follow-up|9|||
131497578|NCT00524368|473450310|FG001|Overall Study|Lost to Follow-up|13|||
131497579|NCT00524368|473450309|FG000|Overall Study|Withdrawal by Subject|4|||
131497580|NCT00524368|473450310|FG001|Overall Study|Withdrawal by Subject|5|||
131497581|NCT00524368|473450309|FG000|Overall Study|Non-compliant|8|||
131497582|NCT00524368|473450310|FG001|Overall Study|Non-compliant|9|||
131497583|NCT00524368|473450309|FG000|Overall Study|Reached a Virologic Endpoint|3|||
131497584|NCT00524368|473450310|FG001|Overall Study|Reached a Virologic Endpoint|2|||
131497585|NCT00524368|473450309|FG000|Overall Study|Sponsor's Decision|2|||
131497586|NCT00524368|473450310|FG001|Overall Study|Sponsor's Decision|0|||
131497587|NCT00524368|473450309|FG000|Overall Study|Ineligible to Continue the study|2|||
131497588|NCT00524368|473450310|FG001|Overall Study|Ineligible to Continue the study|5|||
131497589|NCT00524368|473450309|FG000|Overall Study|Other|3|||
131497590|NCT00524368|473450310|FG001|Overall Study|Other|2|||
131497591|NCT00793598|473450311|FG000|Overall Study|Patient Request|0|||
131497592|NCT00793598|473450312|FG001|Overall Study|Patient Request|1|||
131497593|NCT00793598|473450313|FG002|Overall Study|Patient Request|0|||
131497594|NCT00793598|473450314|FG003|Overall Study|Patient Request|0|||
131497595|NCT00793598|473450315|FG004|Overall Study|Patient Request|0|||
131497596|NCT00793598|473450316|FG005|Overall Study|Patient Request|0|||
131497597|NCT00793598|473450317|FG006|Overall Study|Patient Request|0|||
131497598|NCT00793598|473450318|FG007|Overall Study|Patient Request|0|||
131497599|NCT00793598|473450311|FG000|Overall Study|Protocol Violation|0|||
131497600|NCT00793598|473450312|FG001|Overall Study|Protocol Violation|0|||
131497601|NCT00793598|473450313|FG002|Overall Study|Protocol Violation|0|||
131497602|NCT00793598|473450314|FG003|Overall Study|Protocol Violation|0|||
131497603|NCT00793598|473450315|FG004|Overall Study|Protocol Violation|0|||
131497604|NCT00793598|473450316|FG005|Overall Study|Protocol Violation|0|||
131497605|NCT00793598|473450317|FG006|Overall Study|Protocol Violation|0|||
131497606|NCT00793598|473450318|FG007|Overall Study|Protocol Violation|1|||
131497607|NCT00793598|473450311|FG000|Overall Study|Subject not dosed|0|||
131497608|NCT00793598|473450312|FG001|Overall Study|Subject not dosed|0|||
131497609|NCT00793598|473450313|FG002|Overall Study|Subject not dosed|0|||
131497610|NCT00793598|473450314|FG003|Overall Study|Subject not dosed|0|||
131497611|NCT00793598|473450315|FG004|Overall Study|Subject not dosed|0|||
131497612|NCT00793598|473450316|FG005|Overall Study|Subject not dosed|1|||
131497613|NCT00793598|473450317|FG006|Overall Study|Subject not dosed|0|||
131497614|NCT00793598|473450318|FG007|Overall Study|Subject not dosed|0|||
131497615|NCT02373202|473450329|FG000|Overall Study|Adverse Event|2|||
131497616|NCT02373202|473450330|FG001|Overall Study|Adverse Event|5|||
131497617|NCT02373202|473450331|FG002|Overall Study|Adverse Event|2|||
131497618|NCT02373202|473450332|FG003|Overall Study|Adverse Event|1|||
131497619|NCT02373202|473450329|FG000|Overall Study|Lack of Efficacy|0|||
131497620|NCT02373202|473450330|FG001|Overall Study|Lack of Efficacy|0|||
131497621|NCT02373202|473450331|FG002|Overall Study|Lack of Efficacy|1|||
131497622|NCT02373202|473450332|FG003|Overall Study|Lack of Efficacy|0|||
131497623|NCT02373202|473450329|FG000|Overall Study|Other|0|||
131497624|NCT02373202|473450330|FG001|Overall Study|Other|1|||
131497625|NCT02373202|473450331|FG002|Overall Study|Other|0|||
131497626|NCT02373202|473450332|FG003|Overall Study|Other|0|||
131497627|NCT01411228|473450334|FG000|Overall Study|Lost to Follow-up|0|||
131497628|NCT01411228|473450335|FG001|Overall Study|Lost to Follow-up|0|||
131497629|NCT01411228|473450336|FG002|Overall Study|Lost to Follow-up|1|||
131497630|NCT01411228|473450334|FG000|Overall Study|Withdrawal by Subject|1|||
131497631|NCT01411228|473450335|FG001|Overall Study|Withdrawal by Subject|0|||
131497632|NCT01411228|473450336|FG002|Overall Study|Withdrawal by Subject|0|||
131497633|NCT02141282|473450337|FG000|Overall Study|Adverse event, not related to progression|8|||
131497634|NCT02141282|473450338|FG001|Overall Study|Adverse event, not related to progression|1|||
131497635|NCT02141282|473450339|FG002|Overall Study|Adverse event, not related to progression|3|||
131497636|NCT02141282|473450340|FG003|Overall Study|Adverse event, not related to progression|1|||
131497637|NCT02141282|473450337|FG000|Overall Study|Adverse event, related to progression|1|||
131497638|NCT02141282|473450338|FG001|Overall Study|Adverse event, related to progression|0|||
131497639|NCT02141282|473450339|FG002|Overall Study|Adverse event, related to progression|2|||
131497640|NCT02141282|473450340|FG003|Overall Study|Adverse event, related to progression|0|||
131497641|NCT02141282|473450337|FG000|Overall Study|COVID-19 infection|1|||
131497642|NCT02141282|473450338|FG001|Overall Study|COVID-19 infection|0|||
131497643|NCT02141282|473450339|FG002|Overall Study|COVID-19 infection|0|||
131497644|NCT02141282|473450340|FG003|Overall Study|COVID-19 infection|0|||
131497645|NCT02141282|473450337|FG000|Overall Study|Lost to Follow-up|0|||
131497646|NCT02141282|473450338|FG001|Overall Study|Lost to Follow-up|0|||
131497647|NCT02141282|473450339|FG002|Overall Study|Lost to Follow-up|4|||
131497648|NCT02141282|473450340|FG003|Overall Study|Lost to Follow-up|2|||
131497649|NCT02141282|473450337|FG000|Overall Study|Other, not specified|14|||
131497650|NCT02141282|473450338|FG001|Overall Study|Other, not specified|11|||
131497651|NCT02141282|473450339|FG002|Overall Study|Other, not specified|23|||
131497652|NCT02141282|473450340|FG003|Overall Study|Other, not specified|9|||
131497653|NCT02141282|473450337|FG000|Overall Study|Progressive disease, Richter's|4|||
131497654|NCT02141282|473450338|FG001|Overall Study|Progressive disease, Richter's|1|||
131497655|NCT02141282|473450339|FG002|Overall Study|Progressive disease, Richter's|1|||
131497656|NCT02141282|473450340|FG003|Overall Study|Progressive disease, Richter's|1|||
131497657|NCT02141282|473450337|FG000|Overall Study|Progressive disease per protocol|12|||
131497658|NCT02141282|473450338|FG001|Overall Study|Progressive disease per protocol|7|||
131497659|NCT02141282|473450339|FG002|Overall Study|Progressive disease per protocol|9|||
131497660|NCT02141282|473450340|FG003|Overall Study|Progressive disease per protocol|2|||
131497661|NCT02141282|473450337|FG000|Overall Study|Stem cell transplant|1|||
131497662|NCT02141282|473450338|FG001|Overall Study|Stem cell transplant|0|||
131497663|NCT02141282|473450339|FG002|Overall Study|Stem cell transplant|1|||
131497664|NCT02141282|473450340|FG003|Overall Study|Stem cell transplant|0|||
131497665|NCT02141282|473450337|FG000|Overall Study|Study terminated by Sponsor|0|||
131497666|NCT02141282|473450338|FG001|Overall Study|Study terminated by Sponsor|1|||
131497667|NCT02141282|473450339|FG002|Overall Study|Study terminated by Sponsor|0|||
131497668|NCT02141282|473450340|FG003|Overall Study|Study terminated by Sponsor|0|||
131497669|NCT02141282|473450337|FG000|Overall Study|Subject non-compliance|0|||
131497670|NCT02141282|473450338|FG001|Overall Study|Subject non-compliance|0|||
131497671|NCT02141282|473450339|FG002|Overall Study|Subject non-compliance|1|||
131497672|NCT02141282|473450340|FG003|Overall Study|Subject non-compliance|0|||
131497673|NCT02141282|473450337|FG000|Overall Study|Withdrew consent|2|||
131497674|NCT02141282|473450338|FG001|Overall Study|Withdrew consent|0|||
131497675|NCT02141282|473450339|FG002|Overall Study|Withdrew consent|4|||
131497676|NCT02141282|473450340|FG003|Overall Study|Withdrew consent|0|||
131497677|NCT01752907|473450343|FG000|Overall Study|Withdrawal by Subject|4|||
131497678|NCT01752907|473450344|FG001|Overall Study|Withdrawal by Subject|10|||
131497679|NCT01752907|473450343|FG000|Overall Study|Lost to Follow-up|2|||
131497680|NCT01752907|473450344|FG001|Overall Study|Lost to Follow-up|1|||
131497681|NCT01752907|473450343|FG000|Overall Study|Decision by Sponsor|6|||
131497682|NCT01752907|473450344|FG001|Overall Study|Decision by Sponsor|9|||
131497683|NCT03562481|473450349|FG000|First Intervention|Lost to Follow-up|1|||
131497684|NCT03562481|473450350|FG001|First Intervention|Lost to Follow-up|0|||
131497685|NCT02782780|473450351|FG000|Overall Study|dropped out after randomization.|7|||
131497686|NCT02782780|473450352|FG001|Overall Study|dropped out after randomization.|5|||
131497687|NCT02782780|473450351|FG000|Overall Study|Protocol Violation|0|||
131497688|NCT02782780|473450352|FG001|Overall Study|Protocol Violation|2|||
131497689|NCT02904512|473450353|FG000|Overall Study|Withdrawal by Subject|1|||
131497690|NCT02904512|473450354|FG001|Overall Study|Withdrawal by Subject|0|||
131497691|NCT02904512|473450353|FG000|Overall Study|Transferred to ICU|1|||
131497692|NCT02904512|473450354|FG001|Overall Study|Transferred to ICU|0|||
131497693|NCT02904512|473450353|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
131497694|NCT02904512|473450354|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
131497695|NCT00267046|473450355|FG000|Overall Study|Disease progression|4|||
131497696|NCT00267046|473450356|FG001|Overall Study|Disease progression|2|||
131497697|NCT00267046|473450355|FG000|Overall Study|Chemotoxicity|2|||
131497698|NCT00267046|473450356|FG001|Overall Study|Chemotoxicity|0|||
131497699|NCT00267046|473450355|FG000|Overall Study|Open-label palifermin|2|||
131497700|NCT00267046|473450356|FG001|Overall Study|Open-label palifermin|7|||
131497701|NCT00267046|473450355|FG000|Overall Study|Surgery|3|||
131497702|NCT00267046|473450356|FG001|Overall Study|Surgery|1|||
131497703|NCT00267046|473450355|FG000|Overall Study|Withdrawal by Subject|1|||
131497704|NCT00267046|473450356|FG001|Overall Study|Withdrawal by Subject|0|||
131497705|NCT00267046|473450355|FG000|Overall Study|Radiation|0|||
131497706|NCT00267046|473450356|FG001|Overall Study|Radiation|1|||
131497707|NCT00460408|473450357|FG000|Overall Study|Adverse Event|1|||
131497708|NCT00460408|473450358|FG001|Overall Study|Adverse Event|0|||
131497709|NCT00460408|473450359|FG002|Overall Study|Adverse Event|0|||
131497710|NCT00460408|473450360|FG003|Overall Study|Adverse Event|0|||
131497711|NCT00460408|473450357|FG000|Overall Study|Death|7|||
131497712|NCT00460408|473450358|FG001|Overall Study|Death|0|||
131497713|NCT00460408|473450359|FG002|Overall Study|Death|0|||
131497714|NCT00460408|473450360|FG003|Overall Study|Death|0|||
131497715|NCT00460408|473450357|FG000|Overall Study|Lost to Follow-up|11|||
131497716|NCT00460408|473450358|FG001|Overall Study|Lost to Follow-up|0|||
131497717|NCT00460408|473450359|FG002|Overall Study|Lost to Follow-up|1|||
131497718|NCT00460408|473450360|FG003|Overall Study|Lost to Follow-up|0|||
131497719|NCT00460408|473450357|FG000|Overall Study|Withdrawal by Subject|31|||
131497720|NCT00460408|473450358|FG001|Overall Study|Withdrawal by Subject|0|||
131497721|NCT00460408|473450359|FG002|Overall Study|Withdrawal by Subject|0|||
131497722|NCT00460408|473450360|FG003|Overall Study|Withdrawal by Subject|0|||
131497723|NCT00460408|473450357|FG000|Overall Study|Insufficient clinical response|5|||
131497724|NCT00460408|473450358|FG001|Overall Study|Insufficient clinical response|1|||
131497725|NCT00460408|473450359|FG002|Overall Study|Insufficient clinical response|5|||
131497726|NCT00460408|473450360|FG003|Overall Study|Insufficient clinical response|0|||
131497727|NCT00460408|473450357|FG000|Overall Study|Other|12|||
131497728|NCT00460408|473450358|FG001|Overall Study|Other|2|||
131497729|NCT00460408|473450359|FG002|Overall Study|Other|0|||
131497730|NCT00460408|473450360|FG003|Overall Study|Other|0|||
131497731|NCT03247530|473450366|FG000|Overall Study|Withdrawal by caregiver|19|||
131497732|NCT03247530|473450367|FG001|Overall Study|Withdrawal by caregiver|8|||
131497733|NCT03247530|473450368|FG002|Overall Study|Withdrawal by caregiver|10|||
131497734|NCT03247530|473450366|FG000|Overall Study|Lost to Follow-up|3|||
131497735|NCT03247530|473450367|FG001|Overall Study|Lost to Follow-up|9|||
131497736|NCT03247530|473450368|FG002|Overall Study|Lost to Follow-up|6|||
131497737|NCT03247530|473450366|FG000|Overall Study|Adverse Event|2|||
131497738|NCT03247530|473450367|FG001|Overall Study|Adverse Event|5|||
131497739|NCT03247530|473450368|FG002|Overall Study|Adverse Event|2|||
131497740|NCT03247530|473450366|FG000|Overall Study|Failure to follow procedure|1|||
131497741|NCT03247530|473450367|FG001|Overall Study|Failure to follow procedure|1|||
131497742|NCT03247530|473450368|FG002|Overall Study|Failure to follow procedure|1|||
131497743|NCT03247530|473450366|FG000|Overall Study|Withdrawal by Subject|1|||
131497744|NCT03247530|473450367|FG001|Overall Study|Withdrawal by Subject|1|||
131497745|NCT03247530|473450368|FG002|Overall Study|Withdrawal by Subject|0|||
131497746|NCT03247530|473450366|FG000|Overall Study|Study medication misuse|0|||
131497747|NCT03247530|473450367|FG001|Overall Study|Study medication misuse|1|||
131497748|NCT03247530|473450368|FG002|Overall Study|Study medication misuse|0|||
131497749|NCT03247530|473450366|FG000|Overall Study|Other, multiple categories|1|||
131497750|NCT03247530|473450367|FG001|Overall Study|Other, multiple categories|3|||
131497751|NCT03247530|473450368|FG002|Overall Study|Other, multiple categories|1|||
131497752|NCT04983264|473450369|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
131497753|NCT04983264|473450370|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
131497754|NCT04983264|473450371|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
131497755|NCT04983264|473450369|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
131497756|NCT04983264|473450370|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
131497757|NCT04983264|473450371|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
131497758|NCT01442493|473450373|FG000|Overall Study|withdrawn from study|3|||
131497759|NCT01442493|473450374|FG001|Overall Study|withdrawn from study|2|||
131497760|NCT01986985|473450375|FG000|Overall Study|Withdrawal by Subject|4|||
131497761|NCT01986985|473450375|FG000|Overall Study|Scan not completed due to malfunction|3|||
131497762|NCT02288559|473450376|FG000|Overall Study|Adverse Event|1|||
131497763|NCT02288559|473450377|FG001|Overall Study|Adverse Event|1|||
131497764|NCT02288559|473450378|FG002|Overall Study|Adverse Event|5|||
131497765|NCT02288559|473450379|FG003|Overall Study|Adverse Event|0|||
131497766|NCT02288559|473450376|FG000|Overall Study|Death|0|||
131497767|NCT02288559|473450377|FG001|Overall Study|Death|0|||
131497768|NCT02288559|473450378|FG002|Overall Study|Death|1|||
131497769|NCT02288559|473450379|FG003|Overall Study|Death|0|||
131497770|NCT02288559|473450376|FG000|Overall Study|Lost to Follow-up|0|||
131497771|NCT02288559|473450377|FG001|Overall Study|Lost to Follow-up|0|||
131497772|NCT02288559|473450378|FG002|Overall Study|Lost to Follow-up|0|||
131497773|NCT02288559|473450379|FG003|Overall Study|Lost to Follow-up|1|||
131497774|NCT02288559|473450376|FG000|Overall Study|Withdrawal by Subject|0|||
131497775|NCT02288559|473450377|FG001|Overall Study|Withdrawal by Subject|0|||
131497776|NCT02288559|473450378|FG002|Overall Study|Withdrawal by Subject|2|||
131497777|NCT02288559|473450379|FG003|Overall Study|Withdrawal by Subject|1|||
131497778|NCT02288559|473450376|FG000|Overall Study|Reason Not Specified|0|||
131497779|NCT02288559|473450377|FG001|Overall Study|Reason Not Specified|0|||
131497780|NCT02288559|473450378|FG002|Overall Study|Reason Not Specified|3|||
131497781|NCT02288559|473450379|FG003|Overall Study|Reason Not Specified|0|||
131497782|NCT03303079|473450380|FG000|Overall Study|Adverse Event|0|||
131497783|NCT03303079|473450381|FG001|Overall Study|Adverse Event|1|||
131497784|NCT03303079|473450382|FG002|Overall Study|Adverse Event|3|||
131497785|NCT03303079|473450380|FG000|Overall Study|Protocol Violation|5|||
131497786|NCT03303079|473450381|FG001|Overall Study|Protocol Violation|4|||
131497787|NCT03303079|473450382|FG002|Overall Study|Protocol Violation|7|||
131497788|NCT03303079|473450380|FG000|Overall Study|Withdrawal by Subject|2|||
131497789|NCT03303079|473450381|FG001|Overall Study|Withdrawal by Subject|4|||
131497790|NCT03303079|473450382|FG002|Overall Study|Withdrawal by Subject|2|||
131497791|NCT03303079|473450380|FG000|Overall Study|Other than specified|0|||
131497792|NCT03303079|473450381|FG001|Overall Study|Other than specified|2|||
131497793|NCT03303079|473450382|FG002|Overall Study|Other than specified|0|||
131497794|NCT02005445|473450383|FG000|Overall Study|Dual study enrollment|0|||
131497795|NCT02005445|473450384|FG001|Overall Study|Dual study enrollment|1|||
131497796|NCT00759954|473450385|FG000|Overall Study|Personal reason|1|||
131497797|NCT00759954|473450386|FG001|Overall Study|Personal reason|0|||
131497798|NCT00759954|473450385|FG000|Overall Study|Adverse Event|1|||
131497799|NCT00759954|473450386|FG001|Overall Study|Adverse Event|2|||
131497800|NCT03315208|473450390|FG000|Overall Study|Lost to Follow-up|11|||
131497801|NCT03315208|473450391|FG001|Overall Study|Lost to Follow-up|6|||
131497802|NCT03315208|473450390|FG000|Overall Study|Withdrawal by Subject|2|||
131497803|NCT03315208|473450391|FG001|Overall Study|Withdrawal by Subject|0|||
131497804|NCT02875860|473450392|FG000|Overall Study|Withdrawal by Subject|0|||
131497805|NCT02875860|473450393|FG001|Overall Study|Withdrawal by Subject|1|||
131497806|NCT02320149|473450400|FG000|Overall Study|Adverse Event|3|||
131497807|NCT02320149|473450401|FG001|Overall Study|Adverse Event|7|||
131497808|NCT02320149|473450400|FG000|Overall Study|Withdrawal of Consent|28|||
131497809|NCT02320149|473450401|FG001|Overall Study|Withdrawal of Consent|32|||
131497810|NCT02320149|473450400|FG000|Overall Study|Lost to Follow-up|21|||
131497811|NCT02320149|473450401|FG001|Overall Study|Lost to Follow-up|34|||
131497812|NCT02320149|473450400|FG000|Overall Study|Protocol Violation|2|||
131497813|NCT02320149|473450401|FG001|Overall Study|Protocol Violation|1|||
131497814|NCT02320149|473450400|FG000|Overall Study|Noncompliance with Study Treatment|7|||
131497815|NCT02320149|473450401|FG001|Overall Study|Noncompliance with Study Treatment|2|||
131497816|NCT02320149|473450400|FG000|Overall Study|Lack of Efficacy|0|||
131497817|NCT02320149|473450401|FG001|Overall Study|Lack of Efficacy|1|||
131497818|NCT02320149|473450400|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131497819|NCT02320149|473450401|FG001|Overall Study|Other Miscellaneous Reasons|3|||
131497820|NCT01156311|473450405|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
131497821|NCT01156311|473450406|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
131497822|NCT01156311|473450407|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
131497823|NCT01156311|473450408|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
131497824|NCT01156311|473450405|FG000|2-Month Monotherapy Period|Physician Decision|0|||
131497825|NCT01156311|473450406|FG001|2-Month Monotherapy Period|Physician Decision|1|||
131497826|NCT01156311|473450407|FG002|2-Month Monotherapy Period|Physician Decision|0|||
131497827|NCT01156311|473450408|FG003|2-Month Monotherapy Period|Physician Decision|0|||
131497828|NCT01156311|473450405|FG000|2-Month Monotherapy Period|Other|1|||
131497829|NCT01156311|473450406|FG001|2-Month Monotherapy Period|Other|0|||
131497830|NCT01156311|473450407|FG002|2-Month Monotherapy Period|Other|0|||
131497831|NCT01156311|473450408|FG003|2-Month Monotherapy Period|Other|0|||
131497832|NCT01156311|473450405|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
131497833|NCT01156311|473450406|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
131497834|NCT01156311|473450407|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
131497835|NCT01156311|473450408|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
131497836|NCT01156311|473450405|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
131497837|NCT01156311|473450406|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
131497838|NCT01156311|473450407|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
131497839|NCT01156311|473450408|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
131497840|NCT01156311|473450405|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
131497841|NCT01156311|473450406|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
131497842|NCT01156311|473450407|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
131497843|NCT01156311|473450408|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
131497844|NCT01156311|473450405|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
131497845|NCT01156311|473450406|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
131497846|NCT01156311|473450407|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
131497847|NCT01156311|473450408|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
131497848|NCT01156311|473450405|FG000|6-month Add-on Therapy Period|Other|0|||
131497849|NCT01156311|473450406|FG001|6-month Add-on Therapy Period|Other|0|||
131497850|NCT01156311|473450407|FG002|6-month Add-on Therapy Period|Other|1|||
131497851|NCT01156311|473450408|FG003|6-month Add-on Therapy Period|Other|2|||
131497852|NCT01359449|473450409|FG000|Overall Study|Lost to Follow-up|1|||
131497853|NCT01359449|473450410|FG001|Overall Study|Lost to Follow-up|0|||
131497854|NCT01359449|473450409|FG000|Overall Study|Protocol Violation|0|||
131497855|NCT01359449|473450410|FG001|Overall Study|Protocol Violation|2|||
131497856|NCT01359449|473450409|FG000|Overall Study|Withdrawal by Subject|3|||
131497857|NCT01359449|473450410|FG001|Overall Study|Withdrawal by Subject|2|||
131497858|NCT01830972|473450425|FG000|Part II|Withdrawal by Subject|2|||
131497859|NCT01830972|473450426|FG001|Part II|Withdrawal by Subject|2|||
131497860|NCT01830972|473450425|FG000|Part III|Withdrawal by Subject|1|||
131497861|NCT01830972|473450426|FG001|Part III|Withdrawal by Subject|0|||
131497862|NCT01830972|473450425|FG000|Part III|Noncompliance|1|||
131497863|NCT01830972|473450426|FG001|Part III|Noncompliance|0|||
131497864|NCT01830972|473450425|FG000|Part IV|Withdrawal by Subject|2|||
131497865|NCT01830972|473450426|FG001|Part IV|Withdrawal by Subject|1|||
131497866|NCT01830972|473450425|FG000|Part IV|Non-Compliance|1|||
131497867|NCT01830972|473450426|FG001|Part IV|Non-Compliance|0|||
131497868|NCT01426373|473450430|FG000|Overall Study|Adverse Event|6|||
131497869|NCT01426373|473450430|FG000|Overall Study|Lost to Follow-up|14|||
131497870|NCT01426373|473450430|FG000|Overall Study|Participant Convenience|10|||
131497871|NCT01426373|473450430|FG000|Overall Study|Miscellaneous Reasons|4|||
131497872|NCT00726661|473450431|FG000|Overall Study|Lost to Follow-up|36|||
131497873|NCT00726661|473450432|FG001|Overall Study|Lost to Follow-up|11|||
131497874|NCT00726661|473450431|FG000|Overall Study|Withdrawal by Subject|17|||
131497875|NCT00726661|473450432|FG001|Overall Study|Withdrawal by Subject|13|||
131497876|NCT00726661|473450431|FG000|Overall Study|Trial terminated by sponsor|214|||
131497877|NCT00726661|473450432|FG001|Overall Study|Trial terminated by sponsor|187|||
131497878|NCT00726661|473450431|FG000|Overall Study|Death|475|||
131497879|NCT00726661|473450432|FG001|Overall Study|Death|159|||
131497880|NCT00726661|473450431|FG000|Overall Study|Physician Decision|25|||
131497881|NCT00726661|473450432|FG001|Overall Study|Physician Decision|13|||
131497882|NCT00726661|473450431|FG000|Overall Study|Other|47|||
131497883|NCT00726661|473450432|FG001|Overall Study|Other|35|||
131497884|NCT01285310|473450433|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
131497885|NCT01285310|473450434|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
131497886|NCT01285310|473450435|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
131497887|NCT01285310|473450436|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
131497888|NCT01285310|473450437|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
131497889|NCT01285310|473450433|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
131497890|NCT01285310|473450434|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
131497891|NCT01285310|473450435|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
131497892|NCT01285310|473450436|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
131497893|NCT01285310|473450437|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
131497894|NCT01285310|473450433|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
131497895|NCT01285310|473450434|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
131497896|NCT01285310|473450435|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
131497897|NCT01285310|473450436|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
131497898|NCT01285310|473450437|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
131497899|NCT01285310|473450433|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
131497900|NCT01285310|473450434|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
131497901|NCT01285310|473450435|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
131497902|NCT01285310|473450436|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
131497903|NCT01285310|473450437|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
131497904|NCT01285310|473450433|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
131497905|NCT01285310|473450434|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
131497906|NCT01285310|473450435|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
131497907|NCT01285310|473450436|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
131497908|NCT01285310|473450437|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
131497909|NCT01285310|473450433|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
131497910|NCT01285310|473450434|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
131497911|NCT01285310|473450435|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
131497912|NCT01285310|473450436|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
131497913|NCT01285310|473450437|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
131497914|NCT01285310|473450433|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
131497915|NCT01285310|473450434|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
131497916|NCT01285310|473450435|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
131497917|NCT01285310|473450436|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
131497918|NCT01285310|473450437|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
131497919|NCT01285310|473450433|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
131497920|NCT01285310|473450434|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
131497921|NCT01285310|473450435|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
131497922|NCT01285310|473450436|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
131497923|NCT01285310|473450437|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
131497924|NCT01285310|473450433|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
131497925|NCT01285310|473450434|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
131497926|NCT01285310|473450435|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
131497927|NCT01285310|473450436|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
131497928|NCT01285310|473450437|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
131497929|NCT01285310|473450433|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
131497930|NCT01285310|473450434|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
131497931|NCT01285310|473450435|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
131497932|NCT01285310|473450436|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
131497933|NCT01285310|473450437|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
131497934|NCT01285310|473450433|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
131497935|NCT01285310|473450434|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
131497936|NCT01285310|473450435|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
131497937|NCT01285310|473450436|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
131497938|NCT01285310|473450437|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
131497939|NCT01285310|473450433|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
131497940|NCT01285310|473450434|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
131497941|NCT01285310|473450435|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
131497942|NCT01285310|473450436|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
131497943|NCT01285310|473450437|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
131497944|NCT01574326|473450440|FG000|Overall Study|Randomized but not treated|0|||
131497945|NCT01574326|473450441|FG001|Overall Study|Randomized but not treated|1|||
131497946|NCT01574326|473450440|FG000|Overall Study|Withdrawal by Participant|2|||
131497947|NCT01574326|473450441|FG001|Overall Study|Withdrawal by Participant|4|||
131497948|NCT01574326|473450440|FG000|Overall Study|Physician Decision|5|||
131497949|NCT01574326|473450441|FG001|Overall Study|Physician Decision|3|||
131497950|NCT01574326|473450440|FG000|Overall Study|Adverse Event|1|||
131497951|NCT01574326|473450441|FG001|Overall Study|Adverse Event|3|||
131497952|NCT01574326|473450440|FG000|Overall Study|Other: Mainly kidney transplant|8|||
131497953|NCT01574326|473450441|FG001|Overall Study|Other: Mainly kidney transplant|8|||
131497954|NCT04997161|473450466|FG000|Overall Study|Study terminated by sponsor|3|||
131497955|NCT01442675|473450467|FG000|Overall Study|Protocol Violation|6|||
131497956|NCT01442675|473450467|FG000|Overall Study|Lost to Follow-up|2|||
131497957|NCT01442675|473450467|FG000|Overall Study|Withdrawal by Subject|4|||
131497958|NCT00005937|473450470|FG000|Overall Study|Lack of Efficacy|5|||
131497959|NCT00160251|473450471|FG000|Prior to Amendment 2|Adverse Event|2|||
131497960|NCT00160251|473450472|FG001|Prior to Amendment 2|Adverse Event|1|||
131497961|NCT00160251|473450473|FG002|Prior to Amendment 2|Adverse Event|3|||
131497962|NCT00160251|473450474|FG003|Prior to Amendment 2|Adverse Event|1|||
131497963|NCT00160251|473450475|FG004|Prior to Amendment 2|Adverse Event|1|||
131497964|NCT00160251|473450476|FG005|Prior to Amendment 2|Adverse Event|1|||
131497965|NCT00160251|473450477|FG006|Prior to Amendment 2|Adverse Event|1|||
131497966|NCT00160251|473450478|FG007|Prior to Amendment 2|Adverse Event|0|||
131497967|NCT00160251|473450471|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
131497968|NCT00160251|473450472|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
131497969|NCT00160251|473450473|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
131497970|NCT00160251|473450474|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
131497971|NCT00160251|473450475|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
131497972|NCT00160251|473450476|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
131497973|NCT00160251|473450477|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
131497974|NCT00160251|473450478|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
131497975|NCT00160251|473450471|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
131497976|NCT00160251|473450472|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
131497977|NCT00160251|473450473|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
131497978|NCT00160251|473450474|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
131497979|NCT00160251|473450475|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
131497980|NCT00160251|473450476|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
131497981|NCT00160251|473450477|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
131497982|NCT00160251|473450478|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
131497983|NCT00160251|473450471|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
131497984|NCT00160251|473450472|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
131497985|NCT00160251|473450473|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
131497986|NCT00160251|473450474|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
131497987|NCT00160251|473450475|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
131497988|NCT00160251|473450476|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
131497989|NCT00160251|473450477|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
131497990|NCT00160251|473450478|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
131497991|NCT00160251|473450471|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
131497992|NCT00160251|473450472|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
131497993|NCT00160251|473450473|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
131497994|NCT00160251|473450474|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
131497995|NCT00160251|473450475|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
131497996|NCT00160251|473450476|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
131497997|NCT00160251|473450477|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
131497998|NCT00160251|473450478|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
131497999|NCT00160251|473450471|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
131498000|NCT00160251|473450472|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
131498001|NCT00160251|473450473|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
131498002|NCT00160251|473450474|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
131498003|NCT00160251|473450475|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
131498004|NCT00160251|473450476|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
131498005|NCT00160251|473450477|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
131498006|NCT00160251|473450478|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
131498007|NCT00160251|473450471|FG000|Post-amendment 2|Adverse Event|0|||
131498008|NCT00160251|473450472|FG001|Post-amendment 2|Adverse Event|0|||
131498009|NCT00160251|473450473|FG002|Post-amendment 2|Adverse Event|0|||
131498010|NCT00160251|473450474|FG003|Post-amendment 2|Adverse Event|0|||
131498011|NCT00160251|473450475|FG004|Post-amendment 2|Adverse Event|0|||
131498012|NCT00160251|473450476|FG005|Post-amendment 2|Adverse Event|0|||
131498013|NCT00160251|473450477|FG006|Post-amendment 2|Adverse Event|0|||
131498014|NCT00160251|473450478|FG007|Post-amendment 2|Adverse Event|20|||
131498015|NCT00160251|473450471|FG000|Post-amendment 2|Lack of Efficacy|0|||
131498016|NCT00160251|473450472|FG001|Post-amendment 2|Lack of Efficacy|0|||
131498017|NCT00160251|473450473|FG002|Post-amendment 2|Lack of Efficacy|0|||
131498018|NCT00160251|473450474|FG003|Post-amendment 2|Lack of Efficacy|0|||
131498019|NCT00160251|473450475|FG004|Post-amendment 2|Lack of Efficacy|0|||
131498020|NCT00160251|473450476|FG005|Post-amendment 2|Lack of Efficacy|0|||
131498021|NCT00160251|473450477|FG006|Post-amendment 2|Lack of Efficacy|0|||
131498022|NCT00160251|473450478|FG007|Post-amendment 2|Lack of Efficacy|24|||
131498023|NCT00160251|473450471|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498024|NCT00160251|473450472|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498025|NCT00160251|473450473|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498026|NCT00160251|473450474|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498027|NCT00160251|473450475|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498028|NCT00160251|473450476|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498029|NCT00160251|473450477|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
131498030|NCT00160251|473450478|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
131498031|NCT01574612|473450480|FG000|Overall Study|Adverse Event|3|||
131498032|NCT01574612|473450480|FG000|Overall Study|non compliant with drug|2|||
131498033|NCT01574612|473450480|FG000|Overall Study|Withdrawal by Subject|1|||
131498034|NCT01574612|473450480|FG000|Overall Study|Lost to Follow-up|2|||
131498035|NCT02064868|473451938|FG000|Overall Study|Lost to Follow-up|14|||
131498036|NCT02064868|473451939|FG001|Overall Study|Lost to Follow-up|8|||
131498037|NCT02064868|473451938|FG000|Overall Study|Physician Decision|1|||
131498038|NCT02064868|473451939|FG001|Overall Study|Physician Decision|0|||
131498039|NCT02064868|473451938|FG000|Overall Study|Withdrawal by Subject|14|||
131498040|NCT02064868|473451939|FG001|Overall Study|Withdrawal by Subject|3|||
131498041|NCT02064868|473451938|FG000|Overall Study|Technical Problems or Missing|5|||
131498042|NCT02064868|473451939|FG001|Overall Study|Technical Problems or Missing|2|||
131498043|NCT00464087|473451942|FG000|Overall Study|No PCI per inclusion criteria|0|||
131498044|NCT00464087|473451943|FG001|Overall Study|No PCI per inclusion criteria|0|||
131498045|NCT00464087|473451944|FG002|Overall Study|No PCI per inclusion criteria|29|||
131498046|NCT02692716|473451945|FG000|Overall Study|Lost to Follow-up|2|||
131498047|NCT02692716|473451946|FG001|Overall Study|Lost to Follow-up|5|||
131498048|NCT02692716|473451945|FG000|Overall Study|Withdrawal by Subject|3|||
131498049|NCT02692716|473451946|FG001|Overall Study|Withdrawal by Subject|1|||
131498050|NCT01124422|473451957|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
131498051|NCT01124422|473451958|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
131498052|NCT01124422|473451959|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
131498053|NCT01124422|473451957|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
131498054|NCT01124422|473451958|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
131498055|NCT01124422|473451959|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
131498056|NCT01124422|473451957|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
131498057|NCT01124422|473451958|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
131498058|NCT01124422|473451959|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
131498059|NCT01124422|473451957|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
131498060|NCT01124422|473451958|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
131498061|NCT01124422|473451959|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
131498062|NCT01124422|473451957|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
131498063|NCT01124422|473451958|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
131498064|NCT01124422|473451959|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
131498065|NCT01124422|473451957|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
131498066|NCT01124422|473451958|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
131498067|NCT01124422|473451959|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
131498068|NCT01124422|473451957|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
131498069|NCT01124422|473451958|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
131498070|NCT01124422|473451959|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
131498071|NCT01124422|473451957|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
131498072|NCT01124422|473451958|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
131498073|NCT01124422|473451959|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
131498074|NCT01124422|473451957|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
131498075|NCT01124422|473451958|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
131658087|NCT04445987|474032998|FG004|Overall Study|Adverse Event|4|||
131498076|NCT01124422|473451959|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
131498077|NCT01124422|473451957|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
131498078|NCT01124422|473451958|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
131498079|NCT01124422|473451959|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
131498080|NCT00449540|473451965|FG000|Pretreatment Phase|No migraine experienced|66|||
131498081|NCT00449540|473451966|FG001|Pretreatment Phase|No migraine experienced|0|||
131498082|NCT00449540|473451967|FG002|Pretreatment Phase|No migraine experienced|0|||
131498083|NCT00449540|473451965|FG000|Treatment Phase|did not experience or treat migraine|0|||
131498084|NCT00449540|473451966|FG001|Treatment Phase|did not experience or treat migraine|20|||
131498085|NCT00449540|473451967|FG002|Treatment Phase|did not experience or treat migraine|17|||
131498086|NCT00010374|473451970|FG000|Overall Study|False positive phrenic nerve test|1|||
131498087|NCT01961323|473451971|FG000|Overall Study|Withdrawal by Subject|7|||
131498088|NCT01961323|473451971|FG000|Overall Study|Lost to Follow-up|8|||
131498089|NCT01961323|473451971|FG000|Overall Study|screen failure|34|||
131498090|NCT01881776|473451975|FG000|Overall Study|Lost to Follow-up|1|||
131498091|NCT01881776|473451976|FG001|Overall Study|Lost to Follow-up|2|||
131498092|NCT01881776|473451977|FG002|Overall Study|Lost to Follow-up|1|||
131498093|NCT01881776|473451975|FG000|Overall Study|Protocol Violation|0|||
131498094|NCT01881776|473451976|FG001|Overall Study|Protocol Violation|2|||
131498095|NCT01881776|473451977|FG002|Overall Study|Protocol Violation|1|||
131498096|NCT01741701|473451978|FG000|Overall Study|Adverse Event|5|||
131498097|NCT01741701|473451979|FG001|Overall Study|Adverse Event|1|||
131498098|NCT01741701|473451978|FG000|Overall Study|Withdrawal by Subject|0|||
131498099|NCT01741701|473451979|FG001|Overall Study|Withdrawal by Subject|1|||
131498100|NCT03033394|473451984|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
131498101|NCT03033394|473451984|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
131498102|NCT03033394|473451984|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
131498103|NCT03033394|473451984|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
131498104|NCT03033394|473451984|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
131498105|NCT02036294|473451985|FG000|Overall Study|Death|7|||
131498106|NCT02036294|473451986|FG001|Overall Study|Death|8|||
131498107|NCT02036294|473451985|FG000|Overall Study|Withdrawal by Subject|2|||
131498108|NCT02036294|473451986|FG001|Overall Study|Withdrawal by Subject|3|||
131498109|NCT04952402|473451987|FG000|Overall Study|Lost to Follow-up|1|||
131498110|NCT04952402|473451988|FG001|Overall Study|Lost to Follow-up|3|||
131498111|NCT04952402|473451987|FG000|Overall Study|Lack Of Venous Access|0|||
131498112|NCT04952402|473451988|FG001|Overall Study|Lack Of Venous Access|1|||
131498113|NCT02407704|473451991|FG000|Overall Study|Lost to Follow-up|0|||
131498114|NCT02407704|473451992|FG001|Overall Study|Lost to Follow-up|0|||
131498115|NCT02407704|473451993|FG002|Overall Study|Lost to Follow-up|0|||
131498116|NCT02407704|473451994|FG003|Overall Study|Lost to Follow-up|2|||
131498117|NCT02407704|473451991|FG000|Overall Study|Protocol Violation|0|||
131498118|NCT02407704|473451992|FG001|Overall Study|Protocol Violation|0|||
131498119|NCT02407704|473451993|FG002|Overall Study|Protocol Violation|0|||
131498120|NCT02407704|473451994|FG003|Overall Study|Protocol Violation|1|||
131498121|NCT02407704|473451991|FG000|Overall Study|Withdrawal by Subject|0|||
131498122|NCT02407704|473451992|FG001|Overall Study|Withdrawal by Subject|0|||
131498123|NCT02407704|473451993|FG002|Overall Study|Withdrawal by Subject|1|||
131498124|NCT02407704|473451994|FG003|Overall Study|Withdrawal by Subject|0|||
131498125|NCT01957644|473451997|FG000|Overall Study|Adverse Event|4|||
131498126|NCT01957644|473451998|FG001|Overall Study|Adverse Event|2|||
131498127|NCT01957644|473451999|FG002|Overall Study|Adverse Event|0|||
131498128|NCT01957644|473452000|FG003|Overall Study|Adverse Event|0|||
131498129|NCT01957644|473452001|FG004|Overall Study|Adverse Event|1|||
131498130|NCT01957644|473451997|FG000|Overall Study|Progressive disease / relapse|0|||
131498131|NCT01957644|473451998|FG001|Overall Study|Progressive disease / relapse|1|||
131498132|NCT01957644|473451999|FG002|Overall Study|Progressive disease / relapse|0|||
131498133|NCT01957644|473452000|FG003|Overall Study|Progressive disease / relapse|1|||
131498134|NCT01957644|473452001|FG004|Overall Study|Progressive disease / relapse|0|||
131498135|NCT01957644|473451997|FG000|Overall Study|Other reason|1|||
131498136|NCT01957644|473451998|FG001|Overall Study|Other reason|2|||
131498137|NCT01957644|473451999|FG002|Overall Study|Other reason|1|||
131498138|NCT01957644|473452000|FG003|Overall Study|Other reason|1|||
131498139|NCT01957644|473452001|FG004|Overall Study|Other reason|0|||
131498140|NCT01957644|473451997|FG000|Overall Study|Withdrawal by Subject|1|||
131498141|NCT01957644|473451998|FG001|Overall Study|Withdrawal by Subject|0|||
131498142|NCT01957644|473451999|FG002|Overall Study|Withdrawal by Subject|0|||
131498143|NCT01957644|473452000|FG003|Overall Study|Withdrawal by Subject|0|||
131498144|NCT01957644|473452001|FG004|Overall Study|Withdrawal by Subject|0|||
131498145|NCT01957644|473451997|FG000|Overall Study|Protocol Violation|0|||
131498146|NCT01957644|473451998|FG001|Overall Study|Protocol Violation|1|||
131498147|NCT01957644|473451999|FG002|Overall Study|Protocol Violation|0|||
131498148|NCT01957644|473452000|FG003|Overall Study|Protocol Violation|0|||
131498149|NCT01957644|473452001|FG004|Overall Study|Protocol Violation|0|||
131498150|NCT04044716|473452002|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
131498151|NCT04044716|473452003|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
131498152|NCT04044716|473452004|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
131498153|NCT04044716|473452002|FG000|Overall Study|Lost to Follow-up|2|||
131498154|NCT04044716|473452003|FG001|Overall Study|Lost to Follow-up|3|||
131498155|NCT04044716|473452004|FG002|Overall Study|Lost to Follow-up|0|||
131498156|NCT03049280|473452005|FG000|Overall Study|Physician Decision|1|||
131498157|NCT03681405|473452007|FG000|Overall Study|Found to be ineligible after randomized|1|||
131498158|NCT03681405|473452008|FG001|Overall Study|Found to be ineligible after randomized|0|||
131498159|NCT01714635|473452010|FG000|Overall Study|Discontinued|1|||
131498160|NCT01714635|473452011|FG001|Overall Study|Discontinued|0|||
131498161|NCT01714635|473452012|FG002|Overall Study|Discontinued|2|||
131498162|NCT01714635|473452010|FG000|Overall Study|Missed 6-month exam|1|||
131498163|NCT01714635|473452011|FG001|Overall Study|Missed 6-month exam|0|||
131498164|NCT01714635|473452012|FG002|Overall Study|Missed 6-month exam|0|||
131498165|NCT03978520|473452013|FG000|Overall Study|Adverse Event|2|||
131498166|NCT03978520|473452014|FG001|Overall Study|Adverse Event|5|||
131498167|NCT03978520|473452015|FG002|Overall Study|Adverse Event|3|||
131498168|NCT03978520|473452016|FG003|Overall Study|Adverse Event|5|||
131498169|NCT03978520|473452017|FG004|Overall Study|Adverse Event|6|||
131498170|NCT03978520|473452013|FG000|Overall Study|Withdrawal by Subject|10|||
131498171|NCT03978520|473452014|FG001|Overall Study|Withdrawal by Subject|4|||
131498172|NCT03978520|473452015|FG002|Overall Study|Withdrawal by Subject|5|||
131498173|NCT03978520|473452016|FG003|Overall Study|Withdrawal by Subject|6|||
131498174|NCT03978520|473452017|FG004|Overall Study|Withdrawal by Subject|5|||
131498175|NCT03978520|473452013|FG000|Overall Study|Lost to Follow-up|2|||
131498176|NCT03978520|473452014|FG001|Overall Study|Lost to Follow-up|2|||
131498177|NCT03978520|473452015|FG002|Overall Study|Lost to Follow-up|2|||
131498178|NCT03978520|473452016|FG003|Overall Study|Lost to Follow-up|0|||
131498179|NCT03978520|473452017|FG004|Overall Study|Lost to Follow-up|1|||
131498180|NCT03978520|473452013|FG000|Overall Study|COVID-19 infection|0|||
131498181|NCT03978520|473452014|FG001|Overall Study|COVID-19 infection|1|||
131498182|NCT03978520|473452015|FG002|Overall Study|COVID-19 infection|0|||
131498183|NCT03978520|473452016|FG003|Overall Study|COVID-19 infection|0|||
131498184|NCT03978520|473452017|FG004|Overall Study|COVID-19 infection|0|||
131498185|NCT03978520|473452013|FG000|Overall Study|Other, not specified|9|||
131498186|NCT03978520|473452014|FG001|Overall Study|Other, not specified|4|||
131498187|NCT03978520|473452015|FG002|Overall Study|Other, not specified|1|||
131498188|NCT03978520|473452016|FG003|Overall Study|Other, not specified|1|||
131498189|NCT03978520|473452017|FG004|Overall Study|Other, not specified|2|||
131498190|NCT03978520|473452013|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
131498191|NCT03978520|473452014|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
131498192|NCT03978520|473452015|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
131498193|NCT03978520|473452016|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
131498194|NCT03978520|473452017|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
131498195|NCT00230607|473452018|FG000|Overall Study|Other|3|||
131498196|NCT02860169|473452019|FG000|Part A|Withdrawal by Subject|1|||
131498197|NCT02860169|473452019|FG000|Part A|Other (Screening failure)|6|||
131498198|NCT02860169|473452019|FG000|Part A|Other (Survey not completed)|3|||
131498199|NCT02860169|473452019|FG000|Part A|Other (did not completed consent)|1|||
131498200|NCT02860169|473452019|FG000|Part B|Other (Screening failure)|10|||
131498201|NCT02860169|473452019|FG000|Part B|Withdrawal by Subject|1|||
131498202|NCT02860169|473452019|FG000|Part C|Other (Screening failure)|1|||
131498203|NCT00071513|473452022|FG000|Intervention Component|Withdrawal by Subject|2|||
131498204|NCT00071513|473452023|FG001|Intervention Component|Withdrawal by Subject|3|||
131498205|NCT00071513|473452022|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
131498206|NCT00071513|473452023|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
131498207|NCT01244425|473452025|FG000|Overall Study|Withdrawal by Subject|2|||
131498208|NCT01244425|473452026|FG001|Overall Study|Withdrawal by Subject|2|||
131498209|NCT01244425|473452025|FG000|Overall Study|Adverse Event|1|||
131498210|NCT01244425|473452026|FG001|Overall Study|Adverse Event|1|||
131498211|NCT02743871|473452027|FG000|Overall Study|Lost to Follow-up|0|||
131498212|NCT02743871|473452028|FG001|Overall Study|Lost to Follow-up|0|||
131498213|NCT02743871|473452029|FG002|Overall Study|Lost to Follow-up|0|||
131498214|NCT02743871|473452030|FG003|Overall Study|Lost to Follow-up|1|||
131498215|NCT02743871|473452031|FG004|Overall Study|Lost to Follow-up|0|||
131498216|NCT02743871|473452032|FG005|Overall Study|Lost to Follow-up|0|||
131498217|NCT02743871|473452033|FG006|Overall Study|Lost to Follow-up|1|||
131498218|NCT02743871|473452034|FG007|Overall Study|Lost to Follow-up|0|||
131498219|NCT02743871|473452035|FG008|Overall Study|Lost to Follow-up|0|||
131498220|NCT02743871|473452036|FG009|Overall Study|Lost to Follow-up|0|||
131498221|NCT02743871|473452037|FG010|Overall Study|Lost to Follow-up|0|||
131498222|NCT02743871|473452038|FG011|Overall Study|Lost to Follow-up|2|||
131498223|NCT02743871|473452039|FG012|Overall Study|Lost to Follow-up|0|||
131498224|NCT02743871|473452040|FG013|Overall Study|Lost to Follow-up|0|||
131498225|NCT02743871|473452027|FG000|Overall Study|Withdrawal by Subject|0|||
131498226|NCT02743871|473452028|FG001|Overall Study|Withdrawal by Subject|0|||
131498227|NCT02743871|473452029|FG002|Overall Study|Withdrawal by Subject|0|||
131498228|NCT02743871|473452030|FG003|Overall Study|Withdrawal by Subject|0|||
131498229|NCT02743871|473452031|FG004|Overall Study|Withdrawal by Subject|0|||
131498230|NCT02743871|473452032|FG005|Overall Study|Withdrawal by Subject|0|||
131498231|NCT02743871|473452033|FG006|Overall Study|Withdrawal by Subject|0|||
131498232|NCT02743871|473452034|FG007|Overall Study|Withdrawal by Subject|0|||
131498233|NCT02743871|473452035|FG008|Overall Study|Withdrawal by Subject|0|||
131498234|NCT02743871|473452036|FG009|Overall Study|Withdrawal by Subject|0|||
131498235|NCT02743871|473452037|FG010|Overall Study|Withdrawal by Subject|1|||
131498236|NCT02743871|473452038|FG011|Overall Study|Withdrawal by Subject|0|||
131498237|NCT02743871|473452039|FG012|Overall Study|Withdrawal by Subject|12|||
131498238|NCT02743871|473452040|FG013|Overall Study|Withdrawal by Subject|6|||
131498239|NCT02743871|473452027|FG000|Overall Study|Adverse Event|1|||
131498240|NCT02743871|473452028|FG001|Overall Study|Adverse Event|0|||
131498241|NCT02743871|473452029|FG002|Overall Study|Adverse Event|0|||
131498242|NCT02743871|473452030|FG003|Overall Study|Adverse Event|0|||
131498243|NCT02743871|473452031|FG004|Overall Study|Adverse Event|0|||
131498244|NCT02743871|473452032|FG005|Overall Study|Adverse Event|0|||
131498245|NCT02743871|473452033|FG006|Overall Study|Adverse Event|0|||
131498246|NCT02743871|473452034|FG007|Overall Study|Adverse Event|0|||
131498247|NCT02743871|473452035|FG008|Overall Study|Adverse Event|0|||
131498248|NCT02743871|473452036|FG009|Overall Study|Adverse Event|0|||
131498249|NCT02743871|473452037|FG010|Overall Study|Adverse Event|0|||
131498250|NCT02743871|473452038|FG011|Overall Study|Adverse Event|0|||
131498251|NCT02743871|473452039|FG012|Overall Study|Adverse Event|0|||
131498252|NCT02743871|473452040|FG013|Overall Study|Adverse Event|0|||
131498253|NCT02743871|473452027|FG000|Overall Study|Other|0|||
131498254|NCT02743871|473452028|FG001|Overall Study|Other|0|||
131498255|NCT02743871|473452029|FG002|Overall Study|Other|0|||
131498256|NCT02743871|473452030|FG003|Overall Study|Other|0|||
131498257|NCT02743871|473452031|FG004|Overall Study|Other|0|||
131498258|NCT02743871|473452032|FG005|Overall Study|Other|0|||
131498259|NCT02743871|473452033|FG006|Overall Study|Other|0|||
131498260|NCT02743871|473452034|FG007|Overall Study|Other|0|||
131498261|NCT02743871|473452035|FG008|Overall Study|Other|0|||
131498262|NCT02743871|473452036|FG009|Overall Study|Other|0|||
131498263|NCT02743871|473452037|FG010|Overall Study|Other|0|||
131498264|NCT02743871|473452038|FG011|Overall Study|Other|1|||
131498265|NCT02743871|473452039|FG012|Overall Study|Other|1|||
131498266|NCT02743871|473452040|FG013|Overall Study|Other|1|||
131498267|NCT02743871|473452027|FG000|Overall Study|Protocol Violation|0|||
131498268|NCT02743871|473452028|FG001|Overall Study|Protocol Violation|0|||
131498269|NCT02743871|473452029|FG002|Overall Study|Protocol Violation|0|||
131498270|NCT02743871|473452030|FG003|Overall Study|Protocol Violation|0|||
131498271|NCT02743871|473452031|FG004|Overall Study|Protocol Violation|0|||
131498272|NCT02743871|473452032|FG005|Overall Study|Protocol Violation|0|||
131498273|NCT02743871|473452033|FG006|Overall Study|Protocol Violation|0|||
131498274|NCT02743871|473452034|FG007|Overall Study|Protocol Violation|0|||
131498275|NCT02743871|473452035|FG008|Overall Study|Protocol Violation|0|||
131498276|NCT02743871|473452036|FG009|Overall Study|Protocol Violation|0|||
131498277|NCT02743871|473452037|FG010|Overall Study|Protocol Violation|0|||
131498278|NCT02743871|473452038|FG011|Overall Study|Protocol Violation|0|||
131498279|NCT02743871|473452039|FG012|Overall Study|Protocol Violation|2|||
131498280|NCT02743871|473452040|FG013|Overall Study|Protocol Violation|0|||
131498281|NCT02848651|473452041|FG000|Overall Study|Death|85|||
131498282|NCT02848651|473452041|FG000|Overall Study|Lost to Follow-up|1|||
131498283|NCT02848651|473452041|FG000|Overall Study|Non-Compliance|1|||
131498284|NCT02848651|473452041|FG000|Overall Study|Symptomatic Deterioration|1|||
131498285|NCT02848651|473452041|FG000|Overall Study|Physician Decision|4|||
131498286|NCT02848651|473452041|FG000|Overall Study|Withdrawal by Subject|14|||
131498287|NCT01059799|473452048|FG000|Overall Study|Adverse Event|2|||
131498288|NCT01059799|473452049|FG001|Overall Study|Adverse Event|3|||
131498289|NCT01059799|473452048|FG000|Overall Study|Lack of Efficacy|1|||
131498290|NCT01059799|473452049|FG001|Overall Study|Lack of Efficacy|0|||
131498291|NCT01059799|473452048|FG000|Overall Study|Protocol Violation|3|||
131498292|NCT01059799|473452049|FG001|Overall Study|Protocol Violation|2|||
131498293|NCT01059799|473452048|FG000|Overall Study|Withdrawal criteria|13|||
131498294|NCT01059799|473452049|FG001|Overall Study|Withdrawal criteria|2|||
131498295|NCT01059799|473452048|FG000|Overall Study|Other|12|||
131498296|NCT01059799|473452049|FG001|Overall Study|Other|3|||
131498297|NCT02744391|473452050|FG000|Overall Study|Lost to Follow-up|9|||
131498298|NCT02744391|473452050|FG000|Overall Study|Physician Decision|2|||
131498299|NCT02744391|473452050|FG000|Overall Study|Withdrawal by Subject|3|||
131498300|NCT01428453|473452051|FG000|Overall Study|Adverse Event|2|||
131498301|NCT01428453|473452052|FG001|Overall Study|Adverse Event|7|||
131498302|NCT01428453|473452051|FG000|Overall Study|Protocol Violation|1|||
131498303|NCT01428453|473452052|FG001|Overall Study|Protocol Violation|0|||
131498304|NCT01428453|473452051|FG000|Overall Study|Lost to Follow-up|0|||
131498305|NCT01428453|473452052|FG001|Overall Study|Lost to Follow-up|1|||
131498306|NCT01428453|473452051|FG000|Overall Study|Withdrawal by Subject|3|||
131498307|NCT01428453|473452052|FG001|Overall Study|Withdrawal by Subject|1|||
131498308|NCT01996709|473452053|FG000|Overall Study|Withdrawal by Subject|1|||
131498309|NCT01996709|473452054|FG001|Overall Study|Withdrawal by Subject|0|||
131498310|NCT01996709|473452053|FG000|Overall Study|Lost to Follow-up|3|||
131498311|NCT01996709|473452054|FG001|Overall Study|Lost to Follow-up|0|||
131498312|NCT01996709|473452053|FG000|Overall Study|Subject Non-Compliant|1|||
131498313|NCT01996709|473452054|FG001|Overall Study|Subject Non-Compliant|0|||
131498314|NCT01996709|473452053|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
131498315|NCT01996709|473452054|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
131498316|NCT03789318|473452063|FG000|Overall Study|Adverse Event|0|||
131498317|NCT03789318|473452064|FG001|Overall Study|Adverse Event|0|||
131498318|NCT03789318|473452065|FG002|Overall Study|Adverse Event|1|||
131498319|NCT03789318|473452066|FG003|Overall Study|Adverse Event|1|||
131498320|NCT03789318|473452067|FG004|Overall Study|Adverse Event|0|||
131498321|NCT03789318|473452063|FG000|Overall Study|Lost to Follow-up|0|||
131498322|NCT03789318|473452064|FG001|Overall Study|Lost to Follow-up|0|||
131498323|NCT03789318|473452065|FG002|Overall Study|Lost to Follow-up|1|||
131498324|NCT03789318|473452066|FG003|Overall Study|Lost to Follow-up|0|||
131498325|NCT03789318|473452067|FG004|Overall Study|Lost to Follow-up|0|||
131498326|NCT03789318|473452063|FG000|Overall Study|Withdrawal by Subject|0|||
131498327|NCT03789318|473452064|FG001|Overall Study|Withdrawal by Subject|0|||
131498328|NCT03789318|473452065|FG002|Overall Study|Withdrawal by Subject|1|||
131498329|NCT03789318|473452066|FG003|Overall Study|Withdrawal by Subject|0|||
131498330|NCT03789318|473452067|FG004|Overall Study|Withdrawal by Subject|0|||
131498331|NCT02480114|473452068|FG000|Overall Study|Not completing surveys|3|||
131498332|NCT02480114|473452069|FG001|Overall Study|Not completing surveys|2|||
131498333|NCT02480114|473452068|FG000|Overall Study|Withdrawal by Subject|2|||
131498334|NCT02480114|473452069|FG001|Overall Study|Withdrawal by Subject|4|||
131498335|NCT02480114|473452068|FG000|Overall Study|Disease progression|3|||
131498336|NCT02480114|473452069|FG001|Overall Study|Disease progression|0|||
131498337|NCT02480114|473452068|FG000|Overall Study|Improper completion of survey|1|||
131498338|NCT02480114|473452069|FG001|Overall Study|Improper completion of survey|1|||
131498339|NCT02480114|473452068|FG000|Overall Study|Not eligible|0|||
131498340|NCT02480114|473452069|FG001|Overall Study|Not eligible|1|||
131498341|NCT01535053|473452070|FG000|Overall Study|Ineligible|1|||
131498342|NCT01535053|473452071|FG001|Overall Study|Ineligible|2|||
131498343|NCT00512707|473452072|FG000|Overall Study|Lost to Follow-up|5|||
131498344|NCT00512707|473452073|FG001|Overall Study|Lost to Follow-up|11|||
131498345|NCT00512707|473452072|FG000|Overall Study|Developed skin irritation|2|||
131498346|NCT00512707|473452073|FG001|Overall Study|Developed skin irritation|1|||
131498347|NCT00512707|473452072|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
131498348|NCT00512707|473452073|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
131498349|NCT00512707|473452072|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
131498350|NCT00512707|473452073|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
131498351|NCT03700671|473452074|FG000|Overall Study|Lack of Efficacy|1|||
131498352|NCT03700671|473452075|FG001|Overall Study|Lack of Efficacy|2|||
131498353|NCT01317160|473452076|FG000|Overall Study|Incorrect inclusion|1|||
131498354|NCT01317160|473452077|FG001|Overall Study|Incorrect inclusion|1|||
131498355|NCT01317160|473452076|FG000|Overall Study|Lost to Follow-up|3|||
131498356|NCT01317160|473452077|FG001|Overall Study|Lost to Follow-up|3|||
131498357|NCT01317160|473452076|FG000|Overall Study|Withdrawal by Subject|0|||
131498358|NCT01317160|473452077|FG001|Overall Study|Withdrawal by Subject|2|||
131498359|NCT04405037|473452084|FG000|Overall Study|Withdrawal by Subject|1|||
131498360|NCT04405037|473452085|FG001|Overall Study|Withdrawal by Subject|0|||
131498361|NCT04405037|473452084|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
131498362|NCT04405037|473452085|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
131498363|NCT01955733|473453901|FG000|Period 1|Lost to Follow-up|1|||
131498364|NCT01955733|473453902|FG001|Period 1|Lost to Follow-up|0|||
131498365|NCT01955733|473453903|FG002|Period 1|Lost to Follow-up|0|||
131498366|NCT01955733|473453901|FG000|Period 2|Adverse Event|1|||
131498367|NCT01955733|473453902|FG001|Period 2|Adverse Event|0|||
131498368|NCT01955733|473453903|FG002|Period 2|Adverse Event|0|||
131498369|NCT01955733|473453901|FG000|Period 2|Physician Decision|0|||
131498370|NCT01955733|473453902|FG001|Period 2|Physician Decision|0|||
131498371|NCT01955733|473453903|FG002|Period 2|Physician Decision|1|||
131498372|NCT01955733|473453901|FG000|Period 2|Withdrawal by Subject|1|||
131498373|NCT01955733|473453902|FG001|Period 2|Withdrawal by Subject|3|||
131498374|NCT01955733|473453903|FG002|Period 2|Withdrawal by Subject|2|||
131498375|NCT01955733|473453901|FG000|Period 2|Study terminated by sponsor|8|||
131498376|NCT01955733|473453902|FG001|Period 2|Study terminated by sponsor|14|||
131498377|NCT01955733|473453903|FG002|Period 2|Study terminated by sponsor|16|||
131498378|NCT01955733|473453901|FG000|Period 2|Lost to Follow-up|2|||
131498379|NCT01955733|473453902|FG001|Period 2|Lost to Follow-up|0|||
131498380|NCT01955733|473453903|FG002|Period 2|Lost to Follow-up|0|||
131498381|NCT01955733|473453901|FG000|Period 2|Other not defined above|0|||
131498382|NCT01955733|473453902|FG001|Period 2|Other not defined above|2|||
131498383|NCT01955733|473453903|FG002|Period 2|Other not defined above|2|||
131498384|NCT00733408|473453904|FG000|Overall Study|Adverse Event|4|||
131498385|NCT04221009|473453905|FG000|Overall Study|Withdrawal by Subject|4|||
131498386|NCT00531232|473453906|FG000|Overall Study|Investigator decision|0|||
131498387|NCT00531232|473453907|FG001|Overall Study|Investigator decision|0|||
131498388|NCT00531232|473453908|FG002|Overall Study|Investigator decision|4|||
131498389|NCT00531232|473453906|FG000|Overall Study|Participants refused further treatment|0|||
131498390|NCT00531232|473453907|FG001|Overall Study|Participants refused further treatment|1|||
131498391|NCT00531232|473453908|FG002|Overall Study|Participants refused further treatment|2|||
131498392|NCT00531232|473453906|FG000|Overall Study|Adverse events (AEs)|1|||
131498393|NCT00531232|473453907|FG001|Overall Study|Adverse events (AEs)|2|||
131498394|NCT00531232|473453908|FG002|Overall Study|Adverse events (AEs)|2|||
131498395|NCT00531232|473453906|FG000|Overall Study|Treatment failure|1|||
131498396|NCT00531232|473453907|FG001|Overall Study|Treatment failure|3|||
131498397|NCT00531232|473453908|FG002|Overall Study|Treatment failure|7|||
131498398|NCT00531232|473453906|FG000|Overall Study|Disease recurrence|0|||
131498399|NCT00531232|473453907|FG001|Overall Study|Disease recurrence|0|||
131498400|NCT00531232|473453908|FG002|Overall Study|Disease recurrence|1|||
131498401|NCT00531232|473453906|FG000|Overall Study|Deceased|2|||
131498402|NCT00531232|473453907|FG001|Overall Study|Deceased|2|||
131498403|NCT00531232|473453908|FG002|Overall Study|Deceased|2|||
131498404|NCT00531232|473453906|FG000|Overall Study|Withdrawal by Subject|0|||
131498405|NCT00531232|473453907|FG001|Overall Study|Withdrawal by Subject|1|||
131498406|NCT00531232|473453908|FG002|Overall Study|Withdrawal by Subject|2|||
131498407|NCT00531232|473453906|FG000|Overall Study|Other|0|||
131498408|NCT00531232|473453907|FG001|Overall Study|Other|0|||
131498409|NCT00531232|473453908|FG002|Overall Study|Other|5|||
131498410|NCT02762266|473453909|FG000|Overall Study|Physician Decision|2|||
131498411|NCT02762266|473453910|FG001|Overall Study|Physician Decision|0|||
131498412|NCT01438424|473453911|FG000|Overall Study|Continuing treatment|29|||
131498413|NCT01438424|473453911|FG000|Overall Study|Minimal virologic response|95|||
131498414|NCT01438424|473453911|FG000|Overall Study|Not identified|55|||
131498415|NCT01438424|473453911|FG000|Overall Study|Withdrawal by Subject|104|||
131498416|NCT01438424|473453911|FG000|Overall Study|Progression of chronic hepatitis B|22|||
131498417|NCT01438424|473453911|FG000|Overall Study|Death|22|||
131498418|NCT01438424|473453911|FG000|Overall Study|Adverse Event|17|||
131498419|NCT01438424|473453911|FG000|Overall Study|Lost to Follow-up|17|||
131498420|NCT01438424|473453911|FG000|Overall Study|Abnormal laboratory test result|14|||
131498421|NCT01438424|473453911|FG000|Overall Study|Need for drug prohibited by protocol|14|||
131498422|NCT01438424|473453911|FG000|Overall Study|Pregnancy|7|||
131498423|NCT01438424|473453911|FG000|Overall Study|No longer met inclusion criteria|1|||
131498424|NCT01438424|473453911|FG000|Overall Study|Participant noncompliance|20|||
131498425|NCT04232124|473453912|FG000|Overall Study|Lost to Follow-up|3|||
131498426|NCT02345850|473453918|FG000|Overall Study|Not transplanted|10|||
131498427|NCT02345850|473453919|FG001|Overall Study|Not transplanted|5|||
131498428|NCT02345850|473453920|FG002|Overall Study|Not transplanted|4|||
131498429|NCT02345850|473453918|FG000|Overall Study|Lost to Follow-up|2|||
131498430|NCT02345850|473453919|FG001|Overall Study|Lost to Follow-up|3|||
131498431|NCT02345850|473453920|FG002|Overall Study|Lost to Follow-up|2|||
131498432|NCT02345850|473453918|FG000|Overall Study|Withdrawal by Subject|1|||
131498433|NCT02345850|473453919|FG001|Overall Study|Withdrawal by Subject|0|||
131498434|NCT02345850|473453920|FG002|Overall Study|Withdrawal by Subject|0|||
131498435|NCT01404325|473453928|FG000|Overall Study|Lost to Follow-up|1|||
131498436|NCT01404325|473453929|FG001|Overall Study|Lost to Follow-up|0|||
131498437|NCT01404325|473453928|FG000|Overall Study|Death|2|||
131498438|NCT01404325|473453929|FG001|Overall Study|Death|0|||
131498439|NCT01404325|473453928|FG000|Overall Study|Graft loss/Retransplantation|1|||
131498440|NCT01404325|473453929|FG001|Overall Study|Graft loss/Retransplantation|0|||
131498441|NCT01404325|473453928|FG000|Overall Study|non-specified reason|0|||
131498442|NCT01404325|473453929|FG001|Overall Study|non-specified reason|2|||
131498443|NCT01991067|473453933|FG000|Overall Study|Lost to Follow-up|6|||
131498444|NCT01991067|473453934|FG001|Overall Study|Lost to Follow-up|5|||
131498445|NCT03312933|473453938|FG000|Overall Study|Protocol Violation|15|||
131498446|NCT03312933|473453938|FG000|Overall Study|Lost to Follow-up|36|||
131498447|NCT03312933|473453938|FG000|Overall Study|Withdrawal by Subject|3|||
131498448|NCT00224055|473453944|FG000|Overall Study|Adverse Event|9|||
131498449|NCT00224055|473453945|FG001|Overall Study|Adverse Event|3|||
131498450|NCT00224055|473453944|FG000|Overall Study|Lost to Follow-up|1|||
131498451|NCT00224055|473453945|FG001|Overall Study|Lost to Follow-up|2|||
131498452|NCT00224055|473453944|FG000|Overall Study|Protocol Violation|1|||
131498453|NCT00224055|473453945|FG001|Overall Study|Protocol Violation|1|||
131498454|NCT00224055|473453944|FG000|Overall Study|Inclusion Violation|3|||
131498455|NCT00224055|473453945|FG001|Overall Study|Inclusion Violation|6|||
131498456|NCT00224055|473453944|FG000|Overall Study|Withdrawal by Subject|0|||
131498457|NCT00224055|473453945|FG001|Overall Study|Withdrawal by Subject|2|||
131498458|NCT00224055|473453944|FG000|Overall Study|Other|1|||
131498459|NCT00224055|473453945|FG001|Overall Study|Other|0|||
131498460|NCT01986855|473453946|FG000|Overall Study|Adverse Event|1|||
131498461|NCT01986855|473453947|FG001|Overall Study|Adverse Event|0|||
131498462|NCT01986855|473453948|FG002|Overall Study|Adverse Event|0|||
131498463|NCT01986855|473453946|FG000|Overall Study|Death|3|||
131498464|NCT01986855|473453947|FG001|Overall Study|Death|4|||
131498465|NCT01986855|473453948|FG002|Overall Study|Death|4|||
131498466|NCT01986855|473453946|FG000|Overall Study|Lost to Follow-up|2|||
131498467|NCT01986855|473453947|FG001|Overall Study|Lost to Follow-up|1|||
131498468|NCT01986855|473453948|FG002|Overall Study|Lost to Follow-up|0|||
131498469|NCT01986855|473453946|FG000|Overall Study|Screen Failure|0|||
131498470|NCT01986855|473453947|FG001|Overall Study|Screen Failure|1|||
131498471|NCT01986855|473453948|FG002|Overall Study|Screen Failure|0|||
131498472|NCT01986855|473453946|FG000|Overall Study|Participant Moved|0|||
131498473|NCT01986855|473453947|FG001|Overall Study|Participant Moved|0|||
131498474|NCT01986855|473453948|FG002|Overall Study|Participant Moved|2|||
131498475|NCT01986855|473453946|FG000|Overall Study|Withdrawal by Subject|7|||
131498476|NCT01986855|473453947|FG001|Overall Study|Withdrawal by Subject|8|||
131498477|NCT01986855|473453948|FG002|Overall Study|Withdrawal by Subject|5|||
131498478|NCT00609492|473453951|FG000|Overall Study|Withdrawal by Subject|0|||
131498479|NCT00609492|473453952|FG001|Overall Study|Withdrawal by Subject|2|||
131498480|NCT00609492|473453953|FG002|Overall Study|Withdrawal by Subject|3|||
131498481|NCT00609492|473453951|FG000|Overall Study|Lost to Follow-up|1|||
131498482|NCT00609492|473453952|FG001|Overall Study|Lost to Follow-up|1|||
131498483|NCT00609492|473453953|FG002|Overall Study|Lost to Follow-up|4|||
131498484|NCT00418314|473453954|FG000|Overall Study|Withdrawal by Subject|1|||
131498485|NCT00418314|473453955|FG001|Overall Study|Withdrawal by Subject|2|||
131498486|NCT00931762|473453956|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
131498487|NCT00931762|473453956|FG000|Overall Study|Administrative Problems|5|||
131498488|NCT00931762|473453956|FG000|Overall Study|Death|1|||
131498489|NCT00931762|473453956|FG000|Overall Study|Disease Progression|3|||
131498490|NCT00931762|473453956|FG000|Overall Study|Adverse Event (s)|11|||
131498491|NCT00931762|473453956|FG000|Overall Study|Subject withdrew consent|13|||
131498492|NCT02664441|473453957|FG000|Randomization|Withdrawal by Subject|0|||
131498493|NCT02664441|473453958|FG001|Randomization|Withdrawal by Subject|1|||
131498494|NCT02664441|473453957|FG000|36-week Randomized Trial|Adverse Event|2|||
131498495|NCT02664441|473453958|FG001|36-week Randomized Trial|Adverse Event|0|||
131498496|NCT02664441|473453957|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
131498497|NCT02664441|473453958|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
131498498|NCT02664441|473453957|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
131498499|NCT02664441|473453958|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
131498500|NCT02664441|473453957|FG000|18-week Open Label Extension|Adverse Event|1|||
131498501|NCT02664441|473453958|FG001|18-week Open Label Extension|Adverse Event|0|||
131498502|NCT02664441|473453957|FG000|18-week Open Label Extension|Physician Decision|1|||
131498503|NCT02664441|473453958|FG001|18-week Open Label Extension|Physician Decision|0|||
131498504|NCT02664441|473453957|FG000|18-week Open Label Extension|Death|1|||
131498505|NCT02664441|473453958|FG001|18-week Open Label Extension|Death|0|||
131498506|NCT02664441|473453957|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
131498507|NCT02664441|473453958|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
131498508|NCT01413191|473453959|FG000|Overall Study|Lost to Follow-up|5|||
131498509|NCT01413191|473453959|FG000|Overall Study|Disease Progression|5|||
131498510|NCT01413191|473453959|FG000|Overall Study|Death|1|||
131498511|NCT01702454|473453960|FG000|Overall Study|Consent withdrawal|0|||
131498512|NCT01702454|473453961|FG001|Overall Study|Consent withdrawal|1|||
131498513|NCT01702454|473453960|FG000|Overall Study|Migrated/moved from study area|0|||
131498514|NCT01702454|473453961|FG001|Overall Study|Migrated/moved from study area|1|||
131498515|NCT01702454|473453960|FG000|Overall Study|Lost to Follow-up|3|||
131498516|NCT01702454|473453961|FG001|Overall Study|Lost to Follow-up|6|||
131498517|NCT00710710|473453962|FG000|Overall Study|Consent withdrawn|2|||
131498518|NCT00710710|473453963|FG001|Overall Study|Consent withdrawn|2|||
131498519|NCT00710710|473453962|FG000|Overall Study|Protocol Violation|0|||
131498520|NCT00710710|473453963|FG001|Overall Study|Protocol Violation|1|||
131498521|NCT00710710|473453962|FG000|Overall Study|Adverse Event|3|||
131498522|NCT00710710|473453963|FG001|Overall Study|Adverse Event|3|||
131498523|NCT00710710|473453962|FG000|Overall Study|Progressive disease|40|||
131498524|NCT00710710|473453963|FG001|Overall Study|Progressive disease|38|||
131498525|NCT03510884|473453964|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
131498526|NCT03510884|473453965|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
131498527|NCT03510884|473453966|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
131498528|NCT03510884|473453967|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
131498529|NCT03510884|473453964|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
131498530|NCT03510884|473453965|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
131498531|NCT03510884|473453966|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
131498532|NCT03510884|473453967|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
131498533|NCT03510884|473453964|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
131498534|NCT03510884|473453965|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
131498535|NCT03510884|473453966|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
131498536|NCT03510884|473453967|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
131498537|NCT03510884|473453964|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
131498538|NCT03510884|473453965|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
131498539|NCT03510884|473453966|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
131498540|NCT03510884|473453967|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
131498541|NCT03510884|473453964|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
131498542|NCT03510884|473453965|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
131498543|NCT03510884|473453966|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
131498544|NCT03510884|473453967|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
131498545|NCT03510884|473453964|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
131498546|NCT03510884|473453965|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
131498547|NCT03510884|473453966|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
131498548|NCT03510884|473453967|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
131498549|NCT03510884|473453964|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
131498550|NCT03510884|473453965|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
131498551|NCT03510884|473453966|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
131498552|NCT03510884|473453967|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
131498553|NCT03510884|473453964|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
131498554|NCT03510884|473453965|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
131498555|NCT03510884|473453966|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
131498556|NCT03510884|473453967|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
131498557|NCT03510884|473453964|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
131498558|NCT03510884|473453965|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
131498559|NCT03510884|473453966|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
131498560|NCT03510884|473453967|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
131498561|NCT03510884|473453964|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
131498562|NCT03510884|473453965|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
131498563|NCT03510884|473453966|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
131498564|NCT03510884|473453967|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
131498565|NCT01529346|473453968|FG000|Overall Study|Lost to Follow-up|2|||
131498566|NCT01529346|473453969|FG001|Overall Study|Lost to Follow-up|0|||
131498567|NCT01529346|473453970|FG002|Overall Study|Lost to Follow-up|1|||
131498568|NCT01529346|473453971|FG003|Overall Study|Lost to Follow-up|0|||
131498569|NCT01529346|473453972|FG004|Overall Study|Lost to Follow-up|0|||
131498570|NCT01529346|473453968|FG000|Overall Study|Other|0|||
131498571|NCT01529346|473453969|FG001|Overall Study|Other|1|||
131498572|NCT01529346|473453970|FG002|Overall Study|Other|1|||
131498573|NCT01529346|473453971|FG003|Overall Study|Other|0|||
131498574|NCT01529346|473453972|FG004|Overall Study|Other|0|||
131498575|NCT00589914|473453973|FG000|Overall Study|Adverse Event|19|||
131498576|NCT00589914|473453974|FG001|Overall Study|Adverse Event|10|||
131498577|NCT00589914|473453973|FG000|Overall Study|Death|2|||
131498578|NCT00589914|473453974|FG001|Overall Study|Death|0|||
131498579|NCT00589914|473453973|FG000|Overall Study|Lack of Efficacy|40|||
131498580|NCT00589914|473453974|FG001|Overall Study|Lack of Efficacy|43|||
131498581|NCT00589914|473453973|FG000|Overall Study|Lost to Follow-up|11|||
131498582|NCT00589914|473453974|FG001|Overall Study|Lost to Follow-up|18|||
131498583|NCT00589914|473453973|FG000|Overall Study|Pregnancy|1|||
131498584|NCT00589914|473453974|FG001|Overall Study|Pregnancy|0|||
131498585|NCT00589914|473453973|FG000|Overall Study|Withdrawal by Subject|55|||
131498586|NCT00589914|473453974|FG001|Overall Study|Withdrawal by Subject|49|||
131498587|NCT00589914|473453973|FG000|Overall Study|Other|22|||
131498588|NCT00589914|473453974|FG001|Overall Study|Other|17|||
131498589|NCT01594125|473453979|FG000|Overall Study|Withdrawal by Subject|1|||
131498590|NCT01594125|473453980|FG001|Overall Study|Withdrawal by Subject|0|||
131498591|NCT01594125|473453981|FG002|Overall Study|Withdrawal by Subject|0|||
131498592|NCT01594125|473453982|FG003|Overall Study|Withdrawal by Subject|1|||
131498593|NCT01594125|473453983|FG004|Overall Study|Withdrawal by Subject|0|||
131498594|NCT01594125|473453979|FG000|Overall Study|Progressive Disease|3|||
131498595|NCT01594125|473453980|FG001|Overall Study|Progressive Disease|12|||
131498596|NCT01594125|473453981|FG002|Overall Study|Progressive Disease|3|||
131498597|NCT01594125|473453982|FG003|Overall Study|Progressive Disease|3|||
131498598|NCT01594125|473453983|FG004|Overall Study|Progressive Disease|7|||
131498599|NCT03590041|473453985|FG000|Overall Study|Protocol Violation|4|||
131498600|NCT03590041|473453986|FG001|Overall Study|Protocol Violation|3|||
131498601|NCT03590041|473453985|FG000|Overall Study|No session data recorded|14|||
131498602|NCT03590041|473453986|FG001|Overall Study|No session data recorded|2|||
131498603|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Death|3|||
131498604|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Death|3|||
131498605|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Death|0|||
131498606|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Death|0|||
131498607|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
131498608|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
131498609|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
131498610|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
131498611|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
131498612|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
131498613|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
131498614|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
131498615|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
131498616|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
131498617|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
131498618|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
131498619|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
131498620|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
131498621|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
131498622|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
131498623|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
131498624|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
131498625|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
131498626|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
131498627|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
131498628|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
131498629|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
131498630|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
131498631|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Other|6|||
131498632|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Other|3|||
131498633|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Other|0|||
131498634|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Other|0|||
131498635|NCT02051608|473453987|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
131498636|NCT02051608|473453988|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
131498637|NCT02051608|473453989|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
131498638|NCT02051608|473453990|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
131498639|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Adverse Event|0|||
131498640|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Adverse Event|0|||
131498641|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Adverse Event|6|||
131498642|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Adverse Event|8|||
131498643|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Death|0|||
131498644|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Death|0|||
131498645|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Death|7|||
131498646|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Death|4|||
131498647|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
131498648|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
131498649|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
131498650|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
131498651|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
131498652|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
131498653|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
131498654|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
131498655|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
131498656|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
131498657|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
131498658|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
131498659|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
131498660|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
131498661|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
131498662|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
131498663|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Physician Decision|0|||
131498664|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Physician Decision|0|||
131498665|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Physician Decision|8|||
131498666|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Physician Decision|5|||
131498667|NCT02051608|473453987|FG000|Part 2: Open-label Extension|Other|0|||
131498668|NCT02051608|473453988|FG001|Part 2: Open-label Extension|Other|0|||
131498669|NCT02051608|473453989|FG002|Part 2: Open-label Extension|Other|9|||
131498670|NCT02051608|473453990|FG003|Part 2: Open-label Extension|Other|9|||
131498671|NCT03454893|473453991|FG000|Overall Study|Study Terminated by the Sponsor|5|||
131498672|NCT03454893|473453991|FG000|Overall Study|Did not pass screening|4|||
131498673|NCT01948050|473453994|FG000|Overall Study|Withdrawal by Subject|0|||
131498674|NCT01948050|473453995|FG001|Overall Study|Withdrawal by Subject|1|||
131498675|NCT00558025|473453996|FG000|Overall Study|Adverse Event|1|||
131498676|NCT00558025|473453997|FG001|Overall Study|Adverse Event|1|||
131498677|NCT00558025|473453996|FG000|Overall Study|Withdrawal by Subject|2|||
131498678|NCT00558025|473453997|FG001|Overall Study|Withdrawal by Subject|2|||
131498679|NCT00558025|473453996|FG000|Overall Study|Protocol Violation|1|||
131498680|NCT00558025|473453997|FG001|Overall Study|Protocol Violation|0|||
131498681|NCT01314443|473453998|FG000|Overall Study|Withdrawal by Subject|2|||
131498682|NCT01314443|473453999|FG001|Overall Study|Withdrawal by Subject|1|||
131498683|NCT01314443|473454000|FG002|Overall Study|Withdrawal by Subject|1|||
131498684|NCT01314443|473454001|FG003|Overall Study|Withdrawal by Subject|1|||
131498685|NCT01314443|473453998|FG000|Overall Study|Protocol Violation|2|||
131498686|NCT01314443|473453999|FG001|Overall Study|Protocol Violation|2|||
131498687|NCT01314443|473454000|FG002|Overall Study|Protocol Violation|1|||
131498688|NCT01314443|473454001|FG003|Overall Study|Protocol Violation|1|||
131498689|NCT02709785|473454002|FG000|Overall Study|Withdrawal by Subject|1|||
131498690|NCT02709785|473454003|FG001|Overall Study|Withdrawal by Subject|2|||
131498691|NCT02709785|473454004|FG002|Overall Study|Withdrawal by Subject|1|||
131498692|NCT00276159|473454007|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
131498693|NCT02927431|473454010|FG000|Overall Study|Withdrawal by Subject|0|||
131498694|NCT02927431|473454011|FG001|Overall Study|Withdrawal by Subject|0|||
131498695|NCT02927431|473454012|FG002|Overall Study|Withdrawal by Subject|1|||
131498696|NCT01829191|473454013|FG000|Overall Study|Relocation|0|||
131498697|NCT01829191|473454014|FG001|Overall Study|Relocation|1|||
131498698|NCT01829191|473454013|FG000|Overall Study|Lens discomfort|0|||
131498699|NCT01829191|473454014|FG001|Overall Study|Lens discomfort|3|||
131498700|NCT01829191|473454013|FG000|Overall Study|Lens handling difficulty|1|||
131498701|NCT01829191|473454014|FG001|Overall Study|Lens handling difficulty|4|||
131498702|NCT01829191|473454013|FG000|Overall Study|Protocol Violation|4|||
131498703|NCT01829191|473454014|FG001|Overall Study|Protocol Violation|1|||
131498704|NCT01829191|473454013|FG000|Overall Study|Withdrawal by Subject|2|||
131498705|NCT01829191|473454014|FG001|Overall Study|Withdrawal by Subject|3|||
131498706|NCT01829191|473454013|FG000|Overall Study|Lost to Follow-up|0|||
131498707|NCT01829191|473454014|FG001|Overall Study|Lost to Follow-up|1|||
131498708|NCT01829191|473454013|FG000|Overall Study|Subject was fit for ortho - k|0|||
131498709|NCT01829191|473454014|FG001|Overall Study|Subject was fit for ortho - k|1|||
131498710|NCT00429104|473454015|FG000|Overall Study|Protocol Violation|1|||
131498711|NCT01907815|473454016|FG000|Overall Study|Withdrawal by Subject|1|||
131498712|NCT01907815|473454017|FG001|Overall Study|Withdrawal by Subject|0|||
131498713|NCT02205814|473454018|FG000|Overall Study|Lost to Follow-up|0|||
131498714|NCT02205814|473454019|FG001|Overall Study|Lost to Follow-up|0|||
131498715|NCT02205814|473454020|FG002|Overall Study|Lost to Follow-up|0|||
131498716|NCT02205814|473454021|FG003|Overall Study|Lost to Follow-up|1|||
131498717|NCT02205814|473454018|FG000|Overall Study|Lack of Efficacy|1|||
131498718|NCT02205814|473454019|FG001|Overall Study|Lack of Efficacy|0|||
131498719|NCT02205814|473454020|FG002|Overall Study|Lack of Efficacy|1|||
131498720|NCT02205814|473454021|FG003|Overall Study|Lack of Efficacy|1|||
131498721|NCT02205814|473454018|FG000|Overall Study|Physician Decision|0|||
131498722|NCT02205814|473454019|FG001|Overall Study|Physician Decision|0|||
131498723|NCT02205814|473454020|FG002|Overall Study|Physician Decision|1|||
131498724|NCT02205814|473454021|FG003|Overall Study|Physician Decision|0|||
131498725|NCT02205814|473454018|FG000|Overall Study|Protocol Violation|1|||
131498726|NCT02205814|473454019|FG001|Overall Study|Protocol Violation|0|||
131498727|NCT02205814|473454020|FG002|Overall Study|Protocol Violation|0|||
131498728|NCT02205814|473454021|FG003|Overall Study|Protocol Violation|1|||
131498729|NCT02205814|473454018|FG000|Overall Study|Withdrawal by Subject|0|||
131498730|NCT02205814|473454019|FG001|Overall Study|Withdrawal by Subject|1|||
131498731|NCT02205814|473454020|FG002|Overall Study|Withdrawal by Subject|2|||
131498732|NCT02205814|473454021|FG003|Overall Study|Withdrawal by Subject|1|||
131498733|NCT02205814|473454018|FG000|Overall Study|not compliant with study procedures|0|||
131498734|NCT02205814|473454019|FG001|Overall Study|not compliant with study procedures|0|||
131498735|NCT02205814|473454020|FG002|Overall Study|not compliant with study procedures|1|||
131498736|NCT02205814|473454021|FG003|Overall Study|not compliant with study procedures|0|||
131498737|NCT00143403|473454022|FG000|Overall Study|Adverse Event|3|||
131498738|NCT00143403|473454023|FG001|Overall Study|Adverse Event|8|||
131498739|NCT00143403|473454022|FG000|Overall Study|Death|1|||
131498740|NCT00143403|473454023|FG001|Overall Study|Death|0|||
131498741|NCT00143403|473454022|FG000|Overall Study|Withdrawal by Subject|3|||
131498742|NCT00143403|473454023|FG001|Overall Study|Withdrawal by Subject|12|||
131498743|NCT00143403|473454022|FG000|Overall Study|Relapse|15|||
131498744|NCT00143403|473454023|FG001|Overall Study|Relapse|7|||
131498745|NCT00143403|473454022|FG000|Overall Study|Protocol Violation|2|||
131498746|NCT00143403|473454023|FG001|Overall Study|Protocol Violation|2|||
131498747|NCT00143403|473454022|FG000|Overall Study|specified by site|4|||
131498748|NCT00143403|473454023|FG001|Overall Study|specified by site|9|||
131498749|NCT00143403|473454022|FG000|Overall Study|Randomized Not Treated|7|||
131498750|NCT00143403|473454023|FG001|Overall Study|Randomized Not Treated|8|||
131498751|NCT00514540|473454024|FG000|First-Line Chemo|Withdrawal by Subject|1|||
131498752|NCT00514540|473454024|FG000|First-Line Chemo|Protocol Violation|7|||
131498753|NCT00514540|473454024|FG000|Second-Line|Physician/Patient Decision|31|||
131498754|NCT00587639|473454025|FG000|Overall Study|Withdrawal by Subject|1|||
131498755|NCT01195415|473454026|FG000|Overall Study|No repeat biopsy due to progression|2|||
131498756|NCT00533845|473454027|FG000|Overall Study|Physician Decision|1|||
131498757|NCT00533845|473454028|FG001|Overall Study|Physician Decision|0|||
131498758|NCT02326025|473454037|FG000|Overall Study|Adverse Event|3|||
131498759|NCT02326025|473454038|FG001|Overall Study|Adverse Event|0|||
131498760|NCT02326025|473454037|FG000|Overall Study|Physician Decision|1|||
131498761|NCT02326025|473454038|FG001|Overall Study|Physician Decision|2|||
131498762|NCT02326025|473454037|FG000|Overall Study|Physician and Participant Decision|1|||
131498763|NCT02326025|473454038|FG001|Overall Study|Physician and Participant Decision|0|||
131498764|NCT02326025|473454037|FG000|Overall Study|Withdrawal by Subject|0|||
131498765|NCT02326025|473454038|FG001|Overall Study|Withdrawal by Subject|2|||
131498766|NCT02326025|473454037|FG000|Overall Study|Protocol Violation|0|||
131498767|NCT02326025|473454038|FG001|Overall Study|Protocol Violation|1|||
131498768|NCT00001723|473454039|FG000|Overall Study|Lack of Efficacy|6|||
131498769|NCT00001723|473454040|FG001|Overall Study|Lack of Efficacy|7|||
131498770|NCT00001723|473454039|FG000|Overall Study|Lack of family interest|4|||
131498771|NCT00001723|473454040|FG001|Overall Study|Lack of family interest|5|||
131498772|NCT00001723|473454039|FG000|Overall Study|Lost to Follow-up|2|||
131498773|NCT00001723|473454040|FG001|Overall Study|Lost to Follow-up|2|||
131498774|NCT00001723|473454039|FG000|Overall Study|medication intolerance|1|||
131498775|NCT00001723|473454040|FG001|Overall Study|medication intolerance|2|||
131434047|NCT01188772|473214619|FG001|Overall Study|Terminated by Sponsor|0|||
131434048|NCT01188772|473214620|FG002|Overall Study|Terminated by Sponsor|1|||
131498776|NCT00927784|473454041|FG000|Overall Study|Death|1|||
131498777|NCT00927784|473454042|FG001|Overall Study|Death|0|||
131498778|NCT00927784|473454041|FG000|Overall Study|Withdrawal by Subject|1|||
131498779|NCT00927784|473454042|FG001|Overall Study|Withdrawal by Subject|0|||
131498780|NCT02170051|473454043|FG000|Overall Study|Withdrawal by Subject|10|||
131498781|NCT02170051|473454044|FG001|Overall Study|Withdrawal by Subject|10|||
131498782|NCT02170051|473454043|FG000|Overall Study|Lost to Follow-up|1|||
131498783|NCT02170051|473454044|FG001|Overall Study|Lost to Follow-up|3|||
131498784|NCT02643082|473454045|FG000|Period 1|Adverse Event|1|||
131498785|NCT02643082|473454046|FG001|Period 1|Adverse Event|0|||
131498786|NCT01867021|473454047|FG000|Overall Study|Adverse Event|0|||
131434049|NCT01188772|473214621|FG003|Overall Study|Terminated by Sponsor|0|||
131434050|NCT01188772|473214618|FG000|Overall Study|Treatment Failure|0|||
131434051|NCT01188772|473214619|FG001|Overall Study|Treatment Failure|0|||
131434052|NCT01188772|473214620|FG002|Overall Study|Treatment Failure|1|||
131434053|NCT01188772|473214621|FG003|Overall Study|Treatment Failure|0|||
131434054|NCT01188772|473214618|FG000|Overall Study|Virologic Failure|1|||
131434055|NCT01188772|473214619|FG001|Overall Study|Virologic Failure|0|||
131434056|NCT01188772|473214620|FG002|Overall Study|Virologic Failure|0|||
131434057|NCT01188772|473214621|FG003|Overall Study|Virologic Failure|0|||
131434058|NCT01188772|473214618|FG000|Overall Study|Withdrawal by Subject|0|||
131434059|NCT01188772|473214619|FG001|Overall Study|Withdrawal by Subject|0|||
131434060|NCT01188772|473214620|FG002|Overall Study|Withdrawal by Subject|2|||
131434061|NCT01188772|473214621|FG003|Overall Study|Withdrawal by Subject|0|||
131434062|NCT01433172|473214622|FG000|Overall Study|Withdrawal by Subject|0|||
131434063|NCT01433172|473214623|FG001|Overall Study|Withdrawal by Subject|1|||
131434064|NCT01433172|473214624|FG002|Overall Study|Withdrawal by Subject|0|||
131434065|NCT01433172|473214622|FG000|Overall Study|Disease Progression|0|||
131434066|NCT01433172|473214623|FG001|Overall Study|Disease Progression|0|||
131434067|NCT01433172|473214624|FG002|Overall Study|Disease Progression|1|||
131434068|NCT01433172|473214622|FG000|Overall Study|Death|0|||
131434069|NCT01433172|473214623|FG001|Overall Study|Death|2|||
131434070|NCT01433172|473214624|FG002|Overall Study|Death|0|||
131498787|NCT01867021|473454048|FG001|Overall Study|Adverse Event|1|||
131498788|NCT01867021|473454047|FG000|Overall Study|Not Eligible|0|||
131498789|NCT01867021|473454048|FG001|Overall Study|Not Eligible|1|||
131498790|NCT01867021|473454047|FG000|Overall Study|Death|1|||
131498791|NCT01867021|473454048|FG001|Overall Study|Death|0|||
131498792|NCT01867021|473454047|FG000|Overall Study|Lost to Follow-up|0|||
131498793|NCT01867021|473454048|FG001|Overall Study|Lost to Follow-up|2|||
131498794|NCT01867021|473454047|FG000|Overall Study|Withdrawal by Subject|1|||
131498795|NCT01867021|473454048|FG001|Overall Study|Withdrawal by Subject|6|||
131498796|NCT00881712|473454049|FG000|Overall Study|Death|1|||
131498797|NCT00881712|473454050|FG001|Overall Study|Death|0|||
131498798|NCT00881712|473454051|FG002|Overall Study|Death|0|||
131498799|NCT00881712|473454049|FG000|Overall Study|Withdrawal by Subject|1|||
131498800|NCT00881712|473454050|FG001|Overall Study|Withdrawal by Subject|0|||
131498801|NCT00881712|473454051|FG002|Overall Study|Withdrawal by Subject|0|||
131498802|NCT01324999|473454052|FG000|Overall Study|Adverse Event|3|||
131498803|NCT01324999|473454052|FG000|Overall Study|Withdrawal by Subject|2|||
131498804|NCT01862874|473454055|FG000|Overall Study|Randomized not treated|1|||
131498805|NCT01862874|473454056|FG001|Overall Study|Randomized not treated|0|||
131498806|NCT01862874|473454055|FG000|Overall Study|Adverse Event|0|||
131498807|NCT01862874|473454056|FG001|Overall Study|Adverse Event|3|||
131498808|NCT01862874|473454055|FG000|Overall Study|Lost to Follow-up|26|||
131498809|NCT01862874|473454056|FG001|Overall Study|Lost to Follow-up|29|||
131498810|NCT01862874|473454055|FG000|Overall Study|Physician Decision|5|||
131498811|NCT01862874|473454056|FG001|Overall Study|Physician Decision|3|||
131498812|NCT01862874|473454055|FG000|Overall Study|Withdrawn by parent/guardian|1|||
131498813|NCT01862874|473454056|FG001|Overall Study|Withdrawn by parent/guardian|1|||
131498814|NCT01862874|473454055|FG000|Overall Study|Withdrawal by Subject|46|||
131498815|NCT01862874|473454056|FG001|Overall Study|Withdrawal by Subject|40|||
131498816|NCT01862874|473454055|FG000|Overall Study|Death|0|||
131498817|NCT01862874|473454056|FG001|Overall Study|Death|1|||
131498818|NCT04203238|473455312|FG000|Overall Study|Withdrawal by Subject|1|||
131498819|NCT04203238|473455313|FG001|Overall Study|Withdrawal by Subject|1|||
131498820|NCT04203238|473455312|FG000|Overall Study|Covid-19|3|||
131498821|NCT04203238|473455313|FG001|Overall Study|Covid-19|0|||
131498822|NCT01134783|473455315|FG000|Overall Study|Pregnancy|16|||
131498823|NCT01134783|473455316|FG001|Overall Study|Pregnancy|8|||
131498824|NCT01134783|473455315|FG000|Overall Study|Withdrawal by Subject|15|||
131498825|NCT01134783|473455316|FG001|Overall Study|Withdrawal by Subject|9|||
131498826|NCT01134783|473455315|FG000|Overall Study|Lost to Follow-up|5|||
131498827|NCT01134783|473455316|FG001|Overall Study|Lost to Follow-up|20|||
131498828|NCT02329730|473455317|FG000|Overall Study|Protocol Violation|0|||
131498829|NCT02329730|473455318|FG001|Overall Study|Protocol Violation|0|||
131498830|NCT02329730|473455319|FG002|Overall Study|Protocol Violation|0|||
131498831|NCT02329730|473455320|FG003|Overall Study|Protocol Violation|0|||
131498832|NCT02329730|473455321|FG004|Overall Study|Protocol Violation|2|||
131498833|NCT02329730|473455322|FG005|Overall Study|Protocol Violation|2|||
131498834|NCT02329730|473455323|FG006|Overall Study|Protocol Violation|0|||
131498835|NCT02329730|473455324|FG007|Overall Study|Protocol Violation|0|||
131498836|NCT02329730|473455325|FG008|Overall Study|Protocol Violation|0|||
131498837|NCT02329730|473455326|FG009|Overall Study|Protocol Violation|0|||
131498838|NCT02329730|473455327|FG010|Overall Study|Protocol Violation|0|||
131498839|NCT02329730|473455328|FG011|Overall Study|Protocol Violation|0|||
131498840|NCT02329730|473455317|FG000|Overall Study|Withdrawal by Subject|0|||
131498841|NCT02329730|473455318|FG001|Overall Study|Withdrawal by Subject|0|||
131498842|NCT02329730|473455319|FG002|Overall Study|Withdrawal by Subject|0|||
131498843|NCT02329730|473455320|FG003|Overall Study|Withdrawal by Subject|0|||
131498844|NCT02329730|473455321|FG004|Overall Study|Withdrawal by Subject|1|||
131498845|NCT02329730|473455322|FG005|Overall Study|Withdrawal by Subject|0|||
131498846|NCT02329730|473455323|FG006|Overall Study|Withdrawal by Subject|1|||
131498847|NCT02329730|473455324|FG007|Overall Study|Withdrawal by Subject|1|||
131498848|NCT02329730|473455325|FG008|Overall Study|Withdrawal by Subject|1|||
131498849|NCT02329730|473455326|FG009|Overall Study|Withdrawal by Subject|1|||
131498850|NCT02329730|473455327|FG010|Overall Study|Withdrawal by Subject|0|||
131498851|NCT02329730|473455328|FG011|Overall Study|Withdrawal by Subject|0|||
131498852|NCT02392247|473455333|FG000|Overall Study|Withdrawal by Subject|1|||
131498853|NCT02392247|473455333|FG000|Overall Study|Surgery cancelled; no data|1|||
131498854|NCT03010254|473455334|FG000|Overall Study|Adverse Event|0|||
131498855|NCT03010254|473455335|FG001|Overall Study|Adverse Event|1|||
131498856|NCT03010254|473455334|FG000|Overall Study|Lost to Follow-up|4|||
131498857|NCT03010254|473455335|FG001|Overall Study|Lost to Follow-up|0|||
131498858|NCT03010254|473455334|FG000|Overall Study|Withdrawal by Subject|1|||
131498859|NCT03010254|473455335|FG001|Overall Study|Withdrawal by Subject|1|||
131498860|NCT03010254|473455334|FG000|Overall Study|Other|2|||
131498861|NCT03010254|473455335|FG001|Overall Study|Other|3|||
131498862|NCT02068443|473455336|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131498863|NCT02068443|473455337|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
131498864|NCT02068443|473455338|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
131498865|NCT02068443|473455336|FG000|Overall Study|Voluntary Withdrawal|4|||
131498866|NCT02068443|473455337|FG001|Overall Study|Voluntary Withdrawal|0|||
131498867|NCT02068443|473455338|FG002|Overall Study|Voluntary Withdrawal|1|||
131498868|NCT02068443|473455336|FG000|Overall Study|Lack of Efficacy|2|||
131498869|NCT02068443|473455337|FG001|Overall Study|Lack of Efficacy|1|||
131498870|NCT02068443|473455338|FG002|Overall Study|Lack of Efficacy|0|||
131498871|NCT02068443|473455336|FG000|Overall Study|Other Reason Not Specified|1|||
131498872|NCT02068443|473455337|FG001|Overall Study|Other Reason Not Specified|0|||
131498873|NCT02068443|473455338|FG002|Overall Study|Other Reason Not Specified|0|||
131498874|NCT00848081|473455341|FG000|Overall Study|Adverse Event|6|||
131498875|NCT00848081|473455342|FG001|Overall Study|Adverse Event|7|||
131498876|NCT00848081|473455341|FG000|Overall Study|Protocol Violation|8|||
131498877|NCT00848081|473455342|FG001|Overall Study|Protocol Violation|5|||
131498878|NCT00848081|473455341|FG000|Overall Study|Lost to Follow-up|1|||
131498879|NCT00848081|473455342|FG001|Overall Study|Lost to Follow-up|0|||
131498880|NCT00848081|473455341|FG000|Overall Study|Physician Decision|0|||
131498881|NCT00848081|473455342|FG001|Overall Study|Physician Decision|3|||
131498882|NCT00848081|473455341|FG000|Overall Study|Withdrawal by Subject|5|||
131498883|NCT00848081|473455342|FG001|Overall Study|Withdrawal by Subject|3|||
131498884|NCT02014597|473455343|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
131498885|NCT02014597|473455344|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
131498886|NCT02825992|473455345|FG000|Overall Study|Withdrawal by Subject|4|||
131498887|NCT02825992|473455345|FG000|Overall Study|Lost to Follow-up|2|||
131498888|NCT02825992|473455345|FG000|Overall Study|Procedure terminated|2|||
131498889|NCT02279173|473455346|FG000|Overall Study|Protocol-specified Criteria|67|||
131498890|NCT02279173|473455346|FG000|Overall Study|Withdrawal by Subject|20|||
131498891|NCT02279173|473455346|FG000|Overall Study|Decision by Sponsor|4|||
131498892|NCT02279173|473455346|FG000|Overall Study|Lost to Follow-up|3|||
131498893|NCT00754624|473455347|FG000|Overall Study|Adverse Event|16|||
131498894|NCT00754624|473455347|FG000|Overall Study|Death|1|||
131498895|NCT00754624|473455347|FG000|Overall Study|Physician Decision|8|||
131498896|NCT00754624|473455347|FG000|Overall Study|Protocol Violation|1|||
131498897|NCT00754624|473455347|FG000|Overall Study|Withdrawal by Subject|28|||
131498898|NCT00754624|473455347|FG000|Overall Study|Various|12|||
131498899|NCT00754624|473455347|FG000|Overall Study|Lost to Follow-up|3|||
131498900|NCT00232817|473455351|FG000|Overall Study|Protocol Violation|2|||
131498901|NCT00232817|473455352|FG001|Overall Study|Protocol Violation|1|||
131498902|NCT01463878|473455353|FG000|Overall Study|no longer met criteria for tube feed|2|||
131498903|NCT01463878|473455354|FG001|Overall Study|no longer met criteria for tube feed|2|||
131498904|NCT02436889|473455355|FG000|Overall Study|No improvement in symptoms|1|||
131498905|NCT02436889|473455356|FG001|Overall Study|No improvement in symptoms|0|||
131498906|NCT02436889|473455355|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
131498907|NCT02436889|473455356|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
131498908|NCT00849381|473455357|FG000|Overall Study|Adverse Event|1|||
131498909|NCT00849381|473455357|FG000|Overall Study|Lost to Follow-up|129|||
131498910|NCT00849381|473455357|FG000|Overall Study|Protocol Violation|5|||
131498911|NCT00849381|473455357|FG000|Overall Study|Withdrawal by Subject|6|||
131498912|NCT00849381|473455357|FG000|Overall Study|Other|4|||
131498913|NCT02618434|473455358|FG000|Overall Study|Withdrawal by Subject|0|||
131498914|NCT02618434|473455359|FG001|Overall Study|Withdrawal by Subject|2|||
131498915|NCT02618434|473455360|FG002|Overall Study|Withdrawal by Subject|3|||
131498916|NCT02618434|473455358|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
131498917|NCT02618434|473455359|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
131498918|NCT02618434|473455360|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
131498919|NCT02618434|473455358|FG000|Overall Study|Lost to Follow-up|3|||
131498920|NCT02618434|473455359|FG001|Overall Study|Lost to Follow-up|1|||
131498921|NCT02618434|473455360|FG002|Overall Study|Lost to Follow-up|3|||
131498922|NCT02618434|473455358|FG000|Overall Study|Adverse Event|1|||
131498923|NCT02618434|473455359|FG001|Overall Study|Adverse Event|0|||
131498924|NCT02618434|473455360|FG002|Overall Study|Adverse Event|12|||
131498925|NCT02618434|473455358|FG000|Overall Study|Physician Decision|0|||
131498926|NCT02618434|473455359|FG001|Overall Study|Physician Decision|1|||
131498927|NCT02618434|473455360|FG002|Overall Study|Physician Decision|0|||
131498928|NCT02618434|473455358|FG000|Overall Study|Protocol Violation|0|||
131498929|NCT02618434|473455359|FG001|Overall Study|Protocol Violation|0|||
131498930|NCT02618434|473455360|FG002|Overall Study|Protocol Violation|1|||
131498931|NCT02618434|473455358|FG000|Overall Study|Other, Multiple categories|1|||
131498932|NCT02618434|473455359|FG001|Overall Study|Other, Multiple categories|1|||
131498933|NCT02618434|473455360|FG002|Overall Study|Other, Multiple categories|1|||
131498934|NCT02289898|473455365|FG000|Overall Study|Death|5|||
131498935|NCT02289898|473455366|FG001|Overall Study|Death|4|||
131498936|NCT02289898|473455367|FG002|Overall Study|Death|3|||
131498937|NCT02289898|473455365|FG000|Overall Study|Physician Decision|2|||
131498938|NCT02289898|473455366|FG001|Overall Study|Physician Decision|5|||
131498939|NCT02289898|473455367|FG002|Overall Study|Physician Decision|2|||
131498940|NCT02289898|473455365|FG000|Overall Study|Withdrawal by Subject|0|||
131498941|NCT02289898|473455366|FG001|Overall Study|Withdrawal by Subject|4|||
131498942|NCT02289898|473455367|FG002|Overall Study|Withdrawal by Subject|1|||
131498943|NCT02289898|473455365|FG000|Overall Study|Adverse Event|3|||
131498944|NCT02289898|473455366|FG001|Overall Study|Adverse Event|5|||
131498945|NCT02289898|473455367|FG002|Overall Study|Adverse Event|5|||
131498946|NCT02289898|473455365|FG000|Overall Study|Disease progression|34|||
131498947|NCT02289898|473455366|FG001|Overall Study|Disease progression|28|||
131498948|NCT02289898|473455367|FG002|Overall Study|Disease progression|34|||
131498949|NCT02289898|473455365|FG000|Overall Study|Use of another anticancer therapy|0|||
131498950|NCT02289898|473455366|FG001|Overall Study|Use of another anticancer therapy|0|||
131498951|NCT02289898|473455367|FG002|Overall Study|Use of another anticancer therapy|1|||
131498952|NCT02289898|473455365|FG000|Overall Study|Other|8|||
131498953|NCT02289898|473455366|FG001|Overall Study|Other|7|||
131498954|NCT02289898|473455367|FG002|Overall Study|Other|10|||
131498955|NCT01402544|473455368|FG000|Overall Study|Withdrawal by Subject|6|||
131498956|NCT01828281|473455369|FG000|Overall Study|Withdrawal by Subject|1|||
131498957|NCT01828281|473455370|FG001|Overall Study|Withdrawal by Subject|0|||
131498958|NCT04876274|473455371|FG000|Overall Study|Lost to Follow-up|9|||
131498959|NCT04876274|473455372|FG001|Overall Study|Lost to Follow-up|12|||
131498960|NCT00142584|473455373|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
131498961|NCT00142584|473455374|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
131498962|NCT00142584|473455373|FG000|Overall Study|Withdrawal by Subject|30|||
131498963|NCT00142584|473455374|FG001|Overall Study|Withdrawal by Subject|16|||
131498964|NCT00142584|473455373|FG000|Overall Study|Lost to Follow-up|22|||
131498965|NCT00142584|473455374|FG001|Overall Study|Lost to Follow-up|12|||
131498966|NCT00142584|473455373|FG000|Overall Study|Adverse Event|14|||
131498967|NCT00142584|473455374|FG001|Overall Study|Adverse Event|5|||
131498968|NCT00142584|473455373|FG000|Overall Study|Protocol Violation|4|||
131498969|NCT00142584|473455374|FG001|Overall Study|Protocol Violation|7|||
131498970|NCT00142584|473455373|FG000|Overall Study|Treatment Failure|2|||
131498971|NCT00142584|473455374|FG001|Overall Study|Treatment Failure|0|||
131498972|NCT03070782|473455376|FG000|Overall Study|Adverse Event|3|||
131498973|NCT03070782|473455377|FG001|Overall Study|Adverse Event|0|||
131498974|NCT03070782|473455378|FG002|Overall Study|Adverse Event|3|||
131498975|NCT03070782|473455379|FG003|Overall Study|Adverse Event|1|||
131498976|NCT03070782|473455380|FG004|Overall Study|Adverse Event|6|||
131498977|NCT03070782|473455381|FG005|Overall Study|Adverse Event|2|||
131498978|NCT03070782|473455376|FG000|Overall Study|Withdrawal by Subject|2|||
131498979|NCT03070782|473455377|FG001|Overall Study|Withdrawal by Subject|1|||
131498980|NCT03070782|473455378|FG002|Overall Study|Withdrawal by Subject|1|||
131498981|NCT03070782|473455379|FG003|Overall Study|Withdrawal by Subject|0|||
131498982|NCT03070782|473455380|FG004|Overall Study|Withdrawal by Subject|4|||
131498983|NCT03070782|473455381|FG005|Overall Study|Withdrawal by Subject|3|||
131498984|NCT03070782|473455376|FG000|Overall Study|Reason Not Specified|2|||
131498985|NCT03070782|473455377|FG001|Overall Study|Reason Not Specified|0|||
131498986|NCT03070782|473455378|FG002|Overall Study|Reason Not Specified|0|||
131498987|NCT03070782|473455379|FG003|Overall Study|Reason Not Specified|1|||
131498988|NCT03070782|473455380|FG004|Overall Study|Reason Not Specified|2|||
131498989|NCT03070782|473455381|FG005|Overall Study|Reason Not Specified|1|||
131498990|NCT03070782|473455376|FG000|Overall Study|Ineligibility|0|||
131498991|NCT03070782|473455377|FG001|Overall Study|Ineligibility|0|||
131498992|NCT03070782|473455378|FG002|Overall Study|Ineligibility|0|||
131498993|NCT03070782|473455379|FG003|Overall Study|Ineligibility|1|||
131498994|NCT03070782|473455380|FG004|Overall Study|Ineligibility|0|||
131498995|NCT03070782|473455381|FG005|Overall Study|Ineligibility|1|||
131498996|NCT03070782|473455376|FG000|Overall Study|Pregnancy|0|||
131498997|NCT03070782|473455377|FG001|Overall Study|Pregnancy|0|||
131498998|NCT03070782|473455378|FG002|Overall Study|Pregnancy|0|||
131498999|NCT03070782|473455379|FG003|Overall Study|Pregnancy|1|||
131499000|NCT03070782|473455380|FG004|Overall Study|Pregnancy|0|||
131499001|NCT03070782|473455381|FG005|Overall Study|Pregnancy|0|||
131499002|NCT03070782|473455376|FG000|Overall Study|Investigator Judgement|0|||
131499003|NCT03070782|473455377|FG001|Overall Study|Investigator Judgement|0|||
131499004|NCT03070782|473455378|FG002|Overall Study|Investigator Judgement|0|||
131499005|NCT03070782|473455379|FG003|Overall Study|Investigator Judgement|1|||
131499006|NCT03070782|473455380|FG004|Overall Study|Investigator Judgement|0|||
131499007|NCT03070782|473455381|FG005|Overall Study|Investigator Judgement|0|||
131499008|NCT01083576|473455382|FG000|Overall Study|Treatment Failure|6|||
131499009|NCT01083576|473455383|FG001|Overall Study|Treatment Failure|1|||
131499010|NCT03527966|473455384|FG000|Overall Study|Lost to Follow-up|3|||
131499011|NCT03527966|473455385|FG001|Overall Study|Lost to Follow-up|0|||
131499012|NCT00487747|473455386|FG000|Overall Study|Adverse Event|1|||
131499013|NCT00487747|473455386|FG000|Overall Study|Lost to Follow-up|9|||
131499014|NCT00487747|473455386|FG000|Overall Study|Lack of Efficacy|1|||
131499015|NCT00333866|473455387|FG000|Overall Study|Adverse Event|23|||
131499016|NCT00333866|473455388|FG001|Overall Study|Adverse Event|37|||
131499017|NCT00333866|473455389|FG002|Overall Study|Adverse Event|38|||
131499018|NCT00333866|473455390|FG003|Overall Study|Adverse Event|47|||
131499019|NCT00333866|473455387|FG000|Overall Study|Other|3|||
131499020|NCT00333866|473455388|FG001|Overall Study|Other|2|||
131499021|NCT00333866|473455389|FG002|Overall Study|Other|2|||
131499022|NCT00333866|473455390|FG003|Overall Study|Other|2|||
131499023|NCT00333866|473455387|FG000|Overall Study|Lack of Efficacy|8|||
131499024|NCT00333866|473455388|FG001|Overall Study|Lack of Efficacy|6|||
131499025|NCT00333866|473455389|FG002|Overall Study|Lack of Efficacy|3|||
131499026|NCT00333866|473455390|FG003|Overall Study|Lack of Efficacy|5|||
131499027|NCT00333866|473455387|FG000|Overall Study|Lost to Follow-up|1|||
131499028|NCT00333866|473455388|FG001|Overall Study|Lost to Follow-up|2|||
131499029|NCT00333866|473455389|FG002|Overall Study|Lost to Follow-up|2|||
131499030|NCT00333866|473455390|FG003|Overall Study|Lost to Follow-up|2|||
131499031|NCT00333866|473455387|FG000|Overall Study|Withdrawal by Subject|8|||
131499032|NCT00333866|473455388|FG001|Overall Study|Withdrawal by Subject|14|||
131499033|NCT00333866|473455389|FG002|Overall Study|Withdrawal by Subject|4|||
131499034|NCT00333866|473455390|FG003|Overall Study|Withdrawal by Subject|9|||
131499035|NCT00333866|473455387|FG000|Overall Study|Randomized but not Treated|5|||
131499036|NCT00333866|473455388|FG001|Overall Study|Randomized but not Treated|3|||
131499037|NCT00333866|473455389|FG002|Overall Study|Randomized but not Treated|2|||
131499038|NCT00333866|473455390|FG003|Overall Study|Randomized but not Treated|1|||
131499039|NCT02393547|473455402|FG000|Overall Study|Adverse Event|2|||
131499040|NCT02393547|473455402|FG000|Overall Study|Withdrawal by Subject|3|||
131499041|NCT02393547|473455402|FG000|Overall Study|Lost to Follow-up|1|||
131499042|NCT00673465|473455405|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499043|NCT00673465|473455406|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499044|NCT00673465|473455407|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499045|NCT00673465|473455408|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499046|NCT00673465|473455409|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
131499047|NCT00673465|473455410|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
131499048|NCT00673465|473455411|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499049|NCT00673465|473455412|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499050|NCT00673465|473455413|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499051|NCT00673465|473455414|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499052|NCT00673465|473455415|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499053|NCT00673465|473455416|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
131499054|NCT00673465|473455405|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499055|NCT00673465|473455406|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499056|NCT00673465|473455407|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499057|NCT00673465|473455408|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499058|NCT00673465|473455409|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
131499059|NCT00673465|473455410|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499060|NCT00673465|473455411|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499061|NCT00673465|473455412|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499062|NCT00673465|473455413|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499063|NCT00673465|473455414|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499064|NCT00673465|473455415|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499065|NCT00673465|473455416|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
131499066|NCT01276353|473455417|FG000|Double-blind|Adverse Event|2|||
131499067|NCT01276353|473455418|FG001|Double-blind|Adverse Event|0|||
131499068|NCT01276353|473455417|FG000|Double-blind|Withdrawal by Subject|1|||
131499069|NCT01276353|473455418|FG001|Double-blind|Withdrawal by Subject|0|||
131499070|NCT01276353|473455417|FG000|Extension|Adverse Event|2|||
131499071|NCT01276353|473455418|FG001|Extension|Adverse Event|5|||
131499072|NCT01276353|473455417|FG000|Extension|Withdrawal by Subject|1|||
131499073|NCT01276353|473455418|FG001|Extension|Withdrawal by Subject|2|||
131499074|NCT01276353|473455417|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
131499075|NCT01276353|473455418|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
131499076|NCT01276353|473455417|FG000|Extension|Physician Decision|1|||
131499077|NCT01276353|473455418|FG001|Extension|Physician Decision|0|||
131499078|NCT01276353|473455417|FG000|Extension|Prohibited concomitant medications|0|||
131499079|NCT01276353|473455418|FG001|Extension|Prohibited concomitant medications|1|||
131499080|NCT01996982|473455419|FG000|Overall Study|PI/team left institution|7|||
131499081|NCT01288469|473455424|FG000|Overall Study|Adverse Event|4|||
131499082|NCT01288469|473455425|FG001|Overall Study|Adverse Event|1|||
131499083|NCT01288469|473455426|FG002|Overall Study|Adverse Event|1|||
131499084|NCT01288469|473455424|FG000|Overall Study|Poor compliance to protocol|0|||
131499085|NCT01288469|473455425|FG001|Overall Study|Poor compliance to protocol|1|||
131499086|NCT01288469|473455426|FG002|Overall Study|Poor compliance to protocol|0|||
131499087|NCT01288469|473455424|FG000|Overall Study|Participant Moved|1|||
131499088|NCT01288469|473455425|FG001|Overall Study|Participant Moved|0|||
131499089|NCT01288469|473455426|FG002|Overall Study|Participant Moved|0|||
131499090|NCT01288469|473455424|FG000|Overall Study|Consent withdrawn by subject|1|||
131499091|NCT01288469|473455425|FG001|Overall Study|Consent withdrawn by subject|1|||
131499092|NCT01288469|473455426|FG002|Overall Study|Consent withdrawn by subject|1|||
131499093|NCT01288469|473455424|FG000|Overall Study|Exclusion criteria finally met|1|||
131499094|NCT01288469|473455425|FG001|Overall Study|Exclusion criteria finally met|0|||
131499095|NCT01288469|473455426|FG002|Overall Study|Exclusion criteria finally met|0|||
131499096|NCT00110149|473455428|FG000|Overall Study|Physician Decision|3|||
131499097|NCT00563381|473455429|FG000|Overall Study|Adverse Event|264|||
131499098|NCT00563381|473455430|FG001|Overall Study|Adverse Event|292|||
131499099|NCT00563381|473455429|FG000|Overall Study|Protocol Violation|66|||
131499100|NCT00563381|473455430|FG001|Overall Study|Protocol Violation|74|||
131499101|NCT00563381|473455429|FG000|Overall Study|Lost to Follow-up|7|||
131499102|NCT00563381|473455430|FG001|Overall Study|Lost to Follow-up|15|||
131499103|NCT00563381|473455429|FG000|Overall Study|Withdrawal by Subject|192|||
131499104|NCT00563381|473455430|FG001|Overall Study|Withdrawal by Subject|209|||
131499105|NCT00563381|473455429|FG000|Overall Study|Lack of Efficacy|32|||
131499106|NCT00563381|473455430|FG001|Overall Study|Lack of Efficacy|24|||
131499107|NCT00563381|473455429|FG000|Overall Study|Individual different reasons|24|||
131499108|NCT00563381|473455430|FG001|Overall Study|Individual different reasons|34|||
131499109|NCT02452398|473455431|FG000|Overall Study|Adverse Event|1|||
131499110|NCT02452398|473455431|FG000|Overall Study|Lost to Follow-up|28|||
131499111|NCT02452398|473455431|FG000|Overall Study|Physician Decision|2|||
131499112|NCT02452398|473455431|FG000|Overall Study|Withdrawal by Subject|6|||
131499113|NCT02452398|473455431|FG000|Overall Study|Moved away|4|||
131499114|NCT01957553|473455432|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
131499115|NCT01957553|473455433|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
131499116|NCT01957553|473455432|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
131499117|NCT01957553|473455433|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
131499118|NCT01957553|473455432|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
131499119|NCT01957553|473455433|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
131499120|NCT01957553|473455432|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
131499121|NCT01957553|473455433|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
131499122|NCT01957553|473455432|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
131499123|NCT01957553|473455433|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
131499124|NCT01957553|473455432|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
131499125|NCT01957553|473455433|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
131499126|NCT01957553|473455432|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
131499127|NCT01957553|473455433|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
131499128|NCT01957553|473455432|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
131499129|NCT01957553|473455433|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
131499130|NCT01957553|473455432|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
131499131|NCT01957553|473455433|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
131499132|NCT02733367|473455434|FG000|Overall Study|Withdrawal by Subject|6|||
131499133|NCT01348347|473455435|FG000|Overall Study|Withdrawal by Subject|1|||
131499134|NCT01348347|473455436|FG001|Overall Study|Withdrawal by Subject|1|||
131499135|NCT01348347|473455437|FG002|Overall Study|Withdrawal by Subject|1|||
131499136|NCT01348347|473455435|FG000|Overall Study|Progressive disease|2|||
131499137|NCT01348347|473455436|FG001|Overall Study|Progressive disease|5|||
131499138|NCT01348347|473455437|FG002|Overall Study|Progressive disease|5|||
131499139|NCT02505867|473455442|FG000|Overall Study|Lack of Efficacy|6|||
131499140|NCT02505867|473455443|FG001|Overall Study|Lack of Efficacy|6|||
131499141|NCT03672747|473455445|FG000|Overall Study|Lost to Follow-up|1|||
131499142|NCT03672747|473455446|FG001|Overall Study|Lost to Follow-up|1|||
131499143|NCT03672747|473455447|FG002|Overall Study|Lost to Follow-up|2|||
131499144|NCT03672747|473455448|FG003|Overall Study|Lost to Follow-up|2|||
131499145|NCT03672747|473455449|FG004|Overall Study|Lost to Follow-up|2|||
131499146|NCT03672747|473455450|FG005|Overall Study|Lost to Follow-up|1|||
131499147|NCT01782495|473455453|FG000|Overall Study|Adverse Event|0|||
131499148|NCT01782495|473455454|FG001|Overall Study|Adverse Event|0|||
131499149|NCT01782495|473455455|FG002|Overall Study|Adverse Event|0|||
131499150|NCT01782495|473455456|FG003|Overall Study|Adverse Event|0|||
131499151|NCT01782495|473455457|FG004|Overall Study|Adverse Event|0|||
131499152|NCT01782495|473455458|FG005|Overall Study|Adverse Event|0|||
131499153|NCT01782495|473455459|FG006|Overall Study|Adverse Event|0|||
131499154|NCT01782495|473455460|FG007|Overall Study|Adverse Event|2|||
131499155|NCT01782495|473455461|FG008|Overall Study|Adverse Event|0|||
131499156|NCT01782495|473455462|FG009|Overall Study|Adverse Event|0|||
131499157|NCT01782495|473455463|FG010|Overall Study|Adverse Event|0|||
131499158|NCT01782495|473455453|FG000|Overall Study|Withdrew Consent|0|||
131499159|NCT01782495|473455454|FG001|Overall Study|Withdrew Consent|1|||
131499160|NCT01782495|473455455|FG002|Overall Study|Withdrew Consent|0|||
131499161|NCT01782495|473455456|FG003|Overall Study|Withdrew Consent|0|||
131499162|NCT01782495|473455457|FG004|Overall Study|Withdrew Consent|0|||
131499163|NCT01782495|473455458|FG005|Overall Study|Withdrew Consent|0|||
131499164|NCT01782495|473455459|FG006|Overall Study|Withdrew Consent|0|||
131499165|NCT01782495|473455460|FG007|Overall Study|Withdrew Consent|1|||
131499166|NCT01782495|473455461|FG008|Overall Study|Withdrew Consent|0|||
131499167|NCT01782495|473455462|FG009|Overall Study|Withdrew Consent|0|||
131499168|NCT01782495|473455463|FG010|Overall Study|Withdrew Consent|0|||
131499169|NCT03428360|473455464|FG000|Overall Study|Informed consent withdrawn|5|||
131499170|NCT03428360|473455464|FG000|Overall Study|Withdrawal by Subject|4|||
131499171|NCT03428360|473455464|FG000|Overall Study|Lost to Follow-up|5|||
131499172|NCT03428360|473455464|FG000|Overall Study|Physician Decision|2|||
131499173|NCT03428360|473455464|FG000|Overall Study|Informed consent withdrawn|5|||
131499174|NCT03428360|473455464|FG000|Overall Study|Study terminated by sponsor|10|||
131499175|NCT03428360|473455464|FG000|Overall Study|Non-compliant with study|1|||
131499176|NCT03428360|473455464|FG000|Overall Study|Non-compliant with study drug|3|||
131499177|NCT03428360|473455464|FG000|Overall Study|Death|3|||
131499178|NCT03428360|473455464|FG000|Overall Study|Adverse Event|1|||
131499179|NCT03428360|473455464|FG000|Overall Study|Not on antiepileptic drug|1|||
131499180|NCT03241342|473455470|FG000|Overall Study|Adverse Event|5|||
131499181|NCT03241342|473455471|FG001|Overall Study|Adverse Event|8|||
131499182|NCT03241342|473455472|FG002|Overall Study|Adverse Event|4|||
131499183|NCT03241342|473455470|FG000|Overall Study|Lack of Efficacy|0|||
131499184|NCT03241342|473455471|FG001|Overall Study|Lack of Efficacy|0|||
131499185|NCT03241342|473455472|FG002|Overall Study|Lack of Efficacy|1|||
131499186|NCT03241342|473455470|FG000|Overall Study|noncompliance with study drug|2|||
131499187|NCT03241342|473455471|FG001|Overall Study|noncompliance with study drug|1|||
131499188|NCT03241342|473455472|FG002|Overall Study|noncompliance with study drug|1|||
131499189|NCT03241342|473455470|FG000|Overall Study|sponsor decision|0|||
131499190|NCT03241342|473455471|FG001|Overall Study|sponsor decision|1|||
131499191|NCT03241342|473455472|FG002|Overall Study|sponsor decision|2|||
131499192|NCT03241342|473455470|FG000|Overall Study|not reported|15|||
131499193|NCT03241342|473455471|FG001|Overall Study|not reported|21|||
131499194|NCT03241342|473455472|FG002|Overall Study|not reported|19|||
131499195|NCT01846611|473455474|FG000|Overall Study|Lost to Follow-up|4|||
131499196|NCT01846611|473455475|FG001|Overall Study|Lost to Follow-up|6|||
131499197|NCT01846611|473455474|FG000|Overall Study|Withdrawal by Subject|15|||
131499198|NCT01846611|473455475|FG001|Overall Study|Withdrawal by Subject|19|||
131499199|NCT01846611|473455474|FG000|Overall Study|Other|19|||
131499200|NCT01846611|473455475|FG001|Overall Study|Other|18|||
131499201|NCT00662363|473455476|FG000|Overall Study|Withdrawal by Subject|6|||
131499202|NCT00662363|473455477|FG001|Overall Study|Withdrawal by Subject|5|||
131499203|NCT00662363|473455476|FG000|Overall Study|Adverse Event|0|||
131499204|NCT00662363|473455477|FG001|Overall Study|Adverse Event|3|||
131499205|NCT00662363|473455476|FG000|Overall Study|Discharged early from rehab|4|||
131499206|NCT00662363|473455477|FG001|Overall Study|Discharged early from rehab|1|||
131499207|NCT00662363|473455476|FG000|Overall Study|Protocol Violation|1|||
131499208|NCT00662363|473455477|FG001|Overall Study|Protocol Violation|1|||
131499209|NCT02927080|473457418|FG000|Overall Study|Withdrawal by Subject|0|||
131499210|NCT02927080|473457419|FG001|Overall Study|Withdrawal by Subject|0|||
131499211|NCT02927080|473457420|FG002|Overall Study|Withdrawal by Subject|0|||
131499212|NCT02927080|473457421|FG003|Overall Study|Withdrawal by Subject|0|||
131499213|NCT02927080|473457422|FG004|Overall Study|Withdrawal by Subject|1|||
131499214|NCT02927080|473457423|FG005|Overall Study|Withdrawal by Subject|0|||
131499215|NCT02927080|473457424|FG006|Overall Study|Withdrawal by Subject|1|||
131499216|NCT02927080|473457425|FG007|Overall Study|Withdrawal by Subject|1|||
131499217|NCT02927080|473457426|FG008|Overall Study|Withdrawal by Subject|0|||
131499218|NCT02927080|473457427|FG009|Overall Study|Withdrawal by Subject|2|||
131499219|NCT02927080|473457418|FG000|Overall Study|Willingness to comply with protocol|0|||
131499220|NCT02927080|473457419|FG001|Overall Study|Willingness to comply with protocol|0|||
131499221|NCT02927080|473457420|FG002|Overall Study|Willingness to comply with protocol|0|||
131499222|NCT02927080|473457421|FG003|Overall Study|Willingness to comply with protocol|0|||
131499223|NCT02927080|473457422|FG004|Overall Study|Willingness to comply with protocol|0|||
131499224|NCT02927080|473457423|FG005|Overall Study|Willingness to comply with protocol|0|||
131499225|NCT02927080|473457424|FG006|Overall Study|Willingness to comply with protocol|0|||
131499226|NCT02927080|473457425|FG007|Overall Study|Willingness to comply with protocol|0|||
131499227|NCT02927080|473457426|FG008|Overall Study|Willingness to comply with protocol|0|||
131499228|NCT02927080|473457427|FG009|Overall Study|Willingness to comply with protocol|1|||
131499229|NCT02927080|473457418|FG000|Overall Study|Study terminated by Sponsor|0|||
131499230|NCT02927080|473457419|FG001|Overall Study|Study terminated by Sponsor|0|||
131499231|NCT02927080|473457420|FG002|Overall Study|Study terminated by Sponsor|0|||
131499232|NCT02927080|473457421|FG003|Overall Study|Study terminated by Sponsor|0|||
131499233|NCT02927080|473457422|FG004|Overall Study|Study terminated by Sponsor|0|||
131499234|NCT02927080|473457423|FG005|Overall Study|Study terminated by Sponsor|0|||
131499235|NCT02927080|473457424|FG006|Overall Study|Study terminated by Sponsor|6|||
131499236|NCT02927080|473457425|FG007|Overall Study|Study terminated by Sponsor|7|||
131499237|NCT02927080|473457426|FG008|Overall Study|Study terminated by Sponsor|2|||
131499238|NCT02927080|473457427|FG009|Overall Study|Study terminated by Sponsor|3|||
131499239|NCT02927080|473457418|FG000|Overall Study|Adverse Event|0|||
131499240|NCT02927080|473457419|FG001|Overall Study|Adverse Event|1|||
131499241|NCT02927080|473457420|FG002|Overall Study|Adverse Event|0|||
131499242|NCT02927080|473457421|FG003|Overall Study|Adverse Event|0|||
131499243|NCT02927080|473457422|FG004|Overall Study|Adverse Event|0|||
131499244|NCT02927080|473457423|FG005|Overall Study|Adverse Event|0|||
131499245|NCT02927080|473457424|FG006|Overall Study|Adverse Event|0|||
131499246|NCT02927080|473457425|FG007|Overall Study|Adverse Event|1|||
131499247|NCT02927080|473457426|FG008|Overall Study|Adverse Event|0|||
131499248|NCT02927080|473457427|FG009|Overall Study|Adverse Event|1|||
131499249|NCT02927080|473457418|FG000|Overall Study|Other|0|||
131499250|NCT02927080|473457419|FG001|Overall Study|Other|0|||
131499251|NCT02927080|473457420|FG002|Overall Study|Other|0|||
131499252|NCT02927080|473457421|FG003|Overall Study|Other|0|||
131499253|NCT02927080|473457422|FG004|Overall Study|Other|0|||
131499254|NCT02927080|473457423|FG005|Overall Study|Other|0|||
131499255|NCT02927080|473457424|FG006|Overall Study|Other|1|||
131499256|NCT02927080|473457425|FG007|Overall Study|Other|0|||
131499257|NCT02927080|473457426|FG008|Overall Study|Other|1|||
131499258|NCT02927080|473457427|FG009|Overall Study|Other|0|||
131499259|NCT00664742|473457428|FG000|Overall Study|Withdrawn due to adverse events|3|||
131499260|NCT00664742|473457428|FG000|Overall Study|Withdrawal by Subject|31|||
131499261|NCT00664742|473457428|FG000|Overall Study|Lost to Follow-up|92|||
131499262|NCT04317066|473457429|FG000|Overall Study|Sponsor decision|5|||
131499263|NCT04317066|473457429|FG000|Overall Study|Death|2|||
131499264|NCT00715078|473457430|FG000|Overall Study|Death|29|||
131499265|NCT00715078|473457431|FG001|Overall Study|Death|36|||
131499266|NCT00715078|473457432|FG002|Overall Study|Death|36|||
131499267|NCT00715078|473457430|FG000|Overall Study|Withdrawal by Subject|1|||
131499268|NCT00715078|473457431|FG001|Overall Study|Withdrawal by Subject|0|||
131499269|NCT00715078|473457432|FG002|Overall Study|Withdrawal by Subject|1|||
131499270|NCT00715078|473457430|FG000|Overall Study|Unable to start due to disease prog.|0|||
131499271|NCT00715078|473457431|FG001|Overall Study|Unable to start due to disease prog.|0|||
131499272|NCT00715078|473457432|FG002|Overall Study|Unable to start due to disease prog.|1|||
131499273|NCT00157950|473457433|FG000|Overall Study|Death|1|||
131499274|NCT00157950|473457434|FG001|Overall Study|Death|0|||
131499275|NCT02892760|473457435|FG000|Overall Study|Withdrawal by Subject|3|||
131499276|NCT00386776|473457440|FG000|Overall Study|Withdrawal by Subject|8|||
131499277|NCT01500629|473457441|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
131499278|NCT01500629|473457442|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
131499279|NCT00588848|473457443|FG000|Overall Study|Physician Decision|0|||
131499280|NCT00588848|473457444|FG001|Overall Study|Physician Decision|3|||
131499281|NCT01499667|473457445|FG000|Overall Study|administrative problems|4|||
131499282|NCT01499667|473457446|FG001|Overall Study|administrative problems|5|||
131499283|NCT01499667|473457447|FG002|Overall Study|administrative problems|5|||
131499284|NCT01499667|473457445|FG000|Overall Study|Protocol Violation|1|||
131499285|NCT01499667|473457446|FG001|Overall Study|Protocol Violation|3|||
131499286|NCT01499667|473457447|FG002|Overall Study|Protocol Violation|2|||
131499287|NCT01499667|473457445|FG000|Overall Study|Adverse Event|0|||
131499288|NCT01499667|473457446|FG001|Overall Study|Adverse Event|2|||
131499289|NCT01499667|473457447|FG002|Overall Study|Adverse Event|2|||
131499290|NCT01499667|473457445|FG000|Overall Study|Withdrawal by Subject|2|||
131499291|NCT01499667|473457446|FG001|Overall Study|Withdrawal by Subject|1|||
131499292|NCT01499667|473457447|FG002|Overall Study|Withdrawal by Subject|1|||
131499293|NCT01499667|473457445|FG000|Overall Study|Lack of Efficacy|2|||
131499294|NCT01499667|473457446|FG001|Overall Study|Lack of Efficacy|0|||
131499295|NCT01499667|473457447|FG002|Overall Study|Lack of Efficacy|0|||
131499296|NCT02902965|473457448|FG000|Overall Study|Withdrawal by Subject|10|||
131499297|NCT02673489|473457449|FG000|Treatment Period|Lost to Follow-up|3|||
131499298|NCT02673489|473457450|FG001|Treatment Period|Lost to Follow-up|0|||
131499299|NCT02673489|473457449|FG000|Treatment Period|Participant request to discontinue|1|||
131499300|NCT02673489|473457450|FG001|Treatment Period|Participant request to discontinue|1|||
131499301|NCT02673489|473457449|FG000|Treatment Period|Participant moved to another province|1|||
131499302|NCT02673489|473457450|FG001|Treatment Period|Participant moved to another province|0|||
131499303|NCT02673489|473457449|FG000|Treatment Period|Participant was incarcerated|0|||
131499304|NCT02673489|473457450|FG001|Treatment Period|Participant was incarcerated|1|||
131499305|NCT02673489|473457449|FG000|Treatment Period|Adverse Event|0|||
131499306|NCT02673489|473457450|FG001|Treatment Period|Adverse Event|1|||
131499307|NCT02673489|473457449|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
131499308|NCT02673489|473457450|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
131499309|NCT02673489|473457449|FG000|Follow Up Period|Unable to return for follow-up|0|||
131499310|NCT02673489|473457450|FG001|Follow Up Period|Unable to return for follow-up|1|||
131499311|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
131499312|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
131499313|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
131499314|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
131499315|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
131499316|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
131499317|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
131499318|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
131499319|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
131499320|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
131499321|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
131499322|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
131499323|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
131499324|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
131499325|NCT00293254|473457451|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
131499326|NCT00293254|473457452|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
131499327|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
131499328|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
131499329|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Death|4|||
131499330|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Death|1|||
131499331|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
131499332|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
131499333|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
131499334|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
131499335|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
131499336|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
131499337|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
131499338|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
131499339|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
131499340|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
131499341|NCT00293254|473457451|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
131499342|NCT00293254|473457452|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
131499343|NCT00293254|473457451|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
131499344|NCT00293254|473457452|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
131499345|NCT00293254|473457451|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
131499346|NCT00293254|473457452|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
131499347|NCT00293254|473457451|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
131499348|NCT00293254|473457452|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
131499349|NCT00293254|473457451|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
131499350|NCT00293254|473457452|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
131499351|NCT00293254|473457451|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
131499352|NCT00293254|473457452|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
131499353|NCT00293254|473457451|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
131499354|NCT00293254|473457452|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
131499355|NCT00293254|473457451|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
131499356|NCT00293254|473457452|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
131499357|NCT00293254|473457451|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
131499358|NCT00293254|473457452|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
131499359|NCT00293254|473457451|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
131499360|NCT00293254|473457452|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
131499361|NCT00293254|473457451|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
131499362|NCT00293254|473457452|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
131499363|NCT00293254|473457451|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
131499364|NCT00293254|473457452|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
131499365|NCT02335489|473457453|FG000|Overall Study|Sponsor terminated study|4|||
131499366|NCT02335489|473457453|FG000|Overall Study|Lost to Follow-up|1|||
131499367|NCT02335489|473457453|FG000|Overall Study|Withdrawal by Subject|2|||
131499368|NCT02335489|473457453|FG000|Overall Study|Physician Decision|2|||
131499369|NCT02335489|473457453|FG000|Overall Study|Lack of Efficacy|1|||
131499370|NCT00503308|473457454|FG000|Overall Study|Protocol Violation|2|||
131499371|NCT00503308|473457455|FG001|Overall Study|Protocol Violation|1|||
131499372|NCT00531050|473457456|FG000|Part 1: Period 1|Adverse Event|0|||
131499373|NCT00531050|473457457|FG001|Part 1: Period 1|Adverse Event|1|||
131499374|NCT00531050|473457458|FG002|Part 1: Period 1|Adverse Event|0|||
131499375|NCT00531050|473457459|FG003|Part 1: Period 1|Adverse Event|0|||
131499376|NCT00531050|473457460|FG004|Part 1: Period 1|Adverse Event|0|||
131499377|NCT00531050|473457461|FG005|Part 1: Period 1|Adverse Event|0|||
131499378|NCT00531050|473457456|FG000|Part 1: Period 1|Protocol Deviation|0|||
131499379|NCT00531050|473457457|FG001|Part 1: Period 1|Protocol Deviation|0|||
131499380|NCT00531050|473457458|FG002|Part 1: Period 1|Protocol Deviation|0|||
131499381|NCT00531050|473457459|FG003|Part 1: Period 1|Protocol Deviation|1|||
131499382|NCT00531050|473457460|FG004|Part 1: Period 1|Protocol Deviation|0|||
131499383|NCT00531050|473457461|FG005|Part 1: Period 1|Protocol Deviation|0|||
131499384|NCT00531050|473457456|FG000|Part 1: Period 3|Adverse Event|1|||
131499385|NCT00531050|473457457|FG001|Part 1: Period 3|Adverse Event|0|||
131499386|NCT00531050|473457458|FG002|Part 1: Period 3|Adverse Event|0|||
131499387|NCT00531050|473457459|FG003|Part 1: Period 3|Adverse Event|0|||
131499388|NCT00531050|473457460|FG004|Part 1: Period 3|Adverse Event|0|||
131499389|NCT00531050|473457461|FG005|Part 1: Period 3|Adverse Event|0|||
131499390|NCT00531050|473457456|FG000|Part 2: Period 1|Adverse Event|0|||
131499391|NCT00531050|473457457|FG001|Part 2: Period 1|Adverse Event|0|||
131499392|NCT00531050|473457458|FG002|Part 2: Period 1|Adverse Event|0|||
131499393|NCT00531050|473457459|FG003|Part 2: Period 1|Adverse Event|0|||
131499394|NCT00531050|473457460|FG004|Part 2: Period 1|Adverse Event|0|||
131499395|NCT00531050|473457461|FG005|Part 2: Period 1|Adverse Event|1|||
131499396|NCT00531050|473457456|FG000|Part 2: Period 3|Abnormal test procedure|1|||
131499397|NCT00531050|473457457|FG001|Part 2: Period 3|Abnormal test procedure|0|||
131499398|NCT00531050|473457458|FG002|Part 2: Period 3|Abnormal test procedure|0|||
131499399|NCT00531050|473457459|FG003|Part 2: Period 3|Abnormal test procedure|0|||
131499400|NCT00531050|473457460|FG004|Part 2: Period 3|Abnormal test procedure|0|||
131499401|NCT00531050|473457461|FG005|Part 2: Period 3|Abnormal test procedure|1|||
131499402|NCT02233309|473457462|FG000|Overall Study|Physician Decision|5|||
131499403|NCT00799487|473457465|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
131499404|NCT00799487|473457466|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
131499405|NCT00799487|473457467|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
131499406|NCT00799487|473457465|FG000|Dose Adjustment Period|Adverse Event|2|||
131499407|NCT00799487|473457466|FG001|Dose Adjustment Period|Adverse Event|0|||
131499408|NCT00799487|473457467|FG002|Dose Adjustment Period|Adverse Event|0|||
131499409|NCT00799487|473457465|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
131499410|NCT00799487|473457466|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
131499411|NCT00799487|473457467|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
131499412|NCT00799487|473457465|FG000|Dose Adjustment Period|Investigator Discretion|2|||
131499413|NCT00799487|473457466|FG001|Dose Adjustment Period|Investigator Discretion|0|||
131499414|NCT00799487|473457467|FG002|Dose Adjustment Period|Investigator Discretion|0|||
131499415|NCT00799487|473457465|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
131499416|NCT00799487|473457466|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
131499417|NCT00799487|473457467|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
131499418|NCT00799487|473457465|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
131499419|NCT00799487|473457466|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
131499420|NCT00799487|473457467|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
131499421|NCT00799487|473457465|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
131499422|NCT00799487|473457466|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
131499423|NCT00799487|473457467|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
131499424|NCT00799487|473457465|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
131499425|NCT00799487|473457466|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
131499426|NCT00799487|473457467|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
131499427|NCT00799487|473457465|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
131499428|NCT00799487|473457466|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
131499429|NCT00799487|473457467|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
131499430|NCT00799487|473457465|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
131499431|NCT00799487|473457466|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
131499432|NCT00799487|473457467|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
131499433|NCT00799487|473457465|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
131499434|NCT00799487|473457466|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
131499435|NCT00799487|473457467|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
131499436|NCT00799487|473457465|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
131499437|NCT00799487|473457466|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
131499438|NCT00799487|473457467|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
131499439|NCT04481750|473457468|FG000|Period 1 (Fasted)|Adverse Event|0|||
131499440|NCT04481750|473457469|FG001|Period 1 (Fasted)|Adverse Event|0|||
131499441|NCT04481750|473457470|FG002|Period 1 (Fasted)|Adverse Event|1|||
131499442|NCT04481750|473457471|FG003|Period 1 (Fasted)|Adverse Event|0|||
131499443|NCT04481750|473457472|FG004|Period 1 (Fasted)|Adverse Event|0|||
131499444|NCT04481750|473457473|FG005|Period 1 (Fasted)|Adverse Event|0|||
131499445|NCT04481750|473457474|FG006|Period 1 (Fasted)|Adverse Event|0|||
131499446|NCT04481750|473457475|FG007|Period 1 (Fasted)|Adverse Event|0|||
131499447|NCT04481750|473457476|FG008|Period 1 (Fasted)|Adverse Event|0|||
131499448|NCT04481750|473457477|FG009|Period 1 (Fasted)|Adverse Event|0|||
131499449|NCT04481750|473457478|FG010|Period 1 (Fasted)|Adverse Event|0|||
131499450|NCT03263442|473457479|FG000|Inpatient Phase|Death|1|||
131499451|NCT03263442|473457480|FG001|Inpatient Phase|Death|0|||
131499452|NCT03263442|473457479|FG000|Inpatient Phase|Withdrawal by Subject|1|||
131499453|NCT03263442|473457480|FG001|Inpatient Phase|Withdrawal by Subject|0|||
131499454|NCT03263442|473457479|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
131499455|NCT03263442|473457480|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
131499456|NCT03263442|473457479|FG000|1-month Follow-Up|Lost to Follow-up|1|||
131499457|NCT03263442|473457480|FG001|1-month Follow-Up|Lost to Follow-up|0|||
131499458|NCT03263442|473457479|FG000|3-month Follow-Up|Lost to Follow-up|1|||
131499459|NCT03263442|473457480|FG001|3-month Follow-Up|Lost to Follow-up|3|||
131499460|NCT03263442|473457479|FG000|6-month Follow-Up|Lost to Follow-up|2|||
131499461|NCT03263442|473457480|FG001|6-month Follow-Up|Lost to Follow-up|2|||
131499462|NCT03804879|473457481|FG000|Overall Study|Adverse Event|3|||
131499463|NCT03804879|473457482|FG001|Overall Study|Adverse Event|0|||
131499464|NCT03804879|473457481|FG000|Overall Study|Study Terminated By Sponsor|10|||
131499465|NCT03804879|473457482|FG001|Overall Study|Study Terminated By Sponsor|12|||
131499466|NCT03804879|473457481|FG000|Overall Study|Withdrawal by Subject|3|||
131499467|NCT03804879|473457482|FG001|Overall Study|Withdrawal by Subject|1|||
131499468|NCT01084174|473457483|FG000|Overall Study|gastrointestinal symptoms|1|||
131499469|NCT01084174|473457484|FG001|Overall Study|gastrointestinal symptoms|1|||
131499470|NCT01084174|473457483|FG000|Overall Study|Eosinophilic esophagitis|0|||
131499471|NCT01084174|473457484|FG001|Overall Study|Eosinophilic esophagitis|1|||
131499472|NCT01084174|473457483|FG000|Overall Study|Anaphylaxis|0|||
131499473|NCT01084174|473457484|FG001|Overall Study|Anaphylaxis|1|||
131499474|NCT01084174|473457483|FG000|Overall Study|Participant noncompliance|0|||
131499475|NCT01084174|473457484|FG001|Overall Study|Participant noncompliance|1|||
131499476|NCT01034462|473457485|FG000|Overall Study|Adverse Event|7|||
131499477|NCT01034462|473457486|FG001|Overall Study|Adverse Event|17|||
131499478|NCT01034462|473457485|FG000|Overall Study|Lack of Efficacy|4|||
131499479|NCT01034462|473457486|FG001|Overall Study|Lack of Efficacy|4|||
131499480|NCT01034462|473457485|FG000|Overall Study|Protocol Violation|10|||
131499481|NCT01034462|473457486|FG001|Overall Study|Protocol Violation|7|||
131499482|NCT01034462|473457485|FG000|Overall Study|Withdrawal by Subject|9|||
131499483|NCT01034462|473457486|FG001|Overall Study|Withdrawal by Subject|8|||
131499484|NCT01034462|473457485|FG000|Overall Study|Lost to Follow-up|14|||
131499485|NCT01034462|473457486|FG001|Overall Study|Lost to Follow-up|16|||
131499486|NCT01034462|473457485|FG000|Overall Study|Other reasons|1|||
131499487|NCT01034462|473457486|FG001|Overall Study|Other reasons|2|||
131499488|NCT01484873|473457487|FG000|Overall Study|Withdrawal by Subject|2|||
131499489|NCT02564042|473457488|FG000|Overall Study|Adverse Event|4|||
131499490|NCT02564042|473457489|FG001|Overall Study|Adverse Event|4|||
131499491|NCT02564042|473457490|FG002|Overall Study|Adverse Event|3|||
131499492|NCT02564042|473457491|FG003|Overall Study|Adverse Event|0|||
131499493|NCT02564042|473457492|FG004|Overall Study|Adverse Event|0|||
131499494|NCT02564042|473457493|FG005|Overall Study|Adverse Event|1|||
131499495|NCT02564042|473457488|FG000|Overall Study|Lost to Follow-up|1|||
131499496|NCT02564042|473457489|FG001|Overall Study|Lost to Follow-up|1|||
131499497|NCT02564042|473457490|FG002|Overall Study|Lost to Follow-up|1|||
131499498|NCT02564042|473457491|FG003|Overall Study|Lost to Follow-up|0|||
131499499|NCT02564042|473457492|FG004|Overall Study|Lost to Follow-up|1|||
131499500|NCT02564042|473457493|FG005|Overall Study|Lost to Follow-up|1|||
131499501|NCT02564042|473457488|FG000|Overall Study|Physician Decision|1|||
131499502|NCT02564042|473457489|FG001|Overall Study|Physician Decision|0|||
131499503|NCT02564042|473457490|FG002|Overall Study|Physician Decision|0|||
131499504|NCT02564042|473457491|FG003|Overall Study|Physician Decision|1|||
131499505|NCT02564042|473457492|FG004|Overall Study|Physician Decision|0|||
131499506|NCT02564042|473457493|FG005|Overall Study|Physician Decision|0|||
131499507|NCT02564042|473457488|FG000|Overall Study|Withdrawal by Subject|5|||
131499508|NCT02564042|473457489|FG001|Overall Study|Withdrawal by Subject|3|||
131499509|NCT02564042|473457490|FG002|Overall Study|Withdrawal by Subject|2|||
131499510|NCT02564042|473457491|FG003|Overall Study|Withdrawal by Subject|2|||
131499511|NCT02564042|473457492|FG004|Overall Study|Withdrawal by Subject|10|||
131499512|NCT02564042|473457493|FG005|Overall Study|Withdrawal by Subject|12|||
131499513|NCT01356966|473457494|FG000|Overall Study|Withdrawal by Subject|1|||
131499514|NCT01356966|473457495|FG001|Overall Study|Withdrawal by Subject|2|||
131499515|NCT01356966|473457494|FG000|Overall Study|Physician Decision|1|||
131499516|NCT01356966|473457495|FG001|Overall Study|Physician Decision|0|||
131499517|NCT01549392|473457496|FG000|Overall Study|Withdrawal by Subject|1|||
131499518|NCT01549392|473457497|FG001|Overall Study|Withdrawal by Subject|0|||
131499519|NCT02743806|473457498|FG000|Overall Study|Adverse Event|9|||
131499520|NCT02743806|473457498|FG000|Overall Study|Lost to Follow-up|8|||
131499521|NCT02743806|473457498|FG000|Overall Study|Voluntary Withdrawal|54|||
131499522|NCT02743806|473457498|FG000|Overall Study|Study Termination|65|||
131499523|NCT02743806|473457498|FG000|Overall Study|Pregnancy|6|||
131499524|NCT02743806|473457498|FG000|Overall Study|No Longer Clinically Benefiting|27|||
131499525|NCT02743806|473457498|FG000|Overall Study|Reason Not Specified|12|||
131499526|NCT01988103|473457500|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
131499527|NCT01988103|473457501|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
131499528|NCT01988103|473457502|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
131499529|NCT01988103|473457503|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
131499530|NCT01988103|473457504|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
131499531|NCT01988103|473457500|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
131499532|NCT01988103|473457501|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
131499533|NCT01988103|473457502|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
131499534|NCT01988103|473457503|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
131499535|NCT01988103|473457504|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
131499536|NCT01988103|473457500|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
131499537|NCT01988103|473457501|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
131499538|NCT01988103|473457502|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
131499539|NCT01988103|473457503|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
131499540|NCT01988103|473457504|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
131499541|NCT01988103|473457500|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
131499542|NCT01988103|473457501|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
131499543|NCT01988103|473457502|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
131499544|NCT01988103|473457503|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
131499545|NCT01988103|473457504|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
131499546|NCT01988103|473457500|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
131499547|NCT01988103|473457501|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
131499548|NCT01988103|473457502|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
131499549|NCT01988103|473457503|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
131499550|NCT01988103|473457504|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
131499551|NCT01988103|473457500|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
131499552|NCT01988103|473457501|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
131499553|NCT01988103|473457502|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
131499554|NCT01988103|473457503|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
131499555|NCT01988103|473457504|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
131499556|NCT01988103|473457500|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
131499557|NCT01988103|473457501|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
131499558|NCT01988103|473457502|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
131499559|NCT01988103|473457503|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
131499560|NCT01988103|473457504|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
131499561|NCT00311623|473457508|FG000|Overall Study|Physician Decision|0|||
131499562|NCT00311623|473457509|FG001|Overall Study|Physician Decision|0|||
131499563|NCT00311623|473457510|FG002|Overall Study|Physician Decision|2|||
131499564|NCT02485574|473457527|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
131499565|NCT00255047|473457528|FG000|Overall Study|Serious Adverse Events|2|||
131499566|NCT00255047|473457529|FG001|Overall Study|Serious Adverse Events|1|||
131499567|NCT00255047|473457530|FG002|Overall Study|Serious Adverse Events|2|||
131499568|NCT00255047|473457531|FG003|Overall Study|Serious Adverse Events|1|||
131499569|NCT00255047|473457528|FG000|Overall Study|Adverse Event|0|||
131499570|NCT00255047|473457529|FG001|Overall Study|Adverse Event|3|||
131499571|NCT00255047|473457530|FG002|Overall Study|Adverse Event|2|||
131499572|NCT00255047|473457531|FG003|Overall Study|Adverse Event|1|||
131499573|NCT00255047|473457528|FG000|Overall Study|Protocol Violation|13|||
131499574|NCT00255047|473457529|FG001|Overall Study|Protocol Violation|13|||
131499575|NCT00255047|473457530|FG002|Overall Study|Protocol Violation|16|||
131499576|NCT00255047|473457531|FG003|Overall Study|Protocol Violation|20|||
131499577|NCT00255047|473457528|FG000|Overall Study|Lost to Follow-up|9|||
131499578|NCT00255047|473457529|FG001|Overall Study|Lost to Follow-up|8|||
131499579|NCT00255047|473457530|FG002|Overall Study|Lost to Follow-up|5|||
131499580|NCT00255047|473457531|FG003|Overall Study|Lost to Follow-up|6|||
131499581|NCT00255047|473457528|FG000|Overall Study|Withdrawal by Subject|24|||
131499582|NCT00255047|473457529|FG001|Overall Study|Withdrawal by Subject|23|||
131499583|NCT00255047|473457530|FG002|Overall Study|Withdrawal by Subject|25|||
131499584|NCT00255047|473457531|FG003|Overall Study|Withdrawal by Subject|18|||
131499585|NCT00811473|473457532|FG000|Overall Study|Adverse Event|3|||
131499586|NCT00811473|473457533|FG001|Overall Study|Adverse Event|12|||
131499587|NCT00811473|473457532|FG000|Overall Study|Lost to Follow-up|5|||
131499588|NCT00811473|473457533|FG001|Overall Study|Lost to Follow-up|1|||
131499589|NCT00811473|473457532|FG000|Overall Study|Withdrawal by Subject|2|||
131499590|NCT00811473|473457533|FG001|Overall Study|Withdrawal by Subject|4|||
131499591|NCT00811473|473457532|FG000|Overall Study|Severe non-compliance to protocol|2|||
131499592|NCT00811473|473457533|FG001|Overall Study|Severe non-compliance to protocol|4|||
131499593|NCT00811473|473457532|FG000|Overall Study|Lack of therapeutic response|4|||
131499594|NCT00811473|473457533|FG001|Overall Study|Lack of therapeutic response|1|||
131499595|NCT00811473|473457532|FG000|Overall Study|Condition under investigation worsened|1|||
131499596|NCT00811473|473457533|FG001|Overall Study|Condition under investigation worsened|3|||
131499597|NCT00811473|473457532|FG000|Overall Study|Other 2|4|||
131499598|NCT00811473|473457533|FG001|Overall Study|Other 2|1|||
131499599|NCT00811473|473457532|FG000|Overall Study|Incorrect Enrollment|1|||
131499600|NCT00811473|473457533|FG001|Overall Study|Incorrect Enrollment|0|||
131499601|NCT00811473|473457532|FG000|Overall Study|Safety Reasons|1|||
131499602|NCT00811473|473457533|FG001|Overall Study|Safety Reasons|0|||
131499603|NCT00667368|473457534|FG000|Overall Study|Lost to Follow-up|176|||
131499604|NCT00667368|473457535|FG001|Overall Study|Lost to Follow-up|155|||
131499605|NCT00667368|473457534|FG000|Overall Study|Discontinued early|24|||
131499606|NCT00667368|473457535|FG001|Overall Study|Discontinued early|17|||
131499607|NCT00748033|473457538|FG000|Overall Study|Adverse Event|0|||
131499608|NCT00748033|473457539|FG001|Overall Study|Adverse Event|1|||
131499609|NCT00191789|473457542|FG000|Overall Study|Adverse Event|5|||
131499610|NCT00191789|473457542|FG000|Overall Study|Patient: Satisfactory Response|5|||
131499611|NCT00191789|473457542|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
131499612|NCT00191789|473457542|FG000|Overall Study|Withdrawal by Subject|4|||
131499613|NCT00191789|473457542|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
131499614|NCT00191789|473457542|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
131499615|NCT00191789|473457542|FG000|Overall Study|Death - Not Study-Drug Related|1|||
131499616|NCT01922089|473457543|FG000|Overall Study|Adverse Event|18|||
131499617|NCT01922089|473457544|FG001|Overall Study|Adverse Event|13|||
131499618|NCT01922089|473457543|FG000|Overall Study|Protocol Deviation|10|||
131499619|NCT01922089|473457544|FG001|Overall Study|Protocol Deviation|7|||
131499620|NCT01922089|473457543|FG000|Overall Study|Withdrawal by Subject|3|||
131499621|NCT01922089|473457544|FG001|Overall Study|Withdrawal by Subject|4|||
131499622|NCT01922089|473457543|FG000|Overall Study|administrative problems|4|||
131499623|NCT01922089|473457544|FG001|Overall Study|administrative problems|1|||
131499624|NCT01922089|473457543|FG000|Overall Study|Physician Decision|2|||
131499625|NCT01922089|473457544|FG001|Overall Study|Physician Decision|3|||
131499626|NCT01922089|473457543|FG000|Overall Study|Death|2|||
131499627|NCT01922089|473457544|FG001|Overall Study|Death|1|||
131499628|NCT01922089|473457543|FG000|Overall Study|Lost to Follow-up|0|||
131499629|NCT01922089|473457544|FG001|Overall Study|Lost to Follow-up|1|||
131499630|NCT04903626|473457548|FG000|Overall Study|Lost to Follow-up|6|||
131499631|NCT04903626|473457548|FG000|Overall Study|Withdrawal by Subject|1|||
131499632|NCT04903626|473457548|FG000|Overall Study|Other, Not Specified|1|||
131499633|NCT03060629|473457549|FG000|Overall Study|Death|4|||
131499634|NCT03060629|473457550|FG001|Overall Study|Death|5|||
131499635|NCT03060629|473457549|FG000|Overall Study|Withdrawal by Subject|50|||
131499636|NCT03060629|473457550|FG001|Overall Study|Withdrawal by Subject|35|||
131499637|NCT03060629|473457549|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
131499638|NCT03060629|473457550|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
131499639|NCT03060629|473457549|FG000|Overall Study|Participant Relocate|15|||
131499640|NCT03060629|473457550|FG001|Overall Study|Participant Relocate|15|||
131499641|NCT03060629|473457549|FG000|Overall Study|Unable to Contact Participant|34|||
131499642|NCT03060629|473457550|FG001|Overall Study|Unable to Contact Participant|23|||
131499643|NCT03060629|473457549|FG000|Overall Study|Investigator Decision|7|||
131499644|NCT03060629|473457550|FG001|Overall Study|Investigator Decision|7|||
131499645|NCT03060629|473457549|FG000|Overall Study|Study Terminated by Sponsor|1100|||
131499646|NCT03060629|473457550|FG001|Overall Study|Study Terminated by Sponsor|1123|||
131499647|NCT03060629|473457549|FG000|Overall Study|Other|4|||
131499648|NCT03060629|473457550|FG001|Overall Study|Other|4|||
131499649|NCT01405742|473457554|FG000|Overall Study|Lost to Follow-up|1|||
131499650|NCT01405742|473457555|FG001|Overall Study|Lost to Follow-up|0|||
131499651|NCT00165776|473457557|FG000|Overall Study|Lack of Efficacy|0|||
131499652|NCT00165776|473457558|FG001|Overall Study|Lack of Efficacy|0|||
131499653|NCT00165776|473457559|FG002|Overall Study|Lack of Efficacy|0|||
131499654|NCT00165776|473457560|FG003|Overall Study|Lack of Efficacy|1|||
131499655|NCT00165776|473457557|FG000|Overall Study|Withdrawal by Subject|4|||
131499656|NCT00165776|473457558|FG001|Overall Study|Withdrawal by Subject|1|||
131499657|NCT00165776|473457559|FG002|Overall Study|Withdrawal by Subject|2|||
131499658|NCT00165776|473457560|FG003|Overall Study|Withdrawal by Subject|0|||
131499659|NCT00165776|473457557|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
131499660|NCT00165776|473457558|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
131499661|NCT00165776|473457559|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
131499662|NCT00165776|473457560|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
131499663|NCT02622321|473457563|FG000|Overall Study|Withdrawal by Subject|2|||
131499664|NCT02622321|473457564|FG001|Overall Study|Withdrawal by Subject|0|||
131499665|NCT02622321|473457565|FG002|Overall Study|Withdrawal by Subject|0|||
131499666|NCT02622321|473457566|FG003|Overall Study|Withdrawal by Subject|0|||
131499667|NCT02622321|473457563|FG000|Overall Study|Death|0|||
131499668|NCT02622321|473457564|FG001|Overall Study|Death|0|||
131499669|NCT02622321|473457565|FG002|Overall Study|Death|1|||
131499670|NCT02622321|473457566|FG003|Overall Study|Death|0|||
131499671|NCT02622321|473457563|FG000|Overall Study|Physician Decision|1|||
131499672|NCT02622321|473457564|FG001|Overall Study|Physician Decision|0|||
131499673|NCT02622321|473457565|FG002|Overall Study|Physician Decision|0|||
131499674|NCT02622321|473457566|FG003|Overall Study|Physician Decision|0|||
131499675|NCT00241280|473457568|FG000|Overall Study|Adverse Event|2|||
131499676|NCT00241280|473457569|FG001|Overall Study|Adverse Event|6|||
131499677|NCT00241280|473457568|FG000|Overall Study|Discomfort|11|||
131499678|NCT00241280|473457569|FG001|Overall Study|Discomfort|16|||
131499679|NCT00241280|473457568|FG000|Overall Study|Pregnancy|1|||
131499680|NCT00241280|473457569|FG001|Overall Study|Pregnancy|5|||
131499681|NCT00241280|473457568|FG000|Overall Study|Lost to Follow-up|5|||
131499682|NCT00241280|473457569|FG001|Overall Study|Lost to Follow-up|8|||
131499683|NCT00241280|473457568|FG000|Overall Study|Withdrawal by Subject|7|||
131499684|NCT00241280|473457569|FG001|Overall Study|Withdrawal by Subject|4|||
131499685|NCT00241280|473457568|FG000|Overall Study|Protocol Violation|4|||
131499686|NCT00241280|473457569|FG001|Overall Study|Protocol Violation|10|||
131499687|NCT00241280|473457568|FG000|Overall Study|Relocation|4|||
131499688|NCT00241280|473457569|FG001|Overall Study|Relocation|4|||
131499689|NCT00241280|473457568|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
131499690|NCT00241280|473457569|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
131499691|NCT00241280|473457568|FG000|Overall Study|Unsatisfactory Visual Response|1|||
131499692|NCT00241280|473457569|FG001|Overall Study|Unsatisfactory Visual Response|1|||
131499693|NCT00241280|473457568|FG000|Overall Study|Diabetic|1|||
131499694|NCT00241280|473457569|FG001|Overall Study|Diabetic|0|||
131499695|NCT00241280|473457568|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
131499696|NCT00241280|473457569|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
131499697|NCT00241280|473457568|FG000|Overall Study|Dispensed incorrect test article|1|||
131499698|NCT00241280|473457569|FG001|Overall Study|Dispensed incorrect test article|2|||
131499699|NCT00241280|473457568|FG000|Overall Study|Unacceptable Fit|0|||
131499700|NCT00241280|473457569|FG001|Overall Study|Unacceptable Fit|1|||
131499701|NCT00241280|473457568|FG000|Overall Study|Scheduling Conflict|0|||
131499702|NCT00241280|473457569|FG001|Overall Study|Scheduling Conflict|2|||
131499703|NCT00241280|473457568|FG000|Overall Study|History of Ocular Surgery|0|||
131499704|NCT00241280|473457569|FG001|Overall Study|History of Ocular Surgery|1|||
131499705|NCT00241280|473457568|FG000|Overall Study|Coating on Lens|1|||
131499706|NCT00241280|473457569|FG001|Overall Study|Coating on Lens|0|||
131499707|NCT00241280|473457568|FG000|Overall Study|Excessive Dryness|0|||
131499708|NCT00241280|473457569|FG001|Overall Study|Excessive Dryness|1|||
131499709|NCT00965718|473457571|FG000|Overall Study|Withdrawal by Subject|4|||
131499710|NCT02260921|473457572|FG000|Overall Study|Adverse Event|1|||
131499711|NCT02260921|473457573|FG001|Overall Study|Adverse Event|0|||
131499712|NCT02260921|473457572|FG000|Overall Study|Lost to Follow-up|4|||
131499713|NCT02260921|473457573|FG001|Overall Study|Lost to Follow-up|3|||
131499714|NCT02260921|473457572|FG000|Overall Study|Withdraw Consent|4|||
131499715|NCT02260921|473457573|FG001|Overall Study|Withdraw Consent|1|||
131499716|NCT02260921|473457572|FG000|Overall Study|Death|1|||
131499717|NCT02260921|473457573|FG001|Overall Study|Death|0|||
131499718|NCT02260921|473457572|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
131499719|NCT02260921|473457573|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
131499720|NCT00368355|473457574|FG000|Overall Study|Adverse Event|1|||
131499721|NCT00368355|473457575|FG001|Overall Study|Adverse Event|0|||
131499722|NCT00368355|473457574|FG000|Overall Study|Death|2|||
131499723|NCT00368355|473457575|FG001|Overall Study|Death|4|||
131499724|NCT00368355|473457574|FG000|Overall Study|Relapse|6|||
131499725|NCT00368355|473457575|FG001|Overall Study|Relapse|10|||
131499726|NCT00368355|473457574|FG000|Overall Study|Subsequent transplant|0|||
131499727|NCT00368355|473457575|FG001|Overall Study|Subsequent transplant|3|||
131499728|NCT00368355|473457574|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
131499729|NCT00368355|473457575|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
131499730|NCT03032705|473457581|FG000|Overall Study|Lost to Follow-up|16|||
131499731|NCT03032705|473457582|FG001|Overall Study|Lost to Follow-up|17|||
131499732|NCT03032705|473457581|FG000|Overall Study|did not quality|6|||
131499733|NCT03032705|473457582|FG001|Overall Study|did not quality|6|||
131499734|NCT02759471|473457583|FG000|Overall Study|discomfort|2|||
131499735|NCT00001596|473459367|FG000|Overall Study|Death|1|||
131499736|NCT00001596|473459368|FG001|Overall Study|Death|0|||
131499737|NCT00001596|473459367|FG000|Overall Study|Withdrawal by Subject|3|||
131499738|NCT00001596|473459368|FG001|Overall Study|Withdrawal by Subject|1|||
131499739|NCT00001596|473459367|FG000|Overall Study|Study Termination|12|||
131499740|NCT00001596|473459368|FG001|Overall Study|Study Termination|9|||
131499741|NCT00001596|473459367|FG000|Overall Study|Adverse Event|1|||
131499742|NCT00001596|473459368|FG001|Overall Study|Adverse Event|0|||
131499743|NCT04067544|473459369|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
131499744|NCT02282020|473459372|FG000|Overall Study|Objective Disease Progression|128|||
131499745|NCT02282020|473459373|FG001|Overall Study|Objective Disease Progression|30|||
131499746|NCT02282020|473459372|FG000|Overall Study|Adverse Event|18|||
131499747|NCT02282020|473459373|FG001|Overall Study|Adverse Event|15|||
131499748|NCT02282020|473459372|FG000|Overall Study|Withdrawal by Subject|7|||
131499749|NCT02282020|473459373|FG001|Overall Study|Withdrawal by Subject|10|||
131499750|NCT02282020|473459372|FG000|Overall Study|Miscellaneous|5|||
131499751|NCT02282020|473459373|FG001|Overall Study|Miscellaneous|19|||
131499752|NCT02282020|473459372|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
131499753|NCT02282020|473459373|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
131499754|NCT02282020|473459372|FG000|Overall Study|Developed Discontinuation Criteria|0|||
131499755|NCT02282020|473459373|FG001|Overall Study|Developed Discontinuation Criteria|2|||
131499756|NCT02282020|473459372|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
131499757|NCT02282020|473459373|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
131499758|NCT00082355|473459374|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
131499759|NCT00082355|473459374|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
131499760|NCT00082355|473459374|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
131499761|NCT02259582|473459375|FG000|Overall Study|Physician Decision|0|||
131499762|NCT02259582|473459376|FG001|Overall Study|Physician Decision|1|||
131499763|NCT02259582|473459377|FG002|Overall Study|Physician Decision|0|||
131499764|NCT02259582|473459375|FG000|Overall Study|Death|0|||
131499765|NCT02259582|473459376|FG001|Overall Study|Death|0|||
131499766|NCT02259582|473459377|FG002|Overall Study|Death|1|||
131499767|NCT02259582|473459375|FG000|Overall Study|Adverse Event|1|||
131499768|NCT02259582|473459376|FG001|Overall Study|Adverse Event|0|||
131499769|NCT02259582|473459377|FG002|Overall Study|Adverse Event|1|||
131499770|NCT02259582|473459375|FG000|Overall Study|Withdrawal by Subject|0|||
131499771|NCT02259582|473459376|FG001|Overall Study|Withdrawal by Subject|0|||
131499772|NCT02259582|473459377|FG002|Overall Study|Withdrawal by Subject|1|||
131499773|NCT02259582|473459375|FG000|Overall Study|Disease progression|14|||
131499774|NCT02259582|473459376|FG001|Overall Study|Disease progression|15|||
131499775|NCT02259582|473459377|FG002|Overall Study|Disease progression|17|||
131499776|NCT02259582|473459375|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
131499777|NCT02259582|473459376|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
131499778|NCT02259582|473459377|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
131499779|NCT00759863|473459379|FG000|Overall Study|Death, moved, or lost contact|20|||
131499780|NCT00759863|473459380|FG001|Overall Study|Death, moved, or lost contact|18|||
131499781|NCT00475176|473459386|FG000|Overall Study|Adverse Event|2|||
131499782|NCT00475176|473459386|FG000|Overall Study|Withdrawal by Subject|1|||
131499783|NCT00475176|473459386|FG000|Overall Study|Protocol Violation|1|||
131499784|NCT01585428|473459387|FG000|Overall Study|Death during treatment|1|||
131499785|NCT01585428|473459388|FG001|Overall Study|Death during treatment|0|||
131499786|NCT04273217|473459391|FG000|Overall Study|Lost to Follow-up|0|||
131499787|NCT04273217|473459392|FG001|Overall Study|Lost to Follow-up|0|||
131499788|NCT04273217|473459393|FG002|Overall Study|Lost to Follow-up|0|||
131499789|NCT04273217|473459394|FG003|Overall Study|Lost to Follow-up|0|||
131499790|NCT04273217|473459395|FG004|Overall Study|Lost to Follow-up|0|||
131499791|NCT04273217|473459396|FG005|Overall Study|Lost to Follow-up|1|||
131499792|NCT04273217|473459391|FG000|Overall Study|Participant non-compliance|0|||
131499793|NCT04273217|473459392|FG001|Overall Study|Participant non-compliance|0|||
131499794|NCT04273217|473459393|FG002|Overall Study|Participant non-compliance|0|||
131499795|NCT04273217|473459394|FG003|Overall Study|Participant non-compliance|0|||
131499796|NCT04273217|473459395|FG004|Overall Study|Participant non-compliance|1|||
131499797|NCT04273217|473459396|FG005|Overall Study|Participant non-compliance|0|||
131499798|NCT04273217|473459391|FG000|Overall Study|Positive urine drug screen|1|||
131499799|NCT04273217|473459392|FG001|Overall Study|Positive urine drug screen|0|||
131499800|NCT04273217|473459393|FG002|Overall Study|Positive urine drug screen|1|||
131499801|NCT04273217|473459394|FG003|Overall Study|Positive urine drug screen|0|||
131499802|NCT04273217|473459395|FG004|Overall Study|Positive urine drug screen|0|||
131499803|NCT04273217|473459396|FG005|Overall Study|Positive urine drug screen|1|||
131499804|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
131499805|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
131499806|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
131499807|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
131499808|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
131499809|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
131499810|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
131499811|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
131499812|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Other|4|||
131499813|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Other|1|||
131499814|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
131499815|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
131499816|NCT00303498|473459399|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
131499817|NCT00303498|473459400|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
131499818|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
131499819|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
131499820|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Death|1|||
131499821|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Death|0|||
131499822|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
131499823|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
131499824|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
131499825|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
131499826|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
131499827|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
131499828|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
131499829|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
131499830|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Other|1|||
131499831|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Other|0|||
131499832|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
131499833|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
131499834|NCT00303498|473459399|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
131499835|NCT00303498|473459400|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
131499836|NCT04532099|473459401|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
131499837|NCT04532099|473459402|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
131499838|NCT04532099|473459403|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
131499839|NCT00460031|473459404|FG000|Overall Study|Adverse Event|5|||
131499840|NCT00460031|473459404|FG000|Overall Study|Withdrawal by Subject|5|||
131499841|NCT00460031|473459404|FG000|Overall Study|Death|1|||
131499842|NCT00644995|473459414|FG000|Overall Study|Lost to Follow-up|1|||
131499843|NCT00644995|473459415|FG001|Overall Study|Lost to Follow-up|4|||
131499844|NCT00644995|473459414|FG000|Overall Study|Refused|1|||
131499845|NCT00644995|473459415|FG001|Overall Study|Refused|0|||
131499846|NCT03998189|473459424|FG000|Overall Study|Lack of Efficacy|0|||
131499847|NCT03998189|473459425|FG001|Overall Study|Lack of Efficacy|1|||
131499848|NCT03414424|473459426|FG000|Overall Study|Screened out after consent|0|||
131499849|NCT03414424|473459427|FG001|Overall Study|Screened out after consent|2|||
131499850|NCT03414424|473459426|FG000|Overall Study|Lost to Follow-up|0|||
131499851|NCT03414424|473459427|FG001|Overall Study|Lost to Follow-up|1|||
131499852|NCT02746874|473459428|FG000|Overall Study|Withdrawal by Subject|0|||
131499853|NCT02746874|473459429|FG001|Overall Study|Withdrawal by Subject|1|||
131499854|NCT02746874|473459428|FG000|Overall Study|Surgery Date Changed|0|||
131499855|NCT02746874|473459429|FG001|Overall Study|Surgery Date Changed|2|||
131499856|NCT00022633|473459432|FG000|Overall Study|Adverse Event|11|||
131499857|NCT00022633|473459433|FG001|Overall Study|Adverse Event|1|||
131499858|NCT00022633|473459432|FG000|Overall Study|Refusal unrelated to adverse event|1|||
131499859|NCT00022633|473459433|FG001|Overall Study|Refusal unrelated to adverse event|0|||
131499860|NCT00022633|473459432|FG000|Overall Study|Progression/relapse|9|||
131499861|NCT00022633|473459433|FG001|Overall Study|Progression/relapse|2|||
131499862|NCT00022633|473459432|FG000|Overall Study|Death|4|||
131499863|NCT00022633|473459433|FG001|Overall Study|Death|0|||
131499864|NCT00022633|473459432|FG000|Overall Study|Other - not protocol specified|3|||
131499865|NCT00022633|473459433|FG001|Overall Study|Other - not protocol specified|2|||
131499866|NCT00022633|473459432|FG000|Overall Study|Ineligible|4|||
131499867|NCT00022633|473459433|FG001|Overall Study|Ineligible|0|||
131499868|NCT03402386|473459437|FG000|Overall Study|Adverse Event|3|||
131499869|NCT03402386|473459437|FG000|Overall Study|Physician Decision|1|||
131499870|NCT03402386|473459437|FG000|Overall Study|Difficult to control Hb|2|||
131499871|NCT02956486|473459440|FG000|Core Phase|Adverse Event|51|||
131499872|NCT02956486|473459441|FG001|Core Phase|Adverse Event|88|||
131499873|NCT02956486|473459442|FG002|Core Phase|Adverse Event|0|||
131499874|NCT02956486|473459440|FG000|Core Phase|Lost to Follow-up|8|||
131499875|NCT02956486|473459441|FG001|Core Phase|Lost to Follow-up|6|||
131499876|NCT02956486|473459442|FG002|Core Phase|Lost to Follow-up|0|||
131499877|NCT02956486|473459440|FG000|Core Phase|Inadequate therapeutic effect|4|||
131499878|NCT02956486|473459441|FG001|Core Phase|Inadequate therapeutic effect|5|||
131499879|NCT02956486|473459442|FG002|Core Phase|Inadequate therapeutic effect|0|||
131499880|NCT02956486|473459440|FG000|Core Phase|Withdrawal by Subject|101|||
131499881|NCT02956486|473459441|FG001|Core Phase|Withdrawal by Subject|104|||
131499882|NCT02956486|473459442|FG002|Core Phase|Withdrawal by Subject|0|||
131658088|NCT04445987|474032999|FG005|Overall Study|Adverse Event|0|||
131499883|NCT02956486|473459440|FG000|Core Phase|Study terminated by sponsor|888|||
131499884|NCT02956486|473459441|FG001|Core Phase|Study terminated by sponsor|848|||
131499885|NCT02956486|473459442|FG002|Core Phase|Study terminated by sponsor|0|||
131499886|NCT02956486|473459440|FG000|Core Phase|Other|27|||
131499887|NCT02956486|473459441|FG001|Core Phase|Other|18|||
131499888|NCT02956486|473459442|FG002|Core Phase|Other|0|||
131499889|NCT02956486|473459440|FG000|Core Phase|Not treated|0|||
131499890|NCT02956486|473459441|FG001|Core Phase|Not treated|3|||
131499891|NCT02956486|473459442|FG002|Core Phase|Not treated|0|||
131499892|NCT02956486|473459440|FG000|Extension Phase|Adverse Event|0|||
131499893|NCT02956486|473459441|FG001|Extension Phase|Adverse Event|0|||
131499894|NCT02956486|473459442|FG002|Extension Phase|Adverse Event|2|||
131499895|NCT02956486|473459440|FG000|Extension Phase|Study terminated by sponsor|0|||
131499896|NCT02956486|473459441|FG001|Extension Phase|Study terminated by sponsor|0|||
131499897|NCT02956486|473459442|FG002|Extension Phase|Study terminated by sponsor|16|||
131499898|NCT02956486|473459440|FG000|Extension Phase|Not Treated|0|||
131499899|NCT02956486|473459441|FG001|Extension Phase|Not Treated|0|||
131499900|NCT02956486|473459442|FG002|Extension Phase|Not Treated|1|||
131499901|NCT03325075|473459443|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
131499902|NCT03325075|473459444|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
131499903|NCT03325075|473459445|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
131499904|NCT03325075|473459446|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
131499905|NCT03325075|473459443|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
131499906|NCT03325075|473459444|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
131499907|NCT03325075|473459445|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
131499908|NCT03325075|473459446|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
131499909|NCT03325075|473459443|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
131499910|NCT03325075|473459444|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
131499911|NCT03325075|473459445|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
131499912|NCT03325075|473459446|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
131499913|NCT00422591|473459447|FG000|Overall Study|Physician Decision|4|||
131499914|NCT00422591|473459447|FG000|Overall Study|Withdrawal by Subject|2|||
131499915|NCT01408914|473459450|FG000|Overall Study|Could not complete tx in protocol period|5|||
131499916|NCT01408914|473459451|FG001|Overall Study|Could not complete tx in protocol period|5|||
131499917|NCT01408914|473459452|FG002|Overall Study|Could not complete tx in protocol period|6|||
131499918|NCT01408914|473459450|FG000|Overall Study|Lost to Follow-up|4|||
131499919|NCT01408914|473459451|FG001|Overall Study|Lost to Follow-up|1|||
131499920|NCT01408914|473459452|FG002|Overall Study|Lost to Follow-up|2|||
131499921|NCT01408914|473459450|FG000|Overall Study|Physician Decision|1|||
131499922|NCT01408914|473459451|FG001|Overall Study|Physician Decision|1|||
131499923|NCT01408914|473459452|FG002|Overall Study|Physician Decision|0|||
131499924|NCT01408914|473459450|FG000|Overall Study|Withdrawal by Subject|1|||
131499925|NCT01408914|473459451|FG001|Overall Study|Withdrawal by Subject|0|||
131499926|NCT01408914|473459452|FG002|Overall Study|Withdrawal by Subject|1|||
131499927|NCT01408914|473459450|FG000|Overall Study|Moved out of study jurisdiction|1|||
131499928|NCT01408914|473459451|FG001|Overall Study|Moved out of study jurisdiction|1|||
131499929|NCT01408914|473459452|FG002|Overall Study|Moved out of study jurisdiction|0|||
131499930|NCT01408914|473459450|FG000|Overall Study|Late exclusion|0|||
131499931|NCT01408914|473459451|FG001|Overall Study|Late exclusion|3|||
131499932|NCT01408914|473459452|FG002|Overall Study|Late exclusion|3|||
131499933|NCT01408914|473459450|FG000|Overall Study|Change in local TB/HIV norms|0|||
131499934|NCT01408914|473459451|FG001|Overall Study|Change in local TB/HIV norms|1|||
131499935|NCT01408914|473459452|FG002|Overall Study|Change in local TB/HIV norms|1|||
131499936|NCT01585194|473459460|FG000|Overall Study|Withdrawal by Subject|1|||
131499937|NCT01585194|473459460|FG000|Overall Study|Physician Decision|2|||
131499938|NCT01585194|473459460|FG000|Overall Study|Lack of insurance|1|||
131499939|NCT00732615|473459461|FG000|Overall Study|Withdrawal by Subject|3|||
131499940|NCT00732615|473459462|FG001|Overall Study|Withdrawal by Subject|1|||
131499941|NCT00732615|473459461|FG000|Overall Study|Lost to Follow-up|0|||
131499942|NCT00732615|473459462|FG001|Overall Study|Lost to Follow-up|1|||
131499943|NCT00732615|473459461|FG000|Overall Study|Adverse Event|0|||
131499944|NCT00732615|473459462|FG001|Overall Study|Adverse Event|2|||
131499945|NCT00732615|473459461|FG000|Overall Study|Physician Decision|3|||
131499946|NCT00732615|473459462|FG001|Overall Study|Physician Decision|0|||
131499947|NCT00732615|473459461|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
131499948|NCT00732615|473459462|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
131499949|NCT01333059|473459463|FG000|Overall Study|Physician Decision|3|||
131499950|NCT01333059|473459464|FG001|Overall Study|Physician Decision|3|||
131499951|NCT01333059|473459463|FG000|Overall Study|Protocol Violation|3|||
131499952|NCT01333059|473459464|FG001|Overall Study|Protocol Violation|0|||
131499953|NCT03566823|473459465|FG000|Overall Study|Lack of Efficacy|0|||
131499954|NCT03566823|473459466|FG001|Overall Study|Lack of Efficacy|1|||
131499955|NCT03566823|473459467|FG002|Overall Study|Lack of Efficacy|0|||
131499956|NCT03566823|473459465|FG000|Overall Study|Withdrawal by Subject|1|||
131499957|NCT03566823|473459466|FG001|Overall Study|Withdrawal by Subject|2|||
131499958|NCT03566823|473459467|FG002|Overall Study|Withdrawal by Subject|0|||
131499959|NCT03566823|473459465|FG000|Overall Study|Adverse Event|1|||
131499960|NCT03566823|473459466|FG001|Overall Study|Adverse Event|0|||
131499961|NCT03566823|473459467|FG002|Overall Study|Adverse Event|2|||
131499962|NCT02049957|473459468|FG000|Overall Study|Progressive Disease|5|||
131499963|NCT02049957|473459469|FG001|Overall Study|Progressive Disease|4|||
131499964|NCT02049957|473459470|FG002|Overall Study|Progressive Disease|2|||
131499965|NCT02049957|473459471|FG003|Overall Study|Progressive Disease|2|||
131499966|NCT02049957|473459472|FG004|Overall Study|Progressive Disease|6|||
131499967|NCT02049957|473459473|FG005|Overall Study|Progressive Disease|35|||
131499968|NCT02049957|473459474|FG006|Overall Study|Progressive Disease|7|||
131499969|NCT02049957|473459475|FG007|Overall Study|Progressive Disease|26|||
131499970|NCT02049957|473459476|FG008|Overall Study|Progressive Disease|6|||
131499971|NCT02049957|473459468|FG000|Overall Study|Adverse Event|1|||
131499972|NCT02049957|473459469|FG001|Overall Study|Adverse Event|1|||
131499973|NCT02049957|473459470|FG002|Overall Study|Adverse Event|1|||
131499974|NCT02049957|473459471|FG003|Overall Study|Adverse Event|0|||
131499975|NCT02049957|473459472|FG004|Overall Study|Adverse Event|0|||
131499976|NCT02049957|473459473|FG005|Overall Study|Adverse Event|5|||
131499977|NCT02049957|473459474|FG006|Overall Study|Adverse Event|0|||
131499978|NCT02049957|473459475|FG007|Overall Study|Adverse Event|6|||
131499979|NCT02049957|473459476|FG008|Overall Study|Adverse Event|1|||
131499980|NCT02049957|473459468|FG000|Overall Study|Study Terminated by Sponsor|0|||
131499981|NCT02049957|473459469|FG001|Overall Study|Study Terminated by Sponsor|1|||
131499982|NCT02049957|473459470|FG002|Overall Study|Study Terminated by Sponsor|0|||
131499983|NCT02049957|473459471|FG003|Overall Study|Study Terminated by Sponsor|0|||
131499984|NCT02049957|473459472|FG004|Overall Study|Study Terminated by Sponsor|0|||
131499985|NCT02049957|473459473|FG005|Overall Study|Study Terminated by Sponsor|0|||
131499986|NCT02049957|473459474|FG006|Overall Study|Study Terminated by Sponsor|1|||
131499987|NCT02049957|473459475|FG007|Overall Study|Study Terminated by Sponsor|0|||
131499988|NCT02049957|473459476|FG008|Overall Study|Study Terminated by Sponsor|0|||
131499989|NCT02049957|473459468|FG000|Overall Study|Withdrawal by Subject|0|||
131499990|NCT02049957|473459469|FG001|Overall Study|Withdrawal by Subject|0|||
131499991|NCT02049957|473459470|FG002|Overall Study|Withdrawal by Subject|0|||
131499992|NCT02049957|473459471|FG003|Overall Study|Withdrawal by Subject|1|||
131499993|NCT02049957|473459472|FG004|Overall Study|Withdrawal by Subject|0|||
131499994|NCT02049957|473459473|FG005|Overall Study|Withdrawal by Subject|2|||
131499995|NCT02049957|473459474|FG006|Overall Study|Withdrawal by Subject|0|||
131499996|NCT02049957|473459475|FG007|Overall Study|Withdrawal by Subject|3|||
131499997|NCT02049957|473459476|FG008|Overall Study|Withdrawal by Subject|1|||
131499998|NCT02049957|473459468|FG000|Overall Study|Physician Decision|0|||
131499999|NCT02049957|473459469|FG001|Overall Study|Physician Decision|0|||
131500000|NCT02049957|473459470|FG002|Overall Study|Physician Decision|0|||
131500001|NCT02049957|473459471|FG003|Overall Study|Physician Decision|0|||
131500002|NCT02049957|473459472|FG004|Overall Study|Physician Decision|0|||
131500003|NCT02049957|473459473|FG005|Overall Study|Physician Decision|1|||
131500004|NCT02049957|473459474|FG006|Overall Study|Physician Decision|0|||
131500005|NCT02049957|473459475|FG007|Overall Study|Physician Decision|0|||
131500006|NCT02049957|473459476|FG008|Overall Study|Physician Decision|0|||
131500007|NCT01958008|473459479|FG000|Overall Study|Worsening of disease under study|0|||
131500008|NCT01958008|473459480|FG001|Overall Study|Worsening of disease under study|0|||
131500009|NCT01958008|473459481|FG002|Overall Study|Worsening of disease under study|1|||
131500010|NCT01958008|473459482|FG003|Overall Study|Worsening of disease under study|0|||
131500011|NCT01958008|473459479|FG000|Overall Study|Other adverse event|1|||
131500012|NCT01958008|473459480|FG001|Overall Study|Other adverse event|0|||
131500013|NCT01958008|473459481|FG002|Overall Study|Other adverse event|0|||
131500014|NCT01958008|473459482|FG003|Overall Study|Other adverse event|0|||
131500015|NCT01634360|473459483|FG000|Overall Study|Adverse Event|10|||
131500016|NCT01634360|473459484|FG001|Overall Study|Adverse Event|34|||
131500017|NCT01634360|473459483|FG000|Overall Study|subject withdrew consent|13|||
131500018|NCT01634360|473459484|FG001|Overall Study|subject withdrew consent|23|||
131500019|NCT01634360|473459483|FG000|Overall Study|Protocol Violation|1|||
131500020|NCT01634360|473459484|FG001|Overall Study|Protocol Violation|1|||
131500021|NCT01634360|473459483|FG000|Overall Study|Lack of Efficacy|4|||
131500022|NCT01634360|473459484|FG001|Overall Study|Lack of Efficacy|14|||
131500023|NCT01634360|473459483|FG000|Overall Study|Other|3|||
131500024|NCT01634360|473459484|FG001|Overall Study|Other|20|||
131500025|NCT01634360|473459483|FG000|Overall Study|Study termination by sponsor|18|||
131500026|NCT01634360|473459484|FG001|Overall Study|Study termination by sponsor|44|||
131500027|NCT01414855|473459485|FG000|Overall Study|Death|17|||
131500028|NCT01414855|473459485|FG000|Overall Study|Lost to Follow-up|5|||
131500029|NCT01414855|473459485|FG000|Overall Study|Withdrawal by Subject|7|||
131500030|NCT04851314|473459486|FG000|Overall Study|Unable to complete research set-up procedures|0|||
131500031|NCT04851314|473459487|FG001|Overall Study|Unable to complete research set-up procedures|2|||
131500032|NCT04851314|473459486|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
131500033|NCT04851314|473459487|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
131500034|NCT00867009|473459488|FG000|Induction Period|Nonserious Adverse Event|5|||
131500035|NCT00867009|473459488|FG000|Induction Period|Serious Adverse Event|10|||
131500036|NCT00867009|473459488|FG000|Induction Period|Death due to serious adverse event|6|||
131500037|NCT00867009|473459488|FG000|Induction Period|Death due to Study Disease|4|||
131500038|NCT00867009|473459488|FG000|Induction Period|Protocol Violation|1|||
131500039|NCT00867009|473459488|FG000|Induction Period|Withdrawal by Subject|8|||
131500040|NCT00867009|473459488|FG000|Induction Period|Physician Decision|3|||
131500041|NCT00867009|473459488|FG000|Induction Period|Progressive Disease (PD)|25|||
131500042|NCT00867009|473459488|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
131500043|NCT01850524|473459493|FG000|Overall Study|Lost to Follow-up|5|||
131500044|NCT01850524|473459494|FG001|Overall Study|Lost to Follow-up|10|||
131500045|NCT01850524|473459493|FG000|Overall Study|Withdrawal by Subject|24|||
131500046|NCT01850524|473459494|FG001|Overall Study|Withdrawal by Subject|22|||
131500047|NCT01850524|473459493|FG000|Overall Study|Reason not Specified|142|||
131500048|NCT01850524|473459494|FG001|Overall Study|Reason not Specified|141|||
131500049|NCT02671422|473459498|FG000|Overall Study|Lost to Follow-up|1|||
131500050|NCT02671422|473459498|FG000|Overall Study|Adverse Event|68|||
131500051|NCT02671422|473459498|FG000|Overall Study|Lack of Efficacy|1|||
131500052|NCT02671422|473459498|FG000|Overall Study|Lost to Follow-up|4|||
131500053|NCT02671422|473459498|FG000|Overall Study|Withdrawal by Subject|7|||
131500054|NCT02671422|473459498|FG000|Overall Study|Progressive Disease|156|||
131500055|NCT02671422|473459498|FG000|Overall Study|Worsening of Disease|4|||
131500056|NCT02671422|473459498|FG000|Overall Study|Sponsor decision|5|||
131500057|NCT02671422|473459498|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
131500058|NCT02671422|473459498|FG000|Overall Study|Not treated with Vargatef®|3|||
131500059|NCT02671422|473459498|FG000|Overall Study|Other not defined above|3|||
131500060|NCT04772755|473459499|FG000|Overall Study|Withdrawal by Subject|1|||
131500061|NCT04772755|473459500|FG001|Overall Study|Withdrawal by Subject|0|||
131500062|NCT04772755|473459499|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
131500063|NCT04772755|473459500|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
131500064|NCT01905657|473459501|FG000|Overall Study|Adverse Event|23|||
131500065|NCT01905657|473459502|FG001|Overall Study|Adverse Event|17|||
131500066|NCT01905657|473459503|FG002|Overall Study|Adverse Event|18|||
131500067|NCT01905657|473459501|FG000|Overall Study|Clinical Progression|103|||
131500068|NCT01905657|473459502|FG001|Overall Study|Clinical Progression|78|||
131500069|NCT01905657|473459503|FG002|Overall Study|Clinical Progression|59|||
131500070|NCT01905657|473459501|FG000|Overall Study|Death|40|||
131500071|NCT01905657|473459502|FG001|Overall Study|Death|43|||
131500072|NCT01905657|473459503|FG002|Overall Study|Death|47|||
131500073|NCT01905657|473459501|FG000|Overall Study|Excluded Medication|13|||
131500074|NCT01905657|473459502|FG001|Overall Study|Excluded Medication|16|||
131500075|NCT01905657|473459503|FG002|Overall Study|Excluded Medication|9|||
131500076|NCT01905657|473459501|FG000|Overall Study|Lost to Follow-up|1|||
131500077|NCT01905657|473459502|FG001|Overall Study|Lost to Follow-up|2|||
131500078|NCT01905657|473459503|FG002|Overall Study|Lost to Follow-up|1|||
131500079|NCT01905657|473459501|FG000|Overall Study|Physician Decision|5|||
131500080|NCT01905657|473459502|FG001|Overall Study|Physician Decision|8|||
131500081|NCT01905657|473459503|FG002|Overall Study|Physician Decision|12|||
131500082|NCT01905657|473459501|FG000|Overall Study|Protocol Violation|2|||
131500083|NCT01905657|473459502|FG001|Overall Study|Protocol Violation|1|||
131500084|NCT01905657|473459503|FG002|Overall Study|Protocol Violation|1|||
131500085|NCT01905657|473459501|FG000|Overall Study|Screen Failure|0|||
131500086|NCT01905657|473459502|FG001|Overall Study|Screen Failure|1|||
131500087|NCT01905657|473459503|FG002|Overall Study|Screen Failure|0|||
131500088|NCT01905657|473459501|FG000|Overall Study|Withdrawal by Subject|15|||
131500089|NCT01905657|473459502|FG001|Overall Study|Withdrawal by Subject|21|||
131500090|NCT01905657|473459503|FG002|Overall Study|Withdrawal by Subject|53|||
131500091|NCT01905657|473459501|FG000|Overall Study|Sponsor Decision|1|||
131500092|NCT01905657|473459502|FG001|Overall Study|Sponsor Decision|0|||
131500093|NCT01905657|473459503|FG002|Overall Study|Sponsor Decision|0|||
131500094|NCT04080297|473459505|FG000|Overall Study|Adverse Event|1|||
131500095|NCT04080297|473459506|FG001|Overall Study|Adverse Event|3|||
131500096|NCT04080297|473459505|FG000|Overall Study|concurrent illness|1|||
131500097|NCT04080297|473459506|FG001|Overall Study|concurrent illness|0|||
131500098|NCT04702997|473459507|FG000|Overall Study|Withdrawal by Subject|1|||
131500099|NCT04702997|473459508|FG001|Overall Study|Withdrawal by Subject|1|||
131500100|NCT02200445|473459511|FG000|Overall Study|Lack of Efficacy|1|||
131500101|NCT02200445|473459512|FG001|Overall Study|Lack of Efficacy|2|||
131500102|NCT02200445|473459513|FG002|Overall Study|Lack of Efficacy|2|||
131500103|NCT02200445|473459511|FG000|Overall Study|Adverse Event|0|||
131500104|NCT02200445|473459512|FG001|Overall Study|Adverse Event|2|||
131500105|NCT02200445|473459513|FG002|Overall Study|Adverse Event|0|||
131500106|NCT01031069|473459514|FG000|Overall Study|Serious Adverse Event|0|||
131500107|NCT01031069|473459515|FG001|Overall Study|Serious Adverse Event|1|||
131500108|NCT01031069|473459516|FG002|Overall Study|Serious Adverse Event|0|||
131500109|NCT01031069|473459517|FG003|Overall Study|Serious Adverse Event|0|||
131500110|NCT01031069|473459514|FG000|Overall Study|Withdrawal by Subject|2|||
131500111|NCT01031069|473459515|FG001|Overall Study|Withdrawal by Subject|3|||
131500112|NCT01031069|473459516|FG002|Overall Study|Withdrawal by Subject|18|||
131500113|NCT01031069|473459517|FG003|Overall Study|Withdrawal by Subject|18|||
131500114|NCT01031069|473459514|FG000|Overall Study|Migrated/moved from study area|1|||
131500115|NCT01031069|473459515|FG001|Overall Study|Migrated/moved from study area|2|||
131500116|NCT01031069|473459516|FG002|Overall Study|Migrated/moved from study area|1|||
131500117|NCT01031069|473459517|FG003|Overall Study|Migrated/moved from study area|1|||
131500118|NCT01031069|473459514|FG000|Overall Study|Lost to Follow-up|9|||
131500119|NCT01031069|473459515|FG001|Overall Study|Lost to Follow-up|5|||
131500120|NCT01031069|473459516|FG002|Overall Study|Lost to Follow-up|21|||
131500121|NCT01031069|473459517|FG003|Overall Study|Lost to Follow-up|15|||
131500122|NCT01031069|473459514|FG000|Overall Study|Other|0|||
131500123|NCT01031069|473459515|FG001|Overall Study|Other|0|||
131500124|NCT01031069|473459516|FG002|Overall Study|Other|1|||
131500125|NCT01031069|473459517|FG003|Overall Study|Other|0|||
131500126|NCT01386554|473459523|FG000|Overall Study|Lost to Follow-up|0|||
131500127|NCT01386554|473459524|FG001|Overall Study|Lost to Follow-up|0|||
131500128|NCT01386554|473459525|FG002|Overall Study|Lost to Follow-up|1|||
131500129|NCT01386554|473459523|FG000|Overall Study|Adverse Event|2|||
131500130|NCT01386554|473459524|FG001|Overall Study|Adverse Event|5|||
131500131|NCT01386554|473459525|FG002|Overall Study|Adverse Event|2|||
131500132|NCT01386554|473459523|FG000|Overall Study|Progressive disease|1|||
131500133|NCT01386554|473459524|FG001|Overall Study|Progressive disease|2|||
131500134|NCT01386554|473459525|FG002|Overall Study|Progressive disease|2|||
131500135|NCT01386554|473459523|FG000|Overall Study|Administration of live vaccines|0|||
131500136|NCT01386554|473459524|FG001|Overall Study|Administration of live vaccines|1|||
131500137|NCT01386554|473459525|FG002|Overall Study|Administration of live vaccines|0|||
131500138|NCT01386554|473459523|FG000|Overall Study|Investigator discretion|0|||
131500139|NCT01386554|473459524|FG001|Overall Study|Investigator discretion|0|||
131500140|NCT01386554|473459525|FG002|Overall Study|Investigator discretion|1|||
131500141|NCT01386554|473459523|FG000|Overall Study|Reason not collected|0|||
131500142|NCT01386554|473459524|FG001|Overall Study|Reason not collected|1|||
131500143|NCT01386554|473459525|FG002|Overall Study|Reason not collected|0|||
131500144|NCT03334903|473459527|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
131500145|NCT03334903|473459528|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
131500146|NCT03334903|473459527|FG000|Overall Study|Protocol Violation|1|||
131500147|NCT03334903|473459528|FG001|Overall Study|Protocol Violation|3|||
131500148|NCT03334903|473459527|FG000|Overall Study|Surgery postponed|1|||
131500149|NCT03334903|473459528|FG001|Overall Study|Surgery postponed|0|||
131500150|NCT03334903|473459527|FG000|Overall Study|Adverse Event|1|||
131500151|NCT03334903|473459528|FG001|Overall Study|Adverse Event|1|||
131500152|NCT03334903|473459527|FG000|Overall Study|Withdrawal by Subject|0|||
131500153|NCT03334903|473459528|FG001|Overall Study|Withdrawal by Subject|1|||
131500154|NCT02879305|473459529|FG000|Overall Study|Investigator Site Closed|55|||
131500155|NCT02879305|473459530|FG001|Overall Study|Investigator Site Closed|57|||
131500156|NCT02879305|473459529|FG000|Overall Study|Withdrawal by Subject|44|||
131500157|NCT02879305|473459530|FG001|Overall Study|Withdrawal by Subject|42|||
131500158|NCT02879305|473459529|FG000|Overall Study|Lost to Follow-up|17|||
131500159|NCT02879305|473459530|FG001|Overall Study|Lost to Follow-up|12|||
131500160|NCT02879305|473459529|FG000|Overall Study|Other|1|||
131500161|NCT02879305|473459530|FG001|Overall Study|Other|0|||
131500162|NCT01853826|473461378|FG000|Overall Study|Patients who switched to commercial drug|11|||
131500163|NCT01853826|473461378|FG000|Overall Study|Patient refused to continue medication|21|||
131500164|NCT01853826|473461378|FG000|Overall Study|Lost to Follow-up|2|||
131500165|NCT01853826|473461378|FG000|Overall Study|Non-compliant with protocol|4|||
131500166|NCT01853826|473461378|FG000|Overall Study|Other adverse events (AE)|62|||
131500167|NCT01853826|473461378|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
131500168|NCT01853826|473461378|FG000|Overall Study|Progressive disease|342|||
131500169|NCT01853826|473461378|FG000|Overall Study|Other than listed|13|||
131500170|NCT01853826|473461378|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
131500171|NCT00982488|473461382|FG000|Overall Study|Administrative reason by sponsor|81|||
131500172|NCT00982488|473461383|FG001|Overall Study|Administrative reason by sponsor|3|||
131500173|NCT00982488|473461384|FG002|Overall Study|Administrative reason by sponsor|11|||
131500174|NCT00982488|473461385|FG003|Overall Study|Administrative reason by sponsor|0|||
131500175|NCT00982488|473461386|FG004|Overall Study|Administrative reason by sponsor|0|||
131500176|NCT00982488|473461382|FG000|Overall Study|Adverse event unrelated to study drug|5|||
131500177|NCT00982488|473461383|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131500178|NCT00982488|473461384|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131500179|NCT00982488|473461385|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131500180|NCT00982488|473461386|FG004|Overall Study|Adverse event unrelated to study drug|0|||
131500181|NCT00982488|473461382|FG000|Overall Study|Death|11|||
131500182|NCT00982488|473461383|FG001|Overall Study|Death|0|||
131500183|NCT00982488|473461384|FG002|Overall Study|Death|2|||
131500184|NCT00982488|473461385|FG003|Overall Study|Death|0|||
131500185|NCT00982488|473461386|FG004|Overall Study|Death|0|||
131500186|NCT00982488|473461382|FG000|Overall Study|Disease progression|30|||
131500187|NCT00982488|473461383|FG001|Overall Study|Disease progression|5|||
131500188|NCT00982488|473461384|FG002|Overall Study|Disease progression|10|||
131500189|NCT00982488|473461385|FG003|Overall Study|Disease progression|1|||
131500190|NCT00982488|473461386|FG004|Overall Study|Disease progression|1|||
131500191|NCT00982488|473461382|FG000|Overall Study|Lost to Follow-up|1|||
131500192|NCT00982488|473461383|FG001|Overall Study|Lost to Follow-up|0|||
131500193|NCT00982488|473461384|FG002|Overall Study|Lost to Follow-up|0|||
131500194|NCT00982488|473461385|FG003|Overall Study|Lost to Follow-up|0|||
131500195|NCT00982488|473461386|FG004|Overall Study|Lost to Follow-up|0|||
131500196|NCT00982488|473461382|FG000|Overall Study|Maximum clinical benefit|1|||
131500197|NCT00982488|473461383|FG001|Overall Study|Maximum clinical benefit|1|||
131500198|NCT00982488|473461384|FG002|Overall Study|Maximum clinical benefit|1|||
131500199|NCT00982488|473461385|FG003|Overall Study|Maximum clinical benefit|0|||
131500200|NCT00982488|473461386|FG004|Overall Study|Maximum clinical benefit|0|||
131500201|NCT00982488|473461382|FG000|Overall Study|Other|15|||
131500202|NCT00982488|473461383|FG001|Overall Study|Other|1|||
131500203|NCT00982488|473461384|FG002|Overall Study|Other|3|||
131500204|NCT00982488|473461385|FG003|Overall Study|Other|1|||
131500205|NCT00982488|473461386|FG004|Overall Study|Other|0|||
131500206|NCT00982488|473461382|FG000|Overall Study|Poor compliance/noncompliance|0|||
131500207|NCT00982488|473461383|FG001|Overall Study|Poor compliance/noncompliance|1|||
131500208|NCT00982488|473461384|FG002|Overall Study|Poor compliance/noncompliance|0|||
131500209|NCT00982488|473461385|FG003|Overall Study|Poor compliance/noncompliance|0|||
131500210|NCT00982488|473461386|FG004|Overall Study|Poor compliance/noncompliance|0|||
131500211|NCT00982488|473461382|FG000|Overall Study|Stem cell transplant|2|||
131500212|NCT00982488|473461383|FG001|Overall Study|Stem cell transplant|0|||
131500213|NCT00982488|473461384|FG002|Overall Study|Stem cell transplant|0|||
131500214|NCT00982488|473461385|FG003|Overall Study|Stem cell transplant|1|||
131500215|NCT00982488|473461386|FG004|Overall Study|Stem cell transplant|0|||
131500216|NCT00982488|473461382|FG000|Overall Study|Study drug toxicity|34|||
131500217|NCT00982488|473461383|FG001|Overall Study|Study drug toxicity|1|||
131500218|NCT00982488|473461384|FG002|Overall Study|Study drug toxicity|6|||
131500219|NCT00982488|473461385|FG003|Overall Study|Study drug toxicity|0|||
131500220|NCT00982488|473461386|FG004|Overall Study|Study drug toxicity|0|||
131500221|NCT00982488|473461382|FG000|Overall Study|Withdrawal by Subject|5|||
131500222|NCT00982488|473461383|FG001|Overall Study|Withdrawal by Subject|1|||
131500223|NCT00982488|473461384|FG002|Overall Study|Withdrawal by Subject|1|||
131500224|NCT00982488|473461385|FG003|Overall Study|Withdrawal by Subject|0|||
131500225|NCT00982488|473461386|FG004|Overall Study|Withdrawal by Subject|0|||
131500226|NCT00180414|473461395|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
131500227|NCT00180414|473461396|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
131500228|NCT00463346|473461397|FG000|Overall Study|Withdrawal by Subject|3|||
131500229|NCT00463346|473461398|FG001|Overall Study|Withdrawal by Subject|3|||
131500230|NCT01199289|473461400|FG000|Overall Study|Ineligibility determined|2|||
131500231|NCT01199289|473461401|FG001|Overall Study|Ineligibility determined|1|||
131500232|NCT01199289|473461402|FG002|Overall Study|Ineligibility determined|0|||
131500233|NCT01199289|473461403|FG003|Overall Study|Ineligibility determined|0|||
131500234|NCT01199289|473461400|FG000|Overall Study|Protocol Violation|1|||
131500235|NCT01199289|473461401|FG001|Overall Study|Protocol Violation|0|||
131500236|NCT01199289|473461402|FG002|Overall Study|Protocol Violation|0|||
131500237|NCT01199289|473461403|FG003|Overall Study|Protocol Violation|1|||
131500238|NCT01199289|473461400|FG000|Overall Study|Noncompliance|1|||
131500239|NCT01199289|473461401|FG001|Overall Study|Noncompliance|0|||
131500240|NCT01199289|473461402|FG002|Overall Study|Noncompliance|2|||
131500241|NCT01199289|473461403|FG003|Overall Study|Noncompliance|0|||
131500242|NCT01199289|473461400|FG000|Overall Study|Adverse Event|0|||
131500243|NCT01199289|473461401|FG001|Overall Study|Adverse Event|3|||
131500244|NCT01199289|473461402|FG002|Overall Study|Adverse Event|1|||
131500245|NCT01199289|473461403|FG003|Overall Study|Adverse Event|4|||
131500246|NCT01199289|473461400|FG000|Overall Study|Full consent withdrawn|2|||
131500247|NCT01199289|473461401|FG001|Overall Study|Full consent withdrawn|2|||
131500248|NCT01199289|473461402|FG002|Overall Study|Full consent withdrawn|2|||
131500249|NCT01199289|473461403|FG003|Overall Study|Full consent withdrawn|3|||
131500250|NCT01199289|473461400|FG000|Overall Study|Administrative decision|0|||
131500251|NCT01199289|473461401|FG001|Overall Study|Administrative decision|0|||
131500252|NCT01199289|473461402|FG002|Overall Study|Administrative decision|0|||
131500253|NCT01199289|473461403|FG003|Overall Study|Administrative decision|1|||
131500254|NCT01199289|473461400|FG000|Overall Study|Lost to Follow-up|0|||
131500255|NCT01199289|473461401|FG001|Overall Study|Lost to Follow-up|0|||
131500256|NCT01199289|473461402|FG002|Overall Study|Lost to Follow-up|0|||
131500257|NCT01199289|473461403|FG003|Overall Study|Lost to Follow-up|1|||
131500258|NCT01199289|473461400|FG000|Overall Study|Protocol-specified criteria|3|||
131500259|NCT01199289|473461401|FG001|Overall Study|Protocol-specified criteria|0|||
131500260|NCT01199289|473461402|FG002|Overall Study|Protocol-specified criteria|0|||
131500261|NCT01199289|473461403|FG003|Overall Study|Protocol-specified criteria|1|||
131500262|NCT01199289|473461400|FG000|Overall Study|Pregnancy|0|||
131500263|NCT01199289|473461401|FG001|Overall Study|Pregnancy|1|||
131500264|NCT01199289|473461402|FG002|Overall Study|Pregnancy|0|||
131500265|NCT01199289|473461403|FG003|Overall Study|Pregnancy|1|||
131500266|NCT02723084|473461405|FG000|Overall Study|Withdrawal by Subject|1|||
131500267|NCT02723084|473461406|FG001|Overall Study|Withdrawal by Subject|1|||
131500268|NCT02723084|473461405|FG000|Overall Study|Lost to Follow-up|3|||
131500269|NCT02723084|473461406|FG001|Overall Study|Lost to Follow-up|0|||
131500270|NCT02450903|473461407|FG000|Overall Study|Adverse Event|3|||
131500271|NCT02450903|473461407|FG000|Overall Study|Progressive disease|15|||
131500272|NCT02450903|473461407|FG000|Overall Study|Switched to commercial drug|1|||
131500273|NCT02450903|473461407|FG000|Overall Study|Subject/guardian decision|1|||
131500274|NCT01320085|473461408|FG000|Overall Study|Disease Progression|26|||
131500275|NCT01320085|473461409|FG001|Overall Study|Disease Progression|93|||
131500276|NCT01320085|473461410|FG002|Overall Study|Disease Progression|17|||
131500277|NCT01320085|473461408|FG000|Overall Study|Adverse Event|12|||
131500278|NCT01320085|473461409|FG001|Overall Study|Adverse Event|20|||
131500279|NCT01320085|473461410|FG002|Overall Study|Adverse Event|5|||
131500280|NCT01320085|473461408|FG000|Overall Study|Withdrawal by Subject|2|||
131500281|NCT01320085|473461409|FG001|Overall Study|Withdrawal by Subject|4|||
131500282|NCT01320085|473461410|FG002|Overall Study|Withdrawal by Subject|1|||
131500283|NCT01320085|473461408|FG000|Overall Study|Protocol Deviation|1|||
131500284|NCT01320085|473461409|FG001|Overall Study|Protocol Deviation|0|||
131500285|NCT01320085|473461410|FG002|Overall Study|Protocol Deviation|1|||
131500286|NCT01320085|473461408|FG000|Overall Study|Administrative problems|0|||
131500287|NCT01320085|473461409|FG001|Overall Study|Administrative problems|0|||
131500288|NCT01320085|473461410|FG002|Overall Study|Administrative problems|1|||
131500289|NCT03020407|473461417|FG000|Overall Study|Withdrawal by Subject|2|||
131500290|NCT03020407|473461418|FG001|Overall Study|Withdrawal by Subject|1|||
131500291|NCT03020407|473461417|FG000|Overall Study|Lost to Follow-up|2|||
131500292|NCT03020407|473461418|FG001|Overall Study|Lost to Follow-up|3|||
131500293|NCT03020407|473461417|FG000|Overall Study|Protocol Violation|0|||
131500294|NCT03020407|473461418|FG001|Overall Study|Protocol Violation|1|||
131500295|NCT00708162|473461419|FG000|Randomized Phase|Randomized but Not Treated|7|||
131500296|NCT00708162|473461420|FG001|Randomized Phase|Randomized but Not Treated|5|||
131500297|NCT00708162|473461419|FG000|Randomized Phase|Participant Noncompliance|40|||
131500298|NCT00708162|473461420|FG001|Randomized Phase|Participant Noncompliance|32|||
131500299|NCT00708162|473461419|FG000|Randomized Phase|Lost to Follow-up|34|||
131500300|NCT00708162|473461420|FG001|Randomized Phase|Lost to Follow-up|34|||
131500301|NCT00708162|473461419|FG000|Randomized Phase|Withdrew Consent|31|||
131500302|NCT00708162|473461420|FG001|Randomized Phase|Withdrew Consent|22|||
131500303|NCT00708162|473461419|FG000|Randomized Phase|Lack of Efficacy|14|||
131500304|NCT00708162|473461420|FG001|Randomized Phase|Lack of Efficacy|19|||
131500305|NCT00708162|473461419|FG000|Randomized Phase|Protocol Violation|10|||
131500306|NCT00708162|473461420|FG001|Randomized Phase|Protocol Violation|11|||
131500307|NCT00708162|473461419|FG000|Randomized Phase|Adverse Event|8|||
131500308|NCT00708162|473461420|FG001|Randomized Phase|Adverse Event|12|||
131500309|NCT00708162|473461419|FG000|Randomized Phase|Investigator's Discretion|7|||
131500310|NCT00708162|473461420|FG001|Randomized Phase|Investigator's Discretion|10|||
131500311|NCT00708162|473461419|FG000|Randomized Phase|Death|2|||
131500312|NCT00708162|473461420|FG001|Randomized Phase|Death|9|||
131500313|NCT00708162|473461419|FG000|Randomized Phase|Pregnancy|3|||
131500314|NCT00708162|473461420|FG001|Randomized Phase|Pregnancy|0|||
131500315|NCT00708162|473461419|FG000|Open-Label Phase|Lost to Follow-up|10|||
131500316|NCT00708162|473461420|FG001|Open-Label Phase|Lost to Follow-up|8|||
131500317|NCT00708162|473461419|FG000|Open-Label Phase|Withdrew Consent|12|||
131500318|NCT00708162|473461420|FG001|Open-Label Phase|Withdrew Consent|6|||
131500319|NCT00708162|473461419|FG000|Open-Label Phase|Participant Noncompliance|7|||
131500320|NCT00708162|473461420|FG001|Open-Label Phase|Participant Noncompliance|7|||
131500321|NCT00708162|473461419|FG000|Open-Label Phase|Lack of Efficacy|7|||
131500322|NCT00708162|473461420|FG001|Open-Label Phase|Lack of Efficacy|4|||
131500323|NCT00708162|473461419|FG000|Open-Label Phase|Investigator's Discretion|3|||
131500324|NCT00708162|473461420|FG001|Open-Label Phase|Investigator's Discretion|2|||
131500325|NCT00708162|473461419|FG000|Open-Label Phase|Death|3|||
131500326|NCT00708162|473461420|FG001|Open-Label Phase|Death|1|||
131500327|NCT00708162|473461419|FG000|Open-Label Phase|Adverse Event|1|||
131500328|NCT00708162|473461420|FG001|Open-Label Phase|Adverse Event|2|||
131500329|NCT00708162|473461419|FG000|Open-Label Phase|Other|1|||
131500330|NCT00708162|473461420|FG001|Open-Label Phase|Other|0|||
131500331|NCT00708643|473461421|FG000|Overall Study|Adverse Event|0|||
131500332|NCT00708643|473461422|FG001|Overall Study|Adverse Event|1|||
131500333|NCT02699554|473461423|FG000|Overall Study|Lost to Follow-up|9|||
131500334|NCT00788151|473461424|FG000|Overall Study|Other adverse event|0|||
131500335|NCT00788151|473461425|FG001|Overall Study|Other adverse event|2|||
131500336|NCT00788151|473461424|FG000|Overall Study|Protocol Violation|0|||
131500337|NCT00788151|473461425|FG001|Overall Study|Protocol Violation|1|||
131500338|NCT00788151|473461424|FG000|Overall Study|Withdrawal by Subject|13|||
131500339|NCT00788151|473461425|FG001|Overall Study|Withdrawal by Subject|6|||
131500340|NCT00788151|473461424|FG000|Overall Study|Enrolled but not treated|1|||
131500341|NCT00788151|473461425|FG001|Overall Study|Enrolled but not treated|1|||
131500342|NCT00503009|473461426|FG000|Overall Study|Protocol Violation|1|||
131500343|NCT00503009|473461427|FG001|Overall Study|Protocol Violation|0|||
131500344|NCT00503009|473461428|FG002|Overall Study|Protocol Violation|1|||
131500345|NCT00503009|473461426|FG000|Overall Study|Withdrawal by Subject|0|||
131500346|NCT00503009|473461427|FG001|Overall Study|Withdrawal by Subject|1|||
131500347|NCT00503009|473461428|FG002|Overall Study|Withdrawal by Subject|1|||
131500348|NCT00503009|473461426|FG000|Overall Study|Physician Decision|0|||
131500349|NCT00503009|473461427|FG001|Overall Study|Physician Decision|1|||
131500350|NCT00503009|473461428|FG002|Overall Study|Physician Decision|1|||
131500351|NCT01244906|473461429|FG000|Overall Study|Death|2|||
131500352|NCT01244906|473461429|FG000|Overall Study|Progression of disease post treatment|6|||
131500353|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
131500354|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
131500355|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
131500356|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
131500357|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
131500358|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
131500359|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
131500360|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
131500361|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
131500362|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
131500363|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
131500364|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
131500365|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
131500366|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
131500367|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
131500368|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
131500369|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
131500370|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
131500371|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
131500372|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
131500373|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
131500374|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
131500375|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
131500376|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
131500377|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
131500378|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
131500379|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
131500380|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
131500381|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
131500382|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
131500383|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
131500384|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
131500385|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
131500386|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
131500387|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
131500388|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
131500389|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
131500390|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
131500391|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
131500392|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
131500393|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
131500394|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
131500395|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
131500396|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
131500397|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
131500398|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
131500399|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
131500400|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
131500401|NCT03720470|473461430|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
131500402|NCT03720470|473461431|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
131500403|NCT03720470|473461432|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
131500404|NCT03720470|473461433|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
131500405|NCT03720470|473461434|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
131500406|NCT03720470|473461435|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
131500407|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
131500408|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
131500409|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
131500410|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
131500411|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
131500412|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
131500413|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
131500414|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
131500415|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
131500416|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
131500417|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
131500418|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
131500419|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
131500420|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
131500421|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
131500422|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
131500423|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
131500424|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
131500425|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
131500426|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
131500427|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
131500428|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
131500429|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
131500430|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
131500431|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
131500432|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
131500433|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
131500434|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
131500435|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
131500436|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
131500437|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
131500438|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
131500439|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
131500440|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
131500441|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
131500442|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
131500443|NCT03720470|473461430|FG000|Treatment Period: Final 4 Weeks|Other|0|||
131500444|NCT03720470|473461431|FG001|Treatment Period: Final 4 Weeks|Other|1|||
131500445|NCT03720470|473461432|FG002|Treatment Period: Final 4 Weeks|Other|0|||
131500446|NCT03720470|473461433|FG003|Treatment Period: Final 4 Weeks|Other|2|||
131500447|NCT03720470|473461434|FG004|Treatment Period: Final 4 Weeks|Other|1|||
131500448|NCT03720470|473461435|FG005|Treatment Period: Final 4 Weeks|Other|0|||
131500449|NCT02066233|473461436|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
131500450|NCT02066233|473461437|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
131500451|NCT00103142|473461438|FG000|Overall Study|Adverse Event|1|||
131500452|NCT00103142|473461439|FG001|Overall Study|Adverse Event|0|||
131500453|NCT00103142|473461438|FG000|Overall Study|Progression of disease|2|||
131500454|NCT00103142|473461439|FG001|Overall Study|Progression of disease|1|||
131500455|NCT02772081|473461440|FG000|Overall Study|Physician Decision|1|||
131500456|NCT02772081|473461441|FG001|Overall Study|Physician Decision|1|||
131500457|NCT02772081|473461440|FG000|Overall Study|Death|1|||
131500458|NCT02772081|473461441|FG001|Overall Study|Death|1|||
131500459|NCT02598076|473461442|FG000|Overall Study|Lost to Follow-up|2|||
131500460|NCT02598076|473461443|FG001|Overall Study|Lost to Follow-up|3|||
131500461|NCT01946425|473461444|FG000|Overall Study|Protocol Violation|1|||
131500462|NCT01946425|473461445|FG001|Overall Study|Protocol Violation|0|||
131500463|NCT01946425|473461444|FG000|Overall Study|Withdrawal by Subject|1|||
131500464|NCT01946425|473461445|FG001|Overall Study|Withdrawal by Subject|0|||
131500465|NCT03227029|473461446|FG000|Overall Study|Child Wheezed (no treatment)|0|||
131500466|NCT03227029|473461447|FG001|Overall Study|Child Wheezed (no treatment)|1|||
131500467|NCT03227029|473461448|FG002|Overall Study|Child Wheezed (no treatment)|0|||
131500468|NCT03227029|473461446|FG000|Overall Study|No post RSV season visit due to COVID|3|||
131500469|NCT03227029|473461447|FG001|Overall Study|No post RSV season visit due to COVID|3|||
131500470|NCT03227029|473461448|FG002|Overall Study|No post RSV season visit due to COVID|2|||
131500471|NCT03227029|473461446|FG000|Overall Study|Not able to get to clinic|0|||
131500472|NCT03227029|473461447|FG001|Overall Study|Not able to get to clinic|0|||
131500473|NCT03227029|473461448|FG002|Overall Study|Not able to get to clinic|1|||
131500474|NCT03227029|473461446|FG000|Overall Study|Withdrawal by Subject|1|||
131500475|NCT03227029|473461447|FG001|Overall Study|Withdrawal by Subject|0|||
131500476|NCT03227029|473461448|FG002|Overall Study|Withdrawal by Subject|0|||
131500477|NCT03227029|473461446|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
131500478|NCT03227029|473461447|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
131500479|NCT03227029|473461448|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
131500480|NCT00390858|473461449|FG000|Overall Study|Adverse Event|6|||
131500481|NCT00390858|473461450|FG001|Overall Study|Adverse Event|2|||
131500482|NCT00390858|473461449|FG000|Overall Study|Lack of Efficacy|0|||
131500483|NCT00390858|473461450|FG001|Overall Study|Lack of Efficacy|1|||
131500484|NCT00390858|473461449|FG000|Overall Study|Withdrawal by Subject|3|||
131500485|NCT00390858|473461450|FG001|Overall Study|Withdrawal by Subject|4|||
131500486|NCT01113801|473461451|FG000|Overall Study|Adverse Event|4|||
131500487|NCT01113801|473461452|FG001|Overall Study|Adverse Event|0|||
131500488|NCT01113801|473461453|FG002|Overall Study|Adverse Event|2|||
131500489|NCT01113801|473461454|FG003|Overall Study|Adverse Event|6|||
131500490|NCT01113801|473461451|FG000|Overall Study|Death|4|||
131500491|NCT01113801|473461452|FG001|Overall Study|Death|5|||
131500492|NCT01113801|473461453|FG002|Overall Study|Death|3|||
131500493|NCT01113801|473461454|FG003|Overall Study|Death|4|||
131500494|NCT01113801|473461451|FG000|Overall Study|Protocol Violation|0|||
131500495|NCT01113801|473461452|FG001|Overall Study|Protocol Violation|1|||
131500496|NCT01113801|473461453|FG002|Overall Study|Protocol Violation|0|||
131500497|NCT01113801|473461454|FG003|Overall Study|Protocol Violation|0|||
131500498|NCT01113801|473461451|FG000|Overall Study|Withdrawal by Subject|9|||
131500499|NCT01113801|473461452|FG001|Overall Study|Withdrawal by Subject|7|||
131500500|NCT01113801|473461453|FG002|Overall Study|Withdrawal by Subject|7|||
131500501|NCT01113801|473461454|FG003|Overall Study|Withdrawal by Subject|8|||
131500502|NCT01113801|473461451|FG000|Overall Study|Physician Decision|2|||
131500503|NCT01113801|473461452|FG001|Overall Study|Physician Decision|2|||
131500504|NCT01113801|473461453|FG002|Overall Study|Physician Decision|3|||
131500505|NCT01113801|473461454|FG003|Overall Study|Physician Decision|3|||
131500506|NCT01113801|473461451|FG000|Overall Study|Sponsor Decision|15|||
131500507|NCT01113801|473461452|FG001|Overall Study|Sponsor Decision|21|||
131500508|NCT01113801|473461453|FG002|Overall Study|Sponsor Decision|20|||
131500509|NCT01113801|473461454|FG003|Overall Study|Sponsor Decision|15|||
131500510|NCT01113801|473461451|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
131500511|NCT01113801|473461452|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
131500512|NCT01113801|473461453|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
131500513|NCT01113801|473461454|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
131500514|NCT01949051|473461457|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
131500515|NCT01949051|473461458|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
131500516|NCT01949051|473461459|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
131500517|NCT01949051|473461460|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
131500518|NCT01949051|473461461|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
131500519|NCT01949051|473461462|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
131500520|NCT01949051|473461457|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
131500521|NCT01949051|473461458|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131500522|NCT01949051|473461459|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131500523|NCT01949051|473461460|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131500524|NCT01949051|473461461|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131500525|NCT01949051|473461462|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131500526|NCT01949051|473461457|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
131500527|NCT01949051|473461458|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
131500528|NCT01949051|473461459|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
131500529|NCT01949051|473461460|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
131500530|NCT01949051|473461461|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
131500531|NCT01949051|473461462|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
131500532|NCT01949051|473461457|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
131500533|NCT01949051|473461458|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
131500534|NCT01949051|473461459|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
131500535|NCT01949051|473461460|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
131500536|NCT01949051|473461461|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
131500537|NCT01949051|473461462|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
131500538|NCT01949051|473461457|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
131500539|NCT01949051|473461458|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
131500540|NCT01949051|473461459|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
131500541|NCT01949051|473461460|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
131500542|NCT01949051|473461461|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
131500543|NCT01949051|473461462|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
131500544|NCT01506479|473461464|FG000|Overall Study|Lost to Follow-up|1|||
131500545|NCT01506479|473461465|FG001|Overall Study|Lost to Follow-up|2|||
131500546|NCT01506479|473461466|FG002|Overall Study|Lost to Follow-up|2|||
131500547|NCT01506479|473461464|FG000|Overall Study|Withdrawal by Subject|1|||
131500548|NCT01506479|473461465|FG001|Overall Study|Withdrawal by Subject|2|||
131500549|NCT01506479|473461466|FG002|Overall Study|Withdrawal by Subject|1|||
131500550|NCT01506479|473461464|FG000|Overall Study|Missing assessment|1|||
131500551|NCT01506479|473461465|FG001|Overall Study|Missing assessment|0|||
131500552|NCT01506479|473461466|FG002|Overall Study|Missing assessment|0|||
131500553|NCT01506479|473461464|FG000|Overall Study|Adverse Event|0|||
131500554|NCT01506479|473461465|FG001|Overall Study|Adverse Event|1|||
131500555|NCT01506479|473461466|FG002|Overall Study|Adverse Event|0|||
131500556|NCT01782859|473461467|FG000|Overall Study|Protocol Violation|6|||
131500557|NCT01782859|473461468|FG001|Overall Study|Protocol Violation|6|||
131500558|NCT01782859|473461467|FG000|Overall Study|Withdrawal by Subject|0|||
131500559|NCT01782859|473461468|FG001|Overall Study|Withdrawal by Subject|1|||
131500560|NCT03318315|473461471|FG000|Overall Study|Lost to Follow-up|3|||
131500561|NCT03318315|473461472|FG001|Overall Study|Lost to Follow-up|2|||
131500562|NCT03318315|473461473|FG002|Overall Study|Lost to Follow-up|1|||
131500563|NCT03318315|473461471|FG000|Overall Study|Protocol Violation|1|||
131500564|NCT03318315|473461472|FG001|Overall Study|Protocol Violation|1|||
131500565|NCT03318315|473461473|FG002|Overall Study|Protocol Violation|1|||
131500566|NCT03318315|473461471|FG000|Overall Study|Withdrawal by Subject|0|||
131500567|NCT03318315|473461472|FG001|Overall Study|Withdrawal by Subject|0|||
131500568|NCT03318315|473461473|FG002|Overall Study|Withdrawal by Subject|2|||
131500569|NCT02611778|473461474|FG000|Overall Study|Withdrawal by Subject|2|||
131500570|NCT02611778|473461475|FG001|Overall Study|Withdrawal by Subject|8|||
131500571|NCT02611778|473461474|FG000|Overall Study|Adverse Event|1|||
131500572|NCT02611778|473461475|FG001|Overall Study|Adverse Event|2|||
131500573|NCT02611778|473461474|FG000|Overall Study|Death|2|||
131500574|NCT02611778|473461475|FG001|Overall Study|Death|1|||
131500575|NCT02611778|473461474|FG000|Overall Study|Protocol Violation|1|||
131500576|NCT02611778|473461475|FG001|Overall Study|Protocol Violation|0|||
131500577|NCT02611778|473461474|FG000|Overall Study|Lost to Follow-up|3|||
131500578|NCT02611778|473461475|FG001|Overall Study|Lost to Follow-up|1|||
131500579|NCT02611778|473461474|FG000|Overall Study|Need for alternative treatment|1|||
131500580|NCT02611778|473461475|FG001|Overall Study|Need for alternative treatment|0|||
131500581|NCT02611778|473461474|FG000|Overall Study|Other Reason|2|||
131500582|NCT02611778|473461475|FG001|Overall Study|Other Reason|1|||
131500583|NCT01896531|473461481|FG000|Overall Study|Death|57|||
131500584|NCT01896531|473461482|FG001|Overall Study|Death|59|||
131500585|NCT01896531|473461481|FG000|Overall Study|Lost to Follow-up|3|||
131500586|NCT01896531|473461482|FG001|Overall Study|Lost to Follow-up|0|||
131500587|NCT01896531|473461481|FG000|Overall Study|Non-compliance|0|||
131500588|NCT01896531|473461482|FG001|Overall Study|Non-compliance|1|||
131500589|NCT01896531|473461481|FG000|Overall Study|Study Ended by Sponsor|7|||
131500590|NCT01896531|473461482|FG001|Overall Study|Study Ended by Sponsor|20|||
131500591|NCT01896531|473461481|FG000|Overall Study|Withdrawal by Subject|3|||
131500592|NCT01896531|473461482|FG001|Overall Study|Withdrawal by Subject|2|||
131500593|NCT01896531|473461481|FG000|Overall Study|Death Prior to Treatment|1|||
131500594|NCT01896531|473461482|FG001|Overall Study|Death Prior to Treatment|0|||
131500595|NCT00770289|473461485|FG000|Overall Study|Other|6|||
131500596|NCT02659631|473461486|FG000|Overall Study|Lost to Follow-up|0|||
131500597|NCT02659631|473461487|FG001|Overall Study|Lost to Follow-up|0|||
131500598|NCT02659631|473461488|FG002|Overall Study|Lost to Follow-up|2|||
131500599|NCT02659631|473461489|FG003|Overall Study|Lost to Follow-up|0|||
131500600|NCT02659631|473461490|FG004|Overall Study|Lost to Follow-up|0|||
131500601|NCT02659631|473461491|FG005|Overall Study|Lost to Follow-up|1|||
131500602|NCT02659631|473461492|FG006|Overall Study|Lost to Follow-up|0|||
131500603|NCT02659631|473461493|FG007|Overall Study|Lost to Follow-up|0|||
131500604|NCT02659631|473461494|FG008|Overall Study|Lost to Follow-up|0|||
131500605|NCT02659631|473461495|FG009|Overall Study|Lost to Follow-up|0|||
131500606|NCT02659631|473461486|FG000|Overall Study|Withdrawal prior to treatment|0|||
131500607|NCT02659631|473461487|FG001|Overall Study|Withdrawal prior to treatment|0|||
131500608|NCT02659631|473461488|FG002|Overall Study|Withdrawal prior to treatment|0|||
131500609|NCT02659631|473461489|FG003|Overall Study|Withdrawal prior to treatment|0|||
131500610|NCT02659631|473461490|FG004|Overall Study|Withdrawal prior to treatment|1|||
131500611|NCT02659631|473461491|FG005|Overall Study|Withdrawal prior to treatment|0|||
131500612|NCT02659631|473461492|FG006|Overall Study|Withdrawal prior to treatment|0|||
131500613|NCT02659631|473461493|FG007|Overall Study|Withdrawal prior to treatment|0|||
131500614|NCT02659631|473461494|FG008|Overall Study|Withdrawal prior to treatment|0|||
131500615|NCT02659631|473461495|FG009|Overall Study|Withdrawal prior to treatment|0|||
131500616|NCT02659631|473461486|FG000|Overall Study|Participant refused further follow-up|0|||
131500617|NCT02659631|473461487|FG001|Overall Study|Participant refused further follow-up|0|||
131500618|NCT02659631|473461488|FG002|Overall Study|Participant refused further follow-up|0|||
131500619|NCT02659631|473461489|FG003|Overall Study|Participant refused further follow-up|1|||
131500620|NCT02659631|473461490|FG004|Overall Study|Participant refused further follow-up|0|||
131500621|NCT02659631|473461491|FG005|Overall Study|Participant refused further follow-up|0|||
131500622|NCT02659631|473461492|FG006|Overall Study|Participant refused further follow-up|0|||
131500623|NCT02659631|473461493|FG007|Overall Study|Participant refused further follow-up|0|||
131500624|NCT02659631|473461494|FG008|Overall Study|Participant refused further follow-up|1|||
131500625|NCT02659631|473461495|FG009|Overall Study|Participant refused further follow-up|0|||
131500626|NCT02659631|473461486|FG000|Overall Study|Death (follow-up phase)|1|||
131500627|NCT02659631|473461487|FG001|Overall Study|Death (follow-up phase)|2|||
131500628|NCT02659631|473461488|FG002|Overall Study|Death (follow-up phase)|1|||
131500629|NCT02659631|473461489|FG003|Overall Study|Death (follow-up phase)|1|||
131500630|NCT02659631|473461490|FG004|Overall Study|Death (follow-up phase)|3|||
131500631|NCT02659631|473461491|FG005|Overall Study|Death (follow-up phase)|2|||
131500632|NCT02659631|473461492|FG006|Overall Study|Death (follow-up phase)|0|||
131500633|NCT02659631|473461493|FG007|Overall Study|Death (follow-up phase)|3|||
131500634|NCT02659631|473461494|FG008|Overall Study|Death (follow-up phase)|1|||
131500635|NCT02659631|473461495|FG009|Overall Study|Death (follow-up phase)|0|||
131500636|NCT02659631|473461486|FG000|Overall Study|Death (treatment phase)|0|||
131500637|NCT02659631|473461487|FG001|Overall Study|Death (treatment phase)|0|||
131500638|NCT02659631|473461488|FG002|Overall Study|Death (treatment phase)|0|||
131500639|NCT02659631|473461489|FG003|Overall Study|Death (treatment phase)|0|||
131500640|NCT02659631|473461490|FG004|Overall Study|Death (treatment phase)|1|||
131500641|NCT02659631|473461491|FG005|Overall Study|Death (treatment phase)|0|||
131500642|NCT02659631|473461492|FG006|Overall Study|Death (treatment phase)|1|||
131500643|NCT02659631|473461493|FG007|Overall Study|Death (treatment phase)|0|||
131500644|NCT02659631|473461494|FG008|Overall Study|Death (treatment phase)|0|||
131500645|NCT02659631|473461495|FG009|Overall Study|Death (treatment phase)|0|||
131500646|NCT02377466|473461496|FG000|Overall Study|Other: Randomized and not treated|0|||
131500647|NCT02377466|473461497|FG001|Overall Study|Other: Randomized and not treated|2|||
131500648|NCT04210310|473461498|FG000|Overall Study|Lost to Follow-up|32|||
131500649|NCT04210310|473461499|FG001|Overall Study|Lost to Follow-up|1|||
131500650|NCT00495170|473461500|FG000|Overall Study|Lost to Follow-up|9|||
131500651|NCT00495170|473461500|FG000|Overall Study|Withdrawal by Subject|3|||
131500652|NCT00495170|473461500|FG000|Overall Study|Inappropriate staging|8|||
131500653|NCT00330616|473461503|FG000|Overall Study|Adverse Event|13|||
131500654|NCT00330616|473461503|FG000|Overall Study|Lack of Efficacy|1|||
131500655|NCT00330616|473461503|FG000|Overall Study|Lost to Follow-up|2|||
131500656|NCT00330616|473461503|FG000|Overall Study|Withdrawal by Subject|4|||
131500657|NCT00330616|473461503|FG000|Overall Study|Other|1|||
131500658|NCT04285879|473461518|FG000|Overall Study|Lost to Follow-up|1|||
131500659|NCT04285879|473461519|FG001|Overall Study|Lost to Follow-up|8|||
131500660|NCT04285879|473461518|FG000|Overall Study|medical/surgical exclusion|16|||
131500661|NCT04285879|473461519|FG001|Overall Study|medical/surgical exclusion|0|||
131500662|NCT02056340|473461520|FG000|Overall Study|Lost to Follow-up|5|||
131500663|NCT02056340|473461521|FG001|Overall Study|Lost to Follow-up|5|||
131500664|NCT02056340|473461520|FG000|Overall Study|Withdrawal by Subject|2|||
131500665|NCT02056340|473461521|FG001|Overall Study|Withdrawal by Subject|6|||
131500666|NCT02028065|473461523|FG000|Randomization Through Start Treatment|Not treated|1|||
131500667|NCT02028065|473461524|FG001|Randomization Through Start Treatment|Not treated|3|||
131500668|NCT02028065|473461525|FG002|Randomization Through Start Treatment|Not treated|3|||
131500669|NCT02028065|473461523|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
131500670|NCT02028065|473461524|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
131500671|NCT02028065|473461525|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
131500672|NCT02028065|473461523|FG000|Treatment Through Study Completion|Physician Decision|1|||
131500673|NCT02028065|473461524|FG001|Treatment Through Study Completion|Physician Decision|0|||
131500674|NCT02028065|473461525|FG002|Treatment Through Study Completion|Physician Decision|0|||
131500675|NCT02028065|473461523|FG000|Treatment Through Study Completion|Protocol Violation|1|||
131500676|NCT02028065|473461524|FG001|Treatment Through Study Completion|Protocol Violation|4|||
131500677|NCT02028065|473461525|FG002|Treatment Through Study Completion|Protocol Violation|0|||
131500678|NCT02028065|473461523|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
131500679|NCT02028065|473461524|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
131500680|NCT02028065|473461525|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
131500681|NCT02028065|473461523|FG000|Treatment Through Study Completion|Adverse Event|3|||
131500682|NCT02028065|473461524|FG001|Treatment Through Study Completion|Adverse Event|3|||
131500683|NCT02028065|473461525|FG002|Treatment Through Study Completion|Adverse Event|5|||
131500684|NCT00459667|473461531|FG000|Overall Study|Adverse Event|9|||
131500685|NCT00459667|473461532|FG001|Overall Study|Adverse Event|12|||
131500686|NCT00459667|473461533|FG002|Overall Study|Adverse Event|8|||
131500687|NCT00459667|473461531|FG000|Overall Study|Lost to Follow-up|5|||
131500688|NCT00459667|473461532|FG001|Overall Study|Lost to Follow-up|9|||
131500689|NCT00459667|473461533|FG002|Overall Study|Lost to Follow-up|3|||
131500690|NCT00459667|473461531|FG000|Overall Study|Pregnancy|1|||
131500691|NCT00459667|473461532|FG001|Overall Study|Pregnancy|1|||
131500692|NCT00459667|473461533|FG002|Overall Study|Pregnancy|1|||
131500693|NCT00459667|473461531|FG000|Overall Study|Protocol Violation|1|||
131500694|NCT00459667|473461532|FG001|Overall Study|Protocol Violation|0|||
131500695|NCT00459667|473461533|FG002|Overall Study|Protocol Violation|0|||
131500696|NCT00459667|473461531|FG000|Overall Study|Withdrawal by Subject|3|||
131500697|NCT00459667|473461532|FG001|Overall Study|Withdrawal by Subject|5|||
131500698|NCT00459667|473461533|FG002|Overall Study|Withdrawal by Subject|5|||
131500699|NCT00459667|473461531|FG000|Overall Study|Other disease modifying treatment|1|||
131500700|NCT00459667|473461532|FG001|Overall Study|Other disease modifying treatment|2|||
131500701|NCT00459667|473461533|FG002|Overall Study|Other disease modifying treatment|1|||
131500702|NCT00459667|473461531|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
131500703|NCT00459667|473461532|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
131500704|NCT00459667|473461533|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
131500705|NCT00459667|473461531|FG000|Overall Study|No treatment administered|6|||
131500706|NCT00459667|473461532|FG001|Overall Study|No treatment administered|3|||
131500707|NCT00459667|473461533|FG002|Overall Study|No treatment administered|1|||
131500708|NCT00396591|473461534|FG000|Overall Study|Disease Progression|13|||
131500709|NCT00396591|473461534|FG000|Overall Study|Adverse Event|2|||
131500710|NCT00396591|473461534|FG000|Overall Study|Participant request|1|||
131500711|NCT01013701|473461535|FG000|Overall Study|study prematurely terminated|7|||
131500712|NCT00847704|473461536|FG000|Overall Study|Withdrawal by Subject|1|||
131500713|NCT01572909|473463295|FG000|Overall Study|Adverse Event|7|||
131500714|NCT01572909|473463296|FG001|Overall Study|Adverse Event|2|||
131500715|NCT01572909|473463295|FG000|Overall Study|Death|3|||
131500716|NCT01572909|473463296|FG001|Overall Study|Death|1|||
131500717|NCT01572909|473463295|FG000|Overall Study|Lost to Follow-up|8|||
131500718|NCT01572909|473463296|FG001|Overall Study|Lost to Follow-up|7|||
131500719|NCT01572909|473463295|FG000|Overall Study|Physician Decision|1|||
131500720|NCT01572909|473463296|FG001|Overall Study|Physician Decision|1|||
131500721|NCT01572909|473463295|FG000|Overall Study|Technical Issues|1|||
131500722|NCT01572909|473463296|FG001|Overall Study|Technical Issues|0|||
131500723|NCT01572909|473463295|FG000|Overall Study|Withdrawal by Subject|12|||
131500724|NCT01572909|473463296|FG001|Overall Study|Withdrawal by Subject|11|||
131500725|NCT01572909|473463295|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
131500726|NCT01572909|473463296|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
131500727|NCT03641651|473463297|FG000|Overall Study|organizational issues at one study site|1|||
131500728|NCT04779489|473463298|FG000|Overall Study|Physician Decision|1|||
131500729|NCT00623727|473463299|FG000|Double Blind (DB)|Adverse Event|1|||
131500730|NCT00623727|473463300|FG001|Double Blind (DB)|Adverse Event|3|||
131500731|NCT00623727|473463299|FG000|Double Blind (DB)|Physician Decision|0|||
131500732|NCT00623727|473463300|FG001|Double Blind (DB)|Physician Decision|1|||
131500733|NCT00623727|473463299|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
131500734|NCT00623727|473463300|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
131500735|NCT00623727|473463299|FG000|Double Blind (DB)|Lack of Efficacy|2|||
131500736|NCT00623727|473463300|FG001|Double Blind (DB)|Lack of Efficacy|2|||
131500737|NCT00623727|473463299|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
131500738|NCT00623727|473463300|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
131500739|NCT00623727|473463299|FG000|Double Blind (DB)|Lost to Follow-up|1|||
131500740|NCT00623727|473463300|FG001|Double Blind (DB)|Lost to Follow-up|1|||
131500741|NCT00623727|473463299|FG000|Double Blind (DB)|Protocol Violation|2|||
131500742|NCT00623727|473463300|FG001|Double Blind (DB)|Protocol Violation|2|||
131500743|NCT00623727|473463299|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
131500744|NCT00623727|473463300|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
131500745|NCT00623727|473463299|FG000|Open Label Follow-up|Study termination|0|||
131500746|NCT00623727|473463300|FG001|Open Label Follow-up|Study termination|6|||
131500747|NCT00623727|473463299|FG000|Open Label Follow-up|Participant convenience|0|||
131500748|NCT00623727|473463300|FG001|Open Label Follow-up|Participant convenience|1|||
131500749|NCT00951665|473463301|FG000|Phase 1b|Adverse Event|2|||
131500750|NCT00951665|473463302|FG001|Phase 1b|Adverse Event|1|||
131500751|NCT00951665|473463303|FG002|Phase 1b|Adverse Event|0|||
131500752|NCT00951665|473463304|FG003|Phase 1b|Adverse Event|1|||
131500753|NCT00951665|473463305|FG004|Phase 1b|Adverse Event|0|||
131500754|NCT00951665|473463306|FG005|Phase 1b|Adverse Event|0|||
131500755|NCT00951665|473463301|FG000|Phase 1b|Death|1|||
131500756|NCT00951665|473463302|FG001|Phase 1b|Death|0|||
131500757|NCT00951665|473463303|FG002|Phase 1b|Death|2|||
131500758|NCT00951665|473463304|FG003|Phase 1b|Death|0|||
131500759|NCT00951665|473463305|FG004|Phase 1b|Death|0|||
131500760|NCT00951665|473463306|FG005|Phase 1b|Death|0|||
131500761|NCT00951665|473463301|FG000|Phase 1b|Physician Decision|4|||
131500762|NCT00951665|473463302|FG001|Phase 1b|Physician Decision|0|||
131500763|NCT00951665|473463303|FG002|Phase 1b|Physician Decision|1|||
131500764|NCT00951665|473463304|FG003|Phase 1b|Physician Decision|0|||
131500765|NCT00951665|473463305|FG004|Phase 1b|Physician Decision|0|||
131500766|NCT00951665|473463306|FG005|Phase 1b|Physician Decision|0|||
131500767|NCT00951665|473463301|FG000|Phase 1b|Withdrawal by Subject|0|||
131500768|NCT00951665|473463302|FG001|Phase 1b|Withdrawal by Subject|1|||
131500769|NCT00951665|473463303|FG002|Phase 1b|Withdrawal by Subject|0|||
131500770|NCT00951665|473463304|FG003|Phase 1b|Withdrawal by Subject|0|||
131500771|NCT00951665|473463305|FG004|Phase 1b|Withdrawal by Subject|0|||
131500772|NCT00951665|473463306|FG005|Phase 1b|Withdrawal by Subject|0|||
131500773|NCT00951665|473463301|FG000|Phase 1b|Disease Progression|13|||
131500774|NCT00951665|473463302|FG001|Phase 1b|Disease Progression|2|||
131500775|NCT00951665|473463303|FG002|Phase 1b|Disease Progression|14|||
131500776|NCT00951665|473463304|FG003|Phase 1b|Disease Progression|0|||
131500777|NCT00951665|473463305|FG004|Phase 1b|Disease Progression|0|||
131500778|NCT00951665|473463306|FG005|Phase 1b|Disease Progression|0|||
131500779|NCT00951665|473463301|FG000|Phase 1b|Protocol Violation|2|||
131500780|NCT00951665|473463302|FG001|Phase 1b|Protocol Violation|0|||
131500781|NCT00951665|473463303|FG002|Phase 1b|Protocol Violation|0|||
131500782|NCT00951665|473463304|FG003|Phase 1b|Protocol Violation|0|||
131500783|NCT00951665|473463305|FG004|Phase 1b|Protocol Violation|0|||
131500784|NCT00951665|473463306|FG005|Phase 1b|Protocol Violation|0|||
131500785|NCT00951665|473463301|FG000|Phase 2a|Adverse Event|0|||
131500786|NCT00951665|473463302|FG001|Phase 2a|Adverse Event|0|||
131500787|NCT00951665|473463303|FG002|Phase 2a|Adverse Event|0|||
131500788|NCT00951665|473463304|FG003|Phase 2a|Adverse Event|0|||
131500789|NCT00951665|473463305|FG004|Phase 2a|Adverse Event|2|||
131500790|NCT00951665|473463306|FG005|Phase 2a|Adverse Event|0|||
131500791|NCT00951665|473463301|FG000|Phase 2a|Death|0|||
131500792|NCT00951665|473463302|FG001|Phase 2a|Death|0|||
131500793|NCT00951665|473463303|FG002|Phase 2a|Death|0|||
131500794|NCT00951665|473463304|FG003|Phase 2a|Death|0|||
131500795|NCT00951665|473463305|FG004|Phase 2a|Death|1|||
131500796|NCT00951665|473463306|FG005|Phase 2a|Death|1|||
131500797|NCT00951665|473463301|FG000|Phase 2a|Lost to Follow-up|0|||
131500798|NCT00951665|473463302|FG001|Phase 2a|Lost to Follow-up|0|||
131500799|NCT00951665|473463303|FG002|Phase 2a|Lost to Follow-up|0|||
131500800|NCT00951665|473463304|FG003|Phase 2a|Lost to Follow-up|0|||
131500801|NCT00951665|473463305|FG004|Phase 2a|Lost to Follow-up|1|||
131500802|NCT00951665|473463306|FG005|Phase 2a|Lost to Follow-up|0|||
131500803|NCT00951665|473463301|FG000|Phase 2a|Physician Decision|0|||
131500804|NCT00951665|473463302|FG001|Phase 2a|Physician Decision|0|||
131500805|NCT00951665|473463303|FG002|Phase 2a|Physician Decision|0|||
131500806|NCT00951665|473463304|FG003|Phase 2a|Physician Decision|0|||
131500807|NCT00951665|473463305|FG004|Phase 2a|Physician Decision|0|||
131500808|NCT00951665|473463306|FG005|Phase 2a|Physician Decision|1|||
131500809|NCT00951665|473463301|FG000|Phase 2a|Withdrawal by Subject|0|||
131500810|NCT00951665|473463302|FG001|Phase 2a|Withdrawal by Subject|0|||
131500811|NCT00951665|473463303|FG002|Phase 2a|Withdrawal by Subject|0|||
131500812|NCT00951665|473463304|FG003|Phase 2a|Withdrawal by Subject|0|||
131500813|NCT00951665|473463305|FG004|Phase 2a|Withdrawal by Subject|2|||
131500814|NCT00951665|473463306|FG005|Phase 2a|Withdrawal by Subject|0|||
131500815|NCT00951665|473463301|FG000|Phase 2a|Disease Progression|0|||
131500816|NCT00951665|473463302|FG001|Phase 2a|Disease Progression|0|||
131500817|NCT00951665|473463303|FG002|Phase 2a|Disease Progression|0|||
131500818|NCT00951665|473463304|FG003|Phase 2a|Disease Progression|0|||
131500819|NCT00951665|473463305|FG004|Phase 2a|Disease Progression|6|||
131500820|NCT00951665|473463306|FG005|Phase 2a|Disease Progression|5|||
131500821|NCT00127712|473463312|FG000|Overall Study|Adverse Event|3|||
131500822|NCT00127712|473463313|FG001|Overall Study|Adverse Event|0|||
131500823|NCT00127712|473463312|FG000|Overall Study|Lack of GI access to continue|2|||
131500824|NCT00127712|473463313|FG001|Overall Study|Lack of GI access to continue|0|||
131500825|NCT02642614|473463314|FG000|Overall Study|Adverse Event|1|||
131500826|NCT02642614|473463315|FG001|Overall Study|Adverse Event|1|||
131500827|NCT02642614|473463316|FG002|Overall Study|Adverse Event|2|||
131500828|NCT02642614|473463317|FG003|Overall Study|Adverse Event|2|||
131500829|NCT02642614|473463314|FG000|Overall Study|Lost to Follow-up|1|||
131500830|NCT02642614|473463315|FG001|Overall Study|Lost to Follow-up|0|||
131500831|NCT02642614|473463316|FG002|Overall Study|Lost to Follow-up|0|||
131500832|NCT02642614|473463317|FG003|Overall Study|Lost to Follow-up|0|||
131500833|NCT02642614|473463314|FG000|Overall Study|Withdrawal by Subject|1|||
131500834|NCT02642614|473463315|FG001|Overall Study|Withdrawal by Subject|1|||
131500835|NCT02642614|473463316|FG002|Overall Study|Withdrawal by Subject|0|||
131500836|NCT02642614|473463317|FG003|Overall Study|Withdrawal by Subject|0|||
131500837|NCT01164956|473463318|FG000|Overall Study|Side Effects|1|||
131500838|NCT01164956|473463319|FG001|Overall Study|Side Effects|0|||
131500839|NCT01164956|473463320|FG002|Overall Study|Side Effects|1|||
131500840|NCT01349803|473463323|FG000|Overall Study|Adverse Event|0|||
131500841|NCT01349803|473463324|FG001|Overall Study|Adverse Event|0|||
131500842|NCT01349803|473463325|FG002|Overall Study|Adverse Event|0|||
131500843|NCT01349803|473463326|FG003|Overall Study|Adverse Event|2|||
131500844|NCT01349803|473463323|FG000|Overall Study|Withdrawal by Subject|1|||
131500845|NCT01349803|473463324|FG001|Overall Study|Withdrawal by Subject|0|||
131500846|NCT01349803|473463325|FG002|Overall Study|Withdrawal by Subject|0|||
131500847|NCT01349803|473463326|FG003|Overall Study|Withdrawal by Subject|0|||
131500848|NCT01349803|473463323|FG000|Overall Study|Protocol-specified criteria|0|||
131500849|NCT01349803|473463324|FG001|Overall Study|Protocol-specified criteria|1|||
131500850|NCT01349803|473463325|FG002|Overall Study|Protocol-specified criteria|3|||
131500851|NCT01349803|473463326|FG003|Overall Study|Protocol-specified criteria|0|||
131500852|NCT00100815|473463327|FG000|Overall Study|Progression|24|||
131500853|NCT00100815|473463327|FG000|Overall Study|Adverse Event|18|||
131500854|NCT00100815|473463327|FG000|Overall Study|Death|4|||
131500855|NCT00100815|473463327|FG000|Overall Study|Other|3|||
131500856|NCT01710033|473463328|FG000|Stage 2|Adverse Event|0|||
131500857|NCT01710033|473463329|FG001|Stage 2|Adverse Event|0|||
131500858|NCT01710033|473463330|FG002|Stage 2|Adverse Event|0|||
131500859|NCT01710033|473463331|FG003|Stage 2|Adverse Event|0|||
131500860|NCT01710033|473463332|FG004|Stage 2|Adverse Event|1|||
131500861|NCT01647282|473463334|FG000|Overall Study|Physician Decision|7|||
131500862|NCT01647282|473463335|FG001|Overall Study|Physician Decision|5|||
131500863|NCT00723892|473463341|FG000|Overall Study|Participant not tracked|33|||
131500864|NCT00723892|473463342|FG001|Overall Study|Participant not tracked|35|||
131500865|NCT00723892|473463341|FG000|Overall Study|Virological criterion|24|||
131500866|NCT00723892|473463342|FG001|Overall Study|Virological criterion|9|||
131500867|NCT00723892|473463341|FG000|Overall Study|Withdrawal by Subject|6|||
131500868|NCT00723892|473463342|FG001|Overall Study|Withdrawal by Subject|9|||
131500869|NCT00723892|473463341|FG000|Overall Study|End planned|11|||
131500870|NCT00723892|473463342|FG001|Overall Study|End planned|7|||
131500871|NCT00723892|473463341|FG000|Overall Study|Bad tolerance|5|||
131500872|NCT00723892|473463342|FG001|Overall Study|Bad tolerance|5|||
131500873|NCT00723892|473463341|FG000|Overall Study|Multiple reasons|17|||
131500874|NCT00723892|473463342|FG001|Overall Study|Multiple reasons|12|||
131500875|NCT00723892|473463341|FG000|Overall Study|Other|6|||
131500876|NCT00723892|473463342|FG001|Overall Study|Other|3|||
131500877|NCT00723892|473463341|FG000|Overall Study|Study end|1|||
131500878|NCT00723892|473463342|FG001|Overall Study|Study end|3|||
131500879|NCT00723892|473463341|FG000|Overall Study|Weight loss|1|||
131500880|NCT00723892|473463342|FG001|Overall Study|Weight loss|3|||
131500881|NCT00723892|473463341|FG000|Overall Study|Alcohol abuse|0|||
131500882|NCT00723892|473463342|FG001|Overall Study|Alcohol abuse|1|||
131500883|NCT00723892|473463341|FG000|Overall Study|Intercurrent infection|2|||
131500884|NCT00723892|473463342|FG001|Overall Study|Intercurrent infection|0|||
131500885|NCT00723892|473463341|FG000|Overall Study|Drug addiction|1|||
131500886|NCT00723892|473463342|FG001|Overall Study|Drug addiction|0|||
131500887|NCT02411292|473463346|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
131500888|NCT02411292|473463346|FG000|Overall Study|Death|2|||
131500889|NCT02411292|473463346|FG000|Overall Study|Lost to Follow-up|3|||
131500890|NCT00453921|473463347|FG000|Overall Study|Withdrawal by Subject|1|||
131500891|NCT00453921|473463348|FG001|Overall Study|Withdrawal by Subject|1|||
131500892|NCT00453921|473463349|FG002|Overall Study|Withdrawal by Subject|1|||
131500893|NCT00453921|473463350|FG003|Overall Study|Withdrawal by Subject|1|||
131500894|NCT00453921|473463347|FG000|Overall Study|Lost to Follow-up|0|||
131500895|NCT00453921|473463348|FG001|Overall Study|Lost to Follow-up|0|||
131500896|NCT00453921|473463349|FG002|Overall Study|Lost to Follow-up|1|||
131500897|NCT00453921|473463350|FG003|Overall Study|Lost to Follow-up|0|||
131500898|NCT02232425|473463351|FG000|Overall Study|Lost to Follow-up|6|||
131500899|NCT02232425|473463352|FG001|Overall Study|Lost to Follow-up|2|||
131500900|NCT02232425|473463351|FG000|Overall Study|Adverse Event|2|||
131500901|NCT02232425|473463352|FG001|Overall Study|Adverse Event|0|||
131500902|NCT02232425|473463351|FG000|Overall Study|Withdrawal by Subject|5|||
131500903|NCT02232425|473463352|FG001|Overall Study|Withdrawal by Subject|6|||
131500904|NCT02232425|473463351|FG000|Overall Study|Lack of Efficacy|1|||
131500905|NCT02232425|473463352|FG001|Overall Study|Lack of Efficacy|0|||
131500906|NCT00665353|473463353|FG000|Study Step 1|Adverse Event|1|||
131500907|NCT00665353|473463353|FG000|Study Step 1|Withdrawal by Subject|2|||
131500908|NCT00665353|473463353|FG000|Study Step 2|Lost to Follow-up|2|||
131500909|NCT00665353|473463353|FG000|Study Step 2|Lack of Efficacy|12|||
131500910|NCT00498602|473463354|FG000|Overall Study|Death|0|||
131500911|NCT00498602|473463355|FG001|Overall Study|Death|0|||
131500912|NCT00498602|473463356|FG002|Overall Study|Death|0|||
131500913|NCT00498602|473463357|FG003|Overall Study|Death|0|||
131500914|NCT00498602|473463358|FG004|Overall Study|Death|0|||
131500915|NCT00498602|473463359|FG005|Overall Study|Death|1|||
131434071|NCT01894607|473214628|FG000|Overall Study|Ineligible|1|||
131434072|NCT03259555|473214643|FG000|Overall Study|Adverse Event|6|||
131434073|NCT03259555|473214644|FG001|Overall Study|Adverse Event|4|||
131434074|NCT03259555|473214643|FG000|Overall Study|Lack of Efficacy|6|||
131434075|NCT03259555|473214644|FG001|Overall Study|Lack of Efficacy|4|||
131434076|NCT03259555|473214643|FG000|Overall Study|Lost to Follow-up|0|||
131434077|NCT03259555|473214644|FG001|Overall Study|Lost to Follow-up|2|||
131434078|NCT03259555|473214643|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131434079|NCT03259555|473214644|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131434080|NCT03259555|473214643|FG000|Overall Study|Progressive Disease|0|||
131434081|NCT03259555|473214644|FG001|Overall Study|Progressive Disease|2|||
131434082|NCT03259555|473214643|FG000|Overall Study|Withdrawal by Subject|19|||
131434083|NCT03259555|473214644|FG001|Overall Study|Withdrawal by Subject|16|||
131434084|NCT03259555|473214643|FG000|Overall Study|Physician Decision|1|||
131434085|NCT03259555|473214644|FG001|Overall Study|Physician Decision|2|||
131434086|NCT03259555|473214643|FG000|Overall Study|Other|1|||
131434087|NCT03259555|473214644|FG001|Overall Study|Other|0|||
131434088|NCT04393493|473214646|FG000|First 4 Days of Intervention|Early improvement|5|||
131434089|NCT04393493|473214647|FG001|First 4 Days of Intervention|Early improvement|7|||
131434090|NCT01125800|473214648|FG000|Phase I|Protocol Violation|0|||
131434091|NCT01125800|473214649|FG001|Phase I|Protocol Violation|3|||
131434092|NCT01125800|473214650|FG002|Phase I|Protocol Violation|1|||
131434093|NCT01125800|473214651|FG003|Phase I|Protocol Violation|1|||
131434094|NCT01125800|473214652|FG004|Phase I|Protocol Violation|0|||
131434095|NCT01125800|473214648|FG000|Phase I|Adverse Event|2|||
131434096|NCT01125800|473214649|FG001|Phase I|Adverse Event|2|||
131434097|NCT01125800|473214650|FG002|Phase I|Adverse Event|1|||
131434098|NCT01125800|473214651|FG003|Phase I|Adverse Event|7|||
131434099|NCT01125800|473214652|FG004|Phase I|Adverse Event|0|||
131434100|NCT01125800|473214648|FG000|Phase I|Administrative problems|1|||
131434101|NCT01125800|473214649|FG001|Phase I|Administrative problems|0|||
131434102|NCT01125800|473214650|FG002|Phase I|Administrative problems|0|||
131434103|NCT01125800|473214651|FG003|Phase I|Administrative problems|0|||
131434104|NCT01125800|473214652|FG004|Phase I|Administrative problems|0|||
131434105|NCT01125800|473214648|FG000|Phase I|Withdrawal by Subject|0|||
131434106|NCT01125800|473214649|FG001|Phase I|Withdrawal by Subject|0|||
131434107|NCT01125800|473214650|FG002|Phase I|Withdrawal by Subject|1|||
131434108|NCT01125800|473214651|FG003|Phase I|Withdrawal by Subject|0|||
131434109|NCT01125800|473214652|FG004|Phase I|Withdrawal by Subject|0|||
131434110|NCT01125800|473214648|FG000|Phase I|Disease progression|5|||
131434111|NCT01125800|473214649|FG001|Phase I|Disease progression|4|||
131434112|NCT01125800|473214650|FG002|Phase I|Disease progression|1|||
131434113|NCT01125800|473214651|FG003|Phase I|Disease progression|3|||
131434114|NCT01125800|473214652|FG004|Phase I|Disease progression|0|||
131434115|NCT01125800|473214648|FG000|Phase II|Protocol Violation|0|||
131434116|NCT01125800|473214649|FG001|Phase II|Protocol Violation|0|||
131434117|NCT01125800|473214650|FG002|Phase II|Protocol Violation|0|||
131434118|NCT01125800|473214651|FG003|Phase II|Protocol Violation|0|||
131434119|NCT01125800|473214652|FG004|Phase II|Protocol Violation|1|||
131434120|NCT01125800|473214648|FG000|Phase II|Adverse Event|0|||
131434121|NCT01125800|473214649|FG001|Phase II|Adverse Event|0|||
131434122|NCT01125800|473214650|FG002|Phase II|Adverse Event|0|||
131434123|NCT01125800|473214651|FG003|Phase II|Adverse Event|0|||
131434124|NCT01125800|473214652|FG004|Phase II|Adverse Event|2|||
131434125|NCT01125800|473214648|FG000|Phase II|Disease progression|0|||
131434126|NCT01125800|473214649|FG001|Phase II|Disease progression|0|||
131434127|NCT01125800|473214650|FG002|Phase II|Disease progression|0|||
131434128|NCT01125800|473214651|FG003|Phase II|Disease progression|1|||
131434129|NCT01125800|473214652|FG004|Phase II|Disease progression|8|||
131434130|NCT03370718|473214657|FG000|Overall Study|Withdrawal by Subject|1|||
131434131|NCT01572480|473214662|FG000|Participants Enrolled|Withdrawal by Subject|1|||
131434132|NCT01572480|473214662|FG000|Drug Administration|Discontinued drug/Off Study|1|||
131434133|NCT01572480|473214662|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
131434134|NCT01572480|473214662|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
131434135|NCT04037891|473214663|FG000|Open-label Period|Withdrawal by Subject|1|||
131434136|NCT04037891|473214664|FG001|Open-label Period|Withdrawal by Subject|0|||
131434137|NCT04037891|473214665|FG002|Open-label Period|Withdrawal by Subject|0|||
131434138|NCT04037891|473214663|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
131434139|NCT04037891|473214664|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
131434140|NCT04037891|473214665|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
131434141|NCT03446313|473214666|FG000|Overall Study|Lost to Follow-up|1|||
131434142|NCT03446313|473214667|FG001|Overall Study|Lost to Follow-up|2|||
131434143|NCT03446313|473214666|FG000|Overall Study|Failed primary screening|3|||
131434144|NCT03446313|473214667|FG001|Overall Study|Failed primary screening|0|||
131434145|NCT03446313|473214666|FG000|Overall Study|Diagnosed with terminal cancer|1|||
131434146|NCT03446313|473214667|FG001|Overall Study|Diagnosed with terminal cancer|0|||
131500916|NCT00498602|473463360|FG006|Overall Study|Death|0|||
131500917|NCT00498602|473463354|FG000|Overall Study|Lack of Efficacy|1|||
131500918|NCT00498602|473463355|FG001|Overall Study|Lack of Efficacy|0|||
131500919|NCT00498602|473463356|FG002|Overall Study|Lack of Efficacy|0|||
131500920|NCT00498602|473463357|FG003|Overall Study|Lack of Efficacy|0|||
131500921|NCT00498602|473463358|FG004|Overall Study|Lack of Efficacy|0|||
131500922|NCT00498602|473463359|FG005|Overall Study|Lack of Efficacy|0|||
131500923|NCT00498602|473463360|FG006|Overall Study|Lack of Efficacy|0|||
131500924|NCT00498602|473463354|FG000|Overall Study|Lost to Follow-up|0|||
131500925|NCT00498602|473463355|FG001|Overall Study|Lost to Follow-up|2|||
131500926|NCT00498602|473463356|FG002|Overall Study|Lost to Follow-up|0|||
131500927|NCT00498602|473463357|FG003|Overall Study|Lost to Follow-up|2|||
131500928|NCT00498602|473463358|FG004|Overall Study|Lost to Follow-up|0|||
131500929|NCT00498602|473463359|FG005|Overall Study|Lost to Follow-up|0|||
131500930|NCT00498602|473463360|FG006|Overall Study|Lost to Follow-up|0|||
131500931|NCT00498602|473463354|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
131500932|NCT00498602|473463355|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131500933|NCT00498602|473463356|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
131500934|NCT00498602|473463357|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
131500935|NCT00498602|473463358|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131500936|NCT00498602|473463359|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
131500937|NCT00498602|473463360|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131500938|NCT00498602|473463354|FG000|Overall Study|AE not related to Study Drug|1|||
131500939|NCT00498602|473463355|FG001|Overall Study|AE not related to Study Drug|3|||
131500940|NCT00498602|473463356|FG002|Overall Study|AE not related to Study Drug|0|||
131500941|NCT00498602|473463357|FG003|Overall Study|AE not related to Study Drug|0|||
131500942|NCT00498602|473463358|FG004|Overall Study|AE not related to Study Drug|2|||
131500943|NCT00498602|473463359|FG005|Overall Study|AE not related to Study Drug|2|||
131500944|NCT00498602|473463360|FG006|Overall Study|AE not related to Study Drug|1|||
131500945|NCT00498602|473463354|FG000|Overall Study|Caregiver Request|2|||
131500946|NCT00498602|473463355|FG001|Overall Study|Caregiver Request|2|||
131500947|NCT00498602|473463356|FG002|Overall Study|Caregiver Request|2|||
131500948|NCT00498602|473463357|FG003|Overall Study|Caregiver Request|0|||
131500949|NCT00498602|473463358|FG004|Overall Study|Caregiver Request|1|||
131500950|NCT00498602|473463359|FG005|Overall Study|Caregiver Request|2|||
131500951|NCT00498602|473463360|FG006|Overall Study|Caregiver Request|0|||
131500952|NCT00498602|473463354|FG000|Overall Study|Investigator Request|0|||
131500953|NCT00498602|473463355|FG001|Overall Study|Investigator Request|0|||
131500954|NCT00498602|473463356|FG002|Overall Study|Investigator Request|1|||
131500955|NCT00498602|473463357|FG003|Overall Study|Investigator Request|0|||
131500956|NCT00498602|473463358|FG004|Overall Study|Investigator Request|0|||
131500957|NCT00498602|473463359|FG005|Overall Study|Investigator Request|0|||
131500958|NCT00498602|473463360|FG006|Overall Study|Investigator Request|0|||
131500959|NCT00498602|473463354|FG000|Overall Study|Subject Request|3|||
131500960|NCT00498602|473463355|FG001|Overall Study|Subject Request|0|||
131500961|NCT00498602|473463356|FG002|Overall Study|Subject Request|1|||
131500962|NCT00498602|473463357|FG003|Overall Study|Subject Request|1|||
131500963|NCT00498602|473463358|FG004|Overall Study|Subject Request|1|||
131500964|NCT00498602|473463359|FG005|Overall Study|Subject Request|4|||
131500965|NCT00498602|473463360|FG006|Overall Study|Subject Request|1|||
131500966|NCT00498602|473463354|FG000|Overall Study|Other|2|||
131500967|NCT00498602|473463355|FG001|Overall Study|Other|3|||
131500968|NCT00498602|473463356|FG002|Overall Study|Other|1|||
131500969|NCT00498602|473463357|FG003|Overall Study|Other|0|||
131500970|NCT00498602|473463358|FG004|Overall Study|Other|0|||
131500971|NCT00498602|473463359|FG005|Overall Study|Other|3|||
131500972|NCT00498602|473463360|FG006|Overall Study|Other|0|||
131500973|NCT03103919|473463364|FG000|Overall Study|Adverse Event|2|||
131500974|NCT03103919|473463365|FG001|Overall Study|Adverse Event|2|||
131500975|NCT01291173|473463366|FG000|Overall Study|Adverse Event|0|||
131500976|NCT01291173|473463367|FG001|Overall Study|Adverse Event|3|||
131500977|NCT01291173|473463368|FG002|Overall Study|Adverse Event|1|||
131500978|NCT01291173|473463369|FG003|Overall Study|Adverse Event|3|||
131500979|NCT01291173|473463366|FG000|Overall Study|Protocol Violation|7|||
131500980|NCT01291173|473463367|FG001|Overall Study|Protocol Violation|2|||
131500981|NCT01291173|473463368|FG002|Overall Study|Protocol Violation|2|||
131500982|NCT01291173|473463369|FG003|Overall Study|Protocol Violation|5|||
131500983|NCT01291173|473463366|FG000|Overall Study|Withdrawal by Subject|6|||
131500984|NCT01291173|473463367|FG001|Overall Study|Withdrawal by Subject|4|||
131500985|NCT01291173|473463368|FG002|Overall Study|Withdrawal by Subject|4|||
131500986|NCT01291173|473463369|FG003|Overall Study|Withdrawal by Subject|2|||
131500987|NCT01291173|473463366|FG000|Overall Study|Lost to Follow-up|4|||
131500988|NCT01291173|473463367|FG001|Overall Study|Lost to Follow-up|6|||
131500989|NCT01291173|473463368|FG002|Overall Study|Lost to Follow-up|3|||
131500990|NCT01291173|473463369|FG003|Overall Study|Lost to Follow-up|2|||
131500991|NCT01291173|473463366|FG000|Overall Study|Unable to meet visit schedule|0|||
131500992|NCT01291173|473463367|FG001|Overall Study|Unable to meet visit schedule|0|||
131500993|NCT01291173|473463368|FG002|Overall Study|Unable to meet visit schedule|1|||
131500994|NCT01291173|473463369|FG003|Overall Study|Unable to meet visit schedule|0|||
131500995|NCT01291173|473463366|FG000|Overall Study|Lack of compliance|0|||
131500996|NCT01291173|473463367|FG001|Overall Study|Lack of compliance|0|||
131500997|NCT01291173|473463368|FG002|Overall Study|Lack of compliance|0|||
131500998|NCT01291173|473463369|FG003|Overall Study|Lack of compliance|1|||
131500999|NCT01291173|473463366|FG000|Overall Study|Subject was unblinded|0|||
131501000|NCT01291173|473463367|FG001|Overall Study|Subject was unblinded|0|||
131501001|NCT01291173|473463368|FG002|Overall Study|Subject was unblinded|1|||
131501002|NCT01291173|473463369|FG003|Overall Study|Subject was unblinded|0|||
131501003|NCT01291173|473463366|FG000|Overall Study|Excluded therapy|0|||
131501004|NCT01291173|473463367|FG001|Overall Study|Excluded therapy|0|||
131501005|NCT01291173|473463368|FG002|Overall Study|Excluded therapy|1|||
131501006|NCT01291173|473463369|FG003|Overall Study|Excluded therapy|0|||
131501007|NCT01846507|473463370|FG000|Overall Study|Lost to Follow-up|4|||
131501008|NCT01846507|473463370|FG000|Overall Study|Protocol Violation|1|||
131501009|NCT01846507|473463370|FG000|Overall Study|Missing data|2|||
131501010|NCT00993291|473463374|FG000|Overall Study|Withdrawal by Subject|1|||
131501011|NCT02763189|473463375|FG000|Overall Study|Device failure|0|||
131501012|NCT02763189|473463376|FG001|Overall Study|Device failure|2|||
131501013|NCT00573534|473463377|FG000|Overall Study|oppositional behavior|3|||
131501014|NCT00467259|473463383|FG000|Overall Study|Adverse Event|24|||
131501015|NCT00467259|473463384|FG001|Overall Study|Adverse Event|90|||
131501016|NCT00467259|473463383|FG000|Overall Study|Protocol Violation|1|||
131501017|NCT00467259|473463384|FG001|Overall Study|Protocol Violation|7|||
131501018|NCT00467259|473463383|FG000|Overall Study|Withdrawal by Subject|34|||
131501019|NCT00467259|473463384|FG001|Overall Study|Withdrawal by Subject|108|||
131501020|NCT00467259|473463383|FG000|Overall Study|Physician Decision|0|||
131501021|NCT00467259|473463384|FG001|Overall Study|Physician Decision|2|||
131501022|NCT00467259|473463383|FG000|Overall Study|Lost to Follow-up|14|||
131501023|NCT00467259|473463384|FG001|Overall Study|Lost to Follow-up|34|||
131501024|NCT00467259|473463383|FG000|Overall Study|Site Closed|2|||
131501025|NCT00467259|473463384|FG001|Overall Study|Site Closed|1|||
131501026|NCT01129960|473463392|FG000|Overall Study|Withdrawal by Subject|3|||
131501027|NCT01129960|473463393|FG001|Overall Study|Withdrawal by Subject|0|||
131501028|NCT01129960|473463394|FG002|Overall Study|Withdrawal by Subject|3|||
131501029|NCT01129960|473463395|FG003|Overall Study|Withdrawal by Subject|2|||
131501030|NCT01129960|473463392|FG000|Overall Study|Lack of Efficacy|1|||
131501031|NCT01129960|473463393|FG001|Overall Study|Lack of Efficacy|1|||
131501032|NCT01129960|473463394|FG002|Overall Study|Lack of Efficacy|1|||
131501033|NCT01129960|473463395|FG003|Overall Study|Lack of Efficacy|1|||
131501034|NCT01129960|473463392|FG000|Overall Study|Adverse Event|23|||
131501035|NCT01129960|473463393|FG001|Overall Study|Adverse Event|16|||
131501036|NCT01129960|473463394|FG002|Overall Study|Adverse Event|16|||
131501037|NCT01129960|473463395|FG003|Overall Study|Adverse Event|7|||
131501038|NCT01129960|473463392|FG000|Overall Study|Protocol Violation|1|||
131501039|NCT01129960|473463393|FG001|Overall Study|Protocol Violation|2|||
131501040|NCT01129960|473463394|FG002|Overall Study|Protocol Violation|3|||
131501041|NCT01129960|473463395|FG003|Overall Study|Protocol Violation|0|||
131501042|NCT01129960|473463392|FG000|Overall Study|Lost to Follow-up|0|||
131501043|NCT01129960|473463393|FG001|Overall Study|Lost to Follow-up|2|||
131501044|NCT01129960|473463394|FG002|Overall Study|Lost to Follow-up|3|||
131501045|NCT01129960|473463395|FG003|Overall Study|Lost to Follow-up|3|||
131501046|NCT01129960|473463392|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
131501047|NCT01129960|473463393|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
131501048|NCT01129960|473463394|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
131501049|NCT01129960|473463395|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
131501050|NCT01129960|473463392|FG000|Overall Study|Physician Decision|1|||
131501051|NCT01129960|473463393|FG001|Overall Study|Physician Decision|0|||
131501052|NCT01129960|473463394|FG002|Overall Study|Physician Decision|0|||
131501053|NCT01129960|473463395|FG003|Overall Study|Physician Decision|0|||
131501054|NCT01129960|473463392|FG000|Overall Study|Pregnancy|1|||
131501055|NCT01129960|473463393|FG001|Overall Study|Pregnancy|0|||
131501056|NCT01129960|473463394|FG002|Overall Study|Pregnancy|0|||
131501057|NCT01129960|473463395|FG003|Overall Study|Pregnancy|0|||
131501058|NCT04900220|473463396|FG000|Overall Study|Lost to Follow-up|1|||
131501059|NCT04900220|473463397|FG001|Overall Study|Lost to Follow-up|1|||
131501060|NCT00877383|473463401|FG000|Overall Study|Adverse Event|13|||
131501061|NCT00877383|473463402|FG001|Overall Study|Adverse Event|14|||
131501062|NCT00877383|473463401|FG000|Overall Study|Lost to Follow-up|5|||
131501063|NCT00877383|473463402|FG001|Overall Study|Lost to Follow-up|3|||
131501064|NCT00877383|473463401|FG000|Overall Study|Subject withdrew consent|3|||
131501065|NCT00877383|473463402|FG001|Overall Study|Subject withdrew consent|12|||
131501066|NCT00877383|473463401|FG000|Overall Study|Subject no longer requires study drug|2|||
131501067|NCT00877383|473463402|FG001|Overall Study|Subject no longer requires study drug|0|||
131501068|NCT00877383|473463401|FG000|Overall Study|Administrative problems|2|||
131501069|NCT00877383|473463402|FG001|Overall Study|Administrative problems|0|||
131501070|NCT00877383|473463401|FG000|Overall Study|Protocol deviation|2|||
131501071|NCT00877383|473463402|FG001|Overall Study|Protocol deviation|6|||
131501072|NCT00877383|473463401|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131501073|NCT00877383|473463402|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131501074|NCT00877383|473463401|FG000|Overall Study|Death|1|||
131501075|NCT00877383|473463402|FG001|Overall Study|Death|2|||
131501076|NCT02107482|473463409|FG000|Overall Study|inconveinence|2|||
131501077|NCT02107482|473463409|FG000|Overall Study|Lost to Follow-up|1|||
131501078|NCT02107482|473463409|FG000|Overall Study|Lack of Efficacy|1|||
131501079|NCT04868890|473463410|FG000|Overall Study|Death|2|||
131501080|NCT04868890|473463411|FG001|Overall Study|Death|1|||
131501081|NCT04868890|473463410|FG000|Overall Study|Withdrawal by Subject|1|||
131501082|NCT04868890|473463411|FG001|Overall Study|Withdrawal by Subject|5|||
131501083|NCT03358290|473463413|FG000|Overall Study|Study discontinued by Sponsor|0|||
131501084|NCT03358290|473463414|FG001|Overall Study|Study discontinued by Sponsor|1|||
131501085|NCT03358290|473463415|FG002|Overall Study|Study discontinued by Sponsor|1|||
131501086|NCT03358290|473463416|FG003|Overall Study|Study discontinued by Sponsor|0|||
131501087|NCT03358290|473463417|FG004|Overall Study|Study discontinued by Sponsor|0|||
131501088|NCT03358290|473463413|FG000|Overall Study|Adverse Event|0|||
131501089|NCT03358290|473463414|FG001|Overall Study|Adverse Event|0|||
131501090|NCT03358290|473463415|FG002|Overall Study|Adverse Event|1|||
131501091|NCT03358290|473463416|FG003|Overall Study|Adverse Event|2|||
131501092|NCT03358290|473463417|FG004|Overall Study|Adverse Event|0|||
131501093|NCT03358290|473463413|FG000|Overall Study|Withdrawal by Subject|0|||
131501094|NCT03358290|473463414|FG001|Overall Study|Withdrawal by Subject|0|||
131501095|NCT03358290|473463415|FG002|Overall Study|Withdrawal by Subject|0|||
131501096|NCT03358290|473463416|FG003|Overall Study|Withdrawal by Subject|0|||
131501097|NCT03358290|473463417|FG004|Overall Study|Withdrawal by Subject|1|||
131501098|NCT02999854|473463423|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
131501099|NCT02999854|473463424|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
131501100|NCT02999854|473463423|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
131501101|NCT02999854|473463424|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
131501102|NCT02999854|473463423|FG000|Active Study Phase (up to 18 Months)|Death|7|||
131501103|NCT02999854|473463424|FG001|Active Study Phase (up to 18 Months)|Death|5|||
131501104|NCT02999854|473463423|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
131501105|NCT02999854|473463424|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
131501106|NCT02999854|473463423|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
131501107|NCT02999854|473463424|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
131501108|NCT02999854|473463423|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
131501109|NCT02999854|473463424|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
131501110|NCT02999854|473463423|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
131501111|NCT02999854|473463424|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
131501112|NCT02999854|473463423|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
131501113|NCT02999854|473463424|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
131501114|NCT01339429|473463425|FG000|Overall Study|Withdrawal by Subject|1|||
131501115|NCT01339429|473463425|FG000|Overall Study|Physician Decision|3|||
131501116|NCT01085591|473463426|FG000|Overall Study|Adverse Event|0|||
131501117|NCT01085591|473463427|FG001|Overall Study|Adverse Event|1|||
131501118|NCT01085591|473463428|FG002|Overall Study|Adverse Event|3|||
131501119|NCT01085591|473463426|FG000|Overall Study|Physician Decision|1|||
131501120|NCT01085591|473463427|FG001|Overall Study|Physician Decision|0|||
131501121|NCT01085591|473463428|FG002|Overall Study|Physician Decision|1|||
131501122|NCT01085591|473463426|FG000|Overall Study|Withdrawal by Subject|0|||
131501123|NCT01085591|473463427|FG001|Overall Study|Withdrawal by Subject|2|||
131501124|NCT01085591|473463428|FG002|Overall Study|Withdrawal by Subject|1|||
131501125|NCT01085591|473463426|FG000|Overall Study|Lost to Follow-up|0|||
131501126|NCT01085591|473463427|FG001|Overall Study|Lost to Follow-up|1|||
131501127|NCT01085591|473463428|FG002|Overall Study|Lost to Follow-up|1|||
131501128|NCT01085591|473463426|FG000|Overall Study|Protocol Violation|1|||
131501129|NCT01085591|473463427|FG001|Overall Study|Protocol Violation|1|||
131501130|NCT01085591|473463428|FG002|Overall Study|Protocol Violation|1|||
131501131|NCT01085591|473463426|FG000|Overall Study|Other|0|||
131501132|NCT01085591|473463427|FG001|Overall Study|Other|1|||
131501133|NCT01085591|473463428|FG002|Overall Study|Other|0|||
131501134|NCT01085591|473463426|FG000|Overall Study|Not Properly Consented|1|||
131501135|NCT01085591|473463427|FG001|Overall Study|Not Properly Consented|0|||
131501136|NCT01085591|473463428|FG002|Overall Study|Not Properly Consented|0|||
131501137|NCT04140292|473463429|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
131501138|NCT04140292|473463430|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
131501139|NCT00556712|473463431|FG000|Overall Study|Adverse Event|7|||
131501140|NCT00556712|473463432|FG001|Overall Study|Adverse Event|19|||
131501141|NCT00556712|473463431|FG000|Overall Study|Death|5|||
131501142|NCT00556712|473463432|FG001|Overall Study|Death|10|||
131501143|NCT00556712|473463431|FG000|Overall Study|Progressive Disease|383|||
131501144|NCT00556712|473463432|FG001|Overall Study|Progressive Disease|320|||
131501145|NCT00556712|473463431|FG000|Overall Study|Protocol Violation|3|||
131501146|NCT00556712|473463432|FG001|Overall Study|Protocol Violation|2|||
131501147|NCT00556712|473463431|FG000|Overall Study|Refused Treatment|17|||
131501148|NCT00556712|473463432|FG001|Overall Study|Refused Treatment|16|||
131501149|NCT00556712|473463431|FG000|Overall Study|Failure to Return|2|||
131501150|NCT00556712|473463432|FG001|Overall Study|Failure to Return|3|||
131501151|NCT00556712|473463431|FG000|Overall Study|Other|2|||
131501152|NCT00556712|473463432|FG001|Overall Study|Other|2|||
131501153|NCT00556712|473463431|FG000|Overall Study|Ongoing at Data Cutoff|32|||
131501154|NCT00556712|473463432|FG001|Overall Study|Ongoing at Data Cutoff|66|||
131501155|NCT01962207|473463433|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
131501156|NCT01962207|473463434|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
131501157|NCT01962207|473463435|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
131501158|NCT01962207|473463436|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
131501159|NCT01962207|473463433|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
131501160|NCT01962207|473463434|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
131501161|NCT01962207|473463435|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
131501162|NCT01962207|473463436|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
131501163|NCT01962207|473463433|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
131501164|NCT01962207|473463434|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
131501165|NCT01962207|473463435|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
131501166|NCT01962207|473463436|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
131501167|NCT01962207|473463433|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
131501168|NCT01962207|473463434|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
131501169|NCT01962207|473463435|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
131501170|NCT01962207|473463436|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
131501171|NCT01962207|473463433|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
131501172|NCT01962207|473463434|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
131501173|NCT01962207|473463435|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
131501174|NCT01962207|473463436|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
131501175|NCT01962207|473463433|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
131501176|NCT01962207|473463434|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
131501177|NCT01962207|473463435|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
131501178|NCT01962207|473463436|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
131501179|NCT03036072|473463439|FG000|Overall Study|Death|0|||
131501180|NCT03036072|473463440|FG001|Overall Study|Death|1|||
131501181|NCT03036072|473463439|FG000|Overall Study|Withdrawal by Subject|0|||
131501182|NCT03036072|473463440|FG001|Overall Study|Withdrawal by Subject|1|||
131501183|NCT03036072|473463439|FG000|Overall Study|Physician Decision|0|||
131501184|NCT03036072|473463440|FG001|Overall Study|Physician Decision|1|||
131501185|NCT02484729|473463441|FG000|Overall Study|Failure of IntelliCap Error|0|||
131501186|NCT02484729|473463442|FG001|Overall Study|Failure of IntelliCap Error|0|||
131501187|NCT02484729|473463443|FG002|Overall Study|Failure of IntelliCap Error|0|||
131501188|NCT02484729|473463444|FG003|Overall Study|Failure of IntelliCap Error|0|||
131501189|NCT02484729|473463445|FG004|Overall Study|Failure of IntelliCap Error|0|||
131501190|NCT02484729|473463446|FG005|Overall Study|Failure of IntelliCap Error|0|||
131501191|NCT02484729|473463447|FG006|Overall Study|Failure of IntelliCap Error|0|||
131501192|NCT02484729|473463448|FG007|Overall Study|Failure of IntelliCap Error|0|||
131501193|NCT02484729|473463449|FG008|Overall Study|Failure of IntelliCap Error|0|||
131501194|NCT02484729|473463450|FG009|Overall Study|Failure of IntelliCap Error|1|||
131501195|NCT02111850|473463453|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501196|NCT02111850|473463454|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501197|NCT02111850|473463455|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501198|NCT02111850|473463456|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501199|NCT02111850|473463457|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
131501200|NCT02111850|473463458|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501201|NCT02111850|473463459|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501202|NCT02111850|473463460|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501203|NCT02111850|473463461|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501204|NCT02111850|473463462|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131658089|NCT04445987|474032994|FG000|Overall Study|Lost to Follow-up|4|||
131501205|NCT02111850|473463463|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
131501206|NCT00665847|473463464|FG000|Overall Study|Adverse Event|8|||
131501207|NCT00665847|473463464|FG000|Overall Study|Withdrawal by Subject|2|||
131501208|NCT00665847|473463464|FG000|Overall Study|Subject non-compliant|8|||
131501209|NCT00665847|473463464|FG000|Overall Study|Subject reached a virologic endpoint|4|||
131501210|NCT00665847|473463464|FG000|Overall Study|Resistance to TMC125|1|||
131501211|NCT00665847|473463464|FG000|Overall Study|Subject ineligible to continue the trial|1|||
131501212|NCT00665847|473463464|FG000|Overall Study|Switch to Commercial Medication|1|||
131501213|NCT03605303|473463465|FG000|Period 1|Study Terminated|2|||
131501214|NCT03605303|473463466|FG001|Period 1|Study Terminated|1|||
131501215|NCT00353262|473463467|FG000|Overall Study|Adverse Event|8|||
131501216|NCT00353262|473463467|FG000|Overall Study|Withdrawal by Subject|2|||
131501217|NCT00353262|473463467|FG000|Overall Study|Insufficient Therapeutic Response|13|||
131501218|NCT00353262|473463467|FG000|Overall Study|Progression|1|||
131501219|NCT00353262|473463467|FG000|Overall Study|Surgery|4|||
131501220|NCT00353262|473463467|FG000|Overall Study|Break from Chemotherapy|1|||
131501221|NCT05286307|473463468|FG000|Overall Study|Incomplete outcome assessments|2|||
131501222|NCT05286307|473463469|FG001|Overall Study|Incomplete outcome assessments|1|||
131501223|NCT05286307|473463468|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
131501224|NCT05286307|473463469|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
131501225|NCT05286307|473463468|FG000|Overall Study|Lost to follow up at 6 months|25|||
131501226|NCT05286307|473463469|FG001|Overall Study|Lost to follow up at 6 months|35|||
131501227|NCT05286307|473463468|FG000|Overall Study|Study medication not available|1|||
131501228|NCT05286307|473463469|FG001|Overall Study|Study medication not available|1|||
131501229|NCT01103284|473463470|FG000|Overall Study|Death|2|||
131501230|NCT01103284|473463471|FG001|Overall Study|Death|0|||
131501231|NCT01103284|473463470|FG000|Overall Study|Lost to Follow-up|9|||
131501232|NCT01103284|473463471|FG001|Overall Study|Lost to Follow-up|10|||
131501233|NCT01103284|473463470|FG000|Overall Study|Pregnancy|3|||
131501234|NCT01103284|473463471|FG001|Overall Study|Pregnancy|1|||
131501235|NCT01103284|473463470|FG000|Overall Study|Protocol Violation|12|||
131501236|NCT01103284|473463471|FG001|Overall Study|Protocol Violation|5|||
131501237|NCT01103284|473463470|FG000|Overall Study|Adverse Event|0|||
131501238|NCT01103284|473463471|FG001|Overall Study|Adverse Event|5|||
131501239|NCT01103284|473463470|FG000|Overall Study|Withdrawal by Subject|14|||
131501240|NCT01103284|473463471|FG001|Overall Study|Withdrawal by Subject|18|||
131501241|NCT01103284|473463470|FG000|Overall Study|Dermal Hypersensitivity|0|||
131501242|NCT01103284|473463471|FG001|Overall Study|Dermal Hypersensitivity|1|||
131501243|NCT01103284|473463470|FG000|Overall Study|Termination by the Sponsor|0|||
131501244|NCT01103284|473463471|FG001|Overall Study|Termination by the Sponsor|1|||
131501245|NCT01103284|473463470|FG000|Overall Study|Not described|2|||
131501246|NCT01103284|473463471|FG001|Overall Study|Not described|1|||
131501247|NCT01103284|473463470|FG000|Overall Study|Missing CRF entries for study completion|0|||
131501248|NCT01103284|473463471|FG001|Overall Study|Missing CRF entries for study completion|2|||
131501249|NCT00397982|473465436|FG000|Overall Study|Withdrawal by Subject|1|||
131501250|NCT00397982|473465436|FG000|Overall Study|Adverse Event|1|||
131501251|NCT00397982|473465436|FG000|Overall Study|noncompliance|1|||
131501252|NCT00397982|473465436|FG000|Overall Study|Unrelated health issues|1|||
131501253|NCT02636868|473465437|FG000|Overall Study|Death|0|||
131501254|NCT02636868|473465438|FG001|Overall Study|Death|1|||
131501255|NCT02636868|473465439|FG002|Overall Study|Death|2|||
131501256|NCT03025542|473465440|FG000|Overall Study|Adverse Event|0|||
131501257|NCT03025542|473465441|FG001|Overall Study|Adverse Event|2|||
131501258|NCT03025542|473465440|FG000|Overall Study|Lost to Follow-up|1|||
131501259|NCT03025542|473465441|FG001|Overall Study|Lost to Follow-up|0|||
131501260|NCT03025542|473465440|FG000|Overall Study|Withdrawal by Subject|1|||
131501261|NCT03025542|473465441|FG001|Overall Study|Withdrawal by Subject|0|||
131501262|NCT05024058|473465442|FG000|Treatment|Study terminated by sponsor|5|||
131501263|NCT05024058|473465443|FG001|Treatment|Study terminated by sponsor|6|||
131501264|NCT05024058|473465444|FG002|Treatment|Study terminated by sponsor|4|||
131501265|NCT05024058|473465445|FG003|Treatment|Study terminated by sponsor|2|||
131501266|NCT05024058|473465446|FG004|Treatment|Study terminated by sponsor|3|||
131501267|NCT05024058|473465447|FG005|Treatment|Study terminated by sponsor|3|||
131501268|NCT05024058|473465448|FG006|Treatment|Study terminated by sponsor|1|||
131501269|NCT05024058|473465449|FG007|Treatment|Study terminated by sponsor|3|||
131501270|NCT05024058|473465450|FG008|Treatment|Study terminated by sponsor|6|||
131501271|NCT05024058|473465451|FG009|Treatment|Study terminated by sponsor|6|||
131501272|NCT05024058|473465442|FG000|Follow-up|Withdrawal by Subject|1|||
131501273|NCT05024058|473465443|FG001|Follow-up|Withdrawal by Subject|0|||
131501274|NCT05024058|473465444|FG002|Follow-up|Withdrawal by Subject|1|||
131501275|NCT05024058|473465445|FG003|Follow-up|Withdrawal by Subject|0|||
131501276|NCT05024058|473465446|FG004|Follow-up|Withdrawal by Subject|0|||
131501277|NCT05024058|473465447|FG005|Follow-up|Withdrawal by Subject|0|||
131501278|NCT05024058|473465448|FG006|Follow-up|Withdrawal by Subject|0|||
131501279|NCT05024058|473465449|FG007|Follow-up|Withdrawal by Subject|1|||
131501280|NCT05024058|473465450|FG008|Follow-up|Withdrawal by Subject|0|||
131501281|NCT05024058|473465451|FG009|Follow-up|Withdrawal by Subject|1|||
131501282|NCT00501293|473465452|FG000|Optimization Period|Enrolled in error|1|||
131501283|NCT00501293|473465453|FG001|Optimization Period|Enrolled in error|0|||
131501284|NCT00501293|473465452|FG000|Maintenance Period|Withdrawal by Subject|14|||
131501285|NCT00501293|473465453|FG001|Maintenance Period|Withdrawal by Subject|13|||
131501286|NCT00501293|473465452|FG000|Maintenance Period|Lost to Follow-up|12|||
131501287|NCT00501293|473465453|FG001|Maintenance Period|Lost to Follow-up|7|||
131501288|NCT00501293|473465452|FG000|Maintenance Period|Adverse Event|6|||
131501289|NCT00501293|473465453|FG001|Maintenance Period|Adverse Event|6|||
131501290|NCT00501293|473465452|FG000|Maintenance Period|Protocol Violation|2|||
131501291|NCT00501293|473465453|FG001|Maintenance Period|Protocol Violation|1|||
131501292|NCT00501293|473465452|FG000|Maintenance Period|Lack of Efficacy|4|||
131501293|NCT00501293|473465453|FG001|Maintenance Period|Lack of Efficacy|1|||
131501294|NCT00501293|473465452|FG000|Maintenance Period|Noncompliant with study medication|5|||
131501295|NCT00501293|473465453|FG001|Maintenance Period|Noncompliant with study medication|0|||
131501296|NCT00501293|473465452|FG000|Maintenance Period|Went into rehabilitation|1|||
131501297|NCT00501293|473465453|FG001|Maintenance Period|Went into rehabilitation|0|||
131501298|NCT00501293|473465452|FG000|Maintenance Period|Would not wear patch|1|||
131501299|NCT00501293|473465453|FG001|Maintenance Period|Would not wear patch|0|||
131501300|NCT00501293|473465452|FG000|Maintenance Period|Application site reaction|1|||
131501301|NCT00501293|473465453|FG001|Maintenance Period|Application site reaction|0|||
131501302|NCT00696696|473465459|FG000|Overall Study|Adverse Event|5|||
131501303|NCT00696696|473465459|FG000|Overall Study|Withdrawal by Subject|8|||
131501304|NCT00696696|473465459|FG000|Overall Study|Physician Decision|2|||
131501305|NCT00696696|473465459|FG000|Overall Study|Death|3|||
131501306|NCT02507505|473465460|FG000|Overall Study|Withdrawal by Subject|13|||
131501307|NCT02507505|473465461|FG001|Overall Study|Withdrawal by Subject|11|||
131501308|NCT02507505|473465460|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
131501309|NCT02507505|473465461|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
131501310|NCT02507505|473465460|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
131501311|NCT02507505|473465461|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
131501312|NCT02507505|473465460|FG000|Overall Study|Death before receipt of anesthesia|0|||
131501313|NCT02507505|473465461|FG001|Overall Study|Death before receipt of anesthesia|1|||
131501314|NCT00967798|473465462|FG000|Overall Study|Withdrawal by Subject|5|||
131501315|NCT00967798|473465463|FG001|Overall Study|Withdrawal by Subject|2|||
131501316|NCT00967798|473465462|FG000|Overall Study|Lost to Follow-up|4|||
131501317|NCT00967798|473465463|FG001|Overall Study|Lost to Follow-up|1|||
131501318|NCT03182829|473465464|FG000|Overall Study|Protocol Violation|12|||
131501319|NCT03182829|473465465|FG001|Overall Study|Protocol Violation|12|||
131501320|NCT03182829|473465464|FG000|Overall Study|Other|4|||
131501321|NCT03182829|473465465|FG001|Overall Study|Other|3|||
131501322|NCT03316131|473465466|FG000|Treatment Period 2|Protocol deviation|1|||
131501323|NCT03316131|473465467|FG001|Treatment Period 2|Protocol deviation|0|||
131501324|NCT01409564|473465468|FG000|Overall Study|low medication compliance|4|||
131501325|NCT01409564|473465469|FG001|Overall Study|low medication compliance|3|||
131501326|NCT01409564|473465468|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
131501327|NCT01409564|473465469|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
131501328|NCT00254540|473465470|FG000|Overall Study|Adverse Event|6|||
131501329|NCT00254540|473465471|FG001|Overall Study|Adverse Event|7|||
131501330|NCT00254540|473465470|FG000|Overall Study|Lack of Efficacy|13|||
131501331|NCT00254540|473465471|FG001|Overall Study|Lack of Efficacy|13|||
131501332|NCT00254540|473465470|FG000|Overall Study|Death|0|||
131501333|NCT00254540|473465471|FG001|Overall Study|Death|1|||
131501334|NCT00254540|473465470|FG000|Overall Study|Laboratory Test Abnormality|0|||
131501335|NCT00254540|473465471|FG001|Overall Study|Laboratory Test Abnormality|1|||
131501336|NCT00225251|473465472|FG000|Overall Study|Withdrawal by Subject|1|||
131501337|NCT00225251|473465473|FG001|Overall Study|Withdrawal by Subject|1|||
131501338|NCT01313767|473465477|FG000|Overall Study|Adverse Event|1|||
131501339|NCT01313767|473465478|FG001|Overall Study|Adverse Event|0|||
131501340|NCT01313767|473465477|FG000|Overall Study|Lost to Follow-up|1|||
131501341|NCT01313767|473465478|FG001|Overall Study|Lost to Follow-up|0|||
131501342|NCT01313767|473465477|FG000|Overall Study|Withdrawal by Subject|2|||
131501343|NCT01313767|473465478|FG001|Overall Study|Withdrawal by Subject|1|||
131501344|NCT01313767|473465477|FG000|Overall Study|Protocol Violation|3|||
131501345|NCT01313767|473465478|FG001|Overall Study|Protocol Violation|1|||
131501346|NCT01287897|473465479|FG000|Overall Study|Adverse Event|5|||
131501347|NCT01287897|473465480|FG001|Overall Study|Adverse Event|3|||
131501348|NCT01287897|473465481|FG002|Overall Study|Adverse Event|6|||
131501349|NCT01287897|473465482|FG003|Overall Study|Adverse Event|4|||
131501350|NCT01287897|473465479|FG000|Overall Study|Lack of Efficacy|2|||
131501351|NCT01287897|473465480|FG001|Overall Study|Lack of Efficacy|0|||
131501352|NCT01287897|473465481|FG002|Overall Study|Lack of Efficacy|0|||
131501353|NCT01287897|473465482|FG003|Overall Study|Lack of Efficacy|0|||
131501354|NCT01287897|473465479|FG000|Overall Study|Protocol Violation|1|||
131501355|NCT01287897|473465480|FG001|Overall Study|Protocol Violation|1|||
131501356|NCT01287897|473465481|FG002|Overall Study|Protocol Violation|0|||
131501357|NCT01287897|473465482|FG003|Overall Study|Protocol Violation|1|||
131501358|NCT01287897|473465479|FG000|Overall Study|Lost to Follow-up|0|||
131501359|NCT01287897|473465480|FG001|Overall Study|Lost to Follow-up|0|||
131501360|NCT01287897|473465481|FG002|Overall Study|Lost to Follow-up|2|||
131501361|NCT01287897|473465482|FG003|Overall Study|Lost to Follow-up|0|||
131501362|NCT01287897|473465479|FG000|Overall Study|Withdrawal by Subject|1|||
131501363|NCT01287897|473465480|FG001|Overall Study|Withdrawal by Subject|5|||
131501364|NCT01287897|473465481|FG002|Overall Study|Withdrawal by Subject|3|||
131501365|NCT01287897|473465482|FG003|Overall Study|Withdrawal by Subject|2|||
131501366|NCT01287897|473465479|FG000|Overall Study|Not consented properly|0|||
131501367|NCT01287897|473465480|FG001|Overall Study|Not consented properly|1|||
131501368|NCT01287897|473465481|FG002|Overall Study|Not consented properly|0|||
131501369|NCT01287897|473465482|FG003|Overall Study|Not consented properly|0|||
131501370|NCT01287897|473465479|FG000|Overall Study|Not meeting entrance criteria|1|||
131501371|NCT01287897|473465480|FG001|Overall Study|Not meeting entrance criteria|1|||
131501372|NCT01287897|473465481|FG002|Overall Study|Not meeting entrance criteria|0|||
131501373|NCT01287897|473465482|FG003|Overall Study|Not meeting entrance criteria|0|||
131501374|NCT01287897|473465479|FG000|Overall Study|Other|1|||
131501375|NCT01287897|473465480|FG001|Overall Study|Other|0|||
131501376|NCT01287897|473465481|FG002|Overall Study|Other|1|||
131501377|NCT01287897|473465482|FG003|Overall Study|Other|0|||
131501378|NCT02436356|473465486|FG000|Overall Study|Excluded by MRI Screening|0|||
131501379|NCT02436356|473465487|FG001|Overall Study|Excluded by MRI Screening|0|||
131501380|NCT02436356|473465488|FG002|Overall Study|Excluded by MRI Screening|2|||
131501381|NCT02436356|473465486|FG000|Overall Study|Lost to Follow-up|0|||
131501382|NCT02436356|473465487|FG001|Overall Study|Lost to Follow-up|1|||
131501383|NCT02436356|473465488|FG002|Overall Study|Lost to Follow-up|0|||
131501384|NCT02436356|473465486|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
131501385|NCT02436356|473465487|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
131501386|NCT02436356|473465488|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
131501387|NCT02436356|473465486|FG000|Overall Study|Excluded due to other medical conditions|3|||
131501388|NCT02436356|473465487|FG001|Overall Study|Excluded due to other medical conditions|0|||
131501389|NCT02436356|473465488|FG002|Overall Study|Excluded due to other medical conditions|0|||
131501390|NCT02436356|473465486|FG000|Overall Study|Withdrawal by Subject|1|||
131501391|NCT02436356|473465487|FG001|Overall Study|Withdrawal by Subject|0|||
131501392|NCT02436356|473465488|FG002|Overall Study|Withdrawal by Subject|0|||
131501393|NCT00674661|473465489|FG000|Overall Study|Other|5|||
131501394|NCT00674661|473465490|FG001|Overall Study|Other|7|||
131501395|NCT00674661|473465489|FG000|Overall Study|Lost to Follow-up|6|||
131501396|NCT00674661|473465490|FG001|Overall Study|Lost to Follow-up|3|||
131501397|NCT00674661|473465489|FG000|Overall Study|Withdrawal by Subject|0|||
131501398|NCT00674661|473465490|FG001|Overall Study|Withdrawal by Subject|5|||
131501399|NCT03108027|473465492|FG000|Period 1|Subject/Guardian Decision|0|||
131501400|NCT03108027|473465493|FG001|Period 1|Subject/Guardian Decision|0|||
131501401|NCT03108027|473465494|FG002|Period 1|Subject/Guardian Decision|0|||
131501402|NCT03108027|473465495|FG003|Period 1|Subject/Guardian Decision|2|||
131501403|NCT03108027|473465496|FG004|Period 1|Subject/Guardian Decision|0|||
131501404|NCT03108027|473465497|FG005|Period 1|Subject/Guardian Decision|0|||
131501405|NCT03108027|473465492|FG000|Period 3|Adverse Event|0|||
131501406|NCT03108027|473465493|FG001|Period 3|Adverse Event|1|||
131501407|NCT03108027|473465494|FG002|Period 3|Adverse Event|0|||
131501408|NCT03108027|473465495|FG003|Period 3|Adverse Event|0|||
131501409|NCT03108027|473465496|FG004|Period 3|Adverse Event|0|||
131501410|NCT03108027|473465497|FG005|Period 3|Adverse Event|0|||
131501411|NCT02426892|473465498|FG000|Overall Study|Adverse Event|2|||
131501412|NCT02426892|473465498|FG000|Overall Study|Lack of Efficacy|17|||
131501413|NCT02426892|473465498|FG000|Overall Study|Withdrawal by Subject|1|||
131501414|NCT02574247|473465499|FG000|Overall Study|Withdrawal by Subject|1|||
131501415|NCT02574247|473465500|FG001|Overall Study|Withdrawal by Subject|0|||
131501416|NCT02574247|473465501|FG002|Overall Study|Withdrawal by Subject|0|||
131501417|NCT02574247|473465499|FG000|Overall Study|Did not meet inclusion criteria|4|||
131501418|NCT02574247|473465500|FG001|Overall Study|Did not meet inclusion criteria|3|||
131501419|NCT02574247|473465501|FG002|Overall Study|Did not meet inclusion criteria|5|||
131501420|NCT03178773|473465502|FG000|Overall Study|Death|0|||
131501421|NCT03178773|473465503|FG001|Overall Study|Death|1|||
131501422|NCT03178773|473465502|FG000|Overall Study|Lost to Follow-up|29|||
131501423|NCT03178773|473465503|FG001|Overall Study|Lost to Follow-up|25|||
131501424|NCT03178773|473465502|FG000|Overall Study|Withdrawal by Subject|10|||
131501425|NCT03178773|473465503|FG001|Overall Study|Withdrawal by Subject|14|||
131501426|NCT00268996|473465504|FG000|Overall Study|Adverse Event|11|||
131501427|NCT00268996|473465505|FG001|Overall Study|Adverse Event|7|||
131501428|NCT00268996|473465504|FG000|Overall Study|Lost to Follow-up|3|||
131501429|NCT00268996|473465505|FG001|Overall Study|Lost to Follow-up|1|||
131501430|NCT00268996|473465504|FG000|Overall Study|Withdrawal by Subject|5|||
131501431|NCT00268996|473465505|FG001|Overall Study|Withdrawal by Subject|11|||
131501432|NCT00268996|473465504|FG000|Overall Study|Non-compliance|1|||
131501433|NCT00268996|473465505|FG001|Overall Study|Non-compliance|0|||
131501434|NCT00268996|473465504|FG000|Overall Study|Other|1|||
131501435|NCT00268996|473465505|FG001|Overall Study|Other|1|||
131501436|NCT00451321|473465514|FG000|Overall Study|Lost to Follow-up|3|||
131501437|NCT00451321|473465515|FG001|Overall Study|Lost to Follow-up|3|||
131501438|NCT00451321|473465516|FG002|Overall Study|Lost to Follow-up|1|||
131501439|NCT00451321|473465517|FG003|Overall Study|Lost to Follow-up|3|||
131501440|NCT00451321|473465518|FG004|Overall Study|Lost to Follow-up|0|||
131501441|NCT00451321|473465519|FG005|Overall Study|Lost to Follow-up|1|||
131501442|NCT00451321|473465520|FG006|Overall Study|Lost to Follow-up|0|||
131501443|NCT00451321|473465521|FG007|Overall Study|Lost to Follow-up|0|||
131501444|NCT00451321|473465514|FG000|Overall Study|Withdrawal by Subject|3|||
131501445|NCT00451321|473465515|FG001|Overall Study|Withdrawal by Subject|1|||
131501446|NCT00451321|473465516|FG002|Overall Study|Withdrawal by Subject|0|||
131501447|NCT00451321|473465517|FG003|Overall Study|Withdrawal by Subject|4|||
131501448|NCT00451321|473465518|FG004|Overall Study|Withdrawal by Subject|0|||
131501449|NCT00451321|473465519|FG005|Overall Study|Withdrawal by Subject|0|||
131501450|NCT00451321|473465520|FG006|Overall Study|Withdrawal by Subject|0|||
131501451|NCT00451321|473465521|FG007|Overall Study|Withdrawal by Subject|0|||
131501452|NCT00451321|473465514|FG000|Overall Study|Study closed/terminated|1|||
131501453|NCT00451321|473465515|FG001|Overall Study|Study closed/terminated|1|||
131501454|NCT00451321|473465516|FG002|Overall Study|Study closed/terminated|17|||
131501455|NCT00451321|473465517|FG003|Overall Study|Study closed/terminated|5|||
131501456|NCT00451321|473465518|FG004|Overall Study|Study closed/terminated|7|||
131501457|NCT00451321|473465519|FG005|Overall Study|Study closed/terminated|7|||
131501458|NCT00451321|473465520|FG006|Overall Study|Study closed/terminated|5|||
131501459|NCT00451321|473465521|FG007|Overall Study|Study closed/terminated|3|||
131501460|NCT00451321|473465514|FG000|Overall Study|Sponsor decision to amend protocol|0|||
131501461|NCT00451321|473465515|FG001|Overall Study|Sponsor decision to amend protocol|0|||
131501462|NCT00451321|473465516|FG002|Overall Study|Sponsor decision to amend protocol|0|||
131501463|NCT00451321|473465517|FG003|Overall Study|Sponsor decision to amend protocol|0|||
131501464|NCT00451321|473465518|FG004|Overall Study|Sponsor decision to amend protocol|0|||
131501465|NCT00451321|473465519|FG005|Overall Study|Sponsor decision to amend protocol|1|||
131501466|NCT00451321|473465520|FG006|Overall Study|Sponsor decision to amend protocol|1|||
131501467|NCT00451321|473465521|FG007|Overall Study|Sponsor decision to amend protocol|3|||
131501468|NCT01119131|473465524|FG000|Overall Study|Adverse Event|1|||
131501469|NCT01119131|473465525|FG001|Overall Study|Adverse Event|1|||
131501470|NCT01119131|473465526|FG002|Overall Study|Adverse Event|1|||
131501471|NCT01119131|473465524|FG000|Overall Study|Non-Compliance|1|||
131501472|NCT01119131|473465525|FG001|Overall Study|Non-Compliance|0|||
131501473|NCT01119131|473465526|FG002|Overall Study|Non-Compliance|4|||
131501474|NCT01119131|473465524|FG000|Overall Study|Physician Decision|0|||
131501475|NCT01119131|473465525|FG001|Overall Study|Physician Decision|0|||
131501476|NCT01119131|473465526|FG002|Overall Study|Physician Decision|1|||
131501477|NCT01528254|473465527|FG000|Overall Study|Administrative problems|96|||
131501478|NCT01528254|473465528|FG001|Overall Study|Administrative problems|94|||
131501479|NCT01528254|473465527|FG000|Overall Study|Adverse Event|28|||
131501480|NCT01528254|473465528|FG001|Overall Study|Adverse Event|44|||
131501481|NCT01528254|473465527|FG000|Overall Study|Lost to Follow-up|17|||
131501482|NCT01528254|473465528|FG001|Overall Study|Lost to Follow-up|24|||
131501483|NCT01528254|473465527|FG000|Overall Study|Death|13|||
131501484|NCT01528254|473465528|FG001|Overall Study|Death|9|||
131501485|NCT01528254|473465527|FG000|Overall Study|Protocol deviation|9|||
131501486|NCT01528254|473465528|FG001|Overall Study|Protocol deviation|19|||
131501487|NCT01528254|473465527|FG000|Overall Study|New therapy for study indication|8|||
131501488|NCT01528254|473465528|FG001|Overall Study|New therapy for study indication|6|||
131501489|NCT01528254|473465527|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
131501490|NCT01528254|473465528|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131501491|NCT01528254|473465527|FG000|Overall Study|Withdrawal by Subject|5|||
131501492|NCT01528254|473465528|FG001|Overall Study|Withdrawal by Subject|4|||
131501493|NCT01528254|473465527|FG000|Overall Study|Abnormal laboratory value(s)|3|||
131501494|NCT01528254|473465528|FG001|Overall Study|Abnormal laboratory value(s)|7|||
131501495|NCT01528254|473465527|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131501496|NCT01528254|473465528|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131501497|NCT01528254|473465527|FG000|Overall Study|No longer requires study drug|1|||
131501498|NCT01528254|473465528|FG001|Overall Study|No longer requires study drug|1|||
131501499|NCT01909479|473465529|FG000|From Baseline to Week 26|Adverse Event|3|||
131501500|NCT01909479|473465530|FG001|From Baseline to Week 26|Adverse Event|2|||
131501501|NCT01909479|473465529|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
131501502|NCT01909479|473465530|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
131501503|NCT01909479|473465529|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
131501504|NCT01909479|473465530|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
131501505|NCT01909479|473465529|FG000|26 - 52 Weeks|Adverse Event|0|||
131501506|NCT01909479|473465530|FG001|26 - 52 Weeks|Adverse Event|1|||
131501507|NCT01909479|473465529|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
131501508|NCT01909479|473465530|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
131501509|NCT01909479|473465529|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
131501510|NCT01909479|473465530|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
131501511|NCT01909479|473465529|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
131501512|NCT01909479|473465530|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
131501513|NCT01909479|473465529|FG000|52 Weeks to End of Study|Adverse Event|2|||
131501514|NCT01909479|473465530|FG001|52 Weeks to End of Study|Adverse Event|1|||
131501515|NCT01909479|473465529|FG000|52 Weeks to End of Study|Death|0|||
131501516|NCT01909479|473465530|FG001|52 Weeks to End of Study|Death|1|||
131501517|NCT01909479|473465529|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
131501518|NCT01909479|473465530|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
131501519|NCT01909479|473465529|FG000|52 Weeks to End of Study|Protocol Violation|1|||
131501520|NCT01909479|473465530|FG001|52 Weeks to End of Study|Protocol Violation|0|||
131501521|NCT01909479|473465529|FG000|52 Weeks to End of Study|Progressive disease|1|||
131501522|NCT01909479|473465530|FG001|52 Weeks to End of Study|Progressive disease|1|||
131501523|NCT01909479|473465529|FG000|52 Weeks to End of Study|Personal reasons|2|||
131501524|NCT01909479|473465530|FG001|52 Weeks to End of Study|Personal reasons|1|||
131501525|NCT01909479|473465529|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
131501526|NCT01909479|473465530|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
131501527|NCT01909479|473465529|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
131501528|NCT01909479|473465530|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
131501529|NCT01909479|473465529|FG000|52 Weeks to End of Study|Lack of contact|1|||
131501530|NCT01909479|473465530|FG001|52 Weeks to End of Study|Lack of contact|0|||
131501531|NCT01909479|473465529|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
131501532|NCT01909479|473465530|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
131501533|NCT01909479|473465529|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
131501534|NCT01909479|473465530|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
131501535|NCT03198234|473465533|FG000|Overall Study|Relapse of primary disease|0|||
131501536|NCT03198234|473465534|FG001|Overall Study|Relapse of primary disease|1|||
131501537|NCT03198234|473465535|FG002|Overall Study|Relapse of primary disease|0|||
131501538|NCT02196558|473465536|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
131501539|NCT02196558|473465537|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
131501540|NCT02196558|473465538|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
131501541|NCT02196558|473465536|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
131501542|NCT02196558|473465537|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
131501543|NCT02196558|473465538|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
131501544|NCT02196558|473465536|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
131501545|NCT02196558|473465537|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
131501546|NCT02196558|473465538|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
131501547|NCT02196558|473465536|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
131501548|NCT02196558|473465537|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
131501549|NCT02196558|473465538|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
131501550|NCT02196558|473465536|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
131501551|NCT02196558|473465537|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
131501552|NCT02196558|473465538|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
131501553|NCT02669433|473465542|FG000|Overall Study|Protocol Violation|0|||
131501554|NCT02669433|473465543|FG001|Overall Study|Protocol Violation|4|||
131501555|NCT02669433|473465544|FG002|Overall Study|Protocol Violation|1|||
131501556|NCT02669433|473465542|FG000|Overall Study|Disease Progression|1|||
131501557|NCT02669433|473465543|FG001|Overall Study|Disease Progression|0|||
131501558|NCT02669433|473465544|FG002|Overall Study|Disease Progression|0|||
131501559|NCT02669433|473465542|FG000|Overall Study|Physician Decision|1|||
131501560|NCT02669433|473465543|FG001|Overall Study|Physician Decision|1|||
131501561|NCT02669433|473465544|FG002|Overall Study|Physician Decision|0|||
131501562|NCT02669433|473465542|FG000|Overall Study|Adverse Event|6|||
131501563|NCT02669433|473465543|FG001|Overall Study|Adverse Event|7|||
131501564|NCT02669433|473465544|FG002|Overall Study|Adverse Event|10|||
131501565|NCT02669433|473465542|FG000|Overall Study|Sponsor Termination|1|||
131501566|NCT02669433|473465543|FG001|Overall Study|Sponsor Termination|0|||
131501567|NCT02669433|473465544|FG002|Overall Study|Sponsor Termination|1|||
131501568|NCT02669433|473465542|FG000|Overall Study|Withdrawal by Subject|5|||
131501569|NCT02669433|473465543|FG001|Overall Study|Withdrawal by Subject|1|||
131501570|NCT02669433|473465544|FG002|Overall Study|Withdrawal by Subject|0|||
131501571|NCT02669433|473465542|FG000|Overall Study|Withdrawal by Caregiver|1|||
131501572|NCT02669433|473465543|FG001|Overall Study|Withdrawal by Caregiver|0|||
131501573|NCT02669433|473465544|FG002|Overall Study|Withdrawal by Caregiver|2|||
131501574|NCT02669433|473465542|FG000|Overall Study|Death|0|||
131501575|NCT02669433|473465543|FG001|Overall Study|Death|1|||
131501576|NCT02669433|473465544|FG002|Overall Study|Death|1|||
131501577|NCT00576927|473465545|FG000|Clinical Assessment|Lack of Efficacy|24|||
131501578|NCT00576927|473465545|FG000|Clinical Assessment|Death|1|||
131501579|NCT00576927|473465545|FG000|Clinical Assessment|Withdrawal by Subject|10|||
131501580|NCT00576927|473465545|FG000|Clinical Assessment|Physician Decision|1|||
131501581|NCT00576927|473465545|FG000|Baseline|Physician Decision|9|||
131501582|NCT00576927|473465545|FG000|Baseline|Medication Change by PCP of subject|1|||
131501583|NCT00576927|473465545|FG000|Baseline|Withdrawal by Subject|3|||
131501584|NCT00576927|473465545|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
131501585|NCT00576927|473465545|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
131501586|NCT00576927|473465545|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
131501587|NCT00576927|473465545|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
131501588|NCT00576927|473465545|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
131501589|NCT03266094|473465546|FG000|Overall Study|Lost to Follow-up|1|||
131501590|NCT03266094|473465546|FG000|Overall Study|Withdrawal by Subject|1|||
131501591|NCT03128892|473465547|FG000|Overall Study|Withdrawal by Subject|2|||
131501592|NCT03128892|473465547|FG000|Overall Study|Physician Decision|1|||
131501593|NCT00459108|473465549|FG000|Overall Study|Withdrawal by Subject|5|||
131501594|NCT00459108|473465549|FG000|Overall Study|Adverse Event|3|||
131501595|NCT00459108|473465549|FG000|Overall Study|Death|2|||
131501596|NCT00459108|473465549|FG000|Overall Study|Progression|1|||
131501597|NCT03473808|473465554|FG000|Overall Study|Withdrawal by Subject|1|||
131501598|NCT02157298|473465555|FG000|Overall Study|Adverse Event|1|||
131501599|NCT02157298|473465556|FG001|Overall Study|Adverse Event|0|||
131501600|NCT02157298|473465555|FG000|Overall Study|Subject no longer meets study criteria|1|||
131501601|NCT02157298|473465556|FG001|Overall Study|Subject no longer meets study criteria|2|||
131501602|NCT02157298|473465555|FG000|Overall Study|Poor/Non-compliance|1|||
131501603|NCT02157298|473465556|FG001|Overall Study|Poor/Non-compliance|0|||
131501604|NCT02157298|473465555|FG000|Overall Study|Withdrawal by Subject|1|||
131501605|NCT02157298|473465556|FG001|Overall Study|Withdrawal by Subject|0|||
131501606|NCT03171415|473465557|FG000|Overall Study|Lost to Follow-up|0|||
131501607|NCT03171415|473465558|FG001|Overall Study|Lost to Follow-up|0|||
131501608|NCT03171415|473465559|FG002|Overall Study|Lost to Follow-up|0|||
131501609|NCT03171415|473465560|FG003|Overall Study|Lost to Follow-up|0|||
131501610|NCT03171415|473465561|FG004|Overall Study|Lost to Follow-up|2|||
131501611|NCT04059094|473465562|FG000|Overall Study|Adverse Event|0|||
131501612|NCT04059094|473465563|FG001|Overall Study|Adverse Event|0|||
131501613|NCT04059094|473465564|FG002|Overall Study|Adverse Event|0|||
131501614|NCT04059094|473465565|FG003|Overall Study|Adverse Event|0|||
131501615|NCT04059094|473465566|FG004|Overall Study|Adverse Event|1|||
131501616|NCT04059094|473465562|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
131501617|NCT04059094|473465563|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
131501618|NCT04059094|473465564|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
131501619|NCT04059094|473465565|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
131501620|NCT04059094|473465566|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
131501621|NCT00883116|473465571|FG000|Overall Study|Adverse event unrelated to study drug|5|||
131501622|NCT00883116|473465572|FG001|Overall Study|Adverse event unrelated to study drug|10|||
131501623|NCT00883116|473465571|FG000|Overall Study|Death|6|||
131501624|NCT00883116|473465572|FG001|Overall Study|Death|2|||
131501625|NCT00883116|473465571|FG000|Overall Study|Disease progression|130|||
131501626|NCT00883116|473465572|FG001|Overall Study|Disease progression|128|||
131501627|NCT00883116|473465571|FG000|Overall Study|Lost to Follow-up|0|||
131501628|NCT00883116|473465572|FG001|Overall Study|Lost to Follow-up|1|||
131501629|NCT00883116|473465571|FG000|Overall Study|Maximum clinical benefit|13|||
131501630|NCT00883116|473465572|FG001|Overall Study|Maximum clinical benefit|46|||
131501631|NCT00883116|473465571|FG000|Overall Study|Not identified|3|||
131501632|NCT00883116|473465572|FG001|Overall Study|Not identified|6|||
131501633|NCT00883116|473465571|FG000|Overall Study|Study drug toxicity|36|||
131501634|NCT00883116|473465572|FG001|Overall Study|Study drug toxicity|16|||
131501635|NCT00883116|473465571|FG000|Overall Study|Withdrawal by Subject|14|||
131501636|NCT00883116|473465572|FG001|Overall Study|Withdrawal by Subject|8|||
131501637|NCT00883116|473465571|FG000|Overall Study|No longer meets study criteria|2|||
131501638|NCT00883116|473465572|FG001|Overall Study|No longer meets study criteria|2|||
131501639|NCT03715764|473465573|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
131501640|NCT03715764|473465574|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
131501641|NCT03715764|473465573|FG000|3 Month Follow-up|Lost to Follow-up|2|||
131501642|NCT03715764|473465574|FG001|3 Month Follow-up|Lost to Follow-up|2|||
131501643|NCT03715764|473465573|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
131501644|NCT03715764|473465574|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
131501645|NCT03715764|473465573|FG000|6 Month Follow-up|Lost to Follow-up|3|||
131501646|NCT03715764|473465574|FG001|6 Month Follow-up|Lost to Follow-up|0|||
131501647|NCT03715764|473465573|FG000|12 Month Follow-up|Lost to Follow-up|2|||
131501648|NCT03715764|473465574|FG001|12 Month Follow-up|Lost to Follow-up|3|||
131501649|NCT03715764|473465573|FG000|12 Month Follow-up|Pregnancy|0|||
131501650|NCT03715764|473465574|FG001|12 Month Follow-up|Pregnancy|1|||
131501651|NCT03715764|473465573|FG000|12 Month Follow-up|Surgery|2|||
131501652|NCT03715764|473465574|FG001|12 Month Follow-up|Surgery|0|||
131501653|NCT03715764|473465573|FG000|12 Month Follow-up|Wrong address|1|||
131501654|NCT03715764|473465574|FG001|12 Month Follow-up|Wrong address|0|||
131501655|NCT03715764|473465573|FG000|12 Month Follow-up|No symptoms|1|||
131501656|NCT03715764|473465574|FG001|12 Month Follow-up|No symptoms|0|||
131501657|NCT03715764|473465573|FG000|12 Month Follow-up|Changed primary care centre|0|||
131501658|NCT03715764|473465574|FG001|12 Month Follow-up|Changed primary care centre|1|||
131501659|NCT01361464|473465580|FG000|Overall Study|Death|1|||
131501660|NCT01361464|473465580|FG000|Overall Study|Withdrawal by Subject|2|||
131501661|NCT01106898|473465584|FG000|Overall Study|Adverse Event|6|||
131501662|NCT00818662|473465585|FG000|Overall Study|Adverse Event|5|||
131501663|NCT00818662|473465586|FG001|Overall Study|Adverse Event|14|||
131501664|NCT00818662|473465587|FG002|Overall Study|Adverse Event|4|||
131501665|NCT00818662|473465588|FG003|Overall Study|Adverse Event|3|||
131501666|NCT00818662|473465585|FG000|Overall Study|Withdrawal by Subject|5|||
131501667|NCT00818662|473465586|FG001|Overall Study|Withdrawal by Subject|4|||
131501668|NCT00818662|473465587|FG002|Overall Study|Withdrawal by Subject|2|||
131501669|NCT00818662|473465588|FG003|Overall Study|Withdrawal by Subject|2|||
131501670|NCT00818662|473465585|FG000|Overall Study|Death|1|||
131501671|NCT00818662|473465586|FG001|Overall Study|Death|3|||
131501672|NCT00818662|473465587|FG002|Overall Study|Death|0|||
131501673|NCT00818662|473465588|FG003|Overall Study|Death|0|||
131501674|NCT00818662|473465585|FG000|Overall Study|Physician Decision|1|||
131501675|NCT00818662|473465586|FG001|Overall Study|Physician Decision|0|||
131501676|NCT00818662|473465587|FG002|Overall Study|Physician Decision|0|||
131501677|NCT00818662|473465588|FG003|Overall Study|Physician Decision|0|||
131501678|NCT00818662|473465585|FG000|Overall Study|Lost to Follow-up|0|||
131501679|NCT00818662|473465586|FG001|Overall Study|Lost to Follow-up|0|||
131501680|NCT00818662|473465587|FG002|Overall Study|Lost to Follow-up|0|||
131501681|NCT00818662|473465588|FG003|Overall Study|Lost to Follow-up|1|||
131501682|NCT00818662|473465585|FG000|Overall Study|Unwilling or Unable to Participate|4|||
131501683|NCT00818662|473465586|FG001|Overall Study|Unwilling or Unable to Participate|6|||
131501684|NCT00818662|473465587|FG002|Overall Study|Unwilling or Unable to Participate|2|||
131501685|NCT00818662|473465588|FG003|Overall Study|Unwilling or Unable to Participate|4|||
131501686|NCT00818662|473465585|FG000|Overall Study|Protocol Violation|1|||
131501687|NCT00818662|473465586|FG001|Overall Study|Protocol Violation|1|||
131501688|NCT00818662|473465587|FG002|Overall Study|Protocol Violation|0|||
131501689|NCT00818662|473465588|FG003|Overall Study|Protocol Violation|0|||
131501690|NCT00818662|473465585|FG000|Overall Study|Requires a Prohibited Medication|1|||
131501691|NCT00818662|473465586|FG001|Overall Study|Requires a Prohibited Medication|0|||
131501692|NCT00818662|473465587|FG002|Overall Study|Requires a Prohibited Medication|0|||
131501693|NCT00818662|473465588|FG003|Overall Study|Requires a Prohibited Medication|0|||
131501694|NCT00818662|473465585|FG000|Overall Study|Safety Risk|1|||
131501695|NCT00818662|473465586|FG001|Overall Study|Safety Risk|1|||
131501696|NCT00818662|473465587|FG002|Overall Study|Safety Risk|0|||
131501697|NCT00818662|473465588|FG003|Overall Study|Safety Risk|1|||
131501698|NCT00818662|473465585|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
131501699|NCT00818662|473465586|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
131501700|NCT00818662|473465587|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
131501701|NCT00818662|473465588|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
131501702|NCT00818662|473465585|FG000|Overall Study|Participant's health declined|0|||
131501703|NCT00818662|473465586|FG001|Overall Study|Participant's health declined|0|||
131501704|NCT00818662|473465587|FG002|Overall Study|Participant's health declined|0|||
131501705|NCT00818662|473465588|FG003|Overall Study|Participant's health declined|1|||
131501706|NCT00818662|473465585|FG000|Overall Study|Caregiver to pursue other treatment|0|||
131501707|NCT00818662|473465586|FG001|Overall Study|Caregiver to pursue other treatment|1|||
131501708|NCT00818662|473465587|FG002|Overall Study|Caregiver to pursue other treatment|0|||
131501709|NCT00818662|473465588|FG003|Overall Study|Caregiver to pursue other treatment|0|||
131501710|NCT00818662|473465585|FG000|Overall Study|Moving out of state|0|||
131501711|NCT00818662|473465586|FG001|Overall Study|Moving out of state|0|||
131501712|NCT00818662|473465587|FG002|Overall Study|Moving out of state|0|||
131501713|NCT00818662|473465588|FG003|Overall Study|Moving out of state|1|||
131501714|NCT00818662|473465585|FG000|Overall Study|Declined move to another study site|1|||
131501715|NCT00818662|473465586|FG001|Overall Study|Declined move to another study site|0|||
131501716|NCT00818662|473465587|FG002|Overall Study|Declined move to another study site|0|||
131501717|NCT00818662|473465588|FG003|Overall Study|Declined move to another study site|0|||
131501718|NCT00818662|473465585|FG000|Overall Study|Change in living situation|0|||
131501719|NCT00818662|473465586|FG001|Overall Study|Change in living situation|0|||
131501720|NCT00818662|473465587|FG002|Overall Study|Change in living situation|0|||
131501721|NCT00818662|473465588|FG003|Overall Study|Change in living situation|1|||
131501722|NCT00818662|473465585|FG000|Overall Study|Study partner decision|0|||
131501723|NCT00818662|473465586|FG001|Overall Study|Study partner decision|0|||
131501724|NCT00818662|473465587|FG002|Overall Study|Study partner decision|0|||
131501725|NCT00818662|473465588|FG003|Overall Study|Study partner decision|1|||
131501726|NCT00818662|473465585|FG000|Overall Study|Admitted to long term nursing care|0|||
131501727|NCT00818662|473465586|FG001|Overall Study|Admitted to long term nursing care|1|||
131501728|NCT00818662|473465587|FG002|Overall Study|Admitted to long term nursing care|0|||
131501729|NCT00818662|473465588|FG003|Overall Study|Admitted to long term nursing care|0|||
131501730|NCT01472081|473465589|FG000|Overall Study|Continuing treatment at time of analysis|1|||
131501731|NCT01472081|473465590|FG001|Overall Study|Continuing treatment at time of analysis|4|||
131501732|NCT01472081|473465591|FG002|Overall Study|Continuing treatment at time of analysis|1|||
131501733|NCT01472081|473465592|FG003|Overall Study|Continuing treatment at time of analysis|8|||
131501734|NCT01472081|473465593|FG004|Overall Study|Continuing treatment at time of analysis|9|||
131501735|NCT01472081|473465594|FG005|Overall Study|Continuing treatment at time of analysis|0|||
131501736|NCT01472081|473465589|FG000|Overall Study|Disease Progression|4|||
131501737|NCT01472081|473465590|FG001|Overall Study|Disease Progression|10|||
131501738|NCT01472081|473465591|FG002|Overall Study|Disease Progression|12|||
131501739|NCT01472081|473465592|FG003|Overall Study|Disease Progression|31|||
131501740|NCT01472081|473465593|FG004|Overall Study|Disease Progression|22|||
131501741|NCT01472081|473465594|FG005|Overall Study|Disease Progression|3|||
131501742|NCT01472081|473465589|FG000|Overall Study|Study drug toxicity|2|||
131501743|NCT01472081|473465590|FG001|Overall Study|Study drug toxicity|9|||
131501744|NCT01472081|473465591|FG002|Overall Study|Study drug toxicity|4|||
131501745|NCT01472081|473465592|FG003|Overall Study|Study drug toxicity|6|||
131501746|NCT01472081|473465593|FG004|Overall Study|Study drug toxicity|13|||
131501747|NCT01472081|473465594|FG005|Overall Study|Study drug toxicity|2|||
131501748|NCT01472081|473465589|FG000|Overall Study|Death|0|||
131501749|NCT01472081|473465590|FG001|Overall Study|Death|0|||
131501750|NCT01472081|473465591|FG002|Overall Study|Death|0|||
131501751|NCT01472081|473465592|FG003|Overall Study|Death|0|||
131501752|NCT01472081|473465593|FG004|Overall Study|Death|1|||
131501753|NCT01472081|473465594|FG005|Overall Study|Death|0|||
131501754|NCT01472081|473465589|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
131501755|NCT01472081|473465590|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
131501756|NCT01472081|473465591|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
131501757|NCT01472081|473465592|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
131501758|NCT01472081|473465593|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
131501759|NCT01472081|473465594|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
131501760|NCT01472081|473465589|FG000|Overall Study|Withdrawal by Subject|0|||
131501761|NCT01472081|473465590|FG001|Overall Study|Withdrawal by Subject|0|||
131501762|NCT01472081|473465591|FG002|Overall Study|Withdrawal by Subject|0|||
131501763|NCT01472081|473465592|FG003|Overall Study|Withdrawal by Subject|0|||
131501764|NCT01472081|473465593|FG004|Overall Study|Withdrawal by Subject|0|||
131501765|NCT01472081|473465594|FG005|Overall Study|Withdrawal by Subject|1|||
131501766|NCT01472081|473465589|FG000|Overall Study|Poor/non-compliance|0|||
131501767|NCT01472081|473465590|FG001|Overall Study|Poor/non-compliance|0|||
131501768|NCT01472081|473465591|FG002|Overall Study|Poor/non-compliance|1|||
131501769|NCT01472081|473465592|FG003|Overall Study|Poor/non-compliance|0|||
131501770|NCT01472081|473465593|FG004|Overall Study|Poor/non-compliance|1|||
131501771|NCT01472081|473465594|FG005|Overall Study|Poor/non-compliance|0|||
131501772|NCT01472081|473465589|FG000|Overall Study|No longer meets study criteria|0|||
131501773|NCT01472081|473465590|FG001|Overall Study|No longer meets study criteria|0|||
131501774|NCT01472081|473465591|FG002|Overall Study|No longer meets study criteria|1|||
131501775|NCT01472081|473465592|FG003|Overall Study|No longer meets study criteria|0|||
131501776|NCT01472081|473465593|FG004|Overall Study|No longer meets study criteria|0|||
131501777|NCT01472081|473465594|FG005|Overall Study|No longer meets study criteria|0|||
131501778|NCT01472081|473465589|FG000|Overall Study|Subject request to discontinue treatment|0|||
131501779|NCT01472081|473465590|FG001|Overall Study|Subject request to discontinue treatment|3|||
131501780|NCT01472081|473465591|FG002|Overall Study|Subject request to discontinue treatment|1|||
131501781|NCT01472081|473465592|FG003|Overall Study|Subject request to discontinue treatment|1|||
131501782|NCT01472081|473465593|FG004|Overall Study|Subject request to discontinue treatment|0|||
131501783|NCT01472081|473465594|FG005|Overall Study|Subject request to discontinue treatment|0|||
131501784|NCT01705652|473465595|FG000|Overall Study|Adverse Event|1|||
131501785|NCT01705652|473465596|FG001|Overall Study|Adverse Event|0|||
131501786|NCT01705652|473465595|FG000|Overall Study|Withdrawal by Subject|1|||
131501787|NCT01705652|473465596|FG001|Overall Study|Withdrawal by Subject|2|||
131501788|NCT01705652|473465595|FG000|Overall Study|non-compliance|1|||
131501789|NCT01705652|473465596|FG001|Overall Study|non-compliance|1|||
131501790|NCT00541034|473465598|FG000|Overall Study|Non-Compliance|3|||
131501791|NCT01505868|473465599|FG000|Overall Study|Withdrawal by Subject|1|||
131501792|NCT01505868|473465600|FG001|Overall Study|Withdrawal by Subject|0|||
131501793|NCT01505868|473465601|FG002|Overall Study|Withdrawal by Subject|0|||
131501794|NCT01505868|473465602|FG003|Overall Study|Withdrawal by Subject|0|||
131501795|NCT01505868|473465603|FG004|Overall Study|Withdrawal by Subject|0|||
131501796|NCT02289079|473465604|FG000|Overall Study|Physician Decision|2|||
131501797|NCT02289079|473465605|FG001|Overall Study|Physician Decision|0|||
131501798|NCT02289079|473465604|FG000|Overall Study|Lost to Follow-up|0|||
131501799|NCT02289079|473465605|FG001|Overall Study|Lost to Follow-up|1|||
131501800|NCT03061331|473465606|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
131501801|NCT03061331|473465607|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
131501802|NCT01980875|473465608|FG000|Overall Study|Withdrew Consent|1|||
131501803|NCT01980875|473465609|FG001|Overall Study|Withdrew Consent|1|||
131501804|NCT01980875|473465610|FG002|Overall Study|Withdrew Consent|1|||
131501805|NCT01980875|473465608|FG000|Overall Study|Study Terminated by Sponsor|7|||
131501806|NCT01980875|473465609|FG001|Overall Study|Study Terminated by Sponsor|24|||
131501807|NCT01980875|473465610|FG002|Overall Study|Study Terminated by Sponsor|22|||
131501808|NCT01980875|473465608|FG000|Overall Study|Lost to Follow-up|0|||
131501809|NCT01980875|473465609|FG001|Overall Study|Lost to Follow-up|0|||
131501810|NCT01980875|473465610|FG002|Overall Study|Lost to Follow-up|1|||
131501811|NCT01686633|473465611|FG000|Overall Study|Lack of Efficacy|33|||
131501812|NCT01686633|473465612|FG001|Overall Study|Lack of Efficacy|13|||
131501813|NCT01686633|473465613|FG002|Overall Study|Lack of Efficacy|11|||
131501814|NCT01686633|473465611|FG000|Overall Study|Withdrawal by Subject|8|||
131501815|NCT01686633|473465612|FG001|Overall Study|Withdrawal by Subject|8|||
131501816|NCT01686633|473465613|FG002|Overall Study|Withdrawal by Subject|5|||
131501817|NCT01686633|473465611|FG000|Overall Study|Physician Decision|3|||
131501818|NCT01686633|473465612|FG001|Overall Study|Physician Decision|4|||
131501819|NCT01686633|473465613|FG002|Overall Study|Physician Decision|4|||
131501820|NCT01686633|473465611|FG000|Overall Study|Adverse Event|4|||
131501821|NCT01686633|473465612|FG001|Overall Study|Adverse Event|3|||
131501822|NCT01686633|473465613|FG002|Overall Study|Adverse Event|3|||
131501823|NCT01686633|473465611|FG000|Overall Study|Protocol Violation|2|||
131501824|NCT01686633|473465612|FG001|Overall Study|Protocol Violation|3|||
131501825|NCT01686633|473465613|FG002|Overall Study|Protocol Violation|0|||
131501826|NCT01686633|473465611|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
131501827|NCT01686633|473465612|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
131501828|NCT01686633|473465613|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
131501829|NCT01686633|473465611|FG000|Overall Study|Lost to Follow-up|0|||
131501830|NCT01686633|473465612|FG001|Overall Study|Lost to Follow-up|1|||
131501831|NCT01686633|473465613|FG002|Overall Study|Lost to Follow-up|1|||
131501832|NCT02626520|473465619|FG000|Overall Study|Physician Decision|1|||
131501833|NCT02626520|473465620|FG001|Overall Study|Physician Decision|1|||
131501834|NCT02626520|473465619|FG000|Overall Study|Adverse Event|0|||
131501835|NCT02626520|473465620|FG001|Overall Study|Adverse Event|4|||
131501836|NCT02626520|473465619|FG000|Overall Study|Lack of Efficacy|0|||
131501837|NCT02626520|473465620|FG001|Overall Study|Lack of Efficacy|2|||
131501838|NCT02626520|473465619|FG000|Overall Study|Did not start protocol therapy|0|||
131501839|NCT02626520|473465620|FG001|Overall Study|Did not start protocol therapy|2|||
131501840|NCT02626520|473465619|FG000|Overall Study|Study terminated|0|||
131501841|NCT02626520|473465620|FG001|Overall Study|Study terminated|1|||
131501842|NCT00492115|473465621|FG000|Overall Study|Withdrawal by Subject|3|||
131501843|NCT00492115|473465622|FG001|Overall Study|Withdrawal by Subject|4|||
131501844|NCT03564145|473465623|FG000|Overall Study|Adverse Event|4|||
131501845|NCT03564145|473465623|FG000|Overall Study|Lost to Follow-up|21|||
131501846|NCT03564145|473465623|FG000|Overall Study|Protocol Violation|2|||
131501847|NCT03564145|473465623|FG000|Overall Study|Withdrawal by Subject|48|||
131501848|NCT03564145|473465623|FG000|Overall Study|Study Terminated by Sponsor|146|||
131501849|NCT03564145|473465623|FG000|Overall Study|Physician Decision|1|||
131501850|NCT03564145|473465623|FG000|Overall Study|Other Than Specified|1|||
131501851|NCT03564145|473465623|FG000|Overall Study|Pregnancy|1|||
131501852|NCT03915496|473465626|FG000|Overall Study|Adverse Event|2|||
131501853|NCT03915496|473465627|FG001|Overall Study|Adverse Event|1|||
131501854|NCT03915496|473465628|FG002|Overall Study|Adverse Event|2|||
131501855|NCT02081690|473467809|FG000|Overall Study|Death|3|||
131501856|NCT02081690|473467809|FG000|Overall Study|Physician Decision|3|||
131501857|NCT02081690|473467809|FG000|Overall Study|Withdrawal by Subject|1|||
131501858|NCT03204981|473467811|FG000|Overall Study|Physician Decision|2|||
131501859|NCT03204981|473467811|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
131501860|NCT04244786|473467812|FG000|Overall Study|Adverse Event|0|||
131501861|NCT04244786|473467813|FG001|Overall Study|Adverse Event|0|||
131501862|NCT04244786|473467814|FG002|Overall Study|Adverse Event|2|||
131501863|NCT04244786|473467812|FG000|Overall Study|Withdrawal by Subject|0|||
131501864|NCT04244786|473467813|FG001|Overall Study|Withdrawal by Subject|0|||
131501865|NCT04244786|473467814|FG002|Overall Study|Withdrawal by Subject|5|||
131501866|NCT03745937|473467818|FG000|Overall Study|Withdrawal by Subject|0|||
131501867|NCT03745937|473467819|FG001|Overall Study|Withdrawal by Subject|0|||
131501868|NCT03745937|473467820|FG002|Overall Study|Withdrawal by Subject|0|||
131501869|NCT03745937|473467821|FG003|Overall Study|Withdrawal by Subject|1|||
131501870|NCT03745937|473467818|FG000|Overall Study|Not-specifed|0|||
131501871|NCT03745937|473467819|FG001|Overall Study|Not-specifed|1|||
131501872|NCT03745937|473467820|FG002|Overall Study|Not-specifed|0|||
131501873|NCT03745937|473467821|FG003|Overall Study|Not-specifed|1|||
131501874|NCT00312494|473467822|FG000|Overall Study|Randomized; not treated with study drug|9|||
131501875|NCT00312494|473467823|FG001|Overall Study|Randomized; not treated with study drug|10|||
131501876|NCT00312494|473467824|FG002|Overall Study|Randomized; not treated with study drug|5|||
131501877|NCT00312494|473467822|FG000|Overall Study|Adverse Event|33|||
131501878|NCT00312494|473467823|FG001|Overall Study|Adverse Event|15|||
131501879|NCT00312494|473467824|FG002|Overall Study|Adverse Event|11|||
131501880|NCT00312494|473467822|FG000|Overall Study|Lack of Efficacy|4|||
131501881|NCT00312494|473467823|FG001|Overall Study|Lack of Efficacy|6|||
131501882|NCT00312494|473467824|FG002|Overall Study|Lack of Efficacy|8|||
131501883|NCT00312494|473467822|FG000|Overall Study|Laboratory abnormality|1|||
131501884|NCT00312494|473467823|FG001|Overall Study|Laboratory abnormality|0|||
131501885|NCT00312494|473467824|FG002|Overall Study|Laboratory abnormality|0|||
131501886|NCT00312494|473467822|FG000|Overall Study|Lost to Follow-up|8|||
131501887|NCT00312494|473467823|FG001|Overall Study|Lost to Follow-up|8|||
131501888|NCT00312494|473467824|FG002|Overall Study|Lost to Follow-up|8|||
131501889|NCT00312494|473467822|FG000|Overall Study|Withdrawal by Subject|6|||
131501890|NCT00312494|473467823|FG001|Overall Study|Withdrawal by Subject|9|||
131501891|NCT00312494|473467824|FG002|Overall Study|Withdrawal by Subject|10|||
131501892|NCT00312494|473467822|FG000|Overall Study|Other|10|||
131501893|NCT00312494|473467823|FG001|Overall Study|Other|10|||
131501894|NCT00312494|473467824|FG002|Overall Study|Other|1|||
131501895|NCT02734810|473467826|FG000|Overall Study|Adverse Event|1|||
131501896|NCT02734810|473467827|FG001|Overall Study|Adverse Event|0|||
131501897|NCT02734810|473467826|FG000|Overall Study|Lack of Efficacy|1|||
131501898|NCT02734810|473467827|FG001|Overall Study|Lack of Efficacy|0|||
131501899|NCT00488345|473467828|FG000|Overall Study|Adverse Event|0|||
131501900|NCT00488345|473467829|FG001|Overall Study|Adverse Event|1|||
131501901|NCT00488345|473467830|FG002|Overall Study|Adverse Event|1|||
131501902|NCT00488345|473467828|FG000|Overall Study|Unable to administer antibiotics at home|0|||
131501903|NCT00488345|473467829|FG001|Overall Study|Unable to administer antibiotics at home|1|||
131501904|NCT00488345|473467830|FG002|Overall Study|Unable to administer antibiotics at home|0|||
131501905|NCT00488345|473467828|FG000|Overall Study|Institutional Review Board review|0|||
131501906|NCT00488345|473467829|FG001|Overall Study|Institutional Review Board review|0|||
131501907|NCT00488345|473467830|FG002|Overall Study|Institutional Review Board review|1|||
131501908|NCT00488345|473467828|FG000|Overall Study|Surgical team recommendation|0|||
131501909|NCT00488345|473467829|FG001|Overall Study|Surgical team recommendation|1|||
131501910|NCT00488345|473467830|FG002|Overall Study|Surgical team recommendation|0|||
131501911|NCT00488345|473467828|FG000|Overall Study|Parent/legal guardian request|0|||
131501912|NCT00488345|473467829|FG001|Overall Study|Parent/legal guardian request|1|||
131501913|NCT00488345|473467830|FG002|Overall Study|Parent/legal guardian request|1|||
131501914|NCT00903617|473467835|FG000|Overall Study|Adverse Event|0|||
131501915|NCT00903617|473467836|FG001|Overall Study|Adverse Event|1|||
131501916|NCT00903617|473467837|FG002|Overall Study|Adverse Event|1|||
131501917|NCT00903617|473467838|FG003|Overall Study|Adverse Event|0|||
131501918|NCT00903617|473467835|FG000|Overall Study|Protocol-defined stopping criteria|0|||
131501919|NCT00903617|473467836|FG001|Overall Study|Protocol-defined stopping criteria|2|||
131501920|NCT00903617|473467837|FG002|Overall Study|Protocol-defined stopping criteria|0|||
131501921|NCT00903617|473467838|FG003|Overall Study|Protocol-defined stopping criteria|0|||
131501922|NCT00903617|473467835|FG000|Overall Study|Lost to Follow-up|2|||
131501923|NCT00903617|473467836|FG001|Overall Study|Lost to Follow-up|0|||
131501924|NCT00903617|473467837|FG002|Overall Study|Lost to Follow-up|1|||
131501925|NCT00903617|473467838|FG003|Overall Study|Lost to Follow-up|1|||
131501926|NCT00903617|473467835|FG000|Overall Study|Withdrawal by Subject|1|||
131501927|NCT00903617|473467836|FG001|Overall Study|Withdrawal by Subject|2|||
131501928|NCT00903617|473467837|FG002|Overall Study|Withdrawal by Subject|3|||
131501929|NCT00903617|473467838|FG003|Overall Study|Withdrawal by Subject|0|||
131501930|NCT00407563|473467839|FG000|Overall Study|Patient continues on treatment|1|||
131501931|NCT00592839|473467840|FG000|Overall Study|Withdrawal by Subject|1|||
131501932|NCT00592839|473467841|FG001|Overall Study|Withdrawal by Subject|1|||
131501933|NCT00592839|473467842|FG002|Overall Study|Withdrawal by Subject|3|||
131501934|NCT00592839|473467840|FG000|Overall Study|Protocol Violation|1|||
131501935|NCT00592839|473467841|FG001|Overall Study|Protocol Violation|1|||
131501936|NCT00592839|473467842|FG002|Overall Study|Protocol Violation|2|||
131501937|NCT00592839|473467840|FG000|Overall Study|Adverse Event|0|||
131501938|NCT00592839|473467841|FG001|Overall Study|Adverse Event|1|||
131501939|NCT00592839|473467842|FG002|Overall Study|Adverse Event|0|||
131501940|NCT00592839|473467840|FG000|Overall Study|Lost to Follow-up|0|||
131501941|NCT00592839|473467841|FG001|Overall Study|Lost to Follow-up|1|||
131501942|NCT00592839|473467842|FG002|Overall Study|Lost to Follow-up|1|||
131501943|NCT02169739|473467845|FG000|Overall Study|Lost to Follow-up|0|||
131501944|NCT02169739|473467846|FG001|Overall Study|Lost to Follow-up|4|||
131501945|NCT00350636|473467847|FG000|Overall Study|Adverse Event|19|||
131501946|NCT00350636|473467848|FG001|Overall Study|Adverse Event|13|||
131501947|NCT00350636|473467847|FG000|Overall Study|Protocol Violation|1|||
131501948|NCT00350636|473467848|FG001|Overall Study|Protocol Violation|3|||
131501949|NCT00350636|473467847|FG000|Overall Study|Withdrawal by Subject|13|||
131501950|NCT00350636|473467848|FG001|Overall Study|Withdrawal by Subject|17|||
131501951|NCT00350636|473467847|FG000|Overall Study|Lost to Follow-up|9|||
131501952|NCT00350636|473467848|FG001|Overall Study|Lost to Follow-up|8|||
131501953|NCT00350636|473467847|FG000|Overall Study|Physician Decision|0|||
131501954|NCT00350636|473467848|FG001|Overall Study|Physician Decision|2|||
131501955|NCT00350636|473467847|FG000|Overall Study|Other|1|||
131501956|NCT00350636|473467848|FG001|Overall Study|Other|2|||
131501957|NCT01042236|473467853|FG000|Treatment Period 1|Adverse Event|0|||
131501958|NCT01042236|473467854|FG001|Treatment Period 1|Adverse Event|1|||
131501959|NCT01042236|473467855|FG002|Treatment Period 1|Adverse Event|0|||
131501960|NCT01042236|473467856|FG003|Treatment Period 1|Adverse Event|0|||
131501961|NCT01042236|473467857|FG004|Treatment Period 1|Adverse Event|1|||
131501962|NCT01042236|473467858|FG005|Treatment Period 1|Adverse Event|0|||
131501963|NCT01042236|473467853|FG000|Treatment Period 3|Adverse Event|0|||
131501964|NCT01042236|473467854|FG001|Treatment Period 3|Adverse Event|0|||
131501965|NCT01042236|473467855|FG002|Treatment Period 3|Adverse Event|0|||
131501966|NCT01042236|473467856|FG003|Treatment Period 3|Adverse Event|1|||
131501967|NCT01042236|473467857|FG004|Treatment Period 3|Adverse Event|0|||
131501968|NCT01042236|473467858|FG005|Treatment Period 3|Adverse Event|0|||
131501969|NCT01042236|473467853|FG000|Treatment Period 3|Protocol Violation|0|||
131501970|NCT01042236|473467854|FG001|Treatment Period 3|Protocol Violation|0|||
131501971|NCT01042236|473467855|FG002|Treatment Period 3|Protocol Violation|0|||
131501972|NCT01042236|473467856|FG003|Treatment Period 3|Protocol Violation|1|||
131501973|NCT01042236|473467857|FG004|Treatment Period 3|Protocol Violation|0|||
131501974|NCT01042236|473467858|FG005|Treatment Period 3|Protocol Violation|0|||
131501975|NCT00227903|473467859|FG000|Overall Study|Withdrawal by Subject|2|||
131501976|NCT00227903|473467860|FG001|Overall Study|Withdrawal by Subject|5|||
131501977|NCT00227903|473467859|FG000|Overall Study|Subject moved out of area|1|||
131501978|NCT00227903|473467860|FG001|Overall Study|Subject moved out of area|2|||
131501979|NCT00227903|473467859|FG000|Overall Study|Lost to Follow-up|1|||
131501980|NCT00227903|473467860|FG001|Overall Study|Lost to Follow-up|3|||
131501981|NCT00227903|473467859|FG000|Overall Study|Miscarriage|1|||
131501982|NCT00227903|473467860|FG001|Overall Study|Miscarriage|0|||
131501983|NCT01475331|473467861|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
131501984|NCT01475331|473467862|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
131501985|NCT01475331|473467861|FG000|Overall Study|excessive main duct communication|1|||
131501986|NCT01475331|473467862|FG001|Overall Study|excessive main duct communication|1|||
131501987|NCT01475331|473467861|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
131501988|NCT01475331|473467862|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
131501989|NCT01475331|473467861|FG000|Overall Study|Sign of malignancy during the procedure|2|||
131501990|NCT01475331|473467862|FG001|Overall Study|Sign of malignancy during the procedure|0|||
131501991|NCT01475331|473467861|FG000|Overall Study|cyst found to be prohibitively small|0|||
131501992|NCT01475331|473467862|FG001|Overall Study|cyst found to be prohibitively small|1|||
131501993|NCT01525550|473467863|FG000|Overall Study|Lost to Follow-up|8|||
131501994|NCT01525550|473467864|FG001|Overall Study|Lost to Follow-up|2|||
131501995|NCT01525550|473467863|FG000|Overall Study|Death|19|||
131501996|NCT01525550|473467864|FG001|Overall Study|Death|28|||
131501997|NCT01525550|473467863|FG000|Overall Study|Other|0|||
131501998|NCT01525550|473467864|FG001|Overall Study|Other|4|||
131501999|NCT01525550|473467863|FG000|Overall Study|Sponsor's Decision|30|||
131502000|NCT01525550|473467864|FG001|Overall Study|Sponsor's Decision|11|||
131502001|NCT01525550|473467863|FG000|Overall Study|Withdrawal by Subject|4|||
131502002|NCT01525550|473467864|FG001|Overall Study|Withdrawal by Subject|0|||
131502003|NCT03683758|473467866|FG000|Overall Study|Non-study commitment conflict|1|||
131502004|NCT03683758|473467867|FG001|Overall Study|Non-study commitment conflict|3|||
131502005|NCT03683758|473467866|FG000|Overall Study|Illness preventing participation|1|||
131502006|NCT03683758|473467867|FG001|Overall Study|Illness preventing participation|0|||
131502007|NCT03683758|473467866|FG000|Overall Study|Adverse Event|1|||
131502008|NCT03683758|473467867|FG001|Overall Study|Adverse Event|0|||
131502009|NCT01172847|473467868|FG000|Overall Study|Withdrawal by Subject|3|||
131502010|NCT01163279|473467869|FG000|Overall Study|Withdrawal by Subject|2|||
131502011|NCT01163279|473467870|FG001|Overall Study|Withdrawal by Subject|0|||
131502012|NCT01601626|473467871|FG000|Overall Study|Death|1|||
131502013|NCT01601626|473467872|FG001|Overall Study|Death|1|||
131502014|NCT01601626|473467873|FG002|Overall Study|Death|1|||
131502015|NCT01601626|473467871|FG000|Overall Study|Lost to Follow-up|1|||
131502016|NCT01601626|473467872|FG001|Overall Study|Lost to Follow-up|2|||
131502017|NCT01601626|473467873|FG002|Overall Study|Lost to Follow-up|0|||
131502018|NCT01601626|473467871|FG000|Overall Study|Unable to Get to Clinic|0|||
131502019|NCT01601626|473467872|FG001|Overall Study|Unable to Get to Clinic|1|||
131502020|NCT01601626|473467873|FG002|Overall Study|Unable to Get to Clinic|0|||
131502021|NCT01601626|473467871|FG000|Overall Study|Withdrawal by Subject|0|||
131502022|NCT01601626|473467872|FG001|Overall Study|Withdrawal by Subject|1|||
131502023|NCT01601626|473467873|FG002|Overall Study|Withdrawal by Subject|1|||
131502024|NCT01601626|473467871|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
131502025|NCT01601626|473467872|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
131502026|NCT01601626|473467873|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
131502027|NCT02632552|473467875|FG000|Overall Study|Lost to Follow-up|14|||
131502028|NCT02632552|473467876|FG001|Overall Study|Lost to Follow-up|8|||
131502029|NCT02632552|473467875|FG000|Overall Study|Withdrawal by Subject|2|||
131502030|NCT02632552|473467876|FG001|Overall Study|Withdrawal by Subject|0|||
131502031|NCT02632552|473467875|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
131502032|NCT02632552|473467876|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
131502033|NCT01074450|473467877|FG000|First Intervention|Emesis in Dosing Interval|0|||
131502034|NCT01074450|473467878|FG001|First Intervention|Emesis in Dosing Interval|2|||
131502035|NCT01074450|473467877|FG000|Second Intervention|Protocol Violation|1|||
131502036|NCT01074450|473467878|FG001|Second Intervention|Protocol Violation|0|||
131502037|NCT01074450|473467877|FG000|Second Intervention|Physician Decision|0|||
131502038|NCT01074450|473467878|FG001|Second Intervention|Physician Decision|1|||
131502039|NCT02728895|473467879|FG000|Overall Study|Other|1|||
131502040|NCT02728895|473467880|FG001|Overall Study|Other|2|||
131502041|NCT02728895|473467879|FG000|Overall Study|Withdrawal by Subject|0|||
131502042|NCT02728895|473467880|FG001|Overall Study|Withdrawal by Subject|3|||
131502043|NCT04577118|473467887|FG000|Overall Study|Withdrawal by Subject|4|||
131502044|NCT00810407|473467888|FG000|Overall Study|Protocol Violation|3|||
131502045|NCT00810407|473467888|FG000|Overall Study|No Visit After First Day of Treatment|3|||
131502046|NCT02968563|473467889|FG000|Overall Study|Adverse Event|0|||
131502047|NCT02968563|473467890|FG001|Overall Study|Adverse Event|6|||
131502048|NCT02968563|473467889|FG000|Overall Study|Death|1|||
131502049|NCT02968563|473467890|FG001|Overall Study|Death|1|||
131502050|NCT02968563|473467889|FG000|Overall Study|Lost to Follow-up|0|||
131502051|NCT02968563|473467890|FG001|Overall Study|Lost to Follow-up|1|||
131502052|NCT01382446|473467891|FG000|Overall Study|Withdrawal by Subject|0|||
131502053|NCT01382446|473467892|FG001|Overall Study|Withdrawal by Subject|1|||
131502054|NCT01382446|473467891|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
131502055|NCT01382446|473467892|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
131502056|NCT01928329|473467893|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
131502057|NCT01928329|473467894|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
131502058|NCT01928329|473467893|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
131502059|NCT01928329|473467894|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
131502060|NCT01928329|473467893|FG000|Overall Study|Adverse Event|5|||
131502061|NCT01928329|473467894|FG001|Overall Study|Adverse Event|3|||
131502062|NCT01928329|473467893|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
131502063|NCT01928329|473467894|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
131502064|NCT01928329|473467893|FG000|Overall Study|Withdrawal by Subject|1|||
131502065|NCT01928329|473467894|FG001|Overall Study|Withdrawal by Subject|5|||
131502066|NCT01928329|473467893|FG000|Overall Study|Physician Decision|1|||
131502067|NCT01928329|473467894|FG001|Overall Study|Physician Decision|1|||
131502068|NCT02617511|473467895|FG000|Overall Study|Withdrawal by Subject|1|||
131502069|NCT02617511|473467896|FG001|Overall Study|Withdrawal by Subject|0|||
131502070|NCT02604212|473467899|FG000|Overall Study|Study Terminated by Sponsor|2|||
131502071|NCT02604212|473467900|FG001|Overall Study|Study Terminated by Sponsor|1|||
131502072|NCT02604212|473467901|FG002|Overall Study|Study Terminated by Sponsor|3|||
131502073|NCT02604212|473467902|FG003|Overall Study|Study Terminated by Sponsor|3|||
131502074|NCT02604212|473467899|FG000|Overall Study|Withdrawal by Subject|0|||
131502075|NCT02604212|473467900|FG001|Overall Study|Withdrawal by Subject|0|||
131502076|NCT02604212|473467901|FG002|Overall Study|Withdrawal by Subject|1|||
131502077|NCT02604212|473467902|FG003|Overall Study|Withdrawal by Subject|0|||
131502078|NCT00597766|473467905|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
131502079|NCT00597766|473467906|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
131502080|NCT00597766|473467907|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
131502081|NCT00597766|473467905|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
131502082|NCT00597766|473467906|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
131502083|NCT00597766|473467907|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
131502084|NCT01166763|473467909|FG000|Overall Study|Withdrawal by Subject|3|||
131502085|NCT04339296|473467910|FG000|Overall Study|Refuse to participate after allocation|1|||
131502086|NCT04339296|473467911|FG001|Overall Study|Refuse to participate after allocation|1|||
131502087|NCT04339296|473467910|FG000|Overall Study|Withdrew after completion of baseline|2|||
131502088|NCT04339296|473467911|FG001|Overall Study|Withdrew after completion of baseline|1|||
131502089|NCT04339296|473467910|FG000|Overall Study|Lost to Follow-up|0|||
131502090|NCT04339296|473467911|FG001|Overall Study|Lost to Follow-up|4|||
131502091|NCT04339296|473467910|FG000|Overall Study|Discontinued intervention|5|||
131502092|NCT04339296|473467911|FG001|Overall Study|Discontinued intervention|3|||
131502093|NCT04446377|473467912|FG000|Overall Study|Withdrawal by Subject|6|||
131502094|NCT04446377|473467913|FG001|Overall Study|Withdrawal by Subject|1|||
131502095|NCT04446377|473467912|FG000|Overall Study|Physician Decision|1|||
131502096|NCT04446377|473467913|FG001|Overall Study|Physician Decision|1|||
131502097|NCT04446377|473467912|FG000|Overall Study|Lost to Follow-up|0|||
131502098|NCT04446377|473467913|FG001|Overall Study|Lost to Follow-up|2|||
131502099|NCT04446377|473467912|FG000|Overall Study|Not eligible|0|||
131502100|NCT04446377|473467913|FG001|Overall Study|Not eligible|1|||
131502101|NCT03557151|473467917|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
131502102|NCT03557151|473467918|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
131502103|NCT03557151|473467917|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
131502104|NCT03557151|473467918|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
131502105|NCT03557151|473467917|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
131502106|NCT03557151|473467918|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
131502107|NCT01414075|473467919|FG000|Overall Study|Adverse Event|1|||
131502108|NCT01414075|473467920|FG001|Overall Study|Adverse Event|0|||
131502109|NCT01414075|473467921|FG002|Overall Study|Adverse Event|1|||
131502110|NCT01414075|473467922|FG003|Overall Study|Adverse Event|0|||
131502111|NCT01414075|473467919|FG000|Overall Study|Death|1|||
131502112|NCT01414075|473467920|FG001|Overall Study|Death|0|||
131502113|NCT01414075|473467921|FG002|Overall Study|Death|0|||
131502114|NCT01414075|473467922|FG003|Overall Study|Death|1|||
131502115|NCT01414075|473467919|FG000|Overall Study|Withdrawal by Subject|0|||
131502116|NCT01414075|473467920|FG001|Overall Study|Withdrawal by Subject|0|||
131502117|NCT01414075|473467921|FG002|Overall Study|Withdrawal by Subject|0|||
131502118|NCT01414075|473467922|FG003|Overall Study|Withdrawal by Subject|1|||
131502119|NCT01414075|473467919|FG000|Overall Study|Other than specified|1|||
131502120|NCT01414075|473467920|FG001|Overall Study|Other than specified|0|||
131502121|NCT01414075|473467921|FG002|Overall Study|Other than specified|1|||
131502122|NCT01414075|473467922|FG003|Overall Study|Other than specified|0|||
131502123|NCT02810392|473467924|FG000|Overall Study|Subject too ill to continue|1|||
131502124|NCT02810392|473467925|FG001|Overall Study|Subject too ill to continue|0|||
131502125|NCT02810392|473467924|FG000|Overall Study|COVID 19 research restrictions|0|||
131502126|NCT02810392|473467925|FG001|Overall Study|COVID 19 research restrictions|1|||
131502127|NCT01187043|473467926|FG000|Overall Study|Adverse Event|0|||
131502128|NCT01187043|473467927|FG001|Overall Study|Adverse Event|0|||
131502129|NCT01187043|473467928|FG002|Overall Study|Adverse Event|0|||
131502130|NCT01187043|473467929|FG003|Overall Study|Adverse Event|0|||
131502131|NCT01187043|473467930|FG004|Overall Study|Adverse Event|1|||
131502132|NCT01187043|473467926|FG000|Overall Study|Unable to make scheduled visits|1|||
131502133|NCT01187043|473467927|FG001|Overall Study|Unable to make scheduled visits|0|||
131502134|NCT01187043|473467928|FG002|Overall Study|Unable to make scheduled visits|4|||
131502135|NCT01187043|473467929|FG003|Overall Study|Unable to make scheduled visits|0|||
131658090|NCT04445987|474032995|FG001|Overall Study|Lost to Follow-up|3|||
131502136|NCT01187043|473467930|FG004|Overall Study|Unable to make scheduled visits|1|||
131502137|NCT02457910|473467931|FG000|Overall Study|Withdrawal by Subject|0|||
131502138|NCT02457910|473467932|FG001|Overall Study|Withdrawal by Subject|0|||
131502139|NCT02457910|473467933|FG002|Overall Study|Withdrawal by Subject|0|||
131502140|NCT02457910|473467934|FG003|Overall Study|Withdrawal by Subject|0|||
131502141|NCT02457910|473467935|FG004|Overall Study|Withdrawal by Subject|0|||
131502142|NCT02457910|473467936|FG005|Overall Study|Withdrawal by Subject|1|||
131502143|NCT02457910|473467931|FG000|Overall Study|Adverse Event|0|||
131502144|NCT02457910|473467932|FG001|Overall Study|Adverse Event|2|||
131502145|NCT02457910|473467933|FG002|Overall Study|Adverse Event|1|||
131502146|NCT02457910|473467934|FG003|Overall Study|Adverse Event|1|||
131502147|NCT02457910|473467935|FG004|Overall Study|Adverse Event|1|||
131502148|NCT02457910|473467936|FG005|Overall Study|Adverse Event|3|||
131502149|NCT02457910|473467931|FG000|Overall Study|Disease progression|3|||
131502150|NCT02457910|473467932|FG001|Overall Study|Disease progression|3|||
131502151|NCT02457910|473467933|FG002|Overall Study|Disease progression|1|||
131502152|NCT02457910|473467934|FG003|Overall Study|Disease progression|1|||
131502153|NCT02457910|473467935|FG004|Overall Study|Disease progression|4|||
131502154|NCT02457910|473467936|FG005|Overall Study|Disease progression|6|||
131502155|NCT02457910|473467931|FG000|Overall Study|Other complicating illness|0|||
131502156|NCT02457910|473467932|FG001|Overall Study|Other complicating illness|0|||
131502157|NCT02457910|473467933|FG002|Overall Study|Other complicating illness|0|||
131502158|NCT02457910|473467934|FG003|Overall Study|Other complicating illness|0|||
131502159|NCT02457910|473467935|FG004|Overall Study|Other complicating illness|0|||
131502160|NCT02457910|473467936|FG005|Overall Study|Other complicating illness|1|||
131502161|NCT02457910|473467931|FG000|Overall Study|Death|0|||
131502162|NCT02457910|473467932|FG001|Overall Study|Death|0|||
131502163|NCT02457910|473467933|FG002|Overall Study|Death|1|||
131502164|NCT02457910|473467934|FG003|Overall Study|Death|0|||
131502165|NCT02457910|473467935|FG004|Overall Study|Death|0|||
131502166|NCT02457910|473467936|FG005|Overall Study|Death|0|||
131502167|NCT01722071|473467937|FG000|Overall Study|Protocol Violation|1|||
131502168|NCT01722071|473467938|FG001|Overall Study|Protocol Violation|0|||
131502169|NCT02062879|473467939|FG000|Overall Study|Withdrawal by Subject|4|||
131502170|NCT02062879|473467940|FG001|Overall Study|Withdrawal by Subject|1|||
131502171|NCT00680043|473467941|FG000|Overall Study|Withdrawal by Subject|1|||
131502172|NCT00680043|473467942|FG001|Overall Study|Withdrawal by Subject|0|||
131502173|NCT00680043|473467943|FG002|Overall Study|Withdrawal by Subject|0|||
131502174|NCT00680043|473467941|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
131502175|NCT00680043|473467942|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
131502176|NCT00680043|473467943|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
131502177|NCT00680043|473467941|FG000|Overall Study|Renal Transplant|1|||
131502178|NCT00680043|473467942|FG001|Overall Study|Renal Transplant|0|||
131502179|NCT00680043|473467943|FG002|Overall Study|Renal Transplant|4|||
131502180|NCT00553150|473467944|FG000|Overall Study|Withdrawal by Subject|0|||
131502181|NCT00553150|473467945|FG001|Overall Study|Withdrawal by Subject|0|||
131502182|NCT00553150|473467946|FG002|Overall Study|Withdrawal by Subject|0|||
131502183|NCT00553150|473467947|FG003|Overall Study|Withdrawal by Subject|2|||
131502184|NCT00553150|473467944|FG000|Overall Study|Protocol Violation|0|||
131502185|NCT00553150|473467945|FG001|Overall Study|Protocol Violation|0|||
131502186|NCT00553150|473467946|FG002|Overall Study|Protocol Violation|0|||
131502187|NCT00553150|473467947|FG003|Overall Study|Protocol Violation|1|||
131502188|NCT00553150|473467944|FG000|Overall Study|Ineligible|0|||
131502189|NCT00553150|473467945|FG001|Overall Study|Ineligible|0|||
131502190|NCT00553150|473467946|FG002|Overall Study|Ineligible|0|||
131502191|NCT00553150|473467947|FG003|Overall Study|Ineligible|1|||
131502192|NCT02998840|473467951|FG000|Overall Study|Lost to Follow-up|1|||
131502193|NCT02998840|473467952|FG001|Overall Study|Lost to Follow-up|1|||
131502194|NCT02998840|473467953|FG002|Overall Study|Lost to Follow-up|2|||
131502195|NCT02998840|473467954|FG003|Overall Study|Lost to Follow-up|3|||
131502196|NCT02998840|473467951|FG000|Overall Study|Withdrawal by Subject|1|||
131502197|NCT02998840|473467952|FG001|Overall Study|Withdrawal by Subject|1|||
131502198|NCT02998840|473467953|FG002|Overall Study|Withdrawal by Subject|0|||
131502199|NCT02998840|473467954|FG003|Overall Study|Withdrawal by Subject|1|||
131502200|NCT02998840|473467951|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
131502201|NCT02998840|473467952|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
131502202|NCT02998840|473467953|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
131502203|NCT02998840|473467954|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
131502204|NCT02625259|473467955|FG000|First Intervention (Day 1)|Other|0|||
131502205|NCT02625259|473467956|FG001|First Intervention (Day 1)|Other|0|||
131502206|NCT02625259|473467957|FG002|First Intervention (Day 1)|Other|1|||
131502207|NCT02625259|473467958|FG003|First Intervention (Day 1)|Other|0|||
131502208|NCT02625259|473467959|FG004|First Intervention (Day 1)|Other|0|||
131502209|NCT02625259|473467955|FG000|First Intervention (Day 1)|Adverse Event|2|||
131502210|NCT02625259|473467956|FG001|First Intervention (Day 1)|Adverse Event|1|||
131502211|NCT02625259|473467957|FG002|First Intervention (Day 1)|Adverse Event|0|||
131502212|NCT02625259|473467958|FG003|First Intervention (Day 1)|Adverse Event|0|||
131502213|NCT02625259|473467959|FG004|First Intervention (Day 1)|Adverse Event|0|||
131502214|NCT02625259|473467955|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
131502215|NCT02625259|473467956|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
131502216|NCT02625259|473467957|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131502217|NCT02625259|473467958|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
131502218|NCT02625259|473467959|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
131502219|NCT00513474|473467960|FG000|Overall Study|Death|6|||
131502220|NCT00513474|473467961|FG001|Overall Study|Death|9|||
131502221|NCT00513474|473467960|FG000|Overall Study|Participant Withdrew Consent|1|||
131502222|NCT00513474|473467961|FG001|Overall Study|Participant Withdrew Consent|0|||
131502223|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Adverse Event|82|||
131502224|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Death|6|||
131502225|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
131502226|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
131502227|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
131502228|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
131502229|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
131502230|NCT00195676|473467966|FG000|Period O - Open-label Treatment|Other reasons|68|||
131502231|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
131502232|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
131502233|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
131502234|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
131502235|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
131502236|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
131502237|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
131502238|NCT00195676|473467966|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
131502239|NCT00195676|473467966|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
131502240|NCT00195676|473467966|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
131502241|NCT00195676|473467966|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
131502242|NCT00195676|473467966|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
131502243|NCT00195676|473467966|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
131502244|NCT01189812|473467967|FG000|Overall Study|Withdrawal by Subject|2|||
131502245|NCT01189812|473467968|FG001|Overall Study|Withdrawal by Subject|3|||
131502246|NCT01189812|473467967|FG000|Overall Study|Adverse Event|1|||
131502247|NCT01189812|473467968|FG001|Overall Study|Adverse Event|0|||
131502248|NCT01189812|473467967|FG000|Overall Study|Out of Window|4|||
131502249|NCT01189812|473467968|FG001|Overall Study|Out of Window|3|||
131502250|NCT01189812|473467967|FG000|Overall Study|Moved out of State|1|||
131502251|NCT01189812|473467968|FG001|Overall Study|Moved out of State|2|||
131502252|NCT02953314|473467970|FG000|Overall Study|Adverse Event|0|||
131502253|NCT02953314|473467971|FG001|Overall Study|Adverse Event|1|||
131502254|NCT02953314|473467970|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131502255|NCT02953314|473467971|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
131502256|NCT00535223|473467972|FG000|Overall Study|Withdrawal by Subject|4|||
131502257|NCT00535223|473467973|FG001|Overall Study|Withdrawal by Subject|1|||
131502258|NCT01765153|473467974|FG000|Training Phase 1|Format of intervention differed|1|||
131502259|NCT01765153|473467975|FG001|Training Phase 1|Format of intervention differed|0|||
131502260|NCT01765153|473467974|FG000|Training Phase 1|Poor participation in intervention|0|||
131502261|NCT01765153|473467975|FG001|Training Phase 1|Poor participation in intervention|1|||
131502262|NCT01765153|473467974|FG000|Rest Phase 1|Withdrawal by Subject|0|||
131502263|NCT01765153|473467975|FG001|Rest Phase 1|Withdrawal by Subject|1|||
131502264|NCT01765153|473467974|FG000|Training Phase 2|Withdrawal by Subject|0|||
131502265|NCT01765153|473467975|FG001|Training Phase 2|Withdrawal by Subject|1|||
131502266|NCT01765153|473467974|FG000|Rest Phase 2|Lost to Follow-up|2|||
131502267|NCT01765153|473467975|FG001|Rest Phase 2|Lost to Follow-up|1|||
131502268|NCT02554812|473467976|FG000|Overall Study|Adverse Event|2|||
131502269|NCT02554812|473467977|FG001|Overall Study|Adverse Event|5|||
131502270|NCT02554812|473467978|FG002|Overall Study|Adverse Event|3|||
131502271|NCT02554812|473467979|FG003|Overall Study|Adverse Event|0|||
131502272|NCT02554812|473467980|FG004|Overall Study|Adverse Event|5|||
131502273|NCT02554812|473467981|FG005|Overall Study|Adverse Event|0|||
131502274|NCT02554812|473467982|FG006|Overall Study|Adverse Event|1|||
131502275|NCT02554812|473467983|FG007|Overall Study|Adverse Event|6|||
131502276|NCT02554812|473467984|FG008|Overall Study|Adverse Event|2|||
131502277|NCT02554812|473467985|FG009|Overall Study|Adverse Event|2|||
131502278|NCT02554812|473467986|FG010|Overall Study|Adverse Event|1|||
131502279|NCT02554812|473467987|FG011|Overall Study|Adverse Event|2|||
131502280|NCT02554812|473467988|FG012|Overall Study|Adverse Event|0|||
131502281|NCT02554812|473467989|FG013|Overall Study|Adverse Event|3|||
131502282|NCT02554812|473467990|FG014|Overall Study|Adverse Event|2|||
131502283|NCT02554812|473467991|FG015|Overall Study|Adverse Event|1|||
131502284|NCT02554812|473467992|FG016|Overall Study|Adverse Event|0|||
131502285|NCT02554812|473467993|FG017|Overall Study|Adverse Event|1|||
131502286|NCT02554812|473467994|FG018|Overall Study|Adverse Event|0|||
131502287|NCT02554812|473467995|FG019|Overall Study|Adverse Event|0|||
131502288|NCT02554812|473467996|FG020|Overall Study|Adverse Event|0|||
131502289|NCT02554812|473467997|FG021|Overall Study|Adverse Event|2|||
131502290|NCT02554812|473467998|FG022|Overall Study|Adverse Event|1|||
131502291|NCT02554812|473467999|FG023|Overall Study|Adverse Event|1|||
131502292|NCT02554812|473468000|FG024|Overall Study|Adverse Event|1|||
131502293|NCT02554812|473468001|FG025|Overall Study|Adverse Event|2|||
131502294|NCT02554812|473468002|FG026|Overall Study|Adverse Event|1|||
131502295|NCT02554812|473467976|FG000|Overall Study|Death|1|||
131502296|NCT02554812|473467977|FG001|Overall Study|Death|2|||
131502297|NCT02554812|473467978|FG002|Overall Study|Death|2|||
131502298|NCT02554812|473467979|FG003|Overall Study|Death|2|||
131502299|NCT02554812|473467980|FG004|Overall Study|Death|0|||
131502300|NCT02554812|473467981|FG005|Overall Study|Death|1|||
131502301|NCT02554812|473467982|FG006|Overall Study|Death|1|||
131502302|NCT02554812|473467983|FG007|Overall Study|Death|1|||
131502303|NCT02554812|473467984|FG008|Overall Study|Death|0|||
131502304|NCT02554812|473467985|FG009|Overall Study|Death|0|||
131502305|NCT02554812|473467986|FG010|Overall Study|Death|0|||
131502306|NCT02554812|473467987|FG011|Overall Study|Death|0|||
131502307|NCT02554812|473467988|FG012|Overall Study|Death|0|||
131502308|NCT02554812|473467989|FG013|Overall Study|Death|0|||
131502309|NCT02554812|473467990|FG014|Overall Study|Death|1|||
131502310|NCT02554812|473467991|FG015|Overall Study|Death|1|||
131502311|NCT02554812|473467992|FG016|Overall Study|Death|1|||
131502312|NCT02554812|473467993|FG017|Overall Study|Death|0|||
131502313|NCT02554812|473467994|FG018|Overall Study|Death|1|||
131502314|NCT02554812|473467995|FG019|Overall Study|Death|2|||
131502315|NCT02554812|473467996|FG020|Overall Study|Death|0|||
131502316|NCT02554812|473467997|FG021|Overall Study|Death|1|||
131502317|NCT02554812|473467998|FG022|Overall Study|Death|1|||
131502318|NCT02554812|473467999|FG023|Overall Study|Death|0|||
131502319|NCT02554812|473468000|FG024|Overall Study|Death|0|||
131502320|NCT02554812|473468001|FG025|Overall Study|Death|0|||
131502321|NCT02554812|473468002|FG026|Overall Study|Death|0|||
131502322|NCT02554812|473467976|FG000|Overall Study|Lost to Follow-up|0|||
131502323|NCT02554812|473467977|FG001|Overall Study|Lost to Follow-up|1|||
131502324|NCT02554812|473467978|FG002|Overall Study|Lost to Follow-up|0|||
131502325|NCT02554812|473467979|FG003|Overall Study|Lost to Follow-up|0|||
131502326|NCT02554812|473467980|FG004|Overall Study|Lost to Follow-up|0|||
131502327|NCT02554812|473467981|FG005|Overall Study|Lost to Follow-up|0|||
131502328|NCT02554812|473467982|FG006|Overall Study|Lost to Follow-up|0|||
131502329|NCT02554812|473467983|FG007|Overall Study|Lost to Follow-up|0|||
131502330|NCT02554812|473467984|FG008|Overall Study|Lost to Follow-up|0|||
131502331|NCT02554812|473467985|FG009|Overall Study|Lost to Follow-up|0|||
131502332|NCT02554812|473467986|FG010|Overall Study|Lost to Follow-up|0|||
131502333|NCT02554812|473467987|FG011|Overall Study|Lost to Follow-up|0|||
131502334|NCT02554812|473467988|FG012|Overall Study|Lost to Follow-up|0|||
131502335|NCT02554812|473467989|FG013|Overall Study|Lost to Follow-up|0|||
131502336|NCT02554812|473467990|FG014|Overall Study|Lost to Follow-up|0|||
131502337|NCT02554812|473467991|FG015|Overall Study|Lost to Follow-up|0|||
131502338|NCT02554812|473467992|FG016|Overall Study|Lost to Follow-up|0|||
131502339|NCT02554812|473467993|FG017|Overall Study|Lost to Follow-up|0|||
131502340|NCT02554812|473467994|FG018|Overall Study|Lost to Follow-up|0|||
131502341|NCT02554812|473467995|FG019|Overall Study|Lost to Follow-up|0|||
131502342|NCT02554812|473467996|FG020|Overall Study|Lost to Follow-up|0|||
131502343|NCT02554812|473467997|FG021|Overall Study|Lost to Follow-up|0|||
131502344|NCT02554812|473467998|FG022|Overall Study|Lost to Follow-up|0|||
131502345|NCT02554812|473467999|FG023|Overall Study|Lost to Follow-up|0|||
131502346|NCT02554812|473468000|FG024|Overall Study|Lost to Follow-up|0|||
131502347|NCT02554812|473468001|FG025|Overall Study|Lost to Follow-up|0|||
131502348|NCT02554812|473468002|FG026|Overall Study|Lost to Follow-up|0|||
131502349|NCT02554812|473467976|FG000|Overall Study|Global deterioration of health status|4|||
131502350|NCT02554812|473467977|FG001|Overall Study|Global deterioration of health status|3|||
131502351|NCT02554812|473467978|FG002|Overall Study|Global deterioration of health status|3|||
131502352|NCT02554812|473467979|FG003|Overall Study|Global deterioration of health status|2|||
131502353|NCT02554812|473467980|FG004|Overall Study|Global deterioration of health status|5|||
131502354|NCT02554812|473467981|FG005|Overall Study|Global deterioration of health status|0|||
131502355|NCT02554812|473467982|FG006|Overall Study|Global deterioration of health status|2|||
131502356|NCT02554812|473467983|FG007|Overall Study|Global deterioration of health status|1|||
131502357|NCT02554812|473467984|FG008|Overall Study|Global deterioration of health status|1|||
131502358|NCT02554812|473467985|FG009|Overall Study|Global deterioration of health status|1|||
131502359|NCT02554812|473467986|FG010|Overall Study|Global deterioration of health status|2|||
131502360|NCT02554812|473467987|FG011|Overall Study|Global deterioration of health status|1|||
131502361|NCT02554812|473467988|FG012|Overall Study|Global deterioration of health status|0|||
131502362|NCT02554812|473467989|FG013|Overall Study|Global deterioration of health status|0|||
131502363|NCT02554812|473467990|FG014|Overall Study|Global deterioration of health status|0|||
131502364|NCT02554812|473467991|FG015|Overall Study|Global deterioration of health status|1|||
131658091|NCT04445987|474032996|FG002|Overall Study|Lost to Follow-up|1|||
131502365|NCT02554812|473467992|FG016|Overall Study|Global deterioration of health status|0|||
131502366|NCT02554812|473467993|FG017|Overall Study|Global deterioration of health status|0|||
131502367|NCT02554812|473467994|FG018|Overall Study|Global deterioration of health status|0|||
131502368|NCT02554812|473467995|FG019|Overall Study|Global deterioration of health status|0|||
131502369|NCT02554812|473467996|FG020|Overall Study|Global deterioration of health status|0|||
131502370|NCT02554812|473467997|FG021|Overall Study|Global deterioration of health status|0|||
131502371|NCT02554812|473467998|FG022|Overall Study|Global deterioration of health status|0|||
131502372|NCT02554812|473467999|FG023|Overall Study|Global deterioration of health status|0|||
131502373|NCT02554812|473468000|FG024|Overall Study|Global deterioration of health status|0|||
131502374|NCT02554812|473468001|FG025|Overall Study|Global deterioration of health status|0|||
131502375|NCT02554812|473468002|FG026|Overall Study|Global deterioration of health status|0|||
131502376|NCT02554812|473467976|FG000|Overall Study|Progressive disease|20|||
131502377|NCT02554812|473467977|FG001|Overall Study|Progressive disease|16|||
131502378|NCT02554812|473467978|FG002|Overall Study|Progressive disease|19|||
131502379|NCT02554812|473467979|FG003|Overall Study|Progressive disease|18|||
131502380|NCT02554812|473467980|FG004|Overall Study|Progressive disease|21|||
131502381|NCT02554812|473467981|FG005|Overall Study|Progressive disease|15|||
131502382|NCT02554812|473467982|FG006|Overall Study|Progressive disease|6|||
131502383|NCT02554812|473467983|FG007|Overall Study|Progressive disease|13|||
131502384|NCT02554812|473467984|FG008|Overall Study|Progressive disease|6|||
131502385|NCT02554812|473467985|FG009|Overall Study|Progressive disease|6|||
131502386|NCT02554812|473467986|FG010|Overall Study|Progressive disease|8|||
131502387|NCT02554812|473467987|FG011|Overall Study|Progressive disease|8|||
131502388|NCT02554812|473467988|FG012|Overall Study|Progressive disease|6|||
131502389|NCT02554812|473467989|FG013|Overall Study|Progressive disease|10|||
131502390|NCT02554812|473467990|FG014|Overall Study|Progressive disease|20|||
131502391|NCT02554812|473467991|FG015|Overall Study|Progressive disease|6|||
131502392|NCT02554812|473467992|FG016|Overall Study|Progressive disease|3|||
131502393|NCT02554812|473467993|FG017|Overall Study|Progressive disease|3|||
131502394|NCT02554812|473467994|FG018|Overall Study|Progressive disease|11|||
131502395|NCT02554812|473467995|FG019|Overall Study|Progressive disease|7|||
131502396|NCT02554812|473467996|FG020|Overall Study|Progressive disease|11|||
131502397|NCT02554812|473467997|FG021|Overall Study|Progressive disease|6|||
131502398|NCT02554812|473467998|FG022|Overall Study|Progressive disease|9|||
131502399|NCT02554812|473467999|FG023|Overall Study|Progressive disease|9|||
131502400|NCT02554812|473468000|FG024|Overall Study|Progressive disease|4|||
131502401|NCT02554812|473468001|FG025|Overall Study|Progressive disease|5|||
131502402|NCT02554812|473468002|FG026|Overall Study|Progressive disease|5|||
131502403|NCT02554812|473467976|FG000|Overall Study|Other|0|||
131502404|NCT02554812|473467977|FG001|Overall Study|Other|0|||
131502405|NCT02554812|473467978|FG002|Overall Study|Other|2|||
131502406|NCT02554812|473467979|FG003|Overall Study|Other|3|||
131502407|NCT02554812|473467980|FG004|Overall Study|Other|2|||
131502408|NCT02554812|473467981|FG005|Overall Study|Other|1|||
131502409|NCT02554812|473467982|FG006|Overall Study|Other|0|||
131502410|NCT02554812|473467983|FG007|Overall Study|Other|0|||
131502411|NCT02554812|473467984|FG008|Overall Study|Other|1|||
131502412|NCT02554812|473467985|FG009|Overall Study|Other|1|||
131502413|NCT02554812|473467986|FG010|Overall Study|Other|0|||
131502414|NCT02554812|473467987|FG011|Overall Study|Other|0|||
131502415|NCT02554812|473467988|FG012|Overall Study|Other|1|||
131502416|NCT02554812|473467989|FG013|Overall Study|Other|0|||
131502417|NCT02554812|473467990|FG014|Overall Study|Other|1|||
131502418|NCT02554812|473467991|FG015|Overall Study|Other|0|||
131502419|NCT02554812|473467992|FG016|Overall Study|Other|0|||
131502420|NCT02554812|473467993|FG017|Overall Study|Other|0|||
131502421|NCT02554812|473467994|FG018|Overall Study|Other|0|||
131502422|NCT02554812|473467995|FG019|Overall Study|Other|0|||
131502423|NCT02554812|473467996|FG020|Overall Study|Other|0|||
131502424|NCT02554812|473467997|FG021|Overall Study|Other|2|||
131502425|NCT02554812|473467998|FG022|Overall Study|Other|0|||
131502426|NCT02554812|473467999|FG023|Overall Study|Other|0|||
131502427|NCT02554812|473468000|FG024|Overall Study|Other|0|||
131502428|NCT02554812|473468001|FG025|Overall Study|Other|0|||
131502429|NCT02554812|473468002|FG026|Overall Study|Other|0|||
131502430|NCT02554812|473467976|FG000|Overall Study|Withdrawal by Subject|1|||
131502431|NCT02554812|473467977|FG001|Overall Study|Withdrawal by Subject|0|||
131502432|NCT02554812|473467978|FG002|Overall Study|Withdrawal by Subject|0|||
131502433|NCT02554812|473467979|FG003|Overall Study|Withdrawal by Subject|2|||
131502434|NCT02554812|473467980|FG004|Overall Study|Withdrawal by Subject|2|||
131502435|NCT02554812|473467981|FG005|Overall Study|Withdrawal by Subject|3|||
131502436|NCT02554812|473467982|FG006|Overall Study|Withdrawal by Subject|0|||
131502437|NCT02554812|473467983|FG007|Overall Study|Withdrawal by Subject|0|||
131502438|NCT02554812|473467984|FG008|Overall Study|Withdrawal by Subject|1|||
131502439|NCT02554812|473467985|FG009|Overall Study|Withdrawal by Subject|1|||
131502440|NCT02554812|473467986|FG010|Overall Study|Withdrawal by Subject|0|||
131502441|NCT02554812|473467987|FG011|Overall Study|Withdrawal by Subject|1|||
131502442|NCT02554812|473467988|FG012|Overall Study|Withdrawal by Subject|1|||
131502443|NCT02554812|473467989|FG013|Overall Study|Withdrawal by Subject|1|||
131502444|NCT02554812|473467990|FG014|Overall Study|Withdrawal by Subject|1|||
131502445|NCT02554812|473467991|FG015|Overall Study|Withdrawal by Subject|1|||
131502446|NCT02554812|473467992|FG016|Overall Study|Withdrawal by Subject|3|||
131502447|NCT02554812|473467993|FG017|Overall Study|Withdrawal by Subject|1|||
131502448|NCT02554812|473467994|FG018|Overall Study|Withdrawal by Subject|0|||
131502449|NCT02554812|473467995|FG019|Overall Study|Withdrawal by Subject|2|||
131502450|NCT02554812|473467996|FG020|Overall Study|Withdrawal by Subject|0|||
131502451|NCT02554812|473467997|FG021|Overall Study|Withdrawal by Subject|1|||
131502452|NCT02554812|473467998|FG022|Overall Study|Withdrawal by Subject|0|||
131502453|NCT02554812|473467999|FG023|Overall Study|Withdrawal by Subject|1|||
131502454|NCT02554812|473468000|FG024|Overall Study|Withdrawal by Subject|0|||
131502455|NCT02554812|473468001|FG025|Overall Study|Withdrawal by Subject|0|||
131502456|NCT02554812|473468002|FG026|Overall Study|Withdrawal by Subject|1|||
131502457|NCT02554812|473467976|FG000|Overall Study|Physician Decision|1|||
131502458|NCT02554812|473467977|FG001|Overall Study|Physician Decision|0|||
131502459|NCT02554812|473467978|FG002|Overall Study|Physician Decision|0|||
131502460|NCT02554812|473467979|FG003|Overall Study|Physician Decision|1|||
131502461|NCT02554812|473467980|FG004|Overall Study|Physician Decision|0|||
131502462|NCT02554812|473467981|FG005|Overall Study|Physician Decision|1|||
131502463|NCT02554812|473467982|FG006|Overall Study|Physician Decision|0|||
131502464|NCT02554812|473467983|FG007|Overall Study|Physician Decision|0|||
131502465|NCT02554812|473467984|FG008|Overall Study|Physician Decision|0|||
131502466|NCT02554812|473467985|FG009|Overall Study|Physician Decision|0|||
131502467|NCT02554812|473467986|FG010|Overall Study|Physician Decision|1|||
131502468|NCT02554812|473467987|FG011|Overall Study|Physician Decision|0|||
131502469|NCT02554812|473467988|FG012|Overall Study|Physician Decision|0|||
131502470|NCT02554812|473467989|FG013|Overall Study|Physician Decision|0|||
131502471|NCT02554812|473467990|FG014|Overall Study|Physician Decision|0|||
131502472|NCT02554812|473467991|FG015|Overall Study|Physician Decision|0|||
131502473|NCT02554812|473467992|FG016|Overall Study|Physician Decision|1|||
131502474|NCT02554812|473467993|FG017|Overall Study|Physician Decision|1|||
131502475|NCT02554812|473467994|FG018|Overall Study|Physician Decision|0|||
131502476|NCT02554812|473467995|FG019|Overall Study|Physician Decision|1|||
131502477|NCT02554812|473467996|FG020|Overall Study|Physician Decision|1|||
131502478|NCT02554812|473467997|FG021|Overall Study|Physician Decision|0|||
131502479|NCT02554812|473467998|FG022|Overall Study|Physician Decision|1|||
131502480|NCT02554812|473467999|FG023|Overall Study|Physician Decision|0|||
131502481|NCT02554812|473468000|FG024|Overall Study|Physician Decision|0|||
131502482|NCT02554812|473468001|FG025|Overall Study|Physician Decision|0|||
131502483|NCT02554812|473468002|FG026|Overall Study|Physician Decision|0|||
131502484|NCT02554812|473467976|FG000|Overall Study|Study terminated by sponsor|0|||
131502485|NCT02554812|473467977|FG001|Overall Study|Study terminated by sponsor|0|||
131502486|NCT02554812|473467978|FG002|Overall Study|Study terminated by sponsor|0|||
131502487|NCT02554812|473467979|FG003|Overall Study|Study terminated by sponsor|0|||
131502488|NCT02554812|473467980|FG004|Overall Study|Study terminated by sponsor|0|||
131502489|NCT02554812|473467981|FG005|Overall Study|Study terminated by sponsor|0|||
131502490|NCT02554812|473467982|FG006|Overall Study|Study terminated by sponsor|0|||
131502491|NCT02554812|473467983|FG007|Overall Study|Study terminated by sponsor|0|||
131502492|NCT02554812|473467984|FG008|Overall Study|Study terminated by sponsor|0|||
131502493|NCT02554812|473467985|FG009|Overall Study|Study terminated by sponsor|0|||
131502494|NCT02554812|473467986|FG010|Overall Study|Study terminated by sponsor|0|||
131502495|NCT02554812|473467987|FG011|Overall Study|Study terminated by sponsor|0|||
131502496|NCT02554812|473467988|FG012|Overall Study|Study terminated by sponsor|0|||
131502497|NCT02554812|473467989|FG013|Overall Study|Study terminated by sponsor|0|||
131502498|NCT02554812|473467990|FG014|Overall Study|Study terminated by sponsor|0|||
131502499|NCT02554812|473467991|FG015|Overall Study|Study terminated by sponsor|0|||
131502500|NCT02554812|473467992|FG016|Overall Study|Study terminated by sponsor|0|||
131502501|NCT02554812|473467993|FG017|Overall Study|Study terminated by sponsor|0|||
131502502|NCT02554812|473467994|FG018|Overall Study|Study terminated by sponsor|0|||
131502503|NCT02554812|473467995|FG019|Overall Study|Study terminated by sponsor|0|||
131502504|NCT02554812|473467996|FG020|Overall Study|Study terminated by sponsor|0|||
131502505|NCT02554812|473467997|FG021|Overall Study|Study terminated by sponsor|0|||
131502506|NCT02554812|473467998|FG022|Overall Study|Study terminated by sponsor|0|||
131502507|NCT02554812|473467999|FG023|Overall Study|Study terminated by sponsor|0|||
131502508|NCT02554812|473468000|FG024|Overall Study|Study terminated by sponsor|1|||
131502509|NCT02554812|473468001|FG025|Overall Study|Study terminated by sponsor|0|||
131502510|NCT02554812|473468002|FG026|Overall Study|Study terminated by sponsor|0|||
131502511|NCT02554812|473467976|FG000|Overall Study|No longer meets eligibility criteria|0|||
131502512|NCT02554812|473467977|FG001|Overall Study|No longer meets eligibility criteria|1|||
131502513|NCT02554812|473467978|FG002|Overall Study|No longer meets eligibility criteria|0|||
131502514|NCT02554812|473467979|FG003|Overall Study|No longer meets eligibility criteria|0|||
131502515|NCT02554812|473467980|FG004|Overall Study|No longer meets eligibility criteria|0|||
131502516|NCT02554812|473467981|FG005|Overall Study|No longer meets eligibility criteria|0|||
131502517|NCT02554812|473467982|FG006|Overall Study|No longer meets eligibility criteria|0|||
131502518|NCT02554812|473467983|FG007|Overall Study|No longer meets eligibility criteria|0|||
131502519|NCT02554812|473467984|FG008|Overall Study|No longer meets eligibility criteria|0|||
131502520|NCT02554812|473467985|FG009|Overall Study|No longer meets eligibility criteria|0|||
131502521|NCT02554812|473467986|FG010|Overall Study|No longer meets eligibility criteria|0|||
131502522|NCT02554812|473467987|FG011|Overall Study|No longer meets eligibility criteria|0|||
131502523|NCT02554812|473467988|FG012|Overall Study|No longer meets eligibility criteria|0|||
131502524|NCT02554812|473467989|FG013|Overall Study|No longer meets eligibility criteria|0|||
131502525|NCT02554812|473467990|FG014|Overall Study|No longer meets eligibility criteria|0|||
131502526|NCT02554812|473467991|FG015|Overall Study|No longer meets eligibility criteria|0|||
131502527|NCT02554812|473467992|FG016|Overall Study|No longer meets eligibility criteria|0|||
131502528|NCT02554812|473467993|FG017|Overall Study|No longer meets eligibility criteria|0|||
131502529|NCT02554812|473467994|FG018|Overall Study|No longer meets eligibility criteria|0|||
131502530|NCT02554812|473467995|FG019|Overall Study|No longer meets eligibility criteria|0|||
131502531|NCT02554812|473467996|FG020|Overall Study|No longer meets eligibility criteria|0|||
131502532|NCT02554812|473467997|FG021|Overall Study|No longer meets eligibility criteria|0|||
131502533|NCT02554812|473467998|FG022|Overall Study|No longer meets eligibility criteria|0|||
131502534|NCT02554812|473467999|FG023|Overall Study|No longer meets eligibility criteria|0|||
131502535|NCT02554812|473468000|FG024|Overall Study|No longer meets eligibility criteria|0|||
131502536|NCT02554812|473468001|FG025|Overall Study|No longer meets eligibility criteria|0|||
131502537|NCT02554812|473468002|FG026|Overall Study|No longer meets eligibility criteria|0|||
131502538|NCT00613938|473470061|FG000|Overall Study|Withdrawal by Subject|2|||
131502539|NCT00613938|473470062|FG001|Overall Study|Withdrawal by Subject|4|||
131502540|NCT00613938|473470063|FG002|Overall Study|Withdrawal by Subject|9|||
131502541|NCT00613938|473470064|FG003|Overall Study|Withdrawal by Subject|9|||
131502542|NCT00613938|473470061|FG000|Overall Study|Adverse Event|1|||
131502543|NCT00613938|473470062|FG001|Overall Study|Adverse Event|4|||
131502544|NCT00613938|473470063|FG002|Overall Study|Adverse Event|8|||
131502545|NCT00613938|473470064|FG003|Overall Study|Adverse Event|5|||
131502546|NCT00613938|473470061|FG000|Overall Study|Lack of Efficacy|16|||
131502547|NCT00613938|473470062|FG001|Overall Study|Lack of Efficacy|18|||
131502548|NCT00613938|473470063|FG002|Overall Study|Lack of Efficacy|5|||
131502549|NCT00613938|473470064|FG003|Overall Study|Lack of Efficacy|9|||
131502550|NCT00613938|473470061|FG000|Overall Study|Other|1|||
131502551|NCT00613938|473470062|FG001|Overall Study|Other|2|||
131502552|NCT00613938|473470063|FG002|Overall Study|Other|1|||
131502553|NCT00613938|473470064|FG003|Overall Study|Other|3|||
131502554|NCT03220217|473470065|FG000|Overall Study|Withdrawal by Subject|0|||
131502555|NCT03220217|473470066|FG001|Overall Study|Withdrawal by Subject|1|||
131502556|NCT03220217|473470067|FG002|Overall Study|Withdrawal by Subject|0|||
131502557|NCT03220217|473470065|FG000|Overall Study|Subject Missed Procedure|0|||
131502558|NCT03220217|473470066|FG001|Overall Study|Subject Missed Procedure|0|||
131502559|NCT03220217|473470067|FG002|Overall Study|Subject Missed Procedure|1|||
131502560|NCT01104636|473470070|FG000|Overall Study|Lack of Efficacy|43|||
131502561|NCT01104636|473470070|FG000|Overall Study|Lost to Follow-up|24|||
131502562|NCT01104636|473470070|FG000|Overall Study|Withdrawal by Subject|4|||
131502563|NCT01104636|473470070|FG000|Overall Study|Other|43|||
131502564|NCT01104636|473470070|FG000|Overall Study|Study terminated by sponsor|1|||
131502565|NCT01104636|473470070|FG000|Overall Study|Pregnancy|2|||
131502566|NCT01104636|473470070|FG000|Overall Study|Adverse Event|40|||
131502567|NCT01104636|473470070|FG000|Overall Study|Ongoing|21|||
131502568|NCT01706003|473470071|FG000|Overall Study|Withdrawal by Subject|2|||
131502569|NCT01706003|473470072|FG001|Overall Study|Withdrawal by Subject|0|||
131502570|NCT01706003|473470071|FG000|Overall Study|Not scheduled|3|||
131502571|NCT01706003|473470072|FG001|Overall Study|Not scheduled|0|||
131502572|NCT01706003|473470071|FG000|Overall Study|Lost to Follow-up|6|||
131502573|NCT01706003|473470072|FG001|Overall Study|Lost to Follow-up|4|||
131502574|NCT03055260|473470073|FG000|Overall Study|Withdrawal by Subject|1|||
131502575|NCT03055260|473470074|FG001|Overall Study|Withdrawal by Subject|0|||
131502576|NCT03045328|473470080|FG000|Overall Study|Withdrawal by Subject|2|||
131502577|NCT00249444|473470086|FG000|Overall Study|Lost to Follow-up|2|||
131502578|NCT00249444|473470087|FG001|Overall Study|Lost to Follow-up|2|||
131502579|NCT00249444|473470086|FG000|Overall Study|non-compliant|9|||
131502580|NCT00249444|473470087|FG001|Overall Study|non-compliant|11|||
131502581|NCT00249444|473470086|FG000|Overall Study|Adverse Event|1|||
131502582|NCT00249444|473470087|FG001|Overall Study|Adverse Event|1|||
131502583|NCT00249444|473470086|FG000|Overall Study|life event|0|||
131502584|NCT00249444|473470087|FG001|Overall Study|life event|1|||
131502585|NCT00936910|473470088|FG000|Overall Study|Lack of Efficacy|3|||
131502586|NCT00412854|473470089|FG000|Overall Study|Withdrawn due to adverse events|1|||
131502587|NCT00412854|473470090|FG001|Overall Study|Withdrawn due to adverse events|5|||
131502588|NCT00412854|473470089|FG000|Overall Study|Withdrawn for other reasons|13|||
131502589|NCT00412854|473470090|FG001|Overall Study|Withdrawn for other reasons|11|||
131502590|NCT04483011|473470094|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
131502591|NCT04483011|473470095|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
131502592|NCT03518073|473470096|FG000|Overall Study|Adverse Event|2|||
131502593|NCT03518073|473470097|FG001|Overall Study|Adverse Event|4|||
131502594|NCT03518073|473470098|FG002|Overall Study|Adverse Event|2|||
131502595|NCT03518073|473470096|FG000|Overall Study|Death|2|||
131502596|NCT03518073|473470097|FG001|Overall Study|Death|1|||
131502597|NCT03518073|473470098|FG002|Overall Study|Death|3|||
131502598|NCT03518073|473470096|FG000|Overall Study|Lost to Follow-up|1|||
131502599|NCT03518073|473470097|FG001|Overall Study|Lost to Follow-up|0|||
131502600|NCT03518073|473470098|FG002|Overall Study|Lost to Follow-up|1|||
131502601|NCT03518073|473470096|FG000|Overall Study|Physician Decision|5|||
131502602|NCT03518073|473470097|FG001|Overall Study|Physician Decision|0|||
131502603|NCT03518073|473470098|FG002|Overall Study|Physician Decision|2|||
131502604|NCT03518073|473470096|FG000|Overall Study|Progressive disease|1|||
131502605|NCT03518073|473470097|FG001|Overall Study|Progressive disease|1|||
131502606|NCT03518073|473470098|FG002|Overall Study|Progressive disease|1|||
131502607|NCT03518073|473470096|FG000|Overall Study|Protocol Violation|1|||
131502608|NCT03518073|473470097|FG001|Overall Study|Protocol Violation|0|||
131502609|NCT03518073|473470098|FG002|Overall Study|Protocol Violation|0|||
131502610|NCT03518073|473470096|FG000|Overall Study|Withdrawal by Subject|30|||
131502611|NCT03518073|473470097|FG001|Overall Study|Withdrawal by Subject|34|||
131502612|NCT03518073|473470098|FG002|Overall Study|Withdrawal by Subject|29|||
131502613|NCT03518073|473470096|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
131502614|NCT03518073|473470097|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
131502615|NCT03518073|473470098|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
131502616|NCT03518073|473470096|FG000|Overall Study|Covid-19|1|||
131502617|NCT03518073|473470097|FG001|Overall Study|Covid-19|2|||
131502618|NCT03518073|473470098|FG002|Overall Study|Covid-19|1|||
131502619|NCT03045081|473470099|FG000|Overall Study|Withdrawal by Subject|6|||
131502620|NCT03045081|473470100|FG001|Overall Study|Withdrawal by Subject|11|||
131502621|NCT01853046|473470101|FG000|Overall Study|Withdrawal by Subject|1|||
131502622|NCT01853046|473470102|FG001|Overall Study|Withdrawal by Subject|1|||
131502623|NCT01853046|473470101|FG000|Overall Study|Adverse Event|4|||
131502624|NCT01853046|473470102|FG001|Overall Study|Adverse Event|2|||
131502625|NCT01853046|473470101|FG000|Overall Study|Disease progression|13|||
131502626|NCT01853046|473470102|FG001|Overall Study|Disease progression|3|||
131502627|NCT01485640|473470103|FG000|Overall Study|Adverse Event|10|||
131502628|NCT01485640|473470103|FG000|Overall Study|Lack of Efficacy|2|||
131502629|NCT01485640|473470103|FG000|Overall Study|Protocol Violation|1|||
131502630|NCT01485640|473470103|FG000|Overall Study|Withdrawal by Subject|14|||
131502631|NCT01485640|473470103|FG000|Overall Study|Terminated by Sponsor|95|||
131502632|NCT02057198|473470108|FG000|Overall Study|Death|0|||
131502633|NCT02057198|473470109|FG001|Overall Study|Death|0|||
131502634|NCT02057198|473470110|FG002|Overall Study|Death|1|||
131502635|NCT02057198|473470108|FG000|Overall Study|Discharged early; lost to followup|0|||
131502636|NCT02057198|473470109|FG001|Overall Study|Discharged early; lost to followup|1|||
131502637|NCT02057198|473470110|FG002|Overall Study|Discharged early; lost to followup|0|||
131502638|NCT02355691|473470114|FG000|Overall Study|Loss of Research Personnel|7|||
131502639|NCT02355691|473470115|FG001|Overall Study|Loss of Research Personnel|9|||
131502640|NCT00065507|473470117|FG000|Overall Study|Death|16|||
131502641|NCT00065507|473470118|FG001|Overall Study|Death|17|||
131502642|NCT00065507|473470117|FG000|Overall Study|Adverse Event|4|||
131502643|NCT00065507|473470118|FG001|Overall Study|Adverse Event|3|||
131502644|NCT00065507|473470117|FG000|Overall Study|Lack of Efficacy|0|||
131502645|NCT00065507|473470118|FG001|Overall Study|Lack of Efficacy|6|||
131502646|NCT00065507|473470117|FG000|Overall Study|Poor/Non-compliance|3|||
131502647|NCT00065507|473470118|FG001|Overall Study|Poor/Non-compliance|2|||
131502648|NCT00065507|473470117|FG000|Overall Study|Lost to Follow-up|3|||
131502649|NCT00065507|473470118|FG001|Overall Study|Lost to Follow-up|0|||
131502650|NCT00065507|473470117|FG000|Overall Study|Subject Withdrew Consent|2|||
131502651|NCT00065507|473470118|FG001|Overall Study|Subject Withdrew Consent|1|||
131502652|NCT00065507|473470117|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
131502653|NCT00065507|473470118|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
131502654|NCT03635957|473470119|FG000|Run-In Period|Lost to Follow-up|1|||
131502655|NCT03635957|473470119|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
131502656|NCT02489344|473470122|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
131502657|NCT02489344|473470122|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
131502658|NCT02489344|473470122|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
131502659|NCT02489344|473470122|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
131502660|NCT00546637|473470125|FG000|Overall Study|Adverse Event|46|||
131502661|NCT00546637|473470126|FG001|Overall Study|Adverse Event|20|||
131502662|NCT00546637|473470125|FG000|Overall Study|Lack of Efficacy|5|||
131502663|NCT00546637|473470126|FG001|Overall Study|Lack of Efficacy|5|||
131502664|NCT00546637|473470125|FG000|Overall Study|Lost to Follow-up|2|||
131502665|NCT00546637|473470126|FG001|Overall Study|Lost to Follow-up|2|||
131502666|NCT00546637|473470125|FG000|Overall Study|Other|10|||
131502667|NCT00546637|473470126|FG001|Overall Study|Other|12|||
131502668|NCT00546637|473470125|FG000|Overall Study|Withdrawal by Subject|7|||
131502669|NCT00546637|473470126|FG001|Overall Study|Withdrawal by Subject|9|||
131502670|NCT00546637|473470125|FG000|Overall Study|Randomized, but not treated|3|||
131502671|NCT00546637|473470126|FG001|Overall Study|Randomized, but not treated|1|||
131502672|NCT00450450|473470127|FG000|Overall Study|Death|1|||
131502673|NCT00450450|473470128|FG001|Overall Study|Death|3|||
131502674|NCT00450450|473470127|FG000|Overall Study|Relapse|2|||
131502675|NCT00450450|473470128|FG001|Overall Study|Relapse|0|||
131502676|NCT00450450|473470127|FG000|Overall Study|Missing Data|2|||
131502677|NCT00450450|473470128|FG001|Overall Study|Missing Data|0|||
131502678|NCT04984993|473470129|FG000|Overall Study|Withdrawal by Subject|8|||
131502679|NCT04984993|473470130|FG001|Overall Study|Withdrawal by Subject|2|||
131502680|NCT04984993|473470129|FG000|Overall Study|Lost to Follow-up|2|||
131502681|NCT04984993|473470130|FG001|Overall Study|Lost to Follow-up|2|||
131502682|NCT04984993|473470129|FG000|Overall Study|Both patients moved to another country|4|||
131502683|NCT04984993|473470130|FG001|Overall Study|Both patients moved to another country|0|||
131502684|NCT02865187|473470131|FG000|Overall Study|Lost to Follow-up|12|||
131502685|NCT02865187|473470132|FG001|Overall Study|Lost to Follow-up|7|||
131502686|NCT02865187|473470131|FG000|Overall Study|Adverse Event|1|||
131502687|NCT02865187|473470132|FG001|Overall Study|Adverse Event|0|||
131502688|NCT01110707|473470133|FG000|Overall Study|Protocol Violation|0|||
131502689|NCT01110707|473470134|FG001|Overall Study|Protocol Violation|3|||
131502690|NCT02710045|473470139|FG000|Overall Study|Death|1|||
131502691|NCT02710045|473470140|FG001|Overall Study|Death|2|||
131502692|NCT02710045|473470141|FG002|Overall Study|Death|0|||
131502693|NCT02710045|473470139|FG000|Overall Study|Withdrawal by Subject|6|||
131502694|NCT02710045|473470140|FG001|Overall Study|Withdrawal by Subject|6|||
131502695|NCT02710045|473470141|FG002|Overall Study|Withdrawal by Subject|2|||
131502696|NCT02710045|473470139|FG000|Overall Study|Protocol Violation|1|||
131502697|NCT02710045|473470140|FG001|Overall Study|Protocol Violation|2|||
131502698|NCT02710045|473470141|FG002|Overall Study|Protocol Violation|3|||
131502699|NCT02710045|473470139|FG000|Overall Study|Lost to Follow-up|3|||
131502700|NCT02710045|473470140|FG001|Overall Study|Lost to Follow-up|6|||
131502701|NCT02710045|473470141|FG002|Overall Study|Lost to Follow-up|7|||
131502702|NCT02710045|473470139|FG000|Overall Study|Physician Decision|0|||
131502703|NCT02710045|473470140|FG001|Overall Study|Physician Decision|0|||
131502704|NCT02710045|473470141|FG002|Overall Study|Physician Decision|1|||
131502705|NCT02710045|473470139|FG000|Overall Study|Poor Attendance|0|||
131502706|NCT02710045|473470140|FG001|Overall Study|Poor Attendance|1|||
131502707|NCT02710045|473470141|FG002|Overall Study|Poor Attendance|0|||
131502708|NCT01275833|473470142|FG000|Overall Study|Study terminated|1|||
131502709|NCT01275833|473470143|FG001|Overall Study|Study terminated|1|||
131502710|NCT02733991|473470144|FG000|Overall Study|Adverse Event|1|||
131502711|NCT02733991|473470145|FG001|Overall Study|Adverse Event|0|||
131502712|NCT02733991|473470144|FG000|Overall Study|Withdrawal by Subject|0|||
131502713|NCT02733991|473470145|FG001|Overall Study|Withdrawal by Subject|5|||
131502714|NCT04191499|473470146|FG000|Overall Study|Adverse Event|1|||
131502715|NCT04191499|473470147|FG001|Overall Study|Adverse Event|0|||
131502716|NCT04191499|473470146|FG000|Overall Study|Death|42|||
131502717|NCT04191499|473470147|FG001|Overall Study|Death|55|||
131502718|NCT04191499|473470146|FG000|Overall Study|Lost to Follow-up|4|||
131502719|NCT04191499|473470147|FG001|Overall Study|Lost to Follow-up|1|||
131502720|NCT04191499|473470146|FG000|Overall Study|Physician Decision|1|||
131502721|NCT04191499|473470147|FG001|Overall Study|Physician Decision|0|||
131502722|NCT04191499|473470146|FG000|Overall Study|Progressive Disease|1|||
131502723|NCT04191499|473470147|FG001|Overall Study|Progressive Disease|0|||
131502724|NCT04191499|473470146|FG000|Overall Study|Symptomatic Deterioration|1|||
131502725|NCT04191499|473470147|FG001|Overall Study|Symptomatic Deterioration|0|||
131502726|NCT04191499|473470146|FG000|Overall Study|Withdrawal by Subject|7|||
131502727|NCT04191499|473470147|FG001|Overall Study|Withdrawal by Subject|11|||
131502728|NCT04191499|473470146|FG000|Overall Study|Ongoing in the study|104|||
131502729|NCT04191499|473470147|FG001|Overall Study|Ongoing in the study|97|||
131502730|NCT00680745|473470148|FG000|Overall Study|Withdrawal by Subject|8|||
131502731|NCT00680745|473470149|FG001|Overall Study|Withdrawal by Subject|3|||
131502732|NCT00680745|473470150|FG002|Overall Study|Withdrawal by Subject|2|||
131502733|NCT00680745|473470151|FG003|Overall Study|Withdrawal by Subject|8|||
131502734|NCT00680745|473470148|FG000|Overall Study|Lost to Follow-up|0|||
131502735|NCT00680745|473470149|FG001|Overall Study|Lost to Follow-up|1|||
131502736|NCT00680745|473470150|FG002|Overall Study|Lost to Follow-up|1|||
131502737|NCT00680745|473470151|FG003|Overall Study|Lost to Follow-up|0|||
131502738|NCT00680745|473470148|FG000|Overall Study|Death|1|||
131502739|NCT00680745|473470149|FG001|Overall Study|Death|0|||
131502740|NCT00680745|473470150|FG002|Overall Study|Death|1|||
131502741|NCT00680745|473470151|FG003|Overall Study|Death|0|||
131502742|NCT00680745|473470148|FG000|Overall Study|Adverse Event|5|||
131502743|NCT00680745|473470149|FG001|Overall Study|Adverse Event|3|||
131502744|NCT00680745|473470150|FG002|Overall Study|Adverse Event|3|||
131502745|NCT00680745|473470151|FG003|Overall Study|Adverse Event|3|||
131502746|NCT00680745|473470148|FG000|Overall Study|Poor/Non-compliance|0|||
131502747|NCT00680745|473470149|FG001|Overall Study|Poor/Non-compliance|3|||
131502748|NCT00680745|473470150|FG002|Overall Study|Poor/Non-compliance|0|||
131502749|NCT00680745|473470151|FG003|Overall Study|Poor/Non-compliance|0|||
131502750|NCT00680745|473470148|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
131502751|NCT00680745|473470149|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
131502752|NCT00680745|473470150|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
131502753|NCT00680745|473470151|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
131502754|NCT00680745|473470148|FG000|Overall Study|False Treatment|0|||
131502755|NCT00680745|473470149|FG001|Overall Study|False Treatment|1|||
131502756|NCT00680745|473470150|FG002|Overall Study|False Treatment|3|||
131502757|NCT00680745|473470151|FG003|Overall Study|False Treatment|0|||
131502758|NCT02612428|473470152|FG000|VTL-308|Death|14|||
131502759|NCT02612428|473470153|FG001|VTL-308|Death|16|||
131502760|NCT02612428|473470152|FG000|VTL-308|Withdrawal by Subject|0|||
131502761|NCT02612428|473470153|FG001|VTL-308|Withdrawal by Subject|1|||
131502762|NCT02612428|473470152|FG000|VTL-308E|Death|9|||
131502763|NCT02612428|473470153|FG001|VTL-308E|Death|7|||
131502764|NCT02612428|473470152|FG000|VTL-308E|Lost to Follow-up|2|||
131502765|NCT02612428|473470153|FG001|VTL-308E|Lost to Follow-up|0|||
131502766|NCT00742001|473470154|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
131502767|NCT00742001|473470155|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
131502768|NCT00742001|473470156|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
131502769|NCT00137423|473470157|FG000|Overall Study|Adverse Event|7|||
131502770|NCT00137423|473470158|FG001|Overall Study|Adverse Event|9|||
131502771|NCT00137423|473470157|FG000|Overall Study|consent withdrawn|1|||
131502772|NCT00137423|473470158|FG001|Overall Study|consent withdrawn|1|||
131502773|NCT00137423|473470157|FG000|Overall Study|Lack of Efficacy|31|||
131502774|NCT00137423|473470158|FG001|Overall Study|Lack of Efficacy|33|||
131502775|NCT00137423|473470157|FG000|Overall Study|Death|0|||
131502776|NCT00137423|473470158|FG001|Overall Study|Death|1|||
131502777|NCT03187262|473470160|FG000|Induction|Lack of Efficacy|2|||
131502778|NCT03187262|473470160|FG000|Induction|Progressive Disease|4|||
131502779|NCT03187262|473470160|FG000|Consolidation|Progressive Disease|5|||
131502780|NCT02141997|473470161|FG000|Overall Study|Adverse Event|0|||
131502781|NCT02141997|473470162|FG001|Overall Study|Adverse Event|2|||
131502782|NCT02141997|473470163|FG002|Overall Study|Adverse Event|0|||
131502783|NCT02141997|473470164|FG003|Overall Study|Adverse Event|1|||
131502784|NCT02141997|473470161|FG000|Overall Study|Participant noncompliance|1|||
131502785|NCT02141997|473470162|FG001|Overall Study|Participant noncompliance|0|||
131502786|NCT02141997|473470163|FG002|Overall Study|Participant noncompliance|0|||
131502787|NCT02141997|473470164|FG003|Overall Study|Participant noncompliance|0|||
131502788|NCT02141997|473470161|FG000|Overall Study|Withdrew consent|1|||
131502789|NCT02141997|473470162|FG001|Overall Study|Withdrew consent|0|||
131502790|NCT02141997|473470163|FG002|Overall Study|Withdrew consent|3|||
131502791|NCT02141997|473470164|FG003|Overall Study|Withdrew consent|0|||
131502792|NCT02141997|473470161|FG000|Overall Study|Other|1|||
131502793|NCT02141997|473470162|FG001|Overall Study|Other|4|||
131502794|NCT02141997|473470163|FG002|Overall Study|Other|0|||
131502795|NCT02141997|473470164|FG003|Overall Study|Other|0|||
131502796|NCT00909389|473470165|FG000|Overall Study|Adverse Event|6|||
131502797|NCT00909389|473470165|FG000|Overall Study|Death|4|||
131502798|NCT00909389|473470165|FG000|Overall Study|Poor Compliance|16|||
131502799|NCT00909389|473470165|FG000|Overall Study|Lost to Follow-up|4|||
131502800|NCT00909389|473470165|FG000|Overall Study|No Information|103|||
131502801|NCT00003492|473470166|FG000|Overall Study|Not evaluable|6|||
131502802|NCT00737282|473470169|FG000|Overall Study|Study prematurely terminated|175|||
131502803|NCT00840294|473470170|FG000|Overall Study|Withdrawal by Subject|2|||
131502804|NCT00840294|473470171|FG001|Overall Study|Withdrawal by Subject|1|||
131502805|NCT00840294|473470170|FG000|Overall Study|Protocol Violation|1|||
131502806|NCT00840294|473470171|FG001|Overall Study|Protocol Violation|3|||
131502807|NCT00840294|473470170|FG000|Overall Study|Illness|0|||
131502808|NCT00840294|473470171|FG001|Overall Study|Illness|1|||
131502809|NCT00453544|473470175|FG000|Overall Study|Withdrawal by Subject|1|||
131502810|NCT00453544|473470176|FG001|Overall Study|Withdrawal by Subject|0|||
131502811|NCT00453544|473470177|FG002|Overall Study|Withdrawal by Subject|0|||
131502812|NCT00453544|473470178|FG003|Overall Study|Withdrawal by Subject|0|||
131502813|NCT00453544|473470175|FG000|Overall Study|Primary outcome measure not completed|1|||
131502814|NCT00453544|473470176|FG001|Overall Study|Primary outcome measure not completed|1|||
131502815|NCT00453544|473470177|FG002|Overall Study|Primary outcome measure not completed|0|||
131502816|NCT00453544|473470178|FG003|Overall Study|Primary outcome measure not completed|1|||
131502817|NCT00619801|473470181|FG000|Overall Study|Lack of Efficacy|0|||
131502818|NCT00619801|473470182|FG001|Overall Study|Lack of Efficacy|1|||
131502819|NCT00619801|473470181|FG000|Overall Study|Withdrawal by Subject|1|||
131502820|NCT00619801|473470182|FG001|Overall Study|Withdrawal by Subject|1|||
131502821|NCT00619801|473470181|FG000|Overall Study|Loss of efficacy|0|||
131502822|NCT00619801|473470182|FG001|Overall Study|Loss of efficacy|1|||
131502823|NCT03721276|473470183|FG000|Overall Study|Lost to Follow-up|5|||
131502824|NCT03721276|473470184|FG001|Overall Study|Lost to Follow-up|3|||
131502825|NCT03721276|473470183|FG000|Overall Study|Adverse Event|0|||
131502826|NCT03721276|473470184|FG001|Overall Study|Adverse Event|1|||
131502827|NCT01340898|473470185|FG000|Primary Phase|Serious Adverse Events|0|||
131502828|NCT01340898|473470186|FG001|Primary Phase|Serious Adverse Events|0|||
131502829|NCT01340898|473470187|FG002|Primary Phase|Serious Adverse Events|1|||
131502830|NCT01340898|473470185|FG000|Primary Phase|Withdrawal by Subject|8|||
131502831|NCT01340898|473470186|FG001|Primary Phase|Withdrawal by Subject|7|||
131502832|NCT01340898|473470187|FG002|Primary Phase|Withdrawal by Subject|5|||
131502833|NCT01340898|473470185|FG000|Primary Phase|Migrated/moved from study area|4|||
131502834|NCT01340898|473470186|FG001|Primary Phase|Migrated/moved from study area|1|||
131502835|NCT01340898|473470187|FG002|Primary Phase|Migrated/moved from study area|0|||
131502836|NCT01340898|473470185|FG000|Primary Phase|Lost to Follow-up|4|||
131502837|NCT01340898|473470186|FG001|Primary Phase|Lost to Follow-up|1|||
131502838|NCT01340898|473470187|FG002|Primary Phase|Lost to Follow-up|0|||
131502839|NCT01340898|473470185|FG000|Booster Phase|Withdrawal by Subject|3|||
131502840|NCT01340898|473470186|FG001|Booster Phase|Withdrawal by Subject|0|||
131502841|NCT01340898|473470187|FG002|Booster Phase|Withdrawal by Subject|4|||
131502842|NCT01340898|473470185|FG000|Booster Phase|Migrated/moved from study area|3|||
131502843|NCT01340898|473470186|FG001|Booster Phase|Migrated/moved from study area|0|||
131502844|NCT01340898|473470187|FG002|Booster Phase|Migrated/moved from study area|0|||
131502845|NCT01340898|473470185|FG000|Booster Phase|Lost to Follow-up|4|||
131502846|NCT01340898|473470186|FG001|Booster Phase|Lost to Follow-up|2|||
131502847|NCT01340898|473470187|FG002|Booster Phase|Lost to Follow-up|3|||
131502848|NCT01214629|473470189|FG000|Overall Study|Progressive Disease|1|||
131502849|NCT01214629|473470190|FG001|Overall Study|Progressive Disease|1|||
131502850|NCT01214629|473470191|FG002|Overall Study|Progressive Disease|0|||
131502851|NCT01214629|473470192|FG003|Overall Study|Progressive Disease|1|||
131502852|NCT01214629|473470193|FG004|Overall Study|Progressive Disease|2|||
131502853|NCT01214629|473470194|FG005|Overall Study|Progressive Disease|3|||
131502854|NCT01214629|473470195|FG006|Overall Study|Progressive Disease|1|||
131502855|NCT01214629|473470196|FG007|Overall Study|Progressive Disease|1|||
131502856|NCT01214629|473470197|FG008|Overall Study|Progressive Disease|1|||
131502857|NCT01214629|473470198|FG009|Overall Study|Progressive Disease|5|||
131502858|NCT01214629|473470199|FG010|Overall Study|Progressive Disease|1|||
131502859|NCT01214629|473470189|FG000|Overall Study|Adverse Event|0|||
131502860|NCT01214629|473470190|FG001|Overall Study|Adverse Event|0|||
131502861|NCT01214629|473470191|FG002|Overall Study|Adverse Event|0|||
131502862|NCT01214629|473470192|FG003|Overall Study|Adverse Event|1|||
131502863|NCT01214629|473470193|FG004|Overall Study|Adverse Event|0|||
131502864|NCT01214629|473470194|FG005|Overall Study|Adverse Event|1|||
131502865|NCT01214629|473470195|FG006|Overall Study|Adverse Event|0|||
131502866|NCT01214629|473470196|FG007|Overall Study|Adverse Event|0|||
131502867|NCT01214629|473470197|FG008|Overall Study|Adverse Event|0|||
131502868|NCT01214629|473470198|FG009|Overall Study|Adverse Event|1|||
131502869|NCT01214629|473470199|FG010|Overall Study|Adverse Event|0|||
131502870|NCT01214629|473470189|FG000|Overall Study|Physician Decision|0|||
131502871|NCT01214629|473470190|FG001|Overall Study|Physician Decision|0|||
131502872|NCT01214629|473470191|FG002|Overall Study|Physician Decision|0|||
131502873|NCT01214629|473470192|FG003|Overall Study|Physician Decision|0|||
131502874|NCT01214629|473470193|FG004|Overall Study|Physician Decision|0|||
131502875|NCT01214629|473470194|FG005|Overall Study|Physician Decision|0|||
131502876|NCT01214629|473470195|FG006|Overall Study|Physician Decision|0|||
131502877|NCT01214629|473470196|FG007|Overall Study|Physician Decision|0|||
131502878|NCT01214629|473470197|FG008|Overall Study|Physician Decision|0|||
131502879|NCT01214629|473470198|FG009|Overall Study|Physician Decision|0|||
131502880|NCT01214629|473470199|FG010|Overall Study|Physician Decision|1|||
131502881|NCT01214629|473470189|FG000|Overall Study|Withdrawal by Subject|0|||
131502882|NCT01214629|473470190|FG001|Overall Study|Withdrawal by Subject|0|||
131502883|NCT01214629|473470191|FG002|Overall Study|Withdrawal by Subject|0|||
131502884|NCT01214629|473470192|FG003|Overall Study|Withdrawal by Subject|0|||
131502885|NCT01214629|473470193|FG004|Overall Study|Withdrawal by Subject|0|||
131502886|NCT01214629|473470194|FG005|Overall Study|Withdrawal by Subject|0|||
131502887|NCT01214629|473470195|FG006|Overall Study|Withdrawal by Subject|0|||
131502888|NCT01214629|473470196|FG007|Overall Study|Withdrawal by Subject|0|||
131502889|NCT01214629|473470197|FG008|Overall Study|Withdrawal by Subject|0|||
131502890|NCT01214629|473470198|FG009|Overall Study|Withdrawal by Subject|1|||
131502891|NCT01214629|473470199|FG010|Overall Study|Withdrawal by Subject|0|||
131502892|NCT01829230|473470200|FG000|Overall Study|Protocol Violation|0|||
131502893|NCT01829230|473470201|FG001|Overall Study|Protocol Violation|2|||
131502894|NCT01829230|473470200|FG000|Overall Study|Withdrawal by Subject|0|||
131502895|NCT01829230|473470201|FG001|Overall Study|Withdrawal by Subject|1|||
131502896|NCT01829230|473470200|FG000|Overall Study|Lost to Follow-up|1|||
131502897|NCT01829230|473470201|FG001|Overall Study|Lost to Follow-up|1|||
131502898|NCT04501666|473470202|FG000|Overall Study|Physician Decision|0|||
131502899|NCT04501666|473470203|FG001|Overall Study|Physician Decision|1|||
131502900|NCT04501666|473470202|FG000|Overall Study|Adverse Event|12|||
131502901|NCT04501666|473470203|FG001|Overall Study|Adverse Event|4|||
131502902|NCT04501666|473470202|FG000|Overall Study|Subject's request|10|||
131502903|NCT04501666|473470203|FG001|Overall Study|Subject's request|6|||
131502904|NCT04501666|473470202|FG000|Overall Study|Protocol Deviation|2|||
131502905|NCT04501666|473470203|FG001|Overall Study|Protocol Deviation|1|||
131502906|NCT04501666|473470202|FG000|Overall Study|Other-- site permanently closing|0|||
131502907|NCT04501666|473470203|FG001|Overall Study|Other-- site permanently closing|1|||
131502908|NCT03021265|473470204|FG000|Overall Study|Adverse Event|29|||
131502909|NCT03021265|473470204|FG000|Overall Study|Lack of Efficacy|3|||
131502910|NCT03021265|473470204|FG000|Overall Study|Improved|17|||
131502911|NCT03021265|473470204|FG000|Overall Study|Lost to Follow-up|67|||
131502912|NCT03021265|473470204|FG000|Overall Study|No reason given|2|||
131502913|NCT03021265|473470204|FG000|Overall Study|No visit since the first visit|4|||
131502914|NCT01338493|473470205|FG000|Enrolled|Withdrawal by Subject|1|||
131502915|NCT01338493|473470205|FG000|Enrolled|Patient not implanted|4|||
131502916|NCT01338493|473470205|FG000|Discharge|Death|1|||
131502917|NCT01338493|473470205|FG000|Discharge|Missed visit|1|||
131502918|NCT01338493|473470205|FG000|6 Months Follow up|Lost to Follow-up|11|||
131502919|NCT01338493|473470205|FG000|6 Months Follow up|Missed visit|8|||
131502920|NCT01338493|473470205|FG000|12 Months Follow up|Lost to Follow-up|9|||
131502921|NCT00642941|473470206|FG000|Overall Study|Physician Decision|3|||
131502922|NCT00642941|473470207|FG001|Overall Study|Physician Decision|1|||
131502923|NCT00642941|473470208|FG002|Overall Study|Physician Decision|0|||
131502924|NCT00642941|473470209|FG003|Overall Study|Physician Decision|0|||
131502925|NCT00642941|473470210|FG004|Overall Study|Physician Decision|0|||
131502926|NCT00642941|473470211|FG005|Overall Study|Physician Decision|0|||
131502927|NCT00642941|473470212|FG006|Overall Study|Physician Decision|1|||
131502928|NCT00642941|473470213|FG007|Overall Study|Physician Decision|0|||
131502929|NCT00642941|473470214|FG008|Overall Study|Physician Decision|0|||
131502930|NCT00642941|473470215|FG009|Overall Study|Physician Decision|1|||
131502931|NCT00642941|473470216|FG010|Overall Study|Physician Decision|0|||
131502932|NCT00642941|473470217|FG011|Overall Study|Physician Decision|1|||
131502933|NCT00642941|473470206|FG000|Overall Study|Death|4|||
131502934|NCT00642941|473470207|FG001|Overall Study|Death|0|||
131502935|NCT00642941|473470208|FG002|Overall Study|Death|1|||
131502936|NCT00642941|473470209|FG003|Overall Study|Death|1|||
131502937|NCT00642941|473470210|FG004|Overall Study|Death|2|||
131502938|NCT00642941|473470211|FG005|Overall Study|Death|1|||
131502939|NCT00642941|473470212|FG006|Overall Study|Death|0|||
131502940|NCT00642941|473470213|FG007|Overall Study|Death|0|||
131502941|NCT00642941|473470214|FG008|Overall Study|Death|0|||
131502942|NCT00642941|473470215|FG009|Overall Study|Death|0|||
131502943|NCT00642941|473470216|FG010|Overall Study|Death|0|||
131502944|NCT00642941|473470217|FG011|Overall Study|Death|1|||
131502945|NCT00642941|473470206|FG000|Overall Study|Study closed by Sponsor|0|||
131502946|NCT00642941|473470207|FG001|Overall Study|Study closed by Sponsor|1|||
131502947|NCT00642941|473470208|FG002|Overall Study|Study closed by Sponsor|0|||
131502948|NCT00642941|473470209|FG003|Overall Study|Study closed by Sponsor|0|||
131502949|NCT00642941|473470210|FG004|Overall Study|Study closed by Sponsor|0|||
131502950|NCT00642941|473470211|FG005|Overall Study|Study closed by Sponsor|0|||
131502951|NCT00642941|473470212|FG006|Overall Study|Study closed by Sponsor|0|||
131502952|NCT00642941|473470213|FG007|Overall Study|Study closed by Sponsor|0|||
131502953|NCT00642941|473470214|FG008|Overall Study|Study closed by Sponsor|0|||
131502954|NCT00642941|473470215|FG009|Overall Study|Study closed by Sponsor|0|||
131502955|NCT00642941|473470216|FG010|Overall Study|Study closed by Sponsor|0|||
131502956|NCT00642941|473470217|FG011|Overall Study|Study closed by Sponsor|0|||
131502957|NCT00642941|473470206|FG000|Overall Study|Withdrawal by Subject|1|||
131502958|NCT00642941|473470207|FG001|Overall Study|Withdrawal by Subject|0|||
131502959|NCT00642941|473470208|FG002|Overall Study|Withdrawal by Subject|0|||
131502960|NCT00642941|473470209|FG003|Overall Study|Withdrawal by Subject|2|||
131502961|NCT00642941|473470210|FG004|Overall Study|Withdrawal by Subject|0|||
131502962|NCT00642941|473470211|FG005|Overall Study|Withdrawal by Subject|0|||
131502963|NCT00642941|473470212|FG006|Overall Study|Withdrawal by Subject|2|||
131502964|NCT00642941|473470213|FG007|Overall Study|Withdrawal by Subject|0|||
131502965|NCT00642941|473470214|FG008|Overall Study|Withdrawal by Subject|1|||
131502966|NCT00642941|473470215|FG009|Overall Study|Withdrawal by Subject|0|||
131502967|NCT00642941|473470216|FG010|Overall Study|Withdrawal by Subject|0|||
131502968|NCT00642941|473470217|FG011|Overall Study|Withdrawal by Subject|1|||
131502969|NCT00642941|473470206|FG000|Overall Study|Protocol Violation|0|||
131502970|NCT00642941|473470207|FG001|Overall Study|Protocol Violation|0|||
131502971|NCT00642941|473470208|FG002|Overall Study|Protocol Violation|0|||
131502972|NCT00642941|473470209|FG003|Overall Study|Protocol Violation|0|||
131502973|NCT00642941|473470210|FG004|Overall Study|Protocol Violation|0|||
131502974|NCT00642941|473470211|FG005|Overall Study|Protocol Violation|0|||
131502975|NCT00642941|473470212|FG006|Overall Study|Protocol Violation|1|||
131502976|NCT00642941|473470213|FG007|Overall Study|Protocol Violation|0|||
131502977|NCT00642941|473470214|FG008|Overall Study|Protocol Violation|0|||
131502978|NCT00642941|473470215|FG009|Overall Study|Protocol Violation|0|||
131502979|NCT00642941|473470216|FG010|Overall Study|Protocol Violation|0|||
131502980|NCT00642941|473470217|FG011|Overall Study|Protocol Violation|0|||
131502981|NCT00642941|473470206|FG000|Overall Study|Adverse Event|1|||
131502982|NCT00642941|473470207|FG001|Overall Study|Adverse Event|1|||
131502983|NCT00642941|473470208|FG002|Overall Study|Adverse Event|0|||
131502984|NCT00642941|473470209|FG003|Overall Study|Adverse Event|0|||
131502985|NCT00642941|473470210|FG004|Overall Study|Adverse Event|0|||
131502986|NCT00642941|473470211|FG005|Overall Study|Adverse Event|0|||
131502987|NCT00642941|473470212|FG006|Overall Study|Adverse Event|1|||
131502988|NCT00642941|473470213|FG007|Overall Study|Adverse Event|1|||
131502989|NCT00642941|473470214|FG008|Overall Study|Adverse Event|0|||
131502990|NCT00642941|473470215|FG009|Overall Study|Adverse Event|1|||
131502991|NCT00642941|473470216|FG010|Overall Study|Adverse Event|0|||
131502992|NCT00642941|473470217|FG011|Overall Study|Adverse Event|0|||
131502993|NCT00642941|473470206|FG000|Overall Study|Other|1|||
131502994|NCT00642941|473470207|FG001|Overall Study|Other|1|||
131502995|NCT00642941|473470208|FG002|Overall Study|Other|1|||
131502996|NCT00642941|473470209|FG003|Overall Study|Other|1|||
131502997|NCT00642941|473470210|FG004|Overall Study|Other|0|||
131502998|NCT00642941|473470211|FG005|Overall Study|Other|1|||
131502999|NCT00642941|473470212|FG006|Overall Study|Other|0|||
131503000|NCT00642941|473470213|FG007|Overall Study|Other|1|||
131503001|NCT00642941|473470214|FG008|Overall Study|Other|0|||
131503002|NCT00642941|473470215|FG009|Overall Study|Other|0|||
131503003|NCT00642941|473470216|FG010|Overall Study|Other|0|||
131503004|NCT00642941|473470217|FG011|Overall Study|Other|1|||
131503005|NCT00642941|473470206|FG000|Overall Study|Disease progression|60|||
131503006|NCT00642941|473470207|FG001|Overall Study|Disease progression|50|||
131503007|NCT00642941|473470208|FG002|Overall Study|Disease progression|5|||
131503008|NCT00642941|473470209|FG003|Overall Study|Disease progression|36|||
131503009|NCT00642941|473470210|FG004|Overall Study|Disease progression|23|||
131503010|NCT00642941|473470211|FG005|Overall Study|Disease progression|39|||
131503011|NCT00642941|473470212|FG006|Overall Study|Disease progression|18|||
131503012|NCT00642941|473470213|FG007|Overall Study|Disease progression|12|||
131503013|NCT00642941|473470214|FG008|Overall Study|Disease progression|10|||
131503014|NCT00642941|473470215|FG009|Overall Study|Disease progression|7|||
131503015|NCT00642941|473470216|FG010|Overall Study|Disease progression|12|||
131503016|NCT00642941|473470217|FG011|Overall Study|Disease progression|7|||
131503017|NCT01698801|473470218|FG000|Treatment Phase|Adverse Event|4|||
131503018|NCT01698801|473470218|FG000|Treatment Phase|Protocol Violation|1|||
131503019|NCT01698801|473470218|FG000|Treatment Phase|Other|4|||
131503020|NCT01698801|473470218|FG000|Treatment Phase|Withdrawal by Subject|1|||
131503021|NCT01698801|473470218|FG000|Treatment Phase|Disease progression|1|||
131503022|NCT01698801|473470218|FG000|Follow Up Phase|Withdrawal by Subject|1|||
131503023|NCT01698801|473470218|FG000|Follow Up Phase|Death|4|||
131503024|NCT00656474|473470219|FG000|Overall Study|Other Reason|1|||
131503025|NCT01614067|473470221|FG000|Overall Study|Pregnancy|1|||
131503026|NCT01614067|473470222|FG001|Overall Study|Pregnancy|0|||
131503027|NCT01614067|473470221|FG000|Overall Study|Physician Decision|6|||
131503028|NCT01614067|473470222|FG001|Overall Study|Physician Decision|5|||
131503029|NCT01614067|473470221|FG000|Overall Study|Withdrawal by Subject|0|||
131503030|NCT01614067|473470222|FG001|Overall Study|Withdrawal by Subject|1|||
131503031|NCT01614067|473470221|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
131503032|NCT01614067|473470222|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
131503033|NCT00056407|473470223|FG000|Overall Study|Adverse Event|282|||
131503034|NCT00056407|473470224|FG001|Overall Study|Adverse Event|364|||
131503035|NCT00056407|473470223|FG000|Overall Study|Withdrawal by Subject|377|||
131503036|NCT00056407|473470224|FG001|Overall Study|Withdrawal by Subject|361|||
131503037|NCT00056407|473470223|FG000|Overall Study|Lost to Follow-up|123|||
131503038|NCT00056407|473470224|FG001|Overall Study|Lost to Follow-up|113|||
131503039|NCT00056407|473470223|FG000|Overall Study|Protocol Violation|104|||
131503040|NCT00056407|473470224|FG001|Overall Study|Protocol Violation|95|||
131503041|NCT00056407|473470223|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
131503042|NCT00056407|473470224|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
131503043|NCT00056407|473470223|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
131503044|NCT00056407|473470224|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
131503045|NCT00056407|473470223|FG000|Overall Study|Missing|25|||
131503046|NCT00056407|473470224|FG001|Overall Study|Missing|34|||
131503047|NCT00616655|473470225|FG000|Overall Study|Adverse Event|10|||
131503048|NCT00616655|473470226|FG001|Overall Study|Adverse Event|7|||
131503049|NCT00616655|473470227|FG002|Overall Study|Adverse Event|12|||
131503050|NCT00616655|473470225|FG000|Overall Study|Lack of Efficacy|5|||
131503051|NCT00616655|473470226|FG001|Overall Study|Lack of Efficacy|5|||
131503052|NCT00616655|473470227|FG002|Overall Study|Lack of Efficacy|5|||
131503053|NCT00616655|473470225|FG000|Overall Study|Lost to Follow-up|3|||
131503054|NCT00616655|473470226|FG001|Overall Study|Lost to Follow-up|12|||
131503055|NCT00616655|473470227|FG002|Overall Study|Lost to Follow-up|10|||
131503056|NCT00616655|473470225|FG000|Overall Study|Protocol Violation|2|||
131503057|NCT00616655|473470226|FG001|Overall Study|Protocol Violation|4|||
131503058|NCT00616655|473470227|FG002|Overall Study|Protocol Violation|3|||
131503059|NCT00616655|473470225|FG000|Overall Study|Withdrawal by Subject|9|||
131503060|NCT00616655|473470226|FG001|Overall Study|Withdrawal by Subject|7|||
131503061|NCT00616655|473470227|FG002|Overall Study|Withdrawal by Subject|11|||
131503062|NCT00616655|473470225|FG000|Overall Study|Does not meet in/ex criteria|0|||
131503063|NCT00616655|473470226|FG001|Overall Study|Does not meet in/ex criteria|0|||
131503064|NCT00616655|473470227|FG002|Overall Study|Does not meet in/ex criteria|2|||
131503065|NCT00616655|473470225|FG000|Overall Study|Other|6|||
131503066|NCT00616655|473470226|FG001|Overall Study|Other|6|||
131503067|NCT00616655|473470227|FG002|Overall Study|Other|5|||
131503068|NCT03761147|473470228|FG000|Overall Study|Withdrawal by Subject|6|||
131503069|NCT03761147|473470229|FG001|Overall Study|Withdrawal by Subject|1|||
131503070|NCT03761147|473470228|FG000|Overall Study|Adverse Event|1|||
131503071|NCT03761147|473470229|FG001|Overall Study|Adverse Event|3|||
131503072|NCT02663674|473470233|FG000|Overall Study|Lost to Follow-up|5|||
131503073|NCT02663674|473470234|FG001|Overall Study|Lost to Follow-up|4|||
131503074|NCT02663674|473470233|FG000|Overall Study|Withdrawal by Subject|1|||
131503075|NCT02663674|473470234|FG001|Overall Study|Withdrawal by Subject|4|||
131503076|NCT02663674|473470233|FG000|Overall Study|Physician Decision|1|||
131503077|NCT02663674|473470234|FG001|Overall Study|Physician Decision|1|||
131503078|NCT02663674|473470233|FG000|Overall Study|Other Event (Health Related)|0|||
131503079|NCT02663674|473470234|FG001|Overall Study|Other Event (Health Related)|1|||
131503080|NCT00415909|473471448|FG000|Overall Study|Withdrawal by Subject|2|||
131503081|NCT00415909|473471448|FG000|Overall Study|Death|1|||
131503082|NCT00462761|473471454|FG000|Overall Study|Adverse Event|6|||
131503083|NCT00462761|473471454|FG000|Overall Study|Withdrawal by Subject|9|||
131503084|NCT00462761|473471454|FG000|Overall Study|Physician Decision|5|||
131503085|NCT00462761|473471454|FG000|Overall Study|Disease progression|43|||
131503086|NCT00462761|473471454|FG000|Overall Study|Death|12|||
131503087|NCT00462761|473471454|FG000|Overall Study|Other|1|||
131503088|NCT02345811|473471455|FG000|First Intervention|Withdrawal by Subject|1|||
131503089|NCT02345811|473471456|FG001|First Intervention|Withdrawal by Subject|1|||
131503090|NCT02877082|473471457|FG000|Overall Study|Trial was closed early|5|||
131503091|NCT02522286|473471458|FG000|Overall Study|Withdrawal by Subject|3|||
131503092|NCT02522286|473471459|FG001|Overall Study|Withdrawal by Subject|0|||
131503093|NCT02522286|473471460|FG002|Overall Study|Withdrawal by Subject|0|||
131503094|NCT02522286|473471461|FG003|Overall Study|Withdrawal by Subject|3|||
131503095|NCT03480750|473471462|FG000|Overall Study|Withdrawal by Subject|0|||
131503096|NCT03480750|473471463|FG001|Overall Study|Withdrawal by Subject|1|||
131503097|NCT03480750|473471464|FG002|Overall Study|Withdrawal by Subject|0|||
131503098|NCT03480750|473471465|FG003|Overall Study|Withdrawal by Subject|0|||
131503099|NCT03480750|473471466|FG004|Overall Study|Withdrawal by Subject|0|||
131503100|NCT03480750|473471467|FG005|Overall Study|Withdrawal by Subject|0|||
131503101|NCT03480750|473471462|FG000|Overall Study|The interruption in Trientine shippment|0|||
131503102|NCT03480750|473471463|FG001|Overall Study|The interruption in Trientine shippment|0|||
131503103|NCT03480750|473471464|FG002|Overall Study|The interruption in Trientine shippment|0|||
131503104|NCT03480750|473471465|FG003|Overall Study|The interruption in Trientine shippment|0|||
131503105|NCT03480750|473471466|FG004|Overall Study|The interruption in Trientine shippment|0|||
131503106|NCT03480750|473471467|FG005|Overall Study|The interruption in Trientine shippment|1|||
131503107|NCT00605813|473471468|FG000|Overall Study|Protocol Violation|25|||
131503108|NCT01132482|473471469|FG000|Overall Study|Adverse Event|1|||
131503109|NCT01132482|473471470|FG001|Overall Study|Adverse Event|0|||
131503110|NCT00174915|473471475|FG000|Overall Study|Lost to Follow-up|19|||
131503111|NCT00174915|473471476|FG001|Overall Study|Lost to Follow-up|17|||
131503112|NCT00174915|473471477|FG002|Overall Study|Lost to Follow-up|9|||
131503113|NCT00174915|473471478|FG003|Overall Study|Lost to Follow-up|17|||
131503114|NCT00174915|473471479|FG004|Overall Study|Lost to Follow-up|10|||
131503115|NCT00174915|473471475|FG000|Overall Study|Adverse Event|18|||
131503116|NCT00174915|473471476|FG001|Overall Study|Adverse Event|16|||
131503117|NCT00174915|473471477|FG002|Overall Study|Adverse Event|11|||
131503118|NCT00174915|473471478|FG003|Overall Study|Adverse Event|18|||
131503119|NCT00174915|473471479|FG004|Overall Study|Adverse Event|5|||
131503120|NCT00174915|473471475|FG000|Overall Study|Personal Reason(s)|16|||
131503121|NCT00174915|473471476|FG001|Overall Study|Personal Reason(s)|16|||
131503122|NCT00174915|473471477|FG002|Overall Study|Personal Reason(s)|9|||
131503123|NCT00174915|473471478|FG003|Overall Study|Personal Reason(s)|9|||
131503124|NCT00174915|473471479|FG004|Overall Study|Personal Reason(s)|9|||
131503125|NCT00174915|473471475|FG000|Overall Study|Other|15|||
131503126|NCT00174915|473471476|FG001|Overall Study|Other|8|||
131503127|NCT00174915|473471477|FG002|Overall Study|Other|6|||
131503128|NCT00174915|473471478|FG003|Overall Study|Other|5|||
131503129|NCT00174915|473471479|FG004|Overall Study|Other|3|||
131503130|NCT00174915|473471475|FG000|Overall Study|Gout Flare|13|||
131503131|NCT00174915|473471476|FG001|Overall Study|Gout Flare|6|||
131503132|NCT00174915|473471477|FG002|Overall Study|Gout Flare|8|||
131503133|NCT00174915|473471478|FG003|Overall Study|Gout Flare|1|||
131503134|NCT00174915|473471479|FG004|Overall Study|Gout Flare|0|||
131503135|NCT00174915|473471475|FG000|Overall Study|Protocol Violation|6|||
131503136|NCT00174915|473471476|FG001|Overall Study|Protocol Violation|3|||
131503137|NCT00174915|473471477|FG002|Overall Study|Protocol Violation|3|||
131503138|NCT00174915|473471478|FG003|Overall Study|Protocol Violation|6|||
131503139|NCT00174915|473471479|FG004|Overall Study|Protocol Violation|3|||
131503140|NCT00174915|473471475|FG000|Overall Study|Therapeutic Failure|6|||
131503141|NCT00174915|473471476|FG001|Overall Study|Therapeutic Failure|3|||
131503142|NCT00174915|473471477|FG002|Overall Study|Therapeutic Failure|2|||
131503143|NCT00174915|473471478|FG003|Overall Study|Therapeutic Failure|1|||
131503144|NCT00174915|473471479|FG004|Overall Study|Therapeutic Failure|3|||
131503145|NCT03060447|473471484|FG000|Overall Study|Withdrawal by Subject|2|||
131503146|NCT03060447|473471485|FG001|Overall Study|Withdrawal by Subject|0|||
131503147|NCT00573755|473471486|FG000|Overall Study|Still receiving treatment|1|||
131503148|NCT00573755|473471487|FG001|Overall Study|Still receiving treatment|0|||
131503149|NCT03274440|473471491|FG000|Overall Study|Time commitment too great|1|||
131503150|NCT03274440|473471492|FG001|Overall Study|Time commitment too great|0|||
131503151|NCT03274440|473471493|FG002|Overall Study|Time commitment too great|0|||
131503152|NCT03274440|473471494|FG003|Overall Study|Time commitment too great|1|||
131503153|NCT03274440|473471495|FG004|Overall Study|Time commitment too great|0|||
131503154|NCT03274440|473471496|FG005|Overall Study|Time commitment too great|0|||
131503155|NCT02369341|473471497|FG000|Overall Study|Migrated/moved from study area|1|||
131503156|NCT02369341|473471498|FG001|Overall Study|Migrated/moved from study area|0|||
131503157|NCT03287804|473471499|FG000|Overall Study|Death|1|||
131503158|NCT03287804|473471499|FG000|Overall Study|Physician Decision|2|||
131503159|NCT03287804|473471499|FG000|Overall Study|Progressive disease|8|||
131503160|NCT02707991|473471502|FG000|Overall Study|Protocol Violation|1|||
131503161|NCT02707991|473471503|FG001|Overall Study|Protocol Violation|0|||
131503162|NCT02707991|473471502|FG000|Overall Study|Became ineligible|0|||
131503163|NCT02707991|473471503|FG001|Overall Study|Became ineligible|1|||
131503164|NCT01496313|473471506|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
131503165|NCT01496313|473471507|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
131503166|NCT01496313|473471508|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
131503167|NCT01496313|473471509|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
131503168|NCT01496313|473471510|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
131503169|NCT01496313|473471511|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
131503170|NCT01496313|473471506|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
131503171|NCT01496313|473471507|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
131503172|NCT01496313|473471508|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
131503173|NCT01496313|473471509|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
131503174|NCT01496313|473471510|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
131503175|NCT01496313|473471511|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
131503176|NCT01496313|473471506|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
131503177|NCT01496313|473471507|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
131503178|NCT01496313|473471508|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
131503179|NCT01496313|473471509|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
131503180|NCT01496313|473471510|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
131503181|NCT01496313|473471511|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
131503182|NCT01496313|473471506|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
131503183|NCT01496313|473471507|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
131503184|NCT01496313|473471508|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
131503185|NCT01496313|473471509|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
131503186|NCT01496313|473471510|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
131503187|NCT01496313|473471511|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
131503188|NCT01496313|473471506|FG000|Randomized Period (up to 14 Months)|Other|1|||
131503189|NCT01496313|473471507|FG001|Randomized Period (up to 14 Months)|Other|2|||
131503190|NCT01496313|473471508|FG002|Randomized Period (up to 14 Months)|Other|0|||
131503191|NCT01496313|473471509|FG003|Randomized Period (up to 14 Months)|Other|0|||
131503192|NCT01496313|473471510|FG004|Randomized Period (up to 14 Months)|Other|0|||
131503193|NCT01496313|473471511|FG005|Randomized Period (up to 14 Months)|Other|0|||
131503194|NCT01496313|473471506|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
131503195|NCT01496313|473471507|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
131503196|NCT01496313|473471508|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
131503197|NCT01496313|473471509|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
131503198|NCT01496313|473471510|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
131503199|NCT01496313|473471511|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
131503200|NCT01496313|473471506|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
131503201|NCT01496313|473471507|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
131503202|NCT01496313|473471508|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
131503203|NCT01496313|473471509|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
131503204|NCT01496313|473471510|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
131503205|NCT01496313|473471511|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
131503206|NCT01496313|473471506|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
131503207|NCT01496313|473471507|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
131503208|NCT01496313|473471508|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
131503209|NCT01496313|473471509|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
131503210|NCT01496313|473471510|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
131503211|NCT01496313|473471511|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
131503212|NCT04105998|473471514|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
131503213|NCT04105998|473471515|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
131503214|NCT01050257|473471516|FG000|Overall Study|Adverse Event|4|||
131503215|NCT01050257|473471517|FG001|Overall Study|Adverse Event|4|||
131503216|NCT01050257|473471518|FG002|Overall Study|Adverse Event|2|||
131503217|NCT01050257|473471516|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
131503218|NCT01050257|473471517|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
131503219|NCT01050257|473471518|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
131503220|NCT01050257|473471516|FG000|Overall Study|Withdrawal by Subject|0|||
131503221|NCT01050257|473471517|FG001|Overall Study|Withdrawal by Subject|3|||
131503222|NCT01050257|473471518|FG002|Overall Study|Withdrawal by Subject|0|||
131503223|NCT01050257|473471516|FG000|Overall Study|No reason specified|0|||
131503224|NCT01050257|473471517|FG001|Overall Study|No reason specified|0|||
131503225|NCT01050257|473471518|FG002|Overall Study|No reason specified|2|||
131503226|NCT01050257|473471516|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
131503227|NCT01050257|473471517|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
131503228|NCT01050257|473471518|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
131503229|NCT01050257|473471516|FG000|Overall Study|Violation criteria|0|||
131503230|NCT01050257|473471517|FG001|Overall Study|Violation criteria|1|||
131503231|NCT01050257|473471518|FG002|Overall Study|Violation criteria|0|||
131503232|NCT01050257|473471516|FG000|Overall Study|Failure to return|0|||
131503233|NCT01050257|473471517|FG001|Overall Study|Failure to return|2|||
131503234|NCT01050257|473471518|FG002|Overall Study|Failure to return|0|||
131503235|NCT01050257|473471516|FG000|Overall Study|Death|0|||
131503236|NCT01050257|473471517|FG001|Overall Study|Death|0|||
131503237|NCT01050257|473471518|FG002|Overall Study|Death|1|||
131503238|NCT00278109|473471520|FG000|Overall Study|Adverse Event|3|||
131503239|NCT00278109|473471520|FG000|Overall Study|social circumstances|1|||
131503240|NCT02580357|473471521|FG000|Overall Study|Lost to Follow-up|2|||
131503241|NCT02580357|473471522|FG001|Overall Study|Lost to Follow-up|0|||
131503242|NCT02580357|473471523|FG002|Overall Study|Lost to Follow-up|0|||
131503243|NCT02580357|473471521|FG000|Overall Study|Protocol Violation|1|||
131503244|NCT02580357|473471522|FG001|Overall Study|Protocol Violation|0|||
131503245|NCT02580357|473471523|FG002|Overall Study|Protocol Violation|0|||
131503246|NCT02064166|473471524|FG000|Overall Study|Adverse Event|1|||
131503247|NCT02064166|473471525|FG001|Overall Study|Adverse Event|0|||
131503248|NCT04519645|473471528|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
131503249|NCT04519645|473471529|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
131503250|NCT04519645|473471530|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
131503251|NCT04519645|473471528|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
131503252|NCT04519645|473471529|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
131503253|NCT04519645|473471530|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
131503254|NCT04519645|473471528|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
131503255|NCT04519645|473471529|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
131503256|NCT04519645|473471530|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
131503257|NCT04519645|473471528|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
131503258|NCT04519645|473471529|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
131503259|NCT04519645|473471530|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
131503260|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131503261|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
131503262|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131503263|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131503264|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131503265|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131503266|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131503267|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
131503268|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
131503269|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
131503270|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
131503271|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
131503272|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
131503273|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
131503274|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
131503275|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
131503276|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
131503277|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
131503278|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
131503279|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
131503280|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
131503281|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
131503282|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
131503283|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
131503284|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
131503285|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
131503286|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
131503287|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
131503288|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
131503289|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
131503290|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
131503291|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
131503292|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
131503293|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
131503294|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
131503295|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
131503296|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
131503297|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
131503298|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
131503299|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
131503300|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
131503301|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
131503302|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
131503303|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
131503304|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
131503305|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
131503306|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
131503307|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
131503308|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
131503309|NCT03742037|473471532|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
131503310|NCT03742037|473471533|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
131503311|NCT03742037|473471534|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
131503312|NCT03742037|473471535|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
131503313|NCT03742037|473471536|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
131503314|NCT03742037|473471537|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
131503315|NCT03742037|473471538|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
131503316|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
131503317|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
131503318|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
131503319|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
131503320|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
131503321|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
131503322|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
131503323|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
131503324|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
131503325|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
131503326|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
131503327|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
131503328|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
131503329|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
131503330|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
131503331|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
131503332|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
131503333|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
131503334|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
131503335|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
131503336|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
131503337|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
131503338|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
131503339|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
131503340|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
131503341|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
131503342|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
131503343|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
131503344|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
131503345|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
131503346|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
131503347|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
131503348|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
131503349|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
131503350|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
131503351|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
131503352|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
131503353|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
131503354|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
131503355|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
131503356|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
131503357|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
131503358|NCT03742037|473471532|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
131503359|NCT03742037|473471533|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
131503360|NCT03742037|473471534|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
131503361|NCT03742037|473471535|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
131503362|NCT03742037|473471536|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
131503363|NCT03742037|473471537|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
131503364|NCT03742037|473471538|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
131503365|NCT01026792|473471561|FG000|Overall Study|Protocol Violation|1|||
131503366|NCT02045797|473471562|FG000|Overall Study|Adverse Event|3|||
131503367|NCT02045797|473471563|FG001|Overall Study|Adverse Event|1|||
131503368|NCT02045797|473471564|FG002|Overall Study|Adverse Event|0|||
131503369|NCT02045797|473471562|FG000|Overall Study|Lack of Efficacy|1|||
131503370|NCT02045797|473471563|FG001|Overall Study|Lack of Efficacy|0|||
131503371|NCT02045797|473471564|FG002|Overall Study|Lack of Efficacy|0|||
131503372|NCT02045797|473471562|FG000|Overall Study|Lost to Follow-up|2|||
131503373|NCT02045797|473471563|FG001|Overall Study|Lost to Follow-up|3|||
131503374|NCT02045797|473471564|FG002|Overall Study|Lost to Follow-up|1|||
131503375|NCT02045797|473471562|FG000|Overall Study|Physician Decision|0|||
131503376|NCT02045797|473471563|FG001|Overall Study|Physician Decision|1|||
131503377|NCT02045797|473471564|FG002|Overall Study|Physician Decision|0|||
131503378|NCT02045797|473471562|FG000|Overall Study|Withdrawal by Subject|1|||
131503379|NCT02045797|473471563|FG001|Overall Study|Withdrawal by Subject|2|||
131503380|NCT02045797|473471564|FG002|Overall Study|Withdrawal by Subject|0|||
131503381|NCT03274687|473472479|FG000|Overall Study|Protocol Violation|1|||
131503382|NCT03274687|473472480|FG001|Overall Study|Protocol Violation|1|||
131503383|NCT04734652|473472485|FG000|Overall Study|Withdrawal by Subject|2|||
131503384|NCT04734652|473472486|FG001|Overall Study|Withdrawal by Subject|0|||
131503385|NCT04734652|473472485|FG000|Overall Study|Death|0|||
131503386|NCT04734652|473472486|FG001|Overall Study|Death|1|||
131503387|NCT02132767|473472487|FG000|Overall Study|Death|3|||
131503388|NCT02132767|473472488|FG001|Overall Study|Death|2|||
131503389|NCT02132767|473472487|FG000|Overall Study|Withdrawal by Subject|10|||
131503390|NCT02132767|473472488|FG001|Overall Study|Withdrawal by Subject|9|||
131503391|NCT02132767|473472487|FG000|Overall Study|Lost to Follow-up|4|||
131503392|NCT02132767|473472488|FG001|Overall Study|Lost to Follow-up|4|||
131503393|NCT04267133|473472491|FG000|Overall Study|Withdrawal by Subject|1|||
131503394|NCT04267133|473472491|FG000|Overall Study|Adverse Event|4|||
131503395|NCT05104476|473472493|FG000|Overall Study|Randomized But Not Treated|1|||
131503396|NCT05104476|473472494|FG001|Overall Study|Randomized But Not Treated|2|||
131503397|NCT05104476|473472493|FG000|Overall Study|Adverse Event|2|||
131503398|NCT05104476|473472494|FG001|Overall Study|Adverse Event|2|||
131503399|NCT05104476|473472493|FG000|Overall Study|Withdrawal by Subject|3|||
131503400|NCT05104476|473472494|FG001|Overall Study|Withdrawal by Subject|3|||
131503401|NCT05104476|473472493|FG000|Overall Study|Other Than Specified|0|||
131503402|NCT05104476|473472494|FG001|Overall Study|Other Than Specified|3|||
131503403|NCT04008030|473472495|FG000|Pre-Treatment|Withdrawal by Subject|0|||
131503404|NCT04008030|473472496|FG001|Pre-Treatment|Withdrawal by Subject|0|||
131503405|NCT04008030|473472497|FG002|Pre-Treatment|Withdrawal by Subject|9|||
131503406|NCT04008030|473472495|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
131503407|NCT04008030|473472496|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
131503408|NCT04008030|473472497|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
131503409|NCT04008030|473472495|FG000|Pre-Treatment|Other reasons|0|||
131503410|NCT04008030|473472496|FG001|Pre-Treatment|Other reasons|1|||
131503411|NCT04008030|473472497|FG002|Pre-Treatment|Other reasons|6|||
131503412|NCT04008030|473472495|FG000|Treatment|Withdrawal by Subject|1|||
131503413|NCT04008030|473472496|FG001|Treatment|Withdrawal by Subject|1|||
131503414|NCT04008030|473472497|FG002|Treatment|Withdrawal by Subject|1|||
131503415|NCT04008030|473472495|FG000|Treatment|Death|2|||
131503416|NCT04008030|473472496|FG001|Treatment|Death|4|||
131503417|NCT04008030|473472497|FG002|Treatment|Death|0|||
131503418|NCT04008030|473472495|FG000|Treatment|Pregnancy|0|||
131503419|NCT04008030|473472496|FG001|Treatment|Pregnancy|1|||
131503420|NCT04008030|473472497|FG002|Treatment|Pregnancy|0|||
131503421|NCT04008030|473472495|FG000|Treatment|Participant no longer meets study criteria|0|||
131503422|NCT04008030|473472496|FG001|Treatment|Participant no longer meets study criteria|1|||
131503423|NCT04008030|473472497|FG002|Treatment|Participant no longer meets study criteria|0|||
131503424|NCT04008030|473472495|FG000|Treatment|Other reasons|5|||
131503425|NCT04008030|473472496|FG001|Treatment|Other reasons|13|||
131503426|NCT04008030|473472497|FG002|Treatment|Other reasons|6|||
131503427|NCT04008030|473472495|FG000|Treatment|Disease Progression|137|||
131503428|NCT04008030|473472496|FG001|Treatment|Disease Progression|82|||
131503429|NCT04008030|473472497|FG002|Treatment|Disease Progression|85|||
131503430|NCT04008030|473472495|FG000|Treatment|Study drug toxicity|28|||
131503431|NCT04008030|473472496|FG001|Treatment|Study drug toxicity|48|||
131503432|NCT04008030|473472497|FG002|Treatment|Study drug toxicity|8|||
131503433|NCT04008030|473472495|FG000|Treatment|Adverse Event unrelated to study drug|28|||
131503434|NCT04008030|473472496|FG001|Treatment|Adverse Event unrelated to study drug|22|||
131503435|NCT04008030|473472497|FG002|Treatment|Adverse Event unrelated to study drug|6|||
131503436|NCT04008030|473472495|FG000|Treatment|Maximum Clinical Benefit|0|||
131503437|NCT04008030|473472496|FG001|Treatment|Maximum Clinical Benefit|1|||
131503438|NCT04008030|473472497|FG002|Treatment|Maximum Clinical Benefit|9|||
131503439|NCT04008030|473472495|FG000|Treatment|On-going treatment|13|||
131503440|NCT04008030|473472496|FG001|Treatment|On-going treatment|20|||
131503441|NCT04008030|473472497|FG002|Treatment|On-going treatment|0|||
131503442|NCT00003901|473472501|FG000|Overall Study|Adverse Event|1|||
131503443|NCT00003901|473472501|FG000|Overall Study|Withdrawal by Subject|1|||
131503444|NCT00003901|473472501|FG000|Overall Study|Ineligible|6|||
131503445|NCT00003901|473472501|FG000|Overall Study|CT Scan not within protocol requirement|2|||
131503446|NCT00003901|473472501|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
131503447|NCT00003901|473472501|FG000|Overall Study|Medical problems|6|||
131503448|NCT04447755|473472506|FG000|Overall Study|Death|9|||
131503449|NCT04447755|473472507|FG001|Overall Study|Death|16|||
131503450|NCT04447755|473472508|FG002|Overall Study|Death|8|||
131503451|NCT04447755|473472509|FG003|Overall Study|Death|9|||
131503452|NCT04447755|473472510|FG004|Overall Study|Death|8|||
131503453|NCT04447755|473472511|FG005|Overall Study|Death|9|||
131503454|NCT04447755|473472512|FG006|Overall Study|Death|55|||
131503455|NCT04447755|473472506|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131503456|NCT04447755|473472507|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131503457|NCT04447755|473472508|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131503458|NCT04447755|473472509|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131503459|NCT04447755|473472510|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131503460|NCT04447755|473472511|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131503461|NCT04447755|473472512|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
131503462|NCT04447755|473472506|FG000|Overall Study|Sponsor Decision|0|||
131503463|NCT04447755|473472507|FG001|Overall Study|Sponsor Decision|0|||
131503464|NCT04447755|473472508|FG002|Overall Study|Sponsor Decision|0|||
131503465|NCT04447755|473472509|FG003|Overall Study|Sponsor Decision|0|||
131503466|NCT04447755|473472510|FG004|Overall Study|Sponsor Decision|1|||
131503467|NCT04447755|473472511|FG005|Overall Study|Sponsor Decision|0|||
131503468|NCT04447755|473472512|FG006|Overall Study|Sponsor Decision|10|||
131503469|NCT04447755|473472506|FG000|Overall Study|Lost to Follow-up|0|||
131503470|NCT04447755|473472507|FG001|Overall Study|Lost to Follow-up|0|||
131503471|NCT04447755|473472508|FG002|Overall Study|Lost to Follow-up|0|||
131503472|NCT04447755|473472509|FG003|Overall Study|Lost to Follow-up|0|||
131503473|NCT04447755|473472510|FG004|Overall Study|Lost to Follow-up|0|||
131503474|NCT04447755|473472511|FG005|Overall Study|Lost to Follow-up|0|||
131503475|NCT04447755|473472512|FG006|Overall Study|Lost to Follow-up|1|||
131503476|NCT00383149|473472513|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
131503477|NCT00383149|473472513|FG000|Overall Study|Death|2|||
131503478|NCT00383149|473472513|FG000|Overall Study|Disease Progression|38|||
131503479|NCT00383149|473472513|FG000|Overall Study|Lost to Follow-up|1|||
131503480|NCT00383149|473472513|FG000|Overall Study|Other|1|||
131503481|NCT00383149|473472513|FG000|Overall Study|Study Drug Toxicity|4|||
131503482|NCT00383149|473472513|FG000|Overall Study|Request to Discontinue Treatment|4|||
131503483|NCT00383149|473472513|FG000|Overall Study|Participant Withdrew Consent|1|||
131503484|NCT00450333|473472514|FG000|Overall Study|Study terminated|47|||
131503485|NCT00450333|473472515|FG001|Overall Study|Study terminated|54|||
131503486|NCT00450333|473472516|FG002|Overall Study|Study terminated|16|||
131503487|NCT00450333|473472517|FG003|Overall Study|Study terminated|21|||
131503488|NCT00450333|473472514|FG000|Overall Study|Adverse Event|1|||
131503489|NCT00450333|473472515|FG001|Overall Study|Adverse Event|7|||
131503490|NCT00450333|473472516|FG002|Overall Study|Adverse Event|2|||
131503491|NCT00450333|473472517|FG003|Overall Study|Adverse Event|2|||
131503492|NCT00450333|473472514|FG000|Overall Study|Protocol Violation|1|||
131503493|NCT00450333|473472515|FG001|Overall Study|Protocol Violation|0|||
131503494|NCT00450333|473472516|FG002|Overall Study|Protocol Violation|1|||
131503495|NCT00450333|473472517|FG003|Overall Study|Protocol Violation|0|||
131503496|NCT00450333|473472514|FG000|Overall Study|Withdrawal by Subject|1|||
131503497|NCT00450333|473472515|FG001|Overall Study|Withdrawal by Subject|0|||
131503498|NCT00450333|473472516|FG002|Overall Study|Withdrawal by Subject|3|||
131503499|NCT00450333|473472517|FG003|Overall Study|Withdrawal by Subject|0|||
131503500|NCT00450333|473472514|FG000|Overall Study|Kidney transplant|1|||
131503501|NCT00450333|473472515|FG001|Overall Study|Kidney transplant|0|||
131503502|NCT00450333|473472516|FG002|Overall Study|Kidney transplant|1|||
131503503|NCT00450333|473472517|FG003|Overall Study|Kidney transplant|3|||
131503504|NCT00450333|473472514|FG000|Overall Study|Death|3|||
131503505|NCT00450333|473472515|FG001|Overall Study|Death|2|||
131503506|NCT00450333|473472516|FG002|Overall Study|Death|2|||
131503507|NCT00450333|473472517|FG003|Overall Study|Death|2|||
131503508|NCT00416078|473472521|FG000|Overall Study|Death|3|||
131503509|NCT00416078|473472522|FG001|Overall Study|Death|4|||
131503510|NCT00416078|473472521|FG000|Overall Study|Withdrawal by Subject|3|||
131503511|NCT00416078|473472522|FG001|Overall Study|Withdrawal by Subject|2|||
131503512|NCT00416078|473472521|FG000|Overall Study|Physician Decision|1|||
131503513|NCT00416078|473472522|FG001|Overall Study|Physician Decision|0|||
131503514|NCT00416078|473472521|FG000|Overall Study|Lost to Follow-up|4|||
131503515|NCT00416078|473472522|FG001|Overall Study|Lost to Follow-up|2|||
131503516|NCT00969150|473472530|FG000|Overall Study|Adverse Event|4|||
131503517|NCT00969150|473472531|FG001|Overall Study|Adverse Event|14|||
131503518|NCT00969150|473472530|FG000|Overall Study|Lack of Efficacy|1|||
131503519|NCT00969150|473472531|FG001|Overall Study|Lack of Efficacy|1|||
131503520|NCT00969150|473472530|FG000|Overall Study|Protocol Violation|9|||
131503521|NCT00969150|473472531|FG001|Overall Study|Protocol Violation|12|||
131503522|NCT00969150|473472530|FG000|Overall Study|Withdrawal by Subject|13|||
131503523|NCT00969150|473472531|FG001|Overall Study|Withdrawal by Subject|9|||
131503524|NCT00969150|473472530|FG000|Overall Study|Lost to Follow-up|5|||
131503525|NCT00969150|473472531|FG001|Overall Study|Lost to Follow-up|4|||
131503526|NCT00969150|473472530|FG000|Overall Study|Other reasons|1|||
131503527|NCT00969150|473472531|FG001|Overall Study|Other reasons|0|||
131503528|NCT00461682|473472532|FG000|Overall Study|Protocol Violation|1|||
131503529|NCT04128267|473472540|FG000|Overall Study|Withdrawal by Subject|6|||
131503530|NCT04128267|473472540|FG000|Overall Study|Death|2|||
131503531|NCT04128267|473472540|FG000|Overall Study|Disease progression|1|||
131503532|NCT04128267|473472540|FG000|Overall Study|Participant had other medical issues|4|||
131503533|NCT04128267|473472540|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
131503534|NCT00309842|473472541|FG000|Overall Study|Lost to Follow-up|1|||
131503535|NCT00423150|473472542|FG000|Overall Study|Adverse Event|11|||
131503536|NCT00423150|473472542|FG000|Overall Study|Progression of disease being studied|69|||
131503537|NCT00423150|473472542|FG000|Overall Study|Withdrawal by Subject|1|||
131503538|NCT00423150|473472542|FG000|Overall Study|Non-compliance with protocol|1|||
131503539|NCT00423150|473472542|FG000|Overall Study|Administrative|4|||
131503540|NCT03204305|473472543|FG000|Overall Study|Lost to Follow-up|6|||
131503541|NCT03204305|473472544|FG001|Overall Study|Lost to Follow-up|4|||
131503542|NCT03204305|473472545|FG002|Overall Study|Lost to Follow-up|0|||
131503543|NCT03204305|473472546|FG003|Overall Study|Lost to Follow-up|0|||
131503544|NCT03204305|473472543|FG000|Overall Study|Physician Decision|1|||
131503545|NCT03204305|473472544|FG001|Overall Study|Physician Decision|0|||
131503546|NCT03204305|473472545|FG002|Overall Study|Physician Decision|0|||
131503547|NCT03204305|473472546|FG003|Overall Study|Physician Decision|0|||
131503548|NCT03204305|473472543|FG000|Overall Study|failure to place arterial line|2|||
131503549|NCT03204305|473472544|FG001|Overall Study|failure to place arterial line|1|||
131503550|NCT03204305|473472545|FG002|Overall Study|failure to place arterial line|0|||
131503551|NCT03204305|473472546|FG003|Overall Study|failure to place arterial line|0|||
131503552|NCT03204305|473472543|FG000|Overall Study|Withdrawal by Subject|2|||
131503553|NCT03204305|473472544|FG001|Overall Study|Withdrawal by Subject|0|||
131503554|NCT03204305|473472545|FG002|Overall Study|Withdrawal by Subject|0|||
131503555|NCT03204305|473472546|FG003|Overall Study|Withdrawal by Subject|0|||
131503556|NCT00101907|473472550|FG000|Overall Study|Adverse Event|1|||
131503557|NCT00101907|473472551|FG001|Overall Study|Adverse Event|0|||
131503558|NCT00101907|473472552|FG002|Overall Study|Adverse Event|0|||
131503559|NCT00101907|473472553|FG003|Overall Study|Adverse Event|0|||
131503560|NCT00101907|473472554|FG004|Overall Study|Adverse Event|0|||
131503561|NCT00101907|473472555|FG005|Overall Study|Adverse Event|0|||
131503562|NCT00101907|473472550|FG000|Overall Study|Death|0|||
131503563|NCT00101907|473472551|FG001|Overall Study|Death|1|||
131503564|NCT00101907|473472552|FG002|Overall Study|Death|0|||
131503565|NCT00101907|473472553|FG003|Overall Study|Death|0|||
131503566|NCT00101907|473472554|FG004|Overall Study|Death|3|||
131503567|NCT00101907|473472555|FG005|Overall Study|Death|0|||
131503568|NCT00101907|473472550|FG000|Overall Study|Physician Decision|0|||
131503569|NCT00101907|473472551|FG001|Overall Study|Physician Decision|0|||
131503570|NCT00101907|473472552|FG002|Overall Study|Physician Decision|0|||
131503571|NCT00101907|473472553|FG003|Overall Study|Physician Decision|1|||
131503572|NCT00101907|473472554|FG004|Overall Study|Physician Decision|1|||
131503573|NCT00101907|473472555|FG005|Overall Study|Physician Decision|0|||
131503574|NCT00101907|473472550|FG000|Overall Study|Withdrawal by Subject|1|||
131503575|NCT00101907|473472551|FG001|Overall Study|Withdrawal by Subject|0|||
131503576|NCT00101907|473472552|FG002|Overall Study|Withdrawal by Subject|1|||
131503577|NCT00101907|473472553|FG003|Overall Study|Withdrawal by Subject|0|||
131503578|NCT00101907|473472554|FG004|Overall Study|Withdrawal by Subject|1|||
131503579|NCT00101907|473472555|FG005|Overall Study|Withdrawal by Subject|0|||
131503580|NCT03279692|473472558|FG000|Overall Study|Withdrawal by Subject|1|||
131503581|NCT04219891|473472563|FG000|Overall Study|Lost to Follow-up|3|||
131503582|NCT04219891|473472563|FG000|Overall Study|Withdrawal by Subject|2|||
131503583|NCT04958785|473473357|FG000|Overall Study|Study Terminated by Sponsor|4|||
131503584|NCT04958785|473473358|FG001|Overall Study|Study Terminated by Sponsor|10|||
131503585|NCT04958785|473473359|FG002|Overall Study|Study Terminated by Sponsor|7|||
131503586|NCT04958785|473473360|FG003|Overall Study|Study Terminated by Sponsor|6|||
131503587|NCT04958785|473473361|FG004|Overall Study|Study Terminated by Sponsor|34|||
131503588|NCT04958785|473473357|FG000|Overall Study|Death|2|||
131503589|NCT04958785|473473358|FG001|Overall Study|Death|3|||
131503590|NCT04958785|473473359|FG002|Overall Study|Death|4|||
131503591|NCT04958785|473473360|FG003|Overall Study|Death|5|||
131503592|NCT04958785|473473361|FG004|Overall Study|Death|5|||
131503593|NCT04958785|473473357|FG000|Overall Study|Withdrew consent|2|||
131503594|NCT04958785|473473358|FG001|Overall Study|Withdrew consent|0|||
131503595|NCT04958785|473473359|FG002|Overall Study|Withdrew consent|3|||
131503596|NCT04958785|473473360|FG003|Overall Study|Withdrew consent|1|||
131503597|NCT04958785|473473361|FG004|Overall Study|Withdrew consent|0|||
131503598|NCT04958785|473473357|FG000|Overall Study|Investigator's discretion|0|||
131503599|NCT04958785|473473358|FG001|Overall Study|Investigator's discretion|1|||
131503600|NCT04958785|473473359|FG002|Overall Study|Investigator's discretion|0|||
131503601|NCT04958785|473473360|FG003|Overall Study|Investigator's discretion|1|||
131503602|NCT04958785|473473361|FG004|Overall Study|Investigator's discretion|2|||
131503603|NCT04958785|473473357|FG000|Overall Study|Adverse Event|0|||
131503604|NCT04958785|473473358|FG001|Overall Study|Adverse Event|0|||
131503605|NCT04958785|473473359|FG002|Overall Study|Adverse Event|0|||
131503606|NCT04958785|473473360|FG003|Overall Study|Adverse Event|0|||
131503607|NCT04958785|473473361|FG004|Overall Study|Adverse Event|1|||
131503608|NCT04958785|473473357|FG000|Overall Study|Lost to Follow-up|0|||
131503609|NCT04958785|473473358|FG001|Overall Study|Lost to Follow-up|0|||
131503610|NCT04958785|473473359|FG002|Overall Study|Lost to Follow-up|0|||
131503611|NCT04958785|473473360|FG003|Overall Study|Lost to Follow-up|0|||
131503612|NCT04958785|473473361|FG004|Overall Study|Lost to Follow-up|1|||
131503613|NCT00587561|473473362|FG000|Overall Study|Lost to Follow-up|6|||
131503614|NCT00587561|473473363|FG001|Overall Study|Lost to Follow-up|4|||
131503615|NCT00202644|473473364|FG000|Overall Study|Adverse Event|12|||
131503616|NCT00202644|473473365|FG001|Overall Study|Adverse Event|13|||
131503617|NCT00202644|473473364|FG000|Overall Study|Withdrawal by Subject|8|||
131503618|NCT00202644|473473365|FG001|Overall Study|Withdrawal by Subject|6|||
131503619|NCT00202644|473473364|FG000|Overall Study|Lack of Efficacy|6|||
131503620|NCT00202644|473473365|FG001|Overall Study|Lack of Efficacy|6|||
131503621|NCT00202644|473473364|FG000|Overall Study|Lost to Follow-up|0|||
131503622|NCT00202644|473473365|FG001|Overall Study|Lost to Follow-up|1|||
131503623|NCT00202644|473473364|FG000|Overall Study|Other|9|||
131503624|NCT00202644|473473365|FG001|Overall Study|Other|1|||
131503625|NCT03232281|473473366|FG000|Overall Study|Adverse Event|1|||
131503626|NCT03232281|473473367|FG001|Overall Study|Adverse Event|1|||
131503627|NCT03232281|473473366|FG000|Overall Study|Withdrawal by Subject|5|||
131503628|NCT03232281|473473367|FG001|Overall Study|Withdrawal by Subject|4|||
131503629|NCT03232281|473473366|FG000|Overall Study|Protocol Deviation|1|||
131503630|NCT03232281|473473367|FG001|Overall Study|Protocol Deviation|1|||
131503631|NCT00778700|473473373|FG000|Overall Study|Adverse Event|6|||
131503632|NCT00778700|473473374|FG001|Overall Study|Adverse Event|1|||
131503633|NCT00778700|473473375|FG002|Overall Study|Adverse Event|3|||
131503634|NCT00778700|473473376|FG003|Overall Study|Adverse Event|5|||
131503635|NCT00778700|473473373|FG000|Overall Study|Protocol Violation|1|||
131503636|NCT00778700|473473374|FG001|Overall Study|Protocol Violation|1|||
131503637|NCT00778700|473473375|FG002|Overall Study|Protocol Violation|0|||
131503638|NCT00778700|473473376|FG003|Overall Study|Protocol Violation|0|||
131503639|NCT00778700|473473373|FG000|Overall Study|Subject Withdrew Consent|6|||
131503640|NCT00778700|473473374|FG001|Overall Study|Subject Withdrew Consent|4|||
131503641|NCT00778700|473473375|FG002|Overall Study|Subject Withdrew Consent|1|||
131503642|NCT00778700|473473376|FG003|Overall Study|Subject Withdrew Consent|4|||
131503643|NCT00778700|473473373|FG000|Overall Study|Lost to Follow-up|3|||
131503644|NCT00778700|473473374|FG001|Overall Study|Lost to Follow-up|1|||
131503645|NCT00778700|473473375|FG002|Overall Study|Lost to Follow-up|0|||
131503646|NCT00778700|473473376|FG003|Overall Study|Lost to Follow-up|1|||
131503647|NCT00778700|473473373|FG000|Overall Study|Reason not Specified|2|||
131503648|NCT00778700|473473374|FG001|Overall Study|Reason not Specified|0|||
131503649|NCT00778700|473473375|FG002|Overall Study|Reason not Specified|1|||
131503650|NCT00778700|473473376|FG003|Overall Study|Reason not Specified|3|||
131503651|NCT00778700|473473373|FG000|Overall Study|Other|0|||
131503652|NCT00778700|473473374|FG001|Overall Study|Other|0|||
131503653|NCT00778700|473473375|FG002|Overall Study|Other|1|||
131503654|NCT00778700|473473376|FG003|Overall Study|Other|0|||
131503655|NCT02268864|473473384|FG000|Overall Study|Withdrawal by Subject|2|||
131503656|NCT02268864|473473385|FG001|Overall Study|Withdrawal by Subject|0|||
131503657|NCT02268864|473473386|FG002|Overall Study|Withdrawal by Subject|0|||
131503658|NCT02268864|473473384|FG000|Overall Study|Death|0|||
131503659|NCT02268864|473473385|FG001|Overall Study|Death|1|||
131503660|NCT02268864|473473386|FG002|Overall Study|Death|0|||
131503661|NCT05407675|473473387|FG000|Overall Study|Withdrawal by Subject|0|||
131503662|NCT05407675|473473388|FG001|Overall Study|Withdrawal by Subject|2|||
131503663|NCT05407675|473473389|FG002|Overall Study|Withdrawal by Subject|3|||
131503664|NCT05407675|473473390|FG003|Overall Study|Withdrawal by Subject|5|||
131503665|NCT05407675|473473391|FG004|Overall Study|Withdrawal by Subject|0|||
131503666|NCT05407675|473473392|FG005|Overall Study|Withdrawal by Subject|2|||
131503667|NCT05407675|473473393|FG006|Overall Study|Withdrawal by Subject|0|||
131503668|NCT05407675|473473394|FG007|Overall Study|Withdrawal by Subject|0|||
131503669|NCT05407675|473473395|FG008|Overall Study|Withdrawal by Subject|2|||
131503670|NCT05407675|473473396|FG009|Overall Study|Withdrawal by Subject|0|||
131503671|NCT05407675|473473397|FG010|Overall Study|Withdrawal by Subject|1|||
131503672|NCT05407675|473473398|FG011|Overall Study|Withdrawal by Subject|0|||
131503673|NCT05407675|473473399|FG012|Overall Study|Withdrawal by Subject|0|||
131503674|NCT05407675|473473387|FG000|Overall Study|Site terminated by sponsor|0|||
131503675|NCT05407675|473473388|FG001|Overall Study|Site terminated by sponsor|0|||
131503676|NCT05407675|473473389|FG002|Overall Study|Site terminated by sponsor|1|||
131503677|NCT05407675|473473390|FG003|Overall Study|Site terminated by sponsor|0|||
131503678|NCT05407675|473473391|FG004|Overall Study|Site terminated by sponsor|2|||
131503679|NCT05407675|473473392|FG005|Overall Study|Site terminated by sponsor|0|||
131503680|NCT05407675|473473393|FG006|Overall Study|Site terminated by sponsor|1|||
131503681|NCT05407675|473473394|FG007|Overall Study|Site terminated by sponsor|0|||
131503682|NCT05407675|473473395|FG008|Overall Study|Site terminated by sponsor|0|||
131503683|NCT05407675|473473396|FG009|Overall Study|Site terminated by sponsor|2|||
131503684|NCT05407675|473473397|FG010|Overall Study|Site terminated by sponsor|2|||
131503685|NCT05407675|473473398|FG011|Overall Study|Site terminated by sponsor|2|||
131503686|NCT05407675|473473399|FG012|Overall Study|Site terminated by sponsor|1|||
131503687|NCT05407675|473473387|FG000|Overall Study|Disease Progression|0|||
131503688|NCT05407675|473473388|FG001|Overall Study|Disease Progression|0|||
131503689|NCT05407675|473473389|FG002|Overall Study|Disease Progression|0|||
131503690|NCT05407675|473473390|FG003|Overall Study|Disease Progression|0|||
131503691|NCT05407675|473473391|FG004|Overall Study|Disease Progression|0|||
131503692|NCT05407675|473473392|FG005|Overall Study|Disease Progression|0|||
131503693|NCT05407675|473473393|FG006|Overall Study|Disease Progression|0|||
131503694|NCT05407675|473473394|FG007|Overall Study|Disease Progression|0|||
131503695|NCT05407675|473473395|FG008|Overall Study|Disease Progression|0|||
131503696|NCT05407675|473473396|FG009|Overall Study|Disease Progression|0|||
131503697|NCT05407675|473473397|FG010|Overall Study|Disease Progression|1|||
131503698|NCT05407675|473473398|FG011|Overall Study|Disease Progression|0|||
131503699|NCT05407675|473473399|FG012|Overall Study|Disease Progression|0|||
131503700|NCT05407675|473473387|FG000|Overall Study|Physician Decision|0|||
131503701|NCT05407675|473473388|FG001|Overall Study|Physician Decision|0|||
131503702|NCT05407675|473473389|FG002|Overall Study|Physician Decision|0|||
131503703|NCT05407675|473473390|FG003|Overall Study|Physician Decision|0|||
131503704|NCT05407675|473473391|FG004|Overall Study|Physician Decision|0|||
131503705|NCT05407675|473473392|FG005|Overall Study|Physician Decision|0|||
131503706|NCT05407675|473473393|FG006|Overall Study|Physician Decision|0|||
131503707|NCT05407675|473473394|FG007|Overall Study|Physician Decision|0|||
131503708|NCT05407675|473473395|FG008|Overall Study|Physician Decision|0|||
131503709|NCT05407675|473473396|FG009|Overall Study|Physician Decision|0|||
131503710|NCT05407675|473473397|FG010|Overall Study|Physician Decision|1|||
131503711|NCT05407675|473473398|FG011|Overall Study|Physician Decision|0|||
131503712|NCT05407675|473473399|FG012|Overall Study|Physician Decision|0|||
131503713|NCT05407675|473473387|FG000|Overall Study|Other reasons|0|||
131503714|NCT05407675|473473388|FG001|Overall Study|Other reasons|0|||
131503715|NCT05407675|473473389|FG002|Overall Study|Other reasons|0|||
131503716|NCT05407675|473473390|FG003|Overall Study|Other reasons|0|||
131503717|NCT05407675|473473391|FG004|Overall Study|Other reasons|0|||
131503718|NCT05407675|473473392|FG005|Overall Study|Other reasons|0|||
131503719|NCT05407675|473473393|FG006|Overall Study|Other reasons|0|||
131503720|NCT05407675|473473394|FG007|Overall Study|Other reasons|0|||
131503721|NCT05407675|473473395|FG008|Overall Study|Other reasons|1|||
131503722|NCT05407675|473473396|FG009|Overall Study|Other reasons|1|||
131503723|NCT05407675|473473397|FG010|Overall Study|Other reasons|1|||
131503724|NCT05407675|473473398|FG011|Overall Study|Other reasons|1|||
131503725|NCT05407675|473473399|FG012|Overall Study|Other reasons|0|||
131503726|NCT05407675|473473387|FG000|Overall Study|Death|3|||
131503727|NCT05407675|473473388|FG001|Overall Study|Death|4|||
131503728|NCT05407675|473473389|FG002|Overall Study|Death|3|||
131503729|NCT05407675|473473390|FG003|Overall Study|Death|6|||
131503730|NCT05407675|473473391|FG004|Overall Study|Death|0|||
131503731|NCT05407675|473473392|FG005|Overall Study|Death|2|||
131503732|NCT05407675|473473393|FG006|Overall Study|Death|4|||
131503733|NCT05407675|473473394|FG007|Overall Study|Death|2|||
131503734|NCT05407675|473473395|FG008|Overall Study|Death|2|||
131503735|NCT05407675|473473396|FG009|Overall Study|Death|4|||
131503736|NCT05407675|473473397|FG010|Overall Study|Death|2|||
131503737|NCT05407675|473473398|FG011|Overall Study|Death|1|||
131503738|NCT05407675|473473399|FG012|Overall Study|Death|0|||
131503739|NCT05407675|473473387|FG000|Overall Study|Adverse Event|0|||
131503740|NCT05407675|473473388|FG001|Overall Study|Adverse Event|0|||
131503741|NCT05407675|473473389|FG002|Overall Study|Adverse Event|0|||
131503742|NCT05407675|473473390|FG003|Overall Study|Adverse Event|0|||
131503743|NCT05407675|473473391|FG004|Overall Study|Adverse Event|1|||
131503744|NCT05407675|473473392|FG005|Overall Study|Adverse Event|0|||
131503745|NCT05407675|473473393|FG006|Overall Study|Adverse Event|0|||
131503746|NCT05407675|473473394|FG007|Overall Study|Adverse Event|0|||
131503747|NCT05407675|473473395|FG008|Overall Study|Adverse Event|0|||
131503748|NCT05407675|473473396|FG009|Overall Study|Adverse Event|0|||
131503749|NCT05407675|473473397|FG010|Overall Study|Adverse Event|0|||
131503750|NCT05407675|473473398|FG011|Overall Study|Adverse Event|1|||
131503751|NCT05407675|473473399|FG012|Overall Study|Adverse Event|0|||
131503752|NCT05407675|473473387|FG000|Overall Study|Ongoing Treatment|0|||
131503753|NCT05407675|473473388|FG001|Overall Study|Ongoing Treatment|0|||
131503754|NCT05407675|473473389|FG002|Overall Study|Ongoing Treatment|0|||
131503755|NCT05407675|473473390|FG003|Overall Study|Ongoing Treatment|0|||
131503756|NCT05407675|473473391|FG004|Overall Study|Ongoing Treatment|0|||
131503757|NCT05407675|473473392|FG005|Overall Study|Ongoing Treatment|0|||
131503758|NCT05407675|473473393|FG006|Overall Study|Ongoing Treatment|0|||
131503759|NCT05407675|473473394|FG007|Overall Study|Ongoing Treatment|0|||
131503760|NCT05407675|473473395|FG008|Overall Study|Ongoing Treatment|1|||
131503761|NCT05407675|473473396|FG009|Overall Study|Ongoing Treatment|0|||
131503762|NCT05407675|473473397|FG010|Overall Study|Ongoing Treatment|0|||
131503763|NCT05407675|473473398|FG011|Overall Study|Ongoing Treatment|0|||
131503764|NCT05407675|473473399|FG012|Overall Study|Ongoing Treatment|0|||
131503765|NCT00857220|473473400|FG000|Overall Study|Adverse Event|35|||
131503766|NCT00857220|473473400|FG000|Overall Study|Death|1|||
131503767|NCT00857220|473473400|FG000|Overall Study|Lack of Efficacy|11|||
131503768|NCT00857220|473473400|FG000|Overall Study|Lost to Follow-up|30|||
131503769|NCT00857220|473473400|FG000|Overall Study|Physician Decision|4|||
131503770|NCT00857220|473473400|FG000|Overall Study|Protocol Violation|16|||
131503771|NCT00857220|473473400|FG000|Overall Study|Withdrawal by Subject|67|||
131503772|NCT00857220|473473400|FG000|Overall Study|Clinical Hold|6|||
131503773|NCT00857220|473473400|FG000|Overall Study|Site Closed|5|||
131503774|NCT00857220|473473400|FG000|Overall Study|Miscellaneous|8|||
131503775|NCT03698994|473473401|FG000|Overall Study|Adverse Event|2|||
131503776|NCT03698994|473473401|FG000|Overall Study|Death|1|||
131503777|NCT03698994|473473401|FG000|Overall Study|Physician Decision|1|||
131503778|NCT03698994|473473401|FG000|Overall Study|Withdrawal by Subject|3|||
131503779|NCT03698994|473473401|FG000|Overall Study|Progressive Disease|12|||
131503780|NCT02375113|473473404|FG000|Overall Study|Undisclosed Reason(s).|1|||
131503781|NCT02375113|473473405|FG001|Overall Study|Undisclosed Reason(s).|1|||
131503782|NCT02375113|473473404|FG000|Overall Study|Poor adherence (<70%).|1|||
131503783|NCT02375113|473473405|FG001|Overall Study|Poor adherence (<70%).|0|||
131503784|NCT02375113|473473404|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
131503785|NCT02375113|473473405|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
131503786|NCT04387435|473473411|FG000|Overall Study|Physician Decision|1|||
131503787|NCT03855280|473473412|FG000|Treatment Phase|Adverse Event|1|||
131503788|NCT03855280|473473412|FG000|Treatment Phase|Withdrawal by Subject|1|||
131503789|NCT03855280|473473412|FG000|Continuation Phase|Protocol Violation|1|||
131503790|NCT03855280|473473412|FG000|Continuation Phase|Adverse Event|1|||
131503791|NCT03855280|473473412|FG000|Continuation Phase|Sponsor Concluded Study|1|||
131503792|NCT03338855|473473415|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
131503793|NCT03338855|473473416|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
131503794|NCT00511667|473473417|FG000|Overall Study|Adverse Event|1|||
131503795|NCT00511667|473473418|FG001|Overall Study|Adverse Event|0|||
131503796|NCT00511667|473473417|FG000|Overall Study|Protocol Violation|1|||
131503797|NCT00511667|473473418|FG001|Overall Study|Protocol Violation|1|||
131503798|NCT00511667|473473417|FG000|Overall Study|Withdrawal by Subject|2|||
131503799|NCT00511667|473473418|FG001|Overall Study|Withdrawal by Subject|0|||
131503800|NCT00511667|473473417|FG000|Overall Study|Site terminated|6|||
131503801|NCT00511667|473473418|FG001|Overall Study|Site terminated|1|||
131503802|NCT00511667|473473417|FG000|Overall Study|Other|2|||
131503803|NCT00511667|473473418|FG001|Overall Study|Other|1|||
131503804|NCT02226003|473473419|FG000|Overall Study|Lost to Follow-up|2|||
131503805|NCT02226003|473473420|FG001|Overall Study|Lost to Follow-up|1|||
131503806|NCT02226003|473473421|FG002|Overall Study|Lost to Follow-up|3|||
131503807|NCT02226003|473473419|FG000|Overall Study|Withdrawal by Subject|0|||
131503808|NCT02226003|473473420|FG001|Overall Study|Withdrawal by Subject|0|||
131503809|NCT02226003|473473421|FG002|Overall Study|Withdrawal by Subject|3|||
131503810|NCT01499563|473473424|FG000|Overall Study|Withdrawal by Subject|10|||
131503811|NCT01499563|473473425|FG001|Overall Study|Withdrawal by Subject|11|||
131503812|NCT01499563|473473426|FG002|Overall Study|Withdrawal by Subject|7|||
131503813|NCT01499563|473473427|FG003|Overall Study|Withdrawal by Subject|8|||
131503814|NCT01499563|473473424|FG000|Overall Study|Physician Decision|2|||
131503815|NCT01499563|473473425|FG001|Overall Study|Physician Decision|1|||
131503816|NCT01499563|473473426|FG002|Overall Study|Physician Decision|3|||
131503817|NCT01499563|473473427|FG003|Overall Study|Physician Decision|0|||
131503818|NCT01499563|473473424|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
131503819|NCT01499563|473473425|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
131503820|NCT01499563|473473426|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
131503821|NCT01499563|473473427|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
131503822|NCT01499563|473473424|FG000|Overall Study|Adverse Event|2|||
131503823|NCT01499563|473473425|FG001|Overall Study|Adverse Event|0|||
131503824|NCT01499563|473473426|FG002|Overall Study|Adverse Event|1|||
131503825|NCT01499563|473473427|FG003|Overall Study|Adverse Event|3|||
131503826|NCT01499563|473473424|FG000|Overall Study|Lack of Efficacy|0|||
131503827|NCT01499563|473473425|FG001|Overall Study|Lack of Efficacy|1|||
131503828|NCT01499563|473473426|FG002|Overall Study|Lack of Efficacy|6|||
131503829|NCT01499563|473473427|FG003|Overall Study|Lack of Efficacy|3|||
131503830|NCT01499563|473473424|FG000|Overall Study|Other|8|||
131503831|NCT01499563|473473425|FG001|Overall Study|Other|6|||
131503832|NCT01499563|473473426|FG002|Overall Study|Other|6|||
131503833|NCT01499563|473473427|FG003|Overall Study|Other|4|||
131503834|NCT00597012|473473432|FG000|Overall Study|Death|1|||
131503835|NCT00597012|473473433|FG001|Overall Study|Death|1|||
131503836|NCT00597012|473473432|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
131503837|NCT00597012|473473433|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
131503838|NCT00597012|473473432|FG000|Overall Study|Withdrawal by Subject|7|||
131503839|NCT00597012|473473433|FG001|Overall Study|Withdrawal by Subject|4|||
131503840|NCT00597012|473473432|FG000|Overall Study|Ineligible|2|||
131503841|NCT00597012|473473433|FG001|Overall Study|Ineligible|0|||
131503842|NCT00597012|473473432|FG000|Overall Study|Lost to Follow-up|0|||
131503843|NCT00597012|473473433|FG001|Overall Study|Lost to Follow-up|2|||
131503844|NCT00410761|473474857|FG000|Randomized Treatment Period|Adverse Event|34|||
131503845|NCT00410761|473474858|FG001|Randomized Treatment Period|Adverse Event|3|||
131503846|NCT00410761|473474857|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
131503847|NCT00410761|473474858|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
131503848|NCT00410761|473474857|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
131503849|NCT00410761|473474858|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
131503850|NCT00410761|473474857|FG000|Randomized Treatment Period|Other|69|||
131503851|NCT00410761|473474858|FG001|Randomized Treatment Period|Other|21|||
131503852|NCT00410761|473474857|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
131503853|NCT00410761|473474858|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
131503854|NCT00410761|473474857|FG000|Open-Label Treatment Period|Adverse Event|13|||
131503855|NCT00410761|473474858|FG001|Open-Label Treatment Period|Adverse Event|15|||
131503856|NCT00410761|473474857|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
131503857|NCT00410761|473474858|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
131503858|NCT00410761|473474857|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
131503859|NCT00410761|473474858|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
131503860|NCT00410761|473474857|FG000|Open-Label Treatment Period|Other|18|||
131503861|NCT00410761|473474858|FG001|Open-Label Treatment Period|Other|9|||
131503862|NCT02926924|473474860|FG000|Overall Study|withdrawal - reason unknown|0|||
131503863|NCT02926924|473474861|FG001|Overall Study|withdrawal - reason unknown|1|||
131503864|NCT04568590|473474864|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
131503865|NCT03724812|473474869|FG000|Overall Study|Missed Visit|1|||
131503866|NCT03724812|473474869|FG000|Overall Study|Death|2|||
131503867|NCT03724812|473474869|FG000|Overall Study|Withdrawal by Subject|1|||
131503868|NCT01770379|473474870|FG000|Overall Study|Technical issues|1|||
131503869|NCT01770379|473474871|FG001|Overall Study|Technical issues|0|||
131503870|NCT01770379|473474872|FG002|Overall Study|Technical issues|0|||
131503871|NCT01770379|473474870|FG000|Overall Study|Withdrawal by Subject|7|||
131503872|NCT01770379|473474871|FG001|Overall Study|Withdrawal by Subject|10|||
131503873|NCT01770379|473474872|FG002|Overall Study|Withdrawal by Subject|7|||
131503874|NCT01770379|473474870|FG000|Overall Study|study terminated by sponsor|22|||
131503875|NCT01770379|473474871|FG001|Overall Study|study terminated by sponsor|23|||
131503876|NCT01770379|473474872|FG002|Overall Study|study terminated by sponsor|22|||
131503877|NCT01770379|473474870|FG000|Overall Study|Protocol Violation|0|||
131503878|NCT01770379|473474871|FG001|Overall Study|Protocol Violation|1|||
131503879|NCT01770379|473474872|FG002|Overall Study|Protocol Violation|1|||
131503880|NCT01770379|473474870|FG000|Overall Study|Physician Decision|0|||
131503881|NCT01770379|473474871|FG001|Overall Study|Physician Decision|1|||
131503882|NCT01770379|473474872|FG002|Overall Study|Physician Decision|2|||
131503883|NCT01770379|473474870|FG000|Overall Study|Lost to Follow-up|0|||
131503884|NCT01770379|473474871|FG001|Overall Study|Lost to Follow-up|0|||
131503885|NCT01770379|473474872|FG002|Overall Study|Lost to Follow-up|2|||
131503886|NCT01770379|473474870|FG000|Overall Study|Lack of Efficacy|8|||
131503887|NCT01770379|473474871|FG001|Overall Study|Lack of Efficacy|6|||
131503888|NCT01770379|473474872|FG002|Overall Study|Lack of Efficacy|6|||
131503889|NCT01770379|473474870|FG000|Overall Study|Adverse Event|1|||
131503890|NCT01770379|473474871|FG001|Overall Study|Adverse Event|3|||
131503891|NCT01770379|473474872|FG002|Overall Study|Adverse Event|2|||
131503892|NCT03045887|473474873|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
131503893|NCT03045887|473474874|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503894|NCT03045887|473474875|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503895|NCT03045887|473474876|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503896|NCT03045887|473474877|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503897|NCT03045887|473474878|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503898|NCT03045887|473474879|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503899|NCT03045887|473474880|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503900|NCT03045887|473474881|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503901|NCT03045887|473474882|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
131503902|NCT03045887|473474873|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503903|NCT03045887|473474874|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503904|NCT03045887|473474875|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503905|NCT03045887|473474876|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
131503906|NCT03045887|473474877|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503907|NCT03045887|473474878|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503908|NCT03045887|473474879|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503909|NCT03045887|473474880|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503910|NCT03045887|473474881|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503911|NCT03045887|473474882|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
131503912|NCT03045887|473474873|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
131503913|NCT03045887|473474874|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503914|NCT03045887|473474875|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503915|NCT03045887|473474876|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503916|NCT03045887|473474877|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503917|NCT03045887|473474878|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503918|NCT03045887|473474879|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503919|NCT03045887|473474880|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503920|NCT03045887|473474881|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503921|NCT03045887|473474882|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
131503922|NCT03045887|473474873|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503923|NCT03045887|473474874|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503924|NCT03045887|473474875|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
131503925|NCT03045887|473474876|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
131503926|NCT03045887|473474877|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503927|NCT03045887|473474878|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503928|NCT03045887|473474879|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503929|NCT03045887|473474880|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503930|NCT03045887|473474881|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503931|NCT03045887|473474882|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
131503932|NCT03045887|473474873|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503933|NCT03045887|473474874|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503934|NCT03045887|473474875|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503935|NCT03045887|473474876|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
131503936|NCT03045887|473474877|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503937|NCT03045887|473474878|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503938|NCT03045887|473474879|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503939|NCT03045887|473474880|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503940|NCT03045887|473474881|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503941|NCT03045887|473474882|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131503942|NCT01912287|473474883|FG000|Overall Study|Ineligible|1|||
131503943|NCT01912287|473474884|FG001|Overall Study|Ineligible|0|||
131503944|NCT01912287|473474885|FG002|Overall Study|Ineligible|1|||
131503945|NCT01912287|473474883|FG000|Overall Study|No-show|0|||
131503946|NCT01912287|473474884|FG001|Overall Study|No-show|0|||
131503947|NCT01912287|473474885|FG002|Overall Study|No-show|1|||
131503948|NCT01912287|473474883|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
131503949|NCT01912287|473474884|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
131503950|NCT01912287|473474885|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
131503951|NCT01912287|473474883|FG000|Overall Study|Felt treatment no longer needed|0|||
131503952|NCT01912287|473474884|FG001|Overall Study|Felt treatment no longer needed|1|||
131503953|NCT01912287|473474885|FG002|Overall Study|Felt treatment no longer needed|0|||
131503954|NCT01912287|473474883|FG000|Overall Study|Life circumstances|4|||
131503955|NCT01912287|473474884|FG001|Overall Study|Life circumstances|2|||
131503956|NCT01912287|473474885|FG002|Overall Study|Life circumstances|0|||
131503957|NCT01912287|473474883|FG000|Overall Study|Lost Interest|1|||
131503958|NCT01912287|473474884|FG001|Overall Study|Lost Interest|0|||
131503959|NCT01912287|473474885|FG002|Overall Study|Lost Interest|0|||
131503960|NCT01912287|473474883|FG000|Overall Study|Uknown reason - subject drop out|5|||
131503961|NCT01912287|473474884|FG001|Overall Study|Uknown reason - subject drop out|7|||
131503962|NCT01912287|473474885|FG002|Overall Study|Uknown reason - subject drop out|3|||
131503963|NCT01912287|473474883|FG000|Overall Study|Missed Assesment|1|||
131503964|NCT01912287|473474884|FG001|Overall Study|Missed Assesment|1|||
131503965|NCT01912287|473474885|FG002|Overall Study|Missed Assesment|1|||
131503966|NCT01912287|473474883|FG000|Overall Study|Scheduling/change in availability|17|||
131503967|NCT01912287|473474884|FG001|Overall Study|Scheduling/change in availability|10|||
131503968|NCT01912287|473474885|FG002|Overall Study|Scheduling/change in availability|8|||
131503969|NCT03914326|473474888|FG000|Overall Study|Withdrawal by Subject|27|||
131503970|NCT03914326|473474889|FG001|Overall Study|Withdrawal by Subject|34|||
131503971|NCT03914326|473474888|FG000|Overall Study|Lost to Follow-up|43|||
131503972|NCT03914326|473474889|FG001|Overall Study|Lost to Follow-up|51|||
131503973|NCT03914326|473474888|FG000|Overall Study|Randomised more than once|0|||
131503974|NCT03914326|473474889|FG001|Overall Study|Randomised more than once|1|||
131503975|NCT02024867|473474891|FG000|Overall Study|Protocol Violation|3|||
131503976|NCT02024867|473474892|FG001|Overall Study|Protocol Violation|3|||
131503977|NCT02024867|473474891|FG000|Overall Study|Lost to Follow-up|6|||
131503978|NCT02024867|473474892|FG001|Overall Study|Lost to Follow-up|4|||
131503979|NCT02278263|473474896|FG000|Overall Study|Protocol Violation|7|||
131503980|NCT02278263|473474897|FG001|Overall Study|Protocol Violation|0|||
131503981|NCT02278263|473474898|FG002|Overall Study|Protocol Violation|9|||
131503982|NCT03164928|473474899|FG000|Overall Study|Lost to Follow-up|1|||
131503983|NCT03164928|473474900|FG001|Overall Study|Lost to Follow-up|0|||
131503984|NCT03251079|473474901|FG000|Overall Study|Withdrawal by Subject|1|||
131503985|NCT00455429|473474902|FG000|Overall Study|Study Terminated by Sponsor|0|||
131503986|NCT00455429|473474903|FG001|Overall Study|Study Terminated by Sponsor|0|||
131503987|NCT00455429|473474904|FG002|Overall Study|Study Terminated by Sponsor|0|||
131503988|NCT00455429|473474905|FG003|Overall Study|Study Terminated by Sponsor|3|||
131503989|NCT00455429|473474902|FG000|Overall Study|Lost to Follow-up|1|||
131503990|NCT00455429|473474903|FG001|Overall Study|Lost to Follow-up|0|||
131503991|NCT00455429|473474904|FG002|Overall Study|Lost to Follow-up|0|||
131503992|NCT00455429|473474905|FG003|Overall Study|Lost to Follow-up|3|||
131503993|NCT00455429|473474902|FG000|Overall Study|Withdrawal by Subject|0|||
131503994|NCT00455429|473474903|FG001|Overall Study|Withdrawal by Subject|1|||
131503995|NCT00455429|473474904|FG002|Overall Study|Withdrawal by Subject|1|||
131503996|NCT00455429|473474905|FG003|Overall Study|Withdrawal by Subject|0|||
131503997|NCT00455429|473474902|FG000|Overall Study|Lack of Efficacy|0|||
131503998|NCT00455429|473474903|FG001|Overall Study|Lack of Efficacy|1|||
131503999|NCT00455429|473474904|FG002|Overall Study|Lack of Efficacy|0|||
131504000|NCT00455429|473474905|FG003|Overall Study|Lack of Efficacy|1|||
131504001|NCT00455429|473474902|FG000|Overall Study|Adverse Event|0|||
131504002|NCT00455429|473474903|FG001|Overall Study|Adverse Event|1|||
131504003|NCT00455429|473474904|FG002|Overall Study|Adverse Event|0|||
131504004|NCT00455429|473474905|FG003|Overall Study|Adverse Event|3|||
131504005|NCT00455429|473474902|FG000|Overall Study|Randomly assigned but not treated|0|||
131504006|NCT00455429|473474903|FG001|Overall Study|Randomly assigned but not treated|0|||
131504007|NCT00455429|473474904|FG002|Overall Study|Randomly assigned but not treated|0|||
131504008|NCT00455429|473474905|FG003|Overall Study|Randomly assigned but not treated|2|||
131504009|NCT00455429|473474902|FG000|Overall Study|Personal Reason|1|||
131504010|NCT00455429|473474903|FG001|Overall Study|Personal Reason|0|||
131504011|NCT00455429|473474904|FG002|Overall Study|Personal Reason|0|||
131504012|NCT00455429|473474905|FG003|Overall Study|Personal Reason|0|||
131504013|NCT00455429|473474902|FG000|Overall Study|Non-compliance|0|||
131504014|NCT00455429|473474903|FG001|Overall Study|Non-compliance|0|||
131504015|NCT00455429|473474904|FG002|Overall Study|Non-compliance|0|||
131504016|NCT00455429|473474905|FG003|Overall Study|Non-compliance|1|||
131504017|NCT00455429|473474902|FG000|Overall Study|Other|0|||
131504018|NCT00455429|473474903|FG001|Overall Study|Other|2|||
131504019|NCT00455429|473474904|FG002|Overall Study|Other|0|||
131504020|NCT00455429|473474905|FG003|Overall Study|Other|1|||
131504021|NCT01165554|473474912|FG000|Overall Study|Withdrawal by Subject|23|||
131504022|NCT02951156|473474913|FG000|Overall Study|Death|3|||
131504023|NCT02951156|473474914|FG001|Overall Study|Death|8|||
131504024|NCT02951156|473474915|FG002|Overall Study|Death|5|||
131504025|NCT02951156|473474913|FG000|Overall Study|Progressive disease|1|||
131504026|NCT02951156|473474914|FG001|Overall Study|Progressive disease|0|||
131504027|NCT02951156|473474915|FG002|Overall Study|Progressive disease|1|||
131504028|NCT02951156|473474913|FG000|Overall Study|Withdrawal by Subject|0|||
131504029|NCT02951156|473474914|FG001|Overall Study|Withdrawal by Subject|0|||
131504030|NCT02951156|473474915|FG002|Overall Study|Withdrawal by Subject|1|||
131504031|NCT02951156|473474913|FG000|Overall Study|Study terminated by sponsor|0|||
131504032|NCT02951156|473474914|FG001|Overall Study|Study terminated by sponsor|0|||
131504033|NCT02951156|473474915|FG002|Overall Study|Study terminated by sponsor|1|||
131504034|NCT02951156|473474913|FG000|Overall Study|Other|5|||
131504035|NCT02951156|473474914|FG001|Overall Study|Other|1|||
131504036|NCT02951156|473474915|FG002|Overall Study|Other|2|||
131504037|NCT04351087|473474916|FG000|Overall Study|Lost to Follow-up|7|||
131504038|NCT04351087|473474917|FG001|Overall Study|Lost to Follow-up|3|||
131504039|NCT04351087|473474916|FG000|Overall Study|Withdrawal by Subject|3|||
131504040|NCT04351087|473474917|FG001|Overall Study|Withdrawal by Subject|4|||
131504041|NCT04351087|473474916|FG000|Overall Study|Lack of Efficacy|3|||
131504042|NCT04351087|473474917|FG001|Overall Study|Lack of Efficacy|2|||
131504043|NCT01603459|473474920|FG000|Overall Study|Adverse Event|5|||
131504044|NCT01603459|473474920|FG000|Overall Study|Withdrawal by Subject|5|||
131504045|NCT01603459|473474920|FG000|Overall Study|Lost to Follow-up|3|||
131504046|NCT01603459|473474920|FG000|Overall Study|Predefined discontinuation criteria|3|||
131504047|NCT01603459|473474920|FG000|Overall Study|Non-compliance|1|||
131504048|NCT01603459|473474920|FG000|Overall Study|Administrative reason|1|||
131504049|NCT02335099|473474923|FG000|Treatment|Withdrawal by Subject|1|||
131504050|NCT02335099|473474924|FG001|Treatment|Withdrawal by Subject|3|||
131504051|NCT02335099|473474923|FG000|Treatment|Lost to Follow-up|2|||
131504052|NCT02335099|473474924|FG001|Treatment|Lost to Follow-up|0|||
131504053|NCT02335099|473474923|FG000|Treatment|Death|1|||
131504054|NCT02335099|473474924|FG001|Treatment|Death|0|||
131504055|NCT02335099|473474923|FG000|Treatment|Adverse Event|1|||
131504056|NCT02335099|473474924|FG001|Treatment|Adverse Event|2|||
131504057|NCT02335099|473474923|FG000|Follow-up|Death|0|||
131504058|NCT02335099|473474924|FG001|Follow-up|Death|1|||
131504059|NCT03519347|473474925|FG000|Interventional Crossover Period 1|Death|0|||
131504060|NCT03519347|473474926|FG001|Interventional Crossover Period 1|Death|0|||
131504061|NCT03519347|473474927|FG002|Interventional Crossover Period 1|Death|0|||
131504062|NCT03519347|473474928|FG003|Interventional Crossover Period 1|Death|1|||
131504063|NCT05517382|473474929|FG000|Overall Study|Lost to Follow-up|0|||
131504064|NCT05517382|473474930|FG001|Overall Study|Lost to Follow-up|1|||
131504065|NCT01641692|473474931|FG000|Treatment Period 1|Adverse Event|1|||
131504066|NCT01641692|473474932|FG001|Treatment Period 1|Adverse Event|0|||
131504067|NCT01641692|473474933|FG002|Treatment Period 1|Adverse Event|0|||
131504068|NCT01641692|473474934|FG003|Treatment Period 1|Adverse Event|0|||
131504069|NCT01641692|473474935|FG004|Treatment Period 1|Adverse Event|0|||
131504070|NCT01641692|473474936|FG005|Treatment Period 1|Adverse Event|0|||
131504071|NCT01641692|473474937|FG006|Treatment Period 1|Adverse Event|0|||
131504072|NCT01641692|473474938|FG007|Treatment Period 1|Adverse Event|0|||
131504073|NCT01641692|473474931|FG000|Treatment Period 1|Lack of Efficacy|0|||
131504074|NCT01641692|473474932|FG001|Treatment Period 1|Lack of Efficacy|0|||
131504075|NCT01641692|473474933|FG002|Treatment Period 1|Lack of Efficacy|0|||
131504076|NCT01641692|473474934|FG003|Treatment Period 1|Lack of Efficacy|0|||
131504077|NCT01641692|473474935|FG004|Treatment Period 1|Lack of Efficacy|0|||
131504078|NCT01641692|473474936|FG005|Treatment Period 1|Lack of Efficacy|0|||
131504079|NCT01641692|473474937|FG006|Treatment Period 1|Lack of Efficacy|0|||
131504080|NCT01641692|473474938|FG007|Treatment Period 1|Lack of Efficacy|1|||
131504081|NCT01641692|473474931|FG000|Treatment Period 1|Protocol Violation|1|||
131504082|NCT01641692|473474932|FG001|Treatment Period 1|Protocol Violation|0|||
131504083|NCT01641692|473474933|FG002|Treatment Period 1|Protocol Violation|0|||
131504084|NCT01641692|473474934|FG003|Treatment Period 1|Protocol Violation|0|||
131504085|NCT01641692|473474935|FG004|Treatment Period 1|Protocol Violation|2|||
131504086|NCT01641692|473474936|FG005|Treatment Period 1|Protocol Violation|0|||
131504087|NCT01641692|473474937|FG006|Treatment Period 1|Protocol Violation|0|||
131504088|NCT01641692|473474938|FG007|Treatment Period 1|Protocol Violation|0|||
131504089|NCT01641692|473474931|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
131504090|NCT01641692|473474932|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
131504091|NCT01641692|473474933|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
131504092|NCT01641692|473474934|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
131504093|NCT01641692|473474935|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
131504094|NCT01641692|473474936|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
131504095|NCT01641692|473474937|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
131504096|NCT01641692|473474938|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
131504097|NCT01641692|473474931|FG000|Treatment Period 1|Lost to Follow-up|0|||
131504098|NCT01641692|473474932|FG001|Treatment Period 1|Lost to Follow-up|0|||
131504099|NCT01641692|473474933|FG002|Treatment Period 1|Lost to Follow-up|1|||
131504100|NCT01641692|473474934|FG003|Treatment Period 1|Lost to Follow-up|0|||
131504101|NCT01641692|473474935|FG004|Treatment Period 1|Lost to Follow-up|0|||
131504102|NCT01641692|473474936|FG005|Treatment Period 1|Lost to Follow-up|0|||
131504103|NCT01641692|473474937|FG006|Treatment Period 1|Lost to Follow-up|0|||
131504104|NCT01641692|473474938|FG007|Treatment Period 1|Lost to Follow-up|0|||
131504105|NCT01641692|473474931|FG000|Treatment Period 1|Physician Decision|0|||
131504106|NCT01641692|473474932|FG001|Treatment Period 1|Physician Decision|0|||
131504107|NCT01641692|473474933|FG002|Treatment Period 1|Physician Decision|0|||
131504108|NCT01641692|473474934|FG003|Treatment Period 1|Physician Decision|0|||
131504109|NCT01641692|473474935|FG004|Treatment Period 1|Physician Decision|1|||
131504110|NCT01641692|473474936|FG005|Treatment Period 1|Physician Decision|0|||
131504111|NCT01641692|473474937|FG006|Treatment Period 1|Physician Decision|0|||
131504112|NCT01641692|473474938|FG007|Treatment Period 1|Physician Decision|0|||
131504113|NCT01641692|473474931|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131504114|NCT01641692|473474932|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131504115|NCT01641692|473474933|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131504116|NCT01641692|473474934|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131504117|NCT01641692|473474935|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131504118|NCT01641692|473474936|FG005|Treatment Period 1|Withdrawal by Subject|2|||
131504119|NCT01641692|473474937|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131504120|NCT01641692|473474938|FG007|Treatment Period 1|Withdrawal by Subject|1|||
131504121|NCT01641692|473474931|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
131504122|NCT01641692|473474932|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504123|NCT01641692|473474933|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504124|NCT01641692|473474934|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504125|NCT01641692|473474935|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504126|NCT01641692|473474936|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504127|NCT01641692|473474937|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504128|NCT01641692|473474938|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
131504129|NCT01641692|473474931|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504130|NCT01641692|473474932|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504131|NCT01641692|473474933|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504132|NCT01641692|473474934|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504133|NCT01641692|473474935|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504134|NCT01641692|473474936|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504135|NCT01641692|473474937|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
131504136|NCT01641692|473474938|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131504137|NCT01641692|473474931|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
131504138|NCT01641692|473474932|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504139|NCT01641692|473474933|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
131504140|NCT01641692|473474934|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
131504141|NCT01641692|473474935|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
131504142|NCT01641692|473474936|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504143|NCT01641692|473474937|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504144|NCT01641692|473474938|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
131504145|NCT01641692|473474931|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131504146|NCT01641692|473474932|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131504147|NCT01641692|473474933|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131504148|NCT01641692|473474934|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131504149|NCT01641692|473474935|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131504150|NCT01641692|473474936|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131504151|NCT01641692|473474937|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131504152|NCT01641692|473474938|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131504153|NCT01641692|473474931|FG000|Treatment Period 2|Lack of Efficacy|1|||
131504154|NCT01641692|473474932|FG001|Treatment Period 2|Lack of Efficacy|0|||
131504155|NCT01641692|473474933|FG002|Treatment Period 2|Lack of Efficacy|0|||
131504156|NCT01641692|473474934|FG003|Treatment Period 2|Lack of Efficacy|0|||
131504157|NCT01641692|473474935|FG004|Treatment Period 2|Lack of Efficacy|0|||
131504158|NCT01641692|473474936|FG005|Treatment Period 2|Lack of Efficacy|0|||
131504159|NCT01641692|473474937|FG006|Treatment Period 2|Lack of Efficacy|0|||
131504160|NCT01641692|473474938|FG007|Treatment Period 2|Lack of Efficacy|0|||
131504161|NCT01641692|473474931|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
131504162|NCT01641692|473474932|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504163|NCT01641692|473474933|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504164|NCT01641692|473474934|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504165|NCT01641692|473474935|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504166|NCT01641692|473474936|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504167|NCT01641692|473474937|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504168|NCT01641692|473474938|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131504169|NCT01641692|473474931|FG000|Treatment Period 2|Lost to Follow-up|0|||
131504170|NCT01641692|473474932|FG001|Treatment Period 2|Lost to Follow-up|0|||
131504171|NCT01641692|473474933|FG002|Treatment Period 2|Lost to Follow-up|0|||
131504172|NCT01641692|473474934|FG003|Treatment Period 2|Lost to Follow-up|0|||
131504173|NCT01641692|473474935|FG004|Treatment Period 2|Lost to Follow-up|0|||
131504174|NCT01641692|473474936|FG005|Treatment Period 2|Lost to Follow-up|1|||
131504175|NCT01641692|473474937|FG006|Treatment Period 2|Lost to Follow-up|0|||
131504176|NCT01641692|473474938|FG007|Treatment Period 2|Lost to Follow-up|0|||
131504177|NCT01641692|473474931|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131504178|NCT01641692|473474932|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131504179|NCT01641692|473474933|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131504180|NCT01641692|473474934|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131504181|NCT01641692|473474935|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131504182|NCT01641692|473474936|FG005|Treatment Period 2|Withdrawal by Subject|1|||
131504183|NCT01641692|473474937|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131504184|NCT01641692|473474938|FG007|Treatment Period 2|Withdrawal by Subject|1|||
131504185|NCT01641692|473474931|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504186|NCT01641692|473474932|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504187|NCT01641692|473474933|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504188|NCT01641692|473474934|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504189|NCT01641692|473474935|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
131504190|NCT01641692|473474936|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504191|NCT01641692|473474937|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
131504192|NCT01641692|473474938|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131504193|NCT01641692|473474931|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131504194|NCT01641692|473474932|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131504195|NCT01641692|473474933|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
131504196|NCT01641692|473474934|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131504197|NCT01641692|473474935|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131504198|NCT01641692|473474936|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
131504199|NCT01641692|473474937|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131504200|NCT01641692|473474938|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
131504201|NCT01641692|473474931|FG000|Treatment Period 3|Adverse Event|0|||
131504202|NCT01641692|473474932|FG001|Treatment Period 3|Adverse Event|0|||
131504203|NCT01641692|473474933|FG002|Treatment Period 3|Adverse Event|0|||
131504204|NCT01641692|473474934|FG003|Treatment Period 3|Adverse Event|0|||
131504205|NCT01641692|473474935|FG004|Treatment Period 3|Adverse Event|0|||
131504206|NCT01641692|473474936|FG005|Treatment Period 3|Adverse Event|0|||
131504207|NCT01641692|473474937|FG006|Treatment Period 3|Adverse Event|1|||
131504208|NCT01641692|473474938|FG007|Treatment Period 3|Adverse Event|0|||
131504209|NCT01641692|473474931|FG000|Treatment Period 3|Protocol Violation|0|||
131504210|NCT01641692|473474932|FG001|Treatment Period 3|Protocol Violation|0|||
131504211|NCT01641692|473474933|FG002|Treatment Period 3|Protocol Violation|1|||
131504212|NCT01641692|473474934|FG003|Treatment Period 3|Protocol Violation|0|||
131504213|NCT01641692|473474935|FG004|Treatment Period 3|Protocol Violation|0|||
131504214|NCT01641692|473474936|FG005|Treatment Period 3|Protocol Violation|0|||
131504215|NCT01641692|473474937|FG006|Treatment Period 3|Protocol Violation|0|||
131504216|NCT01641692|473474938|FG007|Treatment Period 3|Protocol Violation|0|||
131504217|NCT01641692|473474931|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504218|NCT01641692|473474932|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504219|NCT01641692|473474933|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504220|NCT01641692|473474934|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504221|NCT01641692|473474935|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504222|NCT01641692|473474936|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504223|NCT01641692|473474937|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
131504224|NCT01641692|473474938|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131504225|NCT01641692|473474931|FG000|Treatment Period 3|Lost to Follow-up|0|||
131504226|NCT01641692|473474932|FG001|Treatment Period 3|Lost to Follow-up|1|||
131504227|NCT01641692|473474933|FG002|Treatment Period 3|Lost to Follow-up|0|||
131504228|NCT01641692|473474934|FG003|Treatment Period 3|Lost to Follow-up|0|||
131504229|NCT01641692|473474935|FG004|Treatment Period 3|Lost to Follow-up|0|||
131504230|NCT01641692|473474936|FG005|Treatment Period 3|Lost to Follow-up|0|||
131504231|NCT01641692|473474937|FG006|Treatment Period 3|Lost to Follow-up|0|||
131504232|NCT01641692|473474938|FG007|Treatment Period 3|Lost to Follow-up|0|||
131504233|NCT01641692|473474931|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504234|NCT01641692|473474932|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504235|NCT01641692|473474933|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504236|NCT01641692|473474934|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504237|NCT01641692|473474935|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504238|NCT01641692|473474936|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
131504239|NCT01641692|473474937|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504240|NCT01641692|473474938|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
131504241|NCT01641692|473474931|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
131504242|NCT01641692|473474932|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
131504243|NCT01641692|473474933|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
131504244|NCT01641692|473474934|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
131504245|NCT01641692|473474935|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
131504246|NCT01641692|473474936|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
131504247|NCT01641692|473474937|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
131504248|NCT01641692|473474938|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
131504249|NCT00484939|473474945|FG000|Overall Study|Death|9|||
131504250|NCT00484939|473474946|FG001|Overall Study|Death|13|||
131504251|NCT00484939|473474945|FG000|Overall Study|Adverse Event|22|||
131504252|NCT00484939|473474946|FG001|Overall Study|Adverse Event|12|||
131504253|NCT00484939|473474945|FG000|Overall Study|Patient Withdrew Consent|19|||
131504254|NCT00484939|473474946|FG001|Overall Study|Patient Withdrew Consent|10|||
131504255|NCT00484939|473474945|FG000|Overall Study|Protocol Violation|3|||
131504256|NCT00484939|473474946|FG001|Overall Study|Protocol Violation|3|||
131504257|NCT00484939|473474945|FG000|Overall Study|Lost to Follow-up|0|||
131504258|NCT00484939|473474946|FG001|Overall Study|Lost to Follow-up|3|||
131504259|NCT00484939|473474945|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
131504260|NCT00484939|473474946|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
131504261|NCT00484939|473474945|FG000|Overall Study|Disease progression|67|||
131504262|NCT00484939|473474946|FG001|Overall Study|Disease progression|88|||
131504263|NCT00484939|473474945|FG000|Overall Study|Screen Failure|2|||
131504264|NCT00484939|473474946|FG001|Overall Study|Screen Failure|2|||
131504265|NCT00484939|473474945|FG000|Overall Study|Reason Not Specified|11|||
131504266|NCT00484939|473474946|FG001|Overall Study|Reason Not Specified|6|||
131504267|NCT04948450|473474947|FG000|Overall Study|Return home|1|||
131504268|NCT04948450|473474948|FG001|Overall Study|Return home|3|||
131504269|NCT01474876|473474951|FG000|Overall Study|Adverse Event|11|||
131504270|NCT01474876|473474952|FG001|Overall Study|Adverse Event|5|||
131504271|NCT01474876|473474953|FG002|Overall Study|Adverse Event|0|||
131504272|NCT01474876|473474951|FG000|Overall Study|Serious Adverse Event|2|||
131504273|NCT01474876|473474952|FG001|Overall Study|Serious Adverse Event|3|||
131504274|NCT01474876|473474953|FG002|Overall Study|Serious Adverse Event|0|||
131504275|NCT01474876|473474951|FG000|Overall Study|Lost to Follow-up|5|||
131504276|NCT01474876|473474952|FG001|Overall Study|Lost to Follow-up|4|||
131504277|NCT01474876|473474953|FG002|Overall Study|Lost to Follow-up|0|||
131504278|NCT01474876|473474951|FG000|Overall Study|Investigator's decision|28|||
131504279|NCT01474876|473474952|FG001|Overall Study|Investigator's decision|6|||
131504280|NCT01474876|473474953|FG002|Overall Study|Investigator's decision|0|||
131504281|NCT01474876|473474951|FG000|Overall Study|Patient's request|19|||
131504282|NCT01474876|473474952|FG001|Overall Study|Patient's request|5|||
131504283|NCT01474876|473474953|FG002|Overall Study|Patient's request|0|||
131504284|NCT01474876|473474951|FG000|Overall Study|Investigator's decision and pt request|1|||
131504285|NCT01474876|473474952|FG001|Overall Study|Investigator's decision and pt request|0|||
131504286|NCT01474876|473474953|FG002|Overall Study|Investigator's decision and pt request|0|||
131504287|NCT01523886|473474954|FG000|Overall Study|surgery cancelled|0|||
131504288|NCT01523886|473474955|FG001|Overall Study|surgery cancelled|1|||
131504289|NCT01173718|473474967|FG000|Overall Study|Death|17|||
131504290|NCT01173718|473474967|FG000|Overall Study|Abandonment of study graft|27|||
131504291|NCT01367158|473474968|FG000|Overall Study|Withdrew consent|0|||
131504292|NCT01367158|473474969|FG001|Overall Study|Withdrew consent|2|||
131504293|NCT01367158|473474970|FG002|Overall Study|Withdrew consent|1|||
131504294|NCT01367158|473474971|FG003|Overall Study|Withdrew consent|0|||
131504295|NCT01367158|473474972|FG004|Overall Study|Withdrew consent|2|||
131504296|NCT01367158|473474973|FG005|Overall Study|Withdrew consent|0|||
131504297|NCT01367158|473474974|FG006|Overall Study|Withdrew consent|0|||
131504298|NCT01367158|473474975|FG007|Overall Study|Withdrew consent|1|||
131504299|NCT01367158|473474976|FG008|Overall Study|Withdrew consent|0|||
131504300|NCT01367158|473474977|FG009|Overall Study|Withdrew consent|0|||
131504301|NCT01367158|473474978|FG010|Overall Study|Withdrew consent|0|||
131504302|NCT01367158|473474968|FG000|Overall Study|Lost to Follow-up|0|||
131504303|NCT01367158|473474969|FG001|Overall Study|Lost to Follow-up|0|||
131504304|NCT01367158|473474970|FG002|Overall Study|Lost to Follow-up|0|||
131504305|NCT01367158|473474971|FG003|Overall Study|Lost to Follow-up|1|||
131504306|NCT01367158|473474972|FG004|Overall Study|Lost to Follow-up|0|||
131504307|NCT01367158|473474973|FG005|Overall Study|Lost to Follow-up|2|||
131504308|NCT01367158|473474974|FG006|Overall Study|Lost to Follow-up|0|||
131504309|NCT01367158|473474975|FG007|Overall Study|Lost to Follow-up|1|||
131504310|NCT01367158|473474976|FG008|Overall Study|Lost to Follow-up|0|||
131504311|NCT01367158|473474977|FG009|Overall Study|Lost to Follow-up|0|||
131504312|NCT01367158|473474978|FG010|Overall Study|Lost to Follow-up|1|||
131504313|NCT01367158|473474968|FG000|Overall Study|Protocol Violation|0|||
131504314|NCT01367158|473474969|FG001|Overall Study|Protocol Violation|1|||
131504315|NCT01367158|473474970|FG002|Overall Study|Protocol Violation|0|||
131504316|NCT01367158|473474971|FG003|Overall Study|Protocol Violation|0|||
131504317|NCT01367158|473474972|FG004|Overall Study|Protocol Violation|0|||
131504318|NCT01367158|473474973|FG005|Overall Study|Protocol Violation|0|||
131504319|NCT01367158|473474974|FG006|Overall Study|Protocol Violation|0|||
131504320|NCT01367158|473474975|FG007|Overall Study|Protocol Violation|0|||
131504321|NCT01367158|473474976|FG008|Overall Study|Protocol Violation|0|||
131504322|NCT01367158|473474977|FG009|Overall Study|Protocol Violation|0|||
131504323|NCT01367158|473474978|FG010|Overall Study|Protocol Violation|0|||
131504324|NCT05198843|473474979|FG000|Overall Study|Lack of Efficacy|1|||
131504325|NCT02472795|473474980|FG000|Overall Study|Adverse Event|0|||
131504326|NCT02472795|473474981|FG001|Overall Study|Adverse Event|1|||
131504327|NCT02472795|473474982|FG002|Overall Study|Adverse Event|0|||
131504328|NCT02472795|473474983|FG003|Overall Study|Adverse Event|0|||
131504329|NCT02472795|473474984|FG004|Overall Study|Adverse Event|2|||
131504330|NCT02472795|473474980|FG000|Overall Study|Withdrawal by Subject|0|||
131504331|NCT02472795|473474981|FG001|Overall Study|Withdrawal by Subject|0|||
131504332|NCT02472795|473474982|FG002|Overall Study|Withdrawal by Subject|0|||
131504333|NCT02472795|473474983|FG003|Overall Study|Withdrawal by Subject|0|||
131504334|NCT02472795|473474984|FG004|Overall Study|Withdrawal by Subject|1|||
131504335|NCT04166513|473474985|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
131504336|NCT04166513|473474986|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
131504337|NCT04166513|473474987|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
131504338|NCT04166513|473474988|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
131504339|NCT04166513|473474985|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
131504340|NCT04166513|473474986|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
131504341|NCT04166513|473474987|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
131504342|NCT04166513|473474988|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
131504343|NCT04166513|473474985|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
131504344|NCT04166513|473474986|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
131504345|NCT04166513|473474987|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
131504346|NCT04166513|473474988|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
131504347|NCT04166513|473474985|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
131504348|NCT04166513|473474986|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
131504349|NCT04166513|473474987|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
131504350|NCT04166513|473474988|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
131504351|NCT04166513|473474985|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
131504352|NCT04166513|473474986|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
131504353|NCT04166513|473474987|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
131504354|NCT04166513|473474988|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
131504355|NCT02750592|473476195|FG000|Overall Study|Adverse Event|3|||
131504356|NCT02750592|473476195|FG000|Overall Study|Lack of Efficacy|2|||
131504357|NCT02981342|473476198|FG000|Overall Study|Adverse Event|0|||
131504358|NCT02981342|473476199|FG001|Overall Study|Adverse Event|0|||
131504359|NCT02981342|473476200|FG002|Overall Study|Adverse Event|0|||
131504360|NCT02981342|473476201|FG003|Overall Study|Adverse Event|1|||
131504361|NCT02981342|473476198|FG000|Overall Study|Death|0|||
131504362|NCT02981342|473476199|FG001|Overall Study|Death|9|||
131504363|NCT02981342|473476200|FG002|Overall Study|Death|9|||
131504364|NCT02981342|473476201|FG003|Overall Study|Death|4|||
131504365|NCT02981342|473476198|FG000|Overall Study|Withdrawal by Subject|0|||
131504366|NCT02981342|473476199|FG001|Overall Study|Withdrawal by Subject|0|||
131504367|NCT02981342|473476200|FG002|Overall Study|Withdrawal by Subject|3|||
131504368|NCT02981342|473476201|FG003|Overall Study|Withdrawal by Subject|1|||
131504369|NCT02981342|473476198|FG000|Overall Study|Study closed by sponsor|0|||
131504370|NCT02981342|473476199|FG001|Overall Study|Study closed by sponsor|0|||
131504371|NCT02981342|473476200|FG002|Overall Study|Study closed by sponsor|1|||
131504372|NCT02981342|473476201|FG003|Overall Study|Study closed by sponsor|1|||
131504373|NCT02981342|473476198|FG000|Overall Study|Randomized, Never Treated|0|||
131504374|NCT02981342|473476199|FG001|Overall Study|Randomized, Never Treated|1|||
131504375|NCT02981342|473476200|FG002|Overall Study|Randomized, Never Treated|0|||
131504376|NCT02981342|473476201|FG003|Overall Study|Randomized, Never Treated|7|||
131504377|NCT02981342|473476198|FG000|Overall Study|Lost to Follow-up|0|||
131504378|NCT02981342|473476199|FG001|Overall Study|Lost to Follow-up|1|||
131504379|NCT02981342|473476200|FG002|Overall Study|Lost to Follow-up|0|||
131504380|NCT02981342|473476201|FG003|Overall Study|Lost to Follow-up|0|||
131504381|NCT05333900|473476202|FG000|Overall Study|Protocol Violation|0|||
131504382|NCT05333900|473476203|FG001|Overall Study|Protocol Violation|1|||
131504383|NCT05333900|473476202|FG000|Overall Study|Withdrawal by Subject|0|||
131504384|NCT05333900|473476203|FG001|Overall Study|Withdrawal by Subject|1|||
131504385|NCT05333900|473476202|FG000|Overall Study|COVID-19 Pandemic|1|||
131504386|NCT05333900|473476203|FG001|Overall Study|COVID-19 Pandemic|1|||
131504387|NCT01851720|473476204|FG000|Overall Study|Lost to Follow-up|0|||
131504388|NCT01851720|473476205|FG001|Overall Study|Lost to Follow-up|1|||
131504389|NCT01870583|473476208|FG000|Overall Study|Protocol Violation|0|||
131504390|NCT01870583|473476209|FG001|Overall Study|Protocol Violation|5|||
131504391|NCT01870583|473476210|FG002|Overall Study|Protocol Violation|3|||
131504392|NCT01870583|473476208|FG000|Overall Study|Lost to Follow-up|11|||
131504393|NCT01870583|473476209|FG001|Overall Study|Lost to Follow-up|13|||
131504394|NCT01870583|473476210|FG002|Overall Study|Lost to Follow-up|5|||
131504395|NCT01394523|473476213|FG000|Overall Study|Unable to place block|1|||
131504396|NCT01394523|473476214|FG001|Overall Study|Unable to place block|0|||
131504397|NCT01394523|473476215|FG002|Overall Study|Unable to place block|0|||
131504398|NCT02389998|473476216|FG000|Overall Study|car accident|1|||
131504399|NCT02389998|473476217|FG001|Overall Study|car accident|0|||
131504400|NCT03525574|473476218|FG000|Overall Study|Adverse Event|15|||
131504401|NCT03525574|473476219|FG001|Overall Study|Adverse Event|0|||
131504402|NCT03525574|473476218|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
131504403|NCT03525574|473476219|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
131504404|NCT03525574|473476218|FG000|Overall Study|Lost to Follow-up|4|||
131504405|NCT03525574|473476219|FG001|Overall Study|Lost to Follow-up|0|||
131504406|NCT03525574|473476218|FG000|Overall Study|Commercial drug is Available for participant|48|||
131504407|NCT03525574|473476219|FG001|Overall Study|Commercial drug is Available for participant|0|||
131504408|NCT03525574|473476218|FG000|Overall Study|Death|1|||
131504409|NCT03525574|473476219|FG001|Overall Study|Death|0|||
131504410|NCT03525574|473476218|FG000|Overall Study|Other non-compliance|2|||
131504411|NCT03525574|473476219|FG001|Overall Study|Other non-compliance|0|||
131504412|NCT03525574|473476218|FG000|Overall Study|Physician Decision|6|||
131504413|NCT03525574|473476219|FG001|Overall Study|Physician Decision|0|||
131504414|NCT03525574|473476218|FG000|Overall Study|Other|58|||
131504415|NCT03525574|473476219|FG001|Overall Study|Other|0|||
131504416|NCT03525574|473476218|FG000|Overall Study|Enrolled but never dosed|1|||
131504417|NCT03525574|473476219|FG001|Overall Study|Enrolled but never dosed|0|||
131504418|NCT03525574|473476218|FG000|Overall Study|Not enrolled in 105 study|0|||
131504419|NCT03525574|473476219|FG001|Overall Study|Not enrolled in 105 study|3|||
131504420|NCT03226392|473476222|FG000|Overall Study|Protocol Deviation|1|||
131504421|NCT03226392|473476223|FG001|Overall Study|Protocol Deviation|0|||
131504422|NCT03226392|473476222|FG000|Overall Study|Physician Decision|1|||
131504423|NCT03226392|473476223|FG001|Overall Study|Physician Decision|0|||
131504424|NCT03226392|473476222|FG000|Overall Study|Lost to Follow-up|1|||
131504425|NCT03226392|473476223|FG001|Overall Study|Lost to Follow-up|0|||
131504426|NCT03226392|473476222|FG000|Overall Study|Adverse Event|1|||
131504427|NCT03226392|473476223|FG001|Overall Study|Adverse Event|0|||
131504428|NCT03226392|473476222|FG000|Overall Study|Technical Problems|0|||
131504429|NCT03226392|473476223|FG001|Overall Study|Technical Problems|2|||
131504430|NCT03226392|473476222|FG000|Overall Study|Subject/Guardian Decision|7|||
131504431|NCT03226392|473476223|FG001|Overall Study|Subject/Guardian Decision|6|||
131504432|NCT00469092|473476224|FG000|Overall Study|Adverse Event|5|||
131504433|NCT00469092|473476225|FG001|Overall Study|Adverse Event|4|||
131504434|NCT00469092|473476224|FG000|Overall Study|Lack of Efficacy|1|||
131504435|NCT00469092|473476225|FG001|Overall Study|Lack of Efficacy|0|||
131504436|NCT00469092|473476224|FG000|Overall Study|Lost to Follow-up|1|||
131504437|NCT00469092|473476225|FG001|Overall Study|Lost to Follow-up|2|||
131504438|NCT00469092|473476224|FG000|Overall Study|Protocol Violation|3|||
131504439|NCT00469092|473476225|FG001|Overall Study|Protocol Violation|3|||
131504440|NCT00469092|473476224|FG000|Overall Study|Withdrawal by Subject|4|||
131504441|NCT00469092|473476225|FG001|Overall Study|Withdrawal by Subject|4|||
131504442|NCT00469092|473476224|FG000|Overall Study|Withdrawal Criteria|3|||
131504443|NCT00469092|473476225|FG001|Overall Study|Withdrawal Criteria|4|||
131504444|NCT00469092|473476224|FG000|Overall Study|Incorrectly Randomised|4|||
131504445|NCT00469092|473476225|FG001|Overall Study|Incorrectly Randomised|3|||
131504446|NCT00469092|473476224|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
131504447|NCT00469092|473476225|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
131504448|NCT00469092|473476224|FG000|Overall Study|Use of lipid lowering drug|1|||
131504449|NCT00469092|473476225|FG001|Overall Study|Use of lipid lowering drug|0|||
131504450|NCT00469092|473476224|FG000|Overall Study|Hypoglycaemic Episodes|1|||
131504451|NCT00469092|473476225|FG001|Overall Study|Hypoglycaemic Episodes|1|||
131504452|NCT00469092|473476224|FG000|Overall Study|Abnormal lab value|1|||
131504453|NCT00469092|473476225|FG001|Overall Study|Abnormal lab value|0|||
131504454|NCT00469092|473476224|FG000|Overall Study|Use of Corticosteroid|1|||
131504455|NCT00469092|473476225|FG001|Overall Study|Use of Corticosteroid|0|||
131504456|NCT02150954|473476226|FG000|Overall Study|Protocol Violation|1|||
131504457|NCT02150954|473476227|FG001|Overall Study|Protocol Violation|0|||
131504458|NCT00518323|473476229|FG000|Overall Study|Lack of Efficacy|14|||
131504459|NCT00518323|473476230|FG001|Overall Study|Lack of Efficacy|2|||
131504460|NCT00518323|473476231|FG002|Overall Study|Lack of Efficacy|4|||
131504461|NCT00518323|473476232|FG003|Overall Study|Lack of Efficacy|20|||
131504462|NCT00518323|473476229|FG000|Overall Study|Withdrawal by Subject|1|||
131504463|NCT00518323|473476230|FG001|Overall Study|Withdrawal by Subject|2|||
131504464|NCT00518323|473476231|FG002|Overall Study|Withdrawal by Subject|4|||
131504465|NCT00518323|473476232|FG003|Overall Study|Withdrawal by Subject|2|||
131504466|NCT00518323|473476229|FG000|Overall Study|Lost to Follow-up|0|||
131504467|NCT00518323|473476230|FG001|Overall Study|Lost to Follow-up|2|||
131504468|NCT00518323|473476231|FG002|Overall Study|Lost to Follow-up|1|||
131504469|NCT00518323|473476232|FG003|Overall Study|Lost to Follow-up|3|||
131504470|NCT00518323|473476229|FG000|Overall Study|Adverse Event|1|||
131504471|NCT00518323|473476230|FG001|Overall Study|Adverse Event|1|||
131504472|NCT00518323|473476231|FG002|Overall Study|Adverse Event|1|||
131504473|NCT00518323|473476232|FG003|Overall Study|Adverse Event|0|||
131504474|NCT00518323|473476229|FG000|Overall Study|Prohibited medication and others|3|||
131504475|NCT00518323|473476230|FG001|Overall Study|Prohibited medication and others|1|||
131504476|NCT00518323|473476231|FG002|Overall Study|Prohibited medication and others|1|||
131504477|NCT00518323|473476232|FG003|Overall Study|Prohibited medication and others|0|||
131504478|NCT01086540|473476233|FG000|Overall Study|Death|3|||
131504479|NCT01086540|473476234|FG001|Overall Study|Death|1|||
131504480|NCT01086540|473476233|FG000|Overall Study|Physician Decision|2|||
131504481|NCT01086540|473476234|FG001|Overall Study|Physician Decision|1|||
131504482|NCT01086540|473476233|FG000|Overall Study|Addition of new therapy for PAH|1|||
131504483|NCT01086540|473476234|FG001|Overall Study|Addition of new therapy for PAH|0|||
131504484|NCT01998737|473476235|FG000|Overall Study|Corrupted database|23|||
131504485|NCT01998737|473476236|FG001|Overall Study|Corrupted database|0|||
131504486|NCT03997383|473476239|FG000|Double-blind Treatment Period|Adverse Event|4|||
131504487|NCT03997383|473476240|FG001|Double-blind Treatment Period|Adverse Event|3|||
131504488|NCT03997383|473476239|FG000|Double-blind Treatment Period|Death|4|||
131504489|NCT03997383|473476240|FG001|Double-blind Treatment Period|Death|4|||
131504490|NCT03997383|473476239|FG000|Double-blind Treatment Period|Physician Decision|2|||
131504491|NCT03997383|473476240|FG001|Double-blind Treatment Period|Physician Decision|0|||
131504492|NCT03997383|473476239|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
131504493|NCT03997383|473476240|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
131504494|NCT03997383|473476239|FG000|Open-label Extension Period|Ongoing|148|||
131504495|NCT03997383|473476240|FG001|Open-label Extension Period|Ongoing|151|||
131504496|NCT03997383|473476239|FG000|Open-label Extension Period|Adverse Event|4|||
131504497|NCT03997383|473476240|FG001|Open-label Extension Period|Adverse Event|1|||
131504498|NCT03997383|473476239|FG000|Open-label Extension Period|Death|8|||
131504499|NCT03997383|473476240|FG001|Open-label Extension Period|Death|9|||
131504500|NCT03997383|473476239|FG000|Open-label Extension Period|Physician Decision|1|||
131504501|NCT03997383|473476240|FG001|Open-label Extension Period|Physician Decision|1|||
131504502|NCT03997383|473476239|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
131504503|NCT03997383|473476240|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
131504504|NCT03997383|473476239|FG000|Open-label Extension Period|Reason Not Specified|2|||
131504505|NCT03997383|473476240|FG001|Open-label Extension Period|Reason Not Specified|0|||
131504506|NCT03880019|473476241|FG000|Overall Study|Competing disease|1|||
131504507|NCT00326950|473476242|FG000|Overall Study|Progressive Disease|1|||
131504508|NCT02118012|473476246|FG000|Overall Study|Adverse Event|0|||
131504509|NCT02118012|473476247|FG001|Overall Study|Adverse Event|1|||
131504510|NCT02118012|473476246|FG000|Overall Study|Physician Decision|0|||
131504511|NCT02118012|473476247|FG001|Overall Study|Physician Decision|1|||
131504512|NCT00171223|473476248|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
131504513|NCT00171223|473476249|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
131504514|NCT00171223|473476250|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
131504515|NCT00171223|473476248|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
131504516|NCT00171223|473476249|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
131504517|NCT00171223|473476250|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
131504518|NCT00171223|473476248|FG000|Overall Study|Abnormal Procedure|1|||
131504519|NCT00171223|473476249|FG001|Overall Study|Abnormal Procedure|0|||
131504520|NCT00171223|473476250|FG002|Overall Study|Abnormal Procedure|0|||
131504521|NCT00171223|473476248|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
131504522|NCT00171223|473476249|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
131504523|NCT00171223|473476250|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
131504524|NCT00171223|473476248|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
131504525|NCT00171223|473476249|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
131504526|NCT00171223|473476250|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
131504527|NCT00171223|473476248|FG000|Overall Study|Protocol Violation|2|||
131504528|NCT00171223|473476249|FG001|Overall Study|Protocol Violation|2|||
131504529|NCT00171223|473476250|FG002|Overall Study|Protocol Violation|3|||
131504530|NCT00171223|473476248|FG000|Overall Study|Participant Withdrew Consent|12|||
131504531|NCT00171223|473476249|FG001|Overall Study|Participant Withdrew Consent|21|||
131504532|NCT00171223|473476250|FG002|Overall Study|Participant Withdrew Consent|15|||
131504533|NCT00171223|473476248|FG000|Overall Study|Lost to Follow-up|5|||
131504534|NCT00171223|473476249|FG001|Overall Study|Lost to Follow-up|2|||
131504535|NCT00171223|473476250|FG002|Overall Study|Lost to Follow-up|3|||
131504536|NCT00171223|473476248|FG000|Overall Study|Administrative Problems|4|||
131504537|NCT00171223|473476249|FG001|Overall Study|Administrative Problems|7|||
131504538|NCT00171223|473476250|FG002|Overall Study|Administrative Problems|6|||
131504539|NCT00171223|473476248|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
131504540|NCT00171223|473476249|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
131504541|NCT00171223|473476250|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
131504542|NCT00171223|473476248|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
131504543|NCT00171223|473476249|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
131504544|NCT00171223|473476250|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
131504545|NCT03447990|473476272|FG000|Overall Study|Withdrawal by Subject|0|||
131504546|NCT03447990|473476273|FG001|Overall Study|Withdrawal by Subject|0|||
131504547|NCT03447990|473476274|FG002|Overall Study|Withdrawal by Subject|0|||
131504548|NCT03447990|473476275|FG003|Overall Study|Withdrawal by Subject|0|||
131504549|NCT03447990|473476276|FG004|Overall Study|Withdrawal by Subject|0|||
131504550|NCT03447990|473476277|FG005|Overall Study|Withdrawal by Subject|0|||
131504551|NCT03447990|473476278|FG006|Overall Study|Withdrawal by Subject|1|||
131504552|NCT02738450|473476279|FG000|Overall Study|Withdrawal by Subject|0|||
131504553|NCT02738450|473476280|FG001|Overall Study|Withdrawal by Subject|2|||
131504554|NCT02738450|473476281|FG002|Overall Study|Withdrawal by Subject|0|||
131504555|NCT00399360|473476289|FG000|Overall Study|Lost to Follow-up|2|||
131504556|NCT00399360|473476290|FG001|Overall Study|Lost to Follow-up|1|||
131504557|NCT00399360|473476291|FG002|Overall Study|Lost to Follow-up|2|||
131504558|NCT00399360|473476292|FG003|Overall Study|Lost to Follow-up|4|||
131504559|NCT00399360|473476289|FG000|Overall Study|Adverse Event|0|||
131504560|NCT00399360|473476290|FG001|Overall Study|Adverse Event|0|||
131504561|NCT00399360|473476291|FG002|Overall Study|Adverse Event|1|||
131504562|NCT00399360|473476292|FG003|Overall Study|Adverse Event|0|||
131504563|NCT00399360|473476289|FG000|Overall Study|Withdrawal by Subject|0|||
131504564|NCT00399360|473476290|FG001|Overall Study|Withdrawal by Subject|2|||
131504565|NCT00399360|473476291|FG002|Overall Study|Withdrawal by Subject|0|||
131504566|NCT00399360|473476292|FG003|Overall Study|Withdrawal by Subject|2|||
131504567|NCT01412021|473476293|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
131504568|NCT01412021|473476293|FG000|Overall Study|Treatment Prior to Approval|3|||
131504569|NCT01412021|473476293|FG000|Overall Study|Transferred to Other Hospital|9|||
131504570|NCT04537234|473476295|FG000|Overall Study|Withdrawal by Subject|2|||
131504571|NCT04537234|473476296|FG001|Overall Study|Withdrawal by Subject|0|||
131658092|NCT04445987|474032997|FG003|Overall Study|Lost to Follow-up|1|||
131504572|NCT01721330|473476297|FG000|Overall Study|Withdrawal by Subject|0|||
131504573|NCT01721330|473476298|FG001|Overall Study|Withdrawal by Subject|1|||
131504574|NCT00296374|473476299|FG000|Overall Study|Adverse Event|14|||
131504575|NCT00296374|473476300|FG001|Overall Study|Adverse Event|10|||
131504576|NCT00296374|473476301|FG002|Overall Study|Adverse Event|7|||
131504577|NCT00296374|473476299|FG000|Overall Study|Withdrawal by Subject|3|||
131504578|NCT00296374|473476300|FG001|Overall Study|Withdrawal by Subject|5|||
131504579|NCT00296374|473476301|FG002|Overall Study|Withdrawal by Subject|11|||
131504580|NCT00296374|473476299|FG000|Overall Study|Incorrect enrollment|3|||
131504581|NCT00296374|473476300|FG001|Overall Study|Incorrect enrollment|3|||
131504582|NCT00296374|473476301|FG002|Overall Study|Incorrect enrollment|4|||
131504583|NCT00296374|473476299|FG000|Overall Study|Protocol Violation|1|||
131504584|NCT00296374|473476300|FG001|Overall Study|Protocol Violation|2|||
131504585|NCT00296374|473476301|FG002|Overall Study|Protocol Violation|3|||
131504586|NCT00296374|473476299|FG000|Overall Study|Lost to Follow-up|3|||
131504587|NCT00296374|473476300|FG001|Overall Study|Lost to Follow-up|1|||
131504588|NCT00296374|473476301|FG002|Overall Study|Lost to Follow-up|1|||
131504589|NCT00296374|473476299|FG000|Overall Study|Relocated to another state|1|||
131504590|NCT00296374|473476300|FG001|Overall Study|Relocated to another state|0|||
131504591|NCT00296374|473476301|FG002|Overall Study|Relocated to another state|0|||
131504592|NCT00296374|473476299|FG000|Overall Study|Stopped drug before end of study visit|0|||
131504593|NCT00296374|473476300|FG001|Overall Study|Stopped drug before end of study visit|1|||
131504594|NCT00296374|473476301|FG002|Overall Study|Stopped drug before end of study visit|0|||
131504595|NCT00296374|473476299|FG000|Overall Study|Nephrologist introduced ACE|0|||
131504596|NCT00296374|473476300|FG001|Overall Study|Nephrologist introduced ACE|1|||
131504597|NCT00296374|473476301|FG002|Overall Study|Nephrologist introduced ACE|0|||
131504598|NCT00296374|473476299|FG000|Overall Study|Pregnancy|0|||
131504599|NCT00296374|473476300|FG001|Overall Study|Pregnancy|0|||
131504600|NCT00296374|473476301|FG002|Overall Study|Pregnancy|2|||
131504601|NCT00296374|473476299|FG000|Overall Study|Other|0|||
131504602|NCT00296374|473476300|FG001|Overall Study|Other|0|||
131504603|NCT00296374|473476301|FG002|Overall Study|Other|1|||
131504604|NCT01786629|473477888|FG000|Overall Study|Lack of Efficacy|0|||
131504605|NCT01786629|473477889|FG001|Overall Study|Lack of Efficacy|4|||
131504606|NCT01786629|473477888|FG000|Overall Study|Adverse Event|0|||
131504607|NCT01786629|473477889|FG001|Overall Study|Adverse Event|1|||
131504608|NCT03712904|473477890|FG000|Overall Study|Death|0|||
131504609|NCT03712904|473477891|FG001|Overall Study|Death|1|||
131504610|NCT03712904|473477890|FG000|Overall Study|Withdrawal by Subject|0|||
131504611|NCT03712904|473477891|FG001|Overall Study|Withdrawal by Subject|1|||
131504612|NCT03712904|473477890|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
131504613|NCT03712904|473477891|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
131504614|NCT05608005|473477893|FG000|Overall Study|Adverse Event|2|||
131504615|NCT05608005|473477894|FG001|Overall Study|Adverse Event|1|||
131504616|NCT05608005|473477895|FG002|Overall Study|Adverse Event|3|||
131504617|NCT05608005|473477893|FG000|Overall Study|Protocol Violation|2|||
131504618|NCT05608005|473477894|FG001|Overall Study|Protocol Violation|3|||
131504619|NCT05608005|473477895|FG002|Overall Study|Protocol Violation|0|||
131504620|NCT05608005|473477893|FG000|Overall Study|Withdrawal by Subject|10|||
131504621|NCT05608005|473477894|FG001|Overall Study|Withdrawal by Subject|12|||
131504622|NCT05608005|473477895|FG002|Overall Study|Withdrawal by Subject|4|||
131504623|NCT05608005|473477893|FG000|Overall Study|Lost to Follow-up|25|||
131504624|NCT05608005|473477894|FG001|Overall Study|Lost to Follow-up|27|||
131504625|NCT05608005|473477895|FG002|Overall Study|Lost to Follow-up|15|||
131504626|NCT05608005|473477893|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
131504627|NCT05608005|473477894|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
131504628|NCT05608005|473477895|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
131504629|NCT04708886|473477896|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
131504630|NCT04708886|473477896|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
131504631|NCT01372501|473477897|FG000|Overall Study|Adverse Event|4|||
131504632|NCT01372501|473477897|FG000|Overall Study|Device migration|1|||
131504633|NCT01466348|473477898|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
131504634|NCT01466348|473477899|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
131504635|NCT03989440|473477900|FG000|Overall Study|COVID-19 travel restrictions|0|||
131504636|NCT03989440|473477901|FG001|Overall Study|COVID-19 travel restrictions|0|||
131504637|NCT03989440|473477902|FG002|Overall Study|COVID-19 travel restrictions|1|||
131504638|NCT03989440|473477903|FG003|Overall Study|COVID-19 travel restrictions|0|||
131504639|NCT03989440|473477904|FG004|Overall Study|COVID-19 travel restrictions|0|||
131504640|NCT03989440|473477905|FG005|Overall Study|COVID-19 travel restrictions|0|||
131504641|NCT03989440|473477900|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
131504642|NCT03989440|473477901|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
131504643|NCT03989440|473477902|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
131504644|NCT03989440|473477903|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
131504645|NCT03989440|473477904|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
131504646|NCT03989440|473477905|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
131504647|NCT02784821|473477910|FG000|Overall Study|Death|0|||
131504648|NCT02784821|473477911|FG001|Overall Study|Death|5|||
131504649|NCT02784821|473477912|FG002|Overall Study|Death|4|||
131504650|NCT02784821|473477913|FG003|Overall Study|Death|5|||
131504651|NCT04741074|473477914|FG000|Overall Study|Withdrawal by Subject|1|||
131504652|NCT04741074|473477915|FG001|Overall Study|Withdrawal by Subject|1|||
131504653|NCT04741074|473477914|FG000|Overall Study|Study terminated prematurely|1|||
131504654|NCT04741074|473477915|FG001|Overall Study|Study terminated prematurely|0|||
131504655|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Death|3|||
131504656|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Death|2|||
131504657|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Death|4|||
131504658|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Death|3|||
131504659|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Death|0|||
131504660|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Death|0|||
131504661|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
131504662|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
131504663|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
131504664|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
131504665|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
131504666|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
131504667|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
131504668|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
131504669|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
131504670|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
131504671|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
131504672|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
131504673|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
131504674|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
131504675|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
131504676|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
131504677|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
131504678|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
131504679|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
131504680|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
131504681|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
131504682|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
131504683|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
131504684|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
131504685|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
131504686|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
131504687|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
131504688|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
131504689|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
131504690|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
131504691|NCT02432846|473477916|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
131504692|NCT02432846|473477917|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
131504693|NCT02432846|473477918|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
131504694|NCT02432846|473477919|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
131504695|NCT02432846|473477920|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
131504696|NCT02432846|473477921|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
131504697|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
131504698|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
131504699|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
131504700|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
131504701|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
131504702|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
131504703|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
131504704|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
131504705|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
131504706|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
131504707|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
131504708|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
131504709|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
131504710|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
131504711|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
131504712|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
131504713|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
131504714|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
131504715|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
131504716|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
131504717|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
131504718|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
131504719|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
131504720|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
131504721|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
131504722|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
131504723|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
131504724|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
131504725|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
131504726|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
131504727|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
131504728|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
131504729|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
131504730|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
131504731|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
131504732|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
131504733|NCT02432846|473477916|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
131504734|NCT02432846|473477917|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
131504735|NCT02432846|473477918|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
131504736|NCT02432846|473477919|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
131504737|NCT02432846|473477920|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
131504738|NCT02432846|473477921|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
131504739|NCT02357901|473477926|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
131504740|NCT02357901|473477927|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
131504741|NCT02357901|473477928|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
131504742|NCT02357901|473477929|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
131504743|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
131504744|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
131504745|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
131504746|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
131504747|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
131504748|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
131504749|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
131504750|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
131504751|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
131504752|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
131504753|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
131504754|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
131504755|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
131504756|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
131504757|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
131504758|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
131504759|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
131504760|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
131504761|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
131504762|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
131504763|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
131504764|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
131504765|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
131504766|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
131504767|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
131504768|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
131504769|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
131504770|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
131504771|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
131504772|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
131504773|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
131504774|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
131504775|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
131504776|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
131504777|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
131504778|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
131504779|NCT02357901|473477926|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
131504780|NCT02357901|473477927|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
131504781|NCT02357901|473477928|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
131504782|NCT02357901|473477929|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
131504783|NCT04788953|473477933|FG000|Overall Study|Adverse Event|1|||
131504784|NCT04788953|473477934|FG001|Overall Study|Adverse Event|1|||
131504785|NCT04788953|473477933|FG000|Overall Study|Withdrawal by Subject|1|||
131504786|NCT04788953|473477934|FG001|Overall Study|Withdrawal by Subject|0|||
131504787|NCT04788953|473477933|FG000|Overall Study|Protocol Violation|0|||
131504788|NCT04788953|473477934|FG001|Overall Study|Protocol Violation|1|||
131504789|NCT00937157|473477935|FG000|Overall Study|Pregnancy|1|||
131504790|NCT00937157|473477935|FG000|Overall Study|Lost to Follow-up|3|||
131504791|NCT01998633|473477938|FG000|Overall Study|Death|1|||
131504792|NCT00413192|473477939|FG000|Overall Study|Disease progression|26|||
131504793|NCT00413192|473477940|FG001|Overall Study|Disease progression|31|||
131504794|NCT00413192|473477941|FG002|Overall Study|Disease progression|16|||
131504795|NCT00413192|473477942|FG003|Overall Study|Disease progression|25|||
131504796|NCT00413192|473477939|FG000|Overall Study|Toxicity|3|||
131504797|NCT00413192|473477940|FG001|Overall Study|Toxicity|2|||
131504798|NCT00413192|473477941|FG002|Overall Study|Toxicity|2|||
131504799|NCT00413192|473477942|FG003|Overall Study|Toxicity|2|||
131504800|NCT00413192|473477939|FG000|Overall Study|Withdrawal by Subject|3|||
131504801|NCT00413192|473477940|FG001|Overall Study|Withdrawal by Subject|5|||
131504802|NCT00413192|473477941|FG002|Overall Study|Withdrawal by Subject|0|||
131504803|NCT00413192|473477942|FG003|Overall Study|Withdrawal by Subject|1|||
131504804|NCT00413192|473477939|FG000|Overall Study|Intercurrent illness|0|||
131504805|NCT00413192|473477940|FG001|Overall Study|Intercurrent illness|0|||
131504806|NCT00413192|473477941|FG002|Overall Study|Intercurrent illness|0|||
131504807|NCT00413192|473477942|FG003|Overall Study|Intercurrent illness|1|||
131504808|NCT00413192|473477939|FG000|Overall Study|Intercurrent death|0|||
131504809|NCT00413192|473477940|FG001|Overall Study|Intercurrent death|1|||
131504810|NCT00413192|473477941|FG002|Overall Study|Intercurrent death|0|||
131504811|NCT00413192|473477942|FG003|Overall Study|Intercurrent death|0|||
131504812|NCT00413192|473477939|FG000|Overall Study|Other|5|||
131504813|NCT00413192|473477940|FG001|Overall Study|Other|1|||
131504814|NCT00413192|473477941|FG002|Overall Study|Other|1|||
131504815|NCT00413192|473477942|FG003|Overall Study|Other|2|||
131504816|NCT00413192|473477939|FG000|Overall Study|Not treated|0|||
131504817|NCT00413192|473477940|FG001|Overall Study|Not treated|0|||
131504818|NCT00413192|473477941|FG002|Overall Study|Not treated|0|||
131504819|NCT00413192|473477942|FG003|Overall Study|Not treated|1|||
131504820|NCT03814746|473477943|FG000|Overall Study|Participant decision|9|||
131504821|NCT03814746|473477944|FG001|Overall Study|Participant decision|6|||
131504822|NCT03814746|473477945|FG002|Overall Study|Participant decision|15|||
131504823|NCT03814746|473477943|FG000|Overall Study|Physician Decision|2|||
131504824|NCT03814746|473477944|FG001|Overall Study|Physician Decision|2|||
131504825|NCT03814746|473477945|FG002|Overall Study|Physician Decision|4|||
131504826|NCT03814746|473477943|FG000|Overall Study|Death|2|||
131504827|NCT03814746|473477944|FG001|Overall Study|Death|2|||
131504828|NCT03814746|473477945|FG002|Overall Study|Death|2|||
131504829|NCT03814746|473477943|FG000|Overall Study|Adverse Event|2|||
131504830|NCT03814746|473477944|FG001|Overall Study|Adverse Event|2|||
131504831|NCT03814746|473477945|FG002|Overall Study|Adverse Event|1|||
131504832|NCT03814746|473477943|FG000|Overall Study|Lost to Follow-up|2|||
131504833|NCT03814746|473477944|FG001|Overall Study|Lost to Follow-up|1|||
131504834|NCT03814746|473477945|FG002|Overall Study|Lost to Follow-up|2|||
131504835|NCT03814746|473477943|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131504836|NCT03814746|473477944|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131504837|NCT03814746|473477945|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131504838|NCT03814746|473477943|FG000|Overall Study|Pregnancy|0|||
131504839|NCT03814746|473477944|FG001|Overall Study|Pregnancy|1|||
131504840|NCT03814746|473477945|FG002|Overall Study|Pregnancy|1|||
131504841|NCT03814746|473477943|FG000|Overall Study|Protocol Violation|1|||
131504842|NCT03814746|473477944|FG001|Overall Study|Protocol Violation|0|||
131504843|NCT03814746|473477945|FG002|Overall Study|Protocol Violation|0|||
131504844|NCT02631850|473477946|FG000|Treatment Period|Lost to Follow-up|0|||
131504845|NCT02631850|473477947|FG001|Treatment Period|Lost to Follow-up|1|||
131504846|NCT02631850|473477948|FG002|Treatment Period|Lost to Follow-up|0|||
131504847|NCT02631850|473477949|FG003|Treatment Period|Lost to Follow-up|0|||
131504848|NCT02631850|473477946|FG000|Treatment Period|Protocol Violation|1|||
131504849|NCT02631850|473477947|FG001|Treatment Period|Protocol Violation|0|||
131504850|NCT02631850|473477948|FG002|Treatment Period|Protocol Violation|0|||
131504851|NCT02631850|473477949|FG003|Treatment Period|Protocol Violation|0|||
131504852|NCT02631850|473477946|FG000|Treatment Period|Withdrawal by Subject|0|||
131504853|NCT02631850|473477947|FG001|Treatment Period|Withdrawal by Subject|5|||
131504854|NCT02631850|473477948|FG002|Treatment Period|Withdrawal by Subject|2|||
131504855|NCT02631850|473477949|FG003|Treatment Period|Withdrawal by Subject|2|||
131504856|NCT02631850|473477946|FG000|Treatment Period|Adverse Event|1|||
131504857|NCT02631850|473477947|FG001|Treatment Period|Adverse Event|0|||
131504858|NCT02631850|473477948|FG002|Treatment Period|Adverse Event|2|||
131504859|NCT02631850|473477949|FG003|Treatment Period|Adverse Event|3|||
131504860|NCT02631850|473477946|FG000|Treatment Period|Family medical issue|1|||
131504861|NCT02631850|473477947|FG001|Treatment Period|Family medical issue|0|||
131504862|NCT02631850|473477948|FG002|Treatment Period|Family medical issue|0|||
131504863|NCT02631850|473477949|FG003|Treatment Period|Family medical issue|0|||
131504864|NCT02631850|473477946|FG000|6 Month Follow up|Lost to Follow-up|5|||
131504865|NCT02631850|473477947|FG001|6 Month Follow up|Lost to Follow-up|8|||
131504866|NCT02631850|473477948|FG002|6 Month Follow up|Lost to Follow-up|3|||
131504867|NCT02631850|473477949|FG003|6 Month Follow up|Lost to Follow-up|5|||
131504868|NCT02631850|473477946|FG000|6 Month Follow up|Withdrawal by Subject|1|||
131504869|NCT02631850|473477947|FG001|6 Month Follow up|Withdrawal by Subject|0|||
131504870|NCT02631850|473477948|FG002|6 Month Follow up|Withdrawal by Subject|0|||
131504871|NCT02631850|473477949|FG003|6 Month Follow up|Withdrawal by Subject|2|||
131504872|NCT02631850|473477946|FG000|6 Month Follow up|Adverse Event|1|||
131504873|NCT02631850|473477947|FG001|6 Month Follow up|Adverse Event|4|||
131504874|NCT02631850|473477948|FG002|6 Month Follow up|Adverse Event|1|||
131504875|NCT02631850|473477949|FG003|6 Month Follow up|Adverse Event|3|||
131504876|NCT02631850|473477946|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
131504877|NCT02631850|473477947|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
131504878|NCT02631850|473477948|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
131504879|NCT02631850|473477949|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
131504880|NCT03992781|473477958|FG000|Overall Study|Lost to Follow-up|5|||
131504881|NCT03992781|473477958|FG000|Overall Study|Adverse Event|1|||
131504882|NCT03992781|473477958|FG000|Overall Study|Lack of Efficacy|5|||
131504883|NCT01266460|473477961|FG000|Overall Study|Adverse Event|3|||
131504884|NCT01266460|473477961|FG000|Overall Study|Withdrawal by Subject|5|||
131504885|NCT01266460|473477961|FG000|Overall Study|Disease Progression|18|||
131504886|NCT01266460|473477961|FG000|Overall Study|Not otherwise specified|8|||
131504887|NCT04499781|473477966|FG000|Overall Study|Lost to Follow-up|2|||
131504888|NCT04499781|473477967|FG001|Overall Study|Lost to Follow-up|3|||
131504889|NCT04499781|473477966|FG000|Overall Study|Withdrawal by Subject|2|||
131504890|NCT04499781|473477967|FG001|Overall Study|Withdrawal by Subject|0|||
131504891|NCT00730912|473477975|FG000|Overall Study|Discontinued|0|||
131504892|NCT00730912|473477976|FG001|Overall Study|Discontinued|0|||
131504893|NCT00730912|473477977|FG002|Overall Study|Discontinued|1|||
131504894|NCT03424265|473477978|FG000|Overall Study|screening failure|1|||
131504895|NCT03424265|473477979|FG001|Overall Study|screening failure|0|||
131504896|NCT03424265|473477978|FG000|Overall Study|Withdrawal by Subject|0|||
131504897|NCT03424265|473477979|FG001|Overall Study|Withdrawal by Subject|2|||
131504898|NCT00391274|473477987|FG000|Overall Study|Death Due to Study Disease|55|||
131504899|NCT00391274|473477988|FG001|Overall Study|Death Due to Study Disease|45|||
131504900|NCT00391274|473477987|FG000|Overall Study|Lost to Follow-up|0|||
131504901|NCT00391274|473477988|FG001|Overall Study|Lost to Follow-up|3|||
131504902|NCT00391274|473477987|FG000|Overall Study|Physician Decision|4|||
131504903|NCT00391274|473477988|FG001|Overall Study|Physician Decision|2|||
131504904|NCT00391274|473477987|FG000|Overall Study|Withdrawal by Subject|0|||
131504905|NCT00391274|473477988|FG001|Overall Study|Withdrawal by Subject|3|||
131504906|NCT00391274|473477987|FG000|Overall Study|Death Due to Adverse Event|1|||
131504907|NCT00391274|473477988|FG001|Overall Study|Death Due to Adverse Event|3|||
131504908|NCT00391274|473477987|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
131504909|NCT00391274|473477988|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
131504910|NCT00391274|473477987|FG000|Overall Study|Death Not Study Related|0|||
131504911|NCT00391274|473477988|FG001|Overall Study|Death Not Study Related|1|||
131504912|NCT03051607|473477989|FG000|Overall Study|Adverse Event|66|||
131504913|NCT00894322|473477991|FG000|Overall Study|Withdrawal by Subject|1|||
131504914|NCT00894322|473477992|FG001|Overall Study|Withdrawal by Subject|0|||
131504915|NCT00894322|473477993|FG002|Overall Study|Withdrawal by Subject|0|||
131504916|NCT01166178|473477994|FG000|Overall Study|Withdrawal by Subject|1|||
131504917|NCT01166178|473477995|FG001|Overall Study|Withdrawal by Subject|0|||
131504918|NCT01166178|473477994|FG000|Overall Study|Study was terminated|20|||
131504919|NCT01166178|473477995|FG001|Overall Study|Study was terminated|8|||
131504920|NCT05104567|473478001|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
131504921|NCT05104567|473478002|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
131504922|NCT05104567|473478003|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
131504923|NCT05104567|473478004|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
131504924|NCT05104567|473478005|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
131504925|NCT05104567|473478006|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
131504926|NCT05104567|473478007|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
131504927|NCT05104567|473478001|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
131504928|NCT05104567|473478002|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
131504929|NCT05104567|473478003|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
131504930|NCT05104567|473478004|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
131504931|NCT05104567|473478005|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
131504932|NCT05104567|473478006|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
131504933|NCT05104567|473478007|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
131504934|NCT05104567|473478001|FG000|Overall Study|Progressive disease|3|||
131504935|NCT05104567|473478002|FG001|Overall Study|Progressive disease|13|||
131504936|NCT05104567|473478003|FG002|Overall Study|Progressive disease|13|||
131504937|NCT05104567|473478004|FG003|Overall Study|Progressive disease|17|||
131504938|NCT05104567|473478005|FG004|Overall Study|Progressive disease|17|||
131504939|NCT05104567|473478006|FG005|Overall Study|Progressive disease|28|||
131504940|NCT05104567|473478007|FG006|Overall Study|Progressive disease|24|||
131504941|NCT05104567|473478001|FG000|Overall Study|Withdrawal by Subject|1|||
131504942|NCT05104567|473478002|FG001|Overall Study|Withdrawal by Subject|1|||
131504943|NCT05104567|473478003|FG002|Overall Study|Withdrawal by Subject|2|||
131504944|NCT05104567|473478004|FG003|Overall Study|Withdrawal by Subject|0|||
131504945|NCT05104567|473478005|FG004|Overall Study|Withdrawal by Subject|0|||
131504946|NCT05104567|473478006|FG005|Overall Study|Withdrawal by Subject|0|||
131504947|NCT05104567|473478007|FG006|Overall Study|Withdrawal by Subject|0|||
131504948|NCT05104567|473478001|FG000|Overall Study|Other|1|||
131504949|NCT05104567|473478002|FG001|Overall Study|Other|1|||
131504950|NCT05104567|473478003|FG002|Overall Study|Other|1|||
131504951|NCT05104567|473478004|FG003|Overall Study|Other|0|||
131504952|NCT05104567|473478005|FG004|Overall Study|Other|0|||
131504953|NCT05104567|473478006|FG005|Overall Study|Other|0|||
131504954|NCT05104567|473478007|FG006|Overall Study|Other|0|||
131504955|NCT00733746|473478012|FG000|Overall Study|Ineligible|5|||
131504956|NCT05778786|473478013|FG000|Period 1|COVID-19 Related|3|||
131504957|NCT05778786|473478014|FG001|Period 1|COVID-19 Related|3|||
131504958|NCT05778786|473478013|FG000|Period 1|Withdrew Consent during Study|1|||
131504959|NCT05778786|473478014|FG001|Period 1|Withdrew Consent during Study|0|||
131504960|NCT05778786|473478013|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
131504961|NCT05778786|473478014|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
131504962|NCT05778786|473478013|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
131504963|NCT05778786|473478014|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
131504964|NCT03658538|473478016|FG000|Overall Study|Death|2|||
131504965|NCT03658538|473478017|FG001|Overall Study|Death|1|||
131504966|NCT03658538|473478016|FG000|Overall Study|Cancer diagnosis|1|||
131504967|NCT03658538|473478017|FG001|Overall Study|Cancer diagnosis|0|||
131504968|NCT03658538|473478016|FG000|Overall Study|Change residence|1|||
131504969|NCT03658538|473478017|FG001|Overall Study|Change residence|2|||
131504970|NCT03658538|473478016|FG000|Overall Study|Lost to Follow-up|3|||
131504971|NCT03658538|473478017|FG001|Overall Study|Lost to Follow-up|3|||
131504972|NCT03658538|473478016|FG000|Overall Study|Unblinded|2|||
131504973|NCT03658538|473478017|FG001|Overall Study|Unblinded|3|||
131504974|NCT03658538|473478016|FG000|Overall Study|Physician Decision|0|||
131504975|NCT03658538|473478017|FG001|Overall Study|Physician Decision|1|||
131504976|NCT03658538|473478016|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
131504977|NCT03658538|473478017|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
131504978|NCT03658538|473478016|FG000|Overall Study|Evicted from home|1|||
131504979|NCT03658538|473478017|FG001|Overall Study|Evicted from home|0|||
131504980|NCT05478252|473478020|FG000|Overall Study|Withdrawal by Subject|2|||
131504981|NCT05478252|473478021|FG001|Overall Study|Withdrawal by Subject|3|||
131504982|NCT05478252|473478020|FG000|Overall Study|Lost to Follow-up|4|||
131504983|NCT05478252|473478021|FG001|Overall Study|Lost to Follow-up|2|||
131504984|NCT05478252|473478020|FG000|Overall Study|Physician Decision|1|||
131504985|NCT05478252|473478021|FG001|Overall Study|Physician Decision|1|||
131504986|NCT05478252|473478020|FG000|Overall Study|Death|1|||
131504987|NCT05478252|473478021|FG001|Overall Study|Death|0|||
131504988|NCT07114198|473478022|FG000|Overall Study|Protocol Violation|1|||
131504989|NCT07114198|473478023|FG001|Overall Study|Protocol Violation|1|||
131504990|NCT00670800|473480500|FG000|Overall Study|2 controls were insulin resistant|0|||
131504991|NCT00670800|473480501|FG001|Overall Study|2 controls were insulin resistant|2|||
131505018|NCT04318080|473480504|FG000|Overall Study|Study closed by sponsor|10|||
131505019|NCT04318080|473480505|FG001|Overall Study|Study closed by sponsor|22|||
131505020|NCT04318080|473480504|FG000|Overall Study|Death|3|||
131505021|NCT04318080|473480505|FG001|Overall Study|Death|9|||
131505022|NCT04318080|473480504|FG000|Overall Study|Withdrawal by Subject|1|||
131505023|NCT04318080|473480505|FG001|Overall Study|Withdrawal by Subject|0|||
131505024|NCT04318080|473480504|FG000|Overall Study|Protocol Deviation|1|||
131505025|NCT04318080|473480505|FG001|Overall Study|Protocol Deviation|0|||
131505026|NCT06308822|473480506|FG000|Overall Study|Mutation Status Not Confirmed|17|||
131505027|NCT06308822|473480506|FG000|Overall Study|Adverse Event|1|||
131505028|NCT06308822|473480506|FG000|Overall Study|Death|5|||
131505029|NCT06308822|473480506|FG000|Overall Study|Disease progression|8|||
131505030|NCT06308822|473480506|FG000|Overall Study|Withdrawal by Subject|1|||
131505031|NCT06308822|473480506|FG000|Overall Study|Physician Decision|3|||
131505032|NCT01852942|473480514|FG000|Overall Study|Physician Decision|1|||
131505033|NCT01852942|473480515|FG001|Overall Study|Physician Decision|0|||
131505034|NCT01852942|473480514|FG000|Overall Study|Death|1|||
131505035|NCT01852942|473480515|FG001|Overall Study|Death|1|||
131505036|NCT01852942|473480514|FG000|Overall Study|Withdrawal by Subject|2|||
131505037|NCT01852942|473480515|FG001|Overall Study|Withdrawal by Subject|3|||
131505038|NCT01852942|473480514|FG000|Overall Study|Lost to Follow-up|1|||
131505039|NCT01852942|473480515|FG001|Overall Study|Lost to Follow-up|2|||
131505040|NCT01921179|473480516|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
131505041|NCT01921179|473480517|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
131505042|NCT01921179|473480516|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
131505043|NCT01921179|473480517|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
131505044|NCT00858442|473480522|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
131505045|NCT00858442|473480523|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
131505046|NCT03970733|473480526|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
131505047|NCT03970733|473480527|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
131505048|NCT03970733|473480528|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
131505049|NCT03970733|473480529|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
131505050|NCT03970733|473480530|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
131505051|NCT03970733|473480526|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
131505052|NCT03970733|473480527|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
131505053|NCT03970733|473480528|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
131505054|NCT03970733|473480529|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
131505055|NCT03970733|473480530|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
131505056|NCT03970733|473480526|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
131505057|NCT03970733|473480527|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
131505058|NCT03970733|473480528|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
131505059|NCT03970733|473480529|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
131505060|NCT03970733|473480530|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
131505061|NCT03970733|473480526|FG000|Main Study Phase (18 Months)|Other|1|||
131505062|NCT03970733|473480527|FG001|Main Study Phase (18 Months)|Other|1|||
131505063|NCT03970733|473480528|FG002|Main Study Phase (18 Months)|Other|0|||
131505064|NCT03970733|473480529|FG003|Main Study Phase (18 Months)|Other|0|||
131505065|NCT03970733|473480530|FG004|Main Study Phase (18 Months)|Other|0|||
131505066|NCT03970733|473480526|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
131505067|NCT03970733|473480527|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
131505068|NCT03970733|473480528|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
131505069|NCT03970733|473480529|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
131505070|NCT03970733|473480530|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
131505071|NCT02189473|473480534|FG000|Overall Study|Death|22|||
131505072|NCT02189473|473480535|FG001|Overall Study|Death|23|||
131505073|NCT02189473|473480534|FG000|Overall Study|Lost to Follow-up|1|||
131505074|NCT02189473|473480535|FG001|Overall Study|Lost to Follow-up|2|||
131505075|NCT01955161|473480536|FG000|Overall Study|Withdrawal before treatment|2|||
131505076|NCT01955161|473480537|FG001|Overall Study|Withdrawal before treatment|0|||
131505077|NCT01955161|473480538|FG002|Overall Study|Withdrawal before treatment|1|||
131505078|NCT01955161|473480536|FG000|Overall Study|Adverse Event|10|||
131505079|NCT01955161|473480537|FG001|Overall Study|Adverse Event|14|||
131505080|NCT01955161|473480538|FG002|Overall Study|Adverse Event|15|||
131505081|NCT01955161|473480536|FG000|Overall Study|Death|1|||
131505082|NCT01955161|473480537|FG001|Overall Study|Death|1|||
131505083|NCT01955161|473480538|FG002|Overall Study|Death|3|||
131505084|NCT01955161|473480536|FG000|Overall Study|Withdrawal by Subject|9|||
131505085|NCT01955161|473480537|FG001|Overall Study|Withdrawal by Subject|8|||
131505086|NCT01955161|473480538|FG002|Overall Study|Withdrawal by Subject|12|||
131505087|NCT01955161|473480536|FG000|Overall Study|Protocol Violation|2|||
131505088|NCT01955161|473480537|FG001|Overall Study|Protocol Violation|0|||
131505089|NCT01955161|473480538|FG002|Overall Study|Protocol Violation|0|||
131505090|NCT01955161|473480536|FG000|Overall Study|Other reason: physician decision|0|||
131505091|NCT01955161|473480537|FG001|Overall Study|Other reason: physician decision|1|||
131505092|NCT01955161|473480538|FG002|Overall Study|Other reason: physician decision|1|||
131505093|NCT01955161|473480536|FG000|Overall Study|Other reason: disallowed medication|1|||
131505094|NCT01955161|473480537|FG001|Overall Study|Other reason: disallowed medication|0|||
131505095|NCT01955161|473480538|FG002|Overall Study|Other reason: disallowed medication|1|||
131505096|NCT01955161|473480536|FG000|Overall Study|Other reason: caregiver unavailable|1|||
131505097|NCT01955161|473480537|FG001|Overall Study|Other reason: caregiver unavailable|0|||
131505098|NCT01955161|473480538|FG002|Overall Study|Other reason: caregiver unavailable|0|||
131505099|NCT01955161|473480536|FG000|Overall Study|Other reason: moved to nursing home|0|||
131505100|NCT01955161|473480537|FG001|Overall Study|Other reason: moved to nursing home|1|||
131505101|NCT01955161|473480538|FG002|Overall Study|Other reason: moved to nursing home|0|||
131658093|NCT04445987|474032998|FG004|Overall Study|Lost to Follow-up|29|||
131505102|NCT01955161|473480536|FG000|Overall Study|Other reason: insufficient compliance|0|||
131505103|NCT01955161|473480537|FG001|Overall Study|Other reason: insufficient compliance|0|||
131505104|NCT01955161|473480538|FG002|Overall Study|Other reason: insufficient compliance|1|||
131505105|NCT01955161|473480536|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
131505106|NCT01955161|473480537|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
131505107|NCT01955161|473480538|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
131505108|NCT01955161|473480536|FG000|Overall Study|Other reason: patient's will|0|||
131505109|NCT01955161|473480537|FG001|Overall Study|Other reason: patient's will|0|||
131505110|NCT01955161|473480538|FG002|Overall Study|Other reason: patient's will|1|||
131505111|NCT01277523|473480539|FG000|Overall Study|Adverse Event|1|||
131505112|NCT01277523|473480540|FG001|Overall Study|Adverse Event|0|||
131505113|NCT01277523|473480541|FG002|Overall Study|Adverse Event|0|||
131505114|NCT01277523|473480539|FG000|Overall Study|Protocol Violation|2|||
131505115|NCT01277523|473480540|FG001|Overall Study|Protocol Violation|0|||
131505116|NCT01277523|473480541|FG002|Overall Study|Protocol Violation|0|||
131505117|NCT01277523|473480539|FG000|Overall Study|Other Reason not Defined|0|||
131505118|NCT01277523|473480540|FG001|Overall Study|Other Reason not Defined|1|||
131505119|NCT01277523|473480541|FG002|Overall Study|Other Reason not Defined|0|||
131505120|NCT01881230|473480547|FG000|Overall Study|Death|2|||
131505121|NCT01881230|473480548|FG001|Overall Study|Death|0|||
131505122|NCT01881230|473480549|FG002|Overall Study|Death|1|||
131505123|NCT01881230|473480547|FG000|Overall Study|Adverse Event|9|||
131505124|NCT01881230|473480548|FG001|Overall Study|Adverse Event|13|||
131505125|NCT01881230|473480549|FG002|Overall Study|Adverse Event|12|||
131505126|NCT01881230|473480547|FG000|Overall Study|Progressive Disease|31|||
131505127|NCT01881230|473480548|FG001|Overall Study|Progressive Disease|35|||
131505128|NCT01881230|473480549|FG002|Overall Study|Progressive Disease|36|||
131505129|NCT01881230|473480547|FG000|Overall Study|Symptomatic Deterioration|3|||
131505130|NCT01881230|473480548|FG001|Overall Study|Symptomatic Deterioration|3|||
131505131|NCT01881230|473480549|FG002|Overall Study|Symptomatic Deterioration|1|||
131505132|NCT01881230|473480547|FG000|Overall Study|Withdrawal by Subject|6|||
131505133|NCT01881230|473480548|FG001|Overall Study|Withdrawal by Subject|4|||
131505134|NCT01881230|473480549|FG002|Overall Study|Withdrawal by Subject|6|||
131505135|NCT01881230|473480547|FG000|Overall Study|Physician Decision|4|||
131505136|NCT01881230|473480548|FG001|Overall Study|Physician Decision|3|||
131505137|NCT01881230|473480549|FG002|Overall Study|Physician Decision|6|||
131505138|NCT01881230|473480547|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131505139|NCT01881230|473480548|FG001|Overall Study|Non-Compliance with Study Drug|2|||
131505140|NCT01881230|473480549|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131505141|NCT01881230|473480547|FG000|Overall Study|Given Commercially Available Drug|0|||
131505142|NCT01881230|473480548|FG001|Overall Study|Given Commercially Available Drug|0|||
131505143|NCT01881230|473480549|FG002|Overall Study|Given Commercially Available Drug|2|||
131505144|NCT01881230|473480547|FG000|Overall Study|Protocol Violation|1|||
131505145|NCT01881230|473480548|FG001|Overall Study|Protocol Violation|1|||
131505146|NCT01881230|473480549|FG002|Overall Study|Protocol Violation|0|||
131505147|NCT01881230|473480547|FG000|Overall Study|Miscellaneous|3|||
131505148|NCT01881230|473480548|FG001|Overall Study|Miscellaneous|3|||
131505149|NCT01881230|473480549|FG002|Overall Study|Miscellaneous|0|||
131505150|NCT01881230|473480547|FG000|Overall Study|Untreated: Other|0|||
131505151|NCT01881230|473480548|FG001|Overall Study|Untreated: Other|0|||
131505152|NCT01881230|473480549|FG002|Overall Study|Untreated: Other|1|||
131505153|NCT01881230|473480547|FG000|Overall Study|Untreated: Death|0|||
131505154|NCT01881230|473480548|FG001|Overall Study|Untreated: Death|0|||
131505155|NCT01881230|473480549|FG002|Overall Study|Untreated: Death|1|||
131505156|NCT01881230|473480547|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
131505157|NCT01881230|473480548|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
131505158|NCT01881230|473480549|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
131505159|NCT02385266|473480550|FG000|Overall Study|Withdrawal by Subject|1|||
131505160|NCT02385266|473480551|FG001|Overall Study|Withdrawal by Subject|3|||
131505161|NCT00112502|473480552|FG000|Overall Study|Withdrawal by Subject|0|||
131505162|NCT00112502|473480553|FG001|Overall Study|Withdrawal by Subject|1|||
131505163|NCT00112502|473480554|FG002|Overall Study|Withdrawal by Subject|1|||
131505164|NCT00112502|473480555|FG003|Overall Study|Withdrawal by Subject|4|||
131505165|NCT00112502|473480556|FG004|Overall Study|Withdrawal by Subject|2|||
131505166|NCT00112502|473480557|FG005|Overall Study|Withdrawal by Subject|5|||
131505167|NCT00112502|473480558|FG006|Overall Study|Withdrawal by Subject|3|||
131505168|NCT00112502|473480559|FG007|Overall Study|Withdrawal by Subject|7|||
131505169|NCT01030523|473480560|FG000|Initial Study (5 Years)|Death|1|||
131505170|NCT01030523|473480561|FG001|Initial Study (5 Years)|Death|0|||
131505171|NCT01030523|473480560|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
131505172|NCT01030523|473480561|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
131505173|NCT01030523|473480560|FG000|Initial Study (5 Years)|Implant failure|1|||
131505174|NCT01030523|473480561|FG001|Initial Study (5 Years)|Implant failure|0|||
131505175|NCT01030523|473480560|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
131505176|NCT01030523|473480561|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
131505177|NCT01030523|473480560|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
131505178|NCT01030523|473480561|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
131505179|NCT01030523|473480560|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
131505180|NCT01030523|473480561|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
131505181|NCT00491387|473480570|FG000|Overall Study|study terminated|20|||
131505182|NCT01132547|473480571|FG000|Overall Study|Withdrawal by Subject|3|||
131505183|NCT01132547|473480572|FG001|Overall Study|Withdrawal by Subject|1|||
131505184|NCT01132547|473480571|FG000|Overall Study|Death|1|||
131505185|NCT01132547|473480572|FG001|Overall Study|Death|0|||
131505186|NCT05811234|473480573|FG000|Overall Study|Loss of Effectiveness|2|||
131505187|NCT05811234|473480573|FG000|Overall Study|Adverse Event|4|||
131505188|NCT05811234|473480573|FG000|Overall Study|Pregnancy|1|||
131505189|NCT05811234|473480573|FG000|Overall Study|Disease progression|1|||
131505190|NCT05811234|473480573|FG000|Overall Study|Withdrawal by Subject|4|||
131505191|NCT05811234|473480573|FG000|Overall Study|Lost to Follow-up|13|||
131505192|NCT05811234|473480573|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
131505193|NCT00227305|473480578|FG000|Overall Study|Adverse Event|40|||
131505194|NCT00227305|473480578|FG000|Overall Study|Withdrawal by Subject|42|||
131505195|NCT00227305|473480578|FG000|Overall Study|Lost to Follow-up|33|||
131505196|NCT00227305|473480578|FG000|Overall Study|Study specific discontinuation|13|||
131505197|NCT00227305|473480578|FG000|Overall Study|MOVED OUT OF AREA|3|||
131505198|NCT00227305|473480578|FG000|Overall Study|Lack of Efficacy|7|||
131505199|NCT00227305|473480578|FG000|Overall Study|Physician Decision|3|||
131505200|NCT00227305|473480578|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
131505201|NCT00227305|473480578|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
131505202|NCT00227305|473480578|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
131505203|NCT00483379|473480581|FG000|Treatment Period|Adverse Event|1|||
131505204|NCT00483379|473480582|FG001|Treatment Period|Adverse Event|0|||
131505205|NCT00483379|473480581|FG000|Treatment Period|Withdrawal by Subject|1|||
131505206|NCT00483379|473480582|FG001|Treatment Period|Withdrawal by Subject|0|||
131505207|NCT03329690|473480584|FG000|Overall Study|Progressive disease per RECIST|85|||
131505208|NCT03329690|473480585|FG001|Overall Study|Progressive disease per RECIST|44|||
131505209|NCT03329690|473480586|FG002|Overall Study|Progressive disease per RECIST|6|||
131505210|NCT03329690|473480587|FG003|Overall Study|Progressive disease per RECIST|16|||
131505211|NCT03329690|473480588|FG004|Overall Study|Progressive disease per RECIST|20|||
131505212|NCT03329690|473480584|FG000|Overall Study|Clinical progression|7|||
131505213|NCT03329690|473480585|FG001|Overall Study|Clinical progression|4|||
131505214|NCT03329690|473480586|FG002|Overall Study|Clinical progression|1|||
131505215|NCT03329690|473480587|FG003|Overall Study|Clinical progression|1|||
131505216|NCT03329690|473480588|FG004|Overall Study|Clinical progression|1|||
131505217|NCT03329690|473480584|FG000|Overall Study|Adverse Event|22|||
131505218|NCT03329690|473480585|FG001|Overall Study|Adverse Event|4|||
131505219|NCT03329690|473480586|FG002|Overall Study|Adverse Event|0|||
131505220|NCT03329690|473480587|FG003|Overall Study|Adverse Event|1|||
131505221|NCT03329690|473480588|FG004|Overall Study|Adverse Event|2|||
131505222|NCT03329690|473480584|FG000|Overall Study|Death|2|||
131505223|NCT03329690|473480585|FG001|Overall Study|Death|0|||
131505224|NCT03329690|473480586|FG002|Overall Study|Death|0|||
131505225|NCT03329690|473480587|FG003|Overall Study|Death|1|||
131505226|NCT03329690|473480588|FG004|Overall Study|Death|0|||
131505227|NCT03329690|473480584|FG000|Overall Study|Withdrawal by Subject|2|||
131505228|NCT03329690|473480585|FG001|Overall Study|Withdrawal by Subject|3|||
131505229|NCT03329690|473480586|FG002|Overall Study|Withdrawal by Subject|0|||
131505230|NCT03329690|473480587|FG003|Overall Study|Withdrawal by Subject|1|||
131505231|NCT03329690|473480588|FG004|Overall Study|Withdrawal by Subject|0|||
131505232|NCT03329690|473480584|FG000|Overall Study|Physician Decision|1|||
131505233|NCT03329690|473480585|FG001|Overall Study|Physician Decision|0|||
131505234|NCT03329690|473480586|FG002|Overall Study|Physician Decision|0|||
131505235|NCT03329690|473480587|FG003|Overall Study|Physician Decision|0|||
131505236|NCT03329690|473480588|FG004|Overall Study|Physician Decision|1|||
131505237|NCT03329690|473480584|FG000|Overall Study|Miscellaneous|6|||
131505238|NCT03329690|473480585|FG001|Overall Study|Miscellaneous|0|||
131505239|NCT03329690|473480586|FG002|Overall Study|Miscellaneous|0|||
131505240|NCT03329690|473480587|FG003|Overall Study|Miscellaneous|0|||
131505241|NCT03329690|473480588|FG004|Overall Study|Miscellaneous|0|||
131505242|NCT03329690|473480584|FG000|Overall Study|Did not receive treatment|1|||
131505243|NCT03329690|473480585|FG001|Overall Study|Did not receive treatment|0|||
131505244|NCT03329690|473480586|FG002|Overall Study|Did not receive treatment|0|||
131505245|NCT03329690|473480587|FG003|Overall Study|Did not receive treatment|1|||
131505246|NCT03329690|473480588|FG004|Overall Study|Did not receive treatment|0|||
131505247|NCT03311659|473480593|FG000|Overall Study|Protocol Violation|1|||
131505248|NCT04053023|473480594|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
131505249|NCT04053023|473480595|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
131505250|NCT00071760|473480596|FG000|Overall Study|Adverse Event|2|||
131505251|NCT00071760|473480597|FG001|Overall Study|Adverse Event|1|||
131505252|NCT00071760|473480596|FG000|Overall Study|Lost to Follow-up|0|||
131505253|NCT00071760|473480597|FG001|Overall Study|Lost to Follow-up|3|||
131505254|NCT00071760|473480596|FG000|Overall Study|Protocol Violation|1|||
131505255|NCT00071760|473480597|FG001|Overall Study|Protocol Violation|0|||
131505256|NCT00071760|473480596|FG000|Overall Study|Withdrawal by Subject|0|||
131505257|NCT00071760|473480597|FG001|Overall Study|Withdrawal by Subject|1|||
131505258|NCT00071760|473480596|FG000|Overall Study|Insufficient Viral Load Response|1|||
131505259|NCT00071760|473480597|FG001|Overall Study|Insufficient Viral Load Response|1|||
131505260|NCT00071760|473480596|FG000|Overall Study|Lack of availability of RTV|1|||
131505261|NCT00071760|473480597|FG001|Overall Study|Lack of availability of RTV|0|||
131505262|NCT00071760|473480596|FG000|Overall Study|Physician Decision|2|||
131505263|NCT00071760|473480597|FG001|Overall Study|Physician Decision|1|||
131505264|NCT00071760|473480596|FG000|Overall Study|Relocation|0|||
131505265|NCT00071760|473480597|FG001|Overall Study|Relocation|1|||
131505266|NCT01994629|473480598|FG000|Overall Study|Withdrawal by Subject|1|||
131505267|NCT01994629|473480599|FG001|Overall Study|Withdrawal by Subject|0|||
131505268|NCT01994629|473480598|FG000|Overall Study|Lost to Follow-up|0|||
131505269|NCT01994629|473480599|FG001|Overall Study|Lost to Follow-up|3|||
131505270|NCT01170091|473480602|FG000|Overall Study|Missing efficacy evaluation|3|||
131505271|NCT01170091|473480602|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
131505272|NCT03559257|473480606|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
131505273|NCT03559257|473480607|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
131505274|NCT03559257|473480606|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131505275|NCT03559257|473480607|FG001|Double Blind Treatment Period|Protocol Violation|4|||
131505276|NCT03559257|473480606|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
131505277|NCT03559257|473480607|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
131505278|NCT03559257|473480606|FG000|Double Blind Treatment Period|Adverse Event|0|||
131505279|NCT03559257|473480607|FG001|Double Blind Treatment Period|Adverse Event|1|||
131505280|NCT03559257|473480606|FG000|Double Blind Treatment Period|Screen Failure|0|||
131505281|NCT03559257|473480607|FG001|Double Blind Treatment Period|Screen Failure|1|||
131505282|NCT03559257|473480606|FG000|Open-label Treatment Period|Adverse Event|1|||
131505283|NCT03559257|473480607|FG001|Open-label Treatment Period|Adverse Event|4|||
131505284|NCT03559257|473480606|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
131505285|NCT03559257|473480607|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
131505286|NCT03559257|473480606|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
131505287|NCT03559257|473480607|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131505288|NCT03559257|473480606|FG000|Open-label Treatment Period|Protocol Violation|2|||
131505289|NCT03559257|473480607|FG001|Open-label Treatment Period|Protocol Violation|0|||
131505290|NCT03559257|473480606|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
131505291|NCT03559257|473480607|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
131505292|NCT03559257|473480606|FG000|Open-label Treatment Period|Physician Decision|0|||
131505293|NCT03559257|473480607|FG001|Open-label Treatment Period|Physician Decision|1|||
131505294|NCT01387347|473480608|FG000|Overall Study|Lost to Follow-up|2|||
131505295|NCT01387347|473480609|FG001|Overall Study|Lost to Follow-up|1|||
131505296|NCT01519960|473480610|FG000|Overall Study|Withdrawal from the study|26|||
131505297|NCT01519960|473480611|FG001|Overall Study|Withdrawal from the study|22|||
131505298|NCT01519960|473480612|FG002|Overall Study|Withdrawal from the study|5|||
131505299|NCT00561080|473480615|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
131505300|NCT00561080|473480616|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
131505301|NCT00561080|473480617|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
131505302|NCT00561080|473480615|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
131505303|NCT00561080|473480616|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
131505304|NCT00561080|473480617|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
131505305|NCT00561080|473480615|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
131505306|NCT00561080|473480616|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
131505307|NCT00561080|473480617|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
131505308|NCT00561080|473480615|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
131505309|NCT00561080|473480616|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
131505310|NCT00561080|473480617|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
131505311|NCT00561080|473480615|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
131505312|NCT00561080|473480616|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
131505313|NCT00561080|473480617|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
131505314|NCT00561080|473480615|FG000|Vaccination Period (up to Month 4)|Other|0|||
131505315|NCT00561080|473480616|FG001|Vaccination Period (up to Month 4)|Other|2|||
131505316|NCT00561080|473480617|FG002|Vaccination Period (up to Month 4)|Other|1|||
131505317|NCT00561080|473480615|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
131505318|NCT00561080|473480616|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
131505319|NCT00561080|473480617|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
131505320|NCT00561080|473480615|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
131505321|NCT00561080|473480616|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
131505322|NCT00561080|473480617|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
131505323|NCT00561080|473480615|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
131505324|NCT00561080|473480616|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
131505325|NCT00561080|473480617|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
131505326|NCT00561080|473480615|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
131505327|NCT00561080|473480616|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
131505328|NCT00561080|473480617|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
131505329|NCT01288287|473480618|FG000|Overall Study|Lost to Follow-up|8|||
131505330|NCT01288287|473480618|FG000|Overall Study|Withdrawal by Subject|4|||
131505331|NCT01288287|473480618|FG000|Overall Study|Lack of Efficacy|13|||
131505332|NCT01288287|473480618|FG000|Overall Study|Other Reason|13|||
131505333|NCT01288287|473480618|FG000|Overall Study|Unknown Reason|1|||
131505334|NCT01288287|473480618|FG000|Overall Study|Unknown Status|7|||
131505335|NCT01092182|473480619|FG000|Overall Study|Death|0|||
131505336|NCT01092182|473480620|FG001|Overall Study|Death|5|||
131505337|NCT01092182|473480621|FG002|Overall Study|Death|3|||
131505338|NCT01092182|473480619|FG000|Overall Study|participant safety|1|||
131505339|NCT01092182|473480620|FG001|Overall Study|participant safety|2|||
131505340|NCT01092182|473480621|FG002|Overall Study|participant safety|0|||
131505341|NCT01092182|473480619|FG000|Overall Study|Physician Decision|0|||
131505342|NCT01092182|473480620|FG001|Overall Study|Physician Decision|6|||
131505343|NCT01092182|473480621|FG002|Overall Study|Physician Decision|0|||
131505344|NCT01092182|473480619|FG000|Overall Study|Did not meet criteria|0|||
131505345|NCT01092182|473480620|FG001|Overall Study|Did not meet criteria|0|||
131505346|NCT01092182|473480621|FG002|Overall Study|Did not meet criteria|25|||
131505347|NCT01092182|473480619|FG000|Overall Study|Non-compliance|0|||
131505348|NCT01092182|473480620|FG001|Overall Study|Non-compliance|3|||
131505349|NCT01092182|473480621|FG002|Overall Study|Non-compliance|0|||
131505350|NCT01092182|473480619|FG000|Overall Study|Participant refused follow-up|0|||
131505351|NCT01092182|473480620|FG001|Overall Study|Participant refused follow-up|2|||
131505352|NCT01092182|473480621|FG002|Overall Study|Participant refused follow-up|0|||
131505353|NCT02515045|473480628|FG000|Overall Study|Adverse Event|0|||
131505354|NCT02515045|473480629|FG001|Overall Study|Adverse Event|3|||
131505355|NCT02515045|473480630|FG002|Overall Study|Adverse Event|3|||
131505356|NCT02515045|473480628|FG000|Overall Study|Lost to Follow-up|0|||
131505357|NCT02515045|473480629|FG001|Overall Study|Lost to Follow-up|1|||
131505358|NCT02515045|473480630|FG002|Overall Study|Lost to Follow-up|1|||
131505359|NCT00238121|473480633|FG000|Overall Study|Withdrawal by Subject|1|||
131505360|NCT00238121|473480634|FG001|Overall Study|Withdrawal by Subject|1|||
131505361|NCT00238121|473480633|FG000|Overall Study|Adverse Event|2|||
131505362|NCT00238121|473480634|FG001|Overall Study|Adverse Event|1|||
131505363|NCT03255382|473480635|FG000|Overall Study|Adverse Event|3|||
131505364|NCT03255382|473480636|FG001|Overall Study|Adverse Event|0|||
131505365|NCT03255382|473480635|FG000|Overall Study|Lost to Follow-up|2|||
131505366|NCT03255382|473480636|FG001|Overall Study|Lost to Follow-up|0|||
131505367|NCT03255382|473480635|FG000|Overall Study|Withdrawal by Subject|2|||
131505368|NCT03255382|473480636|FG001|Overall Study|Withdrawal by Subject|0|||
131505369|NCT03255382|473480635|FG000|Overall Study|Other|6|||
131505370|NCT03255382|473480636|FG001|Overall Study|Other|0|||
131505371|NCT02221284|473480639|FG000|Overall Study|Case Report Forms Uncollected|56|||
131505372|NCT02221284|473480639|FG000|Overall Study|Protocol Deviation|5|||
131505373|NCT02587065|473480641|FG000|Overall Study|Adverse Event|14|||
131505374|NCT02587065|473480641|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
131505375|NCT02587065|473480641|FG000|Overall Study|Non-adherence to the Protocol|3|||
131505376|NCT02587065|473480641|FG000|Overall Study|Discontinuation of Study Medication|2|||
131505377|NCT02587065|473480641|FG000|Overall Study|Reason not Specified|3|||
131505378|NCT02446990|473480645|FG000|Overall Study|Death|485|||
131505379|NCT02446990|473480646|FG001|Overall Study|Death|458|||
131505380|NCT02446990|473480645|FG000|Overall Study|Lost to Follow-up|3|||
131505381|NCT02446990|473480646|FG001|Overall Study|Lost to Follow-up|1|||
131505382|NCT02446990|473480645|FG000|Overall Study|Physician Decision|1|||
131505383|NCT02446990|473480646|FG001|Overall Study|Physician Decision|0|||
131505384|NCT02446990|473480645|FG000|Overall Study|Withdrawal by Subject|231|||
131505385|NCT02446990|473480646|FG001|Overall Study|Withdrawal by Subject|199|||
131505386|NCT01064401|473480647|FG000|Overall Study|Adverse Event|47|||
131505387|NCT01064401|473480648|FG001|Overall Study|Adverse Event|56|||
131505388|NCT01064401|473480647|FG000|Overall Study|Lack of Efficacy|46|||
131505389|NCT01064401|473480648|FG001|Overall Study|Lack of Efficacy|23|||
131505390|NCT01064401|473480647|FG000|Overall Study|Lost to Follow-up|12|||
131505391|NCT01064401|473480648|FG001|Overall Study|Lost to Follow-up|9|||
131505392|NCT01064401|473480647|FG000|Overall Study|Consent Withdrawn|98|||
131505393|NCT01064401|473480648|FG001|Overall Study|Consent Withdrawn|80|||
131505394|NCT01064401|473480647|FG000|Overall Study|Investigator Decision|4|||
131505395|NCT01064401|473480648|FG001|Overall Study|Investigator Decision|6|||
131505396|NCT01064401|473480647|FG000|Overall Study|Death|4|||
131505397|NCT01064401|473480648|FG001|Overall Study|Death|0|||
131505398|NCT01064401|473480647|FG000|Overall Study|Pregnancy|4|||
131505399|NCT01064401|473480648|FG001|Overall Study|Pregnancy|7|||
131505400|NCT01064401|473480647|FG000|Overall Study|Noncompliance|7|||
131505401|NCT01064401|473480648|FG001|Overall Study|Noncompliance|8|||
131505402|NCT01064401|473480647|FG000|Overall Study|Site Closure|4|||
131505403|NCT01064401|473480648|FG001|Overall Study|Site Closure|5|||
131505404|NCT01064401|473480647|FG000|Overall Study|Other|2|||
131505405|NCT01064401|473480648|FG001|Overall Study|Other|1|||
131505406|NCT03158051|473480649|FG000|Overall Study|Lost to Follow-up|41|||
131505407|NCT03158051|473480650|FG001|Overall Study|Lost to Follow-up|47|||
131505408|NCT03158051|473480649|FG000|Overall Study|Physician Decision|6|||
131505409|NCT03158051|473480650|FG001|Overall Study|Physician Decision|7|||
131505410|NCT03158051|473480649|FG000|Overall Study|Withdrawal by Subject|24|||
131505411|NCT03158051|473480650|FG001|Overall Study|Withdrawal by Subject|15|||
131505412|NCT03158051|473480649|FG000|Overall Study|Death|0|||
131505413|NCT03158051|473480650|FG001|Overall Study|Death|1|||
131505414|NCT02738151|473480651|FG000|Overall Study|Randomized but not treated|4|||
131505415|NCT02738151|473480652|FG001|Overall Study|Randomized but not treated|1|||
131505416|NCT02738151|473480651|FG000|Overall Study|Adverse Event|4|||
131505417|NCT02738151|473480652|FG001|Overall Study|Adverse Event|5|||
131505418|NCT02738151|473480651|FG000|Overall Study|Hypoglycemia|0|||
131505419|NCT02738151|473480652|FG001|Overall Study|Hypoglycemia|1|||
131505420|NCT02738151|473480651|FG000|Overall Study|Poor Compliance to Protocol|4|||
131505421|NCT02738151|473480652|FG001|Overall Study|Poor Compliance to Protocol|3|||
131505422|NCT02738151|473480651|FG000|Overall Study|Other than specified above|11|||
131505423|NCT02738151|473480652|FG001|Overall Study|Other than specified above|21|||
131505424|NCT02588833|473480653|FG000|Part 1|Withdrawal by Subject|1|||
131505425|NCT02588833|473480654|FG001|Part 1|Withdrawal by Subject|0|||
131505426|NCT02588833|473480653|FG000|Part 2A|Physician Decision|0|||
131505427|NCT02588833|473480654|FG001|Part 2A|Physician Decision|1|||
131505428|NCT02588833|473480653|FG000|Part 2A|Withdrawal by Subject|0|||
131505429|NCT02588833|473480654|FG001|Part 2A|Withdrawal by Subject|1|||
131505430|NCT02588833|473480653|FG000|Part 2B|Adverse Event|0|||
131505431|NCT02588833|473480654|FG001|Part 2B|Adverse Event|1|||
131505432|NCT02588833|473480653|FG000|Part 2C|Adverse Event|0|||
131505433|NCT02588833|473480654|FG001|Part 2C|Adverse Event|1|||
131505434|NCT02588833|473480653|FG000|Part 2C|Withdrawal by Subject|0|||
131505435|NCT02588833|473480654|FG001|Part 2C|Withdrawal by Subject|1|||
131505436|NCT02588833|473480653|FG000|Part 3 (Safety Follow-up)|Other|0|||
131505437|NCT02588833|473480654|FG001|Part 3 (Safety Follow-up)|Other|2|||
131505438|NCT03333044|473480658|FG000|Overall Study|Pregnancy|1|||
131505439|NCT03333044|473480659|FG001|Overall Study|Pregnancy|0|||
131505440|NCT03333044|473480660|FG002|Overall Study|Pregnancy|0|||
131505441|NCT03333044|473480658|FG000|Overall Study|Lost to Follow-up|0|||
131505442|NCT03333044|473480659|FG001|Overall Study|Lost to Follow-up|14|||
131505443|NCT03333044|473480660|FG002|Overall Study|Lost to Follow-up|6|||
131505444|NCT03649711|473480661|FG000|Overall Study|Adverse Event|0|||
131505445|NCT03649711|473480662|FG001|Overall Study|Adverse Event|1|||
131505446|NCT03649711|473480663|FG002|Overall Study|Adverse Event|0|||
131505447|NCT03649711|473480661|FG000|Overall Study|Kidney Transplant|1|||
131505448|NCT03649711|473480662|FG001|Overall Study|Kidney Transplant|0|||
131505449|NCT03649711|473480663|FG002|Overall Study|Kidney Transplant|0|||
131505450|NCT03188094|473480668|FG000|Overall Study|Screen failure|1|||
131505451|NCT03188094|473480669|FG001|Overall Study|Screen failure|0|||
131505452|NCT03188094|473480670|FG002|Overall Study|Screen failure|0|||
131505453|NCT03188094|473480668|FG000|Overall Study|Pregnancy|3|||
131505454|NCT03188094|473480669|FG001|Overall Study|Pregnancy|0|||
131505455|NCT03188094|473480670|FG002|Overall Study|Pregnancy|0|||
131505456|NCT03188094|473480668|FG000|Overall Study|Ineligible|1|||
131505457|NCT03188094|473480669|FG001|Overall Study|Ineligible|0|||
131505458|NCT03188094|473480670|FG002|Overall Study|Ineligible|0|||
131505459|NCT03188094|473480668|FG000|Overall Study|Lost to Follow-up|0|||
131505460|NCT03188094|473480669|FG001|Overall Study|Lost to Follow-up|0|||
131505461|NCT03188094|473480670|FG002|Overall Study|Lost to Follow-up|17|||
131505462|NCT02921776|473480671|FG000|Overall Study|patient deterioration, fatigue|2|||
131505463|NCT02921776|473480672|FG001|Overall Study|patient deterioration, fatigue|6|||
131505464|NCT02921776|473480673|FG002|Overall Study|patient deterioration, fatigue|0|||
131505465|NCT02921776|473480674|FG003|Overall Study|patient deterioration, fatigue|0|||
131658094|NCT04445987|474032999|FG005|Overall Study|Lost to Follow-up|0|||
131505466|NCT02921776|473480675|FG004|Overall Study|patient deterioration, fatigue|0|||
131505467|NCT02921776|473480676|FG005|Overall Study|patient deterioration, fatigue|0|||
131505468|NCT02921776|473480677|FG006|Overall Study|patient deterioration, fatigue|0|||
131505469|NCT02921776|473480678|FG007|Overall Study|patient deterioration, fatigue|0|||
131505470|NCT02921776|473480671|FG000|Overall Study|Withdrawal by Subject|0|||
131505471|NCT02921776|473480672|FG001|Overall Study|Withdrawal by Subject|2|||
131505472|NCT02921776|473480673|FG002|Overall Study|Withdrawal by Subject|0|||
131505473|NCT02921776|473480674|FG003|Overall Study|Withdrawal by Subject|1|||
131505474|NCT02921776|473480675|FG004|Overall Study|Withdrawal by Subject|1|||
131505475|NCT02921776|473480676|FG005|Overall Study|Withdrawal by Subject|0|||
131505476|NCT02921776|473480677|FG006|Overall Study|Withdrawal by Subject|8|||
131505477|NCT02921776|473480678|FG007|Overall Study|Withdrawal by Subject|1|||
131505478|NCT02921776|473480671|FG000|Overall Study|Death|0|||
131505479|NCT02921776|473480672|FG001|Overall Study|Death|0|||
131505480|NCT02921776|473480673|FG002|Overall Study|Death|0|||
131505481|NCT02921776|473480674|FG003|Overall Study|Death|2|||
131505482|NCT02921776|473480675|FG004|Overall Study|Death|0|||
131505483|NCT02921776|473480676|FG005|Overall Study|Death|0|||
131505484|NCT02921776|473480677|FG006|Overall Study|Death|0|||
131505485|NCT02921776|473480678|FG007|Overall Study|Death|0|||
131505486|NCT02921776|473480671|FG000|Overall Study|extubation or early discharge|0|||
131505487|NCT02921776|473480672|FG001|Overall Study|extubation or early discharge|0|||
131505488|NCT02921776|473480673|FG002|Overall Study|extubation or early discharge|0|||
131505489|NCT02921776|473480674|FG003|Overall Study|extubation or early discharge|5|||
131505490|NCT02921776|473480675|FG004|Overall Study|extubation or early discharge|5|||
131505491|NCT02921776|473480676|FG005|Overall Study|extubation or early discharge|0|||
131505492|NCT02921776|473480677|FG006|Overall Study|extubation or early discharge|0|||
131505493|NCT02921776|473480678|FG007|Overall Study|extubation or early discharge|0|||
131505494|NCT02921776|473480671|FG000|Overall Study|Lost to Follow-up|0|||
131505495|NCT02921776|473480672|FG001|Overall Study|Lost to Follow-up|0|||
131505496|NCT02921776|473480673|FG002|Overall Study|Lost to Follow-up|0|||
131505497|NCT02921776|473480674|FG003|Overall Study|Lost to Follow-up|0|||
131505498|NCT02921776|473480675|FG004|Overall Study|Lost to Follow-up|0|||
131505499|NCT02921776|473480676|FG005|Overall Study|Lost to Follow-up|2|||
131505500|NCT02921776|473480677|FG006|Overall Study|Lost to Follow-up|3|||
131505501|NCT02921776|473480678|FG007|Overall Study|Lost to Follow-up|6|||
131505502|NCT02070744|473480684|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
131505503|NCT02070744|473480685|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
131505504|NCT02070744|473480686|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
131505505|NCT02070744|473480687|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
131505506|NCT02070744|473480688|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
131505507|NCT02070744|473480684|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
131505508|NCT02070744|473480685|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
131505509|NCT02070744|473480686|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
131505510|NCT02070744|473480687|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
131505511|NCT02070744|473480688|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
131505512|NCT02070744|473480684|FG000|OLE Phase (48 Weeks)|Other|0|||
131505513|NCT02070744|473480685|FG001|OLE Phase (48 Weeks)|Other|0|||
131505514|NCT02070744|473480686|FG002|OLE Phase (48 Weeks)|Other|0|||
131505515|NCT02070744|473480687|FG003|OLE Phase (48 Weeks)|Other|0|||
131505516|NCT02070744|473480688|FG004|OLE Phase (48 Weeks)|Other|1|||
131505517|NCT04199117|473480689|FG000|Overall Study|Withdrawal by Subject|3|||
131505518|NCT04199117|473480690|FG001|Overall Study|Withdrawal by Subject|0|||
131505519|NCT04199117|473480691|FG002|Overall Study|Withdrawal by Subject|0|||
131505520|NCT04199117|473480692|FG003|Overall Study|Withdrawal by Subject|1|||
131505521|NCT04199117|473480693|FG004|Overall Study|Withdrawal by Subject|1|||
131505522|NCT04199117|473480694|FG005|Overall Study|Withdrawal by Subject|0|||
131505523|NCT04199117|473480695|FG006|Overall Study|Withdrawal by Subject|0|||
131505524|NCT04199117|473480696|FG007|Overall Study|Withdrawal by Subject|2|||
131505525|NCT04199117|473480697|FG008|Overall Study|Withdrawal by Subject|0|||
131505526|NCT04199117|473480698|FG009|Overall Study|Withdrawal by Subject|0|||
131505527|NCT04199117|473480699|FG010|Overall Study|Withdrawal by Subject|1|||
131505528|NCT04199117|473480700|FG011|Overall Study|Withdrawal by Subject|1|||
131505529|NCT04199117|473480701|FG012|Overall Study|Withdrawal by Subject|2|||
131505530|NCT04199117|473480702|FG013|Overall Study|Withdrawal by Subject|1|||
131505531|NCT04199117|473480703|FG014|Overall Study|Withdrawal by Subject|1|||
131505532|NCT04199117|473480704|FG015|Overall Study|Withdrawal by Subject|1|||
131505533|NCT04199117|473480689|FG000|Overall Study|Death|1|||
131505534|NCT04199117|473480690|FG001|Overall Study|Death|1|||
131505535|NCT04199117|473480691|FG002|Overall Study|Death|0|||
131505536|NCT04199117|473480692|FG003|Overall Study|Death|0|||
131505537|NCT04199117|473480693|FG004|Overall Study|Death|0|||
131505538|NCT04199117|473480694|FG005|Overall Study|Death|0|||
131505539|NCT04199117|473480695|FG006|Overall Study|Death|0|||
131505540|NCT04199117|473480696|FG007|Overall Study|Death|0|||
131505541|NCT04199117|473480697|FG008|Overall Study|Death|0|||
131505542|NCT04199117|473480698|FG009|Overall Study|Death|0|||
131505543|NCT04199117|473480699|FG010|Overall Study|Death|0|||
131505544|NCT04199117|473480700|FG011|Overall Study|Death|1|||
131505545|NCT04199117|473480701|FG012|Overall Study|Death|0|||
131505546|NCT04199117|473480702|FG013|Overall Study|Death|1|||
131505547|NCT04199117|473480703|FG014|Overall Study|Death|0|||
131505548|NCT04199117|473480704|FG015|Overall Study|Death|0|||
131505549|NCT04199117|473480689|FG000|Overall Study|Withdrawal by PI|0|||
131505550|NCT04199117|473480690|FG001|Overall Study|Withdrawal by PI|0|||
131505551|NCT04199117|473480691|FG002|Overall Study|Withdrawal by PI|0|||
131505552|NCT04199117|473480692|FG003|Overall Study|Withdrawal by PI|0|||
131505553|NCT04199117|473480693|FG004|Overall Study|Withdrawal by PI|0|||
131505554|NCT04199117|473480694|FG005|Overall Study|Withdrawal by PI|0|||
131505555|NCT04199117|473480695|FG006|Overall Study|Withdrawal by PI|0|||
131505556|NCT04199117|473480696|FG007|Overall Study|Withdrawal by PI|0|||
131505557|NCT04199117|473480697|FG008|Overall Study|Withdrawal by PI|0|||
131505558|NCT04199117|473480698|FG009|Overall Study|Withdrawal by PI|0|||
131505559|NCT04199117|473480699|FG010|Overall Study|Withdrawal by PI|0|||
131505560|NCT04199117|473480700|FG011|Overall Study|Withdrawal by PI|0|||
131505561|NCT04199117|473480701|FG012|Overall Study|Withdrawal by PI|1|||
131505562|NCT04199117|473480702|FG013|Overall Study|Withdrawal by PI|0|||
131505563|NCT04199117|473480703|FG014|Overall Study|Withdrawal by PI|0|||
131505564|NCT04199117|473480704|FG015|Overall Study|Withdrawal by PI|0|||
131505565|NCT04439253|473482332|FG000|Overall Study|Adverse Event|1|||
131505566|NCT04439253|473482332|FG000|Overall Study|Disease progression|2|||
131505567|NCT04439253|473482332|FG000|Overall Study|Complicating disease|1|||
131505568|NCT00702403|473482333|FG000|From Consent to Engraftment|Progressive leukemia|6|||
131505569|NCT00702403|473482333|FG000|From Consent to Engraftment|Critically ill|2|||
131505570|NCT00702403|473482333|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
131505571|NCT00702403|473482333|FG000|From Consent to Engraftment|Myocardial infarction|1|||
131505572|NCT00702403|473482333|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
131505573|NCT00702403|473482333|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
131505574|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
131505575|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
131505576|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Non-compliance|2|||
131505577|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
131505578|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
131505579|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Suicide|1|||
131505580|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
131505581|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
131505582|NCT00702403|473482333|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
131505583|NCT00380978|473482335|FG000|Overall Study|Refused allocated intervention|0|||
131505584|NCT00380978|473482336|FG001|Overall Study|Refused allocated intervention|6|||
131505585|NCT00380978|473482335|FG000|Overall Study|Wrong study envelope|0|||
131505586|NCT00380978|473482336|FG001|Overall Study|Wrong study envelope|2|||
131505587|NCT00380978|473482335|FG000|Overall Study|Allocation prior to analgesia request|1|||
131505588|NCT00380978|473482336|FG001|Overall Study|Allocation prior to analgesia request|2|||
131505589|NCT00380978|473482335|FG000|Overall Study|Parous patient|1|||
131505590|NCT00380978|473482336|FG001|Overall Study|Parous patient|0|||
131505591|NCT04146545|473482337|FG000|Overall Study|deemed ineligible after randomization|1|||
131505592|NCT04146545|473482338|FG001|Overall Study|deemed ineligible after randomization|0|||
131505593|NCT01729754|473482339|FG000|Part 1|Adverse Event|2|||
131505594|NCT01729754|473482340|FG001|Part 1|Adverse Event|0|||
131505595|NCT01729754|473482341|FG002|Part 1|Adverse Event|0|||
131505596|NCT01729754|473482342|FG003|Part 1|Adverse Event|1|||
131505597|NCT01729754|473482343|FG004|Part 1|Adverse Event|0|||
131505598|NCT01729754|473482344|FG005|Part 1|Adverse Event|0|||
131505599|NCT01729754|473482345|FG006|Part 1|Adverse Event|2|||
131505600|NCT01729754|473482346|FG007|Part 1|Adverse Event|0|||
131505601|NCT01729754|473482347|FG008|Part 1|Adverse Event|0|||
131505602|NCT01729754|473482348|FG009|Part 1|Adverse Event|5|||
131505603|NCT01729754|473482339|FG000|Part 1|Lack of Efficacy|1|||
131505604|NCT01729754|473482340|FG001|Part 1|Lack of Efficacy|0|||
131505605|NCT01729754|473482341|FG002|Part 1|Lack of Efficacy|0|||
131505606|NCT01729754|473482342|FG003|Part 1|Lack of Efficacy|0|||
131505607|NCT01729754|473482343|FG004|Part 1|Lack of Efficacy|0|||
131505608|NCT01729754|473482344|FG005|Part 1|Lack of Efficacy|0|||
131505609|NCT01729754|473482345|FG006|Part 1|Lack of Efficacy|2|||
131505610|NCT01729754|473482346|FG007|Part 1|Lack of Efficacy|0|||
131505611|NCT01729754|473482347|FG008|Part 1|Lack of Efficacy|0|||
131505612|NCT01729754|473482348|FG009|Part 1|Lack of Efficacy|0|||
131505613|NCT01729754|473482339|FG000|Part 1|Lost to Follow-up|1|||
131505614|NCT01729754|473482340|FG001|Part 1|Lost to Follow-up|0|||
131505615|NCT01729754|473482341|FG002|Part 1|Lost to Follow-up|0|||
131505616|NCT01729754|473482342|FG003|Part 1|Lost to Follow-up|2|||
131505617|NCT01729754|473482343|FG004|Part 1|Lost to Follow-up|0|||
131505618|NCT01729754|473482344|FG005|Part 1|Lost to Follow-up|0|||
131505619|NCT01729754|473482345|FG006|Part 1|Lost to Follow-up|3|||
131505620|NCT01729754|473482346|FG007|Part 1|Lost to Follow-up|0|||
131505621|NCT01729754|473482347|FG008|Part 1|Lost to Follow-up|0|||
131505622|NCT01729754|473482348|FG009|Part 1|Lost to Follow-up|3|||
131505623|NCT01729754|473482339|FG000|Part 1|Non-compliance with Study Drug|1|||
131505624|NCT01729754|473482340|FG001|Part 1|Non-compliance with Study Drug|0|||
131505625|NCT01729754|473482341|FG002|Part 1|Non-compliance with Study Drug|0|||
131505626|NCT01729754|473482342|FG003|Part 1|Non-compliance with Study Drug|0|||
131505627|NCT01729754|473482343|FG004|Part 1|Non-compliance with Study Drug|0|||
131505628|NCT01729754|473482344|FG005|Part 1|Non-compliance with Study Drug|0|||
131505629|NCT01729754|473482345|FG006|Part 1|Non-compliance with Study Drug|0|||
131505630|NCT01729754|473482346|FG007|Part 1|Non-compliance with Study Drug|0|||
131505631|NCT01729754|473482347|FG008|Part 1|Non-compliance with Study Drug|0|||
131505632|NCT01729754|473482348|FG009|Part 1|Non-compliance with Study Drug|0|||
131505633|NCT01729754|473482339|FG000|Part 1|Physician Decision|0|||
131505634|NCT01729754|473482340|FG001|Part 1|Physician Decision|0|||
131505635|NCT01729754|473482341|FG002|Part 1|Physician Decision|0|||
131505636|NCT01729754|473482342|FG003|Part 1|Physician Decision|0|||
131505637|NCT01729754|473482343|FG004|Part 1|Physician Decision|0|||
131505638|NCT01729754|473482344|FG005|Part 1|Physician Decision|0|||
131505639|NCT01729754|473482345|FG006|Part 1|Physician Decision|0|||
131505640|NCT01729754|473482346|FG007|Part 1|Physician Decision|0|||
131505641|NCT01729754|473482347|FG008|Part 1|Physician Decision|0|||
131505642|NCT01729754|473482348|FG009|Part 1|Physician Decision|4|||
131505643|NCT01729754|473482339|FG000|Part 1|Pregnancy|0|||
131505644|NCT01729754|473482340|FG001|Part 1|Pregnancy|0|||
131505645|NCT01729754|473482341|FG002|Part 1|Pregnancy|0|||
131505646|NCT01729754|473482342|FG003|Part 1|Pregnancy|1|||
131505647|NCT01729754|473482343|FG004|Part 1|Pregnancy|0|||
131505648|NCT01729754|473482344|FG005|Part 1|Pregnancy|0|||
131505649|NCT01729754|473482345|FG006|Part 1|Pregnancy|0|||
131505650|NCT01729754|473482346|FG007|Part 1|Pregnancy|0|||
131505651|NCT01729754|473482347|FG008|Part 1|Pregnancy|0|||
131505652|NCT01729754|473482348|FG009|Part 1|Pregnancy|1|||
131505653|NCT01729754|473482339|FG000|Part 1|Progressive Disease|0|||
131505654|NCT01729754|473482340|FG001|Part 1|Progressive Disease|0|||
131505655|NCT01729754|473482341|FG002|Part 1|Progressive Disease|0|||
131505656|NCT01729754|473482342|FG003|Part 1|Progressive Disease|0|||
131505657|NCT01729754|473482343|FG004|Part 1|Progressive Disease|0|||
131505658|NCT01729754|473482344|FG005|Part 1|Progressive Disease|0|||
131505659|NCT01729754|473482345|FG006|Part 1|Progressive Disease|0|||
131505660|NCT01729754|473482346|FG007|Part 1|Progressive Disease|0|||
131505661|NCT01729754|473482347|FG008|Part 1|Progressive Disease|0|||
131505662|NCT01729754|473482348|FG009|Part 1|Progressive Disease|1|||
131505663|NCT01729754|473482339|FG000|Part 1|Protocol Violation|2|||
131505664|NCT01729754|473482340|FG001|Part 1|Protocol Violation|0|||
131505665|NCT01729754|473482341|FG002|Part 1|Protocol Violation|0|||
131505666|NCT01729754|473482342|FG003|Part 1|Protocol Violation|1|||
131505667|NCT01729754|473482343|FG004|Part 1|Protocol Violation|0|||
131505668|NCT01729754|473482344|FG005|Part 1|Protocol Violation|0|||
131505669|NCT01729754|473482345|FG006|Part 1|Protocol Violation|1|||
131505670|NCT01729754|473482346|FG007|Part 1|Protocol Violation|0|||
131505671|NCT01729754|473482347|FG008|Part 1|Protocol Violation|0|||
131505672|NCT01729754|473482348|FG009|Part 1|Protocol Violation|0|||
131505673|NCT01729754|473482339|FG000|Part 1|Withdrawal by Subject|5|||
131505674|NCT01729754|473482340|FG001|Part 1|Withdrawal by Subject|0|||
131505675|NCT01729754|473482341|FG002|Part 1|Withdrawal by Subject|0|||
131505676|NCT01729754|473482342|FG003|Part 1|Withdrawal by Subject|7|||
131505677|NCT01729754|473482343|FG004|Part 1|Withdrawal by Subject|0|||
131505678|NCT01729754|473482344|FG005|Part 1|Withdrawal by Subject|0|||
131505679|NCT01729754|473482345|FG006|Part 1|Withdrawal by Subject|5|||
131505680|NCT01729754|473482346|FG007|Part 1|Withdrawal by Subject|0|||
131505681|NCT01729754|473482347|FG008|Part 1|Withdrawal by Subject|0|||
131505682|NCT01729754|473482348|FG009|Part 1|Withdrawal by Subject|6|||
131505683|NCT01729754|473482339|FG000|Part 1|Other Protocol Specified Criteria|2|||
131505684|NCT01729754|473482340|FG001|Part 1|Other Protocol Specified Criteria|0|||
131505685|NCT01729754|473482341|FG002|Part 1|Other Protocol Specified Criteria|0|||
131505686|NCT01729754|473482342|FG003|Part 1|Other Protocol Specified Criteria|0|||
131505687|NCT01729754|473482343|FG004|Part 1|Other Protocol Specified Criteria|0|||
131505688|NCT01729754|473482344|FG005|Part 1|Other Protocol Specified Criteria|0|||
131505689|NCT01729754|473482345|FG006|Part 1|Other Protocol Specified Criteria|1|||
131505690|NCT01729754|473482346|FG007|Part 1|Other Protocol Specified Criteria|0|||
131505691|NCT01729754|473482347|FG008|Part 1|Other Protocol Specified Criteria|0|||
131505692|NCT01729754|473482348|FG009|Part 1|Other Protocol Specified Criteria|4|||
131505693|NCT01729754|473482339|FG000|Part 2|Adverse Event|2|||
131505694|NCT01729754|473482340|FG001|Part 2|Adverse Event|0|||
131505695|NCT01729754|473482341|FG002|Part 2|Adverse Event|0|||
131505696|NCT01729754|473482342|FG003|Part 2|Adverse Event|0|||
131505697|NCT01729754|473482343|FG004|Part 2|Adverse Event|0|||
131505698|NCT01729754|473482344|FG005|Part 2|Adverse Event|0|||
131505699|NCT01729754|473482345|FG006|Part 2|Adverse Event|0|||
131505700|NCT01729754|473482346|FG007|Part 2|Adverse Event|0|||
131505701|NCT01729754|473482347|FG008|Part 2|Adverse Event|1|||
131505702|NCT01729754|473482348|FG009|Part 2|Adverse Event|2|||
131505703|NCT01729754|473482339|FG000|Part 2|Lack of Efficacy|0|||
131505704|NCT01729754|473482340|FG001|Part 2|Lack of Efficacy|0|||
131505705|NCT01729754|473482341|FG002|Part 2|Lack of Efficacy|0|||
131505706|NCT01729754|473482342|FG003|Part 2|Lack of Efficacy|0|||
131505707|NCT01729754|473482343|FG004|Part 2|Lack of Efficacy|0|||
131505708|NCT01729754|473482344|FG005|Part 2|Lack of Efficacy|0|||
131505709|NCT01729754|473482345|FG006|Part 2|Lack of Efficacy|0|||
131505710|NCT01729754|473482346|FG007|Part 2|Lack of Efficacy|0|||
131505711|NCT01729754|473482347|FG008|Part 2|Lack of Efficacy|2|||
131505712|NCT01729754|473482348|FG009|Part 2|Lack of Efficacy|2|||
131505713|NCT01729754|473482339|FG000|Part 2|Lost to Follow-up|0|||
131505714|NCT01729754|473482340|FG001|Part 2|Lost to Follow-up|0|||
131505715|NCT01729754|473482341|FG002|Part 2|Lost to Follow-up|0|||
131505716|NCT01729754|473482342|FG003|Part 2|Lost to Follow-up|2|||
131505717|NCT01729754|473482343|FG004|Part 2|Lost to Follow-up|0|||
131505718|NCT01729754|473482344|FG005|Part 2|Lost to Follow-up|0|||
131505719|NCT01729754|473482345|FG006|Part 2|Lost to Follow-up|0|||
131505720|NCT01729754|473482346|FG007|Part 2|Lost to Follow-up|1|||
131505721|NCT01729754|473482347|FG008|Part 2|Lost to Follow-up|0|||
131505722|NCT01729754|473482348|FG009|Part 2|Lost to Follow-up|2|||
131505723|NCT01729754|473482339|FG000|Part 2|Non-Compliance with Study Drug|0|||
131505724|NCT01729754|473482340|FG001|Part 2|Non-Compliance with Study Drug|0|||
131505725|NCT01729754|473482341|FG002|Part 2|Non-Compliance with Study Drug|0|||
131505726|NCT01729754|473482342|FG003|Part 2|Non-Compliance with Study Drug|0|||
131505727|NCT01729754|473482343|FG004|Part 2|Non-Compliance with Study Drug|0|||
131505728|NCT01729754|473482344|FG005|Part 2|Non-Compliance with Study Drug|0|||
131505729|NCT01729754|473482345|FG006|Part 2|Non-Compliance with Study Drug|0|||
131505730|NCT01729754|473482346|FG007|Part 2|Non-Compliance with Study Drug|0|||
131505731|NCT01729754|473482347|FG008|Part 2|Non-Compliance with Study Drug|0|||
131505732|NCT01729754|473482348|FG009|Part 2|Non-Compliance with Study Drug|1|||
131505733|NCT01729754|473482339|FG000|Part 2|Pregnancy|0|||
131505734|NCT01729754|473482340|FG001|Part 2|Pregnancy|0|||
131505735|NCT01729754|473482341|FG002|Part 2|Pregnancy|0|||
131505736|NCT01729754|473482342|FG003|Part 2|Pregnancy|1|||
131505737|NCT01729754|473482343|FG004|Part 2|Pregnancy|0|||
131505738|NCT01729754|473482344|FG005|Part 2|Pregnancy|0|||
131505739|NCT01729754|473482345|FG006|Part 2|Pregnancy|0|||
131505740|NCT01729754|473482346|FG007|Part 2|Pregnancy|0|||
131505741|NCT01729754|473482347|FG008|Part 2|Pregnancy|0|||
131505742|NCT01729754|473482348|FG009|Part 2|Pregnancy|1|||
131505743|NCT01729754|473482339|FG000|Part 2|Withdrawal by Subject|3|||
131505744|NCT01729754|473482340|FG001|Part 2|Withdrawal by Subject|0|||
131505745|NCT01729754|473482341|FG002|Part 2|Withdrawal by Subject|0|||
131505746|NCT01729754|473482342|FG003|Part 2|Withdrawal by Subject|2|||
131505747|NCT01729754|473482343|FG004|Part 2|Withdrawal by Subject|0|||
131505748|NCT01729754|473482344|FG005|Part 2|Withdrawal by Subject|0|||
131505749|NCT01729754|473482345|FG006|Part 2|Withdrawal by Subject|0|||
131505750|NCT01729754|473482346|FG007|Part 2|Withdrawal by Subject|1|||
131505751|NCT01729754|473482347|FG008|Part 2|Withdrawal by Subject|1|||
131505752|NCT01729754|473482348|FG009|Part 2|Withdrawal by Subject|4|||
131505753|NCT01729754|473482339|FG000|Part 2|Other Protocol Specified Criteria|1|||
131505754|NCT01729754|473482340|FG001|Part 2|Other Protocol Specified Criteria|0|||
131505755|NCT01729754|473482341|FG002|Part 2|Other Protocol Specified Criteria|0|||
131505756|NCT01729754|473482342|FG003|Part 2|Other Protocol Specified Criteria|0|||
131505757|NCT01729754|473482343|FG004|Part 2|Other Protocol Specified Criteria|0|||
131505758|NCT01729754|473482344|FG005|Part 2|Other Protocol Specified Criteria|0|||
131505759|NCT01729754|473482345|FG006|Part 2|Other Protocol Specified Criteria|0|||
131505760|NCT01729754|473482346|FG007|Part 2|Other Protocol Specified Criteria|1|||
131505761|NCT01729754|473482347|FG008|Part 2|Other Protocol Specified Criteria|0|||
131505762|NCT01729754|473482348|FG009|Part 2|Other Protocol Specified Criteria|0|||
131505763|NCT01729754|473482339|FG000|Part 3|Adverse Event|0|||
131505764|NCT01729754|473482340|FG001|Part 3|Adverse Event|0|||
131505765|NCT01729754|473482341|FG002|Part 3|Adverse Event|1|||
131505766|NCT01729754|473482342|FG003|Part 3|Adverse Event|0|||
131505767|NCT01729754|473482343|FG004|Part 3|Adverse Event|0|||
131505768|NCT01729754|473482344|FG005|Part 3|Adverse Event|5|||
131505769|NCT01729754|473482345|FG006|Part 3|Adverse Event|0|||
131505770|NCT01729754|473482346|FG007|Part 3|Adverse Event|0|||
131505771|NCT01729754|473482347|FG008|Part 3|Adverse Event|0|||
131505772|NCT01729754|473482348|FG009|Part 3|Adverse Event|3|||
131505773|NCT01729754|473482339|FG000|Part 3|Death|0|||
131505774|NCT01729754|473482340|FG001|Part 3|Death|0|||
131505775|NCT01729754|473482341|FG002|Part 3|Death|0|||
131505776|NCT01729754|473482342|FG003|Part 3|Death|0|||
131505777|NCT01729754|473482343|FG004|Part 3|Death|0|||
131505778|NCT01729754|473482344|FG005|Part 3|Death|2|||
131505779|NCT01729754|473482345|FG006|Part 3|Death|0|||
131505780|NCT01729754|473482346|FG007|Part 3|Death|0|||
131505781|NCT01729754|473482347|FG008|Part 3|Death|0|||
131505782|NCT01729754|473482348|FG009|Part 3|Death|0|||
131505783|NCT01729754|473482339|FG000|Part 3|Lack of Efficacy|0|||
131505784|NCT01729754|473482340|FG001|Part 3|Lack of Efficacy|0|||
131505785|NCT01729754|473482341|FG002|Part 3|Lack of Efficacy|0|||
131505786|NCT01729754|473482342|FG003|Part 3|Lack of Efficacy|0|||
131505787|NCT01729754|473482343|FG004|Part 3|Lack of Efficacy|2|||
131505788|NCT01729754|473482344|FG005|Part 3|Lack of Efficacy|0|||
131505789|NCT01729754|473482345|FG006|Part 3|Lack of Efficacy|0|||
131505790|NCT01729754|473482346|FG007|Part 3|Lack of Efficacy|0|||
131505791|NCT01729754|473482347|FG008|Part 3|Lack of Efficacy|0|||
131505792|NCT01729754|473482348|FG009|Part 3|Lack of Efficacy|4|||
131505793|NCT01729754|473482339|FG000|Part 3|Lost to Follow-up|0|||
131505794|NCT01729754|473482340|FG001|Part 3|Lost to Follow-up|1|||
131505795|NCT01729754|473482341|FG002|Part 3|Lost to Follow-up|2|||
131505796|NCT01729754|473482342|FG003|Part 3|Lost to Follow-up|0|||
131505797|NCT01729754|473482343|FG004|Part 3|Lost to Follow-up|0|||
131505798|NCT01729754|473482344|FG005|Part 3|Lost to Follow-up|3|||
131505799|NCT01729754|473482345|FG006|Part 3|Lost to Follow-up|0|||
131505800|NCT01729754|473482346|FG007|Part 3|Lost to Follow-up|0|||
131505801|NCT01729754|473482347|FG008|Part 3|Lost to Follow-up|1|||
131505802|NCT01729754|473482348|FG009|Part 3|Lost to Follow-up|0|||
131505803|NCT01729754|473482339|FG000|Part 3|Physician Decision|0|||
131505804|NCT01729754|473482340|FG001|Part 3|Physician Decision|0|||
131505805|NCT01729754|473482341|FG002|Part 3|Physician Decision|1|||
131505806|NCT01729754|473482342|FG003|Part 3|Physician Decision|0|||
131505807|NCT01729754|473482343|FG004|Part 3|Physician Decision|0|||
131505808|NCT01729754|473482344|FG005|Part 3|Physician Decision|0|||
131505809|NCT01729754|473482345|FG006|Part 3|Physician Decision|0|||
131505810|NCT01729754|473482346|FG007|Part 3|Physician Decision|0|||
131505811|NCT01729754|473482347|FG008|Part 3|Physician Decision|0|||
131505812|NCT01729754|473482348|FG009|Part 3|Physician Decision|0|||
131505813|NCT01729754|473482339|FG000|Part 3|Withdrawal by Subject|0|||
131505814|NCT01729754|473482340|FG001|Part 3|Withdrawal by Subject|4|||
131505815|NCT01729754|473482341|FG002|Part 3|Withdrawal by Subject|1|||
131505816|NCT01729754|473482342|FG003|Part 3|Withdrawal by Subject|0|||
131505817|NCT01729754|473482343|FG004|Part 3|Withdrawal by Subject|2|||
131505818|NCT01729754|473482344|FG005|Part 3|Withdrawal by Subject|1|||
131505819|NCT01729754|473482345|FG006|Part 3|Withdrawal by Subject|0|||
131505820|NCT01729754|473482346|FG007|Part 3|Withdrawal by Subject|2|||
131505821|NCT01729754|473482347|FG008|Part 3|Withdrawal by Subject|0|||
131505822|NCT01729754|473482348|FG009|Part 3|Withdrawal by Subject|0|||
131505823|NCT01729754|473482339|FG000|Part 3|Other Protocol Specified Criteria|0|||
131505824|NCT01729754|473482340|FG001|Part 3|Other Protocol Specified Criteria|0|||
131505825|NCT01729754|473482341|FG002|Part 3|Other Protocol Specified Criteria|0|||
131505826|NCT01729754|473482342|FG003|Part 3|Other Protocol Specified Criteria|0|||
131505827|NCT01729754|473482343|FG004|Part 3|Other Protocol Specified Criteria|0|||
131505828|NCT01729754|473482344|FG005|Part 3|Other Protocol Specified Criteria|2|||
131505829|NCT01729754|473482345|FG006|Part 3|Other Protocol Specified Criteria|0|||
131505830|NCT01729754|473482346|FG007|Part 3|Other Protocol Specified Criteria|1|||
131505831|NCT01729754|473482347|FG008|Part 3|Other Protocol Specified Criteria|0|||
131505832|NCT01729754|473482348|FG009|Part 3|Other Protocol Specified Criteria|0|||
131505833|NCT00773292|473482349|FG000|Treatment 48 Weeks|Adverse Event|1|||
131505834|NCT00773292|473482349|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
131505835|NCT02794103|473482350|FG000|Overall Study|Loss to follow up due to high sedation|3|||
131505836|NCT04608500|473482351|FG000|Overall Study|Adverse Event|2|||
131505837|NCT04608500|473482352|FG001|Overall Study|Adverse Event|0|||
131505838|NCT04608500|473482351|FG000|Overall Study|Lost to Follow-up|15|||
131505839|NCT04608500|473482352|FG001|Overall Study|Lost to Follow-up|9|||
131505840|NCT04608500|473482351|FG000|Overall Study|Participant request|11|||
131505841|NCT04608500|473482352|FG001|Overall Study|Participant request|7|||
131505842|NCT04608500|473482351|FG000|Overall Study|Protocol Violation|1|||
131505843|NCT04608500|473482352|FG001|Overall Study|Protocol Violation|0|||
131505844|NCT04608500|473482351|FG000|Overall Study|Other|6|||
131505845|NCT04608500|473482352|FG001|Overall Study|Other|2|||
131505846|NCT00542919|473482353|FG000|Overall Study|Adverse Event|1|||
131505847|NCT00542919|473482354|FG001|Overall Study|Adverse Event|5|||
131505848|NCT00542919|473482355|FG002|Overall Study|Adverse Event|1|||
131505849|NCT00542919|473482353|FG000|Overall Study|Withdrawal by Subject|1|||
131505850|NCT00542919|473482354|FG001|Overall Study|Withdrawal by Subject|0|||
131505851|NCT00542919|473482355|FG002|Overall Study|Withdrawal by Subject|3|||
131505852|NCT00542919|473482353|FG000|Overall Study|Physician Decision|2|||
131505853|NCT00542919|473482354|FG001|Overall Study|Physician Decision|2|||
131505854|NCT00542919|473482355|FG002|Overall Study|Physician Decision|1|||
131505855|NCT00542919|473482353|FG000|Overall Study|Sponsor Decision|1|||
131505856|NCT00542919|473482354|FG001|Overall Study|Sponsor Decision|0|||
131505857|NCT00542919|473482355|FG002|Overall Study|Sponsor Decision|0|||
131505858|NCT00542919|473482353|FG000|Overall Study|Lost to Follow-up|2|||
131505859|NCT00542919|473482354|FG001|Overall Study|Lost to Follow-up|0|||
131505860|NCT00542919|473482355|FG002|Overall Study|Lost to Follow-up|1|||
131505861|NCT02747420|473482356|FG000|Overall Study|Lost to Follow-up|4|||
131505862|NCT02747420|473482357|FG001|Overall Study|Lost to Follow-up|2|||
131505863|NCT02747420|473482356|FG000|Overall Study|Withdrawal by Subject|3|||
131505864|NCT02747420|473482357|FG001|Overall Study|Withdrawal by Subject|2|||
131505865|NCT03662542|473482358|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
131505866|NCT03662542|473482359|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505867|NCT03662542|473482360|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505868|NCT03662542|473482361|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505869|NCT03662542|473482362|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505870|NCT03662542|473482363|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505871|NCT03662542|473482364|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505872|NCT03662542|473482365|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505873|NCT03662542|473482366|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
131505874|NCT03662542|473482358|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505875|NCT03662542|473482359|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
131505876|NCT03662542|473482360|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505877|NCT03662542|473482361|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505878|NCT03662542|473482362|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505879|NCT03662542|473482363|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505880|NCT03662542|473482364|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505881|NCT03662542|473482365|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505882|NCT03662542|473482366|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
131505883|NCT03662542|473482358|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
131505884|NCT03662542|473482359|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
131505885|NCT03662542|473482360|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
131505886|NCT03662542|473482361|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
131505887|NCT03662542|473482362|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
131505888|NCT03662542|473482363|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
131505889|NCT03662542|473482364|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
131505890|NCT03662542|473482365|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
131505891|NCT03662542|473482366|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
131505892|NCT03662542|473482358|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
131505893|NCT03662542|473482359|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505894|NCT03662542|473482360|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505895|NCT03662542|473482361|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505896|NCT03662542|473482362|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505897|NCT03662542|473482363|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505898|NCT03662542|473482364|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505899|NCT03662542|473482365|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505900|NCT03662542|473482366|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131505901|NCT03662542|473482358|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505902|NCT03662542|473482359|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505903|NCT03662542|473482360|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505904|NCT03662542|473482361|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505905|NCT03662542|473482362|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505906|NCT03662542|473482363|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
131505907|NCT03662542|473482364|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505908|NCT03662542|473482365|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505909|NCT03662542|473482366|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
131505910|NCT03662542|473482358|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505911|NCT03662542|473482359|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505912|NCT03662542|473482360|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505913|NCT03662542|473482361|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
131505914|NCT03662542|473482362|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
131505915|NCT03662542|473482363|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505916|NCT03662542|473482364|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505917|NCT03662542|473482365|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505918|NCT03662542|473482366|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
131505919|NCT03662542|473482358|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
131505920|NCT03662542|473482359|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
131505921|NCT03662542|473482360|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
131505922|NCT03662542|473482361|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
131505923|NCT03662542|473482362|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
131505924|NCT03662542|473482363|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
131505925|NCT03662542|473482364|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
131505926|NCT03662542|473482365|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
131505927|NCT03662542|473482366|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
131505928|NCT03662542|473482358|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505929|NCT03662542|473482359|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505930|NCT03662542|473482360|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505931|NCT03662542|473482361|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505932|NCT03662542|473482362|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
131505933|NCT03662542|473482363|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
131505934|NCT03662542|473482364|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505935|NCT03662542|473482365|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505936|NCT03662542|473482366|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
131505937|NCT03662542|473482358|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505938|NCT03662542|473482359|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505939|NCT03662542|473482360|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505940|NCT03662542|473482361|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505941|NCT03662542|473482362|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505942|NCT03662542|473482363|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
131505943|NCT03662542|473482364|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505944|NCT03662542|473482365|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505945|NCT03662542|473482366|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
131505946|NCT03662542|473482358|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505947|NCT03662542|473482359|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505948|NCT03662542|473482360|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505949|NCT03662542|473482361|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505950|NCT03662542|473482362|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505951|NCT03662542|473482363|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505952|NCT03662542|473482364|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505953|NCT03662542|473482365|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
131505954|NCT03662542|473482366|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
131505955|NCT03662542|473482358|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505956|NCT03662542|473482359|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505957|NCT03662542|473482360|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505958|NCT03662542|473482361|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505959|NCT03662542|473482362|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505960|NCT03662542|473482363|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505961|NCT03662542|473482364|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
131505962|NCT03662542|473482365|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
131505963|NCT03662542|473482366|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
131505964|NCT03662542|473482358|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505965|NCT03662542|473482359|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505966|NCT03662542|473482360|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505967|NCT03662542|473482361|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505968|NCT03662542|473482362|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505969|NCT03662542|473482363|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505970|NCT03662542|473482364|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
131505971|NCT03662542|473482365|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131505972|NCT03662542|473482366|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
131505973|NCT03662542|473482358|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
131505974|NCT03662542|473482359|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
131505975|NCT03662542|473482360|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
131505976|NCT03662542|473482361|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
131505977|NCT03662542|473482362|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
131505978|NCT03662542|473482363|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
131505979|NCT03662542|473482364|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
131505980|NCT03662542|473482365|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
131505981|NCT03662542|473482366|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
131505982|NCT01217060|473482369|FG000|Overall Study|Withdrawal by Subject|1|||
131505983|NCT03388138|473482372|FG000|Overall Study|Protocol Violation|1|||
131505984|NCT03388138|473482373|FG001|Overall Study|Protocol Violation|0|||
131505985|NCT01528072|473482376|FG000|Overall Study|Withdrawal by Subject|5|||
131505986|NCT01528072|473482376|FG000|Overall Study|Physician Decision|1|||
131505987|NCT01528072|473482376|FG000|Overall Study|Determined not eligible by AEAC|1|||
131505988|NCT01528072|473482376|FG000|Overall Study|Missed Visit|2|||
131505989|NCT01528072|473482376|FG000|Overall Study|Lost to Follow-up|5|||
131505990|NCT01528072|473482376|FG000|Overall Study|Explanted|2|||
131505991|NCT01528072|473482376|FG000|Overall Study|Site Closure|4|||
131505992|NCT01528072|473482376|FG000|Overall Study|Death|2|||
131505993|NCT01528072|473482376|FG000|Overall Study|Early Termination of Study|52|||
131505994|NCT01859494|473482379|FG000|Overall Study|Adverse Event|1|||
131505995|NCT02769247|473482388|FG000|Overall Study|Withdrawal by Subject|1|||
131505996|NCT02769247|473482389|FG001|Overall Study|Withdrawal by Subject|0|||
131505997|NCT02769247|473482390|FG002|Overall Study|Withdrawal by Subject|0|||
131505998|NCT02769247|473482391|FG003|Overall Study|Withdrawal by Subject|1|||
131505999|NCT02769247|473482388|FG000|Overall Study|Protocol Violation|0|||
131506000|NCT02769247|473482389|FG001|Overall Study|Protocol Violation|0|||
131506001|NCT02769247|473482390|FG002|Overall Study|Protocol Violation|1|||
131506002|NCT02769247|473482391|FG003|Overall Study|Protocol Violation|0|||
131506003|NCT02769247|473482388|FG000|Overall Study|Physician Decision|1|||
131506004|NCT02769247|473482389|FG001|Overall Study|Physician Decision|0|||
131506005|NCT02769247|473482390|FG002|Overall Study|Physician Decision|0|||
131506006|NCT02769247|473482391|FG003|Overall Study|Physician Decision|0|||
131506007|NCT01462084|473482397|FG000|Overall Study|Withdrawal by Subject|1|||
131506008|NCT01462084|473482398|FG001|Overall Study|Withdrawal by Subject|0|||
131506009|NCT01462084|473482397|FG000|Overall Study|Protocol Violation|1|||
131506010|NCT01462084|473482398|FG001|Overall Study|Protocol Violation|1|||
131506011|NCT01996826|473482399|FG000|Overall Study|Lost to Follow-up|6|||
131506012|NCT01996826|473482400|FG001|Overall Study|Lost to Follow-up|2|||
131506013|NCT01996826|473482399|FG000|Overall Study|Physician Decision|1|||
131506014|NCT01996826|473482400|FG001|Overall Study|Physician Decision|1|||
131506015|NCT02092662|473482402|FG000|Overall Study|Lost to Follow-up|13|||
131506016|NCT02092662|473482403|FG001|Overall Study|Lost to Follow-up|0|||
131506017|NCT02337907|473482405|FG000|Overall Study|Other than listed|1|||
131506018|NCT02337907|473482406|FG001|Overall Study|Other than listed|0|||
131506019|NCT02337907|473482407|FG002|Overall Study|Other than listed|0|||
131506020|NCT02337907|473482408|FG003|Overall Study|Other than listed|1|||
131506021|NCT02337907|473482409|FG004|Overall Study|Other than listed|1|||
131506022|NCT02337907|473482410|FG005|Overall Study|Other than listed|0|||
131506023|NCT02337907|473482405|FG000|Overall Study|Withdrawal by Subject|2|||
131506024|NCT02337907|473482406|FG001|Overall Study|Withdrawal by Subject|3|||
131506025|NCT02337907|473482407|FG002|Overall Study|Withdrawal by Subject|0|||
131506026|NCT02337907|473482408|FG003|Overall Study|Withdrawal by Subject|2|||
131506027|NCT02337907|473482409|FG004|Overall Study|Withdrawal by Subject|5|||
131506028|NCT02337907|473482410|FG005|Overall Study|Withdrawal by Subject|0|||
131506029|NCT02337907|473482405|FG000|Overall Study|Lost to Follow-up|0|||
131506030|NCT02337907|473482406|FG001|Overall Study|Lost to Follow-up|0|||
131506031|NCT02337907|473482407|FG002|Overall Study|Lost to Follow-up|0|||
131506032|NCT02337907|473482408|FG003|Overall Study|Lost to Follow-up|0|||
131506033|NCT02337907|473482409|FG004|Overall Study|Lost to Follow-up|0|||
131506034|NCT02337907|473482410|FG005|Overall Study|Lost to Follow-up|1|||
131506035|NCT02337907|473482405|FG000|Overall Study|Adverse Event|1|||
131506036|NCT02337907|473482406|FG001|Overall Study|Adverse Event|1|||
131506037|NCT02337907|473482407|FG002|Overall Study|Adverse Event|1|||
131506038|NCT02337907|473482408|FG003|Overall Study|Adverse Event|1|||
131506039|NCT02337907|473482409|FG004|Overall Study|Adverse Event|4|||
131506040|NCT02337907|473482410|FG005|Overall Study|Adverse Event|0|||
131506041|NCT02488681|473482417|FG000|Overall Study|Implant unsuccessful|7|||
131506042|NCT02809677|473482418|FG000|Overall Study|Withdrawal by Subject|8|||
131506043|NCT03165110|473482419|FG000|Overall Study|Anroid phone software incompatibility|1|||
131506044|NCT05533632|473482420|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
131506045|NCT05533632|473482420|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
131506046|NCT05533632|473482420|FG000|Overall Study|Lost to Follow-up|1|||
131506047|NCT05533632|473482420|FG000|Overall Study|Withdrawal by Subject|4|||
131506048|NCT05533632|473482420|FG000|Overall Study|Adverse Event|4|||
131506049|NCT00613015|473482421|FG000|Overall Study|Lost to Follow-up|0|||
131506050|NCT00613015|473482422|FG001|Overall Study|Lost to Follow-up|1|||
131506051|NCT00613015|473482423|FG002|Overall Study|Lost to Follow-up|3|||
131506052|NCT00613015|473482424|FG003|Overall Study|Lost to Follow-up|3|||
131506053|NCT00613015|473482425|FG004|Overall Study|Lost to Follow-up|2|||
131506054|NCT00613015|473482426|FG005|Overall Study|Lost to Follow-up|3|||
131506055|NCT04327388|473482429|FG000|Overall Study|Adverse Event|17|||
131506056|NCT04327388|473482430|FG001|Overall Study|Adverse Event|18|||
131506057|NCT04327388|473482431|FG002|Overall Study|Adverse Event|9|||
131506058|NCT04327388|473482429|FG000|Overall Study|Other|1|||
131506059|NCT04327388|473482430|FG001|Overall Study|Other|2|||
131506060|NCT04327388|473482431|FG002|Overall Study|Other|0|||
131506061|NCT04327388|473482429|FG000|Overall Study|Randomized and not treated|2|||
131506062|NCT04327388|473482430|FG001|Overall Study|Randomized and not treated|0|||
131506063|NCT04327388|473482431|FG002|Overall Study|Randomized and not treated|2|||
131506064|NCT04120974|473482432|FG000|Overall Study|Death|1|||
131506065|NCT04120974|473482432|FG000|Overall Study|Physician Decision|1|||
131506066|NCT04120974|473482432|FG000|Overall Study|Lost to Follow-up|6|||
131506067|NCT03338062|473482433|FG000|Overall Study|Alternative Therapy|1|||
131506068|NCT03338062|473482434|FG001|Overall Study|Alternative Therapy|0|||
131506069|NCT01558752|473482435|FG000|Overall Study|Physician Decision|2|||
131506070|NCT01558752|473482436|FG001|Overall Study|Physician Decision|0|||
131506071|NCT04340362|473482440|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
131506072|NCT03341533|473482443|FG000|Overall Study|Withdrawal by Subject|1|||
131506073|NCT03341533|473482444|FG001|Overall Study|Withdrawal by Subject|1|||
131506074|NCT03341533|473482443|FG000|Overall Study|Not eligible after randomization|2|||
131506075|NCT03341533|473482444|FG001|Overall Study|Not eligible after randomization|1|||
131506076|NCT02153112|473482446|FG000|Overall Study|Adverse Event|0|||
131506077|NCT02153112|473482447|FG001|Overall Study|Adverse Event|0|||
131506078|NCT02153112|473482448|FG002|Overall Study|Adverse Event|1|||
131506079|NCT02153112|473482449|FG003|Overall Study|Adverse Event|0|||
131506080|NCT02153112|473482450|FG004|Overall Study|Adverse Event|0|||
131506081|NCT02153112|473482451|FG005|Overall Study|Adverse Event|0|||
131506082|NCT02153112|473482452|FG006|Overall Study|Adverse Event|0|||
131506083|NCT02153112|473482453|FG007|Overall Study|Adverse Event|0|||
131506084|NCT02153112|473482454|FG008|Overall Study|Adverse Event|0|||
131506085|NCT02153112|473482455|FG009|Overall Study|Adverse Event|0|||
131506086|NCT02153112|473482446|FG000|Overall Study|Lost to Follow-up|1|||
131506087|NCT02153112|473482447|FG001|Overall Study|Lost to Follow-up|1|||
131506088|NCT02153112|473482448|FG002|Overall Study|Lost to Follow-up|0|||
131506089|NCT02153112|473482449|FG003|Overall Study|Lost to Follow-up|0|||
131506090|NCT02153112|473482450|FG004|Overall Study|Lost to Follow-up|2|||
131506091|NCT02153112|473482451|FG005|Overall Study|Lost to Follow-up|1|||
131506092|NCT02153112|473482452|FG006|Overall Study|Lost to Follow-up|1|||
131506093|NCT02153112|473482453|FG007|Overall Study|Lost to Follow-up|0|||
131506094|NCT02153112|473482454|FG008|Overall Study|Lost to Follow-up|1|||
131506095|NCT02153112|473482455|FG009|Overall Study|Lost to Follow-up|1|||
131506096|NCT02153112|473482446|FG000|Overall Study|Withdrawal by Subject|3|||
131506097|NCT02153112|473482447|FG001|Overall Study|Withdrawal by Subject|1|||
131506098|NCT02153112|473482448|FG002|Overall Study|Withdrawal by Subject|2|||
131506099|NCT02153112|473482449|FG003|Overall Study|Withdrawal by Subject|2|||
131506100|NCT02153112|473482450|FG004|Overall Study|Withdrawal by Subject|1|||
131506101|NCT02153112|473482451|FG005|Overall Study|Withdrawal by Subject|1|||
131506102|NCT02153112|473482452|FG006|Overall Study|Withdrawal by Subject|7|||
131506103|NCT02153112|473482453|FG007|Overall Study|Withdrawal by Subject|2|||
131506104|NCT02153112|473482454|FG008|Overall Study|Withdrawal by Subject|13|||
131506105|NCT02153112|473482455|FG009|Overall Study|Withdrawal by Subject|12|||
131506106|NCT02153112|473482446|FG000|Overall Study|Reason not Specified|0|||
131506107|NCT02153112|473482447|FG001|Overall Study|Reason not Specified|0|||
131506108|NCT02153112|473482448|FG002|Overall Study|Reason not Specified|0|||
131506109|NCT02153112|473482449|FG003|Overall Study|Reason not Specified|0|||
131506110|NCT02153112|473482450|FG004|Overall Study|Reason not Specified|0|||
131506111|NCT02153112|473482451|FG005|Overall Study|Reason not Specified|0|||
131506112|NCT02153112|473482452|FG006|Overall Study|Reason not Specified|0|||
131506113|NCT02153112|473482453|FG007|Overall Study|Reason not Specified|0|||
131506114|NCT02153112|473482454|FG008|Overall Study|Reason not Specified|1|||
131506115|NCT02153112|473482455|FG009|Overall Study|Reason not Specified|1|||
131506116|NCT01675128|473482461|FG000|Overall Study|Disease progression on study|1|||
131506117|NCT01675128|473482462|FG001|Overall Study|Disease progression on study|1|||
131506118|NCT01675128|473482463|FG002|Overall Study|Disease progression on study|1|||
131506119|NCT01675128|473482461|FG000|Overall Study|Refused further treatment|1|||
131506120|NCT01675128|473482462|FG001|Overall Study|Refused further treatment|0|||
131506121|NCT01675128|473482463|FG002|Overall Study|Refused further treatment|0|||
131506122|NCT01675128|473482461|FG000|Overall Study|Pulmonary complication; off study|0|||
131506123|NCT01675128|473482462|FG001|Overall Study|Pulmonary complication; off study|1|||
131506124|NCT01675128|473482463|FG002|Overall Study|Pulmonary complication; off study|0|||
131506125|NCT00832585|473482464|FG000|Overall Study|Withdrawal by Subject|1|||
131506126|NCT00832585|473482464|FG000|Overall Study|Lost to Follow-up|1|||
131506127|NCT02466555|473482469|FG000|Overall Study|Lost to Follow-up|2|||
131506128|NCT04170348|473482470|FG000|Overall Study|Lost to Follow-up|2|||
131506129|NCT04170348|473482471|FG001|Overall Study|Lost to Follow-up|2|||
131506130|NCT04170348|473482470|FG000|Overall Study|Withdrawal by Subject|1|||
131506131|NCT04170348|473482471|FG001|Overall Study|Withdrawal by Subject|5|||
131506132|NCT04170348|473482470|FG000|Overall Study|Non-adherence|1|||
131506133|NCT04170348|473482471|FG001|Overall Study|Non-adherence|1|||
131506134|NCT04170348|473482470|FG000|Overall Study|Adverse Event|1|||
131506135|NCT04170348|473482471|FG001|Overall Study|Adverse Event|0|||
131506136|NCT00529542|473482473|FG000|Overall Study|Withdrawal by Subject|1|||
131506137|NCT00529542|473482474|FG001|Overall Study|Withdrawal by Subject|0|||
131506138|NCT00529542|473482473|FG000|Overall Study|Lost to Follow-up|0|||
131506139|NCT00529542|473482474|FG001|Overall Study|Lost to Follow-up|1|||
131506140|NCT02113956|473482479|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
131506141|NCT02113956|473482480|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
131506142|NCT02113956|473482479|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
131506143|NCT02113956|473482480|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
131506144|NCT02113956|473482479|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
131506145|NCT02113956|473482480|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
131506146|NCT01602380|473482481|FG000|Overall Study|Death|147|||
131506147|NCT01602380|473482482|FG001|Overall Study|Death|145|||
131506148|NCT01602380|473482481|FG000|Overall Study|Withdrawal by Subject|39|||
131506149|NCT01602380|473482482|FG001|Overall Study|Withdrawal by Subject|41|||
131506150|NCT01602380|473482481|FG000|Overall Study|Lost to Follow-up|15|||
131506151|NCT01602380|473482482|FG001|Overall Study|Lost to Follow-up|12|||
131506152|NCT01602380|473482481|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131506153|NCT01602380|473482482|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
131506154|NCT01602380|473482481|FG000|Overall Study|Other|2|||
131506155|NCT01602380|473482482|FG001|Overall Study|Other|0|||
131506156|NCT02005250|473482484|FG000|Overall Study|Lost to Follow-up|15|||
131506157|NCT02005250|473482485|FG001|Overall Study|Lost to Follow-up|5|||
131506158|NCT04007094|473482486|FG000|Overall Study|Lost to Follow-up|1|||
131506159|NCT04007094|473482487|FG001|Overall Study|Lost to Follow-up|1|||
131506160|NCT04350788|473482488|FG000|Overall Study|Lost to Follow-up|6|||
131506161|NCT04350788|473482489|FG001|Overall Study|Lost to Follow-up|2|||
131506162|NCT04350788|473482488|FG000|Overall Study|Withdrawal by Subject|2|||
131506163|NCT04350788|473482489|FG001|Overall Study|Withdrawal by Subject|4|||
131506164|NCT04350788|473482488|FG000|Overall Study|Protocol Violation|4|||
131506165|NCT04350788|473482489|FG001|Overall Study|Protocol Violation|0|||
131506166|NCT05089682|473483549|FG000|Overall Study|Withdrawal by Subject|2|||
131506167|NCT00695396|473483550|FG000|Overall Study|Study Closed Prematurely|5|||
131506168|NCT00695396|473483551|FG001|Overall Study|Study Closed Prematurely|6|||
131506169|NCT00695396|473483552|FG002|Overall Study|Study Closed Prematurely|8|||
131506170|NCT00695396|473483550|FG000|Overall Study|Withdrawal by Subject|2|||
131506171|NCT00695396|473483551|FG001|Overall Study|Withdrawal by Subject|2|||
131506172|NCT00695396|473483552|FG002|Overall Study|Withdrawal by Subject|0|||
131506173|NCT01514760|473483553|FG000|Overall Study|Lost to Follow-up|2|||
131506174|NCT00371254|473483554|FG000|Overall Study|Disease progression|13|||
131506175|NCT00371254|473483555|FG001|Overall Study|Disease progression|13|||
131506176|NCT00371254|473483554|FG000|Overall Study|Study drug toxicity|3|||
131506177|NCT00371254|473483555|FG001|Overall Study|Study drug toxicity|5|||
131506178|NCT00371254|473483554|FG000|Overall Study|Subject request|5|||
131506179|NCT00371254|473483555|FG001|Overall Study|Subject request|0|||
131506180|NCT00371254|473483554|FG000|Overall Study|Investigator Decision|2|||
131506181|NCT00371254|473483555|FG001|Overall Study|Investigator Decision|0|||
131506182|NCT00371254|473483554|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131506183|NCT00371254|473483555|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131506184|NCT00371254|473483554|FG000|Overall Study|Lost to Follow-up|0|||
131506185|NCT00371254|473483555|FG001|Overall Study|Lost to Follow-up|1|||
131506186|NCT00371254|473483554|FG000|Overall Study|Withdrawal by Subject|0|||
131506187|NCT00371254|473483555|FG001|Overall Study|Withdrawal by Subject|1|||
131506188|NCT02914769|473483556|FG000|Overall Study|Protocol Violation|3|||
131506189|NCT02914769|473483557|FG001|Overall Study|Protocol Violation|2|||
131506190|NCT02914769|473483556|FG000|Overall Study|Withdrawal by Subject|0|||
131506191|NCT02914769|473483557|FG001|Overall Study|Withdrawal by Subject|1|||
131506192|NCT01592344|473483560|FG000|Overall Study|Adverse Event|1|||
131506193|NCT01592344|473483561|FG001|Overall Study|Adverse Event|1|||
131506194|NCT01592344|473483560|FG000|Overall Study|Lack of Efficacy|1|||
131506195|NCT01592344|473483561|FG001|Overall Study|Lack of Efficacy|0|||
131506196|NCT01592344|473483560|FG000|Overall Study|not available at primary outcome visit|2|||
131506197|NCT01592344|473483561|FG001|Overall Study|not available at primary outcome visit|4|||
131506198|NCT04969224|473483562|FG000|Overall Study|Adverse Event|1|||
131506199|NCT04969224|473483562|FG000|Overall Study|Enrolled but never dosed|1|||
131506200|NCT04256785|473483565|FG000|Overall Study|Adverse Event|8|||
131506201|NCT04256785|473483566|FG001|Overall Study|Adverse Event|6|||
131506202|NCT04256785|473483565|FG000|Overall Study|Lack of Efficacy|3|||
131506203|NCT04256785|473483566|FG001|Overall Study|Lack of Efficacy|4|||
131506204|NCT04256785|473483565|FG000|Overall Study|Lost to Follow-up|7|||
131506205|NCT04256785|473483566|FG001|Overall Study|Lost to Follow-up|7|||
131506206|NCT04256785|473483565|FG000|Overall Study|Protocol Violation|1|||
131506207|NCT04256785|473483566|FG001|Overall Study|Protocol Violation|0|||
131506208|NCT04256785|473483565|FG000|Overall Study|Withdrawal by Subject|4|||
131506209|NCT04256785|473483566|FG001|Overall Study|Withdrawal by Subject|1|||
131506210|NCT04256785|473483565|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
131506211|NCT04256785|473483566|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
131506212|NCT01374087|473483585|FG000|Overall Study|Adverse Event|1|||
131506213|NCT01374087|473483586|FG001|Overall Study|Adverse Event|0|||
131506214|NCT01374087|473483585|FG000|Overall Study|Disease progression|2|||
131506215|NCT01374087|473483586|FG001|Overall Study|Disease progression|2|||
131506216|NCT01374087|473483585|FG000|Overall Study|Study discontinued|13|||
131506217|NCT01374087|473483586|FG001|Overall Study|Study discontinued|13|||
131506218|NCT03526458|473483587|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
131506219|NCT03526458|473483588|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
131506220|NCT03526458|473483587|FG000|Overall Study|Stone passed, surgery cancelled|2|||
131506221|NCT03526458|473483588|FG001|Overall Study|Stone passed, surgery cancelled|1|||
131506222|NCT03526458|473483587|FG000|Overall Study|Withdrawal by Subject|1|||
131506223|NCT03526458|473483588|FG001|Overall Study|Withdrawal by Subject|0|||
131506224|NCT03526458|473483587|FG000|Overall Study|Physician Decision|2|||
131506225|NCT03526458|473483588|FG001|Overall Study|Physician Decision|1|||
131506226|NCT03526458|473483587|FG000|Overall Study|Lack of equipment|1|||
131506227|NCT03526458|473483588|FG001|Overall Study|Lack of equipment|1|||
131506228|NCT00271947|473483589|FG000|Overall Study|Lost to Follow-up|1|||
131506229|NCT02677987|473483590|FG000|Overall Study|Withdrawal by Subject|3|||
131506230|NCT02677987|473483591|FG001|Overall Study|Withdrawal by Subject|0|||
131506231|NCT02677987|473483590|FG000|Overall Study|Lost to Follow-up|1|||
131506232|NCT02677987|473483591|FG001|Overall Study|Lost to Follow-up|0|||
131506233|NCT01522365|473483592|FG000|Overall Study|Withdrawal by Subject|1|||
131506234|NCT01522365|473483593|FG001|Overall Study|Withdrawal by Subject|1|||
131506235|NCT01522365|473483592|FG000|Overall Study|Lost to Follow-up|1|||
131506236|NCT01522365|473483593|FG001|Overall Study|Lost to Follow-up|1|||
131506237|NCT00673179|473483594|FG000|Overall Study|Toxicity/Complications|3|||
131506238|NCT00673179|473483595|FG001|Overall Study|Toxicity/Complications|0|||
131506239|NCT01120756|473483596|FG000|Overall Study|Withdrawal by Subject|1|||
131506240|NCT01120756|473483597|FG001|Overall Study|Withdrawal by Subject|1|||
131506241|NCT03760146|473483598|FG000|Overall Study|Adverse Event|11|||
131506242|NCT03760146|473483599|FG001|Overall Study|Adverse Event|8|||
131506243|NCT03760146|473483600|FG002|Overall Study|Adverse Event|0|||
131506244|NCT03760146|473483601|FG003|Overall Study|Adverse Event|0|||
131506245|NCT03760146|473483602|FG004|Overall Study|Adverse Event|0|||
131506246|NCT03760146|473483603|FG005|Overall Study|Adverse Event|0|||
131506247|NCT03760146|473483598|FG000|Overall Study|Death|1|||
131506248|NCT03760146|473483599|FG001|Overall Study|Death|0|||
131506249|NCT03760146|473483600|FG002|Overall Study|Death|0|||
131506250|NCT03760146|473483601|FG003|Overall Study|Death|0|||
131506251|NCT03760146|473483602|FG004|Overall Study|Death|0|||
131506252|NCT03760146|473483603|FG005|Overall Study|Death|0|||
131506253|NCT03760146|473483598|FG000|Overall Study|Lost to Follow-up|41|||
131506254|NCT03760146|473483599|FG001|Overall Study|Lost to Follow-up|28|||
131506255|NCT03760146|473483600|FG002|Overall Study|Lost to Follow-up|9|||
131506256|NCT03760146|473483601|FG003|Overall Study|Lost to Follow-up|2|||
131506257|NCT03760146|473483602|FG004|Overall Study|Lost to Follow-up|14|||
131506258|NCT03760146|473483603|FG005|Overall Study|Lost to Follow-up|8|||
131506259|NCT03760146|473483598|FG000|Overall Study|No longer met eligibility criteria|3|||
131506260|NCT03760146|473483599|FG001|Overall Study|No longer met eligibility criteria|9|||
131506261|NCT03760146|473483600|FG002|Overall Study|No longer met eligibility criteria|0|||
131506262|NCT03760146|473483601|FG003|Overall Study|No longer met eligibility criteria|0|||
131506263|NCT03760146|473483602|FG004|Overall Study|No longer met eligibility criteria|1|||
131506264|NCT03760146|473483603|FG005|Overall Study|No longer met eligibility criteria|0|||
131506265|NCT03760146|473483598|FG000|Overall Study|Protocol Violation|21|||
131506266|NCT03760146|473483599|FG001|Overall Study|Protocol Violation|13|||
131506267|NCT03760146|473483600|FG002|Overall Study|Protocol Violation|1|||
131506268|NCT03760146|473483601|FG003|Overall Study|Protocol Violation|0|||
131506269|NCT03760146|473483602|FG004|Overall Study|Protocol Violation|1|||
131506270|NCT03760146|473483603|FG005|Overall Study|Protocol Violation|0|||
131506271|NCT03760146|473483598|FG000|Overall Study|Withdrawal by Subject|19|||
131506272|NCT03760146|473483599|FG001|Overall Study|Withdrawal by Subject|20|||
131506273|NCT03760146|473483600|FG002|Overall Study|Withdrawal by Subject|1|||
131506274|NCT03760146|473483601|FG003|Overall Study|Withdrawal by Subject|0|||
131506275|NCT03760146|473483602|FG004|Overall Study|Withdrawal by Subject|1|||
131506276|NCT03760146|473483603|FG005|Overall Study|Withdrawal by Subject|0|||
131506277|NCT00449644|473483604|FG000|Overall Study|Adverse Event|0|||
131506278|NCT00449644|473483605|FG001|Overall Study|Adverse Event|0|||
131506279|NCT00449644|473483606|FG002|Overall Study|Adverse Event|3|||
131506280|NCT00449644|473483607|FG003|Overall Study|Adverse Event|5|||
131506281|NCT00449644|473483604|FG000|Overall Study|Death|1|||
131506282|NCT00449644|473483605|FG001|Overall Study|Death|0|||
131506283|NCT00449644|473483606|FG002|Overall Study|Death|6|||
131506284|NCT00449644|473483607|FG003|Overall Study|Death|1|||
131506285|NCT00449644|473483604|FG000|Overall Study|Lost to Follow-up|1|||
131506286|NCT00449644|473483605|FG001|Overall Study|Lost to Follow-up|1|||
131506287|NCT00449644|473483606|FG002|Overall Study|Lost to Follow-up|5|||
131506288|NCT00449644|473483607|FG003|Overall Study|Lost to Follow-up|3|||
131506289|NCT00449644|473483604|FG000|Overall Study|Pregnancy|0|||
131506290|NCT00449644|473483605|FG001|Overall Study|Pregnancy|0|||
131506291|NCT00449644|473483606|FG002|Overall Study|Pregnancy|3|||
131506292|NCT00449644|473483607|FG003|Overall Study|Pregnancy|2|||
131506293|NCT00449644|473483604|FG000|Overall Study|Protocol Violation|4|||
131506294|NCT00449644|473483605|FG001|Overall Study|Protocol Violation|4|||
131506295|NCT00449644|473483606|FG002|Overall Study|Protocol Violation|3|||
131506296|NCT00449644|473483607|FG003|Overall Study|Protocol Violation|7|||
131506297|NCT00449644|473483604|FG000|Overall Study|Withdrawal by Subject|3|||
131506298|NCT00449644|473483605|FG001|Overall Study|Withdrawal by Subject|4|||
131506299|NCT00449644|473483606|FG002|Overall Study|Withdrawal by Subject|6|||
131506300|NCT00449644|473483607|FG003|Overall Study|Withdrawal by Subject|7|||
131506301|NCT00449644|473483604|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
131506302|NCT00449644|473483605|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
131506303|NCT00449644|473483606|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
131506304|NCT00449644|473483607|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
131506305|NCT00449644|473483604|FG000|Overall Study|Other|1|||
131506306|NCT00449644|473483605|FG001|Overall Study|Other|4|||
131506307|NCT00449644|473483606|FG002|Overall Study|Other|1|||
131506308|NCT00449644|473483607|FG003|Overall Study|Other|0|||
131506309|NCT00449644|473483604|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
131506310|NCT00449644|473483605|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
131506311|NCT00449644|473483606|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
131506312|NCT00449644|473483607|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
131506313|NCT01082965|473483608|FG000|Overall Study|Protocol Violation|0|||
131506314|NCT01082965|473483609|FG001|Overall Study|Protocol Violation|1|||
131506315|NCT01082965|473483608|FG000|Overall Study|Other|1|||
131506316|NCT01082965|473483609|FG001|Overall Study|Other|1|||
131506317|NCT01559012|473483612|FG000|Overall Study|Withdrawal by Subject|0|||
131506318|NCT01559012|473483613|FG001|Overall Study|Withdrawal by Subject|1|||
131506319|NCT00946712|473483614|FG000|Overall Study|Adverse Event|118|||
131506320|NCT00946712|473483615|FG001|Overall Study|Adverse Event|124|||
131506321|NCT00946712|473483614|FG000|Overall Study|Disease progression|308|||
131506322|NCT00946712|473483615|FG001|Overall Study|Disease progression|404|||
131506323|NCT00946712|473483614|FG000|Overall Study|Death|21|||
131506324|NCT00946712|473483615|FG001|Overall Study|Death|22|||
131506325|NCT00946712|473483614|FG000|Overall Study|No treatment given|25|||
131506326|NCT00946712|473483615|FG001|Overall Study|No treatment given|29|||
131506327|NCT00946712|473483614|FG000|Overall Study|Other reasons|61|||
131506328|NCT00946712|473483615|FG001|Overall Study|Other reasons|73|||
131506329|NCT00946712|473483614|FG000|Overall Study|On Treatment|0|||
131506330|NCT00946712|473483615|FG001|Overall Study|On Treatment|4|||
131506331|NCT00946712|473483614|FG000|Overall Study|Ineligible|14|||
131506332|NCT00946712|473483615|FG001|Overall Study|Ineligible|6|||
131506333|NCT02291055|473483618|FG000|Overall Study|Death|2|||
131506334|NCT02291055|473483619|FG001|Overall Study|Death|2|||
131506335|NCT02291055|473483620|FG002|Overall Study|Death|5|||
131506336|NCT02291055|473483621|FG003|Overall Study|Death|8|||
131506337|NCT02291055|473483622|FG004|Overall Study|Death|12|||
131506338|NCT02291055|473483618|FG000|Overall Study|Lost to Follow-up|0|||
131506339|NCT02291055|473483619|FG001|Overall Study|Lost to Follow-up|0|||
131506340|NCT02291055|473483620|FG002|Overall Study|Lost to Follow-up|0|||
131506341|NCT02291055|473483621|FG003|Overall Study|Lost to Follow-up|1|||
131506342|NCT02291055|473483622|FG004|Overall Study|Lost to Follow-up|2|||
131506343|NCT02291055|473483618|FG000|Overall Study|Withdrawal by Subject|3|||
131506344|NCT02291055|473483619|FG001|Overall Study|Withdrawal by Subject|1|||
131506345|NCT02291055|473483620|FG002|Overall Study|Withdrawal by Subject|1|||
131506346|NCT02291055|473483621|FG003|Overall Study|Withdrawal by Subject|5|||
131506347|NCT02291055|473483622|FG004|Overall Study|Withdrawal by Subject|10|||
131506348|NCT02291055|473483618|FG000|Overall Study|Progressive Disease|0|||
131506349|NCT02291055|473483619|FG001|Overall Study|Progressive Disease|0|||
131506350|NCT02291055|473483620|FG002|Overall Study|Progressive Disease|1|||
131506351|NCT02291055|473483621|FG003|Overall Study|Progressive Disease|4|||
131506352|NCT02291055|473483622|FG004|Overall Study|Progressive Disease|2|||
131506353|NCT02291055|473483618|FG000|Overall Study|Study Terminated by Sponsor|0|||
131506354|NCT02291055|473483619|FG001|Overall Study|Study Terminated by Sponsor|0|||
131506355|NCT02291055|473483620|FG002|Overall Study|Study Terminated by Sponsor|0|||
131506356|NCT02291055|473483621|FG003|Overall Study|Study Terminated by Sponsor|5|||
131506357|NCT02291055|473483622|FG004|Overall Study|Study Terminated by Sponsor|1|||
131506358|NCT02291055|473483618|FG000|Overall Study|Other|0|||
131506359|NCT02291055|473483619|FG001|Overall Study|Other|2|||
131506360|NCT02291055|473483620|FG002|Overall Study|Other|1|||
131506361|NCT02291055|473483621|FG003|Overall Study|Other|4|||
131506362|NCT02291055|473483622|FG004|Overall Study|Other|0|||
131506363|NCT00853723|473483624|FG000|Overall Study|Adverse Event|3|||
131506364|NCT00853723|473483625|FG001|Overall Study|Adverse Event|4|||
131506365|NCT00853723|473483626|FG002|Overall Study|Adverse Event|1|||
131506366|NCT00853723|473483624|FG000|Overall Study|Withdrawal by Subject|2|||
131506367|NCT00853723|473483625|FG001|Overall Study|Withdrawal by Subject|1|||
131506368|NCT00853723|473483626|FG002|Overall Study|Withdrawal by Subject|0|||
131506369|NCT00853723|473483624|FG000|Overall Study|Protocol Violation|1|||
131506370|NCT00853723|473483625|FG001|Overall Study|Protocol Violation|2|||
131506371|NCT00853723|473483626|FG002|Overall Study|Protocol Violation|1|||
131506372|NCT03839212|473483629|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
131506373|NCT00445965|473483630|FG000|Overall Study|Adverse Event|2|||
131506374|NCT00445965|473483630|FG000|Overall Study|Physician Decision|1|||
131506375|NCT00445965|473483630|FG000|Overall Study|Enrolled but not treated|1|||
131506376|NCT00445965|473483630|FG000|Overall Study|Removed due to progressive disease|29|||
131506377|NCT00679263|473483631|FG000|Visit 2/Dose 1|Adverse Event|1|||
131506378|NCT00679263|473483632|FG001|Visit 2/Dose 1|Adverse Event|0|||
131506379|NCT00679263|473483633|FG002|Visit 2/Dose 1|Adverse Event|0|||
131506380|NCT00679263|473483631|FG000|Visit 2/Dose 1|subject not compliance|1|||
131506381|NCT00679263|473483632|FG001|Visit 2/Dose 1|subject not compliance|1|||
131506382|NCT00679263|473483633|FG002|Visit 2/Dose 1|subject not compliance|0|||
131506383|NCT01464346|473483637|FG000|Overall Study|Withdrawal by Subject|0|||
131506384|NCT01464346|473483638|FG001|Overall Study|Withdrawal by Subject|0|||
131506385|NCT01464346|473483639|FG002|Overall Study|Withdrawal by Subject|1|||
131506386|NCT03999892|473483640|FG000|Overall Study|Lost to Follow-up|1|||
131506387|NCT02295995|473483641|FG000|Overall Study|Lost to Follow-up|5|||
131506388|NCT02295995|473483642|FG001|Overall Study|Lost to Follow-up|1|||
131506389|NCT02447081|473483643|FG000|Overall Study|Death|161|||
131506390|NCT02447081|473483643|FG000|Overall Study|Lost to Follow-up|36|||
131506391|NCT02447081|473483643|FG000|Overall Study|Visit not completed|17|||
131506392|NCT02447081|473483643|FG000|Overall Study|unsuccessful implant procedure|10|||
131506393|NCT01848756|473483646|FG000|Overall Study|Adverse Event|1|||
131506394|NCT01848756|473483646|FG000|Overall Study|Withdrawal by Subject|1|||
131506395|NCT01848756|473483646|FG000|Overall Study|Enrolled in Error|1|||
131506396|NCT02075658|473483647|FG000|Overall Study|Physician Decision|2|||
131506397|NCT02075658|473483648|FG001|Overall Study|Physician Decision|2|||
131506398|NCT01498458|473483649|FG000|Overall Study|Adverse Event|4|||
131506399|NCT01498458|473483649|FG000|Overall Study|Physician Decision|3|||
131506400|NCT02406651|473483650|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
131506401|NCT00718328|473483651|FG000|Overall Study|Lost to Follow-up|1|||
131506402|NCT00718328|473483652|FG001|Overall Study|Lost to Follow-up|0|||
131506403|NCT02865915|473483653|FG000|Overall Study|Pregnancy|1|||
131506404|NCT02865915|473483654|FG001|Overall Study|Pregnancy|0|||
131506405|NCT02865915|473483653|FG000|Overall Study|Withdrawal by Subject|1|||
131506406|NCT02865915|473483654|FG001|Overall Study|Withdrawal by Subject|1|||
131506407|NCT02865915|473483653|FG000|Overall Study|Adverse Event|0|||
131506408|NCT02865915|473483654|FG001|Overall Study|Adverse Event|4|||
131506409|NCT02865915|473483653|FG000|Overall Study|Lost to Follow-up|0|||
131506410|NCT02865915|473483654|FG001|Overall Study|Lost to Follow-up|1|||
131506411|NCT02865915|473483653|FG000|Overall Study|Protocol Violation|0|||
131506412|NCT02865915|473483654|FG001|Overall Study|Protocol Violation|1|||
131506413|NCT02865915|473483653|FG000|Overall Study|Study terminated by sponsor|23|||
131506414|NCT02865915|473483654|FG001|Overall Study|Study terminated by sponsor|18|||
131506415|NCT02865915|473483653|FG000|Overall Study|Dosing group discontinued|0|||
131506416|NCT02865915|473483654|FG001|Overall Study|Dosing group discontinued|5|||
131506417|NCT02946047|473483666|FG000|Overall Study|Adverse Event|1|||
131506418|NCT02946047|473483667|FG001|Overall Study|Adverse Event|0|||
131506419|NCT02946047|473483668|FG002|Overall Study|Adverse Event|0|||
131506420|NCT02946047|473483669|FG003|Overall Study|Adverse Event|0|||
131506421|NCT01581307|473483678|FG000|Overall Study|Withdrawal by Subject|1|||
131506422|NCT00378209|473483683|FG000|Overall Study|Progressive disease|11|||
131506423|NCT00378209|473483683|FG000|Overall Study|Adverse Event|3|||
131506424|NCT00378209|473483683|FG000|Overall Study|Initiation of non-protocol therapy|3|||
131506425|NCT00378209|473483683|FG000|Overall Study|Physician Decision|3|||
131506426|NCT00378209|473483683|FG000|Overall Study|Death|1|||
131506427|NCT00378209|473483683|FG000|Overall Study|Treatment delay|1|||
131506428|NCT01894581|473483684|FG000|Overall Study|Withdrawal by Subject|2|||
131506429|NCT01894581|473483685|FG001|Overall Study|Withdrawal by Subject|3|||
131506430|NCT01894581|473483684|FG000|Overall Study|Screen Failure|3|||
131506431|NCT01894581|473483685|FG001|Overall Study|Screen Failure|4|||
131506432|NCT03313804|473483689|FG000|Treatment|Death|5|||
131506433|NCT03313804|473483689|FG000|Treatment|still on treatment|2|||
131506434|NCT03313804|473483689|FG000|Follow Up|still on follow up|3|||
131506435|NCT03795298|473483690|FG000|Overall Study|Death|34|||
131506436|NCT03795298|473483691|FG001|Overall Study|Death|29|||
131506437|NCT03795298|473483690|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
131506438|NCT03795298|473483691|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
131506439|NCT03795298|473483690|FG000|Overall Study|Lost to Follow-up|28|||
131506440|NCT03795298|473483691|FG001|Overall Study|Lost to Follow-up|17|||
131506441|NCT03795298|473483690|FG000|Overall Study|Physician Decision|5|||
131506442|NCT03795298|473483691|FG001|Overall Study|Physician Decision|4|||
131506443|NCT03795298|473483690|FG000|Overall Study|Withdrawal by Subject|43|||
131506444|NCT03795298|473483691|FG001|Overall Study|Withdrawal by Subject|28|||
131506445|NCT03795298|473483690|FG000|Overall Study|Reason not reported|7|||
131506446|NCT03795298|473483691|FG001|Overall Study|Reason not reported|9|||
131506447|NCT04814433|473483692|FG000|Overall Study|Survey not returned|4|||
131506448|NCT04814433|473483693|FG001|Overall Study|Survey not returned|8|||
131506449|NCT04814433|473483694|FG002|Overall Study|Survey not returned|4|||
131506450|NCT04814433|473483695|FG003|Overall Study|Survey not returned|5|||
131506451|NCT01816893|473483696|FG000|Washout Period|Withdrawal by Subject|2|||
131506452|NCT01816893|473483697|FG001|Washout Period|Withdrawal by Subject|0|||
131506453|NCT02016625|473485618|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
131506454|NCT02016625|473485619|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
131506455|NCT02016625|473485618|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
131506456|NCT02016625|473485619|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
131506457|NCT02016625|473485618|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
131506458|NCT02016625|473485619|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
131506459|NCT01190254|473485620|FG000|Overall Study|Adverse Event|3|||
131506460|NCT01190254|473485621|FG001|Overall Study|Adverse Event|6|||
131506461|NCT01190254|473485622|FG002|Overall Study|Adverse Event|8|||
131506462|NCT01190254|473485620|FG000|Overall Study|Lack of Efficacy|7|||
131506463|NCT01190254|473485621|FG001|Overall Study|Lack of Efficacy|4|||
131506464|NCT01190254|473485622|FG002|Overall Study|Lack of Efficacy|5|||
131506465|NCT01190254|473485620|FG000|Overall Study|Lost to Follow-up|4|||
131506466|NCT01190254|473485621|FG001|Overall Study|Lost to Follow-up|2|||
131506467|NCT01190254|473485622|FG002|Overall Study|Lost to Follow-up|0|||
131506468|NCT01190254|473485620|FG000|Overall Study|Withdrawal by Subject|4|||
131506469|NCT01190254|473485621|FG001|Overall Study|Withdrawal by Subject|5|||
131506470|NCT01190254|473485622|FG002|Overall Study|Withdrawal by Subject|7|||
131506471|NCT01190254|473485620|FG000|Overall Study|Protocol Violation|2|||
131506472|NCT01190254|473485621|FG001|Overall Study|Protocol Violation|0|||
131506473|NCT01190254|473485622|FG002|Overall Study|Protocol Violation|2|||
131506474|NCT01190254|473485620|FG000|Overall Study|Did not meet protocol eligibility|1|||
131506475|NCT01190254|473485621|FG001|Overall Study|Did not meet protocol eligibility|0|||
131506476|NCT01190254|473485622|FG002|Overall Study|Did not meet protocol eligibility|0|||
131506477|NCT02603809|473485623|FG000|Overall Study|Withdrawal by Subject|4|||
131506478|NCT02603809|473485624|FG001|Overall Study|Withdrawal by Subject|1|||
131506479|NCT02603809|473485625|FG002|Overall Study|Withdrawal by Subject|2|||
131506480|NCT02603809|473485626|FG003|Overall Study|Withdrawal by Subject|3|||
131506481|NCT02603809|473485627|FG004|Overall Study|Withdrawal by Subject|3|||
131506482|NCT02603809|473485628|FG005|Overall Study|Withdrawal by Subject|4|||
131506483|NCT02603809|473485623|FG000|Overall Study|Lost to Follow-up|2|||
131506484|NCT02603809|473485624|FG001|Overall Study|Lost to Follow-up|3|||
131506485|NCT02603809|473485625|FG002|Overall Study|Lost to Follow-up|1|||
131506486|NCT02603809|473485626|FG003|Overall Study|Lost to Follow-up|4|||
131506487|NCT02603809|473485627|FG004|Overall Study|Lost to Follow-up|2|||
131506488|NCT02603809|473485628|FG005|Overall Study|Lost to Follow-up|2|||
131506489|NCT02603809|473485623|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
131506490|NCT02603809|473485624|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
131506491|NCT02603809|473485625|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
131506492|NCT02603809|473485626|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
131506493|NCT02603809|473485627|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
131506494|NCT02603809|473485628|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
131506495|NCT02603809|473485623|FG000|Overall Study|Physician Decision|0|||
131506496|NCT02603809|473485624|FG001|Overall Study|Physician Decision|0|||
131506497|NCT02603809|473485625|FG002|Overall Study|Physician Decision|0|||
131506498|NCT02603809|473485626|FG003|Overall Study|Physician Decision|1|||
131506499|NCT02603809|473485627|FG004|Overall Study|Physician Decision|2|||
131506500|NCT02603809|473485628|FG005|Overall Study|Physician Decision|1|||
131506501|NCT02603809|473485623|FG000|Overall Study|Adverse Event|3|||
131506502|NCT02603809|473485624|FG001|Overall Study|Adverse Event|0|||
131506503|NCT02603809|473485625|FG002|Overall Study|Adverse Event|2|||
131506504|NCT02603809|473485626|FG003|Overall Study|Adverse Event|2|||
131506505|NCT02603809|473485627|FG004|Overall Study|Adverse Event|1|||
131506506|NCT02603809|473485628|FG005|Overall Study|Adverse Event|1|||
131506507|NCT02603809|473485623|FG000|Overall Study|Lack of Efficacy|0|||
131506508|NCT02603809|473485624|FG001|Overall Study|Lack of Efficacy|1|||
131506509|NCT02603809|473485625|FG002|Overall Study|Lack of Efficacy|0|||
131506510|NCT02603809|473485626|FG003|Overall Study|Lack of Efficacy|0|||
131506511|NCT02603809|473485627|FG004|Overall Study|Lack of Efficacy|0|||
131506512|NCT02603809|473485628|FG005|Overall Study|Lack of Efficacy|1|||
131506513|NCT04729127|473485629|FG000|Overall Study|Suspended/Terminated EI Services|4|||
131506514|NCT04729127|473485630|FG001|Overall Study|Suspended/Terminated EI Services|0|||
131506515|NCT04729127|473485631|FG002|Overall Study|Suspended/Terminated EI Services|4|||
131506516|NCT04729127|473485632|FG003|Overall Study|Suspended/Terminated EI Services|6|||
131506517|NCT04729127|473485633|FG004|Overall Study|Suspended/Terminated EI Services|0|||
131506518|NCT04729127|473485634|FG005|Overall Study|Suspended/Terminated EI Services|6|||
131506519|NCT04729127|473485635|FG006|Overall Study|Suspended/Terminated EI Services|2|||
131506520|NCT04729127|473485636|FG007|Overall Study|Suspended/Terminated EI Services|0|||
131506521|NCT04729127|473485637|FG008|Overall Study|Suspended/Terminated EI Services|2|||
131506522|NCT04729127|473485629|FG000|Overall Study|Withdrawal by Subject|1|||
131506523|NCT04729127|473485630|FG001|Overall Study|Withdrawal by Subject|0|||
131506524|NCT04729127|473485631|FG002|Overall Study|Withdrawal by Subject|1|||
131506525|NCT04729127|473485632|FG003|Overall Study|Withdrawal by Subject|0|||
131506526|NCT04729127|473485633|FG004|Overall Study|Withdrawal by Subject|0|||
131506527|NCT04729127|473485634|FG005|Overall Study|Withdrawal by Subject|0|||
131506528|NCT04729127|473485635|FG006|Overall Study|Withdrawal by Subject|0|||
131506529|NCT04729127|473485636|FG007|Overall Study|Withdrawal by Subject|0|||
131506530|NCT04729127|473485637|FG008|Overall Study|Withdrawal by Subject|0|||
131506531|NCT04729127|473485629|FG000|Overall Study|Switched Agency/Setting|1|||
131506532|NCT04729127|473485630|FG001|Overall Study|Switched Agency/Setting|0|||
131506533|NCT04729127|473485631|FG002|Overall Study|Switched Agency/Setting|1|||
131506534|NCT04729127|473485632|FG003|Overall Study|Switched Agency/Setting|1|||
131506535|NCT04729127|473485633|FG004|Overall Study|Switched Agency/Setting|0|||
131506536|NCT04729127|473485634|FG005|Overall Study|Switched Agency/Setting|1|||
131506537|NCT04729127|473485635|FG006|Overall Study|Switched Agency/Setting|1|||
131506538|NCT04729127|473485636|FG007|Overall Study|Switched Agency/Setting|0|||
131506539|NCT04729127|473485637|FG008|Overall Study|Switched Agency/Setting|1|||
131506540|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
131506541|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
131506542|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
131506543|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
131506544|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
131506545|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
131506546|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
131506547|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
131506548|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
131506549|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
131506550|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
131506551|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
131506552|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
131506553|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
131506554|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
131506555|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
131506556|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
131506557|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
131506558|NCT00887354|473485638|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
131506559|NCT00887354|473485639|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
131506560|NCT00887354|473485638|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
131506561|NCT00887354|473485639|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
131506562|NCT00887354|473485638|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
131506563|NCT00887354|473485639|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
131506564|NCT00887354|473485638|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
131506565|NCT00887354|473485639|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
131506566|NCT00887354|473485638|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
131506567|NCT00887354|473485639|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
131506568|NCT00887354|473485638|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
131506569|NCT00887354|473485639|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
131506570|NCT03257631|473485655|FG000|Overall Study|Death|1|||
131506571|NCT03257631|473485656|FG001|Overall Study|Death|0|||
131506572|NCT03257631|473485657|FG002|Overall Study|Death|1|||
131506573|NCT03257631|473485658|FG003|Overall Study|Death|1|||
131506574|NCT03257631|473485655|FG000|Overall Study|Progressive Disease|10|||
131506575|NCT03257631|473485656|FG001|Overall Study|Progressive Disease|9|||
131506576|NCT03257631|473485657|FG002|Overall Study|Progressive Disease|17|||
131506577|NCT03257631|473485658|FG003|Overall Study|Progressive Disease|8|||
131506578|NCT03257631|473485655|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131506579|NCT03257631|473485656|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131506580|NCT03257631|473485657|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
131506581|NCT03257631|473485658|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
131506582|NCT03257631|473485655|FG000|Overall Study|Adverse Event|0|||
131506583|NCT03257631|473485656|FG001|Overall Study|Adverse Event|0|||
131506584|NCT03257631|473485657|FG002|Overall Study|Adverse Event|2|||
131506585|NCT03257631|473485658|FG003|Overall Study|Adverse Event|0|||
131506586|NCT02529137|473485659|FG000|Overall Study|Discontinuation for different reasons|8|||
131506587|NCT01290666|473485663|FG000|Overall Study|Lost to Follow-up|11|||
131506588|NCT01290666|473485663|FG000|Overall Study|Withdrawal by Subject|23|||
131506589|NCT01290666|473485663|FG000|Overall Study|Early Termination of Study|4|||
131506590|NCT03036098|473485664|FG000|Pre-Treatment|Other Reasons|1|||
131506591|NCT03036098|473485665|FG001|Pre-Treatment|Other Reasons|2|||
131506592|NCT03036098|473485666|FG002|Pre-Treatment|Other Reasons|0|||
131506593|NCT03036098|473485667|FG003|Pre-Treatment|Other Reasons|5|||
131506594|NCT03036098|473485664|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
131506595|NCT03036098|473485665|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
131506596|NCT03036098|473485666|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
131506597|NCT03036098|473485667|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
131506598|NCT03036098|473485664|FG000|Pre-Treatment|Withdrawal by Subject|1|||
131506599|NCT03036098|473485665|FG001|Pre-Treatment|Withdrawal by Subject|14|||
131506600|NCT03036098|473485666|FG002|Pre-Treatment|Withdrawal by Subject|0|||
131506601|NCT03036098|473485667|FG003|Pre-Treatment|Withdrawal by Subject|5|||
131506602|NCT03036098|473485664|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
131506603|NCT03036098|473485665|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
131506604|NCT03036098|473485666|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
131506605|NCT03036098|473485667|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
131506606|NCT03036098|473485664|FG000|Treatment|Disease Progression|130|||
131506607|NCT03036098|473485665|FG001|Treatment|Disease Progression|77|||
131506608|NCT03036098|473485666|FG002|Treatment|Disease Progression|168|||
131506609|NCT03036098|473485667|FG003|Treatment|Disease Progression|50|||
131506610|NCT03036098|473485664|FG000|Treatment|Study Drug Toxicity|95|||
131506611|NCT03036098|473485665|FG001|Treatment|Study Drug Toxicity|45|||
131506612|NCT03036098|473485666|FG002|Treatment|Study Drug Toxicity|26|||
131506613|NCT03036098|473485667|FG003|Treatment|Study Drug Toxicity|22|||
131506614|NCT03036098|473485664|FG000|Treatment|Death|9|||
131506615|NCT03036098|473485665|FG001|Treatment|Death|3|||
131506616|NCT03036098|473485666|FG002|Treatment|Death|1|||
131506617|NCT03036098|473485667|FG003|Treatment|Death|2|||
131506618|NCT03036098|473485664|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
131506619|NCT03036098|473485665|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
131506620|NCT03036098|473485666|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
131506621|NCT03036098|473485667|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
131506622|NCT03036098|473485664|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
131506623|NCT03036098|473485665|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
131506624|NCT03036098|473485666|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
131506625|NCT03036098|473485667|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
131506626|NCT03036098|473485664|FG000|Treatment|Withdrawal by Subject|2|||
131506627|NCT03036098|473485665|FG001|Treatment|Withdrawal by Subject|9|||
131506628|NCT03036098|473485666|FG002|Treatment|Withdrawal by Subject|2|||
131506629|NCT03036098|473485667|FG003|Treatment|Withdrawal by Subject|4|||
131506630|NCT03036098|473485664|FG000|Treatment|Maximum Clinical Benefit|6|||
131506631|NCT03036098|473485665|FG001|Treatment|Maximum Clinical Benefit|1|||
131506632|NCT03036098|473485666|FG002|Treatment|Maximum Clinical Benefit|6|||
131506633|NCT03036098|473485667|FG003|Treatment|Maximum Clinical Benefit|10|||
131506634|NCT03036098|473485664|FG000|Treatment|Poor/Non Compliance|1|||
131506635|NCT03036098|473485665|FG001|Treatment|Poor/Non Compliance|2|||
131506636|NCT03036098|473485666|FG002|Treatment|Poor/Non Compliance|0|||
131506637|NCT03036098|473485667|FG003|Treatment|Poor/Non Compliance|1|||
131506638|NCT03036098|473485664|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
131506639|NCT03036098|473485665|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
131506640|NCT03036098|473485666|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
131506641|NCT03036098|473485667|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
131506642|NCT03036098|473485664|FG000|Treatment|Administrative Reason by Sponsor|1|||
131506643|NCT03036098|473485665|FG001|Treatment|Administrative Reason by Sponsor|0|||
131506644|NCT03036098|473485666|FG002|Treatment|Administrative Reason by Sponsor|2|||
131506645|NCT03036098|473485667|FG003|Treatment|Administrative Reason by Sponsor|1|||
131506646|NCT03036098|473485664|FG000|Treatment|Other Reasons|31|||
131506647|NCT03036098|473485665|FG001|Treatment|Other Reasons|5|||
131506648|NCT03036098|473485666|FG002|Treatment|Other Reasons|21|||
131506649|NCT03036098|473485667|FG003|Treatment|Other Reasons|8|||
131506650|NCT03036098|473485664|FG000|Treatment|Ongoing Treatment|0|||
131506651|NCT03036098|473485665|FG001|Treatment|Ongoing Treatment|0|||
131506652|NCT03036098|473485666|FG002|Treatment|Ongoing Treatment|23|||
131506653|NCT03036098|473485667|FG003|Treatment|Ongoing Treatment|0|||
131506654|NCT02063854|473485669|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
131506655|NCT02063854|473485670|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
131506656|NCT02063854|473485671|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
131506657|NCT02063854|473485672|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
131506658|NCT02063854|473485673|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
131506659|NCT02063854|473485674|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
131506660|NCT02063854|473485675|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
131506661|NCT02063854|473485669|FG000|Overall Study|Major Protocol Deviation|0|||
131506662|NCT02063854|473485670|FG001|Overall Study|Major Protocol Deviation|0|||
131506663|NCT02063854|473485671|FG002|Overall Study|Major Protocol Deviation|3|||
131506664|NCT02063854|473485672|FG003|Overall Study|Major Protocol Deviation|0|||
131506665|NCT02063854|473485673|FG004|Overall Study|Major Protocol Deviation|0|||
131506666|NCT02063854|473485674|FG005|Overall Study|Major Protocol Deviation|0|||
131506667|NCT02063854|473485675|FG006|Overall Study|Major Protocol Deviation|0|||
131506668|NCT02063854|473485669|FG000|Overall Study|Voluntary Withdrawal|2|||
131506669|NCT02063854|473485670|FG001|Overall Study|Voluntary Withdrawal|0|||
131506670|NCT02063854|473485671|FG002|Overall Study|Voluntary Withdrawal|8|||
131658095|NCT04445987|474032994|FG000|Overall Study|Physician Decision|0|||
131506671|NCT02063854|473485672|FG003|Overall Study|Voluntary Withdrawal|1|||
131506672|NCT02063854|473485673|FG004|Overall Study|Voluntary Withdrawal|3|||
131506673|NCT02063854|473485674|FG005|Overall Study|Voluntary Withdrawal|6|||
131506674|NCT02063854|473485675|FG006|Overall Study|Voluntary Withdrawal|1|||
131506675|NCT02063854|473485669|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
131506676|NCT02063854|473485670|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
131506677|NCT02063854|473485671|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
131506678|NCT02063854|473485672|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
131506679|NCT02063854|473485673|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
131506680|NCT02063854|473485674|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
131506681|NCT02063854|473485675|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
131506682|NCT02063854|473485669|FG000|Overall Study|Reason Not Specified|1|||
131506683|NCT02063854|473485670|FG001|Overall Study|Reason Not Specified|0|||
131506684|NCT02063854|473485671|FG002|Overall Study|Reason Not Specified|0|||
131506685|NCT02063854|473485672|FG003|Overall Study|Reason Not Specified|0|||
131506686|NCT02063854|473485673|FG004|Overall Study|Reason Not Specified|0|||
131506687|NCT02063854|473485674|FG005|Overall Study|Reason Not Specified|0|||
131506688|NCT02063854|473485675|FG006|Overall Study|Reason Not Specified|0|||
131506689|NCT02063854|473485669|FG000|Overall Study|Did Not Receive Study Drug|0|||
131506690|NCT02063854|473485670|FG001|Overall Study|Did Not Receive Study Drug|0|||
131506691|NCT02063854|473485671|FG002|Overall Study|Did Not Receive Study Drug|0|||
131506692|NCT02063854|473485672|FG003|Overall Study|Did Not Receive Study Drug|0|||
131506693|NCT02063854|473485673|FG004|Overall Study|Did Not Receive Study Drug|0|||
131506694|NCT02063854|473485674|FG005|Overall Study|Did Not Receive Study Drug|1|||
131506695|NCT02063854|473485675|FG006|Overall Study|Did Not Receive Study Drug|0|||
131506696|NCT03538158|473485676|FG000|Overall Study|Lost to Follow-up|13|||
131506697|NCT03538158|473485677|FG001|Overall Study|Lost to Follow-up|7|||
131506698|NCT03538158|473485676|FG000|Overall Study|Withdrawal by Subject|2|||
131506699|NCT03538158|473485677|FG001|Overall Study|Withdrawal by Subject|1|||
131506700|NCT02255981|473485679|FG000|Overall Study|Lost to Follow-up|3|||
131506701|NCT02255981|473485679|FG000|Overall Study|Withdrawal by Subject|1|||
131506702|NCT01046682|473485682|FG000|Overall Study|Adverse Event|2|||
131506703|NCT01046682|473485683|FG001|Overall Study|Adverse Event|0|||
131506704|NCT01454570|473485684|FG000|Overall Study|Withdrawal by Subject|2|||
131506705|NCT01454570|473485684|FG000|Overall Study|Screen Failure|7|||
131506706|NCT00772707|473485685|FG000|Overall Study|Withdrawn|3|||
131506707|NCT02246673|473485688|FG000|Overall Study|Sponsor Decision|1|||
131506708|NCT02246673|473485689|FG001|Overall Study|Sponsor Decision|0|||
131506709|NCT02246673|473485690|FG002|Overall Study|Sponsor Decision|0|||
131506710|NCT02246673|473485691|FG003|Overall Study|Sponsor Decision|0|||
131506711|NCT02246673|473485692|FG004|Overall Study|Sponsor Decision|0|||
131506712|NCT02246673|473485688|FG000|Overall Study|Withdrawal by Subject|0|||
131506713|NCT02246673|473485689|FG001|Overall Study|Withdrawal by Subject|0|||
131506714|NCT02246673|473485690|FG002|Overall Study|Withdrawal by Subject|0|||
131506715|NCT02246673|473485691|FG003|Overall Study|Withdrawal by Subject|0|||
131506716|NCT02246673|473485692|FG004|Overall Study|Withdrawal by Subject|1|||
131506717|NCT02246673|473485688|FG000|Overall Study|Lost to Follow-up|0|||
131506718|NCT02246673|473485689|FG001|Overall Study|Lost to Follow-up|0|||
131506719|NCT02246673|473485690|FG002|Overall Study|Lost to Follow-up|0|||
131506720|NCT02246673|473485691|FG003|Overall Study|Lost to Follow-up|1|||
131506721|NCT02246673|473485692|FG004|Overall Study|Lost to Follow-up|0|||
131506722|NCT02246673|473485688|FG000|Overall Study|Protocol Violation|0|||
131506723|NCT02246673|473485689|FG001|Overall Study|Protocol Violation|0|||
131506724|NCT02246673|473485690|FG002|Overall Study|Protocol Violation|0|||
131506725|NCT02246673|473485691|FG003|Overall Study|Protocol Violation|1|||
131506726|NCT02246673|473485692|FG004|Overall Study|Protocol Violation|0|||
131506727|NCT02418468|473485694|FG000|Overall Study|Adverse Event|1|||
131506728|NCT02418468|473485695|FG001|Overall Study|Adverse Event|0|||
131506729|NCT02418468|473485694|FG000|Overall Study|Withdrawal of informed consent|1|||
131506730|NCT02418468|473485695|FG001|Overall Study|Withdrawal of informed consent|1|||
131506731|NCT00099437|473485697|FG000|Overall Study|Lost to Follow-up|30|||
131506732|NCT00099437|473485698|FG001|Overall Study|Lost to Follow-up|33|||
131506733|NCT00099437|473485697|FG000|Overall Study|Death|293|||
131506734|NCT00099437|473485698|FG001|Overall Study|Death|261|||
131506735|NCT00099437|473485697|FG000|Overall Study|Withdrawal by Subject|6|||
131506736|NCT00099437|473485698|FG001|Overall Study|Withdrawal by Subject|10|||
131506737|NCT00099437|473485697|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
131506738|NCT00099437|473485698|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
131506739|NCT05413369|473485699|FG000|Overall Study|Adverse Event|1|||
131506740|NCT05413369|473485700|FG001|Overall Study|Adverse Event|1|||
131506741|NCT05413369|473485699|FG000|Overall Study|Withdrawal by Subject|13|||
131506742|NCT05413369|473485700|FG001|Overall Study|Withdrawal by Subject|4|||
131506743|NCT05413369|473485699|FG000|Overall Study|Non-compliance with study schedule|2|||
131506744|NCT05413369|473485700|FG001|Overall Study|Non-compliance with study schedule|1|||
131506745|NCT05413369|473485699|FG000|Overall Study|Other|1|||
131506746|NCT05413369|473485700|FG001|Overall Study|Other|1|||
131506747|NCT00720057|473485701|FG000|Overall Study|Lost to Follow-up|0|||
131506748|NCT00720057|473485702|FG001|Overall Study|Lost to Follow-up|2|||
131506749|NCT00720057|473485701|FG000|Overall Study|Protocol Violation|1|||
131506750|NCT00720057|473485702|FG001|Overall Study|Protocol Violation|0|||
131506751|NCT00720057|473485701|FG000|Overall Study|Withdrawal by Subject|0|||
131506752|NCT00720057|473485702|FG001|Overall Study|Withdrawal by Subject|1|||
131506753|NCT02726074|473485706|FG000|Overall Study|Withdrawal by Subject|4|||
131506754|NCT02726074|473485706|FG000|Overall Study|Adverse Event|14|||
131506755|NCT02726074|473485706|FG000|Overall Study|Protocol Violation|3|||
131506756|NCT02726074|473485706|FG000|Overall Study|Lost to Follow-up|2|||
131506757|NCT02726074|473485706|FG000|Overall Study|Others|3|||
131506758|NCT01679002|473485707|FG000|Overall Study|Adverse Event|1|||
131506759|NCT01679002|473485708|FG001|Overall Study|Adverse Event|1|||
131506760|NCT01679002|473485709|FG002|Overall Study|Adverse Event|0|||
131506761|NCT01179477|473485713|FG000|Overall Study|Death|542|||
131506762|NCT01179477|473485713|FG000|Overall Study|Unsuccessful implant|80|||
131506763|NCT01179477|473485713|FG000|Overall Study|Non-death withdrawal|438|||
131506764|NCT01179477|473485713|FG000|Overall Study|Did not complete final visit|27|||
131506765|NCT00975481|473485718|FG000|Second Intervention Period|Adverse Event|2|||
131506766|NCT00975481|473485719|FG001|Second Intervention Period|Adverse Event|1|||
131506767|NCT00975481|473485720|FG002|Second Intervention Period|Adverse Event|0|||
131506768|NCT00975481|473485721|FG003|Second Intervention Period|Adverse Event|0|||
131506769|NCT00975481|473485722|FG004|Second Intervention Period|Adverse Event|0|||
131506770|NCT00975481|473485723|FG005|Second Intervention Period|Adverse Event|0|||
131506771|NCT00975481|473485718|FG000|Second Intervention Period|Withdrawal by Subject|0|||
131506772|NCT00975481|473485719|FG001|Second Intervention Period|Withdrawal by Subject|0|||
131506773|NCT00975481|473485720|FG002|Second Intervention Period|Withdrawal by Subject|1|||
131506774|NCT00975481|473485721|FG003|Second Intervention Period|Withdrawal by Subject|0|||
131506775|NCT00975481|473485722|FG004|Second Intervention Period|Withdrawal by Subject|0|||
131506776|NCT00975481|473485723|FG005|Second Intervention Period|Withdrawal by Subject|0|||
131506777|NCT00975481|473485718|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
131506778|NCT00975481|473485719|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
131506779|NCT00975481|473485720|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
131506780|NCT00975481|473485721|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
131506781|NCT00975481|473485722|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
131506782|NCT00975481|473485723|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
131506783|NCT00975481|473485718|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
131506784|NCT00975481|473485719|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
131506785|NCT00975481|473485720|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
131506786|NCT00975481|473485721|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
131506787|NCT00975481|473485722|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
131506788|NCT00975481|473485723|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
131506789|NCT00643682|473485724|FG000|Overall Study|did not keep appointment|522|||
131506790|NCT00643682|473485725|FG001|Overall Study|did not keep appointment|509|||
131506791|NCT03630120|473485726|FG000|Overall Study|Disease progression|0|||
131506792|NCT03630120|473485727|FG001|Overall Study|Disease progression|1|||
131506793|NCT03630120|473485728|FG002|Overall Study|Disease progression|1|||
131506794|NCT03630120|473485729|FG003|Overall Study|Disease progression|1|||
131506795|NCT03755414|473485731|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
131506796|NCT03755414|473485732|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
131506797|NCT03755414|473485733|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
131506798|NCT03755414|473485731|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
131506799|NCT03755414|473485732|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
131506800|NCT03755414|473485733|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
131506801|NCT03755414|473485731|FG000|Overall Study|Non-compliance|0|||
131506802|NCT03755414|473485732|FG001|Overall Study|Non-compliance|1|||
131506803|NCT03755414|473485733|FG002|Overall Study|Non-compliance|0|||
131506804|NCT00741039|473485736|FG000|Overall Study|Patient non-compliance|2|||
131506805|NCT00741039|473485737|FG001|Overall Study|Patient non-compliance|0|||
131506806|NCT00322842|473485742|FG000|Overall Study|Withdrawal by Subject|0|||
131506807|NCT00322842|473485743|FG001|Overall Study|Withdrawal by Subject|1|||
131506808|NCT00322842|473485742|FG000|Overall Study|Lost to Follow-up|0|||
131506809|NCT00322842|473485743|FG001|Overall Study|Lost to Follow-up|1|||
131506810|NCT00322842|473485742|FG000|Overall Study|Refused transplant|1|||
131506811|NCT00322842|473485743|FG001|Overall Study|Refused transplant|0|||
131506812|NCT00322842|473485742|FG000|Overall Study|Death|1|||
131506813|NCT00322842|473485743|FG001|Overall Study|Death|0|||
131506814|NCT02068222|473485746|FG000|Overall Study|Lost to Follow-up|1|||
131506815|NCT03011307|473485747|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
131506816|NCT03011307|473485748|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
131506817|NCT03011307|473485747|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
131506818|NCT03011307|473485748|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
131506819|NCT03011307|473485747|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
131506820|NCT03011307|473485748|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
131506821|NCT01782664|473485749|FG000|Overall Study|Adverse Event|2|||
131506822|NCT01782664|473485750|FG001|Overall Study|Adverse Event|2|||
131506823|NCT01782664|473485751|FG002|Overall Study|Adverse Event|2|||
131506824|NCT01782664|473485752|FG003|Overall Study|Adverse Event|2|||
131506825|NCT01782664|473485753|FG004|Overall Study|Adverse Event|0|||
131506826|NCT01782664|473485754|FG005|Overall Study|Adverse Event|0|||
131506827|NCT01782664|473485749|FG000|Overall Study|Lack of Efficacy|2|||
131506828|NCT01782664|473485750|FG001|Overall Study|Lack of Efficacy|0|||
131506829|NCT01782664|473485751|FG002|Overall Study|Lack of Efficacy|2|||
131506830|NCT01782664|473485752|FG003|Overall Study|Lack of Efficacy|2|||
131506831|NCT01782664|473485753|FG004|Overall Study|Lack of Efficacy|0|||
131506832|NCT01782664|473485754|FG005|Overall Study|Lack of Efficacy|0|||
131506833|NCT01782664|473485749|FG000|Overall Study|Protocol Violation|0|||
131506834|NCT01782664|473485750|FG001|Overall Study|Protocol Violation|1|||
131506835|NCT01782664|473485751|FG002|Overall Study|Protocol Violation|0|||
131506836|NCT01782664|473485752|FG003|Overall Study|Protocol Violation|1|||
131506837|NCT01782664|473485753|FG004|Overall Study|Protocol Violation|0|||
131506838|NCT01782664|473485754|FG005|Overall Study|Protocol Violation|0|||
131506839|NCT01782664|473485749|FG000|Overall Study|Withdrawal by Subject|2|||
131506840|NCT01782664|473485750|FG001|Overall Study|Withdrawal by Subject|2|||
131506841|NCT01782664|473485751|FG002|Overall Study|Withdrawal by Subject|0|||
131506842|NCT01782664|473485752|FG003|Overall Study|Withdrawal by Subject|0|||
131506843|NCT01782664|473485753|FG004|Overall Study|Withdrawal by Subject|0|||
131506844|NCT01782664|473485754|FG005|Overall Study|Withdrawal by Subject|0|||
131506845|NCT00651755|473485756|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
131506846|NCT00651755|473485757|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
131506847|NCT00651755|473485756|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
131506848|NCT00651755|473485757|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
131506849|NCT00624052|473485758|FG000|Overall Study|Adverse Event|7|||
131506850|NCT00624052|473485759|FG001|Overall Study|Adverse Event|6|||
131506851|NCT00624052|473485760|FG002|Overall Study|Adverse Event|0|||
131506852|NCT00624052|473485761|FG003|Overall Study|Adverse Event|3|||
131506853|NCT00624052|473485758|FG000|Overall Study|Lack of Efficacy|1|||
131506854|NCT00624052|473485759|FG001|Overall Study|Lack of Efficacy|1|||
131506855|NCT00624052|473485760|FG002|Overall Study|Lack of Efficacy|0|||
131506856|NCT00624052|473485761|FG003|Overall Study|Lack of Efficacy|0|||
131506857|NCT00624052|473485758|FG000|Overall Study|Lost to Follow-up|2|||
131506858|NCT00624052|473485759|FG001|Overall Study|Lost to Follow-up|3|||
131506859|NCT00624052|473485760|FG002|Overall Study|Lost to Follow-up|1|||
131506860|NCT00624052|473485761|FG003|Overall Study|Lost to Follow-up|0|||
131506861|NCT00624052|473485758|FG000|Overall Study|Non compliant with the protocol|2|||
131506862|NCT00624052|473485759|FG001|Overall Study|Non compliant with the protocol|1|||
131506863|NCT00624052|473485760|FG002|Overall Study|Non compliant with the protocol|1|||
131506864|NCT00624052|473485761|FG003|Overall Study|Non compliant with the protocol|1|||
131506865|NCT00624052|473485758|FG000|Overall Study|Consent withdrawn|3|||
131506866|NCT00624052|473485759|FG001|Overall Study|Consent withdrawn|1|||
131506867|NCT00624052|473485760|FG002|Overall Study|Consent withdrawn|1|||
131506868|NCT00624052|473485761|FG003|Overall Study|Consent withdrawn|0|||
131506869|NCT00624052|473485758|FG000|Overall Study|Changed job/ran out if meds|0|||
131506870|NCT00624052|473485759|FG001|Overall Study|Changed job/ran out if meds|2|||
131506871|NCT00624052|473485760|FG002|Overall Study|Changed job/ran out if meds|0|||
131506872|NCT00624052|473485761|FG003|Overall Study|Changed job/ran out if meds|0|||
131506873|NCT00281684|473485764|FG000|Overall Study|Lost to Follow-up|0|||
131506874|NCT00281684|473485765|FG001|Overall Study|Lost to Follow-up|0|||
131506875|NCT00281684|473485766|FG002|Overall Study|Lost to Follow-up|1|||
131506876|NCT00281684|473485767|FG003|Overall Study|Lost to Follow-up|0|||
131506877|NCT00281684|473485764|FG000|Overall Study|Withdrawal by Subject|1|||
131506878|NCT00281684|473485765|FG001|Overall Study|Withdrawal by Subject|0|||
131506879|NCT00281684|473485766|FG002|Overall Study|Withdrawal by Subject|0|||
131506880|NCT00281684|473485767|FG003|Overall Study|Withdrawal by Subject|0|||
131506881|NCT00698581|473485772|FG000|Overall Study|Lack of Efficacy|23|||
131506882|NCT00698581|473485773|FG001|Overall Study|Lack of Efficacy|11|||
131506883|NCT00698581|473485772|FG000|Overall Study|Withdrawal by Subject|6|||
131506884|NCT00698581|473485773|FG001|Overall Study|Withdrawal by Subject|0|||
131506885|NCT00698581|473485772|FG000|Overall Study|Other reason|9|||
131506886|NCT00698581|473485773|FG001|Overall Study|Other reason|1|||
131506887|NCT00698581|473485772|FG000|Overall Study|SAE, non-fatal|1|||
131506888|NCT00698581|473485773|FG001|Overall Study|SAE, non-fatal|0|||
131506889|NCT00698581|473485772|FG000|Overall Study|AE, non-serious non-fatal|4|||
131506890|NCT00698581|473485773|FG001|Overall Study|AE, non-serious non-fatal|0|||
131506891|NCT00698581|473485772|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131506892|NCT00698581|473485773|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131506893|NCT00698581|473485772|FG000|Overall Study|AE of unknown type|1|||
131506894|NCT00698581|473485773|FG001|Overall Study|AE of unknown type|0|||
131506895|NCT03642717|473485776|FG000|Overall Study|Lost to Follow-up|2|||
131506896|NCT03642717|473485776|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
131506897|NCT03642717|473485776|FG000|Overall Study|Taken study drug prior to contract date|3|||
131506898|NCT00302458|473485777|FG000|Overall Study|Lost to Follow-up|1|||
131506899|NCT00302458|473485777|FG000|Overall Study|Ineligible after screening|1|||
131506900|NCT00302458|473485777|FG000|Overall Study|Withdrawal by Subject|1|||
131506901|NCT01531387|473485778|FG000|Overall Study|Early termination of study|11|||
131506902|NCT01531387|473485779|FG001|Overall Study|Early termination of study|11|||
131506903|NCT02642432|473485780|FG000|Overall Study|Adverse Event|2|||
131506904|NCT02642432|473485780|FG000|Overall Study|Withdrew Consent|1|||
131506905|NCT02642432|473485780|FG000|Overall Study|Lost to Follow-up|2|||
131506906|NCT02642432|473485780|FG000|Overall Study|Other|3|||
131506907|NCT03245008|473485781|FG000|Overall Study|Adverse Event|15|||
131506908|NCT03245008|473485782|FG001|Overall Study|Adverse Event|18|||
131506909|NCT03245008|473485783|FG002|Overall Study|Adverse Event|15|||
131506910|NCT03245008|473485784|FG003|Overall Study|Adverse Event|0|||
131506911|NCT03245008|473485785|FG004|Overall Study|Adverse Event|1|||
131506912|NCT03245008|473485781|FG000|Overall Study|Lack of Efficacy|0|||
131506913|NCT03245008|473485782|FG001|Overall Study|Lack of Efficacy|1|||
131506914|NCT03245008|473485783|FG002|Overall Study|Lack of Efficacy|0|||
131506915|NCT03245008|473485784|FG003|Overall Study|Lack of Efficacy|0|||
131506916|NCT03245008|473485785|FG004|Overall Study|Lack of Efficacy|0|||
131506917|NCT03245008|473485781|FG000|Overall Study|Lost to Follow-up|4|||
131506918|NCT03245008|473485782|FG001|Overall Study|Lost to Follow-up|1|||
131506919|NCT03245008|473485783|FG002|Overall Study|Lost to Follow-up|0|||
131506920|NCT03245008|473485784|FG003|Overall Study|Lost to Follow-up|0|||
131506921|NCT03245008|473485785|FG004|Overall Study|Lost to Follow-up|1|||
131506922|NCT03245008|473485781|FG000|Overall Study|Physician Decision|1|||
131506923|NCT03245008|473485782|FG001|Overall Study|Physician Decision|3|||
131506924|NCT03245008|473485783|FG002|Overall Study|Physician Decision|4|||
131506925|NCT03245008|473485784|FG003|Overall Study|Physician Decision|0|||
131506926|NCT03245008|473485785|FG004|Overall Study|Physician Decision|0|||
131506927|NCT03245008|473485781|FG000|Overall Study|Protocol Violation|0|||
131506928|NCT03245008|473485782|FG001|Overall Study|Protocol Violation|1|||
131506929|NCT03245008|473485783|FG002|Overall Study|Protocol Violation|0|||
131506930|NCT03245008|473485784|FG003|Overall Study|Protocol Violation|0|||
131506931|NCT03245008|473485785|FG004|Overall Study|Protocol Violation|0|||
131506932|NCT03245008|473485781|FG000|Overall Study|Withdrawal by Subject|20|||
131506933|NCT03245008|473485782|FG001|Overall Study|Withdrawal by Subject|19|||
131506934|NCT03245008|473485783|FG002|Overall Study|Withdrawal by Subject|11|||
131506935|NCT03245008|473485784|FG003|Overall Study|Withdrawal by Subject|0|||
131506936|NCT03245008|473485785|FG004|Overall Study|Withdrawal by Subject|0|||
131506937|NCT03245008|473485781|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
131506938|NCT03245008|473485782|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
131506939|NCT03245008|473485783|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
131506940|NCT03245008|473485784|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
131506941|NCT03245008|473485785|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
131506942|NCT03245008|473485781|FG000|Overall Study|Failure to meet randomization criteria|0|||
131506943|NCT03245008|473485782|FG001|Overall Study|Failure to meet randomization criteria|1|||
131506944|NCT03245008|473485783|FG002|Overall Study|Failure to meet randomization criteria|0|||
131506945|NCT03245008|473485784|FG003|Overall Study|Failure to meet randomization criteria|1|||
131506946|NCT03245008|473485785|FG004|Overall Study|Failure to meet randomization criteria|0|||
131506947|NCT01286012|473485786|FG000|Overall Study|Adverse Event|3|||
131506948|NCT01286012|473485787|FG001|Overall Study|Adverse Event|3|||
131506949|NCT01286012|473485786|FG000|Overall Study|Death|2|||
131506950|NCT01286012|473485787|FG001|Overall Study|Death|3|||
131506951|NCT01286012|473485786|FG000|Overall Study|Protocol Violation|1|||
131506952|NCT01286012|473485787|FG001|Overall Study|Protocol Violation|1|||
131506953|NCT01286012|473485786|FG000|Overall Study|Withdrawal by Subject|4|||
131506954|NCT01286012|473485787|FG001|Overall Study|Withdrawal by Subject|4|||
131506955|NCT01286012|473485786|FG000|Overall Study|Physician Decision|2|||
131506956|NCT01286012|473485787|FG001|Overall Study|Physician Decision|0|||
131506957|NCT01286012|473485786|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
131506958|NCT01286012|473485787|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
131506959|NCT03971695|473486909|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506960|NCT03971695|473486910|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506961|NCT03971695|473486911|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506962|NCT03971695|473486912|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
131506963|NCT03971695|473486913|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
131506964|NCT03971695|473486914|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506965|NCT03971695|473486915|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506966|NCT03971695|473486916|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506967|NCT03971695|473486917|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
131506968|NCT03971695|473486918|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
131506969|NCT03971695|473486919|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
131506970|NCT03971695|473486920|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
131506971|NCT03971695|473486921|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
131506972|NCT02155738|473486929|FG000|Overall Study|Missing critical information|1|||
131506973|NCT02155738|473486930|FG001|Overall Study|Missing critical information|0|||
131506974|NCT02155738|473486931|FG002|Overall Study|Missing critical information|0|||
131506975|NCT02155738|473486932|FG003|Overall Study|Missing critical information|1|||
131506976|NCT00192504|473486933|FG000|Overall Study|Lost to Follow-up|1|||
131506977|NCT00192504|473486934|FG001|Overall Study|Lost to Follow-up|0|||
131506978|NCT00192504|473486935|FG002|Overall Study|Lost to Follow-up|0|||
131506979|NCT00192504|473486936|FG003|Overall Study|Lost to Follow-up|0|||
131506980|NCT00192504|473486933|FG000|Overall Study|Dosing window missed|0|||
131506981|NCT00192504|473486934|FG001|Overall Study|Dosing window missed|0|||
131506982|NCT00192504|473486935|FG002|Overall Study|Dosing window missed|1|||
131506983|NCT00192504|473486936|FG003|Overall Study|Dosing window missed|0|||
131506984|NCT01139450|473486937|FG000|Overall Study|Withdrawal by Subject|7|||
131506985|NCT01139450|473486938|FG001|Overall Study|Withdrawal by Subject|10|||
131506986|NCT01139450|473486939|FG002|Overall Study|Withdrawal by Subject|13|||
131506987|NCT01139450|473486937|FG000|Overall Study|Lack of Efficacy|3|||
131506988|NCT01139450|473486938|FG001|Overall Study|Lack of Efficacy|1|||
131506989|NCT01139450|473486939|FG002|Overall Study|Lack of Efficacy|8|||
131506990|NCT01139450|473486937|FG000|Overall Study|Protocol Violation|6|||
131506991|NCT01139450|473486938|FG001|Overall Study|Protocol Violation|5|||
131506992|NCT01139450|473486939|FG002|Overall Study|Protocol Violation|2|||
131506993|NCT01139450|473486937|FG000|Overall Study|Lost to Follow-up|9|||
131506994|NCT01139450|473486938|FG001|Overall Study|Lost to Follow-up|7|||
131506995|NCT01139450|473486939|FG002|Overall Study|Lost to Follow-up|11|||
131506996|NCT01139450|473486937|FG000|Overall Study|Administrative|0|||
131506997|NCT01139450|473486938|FG001|Overall Study|Administrative|0|||
131506998|NCT01139450|473486939|FG002|Overall Study|Administrative|1|||
131506999|NCT01139450|473486937|FG000|Overall Study|Adverse Event|2|||
131507000|NCT01139450|473486938|FG001|Overall Study|Adverse Event|2|||
131507001|NCT01139450|473486939|FG002|Overall Study|Adverse Event|3|||
131507002|NCT05129488|473486946|FG000|Overall Study|Protocol Violation|3|||
131507003|NCT04782856|473486947|FG000|Overall Study|Withdrawal by Subject|0|||
131507004|NCT04782856|473486948|FG001|Overall Study|Withdrawal by Subject|1|||
131507005|NCT01465022|473486949|FG000|Overall Study|Lost to Follow-up|15|||
131507006|NCT01465022|473486950|FG001|Overall Study|Lost to Follow-up|14|||
131507007|NCT01465022|473486951|FG002|Overall Study|Lost to Follow-up|0|||
131507008|NCT01465022|473486949|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
131507009|NCT01465022|473486950|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
131507010|NCT01465022|473486951|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
131507011|NCT01465022|473486949|FG000|Overall Study|Not Randomized|0|||
131507012|NCT01465022|473486950|FG001|Overall Study|Not Randomized|0|||
131507013|NCT01465022|473486951|FG002|Overall Study|Not Randomized|70|||
131507014|NCT01327300|473486952|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
131507015|NCT01327300|473486953|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
131507016|NCT03020823|473486954|FG000|Overall Study|Physician Decision|4|||
131507017|NCT03020823|473486954|FG000|Overall Study|Lack of Efficacy|4|||
131507018|NCT03020823|473486954|FG000|Overall Study|Adverse Event|2|||
131507019|NCT03739112|473486955|FG000|Overall Study|Adverse Event|2|||
131507020|NCT03739112|473486956|FG001|Overall Study|Adverse Event|2|||
131507021|NCT03739112|473486955|FG000|Overall Study|Withdrawal by Subject|38|||
131507022|NCT03739112|473486956|FG001|Overall Study|Withdrawal by Subject|19|||
131507023|NCT03739112|473486955|FG000|Overall Study|Lost to Follow-up|31|||
131507024|NCT03739112|473486956|FG001|Overall Study|Lost to Follow-up|33|||
131507025|NCT03739112|473486955|FG000|Overall Study|Protocol Deviation|12|||
131507026|NCT03739112|473486956|FG001|Overall Study|Protocol Deviation|9|||
131507027|NCT03739112|473486955|FG000|Overall Study|Physician Decision|1|||
131507028|NCT03739112|473486956|FG001|Overall Study|Physician Decision|0|||
131507029|NCT03739112|473486955|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
131507030|NCT03739112|473486956|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
131507031|NCT03739112|473486955|FG000|Overall Study|Site went on hold|65|||
131507032|NCT03739112|473486956|FG001|Overall Study|Site went on hold|67|||
131507033|NCT03739112|473486955|FG000|Overall Study|Other than specified|8|||
131507034|NCT03739112|473486956|FG001|Overall Study|Other than specified|5|||
131507035|NCT03739112|473486955|FG000|Overall Study|Randomized but not vaccinated|31|||
131507036|NCT03739112|473486956|FG001|Overall Study|Randomized but not vaccinated|25|||
131507037|NCT04307446|473486957|FG000|Overall Study|Lost to Follow-up|2|||
131507038|NCT04307446|473486958|FG001|Overall Study|Lost to Follow-up|0|||
131507039|NCT00536107|473486962|FG000|Overall Study|Death|5|||
131507040|NCT00536107|473486963|FG001|Overall Study|Death|1|||
131507041|NCT00536107|473486962|FG000|Overall Study|Incorrect enrolment|1|||
131507042|NCT00536107|473486963|FG001|Overall Study|Incorrect enrolment|0|||
131507043|NCT00536107|473486962|FG000|Overall Study|Withdrawal by Subject|0|||
131507044|NCT00536107|473486963|FG001|Overall Study|Withdrawal by Subject|1|||
131507045|NCT00536107|473486962|FG000|Overall Study|Study Termination|2|||
131507046|NCT00536107|473486963|FG001|Overall Study|Study Termination|4|||
131507047|NCT04356963|473486965|FG000|First Session|Withdrawal by Subject|1|||
131507048|NCT04356963|473486965|FG000|Second Session|Withdrawal by Subject|3|||
131507049|NCT04356963|473486965|FG000|Second Session|Lost to Follow-up|1|||
131507050|NCT04356963|473486965|FG000|Third Session|Lost to Follow-up|6|||
131507051|NCT04356963|473486965|FG000|Third Session|Withdrawal by Subject|1|||
131507052|NCT05172544|473486970|FG000|Overall Study|Withdrawal by Subject|1|||
131507053|NCT05172544|473486971|FG001|Overall Study|Withdrawal by Subject|0|||
131507054|NCT05172544|473486972|FG002|Overall Study|Withdrawal by Subject|0|||
131507055|NCT05172544|473486970|FG000|Overall Study|Physician Decision|0|||
131507056|NCT05172544|473486971|FG001|Overall Study|Physician Decision|0|||
131507057|NCT05172544|473486972|FG002|Overall Study|Physician Decision|1|||
131507058|NCT01176266|473486975|FG000|Overall Study|Death|6|||
131507059|NCT01176266|473486975|FG000|Overall Study|Withdrawal by Subject|3|||
131507060|NCT04829318|473486976|FG000|Overall Study|Adverse Event|6|||
131507061|NCT04829318|473486976|FG000|Overall Study|Death|1|||
131507062|NCT04829318|473486976|FG000|Overall Study|Lost to Follow-up|1|||
131507063|NCT04829318|473486976|FG000|Overall Study|Physician Decision|1|||
131507064|NCT04829318|473486976|FG000|Overall Study|Withdrawal by Subject|19|||
131507065|NCT04829318|473486976|FG000|Overall Study|Site terminated by sponsor|1|||
131507066|NCT04829318|473486976|FG000|Overall Study|Sponsor decision|5|||
131507067|NCT04829318|473486976|FG000|Overall Study|Other|1|||
131507068|NCT00728130|473486977|FG000|Overall Study|Withdrawal by Subject|1|||
131507069|NCT00728130|473486977|FG000|Overall Study|Paperwork not completed in time|1|||
131507070|NCT00728130|473486977|FG000|Overall Study|Physician Decision|1|||
131507071|NCT02073279|473486980|FG000|Double-blind Period|Adverse Event|1|||
131507072|NCT02073279|473486981|FG001|Double-blind Period|Adverse Event|1|||
131507073|NCT02073279|473486980|FG000|Double-blind Period|Switched to another treatment|1|||
131507074|NCT02073279|473486981|FG001|Double-blind Period|Switched to another treatment|2|||
131507075|NCT02073279|473486980|FG000|Double-blind Period|Protocol Violation|0|||
131507076|NCT02073279|473486981|FG001|Double-blind Period|Protocol Violation|1|||
131507077|NCT02073279|473486980|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
131507078|NCT02073279|473486981|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
131507079|NCT02073279|473486980|FG000|Double-blind Period|Withdrawal by Subject|2|||
131507080|NCT02073279|473486981|FG001|Double-blind Period|Withdrawal by Subject|2|||
131507081|NCT02073279|473486980|FG000|Open-label Extension Period|Adverse Event|1|||
131507082|NCT02073279|473486981|FG001|Open-label Extension Period|Adverse Event|0|||
131507083|NCT02073279|473486980|FG000|Open-label Extension Period|Lack of Efficacy|1|||
131507084|NCT02073279|473486981|FG001|Open-label Extension Period|Lack of Efficacy|0|||
131507085|NCT02073279|473486980|FG000|Open-label Extension Period|Lost to Follow-up|0|||
131507086|NCT02073279|473486981|FG001|Open-label Extension Period|Lost to Follow-up|4|||
131507087|NCT02073279|473486980|FG000|Open-label Extension Period|Switched to another treatment|1|||
131507088|NCT02073279|473486981|FG001|Open-label Extension Period|Switched to another treatment|4|||
131507089|NCT02073279|473486980|FG000|Open-label Extension Period|Protocol Violation|0|||
131507090|NCT02073279|473486981|FG001|Open-label Extension Period|Protocol Violation|1|||
131507091|NCT02073279|473486980|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
131507092|NCT02073279|473486981|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
131507093|NCT02073279|473486980|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
131507094|NCT02073279|473486981|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
131507095|NCT05075850|473486985|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
131507096|NCT01265849|473486986|FG000|Overall Study|Randomized//Treatment not initiated|1|||
131507097|NCT01265849|473486987|FG001|Overall Study|Randomized//Treatment not initiated|4|||
131507098|NCT01265849|473486988|FG002|Overall Study|Randomized//Treatment not initiated|0|||
131507099|NCT01265849|473486986|FG000|Overall Study|Physician Decision|1|||
131507100|NCT01265849|473486987|FG001|Overall Study|Physician Decision|2|||
131507101|NCT01265849|473486988|FG002|Overall Study|Physician Decision|0|||
131507102|NCT01265849|473486986|FG000|Overall Study|Lost to Follow-up|18|||
131507103|NCT01265849|473486987|FG001|Overall Study|Lost to Follow-up|15|||
131507104|NCT01265849|473486988|FG002|Overall Study|Lost to Follow-up|5|||
131507105|NCT01265849|473486986|FG000|Overall Study|Not otherwise specified|1|||
131507106|NCT01265849|473486987|FG001|Overall Study|Not otherwise specified|6|||
131507107|NCT01265849|473486988|FG002|Overall Study|Not otherwise specified|1|||
131507108|NCT01265849|473486986|FG000|Overall Study|Withdrawal by Subject|25|||
131507109|NCT01265849|473486987|FG001|Overall Study|Withdrawal by Subject|34|||
131507110|NCT01265849|473486988|FG002|Overall Study|Withdrawal by Subject|13|||
131507111|NCT03194321|473486990|FG000|Overall Study|Withdrawal by Subject|1|||
131507112|NCT03194321|473486990|FG000|Overall Study|Lost to Follow-up|1|||
131507113|NCT03194321|473486990|FG000|Overall Study|Travel for Follow-up|1|||
131507114|NCT03803774|473486991|FG000|Dose Escalation|Withdrawal by Subject|0|||
131507115|NCT03803774|473486992|FG001|Dose Escalation|Withdrawal by Subject|0|||
131507116|NCT03803774|473486993|FG002|Dose Escalation|Withdrawal by Subject|0|||
131507117|NCT03803774|473486994|FG003|Dose Escalation|Withdrawal by Subject|1|||
131507118|NCT03803774|473486995|FG004|Dose Escalation|Withdrawal by Subject|0|||
131507119|NCT00271609|473486996|FG000|Overall Study|Adverse Event|11|||
131507120|NCT00271609|473486997|FG001|Overall Study|Adverse Event|3|||
131507121|NCT00271609|473486996|FG000|Overall Study|Withdrawal by Subject|2|||
131507122|NCT00271609|473486997|FG001|Overall Study|Withdrawal by Subject|0|||
131507123|NCT02188589|473486998|FG000|Overall Study|Withdrawal by Subject|5|||
131507124|NCT00878709|473487002|FG000|Overall Study|Withdrawal by Subject|197|||
131507125|NCT00878709|473487003|FG001|Overall Study|Withdrawal by Subject|120|||
131507126|NCT00878709|473487002|FG000|Overall Study|Lost to Follow-up|35|||
131507127|NCT00878709|473487003|FG001|Overall Study|Lost to Follow-up|33|||
131507128|NCT00878709|473487002|FG000|Overall Study|Other Reasons|93|||
131507129|NCT00878709|473487003|FG001|Overall Study|Other Reasons|84|||
131507130|NCT01712854|473487004|FG000|Overall Study|Physician Decision|1|||
131507131|NCT00768300|473487007|FG000|Overall Study|Randomized but not treated|1|||
131507132|NCT00768300|473487008|FG001|Overall Study|Randomized but not treated|1|||
131507133|NCT00768300|473487007|FG000|Overall Study|Adverse Event|10|||
131507134|NCT00768300|473487008|FG001|Overall Study|Adverse Event|2|||
131507135|NCT00768300|473487007|FG000|Overall Study|Protocol Violation|6|||
131507136|NCT00768300|473487008|FG001|Overall Study|Protocol Violation|1|||
131507137|NCT00768300|473487007|FG000|Overall Study|Withdrawal by Subject|13|||
131507138|NCT00768300|473487008|FG001|Overall Study|Withdrawal by Subject|7|||
131507139|NCT00768300|473487007|FG000|Overall Study|Physician Decision|2|||
131507140|NCT00768300|473487008|FG001|Overall Study|Physician Decision|3|||
131507141|NCT00768300|473487007|FG000|Overall Study|Study discontinued by Sponsor|271|||
131507142|NCT00768300|473487008|FG001|Overall Study|Study discontinued by Sponsor|140|||
131507143|NCT00768300|473487007|FG000|Overall Study|Death|21|||
131507144|NCT00768300|473487008|FG001|Overall Study|Death|5|||
131507145|NCT00768300|473487007|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
131507146|NCT00768300|473487008|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
131507147|NCT00768300|473487007|FG000|Overall Study|Screen failure following randomization|1|||
131507148|NCT00768300|473487008|FG001|Overall Study|Screen failure following randomization|0|||
131507149|NCT00768300|473487007|FG000|Overall Study|Received lung transplant|1|||
131507150|NCT00768300|473487008|FG001|Overall Study|Received lung transplant|1|||
131507151|NCT00768300|473487007|FG000|Overall Study|Lost to Follow-up|0|||
131507152|NCT00768300|473487008|FG001|Overall Study|Lost to Follow-up|1|||
131507153|NCT00768300|473487007|FG000|Overall Study|Began prohibited concomitant medication|0|||
131507154|NCT00768300|473487008|FG001|Overall Study|Began prohibited concomitant medication|1|||
131507155|NCT00768300|473487007|FG000|Overall Study|Treated but never dosed with Study drug|1|||
131507156|NCT00768300|473487008|FG001|Overall Study|Treated but never dosed with Study drug|0|||
131507157|NCT00768300|473487007|FG000|Overall Study|Missing data|1|||
131507158|NCT00768300|473487008|FG001|Overall Study|Missing data|0|||
131507159|NCT00663052|473487010|FG000|Overall Study|Adverse Event|6|||
131507160|NCT00663052|473487011|FG001|Overall Study|Adverse Event|3|||
131507161|NCT00663052|473487010|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
131507162|NCT00663052|473487011|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131507163|NCT00663052|473487010|FG000|Overall Study|Protocol Violation|1|||
131507164|NCT00663052|473487011|FG001|Overall Study|Protocol Violation|0|||
131507165|NCT00663052|473487010|FG000|Overall Study|Withdrawal by Subject|2|||
131507166|NCT00663052|473487011|FG001|Overall Study|Withdrawal by Subject|5|||
131507167|NCT00663052|473487010|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
131507168|NCT00663052|473487011|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
131507169|NCT00663052|473487010|FG000|Overall Study|Other|0|||
131507170|NCT00663052|473487011|FG001|Overall Study|Other|1|||
131507171|NCT05760300|473487014|FG000|Overall Study|Adverse Event|0|||
131507172|NCT05760300|473487015|FG001|Overall Study|Adverse Event|0|||
131507173|NCT05760300|473487016|FG002|Overall Study|Adverse Event|1|||
131507174|NCT05760300|473487017|FG003|Overall Study|Adverse Event|0|||
131507175|NCT05760300|473487014|FG000|Overall Study|Participant Decision|1|||
131507176|NCT05760300|473487015|FG001|Overall Study|Participant Decision|0|||
131507177|NCT05760300|473487016|FG002|Overall Study|Participant Decision|0|||
131507178|NCT05760300|473487017|FG003|Overall Study|Participant Decision|0|||
131507179|NCT01252940|473487018|FG000|Main Study Phase|Randomized but not treated|4|||
131507180|NCT01252940|473487019|FG001|Main Study Phase|Randomized but not treated|2|||
131507181|NCT01252940|473487018|FG000|Main Study Phase|Adverse Event|3|||
131507182|NCT01252940|473487019|FG001|Main Study Phase|Adverse Event|1|||
131507183|NCT01252940|473487018|FG000|Main Study Phase|Lack of Efficacy|1|||
131507184|NCT01252940|473487019|FG001|Main Study Phase|Lack of Efficacy|0|||
131507185|NCT01252940|473487018|FG000|Main Study Phase|Lost to Follow-up|6|||
131507186|NCT01252940|473487019|FG001|Main Study Phase|Lost to Follow-up|1|||
131507187|NCT01252940|473487018|FG000|Main Study Phase|Physician Decision|1|||
131507188|NCT01252940|473487019|FG001|Main Study Phase|Physician Decision|0|||
131507189|NCT01252940|473487018|FG000|Main Study Phase|Protocol Violation|4|||
131507190|NCT01252940|473487019|FG001|Main Study Phase|Protocol Violation|2|||
131507191|NCT01252940|473487018|FG000|Main Study Phase|Withdrawal by Subject|6|||
131507192|NCT01252940|473487019|FG001|Main Study Phase|Withdrawal by Subject|5|||
131507193|NCT01252940|473487018|FG000|Main Study Phase|Subject Non-compliance|1|||
131507194|NCT01252940|473487019|FG001|Main Study Phase|Subject Non-compliance|1|||
131507195|NCT01252940|473487018|FG000|Extension Phase|Adverse Event|2|||
131507196|NCT01252940|473487019|FG001|Extension Phase|Adverse Event|1|||
131507197|NCT01252940|473487018|FG000|Extension Phase|Lack of Efficacy|1|||
131507198|NCT01252940|473487019|FG001|Extension Phase|Lack of Efficacy|0|||
131507199|NCT01252940|473487018|FG000|Extension Phase|Lost to Follow-up|5|||
131507200|NCT01252940|473487019|FG001|Extension Phase|Lost to Follow-up|0|||
131507201|NCT01252940|473487018|FG000|Extension Phase|Physician Decision|0|||
131507202|NCT01252940|473487019|FG001|Extension Phase|Physician Decision|1|||
131507203|NCT01252940|473487018|FG000|Extension Phase|Subject Non-compliance|1|||
131507204|NCT01252940|473487019|FG001|Extension Phase|Subject Non-compliance|0|||
131507205|NCT01252940|473487018|FG000|Extension Phase|Withdrawal by Subject|1|||
131507206|NCT01252940|473487019|FG001|Extension Phase|Withdrawal by Subject|1|||
131507207|NCT02496533|473487024|FG000|Overall Study|Lack of data on outcome|3|||
131507208|NCT02496533|473487025|FG001|Overall Study|Lack of data on outcome|0|||
131507209|NCT02496533|473487024|FG000|Overall Study|Patient did not complete all measures|0|||
131507210|NCT02496533|473487025|FG001|Overall Study|Patient did not complete all measures|4|||
131507211|NCT02496533|473487024|FG000|Overall Study|Late for radiologic testing|0|||
131507212|NCT02496533|473487025|FG001|Overall Study|Late for radiologic testing|2|||
131507213|NCT04690751|473487027|FG000|Overall Study|Protocol Violation|0|||
131507214|NCT04690751|473487028|FG001|Overall Study|Protocol Violation|1|||
131507215|NCT04690751|473487029|FG002|Overall Study|Protocol Violation|0|||
131507216|NCT04690751|473487030|FG003|Overall Study|Protocol Violation|1|||
131507217|NCT04690751|473487031|FG004|Overall Study|Protocol Violation|2|||
131507218|NCT04690751|473487032|FG005|Overall Study|Protocol Violation|0|||
131507219|NCT04690751|473487027|FG000|Overall Study|Adverse Event|0|||
131507220|NCT04690751|473487028|FG001|Overall Study|Adverse Event|0|||
131507221|NCT04690751|473487029|FG002|Overall Study|Adverse Event|1|||
131507222|NCT04690751|473487030|FG003|Overall Study|Adverse Event|0|||
131507223|NCT04690751|473487031|FG004|Overall Study|Adverse Event|0|||
131507224|NCT04690751|473487032|FG005|Overall Study|Adverse Event|0|||
131507225|NCT04690751|473487027|FG000|Overall Study|Positive urine drug screen test|0|||
131507226|NCT04690751|473487028|FG001|Overall Study|Positive urine drug screen test|0|||
131507227|NCT04690751|473487029|FG002|Overall Study|Positive urine drug screen test|0|||
131507228|NCT04690751|473487030|FG003|Overall Study|Positive urine drug screen test|0|||
131507229|NCT04690751|473487031|FG004|Overall Study|Positive urine drug screen test|1|||
131507230|NCT04690751|473487032|FG005|Overall Study|Positive urine drug screen test|0|||
131507231|NCT01344161|473487033|FG000|Overall Study|Lost to Follow-up|4|||
131507232|NCT01344161|473487034|FG001|Overall Study|Lost to Follow-up|1|||
131507233|NCT01344161|473487033|FG000|Overall Study|Pregnancy|0|||
131507234|NCT01344161|473487034|FG001|Overall Study|Pregnancy|1|||
131507235|NCT01344161|473487033|FG000|Overall Study|Protocol Violation|1|||
131507236|NCT01344161|473487034|FG001|Overall Study|Protocol Violation|1|||
131507237|NCT04364620|473487036|FG000|Overall Study|Disease Progression|20|||
131507238|NCT04364620|473487036|FG000|Overall Study|Adverse Event|5|||
131507239|NCT04364620|473487036|FG000|Overall Study|Physician Decision|4|||
131507240|NCT04364620|473487036|FG000|Overall Study|Death|3|||
131507241|NCT04364620|473487036|FG000|Overall Study|Other|2|||
131507242|NCT04364620|473487036|FG000|Overall Study|Withdrawal by Subject|1|||
131507243|NCT03759379|473488598|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
131507244|NCT03759379|473488599|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
131507245|NCT03759379|473488598|FG000|Treatment Period|Death|2|||
131507246|NCT03759379|473488599|FG001|Treatment Period|Death|3|||
131507247|NCT03759379|473488598|FG000|Treatment Period|Lost to Follow-up|1|||
131507248|NCT03759379|473488599|FG001|Treatment Period|Lost to Follow-up|0|||
131507249|NCT03759379|473488598|FG000|Treatment Period|Physician Decision|0|||
131507250|NCT03759379|473488599|FG001|Treatment Period|Physician Decision|1|||
131507251|NCT01536379|473488601|FG000|Overall Study|Adverse Event|1|||
131507252|NCT01536379|473488602|FG001|Overall Study|Adverse Event|2|||
131507253|NCT01536379|473488601|FG000|Overall Study|Withdrawal by Subject|1|||
131507254|NCT01536379|473488602|FG001|Overall Study|Withdrawal by Subject|1|||
131507255|NCT04447417|473488605|FG000|Overall Study|Withdrawal by Subject|1|||
131507256|NCT04447417|473488606|FG001|Overall Study|Withdrawal by Subject|0|||
131507257|NCT04447417|473488605|FG000|Overall Study|Failure to meet inclusion criteria|1|||
131507258|NCT04447417|473488606|FG001|Overall Study|Failure to meet inclusion criteria|0|||
131507259|NCT04447417|473488605|FG000|Overall Study|Lost to Follow-up|1|||
131507260|NCT04447417|473488606|FG001|Overall Study|Lost to Follow-up|0|||
131507261|NCT02268409|473488607|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
131507262|NCT02268409|473488607|FG000|Overall Study|Death|1|||
131507263|NCT02268409|473488607|FG000|Overall Study|Lost to Follow-up|1|||
131507264|NCT02268409|473488607|FG000|Overall Study|Protocol Violation|3|||
131507265|NCT02268409|473488607|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
131507266|NCT02268409|473488607|FG000|Overall Study|Withdrawal by Subject|5|||
131507267|NCT02356783|473488608|FG000|Overall Study|Lost to Follow-up|1|||
131507268|NCT02356783|473488609|FG001|Overall Study|Lost to Follow-up|3|||
131507269|NCT01365507|473488611|FG000|Overall Study|Withdrawal Criteria|8|||
131507270|NCT01365507|473488612|FG001|Overall Study|Withdrawal Criteria|5|||
131507271|NCT01365507|473488611|FG000|Overall Study|Unclassified|1|||
131507272|NCT01365507|473488612|FG001|Overall Study|Unclassified|4|||
131507273|NCT00914810|473488617|FG000|Overall Study|Withdrawal by Subject|1|||
131507274|NCT00914810|473488618|FG001|Overall Study|Withdrawal by Subject|0|||
131507275|NCT00914810|473488617|FG000|Overall Study|Relocated out of state|1|||
131507276|NCT00914810|473488618|FG001|Overall Study|Relocated out of state|0|||
131507277|NCT00914810|473488617|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
131507278|NCT00914810|473488618|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
131507279|NCT03102918|473488619|FG000|Overall Study|Protocol Violation|1|||
131507280|NCT03102918|473488620|FG001|Overall Study|Protocol Violation|0|||
131507281|NCT04765358|473488623|FG000|Overall Study|Withdrawal by Subject|1|||
131507282|NCT02731729|473488624|FG000|Overall Study|Death|2|||
131507283|NCT02731729|473488625|FG001|Overall Study|Death|2|||
131507284|NCT02731729|473488624|FG000|Overall Study|Study terminated by Sponsor|6|||
131507285|NCT02731729|473488625|FG001|Overall Study|Study terminated by Sponsor|6|||
131507286|NCT02731729|473488624|FG000|Overall Study|Withdrawal by Subject|1|||
131507287|NCT02731729|473488625|FG001|Overall Study|Withdrawal by Subject|0|||
131507288|NCT03446040|473488628|FG000|Overall Study|Disease progression|3|||
131507289|NCT03446040|473488629|FG001|Overall Study|Disease progression|3|||
131507290|NCT03446040|473488630|FG002|Overall Study|Disease progression|3|||
131507291|NCT03446040|473488631|FG003|Overall Study|Disease progression|4|||
131507292|NCT03446040|473488632|FG004|Overall Study|Disease progression|4|||
131507293|NCT03446040|473488633|FG005|Overall Study|Disease progression|6|||
131507294|NCT03446040|473488634|FG006|Overall Study|Disease progression|3|||
131507295|NCT03446040|473488635|FG007|Overall Study|Disease progression|4|||
131507296|NCT03446040|473488636|FG008|Overall Study|Disease progression|2|||
131507297|NCT03446040|473488637|FG009|Overall Study|Disease progression|4|||
131507298|NCT03446040|473488638|FG010|Overall Study|Disease progression|9|||
131507299|NCT03446040|473488639|FG011|Overall Study|Disease progression|3|||
131507300|NCT03446040|473488640|FG012|Overall Study|Disease progression|7|||
131507301|NCT03446040|473488641|FG013|Overall Study|Disease progression|7|||
131507302|NCT03446040|473488628|FG000|Overall Study|Study drug toxicity|0|||
131507303|NCT03446040|473488629|FG001|Overall Study|Study drug toxicity|0|||
131507304|NCT03446040|473488630|FG002|Overall Study|Study drug toxicity|0|||
131507305|NCT03446040|473488631|FG003|Overall Study|Study drug toxicity|0|||
131507306|NCT03446040|473488632|FG004|Overall Study|Study drug toxicity|0|||
131507307|NCT03446040|473488633|FG005|Overall Study|Study drug toxicity|0|||
131507308|NCT03446040|473488634|FG006|Overall Study|Study drug toxicity|0|||
131507309|NCT03446040|473488635|FG007|Overall Study|Study drug toxicity|0|||
131507310|NCT03446040|473488636|FG008|Overall Study|Study drug toxicity|1|||
131507311|NCT03446040|473488637|FG009|Overall Study|Study drug toxicity|0|||
131507312|NCT03446040|473488638|FG010|Overall Study|Study drug toxicity|0|||
131507313|NCT03446040|473488639|FG011|Overall Study|Study drug toxicity|0|||
131507314|NCT03446040|473488640|FG012|Overall Study|Study drug toxicity|0|||
131507315|NCT03446040|473488641|FG013|Overall Study|Study drug toxicity|0|||
131507316|NCT03446040|473488628|FG000|Overall Study|Adverse Event|0|||
131507317|NCT03446040|473488629|FG001|Overall Study|Adverse Event|0|||
131507318|NCT03446040|473488630|FG002|Overall Study|Adverse Event|0|||
131507319|NCT03446040|473488631|FG003|Overall Study|Adverse Event|0|||
131507320|NCT03446040|473488632|FG004|Overall Study|Adverse Event|0|||
131507321|NCT03446040|473488633|FG005|Overall Study|Adverse Event|2|||
131507322|NCT03446040|473488634|FG006|Overall Study|Adverse Event|0|||
131507323|NCT03446040|473488635|FG007|Overall Study|Adverse Event|0|||
131507324|NCT03446040|473488636|FG008|Overall Study|Adverse Event|1|||
131507325|NCT03446040|473488637|FG009|Overall Study|Adverse Event|0|||
131507326|NCT03446040|473488638|FG010|Overall Study|Adverse Event|0|||
131507327|NCT03446040|473488639|FG011|Overall Study|Adverse Event|0|||
131507328|NCT03446040|473488640|FG012|Overall Study|Adverse Event|0|||
131507329|NCT03446040|473488641|FG013|Overall Study|Adverse Event|0|||
131507330|NCT03446040|473488628|FG000|Overall Study|Death|0|||
131507331|NCT03446040|473488629|FG001|Overall Study|Death|0|||
131507332|NCT03446040|473488630|FG002|Overall Study|Death|0|||
131507333|NCT03446040|473488631|FG003|Overall Study|Death|0|||
131507334|NCT03446040|473488632|FG004|Overall Study|Death|0|||
131507335|NCT03446040|473488633|FG005|Overall Study|Death|0|||
131507336|NCT03446040|473488634|FG006|Overall Study|Death|0|||
131507337|NCT03446040|473488635|FG007|Overall Study|Death|0|||
131507338|NCT03446040|473488636|FG008|Overall Study|Death|0|||
131507339|NCT03446040|473488637|FG009|Overall Study|Death|0|||
131507340|NCT03446040|473488638|FG010|Overall Study|Death|1|||
131507341|NCT03446040|473488639|FG011|Overall Study|Death|0|||
131507342|NCT03446040|473488640|FG012|Overall Study|Death|0|||
131507343|NCT03446040|473488641|FG013|Overall Study|Death|2|||
131507344|NCT03446040|473488628|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
131507345|NCT03446040|473488629|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
131507346|NCT03446040|473488630|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
131507347|NCT03446040|473488631|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
131507348|NCT03446040|473488632|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
131507349|NCT03446040|473488633|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
131507350|NCT03446040|473488634|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
131507351|NCT03446040|473488635|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
131507352|NCT03446040|473488636|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
131507353|NCT03446040|473488637|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
131507354|NCT03446040|473488638|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
131507355|NCT03446040|473488639|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
131507356|NCT03446040|473488640|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
131507357|NCT03446040|473488641|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
131507358|NCT03446040|473488628|FG000|Overall Study|Participant withdrew consent|0|||
131507359|NCT03446040|473488629|FG001|Overall Study|Participant withdrew consent|0|||
131507360|NCT03446040|473488630|FG002|Overall Study|Participant withdrew consent|0|||
131507361|NCT03446040|473488631|FG003|Overall Study|Participant withdrew consent|0|||
131507362|NCT03446040|473488632|FG004|Overall Study|Participant withdrew consent|0|||
131507363|NCT03446040|473488633|FG005|Overall Study|Participant withdrew consent|1|||
131507364|NCT03446040|473488634|FG006|Overall Study|Participant withdrew consent|0|||
131507365|NCT03446040|473488635|FG007|Overall Study|Participant withdrew consent|1|||
131507366|NCT03446040|473488636|FG008|Overall Study|Participant withdrew consent|0|||
131507367|NCT03446040|473488637|FG009|Overall Study|Participant withdrew consent|0|||
131507368|NCT03446040|473488638|FG010|Overall Study|Participant withdrew consent|0|||
131507369|NCT03446040|473488639|FG011|Overall Study|Participant withdrew consent|0|||
131507370|NCT03446040|473488640|FG012|Overall Study|Participant withdrew consent|0|||
131507371|NCT03446040|473488641|FG013|Overall Study|Participant withdrew consent|0|||
131507372|NCT03446040|473488628|FG000|Overall Study|Not reported|0|||
131507373|NCT03446040|473488629|FG001|Overall Study|Not reported|0|||
131507374|NCT03446040|473488630|FG002|Overall Study|Not reported|1|||
131507375|NCT03446040|473488631|FG003|Overall Study|Not reported|0|||
131507376|NCT03446040|473488632|FG004|Overall Study|Not reported|0|||
131507377|NCT03446040|473488633|FG005|Overall Study|Not reported|0|||
131507378|NCT03446040|473488634|FG006|Overall Study|Not reported|0|||
131507379|NCT03446040|473488635|FG007|Overall Study|Not reported|0|||
131507380|NCT03446040|473488636|FG008|Overall Study|Not reported|0|||
131507381|NCT03446040|473488637|FG009|Overall Study|Not reported|0|||
131507382|NCT03446040|473488638|FG010|Overall Study|Not reported|0|||
131507383|NCT03446040|473488639|FG011|Overall Study|Not reported|0|||
131507384|NCT03446040|473488640|FG012|Overall Study|Not reported|0|||
131507385|NCT03446040|473488641|FG013|Overall Study|Not reported|0|||
131507386|NCT02066467|473488642|FG000|Overall Study|Did not undergo implant procedure|24|||
131507387|NCT02066467|473488642|FG000|Overall Study|Attempted to implant withoput success|43|||
131507388|NCT02066467|473488642|FG000|Overall Study|Consent ineligible|1|||
131507389|NCT02066467|473488642|FG000|Overall Study|Death|54|||
131507390|NCT02066467|473488642|FG000|Overall Study|Lost to Follow-up|51|||
131507391|NCT02066467|473488642|FG000|Overall Study|Adverse Event|20|||
131507392|NCT02066467|473488642|FG000|Overall Study|Withdrawal by Subject|16|||
131507393|NCT02066467|473488642|FG000|Overall Study|Physician Decision|2|||
131507394|NCT02066467|473488642|FG000|Overall Study|Not defined|4|||
131507395|NCT00456521|473488643|FG000|Overall Study|Adverse Event|150|||
131507396|NCT00456521|473488644|FG001|Overall Study|Adverse Event|25|||
131507397|NCT00456521|473488643|FG000|Overall Study|Withdrawal by Subject|43|||
131507398|NCT00456521|473488644|FG001|Overall Study|Withdrawal by Subject|24|||
131507399|NCT00456521|473488643|FG000|Overall Study|Lost to Follow-up|22|||
131507400|NCT00456521|473488644|FG001|Overall Study|Lost to Follow-up|17|||
131507401|NCT00456521|473488643|FG000|Overall Study|Lack of Efficacy|3|||
131507402|NCT00456521|473488644|FG001|Overall Study|Lack of Efficacy|6|||
131507403|NCT00456521|473488643|FG000|Overall Study|Protocol Violation|4|||
131507404|NCT00456521|473488644|FG001|Overall Study|Protocol Violation|0|||
131507405|NCT00456521|473488643|FG000|Overall Study|Pregnancy|1|||
131507406|NCT00456521|473488644|FG001|Overall Study|Pregnancy|1|||
131507407|NCT00456521|473488643|FG000|Overall Study|Drug non-compliance, moved, other|26|||
131507408|NCT00456521|473488644|FG001|Overall Study|Drug non-compliance, moved, other|11|||
131507409|NCT01316276|473488645|FG000|Overall Study|Death|1|||
131507410|NCT01316276|473488645|FG000|Overall Study|Adverse Event|19|||
131507411|NCT01316276|473488645|FG000|Overall Study|Withdrawal of consent|24|||
131507412|NCT01316276|473488645|FG000|Overall Study|Lost to Follow-up|1|||
131507413|NCT01316276|473488645|FG000|Overall Study|Other|22|||
131507414|NCT00605475|473488646|FG000|Overall Study|Abnormal Laboratory Values|0|||
131507415|NCT00605475|473488647|FG001|Overall Study|Abnormal Laboratory Values|0|||
131507416|NCT00605475|473488648|FG002|Overall Study|Abnormal Laboratory Values|0|||
131507417|NCT00605475|473488649|FG003|Overall Study|Abnormal Laboratory Values|0|||
131507418|NCT00605475|473488650|FG004|Overall Study|Abnormal Laboratory Values|0|||
131507419|NCT00605475|473488651|FG005|Overall Study|Abnormal Laboratory Values|0|||
131507420|NCT00605475|473488652|FG006|Overall Study|Abnormal Laboratory Values|0|||
131507421|NCT00605475|473488653|FG007|Overall Study|Abnormal Laboratory Values|0|||
131507422|NCT00605475|473488654|FG008|Overall Study|Abnormal Laboratory Values|1|||
131507423|NCT00605475|473488655|FG009|Overall Study|Abnormal Laboratory Values|0|||
131507424|NCT00605475|473488646|FG000|Overall Study|Administrative problems|0|||
131507425|NCT00605475|473488647|FG001|Overall Study|Administrative problems|0|||
131507426|NCT00605475|473488648|FG002|Overall Study|Administrative problems|0|||
131507427|NCT00605475|473488649|FG003|Overall Study|Administrative problems|0|||
131507428|NCT00605475|473488650|FG004|Overall Study|Administrative problems|0|||
131507429|NCT00605475|473488651|FG005|Overall Study|Administrative problems|0|||
131507430|NCT00605475|473488652|FG006|Overall Study|Administrative problems|1|||
131507431|NCT00605475|473488653|FG007|Overall Study|Administrative problems|0|||
131507432|NCT00605475|473488654|FG008|Overall Study|Administrative problems|0|||
131507433|NCT00605475|473488655|FG009|Overall Study|Administrative problems|0|||
131507434|NCT00605475|473488646|FG000|Overall Study|Lost to Follow-up|0|||
131507435|NCT00605475|473488647|FG001|Overall Study|Lost to Follow-up|0|||
131507436|NCT00605475|473488648|FG002|Overall Study|Lost to Follow-up|0|||
131507437|NCT00605475|473488649|FG003|Overall Study|Lost to Follow-up|0|||
131507438|NCT00605475|473488650|FG004|Overall Study|Lost to Follow-up|0|||
131507439|NCT00605475|473488651|FG005|Overall Study|Lost to Follow-up|0|||
131507440|NCT00605475|473488652|FG006|Overall Study|Lost to Follow-up|0|||
131507441|NCT00605475|473488653|FG007|Overall Study|Lost to Follow-up|0|||
131507442|NCT00605475|473488654|FG008|Overall Study|Lost to Follow-up|1|||
131507443|NCT00605475|473488655|FG009|Overall Study|Lost to Follow-up|1|||
131507444|NCT00605475|473488646|FG000|Overall Study|Protocol Violation|0|||
131507445|NCT00605475|473488647|FG001|Overall Study|Protocol Violation|0|||
131507446|NCT00605475|473488648|FG002|Overall Study|Protocol Violation|0|||
131507447|NCT00605475|473488649|FG003|Overall Study|Protocol Violation|0|||
131507448|NCT00605475|473488650|FG004|Overall Study|Protocol Violation|1|||
131507449|NCT00605475|473488651|FG005|Overall Study|Protocol Violation|0|||
131507450|NCT00605475|473488652|FG006|Overall Study|Protocol Violation|0|||
131507451|NCT00605475|473488653|FG007|Overall Study|Protocol Violation|0|||
131507452|NCT00605475|473488654|FG008|Overall Study|Protocol Violation|0|||
131507453|NCT00605475|473488655|FG009|Overall Study|Protocol Violation|0|||
131507454|NCT00605475|473488646|FG000|Overall Study|Withdrawal by Subject|0|||
131507455|NCT00605475|473488647|FG001|Overall Study|Withdrawal by Subject|0|||
131507456|NCT00605475|473488648|FG002|Overall Study|Withdrawal by Subject|0|||
131507457|NCT00605475|473488649|FG003|Overall Study|Withdrawal by Subject|0|||
131507458|NCT00605475|473488650|FG004|Overall Study|Withdrawal by Subject|0|||
131507459|NCT00605475|473488651|FG005|Overall Study|Withdrawal by Subject|2|||
131507460|NCT00605475|473488652|FG006|Overall Study|Withdrawal by Subject|0|||
131507461|NCT00605475|473488653|FG007|Overall Study|Withdrawal by Subject|0|||
131507462|NCT00605475|473488654|FG008|Overall Study|Withdrawal by Subject|0|||
131507463|NCT00605475|473488655|FG009|Overall Study|Withdrawal by Subject|1|||
131507464|NCT02596854|473488656|FG000|Overall Study|Withdrawn|8|||
131507465|NCT01652664|473488657|FG000|Overall Study|Treatment Failure|5|||
131507466|NCT01652664|473488658|FG001|Overall Study|Treatment Failure|1|||
131507467|NCT01652664|473488657|FG000|Overall Study|Inadequate IOP control|1|||
131507468|NCT01652664|473488658|FG001|Overall Study|Inadequate IOP control|0|||
131507469|NCT00297037|473488659|FG000|Overall Study|Withdrawal by Subject|2|||
131507470|NCT00297037|473488660|FG001|Overall Study|Withdrawal by Subject|0|||
131507471|NCT00581776|473488661|FG000|Overall Study|Disease progression or no response|3|||
131507472|NCT00464568|473488664|FG000|Overall Study|Adverse Event|2|||
131507473|NCT03615326|473488665|FG000|Overall Study|Death|266|||
131507474|NCT03615326|473488666|FG001|Overall Study|Death|286|||
131507475|NCT03615326|473488667|FG002|Overall Study|Death|14|||
131507476|NCT03615326|473488668|FG003|Overall Study|Death|17|||
131507477|NCT03615326|473488665|FG000|Overall Study|Lost to Follow-up|0|||
131507478|NCT03615326|473488666|FG001|Overall Study|Lost to Follow-up|1|||
131507479|NCT03615326|473488667|FG002|Overall Study|Lost to Follow-up|0|||
131507480|NCT03615326|473488668|FG003|Overall Study|Lost to Follow-up|0|||
131507481|NCT03615326|473488665|FG000|Overall Study|Withdrawal by Subject|1|||
131507482|NCT03615326|473488666|FG001|Overall Study|Withdrawal by Subject|3|||
131507483|NCT03615326|473488667|FG002|Overall Study|Withdrawal by Subject|0|||
131507484|NCT03615326|473488668|FG003|Overall Study|Withdrawal by Subject|0|||
131507485|NCT03615326|473488665|FG000|Overall Study|Participants Ongoing|83|||
131507486|NCT03615326|473488666|FG001|Overall Study|Participants Ongoing|58|||
131507487|NCT03615326|473488667|FG002|Overall Study|Participants Ongoing|6|||
131507488|NCT03615326|473488668|FG003|Overall Study|Participants Ongoing|3|||
131507489|NCT00405587|473488671|FG000|Overall Study|Death|0|||
131507490|NCT00405587|473488672|FG001|Overall Study|Death|0|||
131507491|NCT00405587|473488673|FG002|Overall Study|Death|0|||
131507492|NCT00405587|473488674|FG003|Overall Study|Death|1|||
131507493|NCT00405587|473488671|FG000|Overall Study|Disease Progression|22|||
131507494|NCT00405587|473488672|FG001|Overall Study|Disease Progression|23|||
131507495|NCT00405587|473488673|FG002|Overall Study|Disease Progression|21|||
131507496|NCT00405587|473488674|FG003|Overall Study|Disease Progression|17|||
131507497|NCT00405587|473488671|FG000|Overall Study|Physician Decision|3|||
131507498|NCT00405587|473488672|FG001|Overall Study|Physician Decision|2|||
131507499|NCT00405587|473488673|FG002|Overall Study|Physician Decision|0|||
131507500|NCT00405587|473488674|FG003|Overall Study|Physician Decision|0|||
131507501|NCT00405587|473488671|FG000|Overall Study|Adverse Event|1|||
131507502|NCT00405587|473488672|FG001|Overall Study|Adverse Event|0|||
131507503|NCT00405587|473488673|FG002|Overall Study|Adverse Event|0|||
131507504|NCT00405587|473488674|FG003|Overall Study|Adverse Event|0|||
131507505|NCT00405587|473488671|FG000|Overall Study|Lost to Follow-up|0|||
131507506|NCT00405587|473488672|FG001|Overall Study|Lost to Follow-up|1|||
131507507|NCT00405587|473488673|FG002|Overall Study|Lost to Follow-up|1|||
131507508|NCT00405587|473488674|FG003|Overall Study|Lost to Follow-up|0|||
131507509|NCT00405587|473488671|FG000|Overall Study|Radiation induced necrosis|0|||
131507510|NCT00405587|473488672|FG001|Overall Study|Radiation induced necrosis|1|||
131507511|NCT00405587|473488673|FG002|Overall Study|Radiation induced necrosis|0|||
131507512|NCT00405587|473488674|FG003|Overall Study|Radiation induced necrosis|0|||
131507513|NCT00405587|473488671|FG000|Overall Study|Withdrawal by Subject|0|||
131507514|NCT00405587|473488672|FG001|Overall Study|Withdrawal by Subject|0|||
131507515|NCT00405587|473488673|FG002|Overall Study|Withdrawal by Subject|0|||
131507516|NCT00405587|473488674|FG003|Overall Study|Withdrawal by Subject|2|||
131507517|NCT00405587|473488671|FG000|Overall Study|Participant not dosed|0|||
131507518|NCT00405587|473488672|FG001|Overall Study|Participant not dosed|1|||
131507519|NCT00405587|473488673|FG002|Overall Study|Participant not dosed|0|||
131507520|NCT00405587|473488674|FG003|Overall Study|Participant not dosed|0|||
131507521|NCT06027866|473488675|FG000|Overall Study|Withdrawal by Subject|2|||
131507522|NCT00930579|473488678|FG000|Overall Study|Withdrawal by Subject|1|||
131507523|NCT00930579|473488678|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
131507524|NCT02672423|473488679|FG000|Period 1|Adverse Event|0|||
131507525|NCT02672423|473488680|FG001|Period 1|Adverse Event|0|||
131507526|NCT02672423|473488681|FG002|Period 1|Adverse Event|0|||
131507527|NCT02672423|473488682|FG003|Period 1|Adverse Event|0|||
131507528|NCT02672423|473488683|FG004|Period 1|Adverse Event|1|||
131507529|NCT02672423|473488684|FG005|Period 1|Adverse Event|0|||
131507530|NCT02672423|473488685|FG006|Period 1|Adverse Event|0|||
131507531|NCT02672423|473488686|FG007|Period 1|Adverse Event|0|||
131507532|NCT02672423|473488687|FG008|Period 1|Adverse Event|0|||
131507533|NCT02672423|473488688|FG009|Period 1|Adverse Event|0|||
131507534|NCT02672423|473488679|FG000|Period 2|Withdrawal by Subject|0|||
131507535|NCT02672423|473488680|FG001|Period 2|Withdrawal by Subject|0|||
131507536|NCT02672423|473488681|FG002|Period 2|Withdrawal by Subject|1|||
131507537|NCT02672423|473488682|FG003|Period 2|Withdrawal by Subject|0|||
131507538|NCT02672423|473488683|FG004|Period 2|Withdrawal by Subject|0|||
131507539|NCT02672423|473488684|FG005|Period 2|Withdrawal by Subject|0|||
131507540|NCT02672423|473488685|FG006|Period 2|Withdrawal by Subject|0|||
131507541|NCT02672423|473488686|FG007|Period 2|Withdrawal by Subject|0|||
131507542|NCT02672423|473488687|FG008|Period 2|Withdrawal by Subject|0|||
131507543|NCT02672423|473488688|FG009|Period 2|Withdrawal by Subject|0|||
131507544|NCT02672423|473488679|FG000|Period 3|Withdrawal by Subject|0|||
131507545|NCT02672423|473488680|FG001|Period 3|Withdrawal by Subject|0|||
131507546|NCT02672423|473488681|FG002|Period 3|Withdrawal by Subject|0|||
131507547|NCT02672423|473488682|FG003|Period 3|Withdrawal by Subject|0|||
131507548|NCT02672423|473488683|FG004|Period 3|Withdrawal by Subject|0|||
131507549|NCT02672423|473488684|FG005|Period 3|Withdrawal by Subject|0|||
131507550|NCT02672423|473488685|FG006|Period 3|Withdrawal by Subject|0|||
131507551|NCT02672423|473488686|FG007|Period 3|Withdrawal by Subject|1|||
131507552|NCT02672423|473488687|FG008|Period 3|Withdrawal by Subject|0|||
131507553|NCT02672423|473488688|FG009|Period 3|Withdrawal by Subject|0|||
131507554|NCT02672423|473488679|FG000|Period 3|Physician Decision|0|||
131507555|NCT02672423|473488680|FG001|Period 3|Physician Decision|0|||
131507556|NCT02672423|473488681|FG002|Period 3|Physician Decision|0|||
131507557|NCT02672423|473488682|FG003|Period 3|Physician Decision|0|||
131507558|NCT02672423|473488683|FG004|Period 3|Physician Decision|0|||
131507559|NCT02672423|473488684|FG005|Period 3|Physician Decision|1|||
131507560|NCT02672423|473488685|FG006|Period 3|Physician Decision|0|||
131507561|NCT02672423|473488686|FG007|Period 3|Physician Decision|0|||
131507562|NCT02672423|473488687|FG008|Period 3|Physician Decision|0|||
131507563|NCT02672423|473488688|FG009|Period 3|Physician Decision|0|||
131507564|NCT02410954|473488693|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
131507565|NCT02410954|473488694|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
131507566|NCT02410954|473488693|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
131507567|NCT02410954|473488694|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
131507568|NCT00949325|473488695|FG000|Overall Study|Adverse Event|0|||
131507569|NCT00949325|473488696|FG001|Overall Study|Adverse Event|2|||
131507570|NCT00949325|473488697|FG002|Overall Study|Adverse Event|0|||
131507571|NCT00791518|473488698|FG000|Overall Study|Protocol Violation|93|||
131507572|NCT01520363|473488699|FG000|Overall Study|Withdrawal by Subject|2|||
131507573|NCT01520363|473488700|FG001|Overall Study|Withdrawal by Subject|0|||
131507574|NCT02154581|473488703|FG000|Overall Study|Lost to Follow-up|7|||
131507575|NCT02154581|473488704|FG001|Overall Study|Lost to Follow-up|8|||
131507576|NCT03886220|473488705|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
131658096|NCT04445987|474032995|FG001|Overall Study|Physician Decision|0|||
131507577|NCT03886220|473488706|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
131507578|NCT03886220|473488705|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
131507579|NCT03886220|473488706|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131507580|NCT03886220|473488705|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
131507581|NCT03886220|473488706|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
131507582|NCT05497284|473488709|FG000|Overall Study|Adverse Event|1|||
131507583|NCT05497284|473488710|FG001|Overall Study|Adverse Event|0|||
131507584|NCT05497284|473488709|FG000|Overall Study|Physician Decision|0|||
131507585|NCT05497284|473488710|FG001|Overall Study|Physician Decision|1|||
131507586|NCT05497284|473488709|FG000|Overall Study|Study terminated by sponsor|7|||
131507587|NCT05497284|473488710|FG001|Overall Study|Study terminated by sponsor|4|||
131507588|NCT05497284|473488709|FG000|Overall Study|Subject Decision|0|||
131507589|NCT05497284|473488710|FG001|Overall Study|Subject Decision|1|||
131507590|NCT03878446|473488711|FG000|Overall Study|Withdrawn by parent or guardian|1|||
131507591|NCT03878446|473488712|FG001|Overall Study|Withdrawn by parent or guardian|0|||
131507592|NCT03878446|473488713|FG002|Overall Study|Withdrawn by parent or guardian|0|||
131507593|NCT03878446|473488714|FG003|Overall Study|Withdrawn by parent or guardian|0|||
131507594|NCT03878446|473488715|FG004|Overall Study|Withdrawn by parent or guardian|0|||
131507595|NCT03615105|473488716|FG000|Overall Study|Protocol Violation|1|||
131507596|NCT03615105|473488717|FG001|Overall Study|Protocol Violation|0|||
131507597|NCT03615105|473488718|FG002|Overall Study|Protocol Violation|0|||
131507598|NCT03615105|473488716|FG000|Overall Study|Death|0|||
131507599|NCT03615105|473488717|FG001|Overall Study|Death|2|||
131507600|NCT03615105|473488718|FG002|Overall Study|Death|0|||
131507649|NCT05041322|473488725|FG000|Baseline|Withdrawal by Subject|1|||
131507650|NCT05041322|473488726|FG001|Baseline|Withdrawal by Subject|0|||
131507651|NCT05041322|473488725|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
131507652|NCT05041322|473488726|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
131507653|NCT05041322|473488725|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
131507654|NCT05041322|473488726|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
131507655|NCT01502423|473488727|FG000|Overall Study|Withdrawal by Subject|0|||
131507656|NCT01502423|473488728|FG001|Overall Study|Withdrawal by Subject|1|||
131507657|NCT00567892|473488729|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
131507658|NCT00567892|473488730|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
131507659|NCT00567892|473488731|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
131507660|NCT00567892|473488732|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
131507661|NCT00567892|473488729|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
131507662|NCT00567892|473488730|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
131507663|NCT00567892|473488731|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
131507664|NCT00567892|473488732|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
131507665|NCT04383743|473488733|FG000|Overall Study|Withdrawal by Subject|1|||
131507666|NCT04383743|473488733|FG000|Overall Study|Adverse Event|1|||
131507667|NCT03482791|473488734|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
131507668|NCT03482791|473488735|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
131507669|NCT01239368|473491726|FG000|Overall Study|Principal investigator discretion|1|||
131507670|NCT01239368|473491727|FG001|Overall Study|Principal investigator discretion|0|||
131507671|NCT01239368|473491728|FG002|Overall Study|Principal investigator discretion|0|||
131507672|NCT01239368|473491729|FG003|Overall Study|Principal investigator discretion|0|||
131507673|NCT01239368|473491730|FG004|Overall Study|Principal investigator discretion|1|||
131507674|NCT01239368|473491731|FG005|Overall Study|Principal investigator discretion|2|||
131507675|NCT01239368|473491732|FG006|Overall Study|Principal investigator discretion|0|||
131507676|NCT01239368|473491733|FG007|Overall Study|Principal investigator discretion|0|||
131507677|NCT01239368|473491734|FG008|Overall Study|Principal investigator discretion|0|||
131507678|NCT01239368|473491735|FG009|Overall Study|Principal investigator discretion|1|||
131507679|NCT01239368|473491726|FG000|Overall Study|Disease progression on study|1|||
131507680|NCT01239368|473491727|FG001|Overall Study|Disease progression on study|1|||
131507681|NCT01239368|473491728|FG002|Overall Study|Disease progression on study|1|||
131507682|NCT01239368|473491729|FG003|Overall Study|Disease progression on study|1|||
131507683|NCT01239368|473491730|FG004|Overall Study|Disease progression on study|4|||
131507684|NCT01239368|473491731|FG005|Overall Study|Disease progression on study|2|||
131507685|NCT01239368|473491732|FG006|Overall Study|Disease progression on study|5|||
131507686|NCT01239368|473491733|FG007|Overall Study|Disease progression on study|0|||
131507687|NCT01239368|473491734|FG008|Overall Study|Disease progression on study|0|||
131507688|NCT01239368|473491735|FG009|Overall Study|Disease progression on study|2|||
131507689|NCT01239368|473491726|FG000|Overall Study|Refused further treatment|0|||
131507690|NCT01239368|473491727|FG001|Overall Study|Refused further treatment|0|||
131507691|NCT01239368|473491728|FG002|Overall Study|Refused further treatment|0|||
131507692|NCT01239368|473491729|FG003|Overall Study|Refused further treatment|0|||
131507693|NCT01239368|473491730|FG004|Overall Study|Refused further treatment|0|||
131507694|NCT01239368|473491731|FG005|Overall Study|Refused further treatment|0|||
131507695|NCT01239368|473491732|FG006|Overall Study|Refused further treatment|0|||
131507696|NCT01239368|473491733|FG007|Overall Study|Refused further treatment|0|||
131507697|NCT01239368|473491734|FG008|Overall Study|Refused further treatment|0|||
131507698|NCT01239368|473491735|FG009|Overall Study|Refused further treatment|1|||
131507699|NCT01239368|473491726|FG000|Overall Study|Death|0|||
131507700|NCT01239368|473491727|FG001|Overall Study|Death|0|||
131507701|NCT01239368|473491728|FG002|Overall Study|Death|0|||
131507702|NCT01239368|473491729|FG003|Overall Study|Death|0|||
131507703|NCT01239368|473491730|FG004|Overall Study|Death|0|||
131507704|NCT01239368|473491731|FG005|Overall Study|Death|0|||
131507705|NCT01239368|473491732|FG006|Overall Study|Death|1|||
131507706|NCT01239368|473491733|FG007|Overall Study|Death|0|||
131507707|NCT01239368|473491734|FG008|Overall Study|Death|0|||
131507708|NCT01239368|473491735|FG009|Overall Study|Death|0|||
131507709|NCT02967692|473491736|FG000|Overall Study|Progressive disease|3|||
131507710|NCT02967692|473491737|FG001|Overall Study|Progressive disease|15|||
131507711|NCT02967692|473491738|FG002|Overall Study|Progressive disease|114|||
131507712|NCT02967692|473491739|FG003|Overall Study|Progressive disease|151|||
131507713|NCT02967692|473491736|FG000|Overall Study|Subject/guardian decision|1|||
131507714|NCT02967692|473491737|FG001|Overall Study|Subject/guardian decision|1|||
131507715|NCT02967692|473491738|FG002|Overall Study|Subject/guardian decision|14|||
131507716|NCT02967692|473491739|FG003|Overall Study|Subject/guardian decision|22|||
131507717|NCT02967692|473491736|FG000|Overall Study|Death|0|||
131507718|NCT02967692|473491737|FG001|Overall Study|Death|1|||
131507719|NCT02967692|473491738|FG002|Overall Study|Death|13|||
131507720|NCT02967692|473491739|FG003|Overall Study|Death|13|||
131507721|NCT02967692|473491736|FG000|Overall Study|Protocol deviation|1|||
131507722|NCT02967692|473491737|FG001|Overall Study|Protocol deviation|0|||
131507723|NCT02967692|473491738|FG002|Overall Study|Protocol deviation|1|||
131507724|NCT02967692|473491739|FG003|Overall Study|Protocol deviation|1|||
131507725|NCT02967692|473491736|FG000|Overall Study|Lost to Follow-up|0|||
131507726|NCT02967692|473491737|FG001|Overall Study|Lost to Follow-up|0|||
131507727|NCT02967692|473491738|FG002|Overall Study|Lost to Follow-up|1|||
131507728|NCT02967692|473491739|FG003|Overall Study|Lost to Follow-up|0|||
131507729|NCT02967692|473491736|FG000|Overall Study|Physician Decision|0|||
131507730|NCT02967692|473491737|FG001|Overall Study|Physician Decision|0|||
131507731|NCT02967692|473491738|FG002|Overall Study|Physician Decision|22|||
131507732|NCT02967692|473491739|FG003|Overall Study|Physician Decision|13|||
131507733|NCT02967692|473491736|FG000|Overall Study|Adverse Event|2|||
131507734|NCT02967692|473491737|FG001|Overall Study|Adverse Event|9|||
131507735|NCT02967692|473491738|FG002|Overall Study|Adverse Event|60|||
131507736|NCT02967692|473491739|FG003|Overall Study|Adverse Event|28|||
131507737|NCT02967692|473491736|FG000|Overall Study|Study terminated by sponsor|2|||
131507738|NCT02967692|473491737|FG001|Overall Study|Study terminated by sponsor|1|||
131507739|NCT02967692|473491738|FG002|Overall Study|Study terminated by sponsor|42|||
131507740|NCT02967692|473491739|FG003|Overall Study|Study terminated by sponsor|37|||
131507741|NCT00939809|473491743|FG000|Overall Study|Adverse Event|2|||
131507742|NCT00939809|473491743|FG000|Overall Study|Death|1|||
131507743|NCT00066066|473491744|FG000|Overall Study|Lost to Follow-up|6|||
131507744|NCT00066066|473491745|FG001|Overall Study|Lost to Follow-up|4|||
131507745|NCT00066066|473491746|FG002|Overall Study|Lost to Follow-up|7|||
131507746|NCT00066066|473491747|FG003|Overall Study|Lost to Follow-up|4|||
131507747|NCT00066066|473491748|FG004|Overall Study|Lost to Follow-up|3|||
131507748|NCT00066066|473491749|FG005|Overall Study|Lost to Follow-up|5|||
131507749|NCT00156533|473491754|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
131507750|NCT00156533|473491755|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
131507751|NCT00156533|473491756|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
131507752|NCT00156533|473491757|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
131507753|NCT00156533|473491754|FG000|Overall Study|Withdrawal by Subject|1|||
131507754|NCT00156533|473491755|FG001|Overall Study|Withdrawal by Subject|0|||
131507755|NCT00156533|473491756|FG002|Overall Study|Withdrawal by Subject|0|||
131507756|NCT00156533|473491757|FG003|Overall Study|Withdrawal by Subject|1|||
131507757|NCT00156533|473491754|FG000|Overall Study|Failed Screening|1|||
131507758|NCT00156533|473491755|FG001|Overall Study|Failed Screening|0|||
131507759|NCT00156533|473491756|FG002|Overall Study|Failed Screening|1|||
131507760|NCT00156533|473491757|FG003|Overall Study|Failed Screening|1|||
131507761|NCT01254227|473491760|FG000|Overall Study|Withdrawal by Subject|6|||
131507762|NCT01254227|473491760|FG000|Overall Study|Lost to Follow-up|6|||
131507763|NCT01254227|473491760|FG000|Overall Study|Adverse Event|5|||
131507764|NCT01254227|473491760|FG000|Overall Study|Abnormal test procedure result|5|||
131507765|NCT01254227|473491760|FG000|Overall Study|Administrative problems|2|||
131507766|NCT01254227|473491760|FG000|Overall Study|Death|1|||
131507767|NCT01254227|473491760|FG000|Overall Study|Protocol deviation|1|||
131507768|NCT03265249|473491763|FG000|Overall Study|Withdrawal by Subject|0|||
131507769|NCT03265249|473491764|FG001|Overall Study|Withdrawal by Subject|1|||
131507770|NCT01614990|473491765|FG000|Overall Study|Protocol Violation|1|||
131507771|NCT01614990|473491766|FG001|Overall Study|Protocol Violation|1|||
131507772|NCT02608268|473491769|FG000|Overall Study|Adverse Event|0|||
131507773|NCT02608268|473491770|FG001|Overall Study|Adverse Event|0|||
131507774|NCT02608268|473491771|FG002|Overall Study|Adverse Event|1|||
131507775|NCT02608268|473491772|FG003|Overall Study|Adverse Event|0|||
131507776|NCT02608268|473491773|FG004|Overall Study|Adverse Event|0|||
131507777|NCT02608268|473491774|FG005|Overall Study|Adverse Event|0|||
131507778|NCT02608268|473491775|FG006|Overall Study|Adverse Event|0|||
131507779|NCT02608268|473491776|FG007|Overall Study|Adverse Event|0|||
131507780|NCT02608268|473491777|FG008|Overall Study|Adverse Event|0|||
131507781|NCT02608268|473491778|FG009|Overall Study|Adverse Event|0|||
131507782|NCT02608268|473491779|FG010|Overall Study|Adverse Event|0|||
131507783|NCT02608268|473491780|FG011|Overall Study|Adverse Event|0|||
131507784|NCT02608268|473491781|FG012|Overall Study|Adverse Event|2|||
131507785|NCT02608268|473491782|FG013|Overall Study|Adverse Event|0|||
131507786|NCT02608268|473491783|FG014|Overall Study|Adverse Event|0|||
131507787|NCT02608268|473491784|FG015|Overall Study|Adverse Event|0|||
131507788|NCT02608268|473491785|FG016|Overall Study|Adverse Event|0|||
131507789|NCT02608268|473491786|FG017|Overall Study|Adverse Event|0|||
131507790|NCT02608268|473491787|FG018|Overall Study|Adverse Event|0|||
131507791|NCT02608268|473491788|FG019|Overall Study|Adverse Event|0|||
131507792|NCT02608268|473491789|FG020|Overall Study|Adverse Event|1|||
131507793|NCT02608268|473491790|FG021|Overall Study|Adverse Event|1|||
131507794|NCT02608268|473491791|FG022|Overall Study|Adverse Event|0|||
131507795|NCT02608268|473491792|FG023|Overall Study|Adverse Event|0|||
131507796|NCT02608268|473491793|FG024|Overall Study|Adverse Event|1|||
131507797|NCT02608268|473491794|FG025|Overall Study|Adverse Event|0|||
131507798|NCT02608268|473491795|FG026|Overall Study|Adverse Event|0|||
131507799|NCT02608268|473491796|FG027|Overall Study|Adverse Event|0|||
131507800|NCT02608268|473491797|FG028|Overall Study|Adverse Event|1|||
131507801|NCT02608268|473491798|FG029|Overall Study|Adverse Event|0|||
131507802|NCT02608268|473491769|FG000|Overall Study|Death|1|||
131507803|NCT02608268|473491770|FG001|Overall Study|Death|0|||
131507804|NCT02608268|473491771|FG002|Overall Study|Death|0|||
131507805|NCT02608268|473491772|FG003|Overall Study|Death|0|||
131507806|NCT02608268|473491773|FG004|Overall Study|Death|0|||
131507807|NCT02608268|473491774|FG005|Overall Study|Death|0|||
131507808|NCT02608268|473491775|FG006|Overall Study|Death|0|||
131507809|NCT02608268|473491776|FG007|Overall Study|Death|0|||
131507810|NCT02608268|473491777|FG008|Overall Study|Death|1|||
131507811|NCT02608268|473491778|FG009|Overall Study|Death|1|||
131507812|NCT02608268|473491779|FG010|Overall Study|Death|0|||
131507813|NCT02608268|473491780|FG011|Overall Study|Death|0|||
131507814|NCT02608268|473491781|FG012|Overall Study|Death|0|||
131507815|NCT02608268|473491782|FG013|Overall Study|Death|0|||
131434147|NCT03446313|473214666|FG000|Overall Study|Excluded from analysis|1|||
131434148|NCT03446313|473214667|FG001|Overall Study|Excluded from analysis|1|||
131507816|NCT02608268|473491783|FG014|Overall Study|Death|0|||
131507817|NCT02608268|473491784|FG015|Overall Study|Death|1|||
131507818|NCT02608268|473491785|FG016|Overall Study|Death|0|||
131507819|NCT02608268|473491786|FG017|Overall Study|Death|1|||
131507820|NCT02608268|473491787|FG018|Overall Study|Death|0|||
131507821|NCT02608268|473491788|FG019|Overall Study|Death|1|||
131507822|NCT02608268|473491789|FG020|Overall Study|Death|1|||
131507823|NCT02608268|473491790|FG021|Overall Study|Death|0|||
131507824|NCT02608268|473491791|FG022|Overall Study|Death|0|||
131507825|NCT02608268|473491792|FG023|Overall Study|Death|0|||
131507826|NCT02608268|473491793|FG024|Overall Study|Death|1|||
131507827|NCT02608268|473491794|FG025|Overall Study|Death|2|||
131507828|NCT02608268|473491795|FG026|Overall Study|Death|0|||
131507829|NCT02608268|473491796|FG027|Overall Study|Death|1|||
131507830|NCT02608268|473491797|FG028|Overall Study|Death|4|||
131507831|NCT02608268|473491798|FG029|Overall Study|Death|0|||
131507832|NCT02608268|473491769|FG000|Overall Study|Physician Decision|0|||
131507833|NCT02608268|473491770|FG001|Overall Study|Physician Decision|0|||
131507834|NCT02608268|473491771|FG002|Overall Study|Physician Decision|0|||
131507835|NCT02608268|473491772|FG003|Overall Study|Physician Decision|0|||
131507836|NCT02608268|473491773|FG004|Overall Study|Physician Decision|0|||
131507837|NCT02608268|473491774|FG005|Overall Study|Physician Decision|0|||
131507838|NCT02608268|473491775|FG006|Overall Study|Physician Decision|0|||
131507839|NCT02608268|473491776|FG007|Overall Study|Physician Decision|0|||
131507840|NCT02608268|473491777|FG008|Overall Study|Physician Decision|0|||
131507841|NCT02608268|473491778|FG009|Overall Study|Physician Decision|0|||
131507842|NCT02608268|473491779|FG010|Overall Study|Physician Decision|1|||
131507843|NCT02608268|473491780|FG011|Overall Study|Physician Decision|0|||
131507844|NCT02608268|473491781|FG012|Overall Study|Physician Decision|0|||
131507845|NCT02608268|473491782|FG013|Overall Study|Physician Decision|1|||
131507846|NCT02608268|473491783|FG014|Overall Study|Physician Decision|0|||
131507847|NCT02608268|473491784|FG015|Overall Study|Physician Decision|0|||
131507848|NCT02608268|473491785|FG016|Overall Study|Physician Decision|0|||
131507849|NCT02608268|473491786|FG017|Overall Study|Physician Decision|0|||
131507850|NCT02608268|473491787|FG018|Overall Study|Physician Decision|0|||
131507851|NCT02608268|473491788|FG019|Overall Study|Physician Decision|0|||
131507852|NCT02608268|473491789|FG020|Overall Study|Physician Decision|0|||
131507853|NCT02608268|473491790|FG021|Overall Study|Physician Decision|0|||
131507854|NCT02608268|473491791|FG022|Overall Study|Physician Decision|1|||
131507855|NCT02608268|473491792|FG023|Overall Study|Physician Decision|1|||
131507856|NCT02608268|473491793|FG024|Overall Study|Physician Decision|1|||
131507857|NCT02608268|473491794|FG025|Overall Study|Physician Decision|0|||
131507858|NCT02608268|473491795|FG026|Overall Study|Physician Decision|0|||
131507859|NCT02608268|473491796|FG027|Overall Study|Physician Decision|2|||
131507860|NCT02608268|473491797|FG028|Overall Study|Physician Decision|1|||
131507861|NCT02608268|473491798|FG029|Overall Study|Physician Decision|1|||
131507862|NCT02608268|473491769|FG000|Overall Study|Progressive disease|12|||
131507863|NCT02608268|473491770|FG001|Overall Study|Progressive disease|8|||
131507864|NCT02608268|473491771|FG002|Overall Study|Progressive disease|13|||
131507865|NCT02608268|473491772|FG003|Overall Study|Progressive disease|5|||
131507866|NCT02608268|473491773|FG004|Overall Study|Progressive disease|2|||
131507867|NCT02608268|473491774|FG005|Overall Study|Progressive disease|4|||
131507868|NCT02608268|473491775|FG006|Overall Study|Progressive disease|6|||
131507869|NCT02608268|473491776|FG007|Overall Study|Progressive disease|2|||
131507870|NCT02608268|473491777|FG008|Overall Study|Progressive disease|5|||
131507871|NCT02608268|473491778|FG009|Overall Study|Progressive disease|6|||
131507872|NCT02608268|473491779|FG010|Overall Study|Progressive disease|5|||
131507873|NCT02608268|473491780|FG011|Overall Study|Progressive disease|5|||
131507874|NCT02608268|473491781|FG012|Overall Study|Progressive disease|4|||
131507875|NCT02608268|473491782|FG013|Overall Study|Progressive disease|11|||
131507876|NCT02608268|473491783|FG014|Overall Study|Progressive disease|6|||
131507877|NCT02608268|473491784|FG015|Overall Study|Progressive disease|3|||
131507878|NCT02608268|473491785|FG016|Overall Study|Progressive disease|5|||
131507879|NCT02608268|473491786|FG017|Overall Study|Progressive disease|5|||
131507880|NCT02608268|473491787|FG018|Overall Study|Progressive disease|5|||
131507881|NCT02608268|473491788|FG019|Overall Study|Progressive disease|2|||
131507882|NCT02608268|473491789|FG020|Overall Study|Progressive disease|10|||
131507883|NCT02608268|473491790|FG021|Overall Study|Progressive disease|4|||
131507884|NCT02608268|473491791|FG022|Overall Study|Progressive disease|5|||
131507885|NCT02608268|473491792|FG023|Overall Study|Progressive disease|5|||
131507886|NCT02608268|473491793|FG024|Overall Study|Progressive disease|3|||
131507887|NCT02608268|473491794|FG025|Overall Study|Progressive disease|11|||
131507888|NCT02608268|473491795|FG026|Overall Study|Progressive disease|16|||
131507889|NCT02608268|473491796|FG027|Overall Study|Progressive disease|11|||
131507890|NCT02608268|473491797|FG028|Overall Study|Progressive disease|10|||
131507891|NCT02608268|473491798|FG029|Overall Study|Progressive disease|15|||
131507892|NCT02608268|473491769|FG000|Overall Study|Subject/guardian decision|1|||
131507893|NCT02608268|473491770|FG001|Overall Study|Subject/guardian decision|1|||
131507894|NCT02608268|473491771|FG002|Overall Study|Subject/guardian decision|2|||
131507895|NCT02608268|473491772|FG003|Overall Study|Subject/guardian decision|0|||
131507896|NCT02608268|473491773|FG004|Overall Study|Subject/guardian decision|0|||
131507897|NCT02608268|473491774|FG005|Overall Study|Subject/guardian decision|0|||
131507898|NCT02608268|473491775|FG006|Overall Study|Subject/guardian decision|0|||
131507899|NCT02608268|473491776|FG007|Overall Study|Subject/guardian decision|0|||
131507900|NCT02608268|473491777|FG008|Overall Study|Subject/guardian decision|2|||
131507901|NCT02608268|473491778|FG009|Overall Study|Subject/guardian decision|2|||
131507902|NCT02608268|473491779|FG010|Overall Study|Subject/guardian decision|0|||
131507903|NCT02608268|473491780|FG011|Overall Study|Subject/guardian decision|1|||
131507904|NCT02608268|473491781|FG012|Overall Study|Subject/guardian decision|0|||
131507905|NCT02608268|473491782|FG013|Overall Study|Subject/guardian decision|1|||
131507906|NCT02608268|473491783|FG014|Overall Study|Subject/guardian decision|0|||
131507907|NCT02608268|473491784|FG015|Overall Study|Subject/guardian decision|1|||
131507908|NCT02608268|473491785|FG016|Overall Study|Subject/guardian decision|0|||
131507909|NCT02608268|473491786|FG017|Overall Study|Subject/guardian decision|0|||
131507910|NCT02608268|473491787|FG018|Overall Study|Subject/guardian decision|1|||
131507911|NCT02608268|473491788|FG019|Overall Study|Subject/guardian decision|0|||
131507912|NCT02608268|473491789|FG020|Overall Study|Subject/guardian decision|0|||
131507913|NCT02608268|473491790|FG021|Overall Study|Subject/guardian decision|0|||
131507914|NCT02608268|473491791|FG022|Overall Study|Subject/guardian decision|1|||
131507915|NCT02608268|473491792|FG023|Overall Study|Subject/guardian decision|0|||
131507916|NCT02608268|473491793|FG024|Overall Study|Subject/guardian decision|0|||
131507917|NCT02608268|473491794|FG025|Overall Study|Subject/guardian decision|1|||
131507918|NCT02608268|473491795|FG026|Overall Study|Subject/guardian decision|1|||
131507919|NCT02608268|473491796|FG027|Overall Study|Subject/guardian decision|1|||
131507920|NCT02608268|473491797|FG028|Overall Study|Subject/guardian decision|1|||
131507921|NCT02608268|473491798|FG029|Overall Study|Subject/guardian decision|0|||
131507922|NCT00706641|473491799|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
131507923|NCT00706641|473491799|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
131507924|NCT00706641|473491799|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
131507925|NCT01012622|473491803|FG000|Overall Study|Withdrawal by Subject|6|||
131507926|NCT01012622|473491803|FG000|Overall Study|Lost to Follow-up|5|||
131507927|NCT01012622|473491803|FG000|Overall Study|Adverse Event|7|||
131507928|NCT01012622|473491803|FG000|Overall Study|non-compliance with the drug|9|||
131507929|NCT01012622|473491803|FG000|Overall Study|Other|1|||
131507930|NCT01012622|473491803|FG000|Overall Study|screening failure|1|||
131507931|NCT01012622|473491803|FG000|Overall Study|withdrawal of consent by a parent|2|||
131507932|NCT02535741|473491804|FG000|Overall Study|Adverse Event|3|||
131507933|NCT02535741|473491804|FG000|Overall Study|Withdrawal by Subject|9|||
131507934|NCT02535741|473491804|FG000|Overall Study|Lost to Follow-up|10|||
131507935|NCT02535741|473491804|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
131507936|NCT02535741|473491804|FG000|Overall Study|Missing data|6|||
131507937|NCT03873987|473491805|FG000|Overall Study|Adverse Event|1|||
131507938|NCT03873987|473491806|FG001|Overall Study|Adverse Event|0|||
131507939|NCT03873987|473491805|FG000|Overall Study|staff was unable to start a new IV line|1|||
131507940|NCT03873987|473491806|FG001|Overall Study|staff was unable to start a new IV line|0|||
131507941|NCT03873987|473491805|FG000|Overall Study|Lost to Follow-up|0|||
131507942|NCT03873987|473491806|FG001|Overall Study|Lost to Follow-up|1|||
131507943|NCT00798369|473491807|FG000|Overall Study|Subject withdrew consent|0|||
131507944|NCT00798369|473491808|FG001|Overall Study|Subject withdrew consent|0|||
131507945|NCT00798369|473491809|FG002|Overall Study|Subject withdrew consent|1|||
131507946|NCT00798369|473491810|FG003|Overall Study|Subject withdrew consent|1|||
131507947|NCT00798369|473491811|FG004|Overall Study|Subject withdrew consent|0|||
131507948|NCT00798369|473491812|FG005|Overall Study|Subject withdrew consent|2|||
131507949|NCT00798369|473491807|FG000|Overall Study|Lost to Follow-up|1|||
131507950|NCT00798369|473491808|FG001|Overall Study|Lost to Follow-up|1|||
131507951|NCT00798369|473491809|FG002|Overall Study|Lost to Follow-up|1|||
131507952|NCT00798369|473491810|FG003|Overall Study|Lost to Follow-up|0|||
131507953|NCT00798369|473491811|FG004|Overall Study|Lost to Follow-up|1|||
131507954|NCT00798369|473491812|FG005|Overall Study|Lost to Follow-up|0|||
131507955|NCT00798369|473491807|FG000|Overall Study|Adminstrative problems|0|||
131507956|NCT00798369|473491808|FG001|Overall Study|Adminstrative problems|0|||
131507957|NCT00798369|473491809|FG002|Overall Study|Adminstrative problems|0|||
131507958|NCT00798369|473491810|FG003|Overall Study|Adminstrative problems|0|||
131507959|NCT00798369|473491811|FG004|Overall Study|Adminstrative problems|0|||
131507960|NCT00798369|473491812|FG005|Overall Study|Adminstrative problems|1|||
131507961|NCT04475588|473491813|FG000|Overall Study|Adverse Event|2|||
131507962|NCT04475588|473491814|FG001|Overall Study|Adverse Event|0|||
131507963|NCT04762680|473491815|FG000|Phase 2|Adverse Event|0|||
131507964|NCT04762680|473491816|FG001|Phase 2|Adverse Event|1|||
131507965|NCT04762680|473491817|FG002|Phase 2|Adverse Event|0|||
131507966|NCT04762680|473491818|FG003|Phase 2|Adverse Event|0|||
131507967|NCT04762680|473491819|FG004|Phase 2|Adverse Event|0|||
131507968|NCT04762680|473491820|FG005|Phase 2|Adverse Event|0|||
131507969|NCT04762680|473491821|FG006|Phase 2|Adverse Event|0|||
131507970|NCT04762680|473491822|FG007|Phase 2|Adverse Event|0|||
131507971|NCT04762680|473491823|FG008|Phase 2|Adverse Event|0|||
131507972|NCT04762680|473491824|FG009|Phase 2|Adverse Event|0|||
131507973|NCT04762680|473491825|FG010|Phase 2|Adverse Event|0|||
131507974|NCT04762680|473491826|FG011|Phase 2|Adverse Event|0|||
131507975|NCT04762680|473491827|FG012|Phase 2|Adverse Event|0|||
131507976|NCT04762680|473491828|FG013|Phase 2|Adverse Event|0|||
131507977|NCT04762680|473491829|FG014|Phase 2|Adverse Event|0|||
131507978|NCT04762680|473491830|FG015|Phase 2|Adverse Event|0|||
131507979|NCT04762680|473491831|FG016|Phase 2|Adverse Event|0|||
131507980|NCT04762680|473491832|FG017|Phase 2|Adverse Event|0|||
131507981|NCT04762680|473491833|FG018|Phase 2|Adverse Event|0|||
131507982|NCT04762680|473491834|FG019|Phase 2|Adverse Event|0|||
131507983|NCT04762680|473491835|FG020|Phase 2|Adverse Event|0|||
131507984|NCT04762680|473491836|FG021|Phase 2|Adverse Event|0|||
131507985|NCT04762680|473491815|FG000|Phase 2|Protocol Violation|5|||
131507986|NCT04762680|473491816|FG001|Phase 2|Protocol Violation|5|||
131507987|NCT04762680|473491817|FG002|Phase 2|Protocol Violation|1|||
131507988|NCT04762680|473491818|FG003|Phase 2|Protocol Violation|0|||
131507989|NCT04762680|473491819|FG004|Phase 2|Protocol Violation|0|||
131507990|NCT04762680|473491820|FG005|Phase 2|Protocol Violation|0|||
131507991|NCT04762680|473491821|FG006|Phase 2|Protocol Violation|0|||
131507992|NCT04762680|473491822|FG007|Phase 2|Protocol Violation|0|||
131507993|NCT04762680|473491823|FG008|Phase 2|Protocol Violation|0|||
131507994|NCT04762680|473491824|FG009|Phase 2|Protocol Violation|0|||
131507995|NCT04762680|473491825|FG010|Phase 2|Protocol Violation|0|||
131507996|NCT04762680|473491826|FG011|Phase 2|Protocol Violation|0|||
131507997|NCT04762680|473491827|FG012|Phase 2|Protocol Violation|0|||
131507998|NCT04762680|473491828|FG013|Phase 2|Protocol Violation|0|||
131507999|NCT04762680|473491829|FG014|Phase 2|Protocol Violation|0|||
131508000|NCT04762680|473491830|FG015|Phase 2|Protocol Violation|0|||
131508001|NCT04762680|473491831|FG016|Phase 2|Protocol Violation|0|||
131508002|NCT04762680|473491832|FG017|Phase 2|Protocol Violation|0|||
131508003|NCT04762680|473491833|FG018|Phase 2|Protocol Violation|0|||
131508004|NCT04762680|473491834|FG019|Phase 2|Protocol Violation|0|||
131508005|NCT04762680|473491835|FG020|Phase 2|Protocol Violation|0|||
131508006|NCT04762680|473491836|FG021|Phase 2|Protocol Violation|0|||
131508007|NCT04762680|473491815|FG000|Phase 2|Withdrawal by Subject|23|||
131508008|NCT04762680|473491816|FG001|Phase 2|Withdrawal by Subject|21|||
131508009|NCT04762680|473491817|FG002|Phase 2|Withdrawal by Subject|28|||
131508010|NCT04762680|473491818|FG003|Phase 2|Withdrawal by Subject|0|||
131508011|NCT04762680|473491819|FG004|Phase 2|Withdrawal by Subject|0|||
131508012|NCT04762680|473491820|FG005|Phase 2|Withdrawal by Subject|0|||
131508013|NCT04762680|473491821|FG006|Phase 2|Withdrawal by Subject|0|||
131508014|NCT04762680|473491822|FG007|Phase 2|Withdrawal by Subject|0|||
131508015|NCT04762680|473491823|FG008|Phase 2|Withdrawal by Subject|0|||
131508016|NCT04762680|473491824|FG009|Phase 2|Withdrawal by Subject|0|||
131508017|NCT04762680|473491825|FG010|Phase 2|Withdrawal by Subject|0|||
131508018|NCT04762680|473491826|FG011|Phase 2|Withdrawal by Subject|0|||
131508019|NCT04762680|473491827|FG012|Phase 2|Withdrawal by Subject|0|||
131508020|NCT04762680|473491828|FG013|Phase 2|Withdrawal by Subject|0|||
131508021|NCT04762680|473491829|FG014|Phase 2|Withdrawal by Subject|0|||
131508022|NCT04762680|473491830|FG015|Phase 2|Withdrawal by Subject|0|||
131508023|NCT04762680|473491831|FG016|Phase 2|Withdrawal by Subject|0|||
131508024|NCT04762680|473491832|FG017|Phase 2|Withdrawal by Subject|0|||
131508025|NCT04762680|473491833|FG018|Phase 2|Withdrawal by Subject|0|||
131508026|NCT04762680|473491834|FG019|Phase 2|Withdrawal by Subject|0|||
131508027|NCT04762680|473491835|FG020|Phase 2|Withdrawal by Subject|0|||
131508028|NCT04762680|473491836|FG021|Phase 2|Withdrawal by Subject|0|||
131508029|NCT04762680|473491815|FG000|Phase 2|Lost to Follow-up|14|||
131508030|NCT04762680|473491816|FG001|Phase 2|Lost to Follow-up|8|||
131508031|NCT04762680|473491817|FG002|Phase 2|Lost to Follow-up|9|||
131508032|NCT04762680|473491818|FG003|Phase 2|Lost to Follow-up|0|||
131508033|NCT04762680|473491819|FG004|Phase 2|Lost to Follow-up|0|||
131508034|NCT04762680|473491820|FG005|Phase 2|Lost to Follow-up|0|||
131508035|NCT04762680|473491821|FG006|Phase 2|Lost to Follow-up|0|||
131508036|NCT04762680|473491822|FG007|Phase 2|Lost to Follow-up|0|||
131508037|NCT04762680|473491823|FG008|Phase 2|Lost to Follow-up|0|||
131508038|NCT04762680|473491824|FG009|Phase 2|Lost to Follow-up|0|||
131508039|NCT04762680|473491825|FG010|Phase 2|Lost to Follow-up|0|||
131508040|NCT04762680|473491826|FG011|Phase 2|Lost to Follow-up|0|||
131508041|NCT04762680|473491827|FG012|Phase 2|Lost to Follow-up|0|||
131508042|NCT04762680|473491828|FG013|Phase 2|Lost to Follow-up|0|||
131508043|NCT04762680|473491829|FG014|Phase 2|Lost to Follow-up|0|||
131508044|NCT04762680|473491830|FG015|Phase 2|Lost to Follow-up|0|||
131508045|NCT04762680|473491831|FG016|Phase 2|Lost to Follow-up|0|||
131508046|NCT04762680|473491832|FG017|Phase 2|Lost to Follow-up|0|||
131508047|NCT04762680|473491833|FG018|Phase 2|Lost to Follow-up|0|||
131508048|NCT04762680|473491834|FG019|Phase 2|Lost to Follow-up|0|||
131508049|NCT04762680|473491835|FG020|Phase 2|Lost to Follow-up|0|||
131508050|NCT04762680|473491836|FG021|Phase 2|Lost to Follow-up|0|||
131508051|NCT04762680|473491815|FG000|Phase 3|Adverse Event|0|||
131508052|NCT04762680|473491816|FG001|Phase 3|Adverse Event|0|||
131508053|NCT04762680|473491817|FG002|Phase 3|Adverse Event|0|||
131508054|NCT04762680|473491818|FG003|Phase 3|Adverse Event|1|||
131508055|NCT04762680|473491819|FG004|Phase 3|Adverse Event|0|||
131508056|NCT04762680|473491820|FG005|Phase 3|Adverse Event|0|||
131508057|NCT04762680|473491821|FG006|Phase 3|Adverse Event|0|||
131508058|NCT04762680|473491822|FG007|Phase 3|Adverse Event|0|||
131508059|NCT04762680|473491823|FG008|Phase 3|Adverse Event|0|||
131508060|NCT04762680|473491824|FG009|Phase 3|Adverse Event|0|||
131508061|NCT04762680|473491825|FG010|Phase 3|Adverse Event|0|||
131508062|NCT04762680|473491826|FG011|Phase 3|Adverse Event|0|||
131508063|NCT04762680|473491827|FG012|Phase 3|Adverse Event|0|||
131508064|NCT04762680|473491828|FG013|Phase 3|Adverse Event|0|||
131508065|NCT04762680|473491829|FG014|Phase 3|Adverse Event|0|||
131508066|NCT04762680|473491830|FG015|Phase 3|Adverse Event|0|||
131508067|NCT04762680|473491831|FG016|Phase 3|Adverse Event|0|||
131508068|NCT04762680|473491832|FG017|Phase 3|Adverse Event|3|||
131508069|NCT04762680|473491833|FG018|Phase 3|Adverse Event|0|||
131508070|NCT04762680|473491834|FG019|Phase 3|Adverse Event|0|||
131508071|NCT04762680|473491835|FG020|Phase 3|Adverse Event|0|||
131508072|NCT04762680|473491836|FG021|Phase 3|Adverse Event|0|||
131508073|NCT04762680|473491815|FG000|Phase 3|Protocol Violation|0|||
131508074|NCT04762680|473491816|FG001|Phase 3|Protocol Violation|0|||
131508075|NCT04762680|473491817|FG002|Phase 3|Protocol Violation|0|||
131508076|NCT04762680|473491818|FG003|Phase 3|Protocol Violation|4|||
131508077|NCT04762680|473491819|FG004|Phase 3|Protocol Violation|1|||
131508078|NCT04762680|473491820|FG005|Phase 3|Protocol Violation|5|||
131508079|NCT04762680|473491821|FG006|Phase 3|Protocol Violation|1|||
131508080|NCT04762680|473491822|FG007|Phase 3|Protocol Violation|0|||
131508081|NCT04762680|473491823|FG008|Phase 3|Protocol Violation|0|||
131508082|NCT04762680|473491824|FG009|Phase 3|Protocol Violation|0|||
131508083|NCT04762680|473491825|FG010|Phase 3|Protocol Violation|0|||
131508084|NCT04762680|473491826|FG011|Phase 3|Protocol Violation|2|||
131508085|NCT04762680|473491827|FG012|Phase 3|Protocol Violation|3|||
131508086|NCT04762680|473491828|FG013|Phase 3|Protocol Violation|0|||
131508087|NCT04762680|473491829|FG014|Phase 3|Protocol Violation|0|||
131508088|NCT04762680|473491830|FG015|Phase 3|Protocol Violation|1|||
131508089|NCT04762680|473491831|FG016|Phase 3|Protocol Violation|0|||
131508090|NCT04762680|473491832|FG017|Phase 3|Protocol Violation|10|||
131508091|NCT04762680|473491833|FG018|Phase 3|Protocol Violation|0|||
131508092|NCT04762680|473491834|FG019|Phase 3|Protocol Violation|0|||
131508093|NCT04762680|473491835|FG020|Phase 3|Protocol Violation|0|||
131508094|NCT04762680|473491836|FG021|Phase 3|Protocol Violation|0|||
131508095|NCT04762680|473491815|FG000|Phase 3|Withdrawal by Subject|0|||
131508096|NCT04762680|473491816|FG001|Phase 3|Withdrawal by Subject|0|||
131508097|NCT04762680|473491817|FG002|Phase 3|Withdrawal by Subject|0|||
131508098|NCT04762680|473491818|FG003|Phase 3|Withdrawal by Subject|13|||
131508099|NCT04762680|473491819|FG004|Phase 3|Withdrawal by Subject|17|||
131508100|NCT04762680|473491820|FG005|Phase 3|Withdrawal by Subject|12|||
131508101|NCT04762680|473491821|FG006|Phase 3|Withdrawal by Subject|8|||
131508102|NCT04762680|473491822|FG007|Phase 3|Withdrawal by Subject|3|||
131508103|NCT04762680|473491823|FG008|Phase 3|Withdrawal by Subject|2|||
131508104|NCT04762680|473491824|FG009|Phase 3|Withdrawal by Subject|4|||
131508105|NCT04762680|473491825|FG010|Phase 3|Withdrawal by Subject|3|||
131508106|NCT04762680|473491826|FG011|Phase 3|Withdrawal by Subject|1|||
131508107|NCT04762680|473491827|FG012|Phase 3|Withdrawal by Subject|3|||
131508108|NCT04762680|473491828|FG013|Phase 3|Withdrawal by Subject|2|||
131508109|NCT04762680|473491829|FG014|Phase 3|Withdrawal by Subject|1|||
131508110|NCT04762680|473491830|FG015|Phase 3|Withdrawal by Subject|4|||
131508111|NCT04762680|473491831|FG016|Phase 3|Withdrawal by Subject|6|||
131508112|NCT04762680|473491832|FG017|Phase 3|Withdrawal by Subject|32|||
131508113|NCT04762680|473491833|FG018|Phase 3|Withdrawal by Subject|0|||
131508114|NCT04762680|473491834|FG019|Phase 3|Withdrawal by Subject|0|||
131508115|NCT04762680|473491835|FG020|Phase 3|Withdrawal by Subject|0|||
131508116|NCT04762680|473491836|FG021|Phase 3|Withdrawal by Subject|0|||
131508117|NCT04762680|473491815|FG000|Phase 3|Lost to Follow-up|0|||
131508118|NCT04762680|473491816|FG001|Phase 3|Lost to Follow-up|0|||
131508119|NCT04762680|473491817|FG002|Phase 3|Lost to Follow-up|0|||
131508120|NCT04762680|473491818|FG003|Phase 3|Lost to Follow-up|9|||
131508121|NCT04762680|473491819|FG004|Phase 3|Lost to Follow-up|22|||
131508122|NCT04762680|473491820|FG005|Phase 3|Lost to Follow-up|24|||
131508123|NCT04762680|473491821|FG006|Phase 3|Lost to Follow-up|2|||
131508124|NCT04762680|473491822|FG007|Phase 3|Lost to Follow-up|4|||
131508125|NCT04762680|473491823|FG008|Phase 3|Lost to Follow-up|6|||
131508126|NCT04762680|473491824|FG009|Phase 3|Lost to Follow-up|4|||
131508127|NCT04762680|473491825|FG010|Phase 3|Lost to Follow-up|3|||
131508128|NCT04762680|473491826|FG011|Phase 3|Lost to Follow-up|0|||
131508129|NCT04762680|473491827|FG012|Phase 3|Lost to Follow-up|5|||
131508130|NCT04762680|473491828|FG013|Phase 3|Lost to Follow-up|4|||
131508131|NCT04762680|473491829|FG014|Phase 3|Lost to Follow-up|6|||
131508132|NCT04762680|473491830|FG015|Phase 3|Lost to Follow-up|1|||
131508133|NCT04762680|473491831|FG016|Phase 3|Lost to Follow-up|1|||
131508134|NCT04762680|473491832|FG017|Phase 3|Lost to Follow-up|66|||
131508135|NCT04762680|473491833|FG018|Phase 3|Lost to Follow-up|0|||
131508136|NCT04762680|473491834|FG019|Phase 3|Lost to Follow-up|0|||
131508137|NCT04762680|473491835|FG020|Phase 3|Lost to Follow-up|0|||
131508138|NCT04762680|473491836|FG021|Phase 3|Lost to Follow-up|0|||
131508139|NCT04762680|473491815|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508140|NCT04762680|473491816|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508141|NCT04762680|473491817|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508142|NCT04762680|473491818|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508143|NCT04762680|473491819|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508144|NCT04762680|473491820|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508145|NCT04762680|473491821|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508146|NCT04762680|473491822|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508147|NCT04762680|473491823|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508148|NCT04762680|473491824|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508149|NCT04762680|473491825|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508150|NCT04762680|473491826|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508151|NCT04762680|473491827|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508152|NCT04762680|473491828|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508153|NCT04762680|473491829|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508154|NCT04762680|473491830|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508155|NCT04762680|473491831|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508156|NCT04762680|473491832|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508157|NCT04762680|473491833|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508158|NCT04762680|473491834|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508159|NCT04762680|473491835|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131508160|NCT04762680|473491836|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
131508161|NCT04762680|473491815|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508162|NCT04762680|473491816|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508163|NCT04762680|473491817|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508164|NCT04762680|473491818|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508165|NCT04762680|473491819|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508166|NCT04762680|473491820|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508167|NCT04762680|473491821|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508168|NCT04762680|473491822|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508169|NCT04762680|473491823|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508170|NCT04762680|473491824|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508171|NCT04762680|473491825|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508172|NCT04762680|473491826|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508173|NCT04762680|473491827|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508174|NCT04762680|473491828|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508175|NCT04762680|473491829|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508176|NCT04762680|473491830|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508177|NCT04762680|473491831|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508178|NCT04762680|473491832|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508179|NCT04762680|473491833|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508180|NCT04762680|473491834|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
131508181|NCT04762680|473491835|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508182|NCT04762680|473491836|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
131508183|NCT02082210|473491837|FG000|Overall Study|Death|0|||
131508184|NCT02082210|473491838|FG001|Overall Study|Death|0|||
131508185|NCT02082210|473491839|FG002|Overall Study|Death|1|||
131508186|NCT02082210|473491840|FG003|Overall Study|Death|1|||
131508187|NCT02082210|473491841|FG004|Overall Study|Death|1|||
131508188|NCT02082210|473491842|FG005|Overall Study|Death|0|||
131508189|NCT02082210|473491837|FG000|Overall Study|Withdrawal by Subject|0|||
131508190|NCT02082210|473491838|FG001|Overall Study|Withdrawal by Subject|0|||
131508191|NCT02082210|473491839|FG002|Overall Study|Withdrawal by Subject|0|||
131508192|NCT02082210|473491840|FG003|Overall Study|Withdrawal by Subject|1|||
131508193|NCT02082210|473491841|FG004|Overall Study|Withdrawal by Subject|2|||
131508194|NCT02082210|473491842|FG005|Overall Study|Withdrawal by Subject|2|||
131508195|NCT02082210|473491837|FG000|Overall Study|Clinical Progression|0|||
131508196|NCT02082210|473491838|FG001|Overall Study|Clinical Progression|0|||
131508197|NCT02082210|473491839|FG002|Overall Study|Clinical Progression|0|||
131508198|NCT02082210|473491840|FG003|Overall Study|Clinical Progression|1|||
131508199|NCT02082210|473491841|FG004|Overall Study|Clinical Progression|0|||
131508200|NCT02082210|473491842|FG005|Overall Study|Clinical Progression|0|||
131508201|NCT02082210|473491837|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
131508202|NCT02082210|473491838|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
131508203|NCT02082210|473491839|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
131508204|NCT02082210|473491840|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
131508205|NCT02082210|473491841|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
131508206|NCT02082210|473491842|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
131508207|NCT02082210|473491837|FG000|Overall Study|Physician Decision|0|||
131508208|NCT02082210|473491838|FG001|Overall Study|Physician Decision|0|||
131508209|NCT02082210|473491839|FG002|Overall Study|Physician Decision|1|||
131508210|NCT02082210|473491840|FG003|Overall Study|Physician Decision|1|||
131508211|NCT02082210|473491841|FG004|Overall Study|Physician Decision|0|||
131508212|NCT02082210|473491842|FG005|Overall Study|Physician Decision|0|||
131508213|NCT02520011|473491847|FG000|Overall Study|Adverse Event|0|||
131508214|NCT02520011|473491848|FG001|Overall Study|Adverse Event|1|||
131508215|NCT02520011|473491849|FG002|Overall Study|Adverse Event|2|||
131508216|NCT02520011|473491847|FG000|Overall Study|Death|0|||
131508217|NCT02520011|473491848|FG001|Overall Study|Death|8|||
131508218|NCT02520011|473491849|FG002|Overall Study|Death|1|||
131508219|NCT02520011|473491847|FG000|Overall Study|Lack of Efficacy|4|||
131508220|NCT02520011|473491848|FG001|Overall Study|Lack of Efficacy|26|||
131508221|NCT02520011|473491849|FG002|Overall Study|Lack of Efficacy|4|||
131508222|NCT02520011|473491847|FG000|Overall Study|Physician Decision|0|||
131508223|NCT02520011|473491848|FG001|Overall Study|Physician Decision|2|||
131508224|NCT02520011|473491849|FG002|Overall Study|Physician Decision|0|||
131508225|NCT02520011|473491847|FG000|Overall Study|Withdrawal by Subject|1|||
131508226|NCT02520011|473491848|FG001|Overall Study|Withdrawal by Subject|3|||
131508227|NCT02520011|473491849|FG002|Overall Study|Withdrawal by Subject|0|||
131508228|NCT02520011|473491847|FG000|Overall Study|Protocol Deviation|0|||
131508229|NCT02520011|473491848|FG001|Overall Study|Protocol Deviation|1|||
131508230|NCT02520011|473491849|FG002|Overall Study|Protocol Deviation|0|||
131508231|NCT02520011|473491847|FG000|Overall Study|Patient went to hospice|0|||
131508232|NCT02520011|473491848|FG001|Overall Study|Patient went to hospice|1|||
131508233|NCT02520011|473491849|FG002|Overall Study|Patient went to hospice|0|||
131508234|NCT02520011|473491847|FG000|Overall Study|Progressive disease following response|0|||
131508235|NCT02520011|473491848|FG001|Overall Study|Progressive disease following response|4|||
131508236|NCT02520011|473491849|FG002|Overall Study|Progressive disease following response|2|||
131508237|NCT01063764|473491850|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
131508238|NCT01063764|473491850|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
131508239|NCT01063764|473491850|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
131508240|NCT01063764|473491850|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
131508241|NCT01063764|473491850|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
131508242|NCT01063764|473491850|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
131508243|NCT01063764|473491850|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
131508244|NCT00697515|473491851|FG000|Dose Optimization Period|Adverse Event|4|||
131508245|NCT00697515|473491852|FG001|Dose Optimization Period|Adverse Event|0|||
131508246|NCT00697515|473491851|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
131508247|NCT00697515|473491852|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
131508248|NCT00697515|473491851|FG000|Dose Optimization Period|Lost to Follow-up|2|||
131508249|NCT00697515|473491852|FG001|Dose Optimization Period|Lost to Follow-up|0|||
131508250|NCT00697515|473491851|FG000|Dose Optimization Period|sponsor request|2|||
131508251|NCT00697515|473491852|FG001|Dose Optimization Period|sponsor request|0|||
131508252|NCT00697515|473491851|FG000|Dose Optimization Period|called to active duty|1|||
131508253|NCT00697515|473491852|FG001|Dose Optimization Period|called to active duty|0|||
131508254|NCT00697515|473491851|FG000|Dose Optimization Period|elevated QTc|1|||
131508255|NCT00697515|473491852|FG001|Dose Optimization Period|elevated QTc|0|||
131508256|NCT00697515|473491851|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
131508257|NCT00697515|473491852|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
131508258|NCT00697515|473491851|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
131508259|NCT00697515|473491852|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
131508260|NCT00697515|473491851|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
131508261|NCT00697515|473491852|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
131508262|NCT00697515|473491851|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
131508263|NCT00697515|473491852|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
131508264|NCT01727141|473491856|FG000|Overall Study|Physician Decision|0|||
131508265|NCT01727141|473491857|FG001|Overall Study|Physician Decision|1|||
131508266|NCT01727141|473491858|FG002|Overall Study|Physician Decision|0|||
131508267|NCT01727141|473491859|FG003|Overall Study|Physician Decision|2|||
131508268|NCT01727141|473491856|FG000|Overall Study|Lost to Follow-up|0|||
131508269|NCT01727141|473491857|FG001|Overall Study|Lost to Follow-up|2|||
131508270|NCT01727141|473491858|FG002|Overall Study|Lost to Follow-up|0|||
131508271|NCT01727141|473491859|FG003|Overall Study|Lost to Follow-up|0|||
131508272|NCT01727141|473491856|FG000|Overall Study|Death|0|||
131508273|NCT01727141|473491857|FG001|Overall Study|Death|1|||
131508274|NCT01727141|473491858|FG002|Overall Study|Death|1|||
131508275|NCT01727141|473491859|FG003|Overall Study|Death|1|||
131508276|NCT01727141|473491856|FG000|Overall Study|Protocol deviation|1|||
131508277|NCT01727141|473491857|FG001|Overall Study|Protocol deviation|1|||
131508278|NCT01727141|473491858|FG002|Overall Study|Protocol deviation|0|||
131508279|NCT01727141|473491859|FG003|Overall Study|Protocol deviation|1|||
131508280|NCT01727141|473491856|FG000|Overall Study|Withdrawal by Subject|4|||
131508281|NCT01727141|473491857|FG001|Overall Study|Withdrawal by Subject|4|||
131508282|NCT01727141|473491858|FG002|Overall Study|Withdrawal by Subject|2|||
131508283|NCT01727141|473491859|FG003|Overall Study|Withdrawal by Subject|11|||
131508284|NCT02603432|473491860|FG000|Overall Study|Adverse Event|1|||
131508285|NCT02603432|473491861|FG001|Overall Study|Adverse Event|0|||
131508286|NCT02603432|473491860|FG000|Overall Study|Death|221|||
131508287|NCT02603432|473491861|FG001|Overall Study|Death|242|||
131508288|NCT02603432|473491860|FG000|Overall Study|Lost to Follow-up|3|||
131508289|NCT02603432|473491861|FG001|Overall Study|Lost to Follow-up|9|||
131508290|NCT02603432|473491860|FG000|Overall Study|Progressive Disease|7|||
131508291|NCT02603432|473491861|FG001|Overall Study|Progressive Disease|5|||
131508292|NCT02603432|473491860|FG000|Overall Study|Withdrawal by Subject|12|||
131508293|NCT02603432|473491861|FG001|Overall Study|Withdrawal by Subject|18|||
131508294|NCT02603432|473491860|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
131508295|NCT02603432|473491861|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131508296|NCT02603432|473491860|FG000|Overall Study|Study terminated by sponsor|74|||
131508297|NCT02603432|473491861|FG001|Overall Study|Study terminated by sponsor|75|||
131508298|NCT02603432|473491860|FG000|Overall Study|Other|13|||
131508299|NCT02603432|473491861|FG001|Overall Study|Other|0|||
131508300|NCT04014075|473491862|FG000|Overall Study|Progressive Disease|53|||
131508301|NCT04014075|473491862|FG000|Overall Study|Adverse Event|15|||
131508302|NCT04014075|473491862|FG000|Overall Study|Clinical Progression|4|||
131508303|NCT04014075|473491862|FG000|Overall Study|Death|2|||
131508304|NCT04014075|473491862|FG000|Overall Study|Withdrawal by Subject|2|||
131508305|NCT04014075|473491862|FG000|Overall Study|Miscellaneous|2|||
131508306|NCT04014075|473491862|FG000|Overall Study|Physician Decision|1|||
131508307|NCT05954052|473491866|FG000|Overall Study|Adverse Event|1|||
131508308|NCT01957462|473491867|FG000|Test Period 1|Withdrawal by Subject|1|||
131508309|NCT01957462|473491868|FG001|Test Period 1|Withdrawal by Subject|0|||
131508310|NCT01957462|473491867|FG000|Test Period 1|Adverse Event|1|||
131508311|NCT01957462|473491868|FG001|Test Period 1|Adverse Event|0|||
131508312|NCT02584504|473491869|FG000|Double-blind Treatment|Participant withdrew consent|0|||
131508313|NCT02584504|473491870|FG001|Double-blind Treatment|Participant withdrew consent|0|||
131508314|NCT02584504|473491871|FG002|Double-blind Treatment|Participant withdrew consent|1|||
131508315|NCT02584504|473491869|FG000|Double-blind Treatment|Adverse Event|0|||
131508316|NCT02584504|473491870|FG001|Double-blind Treatment|Adverse Event|1|||
131508317|NCT02584504|473491871|FG002|Double-blind Treatment|Adverse Event|0|||
131508318|NCT02584504|473491869|FG000|Double-blind Treatment|Family Matter|0|||
131508319|NCT02584504|473491870|FG001|Double-blind Treatment|Family Matter|1|||
131508320|NCT02584504|473491871|FG002|Double-blind Treatment|Family Matter|0|||
131508321|NCT02584504|473491869|FG000|Open-label Treatment|Participant withdrew consent|0|||
131508322|NCT02584504|473491870|FG001|Open-label Treatment|Participant withdrew consent|0|||
131508323|NCT02584504|473491871|FG002|Open-label Treatment|Participant withdrew consent|4|||
131508324|NCT02584504|473491869|FG000|Open-label Treatment|Adverse Event|2|||
131508325|NCT02584504|473491870|FG001|Open-label Treatment|Adverse Event|2|||
131508326|NCT02584504|473491871|FG002|Open-label Treatment|Adverse Event|3|||
131508327|NCT02584504|473491869|FG000|Open-label Treatment|Physician Decision|0|||
131508328|NCT02584504|473491870|FG001|Open-label Treatment|Physician Decision|1|||
131508329|NCT02584504|473491871|FG002|Open-label Treatment|Physician Decision|0|||
131508330|NCT02584504|473491869|FG000|Open-label Treatment|Entered but not treated|0|||
131508331|NCT02584504|473491870|FG001|Open-label Treatment|Entered but not treated|1|||
131508332|NCT02584504|473491871|FG002|Open-label Treatment|Entered but not treated|1|||
131508333|NCT00076011|473491872|FG000|Overall Study|Death|1|||
131508334|NCT00076011|473491872|FG000|Overall Study|Adverse Event|10|||
131508335|NCT00076011|473491872|FG000|Overall Study|Lack of Efficacy|25|||
131508336|NCT00076011|473491872|FG000|Overall Study|Withdrawal by Subject|1|||
131508337|NCT00076011|473491872|FG000|Overall Study|Study terminated by sponsor|3|||
131508338|NCT00076011|473491872|FG000|Overall Study|Other|11|||
131508339|NCT00076011|473491872|FG000|Overall Study|Ongoing|1|||
131508340|NCT04461015|473491885|FG000|Overall Study|IV access lost during the study|0|||
131508341|NCT04461015|473491886|FG001|Overall Study|IV access lost during the study|1|||
131508342|NCT04461015|473491885|FG000|Overall Study|Withdrawal by Subject|0|||
131508343|NCT04461015|473491886|FG001|Overall Study|Withdrawal by Subject|1|||
131508344|NCT00507442|473491892|FG000|Overall Study|Adverse Event|8|||
131508345|NCT00507442|473491893|FG001|Overall Study|Adverse Event|11|||
131508346|NCT00507442|473491894|FG002|Overall Study|Adverse Event|4|||
131508347|NCT00507442|473491895|FG003|Overall Study|Adverse Event|1|||
131508348|NCT00507442|473491892|FG000|Overall Study|Protocol Violation|0|||
131508349|NCT00507442|473491893|FG001|Overall Study|Protocol Violation|1|||
131508350|NCT00507442|473491894|FG002|Overall Study|Protocol Violation|0|||
131508351|NCT00507442|473491895|FG003|Overall Study|Protocol Violation|0|||
131508352|NCT00507442|473491892|FG000|Overall Study|Lost to Follow-up|0|||
131508353|NCT00507442|473491893|FG001|Overall Study|Lost to Follow-up|0|||
131508354|NCT00507442|473491894|FG002|Overall Study|Lost to Follow-up|1|||
131508355|NCT00507442|473491895|FG003|Overall Study|Lost to Follow-up|0|||
131508356|NCT00507442|473491892|FG000|Overall Study|Physician Decision|0|||
131508357|NCT00507442|473491893|FG001|Overall Study|Physician Decision|2|||
131508358|NCT00507442|473491894|FG002|Overall Study|Physician Decision|4|||
131508359|NCT00507442|473491895|FG003|Overall Study|Physician Decision|1|||
131508360|NCT00507442|473491892|FG000|Overall Study|Progressive Disease|2|||
131508361|NCT00507442|473491893|FG001|Overall Study|Progressive Disease|4|||
131508362|NCT00507442|473491894|FG002|Overall Study|Progressive Disease|2|||
131508363|NCT00507442|473491895|FG003|Overall Study|Progressive Disease|0|||
131508364|NCT00507442|473491892|FG000|Overall Study|Withdrawal by Subject|4|||
131508365|NCT00507442|473491893|FG001|Overall Study|Withdrawal by Subject|4|||
131508366|NCT00507442|473491894|FG002|Overall Study|Withdrawal by Subject|2|||
131508367|NCT00507442|473491895|FG003|Overall Study|Withdrawal by Subject|1|||
131508368|NCT00507442|473491892|FG000|Overall Study|Other|2|||
131508369|NCT00507442|473491893|FG001|Overall Study|Other|5|||
131508370|NCT00507442|473491894|FG002|Overall Study|Other|2|||
131508371|NCT00507442|473491895|FG003|Overall Study|Other|2|||
131508372|NCT03425331|473491896|FG000|Overall Study|Withdrawal by Subject|1|||
131508373|NCT03425331|473491896|FG000|Overall Study|Death|1|||
131508374|NCT03425331|473491896|FG000|Overall Study|Adverse Event|1|||
131508375|NCT03425331|473491896|FG000|Overall Study|Disease Progression|2|||
131508376|NCT02864251|473491898|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
131508377|NCT02864251|473491899|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
131508378|NCT02864251|473491900|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
131508379|NCT02864251|473491898|FG000|Pre-Treatment|Withdrawal by Participant|0|||
131508380|NCT02864251|473491899|FG001|Pre-Treatment|Withdrawal by Participant|0|||
131508381|NCT02864251|473491900|FG002|Pre-Treatment|Withdrawal by Participant|4|||
131508382|NCT02864251|473491898|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
131508383|NCT02864251|473491899|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
131508384|NCT02864251|473491900|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
131508385|NCT02864251|473491898|FG000|Pre-Treatment|Other Reasons|0|||
131508386|NCT02864251|473491899|FG001|Pre-Treatment|Other Reasons|1|||
131508387|NCT02864251|473491900|FG002|Pre-Treatment|Other Reasons|1|||
131508388|NCT02864251|473491898|FG000|Treatment|Disease Progression|109|||
131508389|NCT02864251|473491899|FG001|Treatment|Disease Progression|52|||
131508390|NCT02864251|473491900|FG002|Treatment|Disease Progression|101|||
131508391|NCT02864251|473491898|FG000|Treatment|Study Drug Toxicity|9|||
131508392|NCT02864251|473491899|FG001|Treatment|Study Drug Toxicity|4|||
131508393|NCT02864251|473491900|FG002|Treatment|Study Drug Toxicity|10|||
131508394|NCT02864251|473491898|FG000|Treatment|Death|0|||
131508395|NCT02864251|473491899|FG001|Treatment|Death|2|||
131508396|NCT02864251|473491900|FG002|Treatment|Death|3|||
131508397|NCT02864251|473491898|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
131508398|NCT02864251|473491899|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
131508399|NCT02864251|473491900|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
131508400|NCT02864251|473491898|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
131508401|NCT02864251|473491899|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
131508402|NCT02864251|473491900|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
131508403|NCT02864251|473491898|FG000|Treatment|Withdrawal by Participant|8|||
131508404|NCT02864251|473491899|FG001|Treatment|Withdrawal by Participant|5|||
131508405|NCT02864251|473491900|FG002|Treatment|Withdrawal by Participant|13|||
131508406|NCT02864251|473491898|FG000|Treatment|Maximum Clinical Benefit|1|||
131508407|NCT02864251|473491899|FG001|Treatment|Maximum Clinical Benefit|0|||
131508408|NCT02864251|473491900|FG002|Treatment|Maximum Clinical Benefit|1|||
131508409|NCT02864251|473491898|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
131508410|NCT02864251|473491899|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
131508411|NCT02864251|473491900|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
131508412|NCT02864251|473491898|FG000|Treatment|Other Reasons|1|||
131508413|NCT02864251|473491899|FG001|Treatment|Other Reasons|1|||
131508414|NCT02864251|473491900|FG002|Treatment|Other Reasons|4|||
131508415|NCT02864251|473491898|FG000|Treatment|Administrative Reason by Sponsor|1|||
131508416|NCT02864251|473491899|FG001|Treatment|Administrative Reason by Sponsor|0|||
131508417|NCT02864251|473491900|FG002|Treatment|Administrative Reason by Sponsor|0|||
131508418|NCT01817725|473491903|FG000|Overall Study|Withdrawal by Subject|1|||
131508419|NCT01852812|473491904|FG000|Overall Study|Adverse Event|0|||
131508420|NCT01852812|473491905|FG001|Overall Study|Adverse Event|0|||
131508421|NCT01852812|473491906|FG002|Overall Study|Adverse Event|1|||
131508422|NCT01852812|473491904|FG000|Overall Study|Non-compliance With Study Drug|0|||
131508423|NCT01852812|473491905|FG001|Overall Study|Non-compliance With Study Drug|1|||
131508424|NCT01852812|473491906|FG002|Overall Study|Non-compliance With Study Drug|0|||
131508425|NCT02250443|473491907|FG000|Overall Study|Administrative problems|7|||
131508426|NCT02250443|473491907|FG000|Overall Study|Adverse Event|3|||
131508427|NCT01549964|473491908|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
131508428|NCT01549964|473491909|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
131508429|NCT01549964|473491910|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
131508430|NCT01549964|473491911|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
131508431|NCT01549964|473491908|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
131508432|NCT01549964|473491909|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
131508433|NCT01549964|473491910|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
131508434|NCT01549964|473491911|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
131508435|NCT01549964|473491908|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
131508436|NCT01549964|473491909|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
131508437|NCT01549964|473491910|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
131508438|NCT01549964|473491911|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
131508439|NCT01549964|473491908|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
131508440|NCT01549964|473491909|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
131508441|NCT01549964|473491910|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
131508442|NCT01549964|473491911|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
131508443|NCT01549964|473491908|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
131508444|NCT01549964|473491909|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
131508445|NCT01549964|473491910|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
131508446|NCT01549964|473491911|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
131508447|NCT01549964|473491908|FG000|24-Week Treatment Period|Other|1|||
131508448|NCT01549964|473491909|FG001|24-Week Treatment Period|Other|0|||
131508449|NCT01549964|473491910|FG002|24-Week Treatment Period|Other|1|||
131508450|NCT01549964|473491911|FG003|24-Week Treatment Period|Other|0|||
131508451|NCT01549964|473491908|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
131508452|NCT01549964|473491909|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
131508453|NCT01549964|473491910|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
131508454|NCT01549964|473491911|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
131508455|NCT01549964|473491908|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
131508456|NCT01549964|473491909|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
131508457|NCT01549964|473491910|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
131508458|NCT01549964|473491911|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
131508459|NCT01549964|473491908|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
131508460|NCT01549964|473491909|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
131508461|NCT01549964|473491910|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
131508462|NCT01549964|473491911|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
131508463|NCT01549964|473491908|FG000|80-Week Extension Period|Pregnancy|0|||
131508464|NCT01549964|473491909|FG001|80-Week Extension Period|Pregnancy|0|||
131508465|NCT01549964|473491910|FG002|80-Week Extension Period|Pregnancy|1|||
131508466|NCT01549964|473491911|FG003|80-Week Extension Period|Pregnancy|0|||
131508467|NCT01549964|473491908|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
131508468|NCT01549964|473491909|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
131508469|NCT01549964|473491910|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
131508470|NCT01549964|473491911|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
131508471|NCT01549964|473491908|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
131508472|NCT01549964|473491909|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
131508473|NCT01549964|473491910|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
131508474|NCT01549964|473491911|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
131508475|NCT01549964|473491908|FG000|80-Week Extension Period|Lost to Follow-up|1|||
131508476|NCT01549964|473491909|FG001|80-Week Extension Period|Lost to Follow-up|0|||
131508477|NCT01549964|473491910|FG002|80-Week Extension Period|Lost to Follow-up|2|||
131508478|NCT01549964|473491911|FG003|80-Week Extension Period|Lost to Follow-up|1|||
131508479|NCT01549964|473491908|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
131508480|NCT01549964|473491909|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
131508481|NCT01549964|473491910|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
131508482|NCT01549964|473491911|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
131508483|NCT02290821|473491912|FG000|Overall Study|Withdrawal by Subject|1|||
131508484|NCT02290821|473491913|FG001|Overall Study|Withdrawal by Subject|1|||
131508485|NCT02290821|473491912|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
131508486|NCT02290821|473491913|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
131508487|NCT02290821|473491912|FG000|Overall Study|Lost to Follow-up|3|||
131508488|NCT02290821|473491913|FG001|Overall Study|Lost to Follow-up|2|||
131508489|NCT00751348|473491918|FG000|Overall Study|Withdrawal by Subject|5|||
131508490|NCT00751348|473491919|FG001|Overall Study|Withdrawal by Subject|2|||
131508491|NCT00751348|473491918|FG000|Overall Study|Migration from study area|1|||
131508492|NCT00751348|473491919|FG001|Overall Study|Migration from study area|0|||
131508493|NCT00973479|473491926|FG000|Overall Study|Lost to Follow-up|0|||
131508494|NCT00973479|473491927|FG001|Overall Study|Lost to Follow-up|3|||
131508495|NCT00973479|473491926|FG000|Overall Study|Death|2|||
131508496|NCT00973479|473491927|FG001|Overall Study|Death|2|||
131508497|NCT00973479|473491926|FG000|Overall Study|Withdrawal by Subject|15|||
131508498|NCT00973479|473491927|FG001|Overall Study|Withdrawal by Subject|16|||
131508499|NCT00973479|473491926|FG000|Overall Study|Lack of Efficacy|5|||
131508500|NCT00973479|473491927|FG001|Overall Study|Lack of Efficacy|7|||
131508501|NCT00973479|473491926|FG000|Overall Study|Adverse Event|12|||
131508502|NCT00973479|473491927|FG001|Overall Study|Adverse Event|32|||
131508503|NCT00973479|473491926|FG000|Overall Study|Protocol Violation|2|||
131508504|NCT00973479|473491927|FG001|Overall Study|Protocol Violation|2|||
131508505|NCT00973479|473491926|FG000|Overall Study|Other|1|||
131508506|NCT00973479|473491927|FG001|Overall Study|Other|7|||
131508507|NCT00362115|473491928|FG000|Overall Study|Adverse Event|0|||
131508508|NCT00362115|473491929|FG001|Overall Study|Adverse Event|1|||
131508509|NCT00362115|473491930|FG002|Overall Study|Adverse Event|1|||
131508510|NCT00362115|473491931|FG003|Overall Study|Adverse Event|1|||
131508511|NCT00362115|473491932|FG004|Overall Study|Adverse Event|2|||
131508512|NCT00362115|473491933|FG005|Overall Study|Adverse Event|2|||
131508513|NCT00362115|473491934|FG006|Overall Study|Adverse Event|1|||
131508514|NCT00362115|473491928|FG000|Overall Study|Protocol Violation|0|||
131508515|NCT00362115|473491929|FG001|Overall Study|Protocol Violation|0|||
131508516|NCT00362115|473491930|FG002|Overall Study|Protocol Violation|0|||
131508517|NCT00362115|473491931|FG003|Overall Study|Protocol Violation|0|||
131508518|NCT00362115|473491932|FG004|Overall Study|Protocol Violation|0|||
131508519|NCT00362115|473491933|FG005|Overall Study|Protocol Violation|1|||
131508520|NCT00362115|473491934|FG006|Overall Study|Protocol Violation|0|||
131508521|NCT00362115|473491928|FG000|Overall Study|Lost to Follow-up|0|||
131508522|NCT00362115|473491929|FG001|Overall Study|Lost to Follow-up|1|||
131508523|NCT00362115|473491930|FG002|Overall Study|Lost to Follow-up|0|||
131508524|NCT00362115|473491931|FG003|Overall Study|Lost to Follow-up|0|||
131508525|NCT00362115|473491932|FG004|Overall Study|Lost to Follow-up|2|||
131508526|NCT00362115|473491933|FG005|Overall Study|Lost to Follow-up|0|||
131508527|NCT00362115|473491934|FG006|Overall Study|Lost to Follow-up|1|||
131508528|NCT00362115|473491928|FG000|Overall Study|Withdrawal by Subject|1|||
131508529|NCT00362115|473491929|FG001|Overall Study|Withdrawal by Subject|3|||
131508530|NCT00362115|473491930|FG002|Overall Study|Withdrawal by Subject|1|||
131508531|NCT00362115|473491931|FG003|Overall Study|Withdrawal by Subject|0|||
131508532|NCT00362115|473491932|FG004|Overall Study|Withdrawal by Subject|1|||
131508533|NCT00362115|473491933|FG005|Overall Study|Withdrawal by Subject|3|||
131508534|NCT00362115|473491934|FG006|Overall Study|Withdrawal by Subject|4|||
131508535|NCT00362115|473491928|FG000|Overall Study|Lack of Efficacy|1|||
131508536|NCT00362115|473491929|FG001|Overall Study|Lack of Efficacy|0|||
131508537|NCT00362115|473491930|FG002|Overall Study|Lack of Efficacy|5|||
131508538|NCT00362115|473491931|FG003|Overall Study|Lack of Efficacy|2|||
131508539|NCT00362115|473491932|FG004|Overall Study|Lack of Efficacy|2|||
131508540|NCT00362115|473491933|FG005|Overall Study|Lack of Efficacy|0|||
131508541|NCT00362115|473491934|FG006|Overall Study|Lack of Efficacy|3|||
131508542|NCT00362115|473491928|FG000|Overall Study|Physician Decision|0|||
131508543|NCT00362115|473491929|FG001|Overall Study|Physician Decision|0|||
131508544|NCT00362115|473491930|FG002|Overall Study|Physician Decision|0|||
131508545|NCT00362115|473491931|FG003|Overall Study|Physician Decision|0|||
131508546|NCT00362115|473491932|FG004|Overall Study|Physician Decision|0|||
131508547|NCT00362115|473491933|FG005|Overall Study|Physician Decision|0|||
131508548|NCT00362115|473491934|FG006|Overall Study|Physician Decision|3|||
131508549|NCT00362115|473491928|FG000|Overall Study|Other|0|||
131508550|NCT00362115|473491929|FG001|Overall Study|Other|1|||
131508551|NCT00362115|473491930|FG002|Overall Study|Other|0|||
131508552|NCT00362115|473491931|FG003|Overall Study|Other|1|||
131508553|NCT00362115|473491932|FG004|Overall Study|Other|0|||
131508554|NCT00362115|473491933|FG005|Overall Study|Other|1|||
131508555|NCT00362115|473491934|FG006|Overall Study|Other|0|||
131508556|NCT03965962|473491935|FG000|Overall Study|Adverse Event|1|||
131508557|NCT03965962|473491936|FG001|Overall Study|Adverse Event|0|||
131508558|NCT03965962|473491937|FG002|Overall Study|Adverse Event|0|||
131508559|NCT03965962|473491938|FG003|Overall Study|Adverse Event|0|||
131508560|NCT03965962|473491935|FG000|Overall Study|Protocol Violation|21|||
131508561|NCT03965962|473491936|FG001|Overall Study|Protocol Violation|4|||
131508562|NCT03965962|473491937|FG002|Overall Study|Protocol Violation|10|||
131508563|NCT03965962|473491938|FG003|Overall Study|Protocol Violation|5|||
131508564|NCT03965962|473491935|FG000|Overall Study|Lost to Follow-up|0|||
131508565|NCT03965962|473491936|FG001|Overall Study|Lost to Follow-up|1|||
131508566|NCT03965962|473491937|FG002|Overall Study|Lost to Follow-up|0|||
131508567|NCT03965962|473491938|FG003|Overall Study|Lost to Follow-up|0|||
131508568|NCT03965962|473491935|FG000|Overall Study|Withdrawal by Subject|3|||
131508569|NCT03965962|473491936|FG001|Overall Study|Withdrawal by Subject|0|||
131508570|NCT03965962|473491937|FG002|Overall Study|Withdrawal by Subject|0|||
131508571|NCT03965962|473491938|FG003|Overall Study|Withdrawal by Subject|1|||
131508572|NCT02039674|473491943|FG000|Overall Study|Adverse Event|0|||
131508573|NCT02039674|473491944|FG001|Overall Study|Adverse Event|0|||
131508574|NCT02039674|473491945|FG002|Overall Study|Adverse Event|0|||
131508575|NCT02039674|473491946|FG003|Overall Study|Adverse Event|1|||
131508576|NCT02039674|473491947|FG004|Overall Study|Adverse Event|0|||
131508577|NCT02039674|473491948|FG005|Overall Study|Adverse Event|0|||
131508578|NCT02039674|473491949|FG006|Overall Study|Adverse Event|0|||
131508579|NCT02039674|473491950|FG007|Overall Study|Adverse Event|0|||
131508580|NCT02039674|473491951|FG008|Overall Study|Adverse Event|2|||
131508581|NCT02039674|473491952|FG009|Overall Study|Adverse Event|1|||
131508582|NCT02039674|473491953|FG010|Overall Study|Adverse Event|0|||
131508583|NCT02039674|473491954|FG011|Overall Study|Adverse Event|2|||
131508584|NCT02039674|473491955|FG012|Overall Study|Adverse Event|3|||
131508585|NCT02039674|473491956|FG013|Overall Study|Adverse Event|1|||
131508586|NCT02039674|473491943|FG000|Overall Study|Death|2|||
131508587|NCT02039674|473491944|FG001|Overall Study|Death|0|||
131508588|NCT02039674|473491945|FG002|Overall Study|Death|2|||
131508589|NCT02039674|473491946|FG003|Overall Study|Death|3|||
131508590|NCT02039674|473491947|FG004|Overall Study|Death|0|||
131508591|NCT02039674|473491948|FG005|Overall Study|Death|0|||
131508592|NCT02039674|473491949|FG006|Overall Study|Death|1|||
131508593|NCT02039674|473491950|FG007|Overall Study|Death|0|||
131508594|NCT02039674|473491951|FG008|Overall Study|Death|2|||
131508595|NCT02039674|473491952|FG009|Overall Study|Death|0|||
131508596|NCT02039674|473491953|FG010|Overall Study|Death|1|||
131508597|NCT02039674|473491954|FG011|Overall Study|Death|3|||
131508598|NCT02039674|473491955|FG012|Overall Study|Death|2|||
131508599|NCT02039674|473491956|FG013|Overall Study|Death|8|||
131508600|NCT02039674|473491943|FG000|Overall Study|Excluded Medication|1|||
131508601|NCT02039674|473491944|FG001|Overall Study|Excluded Medication|1|||
131508602|NCT02039674|473491945|FG002|Overall Study|Excluded Medication|0|||
131508603|NCT02039674|473491946|FG003|Overall Study|Excluded Medication|1|||
131508604|NCT02039674|473491947|FG004|Overall Study|Excluded Medication|0|||
131508605|NCT02039674|473491948|FG005|Overall Study|Excluded Medication|1|||
131508606|NCT02039674|473491949|FG006|Overall Study|Excluded Medication|0|||
131508607|NCT02039674|473491950|FG007|Overall Study|Excluded Medication|0|||
131508608|NCT02039674|473491951|FG008|Overall Study|Excluded Medication|2|||
131508609|NCT02039674|473491952|FG009|Overall Study|Excluded Medication|3|||
131508610|NCT02039674|473491953|FG010|Overall Study|Excluded Medication|5|||
131508611|NCT02039674|473491954|FG011|Overall Study|Excluded Medication|6|||
131508612|NCT02039674|473491955|FG012|Overall Study|Excluded Medication|8|||
131508613|NCT02039674|473491956|FG013|Overall Study|Excluded Medication|3|||
131508614|NCT02039674|473491943|FG000|Overall Study|Lost to Follow-up|0|||
131508615|NCT02039674|473491944|FG001|Overall Study|Lost to Follow-up|0|||
131508616|NCT02039674|473491945|FG002|Overall Study|Lost to Follow-up|0|||
131508617|NCT02039674|473491946|FG003|Overall Study|Lost to Follow-up|0|||
131508618|NCT02039674|473491947|FG004|Overall Study|Lost to Follow-up|1|||
131508619|NCT02039674|473491948|FG005|Overall Study|Lost to Follow-up|1|||
131508620|NCT02039674|473491949|FG006|Overall Study|Lost to Follow-up|0|||
131508621|NCT02039674|473491950|FG007|Overall Study|Lost to Follow-up|0|||
131508622|NCT02039674|473491951|FG008|Overall Study|Lost to Follow-up|0|||
131508623|NCT02039674|473491952|FG009|Overall Study|Lost to Follow-up|0|||
131508624|NCT02039674|473491953|FG010|Overall Study|Lost to Follow-up|0|||
131508625|NCT02039674|473491954|FG011|Overall Study|Lost to Follow-up|2|||
131508626|NCT02039674|473491955|FG012|Overall Study|Lost to Follow-up|2|||
131508627|NCT02039674|473491956|FG013|Overall Study|Lost to Follow-up|1|||
131508628|NCT02039674|473491943|FG000|Overall Study|Physician Decision|0|||
131508629|NCT02039674|473491944|FG001|Overall Study|Physician Decision|0|||
131508630|NCT02039674|473491945|FG002|Overall Study|Physician Decision|0|||
131508631|NCT02039674|473491946|FG003|Overall Study|Physician Decision|0|||
131508632|NCT02039674|473491947|FG004|Overall Study|Physician Decision|0|||
131508633|NCT02039674|473491948|FG005|Overall Study|Physician Decision|0|||
131508634|NCT02039674|473491949|FG006|Overall Study|Physician Decision|0|||
131508635|NCT02039674|473491950|FG007|Overall Study|Physician Decision|0|||
131508636|NCT02039674|473491951|FG008|Overall Study|Physician Decision|0|||
131508637|NCT02039674|473491952|FG009|Overall Study|Physician Decision|0|||
131508638|NCT02039674|473491953|FG010|Overall Study|Physician Decision|0|||
131508639|NCT02039674|473491954|FG011|Overall Study|Physician Decision|1|||
131508640|NCT02039674|473491955|FG012|Overall Study|Physician Decision|1|||
131508641|NCT02039674|473491956|FG013|Overall Study|Physician Decision|0|||
131508642|NCT02039674|473491943|FG000|Overall Study|Progressive Disease|8|||
131508643|NCT02039674|473491944|FG001|Overall Study|Progressive Disease|8|||
131508644|NCT02039674|473491945|FG002|Overall Study|Progressive Disease|6|||
131508645|NCT02039674|473491946|FG003|Overall Study|Progressive Disease|7|||
131508646|NCT02039674|473491947|FG004|Overall Study|Progressive Disease|9|||
131508647|NCT02039674|473491948|FG005|Overall Study|Progressive Disease|10|||
131508648|NCT02039674|473491949|FG006|Overall Study|Progressive Disease|1|||
131508649|NCT02039674|473491950|FG007|Overall Study|Progressive Disease|3|||
131508650|NCT02039674|473491951|FG008|Overall Study|Progressive Disease|6|||
131508651|NCT02039674|473491952|FG009|Overall Study|Progressive Disease|4|||
131508652|NCT02039674|473491953|FG010|Overall Study|Progressive Disease|0|||
131508653|NCT02039674|473491954|FG011|Overall Study|Progressive Disease|34|||
131508654|NCT02039674|473491955|FG012|Overall Study|Progressive Disease|34|||
131508655|NCT02039674|473491956|FG013|Overall Study|Progressive Disease|18|||
131508656|NCT02039674|473491943|FG000|Overall Study|Withdrawal by Subject|1|||
131508657|NCT02039674|473491944|FG001|Overall Study|Withdrawal by Subject|2|||
131508658|NCT02039674|473491945|FG002|Overall Study|Withdrawal by Subject|3|||
131508659|NCT02039674|473491946|FG003|Overall Study|Withdrawal by Subject|0|||
131508660|NCT02039674|473491947|FG004|Overall Study|Withdrawal by Subject|1|||
131508661|NCT02039674|473491948|FG005|Overall Study|Withdrawal by Subject|0|||
131508662|NCT02039674|473491949|FG006|Overall Study|Withdrawal by Subject|0|||
131508663|NCT02039674|473491950|FG007|Overall Study|Withdrawal by Subject|0|||
131508664|NCT02039674|473491951|FG008|Overall Study|Withdrawal by Subject|0|||
131508665|NCT02039674|473491952|FG009|Overall Study|Withdrawal by Subject|1|||
131508666|NCT02039674|473491953|FG010|Overall Study|Withdrawal by Subject|1|||
131508667|NCT02039674|473491954|FG011|Overall Study|Withdrawal by Subject|4|||
131508668|NCT02039674|473491955|FG012|Overall Study|Withdrawal by Subject|6|||
131508669|NCT02039674|473491956|FG013|Overall Study|Withdrawal by Subject|2|||
131508670|NCT02039674|473491943|FG000|Overall Study|Clinical Progression|0|||
131508671|NCT02039674|473491944|FG001|Overall Study|Clinical Progression|0|||
131508672|NCT02039674|473491945|FG002|Overall Study|Clinical Progression|0|||
131508673|NCT02039674|473491946|FG003|Overall Study|Clinical Progression|0|||
131508674|NCT02039674|473491947|FG004|Overall Study|Clinical Progression|0|||
131508675|NCT02039674|473491948|FG005|Overall Study|Clinical Progression|0|||
131508676|NCT02039674|473491949|FG006|Overall Study|Clinical Progression|1|||
131508677|NCT02039674|473491950|FG007|Overall Study|Clinical Progression|0|||
131508678|NCT02039674|473491951|FG008|Overall Study|Clinical Progression|0|||
131508679|NCT02039674|473491952|FG009|Overall Study|Clinical Progression|0|||
131508680|NCT02039674|473491953|FG010|Overall Study|Clinical Progression|0|||
131508681|NCT02039674|473491954|FG011|Overall Study|Clinical Progression|0|||
131508682|NCT02039674|473491955|FG012|Overall Study|Clinical Progression|1|||
131508683|NCT02039674|473491956|FG013|Overall Study|Clinical Progression|0|||
131508684|NCT02039674|473491943|FG000|Overall Study|Sponsor Decision|1|||
131508685|NCT02039674|473491944|FG001|Overall Study|Sponsor Decision|1|||
131508686|NCT02039674|473491945|FG002|Overall Study|Sponsor Decision|1|||
131508687|NCT02039674|473491946|FG003|Overall Study|Sponsor Decision|1|||
131508688|NCT02039674|473491947|FG004|Overall Study|Sponsor Decision|1|||
131508689|NCT02039674|473491948|FG005|Overall Study|Sponsor Decision|0|||
131508690|NCT02039674|473491949|FG006|Overall Study|Sponsor Decision|0|||
131508691|NCT02039674|473491950|FG007|Overall Study|Sponsor Decision|0|||
131508692|NCT02039674|473491951|FG008|Overall Study|Sponsor Decision|0|||
131508693|NCT02039674|473491952|FG009|Overall Study|Sponsor Decision|3|||
131508694|NCT02039674|473491953|FG010|Overall Study|Sponsor Decision|0|||
131508695|NCT02039674|473491954|FG011|Overall Study|Sponsor Decision|8|||
131508696|NCT02039674|473491955|FG012|Overall Study|Sponsor Decision|5|||
131508697|NCT02039674|473491956|FG013|Overall Study|Sponsor Decision|0|||
131508698|NCT02039674|473491943|FG000|Overall Study|Other|0|||
131508699|NCT02039674|473491944|FG001|Overall Study|Other|0|||
131508700|NCT02039674|473491945|FG002|Overall Study|Other|0|||
131508701|NCT02039674|473491946|FG003|Overall Study|Other|0|||
131508702|NCT02039674|473491947|FG004|Overall Study|Other|0|||
131508703|NCT02039674|473491948|FG005|Overall Study|Other|0|||
131508704|NCT02039674|473491949|FG006|Overall Study|Other|0|||
131508705|NCT02039674|473491950|FG007|Overall Study|Other|0|||
131508706|NCT02039674|473491951|FG008|Overall Study|Other|0|||
131508707|NCT02039674|473491952|FG009|Overall Study|Other|0|||
131508708|NCT02039674|473491953|FG010|Overall Study|Other|0|||
131508709|NCT02039674|473491954|FG011|Overall Study|Other|0|||
131508710|NCT02039674|473491955|FG012|Overall Study|Other|1|||
131508711|NCT02039674|473491956|FG013|Overall Study|Other|0|||
131508712|NCT01826487|473491957|FG000|Overall Study|Adverse Event|1|||
131508713|NCT01826487|473491958|FG001|Overall Study|Adverse Event|1|||
131508714|NCT01826487|473491957|FG000|Overall Study|Lost to Follow-up|1|||
131508715|NCT01826487|473491958|FG001|Overall Study|Lost to Follow-up|0|||
131508716|NCT01826487|473491957|FG000|Overall Study|Withdrawal by Subject|1|||
131508717|NCT01826487|473491958|FG001|Overall Study|Withdrawal by Subject|3|||
131508718|NCT01826487|473491957|FG000|Overall Study|Protocol Violation|1|||
131508719|NCT01826487|473491958|FG001|Overall Study|Protocol Violation|1|||
131508720|NCT01358357|473491959|FG000|Open Label Phase|Adverse Event|0|||
131508721|NCT01358357|473491960|FG001|Open Label Phase|Adverse Event|0|||
131508722|NCT01358357|473491961|FG002|Open Label Phase|Adverse Event|59|||
131508723|NCT01358357|473491959|FG000|Open Label Phase|Lack of Efficacy|0|||
131508724|NCT01358357|473491960|FG001|Open Label Phase|Lack of Efficacy|0|||
131508725|NCT01358357|473491961|FG002|Open Label Phase|Lack of Efficacy|107|||
131508726|NCT01358357|473491959|FG000|Open Label Phase|Lost to Follow-up|0|||
131508727|NCT01358357|473491960|FG001|Open Label Phase|Lost to Follow-up|0|||
131508728|NCT01358357|473491961|FG002|Open Label Phase|Lost to Follow-up|76|||
131508729|NCT01358357|473491959|FG000|Open Label Phase|Protocol Violation|0|||
131508730|NCT01358357|473491960|FG001|Open Label Phase|Protocol Violation|0|||
131508731|NCT01358357|473491961|FG002|Open Label Phase|Protocol Violation|45|||
131508732|NCT01358357|473491959|FG000|Open Label Phase|Withdrawal by Subject|0|||
131508733|NCT01358357|473491960|FG001|Open Label Phase|Withdrawal by Subject|0|||
131508734|NCT01358357|473491961|FG002|Open Label Phase|Withdrawal by Subject|112|||
131508735|NCT01358357|473491959|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
131508736|NCT01358357|473491960|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
131508737|NCT01358357|473491961|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
131508738|NCT01358357|473491959|FG000|Open Label Phase|Terminated at study completion|0|||
131508739|NCT01358357|473491960|FG001|Open Label Phase|Terminated at study completion|0|||
131508740|NCT01358357|473491961|FG002|Open Label Phase|Terminated at study completion|5|||
131508741|NCT01358357|473491959|FG000|Open Label Phase|Mood episode|0|||
131508742|NCT01358357|473491960|FG001|Open Label Phase|Mood episode|0|||
131508743|NCT01358357|473491961|FG002|Open Label Phase|Mood episode|42|||
131508744|NCT01358357|473491959|FG000|Double-Blind Phase|Adverse Event|8|||
131508745|NCT01358357|473491960|FG001|Double-Blind Phase|Adverse Event|5|||
131508746|NCT01358357|473491961|FG002|Double-Blind Phase|Adverse Event|0|||
131508747|NCT01358357|473491959|FG000|Double-Blind Phase|Lost to Follow-up|5|||
131508748|NCT01358357|473491960|FG001|Double-Blind Phase|Lost to Follow-up|7|||
131508749|NCT01358357|473491961|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131508750|NCT01358357|473491959|FG000|Double-Blind Phase|Protocol Violation|1|||
131508751|NCT01358357|473491960|FG001|Double-Blind Phase|Protocol Violation|11|||
131508752|NCT01358357|473491961|FG002|Double-Blind Phase|Protocol Violation|0|||
131508753|NCT01358357|473491959|FG000|Double-Blind Phase|Protocol Violation|16|||
131508754|NCT01358357|473491960|FG001|Double-Blind Phase|Protocol Violation|12|||
131508755|NCT01358357|473491961|FG002|Double-Blind Phase|Protocol Violation|0|||
131508756|NCT01358357|473491959|FG000|Double-Blind Phase|Terminated at study completion|2|||
131508757|NCT01358357|473491960|FG001|Double-Blind Phase|Terminated at study completion|0|||
131508758|NCT01358357|473491961|FG002|Double-Blind Phase|Terminated at study completion|0|||
131508759|NCT01358357|473491959|FG000|Double-Blind Phase|Recurrence of mood event|48|||
131508760|NCT01358357|473491960|FG001|Double-Blind Phase|Recurrence of mood event|64|||
131508761|NCT01358357|473491961|FG002|Double-Blind Phase|Recurrence of mood event|0|||
131508762|NCT01358357|473491959|FG000|Double-Blind Phase|Administrative|0|||
131508763|NCT01358357|473491960|FG001|Double-Blind Phase|Administrative|1|||
131508764|NCT01358357|473491961|FG002|Double-Blind Phase|Administrative|0|||
131508765|NCT01408030|473491962|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
131508766|NCT01408030|473491963|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
131508767|NCT01408030|473491964|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
131508768|NCT01408030|473491965|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
131508769|NCT01408030|473491962|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
131508770|NCT01408030|473491963|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
131508771|NCT01408030|473491964|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
131508772|NCT01408030|473491965|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
131508773|NCT01408030|473491962|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
131508774|NCT01408030|473491963|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
131508775|NCT01408030|473491964|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
131508776|NCT01408030|473491965|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
131508777|NCT01408030|473491962|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
131508778|NCT01408030|473491963|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
131508779|NCT01408030|473491964|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
131508780|NCT01408030|473491965|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
131508781|NCT01408030|473491962|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
131508782|NCT01408030|473491963|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
131508783|NCT01408030|473491964|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
131508784|NCT01408030|473491965|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
131508785|NCT01408030|473491962|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
131508786|NCT01408030|473491963|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
131508787|NCT01408030|473491964|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
131508788|NCT01408030|473491965|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
131508789|NCT01408030|473491962|FG000|Observation Phase (Off Drug)|Other|1|||
131508790|NCT01408030|473491963|FG001|Observation Phase (Off Drug)|Other|1|||
131508791|NCT01408030|473491964|FG002|Observation Phase (Off Drug)|Other|1|||
131508792|NCT01408030|473491965|FG003|Observation Phase (Off Drug)|Other|1|||
131508793|NCT00003641|473491966|FG000|Overall Study|Withdrawal by Subject|0|||
131508794|NCT00003641|473491967|FG001|Overall Study|Withdrawal by Subject|100|||
131508795|NCT00003641|473491966|FG000|Overall Study|Adverse Event|0|||
131508796|NCT00003641|473491967|FG001|Overall Study|Adverse Event|38|||
131508797|NCT00003641|473491966|FG000|Overall Study|Disease progression|0|||
131508798|NCT00003641|473491967|FG001|Overall Study|Disease progression|2|||
131508799|NCT00003641|473491966|FG000|Overall Study|Unknown/missing|0|||
131508800|NCT00003641|473491967|FG001|Overall Study|Unknown/missing|22|||
131508801|NCT00003641|473491966|FG000|Overall Study|Should not receive interferon therapy|2|||
131508802|NCT00003641|473491967|FG001|Overall Study|Should not receive interferon therapy|0|||
131508803|NCT00003641|473491966|FG000|Overall Study|Never started interferon|567|||
131508804|NCT00003641|473491967|FG001|Overall Study|Never started interferon|12|||
131508805|NCT03659916|473491969|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
131508806|NCT03659916|473491970|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
131508807|NCT03659916|473491971|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
131508808|NCT03659916|473491969|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
131508809|NCT03659916|473491970|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
131508810|NCT03659916|473491971|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
131508811|NCT03659916|473491969|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
131508812|NCT03659916|473491970|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
131508813|NCT03659916|473491971|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
131508814|NCT03659916|473491969|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
131508815|NCT03659916|473491970|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
131508816|NCT03659916|473491971|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
131508817|NCT03659916|473491969|FG000|Treatment Period (72 Weeks)|Other|1|||
131508818|NCT03659916|473491970|FG001|Treatment Period (72 Weeks)|Other|3|||
131508819|NCT03659916|473491971|FG002|Treatment Period (72 Weeks)|Other|9|||
131508820|NCT03659916|473491969|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
131508821|NCT03659916|473491970|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
131508822|NCT03659916|473491971|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
131508823|NCT03659916|473491969|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
131508824|NCT03659916|473491970|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
131508825|NCT03659916|473491971|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
131508826|NCT03659916|473491969|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
131508827|NCT03659916|473491970|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
131508828|NCT03659916|473491971|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
131508829|NCT03659916|473491969|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
131508830|NCT03659916|473491970|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
131508831|NCT03659916|473491971|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
131508832|NCT03659916|473491969|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
131508833|NCT03659916|473491970|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
131508834|NCT03659916|473491971|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
131508835|NCT03659916|473491969|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
131508836|NCT03659916|473491970|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
131508837|NCT03659916|473491971|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
131508838|NCT00729183|473491972|FG000|Overall Study|Adverse Event|11|||
131508839|NCT00729183|473491973|FG001|Overall Study|Adverse Event|5|||
131508840|NCT00729183|473491972|FG000|Overall Study|Lack of Efficacy|0|||
131508841|NCT00729183|473491973|FG001|Overall Study|Lack of Efficacy|1|||
131508842|NCT00729183|473491972|FG000|Overall Study|Lost to Follow-up|3|||
131508843|NCT00729183|473491973|FG001|Overall Study|Lost to Follow-up|1|||
131508844|NCT00729183|473491972|FG000|Overall Study|Physician Decision|1|||
131508845|NCT00729183|473491973|FG001|Overall Study|Physician Decision|1|||
131508846|NCT00729183|473491972|FG000|Overall Study|Protocol Violation|1|||
131508847|NCT00729183|473491973|FG001|Overall Study|Protocol Violation|0|||
131508848|NCT00729183|473491972|FG000|Overall Study|Withdrawal by Subject|9|||
131508849|NCT00729183|473491973|FG001|Overall Study|Withdrawal by Subject|7|||
131508850|NCT02867709|473491974|FG000|Treatment Period|Adverse Event|1|||
131508851|NCT02867709|473491975|FG001|Treatment Period|Adverse Event|1|||
131508852|NCT02867709|473491976|FG002|Treatment Period|Adverse Event|2|||
131508853|NCT02867709|473491974|FG000|Treatment Period|Withdrawal of Consent|7|||
131508854|NCT02867709|473491975|FG001|Treatment Period|Withdrawal of Consent|9|||
131508855|NCT02867709|473491976|FG002|Treatment Period|Withdrawal of Consent|8|||
131508856|NCT02867709|473491974|FG000|Treatment Period|Lost to Follow-up|17|||
131508857|NCT02867709|473491975|FG001|Treatment Period|Lost to Follow-up|20|||
131508858|NCT02867709|473491976|FG002|Treatment Period|Lost to Follow-up|20|||
131508859|NCT02867709|473491974|FG000|Treatment Period|Lack of Qualifying Event|42|||
131508860|NCT02867709|473491975|FG001|Treatment Period|Lack of Qualifying Event|55|||
131508861|NCT02867709|473491976|FG002|Treatment Period|Lack of Qualifying Event|42|||
131508862|NCT02867709|473491974|FG000|Treatment Period|Protocol Violation|3|||
131508863|NCT02867709|473491975|FG001|Treatment Period|Protocol Violation|2|||
131508864|NCT02867709|473491976|FG002|Treatment Period|Protocol Violation|3|||
131508865|NCT02867709|473491974|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
131508866|NCT02867709|473491975|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
131508867|NCT02867709|473491976|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
131508868|NCT02867709|473491974|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
131508869|NCT02867709|473491975|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
131508870|NCT02867709|473491976|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
131508871|NCT02867709|473491974|FG000|Safety Follow-up Period|Pregnancy|0|||
131508872|NCT02867709|473491975|FG001|Safety Follow-up Period|Pregnancy|1|||
131508873|NCT02867709|473491976|FG002|Safety Follow-up Period|Pregnancy|0|||
131508874|NCT02867709|473491974|FG000|Safety Follow-up Period|Protocol Violation|0|||
131508875|NCT02867709|473491975|FG001|Safety Follow-up Period|Protocol Violation|1|||
131508876|NCT02867709|473491976|FG002|Safety Follow-up Period|Protocol Violation|1|||
131508877|NCT04709575|473493400|FG000|Overall Study|Withdrawal by Subject|6|||
131508878|NCT04709575|473493401|FG001|Overall Study|Withdrawal by Subject|2|||
131508879|NCT04709575|473493400|FG000|Overall Study|Lost to Follow-up|2|||
131508880|NCT04709575|473493401|FG001|Overall Study|Lost to Follow-up|2|||
131508881|NCT04709575|473493400|FG000|Overall Study|Adverse Event|1|||
131508882|NCT04709575|473493401|FG001|Overall Study|Adverse Event|0|||
131508883|NCT04709575|473493400|FG000|Overall Study|Protocol Violation|1|||
131508884|NCT04709575|473493401|FG001|Overall Study|Protocol Violation|1|||
131508885|NCT03181399|473493402|FG000|6 Months on Treatment|Protocol non-compliance|7|||
131508886|NCT03181399|473493402|FG000|6 Months on Treatment|Adverse Event|4|||
131508887|NCT03181399|473493402|FG000|6 Months on Treatment|Tried alternative treatment|2|||
131508888|NCT03181399|473493402|FG000|6 Months on Treatment|Lost to Follow-up|2|||
131508889|NCT03181399|473493402|FG000|6 Months on Treatment|Personal reasons|1|||
131508890|NCT03181399|473493402|FG000|3 Months Off-treatment|Parent unable to travel|1|||
131508891|NCT00489853|473493405|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
131508892|NCT00489853|473493406|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
131508893|NCT00489853|473493407|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
131508894|NCT00489853|473493405|FG000|Wash-out Period 1|Adverse Event|0|||
131508895|NCT00489853|473493406|FG001|Wash-out Period 1|Adverse Event|1|||
131508896|NCT00489853|473493407|FG002|Wash-out Period 1|Adverse Event|1|||
131508897|NCT00489853|473493405|FG000|Wash-out Period 1|Protocol Violation|0|||
131508898|NCT00489853|473493406|FG001|Wash-out Period 1|Protocol Violation|1|||
131508899|NCT00489853|473493407|FG002|Wash-out Period 1|Protocol Violation|1|||
131508900|NCT00489853|473493405|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
131508901|NCT00489853|473493406|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
131508902|NCT00489853|473493407|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
131508903|NCT00489853|473493405|FG000|Wash-out Period 2|Adverse Event|1|||
131508904|NCT00489853|473493406|FG001|Wash-out Period 2|Adverse Event|1|||
131508905|NCT00489853|473493407|FG002|Wash-out Period 2|Adverse Event|0|||
131508906|NCT00489853|473493405|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
131508907|NCT00489853|473493406|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
131508908|NCT00489853|473493407|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
131508909|NCT00489853|473493405|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
131508910|NCT00489853|473493406|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
131508911|NCT00489853|473493407|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
131508912|NCT00265343|473493408|FG000|Overall Study|Adverse Event|10|||
131508913|NCT00265343|473493409|FG001|Overall Study|Adverse Event|7|||
131508914|NCT00265343|473493408|FG000|Overall Study|Withdrawal by Subject|3|||
131508915|NCT00265343|473493409|FG001|Overall Study|Withdrawal by Subject|9|||
131508916|NCT00265343|473493408|FG000|Overall Study|Other|8|||
131508917|NCT00265343|473493409|FG001|Overall Study|Other|3|||
131508918|NCT02515942|473493413|FG000|Overall Study|Adverse Event|5|||
131508919|NCT02515942|473493414|FG001|Overall Study|Adverse Event|0|||
131508920|NCT02515942|473493415|FG002|Overall Study|Adverse Event|0|||
131508921|NCT02515942|473493413|FG000|Overall Study|Death|0|||
131508922|NCT02515942|473493414|FG001|Overall Study|Death|0|||
131508923|NCT02515942|473493415|FG002|Overall Study|Death|1|||
131508924|NCT02515942|473493413|FG000|Overall Study|Lack of Efficacy|0|||
131508925|NCT02515942|473493414|FG001|Overall Study|Lack of Efficacy|0|||
131508926|NCT02515942|473493415|FG002|Overall Study|Lack of Efficacy|1|||
131508927|NCT02515942|473493413|FG000|Overall Study|Lost to Follow-up|2|||
131508928|NCT02515942|473493414|FG001|Overall Study|Lost to Follow-up|0|||
131508929|NCT02515942|473493415|FG002|Overall Study|Lost to Follow-up|0|||
131508930|NCT02515942|473493413|FG000|Overall Study|Withdrawal by Subject|0|||
131508931|NCT02515942|473493414|FG001|Overall Study|Withdrawal by Subject|3|||
131508932|NCT02515942|473493415|FG002|Overall Study|Withdrawal by Subject|2|||
131508933|NCT01856790|473493418|FG000|Closed Loop Control|Withdrawal by Subject|2|||
131508934|NCT01856790|473493418|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
131508935|NCT03506373|473493421|FG000|Overall Study|Adverse Event|6|||
131508936|NCT03506373|473493421|FG000|Overall Study|Withdrawal by Subject|2|||
131508937|NCT03506373|473493421|FG000|Overall Study|Disease progression|5|||
131508938|NCT03506373|473493421|FG000|Overall Study|Other|3|||
131508939|NCT00885755|473493422|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
131508940|NCT00885755|473493423|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
131508941|NCT00885755|473493424|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
131508942|NCT00885755|473493422|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
131508943|NCT00885755|473493423|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
131508944|NCT00885755|473493424|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
131508945|NCT00885755|473493422|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
131508946|NCT00885755|473493423|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
131658097|NCT04445987|474032996|FG002|Overall Study|Physician Decision|0|||
131508947|NCT00885755|473493424|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
131508948|NCT00885755|473493422|FG000|Part I: Trastuzumab+Taxane|Death|0|||
131508949|NCT00885755|473493423|FG001|Part I: Trastuzumab+Taxane|Death|0|||
131508950|NCT00885755|473493424|FG002|Part I: Trastuzumab+Taxane|Death|1|||
131508951|NCT00885755|473493422|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
131508952|NCT00885755|473493423|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
131508953|NCT00885755|473493424|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
131508954|NCT04343521|473493425|FG000|Overall Study|Adverse Event|0|||
131508955|NCT04343521|473493426|FG001|Overall Study|Adverse Event|2|||
131508956|NCT04343521|473493425|FG000|Overall Study|Death|1|||
131508957|NCT04343521|473493426|FG001|Overall Study|Death|2|||
131508958|NCT04343521|473493425|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
131508959|NCT04343521|473493426|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
131508960|NCT04343521|473493425|FG000|Overall Study|Withdrawal by Subject|70|||
131508961|NCT04343521|473493426|FG001|Overall Study|Withdrawal by Subject|95|||
131508962|NCT04343521|473493425|FG000|Overall Study|Withdrawal by study team|6|||
131508963|NCT04343521|473493426|FG001|Overall Study|Withdrawal by study team|12|||
131508964|NCT00107198|473493427|FG000|Overall Study|Lack of Efficacy|28|||
131508965|NCT00107198|473493427|FG000|Overall Study|Lost to Follow-up|12|||
131508966|NCT00107198|473493427|FG000|Overall Study|Protocol Violation|1|||
131508967|NCT00107198|473493427|FG000|Overall Study|Withdrawal by Subject|6|||
131508968|NCT00107198|473493427|FG000|Overall Study|Ineligible|5|||
131508969|NCT02120950|473493428|FG000|Overall Study|Adverse Event|5|||
131508970|NCT02120950|473493429|FG001|Overall Study|Adverse Event|4|||
131508971|NCT02120950|473493430|FG002|Overall Study|Adverse Event|3|||
131508972|NCT02120950|473493428|FG000|Overall Study|Death|3|||
131508973|NCT02120950|473493429|FG001|Overall Study|Death|0|||
131508974|NCT02120950|473493430|FG002|Overall Study|Death|1|||
131508975|NCT02120950|473493428|FG000|Overall Study|Withdrawal by Subject|6|||
131508976|NCT02120950|473493429|FG001|Overall Study|Withdrawal by Subject|3|||
131508977|NCT02120950|473493430|FG002|Overall Study|Withdrawal by Subject|2|||
131508978|NCT02120950|473493428|FG000|Overall Study|Protocol Violation|1|||
131508979|NCT02120950|473493429|FG001|Overall Study|Protocol Violation|1|||
131508980|NCT02120950|473493430|FG002|Overall Study|Protocol Violation|7|||
131508981|NCT02120950|473493428|FG000|Overall Study|Other reasons|5|||
131508982|NCT02120950|473493429|FG001|Overall Study|Other reasons|4|||
131508983|NCT02120950|473493430|FG002|Overall Study|Other reasons|1|||
131508984|NCT02120950|473493428|FG000|Overall Study|Lost to Follow-up|0|||
131508985|NCT02120950|473493429|FG001|Overall Study|Lost to Follow-up|2|||
131508986|NCT02120950|473493430|FG002|Overall Study|Lost to Follow-up|1|||
131508987|NCT02424383|473493431|FG000|Overall Study|Withdrawal by Subject|32|||
131508988|NCT02424383|473493431|FG000|Overall Study|Death|170|||
131508989|NCT02424383|473493431|FG000|Overall Study|Sponsor's decision|3|||
131508990|NCT02424383|473493431|FG000|Overall Study|Investigator's decision|44|||
131508991|NCT02424383|473493431|FG000|Overall Study|Lost to Follow-up|81|||
131508992|NCT02424383|473493431|FG000|Overall Study|Other|7|||
131508993|NCT02424383|473493431|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
131508994|NCT02438722|473493434|FG000|Overall Study|Adverse Event|12|||
131508995|NCT02438722|473493435|FG001|Overall Study|Adverse Event|9|||
131508996|NCT02438722|473493434|FG000|Overall Study|Refusal unrelated to AE|2|||
131508997|NCT02438722|473493435|FG001|Overall Study|Refusal unrelated to AE|5|||
131508998|NCT02438722|473493434|FG000|Overall Study|Disease progression/relapse|46|||
131508999|NCT02438722|473493435|FG001|Overall Study|Disease progression/relapse|51|||
131509000|NCT02438722|473493434|FG000|Overall Study|Death|0|||
131509001|NCT02438722|473493435|FG001|Overall Study|Death|3|||
131509002|NCT02438722|473493434|FG000|Overall Study|Physician Decision|2|||
131509003|NCT02438722|473493435|FG001|Overall Study|Physician Decision|2|||
131509004|NCT02438722|473493434|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
131509005|NCT02438722|473493435|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
131509006|NCT02438722|473493434|FG000|Overall Study|Withdrawal by Subject|0|||
131509007|NCT02438722|473493435|FG001|Overall Study|Withdrawal by Subject|1|||
131509008|NCT02438722|473493434|FG000|Overall Study|On protocol treatment|15|||
131509009|NCT02438722|473493435|FG001|Overall Study|On protocol treatment|14|||
131509010|NCT02438722|473493434|FG000|Overall Study|Did not receive protocol treatment|5|||
131509011|NCT02438722|473493435|FG001|Overall Study|Did not receive protocol treatment|0|||
131509012|NCT00909779|473493436|FG000|Overall Study|Adverse Event|53|||
131509013|NCT00909779|473493437|FG001|Overall Study|Adverse Event|55|||
131509014|NCT00909779|473493436|FG000|Overall Study|Lack of Efficacy|7|||
131509015|NCT00909779|473493437|FG001|Overall Study|Lack of Efficacy|4|||
131509016|NCT00909779|473493436|FG000|Overall Study|Lost to Follow-up|19|||
131509017|NCT00909779|473493437|FG001|Overall Study|Lost to Follow-up|15|||
131509018|NCT00909779|473493436|FG000|Overall Study|Physician Decision|8|||
131509019|NCT00909779|473493437|FG001|Overall Study|Physician Decision|2|||
131509020|NCT00909779|473493436|FG000|Overall Study|Protocol Violation|2|||
131509021|NCT00909779|473493437|FG001|Overall Study|Protocol Violation|5|||
131509022|NCT00909779|473493436|FG000|Overall Study|Withdrawal by Subject|116|||
131509023|NCT00909779|473493437|FG001|Overall Study|Withdrawal by Subject|80|||
131509024|NCT00909779|473493436|FG000|Overall Study|Site Ceasing Operation|2|||
131509025|NCT00909779|473493437|FG001|Overall Study|Site Ceasing Operation|2|||
131509026|NCT00909779|473493436|FG000|Overall Study|Medical Monitor Decision|1|||
131509027|NCT00909779|473493437|FG001|Overall Study|Medical Monitor Decision|0|||
131509028|NCT00909779|473493436|FG000|Overall Study|Noncompliance|1|||
131509029|NCT00909779|473493437|FG001|Overall Study|Noncompliance|1|||
131509030|NCT00909779|473493436|FG000|Overall Study|Randomized in error|1|||
131509031|NCT00909779|473493437|FG001|Overall Study|Randomized in error|1|||
131509032|NCT02738333|473493441|FG000|Overall Study|Death|1|||
131509033|NCT02738333|473493442|FG001|Overall Study|Death|0|||
131509034|NCT02738333|473493443|FG002|Overall Study|Death|0|||
131509035|NCT02738333|473493441|FG000|Overall Study|Lost to Follow-up|1|||
131509036|NCT02738333|473493442|FG001|Overall Study|Lost to Follow-up|0|||
131509037|NCT02738333|473493443|FG002|Overall Study|Lost to Follow-up|0|||
131509038|NCT01498952|473493445|FG000|Overall Study|Death|2|||
131509039|NCT01498952|473493446|FG001|Overall Study|Death|2|||
131509040|NCT01498952|473493447|FG002|Overall Study|Death|0|||
131509041|NCT01498952|473493448|FG003|Overall Study|Death|0|||
131509042|NCT01498952|473493449|FG004|Overall Study|Death|0|||
131509043|NCT00579826|473493450|FG000|Overall Study|Withdrawal by Subject|5|||
131509044|NCT00579826|473493451|FG001|Overall Study|Withdrawal by Subject|3|||
131509045|NCT04191382|473493452|FG000|Overall Study|Withdrawal by Subject|1|||
131509046|NCT04191382|473493453|FG001|Overall Study|Withdrawal by Subject|0|||
131509047|NCT04191382|473493454|FG002|Overall Study|Withdrawal by Subject|0|||
131509048|NCT05237206|473493455|FG000|Overall Study|screen failure-did not receive treatment|8|||
131509049|NCT05237206|473493455|FG000|Overall Study|did not receive treatment|3|||
131509050|NCT02205333|473493461|FG000|Overall Study|Death|5|||
131509051|NCT02205333|473493462|FG001|Overall Study|Death|6|||
131509052|NCT02205333|473493463|FG002|Overall Study|Death|2|||
131509053|NCT02205333|473493464|FG003|Overall Study|Death|6|||
131509054|NCT02205333|473493465|FG004|Overall Study|Death|5|||
131509055|NCT02205333|473493466|FG005|Overall Study|Death|3|||
131509056|NCT02205333|473493467|FG006|Overall Study|Death|3|||
131509057|NCT02205333|473493468|FG007|Overall Study|Death|2|||
131509058|NCT02205333|473493469|FG008|Overall Study|Death|0|||
131509059|NCT02205333|473493461|FG000|Overall Study|Withdrawal by Subject|1|||
131509060|NCT02205333|473493462|FG001|Overall Study|Withdrawal by Subject|0|||
131509061|NCT02205333|473493463|FG002|Overall Study|Withdrawal by Subject|0|||
131509062|NCT02205333|473493464|FG003|Overall Study|Withdrawal by Subject|1|||
131509063|NCT02205333|473493465|FG004|Overall Study|Withdrawal by Subject|0|||
131509064|NCT02205333|473493466|FG005|Overall Study|Withdrawal by Subject|0|||
131509065|NCT02205333|473493467|FG006|Overall Study|Withdrawal by Subject|2|||
131509066|NCT02205333|473493468|FG007|Overall Study|Withdrawal by Subject|0|||
131509067|NCT02205333|473493469|FG008|Overall Study|Withdrawal by Subject|0|||
131509068|NCT00454987|473493470|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
131509069|NCT00454987|473493471|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
131509070|NCT00454987|473493472|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
131509071|NCT00454987|473493470|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
131509072|NCT00454987|473493471|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
131509073|NCT00454987|473493472|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
131509074|NCT00454987|473493470|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
131509075|NCT00454987|473493471|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
131509076|NCT00454987|473493472|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
131509077|NCT01476696|473493473|FG000|Overall Study|Sponsor decision|2|||
131509078|NCT01476696|473493474|FG001|Overall Study|Sponsor decision|1|||
131509079|NCT01476696|473493475|FG002|Overall Study|Sponsor decision|0|||
131509080|NCT01476696|473493473|FG000|Overall Study|Withdrawal by Subject|1|||
131509081|NCT01476696|473493474|FG001|Overall Study|Withdrawal by Subject|0|||
131509082|NCT01476696|473493475|FG002|Overall Study|Withdrawal by Subject|0|||
131509083|NCT02009046|473493476|FG000|Overall Study|Lost to Follow-up|256|||
131509084|NCT02009046|473493477|FG001|Overall Study|Lost to Follow-up|206|||
131509085|NCT00304356|473493483|FG000|Nitazoxanide|Physician Decision|5|||
131509086|NCT00304356|473493483|FG000|Nitazoxanide|Physician Decision|1|||
131509087|NCT00304356|473493483|FG000|Nitazoxanide|number is 0|1|||
131509088|NCT00304356|473493483|FG000|Nitazoxanide|Physician Decision|1|||
131509089|NCT00304356|473493483|FG000|Nitazoxanide|Physician Decision|1|||
131509090|NCT00304356|473493483|FG000|Nitazoxanide|Physician Decision|1|||
131509091|NCT01737047|473493484|FG000|Overall Study|Death|10|||
131509092|NCT01737047|473493485|FG001|Overall Study|Death|0|||
131509093|NCT01737047|473493486|FG002|Overall Study|Death|1|||
131509094|NCT01737047|473493484|FG000|Overall Study|Withdrawal by Subject|17|||
131509095|NCT01737047|473493485|FG001|Overall Study|Withdrawal by Subject|11|||
131509096|NCT01737047|473493486|FG002|Overall Study|Withdrawal by Subject|4|||
131509097|NCT00335972|473493487|FG000|Overall Study|not given treatments|0|||
131509098|NCT00335972|473493488|FG001|Overall Study|not given treatments|3|||
131509099|NCT02136576|473493491|FG000|Overall Study|Lost to Follow-up|2|||
131509100|NCT02136576|473493492|FG001|Overall Study|Lost to Follow-up|0|||
131509101|NCT02136576|473493493|FG002|Overall Study|Lost to Follow-up|0|||
131509102|NCT00537381|473493494|FG000|Overall Study|Adverse Event|13|||
131509103|NCT00537381|473493495|FG001|Overall Study|Adverse Event|9|||
131509104|NCT00537381|473493494|FG000|Overall Study|Death|3|||
131509105|NCT00537381|473493495|FG001|Overall Study|Death|3|||
131509106|NCT00537381|473493494|FG000|Overall Study|Withdrawal by Subject|5|||
131509107|NCT00537381|473493495|FG001|Overall Study|Withdrawal by Subject|14|||
131509108|NCT00537381|473493494|FG000|Overall Study|Physician Decision|7|||
131509109|NCT00537381|473493495|FG001|Overall Study|Physician Decision|6|||
131509110|NCT00537381|473493494|FG000|Overall Study|Disease Progression|9|||
131509111|NCT00537381|473493495|FG001|Overall Study|Disease Progression|18|||
131509112|NCT00537381|473493494|FG000|Overall Study|Sponsor decision|14|||
131509113|NCT00537381|473493495|FG001|Overall Study|Sponsor decision|9|||
131509114|NCT00537381|473493494|FG000|Overall Study|Other|5|||
131509115|NCT00537381|473493495|FG001|Overall Study|Other|3|||
131509116|NCT02590939|473493496|FG000|Overall Study|Withdrawal by Subject|3|||
131509117|NCT02590939|473493497|FG001|Overall Study|Withdrawal by Subject|1|||
131509118|NCT02590939|473493496|FG000|Overall Study|Failed the nociceptive test|2|||
131509119|NCT02590939|473493497|FG001|Overall Study|Failed the nociceptive test|1|||
131509120|NCT02081079|473493498|FG000|Overall Study|Lack of Efficacy|3|||
131509121|NCT02081079|473493499|FG001|Overall Study|Lack of Efficacy|2|||
131509122|NCT02081079|473493498|FG000|Overall Study|Lost to Follow-up|1|||
131509123|NCT02081079|473493499|FG001|Overall Study|Lost to Follow-up|0|||
131509124|NCT02225743|473493500|FG000|Overall Study|Withdrawal by Subject|18|||
131509125|NCT04837131|473493508|FG000|Overall Study|Death|1|||
131509126|NCT04837131|473493508|FG000|Overall Study|Withdrawal by Subject|1|||
131509127|NCT04837131|473493508|FG000|Overall Study|Adverse Event|1|||
131509128|NCT04837131|473493508|FG000|Overall Study|Protocol Violation|1|||
131509129|NCT01541969|473495038|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
131509130|NCT01541969|473495039|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
131509131|NCT01541969|473495038|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
131509132|NCT01541969|473495039|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
131509133|NCT01541969|473495038|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
131509134|NCT01541969|473495039|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
131509135|NCT01541969|473495038|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
131509136|NCT01541969|473495039|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
131509137|NCT01541969|473495038|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
131509138|NCT01541969|473495039|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
131509139|NCT01541969|473495038|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
131509140|NCT01541969|473495039|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
131509141|NCT01541969|473495038|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
131509142|NCT01541969|473495039|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
131509143|NCT01541969|473495038|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
131509144|NCT01541969|473495039|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
131509145|NCT01541969|473495038|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
131509146|NCT01541969|473495039|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
131509147|NCT01541969|473495038|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
131509148|NCT01541969|473495039|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
131509149|NCT05123222|473495040|FG000|Overall Study|Lost to Follow-up|2|||
131509150|NCT05123222|473495041|FG001|Overall Study|Lost to Follow-up|0|||
131509151|NCT05123222|473495042|FG002|Overall Study|Lost to Follow-up|0|||
131509152|NCT05123222|473495043|FG003|Overall Study|Lost to Follow-up|0|||
131509153|NCT05123222|473495040|FG000|Overall Study|Protocol Violation|0|||
131509154|NCT05123222|473495041|FG001|Overall Study|Protocol Violation|0|||
131509155|NCT05123222|473495042|FG002|Overall Study|Protocol Violation|1|||
131509156|NCT05123222|473495043|FG003|Overall Study|Protocol Violation|0|||
131509157|NCT02255500|473495048|FG000|Overall Study|Withdrawal by Subject|1|||
131509158|NCT02255500|473495049|FG001|Overall Study|Withdrawal by Subject|0|||
131509159|NCT04865354|473495050|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
131509160|NCT04865354|473495051|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
131509161|NCT04865354|473495050|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
131509162|NCT04865354|473495051|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
131509163|NCT04865354|473495050|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
131509164|NCT04865354|473495051|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
131509165|NCT00588822|473495056|FG000|Overall Study|progression of disease|8|||
131509166|NCT04254978|473495058|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
131509167|NCT04254978|473495058|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
131509168|NCT04254978|473495058|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
131509169|NCT04254978|473495058|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
131509170|NCT04254978|473495058|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
131509171|NCT04254978|473495058|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
131509172|NCT02436759|473495059|FG000|Overall Study|Adverse Event|3|||
131509173|NCT02436759|473495060|FG001|Overall Study|Adverse Event|0|||
131509174|NCT02436759|473495059|FG000|Overall Study|Protocol Violation|1|||
131509175|NCT02436759|473495060|FG001|Overall Study|Protocol Violation|0|||
131509176|NCT02436759|473495059|FG000|Overall Study|Withdrawal by Subject|0|||
131509177|NCT02436759|473495060|FG001|Overall Study|Withdrawal by Subject|1|||
131509178|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
131509179|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
131509180|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
131509181|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
131509182|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
131509183|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
131509184|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
131509185|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
131509186|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
131509187|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
131509188|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
131509189|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
131509190|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
131509191|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
131509192|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
131509193|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
131509194|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
131509195|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
131509196|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
131509197|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
131509198|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
131509199|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
131509200|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
131509201|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
131509202|NCT00277212|473495061|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
131509203|NCT00277212|473495062|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
131509204|NCT00277212|473495063|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
131509205|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
131509206|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
131509207|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
131509208|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
131509209|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
131509210|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
131509211|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
131509212|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
131509213|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
131509214|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
131509215|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
131509216|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
131509217|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
131509218|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
131509219|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
131509220|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
131509221|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
131509222|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
131509223|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
131509224|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
131509225|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
131509226|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
131509227|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
131509228|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
131509229|NCT00277212|473495061|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
131509230|NCT00277212|473495062|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
131509231|NCT00277212|473495063|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
131509232|NCT00902564|473495064|FG000|Overall Study|Withdrawal by Subject|2|||
131509233|NCT03336216|473495065|FG000|Randomization|Not reported|2|||
131509234|NCT03336216|473495066|FG001|Randomization|Not reported|0|||
131509235|NCT03336216|473495067|FG002|Randomization|Not reported|1|||
131509236|NCT03336216|473495068|FG003|Randomization|Not reported|0|||
131509237|NCT03336216|473495065|FG000|Randomization|Other reasons|1|||
131509238|NCT03336216|473495066|FG001|Randomization|Other reasons|1|||
131509239|NCT03336216|473495067|FG002|Randomization|Other reasons|1|||
131509240|NCT03336216|473495068|FG003|Randomization|Other reasons|0|||
131509241|NCT03336216|473495065|FG000|Randomization|Participant no longer meets study criteria|0|||
131509242|NCT03336216|473495066|FG001|Randomization|Participant no longer meets study criteria|2|||
131509243|NCT03336216|473495067|FG002|Randomization|Participant no longer meets study criteria|4|||
131509244|NCT03336216|473495068|FG003|Randomization|Participant no longer meets study criteria|1|||
131509245|NCT03336216|473495065|FG000|Randomization|Lost to Follow-up|1|||
131509246|NCT03336216|473495066|FG001|Randomization|Lost to Follow-up|0|||
131509247|NCT03336216|473495067|FG002|Randomization|Lost to Follow-up|0|||
131509248|NCT03336216|473495068|FG003|Randomization|Lost to Follow-up|0|||
131509249|NCT03336216|473495065|FG000|Randomization|Participant withdrew consent|9|||
131509250|NCT03336216|473495066|FG001|Randomization|Participant withdrew consent|1|||
131509251|NCT03336216|473495067|FG002|Randomization|Participant withdrew consent|0|||
131509252|NCT03336216|473495068|FG003|Randomization|Participant withdrew consent|0|||
131509253|NCT03336216|473495065|FG000|Randomization|Adverse Event|1|||
131509254|NCT03336216|473495066|FG001|Randomization|Adverse Event|1|||
131509255|NCT03336216|473495067|FG002|Randomization|Adverse Event|0|||
131509256|NCT03336216|473495068|FG003|Randomization|Adverse Event|0|||
131509257|NCT03336216|473495065|FG000|Treatment|Adverse Event|2|||
131509258|NCT03336216|473495066|FG001|Treatment|Adverse Event|3|||
131509259|NCT03336216|473495067|FG002|Treatment|Adverse Event|4|||
131509260|NCT03336216|473495068|FG003|Treatment|Adverse Event|4|||
131509261|NCT03336216|473495065|FG000|Treatment|Participant request to discontinue treatment|2|||
131509262|NCT03336216|473495066|FG001|Treatment|Participant request to discontinue treatment|1|||
131509263|NCT03336216|473495067|FG002|Treatment|Participant request to discontinue treatment|2|||
131509264|NCT03336216|473495068|FG003|Treatment|Participant request to discontinue treatment|2|||
131509265|NCT03336216|473495065|FG000|Treatment|Participant withdrew consent|7|||
131509266|NCT03336216|473495066|FG001|Treatment|Participant withdrew consent|2|||
131509267|NCT03336216|473495067|FG002|Treatment|Participant withdrew consent|3|||
131509268|NCT03336216|473495068|FG003|Treatment|Participant withdrew consent|2|||
131509269|NCT03336216|473495065|FG000|Treatment|Death|2|||
131509270|NCT03336216|473495066|FG001|Treatment|Death|3|||
131509271|NCT03336216|473495067|FG002|Treatment|Death|3|||
131509272|NCT03336216|473495068|FG003|Treatment|Death|4|||
131509273|NCT03336216|473495065|FG000|Treatment|Participant no longer meets study criteria|0|||
131509274|NCT03336216|473495066|FG001|Treatment|Participant no longer meets study criteria|1|||
131509275|NCT03336216|473495067|FG002|Treatment|Participant no longer meets study criteria|0|||
131509276|NCT03336216|473495068|FG003|Treatment|Participant no longer meets study criteria|0|||
131509277|NCT03336216|473495065|FG000|Treatment|Other reasons|2|||
131509278|NCT03336216|473495066|FG001|Treatment|Other reasons|0|||
131509279|NCT03336216|473495067|FG002|Treatment|Other reasons|0|||
131509280|NCT03336216|473495068|FG003|Treatment|Other reasons|3|||
131509281|NCT03336216|473495065|FG000|Treatment|Disease progression|23|||
131509282|NCT03336216|473495066|FG001|Treatment|Disease progression|34|||
131509283|NCT03336216|473495067|FG002|Treatment|Disease progression|33|||
131509284|NCT03336216|473495068|FG003|Treatment|Disease progression|26|||
131509285|NCT03336216|473495065|FG000|Treatment|Study drug toxicity|0|||
131509286|NCT03336216|473495066|FG001|Treatment|Study drug toxicity|3|||
131509287|NCT03336216|473495067|FG002|Treatment|Study drug toxicity|2|||
131509288|NCT03336216|473495068|FG003|Treatment|Study drug toxicity|0|||
131509289|NCT03336216|473495065|FG000|Treatment|Adverse Event unrelated to study drug|1|||
131509290|NCT03336216|473495066|FG001|Treatment|Adverse Event unrelated to study drug|1|||
131509291|NCT03336216|473495067|FG002|Treatment|Adverse Event unrelated to study drug|1|||
131509292|NCT03336216|473495068|FG003|Treatment|Adverse Event unrelated to study drug|0|||
131509293|NCT03336216|473495065|FG000|Treatment|Disease Recurrence|1|||
131509294|NCT03336216|473495066|FG001|Treatment|Disease Recurrence|0|||
131509295|NCT03336216|473495067|FG002|Treatment|Disease Recurrence|0|||
131509296|NCT03336216|473495068|FG003|Treatment|Disease Recurrence|0|||
131509297|NCT03239470|473495069|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
131509298|NCT03239470|473495070|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
131509299|NCT00922766|473495071|FG000|Overall Study|Death|3|||
131509300|NCT00922766|473495071|FG000|Overall Study|Withdrawal by Subject|2|||
131509301|NCT00922766|473495071|FG000|Overall Study|Other|1|||
131509302|NCT00922766|473495071|FG000|Overall Study|Adverse Event|1|||
131509303|NCT01231581|473495074|FG000|Overall Study|Lost to Follow-up|2|||
131509304|NCT01231581|473495075|FG001|Overall Study|Lost to Follow-up|2|||
131509305|NCT01231581|473495074|FG000|Overall Study|Withdrawal by Subject|6|||
131509306|NCT01231581|473495075|FG001|Overall Study|Withdrawal by Subject|9|||
131509307|NCT01231581|473495074|FG000|Overall Study|Study Closed/Terminated|6|||
131509308|NCT01231581|473495075|FG001|Overall Study|Study Closed/Terminated|5|||
131509309|NCT01231581|473495074|FG000|Overall Study|Death|65|||
131509310|NCT01231581|473495075|FG001|Overall Study|Death|64|||
131509311|NCT01231581|473495074|FG000|Overall Study|Ongoing|1|||
131509312|NCT01231581|473495075|FG001|Overall Study|Ongoing|0|||
131509313|NCT03616912|473495076|FG000|Overall Study|Adverse Event|17|||
131509314|NCT03616912|473495077|FG001|Overall Study|Adverse Event|21|||
131509315|NCT03616912|473495078|FG002|Overall Study|Adverse Event|9|||
131509316|NCT03616912|473495079|FG003|Overall Study|Adverse Event|0|||
131509317|NCT03616912|473495080|FG004|Overall Study|Adverse Event|0|||
131509318|NCT03616912|473495081|FG005|Overall Study|Adverse Event|0|||
131509319|NCT03616912|473495076|FG000|Overall Study|Death|1|||
131509320|NCT03616912|473495077|FG001|Overall Study|Death|1|||
131509321|NCT03616912|473495078|FG002|Overall Study|Death|0|||
131509322|NCT03616912|473495079|FG003|Overall Study|Death|0|||
131509323|NCT03616912|473495080|FG004|Overall Study|Death|0|||
131509324|NCT03616912|473495081|FG005|Overall Study|Death|0|||
131509325|NCT03616912|473495076|FG000|Overall Study|Lack of Efficacy|13|||
131509326|NCT03616912|473495077|FG001|Overall Study|Lack of Efficacy|6|||
131509327|NCT03616912|473495078|FG002|Overall Study|Lack of Efficacy|8|||
131509328|NCT03616912|473495079|FG003|Overall Study|Lack of Efficacy|4|||
131509329|NCT03616912|473495080|FG004|Overall Study|Lack of Efficacy|5|||
131509330|NCT03616912|473495081|FG005|Overall Study|Lack of Efficacy|1|||
131509331|NCT03616912|473495076|FG000|Overall Study|Lost to Follow-up|1|||
131509332|NCT03616912|473495077|FG001|Overall Study|Lost to Follow-up|2|||
131509333|NCT03616912|473495078|FG002|Overall Study|Lost to Follow-up|3|||
131509334|NCT03616912|473495079|FG003|Overall Study|Lost to Follow-up|0|||
131509335|NCT03616912|473495080|FG004|Overall Study|Lost to Follow-up|0|||
131509336|NCT03616912|473495081|FG005|Overall Study|Lost to Follow-up|0|||
131509337|NCT03616912|473495076|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
131509338|NCT03616912|473495077|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
131509339|NCT03616912|473495078|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
131509340|NCT03616912|473495079|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
131509341|NCT03616912|473495080|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
131509342|NCT03616912|473495081|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
131509343|NCT03616912|473495076|FG000|Overall Study|Withdrawal by Subject|12|||
131509344|NCT03616912|473495077|FG001|Overall Study|Withdrawal by Subject|12|||
131509345|NCT03616912|473495078|FG002|Overall Study|Withdrawal by Subject|15|||
131509346|NCT03616912|473495079|FG003|Overall Study|Withdrawal by Subject|2|||
131509347|NCT03616912|473495080|FG004|Overall Study|Withdrawal by Subject|0|||
131509348|NCT03616912|473495081|FG005|Overall Study|Withdrawal by Subject|2|||
131509349|NCT03616912|473495076|FG000|Overall Study|Study Terminated by Sponsor|0|||
131509350|NCT03616912|473495077|FG001|Overall Study|Study Terminated by Sponsor|0|||
131509351|NCT03616912|473495078|FG002|Overall Study|Study Terminated by Sponsor|0|||
131509352|NCT03616912|473495079|FG003|Overall Study|Study Terminated by Sponsor|10|||
131509353|NCT03616912|473495080|FG004|Overall Study|Study Terminated by Sponsor|9|||
131509354|NCT03616912|473495081|FG005|Overall Study|Study Terminated by Sponsor|11|||
131509355|NCT03616912|473495076|FG000|Overall Study|Protocol Deviation|1|||
131509356|NCT03616912|473495077|FG001|Overall Study|Protocol Deviation|1|||
131509357|NCT03616912|473495078|FG002|Overall Study|Protocol Deviation|0|||
131509358|NCT03616912|473495079|FG003|Overall Study|Protocol Deviation|0|||
131509359|NCT03616912|473495080|FG004|Overall Study|Protocol Deviation|0|||
131509360|NCT03616912|473495081|FG005|Overall Study|Protocol Deviation|0|||
131509361|NCT03616912|473495076|FG000|Overall Study|Pregnancy|1|||
131509362|NCT03616912|473495077|FG001|Overall Study|Pregnancy|0|||
131509363|NCT03616912|473495078|FG002|Overall Study|Pregnancy|4|||
131509364|NCT03616912|473495079|FG003|Overall Study|Pregnancy|0|||
131509365|NCT03616912|473495080|FG004|Overall Study|Pregnancy|0|||
131509366|NCT03616912|473495081|FG005|Overall Study|Pregnancy|0|||
131509367|NCT03616912|473495076|FG000|Overall Study|Protocol Violation|1|||
131509368|NCT03616912|473495077|FG001|Overall Study|Protocol Violation|0|||
131509369|NCT03616912|473495078|FG002|Overall Study|Protocol Violation|2|||
131509370|NCT03616912|473495079|FG003|Overall Study|Protocol Violation|0|||
131509371|NCT03616912|473495080|FG004|Overall Study|Protocol Violation|0|||
131509372|NCT03616912|473495081|FG005|Overall Study|Protocol Violation|0|||
131509373|NCT03616912|473495076|FG000|Overall Study|Physician Decision|2|||
131509374|NCT03616912|473495077|FG001|Overall Study|Physician Decision|0|||
131509375|NCT03616912|473495078|FG002|Overall Study|Physician Decision|0|||
131509376|NCT03616912|473495079|FG003|Overall Study|Physician Decision|0|||
131509377|NCT03616912|473495080|FG004|Overall Study|Physician Decision|1|||
131509378|NCT03616912|473495081|FG005|Overall Study|Physician Decision|0|||
131509379|NCT03616912|473495076|FG000|Overall Study|Randomized But Never Treated|0|||
131509380|NCT03616912|473495077|FG001|Overall Study|Randomized But Never Treated|2|||
131509381|NCT03616912|473495078|FG002|Overall Study|Randomized But Never Treated|0|||
131509382|NCT03616912|473495079|FG003|Overall Study|Randomized But Never Treated|0|||
131509383|NCT03616912|473495080|FG004|Overall Study|Randomized But Never Treated|0|||
131509384|NCT03616912|473495081|FG005|Overall Study|Randomized But Never Treated|0|||
131509385|NCT02510794|473495082|FG000|Overall Study|Adverse Event|0|||
131509386|NCT02510794|473495083|FG001|Overall Study|Adverse Event|1|||
131509387|NCT02510794|473495084|FG002|Overall Study|Adverse Event|0|||
131509388|NCT02510794|473495085|FG003|Overall Study|Adverse Event|0|||
131509389|NCT02510794|473495082|FG000|Overall Study|Death|1|||
131509390|NCT02510794|473495083|FG001|Overall Study|Death|2|||
131509391|NCT02510794|473495084|FG002|Overall Study|Death|1|||
131509392|NCT02510794|473495085|FG003|Overall Study|Death|1|||
131509393|NCT02510794|473495082|FG000|Overall Study|Lack of Efficacy|3|||
131509394|NCT02510794|473495083|FG001|Overall Study|Lack of Efficacy|1|||
131509395|NCT02510794|473495084|FG002|Overall Study|Lack of Efficacy|1|||
131509396|NCT02510794|473495085|FG003|Overall Study|Lack of Efficacy|0|||
131509397|NCT02510794|473495082|FG000|Overall Study|Participant moved out of the area|0|||
131509398|NCT02510794|473495083|FG001|Overall Study|Participant moved out of the area|0|||
131509399|NCT02510794|473495084|FG002|Overall Study|Participant moved out of the area|0|||
131509400|NCT02510794|473495085|FG003|Overall Study|Participant moved out of the area|1|||
131509401|NCT02510794|473495082|FG000|Overall Study|Physician Decision|3|||
131509402|NCT02510794|473495083|FG001|Overall Study|Physician Decision|0|||
131509403|NCT02510794|473495084|FG002|Overall Study|Physician Decision|0|||
131509404|NCT02510794|473495085|FG003|Overall Study|Physician Decision|0|||
131509405|NCT02510794|473495082|FG000|Overall Study|Protocol Violation|0|||
131509406|NCT02510794|473495083|FG001|Overall Study|Protocol Violation|0|||
131509407|NCT02510794|473495084|FG002|Overall Study|Protocol Violation|1|||
131509408|NCT02510794|473495085|FG003|Overall Study|Protocol Violation|0|||
131509409|NCT02510794|473495082|FG000|Overall Study|Withdrawal by Subject|1|||
131509410|NCT02510794|473495083|FG001|Overall Study|Withdrawal by Subject|2|||
131509411|NCT02510794|473495084|FG002|Overall Study|Withdrawal by Subject|4|||
131509412|NCT02510794|473495085|FG003|Overall Study|Withdrawal by Subject|3|||
131509413|NCT01649375|473495086|FG000|Up to Week 16|Adverse Event|2|||
131509414|NCT01649375|473495087|FG001|Up to Week 16|Adverse Event|5|||
131509415|NCT01649375|473495088|FG002|Up to Week 16|Adverse Event|4|||
131509416|NCT01649375|473495089|FG003|Up to Week 16|Adverse Event|0|||
131509417|NCT01649375|473495090|FG004|Up to Week 16|Adverse Event|0|||
131509418|NCT01649375|473495086|FG000|Up to Week 16|Lack of Efficacy|0|||
131509419|NCT01649375|473495087|FG001|Up to Week 16|Lack of Efficacy|0|||
131509420|NCT01649375|473495088|FG002|Up to Week 16|Lack of Efficacy|1|||
131509421|NCT01649375|473495089|FG003|Up to Week 16|Lack of Efficacy|0|||
131509422|NCT01649375|473495090|FG004|Up to Week 16|Lack of Efficacy|0|||
131509423|NCT01649375|473495086|FG000|Up to Week 16|Physician Decision|0|||
131509424|NCT01649375|473495087|FG001|Up to Week 16|Physician Decision|0|||
131509425|NCT01649375|473495088|FG002|Up to Week 16|Physician Decision|1|||
131509426|NCT01649375|473495089|FG003|Up to Week 16|Physician Decision|0|||
131509427|NCT01649375|473495090|FG004|Up to Week 16|Physician Decision|0|||
131509428|NCT01649375|473495086|FG000|Up to Week 16|Withdrawal by Subject|2|||
131509429|NCT01649375|473495087|FG001|Up to Week 16|Withdrawal by Subject|1|||
131509430|NCT01649375|473495088|FG002|Up to Week 16|Withdrawal by Subject|2|||
131509431|NCT01649375|473495089|FG003|Up to Week 16|Withdrawal by Subject|0|||
131509432|NCT01649375|473495090|FG004|Up to Week 16|Withdrawal by Subject|0|||
131509433|NCT01649375|473495086|FG000|Up to Week 16|Death|1|||
131509434|NCT01649375|473495087|FG001|Up to Week 16|Death|0|||
131509435|NCT01649375|473495088|FG002|Up to Week 16|Death|0|||
131509436|NCT01649375|473495089|FG003|Up to Week 16|Death|0|||
131509437|NCT01649375|473495090|FG004|Up to Week 16|Death|0|||
131509438|NCT01649375|473495086|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
131509439|NCT01649375|473495087|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
131509440|NCT01649375|473495088|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
131509441|NCT01649375|473495089|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
131509442|NCT01649375|473495090|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
131509443|NCT01649375|473495086|FG000|Week 16 up to Week 260|Non-compliance|0|||
131509444|NCT01649375|473495087|FG001|Week 16 up to Week 260|Non-compliance|1|||
131509445|NCT01649375|473495088|FG002|Week 16 up to Week 260|Non-compliance|0|||
131509446|NCT01649375|473495089|FG003|Week 16 up to Week 260|Non-compliance|1|||
131509447|NCT01649375|473495090|FG004|Week 16 up to Week 260|Non-compliance|0|||
131509448|NCT01649375|473495086|FG000|Week 16 up to Week 260|Physician Decision|0|||
131509449|NCT01649375|473495087|FG001|Week 16 up to Week 260|Physician Decision|2|||
131509450|NCT01649375|473495088|FG002|Week 16 up to Week 260|Physician Decision|0|||
131509451|NCT01649375|473495089|FG003|Week 16 up to Week 260|Physician Decision|0|||
131509452|NCT01649375|473495090|FG004|Week 16 up to Week 260|Physician Decision|0|||
131509453|NCT01649375|473495086|FG000|Week 16 up to Week 260|Technical issues|0|||
131509454|NCT01649375|473495087|FG001|Week 16 up to Week 260|Technical issues|1|||
131509455|NCT01649375|473495088|FG002|Week 16 up to Week 260|Technical issues|0|||
131509456|NCT01649375|473495089|FG003|Week 16 up to Week 260|Technical issues|1|||
131509457|NCT01649375|473495090|FG004|Week 16 up to Week 260|Technical issues|0|||
131509458|NCT01649375|473495086|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
131509459|NCT01649375|473495087|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
131509460|NCT01649375|473495088|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
131509461|NCT01649375|473495089|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
131509462|NCT01649375|473495090|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
131509463|NCT01649375|473495086|FG000|Week 16 up to Week 260|Death|1|||
131509464|NCT01649375|473495087|FG001|Week 16 up to Week 260|Death|1|||
131509465|NCT01649375|473495088|FG002|Week 16 up to Week 260|Death|0|||
131509466|NCT01649375|473495089|FG003|Week 16 up to Week 260|Death|0|||
131509467|NCT01649375|473495090|FG004|Week 16 up to Week 260|Death|0|||
131509468|NCT01649375|473495086|FG000|Week 16 up to Week 260|Adverse Event|5|||
131509469|NCT01649375|473495087|FG001|Week 16 up to Week 260|Adverse Event|2|||
131509470|NCT01649375|473495088|FG002|Week 16 up to Week 260|Adverse Event|0|||
131509471|NCT01649375|473495089|FG003|Week 16 up to Week 260|Adverse Event|3|||
131509472|NCT01649375|473495090|FG004|Week 16 up to Week 260|Adverse Event|2|||
131509473|NCT01124604|473495091|FG000|Overall Study|Adverse Event|10|||
131509474|NCT01124604|473495092|FG001|Overall Study|Adverse Event|1|||
131509475|NCT01124604|473495091|FG000|Overall Study|Lack of Efficacy|1|||
131509476|NCT01124604|473495092|FG001|Overall Study|Lack of Efficacy|0|||
131509477|NCT01124604|473495091|FG000|Overall Study|Withdrawal by Subject|4|||
131509478|NCT01124604|473495092|FG001|Overall Study|Withdrawal by Subject|0|||
131509479|NCT01124604|473495091|FG000|Overall Study|Disease Progression|0|||
131509480|NCT01124604|473495092|FG001|Overall Study|Disease Progression|1|||
131509481|NCT04091646|473495093|FG000|Overall Study|Adverse Event|2|||
131509482|NCT04091646|473495094|FG001|Overall Study|Adverse Event|1|||
131509483|NCT04091646|473495093|FG000|Overall Study|Lost to Follow-up|6|||
131509484|NCT04091646|473495094|FG001|Overall Study|Lost to Follow-up|2|||
131509485|NCT04091646|473495093|FG000|Overall Study|Protocol Violation|0|||
131509486|NCT04091646|473495094|FG001|Overall Study|Protocol Violation|1|||
131509487|NCT04091646|473495093|FG000|Overall Study|Withdrawal by Subject|4|||
131509488|NCT04091646|473495094|FG001|Overall Study|Withdrawal by Subject|1|||
131509489|NCT04091646|473495093|FG000|Overall Study|Participant Incarcerated|1|||
131509490|NCT04091646|473495094|FG001|Overall Study|Participant Incarcerated|0|||
131509491|NCT01762943|473495095|FG000|Overall Study|Physician Decision|1|||
131509492|NCT01762943|473495096|FG001|Overall Study|Physician Decision|1|||
131509493|NCT01762943|473495095|FG000|Overall Study|Protocol Violation|1|||
131509494|NCT01762943|473495096|FG001|Overall Study|Protocol Violation|0|||
131509495|NCT01762943|473495095|FG000|Overall Study|Withdrawal by Subject|2|||
131509496|NCT01762943|473495096|FG001|Overall Study|Withdrawal by Subject|1|||
131509497|NCT00539838|473495097|FG000|Overall Study|Fail to return|2|||
131509498|NCT00539838|473495098|FG001|Overall Study|Fail to return|0|||
131509499|NCT00539838|473495099|FG002|Overall Study|Fail to return|0|||
131509500|NCT00539838|473495097|FG000|Overall Study|Withdrawal by Subject|0|||
131509501|NCT00539838|473495098|FG001|Overall Study|Withdrawal by Subject|4|||
131509502|NCT00539838|473495099|FG002|Overall Study|Withdrawal by Subject|0|||
131509503|NCT00539838|473495097|FG000|Overall Study|Death|0|||
131509504|NCT00539838|473495098|FG001|Overall Study|Death|2|||
131509505|NCT00539838|473495099|FG002|Overall Study|Death|0|||
131509506|NCT00539838|473495097|FG000|Overall Study|Did not cooperate|1|||
131509507|NCT00539838|473495098|FG001|Overall Study|Did not cooperate|0|||
131509508|NCT00539838|473495099|FG002|Overall Study|Did not cooperate|1|||
131509509|NCT00539838|473495097|FG000|Overall Study|Administrative|4|||
131509510|NCT00539838|473495098|FG001|Overall Study|Administrative|0|||
131509511|NCT00539838|473495099|FG002|Overall Study|Administrative|8|||
131509512|NCT02474199|473495103|FG000|Overall Study|Lost to Follow-up|1|||
131509513|NCT02474199|473495104|FG001|Overall Study|Lost to Follow-up|0|||
131509514|NCT02474199|473495105|FG002|Overall Study|Lost to Follow-up|0|||
131509515|NCT02474199|473495106|FG003|Overall Study|Lost to Follow-up|0|||
131509516|NCT02474199|473495103|FG000|Overall Study|Withdrawal by Subject|1|||
131509517|NCT02474199|473495104|FG001|Overall Study|Withdrawal by Subject|2|||
131509518|NCT02474199|473495105|FG002|Overall Study|Withdrawal by Subject|0|||
131509519|NCT02474199|473495106|FG003|Overall Study|Withdrawal by Subject|1|||
131509520|NCT02474199|473495103|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
131509521|NCT02474199|473495104|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
131509522|NCT02474199|473495105|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
131509523|NCT02474199|473495106|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
131509524|NCT02474199|473495103|FG000|Overall Study|Did not meet eligibility criteria|0|||
131509525|NCT02474199|473495104|FG001|Overall Study|Did not meet eligibility criteria|0|||
131509526|NCT02474199|473495105|FG002|Overall Study|Did not meet eligibility criteria|2|||
131509527|NCT02474199|473495106|FG003|Overall Study|Did not meet eligibility criteria|2|||
131509528|NCT01660711|473495107|FG000|Overall Study|Adverse Event|7|||
131509529|NCT01660711|473495107|FG000|Overall Study|Withdrawal by Subject|1|||
131509530|NCT03056755|473495109|FG000|Treatment- Core Phase|Progressive disease|89|||
131658098|NCT04445987|474032997|FG003|Overall Study|Physician Decision|0|||
131509531|NCT03056755|473495110|FG001|Treatment- Core Phase|Progressive disease|88|||
131509532|NCT03056755|473495111|FG002|Treatment- Core Phase|Progressive disease|90|||
131509533|NCT03056755|473495109|FG000|Treatment- Core Phase|Adverse Event|20|||
131509534|NCT03056755|473495110|FG001|Treatment- Core Phase|Adverse Event|14|||
131509535|NCT03056755|473495111|FG002|Treatment- Core Phase|Adverse Event|13|||
131509536|NCT03056755|473495109|FG000|Treatment- Core Phase|Physician Decision|7|||
131509537|NCT03056755|473495110|FG001|Treatment- Core Phase|Physician Decision|13|||
131509538|NCT03056755|473495111|FG002|Treatment- Core Phase|Physician Decision|5|||
131509539|NCT03056755|473495109|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
131509540|NCT03056755|473495110|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
131509541|NCT03056755|473495111|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
131509542|NCT03056755|473495109|FG000|Treatment- Core Phase|Death|3|||
131509543|NCT03056755|473495110|FG001|Treatment- Core Phase|Death|2|||
131509544|NCT03056755|473495111|FG002|Treatment- Core Phase|Death|4|||
131509545|NCT03056755|473495109|FG000|Treatment- Core Phase|Protocol deviation|1|||
131509546|NCT03056755|473495110|FG001|Treatment- Core Phase|Protocol deviation|1|||
131509547|NCT03056755|473495111|FG002|Treatment- Core Phase|Protocol deviation|0|||
131509548|NCT03056755|473495109|FG000|Treatment- Core Phase|Technical problems|1|||
131509549|NCT03056755|473495110|FG001|Treatment- Core Phase|Technical problems|0|||
131509550|NCT03056755|473495111|FG002|Treatment- Core Phase|Technical problems|0|||
131509551|NCT03056755|473495109|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
131509552|NCT03056755|473495110|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
131509553|NCT03056755|473495111|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
131509554|NCT03056755|473495109|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
131509555|NCT03056755|473495110|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
131509556|NCT03056755|473495111|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
131509557|NCT03056755|473495109|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
131509558|NCT03056755|473495110|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
131509559|NCT03056755|473495111|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
131509560|NCT03056755|473495109|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
131509561|NCT03056755|473495110|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
131509562|NCT03056755|473495111|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
131509563|NCT00278954|473495112|FG000|Overall Study|Adverse Event|3|||
131509564|NCT00278954|473495112|FG000|Overall Study|Lost to Follow-up|1|||
131509565|NCT00278954|473495112|FG000|Overall Study|Withdrawal by Subject|1|||
131509566|NCT02419742|473495113|FG000|Overall Study|Adverse Event|2|||
131509567|NCT02419742|473495114|FG001|Overall Study|Adverse Event|0|||
131509568|NCT02419742|473495113|FG000|Overall Study|Disease Progression|0|||
131509569|NCT02419742|473495114|FG001|Overall Study|Disease Progression|1|||
131509570|NCT02419742|473495113|FG000|Overall Study|Withdrew Consent|2|||
131509571|NCT02419742|473495114|FG001|Overall Study|Withdrew Consent|1|||
131509572|NCT02419742|473495113|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
131509573|NCT02419742|473495114|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
131509574|NCT05442554|473495132|FG000|Overall Study|Adverse Event|1|||
131509575|NCT01251380|473495134|FG000|Overall Study|Other (Not otherwise specified)|12|||
131509576|NCT01251380|473495134|FG000|Overall Study|Withdrawal by Subject|6|||
131509577|NCT01251380|473495134|FG000|Overall Study|Lack of Efficacy|1|||
131509578|NCT01251380|473495134|FG000|Overall Study|Adverse Event|1|||
131509579|NCT01251380|473495134|FG000|Overall Study|Lost to Follow-up|2|||
131509580|NCT01154218|473495137|FG000|Third Intervention Period|Adverse Event|0|||
131509581|NCT01154218|473495138|FG001|Third Intervention Period|Adverse Event|1|||
131509582|NCT01154218|473495139|FG002|Third Intervention Period|Adverse Event|0|||
131509583|NCT01154218|473495140|FG003|Third Intervention Period|Adverse Event|0|||
131509584|NCT01154218|473495137|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131509585|NCT01154218|473495138|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131509586|NCT01154218|473495139|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
131509587|NCT01154218|473495140|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
131509588|NCT01154218|473495137|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
131509589|NCT01154218|473495138|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
131509590|NCT01154218|473495139|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
131509591|NCT01154218|473495140|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
131509592|NCT00129129|473495141|FG000|Primary Phase|Adverse Event|2|||
131509593|NCT00129129|473495142|FG001|Primary Phase|Adverse Event|1|||
131509594|NCT00129129|473495143|FG002|Primary Phase|Adverse Event|0|||
131509595|NCT00129129|473495144|FG003|Primary Phase|Adverse Event|0|||
131509596|NCT00129129|473495145|FG004|Primary Phase|Adverse Event|0|||
131509597|NCT00129129|473495141|FG000|Primary Phase|Withdrawal by Subject|12|||
131509598|NCT00129129|473495142|FG001|Primary Phase|Withdrawal by Subject|10|||
131509599|NCT00129129|473495143|FG002|Primary Phase|Withdrawal by Subject|0|||
131509600|NCT00129129|473495144|FG003|Primary Phase|Withdrawal by Subject|0|||
131509601|NCT00129129|473495145|FG004|Primary Phase|Withdrawal by Subject|0|||
131658099|NCT04445987|474032998|FG004|Overall Study|Physician Decision|1|||
131509602|NCT00129129|473495141|FG000|Primary Phase|Migration from study area|1|||
131509603|NCT00129129|473495142|FG001|Primary Phase|Migration from study area|3|||
131509604|NCT00129129|473495143|FG002|Primary Phase|Migration from study area|0|||
131509605|NCT00129129|473495144|FG003|Primary Phase|Migration from study area|0|||
131509606|NCT00129129|473495145|FG004|Primary Phase|Migration from study area|0|||
131509607|NCT00129129|473495141|FG000|Primary Phase|Lost to Follow-up|8|||
131509608|NCT00129129|473495142|FG001|Primary Phase|Lost to Follow-up|6|||
131509609|NCT00129129|473495143|FG002|Primary Phase|Lost to Follow-up|0|||
131509610|NCT00129129|473495144|FG003|Primary Phase|Lost to Follow-up|0|||
131509611|NCT00129129|473495145|FG004|Primary Phase|Lost to Follow-up|0|||
131509612|NCT00129129|473495141|FG000|Primary Phase|Other|2|||
131509613|NCT00129129|473495142|FG001|Primary Phase|Other|5|||
131509614|NCT00129129|473495143|FG002|Primary Phase|Other|0|||
131509615|NCT00129129|473495144|FG003|Primary Phase|Other|0|||
131509616|NCT00129129|473495145|FG004|Primary Phase|Other|0|||
131509617|NCT00129129|473495141|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
131509618|NCT00129129|473495142|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
131509619|NCT00129129|473495143|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
131509620|NCT00129129|473495144|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
131509621|NCT00129129|473495145|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
131509622|NCT00129129|473495141|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
131509623|NCT00129129|473495142|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
131509624|NCT00129129|473495143|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
131509625|NCT00129129|473495144|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
131509626|NCT00129129|473495145|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
131509627|NCT00129129|473495141|FG000|Fourth Dose Phase|Migration from study area|0|||
131509628|NCT00129129|473495142|FG001|Fourth Dose Phase|Migration from study area|0|||
131509629|NCT00129129|473495143|FG002|Fourth Dose Phase|Migration from study area|0|||
131509630|NCT00129129|473495144|FG003|Fourth Dose Phase|Migration from study area|0|||
131509631|NCT00129129|473495145|FG004|Fourth Dose Phase|Migration from study area|2|||
131509632|NCT00129129|473495141|FG000|Fourth Dose Phase|Other|0|||
131509633|NCT00129129|473495142|FG001|Fourth Dose Phase|Other|0|||
131509634|NCT00129129|473495143|FG002|Fourth Dose Phase|Other|0|||
131509635|NCT00129129|473495144|FG003|Fourth Dose Phase|Other|1|||
131509636|NCT00129129|473495145|FG004|Fourth Dose Phase|Other|1|||
131509637|NCT00129129|473495141|FG000|Fourth Dose Phase|Protocol Violation|0|||
131509638|NCT00129129|473495142|FG001|Fourth Dose Phase|Protocol Violation|0|||
131509639|NCT00129129|473495143|FG002|Fourth Dose Phase|Protocol Violation|0|||
131509640|NCT00129129|473495144|FG003|Fourth Dose Phase|Protocol Violation|1|||
131509641|NCT00129129|473495145|FG004|Fourth Dose Phase|Protocol Violation|0|||
131509642|NCT02140567|473495148|FG000|Overall Study|Problems with recording equipment|6|||
131509643|NCT02882854|473495149|FG000|Overall Study|Lost to Follow-up|1|||
131509644|NCT02882854|473495150|FG001|Overall Study|Lost to Follow-up|2|||
131509645|NCT02882854|473495149|FG000|Overall Study|Physician Decision|0|||
131509646|NCT02882854|473495150|FG001|Overall Study|Physician Decision|1|||
131509647|NCT03774433|473495152|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
131509648|NCT00108160|473495157|FG000|Overall Study|Lost to Follow-up|25|||
131509649|NCT00108160|473495158|FG001|Overall Study|Lost to Follow-up|12|||
131509650|NCT00108160|473495157|FG000|Overall Study|Death|1|||
131509651|NCT00108160|473495158|FG001|Overall Study|Death|2|||
131509652|NCT00108160|473495157|FG000|Overall Study|Withdrawal by Subject|4|||
131509653|NCT00108160|473495158|FG001|Overall Study|Withdrawal by Subject|2|||
131509654|NCT00108160|473495157|FG000|Overall Study|Protocol Violation|9|||
131509655|NCT00108160|473495158|FG001|Overall Study|Protocol Violation|5|||
131509656|NCT03082599|473495165|FG000|Overall Study|Lost to Follow-up|1|||
131509657|NCT03082599|473495166|FG001|Overall Study|Lost to Follow-up|0|||
131509658|NCT00578942|473495168|FG000|Overall Study|Lost to Follow-up|1|||
131509659|NCT00600938|473495169|FG000|Core Study|Abnormal test procedure result(s)|3|||
131509660|NCT00600938|473495170|FG001|Core Study|Abnormal test procedure result(s)|2|||
131509661|NCT00600938|473495171|FG002|Core Study|Abnormal test procedure result(s)|0|||
131509662|NCT00600938|473495172|FG003|Core Study|Abnormal test procedure result(s)|0|||
131509663|NCT00600938|473495169|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
131509664|NCT00600938|473495170|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
131509665|NCT00600938|473495171|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
131509666|NCT00600938|473495172|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
131509667|NCT00600938|473495169|FG000|Core Study|Patient withdrew consent|7|||
131509668|NCT00600938|473495170|FG001|Core Study|Patient withdrew consent|12|||
131509669|NCT00600938|473495171|FG002|Core Study|Patient withdrew consent|0|||
131509670|NCT00600938|473495172|FG003|Core Study|Patient withdrew consent|0|||
131509671|NCT00600938|473495169|FG000|Core Study|Lost to Follow-up|3|||
131509672|NCT00600938|473495170|FG001|Core Study|Lost to Follow-up|2|||
131509673|NCT00600938|473495171|FG002|Core Study|Lost to Follow-up|0|||
131509674|NCT00600938|473495172|FG003|Core Study|Lost to Follow-up|0|||
131509675|NCT00600938|473495169|FG000|Core Study|Death|1|||
131509676|NCT00600938|473495170|FG001|Core Study|Death|1|||
131509677|NCT00600938|473495171|FG002|Core Study|Death|0|||
131509678|NCT00600938|473495172|FG003|Core Study|Death|0|||
131509679|NCT00600938|473495169|FG000|Core Study|Protocol Violation|1|||
131509680|NCT00600938|473495170|FG001|Core Study|Protocol Violation|2|||
131509681|NCT00600938|473495171|FG002|Core Study|Protocol Violation|0|||
131509682|NCT00600938|473495172|FG003|Core Study|Protocol Violation|0|||
131509683|NCT00600938|473495169|FG000|Extension Study|Adverse Event|1|||
131509684|NCT00600938|473495170|FG001|Extension Study|Adverse Event|0|||
131509685|NCT00600938|473495171|FG002|Extension Study|Adverse Event|2|||
131509686|NCT00600938|473495172|FG003|Extension Study|Adverse Event|0|||
131509687|NCT00600938|473495169|FG000|Extension Study|Abnormal test procedure results|0|||
131509688|NCT00600938|473495170|FG001|Extension Study|Abnormal test procedure results|1|||
131509689|NCT00600938|473495171|FG002|Extension Study|Abnormal test procedure results|1|||
131509690|NCT00600938|473495172|FG003|Extension Study|Abnormal test procedure results|1|||
131509691|NCT00600938|473495169|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
131509692|NCT00600938|473495170|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
131509693|NCT00600938|473495171|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
131509694|NCT00600938|473495172|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
131509695|NCT00600938|473495169|FG000|Extension Study|Withdrawal by Subject|2|||
131509696|NCT00600938|473495170|FG001|Extension Study|Withdrawal by Subject|2|||
131509697|NCT00600938|473495171|FG002|Extension Study|Withdrawal by Subject|3|||
131509698|NCT00600938|473495172|FG003|Extension Study|Withdrawal by Subject|0|||
131509699|NCT00600938|473495169|FG000|Extension Study|Lost to Follow-up|1|||
131509700|NCT00600938|473495170|FG001|Extension Study|Lost to Follow-up|1|||
131509701|NCT00600938|473495171|FG002|Extension Study|Lost to Follow-up|2|||
131509702|NCT00600938|473495172|FG003|Extension Study|Lost to Follow-up|0|||
131509703|NCT00600938|473495169|FG000|Extension Study|Death|1|||
131509704|NCT00600938|473495170|FG001|Extension Study|Death|0|||
131509705|NCT00600938|473495171|FG002|Extension Study|Death|0|||
131509706|NCT00600938|473495172|FG003|Extension Study|Death|0|||
131509707|NCT04056195|473495173|FG000|Overall Study|Adverse Event|1|||
131509708|NCT04056195|473495174|FG001|Overall Study|Adverse Event|0|||
131509709|NCT04056195|473495175|FG002|Overall Study|Adverse Event|0|||
131509710|NCT04056195|473495173|FG000|Overall Study|Withdrawal by Subject|0|||
131509711|NCT04056195|473495174|FG001|Overall Study|Withdrawal by Subject|1|||
131509712|NCT04056195|473495175|FG002|Overall Study|Withdrawal by Subject|1|||
131509713|NCT04056195|473495173|FG000|Overall Study|Physician Decision|1|||
131509714|NCT04056195|473495174|FG001|Overall Study|Physician Decision|1|||
131509715|NCT04056195|473495175|FG002|Overall Study|Physician Decision|1|||
131509716|NCT00549562|473495176|FG000|Overall Study|Adverse Event|1|||
131509717|NCT00549562|473495176|FG000|Overall Study|Lack of Efficacy|1|||
131509718|NCT00323115|473495177|FG000|Vaccine Administration|Adverse Event|1|||
131509719|NCT00323115|473495177|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
131509720|NCT00004888|473497192|FG000|Overall Study|Adverse Event|5|||
131509721|NCT00004888|473497193|FG001|Overall Study|Adverse Event|10|||
131509722|NCT00004888|473497192|FG000|Overall Study|Withdrawal by Subject|0|||
131509723|NCT00004888|473497193|FG001|Overall Study|Withdrawal by Subject|3|||
131509724|NCT00004888|473497192|FG000|Overall Study|Physician Decision|1|||
131509725|NCT00004888|473497193|FG001|Overall Study|Physician Decision|1|||
131509726|NCT00004888|473497192|FG000|Overall Study|Progressive Disease|4|||
131509727|NCT00004888|473497193|FG001|Overall Study|Progressive Disease|9|||
131509728|NCT00004888|473497192|FG000|Overall Study|Death without progressive disease|0|||
131509729|NCT00004888|473497193|FG001|Overall Study|Death without progressive disease|1|||
131509730|NCT00004888|473497192|FG000|Overall Study|Toxic death|1|||
131509731|NCT00004888|473497193|FG001|Overall Study|Toxic death|0|||
131509732|NCT02579265|473497194|FG000|Overall Study|Weaned off earlier than 28 days|44|||
131509733|NCT02579265|473497195|FG001|Overall Study|Weaned off earlier than 28 days|43|||
131509734|NCT02579265|473497194|FG000|Overall Study|Adverse Event|2|||
131509735|NCT02579265|473497195|FG001|Overall Study|Adverse Event|0|||
131509736|NCT02579265|473497194|FG000|Overall Study|Any other reason not specified|0|||
131509737|NCT02579265|473497195|FG001|Overall Study|Any other reason not specified|2|||
131509738|NCT02579265|473497194|FG000|Overall Study|Withdrawal by Subject|2|||
131509739|NCT02579265|473497195|FG001|Overall Study|Withdrawal by Subject|0|||
131509740|NCT02579265|473497194|FG000|Overall Study|Physician Decision|1|||
131509741|NCT02579265|473497195|FG001|Overall Study|Physician Decision|0|||
131509742|NCT02579265|473497194|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
131509743|NCT02579265|473497195|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
131509744|NCT02174848|473497196|FG000|Overall Study|Adverse Event|2|||
131509745|NCT02174848|473497197|FG001|Overall Study|Adverse Event|1|||
131509746|NCT02174848|473497196|FG000|Overall Study|Withdrawal by Subject|3|||
131509747|NCT02174848|473497197|FG001|Overall Study|Withdrawal by Subject|3|||
131509748|NCT02174848|473497196|FG000|Overall Study|Lost to Follow-up|0|||
131509749|NCT02174848|473497197|FG001|Overall Study|Lost to Follow-up|1|||
131509750|NCT02174848|473497196|FG000|Overall Study|Worsening of disease|1|||
131509751|NCT02174848|473497197|FG001|Overall Study|Worsening of disease|1|||
131509752|NCT02174848|473497196|FG000|Overall Study|Unable to comply with study requirements|1|||
131509753|NCT02174848|473497197|FG001|Overall Study|Unable to comply with study requirements|0|||
131509754|NCT00666757|473497200|FG000|Overall Study|Lost to Follow-up|39|||
131509755|NCT00666757|473497201|FG001|Overall Study|Lost to Follow-up|35|||
131509756|NCT00666757|473497200|FG000|Overall Study|Protocol Violation|23|||
131509757|NCT00666757|473497201|FG001|Overall Study|Protocol Violation|24|||
131509758|NCT00666757|473497200|FG000|Overall Study|Adverse Event|22|||
131509759|NCT00666757|473497201|FG001|Overall Study|Adverse Event|12|||
131509760|NCT00666757|473497200|FG000|Overall Study|Withdrawal by Subject|13|||
131509761|NCT00666757|473497201|FG001|Overall Study|Withdrawal by Subject|17|||
131509762|NCT00666757|473497200|FG000|Overall Study|Lack of Efficacy|3|||
131509763|NCT00666757|473497201|FG001|Overall Study|Lack of Efficacy|6|||
131509764|NCT00666757|473497200|FG000|Overall Study|Physician Decision|0|||
131509765|NCT00666757|473497201|FG001|Overall Study|Physician Decision|2|||
131509766|NCT00666757|473497200|FG000|Overall Study|Sponsor decision|0|||
131509767|NCT00666757|473497201|FG001|Overall Study|Sponsor decision|1|||
131509768|NCT02658890|473497206|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509769|NCT02658890|473497207|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509770|NCT02658890|473497208|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509771|NCT02658890|473497209|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509772|NCT02658890|473497210|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509773|NCT02658890|473497211|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509774|NCT02658890|473497212|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509775|NCT02658890|473497213|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509776|NCT02658890|473497214|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
131509777|NCT02658890|473497215|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509778|NCT02658890|473497216|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509779|NCT02658890|473497217|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509780|NCT02658890|473497218|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509781|NCT02658890|473497219|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509782|NCT02658890|473497220|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509783|NCT02658890|473497221|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509784|NCT02658890|473497222|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509785|NCT02658890|473497223|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509786|NCT02658890|473497224|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509787|NCT02658890|473497225|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509788|NCT02658890|473497226|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509789|NCT02658890|473497227|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509790|NCT02658890|473497228|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509791|NCT02658890|473497229|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131658100|NCT04445987|474032999|FG005|Overall Study|Physician Decision|0|||
131509792|NCT02658890|473497230|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509793|NCT02658890|473497231|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509794|NCT02658890|473497232|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131509795|NCT02658890|473497206|FG000|Treatment Phase|Adverse Event|0|||
131509796|NCT02658890|473497207|FG001|Treatment Phase|Adverse Event|1|||
131509797|NCT02658890|473497208|FG002|Treatment Phase|Adverse Event|2|||
131509798|NCT02658890|473497209|FG003|Treatment Phase|Adverse Event|2|||
131509799|NCT02658890|473497210|FG004|Treatment Phase|Adverse Event|1|||
131509800|NCT02658890|473497211|FG005|Treatment Phase|Adverse Event|0|||
131509801|NCT02658890|473497212|FG006|Treatment Phase|Adverse Event|0|||
131509802|NCT02658890|473497213|FG007|Treatment Phase|Adverse Event|2|||
131509803|NCT02658890|473497214|FG008|Treatment Phase|Adverse Event|1|||
131509804|NCT02658890|473497215|FG009|Treatment Phase|Adverse Event|2|||
131509805|NCT02658890|473497216|FG010|Treatment Phase|Adverse Event|3|||
131509806|NCT02658890|473497217|FG011|Treatment Phase|Adverse Event|0|||
131509807|NCT02658890|473497218|FG012|Treatment Phase|Adverse Event|1|||
131509808|NCT02658890|473497219|FG013|Treatment Phase|Adverse Event|4|||
131509809|NCT02658890|473497220|FG014|Treatment Phase|Adverse Event|0|||
131509810|NCT02658890|473497221|FG015|Treatment Phase|Adverse Event|0|||
131509811|NCT02658890|473497222|FG016|Treatment Phase|Adverse Event|0|||
131509812|NCT02658890|473497223|FG017|Treatment Phase|Adverse Event|0|||
131509813|NCT02658890|473497224|FG018|Treatment Phase|Adverse Event|5|||
131509814|NCT02658890|473497225|FG019|Treatment Phase|Adverse Event|1|||
131509815|NCT02658890|473497226|FG020|Treatment Phase|Adverse Event|3|||
131509816|NCT02658890|473497227|FG021|Treatment Phase|Adverse Event|0|||
131509817|NCT02658890|473497228|FG022|Treatment Phase|Adverse Event|5|||
131509818|NCT02658890|473497229|FG023|Treatment Phase|Adverse Event|0|||
131509819|NCT02658890|473497230|FG024|Treatment Phase|Adverse Event|0|||
131509820|NCT02658890|473497231|FG025|Treatment Phase|Adverse Event|2|||
131509821|NCT02658890|473497232|FG026|Treatment Phase|Adverse Event|1|||
131509822|NCT02658890|473497206|FG000|Treatment Phase|Death|0|||
131509823|NCT02658890|473497207|FG001|Treatment Phase|Death|0|||
131509824|NCT02658890|473497208|FG002|Treatment Phase|Death|0|||
131509825|NCT02658890|473497209|FG003|Treatment Phase|Death|0|||
131509826|NCT02658890|473497210|FG004|Treatment Phase|Death|0|||
131509827|NCT02658890|473497211|FG005|Treatment Phase|Death|0|||
131509828|NCT02658890|473497212|FG006|Treatment Phase|Death|0|||
131509829|NCT02658890|473497213|FG007|Treatment Phase|Death|0|||
131509830|NCT02658890|473497214|FG008|Treatment Phase|Death|0|||
131509831|NCT02658890|473497215|FG009|Treatment Phase|Death|0|||
131509832|NCT02658890|473497216|FG010|Treatment Phase|Death|0|||
131509833|NCT02658890|473497217|FG011|Treatment Phase|Death|0|||
131509834|NCT02658890|473497218|FG012|Treatment Phase|Death|0|||
131509835|NCT02658890|473497219|FG013|Treatment Phase|Death|0|||
131509836|NCT02658890|473497220|FG014|Treatment Phase|Death|0|||
131509837|NCT02658890|473497221|FG015|Treatment Phase|Death|0|||
131509838|NCT02658890|473497222|FG016|Treatment Phase|Death|0|||
131509839|NCT02658890|473497223|FG017|Treatment Phase|Death|0|||
131509840|NCT02658890|473497224|FG018|Treatment Phase|Death|1|||
131509841|NCT02658890|473497225|FG019|Treatment Phase|Death|0|||
131509842|NCT02658890|473497226|FG020|Treatment Phase|Death|0|||
131509843|NCT02658890|473497227|FG021|Treatment Phase|Death|0|||
131509844|NCT02658890|473497228|FG022|Treatment Phase|Death|0|||
131509845|NCT02658890|473497229|FG023|Treatment Phase|Death|0|||
131509846|NCT02658890|473497230|FG024|Treatment Phase|Death|0|||
131509847|NCT02658890|473497231|FG025|Treatment Phase|Death|0|||
131509848|NCT02658890|473497232|FG026|Treatment Phase|Death|0|||
131509849|NCT02658890|473497206|FG000|Treatment Phase|Lost to Follow-up|0|||
131509850|NCT02658890|473497207|FG001|Treatment Phase|Lost to Follow-up|0|||
131509851|NCT02658890|473497208|FG002|Treatment Phase|Lost to Follow-up|0|||
131509852|NCT02658890|473497209|FG003|Treatment Phase|Lost to Follow-up|0|||
131509853|NCT02658890|473497210|FG004|Treatment Phase|Lost to Follow-up|0|||
131509854|NCT02658890|473497211|FG005|Treatment Phase|Lost to Follow-up|0|||
131509855|NCT02658890|473497212|FG006|Treatment Phase|Lost to Follow-up|1|||
131509856|NCT02658890|473497213|FG007|Treatment Phase|Lost to Follow-up|0|||
131509857|NCT02658890|473497214|FG008|Treatment Phase|Lost to Follow-up|0|||
131509858|NCT02658890|473497215|FG009|Treatment Phase|Lost to Follow-up|0|||
131509859|NCT02658890|473497216|FG010|Treatment Phase|Lost to Follow-up|0|||
131509860|NCT02658890|473497217|FG011|Treatment Phase|Lost to Follow-up|0|||
131509861|NCT02658890|473497218|FG012|Treatment Phase|Lost to Follow-up|0|||
131509862|NCT02658890|473497219|FG013|Treatment Phase|Lost to Follow-up|0|||
131509863|NCT02658890|473497220|FG014|Treatment Phase|Lost to Follow-up|0|||
131509864|NCT02658890|473497221|FG015|Treatment Phase|Lost to Follow-up|0|||
131509865|NCT02658890|473497222|FG016|Treatment Phase|Lost to Follow-up|0|||
131509866|NCT02658890|473497223|FG017|Treatment Phase|Lost to Follow-up|0|||
131509867|NCT02658890|473497224|FG018|Treatment Phase|Lost to Follow-up|0|||
131509868|NCT02658890|473497225|FG019|Treatment Phase|Lost to Follow-up|0|||
131509869|NCT02658890|473497226|FG020|Treatment Phase|Lost to Follow-up|0|||
131509870|NCT02658890|473497227|FG021|Treatment Phase|Lost to Follow-up|0|||
131509871|NCT02658890|473497228|FG022|Treatment Phase|Lost to Follow-up|0|||
131509872|NCT02658890|473497229|FG023|Treatment Phase|Lost to Follow-up|0|||
131509873|NCT02658890|473497230|FG024|Treatment Phase|Lost to Follow-up|0|||
131509874|NCT02658890|473497231|FG025|Treatment Phase|Lost to Follow-up|0|||
131509875|NCT02658890|473497232|FG026|Treatment Phase|Lost to Follow-up|0|||
131509876|NCT02658890|473497206|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
131509877|NCT02658890|473497207|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
131509878|NCT02658890|473497208|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
131509879|NCT02658890|473497209|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
131509880|NCT02658890|473497210|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
131509881|NCT02658890|473497211|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
131509882|NCT02658890|473497212|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
131509883|NCT02658890|473497213|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
131509884|NCT02658890|473497214|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
131509885|NCT02658890|473497215|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
131509886|NCT02658890|473497216|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
131509887|NCT02658890|473497217|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
131509888|NCT02658890|473497218|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
131509889|NCT02658890|473497219|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
131509890|NCT02658890|473497220|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
131509891|NCT02658890|473497221|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
131509892|NCT02658890|473497222|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
131509893|NCT02658890|473497223|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
131509894|NCT02658890|473497224|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
131509895|NCT02658890|473497225|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
131509896|NCT02658890|473497226|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
131509897|NCT02658890|473497227|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
131509898|NCT02658890|473497228|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
131509899|NCT02658890|473497229|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
131509900|NCT02658890|473497230|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
131509901|NCT02658890|473497231|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
131509902|NCT02658890|473497232|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
131509903|NCT02658890|473497206|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
131509904|NCT02658890|473497207|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
131509905|NCT02658890|473497208|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
131509906|NCT02658890|473497209|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
131509907|NCT02658890|473497210|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
131509908|NCT02658890|473497211|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
131509909|NCT02658890|473497212|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
131509910|NCT02658890|473497213|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
131509911|NCT02658890|473497214|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
131509912|NCT02658890|473497215|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
131509913|NCT02658890|473497216|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
131509914|NCT02658890|473497217|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
131509915|NCT02658890|473497218|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
131509916|NCT02658890|473497219|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
131509917|NCT02658890|473497220|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
131509918|NCT02658890|473497221|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
131509919|NCT02658890|473497222|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
131509920|NCT02658890|473497223|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
131509921|NCT02658890|473497224|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
131509922|NCT02658890|473497225|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
131509923|NCT02658890|473497226|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
131509924|NCT02658890|473497227|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
131509925|NCT02658890|473497228|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
131509926|NCT02658890|473497229|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
131509927|NCT02658890|473497230|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
131509928|NCT02658890|473497231|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
131509929|NCT02658890|473497232|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
131509930|NCT02658890|473497206|FG000|Treatment Phase|Other Reasons|0|||
131509931|NCT02658890|473497207|FG001|Treatment Phase|Other Reasons|0|||
131509932|NCT02658890|473497208|FG002|Treatment Phase|Other Reasons|0|||
131509933|NCT02658890|473497209|FG003|Treatment Phase|Other Reasons|0|||
131509934|NCT02658890|473497210|FG004|Treatment Phase|Other Reasons|0|||
131509935|NCT02658890|473497211|FG005|Treatment Phase|Other Reasons|0|||
131509936|NCT02658890|473497212|FG006|Treatment Phase|Other Reasons|1|||
131509937|NCT02658890|473497213|FG007|Treatment Phase|Other Reasons|0|||
131509938|NCT02658890|473497214|FG008|Treatment Phase|Other Reasons|1|||
131509939|NCT02658890|473497215|FG009|Treatment Phase|Other Reasons|0|||
131509940|NCT02658890|473497216|FG010|Treatment Phase|Other Reasons|0|||
131509941|NCT02658890|473497217|FG011|Treatment Phase|Other Reasons|0|||
131509942|NCT02658890|473497218|FG012|Treatment Phase|Other Reasons|0|||
131509943|NCT02658890|473497219|FG013|Treatment Phase|Other Reasons|2|||
131509944|NCT02658890|473497220|FG014|Treatment Phase|Other Reasons|0|||
131509945|NCT02658890|473497221|FG015|Treatment Phase|Other Reasons|0|||
131509946|NCT02658890|473497222|FG016|Treatment Phase|Other Reasons|0|||
131509947|NCT02658890|473497223|FG017|Treatment Phase|Other Reasons|0|||
131509948|NCT02658890|473497224|FG018|Treatment Phase|Other Reasons|1|||
131509949|NCT02658890|473497225|FG019|Treatment Phase|Other Reasons|0|||
131509950|NCT02658890|473497226|FG020|Treatment Phase|Other Reasons|0|||
131509951|NCT02658890|473497227|FG021|Treatment Phase|Other Reasons|0|||
131509952|NCT02658890|473497228|FG022|Treatment Phase|Other Reasons|0|||
131509953|NCT02658890|473497229|FG023|Treatment Phase|Other Reasons|0|||
131509954|NCT02658890|473497230|FG024|Treatment Phase|Other Reasons|1|||
131509955|NCT02658890|473497231|FG025|Treatment Phase|Other Reasons|0|||
131509956|NCT02658890|473497232|FG026|Treatment Phase|Other Reasons|1|||
131509957|NCT02658890|473497206|FG000|Treatment Phase|Progressive Disease|6|||
131509958|NCT02658890|473497207|FG001|Treatment Phase|Progressive Disease|7|||
131509959|NCT02658890|473497208|FG002|Treatment Phase|Progressive Disease|6|||
131509960|NCT02658890|473497209|FG003|Treatment Phase|Progressive Disease|12|||
131509961|NCT02658890|473497210|FG004|Treatment Phase|Progressive Disease|6|||
131509962|NCT02658890|473497211|FG005|Treatment Phase|Progressive Disease|18|||
131509963|NCT02658890|473497212|FG006|Treatment Phase|Progressive Disease|12|||
131509964|NCT02658890|473497213|FG007|Treatment Phase|Progressive Disease|19|||
131509965|NCT02658890|473497214|FG008|Treatment Phase|Progressive Disease|26|||
131509966|NCT02658890|473497215|FG009|Treatment Phase|Progressive Disease|8|||
131509967|NCT02658890|473497216|FG010|Treatment Phase|Progressive Disease|7|||
131509968|NCT02658890|473497217|FG011|Treatment Phase|Progressive Disease|9|||
131509969|NCT02658890|473497218|FG012|Treatment Phase|Progressive Disease|8|||
131509970|NCT02658890|473497219|FG013|Treatment Phase|Progressive Disease|29|||
131509971|NCT02658890|473497220|FG014|Treatment Phase|Progressive Disease|6|||
131509972|NCT02658890|473497221|FG015|Treatment Phase|Progressive Disease|2|||
131509973|NCT02658890|473497222|FG016|Treatment Phase|Progressive Disease|32|||
131509974|NCT02658890|473497223|FG017|Treatment Phase|Progressive Disease|14|||
131509975|NCT02658890|473497224|FG018|Treatment Phase|Progressive Disease|40|||
131509976|NCT02658890|473497225|FG019|Treatment Phase|Progressive Disease|32|||
131509977|NCT02658890|473497226|FG020|Treatment Phase|Progressive Disease|19|||
131509978|NCT02658890|473497227|FG021|Treatment Phase|Progressive Disease|30|||
131509979|NCT02658890|473497228|FG022|Treatment Phase|Progressive Disease|15|||
131509980|NCT02658890|473497229|FG023|Treatment Phase|Progressive Disease|0|||
131509981|NCT02658890|473497230|FG024|Treatment Phase|Progressive Disease|0|||
131509982|NCT02658890|473497231|FG025|Treatment Phase|Progressive Disease|14|||
131509983|NCT02658890|473497232|FG026|Treatment Phase|Progressive Disease|11|||
131509984|NCT02658890|473497206|FG000|Treatment Phase|Study Drug Toxicity|0|||
131509985|NCT02658890|473497207|FG001|Treatment Phase|Study Drug Toxicity|0|||
131509986|NCT02658890|473497208|FG002|Treatment Phase|Study Drug Toxicity|2|||
131509987|NCT02658890|473497209|FG003|Treatment Phase|Study Drug Toxicity|0|||
131509988|NCT02658890|473497210|FG004|Treatment Phase|Study Drug Toxicity|0|||
131509989|NCT02658890|473497211|FG005|Treatment Phase|Study Drug Toxicity|0|||
131509990|NCT02658890|473497212|FG006|Treatment Phase|Study Drug Toxicity|0|||
131509991|NCT02658890|473497213|FG007|Treatment Phase|Study Drug Toxicity|0|||
131509992|NCT02658890|473497214|FG008|Treatment Phase|Study Drug Toxicity|3|||
131509993|NCT02658890|473497215|FG009|Treatment Phase|Study Drug Toxicity|0|||
131509994|NCT02658890|473497216|FG010|Treatment Phase|Study Drug Toxicity|1|||
131509995|NCT02658890|473497217|FG011|Treatment Phase|Study Drug Toxicity|1|||
131509996|NCT02658890|473497218|FG012|Treatment Phase|Study Drug Toxicity|2|||
131509997|NCT02658890|473497219|FG013|Treatment Phase|Study Drug Toxicity|9|||
131509998|NCT02658890|473497220|FG014|Treatment Phase|Study Drug Toxicity|0|||
131509999|NCT02658890|473497221|FG015|Treatment Phase|Study Drug Toxicity|1|||
131510000|NCT02658890|473497222|FG016|Treatment Phase|Study Drug Toxicity|1|||
131510001|NCT02658890|473497223|FG017|Treatment Phase|Study Drug Toxicity|0|||
131510002|NCT02658890|473497224|FG018|Treatment Phase|Study Drug Toxicity|8|||
131510003|NCT02658890|473497225|FG019|Treatment Phase|Study Drug Toxicity|3|||
131510004|NCT02658890|473497226|FG020|Treatment Phase|Study Drug Toxicity|2|||
131510005|NCT02658890|473497227|FG021|Treatment Phase|Study Drug Toxicity|0|||
131510006|NCT02658890|473497228|FG022|Treatment Phase|Study Drug Toxicity|8|||
131510007|NCT02658890|473497229|FG023|Treatment Phase|Study Drug Toxicity|0|||
131510008|NCT02658890|473497230|FG024|Treatment Phase|Study Drug Toxicity|0|||
131510009|NCT02658890|473497231|FG025|Treatment Phase|Study Drug Toxicity|2|||
131510010|NCT02658890|473497232|FG026|Treatment Phase|Study Drug Toxicity|0|||
131510011|NCT02658890|473497206|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510012|NCT02658890|473497207|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510013|NCT02658890|473497208|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510014|NCT02658890|473497209|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
131510015|NCT02658890|473497210|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510016|NCT02658890|473497211|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510017|NCT02658890|473497212|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510018|NCT02658890|473497213|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510019|NCT02658890|473497214|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510020|NCT02658890|473497215|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
131658101|NCT04445987|474032994|FG000|Overall Study|Protocol Violation|1|||
131510021|NCT02658890|473497216|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510022|NCT02658890|473497217|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510023|NCT02658890|473497218|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510024|NCT02658890|473497219|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510025|NCT02658890|473497220|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510026|NCT02658890|473497221|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510027|NCT02658890|473497222|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510028|NCT02658890|473497223|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510029|NCT02658890|473497224|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
131510030|NCT02658890|473497225|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510031|NCT02658890|473497226|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510032|NCT02658890|473497227|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510033|NCT02658890|473497228|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
131510034|NCT02658890|473497229|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510035|NCT02658890|473497230|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510036|NCT02658890|473497231|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510037|NCT02658890|473497232|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131510038|NCT02658890|473497206|FG000|Treatment Phase|Withdrawal by Subject|0|||
131510039|NCT02658890|473497207|FG001|Treatment Phase|Withdrawal by Subject|1|||
131510040|NCT02658890|473497208|FG002|Treatment Phase|Withdrawal by Subject|0|||
131510041|NCT02658890|473497209|FG003|Treatment Phase|Withdrawal by Subject|0|||
131510042|NCT02658890|473497210|FG004|Treatment Phase|Withdrawal by Subject|0|||
131510043|NCT02658890|473497211|FG005|Treatment Phase|Withdrawal by Subject|0|||
131510044|NCT02658890|473497212|FG006|Treatment Phase|Withdrawal by Subject|1|||
131510045|NCT02658890|473497213|FG007|Treatment Phase|Withdrawal by Subject|0|||
131510046|NCT02658890|473497214|FG008|Treatment Phase|Withdrawal by Subject|0|||
131510047|NCT02658890|473497215|FG009|Treatment Phase|Withdrawal by Subject|1|||
131510048|NCT02658890|473497216|FG010|Treatment Phase|Withdrawal by Subject|0|||
131510049|NCT02658890|473497217|FG011|Treatment Phase|Withdrawal by Subject|0|||
131510050|NCT02658890|473497218|FG012|Treatment Phase|Withdrawal by Subject|1|||
131510051|NCT02658890|473497219|FG013|Treatment Phase|Withdrawal by Subject|3|||
131510052|NCT02658890|473497220|FG014|Treatment Phase|Withdrawal by Subject|0|||
131510053|NCT02658890|473497221|FG015|Treatment Phase|Withdrawal by Subject|0|||
131510054|NCT02658890|473497222|FG016|Treatment Phase|Withdrawal by Subject|1|||
131510055|NCT02658890|473497223|FG017|Treatment Phase|Withdrawal by Subject|0|||
131510056|NCT02658890|473497224|FG018|Treatment Phase|Withdrawal by Subject|4|||
131510057|NCT02658890|473497225|FG019|Treatment Phase|Withdrawal by Subject|3|||
131510058|NCT02658890|473497226|FG020|Treatment Phase|Withdrawal by Subject|0|||
131510059|NCT02658890|473497227|FG021|Treatment Phase|Withdrawal by Subject|4|||
131510060|NCT02658890|473497228|FG022|Treatment Phase|Withdrawal by Subject|1|||
131510061|NCT02658890|473497229|FG023|Treatment Phase|Withdrawal by Subject|1|||
131510062|NCT02658890|473497230|FG024|Treatment Phase|Withdrawal by Subject|0|||
131510063|NCT02658890|473497231|FG025|Treatment Phase|Withdrawal by Subject|0|||
131510064|NCT02658890|473497232|FG026|Treatment Phase|Withdrawal by Subject|0|||
131510065|NCT03090100|473497233|FG000|Overall Study|Adverse Event|9|||
131510066|NCT03090100|473497234|FG001|Overall Study|Adverse Event|11|||
131510067|NCT03090100|473497233|FG000|Overall Study|Pregnancy|1|||
131510068|NCT03090100|473497234|FG001|Overall Study|Pregnancy|1|||
131510069|NCT03090100|473497233|FG000|Overall Study|Lack of Efficacy|2|||
131510070|NCT03090100|473497234|FG001|Overall Study|Lack of Efficacy|7|||
131510071|NCT03090100|473497233|FG000|Overall Study|Lost to Follow-up|2|||
131510072|NCT03090100|473497234|FG001|Overall Study|Lost to Follow-up|2|||
131510073|NCT03090100|473497233|FG000|Overall Study|Withdrawal by Subject|7|||
131510074|NCT03090100|473497234|FG001|Overall Study|Withdrawal by Subject|19|||
131510075|NCT03090100|473497233|FG000|Overall Study|Protocol Violation|2|||
131510076|NCT03090100|473497234|FG001|Overall Study|Protocol Violation|6|||
131510077|NCT03090100|473497233|FG000|Overall Study|Non-compliance|2|||
131510078|NCT03090100|473497234|FG001|Overall Study|Non-compliance|0|||
131510079|NCT03090100|473497233|FG000|Overall Study|Other|2|||
131510080|NCT03090100|473497234|FG001|Overall Study|Other|2|||
131510081|NCT00159588|473497235|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
131510082|NCT00159588|473497236|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
131510083|NCT00159588|473497237|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
131510084|NCT00952341|473497238|FG000|Cycle 1|Adverse Event|4|||
131510085|NCT00952341|473497239|FG001|Cycle 1|Adverse Event|1|||
131510086|NCT00952341|473497238|FG000|Cycle 1|Withdrawal by Subject|3|||
131510087|NCT00952341|473497239|FG001|Cycle 1|Withdrawal by Subject|8|||
131510088|NCT00952341|473497238|FG000|Cycle 1|Protocol Violation|2|||
131510089|NCT00952341|473497239|FG001|Cycle 1|Protocol Violation|1|||
131510090|NCT00952341|473497238|FG000|Cycle 1|Lost to Follow-up|11|||
131510091|NCT00952341|473497239|FG001|Cycle 1|Lost to Follow-up|2|||
131510092|NCT00952341|473497238|FG000|Cycle 1|Physician Decision|0|||
131510093|NCT00952341|473497239|FG001|Cycle 1|Physician Decision|1|||
131510094|NCT00952341|473497238|FG000|Cycle 2|Withdrawal by Subject|1|||
131510095|NCT00952341|473497239|FG001|Cycle 2|Withdrawal by Subject|1|||
131510096|NCT00952341|473497238|FG000|Cycle 2|Protocol Violation|1|||
131510097|NCT00952341|473497239|FG001|Cycle 2|Protocol Violation|0|||
131510098|NCT00952341|473497238|FG000|Cycle 2|Lost to Follow-up|6|||
131510099|NCT00952341|473497239|FG001|Cycle 2|Lost to Follow-up|9|||
131510100|NCT00952341|473497238|FG000|Cycle 2|Physician Decision|1|||
131510101|NCT00952341|473497239|FG001|Cycle 2|Physician Decision|1|||
131510102|NCT00952341|473497238|FG000|Cycle 2|Progressive Disease|0|||
131510103|NCT00952341|473497239|FG001|Cycle 2|Progressive Disease|1|||
131510104|NCT04920123|473497240|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
131510105|NCT04920123|473497241|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131510106|NCT04920123|473497242|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
131510107|NCT03253848|473497245|FG000|Overall Study|Adverse Event|7|||
131510108|NCT03253848|473497245|FG000|Overall Study|Death|5|||
131510109|NCT03253848|473497245|FG000|Overall Study|initiation of other treatments|3|||
131510110|NCT03253848|473497245|FG000|Overall Study|Other complicating disease|1|||
131510111|NCT03253848|473497245|FG000|Overall Study|Withdrawal by Subject|1|||
131510112|NCT03253848|473497245|FG000|Overall Study|Declining health|1|||
131510113|NCT05352815|473497246|FG000|Overall Study|Withdrawal by Subject|28|||
131510114|NCT05352815|473497247|FG001|Overall Study|Withdrawal by Subject|24|||
131510115|NCT05352815|473497246|FG000|Overall Study|Lost to Follow-up|4|||
131510116|NCT05352815|473497247|FG001|Overall Study|Lost to Follow-up|7|||
131510117|NCT05352815|473497246|FG000|Overall Study|Death|2|||
131510118|NCT05352815|473497247|FG001|Overall Study|Death|3|||
131510119|NCT05352815|473497246|FG000|Overall Study|Site closure|1|||
131510120|NCT05352815|473497247|FG001|Overall Study|Site closure|0|||
131510121|NCT02759120|473497248|FG000|Overall Study|Death|34|||
131510122|NCT02759120|473497249|FG001|Overall Study|Death|36|||
131510123|NCT02759120|473497248|FG000|Overall Study|Lost to Follow-up|4|||
131510124|NCT02759120|473497249|FG001|Overall Study|Lost to Follow-up|7|||
131510125|NCT02759120|473497248|FG000|Overall Study|Physician Decision|3|||
131510126|NCT02759120|473497249|FG001|Overall Study|Physician Decision|0|||
131510127|NCT02759120|473497248|FG000|Overall Study|Withdrawal by Subject|28|||
131510128|NCT02759120|473497249|FG001|Overall Study|Withdrawal by Subject|15|||
131510129|NCT02759120|473497248|FG000|Overall Study|Moved out of area|3|||
131510130|NCT02759120|473497249|FG001|Overall Study|Moved out of area|4|||
131510131|NCT02759120|473497248|FG000|Overall Study|Lung transplant|3|||
131510132|NCT02759120|473497249|FG001|Overall Study|Lung transplant|5|||
131510133|NCT02759120|473497248|FG000|Overall Study|Other reason not completed|10|||
131510134|NCT02759120|473497249|FG001|Overall Study|Other reason not completed|12|||
131510135|NCT03406858|473497251|FG000|Overall Study|Failure to receive treatment drug.|1|||
131510136|NCT03406858|473497251|FG000|Overall Study|ineligible|1|||
131510137|NCT05071183|473497253|FG000|Overall Study|Death|1|||
131510138|NCT05071183|473497254|FG001|Overall Study|Death|2|||
131510139|NCT05071183|473497255|FG002|Overall Study|Death|0|||
131510140|NCT05071183|473497253|FG000|Overall Study|Other Reasons|1|||
131510141|NCT05071183|473497254|FG001|Overall Study|Other Reasons|3|||
131510142|NCT05071183|473497255|FG002|Overall Study|Other Reasons|2|||
131510143|NCT02532647|473497260|FG000|Overall Study|Did not receive trial medication|1|||
131510144|NCT02532647|473497261|FG001|Overall Study|Did not receive trial medication|0|||
131510145|NCT02532647|473497262|FG002|Overall Study|Did not receive trial medication|1|||
131510146|NCT02211131|473497266|FG000|Overall Study|Death|26|||
131510147|NCT02211131|473497267|FG001|Overall Study|Death|16|||
131510148|NCT02211131|473497266|FG000|Overall Study|Lost to Follow-up|4|||
131510149|NCT02211131|473497267|FG001|Overall Study|Lost to Follow-up|3|||
131510150|NCT02211131|473497266|FG000|Overall Study|Decision by Sponsor|1|||
131510151|NCT02211131|473497267|FG001|Overall Study|Decision by Sponsor|1|||
131510152|NCT02211131|473497266|FG000|Overall Study|Withdrawal by Subject|3|||
131510153|NCT02211131|473497267|FG001|Overall Study|Withdrawal by Subject|8|||
131510154|NCT02939560|473497271|FG000|Overall Study|Withdrawal by Subject|2|||
131510155|NCT02939560|473497271|FG000|Overall Study|Protocol Violation|1|||
131510156|NCT03340025|473497274|FG000|Overall Study|Lost to Follow-up|2|||
131510157|NCT03340025|473497275|FG001|Overall Study|Lost to Follow-up|2|||
131510158|NCT02420691|473497278|FG000|Overall Study|Adverse Event|3|||
131510159|NCT02420691|473497278|FG000|Overall Study|Withdrawal by Subject|3|||
131510160|NCT03897179|473497284|FG000|Overall Study|Withdrawal by Subject|1|||
131510161|NCT00704535|473497285|FG000|Overall Study|Adverse Event|2|||
131510162|NCT00704535|473497285|FG000|Overall Study|Death|2|||
131510163|NCT00704535|473497285|FG000|Overall Study|Lost to Follow-up|8|||
131510164|NCT00704535|473497285|FG000|Overall Study|Protocol Violation|10|||
131510165|NCT00704535|473497285|FG000|Overall Study|Completed status not on Case Report Form|124|||
131510166|NCT01480076|473497286|FG000|Overall Study|Run-in Failure|52|||
131510167|NCT01480076|473497286|FG000|Overall Study|Adverse Event|39|||
131510168|NCT01480076|473497286|FG000|Overall Study|Death|2|||
131510169|NCT01480076|473497286|FG000|Overall Study|Disease Progression|5|||
131510170|NCT01480076|473497286|FG000|Overall Study|Non-compliance With Study Protocol|15|||
131510171|NCT01480076|473497286|FG000|Overall Study|Withdrawal by Subject|105|||
131510172|NCT01480076|473497286|FG000|Overall Study|Lost to Follow-up|7|||
131510173|NCT01480076|473497286|FG000|Overall Study|Investigator Decision|13|||
131510174|NCT01480076|473497286|FG000|Overall Study|Other|52|||
131510175|NCT02503332|473497288|FG000|Overall Study|Adverse Event|17|||
131510176|NCT02503332|473497289|FG001|Overall Study|Adverse Event|5|||
131510177|NCT02503332|473497290|FG002|Overall Study|Adverse Event|3|||
131510178|NCT02503332|473497291|FG003|Overall Study|Adverse Event|1|||
131510179|NCT02503332|473497288|FG000|Overall Study|Investigator's Decision|5|||
131510180|NCT02503332|473497289|FG001|Overall Study|Investigator's Decision|1|||
131510181|NCT02503332|473497290|FG002|Overall Study|Investigator's Decision|0|||
131510182|NCT02503332|473497291|FG003|Overall Study|Investigator's Decision|0|||
131510183|NCT02503332|473497288|FG000|Overall Study|Sponsor's Decision|1|||
131510184|NCT02503332|473497289|FG001|Overall Study|Sponsor's Decision|0|||
131510185|NCT02503332|473497290|FG002|Overall Study|Sponsor's Decision|0|||
131510186|NCT02503332|473497291|FG003|Overall Study|Sponsor's Decision|1|||
131510187|NCT02503332|473497288|FG000|Overall Study|Subject Request|6|||
131510188|NCT02503332|473497289|FG001|Overall Study|Subject Request|5|||
131510189|NCT02503332|473497290|FG002|Overall Study|Subject Request|2|||
131510190|NCT02503332|473497291|FG003|Overall Study|Subject Request|1|||
131510191|NCT02503332|473497288|FG000|Overall Study|Death|0|||
131510192|NCT02503332|473497289|FG001|Overall Study|Death|2|||
131510193|NCT02503332|473497290|FG002|Overall Study|Death|2|||
131510194|NCT02503332|473497291|FG003|Overall Study|Death|0|||
131510195|NCT02503332|473497288|FG000|Overall Study|Other|5|||
131510196|NCT02503332|473497289|FG001|Overall Study|Other|6|||
131510197|NCT02503332|473497290|FG002|Overall Study|Other|1|||
131510198|NCT02503332|473497291|FG003|Overall Study|Other|1|||
131510199|NCT01413360|473497292|FG000|Overall Study|Lost to Follow-up|2|||
131510200|NCT01413360|473497292|FG000|Overall Study|Adverse Event|1|||
131510201|NCT05694546|473497295|FG000|Overall Study|Lost to Follow-up|11|||
131510202|NCT01589445|473497296|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
131510203|NCT01589445|473497296|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
131510204|NCT01589445|473497296|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
131510205|NCT01589445|473497296|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
131510206|NCT01589445|473497296|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
131510207|NCT01589445|473497296|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
131510208|NCT01589445|473497296|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
131510209|NCT01589445|473497296|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
131510210|NCT01589445|473497296|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
131510211|NCT01589445|473497296|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
131510212|NCT02625090|473497304|FG000|Overall Study|Participant wants to be pregnant|2|||
131510213|NCT02625090|473497304|FG000|Overall Study|For the Promoter|1|||
131510214|NCT02625090|473497304|FG000|Overall Study|Sponsor's Decision|9|||
131510215|NCT02625090|473497304|FG000|Overall Study|Somnolence|1|||
131510216|NCT02625090|473497304|FG000|Overall Study|Study terminated by Sponsor|7|||
131510217|NCT02625090|473497304|FG000|Overall Study|Negative Benefit/Risk|1|||
131510218|NCT02625090|473497304|FG000|Overall Study|Protocol Deviation|2|||
131510219|NCT02625090|473497304|FG000|Overall Study|Lack of Efficacy|16|||
131510220|NCT02625090|473497304|FG000|Overall Study|Adverse Event|3|||
131510221|NCT02439320|473497305|FG000|Overall Study|Adverse Event|0|||
131510222|NCT02439320|473497306|FG001|Overall Study|Adverse Event|2|||
131510223|NCT02439320|473497307|FG002|Overall Study|Adverse Event|0|||
131510224|NCT02439320|473497305|FG000|Overall Study|Lost to Follow-up|37|||
131510225|NCT02439320|473497306|FG001|Overall Study|Lost to Follow-up|34|||
131510226|NCT02439320|473497307|FG002|Overall Study|Lost to Follow-up|42|||
131510227|NCT02439320|473497305|FG000|Overall Study|Death|0|||
131510228|NCT02439320|473497306|FG001|Overall Study|Death|1|||
131510229|NCT02439320|473497307|FG002|Overall Study|Death|0|||
131510230|NCT02439320|473497305|FG000|Overall Study|Noncompliance with Protocol|10|||
131510231|NCT02439320|473497306|FG001|Overall Study|Noncompliance with Protocol|11|||
131510232|NCT02439320|473497307|FG002|Overall Study|Noncompliance with Protocol|7|||
131510233|NCT02439320|473497305|FG000|Overall Study|Pregnancy|0|||
131510234|NCT02439320|473497306|FG001|Overall Study|Pregnancy|1|||
131510235|NCT02439320|473497307|FG002|Overall Study|Pregnancy|1|||
131510236|NCT02439320|473497305|FG000|Overall Study|Withdrawal by Subject|12|||
131510237|NCT02439320|473497306|FG001|Overall Study|Withdrawal by Subject|16|||
131510238|NCT02439320|473497307|FG002|Overall Study|Withdrawal by Subject|14|||
131510239|NCT02439320|473497305|FG000|Overall Study|Physician Decision|2|||
131510240|NCT02439320|473497306|FG001|Overall Study|Physician Decision|1|||
131510241|NCT02439320|473497307|FG002|Overall Study|Physician Decision|0|||
131510242|NCT02439320|473497305|FG000|Overall Study|Sponsor Request|0|||
131510243|NCT02439320|473497306|FG001|Overall Study|Sponsor Request|2|||
131510244|NCT02439320|473497307|FG002|Overall Study|Sponsor Request|1|||
131510245|NCT02439320|473497305|FG000|Overall Study|Randomization Failure|35|||
131510246|NCT02439320|473497306|FG001|Overall Study|Randomization Failure|46|||
131510247|NCT02439320|473497307|FG002|Overall Study|Randomization Failure|34|||
131510248|NCT02972632|473497308|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
131510249|NCT02972632|473497308|FG000|Overall Study|Lost to Follow-up|4|||
131510250|NCT02972632|473497308|FG000|Overall Study|Voluntary Withdrawal|10|||
131510251|NCT01488097|473497312|FG000|Overall Study|Lost to Follow-up|1|||
131510252|NCT03054870|473497327|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
131510253|NCT03054870|473497327|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
131510254|NCT03089606|473497328|FG000|Overall Study|Progression after Cycle 1|1|||
131510255|NCT02802592|473497330|FG000|Overall Study|Study terminated due to loss of funding|4|||
131510256|NCT01150123|473497331|FG000|Overall Study|Withdrawal by Subject|1|||
131510257|NCT01150123|473497332|FG001|Overall Study|Withdrawal by Subject|1|||
131510258|NCT01150123|473497333|FG002|Overall Study|Withdrawal by Subject|2|||
131510259|NCT01150123|473497334|FG003|Overall Study|Withdrawal by Subject|1|||
131510260|NCT01150123|473497335|FG004|Overall Study|Withdrawal by Subject|1|||
131510261|NCT01150123|473497336|FG005|Overall Study|Withdrawal by Subject|1|||
131510262|NCT01150123|473497337|FG006|Overall Study|Withdrawal by Subject|0|||
131510263|NCT01150123|473497338|FG007|Overall Study|Withdrawal by Subject|3|||
131510264|NCT01150123|473497339|FG008|Overall Study|Withdrawal by Subject|2|||
131510265|NCT01150123|473497340|FG009|Overall Study|Withdrawal by Subject|0|||
131510266|NCT01150123|473497341|FG010|Overall Study|Withdrawal by Subject|1|||
131510267|NCT01150123|473497342|FG011|Overall Study|Withdrawal by Subject|0|||
131510268|NCT01150123|473497343|FG012|Overall Study|Withdrawal by Subject|1|||
131510269|NCT01150123|473497344|FG013|Overall Study|Withdrawal by Subject|0|||
131510270|NCT01150123|473497345|FG014|Overall Study|Withdrawal by Subject|0|||
131510271|NCT01150123|473497346|FG015|Overall Study|Withdrawal by Subject|1|||
131510272|NCT01150123|473497347|FG016|Overall Study|Withdrawal by Subject|0|||
131510273|NCT01150123|473497348|FG017|Overall Study|Withdrawal by Subject|1|||
131510274|NCT01150123|473497331|FG000|Overall Study|Lost to Follow-up|2|||
131510275|NCT01150123|473497332|FG001|Overall Study|Lost to Follow-up|1|||
131510276|NCT01150123|473497333|FG002|Overall Study|Lost to Follow-up|2|||
131510277|NCT01150123|473497334|FG003|Overall Study|Lost to Follow-up|2|||
131510278|NCT01150123|473497335|FG004|Overall Study|Lost to Follow-up|2|||
131510279|NCT01150123|473497336|FG005|Overall Study|Lost to Follow-up|5|||
131510280|NCT01150123|473497337|FG006|Overall Study|Lost to Follow-up|0|||
131510281|NCT01150123|473497338|FG007|Overall Study|Lost to Follow-up|0|||
131510282|NCT01150123|473497339|FG008|Overall Study|Lost to Follow-up|3|||
131510283|NCT01150123|473497340|FG009|Overall Study|Lost to Follow-up|1|||
131510284|NCT01150123|473497341|FG010|Overall Study|Lost to Follow-up|1|||
131510285|NCT01150123|473497342|FG011|Overall Study|Lost to Follow-up|1|||
131510286|NCT01150123|473497343|FG012|Overall Study|Lost to Follow-up|2|||
131510287|NCT01150123|473497344|FG013|Overall Study|Lost to Follow-up|0|||
131510288|NCT01150123|473497345|FG014|Overall Study|Lost to Follow-up|0|||
131510289|NCT01150123|473497346|FG015|Overall Study|Lost to Follow-up|0|||
131510290|NCT01150123|473497347|FG016|Overall Study|Lost to Follow-up|0|||
131510291|NCT01150123|473497348|FG017|Overall Study|Lost to Follow-up|0|||
131510292|NCT00352846|473497351|FG000|Overall Study|Disease progression|0|||
131510293|NCT00352846|473497352|FG001|Overall Study|Disease progression|2|||
131510294|NCT00352846|473497351|FG000|Overall Study|Withdrawal by Subject|3|||
131510295|NCT00352846|473497352|FG001|Overall Study|Withdrawal by Subject|8|||
131510296|NCT00352846|473497351|FG000|Overall Study|Ineligible|3|||
131510297|NCT00352846|473497352|FG001|Overall Study|Ineligible|2|||
131510298|NCT00352846|473497351|FG000|Overall Study|Non-compliance|2|||
131510299|NCT00352846|473497352|FG001|Overall Study|Non-compliance|0|||
131510300|NCT00352846|473497351|FG000|Overall Study|Death|0|||
131510301|NCT00352846|473497352|FG001|Overall Study|Death|1|||
131510302|NCT00788827|473497353|FG000|Overall Study|Lack of Efficacy|2|||
131510303|NCT01527682|473497354|FG000|Overall Study|Protocol Violation|8|||
131510304|NCT03979638|473497358|FG000|Period 1|Physician Decision|1|||
131510305|NCT03979638|473497359|FG001|Period 1|Physician Decision|1|||
131510306|NCT03979638|473497358|FG000|Period 1|Withdrawal by Subject|4|||
131510307|NCT03979638|473497359|FG001|Period 1|Withdrawal by Subject|3|||
131510308|NCT03979638|473497358|FG000|Period 1|Study terminated by Sponsor|1|||
131510309|NCT03979638|473497359|FG001|Period 1|Study terminated by Sponsor|3|||
131510310|NCT03979638|473497358|FG000|Period 1|Protocol Violation|1|||
131510311|NCT03979638|473497359|FG001|Period 1|Protocol Violation|0|||
131510312|NCT03979638|473497358|FG000|Period 2|Study terminated by Sponsor|1|||
131510313|NCT03979638|473497359|FG001|Period 2|Study terminated by Sponsor|1|||
131510314|NCT02028988|473497360|FG000|Overall Study|Withdrawal by Subject|2|||
131510315|NCT00851799|473497361|FG000|Overall Study|Death|1|||
131510316|NCT00851799|473497362|FG001|Overall Study|Death|0|||
131510317|NCT00851799|473497363|FG002|Overall Study|Death|1|||
131510318|NCT00851799|473497361|FG000|Overall Study|Lost to Follow-up|5|||
131510319|NCT00851799|473497362|FG001|Overall Study|Lost to Follow-up|3|||
131510320|NCT00851799|473497363|FG002|Overall Study|Lost to Follow-up|10|||
131510321|NCT00851799|473497361|FG000|Overall Study|Not able to get to clinic|8|||
131510322|NCT00851799|473497362|FG001|Overall Study|Not able to get to clinic|5|||
131510323|NCT00851799|473497363|FG002|Overall Study|Not able to get to clinic|9|||
131510324|NCT00851799|473497361|FG000|Overall Study|Not willing to adhere to requirements|1|||
131510325|NCT00851799|473497362|FG001|Overall Study|Not willing to adhere to requirements|2|||
131510326|NCT00851799|473497363|FG002|Overall Study|Not willing to adhere to requirements|2|||
131510327|NCT00851799|473497361|FG000|Overall Study|Withdrew consent prior study completion|1|||
131510328|NCT00851799|473497362|FG001|Overall Study|Withdrew consent prior study completion|2|||
131510329|NCT00851799|473497363|FG002|Overall Study|Withdrew consent prior study completion|1|||
131510330|NCT00851799|473497361|FG000|Overall Study|Severe Debilitation|0|||
131510331|NCT00851799|473497362|FG001|Overall Study|Severe Debilitation|1|||
131510332|NCT00851799|473497363|FG002|Overall Study|Severe Debilitation|0|||
131510333|NCT00851799|473497361|FG000|Overall Study|Completed protocol due to pregnancy|0|||
131510334|NCT00851799|473497362|FG001|Overall Study|Completed protocol due to pregnancy|0|||
131510335|NCT00851799|473497363|FG002|Overall Study|Completed protocol due to pregnancy|1|||
131510336|NCT04439318|473497366|FG000|Overall Study|Ineligible|1|||
131510337|NCT04439318|473497366|FG000|Overall Study|Never Started Treatment|3|||
131510338|NCT04439318|473497366|FG000|Overall Study|Adverse Event|10|||
131510339|NCT04439318|473497366|FG000|Overall Study|Death|2|||
131510340|NCT04439318|473497366|FG000|Overall Study|Disease Progression|25|||
131510341|NCT04439318|473497366|FG000|Overall Study|Other Complicating Disease|2|||
131510342|NCT04439318|473497366|FG000|Overall Study|Withdrawal by Subject|4|||
131510343|NCT04439318|473497366|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
131510344|NCT04439318|473497366|FG000|Overall Study|Non-Compliance|1|||
131510345|NCT04439318|473497366|FG000|Overall Study|Still on Treatment|1|||
131510346|NCT00699972|473498846|FG000|Overall Study|Adverse Event|7|||
131510347|NCT00699972|473498847|FG001|Overall Study|Adverse Event|9|||
131510348|NCT00699972|473498848|FG002|Overall Study|Adverse Event|24|||
131510349|NCT00699972|473498846|FG000|Overall Study|Lost to Follow-up|0|||
131510350|NCT00699972|473498847|FG001|Overall Study|Lost to Follow-up|2|||
131510351|NCT00699972|473498848|FG002|Overall Study|Lost to Follow-up|0|||
131510352|NCT00699972|473498846|FG000|Overall Study|Withdrawal by Subject|3|||
131510353|NCT00699972|473498847|FG001|Overall Study|Withdrawal by Subject|7|||
131510354|NCT00699972|473498848|FG002|Overall Study|Withdrawal by Subject|4|||
131510355|NCT00699972|473498846|FG000|Overall Study|Lack of Efficacy|2|||
131510356|NCT00699972|473498847|FG001|Overall Study|Lack of Efficacy|0|||
131510357|NCT00699972|473498848|FG002|Overall Study|Lack of Efficacy|2|||
131510358|NCT00699972|473498846|FG000|Overall Study|Administrative/Other|3|||
131510359|NCT00699972|473498847|FG001|Overall Study|Administrative/Other|1|||
131510360|NCT00699972|473498848|FG002|Overall Study|Administrative/Other|4|||
131510361|NCT00699972|473498846|FG000|Overall Study|Randomized, Not Treated|1|||
131510362|NCT00699972|473498847|FG001|Overall Study|Randomized, Not Treated|0|||
131510363|NCT00699972|473498848|FG002|Overall Study|Randomized, Not Treated|1|||
131510364|NCT00644969|473498855|FG000|Treatment Phase|Randomized, not treated|1|||
131510365|NCT00644969|473498856|FG001|Treatment Phase|Randomized, not treated|0|||
131510366|NCT00644969|473498855|FG000|Treatment Phase|Adverse Event|3|||
131510367|NCT00644969|473498856|FG001|Treatment Phase|Adverse Event|0|||
131510368|NCT00644969|473498855|FG000|Treatment Phase|Withdrawal by Subject|4|||
131510369|NCT00644969|473498856|FG001|Treatment Phase|Withdrawal by Subject|0|||
131510370|NCT00644969|473498855|FG000|Treatment Phase|Lost to Follow-up|2|||
131510371|NCT00644969|473498856|FG001|Treatment Phase|Lost to Follow-up|2|||
131510372|NCT00644969|473498855|FG000|Treatment Phase|Other|4|||
131510373|NCT00644969|473498856|FG001|Treatment Phase|Other|1|||
131510374|NCT00644969|473498855|FG000|Post Treatment Phase|Death|1|||
131510375|NCT00644969|473498856|FG001|Post Treatment Phase|Death|0|||
131510376|NCT00644969|473498855|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
131510377|NCT00644969|473498856|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
131510378|NCT00644969|473498855|FG000|Post Treatment Phase|Lost to Follow-up|4|||
131510379|NCT00644969|473498856|FG001|Post Treatment Phase|Lost to Follow-up|1|||
131510380|NCT00644969|473498855|FG000|Post Treatment Phase|Other|1|||
131510381|NCT00644969|473498856|FG001|Post Treatment Phase|Other|0|||
131510382|NCT03509675|473498858|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
131510383|NCT03509675|473498859|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
131510384|NCT03509675|473498858|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
131510385|NCT03509675|473498859|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
131510386|NCT03509675|473498858|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
131510387|NCT03509675|473498859|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
131510388|NCT03509675|473498858|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
131510389|NCT03509675|473498859|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
131510390|NCT01023581|473498865|FG000|Overall Study|Adverse Event|4|||
131510391|NCT01023581|473498866|FG001|Overall Study|Adverse Event|4|||
131510392|NCT01023581|473498867|FG002|Overall Study|Adverse Event|7|||
131510393|NCT01023581|473498868|FG003|Overall Study|Adverse Event|3|||
131510394|NCT01023581|473498869|FG004|Overall Study|Adverse Event|2|||
131510395|NCT01023581|473498870|FG005|Overall Study|Adverse Event|5|||
131510396|NCT01023581|473498871|FG006|Overall Study|Adverse Event|11|||
131510397|NCT01023581|473498865|FG000|Overall Study|Major protocol deviation|2|||
131510398|NCT01023581|473498866|FG001|Overall Study|Major protocol deviation|0|||
131510399|NCT01023581|473498867|FG002|Overall Study|Major protocol deviation|3|||
131510400|NCT01023581|473498868|FG003|Overall Study|Major protocol deviation|0|||
131510401|NCT01023581|473498869|FG004|Overall Study|Major protocol deviation|0|||
131510402|NCT01023581|473498870|FG005|Overall Study|Major protocol deviation|0|||
131510403|NCT01023581|473498871|FG006|Overall Study|Major protocol deviation|0|||
131510404|NCT01023581|473498865|FG000|Overall Study|Lost to Follow-up|4|||
131510405|NCT01023581|473498866|FG001|Overall Study|Lost to Follow-up|8|||
131510406|NCT01023581|473498867|FG002|Overall Study|Lost to Follow-up|7|||
131510407|NCT01023581|473498868|FG003|Overall Study|Lost to Follow-up|2|||
131510408|NCT01023581|473498869|FG004|Overall Study|Lost to Follow-up|5|||
131510409|NCT01023581|473498870|FG005|Overall Study|Lost to Follow-up|2|||
131510410|NCT01023581|473498871|FG006|Overall Study|Lost to Follow-up|2|||
131510411|NCT01023581|473498865|FG000|Overall Study|Withdrawal by Subject|13|||
131510412|NCT01023581|473498866|FG001|Overall Study|Withdrawal by Subject|8|||
131510413|NCT01023581|473498867|FG002|Overall Study|Withdrawal by Subject|16|||
131510414|NCT01023581|473498868|FG003|Overall Study|Withdrawal by Subject|10|||
131510415|NCT01023581|473498869|FG004|Overall Study|Withdrawal by Subject|6|||
131510416|NCT01023581|473498870|FG005|Overall Study|Withdrawal by Subject|8|||
131510417|NCT01023581|473498871|FG006|Overall Study|Withdrawal by Subject|5|||
131510418|NCT01023581|473498865|FG000|Overall Study|Pregnancy|0|||
131510419|NCT01023581|473498866|FG001|Overall Study|Pregnancy|0|||
131510420|NCT01023581|473498867|FG002|Overall Study|Pregnancy|0|||
131510421|NCT01023581|473498868|FG003|Overall Study|Pregnancy|2|||
131510422|NCT01023581|473498869|FG004|Overall Study|Pregnancy|0|||
131510423|NCT01023581|473498870|FG005|Overall Study|Pregnancy|1|||
131510424|NCT01023581|473498871|FG006|Overall Study|Pregnancy|0|||
131510425|NCT01023581|473498865|FG000|Overall Study|Lack of Efficacy|9|||
131510426|NCT01023581|473498866|FG001|Overall Study|Lack of Efficacy|3|||
131510427|NCT01023581|473498867|FG002|Overall Study|Lack of Efficacy|6|||
131510428|NCT01023581|473498868|FG003|Overall Study|Lack of Efficacy|2|||
131510429|NCT01023581|473498869|FG004|Overall Study|Lack of Efficacy|1|||
131510430|NCT01023581|473498870|FG005|Overall Study|Lack of Efficacy|2|||
131510431|NCT01023581|473498871|FG006|Overall Study|Lack of Efficacy|1|||
131510432|NCT01023581|473498865|FG000|Overall Study|Physician Decision|2|||
131510433|NCT01023581|473498866|FG001|Overall Study|Physician Decision|0|||
131510434|NCT01023581|473498867|FG002|Overall Study|Physician Decision|2|||
131510435|NCT01023581|473498868|FG003|Overall Study|Physician Decision|1|||
131510436|NCT01023581|473498869|FG004|Overall Study|Physician Decision|1|||
131510437|NCT01023581|473498870|FG005|Overall Study|Physician Decision|1|||
131510438|NCT01023581|473498871|FG006|Overall Study|Physician Decision|1|||
131510439|NCT01023581|473498865|FG000|Overall Study|Other|1|||
131510440|NCT01023581|473498866|FG001|Overall Study|Other|0|||
131510441|NCT01023581|473498867|FG002|Overall Study|Other|1|||
131510442|NCT01023581|473498868|FG003|Overall Study|Other|0|||
131510443|NCT01023581|473498869|FG004|Overall Study|Other|1|||
131510444|NCT01023581|473498870|FG005|Overall Study|Other|0|||
131510445|NCT01023581|473498871|FG006|Overall Study|Other|0|||
131510446|NCT01723163|473498872|FG000|Treatment Phase|Withdrawal by Subject|14|||
131510447|NCT01723163|473498873|FG001|Treatment Phase|Withdrawal by Subject|6|||
131510448|NCT01723163|473498872|FG000|Treatment Phase|Withdrawal by PI|5|||
131510449|NCT01723163|473498873|FG001|Treatment Phase|Withdrawal by PI|1|||
131510450|NCT01723163|473498872|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
131510451|NCT01723163|473498873|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
131510452|NCT01723163|473498872|FG000|3-Month Follow-up|Unable to Contact|12|||
131510453|NCT01723163|473498873|FG001|3-Month Follow-up|Unable to Contact|19|||
131510454|NCT01723163|473498872|FG000|6-Month Follow-up|Death|1|||
131510455|NCT01723163|473498873|FG001|6-Month Follow-up|Death|0|||
131510456|NCT01723163|473498872|FG000|6-Month Follow-up|Unable to Contact|17|||
131510457|NCT01723163|473498873|FG001|6-Month Follow-up|Unable to Contact|15|||
131510458|NCT01723163|473498872|FG000|12-Month Follow-up|Death|1|||
131510459|NCT01723163|473498873|FG001|12-Month Follow-up|Death|0|||
131510460|NCT01723163|473498872|FG000|12-Month Follow-up|Unable to Contact|23|||
131510461|NCT01723163|473498873|FG001|12-Month Follow-up|Unable to Contact|28|||
131510462|NCT00325754|473498875|FG000|Overall Study|Adverse Event|4|||
131510463|NCT00325754|473498876|FG001|Overall Study|Adverse Event|1|||
131510464|NCT02016482|473498897|FG000|Period A|Adverse Event|3|||
131510465|NCT02016482|473498898|FG001|Period A|Adverse Event|5|||
131510466|NCT02016482|473498897|FG000|Period A|Withdrawal by Subject|3|||
131510467|NCT02016482|473498898|FG001|Period A|Withdrawal by Subject|4|||
131510468|NCT02016482|473498897|FG000|Period A|Lost to Follow-up|3|||
131510469|NCT02016482|473498898|FG001|Period A|Lost to Follow-up|3|||
131510470|NCT02016482|473498897|FG000|Period A|Lack of Efficacy|2|||
131510471|NCT02016482|473498898|FG001|Period A|Lack of Efficacy|1|||
131510472|NCT02016482|473498897|FG000|Period A|Other|3|||
131510473|NCT02016482|473498898|FG001|Period A|Other|0|||
131510474|NCT02016482|473498897|FG000|Period A|Protocol Violation|0|||
131510475|NCT02016482|473498898|FG001|Period A|Protocol Violation|1|||
131510476|NCT02016482|473498897|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
131510477|NCT02016482|473498898|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
131510478|NCT02016482|473498897|FG000|Period B|Withdrawal by Subject|1|||
131510479|NCT02016482|473498898|FG001|Period B|Withdrawal by Subject|1|||
131510480|NCT02016482|473498897|FG000|Period B|Lost to Follow-up|2|||
131510481|NCT02016482|473498898|FG001|Period B|Lost to Follow-up|0|||
131510482|NCT02016482|473498897|FG000|Period B|Lack of Efficacy|6|||
131510483|NCT02016482|473498898|FG001|Period B|Lack of Efficacy|4|||
131510484|NCT02016482|473498897|FG000|Period B|Other|4|||
131510485|NCT02016482|473498898|FG001|Period B|Other|0|||
131510486|NCT02016482|473498897|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
131510487|NCT02016482|473498898|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
131510488|NCT01289847|473498899|FG000|Overall Study|Patient could not comply with visits|1|||
131510489|NCT02872116|473498902|FG000|Pre-Treatment|Disease Progression|0|||
131510490|NCT02872116|473498903|FG001|Pre-Treatment|Disease Progression|1|||
131510491|NCT02872116|473498904|FG002|Pre-Treatment|Disease Progression|0|||
131510492|NCT02872116|473498902|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
131510493|NCT02872116|473498903|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
131510494|NCT02872116|473498904|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
131510495|NCT02872116|473498902|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
131510496|NCT02872116|473498903|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
131510497|NCT02872116|473498904|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
131510498|NCT02872116|473498902|FG000|Pre-Treatment|Participant withdrew consent|2|||
131510499|NCT02872116|473498903|FG001|Pre-Treatment|Participant withdrew consent|20|||
131510500|NCT02872116|473498904|FG002|Pre-Treatment|Participant withdrew consent|3|||
131510501|NCT02872116|473498902|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
131510502|NCT02872116|473498903|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
131510503|NCT02872116|473498904|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
131510504|NCT02872116|473498902|FG000|Pre-Treatment|Other reasons|1|||
131510505|NCT02872116|473498903|FG001|Pre-Treatment|Other reasons|2|||
131510506|NCT02872116|473498904|FG002|Pre-Treatment|Other reasons|2|||
131510507|NCT02872116|473498902|FG000|Treatment|Death|121|||
131510508|NCT02872116|473498903|FG001|Treatment|Death|94|||
131510509|NCT02872116|473498904|FG002|Treatment|Death|68|||
131510510|NCT02872116|473498902|FG000|Treatment|Lost to Follow-up|5|||
131510511|NCT02872116|473498903|FG001|Treatment|Lost to Follow-up|7|||
131510512|NCT02872116|473498904|FG002|Treatment|Lost to Follow-up|3|||
131510513|NCT02872116|473498902|FG000|Treatment|Participant withdrew consent|20|||
131510514|NCT02872116|473498903|FG001|Treatment|Participant withdrew consent|40|||
131510515|NCT02872116|473498904|FG002|Treatment|Participant withdrew consent|8|||
131510516|NCT02872116|473498902|FG000|Treatment|Other reasons|13|||
131510517|NCT02872116|473498903|FG001|Treatment|Other reasons|12|||
131510518|NCT02872116|473498904|FG002|Treatment|Other reasons|5|||
131510519|NCT01709695|473498914|FG000|Overall Study|Withdrawal by Subject|1|||
131510520|NCT01709695|473498915|FG001|Overall Study|Withdrawal by Subject|1|||
131510521|NCT01894152|473498916|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
131510522|NCT01708174|473498917|FG000|Treatment Period|Withdrawal by Subject|1|||
131510523|NCT01708174|473498918|FG001|Treatment Period|Withdrawal by Subject|0|||
131510524|NCT01708174|473498919|FG002|Treatment Period|Withdrawal by Subject|0|||
131510525|NCT01708174|473498917|FG000|Treatment Period|Progressive disease|0|||
131510526|NCT01708174|473498918|FG001|Treatment Period|Progressive disease|1|||
131510527|NCT01708174|473498919|FG002|Treatment Period|Progressive disease|0|||
131510528|NCT01708174|473498917|FG000|Treatment Period|Death|0|||
131510529|NCT01708174|473498918|FG001|Treatment Period|Death|0|||
131510530|NCT01708174|473498919|FG002|Treatment Period|Death|1|||
131510531|NCT01708174|473498917|FG000|Treatment Period|Adverse Event|0|||
131510532|NCT01708174|473498918|FG001|Treatment Period|Adverse Event|1|||
131510533|NCT01708174|473498919|FG002|Treatment Period|Adverse Event|0|||
131510534|NCT00075582|473498920|FG000|Overall Study|Adverse Event|3|||
131510535|NCT00075582|473498921|FG001|Overall Study|Adverse Event|1|||
131510536|NCT00075582|473498920|FG000|Overall Study|Lack of Efficacy|4|||
131510537|NCT00075582|473498921|FG001|Overall Study|Lack of Efficacy|8|||
131510538|NCT00075582|473498920|FG000|Overall Study|Physician Decision|5|||
131510539|NCT00075582|473498921|FG001|Overall Study|Physician Decision|8|||
131510540|NCT00075582|473498920|FG000|Overall Study|Withdrawal by Subject|2|||
131510541|NCT00075582|473498921|FG001|Overall Study|Withdrawal by Subject|2|||
131510542|NCT00075582|473498920|FG000|Overall Study|Ineligible for study|36|||
131510543|NCT00075582|473498921|FG001|Overall Study|Ineligible for study|16|||
131510544|NCT02268812|473498922|FG000|Overall Study|Adverse Event|8|||
131510545|NCT02268812|473498923|FG001|Overall Study|Adverse Event|26|||
131510546|NCT02268812|473498924|FG002|Overall Study|Adverse Event|7|||
131510547|NCT02268812|473498925|FG003|Overall Study|Adverse Event|10|||
131510548|NCT02268812|473498922|FG000|Overall Study|Protocol deviation|0|||
131510549|NCT02268812|473498923|FG001|Overall Study|Protocol deviation|0|||
131510550|NCT02268812|473498924|FG002|Overall Study|Protocol deviation|1|||
131510551|NCT02268812|473498925|FG003|Overall Study|Protocol deviation|0|||
131510552|NCT02268812|473498922|FG000|Overall Study|Withdrawal by Subject|0|||
131510553|NCT02268812|473498923|FG001|Overall Study|Withdrawal by Subject|1|||
131510554|NCT02268812|473498924|FG002|Overall Study|Withdrawal by Subject|0|||
131510555|NCT02268812|473498925|FG003|Overall Study|Withdrawal by Subject|0|||
131510556|NCT02268812|473498922|FG000|Overall Study|Physician Decision|3|||
131510557|NCT02268812|473498923|FG001|Overall Study|Physician Decision|1|||
131510558|NCT02268812|473498924|FG002|Overall Study|Physician Decision|0|||
131510559|NCT02268812|473498925|FG003|Overall Study|Physician Decision|1|||
131510560|NCT02268812|473498922|FG000|Overall Study|Other|5|||
131510561|NCT02268812|473498923|FG001|Overall Study|Other|4|||
131510562|NCT02268812|473498924|FG002|Overall Study|Other|1|||
131510563|NCT02268812|473498925|FG003|Overall Study|Other|3|||
131510564|NCT02385084|473498926|FG000|Period 2|Protocol Violation|0|||
131510565|NCT02385084|473498927|FG001|Period 2|Protocol Violation|0|||
131510566|NCT02385084|473498928|FG002|Period 2|Protocol Violation|1|||
131510567|NCT02385084|473498929|FG003|Period 2|Protocol Violation|0|||
131510568|NCT02385084|473498930|FG004|Period 2|Protocol Violation|0|||
131510569|NCT02385084|473498931|FG005|Period 2|Protocol Violation|0|||
131510570|NCT05045144|473498932|FG000|Overall Study|Lost to Follow-up|3|||
131510571|NCT05045144|473498933|FG001|Overall Study|Lost to Follow-up|2|||
131510572|NCT05045144|473498934|FG002|Overall Study|Lost to Follow-up|3|||
131510573|NCT05045144|473498935|FG003|Overall Study|Lost to Follow-up|5|||
131510574|NCT05045144|473498936|FG004|Overall Study|Lost to Follow-up|13|||
131510575|NCT05045144|473498932|FG000|Overall Study|Withdrawal by Subject|0|||
131510576|NCT05045144|473498933|FG001|Overall Study|Withdrawal by Subject|1|||
131510577|NCT05045144|473498934|FG002|Overall Study|Withdrawal by Subject|0|||
131510578|NCT05045144|473498935|FG003|Overall Study|Withdrawal by Subject|0|||
131510579|NCT05045144|473498936|FG004|Overall Study|Withdrawal by Subject|0|||
131510580|NCT05045144|473498932|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131510581|NCT05045144|473498933|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131510582|NCT05045144|473498934|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131510583|NCT05045144|473498935|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131510584|NCT05045144|473498936|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131510585|NCT02171260|473498938|FG000|Overall Study|Death|0|||
131510586|NCT02171260|473498939|FG001|Overall Study|Death|0|||
131510587|NCT02171260|473498940|FG002|Overall Study|Death|0|||
131510588|NCT02171260|473498941|FG003|Overall Study|Death|1|||
131510589|NCT02171260|473498938|FG000|Overall Study|Physician Decision|1|||
131510590|NCT02171260|473498939|FG001|Overall Study|Physician Decision|0|||
131510591|NCT02171260|473498940|FG002|Overall Study|Physician Decision|1|||
131510592|NCT02171260|473498941|FG003|Overall Study|Physician Decision|0|||
131510593|NCT02171260|473498938|FG000|Overall Study|Withdrawal by Subject|1|||
131510594|NCT02171260|473498939|FG001|Overall Study|Withdrawal by Subject|0|||
131510595|NCT02171260|473498940|FG002|Overall Study|Withdrawal by Subject|0|||
131510596|NCT02171260|473498941|FG003|Overall Study|Withdrawal by Subject|0|||
131510597|NCT02171260|473498938|FG000|Overall Study|Evidence of progressive disease|4|||
131510598|NCT02171260|473498939|FG001|Overall Study|Evidence of progressive disease|6|||
131510599|NCT02171260|473498940|FG002|Overall Study|Evidence of progressive disease|4|||
131510600|NCT02171260|473498941|FG003|Overall Study|Evidence of progressive disease|4|||
131510601|NCT00323492|473498942|FG000|Study Phase 1|Adverse Event|2|||
131510602|NCT00323492|473498943|FG001|Study Phase 1|Adverse Event|0|||
131510603|NCT00323492|473498944|FG002|Study Phase 1|Adverse Event|0|||
131510604|NCT00323492|473498942|FG000|Study Phase 2|Adverse Event|1|||
131510605|NCT00323492|473498943|FG001|Study Phase 2|Adverse Event|0|||
131510606|NCT00323492|473498944|FG002|Study Phase 2|Adverse Event|0|||
131510607|NCT00323492|473498942|FG000|Study Phase 2|Physician Decision|1|||
131510608|NCT00323492|473498943|FG001|Study Phase 2|Physician Decision|0|||
131510609|NCT00323492|473498944|FG002|Study Phase 2|Physician Decision|0|||
131510610|NCT00323492|473498942|FG000|Study Phase 2|Lost to Follow-up|1|||
131510611|NCT00323492|473498943|FG001|Study Phase 2|Lost to Follow-up|0|||
131510612|NCT00323492|473498944|FG002|Study Phase 2|Lost to Follow-up|0|||
131510613|NCT00323492|473498942|FG000|Study Phase 2|Withdrawal by Subject|0|||
131510614|NCT00323492|473498943|FG001|Study Phase 2|Withdrawal by Subject|1|||
131510615|NCT00323492|473498944|FG002|Study Phase 2|Withdrawal by Subject|0|||
131510616|NCT00323492|473498942|FG000|Study Phase 2|Noncompliance with study schedule|0|||
131510617|NCT00323492|473498943|FG001|Study Phase 2|Noncompliance with study schedule|0|||
131510618|NCT00323492|473498944|FG002|Study Phase 2|Noncompliance with study schedule|1|||
131510619|NCT00323492|473498942|FG000|Study Phase 2|Protocol Violation|1|||
131510620|NCT00323492|473498943|FG001|Study Phase 2|Protocol Violation|0|||
131510621|NCT00323492|473498944|FG002|Study Phase 2|Protocol Violation|0|||
131510622|NCT02486042|473498945|FG000|Overall Study|Physician Decision|1|||
131510623|NCT02486042|473498946|FG001|Overall Study|Physician Decision|7|||
131510624|NCT02486042|473498945|FG000|Overall Study|Hospital transfer|2|||
131510625|NCT02486042|473498946|FG001|Overall Study|Hospital transfer|2|||
131510626|NCT02486042|473498945|FG000|Overall Study|Withdrawal by Subject|0|||
131510627|NCT02486042|473498946|FG001|Overall Study|Withdrawal by Subject|2|||
131510628|NCT01466387|473498947|FG000|Overall Study|Adverse Event|0|||
131510629|NCT01466387|473498948|FG001|Overall Study|Adverse Event|0|||
131510630|NCT01466387|473498949|FG002|Overall Study|Adverse Event|1|||
131510631|NCT01466387|473498950|FG003|Overall Study|Adverse Event|1|||
131510632|NCT01466387|473498951|FG004|Overall Study|Adverse Event|0|||
131510633|NCT01466387|473498952|FG005|Overall Study|Adverse Event|0|||
131510634|NCT01466387|473498947|FG000|Overall Study|Lost to Follow-up|0|||
131510635|NCT01466387|473498948|FG001|Overall Study|Lost to Follow-up|0|||
131510636|NCT01466387|473498949|FG002|Overall Study|Lost to Follow-up|0|||
131510637|NCT01466387|473498950|FG003|Overall Study|Lost to Follow-up|0|||
131510638|NCT01466387|473498951|FG004|Overall Study|Lost to Follow-up|0|||
131510639|NCT01466387|473498952|FG005|Overall Study|Lost to Follow-up|1|||
131510640|NCT01466387|473498947|FG000|Overall Study|Protocol Violation|1|||
131510641|NCT01466387|473498948|FG001|Overall Study|Protocol Violation|0|||
131510642|NCT01466387|473498949|FG002|Overall Study|Protocol Violation|0|||
131510643|NCT01466387|473498950|FG003|Overall Study|Protocol Violation|1|||
131510644|NCT01466387|473498951|FG004|Overall Study|Protocol Violation|0|||
131510645|NCT01466387|473498952|FG005|Overall Study|Protocol Violation|0|||
131510646|NCT01319877|473498953|FG000|Overall Study|Lost to Follow-up|100|||
131510647|NCT01319877|473498954|FG001|Overall Study|Lost to Follow-up|37|||
131510648|NCT01319877|473498953|FG000|Overall Study|Physician Decision|2|||
131510649|NCT01319877|473498954|FG001|Overall Study|Physician Decision|0|||
131510650|NCT01319877|473498953|FG000|Overall Study|Disease Progression|2|||
131510651|NCT01319877|473498954|FG001|Overall Study|Disease Progression|2|||
131510652|NCT01319877|473498953|FG000|Overall Study|Withdrawal by Subject|0|||
131510653|NCT01319877|473498954|FG001|Overall Study|Withdrawal by Subject|1|||
131510654|NCT01319877|473498953|FG000|Overall Study|Reason Not Specified|4|||
131510655|NCT01319877|473498954|FG001|Overall Study|Reason Not Specified|5|||
131510656|NCT02347189|473498957|FG000|Overall Study|No implant attempted of study device|9|||
131510657|NCT02347189|473498957|FG000|Overall Study|No primary outcome data available|2|||
131510658|NCT00735878|473498958|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
131510659|NCT00735878|473498959|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
131510660|NCT00735878|473498960|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
131510661|NCT04404855|473498961|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
131510662|NCT04404855|473498962|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
131510663|NCT01359254|473498969|FG000|Overall Study|Death|1|||
131510664|NCT01359254|473498970|FG001|Overall Study|Death|0|||
131510665|NCT04248933|473498971|FG000|Overall Study|Lost to Follow-up|9|||
131510666|NCT04248933|473498971|FG000|Overall Study|Withdrawal by Subject|2|||
131510667|NCT04220411|473498982|FG000|Overall Study|Adverse Event|0|||
131510668|NCT04220411|473498983|FG001|Overall Study|Adverse Event|0|||
131510669|NCT04220411|473498984|FG002|Overall Study|Adverse Event|0|||
131510670|NCT04220411|473498985|FG003|Overall Study|Adverse Event|1|||
131510671|NCT02680639|473498986|FG000|Screening Period|Screen Failure|7|||
131510672|NCT02680639|473498987|FG001|Screening Period|Screen Failure|0|||
131510673|NCT02680639|473498988|FG002|Screening Period|Screen Failure|0|||
131510674|NCT02678676|473498989|FG000|Overall Study|Death|619|||
131510675|NCT02678676|473498990|FG001|Overall Study|Death|649|||
131510676|NCT02678676|473498989|FG000|Overall Study|Withdrawal by Subject|13|||
131510677|NCT02678676|473498990|FG001|Overall Study|Withdrawal by Subject|5|||
131510678|NCT02678676|473498989|FG000|Overall Study|Lost to Follow-up|171|||
131510679|NCT02678676|473498990|FG001|Overall Study|Lost to Follow-up|151|||
131510680|NCT02678676|473498989|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
131510681|NCT02678676|473498990|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
131510682|NCT01342510|473499004|FG000|Overall Study|Protocol Violation|12|||
131510683|NCT01342510|473499005|FG001|Overall Study|Protocol Violation|6|||
131510684|NCT01342510|473499006|FG002|Overall Study|Protocol Violation|13|||
131510685|NCT01342510|473499007|FG003|Overall Study|Protocol Violation|11|||
131510686|NCT01449526|473499008|FG000|Overall Study|Lost to Follow-up|1|||
131510687|NCT01449526|473499009|FG001|Overall Study|Lost to Follow-up|2|||
131510688|NCT01449526|473499008|FG000|Overall Study|Withdrawal by Subject|1|||
131510689|NCT01449526|473499009|FG001|Overall Study|Withdrawal by Subject|1|||
131510690|NCT01449526|473499008|FG000|Overall Study|Symptoms/complaints|0|||
131510691|NCT01449526|473499009|FG001|Overall Study|Symptoms/complaints|1|||
131510692|NCT01449526|473499008|FG000|Overall Study|Lack of Motivation|0|||
131510693|NCT01449526|473499009|FG001|Overall Study|Lack of Motivation|1|||
131510694|NCT01449526|473499008|FG000|Overall Study|Cannot maintain visits|0|||
131510695|NCT01449526|473499009|FG001|Overall Study|Cannot maintain visits|1|||
131510696|NCT01400516|473499010|FG000|Primary Trial|Withdrawal by Subject|0|||
131510697|NCT01400516|473499011|FG001|Primary Trial|Withdrawal by Subject|2|||
131510698|NCT01796197|473499017|FG000|Overall Study|Lost to Follow-up|1|||
131510699|NCT01796197|473499017|FG000|Overall Study|Lack of Efficacy|1|||
131510700|NCT04365556|473499018|FG000|Overall Study|No longer eligible due to treatment plan|1|||
131510701|NCT04365556|473499019|FG001|Overall Study|No longer eligible due to treatment plan|0|||
131510702|NCT04365556|473499018|FG000|Overall Study|Lost to Follow-up|3|||
131510703|NCT04365556|473499019|FG001|Overall Study|Lost to Follow-up|2|||
131510704|NCT05756790|473499020|FG000|Overall Study|Withdrawal by Subject|1|||
131510705|NCT05756790|473499021|FG001|Overall Study|Withdrawal by Subject|1|||
131510706|NCT05756790|473499022|FG002|Overall Study|Withdrawal by Subject|1|||
131510707|NCT05756790|473499023|FG003|Overall Study|Withdrawal by Subject|1|||
131510708|NCT05756790|473499024|FG004|Overall Study|Withdrawal by Subject|0|||
131510709|NCT05756790|473499025|FG005|Overall Study|Withdrawal by Subject|0|||
131510710|NCT05756790|473499020|FG000|Overall Study|Protocol Violation|0|||
131510711|NCT05756790|473499021|FG001|Overall Study|Protocol Violation|0|||
131510712|NCT05756790|473499022|FG002|Overall Study|Protocol Violation|1|||
131510713|NCT05756790|473499023|FG003|Overall Study|Protocol Violation|1|||
131510714|NCT05756790|473499024|FG004|Overall Study|Protocol Violation|0|||
131510715|NCT05756790|473499025|FG005|Overall Study|Protocol Violation|0|||
131510716|NCT05756790|473499020|FG000|Overall Study|Ineligible|0|||
131510717|NCT05756790|473499021|FG001|Overall Study|Ineligible|0|||
131510718|NCT05756790|473499022|FG002|Overall Study|Ineligible|0|||
131510719|NCT05756790|473499023|FG003|Overall Study|Ineligible|0|||
131510720|NCT05756790|473499024|FG004|Overall Study|Ineligible|2|||
131510721|NCT05756790|473499025|FG005|Overall Study|Ineligible|2|||
131510722|NCT02449239|473500300|FG000|Induction Phase|Lack of Efficacy|64|||
131510723|NCT02449239|473500300|FG000|Induction Phase|Adverse Event|1|||
131510724|NCT02449239|473500300|FG000|Induction Phase|Lost to Follow-up|1|||
131510725|NCT02449239|473500300|FG000|Induction Phase|Protocol Violation|1|||
131510726|NCT02449239|473500300|FG000|Induction Phase|Physician Decision|1|||
131510727|NCT02449239|473500300|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
131510728|NCT02449239|473500300|FG000|Induction Phase|Withdrawal by Subject|1|||
131510729|NCT02449239|473500300|FG000|Maintenance Month 3|Lack of Efficacy|14|||
131510730|NCT02449239|473500300|FG000|Maintenance Month 6|Lack of Efficacy|10|||
131510731|NCT02449239|473500300|FG000|Maintenance Month 6|Adverse Event|2|||
131510732|NCT02449239|473500300|FG000|Maintenance Month 6|Physician Decision|1|||
131510733|NCT02449239|473500300|FG000|Maintenance Month 9|Lack of Efficacy|2|||
131510734|NCT02449239|473500300|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
131510735|NCT02449239|473500300|FG000|Maintenance Month 12|Lack of Efficacy|5|||
131510736|NCT02449239|473500300|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
131510737|NCT02449239|473500300|FG000|Maintenance Month 12|Subject moved from area|1|||
131510738|NCT02449239|473500300|FG000|Maintenance Month 15|Lack of Efficacy|1|||
131510739|NCT02449239|473500300|FG000|Maintenance Month 21|Lack of Efficacy|1|||
131510740|NCT02449239|473500300|FG000|Maintenance Month 21|Sponsor decision|1|||
131510741|NCT05664490|473500310|FG000|Overall Study|Withdrawal by Subject|0|||
131510742|NCT05664490|473500311|FG001|Overall Study|Withdrawal by Subject|1|||
131510743|NCT05664490|473500310|FG000|Overall Study|Lost to Follow-up|14|||
131510744|NCT05664490|473500311|FG001|Overall Study|Lost to Follow-up|22|||
131510745|NCT04064294|473500312|FG000|Overall Study|Adverse Event|1|||
131510746|NCT04064294|473500313|FG001|Overall Study|Adverse Event|0|||
131510747|NCT04064294|473500314|FG002|Overall Study|Adverse Event|0|||
131510748|NCT00481195|473500315|FG000|Overall Study|Adverse Event|16|||
131510749|NCT00481195|473500316|FG001|Overall Study|Adverse Event|11|||
131510750|NCT00481195|473500315|FG000|Overall Study|Lack of Efficacy|1|||
131510751|NCT00481195|473500316|FG001|Overall Study|Lack of Efficacy|3|||
131510752|NCT00481195|473500315|FG000|Overall Study|Lost to Follow-up|4|||
131510753|NCT00481195|473500316|FG001|Overall Study|Lost to Follow-up|6|||
131510754|NCT00481195|473500315|FG000|Overall Study|Physician Decision|3|||
131510755|NCT00481195|473500316|FG001|Overall Study|Physician Decision|1|||
131510756|NCT00481195|473500315|FG000|Overall Study|Protocol Violation|10|||
131510757|NCT00481195|473500316|FG001|Overall Study|Protocol Violation|7|||
131510758|NCT00481195|473500315|FG000|Overall Study|Withdrawal by Subject|3|||
131510759|NCT00481195|473500316|FG001|Overall Study|Withdrawal by Subject|9|||
131510760|NCT00481195|473500315|FG000|Overall Study|Miscellaneous|2|||
131510761|NCT00481195|473500316|FG001|Overall Study|Miscellaneous|2|||
131510762|NCT01505608|473500317|FG000|Phase I|Lack of Efficacy|0|||
131510763|NCT01505608|473500318|FG001|Phase I|Lack of Efficacy|4|||
131510764|NCT01505608|473500317|FG000|Phase I|Adverse Event|0|||
131510765|NCT01505608|473500318|FG001|Phase I|Adverse Event|1|||
131510766|NCT01505608|473500317|FG000|Phase I|Withdrawal by Subject|0|||
131510767|NCT01505608|473500318|FG001|Phase I|Withdrawal by Subject|1|||
131510768|NCT01505608|473500317|FG000|Phase II|Lack of Efficacy|2|||
131510769|NCT01505608|473500318|FG001|Phase II|Lack of Efficacy|1|||
131510770|NCT01505608|473500317|FG000|Phase II|Protocol Violation|0|||
131510771|NCT01505608|473500318|FG001|Phase II|Protocol Violation|1|||
131510772|NCT03975647|473500319|FG000|Overall Study|Death|71|||
131510773|NCT03975647|473500320|FG001|Overall Study|Death|63|||
131510774|NCT03975647|473500319|FG000|Overall Study|Lost to Follow-up|2|||
131510775|NCT03975647|473500320|FG001|Overall Study|Lost to Follow-up|2|||
131510776|NCT03975647|473500319|FG000|Overall Study|Subject withdrawal of consent|7|||
131510777|NCT03975647|473500320|FG001|Overall Study|Subject withdrawal of consent|11|||
131510778|NCT00439556|473500321|FG000|Overall Study|Patient was taken off study for non-comp|0|||
131510779|NCT00439556|473500322|FG001|Overall Study|Patient was taken off study for non-comp|1|||
131510780|NCT00439556|473500323|FG002|Overall Study|Patient was taken off study for non-comp|0|||
131510781|NCT02871739|473500324|FG000|Overall Study|Lost to Follow-up|3|||
131510782|NCT02871739|473500325|FG001|Overall Study|Lost to Follow-up|2|||
131510783|NCT02871739|473500326|FG002|Overall Study|Lost to Follow-up|0|||
131510784|NCT02871739|473500327|FG003|Overall Study|Lost to Follow-up|2|||
131510785|NCT01324388|473500330|FG000|Part 1 of Study|Adverse Event|2|||
131510786|NCT01324388|473500331|FG001|Part 1 of Study|Adverse Event|0|||
131510787|NCT01324388|473500332|FG002|Part 1 of Study|Adverse Event|0|||
131510788|NCT01324388|473500333|FG003|Part 1 of Study|Adverse Event|0|||
131510789|NCT01324388|473500330|FG000|Part 1 of Study|Protocol Violation|1|||
131510790|NCT01324388|473500331|FG001|Part 1 of Study|Protocol Violation|2|||
131510791|NCT01324388|473500332|FG002|Part 1 of Study|Protocol Violation|0|||
131510792|NCT01324388|473500333|FG003|Part 1 of Study|Protocol Violation|0|||
131510793|NCT01324388|473500330|FG000|Part 1 of Study|Physician Decision|1|||
131510794|NCT01324388|473500331|FG001|Part 1 of Study|Physician Decision|0|||
131510795|NCT01324388|473500332|FG002|Part 1 of Study|Physician Decision|0|||
131510796|NCT01324388|473500333|FG003|Part 1 of Study|Physician Decision|0|||
131510797|NCT01324388|473500330|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
131510798|NCT01324388|473500331|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
131510799|NCT01324388|473500332|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
131510800|NCT01324388|473500333|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
131510801|NCT01324388|473500330|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
131510802|NCT01324388|473500331|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
131510803|NCT01324388|473500332|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
131510804|NCT01324388|473500333|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
131510805|NCT01405963|473500334|FG000|Overall Study|Moved Away|2|||
131510806|NCT01405963|473500335|FG001|Overall Study|Moved Away|0|||
131510807|NCT01405963|473500334|FG000|Overall Study|Adverse Event|0|||
131510808|NCT01405963|473500335|FG001|Overall Study|Adverse Event|1|||
131510809|NCT01405963|473500334|FG000|Overall Study|Lost to Follow-up|0|||
131510810|NCT01405963|473500335|FG001|Overall Study|Lost to Follow-up|1|||
131510811|NCT01085097|473500336|FG000|Overall Study|Adverse Event|0|||
131510812|NCT01085097|473500337|FG001|Overall Study|Adverse Event|0|||
131510813|NCT01085097|473500338|FG002|Overall Study|Adverse Event|2|||
131510814|NCT01085097|473500336|FG000|Overall Study|Treatment failure|2|||
131510815|NCT01085097|473500337|FG001|Overall Study|Treatment failure|0|||
131510816|NCT01085097|473500338|FG002|Overall Study|Treatment failure|0|||
131510817|NCT01498640|473500341|FG000|Overall Study|Lost to Follow-up|1|||
131510818|NCT01498640|473500341|FG000|Overall Study|Death|1|||
131510819|NCT01498640|473500341|FG000|Overall Study|Other|3|||
131510820|NCT02197806|473500346|FG000|Overall Study|Adverse Event|0|||
131510821|NCT02197806|473500347|FG001|Overall Study|Adverse Event|1|||
131510822|NCT02197806|473500348|FG002|Overall Study|Adverse Event|0|||
131510823|NCT02197806|473500349|FG003|Overall Study|Adverse Event|1|||
131510824|NCT03065244|473500356|FG000|Overall Study|Lost to Follow-up|1|||
131510825|NCT03065244|473500357|FG001|Overall Study|Lost to Follow-up|1|||
131510826|NCT03065244|473500356|FG000|Overall Study|Diagnosed with a different disease|1|||
131510827|NCT03065244|473500357|FG001|Overall Study|Diagnosed with a different disease|1|||
131510828|NCT03065244|473500356|FG000|Overall Study|Protocol Violation|0|||
131510829|NCT03065244|473500357|FG001|Overall Study|Protocol Violation|1|||
131510830|NCT03065244|473500356|FG000|Overall Study|Withdrawal by Subject|1|||
131510831|NCT03065244|473500357|FG001|Overall Study|Withdrawal by Subject|1|||
131510832|NCT03717480|473500358|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
131510833|NCT02965703|473500363|FG000|Overall Study|Withdrawal by Subject|6|||
131510834|NCT02965703|473500364|FG001|Overall Study|Withdrawal by Subject|3|||
131510835|NCT02965703|473500365|FG002|Overall Study|Withdrawal by Subject|1|||
131510836|NCT02965703|473500363|FG000|Overall Study|Protocol Violation|1|||
131510837|NCT02965703|473500364|FG001|Overall Study|Protocol Violation|0|||
131510838|NCT02965703|473500365|FG002|Overall Study|Protocol Violation|0|||
131510839|NCT02965703|473500363|FG000|Overall Study|Adverse Event|1|||
131510840|NCT02965703|473500364|FG001|Overall Study|Adverse Event|1|||
131510841|NCT02965703|473500365|FG002|Overall Study|Adverse Event|0|||
131510842|NCT02965703|473500363|FG000|Overall Study|Lost to Follow-up|2|||
131510843|NCT02965703|473500364|FG001|Overall Study|Lost to Follow-up|1|||
131510844|NCT02965703|473500365|FG002|Overall Study|Lost to Follow-up|1|||
131510845|NCT00768144|473500366|FG000|Overall Study|Adverse Event|13|||
131510846|NCT00768144|473500366|FG000|Overall Study|Progressive Disease|21|||
131510847|NCT00768144|473500366|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
131510848|NCT00768144|473500366|FG000|Overall Study|Pt Withdrew Consent|1|||
131510849|NCT04251221|473500367|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
131510850|NCT04251221|473500368|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
131510851|NCT02968979|473500369|FG000|Overall Study|Protocol Violation|7|||
131510852|NCT02968979|473500369|FG000|Overall Study|Withdrawal by Subject|1|||
131510853|NCT03320564|473500371|FG000|Overall Study|Protocol Violation|1|||
131510854|NCT00994240|473500372|FG000|Overall Study|Lost to Follow-up|3|||
131510855|NCT00994240|473500373|FG001|Overall Study|Lost to Follow-up|2|||
131510856|NCT00994240|473500372|FG000|Overall Study|Withdrawal by Subject|1|||
131510857|NCT00994240|473500373|FG001|Overall Study|Withdrawal by Subject|0|||
131510858|NCT00994240|473500372|FG000|Overall Study|study termination|2|||
131510859|NCT00994240|473500373|FG001|Overall Study|study termination|3|||
131510860|NCT03745144|473500374|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
131510861|NCT03745144|473500375|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
131510862|NCT03745144|473500376|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
131510863|NCT03745144|473500374|FG000|Period 1|Other|0|||
131510864|NCT03745144|473500375|FG001|Period 1|Other|0|||
131510865|NCT03745144|473500376|FG002|Period 1|Other|1|||
131510866|NCT00896337|473500377|FG000|Overall Study|Death|7|||
131510867|NCT00896337|473500377|FG000|Overall Study|Withdrawal by Subject|7|||
131510868|NCT00896337|473500377|FG000|Overall Study|Lost to Follow-up|11|||
131510869|NCT01586819|473500378|FG000|Overall Study|Withdrawal by Subject|1|||
131510870|NCT01586819|473500379|FG001|Overall Study|Withdrawal by Subject|0|||
131510871|NCT04668950|473500380|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
131510872|NCT04668950|473500381|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
131510873|NCT04668950|473500380|FG000|Overall Study|Could not confirm started study medication|15|||
131510874|NCT04668950|473500381|FG001|Overall Study|Could not confirm started study medication|15|||
131510875|NCT04668950|473500380|FG000|Overall Study|Could not confirm baseline status|6|||
131510876|NCT04668950|473500381|FG001|Overall Study|Could not confirm baseline status|2|||
131510877|NCT04668950|473500380|FG000|Overall Study|Drop out and did not start medication|15|||
131510878|NCT04668950|473500381|FG001|Overall Study|Drop out and did not start medication|17|||
131510879|NCT04668950|473500380|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
131510880|NCT04668950|473500381|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
131510881|NCT04668950|473500380|FG000|Overall Study|Other|2|||
131510882|NCT04668950|473500381|FG001|Overall Study|Other|4|||
131510883|NCT01124643|473500387|FG000|Overall Study|Death|1|||
131510884|NCT01063595|473500390|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
131510885|NCT01063595|473500391|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
131510886|NCT01063595|473500390|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
131510887|NCT01063595|473500391|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
131510888|NCT01063595|473500390|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
131510889|NCT01063595|473500391|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
131510890|NCT01063595|473500390|FG000|First Intervention|Adverse Event|1|||
131510891|NCT01063595|473500391|FG001|First Intervention|Adverse Event|4|||
131510892|NCT01063595|473500390|FG000|First Intervention|Withdrawal by Subject|1|||
131510893|NCT01063595|473500391|FG001|First Intervention|Withdrawal by Subject|0|||
131510894|NCT01063595|473500390|FG000|First Intervention|Reason not Specified|0|||
131510895|NCT01063595|473500391|FG001|First Intervention|Reason not Specified|1|||
131510896|NCT04059146|473500392|FG000|Overall Study|Withdrawal by Subject|0|||
131510897|NCT04059146|473500393|FG001|Overall Study|Withdrawal by Subject|1|||
131510898|NCT00747435|473500394|FG000|Overall Study|Lost to Follow-up|2|||
131510899|NCT00747435|473500394|FG000|Overall Study|Withdrawal by Subject|3|||
131510900|NCT00747435|473500394|FG000|Overall Study|Still undergoing follow up|1|||
131510901|NCT01132495|473500399|FG000|Overall Study|Various reasons|40|||
131510902|NCT01132495|473500400|FG001|Overall Study|Various reasons|38|||
131510903|NCT01132495|473500401|FG002|Overall Study|Various reasons|20|||
131510904|NCT01132495|473500402|FG003|Overall Study|Various reasons|12|||
131510905|NCT00082433|473500404|FG000|Overall Study|Adverse Event|12|||
131510906|NCT00082433|473500405|FG001|Overall Study|Adverse Event|17|||
131510907|NCT00082433|473500404|FG000|Overall Study|Death|8|||
131510908|NCT00082433|473500405|FG001|Overall Study|Death|18|||
131510909|NCT00082433|473500404|FG000|Overall Study|Disease Progression/Relapse|270|||
131510910|NCT00082433|473500405|FG001|Overall Study|Disease Progression/Relapse|388|||
131510911|NCT00082433|473500404|FG000|Overall Study|Physician Decision|50|||
131510912|NCT00082433|473500405|FG001|Overall Study|Physician Decision|61|||
131510913|NCT00082433|473500404|FG000|Overall Study|Lost to Follow-up|1|||
131510914|NCT00082433|473500405|FG001|Overall Study|Lost to Follow-up|2|||
131510915|NCT00082433|473500404|FG000|Overall Study|Study Drug Toxicity|179|||
131510916|NCT00082433|473500405|FG001|Overall Study|Study Drug Toxicity|66|||
131510917|NCT00082433|473500404|FG000|Overall Study|Withdrawal by Subject|55|||
131510918|NCT00082433|473500405|FG001|Overall Study|Withdrawal by Subject|30|||
131510919|NCT00082433|473500404|FG000|Overall Study|Still On Treatment|2|||
131510920|NCT00082433|473500405|FG001|Overall Study|Still On Treatment|1|||
131510921|NCT00082433|473500404|FG000|Overall Study|Not Treated|12|||
131510922|NCT00082433|473500405|FG001|Overall Study|Not Treated|11|||
131510923|NCT00082433|473500404|FG000|Overall Study|Ineligible|2|||
131510924|NCT00082433|473500405|FG001|Overall Study|Ineligible|1|||
131510925|NCT00082433|473500404|FG000|Overall Study|Noncompliance|2|||
131510926|NCT00082433|473500405|FG001|Overall Study|Noncompliance|1|||
131510927|NCT00082433|473500404|FG000|Overall Study|New primary cancer|1|||
131510928|NCT00082433|473500405|FG001|Overall Study|New primary cancer|0|||
131510929|NCT00082433|473500404|FG000|Overall Study|Impending surgery|0|||
131510930|NCT00082433|473500405|FG001|Overall Study|Impending surgery|1|||
131510931|NCT01380184|473500408|FG000|Part 1 (19 Days)|Adverse Event|1|||
131510932|NCT01380184|473500408|FG000|Part 2|Adverse Event|5|||
131510933|NCT01380184|473500408|FG000|Part 2|Disease Progression|8|||
131510934|NCT01380184|473500408|FG000|Part 2|Lost to Follow-up|1|||
131510935|NCT04097821|473500409|FG000|Overall Study|Subject Decision|0|||
131510936|NCT04097821|473500410|FG001|Overall Study|Subject Decision|0|||
131510937|NCT04097821|473500411|FG002|Overall Study|Subject Decision|0|||
131510938|NCT04097821|473500412|FG003|Overall Study|Subject Decision|1|||
131510939|NCT04097821|473500413|FG004|Overall Study|Subject Decision|2|||
131510940|NCT04097821|473500414|FG005|Overall Study|Subject Decision|2|||
131510941|NCT04097821|473500415|FG006|Overall Study|Subject Decision|0|||
131510942|NCT04097821|473500416|FG007|Overall Study|Subject Decision|1|||
131510943|NCT04097821|473500409|FG000|Overall Study|Death|0|||
131510944|NCT04097821|473500410|FG001|Overall Study|Death|0|||
131510945|NCT04097821|473500411|FG002|Overall Study|Death|3|||
131510946|NCT04097821|473500412|FG003|Overall Study|Death|1|||
131510947|NCT04097821|473500413|FG004|Overall Study|Death|0|||
131510948|NCT04097821|473500414|FG005|Overall Study|Death|0|||
131510949|NCT04097821|473500415|FG006|Overall Study|Death|0|||
131510950|NCT04097821|473500416|FG007|Overall Study|Death|0|||
131510951|NCT04097821|473500409|FG000|Overall Study|Physician Decision|1|||
131510952|NCT04097821|473500410|FG001|Overall Study|Physician Decision|2|||
131510953|NCT04097821|473500411|FG002|Overall Study|Physician Decision|0|||
131510954|NCT04097821|473500412|FG003|Overall Study|Physician Decision|0|||
131510955|NCT04097821|473500413|FG004|Overall Study|Physician Decision|0|||
131510956|NCT04097821|473500414|FG005|Overall Study|Physician Decision|0|||
131510957|NCT04097821|473500415|FG006|Overall Study|Physician Decision|0|||
131510958|NCT04097821|473500416|FG007|Overall Study|Physician Decision|0|||
131510959|NCT04097821|473500409|FG000|Overall Study|Adverse Event|0|||
131510960|NCT04097821|473500410|FG001|Overall Study|Adverse Event|0|||
131510961|NCT04097821|473500411|FG002|Overall Study|Adverse Event|1|||
131510962|NCT04097821|473500412|FG003|Overall Study|Adverse Event|1|||
131510963|NCT04097821|473500413|FG004|Overall Study|Adverse Event|0|||
131510964|NCT04097821|473500414|FG005|Overall Study|Adverse Event|0|||
131510965|NCT04097821|473500415|FG006|Overall Study|Adverse Event|0|||
131510966|NCT04097821|473500416|FG007|Overall Study|Adverse Event|0|||
131510967|NCT04097821|473500409|FG000|Overall Study|New Therapy For Study Indication|0|||
131510968|NCT04097821|473500410|FG001|Overall Study|New Therapy For Study Indication|0|||
131510969|NCT04097821|473500411|FG002|Overall Study|New Therapy For Study Indication|0|||
131510970|NCT04097821|473500412|FG003|Overall Study|New Therapy For Study Indication|0|||
131510971|NCT04097821|473500413|FG004|Overall Study|New Therapy For Study Indication|0|||
131510972|NCT04097821|473500414|FG005|Overall Study|New Therapy For Study Indication|0|||
131510973|NCT04097821|473500415|FG006|Overall Study|New Therapy For Study Indication|1|||
131510974|NCT04097821|473500416|FG007|Overall Study|New Therapy For Study Indication|0|||
131510975|NCT04243538|473500417|FG000|Overall Study|Withdrawal by Subject|0|||
131510976|NCT04243538|473500418|FG001|Overall Study|Withdrawal by Subject|2|||
131510977|NCT04243538|473500417|FG000|Overall Study|Lost to Follow-up|0|||
131510978|NCT04243538|473500418|FG001|Overall Study|Lost to Follow-up|3|||
131510979|NCT02776917|473500419|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
131510980|NCT00502697|473501873|FG000|Overall Study|Withdrawal by Subject|3|||
131510981|NCT00502697|473501874|FG001|Overall Study|Withdrawal by Subject|1|||
131510982|NCT00502697|473501873|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
131510983|NCT00502697|473501874|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
131510984|NCT00502697|473501873|FG000|Overall Study|found not to meet eligibility criteria|3|||
131510985|NCT00502697|473501874|FG001|Overall Study|found not to meet eligibility criteria|4|||
131510986|NCT00502697|473501873|FG000|Overall Study|did not meet assignment criteria|4|||
131510987|NCT00502697|473501874|FG001|Overall Study|did not meet assignment criteria|2|||
131510988|NCT01545817|473501876|FG000|Pazopanib|Disease progression|51|||
131510989|NCT01545817|473501877|FG001|Pazopanib|Disease progression|0|||
131510990|NCT01545817|473501876|FG000|Pazopanib|Adverse Event|19|||
131510991|NCT01545817|473501877|FG001|Pazopanib|Adverse Event|0|||
131510992|NCT01545817|473501876|FG000|Pazopanib|Other reason|4|||
131510993|NCT01545817|473501877|FG001|Pazopanib|Other reason|0|||
131510994|NCT01545817|473501876|FG000|Everolimus|Other reason|0|||
131510995|NCT01545817|473501877|FG001|Everolimus|Other reason|7|||
131510996|NCT01545817|473501876|FG000|Everolimus|Disease progression|0|||
131510997|NCT01545817|473501877|FG001|Everolimus|Disease progression|25|||
131510998|NCT01545817|473501876|FG000|Everolimus|Adverse Event|0|||
131510999|NCT01545817|473501877|FG001|Everolimus|Adverse Event|6|||
131511000|NCT02622828|473501883|FG000|Overall Study|participant withdrew|3|||
131511001|NCT02780804|473501886|FG000|Overall Study|Death|1|||
131511002|NCT02780804|473501887|FG001|Overall Study|Death|0|||
131511003|NCT02780804|473501888|FG002|Overall Study|Death|0|||
131511004|NCT02780804|473501886|FG000|Overall Study|Lack of Efficacy|5|||
131511005|NCT02780804|473501887|FG001|Overall Study|Lack of Efficacy|8|||
131511006|NCT02780804|473501888|FG002|Overall Study|Lack of Efficacy|4|||
131511007|NCT02780804|473501886|FG000|Overall Study|Physician Decision|0|||
131511008|NCT02780804|473501887|FG001|Overall Study|Physician Decision|0|||
131511009|NCT02780804|473501888|FG002|Overall Study|Physician Decision|2|||
131511010|NCT02780804|473501886|FG000|Overall Study|Withdrawal by Subject|0|||
131511011|NCT02780804|473501887|FG001|Overall Study|Withdrawal by Subject|1|||
131511012|NCT02780804|473501888|FG002|Overall Study|Withdrawal by Subject|0|||
131511013|NCT01921829|473501891|FG000|Overall Study|Withdrawal by Subject|0|||
131511014|NCT01921829|473501892|FG001|Overall Study|Withdrawal by Subject|1|||
131511015|NCT02256891|473501899|FG000|Overall Study|Death|0|||
131511016|NCT02256891|473501900|FG001|Overall Study|Death|2|||
131511017|NCT02256891|473501899|FG000|Overall Study|Lost to Follow-up|0|||
131511018|NCT02256891|473501900|FG001|Overall Study|Lost to Follow-up|3|||
131511019|NCT02256891|473501899|FG000|Overall Study|Physician Decision|7|||
131511020|NCT02256891|473501900|FG001|Overall Study|Physician Decision|3|||
131511021|NCT02256891|473501899|FG000|Overall Study|Screen Fail|5|||
131511022|NCT02256891|473501900|FG001|Overall Study|Screen Fail|4|||
131511023|NCT02256891|473501899|FG000|Overall Study|Equipment Malfunction|0|||
131511024|NCT02256891|473501900|FG001|Overall Study|Equipment Malfunction|1|||
131511025|NCT01344447|473501901|FG000|Overall Study|Adverse Event|1|||
131511026|NCT01344447|473501901|FG000|Overall Study|Protocol Violation|1|||
131511027|NCT01344447|473501901|FG000|Overall Study|Withdrawal by Subject|1|||
131511028|NCT01344447|473501901|FG000|Overall Study|The contrast was not seen|1|||
131511029|NCT01344447|473501901|FG000|Overall Study|Physician Decision|1|||
131511030|NCT01344447|473501901|FG000|Overall Study|MRA unsuccessful|1|||
131511031|NCT01344447|473501901|FG000|Overall Study|Bolus tracking failed|1|||
131511032|NCT01344447|473501901|FG000|Overall Study|Error of power injector|1|||
131511033|NCT03314584|473501913|FG000|Overall Study|Withdrawal by Subject|3|||
131511034|NCT03314584|473501914|FG001|Overall Study|Withdrawal by Subject|3|||
131511035|NCT03314584|473501913|FG000|Overall Study|Lost to Follow-up|4|||
131511036|NCT03314584|473501914|FG001|Overall Study|Lost to Follow-up|0|||
131511037|NCT06134817|473501915|FG000|Overall Study|Physician Departure - termination of study|1|||
131511038|NCT01990495|473501927|FG000|Overall Study|Physician Decision|5|||
131511039|NCT01990495|473501928|FG001|Overall Study|Physician Decision|4|||
131511040|NCT03412084|473501929|FG000|Overall Study|Withdrawal by Subject|2|||
131511041|NCT03412084|473501930|FG001|Overall Study|Withdrawal by Subject|0|||
131511042|NCT03412084|473501929|FG000|Overall Study|Participant moved|1|||
131511043|NCT03412084|473501930|FG001|Overall Study|Participant moved|0|||
131511044|NCT03412084|473501929|FG000|Overall Study|Lost to Follow-up|1|||
131511045|NCT03412084|473501930|FG001|Overall Study|Lost to Follow-up|1|||
131511046|NCT01928862|473501931|FG000|Overall Study|Lost to Follow-up|1|||
131511047|NCT01928862|473501932|FG001|Overall Study|Lost to Follow-up|0|||
131511048|NCT01928862|473501933|FG002|Overall Study|Lost to Follow-up|0|||
131511049|NCT01928862|473501934|FG003|Overall Study|Lost to Follow-up|0|||
131511050|NCT01928862|473501935|FG004|Overall Study|Lost to Follow-up|1|||
131511051|NCT04649164|473501936|FG000|Overall Study|Withdrawal by Subject|1|||
131511052|NCT04649164|473501937|FG001|Overall Study|Withdrawal by Subject|1|||
131511053|NCT04649164|473501938|FG002|Overall Study|Withdrawal by Subject|2|||
131511054|NCT04649164|473501936|FG000|Overall Study|Participant's care recipient expired|0|||
131511055|NCT04649164|473501937|FG001|Overall Study|Participant's care recipient expired|0|||
131511056|NCT04649164|473501938|FG002|Overall Study|Participant's care recipient expired|2|||
131511057|NCT02053753|473501939|FG000|Overall Study|Withdrawal by Subject|2|||
131511058|NCT02053753|473501940|FG001|Overall Study|Withdrawal by Subject|4|||
131511059|NCT02053753|473501939|FG000|Overall Study|Decision by Sponsor|1|||
131511060|NCT02053753|473501940|FG001|Overall Study|Decision by Sponsor|1|||
131511061|NCT02053753|473501939|FG000|Overall Study|Lost to Follow-up|4|||
131511062|NCT02053753|473501940|FG001|Overall Study|Lost to Follow-up|3|||
131511063|NCT02023151|473501947|FG000|Overall Study|Lost to Follow-up|4|||
131511064|NCT03450707|473501948|FG000|Overall Study|Outside enrollment window|4|||
131511065|NCT03450707|473501949|FG001|Overall Study|Outside enrollment window|1|||
131511066|NCT03450707|473501948|FG000|Overall Study|Death|1|||
131511067|NCT03450707|473501949|FG001|Overall Study|Death|0|||
131511068|NCT03450707|473501948|FG000|Overall Study|Indication for thiamine|1|||
131511069|NCT03450707|473501949|FG001|Overall Study|Indication for thiamine|1|||
131511070|NCT03450707|473501948|FG000|Overall Study|Evidence of traumatic brain injury|1|||
131511071|NCT03450707|473501949|FG001|Overall Study|Evidence of traumatic brain injury|0|||
131511072|NCT03450707|473501948|FG000|Overall Study|Following commands|0|||
131511073|NCT03450707|473501949|FG001|Overall Study|Following commands|3|||
131511074|NCT03450707|473501948|FG000|Overall Study|Lactate < 3.5|0|||
131511075|NCT03450707|473501949|FG001|Overall Study|Lactate < 3.5|2|||
131511076|NCT03450707|473501948|FG000|Overall Study|Rearrest with ECMO|0|||
131511077|NCT03450707|473501949|FG001|Overall Study|Rearrest with ECMO|1|||
131511078|NCT03450707|473501948|FG000|Overall Study|Indication for thiamine + head CT results|0|||
131511079|NCT03450707|473501949|FG001|Overall Study|Indication for thiamine + head CT results|1|||
131511080|NCT03450707|473501948|FG000|Overall Study|Family/patient goals of care|0|||
131511081|NCT03450707|473501949|FG001|Overall Study|Family/patient goals of care|1|||
131511082|NCT03343483|473501950|FG000|Overall Study|Death|0|||
131511083|NCT03343483|473501951|FG001|Overall Study|Death|3|||
131511084|NCT03343483|473501950|FG000|Overall Study|Lost to Follow-up|9|||
131511085|NCT03343483|473501951|FG001|Overall Study|Lost to Follow-up|13|||
131511086|NCT03343483|473501950|FG000|Overall Study|Withdrawal by Subject|8|||
131511087|NCT03343483|473501951|FG001|Overall Study|Withdrawal by Subject|17|||
131511088|NCT02932904|473501952|FG000|Overall Study|Reason not Specified|1|||
131511089|NCT02932904|473501953|FG001|Overall Study|Reason not Specified|0|||
131511090|NCT02932904|473501954|FG002|Overall Study|Reason not Specified|2|||
131511091|NCT02932904|473501955|FG003|Overall Study|Reason not Specified|2|||
131511092|NCT02932904|473501952|FG000|Overall Study|Noncompliance with Study Drug|2|||
131511093|NCT02932904|473501953|FG001|Overall Study|Noncompliance with Study Drug|3|||
131511094|NCT02932904|473501954|FG002|Overall Study|Noncompliance with Study Drug|3|||
131511095|NCT02932904|473501955|FG003|Overall Study|Noncompliance with Study Drug|4|||
131511096|NCT02932904|473501952|FG000|Overall Study|Pregnancy|0|||
131511097|NCT02932904|473501953|FG001|Overall Study|Pregnancy|1|||
131511098|NCT02932904|473501954|FG002|Overall Study|Pregnancy|1|||
131511099|NCT02932904|473501955|FG003|Overall Study|Pregnancy|0|||
131511100|NCT02932904|473501952|FG000|Overall Study|Study Termination|0|||
131511101|NCT02932904|473501953|FG001|Overall Study|Study Termination|1|||
131511102|NCT02932904|473501954|FG002|Overall Study|Study Termination|0|||
131511103|NCT02932904|473501955|FG003|Overall Study|Study Termination|0|||
131511104|NCT02932904|473501952|FG000|Overall Study|Voluntary Withdrawal|2|||
131511105|NCT02932904|473501953|FG001|Overall Study|Voluntary Withdrawal|1|||
131511106|NCT02932904|473501954|FG002|Overall Study|Voluntary Withdrawal|4|||
131511107|NCT02932904|473501955|FG003|Overall Study|Voluntary Withdrawal|2|||
131511108|NCT02932904|473501952|FG000|Overall Study|Lost to Follow-up|5|||
131511109|NCT02932904|473501953|FG001|Overall Study|Lost to Follow-up|3|||
131511110|NCT02932904|473501954|FG002|Overall Study|Lost to Follow-up|6|||
131511111|NCT02932904|473501955|FG003|Overall Study|Lost to Follow-up|0|||
131511112|NCT02932904|473501952|FG000|Overall Study|Significant Protocol Deviation|2|||
131511113|NCT02932904|473501953|FG001|Overall Study|Significant Protocol Deviation|3|||
131511114|NCT02932904|473501954|FG002|Overall Study|Significant Protocol Deviation|6|||
131511115|NCT02932904|473501955|FG003|Overall Study|Significant Protocol Deviation|1|||
131511116|NCT02932904|473501952|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
131511117|NCT02932904|473501953|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
131511118|NCT02932904|473501954|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
131511119|NCT02932904|473501955|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
131511120|NCT02932904|473501952|FG000|Overall Study|Randomized But Not Treated|1|||
131511121|NCT02932904|473501953|FG001|Overall Study|Randomized But Not Treated|1|||
131511122|NCT02932904|473501954|FG002|Overall Study|Randomized But Not Treated|0|||
131511123|NCT02932904|473501955|FG003|Overall Study|Randomized But Not Treated|2|||
131511124|NCT00337103|473501956|FG000|Overall Study|Progressive Disease|414|||
131511125|NCT00337103|473501957|FG001|Overall Study|Progressive Disease|410|||
131511126|NCT00337103|473501956|FG000|Overall Study|Adverse Event|45|||
131511127|NCT00337103|473501957|FG001|Overall Study|Adverse Event|59|||
131511128|NCT00337103|473501956|FG000|Overall Study|Subject Choice|34|||
131511129|NCT00337103|473501957|FG001|Overall Study|Subject Choice|27|||
131511130|NCT00337103|473501956|FG000|Overall Study|Clinical Progression|27|||
131511131|NCT00337103|473501957|FG001|Overall Study|Clinical Progression|24|||
131511132|NCT00337103|473501956|FG000|Overall Study|Physician Decision|15|||
131511133|NCT00337103|473501957|FG001|Overall Study|Physician Decision|14|||
131511134|NCT00337103|473501956|FG000|Overall Study|Withdrawal by Subject|8|||
131511135|NCT00337103|473501957|FG001|Overall Study|Withdrawal by Subject|5|||
131511136|NCT00337103|473501956|FG000|Overall Study|Other|5|||
131511137|NCT00337103|473501957|FG001|Overall Study|Other|6|||
131511138|NCT00337103|473501956|FG000|Overall Study|Entry Criteria Not Met|4|||
131511139|NCT00337103|473501957|FG001|Overall Study|Entry Criteria Not Met|1|||
131511140|NCT00337103|473501956|FG000|Overall Study|Lost to Follow-up|1|||
131511141|NCT00337103|473501957|FG001|Overall Study|Lost to Follow-up|2|||
131511142|NCT00337103|473501956|FG000|Overall Study|Death|1|||
131511143|NCT00337103|473501957|FG001|Overall Study|Death|0|||
131511144|NCT01577758|473501958|FG000|Dose Escalation Phase|Adverse Event|0|||
131511145|NCT01577758|473501959|FG001|Dose Escalation Phase|Adverse Event|0|||
131511146|NCT01577758|473501960|FG002|Dose Escalation Phase|Adverse Event|0|||
131511147|NCT01577758|473501961|FG003|Dose Escalation Phase|Adverse Event|0|||
131511148|NCT01577758|473501962|FG004|Dose Escalation Phase|Adverse Event|0|||
131511149|NCT01577758|473501963|FG005|Dose Escalation Phase|Adverse Event|2|||
131511150|NCT01577758|473501964|FG006|Dose Escalation Phase|Adverse Event|1|||
131511151|NCT01577758|473501965|FG007|Dose Escalation Phase|Adverse Event|0|||
131511152|NCT01577758|473501958|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
131511153|NCT01577758|473501959|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
131511154|NCT01577758|473501960|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
131511155|NCT01577758|473501961|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
131511156|NCT01577758|473501962|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
131511157|NCT01577758|473501963|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
131511158|NCT01577758|473501964|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
131511159|NCT01577758|473501965|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
131511160|NCT01577758|473501958|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131511161|NCT01577758|473501959|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131511162|NCT01577758|473501960|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131511163|NCT01577758|473501961|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131511164|NCT01577758|473501962|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
131511165|NCT01577758|473501963|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
131511166|NCT01577758|473501964|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
131511167|NCT01577758|473501965|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
131511168|NCT01577758|473501958|FG000|Dose Escalation Phase|Progression Disease|2|||
131511169|NCT01577758|473501959|FG001|Dose Escalation Phase|Progression Disease|2|||
131511170|NCT01577758|473501960|FG002|Dose Escalation Phase|Progression Disease|1|||
131511171|NCT01577758|473501961|FG003|Dose Escalation Phase|Progression Disease|2|||
131511172|NCT01577758|473501962|FG004|Dose Escalation Phase|Progression Disease|5|||
131511173|NCT01577758|473501963|FG005|Dose Escalation Phase|Progression Disease|0|||
131511174|NCT01577758|473501964|FG006|Dose Escalation Phase|Progression Disease|0|||
131511175|NCT01577758|473501965|FG007|Dose Escalation Phase|Progression Disease|0|||
131511176|NCT01577758|473501958|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511177|NCT01577758|473501959|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511178|NCT01577758|473501960|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511179|NCT01577758|473501961|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511180|NCT01577758|473501962|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511181|NCT01577758|473501963|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511182|NCT01577758|473501964|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
131511183|NCT01577758|473501965|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
131511184|NCT01577758|473501958|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511185|NCT01577758|473501959|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511186|NCT01577758|473501960|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511187|NCT01577758|473501961|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511188|NCT01577758|473501962|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511189|NCT01577758|473501963|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511190|NCT01577758|473501964|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
131511191|NCT01577758|473501965|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
131511192|NCT01577758|473501958|FG000|mCRC Expansion Phase|Progression Disease|0|||
131511193|NCT01577758|473501959|FG001|mCRC Expansion Phase|Progression Disease|0|||
131511194|NCT01577758|473501960|FG002|mCRC Expansion Phase|Progression Disease|0|||
131511195|NCT01577758|473501961|FG003|mCRC Expansion Phase|Progression Disease|0|||
131511196|NCT01577758|473501962|FG004|mCRC Expansion Phase|Progression Disease|0|||
131511197|NCT01577758|473501963|FG005|mCRC Expansion Phase|Progression Disease|0|||
131511198|NCT01577758|473501964|FG006|mCRC Expansion Phase|Progression Disease|0|||
131511199|NCT01577758|473501965|FG007|mCRC Expansion Phase|Progression Disease|19|||
131511200|NCT02404350|473501968|FG000|Overall Study|Adverse Event|2|||
131511201|NCT02404350|473501969|FG001|Overall Study|Adverse Event|2|||
131511202|NCT02404350|473501970|FG002|Overall Study|Adverse Event|3|||
131511203|NCT02404350|473501971|FG003|Overall Study|Adverse Event|9|||
131511204|NCT02404350|473501968|FG000|Overall Study|Lack of Efficacy|3|||
131511205|NCT02404350|473501969|FG001|Overall Study|Lack of Efficacy|1|||
131511206|NCT02404350|473501970|FG002|Overall Study|Lack of Efficacy|0|||
131511207|NCT02404350|473501971|FG003|Overall Study|Lack of Efficacy|3|||
131511208|NCT02404350|473501968|FG000|Overall Study|Lost to Follow-up|2|||
131511209|NCT02404350|473501969|FG001|Overall Study|Lost to Follow-up|0|||
131511210|NCT02404350|473501970|FG002|Overall Study|Lost to Follow-up|0|||
131511211|NCT02404350|473501971|FG003|Overall Study|Lost to Follow-up|1|||
131511212|NCT02404350|473501968|FG000|Overall Study|Physician Decision|1|||
131511213|NCT02404350|473501969|FG001|Overall Study|Physician Decision|0|||
131511214|NCT02404350|473501970|FG002|Overall Study|Physician Decision|0|||
131511215|NCT02404350|473501971|FG003|Overall Study|Physician Decision|2|||
131511216|NCT02404350|473501968|FG000|Overall Study|Pregnancy|0|||
131511217|NCT02404350|473501969|FG001|Overall Study|Pregnancy|0|||
131511218|NCT02404350|473501970|FG002|Overall Study|Pregnancy|0|||
131511219|NCT02404350|473501971|FG003|Overall Study|Pregnancy|1|||
131511220|NCT02404350|473501968|FG000|Overall Study|Withdrawal by Subject|7|||
131511221|NCT02404350|473501969|FG001|Overall Study|Withdrawal by Subject|3|||
131511222|NCT02404350|473501970|FG002|Overall Study|Withdrawal by Subject|3|||
131511223|NCT02404350|473501971|FG003|Overall Study|Withdrawal by Subject|19|||
131511224|NCT02404350|473501968|FG000|Overall Study|Due to Non-compliance with treatment|0|||
131511225|NCT02404350|473501969|FG001|Overall Study|Due to Non-compliance with treatment|0|||
131511226|NCT02404350|473501970|FG002|Overall Study|Due to Non-compliance with treatment|0|||
131511227|NCT02404350|473501971|FG003|Overall Study|Due to Non-compliance with treatment|1|||
131511228|NCT02404350|473501968|FG000|Overall Study|Due to Technical problems|0|||
131511229|NCT02404350|473501969|FG001|Overall Study|Due to Technical problems|0|||
131511230|NCT02404350|473501970|FG002|Overall Study|Due to Technical problems|0|||
131511231|NCT02404350|473501971|FG003|Overall Study|Due to Technical problems|1|||
131511232|NCT00600756|473501972|FG000|Analysis After 6 Months|Adverse Event|43|||
131511233|NCT00600756|473501973|FG001|Analysis After 6 Months|Adverse Event|33|||
131511234|NCT00600756|473501972|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
131511235|NCT00600756|473501973|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
131511236|NCT00600756|473501972|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
131511237|NCT00600756|473501973|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
131511238|NCT00600756|473501972|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
131511239|NCT00600756|473501973|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
131511240|NCT00600756|473501972|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
131511241|NCT00600756|473501973|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
131511242|NCT00600756|473501972|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
131511243|NCT00600756|473501973|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
131511244|NCT00600756|473501972|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
131511245|NCT00600756|473501973|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
131511246|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
131511247|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
131511248|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
131511249|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
131511250|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
131511251|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
131511252|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
131511253|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
131511254|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
131511255|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
131511256|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
131511257|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
131511258|NCT00600756|473501972|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
131511259|NCT00600756|473501973|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
131511260|NCT03969992|473501977|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
131658102|NCT04445987|474032995|FG001|Overall Study|Protocol Violation|0|||
131511261|NCT03969992|473501978|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
131511262|NCT03969992|473501979|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
131511263|NCT03969992|473501977|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
131511264|NCT03969992|473501978|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
131511265|NCT03969992|473501979|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
131511266|NCT03969992|473501977|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
131511267|NCT03969992|473501978|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
131511268|NCT03969992|473501979|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
131511269|NCT03969992|473501977|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
131511270|NCT03969992|473501978|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
131511271|NCT03969992|473501979|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
131511272|NCT03969992|473501977|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
131511273|NCT03969992|473501978|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
131511274|NCT03969992|473501979|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
131511275|NCT02319031|473501980|FG000|Treatment Period|Death|1|||
131511276|NCT02319031|473501981|FG001|Treatment Period|Death|0|||
131511277|NCT03519971|473501983|FG000|Overall Study|Death|142|||
131511278|NCT03519971|473501984|FG001|Overall Study|Death|69|||
131511279|NCT03519971|473501983|FG000|Overall Study|Lost to Follow-up|0|||
131511280|NCT03519971|473501984|FG001|Overall Study|Lost to Follow-up|1|||
131511281|NCT03519971|473501983|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
131511282|NCT03519971|473501984|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
131511283|NCT03519971|473501983|FG000|Overall Study|Withdrawal by Subject|3|||
131511284|NCT03519971|473501984|FG001|Overall Study|Withdrawal by Subject|2|||
131511285|NCT03519971|473501983|FG000|Overall Study|Other|1|||
131511286|NCT03519971|473501984|FG001|Overall Study|Other|0|||
131511287|NCT01524692|473501993|FG000|Overall Study|Withdrawal by Subject|3|||
131511288|NCT04007523|473501995|FG000|Overall Study|Withdrawal by Subject|0|||
131511289|NCT04007523|473501996|FG001|Overall Study|Withdrawal by Subject|1|||
131511290|NCT04007523|473501997|FG002|Overall Study|Withdrawal by Subject|1|||
131511291|NCT04007523|473501998|FG003|Overall Study|Withdrawal by Subject|0|||
131511292|NCT04007523|473501995|FG000|Overall Study|ICU Transfer|0|||
131511293|NCT04007523|473501996|FG001|Overall Study|ICU Transfer|1|||
131511294|NCT04007523|473501997|FG002|Overall Study|ICU Transfer|0|||
131511295|NCT04007523|473501998|FG003|Overall Study|ICU Transfer|0|||
131511296|NCT04007523|473501995|FG000|Overall Study|COVID hospital closure|0|||
131511297|NCT04007523|473501996|FG001|Overall Study|COVID hospital closure|0|||
131511298|NCT04007523|473501997|FG002|Overall Study|COVID hospital closure|1|||
131511299|NCT04007523|473501998|FG003|Overall Study|COVID hospital closure|2|||
131511300|NCT04007523|473501995|FG000|Overall Study|Surgery cancelled|0|||
131511301|NCT04007523|473501996|FG001|Overall Study|Surgery cancelled|0|||
131511302|NCT04007523|473501997|FG002|Overall Study|Surgery cancelled|1|||
131511303|NCT04007523|473501998|FG003|Overall Study|Surgery cancelled|1|||
131511304|NCT01774786|473502002|FG000|Overall Study|Death|300|||
131511305|NCT01774786|473502003|FG001|Overall Study|Death|319|||
131511306|NCT01774786|473502002|FG000|Overall Study|Lost to Follow-up|6|||
131511307|NCT01774786|473502003|FG001|Overall Study|Lost to Follow-up|7|||
131511308|NCT01774786|473502002|FG000|Overall Study|Withdrawal by Subject|18|||
131511309|NCT01774786|473502003|FG001|Overall Study|Withdrawal by Subject|14|||
131511310|NCT01774786|473502002|FG000|Overall Study|Physician Decision|2|||
131511311|NCT01774786|473502003|FG001|Overall Study|Physician Decision|0|||
131511312|NCT01774786|473502002|FG000|Overall Study|Non-compliance|0|||
131511313|NCT01774786|473502003|FG001|Overall Study|Non-compliance|1|||
131511314|NCT01774786|473502002|FG000|Overall Study|Reason Not Specified|2|||
131511315|NCT01774786|473502003|FG001|Overall Study|Reason Not Specified|5|||
131511316|NCT04544293|473502004|FG000|Double-blind|Adverse Event|2|||
131511317|NCT04544293|473502005|FG001|Double-blind|Adverse Event|1|||
131511318|NCT04544293|473502004|FG000|Double-blind|Pregnancy|0|||
131511319|NCT04544293|473502005|FG001|Double-blind|Pregnancy|1|||
131511320|NCT04544293|473502004|FG000|Double-blind|Lost to Follow-up|0|||
131511321|NCT04544293|473502005|FG001|Double-blind|Lost to Follow-up|1|||
131511322|NCT04544293|473502004|FG000|Open-Label Extension|Study ongoing|79|||
131511323|NCT04544293|473502005|FG001|Open-Label Extension|Study ongoing|81|||
131511324|NCT02268786|473502007|FG000|Overall Study|No Euploid Embryos available|42|||
131511325|NCT02268786|473502008|FG001|Overall Study|No Euploid Embryos available|0|||
131511326|NCT02268786|473502007|FG000|Overall Study|Withdrawal by Subject|7|||
131511327|NCT02268786|473502008|FG001|Overall Study|Withdrawal by Subject|14|||
131511328|NCT02268786|473502007|FG000|Overall Study|Thaw Failure|6|||
131511329|NCT02268786|473502008|FG001|Overall Study|Thaw Failure|4|||
131511330|NCT02268786|473502007|FG000|Overall Study|Protocol Violation|1|||
131511331|NCT02268786|473502008|FG001|Overall Study|Protocol Violation|0|||
131511332|NCT00744627|473502009|FG000|Overall Study|Adverse Event|6|||
131511333|NCT00744627|473502010|FG001|Overall Study|Adverse Event|9|||
131511334|NCT00744627|473502009|FG000|Overall Study|Lack of Efficacy|7|||
131511335|NCT00744627|473502010|FG001|Overall Study|Lack of Efficacy|3|||
131511336|NCT00744627|473502009|FG000|Overall Study|Noncompliance|0|||
131511337|NCT00744627|473502010|FG001|Overall Study|Noncompliance|1|||
131511338|NCT00744627|473502009|FG000|Overall Study|Protocol Deviations|0|||
131511339|NCT00744627|473502010|FG001|Overall Study|Protocol Deviations|2|||
131511340|NCT00744627|473502009|FG000|Overall Study|Voluntary Withdrawal|9|||
131511341|NCT00744627|473502010|FG001|Overall Study|Voluntary Withdrawal|6|||
131511342|NCT00744627|473502009|FG000|Overall Study|Lost to Follow-up|2|||
131511343|NCT00744627|473502010|FG001|Overall Study|Lost to Follow-up|1|||
131511344|NCT00744627|473502009|FG000|Overall Study|Other|1|||
131511345|NCT00744627|473502010|FG001|Overall Study|Other|0|||
131511346|NCT03608774|473502015|FG000|Overall Study|Lost to Follow-up|5|||
131511347|NCT03608774|473502016|FG001|Overall Study|Lost to Follow-up|5|||
131511348|NCT03608774|473502015|FG000|Overall Study|Withdrawal by Subject|1|||
131511349|NCT03608774|473502016|FG001|Overall Study|Withdrawal by Subject|0|||
131511350|NCT03608774|473502015|FG000|Overall Study|Protocol Violation|1|||
131511351|NCT03608774|473502016|FG001|Overall Study|Protocol Violation|0|||
131511352|NCT03608774|473502015|FG000|Overall Study|Not eligible at enrollment|0|||
131511353|NCT03608774|473502016|FG001|Overall Study|Not eligible at enrollment|1|||
131511354|NCT03608774|473502015|FG000|Overall Study|Health related event|0|||
131511355|NCT03608774|473502016|FG001|Overall Study|Health related event|1|||
131511356|NCT00642668|473502017|FG000|Overall Study|Lost to Follow-up|1|||
131511357|NCT00642668|473502017|FG000|Overall Study|Adverse Event|2|||
131511358|NCT00642668|473502017|FG000|Overall Study|Death|2|||
131511359|NCT00642668|473502017|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131511360|NCT00642668|473502017|FG000|Overall Study|Failure to Return|1|||
131511361|NCT00642668|473502017|FG000|Overall Study|Dialysis Initiation|5|||
131511362|NCT00642668|473502017|FG000|Overall Study|Blood Transfusion|2|||
131511363|NCT01177540|473502018|FG000|Overall Study|Adverse Event|1|||
131511364|NCT01177540|473502019|FG001|Overall Study|Adverse Event|0|||
131511365|NCT02910167|473502020|FG000|Overall Study|Adverse Event|1|||
131511366|NCT02910167|473502020|FG000|Overall Study|Lost to Follow-up|18|||
131511367|NCT03532295|473502025|FG000|Overall Study|Did not start treatment|0|||
131511368|NCT03532295|473502026|FG001|Overall Study|Did not start treatment|2|||
131511369|NCT00589108|473503672|FG000|Overall Study|Lost to Follow-up|1|||
131511370|NCT00589108|473503673|FG001|Overall Study|Lost to Follow-up|1|||
131511371|NCT00589108|473503674|FG002|Overall Study|Lost to Follow-up|1|||
131511372|NCT00589108|473503672|FG000|Overall Study|Death|3|||
131511373|NCT00589108|473503673|FG001|Overall Study|Death|3|||
131511374|NCT00589108|473503674|FG002|Overall Study|Death|4|||
131511375|NCT03256552|473503675|FG000|Overall Study|Protocol Violation|1|||
131511376|NCT03256552|473503675|FG000|Overall Study|Physician Decision|1|||
131511377|NCT03256552|473503675|FG000|Overall Study|Adverse Event|1|||
131511378|NCT03256552|473503675|FG000|Overall Study|Withdrawal by Subject|2|||
131511379|NCT03026257|473503680|FG000|Overall Study|Adverse Event|3|||
131511380|NCT03026257|473503681|FG001|Overall Study|Adverse Event|0|||
131511381|NCT03026257|473503682|FG002|Overall Study|Adverse Event|0|||
131511382|NCT03026257|473503683|FG003|Overall Study|Adverse Event|0|||
131511383|NCT03026257|473503684|FG004|Overall Study|Adverse Event|0|||
131511384|NCT03026257|473503685|FG005|Overall Study|Adverse Event|0|||
131511385|NCT03026257|473503680|FG000|Overall Study|Lost to Follow-up|1|||
131511386|NCT03026257|473503681|FG001|Overall Study|Lost to Follow-up|0|||
131511387|NCT03026257|473503682|FG002|Overall Study|Lost to Follow-up|0|||
131511388|NCT03026257|473503683|FG003|Overall Study|Lost to Follow-up|0|||
131511389|NCT03026257|473503684|FG004|Overall Study|Lost to Follow-up|0|||
131511390|NCT03026257|473503685|FG005|Overall Study|Lost to Follow-up|0|||
131511391|NCT03026257|473503680|FG000|Overall Study|Protocol Violation|1|||
131511392|NCT03026257|473503681|FG001|Overall Study|Protocol Violation|0|||
131511393|NCT03026257|473503682|FG002|Overall Study|Protocol Violation|0|||
131511394|NCT03026257|473503683|FG003|Overall Study|Protocol Violation|1|||
131511395|NCT03026257|473503684|FG004|Overall Study|Protocol Violation|1|||
131511396|NCT03026257|473503685|FG005|Overall Study|Protocol Violation|0|||
131511397|NCT03026257|473503680|FG000|Overall Study|Withdrawal by Subject|1|||
131511398|NCT03026257|473503681|FG001|Overall Study|Withdrawal by Subject|1|||
131511399|NCT03026257|473503682|FG002|Overall Study|Withdrawal by Subject|0|||
131511400|NCT03026257|473503683|FG003|Overall Study|Withdrawal by Subject|0|||
131511401|NCT03026257|473503684|FG004|Overall Study|Withdrawal by Subject|0|||
131511402|NCT03026257|473503685|FG005|Overall Study|Withdrawal by Subject|0|||
131511403|NCT04380857|473503686|FG000|Overall Study|Lost to Follow-up|3|||
131511404|NCT04380857|473503687|FG001|Overall Study|Lost to Follow-up|3|||
131511405|NCT02558790|473503688|FG000|Overall Study|Lost to Follow-up|2|||
131511406|NCT02558790|473503688|FG000|Overall Study|Physician Decision|1|||
131511407|NCT02558790|473503688|FG000|Overall Study|Withdrawal by Subject|1|||
131511408|NCT02558790|473503688|FG000|Overall Study|Screen Fail|3|||
131511409|NCT00838201|473503689|FG000|Overall Study|Investigator decision, or other reasons|2|||
131511410|NCT00838201|473503690|FG001|Overall Study|Investigator decision, or other reasons|3|||
131511411|NCT00838201|473503689|FG000|Overall Study|Noncompliance|0|||
131511412|NCT00838201|473503690|FG001|Overall Study|Noncompliance|1|||
131511413|NCT00838201|473503689|FG000|Overall Study|Administrative decision|1|||
131511414|NCT00838201|473503690|FG001|Overall Study|Administrative decision|2|||
131511415|NCT00838201|473503689|FG000|Overall Study|Disease progression|3|||
131511416|NCT00838201|473503690|FG001|Overall Study|Disease progression|3|||
131511417|NCT00838201|473503689|FG000|Overall Study|Consent withdrawn|16|||
131511418|NCT00838201|473503690|FG001|Overall Study|Consent withdrawn|19|||
131511419|NCT00838201|473503689|FG000|Overall Study|Lost to Follow-up|4|||
131511420|NCT00838201|473503690|FG001|Overall Study|Lost to Follow-up|3|||
131511421|NCT00838201|473503689|FG000|Overall Study|Adverse Event|5|||
131511422|NCT00838201|473503690|FG001|Overall Study|Adverse Event|9|||
131511423|NCT00838201|473503689|FG000|Overall Study|Death|11|||
131511424|NCT00838201|473503690|FG001|Overall Study|Death|13|||
131511425|NCT05083442|473503691|FG000|Overall Study|Lost to Follow-up|1|||
131511426|NCT05083442|473503692|FG001|Overall Study|Lost to Follow-up|0|||
131511427|NCT05083442|473503691|FG000|Overall Study|Lack of Efficacy|0|||
131511428|NCT05083442|473503692|FG001|Overall Study|Lack of Efficacy|1|||
131511429|NCT05083442|473503691|FG000|Overall Study|Withdrawal by Subject|1|||
131511430|NCT05083442|473503692|FG001|Overall Study|Withdrawal by Subject|3|||
131511431|NCT05083442|473503691|FG000|Overall Study|scheduling difficulties|1|||
131511432|NCT05083442|473503692|FG001|Overall Study|scheduling difficulties|2|||
131511433|NCT05620576|473503695|FG000|Overall Study|Adverse Event|1|||
131511434|NCT05620576|473503696|FG001|Overall Study|Adverse Event|1|||
131511435|NCT05620576|473503695|FG000|Overall Study|Lost to Follow-up|3|||
131511436|NCT05620576|473503696|FG001|Overall Study|Lost to Follow-up|1|||
131511437|NCT05620576|473503695|FG000|Overall Study|Physician Decision|0|||
131511438|NCT05620576|473503696|FG001|Overall Study|Physician Decision|1|||
131511439|NCT05620576|473503695|FG000|Overall Study|Protocol Deviation|1|||
131511440|NCT05620576|473503696|FG001|Overall Study|Protocol Deviation|1|||
131511441|NCT05620576|473503695|FG000|Overall Study|Withdrawal by Subject|2|||
131511442|NCT05620576|473503696|FG001|Overall Study|Withdrawal by Subject|3|||
131511443|NCT04476030|473503697|FG000|Overall Study|Withdrawal by Subject|20|||
131511444|NCT04476030|473503698|FG001|Overall Study|Withdrawal by Subject|16|||
131511445|NCT04476030|473503697|FG000|Overall Study|Adverse Event|10|||
131511446|NCT04476030|473503698|FG001|Overall Study|Adverse Event|11|||
131511447|NCT04476030|473503697|FG000|Overall Study|Lost to Follow-up|7|||
131511448|NCT04476030|473503698|FG001|Overall Study|Lost to Follow-up|4|||
131511449|NCT04476030|473503697|FG000|Overall Study|Physician Decision|1|||
131511450|NCT04476030|473503698|FG001|Overall Study|Physician Decision|1|||
131511451|NCT04476030|473503697|FG000|Overall Study|Protocol Deviation|2|||
131511452|NCT04476030|473503698|FG001|Overall Study|Protocol Deviation|0|||
131511453|NCT04476030|473503697|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
131511454|NCT04476030|473503698|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
131511455|NCT04476030|473503697|FG000|Overall Study|Randomized but not Dosed|2|||
131511456|NCT04476030|473503698|FG001|Overall Study|Randomized but not Dosed|8|||
131511457|NCT04214288|473503700|FG000|Overall Study|Ongoing in the study|41|||
131511458|NCT04214288|473503701|FG001|Overall Study|Ongoing in the study|51|||
131511459|NCT04214288|473503702|FG002|Overall Study|Ongoing in the study|12|||
131511460|NCT04214288|473503703|FG003|Overall Study|Ongoing in the study|39|||
131511461|NCT04214288|473503700|FG000|Overall Study|Adverse Event|1|||
131511462|NCT04214288|473503701|FG001|Overall Study|Adverse Event|0|||
131511463|NCT04214288|473503702|FG002|Overall Study|Adverse Event|0|||
131511464|NCT04214288|473503703|FG003|Overall Study|Adverse Event|0|||
131511465|NCT04214288|473503700|FG000|Overall Study|Death|22|||
131511466|NCT04214288|473503701|FG001|Overall Study|Death|13|||
131511467|NCT04214288|473503702|FG002|Overall Study|Death|7|||
131511468|NCT04214288|473503703|FG003|Overall Study|Death|19|||
131511469|NCT04214288|473503700|FG000|Overall Study|Lost to Follow-up|1|||
131511470|NCT04214288|473503701|FG001|Overall Study|Lost to Follow-up|2|||
131511471|NCT04214288|473503702|FG002|Overall Study|Lost to Follow-up|1|||
131511472|NCT04214288|473503703|FG003|Overall Study|Lost to Follow-up|0|||
131511473|NCT04214288|473503700|FG000|Overall Study|Other|1|||
131511474|NCT04214288|473503701|FG001|Overall Study|Other|2|||
131511475|NCT04214288|473503702|FG002|Overall Study|Other|0|||
131511476|NCT04214288|473503703|FG003|Overall Study|Other|6|||
131511477|NCT04214288|473503700|FG000|Overall Study|Protocol Violation|0|||
131511478|NCT04214288|473503701|FG001|Overall Study|Protocol Violation|1|||
131511479|NCT04214288|473503702|FG002|Overall Study|Protocol Violation|0|||
131511480|NCT04214288|473503703|FG003|Overall Study|Protocol Violation|0|||
131511481|NCT04214288|473503700|FG000|Overall Study|Withdrawal by Subject|8|||
131511482|NCT04214288|473503701|FG001|Overall Study|Withdrawal by Subject|4|||
131511483|NCT04214288|473503702|FG002|Overall Study|Withdrawal by Subject|0|||
131511484|NCT04214288|473503703|FG003|Overall Study|Withdrawal by Subject|9|||
131511485|NCT03168464|473503711|FG000|Overall Study|Death|9|||
131511486|NCT03168464|473503711|FG000|Overall Study|Progression of disease|6|||
131511487|NCT02286193|473503716|FG000|Overall Study|Referred: CRS unable to make contact|62|||
131511488|NCT02286193|473503716|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
131511489|NCT02286193|473503716|FG000|Overall Study|Referred: Declined service|38|||
131511490|NCT03387813|473503719|FG000|Overall Study|Death|40|||
131511491|NCT03387813|473503720|FG001|Overall Study|Death|37|||
131511492|NCT03387813|473503721|FG002|Overall Study|Death|190|||
131511493|NCT03387813|473503719|FG000|Overall Study|Withdrawal by Subject|9|||
131511494|NCT03387813|473503720|FG001|Overall Study|Withdrawal by Subject|19|||
131511495|NCT03387813|473503721|FG002|Overall Study|Withdrawal by Subject|32|||
131511496|NCT03387813|473503719|FG000|Overall Study|Lost to Follow-up|3|||
131511497|NCT03387813|473503720|FG001|Overall Study|Lost to Follow-up|9|||
131511498|NCT03387813|473503721|FG002|Overall Study|Lost to Follow-up|15|||
131511499|NCT03387813|473503719|FG000|Overall Study|Non-Compliance|6|||
131511500|NCT03387813|473503720|FG001|Overall Study|Non-Compliance|6|||
131511501|NCT03387813|473503721|FG002|Overall Study|Non-Compliance|31|||
131511502|NCT03387813|473503719|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
131511503|NCT03387813|473503720|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
131511504|NCT03387813|473503721|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
131511505|NCT01293240|473503722|FG000|Overall Study|Noncompliance|2|||
131511506|NCT03161483|473503727|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
131511507|NCT03161483|473503728|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
131511508|NCT03161483|473503729|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
131511509|NCT03161483|473503730|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
131511510|NCT03161483|473503727|FG000|Treatment Period|Death|1|||
131511511|NCT03161483|473503728|FG001|Treatment Period|Death|0|||
131511512|NCT03161483|473503729|FG002|Treatment Period|Death|0|||
131511513|NCT03161483|473503730|FG003|Treatment Period|Death|0|||
131511514|NCT03161483|473503727|FG000|Treatment Period|Adverse Event|5|||
131511515|NCT03161483|473503728|FG001|Treatment Period|Adverse Event|2|||
131511516|NCT03161483|473503729|FG002|Treatment Period|Adverse Event|1|||
131511517|NCT03161483|473503730|FG003|Treatment Period|Adverse Event|11|||
131511518|NCT03161483|473503727|FG000|Treatment Period|Pregnancy|1|||
131511519|NCT03161483|473503728|FG001|Treatment Period|Pregnancy|0|||
131511520|NCT03161483|473503729|FG002|Treatment Period|Pregnancy|0|||
131511521|NCT03161483|473503730|FG003|Treatment Period|Pregnancy|0|||
131511522|NCT03161483|473503727|FG000|Treatment Period|Lack of Efficacy|0|||
131511523|NCT03161483|473503728|FG001|Treatment Period|Lack of Efficacy|0|||
131511524|NCT03161483|473503729|FG002|Treatment Period|Lack of Efficacy|0|||
131511525|NCT03161483|473503730|FG003|Treatment Period|Lack of Efficacy|1|||
131511526|NCT03161483|473503727|FG000|Treatment Period|Withdrawal by Subject|2|||
131511527|NCT03161483|473503728|FG001|Treatment Period|Withdrawal by Subject|5|||
131511528|NCT03161483|473503729|FG002|Treatment Period|Withdrawal by Subject|2|||
131511529|NCT03161483|473503730|FG003|Treatment Period|Withdrawal by Subject|6|||
131511530|NCT03161483|473503727|FG000|Treatment Period|Lost to Follow-up|0|||
131511531|NCT03161483|473503728|FG001|Treatment Period|Lost to Follow-up|0|||
131511532|NCT03161483|473503729|FG002|Treatment Period|Lost to Follow-up|0|||
131511533|NCT03161483|473503730|FG003|Treatment Period|Lost to Follow-up|1|||
131511534|NCT03161483|473503727|FG000|Treatment Period|Protocol Violation|0|||
131511535|NCT03161483|473503728|FG001|Treatment Period|Protocol Violation|0|||
131511536|NCT03161483|473503729|FG002|Treatment Period|Protocol Violation|0|||
131511537|NCT03161483|473503730|FG003|Treatment Period|Protocol Violation|1|||
131511538|NCT03161483|473503727|FG000|Treatment Period|Other reasons|1|||
131511539|NCT03161483|473503728|FG001|Treatment Period|Other reasons|1|||
131511540|NCT03161483|473503729|FG002|Treatment Period|Other reasons|0|||
131511541|NCT03161483|473503730|FG003|Treatment Period|Other reasons|0|||
131511542|NCT04238728|473503735|FG000|Overall Study|Withdrawal by Subject|1|||
131511543|NCT04238728|473503735|FG000|Overall Study|Lost to Follow-up|2|||
131511544|NCT01256593|473503738|FG000|Overall Study|Protocol Violation|26|||
131511545|NCT01256593|473503738|FG000|Overall Study|No Drug Administration Information|2|||
131511546|NCT01256593|473503738|FG000|Overall Study|No Visit After Treatment|186|||
131511547|NCT04414553|473503739|FG000|Overall Study|Lost to Follow-up|20|||
131511548|NCT03261947|473503740|FG000|Overall Study|Death|10|||
131511549|NCT03261947|473503741|FG001|Overall Study|Death|13|||
131511550|NCT03261947|473503742|FG002|Overall Study|Death|17|||
131511551|NCT03261947|473503743|FG003|Overall Study|Death|12|||
131511552|NCT03261947|473503744|FG004|Overall Study|Death|8|||
131511553|NCT03261947|473503740|FG000|Overall Study|Lost to Follow-up|0|||
131511554|NCT03261947|473503741|FG001|Overall Study|Lost to Follow-up|0|||
131511555|NCT03261947|473503742|FG002|Overall Study|Lost to Follow-up|2|||
131511556|NCT03261947|473503743|FG003|Overall Study|Lost to Follow-up|1|||
131511557|NCT03261947|473503744|FG004|Overall Study|Lost to Follow-up|0|||
131511558|NCT03261947|473503740|FG000|Overall Study|Withdrawal by Subject|0|||
131511559|NCT03261947|473503741|FG001|Overall Study|Withdrawal by Subject|0|||
131511560|NCT03261947|473503742|FG002|Overall Study|Withdrawal by Subject|3|||
131511561|NCT03261947|473503743|FG003|Overall Study|Withdrawal by Subject|0|||
131511562|NCT03261947|473503744|FG004|Overall Study|Withdrawal by Subject|1|||
131511563|NCT03261947|473503740|FG000|Overall Study|Site Terminated by Sponsor|0|||
131511564|NCT03261947|473503741|FG001|Overall Study|Site Terminated by Sponsor|0|||
131511565|NCT03261947|473503742|FG002|Overall Study|Site Terminated by Sponsor|4|||
131511566|NCT03261947|473503743|FG003|Overall Study|Site Terminated by Sponsor|7|||
131511567|NCT03261947|473503744|FG004|Overall Study|Site Terminated by Sponsor|5|||
131511568|NCT03261947|473503740|FG000|Overall Study|Reason not Specified|2|||
131511569|NCT03261947|473503741|FG001|Overall Study|Reason not Specified|0|||
131511570|NCT03261947|473503742|FG002|Overall Study|Reason not Specified|4|||
131511571|NCT03261947|473503743|FG003|Overall Study|Reason not Specified|1|||
131511572|NCT03261947|473503744|FG004|Overall Study|Reason not Specified|3|||
131511573|NCT00228917|473503749|FG000|Overall Study|Migrated/moved from study area|0|||
131511574|NCT00228917|473503750|FG001|Overall Study|Migrated/moved from study area|0|||
131511575|NCT00228917|473503751|FG002|Overall Study|Migrated/moved from study area|0|||
131511576|NCT00228917|473503752|FG003|Overall Study|Migrated/moved from study area|0|||
131511577|NCT00228917|473503753|FG004|Overall Study|Migrated/moved from study area|0|||
131511578|NCT00228917|473503754|FG005|Overall Study|Migrated/moved from study area|2|||
131511579|NCT00228917|473503755|FG006|Overall Study|Migrated/moved from study area|0|||
131511580|NCT00228917|473503756|FG007|Overall Study|Migrated/moved from study area|0|||
131511581|NCT00409617|473503757|FG000|Overall Study|Adverse Event|57|||
131511582|NCT00409617|473503757|FG000|Overall Study|Lack of Efficacy|54|||
131511583|NCT00409617|473503757|FG000|Overall Study|Lost to Follow-up|2|||
131511584|NCT00409617|473503757|FG000|Overall Study|Protocol Violation|24|||
131511585|NCT00409617|473503757|FG000|Overall Study|Withdrawal by Subject|8|||
131511586|NCT00409617|473503757|FG000|Overall Study|Administrative reasons|1|||
131511587|NCT00409617|473503757|FG000|Overall Study|Not described|14|||
131511588|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
131511589|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
131511590|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
131511591|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
131511592|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
131511593|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
131511594|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
131511595|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
131511596|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
131511597|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
131511598|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
131511599|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
131511600|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
131511601|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
131511602|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
131511603|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
131511604|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
131511605|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
131511606|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
131511607|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
131511608|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
131511609|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
131511610|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
131511611|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
131511612|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
131511613|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
131511614|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
131511615|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
131511616|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
131511617|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
131511618|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
131511619|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
131511620|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
131511621|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
131511622|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
131511623|NCT03373383|473503766|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
131511624|NCT03373383|473503767|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
131511625|NCT03373383|473503768|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
131511626|NCT03373383|473503769|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
131511627|NCT03373383|473503770|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
131511628|NCT03373383|473503766|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
131511629|NCT03373383|473503767|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
131511630|NCT03373383|473503768|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
131511631|NCT03373383|473503769|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
131511632|NCT03373383|473503770|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
131511633|NCT03818516|473503773|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
131511634|NCT04372602|473503774|FG000|Overall Study|Withdrawal by Subject|1|||
131511635|NCT04372602|473503775|FG001|Overall Study|Withdrawal by Subject|1|||
131511636|NCT04372602|473503774|FG000|Overall Study|Adverse Event|0|||
131511637|NCT04372602|473503775|FG001|Overall Study|Adverse Event|1|||
131511638|NCT04372602|473503774|FG000|Overall Study|Transitioned to comfort care|0|||
131511639|NCT04372602|473503775|FG001|Overall Study|Transitioned to comfort care|1|||
131511640|NCT02907359|473503776|FG000|Overall Study|Death|234|||
131511641|NCT02907359|473503777|FG001|Overall Study|Death|117|||
131511642|NCT02907359|473503776|FG000|Overall Study|Withdrawal by Subject|6|||
131511643|NCT02907359|473503777|FG001|Overall Study|Withdrawal by Subject|11|||
131511644|NCT02907359|473503776|FG000|Overall Study|Lost to Follow-up|1|||
131511645|NCT02907359|473503777|FG001|Overall Study|Lost to Follow-up|0|||
131511646|NCT02739269|473503782|FG000|Overall Study|Protocol Violation|5|||
131511647|NCT02739269|473503783|FG001|Overall Study|Protocol Violation|0|||
131511648|NCT02739269|473503782|FG000|Overall Study|Cycle cancellation|2|||
131511649|NCT02739269|473503783|FG001|Overall Study|Cycle cancellation|2|||
131511650|NCT02739269|473503782|FG000|Overall Study|Withdrawal by Subject|0|||
131511651|NCT02739269|473503783|FG001|Overall Study|Withdrawal by Subject|2|||
131511652|NCT00923559|473503784|FG000|Overall Study|Lost to Follow-up|2|||
131511653|NCT00923559|473503785|FG001|Overall Study|Lost to Follow-up|3|||
131511654|NCT01951157|473503786|FG000|Overall Study|Progressive Disease|12|||
131511655|NCT01951157|473503787|FG001|Overall Study|Progressive Disease|13|||
131511656|NCT01951157|473503788|FG002|Overall Study|Progressive Disease|10|||
131511657|NCT01951157|473503786|FG000|Overall Study|Treatment-unrelated AE|1|||
131511658|NCT01951157|473503787|FG001|Overall Study|Treatment-unrelated AE|0|||
131511659|NCT01951157|473503788|FG002|Overall Study|Treatment-unrelated AE|3|||
131511660|NCT01951157|473503786|FG000|Overall Study|Study Termination|0|||
131511661|NCT01951157|473503787|FG001|Overall Study|Study Termination|0|||
131511662|NCT01951157|473503788|FG002|Overall Study|Study Termination|1|||
131511663|NCT01951157|473503786|FG000|Overall Study|Physician Decision|5|||
131511664|NCT01951157|473503787|FG001|Overall Study|Physician Decision|3|||
131511665|NCT01951157|473503788|FG002|Overall Study|Physician Decision|2|||
131511666|NCT01951157|473503786|FG000|Overall Study|Non-treatmentrelated death|2|||
131511667|NCT01951157|473503787|FG001|Overall Study|Non-treatmentrelated death|2|||
131511668|NCT01951157|473503788|FG002|Overall Study|Non-treatmentrelated death|2|||
131511669|NCT01951157|473503786|FG000|Overall Study|No treated|0|||
131511670|NCT01951157|473503787|FG001|Overall Study|No treated|1|||
131511671|NCT01951157|473503788|FG002|Overall Study|No treated|0|||
131511672|NCT01951157|473503786|FG000|Overall Study|Treatment-related AE|2|||
131511673|NCT01951157|473503787|FG001|Overall Study|Treatment-related AE|0|||
131511674|NCT01951157|473503788|FG002|Overall Study|Treatment-related AE|4|||
131511675|NCT01951157|473503786|FG000|Overall Study|Consent withdrawn by subject|0|||
131511676|NCT01951157|473503787|FG001|Overall Study|Consent withdrawn by subject|1|||
131511677|NCT01951157|473503788|FG002|Overall Study|Consent withdrawn by subject|3|||
131511678|NCT01951157|473503786|FG000|Overall Study|Treatment-related death|0|||
131511679|NCT01951157|473503787|FG001|Overall Study|Treatment-related death|2|||
131511680|NCT01951157|473503788|FG002|Overall Study|Treatment-related death|0|||
131511681|NCT01200797|473503789|FG000|Overall Study|symptomatic deterioration|2|||
131511682|NCT01200797|473503789|FG000|Overall Study|Adverse Event|4|||
131511683|NCT01200797|473503789|FG000|Overall Study|Disease Progression|13|||
131511684|NCT01644175|473503790|FG000|Overall Study|Randomized But Not Treated|0|||
131511685|NCT01644175|473503791|FG001|Overall Study|Randomized But Not Treated|2|||
131511686|NCT01644175|473503790|FG000|Overall Study|Adverse Event|8|||
131511687|NCT01644175|473503791|FG001|Overall Study|Adverse Event|13|||
131511688|NCT01644175|473503790|FG000|Overall Study|Death|1|||
131511689|NCT01644175|473503791|FG001|Overall Study|Death|2|||
131511690|NCT01644175|473503790|FG000|Overall Study|Poor compliance to protocol|9|||
131511691|NCT01644175|473503791|FG001|Overall Study|Poor compliance to protocol|10|||
131511692|NCT01644175|473503790|FG000|Overall Study|Physician Decision|1|||
131511693|NCT01644175|473503791|FG001|Overall Study|Physician Decision|2|||
131511694|NCT01644175|473503790|FG000|Overall Study|Participant Moved|1|||
131511695|NCT01644175|473503791|FG001|Overall Study|Participant Moved|2|||
131511696|NCT01644175|473503790|FG000|Overall Study|Consent withdrawn by participant|3|||
131511697|NCT01644175|473503791|FG001|Overall Study|Consent withdrawn by participant|4|||
131511698|NCT01644175|473503790|FG000|Overall Study|Related to Autoinjector Administration|2|||
131511699|NCT01644175|473503791|FG001|Overall Study|Related to Autoinjector Administration|1|||
131511700|NCT01644175|473503790|FG000|Overall Study|Last visit outside protocol visit window|4|||
131511701|NCT01644175|473503791|FG001|Overall Study|Last visit outside protocol visit window|11|||
131511702|NCT01644175|473503790|FG000|Overall Study|Selection criteria finally not met|0|||
131511703|NCT01644175|473503791|FG001|Overall Study|Selection criteria finally not met|1|||
131511704|NCT01644175|473503790|FG000|Overall Study|Site closure|2|||
131511705|NCT01644175|473503791|FG001|Overall Study|Site closure|2|||
131511706|NCT01644175|473503790|FG000|Overall Study|Lost to Follow-up|1|||
131511707|NCT01644175|473503791|FG001|Overall Study|Lost to Follow-up|0|||
131511708|NCT01644175|473503790|FG000|Overall Study|Other than specified above|0|||
131511709|NCT01644175|473503791|FG001|Overall Study|Other than specified above|3|||
131511710|NCT02818777|473503799|FG000|Overall Study|Adverse Event|3|||
131511711|NCT01623596|473503806|FG000|Overall Study|Abnormal laboratory values|2|||
131511712|NCT01623596|473503807|FG001|Overall Study|Abnormal laboratory values|0|||
131511713|NCT01623596|473503806|FG000|Overall Study|Administrative problems|9|||
131511714|NCT01623596|473503807|FG001|Overall Study|Administrative problems|13|||
131511715|NCT01623596|473503806|FG000|Overall Study|Adverse Event|20|||
131511716|NCT01623596|473503807|FG001|Overall Study|Adverse Event|29|||
131511717|NCT01623596|473503806|FG000|Overall Study|Death|0|||
131511718|NCT01623596|473503807|FG001|Overall Study|Death|2|||
131511719|NCT01623596|473503806|FG000|Overall Study|Lost to Follow-up|12|||
131511720|NCT01623596|473503807|FG001|Overall Study|Lost to Follow-up|16|||
131511721|NCT01623596|473503806|FG000|Overall Study|Withdrawal by Subject|13|||
131511722|NCT01623596|473503807|FG001|Overall Study|Withdrawal by Subject|31|||
131511723|NCT01623596|473503806|FG000|Overall Study|Patient no longer requires study drug|1|||
131511724|NCT01623596|473503807|FG001|Overall Study|Patient no longer requires study drug|0|||
131511725|NCT01623596|473503806|FG000|Overall Study|Protocol Violation|0|||
131511726|NCT01623596|473503807|FG001|Overall Study|Protocol Violation|6|||
131511727|NCT01623596|473503806|FG000|Overall Study|Lack of Efficacy|5|||
131511728|NCT01623596|473503807|FG001|Overall Study|Lack of Efficacy|3|||
131511729|NCT01324349|473503811|FG000|Overall Study|Death|1|||
131511730|NCT01324349|473503812|FG001|Overall Study|Death|1|||
131511731|NCT01324349|473503811|FG000|Overall Study|Withdrawal by Subject|0|||
131511732|NCT01324349|473503812|FG001|Overall Study|Withdrawal by Subject|1|||
131511733|NCT00748215|473503815|FG000|Overall Study|Withdrawal by Subject|7|||
131511734|NCT00748215|473503816|FG001|Overall Study|Withdrawal by Subject|7|||
131511735|NCT00748215|473503815|FG000|Overall Study|Treatment change|2|||
131511736|NCT00748215|473503816|FG001|Overall Study|Treatment change|1|||
131511737|NCT00748215|473503815|FG000|Overall Study|Change in patient condition|0|||
131511738|NCT00748215|473503816|FG001|Overall Study|Change in patient condition|3|||
131511739|NCT00748215|473503815|FG000|Overall Study|Non-compliant|0|||
131511740|NCT00748215|473503816|FG001|Overall Study|Non-compliant|2|||
131511741|NCT00748215|473503815|FG000|Overall Study|Adverse Event|0|||
131511742|NCT00748215|473503816|FG001|Overall Study|Adverse Event|5|||
131511743|NCT03200899|473503821|FG000|Overall Study|Lost to Follow-up|10|||
131511744|NCT03200899|473503822|FG001|Overall Study|Lost to Follow-up|23|||
131511745|NCT00116831|473505283|FG000|Overall Study|Adverse Event|14|||
131511746|NCT00116831|473505284|FG001|Overall Study|Adverse Event|16|||
131511747|NCT00116831|473505283|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
131511748|NCT00116831|473505284|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
131511749|NCT00116831|473505283|FG000|Overall Study|Lost to Follow-up|8|||
131511750|NCT00116831|473505284|FG001|Overall Study|Lost to Follow-up|6|||
131511751|NCT00116831|473505283|FG000|Overall Study|Protocol Violation|3|||
131511752|NCT00116831|473505284|FG001|Overall Study|Protocol Violation|6|||
131511753|NCT00116831|473505283|FG000|Overall Study|Hypoglycaemic events|1|||
131511754|NCT00116831|473505284|FG001|Overall Study|Hypoglycaemic events|0|||
131511755|NCT00116831|473505283|FG000|Overall Study|Low haemoglobin on screening|1|||
131511756|NCT00116831|473505284|FG001|Overall Study|Low haemoglobin on screening|0|||
131511757|NCT00116831|473505283|FG000|Overall Study|Withdrawn investigational product|1|||
131511758|NCT00116831|473505284|FG001|Overall Study|Withdrawn investigational product|0|||
131511759|NCT00116831|473505283|FG000|Overall Study|Withdrawal by Subject|32|||
131511760|NCT00116831|473505284|FG001|Overall Study|Withdrawal by Subject|32|||
131511761|NCT00116831|473505283|FG000|Overall Study|Insufficient therapeutic effect|0|||
131511762|NCT00116831|473505284|FG001|Overall Study|Insufficient therapeutic effect|1|||
131511763|NCT00116831|473505283|FG000|Overall Study|Missing data for participant|1|||
131511764|NCT00116831|473505284|FG001|Overall Study|Missing data for participant|0|||
131511765|NCT02476968|473505285|FG000|Overall Study|Other|0|||
131511766|NCT02476968|473505286|FG001|Overall Study|Other|2|||
131511767|NCT02476968|473505287|FG002|Overall Study|Other|0|||
131511768|NCT02476968|473505285|FG000|Overall Study|Lost to Follow-up|10|||
131511769|NCT02476968|473505286|FG001|Overall Study|Lost to Follow-up|0|||
131511770|NCT02476968|473505287|FG002|Overall Study|Lost to Follow-up|1|||
131511771|NCT02476968|473505285|FG000|Overall Study|Death|48|||
131511772|NCT02476968|473505286|FG001|Overall Study|Death|8|||
131511773|NCT02476968|473505287|FG002|Overall Study|Death|1|||
131511774|NCT02476968|473505285|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131511775|NCT02476968|473505286|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131511776|NCT02476968|473505287|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
131511777|NCT02476968|473505285|FG000|Overall Study|Patient decision|37|||
131511778|NCT02476968|473505286|FG001|Overall Study|Patient decision|8|||
131511779|NCT02476968|473505287|FG002|Overall Study|Patient decision|0|||
131511780|NCT01859507|473505288|FG000|Overall Study|left the country|4|||
131511781|NCT02404311|473505289|FG000|Part A: Month 0-18|Death|2|||
131511782|NCT02404311|473505290|FG001|Part A: Month 0-18|Death|0|||
131511783|NCT02404311|473505291|FG002|Part A: Month 0-18|Death|0|||
131511784|NCT02404311|473505292|FG003|Part A: Month 0-18|Death|0|||
131511785|NCT02404311|473505293|FG004|Part A: Month 0-18|Death|0|||
131511786|NCT02404311|473505289|FG000|Part A: Month 0-18|Physician Decision|1|||
131511787|NCT02404311|473505290|FG001|Part A: Month 0-18|Physician Decision|0|||
131511788|NCT02404311|473505291|FG002|Part A: Month 0-18|Physician Decision|0|||
131511789|NCT02404311|473505292|FG003|Part A: Month 0-18|Physician Decision|0|||
131511790|NCT02404311|473505293|FG004|Part A: Month 0-18|Physician Decision|0|||
131511791|NCT02404311|473505289|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
131511792|NCT02404311|473505290|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
131511793|NCT02404311|473505291|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
131511794|NCT02404311|473505292|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
131511795|NCT02404311|473505293|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
131511796|NCT02404311|473505289|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
131511797|NCT02404311|473505290|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
131511798|NCT02404311|473505291|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
131511799|NCT02404311|473505292|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
131511800|NCT02404311|473505293|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
131511801|NCT02404311|473505289|FG000|Part A: Month 0-18|HIV Infection|6|||
131511802|NCT02404311|473505290|FG001|Part A: Month 0-18|HIV Infection|2|||
131511803|NCT02404311|473505291|FG002|Part A: Month 0-18|HIV Infection|0|||
131511804|NCT02404311|473505292|FG003|Part A: Month 0-18|HIV Infection|0|||
131511805|NCT02404311|473505293|FG004|Part A: Month 0-18|HIV Infection|0|||
131511806|NCT02404311|473505289|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
131511807|NCT02404311|473505290|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
131511808|NCT02404311|473505291|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
131511809|NCT02404311|473505292|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
131511810|NCT02404311|473505293|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
131511811|NCT00218296|473505301|FG000|Overall Study|Lost to Follow-up|9|||
131511812|NCT00218296|473505302|FG001|Overall Study|Lost to Follow-up|7|||
131511813|NCT00218296|473505301|FG000|Overall Study|Withdrawal by Subject|36|||
131511814|NCT00218296|473505302|FG001|Overall Study|Withdrawal by Subject|47|||
131511815|NCT00218296|473505301|FG000|Overall Study|Randomized but did not enter treatment|66|||
131511816|NCT00218296|473505302|FG001|Overall Study|Randomized but did not enter treatment|67|||
131511817|NCT00097721|473505303|FG000|Overall Study|Adverse Event|8|||
131511818|NCT00097721|473505304|FG001|Overall Study|Adverse Event|1|||
131511819|NCT00097721|473505303|FG000|Overall Study|Withdrawal by Subject|6|||
131511820|NCT00097721|473505304|FG001|Overall Study|Withdrawal by Subject|1|||
131511821|NCT00097721|473505303|FG000|Overall Study|Progressive Disease|55|||
131511822|NCT00097721|473505304|FG001|Overall Study|Progressive Disease|27|||
131511823|NCT00097721|473505303|FG000|Overall Study|Physician Decision|1|||
131511824|NCT00097721|473505304|FG001|Overall Study|Physician Decision|3|||
131511825|NCT00097721|473505303|FG000|Overall Study|Reason not given|1|||
131511826|NCT00097721|473505304|FG001|Overall Study|Reason not given|1|||
131511827|NCT01752855|473505308|FG000|Overall Study|Adverse Event|1|||
131511828|NCT01752855|473505309|FG001|Overall Study|Adverse Event|0|||
131511829|NCT01752855|473505308|FG000|Overall Study|Withdrew Consent|0|||
131511830|NCT01752855|473505309|FG001|Overall Study|Withdrew Consent|2|||
131511831|NCT01752855|473505308|FG000|Overall Study|Lack of Efficacy|0|||
131511832|NCT01752855|473505309|FG001|Overall Study|Lack of Efficacy|2|||
131511833|NCT01478321|473505310|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
131511834|NCT01478321|473505310|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
131511835|NCT01478321|473505310|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
131511836|NCT01478321|473505310|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
131511837|NCT01478321|473505310|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
131511838|NCT01478321|473505310|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
131511839|NCT01478321|473505310|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
131511840|NCT01478321|473505310|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
131511841|NCT00634088|473505313|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
131511842|NCT00634088|473505314|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
131511843|NCT00634088|473505315|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
131511844|NCT00634088|473505316|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
131511845|NCT00634088|473505313|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
131511846|NCT00634088|473505314|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
131511847|NCT00634088|473505315|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
131511848|NCT00634088|473505316|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
131511849|NCT00634088|473505313|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
131511850|NCT00634088|473505314|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
131511851|NCT00634088|473505315|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
131511852|NCT00634088|473505316|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
131511853|NCT00634088|473505313|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
131511854|NCT00634088|473505314|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
131511855|NCT00634088|473505315|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
131511856|NCT00634088|473505316|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
131511857|NCT00634088|473505313|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
131511858|NCT00634088|473505314|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
131511859|NCT00634088|473505315|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
131511860|NCT00634088|473505316|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
131511861|NCT00634088|473505313|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
131511862|NCT00634088|473505314|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
131511863|NCT00634088|473505315|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
131511864|NCT00634088|473505316|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
131511865|NCT01203072|473505319|FG000|Overall Study|Adverse Event|5|||
131511866|NCT01203072|473505320|FG001|Overall Study|Adverse Event|3|||
131511867|NCT01203072|473505321|FG002|Overall Study|Adverse Event|2|||
131511868|NCT01203072|473505322|FG003|Overall Study|Adverse Event|4|||
131511869|NCT01203072|473505323|FG004|Overall Study|Adverse Event|2|||
131511870|NCT01203072|473505319|FG000|Overall Study|Lack of Efficacy|1|||
131511871|NCT01203072|473505320|FG001|Overall Study|Lack of Efficacy|0|||
131511872|NCT01203072|473505321|FG002|Overall Study|Lack of Efficacy|0|||
131511873|NCT01203072|473505322|FG003|Overall Study|Lack of Efficacy|0|||
131511874|NCT01203072|473505323|FG004|Overall Study|Lack of Efficacy|0|||
131511875|NCT01203072|473505319|FG000|Overall Study|Lost to Follow-up|0|||
131511876|NCT01203072|473505320|FG001|Overall Study|Lost to Follow-up|1|||
131511877|NCT01203072|473505321|FG002|Overall Study|Lost to Follow-up|0|||
131511878|NCT01203072|473505322|FG003|Overall Study|Lost to Follow-up|0|||
131511879|NCT01203072|473505323|FG004|Overall Study|Lost to Follow-up|0|||
131511880|NCT01203072|473505319|FG000|Overall Study|Protocol Violation|2|||
131511881|NCT01203072|473505320|FG001|Overall Study|Protocol Violation|0|||
131511882|NCT01203072|473505321|FG002|Overall Study|Protocol Violation|0|||
131511883|NCT01203072|473505322|FG003|Overall Study|Protocol Violation|0|||
131511884|NCT01203072|473505323|FG004|Overall Study|Protocol Violation|1|||
131511885|NCT01203072|473505319|FG000|Overall Study|Withdrawal by Subject|2|||
131511886|NCT01203072|473505320|FG001|Overall Study|Withdrawal by Subject|2|||
131511887|NCT01203072|473505321|FG002|Overall Study|Withdrawal by Subject|1|||
131511888|NCT01203072|473505322|FG003|Overall Study|Withdrawal by Subject|2|||
131511889|NCT01203072|473505323|FG004|Overall Study|Withdrawal by Subject|3|||
131511890|NCT04327999|473505331|FG000|Overall Study|Protocol Violation|1|||
131511891|NCT03735667|473505332|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
131511892|NCT03735667|473505333|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
131511893|NCT03735667|473505334|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
131511894|NCT03735667|473505332|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
131511895|NCT03735667|473505333|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
131511896|NCT03735667|473505334|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
131511897|NCT03735667|473505332|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
131511898|NCT03735667|473505333|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
131511899|NCT03735667|473505334|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
131511900|NCT03735667|473505332|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
131511901|NCT03735667|473505333|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
131511902|NCT03735667|473505334|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
131511903|NCT03735667|473505332|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
131511904|NCT03735667|473505333|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
131511905|NCT03735667|473505334|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
131511906|NCT03735667|473505332|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
131511907|NCT03735667|473505333|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
131511908|NCT03735667|473505334|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
131511909|NCT03735667|473505332|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
131511910|NCT03735667|473505333|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
131511911|NCT03735667|473505334|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
131511912|NCT03735667|473505332|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
131511913|NCT03735667|473505333|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
131511914|NCT03735667|473505334|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
131511915|NCT03735667|473505332|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
131511916|NCT03735667|473505333|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
131511917|NCT03735667|473505334|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
131511918|NCT03735667|473505332|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
131511919|NCT03735667|473505333|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
131511920|NCT03735667|473505334|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
131511921|NCT03735667|473505332|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
131511922|NCT03735667|473505333|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
131511923|NCT03735667|473505334|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
131511924|NCT03735667|473505332|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
131511925|NCT03735667|473505333|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
131511926|NCT03735667|473505334|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
131511927|NCT03792672|473505335|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
131511928|NCT03792672|473505336|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
131658103|NCT04445987|474032996|FG002|Overall Study|Protocol Violation|0|||
131511929|NCT03792672|473505337|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
131511930|NCT03792672|473505338|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
131511931|NCT03792672|473505339|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
131511932|NCT03792672|473505340|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
131511933|NCT03792672|473505335|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
131511934|NCT03792672|473505336|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
131511935|NCT03792672|473505337|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
131511936|NCT03792672|473505338|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
131511937|NCT03792672|473505339|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
131511938|NCT03792672|473505340|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
131511939|NCT03792672|473505335|FG000|Treatment Period 4 (2 Days)|Other|1|||
131511940|NCT03792672|473505336|FG001|Treatment Period 4 (2 Days)|Other|0|||
131511941|NCT03792672|473505337|FG002|Treatment Period 4 (2 Days)|Other|0|||
131511942|NCT03792672|473505338|FG003|Treatment Period 4 (2 Days)|Other|0|||
131511943|NCT03792672|473505339|FG004|Treatment Period 4 (2 Days)|Other|0|||
131511944|NCT03792672|473505340|FG005|Treatment Period 4 (2 Days)|Other|0|||
131511945|NCT00006478|473505342|FG000|Overall Study|Vaccine could not be produced|1|||
131511946|NCT00006478|473505342|FG000|Overall Study|Physician Decision|6|||
131511947|NCT05389657|473505349|FG000|Overall Study|Lost to Follow-up|7|||
131511948|NCT05389657|473505350|FG001|Overall Study|Lost to Follow-up|8|||
131511949|NCT01907828|473505351|FG000|Overall Study|Exclusion criteria not met|0|||
131511950|NCT01907828|473505352|FG001|Overall Study|Exclusion criteria not met|1|||
131511951|NCT01907828|473505351|FG000|Overall Study|Withdrawal by Subject|3|||
131511952|NCT01907828|473505352|FG001|Overall Study|Withdrawal by Subject|4|||
131511953|NCT01907828|473505351|FG000|Overall Study|Lost to Follow-up|3|||
131511954|NCT01907828|473505352|FG001|Overall Study|Lost to Follow-up|0|||
131511955|NCT01907828|473505351|FG000|Overall Study|Participant refused 24-month follow-up|1|||
131511956|NCT01907828|473505352|FG001|Overall Study|Participant refused 24-month follow-up|0|||
131511957|NCT01907828|473505351|FG000|Overall Study|Participant met exclusion criteria|0|||
131511958|NCT01907828|473505352|FG001|Overall Study|Participant met exclusion criteria|1|||
131511959|NCT01073865|473505358|FG000|Overall Study|Reasons other than below|19|||
131511960|NCT01073865|473505359|FG001|Overall Study|Reasons other than below|31|||
131511961|NCT01073865|473505358|FG000|Overall Study|Lost to Follow-up|1|||
131511962|NCT01073865|473505359|FG001|Overall Study|Lost to Follow-up|1|||
131511963|NCT01073865|473505358|FG000|Overall Study|Death|3|||
131511964|NCT01073865|473505359|FG001|Overall Study|Death|2|||
131511965|NCT01073865|473505358|FG000|Overall Study|Withdrawal by Subject|5|||
131511966|NCT01073865|473505359|FG001|Overall Study|Withdrawal by Subject|5|||
131511967|NCT02547129|473505360|FG000|Overall Study|Difficulty with ongoing infection|1|||
131511968|NCT02547129|473505361|FG001|Overall Study|Difficulty with ongoing infection|0|||
131511969|NCT00805766|473505362|FG000|Screening Period|Adverse Event|1|||
131511970|NCT00805766|473505362|FG000|Screening Period|Lack of Efficacy|2|||
131511971|NCT00805766|473505362|FG000|Screening Period|Pregnancy|1|||
131511972|NCT00805766|473505362|FG000|Screening Period|Responder|2|||
131511973|NCT00805766|473505362|FG000|Increased Dose Period|Adverse Event|4|||
131511974|NCT00805766|473505362|FG000|Increased Dose Period|Lack of Efficacy|7|||
131511975|NCT00805766|473505362|FG000|Increased Dose Period|Pregnancy|1|||
131511976|NCT00805766|473505362|FG000|Increased Dose Period|Withdrawal by Subject|1|||
131511977|NCT02063737|473505368|FG000|Overall Study|Lost to Follow-up|11|||
131511978|NCT02063737|473505369|FG001|Overall Study|Lost to Follow-up|4|||
131511979|NCT02159521|473505370|FG000|Overall Study|Enrolled but not treated|3|||
131511980|NCT02159521|473505370|FG000|Overall Study|Withdrawal by Subject|7|||
131511981|NCT02159521|473505370|FG000|Overall Study|Lost to Follow-up|6|||
131511982|NCT02159521|473505370|FG000|Overall Study|Death|1|||
131511983|NCT02159521|473505370|FG000|Overall Study|Other than specified|1|||
131511984|NCT04809220|473505375|FG000|Overall Study|Adverse Event|4|||
131511985|NCT04809220|473505376|FG001|Overall Study|Adverse Event|0|||
131511986|NCT04809220|473505375|FG000|Overall Study|Death|1|||
131511987|NCT04809220|473505376|FG001|Overall Study|Death|0|||
131511988|NCT04809220|473505375|FG000|Overall Study|Lost to Follow-up|3|||
131511989|NCT04809220|473505376|FG001|Overall Study|Lost to Follow-up|0|||
131511990|NCT04809220|473505375|FG000|Overall Study|Physician Decision|0|||
131511991|NCT04809220|473505376|FG001|Overall Study|Physician Decision|1|||
131511992|NCT04809220|473505375|FG000|Overall Study|Withdrawal by Subject|9|||
131511993|NCT04809220|473505376|FG001|Overall Study|Withdrawal by Subject|5|||
131511994|NCT04809220|473505375|FG000|Overall Study|Due to long-term overseas business trips|1|||
131511995|NCT04809220|473505376|FG001|Overall Study|Due to long-term overseas business trips|0|||
131511996|NCT01062555|473505377|FG000|Phase 1|Death|10|||
131511997|NCT01062555|473505378|FG001|Phase 1|Death|17|||
131511998|NCT01062555|473505379|FG002|Phase 1|Death|0|||
131511999|NCT01062555|473505380|FG003|Phase 1|Death|0|||
131512000|NCT01062555|473505377|FG000|Phase 1|Graft Failure|12|||
131512001|NCT01062555|473505378|FG001|Phase 1|Graft Failure|8|||
131512002|NCT01062555|473505379|FG002|Phase 1|Graft Failure|0|||
131512003|NCT01062555|473505380|FG003|Phase 1|Graft Failure|0|||
131512004|NCT01062555|473505377|FG000|Phase 1|Withdrawal by Subject|1|||
131512005|NCT01062555|473505378|FG001|Phase 1|Withdrawal by Subject|1|||
131512006|NCT01062555|473505379|FG002|Phase 1|Withdrawal by Subject|0|||
131512007|NCT01062555|473505380|FG003|Phase 1|Withdrawal by Subject|0|||
131512008|NCT01062555|473505377|FG000|Phase 2|Death|0|||
131512009|NCT01062555|473505378|FG001|Phase 2|Death|0|||
131512010|NCT01062555|473505379|FG002|Phase 2|Death|8|||
131512011|NCT01062555|473505380|FG003|Phase 2|Death|3|||
131512012|NCT01062555|473505377|FG000|Phase 2|Graft failure|0|||
131512013|NCT01062555|473505378|FG001|Phase 2|Graft failure|0|||
131512014|NCT01062555|473505379|FG002|Phase 2|Graft failure|7|||
131512015|NCT01062555|473505380|FG003|Phase 2|Graft failure|4|||
131512016|NCT01062555|473505377|FG000|Phase 2|Withdrawal by Subject|0|||
131512017|NCT01062555|473505378|FG001|Phase 2|Withdrawal by Subject|0|||
131512018|NCT01062555|473505379|FG002|Phase 2|Withdrawal by Subject|0|||
131512019|NCT01062555|473505380|FG003|Phase 2|Withdrawal by Subject|7|||
131512020|NCT01062555|473505377|FG000|Phase 2|Protocol Violation|0|||
131512021|NCT01062555|473505378|FG001|Phase 2|Protocol Violation|0|||
131512022|NCT01062555|473505379|FG002|Phase 2|Protocol Violation|0|||
131512023|NCT01062555|473505380|FG003|Phase 2|Protocol Violation|3|||
131512024|NCT01062555|473505377|FG000|Phase 2|Physician Decision|0|||
131512025|NCT01062555|473505378|FG001|Phase 2|Physician Decision|0|||
131512026|NCT01062555|473505379|FG002|Phase 2|Physician Decision|0|||
131512027|NCT01062555|473505380|FG003|Phase 2|Physician Decision|17|||
131512028|NCT00329407|473505381|FG000|Overall Study|Withdrawal by Subject|1|||
131512029|NCT00978068|473505382|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
131512030|NCT00978068|473505383|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
131512031|NCT00978068|473505382|FG000|Overall Study|Death|1|||
131512032|NCT00978068|473505383|FG001|Overall Study|Death|2|||
131512033|NCT00978068|473505382|FG000|Overall Study|Lost to Follow-up|1|||
131512034|NCT00978068|473505383|FG001|Overall Study|Lost to Follow-up|2|||
131512035|NCT00978068|473505382|FG000|Overall Study|Physician Decision|0|||
131512036|NCT00978068|473505383|FG001|Overall Study|Physician Decision|1|||
131512037|NCT00978068|473505382|FG000|Overall Study|Unable to Comply with Study|0|||
131512038|NCT00978068|473505383|FG001|Overall Study|Unable to Comply with Study|2|||
131512039|NCT03560531|473505384|FG000|Overall Study|Death|4|||
131512040|NCT03560531|473505385|FG001|Overall Study|Death|1|||
131512041|NCT03560531|473505386|FG002|Overall Study|Death|1|||
131512042|NCT03560531|473505387|FG003|Overall Study|Death|2|||
131512043|NCT03560531|473505388|FG004|Overall Study|Death|6|||
131512044|NCT03560531|473505389|FG005|Overall Study|Death|1|||
131512045|NCT03560531|473505390|FG006|Overall Study|Death|4|||
131512046|NCT03560531|473505391|FG007|Overall Study|Death|8|||
131512047|NCT03560531|473505392|FG008|Overall Study|Death|1|||
131512048|NCT03560531|473505393|FG009|Overall Study|Death|3|||
131512049|NCT03560531|473505394|FG010|Overall Study|Death|2|||
131512050|NCT03560531|473505395|FG011|Overall Study|Death|0|||
131512051|NCT03560531|473505396|FG012|Overall Study|Death|4|||
131512052|NCT03560531|473505397|FG013|Overall Study|Death|1|||
131512053|NCT03560531|473505384|FG000|Overall Study|Lost to Follow-up|1|||
131512054|NCT03560531|473505385|FG001|Overall Study|Lost to Follow-up|1|||
131512055|NCT03560531|473505386|FG002|Overall Study|Lost to Follow-up|0|||
131512056|NCT03560531|473505387|FG003|Overall Study|Lost to Follow-up|0|||
131512057|NCT03560531|473505388|FG004|Overall Study|Lost to Follow-up|0|||
131512058|NCT03560531|473505389|FG005|Overall Study|Lost to Follow-up|0|||
131512059|NCT03560531|473505390|FG006|Overall Study|Lost to Follow-up|1|||
131512060|NCT03560531|473505391|FG007|Overall Study|Lost to Follow-up|0|||
131512061|NCT03560531|473505392|FG008|Overall Study|Lost to Follow-up|0|||
131512062|NCT03560531|473505393|FG009|Overall Study|Lost to Follow-up|0|||
131512063|NCT03560531|473505394|FG010|Overall Study|Lost to Follow-up|0|||
131512064|NCT03560531|473505395|FG011|Overall Study|Lost to Follow-up|0|||
131512065|NCT03560531|473505396|FG012|Overall Study|Lost to Follow-up|0|||
131512066|NCT03560531|473505397|FG013|Overall Study|Lost to Follow-up|0|||
131512067|NCT03560531|473505384|FG000|Overall Study|Withdrawal by Subject|1|||
131512068|NCT03560531|473505385|FG001|Overall Study|Withdrawal by Subject|0|||
131512069|NCT03560531|473505386|FG002|Overall Study|Withdrawal by Subject|0|||
131512070|NCT03560531|473505387|FG003|Overall Study|Withdrawal by Subject|0|||
131512071|NCT03560531|473505388|FG004|Overall Study|Withdrawal by Subject|0|||
131512072|NCT03560531|473505389|FG005|Overall Study|Withdrawal by Subject|0|||
131512073|NCT03560531|473505390|FG006|Overall Study|Withdrawal by Subject|0|||
131512074|NCT03560531|473505391|FG007|Overall Study|Withdrawal by Subject|3|||
131512075|NCT03560531|473505392|FG008|Overall Study|Withdrawal by Subject|2|||
131512076|NCT03560531|473505393|FG009|Overall Study|Withdrawal by Subject|0|||
131512077|NCT03560531|473505394|FG010|Overall Study|Withdrawal by Subject|0|||
131512078|NCT03560531|473505395|FG011|Overall Study|Withdrawal by Subject|0|||
131512079|NCT03560531|473505396|FG012|Overall Study|Withdrawal by Subject|2|||
131512080|NCT03560531|473505397|FG013|Overall Study|Withdrawal by Subject|0|||
131512081|NCT03560531|473505384|FG000|Overall Study|Study end per-protocol|1|||
131512082|NCT03560531|473505385|FG001|Overall Study|Study end per-protocol|1|||
131512083|NCT03560531|473505386|FG002|Overall Study|Study end per-protocol|2|||
131512084|NCT03560531|473505387|FG003|Overall Study|Study end per-protocol|0|||
131512085|NCT03560531|473505388|FG004|Overall Study|Study end per-protocol|1|||
131512086|NCT03560531|473505389|FG005|Overall Study|Study end per-protocol|0|||
131512087|NCT03560531|473505390|FG006|Overall Study|Study end per-protocol|0|||
131512088|NCT03560531|473505391|FG007|Overall Study|Study end per-protocol|0|||
131512089|NCT03560531|473505392|FG008|Overall Study|Study end per-protocol|0|||
131512090|NCT03560531|473505393|FG009|Overall Study|Study end per-protocol|0|||
131512091|NCT03560531|473505394|FG010|Overall Study|Study end per-protocol|0|||
131512092|NCT03560531|473505395|FG011|Overall Study|Study end per-protocol|0|||
131512093|NCT03560531|473505396|FG012|Overall Study|Study end per-protocol|0|||
131512094|NCT03560531|473505397|FG013|Overall Study|Study end per-protocol|0|||
131512095|NCT03560531|473505384|FG000|Overall Study|Early study termination by sponsor|9|||
131512096|NCT03560531|473505385|FG001|Overall Study|Early study termination by sponsor|0|||
131512097|NCT03560531|473505386|FG002|Overall Study|Early study termination by sponsor|0|||
131512098|NCT03560531|473505387|FG003|Overall Study|Early study termination by sponsor|4|||
131512099|NCT03560531|473505388|FG004|Overall Study|Early study termination by sponsor|8|||
131512100|NCT03560531|473505389|FG005|Overall Study|Early study termination by sponsor|2|||
131512101|NCT03560531|473505390|FG006|Overall Study|Early study termination by sponsor|5|||
131512102|NCT03560531|473505391|FG007|Overall Study|Early study termination by sponsor|64|||
131512103|NCT03560531|473505392|FG008|Overall Study|Early study termination by sponsor|7|||
131512104|NCT03560531|473505393|FG009|Overall Study|Early study termination by sponsor|2|||
131512105|NCT03560531|473505394|FG010|Overall Study|Early study termination by sponsor|16|||
131512106|NCT03560531|473505395|FG011|Overall Study|Early study termination by sponsor|2|||
131512107|NCT03560531|473505396|FG012|Overall Study|Early study termination by sponsor|6|||
131512108|NCT03560531|473505397|FG013|Overall Study|Early study termination by sponsor|2|||
131512109|NCT01471379|473505398|FG000|Overall Study|Adverse Event|1|||
131512110|NCT01471379|473505399|FG001|Overall Study|Adverse Event|0|||
131512111|NCT01471379|473505400|FG002|Overall Study|Adverse Event|0|||
131512112|NCT01471379|473505398|FG000|Overall Study|Study terminated|0|||
131512113|NCT01471379|473505399|FG001|Overall Study|Study terminated|1|||
131512114|NCT01471379|473505400|FG002|Overall Study|Study terminated|0|||
131512115|NCT02120794|473505401|FG000|Overall Study|Withdrawal by Subject|43|||
131512116|NCT02120794|473505401|FG000|Overall Study|Adverse Event|10|||
131512117|NCT02120794|473505401|FG000|Overall Study|Physician Decision|4|||
131512118|NCT02120794|473505401|FG000|Overall Study|Due to insurance coverage|1|||
131512119|NCT00026793|473505402|FG000|Overall Study|Death on study due to underlying disease|4|||
131512120|NCT00026793|473505402|FG000|Overall Study|Physician Decision|2|||
131512121|NCT00026793|473505402|FG000|Overall Study|Off study|2|||
131512122|NCT04151290|473505403|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
131512123|NCT03913091|473505404|FG000|Overall Study|Lost to Follow-up|18|||
131512124|NCT03913091|473505405|FG001|Overall Study|Lost to Follow-up|11|||
131512125|NCT03913091|473505404|FG000|Overall Study|Required additional meds/surgery|1|||
131512126|NCT03913091|473505405|FG001|Overall Study|Required additional meds/surgery|2|||
131512127|NCT03913091|473505404|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
131512128|NCT03913091|473505405|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
131512129|NCT00969553|473505406|FG000|Overall Study|Progressive disease (PD)|2|||
131512130|NCT00969553|473505407|FG001|Overall Study|Progressive disease (PD)|2|||
131512131|NCT00969553|473505408|FG002|Overall Study|Progressive disease (PD)|6|||
131512132|NCT00969553|473505409|FG003|Overall Study|Progressive disease (PD)|9|||
131512133|NCT00969553|473505410|FG004|Overall Study|Progressive disease (PD)|2|||
131512134|NCT00969553|473505411|FG005|Overall Study|Progressive disease (PD)|4|||
131512135|NCT00969553|473505412|FG006|Overall Study|Progressive disease (PD)|2|||
131512136|NCT00969553|473505413|FG007|Overall Study|Progressive disease (PD)|12|||
131512137|NCT00969553|473505414|FG008|Overall Study|Progressive disease (PD)|3|||
131512138|NCT00969553|473505406|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512139|NCT00969553|473505407|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512140|NCT00969553|473505408|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512141|NCT00969553|473505409|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512142|NCT00969553|473505410|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
131512143|NCT00969553|473505411|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512144|NCT00969553|473505412|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512145|NCT00969553|473505413|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512146|NCT00969553|473505414|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
131512147|NCT00969553|473505406|FG000|Overall Study|Other Adverse Event|0|||
131512148|NCT00969553|473505407|FG001|Overall Study|Other Adverse Event|0|||
131512149|NCT00969553|473505408|FG002|Overall Study|Other Adverse Event|0|||
131512150|NCT00969553|473505409|FG003|Overall Study|Other Adverse Event|1|||
131512151|NCT00969553|473505410|FG004|Overall Study|Other Adverse Event|0|||
131512152|NCT00969553|473505411|FG005|Overall Study|Other Adverse Event|0|||
131512153|NCT00969553|473505412|FG006|Overall Study|Other Adverse Event|1|||
131512154|NCT00969553|473505413|FG007|Overall Study|Other Adverse Event|0|||
131512155|NCT00969553|473505414|FG008|Overall Study|Other Adverse Event|0|||
131512156|NCT00969553|473505406|FG000|Overall Study|Refused cont. medication|1|||
131512157|NCT00969553|473505407|FG001|Overall Study|Refused cont. medication|1|||
131512158|NCT00969553|473505408|FG002|Overall Study|Refused cont. medication|0|||
131512159|NCT00969553|473505409|FG003|Overall Study|Refused cont. medication|2|||
131512160|NCT00969553|473505410|FG004|Overall Study|Refused cont. medication|0|||
131512161|NCT00969553|473505411|FG005|Overall Study|Refused cont. medication|0|||
131512162|NCT00969553|473505412|FG006|Overall Study|Refused cont. medication|0|||
131512163|NCT00969553|473505413|FG007|Overall Study|Refused cont. medication|1|||
131512164|NCT00969553|473505414|FG008|Overall Study|Refused cont. medication|0|||
131512165|NCT00969553|473505406|FG000|Overall Study|Not specified above|0|||
131512166|NCT00969553|473505407|FG001|Overall Study|Not specified above|0|||
131512167|NCT00969553|473505408|FG002|Overall Study|Not specified above|0|||
131512168|NCT00969553|473505409|FG003|Overall Study|Not specified above|4|||
131512169|NCT00969553|473505410|FG004|Overall Study|Not specified above|0|||
131512170|NCT00969553|473505411|FG005|Overall Study|Not specified above|0|||
131512171|NCT00969553|473505412|FG006|Overall Study|Not specified above|1|||
131512172|NCT00969553|473505413|FG007|Overall Study|Not specified above|1|||
131512173|NCT00969553|473505414|FG008|Overall Study|Not specified above|0|||
131512174|NCT04248816|473505415|FG000|Overall Study|Ineligible post-randomization|7|||
131512175|NCT04248816|473505416|FG001|Overall Study|Ineligible post-randomization|21|||
131512176|NCT04248816|473505417|FG002|Overall Study|Ineligible post-randomization|25|||
131512177|NCT04327986|473505418|FG000|Overall Study|Physician Decision|2|||
131512178|NCT04327986|473505419|FG001|Overall Study|Physician Decision|0|||
131512179|NCT04327986|473505420|FG002|Overall Study|Physician Decision|0|||
131512180|NCT04327986|473505418|FG000|Overall Study|Death|1|||
131512181|NCT04327986|473505419|FG001|Overall Study|Death|0|||
131512182|NCT04327986|473505420|FG002|Overall Study|Death|0|||
131512183|NCT00655564|473505421|FG000|Overall Study|Adverse Event|1|||
131512184|NCT00655564|473505421|FG000|Overall Study|Lost to Follow-up|1|||
131512185|NCT00655564|473505421|FG000|Overall Study|Desired Alternate Therapy|1|||
131512186|NCT01077804|473505422|FG000|Overall Study|Unreachable|102|||
131512187|NCT01077804|473505422|FG000|Overall Study|Refused to continue|79|||
131512188|NCT01077804|473505422|FG000|Overall Study|Other|18|||
131512189|NCT02620046|473505424|FG000|Overall Study|Adverse Event|22|||
131512190|NCT02620046|473505425|FG001|Overall Study|Adverse Event|42|||
131512191|NCT02620046|473505424|FG000|Overall Study|Lost to Follow-up|4|||
131512192|NCT02620046|473505425|FG001|Overall Study|Lost to Follow-up|10|||
131512193|NCT02620046|473505424|FG000|Overall Study|Withdrawal by Subject|36|||
131512194|NCT02620046|473505425|FG001|Overall Study|Withdrawal by Subject|66|||
131512195|NCT02620046|473505424|FG000|Overall Study|Site Termination|3|||
131512196|NCT02620046|473505425|FG001|Overall Study|Site Termination|3|||
131512197|NCT02620046|473505424|FG000|Overall Study|Pregnancy|3|||
131512198|NCT02620046|473505425|FG001|Overall Study|Pregnancy|7|||
131512199|NCT02620046|473505424|FG000|Overall Study|Lack of Efficacy|81|||
131512200|NCT02620046|473505425|FG001|Overall Study|Lack of Efficacy|146|||
131512201|NCT02620046|473505424|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
131512202|NCT02620046|473505425|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
131512203|NCT02620046|473505424|FG000|Overall Study|Reason Not Specified|13|||
131512204|NCT02620046|473505425|FG001|Overall Study|Reason Not Specified|21|||
131512205|NCT02620046|473505424|FG000|Overall Study|Significant Protocol Deviation|0|||
131512206|NCT02620046|473505425|FG001|Overall Study|Significant Protocol Deviation|1|||
131512207|NCT04477304|473505426|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
131512208|NCT04477304|473505427|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
131512209|NCT02917031|473505433|FG000|Overall Study|Reason not specified|7|||
131512210|NCT02917031|473505434|FG001|Overall Study|Reason not specified|5|||
131512211|NCT02917031|473505435|FG002|Overall Study|Reason not specified|6|||
131512212|NCT02917031|473505433|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
131512213|NCT02917031|473505434|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
131512214|NCT02917031|473505435|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
131512215|NCT02917031|473505433|FG000|Overall Study|Withdrawal by Subject|3|||
131512216|NCT02917031|473505434|FG001|Overall Study|Withdrawal by Subject|3|||
131512217|NCT02917031|473505435|FG002|Overall Study|Withdrawal by Subject|0|||
131512218|NCT02917031|473505433|FG000|Overall Study|Physician Decision|1|||
131512219|NCT02917031|473505434|FG001|Overall Study|Physician Decision|0|||
131512220|NCT02917031|473505435|FG002|Overall Study|Physician Decision|0|||
131512221|NCT02917031|473505433|FG000|Overall Study|Adverse Event|4|||
131512222|NCT02917031|473505434|FG001|Overall Study|Adverse Event|1|||
131512223|NCT02917031|473505435|FG002|Overall Study|Adverse Event|5|||
131512224|NCT02917031|473505433|FG000|Overall Study|Death|2|||
131512225|NCT02917031|473505434|FG001|Overall Study|Death|3|||
131512226|NCT02917031|473505435|FG002|Overall Study|Death|4|||
131512227|NCT00427635|473507017|FG000|Treatment Phase|Withdrawal by Subject|1|||
131512228|NCT00427635|473507018|FG001|Treatment Phase|Withdrawal by Subject|0|||
131512229|NCT00427635|473507017|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
131512230|NCT00427635|473507018|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
131512231|NCT00136084|473507019|FG000|Overall Study|Death|12|||
131512232|NCT00136084|473507020|FG001|Overall Study|Death|5|||
131512233|NCT00136084|473507019|FG000|Overall Study|Unacceptable toxicity|8|||
131512234|NCT00136084|473507020|FG001|Overall Study|Unacceptable toxicity|11|||
131512235|NCT00136084|473507019|FG000|Overall Study|Relapse|20|||
131512236|NCT00136084|473507020|FG001|Overall Study|Relapse|23|||
131512237|NCT00136084|473507019|FG000|Overall Study|Lost to Follow-up|2|||
131512238|NCT00136084|473507020|FG001|Overall Study|Lost to Follow-up|0|||
131512239|NCT00136084|473507019|FG000|Overall Study|No Response|1|||
131512240|NCT00136084|473507020|FG001|Overall Study|No Response|2|||
131512241|NCT00136084|473507019|FG000|Overall Study|Withdrawal by Subject|5|||
131512242|NCT00136084|473507020|FG001|Overall Study|Withdrawal by Subject|1|||
131512243|NCT00997503|473507021|FG000|Overall Study|Death|53|||
131512244|NCT00997503|473507021|FG000|Overall Study|Withdrawal by Subject|76|||
131512245|NCT00997503|473507021|FG000|Overall Study|Lost to Follow-up|33|||
131512246|NCT00997503|473507021|FG000|Overall Study|Adverse Event|3|||
131512247|NCT00997503|473507021|FG000|Overall Study|Physician Decision|10|||
131512248|NCT00997503|473507021|FG000|Overall Study|Missed 12-month follow-up|85|||
131512249|NCT00997503|473507021|FG000|Overall Study|Other reason|13|||
131512250|NCT01933048|473507022|FG000|Overall Study|Lost to Follow-up|15|||
131512251|NCT01933048|473507023|FG001|Overall Study|Lost to Follow-up|18|||
131512252|NCT01933048|473507022|FG000|Overall Study|personal reasons|1|||
131512253|NCT01933048|473507023|FG001|Overall Study|personal reasons|1|||
131512254|NCT01933048|473507022|FG000|Overall Study|Protocol Violation|7|||
131512255|NCT01933048|473507023|FG001|Overall Study|Protocol Violation|8|||
131512256|NCT01933048|473507022|FG000|Overall Study|Physician Decision|1|||
131512257|NCT01933048|473507023|FG001|Overall Study|Physician Decision|0|||
131512258|NCT01933048|473507022|FG000|Overall Study|unknown reasons|1|||
131512259|NCT01933048|473507023|FG001|Overall Study|unknown reasons|1|||
131512260|NCT01446965|473507024|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
131512261|NCT01446965|473507025|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
131512262|NCT01446965|473507024|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
131512263|NCT01446965|473507025|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
131512264|NCT02852265|473507026|FG000|3-month Follow-up|Lost to Follow-up|1|||
131512265|NCT02852265|473507027|FG001|3-month Follow-up|Lost to Follow-up|1|||
131512266|NCT01828034|473507028|FG000|Overall Study|Withdrawal by Subject|0|||
131512267|NCT01828034|473507029|FG001|Overall Study|Withdrawal by Subject|0|||
131512268|NCT01828034|473507030|FG002|Overall Study|Withdrawal by Subject|0|||
131512269|NCT01828034|473507031|FG003|Overall Study|Withdrawal by Subject|1|||
131512270|NCT02871375|473507032|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
131512271|NCT02871375|473507033|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
131512272|NCT01988571|473507036|FG000|Overall Study|Death|3|||
131512273|NCT01988571|473507037|FG001|Overall Study|Death|1|||
131512274|NCT01988571|473507036|FG000|Overall Study|Physician Decision|2|||
131512275|NCT01988571|473507037|FG001|Overall Study|Physician Decision|1|||
131512276|NCT01988571|473507036|FG000|Overall Study|Lost to Follow-up|3|||
131512277|NCT01988571|473507037|FG001|Overall Study|Lost to Follow-up|0|||
131512278|NCT01988571|473507036|FG000|Overall Study|Withdrawal by Subject|31|||
131512279|NCT01988571|473507037|FG001|Overall Study|Withdrawal by Subject|33|||
131512280|NCT00004412|473507038|FG000|Randomized Period|Moved to Crossover Period|3|||
131512281|NCT00004412|473507039|FG001|Randomized Period|Moved to Crossover Period|0|||
131512282|NCT00004412|473507040|FG002|Randomized Period|Moved to Crossover Period|0|||
131512283|NCT02346136|473507048|FG000|Overall Study|Withdrawal by Subject|7|||
131512284|NCT02346136|473507049|FG001|Overall Study|Withdrawal by Subject|5|||
131512285|NCT02346136|473507048|FG000|Overall Study|Death|1|||
131512286|NCT02346136|473507049|FG001|Overall Study|Death|0|||
131512287|NCT02346136|473507048|FG000|Overall Study|Study termination|14|||
131512288|NCT02346136|473507049|FG001|Overall Study|Study termination|18|||
131512289|NCT00453999|473507055|FG000|Overall Study|Adverse Event|1|||
131512290|NCT00453999|473507056|FG001|Overall Study|Adverse Event|2|||
131512291|NCT00453999|473507057|FG002|Overall Study|Adverse Event|1|||
131512292|NCT00453999|473507055|FG000|Overall Study|Lost to Follow-up|0|||
131512293|NCT00453999|473507056|FG001|Overall Study|Lost to Follow-up|1|||
131512294|NCT00453999|473507057|FG002|Overall Study|Lost to Follow-up|1|||
131512295|NCT00453999|473507055|FG000|Overall Study|Withdrawal by Subject|2|||
131512296|NCT00453999|473507056|FG001|Overall Study|Withdrawal by Subject|1|||
131512297|NCT00453999|473507057|FG002|Overall Study|Withdrawal by Subject|1|||
131512298|NCT00453999|473507055|FG000|Overall Study|Subject Request|2|||
131512299|NCT00453999|473507056|FG001|Overall Study|Subject Request|1|||
131512300|NCT00453999|473507057|FG002|Overall Study|Subject Request|0|||
131512301|NCT01364428|473507067|FG000|Overall Study|Adverse Event|1|||
131512302|NCT01364428|473507068|FG001|Overall Study|Adverse Event|2|||
131512303|NCT01364428|473507067|FG000|Overall Study|Protocol Violation|2|||
131512304|NCT01364428|473507068|FG001|Overall Study|Protocol Violation|0|||
131512305|NCT01364428|473507067|FG000|Overall Study|Withdrawal Criteria|14|||
131512306|NCT01364428|473507068|FG001|Overall Study|Withdrawal Criteria|10|||
131512307|NCT01364428|473507067|FG000|Overall Study|Other|3|||
131512308|NCT01364428|473507068|FG001|Overall Study|Other|3|||
131512309|NCT01987427|473507069|FG000|Overall Study|Adverse Event|4|||
131512310|NCT01987427|473507070|FG001|Overall Study|Adverse Event|2|||
131512311|NCT01987427|473507071|FG002|Overall Study|Adverse Event|8|||
131512312|NCT01987427|473507069|FG000|Overall Study|Lost to Follow-up|6|||
131512313|NCT01987427|473507070|FG001|Overall Study|Lost to Follow-up|6|||
131512314|NCT01987427|473507071|FG002|Overall Study|Lost to Follow-up|9|||
131512315|NCT01987427|473507069|FG000|Overall Study|Withdrawal by Subject|2|||
131512316|NCT01987427|473507070|FG001|Overall Study|Withdrawal by Subject|1|||
131512317|NCT01987427|473507071|FG002|Overall Study|Withdrawal by Subject|3|||
131512318|NCT01987427|473507069|FG000|Overall Study|Lack of Efficacy|1|||
131512319|NCT01987427|473507070|FG001|Overall Study|Lack of Efficacy|0|||
131512320|NCT01987427|473507071|FG002|Overall Study|Lack of Efficacy|0|||
131512321|NCT01987427|473507069|FG000|Overall Study|Other|1|||
131512322|NCT01987427|473507070|FG001|Overall Study|Other|1|||
131512323|NCT01987427|473507071|FG002|Overall Study|Other|0|||
131512324|NCT00743652|473507072|FG000|Overall Study|Parent/Legal Guardian Request|3|||
131512325|NCT00743652|473507073|FG001|Overall Study|Parent/Legal Guardian Request|2|||
131512326|NCT00743652|473507074|FG002|Overall Study|Parent/Legal Guardian Request|2|||
131512327|NCT00743652|473507075|FG003|Overall Study|Parent/Legal Guardian Request|2|||
131512328|NCT00743652|473507076|FG004|Overall Study|Parent/Legal Guardian Request|0|||
131512329|NCT00743652|473507072|FG000|Overall Study|Adverse Event|3|||
131512330|NCT00743652|473507073|FG001|Overall Study|Adverse Event|0|||
131512331|NCT00743652|473507074|FG002|Overall Study|Adverse Event|0|||
131512332|NCT00743652|473507075|FG003|Overall Study|Adverse Event|0|||
131512333|NCT00743652|473507076|FG004|Overall Study|Adverse Event|0|||
131512334|NCT00743652|473507072|FG000|Overall Study|Death|2|||
131512335|NCT00743652|473507073|FG001|Overall Study|Death|0|||
131512336|NCT00743652|473507074|FG002|Overall Study|Death|0|||
131512337|NCT00743652|473507075|FG003|Overall Study|Death|0|||
131512338|NCT00743652|473507076|FG004|Overall Study|Death|0|||
131512339|NCT00743652|473507072|FG000|Overall Study|Investigator Request|0|||
131512340|NCT00743652|473507073|FG001|Overall Study|Investigator Request|0|||
131512341|NCT00743652|473507074|FG002|Overall Study|Investigator Request|0|||
131512342|NCT00743652|473507075|FG003|Overall Study|Investigator Request|2|||
131512343|NCT00743652|473507076|FG004|Overall Study|Investigator Request|0|||
131512344|NCT00743652|473507072|FG000|Overall Study|Other|1|||
131512345|NCT00743652|473507073|FG001|Overall Study|Other|1|||
131512346|NCT00743652|473507074|FG002|Overall Study|Other|0|||
131512347|NCT00743652|473507075|FG003|Overall Study|Other|0|||
131512348|NCT00743652|473507076|FG004|Overall Study|Other|0|||
131512349|NCT00743652|473507072|FG000|Overall Study|Lost to Follow-up|1|||
131512350|NCT00743652|473507073|FG001|Overall Study|Lost to Follow-up|0|||
131512351|NCT00743652|473507074|FG002|Overall Study|Lost to Follow-up|0|||
131512352|NCT00743652|473507075|FG003|Overall Study|Lost to Follow-up|0|||
131512353|NCT00743652|473507076|FG004|Overall Study|Lost to Follow-up|0|||
131512354|NCT03925324|473507080|FG000|Overall Study|Death|1|||
131512355|NCT03925324|473507081|FG001|Overall Study|Death|1|||
131512356|NCT02129803|473507084|FG000|Overall Study|Protocol Violation|4|||
131512357|NCT02129803|473507085|FG001|Overall Study|Protocol Violation|0|||
131512358|NCT02129803|473507084|FG000|Overall Study|Physician Decision|0|||
131512359|NCT02129803|473507085|FG001|Overall Study|Physician Decision|1|||
131512360|NCT02129803|473507084|FG000|Overall Study|Difficulty sleeping|1|||
131512361|NCT02129803|473507085|FG001|Overall Study|Difficulty sleeping|0|||
131512362|NCT02129803|473507084|FG000|Overall Study|Morning headache|0|||
131512363|NCT02129803|473507085|FG001|Overall Study|Morning headache|1|||
131512364|NCT02129803|473507084|FG000|Overall Study|Withdrawal by Subject|1|||
131512365|NCT02129803|473507085|FG001|Overall Study|Withdrawal by Subject|1|||
131512366|NCT00694369|473507086|FG000|Overall Study|Adverse Event|0|||
131512367|NCT00694369|473507087|FG001|Overall Study|Adverse Event|1|||
131512368|NCT00694369|473507088|FG002|Overall Study|Adverse Event|0|||
131512369|NCT00694369|473507089|FG003|Overall Study|Adverse Event|1|||
131512370|NCT00694369|473507090|FG004|Overall Study|Adverse Event|3|||
131512371|NCT00694369|473507086|FG000|Overall Study|Lost to Follow-up|0|||
131512372|NCT00694369|473507087|FG001|Overall Study|Lost to Follow-up|0|||
131512373|NCT00694369|473507088|FG002|Overall Study|Lost to Follow-up|1|||
131512374|NCT00694369|473507089|FG003|Overall Study|Lost to Follow-up|1|||
131512375|NCT00694369|473507090|FG004|Overall Study|Lost to Follow-up|0|||
131512376|NCT00694369|473507086|FG000|Overall Study|Physician Decision|0|||
131512377|NCT00694369|473507087|FG001|Overall Study|Physician Decision|0|||
131512378|NCT00694369|473507088|FG002|Overall Study|Physician Decision|0|||
131512379|NCT00694369|473507089|FG003|Overall Study|Physician Decision|0|||
131512380|NCT00694369|473507090|FG004|Overall Study|Physician Decision|1|||
131512381|NCT00694369|473507086|FG000|Overall Study|Protocol Violation|0|||
131512382|NCT00694369|473507087|FG001|Overall Study|Protocol Violation|1|||
131512383|NCT00694369|473507088|FG002|Overall Study|Protocol Violation|0|||
131512384|NCT00694369|473507089|FG003|Overall Study|Protocol Violation|0|||
131512385|NCT00694369|473507090|FG004|Overall Study|Protocol Violation|0|||
131512386|NCT00694369|473507086|FG000|Overall Study|Withdrawal by Subject|1|||
131512387|NCT00694369|473507087|FG001|Overall Study|Withdrawal by Subject|1|||
131512388|NCT00694369|473507088|FG002|Overall Study|Withdrawal by Subject|1|||
131512389|NCT00694369|473507089|FG003|Overall Study|Withdrawal by Subject|1|||
131512390|NCT00694369|473507090|FG004|Overall Study|Withdrawal by Subject|2|||
131512391|NCT00594464|473507095|FG000|Overall Study|Withdrawal by Subject|1|||
131512392|NCT00594464|473507095|FG000|Overall Study|Delay in operation|2|||
131512393|NCT00775437|473507096|FG000|Overall Study|Loss of efficacy|2|||
131512394|NCT00775437|473507096|FG000|Overall Study|Withdrawal by Subject|3|||
131512395|NCT00775437|473507096|FG000|Overall Study|Lost to Follow-up|1|||
131512396|NCT03131440|473507097|FG000|Overall Study|Withdrawal by Subject|1|||
131512397|NCT03131440|473507098|FG001|Overall Study|Withdrawal by Subject|3|||
131512398|NCT03131440|473507099|FG002|Overall Study|Withdrawal by Subject|0|||
131512399|NCT03131440|473507100|FG003|Overall Study|Withdrawal by Subject|0|||
131512400|NCT03131440|473507101|FG004|Overall Study|Withdrawal by Subject|1|||
131512401|NCT03131440|473507102|FG005|Overall Study|Withdrawal by Subject|0|||
131512402|NCT03131440|473507103|FG006|Overall Study|Withdrawal by Subject|0|||
131512403|NCT03131440|473507104|FG007|Overall Study|Withdrawal by Subject|1|||
131512404|NCT03131440|473507105|FG008|Overall Study|Withdrawal by Subject|1|||
131512405|NCT03131440|473507106|FG009|Overall Study|Withdrawal by Subject|1|||
131512406|NCT03131440|473507107|FG010|Overall Study|Withdrawal by Subject|0|||
131512407|NCT03131440|473507108|FG011|Overall Study|Withdrawal by Subject|1|||
131512408|NCT03131440|473507109|FG012|Overall Study|Withdrawal by Subject|1|||
131512409|NCT03131440|473507110|FG013|Overall Study|Withdrawal by Subject|0|||
131512410|NCT03131440|473507111|FG014|Overall Study|Withdrawal by Subject|1|||
131512411|NCT03131440|473507112|FG015|Overall Study|Withdrawal by Subject|0|||
131512412|NCT03131440|473507113|FG016|Overall Study|Withdrawal by Subject|0|||
131512413|NCT03131440|473507114|FG017|Overall Study|Withdrawal by Subject|0|||
131512414|NCT03131440|473507115|FG018|Overall Study|Withdrawal by Subject|1|||
131512415|NCT03131440|473507116|FG019|Overall Study|Withdrawal by Subject|0|||
131512416|NCT03131440|473507117|FG020|Overall Study|Withdrawal by Subject|1|||
131512417|NCT03131440|473507118|FG021|Overall Study|Withdrawal by Subject|1|||
131512418|NCT03131440|473507119|FG022|Overall Study|Withdrawal by Subject|1|||
131512419|NCT03131440|473507120|FG023|Overall Study|Withdrawal by Subject|0|||
131512420|NCT03131440|473507121|FG024|Overall Study|Withdrawal by Subject|0|||
131512421|NCT03131440|473507122|FG025|Overall Study|Withdrawal by Subject|0|||
131512422|NCT03131440|473507123|FG026|Overall Study|Withdrawal by Subject|0|||
131512423|NCT03131440|473507124|FG027|Overall Study|Withdrawal by Subject|0|||
131512424|NCT03131440|473507125|FG028|Overall Study|Withdrawal by Subject|0|||
131512425|NCT03131440|473507126|FG029|Overall Study|Withdrawal by Subject|0|||
131512426|NCT03131440|473507127|FG030|Overall Study|Withdrawal by Subject|1|||
131512427|NCT03131440|473507128|FG031|Overall Study|Withdrawal by Subject|0|||
131512428|NCT03131440|473507097|FG000|Overall Study|Lost to Follow-up|0|||
131512429|NCT03131440|473507098|FG001|Overall Study|Lost to Follow-up|0|||
131512430|NCT03131440|473507099|FG002|Overall Study|Lost to Follow-up|0|||
131512431|NCT03131440|473507100|FG003|Overall Study|Lost to Follow-up|0|||
131512432|NCT03131440|473507101|FG004|Overall Study|Lost to Follow-up|0|||
131512433|NCT03131440|473507102|FG005|Overall Study|Lost to Follow-up|1|||
131512434|NCT03131440|473507103|FG006|Overall Study|Lost to Follow-up|0|||
131512435|NCT03131440|473507104|FG007|Overall Study|Lost to Follow-up|0|||
131512436|NCT03131440|473507105|FG008|Overall Study|Lost to Follow-up|0|||
131512437|NCT03131440|473507106|FG009|Overall Study|Lost to Follow-up|0|||
131512438|NCT03131440|473507107|FG010|Overall Study|Lost to Follow-up|0|||
131512439|NCT03131440|473507108|FG011|Overall Study|Lost to Follow-up|0|||
131512440|NCT03131440|473507109|FG012|Overall Study|Lost to Follow-up|0|||
131512441|NCT03131440|473507110|FG013|Overall Study|Lost to Follow-up|0|||
131512442|NCT03131440|473507111|FG014|Overall Study|Lost to Follow-up|0|||
131512443|NCT03131440|473507112|FG015|Overall Study|Lost to Follow-up|0|||
131512444|NCT03131440|473507113|FG016|Overall Study|Lost to Follow-up|0|||
131512445|NCT03131440|473507114|FG017|Overall Study|Lost to Follow-up|0|||
131512446|NCT03131440|473507115|FG018|Overall Study|Lost to Follow-up|0|||
131512447|NCT03131440|473507116|FG019|Overall Study|Lost to Follow-up|2|||
131512448|NCT03131440|473507117|FG020|Overall Study|Lost to Follow-up|1|||
131512449|NCT03131440|473507118|FG021|Overall Study|Lost to Follow-up|0|||
131512450|NCT03131440|473507119|FG022|Overall Study|Lost to Follow-up|1|||
131512451|NCT03131440|473507120|FG023|Overall Study|Lost to Follow-up|0|||
131512452|NCT03131440|473507121|FG024|Overall Study|Lost to Follow-up|1|||
131512453|NCT03131440|473507122|FG025|Overall Study|Lost to Follow-up|0|||
131512454|NCT03131440|473507123|FG026|Overall Study|Lost to Follow-up|0|||
131512455|NCT03131440|473507124|FG027|Overall Study|Lost to Follow-up|2|||
131512456|NCT03131440|473507125|FG028|Overall Study|Lost to Follow-up|0|||
131512457|NCT03131440|473507126|FG029|Overall Study|Lost to Follow-up|2|||
131512458|NCT03131440|473507127|FG030|Overall Study|Lost to Follow-up|0|||
131512459|NCT03131440|473507128|FG031|Overall Study|Lost to Follow-up|0|||
131512460|NCT03131440|473507097|FG000|Overall Study|Death|0|||
131512461|NCT03131440|473507098|FG001|Overall Study|Death|0|||
131512462|NCT03131440|473507099|FG002|Overall Study|Death|0|||
131512463|NCT03131440|473507100|FG003|Overall Study|Death|0|||
131512464|NCT03131440|473507101|FG004|Overall Study|Death|0|||
131512465|NCT03131440|473507102|FG005|Overall Study|Death|0|||
131512466|NCT03131440|473507103|FG006|Overall Study|Death|0|||
131512467|NCT03131440|473507104|FG007|Overall Study|Death|0|||
131512468|NCT03131440|473507105|FG008|Overall Study|Death|0|||
131512469|NCT03131440|473507106|FG009|Overall Study|Death|0|||
131512470|NCT03131440|473507107|FG010|Overall Study|Death|0|||
131512471|NCT03131440|473507108|FG011|Overall Study|Death|0|||
131512472|NCT03131440|473507109|FG012|Overall Study|Death|0|||
131512473|NCT03131440|473507110|FG013|Overall Study|Death|0|||
131512474|NCT03131440|473507111|FG014|Overall Study|Death|0|||
131512475|NCT03131440|473507112|FG015|Overall Study|Death|0|||
131512476|NCT03131440|473507113|FG016|Overall Study|Death|0|||
131512477|NCT03131440|473507114|FG017|Overall Study|Death|0|||
131512478|NCT03131440|473507115|FG018|Overall Study|Death|0|||
131512479|NCT03131440|473507116|FG019|Overall Study|Death|0|||
131512480|NCT03131440|473507117|FG020|Overall Study|Death|0|||
131512481|NCT03131440|473507118|FG021|Overall Study|Death|0|||
131512482|NCT03131440|473507119|FG022|Overall Study|Death|0|||
131512483|NCT03131440|473507120|FG023|Overall Study|Death|0|||
131512484|NCT03131440|473507121|FG024|Overall Study|Death|0|||
131512485|NCT03131440|473507122|FG025|Overall Study|Death|1|||
131512486|NCT03131440|473507123|FG026|Overall Study|Death|0|||
131512487|NCT03131440|473507124|FG027|Overall Study|Death|0|||
131512488|NCT03131440|473507125|FG028|Overall Study|Death|0|||
131512489|NCT03131440|473507126|FG029|Overall Study|Death|0|||
131512490|NCT03131440|473507127|FG030|Overall Study|Death|0|||
131512491|NCT03131440|473507128|FG031|Overall Study|Death|0|||
131512492|NCT00746941|473507131|FG000|Overall Study|Death|2|||
131512493|NCT00746941|473507132|FG001|Overall Study|Death|0|||
131512494|NCT00746941|473507133|FG002|Overall Study|Death|0|||
131512495|NCT00746941|473507134|FG003|Overall Study|Death|6|||
131512496|NCT00746941|473507131|FG000|Overall Study|Physician Decision|0|||
131512497|NCT00746941|473507132|FG001|Overall Study|Physician Decision|0|||
131512498|NCT00746941|473507133|FG002|Overall Study|Physician Decision|2|||
131512499|NCT00746941|473507134|FG003|Overall Study|Physician Decision|0|||
131512500|NCT00746941|473507131|FG000|Overall Study|Withdrawal by Subject|3|||
131512501|NCT00746941|473507132|FG001|Overall Study|Withdrawal by Subject|0|||
131512502|NCT00746941|473507133|FG002|Overall Study|Withdrawal by Subject|0|||
131512503|NCT00746941|473507134|FG003|Overall Study|Withdrawal by Subject|2|||
131512504|NCT00746941|473507131|FG000|Overall Study|Other, reason not provided|2|||
131512505|NCT00746941|473507132|FG001|Overall Study|Other, reason not provided|4|||
131512506|NCT00746941|473507133|FG002|Overall Study|Other, reason not provided|0|||
131512507|NCT00746941|473507134|FG003|Overall Study|Other, reason not provided|4|||
131512508|NCT00746941|473507131|FG000|Overall Study|Adverse Event|0|||
131512509|NCT00746941|473507132|FG001|Overall Study|Adverse Event|0|||
131512510|NCT00746941|473507133|FG002|Overall Study|Adverse Event|0|||
131512511|NCT00746941|473507134|FG003|Overall Study|Adverse Event|1|||
131512512|NCT03316885|473507135|FG000|Overall Study|Adverse Event|1|||
131512513|NCT03316885|473507135|FG000|Overall Study|Death|10|||
131512514|NCT03316885|473507135|FG000|Overall Study|Lost to Follow-up|4|||
131512515|NCT03316885|473507135|FG000|Overall Study|Withdrawal by Subject|9|||
131512516|NCT03316885|473507135|FG000|Overall Study|COVID related|8|||
131512517|NCT04371380|473507136|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
131512518|NCT04371380|473507137|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
131512519|NCT04371380|473507138|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
131512520|NCT06049043|473507139|FG000|Overall Study|Lost to Follow-up|11|||
131512521|NCT06049043|473507140|FG001|Overall Study|Lost to Follow-up|9|||
131512522|NCT03216850|473507146|FG000|Overall Study|Pre-analytical error|6|||
131512523|NCT03190889|473507147|FG000|Overall Study|Lost to Follow-up|7|||
131512524|NCT03190889|473507148|FG001|Overall Study|Lost to Follow-up|7|||
131512525|NCT03190889|473507149|FG002|Overall Study|Lost to Follow-up|3|||
131512526|NCT03190889|473507147|FG000|Overall Study|Withdrawal by Subject|1|||
131512527|NCT03190889|473507148|FG001|Overall Study|Withdrawal by Subject|1|||
131512528|NCT03190889|473507149|FG002|Overall Study|Withdrawal by Subject|2|||
131512529|NCT03190889|473507147|FG000|Overall Study|Did not complete protocol|4|||
131512530|NCT03190889|473507148|FG001|Overall Study|Did not complete protocol|9|||
131512531|NCT03190889|473507149|FG002|Overall Study|Did not complete protocol|0|||
131512532|NCT03190889|473507147|FG000|Overall Study|COVID-19|1|||
131512533|NCT03190889|473507148|FG001|Overall Study|COVID-19|0|||
131512534|NCT03190889|473507149|FG002|Overall Study|COVID-19|2|||
131512535|NCT01228747|473507150|FG000|Overall Study|Adverse Event|8|||
131512536|NCT01228747|473507151|FG001|Overall Study|Adverse Event|4|||
131512537|NCT01228747|473507150|FG000|Overall Study|Lack of Efficacy|40|||
131512538|NCT01228747|473507151|FG001|Overall Study|Lack of Efficacy|27|||
131512539|NCT01228747|473507150|FG000|Overall Study|Protocol Violation|6|||
131512540|NCT01228747|473507151|FG001|Overall Study|Protocol Violation|5|||
131512541|NCT01228747|473507150|FG000|Overall Study|Lost to Follow-up|4|||
131512542|NCT01228747|473507151|FG001|Overall Study|Lost to Follow-up|3|||
131512543|NCT01228747|473507150|FG000|Overall Study|Withdrawal by Subject|5|||
131512544|NCT01228747|473507151|FG001|Overall Study|Withdrawal by Subject|1|||
131512545|NCT01228747|473507150|FG000|Overall Study|Other Reason|2|||
131512546|NCT01228747|473507151|FG001|Overall Study|Other Reason|5|||
131512547|NCT00680901|473507155|FG000|Overall Study|Ongoing: On Study Treatment|1|||
131512548|NCT00680901|473507156|FG001|Overall Study|Ongoing: On Study Treatment|0|||
131512549|NCT00680901|473507155|FG000|Overall Study|Ongoing: In Follow Up|1|||
131512550|NCT00680901|473507156|FG001|Overall Study|Ongoing: In Follow Up|0|||
131512551|NCT00680901|473507155|FG000|Overall Study|Adverse Event|1|||
131512552|NCT00680901|473507156|FG001|Overall Study|Adverse Event|1|||
131512553|NCT00680901|473507155|FG000|Overall Study|Lost to Follow-up|3|||
131512554|NCT00680901|473507156|FG001|Overall Study|Lost to Follow-up|5|||
131512555|NCT00680901|473507155|FG000|Overall Study|Subject decided to withdraw from the study|4|||
131512556|NCT00680901|473507156|FG001|Overall Study|Subject decided to withdraw from the study|15|||
131512557|NCT00680901|473507155|FG000|Overall Study|Sponsor decision|1|||
131512558|NCT00680901|473507156|FG001|Overall Study|Sponsor decision|0|||
131512559|NCT00680901|473507155|FG000|Overall Study|Physician Decision|0|||
131512560|NCT00680901|473507156|FG001|Overall Study|Physician Decision|2|||
131512561|NCT00680901|473507155|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
131512562|NCT00680901|473507156|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
131512563|NCT00680901|473507155|FG000|Overall Study|Other protocol defined stopping criteria|17|||
131512564|NCT00680901|473507156|FG001|Overall Study|Other protocol defined stopping criteria|17|||
131512565|NCT00500292|473507157|FG000|Overall Study|Adverse Event|3|||
131512566|NCT00500292|473507158|FG001|Overall Study|Adverse Event|6|||
131512567|NCT00500292|473507159|FG002|Overall Study|Adverse Event|4|||
131512568|NCT00500292|473507157|FG000|Overall Study|Condition under investigation worsened|21|||
131512569|NCT00500292|473507158|FG001|Overall Study|Condition under investigation worsened|23|||
131512570|NCT00500292|473507159|FG002|Overall Study|Condition under investigation worsened|19|||
131512571|NCT00500292|473507157|FG000|Overall Study|Withdrawal by Subject|0|||
131512572|NCT00500292|473507158|FG001|Overall Study|Withdrawal by Subject|1|||
131512573|NCT00500292|473507159|FG002|Overall Study|Withdrawal by Subject|0|||
131512574|NCT00500292|473507157|FG000|Overall Study|Other|1|||
131512575|NCT00500292|473507158|FG001|Overall Study|Other|1|||
131512576|NCT00500292|473507159|FG002|Overall Study|Other|4|||
131512577|NCT02641379|473507169|FG000|Overall Study|Exclusion criterion during screening|1|||
131512578|NCT02641379|473507170|FG001|Overall Study|Exclusion criterion during screening|0|||
131512579|NCT02641379|473507171|FG002|Overall Study|Exclusion criterion during screening|0|||
131512580|NCT02641379|473507172|FG003|Overall Study|Exclusion criterion during screening|1|||
131512581|NCT02641379|473507173|FG004|Overall Study|Exclusion criterion during screening|2|||
131512582|NCT02641379|473507174|FG005|Overall Study|Exclusion criterion during screening|0|||
131512583|NCT02641379|473507175|FG006|Overall Study|Exclusion criterion during screening|0|||
131512584|NCT02641379|473507176|FG007|Overall Study|Exclusion criterion during screening|0|||
131512585|NCT02641379|473507177|FG008|Overall Study|Exclusion criterion during screening|0|||
131512586|NCT02641379|473507178|FG009|Overall Study|Exclusion criterion during screening|0|||
131512587|NCT02641379|473507179|FG010|Overall Study|Exclusion criterion during screening|0|||
131512588|NCT02641379|473507169|FG000|Overall Study|Withdrawal of informed consent|0|||
131512589|NCT02641379|473507170|FG001|Overall Study|Withdrawal of informed consent|1|||
131512590|NCT02641379|473507171|FG002|Overall Study|Withdrawal of informed consent|0|||
131512591|NCT02641379|473507172|FG003|Overall Study|Withdrawal of informed consent|0|||
131512592|NCT02641379|473507173|FG004|Overall Study|Withdrawal of informed consent|0|||
131512593|NCT02641379|473507174|FG005|Overall Study|Withdrawal of informed consent|0|||
131512594|NCT02641379|473507175|FG006|Overall Study|Withdrawal of informed consent|0|||
131512595|NCT02641379|473507176|FG007|Overall Study|Withdrawal of informed consent|1|||
131512596|NCT02641379|473507177|FG008|Overall Study|Withdrawal of informed consent|0|||
131512597|NCT02641379|473507178|FG009|Overall Study|Withdrawal of informed consent|0|||
131512598|NCT02641379|473507179|FG010|Overall Study|Withdrawal of informed consent|0|||
131512599|NCT02641379|473507169|FG000|Overall Study|Adverse Event|7|||
131512600|NCT02641379|473507170|FG001|Overall Study|Adverse Event|8|||
131512601|NCT02641379|473507171|FG002|Overall Study|Adverse Event|2|||
131512602|NCT02641379|473507172|FG003|Overall Study|Adverse Event|2|||
131512603|NCT02641379|473507173|FG004|Overall Study|Adverse Event|5|||
131512604|NCT02641379|473507174|FG005|Overall Study|Adverse Event|1|||
131512605|NCT02641379|473507175|FG006|Overall Study|Adverse Event|5|||
131512606|NCT02641379|473507176|FG007|Overall Study|Adverse Event|0|||
131512607|NCT02641379|473507177|FG008|Overall Study|Adverse Event|1|||
131512608|NCT02641379|473507178|FG009|Overall Study|Adverse Event|1|||
131512609|NCT02641379|473507179|FG010|Overall Study|Adverse Event|5|||
131512610|NCT02641379|473507169|FG000|Overall Study|Lack of Efficacy|0|||
131512611|NCT02641379|473507170|FG001|Overall Study|Lack of Efficacy|0|||
131512612|NCT02641379|473507171|FG002|Overall Study|Lack of Efficacy|2|||
131512613|NCT02641379|473507172|FG003|Overall Study|Lack of Efficacy|0|||
131512614|NCT02641379|473507173|FG004|Overall Study|Lack of Efficacy|0|||
131512615|NCT02641379|473507174|FG005|Overall Study|Lack of Efficacy|2|||
131512616|NCT02641379|473507175|FG006|Overall Study|Lack of Efficacy|0|||
131512617|NCT02641379|473507176|FG007|Overall Study|Lack of Efficacy|5|||
131512618|NCT02641379|473507177|FG008|Overall Study|Lack of Efficacy|0|||
131512619|NCT02641379|473507178|FG009|Overall Study|Lack of Efficacy|0|||
131512620|NCT02641379|473507179|FG010|Overall Study|Lack of Efficacy|0|||
131512621|NCT02641379|473507169|FG000|Overall Study|Participant unable to attend study visit|4|||
131512622|NCT02641379|473507170|FG001|Overall Study|Participant unable to attend study visit|10|||
131512623|NCT02641379|473507171|FG002|Overall Study|Participant unable to attend study visit|1|||
131512624|NCT02641379|473507172|FG003|Overall Study|Participant unable to attend study visit|2|||
131512625|NCT02641379|473507173|FG004|Overall Study|Participant unable to attend study visit|5|||
131512626|NCT02641379|473507174|FG005|Overall Study|Participant unable to attend study visit|1|||
131512627|NCT02641379|473507175|FG006|Overall Study|Participant unable to attend study visit|1|||
131512628|NCT02641379|473507176|FG007|Overall Study|Participant unable to attend study visit|1|||
131512629|NCT02641379|473507177|FG008|Overall Study|Participant unable to attend study visit|0|||
131512630|NCT02641379|473507178|FG009|Overall Study|Participant unable to attend study visit|2|||
131512631|NCT02641379|473507179|FG010|Overall Study|Participant unable to attend study visit|0|||
131512632|NCT02641379|473507169|FG000|Overall Study|Participant's compliance|0|||
131512633|NCT02641379|473507170|FG001|Overall Study|Participant's compliance|1|||
131512634|NCT02641379|473507171|FG002|Overall Study|Participant's compliance|0|||
131512635|NCT02641379|473507172|FG003|Overall Study|Participant's compliance|1|||
131512636|NCT02641379|473507173|FG004|Overall Study|Participant's compliance|0|||
131512637|NCT02641379|473507174|FG005|Overall Study|Participant's compliance|2|||
131512638|NCT02641379|473507175|FG006|Overall Study|Participant's compliance|0|||
131512639|NCT02641379|473507176|FG007|Overall Study|Participant's compliance|0|||
131512640|NCT02641379|473507177|FG008|Overall Study|Participant's compliance|1|||
131512641|NCT02641379|473507178|FG009|Overall Study|Participant's compliance|1|||
131512642|NCT02641379|473507179|FG010|Overall Study|Participant's compliance|1|||
131512643|NCT02641379|473507169|FG000|Overall Study|Participant cannot be reached|4|||
131512644|NCT02641379|473507170|FG001|Overall Study|Participant cannot be reached|4|||
131512645|NCT02641379|473507171|FG002|Overall Study|Participant cannot be reached|0|||
131512646|NCT02641379|473507172|FG003|Overall Study|Participant cannot be reached|8|||
131512647|NCT02641379|473507173|FG004|Overall Study|Participant cannot be reached|2|||
131512648|NCT02641379|473507174|FG005|Overall Study|Participant cannot be reached|1|||
131512649|NCT02641379|473507175|FG006|Overall Study|Participant cannot be reached|0|||
131512650|NCT02641379|473507176|FG007|Overall Study|Participant cannot be reached|1|||
131512651|NCT02641379|473507177|FG008|Overall Study|Participant cannot be reached|0|||
131512652|NCT02641379|473507178|FG009|Overall Study|Participant cannot be reached|2|||
131512653|NCT02641379|473507179|FG010|Overall Study|Participant cannot be reached|1|||
131512654|NCT02641379|473507169|FG000|Overall Study|PCR positive at Week 24|15|||
131512655|NCT02641379|473507170|FG001|Overall Study|PCR positive at Week 24|21|||
131512656|NCT02641379|473507171|FG002|Overall Study|PCR positive at Week 24|62|||
131512657|NCT02641379|473507172|FG003|Overall Study|PCR positive at Week 24|0|||
131512658|NCT02641379|473507173|FG004|Overall Study|PCR positive at Week 24|0|||
131512659|NCT02641379|473507174|FG005|Overall Study|PCR positive at Week 24|6|||
131512660|NCT02641379|473507175|FG006|Overall Study|PCR positive at Week 24|3|||
131512661|NCT02641379|473507176|FG007|Overall Study|PCR positive at Week 24|8|||
131512662|NCT02641379|473507177|FG008|Overall Study|PCR positive at Week 24|0|||
131512663|NCT02641379|473507178|FG009|Overall Study|PCR positive at Week 24|1|||
131512664|NCT02641379|473507179|FG010|Overall Study|PCR positive at Week 24|0|||
131512665|NCT02641379|473507169|FG000|Overall Study|PCR positive at follow up 2|1|||
131512666|NCT02641379|473507170|FG001|Overall Study|PCR positive at follow up 2|0|||
131512667|NCT02641379|473507171|FG002|Overall Study|PCR positive at follow up 2|0|||
131512668|NCT02641379|473507172|FG003|Overall Study|PCR positive at follow up 2|0|||
131512669|NCT02641379|473507173|FG004|Overall Study|PCR positive at follow up 2|0|||
131512670|NCT02641379|473507174|FG005|Overall Study|PCR positive at follow up 2|0|||
131512671|NCT02641379|473507175|FG006|Overall Study|PCR positive at follow up 2|0|||
131512672|NCT02641379|473507176|FG007|Overall Study|PCR positive at follow up 2|0|||
131512673|NCT02641379|473507177|FG008|Overall Study|PCR positive at follow up 2|0|||
131512674|NCT02641379|473507178|FG009|Overall Study|PCR positive at follow up 2|0|||
131512675|NCT02641379|473507179|FG010|Overall Study|PCR positive at follow up 2|0|||
131512676|NCT02641379|473507169|FG000|Overall Study|Participant showed relapse|1|||
131512677|NCT02641379|473507170|FG001|Overall Study|Participant showed relapse|0|||
131512678|NCT02641379|473507171|FG002|Overall Study|Participant showed relapse|0|||
131512679|NCT02641379|473507172|FG003|Overall Study|Participant showed relapse|0|||
131512680|NCT02641379|473507173|FG004|Overall Study|Participant showed relapse|0|||
131512681|NCT02641379|473507174|FG005|Overall Study|Participant showed relapse|0|||
131512682|NCT02641379|473507175|FG006|Overall Study|Participant showed relapse|1|||
131512683|NCT02641379|473507176|FG007|Overall Study|Participant showed relapse|0|||
131512684|NCT02641379|473507177|FG008|Overall Study|Participant showed relapse|0|||
131512685|NCT02641379|473507178|FG009|Overall Study|Participant showed relapse|0|||
131512686|NCT02641379|473507179|FG010|Overall Study|Participant showed relapse|0|||
131512687|NCT02641379|473507169|FG000|Overall Study|Participant stopped study/treatment|1|||
131512688|NCT02641379|473507170|FG001|Overall Study|Participant stopped study/treatment|3|||
131512689|NCT02641379|473507171|FG002|Overall Study|Participant stopped study/treatment|1|||
131512690|NCT02641379|473507172|FG003|Overall Study|Participant stopped study/treatment|0|||
131512691|NCT02641379|473507173|FG004|Overall Study|Participant stopped study/treatment|0|||
131512692|NCT02641379|473507174|FG005|Overall Study|Participant stopped study/treatment|1|||
131512693|NCT02641379|473507175|FG006|Overall Study|Participant stopped study/treatment|2|||
131512694|NCT02641379|473507176|FG007|Overall Study|Participant stopped study/treatment|0|||
131512695|NCT02641379|473507177|FG008|Overall Study|Participant stopped study/treatment|1|||
131512696|NCT02641379|473507178|FG009|Overall Study|Participant stopped study/treatment|0|||
131512697|NCT02641379|473507179|FG010|Overall Study|Participant stopped study/treatment|0|||
131512698|NCT02641379|473507169|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
131512699|NCT02641379|473507170|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
131512700|NCT02641379|473507171|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
131512701|NCT02641379|473507172|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
131512702|NCT02641379|473507173|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
131512703|NCT02641379|473507174|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
131512704|NCT02641379|473507175|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
131512705|NCT02641379|473507176|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
131512706|NCT02641379|473507177|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
131512707|NCT02641379|473507178|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
131512708|NCT02641379|473507179|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
131512709|NCT02641379|473507169|FG000|Overall Study|Financial problems|0|||
131512710|NCT02641379|473507170|FG001|Overall Study|Financial problems|1|||
131512711|NCT02641379|473507171|FG002|Overall Study|Financial problems|0|||
131512712|NCT02641379|473507172|FG003|Overall Study|Financial problems|0|||
131512713|NCT02641379|473507173|FG004|Overall Study|Financial problems|0|||
131512714|NCT02641379|473507174|FG005|Overall Study|Financial problems|0|||
131512715|NCT02641379|473507175|FG006|Overall Study|Financial problems|0|||
131512716|NCT02641379|473507176|FG007|Overall Study|Financial problems|0|||
131512717|NCT02641379|473507177|FG008|Overall Study|Financial problems|0|||
131512718|NCT02641379|473507178|FG009|Overall Study|Financial problems|0|||
131512719|NCT02641379|473507179|FG010|Overall Study|Financial problems|0|||
131512720|NCT02641379|473507169|FG000|Overall Study|PCR positive at Week 68|0|||
131512721|NCT02641379|473507170|FG001|Overall Study|PCR positive at Week 68|1|||
131512722|NCT02641379|473507171|FG002|Overall Study|PCR positive at Week 68|0|||
131512723|NCT02641379|473507172|FG003|Overall Study|PCR positive at Week 68|0|||
131512724|NCT02641379|473507173|FG004|Overall Study|PCR positive at Week 68|0|||
131658104|NCT04445987|474032997|FG003|Overall Study|Protocol Violation|0|||
131512725|NCT02641379|473507174|FG005|Overall Study|PCR positive at Week 68|0|||
131512726|NCT02641379|473507175|FG006|Overall Study|PCR positive at Week 68|0|||
131512727|NCT02641379|473507176|FG007|Overall Study|PCR positive at Week 68|0|||
131512728|NCT02641379|473507177|FG008|Overall Study|PCR positive at Week 68|0|||
131512729|NCT02641379|473507178|FG009|Overall Study|PCR positive at Week 68|0|||
131512730|NCT02641379|473507179|FG010|Overall Study|PCR positive at Week 68|0|||
131512731|NCT02641379|473507169|FG000|Overall Study|PCR positive at Week 48|0|||
131512732|NCT02641379|473507170|FG001|Overall Study|PCR positive at Week 48|1|||
131512733|NCT02641379|473507171|FG002|Overall Study|PCR positive at Week 48|0|||
131512734|NCT02641379|473507172|FG003|Overall Study|PCR positive at Week 48|0|||
131512735|NCT02641379|473507173|FG004|Overall Study|PCR positive at Week 48|0|||
131512736|NCT02641379|473507174|FG005|Overall Study|PCR positive at Week 48|0|||
131512737|NCT02641379|473507175|FG006|Overall Study|PCR positive at Week 48|0|||
131512738|NCT02641379|473507176|FG007|Overall Study|PCR positive at Week 48|0|||
131512739|NCT02641379|473507177|FG008|Overall Study|PCR positive at Week 48|0|||
131512740|NCT02641379|473507178|FG009|Overall Study|PCR positive at Week 48|0|||
131512741|NCT02641379|473507179|FG010|Overall Study|PCR positive at Week 48|0|||
131512742|NCT02641379|473507169|FG000|Overall Study|PCR not performed at Week 12|0|||
131512743|NCT02641379|473507170|FG001|Overall Study|PCR not performed at Week 12|0|||
131512744|NCT02641379|473507171|FG002|Overall Study|PCR not performed at Week 12|1|||
131512745|NCT02641379|473507172|FG003|Overall Study|PCR not performed at Week 12|0|||
131512746|NCT02641379|473507173|FG004|Overall Study|PCR not performed at Week 12|0|||
131512747|NCT02641379|473507174|FG005|Overall Study|PCR not performed at Week 12|0|||
131512748|NCT02641379|473507175|FG006|Overall Study|PCR not performed at Week 12|0|||
131512749|NCT02641379|473507176|FG007|Overall Study|PCR not performed at Week 12|0|||
131512750|NCT02641379|473507177|FG008|Overall Study|PCR not performed at Week 12|0|||
131512751|NCT02641379|473507178|FG009|Overall Study|PCR not performed at Week 12|0|||
131512752|NCT02641379|473507179|FG010|Overall Study|PCR not performed at Week 12|0|||
131512753|NCT02641379|473507169|FG000|Overall Study|No PCR at baseline|0|||
131512754|NCT02641379|473507170|FG001|Overall Study|No PCR at baseline|0|||
131512755|NCT02641379|473507171|FG002|Overall Study|No PCR at baseline|1|||
131512756|NCT02641379|473507172|FG003|Overall Study|No PCR at baseline|0|||
131512757|NCT02641379|473507173|FG004|Overall Study|No PCR at baseline|0|||
131512758|NCT02641379|473507174|FG005|Overall Study|No PCR at baseline|0|||
131512759|NCT02641379|473507175|FG006|Overall Study|No PCR at baseline|0|||
131512760|NCT02641379|473507176|FG007|Overall Study|No PCR at baseline|0|||
131512761|NCT02641379|473507177|FG008|Overall Study|No PCR at baseline|0|||
131512762|NCT02641379|473507178|FG009|Overall Study|No PCR at baseline|0|||
131512763|NCT02641379|473507179|FG010|Overall Study|No PCR at baseline|0|||
131512764|NCT02641379|473507169|FG000|Overall Study|PCR positive at Week 28|0|||
131512765|NCT02641379|473507170|FG001|Overall Study|PCR positive at Week 28|0|||
131512766|NCT02641379|473507171|FG002|Overall Study|PCR positive at Week 28|1|||
131512767|NCT02641379|473507172|FG003|Overall Study|PCR positive at Week 28|0|||
131512768|NCT02641379|473507173|FG004|Overall Study|PCR positive at Week 28|0|||
131512769|NCT02641379|473507174|FG005|Overall Study|PCR positive at Week 28|0|||
131512770|NCT02641379|473507175|FG006|Overall Study|PCR positive at Week 28|0|||
131512771|NCT02641379|473507176|FG007|Overall Study|PCR positive at Week 28|0|||
131512772|NCT02641379|473507177|FG008|Overall Study|PCR positive at Week 28|0|||
131512773|NCT02641379|473507178|FG009|Overall Study|PCR positive at Week 28|0|||
131512774|NCT02641379|473507179|FG010|Overall Study|PCR positive at Week 28|0|||
131512775|NCT02641379|473507169|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
131512776|NCT02641379|473507170|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
131512777|NCT02641379|473507171|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
131512778|NCT02641379|473507172|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
131512779|NCT02641379|473507173|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
131512780|NCT02641379|473507174|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
131512781|NCT02641379|473507175|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
131512782|NCT02641379|473507176|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
131512783|NCT02641379|473507177|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
131512784|NCT02641379|473507178|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
131512785|NCT02641379|473507179|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
131512786|NCT02641379|473507169|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
131512787|NCT02641379|473507170|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
131512788|NCT02641379|473507171|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
131512789|NCT02641379|473507172|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
131512790|NCT02641379|473507173|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
131512791|NCT02641379|473507174|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
131512792|NCT02641379|473507175|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
131512793|NCT02641379|473507176|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
131512794|NCT02641379|473507177|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
131512795|NCT02641379|473507178|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
131512796|NCT02641379|473507179|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
131512797|NCT02641379|473507169|FG000|Overall Study|Baseline viral load unavailable|0|||
131512798|NCT02641379|473507170|FG001|Overall Study|Baseline viral load unavailable|0|||
131512799|NCT02641379|473507171|FG002|Overall Study|Baseline viral load unavailable|0|||
131512800|NCT02641379|473507172|FG003|Overall Study|Baseline viral load unavailable|1|||
131512801|NCT02641379|473507173|FG004|Overall Study|Baseline viral load unavailable|0|||
131512802|NCT02641379|473507174|FG005|Overall Study|Baseline viral load unavailable|0|||
131512803|NCT02641379|473507175|FG006|Overall Study|Baseline viral load unavailable|0|||
131512804|NCT02641379|473507176|FG007|Overall Study|Baseline viral load unavailable|0|||
131512805|NCT02641379|473507177|FG008|Overall Study|Baseline viral load unavailable|0|||
131512806|NCT02641379|473507178|FG009|Overall Study|Baseline viral load unavailable|0|||
131512807|NCT02641379|473507179|FG010|Overall Study|Baseline viral load unavailable|0|||
131512808|NCT02641379|473507169|FG000|Overall Study|Blood could not be drawn|0|||
131512809|NCT02641379|473507170|FG001|Overall Study|Blood could not be drawn|0|||
131512810|NCT02641379|473507171|FG002|Overall Study|Blood could not be drawn|0|||
131512811|NCT02641379|473507172|FG003|Overall Study|Blood could not be drawn|0|||
131512812|NCT02641379|473507173|FG004|Overall Study|Blood could not be drawn|1|||
131512813|NCT02641379|473507174|FG005|Overall Study|Blood could not be drawn|0|||
131512814|NCT02641379|473507175|FG006|Overall Study|Blood could not be drawn|0|||
131512815|NCT02641379|473507176|FG007|Overall Study|Blood could not be drawn|0|||
131512816|NCT02641379|473507177|FG008|Overall Study|Blood could not be drawn|0|||
131512817|NCT02641379|473507178|FG009|Overall Study|Blood could not be drawn|0|||
131512818|NCT02641379|473507179|FG010|Overall Study|Blood could not be drawn|0|||
131512819|NCT02641379|473507169|FG000|Overall Study|Protocol Violation|0|||
131512820|NCT02641379|473507170|FG001|Overall Study|Protocol Violation|0|||
131512821|NCT02641379|473507171|FG002|Overall Study|Protocol Violation|0|||
131512822|NCT02641379|473507172|FG003|Overall Study|Protocol Violation|0|||
131512823|NCT02641379|473507173|FG004|Overall Study|Protocol Violation|2|||
131512824|NCT02641379|473507174|FG005|Overall Study|Protocol Violation|0|||
131512825|NCT02641379|473507175|FG006|Overall Study|Protocol Violation|0|||
131512826|NCT02641379|473507176|FG007|Overall Study|Protocol Violation|0|||
131512827|NCT02641379|473507177|FG008|Overall Study|Protocol Violation|1|||
131512828|NCT02641379|473507178|FG009|Overall Study|Protocol Violation|0|||
131512829|NCT02641379|473507179|FG010|Overall Study|Protocol Violation|0|||
131512830|NCT02641379|473507169|FG000|Overall Study|Participation in sili rescue study|0|||
131512831|NCT02641379|473507170|FG001|Overall Study|Participation in sili rescue study|0|||
131512832|NCT02641379|473507171|FG002|Overall Study|Participation in sili rescue study|0|||
131512833|NCT02641379|473507172|FG003|Overall Study|Participation in sili rescue study|0|||
131512834|NCT02641379|473507173|FG004|Overall Study|Participation in sili rescue study|0|||
131512835|NCT02641379|473507174|FG005|Overall Study|Participation in sili rescue study|1|||
131512836|NCT02641379|473507175|FG006|Overall Study|Participation in sili rescue study|0|||
131512837|NCT02641379|473507176|FG007|Overall Study|Participation in sili rescue study|0|||
131512838|NCT02641379|473507177|FG008|Overall Study|Participation in sili rescue study|0|||
131512839|NCT02641379|473507178|FG009|Overall Study|Participation in sili rescue study|0|||
131512840|NCT02641379|473507179|FG010|Overall Study|Participation in sili rescue study|0|||
131512841|NCT02641379|473507169|FG000|Overall Study|Lost to Follow-up|0|||
131512842|NCT02641379|473507170|FG001|Overall Study|Lost to Follow-up|0|||
131512843|NCT02641379|473507171|FG002|Overall Study|Lost to Follow-up|0|||
131512844|NCT02641379|473507172|FG003|Overall Study|Lost to Follow-up|0|||
131512845|NCT02641379|473507173|FG004|Overall Study|Lost to Follow-up|0|||
131512846|NCT02641379|473507174|FG005|Overall Study|Lost to Follow-up|0|||
131512847|NCT02641379|473507175|FG006|Overall Study|Lost to Follow-up|0|||
131512848|NCT02641379|473507176|FG007|Overall Study|Lost to Follow-up|0|||
131512849|NCT02641379|473507177|FG008|Overall Study|Lost to Follow-up|1|||
131512850|NCT02641379|473507178|FG009|Overall Study|Lost to Follow-up|0|||
131512851|NCT02641379|473507179|FG010|Overall Study|Lost to Follow-up|0|||
131512852|NCT02641379|473507169|FG000|Overall Study|Source data not found|0|||
131512853|NCT02641379|473507170|FG001|Overall Study|Source data not found|0|||
131512854|NCT02641379|473507171|FG002|Overall Study|Source data not found|0|||
131512855|NCT02641379|473507172|FG003|Overall Study|Source data not found|0|||
131512856|NCT02641379|473507173|FG004|Overall Study|Source data not found|0|||
131512857|NCT02641379|473507174|FG005|Overall Study|Source data not found|1|||
131512858|NCT02641379|473507175|FG006|Overall Study|Source data not found|0|||
131512859|NCT02641379|473507176|FG007|Overall Study|Source data not found|0|||
131512860|NCT02641379|473507177|FG008|Overall Study|Source data not found|0|||
131512861|NCT02641379|473507178|FG009|Overall Study|Source data not found|0|||
131512862|NCT02641379|473507179|FG010|Overall Study|Source data not found|0|||
131512863|NCT02641379|473507169|FG000|Overall Study|Participant showed weight reduction|0|||
131512864|NCT02641379|473507170|FG001|Overall Study|Participant showed weight reduction|0|||
131512865|NCT02641379|473507171|FG002|Overall Study|Participant showed weight reduction|0|||
131512866|NCT02641379|473507172|FG003|Overall Study|Participant showed weight reduction|0|||
131512867|NCT02641379|473507173|FG004|Overall Study|Participant showed weight reduction|0|||
131512868|NCT02641379|473507174|FG005|Overall Study|Participant showed weight reduction|0|||
131512869|NCT02641379|473507175|FG006|Overall Study|Participant showed weight reduction|0|||
131512870|NCT02641379|473507176|FG007|Overall Study|Participant showed weight reduction|1|||
131512871|NCT02641379|473507177|FG008|Overall Study|Participant showed weight reduction|0|||
131512872|NCT02641379|473507178|FG009|Overall Study|Participant showed weight reduction|0|||
131512873|NCT02641379|473507179|FG010|Overall Study|Participant showed weight reduction|0|||
131512874|NCT02641379|473507169|FG000|Overall Study|Non-response Week 12|0|||
131512875|NCT02641379|473507170|FG001|Overall Study|Non-response Week 12|0|||
131512876|NCT02641379|473507171|FG002|Overall Study|Non-response Week 12|0|||
131512877|NCT02641379|473507172|FG003|Overall Study|Non-response Week 12|0|||
131512878|NCT02641379|473507173|FG004|Overall Study|Non-response Week 12|0|||
131512879|NCT02641379|473507174|FG005|Overall Study|Non-response Week 12|0|||
131512880|NCT02641379|473507175|FG006|Overall Study|Non-response Week 12|0|||
131512881|NCT02641379|473507176|FG007|Overall Study|Non-response Week 12|1|||
131512882|NCT02641379|473507177|FG008|Overall Study|Non-response Week 12|0|||
131512883|NCT02641379|473507178|FG009|Overall Study|Non-response Week 12|0|||
131512884|NCT02641379|473507179|FG010|Overall Study|Non-response Week 12|0|||
131512885|NCT02641379|473507169|FG000|Overall Study|No 2 Log drop at Week 12|0|||
131512886|NCT02641379|473507170|FG001|Overall Study|No 2 Log drop at Week 12|0|||
131512887|NCT02641379|473507171|FG002|Overall Study|No 2 Log drop at Week 12|0|||
131512888|NCT02641379|473507172|FG003|Overall Study|No 2 Log drop at Week 12|0|||
131512889|NCT02641379|473507173|FG004|Overall Study|No 2 Log drop at Week 12|0|||
131512890|NCT02641379|473507174|FG005|Overall Study|No 2 Log drop at Week 12|0|||
131512891|NCT02641379|473507175|FG006|Overall Study|No 2 Log drop at Week 12|0|||
131512892|NCT02641379|473507176|FG007|Overall Study|No 2 Log drop at Week 12|0|||
131512893|NCT02641379|473507177|FG008|Overall Study|No 2 Log drop at Week 12|0|||
131512894|NCT02641379|473507178|FG009|Overall Study|No 2 Log drop at Week 12|0|||
131512895|NCT02641379|473507179|FG010|Overall Study|No 2 Log drop at Week 12|1|||
131512896|NCT02641379|473507169|FG000|Overall Study|Negative PCR result|0|||
131512897|NCT02641379|473507170|FG001|Overall Study|Negative PCR result|0|||
131512898|NCT02641379|473507171|FG002|Overall Study|Negative PCR result|0|||
131512899|NCT02641379|473507172|FG003|Overall Study|Negative PCR result|0|||
131512900|NCT02641379|473507173|FG004|Overall Study|Negative PCR result|0|||
131512901|NCT02641379|473507174|FG005|Overall Study|Negative PCR result|0|||
131512902|NCT02641379|473507175|FG006|Overall Study|Negative PCR result|0|||
131512903|NCT02641379|473507176|FG007|Overall Study|Negative PCR result|0|||
131512904|NCT02641379|473507177|FG008|Overall Study|Negative PCR result|0|||
131512905|NCT02641379|473507178|FG009|Overall Study|Negative PCR result|1|||
131512906|NCT02641379|473507179|FG010|Overall Study|Negative PCR result|0|||
131512907|NCT02641379|473507169|FG000|Overall Study|Participant's PCR high|0|||
131512908|NCT02641379|473507170|FG001|Overall Study|Participant's PCR high|0|||
131512909|NCT02641379|473507171|FG002|Overall Study|Participant's PCR high|0|||
131512910|NCT02641379|473507172|FG003|Overall Study|Participant's PCR high|0|||
131512911|NCT02641379|473507173|FG004|Overall Study|Participant's PCR high|0|||
131512912|NCT02641379|473507174|FG005|Overall Study|Participant's PCR high|0|||
131512913|NCT02641379|473507175|FG006|Overall Study|Participant's PCR high|0|||
131512914|NCT02641379|473507176|FG007|Overall Study|Participant's PCR high|1|||
131512915|NCT02641379|473507177|FG008|Overall Study|Participant's PCR high|0|||
131512916|NCT02641379|473507178|FG009|Overall Study|Participant's PCR high|0|||
131512917|NCT02641379|473507179|FG010|Overall Study|Participant's PCR high|0|||
131512918|NCT02641379|473507169|FG000|Overall Study|Participant treated after Week 24|0|||
131512919|NCT02641379|473507170|FG001|Overall Study|Participant treated after Week 24|0|||
131512920|NCT02641379|473507171|FG002|Overall Study|Participant treated after Week 24|0|||
131512921|NCT02641379|473507172|FG003|Overall Study|Participant treated after Week 24|0|||
131512922|NCT02641379|473507173|FG004|Overall Study|Participant treated after Week 24|0|||
131512923|NCT02641379|473507174|FG005|Overall Study|Participant treated after Week 24|0|||
131512924|NCT02641379|473507175|FG006|Overall Study|Participant treated after Week 24|0|||
131512925|NCT02641379|473507176|FG007|Overall Study|Participant treated after Week 24|0|||
131512926|NCT02641379|473507177|FG008|Overall Study|Participant treated after Week 24|1|||
131512927|NCT02641379|473507178|FG009|Overall Study|Participant treated after Week 24|0|||
131512928|NCT02641379|473507179|FG010|Overall Study|Participant treated after Week 24|0|||
131512929|NCT02641379|473507169|FG000|Overall Study|Missing PCR result at Week 8|0|||
131512930|NCT02641379|473507170|FG001|Overall Study|Missing PCR result at Week 8|0|||
131512931|NCT02641379|473507171|FG002|Overall Study|Missing PCR result at Week 8|0|||
131512932|NCT02641379|473507172|FG003|Overall Study|Missing PCR result at Week 8|0|||
131512933|NCT02641379|473507173|FG004|Overall Study|Missing PCR result at Week 8|0|||
131512934|NCT02641379|473507174|FG005|Overall Study|Missing PCR result at Week 8|0|||
131512935|NCT02641379|473507175|FG006|Overall Study|Missing PCR result at Week 8|0|||
131512936|NCT02641379|473507176|FG007|Overall Study|Missing PCR result at Week 8|0|||
131512937|NCT02641379|473507177|FG008|Overall Study|Missing PCR result at Week 8|0|||
131512938|NCT02641379|473507178|FG009|Overall Study|Missing PCR result at Week 8|1|||
131512939|NCT02641379|473507179|FG010|Overall Study|Missing PCR result at Week 8|0|||
131512940|NCT02641379|473507169|FG000|Overall Study|PCR positive|0|||
131512941|NCT02641379|473507170|FG001|Overall Study|PCR positive|0|||
131512942|NCT02641379|473507171|FG002|Overall Study|PCR positive|0|||
131512943|NCT02641379|473507172|FG003|Overall Study|PCR positive|0|||
131512944|NCT02641379|473507173|FG004|Overall Study|PCR positive|0|||
131512945|NCT02641379|473507174|FG005|Overall Study|PCR positive|0|||
131512946|NCT02641379|473507175|FG006|Overall Study|PCR positive|1|||
131512947|NCT02641379|473507176|FG007|Overall Study|PCR positive|0|||
131512948|NCT02641379|473507177|FG008|Overall Study|PCR positive|0|||
131512949|NCT02641379|473507178|FG009|Overall Study|PCR positive|0|||
131512950|NCT02641379|473507179|FG010|Overall Study|PCR positive|0|||
131512951|NCT04964128|473507180|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
131512952|NCT04964128|473507180|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
131512953|NCT00856908|473507203|FG000|Overall Study|Lost to Follow-up|1|||
131512954|NCT00856908|473507204|FG001|Overall Study|Lost to Follow-up|0|||
131512955|NCT01070316|473507207|FG000|Extension Phase|Lack of Efficacy|3|||
131512956|NCT01070316|473507207|FG000|Extension Phase|Withdrawal by Subject|1|||
131512957|NCT01712256|473507208|FG000|Overall Study|Lost to Follow-up|1|||
131512958|NCT02196324|473507214|FG000|Overall Study|Withdrawal by Subject|8|||
131512959|NCT02196324|473507215|FG001|Overall Study|Withdrawal by Subject|4|||
131512960|NCT02196324|473507214|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
131512961|NCT02196324|473507215|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
131512962|NCT02196324|473507214|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
131512963|NCT02196324|473507215|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
131512964|NCT02196324|473507214|FG000|Overall Study|Other|1|||
131512965|NCT02196324|473507215|FG001|Overall Study|Other|0|||
131512966|NCT00692770|473507216|FG000|Overall Study|Protocol Violation|2|||
131512967|NCT00692770|473507217|FG001|Overall Study|Protocol Violation|7|||
131512968|NCT00692770|473507216|FG000|Overall Study|Withdrawal by Subject|97|||
131512969|NCT00692770|473507217|FG001|Overall Study|Withdrawal by Subject|36|||
131512970|NCT00692770|473507216|FG000|Overall Study|Adverse Event|136|||
131512971|NCT00692770|473507217|FG001|Overall Study|Adverse Event|41|||
131512972|NCT00692770|473507216|FG000|Overall Study|Death|10|||
131512973|NCT00692770|473507217|FG001|Overall Study|Death|5|||
131512974|NCT00692770|473507216|FG000|Overall Study|Lost to Follow-up|7|||
131512975|NCT00692770|473507217|FG001|Overall Study|Lost to Follow-up|3|||
131512976|NCT00692770|473507216|FG000|Overall Study|Non-compliant with study medication|11|||
131512977|NCT00692770|473507217|FG001|Overall Study|Non-compliant with study medication|5|||
131512978|NCT00692770|473507216|FG000|Overall Study|Progression by clinical judgment|2|||
131512979|NCT00692770|473507217|FG001|Overall Study|Progression by clinical judgment|3|||
131512980|NCT00692770|473507216|FG000|Overall Study|Physician decision not protocol driven|10|||
131512981|NCT00692770|473507217|FG001|Overall Study|Physician decision not protocol driven|14|||
131512982|NCT00692770|473507216|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
131512983|NCT00692770|473507217|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
131512984|NCT00692770|473507216|FG000|Overall Study|Protocol driven decision point|3|||
131512985|NCT00692770|473507217|FG001|Overall Study|Protocol driven decision point|7|||
131512986|NCT00692770|473507216|FG000|Overall Study|Completed all planned assessments|79|||
131512987|NCT00692770|473507217|FG001|Overall Study|Completed all planned assessments|101|||
131512988|NCT00692770|473507216|FG000|Overall Study|Radiological and clinical progression|8|||
131512989|NCT00692770|473507217|FG001|Overall Study|Radiological and clinical progression|8|||
131512990|NCT00692770|473507216|FG000|Overall Study|Clinical endpoint reached|16|||
131512991|NCT00692770|473507217|FG001|Overall Study|Clinical endpoint reached|43|||
131512992|NCT00692770|473507216|FG000|Overall Study|Study terminated by sponsor|2|||
131512993|NCT00692770|473507217|FG001|Overall Study|Study terminated by sponsor|2|||
131512994|NCT00692770|473507216|FG000|Overall Study|Randomized but not treated|3|||
131512995|NCT00692770|473507217|FG001|Overall Study|Randomized but not treated|4|||
131512996|NCT00560950|473507220|FG000|Overall Study|Lost to Follow-up|1|||
131512997|NCT00560950|473507221|FG001|Overall Study|Lost to Follow-up|0|||
131512998|NCT02181556|473508670|FG000|Overall Study|Withdrawal by Subject|1|||
131512999|NCT03711162|473508673|FG000|Overall Study|Adverse Event|5|||
131513000|NCT03711162|473508674|FG001|Overall Study|Adverse Event|2|||
131513001|NCT03711162|473508675|FG002|Overall Study|Adverse Event|4|||
131513002|NCT03711162|473508673|FG000|Overall Study|Death|11|||
131513003|NCT03711162|473508674|FG001|Overall Study|Death|7|||
131513004|NCT03711162|473508675|FG002|Overall Study|Death|8|||
131513005|NCT03711162|473508673|FG000|Overall Study|Lost to Follow-up|1|||
131513006|NCT03711162|473508674|FG001|Overall Study|Lost to Follow-up|0|||
131513007|NCT03711162|473508675|FG002|Overall Study|Lost to Follow-up|1|||
131513008|NCT03711162|473508673|FG000|Overall Study|Study Terminated by Sponsor|139|||
131513009|NCT03711162|473508674|FG001|Overall Study|Study Terminated by Sponsor|152|||
131513010|NCT03711162|473508675|FG002|Overall Study|Study Terminated by Sponsor|146|||
131513011|NCT03711162|473508673|FG000|Overall Study|Withdrawal by Subject|17|||
131513012|NCT03711162|473508674|FG001|Overall Study|Withdrawal by Subject|10|||
131513013|NCT03711162|473508675|FG002|Overall Study|Withdrawal by Subject|10|||
131513014|NCT03711162|473508673|FG000|Overall Study|Miscellaneous|1|||
131513015|NCT03711162|473508674|FG001|Overall Study|Miscellaneous|2|||
131513016|NCT03711162|473508675|FG002|Overall Study|Miscellaneous|2|||
131513017|NCT03711162|473508673|FG000|Overall Study|Not Treated|1|||
131513018|NCT03711162|473508674|FG001|Overall Study|Not Treated|0|||
131513019|NCT03711162|473508675|FG002|Overall Study|Not Treated|1|||
131513020|NCT03711162|473508673|FG000|Overall Study|Physician Decision|0|||
131513021|NCT03711162|473508674|FG001|Overall Study|Physician Decision|2|||
131513022|NCT03711162|473508675|FG002|Overall Study|Physician Decision|0|||
131513023|NCT03711162|473508673|FG000|Overall Study|Lack of Efficacy|0|||
131513024|NCT03711162|473508674|FG001|Overall Study|Lack of Efficacy|0|||
131513025|NCT03711162|473508675|FG002|Overall Study|Lack of Efficacy|2|||
131513026|NCT03711162|473508673|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
131513027|NCT03711162|473508674|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
131513028|NCT03711162|473508675|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
131513029|NCT00394212|473508678|FG000|Overall Study|Lost to Follow-up|3|||
131513030|NCT00394212|473508679|FG001|Overall Study|Lost to Follow-up|0|||
131513031|NCT00394212|473508678|FG000|Overall Study|Withdrawal by Subject|4|||
131513032|NCT00394212|473508679|FG001|Overall Study|Withdrawal by Subject|1|||
131513033|NCT00588445|473508680|FG000|Overall Study|Protocol Violation|1|||
131513034|NCT00588445|473508680|FG000|Overall Study|Withdrawal by Subject|3|||
131513035|NCT00588445|473508680|FG000|Overall Study|Disease Progression|1|||
131513036|NCT00588445|473508680|FG000|Overall Study|Not Treated|10|||
131513037|NCT03240133|473508681|FG000|Overall Study|Withdrawal by Subject|0|||
131513038|NCT03240133|473508682|FG001|Overall Study|Withdrawal by Subject|1|||
131513039|NCT03240133|473508683|FG002|Overall Study|Withdrawal by Subject|0|||
131513040|NCT03240133|473508681|FG000|Overall Study|Adverse Event|1|||
131513041|NCT03240133|473508682|FG001|Overall Study|Adverse Event|1|||
131513042|NCT03240133|473508683|FG002|Overall Study|Adverse Event|0|||
131513043|NCT03240133|473508681|FG000|Overall Study|Rash|1|||
131513044|NCT03240133|473508682|FG001|Overall Study|Rash|0|||
131513045|NCT03240133|473508683|FG002|Overall Study|Rash|0|||
131513046|NCT03240133|473508681|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
131513047|NCT03240133|473508682|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
131513048|NCT03240133|473508683|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
131513049|NCT03240133|473508681|FG000|Overall Study|Intercurrent illness.|0|||
131513050|NCT03240133|473508682|FG001|Overall Study|Intercurrent illness.|1|||
131513051|NCT03240133|473508683|FG002|Overall Study|Intercurrent illness.|0|||
131513052|NCT03240133|473508681|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
131513053|NCT03240133|473508682|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
131513054|NCT03240133|473508683|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
131513055|NCT01176292|473508687|FG000|Overall Study|Lost to Follow-up|2|||
131513056|NCT01176292|473508688|FG001|Overall Study|Lost to Follow-up|4|||
131513057|NCT01176292|473508687|FG000|Overall Study|Adverse Event|1|||
131513058|NCT01176292|473508688|FG001|Overall Study|Adverse Event|1|||
131513059|NCT01176292|473508687|FG000|Overall Study|Physician Decision|0|||
131513060|NCT01176292|473508688|FG001|Overall Study|Physician Decision|2|||
131513061|NCT01176292|473508687|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
131513062|NCT01176292|473508688|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
131513063|NCT00380393|473508689|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
131513064|NCT00380393|473508690|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
131513065|NCT00380393|473508689|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
131513066|NCT00380393|473508690|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
131513067|NCT00380393|473508689|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
131513068|NCT00380393|473508690|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
131513069|NCT00380393|473508689|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
131513070|NCT00380393|473508690|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
131513071|NCT00380393|473508689|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
131513072|NCT00380393|473508690|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
131513073|NCT00380393|473508689|FG000|Month 14|Withdrawal by Subject|9|||
131513074|NCT00380393|473508690|FG001|Month 14|Withdrawal by Subject|7|||
131513075|NCT00380393|473508689|FG000|Month 14|Death|1|||
131513076|NCT00380393|473508690|FG001|Month 14|Death|0|||
131513077|NCT00380393|473508689|FG000|Month 14|Lost to Follow-up|0|||
131513078|NCT00380393|473508690|FG001|Month 14|Lost to Follow-up|1|||
131513079|NCT00380393|473508689|FG000|Month 14|Migrated/moved from study area|39|||
131513080|NCT00380393|473508690|FG001|Month 14|Migrated/moved from study area|42|||
131513081|NCT00380393|473508689|FG000|Month 14|Protocol Violation|2|||
131513082|NCT00380393|473508690|FG001|Month 14|Protocol Violation|0|||
131513083|NCT00380393|473508689|FG000|Month 14|Others|6|||
131513084|NCT00380393|473508690|FG001|Month 14|Others|6|||
131513085|NCT00110812|473508691|FG000|Main Study|Death|0|||
131513086|NCT00110812|473508692|FG001|Main Study|Death|0|||
131513087|NCT00110812|473508693|FG002|Main Study|Death|2|||
131513088|NCT00110812|473508691|FG000|Main Study|Withdrawal by Subject|0|||
131513089|NCT00110812|473508692|FG001|Main Study|Withdrawal by Subject|0|||
131513090|NCT00110812|473508693|FG002|Main Study|Withdrawal by Subject|1|||
131513091|NCT00110812|473508691|FG000|Main Study|Lost to Follow-up|8|||
131513092|NCT00110812|473508692|FG001|Main Study|Lost to Follow-up|11|||
131513093|NCT00110812|473508693|FG002|Main Study|Lost to Follow-up|10|||
131513094|NCT00110812|473508691|FG000|Extended Follow-up|Death|1|||
131513095|NCT00110812|473508692|FG001|Extended Follow-up|Death|0|||
131513096|NCT00110812|473508693|FG002|Extended Follow-up|Death|3|||
131513097|NCT00110812|473508691|FG000|Extended Follow-up|Withdrawal by Subject|0|||
131513098|NCT00110812|473508692|FG001|Extended Follow-up|Withdrawal by Subject|1|||
131513099|NCT00110812|473508693|FG002|Extended Follow-up|Withdrawal by Subject|0|||
131513100|NCT00110812|473508691|FG000|Extended Follow-up|Lost to Follow-up|1|||
131513101|NCT00110812|473508692|FG001|Extended Follow-up|Lost to Follow-up|3|||
131513102|NCT00110812|473508693|FG002|Extended Follow-up|Lost to Follow-up|1|||
131513103|NCT02586493|473508695|FG000|Overall Study|Adverse Event|4|||
131513104|NCT02586493|473508695|FG000|Overall Study|Protocol Violation|6|||
131513105|NCT02586493|473508695|FG000|Overall Study|Lost to Follow-up|1|||
131513106|NCT02586493|473508695|FG000|Overall Study|Withdrawal by Subject|1|||
131513107|NCT03144180|473508701|FG000|Overall Study|STAT Delivery|1|||
131513108|NCT03144180|473508702|FG001|Overall Study|STAT Delivery|1|||
131513109|NCT03144180|473508701|FG000|Overall Study|Provider forgot to fill out forms|1|||
131513110|NCT03144180|473508702|FG001|Overall Study|Provider forgot to fill out forms|3|||
131513111|NCT03144180|473508701|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
131513112|NCT03144180|473508702|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
131513113|NCT03144180|473508701|FG000|Overall Study|Scrub tech removed tube cap|0|||
131513114|NCT03144180|473508702|FG001|Overall Study|Scrub tech removed tube cap|1|||
131513115|NCT02308735|473508707|FG000|Overall Study|Physician Decision|2|||
131513116|NCT02308735|473508708|FG001|Overall Study|Physician Decision|0|||
131513117|NCT02308735|473508709|FG002|Overall Study|Physician Decision|0|||
131513118|NCT02308735|473508710|FG003|Overall Study|Physician Decision|2|||
131513119|NCT04960228|473508715|FG000|Overall Study|Withdrawal by Subject|216|||
131513120|NCT04960228|473508716|FG001|Overall Study|Withdrawal by Subject|35|||
131513121|NCT04960228|473508715|FG000|Overall Study|Failed attention check|69|||
131513122|NCT04960228|473508716|FG001|Overall Study|Failed attention check|148|||
131513123|NCT04960228|473508715|FG000|Overall Study|Flagged for response quality by Dynata|3|||
131513124|NCT04960228|473508716|FG001|Overall Study|Flagged for response quality by Dynata|3|||
131513125|NCT00794196|473508718|FG000|Overall Study|Lost to Follow-up|5|||
131513126|NCT00794196|473508719|FG001|Overall Study|Lost to Follow-up|23|||
131513127|NCT02689258|473508720|FG000|Overall Study|Subject Non-Compliance|0|||
131513128|NCT02689258|473508721|FG001|Overall Study|Subject Non-Compliance|1|||
131513129|NCT02689258|473508722|FG002|Overall Study|Subject Non-Compliance|0|||
131513130|NCT02689258|473508723|FG003|Overall Study|Subject Non-Compliance|0|||
131513131|NCT02689258|473508724|FG004|Overall Study|Subject Non-Compliance|0|||
131513132|NCT02689258|473508725|FG005|Overall Study|Subject Non-Compliance|0|||
131513133|NCT02689258|473508726|FG006|Overall Study|Subject Non-Compliance|0|||
131513134|NCT02689258|473508727|FG007|Overall Study|Subject Non-Compliance|0|||
131513135|NCT02689258|473508728|FG008|Overall Study|Subject Non-Compliance|0|||
131513136|NCT02689258|473508729|FG009|Overall Study|Subject Non-Compliance|0|||
131513137|NCT02689258|473508730|FG010|Overall Study|Subject Non-Compliance|0|||
131513138|NCT02689258|473508731|FG011|Overall Study|Subject Non-Compliance|0|||
131513139|NCT02689258|473508720|FG000|Overall Study|Subject Refusal to Continue|0|||
131513140|NCT02689258|473508721|FG001|Overall Study|Subject Refusal to Continue|1|||
131513141|NCT02689258|473508722|FG002|Overall Study|Subject Refusal to Continue|0|||
131513142|NCT02689258|473508723|FG003|Overall Study|Subject Refusal to Continue|0|||
131513143|NCT02689258|473508724|FG004|Overall Study|Subject Refusal to Continue|0|||
131513144|NCT02689258|473508725|FG005|Overall Study|Subject Refusal to Continue|0|||
131513145|NCT02689258|473508726|FG006|Overall Study|Subject Refusal to Continue|0|||
131513146|NCT02689258|473508727|FG007|Overall Study|Subject Refusal to Continue|0|||
131513147|NCT02689258|473508728|FG008|Overall Study|Subject Refusal to Continue|1|||
131513148|NCT02689258|473508729|FG009|Overall Study|Subject Refusal to Continue|0|||
131513149|NCT02689258|473508730|FG010|Overall Study|Subject Refusal to Continue|0|||
131513150|NCT02689258|473508731|FG011|Overall Study|Subject Refusal to Continue|1|||
131513151|NCT02689258|473508720|FG000|Overall Study|Other|0|||
131513152|NCT02689258|473508721|FG001|Overall Study|Other|2|||
131513153|NCT02689258|473508722|FG002|Overall Study|Other|0|||
131513154|NCT02689258|473508723|FG003|Overall Study|Other|0|||
131513155|NCT02689258|473508724|FG004|Overall Study|Other|1|||
131513156|NCT02689258|473508725|FG005|Overall Study|Other|0|||
131513157|NCT02689258|473508726|FG006|Overall Study|Other|0|||
131513158|NCT02689258|473508727|FG007|Overall Study|Other|0|||
131513159|NCT02689258|473508728|FG008|Overall Study|Other|1|||
131513160|NCT02689258|473508729|FG009|Overall Study|Other|0|||
131513161|NCT02689258|473508730|FG010|Overall Study|Other|0|||
131513162|NCT02689258|473508731|FG011|Overall Study|Other|0|||
131513163|NCT00907374|473508736|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
131513164|NCT00907374|473508737|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
131513165|NCT03742141|473508739|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
131513166|NCT02376166|473508744|FG000|Overall Study|Adverse Event|1|||
131513167|NCT02376166|473508744|FG000|Overall Study|Discontinued metformin early|2|||
131513168|NCT04180020|473508745|FG000|Overall Study|missed visit|18|||
131513169|NCT04180020|473508746|FG001|Overall Study|missed visit|16|||
131513170|NCT04180020|473508745|FG000|Overall Study|Death|2|||
131513171|NCT04180020|473508746|FG001|Overall Study|Death|3|||
131513172|NCT04180020|473508745|FG000|Overall Study|Withdrawal by Subject|1|||
131513173|NCT04180020|473508746|FG001|Overall Study|Withdrawal by Subject|5|||
131513174|NCT04180020|473508745|FG000|Overall Study|incarcerated|1|||
131513175|NCT04180020|473508746|FG001|Overall Study|incarcerated|1|||
131513176|NCT04180020|473508745|FG000|Overall Study|Physician Decision|0|||
131513177|NCT04180020|473508746|FG001|Overall Study|Physician Decision|2|||
131513178|NCT01354496|473508751|FG000|Period 1|Adverse Event|0|||
131513179|NCT01354496|473508752|FG001|Period 1|Adverse Event|0|||
131513180|NCT01354496|473508753|FG002|Period 1|Adverse Event|1|||
131513181|NCT01354496|473508754|FG003|Period 1|Adverse Event|0|||
131513182|NCT01354496|473508755|FG004|Period 1|Adverse Event|0|||
131513183|NCT01354496|473508756|FG005|Period 1|Adverse Event|0|||
131513184|NCT01354496|473508751|FG000|Period 1|Physician Decision|0|||
131513185|NCT01354496|473508752|FG001|Period 1|Physician Decision|0|||
131513186|NCT01354496|473508753|FG002|Period 1|Physician Decision|1|||
131513187|NCT01354496|473508754|FG003|Period 1|Physician Decision|0|||
131513188|NCT01354496|473508755|FG004|Period 1|Physician Decision|0|||
131513189|NCT01354496|473508756|FG005|Period 1|Physician Decision|0|||
131513190|NCT01354496|473508751|FG000|Period 2|Adverse Event|0|||
131513191|NCT01354496|473508752|FG001|Period 2|Adverse Event|0|||
131513192|NCT01354496|473508753|FG002|Period 2|Adverse Event|0|||
131513193|NCT01354496|473508754|FG003|Period 2|Adverse Event|1|||
131513194|NCT01354496|473508755|FG004|Period 2|Adverse Event|0|||
131513195|NCT01354496|473508756|FG005|Period 2|Adverse Event|0|||
131513196|NCT01354496|473508751|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
131513197|NCT01354496|473508752|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
131513198|NCT01354496|473508753|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
131513199|NCT01354496|473508754|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
131513200|NCT01354496|473508755|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
131513201|NCT01354496|473508756|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
131513202|NCT00405548|473508757|FG000|Overall Study|Cognitive Memory problems on study day|1|||
131513203|NCT00405548|473508758|FG001|Overall Study|Cognitive Memory problems on study day|0|||
131513204|NCT00405548|473508757|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
131513205|NCT00405548|473508758|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
131513206|NCT00405548|473508757|FG000|Overall Study|Unable to self-administer shots|1|||
131513207|NCT00405548|473508758|FG001|Overall Study|Unable to self-administer shots|0|||
131513208|NCT00405548|473508757|FG000|Overall Study|Venous access failed during study day|1|||
131513209|NCT00405548|473508758|FG001|Overall Study|Venous access failed during study day|0|||
131513210|NCT00405548|473508757|FG000|Overall Study|Withdrawal by Subject|1|||
131513211|NCT00405548|473508758|FG001|Overall Study|Withdrawal by Subject|0|||
131513212|NCT03554291|473508759|FG000|Overall Study|Death|2|||
131513213|NCT03554291|473508760|FG001|Overall Study|Death|1|||
131513214|NCT03554291|473508759|FG000|Overall Study|Lost to Follow-up|1|||
131513215|NCT03554291|473508760|FG001|Overall Study|Lost to Follow-up|0|||
131513216|NCT03554291|473508759|FG000|Overall Study|Withdrawal by Subject|1|||
131513217|NCT03554291|473508760|FG001|Overall Study|Withdrawal by Subject|0|||
131513218|NCT03554291|473508759|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
131513219|NCT03554291|473508760|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
131513220|NCT02036502|473508761|FG000|Part 1:Dose Determination/Escalation|Death|3|||
131513221|NCT02036502|473508762|FG001|Part 1:Dose Determination/Escalation|Death|2|||
131513222|NCT02036502|473508763|FG002|Part 1:Dose Determination/Escalation|Death|0|||
131513223|NCT02036502|473508764|FG003|Part 1:Dose Determination/Escalation|Death|0|||
131513224|NCT02036502|473508765|FG004|Part 1:Dose Determination/Escalation|Death|0|||
131513225|NCT02036502|473508766|FG005|Part 1:Dose Determination/Escalation|Death|0|||
131513226|NCT02036502|473508767|FG006|Part 1:Dose Determination/Escalation|Death|0|||
131513227|NCT02036502|473508768|FG007|Part 1:Dose Determination/Escalation|Death|0|||
131513228|NCT02036502|473508761|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
131513229|NCT02036502|473508762|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513230|NCT02036502|473508763|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513231|NCT02036502|473508764|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513232|NCT02036502|473508765|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513233|NCT02036502|473508766|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513234|NCT02036502|473508767|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513235|NCT02036502|473508768|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
131513236|NCT02036502|473508761|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513237|NCT02036502|473508762|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
131513238|NCT02036502|473508763|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513239|NCT02036502|473508764|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513240|NCT02036502|473508765|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513241|NCT02036502|473508766|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513242|NCT02036502|473508767|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513243|NCT02036502|473508768|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
131513244|NCT02036502|473508761|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
131513245|NCT02036502|473508762|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
131513246|NCT02036502|473508763|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
131513247|NCT02036502|473508764|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
131513248|NCT02036502|473508765|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
131513249|NCT02036502|473508766|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
131513250|NCT02036502|473508767|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
131513251|NCT02036502|473508768|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
131513252|NCT02036502|473508761|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
131513253|NCT02036502|473508762|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
131513254|NCT02036502|473508763|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
131513255|NCT02036502|473508764|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
131513256|NCT02036502|473508765|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
131513257|NCT02036502|473508766|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
131513258|NCT02036502|473508767|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
131513259|NCT02036502|473508768|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
131513260|NCT02036502|473508761|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513261|NCT02036502|473508762|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513262|NCT02036502|473508763|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
131513263|NCT02036502|473508764|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513264|NCT02036502|473508765|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513265|NCT02036502|473508766|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513266|NCT02036502|473508767|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513267|NCT02036502|473508768|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
131513268|NCT02036502|473508761|FG000|Part 2:Dose Confirmation|Death|0|||
131513269|NCT02036502|473508762|FG001|Part 2:Dose Confirmation|Death|0|||
131513270|NCT02036502|473508763|FG002|Part 2:Dose Confirmation|Death|1|||
131513271|NCT02036502|473508764|FG003|Part 2:Dose Confirmation|Death|0|||
131513272|NCT02036502|473508765|FG004|Part 2:Dose Confirmation|Death|0|||
131513273|NCT02036502|473508766|FG005|Part 2:Dose Confirmation|Death|0|||
131513274|NCT02036502|473508767|FG006|Part 2:Dose Confirmation|Death|0|||
131513275|NCT02036502|473508768|FG007|Part 2:Dose Confirmation|Death|0|||
131513276|NCT02036502|473508761|FG000|Part 2:Dose Confirmation|Not treated|0|||
131513277|NCT02036502|473508762|FG001|Part 2:Dose Confirmation|Not treated|0|||
131513278|NCT02036502|473508763|FG002|Part 2:Dose Confirmation|Not treated|0|||
131513279|NCT02036502|473508764|FG003|Part 2:Dose Confirmation|Not treated|1|||
131513280|NCT02036502|473508765|FG004|Part 2:Dose Confirmation|Not treated|0|||
131513281|NCT02036502|473508766|FG005|Part 2:Dose Confirmation|Not treated|0|||
131513282|NCT02036502|473508767|FG006|Part 2:Dose Confirmation|Not treated|0|||
131513283|NCT02036502|473508768|FG007|Part 2:Dose Confirmation|Not treated|0|||
131513284|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Adverse Event|0|||
131513285|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Adverse Event|0|||
131513286|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Adverse Event|0|||
131513287|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Adverse Event|0|||
131513288|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Adverse Event|0|||
131513289|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Adverse Event|4|||
131513290|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Adverse Event|0|||
131513291|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Adverse Event|2|||
131513292|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Death|0|||
131513293|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Death|0|||
131513294|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Death|0|||
131513295|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Death|0|||
131513296|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Death|0|||
131513297|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Death|24|||
131513298|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Death|0|||
131513299|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Death|3|||
131513300|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513301|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513302|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513303|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513304|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513305|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513306|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
131513307|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
131513308|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Physician Decision|0|||
131513309|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Physician Decision|0|||
131513310|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Physician Decision|0|||
131513311|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Physician Decision|0|||
131513312|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Physician Decision|0|||
131513313|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Physician Decision|1|||
131513314|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Physician Decision|0|||
131513315|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Physician Decision|0|||
131513316|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
131513317|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
131513318|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
131513319|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
131513320|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
131513321|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
131513322|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
131513323|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
131513324|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
131513325|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
131513326|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
131513327|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
131513328|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
131513329|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
131513330|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
131513331|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
131513332|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
131513333|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
131513334|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
131513335|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
131513336|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
131513337|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
131513338|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
131513339|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
131513340|NCT02036502|473508761|FG000|Part 3:Dose Expansion|Not Treated|0|||
131513341|NCT02036502|473508762|FG001|Part 3:Dose Expansion|Not Treated|0|||
131513342|NCT02036502|473508763|FG002|Part 3:Dose Expansion|Not Treated|0|||
131513343|NCT02036502|473508764|FG003|Part 3:Dose Expansion|Not Treated|0|||
131513344|NCT02036502|473508765|FG004|Part 3:Dose Expansion|Not Treated|0|||
131513345|NCT02036502|473508766|FG005|Part 3:Dose Expansion|Not Treated|2|||
131513346|NCT02036502|473508767|FG006|Part 3:Dose Expansion|Not Treated|0|||
131513347|NCT02036502|473508768|FG007|Part 3:Dose Expansion|Not Treated|0|||
131513348|NCT02741700|473508769|FG000|Overall Study|Lost to Follow-up|17|||
131513349|NCT02741700|473508770|FG001|Overall Study|Lost to Follow-up|8|||
131513350|NCT02741700|473508769|FG000|Overall Study|Withdrawal by Subject|2|||
131513351|NCT02741700|473508770|FG001|Overall Study|Withdrawal by Subject|5|||
131513352|NCT02741700|473508769|FG000|Overall Study|Physician Decision|3|||
131513353|NCT02741700|473508770|FG001|Overall Study|Physician Decision|0|||
131513354|NCT02741700|473508769|FG000|Overall Study|Moved out of State|0|||
131513355|NCT02741700|473508770|FG001|Overall Study|Moved out of State|1|||
131513356|NCT02741700|473508769|FG000|Overall Study|Death|4|||
131513357|NCT02741700|473508770|FG001|Overall Study|Death|5|||
131513358|NCT00811577|473508771|FG000|Overall Study|Lost to Follow-up|7|||
131513359|NCT00811577|473508772|FG001|Overall Study|Lost to Follow-up|1|||
131513360|NCT00811577|473508771|FG000|Overall Study|Withdrawal by Subject|3|||
131513361|NCT00811577|473508772|FG001|Overall Study|Withdrawal by Subject|0|||
131513362|NCT01068509|473508773|FG000|Overall Study|Death|0|||
131513363|NCT01068509|473508774|FG001|Overall Study|Death|0|||
131513364|NCT01068509|473508775|FG002|Overall Study|Death|1|||
131513365|NCT01068509|473508773|FG000|Overall Study|Disease Progression|5|||
131513366|NCT01068509|473508774|FG001|Overall Study|Disease Progression|20|||
131513367|NCT01068509|473508775|FG002|Overall Study|Disease Progression|18|||
131513368|NCT01068509|473508773|FG000|Overall Study|Lost to Follow-up|1|||
131513369|NCT01068509|473508774|FG001|Overall Study|Lost to Follow-up|0|||
131513370|NCT01068509|473508775|FG002|Overall Study|Lost to Follow-up|0|||
131513371|NCT01068509|473508773|FG000|Overall Study|Withdrew Consent|0|||
131513372|NCT01068509|473508774|FG001|Overall Study|Withdrew Consent|1|||
131513373|NCT01068509|473508775|FG002|Overall Study|Withdrew Consent|2|||
131513374|NCT01068509|473508773|FG000|Overall Study|Reason Not Specified|0|||
131513375|NCT01068509|473508774|FG001|Overall Study|Reason Not Specified|1|||
131513376|NCT01068509|473508775|FG002|Overall Study|Reason Not Specified|0|||
131513377|NCT02442778|473508777|FG000|Overall Study|Adverse Event|2|||
131513378|NCT02442778|473508778|FG001|Overall Study|Adverse Event|6|||
131513379|NCT02442778|473508779|FG002|Overall Study|Adverse Event|6|||
131513380|NCT02442778|473508777|FG000|Overall Study|Death|0|||
131513381|NCT02442778|473508778|FG001|Overall Study|Death|2|||
131513382|NCT02442778|473508779|FG002|Overall Study|Death|0|||
131513383|NCT02442778|473508777|FG000|Overall Study|Lack of Efficacy|1|||
131513384|NCT02442778|473508778|FG001|Overall Study|Lack of Efficacy|0|||
131513385|NCT02442778|473508779|FG002|Overall Study|Lack of Efficacy|0|||
131513386|NCT02442778|473508777|FG000|Overall Study|Lost to Follow-up|1|||
131513387|NCT02442778|473508778|FG001|Overall Study|Lost to Follow-up|1|||
131513388|NCT02442778|473508779|FG002|Overall Study|Lost to Follow-up|1|||
131513389|NCT02442778|473508777|FG000|Overall Study|Non-compliance with study drug|2|||
131513390|NCT02442778|473508778|FG001|Overall Study|Non-compliance with study drug|0|||
131513391|NCT02442778|473508779|FG002|Overall Study|Non-compliance with study drug|1|||
131513392|NCT02442778|473508777|FG000|Overall Study|Physician Decision|1|||
131513393|NCT02442778|473508778|FG001|Overall Study|Physician Decision|1|||
131513394|NCT02442778|473508779|FG002|Overall Study|Physician Decision|1|||
131513395|NCT02442778|473508777|FG000|Overall Study|Protocol Deviation|3|||
131513396|NCT02442778|473508778|FG001|Overall Study|Protocol Deviation|0|||
131513397|NCT02442778|473508779|FG002|Overall Study|Protocol Deviation|1|||
131513398|NCT02442778|473508777|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
131513399|NCT02442778|473508778|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
131513400|NCT02442778|473508779|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
131513401|NCT02442778|473508777|FG000|Overall Study|Withdrawal by Subject|4|||
131513402|NCT02442778|473508778|FG001|Overall Study|Withdrawal by Subject|4|||
131513403|NCT02442778|473508779|FG002|Overall Study|Withdrawal by Subject|3|||
131513404|NCT02442778|473508777|FG000|Overall Study|Reason not specified|1|||
131513405|NCT02442778|473508778|FG001|Overall Study|Reason not specified|4|||
131513406|NCT02442778|473508779|FG002|Overall Study|Reason not specified|0|||
131513407|NCT01165138|473508782|FG000|Overall Study|Adverse Event|0|||
131513408|NCT01165138|473508783|FG001|Overall Study|Adverse Event|1|||
131513409|NCT01165138|473508784|FG002|Overall Study|Adverse Event|0|||
131513410|NCT01165138|473508785|FG003|Overall Study|Adverse Event|2|||
131513411|NCT01165138|473508782|FG000|Overall Study|Lack of Efficacy|0|||
131513412|NCT01165138|473508783|FG001|Overall Study|Lack of Efficacy|32|||
131513413|NCT01165138|473508784|FG002|Overall Study|Lack of Efficacy|6|||
131513414|NCT01165138|473508785|FG003|Overall Study|Lack of Efficacy|7|||
131513415|NCT01165138|473508782|FG000|Overall Study|Protocol Violation|0|||
131513416|NCT01165138|473508783|FG001|Overall Study|Protocol Violation|7|||
131513417|NCT01165138|473508784|FG002|Overall Study|Protocol Violation|0|||
131513418|NCT01165138|473508785|FG003|Overall Study|Protocol Violation|2|||
131513419|NCT01165138|473508782|FG000|Overall Study|Lost to Follow-up|0|||
131513420|NCT01165138|473508783|FG001|Overall Study|Lost to Follow-up|0|||
131513421|NCT01165138|473508784|FG002|Overall Study|Lost to Follow-up|1|||
131513422|NCT01165138|473508785|FG003|Overall Study|Lost to Follow-up|2|||
131513423|NCT01165138|473508782|FG000|Overall Study|Physician Decision|0|||
131513424|NCT01165138|473508783|FG001|Overall Study|Physician Decision|6|||
131513425|NCT01165138|473508784|FG002|Overall Study|Physician Decision|7|||
131513426|NCT01165138|473508785|FG003|Overall Study|Physician Decision|6|||
131513427|NCT01165138|473508782|FG000|Overall Study|Withdrawal by Subject|0|||
131513428|NCT01165138|473508783|FG001|Overall Study|Withdrawal by Subject|6|||
131513429|NCT01165138|473508784|FG002|Overall Study|Withdrawal by Subject|6|||
131513430|NCT01165138|473508785|FG003|Overall Study|Withdrawal by Subject|3|||
131513431|NCT04982250|473508786|FG000|Overall Study|Lost to Follow-up|0|||
131513432|NCT04982250|473508787|FG001|Overall Study|Lost to Follow-up|26|||
131513433|NCT04982250|473508788|FG002|Overall Study|Lost to Follow-up|0|||
131513434|NCT04982250|473508789|FG003|Overall Study|Lost to Follow-up|0|||
131513435|NCT04982250|473508790|FG004|Overall Study|Lost to Follow-up|72|||
131513436|NCT04982250|473508791|FG005|Overall Study|Lost to Follow-up|69|||
131513437|NCT04982250|473508786|FG000|Overall Study|Not Eligible to Enroll|0|||
131513438|NCT04982250|473508787|FG001|Overall Study|Not Eligible to Enroll|0|||
131513439|NCT04982250|473508788|FG002|Overall Study|Not Eligible to Enroll|0|||
131513440|NCT04982250|473508789|FG003|Overall Study|Not Eligible to Enroll|0|||
131513441|NCT04982250|473508790|FG004|Overall Study|Not Eligible to Enroll|10|||
131513442|NCT04982250|473508791|FG005|Overall Study|Not Eligible to Enroll|7|||
131513443|NCT01148511|473508793|FG000|Exposed to Study Drug|Protocol Violation|2|||
131513444|NCT01148511|473508794|FG001|Exposed to Study Drug|Protocol Violation|0|||
131513445|NCT01148511|473508795|FG002|Exposed to Study Drug|Protocol Violation|0|||
131513446|NCT01148511|473508793|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
131513447|NCT01148511|473508794|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
131513448|NCT01148511|473508795|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
131513449|NCT01148511|473508793|FG000|Randomized|Adverse Event|0|||
131513450|NCT01148511|473508794|FG001|Randomized|Adverse Event|1|||
131513451|NCT01148511|473508795|FG002|Randomized|Adverse Event|0|||
131513452|NCT01148511|473508793|FG000|Randomized|Protocol Violation|0|||
131513453|NCT01148511|473508794|FG001|Randomized|Protocol Violation|2|||
131513454|NCT01148511|473508795|FG002|Randomized|Protocol Violation|1|||
131513455|NCT01148511|473508793|FG000|Randomized|Lost to Follow-up|0|||
131513456|NCT01148511|473508794|FG001|Randomized|Lost to Follow-up|1|||
131513457|NCT01148511|473508795|FG002|Randomized|Lost to Follow-up|1|||
131513458|NCT01148511|473508793|FG000|Randomized|Consent withdrawal|0|||
131513459|NCT01148511|473508794|FG001|Randomized|Consent withdrawal|5|||
131513460|NCT01148511|473508795|FG002|Randomized|Consent withdrawal|3|||
131513461|NCT01148511|473508793|FG000|Randomized|Other|0|||
131513462|NCT01148511|473508794|FG001|Randomized|Other|1|||
131513463|NCT01148511|473508795|FG002|Randomized|Other|1|||
131513464|NCT04258605|473508799|FG000|Overall Study|Death|1|||
131513465|NCT04258605|473508800|FG001|Overall Study|Death|0|||
131513466|NCT04258605|473508799|FG000|Overall Study|Early study termination|21|||
131513467|NCT04258605|473508800|FG001|Overall Study|Early study termination|2|||
131513468|NCT01418937|473508805|FG000|Overall Study|Lost to Follow-up|5|||
131513469|NCT01418937|473508805|FG000|Overall Study|Protocol Violation|1|||
131513470|NCT01418937|473508805|FG000|Overall Study|Pregnancy|1|||
131513471|NCT01418937|473508805|FG000|Overall Study|Withdrawal by Subject|1|||
131513472|NCT00962104|473508806|FG000|Overall Study|Adverse Event|10|||
131513473|NCT00962104|473508807|FG001|Overall Study|Adverse Event|3|||
131513474|NCT00962104|473508806|FG000|Overall Study|Entry Criteria Not Met|1|||
131513475|NCT00962104|473508807|FG001|Overall Study|Entry Criteria Not Met|2|||
131513476|NCT00962104|473508806|FG000|Overall Study|Lack of Efficacy|0|||
131513477|NCT00962104|473508807|FG001|Overall Study|Lack of Efficacy|1|||
131513478|NCT00962104|473508806|FG000|Overall Study|Lost to Follow-up|10|||
131513479|NCT00962104|473508807|FG001|Overall Study|Lost to Follow-up|4|||
131513480|NCT00962104|473508806|FG000|Overall Study|Physician Decision|1|||
131513481|NCT00962104|473508807|FG001|Overall Study|Physician Decision|0|||
131513482|NCT00962104|473508806|FG000|Overall Study|Protocol Violation|6|||
131513483|NCT00962104|473508807|FG001|Overall Study|Protocol Violation|8|||
131513484|NCT00962104|473508806|FG000|Overall Study|Sponsor Decision|0|||
131513485|NCT00962104|473508807|FG001|Overall Study|Sponsor Decision|1|||
131513486|NCT00962104|473508806|FG000|Overall Study|Withdrawal by Subject|10|||
131513487|NCT00962104|473508807|FG001|Overall Study|Withdrawal by Subject|6|||
131513488|NCT00962104|473508806|FG000|Overall Study|Other|2|||
131513489|NCT00962104|473508807|FG001|Overall Study|Other|0|||
131513490|NCT02013167|473508808|FG000|Overall Study|Withdrawal by Subject|15|||
131513491|NCT02013167|473508809|FG001|Overall Study|Withdrawal by Subject|14|||
131513492|NCT02013167|473508808|FG000|Overall Study|Sponsor Decision|1|||
131513493|NCT02013167|473508809|FG001|Overall Study|Sponsor Decision|3|||
131513494|NCT02013167|473508808|FG000|Overall Study|Lost to Follow-up|0|||
131513495|NCT02013167|473508809|FG001|Overall Study|Lost to Follow-up|1|||
131513496|NCT02013167|473508808|FG000|Overall Study|Death|85|||
131513497|NCT02013167|473508809|FG001|Overall Study|Death|160|||
131513498|NCT01113879|473508810|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
131513499|NCT01113879|473508811|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
131513500|NCT00615056|473508813|FG000|Overall Study|Death|31|||
131513501|NCT00615056|473508814|FG001|Overall Study|Death|31|||
131513502|NCT00615056|473508815|FG002|Overall Study|Death|21|||
131513503|NCT00615056|473508816|FG003|Overall Study|Death|23|||
131513504|NCT00615056|473508813|FG000|Overall Study|Lost to Follow-up|1|||
131513505|NCT00615056|473508814|FG001|Overall Study|Lost to Follow-up|2|||
131513506|NCT00615056|473508815|FG002|Overall Study|Lost to Follow-up|4|||
131513507|NCT00615056|473508816|FG003|Overall Study|Lost to Follow-up|5|||
131513508|NCT00615056|473508813|FG000|Overall Study|Other|13|||
131513509|NCT00615056|473508814|FG001|Overall Study|Other|15|||
131513510|NCT00615056|473508815|FG002|Overall Study|Other|10|||
131513511|NCT00615056|473508816|FG003|Overall Study|Other|7|||
131513512|NCT00615056|473508813|FG000|Overall Study|Objective progression or relapse|0|||
131513513|NCT00615056|473508814|FG001|Overall Study|Objective progression or relapse|2|||
131513514|NCT00615056|473508815|FG002|Overall Study|Objective progression or relapse|0|||
131513515|NCT00615056|473508816|FG003|Overall Study|Objective progression or relapse|0|||
131513516|NCT00615056|473508813|FG000|Overall Study|Withdrawal by Subject|0|||
131513517|NCT00615056|473508814|FG001|Overall Study|Withdrawal by Subject|1|||
131513518|NCT00615056|473508815|FG002|Overall Study|Withdrawal by Subject|1|||
131513519|NCT00615056|473508816|FG003|Overall Study|Withdrawal by Subject|0|||
131513520|NCT00615056|473508813|FG000|Overall Study|Discontinued by Sponsor|1|||
131513521|NCT00615056|473508814|FG001|Overall Study|Discontinued by Sponsor|0|||
131513522|NCT00615056|473508815|FG002|Overall Study|Discontinued by Sponsor|0|||
131513523|NCT00615056|473508816|FG003|Overall Study|Discontinued by Sponsor|0|||
131513524|NCT00615056|473508813|FG000|Overall Study|Randomized but not treated|3|||
131513525|NCT00615056|473508814|FG001|Overall Study|Randomized but not treated|0|||
131513526|NCT00615056|473508815|FG002|Overall Study|Randomized but not treated|0|||
131513527|NCT00615056|473508816|FG003|Overall Study|Randomized but not treated|0|||
131513528|NCT00717769|473508817|FG000|Overall Study|Adverse Event|9|||
131513529|NCT00717769|473508818|FG001|Overall Study|Adverse Event|6|||
131513530|NCT00717769|473508819|FG002|Overall Study|Adverse Event|1|||
131513531|NCT00717769|473508817|FG000|Overall Study|Lack of compliance|0|||
131513532|NCT00717769|473508818|FG001|Overall Study|Lack of compliance|2|||
131513533|NCT00717769|473508819|FG002|Overall Study|Lack of compliance|0|||
131513534|NCT00717769|473508817|FG000|Overall Study|Lost to Follow-up|3|||
131513535|NCT00717769|473508818|FG001|Overall Study|Lost to Follow-up|4|||
131513536|NCT00717769|473508819|FG002|Overall Study|Lost to Follow-up|0|||
131513537|NCT00717769|473508817|FG000|Overall Study|Lack of Efficacy|1|||
131513538|NCT00717769|473508818|FG001|Overall Study|Lack of Efficacy|2|||
131513539|NCT00717769|473508819|FG002|Overall Study|Lack of Efficacy|0|||
131513540|NCT00717769|473508817|FG000|Overall Study|Protocol Violation|0|||
131513541|NCT00717769|473508818|FG001|Overall Study|Protocol Violation|2|||
131513542|NCT00717769|473508819|FG002|Overall Study|Protocol Violation|0|||
131513543|NCT00717769|473508817|FG000|Overall Study|Sponsor decision|1|||
131513544|NCT00717769|473508818|FG001|Overall Study|Sponsor decision|0|||
131513545|NCT00717769|473508819|FG002|Overall Study|Sponsor decision|10|||
131513546|NCT00717769|473508817|FG000|Overall Study|Withdrew consent|2|||
131513547|NCT00717769|473508818|FG001|Overall Study|Withdrew consent|2|||
131513548|NCT00717769|473508819|FG002|Overall Study|Withdrew consent|0|||
131513549|NCT02276612|473508820|FG000|Overall Study|Death|1|||
131513550|NCT02276612|473508821|FG001|Overall Study|Death|0|||
131513551|NCT02276612|473508820|FG000|Overall Study|Pregnancy|1|||
131513552|NCT02276612|473508821|FG001|Overall Study|Pregnancy|0|||
131513553|NCT02276612|473508820|FG000|Overall Study|Withdrew Consent|1|||
131513554|NCT02276612|473508821|FG001|Overall Study|Withdrew Consent|0|||
131513555|NCT02276612|473508820|FG000|Overall Study|Lost to Follow-up|1|||
131513556|NCT02276612|473508821|FG001|Overall Study|Lost to Follow-up|0|||
131513557|NCT00262067|473508822|FG000|Overall Study|Death|190|||
131513558|NCT00262067|473508823|FG001|Overall Study|Death|89|||
131513559|NCT00262067|473508824|FG002|Overall Study|Death|186|||
131513560|NCT00262067|473508825|FG003|Overall Study|Death|99|||
131513561|NCT00262067|473508822|FG000|Overall Study|Lost to Follow-up|5|||
131513562|NCT00262067|473508823|FG001|Overall Study|Lost to Follow-up|4|||
131513563|NCT00262067|473508824|FG002|Overall Study|Lost to Follow-up|7|||
131513564|NCT00262067|473508825|FG003|Overall Study|Lost to Follow-up|5|||
131513565|NCT00262067|473508822|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
131513566|NCT00262067|473508823|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
131513567|NCT00262067|473508824|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
131513568|NCT00262067|473508825|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
131513569|NCT00262067|473508822|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
131513570|NCT00262067|473508823|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
131513571|NCT00262067|473508824|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
131513572|NCT00262067|473508825|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
131513573|NCT02849548|473508826|FG000|Overall Study|Lost to Follow-up|1|||
131513574|NCT02849548|473508827|FG001|Overall Study|Lost to Follow-up|2|||
131513575|NCT02849548|473508826|FG000|Overall Study|Protocol Violation|1|||
131513576|NCT02849548|473508827|FG001|Overall Study|Protocol Violation|0|||
131513577|NCT02357147|473508829|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
131513578|NCT02357147|473508830|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
131513579|NCT02357147|473508829|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
131513580|NCT02357147|473508830|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
131513581|NCT02357147|473508829|FG000|Combination Treatment Phase|Investigator Discretion|1|||
131513582|NCT02357147|473508830|FG001|Combination Treatment Phase|Investigator Discretion|1|||
131513583|NCT02357147|473508829|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
131513584|NCT02357147|473508830|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
131513585|NCT02357147|473508829|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
131513586|NCT02357147|473508830|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
131513587|NCT02357147|473508829|FG000|Combination Treatment Phase|Adverse Event|12|||
131513588|NCT02357147|473508830|FG001|Combination Treatment Phase|Adverse Event|4|||
131513589|NCT02357147|473508829|FG000|Combination Treatment Phase|Death|1|||
131513590|NCT02357147|473508830|FG001|Combination Treatment Phase|Death|1|||
131513591|NCT02357147|473508829|FG000|Combination Treatment Phase|Sponsor Decision|0|||
131513592|NCT02357147|473508830|FG001|Combination Treatment Phase|Sponsor Decision|12|||
131513593|NCT02357147|473508829|FG000|Combination Treatment Phase|Other|1|||
131513594|NCT02357147|473508830|FG001|Combination Treatment Phase|Other|0|||
131513595|NCT02357147|473508829|FG000|Combination Treatment Phase|Not treated|0|||
131513596|NCT02357147|473508830|FG001|Combination Treatment Phase|Not treated|2|||
131513597|NCT02357147|473508829|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
131513598|NCT02357147|473508830|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
131513599|NCT02357147|473508829|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
131513600|NCT02357147|473508830|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
131513601|NCT02357147|473508829|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
131513602|NCT02357147|473508830|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
131513603|NCT02357147|473508829|FG000|Maintenance Treatment Phase|Adverse Event|0|||
131513604|NCT02357147|473508830|FG001|Maintenance Treatment Phase|Adverse Event|3|||
131513605|NCT02357147|473508829|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
131513606|NCT02357147|473508830|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
131513607|NCT02357147|473508829|FG000|Maintenance Treatment Phase|Not Treated|1|||
131513608|NCT02357147|473508830|FG001|Maintenance Treatment Phase|Not Treated|0|||
131513609|NCT01940120|473510832|FG000|Overall Study|Death|40|||
131513610|NCT01940120|473510832|FG000|Overall Study|Withdrawal by Subject|8|||
131513611|NCT01572038|473510834|FG000|Overall Study|Death|648|||
131513612|NCT01572038|473510834|FG000|Overall Study|Withdrawal by Subject|204|||
131513613|NCT01572038|473510834|FG000|Overall Study|Lost to Follow-up|81|||
131513614|NCT01572038|473510834|FG000|Overall Study|Physician Decision|20|||
131513615|NCT01572038|473510834|FG000|Overall Study|Patient Decision|14|||
131513616|NCT01572038|473510834|FG000|Overall Study|Progressive Disease|8|||
131513617|NCT01572038|473510834|FG000|Overall Study|Site Closed Before Completing Form|6|||
131513618|NCT01572038|473510834|FG000|Overall Study|Enrolled into Another Trial|3|||
131513619|NCT01572038|473510834|FG000|Overall Study|Participated in Another Trial|3|||
131658105|NCT04445987|474032998|FG004|Overall Study|Protocol Violation|2|||
131513620|NCT01572038|473510834|FG000|Overall Study|Termination by Sponsor|2|||
131513621|NCT01572038|473510834|FG000|Overall Study|Patient Deterioration|1|||
131513622|NCT01572038|473510834|FG000|Overall Study|Sponsor Decision|1|||
131513623|NCT01888497|473510835|FG000|Washout Period 1|Withdrawal by Subject|0|||
131513624|NCT01888497|473510836|FG001|Washout Period 1|Withdrawal by Subject|0|||
131513625|NCT01888497|473510837|FG002|Washout Period 1|Withdrawal by Subject|1|||
131513626|NCT01888497|473510838|FG003|Washout Period 1|Withdrawal by Subject|1|||
131513627|NCT01888497|473510835|FG000|Washout Period 2|Adverse Event|0|||
131513628|NCT01888497|473510836|FG001|Washout Period 2|Adverse Event|0|||
131513629|NCT01888497|473510837|FG002|Washout Period 2|Adverse Event|0|||
131513630|NCT01888497|473510838|FG003|Washout Period 2|Adverse Event|1|||
131513631|NCT01888497|473510835|FG000|Washout Period 2|Withdrawal by Subject|0|||
131513632|NCT01888497|473510836|FG001|Washout Period 2|Withdrawal by Subject|0|||
131513633|NCT01888497|473510837|FG002|Washout Period 2|Withdrawal by Subject|0|||
131513634|NCT01888497|473510838|FG003|Washout Period 2|Withdrawal by Subject|1|||
131513635|NCT04152447|473510839|FG000|Overall Study|Lost to Follow-up|1|||
131513636|NCT04152447|473510840|FG001|Overall Study|Lost to Follow-up|0|||
131513637|NCT04152447|473510839|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
131513638|NCT04152447|473510840|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
131513639|NCT04152447|473510839|FG000|Overall Study|Withdrawal by Subject|0|||
131513640|NCT04152447|473510840|FG001|Overall Study|Withdrawal by Subject|1|||
131513641|NCT04152447|473510839|FG000|Overall Study|Found ineligible after enrolling|1|||
131513642|NCT04152447|473510840|FG001|Overall Study|Found ineligible after enrolling|1|||
131513643|NCT04152447|473510839|FG000|Overall Study|Did not receive VR headset in time.|0|||
131513644|NCT04152447|473510840|FG001|Overall Study|Did not receive VR headset in time.|2|||
131513645|NCT03034954|473510847|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
131513646|NCT03034954|473510848|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
131513647|NCT01275066|473510853|FG000|Overall Study|Withdrawal by Subject|0|||
131513648|NCT01275066|473510854|FG001|Overall Study|Withdrawal by Subject|0|||
131513649|NCT01275066|473510855|FG002|Overall Study|Withdrawal by Subject|1|||
131513650|NCT01275066|473510853|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
131513651|NCT01275066|473510854|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
131513652|NCT01275066|473510855|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
131513653|NCT04200248|473510858|FG000|Overall Study|Personal reasons|0|||
131513654|NCT04200248|473510859|FG001|Overall Study|Personal reasons|0|||
131513655|NCT04200248|473510860|FG002|Overall Study|Personal reasons|1|||
131513656|NCT04200248|473510858|FG000|Overall Study|Discontinued prior to treatment|3|||
131513657|NCT04200248|473510859|FG001|Overall Study|Discontinued prior to treatment|3|||
131513658|NCT04200248|473510860|FG002|Overall Study|Discontinued prior to treatment|2|||
131513659|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
131513660|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
131513661|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
131513662|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
131513663|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
131513664|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
131513665|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
131513666|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
131513667|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
131513668|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
131513669|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
131513670|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
131513671|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
131513672|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
131513673|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
131513674|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
131513675|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
131513676|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
131513677|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
131513678|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
131513679|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
131513680|NCT00934544|473510866|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
131513681|NCT00934544|473510867|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
131513682|NCT00934544|473510868|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
131513683|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
131513684|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
131513685|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
131513686|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
131513687|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
131513688|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
131513689|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
131513690|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
131513691|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
131513692|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
131513693|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
131513694|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
131513695|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
131513696|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
131513697|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
131513698|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
131513699|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
131513700|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
131513701|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
131513702|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
131513703|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
131513704|NCT00934544|473510866|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
131513705|NCT00934544|473510867|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
131513706|NCT00934544|473510868|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
131513707|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
131513708|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
131513709|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
131513710|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
131513711|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
131513712|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
131513713|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
131513714|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
131513715|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
131513716|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
131513717|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
131513718|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
131513719|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
131513720|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
131513721|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
131513722|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
131513723|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
131513724|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
131513725|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
131513726|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
131513727|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
131513728|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
131513729|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
131513730|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
131513731|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
131513732|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
131513733|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
131513734|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
131513735|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
131513736|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
131513737|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
131513738|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
131513739|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
131513740|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
131513741|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
131513742|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
131513743|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
131513744|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
131513745|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
131513746|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
131513747|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
131513748|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
131513749|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
131513750|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
131513751|NCT01218516|473510869|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
131513752|NCT01218516|473510870|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
131513753|NCT01218516|473510871|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
131513754|NCT01218516|473510872|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
131513755|NCT04033003|473510874|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
131513756|NCT04033003|473510875|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
131513757|NCT04033003|473510874|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
131513758|NCT04033003|473510875|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
131513759|NCT04033003|473510874|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
131513760|NCT04033003|473510875|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
131513761|NCT04033003|473510874|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
131513762|NCT04033003|473510875|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
131513763|NCT04033003|473510874|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
131513764|NCT04033003|473510875|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
131513765|NCT04033003|473510874|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
131513766|NCT04033003|473510875|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
131513767|NCT04033003|473510874|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
131513768|NCT04033003|473510875|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
131513769|NCT04033003|473510874|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
131513770|NCT04033003|473510875|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
131513771|NCT04033003|473510874|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
131513772|NCT04033003|473510875|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
131513773|NCT04033003|473510874|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
131513774|NCT04033003|473510875|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
131513775|NCT04033003|473510874|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
131513776|NCT04033003|473510875|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
131513777|NCT04033003|473510874|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
131513778|NCT04033003|473510875|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
131513779|NCT04033003|473510874|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
131513780|NCT04033003|473510875|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
131513781|NCT04171414|473510876|FG000|Overall Study|Death|1|||
131513782|NCT04171414|473510876|FG000|Overall Study|Withdrawal by Subject|1|||
131513783|NCT01714310|473510877|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
131513784|NCT01714310|473510878|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
131513785|NCT01714310|473510879|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
131513786|NCT01714310|473510877|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
131513787|NCT01714310|473510878|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
131513788|NCT01714310|473510879|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
131513789|NCT01714310|473510877|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
131513790|NCT01714310|473510878|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
131513791|NCT01714310|473510879|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
131513792|NCT01714310|473510877|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
131513793|NCT01714310|473510878|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
131513794|NCT01714310|473510879|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
131513795|NCT02487394|473510888|FG000|Phase 1|Withdrawal by Subject|0|||
131513796|NCT02487394|473510889|FG001|Phase 1|Withdrawal by Subject|1|||
131513797|NCT00782210|473510894|FG000|Overall Study|Adverse Event|21|||
131513798|NCT00782210|473510895|FG001|Overall Study|Adverse Event|17|||
131513799|NCT00782210|473510896|FG002|Overall Study|Adverse Event|16|||
131513800|NCT00782210|473510894|FG000|Overall Study|Lost to Follow-up|2|||
131513801|NCT00782210|473510895|FG001|Overall Study|Lost to Follow-up|1|||
131513802|NCT00782210|473510896|FG002|Overall Study|Lost to Follow-up|2|||
131513803|NCT00782210|473510894|FG000|Overall Study|Withdrawal by Subject|11|||
131513804|NCT00782210|473510895|FG001|Overall Study|Withdrawal by Subject|8|||
131513805|NCT00782210|473510896|FG002|Overall Study|Withdrawal by Subject|11|||
131513806|NCT00782210|473510894|FG000|Overall Study|Non compliance with protocol|0|||
131513807|NCT00782210|473510895|FG001|Overall Study|Non compliance with protocol|3|||
131513808|NCT00782210|473510896|FG002|Overall Study|Non compliance with protocol|2|||
131513809|NCT00782210|473510894|FG000|Overall Study|Lack of Efficacy|13|||
131513810|NCT00782210|473510895|FG001|Overall Study|Lack of Efficacy|4|||
131513811|NCT00782210|473510896|FG002|Overall Study|Lack of Efficacy|1|||
131513812|NCT00782210|473510894|FG000|Overall Study|Other reason not described above|3|||
131513813|NCT00782210|473510895|FG001|Overall Study|Other reason not described above|2|||
131513814|NCT00782210|473510896|FG002|Overall Study|Other reason not described above|3|||
131513815|NCT00654381|473510899|FG000|1st Stage|Adverse Event|3|||
131513816|NCT00654381|473510900|FG001|1st Stage|Adverse Event|3|||
131513817|NCT00654381|473510901|FG002|1st Stage|Adverse Event|3|||
131513818|NCT00654381|473510902|FG003|1st Stage|Adverse Event|3|||
131513819|NCT00654381|473510903|FG004|1st Stage|Adverse Event|2|||
131513820|NCT00654381|473510904|FG005|1st Stage|Adverse Event|1|||
131513821|NCT00654381|473510899|FG000|1st Stage|Withdrawal by Subject|0|||
131513822|NCT00654381|473510900|FG001|1st Stage|Withdrawal by Subject|0|||
131513823|NCT00654381|473510901|FG002|1st Stage|Withdrawal by Subject|0|||
131513824|NCT00654381|473510902|FG003|1st Stage|Withdrawal by Subject|1|||
131513825|NCT00654381|473510903|FG004|1st Stage|Withdrawal by Subject|0|||
131513826|NCT00654381|473510904|FG005|1st Stage|Withdrawal by Subject|1|||
131513827|NCT00654381|473510899|FG000|1st Stage|Investigator's decision|0|||
131513828|NCT00654381|473510900|FG001|1st Stage|Investigator's decision|0|||
131513829|NCT00654381|473510901|FG002|1st Stage|Investigator's decision|0|||
131513830|NCT00654381|473510902|FG003|1st Stage|Investigator's decision|1|||
131513831|NCT00654381|473510903|FG004|1st Stage|Investigator's decision|0|||
131513832|NCT00654381|473510904|FG005|1st Stage|Investigator's decision|0|||
131513833|NCT00654381|473510899|FG000|2nd Stage|Adverse Event|2|||
131513834|NCT00654381|473510900|FG001|2nd Stage|Adverse Event|0|||
131513835|NCT00654381|473510901|FG002|2nd Stage|Adverse Event|2|||
131513836|NCT00654381|473510902|FG003|2nd Stage|Adverse Event|3|||
131513837|NCT00654381|473510903|FG004|2nd Stage|Adverse Event|7|||
131513838|NCT00654381|473510904|FG005|2nd Stage|Adverse Event|2|||
131513839|NCT00654381|473510899|FG000|2nd Stage|Withdrawal by Subject|0|||
131513840|NCT00654381|473510900|FG001|2nd Stage|Withdrawal by Subject|0|||
131513841|NCT00654381|473510901|FG002|2nd Stage|Withdrawal by Subject|0|||
131513842|NCT00654381|473510902|FG003|2nd Stage|Withdrawal by Subject|0|||
131513843|NCT00654381|473510903|FG004|2nd Stage|Withdrawal by Subject|1|||
131513844|NCT00654381|473510904|FG005|2nd Stage|Withdrawal by Subject|1|||
131513845|NCT00654381|473510899|FG000|2nd Stage|Investigator's decision|0|||
131513846|NCT00654381|473510900|FG001|2nd Stage|Investigator's decision|0|||
131513847|NCT00654381|473510901|FG002|2nd Stage|Investigator's decision|1|||
131513848|NCT00654381|473510902|FG003|2nd Stage|Investigator's decision|1|||
131513849|NCT00654381|473510903|FG004|2nd Stage|Investigator's decision|0|||
131513850|NCT00654381|473510904|FG005|2nd Stage|Investigator's decision|0|||
131513851|NCT00654381|473510899|FG000|Extension Stage|Adverse Event|1|||
131513852|NCT00654381|473510900|FG001|Extension Stage|Adverse Event|2|||
131513853|NCT00654381|473510901|FG002|Extension Stage|Adverse Event|9|||
131513854|NCT00654381|473510902|FG003|Extension Stage|Adverse Event|7|||
131513855|NCT00654381|473510903|FG004|Extension Stage|Adverse Event|1|||
131513856|NCT00654381|473510904|FG005|Extension Stage|Adverse Event|1|||
131513857|NCT00654381|473510899|FG000|Extension Stage|Protocol Violation|0|||
131513858|NCT00654381|473510900|FG001|Extension Stage|Protocol Violation|0|||
131513859|NCT00654381|473510901|FG002|Extension Stage|Protocol Violation|0|||
131513860|NCT00654381|473510902|FG003|Extension Stage|Protocol Violation|1|||
131513861|NCT00654381|473510903|FG004|Extension Stage|Protocol Violation|0|||
131513862|NCT00654381|473510904|FG005|Extension Stage|Protocol Violation|0|||
131513863|NCT00654381|473510899|FG000|Extension Stage|Lack of Efficacy|0|||
131513864|NCT00654381|473510900|FG001|Extension Stage|Lack of Efficacy|0|||
131513865|NCT00654381|473510901|FG002|Extension Stage|Lack of Efficacy|1|||
131513866|NCT00654381|473510902|FG003|Extension Stage|Lack of Efficacy|0|||
131513867|NCT00654381|473510903|FG004|Extension Stage|Lack of Efficacy|0|||
131513868|NCT00654381|473510904|FG005|Extension Stage|Lack of Efficacy|0|||
131513869|NCT00654381|473510899|FG000|Extension Stage|Withdrawal by Subject|0|||
131513870|NCT00654381|473510900|FG001|Extension Stage|Withdrawal by Subject|0|||
131513871|NCT00654381|473510901|FG002|Extension Stage|Withdrawal by Subject|1|||
131513872|NCT00654381|473510902|FG003|Extension Stage|Withdrawal by Subject|1|||
131513873|NCT00654381|473510903|FG004|Extension Stage|Withdrawal by Subject|1|||
131513874|NCT00654381|473510904|FG005|Extension Stage|Withdrawal by Subject|1|||
131513875|NCT00654381|473510899|FG000|Extension Stage|Closure of the trial site|0|||
131513876|NCT00654381|473510900|FG001|Extension Stage|Closure of the trial site|0|||
131513877|NCT00654381|473510901|FG002|Extension Stage|Closure of the trial site|0|||
131513878|NCT00654381|473510902|FG003|Extension Stage|Closure of the trial site|0|||
131513879|NCT00654381|473510903|FG004|Extension Stage|Closure of the trial site|1|||
131513880|NCT00654381|473510904|FG005|Extension Stage|Closure of the trial site|1|||
131513881|NCT00826267|473510907|FG000|Overall Study|Other Adverse Event|1|||
131513882|NCT00826267|473510908|FG001|Overall Study|Other Adverse Event|0|||
131513883|NCT00826267|473510909|FG002|Overall Study|Other Adverse Event|0|||
131513884|NCT01675882|473510922|FG000|Overall Study|Adverse Event|0|||
131513885|NCT01675882|473510923|FG001|Overall Study|Adverse Event|2|||
131513886|NCT01675882|473510924|FG002|Overall Study|Adverse Event|1|||
131513887|NCT01675882|473510925|FG003|Overall Study|Adverse Event|0|||
131513888|NCT01675882|473510922|FG000|Overall Study|Participant unwilling to continue|2|||
131513889|NCT01675882|473510923|FG001|Overall Study|Participant unwilling to continue|4|||
131513890|NCT01675882|473510924|FG002|Overall Study|Participant unwilling to continue|2|||
131513891|NCT01675882|473510925|FG003|Overall Study|Participant unwilling to continue|1|||
131513892|NCT01675882|473510922|FG000|Overall Study|Lost to Follow-up|0|||
131513893|NCT01675882|473510923|FG001|Overall Study|Lost to Follow-up|1|||
131513894|NCT01675882|473510924|FG002|Overall Study|Lost to Follow-up|0|||
131513895|NCT01675882|473510925|FG003|Overall Study|Lost to Follow-up|0|||
131513896|NCT01675882|473510922|FG000|Overall Study|Non-compliance|0|||
131513897|NCT01675882|473510923|FG001|Overall Study|Non-compliance|0|||
131513898|NCT01675882|473510924|FG002|Overall Study|Non-compliance|0|||
131513899|NCT01675882|473510925|FG003|Overall Study|Non-compliance|1|||
131513900|NCT00994448|473510927|FG000|Overall Study|Adverse Event|1|||
131513901|NCT00994448|473510928|FG001|Overall Study|Adverse Event|0|||
131513902|NCT00994448|473510927|FG000|Overall Study|Lost to Follow-up|5|||
131513903|NCT00994448|473510928|FG001|Overall Study|Lost to Follow-up|1|||
131513904|NCT00994448|473510927|FG000|Overall Study|Withdrawal by Subject|1|||
131513905|NCT00994448|473510928|FG001|Overall Study|Withdrawal by Subject|1|||
131513906|NCT00994448|473510927|FG000|Overall Study|Physician Decision|1|||
131513907|NCT00994448|473510928|FG001|Overall Study|Physician Decision|0|||
131513908|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
131513909|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
131513910|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
131513911|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
131513912|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
131513913|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
131513914|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
131513915|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
131513916|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
131513917|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
131513918|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
131513919|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
131513920|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
131513921|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
131513922|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
131513923|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Death|5|||
131513924|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Death|0|||
131513925|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Death|2|||
131513926|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Death|0|||
131513927|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Death|4|||
131513928|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
131513929|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
131513930|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
131513931|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
131513932|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
131513933|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
131513934|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
131513935|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
131513936|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
131513937|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
131513938|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
131513939|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
131513940|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
131513941|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
131513942|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
131513943|NCT01604343|473510929|FG000|Prior to W52 Administration(Through W52)|Other|15|||
131513944|NCT01604343|473510930|FG001|Prior to W52 Administration(Through W52)|Other|0|||
131513945|NCT01604343|473510931|FG002|Prior to W52 Administration(Through W52)|Other|10|||
131513946|NCT01604343|473510932|FG003|Prior to W52 Administration(Through W52)|Other|0|||
131513947|NCT01604343|473510933|FG004|Prior to W52 Administration(Through W52)|Other|6|||
131513948|NCT01604343|473510929|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
131513949|NCT01604343|473510930|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
131513950|NCT01604343|473510931|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
131513951|NCT01604343|473510932|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
131513952|NCT01604343|473510933|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
131513953|NCT01604343|473510929|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
131513954|NCT01604343|473510930|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
131513955|NCT01604343|473510931|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
131513956|NCT01604343|473510932|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
131513957|NCT01604343|473510933|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
131513958|NCT01604343|473510929|FG000|Week 52 to Week 104|Adverse Event|0|||
131513959|NCT01604343|473510930|FG001|Week 52 to Week 104|Adverse Event|12|||
131513960|NCT01604343|473510931|FG002|Week 52 to Week 104|Adverse Event|26|||
131513961|NCT01604343|473510932|FG003|Week 52 to Week 104|Adverse Event|21|||
131513962|NCT01604343|473510933|FG004|Week 52 to Week 104|Adverse Event|27|||
131513963|NCT01604343|473510929|FG000|Week 52 to Week 104|Death|0|||
131513964|NCT01604343|473510930|FG001|Week 52 to Week 104|Death|4|||
131513965|NCT01604343|473510931|FG002|Week 52 to Week 104|Death|2|||
131513966|NCT01604343|473510932|FG003|Week 52 to Week 104|Death|5|||
131513967|NCT01604343|473510933|FG004|Week 52 to Week 104|Death|0|||
131513968|NCT01604343|473510929|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
131513969|NCT01604343|473510930|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
131513970|NCT01604343|473510931|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
131513971|NCT01604343|473510932|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
131513972|NCT01604343|473510933|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
131513973|NCT01604343|473510929|FG000|Week 52 to Week 104|Physician Decision|0|||
131513974|NCT01604343|473510930|FG001|Week 52 to Week 104|Physician Decision|1|||
131513975|NCT01604343|473510931|FG002|Week 52 to Week 104|Physician Decision|0|||
131513976|NCT01604343|473510932|FG003|Week 52 to Week 104|Physician Decision|0|||
131513977|NCT01604343|473510933|FG004|Week 52 to Week 104|Physician Decision|2|||
131513978|NCT01604343|473510929|FG000|Week 52 to Week 104|Pregnancy|0|||
131513979|NCT01604343|473510930|FG001|Week 52 to Week 104|Pregnancy|0|||
131513980|NCT01604343|473510931|FG002|Week 52 to Week 104|Pregnancy|1|||
131513981|NCT01604343|473510932|FG003|Week 52 to Week 104|Pregnancy|2|||
131513982|NCT01604343|473510933|FG004|Week 52 to Week 104|Pregnancy|1|||
131513983|NCT01604343|473510929|FG000|Week 52 to Week 104|Other|0|||
131513984|NCT01604343|473510930|FG001|Week 52 to Week 104|Other|11|||
131513985|NCT01604343|473510931|FG002|Week 52 to Week 104|Other|11|||
131513986|NCT01604343|473510932|FG003|Week 52 to Week 104|Other|6|||
131513987|NCT01604343|473510933|FG004|Week 52 to Week 104|Other|3|||
131513988|NCT01604343|473510929|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
131513989|NCT01604343|473510930|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
131513990|NCT01604343|473510931|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
131513991|NCT01604343|473510932|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
131513992|NCT01604343|473510933|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
131513993|NCT01604343|473510929|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
131513994|NCT01604343|473510930|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
131513995|NCT01604343|473510931|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
131513996|NCT01604343|473510932|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
131513997|NCT01604343|473510933|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
131513998|NCT01604343|473510929|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
131513999|NCT01604343|473510930|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
131514000|NCT01604343|473510931|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
131514001|NCT01604343|473510932|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
131514002|NCT01604343|473510933|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
131514003|NCT01610791|473510934|FG000|Overall Study|Lost to Follow-up|7|||
131514004|NCT01610791|473510934|FG000|Overall Study|Adverse Event|6|||
131514005|NCT01610791|473510934|FG000|Overall Study|Physician Decision|1|||
131514006|NCT01610791|473510934|FG000|Overall Study|Adverse event and Investigator decision|1|||
131514007|NCT01610791|473510934|FG000|Overall Study|Death|1|||
131514008|NCT01610791|473510934|FG000|Overall Study|Not determined|5|||
131514009|NCT02711800|473510936|FG000|Overall Study|Lost to Follow-up|1|||
131514010|NCT02711800|473510936|FG000|Overall Study|Withdrawal by Subject|1|||
131514011|NCT04164901|473510941|FG000|Overall Study|Withdrawal by Subject|4|||
131514012|NCT04164901|473510942|FG001|Overall Study|Withdrawal by Subject|4|||
131514013|NCT05040152|473510947|FG000|Overall Study|Withdrawal by Subject|5|||
131514014|NCT05040152|473510948|FG001|Overall Study|Withdrawal by Subject|0|||
131514015|NCT05040152|473510947|FG000|Overall Study|Lost to Follow-up|0|||
131514016|NCT05040152|473510948|FG001|Overall Study|Lost to Follow-up|2|||
131514017|NCT02046148|473510956|FG000|Overall Study|Lost to Follow-up|1|||
131514018|NCT02046148|473510957|FG001|Overall Study|Lost to Follow-up|1|||
131514019|NCT02046148|473510956|FG000|Overall Study|Withdrawal by Subject|0|||
131514020|NCT02046148|473510957|FG001|Overall Study|Withdrawal by Subject|2|||
131514021|NCT00314574|473510964|FG000|Overall Study|Death|3|||
131514022|NCT00314574|473510965|FG001|Overall Study|Death|0|||
131514023|NCT00314574|473510964|FG000|Overall Study|Adverse Event|11|||
131514024|NCT00314574|473510965|FG001|Overall Study|Adverse Event|16|||
131514025|NCT00314574|473510964|FG000|Overall Study|Lost to Follow-up|19|||
131514026|NCT00314574|473510965|FG001|Overall Study|Lost to Follow-up|25|||
131514027|NCT00314574|473510964|FG000|Overall Study|Withdrawal by Subject|33|||
131514028|NCT00314574|473510965|FG001|Overall Study|Withdrawal by Subject|22|||
131514029|NCT00314574|473510964|FG000|Overall Study|Physician Decision|22|||
131514030|NCT00314574|473510965|FG001|Overall Study|Physician Decision|15|||
131514031|NCT00314574|473510964|FG000|Overall Study|Pregnancy|6|||
131514032|NCT00314574|473510965|FG001|Overall Study|Pregnancy|4|||
131514033|NCT00314574|473510964|FG000|Overall Study|Data unknown at database lock|0|||
131514034|NCT00314574|473510965|FG001|Overall Study|Data unknown at database lock|1|||
131514035|NCT00449956|473510966|FG000|Overall Study|Adverse Event|7|||
131514036|NCT00449956|473510967|FG001|Overall Study|Adverse Event|1|||
131514037|NCT00449956|473510968|FG002|Overall Study|Adverse Event|6|||
131514038|NCT00449956|473510966|FG000|Overall Study|Lack of Efficacy|0|||
131514039|NCT00449956|473510967|FG001|Overall Study|Lack of Efficacy|0|||
131514040|NCT00449956|473510968|FG002|Overall Study|Lack of Efficacy|1|||
131514041|NCT00449956|473510966|FG000|Overall Study|Protocol Violation|1|||
131514042|NCT00449956|473510967|FG001|Overall Study|Protocol Violation|1|||
131514043|NCT00449956|473510968|FG002|Overall Study|Protocol Violation|1|||
131514044|NCT00449956|473510966|FG000|Overall Study|Withdrawal by Subject|0|||
131514045|NCT00449956|473510967|FG001|Overall Study|Withdrawal by Subject|1|||
131514046|NCT00449956|473510968|FG002|Overall Study|Withdrawal by Subject|0|||
131514047|NCT00449956|473510966|FG000|Overall Study|Physician Decision|2|||
131514048|NCT00449956|473510967|FG001|Overall Study|Physician Decision|1|||
131514049|NCT00449956|473510968|FG002|Overall Study|Physician Decision|1|||
131514050|NCT02086110|473510969|FG000|Overall Study|Withdrawal by Subject|1|||
131514051|NCT02086110|473510970|FG001|Overall Study|Withdrawal by Subject|1|||
131514052|NCT02272413|473510975|FG000|Randomized Through Treatment Start|Not treated|3|||
131514053|NCT02272413|473510976|FG001|Randomized Through Treatment Start|Not treated|5|||
131514054|NCT02272413|473510975|FG000|Pre-switch Period|Adverse Event|38|||
131514055|NCT02272413|473510976|FG001|Pre-switch Period|Adverse Event|37|||
131514056|NCT02272413|473510975|FG000|Pre-switch Period|Death|26|||
131514057|NCT02272413|473510976|FG001|Pre-switch Period|Death|26|||
131514058|NCT02272413|473510975|FG000|Pre-switch Period|Withdrawal by Subject|27|||
131514059|NCT02272413|473510976|FG001|Pre-switch Period|Withdrawal by Subject|15|||
131514060|NCT02272413|473510975|FG000|Pre-switch Period|Physician Decision|6|||
131514061|NCT02272413|473510976|FG001|Pre-switch Period|Physician Decision|18|||
131514062|NCT02272413|473510975|FG000|Pre-switch Period|Progressive disease|185|||
131514063|NCT02272413|473510976|FG001|Pre-switch Period|Progressive disease|173|||
131514064|NCT02272413|473510975|FG000|Pre-switch Period|Lost to Follow-up|0|||
131514065|NCT02272413|473510976|FG001|Pre-switch Period|Lost to Follow-up|2|||
131514066|NCT02272413|473510975|FG000|Pre-switch Period|Protocol Violation|1|||
131514067|NCT02272413|473510976|FG001|Pre-switch Period|Protocol Violation|0|||
131514068|NCT02272413|473510975|FG000|Pre-switch Period|Other than listed|10|||
131514069|NCT02272413|473510976|FG001|Pre-switch Period|Other than listed|11|||
131514070|NCT02272413|473510975|FG000|Post-switch Period|Adverse Event|4|||
131514071|NCT02272413|473510976|FG001|Post-switch Period|Adverse Event|4|||
131514072|NCT02272413|473510975|FG000|Post-switch Period|Death|3|||
131514073|NCT02272413|473510976|FG001|Post-switch Period|Death|2|||
131514074|NCT02272413|473510975|FG000|Post-switch Period|Withdrawal by Subject|1|||
131514075|NCT02272413|473510976|FG001|Post-switch Period|Withdrawal by Subject|2|||
131514076|NCT02272413|473510975|FG000|Post-switch Period|Physician Decision|1|||
131514077|NCT02272413|473510976|FG001|Post-switch Period|Physician Decision|1|||
131514078|NCT02272413|473510975|FG000|Post-switch Period|Progressive disease|21|||
131514079|NCT02272413|473510976|FG001|Post-switch Period|Progressive disease|21|||
131514080|NCT02272413|473510975|FG000|Post-switch Period|Study terminated by sponsor|8|||
131514081|NCT02272413|473510976|FG001|Post-switch Period|Study terminated by sponsor|11|||
131514082|NCT02272413|473510975|FG000|Post-switch Period|Other than listed|4|||
131514083|NCT02272413|473510976|FG001|Post-switch Period|Other than listed|5|||
131514084|NCT00606892|473510979|FG000|First Intervention|Protocol Violation|1|||
131514085|NCT00606892|473510980|FG001|First Intervention|Protocol Violation|4|||
131514086|NCT04116710|473510983|FG000|Overall Study|Death|4|||
131514087|NCT04116710|473510984|FG001|Overall Study|Death|6|||
131514088|NCT04116710|473510985|FG002|Overall Study|Death|3|||
131514089|NCT04116710|473510986|FG003|Overall Study|Death|1|||
131514090|NCT04116710|473510983|FG000|Overall Study|Withdrawal by Subject|0|||
131514091|NCT04116710|473510984|FG001|Overall Study|Withdrawal by Subject|0|||
131514092|NCT04116710|473510985|FG002|Overall Study|Withdrawal by Subject|0|||
131514093|NCT04116710|473510986|FG003|Overall Study|Withdrawal by Subject|1|||
131514094|NCT00582933|473510987|FG000|Overall Study|Physician Decision|3|||
131514095|NCT00149747|473510988|FG000|Overall Study|Death|1|||
131514096|NCT00149747|473510989|FG001|Overall Study|Death|0|||
131514097|NCT00149747|473510988|FG000|Overall Study|Withdrawal by Subject|3|||
131514098|NCT00149747|473510989|FG001|Overall Study|Withdrawal by Subject|3|||
131514099|NCT04753164|473510990|FG000|Overall Study|Adverse Event|0|||
131514100|NCT04753164|473510991|FG001|Overall Study|Adverse Event|2|||
131514101|NCT04753164|473510990|FG000|Overall Study|Withdrawal by Subject|9|||
131514102|NCT04753164|473510991|FG001|Overall Study|Withdrawal by Subject|7|||
131514103|NCT04753164|473510990|FG000|Overall Study|Lost to Follow-up|6|||
131514104|NCT04753164|473510991|FG001|Overall Study|Lost to Follow-up|6|||
131514105|NCT04753164|473510990|FG000|Overall Study|Other|12|||
131514106|NCT04753164|473510991|FG001|Overall Study|Other|5|||
131514107|NCT01183975|473510999|FG000|Overall Study|Lost to Follow-up|73|||
131514108|NCT00850395|473511006|FG000|Overall Study|Death|1|||
131514109|NCT00850395|473511006|FG000|Overall Study|Adverse Event|1|||
131514110|NCT00850395|473511006|FG000|Overall Study|Insufficient clinical response|3|||
131514111|NCT00850395|473511006|FG000|Overall Study|Other|5|||
131514112|NCT00842348|473511007|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
131514113|NCT00842348|473511008|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
131514114|NCT00842348|473511007|FG000|Study 729|Disease progression/death|19|||
131514115|NCT00842348|473511008|FG001|Study 729|Disease progression/death|30|||
131514116|NCT00842348|473511007|FG000|Study 729|Adverse Event|1|||
131514117|NCT00842348|473511008|FG001|Study 729|Adverse Event|1|||
131514118|NCT00842348|473511007|FG000|Study 729|Protocol Violation|1|||
131514119|NCT00842348|473511008|FG001|Study 729|Protocol Violation|1|||
131514120|NCT00842348|473511007|FG000|Study 729|Withdrawal by Subject|2|||
131514121|NCT00842348|473511008|FG001|Study 729|Withdrawal by Subject|4|||
131514122|NCT00842348|473511007|FG000|Study 729|Due to Sponsor stopping the study|1|||
131514123|NCT00842348|473511008|FG001|Study 729|Due to Sponsor stopping the study|1|||
131514124|NCT00842348|473511007|FG000|Study 729|Due to non-availability of IP|0|||
131514125|NCT00842348|473511008|FG001|Study 729|Due to non-availability of IP|1|||
131514126|NCT00842348|473511007|FG000|Study 729|Sponsor's decision|1|||
131514127|NCT00842348|473511008|FG001|Study 729|Sponsor's decision|0|||
131514128|NCT00842348|473511007|FG000|Study 729|Surgical resection|1|||
131514129|NCT00842348|473511008|FG001|Study 729|Surgical resection|0|||
131514130|NCT03962543|473511009|FG000|Treatment Phase|Death|0|||
131514131|NCT03962543|473511010|FG001|Treatment Phase|Death|1|||
131514132|NCT03962543|473511009|FG000|Treatment Phase|Withdrawal by Subject|3|||
131514133|NCT03962543|473511010|FG001|Treatment Phase|Withdrawal by Subject|0|||
131514134|NCT03962543|473511009|FG000|Treatment Phase|Adverse Event|3|||
131514135|NCT03962543|473511010|FG001|Treatment Phase|Adverse Event|12|||
131514136|NCT03962543|473511009|FG000|Treatment Phase|Lost to Follow-up|1|||
131514137|NCT03962543|473511010|FG001|Treatment Phase|Lost to Follow-up|2|||
131514138|NCT03962543|473511009|FG000|Treatment Phase|Radiographic PD|9|||
131514139|NCT03962543|473511010|FG001|Treatment Phase|Radiographic PD|3|||
131514140|NCT03962543|473511009|FG000|Treatment Phase|Participant Decision|3|||
131514141|NCT03962543|473511010|FG001|Treatment Phase|Participant Decision|8|||
131514142|NCT03962543|473511009|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
131514143|NCT03962543|473511010|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
131514144|NCT03962543|473511009|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
131514145|NCT03962543|473511010|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
131514146|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
131514147|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
131514148|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
131514149|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
131514150|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
131514151|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
131514152|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
131514153|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
131514154|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
131514155|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
131514156|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
131514157|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
131514158|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
131514159|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
131514160|NCT03962543|473511009|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
131514161|NCT03962543|473511010|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
131514162|NCT03264404|473512966|FG000|Overall Study|Death|2|||
131514163|NCT03264404|473512966|FG000|Overall Study|Physician Decision|1|||
131514164|NCT03264404|473512966|FG000|Overall Study|Disease Progression|28|||
131514165|NCT03264404|473512966|FG000|Overall Study|Adverse Event|1|||
131514166|NCT03264404|473512966|FG000|Overall Study|Off study prior to treatment|2|||
131514167|NCT03036566|473512973|FG000|Overall Study|Lost to Follow-up|3|||
131514168|NCT01852292|473512977|FG000|Overall Study|Untreated - did not receive study drug|3|||
131514169|NCT01852292|473512978|FG001|Overall Study|Untreated - did not receive study drug|1|||
131514170|NCT01852292|473512977|FG000|Overall Study|Death|9|||
131514171|NCT01852292|473512978|FG001|Overall Study|Death|8|||
131514172|NCT01852292|473512977|FG000|Overall Study|Patient/guardian decision|8|||
131514173|NCT01852292|473512978|FG001|Overall Study|Patient/guardian decision|4|||
131514174|NCT01852292|473512977|FG000|Overall Study|Adverse Event|8|||
131514175|NCT01852292|473512978|FG001|Overall Study|Adverse Event|11|||
131514176|NCT01852292|473512977|FG000|Overall Study|Physician Decision|6|||
131514177|NCT01852292|473512978|FG001|Overall Study|Physician Decision|2|||
131514178|NCT01852292|473512977|FG000|Overall Study|Protocol Violation|2|||
131514179|NCT01852292|473512978|FG001|Overall Study|Protocol Violation|0|||
131514180|NCT01852292|473512977|FG000|Overall Study|Non-compliance with study treatment|1|||
131514181|NCT01852292|473512978|FG001|Overall Study|Non-compliance with study treatment|0|||
131514182|NCT01852292|473512977|FG000|Overall Study|Study terminated by Sponsor|0|||
131514183|NCT01852292|473512978|FG001|Overall Study|Study terminated by Sponsor|1|||
131514184|NCT01852292|473512977|FG000|Overall Study|Progressive disease|42|||
131514185|NCT01852292|473512978|FG001|Overall Study|Progressive disease|52|||
131514186|NCT01914666|473512981|FG000|Treatment Period|Lack of Efficacy|0|||
131514187|NCT01914666|473512982|FG001|Treatment Period|Lack of Efficacy|0|||
131514188|NCT01914666|473512983|FG002|Treatment Period|Lack of Efficacy|2|||
131514189|NCT01914666|473512981|FG000|Treatment Period|Adverse Event|10|||
131514190|NCT01914666|473512982|FG001|Treatment Period|Adverse Event|4|||
131514191|NCT01914666|473512983|FG002|Treatment Period|Adverse Event|2|||
131514192|NCT01914666|473512981|FG000|Treatment Period|Withdrawal by Subject|3|||
131514193|NCT01914666|473512982|FG001|Treatment Period|Withdrawal by Subject|2|||
131514194|NCT01914666|473512983|FG002|Treatment Period|Withdrawal by Subject|2|||
131514195|NCT01914666|473512981|FG000|Treatment Period|Physician Decision|0|||
131514196|NCT01914666|473512982|FG001|Treatment Period|Physician Decision|0|||
131514197|NCT01914666|473512983|FG002|Treatment Period|Physician Decision|2|||
131514198|NCT02586012|473512984|FG000|Overall Study|Withdrawal by Subject|1|||
131514199|NCT02586012|473512985|FG001|Overall Study|Withdrawal by Subject|1|||
131514200|NCT02586012|473512986|FG002|Overall Study|Withdrawal by Subject|0|||
131514201|NCT02586012|473512987|FG003|Overall Study|Withdrawal by Subject|1|||
131514202|NCT02586012|473512988|FG004|Overall Study|Withdrawal by Subject|0|||
131514203|NCT02586012|473512989|FG005|Overall Study|Withdrawal by Subject|2|||
131514204|NCT02586012|473512984|FG000|Overall Study|Protocol Violation|0|||
131514205|NCT02586012|473512985|FG001|Overall Study|Protocol Violation|0|||
131514206|NCT02586012|473512986|FG002|Overall Study|Protocol Violation|0|||
131514207|NCT02586012|473512987|FG003|Overall Study|Protocol Violation|0|||
131514208|NCT02586012|473512988|FG004|Overall Study|Protocol Violation|0|||
131514209|NCT02586012|473512989|FG005|Overall Study|Protocol Violation|1|||
131514210|NCT02586012|473512984|FG000|Overall Study|study terminated|0|||
131514211|NCT02586012|473512985|FG001|Overall Study|study terminated|2|||
131514212|NCT02586012|473512986|FG002|Overall Study|study terminated|1|||
131514213|NCT02586012|473512987|FG003|Overall Study|study terminated|1|||
131514214|NCT02586012|473512988|FG004|Overall Study|study terminated|1|||
131514215|NCT02586012|473512989|FG005|Overall Study|study terminated|0|||
131514216|NCT03252522|473512990|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
131514217|NCT03252522|473512991|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
131514218|NCT03252522|473512992|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
131514219|NCT03252522|473512990|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
131514220|NCT03252522|473512991|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
131514221|NCT03252522|473512992|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
131514222|NCT03252522|473512990|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
131514223|NCT03252522|473512991|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
131514224|NCT03252522|473512992|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
131514225|NCT03252522|473512990|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
131514226|NCT03252522|473512991|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
131514227|NCT03252522|473512992|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
131514228|NCT03252522|473512990|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
131514229|NCT03252522|473512991|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
131514230|NCT03252522|473512992|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
131514231|NCT03252522|473512990|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
131514232|NCT03252522|473512991|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
131514233|NCT03252522|473512992|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
131514234|NCT03252522|473512990|FG000|Phase 2: Open Label|Adverse Event|0|||
131514235|NCT03252522|473512991|FG001|Phase 2: Open Label|Adverse Event|0|||
131514236|NCT03252522|473512992|FG002|Phase 2: Open Label|Adverse Event|2|||
131514237|NCT03252522|473512990|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
131514238|NCT03252522|473512991|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
131514239|NCT03252522|473512992|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
131514240|NCT03299842|473512994|FG000|Overall Study|Caregiver withdrew consent|2|||
131514241|NCT03299842|473512994|FG000|Overall Study|Child would not keep the watch on|3|||
131514242|NCT03277846|473512995|FG000|Overall Study|Inpatient stay too brief|12|||
131514243|NCT03277846|473512996|FG001|Overall Study|Inpatient stay too brief|11|||
131514244|NCT04013191|473512997|FG000|Overall Study|Adverse Event|1|||
131514245|NCT04013191|473512998|FG001|Overall Study|Adverse Event|0|||
131514246|NCT01344369|473513003|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
131514247|NCT01344369|473513004|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
131514248|NCT01344369|473513003|FG000|Washout of 28 Days|Physician Decision|0|||
131514249|NCT01344369|473513004|FG001|Washout of 28 Days|Physician Decision|1|||
131514250|NCT01344369|473513003|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
131514251|NCT01344369|473513004|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
131658106|NCT04445987|474032999|FG005|Overall Study|Protocol Violation|0|||
131514252|NCT01454726|473513008|FG000|Overall Study|Withdrawal by Subject|0|||
131514253|NCT01454726|473513009|FG001|Overall Study|Withdrawal by Subject|1|||
131514254|NCT03848845|473513010|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
131514255|NCT03848845|473513011|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
131514256|NCT03848845|473513012|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
131514257|NCT03848845|473513013|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
131514258|NCT03848845|473513010|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
131514259|NCT03848845|473513011|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
131514260|NCT03848845|473513012|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
131514261|NCT03848845|473513013|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
131514262|NCT03848845|473513010|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
131514263|NCT03848845|473513011|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
131514264|NCT03848845|473513012|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
131514265|NCT03848845|473513013|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
131514266|NCT03848845|473513010|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
131514267|NCT03848845|473513011|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
131514268|NCT03848845|473513012|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
131514269|NCT03848845|473513013|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
131514270|NCT01886833|473513016|FG000|Overall Study|IgA not available from both periods|204|||
131514271|NCT02223767|473513022|FG000|Overall Study|Withdrawal by Subject|4|||
131514272|NCT02223767|473513023|FG001|Overall Study|Withdrawal by Subject|4|||
131514273|NCT00706966|473513024|FG000|Overall Study|Adverse Event|1|||
131514274|NCT02884089|473513027|FG000|Period 1|Dosing error|2|||
131514275|NCT02884089|473513028|FG001|Period 1|Dosing error|2|||
131514276|NCT02884089|473513029|FG002|Period 1|Dosing error|0|||
131514277|NCT02884089|473513030|FG003|Period 1|Dosing error|0|||
131514278|NCT02884089|473513027|FG000|Washout Period 1|Lost to Follow-up|0|||
131514279|NCT02884089|473513028|FG001|Washout Period 1|Lost to Follow-up|1|||
131514280|NCT02884089|473513029|FG002|Washout Period 1|Lost to Follow-up|0|||
131514281|NCT02884089|473513030|FG003|Washout Period 1|Lost to Follow-up|1|||
131514282|NCT02884089|473513027|FG000|Washout Period 1|Withdrawal by Subject|0|||
131514283|NCT02884089|473513028|FG001|Washout Period 1|Withdrawal by Subject|1|||
131514284|NCT02884089|473513029|FG002|Washout Period 1|Withdrawal by Subject|0|||
131514285|NCT02884089|473513030|FG003|Washout Period 1|Withdrawal by Subject|0|||
131514286|NCT02884089|473513027|FG000|Period 2|Adverse Event|1|||
131514287|NCT02884089|473513028|FG001|Period 2|Adverse Event|0|||
131514288|NCT02884089|473513029|FG002|Period 2|Adverse Event|0|||
131514289|NCT02884089|473513030|FG003|Period 2|Adverse Event|0|||
131514290|NCT02884089|473513027|FG000|Period 3|Withdrawal by Subject|0|||
131514291|NCT02884089|473513028|FG001|Period 3|Withdrawal by Subject|0|||
131514292|NCT02884089|473513029|FG002|Period 3|Withdrawal by Subject|1|||
131514293|NCT02884089|473513030|FG003|Period 3|Withdrawal by Subject|0|||
131514294|NCT02884089|473513027|FG000|Washout Period 3|Withdrawal by Subject|0|||
131514295|NCT02884089|473513028|FG001|Washout Period 3|Withdrawal by Subject|0|||
131514296|NCT02884089|473513029|FG002|Washout Period 3|Withdrawal by Subject|1|||
131514297|NCT02884089|473513030|FG003|Washout Period 3|Withdrawal by Subject|0|||
131514298|NCT02884089|473513027|FG000|Washout Period 3|Lost to Follow-up|0|||
131514299|NCT02884089|473513028|FG001|Washout Period 3|Lost to Follow-up|0|||
131514300|NCT02884089|473513029|FG002|Washout Period 3|Lost to Follow-up|0|||
131514301|NCT02884089|473513030|FG003|Washout Period 3|Lost to Follow-up|1|||
131514302|NCT02884089|473513027|FG000|Period 4|Withdrawal by Subject|0|||
131514303|NCT02884089|473513028|FG001|Period 4|Withdrawal by Subject|1|||
131514304|NCT02884089|473513029|FG002|Period 4|Withdrawal by Subject|0|||
131514305|NCT02884089|473513030|FG003|Period 4|Withdrawal by Subject|0|||
131514306|NCT02884089|473513027|FG000|Period 4|Lost to Follow-up|1|||
131514307|NCT02884089|473513028|FG001|Period 4|Lost to Follow-up|0|||
131514308|NCT02884089|473513029|FG002|Period 4|Lost to Follow-up|0|||
131514309|NCT02884089|473513030|FG003|Period 4|Lost to Follow-up|0|||
131514310|NCT02884089|473513027|FG000|Follow-up Visit|Withdrawal by Subject|1|||
131514311|NCT02884089|473513028|FG001|Follow-up Visit|Withdrawal by Subject|0|||
131514312|NCT02884089|473513029|FG002|Follow-up Visit|Withdrawal by Subject|0|||
131514313|NCT02884089|473513030|FG003|Follow-up Visit|Withdrawal by Subject|1|||
131514314|NCT01631474|473513031|FG000|Overall Study|Lost to Follow-up|8|||
131514315|NCT01631474|473513032|FG001|Overall Study|Lost to Follow-up|5|||
131514316|NCT01631474|473513033|FG002|Overall Study|Lost to Follow-up|7|||
131514317|NCT01631474|473513034|FG003|Overall Study|Lost to Follow-up|5|||
131514318|NCT01631474|473513035|FG004|Overall Study|Lost to Follow-up|5|||
131514319|NCT01631474|473513031|FG000|Overall Study|Withdrawal by Subject|4|||
131514320|NCT01631474|473513032|FG001|Overall Study|Withdrawal by Subject|4|||
131514321|NCT01631474|473513033|FG002|Overall Study|Withdrawal by Subject|2|||
131514322|NCT01631474|473513034|FG003|Overall Study|Withdrawal by Subject|6|||
131514323|NCT01631474|473513035|FG004|Overall Study|Withdrawal by Subject|5|||
131514324|NCT01631474|473513031|FG000|Overall Study|Lack of Efficacy|2|||
131514325|NCT01631474|473513032|FG001|Overall Study|Lack of Efficacy|2|||
131514326|NCT01631474|473513033|FG002|Overall Study|Lack of Efficacy|0|||
131514327|NCT01631474|473513034|FG003|Overall Study|Lack of Efficacy|0|||
131514328|NCT01631474|473513035|FG004|Overall Study|Lack of Efficacy|2|||
131514329|NCT01631474|473513031|FG000|Overall Study|Noncompliance with Study Drug|0|||
131514330|NCT01631474|473513032|FG001|Overall Study|Noncompliance with Study Drug|0|||
131514331|NCT01631474|473513033|FG002|Overall Study|Noncompliance with Study Drug|0|||
131514332|NCT01631474|473513034|FG003|Overall Study|Noncompliance with Study Drug|0|||
131514333|NCT01631474|473513035|FG004|Overall Study|Noncompliance with Study Drug|1|||
131514334|NCT01631474|473513031|FG000|Overall Study|Adverse Event|0|||
131514335|NCT01631474|473513032|FG001|Overall Study|Adverse Event|1|||
131514336|NCT01631474|473513033|FG002|Overall Study|Adverse Event|0|||
131514337|NCT01631474|473513034|FG003|Overall Study|Adverse Event|0|||
131514338|NCT01631474|473513035|FG004|Overall Study|Adverse Event|0|||
131514339|NCT02624284|473513036|FG000|Overall Study|Withdrawal by Subject|3|||
131514340|NCT02624284|473513037|FG001|Overall Study|Withdrawal by Subject|6|||
131514341|NCT02624284|473513038|FG002|Overall Study|Withdrawal by Subject|3|||
131514342|NCT02624284|473513036|FG000|Overall Study|Protocol Violation|9|||
131514343|NCT02624284|473513037|FG001|Overall Study|Protocol Violation|10|||
131514344|NCT02624284|473513038|FG002|Overall Study|Protocol Violation|7|||
131514345|NCT02624284|473513036|FG000|Overall Study|Revealed exclusionary condition|2|||
131514346|NCT02624284|473513037|FG001|Overall Study|Revealed exclusionary condition|2|||
131514347|NCT02624284|473513038|FG002|Overall Study|Revealed exclusionary condition|0|||
131514348|NCT02624284|473513036|FG000|Overall Study|Adverse Event|0|||
131514349|NCT02624284|473513037|FG001|Overall Study|Adverse Event|0|||
131514350|NCT02624284|473513038|FG002|Overall Study|Adverse Event|1|||
131514351|NCT01641367|473513041|FG000|Cohorts|Death|18|||
131514352|NCT01641367|473513042|FG001|Cohorts|Death|1|||
131514353|NCT01641367|473513043|FG002|Cohorts|Death|2|||
131514354|NCT01641367|473513044|FG003|Cohorts|Death|0|||
131514355|NCT01641367|473513045|FG004|Cohorts|Death|1|||
131514356|NCT01641367|473513046|FG005|Cohorts|Death|1|||
131514357|NCT01641367|473513047|FG006|Cohorts|Death|0|||
131514358|NCT01641367|473513048|FG007|Cohorts|Death|0|||
131514359|NCT01641367|473513041|FG000|Cohorts|Lost to Follow-up|16|||
131514360|NCT01641367|473513042|FG001|Cohorts|Lost to Follow-up|0|||
131514361|NCT01641367|473513043|FG002|Cohorts|Lost to Follow-up|2|||
131514362|NCT01641367|473513044|FG003|Cohorts|Lost to Follow-up|0|||
131514363|NCT01641367|473513045|FG004|Cohorts|Lost to Follow-up|2|||
131514364|NCT01641367|473513046|FG005|Cohorts|Lost to Follow-up|0|||
131514365|NCT01641367|473513047|FG006|Cohorts|Lost to Follow-up|0|||
131514366|NCT01641367|473513048|FG007|Cohorts|Lost to Follow-up|0|||
131514367|NCT01641367|473513041|FG000|Randomized Adherence Intervention|Death|0|||
131514368|NCT01641367|473513042|FG001|Randomized Adherence Intervention|Death|0|||
131514369|NCT01641367|473513043|FG002|Randomized Adherence Intervention|Death|0|||
131514370|NCT01641367|473513044|FG003|Randomized Adherence Intervention|Death|0|||
131514371|NCT01641367|473513045|FG004|Randomized Adherence Intervention|Death|0|||
131514372|NCT01641367|473513046|FG005|Randomized Adherence Intervention|Death|0|||
131514373|NCT01641367|473513047|FG006|Randomized Adherence Intervention|Death|11|||
131514374|NCT01641367|473513048|FG007|Randomized Adherence Intervention|Death|12|||
131514375|NCT01641367|473513041|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
131514376|NCT01641367|473513042|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
131514377|NCT01641367|473513043|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
131514378|NCT01641367|473513044|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
131514379|NCT01641367|473513045|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
131514380|NCT01641367|473513046|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
131514381|NCT01641367|473513047|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
131514382|NCT01641367|473513048|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
131514383|NCT03100825|473513051|FG000|Overall Study|Participant/Guardian Decision|7|||
131514384|NCT03100825|473513051|FG000|Overall Study|Physician Decision|1|||
131514385|NCT00735371|473513059|FG000|Overall Study|Adverse Event|3|||
131514386|NCT00735371|473513060|FG001|Overall Study|Adverse Event|3|||
131514387|NCT00735371|473513061|FG002|Overall Study|Adverse Event|4|||
131514388|NCT00735371|473513062|FG003|Overall Study|Adverse Event|1|||
131514389|NCT00735371|473513059|FG000|Overall Study|Protocol Violation|2|||
131514390|NCT00735371|473513060|FG001|Overall Study|Protocol Violation|2|||
131514391|NCT00735371|473513061|FG002|Overall Study|Protocol Violation|0|||
131514392|NCT00735371|473513062|FG003|Overall Study|Protocol Violation|3|||
131514393|NCT00735371|473513059|FG000|Overall Study|Withdrawal by Subject|0|||
131514394|NCT00735371|473513060|FG001|Overall Study|Withdrawal by Subject|2|||
131514395|NCT00735371|473513061|FG002|Overall Study|Withdrawal by Subject|2|||
131514396|NCT00735371|473513062|FG003|Overall Study|Withdrawal by Subject|0|||
131514397|NCT00735371|473513059|FG000|Overall Study|Lost to Follow-up|1|||
131514398|NCT00735371|473513060|FG001|Overall Study|Lost to Follow-up|1|||
131514399|NCT00735371|473513061|FG002|Overall Study|Lost to Follow-up|3|||
131514400|NCT00735371|473513062|FG003|Overall Study|Lost to Follow-up|1|||
131514401|NCT00735371|473513059|FG000|Overall Study|Lack of Efficacy|4|||
131514402|NCT00735371|473513060|FG001|Overall Study|Lack of Efficacy|2|||
131514403|NCT00735371|473513061|FG002|Overall Study|Lack of Efficacy|0|||
131514404|NCT00735371|473513062|FG003|Overall Study|Lack of Efficacy|4|||
131514405|NCT00735371|473513059|FG000|Overall Study|Sponsor Decision|3|||
131514406|NCT00735371|473513060|FG001|Overall Study|Sponsor Decision|1|||
131514407|NCT00735371|473513061|FG002|Overall Study|Sponsor Decision|0|||
131514408|NCT00735371|473513062|FG003|Overall Study|Sponsor Decision|1|||
131514409|NCT00735371|473513059|FG000|Overall Study|Protocol Violation|0|||
131514410|NCT00735371|473513060|FG001|Overall Study|Protocol Violation|1|||
131514411|NCT00735371|473513061|FG002|Overall Study|Protocol Violation|2|||
131514412|NCT00735371|473513062|FG003|Overall Study|Protocol Violation|0|||
131514413|NCT00735371|473513059|FG000|Overall Study|Prior Vyvanse Exposure|1|||
131514414|NCT00735371|473513060|FG001|Overall Study|Prior Vyvanse Exposure|1|||
131514415|NCT00735371|473513061|FG002|Overall Study|Prior Vyvanse Exposure|0|||
131514416|NCT00735371|473513062|FG003|Overall Study|Prior Vyvanse Exposure|0|||
131514417|NCT00735371|473513059|FG000|Overall Study|Exclusion criteria|1|||
131514418|NCT00735371|473513060|FG001|Overall Study|Exclusion criteria|0|||
131514419|NCT00735371|473513061|FG002|Overall Study|Exclusion criteria|0|||
131514420|NCT00735371|473513062|FG003|Overall Study|Exclusion criteria|0|||
131514421|NCT00436748|473513067|FG000|Overall Study|Ineligibility Determined|1|||
131514422|NCT00436748|473513068|FG001|Overall Study|Ineligibility Determined|1|||
131514423|NCT00436748|473513067|FG000|Overall Study|Adverse Event|0|||
131514424|NCT00436748|473513068|FG001|Overall Study|Adverse Event|2|||
131514425|NCT00436748|473513067|FG000|Overall Study|Consent Withdrawn|1|||
131514426|NCT00436748|473513068|FG001|Overall Study|Consent Withdrawn|4|||
131514427|NCT00436748|473513067|FG000|Overall Study|Administrative Decision|1|||
131514428|NCT00436748|473513068|FG001|Overall Study|Administrative Decision|0|||
131514429|NCT00436748|473513067|FG000|Overall Study|Lost to Follow-up|0|||
131514430|NCT00436748|473513068|FG001|Overall Study|Lost to Follow-up|1|||
131514431|NCT00436748|473513067|FG000|Overall Study|Protocol-specified Criteria|5|||
131514432|NCT00436748|473513068|FG001|Overall Study|Protocol-specified Criteria|4|||
131514433|NCT00436748|473513067|FG000|Overall Study|Other|3|||
131514434|NCT00436748|473513068|FG001|Overall Study|Other|0|||
131514435|NCT00850200|473513071|FG000|Overall Study|Physician Decision|2|||
131514436|NCT00850200|473513071|FG000|Overall Study|Did not recieve treatment|2|||
131514437|NCT00850200|473513071|FG000|Overall Study|Withdrawal by Subject|1|||
131514438|NCT00048542|473513073|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131514439|NCT00048542|473513074|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
131514440|NCT00048542|473513075|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131514441|NCT00048542|473513076|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131514442|NCT00048542|473513077|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
131514443|NCT00048542|473513078|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
131514444|NCT00048542|473513079|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
131514445|NCT00048542|473513080|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
131514446|NCT00048542|473513073|FG000|Double-Blind Phase|Protocol Violation|0|||
131514447|NCT00048542|473513074|FG001|Double-Blind Phase|Protocol Violation|0|||
131514448|NCT00048542|473513075|FG002|Double-Blind Phase|Protocol Violation|1|||
131514449|NCT00048542|473513076|FG003|Double-Blind Phase|Protocol Violation|0|||
131514450|NCT00048542|473513077|FG004|Double-Blind Phase|Protocol Violation|0|||
131514451|NCT00048542|473513078|FG005|Double-Blind Phase|Protocol Violation|0|||
131514452|NCT00048542|473513079|FG006|Double-Blind Phase|Protocol Violation|0|||
131514453|NCT00048542|473513080|FG007|Double-Blind Phase|Protocol Violation|0|||
131514454|NCT00048542|473513073|FG000|Double-Blind Phase|Sponsor request or decision|2|||
131514455|NCT00048542|473513074|FG001|Double-Blind Phase|Sponsor request or decision|0|||
131514456|NCT00048542|473513075|FG002|Double-Blind Phase|Sponsor request or decision|0|||
131514457|NCT00048542|473513076|FG003|Double-Blind Phase|Sponsor request or decision|0|||
131514458|NCT00048542|473513077|FG004|Double-Blind Phase|Sponsor request or decision|0|||
131514459|NCT00048542|473513078|FG005|Double-Blind Phase|Sponsor request or decision|0|||
131514460|NCT00048542|473513079|FG006|Double-Blind Phase|Sponsor request or decision|0|||
131514461|NCT00048542|473513080|FG007|Double-Blind Phase|Sponsor request or decision|0|||
131514462|NCT00048542|473513073|FG000|Double-Blind Phase|Randomized in error|1|||
131514463|NCT00048542|473513074|FG001|Double-Blind Phase|Randomized in error|0|||
131514464|NCT00048542|473513075|FG002|Double-Blind Phase|Randomized in error|0|||
131514465|NCT00048542|473513076|FG003|Double-Blind Phase|Randomized in error|0|||
131514466|NCT00048542|473513077|FG004|Double-Blind Phase|Randomized in error|0|||
131514467|NCT00048542|473513078|FG005|Double-Blind Phase|Randomized in error|0|||
131514468|NCT00048542|473513079|FG006|Double-Blind Phase|Randomized in error|0|||
131514469|NCT00048542|473513080|FG007|Double-Blind Phase|Randomized in error|0|||
131514470|NCT00048542|473513073|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
131514471|NCT00048542|473513074|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
131514472|NCT00048542|473513075|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
131514473|NCT00048542|473513076|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
131514474|NCT00048542|473513077|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
131514475|NCT00048542|473513078|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
131514476|NCT00048542|473513079|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
131514477|NCT00048542|473513080|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
131514478|NCT00048542|473513073|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514479|NCT00048542|473513074|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514480|NCT00048542|473513075|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514481|NCT00048542|473513076|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514482|NCT00048542|473513077|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514483|NCT00048542|473513078|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
131514484|NCT00048542|473513079|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514485|NCT00048542|473513080|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
131514486|NCT00048542|473513073|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
131514487|NCT00048542|473513074|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
131514488|NCT00048542|473513075|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
131514489|NCT00048542|473513076|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
131514490|NCT00048542|473513077|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
131514491|NCT00048542|473513078|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
131514492|NCT00048542|473513079|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
131514493|NCT00048542|473513080|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
131514494|NCT00048542|473513073|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
131514495|NCT00048542|473513074|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
131514496|NCT00048542|473513075|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
131514497|NCT00048542|473513076|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
131514498|NCT00048542|473513077|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
131514499|NCT00048542|473513078|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
131514500|NCT00048542|473513079|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
131514501|NCT00048542|473513080|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
131514502|NCT00048542|473513073|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
131514503|NCT00048542|473513074|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
131514504|NCT00048542|473513075|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
131514505|NCT00048542|473513076|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
131514506|NCT00048542|473513077|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
131514507|NCT00048542|473513078|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
131514508|NCT00048542|473513079|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
131514509|NCT00048542|473513080|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
131514510|NCT00048542|473513073|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131514511|NCT00048542|473513074|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131514512|NCT00048542|473513075|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131514513|NCT00048542|473513076|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131514514|NCT00048542|473513077|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131514515|NCT00048542|473513078|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131514516|NCT00048542|473513079|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
131514517|NCT00048542|473513080|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
131514518|NCT00048542|473513073|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131514519|NCT00048542|473513074|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131514520|NCT00048542|473513075|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131514521|NCT00048542|473513076|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131514522|NCT00048542|473513077|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131514523|NCT00048542|473513078|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131514524|NCT00048542|473513079|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
131514525|NCT00048542|473513080|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
131514526|NCT00048542|473513073|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
131514527|NCT00048542|473513074|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
131514528|NCT00048542|473513075|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
131514529|NCT00048542|473513076|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
131514530|NCT00048542|473513077|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
131514531|NCT00048542|473513078|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
131514532|NCT00048542|473513079|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
131514533|NCT00048542|473513080|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
131514534|NCT00048542|473513073|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
131514535|NCT00048542|473513074|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
131514536|NCT00048542|473513075|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
131514537|NCT00048542|473513076|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
131514538|NCT00048542|473513077|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
131514539|NCT00048542|473513078|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
131514540|NCT00048542|473513079|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
131514541|NCT00048542|473513080|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
131514542|NCT00048542|473513073|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
131514543|NCT00048542|473513074|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
131514544|NCT00048542|473513075|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
131514545|NCT00048542|473513076|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
131514546|NCT00048542|473513077|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
131514547|NCT00048542|473513078|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
131514548|NCT00048542|473513079|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
131514549|NCT00048542|473513080|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
131514550|NCT00048542|473513073|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
131514551|NCT00048542|473513074|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
131514552|NCT00048542|473513075|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
131514553|NCT00048542|473513076|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
131514554|NCT00048542|473513077|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
131514555|NCT00048542|473513078|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
131514556|NCT00048542|473513079|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
131514557|NCT00048542|473513080|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
131514558|NCT01869192|473513081|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
131514559|NCT01869192|473513082|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
131514560|NCT01869192|473513081|FG000|Postoperative Chemotherapy|Physician Decision|0|||
131514561|NCT01869192|473513082|FG001|Postoperative Chemotherapy|Physician Decision|2|||
131514562|NCT00235872|473513086|FG000|Overall Study|Adverse Event|34|||
131514563|NCT00235872|473513086|FG000|Overall Study|Death|1|||
131514564|NCT00235872|473513086|FG000|Overall Study|Lost to Follow-up|1|||
131514565|NCT00235872|473513086|FG000|Overall Study|Withdrawal by Subject|50|||
131514566|NCT00235872|473513086|FG000|Overall Study|Administrative reason|61|||
131514567|NCT02126969|473513088|FG000|Overall Study|Withdrawal by Subject|1|||
131514568|NCT02126969|473513089|FG001|Overall Study|Withdrawal by Subject|2|||
131514569|NCT00423891|473513090|FG000|Enrolled|Withdrawal by Subject|0|||
131514570|NCT00423891|473513091|FG001|Enrolled|Withdrawal by Subject|0|||
131514571|NCT00423891|473513092|FG002|Enrolled|Withdrawal by Subject|1|||
131514572|NCT00423891|473513090|FG000|Enrolled|Lost to Follow-up|0|||
131514573|NCT00423891|473513091|FG001|Enrolled|Lost to Follow-up|0|||
131514574|NCT00423891|473513092|FG002|Enrolled|Lost to Follow-up|1|||
131514575|NCT00423891|473513090|FG000|Enrolled|No longer met criteria|11|||
131514576|NCT00423891|473513091|FG001|Enrolled|No longer met criteria|2|||
131514577|NCT00423891|473513092|FG002|Enrolled|No longer met criteria|1|||
131514578|NCT00423891|473513090|FG000|Treatment|Withdrawal by Subject|1|||
131514579|NCT00423891|473513091|FG001|Treatment|Withdrawal by Subject|0|||
131514580|NCT00423891|473513092|FG002|Treatment|Withdrawal by Subject|0|||
131514581|NCT00423891|473513090|FG000|Treatment|Lost to Follow-up|1|||
131514582|NCT00423891|473513091|FG001|Treatment|Lost to Follow-up|0|||
131514583|NCT00423891|473513092|FG002|Treatment|Lost to Follow-up|0|||
131514584|NCT00423891|473513090|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
131514585|NCT00423891|473513091|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
131514586|NCT00423891|473513092|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
131514587|NCT00423891|473513090|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
131514588|NCT00423891|473513091|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
131514589|NCT00423891|473513092|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
131514590|NCT00696137|473513105|FG000|Overall Study|Withdrawal by Subject|2|||
131514591|NCT00785486|473513109|FG000|Midazolam Alone|Withdrawal by Subject|1|||
131514592|NCT01640366|473513113|FG000|Overall Study|Withdrawal by Subject|1|||
131514593|NCT01640366|473513113|FG000|Overall Study|Protocol Violation|16|||
131514594|NCT01640366|473513113|FG000|Overall Study|Lost to Follow-up|5|||
131514595|NCT00603746|473513116|FG000|Overall Study|Adverse Event|2|||
131514596|NCT00603746|473513117|FG001|Overall Study|Adverse Event|3|||
131514597|NCT00603746|473513118|FG002|Overall Study|Adverse Event|0|||
131514598|NCT00603746|473513119|FG003|Overall Study|Adverse Event|1|||
131514599|NCT00603746|473513120|FG004|Overall Study|Adverse Event|0|||
131514600|NCT00603746|473513121|FG005|Overall Study|Adverse Event|4|||
131514601|NCT00603746|473513116|FG000|Overall Study|Lack of Efficacy|34|||
131514602|NCT00603746|473513117|FG001|Overall Study|Lack of Efficacy|11|||
131514603|NCT00603746|473513118|FG002|Overall Study|Lack of Efficacy|6|||
131514604|NCT00603746|473513119|FG003|Overall Study|Lack of Efficacy|11|||
131514605|NCT00603746|473513120|FG004|Overall Study|Lack of Efficacy|12|||
131514606|NCT00603746|473513121|FG005|Overall Study|Lack of Efficacy|8|||
131514607|NCT00603746|473513116|FG000|Overall Study|Protocol Violation|0|||
131514608|NCT00603746|473513117|FG001|Overall Study|Protocol Violation|3|||
131514609|NCT00603746|473513118|FG002|Overall Study|Protocol Violation|1|||
131514610|NCT00603746|473513119|FG003|Overall Study|Protocol Violation|0|||
131514611|NCT00603746|473513120|FG004|Overall Study|Protocol Violation|1|||
131514612|NCT00603746|473513121|FG005|Overall Study|Protocol Violation|0|||
131514613|NCT00603746|473513116|FG000|Overall Study|Lost to Follow-up|0|||
131514614|NCT00603746|473513117|FG001|Overall Study|Lost to Follow-up|1|||
131514615|NCT00603746|473513118|FG002|Overall Study|Lost to Follow-up|1|||
131514616|NCT00603746|473513119|FG003|Overall Study|Lost to Follow-up|0|||
131514617|NCT00603746|473513120|FG004|Overall Study|Lost to Follow-up|0|||
131514618|NCT00603746|473513121|FG005|Overall Study|Lost to Follow-up|0|||
131514619|NCT00603746|473513116|FG000|Overall Study|Physician Decision|1|||
131514620|NCT00603746|473513117|FG001|Overall Study|Physician Decision|0|||
131514621|NCT00603746|473513118|FG002|Overall Study|Physician Decision|0|||
131514622|NCT00603746|473513119|FG003|Overall Study|Physician Decision|0|||
131514623|NCT00603746|473513120|FG004|Overall Study|Physician Decision|1|||
131514624|NCT00603746|473513121|FG005|Overall Study|Physician Decision|0|||
131514625|NCT00603746|473513116|FG000|Overall Study|Withdrawal by Subject|1|||
131514626|NCT00603746|473513117|FG001|Overall Study|Withdrawal by Subject|0|||
131514627|NCT00603746|473513118|FG002|Overall Study|Withdrawal by Subject|0|||
131514628|NCT00603746|473513119|FG003|Overall Study|Withdrawal by Subject|1|||
131514629|NCT00603746|473513120|FG004|Overall Study|Withdrawal by Subject|3|||
131514630|NCT00603746|473513121|FG005|Overall Study|Withdrawal by Subject|1|||
131514631|NCT01524627|473513126|FG000|Overall Study|Physician Decision|0|||
131514632|NCT01524627|473513127|FG001|Overall Study|Physician Decision|1|||
131514633|NCT01524627|473513126|FG000|Overall Study|Lost to Follow-up|1|||
131514634|NCT01524627|473513127|FG001|Overall Study|Lost to Follow-up|1|||
131514635|NCT03323658|473513128|FG000|Overall Study|Adverse Event|0|||
131514636|NCT03323658|473513129|FG001|Overall Study|Adverse Event|1|||
131514637|NCT03323658|473513130|FG002|Overall Study|Adverse Event|0|||
131514638|NCT00256698|473513138|FG000|Overall Study|Withdrawal by Subject|7|||
131514639|NCT00256698|473513139|FG001|Overall Study|Withdrawal by Subject|7|||
131514640|NCT00256698|473513138|FG000|Overall Study|Adverse Event|13|||
131514641|NCT00256698|473513139|FG001|Overall Study|Adverse Event|6|||
131514642|NCT00256698|473513138|FG000|Overall Study|Protocol Violation|6|||
131514643|NCT00256698|473513139|FG001|Overall Study|Protocol Violation|5|||
131514644|NCT00256698|473513138|FG000|Overall Study|Lost to Follow-up|1|||
131514645|NCT00256698|473513139|FG001|Overall Study|Lost to Follow-up|3|||
131514646|NCT00256698|473513138|FG000|Overall Study|disease progression|97|||
131514647|NCT00256698|473513139|FG001|Overall Study|disease progression|105|||
131514648|NCT00256698|473513138|FG000|Overall Study|still ongoing at data cut-off|41|||
131514649|NCT00256698|473513139|FG001|Overall Study|still ongoing at data cut-off|46|||
131514650|NCT00256698|473513138|FG000|Overall Study|withdrawn due to osteoporosis|1|||
131514651|NCT00256698|473513139|FG001|Overall Study|withdrawn due to osteoporosis|0|||
131514652|NCT00256698|473513138|FG000|Overall Study|Prematurely Discontinued|1|||
131514653|NCT00256698|473513139|FG001|Overall Study|Prematurely Discontinued|0|||
131514654|NCT00403273|473515155|FG000|Overall Study|Lost to Follow-up|3|||
131514655|NCT00403273|473515156|FG001|Overall Study|Lost to Follow-up|2|||
131514656|NCT00403273|473515155|FG000|Overall Study|Physician Decision|0|||
131514657|NCT00403273|473515156|FG001|Overall Study|Physician Decision|1|||
131514658|NCT00403273|473515155|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
131514659|NCT00403273|473515156|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
131514660|NCT02388737|473515157|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
131514661|NCT02388737|473515158|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
131514662|NCT02388737|473515159|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
131514663|NCT02388737|473515157|FG000|Overall Study|Major Protocol Deviation|18|||
131514664|NCT02388737|473515158|FG001|Overall Study|Major Protocol Deviation|25|||
131514665|NCT02388737|473515159|FG002|Overall Study|Major Protocol Deviation|22|||
131514666|NCT02388737|473515157|FG000|Overall Study|Lost to Follow-up|5|||
131514667|NCT02388737|473515158|FG001|Overall Study|Lost to Follow-up|1|||
131514668|NCT02388737|473515159|FG002|Overall Study|Lost to Follow-up|4|||
131514669|NCT02388737|473515157|FG000|Overall Study|Voluntary Withdrawal|10|||
131514670|NCT02388737|473515158|FG001|Overall Study|Voluntary Withdrawal|18|||
131514671|NCT02388737|473515159|FG002|Overall Study|Voluntary Withdrawal|17|||
131514672|NCT02388737|473515157|FG000|Overall Study|Lack of Efficacy|3|||
131514673|NCT02388737|473515158|FG001|Overall Study|Lack of Efficacy|0|||
131514674|NCT02388737|473515159|FG002|Overall Study|Lack of Efficacy|3|||
131514675|NCT02388737|473515157|FG000|Overall Study|Reason Not Specified|5|||
131514676|NCT02388737|473515158|FG001|Overall Study|Reason Not Specified|5|||
131514677|NCT02388737|473515159|FG002|Overall Study|Reason Not Specified|4|||
131514678|NCT01920932|473515160|FG000|Overall Study|Death|1|||
131514679|NCT01920932|473515160|FG000|Overall Study|Withdrawal of consent|1|||
131514680|NCT01816139|473515161|FG000|Overall Study|Adverse Event|6|||
131514681|NCT01816139|473515162|FG001|Overall Study|Adverse Event|8|||
131514682|NCT01816139|473515161|FG000|Overall Study|Lack of Efficacy|1|||
131514683|NCT01816139|473515162|FG001|Overall Study|Lack of Efficacy|2|||
131514684|NCT01816139|473515161|FG000|Overall Study|Lost to Follow-up|5|||
131514685|NCT01816139|473515162|FG001|Overall Study|Lost to Follow-up|3|||
131514686|NCT01816139|473515161|FG000|Overall Study|Withdrew Consent|6|||
131514687|NCT01816139|473515162|FG001|Overall Study|Withdrew Consent|4|||
131514688|NCT01816139|473515161|FG000|Overall Study|Protocol Violation|6|||
131514689|NCT01816139|473515162|FG001|Overall Study|Protocol Violation|3|||
131514690|NCT01816139|473515161|FG000|Overall Study|Reason not Specified|4|||
131514691|NCT01816139|473515162|FG001|Overall Study|Reason not Specified|2|||
131514692|NCT02342704|473515165|FG000|Overall Study|Physician Decision|0|||
131514693|NCT02342704|473515166|FG001|Overall Study|Physician Decision|3|||
131514694|NCT02342704|473515165|FG000|Overall Study|Sponsor Termination|49|||
131514695|NCT02342704|473515166|FG001|Overall Study|Sponsor Termination|43|||
131514696|NCT02342704|473515165|FG000|Overall Study|Other|0|||
131514697|NCT02342704|473515166|FG001|Overall Study|Other|1|||
131514698|NCT02342704|473515165|FG000|Overall Study|Withdrawal by Subject|1|||
131514699|NCT02342704|473515166|FG001|Overall Study|Withdrawal by Subject|0|||
131514700|NCT02342704|473515165|FG000|Overall Study|Lost to Follow-up|2|||
131514701|NCT02342704|473515166|FG001|Overall Study|Lost to Follow-up|1|||
131514702|NCT02342704|473515165|FG000|Overall Study|Adverse Event|1|||
131514703|NCT02342704|473515166|FG001|Overall Study|Adverse Event|3|||
131514704|NCT02347527|473515167|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
131514705|NCT02347527|473515168|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
131514706|NCT02347527|473515169|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
131514707|NCT02347527|473515170|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
131514708|NCT02347527|473515167|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
131514709|NCT02347527|473515168|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
131514710|NCT02347527|473515169|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
131514711|NCT02347527|473515170|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
131514712|NCT02347527|473515167|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
131514713|NCT02347527|473515168|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
131514714|NCT02347527|473515169|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
131514715|NCT02347527|473515170|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
131514716|NCT02347527|473515167|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
131514717|NCT02347527|473515168|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
131514718|NCT02347527|473515169|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
131514719|NCT02347527|473515170|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
131514720|NCT02347527|473515167|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
131514721|NCT02347527|473515168|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
131514722|NCT02347527|473515169|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
131514723|NCT02347527|473515170|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
131514724|NCT00302003|473515172|FG000|Overall Study|Lack of Efficacy|62|||
131514725|NCT00302003|473515172|FG000|Overall Study|Lost to Follow-up|1|||
131514726|NCT00302003|473515172|FG000|Overall Study|Physician Decision|2|||
131514727|NCT00302003|473515172|FG000|Overall Study|Withdrawal by Subject|5|||
131514728|NCT00302003|473515172|FG000|Overall Study|Ineligible|9|||
131514729|NCT00302003|473515172|FG000|Overall Study|Protocol Violation|1|||
131514730|NCT00283439|473515173|FG000|Overall Study|Adverse Event|0|||
131514731|NCT00283439|473515174|FG001|Overall Study|Adverse Event|0|||
131514732|NCT00283439|473515175|FG002|Overall Study|Adverse Event|0|||
131514733|NCT00283439|473515176|FG003|Overall Study|Adverse Event|1|||
131514734|NCT00283439|473515173|FG000|Overall Study|Death|0|||
131514735|NCT00283439|473515174|FG001|Overall Study|Death|0|||
131514736|NCT00283439|473515175|FG002|Overall Study|Death|1|||
131514737|NCT00283439|473515176|FG003|Overall Study|Death|0|||
131514738|NCT00283439|473515173|FG000|Overall Study|Disease progression|0|||
131514739|NCT00283439|473515174|FG001|Overall Study|Disease progression|1|||
131514740|NCT00283439|473515175|FG002|Overall Study|Disease progression|0|||
131514741|NCT00283439|473515176|FG003|Overall Study|Disease progression|0|||
131514742|NCT00283439|473515173|FG000|Overall Study|Requirement for alternative therapy|1|||
131514743|NCT00283439|473515174|FG001|Overall Study|Requirement for alternative therapy|2|||
131514744|NCT00283439|473515175|FG002|Overall Study|Requirement for alternative therapy|5|||
131514745|NCT00283439|473515176|FG003|Overall Study|Requirement for alternative therapy|2|||
131514746|NCT00283439|473515173|FG000|Overall Study|Stem cell transplant|6|||
131514747|NCT00283439|473515174|FG001|Overall Study|Stem cell transplant|6|||
131514748|NCT00283439|473515175|FG002|Overall Study|Stem cell transplant|4|||
131514749|NCT00283439|473515176|FG003|Overall Study|Stem cell transplant|3|||
131514750|NCT00283439|473515173|FG000|Overall Study|Treatment discontinued|0|||
131514751|NCT00283439|473515174|FG001|Overall Study|Treatment discontinued|2|||
131514752|NCT00283439|473515175|FG002|Overall Study|Treatment discontinued|1|||
131514753|NCT00283439|473515176|FG003|Overall Study|Treatment discontinued|3|||
131514754|NCT00283439|473515173|FG000|Overall Study|Other|1|||
131514755|NCT00283439|473515174|FG001|Overall Study|Other|0|||
131514756|NCT00283439|473515175|FG002|Overall Study|Other|0|||
131514757|NCT00283439|473515176|FG003|Overall Study|Other|0|||
131514758|NCT02042924|473515177|FG000|Overall Study|Early Death|1|||
131514759|NCT01632891|473515178|FG000|Overall Study|Lost to Follow-up|0|||
131514760|NCT01632891|473515179|FG001|Overall Study|Lost to Follow-up|1|||
131514761|NCT01632891|473515178|FG000|Overall Study|Withdrawal by Subject|1|||
131514762|NCT01632891|473515179|FG001|Overall Study|Withdrawal by Subject|0|||
131514763|NCT02919670|473515180|FG000|Overall Study|Only 17 participants met compliance|43|||
131514764|NCT02919670|473515181|FG001|Overall Study|Only 17 participants met compliance|39|||
131514765|NCT00240071|473515182|FG000|Overall Study|Withdrawal by Subject|3|||
131514766|NCT01466270|473515183|FG000|Overall Study|Withdrawal by Subject|4|||
131514767|NCT01466270|473515184|FG001|Overall Study|Withdrawal by Subject|1|||
131514768|NCT01466270|473515183|FG000|Overall Study|Physician Decision|1|||
131514769|NCT01466270|473515184|FG001|Overall Study|Physician Decision|0|||
131514770|NCT01466270|473515183|FG000|Overall Study|Lost to Follow-up|1|||
131514771|NCT01466270|473515184|FG001|Overall Study|Lost to Follow-up|3|||
131514772|NCT01466270|473515183|FG000|Overall Study|Progression|1|||
131514773|NCT01466270|473515184|FG001|Overall Study|Progression|0|||
131514774|NCT01466270|473515183|FG000|Overall Study|Toxicity|4|||
131514775|NCT01466270|473515184|FG001|Overall Study|Toxicity|1|||
131514776|NCT01466270|473515183|FG000|Overall Study|Multiple|1|||
131514777|NCT01466270|473515184|FG001|Overall Study|Multiple|1|||
131514778|NCT04206293|473515189|FG000|Overall Study|Consent withdrawal|1|||
131514779|NCT01454934|473515194|FG000|Overall Study|Clinical progression|28|||
131514780|NCT01454934|473515195|FG001|Overall Study|Clinical progression|25|||
131514781|NCT01454934|473515194|FG000|Overall Study|Other|6|||
131514782|NCT01454934|473515195|FG001|Overall Study|Other|17|||
131514783|NCT01454934|473515194|FG000|Overall Study|Adverse Event|28|||
131514784|NCT01454934|473515195|FG001|Overall Study|Adverse Event|24|||
131514785|NCT01454934|473515194|FG000|Overall Study|Withdrawn consent|2|||
131514786|NCT01454934|473515195|FG001|Overall Study|Withdrawn consent|5|||
131514787|NCT01454934|473515194|FG000|Overall Study|Withdrawal by Subject|11|||
131514788|NCT01454934|473515195|FG001|Overall Study|Withdrawal by Subject|15|||
131514789|NCT01454934|473515194|FG000|Overall Study|Disease progression|194|||
131514790|NCT01454934|473515195|FG001|Overall Study|Disease progression|181|||
131514791|NCT01454934|473515194|FG000|Overall Study|Lost to Follow-up|0|||
131514792|NCT01454934|473515195|FG001|Overall Study|Lost to Follow-up|1|||
131514793|NCT01454934|473515194|FG000|Overall Study|Not treated|1|||
131514794|NCT01454934|473515195|FG001|Overall Study|Not treated|2|||
131514795|NCT00430092|473515196|FG000|Overall Study|Adverse Event|0|||
131514796|NCT00430092|473515197|FG001|Overall Study|Adverse Event|0|||
131514797|NCT00430092|473515198|FG002|Overall Study|Adverse Event|1|||
131514798|NCT00430092|473515196|FG000|Overall Study|Lack of Efficacy|5|||
131514799|NCT00430092|473515197|FG001|Overall Study|Lack of Efficacy|2|||
131514800|NCT00430092|473515198|FG002|Overall Study|Lack of Efficacy|54|||
131514801|NCT00430092|473515196|FG000|Overall Study|Lost to Follow-up|1|||
131514802|NCT00430092|473515197|FG001|Overall Study|Lost to Follow-up|0|||
131514803|NCT00430092|473515198|FG002|Overall Study|Lost to Follow-up|0|||
131514804|NCT00430092|473515196|FG000|Overall Study|Protocol Violation|0|||
131514805|NCT00430092|473515197|FG001|Overall Study|Protocol Violation|1|||
131514806|NCT00430092|473515198|FG002|Overall Study|Protocol Violation|1|||
131514807|NCT00430092|473515196|FG000|Overall Study|Withdrawal by Subject|0|||
131514808|NCT00430092|473515197|FG001|Overall Study|Withdrawal by Subject|1|||
131514809|NCT00430092|473515198|FG002|Overall Study|Withdrawal by Subject|1|||
131514810|NCT02118428|473515199|FG000|Overall Study|Physician Decision|0|||
131514811|NCT02118428|473515200|FG001|Overall Study|Physician Decision|1|||
131514812|NCT02118428|473515201|FG002|Overall Study|Physician Decision|0|||
131514813|NCT02118428|473515199|FG000|Overall Study|Withdrawal by Subject|2|||
131514814|NCT02118428|473515200|FG001|Overall Study|Withdrawal by Subject|2|||
131514815|NCT02118428|473515201|FG002|Overall Study|Withdrawal by Subject|0|||
131514816|NCT02118428|473515199|FG000|Overall Study|Death|7|||
131514817|NCT02118428|473515200|FG001|Overall Study|Death|5|||
131514818|NCT02118428|473515201|FG002|Overall Study|Death|0|||
131514819|NCT02118428|473515199|FG000|Overall Study|Lost to Follow-up|3|||
131514820|NCT02118428|473515200|FG001|Overall Study|Lost to Follow-up|1|||
131514821|NCT02118428|473515201|FG002|Overall Study|Lost to Follow-up|0|||
131514822|NCT02118428|473515199|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
131514823|NCT02118428|473515200|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
131514824|NCT02118428|473515201|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
131514825|NCT00578175|473515214|FG000|Overall Study|Adverse Event|0|||
131514826|NCT00578175|473515215|FG001|Overall Study|Adverse Event|1|||
131514827|NCT00578175|473515216|FG002|Overall Study|Adverse Event|1|||
131514828|NCT00578175|473515214|FG000|Overall Study|Other reasons|70|||
131514829|NCT00578175|473515215|FG001|Overall Study|Other reasons|42|||
131514830|NCT00578175|473515216|FG002|Overall Study|Other reasons|23|||
131514831|NCT04225923|473515220|FG000|Overall Study|Protocol Violation|1|||
131514832|NCT04225923|473515221|FG001|Overall Study|Protocol Violation|0|||
131514833|NCT04225923|473515222|FG002|Overall Study|Protocol Violation|1|||
131514834|NCT04225923|473515220|FG000|Overall Study|Withdrawal by Subject|4|||
131514835|NCT04225923|473515221|FG001|Overall Study|Withdrawal by Subject|1|||
131514836|NCT04225923|473515222|FG002|Overall Study|Withdrawal by Subject|3|||
131514837|NCT04225923|473515220|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
131514838|NCT04225923|473515221|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
131514839|NCT04225923|473515222|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
131514840|NCT01417481|473515223|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131514841|NCT01417481|473515224|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
131514842|NCT00855309|473515225|FG000|Overall Study|patient never recieved drug|1|||
131514843|NCT00855309|473515226|FG001|Overall Study|patient never recieved drug|0|||
131514844|NCT00829296|473515227|FG000|Overall Study|Adverse Event|5|||
131514845|NCT00829296|473515228|FG001|Overall Study|Adverse Event|4|||
131514846|NCT03029624|473515229|FG000|Overall Study|Adverse Event|1|||
131514847|NCT03029624|473515229|FG000|Overall Study|Withdrawal by Subject|1|||
131514848|NCT03029624|473515229|FG000|Overall Study|Lack of Efficacy|1|||
131514849|NCT03029624|473515229|FG000|Overall Study|MRI need|2|||
131514850|NCT01077960|473515233|FG000|Overall Study|Adverse Event|6|||
131514851|NCT01077960|473515233|FG000|Overall Study|Protocol Violation|3|||
131514852|NCT01077960|473515233|FG000|Overall Study|Lost to Follow-up|5|||
131514853|NCT01077960|473515233|FG000|Overall Study|Subject decision|1|||
131514854|NCT01077960|473515233|FG000|Overall Study|Reason unspecified|1|||
131514855|NCT03837899|473515234|FG000|Overall Study|Death|6|||
131514856|NCT03837899|473515235|FG001|Overall Study|Death|8|||
131514857|NCT03837899|473515236|FG002|Overall Study|Death|3|||
131514858|NCT03837899|473515237|FG003|Overall Study|Death|7|||
131514859|NCT03837899|473515238|FG004|Overall Study|Death|8|||
131514860|NCT03837899|473515239|FG005|Overall Study|Death|7|||
131514861|NCT03837899|473515234|FG000|Overall Study|Moved to post-trial access program|0|||
131514862|NCT03837899|473515235|FG001|Overall Study|Moved to post-trial access program|1|||
131514863|NCT03837899|473515236|FG002|Overall Study|Moved to post-trial access program|0|||
131514864|NCT03837899|473515237|FG003|Overall Study|Moved to post-trial access program|0|||
131514865|NCT03837899|473515238|FG004|Overall Study|Moved to post-trial access program|0|||
131514866|NCT03837899|473515239|FG005|Overall Study|Moved to post-trial access program|0|||
131514867|NCT03837899|473515234|FG000|Overall Study|Other|0|||
131514868|NCT03837899|473515235|FG001|Overall Study|Other|0|||
131514869|NCT03837899|473515236|FG002|Overall Study|Other|0|||
131514870|NCT03837899|473515237|FG003|Overall Study|Other|0|||
131514871|NCT03837899|473515238|FG004|Overall Study|Other|0|||
131514872|NCT03837899|473515239|FG005|Overall Study|Other|2|||
131514873|NCT03837899|473515234|FG000|Overall Study|Lost to Follow-up|0|||
131514874|NCT03837899|473515235|FG001|Overall Study|Lost to Follow-up|1|||
131514875|NCT03837899|473515236|FG002|Overall Study|Lost to Follow-up|0|||
131514876|NCT03837899|473515237|FG003|Overall Study|Lost to Follow-up|0|||
131514877|NCT03837899|473515238|FG004|Overall Study|Lost to Follow-up|0|||
131514878|NCT03837899|473515239|FG005|Overall Study|Lost to Follow-up|0|||
131514879|NCT03837899|473515234|FG000|Overall Study|Withdrawal by Subject|0|||
131514880|NCT03837899|473515235|FG001|Overall Study|Withdrawal by Subject|0|||
131514881|NCT03837899|473515236|FG002|Overall Study|Withdrawal by Subject|0|||
131514882|NCT03837899|473515237|FG003|Overall Study|Withdrawal by Subject|1|||
131514883|NCT03837899|473515238|FG004|Overall Study|Withdrawal by Subject|0|||
131514884|NCT03837899|473515239|FG005|Overall Study|Withdrawal by Subject|0|||
131514885|NCT03837899|473515234|FG000|Overall Study|Study specific discontinuation criteria|0|||
131514886|NCT03837899|473515235|FG001|Overall Study|Study specific discontinuation criteria|1|||
131514887|NCT03837899|473515236|FG002|Overall Study|Study specific discontinuation criteria|0|||
131514888|NCT03837899|473515237|FG003|Overall Study|Study specific discontinuation criteria|0|||
131514889|NCT03837899|473515238|FG004|Overall Study|Study specific discontinuation criteria|3|||
131514890|NCT03837899|473515239|FG005|Overall Study|Study specific discontinuation criteria|1|||
131514891|NCT01371656|473515240|FG000|Overall Study|Death|7|||
131514892|NCT01371656|473515241|FG001|Overall Study|Death|4|||
131514893|NCT01371656|473515240|FG000|Overall Study|Physician Decision|46|||
131514894|NCT01371656|473515241|FG001|Overall Study|Physician Decision|7|||
131514895|NCT01371656|473515240|FG000|Overall Study|Withdrawal by Subject|7|||
131514896|NCT01371656|473515241|FG001|Overall Study|Withdrawal by Subject|0|||
131514897|NCT01371656|473515240|FG000|Overall Study|Ineligible|4|||
131514898|NCT01371656|473515241|FG001|Overall Study|Ineligible|3|||
131514899|NCT01465464|473515242|FG000|Overall Study|Adverse Event|96|||
131514900|NCT01465464|473515243|FG001|Overall Study|Adverse Event|49|||
131514901|NCT01465464|473515242|FG000|Overall Study|Lack of Efficacy|139|||
131514902|NCT01465464|473515243|FG001|Overall Study|Lack of Efficacy|190|||
131514903|NCT01465464|473515242|FG000|Overall Study|Physician Decision|13|||
131514904|NCT01465464|473515243|FG001|Overall Study|Physician Decision|5|||
131514905|NCT01465464|473515242|FG000|Overall Study|Protocol Violation|1|||
131514906|NCT01465464|473515243|FG001|Overall Study|Protocol Violation|1|||
131514907|NCT01465464|473515242|FG000|Overall Study|Withdrawal by Subject|46|||
131514908|NCT01465464|473515243|FG001|Overall Study|Withdrawal by Subject|30|||
131514909|NCT01465464|473515242|FG000|Overall Study|Other|9|||
131514910|NCT01465464|473515243|FG001|Overall Study|Other|3|||
131514911|NCT01465464|473515242|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
131514912|NCT01465464|473515243|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
131514913|NCT01554618|473515244|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
131514914|NCT01554618|473515245|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
131514915|NCT01554618|473515244|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
131514916|NCT01554618|473515245|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
131514917|NCT01554618|473515244|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
131514918|NCT01554618|473515245|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
131514919|NCT01554618|473515244|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
131514920|NCT01554618|473515245|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
131514921|NCT01554618|473515244|FG000|Open-Label Extension Period|Physician Decision|0|||
131514922|NCT01554618|473515245|FG001|Open-Label Extension Period|Physician Decision|1|||
131514923|NCT01554618|473515244|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
131514924|NCT01554618|473515245|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
131514925|NCT02244580|473515247|FG000|Overall Study|No cancer tissues available|241|||
131514926|NCT01116232|473515248|FG000|Overall Study|Progressive diease|4|||
131514927|NCT04011410|473515251|FG000|Overall Study|Withdrawal by Subject|1|||
131514928|NCT02357940|473515252|FG000|Overall Study|Adverse Event|0|||
131514929|NCT02357940|473515253|FG001|Overall Study|Adverse Event|1|||
131514930|NCT02357940|473515252|FG000|Overall Study|Investigator's judgement|0|||
131514931|NCT02357940|473515253|FG001|Overall Study|Investigator's judgement|1|||
131514932|NCT02275481|473515254|FG000|Overall Study|Death|2|||
131514933|NCT02275481|473515255|FG001|Overall Study|Death|1|||
131514934|NCT02275481|473515254|FG000|Overall Study|Lost to Follow-up|2|||
131514935|NCT02275481|473515255|FG001|Overall Study|Lost to Follow-up|0|||
131514936|NCT02275481|473515254|FG000|Overall Study|Withdrawal by Subject|3|||
131514937|NCT02275481|473515255|FG001|Overall Study|Withdrawal by Subject|0|||
131514938|NCT02275481|473515254|FG000|Overall Study|all other reasons combined|2|||
131514939|NCT02275481|473515255|FG001|Overall Study|all other reasons combined|1|||
131514940|NCT02275481|473515254|FG000|Overall Study|Physician Decision|0|||
131514941|NCT02275481|473515255|FG001|Overall Study|Physician Decision|1|||
131514942|NCT00291668|473515261|FG000|Overall Study|Lack of Efficacy|1|||
131514943|NCT00291668|473515262|FG001|Overall Study|Lack of Efficacy|0|||
131514944|NCT00291668|473515263|FG002|Overall Study|Lack of Efficacy|0|||
131514945|NCT00291668|473515261|FG000|Overall Study|SAE, non-fatal|1|||
131514946|NCT00291668|473515262|FG001|Overall Study|SAE, non-fatal|1|||
131514947|NCT00291668|473515263|FG002|Overall Study|SAE, non-fatal|1|||
131514948|NCT00291668|473515261|FG000|Overall Study|AE, non-serious non-fatal|1|||
131514949|NCT00291668|473515262|FG001|Overall Study|AE, non-serious non-fatal|0|||
131514950|NCT00291668|473515263|FG002|Overall Study|AE, non-serious non-fatal|0|||
131514951|NCT00291668|473515261|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131514952|NCT00291668|473515262|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131514953|NCT00291668|473515263|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131514954|NCT00313612|473515266|FG000|Overall Study|Patient never received treatment|0|||
131514955|NCT00313612|473515267|FG001|Overall Study|Patient never received treatment|1|||
131514956|NCT00451035|473515268|FG000|Overall Study|Disease progression|11|||
131514957|NCT00451035|473515268|FG000|Overall Study|Death|3|||
131514958|NCT00451035|473515268|FG000|Overall Study|New anti-neoplastic therapy|3|||
131514959|NCT03274986|473515271|FG000|Overall Study|Withdrawal by Subject|0|||
131514960|NCT03274986|473515272|FG001|Overall Study|Withdrawal by Subject|1|||
131514961|NCT03274986|473515271|FG000|Overall Study|Lost to Follow-up|0|||
131514962|NCT03274986|473515272|FG001|Overall Study|Lost to Follow-up|1|||
131514963|NCT01393405|473515273|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
131514964|NCT01393405|473515274|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
131514965|NCT01393405|473515275|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
131514966|NCT01393405|473515273|FG000|Induction Period (week1-16)|Adverse Event|16|||
131514967|NCT01393405|473515274|FG001|Induction Period (week1-16)|Adverse Event|0|||
131514968|NCT01393405|473515275|FG002|Induction Period (week1-16)|Adverse Event|0|||
131514969|NCT01393405|473515273|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
131514970|NCT01393405|473515274|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
131514971|NCT01393405|473515275|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
131514972|NCT01393405|473515273|FG000|Maintenance Period Week|Lack of Efficacy|0|||
131514973|NCT01393405|473515274|FG001|Maintenance Period Week|Lack of Efficacy|22|||
131514974|NCT01393405|473515275|FG002|Maintenance Period Week|Lack of Efficacy|22|||
131514975|NCT01393405|473515273|FG000|Maintenance Period Week|Adverse Event|0|||
131514976|NCT01393405|473515274|FG001|Maintenance Period Week|Adverse Event|5|||
131514977|NCT01393405|473515275|FG002|Maintenance Period Week|Adverse Event|2|||
131514978|NCT01393405|473515273|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
131514979|NCT01393405|473515274|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
131514980|NCT01393405|473515275|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
131514981|NCT01393405|473515273|FG000|Maintenance Period Week|Lost to Follow-up|0|||
131514982|NCT01393405|473515274|FG001|Maintenance Period Week|Lost to Follow-up|1|||
131514983|NCT01393405|473515275|FG002|Maintenance Period Week|Lost to Follow-up|0|||
131514984|NCT03350503|473515281|FG000|Overall Study|Adverse Event|5|||
131514985|NCT03350503|473515281|FG000|Overall Study|Withdrawal by Subject|5|||
131514986|NCT03350503|473515281|FG000|Overall Study|Continuation impossible due to move|4|||
131514987|NCT03350503|473515281|FG000|Overall Study|Physician Decision|3|||
131514988|NCT04536727|473515285|FG000|Overall Study|Lost to Follow-up|1|||
131514989|NCT04536727|473515286|FG001|Overall Study|Lost to Follow-up|1|||
131514990|NCT04536727|473515285|FG000|Overall Study|Death|0|||
131514991|NCT04536727|473515286|FG001|Overall Study|Death|1|||
131514992|NCT01399593|473515287|FG000|Overall Study|Physician Decision|1|||
131514993|NCT01399593|473515288|FG001|Overall Study|Physician Decision|0|||
131514994|NCT01399593|473515287|FG000|Overall Study|Adverse Event|1|||
131514995|NCT01399593|473515288|FG001|Overall Study|Adverse Event|0|||
131514996|NCT01399593|473515287|FG000|Overall Study|Death|1|||
131514997|NCT01399593|473515288|FG001|Overall Study|Death|1|||
131514998|NCT01399593|473515287|FG000|Overall Study|Transplantectomy|0|||
131514999|NCT01399593|473515288|FG001|Overall Study|Transplantectomy|1|||
131515000|NCT00344773|473515292|FG000|Overall Study|Adverse Event|2|||
131515001|NCT00344773|473515292|FG000|Overall Study|Objective Disease Progression|16|||
131515002|NCT00344773|473515292|FG000|Overall Study|Withdrawal by Subject|1|||
131515003|NCT00344773|473515292|FG000|Overall Study|Not Eligible for the study|2|||
131515004|NCT00244712|473515299|FG000|Overall Study|Adverse Event|20|||
131515005|NCT00244712|473515300|FG001|Overall Study|Adverse Event|21|||
131515006|NCT00244712|473515299|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
131515007|NCT00244712|473515300|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
131515008|NCT00244712|473515299|FG000|Overall Study|Lack of Compliance|10|||
131515009|NCT00244712|473515300|FG001|Overall Study|Lack of Compliance|11|||
131515010|NCT00244712|473515299|FG000|Overall Study|Lost to Follow-up|45|||
131515011|NCT00244712|473515300|FG001|Overall Study|Lost to Follow-up|52|||
131515012|NCT00244712|473515299|FG000|Overall Study|Withdrawal by Subject|13|||
131515013|NCT00244712|473515300|FG001|Overall Study|Withdrawal by Subject|23|||
131515014|NCT00244712|473515299|FG000|Overall Study|Protocol Violation, disease progression|13|||
131515015|NCT00244712|473515300|FG001|Overall Study|Protocol Violation, disease progression|11|||
131515016|NCT00500370|473515305|FG000|Overall Study|Adverse Event|9|||
131515017|NCT00500370|473515306|FG001|Overall Study|Adverse Event|3|||
131515018|NCT00500370|473515305|FG000|Overall Study|Lost to Follow-up|10|||
131515019|NCT00500370|473515306|FG001|Overall Study|Lost to Follow-up|10|||
131515020|NCT00500370|473515305|FG000|Overall Study|Protocol Violation|2|||
131515021|NCT00500370|473515306|FG001|Overall Study|Protocol Violation|4|||
131515022|NCT00500370|473515305|FG000|Overall Study|Sponsor Decision|2|||
131515023|NCT00500370|473515306|FG001|Overall Study|Sponsor Decision|0|||
131515024|NCT00500370|473515305|FG000|Overall Study|Subject Decision|10|||
131515025|NCT00500370|473515306|FG001|Overall Study|Subject Decision|17|||
131515026|NCT00714259|473515308|FG000|Overall Study|Death|2|||
131515027|NCT04804813|473515309|FG000|Overall Study|Protocol Violation|2|||
131515028|NCT04804813|473515310|FG001|Overall Study|Protocol Violation|0|||
131515029|NCT04804813|473515309|FG000|Overall Study|Withdrawal by Subject|1|||
131515030|NCT04804813|473515310|FG001|Overall Study|Withdrawal by Subject|0|||
131515031|NCT05627518|473515311|FG000|Treatment Period 1|Adverse Event|0|||
131515032|NCT05627518|473515312|FG001|Treatment Period 1|Adverse Event|0|||
131515033|NCT05627518|473515313|FG002|Treatment Period 1|Adverse Event|1|||
131515034|NCT05627518|473515314|FG003|Treatment Period 1|Adverse Event|0|||
131515035|NCT05627518|473515315|FG004|Treatment Period 1|Adverse Event|0|||
131515036|NCT05627518|473515316|FG005|Treatment Period 1|Adverse Event|0|||
131515037|NCT05627518|473515317|FG006|Treatment Period 1|Adverse Event|0|||
131515038|NCT05627518|473515318|FG007|Treatment Period 1|Adverse Event|1|||
131515039|NCT05627518|473515311|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131515040|NCT05627518|473515312|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131515041|NCT05627518|473515313|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131515042|NCT05627518|473515314|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131515043|NCT05627518|473515315|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131515044|NCT05627518|473515316|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131515045|NCT05627518|473515317|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131515046|NCT05627518|473515318|FG007|Treatment Period 1|Withdrawal by Subject|0|||
131515047|NCT05627518|473515311|FG000|Treatment Period 1|Protocol Violation|0|||
131515048|NCT05627518|473515312|FG001|Treatment Period 1|Protocol Violation|0|||
131515049|NCT05627518|473515313|FG002|Treatment Period 1|Protocol Violation|0|||
131515050|NCT05627518|473515314|FG003|Treatment Period 1|Protocol Violation|0|||
131515051|NCT05627518|473515315|FG004|Treatment Period 1|Protocol Violation|0|||
131515052|NCT05627518|473515316|FG005|Treatment Period 1|Protocol Violation|0|||
131515053|NCT05627518|473515317|FG006|Treatment Period 1|Protocol Violation|6|||
131515054|NCT05627518|473515318|FG007|Treatment Period 1|Protocol Violation|6|||
131515055|NCT05627518|473515311|FG000|Treatment Period 2|Adverse Event|1|||
131515056|NCT05627518|473515312|FG001|Treatment Period 2|Adverse Event|0|||
131515057|NCT05627518|473515313|FG002|Treatment Period 2|Adverse Event|0|||
131515058|NCT05627518|473515314|FG003|Treatment Period 2|Adverse Event|0|||
131515059|NCT05627518|473515315|FG004|Treatment Period 2|Adverse Event|0|||
131515060|NCT05627518|473515316|FG005|Treatment Period 2|Adverse Event|0|||
131515061|NCT05627518|473515317|FG006|Treatment Period 2|Adverse Event|0|||
131515062|NCT05627518|473515318|FG007|Treatment Period 2|Adverse Event|0|||
131515063|NCT05627518|473515311|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131515064|NCT05627518|473515312|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131515065|NCT05627518|473515313|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131515066|NCT05627518|473515314|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131515067|NCT05627518|473515315|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131515068|NCT05627518|473515316|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131515069|NCT05627518|473515317|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131515070|NCT05627518|473515318|FG007|Treatment Period 2|Withdrawal by Subject|0|||
131515071|NCT00574405|473516388|FG000|Overall Study|Withdrawal by Subject|3|||
131515072|NCT00574405|473516389|FG001|Overall Study|Withdrawal by Subject|2|||
131515073|NCT01336738|473516390|FG000|Overall Study|Adverse Event|0|||
131515074|NCT01336738|473516391|FG001|Overall Study|Adverse Event|3|||
131515075|NCT01336738|473516392|FG002|Overall Study|Adverse Event|2|||
131515076|NCT01336738|473516393|FG003|Overall Study|Adverse Event|1|||
131515077|NCT01336738|473516394|FG004|Overall Study|Adverse Event|3|||
131515078|NCT01336738|473516390|FG000|Overall Study|Lost to Follow-up|2|||
131515079|NCT01336738|473516391|FG001|Overall Study|Lost to Follow-up|1|||
131515080|NCT01336738|473516392|FG002|Overall Study|Lost to Follow-up|2|||
131515081|NCT01336738|473516393|FG003|Overall Study|Lost to Follow-up|2|||
131515082|NCT01336738|473516394|FG004|Overall Study|Lost to Follow-up|2|||
131515083|NCT01336738|473516390|FG000|Overall Study|Did not meet entrance criteria|0|||
131515084|NCT01336738|473516391|FG001|Overall Study|Did not meet entrance criteria|1|||
131515085|NCT01336738|473516392|FG002|Overall Study|Did not meet entrance criteria|0|||
131515086|NCT01336738|473516393|FG003|Overall Study|Did not meet entrance criteria|0|||
131515087|NCT01336738|473516394|FG004|Overall Study|Did not meet entrance criteria|0|||
131515088|NCT01336738|473516390|FG000|Overall Study|Protocol Violation|0|||
131515089|NCT01336738|473516391|FG001|Overall Study|Protocol Violation|1|||
131515090|NCT01336738|473516392|FG002|Overall Study|Protocol Violation|0|||
131515091|NCT01336738|473516393|FG003|Overall Study|Protocol Violation|0|||
131515092|NCT01336738|473516394|FG004|Overall Study|Protocol Violation|0|||
131515093|NCT01336738|473516390|FG000|Overall Study|Withdrawal by Subject|2|||
131515094|NCT01336738|473516391|FG001|Overall Study|Withdrawal by Subject|0|||
131515095|NCT01336738|473516392|FG002|Overall Study|Withdrawal by Subject|2|||
131515096|NCT01336738|473516393|FG003|Overall Study|Withdrawal by Subject|1|||
131515097|NCT01336738|473516394|FG004|Overall Study|Withdrawal by Subject|1|||
131515098|NCT01336738|473516390|FG000|Overall Study|Other|3|||
131515099|NCT01336738|473516391|FG001|Overall Study|Other|3|||
131515100|NCT01336738|473516392|FG002|Overall Study|Other|2|||
131515101|NCT01336738|473516393|FG003|Overall Study|Other|3|||
131515102|NCT01336738|473516394|FG004|Overall Study|Other|4|||
131515103|NCT03003520|473516395|FG000|Overall Study|Adverse Event|9|||
131515104|NCT03003520|473516396|FG001|Overall Study|Adverse Event|0|||
131515105|NCT03003520|473516395|FG000|Overall Study|Death|1|||
131515106|NCT03003520|473516396|FG001|Overall Study|Death|0|||
131515107|NCT03003520|473516395|FG000|Overall Study|Other reasons|4|||
131515108|NCT03003520|473516396|FG001|Overall Study|Other reasons|0|||
131515109|NCT03003520|473516395|FG000|Overall Study|Withdrawal by Subject|6|||
131515110|NCT03003520|473516396|FG001|Overall Study|Withdrawal by Subject|0|||
131515111|NCT03003520|473516395|FG000|Overall Study|Progressive disease|9|||
131515112|NCT03003520|473516396|FG001|Overall Study|Progressive disease|1|||
131515113|NCT01332149|473516397|FG000|Overall Study|Adverse Event|11|||
131515114|NCT01332149|473516398|FG001|Overall Study|Adverse Event|9|||
131515115|NCT01332149|473516397|FG000|Overall Study|Other unspecified|5|||
131515116|NCT01332149|473516398|FG001|Overall Study|Other unspecified|7|||
131515117|NCT01332149|473516397|FG000|Overall Study|Protocol Violation|1|||
131515118|NCT01332149|473516398|FG001|Overall Study|Protocol Violation|3|||
131515119|NCT01332149|473516397|FG000|Overall Study|Withdrawal by Subject|4|||
131515120|NCT01332149|473516398|FG001|Overall Study|Withdrawal by Subject|5|||
131515121|NCT01332149|473516397|FG000|Overall Study|Lost to Follow-up|1|||
131515122|NCT01332149|473516398|FG001|Overall Study|Lost to Follow-up|1|||
131515123|NCT01332149|473516397|FG000|Overall Study|Insufficient clinical response|4|||
131515124|NCT01332149|473516398|FG001|Overall Study|Insufficient clinical response|7|||
131515125|NCT01332149|473516397|FG000|Overall Study|Did not meet entrance criteria|3|||
131515126|NCT01332149|473516398|FG001|Overall Study|Did not meet entrance criteria|4|||
131515127|NCT01332149|473516397|FG000|Overall Study|Randomized but not treated|1|||
131515128|NCT01332149|473516398|FG001|Overall Study|Randomized but not treated|2|||
131515129|NCT04615949|473516399|FG000|Overall Study|Withdrawal by Subject|2|||
131515130|NCT04615949|473516400|FG001|Overall Study|Withdrawal by Subject|4|||
131515131|NCT04615949|473516399|FG000|Overall Study|Lost to Follow-up|2|||
131515132|NCT04615949|473516400|FG001|Overall Study|Lost to Follow-up|2|||
131515133|NCT04615949|473516399|FG000|Overall Study|Death|0|||
131515134|NCT04615949|473516400|FG001|Overall Study|Death|2|||
131515135|NCT02554656|473516402|FG000|Overall Study|Protocol Violation|3|||
131515136|NCT03240575|473516403|FG000|Overall Study|Adverse Event|0|||
131515137|NCT03240575|473516404|FG001|Overall Study|Adverse Event|2|||
131515138|NCT03240575|473516405|FG002|Overall Study|Adverse Event|0|||
131515139|NCT03240575|473516406|FG003|Overall Study|Adverse Event|1|||
131515140|NCT03240575|473516403|FG000|Overall Study|Withdrawal by Subject|2|||
131515141|NCT03240575|473516404|FG001|Overall Study|Withdrawal by Subject|11|||
131515142|NCT03240575|473516405|FG002|Overall Study|Withdrawal by Subject|0|||
131515143|NCT03240575|473516406|FG003|Overall Study|Withdrawal by Subject|1|||
131515144|NCT03240575|473516403|FG000|Overall Study|Other|0|||
131515145|NCT03240575|473516404|FG001|Overall Study|Other|1|||
131515146|NCT03240575|473516405|FG002|Overall Study|Other|0|||
131515147|NCT03240575|473516406|FG003|Overall Study|Other|0|||
131515148|NCT03568942|473516409|FG000|Overall Study|Family emergency|1|||
131515149|NCT03568942|473516409|FG000|Overall Study|Lost to Follow-up|1|||
131515150|NCT00749463|473516410|FG000|Overall Study|Adverse Event|0|||
131515151|NCT00749463|473516411|FG001|Overall Study|Adverse Event|4|||
131515152|NCT00749463|473516412|FG002|Overall Study|Adverse Event|1|||
131515153|NCT00749463|473516410|FG000|Overall Study|Withdrawal by Subject|1|||
131515154|NCT00749463|473516411|FG001|Overall Study|Withdrawal by Subject|0|||
131515155|NCT00749463|473516412|FG002|Overall Study|Withdrawal by Subject|0|||
131515156|NCT03569371|473516413|FG000|Overall Study|Lack of Efficacy|1|||
131515157|NCT03569371|473516413|FG000|Overall Study|Lost to Follow-up|1|||
131515158|NCT03569371|473516413|FG000|Overall Study|Adverse Event|1|||
131515159|NCT01982253|473516416|FG000|Overall Study|Withdrawal by Subject|1|||
131515160|NCT01982253|473516417|FG001|Overall Study|Withdrawal by Subject|0|||
131515161|NCT01982253|473516418|FG002|Overall Study|Withdrawal by Subject|0|||
131515162|NCT01982253|473516416|FG000|Overall Study|Study terminated by sponsor|1|||
131515163|NCT01982253|473516417|FG001|Overall Study|Study terminated by sponsor|4|||
131515164|NCT01982253|473516418|FG002|Overall Study|Study terminated by sponsor|4|||
131515165|NCT04145895|473516419|FG000|Overall Study|Physician Decision|2|||
131515166|NCT04145895|473516420|FG001|Overall Study|Physician Decision|0|||
131515167|NCT04145895|473516419|FG000|Overall Study|Withdrawal by Subject|0|||
131515168|NCT04145895|473516420|FG001|Overall Study|Withdrawal by Subject|2|||
131515169|NCT01236755|473516422|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
131515170|NCT01236755|473516422|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
131515171|NCT01236755|473516422|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
131515172|NCT01236755|473516422|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
131515173|NCT00913744|473516423|FG000|Overall Study|Adverse Event|2|||
131515174|NCT00913744|473516424|FG001|Overall Study|Adverse Event|0|||
131515175|NCT00913744|473516423|FG000|Overall Study|Withdrawal by Subject|2|||
131515176|NCT00913744|473516424|FG001|Overall Study|Withdrawal by Subject|1|||
131515177|NCT00913744|473516423|FG000|Overall Study|Death|1|||
131515178|NCT00913744|473516424|FG001|Overall Study|Death|0|||
131515179|NCT00805935|473516425|FG000|Overall Study|Stimulation Failure|1|||
131515180|NCT00805935|473516426|FG001|Overall Study|Stimulation Failure|5|||
131515181|NCT00805935|473516427|FG002|Overall Study|Stimulation Failure|2|||
131515182|NCT00805935|473516428|FG003|Overall Study|Stimulation Failure|2|||
131515183|NCT00805935|473516425|FG000|Overall Study|Cycle cancelled|0|||
131515184|NCT00805935|473516426|FG001|Overall Study|Cycle cancelled|0|||
131515185|NCT00805935|473516427|FG002|Overall Study|Cycle cancelled|2|||
131515186|NCT00805935|473516428|FG003|Overall Study|Cycle cancelled|0|||
131515187|NCT00805935|473516425|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
131515188|NCT00805935|473516426|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
131515189|NCT00805935|473516427|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
131515190|NCT00805935|473516428|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
131515191|NCT00805935|473516425|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
131515192|NCT00805935|473516426|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
131515193|NCT00805935|473516427|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
131515194|NCT00805935|473516428|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
131515195|NCT00805935|473516425|FG000|Overall Study|Lost to Follow-up|1|||
131515196|NCT00805935|473516426|FG001|Overall Study|Lost to Follow-up|0|||
131515197|NCT00805935|473516427|FG002|Overall Study|Lost to Follow-up|0|||
131515198|NCT00805935|473516428|FG003|Overall Study|Lost to Follow-up|0|||
131515199|NCT00805935|473516425|FG000|Overall Study|No positive serum pregnancy|8|||
131515200|NCT00805935|473516426|FG001|Overall Study|No positive serum pregnancy|7|||
131515201|NCT00805935|473516427|FG002|Overall Study|No positive serum pregnancy|6|||
131515202|NCT00805935|473516428|FG003|Overall Study|No positive serum pregnancy|5|||
131515203|NCT00805935|473516425|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131515204|NCT00805935|473516426|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131515205|NCT00805935|473516427|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131515206|NCT00805935|473516428|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
131515207|NCT00805935|473516425|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
131515208|NCT00805935|473516426|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
131515209|NCT00805935|473516427|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
131515210|NCT00805935|473516428|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
131515211|NCT00805935|473516425|FG000|Overall Study|Biochemical pregnancy|0|||
131515212|NCT00805935|473516426|FG001|Overall Study|Biochemical pregnancy|1|||
131515213|NCT00805935|473516427|FG002|Overall Study|Biochemical pregnancy|0|||
131515214|NCT00805935|473516428|FG003|Overall Study|Biochemical pregnancy|0|||
131515215|NCT00805935|473516425|FG000|Overall Study|Chemical pregnancy|0|||
131515216|NCT00805935|473516426|FG001|Overall Study|Chemical pregnancy|5|||
131515217|NCT00805935|473516427|FG002|Overall Study|Chemical pregnancy|3|||
131515218|NCT00805935|473516428|FG003|Overall Study|Chemical pregnancy|2|||
131515219|NCT00805935|473516425|FG000|Overall Study|Ectopic pregnancy|0|||
131515220|NCT00805935|473516426|FG001|Overall Study|Ectopic pregnancy|0|||
131515221|NCT00805935|473516427|FG002|Overall Study|Ectopic pregnancy|1|||
131515222|NCT00805935|473516428|FG003|Overall Study|Ectopic pregnancy|0|||
131515223|NCT00805935|473516425|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
131515224|NCT00805935|473516426|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
131515225|NCT00805935|473516427|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
131515226|NCT00805935|473516428|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
131515227|NCT02945410|473516429|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
131515228|NCT02945410|473516430|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
131515229|NCT02945410|473516431|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
131515230|NCT02945410|473516432|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
131515231|NCT02945410|473516433|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
131515232|NCT02945410|473516434|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
131515233|NCT02945410|473516429|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
131515234|NCT02945410|473516430|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
131515235|NCT02945410|473516431|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
131515236|NCT02945410|473516432|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
131515237|NCT02945410|473516433|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
131515238|NCT02945410|473516434|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
131515239|NCT02945410|473516429|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
131515240|NCT02945410|473516430|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
131515241|NCT02945410|473516431|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
131515242|NCT02945410|473516432|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
131515243|NCT02945410|473516433|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
131515244|NCT02945410|473516434|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
131515245|NCT04904185|473516435|FG000|Overall Study|Expansion failure|1|||
131515246|NCT04904185|473516436|FG001|Overall Study|Expansion failure|0|||
131515247|NCT04904185|473516435|FG000|Overall Study|Late response on prior treatment|1|||
131515248|NCT04904185|473516436|FG001|Overall Study|Late response on prior treatment|0|||
131515249|NCT02433834|473516440|FG000|Overall Study|Protocol-specified criteria|7|||
131515250|NCT02433834|473516440|FG000|Overall Study|Protocol Violation|3|||
131515251|NCT02433834|473516440|FG000|Overall Study|Lost to Follow-up|6|||
131515252|NCT02433834|473516440|FG000|Overall Study|Withdrawal by Subject|14|||
131515253|NCT02433834|473516440|FG000|Overall Study|Adverse Event|6|||
131515254|NCT02433834|473516440|FG000|Overall Study|Physician Decision|1|||
131515255|NCT01539226|473516441|FG000|Overall Study|Withdrawal by Subject|24|||
131515256|NCT01539226|473516442|FG001|Overall Study|Withdrawal by Subject|54|||
131515257|NCT01539226|473516441|FG000|Overall Study|Lost to Follow-up|20|||
131515258|NCT01539226|473516442|FG001|Overall Study|Lost to Follow-up|54|||
131515259|NCT01539226|473516441|FG000|Overall Study|Death|1|||
131515260|NCT01539226|473516442|FG001|Overall Study|Death|2|||
131515261|NCT01539226|473516441|FG000|Overall Study|Adverse Event|2|||
131515262|NCT01539226|473516442|FG001|Overall Study|Adverse Event|0|||
131515263|NCT01539226|473516441|FG000|Overall Study|Pregnancy|13|||
131515264|NCT01539226|473516442|FG001|Overall Study|Pregnancy|29|||
131515265|NCT01539226|473516441|FG000|Overall Study|inappropriate enrollment|0|||
131515266|NCT01539226|473516442|FG001|Overall Study|inappropriate enrollment|1|||
131515267|NCT01539226|473516441|FG000|Overall Study|Multiple Reasons|3|||
131515268|NCT01539226|473516442|FG001|Overall Study|Multiple Reasons|1|||
131515269|NCT01539226|473516441|FG000|Overall Study|not HIV seroconversion-related|93|||
131515270|NCT01539226|473516442|FG001|Overall Study|not HIV seroconversion-related|176|||
131515271|NCT01539226|473516441|FG000|Overall Study|HIV seroconversion-related|55|||
131515272|NCT01539226|473516442|FG001|Overall Study|HIV seroconversion-related|80|||
131515273|NCT01539226|473516441|FG000|Overall Study|Non-compliance|6|||
131515274|NCT01539226|473516442|FG001|Overall Study|Non-compliance|8|||
131515275|NCT05288556|473516450|FG000|Overall Study|Protocol Violation|1|||
131515276|NCT05288556|473516450|FG000|Overall Study|Withdrawal by Subject|1|||
131515277|NCT02775344|473516451|FG000|Overall Study|No ovarian cyst identified|3|||
131515278|NCT02775344|473516452|FG001|Overall Study|No ovarian cyst identified|2|||
131515279|NCT04627064|473516453|FG000|Overall Study|Progressive disease|8|||
131515280|NCT04627064|473516454|FG001|Overall Study|Progressive disease|0|||
131515281|NCT04627064|473516453|FG000|Overall Study|Withdrawal by Subject|2|||
131515282|NCT04627064|473516454|FG001|Overall Study|Withdrawal by Subject|0|||
131515283|NCT04627064|473516453|FG000|Overall Study|Physician Decision|1|||
131515284|NCT04627064|473516454|FG001|Overall Study|Physician Decision|0|||
131515285|NCT00414661|473516455|FG000|Overall Study|Death|2|||
131515286|NCT00414661|473516456|FG001|Overall Study|Death|5|||
131515287|NCT00414661|473516457|FG002|Overall Study|Death|0|||
131515288|NCT00414661|473516458|FG003|Overall Study|Death|0|||
131515289|NCT00414661|473516455|FG000|Overall Study|Lost to Follow-up|1|||
131515290|NCT00414661|473516456|FG001|Overall Study|Lost to Follow-up|4|||
131515291|NCT00414661|473516457|FG002|Overall Study|Lost to Follow-up|0|||
131515292|NCT00414661|473516458|FG003|Overall Study|Lost to Follow-up|1|||
131515293|NCT00414661|473516455|FG000|Overall Study|Withdrawal by Subject|5|||
131515294|NCT00414661|473516456|FG001|Overall Study|Withdrawal by Subject|2|||
131515295|NCT00414661|473516457|FG002|Overall Study|Withdrawal by Subject|2|||
131515296|NCT00414661|473516458|FG003|Overall Study|Withdrawal by Subject|2|||
131515297|NCT00414661|473516455|FG000|Overall Study|Other|6|||
131515298|NCT00414661|473516456|FG001|Overall Study|Other|3|||
131515299|NCT00414661|473516457|FG002|Overall Study|Other|0|||
131515300|NCT00414661|473516458|FG003|Overall Study|Other|0|||
131515301|NCT00357370|473516459|FG000|Cohort 2|Lack of Efficacy|0|||
131515302|NCT00357370|473516460|FG001|Cohort 2|Lack of Efficacy|2|||
131515303|NCT00357370|473516461|FG002|Cohort 2|Lack of Efficacy|1|||
131515304|NCT00357370|473516459|FG000|Cohort 2|Adverse Event|1|||
131515305|NCT00357370|473516460|FG001|Cohort 2|Adverse Event|1|||
131515306|NCT00357370|473516461|FG002|Cohort 2|Adverse Event|1|||
131515307|NCT00357370|473516459|FG000|Cohort 2|Lost to Follow-up|0|||
131515308|NCT00357370|473516460|FG001|Cohort 2|Lost to Follow-up|1|||
131515309|NCT00357370|473516461|FG002|Cohort 2|Lost to Follow-up|0|||
131515310|NCT00357370|473516459|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
131515311|NCT00357370|473516460|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
131515312|NCT00357370|473516461|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
131515313|NCT00357370|473516459|FG000|Cohort 2|Withdrawal by Subject|0|||
131515314|NCT00357370|473516460|FG001|Cohort 2|Withdrawal by Subject|2|||
131515315|NCT00357370|473516461|FG002|Cohort 2|Withdrawal by Subject|0|||
131515316|NCT01143090|473516462|FG000|Overall Study|Lack of Efficacy|2|||
131515317|NCT01143090|473516462|FG000|Overall Study|Adverse Event|17|||
131515318|NCT01143090|473516462|FG000|Overall Study|Lost to Follow-up|9|||
131515319|NCT01143090|473516462|FG000|Overall Study|Protocol Violation|2|||
131515320|NCT01143090|473516462|FG000|Overall Study|Withdrawal by Subject|18|||
131515321|NCT01143090|473516462|FG000|Overall Study|Non-compliance with study drug|1|||
131515322|NCT01143090|473516462|FG000|Overall Study|Failure to meet eligibility criteria|1|||
131515323|NCT01143090|473516462|FG000|Overall Study|Administrative|1|||
131515324|NCT01800916|473516463|FG000|Test Period 1 (1 Week)|Convex product user|0|||
131515325|NCT01800916|473516464|FG001|Test Period 1 (1 Week)|Convex product user|0|||
131515326|NCT01800916|473516465|FG002|Test Period 1 (1 Week)|Convex product user|0|||
131515327|NCT01800916|473516466|FG003|Test Period 1 (1 Week)|Convex product user|1|||
131515328|NCT01800916|473516467|FG004|Test Period 1 (1 Week)|Convex product user|0|||
131515329|NCT01800916|473516468|FG005|Test Period 1 (1 Week)|Convex product user|0|||
131515330|NCT01800916|473516469|FG006|Test Period 1 (1 Week)|Convex product user|0|||
131515331|NCT01800916|473516470|FG007|Test Period 1 (1 Week)|Convex product user|0|||
131515332|NCT01800916|473516471|FG008|Test Period 1 (1 Week)|Convex product user|0|||
131515333|NCT01800916|473516463|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
131515334|NCT01800916|473516464|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
131515335|NCT01800916|473516465|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
131515336|NCT01800916|473516466|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
131515337|NCT01800916|473516467|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
131515338|NCT01800916|473516468|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
131515339|NCT01800916|473516469|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
131515340|NCT01800916|473516470|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
131515341|NCT01800916|473516471|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
131515342|NCT01232296|473516472|FG000|Overall Study|Adverse Event|24|||
131515343|NCT01232296|473516473|FG001|Overall Study|Adverse Event|12|||
131515344|NCT01232296|473516472|FG000|Overall Study|Physician Decision|1|||
131515345|NCT01232296|473516473|FG001|Overall Study|Physician Decision|1|||
131515346|NCT01232296|473516472|FG000|Overall Study|Progressive disease|43|||
131515347|NCT01232296|473516473|FG001|Overall Study|Progressive disease|61|||
131515348|NCT01232296|473516472|FG000|Overall Study|Study terminated by sponsor|0|||
131515349|NCT01232296|473516473|FG001|Overall Study|Study terminated by sponsor|1|||
131515350|NCT01232296|473516472|FG000|Overall Study|Technical problems|3|||
131515351|NCT01232296|473516473|FG001|Overall Study|Technical problems|0|||
131515352|NCT01232296|473516472|FG000|Overall Study|Subject/guardian decision|10|||
131515353|NCT01232296|473516473|FG001|Overall Study|Subject/guardian decision|2|||
131515354|NCT01232296|473516472|FG000|Overall Study|Death|1|||
131515355|NCT01232296|473516473|FG001|Overall Study|Death|6|||
131515356|NCT00937547|473516476|FG000|Overall Study|misdiagnosis|1|||
131515357|NCT00937547|473516477|FG001|Overall Study|misdiagnosis|6|||
131515358|NCT00937547|473516478|FG002|Overall Study|misdiagnosis|7|||
131515359|NCT00325234|473516479|FG000|Overall Study|Adverse Event|10|||
131515360|NCT00325234|473516480|FG001|Overall Study|Adverse Event|7|||
131515361|NCT00325234|473516479|FG000|Overall Study|Death due to Study Disease|1|||
131515362|NCT00325234|473516480|FG001|Overall Study|Death due to Study Disease|0|||
131515363|NCT00325234|473516479|FG000|Overall Study|Entry Criteria Not Met|1|||
131515364|NCT00325234|473516480|FG001|Overall Study|Entry Criteria Not Met|2|||
131515365|NCT00325234|473516479|FG000|Overall Study|Subject Decision|6|||
131515366|NCT00325234|473516480|FG001|Overall Study|Subject Decision|8|||
131515367|NCT00325234|473516479|FG000|Overall Study|Physician Decision|17|||
131515368|NCT00325234|473516480|FG001|Overall Study|Physician Decision|12|||
131515369|NCT00325234|473516479|FG000|Overall Study|Progressive Disease|34|||
131515370|NCT00325234|473516480|FG001|Overall Study|Progressive Disease|37|||
131515371|NCT01234467|473516481|FG000|Overall Study|Adverse Event|3|||
131515372|NCT01234467|473516481|FG000|Overall Study|Death|2|||
131515373|NCT01234467|473516481|FG000|Overall Study|Withdrawal by Subject|2|||
131515374|NCT01234467|473516481|FG000|Overall Study|Disease Progression|2|||
131515375|NCT01234467|473516481|FG000|Overall Study|Clinical deterioration|1|||
131515376|NCT01234467|473516481|FG000|Overall Study|Physician Decision|1|||
131515377|NCT01234467|473516481|FG000|Overall Study|Other complicating disease (stroke)|1|||
131515378|NCT00559962|473516484|FG000|Overall Study|Adverse Event|1|||
131515379|NCT00559962|473516485|FG001|Overall Study|Adverse Event|7|||
131515380|NCT00559962|473516486|FG002|Overall Study|Adverse Event|8|||
131515381|NCT00559962|473516487|FG003|Overall Study|Adverse Event|5|||
131515382|NCT00559962|473516488|FG004|Overall Study|Adverse Event|11|||
131515383|NCT00559962|473516489|FG005|Overall Study|Adverse Event|4|||
131515384|NCT00559962|473516490|FG006|Overall Study|Adverse Event|4|||
131515385|NCT00559962|473516491|FG007|Overall Study|Adverse Event|2|||
131515386|NCT00559962|473516484|FG000|Overall Study|Lost to Follow-up|0|||
131515387|NCT00559962|473516485|FG001|Overall Study|Lost to Follow-up|1|||
131515388|NCT00559962|473516486|FG002|Overall Study|Lost to Follow-up|0|||
131515389|NCT00559962|473516487|FG003|Overall Study|Lost to Follow-up|0|||
131515390|NCT00559962|473516488|FG004|Overall Study|Lost to Follow-up|0|||
131515391|NCT00559962|473516489|FG005|Overall Study|Lost to Follow-up|0|||
131515392|NCT00559962|473516490|FG006|Overall Study|Lost to Follow-up|0|||
131515393|NCT00559962|473516491|FG007|Overall Study|Lost to Follow-up|0|||
131515394|NCT00559962|473516484|FG000|Overall Study|Withdrawal by Subject|1|||
131515395|NCT00559962|473516485|FG001|Overall Study|Withdrawal by Subject|1|||
131515396|NCT00559962|473516486|FG002|Overall Study|Withdrawal by Subject|2|||
131515397|NCT00559962|473516487|FG003|Overall Study|Withdrawal by Subject|0|||
131515398|NCT00559962|473516488|FG004|Overall Study|Withdrawal by Subject|3|||
131515399|NCT00559962|473516489|FG005|Overall Study|Withdrawal by Subject|1|||
131515400|NCT00559962|473516490|FG006|Overall Study|Withdrawal by Subject|0|||
131515401|NCT00559962|473516491|FG007|Overall Study|Withdrawal by Subject|2|||
131515402|NCT00559962|473516484|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
131515403|NCT00559962|473516485|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
131515404|NCT00559962|473516486|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
131515405|NCT00559962|473516487|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
131515406|NCT00559962|473516488|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
131515407|NCT00559962|473516489|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
131515408|NCT00559962|473516490|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
131515409|NCT00559962|473516491|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
131515410|NCT01461096|473516492|FG000|Overall Study|Death|3|||
131515411|NCT01461096|473516493|FG001|Overall Study|Death|6|||
131515412|NCT01461096|473516492|FG000|Overall Study|Severe debilitation, unable to continue|1|||
131515413|NCT01461096|473516493|FG001|Overall Study|Severe debilitation, unable to continue|1|||
131515414|NCT01461096|473516492|FG000|Overall Study|Subj not able to get to clinic|15|||
131515415|NCT01461096|473516493|FG001|Overall Study|Subj not able to get to clinic|13|||
131515416|NCT01461096|473516492|FG000|Overall Study|Site is closing|27|||
131515417|NCT01461096|473516493|FG001|Overall Study|Site is closing|30|||
131515418|NCT01461096|473516492|FG000|Overall Study|Withdrawal by Subject|5|||
131515419|NCT01461096|473516493|FG001|Overall Study|Withdrawal by Subject|3|||
131515420|NCT01461096|473516492|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
131515421|NCT01461096|473516493|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
131515422|NCT01461096|473516492|FG000|Overall Study|Lost to Follow-up|8|||
131515423|NCT01461096|473516493|FG001|Overall Study|Lost to Follow-up|4|||
131515424|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
131515425|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
131515426|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
131515427|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
131515428|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
131515429|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
131515430|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
131515431|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
131515432|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
131515433|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
131515434|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
131515435|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
131515436|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
131515437|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
131515438|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
131515439|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
131515440|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
131515441|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
131515442|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Death|0|||
131515443|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Death|0|||
131515444|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Death|1|||
131515445|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Death|0|||
131515446|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Death|0|||
131515447|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Death|0|||
131515448|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Death|0|||
131515449|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Death|0|||
131515450|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Death|0|||
131515451|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
131515452|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
131515453|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
131515454|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
131515455|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
131515456|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
131515457|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
131515458|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
131515459|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
131515460|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
131515461|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
131515462|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
131515463|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
131515464|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
131515465|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
131515466|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
131515467|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
131515468|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
131515469|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
131515470|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
131515471|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
131515472|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
131515473|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
131515474|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
131515475|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
131515476|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
131515477|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
131515478|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
131515479|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
131515480|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
131515481|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
131515482|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
131515483|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
131515484|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
131515485|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
131515486|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
131515487|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
131515488|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
131515489|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
131515490|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
131515491|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
131515492|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
131515493|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
131515494|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
131515495|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
131515496|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515497|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
131515498|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515499|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515500|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515501|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515502|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515503|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515504|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
131515505|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
131515506|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
131515507|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
131515508|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
131515509|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
131515510|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
131515511|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
131515512|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
131515513|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
131515514|NCT00404352|473516494|FG000|Double Blind (up to 24 Month)|Other|0|||
131515515|NCT00404352|473516495|FG001|Double Blind (up to 24 Month)|Other|1|||
131515516|NCT00404352|473516496|FG002|Double Blind (up to 24 Month)|Other|0|||
131515517|NCT00404352|473516497|FG003|Double Blind (up to 24 Month)|Other|0|||
131515518|NCT00404352|473516498|FG004|Double Blind (up to 24 Month)|Other|0|||
131515519|NCT00404352|473516499|FG005|Double Blind (up to 24 Month)|Other|0|||
131515520|NCT00404352|473516500|FG006|Double Blind (up to 24 Month)|Other|0|||
131515521|NCT00404352|473516501|FG007|Double Blind (up to 24 Month)|Other|0|||
131515522|NCT00404352|473516502|FG008|Double Blind (up to 24 Month)|Other|0|||
131515523|NCT00404352|473516494|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
131515524|NCT00404352|473516495|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
131515525|NCT00404352|473516496|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
131515526|NCT00404352|473516497|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
131515527|NCT00404352|473516498|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
131515528|NCT00404352|473516499|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
131515529|NCT00404352|473516500|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
131515530|NCT00404352|473516501|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
131515531|NCT00404352|473516502|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
131515532|NCT00404352|473516494|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
131515533|NCT00404352|473516495|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
131515534|NCT00404352|473516496|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
131515535|NCT00404352|473516497|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
131515536|NCT00404352|473516498|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
131515537|NCT00404352|473516499|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
131515538|NCT00404352|473516500|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
131515539|NCT00404352|473516501|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
131515540|NCT00404352|473516502|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
131515541|NCT00404352|473516494|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515542|NCT00404352|473516495|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515543|NCT00404352|473516496|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515544|NCT00404352|473516497|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515545|NCT00404352|473516498|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
131515546|NCT00404352|473516499|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515547|NCT00404352|473516500|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515548|NCT00404352|473516501|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515549|NCT00404352|473516502|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
131515550|NCT00404352|473516494|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515551|NCT00404352|473516495|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515552|NCT00404352|473516496|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515553|NCT00404352|473516497|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515554|NCT00404352|473516498|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515555|NCT00404352|473516499|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
131515556|NCT00404352|473516500|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515557|NCT00404352|473516501|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515558|NCT00404352|473516502|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
131515559|NCT00404352|473516494|FG000|Open Label (up to 24 Month)|Disease progression|0|||
131515560|NCT00404352|473516495|FG001|Open Label (up to 24 Month)|Disease progression|0|||
131515561|NCT00404352|473516496|FG002|Open Label (up to 24 Month)|Disease progression|0|||
131515562|NCT00404352|473516497|FG003|Open Label (up to 24 Month)|Disease progression|1|||
131515563|NCT00404352|473516498|FG004|Open Label (up to 24 Month)|Disease progression|0|||
131515564|NCT00404352|473516499|FG005|Open Label (up to 24 Month)|Disease progression|0|||
131515565|NCT00404352|473516500|FG006|Open Label (up to 24 Month)|Disease progression|0|||
131515566|NCT00404352|473516501|FG007|Open Label (up to 24 Month)|Disease progression|0|||
131515567|NCT00404352|473516502|FG008|Open Label (up to 24 Month)|Disease progression|0|||
131515568|NCT00404352|473516494|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515569|NCT00404352|473516495|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515570|NCT00404352|473516496|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515571|NCT00404352|473516497|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515572|NCT00404352|473516498|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515573|NCT00404352|473516499|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515574|NCT00404352|473516500|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
131515575|NCT00404352|473516501|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
131515576|NCT00404352|473516502|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
131515577|NCT00404352|473516494|FG000|Open Label Extension (up to 36 Months)|Other|0|||
131515578|NCT00404352|473516495|FG001|Open Label Extension (up to 36 Months)|Other|0|||
131515579|NCT00404352|473516496|FG002|Open Label Extension (up to 36 Months)|Other|0|||
131515580|NCT00404352|473516497|FG003|Open Label Extension (up to 36 Months)|Other|0|||
131515581|NCT00404352|473516498|FG004|Open Label Extension (up to 36 Months)|Other|0|||
131515582|NCT00404352|473516499|FG005|Open Label Extension (up to 36 Months)|Other|0|||
131515583|NCT00404352|473516500|FG006|Open Label Extension (up to 36 Months)|Other|0|||
131515584|NCT00404352|473516501|FG007|Open Label Extension (up to 36 Months)|Other|0|||
131515585|NCT00404352|473516502|FG008|Open Label Extension (up to 36 Months)|Other|2|||
131515586|NCT04370691|473516505|FG000|Overall Study|Pending visit|48|||
131515587|NCT04370691|473516505|FG000|Overall Study|Have Not Reached Lower Window|15|||
131515588|NCT04370691|473516505|FG000|Overall Study|Termination|14|||
131515589|NCT04370691|473516505|FG000|Overall Study|Missed or Overdue|10|||
131515590|NCT00486265|473516509|FG000|Overall Study|Adverse Event|1|||
131515591|NCT00486265|473516509|FG000|Overall Study|Lack of Efficacy|8|||
131515592|NCT03047135|473516510|FG000|Overall Study|Still being treated|3|||
131515593|NCT04365699|473516511|FG000|Overall Study|Death|2|||
131515594|NCT04365699|473516512|FG001|Overall Study|Death|5|||
131515595|NCT04365699|473516513|FG002|Overall Study|Death|15|||
131515596|NCT02540954|473516514|FG000|Overall Study|Physician Decision|3|||
131515597|NCT02540954|473516515|FG001|Overall Study|Physician Decision|1|||
131515598|NCT02540954|473516514|FG000|Overall Study|Withdrawal by Subject|6|||
131515599|NCT02540954|473516515|FG001|Overall Study|Withdrawal by Subject|5|||
131515600|NCT02540954|473516514|FG000|Overall Study|Lost to Follow-up|1|||
131515601|NCT02540954|473516515|FG001|Overall Study|Lost to Follow-up|1|||
131515602|NCT02540954|473516514|FG000|Overall Study|Adverse Event|4|||
131515603|NCT02540954|473516515|FG001|Overall Study|Adverse Event|2|||
131515604|NCT02540954|473516514|FG000|Overall Study|Death|0|||
131515605|NCT02540954|473516515|FG001|Overall Study|Death|3|||
131515606|NCT02540954|473516514|FG000|Overall Study|Treatment failure|1|||
131515607|NCT02540954|473516515|FG001|Overall Study|Treatment failure|0|||
131515608|NCT02540954|473516514|FG000|Overall Study|Other reason|4|||
131515609|NCT02540954|473516515|FG001|Overall Study|Other reason|2|||
131515610|NCT00834912|473516518|FG000|Treatment Period 1|Adverse Event|0|||
131515611|NCT00834912|473516519|FG001|Treatment Period 1|Adverse Event|1|||
131515612|NCT00834912|473516520|FG002|Treatment Period 1|Adverse Event|0|||
131515613|NCT00834912|473516521|FG003|Treatment Period 1|Adverse Event|1|||
131515614|NCT00834912|473516522|FG004|Treatment Period 1|Adverse Event|0|||
131515615|NCT00834912|473516523|FG005|Treatment Period 1|Adverse Event|0|||
131515616|NCT00834912|473516518|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131515617|NCT00834912|473516519|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131515618|NCT00834912|473516520|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131515619|NCT00834912|473516521|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131515620|NCT00834912|473516522|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131515621|NCT00834912|473516523|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131515622|NCT03829046|473516524|FG000|Overall Study|Withdrawal by Subject|1|||
131515623|NCT03829046|473516525|FG001|Overall Study|Withdrawal by Subject|0|||
131515624|NCT02777125|473516528|FG000|Overall Study|Consent form violation|14|||
131515625|NCT02777125|473516529|FG001|Overall Study|Consent form violation|12|||
131515626|NCT02777125|473516528|FG000|Overall Study|Assent form violation|21|||
131515627|NCT02777125|473516529|FG001|Overall Study|Assent form violation|23|||
131515628|NCT02777125|473516528|FG000|Overall Study|Protocol Violation|8|||
131515629|NCT02777125|473516529|FG001|Overall Study|Protocol Violation|12|||
131515630|NCT06023394|473516530|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
131515631|NCT06023394|473516531|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
131515632|NCT06023394|473516530|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
131515633|NCT06023394|473516531|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
131515634|NCT06023394|473516530|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
131515635|NCT06023394|473516531|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
131515636|NCT06023394|473516530|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
131515637|NCT06023394|473516531|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
131515638|NCT01581593|473518133|FG000|Overall Study|Withdrawal by Subject|1|||
131515639|NCT02970968|473518135|FG000|Overall Study|Withdrawal by Subject|3|||
131515640|NCT02970968|473518136|FG001|Overall Study|Withdrawal by Subject|3|||
131515641|NCT02970968|473518135|FG000|Overall Study|Adverse Event|1|||
131515642|NCT02970968|473518136|FG001|Overall Study|Adverse Event|2|||
131515643|NCT02970968|473518135|FG000|Overall Study|Lost to Follow-up|1|||
131515644|NCT02970968|473518136|FG001|Overall Study|Lost to Follow-up|1|||
131515645|NCT02970968|473518135|FG000|Overall Study|Non-Compliance|0|||
131515646|NCT02970968|473518136|FG001|Overall Study|Non-Compliance|1|||
131515647|NCT02565381|473518137|FG000|Overall Study|Lost to Follow-up|1|||
131515648|NCT02565381|473518138|FG001|Overall Study|Lost to Follow-up|0|||
131515649|NCT02565381|473518139|FG002|Overall Study|Lost to Follow-up|1|||
131515650|NCT05084053|473518142|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
131515651|NCT05084053|473518143|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
131515652|NCT05084053|473518144|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
131515653|NCT05084053|473518145|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
131515654|NCT05084053|473518142|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
131515655|NCT05084053|473518143|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
131515656|NCT05084053|473518144|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
131515657|NCT05084053|473518145|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
131515658|NCT05084053|473518142|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
131515659|NCT05084053|473518143|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
131515660|NCT05084053|473518144|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
131515661|NCT05084053|473518145|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
131515662|NCT00071812|473518146|FG000|24-Week Double-Blind Period|Adverse Event|2|||
131515663|NCT00071812|473518147|FG001|24-Week Double-Blind Period|Adverse Event|3|||
131515664|NCT00071812|473518148|FG002|24-Week Double-Blind Period|Adverse Event|4|||
131515665|NCT00071812|473518149|FG003|24-Week Double-Blind Period|Adverse Event|4|||
131515666|NCT00071812|473518146|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
131515667|NCT00071812|473518147|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
131515668|NCT00071812|473518148|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
131515669|NCT00071812|473518149|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
131515670|NCT00071812|473518146|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
131515671|NCT00071812|473518147|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
131515672|NCT00071812|473518148|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
131515673|NCT00071812|473518149|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
131515674|NCT00071812|473518146|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
131515675|NCT00071812|473518147|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
131515676|NCT00071812|473518148|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
131515677|NCT00071812|473518149|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
131515678|NCT00071812|473518146|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
131515679|NCT00071812|473518147|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
131515680|NCT00071812|473518148|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
131515681|NCT00071812|473518149|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
131515682|NCT00071812|473518146|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
131515683|NCT00071812|473518147|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
131515684|NCT00071812|473518148|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
131515685|NCT00071812|473518149|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
131515686|NCT00071812|473518146|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
131515687|NCT00071812|473518147|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
131515688|NCT00071812|473518148|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
131515689|NCT00071812|473518149|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
131515690|NCT00071812|473518146|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
131515691|NCT00071812|473518147|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
131515692|NCT00071812|473518148|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
131515693|NCT00071812|473518149|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
131515694|NCT00071812|473518146|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131515695|NCT00071812|473518147|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131515696|NCT00071812|473518148|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131515697|NCT00071812|473518149|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
131515698|NCT00071812|473518146|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
131515699|NCT00071812|473518147|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
131515700|NCT00071812|473518148|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
131515701|NCT00071812|473518149|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
131515702|NCT04127786|473518152|FG000|Primary Series|Adverse Event|1|||
131515703|NCT04127786|473518153|FG001|Primary Series|Adverse Event|0|||
131515704|NCT04127786|473518154|FG002|Primary Series|Adverse Event|0|||
131515705|NCT04127786|473518155|FG003|Primary Series|Adverse Event|1|||
131515706|NCT04127786|473518156|FG004|Primary Series|Adverse Event|0|||
131515707|NCT04127786|473518157|FG005|Primary Series|Adverse Event|1|||
131515708|NCT04127786|473518152|FG000|Primary Series|Protocol Violation|5|||
131515709|NCT04127786|473518153|FG001|Primary Series|Protocol Violation|3|||
131515710|NCT04127786|473518154|FG002|Primary Series|Protocol Violation|4|||
131515711|NCT04127786|473518155|FG003|Primary Series|Protocol Violation|3|||
131515712|NCT04127786|473518156|FG004|Primary Series|Protocol Violation|2|||
131515713|NCT04127786|473518157|FG005|Primary Series|Protocol Violation|0|||
131515714|NCT04127786|473518152|FG000|Primary Series|Withdrawal by Subject|0|||
131515715|NCT04127786|473518153|FG001|Primary Series|Withdrawal by Subject|0|||
131515716|NCT04127786|473518154|FG002|Primary Series|Withdrawal by Subject|0|||
131515717|NCT04127786|473518155|FG003|Primary Series|Withdrawal by Subject|1|||
131515718|NCT04127786|473518156|FG004|Primary Series|Withdrawal by Subject|0|||
131515719|NCT04127786|473518157|FG005|Primary Series|Withdrawal by Subject|0|||
131515720|NCT04127786|473518152|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
131515721|NCT04127786|473518153|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
131515722|NCT04127786|473518154|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
131515723|NCT04127786|473518155|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
131515724|NCT04127786|473518156|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
131515725|NCT04127786|473518157|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
131515726|NCT04127786|473518152|FG000|Booster Phase|Withdrawal by Subject|2|||
131515727|NCT04127786|473518153|FG001|Booster Phase|Withdrawal by Subject|0|||
131515728|NCT04127786|473518154|FG002|Booster Phase|Withdrawal by Subject|0|||
131658183|NCT02344290|474033026|FG000|Overall Study|Physician Decision|25|||
131515729|NCT04127786|473518155|FG003|Booster Phase|Withdrawal by Subject|0|||
131515730|NCT04127786|473518156|FG004|Booster Phase|Withdrawal by Subject|0|||
131515731|NCT04127786|473518157|FG005|Booster Phase|Withdrawal by Subject|0|||
131515732|NCT01945489|473518160|FG000|Cycle 1|Adverse Event|2|||
131515733|NCT01945489|473518161|FG001|Cycle 1|Adverse Event|0|||
131515734|NCT01945489|473518160|FG000|Cycle 1|Lost to Follow-up|4|||
131515735|NCT01945489|473518161|FG001|Cycle 1|Lost to Follow-up|0|||
131515736|NCT01945489|473518160|FG000|Cycle 1|Personal Reasons|4|||
131515737|NCT01945489|473518161|FG001|Cycle 1|Personal Reasons|2|||
131515738|NCT01945489|473518160|FG000|Cycle 1|Protocol Violation|0|||
131515739|NCT01945489|473518161|FG001|Cycle 1|Protocol Violation|1|||
131515740|NCT01945489|473518160|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
131515741|NCT01945489|473518161|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
131515742|NCT01945489|473518160|FG000|Cycle 2|Adverse Event|1|||
131515743|NCT01945489|473518161|FG001|Cycle 2|Adverse Event|0|||
131515744|NCT01945489|473518160|FG000|Cycle 2|Lost to Follow-up|0|||
131515745|NCT01945489|473518161|FG001|Cycle 2|Lost to Follow-up|1|||
131515746|NCT00358527|473518162|FG000|Overall Study|Adverse Event|4|||
131515747|NCT00358527|473518163|FG001|Overall Study|Adverse Event|0|||
131515748|NCT00358527|473518162|FG000|Overall Study|Withdrawal by Subject|1|||
131515749|NCT00358527|473518163|FG001|Overall Study|Withdrawal by Subject|1|||
131515750|NCT00358527|473518162|FG000|Overall Study|Non-compliance with protocol|6|||
131515751|NCT00358527|473518163|FG001|Overall Study|Non-compliance with protocol|1|||
131515752|NCT00358527|473518162|FG000|Overall Study|Administrative|2|||
131515753|NCT00358527|473518163|FG001|Overall Study|Administrative|1|||
131515754|NCT04144166|473518166|FG000|Overall Study|Discharged before study start|1|||
131515755|NCT04144166|473518166|FG000|Overall Study|Pregnancy|1|||
131515756|NCT04144166|473518166|FG000|Overall Study|Nail polish could not be removed from finger|1|||
131515757|NCT00697346|473518171|FG000|Overall Study|Adverse Event|4|||
131515758|NCT00697346|473518172|FG001|Overall Study|Adverse Event|5|||
131515759|NCT00697346|473518173|FG002|Overall Study|Adverse Event|0|||
131515760|NCT00697346|473518171|FG000|Overall Study|Progressive Disease|19|||
131515761|NCT00697346|473518172|FG001|Overall Study|Progressive Disease|18|||
131515762|NCT00697346|473518173|FG002|Overall Study|Progressive Disease|0|||
131515763|NCT00697346|473518171|FG000|Overall Study|Symptomatic Deterioration|0|||
131515764|NCT00697346|473518172|FG001|Overall Study|Symptomatic Deterioration|1|||
131515765|NCT00697346|473518173|FG002|Overall Study|Symptomatic Deterioration|0|||
131515766|NCT00697346|473518171|FG000|Overall Study|Withdrawal by Subject|2|||
131515767|NCT00697346|473518172|FG001|Overall Study|Withdrawal by Subject|2|||
131515768|NCT00697346|473518173|FG002|Overall Study|Withdrawal by Subject|0|||
131515769|NCT00697346|473518171|FG000|Overall Study|Reason not Specified|3|||
131515770|NCT00697346|473518172|FG001|Overall Study|Reason not Specified|0|||
131515771|NCT00697346|473518173|FG002|Overall Study|Reason not Specified|1|||
131515772|NCT03643562|473518175|FG000|Overall Study|Adverse Event|1|||
131515773|NCT03643562|473518176|FG001|Overall Study|Adverse Event|0|||
131515774|NCT03643562|473518175|FG000|Overall Study|Lack of Efficacy|0|||
131515775|NCT03643562|473518176|FG001|Overall Study|Lack of Efficacy|1|||
131515776|NCT03643562|473518175|FG000|Overall Study|Physician Decision|0|||
131515777|NCT03643562|473518176|FG001|Overall Study|Physician Decision|1|||
131515778|NCT03643562|473518175|FG000|Overall Study|Study Terminated by Sponsor|2|||
131515779|NCT03643562|473518176|FG001|Overall Study|Study Terminated by Sponsor|10|||
131515780|NCT03643562|473518175|FG000|Overall Study|Withdrawal by Subject|2|||
131515781|NCT03643562|473518176|FG001|Overall Study|Withdrawal by Subject|2|||
131515782|NCT03643562|473518175|FG000|Overall Study|Other than specified|3|||
131515783|NCT03643562|473518176|FG001|Overall Study|Other than specified|2|||
131515784|NCT03909165|473518181|FG000|Overall Study|Physician Decision|0|||
131515785|NCT03909165|473518182|FG001|Overall Study|Physician Decision|1|||
131515786|NCT03909165|473518183|FG002|Overall Study|Physician Decision|0|||
131515787|NCT03909165|473518184|FG003|Overall Study|Physician Decision|0|||
131515788|NCT03909165|473518185|FG004|Overall Study|Physician Decision|0|||
131515789|NCT03909165|473518181|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131515790|NCT03909165|473518182|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131515791|NCT03909165|473518183|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131515792|NCT03909165|473518184|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131515793|NCT03909165|473518185|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131515794|NCT03909165|473518181|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131515795|NCT03909165|473518182|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
131515796|NCT03909165|473518183|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
131515797|NCT03909165|473518184|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
131515798|NCT03909165|473518185|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
131515799|NCT03909165|473518181|FG000|Overall Study|Previous Drug Exposure|0|||
131515800|NCT03909165|473518182|FG001|Overall Study|Previous Drug Exposure|0|||
131515801|NCT03909165|473518183|FG002|Overall Study|Previous Drug Exposure|1|||
131515802|NCT03909165|473518184|FG003|Overall Study|Previous Drug Exposure|0|||
131515803|NCT03909165|473518185|FG004|Overall Study|Previous Drug Exposure|0|||
131515804|NCT03909165|473518181|FG000|Overall Study|Early Discharge|1|||
131515805|NCT03909165|473518182|FG001|Overall Study|Early Discharge|0|||
131515806|NCT03909165|473518183|FG002|Overall Study|Early Discharge|0|||
131515807|NCT03909165|473518184|FG003|Overall Study|Early Discharge|0|||
131515808|NCT03909165|473518185|FG004|Overall Study|Early Discharge|0|||
131515809|NCT04098458|473518189|FG000|Overall Study|Death|1|||
131515810|NCT04098458|473518189|FG000|Overall Study|did not meet study inclusion criteria|3|||
131515811|NCT00006489|473518190|FG000|Overall Study|Adverse Event|3|||
131515812|NCT00006489|473518191|FG001|Overall Study|Adverse Event|2|||
131515813|NCT00006489|473518192|FG002|Overall Study|Adverse Event|4|||
131515814|NCT00006489|473518193|FG003|Overall Study|Adverse Event|3|||
131515815|NCT00006489|473518190|FG000|Overall Study|Withdrawal by Subject|10|||
131515816|NCT00006489|473518191|FG001|Overall Study|Withdrawal by Subject|9|||
131515817|NCT00006489|473518192|FG002|Overall Study|Withdrawal by Subject|9|||
131515818|NCT00006489|473518193|FG003|Overall Study|Withdrawal by Subject|6|||
131515819|NCT00006489|473518190|FG000|Overall Study|Scheduling Conflict|0|||
131515820|NCT00006489|473518191|FG001|Overall Study|Scheduling Conflict|3|||
131515821|NCT00006489|473518192|FG002|Overall Study|Scheduling Conflict|2|||
131515822|NCT00006489|473518193|FG003|Overall Study|Scheduling Conflict|1|||
131515823|NCT00006489|473518190|FG000|Overall Study|Death|0|||
131515824|NCT00006489|473518191|FG001|Overall Study|Death|0|||
131515825|NCT00006489|473518192|FG002|Overall Study|Death|0|||
131515826|NCT00006489|473518193|FG003|Overall Study|Death|1|||
131515827|NCT01533246|473518196|FG000|Overall Study|Adverse Event|1|||
131515828|NCT01533246|473518196|FG000|Overall Study|Withdrawal by Subject|1|||
131515829|NCT03491150|473518197|FG000|Overall Study|Adverse Event|1|||
131515830|NCT03491150|473518198|FG001|Overall Study|Adverse Event|0|||
131515831|NCT03491150|473518197|FG000|Overall Study|Study Terminated by Sponsor|74|||
131515832|NCT03491150|473518198|FG001|Overall Study|Study Terminated by Sponsor|70|||
131515833|NCT03491150|473518197|FG000|Overall Study|Other|0|||
131515834|NCT03491150|473518198|FG001|Overall Study|Other|1|||
131515835|NCT03491150|473518197|FG000|Overall Study|Withdrawal by Subject|1|||
131515836|NCT03491150|473518198|FG001|Overall Study|Withdrawal by Subject|2|||
131515837|NCT00727714|473518199|FG000|Overall Study|Lost to Follow-up|2|||
131515838|NCT05179421|473518203|FG000|First Infusion Day|Adverse Event|1|||
131515839|NCT05179421|473518204|FG001|First Infusion Day|Adverse Event|0|||
131515840|NCT03746522|473518214|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
131515841|NCT03746522|473518215|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
131515842|NCT03746522|473518216|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
131515843|NCT03746522|473518214|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
131515844|NCT03746522|473518215|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
131515845|NCT03746522|473518216|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
131515846|NCT03746522|473518214|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
131515847|NCT03746522|473518215|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
131515848|NCT03746522|473518216|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
131515849|NCT03746522|473518214|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
131515850|NCT03746522|473518215|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
131515851|NCT03746522|473518216|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
131515852|NCT03746522|473518214|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
131515853|NCT03746522|473518215|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
131515854|NCT03746522|473518216|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
131515855|NCT01479621|473518217|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
131515856|NCT01479621|473518218|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131515857|NCT01479621|473518219|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131515858|NCT01479621|473518220|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131515859|NCT01479621|473518221|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131515860|NCT01479621|473518222|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131515861|NCT01479621|473518223|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
131515862|NCT01479621|473518217|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
131515863|NCT01479621|473518218|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131515864|NCT01479621|473518219|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131515865|NCT01479621|473518220|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131515866|NCT01479621|473518221|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131515867|NCT01479621|473518222|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131515868|NCT01479621|473518223|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
131515869|NCT01479621|473518217|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
131515870|NCT01479621|473518218|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131515871|NCT01479621|473518219|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131515872|NCT01479621|473518220|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131515873|NCT01479621|473518221|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131515874|NCT01479621|473518222|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131515875|NCT01479621|473518223|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
131515876|NCT01479621|473518217|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
131515877|NCT01479621|473518218|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131515878|NCT01479621|473518219|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131515879|NCT01479621|473518220|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131515880|NCT01479621|473518221|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131515881|NCT01479621|473518222|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131515882|NCT01479621|473518223|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
131515883|NCT01479621|473518217|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
131515884|NCT01479621|473518218|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131515885|NCT01479621|473518219|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131515886|NCT01479621|473518220|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131515887|NCT01479621|473518221|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131515888|NCT01479621|473518222|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131515889|NCT01479621|473518223|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
131515890|NCT01479621|473518217|FG000|Treatment Period|Adverse Event|0|||
131515891|NCT01479621|473518218|FG001|Treatment Period|Adverse Event|0|||
131515892|NCT01479621|473518219|FG002|Treatment Period|Adverse Event|0|||
131515893|NCT01479621|473518220|FG003|Treatment Period|Adverse Event|0|||
131515894|NCT01479621|473518221|FG004|Treatment Period|Adverse Event|1|||
131515895|NCT01479621|473518222|FG005|Treatment Period|Adverse Event|2|||
131515896|NCT01479621|473518223|FG006|Treatment Period|Adverse Event|2|||
131515897|NCT01479621|473518217|FG000|Treatment Period|Withdrawal by Subject|0|||
131515898|NCT01479621|473518218|FG001|Treatment Period|Withdrawal by Subject|4|||
131515899|NCT01479621|473518219|FG002|Treatment Period|Withdrawal by Subject|2|||
131515900|NCT01479621|473518220|FG003|Treatment Period|Withdrawal by Subject|2|||
131515901|NCT01479621|473518221|FG004|Treatment Period|Withdrawal by Subject|5|||
131515902|NCT01479621|473518222|FG005|Treatment Period|Withdrawal by Subject|5|||
131515903|NCT01479621|473518223|FG006|Treatment Period|Withdrawal by Subject|1|||
131515904|NCT01479621|473518217|FG000|Treatment Period|Physician Decision|0|||
131515905|NCT01479621|473518218|FG001|Treatment Period|Physician Decision|0|||
131515906|NCT01479621|473518219|FG002|Treatment Period|Physician Decision|0|||
131515907|NCT01479621|473518220|FG003|Treatment Period|Physician Decision|0|||
131515908|NCT01479621|473518221|FG004|Treatment Period|Physician Decision|1|||
131515909|NCT01479621|473518222|FG005|Treatment Period|Physician Decision|1|||
131515910|NCT01479621|473518223|FG006|Treatment Period|Physician Decision|0|||
131515911|NCT01479621|473518217|FG000|Treatment Period|Non-compliance to study drug|0|||
131515912|NCT01479621|473518218|FG001|Treatment Period|Non-compliance to study drug|1|||
131515913|NCT01479621|473518219|FG002|Treatment Period|Non-compliance to study drug|0|||
131515914|NCT01479621|473518220|FG003|Treatment Period|Non-compliance to study drug|0|||
131515915|NCT01479621|473518221|FG004|Treatment Period|Non-compliance to study drug|0|||
131515916|NCT01479621|473518222|FG005|Treatment Period|Non-compliance to study drug|0|||
131515917|NCT01479621|473518223|FG006|Treatment Period|Non-compliance to study drug|1|||
131515918|NCT01479621|473518217|FG000|Treatment Period|Protocol Violation|0|||
131515919|NCT01479621|473518218|FG001|Treatment Period|Protocol Violation|9|||
131515920|NCT01479621|473518219|FG002|Treatment Period|Protocol Violation|6|||
131515921|NCT01479621|473518220|FG003|Treatment Period|Protocol Violation|5|||
131515922|NCT01479621|473518221|FG004|Treatment Period|Protocol Violation|2|||
131515923|NCT01479621|473518222|FG005|Treatment Period|Protocol Violation|10|||
131515924|NCT01479621|473518223|FG006|Treatment Period|Protocol Violation|6|||
131515925|NCT01479621|473518217|FG000|Treatment Period|Pregnancy|0|||
131515926|NCT01479621|473518218|FG001|Treatment Period|Pregnancy|0|||
131515927|NCT01479621|473518219|FG002|Treatment Period|Pregnancy|2|||
131515928|NCT01479621|473518220|FG003|Treatment Period|Pregnancy|0|||
131515929|NCT01479621|473518221|FG004|Treatment Period|Pregnancy|0|||
131515930|NCT01479621|473518222|FG005|Treatment Period|Pregnancy|0|||
131515931|NCT01479621|473518223|FG006|Treatment Period|Pregnancy|0|||
131515932|NCT01479621|473518217|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
131515933|NCT01479621|473518218|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
131515934|NCT01479621|473518219|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
131515935|NCT01479621|473518220|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
131515936|NCT01479621|473518221|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
131515937|NCT01479621|473518222|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
131515938|NCT01479621|473518223|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
131515939|NCT01479621|473518217|FG000|Treatment Period|Lost to Follow-up|0|||
131515940|NCT01479621|473518218|FG001|Treatment Period|Lost to Follow-up|0|||
131515941|NCT01479621|473518219|FG002|Treatment Period|Lost to Follow-up|1|||
131515942|NCT01479621|473518220|FG003|Treatment Period|Lost to Follow-up|0|||
131515943|NCT01479621|473518221|FG004|Treatment Period|Lost to Follow-up|2|||
131515944|NCT01479621|473518222|FG005|Treatment Period|Lost to Follow-up|2|||
131515945|NCT01479621|473518223|FG006|Treatment Period|Lost to Follow-up|1|||
131515946|NCT01479621|473518217|FG000|Treatment Period|Met stopping criteria|0|||
131515947|NCT01479621|473518218|FG001|Treatment Period|Met stopping criteria|8|||
131515948|NCT01479621|473518219|FG002|Treatment Period|Met stopping criteria|7|||
131515949|NCT01479621|473518220|FG003|Treatment Period|Met stopping criteria|4|||
131515950|NCT01479621|473518221|FG004|Treatment Period|Met stopping criteria|9|||
131515951|NCT01479621|473518222|FG005|Treatment Period|Met stopping criteria|20|||
131515952|NCT01479621|473518223|FG006|Treatment Period|Met stopping criteria|6|||
131515953|NCT01452412|473518226|FG000|Overall Study|Withdrawal by Subject|15|||
131515954|NCT01452412|473518227|FG001|Overall Study|Withdrawal by Subject|11|||
131515955|NCT01452412|473518226|FG000|Overall Study|Adverse Event|4|||
131515956|NCT01452412|473518227|FG001|Overall Study|Adverse Event|3|||
131515957|NCT01452412|473518226|FG000|Overall Study|Lost to Follow-up|5|||
131515958|NCT01452412|473518227|FG001|Overall Study|Lost to Follow-up|3|||
131515959|NCT01452412|473518226|FG000|Overall Study|Death|1|||
131515960|NCT01452412|473518227|FG001|Overall Study|Death|0|||
131515961|NCT01452412|473518226|FG000|Overall Study|Initiated dialysis|1|||
131515962|NCT01452412|473518227|FG001|Overall Study|Initiated dialysis|0|||
131515963|NCT01452412|473518226|FG000|Overall Study|Other|2|||
131515964|NCT01452412|473518227|FG001|Overall Study|Other|0|||
131515965|NCT03013543|473518228|FG000|Overall Study|Withdrawal by Subject|0|||
131515966|NCT03013543|473518229|FG001|Overall Study|Withdrawal by Subject|2|||
131515967|NCT03013543|473518230|FG002|Overall Study|Withdrawal by Subject|0|||
131515968|NCT03013543|473518231|FG003|Overall Study|Withdrawal by Subject|5|||
131515969|NCT03013543|473518232|FG004|Overall Study|Withdrawal by Subject|6|||
131515970|NCT03013543|473518233|FG005|Overall Study|Withdrawal by Subject|2|||
131515971|NCT03013543|473518234|FG006|Overall Study|Withdrawal by Subject|3|||
131515972|NCT03013543|473518235|FG007|Overall Study|Withdrawal by Subject|1|||
131515973|NCT03013543|473518236|FG008|Overall Study|Withdrawal by Subject|0|||
131515974|NCT03013543|473518237|FG009|Overall Study|Withdrawal by Subject|4|||
131515975|NCT03013543|473518228|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131515976|NCT03013543|473518229|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
131515977|NCT03013543|473518230|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
131515978|NCT03013543|473518231|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
131515979|NCT03013543|473518232|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
131515980|NCT03013543|473518233|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
131515981|NCT03013543|473518234|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
131515982|NCT03013543|473518235|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
131515983|NCT03013543|473518236|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
131515984|NCT03013543|473518237|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
131515985|NCT03013543|473518228|FG000|Overall Study|Other|0|||
131515986|NCT03013543|473518229|FG001|Overall Study|Other|0|||
131515987|NCT03013543|473518230|FG002|Overall Study|Other|2|||
131515988|NCT03013543|473518231|FG003|Overall Study|Other|0|||
131515989|NCT03013543|473518232|FG004|Overall Study|Other|2|||
131515990|NCT03013543|473518233|FG005|Overall Study|Other|0|||
131515991|NCT03013543|473518234|FG006|Overall Study|Other|0|||
131515992|NCT03013543|473518235|FG007|Overall Study|Other|0|||
131515993|NCT03013543|473518236|FG008|Overall Study|Other|1|||
131515994|NCT03013543|473518237|FG009|Overall Study|Other|0|||
131515995|NCT03013543|473518228|FG000|Overall Study|Adverse Event|0|||
131515996|NCT03013543|473518229|FG001|Overall Study|Adverse Event|0|||
131515997|NCT03013543|473518230|FG002|Overall Study|Adverse Event|0|||
131515998|NCT03013543|473518231|FG003|Overall Study|Adverse Event|3|||
131515999|NCT03013543|473518232|FG004|Overall Study|Adverse Event|2|||
131516000|NCT03013543|473518233|FG005|Overall Study|Adverse Event|1|||
131516001|NCT03013543|473518234|FG006|Overall Study|Adverse Event|3|||
131516002|NCT03013543|473518235|FG007|Overall Study|Adverse Event|8|||
131516003|NCT03013543|473518236|FG008|Overall Study|Adverse Event|0|||
131516004|NCT03013543|473518237|FG009|Overall Study|Adverse Event|2|||
131516005|NCT03013543|473518228|FG000|Overall Study|Death|0|||
131516006|NCT03013543|473518229|FG001|Overall Study|Death|0|||
131516007|NCT03013543|473518230|FG002|Overall Study|Death|0|||
131516008|NCT03013543|473518231|FG003|Overall Study|Death|1|||
131516009|NCT03013543|473518232|FG004|Overall Study|Death|0|||
131516010|NCT03013543|473518233|FG005|Overall Study|Death|0|||
131516011|NCT03013543|473518234|FG006|Overall Study|Death|0|||
131516012|NCT03013543|473518235|FG007|Overall Study|Death|0|||
131516013|NCT03013543|473518236|FG008|Overall Study|Death|0|||
131516014|NCT03013543|473518237|FG009|Overall Study|Death|0|||
131516015|NCT03013543|473518228|FG000|Overall Study|Lack of Efficacy|0|||
131516016|NCT03013543|473518229|FG001|Overall Study|Lack of Efficacy|0|||
131516017|NCT03013543|473518230|FG002|Overall Study|Lack of Efficacy|0|||
131516018|NCT03013543|473518231|FG003|Overall Study|Lack of Efficacy|1|||
131516019|NCT03013543|473518232|FG004|Overall Study|Lack of Efficacy|0|||
131516020|NCT03013543|473518233|FG005|Overall Study|Lack of Efficacy|0|||
131516021|NCT03013543|473518234|FG006|Overall Study|Lack of Efficacy|0|||
131516022|NCT03013543|473518235|FG007|Overall Study|Lack of Efficacy|0|||
131516023|NCT03013543|473518236|FG008|Overall Study|Lack of Efficacy|0|||
131516024|NCT03013543|473518237|FG009|Overall Study|Lack of Efficacy|0|||
131516025|NCT03013543|473518228|FG000|Overall Study|Lost to Follow-up|0|||
131516026|NCT03013543|473518229|FG001|Overall Study|Lost to Follow-up|0|||
131516027|NCT03013543|473518230|FG002|Overall Study|Lost to Follow-up|0|||
131516028|NCT03013543|473518231|FG003|Overall Study|Lost to Follow-up|1|||
131516029|NCT03013543|473518232|FG004|Overall Study|Lost to Follow-up|0|||
131516030|NCT03013543|473518233|FG005|Overall Study|Lost to Follow-up|0|||
131516031|NCT03013543|473518234|FG006|Overall Study|Lost to Follow-up|1|||
131516032|NCT03013543|473518235|FG007|Overall Study|Lost to Follow-up|0|||
131516033|NCT03013543|473518236|FG008|Overall Study|Lost to Follow-up|0|||
131516034|NCT03013543|473518237|FG009|Overall Study|Lost to Follow-up|2|||
131516035|NCT03013543|473518228|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131516036|NCT03013543|473518229|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131516037|NCT03013543|473518230|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131516038|NCT03013543|473518231|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131516039|NCT03013543|473518232|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131516040|NCT03013543|473518233|FG005|Overall Study|Non-Compliance With Study Drug|0|||
131516041|NCT03013543|473518234|FG006|Overall Study|Non-Compliance With Study Drug|0|||
131516042|NCT03013543|473518235|FG007|Overall Study|Non-Compliance With Study Drug|0|||
131516043|NCT03013543|473518236|FG008|Overall Study|Non-Compliance With Study Drug|1|||
131516044|NCT03013543|473518237|FG009|Overall Study|Non-Compliance With Study Drug|0|||
131516045|NCT03013543|473518228|FG000|Overall Study|Physician Decision|0|||
131516046|NCT03013543|473518229|FG001|Overall Study|Physician Decision|0|||
131516047|NCT03013543|473518230|FG002|Overall Study|Physician Decision|0|||
131516048|NCT03013543|473518231|FG003|Overall Study|Physician Decision|0|||
131516049|NCT03013543|473518232|FG004|Overall Study|Physician Decision|1|||
131516050|NCT03013543|473518233|FG005|Overall Study|Physician Decision|0|||
131516051|NCT03013543|473518234|FG006|Overall Study|Physician Decision|0|||
131516052|NCT03013543|473518235|FG007|Overall Study|Physician Decision|0|||
131516053|NCT03013543|473518236|FG008|Overall Study|Physician Decision|0|||
131516054|NCT03013543|473518237|FG009|Overall Study|Physician Decision|0|||
131516055|NCT03013543|473518228|FG000|Overall Study|Protocol Violation|0|||
131516056|NCT03013543|473518229|FG001|Overall Study|Protocol Violation|0|||
131516057|NCT03013543|473518230|FG002|Overall Study|Protocol Violation|0|||
131516058|NCT03013543|473518231|FG003|Overall Study|Protocol Violation|0|||
131516059|NCT03013543|473518232|FG004|Overall Study|Protocol Violation|0|||
131516060|NCT03013543|473518233|FG005|Overall Study|Protocol Violation|0|||
131516061|NCT03013543|473518234|FG006|Overall Study|Protocol Violation|0|||
131516062|NCT03013543|473518235|FG007|Overall Study|Protocol Violation|0|||
131516063|NCT03013543|473518236|FG008|Overall Study|Protocol Violation|0|||
131516064|NCT03013543|473518237|FG009|Overall Study|Protocol Violation|1|||
131516065|NCT00323414|473518238|FG000|Overall Study|Withdrawal by Subject|0|||
131516066|NCT00323414|473518239|FG001|Overall Study|Withdrawal by Subject|1|||
131516067|NCT01537783|473518248|FG000|Overall Study|Lost to Follow-up|11|||
131516068|NCT01537783|473518249|FG001|Overall Study|Lost to Follow-up|2|||
131516069|NCT02722928|473518252|FG000|Overall Study|Standard CT was not as required per prot|5|||
131516070|NCT02722928|473518253|FG001|Overall Study|Standard CT was not as required per prot|13|||
131516071|NCT02722928|473518252|FG000|Overall Study|Required Intraoperative MRI|5|||
131516072|NCT02722928|473518253|FG001|Overall Study|Required Intraoperative MRI|7|||
131516073|NCT01838642|473518254|FG000|Overall Study|Died on study|1|||
131516074|NCT01398956|473518255|FG000|Overall Study|Withdrawal by Subject|4|||
131516075|NCT01398956|473518255|FG000|Overall Study|AE, non-serious non-fatal|4|||
131658184|NCT02344290|474033027|FG001|Overall Study|Physician Decision|25|||
131516076|NCT01398956|473518255|FG000|Overall Study|Withdrawal Criteria No.3|1|||
131516077|NCT01398956|473518255|FG000|Overall Study|Subject moved a long distance|1|||
131516078|NCT01557400|473518256|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
131516079|NCT01557400|473518256|FG000|Overall Study|Adverse Event|3|||
131516080|NCT01557400|473518256|FG000|Overall Study|Lost to Follow-up|5|||
131516081|NCT01557400|473518256|FG000|Overall Study|Withdrawal by Subject|9|||
131516082|NCT02281552|473518265|FG000|Overall Study|Medication error|1|||
131516083|NCT02281552|473518266|FG001|Overall Study|Medication error|0|||
131516084|NCT02281552|473518265|FG000|Overall Study|Insufficient clinical response|0|||
131516085|NCT02281552|473518266|FG001|Overall Study|Insufficient clinical response|1|||
131516086|NCT02281552|473518265|FG000|Overall Study|Adverse Event|3|||
131516087|NCT02281552|473518266|FG001|Overall Study|Adverse Event|9|||
131516088|NCT01224639|473518267|FG000|Overall Study|Withdrawal by Subject|0|||
131516089|NCT01224639|473518268|FG001|Overall Study|Withdrawal by Subject|0|||
131516090|NCT01224639|473518269|FG002|Overall Study|Withdrawal by Subject|0|||
131516091|NCT01224639|473518270|FG003|Overall Study|Withdrawal by Subject|0|||
131516092|NCT01224639|473518271|FG004|Overall Study|Withdrawal by Subject|2|||
131516093|NCT01224639|473518272|FG005|Overall Study|Withdrawal by Subject|0|||
131516094|NCT01224639|473518273|FG006|Overall Study|Withdrawal by Subject|1|||
131516095|NCT01224639|473518274|FG007|Overall Study|Withdrawal by Subject|1|||
131516096|NCT01224639|473518267|FG000|Overall Study|Adverse Event|0|||
131516097|NCT01224639|473518268|FG001|Overall Study|Adverse Event|0|||
131516098|NCT01224639|473518269|FG002|Overall Study|Adverse Event|0|||
131516099|NCT01224639|473518270|FG003|Overall Study|Adverse Event|0|||
131516100|NCT01224639|473518271|FG004|Overall Study|Adverse Event|0|||
131516101|NCT01224639|473518272|FG005|Overall Study|Adverse Event|0|||
131516102|NCT01224639|473518273|FG006|Overall Study|Adverse Event|0|||
131516103|NCT01224639|473518274|FG007|Overall Study|Adverse Event|1|||
131516104|NCT03465878|473518275|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
131516105|NCT03465878|473518276|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
131516106|NCT03465878|473518277|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
131516107|NCT03465878|473518278|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
131516108|NCT03465878|473518275|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
131516109|NCT03465878|473518276|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
131516110|NCT03465878|473518277|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
131516111|NCT03465878|473518278|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
131516112|NCT03465878|473518275|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
131516113|NCT03465878|473518276|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
131516114|NCT03465878|473518277|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
131516115|NCT03465878|473518278|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
131516116|NCT04656132|473518279|FG000|Overall Study|Lost to Follow-up|4|||
131516117|NCT04656132|473518279|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
131516118|NCT02321462|473518282|FG000|Overall Study|Withdrawal by Subject|5|||
131516119|NCT02321462|473518283|FG001|Overall Study|Withdrawal by Subject|2|||
131516120|NCT02321462|473518282|FG000|Overall Study|Subject withdrawn before any treatment|1|||
131516121|NCT02321462|473518283|FG001|Overall Study|Subject withdrawn before any treatment|1|||
131516122|NCT01574352|473518289|FG000|Overall Study|Withdrawal by Subject|6|||
131516123|NCT01574352|473518290|FG001|Overall Study|Withdrawal by Subject|13|||
131516124|NCT01574352|473518289|FG000|Overall Study|Injury in non-camp related sport|1|||
131516125|NCT01574352|473518290|FG001|Overall Study|Injury in non-camp related sport|0|||
131516126|NCT02283788|473518295|FG000|Overall Study|Adverse Event|1|||
131516127|NCT02283788|473518296|FG001|Overall Study|Adverse Event|3|||
131516128|NCT02283788|473518297|FG002|Overall Study|Adverse Event|5|||
131516129|NCT02283788|473518298|FG003|Overall Study|Adverse Event|1|||
131516130|NCT02283788|473518295|FG000|Overall Study|Withdrawal by Subject|0|||
131516131|NCT02283788|473518296|FG001|Overall Study|Withdrawal by Subject|1|||
131516132|NCT02283788|473518297|FG002|Overall Study|Withdrawal by Subject|0|||
131516133|NCT02283788|473518298|FG003|Overall Study|Withdrawal by Subject|1|||
131516134|NCT01083433|473520019|FG000|Overall Study|Lost to Follow-up|2|||
131516135|NCT01083433|473520020|FG001|Overall Study|Lost to Follow-up|1|||
131516136|NCT01083433|473520021|FG002|Overall Study|Lost to Follow-up|1|||
131516137|NCT01083433|473520019|FG000|Overall Study|Withdrawal by Subject|0|||
131516138|NCT01083433|473520020|FG001|Overall Study|Withdrawal by Subject|5|||
131516139|NCT01083433|473520021|FG002|Overall Study|Withdrawal by Subject|3|||
131516140|NCT01083433|473520019|FG000|Overall Study|Pregnancy|0|||
131516141|NCT01083433|473520020|FG001|Overall Study|Pregnancy|0|||
131516142|NCT01083433|473520021|FG002|Overall Study|Pregnancy|1|||
131516143|NCT04982029|473520022|FG000|Overall Study|Lost to Follow-up|2|||
131516144|NCT04982029|473520023|FG001|Overall Study|Lost to Follow-up|3|||
131516145|NCT05458856|473520024|FG000|Overall Study|Withdrawal by Subject|5|||
131516146|NCT05458856|473520024|FG000|Overall Study|Death|4|||
131516147|NCT05458856|473520024|FG000|Overall Study|Protocol Deviation|3|||
131516148|NCT05458856|473520024|FG000|Overall Study|Physician Decision|1|||
131516149|NCT05168475|473520025|FG000|Period 1|Protocol Violation|1|||
131516150|NCT05168475|473520025|FG000|Period 1|IMP shortage|2|||
131516151|NCT05168475|473520025|FG000|Period 1|Not randomised|2|||
131516152|NCT05168475|473520025|FG000|Period 2|IMP shortage|1|||
131516153|NCT01589822|473520026|FG000|Overall Study|Withdrawal by Subject|1|||
131516154|NCT01589822|473520027|FG001|Overall Study|Withdrawal by Subject|2|||
131516155|NCT01589822|473520028|FG002|Overall Study|Withdrawal by Subject|0|||
131516156|NCT01589822|473520026|FG000|Overall Study|Death|1|||
131516157|NCT01589822|473520027|FG001|Overall Study|Death|0|||
131516158|NCT01589822|473520028|FG002|Overall Study|Death|0|||
131516159|NCT01589822|473520026|FG000|Overall Study|Missed 90 day visit|2|||
131516160|NCT01589822|473520027|FG001|Overall Study|Missed 90 day visit|1|||
131516161|NCT01589822|473520028|FG002|Overall Study|Missed 90 day visit|1|||
131516162|NCT01140477|473520029|FG000|Overall Study|Lost to Follow-up|4|||
131516163|NCT01140477|473520030|FG001|Overall Study|Lost to Follow-up|0|||
131516164|NCT01140477|473520029|FG000|Overall Study|Withdrawal by Subject|1|||
131516165|NCT01140477|473520030|FG001|Overall Study|Withdrawal by Subject|4|||
131516166|NCT01140477|473520029|FG000|Overall Study|Surgical complication preventing implant|2|||
131516167|NCT01140477|473520030|FG001|Overall Study|Surgical complication preventing implant|0|||
131516168|NCT01140477|473520029|FG000|Overall Study|Death|1|||
131516169|NCT01140477|473520030|FG001|Overall Study|Death|1|||
131516170|NCT01140477|473520029|FG000|Overall Study|Subject explanted|0|||
131516171|NCT01140477|473520030|FG001|Overall Study|Subject explanted|1|||
131516172|NCT00773175|473520031|FG000|Overall Study|Adverse Event|2|||
131516173|NCT00773175|473520032|FG001|Overall Study|Adverse Event|0|||
131516174|NCT00773175|473520031|FG000|Overall Study|Consent Withdrawn|0|||
131516175|NCT00773175|473520032|FG001|Overall Study|Consent Withdrawn|2|||
131516176|NCT02643251|473520041|FG000|Overall Study|Adverse Event|3|||
131516177|NCT02643251|473520042|FG001|Overall Study|Adverse Event|1|||
131516178|NCT02643251|473520041|FG000|Overall Study|Withdrawal by Subject|2|||
131516179|NCT02643251|473520042|FG001|Overall Study|Withdrawal by Subject|0|||
131516180|NCT02643251|473520041|FG000|Overall Study|Lost to Follow-up|4|||
131516181|NCT02643251|473520042|FG001|Overall Study|Lost to Follow-up|1|||
131516182|NCT02643251|473520041|FG000|Overall Study|Protocol Violation|1|||
131516183|NCT02643251|473520042|FG001|Overall Study|Protocol Violation|0|||
131516184|NCT02643251|473520041|FG000|Overall Study|PI Decision to terminate patient|1|||
131516185|NCT02643251|473520042|FG001|Overall Study|PI Decision to terminate patient|0|||
131516186|NCT00333229|473520043|FG000|Overall Study|Lack of Efficacy|0|||
131516187|NCT00333229|473520044|FG001|Overall Study|Lack of Efficacy|1|||
131516188|NCT00348556|473520047|FG000|Overall Study|Adverse Event|1|||
131516189|NCT01944059|473520048|FG000|Overall Study|Lost to Follow-up|1|||
131516190|NCT01944059|473520048|FG000|Overall Study|Physician Decision|3|||
131516191|NCT01944059|473520048|FG000|Overall Study|Withdrawal by Subject|1|||
131516192|NCT01944059|473520048|FG000|Overall Study|Adverse Event|2|||
131516193|NCT02365636|473520058|FG000|Overall Study|Adverse Event|3|||
131516194|NCT02365636|473520059|FG001|Overall Study|Adverse Event|3|||
131516195|NCT02365636|473520060|FG002|Overall Study|Adverse Event|2|||
131516196|NCT02365636|473520058|FG000|Overall Study|Protocol Violation|1|||
131516197|NCT02365636|473520059|FG001|Overall Study|Protocol Violation|4|||
131516198|NCT02365636|473520060|FG002|Overall Study|Protocol Violation|0|||
131516199|NCT02365636|473520058|FG000|Overall Study|Lost to Follow-up|0|||
131516200|NCT02365636|473520059|FG001|Overall Study|Lost to Follow-up|0|||
131516201|NCT02365636|473520060|FG002|Overall Study|Lost to Follow-up|1|||
131516202|NCT02365636|473520058|FG000|Overall Study|Other|2|||
131516203|NCT02365636|473520059|FG001|Overall Study|Other|0|||
131516204|NCT02365636|473520060|FG002|Overall Study|Other|0|||
131516205|NCT00463060|473520069|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
131516206|NCT00463060|473520069|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
131516207|NCT01802775|473520074|FG000|Overall Study|Death|0|||
131516208|NCT01802775|473520075|FG001|Overall Study|Death|3|||
131516209|NCT01802775|473520074|FG000|Overall Study|Reason not provided|0|||
131516210|NCT01802775|473520075|FG001|Overall Study|Reason not provided|1|||
131516211|NCT01802775|473520074|FG000|Overall Study|Physician Decision|1|||
131516212|NCT01802775|473520075|FG001|Overall Study|Physician Decision|0|||
131516213|NCT01802775|473520074|FG000|Overall Study|Adverse Event|1|||
131516214|NCT01802775|473520075|FG001|Overall Study|Adverse Event|1|||
131516215|NCT01802775|473520074|FG000|Overall Study|Withdrawal by Subject|3|||
131516216|NCT01802775|473520075|FG001|Overall Study|Withdrawal by Subject|5|||
131516217|NCT01802775|473520074|FG000|Overall Study|Lost to Follow-up|1|||
131516218|NCT01802775|473520075|FG001|Overall Study|Lost to Follow-up|2|||
131516219|NCT01067352|473520082|FG000|Overall Study|Withdrawal by Subject|1|||
131516220|NCT01067352|473520083|FG001|Overall Study|Withdrawal by Subject|2|||
131516221|NCT01067352|473520084|FG002|Overall Study|Withdrawal by Subject|1|||
131516222|NCT01067352|473520082|FG000|Overall Study|Physician Decision|0|||
131516223|NCT01067352|473520083|FG001|Overall Study|Physician Decision|1|||
131516224|NCT01067352|473520084|FG002|Overall Study|Physician Decision|0|||
131516225|NCT01096784|473520085|FG000|Overall Study|Withdrawal by Subject|2|||
131516226|NCT01096784|473520086|FG001|Overall Study|Withdrawal by Subject|1|||
131516227|NCT01096784|473520085|FG000|Overall Study|Adverse Event|11|||
131516228|NCT01096784|473520086|FG001|Overall Study|Adverse Event|9|||
131516229|NCT01096784|473520085|FG000|Overall Study|Protocol Deviation|2|||
131516230|NCT01096784|473520086|FG001|Overall Study|Protocol Deviation|2|||
131516231|NCT01096784|473520085|FG000|Overall Study|Administrative Decision|0|||
131516232|NCT01096784|473520086|FG001|Overall Study|Administrative Decision|1|||
131516233|NCT01096784|473520085|FG000|Overall Study|Other Unspecified|0|||
131516234|NCT01096784|473520086|FG001|Overall Study|Other Unspecified|1|||
131516235|NCT05923229|473520087|FG000|Overall Study|Withdrawal by Subject|3|||
131516236|NCT05923229|473520088|FG001|Overall Study|Withdrawal by Subject|0|||
131516237|NCT05923229|473520087|FG000|Overall Study|Health related|2|||
131516238|NCT05923229|473520088|FG001|Overall Study|Health related|1|||
131516239|NCT03064126|473520089|FG000|Overall Study|Death|40|||
131516240|NCT03064126|473520090|FG001|Overall Study|Death|16|||
131516241|NCT03064126|473520091|FG002|Overall Study|Death|4|||
131516242|NCT03064126|473520092|FG003|Overall Study|Death|2|||
131516243|NCT03064126|473520089|FG000|Overall Study|Withdrawal by Subject|17|||
131516244|NCT03064126|473520090|FG001|Overall Study|Withdrawal by Subject|9|||
131516245|NCT03064126|473520091|FG002|Overall Study|Withdrawal by Subject|0|||
131516246|NCT03064126|473520092|FG003|Overall Study|Withdrawal by Subject|2|||
131516247|NCT03064126|473520089|FG000|Overall Study|Lost to Follow-up|7|||
131516248|NCT03064126|473520090|FG001|Overall Study|Lost to Follow-up|3|||
131516249|NCT03064126|473520091|FG002|Overall Study|Lost to Follow-up|0|||
131516250|NCT03064126|473520092|FG003|Overall Study|Lost to Follow-up|0|||
131516251|NCT03064126|473520089|FG000|Overall Study|Adverse Event|2|||
131516252|NCT03064126|473520090|FG001|Overall Study|Adverse Event|0|||
131516253|NCT03064126|473520091|FG002|Overall Study|Adverse Event|0|||
131516254|NCT03064126|473520092|FG003|Overall Study|Adverse Event|0|||
131516255|NCT03064126|473520089|FG000|Overall Study|Physician Decision|3|||
131516256|NCT03064126|473520090|FG001|Overall Study|Physician Decision|0|||
131516257|NCT03064126|473520091|FG002|Overall Study|Physician Decision|0|||
131516258|NCT03064126|473520092|FG003|Overall Study|Physician Decision|0|||
131516259|NCT03064126|473520089|FG000|Overall Study|Other reason for early termination|3|||
131516260|NCT03064126|473520090|FG001|Overall Study|Other reason for early termination|2|||
131516261|NCT03064126|473520091|FG002|Overall Study|Other reason for early termination|0|||
131516262|NCT03064126|473520092|FG003|Overall Study|Other reason for early termination|0|||
131516263|NCT03064126|473520089|FG000|Overall Study|Missed Visit|3|||
131516264|NCT03064126|473520090|FG001|Overall Study|Missed Visit|1|||
131516265|NCT03064126|473520091|FG002|Overall Study|Missed Visit|0|||
131516266|NCT03064126|473520092|FG003|Overall Study|Missed Visit|0|||
131516267|NCT02465528|473520093|FG000|Overall Study|Progressive disease|0|||
131516268|NCT02465528|473520094|FG001|Overall Study|Progressive disease|2|||
131516269|NCT02465528|473520095|FG002|Overall Study|Progressive disease|9|||
131516270|NCT02465528|473520096|FG003|Overall Study|Progressive disease|4|||
131516271|NCT02465528|473520093|FG000|Overall Study|Study terminated by sponsor|1|||
131516272|NCT02465528|473520094|FG001|Overall Study|Study terminated by sponsor|2|||
131516273|NCT02465528|473520095|FG002|Overall Study|Study terminated by sponsor|0|||
131516274|NCT02465528|473520096|FG003|Overall Study|Study terminated by sponsor|0|||
131516275|NCT02465528|473520093|FG000|Overall Study|Withdrawal by Subject|0|||
131516276|NCT02465528|473520094|FG001|Overall Study|Withdrawal by Subject|0|||
131516277|NCT02465528|473520095|FG002|Overall Study|Withdrawal by Subject|2|||
131516278|NCT02465528|473520096|FG003|Overall Study|Withdrawal by Subject|0|||
131516279|NCT02465528|473520093|FG000|Overall Study|Adverse Event|0|||
131516280|NCT02465528|473520094|FG001|Overall Study|Adverse Event|0|||
131516281|NCT02465528|473520095|FG002|Overall Study|Adverse Event|0|||
131516282|NCT02465528|473520096|FG003|Overall Study|Adverse Event|1|||
131516283|NCT02465528|473520093|FG000|Overall Study|Physician Decision|0|||
131516284|NCT02465528|473520094|FG001|Overall Study|Physician Decision|0|||
131516285|NCT02465528|473520095|FG002|Overall Study|Physician Decision|1|||
131516286|NCT02465528|473520096|FG003|Overall Study|Physician Decision|0|||
131516287|NCT04476017|473520099|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
131516288|NCT04476017|473520100|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
131516289|NCT02075840|473520101|FG000|Overall Study|Withdrawal by Subject|13|||
131516290|NCT02075840|473520102|FG001|Overall Study|Withdrawal by Subject|22|||
131516291|NCT02075840|473520101|FG000|Overall Study|Reason not specified|1|||
131516292|NCT02075840|473520102|FG001|Overall Study|Reason not specified|0|||
131516293|NCT02075840|473520101|FG000|Overall Study|Adverse Event|0|||
131516294|NCT02075840|473520102|FG001|Overall Study|Adverse Event|2|||
131516295|NCT02075840|473520101|FG000|Overall Study|Death|35|||
131516296|NCT02075840|473520102|FG001|Overall Study|Death|40|||
131516297|NCT02075840|473520101|FG000|Overall Study|Lost to Follow-up|3|||
131516298|NCT02075840|473520102|FG001|Overall Study|Lost to Follow-up|2|||
131516299|NCT02075840|473520101|FG000|Overall Study|Physician Decision|1|||
131516300|NCT02075840|473520102|FG001|Overall Study|Physician Decision|3|||
131516301|NCT02075840|473520101|FG000|Overall Study|Ongoing at CCOD|99|||
131516302|NCT02075840|473520102|FG001|Overall Study|Ongoing at CCOD|82|||
131516303|NCT00846742|473520103|FG000|Overall Study|Withdrawal by Subject|1|||
131516304|NCT03795610|473520104|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
131516305|NCT03795610|473520104|FG000|Overall Study|Withdrawal by Subject|1|||
131516306|NCT03795610|473520104|FG000|Overall Study|Screen Failure (Unknown)|1|||
131516307|NCT04889625|473520121|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
131516308|NCT04889625|473520122|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
131516309|NCT04889625|473520121|FG000|Period 1|Subject out of window|0|||
131516310|NCT04889625|473520122|FG001|Period 1|Subject out of window|1|||
131516311|NCT04889625|473520121|FG000|Period 1|Wrong add power dispensed|0|||
131516312|NCT04889625|473520122|FG001|Period 1|Wrong add power dispensed|1|||
131516313|NCT04889625|473520121|FG000|Period 1|Discontinued due to fitting guide error|1|||
131516314|NCT04889625|473520122|FG001|Period 1|Discontinued due to fitting guide error|1|||
131516315|NCT04889625|473520121|FG000|Period 2|Test article no longer available|1|||
131516316|NCT04889625|473520122|FG001|Period 2|Test article no longer available|0|||
131516317|NCT04889625|473520121|FG000|Period 2|Incorrect lens dispensed|1|||
131516318|NCT04889625|473520122|FG001|Period 2|Incorrect lens dispensed|0|||
131516319|NCT04889625|473520121|FG000|Period 2|Wrong add power dispensed|0|||
131516320|NCT04889625|473520122|FG001|Period 2|Wrong add power dispensed|1|||
131516321|NCT02043015|473520129|FG000|Overall Study|Lost to Follow-up|4|||
131516322|NCT02043015|473520129|FG000|Overall Study|Withdrawal by Subject|4|||
131516323|NCT02043015|473520129|FG000|Overall Study|Removed once target enrollment reached|15|||
131516324|NCT02043015|473520129|FG000|Overall Study|Participant moved away from study city|4|||
131516325|NCT02043015|473520129|FG000|Overall Study|Incarceration|1|||
131516326|NCT04049760|473520131|FG000|Overall Study|Withdrawal by Subject|1|||
131516327|NCT01494610|473520143|FG000|Period 1|Withdrawal by Subject|1|||
131516328|NCT01494610|473520144|FG001|Period 1|Withdrawal by Subject|1|||
131516329|NCT01494610|473520143|FG000|Period 3|Adverse Event|1|||
131516330|NCT01494610|473520144|FG001|Period 3|Adverse Event|0|||
131516331|NCT01494610|473520143|FG000|Period 3|Withdrawal by Subject|1|||
131516332|NCT01494610|473520144|FG001|Period 3|Withdrawal by Subject|0|||
131516333|NCT01494610|473520143|FG000|Period 4|Protocol Violation|1|||
131516334|NCT01494610|473520144|FG001|Period 4|Protocol Violation|0|||
131516335|NCT00477672|473520148|FG000|Overall Study|Adverse Event|3|||
131516336|NCT00477672|473520149|FG001|Overall Study|Adverse Event|5|||
131516337|NCT00477672|473520150|FG002|Overall Study|Adverse Event|6|||
131516338|NCT00477672|473520148|FG000|Overall Study|Death|0|||
131516339|NCT00477672|473520149|FG001|Overall Study|Death|1|||
131516340|NCT00477672|473520150|FG002|Overall Study|Death|0|||
131516341|NCT00477672|473520148|FG000|Overall Study|Disease progression|0|||
131516342|NCT00477672|473520149|FG001|Overall Study|Disease progression|1|||
131516343|NCT00477672|473520150|FG002|Overall Study|Disease progression|0|||
131516344|NCT00477672|473520148|FG000|Overall Study|Physician Decision|1|||
131516345|NCT00477672|473520149|FG001|Overall Study|Physician Decision|0|||
131516346|NCT00477672|473520150|FG002|Overall Study|Physician Decision|0|||
131516347|NCT00477672|473520148|FG000|Overall Study|Protocol noncompliance|0|||
131516348|NCT00477672|473520149|FG001|Overall Study|Protocol noncompliance|2|||
131516349|NCT00477672|473520150|FG002|Overall Study|Protocol noncompliance|0|||
131516350|NCT00477672|473520148|FG000|Overall Study|Consent withdrawn|2|||
131516351|NCT00477672|473520149|FG001|Overall Study|Consent withdrawn|5|||
131516352|NCT00477672|473520150|FG002|Overall Study|Consent withdrawn|10|||
131516353|NCT00477672|473520148|FG000|Overall Study|Discretion of Sponsor|1|||
131516354|NCT00477672|473520149|FG001|Overall Study|Discretion of Sponsor|2|||
131516355|NCT00477672|473520150|FG002|Overall Study|Discretion of Sponsor|0|||
131516356|NCT03571516|473520151|FG000|Overall Study|Severe diarrhea|1|||
131516357|NCT03571516|473520152|FG001|Overall Study|Severe diarrhea|0|||
131516358|NCT03571516|473520151|FG000|Overall Study|Withdrawal by Subject|0|||
131516359|NCT03571516|473520152|FG001|Overall Study|Withdrawal by Subject|1|||
131516360|NCT00677807|473520156|FG000|Overall Study|Adverse Event|4|||
131516361|NCT00677807|473520157|FG001|Overall Study|Adverse Event|1|||
131516362|NCT00677807|473520158|FG002|Overall Study|Adverse Event|6|||
131516363|NCT00677807|473520156|FG000|Overall Study|Lack of Efficacy|0|||
131516364|NCT00677807|473520157|FG001|Overall Study|Lack of Efficacy|0|||
131516365|NCT00677807|473520158|FG002|Overall Study|Lack of Efficacy|2|||
131516366|NCT00677807|473520156|FG000|Overall Study|Participant no longer needs study drug|0|||
131516367|NCT00677807|473520157|FG001|Overall Study|Participant no longer needs study drug|0|||
131516368|NCT00677807|473520158|FG002|Overall Study|Participant no longer needs study drug|1|||
131516369|NCT00677807|473520156|FG000|Overall Study|Withdrawal by Subject|10|||
131516370|NCT00677807|473520157|FG001|Overall Study|Withdrawal by Subject|3|||
131516371|NCT00677807|473520158|FG002|Overall Study|Withdrawal by Subject|6|||
131516372|NCT00677807|473520156|FG000|Overall Study|Lost to Follow-up|2|||
131516373|NCT00677807|473520157|FG001|Overall Study|Lost to Follow-up|2|||
131516374|NCT00677807|473520158|FG002|Overall Study|Lost to Follow-up|2|||
131516375|NCT00677807|473520156|FG000|Overall Study|Administrative problems|1|||
131516376|NCT00677807|473520157|FG001|Overall Study|Administrative problems|1|||
131516377|NCT00677807|473520158|FG002|Overall Study|Administrative problems|2|||
131516378|NCT00677807|473520156|FG000|Overall Study|Death|0|||
131516379|NCT00677807|473520157|FG001|Overall Study|Death|1|||
131516380|NCT00677807|473520158|FG002|Overall Study|Death|1|||
131516381|NCT00677807|473520156|FG000|Overall Study|Protocol Deviation|1|||
131516382|NCT00677807|473520157|FG001|Overall Study|Protocol Deviation|3|||
131516383|NCT00677807|473520158|FG002|Overall Study|Protocol Deviation|0|||
131516384|NCT04019041|473520159|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
131516385|NCT04019041|473520160|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
131516386|NCT04019041|473520161|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
131516387|NCT04019041|473520162|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
131516388|NCT04019041|473520163|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
131516389|NCT04019041|473520164|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
131516390|NCT04019041|473520159|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
131516391|NCT04019041|473520160|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
131516392|NCT04019041|473520161|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
131516393|NCT04019041|473520162|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
131516394|NCT04019041|473520163|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
131516395|NCT04019041|473520164|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
131516396|NCT04019041|473520159|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
131516397|NCT04019041|473520160|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
131516398|NCT04019041|473520161|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
131516399|NCT04019041|473520162|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
131516400|NCT04019041|473520163|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
131516401|NCT04019041|473520164|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
131516402|NCT04019041|473520159|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
131516403|NCT04019041|473520160|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
131516404|NCT04019041|473520161|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
131516405|NCT04019041|473520162|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
131516406|NCT04019041|473520163|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
131516407|NCT04019041|473520164|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
131516408|NCT04019041|473520159|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131516409|NCT04019041|473520160|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131516410|NCT04019041|473520161|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131516411|NCT04019041|473520162|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
131516412|NCT04019041|473520163|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
131516413|NCT04019041|473520164|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
131516414|NCT04019041|473520159|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
131516415|NCT04019041|473520160|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
131516416|NCT04019041|473520161|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
131516417|NCT04019041|473520162|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
131516418|NCT04019041|473520163|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
131516419|NCT04019041|473520164|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
131516420|NCT04019041|473520159|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131516421|NCT04019041|473520160|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131516422|NCT04019041|473520161|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131516423|NCT04019041|473520162|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131516424|NCT04019041|473520163|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
131516425|NCT04019041|473520164|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131516426|NCT04019041|473520159|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131516427|NCT04019041|473520160|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131516428|NCT04019041|473520161|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131516429|NCT04019041|473520162|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
131516430|NCT04019041|473520163|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
131516431|NCT04019041|473520164|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
131516432|NCT04019041|473520159|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131516433|NCT04019041|473520160|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131516434|NCT04019041|473520161|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131516435|NCT04019041|473520162|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131516436|NCT04019041|473520163|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
131516437|NCT04019041|473520164|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
131516438|NCT03925727|473520165|FG000|Overall Study|Adverse Event|4|||
131516439|NCT03925727|473520166|FG001|Overall Study|Adverse Event|0|||
131516440|NCT03925727|473520167|FG002|Overall Study|Adverse Event|3|||
131516441|NCT03925727|473520165|FG000|Overall Study|Protocol Violation|1|||
131516442|NCT03925727|473520166|FG001|Overall Study|Protocol Violation|2|||
131516443|NCT03925727|473520167|FG002|Overall Study|Protocol Violation|2|||
131516444|NCT03925727|473520165|FG000|Overall Study|Withdrawal by Subject|3|||
131516445|NCT03925727|473520166|FG001|Overall Study|Withdrawal by Subject|2|||
131516446|NCT03925727|473520167|FG002|Overall Study|Withdrawal by Subject|4|||
131516447|NCT03925727|473520165|FG000|Overall Study|Administrative Reasons|3|||
131516448|NCT03925727|473520166|FG001|Overall Study|Administrative Reasons|1|||
131516449|NCT03925727|473520167|FG002|Overall Study|Administrative Reasons|2|||
131516450|NCT03925727|473520165|FG000|Overall Study|Randomized in error or Disqualified|8|||
131516451|NCT03925727|473520166|FG001|Overall Study|Randomized in error or Disqualified|1|||
131516452|NCT03925727|473520167|FG002|Overall Study|Randomized in error or Disqualified|7|||
131516453|NCT00314366|473520168|FG000|Overall Study|not treated due to patient medical condi|1|||
131516454|NCT00314366|473520169|FG001|Overall Study|not treated due to patient medical condi|0|||
131516455|NCT01393743|473520170|FG000|Core Study|Adverse Event|5|||
131516456|NCT01393743|473520171|FG001|Core Study|Adverse Event|9|||
131516457|NCT01393743|473520172|FG002|Core Study|Adverse Event|0|||
131516458|NCT01393743|473520170|FG000|Core Study|Lost to Follow-up|1|||
131516459|NCT01393743|473520171|FG001|Core Study|Lost to Follow-up|1|||
131516460|NCT01393743|473520172|FG002|Core Study|Lost to Follow-up|0|||
131516461|NCT01393743|473520170|FG000|Core Study|Participant's Choice|2|||
131516462|NCT01393743|473520171|FG001|Core Study|Participant's Choice|3|||
131516463|NCT01393743|473520172|FG002|Core Study|Participant's Choice|0|||
131516464|NCT01393743|473520170|FG000|Core Study|Inadequate therapeutic effect|2|||
131516465|NCT01393743|473520171|FG001|Core Study|Inadequate therapeutic effect|0|||
131516466|NCT01393743|473520172|FG002|Core Study|Inadequate therapeutic effect|0|||
131516467|NCT01393743|473520170|FG000|Extension Phase|Adverse Event|0|||
131516468|NCT01393743|473520171|FG001|Extension Phase|Adverse Event|0|||
131516469|NCT01393743|473520172|FG002|Extension Phase|Adverse Event|12|||
131516470|NCT01393743|473520170|FG000|Extension Phase|Lost to Follow-up|0|||
131516471|NCT01393743|473520171|FG001|Extension Phase|Lost to Follow-up|0|||
131516472|NCT01393743|473520172|FG002|Extension Phase|Lost to Follow-up|2|||
131516473|NCT01393743|473520170|FG000|Extension Phase|Participant choice|0|||
131516474|NCT01393743|473520171|FG001|Extension Phase|Participant choice|0|||
131516475|NCT01393743|473520172|FG002|Extension Phase|Participant choice|16|||
131516476|NCT01393743|473520170|FG000|Extension Phase|Inadequate therapeutic effect|0|||
131516477|NCT01393743|473520171|FG001|Extension Phase|Inadequate therapeutic effect|0|||
131516478|NCT01393743|473520172|FG002|Extension Phase|Inadequate therapeutic effect|7|||
131516479|NCT01393743|473520170|FG000|Extension Phase|Withdrawal by Subject|0|||
131516480|NCT01393743|473520171|FG001|Extension Phase|Withdrawal by Subject|0|||
131516481|NCT01393743|473520172|FG002|Extension Phase|Withdrawal by Subject|8|||
131516482|NCT01393743|473520170|FG000|Extension Phase|Pregnancy|0|||
131516483|NCT01393743|473520171|FG001|Extension Phase|Pregnancy|0|||
131516484|NCT01393743|473520172|FG002|Extension Phase|Pregnancy|1|||
131516485|NCT01393743|473520170|FG000|Extension Phase|Other|0|||
131516486|NCT01393743|473520171|FG001|Extension Phase|Other|0|||
131516487|NCT01393743|473520172|FG002|Extension Phase|Other|14|||
131516488|NCT03044197|473520181|FG000|Overall Study|Withdrawal by Subject|3|||
131516489|NCT03044197|473520182|FG001|Overall Study|Withdrawal by Subject|1|||
131516490|NCT01282424|473520186|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
131516491|NCT01282424|473520186|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
131516492|NCT01282424|473520186|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
131516493|NCT01282424|473520186|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
131516494|NCT01282424|473520186|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
131516495|NCT01282424|473520186|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
131516496|NCT01282424|473520186|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
131516497|NCT01282424|473520186|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
131516498|NCT05308901|473522155|FG000|Overall Study|Death|6|||
131516499|NCT01904604|473522156|FG000|Overall Study|Withdrew before receiving dosing|0|||
131516500|NCT01904604|473522157|FG001|Overall Study|Withdrew before receiving dosing|1|||
131516501|NCT01904604|473522158|FG002|Overall Study|Withdrew before receiving dosing|0|||
131516502|NCT01904604|473522156|FG000|Overall Study|Non-compliance|1|||
131516503|NCT01904604|473522157|FG001|Overall Study|Non-compliance|0|||
131516504|NCT01904604|473522158|FG002|Overall Study|Non-compliance|0|||
131516505|NCT01904604|473522156|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
131516506|NCT01904604|473522157|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
131516507|NCT01904604|473522158|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
131516508|NCT01904604|473522156|FG000|Overall Study|Patch site reactions|1|||
131516509|NCT01904604|473522157|FG001|Overall Study|Patch site reactions|1|||
131516510|NCT01904604|473522158|FG002|Overall Study|Patch site reactions|0|||
131516511|NCT01904604|473522156|FG000|Overall Study|Increased syncope|0|||
131516512|NCT01904604|473522157|FG001|Overall Study|Increased syncope|1|||
131516513|NCT01904604|473522158|FG002|Overall Study|Increased syncope|0|||
131516514|NCT01904604|473522156|FG000|Overall Study|Unrelated illness|0|||
131516515|NCT01904604|473522157|FG001|Overall Study|Unrelated illness|1|||
131516516|NCT01904604|473522158|FG002|Overall Study|Unrelated illness|0|||
131516517|NCT01904604|473522156|FG000|Overall Study|Passed Week 52 OFC|1|||
131516518|NCT01904604|473522157|FG001|Overall Study|Passed Week 52 OFC|0|||
131516519|NCT01904604|473522158|FG002|Overall Study|Passed Week 52 OFC|0|||
131516520|NCT01904604|473522156|FG000|Overall Study|Withdrawal by Subject|1|||
131516521|NCT01904604|473522157|FG001|Overall Study|Withdrawal by Subject|2|||
131516522|NCT01904604|473522158|FG002|Overall Study|Withdrawal by Subject|0|||
131516523|NCT01904604|473522156|FG000|Overall Study|Participant Relocated|1|||
131516524|NCT01904604|473522157|FG001|Overall Study|Participant Relocated|1|||
131516525|NCT01904604|473522158|FG002|Overall Study|Participant Relocated|1|||
131516526|NCT01904604|473522156|FG000|Overall Study|Lost to Follow-up|0|||
131516527|NCT01904604|473522157|FG001|Overall Study|Lost to Follow-up|0|||
131516528|NCT01904604|473522158|FG002|Overall Study|Lost to Follow-up|1|||
131516529|NCT01481116|473522161|FG000|Overall Study|Adverse Event|26|||
131516530|NCT01481116|473522162|FG001|Overall Study|Adverse Event|26|||
131516531|NCT01481116|473522163|FG002|Overall Study|Adverse Event|42|||
131516532|NCT01481116|473522161|FG000|Overall Study|Major Protocol Deviation|3|||
131516533|NCT01481116|473522162|FG001|Overall Study|Major Protocol Deviation|7|||
131516534|NCT01481116|473522163|FG002|Overall Study|Major Protocol Deviation|1|||
131516535|NCT01481116|473522161|FG000|Overall Study|Lost to Follow-up|8|||
131516536|NCT01481116|473522162|FG001|Overall Study|Lost to Follow-up|12|||
131516537|NCT01481116|473522163|FG002|Overall Study|Lost to Follow-up|11|||
131516538|NCT01481116|473522161|FG000|Overall Study|Withdrawal by Subject|37|||
131516539|NCT01481116|473522162|FG001|Overall Study|Withdrawal by Subject|33|||
131516540|NCT01481116|473522163|FG002|Overall Study|Withdrawal by Subject|37|||
131516541|NCT01481116|473522161|FG000|Overall Study|Study Termination|730|||
131516542|NCT01481116|473522162|FG001|Overall Study|Study Termination|729|||
131516543|NCT01481116|473522163|FG002|Overall Study|Study Termination|713|||
131516544|NCT01481116|473522161|FG000|Overall Study|Pregnancy|0|||
131516545|NCT01481116|473522162|FG001|Overall Study|Pregnancy|0|||
131516546|NCT01481116|473522163|FG002|Overall Study|Pregnancy|1|||
131516547|NCT01481116|473522161|FG000|Overall Study|Lack of Efficacy|3|||
131516548|NCT01481116|473522162|FG001|Overall Study|Lack of Efficacy|3|||
131516549|NCT01481116|473522163|FG002|Overall Study|Lack of Efficacy|1|||
131516550|NCT01481116|473522161|FG000|Overall Study|Contraindications|1|||
131516551|NCT01481116|473522162|FG001|Overall Study|Contraindications|1|||
131516552|NCT01481116|473522163|FG002|Overall Study|Contraindications|0|||
131516553|NCT01481116|473522161|FG000|Overall Study|Other|1|||
131516554|NCT01481116|473522162|FG001|Overall Study|Other|1|||
131516555|NCT01481116|473522163|FG002|Overall Study|Other|0|||
131516556|NCT01481116|473522161|FG000|Overall Study|Participant Started Taking Glipizide|1|||
131516557|NCT01481116|473522162|FG001|Overall Study|Participant Started Taking Glipizide|0|||
131516558|NCT01481116|473522163|FG002|Overall Study|Participant Started Taking Glipizide|0|||
131516559|NCT01481116|473522161|FG000|Overall Study|Participant Moved Out of Area|2|||
131516560|NCT01481116|473522162|FG001|Overall Study|Participant Moved Out of Area|0|||
131516561|NCT01481116|473522163|FG002|Overall Study|Participant Moved Out of Area|1|||
131516562|NCT01481116|473522161|FG000|Overall Study|Participant Moved Out of Country|1|||
131516563|NCT01481116|473522162|FG001|Overall Study|Participant Moved Out of Country|0|||
131516564|NCT01481116|473522163|FG002|Overall Study|Participant Moved Out of Country|1|||
131516565|NCT01481116|473522161|FG000|Overall Study|Investigator Decision|3|||
131516566|NCT01481116|473522162|FG001|Overall Study|Investigator Decision|2|||
131516567|NCT01481116|473522163|FG002|Overall Study|Investigator Decision|1|||
131516568|NCT01481116|473522161|FG000|Overall Study|Sponsor Decision|0|||
131516569|NCT01481116|473522162|FG001|Overall Study|Sponsor Decision|1|||
131516570|NCT01481116|473522163|FG002|Overall Study|Sponsor Decision|3|||
131516571|NCT01481116|473522161|FG000|Overall Study|Non-Compliant With Study Drug|0|||
131516572|NCT01481116|473522162|FG001|Overall Study|Non-Compliant With Study Drug|1|||
131516573|NCT01481116|473522163|FG002|Overall Study|Non-Compliant With Study Drug|1|||
131516574|NCT01481116|473522161|FG000|Overall Study|Investigator's Discretion|2|||
131516575|NCT01481116|473522162|FG001|Overall Study|Investigator's Discretion|0|||
131516576|NCT01481116|473522163|FG002|Overall Study|Investigator's Discretion|0|||
131516577|NCT01481116|473522161|FG000|Overall Study|Death|2|||
131516578|NCT01481116|473522162|FG001|Overall Study|Death|1|||
131516579|NCT01481116|473522163|FG002|Overall Study|Death|0|||
131516580|NCT01481116|473522161|FG000|Overall Study|Hypoglycemic Event|4|||
131516581|NCT01481116|473522162|FG001|Overall Study|Hypoglycemic Event|0|||
131516582|NCT01481116|473522163|FG002|Overall Study|Hypoglycemic Event|0|||
131516583|NCT00640510|473522164|FG000|Overall Study|Lack of Efficacy|0|||
131516584|NCT00640510|473522165|FG001|Overall Study|Lack of Efficacy|1|||
131516585|NCT00640510|473522164|FG000|Overall Study|Protocol Violation|1|||
131516586|NCT00640510|473522165|FG001|Overall Study|Protocol Violation|0|||
131516587|NCT00640510|473522164|FG000|Overall Study|Physician Decision|0|||
131516588|NCT00640510|473522165|FG001|Overall Study|Physician Decision|1|||
131516589|NCT00192075|473522166|FG000|Overall Study|Disease Progression|23|||
131516590|NCT00192075|473522167|FG001|Overall Study|Disease Progression|6|||
131516591|NCT00192075|473522166|FG000|Overall Study|Adverse Event|1|||
131516592|NCT00192075|473522167|FG001|Overall Study|Adverse Event|3|||
131516593|NCT00192075|473522166|FG000|Overall Study|Death|0|||
131516594|NCT00192075|473522167|FG001|Overall Study|Death|1|||
131516595|NCT00192075|473522166|FG000|Overall Study|Lack of Efficacy|0|||
131516596|NCT00192075|473522167|FG001|Overall Study|Lack of Efficacy|0|||
131516597|NCT00192075|473522166|FG000|Overall Study|Physician Decision|3|||
131516598|NCT00192075|473522167|FG001|Overall Study|Physician Decision|0|||
131516599|NCT00192075|473522166|FG000|Overall Study|Withdrawal by Subject|5|||
131516600|NCT00192075|473522167|FG001|Overall Study|Withdrawal by Subject|5|||
131516601|NCT00192075|473522166|FG000|Overall Study|Patient Non-Compliance|0|||
131516602|NCT00192075|473522167|FG001|Overall Study|Patient Non-Compliance|1|||
131516603|NCT00192075|473522166|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
131516604|NCT00192075|473522167|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
131516605|NCT00192075|473522166|FG000|Overall Study|Other|5|||
131516606|NCT00192075|473522167|FG001|Overall Study|Other|2|||
131516607|NCT03325166|473522173|FG000|Overall Study|Adverse Event|1|||
131516608|NCT00910715|473522176|FG000|Overall Study|Lost to Follow-up|22|||
131516609|NCT00910715|473522177|FG001|Overall Study|Lost to Follow-up|26|||
131516610|NCT00910715|473522178|FG002|Overall Study|Lost to Follow-up|0|||
131516611|NCT00770120|473522179|FG000|Overall Study|Progression|31|||
131516612|NCT00770120|473522179|FG000|Overall Study|Adverse Event|11|||
131516613|NCT00770120|473522179|FG000|Overall Study|Not Protocol Specified|11|||
131516614|NCT00770120|473522179|FG000|Overall Study|Death|3|||
131516615|NCT00770120|473522179|FG000|Overall Study|Withdrawal by Subject|2|||
131516616|NCT00770120|473522179|FG000|Overall Study|Ineligible|1|||
131516617|NCT00770120|473522179|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
131516618|NCT00770120|473522179|FG000|Overall Study|Reason under Review|1|||
131516619|NCT01782313|473522180|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
131516620|NCT01782313|473522180|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
131516621|NCT01782313|473522180|FG000|Treated Cycle 3|Progressive Disease|21|||
131516622|NCT01782313|473522180|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
131516623|NCT01782313|473522180|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
131516624|NCT01782313|473522180|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
131516625|NCT01782313|473522180|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
131516626|NCT01782313|473522180|FG000|Survival Follow up|Lost to Follow-up|1|||
131516627|NCT03761628|473522181|FG000|Overall Study|Withdrawal by Subject|3|||
131516628|NCT03761628|473522181|FG000|Overall Study|Physician Decision|1|||
131516629|NCT03761628|473522181|FG000|Overall Study|Pregnancy|1|||
131516630|NCT03761628|473522181|FG000|Overall Study|Lost to Follow-up|1|||
131516631|NCT05358821|473522184|FG000|Overall Study|Withdrawal by Subject|0|||
131516632|NCT05358821|473522185|FG001|Overall Study|Withdrawal by Subject|1|||
131516633|NCT05358821|473522186|FG002|Overall Study|Withdrawal by Subject|0|||
131516634|NCT05358821|473522184|FG000|Overall Study|Withdrawal of Consent|0|||
131516635|NCT05358821|473522185|FG001|Overall Study|Withdrawal of Consent|0|||
131516636|NCT05358821|473522186|FG002|Overall Study|Withdrawal of Consent|1|||
131516637|NCT03752619|473522187|FG000|Overall Study|Lost to Follow-up|2|||
131516638|NCT03752619|473522188|FG001|Overall Study|Lost to Follow-up|1|||
131516639|NCT03752619|473522187|FG000|Overall Study|Withdrawal by Subject|1|||
131516640|NCT03752619|473522188|FG001|Overall Study|Withdrawal by Subject|1|||
131516641|NCT03752619|473522187|FG000|Overall Study|Adverse Event|0|||
131516642|NCT03752619|473522188|FG001|Overall Study|Adverse Event|1|||
131516643|NCT03907683|473522189|FG000|Overall Study|Pregnancy|1|||
131516644|NCT03907683|473522189|FG000|Overall Study|Withdrawal by Subject|1|||
131516645|NCT03400332|473522190|FG000|Pre-Treatment|Other reasons|0|||
131516646|NCT03400332|473522191|FG001|Pre-Treatment|Other reasons|0|||
131516647|NCT03400332|473522192|FG002|Pre-Treatment|Other reasons|0|||
131516648|NCT03400332|473522193|FG003|Pre-Treatment|Other reasons|0|||
131516649|NCT03400332|473522194|FG004|Pre-Treatment|Other reasons|0|||
131516650|NCT03400332|473522195|FG005|Pre-Treatment|Other reasons|0|||
131516651|NCT03400332|473522196|FG006|Pre-Treatment|Other reasons|0|||
131516652|NCT03400332|473522197|FG007|Pre-Treatment|Other reasons|0|||
131516653|NCT03400332|473522198|FG008|Pre-Treatment|Other reasons|1|||
131516654|NCT03400332|473522190|FG000|Pre-Treatment|No longer met study criteria|0|||
131516655|NCT03400332|473522191|FG001|Pre-Treatment|No longer met study criteria|0|||
131516656|NCT03400332|473522192|FG002|Pre-Treatment|No longer met study criteria|0|||
131516657|NCT03400332|473522193|FG003|Pre-Treatment|No longer met study criteria|0|||
131516658|NCT03400332|473522194|FG004|Pre-Treatment|No longer met study criteria|0|||
131516659|NCT03400332|473522195|FG005|Pre-Treatment|No longer met study criteria|0|||
131516660|NCT03400332|473522196|FG006|Pre-Treatment|No longer met study criteria|0|||
131516661|NCT03400332|473522197|FG007|Pre-Treatment|No longer met study criteria|0|||
131516662|NCT03400332|473522198|FG008|Pre-Treatment|No longer met study criteria|1|||
131516663|NCT03400332|473522190|FG000|Pre-Treatment|Withdrawal by Subject|0|||
131516664|NCT03400332|473522191|FG001|Pre-Treatment|Withdrawal by Subject|0|||
131516665|NCT03400332|473522192|FG002|Pre-Treatment|Withdrawal by Subject|0|||
131516666|NCT03400332|473522193|FG003|Pre-Treatment|Withdrawal by Subject|0|||
131516667|NCT03400332|473522194|FG004|Pre-Treatment|Withdrawal by Subject|0|||
131516668|NCT03400332|473522195|FG005|Pre-Treatment|Withdrawal by Subject|0|||
131516669|NCT03400332|473522196|FG006|Pre-Treatment|Withdrawal by Subject|0|||
131516670|NCT03400332|473522197|FG007|Pre-Treatment|Withdrawal by Subject|0|||
131516671|NCT03400332|473522198|FG008|Pre-Treatment|Withdrawal by Subject|1|||
131516672|NCT03400332|473522190|FG000|Treatment|Participant withdrew consent|2|||
131516673|NCT03400332|473522191|FG001|Treatment|Participant withdrew consent|2|||
131516674|NCT03400332|473522192|FG002|Treatment|Participant withdrew consent|0|||
131516675|NCT03400332|473522193|FG003|Treatment|Participant withdrew consent|0|||
131516676|NCT03400332|473522194|FG004|Treatment|Participant withdrew consent|3|||
131516677|NCT03400332|473522195|FG005|Treatment|Participant withdrew consent|3|||
131516678|NCT03400332|473522196|FG006|Treatment|Participant withdrew consent|1|||
131516679|NCT03400332|473522197|FG007|Treatment|Participant withdrew consent|1|||
131516680|NCT03400332|473522198|FG008|Treatment|Participant withdrew consent|1|||
131516681|NCT03400332|473522190|FG000|Treatment|Other reasons|0|||
131516682|NCT03400332|473522191|FG001|Treatment|Other reasons|1|||
131516683|NCT03400332|473522192|FG002|Treatment|Other reasons|1|||
131516684|NCT03400332|473522193|FG003|Treatment|Other reasons|0|||
131516685|NCT03400332|473522194|FG004|Treatment|Other reasons|3|||
131516686|NCT03400332|473522195|FG005|Treatment|Other reasons|1|||
131516687|NCT03400332|473522196|FG006|Treatment|Other reasons|2|||
131516688|NCT03400332|473522197|FG007|Treatment|Other reasons|0|||
131516689|NCT03400332|473522198|FG008|Treatment|Other reasons|1|||
131516690|NCT03400332|473522190|FG000|Treatment|Lost to Follow-up|0|||
131516691|NCT03400332|473522191|FG001|Treatment|Lost to Follow-up|1|||
131516692|NCT03400332|473522192|FG002|Treatment|Lost to Follow-up|0|||
131516693|NCT03400332|473522193|FG003|Treatment|Lost to Follow-up|0|||
131516694|NCT03400332|473522194|FG004|Treatment|Lost to Follow-up|0|||
131516695|NCT03400332|473522195|FG005|Treatment|Lost to Follow-up|0|||
131516696|NCT03400332|473522196|FG006|Treatment|Lost to Follow-up|0|||
131516697|NCT03400332|473522197|FG007|Treatment|Lost to Follow-up|0|||
131516698|NCT03400332|473522198|FG008|Treatment|Lost to Follow-up|0|||
131516699|NCT03400332|473522190|FG000|Treatment|Death|3|||
131516700|NCT03400332|473522191|FG001|Treatment|Death|1|||
131653776|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131516701|NCT03400332|473522192|FG002|Treatment|Death|2|||
131516702|NCT03400332|473522193|FG003|Treatment|Death|3|||
131516703|NCT03400332|473522194|FG004|Treatment|Death|6|||
131516704|NCT03400332|473522195|FG005|Treatment|Death|2|||
131516705|NCT03400332|473522196|FG006|Treatment|Death|1|||
131516706|NCT03400332|473522197|FG007|Treatment|Death|3|||
131516707|NCT03400332|473522198|FG008|Treatment|Death|6|||
131516708|NCT02704364|473522199|FG000|Overall Study|Adverse Event|1|||
131516709|NCT02704364|473522200|FG001|Overall Study|Adverse Event|1|||
131516710|NCT02704364|473522201|FG002|Overall Study|Adverse Event|0|||
131516711|NCT02704364|473522199|FG000|Overall Study|Noncompliance with study drug|1|||
131516712|NCT02704364|473522200|FG001|Overall Study|Noncompliance with study drug|1|||
131516713|NCT02704364|473522201|FG002|Overall Study|Noncompliance with study drug|0|||
131516714|NCT02704364|473522199|FG000|Overall Study|Other|0|||
131516715|NCT02704364|473522200|FG001|Overall Study|Other|1|||
131516716|NCT02704364|473522201|FG002|Overall Study|Other|1|||
131516717|NCT02975934|473522202|FG000|Treatment Phase|Never initiated study drug|0|||
131516718|NCT02975934|473522203|FG001|Treatment Phase|Never initiated study drug|5|||
131516719|NCT02975934|473522204|FG002|Treatment Phase|Never initiated study drug|0|||
131516720|NCT03362502|473522205|FG000|Overall Study|Death|0|||
131516721|NCT03362502|473522206|FG001|Overall Study|Death|0|||
131516722|NCT03362502|473522207|FG002|Overall Study|Death|1|||
131516723|NCT02018458|473522208|FG000|Overall Study|Death|4|||
131516724|NCT02027844|473522232|FG000|Overall Study|Withdrawal by Subject|3|||
131516725|NCT02027844|473522233|FG001|Overall Study|Withdrawal by Subject|2|||
131516726|NCT02027844|473522234|FG002|Overall Study|Withdrawal by Subject|1|||
131516727|NCT02027844|473522232|FG000|Overall Study|Lost to Follow-up|0|||
131516728|NCT02027844|473522233|FG001|Overall Study|Lost to Follow-up|2|||
131516729|NCT02027844|473522234|FG002|Overall Study|Lost to Follow-up|1|||
131516730|NCT02027844|473522232|FG000|Overall Study|Protocol Violation|0|||
131516731|NCT02027844|473522233|FG001|Overall Study|Protocol Violation|2|||
131516732|NCT02027844|473522234|FG002|Overall Study|Protocol Violation|0|||
131516733|NCT02027844|473522232|FG000|Overall Study|Incomlete data|2|||
131516734|NCT02027844|473522233|FG001|Overall Study|Incomlete data|0|||
131516735|NCT02027844|473522234|FG002|Overall Study|Incomlete data|0|||
131516736|NCT00354172|473522235|FG000|Overall Study|Did not receive transplant|1|||
131516737|NCT02659020|473522239|FG000|Overall Study|Adverse Event|0|||
131516738|NCT02659020|473522240|FG001|Overall Study|Adverse Event|0|||
131516739|NCT02659020|473522241|FG002|Overall Study|Adverse Event|0|||
131516740|NCT02659020|473522242|FG003|Overall Study|Adverse Event|2|||
131516741|NCT02659020|473522243|FG004|Overall Study|Adverse Event|0|||
131516742|NCT02659020|473522244|FG005|Overall Study|Adverse Event|0|||
131516743|NCT02659020|473522245|FG006|Overall Study|Adverse Event|2|||
131516744|NCT02659020|473522239|FG000|Overall Study|Lost to Follow-up|1|||
131516745|NCT02659020|473522240|FG001|Overall Study|Lost to Follow-up|2|||
131516746|NCT02659020|473522241|FG002|Overall Study|Lost to Follow-up|1|||
131516747|NCT02659020|473522242|FG003|Overall Study|Lost to Follow-up|6|||
131516748|NCT02659020|473522243|FG004|Overall Study|Lost to Follow-up|1|||
131516749|NCT02659020|473522244|FG005|Overall Study|Lost to Follow-up|5|||
131516750|NCT02659020|473522245|FG006|Overall Study|Lost to Follow-up|0|||
131516751|NCT02659020|473522239|FG000|Overall Study|Physician Decision|0|||
131516752|NCT02659020|473522240|FG001|Overall Study|Physician Decision|0|||
131516753|NCT02659020|473522241|FG002|Overall Study|Physician Decision|0|||
131516754|NCT02659020|473522242|FG003|Overall Study|Physician Decision|1|||
131516755|NCT02659020|473522243|FG004|Overall Study|Physician Decision|1|||
131516756|NCT02659020|473522244|FG005|Overall Study|Physician Decision|0|||
131516757|NCT02659020|473522245|FG006|Overall Study|Physician Decision|1|||
131516758|NCT02659020|473522239|FG000|Overall Study|Withdrawal by Subject|2|||
131516759|NCT02659020|473522240|FG001|Overall Study|Withdrawal by Subject|1|||
131516760|NCT02659020|473522241|FG002|Overall Study|Withdrawal by Subject|0|||
131516761|NCT02659020|473522242|FG003|Overall Study|Withdrawal by Subject|3|||
131516762|NCT02659020|473522243|FG004|Overall Study|Withdrawal by Subject|3|||
131516763|NCT02659020|473522244|FG005|Overall Study|Withdrawal by Subject|6|||
131516764|NCT02659020|473522245|FG006|Overall Study|Withdrawal by Subject|3|||
131516765|NCT02659020|473522239|FG000|Overall Study|Progressive Disease|0|||
131516766|NCT02659020|473522240|FG001|Overall Study|Progressive Disease|0|||
131516767|NCT02659020|473522241|FG002|Overall Study|Progressive Disease|0|||
131516768|NCT02659020|473522242|FG003|Overall Study|Progressive Disease|4|||
131516769|NCT02659020|473522243|FG004|Overall Study|Progressive Disease|1|||
131516770|NCT02659020|473522244|FG005|Overall Study|Progressive Disease|0|||
131516771|NCT02659020|473522245|FG006|Overall Study|Progressive Disease|2|||
131516772|NCT04382911|473522246|FG000|Overall Study|unable to be imaged prior to surgery|2|||
131516773|NCT01120210|473522247|FG000|MAIN INFUSION|Adverse Event|1|||
131516774|NCT01120210|473522248|FG001|MAIN INFUSION|Adverse Event|0|||
131516775|NCT01120210|473522247|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
131516776|NCT01120210|473522248|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
131516777|NCT02052739|473522249|FG000|Overall Study|Withdrew due to Adverse Event|3|||
131516778|NCT02052739|473522250|FG001|Overall Study|Withdrew due to Adverse Event|0|||
131516779|NCT02052739|473522249|FG000|Overall Study|Participant Died|2|||
131516780|NCT02052739|473522250|FG001|Overall Study|Participant Died|1|||
131516781|NCT05619692|473522261|FG000|Overall Study|Adverse Event|2|||
131516782|NCT05619692|473522262|FG001|Overall Study|Adverse Event|2|||
131516783|NCT05619692|473522261|FG000|Overall Study|Withdrawal by Participant|3|||
131516784|NCT05619692|473522262|FG001|Overall Study|Withdrawal by Participant|4|||
131516785|NCT05619692|473522261|FG000|Overall Study|Lost to Follow-up|2|||
131516786|NCT05619692|473522262|FG001|Overall Study|Lost to Follow-up|1|||
131516787|NCT05619692|473522261|FG000|Overall Study|Randomized but not treated|1|||
131516788|NCT05619692|473522262|FG001|Overall Study|Randomized but not treated|3|||
131516789|NCT02457598|473522263|FG000|Overall Study|Progressive Disease|2|||
131516790|NCT02457598|473522264|FG001|Overall Study|Progressive Disease|2|||
131516791|NCT02457598|473522265|FG002|Overall Study|Progressive Disease|1|||
131516792|NCT02457598|473522266|FG003|Overall Study|Progressive Disease|11|||
131516793|NCT02457598|473522267|FG004|Overall Study|Progressive Disease|7|||
131516794|NCT02457598|473522268|FG005|Overall Study|Progressive Disease|3|||
131516795|NCT02457598|473522269|FG006|Overall Study|Progressive Disease|2|||
131516796|NCT02457598|473522270|FG007|Overall Study|Progressive Disease|1|||
131516797|NCT02457598|473522271|FG008|Overall Study|Progressive Disease|1|||
131516798|NCT02457598|473522272|FG009|Overall Study|Progressive Disease|2|||
131516799|NCT02457598|473522273|FG010|Overall Study|Progressive Disease|45|||
131516800|NCT02457598|473522274|FG011|Overall Study|Progressive Disease|6|||
131516801|NCT02457598|473522275|FG012|Overall Study|Progressive Disease|2|||
131516802|NCT02457598|473522276|FG013|Overall Study|Progressive Disease|2|||
131516803|NCT02457598|473522277|FG014|Overall Study|Progressive Disease|10|||
131516804|NCT02457598|473522278|FG015|Overall Study|Progressive Disease|1|||
131516805|NCT02457598|473522279|FG016|Overall Study|Progressive Disease|1|||
131516806|NCT02457598|473522263|FG000|Overall Study|Investigator's Discretion|0|||
131516807|NCT02457598|473522264|FG001|Overall Study|Investigator's Discretion|2|||
131516808|NCT02457598|473522265|FG002|Overall Study|Investigator's Discretion|2|||
131516809|NCT02457598|473522266|FG003|Overall Study|Investigator's Discretion|2|||
131516810|NCT02457598|473522267|FG004|Overall Study|Investigator's Discretion|0|||
131516811|NCT02457598|473522268|FG005|Overall Study|Investigator's Discretion|0|||
131516812|NCT02457598|473522269|FG006|Overall Study|Investigator's Discretion|0|||
131516813|NCT02457598|473522270|FG007|Overall Study|Investigator's Discretion|1|||
131516814|NCT02457598|473522271|FG008|Overall Study|Investigator's Discretion|2|||
131516815|NCT02457598|473522272|FG009|Overall Study|Investigator's Discretion|0|||
131516816|NCT02457598|473522273|FG010|Overall Study|Investigator's Discretion|10|||
131516817|NCT02457598|473522274|FG011|Overall Study|Investigator's Discretion|2|||
131516818|NCT02457598|473522275|FG012|Overall Study|Investigator's Discretion|2|||
131516819|NCT02457598|473522276|FG013|Overall Study|Investigator's Discretion|1|||
131516820|NCT02457598|473522277|FG014|Overall Study|Investigator's Discretion|5|||
131516821|NCT02457598|473522278|FG015|Overall Study|Investigator's Discretion|0|||
131516822|NCT02457598|473522279|FG016|Overall Study|Investigator's Discretion|0|||
131516823|NCT02457598|473522263|FG000|Overall Study|Study Terminated by Sponsor|0|||
131516824|NCT02457598|473522264|FG001|Overall Study|Study Terminated by Sponsor|1|||
131516825|NCT02457598|473522265|FG002|Overall Study|Study Terminated by Sponsor|0|||
131516826|NCT02457598|473522266|FG003|Overall Study|Study Terminated by Sponsor|4|||
131516827|NCT02457598|473522267|FG004|Overall Study|Study Terminated by Sponsor|1|||
131516828|NCT02457598|473522268|FG005|Overall Study|Study Terminated by Sponsor|0|||
131516829|NCT02457598|473522269|FG006|Overall Study|Study Terminated by Sponsor|1|||
131516830|NCT02457598|473522270|FG007|Overall Study|Study Terminated by Sponsor|0|||
131516831|NCT02457598|473522271|FG008|Overall Study|Study Terminated by Sponsor|0|||
131516832|NCT02457598|473522272|FG009|Overall Study|Study Terminated by Sponsor|0|||
131516833|NCT02457598|473522273|FG010|Overall Study|Study Terminated by Sponsor|4|||
131516834|NCT02457598|473522274|FG011|Overall Study|Study Terminated by Sponsor|0|||
131516835|NCT02457598|473522275|FG012|Overall Study|Study Terminated by Sponsor|1|||
131516836|NCT02457598|473522276|FG013|Overall Study|Study Terminated by Sponsor|0|||
131516837|NCT02457598|473522277|FG014|Overall Study|Study Terminated by Sponsor|8|||
131516838|NCT02457598|473522278|FG015|Overall Study|Study Terminated by Sponsor|1|||
131516839|NCT02457598|473522279|FG016|Overall Study|Study Terminated by Sponsor|0|||
131516840|NCT02457598|473522263|FG000|Overall Study|Adverse Event|0|||
131516841|NCT02457598|473522264|FG001|Overall Study|Adverse Event|1|||
131516842|NCT02457598|473522265|FG002|Overall Study|Adverse Event|1|||
131516843|NCT02457598|473522266|FG003|Overall Study|Adverse Event|4|||
131516844|NCT02457598|473522267|FG004|Overall Study|Adverse Event|1|||
131516845|NCT02457598|473522268|FG005|Overall Study|Adverse Event|0|||
131516846|NCT02457598|473522269|FG006|Overall Study|Adverse Event|0|||
131516847|NCT02457598|473522270|FG007|Overall Study|Adverse Event|1|||
131516848|NCT02457598|473522271|FG008|Overall Study|Adverse Event|0|||
131516849|NCT02457598|473522272|FG009|Overall Study|Adverse Event|1|||
131516850|NCT02457598|473522273|FG010|Overall Study|Adverse Event|6|||
131516851|NCT02457598|473522274|FG011|Overall Study|Adverse Event|0|||
131516852|NCT02457598|473522275|FG012|Overall Study|Adverse Event|0|||
131516853|NCT02457598|473522276|FG013|Overall Study|Adverse Event|1|||
131516854|NCT02457598|473522277|FG014|Overall Study|Adverse Event|2|||
131516855|NCT02457598|473522278|FG015|Overall Study|Adverse Event|0|||
131516856|NCT02457598|473522279|FG016|Overall Study|Adverse Event|0|||
131516857|NCT02457598|473522263|FG000|Overall Study|Death|0|||
131516858|NCT02457598|473522264|FG001|Overall Study|Death|0|||
131516859|NCT02457598|473522265|FG002|Overall Study|Death|0|||
131516860|NCT02457598|473522266|FG003|Overall Study|Death|3|||
131516861|NCT02457598|473522267|FG004|Overall Study|Death|0|||
131516862|NCT02457598|473522268|FG005|Overall Study|Death|1|||
131516863|NCT02457598|473522269|FG006|Overall Study|Death|0|||
131516864|NCT02457598|473522270|FG007|Overall Study|Death|0|||
131516865|NCT02457598|473522271|FG008|Overall Study|Death|0|||
131516866|NCT02457598|473522272|FG009|Overall Study|Death|0|||
131516867|NCT02457598|473522273|FG010|Overall Study|Death|3|||
131516868|NCT02457598|473522274|FG011|Overall Study|Death|0|||
131516869|NCT02457598|473522275|FG012|Overall Study|Death|0|||
131516870|NCT02457598|473522276|FG013|Overall Study|Death|1|||
131516871|NCT02457598|473522277|FG014|Overall Study|Death|2|||
131516872|NCT02457598|473522278|FG015|Overall Study|Death|0|||
131516873|NCT02457598|473522279|FG016|Overall Study|Death|1|||
131516874|NCT02457598|473522263|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516875|NCT02457598|473522264|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
131516876|NCT02457598|473522265|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516877|NCT02457598|473522266|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
131516878|NCT02457598|473522267|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516879|NCT02457598|473522268|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516880|NCT02457598|473522269|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516881|NCT02457598|473522270|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
131516882|NCT02457598|473522271|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516883|NCT02457598|473522272|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516884|NCT02457598|473522273|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
131516885|NCT02457598|473522274|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516886|NCT02457598|473522275|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516887|NCT02457598|473522276|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
131516888|NCT02457598|473522277|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
131516889|NCT02457598|473522278|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
131516890|NCT02457598|473522279|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
131516891|NCT02457598|473522263|FG000|Overall Study|Withdrew Consent|0|||
131516892|NCT02457598|473522264|FG001|Overall Study|Withdrew Consent|0|||
131516893|NCT02457598|473522265|FG002|Overall Study|Withdrew Consent|0|||
131516894|NCT02457598|473522266|FG003|Overall Study|Withdrew Consent|0|||
131516895|NCT02457598|473522267|FG004|Overall Study|Withdrew Consent|0|||
131516896|NCT02457598|473522268|FG005|Overall Study|Withdrew Consent|0|||
131516897|NCT02457598|473522269|FG006|Overall Study|Withdrew Consent|0|||
131516898|NCT02457598|473522270|FG007|Overall Study|Withdrew Consent|2|||
131516899|NCT02457598|473522271|FG008|Overall Study|Withdrew Consent|0|||
131516900|NCT02457598|473522272|FG009|Overall Study|Withdrew Consent|0|||
131516901|NCT02457598|473522273|FG010|Overall Study|Withdrew Consent|3|||
131516902|NCT02457598|473522274|FG011|Overall Study|Withdrew Consent|0|||
131516903|NCT02457598|473522275|FG012|Overall Study|Withdrew Consent|0|||
131516904|NCT02457598|473522276|FG013|Overall Study|Withdrew Consent|1|||
131516905|NCT02457598|473522277|FG014|Overall Study|Withdrew Consent|0|||
131516906|NCT02457598|473522278|FG015|Overall Study|Withdrew Consent|0|||
131516907|NCT02457598|473522279|FG016|Overall Study|Withdrew Consent|0|||
131516908|NCT02457598|473522263|FG000|Overall Study|Unacceptable Toxicity|0|||
131516909|NCT02457598|473522264|FG001|Overall Study|Unacceptable Toxicity|0|||
131516910|NCT02457598|473522265|FG002|Overall Study|Unacceptable Toxicity|0|||
131516911|NCT02457598|473522266|FG003|Overall Study|Unacceptable Toxicity|0|||
131516912|NCT02457598|473522267|FG004|Overall Study|Unacceptable Toxicity|0|||
131516913|NCT02457598|473522268|FG005|Overall Study|Unacceptable Toxicity|0|||
131516914|NCT02457598|473522269|FG006|Overall Study|Unacceptable Toxicity|0|||
131516915|NCT02457598|473522270|FG007|Overall Study|Unacceptable Toxicity|0|||
131516916|NCT02457598|473522271|FG008|Overall Study|Unacceptable Toxicity|0|||
131516917|NCT02457598|473522272|FG009|Overall Study|Unacceptable Toxicity|0|||
131516918|NCT02457598|473522273|FG010|Overall Study|Unacceptable Toxicity|1|||
131516919|NCT02457598|473522274|FG011|Overall Study|Unacceptable Toxicity|0|||
131516920|NCT02457598|473522275|FG012|Overall Study|Unacceptable Toxicity|1|||
131516921|NCT02457598|473522276|FG013|Overall Study|Unacceptable Toxicity|1|||
131516922|NCT02457598|473522277|FG014|Overall Study|Unacceptable Toxicity|1|||
131516923|NCT02457598|473522278|FG015|Overall Study|Unacceptable Toxicity|0|||
131516924|NCT02457598|473522279|FG016|Overall Study|Unacceptable Toxicity|0|||
131516925|NCT02457598|473522263|FG000|Overall Study|Intercurrent Illness|0|||
131516926|NCT02457598|473522264|FG001|Overall Study|Intercurrent Illness|0|||
131516927|NCT02457598|473522265|FG002|Overall Study|Intercurrent Illness|0|||
131516928|NCT02457598|473522266|FG003|Overall Study|Intercurrent Illness|0|||
131516929|NCT02457598|473522267|FG004|Overall Study|Intercurrent Illness|0|||
131516930|NCT02457598|473522268|FG005|Overall Study|Intercurrent Illness|0|||
131516931|NCT02457598|473522269|FG006|Overall Study|Intercurrent Illness|0|||
131516932|NCT02457598|473522270|FG007|Overall Study|Intercurrent Illness|0|||
131516933|NCT02457598|473522271|FG008|Overall Study|Intercurrent Illness|0|||
131516934|NCT02457598|473522272|FG009|Overall Study|Intercurrent Illness|0|||
131516935|NCT02457598|473522273|FG010|Overall Study|Intercurrent Illness|1|||
131516936|NCT02457598|473522274|FG011|Overall Study|Intercurrent Illness|0|||
131516937|NCT02457598|473522275|FG012|Overall Study|Intercurrent Illness|0|||
131516938|NCT02457598|473522276|FG013|Overall Study|Intercurrent Illness|0|||
131516939|NCT02457598|473522277|FG014|Overall Study|Intercurrent Illness|0|||
131516940|NCT02457598|473522278|FG015|Overall Study|Intercurrent Illness|0|||
131516941|NCT02457598|473522279|FG016|Overall Study|Intercurrent Illness|0|||
131516942|NCT02457598|473522263|FG000|Overall Study|Protocol Violation|0|||
131516943|NCT02457598|473522264|FG001|Overall Study|Protocol Violation|0|||
131516944|NCT02457598|473522265|FG002|Overall Study|Protocol Violation|0|||
131516945|NCT02457598|473522266|FG003|Overall Study|Protocol Violation|0|||
131516946|NCT02457598|473522267|FG004|Overall Study|Protocol Violation|0|||
131516947|NCT02457598|473522268|FG005|Overall Study|Protocol Violation|0|||
131516948|NCT02457598|473522269|FG006|Overall Study|Protocol Violation|0|||
131516949|NCT02457598|473522270|FG007|Overall Study|Protocol Violation|0|||
131516950|NCT02457598|473522271|FG008|Overall Study|Protocol Violation|0|||
131516951|NCT02457598|473522272|FG009|Overall Study|Protocol Violation|0|||
131516952|NCT02457598|473522273|FG010|Overall Study|Protocol Violation|1|||
131516953|NCT02457598|473522274|FG011|Overall Study|Protocol Violation|0|||
131516954|NCT02457598|473522275|FG012|Overall Study|Protocol Violation|0|||
131516955|NCT02457598|473522276|FG013|Overall Study|Protocol Violation|0|||
131516956|NCT02457598|473522277|FG014|Overall Study|Protocol Violation|0|||
131516957|NCT02457598|473522278|FG015|Overall Study|Protocol Violation|0|||
131516958|NCT02457598|473522279|FG016|Overall Study|Protocol Violation|0|||
131516959|NCT01526889|473522280|FG000|Treatment Period|Adverse Event|2|||
131516960|NCT01526889|473522281|FG001|Treatment Period|Adverse Event|0|||
131516961|NCT01526889|473522280|FG000|Treatment Extension Period|Administrative problems|1|||
131516962|NCT01526889|473522281|FG001|Treatment Extension Period|Administrative problems|0|||
131516963|NCT00974571|473522284|FG000|Overall Study|Adverse Event|31|||
131516964|NCT00974571|473522285|FG001|Overall Study|Adverse Event|4|||
131516965|NCT00974571|473522286|FG002|Overall Study|Adverse Event|27|||
131516966|NCT00974571|473522284|FG000|Overall Study|Lack of Efficacy|3|||
131516967|NCT00974571|473522285|FG001|Overall Study|Lack of Efficacy|2|||
131516968|NCT00974571|473522286|FG002|Overall Study|Lack of Efficacy|9|||
131516969|NCT00974571|473522284|FG000|Overall Study|Lost to Follow-up|2|||
131516970|NCT00974571|473522285|FG001|Overall Study|Lost to Follow-up|1|||
131516971|NCT00974571|473522286|FG002|Overall Study|Lost to Follow-up|2|||
131516972|NCT00974571|473522284|FG000|Overall Study|Protocol Violation|13|||
131516973|NCT00974571|473522285|FG001|Overall Study|Protocol Violation|4|||
131516974|NCT00974571|473522286|FG002|Overall Study|Protocol Violation|18|||
131516975|NCT00974571|473522284|FG000|Overall Study|Withdrawal by Subject|14|||
131516976|NCT00974571|473522285|FG001|Overall Study|Withdrawal by Subject|5|||
131516977|NCT00974571|473522286|FG002|Overall Study|Withdrawal by Subject|16|||
131516978|NCT00974571|473522284|FG000|Overall Study|Patient Moved|1|||
131516979|NCT00974571|473522285|FG001|Overall Study|Patient Moved|0|||
131516980|NCT00974571|473522286|FG002|Overall Study|Patient Moved|1|||
131516981|NCT00974571|473522284|FG000|Overall Study|Other|4|||
131516982|NCT00974571|473522285|FG001|Overall Study|Other|0|||
131516983|NCT00974571|473522286|FG002|Overall Study|Other|10|||
131516984|NCT04334460|473522293|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
131516985|NCT04334460|473522294|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
131516986|NCT04334460|473522293|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
131516987|NCT04334460|473522294|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
131516988|NCT02385799|473522295|FG000|Overall Study|Lost to Follow-up|1|||
131516989|NCT02385799|473522296|FG001|Overall Study|Lost to Follow-up|2|||
131516990|NCT02385799|473522295|FG000|Overall Study|Adverse Event|4|||
131516991|NCT02385799|473522296|FG001|Overall Study|Adverse Event|2|||
131516992|NCT02385799|473522295|FG000|Overall Study|Withdrawal by Subject|0|||
131516993|NCT02385799|473522296|FG001|Overall Study|Withdrawal by Subject|4|||
131516994|NCT00547703|473522299|FG000|Overall Study|Lost to Follow-up|1|||
131516995|NCT00547703|473522300|FG001|Overall Study|Lost to Follow-up|0|||
131516996|NCT03995953|473522303|FG000|Overall Study|Death|3|||
131516997|NCT03995953|473522304|FG001|Overall Study|Death|0|||
131516998|NCT03995953|473522305|FG002|Overall Study|Death|3|||
131516999|NCT03995953|473522306|FG003|Overall Study|Death|0|||
131517000|NCT03995953|473522307|FG004|Overall Study|Death|3|||
131517001|NCT03995953|473522308|FG005|Overall Study|Death|0|||
131517002|NCT03995953|473522309|FG006|Overall Study|Death|0|||
131517003|NCT03995953|473522310|FG007|Overall Study|Death|0|||
131517004|NCT03995953|473522311|FG008|Overall Study|Death|1|||
131517005|NCT03995953|473522312|FG009|Overall Study|Death|0|||
131517006|NCT03995953|473522313|FG010|Overall Study|Death|0|||
131517007|NCT03995953|473522314|FG011|Overall Study|Death|0|||
131517008|NCT03995953|473522303|FG000|Overall Study|Lost to Follow-up|6|||
131517009|NCT03995953|473522304|FG001|Overall Study|Lost to Follow-up|54|||
131517010|NCT03995953|473522305|FG002|Overall Study|Lost to Follow-up|3|||
131517011|NCT03995953|473522306|FG003|Overall Study|Lost to Follow-up|32|||
131517012|NCT03995953|473522307|FG004|Overall Study|Lost to Follow-up|5|||
131517013|NCT03995953|473522308|FG005|Overall Study|Lost to Follow-up|44|||
131517014|NCT03995953|473522309|FG006|Overall Study|Lost to Follow-up|0|||
131517015|NCT03995953|473522310|FG007|Overall Study|Lost to Follow-up|31|||
131517016|NCT03995953|473522311|FG008|Overall Study|Lost to Follow-up|8|||
131517017|NCT03995953|473522312|FG009|Overall Study|Lost to Follow-up|36|||
131517018|NCT03995953|473522313|FG010|Overall Study|Lost to Follow-up|5|||
131517019|NCT03995953|473522314|FG011|Overall Study|Lost to Follow-up|41|||
131517020|NCT03995953|473522303|FG000|Overall Study|Withdrawal by Subject|4|||
131517021|NCT03995953|473522304|FG001|Overall Study|Withdrawal by Subject|0|||
131517022|NCT03995953|473522305|FG002|Overall Study|Withdrawal by Subject|1|||
131517023|NCT03995953|473522306|FG003|Overall Study|Withdrawal by Subject|0|||
131517024|NCT03995953|473522307|FG004|Overall Study|Withdrawal by Subject|1|||
131517025|NCT03995953|473522308|FG005|Overall Study|Withdrawal by Subject|0|||
131517026|NCT03995953|473522309|FG006|Overall Study|Withdrawal by Subject|1|||
131517027|NCT03995953|473522310|FG007|Overall Study|Withdrawal by Subject|0|||
131517028|NCT03995953|473522311|FG008|Overall Study|Withdrawal by Subject|3|||
131517029|NCT03995953|473522312|FG009|Overall Study|Withdrawal by Subject|0|||
131517030|NCT03995953|473522313|FG010|Overall Study|Withdrawal by Subject|3|||
131517031|NCT03995953|473522314|FG011|Overall Study|Withdrawal by Subject|0|||
131517032|NCT03995953|473522303|FG000|Overall Study|Health Issues|0|||
131517033|NCT03995953|473522304|FG001|Overall Study|Health Issues|0|||
131517034|NCT03995953|473522305|FG002|Overall Study|Health Issues|0|||
131517035|NCT03995953|473522306|FG003|Overall Study|Health Issues|0|||
131517036|NCT03995953|473522307|FG004|Overall Study|Health Issues|1|||
131517037|NCT03995953|473522308|FG005|Overall Study|Health Issues|0|||
131517038|NCT03995953|473522309|FG006|Overall Study|Health Issues|0|||
131517039|NCT03995953|473522310|FG007|Overall Study|Health Issues|0|||
131517040|NCT03995953|473522311|FG008|Overall Study|Health Issues|4|||
131517041|NCT03995953|473522312|FG009|Overall Study|Health Issues|0|||
131517042|NCT03995953|473522313|FG010|Overall Study|Health Issues|0|||
131517043|NCT03995953|473522314|FG011|Overall Study|Health Issues|0|||
131517044|NCT03995953|473522303|FG000|Overall Study|Relocated|11|||
131517045|NCT03995953|473522304|FG001|Overall Study|Relocated|0|||
131517046|NCT03995953|473522305|FG002|Overall Study|Relocated|16|||
131517047|NCT03995953|473522306|FG003|Overall Study|Relocated|0|||
131517048|NCT03995953|473522307|FG004|Overall Study|Relocated|14|||
131517049|NCT03995953|473522308|FG005|Overall Study|Relocated|0|||
131517050|NCT03995953|473522309|FG006|Overall Study|Relocated|16|||
131517051|NCT03995953|473522310|FG007|Overall Study|Relocated|0|||
131517052|NCT03995953|473522311|FG008|Overall Study|Relocated|14|||
131517053|NCT03995953|473522312|FG009|Overall Study|Relocated|0|||
131517054|NCT03995953|473522313|FG010|Overall Study|Relocated|15|||
131517055|NCT03995953|473522314|FG011|Overall Study|Relocated|0|||
131517056|NCT02130765|473522315|FG000|Overall Study|Did not receive treatment|4|||
131517057|NCT02130765|473522316|FG001|Overall Study|Did not receive treatment|0|||
131517058|NCT02130765|473522317|FG002|Overall Study|Did not receive treatment|0|||
131517059|NCT02130765|473522318|FG003|Overall Study|Did not receive treatment|0|||
131517060|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
131517061|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
131517062|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
131517063|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
131517064|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
131517065|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
131517066|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
131517067|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
131517068|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
131517069|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
131517070|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
131517071|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
131517072|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
131517073|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
131517074|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
131517075|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
131517076|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
131517077|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
131517078|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
131517079|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
131517080|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Other|3|||
131517081|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Other|0|||
131517082|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Other|2|||
131517083|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Other|2|||
131517084|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Other|7|||
131517085|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517086|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517087|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517088|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
131517089|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517090|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517091|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517092|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517093|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517094|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
131517095|NCT00213148|473522334|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
131517096|NCT00213148|473522335|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
131517097|NCT00213148|473522336|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
131517098|NCT00213148|473522337|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
131517099|NCT00213148|473522338|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
131517100|NCT00213148|473522334|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
131517101|NCT00213148|473522335|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
131517102|NCT00213148|473522336|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
131517103|NCT00213148|473522337|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
131517104|NCT00213148|473522338|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
131517105|NCT00213148|473522334|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
131517106|NCT00213148|473522335|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
131658185|NCT02344290|474033026|FG000|Overall Study|Site Closure|15|||
131517107|NCT00213148|473522336|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
131517108|NCT00213148|473522337|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
131517109|NCT00213148|473522338|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
131517110|NCT00213148|473522334|FG000|Cycle 2 (1 Month)|Other|2|||
131517111|NCT00213148|473522335|FG001|Cycle 2 (1 Month)|Other|1|||
131517112|NCT00213148|473522336|FG002|Cycle 2 (1 Month)|Other|2|||
131517113|NCT00213148|473522337|FG003|Cycle 2 (1 Month)|Other|8|||
131517114|NCT00213148|473522338|FG004|Cycle 2 (1 Month)|Other|7|||
131517115|NCT00213148|473522334|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517116|NCT00213148|473522335|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
131517117|NCT00213148|473522336|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517118|NCT00213148|473522337|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517119|NCT00213148|473522338|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
131517120|NCT00213148|473522334|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
131517121|NCT00213148|473522335|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517122|NCT00213148|473522336|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517123|NCT00213148|473522337|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517124|NCT00213148|473522338|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
131517125|NCT00213148|473522334|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
131517126|NCT00213148|473522335|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
131517127|NCT00213148|473522336|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
131517128|NCT00213148|473522337|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
131517129|NCT00213148|473522338|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
131517130|NCT00213148|473522334|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
131517131|NCT00213148|473522335|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
131517132|NCT00213148|473522336|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
131517133|NCT00213148|473522337|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
131517134|NCT00213148|473522338|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
131517135|NCT00213148|473522334|FG000|Cycle 3 (1 Month)|Other|0|||
131517136|NCT00213148|473522335|FG001|Cycle 3 (1 Month)|Other|0|||
131517137|NCT00213148|473522336|FG002|Cycle 3 (1 Month)|Other|1|||
131517138|NCT00213148|473522337|FG003|Cycle 3 (1 Month)|Other|1|||
131517139|NCT00213148|473522338|FG004|Cycle 3 (1 Month)|Other|0|||
131517140|NCT00989833|473522342|FG000|Overall Study|Lost to Follow-up|0|||
131517141|NCT00989833|473522343|FG001|Overall Study|Lost to Follow-up|1|||
131517142|NCT00989833|473522344|FG002|Overall Study|Lost to Follow-up|0|||
131517143|NCT00989833|473522342|FG000|Overall Study|Protocol Violation|1|||
131517144|NCT00989833|473522343|FG001|Overall Study|Protocol Violation|2|||
131517145|NCT00989833|473522344|FG002|Overall Study|Protocol Violation|1|||
131517146|NCT00989833|473522342|FG000|Overall Study|Withdrawal by Subject|0|||
131517147|NCT00989833|473522343|FG001|Overall Study|Withdrawal by Subject|0|||
131517148|NCT00989833|473522344|FG002|Overall Study|Withdrawal by Subject|1|||
131517149|NCT00989833|473522342|FG000|Overall Study|Incorrectly randomized|1|||
131517150|NCT00989833|473522343|FG001|Overall Study|Incorrectly randomized|0|||
131517151|NCT00989833|473522344|FG002|Overall Study|Incorrectly randomized|0|||
131517152|NCT02469610|473522345|FG000|Overall Study|Death|1|||
131517153|NCT02469610|473522346|FG001|Overall Study|Death|0|||
131517154|NCT02469610|473522345|FG000|Overall Study|Lost to Follow-up|1|||
131517155|NCT02469610|473522346|FG001|Overall Study|Lost to Follow-up|0|||
131517156|NCT02469610|473522345|FG000|Overall Study|exclusion criteria|2|||
131517157|NCT02469610|473522346|FG001|Overall Study|exclusion criteria|1|||
131517158|NCT01806896|473522347|FG000|Overall Study|Adverse Event|2|||
131517159|NCT01806896|473522348|FG001|Overall Study|Adverse Event|0|||
131517160|NCT01806896|473522347|FG000|Overall Study|Other|1|||
131517161|NCT01806896|473522348|FG001|Overall Study|Other|0|||
131517162|NCT02434770|473522349|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
131517163|NCT02434770|473522350|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
131517164|NCT02434770|473522351|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
131517165|NCT02434770|473522349|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
131517166|NCT02434770|473522350|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
131517167|NCT02434770|473522351|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
131517168|NCT02434770|473522349|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
131517169|NCT02434770|473522350|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
131517170|NCT02434770|473522351|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
131517171|NCT02434770|473522349|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
131517172|NCT02434770|473522350|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
131517173|NCT02434770|473522351|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
131517174|NCT02434770|473522349|FG000|Week 1 to Week 18|Death|1|||
131517175|NCT02434770|473522350|FG001|Week 1 to Week 18|Death|0|||
131517176|NCT02434770|473522351|FG002|Week 1 to Week 18|Death|0|||
131517177|NCT02434770|473522349|FG000|Week 18 to Week|Lost to Follow-up|2|||
131517178|NCT02434770|473522350|FG001|Week 18 to Week|Lost to Follow-up|2|||
131517179|NCT02434770|473522351|FG002|Week 18 to Week|Lost to Follow-up|1|||
131517180|NCT02434770|473522349|FG000|Week 18 to Week|Withdrawal by Subject|0|||
131517181|NCT02434770|473522350|FG001|Week 18 to Week|Withdrawal by Subject|0|||
131517182|NCT02434770|473522351|FG002|Week 18 to Week|Withdrawal by Subject|2|||
131517183|NCT02434770|473522349|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
131517184|NCT02434770|473522350|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
131517185|NCT02434770|473522351|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
131517186|NCT00245765|473522352|FG000|Overall Study|Adverse Event|1|||
131517187|NCT00245765|473522353|FG001|Overall Study|Adverse Event|1|||
131517188|NCT00245765|473522354|FG002|Overall Study|Adverse Event|0|||
131517189|NCT00245765|473522352|FG000|Overall Study|Lack of Efficacy|14|||
131517190|NCT00245765|473522353|FG001|Overall Study|Lack of Efficacy|7|||
131517191|NCT00245765|473522354|FG002|Overall Study|Lack of Efficacy|0|||
131517192|NCT00245765|473522352|FG000|Overall Study|Lost to Follow-up|1|||
131517193|NCT00245765|473522353|FG001|Overall Study|Lost to Follow-up|2|||
131517194|NCT00245765|473522354|FG002|Overall Study|Lost to Follow-up|0|||
131517195|NCT00245765|473522352|FG000|Overall Study|Withdrawal by Subject|1|||
131517196|NCT00245765|473522353|FG001|Overall Study|Withdrawal by Subject|0|||
131517197|NCT00245765|473522354|FG002|Overall Study|Withdrawal by Subject|3|||
131517198|NCT00245765|473522352|FG000|Overall Study|Other reason|2|||
131517199|NCT00245765|473522353|FG001|Overall Study|Other reason|0|||
131517200|NCT00245765|473522354|FG002|Overall Study|Other reason|1|||
131517201|NCT00245765|473522352|FG000|Overall Study|Other|13|||
131517202|NCT00245765|473522353|FG001|Overall Study|Other|4|||
131517203|NCT00245765|473522354|FG002|Overall Study|Other|4|||
131517204|NCT00660348|473522355|FG000|Overall Study|Withdrawal by Subject|1|||
131517205|NCT00660348|473522356|FG001|Overall Study|Withdrawal by Subject|0|||
131517206|NCT03316872|473522360|FG000|Overall Study|Death|1|||
131517207|NCT04074317|473522364|FG000|Third Period|Withdrawal by Subject|0|||
131517208|NCT04074317|473522365|FG001|Third Period|Withdrawal by Subject|0|||
131517209|NCT04074317|473522366|FG002|Third Period|Withdrawal by Subject|0|||
131517210|NCT04074317|473522367|FG003|Third Period|Withdrawal by Subject|1|||
131517211|NCT04074317|473522368|FG004|Third Period|Withdrawal by Subject|0|||
131517212|NCT04074317|473522369|FG005|Third Period|Withdrawal by Subject|0|||
131517213|NCT01101841|473524270|FG000|Overall Study|Adverse Event|15|||
131517214|NCT01101841|473524271|FG001|Overall Study|Adverse Event|15|||
131517215|NCT01101841|473524270|FG000|Overall Study|Lost to Follow-up|9|||
131517216|NCT01101841|473524271|FG001|Overall Study|Lost to Follow-up|3|||
131517217|NCT01101841|473524270|FG000|Overall Study|Withdrawal by Subject|21|||
131517218|NCT01101841|473524271|FG001|Overall Study|Withdrawal by Subject|40|||
131517219|NCT01101841|473524270|FG000|Overall Study|Protocol Violation|1|||
131517220|NCT01101841|473524271|FG001|Overall Study|Protocol Violation|1|||
131517221|NCT01101841|473524270|FG000|Overall Study|Physician Decision|0|||
131517222|NCT01101841|473524271|FG001|Overall Study|Physician Decision|2|||
131517223|NCT01101841|473524270|FG000|Overall Study|Lack of Efficacy|0|||
131517224|NCT01101841|473524271|FG001|Overall Study|Lack of Efficacy|2|||
131517225|NCT01101841|473524270|FG000|Overall Study|Other|0|||
131517226|NCT01101841|473524271|FG001|Overall Study|Other|1|||
131517227|NCT01101841|473524270|FG000|Overall Study|Suicidality Tracking Scale|3|||
131517228|NCT01101841|473524271|FG001|Overall Study|Suicidality Tracking Scale|1|||
131517229|NCT01101841|473524270|FG000|Overall Study|Eligibility Criteria|1|||
131517230|NCT01101841|473524271|FG001|Overall Study|Eligibility Criteria|2|||
131517231|NCT00653224|473524276|FG000|Overall Study|Adverse Event|2|||
131517232|NCT00653224|473524277|FG001|Overall Study|Adverse Event|1|||
131517233|NCT00653224|473524276|FG000|Overall Study|Lack of Efficacy|1|||
131517234|NCT00653224|473524277|FG001|Overall Study|Lack of Efficacy|2|||
131517235|NCT00653224|473524276|FG000|Overall Study|Loss of efficacy|1|||
131517236|NCT00653224|473524277|FG001|Overall Study|Loss of efficacy|0|||
131517237|NCT00653224|473524276|FG000|Overall Study|Lost to Follow-up|1|||
131517238|NCT00653224|473524277|FG001|Overall Study|Lost to Follow-up|0|||
131517239|NCT00653224|473524276|FG000|Overall Study|Other|2|||
131517240|NCT00653224|473524277|FG001|Overall Study|Other|4|||
131517241|NCT03756558|473524280|FG000|Overall Study|Death|1|||
131517242|NCT03756558|473524280|FG000|Overall Study|Lost to Follow-up|2|||
131517243|NCT03756558|473524280|FG000|Overall Study|Withdrawal by Subject|2|||
131517244|NCT00145509|473524281|FG000|Overall Study|Adverse Event|10|||
131517245|NCT00145509|473524282|FG001|Overall Study|Adverse Event|3|||
131517246|NCT00145509|473524281|FG000|Overall Study|Lack of Efficacy|3|||
131517247|NCT00145509|473524282|FG001|Overall Study|Lack of Efficacy|1|||
131517248|NCT00145509|473524281|FG000|Overall Study|Lost to Follow-up|5|||
131517249|NCT00145509|473524282|FG001|Overall Study|Lost to Follow-up|9|||
131517250|NCT00145509|473524281|FG000|Overall Study|Withdrew Consent|2|||
131517251|NCT00145509|473524282|FG001|Overall Study|Withdrew Consent|7|||
131517252|NCT00145509|473524281|FG000|Overall Study|Reason not provided|2|||
131517253|NCT00145509|473524282|FG001|Overall Study|Reason not provided|1|||
131517254|NCT00419562|473524283|FG000|Overall Study|Lost to Follow-up|12|||
131517255|NCT00419562|473524284|FG001|Overall Study|Lost to Follow-up|13|||
131517256|NCT00419562|473524283|FG000|Overall Study|Withdrawal by Subject|20|||
131517257|NCT00419562|473524284|FG001|Overall Study|Withdrawal by Subject|18|||
131517258|NCT00419562|473524283|FG000|Overall Study|Participant Institutionalized|1|||
131517259|NCT00419562|473524284|FG001|Overall Study|Participant Institutionalized|0|||
131517260|NCT02789176|473524285|FG000|Overall Study|Death|0|||
131517261|NCT02789176|473524286|FG001|Overall Study|Death|0|||
131517262|NCT02789176|473524287|FG002|Overall Study|Death|3|||
131517263|NCT02789176|473524288|FG003|Overall Study|Death|0|||
131517264|NCT02789176|473524285|FG000|Overall Study|Withdrawal by Subject|0|||
131517265|NCT02789176|473524286|FG001|Overall Study|Withdrawal by Subject|0|||
131517266|NCT02789176|473524287|FG002|Overall Study|Withdrawal by Subject|1|||
131517267|NCT02789176|473524288|FG003|Overall Study|Withdrawal by Subject|0|||
131517268|NCT02789176|473524285|FG000|Overall Study|Lost to Follow-up|8|||
131517269|NCT02789176|473524286|FG001|Overall Study|Lost to Follow-up|2|||
131517270|NCT02789176|473524287|FG002|Overall Study|Lost to Follow-up|6|||
131517271|NCT02789176|473524288|FG003|Overall Study|Lost to Follow-up|1|||
131517272|NCT00355238|473524289|FG000|Overall Study|Adverse event unrelated to study drug|2|||
131517273|NCT00355238|473524290|FG001|Overall Study|Adverse event unrelated to study drug|2|||
131517274|NCT00355238|473524291|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131517275|NCT00355238|473524292|FG003|Overall Study|Adverse event unrelated to study drug|1|||
131517276|NCT00355238|473524289|FG000|Overall Study|Death|1|||
131517277|NCT00355238|473524290|FG001|Overall Study|Death|0|||
131517278|NCT00355238|473524291|FG002|Overall Study|Death|0|||
131517279|NCT00355238|473524292|FG003|Overall Study|Death|0|||
131517280|NCT00355238|473524289|FG000|Overall Study|Disease progression|37|||
131517281|NCT00355238|473524290|FG001|Overall Study|Disease progression|36|||
131517282|NCT00355238|473524291|FG002|Overall Study|Disease progression|16|||
131517283|NCT00355238|473524292|FG003|Overall Study|Disease progression|11|||
131517284|NCT00355238|473524289|FG000|Overall Study|Study drug toxicity|11|||
131517285|NCT00355238|473524290|FG001|Overall Study|Study drug toxicity|7|||
131517286|NCT00355238|473524291|FG002|Overall Study|Study drug toxicity|5|||
131517287|NCT00355238|473524292|FG003|Overall Study|Study drug toxicity|2|||
131517288|NCT00355238|473524289|FG000|Overall Study|Participant withdrew consent|3|||
131517289|NCT00355238|473524290|FG001|Overall Study|Participant withdrew consent|1|||
131517290|NCT00355238|473524291|FG002|Overall Study|Participant withdrew consent|0|||
131517291|NCT00355238|473524292|FG003|Overall Study|Participant withdrew consent|0|||
131517292|NCT00355238|473524289|FG000|Overall Study|Participant request to discontinue study treatment|1|||
131517293|NCT00355238|473524290|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131517294|NCT00355238|473524291|FG002|Overall Study|Participant request to discontinue study treatment|1|||
131517295|NCT00355238|473524292|FG003|Overall Study|Participant request to discontinue study treatment|0|||
131517296|NCT01956110|473524293|FG000|Overall Study|Protocol Violation|25|||
131517297|NCT01956110|473524294|FG001|Overall Study|Protocol Violation|11|||
131517298|NCT01956110|473524293|FG000|Overall Study|Adverse Event|9|||
131517299|NCT01956110|473524294|FG001|Overall Study|Adverse Event|10|||
131517300|NCT01956110|473524293|FG000|Overall Study|Personal reasons|1|||
131517301|NCT01956110|473524294|FG001|Overall Study|Personal reasons|1|||
131517302|NCT01633944|473524297|FG000|Open-label Titration Phase|Adverse Event|109|||
131517303|NCT01633944|473524298|FG001|Open-label Titration Phase|Adverse Event|0|||
131517304|NCT01633944|473524299|FG002|Open-label Titration Phase|Adverse Event|0|||
131517305|NCT01633944|473524297|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
131517306|NCT01633944|473524298|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
131517307|NCT01633944|473524299|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
131517308|NCT01633944|473524297|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
131517309|NCT01633944|473524298|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
131517310|NCT01633944|473524299|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
131517311|NCT01633944|473524297|FG000|Open-label Titration Phase|Protocol Violation|24|||
131517312|NCT01633944|473524298|FG001|Open-label Titration Phase|Protocol Violation|0|||
131517313|NCT01633944|473524299|FG002|Open-label Titration Phase|Protocol Violation|0|||
131517314|NCT01633944|473524297|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
131517315|NCT01633944|473524298|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
131517316|NCT01633944|473524299|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
131517317|NCT01633944|473524297|FG000|Open-label Titration Phase|Other|68|||
131517318|NCT01633944|473524298|FG001|Open-label Titration Phase|Other|0|||
131517319|NCT01633944|473524299|FG002|Open-label Titration Phase|Other|0|||
131517320|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Adverse Event|0|||
131517321|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Adverse Event|13|||
131517322|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Adverse Event|7|||
131517323|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
131517324|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
131517325|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
131517326|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131517327|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
131517328|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
131517329|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
131517330|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
131517331|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
131517332|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131517333|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
131517334|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
131517335|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
131517336|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
131517337|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
131517338|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
131517339|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
131517340|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
131517341|NCT01633944|473524297|FG000|Double-blind Treatment Phase|Other|0|||
131517342|NCT01633944|473524298|FG001|Double-blind Treatment Phase|Other|7|||
131517343|NCT01633944|473524299|FG002|Double-blind Treatment Phase|Other|0|||
131517344|NCT01400841|473524303|FG000|Initial Study Phase (6 Months)|Death|1|||
131517345|NCT01400841|473524303|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
131517346|NCT01467076|473524304|FG000|Overall Study|Lost to Follow-up|1|||
131517347|NCT01467076|473524305|FG001|Overall Study|Lost to Follow-up|0|||
131517348|NCT01467076|473524306|FG002|Overall Study|Lost to Follow-up|0|||
131517349|NCT02506816|473524315|FG000|Overall Study|Adverse Event|3|||
131517350|NCT03364049|473524317|FG000|Overall Study|Death|6|||
131517351|NCT03364049|473524318|FG001|Overall Study|Death|4|||
131517352|NCT03364049|473524319|FG002|Overall Study|Death|5|||
131517353|NCT03364049|473524320|FG003|Overall Study|Death|14|||
131517354|NCT03364049|473524317|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
131517355|NCT03364049|473524318|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
131517356|NCT03364049|473524319|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
131517357|NCT03364049|473524320|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
131517358|NCT03364049|473524317|FG000|Overall Study|Withdrawal by Subject|0|||
131517359|NCT03364049|473524318|FG001|Overall Study|Withdrawal by Subject|1|||
131517360|NCT03364049|473524319|FG002|Overall Study|Withdrawal by Subject|1|||
131517361|NCT03364049|473524320|FG003|Overall Study|Withdrawal by Subject|1|||
131517362|NCT00418691|473524321|FG000|Overall Study|Lost to Follow-up|1|||
131517363|NCT00418691|473524322|FG001|Overall Study|Lost to Follow-up|2|||
131517364|NCT00418691|473524323|FG002|Overall Study|Lost to Follow-up|3|||
131517365|NCT00418691|473524321|FG000|Overall Study|Started new medication voiding entry|0|||
131517366|NCT00418691|473524322|FG001|Overall Study|Started new medication voiding entry|0|||
131517367|NCT00418691|473524323|FG002|Overall Study|Started new medication voiding entry|1|||
131517368|NCT00418691|473524321|FG000|Overall Study|Progressive Disease|1|||
131517369|NCT00418691|473524322|FG001|Overall Study|Progressive Disease|0|||
131517370|NCT00418691|473524323|FG002|Overall Study|Progressive Disease|1|||
131517371|NCT02103478|473524324|FG000|Overall Study|Adverse Event|0|||
131517372|NCT02103478|473524325|FG001|Overall Study|Adverse Event|0|||
131517373|NCT02103478|473524326|FG002|Overall Study|Adverse Event|1|||
131517374|NCT02103478|473524327|FG003|Overall Study|Adverse Event|1|||
131517375|NCT02103478|473524328|FG004|Overall Study|Adverse Event|2|||
131517376|NCT02103478|473524329|FG005|Overall Study|Adverse Event|1|||
131517377|NCT02103478|473524330|FG006|Overall Study|Adverse Event|0|||
131517378|NCT02103478|473524331|FG007|Overall Study|Adverse Event|0|||
131517379|NCT02103478|473524332|FG008|Overall Study|Adverse Event|0|||
131517380|NCT02103478|473524324|FG000|Overall Study|Death|2|||
131517381|NCT02103478|473524325|FG001|Overall Study|Death|2|||
131517382|NCT02103478|473524326|FG002|Overall Study|Death|1|||
131517383|NCT02103478|473524327|FG003|Overall Study|Death|1|||
131517384|NCT02103478|473524328|FG004|Overall Study|Death|5|||
131517385|NCT02103478|473524329|FG005|Overall Study|Death|15|||
131517386|NCT02103478|473524330|FG006|Overall Study|Death|14|||
131517387|NCT02103478|473524331|FG007|Overall Study|Death|10|||
131517388|NCT02103478|473524332|FG008|Overall Study|Death|11|||
131517389|NCT02103478|473524324|FG000|Overall Study|Progressive Disease|2|||
131517390|NCT02103478|473524325|FG001|Overall Study|Progressive Disease|1|||
131517391|NCT02103478|473524326|FG002|Overall Study|Progressive Disease|2|||
131517392|NCT02103478|473524327|FG003|Overall Study|Progressive Disease|0|||
131517393|NCT02103478|473524328|FG004|Overall Study|Progressive Disease|9|||
131517394|NCT02103478|473524329|FG005|Overall Study|Progressive Disease|1|||
131517395|NCT02103478|473524330|FG006|Overall Study|Progressive Disease|2|||
131517396|NCT02103478|473524331|FG007|Overall Study|Progressive Disease|0|||
131517397|NCT02103478|473524332|FG008|Overall Study|Progressive Disease|1|||
131517398|NCT02103478|473524324|FG000|Overall Study|Withdrawal by Subject|2|||
131517399|NCT02103478|473524325|FG001|Overall Study|Withdrawal by Subject|0|||
131517400|NCT02103478|473524326|FG002|Overall Study|Withdrawal by Subject|0|||
131517401|NCT02103478|473524327|FG003|Overall Study|Withdrawal by Subject|4|||
131517402|NCT02103478|473524328|FG004|Overall Study|Withdrawal by Subject|0|||
131517403|NCT02103478|473524329|FG005|Overall Study|Withdrawal by Subject|0|||
131517404|NCT02103478|473524330|FG006|Overall Study|Withdrawal by Subject|1|||
131517405|NCT02103478|473524331|FG007|Overall Study|Withdrawal by Subject|1|||
131517406|NCT02103478|473524332|FG008|Overall Study|Withdrawal by Subject|0|||
131517407|NCT02103478|473524324|FG000|Overall Study|Lost to Follow-up|0|||
131517408|NCT02103478|473524325|FG001|Overall Study|Lost to Follow-up|0|||
131517409|NCT02103478|473524326|FG002|Overall Study|Lost to Follow-up|0|||
131517410|NCT02103478|473524327|FG003|Overall Study|Lost to Follow-up|0|||
131517411|NCT02103478|473524328|FG004|Overall Study|Lost to Follow-up|0|||
131517412|NCT02103478|473524329|FG005|Overall Study|Lost to Follow-up|0|||
131517413|NCT02103478|473524330|FG006|Overall Study|Lost to Follow-up|0|||
131517414|NCT02103478|473524331|FG007|Overall Study|Lost to Follow-up|1|||
131517415|NCT02103478|473524332|FG008|Overall Study|Lost to Follow-up|0|||
131517416|NCT02103478|473524324|FG000|Overall Study|Other|1|||
131517417|NCT02103478|473524325|FG001|Overall Study|Other|3|||
131517418|NCT02103478|473524326|FG002|Overall Study|Other|2|||
131517419|NCT02103478|473524327|FG003|Overall Study|Other|0|||
131517420|NCT02103478|473524328|FG004|Overall Study|Other|3|||
131517421|NCT02103478|473524329|FG005|Overall Study|Other|8|||
131517422|NCT02103478|473524330|FG006|Overall Study|Other|8|||
131517423|NCT02103478|473524331|FG007|Overall Study|Other|4|||
131517424|NCT02103478|473524332|FG008|Overall Study|Other|2|||
131517425|NCT04182100|473524333|FG000|Overall Study|Adverse Event|1|||
131517426|NCT04182100|473524333|FG000|Overall Study|Withdrawal by Subject|1|||
131517427|NCT04988295|473524334|FG000|Overall Study|Withdrawal by Subject|9|||
131517428|NCT04988295|473524335|FG001|Overall Study|Withdrawal by Subject|29|||
131517429|NCT04988295|473524336|FG002|Overall Study|Withdrawal by Subject|6|||
131517430|NCT04988295|473524337|FG003|Overall Study|Withdrawal by Subject|0|||
131517431|NCT04988295|473524334|FG000|Overall Study|Lost to Follow-up|1|||
131517432|NCT04988295|473524335|FG001|Overall Study|Lost to Follow-up|0|||
131517433|NCT04988295|473524336|FG002|Overall Study|Lost to Follow-up|0|||
131517434|NCT04988295|473524337|FG003|Overall Study|Lost to Follow-up|0|||
131517435|NCT04988295|473524334|FG000|Overall Study|Study participation ongoing|186|||
131517436|NCT04988295|473524335|FG001|Overall Study|Study participation ongoing|169|||
131517437|NCT04988295|473524336|FG002|Overall Study|Study participation ongoing|99|||
131517438|NCT04988295|473524337|FG003|Overall Study|Study participation ongoing|119|||
131517439|NCT04649151|473524338|FG000|Overall Study|Pregnancy|0|||
131517440|NCT04649151|473524339|FG001|Overall Study|Pregnancy|0|||
131517441|NCT04649151|473524340|FG002|Overall Study|Pregnancy|0|||
131517442|NCT04649151|473524341|FG003|Overall Study|Pregnancy|0|||
131517443|NCT04649151|473524342|FG004|Overall Study|Pregnancy|3|||
131517444|NCT04649151|473524338|FG000|Overall Study|Physician Decision|10|||
131517445|NCT04649151|473524339|FG001|Overall Study|Physician Decision|0|||
131517446|NCT04649151|473524340|FG002|Overall Study|Physician Decision|0|||
131517447|NCT04649151|473524341|FG003|Overall Study|Physician Decision|1|||
131517448|NCT04649151|473524342|FG004|Overall Study|Physician Decision|1|||
131517449|NCT04649151|473524338|FG000|Overall Study|Protocol Deviation|25|||
131517450|NCT04649151|473524339|FG001|Overall Study|Protocol Deviation|3|||
131517451|NCT04649151|473524340|FG002|Overall Study|Protocol Deviation|0|||
131517452|NCT04649151|473524341|FG003|Overall Study|Protocol Deviation|0|||
131517453|NCT04649151|473524342|FG004|Overall Study|Protocol Deviation|0|||
131517454|NCT04649151|473524338|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
131517455|NCT04649151|473524339|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
131517456|NCT04649151|473524340|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
131517457|NCT04649151|473524341|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
131517458|NCT04649151|473524342|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
131517459|NCT04649151|473524338|FG000|Overall Study|Withdrawal by Subject|370|||
131517460|NCT04649151|473524339|FG001|Overall Study|Withdrawal by Subject|113|||
131517461|NCT04649151|473524340|FG002|Overall Study|Withdrawal by Subject|2|||
131517462|NCT04649151|473524341|FG003|Overall Study|Withdrawal by Subject|7|||
131517463|NCT04649151|473524342|FG004|Overall Study|Withdrawal by Subject|15|||
131517464|NCT04649151|473524338|FG000|Overall Study|Adverse Event|1|||
131517465|NCT04649151|473524339|FG001|Overall Study|Adverse Event|0|||
131517466|NCT04649151|473524340|FG002|Overall Study|Adverse Event|0|||
131517467|NCT04649151|473524341|FG003|Overall Study|Adverse Event|0|||
131517468|NCT04649151|473524342|FG004|Overall Study|Adverse Event|0|||
131517469|NCT04649151|473524338|FG000|Overall Study|Lost to Follow-up|256|||
131517470|NCT04649151|473524339|FG001|Overall Study|Lost to Follow-up|29|||
131517471|NCT04649151|473524340|FG002|Overall Study|Lost to Follow-up|10|||
131517472|NCT04649151|473524341|FG003|Overall Study|Lost to Follow-up|3|||
131517473|NCT04649151|473524342|FG004|Overall Study|Lost to Follow-up|6|||
131517474|NCT04649151|473524338|FG000|Overall Study|Other than specified|59|||
131517475|NCT04649151|473524339|FG001|Overall Study|Other than specified|294|||
131517476|NCT04649151|473524340|FG002|Overall Study|Other than specified|0|||
131517477|NCT04649151|473524341|FG003|Overall Study|Other than specified|0|||
131517478|NCT04649151|473524342|FG004|Overall Study|Other than specified|4|||
131517479|NCT04649151|473524338|FG000|Overall Study|Death|0|||
131517480|NCT04649151|473524339|FG001|Overall Study|Death|0|||
131517481|NCT04649151|473524340|FG002|Overall Study|Death|0|||
131517482|NCT04649151|473524341|FG003|Overall Study|Death|0|||
131517483|NCT04649151|473524342|FG004|Overall Study|Death|1|||
131517484|NCT00433654|473524349|FG000|Overall Study|Death|4|||
131517485|NCT00433654|473524350|FG001|Overall Study|Death|0|||
131517486|NCT00433654|473524349|FG000|Overall Study|Missed visit|6|||
131517487|NCT00433654|473524350|FG001|Overall Study|Missed visit|3|||
131517488|NCT00433654|473524349|FG000|Overall Study|Subject not yet due for visit|4|||
131517489|NCT00433654|473524350|FG001|Overall Study|Subject not yet due for visit|0|||
131517490|NCT00433654|473524349|FG000|Overall Study|Withdrawal by Subject|1|||
131517491|NCT00433654|473524350|FG001|Overall Study|Withdrawal by Subject|2|||
131517492|NCT04033159|473524355|FG000|Washout Period|Physician Decision|0|||
131517493|NCT04033159|473524356|FG001|Washout Period|Physician Decision|1|||
131517494|NCT04033159|473524357|FG002|Washout Period|Physician Decision|0|||
131517495|NCT04033159|473524355|FG000|Washout Period|Study terminated by Sponsor|0|||
131517496|NCT04033159|473524356|FG001|Washout Period|Study terminated by Sponsor|7|||
131517497|NCT04033159|473524357|FG002|Washout Period|Study terminated by Sponsor|0|||
131517498|NCT04033159|473524355|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
131517499|NCT04033159|473524356|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
131517500|NCT04033159|473524357|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
131517501|NCT01428193|473524358|FG000|Overall Study|Physician Decision|1|||
131517502|NCT01428193|473524358|FG000|Overall Study|Elevated screening liver enzymes|1|||
131517503|NCT03762083|473524359|FG000|Overall Study|Withdrawal by Subject|2|||
131517504|NCT03762083|473524359|FG000|Overall Study|Physician Decision|1|||
131517505|NCT00116558|473524360|FG000|Overall Study|Death|11|||
131517506|NCT00116558|473524361|FG001|Overall Study|Death|5|||
131517507|NCT00116558|473524362|FG002|Overall Study|Death|3|||
131517508|NCT00116558|473524360|FG000|Overall Study|Withdrawal by Subject|17|||
131517509|NCT00116558|473524361|FG001|Overall Study|Withdrawal by Subject|3|||
131517510|NCT00116558|473524362|FG002|Overall Study|Withdrawal by Subject|12|||
131517511|NCT00116558|473524360|FG000|Overall Study|disease progression|3|||
131517512|NCT00116558|473524361|FG001|Overall Study|disease progression|7|||
131517513|NCT00116558|473524362|FG002|Overall Study|disease progression|18|||
131517514|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
131517515|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
131517516|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Graft loss|1|||
131517517|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Graft loss|2|||
131517518|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Death|5|||
131517519|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Death|3|||
131517520|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
131517521|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
131517522|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
131517523|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
131517524|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
131517525|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
131517526|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
131517527|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
131517528|NCT00378014|473524363|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
131517529|NCT00378014|473524364|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
131517530|NCT00378014|473524363|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
131517531|NCT00378014|473524364|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
131517532|NCT00378014|473524363|FG000|Extension (Month 12 to Month 59)|Death|1|||
131517533|NCT00378014|473524364|FG001|Extension (Month 12 to Month 59)|Death|2|||
131517534|NCT00378014|473524363|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
131517535|NCT00378014|473524364|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
131517536|NCT00378014|473524363|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
131517537|NCT00378014|473524364|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
131517538|NCT00378014|473524363|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
131517539|NCT00378014|473524364|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
131517540|NCT00378014|473524363|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
131517541|NCT00378014|473524364|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
131517542|NCT02287896|473524370|FG000|Second Injection Visit|Withdrawal by Subject|0|||
131517543|NCT02287896|473524371|FG001|Second Injection Visit|Withdrawal by Subject|1|||
131517544|NCT01639040|473524372|FG000|Overall Study|Adverse Event|1|||
131517545|NCT01639040|473524373|FG001|Overall Study|Adverse Event|0|||
131517546|NCT02552316|473524374|FG000|Overall Study|Withdrawal by Subject|1|||
131517547|NCT02552316|473524374|FG000|Overall Study|Withdrawal due to non-compliance|1|||
131517548|NCT01585766|473524375|FG000|Overall Study|Withdrawal by Subject|0|||
131517549|NCT01585766|473524376|FG001|Overall Study|Withdrawal by Subject|1|||
131517550|NCT01585766|473524377|FG002|Overall Study|Withdrawal by Subject|1|||
131517551|NCT01585766|473524378|FG003|Overall Study|Withdrawal by Subject|0|||
131517552|NCT01585766|473524379|FG004|Overall Study|Withdrawal by Subject|0|||
131517553|NCT01585766|473524380|FG005|Overall Study|Withdrawal by Subject|0|||
131517554|NCT01585766|473524375|FG000|Overall Study|Death|0|||
131517555|NCT01585766|473524376|FG001|Overall Study|Death|1|||
131517556|NCT01585766|473524377|FG002|Overall Study|Death|0|||
131517557|NCT01585766|473524378|FG003|Overall Study|Death|0|||
131517558|NCT01585766|473524379|FG004|Overall Study|Death|0|||
131517559|NCT01585766|473524380|FG005|Overall Study|Death|0|||
131517560|NCT01585766|473524375|FG000|Overall Study|Physician Decision|0|||
131517561|NCT01585766|473524376|FG001|Overall Study|Physician Decision|0|||
131517562|NCT01585766|473524377|FG002|Overall Study|Physician Decision|1|||
131517563|NCT01585766|473524378|FG003|Overall Study|Physician Decision|0|||
131517564|NCT01585766|473524379|FG004|Overall Study|Physician Decision|0|||
131517565|NCT01585766|473524380|FG005|Overall Study|Physician Decision|0|||
131517566|NCT05267054|473524381|FG000|Overall Study|Death|13|||
131517567|NCT05267054|473524382|FG001|Overall Study|Death|14|||
131517568|NCT05267054|473524381|FG000|Overall Study|Study Ended by Sponsor|9|||
131517569|NCT05267054|473524382|FG001|Overall Study|Study Ended by Sponsor|13|||
131517570|NCT05267054|473524381|FG000|Overall Study|Lost to Follow-up|1|||
131517571|NCT05267054|473524382|FG001|Overall Study|Lost to Follow-up|1|||
131517572|NCT05267054|473524381|FG000|Overall Study|Withdrawal by Subject|1|||
131517573|NCT05267054|473524382|FG001|Overall Study|Withdrawal by Subject|1|||
131517574|NCT01403974|473524383|FG000|Overall Study|Progressive disease according to RECIST|3|||
131517575|NCT01403974|473524384|FG001|Overall Study|Progressive disease according to RECIST|3|||
131517576|NCT01403974|473524385|FG002|Overall Study|Progressive disease according to RECIST|2|||
131517577|NCT01403974|473524386|FG003|Overall Study|Progressive disease according to RECIST|3|||
131517578|NCT01403974|473524387|FG004|Overall Study|Progressive disease according to RECIST|3|||
131517579|NCT01403974|473524388|FG005|Overall Study|Progressive disease according to RECIST|2|||
131517580|NCT01403974|473524389|FG006|Overall Study|Progressive disease according to RECIST|3|||
131517581|NCT01403974|473524390|FG007|Overall Study|Progressive disease according to RECIST|2|||
131517582|NCT01403974|473524391|FG008|Overall Study|Progressive disease according to RECIST|6|||
131517583|NCT01403974|473524392|FG009|Overall Study|Progressive disease according to RECIST|2|||
131517584|NCT01403974|473524393|FG010|Overall Study|Progressive disease according to RECIST|3|||
131517585|NCT01403974|473524394|FG011|Overall Study|Progressive disease according to RECIST|2|||
131517586|NCT01403974|473524395|FG012|Overall Study|Progressive disease according to RECIST|2|||
131517587|NCT01403974|473524396|FG013|Overall Study|Progressive disease according to RECIST|3|||
131517588|NCT01403974|473524397|FG014|Overall Study|Progressive disease according to RECIST|1|||
131517589|NCT01403974|473524398|FG015|Overall Study|Progressive disease according to RECIST|8|||
131517590|NCT01403974|473524383|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
131517591|NCT01403974|473524384|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
131517592|NCT01403974|473524385|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
131517593|NCT01403974|473524386|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
131517594|NCT01403974|473524387|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
131517595|NCT01403974|473524388|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
131517596|NCT01403974|473524389|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
131517597|NCT01403974|473524390|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
131517598|NCT01403974|473524391|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
131517599|NCT01403974|473524392|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
131517600|NCT01403974|473524393|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
131517601|NCT01403974|473524394|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
131517602|NCT01403974|473524395|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
131517603|NCT01403974|473524396|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
131517604|NCT01403974|473524397|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
131517605|NCT01403974|473524398|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
131517606|NCT01403974|473524383|FG000|Overall Study|Refused to continue study medication|0|||
131517607|NCT01403974|473524384|FG001|Overall Study|Refused to continue study medication|0|||
131517608|NCT01403974|473524385|FG002|Overall Study|Refused to continue study medication|0|||
131517609|NCT01403974|473524386|FG003|Overall Study|Refused to continue study medication|0|||
131517610|NCT01403974|473524387|FG004|Overall Study|Refused to continue study medication|0|||
131517611|NCT01403974|473524388|FG005|Overall Study|Refused to continue study medication|1|||
131517612|NCT01403974|473524389|FG006|Overall Study|Refused to continue study medication|0|||
131517613|NCT01403974|473524390|FG007|Overall Study|Refused to continue study medication|0|||
131517614|NCT01403974|473524391|FG008|Overall Study|Refused to continue study medication|1|||
131517615|NCT01403974|473524392|FG009|Overall Study|Refused to continue study medication|0|||
131517616|NCT01403974|473524393|FG010|Overall Study|Refused to continue study medication|1|||
131517617|NCT01403974|473524394|FG011|Overall Study|Refused to continue study medication|0|||
131517618|NCT01403974|473524395|FG012|Overall Study|Refused to continue study medication|0|||
131517619|NCT01403974|473524396|FG013|Overall Study|Refused to continue study medication|0|||
131517620|NCT01403974|473524397|FG014|Overall Study|Refused to continue study medication|0|||
131517621|NCT01403974|473524398|FG015|Overall Study|Refused to continue study medication|4|||
131517622|NCT01403974|473524383|FG000|Overall Study|Adverse Event|0|||
131517623|NCT01403974|473524384|FG001|Overall Study|Adverse Event|0|||
131517624|NCT01403974|473524385|FG002|Overall Study|Adverse Event|1|||
131517625|NCT01403974|473524386|FG003|Overall Study|Adverse Event|0|||
131517626|NCT01403974|473524387|FG004|Overall Study|Adverse Event|0|||
131517627|NCT01403974|473524388|FG005|Overall Study|Adverse Event|0|||
131517628|NCT01403974|473524389|FG006|Overall Study|Adverse Event|0|||
131517629|NCT01403974|473524390|FG007|Overall Study|Adverse Event|1|||
131517630|NCT01403974|473524391|FG008|Overall Study|Adverse Event|0|||
131517631|NCT01403974|473524392|FG009|Overall Study|Adverse Event|0|||
131517632|NCT01403974|473524393|FG010|Overall Study|Adverse Event|0|||
131517633|NCT01403974|473524394|FG011|Overall Study|Adverse Event|0|||
131517634|NCT01403974|473524395|FG012|Overall Study|Adverse Event|1|||
131517635|NCT01403974|473524396|FG013|Overall Study|Adverse Event|0|||
131517636|NCT01403974|473524397|FG014|Overall Study|Adverse Event|0|||
131517637|NCT01403974|473524398|FG015|Overall Study|Adverse Event|0|||
131517638|NCT01403974|473524383|FG000|Overall Study|Other than specified|0|||
131517639|NCT01403974|473524384|FG001|Overall Study|Other than specified|0|||
131517640|NCT01403974|473524385|FG002|Overall Study|Other than specified|0|||
131517641|NCT01403974|473524386|FG003|Overall Study|Other than specified|0|||
131517642|NCT01403974|473524387|FG004|Overall Study|Other than specified|0|||
131517643|NCT01403974|473524388|FG005|Overall Study|Other than specified|0|||
131517644|NCT01403974|473524389|FG006|Overall Study|Other than specified|0|||
131517645|NCT01403974|473524390|FG007|Overall Study|Other than specified|0|||
131517646|NCT01403974|473524391|FG008|Overall Study|Other than specified|0|||
131517647|NCT01403974|473524392|FG009|Overall Study|Other than specified|1|||
131517648|NCT01403974|473524393|FG010|Overall Study|Other than specified|0|||
131517649|NCT01403974|473524394|FG011|Overall Study|Other than specified|1|||
131517650|NCT01403974|473524395|FG012|Overall Study|Other than specified|0|||
131517651|NCT01403974|473524396|FG013|Overall Study|Other than specified|0|||
131517652|NCT01403974|473524397|FG014|Overall Study|Other than specified|0|||
131517653|NCT01403974|473524398|FG015|Overall Study|Other than specified|0|||
131517654|NCT04697628|473524399|FG000|Overall Study|Withdrawal by Subject|17|||
131517655|NCT04697628|473524400|FG001|Overall Study|Withdrawal by Subject|23|||
131517656|NCT04697628|473524399|FG000|Overall Study|Lost to Follow-up|0|||
131517657|NCT04697628|473524400|FG001|Overall Study|Lost to Follow-up|4|||
131517658|NCT04697628|473524399|FG000|Overall Study|On-going in study|122|||
131517659|NCT04697628|473524400|FG001|Overall Study|On-going in study|91|||
131517660|NCT02703636|473524401|FG000|Overall Study|Adverse Event|14|||
131517661|NCT02703636|473524401|FG000|Overall Study|Study stopped by sponsor|1|||
131517662|NCT02703636|473524401|FG000|Overall Study|Withdrawal by Subject|1|||
131517663|NCT00393939|473524402|FG000|Overall Study|Protocol Violation|1|||
131517664|NCT00393939|473524403|FG001|Overall Study|Protocol Violation|1|||
131517665|NCT00393939|473524402|FG000|Overall Study|Lost to Follow-up|2|||
131517666|NCT00393939|473524403|FG001|Overall Study|Lost to Follow-up|4|||
131517667|NCT00393939|473524402|FG000|Overall Study|Death|10|||
131517668|NCT00393939|473524403|FG001|Overall Study|Death|4|||
131517669|NCT00393939|473524402|FG000|Overall Study|Sponsor|5|||
131517670|NCT00393939|473524403|FG001|Overall Study|Sponsor|13|||
131517671|NCT00393939|473524402|FG000|Overall Study|Objective progression or relapse|239|||
131517672|NCT00393939|473524403|FG001|Overall Study|Objective progression or relapse|223|||
131517673|NCT00393939|473524402|FG000|Overall Study|Withdrawal by Subject|2|||
131517674|NCT00393939|473524403|FG001|Overall Study|Withdrawal by Subject|7|||
131517675|NCT00393939|473524402|FG000|Overall Study|Other|37|||
131517676|NCT00393939|473524403|FG001|Overall Study|Other|45|||
131517677|NCT03778931|473524404|FG000|Overall Study|Withdrawal by Subject|12|||
131517678|NCT03778931|473524405|FG001|Overall Study|Withdrawal by Subject|25|||
131517679|NCT03778931|473524404|FG000|Overall Study|Physician Decision|1|||
131517680|NCT03778931|473524405|FG001|Overall Study|Physician Decision|3|||
131517681|NCT03778931|473524404|FG000|Overall Study|Participant Noncompliance|1|||
131517682|NCT03778931|473524405|FG001|Overall Study|Participant Noncompliance|1|||
131517683|NCT03778931|473524404|FG000|Overall Study|Lost to Follow-up|4|||
131517684|NCT03778931|473524405|FG001|Overall Study|Lost to Follow-up|1|||
131517685|NCT03778931|473524404|FG000|Overall Study|Death|69|||
131517686|NCT03778931|473524405|FG001|Overall Study|Death|79|||
131517687|NCT00006184|473524406|FG000|Overall Study|Death|1|||
131517688|NCT00006184|473524407|FG001|Overall Study|Death|0|||
131517689|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
131517690|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
131517691|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
131517692|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
131517693|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
131517694|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
131517695|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
131517696|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
131517697|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
131517698|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
131517699|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
131517700|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
131517701|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
131517702|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
131517703|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
131517704|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
131517705|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
131517706|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
131517707|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
131517708|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
131517709|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
131517710|NCT02161718|473524412|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
131517711|NCT02161718|473524413|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
131517712|NCT02161718|473524414|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
131517713|NCT02161718|473524412|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
131517714|NCT02161718|473524413|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
131517715|NCT02161718|473524414|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
131517716|NCT02161718|473524412|FG000|Post- Randomization Period|Lost to Follow-up|0|||
131517717|NCT02161718|473524413|FG001|Post- Randomization Period|Lost to Follow-up|9|||
131517718|NCT02161718|473524414|FG002|Post- Randomization Period|Lost to Follow-up|15|||
131517719|NCT02161718|473524412|FG000|Post- Randomization Period|Adverse Event|0|||
131517720|NCT02161718|473524413|FG001|Post- Randomization Period|Adverse Event|9|||
131517721|NCT02161718|473524414|FG002|Post- Randomization Period|Adverse Event|10|||
131517722|NCT02161718|473524412|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
131517723|NCT02161718|473524413|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
131517724|NCT02161718|473524414|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
131517725|NCT02161718|473524412|FG000|Post- Randomization Period|Physician Decision|0|||
131517726|NCT02161718|473524413|FG001|Post- Randomization Period|Physician Decision|2|||
131517727|NCT02161718|473524414|FG002|Post- Randomization Period|Physician Decision|4|||
131517728|NCT02161718|473524412|FG000|Post- Randomization Period|Protocol Violation|0|||
131517729|NCT02161718|473524413|FG001|Post- Randomization Period|Protocol Violation|2|||
131517730|NCT02161718|473524414|FG002|Post- Randomization Period|Protocol Violation|3|||
131517731|NCT02161718|473524412|FG000|Post- Randomization Period|Lack of Efficacy|0|||
131517732|NCT02161718|473524413|FG001|Post- Randomization Period|Lack of Efficacy|0|||
131517733|NCT02161718|473524414|FG002|Post- Randomization Period|Lack of Efficacy|1|||
131517734|NCT02161718|473524412|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
131517735|NCT02161718|473524413|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
131517736|NCT02161718|473524414|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
131517737|NCT02161718|473524412|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
131517738|NCT02161718|473524413|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
131517739|NCT02161718|473524414|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
131517740|NCT02161718|473524412|FG000|Post- Randomization Period|Relocation|0|||
131517741|NCT02161718|473524413|FG001|Post- Randomization Period|Relocation|3|||
131517742|NCT02161718|473524414|FG002|Post- Randomization Period|Relocation|0|||
131517743|NCT02948842|473524417|FG000|Overall Study|Withdrawal by Subject|4|||
131517744|NCT01215227|473524418|FG000|Overall Study|Adverse Event|11|||
131517745|NCT01215227|473524419|FG001|Overall Study|Adverse Event|11|||
131517746|NCT01215227|473524420|FG002|Overall Study|Adverse Event|4|||
131517747|NCT01215227|473524421|FG003|Overall Study|Adverse Event|8|||
131517748|NCT01215227|473524422|FG004|Overall Study|Adverse Event|7|||
131517749|NCT01215227|473524423|FG005|Overall Study|Adverse Event|6|||
131517750|NCT01215227|473524418|FG000|Overall Study|Treatment Failure|8|||
131517751|NCT01215227|473524419|FG001|Overall Study|Treatment Failure|4|||
131517752|NCT01215227|473524420|FG002|Overall Study|Treatment Failure|1|||
131517753|NCT01215227|473524421|FG003|Overall Study|Treatment Failure|5|||
131517754|NCT01215227|473524422|FG004|Overall Study|Treatment Failure|1|||
131517755|NCT01215227|473524423|FG005|Overall Study|Treatment Failure|1|||
131517756|NCT01215227|473524418|FG000|Overall Study|Lost to Follow-up|1|||
131517757|NCT01215227|473524419|FG001|Overall Study|Lost to Follow-up|4|||
131517758|NCT01215227|473524420|FG002|Overall Study|Lost to Follow-up|1|||
131517759|NCT01215227|473524421|FG003|Overall Study|Lost to Follow-up|1|||
131517760|NCT01215227|473524422|FG004|Overall Study|Lost to Follow-up|1|||
131517761|NCT01215227|473524423|FG005|Overall Study|Lost to Follow-up|2|||
131517762|NCT01215227|473524418|FG000|Overall Study|Subject Withdrew Consent|16|||
131517763|NCT01215227|473524419|FG001|Overall Study|Subject Withdrew Consent|20|||
131517764|NCT01215227|473524420|FG002|Overall Study|Subject Withdrew Consent|7|||
131517765|NCT01215227|473524421|FG003|Overall Study|Subject Withdrew Consent|10|||
131517766|NCT01215227|473524422|FG004|Overall Study|Subject Withdrew Consent|11|||
131517767|NCT01215227|473524423|FG005|Overall Study|Subject Withdrew Consent|8|||
131517768|NCT01215227|473524418|FG000|Overall Study|Non-Compliance With Protocol|2|||
131517769|NCT01215227|473524419|FG001|Overall Study|Non-Compliance With Protocol|6|||
131517770|NCT01215227|473524420|FG002|Overall Study|Non-Compliance With Protocol|1|||
131517771|NCT01215227|473524421|FG003|Overall Study|Non-Compliance With Protocol|0|||
131517772|NCT01215227|473524422|FG004|Overall Study|Non-Compliance With Protocol|0|||
131517773|NCT01215227|473524423|FG005|Overall Study|Non-Compliance With Protocol|0|||
131517774|NCT01215227|473524418|FG000|Overall Study|Administrative|83|||
131517775|NCT01215227|473524419|FG001|Overall Study|Administrative|73|||
131517776|NCT01215227|473524420|FG002|Overall Study|Administrative|42|||
131517777|NCT01215227|473524421|FG003|Overall Study|Administrative|24|||
131517778|NCT01215227|473524422|FG004|Overall Study|Administrative|28|||
131517779|NCT01215227|473524423|FG005|Overall Study|Administrative|40|||
131517780|NCT01215227|473524418|FG000|Overall Study|Missing Status|0|||
131517781|NCT01215227|473524419|FG001|Overall Study|Missing Status|1|||
131517782|NCT01215227|473524420|FG002|Overall Study|Missing Status|0|||
131517783|NCT01215227|473524421|FG003|Overall Study|Missing Status|0|||
131517784|NCT01215227|473524422|FG004|Overall Study|Missing Status|0|||
131517785|NCT01215227|473524423|FG005|Overall Study|Missing Status|0|||
131517786|NCT01215227|473524418|FG000|Overall Study|Randomized but not treated|0|||
131517787|NCT01215227|473524419|FG001|Overall Study|Randomized but not treated|0|||
131517788|NCT01215227|473524420|FG002|Overall Study|Randomized but not treated|1|||
131517789|NCT01215227|473524421|FG003|Overall Study|Randomized but not treated|1|||
131517790|NCT01215227|473524422|FG004|Overall Study|Randomized but not treated|0|||
131658186|NCT02344290|474033027|FG001|Overall Study|Site Closure|19|||
131517791|NCT01215227|473524423|FG005|Overall Study|Randomized but not treated|1|||
131517792|NCT02253810|473524424|FG000|Overall Study|Withdrawal by Subject|2|||
131517793|NCT02253810|473524425|FG001|Overall Study|Withdrawal by Subject|1|||
131517794|NCT02253810|473524424|FG000|Overall Study|Unknown concomitant procedure|3|||
131517795|NCT02253810|473524425|FG001|Overall Study|Unknown concomitant procedure|2|||
131517796|NCT01434290|473524426|FG000|Overall Study|Protocol Violation|6|||
131517797|NCT01434290|473524427|FG001|Overall Study|Protocol Violation|3|||
131517798|NCT01434290|473524426|FG000|Overall Study|No protocol treatment|2|||
131517799|NCT01434290|473524427|FG001|Overall Study|No protocol treatment|4|||
131517800|NCT00558103|473524428|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
131517801|NCT00558103|473524429|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
131517802|NCT00558103|473524430|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
131517803|NCT00558103|473524431|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
131517804|NCT00558103|473524432|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
131517805|NCT00558103|473524433|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
131517806|NCT00558103|473524428|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
131517807|NCT00558103|473524429|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
131517808|NCT00558103|473524430|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
131517809|NCT00558103|473524431|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
131517810|NCT00558103|473524432|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
131517811|NCT00558103|473524433|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
131517812|NCT00558103|473524428|FG000|Randomized Treatment Phase|Disease Progression|1|||
131517813|NCT00558103|473524429|FG001|Randomized Treatment Phase|Disease Progression|0|||
131517814|NCT00558103|473524430|FG002|Randomized Treatment Phase|Disease Progression|1|||
131517815|NCT00558103|473524431|FG003|Randomized Treatment Phase|Disease Progression|0|||
131517816|NCT00558103|473524432|FG004|Randomized Treatment Phase|Disease Progression|0|||
131517817|NCT00558103|473524433|FG005|Randomized Treatment Phase|Disease Progression|0|||
131517818|NCT00558103|473524428|FG000|Randomized Treatment Phase|Adverse Event|0|||
131517819|NCT00558103|473524429|FG001|Randomized Treatment Phase|Adverse Event|0|||
131517820|NCT00558103|473524430|FG002|Randomized Treatment Phase|Adverse Event|0|||
131517821|NCT00558103|473524431|FG003|Randomized Treatment Phase|Adverse Event|1|||
131517822|NCT00558103|473524432|FG004|Randomized Treatment Phase|Adverse Event|1|||
131517823|NCT00558103|473524433|FG005|Randomized Treatment Phase|Adverse Event|0|||
131517824|NCT00558103|473524428|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
131517825|NCT00558103|473524429|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
131517826|NCT00558103|473524430|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
131517827|NCT00558103|473524431|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
131517828|NCT00558103|473524432|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
131517829|NCT00558103|473524433|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
131517830|NCT00558103|473524428|FG000|Monotherapy Extension Phase|Disease Progression|0|||
131517831|NCT00558103|473524429|FG001|Monotherapy Extension Phase|Disease Progression|0|||
131517832|NCT00558103|473524430|FG002|Monotherapy Extension Phase|Disease Progression|0|||
131517833|NCT00558103|473524431|FG003|Monotherapy Extension Phase|Disease Progression|0|||
131517834|NCT00558103|473524432|FG004|Monotherapy Extension Phase|Disease Progression|0|||
131517835|NCT00558103|473524433|FG005|Monotherapy Extension Phase|Disease Progression|8|||
131517836|NCT02741115|473524434|FG000|Overall Study|Adverse Event|1|||
131517837|NCT02741115|473524435|FG001|Overall Study|Adverse Event|0|||
131517838|NCT02741115|473524434|FG000|Overall Study|Lost to Follow-up|7|||
131517839|NCT02741115|473524435|FG001|Overall Study|Lost to Follow-up|4|||
131517840|NCT02741115|473524434|FG000|Overall Study|Withdrawal by Subject|4|||
131517841|NCT02741115|473524435|FG001|Overall Study|Withdrawal by Subject|2|||
131517842|NCT06425458|473524436|FG000|Overall Study|Removed by study team|2|||
131517843|NCT06425458|473524436|FG000|Overall Study|Lost to Follow-up|5|||
131517844|NCT00445328|473524437|FG000|Overall Study|Death|0|||
131517845|NCT00445328|473524438|FG001|Overall Study|Death|1|||
131517846|NCT00445328|473524437|FG000|Overall Study|Adverse Event|0|||
131517847|NCT00445328|473524438|FG001|Overall Study|Adverse Event|3|||
131517848|NCT00445328|473524437|FG000|Overall Study|Other|0|||
131517849|NCT00445328|473524438|FG001|Overall Study|Other|2|||
131517850|NCT00445328|473524437|FG000|Overall Study|Withdrawal by Subject|2|||
131517851|NCT00445328|473524438|FG001|Overall Study|Withdrawal by Subject|0|||
131517852|NCT00445328|473524437|FG000|Overall Study|Protocol Violation|1|||
131517853|NCT00445328|473524438|FG001|Overall Study|Protocol Violation|0|||
131517854|NCT03548584|473526265|FG000|Overall Study|Lost to Follow-up|0|||
131517855|NCT03548584|473526266|FG001|Overall Study|Lost to Follow-up|0|||
131517856|NCT03548584|473526267|FG002|Overall Study|Lost to Follow-up|1|||
131517857|NCT03548584|473526265|FG000|Overall Study|Adverse Event|1|||
131517858|NCT03548584|473526266|FG001|Overall Study|Adverse Event|11|||
131517859|NCT03548584|473526267|FG002|Overall Study|Adverse Event|5|||
131517860|NCT03548584|473526265|FG000|Overall Study|Site Terminated by Sponsor|1|||
131517861|NCT03548584|473526266|FG001|Overall Study|Site Terminated by Sponsor|3|||
131517862|NCT03548584|473526267|FG002|Overall Study|Site Terminated by Sponsor|2|||
131517863|NCT03548584|473526265|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
131517864|NCT03548584|473526266|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
131517865|NCT03548584|473526267|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
131517866|NCT03548584|473526265|FG000|Overall Study|Lack of Efficacy|0|||
131517867|NCT03548584|473526266|FG001|Overall Study|Lack of Efficacy|1|||
131517868|NCT03548584|473526267|FG002|Overall Study|Lack of Efficacy|0|||
131517869|NCT03548584|473526265|FG000|Overall Study|Non-compliance with Study Drug|0|||
131517870|NCT03548584|473526266|FG001|Overall Study|Non-compliance with Study Drug|1|||
131517871|NCT03548584|473526267|FG002|Overall Study|Non-compliance with Study Drug|0|||
131517872|NCT03548584|473526265|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
131517873|NCT03548584|473526266|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
131517874|NCT03548584|473526267|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
131517875|NCT03633396|473526274|FG000|Overall Study|Withdrawal by Subject|4|||
131517876|NCT03633396|473526275|FG001|Overall Study|Withdrawal by Subject|4|||
131517877|NCT03633396|473526274|FG000|Overall Study|Adverse Event|1|||
131517878|NCT03633396|473526275|FG001|Overall Study|Adverse Event|1|||
131517879|NCT03633396|473526274|FG000|Overall Study|Lack of Efficacy|1|||
131517880|NCT03633396|473526275|FG001|Overall Study|Lack of Efficacy|0|||
131517881|NCT03633396|473526274|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
131517882|NCT03633396|473526275|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
131517883|NCT01012817|473526276|FG000|Overall Study|Withdrawal by Subject|0|||
131517884|NCT01012817|473526277|FG001|Overall Study|Withdrawal by Subject|0|||
131517885|NCT01012817|473526278|FG002|Overall Study|Withdrawal by Subject|0|||
131517886|NCT01012817|473526279|FG003|Overall Study|Withdrawal by Subject|1|||
131517887|NCT01012817|473526280|FG004|Overall Study|Withdrawal by Subject|0|||
131517888|NCT01012817|473526281|FG005|Overall Study|Withdrawal by Subject|0|||
131517889|NCT01012817|473526282|FG006|Overall Study|Withdrawal by Subject|0|||
131517890|NCT01012817|473526283|FG007|Overall Study|Withdrawal by Subject|1|||
131517891|NCT01012817|473526284|FG008|Overall Study|Withdrawal by Subject|0|||
131517892|NCT01012817|473526285|FG009|Overall Study|Withdrawal by Subject|0|||
131517893|NCT01012817|473526286|FG010|Overall Study|Withdrawal by Subject|1|||
131517894|NCT01012817|473526287|FG011|Overall Study|Withdrawal by Subject|1|||
131517895|NCT01012817|473526288|FG012|Overall Study|Withdrawal by Subject|0|||
131517896|NCT01012817|473526289|FG013|Overall Study|Withdrawal by Subject|1|||
131517897|NCT01012817|473526276|FG000|Overall Study|Adverse Event|0|||
131517898|NCT01012817|473526277|FG001|Overall Study|Adverse Event|0|||
131517899|NCT01012817|473526278|FG002|Overall Study|Adverse Event|0|||
131517900|NCT01012817|473526279|FG003|Overall Study|Adverse Event|0|||
131517901|NCT01012817|473526280|FG004|Overall Study|Adverse Event|0|||
131517902|NCT01012817|473526281|FG005|Overall Study|Adverse Event|1|||
131517903|NCT01012817|473526282|FG006|Overall Study|Adverse Event|0|||
131517904|NCT01012817|473526283|FG007|Overall Study|Adverse Event|0|||
131517905|NCT01012817|473526284|FG008|Overall Study|Adverse Event|0|||
131517906|NCT01012817|473526285|FG009|Overall Study|Adverse Event|0|||
131517907|NCT01012817|473526286|FG010|Overall Study|Adverse Event|1|||
131517908|NCT01012817|473526287|FG011|Overall Study|Adverse Event|0|||
131517909|NCT01012817|473526288|FG012|Overall Study|Adverse Event|0|||
131517910|NCT01012817|473526289|FG013|Overall Study|Adverse Event|1|||
131517911|NCT00978731|473526290|FG000|Overall Study|Death|4|||
131517912|NCT00978731|473526291|FG001|Overall Study|Death|1|||
131517913|NCT00978731|473526292|FG002|Overall Study|Death|1|||
131517914|NCT00978731|473526293|FG003|Overall Study|Death|0|||
131517915|NCT00978731|473526290|FG000|Overall Study|Lost to Follow-up|0|||
131517916|NCT00978731|473526291|FG001|Overall Study|Lost to Follow-up|0|||
131517917|NCT00978731|473526292|FG002|Overall Study|Lost to Follow-up|0|||
131517918|NCT00978731|473526293|FG003|Overall Study|Lost to Follow-up|1|||
131517919|NCT00978731|473526290|FG000|Overall Study|Adverse Event|5|||
131517920|NCT00978731|473526291|FG001|Overall Study|Adverse Event|2|||
131517921|NCT00978731|473526292|FG002|Overall Study|Adverse Event|0|||
131517922|NCT00978731|473526293|FG003|Overall Study|Adverse Event|0|||
131517923|NCT00978731|473526290|FG000|Overall Study|Participant's request|1|||
131517924|NCT00978731|473526291|FG001|Overall Study|Participant's request|0|||
131517925|NCT00978731|473526292|FG002|Overall Study|Participant's request|0|||
131517926|NCT00978731|473526293|FG003|Overall Study|Participant's request|0|||
131517927|NCT00978731|473526290|FG000|Overall Study|Administrative reason|3|||
131517928|NCT00978731|473526291|FG001|Overall Study|Administrative reason|3|||
131517929|NCT00978731|473526292|FG002|Overall Study|Administrative reason|1|||
131517930|NCT00978731|473526293|FG003|Overall Study|Administrative reason|0|||
131517931|NCT00978731|473526290|FG000|Overall Study|Deterioration without progression|0|||
131517932|NCT00978731|473526291|FG001|Overall Study|Deterioration without progression|1|||
131517933|NCT00978731|473526292|FG002|Overall Study|Deterioration without progression|0|||
131517934|NCT00978731|473526293|FG003|Overall Study|Deterioration without progression|0|||
131517935|NCT00978731|473526290|FG000|Overall Study|Disease progression/relapse|5|||
131517936|NCT00978731|473526291|FG001|Overall Study|Disease progression/relapse|4|||
131517937|NCT00978731|473526292|FG002|Overall Study|Disease progression/relapse|2|||
131517938|NCT00978731|473526293|FG003|Overall Study|Disease progression/relapse|2|||
131517939|NCT00978731|473526290|FG000|Overall Study|Study closure|3|||
131517940|NCT00978731|473526291|FG001|Overall Study|Study closure|4|||
131517941|NCT00978731|473526292|FG002|Overall Study|Study closure|1|||
131517942|NCT00978731|473526293|FG003|Overall Study|Study closure|1|||
131517943|NCT00978731|473526290|FG000|Overall Study|No response|1|||
131517944|NCT00978731|473526291|FG001|Overall Study|No response|0|||
131517945|NCT00978731|473526292|FG002|Overall Study|No response|0|||
131517946|NCT00978731|473526293|FG003|Overall Study|No response|0|||
131517947|NCT01896895|473526296|FG000|Double-blind MP|Physician Decision|0|||
131517948|NCT01896895|473526297|FG001|Double-blind MP|Physician Decision|0|||
131517949|NCT01896895|473526298|FG002|Double-blind MP|Physician Decision|1|||
131517950|NCT01896895|473526299|FG003|Double-blind MP|Physician Decision|0|||
131517951|NCT01896895|473526296|FG000|Double-blind MP|Withdrawal by Subject|0|||
131517952|NCT01896895|473526297|FG001|Double-blind MP|Withdrawal by Subject|2|||
131517953|NCT01896895|473526298|FG002|Double-blind MP|Withdrawal by Subject|1|||
131517954|NCT01896895|473526299|FG003|Double-blind MP|Withdrawal by Subject|0|||
131517955|NCT01896895|473526296|FG000|Double-blind MP|Lost to Follow-up|1|||
131517956|NCT01896895|473526297|FG001|Double-blind MP|Lost to Follow-up|0|||
131517957|NCT01896895|473526298|FG002|Double-blind MP|Lost to Follow-up|1|||
131517958|NCT01896895|473526299|FG003|Double-blind MP|Lost to Follow-up|0|||
131517959|NCT01433263|473526300|FG000|Overall Study|Adverse Event|3|||
131517960|NCT01433263|473526301|FG001|Overall Study|Adverse Event|1|||
131517961|NCT01433263|473526300|FG000|Overall Study|Death|5|||
131517962|NCT01433263|473526301|FG001|Overall Study|Death|3|||
131517963|NCT01433263|473526300|FG000|Overall Study|Lost to Follow-up|0|||
131517964|NCT01433263|473526301|FG001|Overall Study|Lost to Follow-up|1|||
131517965|NCT01433263|473526300|FG000|Overall Study|Protocol Deviation|1|||
131517966|NCT01433263|473526301|FG001|Overall Study|Protocol Deviation|0|||
131517967|NCT01433263|473526300|FG000|Overall Study|Withdrawal by Subject|10|||
131517968|NCT01433263|473526301|FG001|Overall Study|Withdrawal by Subject|7|||
131517969|NCT00293384|473526302|FG000|Overall Study|Non-compliance|2|||
131517970|NCT00293384|473526302|FG000|Overall Study|Missed dosage/study drug|1|||
131517971|NCT00293384|473526302|FG000|Overall Study|Ineligible|2|||
131517972|NCT04482179|473526303|FG000|Overall Study|Death|1|||
131517973|NCT04482179|473526304|FG001|Overall Study|Death|0|||
131517974|NCT04482179|473526303|FG000|Overall Study|Withdrawal by Subject|1|||
131517975|NCT04482179|473526304|FG001|Overall Study|Withdrawal by Subject|0|||
131517976|NCT04709237|473526305|FG000|Overall Study|Lost to Follow-up|1|||
131517977|NCT04709237|473526306|FG001|Overall Study|Lost to Follow-up|0|||
131517978|NCT04709237|473526307|FG002|Overall Study|Lost to Follow-up|0|||
131517979|NCT01302964|473526309|FG000|Overall Study|Adverse Event|1|||
131517980|NCT01302964|473526310|FG001|Overall Study|Adverse Event|0|||
131517981|NCT01359592|473526314|FG000|Initial Registration|Adverse Event|1|||
131517982|NCT01359592|473526315|FG001|Initial Registration|Adverse Event|0|||
131517983|NCT01359592|473526316|FG002|Initial Registration|Adverse Event|0|||
131517984|NCT01359592|473526317|FG003|Initial Registration|Adverse Event|0|||
131517985|NCT01359592|473526314|FG000|Initial Registration|Death|1|||
131517986|NCT01359592|473526315|FG001|Initial Registration|Death|0|||
131517987|NCT01359592|473526316|FG002|Initial Registration|Death|0|||
131517988|NCT01359592|473526317|FG003|Initial Registration|Death|0|||
131517989|NCT01359592|473526314|FG000|Initial Registration|Other reason not protocol specified|1|||
131517990|NCT01359592|473526315|FG001|Initial Registration|Other reason not protocol specified|0|||
131517991|NCT01359592|473526316|FG002|Initial Registration|Other reason not protocol specified|0|||
131517992|NCT01359592|473526317|FG003|Initial Registration|Other reason not protocol specified|0|||
131517993|NCT01359592|473526314|FG000|Initial Registration|Ineligible|26|||
131517994|NCT01359592|473526315|FG001|Initial Registration|Ineligible|0|||
131517995|NCT01359592|473526316|FG002|Initial Registration|Ineligible|0|||
131517996|NCT01359592|473526317|FG003|Initial Registration|Ineligible|0|||
131517997|NCT01359592|473526314|FG000|PET-Directed Therapy|Adverse Event|0|||
131517998|NCT01359592|473526315|FG001|PET-Directed Therapy|Adverse Event|0|||
131517999|NCT01359592|473526316|FG002|PET-Directed Therapy|Adverse Event|1|||
131518000|NCT01359592|473526317|FG003|PET-Directed Therapy|Adverse Event|0|||
131518001|NCT01359592|473526314|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
131518002|NCT01359592|473526315|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
131518003|NCT01359592|473526316|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
131518004|NCT01359592|473526317|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
131518005|NCT01359592|473526314|FG000|PET-Directed Therapy|Ineligible|0|||
131518006|NCT01359592|473526315|FG001|PET-Directed Therapy|Ineligible|0|||
131518007|NCT01359592|473526316|FG002|PET-Directed Therapy|Ineligible|24|||
131518008|NCT01359592|473526317|FG003|PET-Directed Therapy|Ineligible|0|||
131518009|NCT00596011|473526323|FG000|Overall Study|Withdrawal by Subject|2|||
131518010|NCT00596011|473526324|FG001|Overall Study|Withdrawal by Subject|3|||
131518011|NCT00596011|473526323|FG000|Overall Study|Adverse Event|11|||
131518012|NCT00596011|473526324|FG001|Overall Study|Adverse Event|7|||
131518013|NCT00779675|473526329|FG000|Treatment Period|Adverse Event|87|||
131518014|NCT00779675|473526329|FG000|Treatment Period|Treatment Failure|80|||
131518015|NCT00779675|473526329|FG000|Treatment Period|Transferred to Another Study|38|||
131518016|NCT00779675|473526329|FG000|Treatment Period|Lost to Follow-up|23|||
131518017|NCT00779675|473526329|FG000|Treatment Period|Withdrawal by Subject|46|||
131518018|NCT00779675|473526329|FG000|Treatment Period|Protocol Violation|54|||
131518019|NCT00779675|473526329|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
131518020|NCT00779675|473526329|FG000|Treatment Period|Administrative|3|||
131518021|NCT00779675|473526329|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
131518022|NCT00779675|473526329|FG000|Extended Treatment Period|Protocol Violation|13|||
131518023|NCT00779675|473526329|FG000|Extended Treatment Period|Adverse Event|6|||
131518024|NCT00779675|473526329|FG000|Extended Treatment Period|Treatment Failure|11|||
131518025|NCT00779675|473526329|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
131518026|NCT00779675|473526329|FG000|Extended Treatment Period|Lost to Follow-up|6|||
131518027|NCT02821962|473526332|FG000|Overall Study|Lost to Follow-up|2|||
131518028|NCT02821962|473526333|FG001|Overall Study|Lost to Follow-up|0|||
131518029|NCT00749775|473526336|FG000|Overall Study|Protocol Violation|24|||
131518030|NCT00749775|473526336|FG000|Overall Study|Lost to Follow-up|36|||
131518031|NCT00749775|473526336|FG000|Overall Study|No visit after first day of treatment|44|||
131518032|NCT00749775|473526336|FG000|Overall Study|No drug administration|3|||
131518033|NCT04300296|473526337|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
131518034|NCT04300296|473526338|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
131518035|NCT04300296|473526339|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
131518036|NCT04300296|473526340|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
131518037|NCT04300296|473526341|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
131518038|NCT04300296|473526342|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
131518039|NCT04300296|473526337|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
131518040|NCT04300296|473526338|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
131518041|NCT04300296|473526339|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
131518042|NCT04300296|473526340|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
131518043|NCT04300296|473526341|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
131518044|NCT04300296|473526342|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
131518045|NCT04300296|473526337|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
131518046|NCT04300296|473526338|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
131518047|NCT04300296|473526339|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
131518048|NCT04300296|473526340|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
131518049|NCT04300296|473526341|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
131518050|NCT04300296|473526342|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
131518051|NCT04300296|473526337|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
131518052|NCT04300296|473526338|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
131518053|NCT04300296|473526339|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
131518054|NCT04300296|473526340|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
131518055|NCT04300296|473526341|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
131518056|NCT04300296|473526342|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
131518057|NCT04300296|473526337|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
131518058|NCT04300296|473526338|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
131518059|NCT04300296|473526339|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
131518060|NCT04300296|473526340|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
131518061|NCT04300296|473526341|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
131518062|NCT04300296|473526342|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
131518063|NCT04300296|473526337|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
131518064|NCT04300296|473526338|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
131518065|NCT04300296|473526339|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
131518066|NCT04300296|473526340|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
131518067|NCT04300296|473526341|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
131518068|NCT04300296|473526342|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
131518069|NCT04300296|473526337|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
131518070|NCT04300296|473526338|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
131518071|NCT04300296|473526339|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
131518072|NCT04300296|473526340|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
131518073|NCT04300296|473526341|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
131518074|NCT04300296|473526342|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
131518075|NCT00701129|473526343|FG000|Overall Study|Death|2|||
131518076|NCT02412631|473526344|FG000|Overall Study|Adverse Event|1|||
131518077|NCT02412631|473526345|FG001|Overall Study|Adverse Event|2|||
131518078|NCT02412631|473526344|FG000|Overall Study|Lost to Follow-up|5|||
131518079|NCT02412631|473526345|FG001|Overall Study|Lost to Follow-up|9|||
131518080|NCT02412631|473526344|FG000|Overall Study|Withdrawal by Subject|9|||
131518081|NCT02412631|473526345|FG001|Overall Study|Withdrawal by Subject|3|||
131518082|NCT02412631|473526344|FG000|Overall Study|Early stop by FDA|5|||
131518083|NCT02412631|473526345|FG001|Overall Study|Early stop by FDA|2|||
131518084|NCT02412631|473526344|FG000|Overall Study|Unspecified reason|6|||
131518085|NCT02412631|473526345|FG001|Overall Study|Unspecified reason|8|||
131518086|NCT00958776|473526346|FG000|Overall Study|Adverse Event|0|||
131518087|NCT00958776|473526347|FG001|Overall Study|Adverse Event|1|||
131518088|NCT00958776|473526346|FG000|Overall Study|Physician Decision|1|||
131518089|NCT00958776|473526347|FG001|Overall Study|Physician Decision|0|||
131518090|NCT00958776|473526346|FG000|Overall Study|Lost to Follow-up|2|||
131518091|NCT00958776|473526347|FG001|Overall Study|Lost to Follow-up|6|||
131518092|NCT00958776|473526346|FG000|Overall Study|Withdrawal by Subject|7|||
131518093|NCT00958776|473526347|FG001|Overall Study|Withdrawal by Subject|16|||
131518094|NCT00958776|473526346|FG000|Overall Study|Protocol Violation|1|||
131518095|NCT00958776|473526347|FG001|Overall Study|Protocol Violation|1|||
131518096|NCT00958776|473526346|FG000|Overall Study|Death|2|||
131518097|NCT00958776|473526347|FG001|Overall Study|Death|1|||
131518098|NCT00958776|473526346|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
131518099|NCT00958776|473526347|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
131518100|NCT00958776|473526346|FG000|Overall Study|Missing|1|||
131518101|NCT00958776|473526347|FG001|Overall Study|Missing|1|||
131518102|NCT02583256|473526350|FG000|Overall Study|Withdrawal by Subject|0|||
131518103|NCT02583256|473526351|FG001|Overall Study|Withdrawal by Subject|1|||
131518104|NCT02583256|473526352|FG002|Overall Study|Withdrawal by Subject|1|||
131518105|NCT02583256|473526353|FG003|Overall Study|Withdrawal by Subject|0|||
131518106|NCT02583256|473526350|FG000|Overall Study|Lost to Follow-up|1|||
131518107|NCT02583256|473526351|FG001|Overall Study|Lost to Follow-up|1|||
131518108|NCT02583256|473526352|FG002|Overall Study|Lost to Follow-up|0|||
131518109|NCT02583256|473526353|FG003|Overall Study|Lost to Follow-up|1|||
131518110|NCT02583256|473526350|FG000|Overall Study|Administrative/Other|2|||
131518111|NCT02583256|473526351|FG001|Overall Study|Administrative/Other|0|||
131518112|NCT02583256|473526352|FG002|Overall Study|Administrative/Other|1|||
131518113|NCT02583256|473526353|FG003|Overall Study|Administrative/Other|2|||
131518114|NCT04537806|473526356|FG000|Overall Study|Randomized but not treated|1|||
131518115|NCT04537806|473526357|FG001|Overall Study|Randomized but not treated|0|||
131518116|NCT04537806|473526356|FG000|Overall Study|Adverse Event|1|||
131518117|NCT04537806|473526357|FG001|Overall Study|Adverse Event|1|||
131518118|NCT03019627|473526358|FG000|Overall Study|Adverse Event|8|||
131518119|NCT03019627|473526359|FG001|Overall Study|Adverse Event|0|||
131518120|NCT03019627|473526358|FG000|Overall Study|Unrelated to adverse event|1|||
131518121|NCT03019627|473526359|FG001|Overall Study|Unrelated to adverse event|3|||
131518122|NCT03019627|473526358|FG000|Overall Study|Lost to Follow-up|2|||
131518123|NCT03019627|473526359|FG001|Overall Study|Lost to Follow-up|1|||
131518124|NCT03019627|473526358|FG000|Overall Study|not compliance|2|||
131518125|NCT03019627|473526359|FG001|Overall Study|not compliance|2|||
131518126|NCT03019627|473526358|FG000|Overall Study|Other|2|||
131518127|NCT03019627|473526359|FG001|Overall Study|Other|2|||
131518128|NCT02953821|473526360|FG000|Overall Study|Adverse Event|0|||
131518129|NCT02953821|473526361|FG001|Overall Study|Adverse Event|4|||
131518130|NCT02953821|473526360|FG000|Overall Study|Death|1|||
131518131|NCT02953821|473526361|FG001|Overall Study|Death|0|||
131518132|NCT02953821|473526360|FG000|Overall Study|Progressive Disease|5|||
131518133|NCT02953821|473526361|FG001|Overall Study|Progressive Disease|1|||
131518134|NCT02953821|473526360|FG000|Overall Study|Lost to Follow-up|2|||
131518135|NCT02953821|473526361|FG001|Overall Study|Lost to Follow-up|0|||
131518136|NCT02953821|473526360|FG000|Overall Study|Physician Decision|1|||
131518137|NCT02953821|473526361|FG001|Overall Study|Physician Decision|1|||
131518138|NCT02953821|473526360|FG000|Overall Study|Withdrawal by Subject|3|||
131518139|NCT02953821|473526361|FG001|Overall Study|Withdrawal by Subject|3|||
131518140|NCT02953821|473526360|FG000|Overall Study|Change of address|0|||
131518141|NCT02953821|473526361|FG001|Overall Study|Change of address|1|||
131518142|NCT02953821|473526360|FG000|Overall Study|Lack of Efficacy|1|||
131518143|NCT02953821|473526361|FG001|Overall Study|Lack of Efficacy|0|||
131518144|NCT02953821|473526360|FG000|Overall Study|Out of state for indeterminate time|0|||
131518145|NCT02953821|473526361|FG001|Overall Study|Out of state for indeterminate time|1|||
131518146|NCT02953821|473526360|FG000|Overall Study|No improvement|0|||
131518147|NCT02953821|473526361|FG001|Overall Study|No improvement|1|||
131518148|NCT02953821|473526360|FG000|Overall Study|Refused follow-up visit|2|||
131518149|NCT02953821|473526361|FG001|Overall Study|Refused follow-up visit|1|||
131518150|NCT03219333|473526362|FG000|Overall Study|Withdrawal by Subject|9|||
131518151|NCT03219333|473526363|FG001|Overall Study|Withdrawal by Subject|4|||
131518152|NCT03219333|473526362|FG000|Overall Study|Lost to Follow-up|1|||
131518153|NCT03219333|473526363|FG001|Overall Study|Lost to Follow-up|1|||
131518154|NCT03219333|473526362|FG000|Overall Study|Death|104|||
131518155|NCT03219333|473526363|FG001|Overall Study|Death|72|||
131518156|NCT03219333|473526362|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
131518157|NCT03219333|473526363|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
131518158|NCT03219333|473526362|FG000|Overall Study|Other|2|||
131518159|NCT03219333|473526363|FG001|Overall Study|Other|2|||
131518160|NCT00723606|473526364|FG000|Overall Study|Adverse Event|2|||
131518161|NCT00723606|473526365|FG001|Overall Study|Adverse Event|5|||
131518162|NCT00723606|473526364|FG000|Overall Study|Other|2|||
131518163|NCT00723606|473526365|FG001|Overall Study|Other|0|||
131518164|NCT00723606|473526364|FG000|Overall Study|Withdrawal by Subject|0|||
131518165|NCT00723606|473526365|FG001|Overall Study|Withdrawal by Subject|2|||
131518166|NCT05107128|473526366|FG000|Overall Study|Adverse Event|2|||
131518167|NCT05107128|473526367|FG001|Overall Study|Adverse Event|0|||
131518168|NCT05107128|473526366|FG000|Overall Study|Withdrawal by Subject|3|||
131518169|NCT05107128|473526367|FG001|Overall Study|Withdrawal by Subject|3|||
131518170|NCT05107128|473526366|FG000|Overall Study|Withdrawal of Consent|0|||
131518171|NCT05107128|473526367|FG001|Overall Study|Withdrawal of Consent|1|||
131518172|NCT05107128|473526366|FG000|Overall Study|Reason Not Specified|2|||
131518173|NCT05107128|473526367|FG001|Overall Study|Reason Not Specified|0|||
131518174|NCT02350309|473526369|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
131518175|NCT02350309|473526370|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
131518176|NCT02350309|473526371|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
131518177|NCT02350309|473526372|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
131518178|NCT02350309|473526373|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
131518179|NCT02350309|473526374|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
131518180|NCT02350309|473526369|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
131518181|NCT02350309|473526370|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
131518182|NCT02350309|473526371|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
131518183|NCT02350309|473526372|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
131518184|NCT02350309|473526373|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
131518185|NCT02350309|473526374|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
131518186|NCT02942017|473526375|FG000|Overall Study|Adverse Event|0|||
131518187|NCT02942017|473526376|FG001|Overall Study|Adverse Event|1|||
131518188|NCT02942017|473526375|FG000|Overall Study|Withdrawal by Subject|0|||
131518189|NCT02942017|473526376|FG001|Overall Study|Withdrawal by Subject|1|||
131518190|NCT02942017|473526375|FG000|Overall Study|Lost to Follow-up|1|||
131518191|NCT02942017|473526376|FG001|Overall Study|Lost to Follow-up|1|||
131518192|NCT02942017|473526375|FG000|Overall Study|Randomized but not dosed|1|||
131518193|NCT02942017|473526376|FG001|Overall Study|Randomized but not dosed|3|||
131518194|NCT04399161|473526377|FG000|Overall Study|Withdrawal by Subject|1|||
131518195|NCT04399161|473526378|FG001|Overall Study|Withdrawal by Subject|0|||
131518196|NCT04399161|473526379|FG002|Overall Study|Withdrawal by Subject|2|||
131518197|NCT04399161|473526377|FG000|Overall Study|Protocol Violation|1|||
131518198|NCT04399161|473526378|FG001|Overall Study|Protocol Violation|2|||
131518199|NCT04399161|473526379|FG002|Overall Study|Protocol Violation|0|||
131518200|NCT01736696|473526382|FG000|Overall Study|Withdrawal by Subject|0|||
131518201|NCT01736696|473526383|FG001|Overall Study|Withdrawal by Subject|0|||
131518202|NCT01736696|473526384|FG002|Overall Study|Withdrawal by Subject|1|||
131518203|NCT01736696|473526385|FG003|Overall Study|Withdrawal by Subject|0|||
131518204|NCT01736696|473526386|FG004|Overall Study|Withdrawal by Subject|0|||
131518205|NCT01736696|473526387|FG005|Overall Study|Withdrawal by Subject|0|||
131518206|NCT01736696|473526388|FG006|Overall Study|Withdrawal by Subject|0|||
131518207|NCT00838565|473526389|FG000|Overall Study|Withdrawal by Subject|0|||
131518208|NCT00838565|473526390|FG001|Overall Study|Withdrawal by Subject|0|||
131518209|NCT00838565|473526391|FG002|Overall Study|Withdrawal by Subject|1|||
131518210|NCT00838565|473526392|FG003|Overall Study|Withdrawal by Subject|0|||
131518211|NCT00838565|473526393|FG004|Overall Study|Withdrawal by Subject|0|||
131518212|NCT00838565|473526394|FG005|Overall Study|Withdrawal by Subject|2|||
131518213|NCT00838565|473526389|FG000|Overall Study|Other|0|||
131518214|NCT00838565|473526390|FG001|Overall Study|Other|2|||
131518215|NCT00838565|473526391|FG002|Overall Study|Other|0|||
131518216|NCT00838565|473526392|FG003|Overall Study|Other|0|||
131518217|NCT00838565|473526393|FG004|Overall Study|Other|0|||
131518218|NCT00838565|473526394|FG005|Overall Study|Other|0|||
131518219|NCT00838565|473526389|FG000|Overall Study|Randomized but not Treated|0|||
131518220|NCT00838565|473526390|FG001|Overall Study|Randomized but not Treated|1|||
131518221|NCT00838565|473526391|FG002|Overall Study|Randomized but not Treated|0|||
131518222|NCT00838565|473526392|FG003|Overall Study|Randomized but not Treated|0|||
131518223|NCT00838565|473526393|FG004|Overall Study|Randomized but not Treated|0|||
131518224|NCT00838565|473526394|FG005|Overall Study|Randomized but not Treated|0|||
131518225|NCT02114879|473526395|FG000|Overall Study|Withdrawal by Subject|9|||
131518226|NCT02114879|473526396|FG001|Overall Study|Withdrawal by Subject|5|||
131518227|NCT02114879|473526395|FG000|Overall Study|Death|6|||
131518228|NCT02114879|473526396|FG001|Overall Study|Death|11|||
131518229|NCT02114879|473526395|FG000|Overall Study|Lost to Follow-up|4|||
131518230|NCT02114879|473526396|FG001|Overall Study|Lost to Follow-up|6|||
131518231|NCT02114879|473526395|FG000|Overall Study|Physician Decision|0|||
131518232|NCT02114879|473526396|FG001|Overall Study|Physician Decision|2|||
131518233|NCT00458484|473526397|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
131518234|NCT00458484|473526398|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
131518235|NCT00458484|473526399|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
131518236|NCT00458484|473526400|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
131518237|NCT00458484|473526401|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
131518238|NCT00458484|473526402|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
131518239|NCT00458484|473526403|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
131518240|NCT05059600|473526404|FG000|Overall Study|Enrolled but not Treated|10|||
131518241|NCT04538664|473526405|FG000|Overall Study|Withdrawal by Subject|5|||
131518242|NCT04538664|473526406|FG001|Overall Study|Withdrawal by Subject|9|||
131518243|NCT04538664|473526405|FG000|Overall Study|Lost to Follow-up|2|||
131518244|NCT04538664|473526406|FG001|Overall Study|Lost to Follow-up|1|||
131518245|NCT04538664|473526405|FG000|Overall Study|Ongoing|106|||
131518246|NCT04538664|473526406|FG001|Overall Study|Ongoing|115|||
131518247|NCT01455012|473526407|FG000|Overall Study|Adverse Event|0|||
131518248|NCT01455012|473526408|FG001|Overall Study|Adverse Event|2|||
131518249|NCT01455012|473526407|FG000|Overall Study|Lack of Efficacy|6|||
131518250|NCT01455012|473526408|FG001|Overall Study|Lack of Efficacy|1|||
131518251|NCT01455012|473526407|FG000|Overall Study|Withdrawal by Subject|3|||
131518252|NCT01455012|473526408|FG001|Overall Study|Withdrawal by Subject|1|||
131518253|NCT01455012|473526407|FG000|Overall Study|Unknown reason|2|||
131518254|NCT01455012|473526408|FG001|Overall Study|Unknown reason|0|||
131518255|NCT04552587|473526409|FG000|Overall Study|Lost to Follow-up|4|||
131518256|NCT03400033|473526412|FG000|Overall Study|Withdrawal by Subject|1|||
131518257|NCT03400033|473526413|FG001|Overall Study|Withdrawal by Subject|2|||
131518258|NCT02448875|473526414|FG000|Overall Study|Adverse Event|2|||
131518259|NCT02448875|473526415|FG001|Overall Study|Adverse Event|1|||
131518260|NCT02448875|473526416|FG002|Overall Study|Adverse Event|0|||
131518261|NCT02448875|473526414|FG000|Overall Study|Lost to Follow-up|1|||
131518262|NCT02448875|473526415|FG001|Overall Study|Lost to Follow-up|0|||
131518263|NCT02448875|473526416|FG002|Overall Study|Lost to Follow-up|0|||
131518264|NCT02448875|473526414|FG000|Overall Study|Investigator Decision|3|||
131518265|NCT02448875|473526415|FG001|Overall Study|Investigator Decision|0|||
131518266|NCT02448875|473526416|FG002|Overall Study|Investigator Decision|1|||
131518267|NCT02448875|473526414|FG000|Overall Study|Withdrawal by Subject|1|||
131518268|NCT02448875|473526415|FG001|Overall Study|Withdrawal by Subject|0|||
131518269|NCT02448875|473526416|FG002|Overall Study|Withdrawal by Subject|0|||
131518270|NCT00689481|473526422|FG000|Overall Study|Adverse Event|7|||
131518271|NCT00689481|473526423|FG001|Overall Study|Adverse Event|1|||
131518272|NCT00689481|473526422|FG000|Overall Study|Lost to Follow-up|4|||
131518273|NCT00689481|473526423|FG001|Overall Study|Lost to Follow-up|3|||
131518274|NCT00689481|473526422|FG000|Overall Study|Lack of Efficacy|4|||
131518275|NCT00689481|473526423|FG001|Overall Study|Lack of Efficacy|3|||
131518276|NCT00689481|473526422|FG000|Overall Study|Non-compliance with study treatment|1|||
131518277|NCT00689481|473526423|FG001|Overall Study|Non-compliance with study treatment|1|||
131518278|NCT00689481|473526422|FG000|Overall Study|Withdrawal by Subject|8|||
131518279|NCT00689481|473526423|FG001|Overall Study|Withdrawal by Subject|4|||
131518280|NCT00689481|473526422|FG000|Overall Study|Excluded medication started during study|0|||
131518281|NCT00689481|473526423|FG001|Overall Study|Excluded medication started during study|1|||
131518282|NCT00689481|473526422|FG000|Overall Study|Subject early term, left on vacation|0|||
131518283|NCT00689481|473526423|FG001|Overall Study|Subject early term, left on vacation|1|||
131518284|NCT00590954|473526424|FG000|Overall Study|Inevaluable|2|||
131518285|NCT02782949|473526425|FG000|Overall Study|Protocol Violation|1|||
131518286|NCT02782949|473526426|FG001|Overall Study|Protocol Violation|0|||
131518287|NCT02782949|473526425|FG000|Overall Study|Withdrawal by Subject|0|||
131518288|NCT02782949|473526426|FG001|Overall Study|Withdrawal by Subject|1|||
131518289|NCT05723770|473527847|FG000|Overall Study|Lost to Follow-up|4|||
131518290|NCT05723770|473527847|FG000|Overall Study|Withdrawal by Subject|2|||
131518291|NCT00480636|473527848|FG000|Overall Study|Death|12|||
131518292|NCT00480636|473527848|FG000|Overall Study|Lost to Follow-up|4|||
131518293|NCT00480636|473527848|FG000|Overall Study|Other|2|||
131518294|NCT00480636|473527848|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
131518295|NCT00326911|473527849|FG000|Overall Study|Hospitalization prior to treatment|0|||
131518296|NCT00326911|473527850|FG001|Overall Study|Hospitalization prior to treatment|1|||
131518297|NCT00326911|473527849|FG000|Overall Study|Physician decision prior to treatment|1|||
131518298|NCT00326911|473527850|FG001|Overall Study|Physician decision prior to treatment|0|||
131518299|NCT00326911|473527849|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
131518300|NCT00326911|473527850|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
131518301|NCT01470469|473527852|FG000|Overall Study|Withdrawal by Subject|4|||
131518302|NCT01470469|473527853|FG001|Overall Study|Withdrawal by Subject|6|||
131518303|NCT01470469|473527852|FG000|Overall Study|Lack of Efficacy|1|||
131518304|NCT01470469|473527853|FG001|Overall Study|Lack of Efficacy|7|||
131518305|NCT01470469|473527852|FG000|Overall Study|Adverse Event|0|||
131518306|NCT01470469|473527853|FG001|Overall Study|Adverse Event|7|||
131518307|NCT01470469|473527852|FG000|Overall Study|Lost to Follow-up|2|||
131518308|NCT01470469|473527853|FG001|Overall Study|Lost to Follow-up|2|||
131518309|NCT01470469|473527852|FG000|Overall Study|Protocol Violation|1|||
131518310|NCT01470469|473527853|FG001|Overall Study|Protocol Violation|1|||
131518311|NCT01470469|473527852|FG000|Overall Study|Other|2|||
131518312|NCT01470469|473527853|FG001|Overall Study|Other|1|||
131518313|NCT05459129|473527854|FG000|Overall Study|Death|1|||
131518314|NCT05459129|473527855|FG001|Overall Study|Death|0|||
131518315|NCT05459129|473527854|FG000|Overall Study|Study Terminated By Sponsor|5|||
131518316|NCT05459129|473527855|FG001|Overall Study|Study Terminated By Sponsor|6|||
131518317|NCT02504372|473527857|FG000|Overall Study|Death|136|||
131518318|NCT02504372|473527858|FG001|Overall Study|Death|154|||
131518319|NCT02504372|473527857|FG000|Overall Study|Lost to Follow-up|0|||
131518320|NCT02504372|473527858|FG001|Overall Study|Lost to Follow-up|2|||
131518321|NCT02504372|473527857|FG000|Overall Study|Withdrawal of consent|25|||
131518322|NCT02504372|473527858|FG001|Overall Study|Withdrawal of consent|16|||
131518323|NCT02504372|473527857|FG000|Overall Study|Participants ongoing|429|||
131518324|NCT02504372|473527858|FG001|Overall Study|Participants ongoing|415|||
131518325|NCT04530552|473527862|FG000|Overall Study|Physician Decision|0|||
131518326|NCT04530552|473527863|FG001|Overall Study|Physician Decision|1|||
131518327|NCT04530552|473527862|FG000|Overall Study|Withdrawal by Subject|0|||
131518328|NCT04530552|473527863|FG001|Overall Study|Withdrawal by Subject|1|||
131518329|NCT04530552|473527862|FG000|Overall Study|Adverse Event|0|||
131518330|NCT04530552|473527863|FG001|Overall Study|Adverse Event|1|||
131518331|NCT04530552|473527862|FG000|Overall Study|No surgery|0|||
131518332|NCT04530552|473527863|FG001|Overall Study|No surgery|1|||
131518333|NCT00499603|473527871|FG000|Overall Study|Adverse Event|0|||
131518334|NCT00499603|473527872|FG001|Overall Study|Adverse Event|1|||
131518335|NCT03323099|473527873|FG000|Overall Study|Withdrawal by Subject|6|||
131658187|NCT02344290|474033026|FG000|Overall Study|Other|5|||
131518336|NCT03323099|473527874|FG001|Overall Study|Withdrawal by Subject|12|||
131518337|NCT03323099|473527873|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
131518338|NCT03323099|473527874|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
131518339|NCT05132127|473527877|FG000|Overall Study|Adverse Event|1|||
131518340|NCT05220397|473527878|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
131518341|NCT05220397|473527879|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
131518342|NCT05220397|473527880|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
131518343|NCT05220397|473527881|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
131518344|NCT05220397|473527882|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
131518345|NCT01857063|473527883|FG000|Period 1 (7 Days)|Adverse Event|0|||
131518346|NCT01857063|473527884|FG001|Period 1 (7 Days)|Adverse Event|1|||
131518347|NCT01857063|473527883|FG000|Period 1 (7 Days)|Physician Decision|1|||
131518348|NCT01857063|473527884|FG001|Period 1 (7 Days)|Physician Decision|0|||
131518349|NCT01857063|473527883|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
131518350|NCT01857063|473527884|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
131518351|NCT01857063|473527883|FG000|Period 2 (7 Days)|Adverse Event|2|||
131518352|NCT01857063|473527884|FG001|Period 2 (7 Days)|Adverse Event|1|||
131518353|NCT01857063|473527883|FG000|Period 2 (7 Days)|Physician Decision|1|||
131518354|NCT01857063|473527884|FG001|Period 2 (7 Days)|Physician Decision|1|||
131518355|NCT01857063|473527883|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
131518356|NCT01857063|473527884|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
131518357|NCT02375672|473527887|FG000|Overall Study|remain on follow up|20|||
131518358|NCT01256710|473527888|FG000|Overall Study|Death|449|||
131518359|NCT01256710|473527888|FG000|Overall Study|System Explant|67|||
131518360|NCT01256710|473527888|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
131518361|NCT01256710|473527888|FG000|Overall Study|Lost to Follow-up|67|||
131518362|NCT01256710|473527888|FG000|Overall Study|Withdrawal by Subject|29|||
131518363|NCT01256710|473527888|FG000|Overall Study|Physician Decision|9|||
131518364|NCT01256710|473527888|FG000|Overall Study|Subject Noncompliance|2|||
131518365|NCT01256710|473527888|FG000|Overall Study|Study Terminated by Sponsor|273|||
131518366|NCT00058825|473527889|FG000|Overall Study|Relapse|9|||
131518367|NCT00058825|473527889|FG000|Overall Study|Progressive Disease|5|||
131518368|NCT00058825|473527889|FG000|Overall Study|Graft Failure|5|||
131518369|NCT00058825|473527889|FG000|Overall Study|Death|3|||
131518370|NCT04115358|473527890|FG000|Overall Study|exfoliation|0|||
131518371|NCT04115358|473527891|FG001|Overall Study|exfoliation|0|||
131518372|NCT04115358|473527892|FG002|Overall Study|exfoliation|1|||
131518373|NCT01205165|473527894|FG000|Overall Study|Lost to Follow-up|2|||
131518374|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518375|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
131518376|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
131518377|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
131518378|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518379|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518380|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518381|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518382|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518383|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518384|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518385|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518386|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518387|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518388|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518389|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518390|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518391|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518392|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518393|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518394|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518395|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518396|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518397|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
131518398|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518399|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
131658188|NCT02344290|474033027|FG001|Overall Study|Other|3|||
131518400|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518401|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518402|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518403|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518404|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518405|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518406|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518407|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518408|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518409|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518410|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518411|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518412|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518413|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518414|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518415|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518416|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518417|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518418|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518419|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518420|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518421|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131518422|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518423|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
131518424|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518425|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518426|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518427|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518428|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518429|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518430|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518431|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518432|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518433|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518434|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518435|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518436|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518437|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518438|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518439|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518440|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518441|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518442|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518443|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518444|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518445|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
131518446|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
131518447|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
131518448|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
131518449|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
131518450|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518451|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518452|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518453|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518454|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518455|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518456|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518457|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518458|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518459|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518460|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518461|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518462|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518463|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131658416|NCT01531673|474035303|FG004|Overall Study|Lost to Follow-up|1|||
131518464|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518465|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518466|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518467|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518468|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518469|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131518470|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
131518471|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
131518472|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
131518473|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
131518474|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518475|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518476|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518477|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518478|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518479|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518480|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518481|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518482|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518483|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518484|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518485|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518486|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518487|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518488|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518489|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518490|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518491|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518492|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518493|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131518494|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518495|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
131518496|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518497|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
131518498|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518499|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518500|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518501|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518502|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518503|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518504|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518505|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518506|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518507|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518508|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518509|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518510|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518511|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518512|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518513|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518514|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518515|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518516|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518517|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
131518518|NCT02346240|473527895|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518519|NCT02346240|473527896|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518520|NCT02346240|473527897|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
131518521|NCT02346240|473527898|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518522|NCT02346240|473527899|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518523|NCT02346240|473527900|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518524|NCT02346240|473527901|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518525|NCT02346240|473527902|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518526|NCT02346240|473527903|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518527|NCT02346240|473527904|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518528|NCT02346240|473527905|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518529|NCT02346240|473527906|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518530|NCT02346240|473527907|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518531|NCT02346240|473527908|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518532|NCT02346240|473527909|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518533|NCT02346240|473527910|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518534|NCT02346240|473527911|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518535|NCT02346240|473527912|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518536|NCT02346240|473527913|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518537|NCT02346240|473527914|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518538|NCT02346240|473527915|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518539|NCT02346240|473527916|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518540|NCT02346240|473527917|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518541|NCT02346240|473527918|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
131518542|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518543|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518544|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518545|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518546|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518547|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518548|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518549|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
131518550|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
131518551|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518552|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518553|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518554|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518555|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
131518556|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
131518557|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
131518558|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
131518559|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518560|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518561|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518562|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518563|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518564|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518565|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131518566|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518567|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518568|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518569|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518570|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518571|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518572|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518573|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518574|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518575|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518576|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518577|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518578|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518579|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
131518580|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518581|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
131518582|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518583|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518584|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518585|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518586|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518587|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518588|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518589|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131518590|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518591|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518592|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518593|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518594|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518595|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518596|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518597|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518598|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518599|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518600|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518601|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518602|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518603|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518604|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
131518605|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518606|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518607|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518608|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518609|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518610|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518611|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518612|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518613|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
131518614|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518615|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518616|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518617|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518618|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518619|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131518620|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131518621|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131518622|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131518623|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518624|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131518625|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
131518626|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518627|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
131518628|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
131518629|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
131518630|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131518631|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518632|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518633|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518634|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518635|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518636|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518637|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131518638|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518639|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518640|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518641|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518642|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518643|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518644|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518645|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131658417|NCT01531673|474035304|FG005|Overall Study|Lost to Follow-up|0|||
131518646|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518647|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518648|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518649|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518650|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518651|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
131518652|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
131518653|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
131518654|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
131518655|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518656|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518657|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518658|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518659|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518660|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518661|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131518662|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518663|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518664|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518665|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518666|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518667|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518668|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
131518669|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518670|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518671|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518672|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518673|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518674|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518675|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518676|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518677|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518678|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518679|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518680|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518681|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518682|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518683|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518684|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518685|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131518686|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518687|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518688|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518689|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518690|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518691|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518692|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518693|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518694|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
131518695|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518696|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518697|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
131518698|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518699|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
131518700|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
131518701|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518702|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518703|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518704|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518705|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518706|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518707|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518708|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518709|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131518710|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518711|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518712|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518713|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518714|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518715|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518716|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518717|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518718|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518719|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
131518720|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518721|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518722|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518723|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518724|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518725|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518726|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518727|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518728|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518729|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518730|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518731|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518732|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518733|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131518734|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518735|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518736|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518737|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518738|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518739|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518740|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518741|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518742|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518743|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518744|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
131518745|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518746|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518747|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518748|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518749|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518750|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518751|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518752|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518753|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518754|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518755|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518756|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518757|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131518758|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518759|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518760|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131658418|NCT01531673|474035305|FG006|Overall Study|Lost to Follow-up|0|||
131518761|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518762|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518763|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518764|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518765|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518766|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518767|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518768|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518769|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518770|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518771|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518772|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
131518773|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518774|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518775|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518776|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518777|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518778|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518779|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518780|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518781|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
131518782|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518783|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518784|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518785|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518786|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518787|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518788|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518789|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518790|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518791|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518792|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518793|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518794|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518795|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518796|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
131518797|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518798|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518799|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518800|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518801|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518802|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518803|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518804|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518805|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
131518806|NCT02346240|473527895|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518807|NCT02346240|473527896|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518808|NCT02346240|473527897|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518809|NCT02346240|473527898|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518810|NCT02346240|473527899|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518811|NCT02346240|473527900|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518812|NCT02346240|473527901|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518813|NCT02346240|473527902|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518814|NCT02346240|473527903|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518815|NCT02346240|473527904|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518816|NCT02346240|473527905|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518817|NCT02346240|473527906|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518818|NCT02346240|473527907|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518819|NCT02346240|473527908|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518820|NCT02346240|473527909|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
131518821|NCT02346240|473527910|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518822|NCT02346240|473527911|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518823|NCT02346240|473527912|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518824|NCT02346240|473527913|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518825|NCT02346240|473527914|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518826|NCT02346240|473527915|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518827|NCT02346240|473527916|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518828|NCT02346240|473527917|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518829|NCT02346240|473527918|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131518830|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518831|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518832|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518833|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518834|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518835|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518836|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518837|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518838|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518839|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518840|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518841|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518842|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518843|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518844|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518845|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518846|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131518847|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
131518848|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
131518849|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
131518850|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
131518851|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
131518852|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
131518853|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
131518854|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518855|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518856|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518857|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518858|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518859|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518860|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518861|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518862|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518863|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518864|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518865|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518866|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518867|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518868|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518869|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518870|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518871|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518872|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
131518873|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
131518874|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518875|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
131518876|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518877|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
131518878|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518879|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518880|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518881|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518882|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518883|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518884|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518885|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518886|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518887|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518888|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518889|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518890|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518891|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518892|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518893|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518894|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518895|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518896|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
131518897|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518898|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518899|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
131518900|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518901|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
131518902|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518903|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518904|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518905|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518906|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518907|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518908|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518909|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518910|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518911|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518912|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518913|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518914|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518915|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518916|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518917|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518918|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518919|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518920|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518921|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518922|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518923|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
131518924|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518925|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131518926|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518927|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518928|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518929|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518930|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518931|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518932|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518933|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518934|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518935|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518936|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518937|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518938|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518939|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518940|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518941|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518942|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518943|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
131518944|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
131518945|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
131518946|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131518947|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
131518948|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
131518949|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
131518950|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518951|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518952|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518953|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518954|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518955|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518956|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518957|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518958|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518959|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518960|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518961|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518962|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518963|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518964|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518965|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518966|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518967|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518968|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
131518969|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
131518970|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
131518971|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
131518972|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
131518973|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
131518974|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518975|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518976|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518977|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518978|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518979|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518980|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518981|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518982|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518983|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518984|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518985|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518986|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518987|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518988|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518989|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518990|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518991|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518992|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
131518993|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518994|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131518995|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
131518996|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
131658419|NCT01531673|474035306|FG007|Overall Study|Lost to Follow-up|0|||
131518997|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
131518998|NCT02346240|473527895|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131518999|NCT02346240|473527896|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519000|NCT02346240|473527897|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519001|NCT02346240|473527898|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519002|NCT02346240|473527899|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519003|NCT02346240|473527900|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519004|NCT02346240|473527901|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519005|NCT02346240|473527902|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519006|NCT02346240|473527903|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519007|NCT02346240|473527904|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519008|NCT02346240|473527905|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519009|NCT02346240|473527906|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519010|NCT02346240|473527907|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519011|NCT02346240|473527908|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519012|NCT02346240|473527909|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519013|NCT02346240|473527910|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519014|NCT02346240|473527911|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519015|NCT02346240|473527912|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519016|NCT02346240|473527913|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
131519017|NCT02346240|473527914|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519018|NCT02346240|473527915|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519019|NCT02346240|473527916|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519020|NCT02346240|473527917|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519021|NCT02346240|473527918|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
131519022|NCT01573624|473527921|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
131519023|NCT01573624|473527922|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
131519024|NCT01573624|473527923|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
131519025|NCT01573624|473527924|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
131519026|NCT01573624|473527925|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
131519027|NCT01573624|473527926|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
131519028|NCT01573624|473527927|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
131519029|NCT01573624|473527921|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
131519030|NCT01573624|473527922|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
131519031|NCT01573624|473527923|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
131519032|NCT01573624|473527924|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
131519033|NCT01573624|473527925|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
131519034|NCT01573624|473527926|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
131519035|NCT01573624|473527927|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
131519036|NCT01573624|473527921|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
131519037|NCT01573624|473527922|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131519038|NCT01573624|473527923|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131519039|NCT01573624|473527924|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131519040|NCT01573624|473527925|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131519041|NCT01573624|473527926|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131519042|NCT01573624|473527927|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131519043|NCT01573624|473527921|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131519044|NCT01573624|473527922|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131519045|NCT01573624|473527923|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131519046|NCT01573624|473527924|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131519047|NCT01573624|473527925|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131519048|NCT01573624|473527926|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
131519049|NCT01573624|473527927|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131519050|NCT01573624|473527921|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
131519051|NCT01573624|473527922|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
131519052|NCT01573624|473527923|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
131519053|NCT01573624|473527924|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
131519054|NCT01573624|473527925|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
131519055|NCT01573624|473527926|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
131519056|NCT01573624|473527927|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
131519057|NCT01573624|473527921|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
131519058|NCT01573624|473527922|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
131519059|NCT01573624|473527923|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
131519060|NCT01573624|473527924|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
131519061|NCT01573624|473527925|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
131519062|NCT01573624|473527926|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
131519063|NCT01573624|473527927|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
131519064|NCT01573624|473527921|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
131519065|NCT01573624|473527922|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
131519066|NCT01573624|473527923|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
131519067|NCT01573624|473527924|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
131519068|NCT01573624|473527925|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
131519069|NCT01573624|473527926|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
131519070|NCT01573624|473527927|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
131519071|NCT01573624|473527921|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
131519072|NCT01573624|473527922|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131519073|NCT01573624|473527923|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
131519074|NCT01573624|473527924|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
131519075|NCT01573624|473527925|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131519076|NCT01573624|473527926|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131519077|NCT01573624|473527927|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131519078|NCT01573624|473527921|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
131519079|NCT01573624|473527922|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
131519080|NCT01573624|473527923|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
131519081|NCT01573624|473527924|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
131519082|NCT01573624|473527925|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
131519083|NCT01573624|473527926|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
131519084|NCT01573624|473527927|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
131519085|NCT01573624|473527921|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131519086|NCT01573624|473527922|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131519087|NCT01573624|473527923|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131519088|NCT01573624|473527924|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
131519089|NCT01573624|473527925|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131519090|NCT01573624|473527926|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131519091|NCT01573624|473527927|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131519092|NCT01573624|473527921|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519093|NCT01573624|473527922|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519094|NCT01573624|473527923|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519095|NCT01573624|473527924|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519096|NCT01573624|473527925|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519097|NCT01573624|473527926|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519098|NCT01573624|473527927|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519099|NCT01573624|473527921|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
131519100|NCT01573624|473527922|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
131519101|NCT01573624|473527923|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
131519102|NCT01573624|473527924|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
131519103|NCT01573624|473527925|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
131519104|NCT01573624|473527926|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
131519105|NCT01573624|473527927|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
131519106|NCT01573624|473527921|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
131519107|NCT01573624|473527922|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
131519108|NCT01573624|473527923|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
131519109|NCT01573624|473527924|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
131519110|NCT01573624|473527925|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
131519111|NCT01573624|473527926|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
131519112|NCT01573624|473527927|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
131519113|NCT01573624|473527921|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
131519114|NCT01573624|473527922|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
131519115|NCT01573624|473527923|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
131519116|NCT01573624|473527924|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
131519117|NCT01573624|473527925|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
131519118|NCT01573624|473527926|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
131519119|NCT01573624|473527927|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
131519120|NCT01573624|473527921|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131519121|NCT01573624|473527922|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
131519122|NCT01573624|473527923|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
131519123|NCT01573624|473527924|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131519124|NCT01573624|473527925|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131519125|NCT01573624|473527926|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
131519126|NCT01573624|473527927|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131519127|NCT01573624|473527921|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
131519128|NCT01573624|473527922|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
131519129|NCT01573624|473527923|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
131519130|NCT01573624|473527924|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
131519131|NCT01573624|473527925|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
131519132|NCT01573624|473527926|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
131519133|NCT01573624|473527927|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
131519134|NCT01573624|473527921|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
131519135|NCT01573624|473527922|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
131519136|NCT01573624|473527923|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
131519137|NCT01573624|473527924|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
131519138|NCT01573624|473527925|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
131519139|NCT01573624|473527926|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
131519140|NCT01573624|473527927|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
131519141|NCT01573624|473527921|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
131519142|NCT01573624|473527922|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
131519143|NCT01573624|473527923|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
131519144|NCT01573624|473527924|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
131519145|NCT01573624|473527925|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
131519146|NCT01573624|473527926|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
131519147|NCT01573624|473527927|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
131519148|NCT01573624|473527921|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
131519149|NCT01573624|473527922|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
131519150|NCT01573624|473527923|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
131519151|NCT01573624|473527924|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
131519152|NCT01573624|473527925|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
131519153|NCT01573624|473527926|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
131519154|NCT01573624|473527927|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
131519155|NCT01573624|473527921|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
131519156|NCT01573624|473527922|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
131519157|NCT01573624|473527923|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
131519158|NCT01573624|473527924|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
131519159|NCT01573624|473527925|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
131519160|NCT01573624|473527926|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
131519161|NCT01573624|473527927|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
131519162|NCT01573624|473527921|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131519163|NCT01573624|473527922|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131519164|NCT01573624|473527923|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131519165|NCT01573624|473527924|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131519166|NCT01573624|473527925|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
131519167|NCT01573624|473527926|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
131519168|NCT01573624|473527927|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
131519169|NCT01573624|473527921|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519170|NCT01573624|473527922|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519171|NCT01573624|473527923|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519172|NCT01573624|473527924|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519173|NCT01573624|473527925|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519174|NCT01573624|473527926|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
131519175|NCT01573624|473527927|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
131519176|NCT01573624|473527921|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
131519177|NCT01573624|473527922|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131519178|NCT01573624|473527923|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131519179|NCT01573624|473527924|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
131519180|NCT01573624|473527925|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
131519181|NCT01573624|473527926|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
131519182|NCT01573624|473527927|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
131519183|NCT01573624|473527921|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
131519184|NCT01573624|473527922|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
131519185|NCT01573624|473527923|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
131519186|NCT01573624|473527924|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
131519187|NCT01573624|473527925|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
131519188|NCT01573624|473527926|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
131519189|NCT01573624|473527927|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
131519190|NCT01573624|473527921|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
131519191|NCT01573624|473527922|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131519192|NCT01573624|473527923|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131519193|NCT01573624|473527924|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131519194|NCT01573624|473527925|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131519195|NCT01573624|473527926|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131519196|NCT01573624|473527927|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131519197|NCT01573624|473527921|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
131519198|NCT01573624|473527922|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
131519199|NCT01573624|473527923|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
131519200|NCT01573624|473527924|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
131519201|NCT01573624|473527925|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
131519202|NCT01573624|473527926|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
131519203|NCT01573624|473527927|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
131519204|NCT01573624|473527921|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
131519205|NCT01573624|473527922|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131519206|NCT01573624|473527923|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131519207|NCT01573624|473527924|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131519208|NCT01573624|473527925|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131519209|NCT01573624|473527926|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131519210|NCT01573624|473527927|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131519211|NCT02681302|473527928|FG000|Overall Study|Withdrawal by Subject|1|||
131519212|NCT02681302|473527929|FG001|Overall Study|Withdrawal by Subject|1|||
131519213|NCT02681302|473527930|FG002|Overall Study|Withdrawal by Subject|0|||
131519214|NCT02681302|473527931|FG003|Overall Study|Withdrawal by Subject|0|||
131519215|NCT02681302|473527932|FG004|Overall Study|Withdrawal by Subject|1|||
131519216|NCT02681302|473527933|FG005|Overall Study|Withdrawal by Subject|0|||
131519217|NCT02681302|473527928|FG000|Overall Study|Screen Failure|2|||
131519218|NCT02681302|473527929|FG001|Overall Study|Screen Failure|4|||
131519219|NCT02681302|473527930|FG002|Overall Study|Screen Failure|2|||
131519220|NCT02681302|473527931|FG003|Overall Study|Screen Failure|0|||
131519221|NCT02681302|473527932|FG004|Overall Study|Screen Failure|1|||
131519222|NCT02681302|473527933|FG005|Overall Study|Screen Failure|1|||
131519223|NCT02681302|473527928|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
131519224|NCT02681302|473527929|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
131519225|NCT02681302|473527930|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
131519226|NCT02681302|473527931|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
131519227|NCT02681302|473527932|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
131519228|NCT02681302|473527933|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
131519229|NCT02115282|473527934|FG000|Overall Study|Disease progression during treatment|216|||
131519230|NCT02115282|473527935|FG001|Overall Study|Disease progression during treatment|229|||
131519231|NCT02115282|473527934|FG000|Overall Study|Adverse Event|49|||
131519232|NCT02115282|473527935|FG001|Overall Study|Adverse Event|23|||
131519233|NCT02115282|473527934|FG000|Overall Study|Death|1|||
131519234|NCT02115282|473527935|FG001|Overall Study|Death|3|||
131519235|NCT02115282|473527934|FG000|Overall Study|Alternative therapy|1|||
131519236|NCT02115282|473527935|FG001|Overall Study|Alternative therapy|1|||
131519237|NCT02115282|473527934|FG000|Overall Study|Complicating disease|0|||
131519238|NCT02115282|473527935|FG001|Overall Study|Complicating disease|3|||
131519239|NCT02115282|473527934|FG000|Overall Study|Withdrawal by Subject|12|||
131519240|NCT02115282|473527935|FG001|Overall Study|Withdrawal by Subject|10|||
131519241|NCT02115282|473527934|FG000|Overall Study|Symptomatic progression/deterioration|7|||
131519242|NCT02115282|473527935|FG001|Overall Study|Symptomatic progression/deterioration|18|||
131519243|NCT02115282|473527934|FG000|Overall Study|Non-compliance|5|||
131519244|NCT02115282|473527935|FG001|Overall Study|Non-compliance|1|||
131519245|NCT02115282|473527934|FG000|Overall Study|Protocol Violation|2|||
131519246|NCT02115282|473527935|FG001|Overall Study|Protocol Violation|2|||
131519247|NCT02115282|473527934|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
131519248|NCT02115282|473527935|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
131519249|NCT02115282|473527934|FG000|Overall Study|Not start protocol therapy|9|||
131519250|NCT02115282|473527935|FG001|Overall Study|Not start protocol therapy|10|||
131519251|NCT02152995|473527940|FG000|Overall Study|Withdrawal by Subject|1|||
131519252|NCT02152995|473527941|FG001|Overall Study|Withdrawal by Subject|0|||
131519253|NCT00480779|473527943|FG000|Overall Study|Other|2|||
131519254|NCT00480779|473527944|FG001|Overall Study|Other|0|||
131519255|NCT00480779|473527943|FG000|Overall Study|Job and Health-related|0|||
131519256|NCT00480779|473527944|FG001|Overall Study|Job and Health-related|3|||
131519257|NCT04907032|473527945|FG000|Overall Study|Withdrawal by Subject|7|||
131519258|NCT04907032|473527946|FG001|Overall Study|Withdrawal by Subject|1|||
131519259|NCT00613509|473527948|FG000|Cycle 1|Adverse Event|2|||
131519260|NCT00613509|473527949|FG001|Cycle 1|Adverse Event|1|||
131519261|NCT00613509|473527948|FG000|Cycle 1|Disease Progression|2|||
131519262|NCT00613509|473527949|FG001|Cycle 1|Disease Progression|6|||
131519263|NCT00613509|473527948|FG000|Cycle 1|Unacceptable Toxicity|1|||
131519264|NCT00613509|473527949|FG001|Cycle 1|Unacceptable Toxicity|0|||
131519265|NCT00613509|473527948|FG000|Cycle 1|Other administrative reason|0|||
131519266|NCT00613509|473527949|FG001|Cycle 1|Other administrative reason|1|||
131519267|NCT00308711|473527967|FG000|Overall Study|Withdrawal by Subject|1|||
131519268|NCT00308711|473527968|FG001|Overall Study|Withdrawal by Subject|0|||
131519269|NCT00308711|473527969|FG002|Overall Study|Withdrawal by Subject|1|||
131519270|NCT00308711|473527967|FG000|Overall Study|Protocol Violation|0|||
131519271|NCT00308711|473527968|FG001|Overall Study|Protocol Violation|1|||
131519272|NCT00308711|473527969|FG002|Overall Study|Protocol Violation|1|||
131519273|NCT00308711|473527967|FG000|Overall Study|Lost to Follow-up|0|||
131519274|NCT00308711|473527968|FG001|Overall Study|Lost to Follow-up|1|||
131519275|NCT00308711|473527969|FG002|Overall Study|Lost to Follow-up|0|||
131519276|NCT00308711|473527967|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
131519277|NCT00308711|473527968|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
131519278|NCT00308711|473527969|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
131519279|NCT00308711|473527967|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
131519280|NCT00308711|473527968|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
131519281|NCT00308711|473527969|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
131519282|NCT02167256|473527970|FG000|Overall Study|Adverse Event|13|||
131519283|NCT02167256|473527971|FG001|Overall Study|Adverse Event|6|||
131519284|NCT02167256|473527970|FG000|Overall Study|Withdrawal by Subject|4|||
131519285|NCT02167256|473527971|FG001|Overall Study|Withdrawal by Subject|4|||
131519286|NCT02167256|473527970|FG000|Overall Study|non-compliance|3|||
131519287|NCT02167256|473527971|FG001|Overall Study|non-compliance|0|||
131519288|NCT02167256|473527970|FG000|Overall Study|Study partner unable to participate|1|||
131519289|NCT02167256|473527971|FG001|Overall Study|Study partner unable to participate|0|||
131519290|NCT01420081|473527972|FG000|Overall Study|Death|1|||
131519291|NCT01420081|473527973|FG001|Overall Study|Death|0|||
131519292|NCT01420081|473527974|FG002|Overall Study|Death|8|||
131519293|NCT01420081|473527975|FG003|Overall Study|Death|0|||
131519294|NCT01420081|473527976|FG004|Overall Study|Death|7|||
131519295|NCT01420081|473527977|FG005|Overall Study|Death|12|||
131519296|NCT01420081|473527978|FG006|Overall Study|Death|0|||
131519297|NCT01420081|473527979|FG007|Overall Study|Death|1|||
131519298|NCT01420081|473527980|FG008|Overall Study|Death|1|||
131519299|NCT01420081|473527972|FG000|Overall Study|Lost to Follow-up|0|||
131519300|NCT01420081|473527973|FG001|Overall Study|Lost to Follow-up|0|||
131519301|NCT01420081|473527974|FG002|Overall Study|Lost to Follow-up|0|||
131519302|NCT01420081|473527975|FG003|Overall Study|Lost to Follow-up|0|||
131519303|NCT01420081|473527976|FG004|Overall Study|Lost to Follow-up|1|||
131519304|NCT01420081|473527977|FG005|Overall Study|Lost to Follow-up|1|||
131519305|NCT01420081|473527978|FG006|Overall Study|Lost to Follow-up|0|||
131519306|NCT01420081|473527979|FG007|Overall Study|Lost to Follow-up|0|||
131519307|NCT01420081|473527980|FG008|Overall Study|Lost to Follow-up|0|||
131519308|NCT01420081|473527972|FG000|Overall Study|Study Terminated by Sponsor|2|||
131519309|NCT01420081|473527973|FG001|Overall Study|Study Terminated by Sponsor|1|||
131519310|NCT01420081|473527974|FG002|Overall Study|Study Terminated by Sponsor|1|||
131519311|NCT01420081|473527975|FG003|Overall Study|Study Terminated by Sponsor|3|||
131519312|NCT01420081|473527976|FG004|Overall Study|Study Terminated by Sponsor|11|||
131519313|NCT01420081|473527977|FG005|Overall Study|Study Terminated by Sponsor|7|||
131519314|NCT01420081|473527978|FG006|Overall Study|Study Terminated by Sponsor|3|||
131519315|NCT01420081|473527979|FG007|Overall Study|Study Terminated by Sponsor|2|||
131519316|NCT01420081|473527980|FG008|Overall Study|Study Terminated by Sponsor|2|||
131519317|NCT01420081|473527972|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
131519318|NCT01420081|473527973|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
131519319|NCT01420081|473527974|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
131519320|NCT01420081|473527975|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
131519321|NCT01420081|473527976|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
131519322|NCT01420081|473527977|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
131519323|NCT01420081|473527978|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
131519324|NCT01420081|473527979|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
131519325|NCT01420081|473527980|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
131519326|NCT01420081|473527972|FG000|Overall Study|Other Reasons|0|||
131519327|NCT01420081|473527973|FG001|Overall Study|Other Reasons|0|||
131519328|NCT01420081|473527974|FG002|Overall Study|Other Reasons|1|||
131519329|NCT01420081|473527975|FG003|Overall Study|Other Reasons|0|||
131519330|NCT01420081|473527976|FG004|Overall Study|Other Reasons|0|||
131519331|NCT01420081|473527977|FG005|Overall Study|Other Reasons|0|||
131519332|NCT01420081|473527978|FG006|Overall Study|Other Reasons|0|||
131519333|NCT01420081|473527979|FG007|Overall Study|Other Reasons|0|||
131519334|NCT01420081|473527980|FG008|Overall Study|Other Reasons|0|||
131519335|NCT01723228|473527981|FG000|Overall Study|Adverse Event|2|||
131519336|NCT01723228|473527982|FG001|Overall Study|Adverse Event|6|||
131519337|NCT01723228|473527981|FG000|Overall Study|Withdrawal by Subject|2|||
131519338|NCT01723228|473527982|FG001|Overall Study|Withdrawal by Subject|1|||
131519339|NCT01723228|473527981|FG000|Overall Study|Protocol Violation|0|||
131519340|NCT01723228|473527982|FG001|Overall Study|Protocol Violation|2|||
131519341|NCT01723228|473527981|FG000|Overall Study|Lost to Follow-up|2|||
131519342|NCT01723228|473527982|FG001|Overall Study|Lost to Follow-up|1|||
131519343|NCT01723228|473527981|FG000|Overall Study|Other|2|||
131519344|NCT01723228|473527982|FG001|Overall Study|Other|1|||
131519345|NCT01451424|473527985|FG000|Overall Study|Withdrawal by Subject|1|||
131519346|NCT01451424|473527986|FG001|Overall Study|Withdrawal by Subject|1|||
131519347|NCT01451424|473527987|FG002|Overall Study|Withdrawal by Subject|0|||
131519348|NCT01451424|473527988|FG003|Overall Study|Withdrawal by Subject|2|||
131519349|NCT01451424|473527985|FG000|Overall Study|Lost to Follow-up|0|||
131519350|NCT01451424|473527986|FG001|Overall Study|Lost to Follow-up|1|||
131519351|NCT01451424|473527987|FG002|Overall Study|Lost to Follow-up|0|||
131519352|NCT01451424|473527988|FG003|Overall Study|Lost to Follow-up|1|||
131519353|NCT01451424|473527985|FG000|Overall Study|Physician Decision|0|||
131519354|NCT01451424|473527986|FG001|Overall Study|Physician Decision|0|||
131519355|NCT01451424|473527987|FG002|Overall Study|Physician Decision|1|||
131519356|NCT01451424|473527988|FG003|Overall Study|Physician Decision|1|||
131519357|NCT01451424|473527985|FG000|Overall Study|Adverse Event|0|||
131519358|NCT01451424|473527986|FG001|Overall Study|Adverse Event|0|||
131519359|NCT01451424|473527987|FG002|Overall Study|Adverse Event|0|||
131519360|NCT01451424|473527988|FG003|Overall Study|Adverse Event|1|||
131519361|NCT00528528|473527994|FG000|Overall Study|Lost to Follow-up|0|||
131519362|NCT00528528|473527995|FG001|Overall Study|Lost to Follow-up|0|||
131519363|NCT00528528|473527996|FG002|Overall Study|Lost to Follow-up|1|||
131519364|NCT00528528|473527997|FG003|Overall Study|Lost to Follow-up|1|||
131519365|NCT00528528|473527994|FG000|Overall Study|Ineligible to continue the trial|0|||
131519366|NCT00528528|473527995|FG001|Overall Study|Ineligible to continue the trial|0|||
131519367|NCT00528528|473527996|FG002|Overall Study|Ineligible to continue the trial|0|||
131519368|NCT00528528|473527997|FG003|Overall Study|Ineligible to continue the trial|1|||
131519369|NCT00528528|473527994|FG000|Overall Study|Other|0|||
131519370|NCT00528528|473527995|FG001|Overall Study|Other|1|||
131519371|NCT00528528|473527996|FG002|Overall Study|Other|0|||
131519372|NCT00528528|473527997|FG003|Overall Study|Other|0|||
131519373|NCT00528528|473527994|FG000|Overall Study|Withdrawal by Subject|3|||
131519374|NCT00528528|473527995|FG001|Overall Study|Withdrawal by Subject|2|||
131519375|NCT00528528|473527996|FG002|Overall Study|Withdrawal by Subject|1|||
131519376|NCT00528528|473527997|FG003|Overall Study|Withdrawal by Subject|1|||
131519377|NCT00528528|473527994|FG000|Overall Study|Ongoing participant|0|||
131519378|NCT00528528|473527995|FG001|Overall Study|Ongoing participant|0|||
131519379|NCT00528528|473527996|FG002|Overall Study|Ongoing participant|1|||
131519380|NCT00528528|473527997|FG003|Overall Study|Ongoing participant|0|||
131519381|NCT04602624|473527998|FG000|Overall Study|Protocol Deviation|1|||
131519382|NCT04602624|473527998|FG000|Overall Study|Withdrawal by Participant|1|||
131519383|NCT04084769|473527999|FG000|Overall Study|Protocol Violation|1|||
131519384|NCT04084769|473528000|FG001|Overall Study|Protocol Violation|3|||
131519385|NCT04084769|473528001|FG002|Overall Study|Protocol Violation|0|||
131519386|NCT04084769|473528002|FG003|Overall Study|Protocol Violation|1|||
131519387|NCT04084769|473527999|FG000|Overall Study|Withdrawal by Subject|0|||
131519388|NCT04084769|473528000|FG001|Overall Study|Withdrawal by Subject|1|||
131519389|NCT04084769|473528001|FG002|Overall Study|Withdrawal by Subject|0|||
131519390|NCT04084769|473528002|FG003|Overall Study|Withdrawal by Subject|0|||
131519391|NCT04084769|473527999|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131519392|NCT04084769|473528000|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131519393|NCT04084769|473528001|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131519394|NCT04084769|473528002|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131519395|NCT04084769|473527999|FG000|Overall Study|Lost to Follow-up|2|||
131519396|NCT04084769|473528000|FG001|Overall Study|Lost to Follow-up|0|||
131519397|NCT04084769|473528001|FG002|Overall Study|Lost to Follow-up|0|||
131519398|NCT04084769|473528002|FG003|Overall Study|Lost to Follow-up|0|||
131519399|NCT03508219|473528003|FG000|Overall Study|Death|2|||
131519400|NCT03508219|473528003|FG000|Overall Study|Withdrawal by Subject|1|||
131519401|NCT03508219|473528003|FG000|Overall Study|Lost to Follow-up|4|||
131519402|NCT03508219|473528003|FG000|Overall Study|Missed visit|2|||
131519403|NCT03945981|473528004|FG000|Overall Study|Lost to Follow-up|12|||
131519404|NCT03945981|473528004|FG000|Overall Study|Physician Decision|4|||
131519405|NCT03945981|473528004|FG000|Overall Study|Withdrawal by Subject|6|||
131519406|NCT03945981|473528004|FG000|Overall Study|Protocol Violation|1|||
131519407|NCT04466891|473528005|FG000|Overall Study|Death|60|||
131519408|NCT04466891|473528006|FG001|Overall Study|Death|6|||
131519409|NCT04466891|473528005|FG000|Overall Study|Withdrawal by Subject|8|||
131519410|NCT04466891|473528006|FG001|Overall Study|Withdrawal by Subject|1|||
131519411|NCT04466891|473528005|FG000|Overall Study|Study terminated by sponsor|5|||
131519412|NCT04466891|473528006|FG001|Overall Study|Study terminated by sponsor|0|||
131519413|NCT04466891|473528005|FG000|Overall Study|Lost to Follow-up|2|||
131519414|NCT04466891|473528006|FG001|Overall Study|Lost to Follow-up|0|||
131519415|NCT04466891|473528005|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
131519416|NCT04466891|473528006|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
131519417|NCT00316199|473528007|FG000|Overall Study|Adverse Event|2|||
131519418|NCT00316199|473528007|FG000|Overall Study|Death|8|||
131519419|NCT00316199|473528007|FG000|Overall Study|Lost to Follow-up|2|||
131519420|NCT04346615|473529444|FG000|Overall Study|Lost to Follow-up|0|||
131519421|NCT04346615|473529445|FG001|Overall Study|Lost to Follow-up|2|||
131519422|NCT04346615|473529444|FG000|Overall Study|Withdrawal by Subject|1|||
131519423|NCT04346615|473529445|FG001|Overall Study|Withdrawal by Subject|0|||
131519424|NCT04346615|473529444|FG000|Overall Study|Death|5|||
131519425|NCT04346615|473529445|FG001|Overall Study|Death|1|||
131519426|NCT04346615|473529444|FG000|Overall Study|Other|0|||
131519427|NCT04346615|473529445|FG001|Overall Study|Other|2|||
131519428|NCT04346615|473529444|FG000|Overall Study|Randomized not treated|1|||
131519429|NCT04346615|473529445|FG001|Overall Study|Randomized not treated|0|||
131519430|NCT03370341|473529446|FG000|Overall Study|Lost to Follow-up|0|||
131519431|NCT03370341|473529447|FG001|Overall Study|Lost to Follow-up|1|||
131519432|NCT01707004|473529450|FG000|Overall Study|Physician Decision|3|||
131519433|NCT00533949|473529451|FG000|Overall Study|Protocol Violation|12|||
131519434|NCT00533949|473529452|FG001|Overall Study|Protocol Violation|12|||
131519435|NCT00533949|473529453|FG002|Overall Study|Protocol Violation|9|||
131519436|NCT00533949|473529454|FG003|Overall Study|Protocol Violation|9|||
131519437|NCT00533949|473529451|FG000|Overall Study|Withdrawal by Subject|3|||
131519438|NCT00533949|473529452|FG001|Overall Study|Withdrawal by Subject|2|||
131519439|NCT00533949|473529453|FG002|Overall Study|Withdrawal by Subject|1|||
131519440|NCT00533949|473529454|FG003|Overall Study|Withdrawal by Subject|1|||
131519441|NCT00727194|473529455|FG000|Screening Period|Low QMG scores|0|||
131519442|NCT00727194|473529456|FG001|Screening Period|Low QMG scores|0|||
131519443|NCT00727194|473529457|FG002|Screening Period|Low QMG scores|6|||
131519444|NCT00727194|473529455|FG000|Screening Period|Lacked AChR antibodies|0|||
131519445|NCT00727194|473529456|FG001|Screening Period|Lacked AChR antibodies|0|||
131519446|NCT00727194|473529457|FG002|Screening Period|Lacked AChR antibodies|5|||
131519447|NCT00727194|473529455|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
131519448|NCT00727194|473529456|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
131519449|NCT00727194|473529457|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
131519450|NCT00727194|473529455|FG000|Screening Period|Severe infections|0|||
131519451|NCT00727194|473529456|FG001|Screening Period|Severe infections|0|||
131519452|NCT00727194|473529457|FG002|Screening Period|Severe infections|2|||
131519453|NCT00727194|473529455|FG000|Screening Period|History of thymoma|0|||
131519454|NCT00727194|473529456|FG001|Screening Period|History of thymoma|0|||
131519455|NCT00727194|473529457|FG002|Screening Period|History of thymoma|1|||
131519456|NCT00727194|473529455|FG000|Treatment Period 2|Lack of Efficacy|0|||
131519457|NCT00727194|473529456|FG001|Treatment Period 2|Lack of Efficacy|1|||
131519458|NCT00727194|473529457|FG002|Treatment Period 2|Lack of Efficacy|0|||
131519459|NCT04269161|473529463|FG000|Overall Study|Change of modality and no longer eligible|3|||
131519460|NCT04269161|473529464|FG001|Overall Study|Change of modality and no longer eligible|3|||
131519461|NCT04269161|473529463|FG000|Overall Study|Required procedure outside of NICU|1|||
131519462|NCT04269161|473529464|FG001|Overall Study|Required procedure outside of NICU|0|||
131519463|NCT04269161|473529463|FG000|Overall Study|Equipment issue|1|||
131519464|NCT04269161|473529464|FG001|Overall Study|Equipment issue|1|||
131519465|NCT01677195|473529465|FG000|Overall Study|Lost to Follow-up|14|||
131519466|NCT01677195|473529466|FG001|Overall Study|Lost to Follow-up|22|||
131519467|NCT01677195|473529467|FG002|Overall Study|Lost to Follow-up|22|||
131519468|NCT01677195|473529465|FG000|Overall Study|Withdrawal by Subject|1|||
131519469|NCT01677195|473529466|FG001|Overall Study|Withdrawal by Subject|0|||
131519470|NCT01677195|473529467|FG002|Overall Study|Withdrawal by Subject|1|||
131519471|NCT01677195|473529465|FG000|Overall Study|Adverse Event|6|||
131519472|NCT01677195|473529466|FG001|Overall Study|Adverse Event|4|||
131519473|NCT01677195|473529467|FG002|Overall Study|Adverse Event|1|||
131519474|NCT01677195|473529465|FG000|Overall Study|Physician Decision|1|||
131519475|NCT01677195|473529466|FG001|Overall Study|Physician Decision|2|||
131519476|NCT01677195|473529467|FG002|Overall Study|Physician Decision|2|||
131519477|NCT01677195|473529465|FG000|Overall Study|Pregnancy|0|||
131519478|NCT01677195|473529466|FG001|Overall Study|Pregnancy|1|||
131519479|NCT01677195|473529467|FG002|Overall Study|Pregnancy|0|||
131519480|NCT01677195|473529465|FG000|Overall Study|Protocol Violation|7|||
131519481|NCT01677195|473529466|FG001|Overall Study|Protocol Violation|3|||
131519482|NCT01677195|473529467|FG002|Overall Study|Protocol Violation|4|||
131519483|NCT04368429|473529468|FG000|Overall Study|Adverse Event|1|||
131519484|NCT04368429|473529469|FG001|Overall Study|Adverse Event|0|||
131519485|NCT02143414|473529471|FG000|Induction|Adverse Event|1|||
131519486|NCT02143414|473529472|FG001|Induction|Adverse Event|2|||
131519487|NCT02143414|473529471|FG000|Induction|Death|1|||
131519488|NCT02143414|473529472|FG001|Induction|Death|2|||
131519489|NCT02143414|473529471|FG000|Induction|Patient refusal|1|||
131519490|NCT02143414|473529472|FG001|Induction|Patient refusal|1|||
131519491|NCT02143414|473529471|FG000|Induction|Refractory|1|||
131519492|NCT02143414|473529472|FG001|Induction|Refractory|0|||
131519493|NCT02143414|473529471|FG000|Induction|Began alternative treatment|1|||
131519494|NCT02143414|473529472|FG001|Induction|Began alternative treatment|0|||
131519495|NCT02143414|473529471|FG000|Induction|Ineligible for postremission|5|||
131519496|NCT02143414|473529472|FG001|Induction|Ineligible for postremission|1|||
131519497|NCT02143414|473529471|FG000|Post-remission|Adverse Event|0|||
131519498|NCT02143414|473529472|FG001|Post-remission|Adverse Event|2|||
131519499|NCT02143414|473529471|FG000|Post-remission|Disease progression/relapse|5|||
131519500|NCT02143414|473529472|FG001|Post-remission|Disease progression/relapse|0|||
131519501|NCT02143414|473529471|FG000|Maintenance|Adverse Event|4|||
131519502|NCT02143414|473529472|FG001|Maintenance|Adverse Event|6|||
131519503|NCT02143414|473529471|FG000|Maintenance|Disease progression/relapse|3|||
131519504|NCT02143414|473529472|FG001|Maintenance|Disease progression/relapse|2|||
131519505|NCT02143414|473529471|FG000|Maintenance|Patient refusal|2|||
131519506|NCT02143414|473529472|FG001|Maintenance|Patient refusal|1|||
131519507|NCT02143414|473529471|FG000|Maintenance|Physician Decision|1|||
131519508|NCT02143414|473529472|FG001|Maintenance|Physician Decision|0|||
131519509|NCT02143414|473529471|FG000|Maintenance|Death|0|||
131519510|NCT02143414|473529472|FG001|Maintenance|Death|1|||
131519511|NCT02143414|473529471|FG000|Maintenance|On protocol treatment|0|||
131519512|NCT02143414|473529472|FG001|Maintenance|On protocol treatment|6|||
131519513|NCT02896400|473529476|FG000|1 Month Follow-up|Lost to Follow-up|7|||
131519514|NCT02896400|473529477|FG001|1 Month Follow-up|Lost to Follow-up|7|||
131519515|NCT02896400|473529478|FG002|1 Month Follow-up|Lost to Follow-up|5|||
131519516|NCT02896400|473529479|FG003|1 Month Follow-up|Lost to Follow-up|8|||
131519517|NCT02896400|473529480|FG004|1 Month Follow-up|Lost to Follow-up|9|||
131519518|NCT02896400|473529481|FG005|1 Month Follow-up|Lost to Follow-up|6|||
131519519|NCT02896400|473529482|FG006|1 Month Follow-up|Lost to Follow-up|5|||
131519520|NCT02896400|473529483|FG007|1 Month Follow-up|Lost to Follow-up|6|||
131519521|NCT02896400|473529484|FG008|1 Month Follow-up|Lost to Follow-up|4|||
131519522|NCT02896400|473529485|FG009|1 Month Follow-up|Lost to Follow-up|7|||
131519523|NCT02896400|473529486|FG010|1 Month Follow-up|Lost to Follow-up|5|||
131519524|NCT02896400|473529487|FG011|1 Month Follow-up|Lost to Follow-up|5|||
131519525|NCT02896400|473529488|FG012|1 Month Follow-up|Lost to Follow-up|3|||
131519526|NCT02896400|473529489|FG013|1 Month Follow-up|Lost to Follow-up|4|||
131519527|NCT02896400|473529490|FG014|1 Month Follow-up|Lost to Follow-up|1|||
131519528|NCT02896400|473529491|FG015|1 Month Follow-up|Lost to Follow-up|2|||
131519529|NCT02896400|473529476|FG000|1 Month Follow-up|Death|0|||
131519530|NCT02896400|473529477|FG001|1 Month Follow-up|Death|0|||
131519531|NCT02896400|473529478|FG002|1 Month Follow-up|Death|0|||
131519532|NCT02896400|473529479|FG003|1 Month Follow-up|Death|0|||
131519533|NCT02896400|473529480|FG004|1 Month Follow-up|Death|0|||
131519534|NCT02896400|473529481|FG005|1 Month Follow-up|Death|0|||
131519535|NCT02896400|473529482|FG006|1 Month Follow-up|Death|0|||
131519536|NCT02896400|473529483|FG007|1 Month Follow-up|Death|0|||
131519537|NCT02896400|473529484|FG008|1 Month Follow-up|Death|0|||
131519538|NCT02896400|473529485|FG009|1 Month Follow-up|Death|0|||
131519539|NCT02896400|473529486|FG010|1 Month Follow-up|Death|0|||
131519540|NCT02896400|473529487|FG011|1 Month Follow-up|Death|0|||
131519541|NCT02896400|473529488|FG012|1 Month Follow-up|Death|0|||
131519542|NCT02896400|473529489|FG013|1 Month Follow-up|Death|0|||
131519543|NCT02896400|473529490|FG014|1 Month Follow-up|Death|0|||
131519544|NCT02896400|473529491|FG015|1 Month Follow-up|Death|1|||
131519545|NCT02896400|473529476|FG000|3 Month Follow-up|Lost to Follow-up|6|||
131519546|NCT02896400|473529477|FG001|3 Month Follow-up|Lost to Follow-up|3|||
131519547|NCT02896400|473529478|FG002|3 Month Follow-up|Lost to Follow-up|6|||
131519548|NCT02896400|473529479|FG003|3 Month Follow-up|Lost to Follow-up|11|||
131519549|NCT02896400|473529480|FG004|3 Month Follow-up|Lost to Follow-up|12|||
131519550|NCT02896400|473529481|FG005|3 Month Follow-up|Lost to Follow-up|6|||
131519551|NCT02896400|473529482|FG006|3 Month Follow-up|Lost to Follow-up|4|||
131519552|NCT02896400|473529483|FG007|3 Month Follow-up|Lost to Follow-up|3|||
131519553|NCT02896400|473529484|FG008|3 Month Follow-up|Lost to Follow-up|6|||
131519554|NCT02896400|473529485|FG009|3 Month Follow-up|Lost to Follow-up|5|||
131519555|NCT02896400|473529486|FG010|3 Month Follow-up|Lost to Follow-up|6|||
131519556|NCT02896400|473529487|FG011|3 Month Follow-up|Lost to Follow-up|6|||
131519557|NCT02896400|473529488|FG012|3 Month Follow-up|Lost to Follow-up|3|||
131519558|NCT02896400|473529489|FG013|3 Month Follow-up|Lost to Follow-up|5|||
131519559|NCT02896400|473529490|FG014|3 Month Follow-up|Lost to Follow-up|3|||
131519560|NCT02896400|473529491|FG015|3 Month Follow-up|Lost to Follow-up|2|||
131519561|NCT02896400|473529476|FG000|3 Month Follow-up|Death|0|||
131519562|NCT02896400|473529477|FG001|3 Month Follow-up|Death|0|||
131519563|NCT02896400|473529478|FG002|3 Month Follow-up|Death|0|||
131519564|NCT02896400|473529479|FG003|3 Month Follow-up|Death|0|||
131519565|NCT02896400|473529480|FG004|3 Month Follow-up|Death|0|||
131519566|NCT02896400|473529481|FG005|3 Month Follow-up|Death|0|||
131519567|NCT02896400|473529482|FG006|3 Month Follow-up|Death|0|||
131519568|NCT02896400|473529483|FG007|3 Month Follow-up|Death|0|||
131519569|NCT02896400|473529484|FG008|3 Month Follow-up|Death|0|||
131519570|NCT02896400|473529485|FG009|3 Month Follow-up|Death|0|||
131519571|NCT02896400|473529486|FG010|3 Month Follow-up|Death|0|||
131519572|NCT02896400|473529487|FG011|3 Month Follow-up|Death|0|||
131519573|NCT02896400|473529488|FG012|3 Month Follow-up|Death|0|||
131519574|NCT02896400|473529489|FG013|3 Month Follow-up|Death|1|||
131519575|NCT02896400|473529490|FG014|3 Month Follow-up|Death|1|||
131519576|NCT02896400|473529491|FG015|3 Month Follow-up|Death|0|||
131519577|NCT02896400|473529476|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519578|NCT02896400|473529477|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
131519579|NCT02896400|473529478|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519580|NCT02896400|473529479|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519581|NCT02896400|473529480|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
131519582|NCT02896400|473529481|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519583|NCT02896400|473529482|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
131519584|NCT02896400|473529483|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
131519585|NCT02896400|473529484|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519586|NCT02896400|473529485|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519587|NCT02896400|473529486|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
131519588|NCT02896400|473529487|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
131519589|NCT02896400|473529488|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519590|NCT02896400|473529489|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
131519591|NCT02896400|473529490|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
131519592|NCT02896400|473529491|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
131519593|NCT02896400|473529476|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
131519594|NCT02896400|473529477|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
131519595|NCT02896400|473529478|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
131519596|NCT02896400|473529479|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
131519597|NCT02896400|473529480|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
131519598|NCT02896400|473529481|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
131519599|NCT02896400|473529482|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
131519600|NCT02896400|473529483|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
131519601|NCT02896400|473529484|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
131519602|NCT02896400|473529485|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
131519603|NCT02896400|473529486|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
131519604|NCT02896400|473529487|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
131519605|NCT02896400|473529488|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
131519606|NCT02896400|473529489|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
131519607|NCT02896400|473529490|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
131519608|NCT02896400|473529491|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
131519609|NCT00634647|473529492|FG000|Overall Study|death on study|3|||
131519610|NCT00634647|473529492|FG000|Overall Study|refused further treatment|3|||
131519611|NCT00634647|473529492|FG000|Overall Study|declined to participate before treatment|1|||
131519612|NCT00646204|473529495|FG000|Overall Study|Adverse Event|3|||
131519613|NCT00646204|473529496|FG001|Overall Study|Adverse Event|0|||
131519614|NCT00646204|473529495|FG000|Overall Study|Withdrawal by Subject|1|||
131519615|NCT00646204|473529496|FG001|Overall Study|Withdrawal by Subject|0|||
131519616|NCT03107988|473529500|FG000|Overall Study|Adverse Event|0|||
131519617|NCT03107988|473529501|FG001|Overall Study|Adverse Event|0|||
131519618|NCT03107988|473529502|FG002|Overall Study|Adverse Event|0|||
131519619|NCT03107988|473529503|FG003|Overall Study|Adverse Event|1|||
131519620|NCT03107988|473529504|FG004|Overall Study|Adverse Event|0|||
131519621|NCT03107988|473529505|FG005|Overall Study|Adverse Event|1|||
131519622|NCT03107988|473529506|FG006|Overall Study|Adverse Event|0|||
131519623|NCT03107988|473529507|FG007|Overall Study|Adverse Event|1|||
131519624|NCT03107988|473529508|FG008|Overall Study|Adverse Event|0|||
131519625|NCT03107988|473529509|FG009|Overall Study|Adverse Event|0|||
131519626|NCT03107988|473529510|FG010|Overall Study|Adverse Event|0|||
131519627|NCT03107988|473529511|FG011|Overall Study|Adverse Event|0|||
131519628|NCT03107988|473529512|FG012|Overall Study|Adverse Event|0|||
131519629|NCT03107988|473529500|FG000|Overall Study|Disease Progression or Relapse|1|||
131519630|NCT03107988|473529501|FG001|Overall Study|Disease Progression or Relapse|2|||
131519631|NCT03107988|473529502|FG002|Overall Study|Disease Progression or Relapse|2|||
131519632|NCT03107988|473529503|FG003|Overall Study|Disease Progression or Relapse|5|||
131519633|NCT03107988|473529504|FG004|Overall Study|Disease Progression or Relapse|1|||
131519634|NCT03107988|473529505|FG005|Overall Study|Disease Progression or Relapse|1|||
131519635|NCT03107988|473529506|FG006|Overall Study|Disease Progression or Relapse|0|||
131519636|NCT03107988|473529507|FG007|Overall Study|Disease Progression or Relapse|0|||
131519637|NCT03107988|473529508|FG008|Overall Study|Disease Progression or Relapse|0|||
131519638|NCT03107988|473529509|FG009|Overall Study|Disease Progression or Relapse|1|||
131519639|NCT03107988|473529510|FG010|Overall Study|Disease Progression or Relapse|4|||
131519640|NCT03107988|473529511|FG011|Overall Study|Disease Progression or Relapse|0|||
131519641|NCT03107988|473529512|FG012|Overall Study|Disease Progression or Relapse|0|||
131519642|NCT03107988|473529500|FG000|Overall Study|Ineligible|0|||
131519643|NCT03107988|473529501|FG001|Overall Study|Ineligible|0|||
131519644|NCT03107988|473529502|FG002|Overall Study|Ineligible|0|||
131519645|NCT03107988|473529503|FG003|Overall Study|Ineligible|0|||
131519646|NCT03107988|473529504|FG004|Overall Study|Ineligible|0|||
131519647|NCT03107988|473529505|FG005|Overall Study|Ineligible|0|||
131519648|NCT03107988|473529506|FG006|Overall Study|Ineligible|0|||
131519649|NCT03107988|473529507|FG007|Overall Study|Ineligible|0|||
131519650|NCT03107988|473529508|FG008|Overall Study|Ineligible|1|||
131519651|NCT03107988|473529509|FG009|Overall Study|Ineligible|0|||
131519652|NCT03107988|473529510|FG010|Overall Study|Ineligible|0|||
131519653|NCT03107988|473529511|FG011|Overall Study|Ineligible|0|||
131519654|NCT03107988|473529512|FG012|Overall Study|Ineligible|0|||
131519655|NCT00503841|473529513|FG000|Overall Study|All screen failures|44|||
131519656|NCT00326612|473529514|FG000|Overall Study|They did not have a seizure requiring tx|129|||
131519657|NCT00326612|473529515|FG001|Overall Study|They did not have a seizure requiring tx|137|||
131519658|NCT02177266|473529517|FG000|Overall Study|Adverse Event|0|||
131519659|NCT02177266|473529518|FG001|Overall Study|Adverse Event|1|||
131519660|NCT02177266|473529517|FG000|Overall Study|Withdrawal by Subject|1|||
131519661|NCT02177266|473529518|FG001|Overall Study|Withdrawal by Subject|0|||
131519662|NCT00546715|473529520|FG000|Overall Study|Withdrawal by Subject|0|||
131519663|NCT00546715|473529521|FG001|Overall Study|Withdrawal by Subject|1|||
131519664|NCT00546715|473529522|FG002|Overall Study|Withdrawal by Subject|0|||
131519665|NCT00546715|473529523|FG003|Overall Study|Withdrawal by Subject|0|||
131519666|NCT02331446|473529524|FG000|Overall Study|Lost to Follow-up|2|||
131519667|NCT02331446|473529525|FG001|Overall Study|Lost to Follow-up|1|||
131519668|NCT02331446|473529526|FG002|Overall Study|Lost to Follow-up|0|||
131519669|NCT02331446|473529527|FG003|Overall Study|Lost to Follow-up|1|||
131519670|NCT02331446|473529524|FG000|Overall Study|Personal Problem|2|||
131519671|NCT02331446|473529525|FG001|Overall Study|Personal Problem|0|||
131519672|NCT02331446|473529526|FG002|Overall Study|Personal Problem|0|||
131519673|NCT02331446|473529527|FG003|Overall Study|Personal Problem|0|||
131519674|NCT02331446|473529524|FG000|Overall Study|Disease|0|||
131519675|NCT02331446|473529525|FG001|Overall Study|Disease|2|||
131519676|NCT02331446|473529526|FG002|Overall Study|Disease|2|||
131519677|NCT02331446|473529527|FG003|Overall Study|Disease|1|||
131519678|NCT02331446|473529524|FG000|Overall Study|Physician Decision|0|||
131519679|NCT02331446|473529525|FG001|Overall Study|Physician Decision|1|||
131519680|NCT02331446|473529526|FG002|Overall Study|Physician Decision|0|||
131519681|NCT02331446|473529527|FG003|Overall Study|Physician Decision|1|||
131519682|NCT02331446|473529524|FG000|Overall Study|Lost before baseline analysis|0|||
131519683|NCT02331446|473529525|FG001|Overall Study|Lost before baseline analysis|1|||
131519684|NCT02331446|473529526|FG002|Overall Study|Lost before baseline analysis|1|||
131519685|NCT02331446|473529527|FG003|Overall Study|Lost before baseline analysis|0|||
131519686|NCT00976898|473529534|FG000|Overall Study|Protocol Violation|1|||
131519687|NCT00976898|473529534|FG000|Overall Study|Adverse Event|1|||
131519688|NCT00976898|473529534|FG000|Overall Study|Physician Decision|1|||
131519689|NCT00976898|473529534|FG000|Overall Study|Liver Transplant|1|||
131519690|NCT00976898|473529534|FG000|Overall Study|Progressive Disease|1|||
131519691|NCT03670810|473529537|FG000|Main Study|Adverse Event|37|||
131519692|NCT03670810|473529538|FG001|Main Study|Adverse Event|38|||
131519693|NCT03670810|473529539|FG002|Main Study|Adverse Event|3|||
131519694|NCT03670810|473529540|FG003|Main Study|Adverse Event|4|||
131519695|NCT03670810|473529541|FG004|Main Study|Adverse Event|4|||
131519696|NCT03670810|473529542|FG005|Main Study|Adverse Event|5|||
131519697|NCT03670810|473529543|FG006|Main Study|Adverse Event|0|||
131519698|NCT03670810|473529544|FG007|Main Study|Adverse Event|0|||
131519699|NCT03670810|473529545|FG008|Main Study|Adverse Event|0|||
131519700|NCT03670810|473529537|FG000|Main Study|Lack of Efficacy|8|||
131519701|NCT03670810|473529538|FG001|Main Study|Lack of Efficacy|9|||
131519702|NCT03670810|473529539|FG002|Main Study|Lack of Efficacy|3|||
131519703|NCT03670810|473529540|FG003|Main Study|Lack of Efficacy|4|||
131519704|NCT03670810|473529541|FG004|Main Study|Lack of Efficacy|0|||
131519705|NCT03670810|473529542|FG005|Main Study|Lack of Efficacy|0|||
131519706|NCT03670810|473529543|FG006|Main Study|Lack of Efficacy|0|||
131519707|NCT03670810|473529544|FG007|Main Study|Lack of Efficacy|0|||
131519708|NCT03670810|473529545|FG008|Main Study|Lack of Efficacy|0|||
131519709|NCT03670810|473529537|FG000|Main Study|Lost to Follow-up|9|||
131519710|NCT03670810|473529538|FG001|Main Study|Lost to Follow-up|7|||
131519711|NCT03670810|473529539|FG002|Main Study|Lost to Follow-up|4|||
131519712|NCT03670810|473529540|FG003|Main Study|Lost to Follow-up|6|||
131519713|NCT03670810|473529541|FG004|Main Study|Lost to Follow-up|1|||
131519714|NCT03670810|473529542|FG005|Main Study|Lost to Follow-up|0|||
131519715|NCT03670810|473529543|FG006|Main Study|Lost to Follow-up|0|||
131519716|NCT03670810|473529544|FG007|Main Study|Lost to Follow-up|0|||
131519717|NCT03670810|473529545|FG008|Main Study|Lost to Follow-up|0|||
131519718|NCT03670810|473529537|FG000|Main Study|Non-compliance with Study Drug|0|||
131519719|NCT03670810|473529538|FG001|Main Study|Non-compliance with Study Drug|2|||
131519720|NCT03670810|473529539|FG002|Main Study|Non-compliance with Study Drug|3|||
131519721|NCT03670810|473529540|FG003|Main Study|Non-compliance with Study Drug|0|||
131519722|NCT03670810|473529541|FG004|Main Study|Non-compliance with Study Drug|0|||
131519723|NCT03670810|473529542|FG005|Main Study|Non-compliance with Study Drug|0|||
131519724|NCT03670810|473529543|FG006|Main Study|Non-compliance with Study Drug|0|||
131519725|NCT03670810|473529544|FG007|Main Study|Non-compliance with Study Drug|1|||
131519726|NCT03670810|473529545|FG008|Main Study|Non-compliance with Study Drug|0|||
131519727|NCT03670810|473529537|FG000|Main Study|Physician Decision|3|||
131519728|NCT03670810|473529538|FG001|Main Study|Physician Decision|0|||
131519729|NCT03670810|473529539|FG002|Main Study|Physician Decision|1|||
131519730|NCT03670810|473529540|FG003|Main Study|Physician Decision|0|||
131519731|NCT03670810|473529541|FG004|Main Study|Physician Decision|0|||
131519732|NCT03670810|473529542|FG005|Main Study|Physician Decision|0|||
131519733|NCT03670810|473529543|FG006|Main Study|Physician Decision|1|||
131519734|NCT03670810|473529544|FG007|Main Study|Physician Decision|1|||
131519735|NCT03670810|473529545|FG008|Main Study|Physician Decision|0|||
131519736|NCT03670810|473529537|FG000|Main Study|Pregnancy|1|||
131519737|NCT03670810|473529538|FG001|Main Study|Pregnancy|2|||
131519738|NCT03670810|473529539|FG002|Main Study|Pregnancy|0|||
131519739|NCT03670810|473529540|FG003|Main Study|Pregnancy|0|||
131519740|NCT03670810|473529541|FG004|Main Study|Pregnancy|0|||
131519741|NCT03670810|473529542|FG005|Main Study|Pregnancy|0|||
131519742|NCT03670810|473529543|FG006|Main Study|Pregnancy|0|||
131519743|NCT03670810|473529544|FG007|Main Study|Pregnancy|0|||
131519744|NCT03670810|473529545|FG008|Main Study|Pregnancy|0|||
131519745|NCT03670810|473529537|FG000|Main Study|Protocol Deviation|2|||
131519746|NCT03670810|473529538|FG001|Main Study|Protocol Deviation|12|||
131519747|NCT03670810|473529539|FG002|Main Study|Protocol Deviation|8|||
131519748|NCT03670810|473529540|FG003|Main Study|Protocol Deviation|4|||
131519749|NCT03670810|473529541|FG004|Main Study|Protocol Deviation|0|||
131519750|NCT03670810|473529542|FG005|Main Study|Protocol Deviation|0|||
131519751|NCT03670810|473529543|FG006|Main Study|Protocol Deviation|0|||
131519752|NCT03670810|473529544|FG007|Main Study|Protocol Deviation|0|||
131519753|NCT03670810|473529545|FG008|Main Study|Protocol Deviation|0|||
131519754|NCT03670810|473529537|FG000|Main Study|Withdrawal by Subject|21|||
131519755|NCT03670810|473529538|FG001|Main Study|Withdrawal by Subject|21|||
131519756|NCT03670810|473529539|FG002|Main Study|Withdrawal by Subject|8|||
131519757|NCT03670810|473529540|FG003|Main Study|Withdrawal by Subject|9|||
131519758|NCT03670810|473529541|FG004|Main Study|Withdrawal by Subject|5|||
131519759|NCT03670810|473529542|FG005|Main Study|Withdrawal by Subject|2|||
131519760|NCT03670810|473529543|FG006|Main Study|Withdrawal by Subject|1|||
131519761|NCT03670810|473529544|FG007|Main Study|Withdrawal by Subject|1|||
131519762|NCT03670810|473529545|FG008|Main Study|Withdrawal by Subject|0|||
131519763|NCT03670810|473529537|FG000|Main Study|Participant did not want to take the three other treatments|1|||
131519764|NCT03670810|473529538|FG001|Main Study|Participant did not want to take the three other treatments|0|||
131519765|NCT03670810|473529539|FG002|Main Study|Participant did not want to take the three other treatments|0|||
131519766|NCT03670810|473529540|FG003|Main Study|Participant did not want to take the three other treatments|0|||
131519767|NCT03670810|473529541|FG004|Main Study|Participant did not want to take the three other treatments|0|||
131519768|NCT03670810|473529542|FG005|Main Study|Participant did not want to take the three other treatments|0|||
131519769|NCT03670810|473529543|FG006|Main Study|Participant did not want to take the three other treatments|0|||
131519770|NCT03670810|473529544|FG007|Main Study|Participant did not want to take the three other treatments|0|||
131519771|NCT03670810|473529545|FG008|Main Study|Participant did not want to take the three other treatments|0|||
131519772|NCT03670810|473529537|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519773|NCT03670810|473529538|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
131519774|NCT03670810|473529539|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519775|NCT03670810|473529540|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519776|NCT03670810|473529541|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519777|NCT03670810|473529542|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519778|NCT03670810|473529543|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519779|NCT03670810|473529544|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519780|NCT03670810|473529545|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131519781|NCT03670810|473529537|FG000|Main Study|Travel and Coronavirus issues|0|||
131519782|NCT03670810|473529538|FG001|Main Study|Travel and Coronavirus issues|0|||
131519783|NCT03670810|473529539|FG002|Main Study|Travel and Coronavirus issues|0|||
131519784|NCT03670810|473529540|FG003|Main Study|Travel and Coronavirus issues|1|||
131519785|NCT03670810|473529541|FG004|Main Study|Travel and Coronavirus issues|0|||
131519786|NCT03670810|473529542|FG005|Main Study|Travel and Coronavirus issues|0|||
131519787|NCT03670810|473529543|FG006|Main Study|Travel and Coronavirus issues|0|||
131519788|NCT03670810|473529544|FG007|Main Study|Travel and Coronavirus issues|0|||
131519789|NCT03670810|473529545|FG008|Main Study|Travel and Coronavirus issues|0|||
131519790|NCT03670810|473529537|FG000|Open Label Extension|Protocol Deviation|0|||
131519791|NCT03670810|473529538|FG001|Open Label Extension|Protocol Deviation|0|||
131519792|NCT03670810|473529539|FG002|Open Label Extension|Protocol Deviation|0|||
131519793|NCT03670810|473529540|FG003|Open Label Extension|Protocol Deviation|0|||
131519794|NCT03670810|473529541|FG004|Open Label Extension|Protocol Deviation|0|||
131519795|NCT03670810|473529542|FG005|Open Label Extension|Protocol Deviation|0|||
131519796|NCT03670810|473529543|FG006|Open Label Extension|Protocol Deviation|0|||
131519797|NCT03670810|473529544|FG007|Open Label Extension|Protocol Deviation|0|||
131519798|NCT03670810|473529545|FG008|Open Label Extension|Protocol Deviation|5|||
131519799|NCT03670810|473529537|FG000|Open Label Extension|Death|0|||
131519800|NCT03670810|473529538|FG001|Open Label Extension|Death|0|||
131519801|NCT03670810|473529539|FG002|Open Label Extension|Death|0|||
131519802|NCT03670810|473529540|FG003|Open Label Extension|Death|0|||
131519803|NCT03670810|473529541|FG004|Open Label Extension|Death|0|||
131519804|NCT03670810|473529542|FG005|Open Label Extension|Death|0|||
131519805|NCT03670810|473529543|FG006|Open Label Extension|Death|0|||
131519806|NCT03670810|473529544|FG007|Open Label Extension|Death|0|||
131519807|NCT03670810|473529545|FG008|Open Label Extension|Death|1|||
131519808|NCT03670810|473529537|FG000|Open Label Extension|COVID-19|0|||
131519809|NCT03670810|473529538|FG001|Open Label Extension|COVID-19|0|||
131519810|NCT03670810|473529539|FG002|Open Label Extension|COVID-19|0|||
131519811|NCT03670810|473529540|FG003|Open Label Extension|COVID-19|0|||
131519812|NCT03670810|473529541|FG004|Open Label Extension|COVID-19|0|||
131519813|NCT03670810|473529542|FG005|Open Label Extension|COVID-19|0|||
131519814|NCT03670810|473529543|FG006|Open Label Extension|COVID-19|0|||
131519815|NCT03670810|473529544|FG007|Open Label Extension|COVID-19|0|||
131519816|NCT03670810|473529545|FG008|Open Label Extension|COVID-19|1|||
131519817|NCT03670810|473529537|FG000|Open Label Extension|Lack of Efficacy|0|||
131519818|NCT03670810|473529538|FG001|Open Label Extension|Lack of Efficacy|0|||
131519819|NCT03670810|473529539|FG002|Open Label Extension|Lack of Efficacy|0|||
131519820|NCT03670810|473529540|FG003|Open Label Extension|Lack of Efficacy|0|||
131519821|NCT03670810|473529541|FG004|Open Label Extension|Lack of Efficacy|0|||
131519822|NCT03670810|473529542|FG005|Open Label Extension|Lack of Efficacy|0|||
131519823|NCT03670810|473529543|FG006|Open Label Extension|Lack of Efficacy|0|||
131519824|NCT03670810|473529544|FG007|Open Label Extension|Lack of Efficacy|0|||
131519825|NCT03670810|473529545|FG008|Open Label Extension|Lack of Efficacy|39|||
131519826|NCT03670810|473529537|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
131519827|NCT03670810|473529538|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
131519828|NCT03670810|473529539|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
131519829|NCT03670810|473529540|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
131519830|NCT03670810|473529541|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
131519831|NCT03670810|473529542|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
131519832|NCT03670810|473529543|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
131519833|NCT03670810|473529544|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
131519834|NCT03670810|473529545|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
131519835|NCT03670810|473529537|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519836|NCT03670810|473529538|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519837|NCT03670810|473529539|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519838|NCT03670810|473529540|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519839|NCT03670810|473529541|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519840|NCT03670810|473529542|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519841|NCT03670810|473529543|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519842|NCT03670810|473529544|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131519843|NCT03670810|473529545|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
131519844|NCT03670810|473529537|FG000|Open Label Extension|Withdrawal by Subject|0|||
131519845|NCT03670810|473529538|FG001|Open Label Extension|Withdrawal by Subject|0|||
131519846|NCT03670810|473529539|FG002|Open Label Extension|Withdrawal by Subject|0|||
131519847|NCT03670810|473529540|FG003|Open Label Extension|Withdrawal by Subject|0|||
131519848|NCT03670810|473529541|FG004|Open Label Extension|Withdrawal by Subject|0|||
131519849|NCT03670810|473529542|FG005|Open Label Extension|Withdrawal by Subject|0|||
131519850|NCT03670810|473529543|FG006|Open Label Extension|Withdrawal by Subject|0|||
131519851|NCT03670810|473529544|FG007|Open Label Extension|Withdrawal by Subject|0|||
131519852|NCT03670810|473529545|FG008|Open Label Extension|Withdrawal by Subject|46|||
131519853|NCT03670810|473529537|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519854|NCT03670810|473529538|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519855|NCT03670810|473529539|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519856|NCT03670810|473529540|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519857|NCT03670810|473529541|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519858|NCT03670810|473529542|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519859|NCT03670810|473529543|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519860|NCT03670810|473529544|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
131519861|NCT03670810|473529545|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
131519862|NCT03670810|473529537|FG000|Open Label Extension|Physician Decision|0|||
131519863|NCT03670810|473529538|FG001|Open Label Extension|Physician Decision|0|||
131519864|NCT03670810|473529539|FG002|Open Label Extension|Physician Decision|0|||
131519865|NCT03670810|473529540|FG003|Open Label Extension|Physician Decision|0|||
131519866|NCT03670810|473529541|FG004|Open Label Extension|Physician Decision|0|||
131519867|NCT03670810|473529542|FG005|Open Label Extension|Physician Decision|0|||
131519868|NCT03670810|473529543|FG006|Open Label Extension|Physician Decision|0|||
131519869|NCT03670810|473529544|FG007|Open Label Extension|Physician Decision|0|||
131519870|NCT03670810|473529545|FG008|Open Label Extension|Physician Decision|2|||
131519871|NCT03670810|473529537|FG000|Open Label Extension|Non-compliance with study drug|0|||
131519872|NCT03670810|473529538|FG001|Open Label Extension|Non-compliance with study drug|0|||
131519873|NCT03670810|473529539|FG002|Open Label Extension|Non-compliance with study drug|0|||
131519874|NCT03670810|473529540|FG003|Open Label Extension|Non-compliance with study drug|0|||
131519875|NCT03670810|473529541|FG004|Open Label Extension|Non-compliance with study drug|0|||
131519876|NCT03670810|473529542|FG005|Open Label Extension|Non-compliance with study drug|0|||
131519877|NCT03670810|473529543|FG006|Open Label Extension|Non-compliance with study drug|0|||
131519878|NCT03670810|473529544|FG007|Open Label Extension|Non-compliance with study drug|0|||
131658420|NCT01531673|474035307|FG008|Overall Study|Lost to Follow-up|0|||
131519879|NCT03670810|473529545|FG008|Open Label Extension|Non-compliance with study drug|5|||
131519880|NCT03670810|473529537|FG000|Open Label Extension|Pregnancy|0|||
131519881|NCT03670810|473529538|FG001|Open Label Extension|Pregnancy|0|||
131519882|NCT03670810|473529539|FG002|Open Label Extension|Pregnancy|0|||
131519883|NCT03670810|473529540|FG003|Open Label Extension|Pregnancy|0|||
131519884|NCT03670810|473529541|FG004|Open Label Extension|Pregnancy|0|||
131519885|NCT03670810|473529542|FG005|Open Label Extension|Pregnancy|0|||
131519886|NCT03670810|473529543|FG006|Open Label Extension|Pregnancy|0|||
131519887|NCT03670810|473529544|FG007|Open Label Extension|Pregnancy|0|||
131519888|NCT03670810|473529545|FG008|Open Label Extension|Pregnancy|3|||
131519889|NCT03670810|473529537|FG000|Open Label Extension|Adverse Event|0|||
131519890|NCT03670810|473529538|FG001|Open Label Extension|Adverse Event|0|||
131519891|NCT03670810|473529539|FG002|Open Label Extension|Adverse Event|0|||
131519892|NCT03670810|473529540|FG003|Open Label Extension|Adverse Event|0|||
131519893|NCT03670810|473529541|FG004|Open Label Extension|Adverse Event|0|||
131519894|NCT03670810|473529542|FG005|Open Label Extension|Adverse Event|0|||
131519895|NCT03670810|473529543|FG006|Open Label Extension|Adverse Event|0|||
131519896|NCT03670810|473529544|FG007|Open Label Extension|Adverse Event|0|||
131519897|NCT03670810|473529545|FG008|Open Label Extension|Adverse Event|24|||
131519898|NCT03670810|473529537|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
131519899|NCT03670810|473529538|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
131519900|NCT03670810|473529539|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
131519901|NCT03670810|473529540|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
131519902|NCT03670810|473529541|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
131519903|NCT03670810|473529542|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
131519904|NCT03670810|473529543|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
131519905|NCT03670810|473529544|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
131519906|NCT03670810|473529545|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
131519907|NCT03670810|473529537|FG000|Open Label Extension|Lost to Follow-up|0|||
131519908|NCT03670810|473529538|FG001|Open Label Extension|Lost to Follow-up|0|||
131519909|NCT03670810|473529539|FG002|Open Label Extension|Lost to Follow-up|0|||
131519910|NCT03670810|473529540|FG003|Open Label Extension|Lost to Follow-up|0|||
131519911|NCT03670810|473529541|FG004|Open Label Extension|Lost to Follow-up|0|||
131519912|NCT03670810|473529542|FG005|Open Label Extension|Lost to Follow-up|0|||
131519913|NCT03670810|473529543|FG006|Open Label Extension|Lost to Follow-up|0|||
131519914|NCT03670810|473529544|FG007|Open Label Extension|Lost to Follow-up|0|||
131519915|NCT03670810|473529545|FG008|Open Label Extension|Lost to Follow-up|23|||
131519916|NCT06034496|473529547|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
131519917|NCT06034496|473529548|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
131519918|NCT06034496|473529547|FG000|Overall Study|Withdrawal by Subject|5|||
131519919|NCT06034496|473529548|FG001|Overall Study|Withdrawal by Subject|4|||
131519920|NCT03277261|473529551|FG000|Overall Study|Adverse Event|17|||
131519921|NCT03277261|473529552|FG001|Overall Study|Adverse Event|1|||
131519922|NCT03277261|473529551|FG000|Overall Study|Participant Withdrawal of Consent|6|||
131519923|NCT03277261|473529552|FG001|Overall Study|Participant Withdrawal of Consent|15|||
131519924|NCT03277261|473529551|FG000|Overall Study|Investigator / Sponsor Decision|4|||
131519925|NCT03277261|473529552|FG001|Overall Study|Investigator / Sponsor Decision|2|||
131519926|NCT03277261|473529551|FG000|Overall Study|Pregnancy|2|||
131519927|NCT03277261|473529552|FG001|Overall Study|Pregnancy|0|||
131519928|NCT03277261|473529551|FG000|Overall Study|Lost to Follow-up|2|||
131519929|NCT03277261|473529552|FG001|Overall Study|Lost to Follow-up|2|||
131519930|NCT03277261|473529551|FG000|Overall Study|Lack of Efficacy|2|||
131519931|NCT03277261|473529552|FG001|Overall Study|Lack of Efficacy|2|||
131519932|NCT03277261|473529551|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
131519933|NCT03277261|473529552|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
131519934|NCT02644967|473529553|FG000|Overall Study|Death|26|||
131519935|NCT02644967|473529553|FG000|Overall Study|Physician Decision|1|||
131519936|NCT02644967|473529553|FG000|Overall Study|Withdrawal by Subject|2|||
131519937|NCT02644967|473529553|FG000|Overall Study|Protocol Violation|1|||
131519938|NCT02644967|473529553|FG000|Overall Study|Progressive Disease|1|||
131519939|NCT02644967|473529553|FG000|Overall Study|Study Terminated by Sponsor|4|||
131519940|NCT01502644|473529554|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
131519941|NCT01502644|473529555|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
131519942|NCT01502644|473529556|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
131519943|NCT01502644|473529557|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
131519944|NCT01502644|473529554|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
131519945|NCT01502644|473529555|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
131545835|NCT03848403|473620006|FG002|Period 2 (Day 8)|Physician Decision|0|||
131519946|NCT01502644|473529556|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
131519947|NCT01502644|473529557|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
131519948|NCT01502644|473529554|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
131519949|NCT01502644|473529555|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
131519950|NCT01502644|473529556|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
131519951|NCT01502644|473529557|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
131519952|NCT01502644|473529554|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
131519953|NCT01502644|473529555|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
131519954|NCT01502644|473529556|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
131519955|NCT01502644|473529557|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
131519956|NCT01502644|473529554|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
131519957|NCT01502644|473529555|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
131519958|NCT01502644|473529556|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
131519959|NCT01502644|473529557|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
131519960|NCT01552226|473529560|FG000|Overall Study|Withdrawal by Subject|4|||
131519961|NCT01552226|473529561|FG001|Overall Study|Withdrawal by Subject|4|||
131519962|NCT03604692|473529562|FG000|Overall Study|Investigator's Decision|0|||
131519963|NCT03604692|473529563|FG001|Overall Study|Investigator's Decision|0|||
131519964|NCT03604692|473529564|FG002|Overall Study|Investigator's Decision|0|||
131519965|NCT03604692|473529565|FG003|Overall Study|Investigator's Decision|1|||
131519966|NCT03604692|473529566|FG004|Overall Study|Investigator's Decision|0|||
131519967|NCT03604692|473529567|FG005|Overall Study|Investigator's Decision|7|||
131519968|NCT03604692|473529562|FG000|Overall Study|Withdrawal by Subject|0|||
131519969|NCT03604692|473529563|FG001|Overall Study|Withdrawal by Subject|0|||
131519970|NCT03604692|473529564|FG002|Overall Study|Withdrawal by Subject|0|||
131519971|NCT03604692|473529565|FG003|Overall Study|Withdrawal by Subject|0|||
131519972|NCT03604692|473529566|FG004|Overall Study|Withdrawal by Subject|0|||
131519973|NCT03604692|473529567|FG005|Overall Study|Withdrawal by Subject|2|||
131519974|NCT03604692|473529562|FG000|Overall Study|Progressive Disease|1|||
131519975|NCT03604692|473529563|FG001|Overall Study|Progressive Disease|0|||
131519976|NCT03604692|473529564|FG002|Overall Study|Progressive Disease|1|||
131519977|NCT03604692|473529565|FG003|Overall Study|Progressive Disease|0|||
131519978|NCT03604692|473529566|FG004|Overall Study|Progressive Disease|3|||
131519979|NCT03604692|473529567|FG005|Overall Study|Progressive Disease|4|||
131519980|NCT03604692|473529562|FG000|Overall Study|Difficulty Coming into Site|0|||
131519981|NCT03604692|473529563|FG001|Overall Study|Difficulty Coming into Site|0|||
131519982|NCT03604692|473529564|FG002|Overall Study|Difficulty Coming into Site|0|||
131519983|NCT03604692|473529565|FG003|Overall Study|Difficulty Coming into Site|0|||
131519984|NCT03604692|473529566|FG004|Overall Study|Difficulty Coming into Site|0|||
131519985|NCT03604692|473529567|FG005|Overall Study|Difficulty Coming into Site|1|||
131519986|NCT03604692|473529562|FG000|Overall Study|Death|0|||
131519987|NCT03604692|473529563|FG001|Overall Study|Death|0|||
131519988|NCT03604692|473529564|FG002|Overall Study|Death|1|||
131519989|NCT03604692|473529565|FG003|Overall Study|Death|0|||
131519990|NCT03604692|473529566|FG004|Overall Study|Death|0|||
131519991|NCT03604692|473529567|FG005|Overall Study|Death|0|||
131519992|NCT03604692|473529562|FG000|Overall Study|Drug Intolerance|0|||
131519993|NCT03604692|473529563|FG001|Overall Study|Drug Intolerance|0|||
131519994|NCT03604692|473529564|FG002|Overall Study|Drug Intolerance|0|||
131519995|NCT03604692|473529565|FG003|Overall Study|Drug Intolerance|1|||
131519996|NCT03604692|473529566|FG004|Overall Study|Drug Intolerance|0|||
131519997|NCT03604692|473529567|FG005|Overall Study|Drug Intolerance|0|||
131519998|NCT03604692|473529562|FG000|Overall Study|Noncompliance with follow-up visit|0|||
131519999|NCT03604692|473529563|FG001|Overall Study|Noncompliance with follow-up visit|0|||
131520000|NCT03604692|473529564|FG002|Overall Study|Noncompliance with follow-up visit|0|||
131520001|NCT03604692|473529565|FG003|Overall Study|Noncompliance with follow-up visit|1|||
131520002|NCT03604692|473529566|FG004|Overall Study|Noncompliance with follow-up visit|0|||
131520003|NCT03604692|473529567|FG005|Overall Study|Noncompliance with follow-up visit|0|||
131520004|NCT03604692|473529562|FG000|Overall Study|Not Treated|0|||
131520005|NCT03604692|473529563|FG001|Overall Study|Not Treated|0|||
131520006|NCT03604692|473529564|FG002|Overall Study|Not Treated|0|||
131520007|NCT03604692|473529565|FG003|Overall Study|Not Treated|0|||
131520008|NCT03604692|473529566|FG004|Overall Study|Not Treated|1|||
131520009|NCT03604692|473529567|FG005|Overall Study|Not Treated|0|||
131520010|NCT03466411|473529568|FG000|Overall Study|Lost to Follow-up|0|||
131520011|NCT03466411|473529569|FG001|Overall Study|Lost to Follow-up|1|||
131520012|NCT03466411|473529570|FG002|Overall Study|Lost to Follow-up|1|||
131520013|NCT03466411|473529571|FG003|Overall Study|Lost to Follow-up|0|||
131520014|NCT03466411|473529572|FG004|Overall Study|Lost to Follow-up|0|||
131520015|NCT03466411|473529573|FG005|Overall Study|Lost to Follow-up|0|||
131520016|NCT03466411|473529574|FG006|Overall Study|Lost to Follow-up|1|||
131520017|NCT03466411|473529575|FG007|Overall Study|Lost to Follow-up|1|||
131520018|NCT03466411|473529576|FG008|Overall Study|Lost to Follow-up|0|||
131520019|NCT03466411|473529577|FG009|Overall Study|Lost to Follow-up|1|||
131520020|NCT03466411|473529578|FG010|Overall Study|Lost to Follow-up|1|||
131520021|NCT03466411|473529579|FG011|Overall Study|Lost to Follow-up|1|||
131520022|NCT03466411|473529580|FG012|Overall Study|Lost to Follow-up|0|||
131520023|NCT03466411|473529568|FG000|Overall Study|Withdrawal by Subject|14|||
131520024|NCT03466411|473529569|FG001|Overall Study|Withdrawal by Subject|7|||
131520025|NCT03466411|473529570|FG002|Overall Study|Withdrawal by Subject|8|||
131520026|NCT03466411|473529571|FG003|Overall Study|Withdrawal by Subject|4|||
131520027|NCT03466411|473529572|FG004|Overall Study|Withdrawal by Subject|6|||
131520028|NCT03466411|473529573|FG005|Overall Study|Withdrawal by Subject|3|||
131520029|NCT03466411|473529574|FG006|Overall Study|Withdrawal by Subject|6|||
131520030|NCT03466411|473529575|FG007|Overall Study|Withdrawal by Subject|9|||
131520031|NCT03466411|473529576|FG008|Overall Study|Withdrawal by Subject|6|||
131520032|NCT03466411|473529577|FG009|Overall Study|Withdrawal by Subject|11|||
131520033|NCT03466411|473529578|FG010|Overall Study|Withdrawal by Subject|14|||
131520034|NCT03466411|473529579|FG011|Overall Study|Withdrawal by Subject|12|||
131520035|NCT03466411|473529580|FG012|Overall Study|Withdrawal by Subject|7|||
131520036|NCT03466411|473529568|FG000|Overall Study|Other|1|||
131520037|NCT03466411|473529569|FG001|Overall Study|Other|1|||
131520038|NCT03466411|473529570|FG002|Overall Study|Other|0|||
131520039|NCT03466411|473529571|FG003|Overall Study|Other|1|||
131520040|NCT03466411|473529572|FG004|Overall Study|Other|2|||
131520041|NCT03466411|473529573|FG005|Overall Study|Other|0|||
131520042|NCT03466411|473529574|FG006|Overall Study|Other|0|||
131520043|NCT03466411|473529575|FG007|Overall Study|Other|0|||
131520044|NCT03466411|473529576|FG008|Overall Study|Other|0|||
131520045|NCT03466411|473529577|FG009|Overall Study|Other|1|||
131520046|NCT03466411|473529578|FG010|Overall Study|Other|2|||
131520047|NCT03466411|473529579|FG011|Overall Study|Other|0|||
131520048|NCT03466411|473529580|FG012|Overall Study|Other|0|||
131520049|NCT03466411|473529568|FG000|Overall Study|Randomized but not Treated|0|||
131520050|NCT03466411|473529569|FG001|Overall Study|Randomized but not Treated|0|||
131520051|NCT03466411|473529570|FG002|Overall Study|Randomized but not Treated|0|||
131520052|NCT03466411|473529571|FG003|Overall Study|Randomized but not Treated|0|||
131520053|NCT03466411|473529572|FG004|Overall Study|Randomized but not Treated|0|||
131520054|NCT03466411|473529573|FG005|Overall Study|Randomized but not Treated|0|||
131520055|NCT03466411|473529574|FG006|Overall Study|Randomized but not Treated|1|||
131520056|NCT03466411|473529575|FG007|Overall Study|Randomized but not Treated|0|||
131520057|NCT03466411|473529576|FG008|Overall Study|Randomized but not Treated|0|||
131520058|NCT03466411|473529577|FG009|Overall Study|Randomized but not Treated|0|||
131520059|NCT03466411|473529578|FG010|Overall Study|Randomized but not Treated|0|||
131520060|NCT03466411|473529579|FG011|Overall Study|Randomized but not Treated|0|||
131520061|NCT03466411|473529580|FG012|Overall Study|Randomized but not Treated|0|||
131520062|NCT00637195|473529581|FG000|Overall Study|Lost to Follow-up|1|||
131520063|NCT00637195|473529582|FG001|Overall Study|Lost to Follow-up|0|||
131520064|NCT00637195|473529581|FG000|Overall Study|Other|2|||
131520065|NCT00637195|473529582|FG001|Overall Study|Other|0|||
131520066|NCT00637195|473529581|FG000|Overall Study|Withdrawal by Subject|0|||
131520067|NCT00637195|473529582|FG001|Overall Study|Withdrawal by Subject|1|||
131520068|NCT02388997|473529583|FG000|Overall Study|Adverse Event|1|||
131520069|NCT02388997|473529584|FG001|Overall Study|Adverse Event|2|||
131520070|NCT02388997|473529583|FG000|Overall Study|Withdrawal by Subject|2|||
131520071|NCT02388997|473529584|FG001|Overall Study|Withdrawal by Subject|1|||
131520072|NCT02388997|473529583|FG000|Overall Study|Lung function exclusion criteria|0|||
131520073|NCT02388997|473529584|FG001|Overall Study|Lung function exclusion criteria|2|||
131520074|NCT02388997|473529583|FG000|Overall Study|Tested positive for virus during run-in|0|||
131520075|NCT02388997|473529584|FG001|Overall Study|Tested positive for virus during run-in|1|||
131520076|NCT01110915|473529585|FG000|Overall Study|Death|2|||
131520077|NCT01110915|473529586|FG001|Overall Study|Death|1|||
131520078|NCT01110915|473529585|FG000|Overall Study|Lost to Follow-up|1|||
131520079|NCT01110915|473529586|FG001|Overall Study|Lost to Follow-up|0|||
131520080|NCT01110915|473529585|FG000|Overall Study|Withdrawal by Subject|7|||
131520081|NCT01110915|473529586|FG001|Overall Study|Withdrawal by Subject|1|||
131520082|NCT00376168|473529591|FG000|Overall Study|Adverse Event|1|||
131520083|NCT00376168|473529592|FG001|Overall Study|Adverse Event|1|||
131520084|NCT00376168|473529591|FG000|Overall Study|Pregnancy|1|||
131520085|NCT00376168|473529592|FG001|Overall Study|Pregnancy|0|||
131520086|NCT00207142|473529593|FG000|Induction Phase|Adverse Event|9|||
131520087|NCT00207142|473529594|FG001|Induction Phase|Adverse Event|0|||
131520088|NCT00207142|473529595|FG002|Induction Phase|Adverse Event|0|||
131520089|NCT00207142|473529596|FG003|Induction Phase|Adverse Event|0|||
131520090|NCT00207142|473529593|FG000|Induction Phase|Death|1|||
131520091|NCT00207142|473529594|FG001|Induction Phase|Death|0|||
131520092|NCT00207142|473529595|FG002|Induction Phase|Death|0|||
131520093|NCT00207142|473529596|FG003|Induction Phase|Death|0|||
131520094|NCT00207142|473529593|FG000|Induction Phase|Lack of Efficacy|1|||
131520095|NCT00207142|473529594|FG001|Induction Phase|Lack of Efficacy|0|||
131520096|NCT00207142|473529595|FG002|Induction Phase|Lack of Efficacy|0|||
131520097|NCT00207142|473529596|FG003|Induction Phase|Lack of Efficacy|0|||
131520098|NCT00207142|473529593|FG000|Induction Phase|Lost to Follow-up|5|||
131520099|NCT00207142|473529594|FG001|Induction Phase|Lost to Follow-up|0|||
131520100|NCT00207142|473529595|FG002|Induction Phase|Lost to Follow-up|0|||
131520101|NCT00207142|473529596|FG003|Induction Phase|Lost to Follow-up|0|||
131520102|NCT00207142|473529593|FG000|Induction Phase|Physician Decision|2|||
131520103|NCT00207142|473529594|FG001|Induction Phase|Physician Decision|0|||
131520104|NCT00207142|473529595|FG002|Induction Phase|Physician Decision|0|||
131520105|NCT00207142|473529596|FG003|Induction Phase|Physician Decision|0|||
131520106|NCT00207142|473529593|FG000|Induction Phase|Poor/noncompliance|2|||
131520107|NCT00207142|473529594|FG001|Induction Phase|Poor/noncompliance|0|||
131520108|NCT00207142|473529595|FG002|Induction Phase|Poor/noncompliance|0|||
131520109|NCT00207142|473529596|FG003|Induction Phase|Poor/noncompliance|0|||
131520110|NCT00207142|473529593|FG000|Induction Phase|Pregnancy|1|||
131520111|NCT00207142|473529594|FG001|Induction Phase|Pregnancy|0|||
131520112|NCT00207142|473529595|FG002|Induction Phase|Pregnancy|0|||
131520113|NCT00207142|473529596|FG003|Induction Phase|Pregnancy|0|||
131520114|NCT00207142|473529593|FG000|Induction Phase|Subject no longer meets study criteria|3|||
131520115|NCT00207142|473529594|FG001|Induction Phase|Subject no longer meets study criteria|0|||
131520116|NCT00207142|473529595|FG002|Induction Phase|Subject no longer meets study criteria|0|||
131520117|NCT00207142|473529596|FG003|Induction Phase|Subject no longer meets study criteria|0|||
131520118|NCT00207142|473529593|FG000|Induction Phase|Withdrawal by Subject|4|||
131520119|NCT00207142|473529594|FG001|Induction Phase|Withdrawal by Subject|0|||
131520120|NCT00207142|473529595|FG002|Induction Phase|Withdrawal by Subject|0|||
131520121|NCT00207142|473529596|FG003|Induction Phase|Withdrawal by Subject|0|||
131520122|NCT00207142|473529593|FG000|Induction Phase|Incarceration|1|||
131520123|NCT00207142|473529594|FG001|Induction Phase|Incarceration|0|||
131520124|NCT00207142|473529595|FG002|Induction Phase|Incarceration|0|||
131520125|NCT00207142|473529596|FG003|Induction Phase|Incarceration|0|||
131520126|NCT00207142|473529593|FG000|Induction Phase|Missing lab data|1|||
131520127|NCT00207142|473529594|FG001|Induction Phase|Missing lab data|0|||
131520128|NCT00207142|473529595|FG002|Induction Phase|Missing lab data|0|||
131520129|NCT00207142|473529596|FG003|Induction Phase|Missing lab data|0|||
131520130|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
131520131|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
131520132|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
131520133|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
131520134|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
131520135|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
131520136|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
131520137|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
131520138|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
131520139|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
131520140|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
131520141|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
131520142|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
131520143|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
131520144|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
131520145|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
131520146|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
131520147|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
131520148|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
131520149|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
131520150|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
131520151|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
131520152|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
131520153|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
131520154|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
131520155|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
131520156|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
131520157|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
131520158|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Death|0|||
131520159|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Death|0|||
131520160|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Death|0|||
131520161|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Death|1|||
131520162|NCT00207142|473529593|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
131520163|NCT00207142|473529594|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
131520164|NCT00207142|473529595|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
131520165|NCT00207142|473529596|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
131520166|NCT05091528|473529597|FG000|Overall Study|Study Termination by Sponsor|0|||
131520167|NCT05091528|473529598|FG001|Overall Study|Study Termination by Sponsor|1|||
131520168|NCT05091528|473529599|FG002|Overall Study|Study Termination by Sponsor|0|||
131520169|NCT05091528|473529600|FG003|Overall Study|Study Termination by Sponsor|1|||
131520170|NCT01822132|473529601|FG000|Overall Study|Lost to Follow-up|4|||
131520171|NCT01822132|473529602|FG001|Overall Study|Lost to Follow-up|2|||
131520172|NCT02519712|473529603|FG000|Overall Study|Disease Relapse|1|||
131520173|NCT02519712|473529603|FG000|Overall Study|Disease Progression|1|||
131520174|NCT02519712|473529603|FG000|Overall Study|Accruals are donors|2|||
131520175|NCT01247090|473529606|FG000|Overall Study|Physician Decision|1|||
131520176|NCT01247090|473529607|FG001|Overall Study|Physician Decision|0|||
131520177|NCT01247090|473529608|FG002|Overall Study|Physician Decision|0|||
131520178|NCT01247090|473529606|FG000|Overall Study|Withdrawal by Subject|0|||
131520179|NCT01247090|473529607|FG001|Overall Study|Withdrawal by Subject|1|||
131545836|NCT03848403|473620004|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
131520180|NCT01247090|473529608|FG002|Overall Study|Withdrawal by Subject|0|||
131520181|NCT00006916|473529610|FG000|Overall Study|Device not inserted|4|||
131520182|NCT00006916|473529610|FG000|Overall Study|Complication of device insertion|1|||
131520183|NCT00414388|473529614|FG000|Overall Study|Adverse Event|1|||
131520184|NCT03591575|473529616|FG000|Overall Study|Adverse Event|2|||
131520185|NCT03591575|473529617|FG001|Overall Study|Adverse Event|0|||
131520186|NCT03591575|473529616|FG000|Overall Study|Withdrawal by Subject|4|||
131520187|NCT03591575|473529617|FG001|Overall Study|Withdrawal by Subject|1|||
131520188|NCT00218543|473529618|FG000|Overall Study|Lost to Follow-up|8|||
131520189|NCT00218543|473529618|FG000|Overall Study|relocated|1|||
131520190|NCT00218543|473529618|FG000|Overall Study|Withdrawal by Subject|1|||
131520191|NCT00218543|473529618|FG000|Overall Study|Physician Decision|3|||
131520192|NCT00218543|473529618|FG000|Overall Study|Adverse Event|2|||
131520193|NCT01864291|473529619|FG000|Overall Study|need for revision surgery|2|||
131520194|NCT01387607|473529620|FG000|Overall Study|Adverse Event|23|||
131520195|NCT01387607|473529621|FG001|Overall Study|Adverse Event|11|||
131520196|NCT01387607|473529620|FG000|Overall Study|Lack of Efficacy|8|||
131520197|NCT01387607|473529621|FG001|Overall Study|Lack of Efficacy|6|||
131520198|NCT01387607|473529620|FG000|Overall Study|Lost to Follow-up|2|||
131520199|NCT01387607|473529621|FG001|Overall Study|Lost to Follow-up|1|||
131520200|NCT01387607|473529620|FG000|Overall Study|No longer meets eligibility criteria|0|||
131520201|NCT01387607|473529621|FG001|Overall Study|No longer meets eligibility criteria|1|||
131520202|NCT01387607|473529620|FG000|Overall Study|Protocol Violation|1|||
131520203|NCT01387607|473529621|FG001|Overall Study|Protocol Violation|5|||
131520204|NCT01387607|473529620|FG000|Overall Study|Withdrawal by Subject|13|||
131520205|NCT01387607|473529621|FG001|Overall Study|Withdrawal by Subject|14|||
131520206|NCT01387607|473529620|FG000|Overall Study|Other|1|||
131520207|NCT01387607|473529621|FG001|Overall Study|Other|1|||
131520208|NCT01387607|473529620|FG000|Overall Study|Randomized, not treated|3|||
131520209|NCT01387607|473529621|FG001|Overall Study|Randomized, not treated|6|||
131520210|NCT03080961|473529622|FG000|Overall Study|Withdrawal by Subject|3|||
131520211|NCT03091192|473529625|FG000|Overall Study|Study terminated by sponsor|21|||
131520212|NCT03091192|473529626|FG001|Overall Study|Study terminated by sponsor|14|||
131520213|NCT03091192|473529625|FG000|Overall Study|Death|9|||
131520214|NCT03091192|473529626|FG001|Overall Study|Death|13|||
131520215|NCT03091192|473529625|FG000|Overall Study|Withdrawal by Subject|2|||
131520216|NCT03091192|473529626|FG001|Overall Study|Withdrawal by Subject|0|||
131520217|NCT03091192|473529625|FG000|Overall Study|Lost to Follow-up|1|||
131520218|NCT03091192|473529626|FG001|Overall Study|Lost to Follow-up|0|||
131520219|NCT05645432|473529629|FG000|Overall Study|Withdrawal by Subject|1|||
131520220|NCT03195478|473529630|FG000|Overall Study|Disease Progression|5|||
131520221|NCT03195478|473529631|FG001|Overall Study|Disease Progression|4|||
131520222|NCT03195478|473529632|FG002|Overall Study|Disease Progression|6|||
131520223|NCT03195478|473529633|FG003|Overall Study|Disease Progression|1|||
131520224|NCT03195478|473529630|FG000|Overall Study|Study Drug Toxicity|2|||
131520225|NCT03195478|473529631|FG001|Overall Study|Study Drug Toxicity|0|||
131520226|NCT03195478|473529632|FG002|Overall Study|Study Drug Toxicity|0|||
131520227|NCT03195478|473529633|FG003|Overall Study|Study Drug Toxicity|1|||
131520228|NCT03195478|473529630|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
131520229|NCT03195478|473529631|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
131520230|NCT03195478|473529632|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
131520231|NCT03195478|473529633|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
131520232|NCT03195478|473529630|FG000|Overall Study|Participant Withdrew Consent|1|||
131520233|NCT03195478|473529631|FG001|Overall Study|Participant Withdrew Consent|0|||
131520234|NCT03195478|473529632|FG002|Overall Study|Participant Withdrew Consent|0|||
131520235|NCT03195478|473529633|FG003|Overall Study|Participant Withdrew Consent|0|||
131520236|NCT03195478|473529630|FG000|Overall Study|Maximum Clinical benefit|0|||
131520237|NCT03195478|473529631|FG001|Overall Study|Maximum Clinical benefit|0|||
131520238|NCT03195478|473529632|FG002|Overall Study|Maximum Clinical benefit|1|||
131520239|NCT03195478|473529633|FG003|Overall Study|Maximum Clinical benefit|0|||
131520240|NCT03195478|473529630|FG000|Overall Study|Other Reasons|0|||
131520241|NCT03195478|473529631|FG001|Overall Study|Other Reasons|0|||
131520242|NCT03195478|473529632|FG002|Overall Study|Other Reasons|1|||
131520243|NCT03195478|473529633|FG003|Overall Study|Other Reasons|0|||
131545837|NCT03848403|473620005|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
131545838|NCT03848403|473620006|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
131545839|NCT01939548|473620007|FG000|Overall Study|Non compliance|0|||
131545840|NCT01939548|473620008|FG001|Overall Study|Non compliance|2|||
131545841|NCT01939548|473620009|FG002|Overall Study|Non compliance|0|||
131545842|NCT01939548|473620007|FG000|Overall Study|Study Terminated by Sponsor|17|||
131545843|NCT01939548|473620008|FG001|Overall Study|Study Terminated by Sponsor|19|||
131545844|NCT01939548|473620009|FG002|Overall Study|Study Terminated by Sponsor|12|||
131545845|NCT01939548|473620007|FG000|Overall Study|Insufficient Clinical Response|1|||
131545846|NCT01939548|473620008|FG001|Overall Study|Insufficient Clinical Response|0|||
131545847|NCT01939548|473620009|FG002|Overall Study|Insufficient Clinical Response|0|||
131545848|NCT01939548|473620007|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131520244|NCT02472756|473530692|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
131520245|NCT02472756|473530692|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
131520246|NCT02472756|473530692|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
131520247|NCT02472756|473530692|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
131520248|NCT02472756|473530692|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
131520249|NCT00110266|473530694|FG000|Overall Study|Adverse Event|27|||
131520250|NCT00110266|473530694|FG000|Overall Study|Abnormal laboratory value|15|||
131520251|NCT00110266|473530694|FG000|Overall Study|Withdrawal by Subject|16|||
131520252|NCT00110266|473530694|FG000|Overall Study|Death|17|||
131520253|NCT00110266|473530694|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131520254|NCT00110266|473530694|FG000|Overall Study|Participant condition no longer requires study drug|1|||
131520255|NCT02984020|473530695|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
131520256|NCT02984020|473530695|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
131520257|NCT02984020|473530695|FG000|Overall Study|Other significant protocol violation|2|||
131520258|NCT00667342|473530696|FG000|Overall Study|Protocol Violation|1|||
131520259|NCT00667342|473530697|FG001|Overall Study|Protocol Violation|0|||
131520260|NCT00667342|473530698|FG002|Overall Study|Protocol Violation|0|||
131520261|NCT00667342|473530696|FG000|Overall Study|Withdrawal by Subject|1|||
131520262|NCT00667342|473530697|FG001|Overall Study|Withdrawal by Subject|0|||
131520263|NCT00667342|473530698|FG002|Overall Study|Withdrawal by Subject|0|||
131520264|NCT00667342|473530696|FG000|Overall Study|Physician Decision|3|||
131520265|NCT00667342|473530697|FG001|Overall Study|Physician Decision|0|||
131520266|NCT00667342|473530698|FG002|Overall Study|Physician Decision|0|||
131520267|NCT00667342|473530696|FG000|Overall Study|Relapse or tumor progression|9|||
131520268|NCT00667342|473530697|FG001|Overall Study|Relapse or tumor progression|0|||
131520269|NCT00667342|473530698|FG002|Overall Study|Relapse or tumor progression|7|||
131520270|NCT00667342|473530696|FG000|Overall Study|Adverse Event|0|||
131520271|NCT00667342|473530697|FG001|Overall Study|Adverse Event|0|||
131520272|NCT00667342|473530698|FG002|Overall Study|Adverse Event|1|||
131520273|NCT00667342|473530696|FG000|Overall Study|Ineligible|0|||
131520274|NCT00667342|473530697|FG001|Overall Study|Ineligible|0|||
131520275|NCT00667342|473530698|FG002|Overall Study|Ineligible|1|||
131520276|NCT01207778|473530699|FG000|Overall Study|Lost to Follow-up|0|||
131520277|NCT01207778|473530700|FG001|Overall Study|Lost to Follow-up|3|||
131520278|NCT01207778|473530701|FG002|Overall Study|Lost to Follow-up|3|||
131520279|NCT02610192|473530705|FG000|Overall Study|Received other treatment|8|||
131520280|NCT02610192|473530705|FG000|Overall Study|Physician Decision|1|||
131520281|NCT01440322|473530706|FG000|Overall Study|Discomfort|2|||
131520282|NCT01440322|473530707|FG001|Overall Study|Discomfort|0|||
131520283|NCT01440322|473530706|FG000|Overall Study|Biomicroscopy|1|||
131520284|NCT01440322|473530707|FG001|Overall Study|Biomicroscopy|0|||
131520285|NCT01440322|473530706|FG000|Overall Study|Symptoms and Problems|1|||
131520286|NCT01440322|473530707|FG001|Overall Study|Symptoms and Problems|0|||
131520287|NCT01440322|473530706|FG000|Overall Study|Unacceptable Subjective Vision|1|||
131520288|NCT01440322|473530707|FG001|Overall Study|Unacceptable Subjective Vision|0|||
131520289|NCT01440322|473530706|FG000|Overall Study|Other Product Related|1|||
131520290|NCT01440322|473530707|FG001|Overall Study|Other Product Related|0|||
131520291|NCT01440322|473530706|FG000|Overall Study|Unrelated Medical Problem|0|||
131520292|NCT01440322|473530707|FG001|Overall Study|Unrelated Medical Problem|1|||
131520293|NCT01440322|473530706|FG000|Overall Study|Other Non-Product Related|1|||
131520294|NCT01440322|473530707|FG001|Overall Study|Other Non-Product Related|0|||
131520295|NCT00548808|473530708|FG000|Overall Study|Lost to Follow-up|9|||
131520296|NCT00548808|473530709|FG001|Overall Study|Lost to Follow-up|3|||
131520297|NCT00548808|473530708|FG000|Overall Study|Protocol Violation|8|||
131520298|NCT00548808|473530709|FG001|Overall Study|Protocol Violation|8|||
131520299|NCT00548808|473530708|FG000|Overall Study|Withdrawal by Subject|8|||
131520300|NCT00548808|473530709|FG001|Overall Study|Withdrawal by Subject|4|||
131520301|NCT00548808|473530708|FG000|Overall Study|Physician Decision|6|||
131520302|NCT00548808|473530709|FG001|Overall Study|Physician Decision|3|||
131520303|NCT00548808|473530708|FG000|Overall Study|Adverse Event|4|||
131520304|NCT00548808|473530709|FG001|Overall Study|Adverse Event|5|||
131520305|NCT00548808|473530708|FG000|Overall Study|Death|2|||
131520306|NCT00548808|473530709|FG001|Overall Study|Death|0|||
131520307|NCT00548808|473530708|FG000|Overall Study|Entry Criteria Not Met|2|||
131520308|NCT00548808|473530709|FG001|Overall Study|Entry Criteria Not Met|2|||
131520309|NCT00548808|473530708|FG000|Overall Study|Lack of Efficacy|2|||
131520310|NCT00548808|473530709|FG001|Overall Study|Lack of Efficacy|0|||
131520311|NCT00548808|473530708|FG000|Overall Study|Sponsor Decision|1|||
131520312|NCT00548808|473530709|FG001|Overall Study|Sponsor Decision|1|||
131520313|NCT03354429|473530710|FG000|Overall Study|Withdrawal by Subject|8|||
131520314|NCT03354429|473530711|FG001|Overall Study|Withdrawal by Subject|7|||
131520315|NCT03354429|473530710|FG000|Overall Study|Lost to Follow-up|1|||
131520316|NCT03354429|473530711|FG001|Overall Study|Lost to Follow-up|0|||
131520317|NCT02940691|473530712|FG000|Overall Study|Lost to Follow-up|5|||
131520318|NCT02940691|473530712|FG000|Overall Study|Incarceration|1|||
131520319|NCT03912233|473530713|FG000|Overall Study|Adverse Event|1|||
131520320|NCT03912233|473530714|FG001|Overall Study|Adverse Event|0|||
131520321|NCT03912233|473530715|FG002|Overall Study|Adverse Event|0|||
131520322|NCT03912233|473530716|FG003|Overall Study|Adverse Event|0|||
131520323|NCT03912233|473530717|FG004|Overall Study|Adverse Event|0|||
131520324|NCT03912233|473530718|FG005|Overall Study|Adverse Event|0|||
131520325|NCT03912233|473530713|FG000|Overall Study|Physician Decision|1|||
131520326|NCT03912233|473530714|FG001|Overall Study|Physician Decision|0|||
131520327|NCT03912233|473530715|FG002|Overall Study|Physician Decision|0|||
131520328|NCT03912233|473530716|FG003|Overall Study|Physician Decision|0|||
131520329|NCT03912233|473530717|FG004|Overall Study|Physician Decision|0|||
131520330|NCT03912233|473530718|FG005|Overall Study|Physician Decision|0|||
131520331|NCT03912233|473530713|FG000|Overall Study|Other|0|||
131520332|NCT03912233|473530714|FG001|Overall Study|Other|0|||
131520333|NCT03912233|473530715|FG002|Overall Study|Other|0|||
131520334|NCT03912233|473530716|FG003|Overall Study|Other|0|||
131520335|NCT03912233|473530717|FG004|Overall Study|Other|7|||
131520336|NCT03912233|473530718|FG005|Overall Study|Other|12|||
131520337|NCT00654628|473530719|FG000|6-week Active Treatment Period|Adverse Event|9|||
131520338|NCT00654628|473530719|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
131520339|NCT00654628|473530719|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
131520340|NCT00654628|473530719|FG000|6-week Active Treatment Period|Out of window period|1|||
131520341|NCT00654628|473530719|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
131520342|NCT00654628|473530719|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
131520343|NCT00953329|473530724|FG000|Overall Study|Lack of Efficacy|1|||
131520344|NCT02477020|473530727|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
131520345|NCT02477020|473530728|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
131520346|NCT02477020|473530727|FG000|Overall Study|Voluntary Withdrawal|7|||
131520347|NCT02477020|473530728|FG001|Overall Study|Voluntary Withdrawal|16|||
131520348|NCT02477020|473530727|FG000|Overall Study|Reason not Specified|3|||
131520349|NCT02477020|473530728|FG001|Overall Study|Reason not Specified|1|||
131520350|NCT02477020|473530727|FG000|Overall Study|Lack of Efficacy|14|||
131520351|NCT02477020|473530728|FG001|Overall Study|Lack of Efficacy|5|||
131520352|NCT01465802|473530730|FG000|Overall Study|Study terminated by sponsor|1|||
131520353|NCT01465802|473530731|FG001|Overall Study|Study terminated by sponsor|0|||
131520354|NCT01465802|473530732|FG002|Overall Study|Study terminated by sponsor|0|||
131520355|NCT01465802|473530733|FG003|Overall Study|Study terminated by sponsor|1|||
131520356|NCT01465802|473530734|FG004|Overall Study|Study terminated by sponsor|7|||
131520357|NCT01465802|473530730|FG000|Overall Study|Withdrawal by Subject|7|||
131520358|NCT01465802|473530731|FG001|Overall Study|Withdrawal by Subject|7|||
131520359|NCT01465802|473530732|FG002|Overall Study|Withdrawal by Subject|0|||
131520360|NCT01465802|473530733|FG003|Overall Study|Withdrawal by Subject|8|||
131520361|NCT01465802|473530734|FG004|Overall Study|Withdrawal by Subject|1|||
131520362|NCT01465802|473530730|FG000|Overall Study|Lost to Follow-up|1|||
131520363|NCT01465802|473530731|FG001|Overall Study|Lost to Follow-up|1|||
131520364|NCT01465802|473530732|FG002|Overall Study|Lost to Follow-up|0|||
131520365|NCT01465802|473530733|FG003|Overall Study|Lost to Follow-up|0|||
131520366|NCT01465802|473530734|FG004|Overall Study|Lost to Follow-up|0|||
131520367|NCT01465802|473530730|FG000|Overall Study|Reason not specified|9|||
131520368|NCT01465802|473530731|FG001|Overall Study|Reason not specified|4|||
131520369|NCT01465802|473530732|FG002|Overall Study|Reason not specified|0|||
131520370|NCT01465802|473530733|FG003|Overall Study|Reason not specified|10|||
131520371|NCT01465802|473530734|FG004|Overall Study|Reason not specified|2|||
131520372|NCT01465802|473530730|FG000|Overall Study|Death|15|||
131520373|NCT01465802|473530731|FG001|Overall Study|Death|12|||
131520374|NCT01465802|473530732|FG002|Overall Study|Death|0|||
131520375|NCT01465802|473530733|FG003|Overall Study|Death|10|||
131520376|NCT01465802|473530734|FG004|Overall Study|Death|2|||
131520377|NCT01340976|473530735|FG000|Overall Study|Physician Decision|2|||
131520378|NCT01340976|473530736|FG001|Overall Study|Physician Decision|0|||
131520379|NCT01340976|473530737|FG002|Overall Study|Physician Decision|1|||
131520380|NCT01340976|473530738|FG003|Overall Study|Physician Decision|1|||
131520381|NCT01340976|473530739|FG004|Overall Study|Physician Decision|1|||
131520382|NCT01340976|473530740|FG005|Overall Study|Physician Decision|0|||
131520383|NCT01340976|473530735|FG000|Overall Study|Death|0|||
131520384|NCT01340976|473530736|FG001|Overall Study|Death|1|||
131520385|NCT01340976|473530737|FG002|Overall Study|Death|0|||
131520386|NCT01340976|473530738|FG003|Overall Study|Death|0|||
131520387|NCT01340976|473530739|FG004|Overall Study|Death|0|||
131520388|NCT01340976|473530740|FG005|Overall Study|Death|0|||
131520389|NCT01340976|473530735|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
131520390|NCT01340976|473530736|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
131520391|NCT01340976|473530737|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
131520392|NCT01340976|473530738|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
131520393|NCT01340976|473530739|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
131520394|NCT01340976|473530740|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
131520395|NCT01340976|473530735|FG000|Overall Study|Withdrawal by Subject|0|||
131520396|NCT01340976|473530736|FG001|Overall Study|Withdrawal by Subject|0|||
131520397|NCT01340976|473530737|FG002|Overall Study|Withdrawal by Subject|0|||
131520398|NCT01340976|473530738|FG003|Overall Study|Withdrawal by Subject|1|||
131520399|NCT01340976|473530739|FG004|Overall Study|Withdrawal by Subject|1|||
131520400|NCT01340976|473530740|FG005|Overall Study|Withdrawal by Subject|0|||
131520401|NCT01340976|473530735|FG000|Overall Study|Other anemia treatment|1|||
131520402|NCT01340976|473530736|FG001|Overall Study|Other anemia treatment|0|||
131520403|NCT01340976|473530737|FG002|Overall Study|Other anemia treatment|2|||
131520404|NCT01340976|473530738|FG003|Overall Study|Other anemia treatment|1|||
131520405|NCT01340976|473530739|FG004|Overall Study|Other anemia treatment|0|||
131520406|NCT01340976|473530740|FG005|Overall Study|Other anemia treatment|1|||
131520407|NCT01340976|473530735|FG000|Overall Study|Adverse Event|0|||
131520408|NCT01340976|473530736|FG001|Overall Study|Adverse Event|1|||
131520409|NCT01340976|473530737|FG002|Overall Study|Adverse Event|0|||
131520410|NCT01340976|473530738|FG003|Overall Study|Adverse Event|0|||
131520411|NCT01340976|473530739|FG004|Overall Study|Adverse Event|0|||
131520412|NCT01340976|473530740|FG005|Overall Study|Adverse Event|0|||
131520413|NCT01358981|473530741|FG000|Period 1|Withdrawal by Subject|0|||
131520414|NCT01358981|473530742|FG001|Period 1|Withdrawal by Subject|0|||
131520415|NCT01358981|473530743|FG002|Period 1|Withdrawal by Subject|0|||
131520416|NCT01358981|473530744|FG003|Period 1|Withdrawal by Subject|1|||
131520417|NCT01358981|473530745|FG004|Period 1|Withdrawal by Subject|0|||
131520418|NCT01358981|473530746|FG005|Period 1|Withdrawal by Subject|0|||
131520419|NCT01358981|473530747|FG006|Period 1|Withdrawal by Subject|0|||
131520420|NCT03306264|473530757|FG000|Overall Study|Death|33|||
131520421|NCT03306264|473530758|FG001|Overall Study|Death|25|||
131520422|NCT03306264|473530759|FG002|Overall Study|Death|34|||
131520423|NCT03306264|473530760|FG003|Overall Study|Death|34|||
131520424|NCT03306264|473530757|FG000|Overall Study|Complete Consent Withdrawal|4|||
131520425|NCT03306264|473530758|FG001|Overall Study|Complete Consent Withdrawal|4|||
131520426|NCT03306264|473530759|FG002|Overall Study|Complete Consent Withdrawal|1|||
131520427|NCT03306264|473530760|FG003|Overall Study|Complete Consent Withdrawal|8|||
131520428|NCT03306264|473530757|FG000|Overall Study|Lost to Follow-up|1|||
131520429|NCT03306264|473530758|FG001|Overall Study|Lost to Follow-up|0|||
131520430|NCT03306264|473530759|FG002|Overall Study|Lost to Follow-up|1|||
131520431|NCT03306264|473530760|FG003|Overall Study|Lost to Follow-up|0|||
131520432|NCT03306264|473530757|FG000|Overall Study|Rollover to ASTX727-06|10|||
131520433|NCT03306264|473530758|FG001|Overall Study|Rollover to ASTX727-06|18|||
131520434|NCT03306264|473530759|FG002|Overall Study|Rollover to ASTX727-06|4|||
131520435|NCT03306264|473530760|FG003|Overall Study|Rollover to ASTX727-06|2|||
131520436|NCT03306264|473530757|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
131520437|NCT03306264|473530758|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
131520438|NCT03306264|473530759|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
131520439|NCT03306264|473530760|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
131520440|NCT01574703|473530761|FG000|Overall Study|Adverse Event|0|||
131520441|NCT01574703|473530762|FG001|Overall Study|Adverse Event|2|||
131520442|NCT01574703|473530763|FG002|Overall Study|Adverse Event|1|||
131520443|NCT01574703|473530764|FG003|Overall Study|Adverse Event|1|||
131520444|NCT01574703|473530761|FG000|Overall Study|Protocol Violation|0|||
131520445|NCT01574703|473530762|FG001|Overall Study|Protocol Violation|0|||
131520446|NCT01574703|473530763|FG002|Overall Study|Protocol Violation|0|||
131520447|NCT01574703|473530764|FG003|Overall Study|Protocol Violation|1|||
131520448|NCT01574703|473530761|FG000|Overall Study|Unspecified Reason|27|||
131520449|NCT01574703|473530762|FG001|Overall Study|Unspecified Reason|15|||
131520450|NCT01574703|473530763|FG002|Overall Study|Unspecified Reason|20|||
131520451|NCT01574703|473530764|FG003|Overall Study|Unspecified Reason|16|||
131520452|NCT01574703|473530761|FG000|Overall Study|Withdrawal by Subject|53|||
131520453|NCT01574703|473530762|FG001|Overall Study|Withdrawal by Subject|52|||
131520454|NCT01574703|473530763|FG002|Overall Study|Withdrawal by Subject|36|||
131520455|NCT01574703|473530764|FG003|Overall Study|Withdrawal by Subject|61|||
131520456|NCT01574703|473530761|FG000|Overall Study|Met Withdrawal Criteria|0|||
131520457|NCT01574703|473530762|FG001|Overall Study|Met Withdrawal Criteria|1|||
131520458|NCT01574703|473530763|FG002|Overall Study|Met Withdrawal Criteria|1|||
131520459|NCT01574703|473530764|FG003|Overall Study|Met Withdrawal Criteria|0|||
131520460|NCT01574703|473530761|FG000|Overall Study|Lost to Follow-up|43|||
131520461|NCT01574703|473530762|FG001|Overall Study|Lost to Follow-up|41|||
131520462|NCT01574703|473530763|FG002|Overall Study|Lost to Follow-up|46|||
131520463|NCT01574703|473530764|FG003|Overall Study|Lost to Follow-up|35|||
131520464|NCT01574703|473530761|FG000|Overall Study|Death|2|||
131520465|NCT01574703|473530762|FG001|Overall Study|Death|1|||
131520466|NCT01574703|473530763|FG002|Overall Study|Death|1|||
131520467|NCT01574703|473530764|FG003|Overall Study|Death|0|||
131520468|NCT01524770|473530765|FG000|First Intervention|Withdrawal by Subject|1|||
131520469|NCT01524770|473530766|FG001|First Intervention|Withdrawal by Subject|0|||
131520470|NCT01524770|473530765|FG000|First Intervention|Adverse Event|1|||
131520471|NCT01524770|473530766|FG001|First Intervention|Adverse Event|1|||
131520472|NCT01524770|473530765|FG000|First Intervention|Protocol Violation|1|||
131520473|NCT01524770|473530766|FG001|First Intervention|Protocol Violation|0|||
131520474|NCT03467425|473530767|FG000|Overall Study|Adverse Event|9|||
131520475|NCT03467425|473530768|FG001|Overall Study|Adverse Event|9|||
131520476|NCT03467425|473530767|FG000|Overall Study|Lack of Efficacy|3|||
131520477|NCT03467425|473530768|FG001|Overall Study|Lack of Efficacy|1|||
131520478|NCT03467425|473530767|FG000|Overall Study|Protocol Violation|0|||
131520479|NCT03467425|473530768|FG001|Overall Study|Protocol Violation|1|||
131520480|NCT03467425|473530767|FG000|Overall Study|Lost to Follow-up|18|||
131520481|NCT03467425|473530768|FG001|Overall Study|Lost to Follow-up|25|||
131520482|NCT03467425|473530767|FG000|Overall Study|Physician Decision|2|||
131520483|NCT03467425|473530768|FG001|Overall Study|Physician Decision|1|||
131520484|NCT03467425|473530767|FG000|Overall Study|Withdrawal by Subject|15|||
131520485|NCT03467425|473530768|FG001|Overall Study|Withdrawal by Subject|17|||
131520486|NCT02318693|473530769|FG000|Overall Study|Protocol Violation|0|||
131520487|NCT02318693|473530770|FG001|Overall Study|Protocol Violation|1|||
131520488|NCT01282216|473530771|FG000|Overall Study|Graft failure|0|||
131520489|NCT01282216|473530772|FG001|Overall Study|Graft failure|0|||
131520490|NCT01282216|473530773|FG002|Overall Study|Graft failure|3|||
131520491|NCT01282216|473530774|FG003|Overall Study|Graft failure|2|||
131520492|NCT01282216|473530771|FG000|Overall Study|Physician Decision|0|||
131520493|NCT01282216|473530772|FG001|Overall Study|Physician Decision|0|||
131520494|NCT01282216|473530773|FG002|Overall Study|Physician Decision|11|||
131520495|NCT01282216|473530774|FG003|Overall Study|Physician Decision|0|||
131520496|NCT01282216|473530771|FG000|Overall Study|Relapse|0|||
131520497|NCT01282216|473530772|FG001|Overall Study|Relapse|0|||
131520498|NCT01282216|473530773|FG002|Overall Study|Relapse|17|||
131520499|NCT01282216|473530774|FG003|Overall Study|Relapse|6|||
131520500|NCT01282216|473530771|FG000|Overall Study|Death|0|||
131520501|NCT01282216|473530772|FG001|Overall Study|Death|0|||
131520502|NCT01282216|473530773|FG002|Overall Study|Death|2|||
131520503|NCT01282216|473530774|FG003|Overall Study|Death|0|||
131520504|NCT03665038|473530779|FG000|Overall Study|Lost to Follow-up|0|||
131520505|NCT03665038|473530780|FG001|Overall Study|Lost to Follow-up|0|||
131520506|NCT03665038|473530781|FG002|Overall Study|Lost to Follow-up|1|||
131520507|NCT04579679|473530782|FG000|Overall Study|New Antitumor Therapy|6|||
131520508|NCT04579679|473530783|FG001|Overall Study|New Antitumor Therapy|4|||
131520509|NCT04579679|473530784|FG002|Overall Study|New Antitumor Therapy|7|||
131520510|NCT04579679|473530785|FG003|Overall Study|New Antitumor Therapy|0|||
131520511|NCT04579679|473530782|FG000|Overall Study|Withdrawal of Consent|1|||
131520512|NCT04579679|473530783|FG001|Overall Study|Withdrawal of Consent|1|||
131520513|NCT04579679|473530784|FG002|Overall Study|Withdrawal of Consent|2|||
131520514|NCT04579679|473530785|FG003|Overall Study|Withdrawal of Consent|4|||
131520515|NCT04579679|473530782|FG000|Overall Study|Death|2|||
131520516|NCT04579679|473530783|FG001|Overall Study|Death|2|||
131520517|NCT04579679|473530784|FG002|Overall Study|Death|2|||
131520518|NCT04579679|473530785|FG003|Overall Study|Death|0|||
131520519|NCT04579679|473530782|FG000|Overall Study|Adverse Event|0|||
131520520|NCT04579679|473530783|FG001|Overall Study|Adverse Event|4|||
131520521|NCT04579679|473530784|FG002|Overall Study|Adverse Event|0|||
131520522|NCT04579679|473530785|FG003|Overall Study|Adverse Event|0|||
131520523|NCT04579679|473530782|FG000|Overall Study|Disease Progression|9|||
131520524|NCT04579679|473530783|FG001|Overall Study|Disease Progression|13|||
131520525|NCT04579679|473530784|FG002|Overall Study|Disease Progression|7|||
131520526|NCT04579679|473530785|FG003|Overall Study|Disease Progression|0|||
131520527|NCT04579679|473530782|FG000|Overall Study|Physician Decision|0|||
131520528|NCT04579679|473530783|FG001|Overall Study|Physician Decision|0|||
131520529|NCT04579679|473530784|FG002|Overall Study|Physician Decision|1|||
131520530|NCT04579679|473530785|FG003|Overall Study|Physician Decision|0|||
131520531|NCT04579679|473530782|FG000|Overall Study|Study Terminated by Sponsor|2|||
131520532|NCT04579679|473530783|FG001|Overall Study|Study Terminated by Sponsor|7|||
131520533|NCT04579679|473530784|FG002|Overall Study|Study Terminated by Sponsor|1|||
131520534|NCT04579679|473530785|FG003|Overall Study|Study Terminated by Sponsor|0|||
131520535|NCT03238911|473530786|FG000|Overall Study|Withdrawal by Subject|1|||
131520536|NCT03238911|473530787|FG001|Overall Study|Withdrawal by Subject|2|||
131520537|NCT03238911|473530786|FG000|Overall Study|Lost to Follow-up|2|||
131520538|NCT03238911|473530787|FG001|Overall Study|Lost to Follow-up|1|||
131520539|NCT02239536|473530788|FG000|Overall Study|Non-neoplastic polyp|23|||
131520540|NCT02239536|473530789|FG001|Overall Study|Non-neoplastic polyp|17|||
131520541|NCT03890367|473530794|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131520542|NCT03890367|473530795|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131520543|NCT03890367|473530796|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131520544|NCT03890367|473530794|FG000|Overall Study|Protocol deviation|2|||
131520545|NCT03890367|473530795|FG001|Overall Study|Protocol deviation|2|||
131520546|NCT03890367|473530796|FG002|Overall Study|Protocol deviation|1|||
131520547|NCT03890367|473530794|FG000|Overall Study|Lost to Follow-up|1|||
131520548|NCT03890367|473530795|FG001|Overall Study|Lost to Follow-up|1|||
131520549|NCT03890367|473530796|FG002|Overall Study|Lost to Follow-up|0|||
131520550|NCT00679341|473532402|FG000|Overall Study|Disease progression|42|||
131520551|NCT00679341|473532403|FG001|Overall Study|Disease progression|36|||
131520552|NCT00679341|473532402|FG000|Overall Study|Adverse Event|5|||
131520553|NCT00679341|473532403|FG001|Overall Study|Adverse Event|6|||
131520554|NCT00679341|473532402|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
131520555|NCT00679341|473532403|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
131520556|NCT00679341|473532402|FG000|Overall Study|Death|1|||
131520557|NCT00679341|473532403|FG001|Overall Study|Death|1|||
131520558|NCT00679341|473532402|FG000|Overall Study|Other|1|||
131520559|NCT00679341|473532403|FG001|Overall Study|Other|0|||
131520560|NCT00679341|473532402|FG000|Overall Study|Physician Decision|1|||
131520561|NCT00679341|473532403|FG001|Overall Study|Physician Decision|0|||
131520562|NCT00679341|473532402|FG000|Overall Study|Not treated|0|||
131520563|NCT00679341|473532403|FG001|Overall Study|Not treated|2|||
131520564|NCT00679341|473532402|FG000|Overall Study|Physician/patient decision to withdraw|0|||
131520565|NCT00679341|473532403|FG001|Overall Study|Physician/patient decision to withdraw|6|||
131520566|NCT01700179|473532404|FG000|Overall Study|Physician Decision|2|||
131520567|NCT05044234|473532406|FG000|Overall Study|Lost to Follow-up|2|||
131520568|NCT05044234|473532407|FG001|Overall Study|Lost to Follow-up|1|||
131520569|NCT05044234|473532408|FG002|Overall Study|Lost to Follow-up|1|||
131520570|NCT05044234|473532409|FG003|Overall Study|Lost to Follow-up|2|||
131520571|NCT05044234|473532406|FG000|Overall Study|Withdrawal by Subject|6|||
131520572|NCT05044234|473532407|FG001|Overall Study|Withdrawal by Subject|4|||
131520573|NCT05044234|473532408|FG002|Overall Study|Withdrawal by Subject|5|||
131520574|NCT05044234|473532409|FG003|Overall Study|Withdrawal by Subject|8|||
131520575|NCT05044234|473532406|FG000|Overall Study|Study terminated by Sponsor|21|||
131520576|NCT05044234|473532407|FG001|Overall Study|Study terminated by Sponsor|21|||
131520577|NCT05044234|473532408|FG002|Overall Study|Study terminated by Sponsor|20|||
131520578|NCT05044234|473532409|FG003|Overall Study|Study terminated by Sponsor|14|||
131520579|NCT05044234|473532406|FG000|Overall Study|Other, not specified|0|||
131520580|NCT05044234|473532407|FG001|Overall Study|Other, not specified|0|||
131520581|NCT05044234|473532408|FG002|Overall Study|Other, not specified|1|||
131520582|NCT05044234|473532409|FG003|Overall Study|Other, not specified|2|||
131520583|NCT05044234|473532406|FG000|Overall Study|Delayed data entry|0|||
131520584|NCT05044234|473532407|FG001|Overall Study|Delayed data entry|0|||
131520585|NCT05044234|473532408|FG002|Overall Study|Delayed data entry|0|||
131520586|NCT05044234|473532409|FG003|Overall Study|Delayed data entry|1|||
131520587|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Adverse Event|9|||
131520588|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Adverse Event|2|||
131520589|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
131520590|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
131520591|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
131520592|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
131520593|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Physician Decision|1|||
131520594|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Physician Decision|1|||
131520595|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Pregnancy|2|||
131520596|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Pregnancy|0|||
131520597|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
131520598|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
131520599|NCT02896127|473532410|FG000|COMPLETED WEEK 52|Technical problems|1|||
131520600|NCT02896127|473532411|FG001|COMPLETED WEEK 52|Technical problems|0|||
131520601|NCT02896127|473532410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
131520602|NCT02896127|473532411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
131520603|NCT02896127|473532410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
131520604|NCT02896127|473532411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
131520605|NCT02896127|473532410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
131520606|NCT02896127|473532411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
131520607|NCT02896127|473532410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
131520608|NCT02896127|473532411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
131520609|NCT02896127|473532410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
131520610|NCT02896127|473532411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
131520611|NCT00279708|473532412|FG000|Overall Study|Withdrawal by Subject|2|||
131520612|NCT00279708|473532413|FG001|Overall Study|Withdrawal by Subject|3|||
131520613|NCT00279708|473532412|FG000|Overall Study|Adverse Event|1|||
131520614|NCT00279708|473532413|FG001|Overall Study|Adverse Event|1|||
131520615|NCT02488629|473532414|FG000|Overall Study|Lack of Efficacy|3|||
131520616|NCT02488629|473532415|FG001|Overall Study|Lack of Efficacy|1|||
131520617|NCT02488629|473532416|FG002|Overall Study|Lack of Efficacy|0|||
131520618|NCT02488629|473532417|FG003|Overall Study|Lack of Efficacy|0|||
131520619|NCT02488629|473532414|FG000|Overall Study|Withdrawal by Subject|0|||
131520620|NCT02488629|473532415|FG001|Overall Study|Withdrawal by Subject|1|||
131520621|NCT02488629|473532416|FG002|Overall Study|Withdrawal by Subject|0|||
131520622|NCT02488629|473532417|FG003|Overall Study|Withdrawal by Subject|0|||
131520623|NCT01049919|473532420|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
131520624|NCT01049919|473532421|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
131520625|NCT01049919|473532420|FG000|Overall Study|Withdrawal by Subject|5|||
131520626|NCT01049919|473532421|FG001|Overall Study|Withdrawal by Subject|0|||
131520627|NCT01049919|473532420|FG000|Overall Study|Lost to Follow-up|6|||
131520628|NCT01049919|473532421|FG001|Overall Study|Lost to Follow-up|1|||
131520629|NCT01049919|473532420|FG000|Overall Study|Physician Decision|2|||
131520630|NCT01049919|473532421|FG001|Overall Study|Physician Decision|0|||
131520631|NCT01049919|473532420|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
131658421|NCT01531673|474035308|FG009|Overall Study|Lost to Follow-up|0|||
131520632|NCT01049919|473532421|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
131520633|NCT01049919|473532420|FG000|Overall Study|Early study termination by sponsor.|2|||
131520634|NCT01049919|473532421|FG001|Overall Study|Early study termination by sponsor.|0|||
131520635|NCT02566759|473532425|FG000|All Parts|Withdrawal by Subject|0|||
131520636|NCT02566759|473532426|FG001|All Parts|Withdrawal by Subject|1|||
131520637|NCT02566759|473532427|FG002|All Parts|Withdrawal by Subject|0|||
131520638|NCT02566759|473532428|FG003|All Parts|Withdrawal by Subject|0|||
131520639|NCT02566759|473532429|FG004|All Parts|Withdrawal by Subject|0|||
131520640|NCT02566759|473532430|FG005|All Parts|Withdrawal by Subject|0|||
131520641|NCT02566759|473532431|FG006|All Parts|Withdrawal by Subject|0|||
131520642|NCT02566759|473532432|FG007|All Parts|Withdrawal by Subject|0|||
131520643|NCT02566759|473532433|FG008|All Parts|Withdrawal by Subject|0|||
131520644|NCT02566759|473532434|FG009|All Parts|Withdrawal by Subject|0|||
131520645|NCT02566759|473532435|FG010|All Parts|Withdrawal by Subject|0|||
131520646|NCT02566759|473532436|FG011|All Parts|Withdrawal by Subject|0|||
131520647|NCT02566759|473532437|FG012|All Parts|Withdrawal by Subject|0|||
131520648|NCT02566759|473532438|FG013|All Parts|Withdrawal by Subject|0|||
131520649|NCT02566759|473532439|FG014|All Parts|Withdrawal by Subject|0|||
131520650|NCT02566759|473532440|FG015|All Parts|Withdrawal by Subject|0|||
131520651|NCT02566759|473532441|FG016|All Parts|Withdrawal by Subject|0|||
131520652|NCT02566759|473532425|FG000|All Parts|Adverse Event|0|||
131520653|NCT02566759|473532426|FG001|All Parts|Adverse Event|0|||
131520654|NCT02566759|473532427|FG002|All Parts|Adverse Event|0|||
131520655|NCT02566759|473532428|FG003|All Parts|Adverse Event|0|||
131520656|NCT02566759|473532429|FG004|All Parts|Adverse Event|0|||
131520657|NCT02566759|473532430|FG005|All Parts|Adverse Event|0|||
131520658|NCT02566759|473532431|FG006|All Parts|Adverse Event|0|||
131520659|NCT02566759|473532432|FG007|All Parts|Adverse Event|0|||
131520660|NCT02566759|473532433|FG008|All Parts|Adverse Event|0|||
131520661|NCT02566759|473532434|FG009|All Parts|Adverse Event|0|||
131520662|NCT02566759|473532435|FG010|All Parts|Adverse Event|0|||
131520663|NCT02566759|473532436|FG011|All Parts|Adverse Event|0|||
131520664|NCT02566759|473532437|FG012|All Parts|Adverse Event|1|||
131520665|NCT02566759|473532438|FG013|All Parts|Adverse Event|3|||
131520666|NCT02566759|473532439|FG014|All Parts|Adverse Event|0|||
131520667|NCT02566759|473532440|FG015|All Parts|Adverse Event|0|||
131520668|NCT02566759|473532441|FG016|All Parts|Adverse Event|0|||
131520669|NCT02566759|473532425|FG000|All Parts|Other|0|||
131520670|NCT02566759|473532426|FG001|All Parts|Other|0|||
131520671|NCT02566759|473532427|FG002|All Parts|Other|0|||
131520672|NCT02566759|473532428|FG003|All Parts|Other|0|||
131520673|NCT02566759|473532429|FG004|All Parts|Other|0|||
131520674|NCT02566759|473532430|FG005|All Parts|Other|0|||
131520675|NCT02566759|473532431|FG006|All Parts|Other|0|||
131520676|NCT02566759|473532432|FG007|All Parts|Other|0|||
131520677|NCT02566759|473532433|FG008|All Parts|Other|0|||
131520678|NCT02566759|473532434|FG009|All Parts|Other|0|||
131520679|NCT02566759|473532435|FG010|All Parts|Other|0|||
131520680|NCT02566759|473532436|FG011|All Parts|Other|0|||
131520681|NCT02566759|473532437|FG012|All Parts|Other|0|||
131520682|NCT02566759|473532438|FG013|All Parts|Other|2|||
131520683|NCT02566759|473532439|FG014|All Parts|Other|0|||
131520684|NCT02566759|473532440|FG015|All Parts|Other|0|||
131520685|NCT02566759|473532441|FG016|All Parts|Other|0|||
131520686|NCT02566759|473532425|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520687|NCT02566759|473532426|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520688|NCT02566759|473532427|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520689|NCT02566759|473532428|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520690|NCT02566759|473532429|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520691|NCT02566759|473532430|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520692|NCT02566759|473532431|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520693|NCT02566759|473532432|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520694|NCT02566759|473532433|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520695|NCT02566759|473532434|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520696|NCT02566759|473532435|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520697|NCT02566759|473532436|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520698|NCT02566759|473532437|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520699|NCT02566759|473532438|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520700|NCT02566759|473532439|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520701|NCT02566759|473532440|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
131520702|NCT02566759|473532441|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
131520703|NCT01126541|473532442|FG000|Overall Study|Adverse Event|0|||
131520704|NCT01126541|473532443|FG001|Overall Study|Adverse Event|2|||
131520705|NCT01126541|473532444|FG002|Overall Study|Adverse Event|4|||
131520706|NCT01126541|473532442|FG000|Overall Study|Death|0|||
131520707|NCT01126541|473532443|FG001|Overall Study|Death|1|||
131520708|NCT01126541|473532444|FG002|Overall Study|Death|0|||
131520709|NCT01126541|473532442|FG000|Overall Study|Lack of Efficacy|6|||
131520710|NCT01126541|473532443|FG001|Overall Study|Lack of Efficacy|1|||
131520711|NCT01126541|473532444|FG002|Overall Study|Lack of Efficacy|11|||
131520712|NCT01126541|473532442|FG000|Overall Study|Lost to Follow-up|1|||
131520713|NCT01126541|473532443|FG001|Overall Study|Lost to Follow-up|2|||
131520714|NCT01126541|473532444|FG002|Overall Study|Lost to Follow-up|2|||
131520715|NCT01126541|473532442|FG000|Overall Study|Withdrawal by Subject|2|||
131520716|NCT01126541|473532443|FG001|Overall Study|Withdrawal by Subject|5|||
131520717|NCT01126541|473532444|FG002|Overall Study|Withdrawal by Subject|6|||
131520718|NCT01126541|473532442|FG000|Overall Study|Protocol Violation|0|||
131520719|NCT01126541|473532443|FG001|Overall Study|Protocol Violation|0|||
131520720|NCT01126541|473532444|FG002|Overall Study|Protocol Violation|1|||
131520721|NCT01126541|473532442|FG000|Overall Study|Administrative reason or other|1|||
131520722|NCT01126541|473532443|FG001|Overall Study|Administrative reason or other|1|||
131520723|NCT01126541|473532444|FG002|Overall Study|Administrative reason or other|2|||
131520724|NCT01532687|473532445|FG000|Overall Study|Death|2|||
131520725|NCT01532687|473532446|FG001|Overall Study|Death|0|||
131520726|NCT01532687|473532445|FG000|Overall Study|Adverse Event|6|||
131520727|NCT01532687|473532446|FG001|Overall Study|Adverse Event|1|||
131520728|NCT01532687|473532445|FG000|Overall Study|Withdrawal by Subject|1|||
131520729|NCT01532687|473532446|FG001|Overall Study|Withdrawal by Subject|0|||
131520730|NCT01532687|473532445|FG000|Overall Study|Physician Decision|2|||
131520731|NCT01532687|473532446|FG001|Overall Study|Physician Decision|1|||
131520732|NCT01532687|473532445|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
131520733|NCT01532687|473532446|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
131520734|NCT03160703|473532447|FG000|Overall Study|Withdrawal by Subject|0|||
131520735|NCT03160703|473532448|FG001|Overall Study|Withdrawal by Subject|0|||
131520736|NCT03160703|473532449|FG002|Overall Study|Withdrawal by Subject|0|||
131520737|NCT03160703|473532450|FG003|Overall Study|Withdrawal by Subject|1|||
131520738|NCT00226941|473532451|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
131520739|NCT00226941|473532452|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
131520740|NCT00226941|473532453|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
131520741|NCT00226941|473532454|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
131520742|NCT00226941|473532451|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
131520743|NCT00226941|473532452|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
131520744|NCT00226941|473532453|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
131520745|NCT00226941|473532454|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
131520746|NCT01513291|473532455|FG000|Treatment Period|Adverse Event|8|||
131520747|NCT01513291|473532456|FG001|Treatment Period|Adverse Event|4|||
131520748|NCT01513291|473532457|FG002|Treatment Period|Adverse Event|0|||
131520749|NCT01513291|473532458|FG003|Treatment Period|Adverse Event|0|||
131520750|NCT01513291|473532459|FG004|Treatment Period|Adverse Event|0|||
131520751|NCT01513291|473532455|FG000|Treatment Period|Lack of Efficacy|3|||
131520752|NCT01513291|473532456|FG001|Treatment Period|Lack of Efficacy|0|||
131520753|NCT01513291|473532457|FG002|Treatment Period|Lack of Efficacy|0|||
131520754|NCT01513291|473532458|FG003|Treatment Period|Lack of Efficacy|0|||
131520755|NCT01513291|473532459|FG004|Treatment Period|Lack of Efficacy|0|||
131520756|NCT01513291|473532455|FG000|Treatment Period|Lost to Follow-up|2|||
131520757|NCT01513291|473532456|FG001|Treatment Period|Lost to Follow-up|3|||
131520758|NCT01513291|473532457|FG002|Treatment Period|Lost to Follow-up|0|||
131520759|NCT01513291|473532458|FG003|Treatment Period|Lost to Follow-up|0|||
131520760|NCT01513291|473532459|FG004|Treatment Period|Lost to Follow-up|0|||
131520761|NCT01513291|473532455|FG000|Treatment Period|Physician Decision|1|||
131520762|NCT01513291|473532456|FG001|Treatment Period|Physician Decision|0|||
131520763|NCT01513291|473532457|FG002|Treatment Period|Physician Decision|0|||
131520764|NCT01513291|473532458|FG003|Treatment Period|Physician Decision|0|||
131520765|NCT01513291|473532459|FG004|Treatment Period|Physician Decision|0|||
131520766|NCT01513291|473532455|FG000|Treatment Period|Protocol Violation|1|||
131520767|NCT01513291|473532456|FG001|Treatment Period|Protocol Violation|2|||
131520768|NCT01513291|473532457|FG002|Treatment Period|Protocol Violation|0|||
131520769|NCT01513291|473532458|FG003|Treatment Period|Protocol Violation|0|||
131520770|NCT01513291|473532459|FG004|Treatment Period|Protocol Violation|0|||
131520771|NCT01513291|473532455|FG000|Treatment Period|Withdrawal by Subject|8|||
131520772|NCT01513291|473532456|FG001|Treatment Period|Withdrawal by Subject|5|||
131520773|NCT01513291|473532457|FG002|Treatment Period|Withdrawal by Subject|0|||
131520774|NCT01513291|473532458|FG003|Treatment Period|Withdrawal by Subject|0|||
131520775|NCT01513291|473532459|FG004|Treatment Period|Withdrawal by Subject|0|||
131520776|NCT01513291|473532455|FG000|Treatment Period|Randomized not treated|0|||
131520777|NCT01513291|473532456|FG001|Treatment Period|Randomized not treated|2|||
131520778|NCT01513291|473532457|FG002|Treatment Period|Randomized not treated|0|||
131520779|NCT01513291|473532458|FG003|Treatment Period|Randomized not treated|0|||
131520780|NCT01513291|473532459|FG004|Treatment Period|Randomized not treated|0|||
131520781|NCT01513291|473532455|FG000|Run-out Period|Lost to Follow-up|0|||
131520782|NCT01513291|473532456|FG001|Run-out Period|Lost to Follow-up|0|||
131520783|NCT01513291|473532457|FG002|Run-out Period|Lost to Follow-up|0|||
131520784|NCT01513291|473532458|FG003|Run-out Period|Lost to Follow-up|1|||
131520785|NCT01513291|473532459|FG004|Run-out Period|Lost to Follow-up|0|||
131520786|NCT01513291|473532455|FG000|Run-out Period|Withdrawal by Subject|0|||
131520787|NCT01513291|473532456|FG001|Run-out Period|Withdrawal by Subject|0|||
131520788|NCT01513291|473532457|FG002|Run-out Period|Withdrawal by Subject|0|||
131520789|NCT01513291|473532458|FG003|Run-out Period|Withdrawal by Subject|1|||
131520790|NCT01513291|473532459|FG004|Run-out Period|Withdrawal by Subject|0|||
131520791|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
131520792|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
131520793|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
131520794|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
131520795|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
131520796|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
131520797|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
131520798|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
131520799|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
131520800|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
131520801|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
131520802|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
131520803|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
131520804|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
131520805|NCT03732638|473532460|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
131520806|NCT03732638|473532461|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
131520807|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
131520808|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
131520809|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
131520810|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
131520811|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
131520812|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
131520813|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
131520814|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
131520815|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
131520816|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
131520817|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
131520818|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
131520819|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
131520820|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
131520821|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
131520822|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
131520823|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
131520824|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
131520825|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
131520826|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
131520827|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
131520828|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
131520829|NCT03732638|473532460|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
131520830|NCT03732638|473532461|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
131520831|NCT03732638|473532460|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
131520832|NCT03732638|473532461|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
131520833|NCT03732638|473532460|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
131520834|NCT03732638|473532461|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
131520835|NCT03732638|473532460|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
131520836|NCT03732638|473532461|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
131520837|NCT03732638|473532460|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
131520838|NCT03732638|473532461|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
131520839|NCT03728582|473532462|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
131520840|NCT03728582|473532463|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
131520841|NCT03728582|473532462|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
131520842|NCT03728582|473532463|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
131520843|NCT01018264|473532464|FG000|Overall Study|Withdrawal by Subject|1|||
131520844|NCT01018264|473532465|FG001|Overall Study|Withdrawal by Subject|0|||
131520845|NCT01018264|473532464|FG000|Overall Study|Lost to Follow-up|0|||
131520846|NCT01018264|473532465|FG001|Overall Study|Lost to Follow-up|1|||
131520847|NCT01785524|473532466|FG000|Overall Study|Withdrawal by Subject|2|||
131520848|NCT01785524|473532467|FG001|Overall Study|Withdrawal by Subject|2|||
131520849|NCT00767676|473532470|FG000|Overall Study|Investigator error|54|||
131520850|NCT00617240|473532471|FG000|Overall Study|Lack of Efficacy|1|||
131520851|NCT00617240|473532472|FG001|Overall Study|Lack of Efficacy|0|||
131520852|NCT03969212|473532473|FG000|Overall Study|Adverse Event|1|||
131520853|NCT03969212|473532474|FG001|Overall Study|Adverse Event|0|||
131520854|NCT03969212|473532475|FG002|Overall Study|Adverse Event|0|||
131520855|NCT03969212|473532476|FG003|Overall Study|Adverse Event|0|||
131520856|NCT03969212|473532473|FG000|Overall Study|Lost to Follow-up|2|||
131520857|NCT03969212|473532474|FG001|Overall Study|Lost to Follow-up|2|||
131520858|NCT03969212|473532475|FG002|Overall Study|Lost to Follow-up|2|||
131520859|NCT03969212|473532476|FG003|Overall Study|Lost to Follow-up|2|||
131520860|NCT03969212|473532473|FG000|Overall Study|Protocol Violation|0|||
131520861|NCT03969212|473532474|FG001|Overall Study|Protocol Violation|0|||
131520862|NCT03969212|473532475|FG002|Overall Study|Protocol Violation|0|||
131520863|NCT03969212|473532476|FG003|Overall Study|Protocol Violation|1|||
131520864|NCT03969212|473532473|FG000|Overall Study|Withdrawal by Subject|7|||
131520865|NCT03969212|473532474|FG001|Overall Study|Withdrawal by Subject|13|||
131520866|NCT03969212|473532475|FG002|Overall Study|Withdrawal by Subject|5|||
131520867|NCT03969212|473532476|FG003|Overall Study|Withdrawal by Subject|11|||
131520868|NCT03969212|473532473|FG000|Overall Study|Physician Decision|0|||
131520869|NCT03969212|473532474|FG001|Overall Study|Physician Decision|0|||
131520870|NCT03969212|473532475|FG002|Overall Study|Physician Decision|1|||
131520871|NCT03969212|473532476|FG003|Overall Study|Physician Decision|0|||
131520872|NCT03969212|473532473|FG000|Overall Study|Reason not Specified|22|||
131520873|NCT03969212|473532474|FG001|Overall Study|Reason not Specified|23|||
131520874|NCT03969212|473532475|FG002|Overall Study|Reason not Specified|28|||
131520875|NCT03969212|473532476|FG003|Overall Study|Reason not Specified|26|||
131520876|NCT00280566|473532477|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
131520877|NCT00280566|473532478|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
131520878|NCT00280566|473532479|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
131520879|NCT00280566|473532477|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
131520880|NCT00280566|473532478|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
131520881|NCT00280566|473532479|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
131520882|NCT00280566|473532477|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
131520883|NCT00280566|473532478|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
131520884|NCT00280566|473532479|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
131520885|NCT00280566|473532477|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
131520886|NCT00280566|473532478|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
131520887|NCT00280566|473532479|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
131520888|NCT00280566|473532477|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
131520889|NCT00280566|473532478|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
131520890|NCT00280566|473532479|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
131520891|NCT00280566|473532477|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
131520892|NCT00280566|473532478|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
131520893|NCT00280566|473532479|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
131520894|NCT00280566|473532477|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
131520895|NCT00280566|473532478|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
131520896|NCT00280566|473532479|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
131520897|NCT00280566|473532477|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
131520898|NCT00280566|473532478|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
131520899|NCT00280566|473532479|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
131520900|NCT00280566|473532477|FG000|Period 2 Double Blind|Adverse Event|0|||
131520901|NCT00280566|473532478|FG001|Period 2 Double Blind|Adverse Event|11|||
131520902|NCT00280566|473532479|FG002|Period 2 Double Blind|Adverse Event|15|||
131520903|NCT00280566|473532477|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
131520904|NCT00280566|473532478|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
131520905|NCT00280566|473532479|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
131520906|NCT00280566|473532477|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
131520907|NCT00280566|473532478|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
131520908|NCT00280566|473532479|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
131520909|NCT00280566|473532477|FG000|Period 2 Double Blind|miscellaneous|0|||
131520910|NCT00280566|473532478|FG001|Period 2 Double Blind|miscellaneous|10|||
131520911|NCT00280566|473532479|FG002|Period 2 Double Blind|miscellaneous|5|||
131520912|NCT00353366|473532480|FG000|Overall Study|Adverse Event|8|||
131520913|NCT00353366|473532480|FG000|Overall Study|Protocol Violation|12|||
131520914|NCT00353366|473532480|FG000|Overall Study|Withdrawal by Subject|12|||
131520915|NCT00353366|473532480|FG000|Overall Study|Lost to Follow-up|92|||
131520916|NCT00353366|473532480|FG000|Overall Study|Other|19|||
131520917|NCT01302392|473532483|FG000|Overall Study|Lost to Follow-up|1|||
131520918|NCT01302392|473532484|FG001|Overall Study|Lost to Follow-up|0|||
131520919|NCT01302392|473532483|FG000|Overall Study|Withdrawal by Subject|6|||
131520920|NCT01302392|473532484|FG001|Overall Study|Withdrawal by Subject|1|||
131520921|NCT00259857|473532485|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
131520922|NCT00259857|473532486|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
131520923|NCT00259857|473532485|FG000|24 Months Treatment|Lost to Follow-up|0|||
131520924|NCT00259857|473532486|FG001|24 Months Treatment|Lost to Follow-up|3|||
131520925|NCT00670228|473532487|FG000|Overall Study|Adverse Event|1|||
131520926|NCT00670228|473532488|FG001|Overall Study|Adverse Event|0|||
131520927|NCT00670228|473532487|FG000|Overall Study|Death or MACE|0|||
131520928|NCT00670228|473532488|FG001|Overall Study|Death or MACE|1|||
131520929|NCT00670228|473532487|FG000|Overall Study|Not treated|2|||
131520930|NCT00670228|473532488|FG001|Overall Study|Not treated|2|||
131520931|NCT00670228|473532487|FG000|Overall Study|Not meeting the selection criteria|2|||
131520932|NCT00670228|473532488|FG001|Overall Study|Not meeting the selection criteria|0|||
131520933|NCT01813019|473532496|FG000|Overall Study|Adverse Event|0|||
131520934|NCT01813019|473532497|FG001|Overall Study|Adverse Event|3|||
131520935|NCT01813019|473532496|FG000|Overall Study|Withdrawal by Subject|3|||
131520936|NCT01813019|473532497|FG001|Overall Study|Withdrawal by Subject|2|||
131520937|NCT01813019|473532496|FG000|Overall Study|administrative problems|2|||
131520938|NCT01813019|473532497|FG001|Overall Study|administrative problems|0|||
131520939|NCT01813019|473532496|FG000|Overall Study|Protocol Deviation|2|||
131520940|NCT01813019|473532497|FG001|Overall Study|Protocol Deviation|1|||
131520941|NCT03025828|473532498|FG000|Overall Study|Lost to Follow-up|1|||
131520942|NCT01020019|473532499|FG000|Overall Study|Lost to Follow-up|21|||
131520943|NCT01020019|473532500|FG001|Overall Study|Lost to Follow-up|18|||
131520944|NCT01020019|473532499|FG000|Overall Study|Adverse Event|1|||
131520945|NCT01020019|473532500|FG001|Overall Study|Adverse Event|5|||
131520946|NCT01020019|473532499|FG000|Overall Study|not interested in treatment|4|||
131520947|NCT01020019|473532500|FG001|Overall Study|not interested in treatment|4|||
131520948|NCT01020019|473532499|FG000|Overall Study|moving|0|||
131520949|NCT01020019|473532500|FG001|Overall Study|moving|2|||
131520950|NCT04958109|473532501|FG000|Overall Study|Withdrawal by Subject|0|||
131520951|NCT04958109|473532502|FG001|Overall Study|Withdrawal by Subject|1|||
131520952|NCT04958109|473532501|FG000|Overall Study|Lost to Follow-up|0|||
131520953|NCT04958109|473532502|FG001|Overall Study|Lost to Follow-up|1|||
131520954|NCT02214121|473532503|FG000|Part A|Patient decision|2|||
131520955|NCT02214121|473532504|FG001|Part A|Patient decision|0|||
131520956|NCT02214121|473532505|FG002|Part A|Patient decision|0|||
131520957|NCT02214121|473532503|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
131520958|NCT02214121|473532504|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
131520959|NCT02214121|473532505|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
131520960|NCT02214121|473532503|FG000|Part A|Other|1|||
131520961|NCT02214121|473532504|FG001|Part A|Other|0|||
131520962|NCT02214121|473532505|FG002|Part A|Other|0|||
131520963|NCT02214121|473532503|FG000|Part B|Patient decision|0|||
131520964|NCT02214121|473532504|FG001|Part B|Patient decision|1|||
131520965|NCT02214121|473532505|FG002|Part B|Patient decision|0|||
131520966|NCT02214121|473532503|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
131520967|NCT02214121|473532504|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
131520968|NCT02214121|473532505|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
131520969|NCT02214121|473532503|FG000|Part B|Lost to Follow-up|0|||
131520970|NCT02214121|473532504|FG001|Part B|Lost to Follow-up|0|||
131520971|NCT02214121|473532505|FG002|Part B|Lost to Follow-up|1|||
131520972|NCT00715793|473532506|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
131520973|NCT00715793|473532507|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
131520974|NCT00715793|473532506|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
131658422|NCT01531673|474035309|FG010|Overall Study|Lost to Follow-up|0|||
131520975|NCT00715793|473532507|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
131520976|NCT01559311|473532508|FG000|Overall Study|Protocol Violation|0|||
131520977|NCT01559311|473532509|FG001|Overall Study|Protocol Violation|0|||
131520978|NCT01559311|473532510|FG002|Overall Study|Protocol Violation|2|||
131520979|NCT01559311|473532508|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
131520980|NCT01559311|473532509|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
131520981|NCT01559311|473532510|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
131520982|NCT01559311|473532508|FG000|Overall Study|Withdrawal by Subject|2|||
131520983|NCT01559311|473532509|FG001|Overall Study|Withdrawal by Subject|1|||
131520984|NCT01559311|473532510|FG002|Overall Study|Withdrawal by Subject|0|||
131520985|NCT01559311|473532508|FG000|Overall Study|Death|0|||
131520986|NCT01559311|473532509|FG001|Overall Study|Death|2|||
131520987|NCT01559311|473532510|FG002|Overall Study|Death|3|||
131520988|NCT01559311|473532508|FG000|Overall Study|Lost to Follow-up|0|||
131520989|NCT01559311|473532509|FG001|Overall Study|Lost to Follow-up|3|||
131520990|NCT01559311|473532510|FG002|Overall Study|Lost to Follow-up|2|||
131520991|NCT01559311|473532508|FG000|Overall Study|Adverse Event|0|||
131520992|NCT01559311|473532509|FG001|Overall Study|Adverse Event|0|||
131520993|NCT01559311|473532510|FG002|Overall Study|Adverse Event|1|||
131520994|NCT01849588|473532513|FG000|Overall Study|Lack of Efficacy|3|||
131520995|NCT03417141|473532515|FG000|Overall Study|Withdrawal by Subject|1|||
131520996|NCT03417141|473532515|FG000|Overall Study|Protocol Violation|3|||
131520997|NCT02143843|473532517|FG000|Overall Study|Adverse Event|8|||
131520998|NCT02143843|473532517|FG000|Overall Study|Lack of Efficacy|2|||
131520999|NCT02143843|473532517|FG000|Overall Study|Withdrawal by Subject|2|||
131521000|NCT01462357|473532523|FG000|Overall Study|Death|0|||
131521001|NCT01462357|473532524|FG001|Overall Study|Death|0|||
131521002|NCT01462357|473532525|FG002|Overall Study|Death|1|||
131521003|NCT01462357|473532523|FG000|Overall Study|Withdrawal by Subject|3|||
131521004|NCT01462357|473532524|FG001|Overall Study|Withdrawal by Subject|11|||
131521005|NCT01462357|473532525|FG002|Overall Study|Withdrawal by Subject|3|||
131521006|NCT01462357|473532523|FG000|Overall Study|Migrated/moved from study area|2|||
131521007|NCT01462357|473532524|FG001|Overall Study|Migrated/moved from study area|3|||
131521008|NCT01462357|473532525|FG002|Overall Study|Migrated/moved from study area|1|||
131521009|NCT01462357|473532523|FG000|Overall Study|Lost to Follow-up|3|||
131521010|NCT01462357|473532524|FG001|Overall Study|Lost to Follow-up|5|||
131521011|NCT01462357|473532525|FG002|Overall Study|Lost to Follow-up|7|||
131521012|NCT01482767|473532527|FG000|Overall Study|Death|1|||
131521013|NCT01482767|473532528|FG001|Overall Study|Death|1|||
131521014|NCT01482767|473532527|FG000|Overall Study|Withdrawal by Subject|7|||
131521015|NCT01482767|473532528|FG001|Overall Study|Withdrawal by Subject|5|||
131521016|NCT01482767|473532527|FG000|Overall Study|Lost to Follow-up|12|||
131521017|NCT01482767|473532528|FG001|Overall Study|Lost to Follow-up|6|||
131521018|NCT01482767|473532527|FG000|Overall Study|Adverse Event|0|||
131521019|NCT01482767|473532528|FG001|Overall Study|Adverse Event|3|||
131521020|NCT01482767|473532527|FG000|Overall Study|Site closure|22|||
131521021|NCT01482767|473532528|FG001|Overall Study|Site closure|14|||
131521022|NCT01482767|473532527|FG000|Overall Study|Non-adherence to study requirements|4|||
131521023|NCT01482767|473532528|FG001|Overall Study|Non-adherence to study requirements|7|||
131521024|NCT01482767|473532527|FG000|Overall Study|Alternate HCV treatment|7|||
131521025|NCT01482767|473532528|FG001|Overall Study|Alternate HCV treatment|8|||
131521026|NCT01482767|473532527|FG000|Overall Study|Ineligible|0|||
131521027|NCT01482767|473532528|FG001|Overall Study|Ineligible|5|||
131521028|NCT01482767|473532527|FG000|Overall Study|Nurse error|1|||
131521029|NCT01482767|473532528|FG001|Overall Study|Nurse error|0|||
131521030|NCT03385239|473532533|FG000|Overall Study|Voluntary Withdrawal|2|||
131521031|NCT03385239|473532534|FG001|Overall Study|Voluntary Withdrawal|3|||
131521032|NCT03385239|473532535|FG002|Overall Study|Voluntary Withdrawal|2|||
131521033|NCT03385239|473532536|FG003|Overall Study|Voluntary Withdrawal|3|||
131521034|NCT03385239|473532537|FG004|Overall Study|Voluntary Withdrawal|0|||
131521035|NCT03385239|473532533|FG000|Overall Study|Adverse Event|0|||
131521036|NCT03385239|473532534|FG001|Overall Study|Adverse Event|0|||
131521037|NCT03385239|473532535|FG002|Overall Study|Adverse Event|1|||
131521038|NCT03385239|473532536|FG003|Overall Study|Adverse Event|0|||
131521039|NCT03385239|473532537|FG004|Overall Study|Adverse Event|0|||
131521040|NCT03385239|473532533|FG000|Overall Study|Other|0|||
131521041|NCT03385239|473532534|FG001|Overall Study|Other|0|||
131521042|NCT03385239|473532535|FG002|Overall Study|Other|0|||
131521043|NCT03385239|473532536|FG003|Overall Study|Other|1|||
131521044|NCT03385239|473532537|FG004|Overall Study|Other|0|||
131521045|NCT00025883|473532538|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
131521046|NCT00025883|473532538|FG000|Overall Study|no baseline data|1|||
131521047|NCT00025883|473532538|FG000|Overall Study|Death|1|||
131521048|NCT00025883|473532538|FG000|Overall Study|Adverse Event|1|||
131521049|NCT00025883|473532538|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
131521050|NCT02908529|473532540|FG000|Overall Study|Lost to Follow-up|0|||
131521051|NCT02908529|473532541|FG001|Overall Study|Lost to Follow-up|2|||
131521052|NCT02553421|473532542|FG000|Overall Study|Lost to Follow-up|21|||
131521053|NCT02553421|473532543|FG001|Overall Study|Lost to Follow-up|1|||
131521054|NCT02553421|473532542|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
131521055|NCT02553421|473532543|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
131521056|NCT02553421|473532542|FG000|Overall Study|Improper Device Placement|3|||
131521057|NCT02553421|473532543|FG001|Overall Study|Improper Device Placement|0|||
131521058|NCT05569954|473532546|FG000|Overall Study|Lost to Follow-up|3|||
131521059|NCT05569954|473532547|FG001|Overall Study|Lost to Follow-up|4|||
131521060|NCT05569954|473532546|FG000|Overall Study|Protocol Violation|1|||
131521061|NCT05569954|473532547|FG001|Overall Study|Protocol Violation|2|||
131521062|NCT05569954|473532546|FG000|Overall Study|Withdrawal by Subject|4|||
131521063|NCT05569954|473532547|FG001|Overall Study|Withdrawal by Subject|2|||
131521064|NCT01660412|473532548|FG000|Overall Study|Protocol Violation|0|||
131521065|NCT01660412|473532549|FG001|Overall Study|Protocol Violation|3|||
131521066|NCT03013491|473532550|FG000|Main Study|Death|2|||
131521067|NCT03013491|473532551|FG001|Main Study|Death|2|||
131521068|NCT03013491|473532552|FG002|Main Study|Death|5|||
131521069|NCT03013491|473532553|FG003|Main Study|Death|3|||
131521070|NCT03013491|473532554|FG004|Main Study|Death|9|||
131521071|NCT03013491|473532555|FG005|Main Study|Death|12|||
131521072|NCT03013491|473532556|FG006|Main Study|Death|3|||
131521073|NCT03013491|473532557|FG007|Main Study|Death|5|||
131521074|NCT03013491|473532558|FG008|Main Study|Death|1|||
131521075|NCT03013491|473532559|FG009|Main Study|Death|2|||
131521076|NCT03013491|473532560|FG010|Main Study|Death|4|||
131521077|NCT03013491|473532561|FG011|Main Study|Death|1|||
131521078|NCT03013491|473532562|FG012|Main Study|Death|1|||
131521079|NCT03013491|473532563|FG013|Main Study|Death|4|||
131521080|NCT03013491|473532564|FG014|Main Study|Death|0|||
131521081|NCT03013491|473532565|FG015|Main Study|Death|3|||
131521082|NCT03013491|473532566|FG016|Main Study|Death|5|||
131521083|NCT03013491|473532567|FG017|Main Study|Death|1|||
131521084|NCT03013491|473532568|FG018|Main Study|Death|47|||
131521085|NCT03013491|473532550|FG000|Main Study|Lost to Follow-up|0|||
131521086|NCT03013491|473532551|FG001|Main Study|Lost to Follow-up|0|||
131521087|NCT03013491|473532552|FG002|Main Study|Lost to Follow-up|1|||
131521088|NCT03013491|473532553|FG003|Main Study|Lost to Follow-up|0|||
131521089|NCT03013491|473532554|FG004|Main Study|Lost to Follow-up|1|||
131521090|NCT03013491|473532555|FG005|Main Study|Lost to Follow-up|0|||
131521091|NCT03013491|473532556|FG006|Main Study|Lost to Follow-up|0|||
131521092|NCT03013491|473532557|FG007|Main Study|Lost to Follow-up|0|||
131521093|NCT03013491|473532558|FG008|Main Study|Lost to Follow-up|0|||
131521094|NCT03013491|473532559|FG009|Main Study|Lost to Follow-up|0|||
131521095|NCT03013491|473532560|FG010|Main Study|Lost to Follow-up|0|||
131521096|NCT03013491|473532561|FG011|Main Study|Lost to Follow-up|0|||
131521097|NCT03013491|473532562|FG012|Main Study|Lost to Follow-up|0|||
131521098|NCT03013491|473532563|FG013|Main Study|Lost to Follow-up|0|||
131521099|NCT03013491|473532564|FG014|Main Study|Lost to Follow-up|0|||
131521100|NCT03013491|473532565|FG015|Main Study|Lost to Follow-up|0|||
131521101|NCT03013491|473532566|FG016|Main Study|Lost to Follow-up|0|||
131521102|NCT03013491|473532567|FG017|Main Study|Lost to Follow-up|0|||
131521103|NCT03013491|473532568|FG018|Main Study|Lost to Follow-up|3|||
131521104|NCT03013491|473532550|FG000|Main Study|Termination of the study by Sponsor|0|||
131521105|NCT03013491|473532551|FG001|Main Study|Termination of the study by Sponsor|0|||
131521106|NCT03013491|473532552|FG002|Main Study|Termination of the study by Sponsor|2|||
131521107|NCT03013491|473532553|FG003|Main Study|Termination of the study by Sponsor|0|||
131521108|NCT03013491|473532554|FG004|Main Study|Termination of the study by Sponsor|1|||
131521109|NCT03013491|473532555|FG005|Main Study|Termination of the study by Sponsor|2|||
131521110|NCT03013491|473532556|FG006|Main Study|Termination of the study by Sponsor|0|||
131521111|NCT03013491|473532557|FG007|Main Study|Termination of the study by Sponsor|0|||
131521112|NCT03013491|473532558|FG008|Main Study|Termination of the study by Sponsor|1|||
131521113|NCT03013491|473532559|FG009|Main Study|Termination of the study by Sponsor|1|||
131521114|NCT03013491|473532560|FG010|Main Study|Termination of the study by Sponsor|1|||
131521115|NCT03013491|473532561|FG011|Main Study|Termination of the study by Sponsor|2|||
131521116|NCT03013491|473532562|FG012|Main Study|Termination of the study by Sponsor|0|||
131521117|NCT03013491|473532563|FG013|Main Study|Termination of the study by Sponsor|0|||
131521118|NCT03013491|473532564|FG014|Main Study|Termination of the study by Sponsor|0|||
131521119|NCT03013491|473532565|FG015|Main Study|Termination of the study by Sponsor|0|||
131521120|NCT03013491|473532566|FG016|Main Study|Termination of the study by Sponsor|0|||
131521121|NCT03013491|473532567|FG017|Main Study|Termination of the study by Sponsor|1|||
131521122|NCT03013491|473532568|FG018|Main Study|Termination of the study by Sponsor|13|||
131521123|NCT03013491|473532550|FG000|Main Study|Withdrawal by Subject|0|||
131521124|NCT03013491|473532551|FG001|Main Study|Withdrawal by Subject|0|||
131521125|NCT03013491|473532552|FG002|Main Study|Withdrawal by Subject|0|||
131521126|NCT03013491|473532553|FG003|Main Study|Withdrawal by Subject|4|||
131521127|NCT03013491|473532554|FG004|Main Study|Withdrawal by Subject|2|||
131521128|NCT03013491|473532555|FG005|Main Study|Withdrawal by Subject|1|||
131521129|NCT03013491|473532556|FG006|Main Study|Withdrawal by Subject|0|||
131521130|NCT03013491|473532557|FG007|Main Study|Withdrawal by Subject|0|||
131521131|NCT03013491|473532558|FG008|Main Study|Withdrawal by Subject|0|||
131521132|NCT03013491|473532559|FG009|Main Study|Withdrawal by Subject|0|||
131521133|NCT03013491|473532560|FG010|Main Study|Withdrawal by Subject|1|||
131521134|NCT03013491|473532561|FG011|Main Study|Withdrawal by Subject|2|||
131521135|NCT03013491|473532562|FG012|Main Study|Withdrawal by Subject|0|||
131521136|NCT03013491|473532563|FG013|Main Study|Withdrawal by Subject|2|||
131521137|NCT03013491|473532564|FG014|Main Study|Withdrawal by Subject|0|||
131521138|NCT03013491|473532565|FG015|Main Study|Withdrawal by Subject|0|||
131521139|NCT03013491|473532566|FG016|Main Study|Withdrawal by Subject|0|||
131521140|NCT03013491|473532567|FG017|Main Study|Withdrawal by Subject|0|||
131521141|NCT03013491|473532568|FG018|Main Study|Withdrawal by Subject|18|||
131521142|NCT03013491|473532550|FG000|Main Study|Disease progression|0|||
131521143|NCT03013491|473532551|FG001|Main Study|Disease progression|0|||
131521144|NCT03013491|473532552|FG002|Main Study|Disease progression|0|||
131521145|NCT03013491|473532553|FG003|Main Study|Disease progression|1|||
131521146|NCT03013491|473532554|FG004|Main Study|Disease progression|0|||
131521147|NCT03013491|473532555|FG005|Main Study|Disease progression|0|||
131521148|NCT03013491|473532556|FG006|Main Study|Disease progression|0|||
131521149|NCT03013491|473532557|FG007|Main Study|Disease progression|0|||
131521150|NCT03013491|473532558|FG008|Main Study|Disease progression|1|||
131521151|NCT03013491|473532559|FG009|Main Study|Disease progression|0|||
131521152|NCT03013491|473532560|FG010|Main Study|Disease progression|1|||
131521153|NCT03013491|473532561|FG011|Main Study|Disease progression|0|||
131521154|NCT03013491|473532562|FG012|Main Study|Disease progression|0|||
131521155|NCT03013491|473532563|FG013|Main Study|Disease progression|0|||
131521156|NCT03013491|473532564|FG014|Main Study|Disease progression|0|||
131521157|NCT03013491|473532565|FG015|Main Study|Disease progression|0|||
131521158|NCT03013491|473532566|FG016|Main Study|Disease progression|0|||
131521159|NCT03013491|473532567|FG017|Main Study|Disease progression|0|||
131521160|NCT03013491|473532568|FG018|Main Study|Disease progression|4|||
131521161|NCT03013491|473532550|FG000|Main Study|Symptomatic deterioration|0|||
131521162|NCT03013491|473532551|FG001|Main Study|Symptomatic deterioration|0|||
131521163|NCT03013491|473532552|FG002|Main Study|Symptomatic deterioration|0|||
131521164|NCT03013491|473532553|FG003|Main Study|Symptomatic deterioration|0|||
131521165|NCT03013491|473532554|FG004|Main Study|Symptomatic deterioration|0|||
131521166|NCT03013491|473532555|FG005|Main Study|Symptomatic deterioration|1|||
131521167|NCT03013491|473532556|FG006|Main Study|Symptomatic deterioration|0|||
131521168|NCT03013491|473532557|FG007|Main Study|Symptomatic deterioration|0|||
131521169|NCT03013491|473532558|FG008|Main Study|Symptomatic deterioration|0|||
131521170|NCT03013491|473532559|FG009|Main Study|Symptomatic deterioration|0|||
131521171|NCT03013491|473532560|FG010|Main Study|Symptomatic deterioration|0|||
131521172|NCT03013491|473532561|FG011|Main Study|Symptomatic deterioration|0|||
131521173|NCT03013491|473532562|FG012|Main Study|Symptomatic deterioration|0|||
131521174|NCT03013491|473532563|FG013|Main Study|Symptomatic deterioration|0|||
131521175|NCT03013491|473532564|FG014|Main Study|Symptomatic deterioration|0|||
131521176|NCT03013491|473532565|FG015|Main Study|Symptomatic deterioration|0|||
131521177|NCT03013491|473532566|FG016|Main Study|Symptomatic deterioration|0|||
131521178|NCT03013491|473532567|FG017|Main Study|Symptomatic deterioration|0|||
131521179|NCT03013491|473532568|FG018|Main Study|Symptomatic deterioration|0|||
131521180|NCT03013491|473532550|FG000|Main Study|Protocol version 8.0 approval|0|||
131521181|NCT03013491|473532551|FG001|Main Study|Protocol version 8.0 approval|0|||
131521182|NCT03013491|473532552|FG002|Main Study|Protocol version 8.0 approval|0|||
131521183|NCT03013491|473532553|FG003|Main Study|Protocol version 8.0 approval|0|||
131521184|NCT03013491|473532554|FG004|Main Study|Protocol version 8.0 approval|0|||
131521185|NCT03013491|473532555|FG005|Main Study|Protocol version 8.0 approval|0|||
131521186|NCT03013491|473532556|FG006|Main Study|Protocol version 8.0 approval|0|||
131521187|NCT03013491|473532557|FG007|Main Study|Protocol version 8.0 approval|0|||
131521188|NCT03013491|473532558|FG008|Main Study|Protocol version 8.0 approval|0|||
131521189|NCT03013491|473532559|FG009|Main Study|Protocol version 8.0 approval|0|||
131521190|NCT03013491|473532560|FG010|Main Study|Protocol version 8.0 approval|1|||
131521191|NCT03013491|473532561|FG011|Main Study|Protocol version 8.0 approval|0|||
131521192|NCT03013491|473532562|FG012|Main Study|Protocol version 8.0 approval|0|||
131521193|NCT03013491|473532563|FG013|Main Study|Protocol version 8.0 approval|0|||
131521194|NCT03013491|473532564|FG014|Main Study|Protocol version 8.0 approval|0|||
131521195|NCT03013491|473532565|FG015|Main Study|Protocol version 8.0 approval|0|||
131521196|NCT03013491|473532566|FG016|Main Study|Protocol version 8.0 approval|0|||
131521197|NCT03013491|473532567|FG017|Main Study|Protocol version 8.0 approval|0|||
131521198|NCT03013491|473532568|FG018|Main Study|Protocol version 8.0 approval|0|||
131521199|NCT03013491|473532550|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
131521200|NCT03013491|473532551|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
131521201|NCT03013491|473532552|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
131521202|NCT03013491|473532553|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
131521203|NCT03013491|473532554|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
131658423|NCT01531673|474035310|FG011|Overall Study|Lost to Follow-up|0|||
131521204|NCT03013491|473532555|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
131521205|NCT03013491|473532556|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
131521206|NCT03013491|473532557|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
131521207|NCT03013491|473532558|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
131521208|NCT03013491|473532559|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
131521209|NCT03013491|473532560|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
131521210|NCT03013491|473532561|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
131521211|NCT03013491|473532562|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
131521212|NCT03013491|473532563|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
131521213|NCT03013491|473532564|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
131521214|NCT03013491|473532565|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
131521215|NCT03013491|473532566|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
131521216|NCT03013491|473532567|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
131521217|NCT03013491|473532568|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
131521218|NCT03013491|473532550|FG000|Main Study|Start of new anticancer therapy|0|||
131521219|NCT03013491|473532551|FG001|Main Study|Start of new anticancer therapy|0|||
131521220|NCT03013491|473532552|FG002|Main Study|Start of new anticancer therapy|0|||
131521221|NCT03013491|473532553|FG003|Main Study|Start of new anticancer therapy|0|||
131521222|NCT03013491|473532554|FG004|Main Study|Start of new anticancer therapy|0|||
131521223|NCT03013491|473532555|FG005|Main Study|Start of new anticancer therapy|0|||
131521224|NCT03013491|473532556|FG006|Main Study|Start of new anticancer therapy|0|||
131521225|NCT03013491|473532557|FG007|Main Study|Start of new anticancer therapy|0|||
131521226|NCT03013491|473532558|FG008|Main Study|Start of new anticancer therapy|0|||
131521227|NCT03013491|473532559|FG009|Main Study|Start of new anticancer therapy|0|||
131521228|NCT03013491|473532560|FG010|Main Study|Start of new anticancer therapy|0|||
131521229|NCT03013491|473532561|FG011|Main Study|Start of new anticancer therapy|0|||
131521230|NCT03013491|473532562|FG012|Main Study|Start of new anticancer therapy|0|||
131521231|NCT03013491|473532563|FG013|Main Study|Start of new anticancer therapy|0|||
131521232|NCT03013491|473532564|FG014|Main Study|Start of new anticancer therapy|0|||
131521233|NCT03013491|473532565|FG015|Main Study|Start of new anticancer therapy|0|||
131521234|NCT03013491|473532566|FG016|Main Study|Start of new anticancer therapy|0|||
131521235|NCT03013491|473532567|FG017|Main Study|Start of new anticancer therapy|0|||
131521236|NCT03013491|473532568|FG018|Main Study|Start of new anticancer therapy|2|||
131521237|NCT03013491|473532550|FG000|Long-term Extension|Disease progression|0|||
131521238|NCT03013491|473532551|FG001|Long-term Extension|Disease progression|0|||
131521239|NCT03013491|473532552|FG002|Long-term Extension|Disease progression|0|||
131521240|NCT03013491|473532553|FG003|Long-term Extension|Disease progression|1|||
131521241|NCT03013491|473532554|FG004|Long-term Extension|Disease progression|0|||
131521242|NCT03013491|473532555|FG005|Long-term Extension|Disease progression|0|||
131521243|NCT03013491|473532556|FG006|Long-term Extension|Disease progression|0|||
131521244|NCT03013491|473532557|FG007|Long-term Extension|Disease progression|0|||
131521245|NCT03013491|473532558|FG008|Long-term Extension|Disease progression|0|||
131521246|NCT03013491|473532559|FG009|Long-term Extension|Disease progression|0|||
131521247|NCT03013491|473532560|FG010|Long-term Extension|Disease progression|0|||
131521248|NCT03013491|473532561|FG011|Long-term Extension|Disease progression|0|||
131521249|NCT03013491|473532562|FG012|Long-term Extension|Disease progression|0|||
131521250|NCT03013491|473532563|FG013|Long-term Extension|Disease progression|0|||
131521251|NCT03013491|473532564|FG014|Long-term Extension|Disease progression|0|||
131521252|NCT03013491|473532565|FG015|Long-term Extension|Disease progression|0|||
131521253|NCT03013491|473532566|FG016|Long-term Extension|Disease progression|0|||
131521254|NCT03013491|473532567|FG017|Long-term Extension|Disease progression|0|||
131521255|NCT03013491|473532568|FG018|Long-term Extension|Disease progression|1|||
131521256|NCT03013491|473532550|FG000|Long-term Extension|Withdrawal by Subject|0|||
131521257|NCT03013491|473532551|FG001|Long-term Extension|Withdrawal by Subject|0|||
131521258|NCT03013491|473532552|FG002|Long-term Extension|Withdrawal by Subject|0|||
131521259|NCT03013491|473532553|FG003|Long-term Extension|Withdrawal by Subject|0|||
131521260|NCT03013491|473532554|FG004|Long-term Extension|Withdrawal by Subject|0|||
131521261|NCT03013491|473532555|FG005|Long-term Extension|Withdrawal by Subject|0|||
131521262|NCT03013491|473532556|FG006|Long-term Extension|Withdrawal by Subject|0|||
131521263|NCT03013491|473532557|FG007|Long-term Extension|Withdrawal by Subject|1|||
131521264|NCT03013491|473532558|FG008|Long-term Extension|Withdrawal by Subject|0|||
131521265|NCT03013491|473532559|FG009|Long-term Extension|Withdrawal by Subject|0|||
131521266|NCT03013491|473532560|FG010|Long-term Extension|Withdrawal by Subject|0|||
131521267|NCT03013491|473532561|FG011|Long-term Extension|Withdrawal by Subject|0|||
131521268|NCT03013491|473532562|FG012|Long-term Extension|Withdrawal by Subject|0|||
131521269|NCT03013491|473532563|FG013|Long-term Extension|Withdrawal by Subject|0|||
131521270|NCT03013491|473532564|FG014|Long-term Extension|Withdrawal by Subject|0|||
131521271|NCT03013491|473532565|FG015|Long-term Extension|Withdrawal by Subject|0|||
131521272|NCT03013491|473532566|FG016|Long-term Extension|Withdrawal by Subject|0|||
131521273|NCT03013491|473532567|FG017|Long-term Extension|Withdrawal by Subject|0|||
131521274|NCT03013491|473532568|FG018|Long-term Extension|Withdrawal by Subject|0|||
131521275|NCT03013491|473532550|FG000|Long-term Extension|Adverse Event|0|||
131521276|NCT03013491|473532551|FG001|Long-term Extension|Adverse Event|0|||
131521277|NCT03013491|473532552|FG002|Long-term Extension|Adverse Event|0|||
131521278|NCT03013491|473532553|FG003|Long-term Extension|Adverse Event|0|||
131521279|NCT03013491|473532554|FG004|Long-term Extension|Adverse Event|0|||
131521280|NCT03013491|473532555|FG005|Long-term Extension|Adverse Event|0|||
131521281|NCT03013491|473532556|FG006|Long-term Extension|Adverse Event|0|||
131521282|NCT03013491|473532557|FG007|Long-term Extension|Adverse Event|0|||
131521283|NCT03013491|473532558|FG008|Long-term Extension|Adverse Event|0|||
131521284|NCT03013491|473532559|FG009|Long-term Extension|Adverse Event|0|||
131521285|NCT03013491|473532560|FG010|Long-term Extension|Adverse Event|0|||
131521286|NCT03013491|473532561|FG011|Long-term Extension|Adverse Event|0|||
131521287|NCT03013491|473532562|FG012|Long-term Extension|Adverse Event|0|||
131521288|NCT03013491|473532563|FG013|Long-term Extension|Adverse Event|0|||
131521289|NCT03013491|473532564|FG014|Long-term Extension|Adverse Event|0|||
131521290|NCT03013491|473532565|FG015|Long-term Extension|Adverse Event|0|||
131521291|NCT03013491|473532566|FG016|Long-term Extension|Adverse Event|0|||
131521292|NCT03013491|473532567|FG017|Long-term Extension|Adverse Event|0|||
131521293|NCT03013491|473532568|FG018|Long-term Extension|Adverse Event|1|||
131521294|NCT03013491|473532550|FG000|Long-term Extension|Death|0|||
131521295|NCT03013491|473532551|FG001|Long-term Extension|Death|0|||
131521296|NCT03013491|473532552|FG002|Long-term Extension|Death|0|||
131521297|NCT03013491|473532553|FG003|Long-term Extension|Death|0|||
131521298|NCT03013491|473532554|FG004|Long-term Extension|Death|0|||
131521299|NCT03013491|473532555|FG005|Long-term Extension|Death|0|||
131521300|NCT03013491|473532556|FG006|Long-term Extension|Death|0|||
131521301|NCT03013491|473532557|FG007|Long-term Extension|Death|0|||
131521302|NCT03013491|473532558|FG008|Long-term Extension|Death|0|||
131521303|NCT03013491|473532559|FG009|Long-term Extension|Death|0|||
131521304|NCT03013491|473532560|FG010|Long-term Extension|Death|0|||
131521305|NCT03013491|473532561|FG011|Long-term Extension|Death|0|||
131521306|NCT03013491|473532562|FG012|Long-term Extension|Death|0|||
131521307|NCT03013491|473532563|FG013|Long-term Extension|Death|0|||
131521308|NCT03013491|473532564|FG014|Long-term Extension|Death|0|||
131521309|NCT03013491|473532565|FG015|Long-term Extension|Death|0|||
131521310|NCT03013491|473532566|FG016|Long-term Extension|Death|0|||
131521311|NCT03013491|473532567|FG017|Long-term Extension|Death|0|||
131521312|NCT03013491|473532568|FG018|Long-term Extension|Death|1|||
131521313|NCT01038778|473532574|FG000|Overall Study|Withdrawal by Subject|0|||
131521314|NCT01038778|473532575|FG001|Overall Study|Withdrawal by Subject|2|||
131521315|NCT01038778|473532576|FG002|Overall Study|Withdrawal by Subject|3|||
131521316|NCT04740034|473532577|FG000|Overall Study|Death|0|||
131521317|NCT04740034|473532578|FG001|Overall Study|Death|1|||
131521318|NCT04740034|473532579|FG002|Overall Study|Death|2|||
131521319|NCT04740034|473532580|FG003|Overall Study|Death|3|||
131521320|NCT04740034|473532581|FG004|Overall Study|Death|4|||
131521321|NCT04740034|473532582|FG005|Overall Study|Death|4|||
131521322|NCT04740034|473532583|FG006|Overall Study|Death|2|||
131521323|NCT04740034|473532584|FG007|Overall Study|Death|2|||
131521324|NCT04740034|473532585|FG008|Overall Study|Death|2|||
131521325|NCT04740034|473532586|FG009|Overall Study|Death|4|||
131521326|NCT04740034|473532587|FG010|Overall Study|Death|0|||
131521327|NCT04740034|473532577|FG000|Overall Study|Lost to Follow-up|0|||
131521328|NCT04740034|473532578|FG001|Overall Study|Lost to Follow-up|0|||
131521329|NCT04740034|473532579|FG002|Overall Study|Lost to Follow-up|0|||
131521330|NCT04740034|473532580|FG003|Overall Study|Lost to Follow-up|1|||
131521331|NCT04740034|473532581|FG004|Overall Study|Lost to Follow-up|2|||
131521332|NCT04740034|473532582|FG005|Overall Study|Lost to Follow-up|2|||
131521333|NCT04740034|473532583|FG006|Overall Study|Lost to Follow-up|0|||
131521334|NCT04740034|473532584|FG007|Overall Study|Lost to Follow-up|0|||
131521335|NCT04740034|473532585|FG008|Overall Study|Lost to Follow-up|0|||
131521336|NCT04740034|473532586|FG009|Overall Study|Lost to Follow-up|1|||
131521337|NCT04740034|473532587|FG010|Overall Study|Lost to Follow-up|0|||
131521338|NCT04740034|473532577|FG000|Overall Study|Withdrawal by Subject|1|||
131521339|NCT04740034|473532578|FG001|Overall Study|Withdrawal by Subject|0|||
131521340|NCT04740034|473532579|FG002|Overall Study|Withdrawal by Subject|0|||
131521341|NCT04740034|473532580|FG003|Overall Study|Withdrawal by Subject|0|||
131521342|NCT04740034|473532581|FG004|Overall Study|Withdrawal by Subject|0|||
131521343|NCT04740034|473532582|FG005|Overall Study|Withdrawal by Subject|0|||
131521344|NCT04740034|473532583|FG006|Overall Study|Withdrawal by Subject|0|||
131521345|NCT04740034|473532584|FG007|Overall Study|Withdrawal by Subject|1|||
131521346|NCT04740034|473532585|FG008|Overall Study|Withdrawal by Subject|0|||
131521347|NCT04740034|473532586|FG009|Overall Study|Withdrawal by Subject|1|||
131521348|NCT04740034|473532587|FG010|Overall Study|Withdrawal by Subject|0|||
131521349|NCT04740034|473532577|FG000|Overall Study|Decision by sponsor|0|||
131521350|NCT04740034|473532578|FG001|Overall Study|Decision by sponsor|0|||
131521351|NCT04740034|473532579|FG002|Overall Study|Decision by sponsor|1|||
131521352|NCT04740034|473532580|FG003|Overall Study|Decision by sponsor|0|||
131521353|NCT04740034|473532581|FG004|Overall Study|Decision by sponsor|0|||
131521354|NCT04740034|473532582|FG005|Overall Study|Decision by sponsor|0|||
131521355|NCT04740034|473532583|FG006|Overall Study|Decision by sponsor|1|||
131521356|NCT04740034|473532584|FG007|Overall Study|Decision by sponsor|2|||
131521357|NCT04740034|473532585|FG008|Overall Study|Decision by sponsor|1|||
131521358|NCT04740034|473532586|FG009|Overall Study|Decision by sponsor|1|||
131521359|NCT04740034|473532587|FG010|Overall Study|Decision by sponsor|2|||
131521360|NCT03285646|473534111|FG000|Overall Study|Adverse Event|1|||
131521361|NCT03285646|473534112|FG001|Overall Study|Adverse Event|0|||
131521362|NCT03285646|473534111|FG000|Overall Study|Withdrawal by Subject|10|||
131521363|NCT03285646|473534112|FG001|Overall Study|Withdrawal by Subject|2|||
131521364|NCT03285646|473534111|FG000|Overall Study|Lost to Follow-up|2|||
131521365|NCT03285646|473534112|FG001|Overall Study|Lost to Follow-up|1|||
131521366|NCT03285646|473534111|FG000|Overall Study|Investigator/Sponsor Decision|0|||
131521367|NCT03285646|473534112|FG001|Overall Study|Investigator/Sponsor Decision|1|||
131521368|NCT01344057|473534113|FG000|Overall Study|Premature Withdrawal|1|||
131521369|NCT00306592|473534114|FG000|Overall Study|Adverse Event|8|||
131521370|NCT00306592|473534115|FG001|Overall Study|Adverse Event|15|||
131521371|NCT00306592|473534114|FG000|Overall Study|Lost to Follow-up|1|||
131521372|NCT00306592|473534115|FG001|Overall Study|Lost to Follow-up|0|||
131521373|NCT00306592|473534114|FG000|Overall Study|Noncompliance|0|||
131521374|NCT00306592|473534115|FG001|Overall Study|Noncompliance|2|||
131521375|NCT00306592|473534114|FG000|Overall Study|Persistent Antibodies|6|||
131521376|NCT00306592|473534115|FG001|Overall Study|Persistent Antibodies|3|||
131521377|NCT00306592|473534114|FG000|Overall Study|Voluntary|10|||
131521378|NCT00306592|473534115|FG001|Overall Study|Voluntary|6|||
131521379|NCT00306592|473534114|FG000|Overall Study|Other|5|||
131521380|NCT00306592|473534115|FG001|Overall Study|Other|10|||
131521381|NCT00306592|473534114|FG000|Overall Study|Other|1|||
131521382|NCT00306592|473534115|FG001|Overall Study|Other|2|||
131521383|NCT00306592|473534114|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
131521384|NCT00306592|473534115|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
131521385|NCT02652624|473534116|FG000|Randomized Phase|Pregnancy|3|||
131521386|NCT02652624|473534117|FG001|Randomized Phase|Pregnancy|1|||
131521387|NCT02652624|473534116|FG000|Randomized Phase|Investigator's Discretion|0|||
131521388|NCT02652624|473534117|FG001|Randomized Phase|Investigator's Discretion|2|||
131521389|NCT02652624|473534116|FG000|Randomized Phase|Death|0|||
131521390|NCT02652624|473534117|FG001|Randomized Phase|Death|1|||
131521391|NCT02652624|473534116|FG000|Randomized Phase|Lost to Follow-up|0|||
131521392|NCT02652624|473534117|FG001|Randomized Phase|Lost to Follow-up|1|||
131521393|NCT02652624|473534116|FG000|Extension Phase|Lost to Follow-up|3|||
131521394|NCT02652624|473534117|FG001|Extension Phase|Lost to Follow-up|1|||
131521395|NCT02652624|473534116|FG000|Extension Phase|Pregnancy|1|||
131521396|NCT02652624|473534117|FG001|Extension Phase|Pregnancy|1|||
131521397|NCT02652624|473534116|FG000|Extension Phase|Adverse Event|0|||
131521398|NCT02652624|473534117|FG001|Extension Phase|Adverse Event|1|||
131521399|NCT02652624|473534116|FG000|Extension Phase|Withdrew Consent|0|||
131521400|NCT02652624|473534117|FG001|Extension Phase|Withdrew Consent|1|||
131521401|NCT01023659|473534118|FG000|Overall Study|Lost to Follow-up|73|||
131521402|NCT01023659|473534119|FG001|Overall Study|Lost to Follow-up|228|||
131521403|NCT01023659|473534120|FG002|Overall Study|Lost to Follow-up|99|||
131521404|NCT00912405|473534123|FG000|Overall Study|Lost to Follow-up|5|||
131521405|NCT00501540|473534124|FG000|Overall Study|Death|5|||
131521406|NCT00519649|473534125|FG000|Overall Study|Withdrawal by Subject|1|||
131521407|NCT04879745|473534126|FG000|Overall Study|Lost to Follow-up|4|||
131521408|NCT04879745|473534127|FG001|Overall Study|Lost to Follow-up|1|||
131521409|NCT03592641|473534130|FG000|Overall Study|Withdrawal by Subject|1|||
131521410|NCT00436280|473534131|FG000|Period 1: Induction|Adverse Event|8|||
131521411|NCT00436280|473534131|FG000|Period 1: Induction|Progressive Disease|12|||
131521412|NCT00436280|473534131|FG000|Period 1: Induction|Stable Disease|6|||
131521413|NCT00436280|473534131|FG000|Period 1: Induction|Withdrawal by Subject|1|||
131521414|NCT00436280|473534131|FG000|Period 1: Induction|Death|1|||
131521415|NCT00436280|473534131|FG000|Period 2: Consolidation|Adverse Event|1|||
131521416|NCT00436280|473534131|FG000|Period 2: Consolidation|Progressive Disease|10|||
131521417|NCT00436280|473534131|FG000|Period 2: Consolidation|Stable Disease|1|||
131521418|NCT00436280|473534131|FG000|Period 2: Consolidation|Physician Decision|2|||
131521419|NCT00436280|473534131|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
131521420|NCT00436280|473534131|FG000|Period 2: Consolidation|Death|1|||
131521421|NCT00436280|473534131|FG000|Period 3: Maintenance|Adverse Event|6|||
131521422|NCT00436280|473534131|FG000|Period 3: Maintenance|Progressive Disease|12|||
131521423|NCT02984995|473534134|FG000|Overall Study|Required stem cell transplant|13|||
131521424|NCT02984995|473534135|FG001|Overall Study|Required stem cell transplant|2|||
131521425|NCT02984995|473534134|FG000|Overall Study|Progressive disease|11|||
131521426|NCT02984995|473534135|FG001|Overall Study|Progressive disease|1|||
131521427|NCT02984995|473534134|FG000|Overall Study|Adverse Event|1|||
131521428|NCT02984995|473534135|FG001|Overall Study|Adverse Event|0|||
131521429|NCT01034397|473534136|FG000|Overall Study|Lack of compliance|0|||
131521430|NCT01034397|473534137|FG001|Overall Study|Lack of compliance|1|||
131521431|NCT01034397|473534136|FG000|Overall Study|Lack of Efficacy|3|||
131521432|NCT01034397|473534137|FG001|Overall Study|Lack of Efficacy|0|||
131521433|NCT01034397|473534136|FG000|Overall Study|Adverse Event|4|||
131521434|NCT01034397|473534137|FG001|Overall Study|Adverse Event|0|||
131521435|NCT01034397|473534136|FG000|Overall Study|Other|0|||
131521436|NCT01034397|473534137|FG001|Overall Study|Other|1|||
131521437|NCT03217136|473534140|FG000|Overall Study|Lost to Follow-up|2|||
131521438|NCT03217136|473534141|FG001|Overall Study|Lost to Follow-up|1|||
131521439|NCT03217136|473534140|FG000|Overall Study|Site Randomized Participant in Error|0|||
131521440|NCT03217136|473534141|FG001|Overall Study|Site Randomized Participant in Error|1|||
131521441|NCT03217136|473534140|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
131521442|NCT03217136|473534141|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
131521443|NCT03217136|473534140|FG000|Overall Study|Dispensing Error|1|||
131521444|NCT03217136|473534141|FG001|Overall Study|Dispensing Error|0|||
131521445|NCT03217136|473534140|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131521446|NCT03217136|473534141|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131521447|NCT03192150|473534142|FG000|Overall Study|Adverse Event|14|||
131521448|NCT03192150|473534143|FG001|Overall Study|Adverse Event|12|||
131521449|NCT03192150|473534142|FG000|Overall Study|Lack of Efficacy|23|||
131521450|NCT03192150|473534143|FG001|Overall Study|Lack of Efficacy|30|||
131521451|NCT03192150|473534142|FG000|Overall Study|Lost to Follow-up|1|||
131521452|NCT03192150|473534143|FG001|Overall Study|Lost to Follow-up|1|||
131521453|NCT03192150|473534142|FG000|Overall Study|Withdrawal by Subject|4|||
131521454|NCT03192150|473534143|FG001|Overall Study|Withdrawal by Subject|2|||
131521455|NCT03192150|473534142|FG000|Overall Study|Protocol Violation|5|||
131521456|NCT03192150|473534143|FG001|Overall Study|Protocol Violation|2|||
131521457|NCT03192150|473534142|FG000|Overall Study|Surgery Canceled|6|||
131521458|NCT03192150|473534143|FG001|Overall Study|Surgery Canceled|2|||
131521459|NCT03192150|473534142|FG000|Overall Study|Other-Various Administrative Reasons|2|||
131521460|NCT03192150|473534143|FG001|Overall Study|Other-Various Administrative Reasons|5|||
131521461|NCT02579616|473534144|FG000|Overall Study|Participants did not receive treatment|3|||
131521462|NCT01448850|473534145|FG000|Overall Study|Death|3|||
131521463|NCT01448850|473534146|FG001|Overall Study|Death|6|||
131521464|NCT01448850|473534145|FG000|Overall Study|Withdrawal by Subject|13|||
131521465|NCT01448850|473534146|FG001|Overall Study|Withdrawal by Subject|21|||
131521466|NCT01448850|473534145|FG000|Overall Study|Lost to Follow-up|3|||
131521467|NCT01448850|473534146|FG001|Overall Study|Lost to Follow-up|1|||
131521468|NCT01448850|473534145|FG000|Overall Study|Other|15|||
131521469|NCT01448850|473534146|FG001|Overall Study|Other|12|||
131521470|NCT00482391|473534147|FG000|Overall Study|Withdrawal by Subject|1|||
131521471|NCT00482391|473534147|FG000|Overall Study|Adverse Event|1|||
131521472|NCT00482391|473534147|FG000|Overall Study|Death|1|||
131521473|NCT02939404|473534148|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
131521474|NCT02939404|473534149|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
131521475|NCT02939404|473534148|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
131521476|NCT02939404|473534149|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
131521477|NCT04304001|473534154|FG000|Overall Study|Lost to Follow-up|13|||
131521478|NCT04304001|473534155|FG001|Overall Study|Lost to Follow-up|9|||
131521479|NCT06640829|473534165|FG000|Overall Study|Withdrawal by Subject|1|||
131521480|NCT06640829|473534165|FG000|Overall Study|Lost to Follow-up|1|||
131521481|NCT01350128|473534175|FG000|Overall Study|Withdrawal by Subject|3|||
131521482|NCT01350128|473534175|FG000|Overall Study|Protocol discontinuation criteria|8|||
131521483|NCT01350128|473534175|FG000|Overall Study|Physician Decision|1|||
131521484|NCT01350128|473534175|FG000|Overall Study|Lost to Follow-up|2|||
131521485|NCT00261716|473534177|FG000|Overall Study|Withdrawal by Subject|6|||
131521486|NCT00261716|473534178|FG001|Overall Study|Withdrawal by Subject|8|||
131521487|NCT00261716|473534177|FG000|Overall Study|Lost to Follow-up|0|||
131521488|NCT00261716|473534178|FG001|Overall Study|Lost to Follow-up|2|||
131521489|NCT01611259|473534179|FG000|Overall Study|Physician Decision|1|||
131521490|NCT01611259|473534179|FG000|Overall Study|Lack of Efficacy|2|||
131521491|NCT01611259|473534179|FG000|Overall Study|Adverse Event|4|||
131521492|NCT01611259|473534179|FG000|Overall Study|Withdrawal by Subject|7|||
131521493|NCT04936685|473534180|FG000|Overall Study|Protocol Violation|1|||
131521494|NCT04936685|473534181|FG001|Overall Study|Protocol Violation|0|||
131521495|NCT01147653|473534186|FG000|Year 2|Withdrawal by Subject|2|||
131521496|NCT01147653|473534187|FG001|Year 2|Withdrawal by Subject|3|||
131521497|NCT01109316|473534188|FG000|Study Period 1|Adverse Event|0|||
131521498|NCT01109316|473534189|FG001|Study Period 1|Adverse Event|0|||
131521499|NCT01109316|473534190|FG002|Study Period 1|Adverse Event|1|||
131521500|NCT01109316|473534191|FG003|Study Period 1|Adverse Event|0|||
131521501|NCT01109316|473534192|FG004|Study Period 1|Adverse Event|0|||
131521502|NCT01109316|473534193|FG005|Study Period 1|Adverse Event|0|||
131521503|NCT01109316|473534188|FG000|Study Period 1|Lost to Follow-up|0|||
131521504|NCT01109316|473534189|FG001|Study Period 1|Lost to Follow-up|0|||
131521505|NCT01109316|473534190|FG002|Study Period 1|Lost to Follow-up|1|||
131521506|NCT01109316|473534191|FG003|Study Period 1|Lost to Follow-up|1|||
131521507|NCT01109316|473534192|FG004|Study Period 1|Lost to Follow-up|0|||
131521508|NCT01109316|473534193|FG005|Study Period 1|Lost to Follow-up|0|||
131521509|NCT01109316|473534188|FG000|Study Period 1|Withdrawal by Subject|0|||
131521510|NCT01109316|473534189|FG001|Study Period 1|Withdrawal by Subject|0|||
131521511|NCT01109316|473534190|FG002|Study Period 1|Withdrawal by Subject|1|||
131521512|NCT01109316|473534191|FG003|Study Period 1|Withdrawal by Subject|0|||
131521513|NCT01109316|473534192|FG004|Study Period 1|Withdrawal by Subject|2|||
131521514|NCT01109316|473534193|FG005|Study Period 1|Withdrawal by Subject|0|||
131521515|NCT01109316|473534188|FG000|Study Period 1|Sponsor Decision|0|||
131521516|NCT01109316|473534189|FG001|Study Period 1|Sponsor Decision|0|||
131521517|NCT01109316|473534190|FG002|Study Period 1|Sponsor Decision|0|||
131521518|NCT01109316|473534191|FG003|Study Period 1|Sponsor Decision|0|||
131521519|NCT01109316|473534192|FG004|Study Period 1|Sponsor Decision|0|||
131521520|NCT01109316|473534193|FG005|Study Period 1|Sponsor Decision|2|||
131521521|NCT01109316|473534188|FG000|Study Period 2|Entry Criteria Not Met|0|||
131521522|NCT01109316|473534189|FG001|Study Period 2|Entry Criteria Not Met|1|||
131521523|NCT01109316|473534190|FG002|Study Period 2|Entry Criteria Not Met|0|||
131521524|NCT01109316|473534191|FG003|Study Period 2|Entry Criteria Not Met|0|||
131521525|NCT01109316|473534192|FG004|Study Period 2|Entry Criteria Not Met|0|||
131521526|NCT01109316|473534193|FG005|Study Period 2|Entry Criteria Not Met|0|||
131521527|NCT01109316|473534188|FG000|Study Period 2|Physician Decision|0|||
131521528|NCT01109316|473534189|FG001|Study Period 2|Physician Decision|0|||
131521529|NCT01109316|473534190|FG002|Study Period 2|Physician Decision|0|||
131521530|NCT01109316|473534191|FG003|Study Period 2|Physician Decision|1|||
131521531|NCT01109316|473534192|FG004|Study Period 2|Physician Decision|0|||
131521532|NCT01109316|473534193|FG005|Study Period 2|Physician Decision|0|||
131521533|NCT01109316|473534188|FG000|Study Period 2|Protocol Violation|1|||
131521534|NCT01109316|473534189|FG001|Study Period 2|Protocol Violation|0|||
131521535|NCT01109316|473534190|FG002|Study Period 2|Protocol Violation|0|||
131521536|NCT01109316|473534191|FG003|Study Period 2|Protocol Violation|0|||
131521537|NCT01109316|473534192|FG004|Study Period 2|Protocol Violation|0|||
131521538|NCT01109316|473534193|FG005|Study Period 2|Protocol Violation|0|||
131521539|NCT01109316|473534188|FG000|Study Period 2|Withdrawal by Subject|0|||
131521540|NCT01109316|473534189|FG001|Study Period 2|Withdrawal by Subject|0|||
131521541|NCT01109316|473534190|FG002|Study Period 2|Withdrawal by Subject|1|||
131521542|NCT01109316|473534191|FG003|Study Period 2|Withdrawal by Subject|0|||
131521543|NCT01109316|473534192|FG004|Study Period 2|Withdrawal by Subject|0|||
131521544|NCT01109316|473534193|FG005|Study Period 2|Withdrawal by Subject|1|||
131521545|NCT01109316|473534188|FG000|Study Period 3|Lost to Follow-up|0|||
131521546|NCT01109316|473534189|FG001|Study Period 3|Lost to Follow-up|0|||
131521547|NCT01109316|473534190|FG002|Study Period 3|Lost to Follow-up|0|||
131521548|NCT01109316|473534191|FG003|Study Period 3|Lost to Follow-up|0|||
131521549|NCT01109316|473534192|FG004|Study Period 3|Lost to Follow-up|1|||
131521550|NCT01109316|473534193|FG005|Study Period 3|Lost to Follow-up|0|||
131521551|NCT01109316|473534188|FG000|Study Period 3|Withdrawal by Subject|1|||
131521552|NCT01109316|473534189|FG001|Study Period 3|Withdrawal by Subject|0|||
131521553|NCT01109316|473534190|FG002|Study Period 3|Withdrawal by Subject|0|||
131521554|NCT01109316|473534191|FG003|Study Period 3|Withdrawal by Subject|0|||
131521555|NCT01109316|473534192|FG004|Study Period 3|Withdrawal by Subject|1|||
131521556|NCT01109316|473534193|FG005|Study Period 3|Withdrawal by Subject|0|||
131521557|NCT00094653|473534200|FG000|Overall Study|Death|306|||
131521558|NCT00094653|473534201|FG001|Overall Study|Death|100|||
131521559|NCT00094653|473534202|FG002|Overall Study|Death|119|||
131521560|NCT00094653|473534200|FG000|Overall Study|Subject Withdrew Consent|10|||
131521561|NCT00094653|473534201|FG001|Overall Study|Subject Withdrew Consent|2|||
131521562|NCT00094653|473534202|FG002|Overall Study|Subject Withdrew Consent|3|||
131521563|NCT00094653|473534200|FG000|Overall Study|Other|2|||
131521564|NCT00094653|473534201|FG001|Overall Study|Other|2|||
131521565|NCT00094653|473534202|FG002|Overall Study|Other|2|||
131521566|NCT00094653|473534200|FG000|Overall Study|Lost to Follow-up|3|||
131521567|NCT00094653|473534201|FG001|Overall Study|Lost to Follow-up|2|||
131521568|NCT00094653|473534202|FG002|Overall Study|Lost to Follow-up|1|||
131521569|NCT00094653|473534200|FG000|Overall Study|Protocol Violation|0|||
131521570|NCT00094653|473534201|FG001|Overall Study|Protocol Violation|0|||
131521571|NCT00094653|473534202|FG002|Overall Study|Protocol Violation|1|||
131521572|NCT03706690|473534205|FG000|Overall Study|Withdrawal by Subject|8|||
131521573|NCT03706690|473534206|FG001|Overall Study|Withdrawal by Subject|8|||
131521574|NCT03706690|473534205|FG000|Overall Study|Death|143|||
131521575|NCT03706690|473534206|FG001|Overall Study|Death|75|||
131521576|NCT03706690|473534205|FG000|Overall Study|Ongoing at DCO|121|||
131521577|NCT03706690|473534206|FG001|Overall Study|Ongoing at DCO|52|||
131521578|NCT02098109|473534207|FG000|Overall Study|Protocol Violation|3|||
131521579|NCT02098109|473534208|FG001|Overall Study|Protocol Violation|0|||
131521580|NCT01365273|473534209|FG000|Overall Study|Lost to Follow-up|1|||
131521581|NCT01365273|473534210|FG001|Overall Study|Lost to Follow-up|0|||
131521582|NCT01365273|473534209|FG000|Overall Study|Protocol Violation|0|||
131521583|NCT01365273|473534210|FG001|Overall Study|Protocol Violation|1|||
131521584|NCT01365273|473534209|FG000|Overall Study|Physician Decision|1|||
131521585|NCT01365273|473534210|FG001|Overall Study|Physician Decision|0|||
131521586|NCT00854581|473534213|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
131521587|NCT00854581|473534213|FG000|Induction (Up to Day 21)|Death|1|||
131521588|NCT00854581|473534213|FG000|Induction (Up to Day 21)|Physician Decision|1|||
131521589|NCT00854581|473534213|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
131521590|NCT04847674|473534214|FG000|Overall Study|Withdrawal by Subject|0|||
131521591|NCT04847674|473534215|FG001|Overall Study|Withdrawal by Subject|1|||
131521592|NCT04847674|473534216|FG002|Overall Study|Withdrawal by Subject|0|||
131521593|NCT04847674|473534214|FG000|Overall Study|Lost to Follow-up|0|||
131521594|NCT04847674|473534215|FG001|Overall Study|Lost to Follow-up|0|||
131521595|NCT04847674|473534216|FG002|Overall Study|Lost to Follow-up|2|||
131521596|NCT04847674|473534214|FG000|Overall Study|Other than specified|21|||
131521597|NCT04847674|473534215|FG001|Overall Study|Other than specified|20|||
131521598|NCT04847674|473534216|FG002|Overall Study|Other than specified|20|||
131521599|NCT02563028|473534218|FG000|Overall Study|Lack of equipment|1|||
131521600|NCT02563028|473534218|FG000|Overall Study|Unable to elicit VEP post induction|1|||
131521601|NCT03254134|473534219|FG000|Overall Study|Not eligible patients|599|||
131521602|NCT03254134|473534220|FG001|Overall Study|Not eligible patients|3630|||
131521603|NCT03337724|473534225|FG000|Overall Study|Reason not Specified|12|||
131521604|NCT03337724|473534226|FG001|Overall Study|Reason not Specified|21|||
131521605|NCT03337724|473534227|FG002|Overall Study|Reason not Specified|9|||
131521606|NCT03337724|473534228|FG003|Overall Study|Reason not Specified|9|||
131521607|NCT03337724|473534229|FG004|Overall Study|Reason not Specified|29|||
131521608|NCT03337724|473534225|FG000|Overall Study|Withdrawal by Subject|13|||
131521609|NCT03337724|473534226|FG001|Overall Study|Withdrawal by Subject|15|||
131521610|NCT03337724|473534227|FG002|Overall Study|Withdrawal by Subject|4|||
131521611|NCT03337724|473534228|FG003|Overall Study|Withdrawal by Subject|15|||
131521612|NCT03337724|473534229|FG004|Overall Study|Withdrawal by Subject|6|||
131521613|NCT03337724|473534225|FG000|Overall Study|Protocol Deviation|0|||
131521614|NCT03337724|473534226|FG001|Overall Study|Protocol Deviation|1|||
131521615|NCT03337724|473534227|FG002|Overall Study|Protocol Deviation|1|||
131521616|NCT03337724|473534228|FG003|Overall Study|Protocol Deviation|1|||
131521617|NCT03337724|473534229|FG004|Overall Study|Protocol Deviation|0|||
131521618|NCT03337724|473534225|FG000|Overall Study|Adverse Event|1|||
131521619|NCT03337724|473534226|FG001|Overall Study|Adverse Event|1|||
131521620|NCT03337724|473534227|FG002|Overall Study|Adverse Event|0|||
131521621|NCT03337724|473534228|FG003|Overall Study|Adverse Event|1|||
131521622|NCT03337724|473534229|FG004|Overall Study|Adverse Event|0|||
131521623|NCT03337724|473534225|FG000|Overall Study|Death|40|||
131521624|NCT03337724|473534226|FG001|Overall Study|Death|89|||
131521625|NCT03337724|473534227|FG002|Overall Study|Death|43|||
131521626|NCT03337724|473534228|FG003|Overall Study|Death|76|||
131521627|NCT03337724|473534229|FG004|Overall Study|Death|50|||
131521628|NCT03337724|473534225|FG000|Overall Study|Lost to Follow-up|5|||
131521629|NCT03337724|473534226|FG001|Overall Study|Lost to Follow-up|5|||
131521630|NCT03337724|473534227|FG002|Overall Study|Lost to Follow-up|4|||
131521631|NCT03337724|473534228|FG003|Overall Study|Lost to Follow-up|7|||
131521632|NCT03337724|473534229|FG004|Overall Study|Lost to Follow-up|4|||
131521633|NCT03337724|473534225|FG000|Overall Study|Physician Decision|16|||
131521634|NCT03337724|473534226|FG001|Overall Study|Physician Decision|34|||
131521635|NCT03337724|473534227|FG002|Overall Study|Physician Decision|14|||
131521636|NCT03337724|473534228|FG003|Overall Study|Physician Decision|34|||
131521637|NCT03337724|473534229|FG004|Overall Study|Physician Decision|13|||
131521638|NCT03337724|473534225|FG000|Overall Study|Progressive Disease|0|||
131521639|NCT03337724|473534226|FG001|Overall Study|Progressive Disease|2|||
131521640|NCT03337724|473534227|FG002|Overall Study|Progressive Disease|1|||
131521641|NCT03337724|473534228|FG003|Overall Study|Progressive Disease|2|||
131521642|NCT03337724|473534229|FG004|Overall Study|Progressive Disease|0|||
131521643|NCT03337724|473534225|FG000|Overall Study|Symptomatic Deterioration|0|||
131521644|NCT03337724|473534226|FG001|Overall Study|Symptomatic Deterioration|0|||
131521645|NCT03337724|473534227|FG002|Overall Study|Symptomatic Deterioration|0|||
131521646|NCT03337724|473534228|FG003|Overall Study|Symptomatic Deterioration|1|||
131521647|NCT03337724|473534229|FG004|Overall Study|Symptomatic Deterioration|0|||
131521648|NCT03551210|473534231|FG000|Overall Study|Adverse Event|5|||
131521649|NCT03551210|473534232|FG001|Overall Study|Adverse Event|6|||
131521650|NCT03551210|473534231|FG000|Overall Study|Withdrawal by Subject|1|||
131521651|NCT03551210|473534232|FG001|Overall Study|Withdrawal by Subject|7|||
131521652|NCT03551210|473534231|FG000|Overall Study|Needed in other antibiotic treatment|2|||
131521653|NCT03551210|473534232|FG001|Overall Study|Needed in other antibiotic treatment|5|||
131521654|NCT03551210|473534231|FG000|Overall Study|Lost to Follow-up|1|||
131521655|NCT03551210|473534232|FG001|Overall Study|Lost to Follow-up|1|||
131521656|NCT03551210|473534231|FG000|Overall Study|Absence of visit 4 and 5|1|||
131521657|NCT03551210|473534232|FG001|Overall Study|Absence of visit 4 and 5|0|||
131521658|NCT03551210|473534231|FG000|Overall Study|No drug for dispensing|0|||
131521659|NCT03551210|473534232|FG001|Overall Study|No drug for dispensing|1|||
131521660|NCT03265119|473534233|FG000|Overall Study|Adverse Event|2|||
131521661|NCT03265119|473534234|FG001|Overall Study|Adverse Event|1|||
131521662|NCT03265119|473534233|FG000|Overall Study|Lack of Efficacy|3|||
131521663|NCT03265119|473534234|FG001|Overall Study|Lack of Efficacy|0|||
131521664|NCT03265119|473534233|FG000|Overall Study|Protocol Violation|1|||
131521665|NCT03265119|473534234|FG001|Overall Study|Protocol Violation|2|||
131521666|NCT03265119|473534233|FG000|Overall Study|Withdrawal by Subject|2|||
131521667|NCT03265119|473534234|FG001|Overall Study|Withdrawal by Subject|4|||
131521668|NCT03265119|473534233|FG000|Overall Study|Lost to Follow-up|1|||
131521669|NCT03265119|473534234|FG001|Overall Study|Lost to Follow-up|0|||
131521670|NCT03265119|473534233|FG000|Overall Study|Lack of Compliance|1|||
131521671|NCT03265119|473534234|FG001|Overall Study|Lack of Compliance|0|||
131521672|NCT04524403|473535517|FG000|Overall Study|Withdrawal by Subject|10|||
131521673|NCT04524403|473535518|FG001|Overall Study|Withdrawal by Subject|3|||
131521674|NCT04524403|473535519|FG002|Overall Study|Withdrawal by Subject|8|||
131521675|NCT04524403|473535517|FG000|Overall Study|Lost to Follow-up|3|||
131521676|NCT04524403|473535518|FG001|Overall Study|Lost to Follow-up|4|||
131521677|NCT04524403|473535519|FG002|Overall Study|Lost to Follow-up|3|||
131521678|NCT04524403|473535517|FG000|Overall Study|Adverse Event|3|||
131521679|NCT04524403|473535518|FG001|Overall Study|Adverse Event|1|||
131521680|NCT04524403|473535519|FG002|Overall Study|Adverse Event|4|||
131521681|NCT04524403|473535517|FG000|Overall Study|Non-compliant with study drug|1|||
131521682|NCT04524403|473535518|FG001|Overall Study|Non-compliant with study drug|2|||
131521683|NCT04524403|473535519|FG002|Overall Study|Non-compliant with study drug|3|||
131521684|NCT04524403|473535517|FG000|Overall Study|Moved|0|||
131521685|NCT04524403|473535518|FG001|Overall Study|Moved|1|||
131521686|NCT04524403|473535519|FG002|Overall Study|Moved|0|||
131521687|NCT02383758|473535522|FG000|Overall Study|Withdrawal by Subject|0|||
131521688|NCT02383758|473535523|FG001|Overall Study|Withdrawal by Subject|2|||
131521689|NCT03085927|473535524|FG000|Overall Study|Withdrawal by Subject|1|||
131521690|NCT03085927|473535525|FG001|Overall Study|Withdrawal by Subject|4|||
131521691|NCT03085927|473535524|FG000|Overall Study|Lost to Follow-up|3|||
131521692|NCT03085927|473535525|FG001|Overall Study|Lost to Follow-up|1|||
131521693|NCT03085927|473535524|FG000|Overall Study|Death|1|||
131521694|NCT03085927|473535525|FG001|Overall Study|Death|0|||
131521695|NCT03085927|473535524|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
131521696|NCT03085927|473535525|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
131521697|NCT03085927|473535524|FG000|Overall Study|Dyad Became Ineligible|0|||
131521698|NCT03085927|473535525|FG001|Overall Study|Dyad Became Ineligible|1|||
131521699|NCT02349711|473535527|FG000|Overall Study|Withdrawal by Subject|2|||
131521700|NCT02349711|473535528|FG001|Overall Study|Withdrawal by Subject|1|||
131521701|NCT02349711|473535527|FG000|Overall Study|Lost to Follow-up|1|||
131521702|NCT02349711|473535528|FG001|Overall Study|Lost to Follow-up|1|||
131521703|NCT00194012|473535529|FG000|Randomized Phase|Lack of Efficacy|8|||
131521704|NCT00194012|473535530|FG001|Randomized Phase|Lack of Efficacy|18|||
131521705|NCT00194012|473535529|FG000|Randomized Phase|Study nonadherence|2|||
131521706|NCT00194012|473535530|FG001|Randomized Phase|Study nonadherence|1|||
131521707|NCT00194012|473535529|FG000|Randomized Phase|Withdrawal by Subject|3|||
131521708|NCT00194012|473535530|FG001|Randomized Phase|Withdrawal by Subject|3|||
131521709|NCT00194012|473535529|FG000|Randomized Phase|Adverse Event|2|||
131521710|NCT00194012|473535530|FG001|Randomized Phase|Adverse Event|1|||
131521711|NCT00194012|473535529|FG000|Randomized Phase|Participant reported having a rash|1|||
131521712|NCT00194012|473535530|FG001|Randomized Phase|Participant reported having a rash|0|||
131521713|NCT00194012|473535529|FG000|Randomized Phase|Emesis and enuresis|0|||
131521714|NCT00194012|473535530|FG001|Randomized Phase|Emesis and enuresis|1|||
131521715|NCT00194012|473535529|FG000|Randomized Phase|Oral/nasal twitching|0|||
131521716|NCT00194012|473535530|FG001|Randomized Phase|Oral/nasal twitching|1|||
131521717|NCT00194012|473535529|FG000|Open Label Extension (OLE)|Weight Gain|1|||
131521718|NCT00194012|473535530|FG001|Open Label Extension (OLE)|Weight Gain|0|||
131521719|NCT00194012|473535529|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
131521720|NCT00194012|473535530|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
131521721|NCT00194012|473535529|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
131521722|NCT00194012|473535530|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
131521723|NCT00194012|473535529|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
131521724|NCT00194012|473535530|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
131521725|NCT01513317|473535536|FG000|Overall Study|Withdrawal by Subject|15|||
131521726|NCT01513317|473535537|FG001|Overall Study|Withdrawal by Subject|4|||
131521727|NCT01513317|473535536|FG000|Overall Study|Death|1|||
131521728|NCT01513317|473535537|FG001|Overall Study|Death|1|||
131521729|NCT01513317|473535536|FG000|Overall Study|Study terminated by sponsor|18|||
131521730|NCT01513317|473535537|FG001|Overall Study|Study terminated by sponsor|18|||
131521731|NCT01513317|473535536|FG000|Overall Study|Other|0|||
131521732|NCT01513317|473535537|FG001|Overall Study|Other|1|||
131521733|NCT02564198|473535538|FG000|Overall Study|Withdrawal by Subject|2|||
131521734|NCT02564198|473535539|FG001|Overall Study|Withdrawal by Subject|4|||
131521735|NCT02564198|473535540|FG002|Overall Study|Withdrawal by Subject|0|||
131521736|NCT02564198|473535538|FG000|Overall Study|Adverse Event|0|||
131521737|NCT02564198|473535539|FG001|Overall Study|Adverse Event|1|||
131521738|NCT02564198|473535540|FG002|Overall Study|Adverse Event|0|||
131521739|NCT02200042|473535541|FG000|Overall Study|Withdrawal by Subject|0|||
131521740|NCT02200042|473535542|FG001|Overall Study|Withdrawal by Subject|1|||
131521741|NCT02097134|473535543|FG000|Overall Study|Physician Decision|4|||
131521742|NCT02097134|473535543|FG000|Overall Study|Non-Protocol Therapy|1|||
131521743|NCT02097134|473535543|FG000|Overall Study|Progressive Disease|3|||
131521744|NCT02097134|473535543|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
131521745|NCT00298896|473535551|FG000|Overall Study|Death|3|||
131521746|NCT00298896|473535551|FG000|Overall Study|Physician Decision|2|||
131521747|NCT00298896|473535551|FG000|Overall Study|Intercurrent Illness|1|||
131521748|NCT00298896|473535551|FG000|Overall Study|Disease Progression|41|||
131521749|NCT00298896|473535551|FG000|Overall Study|Withdrawal by Subject|2|||
131521750|NCT00298896|473535551|FG000|Overall Study|Assigned to treatment in error|1|||
131521751|NCT02649972|473535554|FG000|Overall Study|Not treated|1|||
131521752|NCT03394391|473535557|FG000|Overall Study|Lost to Follow-up|1|||
131521753|NCT03394391|473535558|FG001|Overall Study|Lost to Follow-up|2|||
131521754|NCT01434823|473535559|FG000|Overall Study|Incomplete data in medical record|4|||
131521755|NCT01434823|473535560|FG001|Overall Study|Incomplete data in medical record|7|||
131521756|NCT01797536|473535561|FG000|Overall Study|Adverse Event|0|||
131521757|NCT01797536|473535562|FG001|Overall Study|Adverse Event|1|||
131521758|NCT01797536|473535563|FG002|Overall Study|Adverse Event|0|||
131521759|NCT01797536|473535564|FG003|Overall Study|Adverse Event|0|||
131521760|NCT00120042|473535565|FG000|Overall Study|all completed protocl|0|||
131521761|NCT00120042|473535566|FG001|Overall Study|all completed protocl|0|||
131521762|NCT00120042|473535567|FG002|Overall Study|all completed protocl|0|||
131521763|NCT01263873|473535570|FG000|Overall Study|One provider unable to complete numbers|1|||
131521764|NCT01263873|473535571|FG001|Overall Study|One provider unable to complete numbers|1|||
131521765|NCT00047463|473535572|FG000|Overall Study|Withdrawal by Subject|0|||
131521766|NCT00047463|473535573|FG001|Overall Study|Withdrawal by Subject|3|||
131521767|NCT01401530|473535575|FG000|Overall Study|Disease Progression|1|||
131521768|NCT01401530|473535576|FG001|Overall Study|Disease Progression|2|||
131521769|NCT01401530|473535577|FG002|Overall Study|Disease Progression|1|||
131521770|NCT01401530|473535575|FG000|Overall Study|Adverse Event|1|||
131521771|NCT01401530|473535576|FG001|Overall Study|Adverse Event|1|||
131521772|NCT01401530|473535577|FG002|Overall Study|Adverse Event|1|||
131521773|NCT01401530|473535575|FG000|Overall Study|Participant Choice|1|||
131521774|NCT01401530|473535576|FG001|Overall Study|Participant Choice|2|||
131521775|NCT01401530|473535577|FG002|Overall Study|Participant Choice|1|||
131521776|NCT01401530|473535575|FG000|Overall Study|Physician Decision|0|||
131521777|NCT01401530|473535576|FG001|Overall Study|Physician Decision|1|||
131521778|NCT01401530|473535577|FG002|Overall Study|Physician Decision|0|||
131521779|NCT01252290|473535584|FG000|Overall Study|Withdrawal by Subject|1|||
131521780|NCT02075437|473535588|FG000|Overall Study|Withdrawal by Subject|5|||
131521781|NCT02075437|473535588|FG000|Overall Study|Lost to Follow-up|1|||
131521782|NCT04439240|473535589|FG000|Overall Study|Ineligible|2|||
131521783|NCT04439240|473535589|FG000|Overall Study|Never started treatment|2|||
131521784|NCT04439240|473535589|FG000|Overall Study|Adverse Event|12|||
131521785|NCT04439240|473535589|FG000|Overall Study|Death|2|||
131521786|NCT04439240|473535589|FG000|Overall Study|Disease progression|25|||
131521787|NCT04439240|473535589|FG000|Overall Study|Other diseases|2|||
131521788|NCT04439240|473535589|FG000|Overall Study|Withdrawal by Subject|3|||
131521789|NCT04439240|473535589|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
131521790|NCT04439240|473535589|FG000|Overall Study|Symptomatic decline|1|||
131521791|NCT04439240|473535589|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
131521792|NCT04439240|473535589|FG000|Overall Study|Clinical progression|1|||
131521793|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Adverse Event|41|||
131521794|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Adverse Event|24|||
131521795|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
131521796|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
131521797|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
131521798|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
131521799|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Physician Decision|0|||
131521800|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Physician Decision|6|||
131521801|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
131521802|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
131521803|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
131521804|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
131521805|NCT00673452|473535590|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
131521806|NCT00673452|473535591|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
131521807|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
131521808|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
131521809|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
131521810|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
131521811|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
131521812|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
131521813|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
131521814|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
131521815|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
131521816|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
131521817|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
131521818|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
131521819|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
131521820|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
131521821|NCT00673452|473535590|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
131521822|NCT00673452|473535591|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
131521823|NCT00813124|473535592|FG000|Overall Study|Death|2|||
131521824|NCT00813124|473535592|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
131521825|NCT00813124|473535592|FG000|Overall Study|Withdrawal by Subject|1|||
131521826|NCT00079274|473535597|FG000|Overall Study|Withdrawal by Subject|111|||
131521827|NCT00079274|473535598|FG001|Overall Study|Withdrawal by Subject|10|||
131521828|NCT00079274|473535599|FG002|Overall Study|Withdrawal by Subject|12|||
131521829|NCT00079274|473535600|FG003|Overall Study|Withdrawal by Subject|163|||
131521830|NCT00079274|473535601|FG004|Overall Study|Withdrawal by Subject|7|||
131521831|NCT00079274|473535602|FG005|Overall Study|Withdrawal by Subject|8|||
131521832|NCT00079274|473535603|FG006|Overall Study|Withdrawal by Subject|0|||
131521833|NCT00079274|473535597|FG000|Overall Study|Adverse Event|130|||
131521834|NCT00079274|473535598|FG001|Overall Study|Adverse Event|8|||
131521835|NCT00079274|473535599|FG002|Overall Study|Adverse Event|8|||
131521836|NCT00079274|473535600|FG003|Overall Study|Adverse Event|184|||
131521837|NCT00079274|473535601|FG004|Overall Study|Adverse Event|7|||
131521838|NCT00079274|473535602|FG005|Overall Study|Adverse Event|8|||
131521839|NCT00079274|473535603|FG006|Overall Study|Adverse Event|0|||
131521840|NCT00079274|473535597|FG000|Overall Study|Recurrence|21|||
131521841|NCT00079274|473535598|FG001|Overall Study|Recurrence|0|||
131521842|NCT00079274|473535599|FG002|Overall Study|Recurrence|1|||
131521843|NCT00079274|473535600|FG003|Overall Study|Recurrence|15|||
131521844|NCT00079274|473535601|FG004|Overall Study|Recurrence|0|||
131521845|NCT00079274|473535602|FG005|Overall Study|Recurrence|2|||
131521846|NCT00079274|473535603|FG006|Overall Study|Recurrence|0|||
131521847|NCT00079274|473535597|FG000|Overall Study|Alternate Treatment|6|||
131521848|NCT00079274|473535598|FG001|Overall Study|Alternate Treatment|1|||
131521849|NCT00079274|473535599|FG002|Overall Study|Alternate Treatment|0|||
131521850|NCT00079274|473535600|FG003|Overall Study|Alternate Treatment|3|||
131521851|NCT00079274|473535601|FG004|Overall Study|Alternate Treatment|0|||
131521852|NCT00079274|473535602|FG005|Overall Study|Alternate Treatment|0|||
131521853|NCT00079274|473535603|FG006|Overall Study|Alternate Treatment|0|||
131521854|NCT00079274|473535597|FG000|Overall Study|Other Medical Problems|6|||
131521855|NCT00079274|473535598|FG001|Overall Study|Other Medical Problems|1|||
131521856|NCT00079274|473535599|FG002|Overall Study|Other Medical Problems|0|||
131521857|NCT00079274|473535600|FG003|Overall Study|Other Medical Problems|7|||
131521858|NCT00079274|473535601|FG004|Overall Study|Other Medical Problems|0|||
131521859|NCT00079274|473535602|FG005|Overall Study|Other Medical Problems|0|||
131521860|NCT00079274|473535603|FG006|Overall Study|Other Medical Problems|0|||
131521861|NCT00079274|473535597|FG000|Overall Study|Death|4|||
131521862|NCT00079274|473535598|FG001|Overall Study|Death|0|||
131521863|NCT00079274|473535599|FG002|Overall Study|Death|1|||
131521864|NCT00079274|473535600|FG003|Overall Study|Death|15|||
131521865|NCT00079274|473535601|FG004|Overall Study|Death|0|||
131521866|NCT00079274|473535602|FG005|Overall Study|Death|0|||
131521867|NCT00079274|473535603|FG006|Overall Study|Death|0|||
131521868|NCT00079274|473535597|FG000|Overall Study|Cytogenetic resistance|0|||
131521869|NCT00079274|473535598|FG001|Overall Study|Cytogenetic resistance|0|||
131521870|NCT00079274|473535599|FG002|Overall Study|Cytogenetic resistance|0|||
131521871|NCT00079274|473535600|FG003|Overall Study|Cytogenetic resistance|2|||
131521872|NCT00079274|473535601|FG004|Overall Study|Cytogenetic resistance|0|||
131521873|NCT00079274|473535602|FG005|Overall Study|Cytogenetic resistance|0|||
131521874|NCT00079274|473535603|FG006|Overall Study|Cytogenetic resistance|0|||
131521875|NCT00079274|473535597|FG000|Overall Study|Other|43|||
131521876|NCT00079274|473535598|FG001|Overall Study|Other|7|||
131521877|NCT00079274|473535599|FG002|Overall Study|Other|5|||
131521878|NCT00079274|473535600|FG003|Overall Study|Other|55|||
131521879|NCT00079274|473535601|FG004|Overall Study|Other|1|||
131521880|NCT00079274|473535602|FG005|Overall Study|Other|2|||
131521881|NCT00079274|473535603|FG006|Overall Study|Other|0|||
131521882|NCT02075320|473535604|FG000|Overall Study|Withdrawal by Subject|2|||
131521883|NCT03773757|473535606|FG000|Overall Study|Withdrawal by Subject|2|||
131521884|NCT03773757|473535607|FG001|Overall Study|Withdrawal by Subject|4|||
131521885|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
131521886|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
131521887|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
131521888|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
131521889|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
131521890|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
131521891|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
131521892|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
131521893|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
131521894|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
131521895|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
131521896|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
131521897|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
131521898|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
131521899|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
131521900|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
131521901|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
131521902|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
131521903|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
131521904|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
131521905|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
131521906|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
131521907|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
131521908|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
131521909|NCT04542070|473535608|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
131521910|NCT04542070|473535609|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
131521911|NCT04542070|473535610|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
131521912|NCT04542070|473535611|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
131521913|NCT04542070|473535608|FG000|Maintenance + Extension Period|Adverse Event|10|||
131521914|NCT04542070|473535609|FG001|Maintenance + Extension Period|Adverse Event|2|||
131521915|NCT04542070|473535610|FG002|Maintenance + Extension Period|Adverse Event|0|||
131521916|NCT04542070|473535611|FG003|Maintenance + Extension Period|Adverse Event|0|||
131521917|NCT04542070|473535608|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
131521918|NCT04542070|473535609|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
131521919|NCT04542070|473535610|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
131521920|NCT04542070|473535611|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
131521921|NCT04542070|473535608|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
131521922|NCT04542070|473535609|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
131521923|NCT04542070|473535610|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
131521924|NCT04542070|473535611|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
131521925|NCT04542070|473535608|FG000|Maintenance + Extension Period|Physician Decision|1|||
131521926|NCT04542070|473535609|FG001|Maintenance + Extension Period|Physician Decision|1|||
131521927|NCT04542070|473535610|FG002|Maintenance + Extension Period|Physician Decision|0|||
131521928|NCT04542070|473535611|FG003|Maintenance + Extension Period|Physician Decision|0|||
131521929|NCT04542070|473535608|FG000|Maintenance + Extension Period|Protocol Violation|2|||
131521930|NCT04542070|473535609|FG001|Maintenance + Extension Period|Protocol Violation|5|||
131521931|NCT04542070|473535610|FG002|Maintenance + Extension Period|Protocol Violation|0|||
131521932|NCT04542070|473535611|FG003|Maintenance + Extension Period|Protocol Violation|0|||
131521933|NCT04542070|473535608|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
131521934|NCT04542070|473535609|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
131521935|NCT04542070|473535610|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
131521936|NCT04542070|473535611|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
131521937|NCT04542070|473535608|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
131521938|NCT04542070|473535609|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
131521939|NCT04542070|473535610|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
131521940|NCT04542070|473535611|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
131521941|NCT04542070|473535608|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
131521942|NCT04542070|473535609|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
131521943|NCT04542070|473535610|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
131521944|NCT04542070|473535611|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
131521945|NCT04542070|473535608|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
131521946|NCT04542070|473535609|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
131521947|NCT04542070|473535610|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
131521948|NCT04542070|473535611|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
131521949|NCT04542070|473535608|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
131521950|NCT04542070|473535609|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
131521951|NCT04542070|473535610|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
131521952|NCT04542070|473535611|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
131521953|NCT04542070|473535608|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
131521954|NCT04542070|473535609|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
131521955|NCT04542070|473535610|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
131521956|NCT04542070|473535611|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
131521957|NCT04542070|473535608|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
131521958|NCT04542070|473535609|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
131521959|NCT04542070|473535610|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
131521960|NCT04542070|473535611|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
131521961|NCT03049813|473535613|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
131521962|NCT03049813|473535614|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
131521963|NCT03049813|473535615|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
131521964|NCT03049813|473535616|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
131521965|NCT03049813|473535613|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
131521966|NCT03049813|473535614|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
131521967|NCT03049813|473535615|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
131521968|NCT03049813|473535616|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
131521969|NCT03049813|473535613|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
131521970|NCT03049813|473535614|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
131521971|NCT03049813|473535615|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
131521972|NCT03049813|473535616|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
131521973|NCT03049813|473535613|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
131521974|NCT03049813|473535614|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
131521975|NCT03049813|473535615|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
131521976|NCT03049813|473535616|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
131521977|NCT00550836|473535617|FG000|Overall Study|Withdrawal by Subject|3|||
131521978|NCT00550836|473535618|FG001|Overall Study|Withdrawal by Subject|9|||
131521979|NCT03921411|473535622|FG000|Overall Study|Withdrawal by Subject|1|||
131521980|NCT03921411|473535622|FG000|Overall Study|Protocol Deviation|2|||
131521981|NCT03921411|473535622|FG000|Overall Study|Enrolled, but never treated|2|||
131521982|NCT03120013|473535623|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131521983|NCT03120013|473535624|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131521984|NCT01541826|473535625|FG000|Overall Study|Lost to Follow-up|2|||
131521985|NCT01541826|473535626|FG001|Overall Study|Lost to Follow-up|3|||
131521986|NCT01541826|473535627|FG002|Overall Study|Lost to Follow-up|0|||
131521987|NCT01541826|473535625|FG000|Overall Study|Withdrawal by Subject|2|||
131521988|NCT01541826|473535626|FG001|Overall Study|Withdrawal by Subject|0|||
131521989|NCT01541826|473535627|FG002|Overall Study|Withdrawal by Subject|0|||
131521990|NCT01339390|473535630|FG000|Overall Study|Death|32|||
131521991|NCT01339390|473535631|FG001|Overall Study|Death|29|||
131521992|NCT01339390|473535630|FG000|Overall Study|Lost to Follow-up|125|||
131521993|NCT01339390|473535631|FG001|Overall Study|Lost to Follow-up|127|||
131521994|NCT00378703|473535632|FG000|Overall Study|Disease progression|59|||
131521995|NCT00378703|473535633|FG001|Overall Study|Disease progression|43|||
131521996|NCT00378703|473535634|FG002|Overall Study|Disease progression|48|||
131521997|NCT00378703|473535635|FG003|Overall Study|Disease progression|49|||
131521998|NCT00378703|473535632|FG000|Overall Study|Adverse Event|11|||
131521999|NCT00378703|473535633|FG001|Overall Study|Adverse Event|17|||
131522000|NCT00378703|473535634|FG002|Overall Study|Adverse Event|20|||
131522001|NCT00378703|473535635|FG003|Overall Study|Adverse Event|18|||
131522002|NCT00378703|473535632|FG000|Overall Study|Death|2|||
131522003|NCT00378703|473535633|FG001|Overall Study|Death|2|||
131522004|NCT00378703|473535634|FG002|Overall Study|Death|4|||
131522005|NCT00378703|473535635|FG003|Overall Study|Death|3|||
131522006|NCT00378703|473535632|FG000|Overall Study|Withdrawal by Subject|4|||
131522007|NCT00378703|473535633|FG001|Overall Study|Withdrawal by Subject|8|||
131522008|NCT00378703|473535634|FG002|Overall Study|Withdrawal by Subject|5|||
131522009|NCT00378703|473535635|FG003|Overall Study|Withdrawal by Subject|7|||
131522010|NCT00378703|473535632|FG000|Overall Study|Physician Decision|1|||
131522011|NCT00378703|473535633|FG001|Overall Study|Physician Decision|4|||
131522012|NCT00378703|473535634|FG002|Overall Study|Physician Decision|1|||
131522013|NCT00378703|473535635|FG003|Overall Study|Physician Decision|0|||
131522014|NCT00378703|473535632|FG000|Overall Study|Alternative therapy|4|||
131522015|NCT00378703|473535633|FG001|Overall Study|Alternative therapy|2|||
131522016|NCT00378703|473535634|FG002|Overall Study|Alternative therapy|0|||
131522017|NCT00378703|473535635|FG003|Overall Study|Alternative therapy|0|||
131522018|NCT00378703|473535632|FG000|Overall Study|Other complicated disease|0|||
131522019|NCT00378703|473535633|FG001|Overall Study|Other complicated disease|2|||
131522020|NCT00378703|473535634|FG002|Overall Study|Other complicated disease|2|||
131522021|NCT00378703|473535635|FG003|Overall Study|Other complicated disease|0|||
131522022|NCT00378703|473535632|FG000|Overall Study|Symptomatic deterioration|0|||
131522023|NCT00378703|473535633|FG001|Overall Study|Symptomatic deterioration|1|||
131522024|NCT00378703|473535634|FG002|Overall Study|Symptomatic deterioration|0|||
131522025|NCT00378703|473535635|FG003|Overall Study|Symptomatic deterioration|2|||
131522026|NCT00378703|473535632|FG000|Overall Study|Surgery|1|||
131522027|NCT00378703|473535633|FG001|Overall Study|Surgery|0|||
131522028|NCT00378703|473535634|FG002|Overall Study|Surgery|0|||
131522029|NCT00378703|473535635|FG003|Overall Study|Surgery|1|||
131522030|NCT00378703|473535632|FG000|Overall Study|Joint decision of physician and patient|1|||
131522031|NCT00378703|473535633|FG001|Overall Study|Joint decision of physician and patient|0|||
131522032|NCT00378703|473535634|FG002|Overall Study|Joint decision of physician and patient|0|||
131522033|NCT00378703|473535635|FG003|Overall Study|Joint decision of physician and patient|0|||
131522034|NCT00378703|473535632|FG000|Overall Study|Adverse events and progressive disease|0|||
131522035|NCT00378703|473535633|FG001|Overall Study|Adverse events and progressive disease|0|||
131522036|NCT00378703|473535634|FG002|Overall Study|Adverse events and progressive disease|0|||
131522037|NCT00378703|473535635|FG003|Overall Study|Adverse events and progressive disease|1|||
131522038|NCT00378703|473535632|FG000|Overall Study|Relocation|0|||
131522039|NCT00378703|473535633|FG001|Overall Study|Relocation|0|||
131522040|NCT00378703|473535634|FG002|Overall Study|Relocation|1|||
131522041|NCT00378703|473535635|FG003|Overall Study|Relocation|0|||
131522042|NCT00378703|473535632|FG000|Overall Study|Ineligible|4|||
131522043|NCT00378703|473535633|FG001|Overall Study|Ineligible|7|||
131522044|NCT00378703|473535634|FG002|Overall Study|Ineligible|7|||
131522045|NCT00378703|473535635|FG003|Overall Study|Ineligible|7|||
131522046|NCT00378703|473535632|FG000|Overall Study|Never started treatment|1|||
131522047|NCT00378703|473535633|FG001|Overall Study|Never started treatment|4|||
131522048|NCT00378703|473535634|FG002|Overall Study|Never started treatment|0|||
131522049|NCT00378703|473535635|FG003|Overall Study|Never started treatment|0|||
131522050|NCT00378703|473535632|FG000|Overall Study|Other|1|||
131522051|NCT00378703|473535633|FG001|Overall Study|Other|1|||
131522052|NCT00378703|473535634|FG002|Overall Study|Other|2|||
131522053|NCT00378703|473535635|FG003|Overall Study|Other|3|||
131522054|NCT02705820|473535636|FG000|Overall Study|Death|2|||
131522055|NCT02705820|473535636|FG000|Overall Study|Disease Progression|34|||
131522056|NCT02705820|473535636|FG000|Overall Study|Clinical Deterioration|3|||
131522057|NCT02702401|473535637|FG000|Overall Study|Death|242|||
131522058|NCT02702401|473535638|FG001|Overall Study|Death|125|||
131522059|NCT02702401|473535637|FG000|Overall Study|Withdrawal by Subject|15|||
131522060|NCT02702401|473535638|FG001|Overall Study|Withdrawal by Subject|5|||
131522061|NCT02702401|473535637|FG000|Overall Study|Sponsor Decision|19|||
131522062|NCT02702401|473535638|FG001|Overall Study|Sponsor Decision|3|||
131522063|NCT02702401|473535637|FG000|Overall Study|Physician Decision|1|||
131522064|NCT02702401|473535638|FG001|Overall Study|Physician Decision|2|||
131522065|NCT02702401|473535637|FG000|Overall Study|Lost to Follow-up|1|||
131522066|NCT02702401|473535638|FG001|Overall Study|Lost to Follow-up|0|||
131522067|NCT04292730|473535648|FG000|Overall Study|Lost to Follow-up|8|||
131522068|NCT04292730|473535649|FG001|Overall Study|Lost to Follow-up|12|||
131522069|NCT04292730|473535650|FG002|Overall Study|Lost to Follow-up|12|||
131522070|NCT04292730|473535651|FG003|Overall Study|Lost to Follow-up|48|||
131522071|NCT04292730|473535648|FG000|Overall Study|Death|2|||
131522072|NCT04292730|473535649|FG001|Overall Study|Death|2|||
131522073|NCT04292730|473535650|FG002|Overall Study|Death|4|||
131522074|NCT04292730|473535651|FG003|Overall Study|Death|12|||
131522075|NCT04292730|473535648|FG000|Overall Study|Withdrew Consent|2|||
131522076|NCT04292730|473535649|FG001|Overall Study|Withdrew Consent|2|||
131522077|NCT04292730|473535650|FG002|Overall Study|Withdrew Consent|5|||
131522078|NCT04292730|473535651|FG003|Overall Study|Withdrew Consent|6|||
131522079|NCT04292730|473535648|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131522080|NCT04292730|473535649|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131522081|NCT04292730|473535650|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131522082|NCT04292730|473535651|FG003|Overall Study|Non-Compliance with Study Drug|0|||
131522083|NCT04292730|473535648|FG000|Overall Study|Protocol Violation|0|||
131522084|NCT04292730|473535649|FG001|Overall Study|Protocol Violation|0|||
131522085|NCT04292730|473535650|FG002|Overall Study|Protocol Violation|1|||
131522086|NCT04292730|473535651|FG003|Overall Study|Protocol Violation|0|||
131522087|NCT04292730|473535648|FG000|Overall Study|Randomized but not Treated|8|||
131522088|NCT04292730|473535649|FG001|Overall Study|Randomized but not Treated|4|||
131522089|NCT04292730|473535650|FG002|Overall Study|Randomized but not Treated|0|||
131522090|NCT04292730|473535651|FG003|Overall Study|Randomized but not Treated|14|||
131522091|NCT01527292|473535652|FG000|Overall Study|Physician Decision|0|||
131522092|NCT01527292|473535653|FG001|Overall Study|Physician Decision|3|||
131522093|NCT00806546|473535654|FG000|Overall Study|Enrolled, not treated|35|||
131522094|NCT00806546|473535654|FG000|Overall Study|Lost to Follow-up|32|||
131522095|NCT00806546|473535654|FG000|Overall Study|Adverse Event|74|||
131522096|NCT00806546|473535654|FG000|Overall Study|Withdrawal by Subject|75|||
131522097|NCT00806546|473535654|FG000|Overall Study|Protocol Violation|49|||
131522098|NCT00806546|473535654|FG000|Overall Study|Various|42|||
131522099|NCT02751983|473535657|FG000|Treatment|Stopped ACT, but Remained in study|2|||
131522100|NCT02751983|473535658|FG001|Treatment|Stopped ACT, but Remained in study|0|||
131522101|NCT02751983|473535657|FG000|Treatment|Discharged prior to beginning ACT|2|||
131522102|NCT02751983|473535658|FG001|Treatment|Discharged prior to beginning ACT|0|||
131522103|NCT02751983|473535657|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
131522104|NCT02751983|473535658|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
131658424|NCT01531673|474035311|FG012|Overall Study|Lost to Follow-up|0|||
131522105|NCT02751983|473535657|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
131522106|NCT02751983|473535658|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
131522107|NCT02751983|473535657|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
131522108|NCT02751983|473535658|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
131522109|NCT00096044|473535659|FG000|Overall Study|Withdrawal by Subject|9|||
131522110|NCT00096044|473535659|FG000|Overall Study|Adverse Event|21|||
131522111|NCT00096044|473535659|FG000|Overall Study|Disease Progression|4|||
131522112|NCT03139916|473535662|FG000|Overall Study|Withdrawal by Subject|2|||
131522113|NCT03139916|473535662|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
131522114|NCT04587193|473535663|FG000|Overall Study|Screen failure after consent|3|||
131522115|NCT04587193|473535664|FG001|Overall Study|Screen failure after consent|0|||
131522116|NCT04587193|473535663|FG000|Overall Study|Device broke during study|3|||
131522117|NCT04587193|473535664|FG001|Overall Study|Device broke during study|2|||
131522118|NCT00813358|473535665|FG000|Overall Study|Death|32|||
131522119|NCT00813358|473535665|FG000|Overall Study|Lost to Follow-up|12|||
131522120|NCT00813358|473535665|FG000|Overall Study|other endpoints|5|||
131522121|NCT00813358|473535665|FG000|Overall Study|Withdrawal by Subject|20|||
131522122|NCT00004031|473535666|FG000|Overall Study|Adverse Event|5|||
131522123|NCT00004031|473535667|FG001|Overall Study|Adverse Event|0|||
131522124|NCT00004031|473535666|FG000|Overall Study|Refusal unrelated to adverse events|2|||
131522125|NCT00004031|473535667|FG001|Overall Study|Refusal unrelated to adverse events|11|||
131522126|NCT00004031|473535666|FG000|Overall Study|Progression/relapse|9|||
131522127|NCT00004031|473535667|FG001|Overall Study|Progression/relapse|4|||
131522128|NCT00004031|473535666|FG000|Overall Study|Death|3|||
131522129|NCT00004031|473535667|FG001|Overall Study|Death|1|||
131522130|NCT00004031|473535666|FG000|Overall Study|Other- not protocol specified|3|||
131522131|NCT00004031|473535667|FG001|Overall Study|Other- not protocol specified|3|||
131522132|NCT00004031|473535666|FG000|Overall Study|Reason under review|3|||
131522133|NCT00004031|473535667|FG001|Overall Study|Reason under review|2|||
131522134|NCT03851016|473535670|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131522135|NCT03851016|473535671|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
131522136|NCT00586469|473535672|FG000|Overall Study|Adverse Event|0|||
131522137|NCT00586469|473535673|FG001|Overall Study|Adverse Event|1|||
131522138|NCT00991302|473537915|FG000|Overall Study|Death|0|||
131522139|NCT00991302|473537916|FG001|Overall Study|Death|1|||
131522140|NCT00991302|473537915|FG000|Overall Study|Lost to Follow-up|14|||
131522141|NCT00991302|473537916|FG001|Overall Study|Lost to Follow-up|12|||
131522142|NCT01709318|473537917|FG000|Overall Study|Adverse Event|3|||
131522143|NCT01709318|473537918|FG001|Overall Study|Adverse Event|4|||
131522144|NCT01709318|473537919|FG002|Overall Study|Adverse Event|2|||
131522145|NCT01709318|473537920|FG003|Overall Study|Adverse Event|2|||
131522146|NCT01709318|473537921|FG004|Overall Study|Adverse Event|0|||
131522147|NCT01709318|473537922|FG005|Overall Study|Adverse Event|1|||
131522148|NCT01709318|473537923|FG006|Overall Study|Adverse Event|2|||
131522149|NCT01709318|473537917|FG000|Overall Study|Lost to Follow-up|2|||
131522150|NCT01709318|473537918|FG001|Overall Study|Lost to Follow-up|0|||
131522151|NCT01709318|473537919|FG002|Overall Study|Lost to Follow-up|0|||
131522152|NCT01709318|473537920|FG003|Overall Study|Lost to Follow-up|0|||
131522153|NCT01709318|473537921|FG004|Overall Study|Lost to Follow-up|1|||
131522154|NCT01709318|473537922|FG005|Overall Study|Lost to Follow-up|1|||
131522155|NCT01709318|473537923|FG006|Overall Study|Lost to Follow-up|1|||
131522156|NCT01709318|473537917|FG000|Overall Study|Non-compliance with Study Drug|0|||
131522157|NCT01709318|473537918|FG001|Overall Study|Non-compliance with Study Drug|2|||
131522158|NCT01709318|473537919|FG002|Overall Study|Non-compliance with Study Drug|1|||
131522159|NCT01709318|473537920|FG003|Overall Study|Non-compliance with Study Drug|1|||
131522160|NCT01709318|473537921|FG004|Overall Study|Non-compliance with Study Drug|0|||
131522161|NCT01709318|473537922|FG005|Overall Study|Non-compliance with Study Drug|0|||
131522162|NCT01709318|473537923|FG006|Overall Study|Non-compliance with Study Drug|2|||
131522163|NCT01709318|473537917|FG000|Overall Study|Physician Decision|0|||
131522164|NCT01709318|473537918|FG001|Overall Study|Physician Decision|0|||
131522165|NCT01709318|473537919|FG002|Overall Study|Physician Decision|0|||
131522166|NCT01709318|473537920|FG003|Overall Study|Physician Decision|0|||
131522167|NCT01709318|473537921|FG004|Overall Study|Physician Decision|0|||
131522168|NCT01709318|473537922|FG005|Overall Study|Physician Decision|0|||
131522169|NCT01709318|473537923|FG006|Overall Study|Physician Decision|1|||
131522170|NCT01709318|473537917|FG000|Overall Study|Pregnancy|0|||
131522171|NCT01709318|473537918|FG001|Overall Study|Pregnancy|0|||
131522172|NCT01709318|473537919|FG002|Overall Study|Pregnancy|0|||
131522173|NCT01709318|473537920|FG003|Overall Study|Pregnancy|0|||
131522174|NCT01709318|473537921|FG004|Overall Study|Pregnancy|1|||
131522175|NCT01709318|473537922|FG005|Overall Study|Pregnancy|0|||
131522176|NCT01709318|473537923|FG006|Overall Study|Pregnancy|0|||
131522177|NCT01709318|473537917|FG000|Overall Study|Protocol Violation|0|||
131522178|NCT01709318|473537918|FG001|Overall Study|Protocol Violation|0|||
131522179|NCT01709318|473537919|FG002|Overall Study|Protocol Violation|0|||
131522180|NCT01709318|473537920|FG003|Overall Study|Protocol Violation|0|||
131522181|NCT01709318|473537921|FG004|Overall Study|Protocol Violation|2|||
131522182|NCT01709318|473537922|FG005|Overall Study|Protocol Violation|0|||
131522183|NCT01709318|473537923|FG006|Overall Study|Protocol Violation|1|||
131522184|NCT01709318|473537917|FG000|Overall Study|Technical Problems|1|||
131522185|NCT01709318|473537918|FG001|Overall Study|Technical Problems|0|||
131522186|NCT01709318|473537919|FG002|Overall Study|Technical Problems|0|||
131522187|NCT01709318|473537920|FG003|Overall Study|Technical Problems|0|||
131522188|NCT01709318|473537921|FG004|Overall Study|Technical Problems|0|||
131522189|NCT01709318|473537922|FG005|Overall Study|Technical Problems|0|||
131522190|NCT01709318|473537923|FG006|Overall Study|Technical Problems|0|||
131522191|NCT01709318|473537917|FG000|Overall Study|Withdrawal by Subject|3|||
131522192|NCT01709318|473537918|FG001|Overall Study|Withdrawal by Subject|0|||
131522193|NCT01709318|473537919|FG002|Overall Study|Withdrawal by Subject|3|||
131522194|NCT01709318|473537920|FG003|Overall Study|Withdrawal by Subject|3|||
131522195|NCT01709318|473537921|FG004|Overall Study|Withdrawal by Subject|0|||
131522196|NCT01709318|473537922|FG005|Overall Study|Withdrawal by Subject|2|||
131522197|NCT01709318|473537923|FG006|Overall Study|Withdrawal by Subject|4|||
131522198|NCT01709318|473537917|FG000|Overall Study|Other Protocol Specified Criteria|0|||
131522199|NCT01709318|473537918|FG001|Overall Study|Other Protocol Specified Criteria|1|||
131522200|NCT01709318|473537919|FG002|Overall Study|Other Protocol Specified Criteria|0|||
131522201|NCT01709318|473537920|FG003|Overall Study|Other Protocol Specified Criteria|0|||
131522202|NCT01709318|473537921|FG004|Overall Study|Other Protocol Specified Criteria|0|||
131522203|NCT01709318|473537922|FG005|Overall Study|Other Protocol Specified Criteria|0|||
131522204|NCT01709318|473537923|FG006|Overall Study|Other Protocol Specified Criteria|0|||
131522205|NCT03228680|473537929|FG000|Overall Study|Adverse Event|13|||
131522206|NCT03228680|473537930|FG001|Overall Study|Adverse Event|18|||
131522207|NCT03228680|473537929|FG000|Overall Study|Randomization failure|0|||
131522208|NCT03228680|473537930|FG001|Overall Study|Randomization failure|1|||
131522209|NCT03228680|473537929|FG000|Overall Study|Withdrawal by Subject|1|||
131522210|NCT03228680|473537930|FG001|Overall Study|Withdrawal by Subject|0|||
131522211|NCT03228680|473537929|FG000|Overall Study|Other|9|||
131522212|NCT03228680|473537930|FG001|Overall Study|Other|16|||
131522213|NCT02148003|473537931|FG000|Overall Study|Failed inclusion criteria|1|||
131522214|NCT02148003|473537932|FG001|Overall Study|Failed inclusion criteria|0|||
131522215|NCT02148003|473537931|FG000|Overall Study|Met exclusion criteria|0|||
131522216|NCT02148003|473537932|FG001|Overall Study|Met exclusion criteria|1|||
131522217|NCT02148003|473537931|FG000|Overall Study|Withdrawal by Subject|0|||
131522218|NCT02148003|473537932|FG001|Overall Study|Withdrawal by Subject|1|||
131522219|NCT02489981|473537933|FG000|Overall Study|Adverse Event|21|||
131522220|NCT02489981|473537933|FG000|Overall Study|Insufficient effectiveness|16|||
131522221|NCT02489981|473537933|FG000|Overall Study|Improved|31|||
131522222|NCT02489981|473537933|FG000|Overall Study|Lost to Follow-up|31|||
131522223|NCT02489981|473537933|FG000|Overall Study|Other than listed|28|||
131522224|NCT00796861|473537934|FG000|Overall Study|Withdrawal by Subject|2|||
131522225|NCT00796861|473537934|FG000|Overall Study|Death|2|||
131522226|NCT03852316|473537937|FG000|Overall Study|Protocol Violation|1|||
131522227|NCT03852316|473537937|FG000|Overall Study|Withdrawal by Subject|2|||
131522228|NCT03852316|473537937|FG000|Overall Study|Enrolled but Device not Utilized|1|||
131522229|NCT02664038|473537941|FG000|13 Week|Lost to Follow-up|7|||
131522230|NCT02664038|473537942|FG001|13 Week|Lost to Follow-up|14|||
131522231|NCT02664038|473537941|FG000|13 Week|Withdrawal by Subject|1|||
131522232|NCT02664038|473537942|FG001|13 Week|Withdrawal by Subject|0|||
131522233|NCT02664038|473537941|FG000|26 Week|Lost to Follow-up|5|||
131522234|NCT02664038|473537942|FG001|26 Week|Lost to Follow-up|4|||
131522235|NCT02606136|473537947|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
131522236|NCT02606136|473537947|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
131522237|NCT02606136|473537947|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
131522238|NCT02606136|473537947|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
131522239|NCT03296696|473537948|FG000|Overall Study|Started Other Antitumor Therapy|1|||
131522240|NCT03296696|473537949|FG001|Overall Study|Started Other Antitumor Therapy|2|||
131522241|NCT03296696|473537950|FG002|Overall Study|Started Other Antitumor Therapy|1|||
131522242|NCT03296696|473537951|FG003|Overall Study|Started Other Antitumor Therapy|2|||
131522243|NCT03296696|473537952|FG004|Overall Study|Started Other Antitumor Therapy|1|||
131522244|NCT03296696|473537953|FG005|Overall Study|Started Other Antitumor Therapy|1|||
131522245|NCT03296696|473537954|FG006|Overall Study|Started Other Antitumor Therapy|2|||
131522246|NCT03296696|473537955|FG007|Overall Study|Started Other Antitumor Therapy|3|||
131522247|NCT03296696|473537956|FG008|Overall Study|Started Other Antitumor Therapy|1|||
131522248|NCT03296696|473537957|FG009|Overall Study|Started Other Antitumor Therapy|0|||
131522249|NCT03296696|473537948|FG000|Overall Study|Death|0|||
131522250|NCT03296696|473537949|FG001|Overall Study|Death|1|||
131522251|NCT03296696|473537950|FG002|Overall Study|Death|1|||
131522252|NCT03296696|473537951|FG003|Overall Study|Death|2|||
131522253|NCT03296696|473537952|FG004|Overall Study|Death|2|||
131522254|NCT03296696|473537953|FG005|Overall Study|Death|3|||
131522255|NCT03296696|473537954|FG006|Overall Study|Death|1|||
131522256|NCT03296696|473537955|FG007|Overall Study|Death|2|||
131522257|NCT03296696|473537956|FG008|Overall Study|Death|0|||
131522258|NCT03296696|473537957|FG009|Overall Study|Death|0|||
131522259|NCT03296696|473537948|FG000|Overall Study|Withdrawal by Subject|0|||
131522260|NCT03296696|473537949|FG001|Overall Study|Withdrawal by Subject|0|||
131522261|NCT03296696|473537950|FG002|Overall Study|Withdrawal by Subject|1|||
131522262|NCT03296696|473537951|FG003|Overall Study|Withdrawal by Subject|0|||
131522263|NCT03296696|473537952|FG004|Overall Study|Withdrawal by Subject|1|||
131522264|NCT03296696|473537953|FG005|Overall Study|Withdrawal by Subject|0|||
131522265|NCT03296696|473537954|FG006|Overall Study|Withdrawal by Subject|0|||
131522266|NCT03296696|473537955|FG007|Overall Study|Withdrawal by Subject|0|||
131522267|NCT03296696|473537956|FG008|Overall Study|Withdrawal by Subject|0|||
131522268|NCT03296696|473537957|FG009|Overall Study|Withdrawal by Subject|1|||
131522269|NCT04694131|473537961|FG000|Overall Study|Withdrawal by Subject|7|||
131522270|NCT04694131|473537961|FG000|Overall Study|Screen Failure|1|||
131522271|NCT04694131|473537961|FG000|Overall Study|High stimulation threshold|3|||
131522272|NCT04456699|473537962|FG000|Overall Study|Death|48|||
131522273|NCT04456699|473537963|FG001|Overall Study|Death|50|||
131522274|NCT04456699|473537964|FG002|Overall Study|Death|52|||
131522275|NCT04456699|473537962|FG000|Overall Study|Physician Decision|0|||
131522276|NCT04456699|473537963|FG001|Overall Study|Physician Decision|0|||
131522277|NCT04456699|473537964|FG002|Overall Study|Physician Decision|2|||
131522278|NCT04456699|473537962|FG000|Overall Study|Sponsor Decision|55|||
131522279|NCT04456699|473537963|FG001|Overall Study|Sponsor Decision|61|||
131522280|NCT04456699|473537964|FG002|Overall Study|Sponsor Decision|50|||
131522281|NCT04456699|473537962|FG000|Overall Study|Withdrawal by Subject|8|||
131522282|NCT04456699|473537963|FG001|Overall Study|Withdrawal by Subject|4|||
131522283|NCT04456699|473537964|FG002|Overall Study|Withdrawal by Subject|5|||
131522285|NCT01859715|473537970|FG000|Overall Study|No 2nd VAS|16|||
131522286|NCT01859715|473537971|FG001|Overall Study|No 2nd VAS|8|||
131522287|NCT01859715|473537972|FG002|Overall Study|No 2nd VAS|23|||
131522288|NCT00086580|473537973|FG000|Treatment Period|Disease progression|9|||
131522289|NCT00086580|473537974|FG001|Treatment Period|Disease progression|8|||
131522290|NCT00086580|473537973|FG000|Treatment Period|Unable to comply with protocol|3|||
131522291|NCT00086580|473537974|FG001|Treatment Period|Unable to comply with protocol|1|||
131522292|NCT00086580|473537973|FG000|Treatment Period|Withdrawal by Subject|7|||
131522293|NCT00086580|473537974|FG001|Treatment Period|Withdrawal by Subject|8|||
131522294|NCT00086580|473537973|FG000|Treatment Period|Physician Decision|13|||
131522295|NCT00086580|473537974|FG001|Treatment Period|Physician Decision|7|||
131522296|NCT00086580|473537973|FG000|Treatment Period|AE - not treatment related|7|||
131522297|NCT00086580|473537974|FG001|Treatment Period|AE - not treatment related|7|||
131522298|NCT00086580|473537973|FG000|Treatment Period|Toxicity - treatment related|15|||
131522299|NCT00086580|473537974|FG001|Treatment Period|Toxicity - treatment related|15|||
131522300|NCT00086580|473537973|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
131522301|NCT00086580|473537974|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
131522302|NCT00086580|473537973|FG000|Treatment Period|Death|5|||
131522303|NCT00086580|473537974|FG001|Treatment Period|Death|7|||
131522304|NCT00086580|473537973|FG000|Treatment Period|Other|5|||
131522305|NCT00086580|473537974|FG001|Treatment Period|Other|3|||
131522306|NCT00086580|473537973|FG000|Follow-up Period|Disease progression|72|||
131522307|NCT00086580|473537974|FG001|Follow-up Period|Disease progression|99|||
131522308|NCT00086580|473537973|FG000|Follow-up Period|Unable to comply with protocol|5|||
131522309|NCT00086580|473537974|FG001|Follow-up Period|Unable to comply with protocol|0|||
131522310|NCT00086580|473537973|FG000|Follow-up Period|Withdrawal by Subject|6|||
131522311|NCT00086580|473537974|FG001|Follow-up Period|Withdrawal by Subject|6|||
131522312|NCT00086580|473537973|FG000|Follow-up Period|Physician Decision|0|||
131522313|NCT00086580|473537974|FG001|Follow-up Period|Physician Decision|1|||
131522314|NCT00086580|473537973|FG000|Follow-up Period|AE - not related|1|||
131522315|NCT00086580|473537974|FG001|Follow-up Period|AE - not related|0|||
131522316|NCT00086580|473537973|FG000|Follow-up Period|Death|13|||
131522317|NCT00086580|473537974|FG001|Follow-up Period|Death|7|||
131522318|NCT00086580|473537973|FG000|Follow-up Period|Other|7|||
131522319|NCT00086580|473537974|FG001|Follow-up Period|Other|6|||
131522320|NCT00086580|473537973|FG000|Observation Period|Unable to comply with protocol|1|||
131522321|NCT00086580|473537974|FG001|Observation Period|Unable to comply with protocol|1|||
131522322|NCT00086580|473537973|FG000|Observation Period|Withdrawal by Subject|4|||
131522323|NCT00086580|473537974|FG001|Observation Period|Withdrawal by Subject|2|||
131522324|NCT00086580|473537973|FG000|Observation Period|Death|33|||
131522325|NCT00086580|473537974|FG001|Observation Period|Death|55|||
131522326|NCT00086580|473537973|FG000|Observation Period|Other|8|||
131522327|NCT00086580|473537974|FG001|Observation Period|Other|7|||
131522328|NCT02047110|473537975|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
131522329|NCT02047110|473537976|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
131522330|NCT02047110|473537977|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
131522331|NCT02047110|473537978|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
131522332|NCT02047110|473537975|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
131522333|NCT02047110|473537976|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
131522334|NCT02047110|473537977|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
131522335|NCT02047110|473537978|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
131522336|NCT02047110|473537975|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
131522337|NCT02047110|473537976|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
131522338|NCT02047110|473537977|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
131522339|NCT02047110|473537978|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
131522340|NCT02047110|473537975|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
131522341|NCT02047110|473537976|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
131522342|NCT02047110|473537977|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
131522343|NCT02047110|473537978|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
131522344|NCT02047110|473537975|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
131522345|NCT02047110|473537976|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
131522346|NCT02047110|473537977|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
131522347|NCT02047110|473537978|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
131522348|NCT02047110|473537975|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
131522349|NCT02047110|473537976|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
131522350|NCT02047110|473537977|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
131522351|NCT02047110|473537978|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
131522352|NCT02047110|473537975|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
131522353|NCT02047110|473537976|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
131522354|NCT02047110|473537977|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
131522355|NCT02047110|473537978|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
131522356|NCT02047110|473537975|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
131522357|NCT02047110|473537976|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
131522358|NCT02047110|473537977|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
131522359|NCT02047110|473537978|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
131522360|NCT02047110|473537975|FG000|Escape Treatment Period|Adverse Event|1|||
131522361|NCT02047110|473537976|FG001|Escape Treatment Period|Adverse Event|2|||
131522362|NCT02047110|473537977|FG002|Escape Treatment Period|Adverse Event|2|||
131522363|NCT02047110|473537978|FG003|Escape Treatment Period|Adverse Event|0|||
131522364|NCT02047110|473537975|FG000|Escape Treatment Period|Other than specified|1|||
131522365|NCT02047110|473537976|FG001|Escape Treatment Period|Other than specified|2|||
131522366|NCT02047110|473537977|FG002|Escape Treatment Period|Other than specified|0|||
131522367|NCT02047110|473537978|FG003|Escape Treatment Period|Other than specified|1|||
131522368|NCT02047110|473537975|FG000|OLE Treatment Period|Other than specified|0|||
131522369|NCT02047110|473537976|FG001|OLE Treatment Period|Other than specified|0|||
131522370|NCT02047110|473537977|FG002|OLE Treatment Period|Other than specified|1|||
131522371|NCT02047110|473537978|FG003|OLE Treatment Period|Other than specified|0|||
131522372|NCT01000051|473537979|FG000|Overall Study|Withdrawal by Subject|1|||
131522373|NCT01000051|473537980|FG001|Overall Study|Withdrawal by Subject|1|||
131522374|NCT01000051|473537979|FG000|Overall Study|Disease Progression|1|||
131522375|NCT01000051|473537980|FG001|Overall Study|Disease Progression|0|||
131522376|NCT01000051|473537979|FG000|Overall Study|Serious noncompliance|1|||
131522377|NCT01000051|473537980|FG001|Overall Study|Serious noncompliance|0|||
131522378|NCT02247349|473537981|FG000|Overall Study|Disease Progression|7|||
131522379|NCT02247349|473537982|FG001|Overall Study|Disease Progression|4|||
131522380|NCT02247349|473537983|FG002|Overall Study|Disease Progression|26|||
131522381|NCT02247349|473537984|FG003|Overall Study|Disease Progression|31|||
131522382|NCT02247349|473537985|FG004|Overall Study|Disease Progression|16|||
131522383|NCT02247349|473537986|FG005|Overall Study|Disease Progression|6|||
131522384|NCT02247349|473537981|FG000|Overall Study|Study drug toxicity|0|||
131522385|NCT02247349|473537982|FG001|Overall Study|Study drug toxicity|1|||
131522386|NCT02247349|473537983|FG002|Overall Study|Study drug toxicity|1|||
131522387|NCT02247349|473537984|FG003|Overall Study|Study drug toxicity|1|||
131522388|NCT02247349|473537985|FG004|Overall Study|Study drug toxicity|2|||
131522389|NCT02247349|473537986|FG005|Overall Study|Study drug toxicity|2|||
131522390|NCT02247349|473537981|FG000|Overall Study|Death|0|||
131522391|NCT02247349|473537982|FG001|Overall Study|Death|0|||
131522392|NCT02247349|473537983|FG002|Overall Study|Death|0|||
131522393|NCT02247349|473537984|FG003|Overall Study|Death|1|||
131522394|NCT02247349|473537985|FG004|Overall Study|Death|0|||
131522395|NCT02247349|473537986|FG005|Overall Study|Death|0|||
131522396|NCT02247349|473537981|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
131522397|NCT02247349|473537982|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
131522398|NCT02247349|473537983|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
131522399|NCT02247349|473537984|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
131522400|NCT02247349|473537985|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
131522401|NCT02247349|473537986|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
131522402|NCT02247349|473537981|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131522403|NCT02247349|473537982|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131522404|NCT02247349|473537983|FG002|Overall Study|Participant request to discontinue study treatment|1|||
131522405|NCT02247349|473537984|FG003|Overall Study|Participant request to discontinue study treatment|2|||
131522406|NCT02247349|473537985|FG004|Overall Study|Participant request to discontinue study treatment|1|||
131522407|NCT02247349|473537986|FG005|Overall Study|Participant request to discontinue study treatment|0|||
131522408|NCT02247349|473537981|FG000|Overall Study|Withdrawal by Subject|0|||
131522409|NCT02247349|473537982|FG001|Overall Study|Withdrawal by Subject|1|||
131522410|NCT02247349|473537983|FG002|Overall Study|Withdrawal by Subject|0|||
131522411|NCT02247349|473537984|FG003|Overall Study|Withdrawal by Subject|0|||
131522412|NCT02247349|473537985|FG004|Overall Study|Withdrawal by Subject|0|||
131522413|NCT02247349|473537986|FG005|Overall Study|Withdrawal by Subject|0|||
131522414|NCT02247349|473537981|FG000|Overall Study|Administrative reason by sponsor|0|||
131522415|NCT02247349|473537982|FG001|Overall Study|Administrative reason by sponsor|0|||
131522416|NCT02247349|473537983|FG002|Overall Study|Administrative reason by sponsor|0|||
131522417|NCT02247349|473537984|FG003|Overall Study|Administrative reason by sponsor|0|||
131522418|NCT02247349|473537985|FG004|Overall Study|Administrative reason by sponsor|1|||
131522419|NCT02247349|473537986|FG005|Overall Study|Administrative reason by sponsor|0|||
131522420|NCT02247349|473537981|FG000|Overall Study|Other reasons|0|||
131522421|NCT02247349|473537982|FG001|Overall Study|Other reasons|0|||
131522422|NCT02247349|473537983|FG002|Overall Study|Other reasons|1|||
131522423|NCT02247349|473537984|FG003|Overall Study|Other reasons|0|||
131522424|NCT02247349|473537985|FG004|Overall Study|Other reasons|0|||
131522425|NCT02247349|473537986|FG005|Overall Study|Other reasons|0|||
131522426|NCT01959581|473537987|FG000|Overall Study|Lost to Follow-up|5|||
131522427|NCT00057746|473537988|FG000|Overall Study|Withdrawal by Subject|0|||
131522428|NCT00057746|473537989|FG001|Overall Study|Withdrawal by Subject|0|||
131522429|NCT00057746|473537990|FG002|Overall Study|Withdrawal by Subject|1|||
131522430|NCT01469065|473537996|FG000|Overall Study|Lack of Efficacy|0|||
131522431|NCT01469065|473537997|FG001|Overall Study|Lack of Efficacy|0|||
131522432|NCT01469065|473537998|FG002|Overall Study|Lack of Efficacy|0|||
131522433|NCT01469065|473537999|FG003|Overall Study|Lack of Efficacy|0|||
131522434|NCT01469065|473538000|FG004|Overall Study|Lack of Efficacy|1|||
131522435|NCT01469065|473537996|FG000|Overall Study|Other|0|||
131522436|NCT01469065|473537997|FG001|Overall Study|Other|1|||
131522437|NCT01469065|473537998|FG002|Overall Study|Other|0|||
131522438|NCT01469065|473537999|FG003|Overall Study|Other|0|||
131522439|NCT01469065|473538000|FG004|Overall Study|Other|0|||
131522440|NCT00179413|473538001|FG000|Overall Study|Adverse Event|38|||
131522441|NCT00179413|473538002|FG001|Overall Study|Adverse Event|20|||
131522442|NCT00179413|473538001|FG000|Overall Study|Withdrawal by Subject|87|||
131522443|NCT00179413|473538002|FG001|Overall Study|Withdrawal by Subject|95|||
131522444|NCT03075644|473538003|FG000|Overall Study|Withdrawal by Subject|1|||
131522445|NCT03075644|473538004|FG001|Overall Study|Withdrawal by Subject|1|||
131522446|NCT01696032|473538005|FG000|Overall Study|Withdrawal by Subject|0|||
131522447|NCT01696032|473538006|FG001|Overall Study|Withdrawal by Subject|0|||
131522448|NCT01696032|473538007|FG002|Overall Study|Withdrawal by Subject|1|||
131522449|NCT01696032|473538008|FG003|Overall Study|Withdrawal by Subject|2|||
131522450|NCT01696032|473538005|FG000|Overall Study|Death|14|||
131522451|NCT01696032|473538006|FG001|Overall Study|Death|4|||
131522452|NCT01696032|473538007|FG002|Overall Study|Death|43|||
131522453|NCT01696032|473538008|FG003|Overall Study|Death|18|||
131522454|NCT01696032|473538005|FG000|Overall Study|Lost to Follow-up|0|||
131522455|NCT01696032|473538006|FG001|Overall Study|Lost to Follow-up|1|||
131522456|NCT01696032|473538007|FG002|Overall Study|Lost to Follow-up|0|||
131522457|NCT01696032|473538008|FG003|Overall Study|Lost to Follow-up|0|||
131522458|NCT01696032|473538005|FG000|Overall Study|Database lock|0|||
131522459|NCT01696032|473538006|FG001|Overall Study|Database lock|1|||
131522460|NCT01696032|473538007|FG002|Overall Study|Database lock|7|||
131522461|NCT01696032|473538008|FG003|Overall Study|Database lock|2|||
131522462|NCT00578565|473538011|FG000|Overall Study|Adverse Event|3|||
131522463|NCT01192152|473538012|FG000|Period 1|left prematurely (while on treatment B)|0|||
131522464|NCT01192152|473538013|FG001|Period 1|left prematurely (while on treatment B)|1|||
131522465|NCT01192152|473538012|FG000|Period 3|family emergency|1|||
131522466|NCT01192152|473538013|FG001|Period 3|family emergency|0|||
131522467|NCT02203591|473538015|FG000|Overall Study|Did not meet treatment day baseline|147|||
131522468|NCT02203591|473538016|FG001|Overall Study|Did not meet treatment day baseline|141|||
131522469|NCT02203591|473538017|FG002|Overall Study|Did not meet treatment day baseline|150|||
131522470|NCT02203591|473538018|FG003|Overall Study|Did not meet treatment day baseline|45|||
131522471|NCT02203591|473538019|FG004|Overall Study|Did not meet treatment day baseline|33|||
131522472|NCT02203591|473538020|FG005|Overall Study|Did not meet treatment day baseline|35|||
131522473|NCT02203591|473538021|FG006|Overall Study|Did not meet treatment day baseline|29|||
131522474|NCT02203591|473538022|FG007|Overall Study|Did not meet treatment day baseline|12|||
131522475|NCT02203591|473538015|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
131522476|NCT02203591|473538016|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
131522477|NCT02203591|473538017|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
131522478|NCT02203591|473538018|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
131522479|NCT02203591|473538019|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
131522480|NCT02203591|473538020|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
131522481|NCT02203591|473538021|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
131522482|NCT02203591|473538022|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
131522483|NCT01565291|473538023|FG000|Overall Study|Withdrawal by Subject|1|||
131522484|NCT01565291|473538024|FG001|Overall Study|Withdrawal by Subject|0|||
131522485|NCT00515827|473538025|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
131522486|NCT00515827|473538026|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
131522487|NCT00515827|473538025|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
131522488|NCT00515827|473538026|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
131522489|NCT01009099|473538029|FG000|Overall Study|Lost to Follow-up|1|||
131522490|NCT01009099|473538030|FG001|Overall Study|Lost to Follow-up|0|||
131522491|NCT01009099|473538029|FG000|Overall Study|Physician Decision|3|||
131522492|NCT01009099|473538030|FG001|Overall Study|Physician Decision|2|||
131522493|NCT01009099|473538029|FG000|Overall Study|Withdrawal by Subject|1|||
131522494|NCT01009099|473538030|FG001|Overall Study|Withdrawal by Subject|1|||
131522495|NCT01009099|473538029|FG000|Overall Study|Death|0|||
131522496|NCT01009099|473538030|FG001|Overall Study|Death|1|||
131522497|NCT01856543|473538044|FG000|Overall Study|Treatment discontinued|6|||
131522498|NCT01856543|473538045|FG001|Overall Study|Treatment discontinued|3|||
131522499|NCT01856543|473538044|FG000|Overall Study|Withdrawn before start|7|||
131522500|NCT01856543|473538045|FG001|Overall Study|Withdrawn before start|3|||
131522501|NCT02457325|473538050|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
131522502|NCT02457325|473538051|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
131522503|NCT01541930|473538052|FG000|Overall Study|Withdrawal by Subject|1|||
131522504|NCT02501096|473538053|FG000|Overall Study|Lost to Follow-up|0|||
131522505|NCT02501096|473538054|FG001|Overall Study|Lost to Follow-up|0|||
131522506|NCT02501096|473538055|FG002|Overall Study|Lost to Follow-up|0|||
131522507|NCT02501096|473538056|FG003|Overall Study|Lost to Follow-up|0|||
131522508|NCT02501096|473538057|FG004|Overall Study|Lost to Follow-up|1|||
131522509|NCT02501096|473538058|FG005|Overall Study|Lost to Follow-up|1|||
131522510|NCT02501096|473538059|FG006|Overall Study|Lost to Follow-up|3|||
131522511|NCT02501096|473538060|FG007|Overall Study|Lost to Follow-up|0|||
131522512|NCT02501096|473538061|FG008|Overall Study|Lost to Follow-up|0|||
131522513|NCT02501096|473538053|FG000|Overall Study|Withdrawal by Subject|1|||
131522514|NCT02501096|473538054|FG001|Overall Study|Withdrawal by Subject|0|||
131522515|NCT02501096|473538055|FG002|Overall Study|Withdrawal by Subject|7|||
131522516|NCT02501096|473538056|FG003|Overall Study|Withdrawal by Subject|13|||
131522517|NCT02501096|473538057|FG004|Overall Study|Withdrawal by Subject|2|||
131522518|NCT02501096|473538058|FG005|Overall Study|Withdrawal by Subject|2|||
131522519|NCT02501096|473538059|FG006|Overall Study|Withdrawal by Subject|2|||
131522520|NCT02501096|473538060|FG007|Overall Study|Withdrawal by Subject|3|||
131522521|NCT02501096|473538061|FG008|Overall Study|Withdrawal by Subject|0|||
131522522|NCT02501096|473538053|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
131522523|NCT02501096|473538054|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
131522524|NCT02501096|473538055|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
131522525|NCT02501096|473538056|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
131522526|NCT02501096|473538057|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
131522527|NCT02501096|473538058|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
131522528|NCT02501096|473538059|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
131522529|NCT02501096|473538060|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
131522530|NCT02501096|473538061|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
131522531|NCT02501096|473538053|FG000|Overall Study|Death|1|||
131522532|NCT02501096|473538054|FG001|Overall Study|Death|1|||
131522533|NCT02501096|473538055|FG002|Overall Study|Death|88|||
131522534|NCT02501096|473538056|FG003|Overall Study|Death|74|||
131522535|NCT02501096|473538057|FG004|Overall Study|Death|15|||
131522536|NCT02501096|473538058|FG005|Overall Study|Death|16|||
131522537|NCT02501096|473538059|FG006|Overall Study|Death|15|||
131522538|NCT02501096|473538060|FG007|Overall Study|Death|16|||
131522539|NCT02501096|473538061|FG008|Overall Study|Death|1|||
131522540|NCT04187196|473538062|FG000|Overall Study|Screen Failure|2|||
131522541|NCT04187196|473538063|FG001|Overall Study|Screen Failure|0|||
131522542|NCT03149237|473538064|FG000|Overall Study|Withdrawal by Subject|4|||
131522543|NCT03149237|473538065|FG001|Overall Study|Withdrawal by Subject|5|||
131522544|NCT01957475|473538066|FG000|Test Period 1|Withdrawal by Subject|1|||
131522545|NCT01957475|473538067|FG001|Test Period 1|Withdrawal by Subject|0|||
131522546|NCT01957475|473538066|FG000|Test Period 1|Other|1|||
131522547|NCT01957475|473538067|FG001|Test Period 1|Other|0|||
131522548|NCT01957475|473538066|FG000|Test Period 1|Lack of Efficacy|0|||
131522549|NCT01957475|473538067|FG001|Test Period 1|Lack of Efficacy|1|||
131522550|NCT01957475|473538066|FG000|Test Period 2|Adverse Event|1|||
131522551|NCT01957475|473538067|FG001|Test Period 2|Adverse Event|0|||
131522552|NCT01552772|473538068|FG000|Overall Study|Lost to Follow-up|2|||
131522553|NCT01552772|473538068|FG000|Overall Study|Adverse Event|1|||
131522554|NCT01552772|473538068|FG000|Overall Study|Protocol Deviation|1|||
131522555|NCT01466192|473538069|FG000|Overall Study|Physician Decision|1|||
131522556|NCT01466192|473538069|FG000|Overall Study|Withdrawal by Subject|3|||
131522557|NCT02920983|473538072|FG000|Dispense 1|Unacceptable Lens Fit|0|||
131522558|NCT02920983|473538073|FG001|Dispense 1|Unacceptable Lens Fit|0|||
131522559|NCT02920983|473538074|FG002|Dispense 1|Unacceptable Lens Fit|0|||
131522560|NCT02920983|473538075|FG003|Dispense 1|Unacceptable Lens Fit|0|||
131522561|NCT02920983|473538076|FG004|Dispense 1|Unacceptable Lens Fit|1|||
131522562|NCT02920983|473538077|FG005|Dispense 1|Unacceptable Lens Fit|0|||
131522563|NCT02920983|473538072|FG000|Dispense 2|Unscceptable lens fit|1|||
131522564|NCT02920983|473538073|FG001|Dispense 2|Unscceptable lens fit|0|||
131522565|NCT02920983|473538074|FG002|Dispense 2|Unscceptable lens fit|0|||
131522566|NCT02920983|473538075|FG003|Dispense 2|Unscceptable lens fit|0|||
131522567|NCT02920983|473538076|FG004|Dispense 2|Unscceptable lens fit|1|||
131522568|NCT02920983|473538077|FG005|Dispense 2|Unscceptable lens fit|0|||
131522569|NCT02920983|473538072|FG000|Dispense 3|Unacceptable Lens Fit|1|||
131522570|NCT02920983|473538073|FG001|Dispense 3|Unacceptable Lens Fit|1|||
131522571|NCT02920983|473538074|FG002|Dispense 3|Unacceptable Lens Fit|0|||
131522572|NCT02920983|473538075|FG003|Dispense 3|Unacceptable Lens Fit|0|||
131522573|NCT02920983|473538076|FG004|Dispense 3|Unacceptable Lens Fit|1|||
131522574|NCT02920983|473538077|FG005|Dispense 3|Unacceptable Lens Fit|0|||
131522575|NCT03878134|473538078|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
131522576|NCT01227512|473538079|FG000|Overall Study|Physician Decision|6|||
131522577|NCT01227512|473538080|FG001|Overall Study|Physician Decision|6|||
131522578|NCT01227512|473538079|FG000|Overall Study|Adverse Event|4|||
131522579|NCT01227512|473538080|FG001|Overall Study|Adverse Event|3|||
131522580|NCT01227512|473538079|FG000|Overall Study|Withdrawal by Subject|3|||
131522581|NCT01227512|473538080|FG001|Overall Study|Withdrawal by Subject|0|||
131522582|NCT01227512|473538079|FG000|Overall Study|Participant met withdrawal criteria|0|||
131522583|NCT01227512|473538080|FG001|Overall Study|Participant met withdrawal criteria|1|||
131522584|NCT04055116|473538087|FG000|First Intervention|Physician Decision|2|||
131522585|NCT04055116|473538088|FG001|First Intervention|Physician Decision|7|||
131522586|NCT02774681|473538089|FG000|Treatment on Study|Progressive Disease|7|||
131522587|NCT02774681|473538089|FG000|Follow-Up for 3 Years|Death|11|||
131522588|NCT02774681|473538089|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
131522589|NCT00773097|473538090|FG000|Overall Study|Withdrawal by Subject|1|||
131522590|NCT00773097|473538090|FG000|Overall Study|Physician Decision|6|||
131522591|NCT01755416|473538092|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
131522592|NCT01755416|473538093|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
131522593|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
131522594|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
131522595|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
131522596|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Death|1|||
131522597|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Death|0|||
131522598|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Death|0|||
131522599|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
131522600|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
131522601|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
131522602|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
131522603|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
131522604|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
131545849|NCT01939548|473620008|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
131522605|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
131522606|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
131522607|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
131522608|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
131522609|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
131522610|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
131522611|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
131522612|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
131522613|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
131522614|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
131522615|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
131522616|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
131522617|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
131522618|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
131522619|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
131522620|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
131522621|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
131522622|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
131522623|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
131522624|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
131522625|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
131522626|NCT03655236|473538094|FG000|Subject Disposition in Part 1 Period|Other|0|||
131522627|NCT03655236|473538095|FG001|Subject Disposition in Part 1 Period|Other|2|||
131522628|NCT03655236|473538096|FG002|Subject Disposition in Part 1 Period|Other|2|||
131522629|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
131522630|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
131522631|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
131522632|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
131522633|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
131522634|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
131522635|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
131522636|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
131522637|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
131522638|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
131522639|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
131522640|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
131522641|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
131522642|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
131522643|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
131522644|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
131522645|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
131522646|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
131522647|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
131522648|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
131522649|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
131522650|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
131522651|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
131522652|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
131522653|NCT03655236|473538094|FG000|Subject Disposition in Part 2 Period|Other|1|||
131522654|NCT03655236|473538095|FG001|Subject Disposition in Part 2 Period|Other|0|||
131522655|NCT03655236|473538096|FG002|Subject Disposition in Part 2 Period|Other|0|||
131522656|NCT02742103|473539745|FG000|Overall Study|Protocol Violation|1|||
131522657|NCT02742103|473539746|FG001|Overall Study|Protocol Violation|0|||
131522658|NCT02742103|473539745|FG000|Overall Study|Death|2|||
131522659|NCT02742103|473539746|FG001|Overall Study|Death|2|||
131522660|NCT02742103|473539745|FG000|Overall Study|Adverse Event|1|||
131522661|NCT02742103|473539746|FG001|Overall Study|Adverse Event|0|||
131522662|NCT02742103|473539745|FG000|Overall Study|Moved to another town|0|||
131522663|NCT02742103|473539746|FG001|Overall Study|Moved to another town|1|||
131522664|NCT02742103|473539745|FG000|Overall Study|Withdrawal by Subject|5|||
131522665|NCT02742103|473539746|FG001|Overall Study|Withdrawal by Subject|2|||
131522666|NCT02573324|473539747|FG000|Overall Study|Withdrawal by Subject|26|||
131522667|NCT02573324|473539748|FG001|Overall Study|Withdrawal by Subject|23|||
131522668|NCT02573324|473539749|FG002|Overall Study|Withdrawal by Subject|3|||
131522669|NCT02573324|473539747|FG000|Overall Study|Lost to Follow-up|4|||
131522670|NCT02573324|473539748|FG001|Overall Study|Lost to Follow-up|5|||
131522671|NCT02573324|473539749|FG002|Overall Study|Lost to Follow-up|0|||
131522672|NCT02573324|473539747|FG000|Overall Study|Study Terminated by Sponsor|107|||
131522673|NCT02573324|473539748|FG001|Overall Study|Study Terminated by Sponsor|89|||
131522674|NCT02573324|473539749|FG002|Overall Study|Study Terminated by Sponsor|2|||
131522675|NCT02573324|473539747|FG000|Overall Study|Death|182|||
131522676|NCT02573324|473539748|FG001|Overall Study|Death|200|||
131522677|NCT02573324|473539749|FG002|Overall Study|Death|1|||
131522678|NCT02573324|473539747|FG000|Overall Study|Other, Not Specified|20|||
131522679|NCT02573324|473539748|FG001|Overall Study|Other, Not Specified|27|||
131522680|NCT02573324|473539749|FG002|Overall Study|Other, Not Specified|0|||
131522681|NCT02573324|473539747|FG000|Overall Study|Unknown Reason|2|||
131522682|NCT02573324|473539748|FG001|Overall Study|Unknown Reason|0|||
131522683|NCT02573324|473539749|FG002|Overall Study|Unknown Reason|0|||
131522684|NCT00600821|473539750|FG000|Overall Study|Death|45|||
131522685|NCT00600821|473539751|FG001|Overall Study|Death|46|||
131522686|NCT00600821|473539750|FG000|Overall Study|Lost to Follow-up|2|||
131522687|NCT00600821|473539751|FG001|Overall Study|Lost to Follow-up|2|||
131522688|NCT00600821|473539750|FG000|Overall Study|Withdrawal by Subject|1|||
131522689|NCT00600821|473539751|FG001|Overall Study|Withdrawal by Subject|1|||
131522690|NCT00600821|473539750|FG000|Overall Study|Terminated by sponsor|8|||
131522691|NCT00600821|473539751|FG001|Overall Study|Terminated by sponsor|6|||
131522692|NCT00600821|473539750|FG000|Overall Study|Objective progression or relapse|0|||
131522693|NCT00600821|473539751|FG001|Overall Study|Objective progression or relapse|1|||
131522694|NCT00600821|473539750|FG000|Overall Study|Randomized but not treated|0|||
131522695|NCT00600821|473539751|FG001|Overall Study|Randomized but not treated|1|||
131522696|NCT00600821|473539750|FG000|Overall Study|Other|2|||
131522697|NCT00600821|473539751|FG001|Overall Study|Other|3|||
131522698|NCT01607905|473539752|FG000|Overall Study|Withdrawal by participant|7|||
131522699|NCT01607905|473539753|FG001|Overall Study|Withdrawal by participant|2|||
131522700|NCT01607905|473539754|FG002|Overall Study|Withdrawal by participant|4|||
131522701|NCT01607905|473539755|FG003|Overall Study|Withdrawal by participant|6|||
131522702|NCT01607905|473539756|FG004|Overall Study|Withdrawal by participant|0|||
131522703|NCT01607905|473539757|FG005|Overall Study|Withdrawal by participant|4|||
131522704|NCT01607905|473539758|FG006|Overall Study|Withdrawal by participant|12|||
131522705|NCT01607905|473539752|FG000|Overall Study|Incidence or severity of AEs|5|||
131522706|NCT01607905|473539753|FG001|Overall Study|Incidence or severity of AEs|1|||
131522707|NCT01607905|473539754|FG002|Overall Study|Incidence or severity of AEs|1|||
131522708|NCT01607905|473539755|FG003|Overall Study|Incidence or severity of AEs|3|||
131522709|NCT01607905|473539756|FG004|Overall Study|Incidence or severity of AEs|0|||
131522710|NCT01607905|473539757|FG005|Overall Study|Incidence or severity of AEs|2|||
131522711|NCT01607905|473539758|FG006|Overall Study|Incidence or severity of AEs|8|||
131522712|NCT01607905|473539752|FG000|Overall Study|Disease progression|44|||
131522713|NCT01607905|473539753|FG001|Overall Study|Disease progression|16|||
131522714|NCT01607905|473539754|FG002|Overall Study|Disease progression|15|||
131522715|NCT01607905|473539755|FG003|Overall Study|Disease progression|11|||
131522716|NCT01607905|473539756|FG004|Overall Study|Disease progression|6|||
131522717|NCT01607905|473539757|FG005|Overall Study|Disease progression|7|||
131522718|NCT01607905|473539758|FG006|Overall Study|Disease progression|21|||
131522719|NCT01607905|473539752|FG000|Overall Study|Non-compliance with study procedures|0|||
131522720|NCT01607905|473539753|FG001|Overall Study|Non-compliance with study procedures|0|||
131522721|NCT01607905|473539754|FG002|Overall Study|Non-compliance with study procedures|0|||
131522722|NCT01607905|473539755|FG003|Overall Study|Non-compliance with study procedures|0|||
131522723|NCT01607905|473539756|FG004|Overall Study|Non-compliance with study procedures|0|||
131522724|NCT01607905|473539757|FG005|Overall Study|Non-compliance with study procedures|0|||
131522725|NCT01607905|473539758|FG006|Overall Study|Non-compliance with study procedures|1|||
131522726|NCT01607905|473539752|FG000|Overall Study|Death|1|||
131522727|NCT01607905|473539753|FG001|Overall Study|Death|1|||
131522728|NCT01607905|473539754|FG002|Overall Study|Death|1|||
131522729|NCT01607905|473539755|FG003|Overall Study|Death|1|||
131522730|NCT01607905|473539756|FG004|Overall Study|Death|0|||
131522731|NCT01607905|473539757|FG005|Overall Study|Death|0|||
131522732|NCT01607905|473539758|FG006|Overall Study|Death|3|||
131522733|NCT01607905|473539752|FG000|Overall Study|Other treatments become available|1|||
131522734|NCT01607905|473539753|FG001|Overall Study|Other treatments become available|0|||
131522735|NCT01607905|473539754|FG002|Overall Study|Other treatments become available|0|||
131522736|NCT01607905|473539755|FG003|Overall Study|Other treatments become available|0|||
131522737|NCT01607905|473539756|FG004|Overall Study|Other treatments become available|0|||
131522738|NCT01607905|473539757|FG005|Overall Study|Other treatments become available|0|||
131522739|NCT01607905|473539758|FG006|Overall Study|Other treatments become available|1|||
131522740|NCT01607905|473539752|FG000|Overall Study|Investigator discretion|0|||
131522741|NCT01607905|473539753|FG001|Overall Study|Investigator discretion|0|||
131522742|NCT01607905|473539754|FG002|Overall Study|Investigator discretion|0|||
131522743|NCT01607905|473539755|FG003|Overall Study|Investigator discretion|0|||
131522744|NCT01607905|473539756|FG004|Overall Study|Investigator discretion|0|||
131522745|NCT01607905|473539757|FG005|Overall Study|Investigator discretion|1|||
131522746|NCT01607905|473539758|FG006|Overall Study|Investigator discretion|0|||
131522747|NCT01607905|473539752|FG000|Overall Study|Other|1|||
131522748|NCT01607905|473539753|FG001|Overall Study|Other|0|||
131522749|NCT01607905|473539754|FG002|Overall Study|Other|0|||
131522750|NCT01607905|473539755|FG003|Overall Study|Other|0|||
131522751|NCT01607905|473539756|FG004|Overall Study|Other|0|||
131522752|NCT01607905|473539757|FG005|Overall Study|Other|0|||
131522753|NCT01607905|473539758|FG006|Overall Study|Other|1|||
131522754|NCT01607905|473539752|FG000|Overall Study|Randomized but not treated|1|||
131522755|NCT01607905|473539753|FG001|Overall Study|Randomized but not treated|0|||
131522756|NCT01607905|473539754|FG002|Overall Study|Randomized but not treated|0|||
131522757|NCT01607905|473539755|FG003|Overall Study|Randomized but not treated|0|||
131522758|NCT01607905|473539756|FG004|Overall Study|Randomized but not treated|1|||
131522759|NCT01607905|473539757|FG005|Overall Study|Randomized but not treated|1|||
131522760|NCT01607905|473539758|FG006|Overall Study|Randomized but not treated|0|||
131522761|NCT01105533|473539759|FG000|Overall Study|Death|0|||
131522762|NCT01105533|473539760|FG001|Overall Study|Death|0|||
131522763|NCT01105533|473539761|FG002|Overall Study|Death|0|||
131522764|NCT01105533|473539762|FG003|Overall Study|Death|0|||
131522765|NCT01105533|473539763|FG004|Overall Study|Death|1|||
131522766|NCT01105533|473539764|FG005|Overall Study|Death|0|||
131522767|NCT01105533|473539765|FG006|Overall Study|Death|0|||
131522768|NCT01105533|473539766|FG007|Overall Study|Death|0|||
131522769|NCT01105533|473539767|FG008|Overall Study|Death|0|||
131522770|NCT01105533|473539759|FG000|Overall Study|Lack of Efficacy|1|||
131522771|NCT01105533|473539760|FG001|Overall Study|Lack of Efficacy|1|||
131522772|NCT01105533|473539761|FG002|Overall Study|Lack of Efficacy|3|||
131522773|NCT01105533|473539762|FG003|Overall Study|Lack of Efficacy|3|||
131522774|NCT01105533|473539763|FG004|Overall Study|Lack of Efficacy|4|||
131522775|NCT01105533|473539764|FG005|Overall Study|Lack of Efficacy|5|||
131522776|NCT01105533|473539765|FG006|Overall Study|Lack of Efficacy|3|||
131522777|NCT01105533|473539766|FG007|Overall Study|Lack of Efficacy|2|||
131522778|NCT01105533|473539767|FG008|Overall Study|Lack of Efficacy|9|||
131522779|NCT01105533|473539759|FG000|Overall Study|Adverse Event|0|||
131522780|NCT01105533|473539760|FG001|Overall Study|Adverse Event|0|||
131522781|NCT01105533|473539761|FG002|Overall Study|Adverse Event|0|||
131522782|NCT01105533|473539762|FG003|Overall Study|Adverse Event|0|||
131522783|NCT01105533|473539763|FG004|Overall Study|Adverse Event|1|||
131522784|NCT01105533|473539764|FG005|Overall Study|Adverse Event|2|||
131522785|NCT01105533|473539765|FG006|Overall Study|Adverse Event|2|||
131522786|NCT01105533|473539766|FG007|Overall Study|Adverse Event|0|||
131522787|NCT01105533|473539767|FG008|Overall Study|Adverse Event|1|||
131522788|NCT01105533|473539759|FG000|Overall Study|Other|0|||
131522789|NCT01105533|473539760|FG001|Overall Study|Other|0|||
131522790|NCT01105533|473539761|FG002|Overall Study|Other|0|||
131522791|NCT01105533|473539762|FG003|Overall Study|Other|0|||
131522792|NCT01105533|473539763|FG004|Overall Study|Other|1|||
131522793|NCT01105533|473539764|FG005|Overall Study|Other|0|||
131522794|NCT01105533|473539765|FG006|Overall Study|Other|3|||
131522795|NCT01105533|473539766|FG007|Overall Study|Other|1|||
131522796|NCT01105533|473539767|FG008|Overall Study|Other|2|||
131522797|NCT01105533|473539759|FG000|Overall Study|Physician Decision|0|||
131522798|NCT01105533|473539760|FG001|Overall Study|Physician Decision|0|||
131522799|NCT01105533|473539761|FG002|Overall Study|Physician Decision|0|||
131522800|NCT01105533|473539762|FG003|Overall Study|Physician Decision|0|||
131522801|NCT01105533|473539763|FG004|Overall Study|Physician Decision|0|||
131522802|NCT01105533|473539764|FG005|Overall Study|Physician Decision|0|||
131522803|NCT01105533|473539765|FG006|Overall Study|Physician Decision|0|||
131522804|NCT01105533|473539766|FG007|Overall Study|Physician Decision|1|||
131522805|NCT01105533|473539767|FG008|Overall Study|Physician Decision|0|||
131522806|NCT02096835|473539769|FG000|Overall Study|Withdrawal by Subject|1|||
131522807|NCT02096835|473539770|FG001|Overall Study|Withdrawal by Subject|0|||
131522808|NCT02096835|473539771|FG002|Overall Study|Withdrawal by Subject|0|||
131522809|NCT02096835|473539769|FG000|Overall Study|converted to open procedures|1|||
131522810|NCT02096835|473539770|FG001|Overall Study|converted to open procedures|0|||
131522811|NCT02096835|473539771|FG002|Overall Study|converted to open procedures|0|||
131522812|NCT02096835|473539769|FG000|Overall Study|Lost to Follow-up|1|||
131522813|NCT02096835|473539770|FG001|Overall Study|Lost to Follow-up|0|||
131522814|NCT02096835|473539771|FG002|Overall Study|Lost to Follow-up|1|||
131522815|NCT03892889|473539772|FG000|Overall Study|Adverse Event|17|||
131522816|NCT03892889|473539772|FG000|Overall Study|Lack of Efficacy|1|||
131522817|NCT03892889|473539772|FG000|Overall Study|Lost to Follow-up|46|||
131522818|NCT03892889|473539772|FG000|Overall Study|Non-compliance with study drug|22|||
131522819|NCT03892889|473539772|FG000|Overall Study|Pregnancy|1|||
131522820|NCT03892889|473539772|FG000|Overall Study|Protocol Deviation|3|||
131522821|NCT03892889|473539772|FG000|Overall Study|Withdrawal by Subject|50|||
131522822|NCT03892889|473539772|FG000|Overall Study|Withdrawal by Caregiver|1|||
131522823|NCT03892889|473539772|FG000|Overall Study|Study Terminated by Sponsor|50|||
131522824|NCT03892889|473539772|FG000|Overall Study|Physician Decision|8|||
131522825|NCT03892889|473539772|FG000|Overall Study|Reason not Specified|5|||
131522826|NCT04101526|473539782|FG000|Overall Study|Did not complete all sleep diary entries|0|||
131522827|NCT04101526|473539783|FG001|Overall Study|Did not complete all sleep diary entries|1|||
131522828|NCT00424372|473539784|FG000|Overall Study|Death|1|||
131522829|NCT00424372|473539784|FG000|Overall Study|Adverse Event|18|||
131522830|NCT00424372|473539784|FG000|Overall Study|Lack of Efficacy|6|||
131522831|NCT00424372|473539784|FG000|Overall Study|Withdrawal by Subject|4|||
131522832|NCT00424372|473539784|FG000|Overall Study|Protocol Violation|1|||
131522833|NCT00424372|473539784|FG000|Overall Study|Health deterioration|1|||
131522834|NCT04622254|473539785|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
131522835|NCT04622254|473539786|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
131522836|NCT04622254|473539787|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
131522837|NCT04622254|473539788|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
131522838|NCT04622254|473539789|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
131522839|NCT04622254|473539790|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
131522840|NCT04622254|473539785|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
131522841|NCT04622254|473539786|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
131522842|NCT04622254|473539787|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
131522843|NCT04622254|473539788|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131522844|NCT04622254|473539789|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131522845|NCT04622254|473539790|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131522846|NCT04622254|473539785|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
131522847|NCT04622254|473539786|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
131522848|NCT04622254|473539787|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
131522849|NCT04622254|473539788|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
131522850|NCT04622254|473539789|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
131522851|NCT04622254|473539790|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
131522852|NCT04622254|473539785|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131522853|NCT04622254|473539786|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
131522854|NCT04622254|473539787|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
131522855|NCT04622254|473539788|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131522856|NCT04622254|473539789|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131522857|NCT04622254|473539790|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131522858|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131522859|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131522860|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131522861|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
131522862|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131522863|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131522864|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131522865|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131522866|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131522867|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
131522868|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131522869|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
131522870|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131522871|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131522872|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131522873|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
131522874|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131522875|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131522876|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131522877|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131522878|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131522879|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
131522880|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131522881|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131522882|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131522883|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131522884|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131522885|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
131522886|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
131522887|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
131522888|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131522889|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131522890|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131522891|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
131522892|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
131522893|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
131522894|NCT04622254|473539785|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
131522895|NCT04622254|473539786|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
131522896|NCT04622254|473539787|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
131522897|NCT04622254|473539788|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
131522898|NCT04622254|473539789|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
131522899|NCT04622254|473539790|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
131522900|NCT00098839|473539791|FG000|Overall Study|Adverse Event|5|||
131522901|NCT00098839|473539792|FG001|Overall Study|Adverse Event|2|||
131522902|NCT00098839|473539791|FG000|Overall Study|Death|1|||
131522903|NCT00098839|473539792|FG001|Overall Study|Death|2|||
131522904|NCT00098839|473539791|FG000|Overall Study|Physician Decision|4|||
131522905|NCT00098839|473539792|FG001|Overall Study|Physician Decision|14|||
131522906|NCT00098839|473539791|FG000|Overall Study|Withdrawal by Subject|1|||
131522907|NCT00098839|473539792|FG001|Overall Study|Withdrawal by Subject|0|||
131522908|NCT00098839|473539791|FG000|Overall Study|Refusal of further protocol therapy|3|||
131522909|NCT00098839|473539792|FG001|Overall Study|Refusal of further protocol therapy|1|||
131522910|NCT00098839|473539791|FG000|Overall Study|Relapse|6|||
131522911|NCT00098839|473539792|FG001|Overall Study|Relapse|3|||
131522912|NCT00098839|473539791|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
131522913|NCT00098839|473539792|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
131522914|NCT00098839|473539791|FG000|Overall Study|Ineligible|2|||
131522915|NCT00098839|473539792|FG001|Overall Study|Ineligible|0|||
131522916|NCT02167035|473539793|FG000|Overall Study|Adverse Event|2|||
131522917|NCT02167035|473539794|FG001|Overall Study|Adverse Event|2|||
131522918|NCT02167035|473539793|FG000|Overall Study|Lost to Follow-up|3|||
131522919|NCT02167035|473539794|FG001|Overall Study|Lost to Follow-up|3|||
131522920|NCT02167035|473539793|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
131522921|NCT02167035|473539794|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
131522922|NCT00844545|473539795|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
131522923|NCT00844545|473539795|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
131522924|NCT00844545|473539795|FG000|Extension Treatment Period|Adverse Event|2|||
131522925|NCT00844545|473539795|FG000|Post Treatment Period|Withdrawal by Subject|1|||
131522926|NCT02039427|473539796|FG000|Overall Study|Duration of surgery > 3h|1|||
131522927|NCT02039427|473539797|FG001|Overall Study|Duration of surgery > 3h|1|||
131522928|NCT02039427|473539798|FG002|Overall Study|Duration of surgery > 3h|0|||
131522929|NCT02039427|473539799|FG003|Overall Study|Duration of surgery > 3h|0|||
131522930|NCT02039427|473539796|FG000|Overall Study|Withdrawal on concent|0|||
131522931|NCT02039427|473539797|FG001|Overall Study|Withdrawal on concent|0|||
131522932|NCT02039427|473539798|FG002|Overall Study|Withdrawal on concent|0|||
131522933|NCT02039427|473539799|FG003|Overall Study|Withdrawal on concent|1|||
131522934|NCT02039427|473539796|FG000|Overall Study|Cancellation of surgery|0|||
131522935|NCT02039427|473539797|FG001|Overall Study|Cancellation of surgery|0|||
131522936|NCT02039427|473539798|FG002|Overall Study|Cancellation of surgery|1|||
131522937|NCT02039427|473539799|FG003|Overall Study|Cancellation of surgery|0|||
131522938|NCT02039427|473539796|FG000|Overall Study|Loss of follow - up|1|||
131522939|NCT02039427|473539797|FG001|Overall Study|Loss of follow - up|0|||
131522940|NCT02039427|473539798|FG002|Overall Study|Loss of follow - up|2|||
131522941|NCT02039427|473539799|FG003|Overall Study|Loss of follow - up|4|||
131522942|NCT02039427|473539796|FG000|Overall Study|Steroid Use|1|||
131522943|NCT02039427|473539797|FG001|Overall Study|Steroid Use|0|||
131522944|NCT02039427|473539798|FG002|Overall Study|Steroid Use|0|||
131522945|NCT02039427|473539799|FG003|Overall Study|Steroid Use|0|||
131522946|NCT01743092|473539800|FG000|Overall Study|Lost to Follow-up|14|||
131522947|NCT01743092|473539801|FG001|Overall Study|Lost to Follow-up|15|||
131522948|NCT03586869|473539807|FG000|Overall Study|Progressive Disease|3|||
131522949|NCT00403455|473539808|FG000|Overall Study|Withdrawal by Subject|1|||
131522950|NCT00087568|473539809|FG000|Overall Study|Adverse Event|4|||
131522951|NCT00087568|473539810|FG001|Overall Study|Adverse Event|0|||
131522952|NCT00087568|473539809|FG000|Overall Study|Withdrawal by Subject|1|||
131522953|NCT00087568|473539810|FG001|Overall Study|Withdrawal by Subject|1|||
131522954|NCT00087568|473539809|FG000|Overall Study|Lost to Follow-up|1|||
131522955|NCT00087568|473539810|FG001|Overall Study|Lost to Follow-up|0|||
131522956|NCT00087568|473539809|FG000|Overall Study|Lack of Efficacy|24|||
131522957|NCT00087568|473539810|FG001|Overall Study|Lack of Efficacy|1|||
131522958|NCT04354831|473539815|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
131522959|NCT04354831|473539816|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
131522960|NCT02732847|473539817|FG000|Overall Study|some filled early|42|||
131522961|NCT02732847|473539818|FG001|Overall Study|some filled early|42|||
131522962|NCT01430585|473539819|FG000|Overall Study|Death|1|||
131522963|NCT01430585|473539819|FG000|Overall Study|Objective Progression or Relapse|3|||
131522964|NCT01430585|473539819|FG000|Overall Study|Study Terminated by Sponsor|3|||
131522965|NCT01430585|473539819|FG000|Overall Study|Other|7|||
131522966|NCT01274637|473539822|FG000|Overall Study|Withdrawal by Subject|0|||
131522967|NCT01274637|473539823|FG001|Overall Study|Withdrawal by Subject|1|||
131522968|NCT01274637|473539822|FG000|Overall Study|Lost to Follow-up|0|||
131522969|NCT01274637|473539823|FG001|Overall Study|Lost to Follow-up|1|||
131522970|NCT02357576|473539826|FG000|Treatment Period|Withdrawal by Subject|0|||
131522971|NCT02357576|473539827|FG001|Treatment Period|Withdrawal by Subject|1|||
131522972|NCT02357576|473539826|FG000|Treatment Period|Physician Decision|0|||
131522973|NCT02357576|473539827|FG001|Treatment Period|Physician Decision|1|||
131522974|NCT02357576|473539826|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
131522975|NCT02357576|473539827|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
131522976|NCT02357576|473539826|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
131522977|NCT02357576|473539827|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
131522978|NCT02357576|473539826|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
131522979|NCT02357576|473539827|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
131522980|NCT02357576|473539826|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
131522981|NCT02357576|473539827|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
131522982|NCT00699699|473539830|FG000|Overall Study|Adverse Event|36|||
131522983|NCT00699699|473539830|FG000|Overall Study|Individual different reasons|21|||
131522984|NCT01632800|473539833|FG000|Overall Study|Subject did not fit in apparatus|1|||
131522985|NCT00720876|473539835|FG000|Overall Study|found to be ineligible after starting tx|2|||
131522986|NCT03495908|473539837|FG000|Overall Study|Withdrawal by Subject|3|||
131522987|NCT03495908|473539838|FG001|Overall Study|Withdrawal by Subject|1|||
131522988|NCT03495908|473539837|FG000|Overall Study|Lost to Follow-up|1|||
131522989|NCT03495908|473539838|FG001|Overall Study|Lost to Follow-up|4|||
131522990|NCT03495908|473539837|FG000|Overall Study|Adverse Event|0|||
131522991|NCT03495908|473539838|FG001|Overall Study|Adverse Event|2|||
131522992|NCT03495908|473539837|FG000|Overall Study|Death|1|||
131522993|NCT03495908|473539838|FG001|Overall Study|Death|0|||
131522994|NCT03495908|473539837|FG000|Overall Study|Physician Decision|5|||
131522995|NCT03495908|473539838|FG001|Overall Study|Physician Decision|4|||
131522996|NCT03495908|473539837|FG000|Overall Study|No documented reason|0|||
131522997|NCT03495908|473539838|FG001|Overall Study|No documented reason|2|||
131522998|NCT03511560|473539844|FG000|Overall Study|Death|0|||
131522999|NCT03511560|473539845|FG001|Overall Study|Death|1|||
131523000|NCT03511560|473539844|FG000|Overall Study|Adverse Event|0|||
131523001|NCT03511560|473539845|FG001|Overall Study|Adverse Event|2|||
131523002|NCT03511560|473539844|FG000|Overall Study|Transplant cancelled|0|||
131523003|NCT03511560|473539845|FG001|Overall Study|Transplant cancelled|1|||
131523004|NCT03511560|473539844|FG000|Overall Study|Patient switched to another drug|1|||
131523005|NCT03511560|473539845|FG001|Overall Study|Patient switched to another drug|0|||
131523006|NCT02985736|473539850|FG000|Overall Study|Lost to Follow-up|3|||
131523007|NCT00382733|473539851|FG000|Overall Study|Withdrawal by Subject|0|||
131523008|NCT00382733|473539852|FG001|Overall Study|Withdrawal by Subject|1|||
131523009|NCT00382733|473539853|FG002|Overall Study|Withdrawal by Subject|0|||
131523010|NCT00382733|473539854|FG003|Overall Study|Withdrawal by Subject|0|||
131523011|NCT00382733|473539855|FG004|Overall Study|Withdrawal by Subject|0|||
131523012|NCT00439140|473539860|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
131523013|NCT00439140|473539861|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
131523014|NCT00439140|473539862|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
131523015|NCT00439140|473539860|FG000|Treatment Cycle 1|Personal reasons|0|||
131523016|NCT00439140|473539861|FG001|Treatment Cycle 1|Personal reasons|2|||
131523017|NCT00439140|473539862|FG002|Treatment Cycle 1|Personal reasons|0|||
131523018|NCT00439140|473539860|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
131523019|NCT00439140|473539861|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
131523020|NCT00439140|473539862|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
131523021|NCT00439140|473539860|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
131523022|NCT00439140|473539861|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
131523023|NCT00439140|473539862|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
131523024|NCT00439140|473539860|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
131523025|NCT00439140|473539861|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
131523026|NCT00439140|473539862|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
131523027|NCT01458171|473539863|FG000|Overall Study|Adverse Event|1|||
131523028|NCT01193556|473539864|FG000|Overall Study|Study termination|26|||
131523029|NCT01193556|473539865|FG001|Overall Study|Study termination|25|||
131523030|NCT05013905|473539866|FG000|Overall Study|Adverse Event|1|||
131523031|NCT05013905|473539866|FG000|Overall Study|Lack of Efficacy|1|||
131523032|NCT03286140|473539870|FG000|Overall Study|Withdrawal by Subject|10|||
131523033|NCT03286140|473539871|FG001|Overall Study|Withdrawal by Subject|5|||
131523034|NCT03286140|473539870|FG000|Overall Study|Lost to Follow-up|5|||
131523035|NCT03286140|473539871|FG001|Overall Study|Lost to Follow-up|10|||
131523036|NCT03286140|473539870|FG000|Overall Study|Failure to comply|0|||
131523037|NCT03286140|473539871|FG001|Overall Study|Failure to comply|1|||
131523038|NCT05402995|473539872|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
131523039|NCT05402995|473539873|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
131523040|NCT05402995|473539874|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
131523041|NCT05402995|473539875|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
131523042|NCT02188485|473539876|FG000|Overall Study|Withdrawal by Subject|2|||
131523043|NCT02188485|473539877|FG001|Overall Study|Withdrawal by Subject|1|||
131523044|NCT02188485|473539876|FG000|Overall Study|PI withdrew, lack of capacity|0|||
131523045|NCT02188485|473539877|FG001|Overall Study|PI withdrew, lack of capacity|2|||
131523046|NCT04497987|473539884|FG000|Overall Study|Adverse Event|1|||
131523047|NCT04497987|473539885|FG001|Overall Study|Adverse Event|0|||
131523048|NCT04497987|473539884|FG000|Overall Study|Death|21|||
131523049|NCT04497987|473539885|FG001|Overall Study|Death|13|||
131523050|NCT04497987|473539884|FG000|Overall Study|Lost to Follow-up|19|||
131523051|NCT04497987|473539885|FG001|Overall Study|Lost to Follow-up|17|||
131523052|NCT04497987|473539884|FG000|Overall Study|Other - as reported by the investigator|22|||
131523053|NCT04497987|473539885|FG001|Overall Study|Other - as reported by the investigator|16|||
131523054|NCT04497987|473539884|FG000|Overall Study|Physician Decision|1|||
131523055|NCT04497987|473539885|FG001|Overall Study|Physician Decision|0|||
131523056|NCT04497987|473539884|FG000|Overall Study|Withdrawal by Subject|35|||
131523057|NCT04497987|473539885|FG001|Overall Study|Withdrawal by Subject|21|||
131523058|NCT00512096|473539889|FG000|Overall Study|Adverse Event|2|||
131523059|NCT00512096|473539889|FG000|Overall Study|Withdrawal by Subject|2|||
131523060|NCT00512096|473539889|FG000|Overall Study|Lack of Efficacy|3|||
131523061|NCT01069289|473539890|FG000|Overall Study|Withdrawal by Subject|15|||
131523062|NCT01069289|473539891|FG001|Overall Study|Withdrawal by Subject|26|||
131523063|NCT01069289|473539890|FG000|Overall Study|Adverse Event|21|||
131523064|NCT01069289|473539891|FG001|Overall Study|Adverse Event|28|||
131523065|NCT01069289|473539890|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131523066|NCT01069289|473539891|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131523067|NCT01069289|473539890|FG000|Overall Study|Severe non-compliance to protocol|3|||
131523068|NCT01069289|473539891|FG001|Overall Study|Severe non-compliance to protocol|2|||
131523069|NCT01069289|473539890|FG000|Overall Study|Due to deteriorating health condition|1|||
131523070|NCT01069289|473539891|FG001|Overall Study|Due to deteriorating health condition|0|||
131523071|NCT00298038|473539892|FG000|Overall Study|Lost to Follow-up|0|||
131523072|NCT00298038|473539893|FG001|Overall Study|Lost to Follow-up|1|||
131523073|NCT00298038|473539892|FG000|Overall Study|Liver Transplant|0|||
131523074|NCT00298038|473539893|FG001|Overall Study|Liver Transplant|1|||
131523075|NCT00298038|473539892|FG000|Overall Study|Protocol Violation|1|||
131523076|NCT00298038|473539893|FG001|Overall Study|Protocol Violation|3|||
131523077|NCT00298038|473539892|FG000|Overall Study|Death|6|||
131523078|NCT00298038|473539893|FG001|Overall Study|Death|3|||
131523079|NCT00298038|473539892|FG000|Overall Study|Withdrawal by Subject|6|||
131523080|NCT00298038|473539893|FG001|Overall Study|Withdrawal by Subject|9|||
131523081|NCT00298038|473539892|FG000|Overall Study|Adverse Event|8|||
131523082|NCT00298038|473539893|FG001|Overall Study|Adverse Event|7|||
131658425|NCT01531673|474035299|FG000|Overall Study|Other|0|||
131523083|NCT00298038|473539892|FG000|Overall Study|Breakthrough overt HE episode|28|||
131523084|NCT00298038|473539893|FG001|Overall Study|Breakthrough overt HE episode|69|||
131523085|NCT00298038|473539892|FG000|Overall Study|Noncompliance|1|||
131523086|NCT00298038|473539893|FG001|Overall Study|Noncompliance|0|||
131523087|NCT00298038|473539892|FG000|Overall Study|Cocaine Abuse|1|||
131523088|NCT00298038|473539893|FG001|Overall Study|Cocaine Abuse|0|||
131523089|NCT00298038|473539892|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
131523090|NCT00298038|473539893|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
131523091|NCT02696096|473539894|FG000|Overall Study|ruled out at screening|1|||
131523092|NCT02696096|473539894|FG000|Overall Study|did not attend second fMRI|1|||
131523093|NCT02047604|473539895|FG000|Overall Study|Withdrawal by Subject|0|||
131523094|NCT02047604|473539896|FG001|Overall Study|Withdrawal by Subject|0|||
131523095|NCT02047604|473539897|FG002|Overall Study|Withdrawal by Subject|0|||
131523096|NCT02047604|473539898|FG003|Overall Study|Withdrawal by Subject|0|||
131523097|NCT02047604|473539899|FG004|Overall Study|Withdrawal by Subject|1|||
131523098|NCT02047604|473539900|FG005|Overall Study|Withdrawal by Subject|1|||
131523099|NCT02707640|473539901|FG000|Overall Study|Adverse Event|4|||
131523100|NCT02707640|473539902|FG001|Overall Study|Adverse Event|2|||
131523101|NCT02707640|473539901|FG000|Overall Study|Death|1|||
131523102|NCT02707640|473539902|FG001|Overall Study|Death|2|||
131523103|NCT02707640|473539901|FG000|Overall Study|Physician Decision|2|||
131523104|NCT02707640|473539902|FG001|Overall Study|Physician Decision|0|||
131523105|NCT02707640|473539901|FG000|Overall Study|Withdrawal by Subject|0|||
131523106|NCT02707640|473539902|FG001|Overall Study|Withdrawal by Subject|1|||
131523107|NCT02707640|473539901|FG000|Overall Study|Participant's Personal Decision|1|||
131523108|NCT02707640|473539902|FG001|Overall Study|Participant's Personal Decision|2|||
131523109|NCT02707640|473539901|FG000|Overall Study|Sponsor Discretion|1|||
131523110|NCT02707640|473539902|FG001|Overall Study|Sponsor Discretion|0|||
131523111|NCT02556710|473541894|FG000|Overall Study|Surgical treatment|3|||
131523112|NCT02556710|473541895|FG001|Overall Study|Surgical treatment|0|||
131523113|NCT02556710|473541894|FG000|Overall Study|Required proscribed pain medication|2|||
131523114|NCT02556710|473541895|FG001|Overall Study|Required proscribed pain medication|1|||
131523115|NCT02556710|473541894|FG000|Overall Study|Lack of Efficacy|1|||
131523116|NCT02556710|473541895|FG001|Overall Study|Lack of Efficacy|0|||
131523117|NCT02556710|473541894|FG000|Overall Study|Worsening osteoarthritis|1|||
131523118|NCT02556710|473541895|FG001|Overall Study|Worsening osteoarthritis|0|||
131523119|NCT02556710|473541894|FG000|Overall Study|Moved out of state|1|||
131523120|NCT02556710|473541895|FG001|Overall Study|Moved out of state|0|||
131523121|NCT02556710|473541894|FG000|Overall Study|Missing reason|3|||
131523122|NCT02556710|473541895|FG001|Overall Study|Missing reason|1|||
131523123|NCT02556710|473541894|FG000|Overall Study|Pain as lack of efficacy|0|||
131523124|NCT02556710|473541895|FG001|Overall Study|Pain as lack of efficacy|4|||
131523125|NCT03042312|473541896|FG000|Overall Study|Administrative Reason|1|||
131523126|NCT03042312|473541897|FG001|Overall Study|Administrative Reason|1|||
131523127|NCT03042312|473541896|FG000|Overall Study|Adverse Event|0|||
131523128|NCT03042312|473541897|FG001|Overall Study|Adverse Event|1|||
131523129|NCT03042312|473541896|FG000|Overall Study|Lost to Follow-up|1|||
131523130|NCT03042312|473541897|FG001|Overall Study|Lost to Follow-up|3|||
131523131|NCT03042312|473541896|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
131523132|NCT03042312|473541897|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
131523133|NCT03042312|473541896|FG000|Overall Study|Withdrawal by Subject|4|||
131523134|NCT03042312|473541897|FG001|Overall Study|Withdrawal by Subject|5|||
131523135|NCT00646958|473541900|FG000|Overall Study|Lack of Efficacy|1|||
131523136|NCT00646958|473541901|FG001|Overall Study|Lack of Efficacy|0|||
131523137|NCT00646958|473541902|FG002|Overall Study|Lack of Efficacy|0|||
131523138|NCT00646958|473541900|FG000|Overall Study|Adverse Event|4|||
131523139|NCT00646958|473541901|FG001|Overall Study|Adverse Event|0|||
131523140|NCT00646958|473541902|FG002|Overall Study|Adverse Event|0|||
131523141|NCT00646958|473541900|FG000|Overall Study|Lost to Follow-up|1|||
131523142|NCT00646958|473541901|FG001|Overall Study|Lost to Follow-up|5|||
131523143|NCT00646958|473541902|FG002|Overall Study|Lost to Follow-up|7|||
131523144|NCT00646958|473541900|FG000|Overall Study|Protocol Violation|1|||
131523145|NCT00646958|473541901|FG001|Overall Study|Protocol Violation|1|||
131523146|NCT00646958|473541902|FG002|Overall Study|Protocol Violation|0|||
131523147|NCT00646958|473541900|FG000|Overall Study|Abnormal screening lab tests|1|||
131523148|NCT00646958|473541901|FG001|Overall Study|Abnormal screening lab tests|1|||
131523149|NCT00646958|473541902|FG002|Overall Study|Abnormal screening lab tests|0|||
131523150|NCT00646958|473541900|FG000|Overall Study|Withdrawal by Subject|1|||
131523151|NCT00646958|473541901|FG001|Overall Study|Withdrawal by Subject|2|||
131523152|NCT00646958|473541902|FG002|Overall Study|Withdrawal by Subject|0|||
131523153|NCT00646958|473541900|FG000|Overall Study|Did not receive study drug|2|||
131523154|NCT00646958|473541901|FG001|Overall Study|Did not receive study drug|0|||
131523155|NCT00646958|473541902|FG002|Overall Study|Did not receive study drug|2|||
131523156|NCT04260191|473541904|FG000|Overall Study|Decision by Sponsor|0|||
131523157|NCT04260191|473541905|FG001|Overall Study|Decision by Sponsor|1|||
131523158|NCT04260191|473541906|FG002|Overall Study|Decision by Sponsor|0|||
131523159|NCT04260191|473541904|FG000|Overall Study|Withdrawal by Subject|1|||
131523160|NCT04260191|473541905|FG001|Overall Study|Withdrawal by Subject|0|||
131523161|NCT04260191|473541906|FG002|Overall Study|Withdrawal by Subject|3|||
131523162|NCT04260191|473541904|FG000|Overall Study|Death|4|||
131523163|NCT04260191|473541905|FG001|Overall Study|Death|3|||
131523164|NCT04260191|473541906|FG002|Overall Study|Death|2|||
131523165|NCT01312909|473541909|FG000|Overall Study|Randomized but not treated|1|||
131523166|NCT01312909|473541910|FG001|Overall Study|Randomized but not treated|3|||
131523167|NCT01312909|473541911|FG002|Overall Study|Randomized but not treated|1|||
131523168|NCT01312909|473541909|FG000|Overall Study|Adverse Event|1|||
131523169|NCT01312909|473541910|FG001|Overall Study|Adverse Event|0|||
131523170|NCT01312909|473541911|FG002|Overall Study|Adverse Event|3|||
131523171|NCT01312909|473541909|FG000|Overall Study|Protocol Violation|2|||
131523172|NCT01312909|473541910|FG001|Overall Study|Protocol Violation|0|||
131523173|NCT01312909|473541911|FG002|Overall Study|Protocol Violation|2|||
131523174|NCT01312909|473541909|FG000|Overall Study|Other|9|||
131523175|NCT01312909|473541910|FG001|Overall Study|Other|6|||
131523176|NCT01312909|473541911|FG002|Overall Study|Other|11|||
131523177|NCT01312909|473541909|FG000|Overall Study|Withdrawal by Subject|8|||
131523178|NCT01312909|473541910|FG001|Overall Study|Withdrawal by Subject|10|||
131523179|NCT01312909|473541911|FG002|Overall Study|Withdrawal by Subject|7|||
131523180|NCT01312909|473541909|FG000|Overall Study|Lost to Follow-up|21|||
131523181|NCT01312909|473541910|FG001|Overall Study|Lost to Follow-up|17|||
131523182|NCT01312909|473541911|FG002|Overall Study|Lost to Follow-up|20|||
131523183|NCT01312909|473541909|FG000|Overall Study|Insufficient clinical response|0|||
131523184|NCT01312909|473541910|FG001|Overall Study|Insufficient clinical response|0|||
131523185|NCT01312909|473541911|FG002|Overall Study|Insufficient clinical response|1|||
131523186|NCT01312909|473541909|FG000|Overall Study|Entrance criteria not met|0|||
131523187|NCT01312909|473541910|FG001|Overall Study|Entrance criteria not met|0|||
131523188|NCT01312909|473541911|FG002|Overall Study|Entrance criteria not met|2|||
131523189|NCT00659646|473541914|FG000|Overall Study|Protocol Violation|12|||
131523190|NCT00659646|473541915|FG001|Overall Study|Protocol Violation|8|||
131523191|NCT00659646|473541914|FG000|Overall Study|Adverse Event|1|||
131523192|NCT00659646|473541915|FG001|Overall Study|Adverse Event|0|||
131523193|NCT00659646|473541914|FG000|Overall Study|Lost to Follow-up|1|||
131523194|NCT00659646|473541915|FG001|Overall Study|Lost to Follow-up|0|||
131523195|NCT00659646|473541914|FG000|Overall Study|protocol noncompliance after randomized|1|||
131523196|NCT00659646|473541915|FG001|Overall Study|protocol noncompliance after randomized|0|||
131523197|NCT00023673|473541916|FG000|Overall Study|Ineligible / no protocol treatment|0|||
131523198|NCT00023673|473541917|FG001|Overall Study|Ineligible / no protocol treatment|0|||
131523199|NCT00023673|473541918|FG002|Overall Study|Ineligible / no protocol treatment|0|||
131523200|NCT00023673|473541919|FG003|Overall Study|Ineligible / no protocol treatment|1|||
131523201|NCT00023673|473541916|FG000|Overall Study|Patient withdrew consent|0|||
131523202|NCT00023673|473541917|FG001|Overall Study|Patient withdrew consent|0|||
131523203|NCT00023673|473541918|FG002|Overall Study|Patient withdrew consent|0|||
131523204|NCT00023673|473541919|FG003|Overall Study|Patient withdrew consent|1|||
131523205|NCT02453594|473541920|FG000|Overall Study|Protocol Violation|0|||
131523206|NCT02453594|473541921|FG001|Overall Study|Protocol Violation|0|||
131523207|NCT02453594|473541922|FG002|Overall Study|Protocol Violation|1|||
131523208|NCT02453594|473541920|FG000|Overall Study|Cohort Was Closed|17|||
131523209|NCT02453594|473541921|FG001|Overall Study|Cohort Was Closed|21|||
131523210|NCT02453594|473541922|FG002|Overall Study|Cohort Was Closed|14|||
131523211|NCT02453594|473541920|FG000|Overall Study|Death|20|||
131523212|NCT02453594|473541921|FG001|Overall Study|Death|24|||
131523213|NCT02453594|473541922|FG002|Overall Study|Death|16|||
131523214|NCT02453594|473541920|FG000|Overall Study|Lost to Follow-up|6|||
131523215|NCT02453594|473541921|FG001|Overall Study|Lost to Follow-up|14|||
131523216|NCT02453594|473541922|FG002|Overall Study|Lost to Follow-up|2|||
131523217|NCT02453594|473541920|FG000|Overall Study|Physician Decision|2|||
131523218|NCT02453594|473541921|FG001|Overall Study|Physician Decision|4|||
131523219|NCT02453594|473541922|FG002|Overall Study|Physician Decision|0|||
131523220|NCT02453594|473541920|FG000|Overall Study|Site Terminated by Sponsor|1|||
131523221|NCT02453594|473541921|FG001|Overall Study|Site Terminated by Sponsor|0|||
131523222|NCT02453594|473541922|FG002|Overall Study|Site Terminated by Sponsor|1|||
131523223|NCT02453594|473541920|FG000|Overall Study|Transitioned to Extension Study|16|||
131523224|NCT02453594|473541921|FG001|Overall Study|Transitioned to Extension Study|9|||
131523225|NCT02453594|473541922|FG002|Overall Study|Transitioned to Extension Study|16|||
131523226|NCT02453594|473541920|FG000|Overall Study|Withdrawal by Subject|7|||
131523227|NCT02453594|473541921|FG001|Overall Study|Withdrawal by Subject|9|||
131523228|NCT02453594|473541922|FG002|Overall Study|Withdrawal by Subject|11|||
131523229|NCT02086591|473541923|FG000|Overall Study|Adverse Event|1|||
131523230|NCT02086591|473541923|FG000|Overall Study|Withdrawal by Subject|1|||
131523231|NCT02086591|473541923|FG000|Overall Study|protocol terminated|3|||
131523232|NCT02660359|473541924|FG000|Overall Study|Protocol Deviation|0|||
131523233|NCT02660359|473541925|FG001|Overall Study|Protocol Deviation|0|||
131523234|NCT02660359|473541926|FG002|Overall Study|Protocol Deviation|1|||
131523235|NCT02660359|473541924|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
131523236|NCT02660359|473541925|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
131523237|NCT02660359|473541926|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
131523238|NCT02660359|473541924|FG000|Overall Study|Lack of Efficacy|1|||
131523239|NCT02660359|473541925|FG001|Overall Study|Lack of Efficacy|1|||
131523240|NCT02660359|473541926|FG002|Overall Study|Lack of Efficacy|1|||
131523241|NCT02660359|473541924|FG000|Overall Study|Adverse Event|0|||
131523242|NCT02660359|473541925|FG001|Overall Study|Adverse Event|1|||
131523243|NCT02660359|473541926|FG002|Overall Study|Adverse Event|0|||
131523244|NCT02660359|473541924|FG000|Overall Study|Other|2|||
131523245|NCT02660359|473541925|FG001|Overall Study|Other|1|||
131523246|NCT02660359|473541926|FG002|Overall Study|Other|3|||
131523247|NCT02660359|473541924|FG000|Overall Study|Withdrawal by Subject|7|||
131523248|NCT02660359|473541925|FG001|Overall Study|Withdrawal by Subject|5|||
131523249|NCT02660359|473541926|FG002|Overall Study|Withdrawal by Subject|8|||
131523250|NCT02660359|473541924|FG000|Overall Study|Lost to Follow-up|3|||
131523251|NCT02660359|473541925|FG001|Overall Study|Lost to Follow-up|3|||
131523252|NCT02660359|473541926|FG002|Overall Study|Lost to Follow-up|0|||
131523253|NCT04532112|473541928|FG000|Overall Study|Adverse Event|3|||
131523254|NCT04532112|473541929|FG001|Overall Study|Adverse Event|0|||
131523255|NCT00529386|473541930|FG000|Overall Study|Lost to Follow-up|1|||
131523256|NCT03348904|473541931|FG000|Overall Study|Administrative reason by the sponsor|0|||
131523257|NCT03348904|473541932|FG001|Overall Study|Administrative reason by the sponsor|1|||
131523258|NCT03348904|473541933|FG002|Overall Study|Administrative reason by the sponsor|0|||
131523259|NCT04086472|473541934|FG000|Overall Study|Lost to Follow-up|1|||
131523260|NCT04086472|473541935|FG001|Overall Study|Lost to Follow-up|0|||
131523261|NCT04086472|473541936|FG002|Overall Study|Lost to Follow-up|0|||
131523262|NCT04086472|473541937|FG003|Overall Study|Lost to Follow-up|0|||
131523263|NCT04086472|473541938|FG004|Overall Study|Lost to Follow-up|1|||
131523264|NCT04086472|473541934|FG000|Overall Study|Physician Decision|0|||
131523265|NCT04086472|473541935|FG001|Overall Study|Physician Decision|1|||
131523266|NCT04086472|473541936|FG002|Overall Study|Physician Decision|1|||
131523267|NCT04086472|473541937|FG003|Overall Study|Physician Decision|0|||
131523268|NCT04086472|473541938|FG004|Overall Study|Physician Decision|0|||
131523269|NCT04086472|473541934|FG000|Overall Study|Withdrawal by Subject|1|||
131523270|NCT04086472|473541935|FG001|Overall Study|Withdrawal by Subject|1|||
131523271|NCT04086472|473541936|FG002|Overall Study|Withdrawal by Subject|1|||
131523272|NCT04086472|473541937|FG003|Overall Study|Withdrawal by Subject|0|||
131523273|NCT04086472|473541938|FG004|Overall Study|Withdrawal by Subject|0|||
131523274|NCT04086472|473541934|FG000|Overall Study|Various reasons|2|||
131523275|NCT04086472|473541935|FG001|Overall Study|Various reasons|0|||
131523276|NCT04086472|473541936|FG002|Overall Study|Various reasons|0|||
131523277|NCT04086472|473541937|FG003|Overall Study|Various reasons|3|||
131523278|NCT04086472|473541938|FG004|Overall Study|Various reasons|1|||
131523279|NCT00048724|473541944|FG000|Overall Study|Adverse Event|53|||
131523280|NCT00048724|473541945|FG001|Overall Study|Adverse Event|12|||
131523281|NCT00048724|473541944|FG000|Overall Study|Withdrawal by Subject|34|||
131523282|NCT00048724|473541945|FG001|Overall Study|Withdrawal by Subject|54|||
131523283|NCT00048724|473541944|FG000|Overall Study|Lost to Follow-up|5|||
131523284|NCT00048724|473541945|FG001|Overall Study|Lost to Follow-up|5|||
131523285|NCT00048724|473541944|FG000|Overall Study|Protocol-defined Clinical Event|17|||
131523286|NCT00048724|473541945|FG001|Overall Study|Protocol-defined Clinical Event|32|||
131523287|NCT00048724|473541944|FG000|Overall Study|Noncompliance With Protocol|4|||
131523288|NCT00048724|473541945|FG001|Overall Study|Noncompliance With Protocol|12|||
131523289|NCT00048724|473541944|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
131523290|NCT00048724|473541945|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
131523291|NCT00048724|473541944|FG000|Overall Study|Administrative|1|||
131523292|NCT00048724|473541945|FG001|Overall Study|Administrative|1|||
131523293|NCT04394351|473541954|FG000|Part A (16 Weeks)|Adverse Event|1|||
131523294|NCT04394351|473541955|FG001|Part A (16 Weeks)|Adverse Event|0|||
131523295|NCT04394351|473541956|FG002|Part A (16 Weeks)|Adverse Event|0|||
131523296|NCT04394351|473541957|FG003|Part A (16 Weeks)|Adverse Event|0|||
131523297|NCT04394351|473541958|FG004|Part A (16 Weeks)|Adverse Event|0|||
131523298|NCT04394351|473541959|FG005|Part A (16 Weeks)|Adverse Event|0|||
131523299|NCT04394351|473541960|FG006|Part A (16 Weeks)|Adverse Event|0|||
131523300|NCT04394351|473541961|FG007|Part A (16 Weeks)|Adverse Event|0|||
131523301|NCT04394351|473541954|FG000|Part A (16 Weeks)|Physician Decision|0|||
131523302|NCT04394351|473541955|FG001|Part A (16 Weeks)|Physician Decision|1|||
131523303|NCT04394351|473541956|FG002|Part A (16 Weeks)|Physician Decision|0|||
131523304|NCT04394351|473541957|FG003|Part A (16 Weeks)|Physician Decision|0|||
131523305|NCT04394351|473541958|FG004|Part A (16 Weeks)|Physician Decision|0|||
131523306|NCT04394351|473541959|FG005|Part A (16 Weeks)|Physician Decision|0|||
131523307|NCT04394351|473541960|FG006|Part A (16 Weeks)|Physician Decision|0|||
131523308|NCT04394351|473541961|FG007|Part A (16 Weeks)|Physician Decision|0|||
131523309|NCT04394351|473541954|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523310|NCT04394351|473541955|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
131523311|NCT04394351|473541956|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523312|NCT04394351|473541957|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523313|NCT04394351|473541958|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523314|NCT04394351|473541959|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523315|NCT04394351|473541960|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523316|NCT04394351|473541961|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
131523317|NCT04394351|473541954|FG000|Part B (36 Weeks)|Adverse Event|0|||
131523318|NCT04394351|473541955|FG001|Part B (36 Weeks)|Adverse Event|0|||
131523319|NCT04394351|473541956|FG002|Part B (36 Weeks)|Adverse Event|0|||
131523320|NCT04394351|473541957|FG003|Part B (36 Weeks)|Adverse Event|0|||
131523321|NCT04394351|473541958|FG004|Part B (36 Weeks)|Adverse Event|0|||
131523322|NCT04394351|473541959|FG005|Part B (36 Weeks)|Adverse Event|0|||
131523323|NCT04394351|473541960|FG006|Part B (36 Weeks)|Adverse Event|1|||
131523324|NCT04394351|473541961|FG007|Part B (36 Weeks)|Adverse Event|0|||
131523325|NCT02992899|473541962|FG000|Overall Study|Withdrawal by Subject|1|||
131523326|NCT02992899|473541963|FG001|Overall Study|Withdrawal by Subject|0|||
131523327|NCT02992899|473541962|FG000|Overall Study|Lost to Follow-up|1|||
131523328|NCT02992899|473541963|FG001|Overall Study|Lost to Follow-up|3|||
131523329|NCT02738775|473541964|FG000|Overall Study|Withdrawal by Subject|0|||
131523330|NCT02738775|473541965|FG001|Overall Study|Withdrawal by Subject|1|||
131523331|NCT02738775|473541966|FG002|Overall Study|Withdrawal by Subject|0|||
131523332|NCT02738775|473541967|FG003|Overall Study|Withdrawal by Subject|0|||
131523333|NCT02738775|473541968|FG004|Overall Study|Withdrawal by Subject|0|||
131523334|NCT02738775|473541969|FG005|Overall Study|Withdrawal by Subject|0|||
131523335|NCT02738775|473541964|FG000|Overall Study|Adverse Event|0|||
131523336|NCT02738775|473541965|FG001|Overall Study|Adverse Event|0|||
131523337|NCT02738775|473541966|FG002|Overall Study|Adverse Event|0|||
131523338|NCT02738775|473541967|FG003|Overall Study|Adverse Event|1|||
131523339|NCT02738775|473541968|FG004|Overall Study|Adverse Event|0|||
131523340|NCT02738775|473541969|FG005|Overall Study|Adverse Event|0|||
131523341|NCT02738775|473541964|FG000|Overall Study|Pregnancy|0|||
131523342|NCT02738775|473541965|FG001|Overall Study|Pregnancy|1|||
131523343|NCT02738775|473541966|FG002|Overall Study|Pregnancy|0|||
131523344|NCT02738775|473541967|FG003|Overall Study|Pregnancy|0|||
131523345|NCT02738775|473541968|FG004|Overall Study|Pregnancy|0|||
131523346|NCT02738775|473541969|FG005|Overall Study|Pregnancy|0|||
131523347|NCT02738775|473541964|FG000|Overall Study|Missing|0|||
131523348|NCT02738775|473541965|FG001|Overall Study|Missing|0|||
131523349|NCT02738775|473541966|FG002|Overall Study|Missing|0|||
131523350|NCT02738775|473541967|FG003|Overall Study|Missing|0|||
131523351|NCT02738775|473541968|FG004|Overall Study|Missing|0|||
131523352|NCT02738775|473541969|FG005|Overall Study|Missing|1|||
131523353|NCT02370888|473541970|FG000|Overall Study|disease progression|2|||
131523354|NCT02370888|473541970|FG000|Overall Study|did not meet chimerism criteria|6|||
131523355|NCT04574362|473541971|FG000|Overall Study|Other|0|||
131523356|NCT04574362|473541972|FG001|Overall Study|Other|5|||
131523357|NCT04574362|473541971|FG000|Overall Study|COVID-19|0|||
131523358|NCT04574362|473541972|FG001|Overall Study|COVID-19|1|||
131523359|NCT04574362|473541971|FG000|Overall Study|Adverse Event|1|||
131523360|NCT04574362|473541972|FG001|Overall Study|Adverse Event|1|||
131523361|NCT04574362|473541971|FG000|Overall Study|Withdrawal by Subject|2|||
131523362|NCT04574362|473541972|FG001|Overall Study|Withdrawal by Subject|4|||
131523363|NCT04574362|473541971|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
131523364|NCT04574362|473541972|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
131523365|NCT04574362|473541971|FG000|Overall Study|Participant refused to come to the hospital|1|||
131523366|NCT04574362|473541972|FG001|Overall Study|Participant refused to come to the hospital|0|||
131523367|NCT04574362|473541971|FG000|Overall Study|Participant refused the visit|1|||
131523368|NCT04574362|473541972|FG001|Overall Study|Participant refused the visit|0|||
131523369|NCT04574362|473541971|FG000|Overall Study|Participant quit early because of business trip|1|||
131523370|NCT04574362|473541972|FG001|Overall Study|Participant quit early because of business trip|0|||
131523371|NCT01060384|473541973|FG000|Overall Study|Withdrawal by Subject|0|||
131523372|NCT01060384|473541974|FG001|Overall Study|Withdrawal by Subject|1|||
131523373|NCT01060384|473541975|FG002|Overall Study|Withdrawal by Subject|0|||
131523374|NCT01060384|473541976|FG003|Overall Study|Withdrawal by Subject|0|||
131523375|NCT01060384|473541977|FG004|Overall Study|Withdrawal by Subject|0|||
131523376|NCT01060384|473541973|FG000|Overall Study|Death|0|||
131523377|NCT01060384|473541974|FG001|Overall Study|Death|0|||
131523378|NCT01060384|473541975|FG002|Overall Study|Death|0|||
131523379|NCT01060384|473541976|FG003|Overall Study|Death|0|||
131523380|NCT01060384|473541977|FG004|Overall Study|Death|1|||
131523381|NCT01060384|473541973|FG000|Overall Study|Intercurrent illness|0|||
131523382|NCT01060384|473541974|FG001|Overall Study|Intercurrent illness|0|||
131523383|NCT01060384|473541975|FG002|Overall Study|Intercurrent illness|0|||
131523384|NCT01060384|473541976|FG003|Overall Study|Intercurrent illness|0|||
131523385|NCT01060384|473541977|FG004|Overall Study|Intercurrent illness|1|||
131523386|NCT00812929|473541980|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
131523387|NCT00812929|473541981|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
131523388|NCT00812929|473541982|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
131523389|NCT00812929|473541983|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
131523390|NCT00812929|473541984|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
131523391|NCT00812929|473541985|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
131658426|NCT01531673|474035300|FG001|Overall Study|Other|0|||
131523392|NCT00812929|473541986|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
131523393|NCT00812929|473541987|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
131523394|NCT00812929|473541988|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
131523395|NCT00812929|473541989|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
131523396|NCT00812929|473541980|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
131523397|NCT00812929|473541981|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
131523398|NCT00812929|473541982|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
131523399|NCT00812929|473541983|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
131523400|NCT00812929|473541984|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
131523401|NCT00812929|473541985|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
131523402|NCT00812929|473541986|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
131523403|NCT00812929|473541987|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
131523404|NCT00812929|473541988|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
131523405|NCT00812929|473541989|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
131523406|NCT00812929|473541980|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
131523407|NCT00812929|473541981|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
131523408|NCT00812929|473541982|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
131523409|NCT00812929|473541983|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
131523410|NCT00812929|473541984|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
131523411|NCT00812929|473541985|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
131523412|NCT00812929|473541986|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
131523413|NCT00812929|473541987|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
131523414|NCT00812929|473541988|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
131523415|NCT00812929|473541989|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
131523416|NCT00211081|473541991|FG000|Overall Study|Withdrawal by Subject|2|||
131523417|NCT01332305|473541992|FG000|Overall Study|Adverse Event|1|||
131523418|NCT01332305|473541993|FG001|Overall Study|Adverse Event|4|||
131523419|NCT01332305|473541994|FG002|Overall Study|Adverse Event|6|||
131523420|NCT01332305|473541995|FG003|Overall Study|Adverse Event|3|||
131523421|NCT01332305|473541996|FG004|Overall Study|Adverse Event|5|||
131523422|NCT01332305|473541992|FG000|Overall Study|Withdrawal by Subject|6|||
131523423|NCT01332305|473541993|FG001|Overall Study|Withdrawal by Subject|5|||
131523424|NCT01332305|473541994|FG002|Overall Study|Withdrawal by Subject|4|||
131523425|NCT01332305|473541995|FG003|Overall Study|Withdrawal by Subject|1|||
131523426|NCT01332305|473541996|FG004|Overall Study|Withdrawal by Subject|0|||
131523427|NCT01332305|473541992|FG000|Overall Study|Lost to Follow-up|0|||
131523428|NCT01332305|473541993|FG001|Overall Study|Lost to Follow-up|2|||
131523429|NCT01332305|473541994|FG002|Overall Study|Lost to Follow-up|3|||
131523430|NCT01332305|473541995|FG003|Overall Study|Lost to Follow-up|2|||
131523431|NCT01332305|473541996|FG004|Overall Study|Lost to Follow-up|3|||
131523432|NCT01332305|473541992|FG000|Overall Study|Protocol Violation|1|||
131523433|NCT01332305|473541993|FG001|Overall Study|Protocol Violation|2|||
131523434|NCT01332305|473541994|FG002|Overall Study|Protocol Violation|1|||
131523435|NCT01332305|473541995|FG003|Overall Study|Protocol Violation|0|||
131523436|NCT01332305|473541996|FG004|Overall Study|Protocol Violation|3|||
131523437|NCT01332305|473541992|FG000|Overall Study|Withdrawal by Sponsor|1|||
131523438|NCT01332305|473541993|FG001|Overall Study|Withdrawal by Sponsor|0|||
131523439|NCT01332305|473541994|FG002|Overall Study|Withdrawal by Sponsor|0|||
131523440|NCT01332305|473541995|FG003|Overall Study|Withdrawal by Sponsor|1|||
131523441|NCT01332305|473541996|FG004|Overall Study|Withdrawal by Sponsor|1|||
131523442|NCT01332305|473541992|FG000|Overall Study|Treatment Failure|1|||
131523443|NCT01332305|473541993|FG001|Overall Study|Treatment Failure|1|||
131523444|NCT01332305|473541994|FG002|Overall Study|Treatment Failure|0|||
131523445|NCT01332305|473541995|FG003|Overall Study|Treatment Failure|0|||
131523446|NCT01332305|473541996|FG004|Overall Study|Treatment Failure|0|||
131523447|NCT01332305|473541992|FG000|Overall Study|Physician Decision|0|||
131523448|NCT01332305|473541993|FG001|Overall Study|Physician Decision|0|||
131523449|NCT01332305|473541994|FG002|Overall Study|Physician Decision|0|||
131523450|NCT01332305|473541995|FG003|Overall Study|Physician Decision|1|||
131523451|NCT01332305|473541996|FG004|Overall Study|Physician Decision|0|||
131523452|NCT01600040|473541997|FG000|Overall Study|Withdrawal by Subject|1|||
131523453|NCT04027686|473541998|FG000|Overall Study|Lost to Follow-up|2|||
131523454|NCT04027686|473541999|FG001|Overall Study|Lost to Follow-up|0|||
131523455|NCT04027686|473541998|FG000|Overall Study|Withdrawal by Subject|0|||
131523456|NCT04027686|473541999|FG001|Overall Study|Withdrawal by Subject|1|||
131523457|NCT03755765|473542009|FG000|Overall Study|Withdrawal by Subject|2|||
131523458|NCT03755765|473542010|FG001|Overall Study|Withdrawal by Subject|4|||
131523459|NCT03755765|473542011|FG002|Overall Study|Withdrawal by Subject|4|||
131523460|NCT02104557|473542012|FG000|Overall Study|Adverse Event|24|||
131523461|NCT02104557|473542012|FG000|Overall Study|Lost to Follow-up|34|||
131523462|NCT02104557|473542012|FG000|Overall Study|Violated the usage and dosage|14|||
131523463|NCT02104557|473542012|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
131523464|NCT02104557|473542012|FG000|Overall Study|Administered Sayana prior to the contract|1|||
131523465|NCT02104557|473542012|FG000|Overall Study|Other|17|||
131523466|NCT02104557|473542012|FG000|Overall Study|Change to other contraception methods|5|||
131523467|NCT02104557|473542012|FG000|Overall Study|Discontinuation due to no pain|1|||
131523468|NCT02104557|473542012|FG000|Overall Study|Withdrawal consent|2|||
131523469|NCT02104557|473542012|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
131523470|NCT02104557|473542012|FG000|Overall Study|Discontinuation of contraception|9|||
131523471|NCT00111228|473542015|FG000|Overall Study|Withdrawal by Subject|5|||
131523472|NCT00111228|473542016|FG001|Overall Study|Withdrawal by Subject|1|||
131523473|NCT00111228|473542017|FG002|Overall Study|Withdrawal by Subject|0|||
131523474|NCT00678691|473542019|FG000|Overall Study|Adverse Event|6|||
131523475|NCT00678691|473542020|FG001|Overall Study|Adverse Event|4|||
131523476|NCT02178475|473542027|FG000|Overall Study|Withdrawal by Subject|7|||
131523477|NCT02178475|473542027|FG000|Overall Study|Lost to Follow-up|10|||
131523478|NCT02178475|473542027|FG000|Overall Study|Death|13|||
131523479|NCT02178475|473542027|FG000|Overall Study|Protocol-specified Criteria|99|||
131523480|NCT00779766|473542028|FG000|Month 24|Serious Adverse Event|2|||
131523481|NCT00779766|473542029|FG001|Month 24|Serious Adverse Event|3|||
131523482|NCT00779766|473542028|FG000|Month 24|Adverse Event|3|||
131523483|NCT00779766|473542029|FG001|Month 24|Adverse Event|3|||
131523484|NCT00779766|473542028|FG000|Month 24|Protocol Violation|3|||
131523485|NCT00779766|473542029|FG001|Month 24|Protocol Violation|1|||
131523486|NCT00779766|473542028|FG000|Month 24|Withdrawal by Subject|159|||
131523487|NCT00779766|473542029|FG001|Month 24|Withdrawal by Subject|127|||
131523488|NCT00779766|473542028|FG000|Month 24|Migrated/moved from study area|138|||
131523489|NCT00779766|473542029|FG001|Month 24|Migrated/moved from study area|162|||
131523490|NCT00779766|473542028|FG000|Month 24|Lost to Follow-up|9|||
131523491|NCT00779766|473542029|FG001|Month 24|Lost to Follow-up|9|||
131523492|NCT00779766|473542028|FG000|Month 24|Other|18|||
131523493|NCT00779766|473542029|FG001|Month 24|Other|27|||
131523494|NCT00779766|473542028|FG000|Month 48|Withdrawal by Subject|68|||
131523495|NCT00779766|473542029|FG001|Month 48|Withdrawal by Subject|63|||
131523496|NCT00779766|473542028|FG000|Month 48|Migrated/moved from study area|76|||
131523497|NCT00779766|473542029|FG001|Month 48|Migrated/moved from study area|75|||
131523498|NCT00779766|473542028|FG000|Month 48|Lost to Follow-up|29|||
131523499|NCT00779766|473542029|FG001|Month 48|Lost to Follow-up|30|||
131523500|NCT00779766|473542028|FG000|Month 48|Other|1|||
131523501|NCT00779766|473542029|FG001|Month 48|Other|0|||
131523502|NCT00779766|473542028|FG000|Month 72|Withdrawal by Subject|55|||
131523503|NCT00779766|473542029|FG001|Month 72|Withdrawal by Subject|71|||
131523504|NCT00779766|473542028|FG000|Month 72|Migrated/moved from study area|124|||
131523505|NCT00779766|473542029|FG001|Month 72|Migrated/moved from study area|109|||
131523506|NCT00779766|473542028|FG000|Month 72|Lost to Follow-up|6|||
131523507|NCT00779766|473542029|FG001|Month 72|Lost to Follow-up|8|||
131523508|NCT00779766|473542028|FG000|Month 72|Other|0|||
131523509|NCT00779766|473542029|FG001|Month 72|Other|1|||
131523510|NCT03235024|473542033|FG000|Overall Study|Adverse Event|2|||
131523511|NCT03235024|473542034|FG001|Overall Study|Adverse Event|2|||
131523512|NCT03235024|473542033|FG000|Overall Study|Death|1|||
131523513|NCT03235024|473542034|FG001|Overall Study|Death|0|||
131523514|NCT03235024|473542033|FG000|Overall Study|Lost to Follow-up|2|||
131523515|NCT03235024|473542034|FG001|Overall Study|Lost to Follow-up|5|||
131523516|NCT03235024|473542033|FG000|Overall Study|Protocol Violation|1|||
131523517|NCT03235024|473542034|FG001|Overall Study|Protocol Violation|0|||
131523518|NCT03235024|473542033|FG000|Overall Study|Withdrawal by Subject|0|||
131523519|NCT03235024|473542034|FG001|Overall Study|Withdrawal by Subject|3|||
131523520|NCT00414050|473542035|FG000|Overall Study|Adverse Event|1|||
131523521|NCT00414050|473542036|FG001|Overall Study|Adverse Event|1|||
131523522|NCT00414050|473542037|FG002|Overall Study|Adverse Event|1|||
131523523|NCT00414050|473542038|FG003|Overall Study|Adverse Event|1|||
131523524|NCT00414050|473542035|FG000|Overall Study|Lost to Follow-up|2|||
131523525|NCT00414050|473542036|FG001|Overall Study|Lost to Follow-up|2|||
131523526|NCT00414050|473542037|FG002|Overall Study|Lost to Follow-up|1|||
131523527|NCT00414050|473542038|FG003|Overall Study|Lost to Follow-up|1|||
131523528|NCT00414050|473542035|FG000|Overall Study|Withdrawal by Subject|5|||
131523529|NCT00414050|473542036|FG001|Overall Study|Withdrawal by Subject|3|||
131523530|NCT00414050|473542037|FG002|Overall Study|Withdrawal by Subject|2|||
131523531|NCT00414050|473542038|FG003|Overall Study|Withdrawal by Subject|4|||
131523532|NCT00414050|473542035|FG000|Overall Study|Subject discontinued for other reason|1|||
131523533|NCT00414050|473542036|FG001|Overall Study|Subject discontinued for other reason|2|||
131523534|NCT00414050|473542037|FG002|Overall Study|Subject discontinued for other reason|2|||
131523535|NCT00414050|473542038|FG003|Overall Study|Subject discontinued for other reason|1|||
131523536|NCT00414050|473542035|FG000|Overall Study|Subject Moved|0|||
131523537|NCT00414050|473542036|FG001|Overall Study|Subject Moved|0|||
131523538|NCT00414050|473542037|FG002|Overall Study|Subject Moved|0|||
131523539|NCT00414050|473542038|FG003|Overall Study|Subject Moved|1|||
131523540|NCT03304379|473542043|FG000|Overall Study|Protocol Violation|8|||
131523541|NCT03304379|473542044|FG001|Overall Study|Protocol Violation|10|||
131523542|NCT03304379|473542045|FG002|Overall Study|Protocol Violation|5|||
131523543|NCT03304379|473542046|FG003|Overall Study|Protocol Violation|0|||
131523544|NCT03304379|473542047|FG004|Overall Study|Protocol Violation|2|||
131523545|NCT03304379|473542043|FG000|Overall Study|Adverse Event|4|||
131523546|NCT03304379|473542044|FG001|Overall Study|Adverse Event|20|||
131523547|NCT03304379|473542045|FG002|Overall Study|Adverse Event|17|||
131523548|NCT03304379|473542046|FG003|Overall Study|Adverse Event|1|||
131523549|NCT03304379|473542047|FG004|Overall Study|Adverse Event|0|||
131523550|NCT03304379|473542043|FG000|Overall Study|Lack of Efficacy|17|||
131523551|NCT03304379|473542044|FG001|Overall Study|Lack of Efficacy|16|||
131523552|NCT03304379|473542045|FG002|Overall Study|Lack of Efficacy|20|||
131523553|NCT03304379|473542046|FG003|Overall Study|Lack of Efficacy|0|||
131523554|NCT03304379|473542047|FG004|Overall Study|Lack of Efficacy|0|||
131523555|NCT03304379|473542043|FG000|Overall Study|Physician Decision|6|||
131653777|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131653778|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131653779|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131653780|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131653781|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
131653782|NCT03083665|474018461|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131653783|NCT03083665|474018462|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131653784|NCT03083665|474018463|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131653785|NCT03083665|474018464|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131653786|NCT03083665|474018465|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131653787|NCT03083665|474018466|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
131653788|NCT02519348|474018469|FG000|Overall Study|Death|31|||
131653789|NCT02519348|474018470|FG001|Overall Study|Death|74|||
131653790|NCT02519348|474018471|FG002|Overall Study|Death|47|||
131653791|NCT02519348|474018472|FG003|Overall Study|Death|54|||
131653792|NCT02519348|474018473|FG004|Overall Study|Death|63|||
131653793|NCT02519348|474018474|FG005|Overall Study|Death|18|||
131653794|NCT02519348|474018475|FG006|Overall Study|Death|2|||
131653795|NCT02519348|474018476|FG007|Overall Study|Death|5|||
131653796|NCT02519348|474018477|FG008|Overall Study|Death|5|||
131653797|NCT02519348|474018469|FG000|Overall Study|Withdrawal by Subject|4|||
131653798|NCT02519348|474018470|FG001|Overall Study|Withdrawal by Subject|7|||
131653799|NCT02519348|474018471|FG002|Overall Study|Withdrawal by Subject|4|||
131653800|NCT02519348|474018472|FG003|Overall Study|Withdrawal by Subject|3|||
131653801|NCT02519348|474018473|FG004|Overall Study|Withdrawal by Subject|3|||
131653802|NCT02519348|474018474|FG005|Overall Study|Withdrawal by Subject|2|||
131653803|NCT02519348|474018475|FG006|Overall Study|Withdrawal by Subject|0|||
131653804|NCT02519348|474018476|FG007|Overall Study|Withdrawal by Subject|0|||
131653805|NCT02519348|474018477|FG008|Overall Study|Withdrawal by Subject|1|||
131653806|NCT02519348|474018469|FG000|Overall Study|Lost to Follow-up|0|||
131653807|NCT02519348|474018470|FG001|Overall Study|Lost to Follow-up|0|||
131653808|NCT02519348|474018471|FG002|Overall Study|Lost to Follow-up|1|||
131653809|NCT02519348|474018472|FG003|Overall Study|Lost to Follow-up|0|||
131653810|NCT02519348|474018473|FG004|Overall Study|Lost to Follow-up|2|||
131653811|NCT02519348|474018474|FG005|Overall Study|Lost to Follow-up|1|||
131653812|NCT02519348|474018475|FG006|Overall Study|Lost to Follow-up|1|||
131653813|NCT02519348|474018476|FG007|Overall Study|Lost to Follow-up|0|||
131653814|NCT02519348|474018477|FG008|Overall Study|Lost to Follow-up|0|||
131653815|NCT02519348|474018469|FG000|Overall Study|Other|0|||
131653816|NCT02519348|474018470|FG001|Overall Study|Other|3|||
131653817|NCT02519348|474018471|FG002|Overall Study|Other|0|||
131653818|NCT02519348|474018472|FG003|Overall Study|Other|0|||
131653819|NCT02519348|474018473|FG004|Overall Study|Other|1|||
131653820|NCT02519348|474018474|FG005|Overall Study|Other|0|||
131653821|NCT02519348|474018475|FG006|Overall Study|Other|0|||
131653822|NCT02519348|474018476|FG007|Overall Study|Other|0|||
131653823|NCT02519348|474018477|FG008|Overall Study|Other|0|||
131653824|NCT02519348|474018469|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
131653825|NCT02519348|474018470|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
131653826|NCT02519348|474018471|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
131653827|NCT02519348|474018472|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
131653828|NCT02519348|474018473|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
131653829|NCT02519348|474018474|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
131653830|NCT02519348|474018475|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
131653831|NCT02519348|474018476|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
131653832|NCT02519348|474018477|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
131653833|NCT04844879|474018478|FG000|Overall Study|Death|1|||
131653834|NCT04844879|474018478|FG000|Overall Study|Withdrawal by Subject|1|||
131653835|NCT04844879|474018478|FG000|Overall Study|Adverse Event|1|||
131653836|NCT04201262|474018483|FG000|Primary Treatment Period|Adverse Event|1|||
131653837|NCT04201262|474018484|FG001|Primary Treatment Period|Adverse Event|2|||
131653838|NCT04201262|474018483|FG000|Primary Treatment Period|Physician Decision|1|||
131653839|NCT04201262|474018484|FG001|Primary Treatment Period|Physician Decision|1|||
131653840|NCT04201262|474018483|FG000|Long-term Extension Period|Death|1|||
131653841|NCT04201262|474018484|FG001|Long-term Extension Period|Death|0|||
131523556|NCT03304379|473542044|FG001|Overall Study|Physician Decision|10|||
131523557|NCT03304379|473542045|FG002|Overall Study|Physician Decision|6|||
131523558|NCT03304379|473542046|FG003|Overall Study|Physician Decision|9|||
131523559|NCT03304379|473542047|FG004|Overall Study|Physician Decision|10|||
131523560|NCT03304379|473542043|FG000|Overall Study|Withdrawal by Subject|26|||
131523561|NCT03304379|473542044|FG001|Overall Study|Withdrawal by Subject|58|||
131523562|NCT03304379|473542045|FG002|Overall Study|Withdrawal by Subject|66|||
131523563|NCT03304379|473542046|FG003|Overall Study|Withdrawal by Subject|3|||
131523564|NCT03304379|473542047|FG004|Overall Study|Withdrawal by Subject|5|||
131523565|NCT03304379|473542043|FG000|Overall Study|Lost to Follow-up|8|||
131523566|NCT03304379|473542044|FG001|Overall Study|Lost to Follow-up|24|||
131523567|NCT03304379|473542045|FG002|Overall Study|Lost to Follow-up|35|||
131523568|NCT03304379|473542046|FG003|Overall Study|Lost to Follow-up|4|||
131523569|NCT03304379|473542047|FG004|Overall Study|Lost to Follow-up|0|||
131523570|NCT03304379|473542043|FG000|Overall Study|Death|1|||
131523571|NCT03304379|473542044|FG001|Overall Study|Death|2|||
131523572|NCT03304379|473542045|FG002|Overall Study|Death|0|||
131523573|NCT03304379|473542046|FG003|Overall Study|Death|0|||
131523574|NCT03304379|473542047|FG004|Overall Study|Death|0|||
131523575|NCT03304379|473542043|FG000|Overall Study|Other|0|||
131523576|NCT03304379|473542044|FG001|Overall Study|Other|1|||
131523577|NCT03304379|473542045|FG002|Overall Study|Other|0|||
131523578|NCT03304379|473542046|FG003|Overall Study|Other|0|||
131523579|NCT03304379|473542047|FG004|Overall Study|Other|0|||
131523580|NCT00835406|473542056|FG000|Period: First Intervention|Adverse Event|0|||
131523581|NCT00835406|473542057|FG001|Period: First Intervention|Adverse Event|1|||
131523582|NCT00835406|473542056|FG000|Period: First Intervention|Withdrawal by Subject|2|||
131523583|NCT00835406|473542057|FG001|Period: First Intervention|Withdrawal by Subject|0|||
131523584|NCT00835406|473542056|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
131523585|NCT00835406|473542057|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
131523586|NCT02550652|473542058|FG000|Overall Study|Death|1|||
131523587|NCT02550652|473542059|FG001|Overall Study|Death|4|||
131523588|NCT02550652|473542058|FG000|Overall Study|Lack of Efficacy|1|||
131523589|NCT02550652|473542059|FG001|Overall Study|Lack of Efficacy|0|||
131523590|NCT02550652|473542058|FG000|Overall Study|Withdrawal by Subject|4|||
131523591|NCT02550652|473542059|FG001|Overall Study|Withdrawal by Subject|7|||
131523592|NCT02550652|473542058|FG000|Overall Study|Post Trial Access|1|||
131523593|NCT02550652|473542059|FG001|Overall Study|Post Trial Access|0|||
131523594|NCT02550652|473542058|FG000|Overall Study|Lost to Follow-up|1|||
131523595|NCT02550652|473542059|FG001|Overall Study|Lost to Follow-up|3|||
131523596|NCT02550652|473542058|FG000|Overall Study|Physician Decision|0|||
131523597|NCT02550652|473542059|FG001|Overall Study|Physician Decision|2|||
131523598|NCT02550652|473542058|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
131523599|NCT02550652|473542059|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
131523600|NCT01706250|473542060|FG000|Overall Study|Lost to Follow-up|2|||
131523601|NCT02486406|473542061|FG000|Overall Study|Withdrew consent|1|||
131523602|NCT02486406|473542062|FG001|Overall Study|Withdrew consent|0|||
131523603|NCT02486406|473542063|FG002|Overall Study|Withdrew consent|0|||
131523604|NCT02486406|473542064|FG003|Overall Study|Withdrew consent|1|||
131523605|NCT02486406|473542061|FG000|Overall Study|Lost to Follow-up|1|||
131523606|NCT02486406|473542062|FG001|Overall Study|Lost to Follow-up|3|||
131523607|NCT02486406|473542063|FG002|Overall Study|Lost to Follow-up|1|||
131523608|NCT02486406|473542064|FG003|Overall Study|Lost to Follow-up|3|||
131523609|NCT02486406|473542061|FG000|Overall Study|Other, not specified|0|||
131523610|NCT02486406|473542062|FG001|Overall Study|Other, not specified|0|||
131523611|NCT02486406|473542063|FG002|Overall Study|Other, not specified|1|||
131523612|NCT02486406|473542064|FG003|Overall Study|Other, not specified|0|||
131523613|NCT01826825|473542065|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
131523614|NCT01826825|473542066|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
131523615|NCT01858194|473542067|FG000|Overall Study|Total Artificial Heart Implant|0|||
131523616|NCT01858194|473542068|FG001|Overall Study|Total Artificial Heart Implant|1|||
131523617|NCT01858194|473542067|FG000|Overall Study|Lost to Follow-up|0|||
131523618|NCT01858194|473542068|FG001|Overall Study|Lost to Follow-up|1|||
131523619|NCT00799617|473542072|FG000|Main Testosterone Trial|Randomized in error|1|||
131523620|NCT00799617|473542073|FG001|Main Testosterone Trial|Randomized in error|1|||
131523621|NCT00799617|473542072|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
131523622|NCT00799617|473542073|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
131523623|NCT00799617|473542072|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
131523624|NCT00799617|473542073|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
131523625|NCT00799617|473542072|FG000|Sexual Funtion Trial|No Baseline Data|4|||
131523626|NCT00799617|473542073|FG001|Sexual Funtion Trial|No Baseline Data|7|||
131523627|NCT00799617|473542072|FG000|Physical Function Trial|Lost to Follow-up|6|||
131523628|NCT00799617|473542073|FG001|Physical Function Trial|Lost to Follow-up|11|||
131523629|NCT00799617|473542072|FG000|Vitality Trial|Lost to Follow-up|7|||
131523630|NCT00799617|473542073|FG001|Vitality Trial|Lost to Follow-up|22|||
131523631|NCT00799617|473542072|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
131523632|NCT00799617|473542073|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
131523633|NCT00799617|473542072|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
131523634|NCT00799617|473542073|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
131523635|NCT00799617|473542072|FG000|Bone Trial|Month 12 scan not available|6|||
131523636|NCT00799617|473542073|FG001|Bone Trial|Month 12 scan not available|16|||
131523637|NCT00799617|473542072|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
131523638|NCT00799617|473542073|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
131523639|NCT00799617|473542072|FG000|Anemia Trial|Withdrawal by Subject|3|||
131523640|NCT00799617|473542073|FG001|Anemia Trial|Withdrawal by Subject|3|||
131523641|NCT04545515|473542074|FG000|Overall Study|Adverse Event|1|||
131523642|NCT04545515|473542074|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
131523643|NCT04545515|473542074|FG000|Overall Study|Commercial drug is available for participant|7|||
131523644|NCT00958880|473542075|FG000|Overall Study|Lost to Follow-up|2|||
131523645|NCT00958880|473542076|FG001|Overall Study|Lost to Follow-up|2|||
131523646|NCT01848990|473542077|FG000|Overall Study|Adverse Event|6|||
131523647|NCT01848990|473542078|FG001|Overall Study|Adverse Event|2|||
131523648|NCT01848990|473542079|FG002|Overall Study|Adverse Event|0|||
131523649|NCT01848990|473542077|FG000|Overall Study|Lost to Follow-up|6|||
131523650|NCT01848990|473542078|FG001|Overall Study|Lost to Follow-up|2|||
131523651|NCT01848990|473542079|FG002|Overall Study|Lost to Follow-up|2|||
131523652|NCT01848990|473542077|FG000|Overall Study|Protocol Violation|1|||
131523653|NCT01848990|473542078|FG001|Overall Study|Protocol Violation|1|||
131523654|NCT01848990|473542079|FG002|Overall Study|Protocol Violation|0|||
131523655|NCT01848990|473542077|FG000|Overall Study|Withdrawal by Subject|29|||
131523656|NCT01848990|473542078|FG001|Overall Study|Withdrawal by Subject|10|||
131523657|NCT01848990|473542079|FG002|Overall Study|Withdrawal by Subject|11|||
131523658|NCT01848990|473542077|FG000|Overall Study|Physician Decision|1|||
131523659|NCT01848990|473542078|FG001|Overall Study|Physician Decision|1|||
131523660|NCT01848990|473542079|FG002|Overall Study|Physician Decision|0|||
131523661|NCT01848990|473542077|FG000|Overall Study|Non Compliance|1|||
131523662|NCT01848990|473542078|FG001|Overall Study|Non Compliance|0|||
131523663|NCT01848990|473542079|FG002|Overall Study|Non Compliance|0|||
131523664|NCT01848990|473542077|FG000|Overall Study|Death|1|||
131523665|NCT01848990|473542078|FG001|Overall Study|Death|0|||
131523666|NCT01848990|473542079|FG002|Overall Study|Death|1|||
131523667|NCT01848990|473542077|FG000|Overall Study|Other|1|||
131523668|NCT01848990|473542078|FG001|Overall Study|Other|4|||
131523669|NCT01848990|473542079|FG002|Overall Study|Other|2|||
131523670|NCT01712984|473542082|FG000|Overall Study|Adverse Event|0|||
131523671|NCT01712984|473542083|FG001|Overall Study|Adverse Event|0|||
131523672|NCT01712984|473542084|FG002|Overall Study|Adverse Event|1|||
131523673|NCT01712984|473542082|FG000|Overall Study|Protocol Violation|2|||
131523674|NCT01712984|473542083|FG001|Overall Study|Protocol Violation|0|||
131523675|NCT01712984|473542084|FG002|Overall Study|Protocol Violation|1|||
131523676|NCT01712984|473542082|FG000|Overall Study|Lost to Follow-up|8|||
131523677|NCT01712984|473542083|FG001|Overall Study|Lost to Follow-up|10|||
131523678|NCT01712984|473542084|FG002|Overall Study|Lost to Follow-up|1|||
131523679|NCT01712984|473542082|FG000|Overall Study|Withdrawal by Subject|6|||
131523680|NCT01712984|473542083|FG001|Overall Study|Withdrawal by Subject|6|||
131523681|NCT01712984|473542084|FG002|Overall Study|Withdrawal by Subject|7|||
131523682|NCT02517905|473542089|FG000|Overall Study|Lost to Follow-up|4|||
131523683|NCT02517905|473542090|FG001|Overall Study|Lost to Follow-up|0|||
131523684|NCT02517905|473542089|FG000|Overall Study|Withdrawal by Subject|4|||
131523685|NCT02517905|473542090|FG001|Overall Study|Withdrawal by Subject|0|||
131523686|NCT02517905|473542089|FG000|Overall Study|Screen failure|2|||
131523687|NCT02517905|473542090|FG001|Overall Study|Screen failure|2|||
131523688|NCT04258839|473543784|FG000|Overall Study|Adverse Event|2|||
131523689|NCT04258839|473543785|FG001|Overall Study|Adverse Event|4|||
131523690|NCT04258839|473543784|FG000|Overall Study|Lack of Efficacy|0|||
131523691|NCT04258839|473543785|FG001|Overall Study|Lack of Efficacy|2|||
131523692|NCT04258839|473543784|FG000|Overall Study|Lost to Follow-up|2|||
131523693|NCT04258839|473543785|FG001|Overall Study|Lost to Follow-up|0|||
131523694|NCT04258839|473543784|FG000|Overall Study|Withdrawal by Subject|1|||
131523695|NCT04258839|473543785|FG001|Overall Study|Withdrawal by Subject|2|||
131523696|NCT04258839|473543784|FG000|Overall Study|Withdrawal by Caregiver|5|||
131523697|NCT04258839|473543785|FG001|Overall Study|Withdrawal by Caregiver|6|||
131523698|NCT04258839|473543784|FG000|Overall Study|Reason not Specified|0|||
131523699|NCT04258839|473543785|FG001|Overall Study|Reason not Specified|1|||
131523700|NCT02602288|473543790|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
131523701|NCT02602288|473543791|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
131523702|NCT02602288|473543790|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
131523703|NCT02602288|473543791|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
131523704|NCT02602288|473543790|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
131523705|NCT02602288|473543791|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
131523706|NCT02602288|473543790|FG000|12 Month Follow-up|Lost to Follow-up|0|||
131523707|NCT02602288|473543791|FG001|12 Month Follow-up|Lost to Follow-up|4|||
131523708|NCT02602288|473543790|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
131523709|NCT02602288|473543791|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
131523710|NCT01310413|473543792|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
131523711|NCT01310413|473543793|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
131523712|NCT01310413|473543794|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
131523713|NCT01310413|473543795|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
131523714|NCT01310413|473543796|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
131523715|NCT01310413|473543797|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
131523716|NCT01310413|473543798|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
131523717|NCT01310413|473543792|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
131523718|NCT01310413|473543793|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
131523719|NCT01310413|473543794|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
131523720|NCT01310413|473543795|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
131523721|NCT01310413|473543796|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
131523722|NCT01310413|473543797|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
131523723|NCT01310413|473543798|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
131523724|NCT01310413|473543792|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
131523725|NCT01310413|473543793|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
131523726|NCT01310413|473543794|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
131523727|NCT01310413|473543795|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
131523728|NCT01310413|473543796|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
131523729|NCT01310413|473543797|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
131523730|NCT01310413|473543798|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
131523731|NCT01310413|473543792|FG000|Day 0 to Day 385|Other|1|||
131523732|NCT01310413|473543793|FG001|Day 0 to Day 385|Other|0|||
131523733|NCT01310413|473543794|FG002|Day 0 to Day 385|Other|3|||
131523734|NCT01310413|473543795|FG003|Day 0 to Day 385|Other|0|||
131523735|NCT01310413|473543796|FG004|Day 0 to Day 385|Other|0|||
131523736|NCT01310413|473543797|FG005|Day 0 to Day 385|Other|0|||
131523737|NCT01310413|473543798|FG006|Day 0 to Day 385|Other|0|||
131523738|NCT01310413|473543792|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
131523739|NCT01310413|473543793|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
131523740|NCT01310413|473543794|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
131523741|NCT01310413|473543795|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
131523742|NCT01310413|473543796|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
131523743|NCT01310413|473543797|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
131523744|NCT01310413|473543798|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
131523745|NCT01310413|473543792|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
131523746|NCT01310413|473543793|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
131523747|NCT01310413|473543794|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
131523748|NCT01310413|473543795|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
131523749|NCT01310413|473543796|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
131523750|NCT01310413|473543797|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
131523751|NCT01310413|473543798|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
131523752|NCT00612066|473543799|FG000|Overall Study|Adverse Event|1|||
131523753|NCT00630877|473543800|FG000|Overall Study|Adverse Event|11|||
131523754|NCT00630877|473543801|FG001|Overall Study|Adverse Event|8|||
131523755|NCT00630877|473543802|FG002|Overall Study|Adverse Event|7|||
131523756|NCT00630877|473543800|FG000|Overall Study|Withdrawal by Subject|3|||
131523757|NCT00630877|473543801|FG001|Overall Study|Withdrawal by Subject|4|||
131523758|NCT00630877|473543802|FG002|Overall Study|Withdrawal by Subject|0|||
131523759|NCT00630877|473543800|FG000|Overall Study|Lost to Follow-up|2|||
131523760|NCT00630877|473543801|FG001|Overall Study|Lost to Follow-up|0|||
131523761|NCT00630877|473543802|FG002|Overall Study|Lost to Follow-up|0|||
131523762|NCT00630877|473543800|FG000|Overall Study|Noncompliance|2|||
131523763|NCT00630877|473543801|FG001|Overall Study|Noncompliance|3|||
131523764|NCT00630877|473543802|FG002|Overall Study|Noncompliance|1|||
131523765|NCT00630877|473543800|FG000|Overall Study|Protocol violation|1|||
131523766|NCT00630877|473543801|FG001|Overall Study|Protocol violation|0|||
131523767|NCT00630877|473543802|FG002|Overall Study|Protocol violation|1|||
131523768|NCT00630877|473543800|FG000|Overall Study|Personal reasons|0|||
131523769|NCT00630877|473543801|FG001|Overall Study|Personal reasons|0|||
131523770|NCT00630877|473543802|FG002|Overall Study|Personal reasons|1|||
131523771|NCT01519518|473543803|FG000|Overall Study|Consent not available|7|||
131523772|NCT01519518|473543804|FG001|Overall Study|Consent not available|10|||
131523773|NCT02033889|473543805|FG000|Overall Study|Adverse Event|3|||
131523774|NCT02033889|473543806|FG001|Overall Study|Adverse Event|1|||
131523775|NCT02033889|473543807|FG002|Overall Study|Adverse Event|3|||
131523776|NCT02033889|473543805|FG000|Overall Study|Death|3|||
131523777|NCT02033889|473543806|FG001|Overall Study|Death|1|||
131523778|NCT02033889|473543807|FG002|Overall Study|Death|2|||
131523779|NCT02033889|473543805|FG000|Overall Study|Excluded Medication|1|||
131523780|NCT02033889|473543806|FG001|Overall Study|Excluded Medication|1|||
131523781|NCT02033889|473543807|FG002|Overall Study|Excluded Medication|0|||
131523782|NCT02033889|473543805|FG000|Overall Study|Lost to Follow-up|8|||
131523783|NCT02033889|473543806|FG001|Overall Study|Lost to Follow-up|5|||
131653842|NCT03307785|474018485|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
131523784|NCT02033889|473543807|FG002|Overall Study|Lost to Follow-up|6|||
131523785|NCT02033889|473543805|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131523786|NCT02033889|473543806|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131523787|NCT02033889|473543807|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131523788|NCT02033889|473543805|FG000|Overall Study|Physician Decision|0|||
131523789|NCT02033889|473543806|FG001|Overall Study|Physician Decision|1|||
131523790|NCT02033889|473543807|FG002|Overall Study|Physician Decision|1|||
131523791|NCT02033889|473543805|FG000|Overall Study|Participant moved|0|||
131523792|NCT02033889|473543806|FG001|Overall Study|Participant moved|1|||
131523793|NCT02033889|473543807|FG002|Overall Study|Participant moved|0|||
131523794|NCT02033889|473543805|FG000|Overall Study|Withdrawal by Subject|18|||
131523795|NCT02033889|473543806|FG001|Overall Study|Withdrawal by Subject|10|||
131523796|NCT02033889|473543807|FG002|Overall Study|Withdrawal by Subject|13|||
131523797|NCT01913041|473543809|FG000|Overall Study|Protocol Violation|35|||
131523798|NCT01913041|473543809|FG000|Overall Study|Withdrawal by Subject|3|||
131523799|NCT01913041|473543809|FG000|Overall Study|Physician Decision|1|||
131523800|NCT01610700|473543811|FG000|Overall Study|Adverse Event|3|||
131523801|NCT01610700|473543812|FG001|Overall Study|Adverse Event|1|||
131523802|NCT01610700|473543811|FG000|Overall Study|Withdrawal by Subject|0|||
131523803|NCT01610700|473543812|FG001|Overall Study|Withdrawal by Subject|1|||
131523804|NCT01610700|473543811|FG000|Overall Study|subject took one dose of street cannabis|0|||
131523805|NCT01610700|473543812|FG001|Overall Study|subject took one dose of street cannabis|1|||
131523806|NCT00938431|473543819|FG000|Overall Study|Adverse Event|5|||
131523807|NCT00938431|473543820|FG001|Overall Study|Adverse Event|8|||
131523808|NCT00938431|473543821|FG002|Overall Study|Adverse Event|6|||
131523809|NCT00938431|473543819|FG000|Overall Study|Lack of Efficacy|0|||
131523810|NCT00938431|473543820|FG001|Overall Study|Lack of Efficacy|1|||
131523811|NCT00938431|473543821|FG002|Overall Study|Lack of Efficacy|0|||
131523812|NCT00938431|473543819|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
131523813|NCT00938431|473543820|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
131523814|NCT00938431|473543821|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
131523815|NCT00938431|473543819|FG000|Overall Study|Dosing compliance issue|0|||
131523816|NCT00938431|473543820|FG001|Overall Study|Dosing compliance issue|0|||
131523817|NCT00938431|473543821|FG002|Overall Study|Dosing compliance issue|1|||
131523818|NCT00938431|473543819|FG000|Overall Study|Reached maximum dose early|0|||
131523819|NCT00938431|473543820|FG001|Overall Study|Reached maximum dose early|0|||
131523820|NCT00938431|473543821|FG002|Overall Study|Reached maximum dose early|1|||
131523821|NCT01529645|473543822|FG000|Overall Study|Lost to Follow-up|0|||
131523822|NCT01529645|473543823|FG001|Overall Study|Lost to Follow-up|1|||
131523823|NCT01529645|473543824|FG002|Overall Study|Lost to Follow-up|1|||
131523824|NCT01529645|473543825|FG003|Overall Study|Lost to Follow-up|1|||
131523825|NCT01529645|473543826|FG004|Overall Study|Lost to Follow-up|1|||
131523826|NCT01529645|473543827|FG005|Overall Study|Lost to Follow-up|0|||
131523827|NCT01529645|473543828|FG006|Overall Study|Lost to Follow-up|2|||
131523828|NCT01529645|473543829|FG007|Overall Study|Lost to Follow-up|0|||
131523829|NCT01529645|473543830|FG008|Overall Study|Lost to Follow-up|1|||
131523830|NCT01529645|473543831|FG009|Overall Study|Lost to Follow-up|0|||
131523831|NCT01529645|473543822|FG000|Overall Study|SAE - Premature contractions|0|||
131523832|NCT01529645|473543823|FG001|Overall Study|SAE - Premature contractions|0|||
131523833|NCT01529645|473543824|FG002|Overall Study|SAE - Premature contractions|1|||
131523834|NCT01529645|473543825|FG003|Overall Study|SAE - Premature contractions|0|||
131523835|NCT01529645|473543826|FG004|Overall Study|SAE - Premature contractions|0|||
131523836|NCT01529645|473543827|FG005|Overall Study|SAE - Premature contractions|0|||
131523837|NCT01529645|473543828|FG006|Overall Study|SAE - Premature contractions|0|||
131523838|NCT01529645|473543829|FG007|Overall Study|SAE - Premature contractions|0|||
131523839|NCT01529645|473543830|FG008|Overall Study|SAE - Premature contractions|0|||
131523840|NCT01529645|473543831|FG009|Overall Study|SAE - Premature contractions|0|||
131523841|NCT01529645|473543822|FG000|Overall Study|Withdrawal by Subject|2|||
131523842|NCT01529645|473543823|FG001|Overall Study|Withdrawal by Subject|0|||
131523843|NCT01529645|473543824|FG002|Overall Study|Withdrawal by Subject|0|||
131523844|NCT01529645|473543825|FG003|Overall Study|Withdrawal by Subject|1|||
131523845|NCT01529645|473543826|FG004|Overall Study|Withdrawal by Subject|1|||
131523846|NCT01529645|473543827|FG005|Overall Study|Withdrawal by Subject|1|||
131523847|NCT01529645|473543828|FG006|Overall Study|Withdrawal by Subject|0|||
131523848|NCT01529645|473543829|FG007|Overall Study|Withdrawal by Subject|0|||
131523849|NCT01529645|473543830|FG008|Overall Study|Withdrawal by Subject|0|||
131523850|NCT01529645|473543831|FG009|Overall Study|Withdrawal by Subject|0|||
131523851|NCT01774903|473543832|FG000|Overall Study|Adverse Event|7|||
131523852|NCT01774903|473543832|FG000|Overall Study|Withdrawal by Subject|2|||
131523853|NCT01774903|473543832|FG000|Overall Study|Lack of Efficacy|1|||
131523854|NCT01774903|473543832|FG000|Overall Study|Ineligible to continue the trial|1|||
131523855|NCT01602315|473543833|FG000|Overall Study|Protocol Violation|0|||
131523856|NCT01602315|473543834|FG001|Overall Study|Protocol Violation|0|||
131523857|NCT01602315|473543835|FG002|Overall Study|Protocol Violation|0|||
131523858|NCT01602315|473543836|FG003|Overall Study|Protocol Violation|0|||
131523859|NCT01602315|473543837|FG004|Overall Study|Protocol Violation|0|||
131523860|NCT01602315|473543838|FG005|Overall Study|Protocol Violation|1|||
131523861|NCT01602315|473543839|FG006|Overall Study|Protocol Violation|0|||
131523862|NCT01602315|473543833|FG000|Overall Study|Physician Decision|2|||
131523863|NCT01602315|473543834|FG001|Overall Study|Physician Decision|0|||
131523864|NCT01602315|473543835|FG002|Overall Study|Physician Decision|0|||
131523865|NCT01602315|473543836|FG003|Overall Study|Physician Decision|0|||
131523866|NCT01602315|473543837|FG004|Overall Study|Physician Decision|2|||
131523867|NCT01602315|473543838|FG005|Overall Study|Physician Decision|1|||
131523868|NCT01602315|473543839|FG006|Overall Study|Physician Decision|1|||
131523869|NCT01602315|473543833|FG000|Overall Study|Disease progression|6|||
131523870|NCT01602315|473543834|FG001|Overall Study|Disease progression|3|||
131523871|NCT01602315|473543835|FG002|Overall Study|Disease progression|10|||
131523872|NCT01602315|473543836|FG003|Overall Study|Disease progression|1|||
131523873|NCT01602315|473543837|FG004|Overall Study|Disease progression|41|||
131523874|NCT01602315|473543838|FG005|Overall Study|Disease progression|12|||
131523875|NCT01602315|473543839|FG006|Overall Study|Disease progression|15|||
131523876|NCT01602315|473543833|FG000|Overall Study|Death|1|||
131523877|NCT01602315|473543834|FG001|Overall Study|Death|1|||
131523878|NCT01602315|473543835|FG002|Overall Study|Death|1|||
131523879|NCT01602315|473543836|FG003|Overall Study|Death|1|||
131523880|NCT01602315|473543837|FG004|Overall Study|Death|7|||
131523881|NCT01602315|473543838|FG005|Overall Study|Death|2|||
131523882|NCT01602315|473543839|FG006|Overall Study|Death|2|||
131523883|NCT01602315|473543833|FG000|Overall Study|Withdrawal by Subject|2|||
131523884|NCT01602315|473543834|FG001|Overall Study|Withdrawal by Subject|0|||
131523885|NCT01602315|473543835|FG002|Overall Study|Withdrawal by Subject|2|||
131523886|NCT01602315|473543836|FG003|Overall Study|Withdrawal by Subject|0|||
131523887|NCT01602315|473543837|FG004|Overall Study|Withdrawal by Subject|6|||
131523888|NCT01602315|473543838|FG005|Overall Study|Withdrawal by Subject|0|||
131523889|NCT01602315|473543839|FG006|Overall Study|Withdrawal by Subject|1|||
131523890|NCT01602315|473543833|FG000|Overall Study|Adverse Event|5|||
131523891|NCT01602315|473543834|FG001|Overall Study|Adverse Event|1|||
131523892|NCT01602315|473543835|FG002|Overall Study|Adverse Event|5|||
131523893|NCT01602315|473543836|FG003|Overall Study|Adverse Event|4|||
131523894|NCT01602315|473543837|FG004|Overall Study|Adverse Event|15|||
131523895|NCT01602315|473543838|FG005|Overall Study|Adverse Event|3|||
131523896|NCT01602315|473543839|FG006|Overall Study|Adverse Event|9|||
131523897|NCT01602315|473543833|FG000|Overall Study|Subject/guardian decision|0|||
131523898|NCT01602315|473543834|FG001|Overall Study|Subject/guardian decision|0|||
131523899|NCT01602315|473543835|FG002|Overall Study|Subject/guardian decision|0|||
131523900|NCT01602315|473543836|FG003|Overall Study|Subject/guardian decision|0|||
131523901|NCT01602315|473543837|FG004|Overall Study|Subject/guardian decision|0|||
131523902|NCT01602315|473543838|FG005|Overall Study|Subject/guardian decision|0|||
131523903|NCT01602315|473543839|FG006|Overall Study|Subject/guardian decision|1|||
131523904|NCT01602315|473543833|FG000|Overall Study|Cross-over patients to combo treatment|0|||
131523905|NCT01602315|473543834|FG001|Overall Study|Cross-over patients to combo treatment|0|||
131523906|NCT01602315|473543835|FG002|Overall Study|Cross-over patients to combo treatment|0|||
131523907|NCT01602315|473543836|FG003|Overall Study|Cross-over patients to combo treatment|0|||
131523908|NCT01602315|473543837|FG004|Overall Study|Cross-over patients to combo treatment|0|||
131523909|NCT01602315|473543838|FG005|Overall Study|Cross-over patients to combo treatment|16|||
131523910|NCT01602315|473543839|FG006|Overall Study|Cross-over patients to combo treatment|0|||
131523911|NCT02212730|473543842|FG000|Overall Study|Tumor not of the required cell histology|1|||
131523912|NCT02212730|473543843|FG001|Overall Study|Tumor not of the required cell histology|0|||
131523913|NCT02212730|473543842|FG000|Overall Study|Withdrawal by Subject|1|||
131523914|NCT02212730|473543843|FG001|Overall Study|Withdrawal by Subject|0|||
131523915|NCT02212730|473543842|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
131523916|NCT02212730|473543843|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
131523917|NCT02880371|473543844|FG000|Phase 1b|Lost to Follow-up|1|||
131523918|NCT02880371|473543845|FG001|Phase 1b|Lost to Follow-up|0|||
131523919|NCT02880371|473543846|FG002|Phase 1b|Lost to Follow-up|0|||
131523920|NCT02880371|473543847|FG003|Phase 1b|Lost to Follow-up|0|||
131523921|NCT02880371|473543848|FG004|Phase 1b|Lost to Follow-up|0|||
131523922|NCT02880371|473543849|FG005|Phase 1b|Lost to Follow-up|0|||
131523923|NCT02880371|473543850|FG006|Phase 1b|Lost to Follow-up|0|||
131523924|NCT02880371|473543851|FG007|Phase 1b|Lost to Follow-up|0|||
131523925|NCT02880371|473543844|FG000|Phase 1b|Participants terminated by Sponsor|1|||
131523926|NCT02880371|473543845|FG001|Phase 1b|Participants terminated by Sponsor|0|||
131523927|NCT02880371|473543846|FG002|Phase 1b|Participants terminated by Sponsor|0|||
131523928|NCT02880371|473543847|FG003|Phase 1b|Participants terminated by Sponsor|0|||
131523929|NCT02880371|473543848|FG004|Phase 1b|Participants terminated by Sponsor|0|||
131523930|NCT02880371|473543849|FG005|Phase 1b|Participants terminated by Sponsor|0|||
131523931|NCT02880371|473543850|FG006|Phase 1b|Participants terminated by Sponsor|0|||
131523932|NCT02880371|473543851|FG007|Phase 1b|Participants terminated by Sponsor|0|||
131523933|NCT02880371|473543844|FG000|Phase 1b|Withdrawal by Subject|0|||
131523934|NCT02880371|473543845|FG001|Phase 1b|Withdrawal by Subject|0|||
131523935|NCT02880371|473543846|FG002|Phase 1b|Withdrawal by Subject|1|||
131523936|NCT02880371|473543847|FG003|Phase 1b|Withdrawal by Subject|0|||
131523937|NCT02880371|473543848|FG004|Phase 1b|Withdrawal by Subject|0|||
131523938|NCT02880371|473543849|FG005|Phase 1b|Withdrawal by Subject|0|||
131523939|NCT02880371|473543850|FG006|Phase 1b|Withdrawal by Subject|0|||
131523940|NCT02880371|473543851|FG007|Phase 1b|Withdrawal by Subject|0|||
131523941|NCT02880371|473543844|FG000|Phase 1b|Death|4|||
131523942|NCT02880371|473543845|FG001|Phase 1b|Death|6|||
131523943|NCT02880371|473543846|FG002|Phase 1b|Death|5|||
131523944|NCT02880371|473543847|FG003|Phase 1b|Death|1|||
131523945|NCT02880371|473543848|FG004|Phase 1b|Death|0|||
131523946|NCT02880371|473543849|FG005|Phase 1b|Death|0|||
131523947|NCT02880371|473543850|FG006|Phase 1b|Death|0|||
131523948|NCT02880371|473543851|FG007|Phase 1b|Death|0|||
131523949|NCT02880371|473543844|FG000|Phase 1b|Enrolled but not Treated|0|||
131523950|NCT02880371|473543845|FG001|Phase 1b|Enrolled but not Treated|1|||
131523951|NCT02880371|473543846|FG002|Phase 1b|Enrolled but not Treated|0|||
131523952|NCT02880371|473543847|FG003|Phase 1b|Enrolled but not Treated|0|||
131523953|NCT02880371|473543848|FG004|Phase 1b|Enrolled but not Treated|0|||
131523954|NCT02880371|473543849|FG005|Phase 1b|Enrolled but not Treated|0|||
131523955|NCT02880371|473543850|FG006|Phase 1b|Enrolled but not Treated|0|||
131523956|NCT02880371|473543851|FG007|Phase 1b|Enrolled but not Treated|0|||
131523957|NCT02880371|473543844|FG000|Phase 2|Enrolled but not Treated|0|||
131523958|NCT02880371|473543845|FG001|Phase 2|Enrolled but not Treated|0|||
131523959|NCT02880371|473543846|FG002|Phase 2|Enrolled but not Treated|0|||
131523960|NCT02880371|473543847|FG003|Phase 2|Enrolled but not Treated|0|||
131523961|NCT02880371|473543848|FG004|Phase 2|Enrolled but not Treated|0|||
131523962|NCT02880371|473543849|FG005|Phase 2|Enrolled but not Treated|1|||
131523963|NCT02880371|473543850|FG006|Phase 2|Enrolled but not Treated|1|||
131523964|NCT02880371|473543851|FG007|Phase 2|Enrolled but not Treated|0|||
131523965|NCT02880371|473543844|FG000|Phase 2|Other|0|||
131523966|NCT02880371|473543845|FG001|Phase 2|Other|0|||
131523967|NCT02880371|473543846|FG002|Phase 2|Other|0|||
131523968|NCT02880371|473543847|FG003|Phase 2|Other|0|||
131523969|NCT02880371|473543848|FG004|Phase 2|Other|0|||
131523970|NCT02880371|473543849|FG005|Phase 2|Other|1|||
131523971|NCT02880371|473543850|FG006|Phase 2|Other|2|||
131523972|NCT02880371|473543851|FG007|Phase 2|Other|1|||
131523973|NCT02880371|473543844|FG000|Phase 2|Participants terminated by Sponsor|0|||
131523974|NCT02880371|473543845|FG001|Phase 2|Participants terminated by Sponsor|0|||
131523975|NCT02880371|473543846|FG002|Phase 2|Participants terminated by Sponsor|0|||
131523976|NCT02880371|473543847|FG003|Phase 2|Participants terminated by Sponsor|0|||
131523977|NCT02880371|473543848|FG004|Phase 2|Participants terminated by Sponsor|1|||
131523978|NCT02880371|473543849|FG005|Phase 2|Participants terminated by Sponsor|6|||
131523979|NCT02880371|473543850|FG006|Phase 2|Participants terminated by Sponsor|1|||
131523980|NCT02880371|473543851|FG007|Phase 2|Participants terminated by Sponsor|5|||
131523981|NCT02880371|473543844|FG000|Phase 2|Death|0|||
131523982|NCT02880371|473543845|FG001|Phase 2|Death|0|||
131523983|NCT02880371|473543846|FG002|Phase 2|Death|0|||
131523984|NCT02880371|473543847|FG003|Phase 2|Death|0|||
131523985|NCT02880371|473543848|FG004|Phase 2|Death|1|||
131523986|NCT02880371|473543849|FG005|Phase 2|Death|10|||
131523987|NCT02880371|473543850|FG006|Phase 2|Death|20|||
131523988|NCT02880371|473543851|FG007|Phase 2|Death|5|||
131523989|NCT02880371|473543844|FG000|Phase 2|Lost to Follow-up|0|||
131523990|NCT02880371|473543845|FG001|Phase 2|Lost to Follow-up|0|||
131523991|NCT02880371|473543846|FG002|Phase 2|Lost to Follow-up|0|||
131523992|NCT02880371|473543847|FG003|Phase 2|Lost to Follow-up|0|||
131523993|NCT02880371|473543848|FG004|Phase 2|Lost to Follow-up|0|||
131523994|NCT02880371|473543849|FG005|Phase 2|Lost to Follow-up|0|||
131523995|NCT02880371|473543850|FG006|Phase 2|Lost to Follow-up|3|||
131523996|NCT02880371|473543851|FG007|Phase 2|Lost to Follow-up|0|||
131523997|NCT02880371|473543844|FG000|Phase 2|Withdrawal by Subject|0|||
131523998|NCT02880371|473543845|FG001|Phase 2|Withdrawal by Subject|0|||
131523999|NCT02880371|473543846|FG002|Phase 2|Withdrawal by Subject|0|||
131524000|NCT02880371|473543847|FG003|Phase 2|Withdrawal by Subject|0|||
131524001|NCT02880371|473543848|FG004|Phase 2|Withdrawal by Subject|0|||
131524002|NCT02880371|473543849|FG005|Phase 2|Withdrawal by Subject|1|||
131524003|NCT02880371|473543850|FG006|Phase 2|Withdrawal by Subject|1|||
131524004|NCT02880371|473543851|FG007|Phase 2|Withdrawal by Subject|0|||
131524005|NCT02880371|473543844|FG000|Phase 2|End of Study page not completed by error|0|||
131524006|NCT02880371|473543845|FG001|Phase 2|End of Study page not completed by error|0|||
131524007|NCT02880371|473543846|FG002|Phase 2|End of Study page not completed by error|0|||
131524008|NCT02880371|473543847|FG003|Phase 2|End of Study page not completed by error|0|||
131524009|NCT02880371|473543848|FG004|Phase 2|End of Study page not completed by error|0|||
131524010|NCT02880371|473543849|FG005|Phase 2|End of Study page not completed by error|1|||
131524011|NCT02880371|473543850|FG006|Phase 2|End of Study page not completed by error|0|||
131524012|NCT02880371|473543851|FG007|Phase 2|End of Study page not completed by error|0|||
131524013|NCT01777997|473543854|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
131524014|NCT01777997|473543854|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
131524015|NCT01777997|473543854|FG000|Weeks 48 to 72/96 on ART|Death|1|||
131524016|NCT01777997|473543854|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
131524017|NCT02932891|473543860|FG000|Overall Study|Lost to Follow-up|2|||
131524018|NCT02932891|473543860|FG000|Overall Study|HPA Suppress|2|||
131524019|NCT00451282|473543863|FG000|Overall Study|Lost to Follow-up|6|||
131524020|NCT00451282|473543864|FG001|Overall Study|Lost to Follow-up|5|||
131524021|NCT00577122|473543865|FG000|Overall Study|Adverse Event|0|||
131524022|NCT00577122|473543866|FG001|Overall Study|Adverse Event|2|||
131524023|NCT00577122|473543865|FG000|Overall Study|Progression, relapse during active trt|6|||
131524024|NCT00577122|473543866|FG001|Overall Study|Progression, relapse during active trt|8|||
131524025|NCT00577122|473543865|FG000|Overall Study|Prog, refract disease during active trt|8|||
131524026|NCT00577122|473543866|FG001|Overall Study|Prog, refract disease during active trt|5|||
131524027|NCT00577122|473543865|FG000|Overall Study|Alternative Therapy|0|||
131524028|NCT00577122|473543866|FG001|Overall Study|Alternative Therapy|1|||
131524029|NCT00440271|473543868|FG000|Overall Study|Protocol Violation|1|||
131524030|NCT00440271|473543869|FG001|Overall Study|Protocol Violation|1|||
131524031|NCT00440271|473543868|FG000|Overall Study|Adverse Event|0|||
131524032|NCT00440271|473543869|FG001|Overall Study|Adverse Event|1|||
131524033|NCT00440271|473543868|FG000|Overall Study|Lost to Follow-up|1|||
131524034|NCT00440271|473543869|FG001|Overall Study|Lost to Follow-up|0|||
131524035|NCT00440271|473543868|FG000|Overall Study|Withdrawal by Subject|0|||
131524036|NCT00440271|473543869|FG001|Overall Study|Withdrawal by Subject|2|||
131524037|NCT00440271|473543868|FG000|Overall Study|Lack of Efficacy|0|||
131524038|NCT00440271|473543869|FG001|Overall Study|Lack of Efficacy|1|||
131524039|NCT00440271|473543868|FG000|Overall Study|Due to closure of trial|8|||
131524040|NCT00440271|473543869|FG001|Overall Study|Due to closure of trial|10|||
131524041|NCT00440271|473543868|FG000|Overall Study|Other|2|||
131524042|NCT00440271|473543869|FG001|Overall Study|Other|0|||
131524043|NCT00723801|473543877|FG000|Overall Study|Lost to Follow-up|1|||
131524044|NCT00723801|473543878|FG001|Overall Study|Lost to Follow-up|2|||
131524045|NCT00723801|473543877|FG000|Overall Study|Protocol Violation|2|||
131524046|NCT00723801|473543878|FG001|Overall Study|Protocol Violation|1|||
131524047|NCT01565993|473543887|FG000|Overall Study|Physician Decision|0|||
131524048|NCT01565993|473543888|FG001|Overall Study|Physician Decision|3|||
131524049|NCT01824303|473543889|FG000|Randomized Study|Withdrawal by Subject|1|||
131524050|NCT01824303|473543890|FG001|Randomized Study|Withdrawal by Subject|1|||
131524051|NCT01824303|473543889|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
131524052|NCT01824303|473543890|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
131524053|NCT02809976|473543891|FG000|Overall Study|Lost to Follow-up|1|||
131524054|NCT02809976|473543891|FG000|Overall Study|Withdrawal by Subject|1|||
131524055|NCT00113516|473543892|FG000|Part 1|Adverse Event|6|||
131524056|NCT00113516|473543893|FG001|Part 1|Adverse Event|0|||
131524057|NCT00113516|473543892|FG000|Part 1|Death|3|||
131524058|NCT00113516|473543893|FG001|Part 1|Death|0|||
131524059|NCT00113516|473543892|FG000|Part 1|Other|3|||
131524060|NCT00113516|473543893|FG001|Part 1|Other|0|||
131524061|NCT00113516|473543892|FG000|Part 1|Withdrawal by Subject|2|||
131524062|NCT00113516|473543893|FG001|Part 1|Withdrawal by Subject|0|||
131524063|NCT00113516|473543892|FG000|Part 1|Lack of Efficacy|2|||
131524064|NCT00113516|473543893|FG001|Part 1|Lack of Efficacy|0|||
131524065|NCT00113516|473543892|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
131524066|NCT00113516|473543893|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
131524067|NCT00113516|473543892|FG000|Part 1|Laboratory Abnormality|1|||
131524068|NCT00113516|473543893|FG001|Part 1|Laboratory Abnormality|0|||
131524069|NCT00113516|473543892|FG000|Part 1|Ongoing|1|||
131524070|NCT00113516|473543893|FG001|Part 1|Ongoing|0|||
131524071|NCT00113516|473543892|FG000|Part 1|Missing|65|||
131524072|NCT00113516|473543893|FG001|Part 1|Missing|0|||
131524073|NCT00113516|473543892|FG000|Part 2|Adverse Event|0|||
131524074|NCT00113516|473543893|FG001|Part 2|Adverse Event|16|||
131524075|NCT00113516|473543892|FG000|Part 2|Death|0|||
131524076|NCT00113516|473543893|FG001|Part 2|Death|5|||
131524077|NCT00113516|473543892|FG000|Part 2|Lack of Efficacy|0|||
131524078|NCT00113516|473543893|FG001|Part 2|Lack of Efficacy|37|||
131524079|NCT00113516|473543892|FG000|Part 2|Withdrawal by Subject|0|||
131524080|NCT00113516|473543893|FG001|Part 2|Withdrawal by Subject|3|||
131524081|NCT00113516|473543892|FG000|Part 2|Other|0|||
131524082|NCT00113516|473543893|FG001|Part 2|Other|3|||
131524083|NCT00113516|473543892|FG000|Part 2|Laboratory Abnormality|0|||
131524084|NCT00113516|473543893|FG001|Part 2|Laboratory Abnormality|1|||
131524085|NCT00113516|473543892|FG000|Part 2|Ongoing|0|||
131524086|NCT00113516|473543893|FG001|Part 2|Ongoing|1|||
131524087|NCT00642304|473543894|FG000|Overall Study|Adverse Event|1|||
131524088|NCT00642304|473543894|FG000|Overall Study|Death|1|||
131524089|NCT00642304|473543894|FG000|Overall Study|Blood transfusion|2|||
131524090|NCT00642304|473543894|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
131524091|NCT00642304|473543894|FG000|Overall Study|Transplantation|1|||
131524092|NCT00812812|473543895|FG000|Overall Study|Adverse Event|2|||
131524093|NCT00812812|473543896|FG001|Overall Study|Adverse Event|1|||
131524094|NCT00812812|473543895|FG000|Overall Study|Lack of Efficacy|1|||
131524095|NCT00812812|473543896|FG001|Overall Study|Lack of Efficacy|0|||
131524096|NCT00812812|473543895|FG000|Overall Study|Lost to Follow-up|0|||
131524097|NCT00812812|473543896|FG001|Overall Study|Lost to Follow-up|1|||
131524098|NCT00812812|473543895|FG000|Overall Study|Withdrawal by Subject|0|||
131524099|NCT00812812|473543896|FG001|Overall Study|Withdrawal by Subject|2|||
131524100|NCT01412424|473543900|FG000|Core Treatment Period|Treatment Failure|24|||
131524101|NCT01412424|473543900|FG000|Core Treatment Period|Adverse Event|21|||
131524102|NCT01412424|473543900|FG000|Core Treatment Period|Patient Request|5|||
131524103|NCT01412424|473543900|FG000|Core Treatment Period|Lost to Follow-up|2|||
131524104|NCT01412424|473543900|FG000|Core Treatment Period|Sponsor Request|1|||
131524105|NCT01412424|473543900|FG000|Extension Treatment Period|Adverse Event|2|||
131524106|NCT01412424|473543900|FG000|Extension Treatment Period|Treatment Failure|2|||
131524107|NCT01412424|473543900|FG000|Extension Treatment Period|Patient Request|2|||
131524108|NCT00684424|473543909|FG000|Overall Study|Adverse Event|1|||
131524109|NCT00684424|473543909|FG000|Overall Study|Lost to Follow-up|2|||
131524110|NCT00684424|473543909|FG000|Overall Study|Other|2|||
131524111|NCT02410811|473543910|FG000|Overall Study|Withdrawal by Subject|0|||
131524112|NCT02410811|473543911|FG001|Overall Study|Withdrawal by Subject|0|||
131524113|NCT02410811|473543912|FG002|Overall Study|Withdrawal by Subject|1|||
131524114|NCT02410811|473543913|FG003|Overall Study|Withdrawal by Subject|0|||
131524115|NCT01752933|473543916|FG000|Treatment|Disease Progression|3|||
131524116|NCT01752933|473543917|FG001|Treatment|Disease Progression|29|||
131524117|NCT01752933|473543916|FG000|Treatment|Withdrawal by Subject|0|||
131524118|NCT01752933|473543917|FG001|Treatment|Withdrawal by Subject|5|||
131524119|NCT01752933|473543916|FG000|Treatment|Adverse Event|1|||
131524120|NCT01752933|473543917|FG001|Treatment|Adverse Event|4|||
131524121|NCT01752933|473543916|FG000|Treatment|Physician Decision|0|||
131524122|NCT01752933|473543917|FG001|Treatment|Physician Decision|3|||
131524123|NCT01752933|473543916|FG000|Treatment|Death|0|||
131524124|NCT01752933|473543917|FG001|Treatment|Death|2|||
131524125|NCT01752933|473543916|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
131524126|NCT01752933|473543917|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
131524127|NCT01752933|473543916|FG000|Treatment|Patient noncompliant|0|||
131524128|NCT01752933|473543917|FG001|Treatment|Patient noncompliant|1|||
131524129|NCT01752933|473543916|FG000|Treatment|Patient unable to travel to appointments|0|||
131524130|NCT01752933|473543917|FG001|Treatment|Patient unable to travel to appointments|1|||
131524131|NCT01752933|473543916|FG000|Overall Study and Follow-up|Death|4|||
131524132|NCT01752933|473543917|FG001|Overall Study and Follow-up|Death|34|||
131524133|NCT01752933|473543916|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
131524134|NCT01752933|473543917|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
131524135|NCT01752933|473543916|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
131524136|NCT01752933|473543917|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
131524137|NCT01752933|473543916|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
131524138|NCT01752933|473543917|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
131524139|NCT03181542|473543918|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
131524140|NCT03181542|473543919|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
131524141|NCT01071512|473543920|FG000|Overall Study|Adverse Event|1|||
131524142|NCT01071512|473543920|FG000|Overall Study|Development of antibodies to drug|2|||
131524143|NCT01071512|473543920|FG000|Overall Study|positive anti-JC virus antibody test|2|||
131524144|NCT00678561|473543925|FG000|Overall Study|Adverse Event|0|||
131524145|NCT00678561|473543926|FG001|Overall Study|Adverse Event|1|||
131524146|NCT00678561|473543927|FG002|Overall Study|Adverse Event|1|||
131524147|NCT00678561|473543928|FG003|Overall Study|Adverse Event|0|||
131524148|NCT00678561|473543929|FG004|Overall Study|Adverse Event|1|||
131524149|NCT00678561|473543930|FG005|Overall Study|Adverse Event|0|||
131524150|NCT00678561|473543931|FG006|Overall Study|Adverse Event|0|||
131524151|NCT00678561|473543932|FG007|Overall Study|Adverse Event|0|||
131524152|NCT00678561|473543925|FG000|Overall Study|Protocol Violation|0|||
131524153|NCT00678561|473543926|FG001|Overall Study|Protocol Violation|0|||
131524154|NCT00678561|473543927|FG002|Overall Study|Protocol Violation|0|||
131524155|NCT00678561|473543928|FG003|Overall Study|Protocol Violation|0|||
131524156|NCT00678561|473543929|FG004|Overall Study|Protocol Violation|1|||
131524157|NCT00678561|473543930|FG005|Overall Study|Protocol Violation|1|||
131524158|NCT00678561|473543931|FG006|Overall Study|Protocol Violation|0|||
131524159|NCT00678561|473543932|FG007|Overall Study|Protocol Violation|0|||
131524160|NCT00678561|473543925|FG000|Overall Study|Withdrawal by Subject|0|||
131524161|NCT00678561|473543926|FG001|Overall Study|Withdrawal by Subject|0|||
131524162|NCT00678561|473543927|FG002|Overall Study|Withdrawal by Subject|0|||
131524163|NCT00678561|473543928|FG003|Overall Study|Withdrawal by Subject|0|||
131524164|NCT00678561|473543929|FG004|Overall Study|Withdrawal by Subject|0|||
131524165|NCT00678561|473543930|FG005|Overall Study|Withdrawal by Subject|0|||
131524166|NCT00678561|473543931|FG006|Overall Study|Withdrawal by Subject|0|||
131524167|NCT00678561|473543932|FG007|Overall Study|Withdrawal by Subject|1|||
131524168|NCT00437034|473543933|FG000|Overall Study|Adverse Event|1|||
131524169|NCT00437034|473543933|FG000|Overall Study|Disease progression during treatment|5|||
131524170|NCT00853658|473543935|FG000|Overall Study|Death|713|||
131524171|NCT00853658|473543936|FG001|Overall Study|Death|768|||
131524172|NCT00853658|473543937|FG002|Overall Study|Death|753|||
131524173|NCT00853658|473543935|FG000|Overall Study|Lost to Follow-up|11|||
131524174|NCT00853658|473543936|FG001|Overall Study|Lost to Follow-up|6|||
131524175|NCT00853658|473543937|FG002|Overall Study|Lost to Follow-up|11|||
131524176|NCT00853658|473543935|FG000|Overall Study|H.A. Request|26|||
131524177|NCT00853658|473543936|FG001|Overall Study|H.A. Request|23|||
131524178|NCT00853658|473543937|FG002|Overall Study|H.A. Request|19|||
131524179|NCT00853658|473543935|FG000|Overall Study|IRB request|0|||
131524180|NCT00853658|473543936|FG001|Overall Study|IRB request|0|||
131524181|NCT00853658|473543937|FG002|Overall Study|IRB request|2|||
131524182|NCT00853658|473543935|FG000|Overall Study|Vital Status known (alive) at study end|2|||
131524183|NCT00853658|473543936|FG001|Overall Study|Vital Status known (alive) at study end|3|||
131524184|NCT00853658|473543937|FG002|Overall Study|Vital Status known (alive) at study end|3|||
131524185|NCT00853658|473543935|FG000|Overall Study|Vital Status unknown at study end|1|||
131524186|NCT00853658|473543936|FG001|Overall Study|Vital Status unknown at study end|1|||
131524187|NCT00853658|473543937|FG002|Overall Study|Vital Status unknown at study end|0|||
131524188|NCT00853658|473543935|FG000|Overall Study|Vital Status at study end N/A|8|||
131524189|NCT00853658|473543936|FG001|Overall Study|Vital Status at study end N/A|10|||
131524190|NCT00853658|473543937|FG002|Overall Study|Vital Status at study end N/A|10|||
131524191|NCT00853658|473543935|FG000|Overall Study|Patient's request|21|||
131524192|NCT00853658|473543936|FG001|Overall Study|Patient's request|17|||
131524193|NCT00853658|473543937|FG002|Overall Study|Patient's request|11|||
131524194|NCT00853658|473543935|FG000|Overall Study|Missing study completion information|5|||
131524195|NCT00853658|473543936|FG001|Overall Study|Missing study completion information|4|||
131524196|NCT00853658|473543937|FG002|Overall Study|Missing study completion information|6|||
131524197|NCT01643473|473546186|FG000|Overall Study|Lost to Follow-up|1|||
131524198|NCT01643473|473546187|FG001|Overall Study|Lost to Follow-up|0|||
131524199|NCT02343458|473546191|FG000|Overall Study|Adverse Event|15|||
131524200|NCT02343458|473546192|FG001|Overall Study|Adverse Event|14|||
131524201|NCT02343458|473546193|FG002|Overall Study|Adverse Event|15|||
131524202|NCT02343458|473546194|FG003|Overall Study|Adverse Event|3|||
131524203|NCT02343458|473546191|FG000|Overall Study|Lack of Efficacy|3|||
131524204|NCT02343458|473546192|FG001|Overall Study|Lack of Efficacy|8|||
131524205|NCT02343458|473546193|FG002|Overall Study|Lack of Efficacy|4|||
131524206|NCT02343458|473546194|FG003|Overall Study|Lack of Efficacy|8|||
131524207|NCT02343458|473546191|FG000|Overall Study|Withdrawal by Subject|18|||
131524208|NCT02343458|473546192|FG001|Overall Study|Withdrawal by Subject|17|||
131524209|NCT02343458|473546193|FG002|Overall Study|Withdrawal by Subject|23|||
131524210|NCT02343458|473546194|FG003|Overall Study|Withdrawal by Subject|14|||
131524211|NCT02343458|473546191|FG000|Overall Study|Physician Decision|1|||
131524212|NCT02343458|473546192|FG001|Overall Study|Physician Decision|4|||
131524213|NCT02343458|473546193|FG002|Overall Study|Physician Decision|2|||
131524214|NCT02343458|473546194|FG003|Overall Study|Physician Decision|2|||
131524215|NCT02343458|473546191|FG000|Overall Study|Lost to Follow-up|5|||
131524216|NCT02343458|473546192|FG001|Overall Study|Lost to Follow-up|5|||
131524217|NCT02343458|473546193|FG002|Overall Study|Lost to Follow-up|3|||
131524218|NCT02343458|473546194|FG003|Overall Study|Lost to Follow-up|1|||
131524219|NCT02343458|473546191|FG000|Overall Study|Protocol Violation|2|||
131524220|NCT02343458|473546192|FG001|Overall Study|Protocol Violation|5|||
131524221|NCT02343458|473546193|FG002|Overall Study|Protocol Violation|2|||
131524222|NCT02343458|473546194|FG003|Overall Study|Protocol Violation|2|||
131524223|NCT02343458|473546191|FG000|Overall Study|Protocol Specified Criteria|17|||
131524224|NCT02343458|473546192|FG001|Overall Study|Protocol Specified Criteria|13|||
131524225|NCT02343458|473546193|FG002|Overall Study|Protocol Specified Criteria|14|||
131524226|NCT02343458|473546194|FG003|Overall Study|Protocol Specified Criteria|8|||
131524227|NCT01265953|473546195|FG000|Overall Study|Non compliance|5|||
131524228|NCT01265953|473546196|FG001|Overall Study|Non compliance|3|||
131524229|NCT02648698|473546198|FG000|Overall Study|Protocol Violation|1|||
131524230|NCT02648698|473546199|FG001|Overall Study|Protocol Violation|5|||
131524231|NCT01640301|473546200|FG000|Overall Study|Death|0|||
131524232|NCT01640301|473546201|FG001|Overall Study|Death|8|||
131524233|NCT02391948|473546206|FG000|6-month Assessment|Death|0|||
131524234|NCT02391948|473546207|FG001|6-month Assessment|Death|0|||
131524235|NCT02391948|473546208|FG002|6-month Assessment|Death|0|||
131524236|NCT02391948|473546209|FG003|6-month Assessment|Death|0|||
131524237|NCT02391948|473546210|FG004|6-month Assessment|Death|1|||
131524238|NCT02391948|473546206|FG000|6-month Assessment|Withdrawal by Subject|0|||
131524239|NCT02391948|473546207|FG001|6-month Assessment|Withdrawal by Subject|0|||
131524240|NCT02391948|473546208|FG002|6-month Assessment|Withdrawal by Subject|1|||
131524241|NCT02391948|473546209|FG003|6-month Assessment|Withdrawal by Subject|2|||
131524242|NCT02391948|473546210|FG004|6-month Assessment|Withdrawal by Subject|0|||
131524243|NCT02391948|473546206|FG000|6-month Assessment|Lost to Follow-up|4|||
131524244|NCT02391948|473546207|FG001|6-month Assessment|Lost to Follow-up|5|||
131524245|NCT02391948|473546208|FG002|6-month Assessment|Lost to Follow-up|2|||
131524246|NCT02391948|473546209|FG003|6-month Assessment|Lost to Follow-up|3|||
131524247|NCT02391948|473546210|FG004|6-month Assessment|Lost to Follow-up|1|||
131524248|NCT02391948|473546206|FG000|6-month Assessment|Medical issue/illness|1|||
131524249|NCT02391948|473546207|FG001|6-month Assessment|Medical issue/illness|1|||
131524250|NCT02391948|473546208|FG002|6-month Assessment|Medical issue/illness|0|||
131524251|NCT02391948|473546209|FG003|6-month Assessment|Medical issue/illness|0|||
131524252|NCT02391948|473546210|FG004|6-month Assessment|Medical issue/illness|0|||
131524253|NCT02391948|473546206|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
131524254|NCT02391948|473546207|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
131524255|NCT02391948|473546208|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
131524256|NCT02391948|473546209|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
131524257|NCT02391948|473546210|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
131524258|NCT02391948|473546206|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
131524259|NCT02391948|473546207|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
131524260|NCT02391948|473546208|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
131524261|NCT02391948|473546209|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
131524262|NCT02391948|473546210|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
131524263|NCT02391948|473546206|FG000|12-month Assessment|Death|0|||
131524264|NCT02391948|473546207|FG001|12-month Assessment|Death|0|||
131524265|NCT02391948|473546208|FG002|12-month Assessment|Death|0|||
131524266|NCT02391948|473546209|FG003|12-month Assessment|Death|1|||
131524267|NCT02391948|473546210|FG004|12-month Assessment|Death|0|||
131524268|NCT02391948|473546206|FG000|12-month Assessment|Withdrawal by Subject|1|||
131524269|NCT02391948|473546207|FG001|12-month Assessment|Withdrawal by Subject|0|||
131524270|NCT02391948|473546208|FG002|12-month Assessment|Withdrawal by Subject|0|||
131524271|NCT02391948|473546209|FG003|12-month Assessment|Withdrawal by Subject|1|||
131524272|NCT02391948|473546210|FG004|12-month Assessment|Withdrawal by Subject|0|||
131524273|NCT02391948|473546206|FG000|12-month Assessment|Lost to Follow-up|5|||
131524274|NCT02391948|473546207|FG001|12-month Assessment|Lost to Follow-up|4|||
131524275|NCT02391948|473546208|FG002|12-month Assessment|Lost to Follow-up|4|||
131524276|NCT02391948|473546209|FG003|12-month Assessment|Lost to Follow-up|4|||
131524277|NCT02391948|473546210|FG004|12-month Assessment|Lost to Follow-up|5|||
131524278|NCT02391948|473546206|FG000|12-month Assessment|Medical issue/illness|0|||
131524279|NCT02391948|473546207|FG001|12-month Assessment|Medical issue/illness|1|||
131524280|NCT02391948|473546208|FG002|12-month Assessment|Medical issue/illness|0|||
131524281|NCT02391948|473546209|FG003|12-month Assessment|Medical issue/illness|1|||
131524282|NCT02391948|473546210|FG004|12-month Assessment|Medical issue/illness|0|||
131524283|NCT02391948|473546206|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
131524284|NCT02391948|473546207|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
131524285|NCT02391948|473546208|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
131524286|NCT02391948|473546209|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
131524287|NCT02391948|473546210|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
131524288|NCT02391948|473546206|FG000|18-month Assessment|Death|0|||
131524289|NCT02391948|473546207|FG001|18-month Assessment|Death|0|||
131524290|NCT02391948|473546208|FG002|18-month Assessment|Death|0|||
131524291|NCT02391948|473546209|FG003|18-month Assessment|Death|1|||
131524292|NCT02391948|473546210|FG004|18-month Assessment|Death|1|||
131524293|NCT02391948|473546206|FG000|18-month Assessment|Withdrawal by Subject|1|||
131524294|NCT02391948|473546207|FG001|18-month Assessment|Withdrawal by Subject|0|||
131524295|NCT02391948|473546208|FG002|18-month Assessment|Withdrawal by Subject|0|||
131524296|NCT02391948|473546209|FG003|18-month Assessment|Withdrawal by Subject|1|||
131524297|NCT02391948|473546210|FG004|18-month Assessment|Withdrawal by Subject|0|||
131524298|NCT02391948|473546206|FG000|18-month Assessment|Lost to Follow-up|2|||
131524299|NCT02391948|473546207|FG001|18-month Assessment|Lost to Follow-up|6|||
131524300|NCT02391948|473546208|FG002|18-month Assessment|Lost to Follow-up|2|||
131524301|NCT02391948|473546209|FG003|18-month Assessment|Lost to Follow-up|2|||
131524302|NCT02391948|473546210|FG004|18-month Assessment|Lost to Follow-up|3|||
131524303|NCT02391948|473546206|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
131524304|NCT02391948|473546207|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
131524305|NCT02391948|473546208|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
131524306|NCT02391948|473546209|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
131524307|NCT02391948|473546210|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
131524308|NCT02391948|473546206|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
131524309|NCT02391948|473546207|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
131524310|NCT02391948|473546208|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
131524311|NCT02391948|473546209|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
131524312|NCT02391948|473546210|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
131524313|NCT02391948|473546206|FG000|24-month Assessment|Death|0|||
131524314|NCT02391948|473546207|FG001|24-month Assessment|Death|0|||
131524315|NCT02391948|473546208|FG002|24-month Assessment|Death|0|||
131524316|NCT02391948|473546209|FG003|24-month Assessment|Death|0|||
131524317|NCT02391948|473546210|FG004|24-month Assessment|Death|1|||
131524318|NCT02391948|473546206|FG000|24-month Assessment|Withdrawal by Subject|1|||
131524319|NCT02391948|473546207|FG001|24-month Assessment|Withdrawal by Subject|1|||
131524320|NCT02391948|473546208|FG002|24-month Assessment|Withdrawal by Subject|0|||
131524321|NCT02391948|473546209|FG003|24-month Assessment|Withdrawal by Subject|0|||
131524322|NCT02391948|473546210|FG004|24-month Assessment|Withdrawal by Subject|1|||
131524323|NCT02391948|473546206|FG000|24-month Assessment|Lost to Follow-up|5|||
131524324|NCT02391948|473546207|FG001|24-month Assessment|Lost to Follow-up|4|||
131524325|NCT02391948|473546208|FG002|24-month Assessment|Lost to Follow-up|0|||
131524326|NCT02391948|473546209|FG003|24-month Assessment|Lost to Follow-up|0|||
131524327|NCT02391948|473546210|FG004|24-month Assessment|Lost to Follow-up|0|||
131524328|NCT02391948|473546206|FG000|24-month Assessment|Medical issue/illness|0|||
131524329|NCT02391948|473546207|FG001|24-month Assessment|Medical issue/illness|0|||
131524330|NCT02391948|473546208|FG002|24-month Assessment|Medical issue/illness|1|||
131524331|NCT02391948|473546209|FG003|24-month Assessment|Medical issue/illness|0|||
131524332|NCT02391948|473546210|FG004|24-month Assessment|Medical issue/illness|0|||
131524333|NCT02391948|473546206|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
131524334|NCT02391948|473546207|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
131524335|NCT02391948|473546208|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
131524336|NCT02391948|473546209|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
131524337|NCT02391948|473546210|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
131524338|NCT01639001|473546211|FG000|Overall Study|Refused further follow-up|9|||
131524339|NCT01639001|473546212|FG001|Overall Study|Refused further follow-up|12|||
131524340|NCT01639001|473546211|FG000|Overall Study|Lost to Follow-up|3|||
131524341|NCT01639001|473546212|FG001|Overall Study|Lost to Follow-up|0|||
131524342|NCT01639001|473546211|FG000|Overall Study|Death|62|||
131524343|NCT01639001|473546212|FG001|Overall Study|Death|61|||
131524344|NCT01639001|473546211|FG000|Overall Study|Randomized but not treated|0|||
131524345|NCT01639001|473546212|FG001|Overall Study|Randomized but not treated|2|||
131524346|NCT01639001|473546211|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
131524347|NCT01639001|473546212|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
131524348|NCT01969838|473546213|FG000|Double-blind Phase|Adverse Event|10|||
131524349|NCT01969838|473546214|FG001|Double-blind Phase|Adverse Event|4|||
131524350|NCT01969838|473546215|FG002|Double-blind Phase|Adverse Event|0|||
131524351|NCT01969838|473546216|FG003|Double-blind Phase|Adverse Event|0|||
131524352|NCT01969838|473546213|FG000|Double-blind Phase|Death|5|||
131524353|NCT01969838|473546214|FG001|Double-blind Phase|Death|2|||
131524354|NCT01969838|473546215|FG002|Double-blind Phase|Death|0|||
131524355|NCT01969838|473546216|FG003|Double-blind Phase|Death|0|||
131524356|NCT01969838|473546213|FG000|Double-blind Phase|Physician Decision|5|||
131524357|NCT01969838|473546214|FG001|Double-blind Phase|Physician Decision|1|||
131524358|NCT01969838|473546215|FG002|Double-blind Phase|Physician Decision|0|||
131524359|NCT01969838|473546216|FG003|Double-blind Phase|Physician Decision|0|||
131524360|NCT01969838|473546213|FG000|Double-blind Phase|Subject Decision|4|||
131524361|NCT01969838|473546214|FG001|Double-blind Phase|Subject Decision|2|||
131524362|NCT01969838|473546215|FG002|Double-blind Phase|Subject Decision|0|||
131524363|NCT01969838|473546216|FG003|Double-blind Phase|Subject Decision|0|||
131524364|NCT01969838|473546213|FG000|Double-blind Phase|Disease Progression|2|||
131524365|NCT01969838|473546214|FG001|Double-blind Phase|Disease Progression|0|||
131524366|NCT01969838|473546215|FG002|Double-blind Phase|Disease Progression|0|||
131524367|NCT01969838|473546216|FG003|Double-blind Phase|Disease Progression|0|||
131524368|NCT01969838|473546213|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
131524369|NCT01969838|473546214|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
131524370|NCT01969838|473546215|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
131524371|NCT01969838|473546216|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
131524372|NCT01969838|473546213|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
131524373|NCT01969838|473546214|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
131524374|NCT01969838|473546215|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
131524375|NCT01969838|473546216|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
131524376|NCT01969838|473546213|FG000|Open-label Phase|Adverse Event|0|||
131524377|NCT01969838|473546214|FG001|Open-label Phase|Adverse Event|0|||
131524378|NCT01969838|473546215|FG002|Open-label Phase|Adverse Event|37|||
131524379|NCT01969838|473546216|FG003|Open-label Phase|Adverse Event|49|||
131524380|NCT01969838|473546213|FG000|Open-label Phase|Disease Progression|0|||
131524381|NCT01969838|473546214|FG001|Open-label Phase|Disease Progression|0|||
131524382|NCT01969838|473546215|FG002|Open-label Phase|Disease Progression|26|||
131524383|NCT01969838|473546216|FG003|Open-label Phase|Disease Progression|27|||
131524384|NCT01969838|473546213|FG000|Open-label Phase|Lack of Efficacy|0|||
131524385|NCT01969838|473546214|FG001|Open-label Phase|Lack of Efficacy|0|||
131524386|NCT01969838|473546215|FG002|Open-label Phase|Lack of Efficacy|17|||
131524387|NCT01969838|473546216|FG003|Open-label Phase|Lack of Efficacy|19|||
131524388|NCT01969838|473546213|FG000|Open-label Phase|Subject Decision|0|||
131524389|NCT01969838|473546214|FG001|Open-label Phase|Subject Decision|0|||
131524390|NCT01969838|473546215|FG002|Open-label Phase|Subject Decision|14|||
131524391|NCT01969838|473546216|FG003|Open-label Phase|Subject Decision|15|||
131524392|NCT01969838|473546213|FG000|Open-label Phase|Death|0|||
131524393|NCT01969838|473546214|FG001|Open-label Phase|Death|0|||
131524394|NCT01969838|473546215|FG002|Open-label Phase|Death|13|||
131524395|NCT01969838|473546216|FG003|Open-label Phase|Death|11|||
131524396|NCT01969838|473546213|FG000|Open-label Phase|Physician Decision|0|||
131524397|NCT01969838|473546214|FG001|Open-label Phase|Physician Decision|0|||
131524398|NCT01969838|473546215|FG002|Open-label Phase|Physician Decision|9|||
131524399|NCT01969838|473546216|FG003|Open-label Phase|Physician Decision|14|||
131524400|NCT01969838|473546213|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
131524401|NCT01969838|473546214|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
131524402|NCT01969838|473546215|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
131658427|NCT01531673|474035301|FG002|Overall Study|Other|0|||
131524403|NCT01969838|473546216|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
131524404|NCT02944578|473546219|FG000|Overall Study|Physician Decision|1|||
131524405|NCT02944578|473546220|FG001|Overall Study|Physician Decision|0|||
131524406|NCT00807092|473546221|FG000|Overall Study|Adverse Event|0|||
131524407|NCT00807092|473546222|FG001|Overall Study|Adverse Event|1|||
131524408|NCT00807092|473546221|FG000|Overall Study|Protocol Violation|0|||
131524409|NCT00807092|473546222|FG001|Overall Study|Protocol Violation|2|||
131524410|NCT00807092|473546221|FG000|Overall Study|Withdrawal by Subject|1|||
131524411|NCT00807092|473546222|FG001|Overall Study|Withdrawal by Subject|0|||
131524412|NCT00807092|473546221|FG000|Overall Study|CGMS data collection failed|0|||
131524413|NCT00807092|473546222|FG001|Overall Study|CGMS data collection failed|1|||
131524414|NCT04116229|473546223|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
131524415|NCT04116229|473546224|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
131524416|NCT04116229|473546223|FG000|Overall Study|Scheduling not possible.|0|||
131524417|NCT04116229|473546224|FG001|Overall Study|Scheduling not possible.|1|||
131524418|NCT02863354|473546230|FG000|Year 1|Lost to Follow-up|1|||
131524419|NCT02863354|473546231|FG001|Year 1|Lost to Follow-up|1|||
131524420|NCT02863354|473546230|FG000|Year 1|Withdrawal by Subject|3|||
131524421|NCT02863354|473546231|FG001|Year 1|Withdrawal by Subject|0|||
131524422|NCT02863354|473546230|FG000|Year 1|Death|0|||
131524423|NCT02863354|473546231|FG001|Year 1|Death|1|||
131524424|NCT02863354|473546230|FG000|Year 2|Lost to Follow-up|2|||
131524425|NCT02863354|473546231|FG001|Year 2|Lost to Follow-up|2|||
131524426|NCT00705575|473546235|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131524427|NCT00705575|473546236|FG001|Overall Study|Abnormal laboratory value(s)|3|||
131524428|NCT00705575|473546235|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131524429|NCT00705575|473546236|FG001|Overall Study|Abnormal test procedure result(s)|12|||
131524430|NCT00705575|473546235|FG000|Overall Study|Adverse Event|11|||
131524431|NCT00705575|473546236|FG001|Overall Study|Adverse Event|15|||
131524432|NCT00705575|473546235|FG000|Overall Study|Lost to Follow-up|3|||
131524433|NCT00705575|473546236|FG001|Overall Study|Lost to Follow-up|4|||
131524434|NCT00705575|473546235|FG000|Overall Study|Protocol Violation|2|||
131524435|NCT00705575|473546236|FG001|Overall Study|Protocol Violation|2|||
131524436|NCT00705575|473546235|FG000|Overall Study|Withdrawal by Subject|5|||
131524437|NCT00705575|473546236|FG001|Overall Study|Withdrawal by Subject|10|||
131524438|NCT02170727|473546237|FG000|Overall Study|Lost to Follow-up|1|||
131524439|NCT02170727|473546238|FG001|Overall Study|Lost to Follow-up|0|||
131524440|NCT02170727|473546237|FG000|Overall Study|Withdrawal by Subject|2|||
131524441|NCT02170727|473546238|FG001|Overall Study|Withdrawal by Subject|0|||
131524442|NCT01599650|473546239|FG000|Overall Study|Administrative issue|1|||
131524443|NCT01599650|473546240|FG001|Overall Study|Administrative issue|0|||
131524444|NCT01599650|473546241|FG002|Overall Study|Administrative issue|1|||
131524445|NCT01599650|473546239|FG000|Overall Study|Physician Decision|2|||
131524446|NCT01599650|473546240|FG001|Overall Study|Physician Decision|0|||
131524447|NCT01599650|473546241|FG002|Overall Study|Physician Decision|7|||
131524448|NCT01599650|473546239|FG000|Overall Study|Protocol Violation|0|||
131524449|NCT01599650|473546240|FG001|Overall Study|Protocol Violation|3|||
131524450|NCT01599650|473546241|FG002|Overall Study|Protocol Violation|0|||
131524451|NCT01599650|473546239|FG000|Overall Study|Death|2|||
131524452|NCT01599650|473546240|FG001|Overall Study|Death|1|||
131524453|NCT01599650|473546241|FG002|Overall Study|Death|2|||
131524454|NCT01599650|473546239|FG000|Overall Study|Lost to Follow-up|3|||
131524455|NCT01599650|473546240|FG001|Overall Study|Lost to Follow-up|3|||
131524456|NCT01599650|473546241|FG002|Overall Study|Lost to Follow-up|3|||
131524457|NCT01599650|473546239|FG000|Overall Study|Withdrawal by Subject|11|||
131524458|NCT01599650|473546240|FG001|Overall Study|Withdrawal by Subject|11|||
131524459|NCT01599650|473546241|FG002|Overall Study|Withdrawal by Subject|10|||
131524460|NCT01599650|473546239|FG000|Overall Study|Adverse Event|3|||
131524461|NCT01599650|473546240|FG001|Overall Study|Adverse Event|8|||
131524462|NCT01599650|473546241|FG002|Overall Study|Adverse Event|4|||
131524463|NCT00179647|473546249|FG000|Overall Study|Adverse Event|294|||
131524464|NCT00179647|473546249|FG000|Overall Study|Lack of Efficacy|478|||
131524465|NCT00179647|473546249|FG000|Overall Study|Withdrawal by Subject|83|||
131524466|NCT00179647|473546249|FG000|Overall Study|Lost to Follow-up|4|||
131524467|NCT00179647|473546249|FG000|Overall Study|Death|94|||
131524468|NCT00179647|473546249|FG000|Overall Study|Other|960|||
131524469|NCT04154631|473546250|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
131524470|NCT04154631|473546251|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
131524471|NCT02138214|473546254|FG000|Overall Study|Withdrawal by Subject|0|||
131524472|NCT02138214|473546255|FG001|Overall Study|Withdrawal by Subject|1|||
131524473|NCT02138214|473546256|FG002|Overall Study|Withdrawal by Subject|0|||
131524474|NCT02138214|473546254|FG000|Overall Study|Lost to Follow-up|0|||
131524475|NCT02138214|473546255|FG001|Overall Study|Lost to Follow-up|2|||
131524476|NCT02138214|473546256|FG002|Overall Study|Lost to Follow-up|4|||
131524477|NCT02138214|473546254|FG000|Overall Study|Screen Failure|0|||
131524478|NCT02138214|473546255|FG001|Overall Study|Screen Failure|1|||
131524479|NCT02138214|473546256|FG002|Overall Study|Screen Failure|0|||
131524480|NCT02185768|473546257|FG000|Overall Study|Patients were not treated|2|||
131524481|NCT02158039|473546268|FG000|Overall Study|Withdrawal by Subject|1|||
131524482|NCT02158039|473546268|FG000|Overall Study|Screen Failure|9|||
131524483|NCT03062891|473546280|FG000|Overall Study|Withdrawal by Subject|2|||
131524484|NCT03062891|473546281|FG001|Overall Study|Withdrawal by Subject|0|||
131524485|NCT03062891|473546280|FG000|Overall Study|Lost to Follow-up|50|||
131524486|NCT03062891|473546281|FG001|Overall Study|Lost to Follow-up|38|||
131524487|NCT02127307|473546282|FG000|Overall Study|Protocol Violation|36|||
131524488|NCT02127307|473546282|FG000|Overall Study|Lost to Follow-up|2|||
131524489|NCT02127307|473546282|FG000|Overall Study|Death|101|||
131524490|NCT02127307|473546282|FG000|Overall Study|Other than specified above|169|||
131524491|NCT03509948|473546283|FG000|Overall Study|Protocol Violation|0|||
131524492|NCT03509948|473546284|FG001|Overall Study|Protocol Violation|1|||
131524493|NCT03221257|473546285|FG000|Overall Study|Lost to Follow-up|0|||
131524494|NCT03221257|473546286|FG001|Overall Study|Lost to Follow-up|1|||
131524495|NCT03221257|473546285|FG000|Overall Study|Withdrawal by Subject|1|||
131524496|NCT03221257|473546286|FG001|Overall Study|Withdrawal by Subject|1|||
131524497|NCT01334866|473546290|FG000|Overall Study|Withdrawal by Subject|10|||
131524498|NCT01334866|473546290|FG000|Overall Study|Lost to Follow-up|3|||
131524499|NCT01334866|473546290|FG000|Overall Study|Physician Decision|3|||
131524500|NCT01334866|473546290|FG000|Overall Study|medically necessary prior to procedure|2|||
131524501|NCT01334866|473546290|FG000|Overall Study|medically necessary post-procedure|1|||
131524502|NCT01687166|473546303|FG000|Overall Study|Attempt subject|2|||
131524503|NCT01687166|473546304|FG001|Overall Study|Attempt subject|3|||
131524504|NCT01687166|473546305|FG002|Overall Study|Attempt subject|2|||
131524505|NCT01687166|473546306|FG003|Overall Study|Attempt subject|0|||
131524506|NCT01687166|473546303|FG000|Overall Study|Did not meet eligibility criteria|4|||
131524507|NCT01687166|473546304|FG001|Overall Study|Did not meet eligibility criteria|6|||
131524508|NCT01687166|473546305|FG002|Overall Study|Did not meet eligibility criteria|1|||
131524509|NCT01687166|473546306|FG003|Overall Study|Did not meet eligibility criteria|1|||
131524510|NCT01687166|473546303|FG000|Overall Study|Adverse Event|2|||
131524511|NCT01687166|473546304|FG001|Overall Study|Adverse Event|1|||
131524512|NCT01687166|473546305|FG002|Overall Study|Adverse Event|0|||
131524513|NCT01687166|473546306|FG003|Overall Study|Adverse Event|0|||
131524514|NCT01687166|473546303|FG000|Overall Study|Physician Decision|3|||
131524515|NCT01687166|473546304|FG001|Overall Study|Physician Decision|2|||
131524516|NCT01687166|473546305|FG002|Overall Study|Physician Decision|1|||
131524517|NCT01687166|473546306|FG003|Overall Study|Physician Decision|0|||
131524518|NCT01687166|473546303|FG000|Overall Study|Withdrawal by Subject|11|||
131524519|NCT01687166|473546304|FG001|Overall Study|Withdrawal by Subject|4|||
131524520|NCT01687166|473546305|FG002|Overall Study|Withdrawal by Subject|3|||
131524521|NCT01687166|473546306|FG003|Overall Study|Withdrawal by Subject|0|||
131524522|NCT01687166|473546303|FG000|Overall Study|Lost to Follow-up|2|||
131524523|NCT01687166|473546304|FG001|Overall Study|Lost to Follow-up|5|||
131524524|NCT01687166|473546305|FG002|Overall Study|Lost to Follow-up|1|||
131524525|NCT01687166|473546306|FG003|Overall Study|Lost to Follow-up|0|||
131524526|NCT01687166|473546303|FG000|Overall Study|Equipment/Device Availability|0|||
131524527|NCT01687166|473546304|FG001|Overall Study|Equipment/Device Availability|1|||
131524528|NCT01687166|473546305|FG002|Overall Study|Equipment/Device Availability|0|||
131524529|NCT01687166|473546306|FG003|Overall Study|Equipment/Device Availability|0|||
131524530|NCT01687166|473546303|FG000|Overall Study|Death|1|||
131524531|NCT01687166|473546304|FG001|Overall Study|Death|1|||
131524532|NCT01687166|473546305|FG002|Overall Study|Death|0|||
131524533|NCT01687166|473546306|FG003|Overall Study|Death|0|||
131524534|NCT01687166|473546303|FG000|Overall Study|Protocol Violation|1|||
131524535|NCT01687166|473546304|FG001|Overall Study|Protocol Violation|1|||
131524536|NCT01687166|473546305|FG002|Overall Study|Protocol Violation|1|||
131524537|NCT01687166|473546306|FG003|Overall Study|Protocol Violation|0|||
131524538|NCT01687166|473546303|FG000|Overall Study|Subject moved out of state|0|||
131524539|NCT01687166|473546304|FG001|Overall Study|Subject moved out of state|1|||
131524540|NCT01687166|473546305|FG002|Overall Study|Subject moved out of state|0|||
131524541|NCT01687166|473546306|FG003|Overall Study|Subject moved out of state|0|||
131524542|NCT01687166|473546303|FG000|Overall Study|Patient unable to be compliant|1|||
131524543|NCT01687166|473546304|FG001|Overall Study|Patient unable to be compliant|0|||
131524544|NCT01687166|473546305|FG002|Overall Study|Patient unable to be compliant|0|||
131524545|NCT01687166|473546306|FG003|Overall Study|Patient unable to be compliant|0|||
131524546|NCT01687166|473546303|FG000|Overall Study|Physician choice to use different device|1|||
131524547|NCT01687166|473546304|FG001|Overall Study|Physician choice to use different device|2|||
131524548|NCT01687166|473546305|FG002|Overall Study|Physician choice to use different device|4|||
131524549|NCT01687166|473546306|FG003|Overall Study|Physician choice to use different device|0|||
131524550|NCT01687166|473546303|FG000|Overall Study|Insurance|0|||
131524551|NCT01687166|473546304|FG001|Overall Study|Insurance|0|||
131524552|NCT01687166|473546305|FG002|Overall Study|Insurance|1|||
131524553|NCT01687166|473546306|FG003|Overall Study|Insurance|1|||
131524554|NCT02755831|473546307|FG000|Overall Study|Lost to Follow-up|3|||
131524555|NCT02755831|473546308|FG001|Overall Study|Lost to Follow-up|3|||
131524556|NCT02296112|473546309|FG000|Overall Study|Disease progression|7|||
131524557|NCT02296112|473546309|FG000|Overall Study|Toxicity|1|||
131658428|NCT01531673|474035302|FG003|Overall Study|Other|1|||
131524558|NCT02296112|473546309|FG000|Overall Study|Began an alternate therapy|1|||
131524559|NCT02442830|473546310|FG000|Overall Study|Technical Failure|0|||
131524560|NCT02442830|473546311|FG001|Overall Study|Technical Failure|1|||
131524561|NCT01516879|473546312|FG000|Overall Study|Withdrawal by Subject|9|||
131524562|NCT01516879|473546313|FG001|Overall Study|Withdrawal by Subject|11|||
131524563|NCT01516879|473546312|FG000|Overall Study|Death|0|||
131524564|NCT01516879|473546313|FG001|Overall Study|Death|2|||
131524565|NCT01516879|473546312|FG000|Overall Study|Lost to Follow-up|2|||
131524566|NCT01516879|473546313|FG001|Overall Study|Lost to Follow-up|11|||
131524567|NCT01516879|473546312|FG000|Overall Study|Other|5|||
131524568|NCT01516879|473546313|FG001|Overall Study|Other|10|||
131524569|NCT00183872|473546314|FG000|Overall Study|Death|3|||
131524570|NCT00183872|473546314|FG000|Overall Study|Adverse Event|9|||
131524571|NCT00183872|473546314|FG000|Overall Study|Withdrawal by Subject|2|||
131524572|NCT00183872|473546314|FG000|Overall Study|Drug delayed more than 28 days|2|||
131524573|NCT01720069|473546315|FG000|Overall Study|Could not use e-diary correctly|0|||
131524574|NCT01720069|473546316|FG001|Overall Study|Could not use e-diary correctly|1|||
131524575|NCT01720069|473546317|FG002|Overall Study|Could not use e-diary correctly|1|||
131524576|NCT01720069|473546315|FG000|Overall Study|Randomised without baseline values|0|||
131524577|NCT01720069|473546316|FG001|Overall Study|Randomised without baseline values|0|||
131524578|NCT01720069|473546317|FG002|Overall Study|Randomised without baseline values|1|||
131524579|NCT01720069|473546315|FG000|Overall Study|Adverse Event|0|||
131524580|NCT01720069|473546316|FG001|Overall Study|Adverse Event|0|||
131524581|NCT01720069|473546317|FG002|Overall Study|Adverse Event|1|||
131524582|NCT01720069|473546315|FG000|Overall Study|Lack of Efficacy|0|||
131524583|NCT01720069|473546316|FG001|Overall Study|Lack of Efficacy|4|||
131524584|NCT01720069|473546317|FG002|Overall Study|Lack of Efficacy|0|||
131524585|NCT01720069|473546315|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
131524586|NCT01720069|473546316|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
131524587|NCT01720069|473546317|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
131524588|NCT01720069|473546315|FG000|Overall Study|Withdrawal by Subject|0|||
131524589|NCT01720069|473546316|FG001|Overall Study|Withdrawal by Subject|2|||
131524590|NCT01720069|473546317|FG002|Overall Study|Withdrawal by Subject|1|||
131524591|NCT01720069|473546315|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
131524592|NCT01720069|473546316|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
131524593|NCT01720069|473546317|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
131524594|NCT01720069|473546315|FG000|Overall Study|Non-compliance on using e-diary|0|||
131524595|NCT01720069|473546316|FG001|Overall Study|Non-compliance on using e-diary|0|||
131524596|NCT01720069|473546317|FG002|Overall Study|Non-compliance on using e-diary|1|||
131524597|NCT01720069|473546315|FG000|Overall Study|Lost to Follow-up|0|||
131524598|NCT01720069|473546316|FG001|Overall Study|Lost to Follow-up|0|||
131524599|NCT01720069|473546317|FG002|Overall Study|Lost to Follow-up|1|||
131524600|NCT00508742|473546318|FG000|Period 1: Infant Series|Adverse Event|5|||
131524601|NCT00508742|473546319|FG001|Period 1: Infant Series|Adverse Event|4|||
131524602|NCT00508742|473546318|FG000|Period 1: Infant Series|Protocol Violation|1|||
131524603|NCT00508742|473546319|FG001|Period 1: Infant Series|Protocol Violation|0|||
131524604|NCT00508742|473546318|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
131524605|NCT00508742|473546319|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
131524606|NCT00508742|473546318|FG000|Period 1: Infant Series|Physician Decision|1|||
131524607|NCT00508742|473546319|FG001|Period 1: Infant Series|Physician Decision|0|||
131524608|NCT00508742|473546318|FG000|Period 1: Infant Series|Other|4|||
131524609|NCT00508742|473546319|FG001|Period 1: Infant Series|Other|1|||
131524610|NCT00508742|473546318|FG000|Period 2: After Infant Series|Adverse Event|2|||
131524611|NCT00508742|473546319|FG001|Period 2: After Infant Series|Adverse Event|6|||
131524612|NCT00508742|473546318|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
131524613|NCT00508742|473546319|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
131524614|NCT00508742|473546318|FG000|Period 2: After Infant Series|Protocol Violation|1|||
131524615|NCT00508742|473546319|FG001|Period 2: After Infant Series|Protocol Violation|0|||
131524616|NCT00508742|473546318|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
131524617|NCT00508742|473546319|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
131524618|NCT00508742|473546318|FG000|Period 2: After Infant Series|Failed to Return|1|||
131524619|NCT00508742|473546319|FG001|Period 2: After Infant Series|Failed to Return|0|||
131524620|NCT00508742|473546318|FG000|Period 2: After Infant Series|Other|2|||
131524621|NCT00508742|473546319|FG001|Period 2: After Infant Series|Other|1|||
131524622|NCT00508742|473546318|FG000|Period 3: Toddler Dose|Adverse Event|1|||
131524623|NCT00508742|473546319|FG001|Period 3: Toddler Dose|Adverse Event|0|||
131524624|NCT00508742|473546318|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
131524625|NCT00508742|473546319|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
131524626|NCT00508742|473546318|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
131524627|NCT00508742|473546319|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
131524628|NCT00508742|473546318|FG000|Period 3: Toddler Dose|Other|5|||
131524629|NCT00508742|473546319|FG001|Period 3: Toddler Dose|Other|4|||
131524630|NCT04568122|473546320|FG000|Overall Study|Lost to Follow-up|48|||
131653843|NCT03307785|474018486|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
131524631|NCT04568122|473546321|FG001|Overall Study|Lost to Follow-up|44|||
131524632|NCT04568122|473546322|FG002|Overall Study|Lost to Follow-up|4|||
131524633|NCT04568122|473546323|FG003|Overall Study|Lost to Follow-up|0|||
131524634|NCT04568122|473546324|FG004|Overall Study|Lost to Follow-up|0|||
131524635|NCT00700011|473546330|FG000|Overall Study|Death|0|||
131524636|NCT00700011|473546331|FG001|Overall Study|Death|1|||
131524637|NCT02460224|473546333|FG000|Overall Study|Adverse Event|0|||
131524638|NCT02460224|473546334|FG001|Overall Study|Adverse Event|0|||
131524639|NCT02460224|473546335|FG002|Overall Study|Adverse Event|0|||
131524640|NCT02460224|473546336|FG003|Overall Study|Adverse Event|0|||
131524641|NCT02460224|473546337|FG004|Overall Study|Adverse Event|0|||
131524642|NCT02460224|473546338|FG005|Overall Study|Adverse Event|0|||
131524643|NCT02460224|473546339|FG006|Overall Study|Adverse Event|1|||
131524644|NCT02460224|473546340|FG007|Overall Study|Adverse Event|0|||
131524645|NCT02460224|473546341|FG008|Overall Study|Adverse Event|0|||
131524646|NCT02460224|473546342|FG009|Overall Study|Adverse Event|0|||
131524647|NCT02460224|473546343|FG010|Overall Study|Adverse Event|0|||
131524648|NCT02460224|473546344|FG011|Overall Study|Adverse Event|0|||
131524649|NCT02460224|473546345|FG012|Overall Study|Adverse Event|1|||
131524650|NCT02460224|473546346|FG013|Overall Study|Adverse Event|0|||
131524651|NCT02460224|473546347|FG014|Overall Study|Adverse Event|0|||
131524652|NCT02460224|473546348|FG015|Overall Study|Adverse Event|0|||
131524653|NCT02460224|473546349|FG016|Overall Study|Adverse Event|1|||
131524654|NCT02460224|473546350|FG017|Overall Study|Adverse Event|0|||
131524655|NCT02460224|473546351|FG018|Overall Study|Adverse Event|1|||
131524656|NCT02460224|473546352|FG019|Overall Study|Adverse Event|0|||
131524657|NCT02460224|473546353|FG020|Overall Study|Adverse Event|1|||
131524658|NCT02460224|473546354|FG021|Overall Study|Adverse Event|1|||
131524659|NCT02460224|473546355|FG022|Overall Study|Adverse Event|1|||
131524660|NCT02460224|473546356|FG023|Overall Study|Adverse Event|0|||
131524661|NCT02460224|473546357|FG024|Overall Study|Adverse Event|0|||
131524662|NCT02460224|473546358|FG025|Overall Study|Adverse Event|0|||
131524663|NCT02460224|473546359|FG026|Overall Study|Adverse Event|11|||
131524664|NCT02460224|473546360|FG027|Overall Study|Adverse Event|1|||
131524665|NCT02460224|473546361|FG028|Overall Study|Adverse Event|6|||
131524666|NCT02460224|473546333|FG000|Overall Study|Death|0|||
131524667|NCT02460224|473546334|FG001|Overall Study|Death|0|||
131524668|NCT02460224|473546335|FG002|Overall Study|Death|0|||
131524669|NCT02460224|473546336|FG003|Overall Study|Death|0|||
131524670|NCT02460224|473546337|FG004|Overall Study|Death|0|||
131524671|NCT02460224|473546338|FG005|Overall Study|Death|2|||
131524672|NCT02460224|473546339|FG006|Overall Study|Death|1|||
131524673|NCT02460224|473546340|FG007|Overall Study|Death|0|||
131524674|NCT02460224|473546341|FG008|Overall Study|Death|0|||
131524675|NCT02460224|473546342|FG009|Overall Study|Death|1|||
131524676|NCT02460224|473546343|FG010|Overall Study|Death|0|||
131524677|NCT02460224|473546344|FG011|Overall Study|Death|0|||
131524678|NCT02460224|473546345|FG012|Overall Study|Death|0|||
131524679|NCT02460224|473546346|FG013|Overall Study|Death|1|||
131524680|NCT02460224|473546347|FG014|Overall Study|Death|0|||
131524681|NCT02460224|473546348|FG015|Overall Study|Death|0|||
131524682|NCT02460224|473546349|FG016|Overall Study|Death|2|||
131524683|NCT02460224|473546350|FG017|Overall Study|Death|1|||
131524684|NCT02460224|473546351|FG018|Overall Study|Death|0|||
131524685|NCT02460224|473546352|FG019|Overall Study|Death|2|||
131524686|NCT02460224|473546353|FG020|Overall Study|Death|0|||
131524687|NCT02460224|473546354|FG021|Overall Study|Death|0|||
131524688|NCT02460224|473546355|FG022|Overall Study|Death|0|||
131524689|NCT02460224|473546356|FG023|Overall Study|Death|0|||
131524690|NCT02460224|473546357|FG024|Overall Study|Death|1|||
131524691|NCT02460224|473546358|FG025|Overall Study|Death|1|||
131524692|NCT02460224|473546359|FG026|Overall Study|Death|5|||
131524693|NCT02460224|473546360|FG027|Overall Study|Death|0|||
131524694|NCT02460224|473546361|FG028|Overall Study|Death|1|||
131524695|NCT02460224|473546333|FG000|Overall Study|Lost to Follow-up|0|||
131524696|NCT02460224|473546334|FG001|Overall Study|Lost to Follow-up|0|||
131524697|NCT02460224|473546335|FG002|Overall Study|Lost to Follow-up|0|||
131524698|NCT02460224|473546336|FG003|Overall Study|Lost to Follow-up|0|||
131524699|NCT02460224|473546337|FG004|Overall Study|Lost to Follow-up|0|||
131524700|NCT02460224|473546338|FG005|Overall Study|Lost to Follow-up|0|||
131524701|NCT02460224|473546339|FG006|Overall Study|Lost to Follow-up|0|||
131524702|NCT02460224|473546340|FG007|Overall Study|Lost to Follow-up|0|||
131524703|NCT02460224|473546341|FG008|Overall Study|Lost to Follow-up|0|||
131524704|NCT02460224|473546342|FG009|Overall Study|Lost to Follow-up|0|||
131524705|NCT02460224|473546343|FG010|Overall Study|Lost to Follow-up|0|||
131524706|NCT02460224|473546344|FG011|Overall Study|Lost to Follow-up|0|||
131524707|NCT02460224|473546345|FG012|Overall Study|Lost to Follow-up|0|||
131524708|NCT02460224|473546346|FG013|Overall Study|Lost to Follow-up|0|||
131524709|NCT02460224|473546347|FG014|Overall Study|Lost to Follow-up|0|||
131524710|NCT02460224|473546348|FG015|Overall Study|Lost to Follow-up|0|||
131524711|NCT02460224|473546349|FG016|Overall Study|Lost to Follow-up|0|||
131524712|NCT02460224|473546350|FG017|Overall Study|Lost to Follow-up|0|||
131524713|NCT02460224|473546351|FG018|Overall Study|Lost to Follow-up|0|||
131524714|NCT02460224|473546352|FG019|Overall Study|Lost to Follow-up|0|||
131524715|NCT02460224|473546353|FG020|Overall Study|Lost to Follow-up|0|||
131524716|NCT02460224|473546354|FG021|Overall Study|Lost to Follow-up|0|||
131524717|NCT02460224|473546355|FG022|Overall Study|Lost to Follow-up|1|||
131524718|NCT02460224|473546356|FG023|Overall Study|Lost to Follow-up|0|||
131524719|NCT02460224|473546357|FG024|Overall Study|Lost to Follow-up|0|||
131524720|NCT02460224|473546358|FG025|Overall Study|Lost to Follow-up|0|||
131524721|NCT02460224|473546359|FG026|Overall Study|Lost to Follow-up|0|||
131524722|NCT02460224|473546360|FG027|Overall Study|Lost to Follow-up|0|||
131524723|NCT02460224|473546361|FG028|Overall Study|Lost to Follow-up|0|||
131524724|NCT02460224|473546333|FG000|Overall Study|Physician Decision|0|||
131524725|NCT02460224|473546334|FG001|Overall Study|Physician Decision|1|||
131524726|NCT02460224|473546335|FG002|Overall Study|Physician Decision|0|||
131524727|NCT02460224|473546336|FG003|Overall Study|Physician Decision|0|||
131524728|NCT02460224|473546337|FG004|Overall Study|Physician Decision|1|||
131524729|NCT02460224|473546338|FG005|Overall Study|Physician Decision|0|||
131524730|NCT02460224|473546339|FG006|Overall Study|Physician Decision|0|||
131524731|NCT02460224|473546340|FG007|Overall Study|Physician Decision|1|||
131524732|NCT02460224|473546341|FG008|Overall Study|Physician Decision|0|||
131524733|NCT02460224|473546342|FG009|Overall Study|Physician Decision|0|||
131524734|NCT02460224|473546343|FG010|Overall Study|Physician Decision|0|||
131524735|NCT02460224|473546344|FG011|Overall Study|Physician Decision|1|||
131524736|NCT02460224|473546345|FG012|Overall Study|Physician Decision|0|||
131524737|NCT02460224|473546346|FG013|Overall Study|Physician Decision|1|||
131524738|NCT02460224|473546347|FG014|Overall Study|Physician Decision|0|||
131524739|NCT02460224|473546348|FG015|Overall Study|Physician Decision|0|||
131524740|NCT02460224|473546349|FG016|Overall Study|Physician Decision|2|||
131524741|NCT02460224|473546350|FG017|Overall Study|Physician Decision|1|||
131524742|NCT02460224|473546351|FG018|Overall Study|Physician Decision|1|||
131524743|NCT02460224|473546352|FG019|Overall Study|Physician Decision|2|||
131524744|NCT02460224|473546353|FG020|Overall Study|Physician Decision|1|||
131524745|NCT02460224|473546354|FG021|Overall Study|Physician Decision|1|||
131524746|NCT02460224|473546355|FG022|Overall Study|Physician Decision|0|||
131524747|NCT02460224|473546356|FG023|Overall Study|Physician Decision|0|||
131524748|NCT02460224|473546357|FG024|Overall Study|Physician Decision|1|||
131524749|NCT02460224|473546358|FG025|Overall Study|Physician Decision|0|||
131524750|NCT02460224|473546359|FG026|Overall Study|Physician Decision|14|||
131524751|NCT02460224|473546360|FG027|Overall Study|Physician Decision|1|||
131524752|NCT02460224|473546361|FG028|Overall Study|Physician Decision|6|||
131524753|NCT02460224|473546333|FG000|Overall Study|Progressive disease|15|||
131524754|NCT02460224|473546334|FG001|Overall Study|Progressive disease|11|||
131524755|NCT02460224|473546335|FG002|Overall Study|Progressive disease|5|||
131524756|NCT02460224|473546336|FG003|Overall Study|Progressive disease|6|||
131524757|NCT02460224|473546337|FG004|Overall Study|Progressive disease|3|||
131524758|NCT02460224|473546338|FG005|Overall Study|Progressive disease|26|||
131524759|NCT02460224|473546339|FG006|Overall Study|Progressive disease|28|||
131524760|NCT02460224|473546340|FG007|Overall Study|Progressive disease|4|||
131524761|NCT02460224|473546341|FG008|Overall Study|Progressive disease|5|||
131524762|NCT02460224|473546342|FG009|Overall Study|Progressive disease|9|||
131524763|NCT02460224|473546343|FG010|Overall Study|Progressive disease|5|||
131524764|NCT02460224|473546344|FG011|Overall Study|Progressive disease|4|||
131524765|NCT02460224|473546345|FG012|Overall Study|Progressive disease|5|||
131524766|NCT02460224|473546346|FG013|Overall Study|Progressive disease|4|||
131524767|NCT02460224|473546347|FG014|Overall Study|Progressive disease|5|||
131524768|NCT02460224|473546348|FG015|Overall Study|Progressive disease|5|||
131524769|NCT02460224|473546349|FG016|Overall Study|Progressive disease|15|||
131524770|NCT02460224|473546350|FG017|Overall Study|Progressive disease|3|||
131524771|NCT02460224|473546351|FG018|Overall Study|Progressive disease|8|||
131524772|NCT02460224|473546352|FG019|Overall Study|Progressive disease|3|||
131524773|NCT02460224|473546353|FG020|Overall Study|Progressive disease|4|||
131524774|NCT02460224|473546354|FG021|Overall Study|Progressive disease|9|||
131524775|NCT02460224|473546355|FG022|Overall Study|Progressive disease|4|||
131524776|NCT02460224|473546356|FG023|Overall Study|Progressive disease|11|||
131524777|NCT02460224|473546357|FG024|Overall Study|Progressive disease|4|||
131524778|NCT02460224|473546358|FG025|Overall Study|Progressive disease|5|||
131524779|NCT02460224|473546359|FG026|Overall Study|Progressive disease|85|||
131524780|NCT02460224|473546360|FG027|Overall Study|Progressive disease|17|||
131524781|NCT02460224|473546361|FG028|Overall Study|Progressive disease|77|||
131524782|NCT02460224|473546333|FG000|Overall Study|Subject/guardian decision|2|||
131524783|NCT02460224|473546334|FG001|Overall Study|Subject/guardian decision|0|||
131524784|NCT02460224|473546335|FG002|Overall Study|Subject/guardian decision|1|||
131524785|NCT02460224|473546336|FG003|Overall Study|Subject/guardian decision|0|||
131524786|NCT02460224|473546337|FG004|Overall Study|Subject/guardian decision|2|||
131524787|NCT02460224|473546338|FG005|Overall Study|Subject/guardian decision|2|||
131524788|NCT02460224|473546339|FG006|Overall Study|Subject/guardian decision|0|||
131524789|NCT02460224|473546340|FG007|Overall Study|Subject/guardian decision|0|||
131524790|NCT02460224|473546341|FG008|Overall Study|Subject/guardian decision|1|||
131524791|NCT02460224|473546342|FG009|Overall Study|Subject/guardian decision|1|||
131524792|NCT02460224|473546343|FG010|Overall Study|Subject/guardian decision|0|||
131524793|NCT02460224|473546344|FG011|Overall Study|Subject/guardian decision|1|||
131524794|NCT02460224|473546345|FG012|Overall Study|Subject/guardian decision|0|||
131524795|NCT02460224|473546346|FG013|Overall Study|Subject/guardian decision|0|||
131524796|NCT02460224|473546347|FG014|Overall Study|Subject/guardian decision|0|||
131524797|NCT02460224|473546348|FG015|Overall Study|Subject/guardian decision|1|||
131524798|NCT02460224|473546349|FG016|Overall Study|Subject/guardian decision|0|||
131524799|NCT02460224|473546350|FG017|Overall Study|Subject/guardian decision|1|||
131524800|NCT02460224|473546351|FG018|Overall Study|Subject/guardian decision|2|||
131524801|NCT02460224|473546352|FG019|Overall Study|Subject/guardian decision|0|||
131524802|NCT02460224|473546353|FG020|Overall Study|Subject/guardian decision|0|||
131524803|NCT02460224|473546354|FG021|Overall Study|Subject/guardian decision|1|||
131524804|NCT02460224|473546355|FG022|Overall Study|Subject/guardian decision|0|||
131524805|NCT02460224|473546356|FG023|Overall Study|Subject/guardian decision|0|||
131524806|NCT02460224|473546357|FG024|Overall Study|Subject/guardian decision|0|||
131524807|NCT02460224|473546358|FG025|Overall Study|Subject/guardian decision|0|||
131524808|NCT02460224|473546359|FG026|Overall Study|Subject/guardian decision|6|||
131524809|NCT02460224|473546360|FG027|Overall Study|Subject/guardian decision|2|||
131524810|NCT02460224|473546361|FG028|Overall Study|Subject/guardian decision|3|||
131524811|NCT02797262|473546362|FG000|Overall Study|Withdrawal by Subject|5|||
131524812|NCT02797262|473546363|FG001|Overall Study|Withdrawal by Subject|1|||
131524813|NCT02797262|473546362|FG000|Overall Study|Lost to Follow-up|10|||
131524814|NCT02797262|473546363|FG001|Overall Study|Lost to Follow-up|7|||
131524815|NCT02797262|473546362|FG000|Overall Study|Death|1|||
131524816|NCT02797262|473546363|FG001|Overall Study|Death|2|||
131524817|NCT02797262|473546362|FG000|Overall Study|Adverse Event|1|||
131524818|NCT02797262|473546363|FG001|Overall Study|Adverse Event|0|||
131524819|NCT02797262|473546362|FG000|Overall Study|COVID-19|2|||
131524820|NCT02797262|473546363|FG001|Overall Study|COVID-19|1|||
131524821|NCT02797262|473546362|FG000|Overall Study|Out-of-country|1|||
131524822|NCT02797262|473546363|FG001|Overall Study|Out-of-country|0|||
131524823|NCT01600586|473546364|FG000|Overall Study|Physician Decision|3|||
131524824|NCT01600586|473546365|FG001|Overall Study|Physician Decision|3|||
131524825|NCT03146650|473546367|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
131524826|NCT03146650|473546367|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
131524827|NCT03146650|473546367|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
131524828|NCT03146650|473546367|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
131524829|NCT03146650|473546367|FG000|2 Year Follow-up|Death|11|||
131524830|NCT03146650|473546367|FG000|2 Year Follow-up|Still in follow-up|7|||
131524831|NCT03146650|473546367|FG000|2 Year Follow-up|Lost to Follow-up|1|||
131524832|NCT00983814|473546370|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
131524833|NCT00983814|473546371|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
131524834|NCT00983814|473546372|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
131524835|NCT00983814|473546370|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
131524836|NCT00983814|473546371|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
131524837|NCT00983814|473546372|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
131524838|NCT00983814|473546370|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
131524839|NCT00983814|473546371|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
131524840|NCT00983814|473546372|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
131524841|NCT00983814|473546370|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
131524842|NCT00983814|473546371|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
131524843|NCT00983814|473546372|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
131524844|NCT00983814|473546370|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
131524845|NCT00983814|473546371|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
131524846|NCT00983814|473546372|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
131524847|NCT03333486|473546373|FG000|Overall Study|Withdrawal by Subject|1|||
131524848|NCT03333486|473546373|FG000|Overall Study|Lost to Follow-up|1|||
131524849|NCT01976845|473546376|FG000|Overall Study|Physician Decision|8|||
131524850|NCT01976845|473546377|FG001|Overall Study|Physician Decision|8|||
131524851|NCT01976845|473546378|FG002|Overall Study|Physician Decision|3|||
131524852|NCT01818336|473547687|FG000|Overall Study|Declined retest visit|0|||
131524853|NCT01818336|473547688|FG001|Overall Study|Declined retest visit|11|||
131524854|NCT01818336|473547687|FG000|Overall Study|Lost to Follow-up|0|||
131524855|NCT01818336|473547688|FG001|Overall Study|Lost to Follow-up|1|||
131524856|NCT00827372|473547693|FG000|Overall Study|Adverse Event|5|||
131524857|NCT00827372|473547693|FG000|Overall Study|Lack of Efficacy|3|||
131524858|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
131524859|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131524860|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131524861|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131524862|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131524863|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131524864|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
131524865|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131524866|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131524867|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131524868|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131524869|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131524870|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
131524871|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131524872|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131524873|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131524874|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131524875|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131524876|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
131524877|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131524878|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131524879|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131524880|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131524881|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131524882|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
131524883|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131524884|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131524885|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131524886|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131524887|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131524888|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
131524889|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
131524890|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
131524891|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
131524892|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
131524893|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
131524894|NCT02139644|473547694|FG000|Run-In Period (Pre-assignment)|Other|6|||
131524895|NCT02139644|473547695|FG001|Run-In Period (Pre-assignment)|Other|0|||
131524896|NCT02139644|473547696|FG002|Run-In Period (Pre-assignment)|Other|0|||
131524897|NCT02139644|473547697|FG003|Run-In Period (Pre-assignment)|Other|0|||
131524898|NCT02139644|473547698|FG004|Run-In Period (Pre-assignment)|Other|0|||
131524899|NCT02139644|473547699|FG005|Run-In Period (Pre-assignment)|Other|0|||
131524900|NCT02139644|473547694|FG000|Treatment Period|Adverse Event|0|||
131524901|NCT02139644|473547695|FG001|Treatment Period|Adverse Event|0|||
131524902|NCT02139644|473547696|FG002|Treatment Period|Adverse Event|3|||
131524903|NCT02139644|473547697|FG003|Treatment Period|Adverse Event|2|||
131524904|NCT02139644|473547698|FG004|Treatment Period|Adverse Event|1|||
131524905|NCT02139644|473547699|FG005|Treatment Period|Adverse Event|6|||
131524906|NCT02139644|473547694|FG000|Treatment Period|Withdrawal by Subject|0|||
131524907|NCT02139644|473547695|FG001|Treatment Period|Withdrawal by Subject|0|||
131524908|NCT02139644|473547696|FG002|Treatment Period|Withdrawal by Subject|2|||
131524909|NCT02139644|473547697|FG003|Treatment Period|Withdrawal by Subject|2|||
131524910|NCT02139644|473547698|FG004|Treatment Period|Withdrawal by Subject|3|||
131524911|NCT02139644|473547699|FG005|Treatment Period|Withdrawal by Subject|2|||
131524912|NCT02139644|473547694|FG000|Treatment Period|Non-compliance|0|||
131524913|NCT02139644|473547695|FG001|Treatment Period|Non-compliance|0|||
131524914|NCT02139644|473547696|FG002|Treatment Period|Non-compliance|0|||
131524915|NCT02139644|473547697|FG003|Treatment Period|Non-compliance|1|||
131524916|NCT02139644|473547698|FG004|Treatment Period|Non-compliance|0|||
131524917|NCT02139644|473547699|FG005|Treatment Period|Non-compliance|0|||
131524918|NCT02139644|473547694|FG000|Treatment Period|Protocol Violation|0|||
131524919|NCT02139644|473547695|FG001|Treatment Period|Protocol Violation|0|||
131524920|NCT02139644|473547696|FG002|Treatment Period|Protocol Violation|0|||
131524921|NCT02139644|473547697|FG003|Treatment Period|Protocol Violation|1|||
131524922|NCT02139644|473547698|FG004|Treatment Period|Protocol Violation|1|||
131524923|NCT02139644|473547699|FG005|Treatment Period|Protocol Violation|1|||
131524924|NCT02139644|473547694|FG000|Treatment Period|Disease progression|0|||
131524925|NCT02139644|473547695|FG001|Treatment Period|Disease progression|0|||
131524926|NCT02139644|473547696|FG002|Treatment Period|Disease progression|0|||
131524927|NCT02139644|473547697|FG003|Treatment Period|Disease progression|1|||
131524928|NCT02139644|473547698|FG004|Treatment Period|Disease progression|1|||
131524929|NCT02139644|473547699|FG005|Treatment Period|Disease progression|2|||
131524930|NCT02139644|473547694|FG000|Treatment Period|Lost to Follow-up|0|||
131524931|NCT02139644|473547695|FG001|Treatment Period|Lost to Follow-up|0|||
131524932|NCT02139644|473547696|FG002|Treatment Period|Lost to Follow-up|1|||
131524933|NCT02139644|473547697|FG003|Treatment Period|Lost to Follow-up|1|||
131524934|NCT02139644|473547698|FG004|Treatment Period|Lost to Follow-up|1|||
131524935|NCT02139644|473547699|FG005|Treatment Period|Lost to Follow-up|1|||
131524936|NCT02139644|473547694|FG000|Treatment Period|Lack of Efficacy|0|||
131524937|NCT02139644|473547695|FG001|Treatment Period|Lack of Efficacy|0|||
131524938|NCT02139644|473547696|FG002|Treatment Period|Lack of Efficacy|1|||
131524939|NCT02139644|473547697|FG003|Treatment Period|Lack of Efficacy|0|||
131524940|NCT02139644|473547698|FG004|Treatment Period|Lack of Efficacy|1|||
131524941|NCT02139644|473547699|FG005|Treatment Period|Lack of Efficacy|4|||
131524942|NCT02139644|473547694|FG000|Treatment Period|Other|0|||
131524943|NCT02139644|473547695|FG001|Treatment Period|Other|3|||
131524944|NCT02139644|473547696|FG002|Treatment Period|Other|1|||
131524945|NCT02139644|473547697|FG003|Treatment Period|Other|1|||
131524946|NCT02139644|473547698|FG004|Treatment Period|Other|0|||
131524947|NCT02139644|473547699|FG005|Treatment Period|Other|1|||
131524948|NCT03328897|473547700|FG000|Randomized-treatment Epoch|Adverse Event|4|||
131524949|NCT03328897|473547701|FG001|Randomized-treatment Epoch|Adverse Event|1|||
131524950|NCT03328897|473547702|FG002|Randomized-treatment Epoch|Adverse Event|1|||
131524951|NCT03328897|473547700|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
131524952|NCT03328897|473547701|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
131524953|NCT03328897|473547702|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
131524954|NCT03328897|473547700|FG000|Randomized-treatment Epoch|Pregnancy|3|||
131524955|NCT03328897|473547701|FG001|Randomized-treatment Epoch|Pregnancy|0|||
131524956|NCT03328897|473547702|FG002|Randomized-treatment Epoch|Pregnancy|0|||
131524957|NCT03328897|473547700|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
131524958|NCT03328897|473547701|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
131524959|NCT03328897|473547702|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
131524960|NCT03328897|473547700|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
131524961|NCT03328897|473547701|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
131524962|NCT03328897|473547702|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
131524963|NCT03328897|473547700|FG000|Follow-up Epoch|Adverse Event|4|||
131524964|NCT03328897|473547701|FG001|Follow-up Epoch|Adverse Event|0|||
131524965|NCT03328897|473547702|FG002|Follow-up Epoch|Adverse Event|1|||
131524966|NCT03328897|473547700|FG000|Follow-up Epoch|Lack of Efficacy|1|||
131524967|NCT03328897|473547701|FG001|Follow-up Epoch|Lack of Efficacy|1|||
131524968|NCT03328897|473547702|FG002|Follow-up Epoch|Lack of Efficacy|1|||
131524969|NCT03328897|473547700|FG000|Follow-up Epoch|Lost to Follow-up|0|||
131524970|NCT03328897|473547701|FG001|Follow-up Epoch|Lost to Follow-up|1|||
131524971|NCT03328897|473547702|FG002|Follow-up Epoch|Lost to Follow-up|0|||
131524972|NCT03328897|473547700|FG000|Follow-up Epoch|Pregnancy|1|||
131524973|NCT03328897|473547701|FG001|Follow-up Epoch|Pregnancy|0|||
131524974|NCT03328897|473547702|FG002|Follow-up Epoch|Pregnancy|0|||
131524975|NCT03328897|473547700|FG000|Follow-up Epoch|Patient/guardian decision|2|||
131524976|NCT03328897|473547701|FG001|Follow-up Epoch|Patient/guardian decision|1|||
131524977|NCT03328897|473547702|FG002|Follow-up Epoch|Patient/guardian decision|0|||
131524978|NCT00941733|473547703|FG000|Overall Study|Death|24|||
131524979|NCT00941733|473547704|FG001|Overall Study|Death|10|||
131524980|NCT00941733|473547703|FG000|Overall Study|Withdrawal by Subject|14|||
131524981|NCT00941733|473547704|FG001|Overall Study|Withdrawal by Subject|6|||
131524982|NCT00941733|473547703|FG000|Overall Study|Adverse Event|20|||
131524983|NCT00941733|473547704|FG001|Overall Study|Adverse Event|4|||
131524984|NCT00941733|473547703|FG000|Overall Study|Lost to Follow-up|1|||
131524985|NCT00941733|473547704|FG001|Overall Study|Lost to Follow-up|2|||
131524986|NCT00941733|473547703|FG000|Overall Study|Protocol Violation|15|||
131524987|NCT00941733|473547704|FG001|Overall Study|Protocol Violation|6|||
131524988|NCT02080091|473547705|FG000|Overall Study|Study Terminated|22|||
131524989|NCT02080091|473547705|FG000|Overall Study|Death|1|||
131524990|NCT02080091|473547705|FG000|Overall Study|Withdrawal by Subject|1|||
131524991|NCT02080091|473547705|FG000|Overall Study|Other|1|||
131524992|NCT00408993|473547710|FG000|Overall Study|Adverse Event|15|||
131524993|NCT00408993|473547711|FG001|Overall Study|Adverse Event|4|||
131524994|NCT00408993|473547710|FG000|Overall Study|Protocol Violation|1|||
131524995|NCT00408993|473547711|FG001|Overall Study|Protocol Violation|6|||
131524996|NCT00408993|473547710|FG000|Overall Study|Lack of Efficacy|1|||
131524997|NCT00408993|473547711|FG001|Overall Study|Lack of Efficacy|4|||
131524998|NCT00408993|473547710|FG000|Overall Study|Withdrawal by Subject|2|||
131524999|NCT00408993|473547711|FG001|Overall Study|Withdrawal by Subject|3|||
131525000|NCT03738865|473547712|FG000|Overall Study|Withdrawal by Subject|3|||
131525001|NCT03738865|473547713|FG001|Overall Study|Withdrawal by Subject|3|||
131525002|NCT03738865|473547712|FG000|Overall Study|Adverse Event|2|||
131525003|NCT03738865|473547713|FG001|Overall Study|Adverse Event|0|||
131525004|NCT03738865|473547712|FG000|Overall Study|Physician Decision|0|||
131525005|NCT03738865|473547713|FG001|Overall Study|Physician Decision|1|||
131525006|NCT00961259|473547714|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
131525007|NCT00961259|473547715|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
131525008|NCT00961259|473547716|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
131525009|NCT02691455|473547717|FG000|Overall Study|Withdrawal by Subject|1|||
131525010|NCT02691455|473547718|FG001|Overall Study|Withdrawal by Subject|2|||
131525011|NCT02691455|473547717|FG000|Overall Study|Lost to Follow-up|15|||
131525012|NCT02691455|473547718|FG001|Overall Study|Lost to Follow-up|15|||
131525013|NCT01863446|473547720|FG000|Overall Study|Withdrawal by Subject|1|||
131525014|NCT01863446|473547721|FG001|Overall Study|Withdrawal by Subject|0|||
131525015|NCT01863446|473547722|FG002|Overall Study|Withdrawal by Subject|1|||
131525016|NCT01863446|473547723|FG003|Overall Study|Withdrawal by Subject|2|||
131525017|NCT01863446|473547720|FG000|Overall Study|Physician Decision|0|||
131525018|NCT01863446|473547721|FG001|Overall Study|Physician Decision|0|||
131525019|NCT01863446|473547722|FG002|Overall Study|Physician Decision|1|||
131525020|NCT01863446|473547723|FG003|Overall Study|Physician Decision|0|||
131525021|NCT02252081|473547724|FG000|Overall Study|Withdrawal by Subject|2|||
131525022|NCT02252081|473547725|FG001|Overall Study|Withdrawal by Subject|1|||
131525023|NCT02252081|473547724|FG000|Overall Study|Adverse Event|4|||
131525024|NCT02252081|473547725|FG001|Overall Study|Adverse Event|1|||
131525025|NCT02252081|473547724|FG000|Overall Study|non compliance & others|0|||
131525026|NCT02252081|473547725|FG001|Overall Study|non compliance & others|2|||
131525027|NCT01276327|473547732|FG000|Overall Study|Adverse Event|1|||
131525028|NCT01276327|473547733|FG001|Overall Study|Adverse Event|3|||
131525029|NCT01276327|473547732|FG000|Overall Study|Withdrawal by Subject|1|||
131525030|NCT01276327|473547733|FG001|Overall Study|Withdrawal by Subject|0|||
131525031|NCT01794949|473547734|FG000|Overall Study|Lost to Follow-up|1|||
131525032|NCT01794949|473547735|FG001|Overall Study|Lost to Follow-up|0|||
131525033|NCT04713748|473547737|FG000|Overall Study|Not enough kits allocated|35|||
131525034|NCT01410110|473547744|FG000|Overall Study|Withdrawal by Subject|4|||
131525035|NCT01410110|473547745|FG001|Overall Study|Withdrawal by Subject|2|||
131525036|NCT02802345|473547749|FG000|Overall Study|Not Treated|0|||
131525037|NCT02802345|473547750|FG001|Overall Study|Not Treated|1|||
131525038|NCT02802345|473547749|FG000|Overall Study|Adverse Event|28|||
131525039|NCT02802345|473547750|FG001|Overall Study|Adverse Event|20|||
131525040|NCT02802345|473547749|FG000|Overall Study|Withdrawal by Subject|3|||
131525041|NCT02802345|473547750|FG001|Overall Study|Withdrawal by Subject|3|||
131525042|NCT02802345|473547749|FG000|Overall Study|Protocol Violation|0|||
131525043|NCT02802345|473547750|FG001|Overall Study|Protocol Violation|1|||
131525044|NCT02802345|473547749|FG000|Overall Study|Other than listed|1|||
131525045|NCT02802345|473547750|FG001|Overall Study|Other than listed|5|||
131525046|NCT04632940|473547751|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
131525047|NCT04632940|473547752|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
131525048|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
131525049|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
131525050|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
131525051|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
131525052|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
131525053|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
131525054|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
131525055|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
131525056|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
131525057|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
131525058|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Other than specified|0|||
131525059|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Other than specified|1|||
131525060|NCT04632940|473547751|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
131525061|NCT04632940|473547752|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
131525062|NCT05857527|473547755|FG000|Overall Study|Withdrawal by Subject|0|||
131525063|NCT05857527|473547756|FG001|Overall Study|Withdrawal by Subject|1|||
131525064|NCT02799082|473547759|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
131525065|NCT02799082|473547760|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
131525066|NCT02799082|473547759|FG000|Overall Study|Protocol Violation|0|||
131525067|NCT02799082|473547760|FG001|Overall Study|Protocol Violation|1|||
131525068|NCT01748994|473547765|FG000|Overall Study|Lost to Follow-up|8|||
131525069|NCT01748994|473547766|FG001|Overall Study|Lost to Follow-up|6|||
131525070|NCT02520531|473547769|FG000|Overall Study|Revision of study device components|2|||
131525071|NCT02520531|473547770|FG001|Overall Study|Revision of study device components|2|||
131525072|NCT02520531|473547769|FG000|Overall Study|Death|1|||
131525073|NCT02520531|473547770|FG001|Overall Study|Death|2|||
131525074|NCT02520531|473547769|FG000|Overall Study|Lost to Follow-up|1|||
131525075|NCT02520531|473547770|FG001|Overall Study|Lost to Follow-up|1|||
131525076|NCT02520531|473547769|FG000|Overall Study|Meet exclusion criterion|0|||
131525077|NCT02520531|473547770|FG001|Overall Study|Meet exclusion criterion|1|||
131525078|NCT02520531|473547769|FG000|Overall Study|Withdrawal by Subject|1|||
131525079|NCT02520531|473547770|FG001|Overall Study|Withdrawal by Subject|0|||
131525080|NCT02520531|473547769|FG000|Overall Study|Not study device|1|||
131525081|NCT02520531|473547770|FG001|Overall Study|Not study device|0|||
131525082|NCT01723904|473547774|FG000|Overall Study|Noncompliant|3|||
131525083|NCT01723904|473547774|FG000|Overall Study|Adverse Event|5|||
131525084|NCT01723904|473547774|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
131525085|NCT01649856|473547785|FG000|Overall Study|Withdrawal by Subject|14|||
131525086|NCT01649856|473547786|FG001|Overall Study|Withdrawal by Subject|14|||
131525087|NCT01649856|473547785|FG000|Overall Study|Protocol Violation|4|||
131525088|NCT01649856|473547786|FG001|Overall Study|Protocol Violation|4|||
131525089|NCT01649856|473547785|FG000|Overall Study|Treatment Failure|1|||
131525090|NCT01649856|473547786|FG001|Overall Study|Treatment Failure|1|||
131525091|NCT01649856|473547785|FG000|Overall Study|Death|69|||
131525092|NCT01649856|473547786|FG001|Overall Study|Death|34|||
131525093|NCT01649856|473547785|FG000|Overall Study|Stable or Progressed Disease|5|||
131525094|NCT01649856|473547786|FG001|Overall Study|Stable or Progressed Disease|3|||
131525095|NCT01649856|473547785|FG000|Overall Study|Lost to Follow-up|20|||
131525096|NCT01649856|473547786|FG001|Overall Study|Lost to Follow-up|16|||
131525097|NCT01649856|473547785|FG000|Overall Study|Lack of Compliance|6|||
131525098|NCT01649856|473547786|FG001|Overall Study|Lack of Compliance|1|||
131525099|NCT01649856|473547785|FG000|Overall Study|Other|20|||
131525100|NCT01649856|473547786|FG001|Overall Study|Other|5|||
131525101|NCT00622635|473547787|FG000|Treatment Period 1|Adverse Event|0|||
131525102|NCT00622635|473547788|FG001|Treatment Period 1|Adverse Event|0|||
131525103|NCT00622635|473547789|FG002|Treatment Period 1|Adverse Event|1|||
131525104|NCT00622635|473547790|FG003|Treatment Period 1|Adverse Event|0|||
131525105|NCT00622635|473547791|FG004|Treatment Period 1|Adverse Event|0|||
131525106|NCT00622635|473547792|FG005|Treatment Period 1|Adverse Event|0|||
131525107|NCT00622635|473547787|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131525108|NCT00622635|473547788|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131525109|NCT00622635|473547789|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131525110|NCT00622635|473547790|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131525111|NCT00622635|473547791|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131525112|NCT00622635|473547792|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131525113|NCT00622635|473547787|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
131525114|NCT00622635|473547788|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
131525115|NCT00622635|473547789|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
131525116|NCT00622635|473547790|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
131525117|NCT00622635|473547791|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
131525118|NCT00622635|473547792|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
131525119|NCT00622635|473547787|FG000|Treatment Period 2|Adverse Event|1|||
131525120|NCT00622635|473547788|FG001|Treatment Period 2|Adverse Event|0|||
131525121|NCT00622635|473547789|FG002|Treatment Period 2|Adverse Event|0|||
131525122|NCT00622635|473547790|FG003|Treatment Period 2|Adverse Event|0|||
131525123|NCT00622635|473547791|FG004|Treatment Period 2|Adverse Event|0|||
131525124|NCT00622635|473547792|FG005|Treatment Period 2|Adverse Event|0|||
131525125|NCT00622635|473547787|FG000|Treatment Period 3|Adverse Event|0|||
131525126|NCT00622635|473547788|FG001|Treatment Period 3|Adverse Event|0|||
131525127|NCT00622635|473547789|FG002|Treatment Period 3|Adverse Event|0|||
131525128|NCT00622635|473547790|FG003|Treatment Period 3|Adverse Event|2|||
131525129|NCT00622635|473547791|FG004|Treatment Period 3|Adverse Event|0|||
131525130|NCT00622635|473547792|FG005|Treatment Period 3|Adverse Event|0|||
131525131|NCT00622635|473547787|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131525132|NCT00622635|473547788|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131525133|NCT00622635|473547789|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131525134|NCT00622635|473547790|FG003|Treatment Period 3|Withdrawal by Subject|1|||
131525135|NCT00622635|473547791|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131525136|NCT00622635|473547792|FG005|Treatment Period 3|Withdrawal by Subject|0|||
131525137|NCT03027466|473547793|FG000|Overall Study|Opting out of the app|1869|||
131525138|NCT03027466|473547794|FG001|Overall Study|Opting out of the app|1819|||
131525139|NCT03027466|473547795|FG002|Overall Study|Opting out of the app|1743|||
131525140|NCT03027466|473547796|FG003|Overall Study|Opting out of the app|1821|||
131525141|NCT00931307|473547801|FG000|Overall Study|Lack of Efficacy|12|||
131525142|NCT00931307|473547801|FG000|Overall Study|Biomicroscopy|1|||
131525143|NCT02447991|473547804|FG000|Overall Study|Withdrawn by subject - no data|0|||
131525144|NCT02447991|473547805|FG001|Overall Study|Withdrawn by subject - no data|2|||
131525145|NCT02447991|473547804|FG000|Overall Study|Withdrawn by Subject - with data|4|||
131525146|NCT02447991|473547805|FG001|Overall Study|Withdrawn by Subject - with data|4|||
131525147|NCT02447991|473547804|FG000|Overall Study|Lost to Follow-up - no data|3|||
131525148|NCT02447991|473547805|FG001|Overall Study|Lost to Follow-up - no data|6|||
131525149|NCT02447991|473547804|FG000|Overall Study|Lost to follow-up - with data|0|||
131525150|NCT02447991|473547805|FG001|Overall Study|Lost to follow-up - with data|3|||
131525151|NCT02447991|473547804|FG000|Overall Study|End of study - no treatment results|3|||
131525152|NCT02447991|473547805|FG001|Overall Study|End of study - no treatment results|6|||
131525153|NCT02447991|473547804|FG000|Overall Study|End of study - partial treatment results|0|||
131525154|NCT02447991|473547805|FG001|Overall Study|End of study - partial treatment results|9|||
131525155|NCT00459134|473547806|FG000|Overall Study|Physician Decision|1|||
131525156|NCT00459134|473547807|FG001|Overall Study|Physician Decision|1|||
131525157|NCT00459134|473547806|FG000|Overall Study|Withdrawal by Subject|8|||
131525158|NCT00459134|473547807|FG001|Overall Study|Withdrawal by Subject|7|||
131525159|NCT00459134|473547806|FG000|Overall Study|Lost to Follow-up|6|||
131525160|NCT00459134|473547807|FG001|Overall Study|Lost to Follow-up|7|||
131525161|NCT00459134|473547806|FG000|Overall Study|Surgery|1|||
131525162|NCT00459134|473547807|FG001|Overall Study|Surgery|2|||
131525163|NCT00459134|473547806|FG000|Overall Study|Toxicity|4|||
131525164|NCT00459134|473547807|FG001|Overall Study|Toxicity|5|||
131525165|NCT00459134|473547806|FG000|Overall Study|Progression|1|||
131525166|NCT00459134|473547807|FG001|Overall Study|Progression|0|||
131525167|NCT00459134|473547806|FG000|Overall Study|Multiple Reasons|2|||
131525168|NCT00459134|473547807|FG001|Overall Study|Multiple Reasons|3|||
131525169|NCT00829621|473547808|FG000|Overall Study|Death|1|||
131525170|NCT00829621|473547809|FG001|Overall Study|Death|0|||
131525171|NCT00829621|473547808|FG000|Overall Study|Lost to Follow-up|3|||
131525172|NCT00829621|473547809|FG001|Overall Study|Lost to Follow-up|4|||
131525173|NCT00774995|473547810|FG000|Overall Study|Protocol Violation|0|||
131525174|NCT00774995|473547811|FG001|Overall Study|Protocol Violation|0|||
131525175|NCT00774995|473547812|FG002|Overall Study|Protocol Violation|1|||
131525176|NCT00774995|473547813|FG003|Overall Study|Protocol Violation|0|||
131525177|NCT03246529|473547814|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
131525178|NCT03246529|473547815|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
131525179|NCT03246529|473547816|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
131525180|NCT03246529|473547814|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
131525181|NCT03246529|473547815|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
131525182|NCT03246529|473547816|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
131525183|NCT03246529|473547814|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
131525184|NCT03246529|473547815|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
131525185|NCT03246529|473547816|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
131525186|NCT03246529|473547814|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
131525187|NCT03246529|473547815|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
131525188|NCT03246529|473547816|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
131525189|NCT03246529|473547814|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
131525190|NCT03246529|473547815|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
131525191|NCT03246529|473547816|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
131525192|NCT03246529|473547814|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
131525193|NCT03246529|473547815|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
131525194|NCT03246529|473547816|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
131525195|NCT03246529|473547814|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
131525196|NCT03246529|473547815|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
131525197|NCT03246529|473547816|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
131525198|NCT03246529|473547814|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
131525199|NCT03246529|473547815|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
131525200|NCT03246529|473547816|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
131525201|NCT03246529|473547814|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
131525202|NCT03246529|473547815|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
131525203|NCT03246529|473547816|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
131525204|NCT01209624|473547817|FG000|Overall Study|Death|2|||
131525205|NCT01209624|473547817|FG000|Overall Study|Adverse Event|13|||
131525206|NCT01209624|473547817|FG000|Overall Study|Lack of Efficacy|17|||
131525207|NCT01209624|473547817|FG000|Overall Study|Lost to Follow-up|290|||
131525208|NCT01209624|473547817|FG000|Overall Study|Other|4|||
131525209|NCT00441337|473547828|FG000|Overall Study|Disease Progression|6|||
131525210|NCT00441337|473547829|FG001|Overall Study|Disease Progression|6|||
131525211|NCT00441337|473547830|FG002|Overall Study|Disease Progression|4|||
131525212|NCT00441337|473547831|FG003|Overall Study|Disease Progression|18|||
131525213|NCT00441337|473547828|FG000|Overall Study|Lost to Follow-up|0|||
131525214|NCT00441337|473547829|FG001|Overall Study|Lost to Follow-up|0|||
131525215|NCT00441337|473547830|FG002|Overall Study|Lost to Follow-up|0|||
131525216|NCT00441337|473547831|FG003|Overall Study|Lost to Follow-up|1|||
131525217|NCT00441337|473547828|FG000|Overall Study|Sponsor Decision|0|||
131525218|NCT00441337|473547829|FG001|Overall Study|Sponsor Decision|0|||
131525219|NCT00441337|473547830|FG002|Overall Study|Sponsor Decision|1|||
131525220|NCT00441337|473547831|FG003|Overall Study|Sponsor Decision|2|||
131525221|NCT00441337|473547828|FG000|Overall Study|Did not meet inclusion criteria|0|||
131525222|NCT00441337|473547829|FG001|Overall Study|Did not meet inclusion criteria|0|||
131525223|NCT00441337|473547830|FG002|Overall Study|Did not meet inclusion criteria|1|||
131525224|NCT00441337|473547831|FG003|Overall Study|Did not meet inclusion criteria|0|||
131525225|NCT02293005|473549471|FG000|Overall Study|Adverse Event|2|||
131525226|NCT02293005|473549471|FG000|Overall Study|Death|4|||
131525227|NCT02293005|473549471|FG000|Overall Study|Lost to Follow-up|1|||
131525228|NCT02293005|473549471|FG000|Overall Study|Withdrawal by Subject|2|||
131525229|NCT02293005|473549471|FG000|Overall Study|Progression|17|||
131525230|NCT00608829|473549475|FG000|Overall Study|Death|6|||
131525231|NCT00608829|473549475|FG000|Overall Study|Withdrawal by Subject|4|||
131525232|NCT00608829|473549475|FG000|Overall Study|Subject refuses to follow up or return.|5|||
131525233|NCT02564471|473549476|FG000|Overall Study|Adverse Event|1|||
131525234|NCT02564471|473549477|FG001|Overall Study|Adverse Event|0|||
131525235|NCT02564471|473549478|FG002|Overall Study|Adverse Event|0|||
131525236|NCT02564471|473549479|FG003|Overall Study|Adverse Event|0|||
131525237|NCT02564471|473549476|FG000|Overall Study|Withdrawal by Subject|2|||
131525238|NCT02564471|473549477|FG001|Overall Study|Withdrawal by Subject|1|||
131525239|NCT02564471|473549478|FG002|Overall Study|Withdrawal by Subject|3|||
131525240|NCT02564471|473549479|FG003|Overall Study|Withdrawal by Subject|0|||
131525241|NCT02564471|473549476|FG000|Overall Study|Lost to Follow-up|0|||
131525242|NCT02564471|473549477|FG001|Overall Study|Lost to Follow-up|2|||
131525243|NCT02564471|473549478|FG002|Overall Study|Lost to Follow-up|0|||
131525244|NCT02564471|473549479|FG003|Overall Study|Lost to Follow-up|0|||
131525245|NCT02805257|473549480|FG000|Overall Study|Lost to Follow-up|7|||
131525246|NCT02805257|473549481|FG001|Overall Study|Lost to Follow-up|6|||
131525247|NCT02805257|473549480|FG000|Overall Study|Death|0|||
131525248|NCT02805257|473549481|FG001|Overall Study|Death|1|||
131525249|NCT02766608|473549487|FG000|Overall Study|Adverse Event|27|||
131525250|NCT02766608|473549488|FG001|Overall Study|Adverse Event|22|||
131525251|NCT02766608|473549489|FG002|Overall Study|Adverse Event|17|||
131525252|NCT02766608|473549490|FG003|Overall Study|Adverse Event|13|||
131525253|NCT02766608|473549491|FG004|Overall Study|Adverse Event|12|||
131525254|NCT02766608|473549487|FG000|Overall Study|Withdrawal by Subject|21|||
131525255|NCT02766608|473549488|FG001|Overall Study|Withdrawal by Subject|20|||
131525256|NCT02766608|473549489|FG002|Overall Study|Withdrawal by Subject|24|||
131525257|NCT02766608|473549490|FG003|Overall Study|Withdrawal by Subject|13|||
131525258|NCT02766608|473549491|FG004|Overall Study|Withdrawal by Subject|10|||
131525259|NCT02766608|473549487|FG000|Overall Study|Lack of Efficacy|16|||
131525260|NCT02766608|473549488|FG001|Overall Study|Lack of Efficacy|15|||
131525261|NCT02766608|473549489|FG002|Overall Study|Lack of Efficacy|32|||
131525262|NCT02766608|473549490|FG003|Overall Study|Lack of Efficacy|8|||
131525263|NCT02766608|473549491|FG004|Overall Study|Lack of Efficacy|2|||
131525264|NCT02766608|473549487|FG000|Overall Study|Lost to Follow-up|6|||
131525265|NCT02766608|473549488|FG001|Overall Study|Lost to Follow-up|3|||
131525266|NCT02766608|473549489|FG002|Overall Study|Lost to Follow-up|5|||
131525267|NCT02766608|473549490|FG003|Overall Study|Lost to Follow-up|2|||
131525268|NCT02766608|473549491|FG004|Overall Study|Lost to Follow-up|2|||
131525269|NCT02766608|473549487|FG000|Overall Study|Physician Decision|3|||
131525270|NCT02766608|473549488|FG001|Overall Study|Physician Decision|2|||
131525271|NCT02766608|473549489|FG002|Overall Study|Physician Decision|3|||
131525272|NCT02766608|473549490|FG003|Overall Study|Physician Decision|1|||
131525273|NCT02766608|473549491|FG004|Overall Study|Physician Decision|2|||
131525274|NCT02766608|473549487|FG000|Overall Study|Protocol disc criteria|3|||
131525275|NCT02766608|473549488|FG001|Overall Study|Protocol disc criteria|3|||
131525276|NCT02766608|473549489|FG002|Overall Study|Protocol disc criteria|4|||
131525277|NCT02766608|473549490|FG003|Overall Study|Protocol disc criteria|0|||
131525278|NCT02766608|473549491|FG004|Overall Study|Protocol disc criteria|0|||
131525279|NCT02766608|473549487|FG000|Overall Study|Protocol Violation|0|||
131525280|NCT02766608|473549488|FG001|Overall Study|Protocol Violation|4|||
131525281|NCT02766608|473549489|FG002|Overall Study|Protocol Violation|4|||
131525282|NCT02766608|473549490|FG003|Overall Study|Protocol Violation|0|||
131525283|NCT02766608|473549491|FG004|Overall Study|Protocol Violation|1|||
131525284|NCT02766608|473549487|FG000|Overall Study|Administrative Reasons|3|||
131525285|NCT02766608|473549488|FG001|Overall Study|Administrative Reasons|1|||
131525286|NCT02766608|473549489|FG002|Overall Study|Administrative Reasons|1|||
131525287|NCT02766608|473549490|FG003|Overall Study|Administrative Reasons|0|||
131525288|NCT02766608|473549491|FG004|Overall Study|Administrative Reasons|0|||
131525289|NCT02066298|473549492|FG000|Overall Study|Lost to Follow-up|3|||
131525290|NCT02066298|473549493|FG001|Overall Study|Lost to Follow-up|2|||
131525291|NCT02066298|473549494|FG002|Overall Study|Lost to Follow-up|3|||
131525292|NCT02066298|473549495|FG003|Overall Study|Lost to Follow-up|2|||
131525293|NCT02066298|473549496|FG004|Overall Study|Lost to Follow-up|3|||
131525294|NCT02066298|473549497|FG005|Overall Study|Lost to Follow-up|4|||
131525295|NCT02066298|473549492|FG000|Overall Study|Withdrawal by Subject|6|||
131525296|NCT02066298|473549493|FG001|Overall Study|Withdrawal by Subject|6|||
131525297|NCT02066298|473549494|FG002|Overall Study|Withdrawal by Subject|6|||
131525298|NCT02066298|473549495|FG003|Overall Study|Withdrawal by Subject|4|||
131525299|NCT02066298|473549496|FG004|Overall Study|Withdrawal by Subject|5|||
131525300|NCT02066298|473549497|FG005|Overall Study|Withdrawal by Subject|8|||
131525301|NCT02066298|473549492|FG000|Overall Study|Physician Decision|0|||
131525302|NCT02066298|473549493|FG001|Overall Study|Physician Decision|0|||
131525303|NCT02066298|473549494|FG002|Overall Study|Physician Decision|1|||
131525304|NCT02066298|473549495|FG003|Overall Study|Physician Decision|0|||
131525305|NCT02066298|473549496|FG004|Overall Study|Physician Decision|1|||
131525306|NCT02066298|473549497|FG005|Overall Study|Physician Decision|0|||
131525307|NCT03143829|473549499|FG000|Overall Study|Withdrawal by Subject|2|||
131525308|NCT03143829|473549500|FG001|Overall Study|Withdrawal by Subject|5|||
131525309|NCT03143829|473549499|FG000|Overall Study|Lost to Follow-up|0|||
131525310|NCT03143829|473549500|FG001|Overall Study|Lost to Follow-up|2|||
131525311|NCT03143829|473549499|FG000|Overall Study|Death|1|||
131525312|NCT03143829|473549500|FG001|Overall Study|Death|1|||
131525313|NCT03143829|473549499|FG000|Overall Study|changed treatment, no longer eligible|2|||
131525314|NCT03143829|473549500|FG001|Overall Study|changed treatment, no longer eligible|2|||
131525315|NCT00672477|473549502|FG000|Overall Study|Adverse Event|10|||
131525316|NCT00672477|473549503|FG001|Overall Study|Adverse Event|7|||
131525317|NCT00672477|473549502|FG000|Overall Study|Death|7|||
131525318|NCT00672477|473549503|FG001|Overall Study|Death|11|||
131525319|NCT00672477|473549502|FG000|Overall Study|Physician Decision|2|||
131525320|NCT00672477|473549503|FG001|Overall Study|Physician Decision|0|||
131525321|NCT00672477|473549502|FG000|Overall Study|Protocol Violation|1|||
131525322|NCT00672477|473549503|FG001|Overall Study|Protocol Violation|1|||
131525323|NCT00672477|473549502|FG000|Overall Study|Withdrawal by Subject|5|||
131525324|NCT00672477|473549503|FG001|Overall Study|Withdrawal by Subject|3|||
131525325|NCT00672477|473549502|FG000|Overall Study|Lack of Efficacy|1|||
131525326|NCT00672477|473549503|FG001|Overall Study|Lack of Efficacy|1|||
131525327|NCT00672477|473549502|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
131525328|NCT00672477|473549503|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
131525329|NCT02348489|473549504|FG000|Overall Study|Death|336|||
131525330|NCT02348489|473549505|FG001|Overall Study|Death|335|||
131525331|NCT02348489|473549504|FG000|Overall Study|Withdrawal by Subject|14|||
131525332|NCT02348489|473549505|FG001|Overall Study|Withdrawal by Subject|27|||
131525333|NCT02348489|473549504|FG000|Overall Study|Lost to Follow-up|3|||
131525334|NCT02348489|473549505|FG001|Overall Study|Lost to Follow-up|5|||
131525335|NCT02866682|473549506|FG000|Overall Study|Death|0|||
131525336|NCT02866682|473549507|FG001|Overall Study|Death|1|||
131525337|NCT02866682|473549506|FG000|Overall Study|Lost to Follow-up|0|||
131525338|NCT02866682|473549507|FG001|Overall Study|Lost to Follow-up|4|||
131525339|NCT02866682|473549506|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
131525340|NCT02866682|473549507|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
131525341|NCT02866682|473549506|FG000|Overall Study|Other|0|||
131525342|NCT02866682|473549507|FG001|Overall Study|Other|1|||
131525343|NCT01750268|473549509|FG000|Overall Study|Lost to Follow-up|0|||
131525344|NCT01750268|473549510|FG001|Overall Study|Lost to Follow-up|2|||
131525345|NCT01750268|473549509|FG000|Overall Study|Physician Decision|0|||
131525346|NCT01750268|473549510|FG001|Overall Study|Physician Decision|3|||
131525347|NCT01750268|473549509|FG000|Overall Study|Withdrawal by Subject|2|||
131525348|NCT01750268|473549510|FG001|Overall Study|Withdrawal by Subject|0|||
131525349|NCT02886572|473549513|FG000|Overall Study|Death|8|||
131525350|NCT03087591|473549514|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
131525351|NCT03087591|473549514|FG000|Overall Study|Withdrawal by Subject|1|||
131525352|NCT02621606|473549515|FG000|Overall Study|Withdrawal by Subject|0|||
131525353|NCT02621606|473549516|FG001|Overall Study|Withdrawal by Subject|1|||
131525354|NCT02621606|473549517|FG002|Overall Study|Withdrawal by Subject|0|||
131525355|NCT00274716|473549518|FG000|Phase A|Other non-reported reason|4|||
131525356|NCT00274716|473549519|FG001|Phase A|Other non-reported reason|2|||
131525357|NCT00274716|473549520|FG002|Phase A|Other non-reported reason|1|||
131525358|NCT00274716|473549521|FG003|Phase A|Other non-reported reason|2|||
131525359|NCT00274716|473549522|FG004|Phase A|Other non-reported reason|0|||
131525360|NCT00274716|473549523|FG005|Phase A|Other non-reported reason|1|||
131525361|NCT00274716|473549518|FG000|Phase A|Participant moved|0|||
131525362|NCT00274716|473549519|FG001|Phase A|Participant moved|0|||
131525363|NCT00274716|473549520|FG002|Phase A|Participant moved|1|||
131525364|NCT00274716|473549521|FG003|Phase A|Participant moved|0|||
131525365|NCT00274716|473549522|FG004|Phase A|Participant moved|0|||
131525366|NCT00274716|473549523|FG005|Phase A|Participant moved|1|||
131525367|NCT00274716|473549518|FG000|Phase A|Site Terminated|0|||
131525368|NCT00274716|473549519|FG001|Phase A|Site Terminated|0|||
131525369|NCT00274716|473549520|FG002|Phase A|Site Terminated|0|||
131525370|NCT00274716|473549521|FG003|Phase A|Site Terminated|1|||
131525371|NCT00274716|473549522|FG004|Phase A|Site Terminated|0|||
131525372|NCT00274716|473549523|FG005|Phase A|Site Terminated|0|||
131525373|NCT00274716|473549518|FG000|Phase A|Protocol Violation|1|||
131525374|NCT00274716|473549519|FG001|Phase A|Protocol Violation|0|||
131525375|NCT00274716|473549520|FG002|Phase A|Protocol Violation|0|||
131525376|NCT00274716|473549521|FG003|Phase A|Protocol Violation|1|||
131525377|NCT00274716|473549522|FG004|Phase A|Protocol Violation|0|||
131525378|NCT00274716|473549523|FG005|Phase A|Protocol Violation|0|||
131525379|NCT00274716|473549518|FG000|Phase A|Met criteria for discontinuation|1|||
131525380|NCT00274716|473549519|FG001|Phase A|Met criteria for discontinuation|1|||
131525381|NCT00274716|473549520|FG002|Phase A|Met criteria for discontinuation|0|||
131525382|NCT00274716|473549521|FG003|Phase A|Met criteria for discontinuation|0|||
131525383|NCT00274716|473549522|FG004|Phase A|Met criteria for discontinuation|0|||
131525384|NCT00274716|473549523|FG005|Phase A|Met criteria for discontinuation|0|||
131525385|NCT00274716|473549518|FG000|Phase A|Withdrawal by Subject|2|||
131525386|NCT00274716|473549519|FG001|Phase A|Withdrawal by Subject|2|||
131525387|NCT00274716|473549520|FG002|Phase A|Withdrawal by Subject|1|||
131525388|NCT00274716|473549521|FG003|Phase A|Withdrawal by Subject|3|||
131525389|NCT00274716|473549522|FG004|Phase A|Withdrawal by Subject|0|||
131525390|NCT00274716|473549523|FG005|Phase A|Withdrawal by Subject|1|||
131525391|NCT00274716|473549518|FG000|Phase A|Adverse Event|2|||
131525392|NCT00274716|473549519|FG001|Phase A|Adverse Event|3|||
131525393|NCT00274716|473549520|FG002|Phase A|Adverse Event|3|||
131525394|NCT00274716|473549521|FG003|Phase A|Adverse Event|0|||
131525395|NCT00274716|473549522|FG004|Phase A|Adverse Event|2|||
131525396|NCT00274716|473549523|FG005|Phase A|Adverse Event|0|||
131525397|NCT00274716|473549518|FG000|Phase A|Completed but did not enter Phase B|1|||
131525398|NCT00274716|473549519|FG001|Phase A|Completed but did not enter Phase B|2|||
131525399|NCT00274716|473549520|FG002|Phase A|Completed but did not enter Phase B|2|||
131525400|NCT00274716|473549521|FG003|Phase A|Completed but did not enter Phase B|2|||
131525401|NCT00274716|473549522|FG004|Phase A|Completed but did not enter Phase B|1|||
131525402|NCT00274716|473549523|FG005|Phase A|Completed but did not enter Phase B|1|||
131525403|NCT00274716|473549518|FG000|Phase B|Adverse Event|0|||
131525404|NCT00274716|473549519|FG001|Phase B|Adverse Event|0|||
131653844|NCT03307785|474018487|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
131525405|NCT00274716|473549520|FG002|Phase B|Adverse Event|2|||
131525406|NCT00274716|473549521|FG003|Phase B|Adverse Event|0|||
131525407|NCT00274716|473549522|FG004|Phase B|Adverse Event|0|||
131525408|NCT00274716|473549523|FG005|Phase B|Adverse Event|1|||
131525409|NCT00274716|473549518|FG000|Phase B|Protocol Violation|0|||
131525410|NCT00274716|473549519|FG001|Phase B|Protocol Violation|2|||
131525411|NCT00274716|473549520|FG002|Phase B|Protocol Violation|0|||
131525412|NCT00274716|473549521|FG003|Phase B|Protocol Violation|0|||
131525413|NCT00274716|473549522|FG004|Phase B|Protocol Violation|0|||
131525414|NCT00274716|473549523|FG005|Phase B|Protocol Violation|0|||
131525415|NCT00274716|473549518|FG000|Phase B|Withdrawal by Subject|0|||
131525416|NCT00274716|473549519|FG001|Phase B|Withdrawal by Subject|1|||
131525417|NCT00274716|473549520|FG002|Phase B|Withdrawal by Subject|0|||
131525418|NCT00274716|473549521|FG003|Phase B|Withdrawal by Subject|0|||
131525419|NCT00274716|473549522|FG004|Phase B|Withdrawal by Subject|0|||
131525420|NCT00274716|473549523|FG005|Phase B|Withdrawal by Subject|0|||
131525421|NCT00274716|473549518|FG000|Phase B|Participant moved|1|||
131525422|NCT00274716|473549519|FG001|Phase B|Participant moved|0|||
131525423|NCT00274716|473549520|FG002|Phase B|Participant moved|0|||
131525424|NCT00274716|473549521|FG003|Phase B|Participant moved|0|||
131525425|NCT00274716|473549522|FG004|Phase B|Participant moved|0|||
131525426|NCT00274716|473549523|FG005|Phase B|Participant moved|0|||
131525427|NCT00274716|473549518|FG000|Phase B|Other non-reported reason|0|||
131525428|NCT00274716|473549519|FG001|Phase B|Other non-reported reason|0|||
131525429|NCT00274716|473549520|FG002|Phase B|Other non-reported reason|1|||
131525430|NCT00274716|473549521|FG003|Phase B|Other non-reported reason|1|||
131525431|NCT00274716|473549522|FG004|Phase B|Other non-reported reason|0|||
131525432|NCT00274716|473549523|FG005|Phase B|Other non-reported reason|0|||
131525433|NCT00274716|473549518|FG000|Phase B|Lost to Follow-up|0|||
131525434|NCT00274716|473549519|FG001|Phase B|Lost to Follow-up|1|||
131525435|NCT00274716|473549520|FG002|Phase B|Lost to Follow-up|0|||
131525436|NCT00274716|473549521|FG003|Phase B|Lost to Follow-up|0|||
131525437|NCT00274716|473549522|FG004|Phase B|Lost to Follow-up|0|||
131525438|NCT00274716|473549523|FG005|Phase B|Lost to Follow-up|0|||
131525439|NCT01694706|473549524|FG000|Overall Study|Adverse Event|0|||
131525440|NCT01694706|473549525|FG001|Overall Study|Adverse Event|1|||
131525441|NCT01694706|473549526|FG002|Overall Study|Adverse Event|0|||
131525442|NCT01694706|473549524|FG000|Overall Study|other reason not defined above|1|||
131525443|NCT01694706|473549525|FG001|Overall Study|other reason not defined above|0|||
131525444|NCT01694706|473549526|FG002|Overall Study|other reason not defined above|0|||
131525445|NCT00975975|473549527|FG000|Overall Study|Death|6|||
131525446|NCT01252251|473549528|FG000|Overall Study|Withdrawal by Subject|1|||
131525447|NCT01324024|473549529|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
131525448|NCT01324024|473549530|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131525449|NCT01923181|473549531|FG000|Overall Study|Protocol Violation|2|||
131525450|NCT01923181|473549532|FG001|Overall Study|Protocol Violation|2|||
131525451|NCT01923181|473549533|FG002|Overall Study|Protocol Violation|0|||
131525452|NCT01923181|473549534|FG003|Overall Study|Protocol Violation|2|||
131525453|NCT01923181|473549535|FG004|Overall Study|Protocol Violation|2|||
131525454|NCT01923181|473549536|FG005|Overall Study|Protocol Violation|1|||
131525455|NCT01923181|473549537|FG006|Overall Study|Protocol Violation|1|||
131525456|NCT01923181|473549538|FG007|Overall Study|Protocol Violation|2|||
131525457|NCT01923181|473549539|FG008|Overall Study|Protocol Violation|1|||
131525458|NCT01923181|473549531|FG000|Overall Study|Withdrawal by Subject|0|||
131525459|NCT01923181|473549532|FG001|Overall Study|Withdrawal by Subject|1|||
131525460|NCT01923181|473549533|FG002|Overall Study|Withdrawal by Subject|0|||
131525461|NCT01923181|473549534|FG003|Overall Study|Withdrawal by Subject|1|||
131525462|NCT01923181|473549535|FG004|Overall Study|Withdrawal by Subject|4|||
131525463|NCT01923181|473549536|FG005|Overall Study|Withdrawal by Subject|2|||
131525464|NCT01923181|473549537|FG006|Overall Study|Withdrawal by Subject|4|||
131525465|NCT01923181|473549538|FG007|Overall Study|Withdrawal by Subject|3|||
131525466|NCT01923181|473549539|FG008|Overall Study|Withdrawal by Subject|1|||
131525467|NCT01923181|473549531|FG000|Overall Study|Other|1|||
131525468|NCT01923181|473549532|FG001|Overall Study|Other|0|||
131525469|NCT01923181|473549533|FG002|Overall Study|Other|0|||
131525470|NCT01923181|473549534|FG003|Overall Study|Other|1|||
131525471|NCT01923181|473549535|FG004|Overall Study|Other|0|||
131525472|NCT01923181|473549536|FG005|Overall Study|Other|0|||
131525473|NCT01923181|473549537|FG006|Overall Study|Other|0|||
131525474|NCT01923181|473549538|FG007|Overall Study|Other|0|||
131525475|NCT01923181|473549539|FG008|Overall Study|Other|0|||
131525476|NCT01923181|473549531|FG000|Overall Study|Lost to Follow-up|0|||
131525477|NCT01923181|473549532|FG001|Overall Study|Lost to Follow-up|3|||
131525478|NCT01923181|473549533|FG002|Overall Study|Lost to Follow-up|2|||
131525479|NCT01923181|473549534|FG003|Overall Study|Lost to Follow-up|1|||
131525480|NCT01923181|473549535|FG004|Overall Study|Lost to Follow-up|2|||
131525481|NCT01923181|473549536|FG005|Overall Study|Lost to Follow-up|1|||
131525482|NCT01923181|473549537|FG006|Overall Study|Lost to Follow-up|3|||
131525483|NCT01923181|473549538|FG007|Overall Study|Lost to Follow-up|3|||
131525484|NCT01923181|473549539|FG008|Overall Study|Lost to Follow-up|1|||
131525485|NCT01257204|473549540|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131525486|NCT01257204|473549541|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
131525487|NCT01257204|473549542|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
131525488|NCT01257204|473549540|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
131525489|NCT01257204|473549541|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
131525490|NCT01257204|473549542|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
131525491|NCT01257204|473549540|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
131525492|NCT01257204|473549541|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
131525493|NCT01257204|473549542|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
131525494|NCT01257204|473549540|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131525495|NCT01257204|473549541|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
131525496|NCT01257204|473549542|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131525497|NCT01257204|473549540|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
131525498|NCT01257204|473549541|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
131525499|NCT01257204|473549542|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
131525500|NCT01257204|473549540|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
131525501|NCT01257204|473549541|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
131525502|NCT01257204|473549542|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
131525503|NCT01257204|473549540|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
131525504|NCT01257204|473549541|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
131525505|NCT01257204|473549542|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
131525506|NCT01257204|473549540|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
131525507|NCT01257204|473549541|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
131525508|NCT01257204|473549542|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
131525509|NCT01257204|473549540|FG000|Follow-up Period (up to Week 48)|Other|0|||
131525510|NCT01257204|473549541|FG001|Follow-up Period (up to Week 48)|Other|0|||
131525511|NCT01257204|473549542|FG002|Follow-up Period (up to Week 48)|Other|5|||
131525512|NCT02840877|473549543|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
131525513|NCT02840877|473549543|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
131525514|NCT02840877|473549543|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
131525515|NCT02840877|473549543|FG000|Baseline to 12 Weeks|Death|1|||
131525516|NCT02840877|473549543|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
131525517|NCT02840877|473549543|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
131525518|NCT02840877|473549543|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
131525519|NCT02840877|473549543|FG000|12 Weeks to 6 Months|Treatment failure|1|||
131525520|NCT02840877|473549543|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
131525521|NCT02840877|473549543|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
131525522|NCT02840877|473549543|FG000|12 Weeks to 6 Months|Death|1|||
131525523|NCT02840877|473549543|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
131525524|NCT02840877|473549543|FG000|6 Months to 18 Months|Treatment failure|7|||
131525525|NCT02840877|473549543|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
131525526|NCT02840877|473549543|FG000|6 Months to 18 Months|Moved/transferred out|6|||
131525527|NCT02840877|473549543|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
131525528|NCT02840877|473549543|FG000|6 Months to 18 Months|Death|4|||
131525529|NCT02840877|473549543|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
131525530|NCT02840877|473549543|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
131525531|NCT02840877|473549543|FG000|6 Months to 18 Months|Still in study.|14|||
131525532|NCT03766646|473549546|FG000|Overall Study|Withdrawal by Subject|1|||
131525533|NCT03766646|473549547|FG001|Overall Study|Withdrawal by Subject|0|||
131525534|NCT03766646|473549546|FG000|Overall Study|Protocol Violation|0|||
131525535|NCT03766646|473549547|FG001|Overall Study|Protocol Violation|3|||
131525536|NCT03224468|473549571|FG000|Overall Study|Did not obtain MM card|53|||
131525537|NCT03224468|473549572|FG001|Overall Study|Did not obtain MM card|0|||
131525538|NCT03224468|473549571|FG000|Overall Study|Lost to Follow-up|4|||
131525539|NCT03224468|473549572|FG001|Overall Study|Lost to Follow-up|11|||
131525540|NCT03224468|473549571|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
131525541|NCT03224468|473549572|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
131525542|NCT03295201|473549573|FG000|Overall Study|Lost to Follow-up|1|||
131525543|NCT03295201|473549574|FG001|Overall Study|Lost to Follow-up|1|||
131525544|NCT03295201|473549573|FG000|Overall Study|Hospital admission|0|||
131525545|NCT03295201|473549574|FG001|Overall Study|Hospital admission|1|||
131525546|NCT03251924|473549575|FG000|Overall Study|Disease Progression|6|||
131525547|NCT03251924|473549576|FG001|Overall Study|Disease Progression|6|||
131525548|NCT03251924|473549577|FG002|Overall Study|Disease Progression|7|||
131525549|NCT03251924|473549578|FG003|Overall Study|Disease Progression|8|||
131525550|NCT03251924|473549579|FG004|Overall Study|Disease Progression|8|||
131525551|NCT03251924|473549580|FG005|Overall Study|Disease Progression|7|||
131525552|NCT03251924|473549581|FG006|Overall Study|Disease Progression|6|||
131525553|NCT03251924|473549582|FG007|Overall Study|Disease Progression|10|||
131525554|NCT03251924|473549583|FG008|Overall Study|Disease Progression|6|||
131525555|NCT03251924|473549575|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
131525556|NCT03251924|473549576|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
131525557|NCT03251924|473549577|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
131525558|NCT03251924|473549578|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
131525559|NCT03251924|473549579|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
131525560|NCT03251924|473549580|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
131525561|NCT03251924|473549581|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
131525562|NCT03251924|473549582|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
131525563|NCT03251924|473549583|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
131525564|NCT03251924|473549575|FG000|Overall Study|Death|0|||
131525565|NCT03251924|473549576|FG001|Overall Study|Death|1|||
131525566|NCT03251924|473549577|FG002|Overall Study|Death|0|||
131525567|NCT03251924|473549578|FG003|Overall Study|Death|1|||
131525568|NCT03251924|473549579|FG004|Overall Study|Death|1|||
131525569|NCT03251924|473549580|FG005|Overall Study|Death|1|||
131525570|NCT03251924|473549581|FG006|Overall Study|Death|0|||
131525571|NCT03251924|473549582|FG007|Overall Study|Death|0|||
131525572|NCT03251924|473549583|FG008|Overall Study|Death|0|||
131525573|NCT03251924|473549575|FG000|Overall Study|Study Drug Toxicity|0|||
131525574|NCT03251924|473549576|FG001|Overall Study|Study Drug Toxicity|0|||
131525575|NCT03251924|473549577|FG002|Overall Study|Study Drug Toxicity|0|||
131525576|NCT03251924|473549578|FG003|Overall Study|Study Drug Toxicity|1|||
131525577|NCT03251924|473549579|FG004|Overall Study|Study Drug Toxicity|0|||
131525578|NCT03251924|473549580|FG005|Overall Study|Study Drug Toxicity|0|||
131525579|NCT03251924|473549581|FG006|Overall Study|Study Drug Toxicity|0|||
131525580|NCT03251924|473549582|FG007|Overall Study|Study Drug Toxicity|0|||
131525581|NCT03251924|473549583|FG008|Overall Study|Study Drug Toxicity|1|||
131525582|NCT03251924|473549575|FG000|Overall Study|Other Reasons|0|||
131525583|NCT03251924|473549576|FG001|Overall Study|Other Reasons|0|||
131525584|NCT03251924|473549577|FG002|Overall Study|Other Reasons|0|||
131525585|NCT03251924|473549578|FG003|Overall Study|Other Reasons|0|||
131525586|NCT03251924|473549579|FG004|Overall Study|Other Reasons|0|||
131525587|NCT03251924|473549580|FG005|Overall Study|Other Reasons|0|||
131525588|NCT03251924|473549581|FG006|Overall Study|Other Reasons|0|||
131525589|NCT03251924|473549582|FG007|Overall Study|Other Reasons|0|||
131525590|NCT03251924|473549583|FG008|Overall Study|Other Reasons|1|||
131525591|NCT03251924|473549575|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131525592|NCT03251924|473549576|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131525593|NCT03251924|473549577|FG002|Overall Study|Participant request to discontinue study treatment|0|||
131525594|NCT03251924|473549578|FG003|Overall Study|Participant request to discontinue study treatment|0|||
131525595|NCT03251924|473549579|FG004|Overall Study|Participant request to discontinue study treatment|0|||
131525596|NCT03251924|473549580|FG005|Overall Study|Participant request to discontinue study treatment|0|||
131525597|NCT03251924|473549581|FG006|Overall Study|Participant request to discontinue study treatment|0|||
131525598|NCT03251924|473549582|FG007|Overall Study|Participant request to discontinue study treatment|1|||
131525599|NCT03251924|473549583|FG008|Overall Study|Participant request to discontinue study treatment|0|||
131525600|NCT00153101|473549584|FG000|Overall Study|Lost to Follow-up|14|||
131525601|NCT00153101|473549585|FG001|Overall Study|Lost to Follow-up|14|||
131525602|NCT00153101|473549586|FG002|Overall Study|Lost to Follow-up|12|||
131525603|NCT00153101|473549587|FG003|Overall Study|Lost to Follow-up|5|||
131525604|NCT00153101|473549588|FG004|Overall Study|Lost to Follow-up|5|||
131525605|NCT00153101|473549584|FG000|Overall Study|Withdrawal by Subject|3|||
131525606|NCT00153101|473549585|FG001|Overall Study|Withdrawal by Subject|4|||
131525607|NCT00153101|473549586|FG002|Overall Study|Withdrawal by Subject|3|||
131525608|NCT00153101|473549587|FG003|Overall Study|Withdrawal by Subject|3|||
131525609|NCT00153101|473549588|FG004|Overall Study|Withdrawal by Subject|5|||
131525610|NCT02610140|473549589|FG000|Randomization and Treatment Period|Radiological progression|23|||
131525611|NCT02610140|473549590|FG001|Randomization and Treatment Period|Radiological progression|15|||
131525612|NCT02610140|473549589|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
131525613|NCT02610140|473549590|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
131525614|NCT02610140|473549589|FG000|Randomization and Treatment Period|Protocol Violation|1|||
131525615|NCT02610140|473549590|FG001|Randomization and Treatment Period|Protocol Violation|0|||
131525616|NCT02610140|473549589|FG000|Randomization and Treatment Period|Physician Decision|0|||
131525617|NCT02610140|473549590|FG001|Randomization and Treatment Period|Physician Decision|1|||
131525618|NCT02610140|473549589|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
131525619|NCT02610140|473549590|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
131525620|NCT02610140|473549589|FG000|Randomization and Treatment Period|Death|7|||
131525621|NCT02610140|473549590|FG001|Randomization and Treatment Period|Death|1|||
131525622|NCT02610140|473549589|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
131525623|NCT02610140|473549590|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
131525624|NCT02610140|473549589|FG000|Randomization and Treatment Period|Adverse Event|44|||
131525625|NCT02610140|473549590|FG001|Randomization and Treatment Period|Adverse Event|13|||
131525626|NCT02610140|473549589|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
131525627|NCT02610140|473549590|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
131525628|NCT02610140|473549589|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
131525629|NCT02610140|473549590|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
131525630|NCT02610140|473549589|FG000|Randomization and Treatment Period|Not treated|3|||
131525631|NCT02610140|473549590|FG001|Randomization and Treatment Period|Not treated|10|||
131525632|NCT02610140|473549589|FG000|Safety Follow-up|Other|0|||
131525633|NCT02610140|473549590|FG001|Safety Follow-up|Other|2|||
131525634|NCT02610140|473549589|FG000|Safety Follow-up|Lost to Follow-up|1|||
131525635|NCT02610140|473549590|FG001|Safety Follow-up|Lost to Follow-up|0|||
131525636|NCT02610140|473549589|FG000|Safety Follow-up|No follow-up|5|||
131525637|NCT02610140|473549590|FG001|Safety Follow-up|No follow-up|3|||
131525638|NCT02610140|473549589|FG000|Safety Follow-up|Death|12|||
131525639|NCT02610140|473549590|FG001|Safety Follow-up|Death|2|||
131525640|NCT02610140|473549589|FG000|Safety Follow-up|Deterioration of general conditions|15|||
131525641|NCT02610140|473549590|FG001|Safety Follow-up|Deterioration of general conditions|5|||
131525642|NCT02610140|473549589|FG000|Safety Follow-up|Withdrawal by Subject|12|||
131525643|NCT02610140|473549590|FG001|Safety Follow-up|Withdrawal by Subject|12|||
131525644|NCT02610140|473549589|FG000|Active Follow-up|Progressive disease - radiological|30|||
131525645|NCT02610140|473549590|FG001|Active Follow-up|Progressive disease - radiological|22|||
131525646|NCT02610140|473549589|FG000|Active Follow-up|Death|8|||
131525647|NCT02610140|473549590|FG001|Active Follow-up|Death|1|||
131525648|NCT02610140|473549589|FG000|Active Follow-up|Withdrawal by Subject|4|||
131525649|NCT02610140|473549590|FG001|Active Follow-up|Withdrawal by Subject|0|||
131525650|NCT02610140|473549589|FG000|Active Follow-up|Progressive disease - clinical|1|||
131525651|NCT02610140|473549590|FG001|Active Follow-up|Progressive disease - clinical|2|||
131525652|NCT02610140|473549589|FG000|Active Follow-up|Deterioration of general conditions|1|||
131525653|NCT02610140|473549590|FG001|Active Follow-up|Deterioration of general conditions|0|||
131525654|NCT02610140|473549589|FG000|Active Follow-up|Ongoing but not completed|4|||
131525655|NCT02610140|473549590|FG001|Active Follow-up|Ongoing but not completed|1|||
131525656|NCT02610140|473549589|FG000|Long-term Follow-up|Death|86|||
131525657|NCT02610140|473549590|FG001|Long-term Follow-up|Death|44|||
131525658|NCT02610140|473549589|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
131525659|NCT02610140|473549590|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
131525660|NCT02610140|473549589|FG000|Long-term Follow-up|Lost to Follow-up|1|||
131525661|NCT02610140|473549590|FG001|Long-term Follow-up|Lost to Follow-up|2|||
131525662|NCT02610140|473549589|FG000|Long-term Follow-up|Ongoing but not completed|30|||
131525663|NCT02610140|473549590|FG001|Long-term Follow-up|Ongoing but not completed|17|||
131525664|NCT03169153|473549591|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
131525665|NCT03169153|473549592|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
131525666|NCT03169153|473549591|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
131525667|NCT03169153|473549592|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
131525668|NCT03169153|473549591|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
131525669|NCT03169153|473549592|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
131525670|NCT03169153|473549591|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
131525671|NCT03169153|473549592|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
131525672|NCT00887341|473549593|FG000|Overall Study|Refused treatment|1|||
131525673|NCT00887341|473549594|FG001|Overall Study|Refused treatment|0|||
131525674|NCT00887341|473549593|FG000|Overall Study|Withdrawal by Subject|1|||
131525675|NCT00887341|473549594|FG001|Overall Study|Withdrawal by Subject|1|||
131525676|NCT00887341|473549593|FG000|Overall Study|Adverse Event|0|||
131525677|NCT00887341|473549594|FG001|Overall Study|Adverse Event|1|||
131525678|NCT00887341|473549593|FG000|Overall Study|Lost to Follow-up|0|||
131525679|NCT00887341|473549594|FG001|Overall Study|Lost to Follow-up|1|||
131525680|NCT02617589|473549595|FG000|Randomization|Request to Discontinue Study Treatment|1|||
131525681|NCT02617589|473549596|FG001|Randomization|Request to Discontinue Study Treatment|3|||
131525682|NCT02617589|473549595|FG000|Randomization|Participant Withdrew Consent|1|||
131525683|NCT02617589|473549596|FG001|Randomization|Participant Withdrew Consent|2|||
131525684|NCT02617589|473549595|FG000|Treatment|Other Reasons|3|||
131525685|NCT02617589|473549596|FG001|Treatment|Other Reasons|3|||
131525686|NCT02617589|473549595|FG000|Treatment|Poor/Non Compliance|1|||
131525687|NCT02617589|473549596|FG001|Treatment|Poor/Non Compliance|1|||
131525688|NCT02617589|473549595|FG000|Treatment|Maximum Clinical Benefit|0|||
131525689|NCT02617589|473549596|FG001|Treatment|Maximum Clinical Benefit|2|||
131525690|NCT02617589|473549595|FG000|Treatment|Participant Withdrew Consent|2|||
131525691|NCT02617589|473549596|FG001|Treatment|Participant Withdrew Consent|6|||
131525692|NCT02617589|473549595|FG000|Treatment|Participant Request to Discontinue|12|||
131525693|NCT02617589|473549596|FG001|Treatment|Participant Request to Discontinue|21|||
131525694|NCT02617589|473549595|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
131525695|NCT02617589|473549596|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
131525696|NCT02617589|473549595|FG000|Treatment|Death|1|||
131525697|NCT02617589|473549596|FG001|Treatment|Death|1|||
131525698|NCT02617589|473549595|FG000|Treatment|Study Drug Toxicity|27|||
131525699|NCT02617589|473549596|FG001|Treatment|Study Drug Toxicity|20|||
131525700|NCT02617589|473549595|FG000|Treatment|Disease Progression|216|||
131525701|NCT02617589|473549596|FG001|Treatment|Disease Progression|136|||
131525702|NCT01591681|473549599|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
131525703|NCT01591681|473549599|FG000|Overall Study|Failed to use system during run-in|1|||
131525704|NCT00281840|473549602|FG000|Overall Study|Adverse Event|12|||
131525705|NCT00281840|473549602|FG000|Overall Study|Physician Decision|6|||
131525706|NCT00281840|473549602|FG000|Overall Study|Withdrawal by Subject|3|||
131525707|NCT00281840|473549602|FG000|Overall Study|Disease Progression|2|||
131525708|NCT00281840|473549602|FG000|Overall Study|exceed maximum delay in treatment|1|||
131525709|NCT00281840|473549602|FG000|Overall Study|Complicating Disease|1|||
131525710|NCT01079234|473549605|FG000|Main: Week 0 to 26|Adverse Event|5|||
131525711|NCT01079234|473549606|FG001|Main: Week 0 to 26|Adverse Event|4|||
131525712|NCT01079234|473549607|FG002|Main: Week 0 to 26|Adverse Event|1|||
131525713|NCT01079234|473549608|FG003|Main: Week 0 to 26|Adverse Event|0|||
131525714|NCT01079234|473549605|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
131525715|NCT01079234|473549606|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
131525716|NCT01079234|473549607|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
131525717|NCT01079234|473549608|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
131525718|NCT01079234|473549605|FG000|Main: Week 0 to 26|Protocol Violation|6|||
131525719|NCT01079234|473549606|FG001|Main: Week 0 to 26|Protocol Violation|2|||
131525720|NCT01079234|473549607|FG002|Main: Week 0 to 26|Protocol Violation|4|||
131525721|NCT01079234|473549608|FG003|Main: Week 0 to 26|Protocol Violation|0|||
131525722|NCT01079234|473549605|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
131525723|NCT01079234|473549606|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
131525724|NCT01079234|473549607|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
131525725|NCT01079234|473549608|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
131525726|NCT01079234|473549605|FG000|Main: Week 0 to 26|Unclassified|7|||
131525727|NCT01079234|473549606|FG001|Main: Week 0 to 26|Unclassified|13|||
131525728|NCT01079234|473549607|FG002|Main: Week 0 to 26|Unclassified|4|||
131525729|NCT01079234|473549608|FG003|Main: Week 0 to 26|Unclassified|0|||
131525730|NCT01079234|473549605|FG000|Extension: Week 27 to 52|Adverse Event|0|||
131525731|NCT01079234|473549606|FG001|Extension: Week 27 to 52|Adverse Event|0|||
131525732|NCT01079234|473549607|FG002|Extension: Week 27 to 52|Adverse Event|1|||
131525733|NCT01079234|473549608|FG003|Extension: Week 27 to 52|Adverse Event|0|||
131525734|NCT01079234|473549605|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
131525735|NCT01079234|473549606|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
131525736|NCT01079234|473549607|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
131525737|NCT01079234|473549608|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
131525738|NCT01079234|473549605|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
131525739|NCT01079234|473549606|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
131525740|NCT01079234|473549607|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
131525741|NCT01079234|473549608|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
131525742|NCT01079234|473549605|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
131525743|NCT01079234|473549606|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
131525744|NCT01079234|473549607|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
131525745|NCT01079234|473549608|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
131525746|NCT01079234|473549605|FG000|Extension: Week 27 to 52|Unclassified|0|||
131525747|NCT01079234|473549606|FG001|Extension: Week 27 to 52|Unclassified|0|||
131525748|NCT01079234|473549607|FG002|Extension: Week 27 to 52|Unclassified|4|||
131525749|NCT01079234|473549608|FG003|Extension: Week 27 to 52|Unclassified|7|||
131525750|NCT01312961|473549615|FG000|Overall Study|Adverse Event|3|||
131525751|NCT01312961|473549616|FG001|Overall Study|Adverse Event|3|||
131525752|NCT01312961|473549615|FG000|Overall Study|Lack of Efficacy|11|||
131525753|NCT01312961|473549616|FG001|Overall Study|Lack of Efficacy|1|||
131525754|NCT01312961|473549615|FG000|Overall Study|Poor compliance to protocol|1|||
131525755|NCT01312961|473549616|FG001|Overall Study|Poor compliance to protocol|0|||
131525756|NCT01312961|473549615|FG000|Overall Study|Other than specified above|2|||
131525757|NCT01312961|473549616|FG001|Overall Study|Other than specified above|3|||
131525758|NCT00205712|473549618|FG000|Overall Study|Lost to Follow-up|0|||
131525759|NCT00205712|473549619|FG001|Overall Study|Lost to Follow-up|1|||
131525760|NCT01337297|473549629|FG000|Overall Study|They entered to single anodal tDCS|4|||
131525761|NCT01337297|473549630|FG001|Overall Study|They entered to single anodal tDCS|3|||
131525762|NCT01337297|473549629|FG000|Overall Study|Lost to Follow-up|1|||
131525763|NCT01337297|473549630|FG001|Overall Study|Lost to Follow-up|3|||
131525764|NCT01898793|473549633|FG000|Overall Study|Death|2|||
131525765|NCT01898793|473549634|FG001|Overall Study|Death|1|||
131525766|NCT01898793|473549635|FG002|Overall Study|Death|4|||
131525767|NCT01898793|473549636|FG003|Overall Study|Death|0|||
131525768|NCT01898793|473549637|FG004|Overall Study|Death|0|||
131525769|NCT01898793|473549638|FG005|Overall Study|Death|0|||
131525770|NCT01898793|473549639|FG006|Overall Study|Death|0|||
131525771|NCT00965848|473549644|FG000|Overall Study|Protocol Violation|3|||
131525772|NCT00965848|473549645|FG001|Overall Study|Protocol Violation|0|||
131525773|NCT00965848|473549646|FG002|Overall Study|Protocol Violation|1|||
131525774|NCT00965848|473549644|FG000|Overall Study|Death|11|||
131525775|NCT00965848|473549645|FG001|Overall Study|Death|1|||
131525776|NCT00965848|473549646|FG002|Overall Study|Death|5|||
131525777|NCT00965848|473549644|FG000|Overall Study|Lost to Follow-up|0|||
131525778|NCT00965848|473549645|FG001|Overall Study|Lost to Follow-up|0|||
131525779|NCT00965848|473549646|FG002|Overall Study|Lost to Follow-up|1|||
131525780|NCT00965848|473549644|FG000|Overall Study|Withdrawal by Subject|1|||
131525781|NCT00965848|473549645|FG001|Overall Study|Withdrawal by Subject|0|||
131525782|NCT00965848|473549646|FG002|Overall Study|Withdrawal by Subject|0|||
131525783|NCT00965848|473549644|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
131525784|NCT00965848|473549645|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
131525785|NCT00965848|473549646|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
131525786|NCT00965848|473549644|FG000|Overall Study|Not Clinically Evaluable|7|||
131525787|NCT00965848|473549645|FG001|Overall Study|Not Clinically Evaluable|1|||
131525788|NCT00965848|473549646|FG002|Overall Study|Not Clinically Evaluable|1|||
131525789|NCT00965848|473549644|FG000|Overall Study|Other|5|||
131525790|NCT00965848|473549645|FG001|Overall Study|Other|0|||
131525791|NCT00965848|473549646|FG002|Overall Study|Other|1|||
131525792|NCT06748040|473549647|FG000|Overall Study|Death|3|||
131525793|NCT06748040|473549648|FG001|Overall Study|Death|4|||
131525794|NCT06748040|473549647|FG000|Overall Study|Lost to Follow-up|134|||
131525795|NCT06748040|473549648|FG001|Overall Study|Lost to Follow-up|132|||
131525796|NCT06748040|473549647|FG000|Overall Study|Withdrawal by Subject|3|||
131525797|NCT06748040|473549648|FG001|Overall Study|Withdrawal by Subject|5|||
131525798|NCT01076400|473551704|FG000|Overall Study|Adverse Event|2|||
131525799|NCT01076400|473551705|FG001|Overall Study|Adverse Event|0|||
131525800|NCT01076400|473551706|FG002|Overall Study|Adverse Event|0|||
131525801|NCT01076400|473551704|FG000|Overall Study|Progressive Disease|5|||
131525802|NCT01076400|473551705|FG001|Overall Study|Progressive Disease|0|||
131525803|NCT01076400|473551706|FG002|Overall Study|Progressive Disease|0|||
131525804|NCT03019536|473551708|FG000|Overall Study|Withdrawal by Subject|1|||
131525805|NCT03019536|473551709|FG001|Overall Study|Withdrawal by Subject|1|||
131525806|NCT03019536|473551710|FG002|Overall Study|Withdrawal by Subject|0|||
131525807|NCT03019536|473551708|FG000|Overall Study|Adverse Event|0|||
131525808|NCT03019536|473551709|FG001|Overall Study|Adverse Event|0|||
131525809|NCT03019536|473551710|FG002|Overall Study|Adverse Event|2|||
131525810|NCT00182689|473551718|FG000|Overall Study|Adverse Event|8|||
131525811|NCT00182689|473551719|FG001|Overall Study|Adverse Event|11|||
131525812|NCT00182689|473551718|FG000|Overall Study|Withdrawal by Subject|2|||
131525813|NCT00182689|473551719|FG001|Overall Study|Withdrawal by Subject|2|||
131525814|NCT00182689|473551718|FG000|Overall Study|Progression|27|||
131525815|NCT00182689|473551719|FG001|Overall Study|Progression|29|||
131525816|NCT00182689|473551718|FG000|Overall Study|Death|1|||
131525817|NCT00182689|473551719|FG001|Overall Study|Death|0|||
131525818|NCT00182689|473551718|FG000|Overall Study|not protocol specified|0|||
131525819|NCT00182689|473551719|FG001|Overall Study|not protocol specified|3|||
131525820|NCT00182689|473551718|FG000|Overall Study|Ineligible|1|||
131525821|NCT00182689|473551719|FG001|Overall Study|Ineligible|4|||
131525822|NCT00182689|473551718|FG000|Overall Study|Never received treatment|1|||
131525823|NCT00182689|473551719|FG001|Overall Study|Never received treatment|0|||
131525824|NCT00201006|473551720|FG000|Overall Study|Withdrawal by Subject|7|||
131525825|NCT00201006|473551721|FG001|Overall Study|Withdrawal by Subject|2|||
131525826|NCT00201006|473551722|FG002|Overall Study|Withdrawal by Subject|3|||
131525827|NCT00201006|473551720|FG000|Overall Study|Adverse Event|1|||
131525828|NCT00201006|473551721|FG001|Overall Study|Adverse Event|0|||
131525829|NCT00201006|473551722|FG002|Overall Study|Adverse Event|1|||
131525830|NCT01040871|473551723|FG000|Overall Study|Adverse Event|6|||
131525831|NCT01040871|473551724|FG001|Overall Study|Adverse Event|2|||
131525832|NCT01040871|473551723|FG000|Overall Study|Withdrawal by Subject|2|||
131525833|NCT01040871|473551724|FG001|Overall Study|Withdrawal by Subject|0|||
131525834|NCT01040871|473551723|FG000|Overall Study|Death|1|||
131525835|NCT01040871|473551724|FG001|Overall Study|Death|3|||
131525836|NCT01040871|473551723|FG000|Overall Study|Lack of Efficacy|1|||
131525837|NCT01040871|473551724|FG001|Overall Study|Lack of Efficacy|1|||
131525838|NCT01040871|473551723|FG000|Overall Study|drug supply issue|1|||
131525839|NCT01040871|473551724|FG001|Overall Study|drug supply issue|0|||
131525840|NCT01040871|473551723|FG000|Overall Study|Randomized and Not Treated|2|||
131525841|NCT01040871|473551724|FG001|Overall Study|Randomized and Not Treated|1|||
131525842|NCT00673049|473551728|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
131525843|NCT00673049|473551729|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
131525844|NCT00673049|473551730|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
131525845|NCT00673049|473551731|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
131525846|NCT00673049|473551728|FG000|Before Progression on Erlotinib|Death|235|||
131525847|NCT00673049|473551729|FG001|Before Progression on Erlotinib|Death|167|||
131525848|NCT00673049|473551730|FG002|Before Progression on Erlotinib|Death|1|||
131525849|NCT00673049|473551731|FG003|Before Progression on Erlotinib|Death|0|||
131525850|NCT00673049|473551728|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
131525851|NCT00673049|473551729|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
131525852|NCT00673049|473551730|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
131525853|NCT00673049|473551731|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
131658429|NCT01531673|474035303|FG004|Overall Study|Other|0|||
131525854|NCT00673049|473551728|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
131525855|NCT00673049|473551729|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
131525856|NCT00673049|473551730|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
131525857|NCT00673049|473551731|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
131525858|NCT00673049|473551728|FG000|Before Progression on Erlotinib|Other|1|||
131525859|NCT00673049|473551729|FG001|Before Progression on Erlotinib|Other|2|||
131525860|NCT00673049|473551730|FG002|Before Progression on Erlotinib|Other|0|||
131525861|NCT00673049|473551731|FG003|Before Progression on Erlotinib|Other|0|||
131525862|NCT00673049|473551728|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
131525863|NCT00673049|473551729|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
131525864|NCT00673049|473551730|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
131525865|NCT00673049|473551731|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
131525866|NCT00673049|473551728|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
131525867|NCT00673049|473551729|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
131525868|NCT00673049|473551730|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
131525869|NCT00673049|473551731|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
131525870|NCT00673049|473551728|FG000|After Progression on Erlotinib|Death|0|||
131525871|NCT00673049|473551729|FG001|After Progression on Erlotinib|Death|0|||
131525872|NCT00673049|473551730|FG002|After Progression on Erlotinib|Death|0|||
131525873|NCT00673049|473551731|FG003|After Progression on Erlotinib|Death|71|||
131525874|NCT00673049|473551728|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
131525875|NCT00673049|473551729|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
131525876|NCT00673049|473551730|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
131525877|NCT00673049|473551731|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
131525878|NCT00673049|473551728|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
131525879|NCT00673049|473551729|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
131525880|NCT00673049|473551730|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
131525881|NCT00673049|473551731|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
131525882|NCT00673049|473551728|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
131525883|NCT00673049|473551729|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
131525884|NCT00673049|473551730|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
131525885|NCT00673049|473551731|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
131525886|NCT00924950|473551732|FG000|Overall Study|Lost to Follow-up|2|||
131525887|NCT04193202|473551733|FG000|Overall Study|Adverse Event|2|||
131525888|NCT04193202|473551734|FG001|Overall Study|Adverse Event|1|||
131525889|NCT04193202|473551733|FG000|Overall Study|Death|0|||
131525890|NCT04193202|473551734|FG001|Overall Study|Death|1|||
131525891|NCT04193202|473551733|FG000|Overall Study|Physician Decision|1|||
131525892|NCT04193202|473551734|FG001|Overall Study|Physician Decision|1|||
131525893|NCT04193202|473551733|FG000|Overall Study|Protocol Violation|2|||
131525894|NCT04193202|473551734|FG001|Overall Study|Protocol Violation|2|||
131525895|NCT04193202|473551733|FG000|Overall Study|Withdrawal by Subject|11|||
131525896|NCT04193202|473551734|FG001|Overall Study|Withdrawal by Subject|5|||
131525897|NCT02979535|473551735|FG000|Overall Study|Non compliance with the protocol|78|||
131525898|NCT02979535|473551736|FG001|Overall Study|Non compliance with the protocol|82|||
131525899|NCT02979535|473551735|FG000|Overall Study|Consent withdrawn by participant|11|||
131525900|NCT02979535|473551736|FG001|Overall Study|Consent withdrawn by participant|18|||
131525901|NCT02979535|473551735|FG000|Overall Study|Lost to Follow-up|6|||
131525902|NCT02979535|473551736|FG001|Overall Study|Lost to Follow-up|1|||
131525903|NCT00982319|473551739|FG000|Overall Study|Surgery date change|1|||
131525904|NCT00982319|473551740|FG001|Overall Study|Surgery date change|0|||
131525905|NCT00982319|473551739|FG000|Overall Study|Preop values out of acceptable range|1|||
131525906|NCT00982319|473551740|FG001|Overall Study|Preop values out of acceptable range|1|||
131525907|NCT00982319|473551739|FG000|Overall Study|Pregnancy|0|||
131525908|NCT00982319|473551740|FG001|Overall Study|Pregnancy|1|||
131525909|NCT02057757|473551747|FG000|Overall Study|Withdrawal by Subject|3|||
131525910|NCT02057757|473551748|FG001|Overall Study|Withdrawal by Subject|5|||
131525911|NCT02057757|473551747|FG000|Overall Study|Death|2|||
131525912|NCT02057757|473551748|FG001|Overall Study|Death|0|||
131525913|NCT02057757|473551747|FG000|Overall Study|Lost to Follow-up|8|||
131525914|NCT02057757|473551748|FG001|Overall Study|Lost to Follow-up|3|||
131525915|NCT02057757|473551747|FG000|Overall Study|Non-compliance|1|||
131525916|NCT02057757|473551748|FG001|Overall Study|Non-compliance|0|||
131525917|NCT03614793|473551749|FG000|Overall Study|Lost to Follow-up|1|||
131525918|NCT03614793|473551750|FG001|Overall Study|Lost to Follow-up|2|||
131525919|NCT03614793|473551749|FG000|Overall Study|Lack of Efficacy|0|||
131525920|NCT03614793|473551750|FG001|Overall Study|Lack of Efficacy|5|||
131525921|NCT03614793|473551749|FG000|Overall Study|Withdrawal by Subject|0|||
131525922|NCT03614793|473551750|FG001|Overall Study|Withdrawal by Subject|1|||
131525923|NCT03614793|473551749|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
131525924|NCT03614793|473551750|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
131525925|NCT02082522|473551751|FG000|Overall Study|Sponsor termination|5|||
131525926|NCT02082522|473551752|FG001|Overall Study|Sponsor termination|3|||
131525927|NCT02082522|473551751|FG000|Overall Study|Withdrawal by Subject|2|||
131525928|NCT02082522|473551752|FG001|Overall Study|Withdrawal by Subject|4|||
131525929|NCT02082522|473551751|FG000|Overall Study|Death|1|||
131525930|NCT02082522|473551752|FG001|Overall Study|Death|0|||
131525931|NCT02082522|473551751|FG000|Overall Study|Lost to Follow-up|1|||
131525932|NCT02082522|473551752|FG001|Overall Study|Lost to Follow-up|0|||
131525933|NCT02082522|473551751|FG000|Overall Study|Physician Decision|3|||
131525934|NCT02082522|473551752|FG001|Overall Study|Physician Decision|1|||
131525935|NCT02082522|473551751|FG000|Overall Study|Disease progression|2|||
131525936|NCT02082522|473551752|FG001|Overall Study|Disease progression|2|||
131525937|NCT02082522|473551751|FG000|Overall Study|Chemotherapy change|1|||
131525938|NCT02082522|473551752|FG001|Overall Study|Chemotherapy change|3|||
131525939|NCT00456092|473551753|FG000|Extension Phase|Grade 2 or Greater AE|2|||
131525940|NCT00456092|473551754|FG001|Extension Phase|Grade 2 or Greater AE|2|||
131525941|NCT00456092|473551755|FG002|Extension Phase|Grade 2 or Greater AE|0|||
131525942|NCT00456092|473551756|FG003|Extension Phase|Grade 2 or Greater AE|0|||
131525943|NCT00456092|473551757|FG004|Extension Phase|Grade 2 or Greater AE|2|||
131525944|NCT00456092|473551753|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
131525945|NCT00456092|473551754|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
131525946|NCT00456092|473551755|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
131525947|NCT00456092|473551756|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
131525948|NCT00456092|473551757|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
131525949|NCT00456092|473551753|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
131525950|NCT00456092|473551754|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
131525951|NCT00456092|473551755|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
131525952|NCT00456092|473551756|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
131525953|NCT00456092|473551757|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
131525954|NCT00456092|473551753|FG000|Extension Phase|Withdrew Consent|2|||
131525955|NCT00456092|473551754|FG001|Extension Phase|Withdrew Consent|0|||
131525956|NCT00456092|473551755|FG002|Extension Phase|Withdrew Consent|0|||
131525957|NCT00456092|473551756|FG003|Extension Phase|Withdrew Consent|0|||
131525958|NCT00456092|473551757|FG004|Extension Phase|Withdrew Consent|0|||
131525959|NCT00456092|473551753|FG000|Extension Phase|Lost to Follow-up|1|||
131525960|NCT00456092|473551754|FG001|Extension Phase|Lost to Follow-up|1|||
131525961|NCT00456092|473551755|FG002|Extension Phase|Lost to Follow-up|0|||
131525962|NCT00456092|473551756|FG003|Extension Phase|Lost to Follow-up|0|||
131525963|NCT00456092|473551757|FG004|Extension Phase|Lost to Follow-up|1|||
131525964|NCT00456092|473551753|FG000|Extension Phase|Other|2|||
131525965|NCT00456092|473551754|FG001|Extension Phase|Other|0|||
131525966|NCT00456092|473551755|FG002|Extension Phase|Other|0|||
131525967|NCT00456092|473551756|FG003|Extension Phase|Other|1|||
131525968|NCT00456092|473551757|FG004|Extension Phase|Other|1|||
131525969|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
131525970|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
131525971|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
131525972|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
131525973|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
131525974|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
131525975|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
131525976|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
131525977|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
131525978|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
131525979|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
131525980|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
131525981|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
131525982|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
131525983|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
131525984|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
131525985|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
131525986|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
131525987|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
131525988|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
131525989|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
131525990|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
131525991|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
131525992|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
131525993|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
131525994|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
131525995|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
131525996|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
131525997|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
131525998|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
131525999|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
131526000|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
131526001|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
131526002|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
131526003|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
131526004|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
131526005|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
131526006|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
131526007|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
131526008|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
131526009|NCT00456092|473551753|FG000|Treatment Phase (12 Weeks)|Other|1|||
131526010|NCT00456092|473551754|FG001|Treatment Phase (12 Weeks)|Other|0|||
131526011|NCT00456092|473551755|FG002|Treatment Phase (12 Weeks)|Other|1|||
131526012|NCT00456092|473551756|FG003|Treatment Phase (12 Weeks)|Other|0|||
131526013|NCT00456092|473551757|FG004|Treatment Phase (12 Weeks)|Other|0|||
131526014|NCT01168999|473551758|FG000|Overall Study|Lost to Follow-up|2|||
131526015|NCT01168999|473551759|FG001|Overall Study|Lost to Follow-up|1|||
131526016|NCT01168999|473551760|FG002|Overall Study|Lost to Follow-up|0|||
131526017|NCT01168999|473551761|FG003|Overall Study|Lost to Follow-up|0|||
131526018|NCT03603964|473551762|FG000|Overall Study|Death|9|||
131526019|NCT03603964|473551762|FG000|Overall Study|Withdrawal by participant|7|||
131526020|NCT03603964|473551762|FG000|Overall Study|Study terminated by Sponsor|19|||
131526021|NCT00563797|473551763|FG000|Overall Study|Lost to Follow-up|7|||
131526022|NCT00563797|473551764|FG001|Overall Study|Lost to Follow-up|2|||
131526023|NCT04317586|473551765|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
131526024|NCT04317586|473551765|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
131526025|NCT03003676|473551766|FG000|Overall Study|Lack of Efficacy|5|||
131526026|NCT03003676|473551767|FG001|Overall Study|Lack of Efficacy|7|||
131526027|NCT03003676|473551766|FG000|Overall Study|Withdrawal by Subject|0|||
131526028|NCT03003676|473551767|FG001|Overall Study|Withdrawal by Subject|1|||
131526029|NCT03003676|473551766|FG000|Overall Study|Hepatitis B infection|1|||
131526030|NCT03003676|473551767|FG001|Overall Study|Hepatitis B infection|0|||
131526031|NCT00530023|473551773|FG000|Overall Study|Withdrawal by Subject|0|||
131526032|NCT00530023|473551774|FG001|Overall Study|Withdrawal by Subject|1|||
131526033|NCT02461589|473551775|FG000|Overall Study|Withdrawal by Subject|5|||
131526034|NCT02461589|473551776|FG001|Overall Study|Withdrawal by Subject|1|||
131526035|NCT02461589|473551777|FG002|Overall Study|Withdrawal by Subject|3|||
131526036|NCT02461589|473551778|FG003|Overall Study|Withdrawal by Subject|2|||
131526037|NCT02461589|473551779|FG004|Overall Study|Withdrawal by Subject|1|||
131526038|NCT02461589|473551780|FG005|Overall Study|Withdrawal by Subject|2|||
131526039|NCT02461589|473551781|FG006|Overall Study|Withdrawal by Subject|1|||
131526040|NCT02461589|473551782|FG007|Overall Study|Withdrawal by Subject|3|||
131526041|NCT02461589|473551783|FG008|Overall Study|Withdrawal by Subject|3|||
131526042|NCT02461589|473551784|FG009|Overall Study|Withdrawal by Subject|1|||
131526043|NCT02461589|473551775|FG000|Overall Study|Lost to Follow-up|0|||
131526044|NCT02461589|473551776|FG001|Overall Study|Lost to Follow-up|0|||
131526045|NCT02461589|473551777|FG002|Overall Study|Lost to Follow-up|2|||
131526046|NCT02461589|473551778|FG003|Overall Study|Lost to Follow-up|3|||
131526047|NCT02461589|473551779|FG004|Overall Study|Lost to Follow-up|1|||
131526048|NCT02461589|473551780|FG005|Overall Study|Lost to Follow-up|1|||
131526049|NCT02461589|473551781|FG006|Overall Study|Lost to Follow-up|3|||
131526050|NCT02461589|473551782|FG007|Overall Study|Lost to Follow-up|1|||
131526051|NCT02461589|473551783|FG008|Overall Study|Lost to Follow-up|3|||
131526052|NCT02461589|473551784|FG009|Overall Study|Lost to Follow-up|1|||
131526053|NCT02461589|473551775|FG000|Overall Study|Death|0|||
131526054|NCT02461589|473551776|FG001|Overall Study|Death|0|||
131526055|NCT02461589|473551777|FG002|Overall Study|Death|0|||
131526056|NCT02461589|473551778|FG003|Overall Study|Death|0|||
131526057|NCT02461589|473551779|FG004|Overall Study|Death|0|||
131526058|NCT02461589|473551780|FG005|Overall Study|Death|0|||
131526059|NCT02461589|473551781|FG006|Overall Study|Death|0|||
131526060|NCT02461589|473551782|FG007|Overall Study|Death|1|||
131526061|NCT02461589|473551783|FG008|Overall Study|Death|0|||
131526062|NCT02461589|473551784|FG009|Overall Study|Death|0|||
131526063|NCT02461589|473551775|FG000|Overall Study|Unclassified|0|||
131526064|NCT02461589|473551776|FG001|Overall Study|Unclassified|0|||
131526065|NCT02461589|473551777|FG002|Overall Study|Unclassified|0|||
131526066|NCT02461589|473551778|FG003|Overall Study|Unclassified|0|||
131526067|NCT02461589|473551779|FG004|Overall Study|Unclassified|0|||
131526068|NCT02461589|473551780|FG005|Overall Study|Unclassified|0|||
131526069|NCT02461589|473551781|FG006|Overall Study|Unclassified|1|||
131526070|NCT02461589|473551782|FG007|Overall Study|Unclassified|0|||
131526071|NCT02461589|473551783|FG008|Overall Study|Unclassified|0|||
131526072|NCT02461589|473551784|FG009|Overall Study|Unclassified|2|||
131526073|NCT02461589|473551775|FG000|Overall Study|Missing follow-up information|1|||
131526074|NCT02461589|473551776|FG001|Overall Study|Missing follow-up information|1|||
131526075|NCT02461589|473551777|FG002|Overall Study|Missing follow-up information|0|||
131526076|NCT02461589|473551778|FG003|Overall Study|Missing follow-up information|0|||
131526077|NCT02461589|473551779|FG004|Overall Study|Missing follow-up information|0|||
131526078|NCT02461589|473551780|FG005|Overall Study|Missing follow-up information|0|||
131526079|NCT02461589|473551781|FG006|Overall Study|Missing follow-up information|1|||
131526080|NCT02461589|473551782|FG007|Overall Study|Missing follow-up information|0|||
131526081|NCT02461589|473551783|FG008|Overall Study|Missing follow-up information|0|||
131526082|NCT02461589|473551784|FG009|Overall Study|Missing follow-up information|0|||
131526083|NCT02461589|473551775|FG000|Overall Study|Withdrawal from trial before exposure|0|||
131526084|NCT02461589|473551776|FG001|Overall Study|Withdrawal from trial before exposure|0|||
131526085|NCT02461589|473551777|FG002|Overall Study|Withdrawal from trial before exposure|0|||
131526086|NCT02461589|473551778|FG003|Overall Study|Withdrawal from trial before exposure|0|||
131526087|NCT02461589|473551779|FG004|Overall Study|Withdrawal from trial before exposure|0|||
131526088|NCT02461589|473551780|FG005|Overall Study|Withdrawal from trial before exposure|0|||
131526089|NCT02461589|473551781|FG006|Overall Study|Withdrawal from trial before exposure|0|||
131526090|NCT02461589|473551782|FG007|Overall Study|Withdrawal from trial before exposure|0|||
131526091|NCT02461589|473551783|FG008|Overall Study|Withdrawal from trial before exposure|0|||
131526092|NCT02461589|473551784|FG009|Overall Study|Withdrawal from trial before exposure|1|||
131526093|NCT04067141|473551785|FG000|First Intervention|Withdrawal by Subject|0|||
131526094|NCT04067141|473551786|FG001|First Intervention|Withdrawal by Subject|1|||
131526095|NCT04067141|473551785|FG000|Second Intervention|Adverse Event|0|||
131526096|NCT04067141|473551786|FG001|Second Intervention|Adverse Event|2|||
131526097|NCT01038921|473551787|FG000|Overall Study|Withdrawal by Subject|1|||
131526098|NCT01038921|473551788|FG001|Overall Study|Withdrawal by Subject|0|||
131526099|NCT01038921|473551787|FG000|Overall Study|Physician Decision|1|||
131526100|NCT01038921|473551788|FG001|Overall Study|Physician Decision|0|||
131526101|NCT01978119|473551789|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
131526102|NCT01978119|473551790|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
131526103|NCT01978119|473551789|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131526104|NCT01978119|473551790|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131526105|NCT01978119|473551789|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131526106|NCT01978119|473551790|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
131526107|NCT04327934|473551791|FG000|Overall Study|Did not qualify|7|||
131526108|NCT04327934|473551792|FG001|Overall Study|Did not qualify|4|||
131526109|NCT04327934|473551791|FG000|Overall Study|Physician Decision|0|||
131526110|NCT04327934|473551792|FG001|Overall Study|Physician Decision|1|||
131526111|NCT03095417|473551797|FG000|Overall Study|missed|1|||
131526112|NCT03095417|473551798|FG001|Overall Study|missed|2|||
131526113|NCT03095417|473551799|FG002|Overall Study|missed|0|||
131526114|NCT03095417|473551800|FG003|Overall Study|missed|1|||
131526115|NCT03095417|473551797|FG000|Overall Study|Lost to Follow-up|2|||
131526116|NCT03095417|473551798|FG001|Overall Study|Lost to Follow-up|2|||
131526117|NCT03095417|473551799|FG002|Overall Study|Lost to Follow-up|1|||
131526118|NCT03095417|473551800|FG003|Overall Study|Lost to Follow-up|0|||
131526119|NCT03095417|473551797|FG000|Overall Study|refusal|0|||
131526120|NCT03095417|473551798|FG001|Overall Study|refusal|1|||
131526121|NCT03095417|473551799|FG002|Overall Study|refusal|0|||
131526122|NCT03095417|473551800|FG003|Overall Study|refusal|1|||
131526123|NCT03095417|473551797|FG000|Overall Study|Withdrawal by Subject|8|||
131526124|NCT03095417|473551798|FG001|Overall Study|Withdrawal by Subject|2|||
131526125|NCT03095417|473551799|FG002|Overall Study|Withdrawal by Subject|5|||
131526126|NCT03095417|473551800|FG003|Overall Study|Withdrawal by Subject|4|||
131526127|NCT03095417|473551797|FG000|Overall Study|Physician Decision|1|||
131526128|NCT03095417|473551798|FG001|Overall Study|Physician Decision|2|||
131526129|NCT03095417|473551799|FG002|Overall Study|Physician Decision|2|||
131526130|NCT03095417|473551800|FG003|Overall Study|Physician Decision|2|||
131526131|NCT03095417|473551797|FG000|Overall Study|Death|1|||
131526132|NCT03095417|473551798|FG001|Overall Study|Death|2|||
131526133|NCT03095417|473551799|FG002|Overall Study|Death|1|||
131526134|NCT03095417|473551800|FG003|Overall Study|Death|3|||
131526135|NCT01490060|473551801|FG000|Cycle 1|Change of Treatment|0|||
131526136|NCT01490060|473551802|FG001|Cycle 1|Change of Treatment|1|||
131526137|NCT01490060|473551803|FG002|Cycle 1|Change of Treatment|1|||
131526138|NCT01490060|473551804|FG003|Cycle 1|Change of Treatment|1|||
131526139|NCT01490060|473551801|FG000|Cycle 1|Insurance Denied|0|||
131526140|NCT01490060|473551802|FG001|Cycle 1|Insurance Denied|0|||
131526141|NCT01490060|473551803|FG002|Cycle 1|Insurance Denied|2|||
131526142|NCT01490060|473551804|FG003|Cycle 1|Insurance Denied|0|||
131526143|NCT01490060|473551801|FG000|Cycle 1|Withdrawal by Subject|0|||
131526144|NCT01490060|473551802|FG001|Cycle 1|Withdrawal by Subject|0|||
131526145|NCT01490060|473551803|FG002|Cycle 1|Withdrawal by Subject|0|||
131526146|NCT01490060|473551804|FG003|Cycle 1|Withdrawal by Subject|1|||
131526147|NCT01490060|473551801|FG000|Cycle 1|Treatment at Another Facility|0|||
131526148|NCT01490060|473551802|FG001|Cycle 1|Treatment at Another Facility|0|||
131526149|NCT01490060|473551803|FG002|Cycle 1|Treatment at Another Facility|0|||
131526150|NCT01490060|473551804|FG003|Cycle 1|Treatment at Another Facility|1|||
131526151|NCT01490060|473551801|FG000|Cycle 2|Change of Treatment|1|||
131526152|NCT01490060|473551802|FG001|Cycle 2|Change of Treatment|1|||
131526153|NCT01490060|473551803|FG002|Cycle 2|Change of Treatment|0|||
131526154|NCT01490060|473551804|FG003|Cycle 2|Change of Treatment|0|||
131526155|NCT01490060|473551801|FG000|Cycle 2|Non-Compliance|0|||
131526156|NCT01490060|473551802|FG001|Cycle 2|Non-Compliance|0|||
131526157|NCT01490060|473551803|FG002|Cycle 2|Non-Compliance|1|||
131526158|NCT01490060|473551804|FG003|Cycle 2|Non-Compliance|0|||
131526159|NCT01490060|473551801|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
131526160|NCT01490060|473551802|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
131526161|NCT01490060|473551803|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
131526162|NCT01490060|473551804|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
131526163|NCT01877421|473551805|FG000|Phase 2|Lost to Follow-up|0|||
131526164|NCT01877421|473551806|FG001|Phase 2|Lost to Follow-up|0|||
131526165|NCT01877421|473551807|FG002|Phase 2|Lost to Follow-up|0|||
131526166|NCT01877421|473551808|FG003|Phase 2|Lost to Follow-up|0|||
131526167|NCT01877421|473551809|FG004|Phase 2|Lost to Follow-up|0|||
131526168|NCT01877421|473551810|FG005|Phase 2|Lost to Follow-up|0|||
131526169|NCT01877421|473551811|FG006|Phase 2|Lost to Follow-up|1|||
131526170|NCT01877421|473551812|FG007|Phase 2|Lost to Follow-up|0|||
131526171|NCT01877421|473551813|FG008|Phase 2|Lost to Follow-up|0|||
131526172|NCT01877421|473551814|FG009|Phase 2|Lost to Follow-up|0|||
131526173|NCT01877421|473551815|FG010|Phase 2|Lost to Follow-up|0|||
131526174|NCT01877421|473551816|FG011|Phase 2|Lost to Follow-up|0|||
131526175|NCT01877421|473551817|FG012|Phase 2|Lost to Follow-up|0|||
131526176|NCT01877421|473551818|FG013|Phase 2|Lost to Follow-up|0|||
131526177|NCT01877421|473551819|FG014|Phase 2|Lost to Follow-up|0|||
131526178|NCT01877421|473551820|FG015|Phase 2|Lost to Follow-up|0|||
131526179|NCT01877421|473551821|FG016|Phase 2|Lost to Follow-up|0|||
131526180|NCT01877421|473551822|FG017|Phase 2|Lost to Follow-up|0|||
131526181|NCT01877421|473551805|FG000|Phase 2|Withdrawal by Subject|0|||
131526182|NCT01877421|473551806|FG001|Phase 2|Withdrawal by Subject|0|||
131526183|NCT01877421|473551807|FG002|Phase 2|Withdrawal by Subject|0|||
131526184|NCT01877421|473551808|FG003|Phase 2|Withdrawal by Subject|0|||
131526185|NCT01877421|473551809|FG004|Phase 2|Withdrawal by Subject|0|||
131526186|NCT01877421|473551810|FG005|Phase 2|Withdrawal by Subject|0|||
131526187|NCT01877421|473551811|FG006|Phase 2|Withdrawal by Subject|0|||
131526188|NCT01877421|473551812|FG007|Phase 2|Withdrawal by Subject|0|||
131526189|NCT01877421|473551813|FG008|Phase 2|Withdrawal by Subject|1|||
131526190|NCT01877421|473551814|FG009|Phase 2|Withdrawal by Subject|0|||
131526191|NCT01877421|473551815|FG010|Phase 2|Withdrawal by Subject|1|||
131526192|NCT01877421|473551816|FG011|Phase 2|Withdrawal by Subject|0|||
131526193|NCT01877421|473551817|FG012|Phase 2|Withdrawal by Subject|1|||
131526194|NCT01877421|473551818|FG013|Phase 2|Withdrawal by Subject|0|||
131526195|NCT01877421|473551819|FG014|Phase 2|Withdrawal by Subject|0|||
131526196|NCT01877421|473551820|FG015|Phase 2|Withdrawal by Subject|1|||
131526197|NCT01877421|473551821|FG016|Phase 2|Withdrawal by Subject|0|||
131526198|NCT01877421|473551822|FG017|Phase 2|Withdrawal by Subject|0|||
131526199|NCT01877421|473551805|FG000|Phase 2|Protocol Violation|0|||
131526200|NCT01877421|473551806|FG001|Phase 2|Protocol Violation|0|||
131526201|NCT01877421|473551807|FG002|Phase 2|Protocol Violation|0|||
131526202|NCT01877421|473551808|FG003|Phase 2|Protocol Violation|0|||
131526203|NCT01877421|473551809|FG004|Phase 2|Protocol Violation|0|||
131526204|NCT01877421|473551810|FG005|Phase 2|Protocol Violation|0|||
131526205|NCT01877421|473551811|FG006|Phase 2|Protocol Violation|0|||
131526206|NCT01877421|473551812|FG007|Phase 2|Protocol Violation|0|||
131526207|NCT01877421|473551813|FG008|Phase 2|Protocol Violation|0|||
131526208|NCT01877421|473551814|FG009|Phase 2|Protocol Violation|0|||
131526209|NCT01877421|473551815|FG010|Phase 2|Protocol Violation|1|||
131526210|NCT01877421|473551816|FG011|Phase 2|Protocol Violation|0|||
131526211|NCT01877421|473551817|FG012|Phase 2|Protocol Violation|0|||
131526212|NCT01877421|473551818|FG013|Phase 2|Protocol Violation|0|||
131526213|NCT01877421|473551819|FG014|Phase 2|Protocol Violation|0|||
131526214|NCT01877421|473551820|FG015|Phase 2|Protocol Violation|0|||
131526215|NCT01877421|473551821|FG016|Phase 2|Protocol Violation|0|||
131526216|NCT01877421|473551822|FG017|Phase 2|Protocol Violation|0|||
131526217|NCT01047683|473551823|FG000|Overall Study|Adverse Event|3|||
131526218|NCT01047683|473551824|FG001|Overall Study|Adverse Event|1|||
131526219|NCT01047683|473551825|FG002|Overall Study|Adverse Event|0|||
131526220|NCT01047683|473551823|FG000|Overall Study|Withdrew Consent|1|||
131526221|NCT01047683|473551824|FG001|Overall Study|Withdrew Consent|4|||
131526222|NCT01047683|473551825|FG002|Overall Study|Withdrew Consent|2|||
131526223|NCT01047683|473551823|FG000|Overall Study|Lost to Follow-up|0|||
131526224|NCT01047683|473551824|FG001|Overall Study|Lost to Follow-up|1|||
131526225|NCT01047683|473551825|FG002|Overall Study|Lost to Follow-up|0|||
131526226|NCT01047683|473551823|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
131526227|NCT01047683|473551824|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
131526228|NCT01047683|473551825|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
131526229|NCT03698773|473551827|FG000|Overall Study|Lost to Follow-up|2|||
131526230|NCT03698773|473551828|FG001|Overall Study|Lost to Follow-up|1|||
131526231|NCT00908960|473551829|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
131526232|NCT00908960|473551830|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
131526233|NCT00908960|473551831|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
131653845|NCT03307785|474018488|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
131526234|NCT01158924|473551833|FG000|Overall Study|Withdrawal by Subject|1|||
131526235|NCT01158924|473551834|FG001|Overall Study|Withdrawal by Subject|2|||
131526236|NCT01158924|473551833|FG000|Overall Study|Lost to Follow-up|0|||
131526237|NCT01158924|473551834|FG001|Overall Study|Lost to Follow-up|1|||
131526238|NCT03795922|473551835|FG000|Overall Study|Adverse Event|2|||
131526239|NCT03795922|473551836|FG001|Overall Study|Adverse Event|1|||
131526240|NCT03795922|473551835|FG000|Overall Study|Withdrawal by Subject|5|||
131526241|NCT03795922|473551836|FG001|Overall Study|Withdrawal by Subject|13|||
131526242|NCT03795922|473551835|FG000|Overall Study|Lost to Follow-up|2|||
131526243|NCT03795922|473551836|FG001|Overall Study|Lost to Follow-up|3|||
131526244|NCT03795922|473551835|FG000|Overall Study|Pregnancy|0|||
131526245|NCT03795922|473551836|FG001|Overall Study|Pregnancy|1|||
131526246|NCT03795922|473551835|FG000|Overall Study|Physician Decision|1|||
131526247|NCT03795922|473551836|FG001|Overall Study|Physician Decision|2|||
131526248|NCT03795922|473551835|FG000|Overall Study|Protocol Violation|0|||
131526249|NCT03795922|473551836|FG001|Overall Study|Protocol Violation|1|||
131526250|NCT03795922|473551835|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
131526251|NCT03795922|473551836|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
131526252|NCT00724451|473551840|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
131526253|NCT00724451|473551840|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
131526254|NCT00724451|473551840|FG000|Overall Study|Not Eligible for Treatment|431|||
131526255|NCT00724451|473551840|FG000|Overall Study|Participant Refused Treatment|89|||
131526256|NCT00724451|473551840|FG000|Overall Study|Never Started Treatment|89|||
131526257|NCT00724451|473551840|FG000|Overall Study|Unknown; No Data Sources Available|9|||
131526258|NCT00724451|473551840|FG000|Overall Study|Physician Decision|116|||
131526259|NCT00724451|473551840|FG000|Overall Study|Withdrawal by Subject|45|||
131526260|NCT00724451|473551840|FG000|Overall Study|Investigator + Participant Decision|13|||
131526261|NCT01260922|473551842|FG000|First Intervention|Withdrawal by Subject|0|||
131526262|NCT01260922|473551843|FG001|First Intervention|Withdrawal by Subject|1|||
131526263|NCT01260922|473551842|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
131526264|NCT01260922|473551843|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
131526265|NCT01260922|473551842|FG000|Second Intervention|Emesis|0|||
131526266|NCT01260922|473551843|FG001|Second Intervention|Emesis|2|||
131526267|NCT02822794|473551848|FG000|Overall Study|Withdrew Consent|1|||
131526268|NCT02822794|473551849|FG001|Overall Study|Withdrew Consent|0|||
131526269|NCT00733824|473551850|FG000|Phase I|Withdrawal by Subject|1|||
131526270|NCT00733824|473551851|FG001|Phase I|Withdrawal by Subject|0|||
131526271|NCT00733824|473551852|FG002|Phase I|Withdrawal by Subject|0|||
131526272|NCT00733824|473551853|FG003|Phase I|Withdrawal by Subject|0|||
131526273|NCT00733824|473551854|FG004|Phase I|Withdrawal by Subject|0|||
131526274|NCT01243944|473551855|FG000|Overall Study|Adverse Event|15|||
131526275|NCT01243944|473551856|FG001|Overall Study|Adverse Event|13|||
131526276|NCT01243944|473551855|FG000|Overall Study|Lost to Follow-up|2|||
131526277|NCT01243944|473551856|FG001|Overall Study|Lost to Follow-up|1|||
131526278|NCT01243944|473551855|FG000|Overall Study|Physician Decision|2|||
131526279|NCT01243944|473551856|FG001|Overall Study|Physician Decision|7|||
131526280|NCT01243944|473551855|FG000|Overall Study|Disease progression|12|||
131526281|NCT01243944|473551856|FG001|Overall Study|Disease progression|11|||
131526282|NCT01243944|473551855|FG000|Overall Study|Protocol deviation|1|||
131526283|NCT01243944|473551856|FG001|Overall Study|Protocol deviation|1|||
131526284|NCT01243944|473551855|FG000|Overall Study|Participant decision|10|||
131526285|NCT01243944|473551856|FG001|Overall Study|Participant decision|15|||
131526286|NCT01243944|473551855|FG000|Overall Study|Death|2|||
131526287|NCT01243944|473551856|FG001|Overall Study|Death|3|||
131526288|NCT01243944|473551855|FG000|Overall Study|Non-compliance with study treatment|1|||
131526289|NCT01243944|473551856|FG001|Overall Study|Non-compliance with study treatment|0|||
131526290|NCT01416805|473551857|FG000|Overall Study|Lost to Follow-up|4|||
131526291|NCT01416805|473551858|FG001|Overall Study|Lost to Follow-up|4|||
131526292|NCT02480621|473551859|FG000|Randomization|Withdrawal by Subject|1|||
131526293|NCT02480621|473551860|FG001|Randomization|Withdrawal by Subject|0|||
131526294|NCT02480621|473551859|FG000|Randomization|Surgeon did not give intervention|0|||
131526295|NCT02480621|473551860|FG001|Randomization|Surgeon did not give intervention|1|||
131526296|NCT02480621|473551859|FG000|Follow Up|Lost to Follow-up|4|||
131526297|NCT02480621|473551860|FG001|Follow Up|Lost to Follow-up|2|||
131526298|NCT03056690|473551861|FG000|Overall Study|Adverse Event|3|||
131526299|NCT03056690|473551862|FG001|Overall Study|Adverse Event|2|||
131526300|NCT03056690|473551861|FG000|Overall Study|Lack of Efficacy|1|||
131526301|NCT03056690|473551862|FG001|Overall Study|Lack of Efficacy|2|||
131526302|NCT03056690|473551861|FG000|Overall Study|Lost to Follow-up|3|||
131526303|NCT03056690|473551862|FG001|Overall Study|Lost to Follow-up|2|||
131526304|NCT03056690|473551861|FG000|Overall Study|Protocol Violation|2|||
131526305|NCT03056690|473551862|FG001|Overall Study|Protocol Violation|2|||
131526306|NCT03056690|473551861|FG000|Overall Study|Withdrawal by Subject|3|||
131526307|NCT03056690|473551862|FG001|Overall Study|Withdrawal by Subject|6|||
131658430|NCT01531673|474035304|FG005|Overall Study|Other|0|||
131526308|NCT03056690|473551861|FG000|Overall Study|Non-compliance with Study Drug|1|||
131526309|NCT03056690|473551862|FG001|Overall Study|Non-compliance with Study Drug|0|||
131526310|NCT03056690|473551861|FG000|Overall Study|Miscellaneous|1|||
131526311|NCT03056690|473551862|FG001|Overall Study|Miscellaneous|2|||
131526312|NCT01652716|473551869|FG000|Overall Study|Loss of glucose control|1|||
131526313|NCT01652716|473551870|FG001|Overall Study|Loss of glucose control|0|||
131526314|NCT01652716|473551869|FG000|Overall Study|Administrative|0|||
131526315|NCT01652716|473551870|FG001|Overall Study|Administrative|2|||
131526316|NCT01652716|473551869|FG000|Overall Study|Investigator decision|1|||
131526317|NCT01652716|473551870|FG001|Overall Study|Investigator decision|4|||
131526318|NCT01652716|473551869|FG000|Overall Study|Lost to Follow-up|12|||
131526319|NCT01652716|473551870|FG001|Overall Study|Lost to Follow-up|11|||
131526320|NCT01652716|473551869|FG000|Overall Study|Protocol Violation|2|||
131526321|NCT01652716|473551870|FG001|Overall Study|Protocol Violation|1|||
131526322|NCT01652716|473551869|FG000|Overall Study|Adverse Event|7|||
131526323|NCT01652716|473551870|FG001|Overall Study|Adverse Event|10|||
131526324|NCT01652716|473551869|FG000|Overall Study|Withdrawal by Subject|33|||
131526325|NCT01652716|473551870|FG001|Overall Study|Withdrawal by Subject|18|||
131526326|NCT02778204|473551871|FG000|Overall Study|Adverse Event|1|||
131526327|NCT02778204|473551872|FG001|Overall Study|Adverse Event|0|||
131526328|NCT02778204|473551873|FG002|Overall Study|Adverse Event|0|||
131526329|NCT02778204|473551874|FG003|Overall Study|Adverse Event|0|||
131526330|NCT02778204|473551871|FG000|Overall Study|Withdrawal by Subject|0|||
131526331|NCT02778204|473551872|FG001|Overall Study|Withdrawal by Subject|0|||
131526332|NCT02778204|473551873|FG002|Overall Study|Withdrawal by Subject|1|||
131526333|NCT02778204|473551874|FG003|Overall Study|Withdrawal by Subject|2|||
131526334|NCT02778204|473551871|FG000|Overall Study|Lost to Follow-up|1|||
131526335|NCT02778204|473551872|FG001|Overall Study|Lost to Follow-up|0|||
131526336|NCT02778204|473551873|FG002|Overall Study|Lost to Follow-up|2|||
131526337|NCT02778204|473551874|FG003|Overall Study|Lost to Follow-up|1|||
131526338|NCT02778204|473551871|FG000|Overall Study|Protocol Violation|0|||
131526339|NCT02778204|473551872|FG001|Overall Study|Protocol Violation|0|||
131526340|NCT02778204|473551873|FG002|Overall Study|Protocol Violation|1|||
131526341|NCT02778204|473551874|FG003|Overall Study|Protocol Violation|0|||
131526342|NCT02778204|473551871|FG000|Overall Study|Eligibility Violation|0|||
131526343|NCT02778204|473551872|FG001|Overall Study|Eligibility Violation|0|||
131526344|NCT02778204|473551873|FG002|Overall Study|Eligibility Violation|0|||
131526345|NCT02778204|473551874|FG003|Overall Study|Eligibility Violation|1|||
131526346|NCT02052466|473551875|FG000|Overall Study|Withdrawal by Subject|1|||
131526347|NCT02052466|473551875|FG000|Overall Study|Acromial fracture|1|||
131526348|NCT01328002|473551879|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
131526349|NCT01328002|473551880|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
131526350|NCT01328002|473551879|FG000|Open-Label Period|Adverse Event|8|||
131526351|NCT01328002|473551880|FG001|Open-Label Period|Adverse Event|0|||
131526352|NCT01328002|473551879|FG000|Open-Label Period|Lack of Efficacy|3|||
131526353|NCT01328002|473551880|FG001|Open-Label Period|Lack of Efficacy|0|||
131526354|NCT01328002|473551879|FG000|Open-Label Period|Protocol Violation|2|||
131526355|NCT01328002|473551880|FG001|Open-Label Period|Protocol Violation|0|||
131526356|NCT01328002|473551879|FG000|Open-Label Period|Withdrawal by Subject|9|||
131526357|NCT01328002|473551880|FG001|Open-Label Period|Withdrawal by Subject|0|||
131526358|NCT01328002|473551879|FG000|Open-Label Period|Lost to Follow-up|6|||
131526359|NCT01328002|473551880|FG001|Open-Label Period|Lost to Follow-up|0|||
131526360|NCT01328002|473551879|FG000|Open-Label Period|Other Reason|2|||
131526361|NCT01328002|473551880|FG001|Open-Label Period|Other Reason|0|||
131526362|NCT01328002|473551879|FG000|Double-Blind Period|Adverse Event|1|||
131526363|NCT01328002|473551880|FG001|Double-Blind Period|Adverse Event|0|||
131526364|NCT01328002|473551879|FG000|Double-Blind Period|Lack of Efficacy|1|||
131526365|NCT01328002|473551880|FG001|Double-Blind Period|Lack of Efficacy|0|||
131526366|NCT00813761|473551881|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
131526367|NCT00813761|473551882|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
131526368|NCT00813761|473551883|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
131526369|NCT00813761|473551884|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
131526370|NCT00813761|473551881|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
131526371|NCT00813761|473551882|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
131526372|NCT00813761|473551883|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
131526373|NCT00813761|473551884|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
131526374|NCT00813761|473551881|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
131526375|NCT00813761|473551882|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
131526376|NCT00813761|473551883|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
131526377|NCT00813761|473551884|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
131526378|NCT00813761|473551881|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
131526379|NCT00813761|473551882|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
131526380|NCT00813761|473551883|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
131526381|NCT00813761|473551884|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
131526382|NCT00813761|473551881|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
131526383|NCT00813761|473551882|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
131526384|NCT00813761|473551883|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
131526385|NCT00813761|473551884|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
131526386|NCT00813761|473551881|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
131526387|NCT00813761|473551882|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
131526388|NCT00813761|473551883|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
131658431|NCT01531673|474035305|FG006|Overall Study|Other|0|||
131526389|NCT00813761|473551884|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
131526390|NCT00813761|473551881|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
131526391|NCT00813761|473551882|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
131526392|NCT00813761|473551883|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
131526393|NCT00813761|473551884|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
131526394|NCT00813761|473551881|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
131526395|NCT00813761|473551882|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
131526396|NCT00813761|473551883|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
131526397|NCT00813761|473551884|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
131526398|NCT00813761|473551881|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
131526399|NCT00813761|473551882|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
131526400|NCT00813761|473551883|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
131526401|NCT00813761|473551884|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
131526402|NCT00813761|473551881|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
131526403|NCT00813761|473551882|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
131526404|NCT00813761|473551883|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
131526405|NCT00813761|473551884|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
131526406|NCT00813761|473551881|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
131526407|NCT00813761|473551882|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
131526408|NCT00813761|473551883|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
131526409|NCT00813761|473551884|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
131526410|NCT00813761|473551881|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
131526411|NCT00813761|473551882|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
131526412|NCT00813761|473551883|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
131526413|NCT00813761|473551884|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
131526414|NCT01208233|473551885|FG000|Overall Study|Adverse Event|0|||
131526415|NCT01208233|473551886|FG001|Overall Study|Adverse Event|1|||
131526416|NCT01208233|473551887|FG002|Overall Study|Adverse Event|2|||
131526417|NCT01208233|473551888|FG003|Overall Study|Adverse Event|0|||
131526418|NCT01208233|473551889|FG004|Overall Study|Adverse Event|3|||
131526419|NCT01208233|473551890|FG005|Overall Study|Adverse Event|5|||
131526420|NCT01208233|473551885|FG000|Overall Study|Death|0|||
131526421|NCT01208233|473551886|FG001|Overall Study|Death|0|||
131526422|NCT01208233|473551887|FG002|Overall Study|Death|0|||
131526423|NCT01208233|473551888|FG003|Overall Study|Death|0|||
131526424|NCT01208233|473551889|FG004|Overall Study|Death|3|||
131526425|NCT01208233|473551890|FG005|Overall Study|Death|5|||
131526426|NCT01208233|473551885|FG000|Overall Study|Did not meet entrance criteria|2|||
131526427|NCT01208233|473551886|FG001|Overall Study|Did not meet entrance criteria|1|||
131526428|NCT01208233|473551887|FG002|Overall Study|Did not meet entrance criteria|1|||
131526429|NCT01208233|473551888|FG003|Overall Study|Did not meet entrance criteria|0|||
131526430|NCT01208233|473551889|FG004|Overall Study|Did not meet entrance criteria|1|||
131526431|NCT01208233|473551890|FG005|Overall Study|Did not meet entrance criteria|0|||
131526432|NCT01208233|473551885|FG000|Overall Study|Medication error without adverse event|0|||
131526433|NCT01208233|473551886|FG001|Overall Study|Medication error without adverse event|0|||
131526434|NCT01208233|473551887|FG002|Overall Study|Medication error without adverse event|0|||
131526435|NCT01208233|473551888|FG003|Overall Study|Medication error without adverse event|0|||
131526436|NCT01208233|473551889|FG004|Overall Study|Medication error without adverse event|0|||
131526437|NCT01208233|473551890|FG005|Overall Study|Medication error without adverse event|1|||
131526438|NCT01208233|473551885|FG000|Overall Study|Study terminated by sponsor|0|||
131526439|NCT01208233|473551886|FG001|Overall Study|Study terminated by sponsor|0|||
131526440|NCT01208233|473551887|FG002|Overall Study|Study terminated by sponsor|0|||
131526441|NCT01208233|473551888|FG003|Overall Study|Study terminated by sponsor|0|||
131526442|NCT01208233|473551889|FG004|Overall Study|Study terminated by sponsor|10|||
131526443|NCT01208233|473551890|FG005|Overall Study|Study terminated by sponsor|7|||
131526444|NCT01208233|473551885|FG000|Overall Study|Protocol Violation|0|||
131526445|NCT01208233|473551886|FG001|Overall Study|Protocol Violation|0|||
131526446|NCT01208233|473551887|FG002|Overall Study|Protocol Violation|0|||
131526447|NCT01208233|473551888|FG003|Overall Study|Protocol Violation|0|||
131526448|NCT01208233|473551889|FG004|Overall Study|Protocol Violation|3|||
131526449|NCT01208233|473551890|FG005|Overall Study|Protocol Violation|0|||
131526450|NCT01208233|473551885|FG000|Overall Study|Other|2|||
131526451|NCT01208233|473551886|FG001|Overall Study|Other|1|||
131526452|NCT01208233|473551887|FG002|Overall Study|Other|0|||
131526453|NCT01208233|473551888|FG003|Overall Study|Other|0|||
131526454|NCT01208233|473551889|FG004|Overall Study|Other|0|||
131526455|NCT01208233|473551890|FG005|Overall Study|Other|1|||
131526456|NCT01208233|473551885|FG000|Overall Study|Withdrawal by Subject|1|||
131526457|NCT01208233|473551886|FG001|Overall Study|Withdrawal by Subject|0|||
131526458|NCT01208233|473551887|FG002|Overall Study|Withdrawal by Subject|1|||
131526459|NCT01208233|473551888|FG003|Overall Study|Withdrawal by Subject|1|||
131526460|NCT01208233|473551889|FG004|Overall Study|Withdrawal by Subject|4|||
131526461|NCT01208233|473551890|FG005|Overall Study|Withdrawal by Subject|2|||
131526462|NCT01181895|473551892|FG000|Overall Study|Adverse Event|3|||
131526463|NCT01181895|473551893|FG001|Overall Study|Adverse Event|1|||
131526464|NCT01181895|473551894|FG002|Overall Study|Adverse Event|1|||
131526465|NCT01181895|473551892|FG000|Overall Study|Lack of Efficacy|8|||
131526466|NCT01181895|473551893|FG001|Overall Study|Lack of Efficacy|9|||
131526467|NCT01181895|473551894|FG002|Overall Study|Lack of Efficacy|9|||
131526468|NCT01181895|473551892|FG000|Overall Study|Protocol Violation|2|||
131526469|NCT01181895|473551893|FG001|Overall Study|Protocol Violation|1|||
131526470|NCT01181895|473551894|FG002|Overall Study|Protocol Violation|0|||
131526471|NCT01181895|473551892|FG000|Overall Study|Lost to Follow-up|0|||
131526472|NCT01181895|473551893|FG001|Overall Study|Lost to Follow-up|1|||
131526473|NCT01181895|473551894|FG002|Overall Study|Lost to Follow-up|2|||
131526474|NCT01181895|473551892|FG000|Overall Study|Investigator Discretion|1|||
131526475|NCT01181895|473551893|FG001|Overall Study|Investigator Discretion|2|||
131526476|NCT01181895|473551894|FG002|Overall Study|Investigator Discretion|1|||
131526477|NCT01181895|473551892|FG000|Overall Study|Withdrawal by Subject|3|||
131526478|NCT01181895|473551893|FG001|Overall Study|Withdrawal by Subject|0|||
131526479|NCT01181895|473551894|FG002|Overall Study|Withdrawal by Subject|5|||
131526480|NCT01114516|473551900|FG000|Overall Study|Lost to Follow-up|2|||
131526481|NCT01114516|473551901|FG001|Overall Study|Lost to Follow-up|1|||
131526482|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526483|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526484|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526485|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526486|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
131526487|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526488|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526489|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
131526490|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
131526491|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526492|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
131526493|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
131526494|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526495|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526496|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526497|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
131526498|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
131526499|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
131526500|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
131526501|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
131526502|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
131526503|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
131526504|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
131526505|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
131526506|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
131526507|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
131526508|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
131526509|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
131526510|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
131526511|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
131526512|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
131526513|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
131526514|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526515|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526516|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526517|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526518|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526519|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
131526520|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
131526521|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526522|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526523|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
131526524|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
131526525|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
131526526|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526527|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526528|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526529|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131526530|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131653846|NCT03307785|474018489|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
131653847|NCT03307785|474018490|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
131526531|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526532|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526533|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526534|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526535|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
131526536|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526537|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526538|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526539|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526540|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526541|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
131526542|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526543|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526544|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526545|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
131526546|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526547|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526548|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526549|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526550|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526551|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
131526552|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526553|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526554|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526555|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526556|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526557|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526558|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526559|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526560|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526561|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
131526562|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526563|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526564|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526565|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526566|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526567|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526568|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526569|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526570|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
131526571|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526572|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526573|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526574|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526575|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526576|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526577|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131526578|NCT01609556|473551905|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
131526579|NCT01609556|473551906|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526580|NCT01609556|473551907|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526581|NCT01609556|473551908|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526582|NCT01609556|473551909|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526583|NCT01609556|473551910|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
131526584|NCT01609556|473551911|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526585|NCT01609556|473551912|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526586|NCT01609556|473551913|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526587|NCT01609556|473551914|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526588|NCT01609556|473551915|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
131526589|NCT01609556|473551916|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526590|NCT01609556|473551917|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526591|NCT01609556|473551918|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526592|NCT01609556|473551919|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131526593|NCT01609556|473551920|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131658432|NCT01531673|474035306|FG007|Overall Study|Other|0|||
131526594|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526595|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526596|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526597|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526598|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526599|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526600|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526601|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526602|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526603|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526604|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526605|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
131526606|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
131526607|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
131526608|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
131526609|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
131526610|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526611|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526612|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526613|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526614|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526615|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526616|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526617|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526618|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526619|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526620|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526621|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
131526622|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
131526623|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
131526624|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
131526625|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
131526626|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526627|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526628|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526629|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526630|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526631|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526632|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526633|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526634|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526635|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526636|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526637|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
131526638|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
131526639|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
131526640|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
131526641|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
131526642|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526643|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526644|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526645|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526646|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526647|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526648|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526649|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526650|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526651|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526652|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526653|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526654|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
131526655|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526656|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526657|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131526658|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131658433|NCT01531673|474035307|FG008|Overall Study|Other|0|||
131526659|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526660|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526661|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526662|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526663|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526664|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526665|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526666|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526667|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526668|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526669|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131526670|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
131526671|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
131526672|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
131526673|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
131526674|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526675|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526676|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526677|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526678|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526679|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526680|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526681|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526682|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526683|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526684|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526685|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526686|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526687|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526688|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
131526689|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
131526690|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526691|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526692|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526693|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526694|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526695|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526696|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526697|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526698|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526699|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526700|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526701|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526702|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
131526703|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
131526704|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
131526705|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
131526706|NCT01609556|473551905|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526707|NCT01609556|473551906|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526708|NCT01609556|473551907|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526709|NCT01609556|473551908|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526710|NCT01609556|473551909|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526711|NCT01609556|473551910|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526712|NCT01609556|473551911|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526713|NCT01609556|473551912|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526714|NCT01609556|473551913|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526715|NCT01609556|473551914|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526716|NCT01609556|473551915|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526717|NCT01609556|473551916|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526718|NCT01609556|473551917|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
131526719|NCT01609556|473551918|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526720|NCT01609556|473551919|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526721|NCT01609556|473551920|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131526722|NCT03964454|473551926|FG000|Overall Study|Lost to Follow-up|13|||
131526723|NCT03964454|473551927|FG001|Overall Study|Lost to Follow-up|7|||
131526724|NCT03964454|473551926|FG000|Overall Study|Withdrawal by Subject|4|||
131526725|NCT03964454|473551927|FG001|Overall Study|Withdrawal by Subject|11|||
131526726|NCT01175824|473553561|FG000|Overall Study|Adverse Event|2|||
131526727|NCT01175824|473553562|FG001|Overall Study|Adverse Event|1|||
131526728|NCT01175824|473553561|FG000|Overall Study|Lack of Efficacy|2|||
131526729|NCT01175824|473553562|FG001|Overall Study|Lack of Efficacy|0|||
131526730|NCT01175824|473553561|FG000|Overall Study|Lost to Follow-up|0|||
131526731|NCT01175824|473553562|FG001|Overall Study|Lost to Follow-up|1|||
131526732|NCT01175824|473553561|FG000|Overall Study|Physician Decision|0|||
131526733|NCT01175824|473553562|FG001|Overall Study|Physician Decision|4|||
131526734|NCT01175824|473553561|FG000|Overall Study|Protocol Violation|2|||
131526735|NCT01175824|473553562|FG001|Overall Study|Protocol Violation|5|||
131526736|NCT01175824|473553561|FG000|Overall Study|Withdrawal by Subject|3|||
131526737|NCT01175824|473553562|FG001|Overall Study|Withdrawal by Subject|7|||
131526738|NCT01175824|473553561|FG000|Overall Study|Sponsor Decision|1|||
131526739|NCT01175824|473553562|FG001|Overall Study|Sponsor Decision|0|||
131526740|NCT01175824|473553561|FG000|Overall Study|Entry Criteria Not Met|6|||
131526741|NCT01175824|473553562|FG001|Overall Study|Entry Criteria Not Met|4|||
131526742|NCT04820673|473553563|FG000|Overall Study|Adverse Event|6|||
131526743|NCT04820673|473553563|FG000|Overall Study|Due to Lack of Effectiveness|1|||
131526744|NCT04820673|473553563|FG000|Overall Study|Pregnancy|1|||
131526745|NCT04820673|473553563|FG000|Overall Study|Voluntary Withdrawal|20|||
131526746|NCT04820673|473553563|FG000|Overall Study|Lost to Follow-up|10|||
131526747|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
131526748|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
131526749|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
131526750|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131526751|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131526752|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131526753|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131526754|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131526755|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131526756|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
131526757|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
131526758|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
131526759|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131526760|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131526761|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131526762|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131526763|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131526764|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131526765|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526766|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
131526767|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
131526768|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526769|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526770|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526771|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526772|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526773|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131526774|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
131526775|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
131526776|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
131526777|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131526778|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131526779|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131526780|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131526781|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131526782|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131526783|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526784|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
131526785|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526786|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526787|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526788|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526789|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526790|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526791|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
131526792|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
131526793|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131653848|NCT03307785|474018491|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
131526794|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526795|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526796|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526797|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526798|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526799|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526800|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131526801|NCT01172938|473553564|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526802|NCT01172938|473553565|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
131526803|NCT01172938|473553566|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
131526804|NCT01172938|473553567|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526805|NCT01172938|473553568|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526806|NCT01172938|473553569|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526807|NCT01172938|473553570|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526808|NCT01172938|473553571|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526809|NCT01172938|473553572|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
131526810|NCT01172938|473553564|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
131526811|NCT01172938|473553565|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
131526812|NCT01172938|473553566|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
131526813|NCT01172938|473553567|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
131526814|NCT01172938|473553568|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
131526815|NCT01172938|473553569|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
131526816|NCT01172938|473553570|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
131526817|NCT01172938|473553571|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
131526818|NCT01172938|473553572|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
131526819|NCT01172938|473553564|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
131526820|NCT01172938|473553565|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
131526821|NCT01172938|473553566|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
131526822|NCT01172938|473553567|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
131526823|NCT01172938|473553568|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
131526824|NCT01172938|473553569|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
131526825|NCT01172938|473553570|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
131526826|NCT01172938|473553571|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
131526827|NCT01172938|473553572|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
131526828|NCT01172938|473553564|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526829|NCT01172938|473553565|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526830|NCT01172938|473553566|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
131526831|NCT01172938|473553567|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526832|NCT01172938|473553568|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526833|NCT01172938|473553569|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526834|NCT01172938|473553570|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526835|NCT01172938|473553571|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526836|NCT01172938|473553572|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
131526837|NCT01172938|473553564|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
131526838|NCT01172938|473553565|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
131526839|NCT01172938|473553566|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
131526840|NCT01172938|473553567|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
131526841|NCT01172938|473553568|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
131526842|NCT01172938|473553569|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
131526843|NCT01172938|473553570|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
131526844|NCT01172938|473553571|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
131526845|NCT01172938|473553572|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
131526846|NCT01172938|473553564|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
131526847|NCT01172938|473553565|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
131526848|NCT01172938|473553566|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
131526849|NCT01172938|473553567|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
131526850|NCT01172938|473553568|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
131526851|NCT01172938|473553569|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
131526852|NCT01172938|473553570|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
131526853|NCT01172938|473553571|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
131526854|NCT01172938|473553572|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
131526855|NCT01172938|473553564|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
131526856|NCT01172938|473553565|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
131526857|NCT01172938|473553566|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
131658434|NCT01531673|474035308|FG009|Overall Study|Other|1|||
131526858|NCT01172938|473553567|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
131526859|NCT01172938|473553568|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
131526860|NCT01172938|473553569|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
131526861|NCT01172938|473553570|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
131526862|NCT01172938|473553571|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
131526863|NCT01172938|473553572|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
131526864|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
131526865|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
131526866|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
131526867|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
131526868|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
131526869|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
131526870|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
131526871|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
131526872|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
131526873|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
131526874|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
131526875|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
131526876|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
131526877|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
131526878|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
131526879|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
131526880|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
131526881|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
131526882|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526883|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526884|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
131526885|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526886|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526887|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526888|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526889|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526890|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
131526891|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
131526892|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
131526893|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
131526894|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
131526895|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
131526896|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
131526897|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
131526898|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
131526899|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
131526900|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526901|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526902|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
131526903|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526904|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526905|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526906|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526907|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526908|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
131526909|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
131526910|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
131526911|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
131526912|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
131526913|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
131526914|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
131526915|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
131526916|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
131526917|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
131526918|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526919|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
131526920|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526921|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526922|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526923|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526924|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526925|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
131526926|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
131526927|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526928|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
131526929|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526930|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526931|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526932|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526933|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526934|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526935|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131526936|NCT01172938|473553564|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526937|NCT01172938|473553565|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526938|NCT01172938|473553566|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526939|NCT01172938|473553567|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526940|NCT01172938|473553568|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526941|NCT01172938|473553569|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526942|NCT01172938|473553570|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526943|NCT01172938|473553571|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
131526944|NCT01172938|473553572|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
131526945|NCT01172938|473553564|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
131526946|NCT01172938|473553565|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
131526947|NCT01172938|473553566|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
131526948|NCT01172938|473553567|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
131526949|NCT01172938|473553568|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
131526950|NCT01172938|473553569|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
131526951|NCT01172938|473553570|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
131526952|NCT01172938|473553571|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
131526953|NCT01172938|473553572|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
131526954|NCT01172938|473553564|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
131526955|NCT01172938|473553565|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
131526956|NCT01172938|473553566|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
131526957|NCT01172938|473553567|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
131526958|NCT01172938|473553568|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
131526959|NCT01172938|473553569|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
131526960|NCT01172938|473553570|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
131526961|NCT01172938|473553571|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
131526962|NCT01172938|473553572|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
131526963|NCT01172938|473553564|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526964|NCT01172938|473553565|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526965|NCT01172938|473553566|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526966|NCT01172938|473553567|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526967|NCT01172938|473553568|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526968|NCT01172938|473553569|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526969|NCT01172938|473553570|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526970|NCT01172938|473553571|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
131526971|NCT01172938|473553572|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
131526972|NCT01172938|473553564|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526973|NCT01172938|473553565|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
131526974|NCT01172938|473553566|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526975|NCT01172938|473553567|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526976|NCT01172938|473553568|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526977|NCT01172938|473553569|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526978|NCT01172938|473553570|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526979|NCT01172938|473553571|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526980|NCT01172938|473553572|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
131526981|NCT01172938|473553564|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526982|NCT01172938|473553565|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526983|NCT01172938|473553566|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
131526984|NCT01172938|473553567|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526985|NCT01172938|473553568|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526986|NCT01172938|473553569|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526987|NCT01172938|473553570|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526988|NCT01172938|473553571|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526989|NCT01172938|473553572|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
131526990|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
131526991|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
131526992|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
131526993|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
131526994|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
131526995|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
131526996|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
131526997|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
131526998|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
131526999|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
131527000|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
131527001|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
131527002|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
131527003|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
131527004|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
131527005|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
131527006|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
131527007|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
131527008|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131527009|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
131527010|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
131527011|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131527012|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131527013|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131527014|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131527015|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
131527016|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
131527017|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527018|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527019|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
131527020|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527021|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527022|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527023|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527024|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
131527025|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
131527026|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527027|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527028|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527029|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527030|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527031|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527032|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527033|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
131527034|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
131527035|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
131527036|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
131527037|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
131527038|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
131527039|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
131527040|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
131527041|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
131527042|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
131527043|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
131527044|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527045|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527046|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
131527047|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527048|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527049|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527050|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527051|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527052|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
131527053|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527054|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
131527055|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527056|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527057|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527058|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527059|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527060|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
131527061|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
131527062|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
131527063|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
131527064|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
131527065|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
131527066|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
131527067|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
131527068|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
131527069|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
131527070|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
131527071|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527072|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527073|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
131527074|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527075|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527076|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527077|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527078|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527079|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
131527080|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527081|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527082|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
131527083|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527084|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527085|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527086|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527087|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527088|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131527089|NCT01172938|473553564|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527090|NCT01172938|473553565|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527091|NCT01172938|473553566|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527092|NCT01172938|473553567|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527093|NCT01172938|473553568|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527094|NCT01172938|473553569|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527095|NCT01172938|473553570|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527096|NCT01172938|473553571|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
131527097|NCT01172938|473553572|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
131527098|NCT00003498|473553573|FG000|Overall Study|Not evaluable.|4|||
131527099|NCT05282004|473553577|FG000|Overall Study|Adverse Event|2|||
131527100|NCT00889421|473553578|FG000|Overall Study|Lack of Efficacy|3|||
131527101|NCT01958918|473553579|FG000|Overall Study|Death|1|||
131527102|NCT01958918|473553580|FG001|Overall Study|Death|3|||
131527103|NCT01958918|473553579|FG000|Overall Study|Lost to Follow-up|4|||
131527104|NCT01958918|473553580|FG001|Overall Study|Lost to Follow-up|7|||
131527105|NCT01958918|473553579|FG000|Overall Study|Withdrawal by Subject|13|||
131527106|NCT01958918|473553580|FG001|Overall Study|Withdrawal by Subject|8|||
131527107|NCT01958918|473553579|FG000|Overall Study|Lack of Efficacy|13|||
131527108|NCT01958918|473553580|FG001|Overall Study|Lack of Efficacy|10|||
131527109|NCT01958918|473553579|FG000|Overall Study|Adverse Event|12|||
131527110|NCT01958918|473553580|FG001|Overall Study|Adverse Event|12|||
131527111|NCT01958918|473553579|FG000|Overall Study|administrative problems|0|||
131527112|NCT01958918|473553580|FG001|Overall Study|administrative problems|2|||
131527113|NCT02013765|473553584|FG000|Overall Study|Trial was terminated by sponsor|1|||
131527114|NCT00659269|473553585|FG000|Overall Study|Physician Decision|1|||
131527115|NCT00659269|473553586|FG001|Overall Study|Physician Decision|1|||
131527116|NCT01158222|473553587|FG000|Overall Study|Not eligible for intermediate phase|17|||
131527117|NCT00718042|473553588|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
131527118|NCT00718042|473553589|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
131527119|NCT00718042|473553590|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
131527120|NCT00718042|473553591|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
131527121|NCT00718042|473553592|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
131527122|NCT00718042|473553593|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
131527123|NCT00718042|473553588|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
131527124|NCT00718042|473553589|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
131527125|NCT00718042|473553590|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
131527126|NCT00718042|473553591|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
131527127|NCT00718042|473553592|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
131527128|NCT00718042|473553593|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
131527129|NCT00718042|473553588|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
131527130|NCT00718042|473553589|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
131527131|NCT00718042|473553590|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
131527132|NCT00718042|473553591|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
131527133|NCT00718042|473553592|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
131527134|NCT00718042|473553593|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
131527135|NCT00718042|473553588|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
131527136|NCT00718042|473553589|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
131527137|NCT00718042|473553590|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
131527138|NCT00718042|473553591|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
131527139|NCT00718042|473553592|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
131527140|NCT00718042|473553593|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
131527141|NCT00718042|473553588|FG000|Donor Follow-up|Lost to Follow-up|13|||
131527142|NCT00718042|473553589|FG001|Donor Follow-up|Lost to Follow-up|0|||
131527143|NCT00718042|473553590|FG002|Donor Follow-up|Lost to Follow-up|0|||
131527144|NCT00718042|473553591|FG003|Donor Follow-up|Lost to Follow-up|0|||
131527145|NCT00718042|473553592|FG004|Donor Follow-up|Lost to Follow-up|19|||
131527146|NCT00718042|473553593|FG005|Donor Follow-up|Lost to Follow-up|0|||
131527147|NCT02443298|473553594|FG000|Overall Study|Adverse Event|3|||
131527148|NCT02443298|473553595|FG001|Overall Study|Adverse Event|3|||
131527149|NCT02443298|473553594|FG000|Overall Study|Withdrawal by Subject|1|||
131527150|NCT02443298|473553595|FG001|Overall Study|Withdrawal by Subject|2|||
131527151|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
131527152|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
131527153|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
131527154|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
131527155|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
131527156|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
131527157|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
131527158|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
131527159|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
131527160|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
131527161|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
131527162|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
131527163|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
131527164|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
131527165|NCT02464969|473553596|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
131527166|NCT02464969|473553597|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
131527167|NCT02464969|473553596|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
131527168|NCT02464969|473553597|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
131527169|NCT02464969|473553596|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
131527170|NCT02464969|473553597|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
131527171|NCT02464969|473553596|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
131527172|NCT02464969|473553597|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
131527173|NCT02399085|473553602|FG000|Overall Study|Adverse Event|16|||
131527174|NCT02399085|473553602|FG000|Overall Study|Death|2|||
131527175|NCT02399085|473553602|FG000|Overall Study|Withdrawal by Subject|8|||
131527176|NCT02399085|473553602|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
131527177|NCT02399085|473553602|FG000|Overall Study|Physician Decision|5|||
131527178|NCT00833924|473553603|FG000|Overall Study|Death|21|||
131527179|NCT00833924|473553603|FG000|Overall Study|Conversion|2|||
131527180|NCT00833924|473553603|FG000|Overall Study|Lost to Follow-up|2|||
131527181|NCT00833924|473553603|FG000|Overall Study|Withdrawal by Subject|13|||
131527182|NCT00833924|473553603|FG000|Overall Study|In study follow-up|71|||
131527183|NCT03732248|473553604|FG000|Overall Study|Withdrawal by Subject|1|||
131527184|NCT03732248|473553605|FG001|Overall Study|Withdrawal by Subject|0|||
131527185|NCT01525082|473553610|FG000|Overall Study|Death|1|||
131527186|NCT02543346|473553615|FG000|Second Priming Visit|Withdrawal by Subject|0|||
131527187|NCT02543346|473553616|FG001|Second Priming Visit|Withdrawal by Subject|2|||
131527188|NCT02543346|473553617|FG002|Second Priming Visit|Withdrawal by Subject|2|||
131527189|NCT02543346|473553618|FG003|Second Priming Visit|Withdrawal by Subject|2|||
131527190|NCT02543346|473553615|FG000|Second Priming Visit|Adverse Event|1|||
131527191|NCT02543346|473553616|FG001|Second Priming Visit|Adverse Event|0|||
131527192|NCT02543346|473553617|FG002|Second Priming Visit|Adverse Event|0|||
131527193|NCT02543346|473553618|FG003|Second Priming Visit|Adverse Event|0|||
131527194|NCT01767116|473553619|FG000|Overall Study|Lost to Follow-up|2|||
131527195|NCT01767116|473553620|FG001|Overall Study|Lost to Follow-up|2|||
131527196|NCT02141516|473553625|FG000|Overall Study|Adverse Event|0|||
131527197|NCT02141516|473553626|FG001|Overall Study|Adverse Event|1|||
131527198|NCT02141516|473553627|FG002|Overall Study|Adverse Event|0|||
131527199|NCT02141516|473553625|FG000|Overall Study|Lost to Follow-up|0|||
131527200|NCT02141516|473553626|FG001|Overall Study|Lost to Follow-up|1|||
131527201|NCT02141516|473553627|FG002|Overall Study|Lost to Follow-up|0|||
131527202|NCT02141516|473553625|FG000|Overall Study|Other|0|||
131527203|NCT02141516|473553626|FG001|Overall Study|Other|3|||
131527204|NCT02141516|473553627|FG002|Overall Study|Other|0|||
131527205|NCT01440946|473553628|FG000|Overall Study|Lost to Follow-up|1|||
131527206|NCT01440946|473553629|FG001|Overall Study|Lost to Follow-up|1|||
131527207|NCT01440946|473553628|FG000|Overall Study|Physician Decision|1|||
131527208|NCT01440946|473553629|FG001|Overall Study|Physician Decision|0|||
131527209|NCT01975389|473553630|FG000|Overall Study|Adverse Event|10|||
131527210|NCT01975389|473553631|FG001|Overall Study|Adverse Event|6|||
131527211|NCT01975389|473553630|FG000|Overall Study|Death|61|||
131527212|NCT01975389|473553631|FG001|Overall Study|Death|54|||
131527213|NCT01975389|473553630|FG000|Overall Study|Lost to Follow-up|81|||
131527214|NCT01975389|473553631|FG001|Overall Study|Lost to Follow-up|86|||
131527215|NCT01975389|473553630|FG000|Overall Study|Withdrawal by Subject|90|||
131527216|NCT01975389|473553631|FG001|Overall Study|Withdrawal by Subject|76|||
131527217|NCT01975389|473553630|FG000|Overall Study|Other|6|||
131527218|NCT01975389|473553631|FG001|Overall Study|Other|9|||
131527219|NCT01975389|473553630|FG000|Overall Study|Randomized, not treated|4|||
131527220|NCT01975389|473553631|FG001|Overall Study|Randomized, not treated|5|||
131527221|NCT03299192|473553632|FG000|Overall Study|Fell before classes started|1|||
131527222|NCT03299192|473553633|FG001|Overall Study|Fell before classes started|0|||
131527223|NCT03299192|473553634|FG002|Overall Study|Fell before classes started|0|||
131527224|NCT03299192|473553632|FG000|Overall Study|Other|0|||
131527225|NCT03299192|473553633|FG001|Overall Study|Other|2|||
131527226|NCT03299192|473553634|FG002|Overall Study|Other|1|||
131527227|NCT00235989|473553640|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
131527228|NCT00235989|473553641|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
131527229|NCT00235989|473553642|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
131527230|NCT00235989|473553643|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
131527231|NCT00235989|473553644|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
131527232|NCT00235989|473553645|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
131527233|NCT00235989|473553640|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
131527234|NCT00235989|473553641|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
131527235|NCT00235989|473553642|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
131527236|NCT00235989|473553643|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
131527237|NCT00235989|473553644|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
131527238|NCT00235989|473553645|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
131527239|NCT00235989|473553640|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
131527240|NCT00235989|473553641|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
131527241|NCT00235989|473553642|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
131527242|NCT00235989|473553643|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
131527243|NCT00235989|473553644|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
131527244|NCT00235989|473553645|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
131527245|NCT00235989|473553640|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
131527246|NCT00235989|473553641|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
131527247|NCT00235989|473553642|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
131527248|NCT00235989|473553643|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
131527249|NCT00235989|473553644|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
131527250|NCT00235989|473553645|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
131527251|NCT00235989|473553640|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
131527252|NCT00235989|473553641|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
131527253|NCT00235989|473553642|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
131527254|NCT00235989|473553643|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
131527255|NCT00235989|473553644|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
131527256|NCT00235989|473553645|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
131527257|NCT00983580|473553647|FG000|Overall Study|Cancel Prior to treatment|1|||
131527258|NCT00983580|473553648|FG001|Overall Study|Cancel Prior to treatment|3|||
131527259|NCT00983580|473553647|FG000|Overall Study|Protocol Violation|1|||
131527260|NCT00983580|473553648|FG001|Overall Study|Protocol Violation|1|||
131527261|NCT00983580|473553647|FG000|Overall Study|Ineligible|3|||
131527262|NCT00983580|473553648|FG001|Overall Study|Ineligible|0|||
131527263|NCT02316717|473553653|FG000|Overall Study|Adverse Event|2|||
131527264|NCT02316717|473553654|FG001|Overall Study|Adverse Event|2|||
131527265|NCT02316717|473553655|FG002|Overall Study|Adverse Event|0|||
131527266|NCT02316717|473553653|FG000|Overall Study|Lost to Follow-up|1|||
131527267|NCT02316717|473553654|FG001|Overall Study|Lost to Follow-up|2|||
131527268|NCT02316717|473553655|FG002|Overall Study|Lost to Follow-up|1|||
131527269|NCT02316717|473553653|FG000|Overall Study|Non compliance|3|||
131527270|NCT02316717|473553654|FG001|Overall Study|Non compliance|1|||
131527271|NCT02316717|473553655|FG002|Overall Study|Non compliance|0|||
131527272|NCT02316717|473553653|FG000|Overall Study|Protocol Violation|2|||
131527273|NCT02316717|473553654|FG001|Overall Study|Protocol Violation|0|||
131527274|NCT02316717|473553655|FG002|Overall Study|Protocol Violation|0|||
131527275|NCT02316717|473553653|FG000|Overall Study|Withdrawal by Subject|2|||
131527276|NCT02316717|473553654|FG001|Overall Study|Withdrawal by Subject|1|||
131527277|NCT02316717|473553655|FG002|Overall Study|Withdrawal by Subject|1|||
131527278|NCT02316717|473553653|FG000|Overall Study|Death|0|||
131527279|NCT02316717|473553654|FG001|Overall Study|Death|0|||
131527280|NCT02316717|473553655|FG002|Overall Study|Death|1|||
131527281|NCT02316717|473553653|FG000|Overall Study|Physician Decision|0|||
131527282|NCT02316717|473553654|FG001|Overall Study|Physician Decision|1|||
131527283|NCT02316717|473553655|FG002|Overall Study|Physician Decision|0|||
131527284|NCT02316717|473553653|FG000|Overall Study|TBC|1|||
131527285|NCT02316717|473553654|FG001|Overall Study|TBC|0|||
131527286|NCT02316717|473553655|FG002|Overall Study|TBC|0|||
131527287|NCT00298831|473553656|FG000|Overall Study|Adverse Event|1|||
131527288|NCT00298831|473553656|FG000|Overall Study|Lost to Follow-up|3|||
131527289|NCT00298831|473553656|FG000|Overall Study|Withdrawal by Subject|1|||
131527290|NCT00298831|473553656|FG000|Overall Study|Participants did not receive treatment|27|||
131527291|NCT04122443|473553657|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
131527292|NCT04122443|473553658|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
131527293|NCT04122443|473553659|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
131527294|NCT04122443|473553657|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
131527295|NCT04122443|473553658|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
131527296|NCT04122443|473553659|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
131527297|NCT01072201|473553660|FG000|Overall Study|Lost to Follow-up|0|||
131527298|NCT01072201|473553661|FG001|Overall Study|Lost to Follow-up|1|||
131527299|NCT00360334|473553662|FG000|Overall Study|Adverse Event|7|||
131527300|NCT00360334|473553663|FG001|Overall Study|Adverse Event|4|||
131527301|NCT00360334|473553662|FG000|Overall Study|Protocol Violation|1|||
131527302|NCT00360334|473553663|FG001|Overall Study|Protocol Violation|1|||
131527303|NCT00360334|473553662|FG000|Overall Study|Physician Decision|2|||
131527304|NCT00360334|473553663|FG001|Overall Study|Physician Decision|3|||
131527305|NCT00360334|473553662|FG000|Overall Study|Lack of Efficacy|0|||
131527306|NCT00360334|473553663|FG001|Overall Study|Lack of Efficacy|1|||
131527307|NCT00360334|473553662|FG000|Overall Study|Entry criterion not met|1|||
131527308|NCT00360334|473553663|FG001|Overall Study|Entry criterion not met|2|||
131527309|NCT00360334|473553662|FG000|Overall Study|Subject decision|8|||
131527310|NCT00360334|473553663|FG001|Overall Study|Subject decision|2|||
131527311|NCT00595582|473553664|FG000|Overall Study|Pilot study that PI terminated|2|||
131527312|NCT00595582|473553664|FG000|Overall Study|Lost to Follow-up|1|||
131527313|NCT00595582|473553664|FG000|Overall Study|Adverse Event|2|||
131527314|NCT00595582|473553664|FG000|Overall Study|Physician Decision|5|||
131527315|NCT01978184|473553665|FG000|Overall Study|Progressive disease|5|||
131527316|NCT01978184|473553666|FG001|Overall Study|Progressive disease|5|||
131527317|NCT01978184|473553665|FG000|Overall Study|Other than PDA|2|||
131527318|NCT01978184|473553666|FG001|Overall Study|Other than PDA|2|||
131527319|NCT01978184|473553665|FG000|Overall Study|Physician Decision|0|||
131527320|NCT01978184|473553666|FG001|Overall Study|Physician Decision|3|||
131527321|NCT01978184|473553665|FG000|Overall Study|Noncompliance|1|||
131527322|NCT01978184|473553666|FG001|Overall Study|Noncompliance|2|||
131527323|NCT01978184|473553665|FG000|Overall Study|Death|1|||
131527324|NCT01978184|473553666|FG001|Overall Study|Death|0|||
131527325|NCT01978184|473553665|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
131527326|NCT01978184|473553666|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
131527327|NCT00691210|473553671|FG000|Overall Study|Progression of Disease|0|||
131527328|NCT00691210|473553672|FG001|Overall Study|Progression of Disease|0|||
131527329|NCT00691210|473553673|FG002|Overall Study|Progression of Disease|0|||
131527330|NCT00691210|473553674|FG003|Overall Study|Progression of Disease|2|||
131527331|NCT00691210|473553675|FG004|Overall Study|Progression of Disease|0|||
131527332|NCT00691210|473553676|FG005|Overall Study|Progression of Disease|0|||
131527333|NCT00691210|473553677|FG006|Overall Study|Progression of Disease|0|||
131527334|NCT00691210|473553678|FG007|Overall Study|Progression of Disease|0|||
131527335|NCT00691210|473553671|FG000|Overall Study|Lack of Efficacy|0|||
131527336|NCT00691210|473553672|FG001|Overall Study|Lack of Efficacy|0|||
131527337|NCT00691210|473553673|FG002|Overall Study|Lack of Efficacy|0|||
131527338|NCT00691210|473553674|FG003|Overall Study|Lack of Efficacy|1|||
131527339|NCT00691210|473553675|FG004|Overall Study|Lack of Efficacy|0|||
131527340|NCT00691210|473553676|FG005|Overall Study|Lack of Efficacy|1|||
131527341|NCT00691210|473553677|FG006|Overall Study|Lack of Efficacy|0|||
131527342|NCT00691210|473553678|FG007|Overall Study|Lack of Efficacy|0|||
131527343|NCT01306617|473553680|FG000|Overall Study|Adverse Event|1|||
131527344|NCT01306617|473553681|FG001|Overall Study|Adverse Event|0|||
131527345|NCT01306617|473553682|FG002|Overall Study|Adverse Event|0|||
131527346|NCT01306617|473553680|FG000|Overall Study|Virologic Failure|0|||
131527347|NCT01306617|473553681|FG001|Overall Study|Virologic Failure|0|||
131527348|NCT01306617|473553682|FG002|Overall Study|Virologic Failure|5|||
131527349|NCT01306617|473553680|FG000|Overall Study|Non-compliance|0|||
131527350|NCT01306617|473553681|FG001|Overall Study|Non-compliance|1|||
131527351|NCT01306617|473553682|FG002|Overall Study|Non-compliance|0|||
131527352|NCT00555438|473553688|FG000|10 Days Post-operative|Death|4|||
131527353|NCT00555438|473553688|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
131527354|NCT00061048|473553689|FG000|Overall Study|Adverse Event|2|||
131527355|NCT00061048|473553689|FG000|Overall Study|disease progression|20|||
131527356|NCT01431508|473553690|FG000|Overall Study|Lack of Efficacy|1|||
131527357|NCT01431508|473553690|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
131527358|NCT00129259|473553691|FG000|Overall Study|Lost to Follow-up|1|||
131527359|NCT00129259|473553692|FG001|Overall Study|Lost to Follow-up|1|||
131527360|NCT00129259|473553691|FG000|Overall Study|Withdrawal by Subject|2|||
131527361|NCT00129259|473553692|FG001|Overall Study|Withdrawal by Subject|1|||
131527362|NCT00129259|473553691|FG000|Overall Study|Only available minimal phone assessments|0|||
131527363|NCT00129259|473553692|FG001|Overall Study|Only available minimal phone assessments|1|||
131527364|NCT00023452|473553694|FG000|Overall Study|Ineligible for Study|163|||
131527365|NCT00023452|473553695|FG001|Overall Study|Ineligible for Study|159|||
131527366|NCT00023452|473553694|FG000|Overall Study|Out of Window|129|||
131527367|NCT00023452|473553695|FG001|Overall Study|Out of Window|69|||
131527368|NCT00023452|473553694|FG000|Overall Study|Death|2|||
131527369|NCT00023452|473553695|FG001|Overall Study|Death|0|||
131527370|NCT00023452|473553694|FG000|Overall Study|Withdrawal by Subject|66|||
131527371|NCT00023452|473553695|FG001|Overall Study|Withdrawal by Subject|54|||
131527372|NCT00023452|473553694|FG000|Overall Study|Adverse Event|139|||
131527373|NCT00023452|473553695|FG001|Overall Study|Adverse Event|196|||
131527374|NCT00023452|473553694|FG000|Overall Study|Lost to Follow-up|293|||
131527375|NCT00023452|473553695|FG001|Overall Study|Lost to Follow-up|60|||
131527376|NCT00023452|473553694|FG000|Overall Study|Physician Decision|49|||
131527377|NCT00023452|473553695|FG001|Overall Study|Physician Decision|21|||
131527378|NCT00023452|473553694|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
131527379|NCT00023452|473553695|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
131527380|NCT00023452|473553694|FG000|Overall Study|Pregnant|53|||
131527381|NCT00023452|473553695|FG001|Overall Study|Pregnant|20|||
131527382|NCT00023452|473553694|FG000|Overall Study|Other|204|||
131527383|NCT00023452|473553695|FG001|Overall Study|Other|69|||
131527384|NCT05789875|473553696|FG000|Overall Study|Lost to Follow-up|6|||
131527385|NCT01940705|473553698|FG000|Overall Study|Lost to Follow-up|1|||
131527386|NCT01940705|473553699|FG001|Overall Study|Lost to Follow-up|3|||
131527387|NCT01940705|473553700|FG002|Overall Study|Lost to Follow-up|2|||
131527388|NCT01940705|473553701|FG003|Overall Study|Lost to Follow-up|2|||
131527389|NCT01940705|473553698|FG000|Overall Study|Withdrawal by Subject|2|||
131527390|NCT01940705|473553699|FG001|Overall Study|Withdrawal by Subject|2|||
131527391|NCT01940705|473553700|FG002|Overall Study|Withdrawal by Subject|3|||
131527392|NCT01940705|473553701|FG003|Overall Study|Withdrawal by Subject|2|||
131527393|NCT01940705|473553698|FG000|Overall Study|Intervention not given|0|||
131527394|NCT01940705|473553699|FG001|Overall Study|Intervention not given|3|||
131527395|NCT01940705|473553700|FG002|Overall Study|Intervention not given|3|||
131527396|NCT01940705|473553701|FG003|Overall Study|Intervention not given|0|||
131527397|NCT01940705|473553698|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
131527398|NCT01940705|473553699|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
131527399|NCT01940705|473553700|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
131527400|NCT01940705|473553701|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
131527401|NCT01632579|473553702|FG000|Washout Period|Adverse Event|1|||
131527402|NCT01632579|473553703|FG001|Washout Period|Adverse Event|0|||
131527403|NCT01632579|473553704|FG002|Washout Period|Adverse Event|0|||
131527404|NCT01632579|473553705|FG003|Washout Period|Adverse Event|0|||
131527405|NCT01632579|473553706|FG004|Washout Period|Adverse Event|0|||
131527406|NCT01632579|473553707|FG005|Washout Period|Adverse Event|0|||
131527407|NCT01632579|473553708|FG006|Washout Period|Adverse Event|0|||
131527408|NCT01632579|473553709|FG007|Washout Period|Adverse Event|0|||
131527409|NCT01632579|473553710|FG008|Washout Period|Adverse Event|0|||
131527410|NCT01632579|473553702|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
131527411|NCT01632579|473553703|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
131527412|NCT01632579|473553704|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
131527413|NCT01632579|473553705|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
131527414|NCT01632579|473553706|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
131527415|NCT01632579|473553707|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
131527416|NCT01632579|473553708|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
131527417|NCT01632579|473553709|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
131527418|NCT01632579|473553710|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
131527419|NCT03779841|473553711|FG000|Randomized Population|Did Not Receive Treatment|3|||
131527420|NCT03779841|473553712|FG001|Randomized Population|Did Not Receive Treatment|1|||
131527421|NCT03779841|473553713|FG002|Randomized Population|Did Not Receive Treatment|0|||
131527422|NCT03779841|473553711|FG000|Treated (Safety) Population|Adverse Event|1|||
131527423|NCT03779841|473553712|FG001|Treated (Safety) Population|Adverse Event|1|||
131527424|NCT03779841|473553713|FG002|Treated (Safety) Population|Adverse Event|0|||
131527425|NCT03779841|473553711|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
131527426|NCT03779841|473553712|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
131527427|NCT03779841|473553713|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
131527428|NCT03779841|473553711|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
131527429|NCT03779841|473553712|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
131527430|NCT03779841|473553713|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
131527431|NCT03779841|473553711|FG000|Treated (Safety) Population|Death|1|||
131527432|NCT03779841|473553712|FG001|Treated (Safety) Population|Death|0|||
131527433|NCT03779841|473553713|FG002|Treated (Safety) Population|Death|2|||
131527434|NCT02788175|473553714|FG000|Overall Study|Protocol Violation|3|||
131527435|NCT02788175|473553714|FG000|Overall Study|Withdrawal by Subject|4|||
131527436|NCT02788175|473553714|FG000|Overall Study|Ineligible prior to study agent|6|||
131527437|NCT03403634|473553719|FG000|Overall Study|Disease progression|3|||
131527438|NCT03403634|473553719|FG000|Overall Study|Did not meet eligibility criteria|4|||
131527439|NCT01043874|473556069|FG000|Overall Study|Adverse Event|3|||
131527440|NCT01043874|473556069|FG000|Overall Study|Withdrawal by Subject|1|||
131527441|NCT01043874|473556069|FG000|Overall Study|Lack of Efficacy|1|||
131527442|NCT01043874|473556069|FG000|Overall Study|Administrative Problems|1|||
131527443|NCT03422003|473556070|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
131527444|NCT03422003|473556071|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
131527445|NCT03422003|473556070|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
131527446|NCT03422003|473556071|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
131527447|NCT00966940|473556072|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
131527448|NCT00966940|473556073|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
131527449|NCT00966940|473556072|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
131527450|NCT00966940|473556073|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
131527451|NCT02696850|473556076|FG000|Overall Study|Withdrawal by Subject|3|||
131527452|NCT02696850|473556077|FG001|Overall Study|Withdrawal by Subject|3|||
131527453|NCT02696850|473556076|FG000|Overall Study|Lost to Follow-up|8|||
131527454|NCT02696850|473556077|FG001|Overall Study|Lost to Follow-up|5|||
131527455|NCT03455855|473556078|FG000|Overall Study|Lost to Follow-up|4|||
131527456|NCT03455855|473556079|FG001|Overall Study|Lost to Follow-up|2|||
131527457|NCT00767000|473556086|FG000|54-week Study|Adverse Event|4|||
131527458|NCT00767000|473556087|FG001|54-week Study|Adverse Event|6|||
131527459|NCT00767000|473556088|FG002|54-week Study|Adverse Event|6|||
131527460|NCT00767000|473556089|FG003|54-week Study|Adverse Event|8|||
131527461|NCT00767000|473556090|FG004|54-week Study|Adverse Event|4|||
131527462|NCT00767000|473556086|FG000|54-week Study|Creaninine/creatinine clearance|2|||
131527463|NCT00767000|473556087|FG001|54-week Study|Creaninine/creatinine clearance|1|||
131527464|NCT00767000|473556088|FG002|54-week Study|Creaninine/creatinine clearance|2|||
131527465|NCT00767000|473556089|FG003|54-week Study|Creaninine/creatinine clearance|2|||
131527466|NCT00767000|473556090|FG004|54-week Study|Creaninine/creatinine clearance|4|||
131527467|NCT00767000|473556086|FG000|54-week Study|Hyperglycemia|0|||
131527468|NCT00767000|473556087|FG001|54-week Study|Hyperglycemia|0|||
131527469|NCT00767000|473556088|FG002|54-week Study|Hyperglycemia|1|||
131527470|NCT00767000|473556089|FG003|54-week Study|Hyperglycemia|0|||
131527471|NCT00767000|473556090|FG004|54-week Study|Hyperglycemia|1|||
131527472|NCT00767000|473556086|FG000|54-week Study|Hypoglycemia|0|||
131527473|NCT00767000|473556087|FG001|54-week Study|Hypoglycemia|1|||
131527474|NCT00767000|473556088|FG002|54-week Study|Hypoglycemia|0|||
131527475|NCT00767000|473556089|FG003|54-week Study|Hypoglycemia|0|||
131527476|NCT00767000|473556090|FG004|54-week Study|Hypoglycemia|0|||
131527477|NCT00767000|473556086|FG000|54-week Study|Interruption of study medication|0|||
131527478|NCT00767000|473556087|FG001|54-week Study|Interruption of study medication|0|||
131527479|NCT00767000|473556088|FG002|54-week Study|Interruption of study medication|1|||
131527480|NCT00767000|473556089|FG003|54-week Study|Interruption of study medication|0|||
131527481|NCT00767000|473556090|FG004|54-week Study|Interruption of study medication|0|||
131527482|NCT00767000|473556086|FG000|54-week Study|Lack of Efficacy|2|||
131527483|NCT00767000|473556087|FG001|54-week Study|Lack of Efficacy|0|||
131527484|NCT00767000|473556088|FG002|54-week Study|Lack of Efficacy|1|||
131527485|NCT00767000|473556089|FG003|54-week Study|Lack of Efficacy|0|||
131527486|NCT00767000|473556090|FG004|54-week Study|Lack of Efficacy|5|||
131527487|NCT00767000|473556086|FG000|54-week Study|Lost to Follow-up|4|||
131527488|NCT00767000|473556087|FG001|54-week Study|Lost to Follow-up|0|||
131527489|NCT00767000|473556088|FG002|54-week Study|Lost to Follow-up|1|||
131527490|NCT00767000|473556089|FG003|54-week Study|Lost to Follow-up|4|||
131527491|NCT00767000|473556090|FG004|54-week Study|Lost to Follow-up|2|||
131527492|NCT00767000|473556086|FG000|54-week Study|Physician Decision|4|||
131527493|NCT00767000|473556087|FG001|54-week Study|Physician Decision|0|||
131527494|NCT00767000|473556088|FG002|54-week Study|Physician Decision|1|||
131527495|NCT00767000|473556089|FG003|54-week Study|Physician Decision|1|||
131527496|NCT00767000|473556090|FG004|54-week Study|Physician Decision|1|||
131527497|NCT00767000|473556086|FG000|54-week Study|Progressive disease|0|||
131527498|NCT00767000|473556087|FG001|54-week Study|Progressive disease|0|||
131527499|NCT00767000|473556088|FG002|54-week Study|Progressive disease|1|||
131527500|NCT00767000|473556089|FG003|54-week Study|Progressive disease|0|||
131527501|NCT00767000|473556090|FG004|54-week Study|Progressive disease|0|||
131527502|NCT00767000|473556086|FG000|54-week Study|Protocol Violation|0|||
131527503|NCT00767000|473556087|FG001|54-week Study|Protocol Violation|0|||
131527504|NCT00767000|473556088|FG002|54-week Study|Protocol Violation|1|||
131527505|NCT00767000|473556089|FG003|54-week Study|Protocol Violation|2|||
131527506|NCT00767000|473556090|FG004|54-week Study|Protocol Violation|0|||
131527507|NCT00767000|473556086|FG000|54-week Study|Withdrawal by Subject|2|||
131527508|NCT00767000|473556087|FG001|54-week Study|Withdrawal by Subject|3|||
131527509|NCT00767000|473556088|FG002|54-week Study|Withdrawal by Subject|5|||
131527510|NCT00767000|473556089|FG003|54-week Study|Withdrawal by Subject|11|||
131527511|NCT00767000|473556090|FG004|54-week Study|Withdrawal by Subject|13|||
131527512|NCT00767000|473556086|FG000|54-week Study|Study terminated by sponsor|90|||
131527513|NCT00767000|473556087|FG001|54-week Study|Study terminated by sponsor|102|||
131527514|NCT00767000|473556088|FG002|54-week Study|Study terminated by sponsor|89|||
131527515|NCT00767000|473556089|FG003|54-week Study|Study terminated by sponsor|196|||
131527516|NCT00767000|473556090|FG004|54-week Study|Study terminated by sponsor|194|||
131527517|NCT00767000|473556086|FG000|54-week Study|Reason not reported|0|||
131527518|NCT00767000|473556087|FG001|54-week Study|Reason not reported|0|||
131527519|NCT00767000|473556088|FG002|54-week Study|Reason not reported|0|||
131527520|NCT00767000|473556089|FG003|54-week Study|Reason not reported|1|||
131527521|NCT00767000|473556090|FG004|54-week Study|Reason not reported|0|||
131527522|NCT00767000|473556086|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
131527523|NCT00767000|473556087|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
131527524|NCT00767000|473556088|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
131527525|NCT00767000|473556089|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
131527526|NCT00767000|473556090|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
131527527|NCT02530619|473556091|FG000|Registered for Study|Withdrawal by Subject|2|||
131527528|NCT02530619|473556091|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
131527529|NCT02530619|473556091|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
131527530|NCT02530619|473556091|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
131527531|NCT02530619|473556091|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
131527532|NCT02530619|473556091|FG000|Follow-up Period (6 Months)|Death|4|||
131527533|NCT02530619|473556091|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
131527534|NCT02530619|473556091|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
131527535|NCT00009737|473556093|FG000|Overall Study|Adverse Event|112|||
131527536|NCT00009737|473556094|FG001|Overall Study|Adverse Event|75|||
131527537|NCT00009737|473556093|FG000|Overall Study|Death|4|||
131527538|NCT00009737|473556094|FG001|Overall Study|Death|6|||
131527539|NCT00009737|473556093|FG000|Overall Study|Lack of Efficacy|17|||
131527540|NCT00009737|473556094|FG001|Overall Study|Lack of Efficacy|15|||
131527541|NCT00009737|473556093|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
131527542|NCT00009737|473556094|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
131527543|NCT00009737|473556093|FG000|Overall Study|Other Protocol Violation|1|||
131527544|NCT00009737|473556094|FG001|Overall Study|Other Protocol Violation|0|||
131527545|NCT00009737|473556093|FG000|Overall Study|Refused Treatment|15|||
131527546|NCT00009737|473556094|FG001|Overall Study|Refused Treatment|16|||
131527547|NCT00009737|473556093|FG000|Overall Study|Lost to Follow-up|1|||
131527548|NCT00009737|473556094|FG001|Overall Study|Lost to Follow-up|1|||
131527549|NCT00009737|473556093|FG000|Overall Study|Administrative/Other Reasons|7|||
131527550|NCT00009737|473556094|FG001|Overall Study|Administrative/Other Reasons|1|||
131527551|NCT01163682|473556098|FG000|Overall Study|Lost to Follow-up|6|||
131527552|NCT01163682|473556099|FG001|Overall Study|Lost to Follow-up|9|||
131527553|NCT00359762|473556102|FG000|Period II|Adverse Event|17|||
131527554|NCT00359762|473556103|FG001|Period II|Adverse Event|0|||
131527555|NCT00359762|473556104|FG002|Period II|Adverse Event|0|||
131527556|NCT00359762|473556105|FG003|Period II|Adverse Event|0|||
131527557|NCT00359762|473556106|FG004|Period II|Adverse Event|49|||
131527558|NCT00359762|473556102|FG000|Period II|Protocol Violation|18|||
131527559|NCT00359762|473556103|FG001|Period II|Protocol Violation|0|||
131527560|NCT00359762|473556104|FG002|Period II|Protocol Violation|0|||
131527561|NCT00359762|473556105|FG003|Period II|Protocol Violation|0|||
131527562|NCT00359762|473556106|FG004|Period II|Protocol Violation|11|||
131527563|NCT00359762|473556102|FG000|Period II|Physician Decision|17|||
131527564|NCT00359762|473556103|FG001|Period II|Physician Decision|0|||
131527565|NCT00359762|473556104|FG002|Period II|Physician Decision|0|||
131527566|NCT00359762|473556105|FG003|Period II|Physician Decision|0|||
131527567|NCT00359762|473556106|FG004|Period II|Physician Decision|23|||
131527568|NCT00359762|473556102|FG000|Period II|Death|2|||
131527569|NCT00359762|473556103|FG001|Period II|Death|0|||
131527570|NCT00359762|473556104|FG002|Period II|Death|0|||
131527571|NCT00359762|473556105|FG003|Period II|Death|0|||
131527572|NCT00359762|473556106|FG004|Period II|Death|4|||
131653849|NCT03307785|474018492|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
131527573|NCT00359762|473556102|FG000|Period II|Lack of Efficacy|11|||
131527574|NCT00359762|473556103|FG001|Period II|Lack of Efficacy|0|||
131527575|NCT00359762|473556104|FG002|Period II|Lack of Efficacy|0|||
131527576|NCT00359762|473556105|FG003|Period II|Lack of Efficacy|0|||
131527577|NCT00359762|473556106|FG004|Period II|Lack of Efficacy|8|||
131527578|NCT00359762|473556102|FG000|Period II|Lost to follow up|5|||
131527579|NCT00359762|473556103|FG001|Period II|Lost to follow up|0|||
131527580|NCT00359762|473556104|FG002|Period II|Lost to follow up|0|||
131527581|NCT00359762|473556105|FG003|Period II|Lost to follow up|0|||
131527582|NCT00359762|473556106|FG004|Period II|Lost to follow up|5|||
131527583|NCT00359762|473556102|FG000|Period II|Entry Criteria Not Met|8|||
131527584|NCT00359762|473556103|FG001|Period II|Entry Criteria Not Met|0|||
131527585|NCT00359762|473556104|FG002|Period II|Entry Criteria Not Met|0|||
131527586|NCT00359762|473556105|FG003|Period II|Entry Criteria Not Met|0|||
131527587|NCT00359762|473556106|FG004|Period II|Entry Criteria Not Met|4|||
131527588|NCT00359762|473556102|FG000|Period II|Subject Decision|50|||
131527589|NCT00359762|473556103|FG001|Period II|Subject Decision|0|||
131527590|NCT00359762|473556104|FG002|Period II|Subject Decision|0|||
131527591|NCT00359762|473556105|FG003|Period II|Subject Decision|0|||
131527592|NCT00359762|473556106|FG004|Period II|Subject Decision|70|||
131527593|NCT00359762|473556102|FG000|Period III|Protocol Violation|0|||
131527594|NCT00359762|473556103|FG001|Period III|Protocol Violation|5|||
131527595|NCT00359762|473556104|FG002|Period III|Protocol Violation|3|||
131527596|NCT00359762|473556105|FG003|Period III|Protocol Violation|8|||
131527597|NCT00359762|473556106|FG004|Period III|Protocol Violation|0|||
131527598|NCT00359762|473556102|FG000|Period III|Adverse Event|0|||
131527599|NCT00359762|473556103|FG001|Period III|Adverse Event|3|||
131527600|NCT00359762|473556104|FG002|Period III|Adverse Event|4|||
131527601|NCT00359762|473556105|FG003|Period III|Adverse Event|10|||
131527602|NCT00359762|473556106|FG004|Period III|Adverse Event|0|||
131527603|NCT00359762|473556102|FG000|Period III|Physician Decision|0|||
131527604|NCT00359762|473556103|FG001|Period III|Physician Decision|5|||
131527605|NCT00359762|473556104|FG002|Period III|Physician Decision|9|||
131527606|NCT00359762|473556105|FG003|Period III|Physician Decision|15|||
131527607|NCT00359762|473556106|FG004|Period III|Physician Decision|0|||
131527608|NCT00359762|473556102|FG000|Period III|Lack of Efficacy|0|||
131527609|NCT00359762|473556103|FG001|Period III|Lack of Efficacy|7|||
131527610|NCT00359762|473556104|FG002|Period III|Lack of Efficacy|5|||
131527611|NCT00359762|473556105|FG003|Period III|Lack of Efficacy|9|||
131527612|NCT00359762|473556106|FG004|Period III|Lack of Efficacy|0|||
131527613|NCT00359762|473556102|FG000|Period III|Lost to follow up|0|||
131527614|NCT00359762|473556103|FG001|Period III|Lost to follow up|1|||
131527615|NCT00359762|473556104|FG002|Period III|Lost to follow up|1|||
131527616|NCT00359762|473556105|FG003|Period III|Lost to follow up|2|||
131527617|NCT00359762|473556106|FG004|Period III|Lost to follow up|0|||
131527618|NCT00359762|473556102|FG000|Period III|Entry Criteria Not Met|0|||
131527619|NCT00359762|473556103|FG001|Period III|Entry Criteria Not Met|1|||
131527620|NCT00359762|473556104|FG002|Period III|Entry Criteria Not Met|0|||
131527621|NCT00359762|473556105|FG003|Period III|Entry Criteria Not Met|1|||
131527622|NCT00359762|473556106|FG004|Period III|Entry Criteria Not Met|0|||
131527623|NCT00359762|473556102|FG000|Period III|Subject Decision|0|||
131527624|NCT00359762|473556103|FG001|Period III|Subject Decision|7|||
131527625|NCT00359762|473556104|FG002|Period III|Subject Decision|8|||
131527626|NCT00359762|473556105|FG003|Period III|Subject Decision|20|||
131527627|NCT00359762|473556106|FG004|Period III|Subject Decision|0|||
131527628|NCT01033747|473556110|FG000|Overall Study|Adverse Event|9|||
131527629|NCT01033747|473556111|FG001|Overall Study|Adverse Event|4|||
131527630|NCT01033747|473556110|FG000|Overall Study|Abnormal Laboratory Value|1|||
131527631|NCT01033747|473556111|FG001|Overall Study|Abnormal Laboratory Value|0|||
131527632|NCT01033747|473556110|FG000|Overall Study|Abnormal test procedure|0|||
131527633|NCT01033747|473556111|FG001|Overall Study|Abnormal test procedure|1|||
131527634|NCT01033747|473556110|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
131527635|NCT01033747|473556111|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131527636|NCT01033747|473556110|FG000|Overall Study|Protocol Violation|1|||
131527637|NCT01033747|473556111|FG001|Overall Study|Protocol Violation|0|||
131527638|NCT01033747|473556110|FG000|Overall Study|Withdrawal by Subject|9|||
131527639|NCT01033747|473556111|FG001|Overall Study|Withdrawal by Subject|6|||
131527640|NCT01033747|473556110|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
131527641|NCT01033747|473556111|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
131527642|NCT01033747|473556110|FG000|Overall Study|Stopped at end of Extension 1|2|||
131527643|NCT01033747|473556111|FG001|Overall Study|Stopped at end of Extension 1|0|||
131527644|NCT02956629|473556112|FG000|Overall Study|Adverse Event|0|||
131527645|NCT02956629|473556113|FG001|Overall Study|Adverse Event|0|||
131527646|NCT02956629|473556114|FG002|Overall Study|Adverse Event|1|||
131527647|NCT02956629|473556115|FG003|Overall Study|Adverse Event|0|||
131527648|NCT02956629|473556116|FG004|Overall Study|Adverse Event|0|||
131527649|NCT02956629|473556117|FG005|Overall Study|Adverse Event|0|||
131527650|NCT02956629|473556112|FG000|Overall Study|Lost to Follow-up|2|||
131527651|NCT02956629|473556113|FG001|Overall Study|Lost to Follow-up|5|||
131527652|NCT02956629|473556114|FG002|Overall Study|Lost to Follow-up|3|||
131527653|NCT02956629|473556115|FG003|Overall Study|Lost to Follow-up|1|||
131527654|NCT02956629|473556116|FG004|Overall Study|Lost to Follow-up|0|||
131527655|NCT02956629|473556117|FG005|Overall Study|Lost to Follow-up|1|||
131527656|NCT02956629|473556112|FG000|Overall Study|Withdrawal by Subject|3|||
131527657|NCT02956629|473556113|FG001|Overall Study|Withdrawal by Subject|1|||
131527658|NCT02956629|473556114|FG002|Overall Study|Withdrawal by Subject|0|||
131527659|NCT02956629|473556115|FG003|Overall Study|Withdrawal by Subject|0|||
131527660|NCT02956629|473556116|FG004|Overall Study|Withdrawal by Subject|0|||
131527661|NCT02956629|473556117|FG005|Overall Study|Withdrawal by Subject|0|||
131527662|NCT04808609|473556122|FG000|Overall Study|Lost to Follow-up|0|||
131527663|NCT04808609|473556123|FG001|Overall Study|Lost to Follow-up|2|||
131527664|NCT04808609|473556122|FG000|Overall Study|Administrative Withdrawal|0|||
131527665|NCT04808609|473556123|FG001|Overall Study|Administrative Withdrawal|1|||
131527666|NCT01993719|473556126|FG000|First Drug Administration|Not treated|1|||
131527667|NCT01993719|473556127|FG001|First Drug Administration|Not treated|0|||
131527668|NCT01993719|473556128|FG002|First Drug Administration|Not treated|0|||
131527669|NCT01993719|473556129|FG003|First Drug Administration|Not treated|0|||
131527670|NCT01993719|473556130|FG004|First Drug Administration|Not treated|0|||
131527671|NCT01931839|473556134|FG000|Overall Study|Death|0|||
131527672|NCT01931839|473556135|FG001|Overall Study|Death|1|||
131527673|NCT01931839|473556136|FG002|Overall Study|Death|2|||
131527674|NCT01931839|473556137|FG003|Overall Study|Death|0|||
131527675|NCT01931839|473556138|FG004|Overall Study|Death|0|||
131527676|NCT01931839|473556139|FG005|Overall Study|Death|0|||
131527677|NCT01931839|473556140|FG006|Overall Study|Death|0|||
131527678|NCT01931839|473556134|FG000|Overall Study|Physician Decision|1|||
131527679|NCT01931839|473556135|FG001|Overall Study|Physician Decision|0|||
131527680|NCT01931839|473556136|FG002|Overall Study|Physician Decision|1|||
131527681|NCT01931839|473556137|FG003|Overall Study|Physician Decision|0|||
131527682|NCT01931839|473556138|FG004|Overall Study|Physician Decision|0|||
131527683|NCT01931839|473556139|FG005|Overall Study|Physician Decision|0|||
131527684|NCT01931839|473556140|FG006|Overall Study|Physician Decision|1|||
131527685|NCT01931839|473556134|FG000|Overall Study|Withdrawal of consent|0|||
131527686|NCT01931839|473556135|FG001|Overall Study|Withdrawal of consent|0|||
131527687|NCT01931839|473556136|FG002|Overall Study|Withdrawal of consent|0|||
131527688|NCT01931839|473556137|FG003|Overall Study|Withdrawal of consent|0|||
131527689|NCT01931839|473556138|FG004|Overall Study|Withdrawal of consent|1|||
131527690|NCT01931839|473556139|FG005|Overall Study|Withdrawal of consent|0|||
131527691|NCT01931839|473556140|FG006|Overall Study|Withdrawal of consent|0|||
131527692|NCT01931839|473556134|FG000|Overall Study|Adverse Event|9|||
131527693|NCT01931839|473556135|FG001|Overall Study|Adverse Event|4|||
131527694|NCT01931839|473556136|FG002|Overall Study|Adverse Event|1|||
131527695|NCT01931839|473556137|FG003|Overall Study|Adverse Event|3|||
131527696|NCT01931839|473556138|FG004|Overall Study|Adverse Event|0|||
131527697|NCT01931839|473556139|FG005|Overall Study|Adverse Event|0|||
131527698|NCT01931839|473556140|FG006|Overall Study|Adverse Event|1|||
131527699|NCT01931839|473556134|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
131527700|NCT01931839|473556135|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
131527701|NCT01931839|473556136|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
131527702|NCT01931839|473556137|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
131527703|NCT01931839|473556138|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
131527704|NCT01931839|473556139|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
131527705|NCT01931839|473556140|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
131527706|NCT01931839|473556134|FG000|Overall Study|Other non-compliance|15|||
131527707|NCT01931839|473556135|FG001|Overall Study|Other non-compliance|9|||
131527708|NCT01931839|473556136|FG002|Overall Study|Other non-compliance|12|||
131527709|NCT01931839|473556137|FG003|Overall Study|Other non-compliance|3|||
131527710|NCT01931839|473556138|FG004|Overall Study|Other non-compliance|0|||
131527711|NCT01931839|473556139|FG005|Overall Study|Other non-compliance|3|||
131527712|NCT01931839|473556140|FG006|Overall Study|Other non-compliance|0|||
131527713|NCT01931839|473556134|FG000|Overall Study|Lost to Follow-up|1|||
131527714|NCT01931839|473556135|FG001|Overall Study|Lost to Follow-up|2|||
131527715|NCT01931839|473556136|FG002|Overall Study|Lost to Follow-up|4|||
131527716|NCT01931839|473556137|FG003|Overall Study|Lost to Follow-up|5|||
131527717|NCT01931839|473556138|FG004|Overall Study|Lost to Follow-up|0|||
131527718|NCT01931839|473556139|FG005|Overall Study|Lost to Follow-up|0|||
131527719|NCT01931839|473556140|FG006|Overall Study|Lost to Follow-up|0|||
131527720|NCT01931839|473556134|FG000|Overall Study|Other|4|||
131527721|NCT01931839|473556135|FG001|Overall Study|Other|2|||
131527722|NCT01931839|473556136|FG002|Overall Study|Other|6|||
131527723|NCT01931839|473556137|FG003|Overall Study|Other|0|||
131527724|NCT01931839|473556138|FG004|Overall Study|Other|0|||
131527725|NCT01931839|473556139|FG005|Overall Study|Other|0|||
131527726|NCT01931839|473556140|FG006|Overall Study|Other|0|||
131527727|NCT04382326|473556141|FG000|Overall Study|Adverse Event, not serious|1|||
131527728|NCT04382326|473556142|FG001|Overall Study|Adverse Event, not serious|2|||
131527729|NCT04382326|473556141|FG000|Overall Study|Other|1|||
131527730|NCT04382326|473556142|FG001|Overall Study|Other|0|||
131527731|NCT04382326|473556141|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
131653850|NCT03307785|474018493|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
131527732|NCT04382326|473556142|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
131527733|NCT04382326|473556141|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
131527734|NCT04382326|473556142|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
131527735|NCT04382326|473556141|FG000|Overall Study|Protocol Violation|29|||
131527736|NCT04382326|473556142|FG001|Overall Study|Protocol Violation|23|||
131527737|NCT04382326|473556141|FG000|Overall Study|Physician Decision|0|||
131527738|NCT04382326|473556142|FG001|Overall Study|Physician Decision|1|||
131527739|NCT04382326|473556141|FG000|Overall Study|Lost to Follow-up|48|||
131527740|NCT04382326|473556142|FG001|Overall Study|Lost to Follow-up|63|||
131527741|NCT04382326|473556141|FG000|Overall Study|Adverse Event, non-fatal|1|||
131527742|NCT04382326|473556142|FG001|Overall Study|Adverse Event, non-fatal|1|||
131527743|NCT01762761|473556143|FG000|Overall Study|Adverse Event|15|||
131527744|NCT01762761|473556144|FG001|Overall Study|Adverse Event|17|||
131527745|NCT01762761|473556143|FG000|Overall Study|Lack of Efficacy|9|||
131527746|NCT01762761|473556144|FG001|Overall Study|Lack of Efficacy|25|||
131527747|NCT01762761|473556143|FG000|Overall Study|Protocol Violation|1|||
131527748|NCT01762761|473556144|FG001|Overall Study|Protocol Violation|1|||
131527749|NCT01762761|473556143|FG000|Overall Study|Study closed/terminated|0|||
131527750|NCT01762761|473556144|FG001|Overall Study|Study closed/terminated|2|||
131527751|NCT01762761|473556143|FG000|Overall Study|Lost to Follow-up|3|||
131527752|NCT01762761|473556144|FG001|Overall Study|Lost to Follow-up|6|||
131527753|NCT01762761|473556143|FG000|Overall Study|Physician Decision|4|||
131527754|NCT01762761|473556144|FG001|Overall Study|Physician Decision|6|||
131527755|NCT01762761|473556143|FG000|Overall Study|Withdrawal by Subject|7|||
131527756|NCT01762761|473556144|FG001|Overall Study|Withdrawal by Subject|8|||
131527757|NCT02352493|473556145|FG000|Overall Study|Pregnancy|0|||
131527758|NCT02352493|473556146|FG001|Overall Study|Pregnancy|0|||
131527759|NCT02352493|473556147|FG002|Overall Study|Pregnancy|0|||
131527760|NCT02352493|473556148|FG003|Overall Study|Pregnancy|0|||
131527761|NCT02352493|473556149|FG004|Overall Study|Pregnancy|0|||
131527762|NCT02352493|473556150|FG005|Overall Study|Pregnancy|0|||
131527763|NCT02352493|473556151|FG006|Overall Study|Pregnancy|1|||
131527764|NCT02352493|473556152|FG007|Overall Study|Pregnancy|0|||
131527765|NCT02352493|473556153|FG008|Overall Study|Pregnancy|1|||
131527766|NCT02352493|473556154|FG009|Overall Study|Pregnancy|0|||
131527767|NCT02352493|473556155|FG010|Overall Study|Pregnancy|0|||
131527768|NCT02352493|473556156|FG011|Overall Study|Pregnancy|0|||
131527769|NCT02352493|473556157|FG012|Overall Study|Pregnancy|0|||
131527770|NCT02352493|473556158|FG013|Overall Study|Pregnancy|0|||
131527771|NCT02352493|473556159|FG014|Overall Study|Pregnancy|0|||
131527772|NCT02352493|473556160|FG015|Overall Study|Pregnancy|0|||
131527773|NCT02352493|473556161|FG016|Overall Study|Pregnancy|0|||
131527774|NCT02352493|473556162|FG017|Overall Study|Pregnancy|0|||
131527775|NCT02352493|473556145|FG000|Overall Study|Withdrawal by Subject|0|||
131527776|NCT02352493|473556146|FG001|Overall Study|Withdrawal by Subject|0|||
131527777|NCT02352493|473556147|FG002|Overall Study|Withdrawal by Subject|0|||
131527778|NCT02352493|473556148|FG003|Overall Study|Withdrawal by Subject|0|||
131527779|NCT02352493|473556149|FG004|Overall Study|Withdrawal by Subject|0|||
131527780|NCT02352493|473556150|FG005|Overall Study|Withdrawal by Subject|0|||
131527781|NCT02352493|473556151|FG006|Overall Study|Withdrawal by Subject|0|||
131527782|NCT02352493|473556152|FG007|Overall Study|Withdrawal by Subject|0|||
131527783|NCT02352493|473556153|FG008|Overall Study|Withdrawal by Subject|1|||
131527784|NCT02352493|473556154|FG009|Overall Study|Withdrawal by Subject|0|||
131527785|NCT02352493|473556155|FG010|Overall Study|Withdrawal by Subject|0|||
131527786|NCT02352493|473556156|FG011|Overall Study|Withdrawal by Subject|0|||
131527787|NCT02352493|473556157|FG012|Overall Study|Withdrawal by Subject|0|||
131527788|NCT02352493|473556158|FG013|Overall Study|Withdrawal by Subject|0|||
131527789|NCT02352493|473556159|FG014|Overall Study|Withdrawal by Subject|1|||
131527790|NCT02352493|473556160|FG015|Overall Study|Withdrawal by Subject|0|||
131527791|NCT02352493|473556161|FG016|Overall Study|Withdrawal by Subject|0|||
131527792|NCT02352493|473556162|FG017|Overall Study|Withdrawal by Subject|0|||
131527793|NCT02352493|473556145|FG000|Overall Study|Lost to Follow-up|0|||
131527794|NCT02352493|473556146|FG001|Overall Study|Lost to Follow-up|0|||
131527795|NCT02352493|473556147|FG002|Overall Study|Lost to Follow-up|0|||
131527796|NCT02352493|473556148|FG003|Overall Study|Lost to Follow-up|0|||
131527797|NCT02352493|473556149|FG004|Overall Study|Lost to Follow-up|0|||
131527798|NCT02352493|473556150|FG005|Overall Study|Lost to Follow-up|0|||
131527799|NCT02352493|473556151|FG006|Overall Study|Lost to Follow-up|0|||
131527800|NCT02352493|473556152|FG007|Overall Study|Lost to Follow-up|0|||
131527801|NCT02352493|473556153|FG008|Overall Study|Lost to Follow-up|0|||
131527802|NCT02352493|473556154|FG009|Overall Study|Lost to Follow-up|1|||
131527803|NCT02352493|473556155|FG010|Overall Study|Lost to Follow-up|0|||
131527804|NCT02352493|473556156|FG011|Overall Study|Lost to Follow-up|0|||
131527805|NCT02352493|473556157|FG012|Overall Study|Lost to Follow-up|1|||
131527806|NCT02352493|473556158|FG013|Overall Study|Lost to Follow-up|2|||
131527807|NCT02352493|473556159|FG014|Overall Study|Lost to Follow-up|0|||
131527808|NCT02352493|473556160|FG015|Overall Study|Lost to Follow-up|0|||
131527809|NCT02352493|473556161|FG016|Overall Study|Lost to Follow-up|0|||
131527810|NCT02352493|473556162|FG017|Overall Study|Lost to Follow-up|0|||
131527811|NCT01465334|473556163|FG000|Overall Study|Disease Progression|1|||
131527812|NCT01465334|473556164|FG001|Overall Study|Disease Progression|0|||
131527813|NCT01465334|473556163|FG000|Overall Study|Adverse Event|1|||
131527814|NCT01465334|473556164|FG001|Overall Study|Adverse Event|0|||
131527815|NCT01465334|473556163|FG000|Overall Study|Richter's transformation|0|||
131527816|NCT01465334|473556164|FG001|Overall Study|Richter's transformation|3|||
131527817|NCT01465334|473556163|FG000|Overall Study|Refractory Disease|0|||
131527818|NCT01465334|473556164|FG001|Overall Study|Refractory Disease|3|||
131527819|NCT00572572|473556165|FG000|Overall Study|Withdrawal by Subject|3|||
131527820|NCT00572572|473556166|FG001|Overall Study|Withdrawal by Subject|6|||
131527821|NCT01831089|473556167|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
131527822|NCT01831089|473556168|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
131527823|NCT01831089|473556169|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
131527824|NCT01831089|473556170|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
131527825|NCT01831089|473556171|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
131527826|NCT01831089|473556172|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
131527827|NCT01831089|473556167|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
131527828|NCT01831089|473556168|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
131527829|NCT01831089|473556169|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
131527830|NCT01831089|473556170|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
131527831|NCT01831089|473556171|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
131527832|NCT01831089|473556172|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
131527833|NCT01831089|473556167|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
131527834|NCT01831089|473556168|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
131527835|NCT01831089|473556169|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
131527836|NCT01831089|473556170|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
131527837|NCT01831089|473556171|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
131527838|NCT01831089|473556172|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
131527839|NCT01831089|473556167|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
131527840|NCT01831089|473556168|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
131527841|NCT01831089|473556169|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
131527842|NCT01831089|473556170|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
131527843|NCT01831089|473556171|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
131527844|NCT01831089|473556172|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
131527845|NCT01831089|473556167|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
131527846|NCT01831089|473556168|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
131527847|NCT01831089|473556169|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
131527848|NCT01831089|473556170|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
131527849|NCT01831089|473556171|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
131527850|NCT01831089|473556172|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
131527851|NCT01831089|473556167|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
131527852|NCT01831089|473556168|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
131527853|NCT01831089|473556169|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
131527854|NCT01831089|473556170|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
131527855|NCT01831089|473556171|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
131527856|NCT01831089|473556172|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
131527857|NCT01831089|473556167|FG000|Cohort III: Dose Level 3|Global end of study|0|||
131527858|NCT01831089|473556168|FG001|Cohort III: Dose Level 3|Global end of study|0|||
131527859|NCT01831089|473556169|FG002|Cohort III: Dose Level 3|Global end of study|1|||
131527860|NCT01831089|473556170|FG003|Cohort III: Dose Level 3|Global end of study|0|||
131527861|NCT01831089|473556171|FG004|Cohort III: Dose Level 3|Global end of study|0|||
131527862|NCT01831089|473556172|FG005|Cohort III: Dose Level 3|Global end of study|0|||
131527863|NCT01831089|473556167|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
131527864|NCT01831089|473556168|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
131527865|NCT01831089|473556169|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
131527866|NCT01831089|473556170|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
131527867|NCT01831089|473556171|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
131527868|NCT01831089|473556172|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
131527869|NCT01831089|473556167|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
131527870|NCT01831089|473556168|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
131527871|NCT01831089|473556169|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
131527872|NCT01831089|473556170|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
131527873|NCT01831089|473556171|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
131527874|NCT01831089|473556172|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
131527875|NCT01831089|473556167|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
131527876|NCT01831089|473556168|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
131527877|NCT01831089|473556169|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
131527878|NCT01831089|473556170|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
131527879|NCT01831089|473556171|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
131527880|NCT01831089|473556172|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
131527881|NCT01831089|473556167|FG000|Cohort V: Dose Level 5|Death|0|||
131527882|NCT01831089|473556168|FG001|Cohort V: Dose Level 5|Death|0|||
131527883|NCT01831089|473556169|FG002|Cohort V: Dose Level 5|Death|0|||
131527884|NCT01831089|473556170|FG003|Cohort V: Dose Level 5|Death|0|||
131527885|NCT01831089|473556171|FG004|Cohort V: Dose Level 5|Death|1|||
131527886|NCT01831089|473556172|FG005|Cohort V: Dose Level 5|Death|0|||
131527887|NCT01831089|473556167|FG000|Cohort V: Dose Level 5|Global end of study|0|||
131527888|NCT01831089|473556168|FG001|Cohort V: Dose Level 5|Global end of study|0|||
131527889|NCT01831089|473556169|FG002|Cohort V: Dose Level 5|Global end of study|0|||
131527890|NCT01831089|473556170|FG003|Cohort V: Dose Level 5|Global end of study|0|||
131527891|NCT01831089|473556171|FG004|Cohort V: Dose Level 5|Global end of study|2|||
131527892|NCT01831089|473556172|FG005|Cohort V: Dose Level 5|Global end of study|0|||
131527893|NCT01831089|473556167|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
131527894|NCT01831089|473556168|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
131527895|NCT01831089|473556169|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
131527896|NCT01831089|473556170|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
131527897|NCT01831089|473556171|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
131527898|NCT01831089|473556172|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
131527899|NCT01831089|473556167|FG000|Cohort B: Arm B|Progressive disease|0|||
131527900|NCT01831089|473556168|FG001|Cohort B: Arm B|Progressive disease|0|||
131527901|NCT01831089|473556169|FG002|Cohort B: Arm B|Progressive disease|0|||
131527902|NCT01831089|473556170|FG003|Cohort B: Arm B|Progressive disease|0|||
131527903|NCT01831089|473556171|FG004|Cohort B: Arm B|Progressive disease|0|||
131527904|NCT01831089|473556172|FG005|Cohort B: Arm B|Progressive disease|8|||
131527905|NCT01831089|473556167|FG000|Cohort B: Arm B|Physician Decision|0|||
131527906|NCT01831089|473556168|FG001|Cohort B: Arm B|Physician Decision|0|||
131527907|NCT01831089|473556169|FG002|Cohort B: Arm B|Physician Decision|0|||
131527908|NCT01831089|473556170|FG003|Cohort B: Arm B|Physician Decision|0|||
131527909|NCT01831089|473556171|FG004|Cohort B: Arm B|Physician Decision|0|||
131527910|NCT01831089|473556172|FG005|Cohort B: Arm B|Physician Decision|2|||
131527911|NCT01831089|473556167|FG000|Cohort B: Arm B|Never treated|0|||
131527912|NCT01831089|473556168|FG001|Cohort B: Arm B|Never treated|0|||
131527913|NCT01831089|473556169|FG002|Cohort B: Arm B|Never treated|0|||
131527914|NCT01831089|473556170|FG003|Cohort B: Arm B|Never treated|0|||
131527915|NCT01831089|473556171|FG004|Cohort B: Arm B|Never treated|0|||
131527916|NCT01831089|473556172|FG005|Cohort B: Arm B|Never treated|2|||
131527917|NCT01831089|473556167|FG000|Cohort B: Arm B|Adverse Event|0|||
131527918|NCT01831089|473556168|FG001|Cohort B: Arm B|Adverse Event|0|||
131527919|NCT01831089|473556169|FG002|Cohort B: Arm B|Adverse Event|0|||
131527920|NCT01831089|473556170|FG003|Cohort B: Arm B|Adverse Event|0|||
131527921|NCT01831089|473556171|FG004|Cohort B: Arm B|Adverse Event|0|||
131527922|NCT01831089|473556172|FG005|Cohort B: Arm B|Adverse Event|1|||
131527923|NCT01831089|473556167|FG000|Cohort B: Arm B|Global end of study|0|||
131527924|NCT01831089|473556168|FG001|Cohort B: Arm B|Global end of study|0|||
131527925|NCT01831089|473556169|FG002|Cohort B: Arm B|Global end of study|0|||
131527926|NCT01831089|473556170|FG003|Cohort B: Arm B|Global end of study|0|||
131527927|NCT01831089|473556171|FG004|Cohort B: Arm B|Global end of study|0|||
131527928|NCT01831089|473556172|FG005|Cohort B: Arm B|Global end of study|1|||
131527929|NCT02114892|473556178|FG000|Overall Study|Lost to Follow-up|1|||
131527930|NCT02114892|473556179|FG001|Overall Study|Lost to Follow-up|2|||
131527931|NCT03525834|473556182|FG000|Overall Study|Progressive disease|1|||
131527932|NCT01751568|473556187|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
131527933|NCT01751568|473556188|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
131527934|NCT01751568|473556189|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
131527935|NCT02660944|473556198|FG000|Overall Study|Adverse Event|3|||
131527936|NCT02660944|473556199|FG001|Overall Study|Adverse Event|4|||
131527937|NCT02660944|473556198|FG000|Overall Study|Physician Decision|3|||
131527938|NCT02660944|473556199|FG001|Overall Study|Physician Decision|1|||
131527939|NCT02660944|473556198|FG000|Overall Study|Withdrawal by Subject|5|||
131527940|NCT02660944|473556199|FG001|Overall Study|Withdrawal by Subject|3|||
131527941|NCT02660944|473556198|FG000|Overall Study|Lost to Follow-up|4|||
131527942|NCT02660944|473556199|FG001|Overall Study|Lost to Follow-up|1|||
131527943|NCT02660944|473556198|FG000|Overall Study|Subject schedule|0|||
131527944|NCT02660944|473556199|FG001|Overall Study|Subject schedule|1|||
131527945|NCT02660944|473556198|FG000|Overall Study|Exclusion criteria met|2|||
131527946|NCT02660944|473556199|FG001|Overall Study|Exclusion criteria met|0|||
131527947|NCT03586999|473556200|FG000|Overall Study|Lack of Efficacy|2|||
131527948|NCT04096560|473556201|FG000|Overall Study|Reason not Specified|1|||
131527949|NCT04096560|473556202|FG001|Overall Study|Reason not Specified|0|||
131527950|NCT04096560|473556203|FG002|Overall Study|Reason not Specified|0|||
131527951|NCT04096560|473556204|FG003|Overall Study|Reason not Specified|0|||
131527952|NCT04096560|473556205|FG004|Overall Study|Reason not Specified|1|||
131527953|NCT04096560|473556206|FG005|Overall Study|Reason not Specified|1|||
131527954|NCT04096560|473556207|FG006|Overall Study|Reason not Specified|1|||
131527955|NCT04096560|473556208|FG007|Overall Study|Reason not Specified|0|||
131527956|NCT04096560|473556201|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
131527957|NCT04096560|473556202|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
131527958|NCT04096560|473556203|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
131527959|NCT04096560|473556204|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
131527960|NCT04096560|473556205|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
131527961|NCT04096560|473556206|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
131527962|NCT04096560|473556207|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
131527963|NCT04096560|473556208|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
131527964|NCT04096560|473556201|FG000|Overall Study|Study Terminated by Sponsor|0|||
131527965|NCT04096560|473556202|FG001|Overall Study|Study Terminated by Sponsor|0|||
131527966|NCT04096560|473556203|FG002|Overall Study|Study Terminated by Sponsor|0|||
131527967|NCT04096560|473556204|FG003|Overall Study|Study Terminated by Sponsor|5|||
131527968|NCT04096560|473556205|FG004|Overall Study|Study Terminated by Sponsor|6|||
131527969|NCT04096560|473556206|FG005|Overall Study|Study Terminated by Sponsor|4|||
131527970|NCT04096560|473556207|FG006|Overall Study|Study Terminated by Sponsor|6|||
131527971|NCT04096560|473556208|FG007|Overall Study|Study Terminated by Sponsor|1|||
131527972|NCT04096560|473556201|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527973|NCT04096560|473556202|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527974|NCT04096560|473556203|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527975|NCT04096560|473556204|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527976|NCT04096560|473556205|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527977|NCT04096560|473556206|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527978|NCT04096560|473556207|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
131527979|NCT04096560|473556208|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
131527980|NCT01485861|473556209|FG000|Phase Ib|Death|1|||
131527981|NCT01485861|473556210|FG001|Phase Ib|Death|0|||
131527982|NCT01485861|473556211|FG002|Phase Ib|Death|0|||
131527983|NCT01485861|473556212|FG003|Phase Ib|Death|0|||
131527984|NCT01485861|473556213|FG004|Phase Ib|Death|0|||
131527985|NCT01485861|473556214|FG005|Phase Ib|Death|0|||
131527986|NCT01485861|473556209|FG000|Phase Ib|Physician Decision|1|||
131527987|NCT01485861|473556210|FG001|Phase Ib|Physician Decision|1|||
131527988|NCT01485861|473556211|FG002|Phase Ib|Physician Decision|0|||
131527989|NCT01485861|473556212|FG003|Phase Ib|Physician Decision|0|||
131527990|NCT01485861|473556213|FG004|Phase Ib|Physician Decision|0|||
131527991|NCT01485861|473556214|FG005|Phase Ib|Physician Decision|0|||
131527992|NCT01485861|473556209|FG000|Phase Ib|Adverse Event|0|||
131527993|NCT01485861|473556210|FG001|Phase Ib|Adverse Event|4|||
131527994|NCT01485861|473556211|FG002|Phase Ib|Adverse Event|0|||
131527995|NCT01485861|473556212|FG003|Phase Ib|Adverse Event|0|||
131527996|NCT01485861|473556213|FG004|Phase Ib|Adverse Event|0|||
131527997|NCT01485861|473556214|FG005|Phase Ib|Adverse Event|0|||
131527998|NCT01485861|473556209|FG000|Phase Ib|Progression of disease|5|||
131527999|NCT01485861|473556210|FG001|Phase Ib|Progression of disease|0|||
131528000|NCT01485861|473556211|FG002|Phase Ib|Progression of disease|0|||
131528001|NCT01485861|473556212|FG003|Phase Ib|Progression of disease|0|||
131528002|NCT01485861|473556213|FG004|Phase Ib|Progression of disease|0|||
131528003|NCT01485861|473556214|FG005|Phase Ib|Progression of disease|0|||
131528004|NCT01485861|473556209|FG000|Phase Ib|Other|3|||
131528005|NCT01485861|473556210|FG001|Phase Ib|Other|0|||
131528006|NCT01485861|473556211|FG002|Phase Ib|Other|0|||
131528007|NCT01485861|473556212|FG003|Phase Ib|Other|0|||
131528008|NCT01485861|473556213|FG004|Phase Ib|Other|0|||
131528009|NCT01485861|473556214|FG005|Phase Ib|Other|0|||
131528010|NCT01485861|473556209|FG000|Phase Ib|Withdrawal by Subject|4|||
131528011|NCT01485861|473556210|FG001|Phase Ib|Withdrawal by Subject|1|||
131528012|NCT01485861|473556211|FG002|Phase Ib|Withdrawal by Subject|0|||
131528013|NCT01485861|473556212|FG003|Phase Ib|Withdrawal by Subject|0|||
131528014|NCT01485861|473556213|FG004|Phase Ib|Withdrawal by Subject|0|||
131528015|NCT01485861|473556214|FG005|Phase Ib|Withdrawal by Subject|0|||
131528016|NCT01485861|473556209|FG000|Phase II|Death|0|||
131528017|NCT01485861|473556210|FG001|Phase II|Death|0|||
131528018|NCT01485861|473556211|FG002|Phase II|Death|67|||
131528019|NCT01485861|473556212|FG003|Phase II|Death|71|||
131528020|NCT01485861|473556213|FG004|Phase II|Death|68|||
131528021|NCT01485861|473556214|FG005|Phase II|Death|0|||
131528022|NCT01485861|473556209|FG000|Phase II|Progression of Disease|0|||
131528023|NCT01485861|473556210|FG001|Phase II|Progression of Disease|0|||
131528024|NCT01485861|473556211|FG002|Phase II|Progression of Disease|1|||
131528025|NCT01485861|473556212|FG003|Phase II|Progression of Disease|0|||
131528026|NCT01485861|473556213|FG004|Phase II|Progression of Disease|0|||
131528027|NCT01485861|473556214|FG005|Phase II|Progression of Disease|0|||
131528028|NCT01485861|473556209|FG000|Phase II|Other|0|||
131528029|NCT01485861|473556210|FG001|Phase II|Other|0|||
131528030|NCT01485861|473556211|FG002|Phase II|Other|0|||
131528031|NCT01485861|473556212|FG003|Phase II|Other|1|||
131528032|NCT01485861|473556213|FG004|Phase II|Other|0|||
131528033|NCT01485861|473556214|FG005|Phase II|Other|0|||
131528034|NCT01485861|473556209|FG000|Phase II|Withdrawal by Subject|0|||
131528035|NCT01485861|473556210|FG001|Phase II|Withdrawal by Subject|0|||
131528036|NCT01485861|473556211|FG002|Phase II|Withdrawal by Subject|6|||
131528037|NCT01485861|473556212|FG003|Phase II|Withdrawal by Subject|3|||
131528038|NCT01485861|473556213|FG004|Phase II|Withdrawal by Subject|4|||
131528039|NCT01485861|473556214|FG005|Phase II|Withdrawal by Subject|0|||
131528040|NCT01485861|473556209|FG000|Phase II|Lost to Follow-up|0|||
131528041|NCT01485861|473556210|FG001|Phase II|Lost to Follow-up|0|||
131528042|NCT01485861|473556211|FG002|Phase II|Lost to Follow-up|2|||
131528043|NCT01485861|473556212|FG003|Phase II|Lost to Follow-up|3|||
131528044|NCT01485861|473556213|FG004|Phase II|Lost to Follow-up|5|||
131528045|NCT01485861|473556214|FG005|Phase II|Lost to Follow-up|0|||
131528046|NCT01485861|473556209|FG000|Phase II|Study Ended|0|||
131528047|NCT01485861|473556210|FG001|Phase II|Study Ended|0|||
131528048|NCT01485861|473556211|FG002|Phase II|Study Ended|7|||
131528049|NCT01485861|473556212|FG003|Phase II|Study Ended|8|||
131528050|NCT01485861|473556213|FG004|Phase II|Study Ended|6|||
131528051|NCT01485861|473556214|FG005|Phase II|Study Ended|0|||
131528052|NCT01485861|473556209|FG000|Safety Phase|Death|0|||
131528053|NCT01485861|473556210|FG001|Safety Phase|Death|0|||
131528054|NCT01485861|473556211|FG002|Safety Phase|Death|0|||
131528055|NCT01485861|473556212|FG003|Safety Phase|Death|0|||
131528056|NCT01485861|473556213|FG004|Safety Phase|Death|0|||
131528057|NCT01485861|473556214|FG005|Safety Phase|Death|2|||
131528058|NCT01485861|473556209|FG000|Safety Phase|Adverse Event|0|||
131528059|NCT01485861|473556210|FG001|Safety Phase|Adverse Event|0|||
131528060|NCT01485861|473556211|FG002|Safety Phase|Adverse Event|0|||
131528061|NCT01485861|473556212|FG003|Safety Phase|Adverse Event|0|||
131528062|NCT01485861|473556213|FG004|Safety Phase|Adverse Event|0|||
131528063|NCT01485861|473556214|FG005|Safety Phase|Adverse Event|1|||
131528064|NCT01485861|473556209|FG000|Safety Phase|Other|0|||
131528065|NCT01485861|473556210|FG001|Safety Phase|Other|0|||
131528066|NCT01485861|473556211|FG002|Safety Phase|Other|0|||
131528067|NCT01485861|473556212|FG003|Safety Phase|Other|0|||
131528068|NCT01485861|473556213|FG004|Safety Phase|Other|0|||
131528069|NCT01485861|473556214|FG005|Safety Phase|Other|5|||
131528070|NCT01485861|473556209|FG000|Safety Phase|Progression of Disease|0|||
131528071|NCT01485861|473556210|FG001|Safety Phase|Progression of Disease|0|||
131528072|NCT01485861|473556211|FG002|Safety Phase|Progression of Disease|0|||
131528073|NCT01485861|473556212|FG003|Safety Phase|Progression of Disease|0|||
131528074|NCT01485861|473556213|FG004|Safety Phase|Progression of Disease|0|||
131528075|NCT01485861|473556214|FG005|Safety Phase|Progression of Disease|9|||
131528076|NCT01485861|473556209|FG000|Safety Phase|Withdrawal by Subject|0|||
131528077|NCT01485861|473556210|FG001|Safety Phase|Withdrawal by Subject|0|||
131528078|NCT01485861|473556211|FG002|Safety Phase|Withdrawal by Subject|0|||
131528079|NCT01485861|473556212|FG003|Safety Phase|Withdrawal by Subject|0|||
131528080|NCT01485861|473556213|FG004|Safety Phase|Withdrawal by Subject|0|||
131528081|NCT01485861|473556214|FG005|Safety Phase|Withdrawal by Subject|6|||
131528082|NCT01485861|473556209|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
131528083|NCT01485861|473556210|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
131528084|NCT01485861|473556211|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
131528085|NCT01485861|473556212|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
131528086|NCT01485861|473556213|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
131528087|NCT01485861|473556214|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
131528088|NCT01229436|473556215|FG000|Overall Study|Withdrawal by Subject|2|||
131528089|NCT01229436|473556215|FG000|Overall Study|Lost to Follow-up|3|||
131528090|NCT02266381|473556218|FG000|Overall Study|Physician Decision|3|||
131528091|NCT02266381|473556219|FG001|Overall Study|Physician Decision|5|||
131528092|NCT02266381|473556220|FG002|Overall Study|Physician Decision|4|||
131528093|NCT01731171|473556238|FG000|Overall Study|Withdrawal by Subject|4|||
131528094|NCT01731171|473556239|FG001|Overall Study|Withdrawal by Subject|1|||
131528095|NCT01731171|473556238|FG000|Overall Study|Lost to Follow-up|3|||
131528096|NCT01731171|473556239|FG001|Overall Study|Lost to Follow-up|2|||
131528097|NCT01731171|473556238|FG000|Overall Study|Moved out of Area|0|||
131528098|NCT01731171|473556239|FG001|Overall Study|Moved out of Area|2|||
131528099|NCT01731171|473556238|FG000|Overall Study|Terminated for Lack of Adherence|0|||
131528100|NCT01731171|473556239|FG001|Overall Study|Terminated for Lack of Adherence|1|||
131528101|NCT01731171|473556238|FG000|Overall Study|Terminated for Safety Reasons|0|||
131528102|NCT01731171|473556239|FG001|Overall Study|Terminated for Safety Reasons|1|||
131528103|NCT03653429|473556242|FG000|Overall Study|Physician Decision|4|||
131528104|NCT03653429|473556243|FG001|Overall Study|Physician Decision|10|||
131528105|NCT00403546|473556244|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
131528106|NCT00403546|473556245|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
131528107|NCT00403546|473556246|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
131528108|NCT00403546|473556244|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
131528109|NCT00403546|473556245|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
131528110|NCT00403546|473556246|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
131528111|NCT00403546|473556244|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
131528112|NCT00403546|473556245|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
131528113|NCT00403546|473556246|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
131528114|NCT00403546|473556244|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
131528115|NCT00403546|473556245|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
131528116|NCT00403546|473556246|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
131528117|NCT00403546|473556244|FG000|Screening Phase|Screening Failure|22|||
131528118|NCT00403546|473556245|FG001|Screening Phase|Screening Failure|0|||
131528119|NCT00403546|473556246|FG002|Screening Phase|Screening Failure|0|||
131528120|NCT00403546|473556244|FG000|Screening Phase|Adverse Event|1|||
131528121|NCT00403546|473556245|FG001|Screening Phase|Adverse Event|0|||
131528122|NCT00403546|473556246|FG002|Screening Phase|Adverse Event|0|||
131528123|NCT00403546|473556244|FG000|Screening Phase|Terminated Prior to Randomization|5|||
131528124|NCT00403546|473556245|FG001|Screening Phase|Terminated Prior to Randomization|0|||
131528125|NCT00403546|473556246|FG002|Screening Phase|Terminated Prior to Randomization|0|||
131528126|NCT00403546|473556244|FG000|Randomized Trial|Early Terminations|0|||
131528127|NCT00403546|473556245|FG001|Randomized Trial|Early Terminations|17|||
131528128|NCT00403546|473556246|FG002|Randomized Trial|Early Terminations|16|||
131528129|NCT02604589|473556250|FG000|Overall Study|catheter dislodgement|0|||
131528130|NCT02604589|473556251|FG001|Overall Study|catheter dislodgement|0|||
131528131|NCT02604589|473556252|FG002|Overall Study|catheter dislodgement|1|||
131528132|NCT00793910|473556255|FG000|Overall Study|discarded study pills|0|||
131528133|NCT00793910|473556256|FG001|Overall Study|discarded study pills|1|||
131528134|NCT00793910|473556255|FG000|Overall Study|did not pick up medications|1|||
131528135|NCT00793910|473556256|FG001|Overall Study|did not pick up medications|1|||
131528136|NCT00793910|473556255|FG000|Overall Study|ineligible based on entry criteria|2|||
131528137|NCT00793910|473556256|FG001|Overall Study|ineligible based on entry criteria|3|||
131528138|NCT00793910|473556255|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
131528139|NCT00793910|473556256|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
131528140|NCT00793910|473556255|FG000|Overall Study|Withdrawal by Subject|0|||
131528141|NCT00793910|473556256|FG001|Overall Study|Withdrawal by Subject|1|||
131528142|NCT01700946|473556257|FG000|Overall Study|Lost to Follow-up|1|||
131528143|NCT01700946|473556258|FG001|Overall Study|Lost to Follow-up|0|||
131528144|NCT01700946|473556257|FG000|Overall Study|Physician Decision|7|||
131528145|NCT01700946|473556258|FG001|Overall Study|Physician Decision|12|||
131528146|NCT01700946|473556257|FG000|Overall Study|Withdrawal by Subject|0|||
131528147|NCT01700946|473556258|FG001|Overall Study|Withdrawal by Subject|2|||
131528148|NCT01700946|473556257|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
131528149|NCT01700946|473556258|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
131528150|NCT01700946|473556257|FG000|Overall Study|Relapse|2|||
131528151|NCT01700946|473556258|FG001|Overall Study|Relapse|1|||
131528152|NCT01700946|473556257|FG000|Overall Study|Unacceptable toxicity|1|||
131528153|NCT01700946|473556258|FG001|Overall Study|Unacceptable toxicity|0|||
131528154|NCT05061446|473556269|FG000|Overall Study|Adverse Event|2|||
131528155|NCT05061446|473556270|FG001|Overall Study|Adverse Event|0|||
131528156|NCT05061446|473556271|FG002|Overall Study|Adverse Event|0|||
131528157|NCT05061446|473556269|FG000|Overall Study|Participant no longer available due to personal reason|0|||
131528158|NCT05061446|473556270|FG001|Overall Study|Participant no longer available due to personal reason|1|||
131528159|NCT05061446|473556271|FG002|Overall Study|Participant no longer available due to personal reason|0|||
131528160|NCT00861341|473556272|FG000|Overall Study|Withdrawal by Subject|2|||
131528161|NCT01916304|473556273|FG000|Overall Study|Screening failure|17|||
131528162|NCT03149328|473556274|FG000|Overall Study|Withdrawal by Subject|30|||
131528163|NCT03149328|473556275|FG001|Overall Study|Withdrawal by Subject|26|||
131528164|NCT03149328|473556274|FG000|Overall Study|Changed Dialysis Modality|18|||
131528165|NCT03149328|473556275|FG001|Overall Study|Changed Dialysis Modality|1|||
131528166|NCT03149328|473556274|FG000|Overall Study|Transplant|9|||
131528167|NCT03149328|473556275|FG001|Overall Study|Transplant|1|||
131528168|NCT03149328|473556274|FG000|Overall Study|Lost to Follow-up|25|||
131528169|NCT03149328|473556275|FG001|Overall Study|Lost to Follow-up|16|||
131528170|NCT03149328|473556274|FG000|Overall Study|Left Study Site|1|||
131528171|NCT03149328|473556275|FG001|Overall Study|Left Study Site|2|||
131528172|NCT03149328|473556274|FG000|Overall Study|Language Barrier|1|||
131528173|NCT03149328|473556275|FG001|Overall Study|Language Barrier|0|||
131528174|NCT04028388|473556282|FG000|Overall Study|Evaluations missing|3|||
131528175|NCT04028388|473556283|FG001|Overall Study|Evaluations missing|6|||
131528176|NCT04028388|473556282|FG000|Overall Study|Not started|2|||
131528177|NCT04028388|473556283|FG001|Overall Study|Not started|0|||
131528178|NCT02758236|473556284|FG000|Overall Study|Investigator discretion|43|||
131528179|NCT01994395|473556285|FG000|Overall Study|Withdrawal by Subject|1|||
131528180|NCT01994395|473556286|FG001|Overall Study|Withdrawal by Subject|2|||
131528181|NCT00162136|473556289|FG000|Overall Study|Adverse Event|1|||
131528182|NCT00162136|473556289|FG000|Overall Study|Death|1|||
131528183|NCT00162136|473556289|FG000|Overall Study|Disease Progression/Relapse|23|||
131528184|NCT00162136|473556289|FG000|Overall Study|Investigator Request|5|||
131528185|NCT00162136|473556289|FG000|Overall Study|Study Drug Toxicity|4|||
131528186|NCT00162136|473556289|FG000|Overall Study|Withdrawal by Subject|1|||
131528187|NCT03930745|473556290|FG000|Overall Study|Lost to Follow-up|10|||
131528188|NCT03930745|473556291|FG001|Overall Study|Lost to Follow-up|5|||
131528189|NCT03930745|473556290|FG000|Overall Study|Withdrawal by Subject|1|||
131528190|NCT03930745|473556291|FG001|Overall Study|Withdrawal by Subject|2|||
131528191|NCT03930745|473556290|FG000|Overall Study|Protocol Violation|2|||
131528192|NCT03930745|473556291|FG001|Overall Study|Protocol Violation|2|||
131528193|NCT03930745|473556290|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
131528194|NCT03930745|473556291|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
131528195|NCT03930745|473556290|FG000|Overall Study|Adverse Event|0|||
131528196|NCT03930745|473556291|FG001|Overall Study|Adverse Event|1|||
131528197|NCT03930745|473556290|FG000|Overall Study|Pregnancy|0|||
131528198|NCT03930745|473556291|FG001|Overall Study|Pregnancy|1|||
131528199|NCT00818441|473556296|FG000|Overall Study|Death|69|||
131528200|NCT00818441|473556297|FG001|Overall Study|Death|26|||
131528201|NCT00818441|473556296|FG000|Overall Study|Other|5|||
131528202|NCT00818441|473556297|FG001|Overall Study|Other|0|||
131528203|NCT00818441|473556296|FG000|Overall Study|Lost to Follow-up|2|||
131528204|NCT00818441|473556297|FG001|Overall Study|Lost to Follow-up|1|||
131528205|NCT00818441|473556296|FG000|Overall Study|Withdrawal by Subject|2|||
131528206|NCT00818441|473556297|FG001|Overall Study|Withdrawal by Subject|0|||
131528207|NCT00818441|473556296|FG000|Overall Study|Adverse Event|0|||
131528208|NCT00818441|473556297|FG001|Overall Study|Adverse Event|1|||
131528209|NCT00818441|473556296|FG000|Overall Study|Study terminated by sponsor|11|||
131528210|NCT00818441|473556297|FG001|Overall Study|Study terminated by sponsor|2|||
131528211|NCT03483623|473556310|FG000|Overall Study|43 complete sets achieved|1|||
131528212|NCT02770391|473556311|FG000|Overall Study|Lost to Follow-up|2|||
131528213|NCT02770391|473556311|FG000|Overall Study|Withdrawal by Subject|1|||
131528214|NCT02770391|473556311|FG000|Overall Study|Surgery delayed unevaluable|2|||
131528215|NCT02770391|473556311|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
131528216|NCT00612313|473556316|FG000|Overall Study|Withdrawal by Subject|6|||
131528217|NCT00612313|473556317|FG001|Overall Study|Withdrawal by Subject|9|||
131528218|NCT00612313|473556316|FG000|Overall Study|Lost to Follow-up|11|||
131528219|NCT00612313|473556317|FG001|Overall Study|Lost to Follow-up|4|||
131528220|NCT03136068|473557573|FG000|Overall Study|Lost to Follow-up|1|||
131528221|NCT03136068|473557574|FG001|Overall Study|Lost to Follow-up|1|||
131528222|NCT03136068|473557573|FG000|Overall Study|Protocol Violation|1|||
131528223|NCT03136068|473557574|FG001|Overall Study|Protocol Violation|0|||
131528224|NCT00432380|473557580|FG000|Overall Study|Migrated/moved from study area|3|||
131528225|NCT00432380|473557581|FG001|Overall Study|Migrated/moved from study area|4|||
131528226|NCT00432380|473557582|FG002|Overall Study|Migrated/moved from study area|1|||
131528227|NCT00432380|473557580|FG000|Overall Study|Adverse Event|1|||
131528228|NCT00432380|473557581|FG001|Overall Study|Adverse Event|0|||
131528229|NCT00432380|473557582|FG002|Overall Study|Adverse Event|0|||
131528230|NCT01337089|473557583|FG000|Overall Study|Adverse Event|237|||
131528231|NCT01337089|473557583|FG000|Overall Study|Withdrawal by Subject|129|||
131528232|NCT01337089|473557583|FG000|Overall Study|Withdrawal by Investigator|33|||
131528233|NCT01337089|473557583|FG000|Overall Study|Met Withdrawal Criteria|3|||
131528234|NCT01337089|473557583|FG000|Overall Study|Lost to Follow-up|2|||
131528235|NCT01627249|473557584|FG000|Overall Study|Death|3|||
131528236|NCT01627249|473557585|FG001|Overall Study|Death|5|||
131528237|NCT01627249|473557586|FG002|Overall Study|Death|3|||
131528238|NCT01627249|473557584|FG000|Overall Study|Withdrawal by Subject|12|||
131528239|NCT01627249|473557585|FG001|Overall Study|Withdrawal by Subject|6|||
131528240|NCT01627249|473557586|FG002|Overall Study|Withdrawal by Subject|9|||
131528241|NCT01627249|473557584|FG000|Overall Study|Missed Visit|1|||
131528242|NCT01627249|473557585|FG001|Overall Study|Missed Visit|1|||
131528243|NCT01627249|473557586|FG002|Overall Study|Missed Visit|0|||
131528244|NCT02627677|473557588|FG000|Overall Study|Adverse event (not progressive disease)|1|||
131528245|NCT02627677|473557589|FG001|Overall Study|Adverse event (not progressive disease)|4|||
131528246|NCT02627677|473557590|FG002|Overall Study|Adverse event (not progressive disease)|1|||
131528247|NCT02627677|473557588|FG000|Overall Study|Progressive disease|1|||
131528248|NCT02627677|473557589|FG001|Overall Study|Progressive disease|3|||
131528249|NCT02627677|473557590|FG002|Overall Study|Progressive disease|0|||
131528250|NCT02627677|473557588|FG000|Overall Study|Lack of Efficacy|1|||
131528251|NCT02627677|473557589|FG001|Overall Study|Lack of Efficacy|2|||
131528252|NCT02627677|473557590|FG002|Overall Study|Lack of Efficacy|0|||
131528253|NCT02627677|473557588|FG000|Overall Study|Lost to Follow-up|0|||
131528254|NCT02627677|473557589|FG001|Overall Study|Lost to Follow-up|0|||
131528255|NCT02627677|473557590|FG002|Overall Study|Lost to Follow-up|1|||
131528256|NCT02627677|473557588|FG000|Overall Study|Pregnancy|0|||
131528257|NCT02627677|473557589|FG001|Overall Study|Pregnancy|1|||
131528258|NCT02627677|473557590|FG002|Overall Study|Pregnancy|0|||
131528259|NCT02627677|473557588|FG000|Overall Study|Study Terminated by Sponsor|5|||
131528260|NCT02627677|473557589|FG001|Overall Study|Study Terminated by Sponsor|10|||
131528261|NCT02627677|473557590|FG002|Overall Study|Study Terminated by Sponsor|6|||
131528262|NCT02627677|473557588|FG000|Overall Study|Physician Decision|0|||
131528263|NCT02627677|473557589|FG001|Overall Study|Physician Decision|0|||
131528264|NCT02627677|473557590|FG002|Overall Study|Physician Decision|2|||
131528265|NCT02627677|473557588|FG000|Overall Study|Withdrawal by Subject|2|||
131528266|NCT02627677|473557589|FG001|Overall Study|Withdrawal by Subject|1|||
131528267|NCT02627677|473557590|FG002|Overall Study|Withdrawal by Subject|1|||
131528268|NCT02627677|473557588|FG000|Overall Study|Reason not Specified|0|||
131528269|NCT02627677|473557589|FG001|Overall Study|Reason not Specified|0|||
131528270|NCT02627677|473557590|FG002|Overall Study|Reason not Specified|1|||
131528271|NCT02627677|473557588|FG000|Overall Study|Randomized but not Treated|1|||
131528272|NCT02627677|473557589|FG001|Overall Study|Randomized but not Treated|0|||
131528273|NCT02627677|473557590|FG002|Overall Study|Randomized but not Treated|0|||
131528274|NCT02044510|473557591|FG000|Overall Study|Adverse Event|1|||
131528275|NCT02044510|473557592|FG001|Overall Study|Adverse Event|2|||
131528276|NCT00581945|473557595|FG000|Overall Study|Adverse Event|4|||
131528277|NCT00581945|473557596|FG001|Overall Study|Adverse Event|4|||
131528278|NCT00581945|473557595|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131528279|NCT00581945|473557596|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131528280|NCT00581945|473557595|FG000|Overall Study|Withdrawal by Subject|2|||
131528281|NCT00581945|473557596|FG001|Overall Study|Withdrawal by Subject|6|||
131528282|NCT00581945|473557595|FG000|Overall Study|Death|1|||
131528283|NCT00581945|473557596|FG001|Overall Study|Death|0|||
131528284|NCT00587587|473557599|FG000|Overall Study|Lost to Follow-up|6|||
131528285|NCT00587587|473557600|FG001|Overall Study|Lost to Follow-up|1|||
131528286|NCT02039505|473557602|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
131528287|NCT02039505|473557603|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
131528288|NCT02039505|473557604|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
131528289|NCT02039505|473557605|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
131528290|NCT02039505|473557606|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
131528291|NCT02039505|473557607|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
131528292|NCT02039505|473557608|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
131528293|NCT02039505|473557602|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
131528294|NCT02039505|473557603|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
131528295|NCT02039505|473557604|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
131528296|NCT02039505|473557605|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
131528297|NCT02039505|473557606|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
131528298|NCT02039505|473557607|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
131528299|NCT02039505|473557608|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
131528300|NCT02039505|473557602|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
131528301|NCT02039505|473557603|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
131528302|NCT02039505|473557604|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
131528303|NCT02039505|473557605|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
131528304|NCT02039505|473557606|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
131528305|NCT02039505|473557607|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
131528306|NCT02039505|473557608|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
131528307|NCT02039505|473557602|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
131528308|NCT02039505|473557603|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
131528309|NCT02039505|473557604|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
131528310|NCT02039505|473557605|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
131528311|NCT02039505|473557606|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
131528312|NCT02039505|473557607|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
131528313|NCT02039505|473557608|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
131528314|NCT02039505|473557602|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
131528315|NCT02039505|473557603|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
131528316|NCT02039505|473557604|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
131528317|NCT02039505|473557605|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
131528318|NCT02039505|473557606|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
131528319|NCT02039505|473557607|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
131528320|NCT02039505|473557608|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
131528321|NCT02039505|473557602|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
131528322|NCT02039505|473557603|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
131528323|NCT02039505|473557604|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
131528324|NCT02039505|473557605|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
131528325|NCT02039505|473557606|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
131528326|NCT02039505|473557607|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
131528327|NCT02039505|473557608|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
131528328|NCT02039505|473557602|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131528329|NCT02039505|473557603|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131528330|NCT02039505|473557604|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131528331|NCT02039505|473557605|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
131528332|NCT02039505|473557606|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131528333|NCT02039505|473557607|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131528334|NCT02039505|473557608|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131528335|NCT02039505|473557602|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
131528336|NCT02039505|473557603|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
131528337|NCT02039505|473557604|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
131528338|NCT02039505|473557605|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
131528339|NCT02039505|473557606|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
131528340|NCT02039505|473557607|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
131528341|NCT02039505|473557608|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
131528342|NCT02039505|473557602|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
131528343|NCT02039505|473557603|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
131528344|NCT02039505|473557604|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
131528345|NCT02039505|473557605|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
131528346|NCT02039505|473557606|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
131528347|NCT02039505|473557607|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
131528348|NCT02039505|473557608|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
131528349|NCT02039505|473557602|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
131528350|NCT02039505|473557603|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
131528351|NCT02039505|473557604|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
131528352|NCT02039505|473557605|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
131528353|NCT02039505|473557606|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
131528354|NCT02039505|473557607|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
131528355|NCT02039505|473557608|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
131528356|NCT02039505|473557602|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131528357|NCT02039505|473557603|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131528358|NCT02039505|473557604|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131528359|NCT02039505|473557605|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131528360|NCT02039505|473557606|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131528361|NCT02039505|473557607|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131528362|NCT02039505|473557608|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
131528363|NCT00633984|473557609|FG000|Overall Study|Lost to Follow-up|0|||
131528364|NCT00633984|473557610|FG001|Overall Study|Lost to Follow-up|6|||
131528365|NCT00633984|473557609|FG000|Overall Study|Withdrawal by Subject|8|||
131528366|NCT00633984|473557610|FG001|Overall Study|Withdrawal by Subject|7|||
131528367|NCT00633984|473557609|FG000|Overall Study|Hospitalized|1|||
131528368|NCT00633984|473557610|FG001|Overall Study|Hospitalized|0|||
131528369|NCT02496884|473557611|FG000|Overall Study|Counted twice as enrolled|2|||
131528370|NCT02496884|473557612|FG001|Overall Study|Counted twice as enrolled|0|||
131528371|NCT02496884|473557613|FG002|Overall Study|Counted twice as enrolled|0|||
131528372|NCT02496884|473557614|FG003|Overall Study|Counted twice as enrolled|0|||
131528373|NCT02496884|473557611|FG000|Overall Study|Withdrawal by Subject|0|||
131528374|NCT02496884|473557612|FG001|Overall Study|Withdrawal by Subject|3|||
131528375|NCT02496884|473557613|FG002|Overall Study|Withdrawal by Subject|0|||
131528376|NCT02496884|473557614|FG003|Overall Study|Withdrawal by Subject|0|||
131528377|NCT00097591|473557615|FG000|Overall Study|Withdrawal of consent|342|||
131528378|NCT00097591|473557616|FG001|Overall Study|Withdrawal of consent|323|||
131528379|NCT00097591|473557615|FG000|Overall Study|Less than 6 months on study drug|9|||
131528380|NCT00097591|473557616|FG001|Overall Study|Less than 6 months on study drug|7|||
131528381|NCT00097591|473557615|FG000|Overall Study|Unable to attend termination visit|53|||
131528382|NCT00097591|473557616|FG001|Overall Study|Unable to attend termination visit|51|||
131528383|NCT00097591|473557615|FG000|Overall Study|Lost to follow up|6|||
131528384|NCT00097591|473557616|FG001|Overall Study|Lost to follow up|10|||
131528385|NCT00097591|473557615|FG000|Overall Study|Other|0|||
131528386|NCT00097591|473557616|FG001|Overall Study|Other|3|||
131528387|NCT01557946|473557623|FG000|Overall Study|Adverse Event|3|||
131528388|NCT01557946|473557624|FG001|Overall Study|Adverse Event|0|||
131528389|NCT00575588|473557628|FG000|Overall Study|Adverse Event|11|||
131528390|NCT00575588|473557629|FG001|Overall Study|Adverse Event|13|||
131528391|NCT00575588|473557628|FG000|Overall Study|Withdrawal by Subject|27|||
131528392|NCT00575588|473557629|FG001|Overall Study|Withdrawal by Subject|31|||
131528393|NCT00575588|473557628|FG000|Overall Study|Lost to Follow-up|1|||
131528394|NCT00575588|473557629|FG001|Overall Study|Lost to Follow-up|3|||
131528395|NCT00575588|473557628|FG000|Overall Study|Death|4|||
131528396|NCT00575588|473557629|FG001|Overall Study|Death|2|||
131528397|NCT00575588|473557628|FG000|Overall Study|Incorrect enrollment|8|||
131528398|NCT00575588|473557629|FG001|Overall Study|Incorrect enrollment|4|||
131528399|NCT00575588|473557628|FG000|Overall Study|Study specific discontinuation criteria|203|||
131528400|NCT00575588|473557629|FG001|Overall Study|Study specific discontinuation criteria|218|||
131528401|NCT00575588|473557628|FG000|Overall Study|Severe non-compliance to protocol|5|||
131528402|NCT00575588|473557629|FG001|Overall Study|Severe non-compliance to protocol|7|||
131528403|NCT00575588|473557628|FG000|Overall Study|Safety reasons|2|||
131528404|NCT00575588|473557629|FG001|Overall Study|Safety reasons|1|||
131528405|NCT00575588|473557628|FG000|Overall Study|Elevated triglyceride|1|||
131528406|NCT00575588|473557629|FG001|Overall Study|Elevated triglyceride|0|||
131528407|NCT00575588|473557628|FG000|Overall Study|Patient moved|1|||
131528408|NCT00575588|473557629|FG001|Overall Study|Patient moved|3|||
131528409|NCT00575588|473557628|FG000|Overall Study|Impossible to determine HbA1c|0|||
131528410|NCT00575588|473557629|FG001|Overall Study|Impossible to determine HbA1c|1|||
131528411|NCT00614939|473557630|FG000|Overall Study|Withdrawal by Subject|10|||
131528412|NCT00614939|473557631|FG001|Overall Study|Withdrawal by Subject|17|||
131528413|NCT00614939|473557630|FG000|Overall Study|Study specific discontinuation criteris|13|||
131528414|NCT00614939|473557631|FG001|Overall Study|Study specific discontinuation criteris|16|||
131528415|NCT00614939|473557630|FG000|Overall Study|Adverse Event|2|||
131528416|NCT00614939|473557631|FG001|Overall Study|Adverse Event|5|||
131528417|NCT00614939|473557630|FG000|Overall Study|Incorrect enrollment|1|||
131528418|NCT00614939|473557631|FG001|Overall Study|Incorrect enrollment|2|||
131528419|NCT00614939|473557630|FG000|Overall Study|Death|4|||
131528420|NCT00614939|473557631|FG001|Overall Study|Death|3|||
131528421|NCT00614939|473557630|FG000|Overall Study|Poor/non-compliance|4|||
131528422|NCT00614939|473557631|FG001|Overall Study|Poor/non-compliance|0|||
131528423|NCT00614939|473557630|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
131528424|NCT00614939|473557631|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
131528425|NCT00840970|473557632|FG000|Overall Study|Adverse Event|0|||
131528426|NCT00840970|473557633|FG001|Overall Study|Adverse Event|0|||
131528427|NCT00840970|473557634|FG002|Overall Study|Adverse Event|1|||
131528428|NCT00504829|473557635|FG000|Overall Study|Protocol Violation|6|||
131528429|NCT00504829|473557636|FG001|Overall Study|Protocol Violation|4|||
131528430|NCT00504829|473557637|FG002|Overall Study|Protocol Violation|10|||
131528431|NCT01854827|473557638|FG000|Overall Study|Death|1|||
131528432|NCT02571452|473557639|FG000|Overall Study Treatment|Protocol Violation|0|||
131528433|NCT02571452|473557640|FG001|Overall Study Treatment|Protocol Violation|1|||
131528434|NCT02571452|473557639|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
131528435|NCT02571452|473557640|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
131528436|NCT02571452|473557639|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
131528437|NCT02571452|473557640|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
131528438|NCT00534352|473557641|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
131528439|NCT00534352|473557641|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
131528440|NCT00534352|473557641|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
131528441|NCT00534352|473557641|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
131528442|NCT00534352|473557641|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
131528443|NCT00534352|473557641|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
131528444|NCT04788147|473557642|FG000|Overall Study|Screen Failure|3|||
131528445|NCT04788147|473557643|FG001|Overall Study|Screen Failure|10|||
131528446|NCT04788147|473557642|FG000|Overall Study|Incomplete RMRS image session|2|||
131528447|NCT04788147|473557643|FG001|Overall Study|Incomplete RMRS image session|0|||
131528448|NCT05101252|473557644|FG000|Overall Study|Unsatisfactory Test Article|1|||
131528449|NCT05101252|473557645|FG001|Overall Study|Unsatisfactory Test Article|0|||
131528450|NCT05101252|473557644|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
131528451|NCT05101252|473557645|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
131528452|NCT05101252|473557644|FG000|Overall Study|Withdrew Consent during study|0|||
131528453|NCT05101252|473557645|FG001|Overall Study|Withdrew Consent during study|1|||
131528454|NCT05101252|473557644|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
131528455|NCT05101252|473557645|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
131528456|NCT02401672|473557648|FG000|Overall Study|Withdrawal by Subject|1|||
131528457|NCT02401672|473557649|FG001|Overall Study|Withdrawal by Subject|3|||
131528458|NCT00701051|473557650|FG000|Screening|Failed Screening|40|||
131528459|NCT00701051|473557651|FG001|Screening|Failed Screening|0|||
131528460|NCT00701051|473557652|FG002|Screening|Failed Screening|0|||
131528461|NCT00701051|473557650|FG000|Screening|Time conflicts|19|||
131528462|NCT00701051|473557651|FG001|Screening|Time conflicts|0|||
131528463|NCT00701051|473557652|FG002|Screening|Time conflicts|0|||
131528464|NCT00701051|473557650|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
131528465|NCT00701051|473557651|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
131528466|NCT00701051|473557652|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
131528467|NCT02059148|473557653|FG000|Treatment 1|Protocol Violation|0|||
131528468|NCT02059148|473557654|FG001|Treatment 1|Protocol Violation|0|||
131528469|NCT02059148|473557655|FG002|Treatment 1|Protocol Violation|0|||
131528470|NCT02059148|473557656|FG003|Treatment 1|Protocol Violation|0|||
131528471|NCT02059148|473557657|FG004|Treatment 1|Protocol Violation|0|||
131528472|NCT02059148|473557658|FG005|Treatment 1|Protocol Violation|1|||
131528473|NCT03321981|473557660|FG000|Overall Study|Progressive Disease (PD)|15|||
131528474|NCT03321981|473557661|FG001|Overall Study|Progressive Disease (PD)|30|||
131528475|NCT03321981|473557662|FG002|Overall Study|Progressive Disease (PD)|47|||
131528476|NCT03321981|473557660|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
131528477|NCT03321981|473557661|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
131528478|NCT03321981|473557662|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
131528479|NCT03321981|473557660|FG000|Overall Study|Adverse Event|0|||
131528480|NCT03321981|473557661|FG001|Overall Study|Adverse Event|0|||
131528481|NCT03321981|473557662|FG002|Overall Study|Adverse Event|2|||
131528482|NCT03321981|473557660|FG000|Overall Study|symptomatic deterioration|0|||
131528483|NCT03321981|473557661|FG001|Overall Study|symptomatic deterioration|1|||
131528484|NCT03321981|473557662|FG002|Overall Study|symptomatic deterioration|1|||
131528485|NCT03321981|473557660|FG000|Overall Study|Lack of compliance|0|||
131528486|NCT03321981|473557661|FG001|Overall Study|Lack of compliance|1|||
131528487|NCT03321981|473557662|FG002|Overall Study|Lack of compliance|0|||
131528488|NCT03321981|473557660|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
131528489|NCT03321981|473557661|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
131528490|NCT03321981|473557662|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
131528491|NCT03321981|473557660|FG000|Overall Study|Death|0|||
131528492|NCT03321981|473557661|FG001|Overall Study|Death|1|||
131528493|NCT03321981|473557662|FG002|Overall Study|Death|0|||
131528494|NCT03321981|473557660|FG000|Overall Study|Subject withdrawal of investigational product|0|||
131528495|NCT03321981|473557661|FG001|Overall Study|Subject withdrawal of investigational product|1|||
131528496|NCT03321981|473557662|FG002|Overall Study|Subject withdrawal of investigational product|0|||
131528497|NCT03321981|473557660|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
131528498|NCT03321981|473557661|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
131528499|NCT03321981|473557662|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
131528500|NCT03321981|473557660|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
131528501|NCT03321981|473557661|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
131528502|NCT03321981|473557662|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
131528503|NCT04111497|473557663|FG000|Overall Study|relapse of primary disease|1|||
131528504|NCT04111497|473557663|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
131528505|NCT03880578|473557664|FG000|Overall Study|Withdrawal by Subject|0|||
131528506|NCT03880578|473557665|FG001|Overall Study|Withdrawal by Subject|3|||
131528507|NCT03880578|473557666|FG002|Overall Study|Withdrawal by Subject|1|||
131528508|NCT03880578|473557664|FG000|Overall Study|Death|0|||
131528509|NCT03880578|473557665|FG001|Overall Study|Death|1|||
131528510|NCT03880578|473557666|FG002|Overall Study|Death|0|||
131528511|NCT04934670|473557667|FG000|Overall Study|Death|4|||
131528512|NCT04934670|473557668|FG001|Overall Study|Death|0|||
131528513|NCT04934670|473557667|FG000|Overall Study|Lost to Follow-up|1|||
131528514|NCT04934670|473557668|FG001|Overall Study|Lost to Follow-up|4|||
131528515|NCT02460198|473557669|FG000|Overall Study|Adverse Event|1|||
131528516|NCT02460198|473557670|FG001|Overall Study|Adverse Event|3|||
131528517|NCT02460198|473557669|FG000|Overall Study|Death|36|||
131528518|NCT02460198|473557670|FG001|Overall Study|Death|28|||
131528519|NCT02460198|473557669|FG000|Overall Study|Lost to Follow-up|1|||
131528520|NCT02460198|473557670|FG001|Overall Study|Lost to Follow-up|1|||
131528521|NCT02460198|473557669|FG000|Overall Study|Transferred to Extension Study|15|||
131528522|NCT02460198|473557670|FG001|Overall Study|Transferred to Extension Study|15|||
131528523|NCT02460198|473557669|FG000|Overall Study|Withdrawal by Subject|2|||
131528524|NCT02460198|473557670|FG001|Overall Study|Withdrawal by Subject|4|||
131528525|NCT02460198|473557669|FG000|Overall Study|Site Terminated By Sponsor|0|||
131528526|NCT02460198|473557670|FG001|Overall Study|Site Terminated By Sponsor|1|||
131528527|NCT02460198|473557669|FG000|Overall Study|Did Not Continue on Extension Study|6|||
131528528|NCT02460198|473557670|FG001|Overall Study|Did Not Continue on Extension Study|11|||
131528529|NCT04382612|473557671|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
131528530|NCT04666441|473557672|FG000|Overall Study|Lost to Follow-up|1|||
131528531|NCT04666441|473557673|FG001|Overall Study|Lost to Follow-up|4|||
131528532|NCT04666441|473557674|FG002|Overall Study|Lost to Follow-up|1|||
131528533|NCT04666441|473557675|FG003|Overall Study|Lost to Follow-up|3|||
131528534|NCT04666441|473557676|FG004|Overall Study|Lost to Follow-up|0|||
131528535|NCT04666441|473557677|FG005|Overall Study|Lost to Follow-up|2|||
131528536|NCT04666441|473557678|FG006|Overall Study|Lost to Follow-up|2|||
131528537|NCT04666441|473557679|FG007|Overall Study|Lost to Follow-up|2|||
131528538|NCT04666441|473557672|FG000|Overall Study|Subject Decision|1|||
131528539|NCT04666441|473557673|FG001|Overall Study|Subject Decision|1|||
131528540|NCT04666441|473557674|FG002|Overall Study|Subject Decision|3|||
131528541|NCT04666441|473557675|FG003|Overall Study|Subject Decision|1|||
131528542|NCT04666441|473557676|FG004|Overall Study|Subject Decision|0|||
131528543|NCT04666441|473557677|FG005|Overall Study|Subject Decision|1|||
131528544|NCT04666441|473557678|FG006|Overall Study|Subject Decision|3|||
131528545|NCT04666441|473557679|FG007|Overall Study|Subject Decision|2|||
131528546|NCT03285477|473557681|FG000|Treatment and Response Assessment Period|Death|1|||
131528547|NCT03285477|473557682|FG001|Treatment and Response Assessment Period|Death|0|||
131528548|NCT03285477|473557681|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
131658435|NCT01531673|474035309|FG010|Overall Study|Other|0|||
131528549|NCT03285477|473557682|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
131528550|NCT03285477|473557681|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
131528551|NCT03285477|473557682|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
131528552|NCT03285477|473557681|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
131528553|NCT03285477|473557682|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
131528554|NCT03285477|473557681|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
131528555|NCT03285477|473557682|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
131528556|NCT00836875|473557687|FG000|Overall Study|Death|3|||
131528557|NCT00836875|473557688|FG001|Overall Study|Death|2|||
131528558|NCT00836875|473557687|FG000|Overall Study|Withdrawal by Subject|0|||
131528559|NCT00836875|473557688|FG001|Overall Study|Withdrawal by Subject|1|||
131528560|NCT01045447|473559634|FG000|Overall Study|Adverse Event|0|||
131528561|NCT01045447|473559635|FG001|Overall Study|Adverse Event|1|||
131528562|NCT01045447|473559634|FG000|Overall Study|Lack of Efficacy|3|||
131528563|NCT01045447|473559635|FG001|Overall Study|Lack of Efficacy|1|||
131528564|NCT01045447|473559634|FG000|Overall Study|Protocol Violation|6|||
131528565|NCT01045447|473559635|FG001|Overall Study|Protocol Violation|3|||
131528566|NCT01045447|473559634|FG000|Overall Study|Withdrawal Criteria|10|||
131528567|NCT01045447|473559635|FG001|Overall Study|Withdrawal Criteria|10|||
131528568|NCT01045447|473559634|FG000|Overall Study|Unclassified|17|||
131528569|NCT01045447|473559635|FG001|Overall Study|Unclassified|13|||
131528570|NCT00129987|473559637|FG000|1st Educational Session|Withdrawal by Subject|141|||
131528571|NCT00129987|473559638|FG001|1st Educational Session|Withdrawal by Subject|109|||
131528572|NCT00129987|473559637|FG000|1 Year|Withdrawal by Subject|32|||
131528573|NCT00129987|473559638|FG001|1 Year|Withdrawal by Subject|21|||
131528574|NCT00116805|473559642|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
131528575|NCT00116805|473559643|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
131528576|NCT00116805|473559642|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
131528577|NCT00116805|473559643|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
131528578|NCT00116805|473559642|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
131528579|NCT00116805|473559643|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
131528580|NCT00116805|473559642|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
131528581|NCT00116805|473559643|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
131528582|NCT00116805|473559642|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
131528583|NCT00116805|473559643|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
131528584|NCT00116805|473559642|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
131528585|NCT00116805|473559643|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
131528586|NCT00116805|473559642|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
131528587|NCT00116805|473559643|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
131528588|NCT00116805|473559642|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
131528589|NCT00116805|473559643|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
131528590|NCT00116805|473559642|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
131528591|NCT00116805|473559643|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
131528592|NCT00116805|473559642|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
131528593|NCT00116805|473559643|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
131528594|NCT00116805|473559642|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
131528595|NCT00116805|473559643|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
131528596|NCT00116805|473559642|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
131528597|NCT00116805|473559643|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
131528598|NCT00116805|473559642|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
131528599|NCT00116805|473559643|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
131528600|NCT00116805|473559642|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
131528601|NCT00116805|473559643|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
131528602|NCT00116805|473559642|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
131528603|NCT00116805|473559643|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
131528604|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
131528605|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
131528606|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
131528607|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
131528608|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
131528609|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
131528610|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
131528611|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
131528612|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
131528613|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
131528614|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
131528615|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
131528616|NCT00116805|473559642|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
131528617|NCT00116805|473559643|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
131528618|NCT00116805|473559642|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
131528619|NCT00116805|473559643|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
131528620|NCT00116805|473559642|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
131528621|NCT00116805|473559643|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
131528622|NCT00116805|473559642|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
131528623|NCT00116805|473559643|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
131528624|NCT00116805|473559642|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
131528625|NCT00116805|473559643|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
131528626|NCT00116805|473559642|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
131528627|NCT00116805|473559643|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
131528628|NCT00116805|473559642|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
131528629|NCT00116805|473559643|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
131528630|NCT00116805|473559642|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
131528631|NCT00116805|473559643|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
131528632|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
131528633|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
131528634|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
131528635|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
131528636|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
131528637|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
131528638|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
131528639|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
131528640|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
131528641|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
131528642|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
131528643|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
131528644|NCT00116805|473559642|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
131528645|NCT00116805|473559643|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
131528646|NCT00116805|473559642|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
131528647|NCT00116805|473559643|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
131528648|NCT00116805|473559642|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
131528649|NCT00116805|473559643|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
131528650|NCT00116805|473559642|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
131528651|NCT00116805|473559643|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
131528652|NCT00116805|473559642|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
131528653|NCT00116805|473559643|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
131528654|NCT00116805|473559642|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
131528655|NCT00116805|473559643|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
131528656|NCT00116805|473559642|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
131528657|NCT00116805|473559643|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
131528658|NCT00116805|473559642|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
131528659|NCT00116805|473559643|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
131528660|NCT00116805|473559642|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
131528661|NCT00116805|473559643|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
131528662|NCT00116805|473559642|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
131528663|NCT00116805|473559643|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
131528664|NCT01782131|473559644|FG000|Overall Study|Death|93|||
131528665|NCT01782131|473559645|FG001|Overall Study|Death|96|||
131528666|NCT01782131|473559644|FG000|Overall Study|Lost to Follow-up|1|||
131528667|NCT01782131|473559645|FG001|Overall Study|Lost to Follow-up|3|||
131528668|NCT01782131|473559644|FG000|Overall Study|Withdrawal by Subject|10|||
131528669|NCT01782131|473559645|FG001|Overall Study|Withdrawal by Subject|10|||
131528670|NCT01782131|473559644|FG000|Overall Study|Randomized but not treated|5|||
131528671|NCT01782131|473559645|FG001|Overall Study|Randomized but not treated|5|||
131528672|NCT01782131|473559644|FG000|Overall Study|Reason not provided|0|||
131528673|NCT01782131|473559645|FG001|Overall Study|Reason not provided|1|||
131528674|NCT00796718|473559646|FG000|Overall Study|Adverse Event|2|||
131528675|NCT00796718|473559646|FG000|Overall Study|Exclusion Criteria|1|||
131528676|NCT00796718|473559646|FG000|Overall Study|Lost to Follow-up|5|||
131528677|NCT00796718|473559646|FG000|Overall Study|Withdrawal by Informed Consent|1|||
131528678|NCT03266588|473559647|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
131528679|NCT03266588|473559648|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
131528680|NCT03266588|473559649|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
131528681|NCT03266588|473559647|FG000|Observational Period|Withdrawal by Subject|44|||
131528682|NCT03266588|473559648|FG001|Observational Period|Withdrawal by Subject|22|||
131528683|NCT03266588|473559649|FG002|Observational Period|Withdrawal by Subject|13|||
131528684|NCT03266588|473559647|FG000|Observational Period|Non-compliance|18|||
131528685|NCT03266588|473559648|FG001|Observational Period|Non-compliance|12|||
131528686|NCT03266588|473559649|FG002|Observational Period|Non-compliance|10|||
131528687|NCT03266588|473559647|FG000|Observational Period|Lost to Follow-up|8|||
131528688|NCT03266588|473559648|FG001|Observational Period|Lost to Follow-up|12|||
131528689|NCT03266588|473559649|FG002|Observational Period|Lost to Follow-up|4|||
131528690|NCT03266588|473559647|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
131528691|NCT03266588|473559648|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
131528692|NCT03266588|473559649|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
131528693|NCT03266588|473559647|FG000|Observational Period|Protocol Deviation|1|||
131528694|NCT03266588|473559648|FG001|Observational Period|Protocol Deviation|0|||
131528695|NCT03266588|473559649|FG002|Observational Period|Protocol Deviation|0|||
131528696|NCT03266588|473559647|FG000|Observational Period|Other Reasons|3|||
131528697|NCT03266588|473559648|FG001|Observational Period|Other Reasons|0|||
131528698|NCT03266588|473559649|FG002|Observational Period|Other Reasons|1|||
131528699|NCT03266588|473559647|FG000|Long-term Treatment Period|Adverse Event|33|||
131528700|NCT03266588|473559648|FG001|Long-term Treatment Period|Adverse Event|17|||
131528701|NCT03266588|473559649|FG002|Long-term Treatment Period|Adverse Event|8|||
131528702|NCT03266588|473559647|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
131528703|NCT03266588|473559648|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
131528704|NCT03266588|473559649|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
131528705|NCT03266588|473559647|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
131528706|NCT03266588|473559648|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
131528707|NCT03266588|473559649|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
131528708|NCT03266588|473559647|FG000|Long-term Treatment Period|Non-Compliance|126|||
131528709|NCT03266588|473559648|FG001|Long-term Treatment Period|Non-Compliance|57|||
131528710|NCT03266588|473559649|FG002|Long-term Treatment Period|Non-Compliance|7|||
131528711|NCT03266588|473559647|FG000|Long-term Treatment Period|Pregnancy|11|||
131528712|NCT03266588|473559648|FG001|Long-term Treatment Period|Pregnancy|5|||
131528713|NCT03266588|473559649|FG002|Long-term Treatment Period|Pregnancy|0|||
131528714|NCT03266588|473559647|FG000|Long-term Treatment Period|Protocol Deviation|17|||
131528715|NCT03266588|473559648|FG001|Long-term Treatment Period|Protocol Deviation|10|||
131528716|NCT03266588|473559649|FG002|Long-term Treatment Period|Protocol Deviation|4|||
131528717|NCT03266588|473559647|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
131528718|NCT03266588|473559648|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
131528719|NCT03266588|473559649|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
131528720|NCT03266588|473559647|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
131528721|NCT03266588|473559648|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
131528722|NCT03266588|473559649|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
131528723|NCT03266588|473559647|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
131528724|NCT03266588|473559648|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
131528725|NCT03266588|473559649|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
131528726|NCT03266588|473559647|FG000|Long-term Treatment Period|Other Reasons|5|||
131528727|NCT03266588|473559648|FG001|Long-term Treatment Period|Other Reasons|0|||
131528728|NCT03266588|473559649|FG002|Long-term Treatment Period|Other Reasons|0|||
131528729|NCT03266588|473559647|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
131528730|NCT03266588|473559648|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
131528731|NCT03266588|473559649|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
131528732|NCT00317772|473559650|FG000|Overall Study|Adverse Event|0|||
131528733|NCT00317772|473559651|FG001|Overall Study|Adverse Event|0|||
131528734|NCT00317772|473559652|FG002|Overall Study|Adverse Event|0|||
131528735|NCT00317772|473559653|FG003|Overall Study|Adverse Event|2|||
131528736|NCT00317772|473559650|FG000|Overall Study|Disease Progression|2|||
131528737|NCT00317772|473559651|FG001|Overall Study|Disease Progression|2|||
131528738|NCT00317772|473559652|FG002|Overall Study|Disease Progression|1|||
131528739|NCT00317772|473559653|FG003|Overall Study|Disease Progression|7|||
131528740|NCT01075321|473559660|FG000|Overall Study|Withdrawal by Subject|0|||
131528741|NCT01075321|473559661|FG001|Overall Study|Withdrawal by Subject|0|||
131528742|NCT01075321|473559662|FG002|Overall Study|Withdrawal by Subject|1|||
131528743|NCT01075321|473559663|FG003|Overall Study|Withdrawal by Subject|1|||
131528744|NCT01075321|473559660|FG000|Overall Study|Protocol Violation|0|||
131528745|NCT01075321|473559661|FG001|Overall Study|Protocol Violation|0|||
131528746|NCT01075321|473559662|FG002|Overall Study|Protocol Violation|1|||
131528747|NCT01075321|473559663|FG003|Overall Study|Protocol Violation|0|||
131528748|NCT01075321|473559660|FG000|Overall Study|Treatment Incomplete due to progression|1|||
131528749|NCT01075321|473559661|FG001|Overall Study|Treatment Incomplete due to progression|0|||
131528750|NCT01075321|473559662|FG002|Overall Study|Treatment Incomplete due to progression|0|||
131528751|NCT01075321|473559663|FG003|Overall Study|Treatment Incomplete due to progression|0|||
131528752|NCT01075321|473559660|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
131528753|NCT01075321|473559661|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
131528754|NCT01075321|473559662|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
131528755|NCT01075321|473559663|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
131528756|NCT01933334|473559667|FG000|Overall Study|Adverse Event|5|||
131528757|NCT01933334|473559668|FG001|Overall Study|Adverse Event|1|||
131528758|NCT01933334|473559667|FG000|Overall Study|Withdrawal by Subject|0|||
131528759|NCT01933334|473559668|FG001|Overall Study|Withdrawal by Subject|1|||
131528760|NCT02032901|473559669|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
131528761|NCT02032901|473559670|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
131528762|NCT02032901|473559669|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
131528763|NCT02032901|473559670|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
131528764|NCT01722331|473559671|FG000|Part 1|Adverse Event|5|||
131528765|NCT01722331|473559672|FG001|Part 1|Adverse Event|0|||
131528766|NCT01722331|473559673|FG002|Part 1|Adverse Event|0|||
131528767|NCT01722331|473559674|FG003|Part 1|Adverse Event|0|||
131528768|NCT01722331|473559675|FG004|Part 1|Adverse Event|0|||
131528769|NCT01722331|473559676|FG005|Part 1|Adverse Event|0|||
131528770|NCT01722331|473559677|FG006|Part 1|Adverse Event|0|||
131528771|NCT01722331|473559671|FG000|Part 1|Lack of Efficacy|0|||
131528772|NCT01722331|473559672|FG001|Part 1|Lack of Efficacy|0|||
131528773|NCT01722331|473559673|FG002|Part 1|Lack of Efficacy|1|||
131528774|NCT01722331|473559674|FG003|Part 1|Lack of Efficacy|0|||
131528775|NCT01722331|473559675|FG004|Part 1|Lack of Efficacy|2|||
131528776|NCT01722331|473559676|FG005|Part 1|Lack of Efficacy|0|||
131528777|NCT01722331|473559677|FG006|Part 1|Lack of Efficacy|0|||
131528778|NCT01722331|473559671|FG000|Part 1|Lost to Follow-up|1|||
131528779|NCT01722331|473559672|FG001|Part 1|Lost to Follow-up|0|||
131528780|NCT01722331|473559673|FG002|Part 1|Lost to Follow-up|2|||
131528781|NCT01722331|473559674|FG003|Part 1|Lost to Follow-up|0|||
131528782|NCT01722331|473559675|FG004|Part 1|Lost to Follow-up|1|||
131528783|NCT01722331|473559676|FG005|Part 1|Lost to Follow-up|0|||
131528784|NCT01722331|473559677|FG006|Part 1|Lost to Follow-up|0|||
131528785|NCT01722331|473559671|FG000|Part 1|Physician Decision|0|||
131528786|NCT01722331|473559672|FG001|Part 1|Physician Decision|0|||
131528787|NCT01722331|473559673|FG002|Part 1|Physician Decision|3|||
131528788|NCT01722331|473559674|FG003|Part 1|Physician Decision|0|||
131528789|NCT01722331|473559675|FG004|Part 1|Physician Decision|1|||
131528790|NCT01722331|473559676|FG005|Part 1|Physician Decision|0|||
131528791|NCT01722331|473559677|FG006|Part 1|Physician Decision|0|||
131528792|NCT01722331|473559671|FG000|Part 1|Pregnancy|1|||
131528793|NCT01722331|473559672|FG001|Part 1|Pregnancy|0|||
131528794|NCT01722331|473559673|FG002|Part 1|Pregnancy|0|||
131528795|NCT01722331|473559674|FG003|Part 1|Pregnancy|0|||
131528796|NCT01722331|473559675|FG004|Part 1|Pregnancy|0|||
131528797|NCT01722331|473559676|FG005|Part 1|Pregnancy|0|||
131528798|NCT01722331|473559677|FG006|Part 1|Pregnancy|0|||
131528799|NCT01722331|473559671|FG000|Part 1|Progressive Disease|0|||
131528800|NCT01722331|473559672|FG001|Part 1|Progressive Disease|0|||
131528801|NCT01722331|473559673|FG002|Part 1|Progressive Disease|0|||
131528802|NCT01722331|473559674|FG003|Part 1|Progressive Disease|0|||
131528803|NCT01722331|473559675|FG004|Part 1|Progressive Disease|1|||
131528804|NCT01722331|473559676|FG005|Part 1|Progressive Disease|0|||
131528805|NCT01722331|473559677|FG006|Part 1|Progressive Disease|0|||
131528806|NCT01722331|473559671|FG000|Part 1|Protocol Violation|1|||
131528807|NCT01722331|473559672|FG001|Part 1|Protocol Violation|0|||
131528808|NCT01722331|473559673|FG002|Part 1|Protocol Violation|0|||
131528809|NCT01722331|473559674|FG003|Part 1|Protocol Violation|0|||
131528810|NCT01722331|473559675|FG004|Part 1|Protocol Violation|1|||
131528811|NCT01722331|473559676|FG005|Part 1|Protocol Violation|0|||
131528812|NCT01722331|473559677|FG006|Part 1|Protocol Violation|0|||
131528813|NCT01722331|473559671|FG000|Part 1|Withdrawal by Subject|2|||
131528814|NCT01722331|473559672|FG001|Part 1|Withdrawal by Subject|0|||
131528815|NCT01722331|473559673|FG002|Part 1|Withdrawal by Subject|3|||
131528816|NCT01722331|473559674|FG003|Part 1|Withdrawal by Subject|0|||
131528817|NCT01722331|473559675|FG004|Part 1|Withdrawal by Subject|3|||
131528818|NCT01722331|473559676|FG005|Part 1|Withdrawal by Subject|0|||
131528819|NCT01722331|473559677|FG006|Part 1|Withdrawal by Subject|0|||
131528820|NCT01722331|473559671|FG000|Part 2|Adverse Event|3|||
131528821|NCT01722331|473559672|FG001|Part 2|Adverse Event|0|||
131528822|NCT01722331|473559673|FG002|Part 2|Adverse Event|0|||
131528823|NCT01722331|473559674|FG003|Part 2|Adverse Event|0|||
131528824|NCT01722331|473559675|FG004|Part 2|Adverse Event|0|||
131528825|NCT01722331|473559676|FG005|Part 2|Adverse Event|1|||
131528826|NCT01722331|473559677|FG006|Part 2|Adverse Event|0|||
131528827|NCT01722331|473559671|FG000|Part 2|Lack of Efficacy|3|||
131528828|NCT01722331|473559672|FG001|Part 2|Lack of Efficacy|0|||
131528829|NCT01722331|473559673|FG002|Part 2|Lack of Efficacy|11|||
131528830|NCT01722331|473559674|FG003|Part 2|Lack of Efficacy|0|||
131528831|NCT01722331|473559675|FG004|Part 2|Lack of Efficacy|0|||
131528832|NCT01722331|473559676|FG005|Part 2|Lack of Efficacy|3|||
131528833|NCT01722331|473559677|FG006|Part 2|Lack of Efficacy|3|||
131528834|NCT01722331|473559671|FG000|Part 2|Lost to Follow-up|0|||
131528835|NCT01722331|473559672|FG001|Part 2|Lost to Follow-up|0|||
131528836|NCT01722331|473559673|FG002|Part 2|Lost to Follow-up|3|||
131528837|NCT01722331|473559674|FG003|Part 2|Lost to Follow-up|0|||
131528838|NCT01722331|473559675|FG004|Part 2|Lost to Follow-up|0|||
131528839|NCT01722331|473559676|FG005|Part 2|Lost to Follow-up|1|||
131528840|NCT01722331|473559677|FG006|Part 2|Lost to Follow-up|1|||
131528841|NCT01722331|473559671|FG000|Part 2|Non-Compliance with Study Drug|1|||
131528842|NCT01722331|473559672|FG001|Part 2|Non-Compliance with Study Drug|0|||
131528843|NCT01722331|473559673|FG002|Part 2|Non-Compliance with Study Drug|1|||
131528844|NCT01722331|473559674|FG003|Part 2|Non-Compliance with Study Drug|0|||
131528845|NCT01722331|473559675|FG004|Part 2|Non-Compliance with Study Drug|0|||
131528846|NCT01722331|473559676|FG005|Part 2|Non-Compliance with Study Drug|0|||
131528847|NCT01722331|473559677|FG006|Part 2|Non-Compliance with Study Drug|0|||
131528848|NCT01722331|473559671|FG000|Part 2|Physician Decision|0|||
131528849|NCT01722331|473559672|FG001|Part 2|Physician Decision|0|||
131528850|NCT01722331|473559673|FG002|Part 2|Physician Decision|2|||
131528851|NCT01722331|473559674|FG003|Part 2|Physician Decision|0|||
131528852|NCT01722331|473559675|FG004|Part 2|Physician Decision|0|||
131528853|NCT01722331|473559676|FG005|Part 2|Physician Decision|0|||
131528854|NCT01722331|473559677|FG006|Part 2|Physician Decision|0|||
131528855|NCT01722331|473559671|FG000|Part 2|Pregnancy|0|||
131528856|NCT01722331|473559672|FG001|Part 2|Pregnancy|0|||
131528857|NCT01722331|473559673|FG002|Part 2|Pregnancy|0|||
131528858|NCT01722331|473559674|FG003|Part 2|Pregnancy|0|||
131528859|NCT01722331|473559675|FG004|Part 2|Pregnancy|0|||
131528860|NCT01722331|473559676|FG005|Part 2|Pregnancy|1|||
131528861|NCT01722331|473559677|FG006|Part 2|Pregnancy|0|||
131528862|NCT01722331|473559671|FG000|Part 2|Progressive Disease|0|||
131528863|NCT01722331|473559672|FG001|Part 2|Progressive Disease|0|||
131528864|NCT01722331|473559673|FG002|Part 2|Progressive Disease|1|||
131528865|NCT01722331|473559674|FG003|Part 2|Progressive Disease|0|||
131528866|NCT01722331|473559675|FG004|Part 2|Progressive Disease|0|||
131528867|NCT01722331|473559676|FG005|Part 2|Progressive Disease|0|||
131528868|NCT01722331|473559677|FG006|Part 2|Progressive Disease|0|||
131528869|NCT01722331|473559671|FG000|Part 2|Protocol Violation|1|||
131528870|NCT01722331|473559672|FG001|Part 2|Protocol Violation|0|||
131528871|NCT01722331|473559673|FG002|Part 2|Protocol Violation|0|||
131528872|NCT01722331|473559674|FG003|Part 2|Protocol Violation|0|||
131528873|NCT01722331|473559675|FG004|Part 2|Protocol Violation|0|||
131528874|NCT01722331|473559676|FG005|Part 2|Protocol Violation|0|||
131528875|NCT01722331|473559677|FG006|Part 2|Protocol Violation|0|||
131528876|NCT01722331|473559671|FG000|Part 2|Withdrawal by Subject|5|||
131528877|NCT01722331|473559672|FG001|Part 2|Withdrawal by Subject|0|||
131528878|NCT01722331|473559673|FG002|Part 2|Withdrawal by Subject|3|||
131528879|NCT01722331|473559674|FG003|Part 2|Withdrawal by Subject|0|||
131528880|NCT01722331|473559675|FG004|Part 2|Withdrawal by Subject|0|||
131528881|NCT01722331|473559676|FG005|Part 2|Withdrawal by Subject|2|||
131528882|NCT01722331|473559677|FG006|Part 2|Withdrawal by Subject|2|||
131528883|NCT01722331|473559671|FG000|Part 2|Other Protocol Specified Criteria|6|||
131528884|NCT01722331|473559672|FG001|Part 2|Other Protocol Specified Criteria|0|||
131528885|NCT01722331|473559673|FG002|Part 2|Other Protocol Specified Criteria|10|||
131528886|NCT01722331|473559674|FG003|Part 2|Other Protocol Specified Criteria|0|||
131528887|NCT01722331|473559675|FG004|Part 2|Other Protocol Specified Criteria|0|||
131528888|NCT01722331|473559676|FG005|Part 2|Other Protocol Specified Criteria|2|||
131528889|NCT01722331|473559677|FG006|Part 2|Other Protocol Specified Criteria|1|||
131528890|NCT01722331|473559671|FG000|Part 3|Adverse Event|2|||
131528891|NCT01722331|473559672|FG001|Part 3|Adverse Event|2|||
131528892|NCT01722331|473559673|FG002|Part 3|Adverse Event|0|||
131528893|NCT01722331|473559674|FG003|Part 3|Adverse Event|1|||
131528894|NCT01722331|473559675|FG004|Part 3|Adverse Event|0|||
131528895|NCT01722331|473559676|FG005|Part 3|Adverse Event|0|||
131528896|NCT01722331|473559677|FG006|Part 3|Adverse Event|0|||
131528897|NCT01722331|473559671|FG000|Part 3|Death|1|||
131528898|NCT01722331|473559672|FG001|Part 3|Death|0|||
131528899|NCT01722331|473559673|FG002|Part 3|Death|0|||
131528900|NCT01722331|473559674|FG003|Part 3|Death|0|||
131528901|NCT01722331|473559675|FG004|Part 3|Death|0|||
131528902|NCT01722331|473559676|FG005|Part 3|Death|0|||
131528903|NCT01722331|473559677|FG006|Part 3|Death|0|||
131528904|NCT01722331|473559671|FG000|Part 3|Lack of Efficacy|1|||
131528905|NCT01722331|473559672|FG001|Part 3|Lack of Efficacy|0|||
131528906|NCT01722331|473559673|FG002|Part 3|Lack of Efficacy|0|||
131528907|NCT01722331|473559674|FG003|Part 3|Lack of Efficacy|0|||
131528908|NCT01722331|473559675|FG004|Part 3|Lack of Efficacy|0|||
131528909|NCT01722331|473559676|FG005|Part 3|Lack of Efficacy|0|||
131528910|NCT01722331|473559677|FG006|Part 3|Lack of Efficacy|0|||
131528911|NCT01722331|473559671|FG000|Part 3|Lost to Follow-up|3|||
131528912|NCT01722331|473559672|FG001|Part 3|Lost to Follow-up|4|||
131528913|NCT01722331|473559673|FG002|Part 3|Lost to Follow-up|0|||
131528914|NCT01722331|473559674|FG003|Part 3|Lost to Follow-up|0|||
131528915|NCT01722331|473559675|FG004|Part 3|Lost to Follow-up|0|||
131528916|NCT01722331|473559676|FG005|Part 3|Lost to Follow-up|1|||
131528917|NCT01722331|473559677|FG006|Part 3|Lost to Follow-up|0|||
131528918|NCT01722331|473559671|FG000|Part 3|Non-Compliance with Study Drug|0|||
131528919|NCT01722331|473559672|FG001|Part 3|Non-Compliance with Study Drug|1|||
131528920|NCT01722331|473559673|FG002|Part 3|Non-Compliance with Study Drug|0|||
131528921|NCT01722331|473559674|FG003|Part 3|Non-Compliance with Study Drug|0|||
131528922|NCT01722331|473559675|FG004|Part 3|Non-Compliance with Study Drug|0|||
131528923|NCT01722331|473559676|FG005|Part 3|Non-Compliance with Study Drug|0|||
131528924|NCT01722331|473559677|FG006|Part 3|Non-Compliance with Study Drug|0|||
131528925|NCT01722331|473559671|FG000|Part 3|Physician Decision|1|||
131528926|NCT01722331|473559672|FG001|Part 3|Physician Decision|1|||
131528927|NCT01722331|473559673|FG002|Part 3|Physician Decision|0|||
131528928|NCT01722331|473559674|FG003|Part 3|Physician Decision|0|||
131528929|NCT01722331|473559675|FG004|Part 3|Physician Decision|0|||
131528930|NCT01722331|473559676|FG005|Part 3|Physician Decision|0|||
131528931|NCT01722331|473559677|FG006|Part 3|Physician Decision|1|||
131528932|NCT01722331|473559671|FG000|Part 3|Protocol Violation|2|||
131528933|NCT01722331|473559672|FG001|Part 3|Protocol Violation|1|||
131528934|NCT01722331|473559673|FG002|Part 3|Protocol Violation|0|||
131528935|NCT01722331|473559674|FG003|Part 3|Protocol Violation|0|||
131528936|NCT01722331|473559675|FG004|Part 3|Protocol Violation|0|||
131528937|NCT01722331|473559676|FG005|Part 3|Protocol Violation|0|||
131528938|NCT01722331|473559677|FG006|Part 3|Protocol Violation|0|||
131528939|NCT01722331|473559671|FG000|Part 3|Withdrawal by Subject|4|||
131528940|NCT01722331|473559672|FG001|Part 3|Withdrawal by Subject|7|||
131528941|NCT01722331|473559673|FG002|Part 3|Withdrawal by Subject|0|||
131528942|NCT01722331|473559674|FG003|Part 3|Withdrawal by Subject|0|||
131528943|NCT01722331|473559675|FG004|Part 3|Withdrawal by Subject|0|||
131528944|NCT01722331|473559676|FG005|Part 3|Withdrawal by Subject|2|||
131528945|NCT01722331|473559677|FG006|Part 3|Withdrawal by Subject|1|||
131528946|NCT01722331|473559671|FG000|Part 3|Other Protocol Specified Criteria|1|||
131528947|NCT01722331|473559672|FG001|Part 3|Other Protocol Specified Criteria|1|||
131528948|NCT01722331|473559673|FG002|Part 3|Other Protocol Specified Criteria|0|||
131528949|NCT01722331|473559674|FG003|Part 3|Other Protocol Specified Criteria|0|||
131528950|NCT01722331|473559675|FG004|Part 3|Other Protocol Specified Criteria|0|||
131528951|NCT01722331|473559676|FG005|Part 3|Other Protocol Specified Criteria|0|||
131528952|NCT01722331|473559677|FG006|Part 3|Other Protocol Specified Criteria|0|||
131528953|NCT00262834|473559678|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
131528954|NCT00262834|473559679|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
131528955|NCT00003457|473559682|FG000|Overall Study|Not evaluable|9|||
131528956|NCT02525133|473559688|FG000|Overall Study|Adverse Event|0|||
131528957|NCT02525133|473559689|FG001|Overall Study|Adverse Event|1|||
131528958|NCT02525133|473559688|FG000|Overall Study|Death|0|||
131528959|NCT02525133|473559689|FG001|Overall Study|Death|1|||
131528960|NCT02525133|473559688|FG000|Overall Study|did not meet randomization criteria|1|||
131528961|NCT02525133|473559689|FG001|Overall Study|did not meet randomization criteria|0|||
131528962|NCT02525133|473559688|FG000|Overall Study|Lost to Follow-up|5|||
131528963|NCT02525133|473559689|FG001|Overall Study|Lost to Follow-up|1|||
131528964|NCT02525133|473559688|FG000|Overall Study|randomized not enrolled|3|||
131528965|NCT02525133|473559689|FG001|Overall Study|randomized not enrolled|0|||
131528966|NCT02525133|473559688|FG000|Overall Study|Withdrawal by Subject|1|||
131528967|NCT02525133|473559689|FG001|Overall Study|Withdrawal by Subject|0|||
131528968|NCT01075074|473559690|FG000|Overall Study|Surgeon changed to open incisional case|1|||
131528969|NCT01075074|473559691|FG001|Overall Study|Surgeon changed to open incisional case|2|||
131528970|NCT01075074|473559692|FG002|Overall Study|Surgeon changed to open incisional case|2|||
131528971|NCT01054729|473559693|FG000|Overall Study|Randomized but Not Treated|0|||
131528972|NCT01054729|473559694|FG001|Overall Study|Randomized but Not Treated|1|||
131528973|NCT01054729|473559695|FG002|Overall Study|Randomized but Not Treated|0|||
131528974|NCT01054729|473559696|FG003|Overall Study|Randomized but Not Treated|0|||
131528975|NCT01054729|473559693|FG000|Overall Study|Adverse Event|1|||
131528976|NCT01054729|473559694|FG001|Overall Study|Adverse Event|1|||
131528977|NCT01054729|473559695|FG002|Overall Study|Adverse Event|2|||
131528978|NCT01054729|473559696|FG003|Overall Study|Adverse Event|1|||
131528979|NCT01054729|473559693|FG000|Overall Study|Withdrawal by Subject|1|||
131528980|NCT01054729|473559694|FG001|Overall Study|Withdrawal by Subject|0|||
131528981|NCT01054729|473559695|FG002|Overall Study|Withdrawal by Subject|1|||
131528982|NCT01054729|473559696|FG003|Overall Study|Withdrawal by Subject|0|||
131528983|NCT01054729|473559693|FG000|Overall Study|Lost to Follow-up|0|||
131528984|NCT01054729|473559694|FG001|Overall Study|Lost to Follow-up|1|||
131528985|NCT01054729|473559695|FG002|Overall Study|Lost to Follow-up|0|||
131528986|NCT01054729|473559696|FG003|Overall Study|Lost to Follow-up|0|||
131528987|NCT01054729|473559693|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
131528988|NCT01054729|473559694|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
131528989|NCT01054729|473559695|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
131528990|NCT01054729|473559696|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
131528991|NCT01054729|473559693|FG000|Overall Study|Non-responder|1|||
131528992|NCT01054729|473559694|FG001|Overall Study|Non-responder|0|||
131528993|NCT01054729|473559695|FG002|Overall Study|Non-responder|1|||
131528994|NCT01054729|473559696|FG003|Overall Study|Non-responder|1|||
131528995|NCT01054729|473559693|FG000|Overall Study|PEG/RBV Non-responder|1|||
131528996|NCT01054729|473559694|FG001|Overall Study|PEG/RBV Non-responder|0|||
131528997|NCT01054729|473559695|FG002|Overall Study|PEG/RBV Non-responder|1|||
131528998|NCT01054729|473559696|FG003|Overall Study|PEG/RBV Non-responder|0|||
131528999|NCT01054729|473559693|FG000|Overall Study|Personal/Obligations|0|||
131529000|NCT01054729|473559694|FG001|Overall Study|Personal/Obligations|1|||
131529001|NCT01054729|473559695|FG002|Overall Study|Personal/Obligations|0|||
131529002|NCT01054729|473559696|FG003|Overall Study|Personal/Obligations|0|||
131529003|NCT01054729|473559693|FG000|Overall Study|Subject moved|0|||
131529004|NCT01054729|473559694|FG001|Overall Study|Subject moved|0|||
131529005|NCT01054729|473559695|FG002|Overall Study|Subject moved|1|||
131529006|NCT01054729|473559696|FG003|Overall Study|Subject moved|0|||
131529007|NCT01054729|473559693|FG000|Overall Study|Lack of Efficacy|0|||
131529008|NCT01054729|473559694|FG001|Overall Study|Lack of Efficacy|0|||
131529009|NCT01054729|473559695|FG002|Overall Study|Lack of Efficacy|0|||
131529010|NCT01054729|473559696|FG003|Overall Study|Lack of Efficacy|1|||
131529011|NCT04265755|473559697|FG000|Overall Study|Withdrawal by Subject|39|||
131529012|NCT04265755|473559697|FG000|Overall Study|Decision by sponsor|2|||
131529013|NCT04265755|473559697|FG000|Overall Study|Lost to Follow-up|11|||
131529014|NCT04265755|473559697|FG000|Overall Study|Death|1|||
131529015|NCT01575561|473559698|FG000|Overall Study|Adverse Event|9|||
131529016|NCT01575561|473559698|FG000|Overall Study|Lack of Efficacy|8|||
131529017|NCT01575561|473559698|FG000|Overall Study|Lost to Follow-up|6|||
131529018|NCT01575561|473559698|FG000|Overall Study|Protocol Violation|4|||
131529019|NCT01575561|473559698|FG000|Overall Study|Withdrawal by Subject|11|||
131529020|NCT01575561|473559698|FG000|Overall Study|administration|1|||
131529021|NCT01992536|473559699|FG000|Overall Study|Administrative Reason|0|||
131529022|NCT01992536|473559700|FG001|Overall Study|Administrative Reason|0|||
131529023|NCT01992536|473559701|FG002|Overall Study|Administrative Reason|0|||
131529024|NCT01992536|473559702|FG003|Overall Study|Administrative Reason|0|||
131529025|NCT01992536|473559703|FG004|Overall Study|Administrative Reason|0|||
131529026|NCT01992536|473559704|FG005|Overall Study|Administrative Reason|0|||
131529027|NCT01992536|473559705|FG006|Overall Study|Administrative Reason|7|||
131529028|NCT01992536|473559706|FG007|Overall Study|Administrative Reason|0|||
131529029|NCT01992536|473559707|FG008|Overall Study|Administrative Reason|0|||
131529030|NCT01992536|473559708|FG009|Overall Study|Administrative Reason|0|||
131529031|NCT01992536|473559699|FG000|Overall Study|Lost to Follow-up|4|||
131529032|NCT01992536|473559700|FG001|Overall Study|Lost to Follow-up|2|||
131529033|NCT01992536|473559701|FG002|Overall Study|Lost to Follow-up|1|||
131529034|NCT01992536|473559702|FG003|Overall Study|Lost to Follow-up|0|||
131529035|NCT01992536|473559703|FG004|Overall Study|Lost to Follow-up|0|||
131529036|NCT01992536|473559704|FG005|Overall Study|Lost to Follow-up|1|||
131529037|NCT01992536|473559705|FG006|Overall Study|Lost to Follow-up|0|||
131529038|NCT01992536|473559706|FG007|Overall Study|Lost to Follow-up|0|||
131529039|NCT01992536|473559707|FG008|Overall Study|Lost to Follow-up|1|||
131529040|NCT01992536|473559708|FG009|Overall Study|Lost to Follow-up|1|||
131529041|NCT01992536|473559699|FG000|Overall Study|Withdrawal by Subject|0|||
131529042|NCT01992536|473559700|FG001|Overall Study|Withdrawal by Subject|1|||
131529043|NCT01992536|473559701|FG002|Overall Study|Withdrawal by Subject|0|||
131529044|NCT01992536|473559702|FG003|Overall Study|Withdrawal by Subject|2|||
131529045|NCT01992536|473559703|FG004|Overall Study|Withdrawal by Subject|0|||
131529046|NCT01992536|473559704|FG005|Overall Study|Withdrawal by Subject|0|||
131529047|NCT01992536|473559705|FG006|Overall Study|Withdrawal by Subject|0|||
131529048|NCT01992536|473559706|FG007|Overall Study|Withdrawal by Subject|0|||
131529049|NCT01992536|473559707|FG008|Overall Study|Withdrawal by Subject|0|||
131529050|NCT01992536|473559708|FG009|Overall Study|Withdrawal by Subject|0|||
131529051|NCT00406029|473559716|FG000|Overall Study|Adverse Event|12|||
131529052|NCT00406029|473559717|FG001|Overall Study|Adverse Event|2|||
131529053|NCT00406029|473559718|FG002|Overall Study|Adverse Event|5|||
131529054|NCT00406029|473559719|FG003|Overall Study|Adverse Event|10|||
131529055|NCT00406029|473559720|FG004|Overall Study|Adverse Event|7|||
131529056|NCT00406029|473559716|FG000|Overall Study|Withdrawal by Subject|3|||
131529057|NCT00406029|473559717|FG001|Overall Study|Withdrawal by Subject|4|||
131529058|NCT00406029|473559718|FG002|Overall Study|Withdrawal by Subject|2|||
131529059|NCT00406029|473559719|FG003|Overall Study|Withdrawal by Subject|2|||
131529060|NCT00406029|473559720|FG004|Overall Study|Withdrawal by Subject|0|||
131529061|NCT00406029|473559716|FG000|Overall Study|Protocol Violation|1|||
131529062|NCT00406029|473559717|FG001|Overall Study|Protocol Violation|2|||
131529063|NCT00406029|473559718|FG002|Overall Study|Protocol Violation|0|||
131529064|NCT00406029|473559719|FG003|Overall Study|Protocol Violation|2|||
131529065|NCT00406029|473559720|FG004|Overall Study|Protocol Violation|0|||
131529066|NCT00406029|473559716|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
131529067|NCT00406029|473559717|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
131529068|NCT00406029|473559718|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
131529069|NCT00406029|473559719|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
131529070|NCT00406029|473559720|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
131529071|NCT00406029|473559716|FG000|Overall Study|Randomized in Error|0|||
131529072|NCT00406029|473559717|FG001|Overall Study|Randomized in Error|0|||
131529073|NCT00406029|473559718|FG002|Overall Study|Randomized in Error|2|||
131529074|NCT00406029|473559719|FG003|Overall Study|Randomized in Error|3|||
131529075|NCT00406029|473559720|FG004|Overall Study|Randomized in Error|1|||
131529076|NCT03669081|473559721|FG000|Overall Study|Data could not be validated|1|||
131529077|NCT03669081|473559722|FG001|Overall Study|Data could not be validated|1|||
131529078|NCT01925183|473559723|FG000|Overall Study|Adverse Event|1|||
131529079|NCT01925183|473559724|FG001|Overall Study|Adverse Event|0|||
131529080|NCT01046110|473559725|FG000|Overall Study|Adverse Event|9|||
131529081|NCT01046110|473559726|FG001|Overall Study|Adverse Event|2|||
131529082|NCT01046110|473559725|FG000|Overall Study|Lack of Efficacy|0|||
131529083|NCT01046110|473559726|FG001|Overall Study|Lack of Efficacy|1|||
131529084|NCT01046110|473559725|FG000|Overall Study|Protocol Violation|7|||
131529085|NCT01046110|473559726|FG001|Overall Study|Protocol Violation|12|||
131529086|NCT01046110|473559725|FG000|Overall Study|Withdrawal Criteria|3|||
131529087|NCT01046110|473559726|FG001|Overall Study|Withdrawal Criteria|5|||
131529088|NCT01046110|473559725|FG000|Overall Study|Unclassified|36|||
131529089|NCT01046110|473559726|FG001|Overall Study|Unclassified|35|||
131529090|NCT04079933|473559731|FG000|Overall Study|Withdrawal by Subject|3|||
131529091|NCT04079933|473559732|FG001|Overall Study|Withdrawal by Subject|4|||
131529092|NCT04079933|473559731|FG000|Overall Study|Lost to Follow-up|0|||
131529093|NCT04079933|473559732|FG001|Overall Study|Lost to Follow-up|1|||
131529094|NCT04796610|473559733|FG000|Overall Study|Withdrawal by Subject|1|||
131529095|NCT04796610|473559734|FG001|Overall Study|Withdrawal by Subject|0|||
131529096|NCT04796610|473559735|FG002|Overall Study|Withdrawal by Subject|0|||
131529097|NCT04796610|473559736|FG003|Overall Study|Withdrawal by Subject|0|||
131529098|NCT04796610|473559733|FG000|Overall Study|Lost to Follow-up|2|||
131529099|NCT04796610|473559734|FG001|Overall Study|Lost to Follow-up|0|||
131529100|NCT04796610|473559735|FG002|Overall Study|Lost to Follow-up|1|||
131529101|NCT04796610|473559736|FG003|Overall Study|Lost to Follow-up|1|||
131529102|NCT01459796|473559737|FG000|Overall Study|Non compliance with protocol|2|||
131529103|NCT01459796|473559738|FG001|Overall Study|Non compliance with protocol|4|||
131529104|NCT01459796|473559737|FG000|Overall Study|Adverse Event|5|||
131529105|NCT01459796|473559738|FG001|Overall Study|Adverse Event|5|||
131529106|NCT01459796|473559737|FG000|Overall Study|Withdrawal by Subject|6|||
131529107|NCT01459796|473559738|FG001|Overall Study|Withdrawal by Subject|3|||
131529108|NCT01459796|473559737|FG000|Overall Study|Lost to Follow-up|5|||
131529109|NCT01459796|473559738|FG001|Overall Study|Lost to Follow-up|4|||
131529110|NCT01459796|473559737|FG000|Overall Study|Reason unspecified|1|||
131529111|NCT01459796|473559738|FG001|Overall Study|Reason unspecified|2|||
131529112|NCT01459796|473559737|FG000|Overall Study|Decision by the sponsor|75|||
131529113|NCT01459796|473559738|FG001|Overall Study|Decision by the sponsor|108|||
131529114|NCT00345579|473559739|FG000|Overall Study|Adverse Event|9|||
131529115|NCT00345579|473559740|FG001|Overall Study|Adverse Event|6|||
131529116|NCT00345579|473559739|FG000|Overall Study|Protocol Violation|14|||
131529117|NCT00345579|473559740|FG001|Overall Study|Protocol Violation|5|||
131529118|NCT00345579|473559739|FG000|Overall Study|Withdrawal by Subject|50|||
131529119|NCT00345579|473559740|FG001|Overall Study|Withdrawal by Subject|17|||
131529120|NCT00345579|473559739|FG000|Overall Study|Lost to Follow-up|82|||
131529121|NCT00345579|473559740|FG001|Overall Study|Lost to Follow-up|36|||
131529122|NCT00345579|473559739|FG000|Overall Study|Other|9|||
131529123|NCT00345579|473559740|FG001|Overall Study|Other|1|||
131529124|NCT00413413|473559741|FG000|Single-Blind|Adverse Event|0|||
131529125|NCT00413413|473559742|FG001|Single-Blind|Adverse Event|9|||
131529126|NCT00413413|473559743|FG002|Single-Blind|Adverse Event|0|||
131529127|NCT00413413|473559741|FG000|Single-Blind|Lack of Efficacy|0|||
131529128|NCT00413413|473559742|FG001|Single-Blind|Lack of Efficacy|5|||
131529129|NCT00413413|473559743|FG002|Single-Blind|Lack of Efficacy|0|||
131529130|NCT00413413|473559741|FG000|Single-Blind|Subject no longer requires study drug|0|||
131529131|NCT00413413|473559742|FG001|Single-Blind|Subject no longer requires study drug|151|||
131529132|NCT00413413|473559743|FG002|Single-Blind|Subject no longer requires study drug|0|||
131529133|NCT00413413|473559741|FG000|Single-Blind|Protocol Violation|0|||
131529134|NCT00413413|473559742|FG001|Single-Blind|Protocol Violation|16|||
131529135|NCT00413413|473559743|FG002|Single-Blind|Protocol Violation|0|||
131529136|NCT00413413|473559741|FG000|Single-Blind|Withdrawal by Subject|0|||
131529137|NCT00413413|473559742|FG001|Single-Blind|Withdrawal by Subject|27|||
131529138|NCT00413413|473559743|FG002|Single-Blind|Withdrawal by Subject|0|||
131529139|NCT00413413|473559741|FG000|Single-Blind|Lost to Follow-up|0|||
131529140|NCT00413413|473559742|FG001|Single-Blind|Lost to Follow-up|8|||
131529141|NCT00413413|473559743|FG002|Single-Blind|Lost to Follow-up|0|||
131529142|NCT00413413|473559741|FG000|Double-Blind|Adverse Event|6|||
131529143|NCT00413413|473559742|FG001|Double-Blind|Adverse Event|0|||
131529144|NCT00413413|473559743|FG002|Double-Blind|Adverse Event|5|||
131529145|NCT00413413|473559741|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
131529146|NCT00413413|473559742|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
131529147|NCT00413413|473559743|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
131529148|NCT00413413|473559741|FG000|Double-Blind|Protocol deviation|1|||
131529149|NCT00413413|473559742|FG001|Double-Blind|Protocol deviation|2|||
131529150|NCT00413413|473559743|FG002|Double-Blind|Protocol deviation|1|||
131529151|NCT00413413|473559741|FG000|Double-Blind|Subject withdrew consent|4|||
131529152|NCT00413413|473559742|FG001|Double-Blind|Subject withdrew consent|6|||
131529153|NCT00413413|473559743|FG002|Double-Blind|Subject withdrew consent|9|||
131529154|NCT00413413|473559741|FG000|Double-Blind|Lost to Follow-up|3|||
131529155|NCT00413413|473559742|FG001|Double-Blind|Lost to Follow-up|4|||
131529156|NCT00413413|473559743|FG002|Double-Blind|Lost to Follow-up|2|||
131529157|NCT02673697|473559746|FG000|Overall Study|Adverse Event|2|||
131529158|NCT02673697|473559747|FG001|Overall Study|Adverse Event|0|||
131529159|NCT02673697|473559746|FG000|Overall Study|Death|32|||
131529160|NCT02673697|473559747|FG001|Overall Study|Death|24|||
131529161|NCT02673697|473559746|FG000|Overall Study|Lost to Follow-up|5|||
131529162|NCT02673697|473559747|FG001|Overall Study|Lost to Follow-up|2|||
131529163|NCT02673697|473559746|FG000|Overall Study|Physician Decision|2|||
131529164|NCT02673697|473559747|FG001|Overall Study|Physician Decision|1|||
131529165|NCT02673697|473559746|FG000|Overall Study|Withdrawal by Subject|10|||
131529166|NCT02673697|473559747|FG001|Overall Study|Withdrawal by Subject|7|||
131529167|NCT02673697|473559746|FG000|Overall Study|Change subj medical status|1|||
131529168|NCT02673697|473559747|FG001|Overall Study|Change subj medical status|2|||
131529169|NCT02673697|473559746|FG000|Overall Study|Explant|10|||
131529170|NCT02673697|473559747|FG001|Overall Study|Explant|5|||
131529171|NCT02673697|473559746|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
131529172|NCT02673697|473559747|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
131529173|NCT00437489|473559748|FG000|Overall Study|Study terminated by sponsor|23|||
131529174|NCT00437489|473559749|FG001|Overall Study|Study terminated by sponsor|21|||
131529175|NCT00437489|473559748|FG000|Overall Study|Lost to Follow-up|0|||
131529176|NCT00437489|473559749|FG001|Overall Study|Lost to Follow-up|1|||
131529177|NCT03634579|473559756|FG000|Overall Study|study termination|9|||
131529178|NCT03321019|473559764|FG000|Overall Study|Withdrawal by Subject|0|||
131529179|NCT03321019|473559765|FG001|Overall Study|Withdrawal by Subject|6|||
131529180|NCT03321019|473559764|FG000|Overall Study|Lost to Follow-up|0|||
131529181|NCT03321019|473559765|FG001|Overall Study|Lost to Follow-up|22|||
131529182|NCT00817089|473559766|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
131529183|NCT00817089|473559767|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
131529184|NCT00817089|473559768|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
131529185|NCT00817089|473559769|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
131529186|NCT00817089|473559766|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
131529187|NCT00817089|473559767|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
131529188|NCT00817089|473559768|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
131529189|NCT00817089|473559769|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
131529190|NCT03783923|473559770|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
131529191|NCT03783923|473559771|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
131529192|NCT03783923|473559770|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
131529193|NCT03783923|473559771|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
131529194|NCT03783923|473559770|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131529195|NCT03783923|473559771|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
131529196|NCT03783923|473559770|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
131529197|NCT03783923|473559771|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
131529198|NCT03783923|473559770|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
131529199|NCT03783923|473559771|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
131529200|NCT01785602|473559775|FG000|Overall Study|Withdrawal by Subject|2|||
131529201|NCT01785602|473559776|FG001|Overall Study|Withdrawal by Subject|0|||
131529202|NCT01785602|473559775|FG000|Overall Study|Lost to Follow-up|1|||
131529203|NCT01785602|473559776|FG001|Overall Study|Lost to Follow-up|1|||
131529204|NCT01785602|473559775|FG000|Overall Study|Adverse Event|3|||
131529205|NCT01785602|473559776|FG001|Overall Study|Adverse Event|5|||
131529206|NCT01785602|473559775|FG000|Overall Study|Administrative problems|7|||
131529207|NCT01785602|473559776|FG001|Overall Study|Administrative problems|3|||
131529208|NCT02041429|473559778|FG000|Overall Study|Progressive Disease|2|||
131529209|NCT02041429|473559779|FG001|Overall Study|Progressive Disease|2|||
131529210|NCT02041429|473559780|FG002|Overall Study|Progressive Disease|3|||
131529211|NCT02041429|473559781|FG003|Overall Study|Progressive Disease|2|||
131529212|NCT02041429|473559778|FG000|Overall Study|Toxicity|0|||
131529213|NCT02041429|473559779|FG001|Overall Study|Toxicity|1|||
131529214|NCT02041429|473559780|FG002|Overall Study|Toxicity|4|||
131529215|NCT02041429|473559781|FG003|Overall Study|Toxicity|2|||
131529216|NCT02041429|473559778|FG000|Overall Study|Withdrawal by Subject|0|||
131529217|NCT02041429|473559779|FG001|Overall Study|Withdrawal by Subject|1|||
131529218|NCT02041429|473559780|FG002|Overall Study|Withdrawal by Subject|0|||
131529219|NCT02041429|473559781|FG003|Overall Study|Withdrawal by Subject|0|||
131529220|NCT02041429|473559778|FG000|Overall Study|On Maintenance Therapy|1|||
131529221|NCT02041429|473559779|FG001|Overall Study|On Maintenance Therapy|0|||
131529222|NCT02041429|473559780|FG002|Overall Study|On Maintenance Therapy|0|||
131529223|NCT02041429|473559781|FG003|Overall Study|On Maintenance Therapy|2|||
131529224|NCT00101101|473559782|FG000|Overall Study|never received vaccine|20|||
131529225|NCT01418209|473559783|FG000|Overall Study|Withdrawal by Subject|1|||
131529226|NCT01418209|473559784|FG001|Overall Study|Withdrawal by Subject|0|||
131529227|NCT01418209|473559785|FG002|Overall Study|Withdrawal by Subject|1|||
131529228|NCT01418209|473559783|FG000|Overall Study|Did not provide hot flash diary data|1|||
131529229|NCT01418209|473559784|FG001|Overall Study|Did not provide hot flash diary data|3|||
131529230|NCT01418209|473559785|FG002|Overall Study|Did not provide hot flash diary data|3|||
131529231|NCT01603875|473559787|FG000|Overall Study|Preexisting rabies antibody|3|||
131529232|NCT01603875|473559788|FG001|Overall Study|Preexisting rabies antibody|4|||
131529233|NCT01603875|473559789|FG002|Overall Study|Preexisting rabies antibody|3|||
131529234|NCT01603875|473559787|FG000|Overall Study|Lost to Follow-up|4|||
131529235|NCT01603875|473559788|FG001|Overall Study|Lost to Follow-up|3|||
131529236|NCT01603875|473559789|FG002|Overall Study|Lost to Follow-up|6|||
131529237|NCT01603875|473559787|FG000|Overall Study|Protocol Violation|0|||
131529238|NCT01603875|473559788|FG001|Overall Study|Protocol Violation|1|||
131529239|NCT01603875|473559789|FG002|Overall Study|Protocol Violation|0|||
131529240|NCT01971346|473559790|FG000|Overall Study|Protocol Violation|3|||
131529241|NCT01971346|473559790|FG000|Overall Study|Lost to Follow-up|2|||
131529242|NCT01971346|473559790|FG000|Overall Study|Withdrawal by Subject|2|||
131529243|NCT01971346|473559790|FG000|Overall Study|Physician Decision|1|||
131529244|NCT01578551|473559796|FG000|Overall Study|Adverse Event|1|||
131529245|NCT01578551|473559797|FG001|Overall Study|Adverse Event|0|||
131529246|NCT00766415|473559798|FG000|Overall Study|Withdrawal by Subject|0|||
131529247|NCT00766415|473559799|FG001|Overall Study|Withdrawal by Subject|1|||
131529248|NCT02752048|473559800|FG000|Overall Study|Withdrawal by Subject|0|||
131529249|NCT02752048|473559801|FG001|Overall Study|Withdrawal by Subject|0|||
131529250|NCT02752048|473559802|FG002|Overall Study|Withdrawal by Subject|3|||
131529251|NCT01312467|473559805|FG000|Overall Study|Adverse Event|4|||
131529252|NCT01312467|473559805|FG000|Overall Study|Lost to Follow-up|1|||
131529253|NCT01312467|473559805|FG000|Overall Study|Withdrawal by Subject|2|||
131529254|NCT01312467|473559805|FG000|Overall Study|Deported to country of origin|1|||
131529255|NCT01312467|473559805|FG000|Overall Study|Another medical condition|1|||
131529256|NCT01312467|473559805|FG000|Overall Study|Ineligible|4|||
131529257|NCT00132769|473559806|FG000|Overall Study|Withdrawal by Subject|1|||
131529258|NCT00132769|473559807|FG001|Overall Study|Withdrawal by Subject|3|||
131529259|NCT00132769|473559806|FG000|Overall Study|Lack of Efficacy|7|||
131529260|NCT00132769|473559807|FG001|Overall Study|Lack of Efficacy|6|||
131529261|NCT00132769|473559806|FG000|Overall Study|Adverse Event|2|||
131529262|NCT00132769|473559807|FG001|Overall Study|Adverse Event|1|||
131529263|NCT00132769|473559806|FG000|Overall Study|Protocol Violation|1|||
131529264|NCT00132769|473559807|FG001|Overall Study|Protocol Violation|1|||
131529265|NCT04452344|473559808|FG000|Overall Study|Withdrawal by Subject|3|||
131529266|NCT04452344|473559809|FG001|Overall Study|Withdrawal by Subject|6|||
131529267|NCT04452344|473559808|FG000|Overall Study|Adverse Event|1|||
131529268|NCT04452344|473559809|FG001|Overall Study|Adverse Event|2|||
131529269|NCT04452344|473559808|FG000|Overall Study|Lost to Follow-up|2|||
131529270|NCT04452344|473559809|FG001|Overall Study|Lost to Follow-up|2|||
131529271|NCT04452344|473559808|FG000|Overall Study|No Post-Op Visit|6|||
131529272|NCT04452344|473559809|FG001|Overall Study|No Post-Op Visit|7|||
131529273|NCT04095858|473559815|FG000|Overall Study|Death|1|||
131529274|NCT04095858|473559816|FG001|Overall Study|Death|0|||
131529275|NCT04095858|473559815|FG000|Overall Study|Study terminated by Sponsor|2|||
131529276|NCT04095858|473559816|FG001|Overall Study|Study terminated by Sponsor|4|||
131529277|NCT01344460|473559817|FG000|Overall Study|Withdrawal by Subject|1|||
131529278|NCT01344460|473559817|FG000|Overall Study|Lost to Follow-up|2|||
131529279|NCT00560833|473559818|FG000|Overall Study|Adverse Event|16|||
131529280|NCT00560833|473559819|FG001|Overall Study|Adverse Event|10|||
131529281|NCT00560833|473559820|FG002|Overall Study|Adverse Event|25|||
131529282|NCT00560833|473559821|FG003|Overall Study|Adverse Event|23|||
131529283|NCT00560833|473559822|FG004|Overall Study|Adverse Event|35|||
131529284|NCT00560833|473559818|FG000|Overall Study|Lost to Follow-up|0|||
131529285|NCT00560833|473559819|FG001|Overall Study|Lost to Follow-up|0|||
131529286|NCT00560833|473559820|FG002|Overall Study|Lost to Follow-up|1|||
131529287|NCT00560833|473559821|FG003|Overall Study|Lost to Follow-up|0|||
131529288|NCT00560833|473559822|FG004|Overall Study|Lost to Follow-up|0|||
131529289|NCT00560833|473559818|FG000|Overall Study|Lack of Efficacy|22|||
131529290|NCT00560833|473559819|FG001|Overall Study|Lack of Efficacy|9|||
131529291|NCT00560833|473559820|FG002|Overall Study|Lack of Efficacy|6|||
131529292|NCT00560833|473559821|FG003|Overall Study|Lack of Efficacy|4|||
131529293|NCT00560833|473559822|FG004|Overall Study|Lack of Efficacy|4|||
131529294|NCT00560833|473559818|FG000|Overall Study|Participant uncooperative|5|||
131529295|NCT00560833|473559819|FG001|Overall Study|Participant uncooperative|5|||
131529296|NCT00560833|473559820|FG002|Overall Study|Participant uncooperative|4|||
131529297|NCT00560833|473559821|FG003|Overall Study|Participant uncooperative|4|||
131529298|NCT00560833|473559822|FG004|Overall Study|Participant uncooperative|2|||
131529299|NCT00560833|473559818|FG000|Overall Study|Other|1|||
131529300|NCT00560833|473559819|FG001|Overall Study|Other|1|||
131529301|NCT00560833|473559820|FG002|Overall Study|Other|3|||
131529302|NCT00560833|473559821|FG003|Overall Study|Other|0|||
131529303|NCT00560833|473559822|FG004|Overall Study|Other|0|||
131529304|NCT00560833|473559818|FG000|Overall Study|Never received drug|0|||
131529305|NCT00560833|473559819|FG001|Overall Study|Never received drug|1|||
131529306|NCT00560833|473559820|FG002|Overall Study|Never received drug|0|||
131529307|NCT00560833|473559821|FG003|Overall Study|Never received drug|0|||
131529308|NCT00560833|473559822|FG004|Overall Study|Never received drug|1|||
131529309|NCT00898677|473559825|FG000|Overall Study|Adverse Event|0|||
131529310|NCT00898677|473559826|FG001|Overall Study|Adverse Event|0|||
131529311|NCT00898677|473559827|FG002|Overall Study|Adverse Event|1|||
131529312|NCT00898677|473559828|FG003|Overall Study|Adverse Event|0|||
131529313|NCT00898677|473559825|FG000|Overall Study|Lost to Follow-up|0|||
131529314|NCT00898677|473559826|FG001|Overall Study|Lost to Follow-up|0|||
131529315|NCT00898677|473559827|FG002|Overall Study|Lost to Follow-up|2|||
131529316|NCT00898677|473559828|FG003|Overall Study|Lost to Follow-up|0|||
131529317|NCT00898677|473559825|FG000|Overall Study|Protocol Violation|1|||
131529318|NCT00898677|473559826|FG001|Overall Study|Protocol Violation|1|||
131529319|NCT00898677|473559827|FG002|Overall Study|Protocol Violation|2|||
131529320|NCT00898677|473559828|FG003|Overall Study|Protocol Violation|0|||
131529321|NCT00898677|473559825|FG000|Overall Study|Withdrawal by Subject|0|||
131529322|NCT00898677|473559826|FG001|Overall Study|Withdrawal by Subject|0|||
131529323|NCT00898677|473559827|FG002|Overall Study|Withdrawal by Subject|0|||
131529324|NCT00898677|473559828|FG003|Overall Study|Withdrawal by Subject|1|||
131529325|NCT00898677|473559825|FG000|Overall Study|Not Treated: Adverse Event|0|||
131529326|NCT00898677|473559826|FG001|Overall Study|Not Treated: Adverse Event|2|||
131529327|NCT00898677|473559827|FG002|Overall Study|Not Treated: Adverse Event|1|||
131529328|NCT00898677|473559828|FG003|Overall Study|Not Treated: Adverse Event|0|||
131529329|NCT00898677|473559825|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
131529330|NCT00898677|473559826|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
131529331|NCT00898677|473559827|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
131529332|NCT00898677|473559828|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
131529333|NCT00898677|473559825|FG000|Overall Study|Not Treated: Pregnancy|0|||
131529334|NCT00898677|473559826|FG001|Overall Study|Not Treated: Pregnancy|0|||
131529335|NCT00898677|473559827|FG002|Overall Study|Not Treated: Pregnancy|1|||
131529336|NCT00898677|473559828|FG003|Overall Study|Not Treated: Pregnancy|0|||
131529337|NCT00898677|473559825|FG000|Overall Study|Not Treated: Protocol Violation|2|||
131529338|NCT00898677|473559826|FG001|Overall Study|Not Treated: Protocol Violation|0|||
131529339|NCT00898677|473559827|FG002|Overall Study|Not Treated: Protocol Violation|2|||
131529340|NCT00898677|473559828|FG003|Overall Study|Not Treated: Protocol Violation|0|||
131529341|NCT00898677|473559825|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
131529342|NCT00898677|473559826|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
131529343|NCT00898677|473559827|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
131529344|NCT00898677|473559828|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
131529345|NCT00898677|473559825|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
131529346|NCT00898677|473559826|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
131529347|NCT00898677|473559827|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
131529348|NCT00898677|473559828|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
131529349|NCT00898677|473559825|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
131529350|NCT00898677|473559826|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
131529351|NCT00898677|473559827|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
131529352|NCT00898677|473559828|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
131529353|NCT00898677|473559825|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
131529354|NCT00898677|473559826|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
131529355|NCT00898677|473559827|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
131529356|NCT00898677|473559828|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
131529357|NCT00898677|473559825|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
131529358|NCT00898677|473559826|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
131529359|NCT00898677|473559827|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
131529360|NCT00898677|473559828|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
131529361|NCT00898677|473559825|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
131529362|NCT00898677|473559826|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
131529363|NCT00898677|473559827|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
131529364|NCT00898677|473559828|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
131529365|NCT00898677|473559825|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
131529366|NCT00898677|473559826|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
131529367|NCT00898677|473559827|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
131529368|NCT00898677|473559828|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
131529369|NCT01071395|473561829|FG000|Overall Study|Withdrawal by Subject|2|||
131529370|NCT01071395|473561830|FG001|Overall Study|Withdrawal by Subject|1|||
131529371|NCT01071395|473561829|FG000|Overall Study|Adverse Event|3|||
131529372|NCT01071395|473561830|FG001|Overall Study|Adverse Event|1|||
131529373|NCT01539291|473561831|FG000|Study GS-US-312-0116|Adverse Event|9|||
131529374|NCT01539291|473561832|FG001|Study GS-US-312-0116|Adverse Event|0|||
131529375|NCT01539291|473561833|FG002|Study GS-US-312-0116|Adverse Event|0|||
131529376|NCT01539291|473561834|FG003|Study GS-US-312-0116|Adverse Event|0|||
131529377|NCT01539291|473561831|FG000|Study GS-US-312-0116|Physician Decision|1|||
131529378|NCT01539291|473561832|FG001|Study GS-US-312-0116|Physician Decision|0|||
131529379|NCT01539291|473561833|FG002|Study GS-US-312-0116|Physician Decision|0|||
131529380|NCT01539291|473561834|FG003|Study GS-US-312-0116|Physician Decision|0|||
131529381|NCT01539291|473561831|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
131529382|NCT01539291|473561832|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
131529383|NCT01539291|473561833|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
131529384|NCT01539291|473561834|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
131529385|NCT01539291|473561831|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
131529386|NCT01539291|473561832|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
131529387|NCT01539291|473561833|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
131529388|NCT01539291|473561834|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
131529389|NCT01539291|473561831|FG000|Study GS-US-312-0116|Other|1|||
131529390|NCT01539291|473561832|FG001|Study GS-US-312-0116|Other|0|||
131529391|NCT01539291|473561833|FG002|Study GS-US-312-0116|Other|0|||
131529392|NCT01539291|473561834|FG003|Study GS-US-312-0116|Other|0|||
131529393|NCT01539291|473561831|FG000|Study GS-US-312-0117|Adverse Event|22|||
131529394|NCT01539291|473561832|FG001|Study GS-US-312-0117|Adverse Event|1|||
131529395|NCT01539291|473561833|FG002|Study GS-US-312-0117|Adverse Event|9|||
131529396|NCT01539291|473561834|FG003|Study GS-US-312-0117|Adverse Event|12|||
131529397|NCT01539291|473561831|FG000|Study GS-US-312-0117|Physician Decision|9|||
131529398|NCT01539291|473561832|FG001|Study GS-US-312-0117|Physician Decision|0|||
131529399|NCT01539291|473561833|FG002|Study GS-US-312-0117|Physician Decision|6|||
131529400|NCT01539291|473561834|FG003|Study GS-US-312-0117|Physician Decision|4|||
131529401|NCT01539291|473561831|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
131529402|NCT01539291|473561832|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
131529403|NCT01539291|473561833|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
131529404|NCT01539291|473561834|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
131529405|NCT01539291|473561831|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
131529406|NCT01539291|473561832|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
131529407|NCT01539291|473561833|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
131529408|NCT01539291|473561834|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
131529409|NCT01539291|473561831|FG000|Study GS-US-312-0117|Other|2|||
131529410|NCT01539291|473561832|FG001|Study GS-US-312-0117|Other|1|||
131529411|NCT01539291|473561833|FG002|Study GS-US-312-0117|Other|1|||
131529412|NCT01539291|473561834|FG003|Study GS-US-312-0117|Other|1|||
131529413|NCT02239510|473561837|FG000|Overall Study|Lost to Follow-up|2|||
131529414|NCT02239510|473561838|FG001|Overall Study|Lost to Follow-up|1|||
131529415|NCT03859323|473561841|FG000|Overall Study|Lost to Follow-up|0|||
131529416|NCT03859323|473561842|FG001|Overall Study|Lost to Follow-up|0|||
131529417|NCT03859323|473561843|FG002|Overall Study|Lost to Follow-up|0|||
131529418|NCT03859323|473561844|FG003|Overall Study|Lost to Follow-up|0|||
131529419|NCT03859323|473561845|FG004|Overall Study|Lost to Follow-up|0|||
131529420|NCT03859323|473561846|FG005|Overall Study|Lost to Follow-up|0|||
131529421|NCT03859323|473561847|FG006|Overall Study|Lost to Follow-up|1|||
131529422|NCT03859323|473561848|FG007|Overall Study|Lost to Follow-up|0|||
131529423|NCT03859323|473561849|FG008|Overall Study|Lost to Follow-up|0|||
131529424|NCT03859323|473561850|FG009|Overall Study|Lost to Follow-up|0|||
131529425|NCT03859323|473561851|FG010|Overall Study|Lost to Follow-up|0|||
131529426|NCT03859323|473561852|FG011|Overall Study|Lost to Follow-up|0|||
131529427|NCT03859323|473561853|FG012|Overall Study|Lost to Follow-up|0|||
131529428|NCT03859323|473561841|FG000|Overall Study|Withdrawal by Subject|0|||
131529429|NCT03859323|473561842|FG001|Overall Study|Withdrawal by Subject|0|||
131529430|NCT03859323|473561843|FG002|Overall Study|Withdrawal by Subject|1|||
131529431|NCT03859323|473561844|FG003|Overall Study|Withdrawal by Subject|0|||
131529432|NCT03859323|473561845|FG004|Overall Study|Withdrawal by Subject|0|||
131529433|NCT03859323|473561846|FG005|Overall Study|Withdrawal by Subject|1|||
131529434|NCT03859323|473561847|FG006|Overall Study|Withdrawal by Subject|0|||
131529435|NCT03859323|473561848|FG007|Overall Study|Withdrawal by Subject|0|||
131529436|NCT03859323|473561849|FG008|Overall Study|Withdrawal by Subject|0|||
131529437|NCT03859323|473561850|FG009|Overall Study|Withdrawal by Subject|1|||
131529438|NCT03859323|473561851|FG010|Overall Study|Withdrawal by Subject|1|||
131529439|NCT03859323|473561852|FG011|Overall Study|Withdrawal by Subject|2|||
131529440|NCT03859323|473561853|FG012|Overall Study|Withdrawal by Subject|1|||
131529441|NCT03859323|473561841|FG000|Overall Study|Pregnancy|0|||
131529442|NCT03859323|473561842|FG001|Overall Study|Pregnancy|0|||
131529443|NCT03859323|473561843|FG002|Overall Study|Pregnancy|0|||
131529444|NCT03859323|473561844|FG003|Overall Study|Pregnancy|0|||
131529445|NCT03859323|473561845|FG004|Overall Study|Pregnancy|0|||
131529446|NCT03859323|473561846|FG005|Overall Study|Pregnancy|0|||
131529447|NCT03859323|473561847|FG006|Overall Study|Pregnancy|0|||
131529448|NCT03859323|473561848|FG007|Overall Study|Pregnancy|0|||
131529449|NCT03859323|473561849|FG008|Overall Study|Pregnancy|0|||
131529450|NCT03859323|473561850|FG009|Overall Study|Pregnancy|1|||
131529451|NCT03859323|473561851|FG010|Overall Study|Pregnancy|0|||
131529452|NCT03859323|473561852|FG011|Overall Study|Pregnancy|0|||
131529453|NCT03859323|473561853|FG012|Overall Study|Pregnancy|0|||
131529454|NCT01404312|473561856|FG000|Overall Study|Death|21|||
131529455|NCT01404312|473561857|FG001|Overall Study|Death|27|||
131529456|NCT01404312|473561856|FG000|Overall Study|Withdrawal by Subject|15|||
131529457|NCT01404312|473561857|FG001|Overall Study|Withdrawal by Subject|18|||
131529458|NCT01404312|473561856|FG000|Overall Study|Participant Unable to get to clinic|93|||
131529459|NCT01404312|473561857|FG001|Overall Study|Participant Unable to get to clinic|103|||
131529460|NCT01404312|473561856|FG000|Overall Study|Lost to Follow-up|115|||
131529461|NCT01404312|473561857|FG001|Overall Study|Lost to Follow-up|111|||
131529462|NCT01404312|473561856|FG000|Overall Study|Site closed|22|||
131529463|NCT01404312|473561857|FG001|Overall Study|Site closed|21|||
131529464|NCT01404312|473561856|FG000|Overall Study|Participant not willing to adhere to req|31|||
131529465|NCT01404312|473561857|FG001|Overall Study|Participant not willing to adhere to req|29|||
131529466|NCT01404312|473561856|FG000|Overall Study|Severe debilitation, unable to continue|1|||
131529467|NCT01404312|473561857|FG001|Overall Study|Severe debilitation, unable to continue|2|||
131529468|NCT04419493|473561858|FG000|Wash-out After Period 1|Adverse Event|1|||
131529469|NCT04419493|473561859|FG001|Wash-out After Period 1|Adverse Event|2|||
131529470|NCT04419493|473561860|FG002|Wash-out After Period 1|Adverse Event|1|||
131529471|NCT04419493|473561861|FG003|Wash-out After Period 1|Adverse Event|0|||
131529472|NCT00524134|473561862|FG000|Overall Study|Withdrawal by Subject|1|||
131529473|NCT00524134|473561862|FG000|Overall Study|Physician Decision|1|||
131529474|NCT03794089|473561863|FG000|Overall Study|Lost to Follow-up|4|||
131529475|NCT03794089|473561864|FG001|Overall Study|Lost to Follow-up|1|||
131529476|NCT03794089|473561863|FG000|Overall Study|Withdrawal by Subject|2|||
131529477|NCT03794089|473561864|FG001|Overall Study|Withdrawal by Subject|0|||
131529478|NCT03985423|473561865|FG000|Overall Study|Adverse Event|1|||
131529479|NCT03985423|473561865|FG000|Overall Study|Death|2|||
131529480|NCT03985423|473561865|FG000|Overall Study|Physician Decision|1|||
131529481|NCT03985423|473561865|FG000|Overall Study|Withdrawal by Subject|2|||
131529482|NCT03985423|473561865|FG000|Overall Study|Lack of insurance and citizenship|1|||
131529483|NCT01073618|473561868|FG000|Overall Study|Death|208|||
131529484|NCT01073618|473561868|FG000|Overall Study|Adverse Event|19|||
131529485|NCT01073618|473561868|FG000|Overall Study|Other|80|||
131529486|NCT00982020|473561869|FG000|Overall Study|Adverse Event|19|||
131529487|NCT00982020|473561870|FG001|Overall Study|Adverse Event|15|||
131529488|NCT00982020|473561869|FG000|Overall Study|Withdrawal by Subject|11|||
131529489|NCT00982020|473561870|FG001|Overall Study|Withdrawal by Subject|14|||
131529490|NCT00982020|473561869|FG000|Overall Study|Lost to Follow-up|5|||
131529491|NCT00982020|473561870|FG001|Overall Study|Lost to Follow-up|11|||
131529492|NCT00982020|473561869|FG000|Overall Study|Lack of Efficacy|10|||
131529493|NCT00982020|473561870|FG001|Overall Study|Lack of Efficacy|4|||
131529494|NCT00982020|473561869|FG000|Overall Study|Parent/Caregiver Decision|5|||
131529495|NCT00982020|473561870|FG001|Overall Study|Parent/Caregiver Decision|5|||
131529496|NCT00982020|473561869|FG000|Overall Study|Treatment Non-compliance|3|||
131529497|NCT00982020|473561870|FG001|Overall Study|Treatment Non-compliance|6|||
131529498|NCT00982020|473561869|FG000|Overall Study|Physician Decision|2|||
131529499|NCT00982020|473561870|FG001|Overall Study|Physician Decision|5|||
131529500|NCT00982020|473561869|FG000|Overall Study|Entry Criteria Not Met|2|||
131529501|NCT00982020|473561870|FG001|Overall Study|Entry Criteria Not Met|1|||
131529502|NCT00982020|473561869|FG000|Overall Study|Protocol Violation|0|||
131529503|NCT00982020|473561870|FG001|Overall Study|Protocol Violation|2|||
131529504|NCT00982020|473561869|FG000|Overall Study|Clinical Relapse|0|||
131529505|NCT00982020|473561870|FG001|Overall Study|Clinical Relapse|1|||
131529506|NCT00466193|473561871|FG000|Overall Study|Adverse Event|0|||
131529507|NCT00466193|473561872|FG001|Overall Study|Adverse Event|1|||
131529508|NCT00466193|473561871|FG000|Overall Study|Lost to Follow-up|2|||
131529509|NCT00466193|473561872|FG001|Overall Study|Lost to Follow-up|4|||
131529510|NCT00466193|473561871|FG000|Overall Study|Physician Decision|1|||
131529511|NCT00466193|473561872|FG001|Overall Study|Physician Decision|0|||
131529512|NCT00466193|473561871|FG000|Overall Study|Protocol Violation|1|||
131529513|NCT00466193|473561872|FG001|Overall Study|Protocol Violation|1|||
131529514|NCT00466193|473561871|FG000|Overall Study|Withdrawal by Subject|7|||
131529515|NCT00466193|473561872|FG001|Overall Study|Withdrawal by Subject|2|||
131529516|NCT00466193|473561871|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
131529517|NCT00466193|473561872|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
131529518|NCT02246998|473561873|FG000|Overall Study|Adverse Event|0|||
131529519|NCT02246998|473561874|FG001|Overall Study|Adverse Event|1|||
131529520|NCT02246998|473561875|FG002|Overall Study|Adverse Event|1|||
131529521|NCT02246998|473561876|FG003|Overall Study|Adverse Event|0|||
131529522|NCT02246998|473561873|FG000|Overall Study|Lost to Follow-up|1|||
131529523|NCT02246998|473561874|FG001|Overall Study|Lost to Follow-up|0|||
131529524|NCT02246998|473561875|FG002|Overall Study|Lost to Follow-up|0|||
131529525|NCT02246998|473561876|FG003|Overall Study|Lost to Follow-up|1|||
131529526|NCT02246998|473561873|FG000|Overall Study|Randomized but Never Dosed|1|||
131529527|NCT02246998|473561874|FG001|Overall Study|Randomized but Never Dosed|2|||
131529528|NCT02246998|473561875|FG002|Overall Study|Randomized but Never Dosed|2|||
131529529|NCT02246998|473561876|FG003|Overall Study|Randomized but Never Dosed|1|||
131529530|NCT01343082|473561879|FG000|The run-in Period|Not meeting criteria|3|||
131529531|NCT01343082|473561880|FG001|The run-in Period|Not meeting criteria|4|||
131529532|NCT01343082|473561881|FG002|The run-in Period|Not meeting criteria|5|||
131529533|NCT01343082|473561879|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
131529534|NCT01343082|473561880|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
131529535|NCT01343082|473561881|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
131529536|NCT01343082|473561879|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
131529537|NCT01343082|473561880|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
131529538|NCT01343082|473561881|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
131529539|NCT01343082|473561879|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
131529540|NCT01343082|473561880|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
131529541|NCT01343082|473561881|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
131529542|NCT01343082|473561879|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
131529543|NCT01343082|473561880|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
131529544|NCT01343082|473561881|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
131529545|NCT02554773|473561882|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
131529546|NCT02554773|473561883|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
131529547|NCT02554773|473561882|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
131529548|NCT02554773|473561883|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
131529549|NCT02554773|473561882|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
131529550|NCT02554773|473561883|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
131529551|NCT02554773|473561882|FG000|Original Dose Regimen (SAS 1)|Death|1|||
131529552|NCT02554773|473561883|FG001|Original Dose Regimen (SAS 1)|Death|0|||
131529553|NCT02554773|473561882|FG000|Original Dose Regimen (SAS 1)|Other|4|||
131529554|NCT02554773|473561883|FG001|Original Dose Regimen (SAS 1)|Other|0|||
131529555|NCT02554773|473561882|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
131529556|NCT02554773|473561883|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
131529557|NCT02554773|473561882|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
131529558|NCT02554773|473561883|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
131529559|NCT02554773|473561882|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
131529560|NCT02554773|473561883|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
131529561|NCT02554773|473561882|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
131529562|NCT02554773|473561883|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
131529563|NCT01854554|473561884|FG000|Overall Study|Denial of Insurance Coverage|12|||
131529564|NCT01854554|473561885|FG001|Overall Study|Denial of Insurance Coverage|0|||
131529565|NCT01854554|473561884|FG000|Overall Study|Decided to get treatment locally|1|||
131529566|NCT01854554|473561885|FG001|Overall Study|Decided to get treatment locally|5|||
131529567|NCT01854554|473561884|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
131529568|NCT01854554|473561885|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
131529569|NCT01854554|473561884|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
131529570|NCT01854554|473561885|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
131529571|NCT01854554|473561884|FG000|Overall Study|Progression|0|||
131529572|NCT01854554|473561885|FG001|Overall Study|Progression|1|||
131529573|NCT01854554|473561884|FG000|Overall Study|Lost to Follow-up|0|||
131529574|NCT01854554|473561885|FG001|Overall Study|Lost to Follow-up|1|||
131529575|NCT02819726|473561886|FG000|Part A (All Participants)|Lost to Follow-up|0|||
131529576|NCT02819726|473561887|FG001|Part A (All Participants)|Lost to Follow-up|1|||
131529577|NCT02819726|473561888|FG002|Part A (All Participants)|Lost to Follow-up|0|||
131529578|NCT02819726|473561889|FG003|Part A (All Participants)|Lost to Follow-up|0|||
131529579|NCT02819726|473561886|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
131529580|NCT02819726|473561887|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
131529581|NCT02819726|473561888|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
131529582|NCT02819726|473561889|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
131529583|NCT02819726|473561886|FG000|Part A (All Participants)|Protocol non-compliance|3|||
131529584|NCT02819726|473561887|FG001|Part A (All Participants)|Protocol non-compliance|4|||
131529585|NCT02819726|473561888|FG002|Part A (All Participants)|Protocol non-compliance|5|||
131529586|NCT02819726|473561889|FG003|Part A (All Participants)|Protocol non-compliance|0|||
131529587|NCT02819726|473561886|FG000|Part B (All Participants)|Lost to Follow-up|1|||
131529588|NCT02819726|473561887|FG001|Part B (All Participants)|Lost to Follow-up|1|||
131529589|NCT02819726|473561888|FG002|Part B (All Participants)|Lost to Follow-up|2|||
131529590|NCT02819726|473561889|FG003|Part B (All Participants)|Lost to Follow-up|2|||
131529591|NCT02819726|473561886|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
131529592|NCT02819726|473561887|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
131529593|NCT02819726|473561888|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
131529594|NCT02819726|473561889|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
131529595|NCT02819726|473561886|FG000|Part B (All Participants)|Protocol non-compliance|0|||
131529596|NCT02819726|473561887|FG001|Part B (All Participants)|Protocol non-compliance|0|||
131529597|NCT02819726|473561888|FG002|Part B (All Participants)|Protocol non-compliance|1|||
131529598|NCT02819726|473561889|FG003|Part B (All Participants)|Protocol non-compliance|0|||
131529599|NCT02613481|473561890|FG000|Overall Study|Lost to Follow-up|7|||
131529600|NCT02613481|473561890|FG000|Overall Study|Withdrawal by Subject|2|||
131529601|NCT00844194|473561891|FG000|Overall Study|Adverse Event|17|||
131529602|NCT00844194|473561892|FG001|Overall Study|Adverse Event|5|||
131529603|NCT00844194|473561891|FG000|Overall Study|Protocol Violation|1|||
131529604|NCT00844194|473561892|FG001|Overall Study|Protocol Violation|1|||
131529605|NCT00844194|473561891|FG000|Overall Study|Lost to Follow-up|1|||
131529606|NCT00844194|473561892|FG001|Overall Study|Lost to Follow-up|1|||
131529607|NCT00844194|473561891|FG000|Overall Study|Withdrawal by Subject|2|||
131529608|NCT00844194|473561892|FG001|Overall Study|Withdrawal by Subject|1|||
131529609|NCT00844194|473561891|FG000|Overall Study|Lack of Efficacy|3|||
131529610|NCT00844194|473561892|FG001|Overall Study|Lack of Efficacy|0|||
131529611|NCT00844194|473561891|FG000|Overall Study|Other reason (not specified)|1|||
131529612|NCT00844194|473561892|FG001|Overall Study|Other reason (not specified)|0|||
131529613|NCT02647658|473561893|FG000|Overall Study|Consent refusal|15|||
131529614|NCT02647658|473561894|FG001|Overall Study|Consent refusal|24|||
131529615|NCT00803023|473561895|FG000|Overall Study|Adverse Event|5|||
131529616|NCT00803023|473561896|FG001|Overall Study|Adverse Event|4|||
131529617|NCT00803023|473561897|FG002|Overall Study|Adverse Event|8|||
131529618|NCT00803023|473561898|FG003|Overall Study|Adverse Event|6|||
131529619|NCT00803023|473561895|FG000|Overall Study|Withdrawal by Subject|0|||
131529620|NCT00803023|473561896|FG001|Overall Study|Withdrawal by Subject|2|||
131529621|NCT00803023|473561897|FG002|Overall Study|Withdrawal by Subject|0|||
131529622|NCT00803023|473561898|FG003|Overall Study|Withdrawal by Subject|0|||
131529623|NCT00803023|473561895|FG000|Overall Study|Lost to Follow-up|0|||
131529624|NCT00803023|473561896|FG001|Overall Study|Lost to Follow-up|1|||
131529625|NCT00803023|473561897|FG002|Overall Study|Lost to Follow-up|2|||
131529626|NCT00803023|473561898|FG003|Overall Study|Lost to Follow-up|1|||
131529627|NCT00803023|473561895|FG000|Overall Study|Lack of Efficacy|0|||
131529628|NCT00803023|473561896|FG001|Overall Study|Lack of Efficacy|1|||
131529629|NCT00803023|473561897|FG002|Overall Study|Lack of Efficacy|1|||
131529630|NCT00803023|473561898|FG003|Overall Study|Lack of Efficacy|1|||
131529631|NCT01542528|473561899|FG000|Overall Study|Lost to Follow-up|2|||
131529632|NCT01542528|473561900|FG001|Overall Study|Lost to Follow-up|1|||
131529633|NCT01542528|473561899|FG000|Overall Study|Physician Decision|1|||
131529634|NCT01542528|473561900|FG001|Overall Study|Physician Decision|0|||
131529635|NCT01542528|473561899|FG000|Overall Study|Withdrawal by Subject|9|||
131529636|NCT01542528|473561900|FG001|Overall Study|Withdrawal by Subject|6|||
131529637|NCT01709227|473561907|FG000|Overall Study|Physician Decision|1|||
131529638|NCT01709227|473561908|FG001|Overall Study|Physician Decision|0|||
131529639|NCT01709227|473561907|FG000|Overall Study|Pleural Peritoneal communication|0|||
131529640|NCT01709227|473561908|FG001|Overall Study|Pleural Peritoneal communication|9|||
131529641|NCT00389324|473561911|FG000|Run-In Phase|Adverse Event|1|||
131529642|NCT00389324|473561911|FG000|Run-In Phase|Lost to Follow-up|1|||
131529643|NCT00389324|473561911|FG000|Run-In Phase|Withdrawal by Subject|1|||
131529644|NCT00389324|473561911|FG000|Subcutaneous Phase|Adverse Event|2|||
131529645|NCT00389324|473561911|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
131529646|NCT00389324|473561911|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
131529647|NCT00389324|473561911|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
131529648|NCT02317575|473561912|FG000|Period 1|Difficulty with venous cannulation|0|||
131529649|NCT02317575|473561913|FG001|Period 1|Difficulty with venous cannulation|1|||
131529650|NCT02317575|473561914|FG002|Period 1|Difficulty with venous cannulation|0|||
131529651|NCT02317575|473561915|FG003|Period 1|Difficulty with venous cannulation|0|||
131529652|NCT02317575|473561916|FG004|Period 1|Difficulty with venous cannulation|0|||
131529653|NCT02317575|473561912|FG000|Period 1|Withdrawal by Subject|1|||
131529654|NCT02317575|473561913|FG001|Period 1|Withdrawal by Subject|0|||
131529655|NCT02317575|473561914|FG002|Period 1|Withdrawal by Subject|0|||
131529656|NCT02317575|473561915|FG003|Period 1|Withdrawal by Subject|0|||
131529657|NCT02317575|473561916|FG004|Period 1|Withdrawal by Subject|0|||
131529658|NCT01666002|473561921|FG000|Overall Study|Lost to Follow-up|5|||
131529659|NCT01666002|473561922|FG001|Overall Study|Lost to Follow-up|0|||
131529660|NCT01233817|473561923|FG000|Overall Study|Lost to Follow-up|1|||
131529661|NCT01233817|473561923|FG000|Overall Study|Withdrawal by Subject|2|||
131529662|NCT02159482|473561924|FG000|Overall Study|Withdrawal by Subject|2|||
131529663|NCT02159482|473561924|FG000|Overall Study|Physician Decision|3|||
131529664|NCT01248884|473561927|FG000|Overall Study|Withdrawal by Subject|1|||
131529665|NCT01248884|473561928|FG001|Overall Study|Withdrawal by Subject|3|||
131529666|NCT01248884|473561929|FG002|Overall Study|Withdrawal by Subject|1|||
131529667|NCT01248884|473561927|FG000|Overall Study|Adverse Event|1|||
131529668|NCT01248884|473561928|FG001|Overall Study|Adverse Event|0|||
131529669|NCT01248884|473561929|FG002|Overall Study|Adverse Event|0|||
131529670|NCT02511431|473561930|FG000|Treatment|Lost to Follow-up|0|||
131529671|NCT02511431|473561931|FG001|Treatment|Lost to Follow-up|0|||
131529672|NCT02511431|473561932|FG002|Treatment|Lost to Follow-up|1|||
131529673|NCT02511431|473561933|FG003|Treatment|Lost to Follow-up|0|||
131529674|NCT02511431|473561934|FG004|Treatment|Lost to Follow-up|0|||
131529675|NCT02511431|473561935|FG005|Treatment|Lost to Follow-up|1|||
131529676|NCT04479618|473561936|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
131529677|NCT04479618|473561937|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
131529678|NCT04479618|473561938|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
131529679|NCT04479618|473561936|FG000|Overall Study|Lack of Efficacy|1|||
131529680|NCT04479618|473561937|FG001|Overall Study|Lack of Efficacy|0|||
131529681|NCT04479618|473561938|FG002|Overall Study|Lack of Efficacy|0|||
131529682|NCT04479618|473561936|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
131529683|NCT04479618|473561937|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
131529684|NCT04479618|473561938|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
131529685|NCT04479618|473561936|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
131529686|NCT04479618|473561937|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
131529687|NCT04479618|473561938|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
131529688|NCT04479618|473561936|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
131529689|NCT04479618|473561937|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
131529690|NCT04479618|473561938|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
131529691|NCT04479618|473561936|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
131529692|NCT04479618|473561937|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
131529693|NCT04479618|473561938|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
131529694|NCT01202773|473561939|FG000|Overall Study|Adverse Event|4|||
131529695|NCT01202773|473561940|FG001|Overall Study|Adverse Event|5|||
131529696|NCT01202773|473561941|FG002|Overall Study|Adverse Event|5|||
131529697|NCT01202773|473561939|FG000|Overall Study|Lack of Efficacy|5|||
131529698|NCT01202773|473561940|FG001|Overall Study|Lack of Efficacy|4|||
131529699|NCT01202773|473561941|FG002|Overall Study|Lack of Efficacy|9|||
131529700|NCT01202773|473561939|FG000|Overall Study|Entry Criteria Not Met|2|||
131529701|NCT01202773|473561940|FG001|Overall Study|Entry Criteria Not Met|0|||
131529702|NCT01202773|473561941|FG002|Overall Study|Entry Criteria Not Met|1|||
131529703|NCT01202773|473561939|FG000|Overall Study|Lost to Follow-up|1|||
131529704|NCT01202773|473561940|FG001|Overall Study|Lost to Follow-up|2|||
131529705|NCT01202773|473561941|FG002|Overall Study|Lost to Follow-up|2|||
131529706|NCT01202773|473561939|FG000|Overall Study|Withdrawal by Subject|13|||
131529707|NCT01202773|473561940|FG001|Overall Study|Withdrawal by Subject|6|||
131529708|NCT01202773|473561941|FG002|Overall Study|Withdrawal by Subject|5|||
131529709|NCT01202773|473561939|FG000|Overall Study|Physician Decision|2|||
131529710|NCT01202773|473561940|FG001|Overall Study|Physician Decision|0|||
131529711|NCT01202773|473561941|FG002|Overall Study|Physician Decision|0|||
131529712|NCT01202773|473561939|FG000|Overall Study|Protocol Violation|11|||
131529713|NCT01202773|473561940|FG001|Overall Study|Protocol Violation|6|||
131529714|NCT01202773|473561941|FG002|Overall Study|Protocol Violation|10|||
131529715|NCT01202773|473561939|FG000|Overall Study|Sponsor Decision|19|||
131529716|NCT01202773|473561940|FG001|Overall Study|Sponsor Decision|20|||
131529717|NCT01202773|473561941|FG002|Overall Study|Sponsor Decision|23|||
131529718|NCT01430130|473561946|FG000|Overall Study|Lost to Follow-up|1|||
131529719|NCT01430130|473561946|FG000|Overall Study|Infection on Control Side of Incision|1|||
131529720|NCT02667912|473561950|FG000|Overall Study|Death|3|||
131529721|NCT02667912|473561951|FG001|Overall Study|Death|1|||
131529722|NCT02667912|473561950|FG000|Overall Study|Withdrawal by Subject|1|||
131529723|NCT02667912|473561951|FG001|Overall Study|Withdrawal by Subject|2|||
131529724|NCT02667912|473561950|FG000|Overall Study|Withdrawal by Subject|1|||
131529725|NCT02667912|473561951|FG001|Overall Study|Withdrawal by Subject|0|||
131529726|NCT04443218|473561952|FG000|Overall Study|Exited study for other reasons|9|||
131529727|NCT04443218|473561952|FG000|Overall Study|Withdrawal by Subject|1|||
131529728|NCT04443218|473561952|FG000|Overall Study|Lost to Follow-up|4|||
131529729|NCT04443218|473561952|FG000|Overall Study|Death|19|||
131529730|NCT02843568|473561953|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
131529731|NCT02843568|473561954|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
131529732|NCT02843568|473561953|FG000|Overall Study|Death|3|||
131529733|NCT02843568|473561954|FG001|Overall Study|Death|3|||
131529734|NCT02843568|473561953|FG000|Overall Study|Withdrawal by Subject|1|||
131529735|NCT02843568|473561954|FG001|Overall Study|Withdrawal by Subject|1|||
131529736|NCT02843568|473561953|FG000|Overall Study|Lost to Follow-up|2|||
131529737|NCT02843568|473561954|FG001|Overall Study|Lost to Follow-up|0|||
131529738|NCT03207750|473561973|FG000|Overall Study|Adverse Event|3|||
131529739|NCT03207750|473561974|FG001|Overall Study|Adverse Event|2|||
131529740|NCT03207750|473561973|FG000|Overall Study|Lost to Follow-up|21|||
131529741|NCT03207750|473561974|FG001|Overall Study|Lost to Follow-up|29|||
131529742|NCT03207750|473561973|FG000|Overall Study|Protocol Violation|0|||
131529743|NCT03207750|473561974|FG001|Overall Study|Protocol Violation|1|||
131529744|NCT03207750|473561973|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
131529745|NCT03207750|473561974|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
131529746|NCT03207750|473561973|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
131529747|NCT03207750|473561974|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
131529748|NCT03207750|473561973|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
131529749|NCT03207750|473561974|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
131529750|NCT03207750|473561973|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
131529751|NCT03207750|473561974|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
131529752|NCT03207750|473561973|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
131529753|NCT03207750|473561974|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
131529754|NCT03893448|473561975|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
131529755|NCT03893448|473561976|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
131529756|NCT03893448|473561975|FG000|Overall Study|Physician Decision|8|||
131529757|NCT03893448|473561976|FG001|Overall Study|Physician Decision|14|||
131529758|NCT03893448|473561975|FG000|Overall Study|Lost to Follow-up|34|||
131529759|NCT03893448|473561976|FG001|Overall Study|Lost to Follow-up|27|||
131529760|NCT03893448|473561975|FG000|Overall Study|Death|1|||
131529761|NCT03893448|473561976|FG001|Overall Study|Death|0|||
131529762|NCT01592708|473561978|FG000|Overall Study|Protocol Violation|3|||
131529763|NCT01592708|473561979|FG001|Overall Study|Protocol Violation|0|||
131529764|NCT02199691|473561980|FG000|Overall Study|Protocol Violation|3|||
131529765|NCT02199691|473561981|FG001|Overall Study|Protocol Violation|3|||
131529766|NCT02199691|473561982|FG002|Overall Study|Protocol Violation|6|||
131529767|NCT02199691|473561983|FG003|Overall Study|Protocol Violation|7|||
131529768|NCT02199691|473561980|FG000|Overall Study|Withdrawal by Subject|5|||
131529769|NCT02199691|473561981|FG001|Overall Study|Withdrawal by Subject|3|||
131529770|NCT02199691|473561982|FG002|Overall Study|Withdrawal by Subject|12|||
131529771|NCT02199691|473561983|FG003|Overall Study|Withdrawal by Subject|13|||
131529772|NCT02199691|473561980|FG000|Overall Study|Lost to Follow-up|2|||
131529773|NCT02199691|473561981|FG001|Overall Study|Lost to Follow-up|1|||
131529774|NCT02199691|473561982|FG002|Overall Study|Lost to Follow-up|9|||
131529775|NCT02199691|473561983|FG003|Overall Study|Lost to Follow-up|10|||
131529776|NCT03823651|473561984|FG000|Overall Study|Death|5|||
131529777|NCT03823651|473561985|FG001|Overall Study|Death|0|||
131529778|NCT03823651|473561984|FG000|Overall Study|Physician Decision|1|||
131529779|NCT03823651|473561985|FG001|Overall Study|Physician Decision|0|||
131529780|NCT03823651|473561984|FG000|Overall Study|Caregiver to patient who died|0|||
131529781|NCT03823651|473561985|FG001|Overall Study|Caregiver to patient who died|5|||
131529782|NCT03823651|473561984|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
131529783|NCT03823651|473561985|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
131529784|NCT00428610|473561986|FG000|Overall Study|Death Due to Adverse Event|3|||
131529785|NCT00428610|473561987|FG001|Overall Study|Death Due to Adverse Event|0|||
131529786|NCT00428610|473561988|FG002|Overall Study|Death Due to Adverse Event|5|||
131529787|NCT00428610|473561986|FG000|Overall Study|Death Due to Progressive Disease|0|||
131529788|NCT00428610|473561987|FG001|Overall Study|Death Due to Progressive Disease|0|||
131529789|NCT00428610|473561988|FG002|Overall Study|Death Due to Progressive Disease|2|||
131529790|NCT00428610|473561986|FG000|Overall Study|Adverse Event|2|||
131529791|NCT00428610|473561987|FG001|Overall Study|Adverse Event|3|||
131529792|NCT00428610|473561988|FG002|Overall Study|Adverse Event|2|||
131529793|NCT00428610|473561986|FG000|Overall Study|Investigator Decision|2|||
131529794|NCT00428610|473561987|FG001|Overall Study|Investigator Decision|1|||
131529795|NCT00428610|473561988|FG002|Overall Study|Investigator Decision|1|||
131529796|NCT00428610|473561986|FG000|Overall Study|Progressive Disease|42|||
131529797|NCT00428610|473561987|FG001|Overall Study|Progressive Disease|14|||
131529798|NCT00428610|473561988|FG002|Overall Study|Progressive Disease|22|||
131529799|NCT00428610|473561986|FG000|Overall Study|Withdrawal by Subject|4|||
131529800|NCT00428610|473561987|FG001|Overall Study|Withdrawal by Subject|0|||
131529801|NCT00428610|473561988|FG002|Overall Study|Withdrawal by Subject|0|||
131529802|NCT05350449|473561989|FG000|Overall Study|Withdrawal by Subject|4|||
131529803|NCT05350449|473561990|FG001|Overall Study|Withdrawal by Subject|8|||
131529804|NCT01921348|473563888|FG000|Overall Study|Withdrawal by Subject|1|||
131529805|NCT01921348|473563889|FG001|Overall Study|Withdrawal by Subject|0|||
131529806|NCT01921348|473563888|FG000|Overall Study|Lost to Follow-up|0|||
131529807|NCT01921348|473563889|FG001|Overall Study|Lost to Follow-up|2|||
131529808|NCT04831736|473563892|FG000|Overall Study|Withdrawal by Subject|0|||
131529809|NCT04831736|473563893|FG001|Overall Study|Withdrawal by Subject|1|||
131529810|NCT00795600|473563897|FG000|Overall Study|Adverse Event|1|||
131529811|NCT00795600|473563898|FG001|Overall Study|Adverse Event|1|||
131529812|NCT00795600|473563897|FG000|Overall Study|Protocol Violation|1|||
131529813|NCT00795600|473563898|FG001|Overall Study|Protocol Violation|2|||
131529814|NCT00795600|473563897|FG000|Overall Study|Withdrawal by Subject|1|||
131529815|NCT00795600|473563898|FG001|Overall Study|Withdrawal by Subject|0|||
131529816|NCT00795600|473563897|FG000|Overall Study|Unclassified|1|||
131529817|NCT00795600|473563898|FG001|Overall Study|Unclassified|1|||
131529818|NCT03936244|473563899|FG000|Overall Study|Lost to Follow-up|5|||
131529819|NCT03936244|473563900|FG001|Overall Study|Lost to Follow-up|1|||
131529820|NCT03936244|473563899|FG000|Overall Study|Physician Decision|7|||
131529821|NCT03936244|473563900|FG001|Overall Study|Physician Decision|3|||
131529822|NCT01114646|473563901|FG000|Overall Study|Withdrawal by Subject|3|||
131529823|NCT01114646|473563902|FG001|Overall Study|Withdrawal by Subject|2|||
131529824|NCT02828111|473563912|FG000|Overall Study|Withdrawal by Subject|0|||
131529825|NCT02828111|473563913|FG001|Overall Study|Withdrawal by Subject|0|||
131529826|NCT02828111|473563914|FG002|Overall Study|Withdrawal by Subject|2|||
131529827|NCT02828111|473563915|FG003|Overall Study|Withdrawal by Subject|0|||
131529828|NCT02828111|473563916|FG004|Overall Study|Withdrawal by Subject|0|||
131529829|NCT02828111|473563912|FG000|Overall Study|Lost to Follow-up|0|||
131529830|NCT02828111|473563913|FG001|Overall Study|Lost to Follow-up|0|||
131529831|NCT02828111|473563914|FG002|Overall Study|Lost to Follow-up|0|||
131529832|NCT02828111|473563915|FG003|Overall Study|Lost to Follow-up|1|||
131529833|NCT02828111|473563916|FG004|Overall Study|Lost to Follow-up|1|||
131529834|NCT00462384|473563917|FG000|Overall Study|Adverse Event|2|||
131529835|NCT00462384|473563917|FG000|Overall Study|Death|2|||
131529836|NCT00462384|473563917|FG000|Overall Study|Withdrawal by Subject|1|||
131529837|NCT00462384|473563917|FG000|Overall Study|Other|4|||
131529838|NCT00346034|473563918|FG000|Overall Study|Adverse Event|34|||
131529839|NCT00346034|473563918|FG000|Overall Study|Lack of Efficacy|8|||
131529840|NCT00346034|473563918|FG000|Overall Study|Withdrawal by Subject|13|||
131529841|NCT00346034|473563918|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
131529842|NCT00346034|473563918|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
131529843|NCT01732835|473563921|FG000|6-month Primary Endpoint|Did not receive device|19|||
131529844|NCT01732835|473563921|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
131529845|NCT01732835|473563921|FG000|6-month Primary Endpoint|Adverse Event|3|||
131529846|NCT01732835|473563921|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
131529847|NCT01732835|473563921|FG000|2-year Extended Follow-up|Adverse Event|3|||
131529848|NCT01732835|473563921|FG000|2-year Extended Follow-up|Death|1|||
131529849|NCT02334748|473563922|FG000|Overall Study|Adverse Event|1|||
131529850|NCT02334748|473563922|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
131529851|NCT02334748|473563922|FG000|Overall Study|Patient no longer required study drug|2|||
131529852|NCT02334748|473563922|FG000|Overall Study|Lack of Efficacy|4|||
131529853|NCT02493361|473563923|FG000|Overall Study|Withdrawal by Subject|3|||
131529854|NCT01046643|473563924|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
131529855|NCT01046643|473563925|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
131529856|NCT01046643|473563926|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
131529857|NCT01046643|473563927|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
131529858|NCT00022516|473563928|FG000|Overall Study|Adverse Event|0|||
131529859|NCT00022516|473563929|FG001|Overall Study|Adverse Event|59|||
131529860|NCT00022516|473563928|FG000|Overall Study|Lack of Efficacy|0|||
131529861|NCT00022516|473563929|FG001|Overall Study|Lack of Efficacy|27|||
131529862|NCT00022516|473563928|FG000|Overall Study|Physician Decision|0|||
131529863|NCT00022516|473563929|FG001|Overall Study|Physician Decision|1|||
131529864|NCT00022516|473563928|FG000|Overall Study|Protocol Violation|1|||
131529865|NCT00022516|473563929|FG001|Overall Study|Protocol Violation|3|||
131529866|NCT00022516|473563928|FG000|Overall Study|Withdrawal by Subject|2|||
131529867|NCT00022516|473563929|FG001|Overall Study|Withdrawal by Subject|113|||
131529868|NCT00022516|473563928|FG000|Overall Study|Incomplete documentation|0|||
131529869|NCT00022516|473563929|FG001|Overall Study|Incomplete documentation|27|||
131529870|NCT03067441|473563931|FG000|Overall Study|Withdrawal by Subject|16|||
131529871|NCT03067441|473563932|FG001|Overall Study|Withdrawal by Subject|34|||
131529872|NCT03067441|473563931|FG000|Overall Study|Lost to Follow-up|7|||
131529873|NCT03067441|473563932|FG001|Overall Study|Lost to Follow-up|5|||
131529874|NCT03067441|473563931|FG000|Overall Study|Adverse Event|7|||
131529875|NCT03067441|473563932|FG001|Overall Study|Adverse Event|14|||
131529876|NCT03067441|473563931|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
131529877|NCT03067441|473563932|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
131529878|NCT03067441|473563931|FG000|Overall Study|Physician Decision|1|||
131529879|NCT03067441|473563932|FG001|Overall Study|Physician Decision|3|||
131529880|NCT03067441|473563931|FG000|Overall Study|Other|1|||
131529881|NCT03067441|473563932|FG001|Overall Study|Other|1|||
131529882|NCT02056301|473563940|FG000|Overall Study|Protocol Violation|1|||
131529883|NCT02056301|473563941|FG001|Overall Study|Protocol Violation|2|||
131529884|NCT02056301|473563940|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
131529885|NCT02056301|473563941|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
131529886|NCT02056301|473563940|FG000|Overall Study|Withdrawal by Subject|0|||
131529887|NCT02056301|473563941|FG001|Overall Study|Withdrawal by Subject|1|||
131529888|NCT02056301|473563940|FG000|Overall Study|Issues with epidural|0|||
131529889|NCT02056301|473563941|FG001|Overall Study|Issues with epidural|3|||
131529890|NCT02209324|473563945|FG000|Overall Study|Adverse Event|2|||
131529891|NCT02209324|473563945|FG000|Overall Study|Lack of Efficacy|1|||
131529892|NCT02209324|473563945|FG000|Overall Study|Lost to Follow-up|1|||
131529893|NCT02209324|473563945|FG000|Overall Study|Physician Decision|3|||
131529894|NCT02209324|473563945|FG000|Overall Study|Protocol Violation|14|||
131529895|NCT02209324|473563945|FG000|Overall Study|Withdrawal by Subject|8|||
131529896|NCT02209324|473563945|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
131529897|NCT02209324|473563945|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
131529898|NCT02209324|473563945|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
131529899|NCT03433456|473563946|FG000|Overall Study|Death|1|||
131529900|NCT03433456|473563947|FG001|Overall Study|Death|1|||
131529901|NCT03433456|473563946|FG000|Overall Study|Lost to Follow-up|14|||
131529902|NCT03433456|473563947|FG001|Overall Study|Lost to Follow-up|11|||
131529903|NCT03433456|473563946|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
131529904|NCT03433456|473563947|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
131529905|NCT03105362|473563948|FG000|Overall Study|Withdrawal by Subject|1|||
131529906|NCT03105362|473563948|FG000|Overall Study|Lost to Follow-up|1|||
131529907|NCT01198600|473563949|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
131529908|NCT01198600|473563950|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
131529909|NCT01198600|473563951|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
131529910|NCT01198600|473563952|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
131529911|NCT01198600|473563949|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
131529912|NCT01198600|473563950|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
131529913|NCT01198600|473563951|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
131529914|NCT01198600|473563952|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
131529915|NCT01198600|473563949|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
131529916|NCT01198600|473563950|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
131529917|NCT01198600|473563951|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
131529918|NCT01198600|473563952|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
131529919|NCT01198600|473563949|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
131529920|NCT01198600|473563950|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
131529921|NCT01198600|473563951|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
131529922|NCT01198600|473563952|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
131529923|NCT01198600|473563949|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
131529924|NCT01198600|473563950|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
131529925|NCT01198600|473563951|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
131529926|NCT01198600|473563952|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
131529927|NCT01198600|473563949|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
131529928|NCT01198600|473563950|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
131529929|NCT01198600|473563951|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
131529930|NCT01198600|473563952|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
131529931|NCT01198600|473563949|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
131529932|NCT01198600|473563950|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
131529933|NCT01198600|473563951|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
131529934|NCT01198600|473563952|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
131529935|NCT04177108|473563953|FG000|Overall Study|Withdrawal by Subject|4|||
131529936|NCT04177108|473563954|FG001|Overall Study|Withdrawal by Subject|8|||
131529937|NCT04177108|473563955|FG002|Overall Study|Withdrawal by Subject|9|||
131529938|NCT04177108|473563956|FG003|Overall Study|Withdrawal by Subject|11|||
131529939|NCT04177108|473563957|FG004|Overall Study|Withdrawal by Subject|13|||
131529940|NCT04177108|473563953|FG000|Overall Study|Physician Decision|23|||
131529941|NCT04177108|473563954|FG001|Overall Study|Physician Decision|15|||
131529942|NCT04177108|473563955|FG002|Overall Study|Physician Decision|18|||
131529943|NCT04177108|473563956|FG003|Overall Study|Physician Decision|29|||
131529944|NCT04177108|473563957|FG004|Overall Study|Physician Decision|23|||
131529945|NCT04177108|473563953|FG000|Overall Study|Reason Not Specified|0|||
131529946|NCT04177108|473563954|FG001|Overall Study|Reason Not Specified|1|||
131529947|NCT04177108|473563955|FG002|Overall Study|Reason Not Specified|0|||
131529948|NCT04177108|473563956|FG003|Overall Study|Reason Not Specified|0|||
131529949|NCT04177108|473563957|FG004|Overall Study|Reason Not Specified|2|||
131529950|NCT04177108|473563953|FG000|Overall Study|Lost to Follow-up|0|||
131529951|NCT04177108|473563954|FG001|Overall Study|Lost to Follow-up|0|||
131529952|NCT04177108|473563955|FG002|Overall Study|Lost to Follow-up|1|||
131529953|NCT04177108|473563956|FG003|Overall Study|Lost to Follow-up|1|||
131529954|NCT04177108|473563957|FG004|Overall Study|Lost to Follow-up|1|||
131529955|NCT04177108|473563953|FG000|Overall Study|Death|16|||
131529956|NCT04177108|473563954|FG001|Overall Study|Death|19|||
131529957|NCT04177108|473563955|FG002|Overall Study|Death|13|||
131529958|NCT04177108|473563956|FG003|Overall Study|Death|17|||
131529959|NCT04177108|473563957|FG004|Overall Study|Death|18|||
131529960|NCT04496258|473563961|FG000|Overall Study|Withdrawal by Subject|2|||
131529961|NCT04496258|473563962|FG001|Overall Study|Withdrawal by Subject|1|||
131529962|NCT01427712|473563963|FG000|Overall Study|Transfer to a different hospital|2|||
131529963|NCT01427712|473563963|FG000|Overall Study|Lost to Follow-up|1|||
131529964|NCT01427712|473563963|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
131529965|NCT01427712|473563963|FG000|Overall Study|Failure to visit|1|||
131529966|NCT04798586|473563965|FG000|Overall Study|Death|2|||
131529967|NCT04433767|473563967|FG000|Overall Study|Adverse Event|1|||
131529968|NCT00661492|473563972|FG000|Overall Study|Adverse Event|16|||
131529969|NCT00661492|473563973|FG001|Overall Study|Adverse Event|13|||
131529970|NCT00661492|473563972|FG000|Overall Study|Disease Progression|44|||
131529971|NCT00661492|473563973|FG001|Overall Study|Disease Progression|14|||
131529972|NCT00661492|473563972|FG000|Overall Study|Patient Request|6|||
131529973|NCT00661492|473563973|FG001|Overall Study|Patient Request|1|||
131529974|NCT00661492|473563972|FG000|Overall Study|Investigator Request|1|||
131529975|NCT00661492|473563973|FG001|Overall Study|Investigator Request|0|||
131529976|NCT00661492|473563972|FG000|Overall Study|Lost to Follow-up|0|||
131529977|NCT00661492|473563973|FG001|Overall Study|Lost to Follow-up|1|||
131529978|NCT00661492|473563972|FG000|Overall Study|Other|1|||
131529979|NCT00661492|473563973|FG001|Overall Study|Other|0|||
131529980|NCT03855189|473563974|FG000|Overall Study|Adverse Event|5|||
131529981|NCT03855189|473563975|FG001|Overall Study|Adverse Event|2|||
131529982|NCT03855189|473563976|FG002|Overall Study|Adverse Event|4|||
131529983|NCT03855189|473563974|FG000|Overall Study|Treatment Failure|1|||
131529984|NCT03855189|473563975|FG001|Overall Study|Treatment Failure|1|||
131529985|NCT03855189|473563976|FG002|Overall Study|Treatment Failure|2|||
131529986|NCT03855189|473563974|FG000|Overall Study|Noncompliance with Protocol|0|||
131529987|NCT03855189|473563975|FG001|Overall Study|Noncompliance with Protocol|1|||
131529988|NCT03855189|473563976|FG002|Overall Study|Noncompliance with Protocol|0|||
131529989|NCT03855189|473563974|FG000|Overall Study|Did Not Return|4|||
131529990|NCT03855189|473563975|FG001|Overall Study|Did Not Return|3|||
131529991|NCT03855189|473563976|FG002|Overall Study|Did Not Return|0|||
131529992|NCT00099983|473563977|FG000|Overall Study|Lost to Follow-up|2|||
131529993|NCT00099983|473563978|FG001|Overall Study|Lost to Follow-up|3|||
131529994|NCT00099983|473563977|FG000|Overall Study|Missing Source Documents|14|||
131529995|NCT00099983|473563978|FG001|Overall Study|Missing Source Documents|15|||
131529996|NCT00099983|473563977|FG000|Overall Study|Withdrawal by Subject|3|||
131529997|NCT00099983|473563978|FG001|Overall Study|Withdrawal by Subject|2|||
131529998|NCT00099983|473563977|FG000|Overall Study|Adverse Event|1|||
131529999|NCT00099983|473563978|FG001|Overall Study|Adverse Event|1|||
131530000|NCT00099983|473563977|FG000|Overall Study|Lack of Efficacy|0|||
131530001|NCT00099983|473563978|FG001|Overall Study|Lack of Efficacy|1|||
131530002|NCT00099983|473563977|FG000|Overall Study|Unable to return for appointments|1|||
131530003|NCT00099983|473563978|FG001|Overall Study|Unable to return for appointments|1|||
131530004|NCT00099983|473563977|FG000|Overall Study|Moved|1|||
131530005|NCT00099983|473563978|FG001|Overall Study|Moved|0|||
131530006|NCT00099983|473563977|FG000|Overall Study|Other psychiatric problem|1|||
131530007|NCT00099983|473563978|FG001|Overall Study|Other psychiatric problem|0|||
131530008|NCT00099983|473563977|FG000|Overall Study|Incarcerated|0|||
131530009|NCT00099983|473563978|FG001|Overall Study|Incarcerated|1|||
131530010|NCT00099983|473563977|FG000|Overall Study|Intolerant of burden of visits|0|||
131530011|NCT00099983|473563978|FG001|Overall Study|Intolerant of burden of visits|1|||
131530012|NCT00099983|473563977|FG000|Overall Study|Other issue|1|||
131530013|NCT00099983|473563978|FG001|Overall Study|Other issue|0|||
131530014|NCT00803634|473563979|FG000|Overall Study|Withdrew Consent|1|||
131530015|NCT00803634|473563980|FG001|Overall Study|Withdrew Consent|0|||
131530016|NCT00803634|473563979|FG000|Overall Study|Lost to Follow-up|2|||
131530017|NCT00803634|473563980|FG001|Overall Study|Lost to Follow-up|3|||
131530018|NCT00803634|473563979|FG000|Overall Study|Death|3|||
131530019|NCT00803634|473563980|FG001|Overall Study|Death|2|||
131530020|NCT04307186|473563981|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
131530021|NCT04307186|473563981|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
131530022|NCT04307186|473563981|FG000|Washout 3-14 Days|Progressive disease|1|||
131530023|NCT04307186|473563981|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
131530024|NCT04307186|473563981|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
131530025|NCT03238001|473563985|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
131530026|NCT03238001|473563985|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
131530027|NCT03238001|473563985|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
131530028|NCT03238001|473563985|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
131530029|NCT03238001|473563985|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
131530030|NCT03238001|473563985|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
131530031|NCT03238001|473563985|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
131530032|NCT03238001|473563985|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
131530033|NCT01827904|473563986|FG000|Main Study|Withdrawal by Subject|1|||
131530034|NCT01827904|473563987|FG001|Main Study|Withdrawal by Subject|0|||
131530035|NCT01827904|473563988|FG002|Main Study|Withdrawal by Subject|0|||
131530036|NCT01827904|473563986|FG000|Main Study|Adverse Event|1|||
131530037|NCT01827904|473563987|FG001|Main Study|Adverse Event|0|||
131530038|NCT01827904|473563988|FG002|Main Study|Adverse Event|0|||
131530039|NCT01827904|473563986|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
131530040|NCT01827904|473563987|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
131530041|NCT01827904|473563988|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
131530042|NCT01827904|473563986|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
131530043|NCT01827904|473563987|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
131530044|NCT01827904|473563988|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
131530045|NCT01827904|473563986|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
131530046|NCT01827904|473563987|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
131530047|NCT01827904|473563988|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
131530048|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
131530049|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
131530050|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
131530051|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
131530052|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
131530053|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
131530054|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
131530055|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
131530056|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
131530057|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
131530058|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
131530059|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
131530060|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Physician Decision|1|||
131530061|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Physician Decision|0|||
131530062|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Physician Decision|0|||
131530063|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
131530064|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
131530065|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
131530066|NCT01827904|473563986|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
131530067|NCT01827904|473563987|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
131530068|NCT01827904|473563988|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
131530069|NCT01866709|473563992|FG000|Overall Study|Adverse Event|1|||
131530070|NCT01866709|473563993|FG001|Overall Study|Adverse Event|0|||
131530071|NCT03791398|473563994|FG000|Overall Study|Progression of Disease Under Study|2|||
131530072|NCT03791398|473563995|FG001|Overall Study|Progression of Disease Under Study|0|||
131530073|NCT03791398|473563996|FG002|Overall Study|Progression of Disease Under Study|0|||
131530074|NCT02207829|473563997|FG000|Overall Study|Adverse Event|10|||
131530075|NCT02207829|473563998|FG001|Overall Study|Adverse Event|9|||
131530076|NCT02207829|473563997|FG000|Overall Study|Lack of Efficacy|7|||
131530077|NCT02207829|473563998|FG001|Overall Study|Lack of Efficacy|5|||
131530078|NCT02207829|473563997|FG000|Overall Study|Lost to Follow-up|2|||
131530079|NCT02207829|473563998|FG001|Overall Study|Lost to Follow-up|2|||
131530080|NCT02207829|473563997|FG000|Overall Study|Protocol deviation|5|||
131530081|NCT02207829|473563998|FG001|Overall Study|Protocol deviation|4|||
131530082|NCT02207829|473563997|FG000|Overall Study|Withdrew consent|18|||
131530083|NCT02207829|473563998|FG001|Overall Study|Withdrew consent|14|||
131530084|NCT00766376|473563999|FG000|Overall Study|Withdrawal by Subject|27|||
131530085|NCT01800903|473564000|FG000|Second Test Period|unable to catheterise|1|||
131530086|NCT01800903|473564001|FG001|Second Test Period|unable to catheterise|0|||
131530087|NCT01800903|473564002|FG002|Second Test Period|unable to catheterise|0|||
131530088|NCT01800903|473564003|FG003|Second Test Period|unable to catheterise|0|||
131530089|NCT01800903|473564004|FG004|Second Test Period|unable to catheterise|0|||
131530090|NCT01800903|473564005|FG005|Second Test Period|unable to catheterise|0|||
131530091|NCT01110239|473564010|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
131530092|NCT01110239|473564011|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
131530093|NCT01110239|473564012|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
131530094|NCT01110239|473564013|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
131530095|NCT01110239|473564010|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
131530096|NCT01110239|473564011|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
131530097|NCT01110239|473564012|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
131530098|NCT01110239|473564013|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
131530099|NCT00080223|473564018|FG000|Overall Study|Adverse Event|23|||
131530100|NCT00080223|473564018|FG000|Overall Study|Death|21|||
131530101|NCT00080223|473564018|FG000|Overall Study|Withdrawal by Subject|13|||
131530102|NCT00080223|473564018|FG000|Overall Study|Lung Transplantation|9|||
131530103|NCT00080223|473564018|FG000|Overall Study|Non-compliance With Study Treatment|7|||
131530104|NCT00080223|473564018|FG000|Overall Study|Participant unwilling to continue|2|||
131530105|NCT00080223|473564018|FG000|Overall Study|Physician Decision|1|||
131530106|NCT04369469|473564025|FG000|Overall Study|Lost to Follow-up|2|||
131530107|NCT04369469|473564026|FG001|Overall Study|Lost to Follow-up|4|||
131530108|NCT04369469|473564025|FG000|Overall Study|Physician Decision|2|||
131530109|NCT04369469|473564026|FG001|Overall Study|Physician Decision|1|||
131530110|NCT04369469|473564025|FG000|Overall Study|Withdrawal by Subject|2|||
131530111|NCT04369469|473564026|FG001|Overall Study|Withdrawal by Subject|3|||
131530112|NCT04369469|473564025|FG000|Overall Study|Adverse Event|1|||
131530113|NCT04369469|473564026|FG001|Overall Study|Adverse Event|0|||
131530114|NCT04369469|473564025|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
131530115|NCT04369469|473564026|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
131530116|NCT04369469|473564025|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
131530117|NCT04369469|473564026|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
131530118|NCT04369469|473564025|FG000|Overall Study|Unable to Provide Consent|0|||
131530119|NCT04369469|473564026|FG001|Overall Study|Unable to Provide Consent|1|||
131530120|NCT05204134|473564027|FG000|Overall Study|Withdrawal by Subject|3|||
131530121|NCT05204134|473564027|FG000|Overall Study|Physician Decision|1|||
131530122|NCT03099382|473564031|FG000|Overall Study|Protocol Violation|2|||
131530123|NCT03099382|473564032|FG001|Overall Study|Protocol Violation|3|||
131530124|NCT00499369|473564033|FG000|Overall Study|Adverse Event|2|||
131530125|NCT00499369|473564034|FG001|Overall Study|Adverse Event|2|||
131530126|NCT00499369|473564035|FG002|Overall Study|Adverse Event|3|||
131530127|NCT00499369|473564036|FG003|Overall Study|Adverse Event|1|||
131530128|NCT00499369|473564037|FG004|Overall Study|Adverse Event|2|||
131530129|NCT00499369|473564033|FG000|Overall Study|Withdrawal by Subject|0|||
131530130|NCT00499369|473564034|FG001|Overall Study|Withdrawal by Subject|1|||
131530131|NCT00499369|473564035|FG002|Overall Study|Withdrawal by Subject|1|||
131530132|NCT00499369|473564036|FG003|Overall Study|Withdrawal by Subject|0|||
131530133|NCT00499369|473564037|FG004|Overall Study|Withdrawal by Subject|0|||
131530134|NCT00499369|473564033|FG000|Overall Study|Progression|10|||
131530135|NCT00499369|473564034|FG001|Overall Study|Progression|12|||
131530136|NCT00499369|473564035|FG002|Overall Study|Progression|9|||
131530137|NCT00499369|473564036|FG003|Overall Study|Progression|6|||
131530138|NCT00499369|473564037|FG004|Overall Study|Progression|10|||
131530139|NCT00499369|473564033|FG000|Overall Study|Death|0|||
131530140|NCT00499369|473564034|FG001|Overall Study|Death|1|||
131530141|NCT00499369|473564035|FG002|Overall Study|Death|0|||
131530142|NCT00499369|473564036|FG003|Overall Study|Death|0|||
131530143|NCT00499369|473564037|FG004|Overall Study|Death|0|||
131530144|NCT00499369|473564033|FG000|Overall Study|Not protocol specified|2|||
131530145|NCT00499369|473564034|FG001|Overall Study|Not protocol specified|0|||
131530146|NCT00499369|473564035|FG002|Overall Study|Not protocol specified|3|||
131530147|NCT00499369|473564036|FG003|Overall Study|Not protocol specified|1|||
131530148|NCT00499369|473564037|FG004|Overall Study|Not protocol specified|0|||
131530149|NCT00499369|473564033|FG000|Overall Study|Ineligible|2|||
131530150|NCT00499369|473564034|FG001|Overall Study|Ineligible|2|||
131530151|NCT00499369|473564035|FG002|Overall Study|Ineligible|1|||
131530152|NCT00499369|473564036|FG003|Overall Study|Ineligible|1|||
131530153|NCT00499369|473564037|FG004|Overall Study|Ineligible|0|||
131530154|NCT01802411|473564038|FG000|Overall Study|Death|2|||
131530155|NCT01802411|473564039|FG001|Overall Study|Death|1|||
131530156|NCT01802411|473564038|FG000|Overall Study|Adverse Event|2|||
131530157|NCT01802411|473564039|FG001|Overall Study|Adverse Event|7|||
131530158|NCT01802411|473564038|FG000|Overall Study|Lack of Efficacy|8|||
131530159|NCT01802411|473564039|FG001|Overall Study|Lack of Efficacy|10|||
131530160|NCT01802411|473564038|FG000|Overall Study|Withdrawal by Subject|0|||
131530161|NCT01802411|473564039|FG001|Overall Study|Withdrawal by Subject|2|||
131530162|NCT01802411|473564038|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
131530163|NCT01802411|473564039|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
131530164|NCT01802411|473564038|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
131530165|NCT01802411|473564039|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
131530166|NCT01802411|473564038|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
131530167|NCT01802411|473564039|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
131530168|NCT03283670|473564042|FG000|Placebo Gas|Withdrawal by Subject|2|||
131530169|NCT03283670|473564042|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
131530170|NCT03283670|473564042|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
131530171|NCT01059617|473564043|FG000|Overall Study|Other|7|||
131530172|NCT01059617|473564044|FG001|Overall Study|Other|1|||
131530173|NCT01059617|473564045|FG002|Overall Study|Other|8|||
131530174|NCT01059617|473564046|FG003|Overall Study|Other|6|||
131530175|NCT00852397|473564048|FG000|Overall Study|Adverse Event|4|||
131530176|NCT00852397|473564049|FG001|Overall Study|Adverse Event|6|||
131530177|NCT00852397|473564050|FG002|Overall Study|Adverse Event|4|||
131530178|NCT00852397|473564048|FG000|Overall Study|Death|0|||
131530179|NCT00852397|473564049|FG001|Overall Study|Death|0|||
131530180|NCT00852397|473564050|FG002|Overall Study|Death|1|||
131530181|NCT00852397|473564048|FG000|Overall Study|Withdrawal by Subject|4|||
131530182|NCT00852397|473564049|FG001|Overall Study|Withdrawal by Subject|1|||
131530183|NCT00852397|473564050|FG002|Overall Study|Withdrawal by Subject|2|||
131530184|NCT00852397|473564048|FG000|Overall Study|Study terminated by sponsor|2|||
131530185|NCT00852397|473564049|FG001|Overall Study|Study terminated by sponsor|1|||
131530186|NCT00852397|473564050|FG002|Overall Study|Study terminated by sponsor|6|||
131530187|NCT00852397|473564048|FG000|Overall Study|Difficulty in study site visit|1|||
131530188|NCT00852397|473564049|FG001|Overall Study|Difficulty in study site visit|0|||
131530189|NCT00852397|473564050|FG002|Overall Study|Difficulty in study site visit|0|||
131530190|NCT00852397|473564048|FG000|Overall Study|Protocol Violation|0|||
131530191|NCT00852397|473564049|FG001|Overall Study|Protocol Violation|0|||
131530192|NCT00852397|473564050|FG002|Overall Study|Protocol Violation|1|||
131530193|NCT03864614|473564057|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
131530194|NCT03864614|473564058|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
131530195|NCT03864614|473564059|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
131530196|NCT03864614|473564060|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
131530197|NCT03864614|473564057|FG000|Overall Study|Withdrawal by Subject|72|||
131530198|NCT03864614|473564058|FG001|Overall Study|Withdrawal by Subject|100|||
131530199|NCT03864614|473564059|FG002|Overall Study|Withdrawal by Subject|1|||
131530200|NCT03864614|473564060|FG003|Overall Study|Withdrawal by Subject|21|||
131530201|NCT03864614|473564057|FG000|Overall Study|Lost to Follow-up|45|||
131530202|NCT03864614|473564058|FG001|Overall Study|Lost to Follow-up|54|||
131530203|NCT03864614|473564059|FG002|Overall Study|Lost to Follow-up|0|||
131530204|NCT03864614|473564060|FG003|Overall Study|Lost to Follow-up|9|||
131530205|NCT03864614|473564057|FG000|Overall Study|Adverse Event|42|||
131530206|NCT03864614|473564058|FG001|Overall Study|Adverse Event|30|||
131530207|NCT03864614|473564059|FG002|Overall Study|Adverse Event|1|||
131530208|NCT03864614|473564060|FG003|Overall Study|Adverse Event|9|||
131530209|NCT03864614|473564057|FG000|Overall Study|Protocol Deviation|6|||
131530210|NCT03864614|473564058|FG001|Overall Study|Protocol Deviation|26|||
131530211|NCT03864614|473564059|FG002|Overall Study|Protocol Deviation|0|||
131530212|NCT03864614|473564060|FG003|Overall Study|Protocol Deviation|1|||
131530213|NCT03864614|473564057|FG000|Overall Study|Physician Decision|7|||
131530214|NCT03864614|473564058|FG001|Overall Study|Physician Decision|10|||
131530215|NCT03864614|473564059|FG002|Overall Study|Physician Decision|1|||
131530216|NCT03864614|473564060|FG003|Overall Study|Physician Decision|5|||
131530217|NCT03864614|473564057|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
131530218|NCT03864614|473564058|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
131530219|NCT03864614|473564059|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
131530220|NCT03864614|473564060|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
131530221|NCT03864614|473564057|FG000|Overall Study|Sponsor Decision|1|||
131530222|NCT03864614|473564058|FG001|Overall Study|Sponsor Decision|2|||
131530223|NCT03864614|473564059|FG002|Overall Study|Sponsor Decision|0|||
131530224|NCT03864614|473564060|FG003|Overall Study|Sponsor Decision|0|||
131530225|NCT03864614|473564057|FG000|Overall Study|Pregnancy|0|||
131530226|NCT03864614|473564058|FG001|Overall Study|Pregnancy|1|||
131530227|NCT03864614|473564059|FG002|Overall Study|Pregnancy|0|||
131530228|NCT03864614|473564060|FG003|Overall Study|Pregnancy|0|||
131530229|NCT03864614|473564057|FG000|Overall Study|Other|7|||
131530230|NCT03864614|473564058|FG001|Overall Study|Other|9|||
131530231|NCT03864614|473564059|FG002|Overall Study|Other|1|||
131530232|NCT03864614|473564060|FG003|Overall Study|Other|4|||
131530233|NCT03864614|473564057|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
131530234|NCT03864614|473564058|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
131530235|NCT03864614|473564059|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
131530236|NCT03864614|473564060|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
131530237|NCT01850004|473564061|FG000|Overall Study|Poor/Non-compliance|1|||
131530238|NCT01850004|473564061|FG000|Overall Study|Participant Withdrew Consent|9|||
131530239|NCT01850004|473564061|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
131530240|NCT01850004|473564061|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
131530241|NCT01850004|473564061|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
131530242|NCT01850004|473564061|FG000|Overall Study|Other Reasons|2|||
131530243|NCT01850004|473564061|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
131530244|NCT01850004|473564061|FG000|Overall Study|Maximum Clinical Benefit|4|||
131530245|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
131530246|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
131530247|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
131530248|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
131530249|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Adverse Event|5|||
131530250|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Adverse Event|3|||
131530251|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Adverse Event|4|||
131530252|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Adverse Event|10|||
131530253|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
131530254|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
131530255|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
131530256|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
131530257|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
131530258|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
131530259|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
131530260|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
131530261|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Pregnancy|5|||
131530262|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Pregnancy|0|||
131530263|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Pregnancy|3|||
131530264|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Pregnancy|2|||
131530265|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Non-compliance|1|||
131530266|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Non-compliance|4|||
131530267|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Non-compliance|0|||
131530268|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Non-compliance|3|||
131530269|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Other|0|||
131530270|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Other|3|||
131530271|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Other|3|||
131530272|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Other|1|||
131530273|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
131530274|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
131530275|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
131530276|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
131530277|NCT01760954|473565809|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
131530278|NCT01760954|473565810|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
131530279|NCT01760954|473565811|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
131530280|NCT01760954|473565812|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
131530281|NCT01760954|473565809|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
131530282|NCT01760954|473565810|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
131530283|NCT01760954|473565811|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
131530284|NCT01760954|473565812|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
131530285|NCT01760954|473565809|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
131530286|NCT01760954|473565810|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
131530287|NCT01760954|473565811|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
131530288|NCT01760954|473565812|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
131530289|NCT01760954|473565809|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
131530290|NCT01760954|473565810|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
131530291|NCT01760954|473565811|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
131530292|NCT01760954|473565812|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
131530293|NCT01760954|473565809|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
131530294|NCT01760954|473565810|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
131530295|NCT01760954|473565811|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
131530296|NCT01760954|473565812|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
131530297|NCT01760954|473565809|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
131530298|NCT01760954|473565810|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
131530299|NCT01760954|473565811|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
131530300|NCT01760954|473565812|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
131530301|NCT01760954|473565809|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
131530302|NCT01760954|473565810|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
131530303|NCT01760954|473565811|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
131530304|NCT01760954|473565812|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
131530305|NCT03320070|473565813|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
131530306|NCT03320070|473565814|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
131530307|NCT03320070|473565813|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
131530308|NCT03320070|473565814|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
131530309|NCT03320070|473565813|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
131530310|NCT03320070|473565814|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
131530311|NCT03320070|473565813|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
131530312|NCT03320070|473565814|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
131530313|NCT03320070|473565813|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
131530314|NCT03320070|473565814|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
131530315|NCT03320070|473565813|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
131530316|NCT03320070|473565814|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
131530317|NCT00353704|473565831|FG000|Overall Study|Protocol Violation|3|||
131530318|NCT00353704|473565832|FG001|Overall Study|Protocol Violation|1|||
131530319|NCT02473614|473565833|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
131530320|NCT02473614|473565834|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
131530321|NCT01154166|473565835|FG000|Overall Study|Adverse Event|14|||
131530322|NCT01154166|473565836|FG001|Overall Study|Adverse Event|9|||
131530323|NCT01154166|473565835|FG000|Overall Study|Lost to Follow-up|1|||
131530324|NCT01154166|473565836|FG001|Overall Study|Lost to Follow-up|1|||
131530325|NCT01154166|473565835|FG000|Overall Study|Protocol Violation|4|||
131530326|NCT01154166|473565836|FG001|Overall Study|Protocol Violation|1|||
131530327|NCT01154166|473565835|FG000|Overall Study|Withdrawal by Subject|10|||
131530328|NCT01154166|473565836|FG001|Overall Study|Withdrawal by Subject|1|||
131530329|NCT01154166|473565835|FG000|Overall Study|Lack of Efficacy|3|||
131530330|NCT01154166|473565836|FG001|Overall Study|Lack of Efficacy|0|||
131530331|NCT01154166|473565835|FG000|Overall Study|Disease Progression|1|||
131530332|NCT01154166|473565836|FG001|Overall Study|Disease Progression|0|||
131530333|NCT01154166|473565835|FG000|Overall Study|Poor Compliance|1|||
131530334|NCT01154166|473565836|FG001|Overall Study|Poor Compliance|0|||
131530335|NCT01375049|473565837|FG000|Overall Study|Adverse Event|2|||
131530336|NCT01375049|473565837|FG000|Overall Study|Lost to Follow-up|1|||
131530337|NCT01375049|473565837|FG000|Overall Study|Withdrawal by Subject|2|||
131530338|NCT01375049|473565837|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
131530339|NCT04121962|473565840|FG000|Overall Study|Lost to Follow-up|42|||
131530340|NCT04121962|473565841|FG001|Overall Study|Lost to Follow-up|39|||
131530341|NCT01175382|473565842|FG000|Overall Study|Lost to Follow-up|4|||
131530342|NCT01175382|473565843|FG001|Overall Study|Lost to Follow-up|3|||
131530343|NCT01175382|473565844|FG002|Overall Study|Lost to Follow-up|1|||
131530344|NCT01175382|473565842|FG000|Overall Study|Physician Decision|0|||
131530345|NCT01175382|473565843|FG001|Overall Study|Physician Decision|1|||
131530346|NCT01175382|473565844|FG002|Overall Study|Physician Decision|0|||
131530347|NCT01175382|473565842|FG000|Overall Study|Withdrawal by Subject|0|||
131530348|NCT01175382|473565843|FG001|Overall Study|Withdrawal by Subject|0|||
131530349|NCT01175382|473565844|FG002|Overall Study|Withdrawal by Subject|1|||
131530350|NCT01175382|473565842|FG000|Overall Study|No longer having problem|1|||
131530351|NCT01175382|473565843|FG001|Overall Study|No longer having problem|0|||
131530352|NCT01175382|473565844|FG002|Overall Study|No longer having problem|1|||
131530353|NCT01175382|473565842|FG000|Overall Study|Unable/unwilling to attend visits|3|||
131530354|NCT01175382|473565843|FG001|Overall Study|Unable/unwilling to attend visits|1|||
131530355|NCT01175382|473565844|FG002|Overall Study|Unable/unwilling to attend visits|2|||
131530356|NCT01175382|473565842|FG000|Overall Study|Unwilling to follow protocol|0|||
131530357|NCT01175382|473565843|FG001|Overall Study|Unwilling to follow protocol|1|||
131530358|NCT01175382|473565844|FG002|Overall Study|Unwilling to follow protocol|0|||
131530359|NCT01175382|473565842|FG000|Overall Study|Unable to tolerate study meds|0|||
131530360|NCT01175382|473565843|FG001|Overall Study|Unable to tolerate study meds|1|||
131530361|NCT01175382|473565844|FG002|Overall Study|Unable to tolerate study meds|1|||
131530362|NCT00774787|473565845|FG000|Overall Study|Lost to Follow-up|1|||
131530363|NCT02019719|473565846|FG000|Overall Study|Adverse Event|1|||
131530364|NCT02019719|473565847|FG001|Overall Study|Adverse Event|0|||
131530365|NCT02019719|473565848|FG002|Overall Study|Adverse Event|0|||
131530366|NCT02019719|473565849|FG003|Overall Study|Adverse Event|1|||
131530367|NCT02019719|473565850|FG004|Overall Study|Adverse Event|1|||
131530368|NCT02019719|473565846|FG000|Overall Study|Protocol Violation|1|||
131530369|NCT02019719|473565847|FG001|Overall Study|Protocol Violation|1|||
131530370|NCT02019719|473565848|FG002|Overall Study|Protocol Violation|0|||
131530371|NCT02019719|473565849|FG003|Overall Study|Protocol Violation|0|||
131530372|NCT02019719|473565850|FG004|Overall Study|Protocol Violation|0|||
131530373|NCT02019719|473565846|FG000|Overall Study|Protocol defined stopping criteria|2|||
131530374|NCT02019719|473565847|FG001|Overall Study|Protocol defined stopping criteria|0|||
131530375|NCT02019719|473565848|FG002|Overall Study|Protocol defined stopping criteria|0|||
131530376|NCT02019719|473565849|FG003|Overall Study|Protocol defined stopping criteria|1|||
131530377|NCT02019719|473565850|FG004|Overall Study|Protocol defined stopping criteria|1|||
131530378|NCT02019719|473565846|FG000|Overall Study|Physician Decision|2|||
131530379|NCT02019719|473565847|FG001|Overall Study|Physician Decision|0|||
131530380|NCT02019719|473565848|FG002|Overall Study|Physician Decision|0|||
131530381|NCT02019719|473565849|FG003|Overall Study|Physician Decision|0|||
131530382|NCT02019719|473565850|FG004|Overall Study|Physician Decision|0|||
131530383|NCT02731131|473565854|FG000|Overall Study|Psychiatric Disorder|0|||
131530384|NCT02731131|473565855|FG001|Overall Study|Psychiatric Disorder|1|||
131530385|NCT02731131|473565854|FG000|Overall Study|Refused Therapy|0|||
131530386|NCT02731131|473565855|FG001|Overall Study|Refused Therapy|1|||
131530387|NCT02348216|473565860|FG000|Overall Study|Death|5|||
131530388|NCT02348216|473565861|FG001|Overall Study|Death|53|||
131530389|NCT02348216|473565862|FG002|Overall Study|Death|11|||
131530390|NCT02348216|473565863|FG003|Overall Study|Death|20|||
131530391|NCT02348216|473565864|FG004|Overall Study|Death|16|||
131530392|NCT02348216|473565865|FG005|Overall Study|Death|32|||
131530393|NCT02348216|473565866|FG006|Overall Study|Death|17|||
131530394|NCT02348216|473565860|FG000|Overall Study|Full consent withdrawal|0|||
131530395|NCT02348216|473565861|FG001|Overall Study|Full consent withdrawal|0|||
131530396|NCT02348216|473565862|FG002|Overall Study|Full consent withdrawal|0|||
131530397|NCT02348216|473565863|FG003|Overall Study|Full consent withdrawal|1|||
131530398|NCT02348216|473565864|FG004|Overall Study|Full consent withdrawal|3|||
131530399|NCT02348216|473565865|FG005|Overall Study|Full consent withdrawal|0|||
131530400|NCT02348216|473565866|FG006|Overall Study|Full consent withdrawal|3|||
131530401|NCT02348216|473565860|FG000|Overall Study|Lost to Follow-up|0|||
131530402|NCT02348216|473565861|FG001|Overall Study|Lost to Follow-up|5|||
131530403|NCT02348216|473565862|FG002|Overall Study|Lost to Follow-up|2|||
131530404|NCT02348216|473565863|FG003|Overall Study|Lost to Follow-up|0|||
131530405|NCT02348216|473565864|FG004|Overall Study|Lost to Follow-up|1|||
131530406|NCT02348216|473565865|FG005|Overall Study|Lost to Follow-up|1|||
131530407|NCT02348216|473565866|FG006|Overall Study|Lost to Follow-up|1|||
131530408|NCT02348216|473565860|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
131530409|NCT02348216|473565861|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
131530410|NCT02348216|473565862|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
131530411|NCT02348216|473565863|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
131530412|NCT02348216|473565864|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
131530413|NCT02348216|473565865|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
131530414|NCT02348216|473565866|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
131530415|NCT02348216|473565860|FG000|Overall Study|Reason not specified|2|||
131530416|NCT02348216|473565861|FG001|Overall Study|Reason not specified|19|||
131530417|NCT02348216|473565862|FG002|Overall Study|Reason not specified|11|||
131530418|NCT02348216|473565863|FG003|Overall Study|Reason not specified|17|||
131530419|NCT02348216|473565864|FG004|Overall Study|Reason not specified|21|||
131530420|NCT02348216|473565865|FG005|Overall Study|Reason not specified|17|||
131530421|NCT02348216|473565866|FG006|Overall Study|Reason not specified|19|||
131530422|NCT01055639|473565867|FG000|Overall Study|Adverse Event|0|||
131530423|NCT01055639|473565868|FG001|Overall Study|Adverse Event|1|||
131530424|NCT01055639|473565867|FG000|Overall Study|Lack of Efficacy|0|||
131530425|NCT01055639|473565868|FG001|Overall Study|Lack of Efficacy|1|||
131530426|NCT01055639|473565867|FG000|Overall Study|Lost to Follow-up|8|||
131530427|NCT01055639|473565868|FG001|Overall Study|Lost to Follow-up|11|||
131530428|NCT01055639|473565867|FG000|Overall Study|Protocol Violation|5|||
131530429|NCT01055639|473565868|FG001|Overall Study|Protocol Violation|5|||
131530430|NCT01055639|473565867|FG000|Overall Study|Withdrawal by Subject|8|||
131530431|NCT01055639|473565868|FG001|Overall Study|Withdrawal by Subject|11|||
131530432|NCT00562159|473565869|FG000|Overall Study|Adverse Event|11|||
131530433|NCT00562159|473565870|FG001|Overall Study|Adverse Event|8|||
131530434|NCT00562159|473565869|FG000|Overall Study|Lost to Follow-up|5|||
131530435|NCT00562159|473565870|FG001|Overall Study|Lost to Follow-up|4|||
131530436|NCT00562159|473565869|FG000|Overall Study|Withdrawal by Subject|9|||
131530437|NCT00562159|473565870|FG001|Overall Study|Withdrawal by Subject|8|||
131530438|NCT00562159|473565869|FG000|Overall Study|Protocol Violation|12|||
131530439|NCT00562159|473565870|FG001|Overall Study|Protocol Violation|12|||
131530440|NCT00562159|473565869|FG000|Overall Study|Did not meet protocol eligibility|1|||
131530441|NCT00562159|473565870|FG001|Overall Study|Did not meet protocol eligibility|1|||
131530442|NCT00765245|473565871|FG000|Overall Study|disease progression|3|||
131530443|NCT00765245|473565872|FG001|Overall Study|disease progression|2|||
131530444|NCT00765245|473565871|FG000|Overall Study|Withdrawal by Subject|3|||
131530445|NCT00765245|473565872|FG001|Overall Study|Withdrawal by Subject|0|||
131530446|NCT00765245|473565871|FG000|Overall Study|Adverse Event|5|||
131530447|NCT00765245|473565872|FG001|Overall Study|Adverse Event|0|||
131530448|NCT00765245|473565871|FG000|Overall Study|Physician Decision|1|||
131530449|NCT00765245|473565872|FG001|Overall Study|Physician Decision|0|||
131530450|NCT00765245|473565871|FG000|Overall Study|Death|1|||
131530451|NCT00765245|473565872|FG001|Overall Study|Death|0|||
131530452|NCT01181921|473565876|FG000|Overall Study|Lost to Follow-up|1|||
131530453|NCT02546544|473565877|FG000|Overall Study|Disease Progression|14|||
131530454|NCT02546544|473565877|FG000|Overall Study|Adverse Event|1|||
131530455|NCT02546544|473565877|FG000|Overall Study|Withdrawal by Subject|1|||
131530456|NCT02223390|473565878|FG000|Overall Study|Lost to Follow-up|9|||
131530457|NCT02223390|473565879|FG001|Overall Study|Lost to Follow-up|4|||
131530458|NCT02548962|473565881|FG000|Overall Study|Withdrawal by Subject|1|||
131530459|NCT02548962|473565882|FG001|Overall Study|Withdrawal by Subject|0|||
131530460|NCT00736996|473565886|FG000|Overall Study|Lost to Follow-up|1|||
131530461|NCT00736996|473565887|FG001|Overall Study|Lost to Follow-up|9|||
131530462|NCT00736996|473565888|FG002|Overall Study|Lost to Follow-up|2|||
131530463|NCT01131312|473565889|FG000|Overall Study|Lost to Follow-up|425|||
131530464|NCT01131312|473565890|FG001|Overall Study|Lost to Follow-up|229|||
131530465|NCT01131312|473565891|FG002|Overall Study|Lost to Follow-up|351|||
131530466|NCT03447769|473565892|FG000|Overall Study|Progressive disease|138|||
131530467|NCT03447769|473565893|FG001|Overall Study|Progressive disease|148|||
131530468|NCT03447769|473565892|FG000|Overall Study|Study terminated by Sponsor|60|||
131530469|NCT03447769|473565893|FG001|Overall Study|Study terminated by Sponsor|44|||
131530470|NCT03447769|473565892|FG000|Overall Study|Adverse Event|34|||
131530471|NCT03447769|473565893|FG001|Overall Study|Adverse Event|31|||
131530472|NCT03447769|473565892|FG000|Overall Study|Patient decision|27|||
131530473|NCT03447769|473565893|FG001|Overall Study|Patient decision|27|||
131530474|NCT03447769|473565892|FG000|Overall Study|Protocol deviation|4|||
131530475|NCT03447769|473565893|FG001|Overall Study|Protocol deviation|6|||
131530476|NCT03447769|473565892|FG000|Overall Study|Death|2|||
131530477|NCT03447769|473565893|FG001|Overall Study|Death|7|||
131530478|NCT03447769|473565892|FG000|Overall Study|Technical problems|1|||
131530479|NCT03447769|473565893|FG001|Overall Study|Technical problems|0|||
131530480|NCT03447769|473565892|FG000|Overall Study|Lost to Follow-up|0|||
131530481|NCT03447769|473565893|FG001|Overall Study|Lost to Follow-up|1|||
131530482|NCT03447769|473565892|FG000|Overall Study|Physician Decision|13|||
131530483|NCT03447769|473565893|FG001|Overall Study|Physician Decision|5|||
131530484|NCT01255358|473565894|FG000|Overall Study|Adverse Event|2|||
131530485|NCT01255358|473565894|FG000|Overall Study|Protocol Violation|2|||
131530486|NCT01343407|473565895|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
131530487|NCT01343407|473565896|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
131530488|NCT01343407|473565897|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
131530489|NCT01343407|473565898|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
131530490|NCT01343407|473565899|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
131530491|NCT01343407|473565900|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
131530492|NCT01343407|473565895|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
131530493|NCT01343407|473565896|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
131530494|NCT01343407|473565897|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
131530495|NCT01343407|473565898|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
131530496|NCT01343407|473565899|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
131530497|NCT01343407|473565900|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
131530498|NCT03950739|473565901|FG000|Treatment Phase|Adverse Event|2|||
131530499|NCT03950739|473565901|FG000|Optional Extension Phase|Death|1|||
131530500|NCT03950739|473565901|FG000|Optional Extension Phase|Progressive Disease|5|||
131530501|NCT03950739|473565901|FG000|Optional Extension Phase|Adverse Event|7|||
131530502|NCT03950739|473565901|FG000|Optional Extension Phase|Lost to Follow-up|2|||
131530503|NCT03950739|473565901|FG000|Optional Extension Phase|Site Closure|2|||
131530504|NCT03950739|473565901|FG000|Optional Extension Phase|Pregnancy|1|||
131530505|NCT00797667|473565904|FG000|Overall Study|Lack of Efficacy|0|||
131530506|NCT00797667|473565905|FG001|Overall Study|Lack of Efficacy|1|||
131530507|NCT00797667|473565906|FG002|Overall Study|Lack of Efficacy|0|||
131530508|NCT00797667|473565904|FG000|Overall Study|Lost to Follow-up|8|||
131530509|NCT00797667|473565905|FG001|Overall Study|Lost to Follow-up|12|||
131530510|NCT00797667|473565906|FG002|Overall Study|Lost to Follow-up|2|||
131530511|NCT00797667|473565904|FG000|Overall Study|Physician Decision|3|||
131530512|NCT00797667|473565905|FG001|Overall Study|Physician Decision|1|||
131530513|NCT00797667|473565906|FG002|Overall Study|Physician Decision|0|||
131530514|NCT00797667|473565904|FG000|Overall Study|Pregnancy|2|||
131530515|NCT00797667|473565905|FG001|Overall Study|Pregnancy|0|||
131530516|NCT00797667|473565906|FG002|Overall Study|Pregnancy|0|||
131530517|NCT00797667|473565904|FG000|Overall Study|Protocol Violation|2|||
131530518|NCT00797667|473565905|FG001|Overall Study|Protocol Violation|7|||
131530519|NCT00797667|473565906|FG002|Overall Study|Protocol Violation|0|||
131530520|NCT00797667|473565904|FG000|Overall Study|Study Terminated by Sponsor|217|||
131530521|NCT00797667|473565905|FG001|Overall Study|Study Terminated by Sponsor|216|||
131530522|NCT00797667|473565906|FG002|Overall Study|Study Terminated by Sponsor|115|||
131530523|NCT00797667|473565904|FG000|Overall Study|Withdrawal by Subject|9|||
131530524|NCT00797667|473565905|FG001|Overall Study|Withdrawal by Subject|14|||
131530525|NCT00797667|473565906|FG002|Overall Study|Withdrawal by Subject|2|||
131530526|NCT00797667|473565904|FG000|Overall Study|Adverse Event|19|||
131530527|NCT00797667|473565905|FG001|Overall Study|Adverse Event|8|||
131530528|NCT00797667|473565906|FG002|Overall Study|Adverse Event|8|||
131530529|NCT01986829|473565907|FG000|Overall Study|Death|1|||
131530530|NCT02504866|473565908|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
131530531|NCT02504866|473565909|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
131530532|NCT02504866|473565910|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
131530533|NCT00781326|473565913|FG000|Phase I|Adverse Event|1|||
131530534|NCT00781326|473565913|FG000|Phase I|Withdrawal by Subject|1|||
131530535|NCT00781326|473565913|FG000|Phase I|Physician Decision|2|||
131530536|NCT00096941|473565914|FG000|Overall Study|disease progression|3|||
131530537|NCT01343056|473565915|FG000|Overall Study|Lost to Follow-up|7|||
131530538|NCT01343056|473565916|FG001|Overall Study|Lost to Follow-up|5|||
131530539|NCT01343056|473565917|FG002|Overall Study|Lost to Follow-up|3|||
131530540|NCT01343056|473565918|FG003|Overall Study|Lost to Follow-up|9|||
131530541|NCT03231371|473565919|FG000|Overall Study|Withdrawal by Subject|1|||
131530542|NCT03231371|473565919|FG000|Overall Study|chose or were ineligible to have MRI|12|||
131530543|NCT03029208|473565920|FG000|Overall Study|Withdrawal by Subject|2|||
131530544|NCT03029208|473565921|FG001|Overall Study|Withdrawal by Subject|3|||
131530545|NCT03029208|473565920|FG000|Overall Study|Lost to Follow-up|0|||
131530546|NCT03029208|473565921|FG001|Overall Study|Lost to Follow-up|1|||
131530547|NCT05799495|473565925|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
131530548|NCT05799495|473565926|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
131530549|NCT05799495|473565927|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
131530550|NCT05799495|473565928|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
131530551|NCT05799495|473565925|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
131530552|NCT05799495|473565926|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
131530553|NCT05799495|473565927|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
131530554|NCT05799495|473565928|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
131530555|NCT05799495|473565925|FG000|Treatment (Up to 5 Days)|Other|0|||
131530556|NCT05799495|473565926|FG001|Treatment (Up to 5 Days)|Other|1|||
131530557|NCT05799495|473565927|FG002|Treatment (Up to 5 Days)|Other|0|||
131530558|NCT05799495|473565928|FG003|Treatment (Up to 5 Days)|Other|0|||
131530559|NCT05799495|473565925|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
131530560|NCT05799495|473565926|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
131530561|NCT05799495|473565927|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
131530562|NCT05799495|473565928|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
131530563|NCT05799495|473565925|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
131530564|NCT05799495|473565926|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
131530565|NCT05799495|473565927|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
131530566|NCT05799495|473565928|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
131530567|NCT05799495|473565925|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131530568|NCT05799495|473565926|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131530569|NCT05799495|473565927|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
131530570|NCT05799495|473565928|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
131530571|NCT03694548|473565929|FG000|Part A Survey|Protocol Violation|3|||
131530572|NCT03694548|473565930|FG001|Part A Survey|Protocol Violation|3|||
131530573|NCT03694548|473565931|FG002|Part A Survey|Protocol Violation|0|||
131530574|NCT03694548|473565929|FG000|Part B Yoga Program|Protocol Violation|0|||
131530575|NCT03694548|473565930|FG001|Part B Yoga Program|Protocol Violation|0|||
131530576|NCT03694548|473565931|FG002|Part B Yoga Program|Protocol Violation|3|||
131530577|NCT03694548|473565929|FG000|Part B Yoga Program|Did not attend intervention|0|||
131530578|NCT03694548|473565930|FG001|Part B Yoga Program|Did not attend intervention|0|||
131530579|NCT03694548|473565931|FG002|Part B Yoga Program|Did not attend intervention|8|||
131530580|NCT01669343|473565932|FG000|Part A: All Patients|Withdrawal by Subject|7|||
131530581|NCT01669343|473565932|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
131530582|NCT01669343|473565932|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
131530583|NCT01669343|473565932|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
131530584|NCT01669343|473565932|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
131530585|NCT02371369|473565933|FG000|Part 1|Physician Decision|0|||
131530586|NCT02371369|473565934|FG001|Part 1|Physician Decision|3|||
131530587|NCT02371369|473565933|FG000|Part 1|Adverse Event|8|||
131530588|NCT02371369|473565934|FG001|Part 1|Adverse Event|0|||
131530589|NCT02371369|473565933|FG000|Part 1|Withdrawal by Subject|1|||
131530590|NCT02371369|473565934|FG001|Part 1|Withdrawal by Subject|6|||
131530591|NCT02371369|473565933|FG000|Part 1|Disease progression|0|||
131530592|NCT02371369|473565934|FG001|Part 1|Disease progression|1|||
131530593|NCT02371369|473565933|FG000|Part 1|Protocol Violation|0|||
131530594|NCT02371369|473565934|FG001|Part 1|Protocol Violation|1|||
131530595|NCT02371369|473565933|FG000|Part 2|Adverse Event|6|||
131530596|NCT02371369|473565934|FG001|Part 2|Adverse Event|5|||
131530597|NCT02371369|473565933|FG000|Part 2|Withdrawal by Subject|16|||
131530598|NCT02371369|473565934|FG001|Part 2|Withdrawal by Subject|6|||
131530599|NCT02371369|473565933|FG000|Part 2|Investigator decision|1|||
131530600|NCT02371369|473565934|FG001|Part 2|Investigator decision|2|||
131530601|NCT02371369|473565933|FG000|Part 2|Death|0|||
131530602|NCT02371369|473565934|FG001|Part 2|Death|1|||
131530603|NCT02371369|473565933|FG000|Part 2|Disease progression|1|||
131530604|NCT02371369|473565934|FG001|Part 2|Disease progression|0|||
131530605|NCT02371369|473565933|FG000|Part 2|Subject Noncompliance|1|||
131530606|NCT02371369|473565934|FG001|Part 2|Subject Noncompliance|0|||
131530607|NCT02371369|473565933|FG000|Part 2|Lost to Follow-up|1|||
131530608|NCT02371369|473565934|FG001|Part 2|Lost to Follow-up|1|||
131530609|NCT02371369|473565933|FG000|Part 2|Subject transitioned to commercial supply|6|||
131530610|NCT02371369|473565934|FG001|Part 2|Subject transitioned to commercial supply|4|||
131530611|NCT02371369|473565933|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
131530612|NCT02371369|473565934|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
131530613|NCT02371369|473565933|FG000|Part 2|Surgical resection of tumor|1|||
131530614|NCT02371369|473565934|FG001|Part 2|Surgical resection of tumor|1|||
131530615|NCT02371369|473565933|FG000|Part 2|Other|0|||
131530616|NCT02371369|473565934|FG001|Part 2|Other|1|||
131530617|NCT00439777|473565938|FG000|Treatment Period|Death|29|||
131530618|NCT00439777|473565939|FG001|Treatment Period|Death|21|||
131530619|NCT00439777|473565938|FG000|Treatment Period|Study terminated by sponsor|125|||
131530620|NCT00439777|473565939|FG001|Treatment Period|Study terminated by sponsor|132|||
131530621|NCT00439777|473565938|FG000|Treatment Period|Site closed by investigator|0|||
131530622|NCT00439777|473565939|FG001|Treatment Period|Site closed by investigator|1|||
131530623|NCT00439777|473565938|FG000|Treatment Period|Did not take study treatment|7|||
131530624|NCT00439777|473565939|FG001|Treatment Period|Did not take study treatment|8|||
131530625|NCT00439777|473565938|FG000|Treatment Period|Adverse Event|111|||
131530626|NCT00439777|473565939|FG001|Treatment Period|Adverse Event|92|||
131530627|NCT00439777|473565938|FG000|Treatment Period|Protocol Violation|23|||
131530628|NCT00439777|473565939|FG001|Treatment Period|Protocol Violation|30|||
131530629|NCT00439777|473565938|FG000|Treatment Period|Withdrawal by Subject|66|||
131530630|NCT00439777|473565939|FG001|Treatment Period|Withdrawal by Subject|118|||
131530631|NCT00439777|473565938|FG000|Treatment Period|Lack of Efficacy|1|||
131530632|NCT00439777|473565939|FG001|Treatment Period|Lack of Efficacy|4|||
131530633|NCT00439777|473565938|FG000|Treatment Period|Lost to Follow-up|8|||
131530634|NCT00439777|473565939|FG001|Treatment Period|Lost to Follow-up|10|||
131530635|NCT00439777|473565938|FG000|Treatment Period|Protocol driven decision point|1|||
131530636|NCT00439777|473565939|FG001|Treatment Period|Protocol driven decision point|3|||
131530637|NCT00439777|473565938|FG000|Treatment Period|Physician Decision|7|||
131530638|NCT00439777|473565939|FG001|Treatment Period|Physician Decision|18|||
131530639|NCT00439777|473565938|FG000|Treatment Period|Clinical endpoint reached|26|||
131530640|NCT00439777|473565939|FG001|Treatment Period|Clinical endpoint reached|13|||
131530641|NCT00439777|473565938|FG000|Treatment Period|Technical problems|3|||
131530642|NCT00439777|473565939|FG001|Treatment Period|Technical problems|1|||
131530643|NCT00439777|473565938|FG000|Treatment Period|Participant convenience|12|||
131530644|NCT00439777|473565939|FG001|Treatment Period|Participant convenience|8|||
131530645|NCT00439777|473565938|FG000|Observational Period|Protocol Violation|0|||
131530646|NCT00439777|473565939|FG001|Observational Period|Protocol Violation|2|||
131530647|NCT00439777|473565938|FG000|Observational Period|Withdrawal by Subject|9|||
131530648|NCT00439777|473565939|FG001|Observational Period|Withdrawal by Subject|5|||
131530649|NCT00439777|473565938|FG000|Observational Period|Lost to Follow-up|1|||
131530650|NCT00439777|473565939|FG001|Observational Period|Lost to Follow-up|11|||
131530651|NCT00439777|473565938|FG000|Observational Period|Death|27|||
131530652|NCT00439777|473565939|FG001|Observational Period|Death|20|||
131530653|NCT00439777|473565938|FG000|Observational Period|Study terminated by sponsor|3|||
131530654|NCT00439777|473565939|FG001|Observational Period|Study terminated by sponsor|1|||
131530655|NCT00439777|473565938|FG000|Observational Period|Protocol driven decision point|0|||
131530656|NCT00439777|473565939|FG001|Observational Period|Protocol driven decision point|1|||
131530657|NCT00439777|473565938|FG000|Observational Period|Lack of Efficacy|1|||
131530658|NCT00439777|473565939|FG001|Observational Period|Lack of Efficacy|0|||
131530659|NCT00439777|473565938|FG000|Observational Period|Technical problems|0|||
131530660|NCT00439777|473565939|FG001|Observational Period|Technical problems|1|||
131530661|NCT01024387|473565940|FG000|Overall Study|Radiographic Progression|29|||
131530662|NCT01024387|473565940|FG000|Overall Study|Symptomatic Progression|10|||
131530663|NCT01024387|473565940|FG000|Overall Study|Physician Decision|5|||
131530664|NCT01024387|473565940|FG000|Overall Study|Withdrawal by Subject|5|||
131530665|NCT01024387|473565940|FG000|Overall Study|Death|2|||
131530666|NCT01024387|473565940|FG000|Overall Study|Prolonged Treatment Delay|1|||
131530667|NCT01024387|473565940|FG000|Overall Study|Adverse Event|3|||
131530668|NCT01024387|473565940|FG000|Overall Study|Other|5|||
131530669|NCT01143259|473565941|FG000|Overall Study|Withdrawal by Subject|3|||
131530670|NCT01143259|473565942|FG001|Overall Study|Withdrawal by Subject|2|||
131530671|NCT01143259|473565941|FG000|Overall Study|Protocol Violation|13|||
131530672|NCT01143259|473565942|FG001|Overall Study|Protocol Violation|9|||
131530673|NCT01143259|473565941|FG000|Overall Study|Screen Failure|7|||
131530674|NCT01143259|473565942|FG001|Overall Study|Screen Failure|9|||
131530675|NCT02641080|473565943|FG000|Overall Study|Physician Decision|2|||
131530676|NCT02641080|473565944|FG001|Overall Study|Physician Decision|0|||
131530677|NCT02641080|473565943|FG000|Overall Study|Withdrawal by Subject|0|||
131530678|NCT02641080|473565944|FG001|Overall Study|Withdrawal by Subject|1|||
131530679|NCT02641080|473565943|FG000|Overall Study|Rehab Center denied use of pumps|0|||
131530680|NCT02641080|473565944|FG001|Overall Study|Rehab Center denied use of pumps|3|||
131530681|NCT02641080|473565943|FG000|Overall Study|Lost to Follow-up|0|||
131530682|NCT02641080|473565944|FG001|Overall Study|Lost to Follow-up|3|||
131530683|NCT03864900|473565951|FG000|Overall Study|Withdrawal by Subject|1|||
131530684|NCT03864900|473565952|FG001|Overall Study|Withdrawal by Subject|1|||
131530685|NCT03864900|473565951|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
131530686|NCT03864900|473565952|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
131530687|NCT00759109|473565954|FG000|Overall Study|Adverse Event|17|||
131530688|NCT00759109|473565955|FG001|Overall Study|Adverse Event|12|||
131530689|NCT00759109|473565954|FG000|Overall Study|Inability to comply|1|||
131530690|NCT00759109|473565955|FG001|Overall Study|Inability to comply|1|||
131530691|NCT00759109|473565954|FG000|Overall Study|Withdrawal by Subject|9|||
131530692|NCT00759109|473565955|FG001|Overall Study|Withdrawal by Subject|5|||
131530693|NCT00759109|473565954|FG000|Overall Study|Death|4|||
131530694|NCT00759109|473565955|FG001|Overall Study|Death|3|||
131530695|NCT00759109|473565954|FG000|Overall Study|Lost to Follow-up|4|||
131530696|NCT00759109|473565955|FG001|Overall Study|Lost to Follow-up|6|||
131530697|NCT00759109|473565954|FG000|Overall Study|Started new therapy|2|||
131530698|NCT00759109|473565955|FG001|Overall Study|Started new therapy|6|||
131530699|NCT00759109|473565954|FG000|Overall Study|HCV RNA negative|1|||
131530700|NCT00759109|473565955|FG001|Overall Study|HCV RNA negative|0|||
131530701|NCT00759109|473565954|FG000|Overall Study|Participant moved to a different city|0|||
131530702|NCT00759109|473565955|FG001|Overall Study|Participant moved to a different city|1|||
131530703|NCT00759109|473565954|FG000|Overall Study|Participant had a liver transplant|0|||
131530704|NCT00759109|473565955|FG001|Overall Study|Participant had a liver transplant|1|||
131530705|NCT00759109|473565954|FG000|Overall Study|Lost during study|1|||
131530706|NCT00759109|473565955|FG001|Overall Study|Lost during study|0|||
131530707|NCT03165045|473565956|FG000|Visit 1|No registration after visit 1|9|||
131530708|NCT03165045|473565956|FG000|Visit 1|No treatment documented|10|||
131530709|NCT03165045|473565956|FG000|Visit 1|No visit 1|10|||
131530710|NCT03165045|473565956|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
131530711|NCT03165045|473565956|FG000|Visit 2|No available total CCQ score at all|29|||
131530712|NCT03165045|473565956|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
131530713|NCT03191903|473565960|FG000|Overall Study|Withdrawal by Subject|6|||
131530714|NCT03191903|473565961|FG001|Overall Study|Withdrawal by Subject|5|||
131530715|NCT03191903|473565962|FG002|Overall Study|Withdrawal by Subject|4|||
131530716|NCT03191903|473565960|FG000|Overall Study|Adverse Event|1|||
131530717|NCT03191903|473565961|FG001|Overall Study|Adverse Event|0|||
131530718|NCT03191903|473565962|FG002|Overall Study|Adverse Event|0|||
131530719|NCT00503685|473565966|FG000|Overall Study|Adverse Event|0|||
131530720|NCT00503685|473565967|FG001|Overall Study|Adverse Event|0|||
131530721|NCT00503685|473565968|FG002|Overall Study|Adverse Event|2|||
131530722|NCT00503685|473565966|FG000|Overall Study|Withdrawal by Subject|0|||
131530723|NCT00503685|473565967|FG001|Overall Study|Withdrawal by Subject|1|||
131530724|NCT00503685|473565968|FG002|Overall Study|Withdrawal by Subject|0|||
131530725|NCT00503685|473565966|FG000|Overall Study|Protocol Violation|0|||
131530726|NCT00503685|473565967|FG001|Overall Study|Protocol Violation|1|||
131530727|NCT00503685|473565968|FG002|Overall Study|Protocol Violation|0|||
131530728|NCT00503685|473565966|FG000|Overall Study|Eligibility Criteria Not Met|0|||
131530729|NCT00503685|473565967|FG001|Overall Study|Eligibility Criteria Not Met|1|||
131530730|NCT00503685|473565968|FG002|Overall Study|Eligibility Criteria Not Met|0|||
131530731|NCT00927927|473565969|FG000|Overall Study|Withdrawal by Subject|0|||
131530732|NCT00927927|473565970|FG001|Overall Study|Withdrawal by Subject|0|||
131530733|NCT00927927|473565971|FG002|Overall Study|Withdrawal by Subject|0|||
131530734|NCT00927927|473565972|FG003|Overall Study|Withdrawal by Subject|0|||
131530735|NCT00927927|473565973|FG004|Overall Study|Withdrawal by Subject|0|||
131530736|NCT00927927|473565974|FG005|Overall Study|Withdrawal by Subject|0|||
131658436|NCT01531673|474035310|FG011|Overall Study|Other|0|||
131530737|NCT00927927|473565975|FG006|Overall Study|Withdrawal by Subject|0|||
131530738|NCT00927927|473565976|FG007|Overall Study|Withdrawal by Subject|2|||
131530739|NCT00927927|473565977|FG008|Overall Study|Withdrawal by Subject|0|||
131530740|NCT00927927|473565978|FG009|Overall Study|Withdrawal by Subject|0|||
131530741|NCT00927927|473565979|FG010|Overall Study|Withdrawal by Subject|0|||
131530742|NCT00927927|473565980|FG011|Overall Study|Withdrawal by Subject|2|||
131530743|NCT00927927|473565981|FG012|Overall Study|Withdrawal by Subject|0|||
131530744|NCT00927927|473565982|FG013|Overall Study|Withdrawal by Subject|0|||
131530745|NCT00927927|473565983|FG014|Overall Study|Withdrawal by Subject|0|||
131530746|NCT02838017|473565986|FG000|Overall Study|Lost to Follow-up|14|||
131530747|NCT02838017|473565987|FG001|Overall Study|Lost to Follow-up|11|||
131530748|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
131530749|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
131530750|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
131530751|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
131530752|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
131530753|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
131530754|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
131530755|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
131530756|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
131530757|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
131530758|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
131530759|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
131530760|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
131530761|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
131530762|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
131530763|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
131530764|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
131530765|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
131530766|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
131530767|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
131530768|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
131530769|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
131530770|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
131530771|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
131530772|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
131530773|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
131530774|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
131530775|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
131530776|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
131530777|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
131530778|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
131530779|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
131530780|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
131530781|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
131530782|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
131530783|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
131530784|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
131530785|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
131530786|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
131530787|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
131530788|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
131530789|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
131530790|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
131530791|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
131530792|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
131530793|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
131530794|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
131530795|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
131530796|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
131530797|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
131530798|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
131530799|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
131530800|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
131530801|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
131530802|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
131530803|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
131530804|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
131530805|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
131530806|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
131530807|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
131530808|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
131530809|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
131530810|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
131530811|NCT01884350|473565988|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
131530812|NCT01884350|473565989|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
131530813|NCT01884350|473565990|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
131530814|NCT02345512|473565991|FG000|Overall Study|Adverse Event|1|||
131530815|NCT02345512|473565991|FG000|Overall Study|Withdrawal by Subject|1|||
131530816|NCT01968434|473565994|FG000|Overall Study|Lost to Follow-up|3|||
131530817|NCT01968434|473565995|FG001|Overall Study|Lost to Follow-up|6|||
131530818|NCT00074282|473567662|FG000|Step 1|Adverse Event|32|||
131530819|NCT00074282|473567663|FG001|Step 1|Adverse Event|0|||
131530820|NCT00074282|473567664|FG002|Step 1|Adverse Event|0|||
131530821|NCT00074282|473567662|FG000|Step 1|Death|6|||
131530822|NCT00074282|473567663|FG001|Step 1|Death|0|||
131530823|NCT00074282|473567664|FG002|Step 1|Death|0|||
131530824|NCT00074282|473567662|FG000|Step 1|Withdrawal by Subject|7|||
131530825|NCT00074282|473567663|FG001|Step 1|Withdrawal by Subject|0|||
131530826|NCT00074282|473567664|FG002|Step 1|Withdrawal by Subject|0|||
131530827|NCT00074282|473567662|FG000|Step 1|Disease progression|2|||
131530828|NCT00074282|473567663|FG001|Step 1|Disease progression|0|||
131530829|NCT00074282|473567664|FG002|Step 1|Disease progression|0|||
131530830|NCT00074282|473567662|FG000|Step 1|Alternative therapy|2|||
131530831|NCT00074282|473567663|FG001|Step 1|Alternative therapy|0|||
131530832|NCT00074282|473567664|FG002|Step 1|Alternative therapy|0|||
131530833|NCT00074282|473567662|FG000|Step 1|Other complicating disease|2|||
131530834|NCT00074282|473567663|FG001|Step 1|Other complicating disease|0|||
131530835|NCT00074282|473567664|FG002|Step 1|Other complicating disease|0|||
131530836|NCT00074282|473567662|FG000|Step 1|Physician Decision|1|||
131530837|NCT00074282|473567663|FG001|Step 1|Physician Decision|0|||
131530838|NCT00074282|473567664|FG002|Step 1|Physician Decision|0|||
131530839|NCT00074282|473567662|FG000|Step 1|Ineligible|4|||
131530840|NCT00074282|473567663|FG001|Step 1|Ineligible|0|||
131530841|NCT00074282|473567664|FG002|Step 1|Ineligible|0|||
131530842|NCT00074282|473567662|FG000|Step 1|Never started treatment|2|||
131530843|NCT00074282|473567663|FG001|Step 1|Never started treatment|0|||
131530844|NCT00074282|473567664|FG002|Step 1|Never started treatment|0|||
131530845|NCT00074282|473567662|FG000|Step 2|Adverse Event|0|||
131530846|NCT00074282|473567663|FG001|Step 2|Adverse Event|2|||
131530847|NCT00074282|473567664|FG002|Step 2|Adverse Event|12|||
131530848|NCT00074282|473567662|FG000|Step 2|Disease progression|0|||
131530849|NCT00074282|473567663|FG001|Step 2|Disease progression|0|||
131530850|NCT00074282|473567664|FG002|Step 2|Disease progression|5|||
131530851|NCT00074282|473567662|FG000|Step 2|Death|0|||
131530852|NCT00074282|473567663|FG001|Step 2|Death|0|||
131530853|NCT00074282|473567664|FG002|Step 2|Death|3|||
131530854|NCT00074282|473567662|FG000|Step 2|Withdrawal by Subject|0|||
131530855|NCT00074282|473567663|FG001|Step 2|Withdrawal by Subject|0|||
131530856|NCT00074282|473567664|FG002|Step 2|Withdrawal by Subject|2|||
131530857|NCT00074282|473567662|FG000|Step 2|Physician Decision|0|||
131530858|NCT00074282|473567663|FG001|Step 2|Physician Decision|0|||
131530859|NCT00074282|473567664|FG002|Step 2|Physician Decision|1|||
131530860|NCT00074282|473567662|FG000|Step 2|Ineligible|0|||
131530861|NCT00074282|473567663|FG001|Step 2|Ineligible|0|||
131530862|NCT00074282|473567664|FG002|Step 2|Ineligible|1|||
131530863|NCT00464542|473567665|FG000|Pre-treatment|Withdrawal by Subject|2|||
131530864|NCT02055352|473567666|FG000|Overall Study|Adverse Event|0|||
131530865|NCT02055352|473567667|FG001|Overall Study|Adverse Event|1|||
131530866|NCT02055352|473567666|FG000|Overall Study|Non-eligible|0|||
131530867|NCT02055352|473567667|FG001|Overall Study|Non-eligible|1|||
131530868|NCT02055352|473567666|FG000|Overall Study|Poor compliance|1|||
131530869|NCT02055352|473567667|FG001|Overall Study|Poor compliance|1|||
131530870|NCT02055352|473567666|FG000|Overall Study|Death|1|||
131530871|NCT02055352|473567667|FG001|Overall Study|Death|2|||
131530872|NCT02055352|473567666|FG000|Overall Study|Patient decision|1|||
131530873|NCT02055352|473567667|FG001|Overall Study|Patient decision|1|||
131530874|NCT02055352|473567666|FG000|Overall Study|Use of prohibited treatment|0|||
131530875|NCT02055352|473567667|FG001|Overall Study|Use of prohibited treatment|3|||
131530876|NCT02055352|473567666|FG000|Overall Study|AE, study drug would be detrimental|1|||
131530877|NCT02055352|473567667|FG001|Overall Study|AE, study drug would be detrimental|3|||
131530878|NCT02055352|473567666|FG000|Overall Study|Withdrawal of informed consent|1|||
131530879|NCT02055352|473567667|FG001|Overall Study|Withdrawal of informed consent|0|||
131530880|NCT02055352|473567666|FG000|Overall Study|Reason unknown|1|||
131530881|NCT02055352|473567667|FG001|Overall Study|Reason unknown|5|||
131530882|NCT01159938|473567674|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
131530883|NCT01159938|473567675|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
131530884|NCT01159938|473567676|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
131530885|NCT01159938|473567677|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
131530886|NCT01159938|473567678|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
131530887|NCT02416791|473567679|FG000|6 Months|Lost to Follow-up|0|||
131530888|NCT02416791|473567680|FG001|6 Months|Lost to Follow-up|0|||
131530889|NCT02416791|473567681|FG002|6 Months|Lost to Follow-up|1|||
131530890|NCT02162810|473567684|FG000|Overall Study|Protocol Violation|1|||
131530891|NCT02162810|473567685|FG001|Overall Study|Protocol Violation|0|||
131530892|NCT02162810|473567684|FG000|Overall Study|patients did not report compliance|4|||
131530893|NCT02162810|473567685|FG001|Overall Study|patients did not report compliance|1|||
131530894|NCT02519504|473567690|FG000|Overall Study|Protocol Violation|6|||
131530895|NCT02519504|473567691|FG001|Overall Study|Protocol Violation|5|||
131530896|NCT02519504|473567690|FG000|Overall Study|Ineligible for direct testing|12|||
131530897|NCT02519504|473567691|FG001|Overall Study|Ineligible for direct testing|12|||
131530898|NCT02519504|473567690|FG000|Overall Study|Did not participate in direct testing|95|||
131530899|NCT02519504|473567691|FG001|Overall Study|Did not participate in direct testing|86|||
131530900|NCT01197950|473567692|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
131530901|NCT01197950|473567693|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
131530902|NCT01197950|473567694|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
131530903|NCT02553330|473567695|FG000|Overall Study|Study Terminated by Sponsor|2|||
131530904|NCT02553330|473567696|FG001|Overall Study|Study Terminated by Sponsor|13|||
131530905|NCT02553330|473567697|FG002|Overall Study|Study Terminated by Sponsor|12|||
131530906|NCT02553330|473567695|FG000|Overall Study|Withdrawal by Subject|3|||
131530907|NCT02553330|473567696|FG001|Overall Study|Withdrawal by Subject|19|||
131530908|NCT02553330|473567697|FG002|Overall Study|Withdrawal by Subject|21|||
131530909|NCT02553330|473567695|FG000|Overall Study|Other|0|||
131530910|NCT02553330|473567696|FG001|Overall Study|Other|1|||
131530911|NCT02553330|473567697|FG002|Overall Study|Other|0|||
131530912|NCT02553330|473567695|FG000|Overall Study|Non compliance to study treatment|0|||
131530913|NCT02553330|473567696|FG001|Overall Study|Non compliance to study treatment|1|||
131530914|NCT02553330|473567697|FG002|Overall Study|Non compliance to study treatment|0|||
131530915|NCT02553330|473567695|FG000|Overall Study|Adverse Event|0|||
131530916|NCT02553330|473567696|FG001|Overall Study|Adverse Event|1|||
131530917|NCT02553330|473567697|FG002|Overall Study|Adverse Event|0|||
131530918|NCT02553330|473567695|FG000|Overall Study|Lost to Follow-up|0|||
131530919|NCT02553330|473567696|FG001|Overall Study|Lost to Follow-up|4|||
131530920|NCT02553330|473567697|FG002|Overall Study|Lost to Follow-up|4|||
131530921|NCT03551938|473567698|FG000|3-Month Follow Up|Lost to Follow-up|39|||
131530922|NCT03551938|473567699|FG001|3-Month Follow Up|Lost to Follow-up|38|||
131530923|NCT03551938|473567698|FG000|6-Month Follow Up|Lost to Follow-up|46|||
131530924|NCT03551938|473567699|FG001|6-Month Follow Up|Lost to Follow-up|42|||
131530925|NCT03551938|473567698|FG000|9-Month Follow Up|Lost to Follow-up|44|||
131530926|NCT03551938|473567699|FG001|9-Month Follow Up|Lost to Follow-up|43|||
131530927|NCT04137380|473567707|FG000|Overall Study|Physician Decision|0|||
131530928|NCT04137380|473567708|FG001|Overall Study|Physician Decision|0|||
131530929|NCT04137380|473567709|FG002|Overall Study|Physician Decision|0|||
131530930|NCT04137380|473567710|FG003|Overall Study|Physician Decision|1|||
131530931|NCT04137380|473567711|FG004|Overall Study|Physician Decision|0|||
131530932|NCT04137380|473567712|FG005|Overall Study|Physician Decision|0|||
131530933|NCT04137380|473567713|FG006|Overall Study|Physician Decision|0|||
131530934|NCT02265705|473567717|FG000|Treatment Period Week 0-24|Adverse Event|3|||
131530935|NCT02265705|473567718|FG001|Treatment Period Week 0-24|Adverse Event|2|||
131530936|NCT02265705|473567719|FG002|Treatment Period Week 0-24|Adverse Event|0|||
131530937|NCT02265705|473567720|FG003|Treatment Period Week 0-24|Adverse Event|0|||
131530938|NCT02265705|473567721|FG004|Treatment Period Week 0-24|Adverse Event|0|||
131530939|NCT02265705|473567722|FG005|Treatment Period Week 0-24|Adverse Event|0|||
131530940|NCT02265705|473567723|FG006|Treatment Period Week 0-24|Adverse Event|0|||
131530941|NCT02265705|473567717|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
131530942|NCT02265705|473567718|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
131530943|NCT02265705|473567719|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
131530944|NCT02265705|473567720|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
131530945|NCT02265705|473567721|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
131530946|NCT02265705|473567722|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
131530947|NCT02265705|473567723|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
131530948|NCT02265705|473567717|FG000|Treatment Period Week 0-24|Physician Decision|1|||
131530949|NCT02265705|473567718|FG001|Treatment Period Week 0-24|Physician Decision|0|||
131530950|NCT02265705|473567719|FG002|Treatment Period Week 0-24|Physician Decision|0|||
131530951|NCT02265705|473567720|FG003|Treatment Period Week 0-24|Physician Decision|0|||
131530952|NCT02265705|473567721|FG004|Treatment Period Week 0-24|Physician Decision|0|||
131530953|NCT02265705|473567722|FG005|Treatment Period Week 0-24|Physician Decision|0|||
131530954|NCT02265705|473567723|FG006|Treatment Period Week 0-24|Physician Decision|0|||
131530955|NCT02265705|473567717|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
131530956|NCT02265705|473567718|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
131530957|NCT02265705|473567719|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
131530958|NCT02265705|473567720|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
131530959|NCT02265705|473567721|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
131530960|NCT02265705|473567722|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
131530961|NCT02265705|473567723|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
131530962|NCT02265705|473567717|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
131530963|NCT02265705|473567718|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
131530964|NCT02265705|473567719|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
131530965|NCT02265705|473567720|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
131530966|NCT02265705|473567721|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
131530967|NCT02265705|473567722|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
131530968|NCT02265705|473567723|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
131530969|NCT02265705|473567717|FG000|Rescue Period|Withdrawal by Subject|0|||
131530970|NCT02265705|473567718|FG001|Rescue Period|Withdrawal by Subject|0|||
131530971|NCT02265705|473567719|FG002|Rescue Period|Withdrawal by Subject|1|||
131530972|NCT02265705|473567720|FG003|Rescue Period|Withdrawal by Subject|0|||
131530973|NCT02265705|473567721|FG004|Rescue Period|Withdrawal by Subject|0|||
131530974|NCT02265705|473567722|FG005|Rescue Period|Withdrawal by Subject|0|||
131530975|NCT02265705|473567723|FG006|Rescue Period|Withdrawal by Subject|0|||
131530976|NCT02265705|473567717|FG000|Rescue Period|Death|0|||
131530977|NCT02265705|473567718|FG001|Rescue Period|Death|0|||
131530978|NCT02265705|473567719|FG002|Rescue Period|Death|1|||
131530979|NCT02265705|473567720|FG003|Rescue Period|Death|0|||
131530980|NCT02265705|473567721|FG004|Rescue Period|Death|0|||
131530981|NCT02265705|473567722|FG005|Rescue Period|Death|0|||
131530982|NCT02265705|473567723|FG006|Rescue Period|Death|0|||
131530983|NCT02265705|473567717|FG000|Rescue Period|Lack of Efficacy|0|||
131530984|NCT02265705|473567718|FG001|Rescue Period|Lack of Efficacy|0|||
131530985|NCT02265705|473567719|FG002|Rescue Period|Lack of Efficacy|1|||
131530986|NCT02265705|473567720|FG003|Rescue Period|Lack of Efficacy|0|||
131530987|NCT02265705|473567721|FG004|Rescue Period|Lack of Efficacy|0|||
131530988|NCT02265705|473567722|FG005|Rescue Period|Lack of Efficacy|0|||
131530989|NCT02265705|473567723|FG006|Rescue Period|Lack of Efficacy|0|||
131530990|NCT02265705|473567717|FG000|Open Label Period|Adverse Event|0|||
131530991|NCT02265705|473567718|FG001|Open Label Period|Adverse Event|0|||
131530992|NCT02265705|473567719|FG002|Open Label Period|Adverse Event|0|||
131530993|NCT02265705|473567720|FG003|Open Label Period|Adverse Event|2|||
131530994|NCT02265705|473567721|FG004|Open Label Period|Adverse Event|2|||
131530995|NCT02265705|473567722|FG005|Open Label Period|Adverse Event|0|||
131530996|NCT02265705|473567723|FG006|Open Label Period|Adverse Event|0|||
131530997|NCT02265705|473567717|FG000|Open Label Period|Physician Decision|0|||
131530998|NCT02265705|473567718|FG001|Open Label Period|Physician Decision|0|||
131530999|NCT02265705|473567719|FG002|Open Label Period|Physician Decision|0|||
131531000|NCT02265705|473567720|FG003|Open Label Period|Physician Decision|0|||
131531001|NCT02265705|473567721|FG004|Open Label Period|Physician Decision|1|||
131531002|NCT02265705|473567722|FG005|Open Label Period|Physician Decision|0|||
131531003|NCT02265705|473567723|FG006|Open Label Period|Physician Decision|0|||
131531004|NCT02265705|473567717|FG000|Open Label Period|Withdrawal by Subject|0|||
131531005|NCT02265705|473567718|FG001|Open Label Period|Withdrawal by Subject|0|||
131531006|NCT02265705|473567719|FG002|Open Label Period|Withdrawal by Subject|0|||
131531007|NCT02265705|473567720|FG003|Open Label Period|Withdrawal by Subject|0|||
131531008|NCT02265705|473567721|FG004|Open Label Period|Withdrawal by Subject|2|||
131531009|NCT02265705|473567722|FG005|Open Label Period|Withdrawal by Subject|0|||
131531010|NCT02265705|473567723|FG006|Open Label Period|Withdrawal by Subject|0|||
131531011|NCT02265705|473567717|FG000|Follow-up Period|Sponsor Decision|0|||
131531012|NCT02265705|473567718|FG001|Follow-up Period|Sponsor Decision|0|||
131531013|NCT02265705|473567719|FG002|Follow-up Period|Sponsor Decision|0|||
131531014|NCT02265705|473567720|FG003|Follow-up Period|Sponsor Decision|0|||
131531015|NCT02265705|473567721|FG004|Follow-up Period|Sponsor Decision|0|||
131531016|NCT02265705|473567722|FG005|Follow-up Period|Sponsor Decision|1|||
131531017|NCT02265705|473567723|FG006|Follow-up Period|Sponsor Decision|6|||
131531018|NCT02265705|473567717|FG000|Follow-up Period|Adverse Event|0|||
131531019|NCT02265705|473567718|FG001|Follow-up Period|Adverse Event|0|||
131531020|NCT02265705|473567719|FG002|Follow-up Period|Adverse Event|0|||
131531021|NCT02265705|473567720|FG003|Follow-up Period|Adverse Event|0|||
131531022|NCT02265705|473567721|FG004|Follow-up Period|Adverse Event|0|||
131531023|NCT02265705|473567722|FG005|Follow-up Period|Adverse Event|0|||
131531024|NCT02265705|473567723|FG006|Follow-up Period|Adverse Event|3|||
131531025|NCT02265705|473567717|FG000|Follow-up Period|Physician Decision|0|||
131531026|NCT02265705|473567718|FG001|Follow-up Period|Physician Decision|0|||
131531027|NCT02265705|473567719|FG002|Follow-up Period|Physician Decision|0|||
131531028|NCT02265705|473567720|FG003|Follow-up Period|Physician Decision|0|||
131531029|NCT02265705|473567721|FG004|Follow-up Period|Physician Decision|0|||
131531030|NCT02265705|473567722|FG005|Follow-up Period|Physician Decision|0|||
131531031|NCT02265705|473567723|FG006|Follow-up Period|Physician Decision|1|||
131531032|NCT02265705|473567717|FG000|Follow-up Period|Withdrawal by Subject|0|||
131531033|NCT02265705|473567718|FG001|Follow-up Period|Withdrawal by Subject|0|||
131531034|NCT02265705|473567719|FG002|Follow-up Period|Withdrawal by Subject|0|||
131531035|NCT02265705|473567720|FG003|Follow-up Period|Withdrawal by Subject|0|||
131531036|NCT02265705|473567721|FG004|Follow-up Period|Withdrawal by Subject|0|||
131531037|NCT02265705|473567722|FG005|Follow-up Period|Withdrawal by Subject|0|||
131531038|NCT02265705|473567723|FG006|Follow-up Period|Withdrawal by Subject|1|||
131531039|NCT00779246|473567724|FG000|Overall Study|Missing sufficient data for analysis|33|||
131531040|NCT00779246|473567725|FG001|Overall Study|Missing sufficient data for analysis|53|||
131531041|NCT03465540|473567726|FG000|Overall Study|Withdrawal by Subject|0|||
131531042|NCT03465540|473567727|FG001|Overall Study|Withdrawal by Subject|0|||
131531043|NCT03465540|473567728|FG002|Overall Study|Withdrawal by Subject|1|||
131531044|NCT03465540|473567729|FG003|Overall Study|Withdrawal by Subject|1|||
131531045|NCT03465540|473567730|FG004|Overall Study|Withdrawal by Subject|1|||
131531046|NCT03465540|473567731|FG005|Overall Study|Withdrawal by Subject|0|||
131531047|NCT03465540|473567726|FG000|Overall Study|Lost to Follow-up|0|||
131531048|NCT03465540|473567727|FG001|Overall Study|Lost to Follow-up|1|||
131531049|NCT03465540|473567728|FG002|Overall Study|Lost to Follow-up|0|||
131531050|NCT03465540|473567729|FG003|Overall Study|Lost to Follow-up|0|||
131531051|NCT03465540|473567730|FG004|Overall Study|Lost to Follow-up|1|||
131531052|NCT03465540|473567731|FG005|Overall Study|Lost to Follow-up|0|||
131531053|NCT03465540|473567726|FG000|Overall Study|Death|1|||
131531054|NCT03465540|473567727|FG001|Overall Study|Death|1|||
131531055|NCT03465540|473567728|FG002|Overall Study|Death|0|||
131531056|NCT03465540|473567729|FG003|Overall Study|Death|2|||
131531057|NCT03465540|473567730|FG004|Overall Study|Death|0|||
131531058|NCT03465540|473567731|FG005|Overall Study|Death|2|||
131531059|NCT03465540|473567726|FG000|Overall Study|Protocol specified criteria|0|||
131531060|NCT03465540|473567727|FG001|Overall Study|Protocol specified criteria|2|||
131531061|NCT03465540|473567728|FG002|Overall Study|Protocol specified criteria|2|||
131531062|NCT03465540|473567729|FG003|Overall Study|Protocol specified criteria|0|||
131531063|NCT03465540|473567730|FG004|Overall Study|Protocol specified criteria|2|||
131531064|NCT03465540|473567731|FG005|Overall Study|Protocol specified criteria|0|||
131531065|NCT02844946|473567732|FG000|Overall Study|Lost to Follow-up|7|||
131531066|NCT02844946|473567733|FG001|Overall Study|Lost to Follow-up|0|||
131531067|NCT02806986|473567734|FG000|Treatment Stage 1|Adverse Event|1|||
131531068|NCT02806986|473567734|FG000|Treatment Stage 2|Adverse Event|3|||
131531069|NCT02806986|473567734|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
131531070|NCT04000165|473567735|FG000|Overall Study|Physician Decision|1|||
131531071|NCT04000165|473567735|FG000|Overall Study|Withdrawal by Subject|1|||
131531072|NCT02079805|473567736|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131531073|NCT02079805|473567737|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131531074|NCT02079805|473567736|FG000|Overall Study|Voluntary Withdrawal|0|||
131531075|NCT02079805|473567737|FG001|Overall Study|Voluntary Withdrawal|1|||
131531076|NCT01753193|473567738|FG000|Overall Study|Withdrawal by Subject|23|||
131531077|NCT01753193|473567738|FG000|Overall Study|Lost to Follow-up|6|||
131531078|NCT01753193|473567738|FG000|Overall Study|Death|1|||
131531079|NCT01753193|473567738|FG000|Overall Study|Other|16|||
131531080|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
131531081|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
131531082|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
131531083|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
131531084|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
131531085|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
131531086|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
131531087|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
131531088|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
131531089|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
131531090|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
131531091|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
131531092|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
131531093|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
131531094|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
131531095|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
131531096|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
131531097|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
131531098|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
131531099|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
131531100|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
131531101|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
131658437|NCT01531673|474035311|FG012|Overall Study|Other|0|||
131531102|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
131531103|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
131531104|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
131531105|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
131531106|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
131531107|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
131531108|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
131531109|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
131531110|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
131531111|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
131531112|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
131531113|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
131531114|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
131531115|NCT00383435|473567739|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
131531116|NCT00383435|473567740|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
131531117|NCT00383435|473567741|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
131531118|NCT00383435|473567742|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
131531119|NCT00383435|473567743|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
131531120|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
131531121|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
131531122|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
131531123|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
131531124|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
131531125|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
131531126|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
131531127|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
131531128|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
131531129|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
131531130|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
131531131|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
131531132|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
131531133|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
131531134|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
131531135|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
131531136|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
131531137|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
131531138|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
131531139|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
131531140|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131531141|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
131531142|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
131531143|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
131531144|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131531145|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
131531146|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131531147|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131531148|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131531149|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
131531150|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131531151|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131531152|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131531153|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131531154|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131531155|NCT00383435|473567739|FG000|26-Week Treatment Safety Extension|Administrative|1|||
131531156|NCT00383435|473567740|FG001|26-Week Treatment Safety Extension|Administrative|1|||
131531157|NCT00383435|473567741|FG002|26-Week Treatment Safety Extension|Administrative|0|||
131531158|NCT00383435|473567742|FG003|26-Week Treatment Safety Extension|Administrative|1|||
131531159|NCT00383435|473567743|FG004|26-Week Treatment Safety Extension|Administrative|0|||
131531160|NCT02682264|473567744|FG000|Overall Study|Withdrawal by Subject|56|||
131531161|NCT02682264|473567745|FG001|Overall Study|Withdrawal by Subject|45|||
131531162|NCT02682264|473567744|FG000|Overall Study|Lost to Follow-up|49|||
131531163|NCT02682264|473567745|FG001|Overall Study|Lost to Follow-up|41|||
131531164|NCT02682264|473567744|FG000|Overall Study|Lack of Efficacy|14|||
131531165|NCT02682264|473567745|FG001|Overall Study|Lack of Efficacy|16|||
131531166|NCT02682264|473567744|FG000|Overall Study|Withdrawal by Parent|6|||
131531167|NCT02682264|473567745|FG001|Overall Study|Withdrawal by Parent|7|||
131531168|NCT02682264|473567744|FG000|Overall Study|Adverse Event|9|||
131531169|NCT02682264|473567745|FG001|Overall Study|Adverse Event|0|||
131531170|NCT02682264|473567744|FG000|Overall Study|Noncompliance with study drug|1|||
131531171|NCT02682264|473567745|FG001|Overall Study|Noncompliance with study drug|4|||
131531172|NCT02682264|473567744|FG000|Overall Study|Pregnancy|1|||
131531173|NCT02682264|473567745|FG001|Overall Study|Pregnancy|2|||
131531174|NCT02682264|473567744|FG000|Overall Study|Recovery|1|||
131531175|NCT02682264|473567745|FG001|Overall Study|Recovery|2|||
131531176|NCT02682264|473567744|FG000|Overall Study|Progressive Disease|1|||
131531177|NCT02682264|473567745|FG001|Overall Study|Progressive Disease|0|||
131531178|NCT02682264|473567744|FG000|Overall Study|Technical Problems|0|||
131531179|NCT02682264|473567745|FG001|Overall Study|Technical Problems|1|||
131531180|NCT02682264|473567744|FG000|Overall Study|Moved abroad and unable to continue|0|||
131531181|NCT02682264|473567745|FG001|Overall Study|Moved abroad and unable to continue|3|||
131531182|NCT02682264|473567744|FG000|Overall Study|Stopped test article application|0|||
131531183|NCT02682264|473567745|FG001|Overall Study|Stopped test article application|1|||
131531184|NCT03264989|473567749|FG000|Overall Study|Lost to Follow-up|1|||
131531185|NCT03264989|473567750|FG001|Overall Study|Lost to Follow-up|0|||
131531186|NCT03264989|473567749|FG000|Overall Study|New Therapy for study Indication|1|||
131531187|NCT03264989|473567750|FG001|Overall Study|New Therapy for study Indication|0|||
131531188|NCT03264989|473567749|FG000|Overall Study|Protocol Violation|0|||
131531189|NCT03264989|473567750|FG001|Overall Study|Protocol Violation|1|||
131531190|NCT03264989|473567749|FG000|Overall Study|Patient decision|13|||
131531191|NCT03264989|473567750|FG001|Overall Study|Patient decision|0|||
131531192|NCT03264989|473567749|FG000|Overall Study|Physician Decision|6|||
131531193|NCT03264989|473567750|FG001|Overall Study|Physician Decision|4|||
131531194|NCT03264989|473567749|FG000|Overall Study|Adverse Event|2|||
131531195|NCT03264989|473567750|FG001|Overall Study|Adverse Event|1|||
131531196|NCT03264989|473567749|FG000|Overall Study|Death|1|||
131531197|NCT03264989|473567750|FG001|Overall Study|Death|1|||
131531198|NCT03264989|473567749|FG000|Overall Study|Pregnancy|2|||
131531199|NCT03264989|473567750|FG001|Overall Study|Pregnancy|0|||
131531200|NCT03264989|473567749|FG000|Overall Study|End of Study|19|||
131531201|NCT03264989|473567750|FG001|Overall Study|End of Study|5|||
131531202|NCT01775137|473567751|FG000|Overall Study|Death|1|||
131531203|NCT01775137|473567751|FG000|Overall Study|Protocol deviation|2|||
131531204|NCT01775137|473567751|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131531205|NCT01775137|473567751|FG000|Overall Study|Adverse Event|1|||
131531206|NCT01775137|473567751|FG000|Overall Study|Withdrawal by participants|5|||
131531207|NCT00096135|473567760|FG000|Overall Study|Physician Decision|20|||
131531208|NCT00096135|473567761|FG001|Overall Study|Physician Decision|4|||
131531209|NCT00096135|473567760|FG000|Overall Study|Refusal of further protocol therapy|4|||
131531210|NCT00096135|473567761|FG001|Overall Study|Refusal of further protocol therapy|1|||
131531211|NCT00096135|473567760|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
131531212|NCT00096135|473567761|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
131531213|NCT00096135|473567760|FG000|Overall Study|Other, specify|15|||
131531214|NCT00096135|473567761|FG001|Overall Study|Other, specify|3|||
131531215|NCT00096135|473567760|FG000|Overall Study|Ineligible|2|||
131531216|NCT00096135|473567761|FG001|Overall Study|Ineligible|0|||
131531217|NCT00874029|473567763|FG000|Overall Study|Withdrawal by Subject|10|||
131531218|NCT00874029|473567763|FG000|Overall Study|Pregnancy|4|||
131531219|NCT00874029|473567763|FG000|Overall Study|Physician Decision|1|||
131531220|NCT00874029|473567763|FG000|Overall Study|Adverse Event|1|||
131531221|NCT00874029|473567763|FG000|Overall Study|Lost to Follow-up|5|||
131531222|NCT00856583|473567764|FG000|Overall Study|Lack of Efficacy|389|||
131531223|NCT00856583|473567765|FG001|Overall Study|Lack of Efficacy|377|||
131531224|NCT00856583|473567764|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
131531225|NCT00856583|473567765|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
131531226|NCT00856583|473567764|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
131531227|NCT00856583|473567765|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
131531228|NCT00856583|473567764|FG000|Overall Study|Non-compliance|305|||
131531229|NCT00856583|473567765|FG001|Overall Study|Non-compliance|262|||
131531230|NCT00856583|473567764|FG000|Overall Study|Withdrawal by Subject|1092|||
131531231|NCT00856583|473567765|FG001|Overall Study|Withdrawal by Subject|919|||
131531232|NCT00856583|473567764|FG000|Overall Study|Physician Decision|59|||
131531233|NCT00856583|473567765|FG001|Overall Study|Physician Decision|82|||
131531234|NCT00856583|473567764|FG000|Overall Study|Pregnancy|14|||
131531235|NCT00856583|473567765|FG001|Overall Study|Pregnancy|5|||
131531236|NCT00856583|473567764|FG000|Overall Study|Other|92|||
131531237|NCT00856583|473567765|FG001|Overall Study|Other|104|||
131531238|NCT00856583|473567764|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
131531239|NCT00856583|473567765|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
131531240|NCT02328326|473567768|FG000|Overall Study|Withdrawal by Subject|10|||
131531241|NCT02328326|473567769|FG001|Overall Study|Withdrawal by Subject|3|||
131531242|NCT02328326|473567768|FG000|Overall Study|Death|2|||
131531243|NCT02328326|473567769|FG001|Overall Study|Death|1|||
131531244|NCT02328326|473567768|FG000|Overall Study|Lost to Follow-up|10|||
131531245|NCT02328326|473567769|FG001|Overall Study|Lost to Follow-up|4|||
131531246|NCT00305058|473567783|FG000|Overall Study|Participant too young|1|||
131531247|NCT00305058|473567784|FG001|Overall Study|Participant too young|0|||
131531248|NCT00305058|473567783|FG000|Overall Study|Missing data collection instrument|3|||
131531249|NCT00305058|473567784|FG001|Overall Study|Missing data collection instrument|2|||
131531250|NCT00305058|473567783|FG000|Overall Study|Missing outcome data|3|||
131531251|NCT00305058|473567784|FG001|Overall Study|Missing outcome data|2|||
131531252|NCT04102501|473567787|FG000|Overall Study|Withdrawal by Subject|7|||
131531253|NCT04102501|473567788|FG001|Overall Study|Withdrawal by Subject|9|||
131531254|NCT04102501|473567787|FG000|Overall Study|Adverse Event|1|||
131531255|NCT04102501|473567788|FG001|Overall Study|Adverse Event|3|||
131531256|NCT00968617|473567789|FG000|Overall Study|Study terminated by sponsor|6|||
131531257|NCT00784043|473567792|FG000|Overall Study|Withdrawal by Subject|8|||
131531258|NCT00784043|473567793|FG001|Overall Study|Withdrawal by Subject|5|||
131531259|NCT00784043|473567792|FG000|Overall Study|Protocol Terminated|23|||
131531260|NCT00784043|473567793|FG001|Overall Study|Protocol Terminated|1|||
131531261|NCT03965052|473567795|FG000|Overall Study|Protocol Violation|1|||
131531262|NCT03965052|473567796|FG001|Overall Study|Protocol Violation|0|||
131531263|NCT00499889|473567802|FG000|Overall Study|Infection prior to treatment|1|||
131531264|NCT00142909|473567806|FG000|Randomization|Various Reasons|7|||
131531265|NCT00142909|473567807|FG001|Randomization|Various Reasons|10|||
131531266|NCT00142909|473567806|FG000|Medications Begin|Protocol Violation|2|||
131531267|NCT00142909|473567807|FG001|Medications Begin|Protocol Violation|0|||
131531268|NCT00142909|473567806|FG000|Medications Begin|Withdrawal by Subject|5|||
131531269|NCT00142909|473567807|FG001|Medications Begin|Withdrawal by Subject|3|||
131531270|NCT00142909|473567806|FG000|Medications Begin|Withdrawal by Subject|2|||
131531271|NCT00142909|473567807|FG001|Medications Begin|Withdrawal by Subject|0|||
131531272|NCT03135522|473567808|FG000|Overall Study|Adverse Event|1|||
131531273|NCT03135522|473567809|FG001|Overall Study|Adverse Event|0|||
131531274|NCT01898195|473567810|FG000|Smoking Abstinence|Did not have good measurements|35|||
131531275|NCT01898195|473567811|FG001|Smoking Abstinence|Did not have good measurements|38|||
131531276|NCT01898195|473567812|FG002|Smoking Abstinence|Did not have good measurements|36|||
131531277|NCT02120924|473567813|FG000|Overall Study|Lack of Efficacy|1|||
131531278|NCT02120924|473567814|FG001|Overall Study|Lack of Efficacy|2|||
131531279|NCT02120924|473567815|FG002|Overall Study|Lack of Efficacy|3|||
131531280|NCT02120924|473567813|FG000|Overall Study|Adverse Event|0|||
131531281|NCT02120924|473567814|FG001|Overall Study|Adverse Event|1|||
131531282|NCT02120924|473567815|FG002|Overall Study|Adverse Event|3|||
131531283|NCT02120924|473567813|FG000|Overall Study|Withdrawal by Subject|16|||
131531284|NCT02120924|473567814|FG001|Overall Study|Withdrawal by Subject|20|||
131531285|NCT02120924|473567815|FG002|Overall Study|Withdrawal by Subject|8|||
131531286|NCT02120924|473567813|FG000|Overall Study|Lost to Follow-up|14|||
131531287|NCT02120924|473567814|FG001|Overall Study|Lost to Follow-up|14|||
131531288|NCT02120924|473567815|FG002|Overall Study|Lost to Follow-up|11|||
131531289|NCT02120924|473567813|FG000|Overall Study|Pregnancy|2|||
131531290|NCT02120924|473567814|FG001|Overall Study|Pregnancy|0|||
131531291|NCT02120924|473567815|FG002|Overall Study|Pregnancy|0|||
131531292|NCT02120924|473567813|FG000|Overall Study|Protocol Violation|3|||
131531293|NCT02120924|473567814|FG001|Overall Study|Protocol Violation|7|||
131531294|NCT02120924|473567815|FG002|Overall Study|Protocol Violation|2|||
131531295|NCT02120924|473567813|FG000|Overall Study|Physician Decision|0|||
131531296|NCT02120924|473567814|FG001|Overall Study|Physician Decision|1|||
131531297|NCT02120924|473567815|FG002|Overall Study|Physician Decision|1|||
131531298|NCT02120924|473567813|FG000|Overall Study|Death|1|||
131531299|NCT02120924|473567814|FG001|Overall Study|Death|0|||
131531300|NCT02120924|473567815|FG002|Overall Study|Death|0|||
131531301|NCT02120924|473567813|FG000|Overall Study|Compliance with IP|5|||
131531302|NCT02120924|473567814|FG001|Overall Study|Compliance with IP|1|||
131531303|NCT02120924|473567815|FG002|Overall Study|Compliance with IP|1|||
131531304|NCT00136955|473569505|FG000|Overall Study|Adverse Event|8|||
131531305|NCT00136955|473569505|FG000|Overall Study|Lost to Follow-up|1|||
131531306|NCT00136955|473569505|FG000|Overall Study|Withdrawal by Subject|2|||
131531307|NCT00136955|473569505|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
131531308|NCT04450264|473569506|FG000|Overall Study|Incomplete survey|13|||
131531309|NCT04450264|473569507|FG001|Overall Study|Incomplete survey|19|||
131531310|NCT04401579|473569514|FG000|Overall Study|Death|23|||
131531311|NCT04401579|473569515|FG001|Overall Study|Death|36|||
131531312|NCT04401579|473569514|FG000|Overall Study|Lost to Follow-up|40|||
131531313|NCT04401579|473569515|FG001|Overall Study|Lost to Follow-up|41|||
131531314|NCT04401579|473569514|FG000|Overall Study|Withdrawal by Subject|8|||
131531315|NCT04401579|473569515|FG001|Overall Study|Withdrawal by Subject|16|||
131531316|NCT04401579|473569514|FG000|Overall Study|Physician Decision|1|||
131531317|NCT04401579|473569515|FG001|Overall Study|Physician Decision|2|||
131531318|NCT04401579|473569514|FG000|Overall Study|Became ineligible after enrollment|1|||
131531319|NCT04401579|473569515|FG001|Overall Study|Became ineligible after enrollment|1|||
131531320|NCT04401579|473569514|FG000|Overall Study|Enrolled but treatment not administered|7|||
131531321|NCT04401579|473569515|FG001|Overall Study|Enrolled but treatment not administered|9|||
131531322|NCT04401579|473569514|FG000|Overall Study|Adverse Event|2|||
131531323|NCT04401579|473569515|FG001|Overall Study|Adverse Event|1|||
131531324|NCT04401579|473569514|FG000|Overall Study|Scheduling error|1|||
131531325|NCT04401579|473569515|FG001|Overall Study|Scheduling error|2|||
131531326|NCT04401579|473569514|FG000|Overall Study|Transferred to another hospital|1|||
131531327|NCT04401579|473569515|FG001|Overall Study|Transferred to another hospital|2|||
131531328|NCT00489970|473569516|FG000|Persistence Year 9|Lost to Follow-up|2|||
131531329|NCT00489970|473569517|FG001|Persistence Year 9|Lost to Follow-up|2|||
131531330|NCT00489970|473569518|FG002|Persistence Year 9|Lost to Follow-up|3|||
131531331|NCT00489970|473569516|FG000|Persistence Year 9|Other|1|||
131531332|NCT00489970|473569517|FG001|Persistence Year 9|Other|0|||
131531333|NCT00489970|473569518|FG002|Persistence Year 9|Other|2|||
131531334|NCT02707055|473569519|FG000|Phase 1|Withdrawal by Subject|1|||
131531335|NCT02707055|473569520|FG001|Phase 1|Withdrawal by Subject|2|||
131531336|NCT02707055|473569519|FG000|Phase 1|Physician Decision|0|||
131531337|NCT02707055|473569520|FG001|Phase 1|Physician Decision|1|||
131531338|NCT02707055|473569519|FG000|Phase 2|Adverse Event|1|||
131531339|NCT02707055|473569520|FG001|Phase 2|Adverse Event|2|||
131531340|NCT03564496|473569521|FG000|Overall Study|Withdrawal by Subject|1|||
131531341|NCT03564496|473569522|FG001|Overall Study|Withdrawal by Subject|1|||
131531342|NCT03564496|473569523|FG002|Overall Study|Withdrawal by Subject|0|||
131531343|NCT03564496|473569521|FG000|Overall Study|Screen failure|0|||
131531344|NCT03564496|473569522|FG001|Overall Study|Screen failure|3|||
131531345|NCT03564496|473569523|FG002|Overall Study|Screen failure|0|||
131531346|NCT03521635|473569524|FG000|Overall Study|Adverse Event|1|||
131531347|NCT03521635|473569525|FG001|Overall Study|Adverse Event|1|||
131531348|NCT03521635|473569524|FG000|Overall Study|Refused to complete study visit|1|||
131531349|NCT03521635|473569525|FG001|Overall Study|Refused to complete study visit|0|||
131531350|NCT03521635|473569524|FG000|Overall Study|Refused to continue trial medication|2|||
131531351|NCT03521635|473569525|FG001|Overall Study|Refused to continue trial medication|2|||
131531352|NCT03521635|473569524|FG000|Overall Study|Lost to Follow-up|0|||
131531353|NCT03521635|473569525|FG001|Overall Study|Lost to Follow-up|1|||
131531354|NCT03521635|473569524|FG000|Overall Study|Meet exclusion criteria|0|||
131531355|NCT03521635|473569525|FG001|Overall Study|Meet exclusion criteria|1|||
131531356|NCT03521635|473569524|FG000|Overall Study|Patient not taken study medicine|0|||
131531357|NCT03521635|473569525|FG001|Overall Study|Patient not taken study medicine|1|||
131531358|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Adverse Event|5|||
131531359|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Adverse Event|8|||
131531360|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Adverse Event|4|||
131531361|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Adverse Event|8|||
131531362|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
131531363|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
131531364|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
131531365|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
131531366|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
131531367|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
131531368|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
131531369|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
131531370|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Physician Decision|1|||
131531371|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Physician Decision|0|||
131531372|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Physician Decision|0|||
131531373|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Physician Decision|0|||
131531374|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
131531375|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
131531376|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
131531377|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
131531378|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Pregnancy|0|||
131531379|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Pregnancy|1|||
131531380|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Pregnancy|0|||
131531381|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Pregnancy|0|||
131531382|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
131531383|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
131531384|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
131531385|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
131531386|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Death|0|||
131531387|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Death|1|||
131531388|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Death|0|||
131531389|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Death|0|||
131531390|NCT00071487|473569529|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
131531391|NCT00071487|473569530|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
131531392|NCT00071487|473569531|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
131531393|NCT00071487|473569532|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
131531394|NCT00071487|473569529|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
131531395|NCT00071487|473569530|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
131531396|NCT00071487|473569531|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
131531397|NCT00071487|473569532|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
131531398|NCT00071487|473569529|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
131531399|NCT00071487|473569530|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
131531400|NCT00071487|473569531|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
131531401|NCT00071487|473569532|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
131531402|NCT00071487|473569529|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131531403|NCT00071487|473569530|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131531404|NCT00071487|473569531|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131531405|NCT00071487|473569532|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
131531406|NCT00071487|473569529|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
131531407|NCT00071487|473569530|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
131531408|NCT00071487|473569531|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
131531409|NCT00071487|473569532|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
131531410|NCT00071487|473569529|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
131531411|NCT00071487|473569530|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
131531412|NCT00071487|473569531|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
131531413|NCT00071487|473569532|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
131531414|NCT00071487|473569529|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
131531415|NCT00071487|473569530|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
131531416|NCT00071487|473569531|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
131531417|NCT00071487|473569532|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
131531418|NCT02318329|473569533|FG000|Overall Study|Progressive Disease|2|||
131531419|NCT02318329|473569534|FG001|Overall Study|Progressive Disease|3|||
131531420|NCT02318329|473569535|FG002|Overall Study|Progressive Disease|2|||
131531421|NCT02318329|473569536|FG003|Overall Study|Progressive Disease|3|||
131531422|NCT02318329|473569537|FG004|Overall Study|Progressive Disease|3|||
131531423|NCT02318329|473569538|FG005|Overall Study|Progressive Disease|3|||
131531424|NCT02318329|473569539|FG006|Overall Study|Progressive Disease|1|||
131531425|NCT02318329|473569540|FG007|Overall Study|Progressive Disease|1|||
131531426|NCT02318329|473569541|FG008|Overall Study|Progressive Disease|5|||
131531427|NCT02318329|473569542|FG009|Overall Study|Progressive Disease|39|||
131531428|NCT02318329|473569533|FG000|Overall Study|Death|0|||
131531429|NCT02318329|473569534|FG001|Overall Study|Death|0|||
131531430|NCT02318329|473569535|FG002|Overall Study|Death|0|||
131531431|NCT02318329|473569536|FG003|Overall Study|Death|0|||
131531432|NCT02318329|473569537|FG004|Overall Study|Death|0|||
131531433|NCT02318329|473569538|FG005|Overall Study|Death|0|||
131531434|NCT02318329|473569539|FG006|Overall Study|Death|0|||
131531435|NCT02318329|473569540|FG007|Overall Study|Death|0|||
131531436|NCT02318329|473569541|FG008|Overall Study|Death|0|||
131531437|NCT02318329|473569542|FG009|Overall Study|Death|5|||
131531438|NCT02318329|473569533|FG000|Overall Study|Lost to Follow-up|0|||
131531439|NCT02318329|473569534|FG001|Overall Study|Lost to Follow-up|0|||
131531440|NCT02318329|473569535|FG002|Overall Study|Lost to Follow-up|0|||
131531441|NCT02318329|473569536|FG003|Overall Study|Lost to Follow-up|0|||
131531442|NCT02318329|473569537|FG004|Overall Study|Lost to Follow-up|0|||
131531443|NCT02318329|473569538|FG005|Overall Study|Lost to Follow-up|0|||
131531444|NCT02318329|473569539|FG006|Overall Study|Lost to Follow-up|0|||
131531445|NCT02318329|473569540|FG007|Overall Study|Lost to Follow-up|0|||
131531446|NCT02318329|473569541|FG008|Overall Study|Lost to Follow-up|0|||
131531447|NCT02318329|473569542|FG009|Overall Study|Lost to Follow-up|1|||
131531448|NCT02318329|473569533|FG000|Overall Study|Withdrawal by Subject|0|||
131531449|NCT02318329|473569534|FG001|Overall Study|Withdrawal by Subject|0|||
131531450|NCT02318329|473569535|FG002|Overall Study|Withdrawal by Subject|0|||
131531451|NCT02318329|473569536|FG003|Overall Study|Withdrawal by Subject|0|||
131531452|NCT02318329|473569537|FG004|Overall Study|Withdrawal by Subject|0|||
131531453|NCT02318329|473569538|FG005|Overall Study|Withdrawal by Subject|0|||
131531454|NCT02318329|473569539|FG006|Overall Study|Withdrawal by Subject|0|||
131531455|NCT02318329|473569540|FG007|Overall Study|Withdrawal by Subject|0|||
131531456|NCT02318329|473569541|FG008|Overall Study|Withdrawal by Subject|0|||
131531457|NCT02318329|473569542|FG009|Overall Study|Withdrawal by Subject|6|||
131531458|NCT02318329|473569533|FG000|Overall Study|Other|1|||
131531459|NCT02318329|473569534|FG001|Overall Study|Other|1|||
131531460|NCT02318329|473569535|FG002|Overall Study|Other|1|||
131531461|NCT02318329|473569536|FG003|Overall Study|Other|0|||
131531462|NCT02318329|473569537|FG004|Overall Study|Other|0|||
131531463|NCT02318329|473569538|FG005|Overall Study|Other|0|||
131531464|NCT02318329|473569539|FG006|Overall Study|Other|0|||
131531465|NCT02318329|473569540|FG007|Overall Study|Other|0|||
131531466|NCT02318329|473569541|FG008|Overall Study|Other|1|||
131531467|NCT02318329|473569542|FG009|Overall Study|Other|1|||
131531468|NCT00086346|473569543|FG000|Randomization|Did not receive test article|4|||
131531469|NCT00086346|473569544|FG001|Randomization|Did not receive test article|4|||
131531470|NCT00086346|473569543|FG000|Patients Dosed With Test Article|Adverse Event|94|||
131531471|NCT00086346|473569544|FG001|Patients Dosed With Test Article|Adverse Event|11|||
131531472|NCT00086346|473569543|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
131531473|NCT00086346|473569544|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
131531474|NCT00086346|473569543|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
131531475|NCT00086346|473569544|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
131531476|NCT00086346|473569543|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
131531477|NCT00086346|473569544|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
131531478|NCT00086346|473569543|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
131531479|NCT00086346|473569544|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
131531480|NCT00086346|473569543|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
131531481|NCT00086346|473569544|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
131531482|NCT04495374|473569545|FG000|Overall Study|Protocol Violation|2|||
131531483|NCT04495374|473569546|FG001|Overall Study|Protocol Violation|1|||
131531484|NCT01303627|473569547|FG000|Overall Study|the failure while performing URS|0|||
131531485|NCT01303627|473569548|FG001|Overall Study|the failure while performing URS|1|||
131531486|NCT04535037|473569550|FG000|Overall Study|Protocol Violation|1|||
131531487|NCT04535037|473569551|FG001|Overall Study|Protocol Violation|0|||
131531488|NCT04535037|473569550|FG000|Overall Study|Withdrawal by Subject|8|||
131531489|NCT04535037|473569551|FG001|Overall Study|Withdrawal by Subject|9|||
131531490|NCT04535037|473569550|FG000|Overall Study|Migrated / moved from the study area|1|||
131531491|NCT04535037|473569551|FG001|Overall Study|Migrated / moved from the study area|4|||
131531492|NCT04535037|473569550|FG000|Overall Study|Other|2|||
131531493|NCT04535037|473569551|FG001|Overall Study|Other|5|||
131531494|NCT02031276|473569552|FG000|Period 1 Double-blind IV|Adverse Event|6|||
131531495|NCT02031276|473569553|FG001|Period 1 Double-blind IV|Adverse Event|5|||
131531496|NCT02031276|473569554|FG002|Period 1 Double-blind IV|Adverse Event|1|||
131531497|NCT02031276|473569552|FG000|Period 1 Double-blind IV|Other|0|||
131531498|NCT02031276|473569553|FG001|Period 1 Double-blind IV|Other|1|||
131531499|NCT02031276|473569554|FG002|Period 1 Double-blind IV|Other|0|||
131531500|NCT02031276|473569552|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
131531501|NCT02031276|473569553|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
131531502|NCT02031276|473569554|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
131531503|NCT02031276|473569552|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
131531504|NCT02031276|473569553|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
131531505|NCT02031276|473569554|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
131531506|NCT02031276|473569552|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
131531507|NCT02031276|473569553|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
131531508|NCT02031276|473569554|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
131531509|NCT02031276|473569552|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
131531510|NCT02031276|473569553|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
131531511|NCT02031276|473569554|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
131531512|NCT02031276|473569552|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
131531513|NCT02031276|473569553|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
131531514|NCT02031276|473569554|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
131531515|NCT02031276|473569552|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
131531516|NCT02031276|473569553|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
131531517|NCT02031276|473569554|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
131531518|NCT02031276|473569552|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
131531519|NCT02031276|473569553|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
131531520|NCT02031276|473569554|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
131531521|NCT01148810|473569555|FG000|Overall Study|Adverse Event|0|||
131531522|NCT01148810|473569556|FG001|Overall Study|Adverse Event|2|||
131531523|NCT01148810|473569555|FG000|Overall Study|Lack of Efficacy|0|||
131531524|NCT01148810|473569556|FG001|Overall Study|Lack of Efficacy|1|||
131531525|NCT01148810|473569555|FG000|Overall Study|Withdrawal by Subject|0|||
131531526|NCT01148810|473569556|FG001|Overall Study|Withdrawal by Subject|2|||
131531527|NCT01148810|473569555|FG000|Overall Study|Protocol Violation|1|||
131531528|NCT01148810|473569556|FG001|Overall Study|Protocol Violation|0|||
131531529|NCT02417246|473569563|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
131531530|NCT02417246|473569564|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
131531531|NCT02417246|473569563|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
131531532|NCT02417246|473569564|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
131531533|NCT02417246|473569563|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
131531534|NCT02417246|473569564|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
131531535|NCT02417246|473569563|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
131531536|NCT02417246|473569564|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
131531537|NCT04408469|473569565|FG000|Overall Study|Lost to Follow-up|6|||
131531538|NCT04408469|473569566|FG001|Overall Study|Lost to Follow-up|9|||
131531539|NCT04408469|473569565|FG000|Overall Study|Withdrawal by Subject|6|||
131531540|NCT04408469|473569566|FG001|Overall Study|Withdrawal by Subject|1|||
131531541|NCT04408469|473569565|FG000|Overall Study|Dismissal due to ineligibility|0|||
131531542|NCT04408469|473569566|FG001|Overall Study|Dismissal due to ineligibility|1|||
131531543|NCT04321460|473569567|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
131658438|NCT00264303|474035312|FG000|Overall Study|Adverse Event|4|||
131531544|NCT04321460|473569568|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
131531545|NCT01308749|473569569|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
131531546|NCT01308749|473569570|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
131531547|NCT01308749|473569569|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
131531548|NCT01308749|473569570|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
131531549|NCT01308749|473569569|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
131531550|NCT01308749|473569570|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
131531551|NCT04726709|473569571|FG000|Overall Study|Withdrawal by Subject|2|||
131531552|NCT04726709|473569572|FG001|Overall Study|Withdrawal by Subject|2|||
131531553|NCT03434119|473569575|FG000|Overall Study|Randomized but not treated|1|||
131531554|NCT03434119|473569576|FG001|Overall Study|Randomized but not treated|0|||
131531555|NCT03434119|473569575|FG000|Overall Study|Adverse Event|1|||
131531556|NCT03434119|473569576|FG001|Overall Study|Adverse Event|0|||
131531557|NCT03434119|473569575|FG000|Overall Study|Poor Compliance to Protocol|0|||
131531558|NCT03434119|473569576|FG001|Overall Study|Poor Compliance to Protocol|1|||
131531559|NCT03434119|473569575|FG000|Overall Study|Study Terminated by Sponsor|91|||
131531560|NCT03434119|473569576|FG001|Overall Study|Study Terminated by Sponsor|102|||
131531561|NCT03434119|473569575|FG000|Overall Study|Withdrawal by Subject|7|||
131531562|NCT03434119|473569576|FG001|Overall Study|Withdrawal by Subject|5|||
131531563|NCT03434119|473569575|FG000|Overall Study|Other than specified|7|||
131531564|NCT03434119|473569576|FG001|Overall Study|Other than specified|5|||
131531565|NCT03579459|473569578|FG000|Overall Study|Adverse Event|7|||
131531566|NCT03579459|473569579|FG001|Overall Study|Adverse Event|6|||
131531567|NCT03579459|473569580|FG002|Overall Study|Adverse Event|2|||
131531568|NCT03579459|473569581|FG003|Overall Study|Adverse Event|6|||
131531569|NCT03579459|473569578|FG000|Overall Study|Death|1|||
131531570|NCT03579459|473569579|FG001|Overall Study|Death|0|||
131531571|NCT03579459|473569580|FG002|Overall Study|Death|1|||
131531572|NCT03579459|473569581|FG003|Overall Study|Death|2|||
131531573|NCT03579459|473569578|FG000|Overall Study|Lost to Follow-up|6|||
131531574|NCT03579459|473569579|FG001|Overall Study|Lost to Follow-up|2|||
131531575|NCT03579459|473569580|FG002|Overall Study|Lost to Follow-up|4|||
131531576|NCT03579459|473569581|FG003|Overall Study|Lost to Follow-up|1|||
131531577|NCT03579459|473569578|FG000|Overall Study|Physician Decision|0|||
131531578|NCT03579459|473569579|FG001|Overall Study|Physician Decision|1|||
131531579|NCT03579459|473569580|FG002|Overall Study|Physician Decision|0|||
131531580|NCT03579459|473569581|FG003|Overall Study|Physician Decision|1|||
131531581|NCT03579459|473569578|FG000|Overall Study|Protocol Violation|1|||
131531582|NCT03579459|473569579|FG001|Overall Study|Protocol Violation|2|||
131531583|NCT03579459|473569580|FG002|Overall Study|Protocol Violation|3|||
131531584|NCT03579459|473569581|FG003|Overall Study|Protocol Violation|5|||
131531585|NCT03579459|473569578|FG000|Overall Study|Withdrawal by Subject|12|||
131531586|NCT03579459|473569579|FG001|Overall Study|Withdrawal by Subject|8|||
131531587|NCT03579459|473569580|FG002|Overall Study|Withdrawal by Subject|11|||
131531588|NCT03579459|473569581|FG003|Overall Study|Withdrawal by Subject|8|||
131531589|NCT03579459|473569578|FG000|Overall Study|Medication error without associated adverse event|2|||
131531590|NCT03579459|473569579|FG001|Overall Study|Medication error without associated adverse event|1|||
131531591|NCT03579459|473569580|FG002|Overall Study|Medication error without associated adverse event|1|||
131531592|NCT03579459|473569581|FG003|Overall Study|Medication error without associated adverse event|0|||
131531593|NCT03579459|473569578|FG000|Overall Study|Other|0|||
131531594|NCT03579459|473569579|FG001|Overall Study|Other|1|||
131531595|NCT03579459|473569580|FG002|Overall Study|Other|1|||
131531596|NCT03579459|473569581|FG003|Overall Study|Other|0|||
131531597|NCT03579459|473569578|FG000|Overall Study|Randomized not vaccinated|0|||
131531598|NCT03579459|473569579|FG001|Overall Study|Randomized not vaccinated|2|||
131531599|NCT03579459|473569580|FG002|Overall Study|Randomized not vaccinated|0|||
131531600|NCT03579459|473569581|FG003|Overall Study|Randomized not vaccinated|1|||
131531601|NCT00148343|473569582|FG000|Overall Study|Withdrawal by Subject|12|||
131531602|NCT00148343|473569583|FG001|Overall Study|Withdrawal by Subject|7|||
131531603|NCT00148343|473569582|FG000|Overall Study|Physician Decision|3|||
131531604|NCT00148343|473569583|FG001|Overall Study|Physician Decision|4|||
131531605|NCT02528214|473569591|FG000|Overall Study|Protocol Violation|0|||
131531606|NCT02528214|473569592|FG001|Overall Study|Protocol Violation|1|||
131531607|NCT02528214|473569591|FG000|Overall Study|Adverse Event|0|||
131531608|NCT02528214|473569592|FG001|Overall Study|Adverse Event|1|||
131531609|NCT02528214|473569591|FG000|Overall Study|Other than specified above|0|||
131531610|NCT02528214|473569592|FG001|Overall Study|Other than specified above|1|||
131531611|NCT00407537|473569593|FG000|Overall Study|Death|5|||
131531612|NCT00407537|473569594|FG001|Overall Study|Death|2|||
131531613|NCT00407537|473569593|FG000|Overall Study|Adverse Event|36|||
131531614|NCT00407537|473569594|FG001|Overall Study|Adverse Event|0|||
131531615|NCT00407537|473569593|FG000|Overall Study|Lost to Follow-up|12|||
131531616|NCT00407537|473569594|FG001|Overall Study|Lost to Follow-up|19|||
131531617|NCT00407537|473569593|FG000|Overall Study|Other|6|||
131531618|NCT00407537|473569594|FG001|Overall Study|Other|7|||
131531619|NCT00407537|473569593|FG000|Overall Study|Withdrawal by Subject|34|||
131531620|NCT00407537|473569594|FG001|Overall Study|Withdrawal by Subject|16|||
131531621|NCT00583557|473569595|FG000|Overall Study|Withdrawal by Subject|18|||
131531622|NCT00583557|473569595|FG000|Overall Study|Adverse Event|9|||
131531623|NCT00583557|473569595|FG000|Overall Study|Lack of Efficacy|31|||
131531624|NCT00583557|473569595|FG000|Overall Study|Lack of Compliance|5|||
131531625|NCT00583557|473569595|FG000|Overall Study|Other|5|||
131531626|NCT00583557|473569595|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
131531627|NCT01040130|473569603|FG000|Overall Study|Adverse Event|1|||
131531628|NCT01040130|473569604|FG001|Overall Study|Adverse Event|1|||
131531629|NCT01040130|473569605|FG002|Overall Study|Adverse Event|0|||
131531630|NCT01040130|473569606|FG003|Overall Study|Adverse Event|5|||
131531631|NCT01040130|473569607|FG004|Overall Study|Adverse Event|0|||
131531632|NCT01040130|473569608|FG005|Overall Study|Adverse Event|3|||
131531633|NCT01040130|473569603|FG000|Overall Study|Protocol Violation|0|||
131531634|NCT01040130|473569604|FG001|Overall Study|Protocol Violation|0|||
131531635|NCT01040130|473569605|FG002|Overall Study|Protocol Violation|2|||
131531636|NCT01040130|473569606|FG003|Overall Study|Protocol Violation|0|||
131531637|NCT01040130|473569607|FG004|Overall Study|Protocol Violation|0|||
131531638|NCT01040130|473569608|FG005|Overall Study|Protocol Violation|0|||
131531639|NCT01040130|473569603|FG000|Overall Study|Withdrawal by Subject|0|||
131531640|NCT01040130|473569604|FG001|Overall Study|Withdrawal by Subject|2|||
131531641|NCT01040130|473569605|FG002|Overall Study|Withdrawal by Subject|0|||
131531642|NCT01040130|473569606|FG003|Overall Study|Withdrawal by Subject|0|||
131531643|NCT01040130|473569607|FG004|Overall Study|Withdrawal by Subject|0|||
131531644|NCT01040130|473569608|FG005|Overall Study|Withdrawal by Subject|1|||
131531645|NCT01040130|473569603|FG000|Overall Study|Other reasons not listed above|2|||
131531646|NCT01040130|473569604|FG001|Overall Study|Other reasons not listed above|0|||
131531647|NCT01040130|473569605|FG002|Overall Study|Other reasons not listed above|0|||
131531648|NCT01040130|473569606|FG003|Overall Study|Other reasons not listed above|0|||
131531649|NCT01040130|473569607|FG004|Overall Study|Other reasons not listed above|0|||
131531650|NCT01040130|473569608|FG005|Overall Study|Other reasons not listed above|0|||
131531651|NCT00553267|473569611|FG000|Overall Study|Adverse Event|8|||
131531652|NCT00553267|473569612|FG001|Overall Study|Adverse Event|10|||
131531653|NCT00553267|473569613|FG002|Overall Study|Adverse Event|5|||
131531654|NCT00553267|473569611|FG000|Overall Study|Non compliant with protocol|3|||
131531655|NCT00553267|473569612|FG001|Overall Study|Non compliant with protocol|3|||
131531656|NCT00553267|473569613|FG002|Overall Study|Non compliant with protocol|2|||
131531657|NCT00553267|473569611|FG000|Overall Study|Lost to Follow-up|0|||
131531658|NCT00553267|473569612|FG001|Overall Study|Lost to Follow-up|0|||
131531659|NCT00553267|473569613|FG002|Overall Study|Lost to Follow-up|1|||
131531660|NCT00553267|473569611|FG000|Overall Study|Consent withdrawn|2|||
131531661|NCT00553267|473569612|FG001|Overall Study|Consent withdrawn|3|||
131531662|NCT00553267|473569613|FG002|Overall Study|Consent withdrawn|1|||
131531663|NCT00553267|473569611|FG000|Overall Study|Specified category|1|||
131531664|NCT00553267|473569612|FG001|Overall Study|Specified category|2|||
131531665|NCT00553267|473569613|FG002|Overall Study|Specified category|1|||
131531666|NCT01310036|473569614|FG000|Overall Study|Administrative/other|10|||
131531667|NCT01310036|473569614|FG000|Overall Study|Withdrew Consent|11|||
131531668|NCT01310036|473569614|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
131531669|NCT01310036|473569614|FG000|Overall Study|Progression of Disease|164|||
131531670|NCT01310036|473569614|FG000|Overall Study|Death|1|||
131531671|NCT01310036|473569614|FG000|Overall Study|Adverse event or intercurrent illness|12|||
131531672|NCT01175668|473569615|FG000|Overall Study|Withdrawal by Subject|2|||
131531673|NCT01175668|473569616|FG001|Overall Study|Withdrawal by Subject|0|||
131531674|NCT02937545|473569618|FG000|Overall Study|Withdrawal by Subject|1|||
131531675|NCT02937545|473569619|FG001|Overall Study|Withdrawal by Subject|2|||
131531676|NCT02937545|473569620|FG002|Overall Study|Withdrawal by Subject|6|||
131531677|NCT02937545|473569621|FG003|Overall Study|Withdrawal by Subject|7|||
131531678|NCT02937545|473569618|FG000|Overall Study|Lost to Follow-up|1|||
131531679|NCT02937545|473569619|FG001|Overall Study|Lost to Follow-up|0|||
131531680|NCT02937545|473569620|FG002|Overall Study|Lost to Follow-up|0|||
131531681|NCT02937545|473569621|FG003|Overall Study|Lost to Follow-up|0|||
131531682|NCT01985126|473569626|FG000|Overall Study|Death|15|||
131531683|NCT01985126|473569627|FG001|Overall Study|Death|69|||
131531684|NCT01985126|473569626|FG000|Overall Study|Lost to Follow-up|0|||
131531685|NCT01985126|473569627|FG001|Overall Study|Lost to Follow-up|8|||
131531686|NCT01985126|473569626|FG000|Overall Study|Study Terminated By Sponsor|1|||
131531687|NCT01985126|473569627|FG001|Overall Study|Study Terminated By Sponsor|22|||
131531688|NCT01985126|473569626|FG000|Overall Study|Withdrawal by Subject|2|||
131531689|NCT01985126|473569627|FG001|Overall Study|Withdrawal by Subject|7|||
131531690|NCT01618838|473569628|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
131531691|NCT03835533|473569631|FG000|Overall Study|Death|5|||
131531692|NCT03835533|473569632|FG001|Overall Study|Death|10|||
131531693|NCT03835533|473569633|FG002|Overall Study|Death|9|||
131531694|NCT03835533|473569631|FG000|Overall Study|Withdrawal by Subject|2|||
131531695|NCT03835533|473569632|FG001|Overall Study|Withdrawal by Subject|2|||
131531696|NCT03835533|473569633|FG002|Overall Study|Withdrawal by Subject|2|||
131531697|NCT03835533|473569631|FG000|Overall Study|Lost to Follow-up|1|||
131531698|NCT03835533|473569632|FG001|Overall Study|Lost to Follow-up|0|||
131531699|NCT03835533|473569633|FG002|Overall Study|Lost to Follow-up|0|||
131531700|NCT01136291|473569634|FG000|Overall Study|Lost to Follow-up|1|||
131531701|NCT01136291|473569635|FG001|Overall Study|Lost to Follow-up|1|||
131531702|NCT01870843|473569646|FG000|Overall Study|Adverse Event|10|||
131531703|NCT01870843|473569646|FG000|Overall Study|Lost to Follow-up|24|||
131531704|NCT01870843|473569646|FG000|Overall Study|Death|1|||
131531705|NCT01870843|473569646|FG000|Overall Study|Withdrawal by Subject|18|||
131531706|NCT01910519|473569647|FG000|Overall Study|Withdrawal by Subject|2|||
131531707|NCT01910519|473569648|FG001|Overall Study|Withdrawal by Subject|0|||
131531708|NCT01910519|473569647|FG000|Overall Study|Adverse Event|2|||
131531709|NCT01910519|473569648|FG001|Overall Study|Adverse Event|0|||
131531710|NCT01664078|473569651|FG000|Overall Study|Death|9|||
131531711|NCT01664078|473569651|FG000|Overall Study|Withdrawal by Subject|4|||
131531712|NCT01664078|473569651|FG000|Overall Study|Lost to Follow-up|2|||
131531713|NCT01664078|473569651|FG000|Overall Study|missed 5 year visit|1|||
131531714|NCT01664078|473569651|FG000|Overall Study|Other|53|||
131531715|NCT02720484|473569654|FG000|Treatment on Study|Adverse Event|1|||
131531716|NCT02720484|473569654|FG000|Treatment on Study|Withdrawal by Subject|1|||
131531717|NCT02720484|473569654|FG000|Treatment on Study|Progressive Disease|4|||
131531718|NCT02720484|473569654|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
131531719|NCT02720484|473569654|FG000|Follow Up for 2 Years|Death|3|||
131531720|NCT02720484|473569654|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
131531721|NCT05070897|473569660|FG000|Overall Study|Protocol Violation|123|||
131531722|NCT05070897|473569661|FG001|Overall Study|Protocol Violation|68|||
131531723|NCT01617629|473569662|FG000|Overall Study|Death|2|||
131531724|NCT01617629|473569662|FG000|Overall Study|Investigator's Clinical Judgement|1|||
131531725|NCT01617629|473569662|FG000|Overall Study|Reason Not Specified|1|||
131531726|NCT01617629|473569662|FG000|Overall Study|Participant Withdrew Consent|2|||
131531727|NCT01337245|473569663|FG000|Overall Study|Lost to Follow-up|1|||
131531728|NCT01663636|473569664|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
131531729|NCT01663636|473569665|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
131531730|NCT03832946|473569666|FG000|Overall Study|Adverse Event|3|||
131531731|NCT03832946|473569667|FG001|Overall Study|Adverse Event|1|||
131531732|NCT03832946|473569666|FG000|Overall Study|Lost to Follow-up|1|||
131531733|NCT03832946|473569667|FG001|Overall Study|Lost to Follow-up|0|||
131531734|NCT03832946|473569666|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
131531735|NCT03832946|473569667|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
131531736|NCT03832946|473569666|FG000|Overall Study|Lack of Efficacy|1|||
131531737|NCT03832946|473569667|FG001|Overall Study|Lack of Efficacy|0|||
131531738|NCT03832946|473569666|FG000|Overall Study|Withdrawal by Subject|12|||
131531739|NCT03832946|473569667|FG001|Overall Study|Withdrawal by Subject|9|||
131531740|NCT02863991|473569672|FG000|Overall Study|Death|0|||
131531741|NCT02863991|473569673|FG001|Overall Study|Death|3|||
131531742|NCT02863991|473569672|FG000|Overall Study|Lack of Efficacy|0|||
131531743|NCT02863991|473569673|FG001|Overall Study|Lack of Efficacy|1|||
131531744|NCT02863991|473569672|FG000|Overall Study|Study Terminated|2|||
131531745|NCT02863991|473569673|FG001|Overall Study|Study Terminated|8|||
131531746|NCT00364858|473569674|FG000|Overall Study|Adverse Event|1|||
131531747|NCT00364858|473569675|FG001|Overall Study|Adverse Event|5|||
131531748|NCT00364858|473569674|FG000|Overall Study|Withdrawal by Subject|1|||
131531749|NCT00364858|473569675|FG001|Overall Study|Withdrawal by Subject|1|||
131531750|NCT00364858|473569674|FG000|Overall Study|Pregnancy|1|||
131531751|NCT00364858|473569675|FG001|Overall Study|Pregnancy|1|||
131531752|NCT00364858|473569674|FG000|Overall Study|Clinical failure|2|||
131531753|NCT00364858|473569675|FG001|Overall Study|Clinical failure|13|||
131531754|NCT00364858|473569674|FG000|Overall Study|Discontinuation at baseline|1|||
131531755|NCT00364858|473569675|FG001|Overall Study|Discontinuation at baseline|0|||
131531756|NCT00364858|473569674|FG000|Overall Study|Non-compliant|1|||
131531757|NCT00364858|473569675|FG001|Overall Study|Non-compliant|0|||
131531758|NCT00364858|473569674|FG000|Overall Study|Return to Q2 regimen|0|||
131531759|NCT00364858|473569675|FG001|Overall Study|Return to Q2 regimen|1|||
131531760|NCT00364858|473569674|FG000|Overall Study|Clinical baseline issue|0|||
131531761|NCT00364858|473569675|FG001|Overall Study|Clinical baseline issue|1|||
131531762|NCT01307501|473569676|FG000|Overall Study|Treatment Failure|1|||
131531763|NCT01307501|473569676|FG000|Overall Study|Death|20|||
131531764|NCT01307501|473569676|FG000|Overall Study|Lost to Follow-up|1|||
131531765|NCT01307501|473569676|FG000|Overall Study|Starting Hospice|1|||
131531766|NCT02730819|473569677|FG000|Overall Study|Lost to Follow-up|9|||
131531767|NCT01660906|473569679|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
131531768|NCT01438541|473569681|FG000|Overall Study|Physician Decision|1|||
131531769|NCT01438541|473569681|FG000|Overall Study|Withdrawal by Subject|1|||
131531770|NCT01438541|473569681|FG000|Overall Study|discharge from the hospital|5|||
131531771|NCT01773226|473571933|FG000|Overall Study|Withdrawal by Subject|1|||
131531772|NCT05349617|473571939|FG000|Overall Study|Death|1|||
131531773|NCT05349617|473571940|FG001|Overall Study|Death|1|||
131531774|NCT05349617|473571939|FG000|Overall Study|Lost to Follow-up|3|||
131531775|NCT05349617|473571940|FG001|Overall Study|Lost to Follow-up|8|||
131531776|NCT05349617|473571939|FG000|Overall Study|Withdrawal by Subject|2|||
131531777|NCT05349617|473571940|FG001|Overall Study|Withdrawal by Subject|10|||
131531778|NCT02367911|473571945|FG000|Overall Study|Withdrawal by Subject|3|||
131531779|NCT02367911|473571946|FG001|Overall Study|Withdrawal by Subject|2|||
131531780|NCT02367911|473571945|FG000|Overall Study|Lost to Follow-up|2|||
131531781|NCT02367911|473571946|FG001|Overall Study|Lost to Follow-up|2|||
131531782|NCT00902304|473571947|FG000|Overall Study|Adverse Event|4|||
131531783|NCT00902304|473571948|FG001|Overall Study|Adverse Event|10|||
131531784|NCT00902304|473571949|FG002|Overall Study|Adverse Event|25|||
131531785|NCT00902304|473571947|FG000|Overall Study|Investigator discretion|3|||
131531786|NCT00902304|473571948|FG001|Overall Study|Investigator discretion|5|||
131531787|NCT00902304|473571949|FG002|Overall Study|Investigator discretion|13|||
131531788|NCT00902304|473571947|FG000|Overall Study|Lost to Follow-up|7|||
131531789|NCT00902304|473571948|FG001|Overall Study|Lost to Follow-up|7|||
131531790|NCT00902304|473571949|FG002|Overall Study|Lost to Follow-up|7|||
131531791|NCT00902304|473571947|FG000|Overall Study|Protocol Violation|9|||
131531792|NCT00902304|473571948|FG001|Overall Study|Protocol Violation|18|||
131531793|NCT00902304|473571949|FG002|Overall Study|Protocol Violation|20|||
131531794|NCT00902304|473571947|FG000|Overall Study|Withdrawal by Subject|32|||
131531795|NCT00902304|473571948|FG001|Overall Study|Withdrawal by Subject|22|||
131531796|NCT00902304|473571949|FG002|Overall Study|Withdrawal by Subject|43|||
131531797|NCT00902304|473571947|FG000|Overall Study|includes pregnancy|3|||
131531798|NCT00902304|473571948|FG001|Overall Study|includes pregnancy|9|||
131531799|NCT00902304|473571949|FG002|Overall Study|includes pregnancy|2|||
131531800|NCT05706506|473571950|FG000|Overall Study|Adverse Event|1|||
131531801|NCT05706506|473571950|FG000|Overall Study|Withdrawal by Subject|4|||
131531802|NCT05706506|473571950|FG000|Overall Study|Lost to Follow-up|2|||
131531803|NCT05706506|473571950|FG000|Overall Study|Inadvertent Enrolment|12|||
131531804|NCT05706506|473571950|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
131531805|NCT05706506|473571950|FG000|Overall Study|Participant Moved Out of State|1|||
131531806|NCT05732454|473571951|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
131531807|NCT05732454|473571952|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
131531808|NCT05732454|473571951|FG000|Part 1: DB Period|Adverse Event|1|||
131531809|NCT05732454|473571952|FG001|Part 1: DB Period|Adverse Event|0|||
131531810|NCT05732454|473571951|FG000|Part 1: DB Period|Lost to Follow-up|1|||
131531811|NCT05732454|473571952|FG001|Part 1: DB Period|Lost to Follow-up|0|||
131531812|NCT05732454|473571951|FG000|Part 1: DB Period|Protocol Violation|0|||
131531813|NCT05732454|473571952|FG001|Part 1: DB Period|Protocol Violation|1|||
131531814|NCT05732454|473571951|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
131531815|NCT05732454|473571952|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
131531816|NCT05732454|473571951|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
131531817|NCT05732454|473571952|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
131531818|NCT05732454|473571951|FG000|Part 1: OLE Period|Adverse Event|0|||
131531819|NCT05732454|473571952|FG001|Part 1: OLE Period|Adverse Event|1|||
131531820|NCT05732454|473571951|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
131531821|NCT05732454|473571952|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
131531822|NCT01153633|473571953|FG000|Overall Study|Protocol Violation|1|||
131531823|NCT01153633|473571954|FG001|Overall Study|Protocol Violation|1|||
131531824|NCT01153633|473571953|FG000|Overall Study|Therapeutic failure|3|||
131531825|NCT01153633|473571954|FG001|Overall Study|Therapeutic failure|3|||
131531826|NCT04837482|473571955|FG000|Period 2|Withdrawal by Subject|0|||
131531827|NCT04837482|473571956|FG001|Period 2|Withdrawal by Subject|1|||
131531828|NCT02646423|473571957|FG000|Overall Study|Adverse Event|5|||
131531829|NCT02646423|473571958|FG001|Overall Study|Adverse Event|7|||
131531830|NCT02646423|473571957|FG000|Overall Study|Ineligible|2|||
131531831|NCT02646423|473571958|FG001|Overall Study|Ineligible|1|||
131531832|NCT02807948|473571959|FG000|Overall Study|Physician Decision|1|||
131531833|NCT02807948|473571960|FG001|Overall Study|Physician Decision|0|||
131531834|NCT01054820|473571961|FG000|Overall Study|Withdrawal by Subject|2|||
131531835|NCT00996996|473571966|FG000|Overall Study|Progressive Disease|10|||
131531836|NCT00996996|473571966|FG000|Overall Study|Non-compliance|8|||
131531837|NCT00996996|473571966|FG000|Overall Study|Lost to Follow-up|9|||
131531838|NCT00996996|473571966|FG000|Overall Study|Death|5|||
131531839|NCT00996996|473571966|FG000|Overall Study|Did Not Receive Study Medications|1|||
131531840|NCT00760929|473571967|FG000|Overall Study|Adverse Event|2|||
131531841|NCT00760929|473571968|FG001|Overall Study|Adverse Event|0|||
131531842|NCT00760929|473571969|FG002|Overall Study|Adverse Event|6|||
131531843|NCT00760929|473571970|FG003|Overall Study|Adverse Event|10|||
131531844|NCT00760929|473571967|FG000|Overall Study|Lack of Efficacy|0|||
131531845|NCT00760929|473571968|FG001|Overall Study|Lack of Efficacy|2|||
131531846|NCT00760929|473571969|FG002|Overall Study|Lack of Efficacy|1|||
131531847|NCT00760929|473571970|FG003|Overall Study|Lack of Efficacy|0|||
131531848|NCT00760929|473571967|FG000|Overall Study|Withdrawal by Subject|1|||
131531849|NCT00760929|473571968|FG001|Overall Study|Withdrawal by Subject|0|||
131531850|NCT00760929|473571969|FG002|Overall Study|Withdrawal by Subject|9|||
131531851|NCT00760929|473571970|FG003|Overall Study|Withdrawal by Subject|1|||
131531852|NCT00760929|473571967|FG000|Overall Study|Lost to Follow-up|0|||
131531853|NCT00760929|473571968|FG001|Overall Study|Lost to Follow-up|0|||
131531854|NCT00760929|473571969|FG002|Overall Study|Lost to Follow-up|1|||
131531855|NCT00760929|473571970|FG003|Overall Study|Lost to Follow-up|0|||
131531856|NCT00760929|473571967|FG000|Overall Study|Progression of Disease|21|||
131531857|NCT00760929|473571968|FG001|Overall Study|Progression of Disease|26|||
131531858|NCT00760929|473571969|FG002|Overall Study|Progression of Disease|38|||
131531859|NCT00760929|473571970|FG003|Overall Study|Progression of Disease|42|||
131531860|NCT00760929|473571967|FG000|Overall Study|Other|2|||
131531861|NCT00760929|473571968|FG001|Overall Study|Other|0|||
131531862|NCT00760929|473571969|FG002|Overall Study|Other|2|||
131531863|NCT00760929|473571970|FG003|Overall Study|Other|1|||
131531864|NCT00760929|473571967|FG000|Overall Study|Death|0|||
131531865|NCT00760929|473571968|FG001|Overall Study|Death|0|||
131531866|NCT00760929|473571969|FG002|Overall Study|Death|1|||
131531867|NCT00760929|473571970|FG003|Overall Study|Death|0|||
131531868|NCT00760929|473571967|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
131531869|NCT00760929|473571968|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
131531870|NCT00760929|473571969|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
131531871|NCT00760929|473571970|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
131531872|NCT01227889|473571973|FG000|Randomized Phase (RP)|Adverse Event|13|||
131531873|NCT01227889|473571974|FG001|Randomized Phase (RP)|Adverse Event|0|||
131531874|NCT01227889|473571973|FG000|Randomized Phase (RP)|Physician Decision|13|||
131531875|NCT01227889|473571974|FG001|Randomized Phase (RP)|Physician Decision|5|||
131531876|NCT01227889|473571973|FG000|Randomized Phase (RP)|Progressive Disease|135|||
131531877|NCT01227889|473571974|FG001|Randomized Phase (RP)|Progressive Disease|52|||
131531878|NCT01227889|473571973|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
131531879|NCT01227889|473571974|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
131531880|NCT01227889|473571973|FG000|Randomized Phase (RP)|Missing|1|||
131531881|NCT01227889|473571974|FG001|Randomized Phase (RP)|Missing|3|||
131531882|NCT01227889|473571973|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
131531883|NCT01227889|473571974|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
131531884|NCT01227889|473571973|FG000|Crossover Phase|Adverse Event|0|||
131531885|NCT01227889|473571974|FG001|Crossover Phase|Adverse Event|1|||
131531886|NCT01227889|473571973|FG000|Crossover Phase|Physician Decision|0|||
131531887|NCT01227889|473571974|FG001|Crossover Phase|Physician Decision|3|||
131531888|NCT01227889|473571973|FG000|Crossover Phase|Progressive Disease|0|||
131531889|NCT01227889|473571974|FG001|Crossover Phase|Progressive Disease|31|||
131531890|NCT01227889|473571973|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
131531891|NCT01227889|473571974|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
131531892|NCT01227889|473571973|FG000|Crossover Phase|Withdrawal by Subject|0|||
131531893|NCT01227889|473571974|FG001|Crossover Phase|Withdrawal by Subject|1|||
131531894|NCT03268811|473571975|FG000|Overall Study|Adverse Event|0|||
131531895|NCT03268811|473571976|FG001|Overall Study|Adverse Event|1|||
131531896|NCT04827212|473571984|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
131531897|NCT04827212|473571985|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
131531898|NCT04827212|473571984|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
131531899|NCT04827212|473571985|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
131531900|NCT00941603|473571996|FG000|Overall Study|Adverse Event|10|||
131531901|NCT00941603|473571997|FG001|Overall Study|Adverse Event|15|||
131531902|NCT00941603|473571998|FG002|Overall Study|Adverse Event|5|||
131531903|NCT00941603|473571999|FG003|Overall Study|Adverse Event|1|||
131531904|NCT00941603|473572000|FG004|Overall Study|Adverse Event|4|||
131531905|NCT00941603|473572001|FG005|Overall Study|Adverse Event|0|||
131531906|NCT00941603|473571996|FG000|Overall Study|Lost to Follow-up|0|||
131531907|NCT00941603|473571997|FG001|Overall Study|Lost to Follow-up|0|||
131531908|NCT00941603|473571998|FG002|Overall Study|Lost to Follow-up|0|||
131531909|NCT00941603|473571999|FG003|Overall Study|Lost to Follow-up|1|||
131531910|NCT00941603|473572000|FG004|Overall Study|Lost to Follow-up|0|||
131531911|NCT00941603|473572001|FG005|Overall Study|Lost to Follow-up|2|||
131531912|NCT00941603|473571996|FG000|Overall Study|Withdrawal by Subject|0|||
131531913|NCT00941603|473571997|FG001|Overall Study|Withdrawal by Subject|0|||
131531914|NCT00941603|473571998|FG002|Overall Study|Withdrawal by Subject|0|||
131531915|NCT00941603|473571999|FG003|Overall Study|Withdrawal by Subject|2|||
131531916|NCT00941603|473572000|FG004|Overall Study|Withdrawal by Subject|0|||
131531917|NCT00941603|473572001|FG005|Overall Study|Withdrawal by Subject|1|||
131531918|NCT00941603|473571996|FG000|Overall Study|Protocol Violation|0|||
131531919|NCT00941603|473571997|FG001|Overall Study|Protocol Violation|1|||
131531920|NCT00941603|473571998|FG002|Overall Study|Protocol Violation|0|||
131531921|NCT00941603|473571999|FG003|Overall Study|Protocol Violation|0|||
131531922|NCT00941603|473572000|FG004|Overall Study|Protocol Violation|0|||
131531923|NCT00941603|473572001|FG005|Overall Study|Protocol Violation|0|||
131531924|NCT00941603|473571996|FG000|Overall Study|Did not meet protocol eligibility|1|||
131531925|NCT00941603|473571997|FG001|Overall Study|Did not meet protocol eligibility|0|||
131531926|NCT00941603|473571998|FG002|Overall Study|Did not meet protocol eligibility|0|||
131531927|NCT00941603|473571999|FG003|Overall Study|Did not meet protocol eligibility|0|||
131531928|NCT00941603|473572000|FG004|Overall Study|Did not meet protocol eligibility|0|||
131531929|NCT00941603|473572001|FG005|Overall Study|Did not meet protocol eligibility|0|||
131531930|NCT02014116|473572003|FG000|Overall Study|Progressive Disease|3|||
131531931|NCT02014116|473572004|FG001|Overall Study|Progressive Disease|4|||
131531932|NCT02014116|473572005|FG002|Overall Study|Progressive Disease|2|||
131531933|NCT02014116|473572006|FG003|Overall Study|Progressive Disease|6|||
131531934|NCT02014116|473572007|FG004|Overall Study|Progressive Disease|1|||
131531935|NCT02014116|473572008|FG005|Overall Study|Progressive Disease|13|||
131531936|NCT02014116|473572009|FG006|Overall Study|Progressive Disease|1|||
131531937|NCT02014116|473572010|FG007|Overall Study|Progressive Disease|3|||
131531938|NCT02014116|473572011|FG008|Overall Study|Progressive Disease|7|||
131531939|NCT02014116|473572003|FG000|Overall Study|Adverse Event|0|||
131531940|NCT02014116|473572004|FG001|Overall Study|Adverse Event|0|||
131531941|NCT02014116|473572005|FG002|Overall Study|Adverse Event|0|||
131531942|NCT02014116|473572006|FG003|Overall Study|Adverse Event|0|||
131531943|NCT02014116|473572007|FG004|Overall Study|Adverse Event|1|||
131531944|NCT02014116|473572008|FG005|Overall Study|Adverse Event|0|||
131531945|NCT02014116|473572009|FG006|Overall Study|Adverse Event|0|||
131531946|NCT02014116|473572010|FG007|Overall Study|Adverse Event|1|||
131531947|NCT02014116|473572011|FG008|Overall Study|Adverse Event|0|||
131531948|NCT02014116|473572003|FG000|Overall Study|Lost to Follow-up|0|||
131531949|NCT02014116|473572004|FG001|Overall Study|Lost to Follow-up|0|||
131531950|NCT02014116|473572005|FG002|Overall Study|Lost to Follow-up|0|||
131531951|NCT02014116|473572006|FG003|Overall Study|Lost to Follow-up|0|||
131531952|NCT02014116|473572007|FG004|Overall Study|Lost to Follow-up|0|||
131531953|NCT02014116|473572008|FG005|Overall Study|Lost to Follow-up|1|||
131531954|NCT02014116|473572009|FG006|Overall Study|Lost to Follow-up|0|||
131531955|NCT02014116|473572010|FG007|Overall Study|Lost to Follow-up|0|||
131531956|NCT02014116|473572011|FG008|Overall Study|Lost to Follow-up|1|||
131531957|NCT02014116|473572003|FG000|Overall Study|Death|0|||
131531958|NCT02014116|473572004|FG001|Overall Study|Death|0|||
131531959|NCT02014116|473572005|FG002|Overall Study|Death|0|||
131531960|NCT02014116|473572006|FG003|Overall Study|Death|0|||
131531961|NCT02014116|473572007|FG004|Overall Study|Death|0|||
131531962|NCT02014116|473572008|FG005|Overall Study|Death|0|||
131531963|NCT02014116|473572009|FG006|Overall Study|Death|0|||
131531964|NCT02014116|473572010|FG007|Overall Study|Death|1|||
131531965|NCT02014116|473572011|FG008|Overall Study|Death|1|||
131531966|NCT02014116|473572003|FG000|Overall Study|Withdrawal by Subject|0|||
131531967|NCT02014116|473572004|FG001|Overall Study|Withdrawal by Subject|0|||
131531968|NCT02014116|473572005|FG002|Overall Study|Withdrawal by Subject|1|||
131531969|NCT02014116|473572006|FG003|Overall Study|Withdrawal by Subject|1|||
131531970|NCT02014116|473572007|FG004|Overall Study|Withdrawal by Subject|0|||
131531971|NCT02014116|473572008|FG005|Overall Study|Withdrawal by Subject|1|||
131531972|NCT02014116|473572009|FG006|Overall Study|Withdrawal by Subject|0|||
131531973|NCT02014116|473572010|FG007|Overall Study|Withdrawal by Subject|0|||
131531974|NCT02014116|473572011|FG008|Overall Study|Withdrawal by Subject|0|||
131531975|NCT02014116|473572003|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
131531976|NCT02014116|473572004|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
131531977|NCT02014116|473572005|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
131531978|NCT02014116|473572006|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
131531979|NCT02014116|473572007|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
131531980|NCT02014116|473572008|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
131531981|NCT02014116|473572009|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
131531982|NCT02014116|473572010|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
131531983|NCT02014116|473572011|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
131531984|NCT02014116|473572003|FG000|Overall Study|Physician Decision|0|||
131531985|NCT02014116|473572004|FG001|Overall Study|Physician Decision|0|||
131531986|NCT02014116|473572005|FG002|Overall Study|Physician Decision|0|||
131531987|NCT02014116|473572006|FG003|Overall Study|Physician Decision|0|||
131531988|NCT02014116|473572007|FG004|Overall Study|Physician Decision|0|||
131531989|NCT02014116|473572008|FG005|Overall Study|Physician Decision|0|||
131531990|NCT02014116|473572009|FG006|Overall Study|Physician Decision|0|||
131531991|NCT02014116|473572010|FG007|Overall Study|Physician Decision|0|||
131531992|NCT02014116|473572011|FG008|Overall Study|Physician Decision|1|||
131531993|NCT02347761|473572012|FG000|All Collected|Death|1|||
131531994|NCT02347761|473572013|FG001|All Collected|Death|0|||
131531995|NCT02347761|473572014|FG002|All Collected|Death|0|||
131531996|NCT02347761|473572012|FG000|All Collected|Lost to Follow-up|3|||
131531997|NCT02347761|473572013|FG001|All Collected|Lost to Follow-up|2|||
131531998|NCT02347761|473572014|FG002|All Collected|Lost to Follow-up|3|||
131531999|NCT02347761|473572012|FG000|All Collected|Withdrawal by Subject|11|||
131532000|NCT02347761|473572013|FG001|All Collected|Withdrawal by Subject|11|||
131532001|NCT02347761|473572014|FG002|All Collected|Withdrawal by Subject|22|||
131532002|NCT02347761|473572012|FG000|All Collected|invetigator disretion|2|||
131532003|NCT02347761|473572013|FG001|All Collected|invetigator disretion|0|||
131532004|NCT02347761|473572014|FG002|All Collected|invetigator disretion|0|||
131532005|NCT02347761|473572012|FG000|All Collected|instillation site pain|0|||
131532006|NCT02347761|473572013|FG001|All Collected|instillation site pain|0|||
131532007|NCT02347761|473572014|FG002|All Collected|instillation site pain|1|||
131532008|NCT02347761|473572012|FG000|All Collected|exacerbation of COPD|0|||
131532009|NCT02347761|473572013|FG001|All Collected|exacerbation of COPD|0|||
131532010|NCT02347761|473572014|FG002|All Collected|exacerbation of COPD|1|||
131532011|NCT02347761|473572012|FG000|All Collected|moved/travel|0|||
131532012|NCT02347761|473572013|FG001|All Collected|moved/travel|1|||
131532013|NCT02347761|473572014|FG002|All Collected|moved/travel|0|||
131532014|NCT02347761|473572012|FG000|On Study Treatment|Lack of Efficacy|2|||
131532015|NCT02347761|473572013|FG001|On Study Treatment|Lack of Efficacy|3|||
131532016|NCT02347761|473572014|FG002|On Study Treatment|Lack of Efficacy|4|||
131532017|NCT02347761|473572012|FG000|On Study Treatment|non-compliance with study medication|0|||
131532018|NCT02347761|473572013|FG001|On Study Treatment|non-compliance with study medication|0|||
131532019|NCT02347761|473572014|FG002|On Study Treatment|non-compliance with study medication|2|||
131532020|NCT02347761|473572012|FG000|On Study Treatment|Withdrawal by Subject|7|||
131532021|NCT02347761|473572013|FG001|On Study Treatment|Withdrawal by Subject|3|||
131532022|NCT02347761|473572014|FG002|On Study Treatment|Withdrawal by Subject|5|||
131532023|NCT02347761|473572012|FG000|On Study Treatment|move/travel|2|||
131532024|NCT02347761|473572013|FG001|On Study Treatment|move/travel|6|||
131532025|NCT02347761|473572014|FG002|On Study Treatment|move/travel|5|||
131532026|NCT02347761|473572012|FG000|On Study Treatment|dissastisfaction with device|2|||
131532027|NCT02347761|473572013|FG001|On Study Treatment|dissastisfaction with device|1|||
131532028|NCT02347761|473572014|FG002|On Study Treatment|dissastisfaction with device|4|||
131532029|NCT02347761|473572012|FG000|On Study Treatment|Lost to Follow-up|2|||
131532030|NCT02347761|473572013|FG001|On Study Treatment|Lost to Follow-up|1|||
131532031|NCT02347761|473572014|FG002|On Study Treatment|Lost to Follow-up|1|||
131532032|NCT02347761|473572012|FG000|On Study Treatment|investigator discretion|2|||
131532033|NCT02347761|473572013|FG001|On Study Treatment|investigator discretion|0|||
131532034|NCT02347761|473572014|FG002|On Study Treatment|investigator discretion|0|||
131532035|NCT02347761|473572012|FG000|On Study Treatment|durg not working|0|||
131532036|NCT02347761|473572013|FG001|On Study Treatment|durg not working|1|||
131532037|NCT02347761|473572014|FG002|On Study Treatment|durg not working|1|||
131532038|NCT02347761|473572012|FG000|On Study Treatment|Adverse Event|10|||
131532039|NCT02347761|473572013|FG001|On Study Treatment|Adverse Event|8|||
131532040|NCT02347761|473572014|FG002|On Study Treatment|Adverse Event|20|||
131532041|NCT03879798|473572015|FG000|Overall Study|Adverse Event|0|||
131532042|NCT03879798|473572016|FG001|Overall Study|Adverse Event|0|||
131532043|NCT03879798|473572017|FG002|Overall Study|Adverse Event|0|||
131532044|NCT03879798|473572018|FG003|Overall Study|Adverse Event|0|||
131532045|NCT03879798|473572019|FG004|Overall Study|Adverse Event|0|||
131532046|NCT03879798|473572020|FG005|Overall Study|Adverse Event|1|||
131532047|NCT03879798|473572015|FG000|Overall Study|Lack of Efficacy|0|||
131532048|NCT03879798|473572016|FG001|Overall Study|Lack of Efficacy|0|||
131532049|NCT03879798|473572017|FG002|Overall Study|Lack of Efficacy|0|||
131532050|NCT03879798|473572018|FG003|Overall Study|Lack of Efficacy|0|||
131532051|NCT03879798|473572019|FG004|Overall Study|Lack of Efficacy|0|||
131532052|NCT03879798|473572020|FG005|Overall Study|Lack of Efficacy|1|||
131532053|NCT03879798|473572015|FG000|Overall Study|Withdrawal by Subject|0|||
131532054|NCT03879798|473572016|FG001|Overall Study|Withdrawal by Subject|0|||
131532055|NCT03879798|473572017|FG002|Overall Study|Withdrawal by Subject|0|||
131532056|NCT03879798|473572018|FG003|Overall Study|Withdrawal by Subject|0|||
131532057|NCT03879798|473572019|FG004|Overall Study|Withdrawal by Subject|0|||
131532058|NCT03879798|473572020|FG005|Overall Study|Withdrawal by Subject|1|||
131532059|NCT03625570|473572021|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
131532060|NCT03625570|473572022|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
131532061|NCT03625570|473572021|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
131532062|NCT03625570|473572022|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
131532063|NCT03625570|473572021|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
131532064|NCT03625570|473572022|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
131532065|NCT05348681|473572026|FG000|Overall Study|Study terminated by Sponsor|8|||
131532066|NCT05348681|473572027|FG001|Overall Study|Study terminated by Sponsor|3|||
131532067|NCT05348681|473572026|FG000|Overall Study|Withdrawal by Subject|1|||
131532068|NCT05348681|473572027|FG001|Overall Study|Withdrawal by Subject|1|||
131532069|NCT05348681|473572026|FG000|Overall Study|Lost to Follow-up|1|||
131532070|NCT05348681|473572027|FG001|Overall Study|Lost to Follow-up|1|||
131532071|NCT05348681|473572026|FG000|Overall Study|Adverse Event|1|||
131532072|NCT05348681|473572027|FG001|Overall Study|Adverse Event|0|||
131532073|NCT05348681|473572026|FG000|Overall Study|Other|2|||
131532074|NCT05348681|473572027|FG001|Overall Study|Other|1|||
131532075|NCT00782340|473572028|FG000|Open Label Titration|Adverse Event|12|||
131532076|NCT00782340|473572029|FG001|Open Label Titration|Adverse Event|0|||
131532077|NCT00782340|473572030|FG002|Open Label Titration|Adverse Event|0|||
131532078|NCT00782340|473572028|FG000|Open Label Titration|Treatment failure|50|||
131532079|NCT00782340|473572029|FG001|Open Label Titration|Treatment failure|0|||
131532080|NCT00782340|473572030|FG002|Open Label Titration|Treatment failure|0|||
131532081|NCT00782340|473572028|FG000|Open Label Titration|Protocol Violation|5|||
131532082|NCT00782340|473572029|FG001|Open Label Titration|Protocol Violation|0|||
131532083|NCT00782340|473572030|FG002|Open Label Titration|Protocol Violation|0|||
131532084|NCT00782340|473572028|FG000|Open Label Titration|Withdrawal by Subject|5|||
131532085|NCT00782340|473572029|FG001|Open Label Titration|Withdrawal by Subject|0|||
131532086|NCT00782340|473572030|FG002|Open Label Titration|Withdrawal by Subject|0|||
131532087|NCT00782340|473572028|FG000|Open Label Titration|Enrollment capped|16|||
131532088|NCT00782340|473572029|FG001|Open Label Titration|Enrollment capped|0|||
131532089|NCT00782340|473572030|FG002|Open Label Titration|Enrollment capped|0|||
131532090|NCT00782340|473572028|FG000|Open Label Titration|Did not meet responder criteria|2|||
131532091|NCT00782340|473572029|FG001|Open Label Titration|Did not meet responder criteria|0|||
131532092|NCT00782340|473572030|FG002|Open Label Titration|Did not meet responder criteria|0|||
131532093|NCT00782340|473572028|FG000|Open Label Titration|Lost to Follow-up|5|||
131532094|NCT00782340|473572029|FG001|Open Label Titration|Lost to Follow-up|0|||
131532095|NCT00782340|473572030|FG002|Open Label Titration|Lost to Follow-up|0|||
131532096|NCT00782340|473572028|FG000|Open Label Titration|Randomized in error|6|||
131532097|NCT00782340|473572029|FG001|Open Label Titration|Randomized in error|0|||
131532098|NCT00782340|473572030|FG002|Open Label Titration|Randomized in error|0|||
131532099|NCT01568047|473572036|FG000|Overall Study|Ineligibility|1|||
131532100|NCT01568047|473572037|FG001|Overall Study|Ineligibility|0|||
131532101|NCT01568047|473572038|FG002|Overall Study|Ineligibility|0|||
131532102|NCT01568047|473572039|FG003|Overall Study|Ineligibility|0|||
131532103|NCT01568047|473572036|FG000|Overall Study|Withdrawal by Subject|0|||
131532104|NCT01568047|473572037|FG001|Overall Study|Withdrawal by Subject|1|||
131532105|NCT01568047|473572038|FG002|Overall Study|Withdrawal by Subject|0|||
131532106|NCT01568047|473572039|FG003|Overall Study|Withdrawal by Subject|0|||
131532107|NCT01568047|473572036|FG000|Overall Study|Adverse Event|0|||
131532108|NCT01568047|473572037|FG001|Overall Study|Adverse Event|0|||
131532109|NCT01568047|473572038|FG002|Overall Study|Adverse Event|1|||
131532110|NCT01568047|473572039|FG003|Overall Study|Adverse Event|1|||
131532111|NCT01944046|473572040|FG000|Randomized to DB|Adverse Event|5|||
131532112|NCT01944046|473572041|FG001|Randomized to DB|Adverse Event|2|||
131532113|NCT01944046|473572040|FG000|Randomized to DB|Clinical Worsening|3|||
131532114|NCT01944046|473572041|FG001|Randomized to DB|Clinical Worsening|2|||
131532115|NCT01944046|473572040|FG000|Randomized to DB|Lost to Follow-up|3|||
131532116|NCT01944046|473572041|FG001|Randomized to DB|Lost to Follow-up|3|||
131532117|NCT01944046|473572040|FG000|Randomized to DB|Withdrawal by Subject|2|||
131532118|NCT01944046|473572041|FG001|Randomized to DB|Withdrawal by Subject|4|||
131532119|NCT01944046|473572040|FG000|Randomized to DB|Physician Decision|1|||
131532120|NCT01944046|473572041|FG001|Randomized to DB|Physician Decision|2|||
131532121|NCT01944046|473572040|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
131532122|NCT01944046|473572041|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
131532123|NCT01944046|473572040|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
131532124|NCT01944046|473572041|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
131532125|NCT01944046|473572040|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
131532126|NCT01944046|473572041|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
131532127|NCT01944046|473572040|FG000|Open Label Eligible and Consented|Adverse Event|6|||
131532128|NCT01944046|473572041|FG001|Open Label Eligible and Consented|Adverse Event|1|||
131532129|NCT01944046|473572040|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
131532130|NCT01944046|473572041|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
131532131|NCT01944046|473572040|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
131532132|NCT01944046|473572041|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
131532133|NCT02007577|473572043|FG000|Overall Study|Adverse Event|1|||
131532134|NCT02007577|473572044|FG001|Overall Study|Adverse Event|0|||
131532135|NCT02007577|473572043|FG000|Overall Study|Withdrawal by Subject|0|||
131532136|NCT02007577|473572044|FG001|Overall Study|Withdrawal by Subject|1|||
131532137|NCT02504294|473572045|FG000|Overall Study|Adverse Event|15|||
131532138|NCT02504294|473572046|FG001|Overall Study|Adverse Event|12|||
131532139|NCT02504294|473572045|FG000|Overall Study|Withdrawal by Subject|7|||
131532140|NCT02504294|473572046|FG001|Overall Study|Withdrawal by Subject|1|||
131532141|NCT02504294|473572045|FG000|Overall Study|Protocol Violation|27|||
131532142|NCT02504294|473572046|FG001|Overall Study|Protocol Violation|26|||
131532143|NCT02504294|473572045|FG000|Overall Study|Physician Decision|1|||
131532144|NCT02504294|473572046|FG001|Overall Study|Physician Decision|2|||
131532145|NCT02504294|473572045|FG000|Overall Study|Lost to Follow-up|6|||
131532146|NCT02504294|473572046|FG001|Overall Study|Lost to Follow-up|7|||
131532147|NCT01953926|473572047|FG000|Overall Study|Withdrawal by Subject|23|||
131532148|NCT01953926|473572048|FG001|Overall Study|Withdrawal by Subject|3|||
131532149|NCT01953926|473572049|FG002|Overall Study|Withdrawal by Subject|3|||
131532150|NCT01953926|473572050|FG003|Overall Study|Withdrawal by Subject|5|||
131532151|NCT01953926|473572051|FG004|Overall Study|Withdrawal by Subject|6|||
131532152|NCT01953926|473572052|FG005|Overall Study|Withdrawal by Subject|0|||
131532153|NCT01953926|473572053|FG006|Overall Study|Withdrawal by Subject|1|||
131532154|NCT01953926|473572047|FG000|Overall Study|Physician Decision|1|||
131532155|NCT01953926|473572048|FG001|Overall Study|Physician Decision|0|||
131532156|NCT01953926|473572049|FG002|Overall Study|Physician Decision|0|||
131532157|NCT01953926|473572050|FG003|Overall Study|Physician Decision|0|||
131532158|NCT01953926|473572051|FG004|Overall Study|Physician Decision|2|||
131532159|NCT01953926|473572052|FG005|Overall Study|Physician Decision|0|||
131532160|NCT01953926|473572053|FG006|Overall Study|Physician Decision|0|||
131532161|NCT01953926|473572047|FG000|Overall Study|Lost to Follow-up|18|||
131532162|NCT01953926|473572048|FG001|Overall Study|Lost to Follow-up|3|||
131532163|NCT01953926|473572049|FG002|Overall Study|Lost to Follow-up|0|||
131532164|NCT01953926|473572050|FG003|Overall Study|Lost to Follow-up|5|||
131532165|NCT01953926|473572051|FG004|Overall Study|Lost to Follow-up|3|||
131532166|NCT01953926|473572052|FG005|Overall Study|Lost to Follow-up|0|||
131532167|NCT01953926|473572053|FG006|Overall Study|Lost to Follow-up|0|||
131532168|NCT01953926|473572047|FG000|Overall Study|Protocol Violation|1|||
131532169|NCT01953926|473572048|FG001|Overall Study|Protocol Violation|0|||
131532170|NCT01953926|473572049|FG002|Overall Study|Protocol Violation|0|||
131532171|NCT01953926|473572050|FG003|Overall Study|Protocol Violation|0|||
131532172|NCT01953926|473572051|FG004|Overall Study|Protocol Violation|0|||
131532173|NCT01953926|473572052|FG005|Overall Study|Protocol Violation|0|||
131532174|NCT01953926|473572053|FG006|Overall Study|Protocol Violation|0|||
131532175|NCT01953926|473572047|FG000|Overall Study|Other, Disease progression|2|||
131532176|NCT01953926|473572048|FG001|Overall Study|Other, Disease progression|1|||
131532177|NCT01953926|473572049|FG002|Overall Study|Other, Disease progression|0|||
131532178|NCT01953926|473572050|FG003|Overall Study|Other, Disease progression|0|||
131532179|NCT01953926|473572051|FG004|Overall Study|Other, Disease progression|1|||
131532180|NCT01953926|473572052|FG005|Overall Study|Other, Disease progression|0|||
131532181|NCT01953926|473572053|FG006|Overall Study|Other, Disease progression|0|||
131532182|NCT01953926|473572047|FG000|Overall Study|Discontinuation of study by sponsor|41|||
131532183|NCT01953926|473572048|FG001|Overall Study|Discontinuation of study by sponsor|7|||
131532184|NCT01953926|473572049|FG002|Overall Study|Discontinuation of study by sponsor|5|||
131532185|NCT01953926|473572050|FG003|Overall Study|Discontinuation of study by sponsor|12|||
131532186|NCT01953926|473572051|FG004|Overall Study|Discontinuation of study by sponsor|46|||
131532187|NCT01953926|473572052|FG005|Overall Study|Discontinuation of study by sponsor|5|||
131532188|NCT01953926|473572053|FG006|Overall Study|Discontinuation of study by sponsor|6|||
131532189|NCT01953926|473572047|FG000|Overall Study|Not Treated|1|||
131532190|NCT01953926|473572048|FG001|Overall Study|Not Treated|0|||
131532191|NCT01953926|473572049|FG002|Overall Study|Not Treated|1|||
131532192|NCT01953926|473572050|FG003|Overall Study|Not Treated|0|||
131532193|NCT01953926|473572051|FG004|Overall Study|Not Treated|0|||
131532194|NCT01953926|473572052|FG005|Overall Study|Not Treated|0|||
131532195|NCT01953926|473572053|FG006|Overall Study|Not Treated|0|||
131532196|NCT02338362|473572054|FG000|Overall Study|Withdrawal by Subject|1|||
131532197|NCT02338362|473572055|FG001|Overall Study|Withdrawal by Subject|1|||
131532198|NCT06281548|473572056|FG000|Overall Study|Lost to Follow-up|3|||
131532199|NCT00288587|473572057|FG000|Overall Study|Death|4|||
131532200|NCT00288587|473572058|FG001|Overall Study|Death|4|||
131532201|NCT00288587|473572057|FG000|Overall Study|Transplant|0|||
131532202|NCT00288587|473572058|FG001|Overall Study|Transplant|3|||
131532203|NCT00288587|473572057|FG000|Overall Study|Adverse Event|0|||
131532204|NCT00288587|473572058|FG001|Overall Study|Adverse Event|1|||
131532205|NCT00288587|473572057|FG000|Overall Study|Physician Decision|0|||
131532206|NCT00288587|473572058|FG001|Overall Study|Physician Decision|2|||
131532207|NCT00288587|473572057|FG000|Overall Study|Severe Aortic Stenosis|1|||
131532208|NCT00288587|473572058|FG001|Overall Study|Severe Aortic Stenosis|0|||
131532209|NCT01434602|473572059|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
131532210|NCT01434602|473572060|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
131532211|NCT01434602|473572061|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
131532212|NCT01434602|473572062|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
131532213|NCT01434602|473572063|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
131532214|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
131532215|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
131532216|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
131532217|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
131532218|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
131532219|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
131532220|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
131532221|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
131532222|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
131532223|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
131532224|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
131532225|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
131532226|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
131532227|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
131532228|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
131532229|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
131532230|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
131532231|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
131532232|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
131532233|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
131532234|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
131532235|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
131532236|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
131532237|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
131532238|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
131532239|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
131532240|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
131532241|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
131532242|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
131532243|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
131532244|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
131532245|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
131532246|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
131532247|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
131532248|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
131532249|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
131532250|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
131532251|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
131532252|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
131532253|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
131532254|NCT01434602|473572059|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
131532255|NCT01434602|473572060|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
131532256|NCT01434602|473572061|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
131532257|NCT01434602|473572062|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
131532258|NCT01434602|473572063|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
131532259|NCT02911948|473572070|FG000|Overall Study|Protocol Violation|0|||
131532260|NCT02911948|473572071|FG001|Overall Study|Protocol Violation|1|||
131532261|NCT02911948|473572070|FG000|Overall Study|Withdrawal by Subject|0|||
131532262|NCT02911948|473572071|FG001|Overall Study|Withdrawal by Subject|2|||
131532263|NCT02911948|473572070|FG000|Overall Study|Lack of Efficacy|0|||
131532264|NCT02911948|473572071|FG001|Overall Study|Lack of Efficacy|1|||
131532265|NCT02911948|473572070|FG000|Overall Study|Unclassified|0|||
131532266|NCT02911948|473572071|FG001|Overall Study|Unclassified|3|||
131532267|NCT00586105|473572072|FG000|Overall Study|Adverse Event|4|||
131532268|NCT00586105|473572072|FG000|Overall Study|Death|2|||
131532269|NCT00586105|473572072|FG000|Overall Study|Protocol Violation|1|||
131532270|NCT00586105|473572072|FG000|Overall Study|Withdrawal by Subject|3|||
131532271|NCT00586105|473572072|FG000|Overall Study|Disease progression|19|||
131532272|NCT00586105|473572072|FG000|Overall Study|Switched to commercial drug|9|||
131532273|NCT00586105|473572072|FG000|Overall Study|Reason not reported|1|||
131532274|NCT02308033|473572075|FG000|Overall Study|Normal Gram stain at Baseline|13|||
131532275|NCT02308033|473572076|FG001|Overall Study|Normal Gram stain at Baseline|10|||
131532276|NCT02308033|473572075|FG000|Overall Study|Positive for STD at Baseline|7|||
131532277|NCT02308033|473572076|FG001|Overall Study|Positive for STD at Baseline|4|||
131532278|NCT02308033|473572075|FG000|Overall Study|Lost to Follow-up|6|||
131532279|NCT02308033|473572076|FG001|Overall Study|Lost to Follow-up|5|||
131532280|NCT00345397|473572077|FG000|Overall Study|Death|1|||
131532281|NCT04266028|473572078|FG000|Overall Study|Adverse Event|0|||
131532282|NCT04266028|473572079|FG001|Overall Study|Adverse Event|0|||
131532283|NCT04266028|473572080|FG002|Overall Study|Adverse Event|1|||
131532284|NCT04266028|473572081|FG003|Overall Study|Adverse Event|0|||
131532285|NCT04266028|473572082|FG004|Overall Study|Adverse Event|1|||
131532286|NCT04266028|473572083|FG005|Overall Study|Adverse Event|0|||
131532287|NCT04266028|473572084|FG006|Overall Study|Adverse Event|2|||
131532288|NCT04266028|473572085|FG007|Overall Study|Adverse Event|0|||
131532289|NCT04266028|473572078|FG000|Overall Study|temporary halt of the study|0|||
131532290|NCT04266028|473572079|FG001|Overall Study|temporary halt of the study|0|||
131532291|NCT04266028|473572080|FG002|Overall Study|temporary halt of the study|0|||
131532292|NCT04266028|473572081|FG003|Overall Study|temporary halt of the study|0|||
131532293|NCT04266028|473572082|FG004|Overall Study|temporary halt of the study|0|||
131532294|NCT04266028|473572083|FG005|Overall Study|temporary halt of the study|0|||
131532295|NCT04266028|473572084|FG006|Overall Study|temporary halt of the study|2|||
131532296|NCT04266028|473572085|FG007|Overall Study|temporary halt of the study|1|||
131532297|NCT04266028|473572078|FG000|Overall Study|Onset of birch pollen season|0|||
131532298|NCT04266028|473572079|FG001|Overall Study|Onset of birch pollen season|0|||
131532299|NCT04266028|473572080|FG002|Overall Study|Onset of birch pollen season|0|||
131532300|NCT04266028|473572081|FG003|Overall Study|Onset of birch pollen season|0|||
131532301|NCT04266028|473572082|FG004|Overall Study|Onset of birch pollen season|1|||
131532302|NCT04266028|473572083|FG005|Overall Study|Onset of birch pollen season|0|||
131532303|NCT04266028|473572084|FG006|Overall Study|Onset of birch pollen season|0|||
131532304|NCT04266028|473572085|FG007|Overall Study|Onset of birch pollen season|0|||
131532305|NCT03021187|473572088|FG000|Overall Study|Death|0|||
131532306|NCT03021187|473572089|FG001|Overall Study|Death|0|||
131532307|NCT03021187|473572090|FG002|Overall Study|Death|3|||
131532308|NCT03021187|473572091|FG003|Overall Study|Death|0|||
131532309|NCT03021187|473572088|FG000|Overall Study|Withdrawal by Subject|0|||
131532310|NCT03021187|473572089|FG001|Overall Study|Withdrawal by Subject|6|||
131532311|NCT03021187|473572090|FG002|Overall Study|Withdrawal by Subject|2|||
131532312|NCT03021187|473572091|FG003|Overall Study|Withdrawal by Subject|5|||
131532313|NCT03021187|473572088|FG000|Overall Study|Lost to Follow-up|10|||
131532314|NCT03021187|473572089|FG001|Overall Study|Lost to Follow-up|3|||
131532315|NCT03021187|473572090|FG002|Overall Study|Lost to Follow-up|1|||
131532316|NCT03021187|473572091|FG003|Overall Study|Lost to Follow-up|4|||
131532317|NCT03351049|473572094|FG000|Overall Study|Withdrawal|26|||
131532318|NCT03351049|473572095|FG001|Overall Study|Withdrawal|22|||
131532319|NCT00558285|473572099|FG000|Overall Study|Adverse Event|1|||
131532320|NCT00558285|473572100|FG001|Overall Study|Adverse Event|1|||
131532321|NCT00558285|473572101|FG002|Overall Study|Adverse Event|4|||
131532322|NCT00558285|473572102|FG003|Overall Study|Adverse Event|1|||
131532323|NCT00558285|473572103|FG004|Overall Study|Adverse Event|2|||
131532324|NCT00558285|473572099|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131532325|NCT00558285|473572100|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131532326|NCT00558285|473572101|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131532327|NCT00558285|473572102|FG003|Overall Study|Abnormal test procedure result(s)|0|||
131532328|NCT00558285|473572103|FG004|Overall Study|Abnormal test procedure result(s)|0|||
131532329|NCT00558285|473572099|FG000|Overall Study|Subject withdrew consent|2|||
131532330|NCT00558285|473572100|FG001|Overall Study|Subject withdrew consent|0|||
131532331|NCT00558285|473572101|FG002|Overall Study|Subject withdrew consent|1|||
131532332|NCT00558285|473572102|FG003|Overall Study|Subject withdrew consent|1|||
131532333|NCT00558285|473572103|FG004|Overall Study|Subject withdrew consent|1|||
131532334|NCT00558285|473572099|FG000|Overall Study|Lost to Follow-up|1|||
131532335|NCT00558285|473572100|FG001|Overall Study|Lost to Follow-up|1|||
131532336|NCT00558285|473572101|FG002|Overall Study|Lost to Follow-up|0|||
131532337|NCT00558285|473572102|FG003|Overall Study|Lost to Follow-up|0|||
131532338|NCT00558285|473572103|FG004|Overall Study|Lost to Follow-up|0|||
131532339|NCT00558285|473572099|FG000|Overall Study|Administrative problems|0|||
131532340|NCT00558285|473572100|FG001|Overall Study|Administrative problems|0|||
131532341|NCT00558285|473572101|FG002|Overall Study|Administrative problems|0|||
131532342|NCT00558285|473572102|FG003|Overall Study|Administrative problems|1|||
131532343|NCT00558285|473572103|FG004|Overall Study|Administrative problems|1|||
131532344|NCT00558285|473572099|FG000|Overall Study|Protocol deviation|1|||
131532345|NCT00558285|473572100|FG001|Overall Study|Protocol deviation|1|||
131532346|NCT00558285|473572101|FG002|Overall Study|Protocol deviation|0|||
131532347|NCT00558285|473572102|FG003|Overall Study|Protocol deviation|1|||
131532348|NCT00558285|473572103|FG004|Overall Study|Protocol deviation|0|||
131532349|NCT02121847|473572104|FG000|Overall Study|Administrative Reasons|1|||
131532350|NCT02121847|473572104|FG000|Overall Study|Adverse Event|2|||
131532351|NCT02663817|473572105|FG000|Overall Study|Screen failure|2|||
131532352|NCT03478891|473572106|FG000|Overall Study|Enrolled, but product never administered|0|||
131532353|NCT03478891|473572107|FG001|Overall Study|Enrolled, but product never administered|0|||
131532354|NCT03478891|473572108|FG002|Overall Study|Enrolled, but product never administered|1|||
131532355|NCT03478891|473572106|FG000|Overall Study|Moved from area|0|||
131532356|NCT03478891|473572107|FG001|Overall Study|Moved from area|0|||
131532357|NCT03478891|473572108|FG002|Overall Study|Moved from area|1|||
131532358|NCT03478891|473572106|FG000|Overall Study|Lost to Follow-up|1|||
131532359|NCT03478891|473572107|FG001|Overall Study|Lost to Follow-up|0|||
131532360|NCT03478891|473572108|FG002|Overall Study|Lost to Follow-up|1|||
131532361|NCT00809757|473572109|FG000|Overall Study|Adverse Event|2|||
131532362|NCT00809757|473572110|FG001|Overall Study|Adverse Event|3|||
131532363|NCT00809757|473572111|FG002|Overall Study|Adverse Event|3|||
131532364|NCT00809757|473572109|FG000|Overall Study|Lost to Follow-up|0|||
131532365|NCT00809757|473572110|FG001|Overall Study|Lost to Follow-up|0|||
131532366|NCT00809757|473572111|FG002|Overall Study|Lost to Follow-up|1|||
131532367|NCT00809757|473572109|FG000|Overall Study|Protocol Violation|1|||
131532368|NCT00809757|473572110|FG001|Overall Study|Protocol Violation|1|||
131532369|NCT00809757|473572111|FG002|Overall Study|Protocol Violation|1|||
131532370|NCT00809757|473572109|FG000|Overall Study|Withdrawal by Subject|2|||
131532371|NCT00809757|473572110|FG001|Overall Study|Withdrawal by Subject|1|||
131532372|NCT00809757|473572111|FG002|Overall Study|Withdrawal by Subject|3|||
131532373|NCT00809757|473572109|FG000|Overall Study|Subject Uncooperative|1|||
131532374|NCT00809757|473572110|FG001|Overall Study|Subject Uncooperative|0|||
131532375|NCT00809757|473572111|FG002|Overall Study|Subject Uncooperative|2|||
131658439|NCT00264303|474035313|FG001|Overall Study|Adverse Event|3|||
131532376|NCT00809757|473572109|FG000|Overall Study|Noncompliance with Medication|0|||
131532377|NCT00809757|473572110|FG001|Overall Study|Noncompliance with Medication|0|||
131532378|NCT00809757|473572111|FG002|Overall Study|Noncompliance with Medication|1|||
131532379|NCT00253864|473572112|FG000|Overall Study|Lost to Follow-up|5|||
131532380|NCT00253864|473572113|FG001|Overall Study|Lost to Follow-up|8|||
131532381|NCT01410448|473572117|FG000|Overall Study|No conversion to everolimus|0|||
131532382|NCT01410448|473572118|FG001|Overall Study|No conversion to everolimus|24|||
131532383|NCT01410448|473572117|FG000|Overall Study|Graft loss|4|||
131532384|NCT01410448|473572118|FG001|Overall Study|Graft loss|1|||
131532385|NCT01410448|473572117|FG000|Overall Study|Administrative issues|2|||
131532386|NCT01410448|473572118|FG001|Overall Study|Administrative issues|1|||
131532387|NCT01410448|473572117|FG000|Overall Study|Lost to Follow-up|1|||
131532388|NCT01410448|473572118|FG001|Overall Study|Lost to Follow-up|0|||
131532389|NCT01410448|473572117|FG000|Overall Study|Withdrawal by Subject|3|||
131532390|NCT01410448|473572118|FG001|Overall Study|Withdrawal by Subject|2|||
131532391|NCT01410448|473572117|FG000|Overall Study|Protocol Violation|0|||
131532392|NCT01410448|473572118|FG001|Overall Study|Protocol Violation|4|||
131532393|NCT01410448|473572117|FG000|Overall Study|Death|2|||
131532394|NCT01410448|473572118|FG001|Overall Study|Death|3|||
131532395|NCT00360529|473572119|FG000|Overall Study|Adverse Event|10|||
131532396|NCT00360529|473572120|FG001|Overall Study|Adverse Event|23|||
131532397|NCT00360529|473572121|FG002|Overall Study|Adverse Event|33|||
131532398|NCT00360529|473572119|FG000|Overall Study|Protocol Violation|3|||
131532399|NCT00360529|473572120|FG001|Overall Study|Protocol Violation|3|||
131532400|NCT00360529|473572121|FG002|Overall Study|Protocol Violation|11|||
131532401|NCT00360529|473572119|FG000|Overall Study|Lost to Follow-up|14|||
131532402|NCT00360529|473572120|FG001|Overall Study|Lost to Follow-up|10|||
131532403|NCT00360529|473572121|FG002|Overall Study|Lost to Follow-up|13|||
131532404|NCT00360529|473572119|FG000|Overall Study|Withdrawal by Subject|22|||
131532405|NCT00360529|473572120|FG001|Overall Study|Withdrawal by Subject|14|||
131532406|NCT00360529|473572121|FG002|Overall Study|Withdrawal by Subject|18|||
131532407|NCT00360529|473572119|FG000|Overall Study|Lack of Efficacy|8|||
131532408|NCT00360529|473572120|FG001|Overall Study|Lack of Efficacy|6|||
131532409|NCT00360529|473572121|FG002|Overall Study|Lack of Efficacy|5|||
131532410|NCT00360529|473572119|FG000|Overall Study|Reason discontinued not explained above|4|||
131532411|NCT00360529|473572120|FG001|Overall Study|Reason discontinued not explained above|9|||
131532412|NCT00360529|473572121|FG002|Overall Study|Reason discontinued not explained above|11|||
131532413|NCT03712917|473572124|FG000|Overall Study|Pregnancy|0|||
131532414|NCT03712917|473572125|FG001|Overall Study|Pregnancy|0|||
131532415|NCT03712917|473572126|FG002|Overall Study|Pregnancy|1|||
131532416|NCT03712917|473572124|FG000|Overall Study|Adverse Event|0|||
131532417|NCT03712917|473572125|FG001|Overall Study|Adverse Event|4|||
131532418|NCT03712917|473572126|FG002|Overall Study|Adverse Event|3|||
131532419|NCT03712917|473572124|FG000|Overall Study|Lost to Follow-up|9|||
131532420|NCT03712917|473572125|FG001|Overall Study|Lost to Follow-up|4|||
131532421|NCT03712917|473572126|FG002|Overall Study|Lost to Follow-up|5|||
131532422|NCT02091167|473572128|FG000|Overall Study|Lost to Follow-up|0|||
131532423|NCT02091167|473572129|FG001|Overall Study|Lost to Follow-up|2|||
131532424|NCT03096782|473572130|FG000|Overall Study|Death|1|||
131532425|NCT03096782|473572130|FG000|Overall Study|Participant Relapsed|1|||
131532426|NCT00932893|473572137|FG000|Overall Study|Death|115|||
131532427|NCT00932893|473572138|FG001|Overall Study|Death|24|||
131532428|NCT00932893|473572137|FG000|Overall Study|Lost to Follow-up|8|||
131532429|NCT00932893|473572138|FG001|Overall Study|Lost to Follow-up|0|||
131532430|NCT00932893|473572137|FG000|Overall Study|Withdrawal by Subject|5|||
131532431|NCT00932893|473572138|FG001|Overall Study|Withdrawal by Subject|2|||
131532432|NCT00932893|473572137|FG000|Overall Study|Other|5|||
131532433|NCT00932893|473572138|FG001|Overall Study|Other|144|||
131532434|NCT00724282|473574308|FG000|Overall Study|Withdrawal by Subject|3|||
131532435|NCT00724282|473574308|FG000|Overall Study|Physician Decision|1|||
131532436|NCT00993447|473574309|FG000|Overall Study|Withdrawal by Subject|23|||
131532437|NCT00993447|473574310|FG001|Overall Study|Withdrawal by Subject|8|||
131532438|NCT00993447|473574309|FG000|Overall Study|Protocol Violation|12|||
131532439|NCT00993447|473574310|FG001|Overall Study|Protocol Violation|8|||
131532440|NCT00993447|473574309|FG000|Overall Study|Lost to Follow-up|1|||
131532441|NCT00993447|473574310|FG001|Overall Study|Lost to Follow-up|3|||
131532442|NCT00993447|473574309|FG000|Overall Study|Adverse Event|1|||
131532443|NCT00993447|473574310|FG001|Overall Study|Adverse Event|0|||
131532444|NCT00970502|473574312|FG000|Overall Study|Withdrawal by Subject|1|||
131532445|NCT03811912|473574313|FG000|Overall Study|Withdrew Consent|4|||
131532446|NCT03811912|473574314|FG001|Overall Study|Withdrew Consent|2|||
131532447|NCT01438411|473574315|FG000|Overall Study|Adverse Event|8|||
131532448|NCT01438411|473574315|FG000|Overall Study|Lost to Follow-up|1|||
131532449|NCT01438411|473574315|FG000|Overall Study|Lack of Efficacy|1|||
131532450|NCT01438411|473574315|FG000|Overall Study|Withdrawal by Subject|3|||
131532451|NCT01863680|473574316|FG000|Overall Study|Adverse Event|17|||
131532452|NCT01863680|473574316|FG000|Overall Study|Risk of OHSS|17|||
131532453|NCT01863680|473574316|FG000|Overall Study|Spontaneous pregnancy|2|||
131532454|NCT01863680|473574316|FG000|Overall Study|Withdrawal by Subject|1|||
131532455|NCT01863680|473574316|FG000|Overall Study|Did not undergo IVF/ET|14|||
131532456|NCT01863680|473574316|FG000|Overall Study|Other|6|||
131532457|NCT00618514|473574317|FG000|Overall Study|Lost to Follow-up|11|||
131532458|NCT00618514|473574318|FG001|Overall Study|Lost to Follow-up|12|||
131532459|NCT00618514|473574319|FG002|Overall Study|Lost to Follow-up|4|||
131532460|NCT00566228|473574320|FG000|Overall Study|Withdrawal by Subject|1|||
131532461|NCT00566228|473574321|FG001|Overall Study|Withdrawal by Subject|0|||
131532462|NCT00566228|473574320|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
131532463|NCT00566228|473574321|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
131532464|NCT00566228|473574320|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
131532465|NCT00566228|473574321|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
131532466|NCT00566228|473574320|FG000|Overall Study|progressed before infusion could occur|0|||
131532467|NCT00566228|473574321|FG001|Overall Study|progressed before infusion could occur|1|||
131532468|NCT02053350|473574324|FG000|Overall Study|Withdrawal by Subject|1|||
131532469|NCT02053350|473574324|FG000|Overall Study|Adverse Event|4|||
131532470|NCT02244944|473574325|FG000|Overall Study|Withdrawal by Subject|1|||
131532471|NCT02244944|473574325|FG000|Overall Study|Study Terminated|1|||
131532472|NCT01159691|473574326|FG000|Overall Study|Lost to Follow-up|2|||
131532473|NCT01159691|473574326|FG000|Overall Study|Unknown reasons|1|||
131532474|NCT01159691|473574326|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
131532475|NCT01159691|473574326|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
131532476|NCT01159691|473574326|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
131532477|NCT01159691|473574326|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
131532478|NCT01159691|473574326|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
131532479|NCT01159691|473574326|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
131532480|NCT01928719|473574327|FG000|Overall Study|Lost to Follow-up|26|||
131532481|NCT01928719|473574328|FG001|Overall Study|Lost to Follow-up|11|||
131532482|NCT01928719|473574327|FG000|Overall Study|Withdrawal by Subject|22|||
131532483|NCT01928719|473574328|FG001|Overall Study|Withdrawal by Subject|7|||
131532484|NCT01928719|473574327|FG000|Overall Study|Protocol Violation|3|||
131532485|NCT01928719|473574328|FG001|Overall Study|Protocol Violation|1|||
131532486|NCT01928719|473574327|FG000|Overall Study|Adverse Event|1|||
131532487|NCT01928719|473574328|FG001|Overall Study|Adverse Event|0|||
131532488|NCT04579757|473574331|FG000|Overall Study|Adverse Event|0|||
131532489|NCT04579757|473574332|FG001|Overall Study|Adverse Event|0|||
131532490|NCT04579757|473574333|FG002|Overall Study|Adverse Event|0|||
131532491|NCT04579757|473574334|FG003|Overall Study|Adverse Event|2|||
131532492|NCT04579757|473574335|FG004|Overall Study|Adverse Event|1|||
131532493|NCT04579757|473574336|FG005|Overall Study|Adverse Event|1|||
131532494|NCT04579757|473574337|FG006|Overall Study|Adverse Event|0|||
131532495|NCT04579757|473574338|FG007|Overall Study|Adverse Event|0|||
131532496|NCT04579757|473574339|FG008|Overall Study|Adverse Event|0|||
131532497|NCT04579757|473574331|FG000|Overall Study|Death|4|||
131532498|NCT04579757|473574332|FG001|Overall Study|Death|1|||
131532499|NCT04579757|473574333|FG002|Overall Study|Death|14|||
131532500|NCT04579757|473574334|FG003|Overall Study|Death|3|||
131532501|NCT04579757|473574335|FG004|Overall Study|Death|2|||
131532502|NCT04579757|473574336|FG005|Overall Study|Death|7|||
131532503|NCT04579757|473574337|FG006|Overall Study|Death|0|||
131532504|NCT04579757|473574338|FG007|Overall Study|Death|1|||
131532505|NCT04579757|473574339|FG008|Overall Study|Death|3|||
131532506|NCT04579757|473574331|FG000|Overall Study|Physician Decision|0|||
131532507|NCT04579757|473574332|FG001|Overall Study|Physician Decision|0|||
131532508|NCT04579757|473574333|FG002|Overall Study|Physician Decision|0|||
131532509|NCT04579757|473574334|FG003|Overall Study|Physician Decision|2|||
131532510|NCT04579757|473574335|FG004|Overall Study|Physician Decision|1|||
131532511|NCT04579757|473574336|FG005|Overall Study|Physician Decision|1|||
131532512|NCT04579757|473574337|FG006|Overall Study|Physician Decision|1|||
131532513|NCT04579757|473574338|FG007|Overall Study|Physician Decision|0|||
131532514|NCT04579757|473574339|FG008|Overall Study|Physician Decision|0|||
131532515|NCT04579757|473574331|FG000|Overall Study|Study Terminated By Sponsor|0|||
131532516|NCT04579757|473574332|FG001|Overall Study|Study Terminated By Sponsor|0|||
131532517|NCT04579757|473574333|FG002|Overall Study|Study Terminated By Sponsor|0|||
131532518|NCT04579757|473574334|FG003|Overall Study|Study Terminated By Sponsor|0|||
131532519|NCT04579757|473574335|FG004|Overall Study|Study Terminated By Sponsor|2|||
131532520|NCT04579757|473574336|FG005|Overall Study|Study Terminated By Sponsor|0|||
131532521|NCT04579757|473574337|FG006|Overall Study|Study Terminated By Sponsor|0|||
131532522|NCT04579757|473574338|FG007|Overall Study|Study Terminated By Sponsor|2|||
131532523|NCT04579757|473574339|FG008|Overall Study|Study Terminated By Sponsor|0|||
131532524|NCT04579757|473574331|FG000|Overall Study|Withdrawal by Subject|1|||
131532525|NCT04579757|473574332|FG001|Overall Study|Withdrawal by Subject|1|||
131532526|NCT04579757|473574333|FG002|Overall Study|Withdrawal by Subject|0|||
131532527|NCT04579757|473574334|FG003|Overall Study|Withdrawal by Subject|0|||
131532528|NCT04579757|473574335|FG004|Overall Study|Withdrawal by Subject|2|||
131532529|NCT04579757|473574336|FG005|Overall Study|Withdrawal by Subject|1|||
131532530|NCT04579757|473574337|FG006|Overall Study|Withdrawal by Subject|0|||
131532531|NCT04579757|473574338|FG007|Overall Study|Withdrawal by Subject|3|||
131532532|NCT04579757|473574339|FG008|Overall Study|Withdrawal by Subject|0|||
131532533|NCT04579757|473574331|FG000|Overall Study|Radiological or Clinical PD|1|||
131532534|NCT04579757|473574332|FG001|Overall Study|Radiological or Clinical PD|4|||
131532535|NCT04579757|473574333|FG002|Overall Study|Radiological or Clinical PD|1|||
131532536|NCT04579757|473574334|FG003|Overall Study|Radiological or Clinical PD|3|||
131532537|NCT04579757|473574335|FG004|Overall Study|Radiological or Clinical PD|9|||
131532538|NCT04579757|473574336|FG005|Overall Study|Radiological or Clinical PD|4|||
131532539|NCT04579757|473574337|FG006|Overall Study|Radiological or Clinical PD|2|||
131532540|NCT04579757|473574338|FG007|Overall Study|Radiological or Clinical PD|2|||
131532541|NCT04579757|473574339|FG008|Overall Study|Radiological or Clinical PD|0|||
131532542|NCT04579757|473574331|FG000|Overall Study|Start of New Therapy|0|||
131532543|NCT04579757|473574332|FG001|Overall Study|Start of New Therapy|0|||
131532544|NCT04579757|473574333|FG002|Overall Study|Start of New Therapy|0|||
131532545|NCT04579757|473574334|FG003|Overall Study|Start of New Therapy|0|||
131532546|NCT04579757|473574335|FG004|Overall Study|Start of New Therapy|2|||
131532547|NCT04579757|473574336|FG005|Overall Study|Start of New Therapy|1|||
131532548|NCT04579757|473574337|FG006|Overall Study|Start of New Therapy|0|||
131532549|NCT04579757|473574338|FG007|Overall Study|Start of New Therapy|0|||
131532550|NCT04579757|473574339|FG008|Overall Study|Start of New Therapy|0|||
131532551|NCT02332720|473574340|FG000|Part A and Part B|Lost to Follow-up|1|||
131532552|NCT02332720|473574341|FG001|Part A and Part B|Lost to Follow-up|0|||
131532553|NCT02332720|473574342|FG002|Part A and Part B|Lost to Follow-up|0|||
131532554|NCT02332720|473574343|FG003|Part A and Part B|Lost to Follow-up|0|||
131532555|NCT02332720|473574344|FG004|Part A and Part B|Lost to Follow-up|0|||
131532556|NCT02332720|473574345|FG005|Part A and Part B|Lost to Follow-up|2|||
131532557|NCT02332720|473574346|FG006|Part A and Part B|Lost to Follow-up|1|||
131532558|NCT02332720|473574347|FG007|Part A and Part B|Lost to Follow-up|1|||
131532559|NCT02332720|473574348|FG008|Part A and Part B|Lost to Follow-up|0|||
131532560|NCT02332720|473574349|FG009|Part A and Part B|Lost to Follow-up|0|||
131532561|NCT02332720|473574350|FG010|Part A and Part B|Lost to Follow-up|0|||
131532562|NCT02332720|473574351|FG011|Part A and Part B|Lost to Follow-up|0|||
131532563|NCT02332720|473574352|FG012|Part A and Part B|Lost to Follow-up|0|||
131532564|NCT02332720|473574353|FG013|Part A and Part B|Lost to Follow-up|0|||
131532565|NCT02332720|473574354|FG014|Part A and Part B|Lost to Follow-up|0|||
131532566|NCT02332720|473574355|FG015|Part A and Part B|Lost to Follow-up|1|||
131532567|NCT02332720|473574356|FG016|Part A and Part B|Lost to Follow-up|0|||
131532568|NCT02332720|473574357|FG017|Part A and Part B|Lost to Follow-up|0|||
131532569|NCT02332720|473574358|FG018|Part A and Part B|Lost to Follow-up|0|||
131532570|NCT02332720|473574359|FG019|Part A and Part B|Lost to Follow-up|0|||
131532571|NCT02332720|473574360|FG020|Part A and Part B|Lost to Follow-up|0|||
131532572|NCT02332720|473574361|FG021|Part A and Part B|Lost to Follow-up|0|||
131532573|NCT02332720|473574362|FG022|Part A and Part B|Lost to Follow-up|0|||
131532574|NCT02332720|473574340|FG000|Part A and Part B|Adverse Event|0|||
131532575|NCT02332720|473574341|FG001|Part A and Part B|Adverse Event|0|||
131532576|NCT02332720|473574342|FG002|Part A and Part B|Adverse Event|0|||
131532577|NCT02332720|473574343|FG003|Part A and Part B|Adverse Event|0|||
131532578|NCT02332720|473574344|FG004|Part A and Part B|Adverse Event|0|||
131532579|NCT02332720|473574345|FG005|Part A and Part B|Adverse Event|0|||
131532580|NCT02332720|473574346|FG006|Part A and Part B|Adverse Event|0|||
131532581|NCT02332720|473574347|FG007|Part A and Part B|Adverse Event|0|||
131532582|NCT02332720|473574348|FG008|Part A and Part B|Adverse Event|0|||
131532583|NCT02332720|473574349|FG009|Part A and Part B|Adverse Event|0|||
131532584|NCT02332720|473574350|FG010|Part A and Part B|Adverse Event|0|||
131532585|NCT02332720|473574351|FG011|Part A and Part B|Adverse Event|0|||
131532586|NCT02332720|473574352|FG012|Part A and Part B|Adverse Event|0|||
131532587|NCT02332720|473574353|FG013|Part A and Part B|Adverse Event|0|||
131532588|NCT02332720|473574354|FG014|Part A and Part B|Adverse Event|0|||
131532589|NCT02332720|473574355|FG015|Part A and Part B|Adverse Event|0|||
131532590|NCT02332720|473574356|FG016|Part A and Part B|Adverse Event|0|||
131532591|NCT02332720|473574357|FG017|Part A and Part B|Adverse Event|1|||
131532592|NCT02332720|473574358|FG018|Part A and Part B|Adverse Event|0|||
131532593|NCT02332720|473574359|FG019|Part A and Part B|Adverse Event|0|||
131532594|NCT02332720|473574360|FG020|Part A and Part B|Adverse Event|0|||
131532595|NCT02332720|473574361|FG021|Part A and Part B|Adverse Event|0|||
131532596|NCT02332720|473574362|FG022|Part A and Part B|Adverse Event|0|||
131532597|NCT02332720|473574340|FG000|Part A and Part B|Physician Decision|0|||
131532598|NCT02332720|473574341|FG001|Part A and Part B|Physician Decision|0|||
131532599|NCT02332720|473574342|FG002|Part A and Part B|Physician Decision|0|||
131532600|NCT02332720|473574343|FG003|Part A and Part B|Physician Decision|0|||
131532601|NCT02332720|473574344|FG004|Part A and Part B|Physician Decision|0|||
131532602|NCT02332720|473574345|FG005|Part A and Part B|Physician Decision|0|||
131532603|NCT02332720|473574346|FG006|Part A and Part B|Physician Decision|0|||
131532604|NCT02332720|473574347|FG007|Part A and Part B|Physician Decision|0|||
131532605|NCT02332720|473574348|FG008|Part A and Part B|Physician Decision|0|||
131532606|NCT02332720|473574349|FG009|Part A and Part B|Physician Decision|0|||
131532607|NCT02332720|473574350|FG010|Part A and Part B|Physician Decision|0|||
131532608|NCT02332720|473574351|FG011|Part A and Part B|Physician Decision|0|||
131532609|NCT02332720|473574352|FG012|Part A and Part B|Physician Decision|0|||
131532610|NCT02332720|473574353|FG013|Part A and Part B|Physician Decision|0|||
131532611|NCT02332720|473574354|FG014|Part A and Part B|Physician Decision|0|||
131532612|NCT02332720|473574355|FG015|Part A and Part B|Physician Decision|0|||
131532613|NCT02332720|473574356|FG016|Part A and Part B|Physician Decision|0|||
131532614|NCT02332720|473574357|FG017|Part A and Part B|Physician Decision|0|||
131532615|NCT02332720|473574358|FG018|Part A and Part B|Physician Decision|1|||
131532616|NCT02332720|473574359|FG019|Part A and Part B|Physician Decision|0|||
131532617|NCT02332720|473574360|FG020|Part A and Part B|Physician Decision|0|||
131532618|NCT02332720|473574361|FG021|Part A and Part B|Physician Decision|0|||
131532619|NCT02332720|473574362|FG022|Part A and Part B|Physician Decision|0|||
131532620|NCT02332720|473574340|FG000|Part A and Part B|Withdrawal by Subject|0|||
131532621|NCT02332720|473574341|FG001|Part A and Part B|Withdrawal by Subject|0|||
131532622|NCT02332720|473574342|FG002|Part A and Part B|Withdrawal by Subject|0|||
131532623|NCT02332720|473574343|FG003|Part A and Part B|Withdrawal by Subject|0|||
131532624|NCT02332720|473574344|FG004|Part A and Part B|Withdrawal by Subject|0|||
131532625|NCT02332720|473574345|FG005|Part A and Part B|Withdrawal by Subject|1|||
131532626|NCT02332720|473574346|FG006|Part A and Part B|Withdrawal by Subject|0|||
131532627|NCT02332720|473574347|FG007|Part A and Part B|Withdrawal by Subject|0|||
131532628|NCT02332720|473574348|FG008|Part A and Part B|Withdrawal by Subject|0|||
131532629|NCT02332720|473574349|FG009|Part A and Part B|Withdrawal by Subject|0|||
131532630|NCT02332720|473574350|FG010|Part A and Part B|Withdrawal by Subject|0|||
131532631|NCT02332720|473574351|FG011|Part A and Part B|Withdrawal by Subject|0|||
131532632|NCT02332720|473574352|FG012|Part A and Part B|Withdrawal by Subject|0|||
131532633|NCT02332720|473574353|FG013|Part A and Part B|Withdrawal by Subject|0|||
131532634|NCT02332720|473574354|FG014|Part A and Part B|Withdrawal by Subject|0|||
131532635|NCT02332720|473574355|FG015|Part A and Part B|Withdrawal by Subject|0|||
131532636|NCT02332720|473574356|FG016|Part A and Part B|Withdrawal by Subject|0|||
131532637|NCT02332720|473574357|FG017|Part A and Part B|Withdrawal by Subject|0|||
131532638|NCT02332720|473574358|FG018|Part A and Part B|Withdrawal by Subject|0|||
131532639|NCT02332720|473574359|FG019|Part A and Part B|Withdrawal by Subject|1|||
131532640|NCT02332720|473574360|FG020|Part A and Part B|Withdrawal by Subject|0|||
131532641|NCT02332720|473574361|FG021|Part A and Part B|Withdrawal by Subject|0|||
131532642|NCT02332720|473574362|FG022|Part A and Part B|Withdrawal by Subject|0|||
131532643|NCT00384085|473574363|FG000|Overall Study|Adverse Event|5|||
131532644|NCT00384085|473574364|FG001|Overall Study|Adverse Event|5|||
131532645|NCT00384085|473574365|FG002|Overall Study|Adverse Event|4|||
131532646|NCT00384085|473574363|FG000|Overall Study|Lack of Efficacy|0|||
131532647|NCT00384085|473574364|FG001|Overall Study|Lack of Efficacy|3|||
131532648|NCT00384085|473574365|FG002|Overall Study|Lack of Efficacy|2|||
131532649|NCT00384085|473574363|FG000|Overall Study|No longer Requires Study Treatment|1|||
131532650|NCT00384085|473574364|FG001|Overall Study|No longer Requires Study Treatment|0|||
131532651|NCT00384085|473574365|FG002|Overall Study|No longer Requires Study Treatment|1|||
131532652|NCT00384085|473574363|FG000|Overall Study|Protocol Violation|2|||
131532653|NCT00384085|473574364|FG001|Overall Study|Protocol Violation|2|||
131532654|NCT00384085|473574365|FG002|Overall Study|Protocol Violation|2|||
131532655|NCT00384085|473574363|FG000|Overall Study|Lost to Follow-up|9|||
131532656|NCT00384085|473574364|FG001|Overall Study|Lost to Follow-up|9|||
131532657|NCT00384085|473574365|FG002|Overall Study|Lost to Follow-up|10|||
131532658|NCT00384085|473574363|FG000|Overall Study|Progressive Disease|0|||
131532659|NCT00384085|473574364|FG001|Overall Study|Progressive Disease|1|||
131532660|NCT00384085|473574365|FG002|Overall Study|Progressive Disease|0|||
131532661|NCT00384085|473574363|FG000|Overall Study|Withdrawal by Subject|14|||
131532662|NCT00384085|473574364|FG001|Overall Study|Withdrawal by Subject|19|||
131532663|NCT00384085|473574365|FG002|Overall Study|Withdrawal by Subject|29|||
131532664|NCT00384085|473574363|FG000|Overall Study|Patient non-compliant|4|||
131532665|NCT00384085|473574364|FG001|Overall Study|Patient non-compliant|4|||
131532666|NCT00384085|473574365|FG002|Overall Study|Patient non-compliant|5|||
131532667|NCT00384085|473574363|FG000|Overall Study|Physician Decision|1|||
131532668|NCT00384085|473574364|FG001|Overall Study|Physician Decision|0|||
131532669|NCT00384085|473574365|FG002|Overall Study|Physician Decision|0|||
131532670|NCT00384085|473574363|FG000|Overall Study|Loss of site personnel|1|||
131532671|NCT00384085|473574364|FG001|Overall Study|Loss of site personnel|0|||
131532672|NCT00384085|473574365|FG002|Overall Study|Loss of site personnel|1|||
131532673|NCT00384085|473574363|FG000|Overall Study|Sponsor decision|1|||
131532674|NCT00384085|473574364|FG001|Overall Study|Sponsor decision|2|||
131532675|NCT00384085|473574365|FG002|Overall Study|Sponsor decision|1|||
131532676|NCT00384085|473574363|FG000|Overall Study|Patient moved|1|||
131532677|NCT00384085|473574364|FG001|Overall Study|Patient moved|0|||
131532678|NCT00384085|473574365|FG002|Overall Study|Patient moved|1|||
131532679|NCT00384085|473574363|FG000|Overall Study|Patient required surgery|0|||
131532680|NCT00384085|473574364|FG001|Overall Study|Patient required surgery|1|||
131532681|NCT00384085|473574365|FG002|Overall Study|Patient required surgery|0|||
131532682|NCT03725982|473574368|FG000|First Intervention|Withdrawal by Subject|0|||
131532683|NCT03725982|473574369|FG001|First Intervention|Withdrawal by Subject|1|||
131532684|NCT03725982|473574368|FG000|First Intervention|Physician Decision|1|||
131532685|NCT03725982|473574369|FG001|First Intervention|Physician Decision|1|||
131532686|NCT03832010|473574372|FG000|Overall Study|Withdrawal by Subject|2|||
131532687|NCT03832010|473574373|FG001|Overall Study|Withdrawal by Subject|1|||
131532688|NCT03832010|473574374|FG002|Overall Study|Withdrawal by Subject|0|||
131532689|NCT03832010|473574372|FG000|Overall Study|Lost to Follow-up|2|||
131532690|NCT03832010|473574373|FG001|Overall Study|Lost to Follow-up|1|||
131532691|NCT03832010|473574374|FG002|Overall Study|Lost to Follow-up|1|||
131532692|NCT00352365|473574375|FG000|Induction Therapy|Adverse Event|7|||
131532693|NCT00352365|473574375|FG000|Induction Therapy|Progression/Relapse|8|||
131532694|NCT00352365|473574375|FG000|Induction Therapy|Death|7|||
131532695|NCT00352365|473574375|FG000|Induction Therapy|Not protocol specified|1|||
131532696|NCT00352365|473574375|FG000|Induction Therapy|Not eligible|3|||
131532697|NCT00352365|473574375|FG000|Induction Therapy|Death before starting protocol therapy|1|||
131532698|NCT00352365|473574375|FG000|Maintenance Therapy|Progression/Relapse|3|||
131532699|NCT00352365|473574375|FG000|Maintenance Therapy|Death|2|||
131532700|NCT00352365|473574375|FG000|Maintenance Therapy|Not protocol specified|3|||
131532701|NCT00352365|473574375|FG000|Maintenance Therapy|Not eligible|4|||
131532702|NCT00987467|473574379|FG000|Overall Study|Lost to Follow-up|2|||
131532703|NCT00512135|473574380|FG000|Overall Study|Not Treated|5|||
131532704|NCT00512135|473574380|FG000|Overall Study|Lack of Efficacy|2|||
131532705|NCT00512135|473574380|FG000|Overall Study|Adverse Event|6|||
131532706|NCT00512135|473574380|FG000|Overall Study|Withdrawal by Subject|22|||
131532707|NCT00512135|473574380|FG000|Overall Study|Lost to Follow-up|27|||
131532708|NCT00512135|473574380|FG000|Overall Study|Other|22|||
131532709|NCT00377819|473574381|FG000|Overall Study|Adverse Event|2|||
131532710|NCT00377819|473574382|FG001|Overall Study|Adverse Event|3|||
131532711|NCT00377819|473574381|FG000|Overall Study|Withdrawal by Subject|10|||
131532712|NCT00377819|473574382|FG001|Overall Study|Withdrawal by Subject|4|||
131532713|NCT00377819|473574381|FG000|Overall Study|Death|0|||
131532714|NCT00377819|473574382|FG001|Overall Study|Death|1|||
131532715|NCT00377819|473574381|FG000|Overall Study|Lost to Follow-up|0|||
131532716|NCT00377819|473574382|FG001|Overall Study|Lost to Follow-up|1|||
131532717|NCT00377819|473574381|FG000|Overall Study|Protocol Violation|1|||
131532718|NCT00377819|473574382|FG001|Overall Study|Protocol Violation|1|||
131532719|NCT03727750|473574383|FG000|Overall Study|Death|45|||
131532720|NCT03727750|473574383|FG000|Overall Study|Withdrawal by Subject|2|||
131532721|NCT03727750|473574383|FG000|Overall Study|Lost to Follow-up|1|||
131532722|NCT03727750|473574383|FG000|Overall Study|Other|1|||
131532723|NCT02624804|473574384|FG000|Overall Study|Screen Failure|5|||
131532724|NCT03073603|473574388|FG000|Overall Study|Noncompliance|3|||
131532725|NCT03073603|473574389|FG001|Overall Study|Noncompliance|1|||
131532726|NCT03073603|473574388|FG000|Overall Study|Adverse Event|5|||
131532727|NCT03073603|473574389|FG001|Overall Study|Adverse Event|3|||
131532728|NCT03073603|473574388|FG000|Overall Study|Physician Decision|1|||
131532729|NCT03073603|473574389|FG001|Overall Study|Physician Decision|2|||
131532730|NCT03073603|473574388|FG000|Overall Study|Required treatment not allowed by protocol|1|||
131532731|NCT03073603|473574389|FG001|Overall Study|Required treatment not allowed by protocol|0|||
131532732|NCT03073603|473574388|FG000|Overall Study|Financial or insurance-related|8|||
131532733|NCT03073603|473574389|FG001|Overall Study|Financial or insurance-related|0|||
131532734|NCT03073603|473574388|FG000|Overall Study|Withdrawal by Subject|0|||
131532735|NCT03073603|473574389|FG001|Overall Study|Withdrawal by Subject|1|||
131532736|NCT03073603|473574388|FG000|Overall Study|Discontinued DMT|4|||
131532737|NCT03073603|473574389|FG001|Overall Study|Discontinued DMT|0|||
131532738|NCT03073603|473574388|FG000|Overall Study|Restarted DMT|0|||
131532739|NCT03073603|473574389|FG001|Overall Study|Restarted DMT|1|||
131532740|NCT01659021|473574390|FG000|Main Study|Adverse Event|2|||
131532741|NCT01659021|473574391|FG001|Main Study|Adverse Event|3|||
131532742|NCT01659021|473574390|FG000|Main Study|Lost to Follow-up|1|||
131532743|NCT01659021|473574391|FG001|Main Study|Lost to Follow-up|0|||
131532744|NCT01659021|473574390|FG000|Main Study|Unknown Reasons|2|||
131532745|NCT01659021|473574391|FG001|Main Study|Unknown Reasons|1|||
131532746|NCT01659021|473574390|FG000|Main Study|Physician Decision|34|||
131532747|NCT01659021|473574391|FG001|Main Study|Physician Decision|16|||
131532748|NCT01659021|473574390|FG000|Main Study|Withdrawal by Subject|19|||
131532749|NCT01659021|473574391|FG001|Main Study|Withdrawal by Subject|16|||
131532750|NCT01659021|473574390|FG000|Main Study|Study Terminated by Sponsor|16|||
131532751|NCT01659021|473574391|FG001|Main Study|Study Terminated by Sponsor|1|||
131532752|NCT01659021|473574390|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
131532753|NCT01659021|473574391|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
131532754|NCT01659021|473574390|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
131532755|NCT01659021|473574391|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
131532756|NCT03058679|473574397|FG000|Baseline to Week 6|Lost to Follow-up|3|||
131532757|NCT03058679|473574398|FG001|Baseline to Week 6|Lost to Follow-up|2|||
131532758|NCT03058679|473574397|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
131532759|NCT03058679|473574398|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
131532760|NCT03058679|473574397|FG000|Baseline to Week 6|Adverse Event|6|||
131532761|NCT03058679|473574398|FG001|Baseline to Week 6|Adverse Event|6|||
131532762|NCT03058679|473574397|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
131532763|NCT03058679|473574398|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
131658440|NCT00264303|474035312|FG000|Overall Study|Lack of Efficacy|10|||
131532764|NCT03058679|473574397|FG000|Baseline to Week 6|Difficulty following the diet|0|||
131532765|NCT03058679|473574398|FG001|Baseline to Week 6|Difficulty following the diet|2|||
131532766|NCT03058679|473574397|FG000|Baseline to Week 6|Physician Decision|1|||
131532767|NCT03058679|473574398|FG001|Baseline to Week 6|Physician Decision|0|||
131532768|NCT03058679|473574397|FG000|Week 6 to Week 12|Change in medication|5|||
131532769|NCT03058679|473574398|FG001|Week 6 to Week 12|Change in medication|7|||
131532770|NCT03058679|473574397|FG000|Week 6 to Week 12|Adverse Event|4|||
131532771|NCT03058679|473574398|FG001|Week 6 to Week 12|Adverse Event|3|||
131532772|NCT03058679|473574397|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
131532773|NCT03058679|473574398|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
131532774|NCT03058679|473574397|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
131532775|NCT03058679|473574398|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
131532776|NCT00574080|473574399|FG000|Overall Study|Death|10|||
131532777|NCT00574080|473574400|FG001|Overall Study|Death|10|||
131532778|NCT00599326|473574401|FG000|Overall Study|Lost to Follow-up|1|||
131532779|NCT00599326|473574401|FG000|Overall Study|Noncompliant|1|||
131532780|NCT00784810|473574404|FG000|Overall Study|Adverse Event|32|||
131532781|NCT00784810|473574405|FG001|Overall Study|Adverse Event|20|||
131532782|NCT00784810|473574404|FG000|Overall Study|Lack of Efficacy|14|||
131532783|NCT00784810|473574405|FG001|Overall Study|Lack of Efficacy|11|||
131532784|NCT00784810|473574404|FG000|Overall Study|Withdrawal by Subject|11|||
131532785|NCT00784810|473574405|FG001|Overall Study|Withdrawal by Subject|9|||
131532786|NCT00784810|473574404|FG000|Overall Study|Administrative|5|||
131532787|NCT00784810|473574405|FG001|Overall Study|Administrative|8|||
131532788|NCT00784810|473574404|FG000|Overall Study|Lost to Follow-up|1|||
131532789|NCT00784810|473574405|FG001|Overall Study|Lost to Follow-up|1|||
131532790|NCT02862106|473574406|FG000|Overall Study|Adverse Event|4|||
131532791|NCT02862106|473574407|FG001|Overall Study|Adverse Event|0|||
131532792|NCT02862106|473574406|FG000|Overall Study|Protocol Violation|16|||
131532793|NCT02862106|473574407|FG001|Overall Study|Protocol Violation|1|||
131532794|NCT02862106|473574406|FG000|Overall Study|Lost to Follow-up|15|||
131532795|NCT02862106|473574407|FG001|Overall Study|Lost to Follow-up|5|||
131532796|NCT02862106|473574406|FG000|Overall Study|Withdrawal by Subject|2|||
131532797|NCT02862106|473574407|FG001|Overall Study|Withdrawal by Subject|0|||
131532798|NCT02862106|473574406|FG000|Overall Study|Subjects moved to other city|1|||
131532799|NCT02862106|473574407|FG001|Overall Study|Subjects moved to other city|0|||
131532800|NCT00563784|473574410|FG000|Overall Study|Withdrawal by Subject|2|||
131532801|NCT00563784|473574410|FG000|Overall Study|Screen Failures|20|||
131532802|NCT04360824|473574411|FG000|Overall Study|Withdrawal by Subject|2|||
131532803|NCT04360824|473574412|FG001|Overall Study|Withdrawal by Subject|1|||
131532804|NCT04360824|473574411|FG000|Overall Study|Did not receive assigned treatment|1|||
131532805|NCT04360824|473574412|FG001|Overall Study|Did not receive assigned treatment|3|||
131532806|NCT00320216|473574413|FG000|Overall Study|Adverse Event|0|||
131532807|NCT00320216|473574414|FG001|Overall Study|Adverse Event|6|||
131532808|NCT00320216|473574415|FG002|Overall Study|Adverse Event|0|||
131532809|NCT00320216|473574416|FG003|Overall Study|Adverse Event|2|||
131532810|NCT00320216|473574417|FG004|Overall Study|Adverse Event|2|||
131532811|NCT00320216|473574413|FG000|Overall Study|Lack of Efficacy|6|||
131532812|NCT00320216|473574414|FG001|Overall Study|Lack of Efficacy|2|||
131532813|NCT00320216|473574415|FG002|Overall Study|Lack of Efficacy|1|||
131532814|NCT00320216|473574416|FG003|Overall Study|Lack of Efficacy|0|||
131532815|NCT00320216|473574417|FG004|Overall Study|Lack of Efficacy|1|||
131532816|NCT00320216|473574413|FG000|Overall Study|Lost to Follow-up|3|||
131532817|NCT00320216|473574414|FG001|Overall Study|Lost to Follow-up|0|||
131532818|NCT00320216|473574415|FG002|Overall Study|Lost to Follow-up|0|||
131532819|NCT00320216|473574416|FG003|Overall Study|Lost to Follow-up|0|||
131532820|NCT00320216|473574417|FG004|Overall Study|Lost to Follow-up|0|||
131532821|NCT00320216|473574413|FG000|Overall Study|Other|7|||
131532822|NCT00320216|473574414|FG001|Overall Study|Other|2|||
131532823|NCT00320216|473574415|FG002|Overall Study|Other|5|||
131532824|NCT00320216|473574416|FG003|Overall Study|Other|1|||
131532825|NCT00320216|473574417|FG004|Overall Study|Other|3|||
131532826|NCT00377676|473574418|FG000|Overall Study|Adverse Event|498|||
131532827|NCT00377676|473574419|FG001|Overall Study|Adverse Event|107|||
131532828|NCT00377676|473574418|FG000|Overall Study|Protocol Violation|33|||
131532829|NCT00377676|473574419|FG001|Overall Study|Protocol Violation|27|||
131532830|NCT00377676|473574418|FG000|Overall Study|Death|5|||
131532831|NCT00377676|473574419|FG001|Overall Study|Death|2|||
131532832|NCT00377676|473574418|FG000|Overall Study|Withdrawal by Subject|187|||
131532833|NCT00377676|473574419|FG001|Overall Study|Withdrawal by Subject|72|||
131532834|NCT00377676|473574418|FG000|Overall Study|Lost to Follow-up|120|||
131532835|NCT00377676|473574419|FG001|Overall Study|Lost to Follow-up|56|||
131532836|NCT00377676|473574418|FG000|Overall Study|Other|118|||
131532837|NCT00377676|473574419|FG001|Overall Study|Other|58|||
131532838|NCT01380327|473574424|FG000|Overall Study|Lost to Follow-up|0|||
131532839|NCT01380327|473574425|FG001|Overall Study|Lost to Follow-up|1|||
131532840|NCT01380327|473574426|FG002|Overall Study|Lost to Follow-up|1|||
131532841|NCT01380327|473574424|FG000|Overall Study|Protocol Violation|3|||
131532842|NCT01380327|473574425|FG001|Overall Study|Protocol Violation|2|||
131532843|NCT01380327|473574426|FG002|Overall Study|Protocol Violation|3|||
131532844|NCT01380327|473574424|FG000|Overall Study|Withdrawal by Subject|0|||
131532845|NCT01380327|473574425|FG001|Overall Study|Withdrawal by Subject|0|||
131532846|NCT01380327|473574426|FG002|Overall Study|Withdrawal by Subject|1|||
131532847|NCT01380327|473574424|FG000|Overall Study|Housing situation precluded ability to k|0|||
131532848|NCT01380327|473574425|FG001|Overall Study|Housing situation precluded ability to k|0|||
131532849|NCT01380327|473574426|FG002|Overall Study|Housing situation precluded ability to k|1|||
131532850|NCT01380327|473574424|FG000|Overall Study|Questionable onset of epilepsy|0|||
131532851|NCT01380327|473574425|FG001|Overall Study|Questionable onset of epilepsy|0|||
131532852|NCT01380327|473574426|FG002|Overall Study|Questionable onset of epilepsy|1|||
131532853|NCT03646513|473574430|FG000|Overall Study|Premature study termination|4|||
131532854|NCT03359096|473574431|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
131532855|NCT03359096|473574432|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
131532856|NCT03359096|473574431|FG000|First Intervention (4 Weeks)|Death|1|||
131532857|NCT03359096|473574432|FG001|First Intervention (4 Weeks)|Death|0|||
131532858|NCT03359096|473574431|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
131532859|NCT03359096|473574432|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
131532860|NCT03585244|473574437|FG000|Overall Study|Withdrawal by Subject|15|||
131532861|NCT03538626|473574440|FG000|Overall Study|Withdrawal by Subject|0|||
131532862|NCT03538626|473574441|FG001|Overall Study|Withdrawal by Subject|1|||
131532863|NCT03538626|473574442|FG002|Overall Study|Withdrawal by Subject|0|||
131532864|NCT03538626|473574443|FG003|Overall Study|Withdrawal by Subject|0|||
131532865|NCT03538626|473574444|FG004|Overall Study|Withdrawal by Subject|0|||
131532866|NCT03538626|473574445|FG005|Overall Study|Withdrawal by Subject|0|||
131532867|NCT03538626|473574446|FG006|Overall Study|Withdrawal by Subject|0|||
131532868|NCT03538626|473574447|FG007|Overall Study|Withdrawal by Subject|0|||
131532869|NCT03538626|473574440|FG000|Overall Study|Lost to Follow-up|0|||
131532870|NCT03538626|473574441|FG001|Overall Study|Lost to Follow-up|0|||
131532871|NCT03538626|473574442|FG002|Overall Study|Lost to Follow-up|0|||
131532872|NCT03538626|473574443|FG003|Overall Study|Lost to Follow-up|0|||
131532873|NCT03538626|473574444|FG004|Overall Study|Lost to Follow-up|0|||
131532874|NCT03538626|473574445|FG005|Overall Study|Lost to Follow-up|0|||
131532875|NCT03538626|473574446|FG006|Overall Study|Lost to Follow-up|1|||
131532876|NCT03538626|473574447|FG007|Overall Study|Lost to Follow-up|0|||
131532877|NCT01764945|473574452|FG000|Overall Study|Adverse Event|0|||
131532878|NCT01764945|473574453|FG001|Overall Study|Adverse Event|1|||
131532879|NCT01764945|473574454|FG002|Overall Study|Adverse Event|0|||
131532880|NCT01764945|473574455|FG003|Overall Study|Adverse Event|0|||
131532881|NCT01764945|473574456|FG004|Overall Study|Adverse Event|0|||
131532882|NCT01764945|473574457|FG005|Overall Study|Adverse Event|0|||
131532883|NCT01764945|473574458|FG006|Overall Study|Adverse Event|1|||
131532884|NCT01764945|473574459|FG007|Overall Study|Adverse Event|0|||
131532885|NCT05077267|473574460|FG000|Treatment Period|Lost to Follow-up|0|||
131532886|NCT05077267|473574461|FG001|Treatment Period|Lost to Follow-up|1|||
131532887|NCT05077267|473574462|FG002|Treatment Period|Lost to Follow-up|0|||
131532888|NCT05077267|473574460|FG000|Treatment Period|Withdrawal by Subject|0|||
131532889|NCT05077267|473574461|FG001|Treatment Period|Withdrawal by Subject|1|||
131532890|NCT05077267|473574462|FG002|Treatment Period|Withdrawal by Subject|0|||
131532891|NCT05077267|473574460|FG000|Follow-up Period|Lost to Follow-up|0|||
131532892|NCT05077267|473574461|FG001|Follow-up Period|Lost to Follow-up|5|||
131532893|NCT05077267|473574462|FG002|Follow-up Period|Lost to Follow-up|7|||
131532894|NCT05077267|473574460|FG000|Follow-up Period|Withdrawal by Subject|0|||
131532895|NCT05077267|473574461|FG001|Follow-up Period|Withdrawal by Subject|2|||
131532896|NCT05077267|473574462|FG002|Follow-up Period|Withdrawal by Subject|5|||
131532897|NCT05077267|473574460|FG000|Follow-up Period|Study terminated by sponsor|0|||
131532898|NCT05077267|473574461|FG001|Follow-up Period|Study terminated by sponsor|27|||
131532899|NCT05077267|473574462|FG002|Follow-up Period|Study terminated by sponsor|23|||
131532900|NCT05077267|473574460|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
131532901|NCT05077267|473574461|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
131532902|NCT05077267|473574462|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
131532903|NCT05077267|473574460|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
131532904|NCT05077267|473574461|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
131532905|NCT05077267|473574462|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
131532906|NCT01587651|473574463|FG000|Overall Study|Adverse Event|0|||
131532907|NCT01587651|473574464|FG001|Overall Study|Adverse Event|1|||
131532908|NCT01587651|473574465|FG002|Overall Study|Adverse Event|0|||
131532909|NCT01587651|473574463|FG000|Overall Study|Protocol Violation|0|||
131532910|NCT01587651|473574464|FG001|Overall Study|Protocol Violation|1|||
131532911|NCT01587651|473574465|FG002|Overall Study|Protocol Violation|1|||
131532912|NCT01587651|473574463|FG000|Overall Study|Withdrawal by Subject|0|||
131532913|NCT01587651|473574464|FG001|Overall Study|Withdrawal by Subject|1|||
131532914|NCT01587651|473574465|FG002|Overall Study|Withdrawal by Subject|0|||
131532915|NCT03325712|473574466|FG000|Overall Study|Protocol Violation|0|||
131532916|NCT03325712|473574467|FG001|Overall Study|Protocol Violation|0|||
131532917|NCT03325712|473574468|FG002|Overall Study|Protocol Violation|0|||
131532918|NCT03325712|473574469|FG003|Overall Study|Protocol Violation|0|||
131532919|NCT03325712|473574470|FG004|Overall Study|Protocol Violation|1|||
131532920|NCT03325712|473574471|FG005|Overall Study|Protocol Violation|0|||
131532921|NCT03325712|473574472|FG006|Overall Study|Protocol Violation|0|||
131532922|NCT03325712|473574473|FG007|Overall Study|Protocol Violation|0|||
131532923|NCT03325712|473574466|FG000|Overall Study|Adverse Event|0|||
131532924|NCT03325712|473574467|FG001|Overall Study|Adverse Event|0|||
131532925|NCT03325712|473574468|FG002|Overall Study|Adverse Event|0|||
131532926|NCT03325712|473574469|FG003|Overall Study|Adverse Event|0|||
131532927|NCT03325712|473574470|FG004|Overall Study|Adverse Event|1|||
131532928|NCT03325712|473574471|FG005|Overall Study|Adverse Event|0|||
131532929|NCT03325712|473574472|FG006|Overall Study|Adverse Event|0|||
131532930|NCT03325712|473574473|FG007|Overall Study|Adverse Event|0|||
131532931|NCT03550313|473574474|FG000|Overall Study|Adverse Event|0|||
131532932|NCT03550313|473574475|FG001|Overall Study|Adverse Event|1|||
131532933|NCT03550313|473574476|FG002|Overall Study|Adverse Event|0|||
131532934|NCT03550313|473574474|FG000|Overall Study|Lost to Follow-up|5|||
131532935|NCT03550313|473574475|FG001|Overall Study|Lost to Follow-up|7|||
131532936|NCT03550313|473574476|FG002|Overall Study|Lost to Follow-up|12|||
131532937|NCT03550313|473574474|FG000|Overall Study|Study terminated by sponsor|44|||
131532938|NCT03550313|473574475|FG001|Overall Study|Study terminated by sponsor|37|||
131532939|NCT03550313|473574476|FG002|Overall Study|Study terminated by sponsor|48|||
131532940|NCT03550313|473574474|FG000|Overall Study|No longer met eligibility criteria|3|||
131532941|NCT03550313|473574475|FG001|Overall Study|No longer met eligibility criteria|5|||
131532942|NCT03550313|473574476|FG002|Overall Study|No longer met eligibility criteria|6|||
131532943|NCT03550313|473574474|FG000|Overall Study|Withdrawal by parent/guardian|20|||
131532944|NCT03550313|473574475|FG001|Overall Study|Withdrawal by parent/guardian|18|||
131532945|NCT03550313|473574476|FG002|Overall Study|Withdrawal by parent/guardian|26|||
131532946|NCT03550313|473574474|FG000|Overall Study|Other|4|||
131532947|NCT03550313|473574475|FG001|Overall Study|Other|2|||
131532948|NCT03550313|473574476|FG002|Overall Study|Other|2|||
131532949|NCT03550313|473574474|FG000|Overall Study|Randomized but not vaccinated|3|||
131532950|NCT03550313|473574475|FG001|Overall Study|Randomized but not vaccinated|23|||
131532951|NCT03550313|473574476|FG002|Overall Study|Randomized but not vaccinated|2|||
131532952|NCT03550313|473574474|FG000|Overall Study|Sites terminated due to quality issues|18|||
131532953|NCT03550313|473574475|FG001|Overall Study|Sites terminated due to quality issues|17|||
131532954|NCT03550313|473574476|FG002|Overall Study|Sites terminated due to quality issues|18|||
131532955|NCT00380068|473574478|FG000|Overall Study|Adverse Event|40|||
131532956|NCT00380068|473574478|FG000|Overall Study|Withdrawal by Subject|10|||
131532957|NCT00380068|473574478|FG000|Overall Study|Not compliant|6|||
131532958|NCT00380068|473574478|FG000|Overall Study|Lost to Follow-up|1|||
131532959|NCT00380068|473574478|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
131532960|NCT00380068|473574478|FG000|Overall Study|Lung transplant|3|||
131532961|NCT00380068|473574478|FG000|Overall Study|Physician Decision|2|||
131532962|NCT00380068|473574478|FG000|Overall Study|Partipant moved away|1|||
131532963|NCT00380068|473574478|FG000|Overall Study|Lack of Efficacy|5|||
131532964|NCT01297062|473574479|FG000|Overall Study|Adverse Event|2|||
131532965|NCT01297062|473574480|FG001|Overall Study|Adverse Event|0|||
131532966|NCT01297062|473574481|FG002|Overall Study|Adverse Event|1|||
131532967|NCT01297062|473574482|FG003|Overall Study|Adverse Event|0|||
131532968|NCT01297062|473574483|FG004|Overall Study|Adverse Event|0|||
131532969|NCT01297062|473574484|FG005|Overall Study|Adverse Event|0|||
131532970|NCT01297062|473574485|FG006|Overall Study|Adverse Event|0|||
131532971|NCT01297062|473574479|FG000|Overall Study|Physician Decision|1|||
131532972|NCT01297062|473574480|FG001|Overall Study|Physician Decision|0|||
131532973|NCT01297062|473574481|FG002|Overall Study|Physician Decision|1|||
131532974|NCT01297062|473574482|FG003|Overall Study|Physician Decision|0|||
131532975|NCT01297062|473574483|FG004|Overall Study|Physician Decision|0|||
131532976|NCT01297062|473574484|FG005|Overall Study|Physician Decision|0|||
131532977|NCT01297062|473574485|FG006|Overall Study|Physician Decision|6|||
131532978|NCT01297062|473574479|FG000|Overall Study|Protocol Violation|0|||
131532979|NCT01297062|473574480|FG001|Overall Study|Protocol Violation|0|||
131532980|NCT01297062|473574481|FG002|Overall Study|Protocol Violation|0|||
131532981|NCT01297062|473574482|FG003|Overall Study|Protocol Violation|0|||
131532982|NCT01297062|473574483|FG004|Overall Study|Protocol Violation|1|||
131532983|NCT01297062|473574484|FG005|Overall Study|Protocol Violation|0|||
131532984|NCT01297062|473574485|FG006|Overall Study|Protocol Violation|0|||
131532985|NCT01297062|473574479|FG000|Overall Study|Subject Decision|1|||
131532986|NCT01297062|473574480|FG001|Overall Study|Subject Decision|1|||
131532987|NCT01297062|473574481|FG002|Overall Study|Subject Decision|0|||
131532988|NCT01297062|473574482|FG003|Overall Study|Subject Decision|1|||
131532989|NCT01297062|473574483|FG004|Overall Study|Subject Decision|1|||
131532990|NCT01297062|473574484|FG005|Overall Study|Subject Decision|1|||
131532991|NCT01297062|473574485|FG006|Overall Study|Subject Decision|2|||
131532992|NCT04964089|473574486|FG000|Overall Study|Adverse Event|8|||
131532993|NCT04964089|473574487|FG001|Overall Study|Adverse Event|6|||
131532994|NCT04964089|473574486|FG000|Overall Study|Non-compliance with study schedule|1|||
131532995|NCT04964089|473574487|FG001|Overall Study|Non-compliance with study schedule|0|||
131532996|NCT04964089|473574486|FG000|Overall Study|Withdrawal by Subject|6|||
131532997|NCT04964089|473574487|FG001|Overall Study|Withdrawal by Subject|5|||
131532998|NCT04964089|473574486|FG000|Overall Study|Lost to Follow-up|1|||
131532999|NCT04964089|473574487|FG001|Overall Study|Lost to Follow-up|1|||
131533000|NCT04964089|473574486|FG000|Overall Study|Progressive disease|4|||
131533001|NCT04964089|473574487|FG001|Overall Study|Progressive disease|0|||
131533002|NCT04964089|473574486|FG000|Overall Study|Physician Decision|1|||
131533003|NCT04964089|473574487|FG001|Overall Study|Physician Decision|0|||
131533004|NCT04964089|473574486|FG000|Overall Study|Participant did not want to continue study treatment|1|||
131533005|NCT04964089|473574487|FG001|Overall Study|Participant did not want to continue study treatment|0|||
131533006|NCT04964089|473574486|FG000|Overall Study|Participant moved to different state|1|||
131533007|NCT04964089|473574487|FG001|Overall Study|Participant moved to different state|0|||
131533008|NCT04964089|473574486|FG000|Overall Study|Participant decided to discontinue|0|||
131533009|NCT04964089|473574487|FG001|Overall Study|Participant decided to discontinue|1|||
131533010|NCT01165281|473574493|FG000|Overall Study|Adverse Event|12|||
131533011|NCT01165281|473574494|FG001|Overall Study|Adverse Event|14|||
131533012|NCT01165281|473574493|FG000|Overall Study|Death|3|||
131533013|NCT01165281|473574494|FG001|Overall Study|Death|4|||
131533014|NCT01165281|473574493|FG000|Overall Study|Lack of Efficacy|4|||
131533015|NCT01165281|473574494|FG001|Overall Study|Lack of Efficacy|1|||
131533016|NCT01165281|473574493|FG000|Overall Study|Lost to Follow-up|0|||
131533017|NCT01165281|473574494|FG001|Overall Study|Lost to Follow-up|1|||
131533018|NCT01165281|473574493|FG000|Overall Study|Physician Decision|8|||
131533019|NCT01165281|473574494|FG001|Overall Study|Physician Decision|1|||
131533020|NCT01165281|473574493|FG000|Overall Study|Protocol Violation|6|||
131533021|NCT01165281|473574494|FG001|Overall Study|Protocol Violation|5|||
131533022|NCT01165281|473574493|FG000|Overall Study|Withdrawal by Subject|8|||
131533023|NCT01165281|473574494|FG001|Overall Study|Withdrawal by Subject|7|||
131533024|NCT01165281|473574493|FG000|Overall Study|Noncompliance with Study Drug|1|||
131533025|NCT01165281|473574494|FG001|Overall Study|Noncompliance with Study Drug|4|||
131533026|NCT01165281|473574493|FG000|Overall Study|Progressive Disease|10|||
131533027|NCT01165281|473574494|FG001|Overall Study|Progressive Disease|14|||
131533028|NCT01165281|473574493|FG000|Overall Study|Other|6|||
131533029|NCT01165281|473574494|FG001|Overall Study|Other|0|||
131533030|NCT00363766|473574499|FG000|Overall Study|Progressive Disease|15|||
131533031|NCT00363766|473574500|FG001|Overall Study|Progressive Disease|9|||
131533032|NCT00363766|473574499|FG000|Overall Study|Adverse Event|10|||
131533033|NCT00363766|473574500|FG001|Overall Study|Adverse Event|2|||
131533034|NCT00363766|473574499|FG000|Overall Study|Disease Related Death|1|||
131533035|NCT00363766|473574500|FG001|Overall Study|Disease Related Death|3|||
131533036|NCT00363766|473574499|FG000|Overall Study|Not Disease Related Death|3|||
131533037|NCT00363766|473574500|FG001|Overall Study|Not Disease Related Death|4|||
131533038|NCT00363766|473574499|FG000|Overall Study|Withdrawal by Subject|2|||
131533039|NCT00363766|473574500|FG001|Overall Study|Withdrawal by Subject|0|||
131533040|NCT00363766|473574499|FG000|Overall Study|Physician Decision|1|||
131533041|NCT00363766|473574500|FG001|Overall Study|Physician Decision|2|||
131533042|NCT02005471|473574501|FG000|Main Study|Adverse Event|0|||
131533043|NCT02005471|473574502|FG001|Main Study|Adverse Event|1|||
131533044|NCT02005471|473574503|FG002|Main Study|Adverse Event|0|||
131533045|NCT02005471|473574504|FG003|Main Study|Adverse Event|0|||
131533046|NCT02005471|473574501|FG000|Main Study|Death|83|||
131533047|NCT02005471|473574502|FG001|Main Study|Death|52|||
131533048|NCT02005471|473574503|FG002|Main Study|Death|0|||
131533049|NCT02005471|473574504|FG003|Main Study|Death|0|||
131533050|NCT02005471|473574501|FG000|Main Study|Lost to Follow-up|4|||
131533051|NCT02005471|473574502|FG001|Main Study|Lost to Follow-up|5|||
131533052|NCT02005471|473574503|FG002|Main Study|Lost to Follow-up|0|||
131533053|NCT02005471|473574504|FG003|Main Study|Lost to Follow-up|0|||
131533054|NCT02005471|473574501|FG000|Main Study|Physician Decision|3|||
131533055|NCT02005471|473574502|FG001|Main Study|Physician Decision|1|||
131533056|NCT02005471|473574503|FG002|Main Study|Physician Decision|0|||
131533057|NCT02005471|473574504|FG003|Main Study|Physician Decision|0|||
131533058|NCT02005471|473574501|FG000|Main Study|Withdrawal by Subject|26|||
131533059|NCT02005471|473574502|FG001|Main Study|Withdrawal by Subject|11|||
131533060|NCT02005471|473574503|FG002|Main Study|Withdrawal by Subject|0|||
131533061|NCT02005471|473574504|FG003|Main Study|Withdrawal by Subject|0|||
131533062|NCT02005471|473574501|FG000|Main Study|Reason not Specified|0|||
131533063|NCT02005471|473574502|FG001|Main Study|Reason not Specified|6|||
131533064|NCT02005471|473574503|FG002|Main Study|Reason not Specified|0|||
131533065|NCT02005471|473574504|FG003|Main Study|Reason not Specified|0|||
131533066|NCT02005471|473574501|FG000|Main Study|Randomized but not Dosed|8|||
131533067|NCT02005471|473574502|FG001|Main Study|Randomized but not Dosed|0|||
131533068|NCT02005471|473574503|FG002|Main Study|Randomized but not Dosed|0|||
131533069|NCT02005471|473574504|FG003|Main Study|Randomized but not Dosed|0|||
131533070|NCT02005471|473574501|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
131533071|NCT02005471|473574502|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
131533072|NCT02005471|473574503|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
131533073|NCT02005471|473574504|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
131533074|NCT02005471|473574501|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
131533075|NCT02005471|473574502|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
131533076|NCT02005471|473574503|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
131533077|NCT02005471|473574504|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
131533078|NCT02005471|473574501|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
131533079|NCT02005471|473574502|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
131533080|NCT02005471|473574503|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
131533081|NCT02005471|473574504|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
131533082|NCT00627705|473574505|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
131533083|NCT00627705|473574506|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
131533084|NCT00627705|473574505|FG000|Overall Study|Adverse Event|1|||
131533085|NCT00627705|473574506|FG001|Overall Study|Adverse Event|0|||
131533086|NCT00627705|473574505|FG000|Overall Study|Withdrawal by Subject|0|||
131533087|NCT00627705|473574506|FG001|Overall Study|Withdrawal by Subject|2|||
131533088|NCT00627705|473574505|FG000|Overall Study|Lost to Follow-up|0|||
131533089|NCT00627705|473574506|FG001|Overall Study|Lost to Follow-up|1|||
131533090|NCT01218438|473574515|FG000|Epoch 1|Physician Decision|2|||
131533091|NCT01218438|473574515|FG000|Epoch 1|Adverse Event|1|||
131533092|NCT01218438|473574515|FG000|Epoch 3|Withdrawal by Subject|3|||
131533093|NCT01218438|473574515|FG000|Epoch 3|Adverse Event|1|||
131533094|NCT01218438|473574515|FG000|Epoch 4|Physician Decision|1|||
131533095|NCT01218438|473574515|FG000|Epoch 4|Withdrawal by Subject|2|||
131533096|NCT03662750|473574516|FG000|Overall Study|Withdrawal by Subject|1|||
131533097|NCT04295564|473576663|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
131533098|NCT04295564|473576664|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
131533099|NCT01682460|473576665|FG000|Overall Study|Withdrawal by Subject|2|||
131533100|NCT01682460|473576665|FG000|Overall Study|Did not meet inclusion criteria|2|||
131533101|NCT02105116|473576666|FG000|Overall Study|not eligible for step 2 of trial|5|||
131533102|NCT02105116|473576666|FG000|Overall Study|Death|1|||
131533103|NCT00773968|473576667|FG000|Overall Study|Adverse Event|2|||
131533104|NCT00773968|473576667|FG000|Overall Study|Death|1|||
131533105|NCT00773968|473576667|FG000|Overall Study|Failure to Return|2|||
131533106|NCT00773968|473576667|FG000|Overall Study|Lack of Efficacy|3|||
131533107|NCT00773968|473576667|FG000|Overall Study|Protocol Violation|1|||
131533108|NCT00773968|473576667|FG000|Overall Study|Withdrawal by Subject|11|||
131533109|NCT00773968|473576667|FG000|Overall Study|Screen Failure|17|||
131533110|NCT00773968|473576667|FG000|Overall Study|Other|8|||
131533111|NCT00263666|473576668|FG000|Overall Study|Adverse Event|6|||
131533112|NCT00263666|473576669|FG001|Overall Study|Adverse Event|8|||
131533113|NCT00263666|473576668|FG000|Overall Study|Lost to Follow-up|1|||
131533114|NCT00263666|473576669|FG001|Overall Study|Lost to Follow-up|2|||
131533115|NCT00263666|473576668|FG000|Overall Study|Withdrawal by Subject|0|||
131533116|NCT00263666|473576669|FG001|Overall Study|Withdrawal by Subject|1|||
131533117|NCT02492100|473576670|FG000|Overall Study|Death|1|||
131533118|NCT04743908|473576671|FG000|Overall Study|Death|1|||
131533119|NCT04743908|473576672|FG001|Overall Study|Death|0|||
131533120|NCT04743908|473576671|FG000|Overall Study|Lost to Follow-up|181|||
131533121|NCT04743908|473576672|FG001|Overall Study|Lost to Follow-up|180|||
131533122|NCT04743908|473576671|FG000|Overall Study|Withdrawal by Subject|1|||
131533123|NCT04743908|473576672|FG001|Overall Study|Withdrawal by Subject|2|||
131533124|NCT00328510|473576673|FG000|Overall Study|Gag disorder, could not use frame|4|||
131533125|NCT00328510|473576674|FG001|Overall Study|Gag disorder, could not use frame|0|||
131533126|NCT00328510|473576673|FG000|Overall Study|Dentition problems, could not use frame|1|||
131533127|NCT00328510|473576674|FG001|Overall Study|Dentition problems, could not use frame|0|||
131533128|NCT00328510|473576673|FG000|Overall Study|Withdrawal by Subject|4|||
131533129|NCT00328510|473576674|FG001|Overall Study|Withdrawal by Subject|2|||
131533130|NCT00328510|473576673|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
131533131|NCT00328510|473576674|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
131533132|NCT00328510|473576673|FG000|Overall Study|Treatment changed to a single fraction|1|||
131533133|NCT00328510|473576674|FG001|Overall Study|Treatment changed to a single fraction|1|||
131533134|NCT03240588|473576678|FG000|Overall Study|Death|3|||
131533135|NCT03240588|473576679|FG001|Overall Study|Death|0|||
131533136|NCT03240588|473576680|FG002|Overall Study|Death|0|||
131533137|NCT03240588|473576678|FG000|Overall Study|Adverse Event|5|||
131533138|NCT03240588|473576679|FG001|Overall Study|Adverse Event|4|||
131533139|NCT03240588|473576680|FG002|Overall Study|Adverse Event|0|||
131533140|NCT03240588|473576678|FG000|Overall Study|Lost to Follow-up|9|||
131533141|NCT03240588|473576679|FG001|Overall Study|Lost to Follow-up|4|||
131533142|NCT03240588|473576680|FG002|Overall Study|Lost to Follow-up|0|||
131533143|NCT03240588|473576678|FG000|Overall Study|Physician Decision|3|||
131533144|NCT03240588|473576679|FG001|Overall Study|Physician Decision|2|||
131533145|NCT03240588|473576680|FG002|Overall Study|Physician Decision|0|||
131533146|NCT03240588|473576678|FG000|Overall Study|Did not meet eligibility criteria|0|||
131533147|NCT03240588|473576679|FG001|Overall Study|Did not meet eligibility criteria|6|||
131533148|NCT03240588|473576680|FG002|Overall Study|Did not meet eligibility criteria|0|||
131533149|NCT03240588|473576678|FG000|Overall Study|No longer meets protocol criteria|12|||
131533150|NCT03240588|473576679|FG001|Overall Study|No longer meets protocol criteria|7|||
131533151|NCT03240588|473576680|FG002|Overall Study|No longer meets protocol criteria|0|||
131533152|NCT03240588|473576678|FG000|Overall Study|Withdrawal by Subject|60|||
131533153|NCT03240588|473576679|FG001|Overall Study|Withdrawal by Subject|52|||
131533154|NCT03240588|473576680|FG002|Overall Study|Withdrawal by Subject|7|||
131533155|NCT03240588|473576678|FG000|Overall Study|Other, additional details not available.|0|||
131533156|NCT03240588|473576679|FG001|Overall Study|Other, additional details not available.|12|||
131533157|NCT03240588|473576680|FG002|Overall Study|Other, additional details not available.|1|||
131533158|NCT03240588|473576678|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
131533159|NCT03240588|473576679|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
131533160|NCT03240588|473576680|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
131533161|NCT03240588|473576678|FG000|Overall Study|Closure of study|55|||
131533162|NCT03240588|473576679|FG001|Overall Study|Closure of study|3|||
131533163|NCT03240588|473576680|FG002|Overall Study|Closure of study|0|||
131533164|NCT03240588|473576678|FG000|Overall Study|Subject non-compliance|23|||
131533165|NCT03240588|473576679|FG001|Overall Study|Subject non-compliance|2|||
131533166|NCT03240588|473576680|FG002|Overall Study|Subject non-compliance|1|||
131533167|NCT03240588|473576678|FG000|Overall Study|Device Deficiency|1|||
131533168|NCT03240588|473576679|FG001|Overall Study|Device Deficiency|0|||
131533169|NCT03240588|473576680|FG002|Overall Study|Device Deficiency|0|||
131533170|NCT03240588|473576678|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
131533171|NCT03240588|473576679|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
131533172|NCT03240588|473576680|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
131533173|NCT03422250|473576681|FG000|Intervention|Adverse Event|0|||
131533174|NCT03422250|473576682|FG001|Intervention|Adverse Event|1|||
131533175|NCT03422250|473576683|FG002|Intervention|Adverse Event|0|||
131533176|NCT03422250|473576684|FG003|Intervention|Adverse Event|1|||
131533177|NCT03422250|473576681|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
131533178|NCT03422250|473576682|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
131533179|NCT03422250|473576683|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
131533180|NCT03422250|473576684|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
131533181|NCT03422250|473576681|FG000|Follow-up|Withdrawal by Subject|0|||
131533182|NCT03422250|473576682|FG001|Follow-up|Withdrawal by Subject|0|||
131533183|NCT03422250|473576683|FG002|Follow-up|Withdrawal by Subject|0|||
131533184|NCT03422250|473576684|FG003|Follow-up|Withdrawal by Subject|1|||
131533185|NCT03422250|473576681|FG000|Follow-up|Adverse Event|0|||
131533186|NCT03422250|473576682|FG001|Follow-up|Adverse Event|0|||
131533187|NCT03422250|473576683|FG002|Follow-up|Adverse Event|0|||
131533188|NCT03422250|473576684|FG003|Follow-up|Adverse Event|1|||
131533189|NCT02091726|473576687|FG000|Overall Study|Lost to Follow-up|6|||
131533190|NCT00467870|473576688|FG000|Overall Study|Adverse Event|13|||
131533191|NCT00467870|473576689|FG001|Overall Study|Adverse Event|9|||
131533192|NCT00467870|473576690|FG002|Overall Study|Adverse Event|1|||
131533193|NCT00467870|473576691|FG003|Overall Study|Adverse Event|15|||
131533194|NCT00467870|473576692|FG004|Overall Study|Adverse Event|15|||
131533195|NCT00467870|473576693|FG005|Overall Study|Adverse Event|1|||
131533196|NCT00467870|473576688|FG000|Overall Study|Protocol Violation|2|||
131533197|NCT00467870|473576689|FG001|Overall Study|Protocol Violation|1|||
131533198|NCT00467870|473576690|FG002|Overall Study|Protocol Violation|1|||
131533199|NCT00467870|473576691|FG003|Overall Study|Protocol Violation|2|||
131533200|NCT00467870|473576692|FG004|Overall Study|Protocol Violation|0|||
131533201|NCT00467870|473576693|FG005|Overall Study|Protocol Violation|0|||
131533202|NCT00467870|473576688|FG000|Overall Study|Withdrawal by Subject|14|||
131533203|NCT00467870|473576689|FG001|Overall Study|Withdrawal by Subject|21|||
131533204|NCT00467870|473576690|FG002|Overall Study|Withdrawal by Subject|0|||
131533205|NCT00467870|473576691|FG003|Overall Study|Withdrawal by Subject|9|||
131533206|NCT00467870|473576692|FG004|Overall Study|Withdrawal by Subject|10|||
131533207|NCT00467870|473576693|FG005|Overall Study|Withdrawal by Subject|1|||
131533208|NCT00467870|473576688|FG000|Overall Study|Lost to Follow-up|5|||
131533209|NCT00467870|473576689|FG001|Overall Study|Lost to Follow-up|3|||
131533210|NCT00467870|473576690|FG002|Overall Study|Lost to Follow-up|1|||
131533211|NCT00467870|473576691|FG003|Overall Study|Lost to Follow-up|1|||
131533212|NCT00467870|473576692|FG004|Overall Study|Lost to Follow-up|3|||
131533213|NCT00467870|473576693|FG005|Overall Study|Lost to Follow-up|0|||
131533214|NCT00467870|473576688|FG000|Overall Study|Subject Non-compliance|3|||
131533215|NCT00467870|473576689|FG001|Overall Study|Subject Non-compliance|4|||
131533216|NCT00467870|473576690|FG002|Overall Study|Subject Non-compliance|0|||
131533217|NCT00467870|473576691|FG003|Overall Study|Subject Non-compliance|1|||
131533218|NCT00467870|473576692|FG004|Overall Study|Subject Non-compliance|5|||
131533219|NCT00467870|473576693|FG005|Overall Study|Subject Non-compliance|0|||
131533220|NCT00467870|473576688|FG000|Overall Study|Other/Unknown|8|||
131533221|NCT00467870|473576689|FG001|Overall Study|Other/Unknown|5|||
131533222|NCT00467870|473576690|FG002|Overall Study|Other/Unknown|1|||
131533223|NCT00467870|473576691|FG003|Overall Study|Other/Unknown|5|||
131533224|NCT00467870|473576692|FG004|Overall Study|Other/Unknown|4|||
131533225|NCT00467870|473576693|FG005|Overall Study|Other/Unknown|0|||
131533226|NCT00321919|473576694|FG000|Overall Study|Adverse Event|17|||
131533227|NCT00321919|473576695|FG001|Overall Study|Adverse Event|10|||
131533228|NCT00321919|473576694|FG000|Overall Study|Death|21|||
131533229|NCT00321919|473576695|FG001|Overall Study|Death|17|||
131533230|NCT00321919|473576694|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131533231|NCT00321919|473576695|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131533232|NCT00321919|473576694|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131533233|NCT00321919|473576695|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131533234|NCT00321919|473576694|FG000|Overall Study|Refused Treatment|23|||
131533235|NCT00321919|473576695|FG001|Overall Study|Refused Treatment|14|||
131533236|NCT00321919|473576694|FG000|Overall Study|Other Protocol Violation|2|||
131533237|NCT00321919|473576695|FG001|Overall Study|Other Protocol Violation|3|||
131533238|NCT00321919|473576694|FG000|Overall Study|Failure to Return|3|||
131533239|NCT00321919|473576695|FG001|Overall Study|Failure to Return|1|||
131533240|NCT00321919|473576694|FG000|Overall Study|Other withdrawal reason|7|||
131533241|NCT00321919|473576695|FG001|Overall Study|Other withdrawal reason|6|||
131533242|NCT04757649|473576699|FG000|Overall Study|Withdrawal by Subject|1|||
131533243|NCT04757649|473576699|FG000|Overall Study|Adverse Event|1|||
131533244|NCT01286779|473576700|FG000|Overall Study|Withdrawal by Subject|9|||
131533245|NCT01286779|473576700|FG000|Overall Study|Protocol Violation|5|||
131533246|NCT01286779|473576700|FG000|Overall Study|Physician Decision|2|||
131533247|NCT01286779|473576700|FG000|Overall Study|Participant had scheduled surgery|1|||
131533248|NCT01286779|473576700|FG000|Overall Study|Participant moved to another country|1|||
131533249|NCT01286779|473576700|FG000|Overall Study|Discontinued by sponsor|1|||
131533250|NCT02896855|473576705|FG000|Overall Study|Death|50|||
131533251|NCT02896855|473576706|FG001|Overall Study|Death|40|||
131533252|NCT02896855|473576705|FG000|Overall Study|Lost to Follow-up|15|||
131533253|NCT02896855|473576706|FG001|Overall Study|Lost to Follow-up|9|||
131533254|NCT02896855|473576705|FG000|Overall Study|Withdrawal by Subject|7|||
131533255|NCT02896855|473576706|FG001|Overall Study|Withdrawal by Subject|4|||
131533256|NCT02508311|473576707|FG000|Overall Study|Withdrawal by Subject|1|||
131533257|NCT02508311|473576708|FG001|Overall Study|Withdrawal by Subject|0|||
131533258|NCT01205685|473576709|FG000|Overall Study|Disease Progression|10|||
131533259|NCT01205685|473576709|FG000|Overall Study|Withdrawal by Subject|1|||
131533260|NCT02169674|473576710|FG000|Overall Study|Withdrawal by Subject|2|||
131533261|NCT02169674|473576711|FG001|Overall Study|Withdrawal by Subject|1|||
131533262|NCT02169674|473576710|FG000|Overall Study|Seroprotected|30|||
131533263|NCT02169674|473576711|FG001|Overall Study|Seroprotected|76|||
131533264|NCT02169674|473576710|FG000|Overall Study|Lost to Follow-up|0|||
131533265|NCT02169674|473576711|FG001|Overall Study|Lost to Follow-up|1|||
131533266|NCT00304070|473576712|FG000|Overall Study|Death|0|||
131533267|NCT00304070|473576713|FG001|Overall Study|Death|0|||
131533268|NCT00304070|473576714|FG002|Overall Study|Death|3|||
131533269|NCT00304070|473576712|FG000|Overall Study|Lost to Follow-up|0|||
131533270|NCT00304070|473576713|FG001|Overall Study|Lost to Follow-up|0|||
131533271|NCT00304070|473576714|FG002|Overall Study|Lost to Follow-up|1|||
131533272|NCT00304070|473576712|FG000|Overall Study|Physician Decision|0|||
131533273|NCT00304070|473576713|FG001|Overall Study|Physician Decision|0|||
131533274|NCT00304070|473576714|FG002|Overall Study|Physician Decision|3|||
131533275|NCT00304070|473576712|FG000|Overall Study|Withdrawal by Subject|0|||
131533276|NCT00304070|473576713|FG001|Overall Study|Withdrawal by Subject|0|||
131533277|NCT00304070|473576714|FG002|Overall Study|Withdrawal by Subject|1|||
131533278|NCT00304070|473576712|FG000|Overall Study|Progressive Disease|3|||
131533279|NCT00304070|473576713|FG001|Overall Study|Progressive Disease|7|||
131533280|NCT00304070|473576714|FG002|Overall Study|Progressive Disease|4|||
131533281|NCT02219932|473576720|FG000|Overall Study|Other|5|||
131533282|NCT02219932|473576721|FG001|Overall Study|Other|11|||
131533283|NCT02219932|473576720|FG000|Overall Study|Death|1|||
131533284|NCT02219932|473576721|FG001|Overall Study|Death|1|||
131533285|NCT02219932|473576720|FG000|Overall Study|Investigator Decision|0|||
131533286|NCT02219932|473576721|FG001|Overall Study|Investigator Decision|1|||
131533287|NCT02219932|473576720|FG000|Overall Study|Consent Withdrawn|11|||
131533288|NCT02219932|473576721|FG001|Overall Study|Consent Withdrawn|7|||
131533289|NCT02219932|473576720|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
131533290|NCT02219932|473576721|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
131533291|NCT02219932|473576720|FG000|Overall Study|Protocol Violation|10|||
131533292|NCT02219932|473576721|FG001|Overall Study|Protocol Violation|6|||
131533293|NCT02219932|473576720|FG000|Overall Study|Pregnancy|1|||
131533294|NCT02219932|473576721|FG001|Overall Study|Pregnancy|0|||
131533295|NCT02219932|473576720|FG000|Overall Study|Lost to Follow-up|4|||
131533296|NCT02219932|473576721|FG001|Overall Study|Lost to Follow-up|2|||
131533297|NCT02219932|473576720|FG000|Overall Study|Adverse Event|23|||
131533298|NCT02219932|473576721|FG001|Overall Study|Adverse Event|21|||
131533299|NCT00093145|473576722|FG000|Overall Study|Unacceptable Toxicity Only|2|||
131533300|NCT00093145|473576722|FG000|Overall Study|Physician Decision|5|||
131533301|NCT00093145|473576722|FG000|Overall Study|Withdrawal by Subject|9|||
131533302|NCT00093145|473576722|FG000|Overall Study|Other|1|||
131533303|NCT04389840|473576723|FG000|Overall Study|Adverse Event|0|||
131533304|NCT04389840|473576724|FG001|Overall Study|Adverse Event|0|||
131533305|NCT04389840|473576725|FG002|Overall Study|Adverse Event|0|||
131533306|NCT04389840|473576726|FG003|Overall Study|Adverse Event|1|||
131533307|NCT04389840|473576727|FG004|Overall Study|Adverse Event|0|||
131533308|NCT04389840|473576728|FG005|Overall Study|Adverse Event|0|||
131533309|NCT04389840|473576723|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
131533310|NCT04389840|473576724|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
131533311|NCT04389840|473576725|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
131533312|NCT04389840|473576726|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
131533313|NCT04389840|473576727|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
131533314|NCT04389840|473576728|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
131533315|NCT04389840|473576723|FG000|Overall Study|Death|0|||
131533316|NCT04389840|473576724|FG001|Overall Study|Death|1|||
131533317|NCT04389840|473576725|FG002|Overall Study|Death|0|||
131533318|NCT04389840|473576726|FG003|Overall Study|Death|0|||
131533319|NCT04389840|473576727|FG004|Overall Study|Death|0|||
131533320|NCT04389840|473576728|FG005|Overall Study|Death|0|||
131533321|NCT02365467|473576729|FG000|Overall Study|Death|3|||
131533322|NCT02043782|473576730|FG000|Period 1|Adverse Event|0|||
131533323|NCT02043782|473576731|FG001|Period 1|Adverse Event|0|||
131533324|NCT02043782|473576732|FG002|Period 1|Adverse Event|1|||
131533325|NCT02043782|473576733|FG003|Period 1|Adverse Event|0|||
131533326|NCT02043782|473576734|FG004|Period 1|Adverse Event|0|||
131533327|NCT02043782|473576735|FG005|Period 1|Adverse Event|0|||
131533328|NCT01306162|473576738|FG000|Period 1|Adverse Event|0|||
131533329|NCT01306162|473576739|FG001|Period 1|Adverse Event|0|||
131533330|NCT01306162|473576740|FG002|Period 1|Adverse Event|0|||
131533331|NCT01306162|473576741|FG003|Period 1|Adverse Event|1|||
131533332|NCT01306162|473576738|FG000|Washout 1|Non-compliance to protocol|0|||
131533333|NCT01306162|473576739|FG001|Washout 1|Non-compliance to protocol|1|||
131533334|NCT01306162|473576740|FG002|Washout 1|Non-compliance to protocol|0|||
131533335|NCT01306162|473576741|FG003|Washout 1|Non-compliance to protocol|0|||
131533360|NCT02252211|473576749|FG000|Overall Study|Adverse Event|0|||
131533361|NCT02252211|473576750|FG001|Overall Study|Adverse Event|1|||
131533362|NCT02252211|473576751|FG002|Overall Study|Adverse Event|0|||
131533363|NCT02252211|473576749|FG000|Overall Study|Progressive disease|3|||
131533364|NCT02252211|473576750|FG001|Overall Study|Progressive disease|2|||
131533365|NCT02252211|473576751|FG002|Overall Study|Progressive disease|0|||
131533366|NCT02252211|473576749|FG000|Overall Study|Withdrawal by Subject|1|||
131533367|NCT02252211|473576750|FG001|Overall Study|Withdrawal by Subject|0|||
131533368|NCT02252211|473576751|FG002|Overall Study|Withdrawal by Subject|0|||
131533369|NCT02252211|473576749|FG000|Overall Study|Serious Adverse Event During Screening|1|||
131533370|NCT02252211|473576750|FG001|Overall Study|Serious Adverse Event During Screening|0|||
131533371|NCT02252211|473576751|FG002|Overall Study|Serious Adverse Event During Screening|1|||
131533372|NCT00968669|473576752|FG000|Overall Study|Lost to Follow-up|5|||
131533373|NCT00968669|473576753|FG001|Overall Study|Lost to Follow-up|2|||
131533374|NCT00968669|473576754|FG002|Overall Study|Lost to Follow-up|1|||
131533375|NCT00968669|473576755|FG003|Overall Study|Lost to Follow-up|4|||
131533376|NCT00968669|473576752|FG000|Overall Study|Withdrawal by Subject|9|||
131533377|NCT00968669|473576753|FG001|Overall Study|Withdrawal by Subject|7|||
131533378|NCT00968669|473576754|FG002|Overall Study|Withdrawal by Subject|5|||
131533379|NCT00968669|473576755|FG003|Overall Study|Withdrawal by Subject|3|||
131533380|NCT00968669|473576752|FG000|Overall Study|Pregnancy|0|||
131533381|NCT00968669|473576753|FG001|Overall Study|Pregnancy|0|||
131533382|NCT00968669|473576754|FG002|Overall Study|Pregnancy|2|||
131533383|NCT00968669|473576755|FG003|Overall Study|Pregnancy|0|||
131533384|NCT00968669|473576752|FG000|Overall Study|AE|1|||
131533385|NCT00968669|473576753|FG001|Overall Study|AE|0|||
131533386|NCT00968669|473576754|FG002|Overall Study|AE|0|||
131533387|NCT00968669|473576755|FG003|Overall Study|AE|0|||
131533388|NCT00968669|473576752|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
131533389|NCT00968669|473576753|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
131533390|NCT00968669|473576754|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
131533391|NCT00968669|473576755|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
131533392|NCT00968669|473576752|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
131533393|NCT00968669|473576753|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
131533394|NCT00968669|473576754|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
131533395|NCT00968669|473576755|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
131533396|NCT00968669|473576752|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
131533397|NCT00968669|473576753|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
131533398|NCT00968669|473576754|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
131533399|NCT00968669|473576755|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
131533400|NCT00968669|473576752|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
131533401|NCT00968669|473576753|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
131533402|NCT00968669|473576754|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
131533403|NCT00968669|473576755|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
131533404|NCT00968669|473576752|FG000|Overall Study|EARLY WITHDRAWAL|0|||
131533405|NCT00968669|473576753|FG001|Overall Study|EARLY WITHDRAWAL|1|||
131533406|NCT00968669|473576754|FG002|Overall Study|EARLY WITHDRAWAL|0|||
131533407|NCT00968669|473576755|FG003|Overall Study|EARLY WITHDRAWAL|0|||
131533408|NCT00968669|473576752|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
131533409|NCT00968669|473576753|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
131533410|NCT00968669|473576754|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
131533411|NCT00968669|473576755|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
131533412|NCT00968669|473576752|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
131533413|NCT00968669|473576753|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
131533414|NCT00968669|473576754|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
131533415|NCT00968669|473576755|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
131533416|NCT00968669|473576752|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
131533417|NCT00968669|473576753|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
131533418|NCT00968669|473576754|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
131533419|NCT00968669|473576755|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
131533420|NCT00968669|473576752|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
131533421|NCT00968669|473576753|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
131533422|NCT00968669|473576754|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
131533423|NCT00968669|473576755|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
131533424|NCT00968669|473576752|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
131533425|NCT00968669|473576753|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
131533426|NCT00968669|473576754|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
131533427|NCT00968669|473576755|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
131533428|NCT00968669|473576752|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
131533429|NCT00968669|473576753|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
131533430|NCT00968669|473576754|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
131533431|NCT00968669|473576755|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
131533432|NCT00968669|473576752|FG000|Overall Study|SPONSOR DECISION|0|||
131533433|NCT00968669|473576753|FG001|Overall Study|SPONSOR DECISION|1|||
131533434|NCT00968669|473576754|FG002|Overall Study|SPONSOR DECISION|0|||
131533435|NCT00968669|473576755|FG003|Overall Study|SPONSOR DECISION|0|||
131533436|NCT00968669|473576752|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
131533437|NCT00968669|473576753|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
131533438|NCT00968669|473576754|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
131533439|NCT00968669|473576755|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
131533440|NCT00968669|473576752|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
131533441|NCT00968669|473576753|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
131533442|NCT00968669|473576754|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
131533443|NCT00968669|473576755|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
131533444|NCT00968669|473576752|FG000|Overall Study|SUBJECT INCARCERATED|0|||
131533445|NCT00968669|473576753|FG001|Overall Study|SUBJECT INCARCERATED|1|||
131533446|NCT00968669|473576754|FG002|Overall Study|SUBJECT INCARCERATED|0|||
131533447|NCT00968669|473576755|FG003|Overall Study|SUBJECT INCARCERATED|0|||
131533448|NCT00968669|473576752|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
131533449|NCT00968669|473576753|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
131533450|NCT00968669|473576754|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
131533451|NCT00968669|473576755|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
131658441|NCT00264303|474035313|FG001|Overall Study|Lack of Efficacy|13|||
131533452|NCT00968669|473576752|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
131533453|NCT00968669|473576753|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
131533454|NCT00968669|473576754|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
131533455|NCT00968669|473576755|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
131533456|NCT00833989|473576757|FG000|Overall Study|Physician Decision|0|||
131533457|NCT00833989|473576758|FG001|Overall Study|Physician Decision|0|||
131533458|NCT00833989|473576759|FG002|Overall Study|Physician Decision|0|||
131533459|NCT00833989|473576760|FG003|Overall Study|Physician Decision|1|||
131533460|NCT00833989|473576757|FG000|Overall Study|Withdrawal by Subject|3|||
131533461|NCT00833989|473576758|FG001|Overall Study|Withdrawal by Subject|0|||
131533462|NCT00833989|473576759|FG002|Overall Study|Withdrawal by Subject|1|||
131533463|NCT00833989|473576760|FG003|Overall Study|Withdrawal by Subject|1|||
131533464|NCT01949480|473576761|FG000|Overall Study|Physician Decision|5|||
131533465|NCT01949480|473576762|FG001|Overall Study|Physician Decision|8|||
131533466|NCT00144339|473576763|FG000|Overall Study|Adverse Event|746|||
131533467|NCT00144339|473576764|FG001|Overall Study|Adverse Event|627|||
131533468|NCT00144339|473576763|FG000|Overall Study|Protocol Violation|75|||
131533469|NCT00144339|473576764|FG001|Overall Study|Protocol Violation|48|||
131533470|NCT00144339|473576763|FG000|Overall Study|Withdrawal by Subject|403|||
131533471|NCT00144339|473576764|FG001|Overall Study|Withdrawal by Subject|300|||
131533472|NCT00144339|473576763|FG000|Overall Study|Lost to Follow-up|76|||
131533473|NCT00144339|473576764|FG001|Overall Study|Lost to Follow-up|64|||
131533474|NCT00144339|473576763|FG000|Overall Study|Other|58|||
131533475|NCT00144339|473576764|FG001|Overall Study|Other|60|||
131533476|NCT01109992|473576765|FG000|Overall Study|Withdrawal by Subject|0|||
131533477|NCT01109992|473576766|FG001|Overall Study|Withdrawal by Subject|1|||
131533478|NCT01109992|473576765|FG000|Overall Study|Movement during rest scan.|0|||
131533479|NCT01109992|473576766|FG001|Overall Study|Movement during rest scan.|1|||
131533480|NCT00690755|473576767|FG000|Overall Study|Physician Decision|2|||
131533481|NCT00690755|473576768|FG001|Overall Study|Physician Decision|0|||
131533482|NCT00690755|473576769|FG002|Overall Study|Physician Decision|46|||
131533483|NCT00690755|473576770|FG003|Overall Study|Physician Decision|5|||
131533484|NCT00690755|473576771|FG004|Overall Study|Physician Decision|0|||
131533485|NCT00690755|473576772|FG005|Overall Study|Physician Decision|4|||
131533486|NCT00690755|473576773|FG006|Overall Study|Physician Decision|0|||
131533487|NCT02952924|473576774|FG000|Overall Study|Protocol Violation|0|||
131533488|NCT02952924|473576775|FG001|Overall Study|Protocol Violation|0|||
131533489|NCT02952924|473576776|FG002|Overall Study|Protocol Violation|0|||
131533490|NCT02952924|473576777|FG003|Overall Study|Protocol Violation|0|||
131533491|NCT02952924|473576778|FG004|Overall Study|Protocol Violation|0|||
131533492|NCT02952924|473576779|FG005|Overall Study|Protocol Violation|0|||
131533493|NCT02952924|473576780|FG006|Overall Study|Protocol Violation|0|||
131533494|NCT02952924|473576781|FG007|Overall Study|Protocol Violation|0|||
131533495|NCT02952924|473576782|FG008|Overall Study|Protocol Violation|0|||
131533496|NCT02952924|473576783|FG009|Overall Study|Protocol Violation|0|||
131533497|NCT02952924|473576784|FG010|Overall Study|Protocol Violation|0|||
131533498|NCT02952924|473576785|FG011|Overall Study|Protocol Violation|0|||
131533499|NCT02952924|473576786|FG012|Overall Study|Protocol Violation|0|||
131533500|NCT02952924|473576787|FG013|Overall Study|Protocol Violation|0|||
131533501|NCT02952924|473576788|FG014|Overall Study|Protocol Violation|0|||
131533502|NCT02952924|473576789|FG015|Overall Study|Protocol Violation|0|||
131533503|NCT02952924|473576790|FG016|Overall Study|Protocol Violation|0|||
131533504|NCT02952924|473576791|FG017|Overall Study|Protocol Violation|0|||
131533505|NCT02952924|473576792|FG018|Overall Study|Protocol Violation|0|||
131533506|NCT02952924|473576793|FG019|Overall Study|Protocol Violation|1|||
131533507|NCT02952924|473576794|FG020|Overall Study|Protocol Violation|0|||
131533508|NCT02952924|473576795|FG021|Overall Study|Protocol Violation|0|||
131533509|NCT02952924|473576774|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
131533510|NCT02952924|473576775|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
131533511|NCT02952924|473576776|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
131533512|NCT02952924|473576777|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
131533513|NCT02952924|473576778|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
131533514|NCT02952924|473576779|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
131533515|NCT02952924|473576780|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
131533516|NCT02952924|473576781|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
131533517|NCT02952924|473576782|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
131533518|NCT02952924|473576783|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
131533519|NCT02952924|473576784|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
131533520|NCT02952924|473576785|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
131533521|NCT02952924|473576786|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
131533522|NCT02952924|473576787|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
131533523|NCT02952924|473576788|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
131533524|NCT02952924|473576789|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
131533525|NCT02952924|473576790|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
131533526|NCT02952924|473576791|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
131533527|NCT02952924|473576792|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
131533528|NCT02952924|473576793|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
131533529|NCT02952924|473576794|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
131533530|NCT02952924|473576795|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
131533531|NCT02952924|473576774|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533532|NCT02952924|473576775|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533533|NCT02952924|473576776|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533534|NCT02952924|473576777|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533535|NCT02952924|473576778|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533536|NCT02952924|473576779|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533537|NCT02952924|473576780|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533538|NCT02952924|473576781|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533539|NCT02952924|473576782|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533540|NCT02952924|473576783|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533541|NCT02952924|473576784|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533542|NCT02952924|473576785|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533543|NCT02952924|473576786|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533544|NCT02952924|473576787|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533545|NCT02952924|473576788|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533546|NCT02952924|473576789|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533547|NCT02952924|473576790|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533548|NCT02952924|473576791|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533549|NCT02952924|473576792|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533550|NCT02952924|473576793|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533551|NCT02952924|473576794|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
131533552|NCT02952924|473576795|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
131533553|NCT02952924|473576774|FG000|Overall Study|Noncompliance with study drug|0|||
131533554|NCT02952924|473576775|FG001|Overall Study|Noncompliance with study drug|0|||
131533555|NCT02952924|473576776|FG002|Overall Study|Noncompliance with study drug|0|||
131533556|NCT02952924|473576777|FG003|Overall Study|Noncompliance with study drug|0|||
131533557|NCT02952924|473576778|FG004|Overall Study|Noncompliance with study drug|0|||
131533558|NCT02952924|473576779|FG005|Overall Study|Noncompliance with study drug|0|||
131533559|NCT02952924|473576780|FG006|Overall Study|Noncompliance with study drug|0|||
131533560|NCT02952924|473576781|FG007|Overall Study|Noncompliance with study drug|0|||
131533561|NCT02952924|473576782|FG008|Overall Study|Noncompliance with study drug|0|||
131533562|NCT02952924|473576783|FG009|Overall Study|Noncompliance with study drug|0|||
131533563|NCT02952924|473576784|FG010|Overall Study|Noncompliance with study drug|0|||
131533564|NCT02952924|473576785|FG011|Overall Study|Noncompliance with study drug|0|||
131533565|NCT02952924|473576786|FG012|Overall Study|Noncompliance with study drug|0|||
131533566|NCT02952924|473576787|FG013|Overall Study|Noncompliance with study drug|0|||
131533567|NCT02952924|473576788|FG014|Overall Study|Noncompliance with study drug|0|||
131533568|NCT02952924|473576789|FG015|Overall Study|Noncompliance with study drug|0|||
131533569|NCT02952924|473576790|FG016|Overall Study|Noncompliance with study drug|0|||
131533570|NCT02952924|473576791|FG017|Overall Study|Noncompliance with study drug|0|||
131533571|NCT02952924|473576792|FG018|Overall Study|Noncompliance with study drug|0|||
131533572|NCT02952924|473576793|FG019|Overall Study|Noncompliance with study drug|0|||
131533573|NCT02952924|473576794|FG020|Overall Study|Noncompliance with study drug|0|||
131533574|NCT02952924|473576795|FG021|Overall Study|Noncompliance with study drug|1|||
131533575|NCT02105948|473576800|FG000|Overall Study|Adverse Event|10|||
131533576|NCT02105948|473576801|FG001|Overall Study|Adverse Event|7|||
131533577|NCT02105948|473576802|FG002|Overall Study|Adverse Event|11|||
131533578|NCT02105948|473576803|FG003|Overall Study|Adverse Event|11|||
131533579|NCT02105948|473576800|FG000|Overall Study|Lack of Efficacy|0|||
131533580|NCT02105948|473576801|FG001|Overall Study|Lack of Efficacy|1|||
131533581|NCT02105948|473576802|FG002|Overall Study|Lack of Efficacy|3|||
131533582|NCT02105948|473576803|FG003|Overall Study|Lack of Efficacy|2|||
131533583|NCT02105948|473576800|FG000|Overall Study|Lost to Follow-up|0|||
131533584|NCT02105948|473576801|FG001|Overall Study|Lost to Follow-up|0|||
131533585|NCT02105948|473576802|FG002|Overall Study|Lost to Follow-up|2|||
131533586|NCT02105948|473576803|FG003|Overall Study|Lost to Follow-up|1|||
131533587|NCT02105948|473576800|FG000|Overall Study|Physician Decision|2|||
131533588|NCT02105948|473576801|FG001|Overall Study|Physician Decision|2|||
131533589|NCT02105948|473576802|FG002|Overall Study|Physician Decision|2|||
131533590|NCT02105948|473576803|FG003|Overall Study|Physician Decision|2|||
131533591|NCT02105948|473576800|FG000|Overall Study|Withdrawal by Subject|15|||
131533592|NCT02105948|473576801|FG001|Overall Study|Withdrawal by Subject|10|||
131533593|NCT02105948|473576802|FG002|Overall Study|Withdrawal by Subject|10|||
131533594|NCT02105948|473576803|FG003|Overall Study|Withdrawal by Subject|11|||
131533595|NCT01934218|473576805|FG000|Double-blind Phase|Adverse Event|8|||
131533596|NCT01934218|473576806|FG001|Double-blind Phase|Adverse Event|8|||
131533597|NCT01934218|473576805|FG000|Double-blind Phase|Lack of Efficacy|6|||
131533598|NCT01934218|473576806|FG001|Double-blind Phase|Lack of Efficacy|7|||
131533599|NCT01934218|473576805|FG000|Double-blind Phase|Lost to Follow-up|7|||
131533600|NCT01934218|473576806|FG001|Double-blind Phase|Lost to Follow-up|14|||
131533601|NCT01934218|473576805|FG000|Double-blind Phase|Physician Decision|1|||
131533602|NCT01934218|473576806|FG001|Double-blind Phase|Physician Decision|2|||
131533603|NCT01934218|473576805|FG000|Double-blind Phase|Protocol Violation|4|||
131533604|NCT01934218|473576806|FG001|Double-blind Phase|Protocol Violation|0|||
131533605|NCT01934218|473576805|FG000|Double-blind Phase|Withdrawal by Subject|16|||
131533606|NCT01934218|473576806|FG001|Double-blind Phase|Withdrawal by Subject|13|||
131533607|NCT01934218|473576805|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
131533608|NCT01934218|473576806|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
131533609|NCT01934218|473576805|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
131533610|NCT01934218|473576806|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
131533611|NCT01934218|473576805|FG000|Open-Label Phase|Adverse Event|2|||
131533612|NCT01934218|473576806|FG001|Open-Label Phase|Adverse Event|4|||
131533613|NCT01934218|473576805|FG000|Open-Label Phase|Lack of Efficacy|1|||
131533614|NCT01934218|473576806|FG001|Open-Label Phase|Lack of Efficacy|4|||
131533615|NCT01934218|473576805|FG000|Open-Label Phase|Lost to Follow-up|4|||
131533616|NCT01934218|473576806|FG001|Open-Label Phase|Lost to Follow-up|2|||
131533617|NCT01934218|473576805|FG000|Open-Label Phase|Physician Decision|1|||
131533618|NCT01934218|473576806|FG001|Open-Label Phase|Physician Decision|0|||
131533619|NCT01934218|473576805|FG000|Open-Label Phase|Protocol Violation|1|||
131533620|NCT01934218|473576806|FG001|Open-Label Phase|Protocol Violation|0|||
131533621|NCT01934218|473576805|FG000|Open-Label Phase|Withdrawal by Subject|13|||
131533622|NCT01934218|473576806|FG001|Open-Label Phase|Withdrawal by Subject|11|||
131533623|NCT01934218|473576805|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
131533624|NCT01934218|473576806|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
131533625|NCT01934218|473576805|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
131533626|NCT01934218|473576806|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
131533627|NCT02232893|473576807|FG000|Overall Study|Withdrawal by Subject|4|||
131533628|NCT02232893|473576808|FG001|Overall Study|Withdrawal by Subject|1|||
131533629|NCT02232893|473576807|FG000|Overall Study|Adverse Event|0|||
131533630|NCT02232893|473576808|FG001|Overall Study|Adverse Event|1|||
131533631|NCT02232893|473576807|FG000|Overall Study|Sponsor request early termination|0|||
131533632|NCT02232893|473576808|FG001|Overall Study|Sponsor request early termination|1|||
131533633|NCT02232893|473576807|FG000|Overall Study|Developed exclusion criteria|0|||
131533634|NCT02232893|473576808|FG001|Overall Study|Developed exclusion criteria|1|||
131533635|NCT02232893|473576807|FG000|Overall Study|Other|0|||
131533636|NCT02232893|473576808|FG001|Overall Study|Other|3|||
131533637|NCT03867734|473576812|FG000|Overall Study|Lost to Follow-up|2|||
131533638|NCT01660763|473576818|FG000|Overall Study|Lack of Efficacy|45|||
131533639|NCT01660763|473576819|FG001|Overall Study|Lack of Efficacy|50|||
131533640|NCT01660763|473576818|FG000|Overall Study|Adverse Event|22|||
131533641|NCT01660763|473576819|FG001|Overall Study|Adverse Event|7|||
131533642|NCT01660763|473576818|FG000|Overall Study|Protocol Violation|1|||
131533643|NCT01660763|473576819|FG001|Overall Study|Protocol Violation|0|||
131533644|NCT01660763|473576818|FG000|Overall Study|Withdrawal by Subject|4|||
131533645|NCT01660763|473576819|FG001|Overall Study|Withdrawal by Subject|0|||
131533646|NCT01660763|473576818|FG000|Overall Study|Patient ready for early discharge|28|||
131533647|NCT01660763|473576819|FG001|Overall Study|Patient ready for early discharge|4|||
131533648|NCT02265237|473576821|FG000|As Treated (Overall Study)|Adverse Event|1|||
131533649|NCT02265237|473576822|FG001|As Treated (Overall Study)|Adverse Event|1|||
131533650|NCT02265237|473576823|FG002|As Treated (Overall Study)|Adverse Event|0|||
131533651|NCT02265237|473576824|FG003|As Treated (Overall Study)|Adverse Event|0|||
131533652|NCT02265237|473576821|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
131533653|NCT02265237|473576822|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
131533654|NCT02265237|473576823|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
131533655|NCT02265237|473576824|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
131533656|NCT02265237|473576821|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
131533657|NCT02265237|473576822|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
131533658|NCT02265237|473576823|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
131533659|NCT02265237|473576824|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
131533660|NCT02265237|473576821|FG000|As Treated (Overall Study)|Other|2|||
131533661|NCT02265237|473576822|FG001|As Treated (Overall Study)|Other|0|||
131533662|NCT02265237|473576823|FG002|As Treated (Overall Study)|Other|3|||
131533663|NCT02265237|473576824|FG003|As Treated (Overall Study)|Other|1|||
131533664|NCT01178853|473576826|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
131533665|NCT01178853|473576827|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
131533666|NCT01178853|473576826|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
131533667|NCT01178853|473576827|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
131533668|NCT01178853|473576826|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
131533669|NCT01178853|473576827|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
131533670|NCT01178853|473576826|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
131533671|NCT01178853|473576827|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
131533672|NCT01178853|473576826|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
131533673|NCT01178853|473576827|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
131533674|NCT00839072|473576828|FG000|First Intervention Period|Withdrawal by Subject|1|||
131533675|NCT00839072|473576829|FG001|First Intervention Period|Withdrawal by Subject|0|||
131533676|NCT00839072|473576828|FG000|First Intervention Period|Adverse Event|1|||
131533677|NCT00839072|473576829|FG001|First Intervention Period|Adverse Event|1|||
131533678|NCT00839072|473576828|FG000|Second Intervention Period|Withdrawal by Subject|1|||
131533679|NCT00839072|473576829|FG001|Second Intervention Period|Withdrawal by Subject|0|||
131533680|NCT01458574|473576830|FG000|Overall Study|Adverse Event|5|||
131533681|NCT01458574|473576831|FG001|Overall Study|Adverse Event|9|||
131533682|NCT01458574|473576832|FG002|Overall Study|Adverse Event|7|||
131533683|NCT01458574|473576830|FG000|Overall Study|Lack of Efficacy|70|||
131533684|NCT01458574|473576831|FG001|Overall Study|Lack of Efficacy|53|||
131533685|NCT01458574|473576832|FG002|Overall Study|Lack of Efficacy|132|||
131533686|NCT01458574|473576830|FG000|Overall Study|Lost to Follow-up|3|||
131533687|NCT01458574|473576831|FG001|Overall Study|Lost to Follow-up|2|||
131533688|NCT01458574|473576832|FG002|Overall Study|Lost to Follow-up|1|||
131533689|NCT01458574|473576830|FG000|Overall Study|Pregnancy|1|||
131533690|NCT01458574|473576831|FG001|Overall Study|Pregnancy|1|||
131533691|NCT01458574|473576832|FG002|Overall Study|Pregnancy|0|||
131533692|NCT01458574|473576830|FG000|Overall Study|Protocol Violation|0|||
131533693|NCT01458574|473576831|FG001|Overall Study|Protocol Violation|1|||
131533694|NCT01458574|473576832|FG002|Overall Study|Protocol Violation|0|||
131533695|NCT01458574|473576830|FG000|Overall Study|Withdrawal by Subject|6|||
131533696|NCT01458574|473576831|FG001|Overall Study|Withdrawal by Subject|3|||
131533697|NCT01458574|473576832|FG002|Overall Study|Withdrawal by Subject|5|||
131533698|NCT01458574|473576830|FG000|Overall Study|Other|2|||
131533699|NCT01458574|473576831|FG001|Overall Study|Other|1|||
131533700|NCT01458574|473576832|FG002|Overall Study|Other|0|||
131533701|NCT01458574|473576830|FG000|Overall Study|Randomized but not treated|0|||
131533702|NCT01458574|473576831|FG001|Overall Study|Randomized but not treated|1|||
131533703|NCT01458574|473576832|FG002|Overall Study|Randomized but not treated|0|||
131533704|NCT02125786|473576833|FG000|Overall Study|Still in Follow-up|3|||
131533705|NCT02125786|473576833|FG000|Overall Study|Screen Failure|2|||
131533706|NCT02125786|473576833|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
131533707|NCT02125786|473576833|FG000|Overall Study|Progressive Disease|44|||
131533708|NCT02125786|473576833|FG000|Overall Study|Death|8|||
131533709|NCT01682837|473576834|FG000|Baseline|Withdrawal by Subject|5|||
131533710|NCT04782323|473576837|FG000|Overall Study|Death|1|||
131533711|NCT04782323|473576838|FG001|Overall Study|Death|0|||
131533712|NCT04782323|473576839|FG002|Overall Study|Death|0|||
131533713|NCT04782323|473576840|FG003|Overall Study|Death|0|||
131533714|NCT04782323|473576841|FG004|Overall Study|Death|1|||
131533715|NCT04782323|473576842|FG005|Overall Study|Death|1|||
131533716|NCT04782323|473576843|FG006|Overall Study|Death|1|||
131533717|NCT04782323|473576844|FG007|Overall Study|Death|0|||
131533718|NCT04782323|473576837|FG000|Overall Study|Withdrawal by Subject|0|||
131533719|NCT04782323|473576838|FG001|Overall Study|Withdrawal by Subject|0|||
131533720|NCT04782323|473576839|FG002|Overall Study|Withdrawal by Subject|1|||
131533721|NCT04782323|473576840|FG003|Overall Study|Withdrawal by Subject|0|||
131533722|NCT04782323|473576841|FG004|Overall Study|Withdrawal by Subject|0|||
131533723|NCT04782323|473576842|FG005|Overall Study|Withdrawal by Subject|1|||
131533724|NCT04782323|473576843|FG006|Overall Study|Withdrawal by Subject|0|||
131533725|NCT04782323|473576844|FG007|Overall Study|Withdrawal by Subject|1|||
131533726|NCT04782323|473576837|FG000|Overall Study|Lost to Follow-up|0|||
131533727|NCT04782323|473576838|FG001|Overall Study|Lost to Follow-up|1|||
131533728|NCT04782323|473576839|FG002|Overall Study|Lost to Follow-up|1|||
131533729|NCT04782323|473576840|FG003|Overall Study|Lost to Follow-up|0|||
131533730|NCT04782323|473576841|FG004|Overall Study|Lost to Follow-up|0|||
131533731|NCT04782323|473576842|FG005|Overall Study|Lost to Follow-up|1|||
131533732|NCT04782323|473576843|FG006|Overall Study|Lost to Follow-up|1|||
131533733|NCT04782323|473576844|FG007|Overall Study|Lost to Follow-up|2|||
131533734|NCT04782323|473576837|FG000|Overall Study|randomization in error|1|||
131533735|NCT04782323|473576838|FG001|Overall Study|randomization in error|0|||
131533736|NCT04782323|473576839|FG002|Overall Study|randomization in error|0|||
131533737|NCT04782323|473576840|FG003|Overall Study|randomization in error|0|||
131533738|NCT04782323|473576841|FG004|Overall Study|randomization in error|0|||
131533739|NCT04782323|473576842|FG005|Overall Study|randomization in error|0|||
131533740|NCT04782323|473576843|FG006|Overall Study|randomization in error|0|||
131533741|NCT04782323|473576844|FG007|Overall Study|randomization in error|0|||
131533742|NCT03832192|473576849|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
131533743|NCT03832192|473576850|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
131533744|NCT03738150|473576851|FG000|Base Study|Withdrawal by Subject|1|||
131533745|NCT03738150|473576851|FG000|Extension Study|Withdrawal by Subject|1|||
131533746|NCT00838110|473578655|FG000|Overall Study|Death|0|||
131533747|NCT00838110|473578656|FG001|Overall Study|Death|0|||
131533748|NCT00838110|473578657|FG002|Overall Study|Death|1|||
131533749|NCT00838110|473578658|FG003|Overall Study|Death|2|||
131533750|NCT00838110|473578655|FG000|Overall Study|Adverse Event|11|||
131533751|NCT00838110|473578656|FG001|Overall Study|Adverse Event|10|||
131533752|NCT00838110|473578657|FG002|Overall Study|Adverse Event|8|||
131533753|NCT00838110|473578658|FG003|Overall Study|Adverse Event|7|||
131533754|NCT00838110|473578655|FG000|Overall Study|Withdrawal by Subject|5|||
131533755|NCT00838110|473578656|FG001|Overall Study|Withdrawal by Subject|6|||
131533756|NCT00838110|473578657|FG002|Overall Study|Withdrawal by Subject|3|||
131533757|NCT00838110|473578658|FG003|Overall Study|Withdrawal by Subject|4|||
131533758|NCT00838110|473578655|FG000|Overall Study|Other|3|||
131533759|NCT00838110|473578656|FG001|Overall Study|Other|3|||
131533760|NCT00838110|473578657|FG002|Overall Study|Other|3|||
131533761|NCT00838110|473578658|FG003|Overall Study|Other|2|||
131533762|NCT00838110|473578655|FG000|Overall Study|Protocol Violation|0|||
131533763|NCT00838110|473578656|FG001|Overall Study|Protocol Violation|2|||
131533764|NCT00838110|473578657|FG002|Overall Study|Protocol Violation|1|||
131533765|NCT00838110|473578658|FG003|Overall Study|Protocol Violation|1|||
131533766|NCT00838110|473578655|FG000|Overall Study|Lost to Follow-up|3|||
131533767|NCT00838110|473578656|FG001|Overall Study|Lost to Follow-up|0|||
131533768|NCT00838110|473578657|FG002|Overall Study|Lost to Follow-up|0|||
131533769|NCT00838110|473578658|FG003|Overall Study|Lost to Follow-up|0|||
131533770|NCT00838110|473578655|FG000|Overall Study|Did not meet eligibility criteria|0|||
131533771|NCT00838110|473578656|FG001|Overall Study|Did not meet eligibility criteria|0|||
131533772|NCT00838110|473578657|FG002|Overall Study|Did not meet eligibility criteria|1|||
131533773|NCT00838110|473578658|FG003|Overall Study|Did not meet eligibility criteria|2|||
131533774|NCT00838110|473578655|FG000|Overall Study|Randomized but not treated|0|||
131533775|NCT00838110|473578656|FG001|Overall Study|Randomized but not treated|1|||
131533776|NCT00838110|473578657|FG002|Overall Study|Randomized but not treated|0|||
131533777|NCT00838110|473578658|FG003|Overall Study|Randomized but not treated|0|||
131533778|NCT01262651|473578659|FG000|Overall Study|Adverse Event|40|||
131533779|NCT01262651|473578660|FG001|Overall Study|Adverse Event|35|||
131533780|NCT01262651|473578659|FG000|Overall Study|Withdrawal by Subject|15|||
131533781|NCT01262651|473578660|FG001|Overall Study|Withdrawal by Subject|11|||
131533782|NCT01262651|473578659|FG000|Overall Study|Withdrawal by Investigator|2|||
131533783|NCT01262651|473578660|FG001|Overall Study|Withdrawal by Investigator|2|||
131533784|NCT01262651|473578659|FG000|Overall Study|Met Withdrawal Criteria|1|||
131533785|NCT01262651|473578660|FG001|Overall Study|Met Withdrawal Criteria|0|||
131533786|NCT04969783|473578666|FG000|Overall Study|Lost to Follow-up|2|||
131533787|NCT04969783|473578667|FG001|Overall Study|Lost to Follow-up|0|||
131533788|NCT04969783|473578666|FG000|Overall Study|Withdrawal by Subject|4|||
131533789|NCT04969783|473578667|FG001|Overall Study|Withdrawal by Subject|0|||
131533790|NCT04969783|473578666|FG000|Overall Study|Physician Decision|6|||
131533791|NCT04969783|473578667|FG001|Overall Study|Physician Decision|0|||
131533792|NCT02349295|473578668|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
131533793|NCT02349295|473578669|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
131533794|NCT02349295|473578670|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
131533795|NCT02349295|473578671|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533796|NCT02349295|473578672|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533797|NCT02349295|473578673|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533798|NCT02349295|473578674|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533799|NCT02349295|473578675|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533800|NCT02349295|473578676|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533801|NCT02349295|473578677|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533802|NCT02349295|473578678|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533803|NCT02349295|473578679|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533804|NCT02349295|473578680|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533805|NCT02349295|473578681|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131533806|NCT02349295|473578668|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
131533807|NCT02349295|473578669|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
131533808|NCT02349295|473578670|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
131533809|NCT02349295|473578671|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533810|NCT02349295|473578672|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533811|NCT02349295|473578673|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533812|NCT02349295|473578674|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533813|NCT02349295|473578675|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533814|NCT02349295|473578676|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533815|NCT02349295|473578677|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533816|NCT02349295|473578678|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533817|NCT02349295|473578679|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131658442|NCT00264303|474035312|FG000|Overall Study|Lost to Follow-up|3|||
131533818|NCT02349295|473578680|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533819|NCT02349295|473578681|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131533820|NCT02349295|473578668|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
131533821|NCT02349295|473578669|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
131533822|NCT02349295|473578670|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
131533823|NCT02349295|473578671|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533824|NCT02349295|473578672|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533825|NCT02349295|473578673|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533826|NCT02349295|473578674|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533827|NCT02349295|473578675|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533828|NCT02349295|473578676|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533829|NCT02349295|473578677|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533830|NCT02349295|473578678|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533831|NCT02349295|473578679|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533832|NCT02349295|473578680|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533833|NCT02349295|473578681|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
131533834|NCT02349295|473578668|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
131533835|NCT02349295|473578669|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
131533836|NCT02349295|473578670|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
131533837|NCT02349295|473578671|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533838|NCT02349295|473578672|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533839|NCT02349295|473578673|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533840|NCT02349295|473578674|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533841|NCT02349295|473578675|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533842|NCT02349295|473578676|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533843|NCT02349295|473578677|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533844|NCT02349295|473578678|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533845|NCT02349295|473578679|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533846|NCT02349295|473578680|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533847|NCT02349295|473578681|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
131533848|NCT02349295|473578668|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533849|NCT02349295|473578669|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
131533850|NCT02349295|473578670|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
131533851|NCT02349295|473578671|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533852|NCT02349295|473578672|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533853|NCT02349295|473578673|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533854|NCT02349295|473578674|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533855|NCT02349295|473578675|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533856|NCT02349295|473578676|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533857|NCT02349295|473578677|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533858|NCT02349295|473578678|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533859|NCT02349295|473578679|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533860|NCT02349295|473578680|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533861|NCT02349295|473578681|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
131533862|NCT02349295|473578668|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
131533863|NCT02349295|473578669|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
131533864|NCT02349295|473578670|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
131533865|NCT02349295|473578671|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
131533866|NCT02349295|473578672|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
131533867|NCT02349295|473578673|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
131533868|NCT02349295|473578674|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
131533869|NCT02349295|473578675|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
131533870|NCT02349295|473578676|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
131533871|NCT02349295|473578677|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
131533872|NCT02349295|473578678|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
131533873|NCT02349295|473578679|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
131533874|NCT02349295|473578680|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
131533875|NCT02349295|473578681|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
131533876|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533877|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533878|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533879|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533880|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533881|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533882|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533883|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
131533884|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
131533885|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
131533886|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
131533887|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533888|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533889|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
131533890|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533891|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533892|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533893|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533894|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533895|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533896|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533897|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
131533898|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
131533899|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
131533900|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
131533901|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533902|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533903|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
131533904|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533905|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533906|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533907|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533908|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533909|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533910|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533911|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
131533912|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533913|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
131533914|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533915|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533916|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533917|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
131533918|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
131533919|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
131533920|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
131533921|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
131533922|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
131533923|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
131533924|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
131533925|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
131533926|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
131533927|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
131533928|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
131533929|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
131533930|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
131533931|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
131533932|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533933|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533934|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533935|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533936|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533937|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533938|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533939|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
131533940|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
131533941|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
131533942|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
131533943|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533944|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533945|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131533946|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533947|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533948|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533949|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533950|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533951|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533952|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533953|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
131533954|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
131533955|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533956|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533957|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533958|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533959|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
131533960|NCT02349295|473578668|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533961|NCT02349295|473578669|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533962|NCT02349295|473578670|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533963|NCT02349295|473578671|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533964|NCT02349295|473578672|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533965|NCT02349295|473578673|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533966|NCT02349295|473578674|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533967|NCT02349295|473578675|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
131533968|NCT02349295|473578676|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
131533969|NCT02349295|473578677|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533970|NCT02349295|473578678|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533971|NCT02349295|473578679|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533972|NCT02349295|473578680|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533973|NCT02349295|473578681|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
131533974|NCT02349295|473578668|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533975|NCT02349295|473578669|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533976|NCT02349295|473578670|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533977|NCT02349295|473578671|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533978|NCT02349295|473578672|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533979|NCT02349295|473578673|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533980|NCT02349295|473578674|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533981|NCT02349295|473578675|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533982|NCT02349295|473578676|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533983|NCT02349295|473578677|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533984|NCT02349295|473578678|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
131533985|NCT02349295|473578679|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
131533986|NCT02349295|473578680|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
131533987|NCT02349295|473578681|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
131533988|NCT02349295|473578668|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533989|NCT02349295|473578669|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533990|NCT02349295|473578670|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533991|NCT02349295|473578671|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533992|NCT02349295|473578672|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533993|NCT02349295|473578673|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533994|NCT02349295|473578674|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533995|NCT02349295|473578675|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533996|NCT02349295|473578676|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533997|NCT02349295|473578677|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533998|NCT02349295|473578678|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131533999|NCT02349295|473578679|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
131534000|NCT02349295|473578680|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
131534001|NCT02349295|473578681|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131534002|NCT02349295|473578668|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534003|NCT02349295|473578669|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534004|NCT02349295|473578670|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534005|NCT02349295|473578671|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534006|NCT02349295|473578672|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534007|NCT02349295|473578673|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534008|NCT02349295|473578674|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534009|NCT02349295|473578675|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534010|NCT02349295|473578676|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534011|NCT02349295|473578677|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534012|NCT02349295|473578678|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534013|NCT02349295|473578679|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
131534014|NCT02349295|473578680|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
131534015|NCT02349295|473578681|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
131534016|NCT02349295|473578668|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534017|NCT02349295|473578669|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534018|NCT02349295|473578670|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534019|NCT02349295|473578671|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534020|NCT02349295|473578672|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534021|NCT02349295|473578673|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534022|NCT02349295|473578674|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534023|NCT02349295|473578675|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534024|NCT02349295|473578676|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534025|NCT02349295|473578677|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534026|NCT02349295|473578678|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534027|NCT02349295|473578679|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
131534028|NCT02349295|473578680|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534029|NCT02349295|473578681|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
131534030|NCT02349295|473578668|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534031|NCT02349295|473578669|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534032|NCT02349295|473578670|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534033|NCT02349295|473578671|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534034|NCT02349295|473578672|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534035|NCT02349295|473578673|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534036|NCT02349295|473578674|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534037|NCT02349295|473578675|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534038|NCT02349295|473578676|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534039|NCT02349295|473578677|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534040|NCT02349295|473578678|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534041|NCT02349295|473578679|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
131534042|NCT02349295|473578680|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534043|NCT02349295|473578681|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
131534044|NCT02863926|473578682|FG000|Overall Study|Physician Decision|1|||
131534045|NCT02863926|473578683|FG001|Overall Study|Physician Decision|0|||
131534046|NCT02863926|473578682|FG000|Overall Study|Lost to Follow-up|1|||
131534047|NCT02863926|473578683|FG001|Overall Study|Lost to Follow-up|1|||
131534048|NCT01914926|473578699|FG000|Overall Study|Adverse Event|1|||
131534049|NCT01914926|473578700|FG001|Overall Study|Adverse Event|0|||
131534050|NCT01914926|473578699|FG000|Overall Study|uncooperative, agitated and removed|0|||
131534051|NCT01914926|473578700|FG001|Overall Study|uncooperative, agitated and removed|1|||
131534052|NCT02261363|473578701|FG000|Overall Study|Lost to Follow-up|21|||
131534053|NCT01517802|473578702|FG000|Overall Study|Death|1|||
131534054|NCT02590354|473578703|FG000|Phase 1|Active hepatitis B or C infection|1|||
131534055|NCT02590354|473578703|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
131534056|NCT02590354|473578703|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
131534057|NCT02590354|473578703|FG000|Phase 1|Subject does not want to participate|20|||
131534058|NCT02590354|473578703|FG000|Phase 1|Lost to Follow-up|1|||
131534059|NCT02590354|473578703|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
131534060|NCT02099838|473578704|FG000|Overall Study|Death|1|||
131534061|NCT02099838|473578705|FG001|Overall Study|Death|0|||
131534062|NCT02099838|473578704|FG000|Overall Study|Lost to Follow-up|3|||
131534063|NCT02099838|473578705|FG001|Overall Study|Lost to Follow-up|1|||
131534064|NCT02099838|473578704|FG000|Overall Study|Withdrawal by Subject|0|||
131534065|NCT02099838|473578705|FG001|Overall Study|Withdrawal by Subject|1|||
131534066|NCT02301143|473578706|FG000|Induction Period|Enrolled But Not Treated|1|||
131534067|NCT02301143|473578707|FG001|Induction Period|Enrolled But Not Treated|0|||
131534068|NCT02301143|473578706|FG000|Induction Period|Death|1|||
131534069|NCT02301143|473578707|FG001|Induction Period|Death|0|||
131534070|NCT02301143|473578706|FG000|Induction Period|Adverse Event|22|||
131534071|NCT02301143|473578707|FG001|Induction Period|Adverse Event|0|||
131534072|NCT02301143|473578706|FG000|Induction Period|Progressive Disease|8|||
131534073|NCT02301143|473578707|FG001|Induction Period|Progressive Disease|0|||
131534074|NCT02301143|473578706|FG000|Induction Period|Withdrawal by Subject|3|||
131534075|NCT02301143|473578707|FG001|Induction Period|Withdrawal by Subject|0|||
131534076|NCT02301143|473578706|FG000|Induction Period|Noncompliance with Study Drug|1|||
131534077|NCT02301143|473578707|FG001|Induction Period|Noncompliance with Study Drug|0|||
131534078|NCT02301143|473578706|FG000|Induction Period|Physician Decision|4|||
131534079|NCT02301143|473578707|FG001|Induction Period|Physician Decision|0|||
131534080|NCT02301143|473578706|FG000|Induction Period|Symptomatic Deterioration|2|||
131534081|NCT02301143|473578707|FG001|Induction Period|Symptomatic Deterioration|0|||
131534082|NCT02301143|473578706|FG000|Induction Period|Protocol Violation|2|||
131534083|NCT02301143|473578707|FG001|Induction Period|Protocol Violation|0|||
131534084|NCT02301143|473578706|FG000|Induction Period|Other|1|||
131534085|NCT02301143|473578707|FG001|Induction Period|Other|0|||
131534086|NCT02301143|473578706|FG000|Investigator's Choice|Adverse Event|0|||
131534087|NCT02301143|473578707|FG001|Investigator's Choice|Adverse Event|3|||
131534088|NCT02301143|473578706|FG000|Investigator's Choice|Progressive Disease|0|||
131534089|NCT02301143|473578707|FG001|Investigator's Choice|Progressive Disease|3|||
131534090|NCT02301143|473578706|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
131534091|NCT02301143|473578707|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
131534092|NCT02301143|473578706|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
131534093|NCT02301143|473578707|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
131534094|NCT02301143|473578706|FG000|Investigator's Choice|Other|0|||
131534095|NCT02301143|473578707|FG001|Investigator's Choice|Other|1|||
131534096|NCT02301143|473578706|FG000|Investigator's Choice|Unresectable Surgery|0|||
131534097|NCT02301143|473578707|FG001|Investigator's Choice|Unresectable Surgery|1|||
131534098|NCT02536508|473578710|FG000|Overall Study|Withdrawal by Subject|18|||
131534099|NCT02536508|473578711|FG001|Overall Study|Withdrawal by Subject|13|||
131534100|NCT02536508|473578712|FG002|Overall Study|Withdrawal by Subject|7|||
131534101|NCT02536508|473578710|FG000|Overall Study|Adverse Event|14|||
131534102|NCT02536508|473578711|FG001|Overall Study|Adverse Event|13|||
131534103|NCT02536508|473578712|FG002|Overall Study|Adverse Event|6|||
131534104|NCT02536508|473578710|FG000|Overall Study|Lost to Follow-up|12|||
131534105|NCT02536508|473578711|FG001|Overall Study|Lost to Follow-up|4|||
131534106|NCT02536508|473578712|FG002|Overall Study|Lost to Follow-up|0|||
131534107|NCT02536508|473578710|FG000|Overall Study|Lack of Efficacy|3|||
131534108|NCT02536508|473578711|FG001|Overall Study|Lack of Efficacy|5|||
131534109|NCT02536508|473578712|FG002|Overall Study|Lack of Efficacy|4|||
131534110|NCT02536508|473578710|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
131534111|NCT02536508|473578711|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
131534112|NCT02536508|473578712|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
131534113|NCT02536508|473578710|FG000|Overall Study|Physician Decision|0|||
131534114|NCT02536508|473578711|FG001|Overall Study|Physician Decision|4|||
131534115|NCT02536508|473578712|FG002|Overall Study|Physician Decision|2|||
131534116|NCT02536508|473578710|FG000|Overall Study|Major Protocol Deviation|2|||
131534117|NCT02536508|473578711|FG001|Overall Study|Major Protocol Deviation|2|||
131534118|NCT02536508|473578712|FG002|Overall Study|Major Protocol Deviation|2|||
131534119|NCT02536508|473578710|FG000|Overall Study|Administrative Reasons|0|||
131534120|NCT02536508|473578711|FG001|Overall Study|Administrative Reasons|1|||
131534121|NCT02536508|473578712|FG002|Overall Study|Administrative Reasons|0|||
131534122|NCT00823719|473578715|FG000|Overall Study|Adverse Event|1|||
131534123|NCT00823719|473578716|FG001|Overall Study|Adverse Event|2|||
131534124|NCT00823719|473578715|FG000|Overall Study|Physician Decision|1|||
131534125|NCT00823719|473578716|FG001|Overall Study|Physician Decision|4|||
131534126|NCT00823719|473578715|FG000|Overall Study|Withdrawal by Subject|0|||
131534127|NCT00823719|473578716|FG001|Overall Study|Withdrawal by Subject|1|||
131534128|NCT00823719|473578715|FG000|Overall Study|Disease Progression|4|||
131534129|NCT00823719|473578716|FG001|Overall Study|Disease Progression|4|||
131534130|NCT06027216|473578719|FG000|Overall Study|Did not qualify|8|||
131534131|NCT04287920|473578720|FG000|Overall Study|Lost to Follow-up|1|||
131534132|NCT04287920|473578721|FG001|Overall Study|Lost to Follow-up|1|||
131534133|NCT04287920|473578720|FG000|Overall Study|Withdrawal by Subject|0|||
131534134|NCT04287920|473578721|FG001|Overall Study|Withdrawal by Subject|3|||
131534135|NCT04313634|473578722|FG000|Overall Study|Adverse Event|2|||
131534136|NCT04313634|473578723|FG001|Overall Study|Adverse Event|2|||
131534137|NCT04313634|473578724|FG002|Overall Study|Adverse Event|0|||
131534138|NCT04313634|473578722|FG000|Overall Study|Withdrawal by Subject|1|||
131534139|NCT04313634|473578723|FG001|Overall Study|Withdrawal by Subject|0|||
131534140|NCT04313634|473578724|FG002|Overall Study|Withdrawal by Subject|1|||
131534141|NCT04313634|473578722|FG000|Overall Study|Protocol Violation|0|||
131534142|NCT04313634|473578723|FG001|Overall Study|Protocol Violation|0|||
131534143|NCT04313634|473578724|FG002|Overall Study|Protocol Violation|1|||
131534144|NCT01220557|473578726|FG000|Overall Study|Lost to Follow-up|5|||
131534145|NCT01220557|473578727|FG001|Overall Study|Lost to Follow-up|3|||
131534146|NCT01220557|473578726|FG000|Overall Study|attended less than 6 lessons|1|||
131534147|NCT01220557|473578727|FG001|Overall Study|attended less than 6 lessons|2|||
131534148|NCT04323436|473578731|FG000|Overall Study|Adverse Event|7|||
131534149|NCT04323436|473578732|FG001|Overall Study|Adverse Event|0|||
131534150|NCT04323436|473578733|FG002|Overall Study|Adverse Event|0|||
131534151|NCT04323436|473578731|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
131534152|NCT04323436|473578732|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
131534153|NCT04323436|473578733|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
131534154|NCT04323436|473578731|FG000|Overall Study|Death|1|||
131534155|NCT04323436|473578732|FG001|Overall Study|Death|0|||
131534156|NCT04323436|473578733|FG002|Overall Study|Death|0|||
131534157|NCT04323436|473578731|FG000|Overall Study|Physician Decision|2|||
131534158|NCT04323436|473578732|FG001|Overall Study|Physician Decision|0|||
131534159|NCT04323436|473578733|FG002|Overall Study|Physician Decision|0|||
131534160|NCT04323436|473578731|FG000|Overall Study|Progressive disease|10|||
131534161|NCT04323436|473578732|FG001|Overall Study|Progressive disease|0|||
131534162|NCT04323436|473578733|FG002|Overall Study|Progressive disease|0|||
131534163|NCT04323436|473578731|FG000|Overall Study|Subject decision|3|||
131534164|NCT04323436|473578732|FG001|Overall Study|Subject decision|0|||
131534165|NCT04323436|473578733|FG002|Overall Study|Subject decision|0|||
131534166|NCT01196975|473578736|FG000|Overall Study|Adverse Event|2|||
131534167|NCT01196975|473578737|FG001|Overall Study|Adverse Event|2|||
131534168|NCT01196975|473578738|FG002|Overall Study|Adverse Event|0|||
131534169|NCT01196975|473578739|FG003|Overall Study|Adverse Event|0|||
131534170|NCT01196975|473578740|FG004|Overall Study|Adverse Event|2|||
131534171|NCT01196975|473578736|FG000|Overall Study|Withdrawal by Subject|2|||
131534172|NCT01196975|473578737|FG001|Overall Study|Withdrawal by Subject|1|||
131534173|NCT01196975|473578738|FG002|Overall Study|Withdrawal by Subject|0|||
131534174|NCT01196975|473578739|FG003|Overall Study|Withdrawal by Subject|1|||
131534175|NCT01196975|473578740|FG004|Overall Study|Withdrawal by Subject|0|||
131534176|NCT01196975|473578736|FG000|Overall Study|Lost to Follow-up|11|||
131534177|NCT01196975|473578737|FG001|Overall Study|Lost to Follow-up|6|||
131534178|NCT01196975|473578738|FG002|Overall Study|Lost to Follow-up|5|||
131534179|NCT01196975|473578739|FG003|Overall Study|Lost to Follow-up|5|||
131534180|NCT01196975|473578740|FG004|Overall Study|Lost to Follow-up|11|||
131534181|NCT01365494|473578741|FG000|Overall Study|Adverse Event|1|||
131534182|NCT01365494|473578742|FG001|Overall Study|Adverse Event|0|||
131534183|NCT01365494|473578741|FG000|Overall Study|Withdrawal by Subject|0|||
131534184|NCT01365494|473578742|FG001|Overall Study|Withdrawal by Subject|1|||
131534185|NCT01365494|473578741|FG000|Overall Study|Lost to Follow-up|1|||
131534186|NCT01365494|473578742|FG001|Overall Study|Lost to Follow-up|2|||
131534187|NCT04558346|473578753|FG000|Overall Study|Withdrawal by Subject|2|||
131534188|NCT04558346|473578754|FG001|Overall Study|Withdrawal by Subject|0|||
131534189|NCT04558346|473578753|FG000|Overall Study|Lost to Follow-up|0|||
131534190|NCT04558346|473578754|FG001|Overall Study|Lost to Follow-up|1|||
131534191|NCT04558346|473578753|FG000|Overall Study|Adverse Event|0|||
131534192|NCT04558346|473578754|FG001|Overall Study|Adverse Event|1|||
131534193|NCT02715765|473578755|FG000|Overall Study|Study Termination|3|||
131534194|NCT02715765|473578756|FG001|Overall Study|Study Termination|0|||
131534195|NCT02715765|473578757|FG002|Overall Study|Study Termination|0|||
131534196|NCT00724971|473578758|FG000|Overall Study|Adverse Event|5|||
131534197|NCT00724971|473578758|FG000|Overall Study|Withdrawal by Subject|1|||
131534198|NCT01692197|473578762|FG000|Overall Study|Failed Screening|3|||
131534199|NCT03394924|473578766|FG000|Overall Study|Adverse Event|0|||
131534200|NCT03394924|473578767|FG001|Overall Study|Adverse Event|5|||
131534201|NCT03394924|473578768|FG002|Overall Study|Adverse Event|0|||
131534202|NCT03394924|473578766|FG000|Overall Study|Withdrawal by Subject|2|||
131534203|NCT03394924|473578767|FG001|Overall Study|Withdrawal by Subject|0|||
131534204|NCT03394924|473578768|FG002|Overall Study|Withdrawal by Subject|0|||
131534205|NCT03394924|473578766|FG000|Overall Study|Lost to Follow-up|0|||
131534206|NCT03394924|473578767|FG001|Overall Study|Lost to Follow-up|1|||
131534207|NCT03394924|473578768|FG002|Overall Study|Lost to Follow-up|0|||
131534208|NCT03394924|473578766|FG000|Overall Study|Did not meet all inclusion criteria|1|||
131534209|NCT03394924|473578767|FG001|Overall Study|Did not meet all inclusion criteria|0|||
131534210|NCT03394924|473578768|FG002|Overall Study|Did not meet all inclusion criteria|0|||
131534211|NCT03588572|473578771|FG000|Visitation 1|Lack of Efficacy|1|||
131534212|NCT03588572|473578772|FG001|Visitation 1|Lack of Efficacy|1|||
131534213|NCT03588572|473578771|FG000|Visitation 2|Lost to Follow-up|1|||
131534214|NCT03588572|473578772|FG001|Visitation 2|Lost to Follow-up|1|||
131534215|NCT03588572|473578771|FG000|Visitation 2|Lack of Efficacy|0|||
131534216|NCT03588572|473578772|FG001|Visitation 2|Lack of Efficacy|1|||
131534217|NCT03588572|473578771|FG000|Visitation 2|Withdrawal by Subject|1|||
131534218|NCT03588572|473578772|FG001|Visitation 2|Withdrawal by Subject|0|||
131534219|NCT03588572|473578771|FG000|Visitation 3|Lost to Follow-up|1|||
131534220|NCT03588572|473578772|FG001|Visitation 3|Lost to Follow-up|1|||
131534221|NCT03588572|473578771|FG000|Visitation 3|Physician Decision|1|||
131534222|NCT03588572|473578772|FG001|Visitation 3|Physician Decision|1|||
131534223|NCT03588572|473578771|FG000|Visitation 3|Withdrawal by Subject|1|||
131534224|NCT03588572|473578772|FG001|Visitation 3|Withdrawal by Subject|0|||
131534225|NCT02276482|473578773|FG000|Overall Study|Adverse Event|1|||
131534226|NCT02276482|473578774|FG001|Overall Study|Adverse Event|0|||
131534227|NCT02276482|473578773|FG000|Overall Study|Withdrawal by Subject|1|||
131534228|NCT02276482|473578774|FG001|Overall Study|Withdrawal by Subject|0|||
131534229|NCT02276482|473578773|FG000|Overall Study|Gram-negative infection|1|||
131534230|NCT02276482|473578774|FG001|Overall Study|Gram-negative infection|0|||
131534231|NCT02276482|473578773|FG000|Overall Study|Reason not specified|0|||
131534232|NCT02276482|473578774|FG001|Overall Study|Reason not specified|1|||
131534233|NCT03387852|473578778|FG000|Overall Study|Adverse event (AE)|3|||
131534234|NCT03387852|473578779|FG001|Overall Study|Adverse event (AE)|0|||
131534235|NCT03387852|473578780|FG002|Overall Study|Adverse event (AE)|2|||
131534236|NCT03387852|473578781|FG003|Overall Study|Adverse event (AE)|0|||
131534237|NCT03387852|473578778|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
131534238|NCT03387852|473578779|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
131658443|NCT00264303|474035313|FG001|Overall Study|Lost to Follow-up|3|||
131534239|NCT03387852|473578780|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
131534240|NCT03387852|473578781|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
131534241|NCT03387852|473578778|FG000|Overall Study|Withdrawal by participant|1|||
131534242|NCT03387852|473578779|FG001|Overall Study|Withdrawal by participant|1|||
131534243|NCT03387852|473578780|FG002|Overall Study|Withdrawal by participant|3|||
131534244|NCT03387852|473578781|FG003|Overall Study|Withdrawal by participant|2|||
131534245|NCT03387852|473578778|FG000|Overall Study|Other- Unspecified|1|||
131534246|NCT03387852|473578779|FG001|Overall Study|Other- Unspecified|1|||
131534247|NCT03387852|473578780|FG002|Overall Study|Other- Unspecified|2|||
131534248|NCT03387852|473578781|FG003|Overall Study|Other- Unspecified|1|||
131534249|NCT03387852|473578778|FG000|Overall Study|Poor compliance to protocol|0|||
131534250|NCT03387852|473578779|FG001|Overall Study|Poor compliance to protocol|0|||
131534251|NCT03387852|473578780|FG002|Overall Study|Poor compliance to protocol|0|||
131534252|NCT03387852|473578781|FG003|Overall Study|Poor compliance to protocol|1|||
131534253|NCT03387852|473578778|FG000|Overall Study|Randomized and not treated|0|||
131534254|NCT03387852|473578779|FG001|Overall Study|Randomized and not treated|0|||
131534255|NCT03387852|473578780|FG002|Overall Study|Randomized and not treated|0|||
131534256|NCT03387852|473578781|FG003|Overall Study|Randomized and not treated|1|||
131534257|NCT00659334|473578786|FG000|Overall Study|Screen Failure|8|||
131534258|NCT00659334|473578787|FG001|Overall Study|Screen Failure|5|||
131534259|NCT00659334|473578788|FG002|Overall Study|Screen Failure|0|||
131534260|NCT00659334|473578789|FG003|Overall Study|Screen Failure|0|||
131534261|NCT00659334|473578790|FG004|Overall Study|Screen Failure|0|||
131534262|NCT00659334|473578791|FG005|Overall Study|Screen Failure|0|||
131534263|NCT00659334|473578792|FG006|Overall Study|Screen Failure|1|||
131534264|NCT01174342|473578793|FG000|Overall Study|Conversion to cesarean section|4|||
131534265|NCT04177758|473578794|FG000|Overall Study|Lost to Follow-up|19|||
131534266|NCT04177758|473578795|FG001|Overall Study|Lost to Follow-up|11|||
131534267|NCT01308580|473578796|FG000|Overall Study|Lost to Follow-up|12|||
131534268|NCT01308580|473578797|FG001|Overall Study|Lost to Follow-up|7|||
131534269|NCT02535065|473578798|FG000|Overall Study|Death|13|||
131534270|NCT02535065|473578798|FG000|Overall Study|Lost to Follow-up|1|||
131534271|NCT02535065|473578798|FG000|Overall Study|Withdrawal by Subject|6|||
131534272|NCT00110617|473578800|FG000|Overall Study|Adverse Event|2|||
131534273|NCT00110617|473578801|FG001|Overall Study|Adverse Event|4|||
131534274|NCT00110617|473578800|FG000|Overall Study|Abnormal Laboratory Value|4|||
131534275|NCT00110617|473578801|FG001|Overall Study|Abnormal Laboratory Value|2|||
131534276|NCT00110617|473578800|FG000|Overall Study|Lack of Efficacy|1|||
131534277|NCT00110617|473578801|FG001|Overall Study|Lack of Efficacy|0|||
131534278|NCT00110617|473578800|FG000|Overall Study|Patient no longer requires study drug|1|||
131534279|NCT00110617|473578801|FG001|Overall Study|Patient no longer requires study drug|0|||
131534280|NCT00110617|473578800|FG000|Overall Study|Protocol Violation|5|||
131534281|NCT00110617|473578801|FG001|Overall Study|Protocol Violation|0|||
131534282|NCT00110617|473578800|FG000|Overall Study|Withdrawal by Subject|10|||
131534283|NCT00110617|473578801|FG001|Overall Study|Withdrawal by Subject|4|||
131534284|NCT00110617|473578800|FG000|Overall Study|Lost to Follow-up|9|||
131534285|NCT00110617|473578801|FG001|Overall Study|Lost to Follow-up|1|||
131534286|NCT00110617|473578800|FG000|Overall Study|Administrative problems|6|||
131534287|NCT00110617|473578801|FG001|Overall Study|Administrative problems|5|||
131534288|NCT00110617|473578800|FG000|Overall Study|Death|1|||
131534289|NCT00110617|473578801|FG001|Overall Study|Death|1|||
131534290|NCT00110617|473578800|FG000|Overall Study|Did not receive study drug|0|||
131534291|NCT00110617|473578801|FG001|Overall Study|Did not receive study drug|12|||
131534292|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
131534293|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
131534294|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
131534295|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
131534296|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
131534297|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
131534298|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
131534299|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
131534300|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
131534301|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
131534302|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
131534303|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
131534304|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
131534305|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
131534306|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
131534307|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
131534308|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
131534309|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
131534310|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
131534311|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
131534312|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
131534313|NCT01781572|473578803|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
131534314|NCT01781572|473578804|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
131534315|NCT01781572|473578805|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
131534316|NCT01781572|473578803|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
131534317|NCT01781572|473578804|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
131534318|NCT01781572|473578805|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
131534319|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
131534320|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
131534321|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
131534322|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
131534323|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
131534324|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
131534325|NCT01781572|473578803|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
131534326|NCT01781572|473578804|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
131534327|NCT01781572|473578805|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
131534328|NCT01781572|473578803|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
131534329|NCT01781572|473578804|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
131534330|NCT01781572|473578805|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
131534331|NCT01781572|473578803|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
131534332|NCT01781572|473578804|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
131534333|NCT01781572|473578805|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
131534334|NCT01781572|473578803|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
131534335|NCT01781572|473578804|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
131534336|NCT01781572|473578805|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
131534337|NCT01781572|473578803|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
131534338|NCT01781572|473578804|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
131534339|NCT01781572|473578805|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
131534340|NCT01781572|473578803|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
131534341|NCT01781572|473578804|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
131534342|NCT01781572|473578805|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
131534343|NCT01781572|473578803|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
131534344|NCT01781572|473578804|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
131534345|NCT01781572|473578805|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
131534346|NCT00045110|473578806|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
131534347|NCT00045110|473578807|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
131534348|NCT00045110|473578808|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
131534349|NCT00045110|473578806|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
131534350|NCT00045110|473578807|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
131534351|NCT00045110|473578808|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
131534352|NCT00045110|473578806|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
131534353|NCT00045110|473578807|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
131534354|NCT00045110|473578808|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
131534355|NCT01218646|473578809|FG000|Overall Study|Adverse Event|0|||
131534356|NCT01218646|473578810|FG001|Overall Study|Adverse Event|0|||
131534357|NCT01218646|473578811|FG002|Overall Study|Adverse Event|1|||
131534358|NCT01218646|473578812|FG003|Overall Study|Adverse Event|0|||
131534359|NCT01218646|473578809|FG000|Overall Study|Lost to Follow-up|1|||
131534360|NCT01218646|473578810|FG001|Overall Study|Lost to Follow-up|0|||
131534361|NCT01218646|473578811|FG002|Overall Study|Lost to Follow-up|0|||
131534362|NCT01218646|473578812|FG003|Overall Study|Lost to Follow-up|0|||
131534363|NCT01218646|473578809|FG000|Overall Study|Protocol Violation|0|||
131534364|NCT01218646|473578810|FG001|Overall Study|Protocol Violation|0|||
131534365|NCT01218646|473578811|FG002|Overall Study|Protocol Violation|1|||
131534366|NCT01218646|473578812|FG003|Overall Study|Protocol Violation|1|||
131534367|NCT03156023|473578818|FG000|Overall Study|Withdrawal by Subject|1|||
131534368|NCT03156023|473578819|FG001|Overall Study|Withdrawal by Subject|0|||
131534369|NCT03156023|473578820|FG002|Overall Study|Withdrawal by Subject|2|||
131534370|NCT03156023|473578821|FG003|Overall Study|Withdrawal by Subject|1|||
131534371|NCT03156023|473578822|FG004|Overall Study|Withdrawal by Subject|1|||
131534372|NCT03156023|473578818|FG000|Overall Study|Lost to Follow-up|0|||
131534373|NCT03156023|473578819|FG001|Overall Study|Lost to Follow-up|0|||
131534374|NCT03156023|473578820|FG002|Overall Study|Lost to Follow-up|0|||
131534375|NCT03156023|473578821|FG003|Overall Study|Lost to Follow-up|0|||
131534376|NCT03156023|473578822|FG004|Overall Study|Lost to Follow-up|1|||
131534377|NCT00726752|473578823|FG000|Overall Study|Lack of Efficacy|6|||
131534378|NCT04827576|473581438|FG000|Overall Study|Death|5|||
131534379|NCT04827576|473581439|FG001|Overall Study|Death|17|||
131534380|NCT04827576|473581440|FG002|Overall Study|Death|17|||
131534381|NCT04827576|473581441|FG003|Overall Study|Death|32|||
131534382|NCT04827576|473581438|FG000|Overall Study|Study Terminated by Sponsor|2|||
131534383|NCT04827576|473581439|FG001|Overall Study|Study Terminated by Sponsor|9|||
131534384|NCT04827576|473581440|FG002|Overall Study|Study Terminated by Sponsor|7|||
131534385|NCT04827576|473581441|FG003|Overall Study|Study Terminated by Sponsor|5|||
131534386|NCT04827576|473581438|FG000|Overall Study|Investigator's Discretion|1|||
131534387|NCT04827576|473581439|FG001|Overall Study|Investigator's Discretion|0|||
131534388|NCT04827576|473581440|FG002|Overall Study|Investigator's Discretion|2|||
131534389|NCT04827576|473581441|FG003|Overall Study|Investigator's Discretion|5|||
131534390|NCT04827576|473581438|FG000|Overall Study|Withdrew Consent|0|||
131534391|NCT04827576|473581439|FG001|Overall Study|Withdrew Consent|3|||
131534392|NCT04827576|473581440|FG002|Overall Study|Withdrew Consent|0|||
131534393|NCT04827576|473581441|FG003|Overall Study|Withdrew Consent|0|||
131534394|NCT04827576|473581438|FG000|Overall Study|Lost to Follow-up|1|||
131534395|NCT04827576|473581439|FG001|Overall Study|Lost to Follow-up|0|||
131534396|NCT04827576|473581440|FG002|Overall Study|Lost to Follow-up|0|||
131534397|NCT04827576|473581441|FG003|Overall Study|Lost to Follow-up|0|||
131534398|NCT04537923|473581442|FG000|Overall Study|Adverse Event|2|||
131534399|NCT04537923|473581443|FG001|Overall Study|Adverse Event|1|||
131534400|NCT04537923|473581444|FG002|Overall Study|Adverse Event|2|||
131534401|NCT04537923|473581445|FG003|Overall Study|Adverse Event|4|||
131534402|NCT04537923|473581442|FG000|Overall Study|Death|3|||
131534403|NCT04537923|473581443|FG001|Overall Study|Death|3|||
131534404|NCT04537923|473581444|FG002|Overall Study|Death|1|||
131534405|NCT04537923|473581445|FG003|Overall Study|Death|11|||
131534406|NCT04537923|473581442|FG000|Overall Study|Lost to Follow-up|1|||
131534407|NCT04537923|473581443|FG001|Overall Study|Lost to Follow-up|2|||
131534408|NCT04537923|473581444|FG002|Overall Study|Lost to Follow-up|1|||
131534409|NCT04537923|473581445|FG003|Overall Study|Lost to Follow-up|6|||
131534410|NCT04537923|473581442|FG000|Overall Study|Physician Decision|1|||
131534411|NCT04537923|473581443|FG001|Overall Study|Physician Decision|0|||
131534412|NCT04537923|473581444|FG002|Overall Study|Physician Decision|2|||
131534413|NCT04537923|473581445|FG003|Overall Study|Physician Decision|5|||
131534414|NCT04537923|473581442|FG000|Overall Study|Pregnancy|1|||
131534415|NCT04537923|473581443|FG001|Overall Study|Pregnancy|0|||
131534416|NCT04537923|473581444|FG002|Overall Study|Pregnancy|0|||
131534417|NCT04537923|473581445|FG003|Overall Study|Pregnancy|0|||
131534418|NCT04537923|473581442|FG000|Overall Study|Withdrawal by Subject|4|||
131534419|NCT04537923|473581443|FG001|Overall Study|Withdrawal by Subject|4|||
131534420|NCT04537923|473581444|FG002|Overall Study|Withdrawal by Subject|4|||
131534421|NCT04537923|473581445|FG003|Overall Study|Withdrawal by Subject|58|||
131534422|NCT04537923|473581442|FG000|Overall Study|Missed study visits|2|||
131534423|NCT04537923|473581443|FG001|Overall Study|Missed study visits|0|||
131534424|NCT04537923|473581444|FG002|Overall Study|Missed study visits|0|||
131534425|NCT04537923|473581445|FG003|Overall Study|Missed study visits|3|||
131534426|NCT04537923|473581442|FG000|Overall Study|Sponsor's decision|0|||
131534427|NCT04537923|473581443|FG001|Overall Study|Sponsor's decision|0|||
131534428|NCT04537923|473581444|FG002|Overall Study|Sponsor's decision|1|||
131534429|NCT04537923|473581445|FG003|Overall Study|Sponsor's decision|1|||
131534430|NCT04537923|473581442|FG000|Overall Study|Safety reasons|1|||
131534431|NCT04537923|473581443|FG001|Overall Study|Safety reasons|0|||
131534432|NCT04537923|473581444|FG002|Overall Study|Safety reasons|0|||
131534433|NCT04537923|473581445|FG003|Overall Study|Safety reasons|0|||
131534434|NCT01261611|473581446|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
131534435|NCT01261611|473581447|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
131534436|NCT01261611|473581448|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
131534437|NCT01261611|473581446|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
131534438|NCT01261611|473581447|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
131534439|NCT01261611|473581448|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
131534440|NCT01261611|473581446|FG000|Treatment Cycle 1|Adverse Event|0|||
131534441|NCT01261611|473581447|FG001|Treatment Cycle 1|Adverse Event|1|||
131534442|NCT01261611|473581448|FG002|Treatment Cycle 1|Adverse Event|0|||
131534443|NCT01261611|473581446|FG000|Treatment Cycle 1|Protocol Violation|0|||
131534444|NCT01261611|473581447|FG001|Treatment Cycle 1|Protocol Violation|0|||
131534445|NCT01261611|473581448|FG002|Treatment Cycle 1|Protocol Violation|2|||
131534446|NCT01261611|473581446|FG000|Treatment Cycle 2|Completed study|4|||
131534447|NCT01261611|473581447|FG001|Treatment Cycle 2|Completed study|0|||
131534448|NCT01261611|473581448|FG002|Treatment Cycle 2|Completed study|0|||
131534449|NCT01261611|473581446|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
131534450|NCT01261611|473581447|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
131534451|NCT01261611|473581448|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
131534452|NCT01261611|473581446|FG000|Treatment Cycle 2|Adverse Event|1|||
131534453|NCT01261611|473581447|FG001|Treatment Cycle 2|Adverse Event|0|||
131534454|NCT01261611|473581448|FG002|Treatment Cycle 2|Adverse Event|0|||
131534455|NCT01261611|473581446|FG000|Treatment Cycle 2|Protocol Violation|2|||
131534456|NCT01261611|473581447|FG001|Treatment Cycle 2|Protocol Violation|0|||
131534457|NCT01261611|473581448|FG002|Treatment Cycle 2|Protocol Violation|0|||
131534458|NCT01261611|473581446|FG000|Treatment Cycle 2|Not otherwise specified|2|||
131534459|NCT01261611|473581447|FG001|Treatment Cycle 2|Not otherwise specified|0|||
131534460|NCT01261611|473581448|FG002|Treatment Cycle 2|Not otherwise specified|0|||
131534461|NCT01261611|473581446|FG000|Treatment Cycle 3|Completed study|24|||
131534462|NCT01261611|473581447|FG001|Treatment Cycle 3|Completed study|0|||
131534463|NCT01261611|473581448|FG002|Treatment Cycle 3|Completed study|0|||
131534464|NCT01261611|473581446|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
131534465|NCT01261611|473581447|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
131534466|NCT01261611|473581448|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
131534467|NCT01261611|473581446|FG000|Treatment Cycle 3|Adverse Event|1|||
131534468|NCT01261611|473581447|FG001|Treatment Cycle 3|Adverse Event|0|||
131534469|NCT01261611|473581448|FG002|Treatment Cycle 3|Adverse Event|0|||
131534470|NCT01261611|473581446|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
131534471|NCT01261611|473581447|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
131534472|NCT01261611|473581448|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
131534473|NCT01261611|473581446|FG000|Treatment Cycle 4|Completed study|87|||
131534474|NCT01261611|473581447|FG001|Treatment Cycle 4|Completed study|0|||
131534475|NCT01261611|473581448|FG002|Treatment Cycle 4|Completed study|0|||
131534476|NCT01261611|473581446|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
131534477|NCT01261611|473581447|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
131534478|NCT01261611|473581448|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
131534479|NCT01261611|473581446|FG000|Treatment Cycle 4|Adverse Event|1|||
131534480|NCT01261611|473581447|FG001|Treatment Cycle 4|Adverse Event|0|||
131534481|NCT01261611|473581448|FG002|Treatment Cycle 4|Adverse Event|0|||
131534482|NCT01261611|473581446|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
131534483|NCT01261611|473581447|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
131534484|NCT01261611|473581448|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
131534485|NCT01261611|473581446|FG000|Treatment Cycle 4|Not otherwise specified|3|||
131534486|NCT01261611|473581447|FG001|Treatment Cycle 4|Not otherwise specified|0|||
131534487|NCT01261611|473581448|FG002|Treatment Cycle 4|Not otherwise specified|0|||
131534488|NCT01261611|473581446|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
131534489|NCT01261611|473581447|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
131534490|NCT01261611|473581448|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
131534491|NCT01261611|473581446|FG000|Treatment Cycle 5|Adverse Event|1|||
131534492|NCT01261611|473581447|FG001|Treatment Cycle 5|Adverse Event|0|||
131534493|NCT01261611|473581448|FG002|Treatment Cycle 5|Adverse Event|0|||
131534494|NCT01261611|473581446|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
131534495|NCT01261611|473581447|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
131534496|NCT01261611|473581448|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
131534497|NCT02527798|473581449|FG000|Overall Study|Physician Decision|1|||
131534498|NCT02527798|473581450|FG001|Overall Study|Physician Decision|0|||
131534499|NCT02527798|473581451|FG002|Overall Study|Physician Decision|1|||
131534500|NCT02527798|473581452|FG003|Overall Study|Physician Decision|1|||
131534501|NCT02527798|473581453|FG004|Overall Study|Physician Decision|0|||
131534502|NCT02527798|473581454|FG005|Overall Study|Physician Decision|0|||
131534503|NCT02527798|473581449|FG000|Overall Study|Death|0|||
131534504|NCT02527798|473581450|FG001|Overall Study|Death|0|||
131534505|NCT02527798|473581451|FG002|Overall Study|Death|1|||
131534506|NCT02527798|473581452|FG003|Overall Study|Death|0|||
131534507|NCT02527798|473581453|FG004|Overall Study|Death|0|||
131534508|NCT02527798|473581454|FG005|Overall Study|Death|0|||
131534509|NCT02527798|473581449|FG000|Overall Study|Withdrawal by Subject|0|||
131534510|NCT02527798|473581450|FG001|Overall Study|Withdrawal by Subject|1|||
131534511|NCT02527798|473581451|FG002|Overall Study|Withdrawal by Subject|2|||
131534512|NCT02527798|473581452|FG003|Overall Study|Withdrawal by Subject|0|||
131534513|NCT02527798|473581453|FG004|Overall Study|Withdrawal by Subject|0|||
131534514|NCT02527798|473581454|FG005|Overall Study|Withdrawal by Subject|0|||
131534515|NCT02527798|473581449|FG000|Overall Study|Reason undisclosed|1|||
131534516|NCT02527798|473581450|FG001|Overall Study|Reason undisclosed|0|||
131534517|NCT02527798|473581451|FG002|Overall Study|Reason undisclosed|1|||
131534518|NCT02527798|473581452|FG003|Overall Study|Reason undisclosed|0|||
131534519|NCT02527798|473581453|FG004|Overall Study|Reason undisclosed|0|||
131534520|NCT02527798|473581454|FG005|Overall Study|Reason undisclosed|0|||
131534521|NCT02527798|473581449|FG000|Overall Study|Did not receive intervention|1|||
131534522|NCT02527798|473581450|FG001|Overall Study|Did not receive intervention|1|||
131534523|NCT02527798|473581451|FG002|Overall Study|Did not receive intervention|0|||
131534524|NCT02527798|473581452|FG003|Overall Study|Did not receive intervention|0|||
131534525|NCT02527798|473581453|FG004|Overall Study|Did not receive intervention|0|||
131534526|NCT02527798|473581454|FG005|Overall Study|Did not receive intervention|0|||
131534527|NCT02041195|473581457|FG000|Overall Study|Adverse Event|1|||
131534528|NCT02041195|473581458|FG001|Overall Study|Adverse Event|2|||
131534529|NCT02041195|473581459|FG002|Overall Study|Adverse Event|0|||
131534530|NCT02041195|473581460|FG003|Overall Study|Adverse Event|0|||
131534531|NCT02041195|473581461|FG004|Overall Study|Adverse Event|0|||
131534532|NCT02041195|473581462|FG005|Overall Study|Adverse Event|0|||
131534533|NCT02041195|473581463|FG006|Overall Study|Adverse Event|3|||
131534534|NCT02041195|473581464|FG007|Overall Study|Adverse Event|0|||
131534535|NCT02041195|473581457|FG000|Overall Study|Withdrawal by Subject|1|||
131534536|NCT02041195|473581458|FG001|Overall Study|Withdrawal by Subject|0|||
131534537|NCT02041195|473581459|FG002|Overall Study|Withdrawal by Subject|0|||
131534538|NCT02041195|473581460|FG003|Overall Study|Withdrawal by Subject|0|||
131534539|NCT02041195|473581461|FG004|Overall Study|Withdrawal by Subject|0|||
131534540|NCT02041195|473581462|FG005|Overall Study|Withdrawal by Subject|0|||
131534541|NCT02041195|473581463|FG006|Overall Study|Withdrawal by Subject|4|||
131534542|NCT02041195|473581464|FG007|Overall Study|Withdrawal by Subject|3|||
131534543|NCT02041195|473581457|FG000|Overall Study|Unable to comply with study visits|0|||
131534544|NCT02041195|473581458|FG001|Overall Study|Unable to comply with study visits|1|||
131534545|NCT02041195|473581459|FG002|Overall Study|Unable to comply with study visits|0|||
131534546|NCT02041195|473581460|FG003|Overall Study|Unable to comply with study visits|0|||
131534547|NCT02041195|473581461|FG004|Overall Study|Unable to comply with study visits|1|||
131534548|NCT02041195|473581462|FG005|Overall Study|Unable to comply with study visits|0|||
131534549|NCT02041195|473581463|FG006|Overall Study|Unable to comply with study visits|0|||
131534550|NCT02041195|473581464|FG007|Overall Study|Unable to comply with study visits|0|||
131534551|NCT00674986|473581465|FG000|Overall Study|Adverse Event|2|||
131534552|NCT00674986|473581466|FG001|Overall Study|Adverse Event|1|||
131534553|NCT00674986|473581465|FG000|Overall Study|Subject withdrew consent|12|||
131534554|NCT00674986|473581466|FG001|Overall Study|Subject withdrew consent|19|||
131534555|NCT00674986|473581465|FG000|Overall Study|Lost to Follow-up|25|||
131534556|NCT00674986|473581466|FG001|Overall Study|Lost to Follow-up|53|||
131534557|NCT00674986|473581465|FG000|Overall Study|Other reasons|4|||
131534558|NCT00674986|473581466|FG001|Overall Study|Other reasons|8|||
131534559|NCT04546581|473581469|FG000|Overall Study|Adverse Event|9|||
131534560|NCT04546581|473581470|FG001|Overall Study|Adverse Event|3|||
131534561|NCT04546581|473581469|FG000|Overall Study|Physician Decision|0|||
131534562|NCT04546581|473581470|FG001|Overall Study|Physician Decision|1|||
131534563|NCT04546581|473581469|FG000|Overall Study|Protocol Violation|1|||
131534564|NCT04546581|473581470|FG001|Overall Study|Protocol Violation|2|||
131534565|NCT04546581|473581469|FG000|Overall Study|Withdrawal by Subject|3|||
131534566|NCT04546581|473581470|FG001|Overall Study|Withdrawal by Subject|7|||
131534567|NCT01585103|473581472|FG000|Overall Study|Unable to swallow Cytosponge|6|||
131534568|NCT01349569|473581474|FG000|Overall Study|Lack of Efficacy|4|||
131534569|NCT01747772|473581475|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
131534570|NCT00626522|473581476|FG000|Overall Study|Protocol Violation|0|||
131534571|NCT00626522|473581477|FG001|Overall Study|Protocol Violation|0|||
131534572|NCT00626522|473581478|FG002|Overall Study|Protocol Violation|0|||
131534573|NCT00626522|473581479|FG003|Overall Study|Protocol Violation|0|||
131534574|NCT00626522|473581480|FG004|Overall Study|Protocol Violation|1|||
131534575|NCT00626522|473581481|FG005|Overall Study|Protocol Violation|0|||
131534576|NCT00626522|473581476|FG000|Overall Study|Adverse Event|2|||
131534577|NCT00626522|473581477|FG001|Overall Study|Adverse Event|1|||
131534578|NCT00626522|473581478|FG002|Overall Study|Adverse Event|2|||
131534579|NCT00626522|473581479|FG003|Overall Study|Adverse Event|0|||
131534580|NCT00626522|473581480|FG004|Overall Study|Adverse Event|1|||
131534581|NCT00626522|473581481|FG005|Overall Study|Adverse Event|1|||
131534582|NCT00626522|473581476|FG000|Overall Study|Withdrawal by Subject|2|||
131534583|NCT00626522|473581477|FG001|Overall Study|Withdrawal by Subject|5|||
131534584|NCT00626522|473581478|FG002|Overall Study|Withdrawal by Subject|5|||
131534585|NCT00626522|473581479|FG003|Overall Study|Withdrawal by Subject|0|||
131534586|NCT00626522|473581480|FG004|Overall Study|Withdrawal by Subject|4|||
131534587|NCT00626522|473581481|FG005|Overall Study|Withdrawal by Subject|1|||
131534588|NCT00626522|473581476|FG000|Overall Study|COPD exacerbation|0|||
131534589|NCT00626522|473581477|FG001|Overall Study|COPD exacerbation|0|||
131534590|NCT00626522|473581478|FG002|Overall Study|COPD exacerbation|0|||
131534591|NCT00626522|473581479|FG003|Overall Study|COPD exacerbation|1|||
131534592|NCT00626522|473581480|FG004|Overall Study|COPD exacerbation|1|||
131534593|NCT00626522|473581481|FG005|Overall Study|COPD exacerbation|0|||
131534594|NCT00626522|473581476|FG000|Overall Study|Lost to Follow-up|0|||
131534595|NCT00626522|473581477|FG001|Overall Study|Lost to Follow-up|1|||
131534596|NCT00626522|473581478|FG002|Overall Study|Lost to Follow-up|0|||
131534597|NCT00626522|473581479|FG003|Overall Study|Lost to Follow-up|0|||
131534598|NCT00626522|473581480|FG004|Overall Study|Lost to Follow-up|0|||
131534599|NCT00626522|473581481|FG005|Overall Study|Lost to Follow-up|0|||
131534600|NCT00626522|473581476|FG000|Overall Study|Inconsistent reason reported|1|||
131534601|NCT00626522|473581477|FG001|Overall Study|Inconsistent reason reported|0|||
131534602|NCT00626522|473581478|FG002|Overall Study|Inconsistent reason reported|0|||
131534603|NCT00626522|473581479|FG003|Overall Study|Inconsistent reason reported|0|||
131534604|NCT00626522|473581480|FG004|Overall Study|Inconsistent reason reported|0|||
131534605|NCT00626522|473581481|FG005|Overall Study|Inconsistent reason reported|0|||
131534606|NCT00626522|473581476|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
131534607|NCT00626522|473581477|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
131534608|NCT00626522|473581478|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
131534609|NCT00626522|473581479|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
131534610|NCT00626522|473581480|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
131534611|NCT00626522|473581481|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
131534612|NCT02280044|473581482|FG000|Overall Study|Planned alternate|0|||
131534613|NCT02280044|473581483|FG001|Overall Study|Planned alternate|2|||
131534614|NCT00896168|473581485|FG000|Overall Study|Adverse Event|4|||
131534615|NCT00896168|473581486|FG001|Overall Study|Adverse Event|7|||
131534616|NCT00896168|473581485|FG000|Overall Study|Treatment failure|8|||
131534617|NCT00896168|473581486|FG001|Overall Study|Treatment failure|10|||
131534618|NCT00896168|473581485|FG000|Overall Study|Lost to Follow-up|1|||
131534619|NCT00896168|473581486|FG001|Overall Study|Lost to Follow-up|1|||
131534620|NCT00896168|473581485|FG000|Overall Study|Other|1|||
131534621|NCT00896168|473581486|FG001|Overall Study|Other|1|||
131534622|NCT01944631|473581495|FG000|Overall Study|Adverse Event|1|||
131534623|NCT01944631|473581496|FG001|Overall Study|Adverse Event|0|||
131534624|NCT01944631|473581495|FG000|Overall Study|Lost to Follow-up|3|||
131534625|NCT01944631|473581496|FG001|Overall Study|Lost to Follow-up|1|||
131534626|NCT01944631|473581495|FG000|Overall Study|Withdrawal by Subject|0|||
131534627|NCT01944631|473581496|FG001|Overall Study|Withdrawal by Subject|1|||
131534628|NCT03822533|473581497|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
131534629|NCT03822533|473581498|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
131534630|NCT03822533|473581497|FG000|3 Month Follow-up|Lost to Follow-up|2|||
131534631|NCT03822533|473581498|FG001|3 Month Follow-up|Lost to Follow-up|2|||
131534632|NCT03822533|473581497|FG000|6 Month Follow-up|Lost to Follow-up|3|||
131534633|NCT03822533|473581498|FG001|6 Month Follow-up|Lost to Follow-up|0|||
131534634|NCT03822533|473581497|FG000|12 Month Follow-up|Lost to Follow-up|2|||
131534635|NCT03822533|473581498|FG001|12 Month Follow-up|Lost to Follow-up|3|||
131534636|NCT03822533|473581497|FG000|12 Month Follow-up|Pregnancy|0|||
131534637|NCT03822533|473581498|FG001|12 Month Follow-up|Pregnancy|1|||
131534638|NCT03822533|473581497|FG000|12 Month Follow-up|Surgery|2|||
131534639|NCT03822533|473581498|FG001|12 Month Follow-up|Surgery|0|||
131534640|NCT03822533|473581497|FG000|12 Month Follow-up|Wrong address|1|||
131534641|NCT03822533|473581498|FG001|12 Month Follow-up|Wrong address|0|||
131534642|NCT03822533|473581497|FG000|12 Month Follow-up|No symptoms|1|||
131534643|NCT03822533|473581498|FG001|12 Month Follow-up|No symptoms|0|||
131534644|NCT03822533|473581497|FG000|12 Month Follow-up|Changed primary care center|0|||
131534645|NCT03822533|473581498|FG001|12 Month Follow-up|Changed primary care center|1|||
131534646|NCT02489500|473581499|FG000|Overall Study|Death|1|||
131534647|NCT02489500|473581500|FG001|Overall Study|Death|1|||
131534648|NCT01917526|473581501|FG000|Overall Study|Protocol Violation|1|||
131534649|NCT01917526|473581502|FG001|Overall Study|Protocol Violation|1|||
131534650|NCT02460991|473581504|FG000|Overall Study|Withdrawal by Subject|0|||
131534651|NCT02460991|473581505|FG001|Overall Study|Withdrawal by Subject|2|||
131534652|NCT00434057|473581506|FG000|Overall Study|Withdrawal by Subject|1|||
131534653|NCT02473952|473581508|FG000|Overall Study|Adverse Event|2|||
131534654|NCT02473952|473581509|FG001|Overall Study|Adverse Event|2|||
131534655|NCT02473952|473581508|FG000|Overall Study|Withdrawal by Subject|0|||
131534656|NCT02473952|473581509|FG001|Overall Study|Withdrawal by Subject|6|||
131534657|NCT00455195|473581510|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
131534658|NCT00455195|473581511|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
131534659|NCT00455195|473581510|FG000|Double-blind Study AGLU02704|Death|1|||
131534660|NCT00455195|473581511|FG001|Double-blind Study AGLU02704|Death|0|||
131534661|NCT00455195|473581510|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
131534662|NCT00455195|473581511|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
131534663|NCT00455195|473581510|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
131534664|NCT00455195|473581511|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
131534665|NCT02117570|473581512|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
131534666|NCT02117570|473581513|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
131534667|NCT02117570|473581514|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
131534668|NCT02117570|473581512|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
131534669|NCT02117570|473581513|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
131534670|NCT02117570|473581514|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
131534671|NCT02117570|473581512|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
131534672|NCT02117570|473581513|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
131534673|NCT02117570|473581514|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
131534674|NCT02117570|473581512|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
131534675|NCT02117570|473581513|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
131534676|NCT02117570|473581514|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
131534677|NCT02117570|473581512|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
131534678|NCT02117570|473581513|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
131534679|NCT02117570|473581514|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
131534680|NCT02117570|473581512|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
131534681|NCT02117570|473581513|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
131534682|NCT02117570|473581514|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
131534683|NCT02117570|473581512|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
131534684|NCT02117570|473581513|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
131534685|NCT02117570|473581514|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
131534686|NCT02148250|473581515|FG000|Screening|Withdrawal by Subject|5|||
131534687|NCT02148250|473581516|FG001|Screening|Withdrawal by Subject|0|||
131534688|NCT03701555|473581517|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
131534689|NCT03701555|473581518|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
131534690|NCT03701555|473581519|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
131534691|NCT03701555|473581520|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
131534692|NCT03701555|473581521|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
131534693|NCT03701555|473581522|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
131534694|NCT03701555|473581523|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
131534695|NCT03701555|473581524|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
131534696|NCT03701555|473581525|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
131534697|NCT03701555|473581526|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
131534698|NCT03701555|473581527|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
131534699|NCT03701555|473581528|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
131534700|NCT03701555|473581529|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
131534701|NCT03701555|473581530|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
131534702|NCT03701555|473581531|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
131534703|NCT03701555|473581532|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
131534704|NCT03701555|473581533|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
131534705|NCT03701555|473581534|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
131534706|NCT03701555|473581535|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
131534707|NCT03701555|473581536|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
131534708|NCT03701555|473581537|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
131534709|NCT03701555|473581538|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
131534710|NCT03701555|473581539|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
131534711|NCT03701555|473581540|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
131534712|NCT03701555|473581541|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
131534713|NCT03701555|473581542|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
131534714|NCT03701555|473581543|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
131534715|NCT03701555|473581544|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
131534716|NCT03701555|473581545|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
131534717|NCT03701555|473581546|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
131534718|NCT03701555|473581547|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
131534719|NCT03701555|473581548|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
131534720|NCT03701555|473581549|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
131534721|NCT03701555|473581550|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
131534722|NCT03701555|473581551|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
131534723|NCT03701555|473581552|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
131534724|NCT03701555|473581517|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
131534725|NCT03701555|473581518|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
131534726|NCT03701555|473581519|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
131534727|NCT03701555|473581520|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
131534728|NCT03701555|473581521|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
131534729|NCT03701555|473581522|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
131534730|NCT03701555|473581523|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
131534731|NCT03701555|473581524|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
131534732|NCT03701555|473581525|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
131534733|NCT03701555|473581526|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
131534734|NCT03701555|473581527|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
131534735|NCT03701555|473581528|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
131534736|NCT03701555|473581529|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
131534737|NCT03701555|473581530|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
131534738|NCT03701555|473581531|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
131534739|NCT03701555|473581532|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
131534740|NCT03701555|473581533|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
131534741|NCT03701555|473581534|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
131534742|NCT03701555|473581535|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
131534743|NCT03701555|473581536|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
131534744|NCT03701555|473581537|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
131534745|NCT03701555|473581538|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
131534746|NCT03701555|473581539|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
131534747|NCT03701555|473581540|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
131534748|NCT03701555|473581541|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
131534749|NCT03701555|473581542|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
131534750|NCT03701555|473581543|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
131534751|NCT03701555|473581544|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
131534752|NCT03701555|473581545|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
131534753|NCT03701555|473581546|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
131534754|NCT03701555|473581547|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
131534755|NCT03701555|473581548|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
131534756|NCT03701555|473581549|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
131534757|NCT03701555|473581550|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
131534758|NCT03701555|473581551|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
131534759|NCT03701555|473581552|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
131534760|NCT03701555|473581517|FG000|Part 2 (Day 1)|Other|0|||
131534761|NCT03701555|473581518|FG001|Part 2 (Day 1)|Other|0|||
131534762|NCT03701555|473581519|FG002|Part 2 (Day 1)|Other|0|||
131534763|NCT03701555|473581520|FG003|Part 2 (Day 1)|Other|0|||
131534764|NCT03701555|473581521|FG004|Part 2 (Day 1)|Other|0|||
131534765|NCT03701555|473581522|FG005|Part 2 (Day 1)|Other|0|||
131534766|NCT03701555|473581523|FG006|Part 2 (Day 1)|Other|0|||
131534767|NCT03701555|473581524|FG007|Part 2 (Day 1)|Other|0|||
131534768|NCT03701555|473581525|FG008|Part 2 (Day 1)|Other|0|||
131534769|NCT03701555|473581526|FG009|Part 2 (Day 1)|Other|0|||
131534770|NCT03701555|473581527|FG010|Part 2 (Day 1)|Other|3|||
131534771|NCT03701555|473581528|FG011|Part 2 (Day 1)|Other|1|||
131534772|NCT03701555|473581529|FG012|Part 2 (Day 1)|Other|0|||
131534773|NCT03701555|473581530|FG013|Part 2 (Day 1)|Other|1|||
131534774|NCT03701555|473581531|FG014|Part 2 (Day 1)|Other|0|||
131534775|NCT03701555|473581532|FG015|Part 2 (Day 1)|Other|2|||
131534776|NCT03701555|473581533|FG016|Part 2 (Day 1)|Other|2|||
131534777|NCT03701555|473581534|FG017|Part 2 (Day 1)|Other|0|||
131534778|NCT03701555|473581535|FG018|Part 2 (Day 1)|Other|0|||
131534779|NCT03701555|473581536|FG019|Part 2 (Day 1)|Other|0|||
131534780|NCT03701555|473581537|FG020|Part 2 (Day 1)|Other|0|||
131534781|NCT03701555|473581538|FG021|Part 2 (Day 1)|Other|0|||
131534782|NCT03701555|473581539|FG022|Part 2 (Day 1)|Other|0|||
131534783|NCT03701555|473581540|FG023|Part 2 (Day 1)|Other|0|||
131534784|NCT03701555|473581541|FG024|Part 2 (Day 1)|Other|0|||
131534785|NCT03701555|473581542|FG025|Part 2 (Day 1)|Other|0|||
131534786|NCT03701555|473581543|FG026|Part 2 (Day 1)|Other|0|||
131534787|NCT03701555|473581544|FG027|Part 2 (Day 1)|Other|0|||
131534788|NCT03701555|473581545|FG028|Part 2 (Day 1)|Other|0|||
131534789|NCT03701555|473581546|FG029|Part 2 (Day 1)|Other|0|||
131534790|NCT03701555|473581547|FG030|Part 2 (Day 1)|Other|0|||
131534791|NCT03701555|473581548|FG031|Part 2 (Day 1)|Other|0|||
131534792|NCT03701555|473581549|FG032|Part 2 (Day 1)|Other|0|||
131534793|NCT03701555|473581550|FG033|Part 2 (Day 1)|Other|0|||
131534794|NCT03701555|473581551|FG034|Part 2 (Day 1)|Other|0|||
131534795|NCT03701555|473581552|FG035|Part 2 (Day 1)|Other|0|||
131534796|NCT03701555|473581517|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
131534797|NCT03701555|473581518|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
131534798|NCT03701555|473581519|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
131534799|NCT03701555|473581520|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
131534800|NCT03701555|473581521|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
131534801|NCT03701555|473581522|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
131534802|NCT03701555|473581523|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
131534803|NCT03701555|473581524|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
131534804|NCT03701555|473581525|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
131534805|NCT03701555|473581526|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
131534806|NCT03701555|473581527|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
131534807|NCT03701555|473581528|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
131534808|NCT03701555|473581529|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
131534809|NCT03701555|473581530|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
131534810|NCT03701555|473581531|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
131534811|NCT03701555|473581532|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
131534812|NCT03701555|473581533|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
131534813|NCT03701555|473581534|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
131534814|NCT03701555|473581535|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
131534815|NCT03701555|473581536|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
131534816|NCT03701555|473581537|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
131534817|NCT03701555|473581538|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
131534818|NCT03701555|473581539|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
131534819|NCT03701555|473581540|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
131534820|NCT03701555|473581541|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
131534821|NCT03701555|473581542|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
131534822|NCT03701555|473581543|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
131534823|NCT03701555|473581544|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
131534824|NCT03701555|473581545|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
131534825|NCT03701555|473581546|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
131534826|NCT03701555|473581547|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
131534827|NCT03701555|473581548|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
131534828|NCT03701555|473581549|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
131534829|NCT03701555|473581550|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
131534830|NCT03701555|473581551|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
131534831|NCT03701555|473581552|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
131534832|NCT03701555|473581517|FG000|Part 3 (Day 1)|Subject Decision|0|||
131534833|NCT03701555|473581518|FG001|Part 3 (Day 1)|Subject Decision|0|||
131534834|NCT03701555|473581519|FG002|Part 3 (Day 1)|Subject Decision|0|||
131534835|NCT03701555|473581520|FG003|Part 3 (Day 1)|Subject Decision|0|||
131534836|NCT03701555|473581521|FG004|Part 3 (Day 1)|Subject Decision|0|||
131534837|NCT03701555|473581522|FG005|Part 3 (Day 1)|Subject Decision|0|||
131534838|NCT03701555|473581523|FG006|Part 3 (Day 1)|Subject Decision|0|||
131534839|NCT03701555|473581524|FG007|Part 3 (Day 1)|Subject Decision|0|||
131534840|NCT03701555|473581525|FG008|Part 3 (Day 1)|Subject Decision|0|||
131534841|NCT03701555|473581526|FG009|Part 3 (Day 1)|Subject Decision|0|||
131534842|NCT03701555|473581527|FG010|Part 3 (Day 1)|Subject Decision|0|||
131534843|NCT03701555|473581528|FG011|Part 3 (Day 1)|Subject Decision|0|||
131534844|NCT03701555|473581529|FG012|Part 3 (Day 1)|Subject Decision|0|||
131534845|NCT03701555|473581530|FG013|Part 3 (Day 1)|Subject Decision|0|||
131534846|NCT03701555|473581531|FG014|Part 3 (Day 1)|Subject Decision|0|||
131534847|NCT03701555|473581532|FG015|Part 3 (Day 1)|Subject Decision|0|||
131534848|NCT03701555|473581533|FG016|Part 3 (Day 1)|Subject Decision|0|||
131534849|NCT03701555|473581534|FG017|Part 3 (Day 1)|Subject Decision|0|||
131534850|NCT03701555|473581535|FG018|Part 3 (Day 1)|Subject Decision|0|||
131534851|NCT03701555|473581536|FG019|Part 3 (Day 1)|Subject Decision|0|||
131534852|NCT03701555|473581537|FG020|Part 3 (Day 1)|Subject Decision|0|||
131534853|NCT03701555|473581538|FG021|Part 3 (Day 1)|Subject Decision|0|||
131534854|NCT03701555|473581539|FG022|Part 3 (Day 1)|Subject Decision|0|||
131534855|NCT03701555|473581540|FG023|Part 3 (Day 1)|Subject Decision|0|||
131534856|NCT03701555|473581541|FG024|Part 3 (Day 1)|Subject Decision|0|||
131534857|NCT03701555|473581542|FG025|Part 3 (Day 1)|Subject Decision|0|||
131534858|NCT03701555|473581543|FG026|Part 3 (Day 1)|Subject Decision|1|||
131534859|NCT03701555|473581544|FG027|Part 3 (Day 1)|Subject Decision|0|||
131534860|NCT03701555|473581545|FG028|Part 3 (Day 1)|Subject Decision|0|||
131534861|NCT03701555|473581546|FG029|Part 3 (Day 1)|Subject Decision|0|||
131534862|NCT03701555|473581547|FG030|Part 3 (Day 1)|Subject Decision|0|||
131534863|NCT03701555|473581548|FG031|Part 3 (Day 1)|Subject Decision|2|||
131534864|NCT03701555|473581549|FG032|Part 3 (Day 1)|Subject Decision|1|||
131534865|NCT03701555|473581550|FG033|Part 3 (Day 1)|Subject Decision|1|||
131534866|NCT03701555|473581551|FG034|Part 3 (Day 1)|Subject Decision|0|||
131534867|NCT03701555|473581552|FG035|Part 3 (Day 1)|Subject Decision|0|||
131534868|NCT03701555|473581517|FG000|Part 3 (Day 1)|Other|0|||
131534869|NCT03701555|473581518|FG001|Part 3 (Day 1)|Other|0|||
131534870|NCT03701555|473581519|FG002|Part 3 (Day 1)|Other|0|||
131534871|NCT03701555|473581520|FG003|Part 3 (Day 1)|Other|0|||
131534872|NCT03701555|473581521|FG004|Part 3 (Day 1)|Other|0|||
131534873|NCT03701555|473581522|FG005|Part 3 (Day 1)|Other|0|||
131534874|NCT03701555|473581523|FG006|Part 3 (Day 1)|Other|0|||
131534875|NCT03701555|473581524|FG007|Part 3 (Day 1)|Other|0|||
131534876|NCT03701555|473581525|FG008|Part 3 (Day 1)|Other|0|||
131534877|NCT03701555|473581526|FG009|Part 3 (Day 1)|Other|0|||
131534878|NCT03701555|473581527|FG010|Part 3 (Day 1)|Other|0|||
131534879|NCT03701555|473581528|FG011|Part 3 (Day 1)|Other|0|||
131534880|NCT03701555|473581529|FG012|Part 3 (Day 1)|Other|0|||
131534881|NCT03701555|473581530|FG013|Part 3 (Day 1)|Other|0|||
131534882|NCT03701555|473581531|FG014|Part 3 (Day 1)|Other|0|||
131534883|NCT03701555|473581532|FG015|Part 3 (Day 1)|Other|0|||
131534884|NCT03701555|473581533|FG016|Part 3 (Day 1)|Other|0|||
131534885|NCT03701555|473581534|FG017|Part 3 (Day 1)|Other|0|||
131534886|NCT03701555|473581535|FG018|Part 3 (Day 1)|Other|0|||
131534887|NCT03701555|473581536|FG019|Part 3 (Day 1)|Other|0|||
131534888|NCT03701555|473581537|FG020|Part 3 (Day 1)|Other|0|||
131534889|NCT03701555|473581538|FG021|Part 3 (Day 1)|Other|0|||
131534890|NCT03701555|473581539|FG022|Part 3 (Day 1)|Other|0|||
131534891|NCT03701555|473581540|FG023|Part 3 (Day 1)|Other|0|||
131534892|NCT03701555|473581541|FG024|Part 3 (Day 1)|Other|1|||
131534893|NCT03701555|473581542|FG025|Part 3 (Day 1)|Other|1|||
131534894|NCT03701555|473581543|FG026|Part 3 (Day 1)|Other|0|||
131534895|NCT03701555|473581544|FG027|Part 3 (Day 1)|Other|0|||
131534896|NCT03701555|473581545|FG028|Part 3 (Day 1)|Other|0|||
131534897|NCT03701555|473581546|FG029|Part 3 (Day 1)|Other|1|||
131534898|NCT03701555|473581547|FG030|Part 3 (Day 1)|Other|1|||
131534899|NCT03701555|473581548|FG031|Part 3 (Day 1)|Other|0|||
131534900|NCT03701555|473581549|FG032|Part 3 (Day 1)|Other|1|||
131534901|NCT03701555|473581550|FG033|Part 3 (Day 1)|Other|1|||
131534902|NCT03701555|473581551|FG034|Part 3 (Day 1)|Other|0|||
131534903|NCT03701555|473581552|FG035|Part 3 (Day 1)|Other|0|||
131534904|NCT02370602|473581555|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131534905|NCT02370602|473581556|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131534906|NCT02370602|473581557|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131534907|NCT02370602|473581558|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
131534908|NCT02370602|473581559|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131534909|NCT02370602|473581560|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
131534910|NCT03349710|473581561|FG000|Treatment Period|Death|0|||
131534911|NCT03349710|473581562|FG001|Treatment Period|Death|0|||
131534912|NCT03349710|473581563|FG002|Treatment Period|Death|1|||
131534913|NCT03349710|473581564|FG003|Treatment Period|Death|0|||
131534914|NCT03349710|473581561|FG000|Treatment Period|Disease Progression|0|||
131534915|NCT03349710|473581562|FG001|Treatment Period|Disease Progression|2|||
131534916|NCT03349710|473581563|FG002|Treatment Period|Disease Progression|0|||
131534917|NCT03349710|473581564|FG003|Treatment Period|Disease Progression|1|||
131534918|NCT03349710|473581561|FG000|Treatment Period|Study Drug Toxicity|1|||
131534919|NCT03349710|473581562|FG001|Treatment Period|Study Drug Toxicity|0|||
131534920|NCT03349710|473581563|FG002|Treatment Period|Study Drug Toxicity|1|||
131534921|NCT03349710|473581564|FG003|Treatment Period|Study Drug Toxicity|1|||
131534922|NCT03349710|473581561|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
131534923|NCT03349710|473581562|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
131534924|NCT03349710|473581563|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
131534925|NCT03349710|473581564|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
131534926|NCT03349710|473581561|FG000|Treatment Period|admin reason by sponsor|0|||
131534927|NCT03349710|473581562|FG001|Treatment Period|admin reason by sponsor|7|||
131534928|NCT03349710|473581563|FG002|Treatment Period|admin reason by sponsor|0|||
131534929|NCT03349710|473581564|FG003|Treatment Period|admin reason by sponsor|19|||
131534930|NCT03349710|473581561|FG000|Treatment Period|Other Reason|2|||
131534931|NCT03349710|473581562|FG001|Treatment Period|Other Reason|0|||
131534932|NCT03349710|473581563|FG002|Treatment Period|Other Reason|2|||
131534933|NCT03349710|473581564|FG003|Treatment Period|Other Reason|1|||
131534934|NCT03349710|473581561|FG000|Treatment Period|completed|6|||
131534935|NCT03349710|473581562|FG001|Treatment Period|completed|0|||
131534936|NCT03349710|473581563|FG002|Treatment Period|completed|18|||
131534937|NCT03349710|473581564|FG003|Treatment Period|completed|1|||
131534938|NCT03349710|473581561|FG000|Treatment Period|participant request to discontinue|0|||
131534939|NCT03349710|473581562|FG001|Treatment Period|participant request to discontinue|0|||
131534940|NCT03349710|473581563|FG002|Treatment Period|participant request to discontinue|4|||
131534941|NCT03349710|473581564|FG003|Treatment Period|participant request to discontinue|0|||
131534942|NCT03349710|473581561|FG000|Treatment Period|participant withdrew consent|1|||
131534943|NCT03349710|473581562|FG001|Treatment Period|participant withdrew consent|0|||
131534944|NCT03349710|473581563|FG002|Treatment Period|participant withdrew consent|0|||
131534945|NCT03349710|473581564|FG003|Treatment Period|participant withdrew consent|0|||
131534946|NCT01296568|473581565|FG000|Continued Access Phase|Lost to Follow-up|1|||
131534947|NCT01296568|473581565|FG000|Continued Access Phase|Withdrawal by Subject|1|||
131534948|NCT01296568|473581565|FG000|Continued Access Phase|Disease Progression|1|||
131534949|NCT00237744|473581566|FG000|Overall Study|Withdrawal by Subject|3|||
131534950|NCT00237744|473581567|FG001|Overall Study|Withdrawal by Subject|1|||
131534951|NCT00237744|473581568|FG002|Overall Study|Withdrawal by Subject|0|||
131534952|NCT04258020|473581569|FG000|Overall Study|Withdrawal by Subject|1|||
131534953|NCT04258020|473581570|FG001|Overall Study|Withdrawal by Subject|0|||
131534954|NCT02097472|473581571|FG000|Received Vaccination 2|Adverse Event|0|||
131534955|NCT02097472|473581572|FG001|Received Vaccination 2|Adverse Event|0|||
131534956|NCT02097472|473581573|FG002|Received Vaccination 2|Adverse Event|0|||
131534957|NCT02097472|473581574|FG003|Received Vaccination 2|Adverse Event|0|||
131534958|NCT02097472|473581575|FG004|Received Vaccination 2|Adverse Event|0|||
131534959|NCT02097472|473581576|FG005|Received Vaccination 2|Adverse Event|0|||
131534960|NCT02097472|473581577|FG006|Received Vaccination 2|Adverse Event|1|||
131534961|NCT02097472|473581578|FG007|Received Vaccination 2|Adverse Event|0|||
131534962|NCT03305016|473581579|FG000|Overall Study|Withdrawal by Subject|2|||
131534963|NCT02119416|473581580|FG000|Overall Study|Protocol Violation|1|||
131534964|NCT02119416|473581581|FG001|Overall Study|Protocol Violation|1|||
131534965|NCT02119416|473581582|FG002|Overall Study|Protocol Violation|1|||
131534966|NCT02119416|473581580|FG000|Overall Study|wrong pubertal stage|1|||
131534967|NCT02119416|473581581|FG001|Overall Study|wrong pubertal stage|0|||
131534968|NCT02119416|473581582|FG002|Overall Study|wrong pubertal stage|1|||
131534969|NCT01519206|473581585|FG000|Overall Study|Lost to Follow-up|3|||
131534970|NCT01519206|473581585|FG000|Overall Study|Missed Visit|2|||
131534971|NCT03043664|473581586|FG000|Overall Study|Lost to Follow-up|1|||
131534972|NCT03593655|473581587|FG000|First Product Use Period|Withdrawal by Subject|1|||
131534973|NCT03593655|473581588|FG001|First Product Use Period|Withdrawal by Subject|1|||
131534974|NCT03593655|473581587|FG000|First Product Use Period|Lost to Follow-up|1|||
131534975|NCT03593655|473581588|FG001|First Product Use Period|Lost to Follow-up|3|||
131534976|NCT03593655|473581587|FG000|Second Product Use Period|Withdrawal by Subject|1|||
131534977|NCT03593655|473581588|FG001|Second Product Use Period|Withdrawal by Subject|1|||
131534978|NCT03593655|473581587|FG000|Second Product Use Period|Lost to Follow-up|1|||
131534979|NCT03593655|473581588|FG001|Second Product Use Period|Lost to Follow-up|0|||
131534980|NCT03593655|473581587|FG000|Third Product Use Period|Lost to Follow-up|1|||
131534981|NCT03593655|473581588|FG001|Third Product Use Period|Lost to Follow-up|2|||
131534982|NCT03593655|473581587|FG000|Third Product Use Period|Physician Decision|0|||
131534983|NCT03593655|473581588|FG001|Third Product Use Period|Physician Decision|1|||
131534984|NCT03593655|473581587|FG000|Third Product Use Period|Withdrawal by Subject|0|||
131534985|NCT03593655|473581588|FG001|Third Product Use Period|Withdrawal by Subject|1|||
131534986|NCT05046795|473581591|FG000|Overall Study|Adverse Event|13|||
131534987|NCT05046795|473581592|FG001|Overall Study|Adverse Event|15|||
131534988|NCT05046795|473581591|FG000|Overall Study|Withdrawal by Subject|4|||
131534989|NCT05046795|473581592|FG001|Overall Study|Withdrawal by Subject|7|||
131534990|NCT05046795|473581591|FG000|Overall Study|Physician Decision|1|||
131534991|NCT05046795|473581592|FG001|Overall Study|Physician Decision|2|||
131534992|NCT05046795|473581591|FG000|Overall Study|Protocol Violation|1|||
131534993|NCT05046795|473581592|FG001|Overall Study|Protocol Violation|2|||
131534994|NCT05046795|473581591|FG000|Overall Study|Death|1|||
131534995|NCT05046795|473581592|FG001|Overall Study|Death|0|||
131534996|NCT05046795|473581591|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
131534997|NCT05046795|473581592|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
131534998|NCT02864082|473581593|FG000|Overall Study|Adverse Event|1|||
131534999|NCT02864082|473581594|FG001|Overall Study|Adverse Event|1|||
131535000|NCT02864082|473581593|FG000|Overall Study|Lost to Follow-up|0|||
131535001|NCT02864082|473581594|FG001|Overall Study|Lost to Follow-up|1|||
131535002|NCT02864082|473581593|FG000|Overall Study|Withdrawal by Subject|2|||
131535003|NCT02864082|473581594|FG001|Overall Study|Withdrawal by Subject|2|||
131535004|NCT01127178|473581595|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
131535005|NCT01127178|473581596|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
131535006|NCT01127178|473581595|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
131535007|NCT01127178|473581596|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
131535008|NCT01127178|473581595|FG000|Dose Escalation: Treatment Phase|Other|2|||
131535009|NCT01127178|473581596|FG001|Dose Escalation: Treatment Phase|Other|0|||
131535010|NCT01127178|473581595|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
131535011|NCT01127178|473581596|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
131535012|NCT01127178|473581595|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
131535013|NCT01127178|473581596|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
131535014|NCT01127178|473581595|FG000|Dose Escalation: Extension Phase|Other|1|||
131535015|NCT01127178|473581596|FG001|Dose Escalation: Extension Phase|Other|0|||
131535016|NCT04139317|473581597|FG000|Overall Study|Adverse Event|10|||
131535017|NCT04139317|473581598|FG001|Overall Study|Adverse Event|2|||
131535018|NCT04139317|473581597|FG000|Overall Study|Death|6|||
131535019|NCT04139317|473581598|FG001|Overall Study|Death|4|||
131535020|NCT04139317|473581597|FG000|Overall Study|Lost to Follow-up|1|||
131535021|NCT04139317|473581598|FG001|Overall Study|Lost to Follow-up|0|||
131535022|NCT04139317|473581597|FG000|Overall Study|Physician Decision|3|||
131535023|NCT04139317|473581598|FG001|Overall Study|Physician Decision|1|||
131535024|NCT04139317|473581597|FG000|Overall Study|Progressive Disease|19|||
131535025|NCT04139317|473581598|FG001|Overall Study|Progressive Disease|9|||
131535026|NCT04139317|473581597|FG000|Overall Study|Subject Decision|2|||
131535027|NCT04139317|473581598|FG001|Overall Study|Subject Decision|2|||
131535028|NCT03621696|473581599|FG000|Overall Study|Not eligible|0|||
131535029|NCT03621696|473581600|FG001|Overall Study|Not eligible|0|||
131535030|NCT03621696|473581601|FG002|Overall Study|Not eligible|0|||
131535031|NCT03621696|473581602|FG003|Overall Study|Not eligible|5|||
131535032|NCT03621696|473581599|FG000|Overall Study|Withdrawal by Subject|1|||
131535033|NCT03621696|473581600|FG001|Overall Study|Withdrawal by Subject|1|||
131535034|NCT03621696|473581601|FG002|Overall Study|Withdrawal by Subject|1|||
131535035|NCT03621696|473581602|FG003|Overall Study|Withdrawal by Subject|0|||
131535036|NCT03621696|473581599|FG000|Overall Study|Physician Decision|0|||
131535037|NCT03621696|473581600|FG001|Overall Study|Physician Decision|0|||
131535038|NCT03621696|473581601|FG002|Overall Study|Physician Decision|1|||
131535039|NCT03621696|473581602|FG003|Overall Study|Physician Decision|0|||
131535040|NCT04349553|473581603|FG000|Overall Study|Withdrawal by Subject|1|||
131535041|NCT04349553|473581604|FG001|Overall Study|Withdrawal by Subject|0|||
131535042|NCT04349553|473581605|FG002|Overall Study|Withdrawal by Subject|1|||
131535043|NCT04349553|473581606|FG003|Overall Study|Withdrawal by Subject|0|||
131535044|NCT02372396|473581611|FG000|Overall Study|Lost to Follow-up|7|||
131535045|NCT02372396|473581612|FG001|Overall Study|Lost to Follow-up|9|||
131535046|NCT01272934|473581615|FG000|Overall Study|Adverse Event|0|||
131535047|NCT01272934|473581616|FG001|Overall Study|Adverse Event|1|||
131535048|NCT01272934|473581615|FG000|Overall Study|Abnormal Laboratory Value|0|||
131535049|NCT01272934|473581616|FG001|Overall Study|Abnormal Laboratory Value|1|||
131535050|NCT00214136|473581617|FG000|Overall Study|Death|5|||
131535051|NCT02310750|473581622|FG000|HP Period 1|Lost to Follow-up|0|||
131535052|NCT02310750|473581623|FG001|HP Period 1|Lost to Follow-up|0|||
131535053|NCT02310750|473581624|FG002|HP Period 1|Lost to Follow-up|0|||
131535054|NCT02310750|473581625|FG003|HP Period 1|Lost to Follow-up|0|||
131535055|NCT02310750|473581626|FG004|HP Period 1|Lost to Follow-up|0|||
131535056|NCT02310750|473581627|FG005|HP Period 1|Lost to Follow-up|0|||
131535057|NCT02310750|473581628|FG006|HP Period 1|Lost to Follow-up|1|||
131535058|NCT02310750|473581629|FG007|HP Period 1|Lost to Follow-up|0|||
131535059|NCT02310750|473581630|FG008|HP Period 1|Lost to Follow-up|0|||
131535060|NCT02310750|473581631|FG009|HP Period 1|Lost to Follow-up|0|||
131535061|NCT02310750|473581632|FG010|HP Period 1|Lost to Follow-up|0|||
131535062|NCT02310750|473581633|FG011|HP Period 1|Lost to Follow-up|0|||
131535063|NCT02310750|473581634|FG012|HP Period 1|Lost to Follow-up|0|||
131535064|NCT02310750|473581635|FG013|HP Period 1|Lost to Follow-up|0|||
131535065|NCT02310750|473581636|FG014|HP Period 1|Lost to Follow-up|0|||
131535066|NCT02310750|473581637|FG015|HP Period 1|Lost to Follow-up|0|||
131535067|NCT02310750|473581622|FG000|HP Period 1|Withdrawal by Subject|1|||
131535068|NCT02310750|473581623|FG001|HP Period 1|Withdrawal by Subject|0|||
131535069|NCT02310750|473581624|FG002|HP Period 1|Withdrawal by Subject|0|||
131535070|NCT02310750|473581625|FG003|HP Period 1|Withdrawal by Subject|1|||
131535071|NCT02310750|473581626|FG004|HP Period 1|Withdrawal by Subject|0|||
131535072|NCT02310750|473581627|FG005|HP Period 1|Withdrawal by Subject|0|||
131535073|NCT02310750|473581628|FG006|HP Period 1|Withdrawal by Subject|0|||
131535074|NCT02310750|473581629|FG007|HP Period 1|Withdrawal by Subject|0|||
131535075|NCT02310750|473581630|FG008|HP Period 1|Withdrawal by Subject|0|||
131535076|NCT02310750|473581631|FG009|HP Period 1|Withdrawal by Subject|0|||
131535077|NCT02310750|473581632|FG010|HP Period 1|Withdrawal by Subject|0|||
131535078|NCT02310750|473581633|FG011|HP Period 1|Withdrawal by Subject|0|||
131535079|NCT02310750|473581634|FG012|HP Period 1|Withdrawal by Subject|0|||
131535080|NCT02310750|473581635|FG013|HP Period 1|Withdrawal by Subject|0|||
131535081|NCT02310750|473581636|FG014|HP Period 1|Withdrawal by Subject|0|||
131535082|NCT02310750|473581637|FG015|HP Period 1|Withdrawal by Subject|0|||
131535083|NCT02310750|473581622|FG000|HP Washout 1|Lost to Follow-up|0|||
131535084|NCT02310750|473581623|FG001|HP Washout 1|Lost to Follow-up|0|||
131535085|NCT02310750|473581624|FG002|HP Washout 1|Lost to Follow-up|1|||
131535086|NCT02310750|473581625|FG003|HP Washout 1|Lost to Follow-up|1|||
131535087|NCT02310750|473581626|FG004|HP Washout 1|Lost to Follow-up|2|||
131535088|NCT02310750|473581627|FG005|HP Washout 1|Lost to Follow-up|2|||
131535089|NCT02310750|473581628|FG006|HP Washout 1|Lost to Follow-up|3|||
131535090|NCT02310750|473581629|FG007|HP Washout 1|Lost to Follow-up|0|||
131535091|NCT02310750|473581630|FG008|HP Washout 1|Lost to Follow-up|0|||
131535092|NCT02310750|473581631|FG009|HP Washout 1|Lost to Follow-up|0|||
131535093|NCT02310750|473581632|FG010|HP Washout 1|Lost to Follow-up|0|||
131535094|NCT02310750|473581633|FG011|HP Washout 1|Lost to Follow-up|0|||
131535095|NCT02310750|473581634|FG012|HP Washout 1|Lost to Follow-up|0|||
131535096|NCT02310750|473581635|FG013|HP Washout 1|Lost to Follow-up|0|||
131535097|NCT02310750|473581636|FG014|HP Washout 1|Lost to Follow-up|0|||
131535098|NCT02310750|473581637|FG015|HP Washout 1|Lost to Follow-up|0|||
131535099|NCT02310750|473581622|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535100|NCT02310750|473581623|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535101|NCT02310750|473581624|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535102|NCT02310750|473581625|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
131535103|NCT02310750|473581626|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535104|NCT02310750|473581627|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
131535105|NCT02310750|473581628|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535106|NCT02310750|473581629|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535107|NCT02310750|473581630|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
131535108|NCT02310750|473581631|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
131535109|NCT02310750|473581632|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535110|NCT02310750|473581633|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535111|NCT02310750|473581634|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535112|NCT02310750|473581635|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535113|NCT02310750|473581636|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535114|NCT02310750|473581637|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
131535115|NCT02310750|473581622|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535116|NCT02310750|473581623|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535117|NCT02310750|473581624|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535118|NCT02310750|473581625|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535119|NCT02310750|473581626|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535120|NCT02310750|473581627|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535121|NCT02310750|473581628|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535122|NCT02310750|473581629|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535123|NCT02310750|473581630|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535124|NCT02310750|473581631|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
131535125|NCT02310750|473581632|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535126|NCT02310750|473581633|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535127|NCT02310750|473581634|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535128|NCT02310750|473581635|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535129|NCT02310750|473581636|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535130|NCT02310750|473581637|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
131535131|NCT02310750|473581622|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535132|NCT02310750|473581623|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535133|NCT02310750|473581624|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535134|NCT02310750|473581625|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535135|NCT02310750|473581626|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535136|NCT02310750|473581627|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535137|NCT02310750|473581628|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535138|NCT02310750|473581629|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
131535139|NCT02310750|473581630|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
131535140|NCT02310750|473581631|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
131535141|NCT02310750|473581632|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535142|NCT02310750|473581633|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535143|NCT02310750|473581634|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535144|NCT02310750|473581635|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535145|NCT02310750|473581636|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535146|NCT02310750|473581637|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131535147|NCT02310750|473581622|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535148|NCT02310750|473581623|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535149|NCT02310750|473581624|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535150|NCT02310750|473581625|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535151|NCT02310750|473581626|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535152|NCT02310750|473581627|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535153|NCT02310750|473581628|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535154|NCT02310750|473581629|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
131535155|NCT02310750|473581630|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
131535156|NCT02310750|473581631|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535157|NCT02310750|473581632|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535158|NCT02310750|473581633|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535159|NCT02310750|473581634|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535160|NCT02310750|473581635|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535161|NCT02310750|473581636|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535162|NCT02310750|473581637|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131535163|NCT02310750|473581622|FG000|HP Washout 2|Lost to Follow-up|0|||
131535164|NCT02310750|473581623|FG001|HP Washout 2|Lost to Follow-up|0|||
131535165|NCT02310750|473581624|FG002|HP Washout 2|Lost to Follow-up|0|||
131535166|NCT02310750|473581625|FG003|HP Washout 2|Lost to Follow-up|0|||
131535167|NCT02310750|473581626|FG004|HP Washout 2|Lost to Follow-up|1|||
131535168|NCT02310750|473581627|FG005|HP Washout 2|Lost to Follow-up|0|||
131535169|NCT02310750|473581628|FG006|HP Washout 2|Lost to Follow-up|7|||
131535170|NCT02310750|473581629|FG007|HP Washout 2|Lost to Follow-up|0|||
131535171|NCT02310750|473581630|FG008|HP Washout 2|Lost to Follow-up|0|||
131535172|NCT02310750|473581631|FG009|HP Washout 2|Lost to Follow-up|0|||
131535173|NCT02310750|473581632|FG010|HP Washout 2|Lost to Follow-up|0|||
131535174|NCT02310750|473581633|FG011|HP Washout 2|Lost to Follow-up|0|||
131535175|NCT02310750|473581634|FG012|HP Washout 2|Lost to Follow-up|0|||
131535176|NCT02310750|473581635|FG013|HP Washout 2|Lost to Follow-up|0|||
131535177|NCT02310750|473581636|FG014|HP Washout 2|Lost to Follow-up|0|||
131535178|NCT02310750|473581637|FG015|HP Washout 2|Lost to Follow-up|0|||
131535179|NCT01226745|473581640|FG000|Overall Study|Did not complete schedule of assessments|8|||
131535180|NCT01226745|473581641|FG001|Overall Study|Did not complete schedule of assessments|3|||
131535181|NCT01226745|473581642|FG002|Overall Study|Did not complete schedule of assessments|6|||
131535182|NCT01226745|473581643|FG003|Overall Study|Did not complete schedule of assessments|0|||
131535183|NCT01226745|473581644|FG004|Overall Study|Did not complete schedule of assessments|0|||
131535184|NCT01226745|473581645|FG005|Overall Study|Did not complete schedule of assessments|1|||
131535185|NCT01226745|473581640|FG000|Overall Study|Lost to Follow-up|2|||
131535186|NCT01226745|473581641|FG001|Overall Study|Lost to Follow-up|6|||
131535187|NCT01226745|473581642|FG002|Overall Study|Lost to Follow-up|6|||
131535188|NCT01226745|473581643|FG003|Overall Study|Lost to Follow-up|1|||
131535189|NCT01226745|473581644|FG004|Overall Study|Lost to Follow-up|1|||
131535190|NCT01226745|473581645|FG005|Overall Study|Lost to Follow-up|2|||
131535191|NCT01226745|473581640|FG000|Overall Study|Death|1|||
131535192|NCT01226745|473581641|FG001|Overall Study|Death|0|||
131535193|NCT01226745|473581642|FG002|Overall Study|Death|0|||
131535194|NCT01226745|473581643|FG003|Overall Study|Death|0|||
131535195|NCT01226745|473581644|FG004|Overall Study|Death|0|||
131535196|NCT01226745|473581645|FG005|Overall Study|Death|1|||
131535197|NCT01226745|473581640|FG000|Overall Study|Other|6|||
131535198|NCT01226745|473581641|FG001|Overall Study|Other|7|||
131535199|NCT01226745|473581642|FG002|Overall Study|Other|8|||
131535200|NCT01226745|473581643|FG003|Overall Study|Other|4|||
131535201|NCT01226745|473581644|FG004|Overall Study|Other|3|||
131535202|NCT01226745|473581645|FG005|Overall Study|Other|1|||
131535203|NCT01435577|473581648|FG000|Overall Study|Adverse Event|10|||
131535204|NCT01435577|473581649|FG001|Overall Study|Adverse Event|0|||
131535205|NCT01435577|473581648|FG000|Overall Study|Lack of Efficacy|7|||
131535206|NCT01435577|473581649|FG001|Overall Study|Lack of Efficacy|51|||
131535207|NCT01435577|473581648|FG000|Overall Study|Alternative treatment started|0|||
131535208|NCT01435577|473581649|FG001|Overall Study|Alternative treatment started|1|||
131535209|NCT00718718|473581651|FG000|Prior to Week 12|Adverse Event|0|||
131535210|NCT00718718|473581652|FG001|Prior to Week 12|Adverse Event|0|||
131535211|NCT00718718|473581653|FG002|Prior to Week 12|Adverse Event|0|||
131535212|NCT00718718|473581654|FG003|Prior to Week 12|Adverse Event|0|||
131535213|NCT00718718|473581655|FG004|Prior to Week 12|Adverse Event|0|||
131535214|NCT00718718|473581656|FG005|Prior to Week 12|Adverse Event|0|||
131535215|NCT00718718|473581657|FG006|Prior to Week 12|Adverse Event|0|||
131535216|NCT00718718|473581658|FG007|Prior to Week 12|Adverse Event|1|||
131535217|NCT00718718|473581659|FG008|Prior to Week 12|Adverse Event|1|||
131535218|NCT00718718|473581660|FG009|Prior to Week 12|Adverse Event|0|||
131535219|NCT00718718|473581651|FG000|Prior to Week 12|Withdrawal by Subject|0|||
131535220|NCT00718718|473581652|FG001|Prior to Week 12|Withdrawal by Subject|0|||
131535221|NCT00718718|473581653|FG002|Prior to Week 12|Withdrawal by Subject|0|||
131535222|NCT00718718|473581654|FG003|Prior to Week 12|Withdrawal by Subject|0|||
131535223|NCT00718718|473581655|FG004|Prior to Week 12|Withdrawal by Subject|3|||
131535224|NCT00718718|473581656|FG005|Prior to Week 12|Withdrawal by Subject|0|||
131535225|NCT00718718|473581657|FG006|Prior to Week 12|Withdrawal by Subject|1|||
131535226|NCT00718718|473581658|FG007|Prior to Week 12|Withdrawal by Subject|1|||
131535227|NCT00718718|473581659|FG008|Prior to Week 12|Withdrawal by Subject|1|||
131535228|NCT00718718|473581660|FG009|Prior to Week 12|Withdrawal by Subject|0|||
131535229|NCT00718718|473581651|FG000|Prior to Week 12|Other|1|||
131535230|NCT00718718|473581652|FG001|Prior to Week 12|Other|0|||
131535231|NCT00718718|473581653|FG002|Prior to Week 12|Other|1|||
131535232|NCT00718718|473581654|FG003|Prior to Week 12|Other|0|||
131535233|NCT00718718|473581655|FG004|Prior to Week 12|Other|0|||
131535234|NCT00718718|473581656|FG005|Prior to Week 12|Other|0|||
131535235|NCT00718718|473581657|FG006|Prior to Week 12|Other|0|||
131535236|NCT00718718|473581658|FG007|Prior to Week 12|Other|0|||
131535237|NCT00718718|473581659|FG008|Prior to Week 12|Other|0|||
131535238|NCT00718718|473581660|FG009|Prior to Week 12|Other|0|||
131535239|NCT00718718|473581651|FG000|Week 12 to End of Study|Adverse Event|0|||
131535240|NCT00718718|473581652|FG001|Week 12 to End of Study|Adverse Event|0|||
131535241|NCT00718718|473581653|FG002|Week 12 to End of Study|Adverse Event|0|||
131535242|NCT00718718|473581654|FG003|Week 12 to End of Study|Adverse Event|0|||
131535243|NCT00718718|473581655|FG004|Week 12 to End of Study|Adverse Event|0|||
131535244|NCT00718718|473581656|FG005|Week 12 to End of Study|Adverse Event|0|||
131535245|NCT00718718|473581657|FG006|Week 12 to End of Study|Adverse Event|0|||
131535246|NCT00718718|473581658|FG007|Week 12 to End of Study|Adverse Event|1|||
131535247|NCT00718718|473581659|FG008|Week 12 to End of Study|Adverse Event|0|||
131535248|NCT00718718|473581660|FG009|Week 12 to End of Study|Adverse Event|0|||
131535249|NCT00718718|473581651|FG000|Week 12 to End of Study|Death|0|||
131535250|NCT00718718|473581652|FG001|Week 12 to End of Study|Death|0|||
131535251|NCT00718718|473581653|FG002|Week 12 to End of Study|Death|0|||
131535252|NCT00718718|473581654|FG003|Week 12 to End of Study|Death|0|||
131535253|NCT00718718|473581655|FG004|Week 12 to End of Study|Death|0|||
131535254|NCT00718718|473581656|FG005|Week 12 to End of Study|Death|1|||
131535255|NCT00718718|473581657|FG006|Week 12 to End of Study|Death|0|||
131535256|NCT00718718|473581658|FG007|Week 12 to End of Study|Death|0|||
131535257|NCT00718718|473581659|FG008|Week 12 to End of Study|Death|0|||
131535258|NCT00718718|473581660|FG009|Week 12 to End of Study|Death|0|||
131535259|NCT00718718|473581651|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
131535260|NCT00718718|473581652|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
131535261|NCT00718718|473581653|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
131535262|NCT00718718|473581654|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
131535263|NCT00718718|473581655|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
131535264|NCT00718718|473581656|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
131535265|NCT00718718|473581657|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
131535266|NCT00718718|473581658|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
131535267|NCT00718718|473581659|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
131535268|NCT00718718|473581660|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
131535269|NCT00718718|473581651|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
131535270|NCT00718718|473581652|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
131535271|NCT00718718|473581653|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
131535272|NCT00718718|473581654|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
131535273|NCT00718718|473581655|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
131535274|NCT00718718|473581656|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
131535275|NCT00718718|473581657|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
131535276|NCT00718718|473581658|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
131535277|NCT00718718|473581659|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
131535278|NCT00718718|473581660|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
131535279|NCT00718718|473581651|FG000|Week 12 to End of Study|Other|0|||
131535280|NCT00718718|473581652|FG001|Week 12 to End of Study|Other|1|||
131535281|NCT00718718|473581653|FG002|Week 12 to End of Study|Other|0|||
131535282|NCT00718718|473581654|FG003|Week 12 to End of Study|Other|1|||
131535283|NCT00718718|473581655|FG004|Week 12 to End of Study|Other|0|||
131535284|NCT00718718|473581656|FG005|Week 12 to End of Study|Other|0|||
131535285|NCT00718718|473581657|FG006|Week 12 to End of Study|Other|1|||
131535286|NCT00718718|473581658|FG007|Week 12 to End of Study|Other|0|||
131535287|NCT00718718|473581659|FG008|Week 12 to End of Study|Other|0|||
131535288|NCT00718718|473581660|FG009|Week 12 to End of Study|Other|0|||
131535289|NCT01462344|473581661|FG000|Overall Study|Withdrawal by Subject|245|||
131535290|NCT01462344|473581662|FG001|Overall Study|Withdrawal by Subject|226|||
131535291|NCT01462344|473581661|FG000|Overall Study|Adverse Event|24|||
131535292|NCT01462344|473581662|FG001|Overall Study|Adverse Event|23|||
131535293|NCT01462344|473581661|FG000|Overall Study|Asthma Exacerbation|34|||
131535294|NCT01462344|473581662|FG001|Overall Study|Asthma Exacerbation|35|||
131535295|NCT01462344|473581661|FG000|Overall Study|Lack of Efficacy|5|||
131535296|NCT01462344|473581662|FG001|Overall Study|Lack of Efficacy|6|||
131535297|NCT01462344|473581661|FG000|Overall Study|Protocol Violation|68|||
131535298|NCT01462344|473581662|FG001|Overall Study|Protocol Violation|53|||
131535299|NCT01462344|473581661|FG000|Overall Study|Lost to Follow-up|7|||
131535300|NCT01462344|473581662|FG001|Overall Study|Lost to Follow-up|7|||
131535301|NCT01003249|473581663|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131535302|NCT01003249|473581664|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
131535303|NCT01003249|473581663|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
131535304|NCT01003249|473581664|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
131535305|NCT01003249|473581663|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
131535306|NCT01003249|473581664|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131535307|NCT01003249|473581663|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
131535308|NCT01003249|473581664|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
131535309|NCT01962974|473581665|FG000|Overall Study|Study termination|7|||
131535310|NCT03086447|473581666|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131535311|NCT03086447|473581667|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
131535312|NCT03086447|473581666|FG000|Overall Study|Lost Lens|2|||
131535313|NCT03086447|473581667|FG001|Overall Study|Lost Lens|5|||
131535314|NCT03086447|473581666|FG000|Overall Study|Product quality complaint|0|||
131535315|NCT03086447|473581667|FG001|Overall Study|Product quality complaint|1|||
131535316|NCT03086447|473581666|FG000|Overall Study|Lens Damage|1|||
131535317|NCT03086447|473581667|FG001|Overall Study|Lens Damage|6|||
131535318|NCT03086447|473581666|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
131535319|NCT03086447|473581667|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
131535320|NCT03086447|473581666|FG000|Overall Study|Test Article No Longer Available|1|||
131535321|NCT03086447|473581667|FG001|Overall Study|Test Article No Longer Available|0|||
131535322|NCT03086447|473581666|FG000|Overall Study|Protocol Violation|2|||
131535323|NCT03086447|473581667|FG001|Overall Study|Protocol Violation|4|||
131535324|NCT03086447|473581666|FG000|Overall Study|Lost to Follow-up|0|||
131535325|NCT03086447|473581667|FG001|Overall Study|Lost to Follow-up|1|||
131535326|NCT03086447|473581666|FG000|Overall Study|Adverse Event|3|||
131535327|NCT03086447|473581667|FG001|Overall Study|Adverse Event|0|||
131535328|NCT03086447|473581666|FG000|Overall Study|Lens Discomfort|2|||
131535329|NCT03086447|473581667|FG001|Overall Study|Lens Discomfort|1|||
131535330|NCT04745169|473582936|FG000|Overall Study|Kidney transplantation|1|||
131535331|NCT04745169|473582936|FG000|Overall Study|Participant health problems|3|||
131535332|NCT04745169|473582936|FG000|Overall Study|Physician Decision|2|||
131535333|NCT02891187|473582937|FG000|Overall Study|Lost to Follow-up|1|||
131535334|NCT02891187|473582938|FG001|Overall Study|Lost to Follow-up|2|||
131535335|NCT02395120|473582941|FG000|Overall Study|Missed follow-up dental exam|57|||
131535336|NCT02395120|473582942|FG001|Overall Study|Missed follow-up dental exam|62|||
131535337|NCT02395120|473582943|FG002|Overall Study|Missed follow-up dental exam|6|||
131535338|NCT02395120|473582944|FG003|Overall Study|Missed follow-up dental exam|6|||
131535339|NCT02395120|473582945|FG004|Overall Study|Missed follow-up dental exam|51|||
131535340|NCT02526693|473582949|FG000|Overall Study|Physician Decision|3|||
131535341|NCT02526693|473582950|FG001|Overall Study|Physician Decision|1|||
131535342|NCT01983293|473582951|FG000|Overall Study|Withdrawal by Subject|29|||
131535343|NCT01983293|473582952|FG001|Overall Study|Withdrawal by Subject|15|||
131535344|NCT01983293|473582951|FG000|Overall Study|Missing 12-month visit|3|||
131535345|NCT01983293|473582952|FG001|Overall Study|Missing 12-month visit|3|||
131535346|NCT01983293|473582951|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
131535347|NCT01983293|473582952|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
131535348|NCT01275625|473582953|FG000|Overall Study|Death|1|||
131535349|NCT01275625|473582953|FG000|Overall Study|Lack of Efficacy|2|||
131535350|NCT01275625|473582953|FG000|Overall Study|Lost to Follow-up|1|||
131535351|NCT01275625|473582953|FG000|Overall Study|Withdrawal by Subject|3|||
131535352|NCT01275625|473582953|FG000|Overall Study|Protocol Violation|1|||
131535353|NCT01275625|473582953|FG000|Overall Study|Adverse Event|4|||
131535354|NCT01275625|473582953|FG000|Overall Study|Other|1|||
131535355|NCT03581305|473582954|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
131535356|NCT03581305|473582955|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
131535357|NCT03581305|473582954|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
131535358|NCT03581305|473582955|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
131535359|NCT03581305|473582954|FG000|Serotonergic Study|Withdrawal by Subject|5|||
131535360|NCT03581305|473582955|FG001|Serotonergic Study|Withdrawal by Subject|1|||
131535361|NCT01003899|473582956|FG000|Overall Study|Other Adverse Event|8|||
131535362|NCT01003899|473582956|FG000|Overall Study|Not entered|4|||
131535363|NCT01003899|473582956|FG000|Overall Study|Not treated|1|||
131535364|NCT01003899|473582956|FG000|Overall Study|Progressive disease|34|||
131535365|NCT01412944|473582959|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
131535366|NCT01412944|473582960|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
131535367|NCT01412944|473582961|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
131535368|NCT01412944|473582962|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
131535369|NCT01412944|473582963|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
131535370|NCT01412944|473582964|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
131535371|NCT01412944|473582959|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
131535372|NCT01412944|473582960|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
131535373|NCT01412944|473582961|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
131535374|NCT01412944|473582962|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
131535375|NCT01412944|473582963|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
131535376|NCT01412944|473582964|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
131535377|NCT01412944|473582959|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
131535378|NCT01412944|473582960|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
131535379|NCT01412944|473582961|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
131535380|NCT01412944|473582962|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
131535381|NCT01412944|473582963|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
131535382|NCT01412944|473582964|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
131535383|NCT01412944|473582959|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
131535384|NCT01412944|473582960|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
131535385|NCT01412944|473582961|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
131535386|NCT01412944|473582962|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
131535387|NCT01412944|473582963|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
131535388|NCT01412944|473582964|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
131535389|NCT01412944|473582959|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
131535390|NCT01412944|473582960|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
131535391|NCT01412944|473582961|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
131535392|NCT01412944|473582962|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
131535393|NCT01412944|473582963|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
131535394|NCT01412944|473582964|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
131535395|NCT01412944|473582959|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
131535396|NCT01412944|473582960|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
131535397|NCT01412944|473582961|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
131535398|NCT01412944|473582962|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
131535399|NCT01412944|473582963|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
131535400|NCT01412944|473582964|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
131535401|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535402|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535403|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
131535404|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
131535405|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
131535406|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535407|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Adverse Event|0|||
131535408|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Adverse Event|0|||
131535409|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Adverse Event|0|||
131535410|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Adverse Event|0|||
131535411|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Adverse Event|1|||
131535412|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Adverse Event|0|||
131535413|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
131535414|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
131535415|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
131535416|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
131535417|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
131535418|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
131535419|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535420|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535421|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535422|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535423|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535424|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
131535425|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535426|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535427|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535428|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535429|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
131535430|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535431|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
131535432|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
131535433|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535434|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535435|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535436|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131535437|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
131535438|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
131535439|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
131535440|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
131535441|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
131535442|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
131535443|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535444|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
131535445|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535446|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535447|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535448|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
131535449|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535450|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
131535451|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535452|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535453|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535454|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
131535455|NCT01412944|473582959|FG000|Entire: IV + Maintenance|Adverse Event|0|||
131535456|NCT01412944|473582960|FG001|Entire: IV + Maintenance|Adverse Event|1|||
131535457|NCT01412944|473582961|FG002|Entire: IV + Maintenance|Adverse Event|0|||
131535458|NCT01412944|473582962|FG003|Entire: IV + Maintenance|Adverse Event|0|||
131535459|NCT01412944|473582963|FG004|Entire: IV + Maintenance|Adverse Event|0|||
131535460|NCT01412944|473582964|FG005|Entire: IV + Maintenance|Adverse Event|0|||
131535461|NCT01990950|473582965|FG000|Overall Study|Death|3|||
131535462|NCT01990950|473582965|FG000|Overall Study|Lost to Follow-up|2|||
131535463|NCT01990950|473582965|FG000|Overall Study|Withdrawal by Subject|6|||
131535464|NCT01259713|473582967|FG000|Overall Study|Adverse Event|54|||
131535465|NCT01259713|473582968|FG001|Overall Study|Adverse Event|23|||
131535466|NCT01259713|473582967|FG000|Overall Study|Death Not Related to IFI|8|||
131535467|NCT01259713|473582968|FG001|Overall Study|Death Not Related to IFI|1|||
131535468|NCT01259713|473582967|FG000|Overall Study|Investigators Discretion|14|||
131535469|NCT01259713|473582968|FG001|Overall Study|Investigators Discretion|6|||
131535470|NCT01259713|473582967|FG000|Overall Study|Lack of Efficacy|2|||
131535471|NCT01259713|473582968|FG001|Overall Study|Lack of Efficacy|0|||
131535472|NCT01259713|473582967|FG000|Overall Study|Protocol Violation|5|||
131535473|NCT01259713|473582968|FG001|Overall Study|Protocol Violation|4|||
131535474|NCT01259713|473582967|FG000|Overall Study|Subject Withdrew Consent|12|||
131535475|NCT01259713|473582968|FG001|Overall Study|Subject Withdrew Consent|7|||
131535476|NCT06111742|473582969|FG000|Overall Study|Did not receive intervention|1|||
131535477|NCT06111742|473582970|FG001|Overall Study|Did not receive intervention|0|||
131535478|NCT06111742|473582971|FG002|Overall Study|Did not receive intervention|0|||
131535479|NCT06111742|473582969|FG000|Overall Study|Withdrawal by Subject|2|||
131535480|NCT06111742|473582970|FG001|Overall Study|Withdrawal by Subject|0|||
131535481|NCT06111742|473582971|FG002|Overall Study|Withdrawal by Subject|0|||
131535482|NCT04717596|473582972|FG000|Overall Study|Withdrawal by Subject|4|||
131535483|NCT00922428|473582977|FG000|Overall Study|retrospective/extremely implausible data|2|||
131535484|NCT00922428|473582977|FG000|Overall Study|no medication use or questionable use|13|||
131535485|NCT00448539|473582978|FG000|Overall Study|Medication non-compliance|4|||
131535486|NCT00448539|473582979|FG001|Overall Study|Medication non-compliance|1|||
131535487|NCT00448539|473582978|FG000|Overall Study|Protocol Violation|1|||
131535488|NCT00448539|473582979|FG001|Overall Study|Protocol Violation|0|||
131535489|NCT00448539|473582978|FG000|Overall Study|Request of the investigator or sponsor|67|||
131535490|NCT00448539|473582979|FG001|Overall Study|Request of the investigator or sponsor|54|||
131535491|NCT00448539|473582978|FG000|Overall Study|Withdrawal by Subject|20|||
131535492|NCT00448539|473582979|FG001|Overall Study|Withdrawal by Subject|24|||
131535493|NCT00448539|473582978|FG000|Overall Study|Diary non-compliance|1|||
131535494|NCT00448539|473582979|FG001|Overall Study|Diary non-compliance|0|||
131535495|NCT00448539|473582978|FG000|Overall Study|Adverse Event|9|||
131535496|NCT00448539|473582979|FG001|Overall Study|Adverse Event|26|||
131535497|NCT00448539|473582978|FG000|Overall Study|Lack of Efficacy|27|||
131535498|NCT00448539|473582979|FG001|Overall Study|Lack of Efficacy|40|||
131535499|NCT00448539|473582978|FG000|Overall Study|Miscellaneous|2|||
131535500|NCT00448539|473582979|FG001|Overall Study|Miscellaneous|1|||
131535501|NCT00448539|473582978|FG000|Overall Study|Change of meds|2|||
131535502|NCT00448539|473582979|FG001|Overall Study|Change of meds|3|||
131535503|NCT00448539|473582978|FG000|Overall Study|Lost to Follow-up|1|||
131535504|NCT00448539|473582979|FG001|Overall Study|Lost to Follow-up|3|||
131535505|NCT02103439|473582980|FG000|Overall Study|Adverse Event|0|||
131535506|NCT02103439|473582981|FG001|Overall Study|Adverse Event|2|||
131535507|NCT02103439|473582980|FG000|Overall Study|Withdrawal by Subject|3|||
131535508|NCT02103439|473582981|FG001|Overall Study|Withdrawal by Subject|1|||
131535509|NCT00695903|473582982|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
131535510|NCT00695903|473582983|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
131535511|NCT00695903|473582982|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
131535512|NCT00695903|473582983|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
131535513|NCT00695903|473582982|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
131535514|NCT00695903|473582983|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
131535515|NCT00695903|473582982|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
131535516|NCT00695903|473582983|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
131535517|NCT00695903|473582982|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
131535518|NCT00695903|473582983|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
131535519|NCT00695903|473582982|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
131535520|NCT00695903|473582983|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
131535521|NCT00695903|473582982|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
131535522|NCT00695903|473582983|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
131535523|NCT00695903|473582982|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
131535524|NCT00695903|473582983|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
131535525|NCT00695903|473582982|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
131535526|NCT00695903|473582983|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
131535527|NCT03966157|473582984|FG000|Overall Study|Physician Decision|1|||
131535528|NCT03966157|473582985|FG001|Overall Study|Physician Decision|0|||
131535529|NCT02384759|473582987|FG000|Overall Study|Patients not treated|3|||
131535530|NCT02384759|473582988|FG001|Overall Study|Patients not treated|2|||
131535531|NCT03732209|473582990|FG000|Overall Study|Lost to Follow-up|4|||
131535532|NCT03732209|473582991|FG001|Overall Study|Lost to Follow-up|4|||
131535533|NCT03732209|473582990|FG000|Overall Study|Withdrawal by Subject|8|||
131535534|NCT03732209|473582991|FG001|Overall Study|Withdrawal by Subject|9|||
131535535|NCT02063724|473582992|FG000|Overall Study|Disease progression|1|||
131535536|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
131535537|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
131535538|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
131535539|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
131535540|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
131535541|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
131535542|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
131535543|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
131535544|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
131535545|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
131535546|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
131535547|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
131535548|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
131535549|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
131535550|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
131535551|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
131535552|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
131535553|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
131535554|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
131535555|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
131535556|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
131535557|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
131535558|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
131535559|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
131535560|NCT01715805|473582993|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
131535561|NCT01715805|473582994|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
131535562|NCT01715805|473582995|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
131535563|NCT01715805|473582996|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
131535564|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
131535565|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
131535566|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
131535567|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
131535568|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
131535569|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
131535570|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
131535571|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
131535572|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
131535573|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
131535574|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
131535575|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
131535576|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
131535577|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
131535578|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
131535579|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
131535580|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
131535581|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
131535582|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
131535583|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
131535584|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
131535585|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
131535586|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
131535587|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
131535588|NCT01715805|473582993|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
131535589|NCT01715805|473582994|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
131535590|NCT01715805|473582995|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
131535591|NCT01715805|473582996|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
131535592|NCT01618864|473582999|FG000|Overall Study|Withdrawal by Subject|2|||
131535593|NCT01618864|473582999|FG000|Overall Study|Lost to Follow-up|2|||
131535594|NCT05177770|473583000|FG000|Overall Study|Death|4|||
131535595|NCT05177770|473583000|FG000|Overall Study|Withdrawal by Subject|1|||
131535596|NCT05177770|473583000|FG000|Overall Study|Adverse Event prior to dosing|1|||
131535597|NCT00709722|473583005|FG000|Overall Study|Adverse Event|1|||
131535598|NCT04667117|473583006|FG000|Investigational Period|Lost to Follow-up|0|||
131535599|NCT04667117|473583007|FG001|Investigational Period|Lost to Follow-up|0|||
131535600|NCT04667117|473583008|FG002|Investigational Period|Lost to Follow-up|1|||
131535601|NCT04667117|473583006|FG000|Investigational Period|Protocol Deviation|0|||
131535602|NCT04667117|473583007|FG001|Investigational Period|Protocol Deviation|1|||
131535603|NCT04667117|473583008|FG002|Investigational Period|Protocol Deviation|0|||
131535604|NCT04667117|473583006|FG000|Extension Period|Lost to Follow-up|1|||
131535605|NCT04667117|473583007|FG001|Extension Period|Lost to Follow-up|0|||
131535606|NCT04667117|473583008|FG002|Extension Period|Lost to Follow-up|0|||
131535607|NCT01650259|473583022|FG000|Overall Study|Improvement|105|||
131535608|NCT01650259|473583023|FG001|Overall Study|Improvement|0|||
131535609|NCT01650259|473583022|FG000|Overall Study|Adverse Event|127|||
131535610|NCT01650259|473583023|FG001|Overall Study|Adverse Event|0|||
131535611|NCT01650259|473583022|FG000|Overall Study|Lack of Efficacy|143|||
131535612|NCT01650259|473583023|FG001|Overall Study|Lack of Efficacy|0|||
131535613|NCT01650259|473583022|FG000|Overall Study|Lost to Follow-up|435|||
131535614|NCT01650259|473583023|FG001|Overall Study|Lost to Follow-up|0|||
131535615|NCT01650259|473583022|FG000|Overall Study|Patients had no visit after entry|70|||
131535616|NCT01650259|473583023|FG001|Overall Study|Patients had no visit after entry|0|||
131535617|NCT01650259|473583022|FG000|Overall Study|CRF not collected|98|||
131535618|NCT01650259|473583023|FG001|Overall Study|CRF not collected|82|||
131535619|NCT01650259|473583022|FG000|Overall Study|Not treated|1|||
131535620|NCT01650259|473583023|FG001|Overall Study|Not treated|7|||
131535621|NCT01650259|473583022|FG000|Overall Study|Other than listed|64|||
131535622|NCT01650259|473583023|FG001|Overall Study|Other than listed|146|||
131535623|NCT02663128|473583030|FG000|Period 2|Physician Decision|0|||
131535624|NCT02663128|473583031|FG001|Period 2|Physician Decision|0|||
131535625|NCT02663128|473583032|FG002|Period 2|Physician Decision|0|||
131535626|NCT02663128|473583033|FG003|Period 2|Physician Decision|0|||
131535627|NCT02663128|473583034|FG004|Period 2|Physician Decision|1|||
131535628|NCT02663128|473583035|FG005|Period 2|Physician Decision|0|||
131535629|NCT01358526|473583036|FG000|Open-label Titration Period|Adverse Event|95|||
131535630|NCT01358526|473583037|FG001|Open-label Titration Period|Adverse Event|0|||
131535631|NCT01358526|473583038|FG002|Open-label Titration Period|Adverse Event|0|||
131535632|NCT01358526|473583036|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
131535633|NCT01358526|473583037|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
131535634|NCT01358526|473583038|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
131535635|NCT01358526|473583036|FG000|Open-label Titration Period|Lost to Follow-up|25|||
131535636|NCT01358526|473583037|FG001|Open-label Titration Period|Lost to Follow-up|0|||
131535637|NCT01358526|473583038|FG002|Open-label Titration Period|Lost to Follow-up|0|||
131535638|NCT01358526|473583036|FG000|Open-label Titration Period|Lack of Efficacy|107|||
131535639|NCT01358526|473583037|FG001|Open-label Titration Period|Lack of Efficacy|0|||
131535640|NCT01358526|473583038|FG002|Open-label Titration Period|Lack of Efficacy|0|||
131535641|NCT01358526|473583036|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
131535642|NCT01358526|473583037|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
131535643|NCT01358526|473583038|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
131535644|NCT01358526|473583036|FG000|Open-label Titration Period|Administrative|8|||
131535645|NCT01358526|473583037|FG001|Open-label Titration Period|Administrative|0|||
131535646|NCT01358526|473583038|FG002|Open-label Titration Period|Administrative|0|||
131535647|NCT01358526|473583036|FG000|Open-label Titration Period|Did not qualify|178|||
131535648|NCT01358526|473583037|FG001|Open-label Titration Period|Did not qualify|0|||
131535649|NCT01358526|473583038|FG002|Open-label Titration Period|Did not qualify|0|||
131535650|NCT01358526|473583036|FG000|Double-blind Phase|Adverse Event|0|||
131535651|NCT01358526|473583037|FG001|Double-blind Phase|Adverse Event|24|||
131535652|NCT01358526|473583038|FG002|Double-blind Phase|Adverse Event|23|||
131535653|NCT01358526|473583036|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131535654|NCT01358526|473583037|FG001|Double-blind Phase|Withdrawal by Subject|10|||
131535655|NCT01358526|473583038|FG002|Double-blind Phase|Withdrawal by Subject|8|||
131535656|NCT01358526|473583036|FG000|Double-blind Phase|Lost to Follow-up|0|||
131535657|NCT01358526|473583037|FG001|Double-blind Phase|Lost to Follow-up|4|||
131535658|NCT01358526|473583038|FG002|Double-blind Phase|Lost to Follow-up|1|||
131535659|NCT01358526|473583036|FG000|Double-blind Phase|Lack of Efficacy|0|||
131535660|NCT01358526|473583037|FG001|Double-blind Phase|Lack of Efficacy|31|||
131535661|NCT01358526|473583038|FG002|Double-blind Phase|Lack of Efficacy|73|||
131535662|NCT01358526|473583036|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
131535663|NCT01358526|473583037|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
131535664|NCT01358526|473583038|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
131535665|NCT01358526|473583036|FG000|Double-blind Phase|Administrative|0|||
131535666|NCT01358526|473583037|FG001|Double-blind Phase|Administrative|6|||
131535667|NCT01358526|473583038|FG002|Double-blind Phase|Administrative|10|||
131535668|NCT03277313|473583050|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
131535669|NCT03277313|473583051|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
131535670|NCT03277313|473583050|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
131535671|NCT03277313|473583051|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
131535672|NCT03277313|473583050|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
131535673|NCT03277313|473583051|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
131535674|NCT03277313|473583050|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
131535675|NCT03277313|473583051|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
131535676|NCT03277313|473583050|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
131535677|NCT03277313|473583051|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
131535678|NCT02132611|473583054|FG000|Overall Study|Death|2|||
131535679|NCT02194621|473583056|FG000|Overall Study|6 withdrew prior to randomization|2|||
131535680|NCT02194621|473583057|FG001|Overall Study|6 withdrew prior to randomization|2|||
131535681|NCT02194621|473583058|FG002|Overall Study|6 withdrew prior to randomization|2|||
131535682|NCT02194621|473583056|FG000|Overall Study|Withdrawal by Subject|4|||
131535683|NCT02194621|473583057|FG001|Overall Study|Withdrawal by Subject|4|||
131535684|NCT02194621|473583058|FG002|Overall Study|Withdrawal by Subject|7|||
131535685|NCT02763384|473583066|FG000|Overall Study|Physician Decision|1|||
131535686|NCT02763384|473583066|FG000|Overall Study|Rapid decline - went on hospice|1|||
131535687|NCT02493127|473583067|FG000|Overall Study|Lost to Follow-up|1|||
131535688|NCT02493127|473583068|FG001|Overall Study|Lost to Follow-up|1|||
131535689|NCT02075593|473583077|FG000|Overall Study|Withdrawal by Subject|1|||
131535690|NCT00660010|473583078|FG000|Overall Study|Withdrawal by Subject|2|||
131535691|NCT00660010|473583078|FG000|Overall Study|Lost to Follow-up|3|||
131535692|NCT00660010|473583078|FG000|Overall Study|Adverse Event|1|||
131535693|NCT00660010|473583078|FG000|Overall Study|Noncompliance with visit schedule|3|||
131535694|NCT06167031|473583079|FG000|Overall Study|Lost to Follow-up|5|||
131535695|NCT06167031|473583080|FG001|Overall Study|Lost to Follow-up|1|||
131535696|NCT00920426|473584941|FG000|ITZ111451|Adverse Event|1|||
131535697|NCT00920426|473584942|FG001|ITZ111451|Adverse Event|0|||
131535698|NCT00920426|473584943|FG002|ITZ111451|Adverse Event|0|||
131535699|NCT00920426|473584944|FG003|ITZ111451|Adverse Event|0|||
131535700|NCT01432366|473584945|FG000|Overall Study|Non-Responder|7|||
131535701|NCT01432366|473584945|FG000|Overall Study|Adverse Event|8|||
131535702|NCT01432366|473584945|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
131535703|NCT01432366|473584945|FG000|Overall Study|Pregnancy|1|||
131535704|NCT01432366|473584945|FG000|Overall Study|Lost to Follow-up|13|||
131535705|NCT01432366|473584945|FG000|Overall Study|Lack of Efficacy|1|||
131535706|NCT01432366|473584945|FG000|Overall Study|Site Closed|20|||
131535707|NCT01432366|473584945|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
131535708|NCT01432366|473584945|FG000|Overall Study|Other|14|||
131535709|NCT01808690|473584946|FG000|Overall Study|Withdrawal by Subject|1|||
131535710|NCT01808690|473584947|FG001|Overall Study|Withdrawal by Subject|2|||
131535711|NCT00377234|473584951|FG000|Overall Study|Adverse Event|14|||
131535712|NCT00377234|473584952|FG001|Overall Study|Adverse Event|17|||
131535713|NCT00377234|473584951|FG000|Overall Study|Withdrawal by Subject|11|||
131535714|NCT00377234|473584952|FG001|Overall Study|Withdrawal by Subject|9|||
131535715|NCT00377234|473584951|FG000|Overall Study|Lost to Follow-up|4|||
131535716|NCT00377234|473584952|FG001|Overall Study|Lost to Follow-up|2|||
131535717|NCT00377234|473584951|FG000|Overall Study|Administrative|2|||
131535718|NCT00377234|473584952|FG001|Overall Study|Administrative|1|||
131535719|NCT00377234|473584951|FG000|Overall Study|Not assigned|3|||
131535720|NCT00377234|473584952|FG001|Overall Study|Not assigned|2|||
131535721|NCT01880424|473584953|FG000|Overall Study|Adverse Event|7|||
131535722|NCT01880424|473584954|FG001|Overall Study|Adverse Event|6|||
131535723|NCT01880424|473584953|FG000|Overall Study|Lack of Efficacy|1|||
131535724|NCT01880424|473584954|FG001|Overall Study|Lack of Efficacy|4|||
131535725|NCT01880424|473584953|FG000|Overall Study|Lost to Follow-up|3|||
131535726|NCT01880424|473584954|FG001|Overall Study|Lost to Follow-up|2|||
131535727|NCT01880424|473584953|FG000|Overall Study|Protocol Violation|11|||
131535728|NCT01880424|473584954|FG001|Overall Study|Protocol Violation|13|||
131535729|NCT01880424|473584953|FG000|Overall Study|Withdrawal by Subject|10|||
131535730|NCT01880424|473584954|FG001|Overall Study|Withdrawal by Subject|30|||
131535731|NCT01880424|473584953|FG000|Overall Study|Other|1|||
131535732|NCT01880424|473584954|FG001|Overall Study|Other|0|||
131535733|NCT01798927|473584957|FG000|Overall Study|Withdrawal by Subject|1|||
131535734|NCT03750552|473584958|FG000|Overall Study|Adverse Event|5|||
131535735|NCT03750552|473584959|FG001|Overall Study|Adverse Event|1|||
131535736|NCT03750552|473584958|FG000|Overall Study|Withdrawal by Subject|1|||
131535737|NCT03750552|473584959|FG001|Overall Study|Withdrawal by Subject|1|||
131535738|NCT03750552|473584958|FG000|Overall Study|Other|2|||
131535739|NCT03750552|473584959|FG001|Overall Study|Other|0|||
131535740|NCT02062632|473584962|FG000|Overall Study|No treatment data|1|||
131535741|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
131535742|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
131535743|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
131535744|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
131535745|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
131535746|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
131535747|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
131535748|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
131535749|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
131535750|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
131535751|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
131535752|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
131535753|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
131535754|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
131535755|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
131535756|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
131535757|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
131535758|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
131535759|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
131535760|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
131535761|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
131535762|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
131535763|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
131535764|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
131535765|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535766|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535767|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535768|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535769|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535770|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535771|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535772|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535773|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535774|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535775|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535776|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535777|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535778|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535779|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535780|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131535781|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535782|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535783|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
131535784|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
131535785|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
131535786|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535787|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535788|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535789|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535790|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535791|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535792|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535793|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535794|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535795|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535796|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535797|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535798|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535799|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535800|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
131535801|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
131535802|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
131535803|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
131535804|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
131535805|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
131535806|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
131535807|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
131535808|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
131535809|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
131535810|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
131535811|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
131535812|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
131535813|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
131535814|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
131535815|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
131535816|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
131535817|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
131658518|NCT01142232|474035351|FG000|Overall Study|Physician Decision|0|||
131535818|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
131535819|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
131535820|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
131535821|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
131535822|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535823|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535824|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535825|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535826|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535827|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535828|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535829|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535830|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535831|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535832|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535833|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535834|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535835|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535836|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535837|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535838|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535839|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535840|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
131535841|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
131535842|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
131535843|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535844|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
131535845|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
131535846|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535847|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535848|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535849|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535850|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535851|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535852|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535853|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535854|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535855|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535856|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535857|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535858|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535859|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535860|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
131535861|NCT01490632|473584964|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535862|NCT01490632|473584965|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535863|NCT01490632|473584966|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535864|NCT01490632|473584967|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535865|NCT01490632|473584968|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
131535866|NCT01490632|473584969|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535867|NCT01490632|473584970|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535868|NCT01490632|473584971|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535869|NCT01490632|473584972|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535870|NCT01490632|473584973|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535871|NCT01490632|473584974|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535872|NCT01490632|473584975|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535873|NCT01490632|473584976|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535874|NCT01490632|473584977|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535875|NCT01490632|473584978|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535876|NCT01490632|473584979|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535877|NCT01490632|473584980|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535878|NCT01490632|473584981|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535879|NCT01490632|473584982|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535880|NCT01490632|473584983|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
131535881|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535882|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535883|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535884|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535885|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535886|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
131535887|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
131535888|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535889|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535890|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
131535891|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
131535892|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
131535893|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535894|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535895|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535896|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535897|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535898|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535899|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535900|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
131535901|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535902|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535903|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535904|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535905|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535906|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535907|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
131535908|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535909|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
131535910|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
131535911|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
131535912|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535913|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535914|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535915|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535916|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535917|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535918|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535919|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535920|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
131535921|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535922|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535923|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535924|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535925|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535926|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535927|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
131535928|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535929|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535930|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
131535931|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535932|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535933|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535934|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535935|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535936|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535937|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535938|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535939|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535940|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131535941|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535942|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535943|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535944|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535945|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535946|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535947|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
131535948|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535949|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535950|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535951|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535952|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535953|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535954|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535955|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535956|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535957|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535958|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535959|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535960|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
131535961|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535962|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535963|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535964|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535965|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535966|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
131535967|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535968|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535969|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535970|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535971|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535972|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535973|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535974|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535975|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535976|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535977|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535978|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535979|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535980|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
131535981|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535982|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535983|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535984|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535985|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535986|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535987|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
131535988|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535989|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
131535990|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535991|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
131535992|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
131535993|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535994|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535995|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535996|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535997|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535998|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131535999|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131536000|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131536001|NCT01490632|473584964|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536002|NCT01490632|473584965|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536003|NCT01490632|473584966|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536004|NCT01490632|473584967|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536005|NCT01490632|473584968|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536006|NCT01490632|473584969|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
131536007|NCT01490632|473584970|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
131536008|NCT01490632|473584971|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
131536009|NCT01490632|473584972|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
131536010|NCT01490632|473584973|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
131536011|NCT01490632|473584974|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
131536012|NCT01490632|473584975|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
131536013|NCT01490632|473584976|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536014|NCT01490632|473584977|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536015|NCT01490632|473584978|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536016|NCT01490632|473584979|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536017|NCT01490632|473584980|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536018|NCT01490632|473584981|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536019|NCT01490632|473584982|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536020|NCT01490632|473584983|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
131536021|NCT01490632|473584964|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536022|NCT01490632|473584965|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536023|NCT01490632|473584966|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536024|NCT01490632|473584967|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536025|NCT01490632|473584968|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536026|NCT01490632|473584969|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536027|NCT01490632|473584970|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536028|NCT01490632|473584971|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536029|NCT01490632|473584972|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536030|NCT01490632|473584973|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536031|NCT01490632|473584974|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536032|NCT01490632|473584975|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536033|NCT01490632|473584976|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536034|NCT01490632|473584977|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536035|NCT01490632|473584978|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
131536036|NCT01490632|473584979|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
131536037|NCT01490632|473584980|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536038|NCT01490632|473584981|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536039|NCT01490632|473584982|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536040|NCT01490632|473584983|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
131536041|NCT01490632|473584964|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536042|NCT01490632|473584965|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536043|NCT01490632|473584966|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536044|NCT01490632|473584967|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536045|NCT01490632|473584968|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536046|NCT01490632|473584969|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536047|NCT01490632|473584970|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536048|NCT01490632|473584971|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536049|NCT01490632|473584972|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536050|NCT01490632|473584973|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536051|NCT01490632|473584974|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536052|NCT01490632|473584975|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536053|NCT01490632|473584976|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536054|NCT01490632|473584977|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
131536055|NCT01490632|473584978|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536056|NCT01490632|473584979|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536057|NCT01490632|473584980|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536058|NCT01490632|473584981|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536059|NCT01490632|473584982|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536060|NCT01490632|473584983|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
131536061|NCT01490632|473584964|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536062|NCT01490632|473584965|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536063|NCT01490632|473584966|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536064|NCT01490632|473584967|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536065|NCT01490632|473584968|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536066|NCT01490632|473584969|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536067|NCT01490632|473584970|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536068|NCT01490632|473584971|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536069|NCT01490632|473584972|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536070|NCT01490632|473584973|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536071|NCT01490632|473584974|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536072|NCT01490632|473584975|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536073|NCT01490632|473584976|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536074|NCT01490632|473584977|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536075|NCT01490632|473584978|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
131536076|NCT01490632|473584979|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
131536077|NCT01490632|473584980|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536078|NCT01490632|473584981|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536079|NCT01490632|473584982|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536080|NCT01490632|473584983|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
131536081|NCT01490632|473584964|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536082|NCT01490632|473584965|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536083|NCT01490632|473584966|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536084|NCT01490632|473584967|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536085|NCT01490632|473584968|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536086|NCT01490632|473584969|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536087|NCT01490632|473584970|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536088|NCT01490632|473584971|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536089|NCT01490632|473584972|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536090|NCT01490632|473584973|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536091|NCT01490632|473584974|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536092|NCT01490632|473584975|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536093|NCT01490632|473584976|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
131536094|NCT01490632|473584977|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
131536095|NCT01490632|473584978|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
131536096|NCT01490632|473584979|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
131536097|NCT01490632|473584980|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536098|NCT01490632|473584981|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536099|NCT01490632|473584982|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536100|NCT01490632|473584983|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
131536101|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
131536102|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
131536103|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
131536104|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
131536105|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
131536106|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
131536107|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
131536108|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
131536109|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
131536110|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
131536111|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
131536112|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
131536113|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
131536114|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
131536115|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
131536116|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
131536117|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
131536118|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
131536119|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
131536120|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
131536121|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Death|0|||
131536122|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Death|0|||
131536123|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Death|0|||
131536124|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Death|0|||
131536125|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Death|0|||
131536126|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Death|0|||
131536127|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Death|0|||
131536128|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Death|0|||
131536129|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Death|0|||
131536130|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Death|0|||
131536131|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Death|0|||
131536132|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Death|0|||
131536133|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Death|0|||
131536134|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Death|0|||
131536135|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Death|0|||
131536136|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Death|0|||
131536137|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Death|0|||
131536138|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Death|0|||
131536139|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Death|1|||
131536140|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Death|0|||
131536141|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536142|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536143|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536144|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536145|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536146|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536147|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536148|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536149|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536150|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536151|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536152|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536153|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536154|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536155|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536156|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536157|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
131536158|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
131536159|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
131536160|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
131536161|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536162|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536163|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536164|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536165|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536166|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536167|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536168|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536169|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536170|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536171|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536172|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536173|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536174|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536175|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536176|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536177|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536178|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536179|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
131536180|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
131536181|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
131536182|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
131536183|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
131536184|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
131536185|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
131536186|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
131536187|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
131536188|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
131536189|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
131536190|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
131536191|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
131536192|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
131536193|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
131536194|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
131536195|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
131536196|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
131536197|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
131536198|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
131536199|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
131536200|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
131536201|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
131536202|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
131536203|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
131536204|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
131536205|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
131536206|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
131536207|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
131536208|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
131536209|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
131536210|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
131536211|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
131536212|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
131536213|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
131536214|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
131536215|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
131536216|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
131536217|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
131536218|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
131536219|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
131536220|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
131536221|NCT01490632|473584964|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536222|NCT01490632|473584965|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536223|NCT01490632|473584966|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536224|NCT01490632|473584967|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536225|NCT01490632|473584968|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536226|NCT01490632|473584969|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536227|NCT01490632|473584970|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536228|NCT01490632|473584971|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536229|NCT01490632|473584972|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536230|NCT01490632|473584973|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536231|NCT01490632|473584974|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536232|NCT01490632|473584975|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536233|NCT01490632|473584976|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536234|NCT01490632|473584977|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536235|NCT01490632|473584978|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536236|NCT01490632|473584979|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536237|NCT01490632|473584980|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
131536238|NCT01490632|473584981|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
131536239|NCT01490632|473584982|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
131536240|NCT01490632|473584983|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
131536241|NCT00856856|473584989|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
131536242|NCT00856856|473584989|FG000|4-year Clinical Follow-up|Missed visit|1|||
131536243|NCT02696317|473584993|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
131536244|NCT02696317|473584994|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
131536245|NCT02696317|473584993|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
131536246|NCT02696317|473584994|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
131536247|NCT01343368|473584995|FG000|Overall Study|Death|1|||
131536248|NCT01343368|473584996|FG001|Overall Study|Death|0|||
131536249|NCT01343368|473584995|FG000|Overall Study|Lost to Follow-up|1|||
131536250|NCT01343368|473584996|FG001|Overall Study|Lost to Follow-up|0|||
131536251|NCT04955639|473584997|FG000|Overall Study|Withdrawal by Subject|2|||
131536252|NCT04955639|473584998|FG001|Overall Study|Withdrawal by Subject|2|||
131536253|NCT04955639|473584997|FG000|Overall Study|Week 26 survey not completed|2|||
131536254|NCT04955639|473584998|FG001|Overall Study|Week 26 survey not completed|2|||
131536255|NCT04447404|473584999|FG000|Overall Study|Death|2|||
131536256|NCT04447404|473585000|FG001|Overall Study|Death|0|||
131536257|NCT00321854|473585001|FG000|Overall Study|Adverse Event|41|||
131536258|NCT00321854|473585002|FG001|Overall Study|Adverse Event|43|||
131536259|NCT00321854|473585001|FG000|Overall Study|Lack of Efficacy|9|||
131536260|NCT00321854|473585002|FG001|Overall Study|Lack of Efficacy|14|||
131536261|NCT00321854|473585001|FG000|Overall Study|Protocol Violation|6|||
131536262|NCT00321854|473585002|FG001|Overall Study|Protocol Violation|5|||
131536263|NCT00321854|473585001|FG000|Overall Study|Lost to Follow-up|0|||
131536264|NCT00321854|473585002|FG001|Overall Study|Lost to Follow-up|2|||
131536265|NCT00321854|473585001|FG000|Overall Study|Withdrawal by Subject|6|||
131536266|NCT00321854|473585002|FG001|Overall Study|Withdrawal by Subject|17|||
131536267|NCT00321854|473585001|FG000|Overall Study|Other|1|||
131536268|NCT00321854|473585002|FG001|Overall Study|Other|1|||
131536269|NCT01369342|473585003|FG000|Overall Study|Withdrawal by Subject|7|||
131536270|NCT01369342|473585004|FG001|Overall Study|Withdrawal by Subject|7|||
131536271|NCT01369342|473585005|FG002|Overall Study|Withdrawal by Subject|2|||
131536272|NCT01369342|473585003|FG000|Overall Study|Lost to Follow-up|5|||
131536273|NCT01369342|473585004|FG001|Overall Study|Lost to Follow-up|2|||
131536274|NCT01369342|473585005|FG002|Overall Study|Lost to Follow-up|1|||
131536275|NCT01369342|473585003|FG000|Overall Study|Not Treated|1|||
131536276|NCT01369342|473585004|FG001|Overall Study|Not Treated|0|||
131536277|NCT01369342|473585005|FG002|Overall Study|Not Treated|0|||
131536278|NCT04723576|473585006|FG000|Overall Study|Withdrawal by Subject|2133|||
131536279|NCT04723576|473585007|FG001|Overall Study|Withdrawal by Subject|3234|||
131536280|NCT00413153|473585008|FG000|Overall Study|Withdrawal by Subject|1|||
131536281|NCT00413153|473585009|FG001|Overall Study|Withdrawal by Subject|1|||
131536282|NCT00413153|473585008|FG000|Overall Study|Adverse Event|1|||
131536283|NCT00413153|473585009|FG001|Overall Study|Adverse Event|0|||
131536284|NCT03204279|473585010|FG000|Overall Study|Withdrawal by Subject|0|||
131536285|NCT03204279|473585011|FG001|Overall Study|Withdrawal by Subject|1|||
131536286|NCT04969250|473585012|FG000|Overall Study|Protocol Violation|0|||
131536287|NCT04969250|473585013|FG001|Overall Study|Protocol Violation|2|||
131536288|NCT04969250|473585014|FG002|Overall Study|Protocol Violation|3|||
131536289|NCT04969250|473585015|FG003|Overall Study|Protocol Violation|8|||
131658519|NCT01142232|474035352|FG001|Overall Study|Physician Decision|1|||
131536290|NCT04969250|473585012|FG000|Overall Study|Withdrawal by Subject|0|||
131536291|NCT04969250|473585013|FG001|Overall Study|Withdrawal by Subject|1|||
131536292|NCT04969250|473585014|FG002|Overall Study|Withdrawal by Subject|0|||
131536293|NCT04969250|473585015|FG003|Overall Study|Withdrawal by Subject|0|||
131536294|NCT02278328|473585016|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
131536295|NCT02278328|473585017|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
131536296|NCT02278328|473585018|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
131536297|NCT02278328|473585016|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
131536298|NCT02278328|473585017|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
131536299|NCT02278328|473585018|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
131536300|NCT02278328|473585016|FG000|Neuropsych Screening|incomplete consent|0|||
131536301|NCT02278328|473585017|FG001|Neuropsych Screening|incomplete consent|0|||
131536302|NCT02278328|473585018|FG002|Neuropsych Screening|incomplete consent|2|||
131536303|NCT03834779|473585023|FG000|Overall Study|Death|1|||
131536304|NCT03834779|473585024|FG001|Overall Study|Death|2|||
131536305|NCT03834779|473585023|FG000|Overall Study|Lost to Follow-up|6|||
131536306|NCT03834779|473585024|FG001|Overall Study|Lost to Follow-up|4|||
131536307|NCT01292928|473585025|FG000|Overall Study|Death|8|||
131536308|NCT01292928|473585025|FG000|Overall Study|Withdrawal by Subject|8|||
131536309|NCT01292928|473585025|FG000|Overall Study|Lost to Follow-up|6|||
131536310|NCT01292928|473585025|FG000|Overall Study|Physician Decision|2|||
131536311|NCT00130533|473585030|FG000|Overall Study|Withdrawal by Subject|33|||
131536312|NCT00130533|473585031|FG001|Overall Study|Withdrawal by Subject|6|||
131536313|NCT00130533|473585030|FG000|Overall Study|Adverse Event|34|||
131536314|NCT00130533|473585031|FG001|Overall Study|Adverse Event|1|||
131536315|NCT00130533|473585030|FG000|Overall Study|Disease relapse|9|||
131536316|NCT00130533|473585031|FG001|Overall Study|Disease relapse|13|||
131536317|NCT00130533|473585030|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
131536318|NCT00130533|473585031|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
131536319|NCT00130533|473585030|FG000|Overall Study|Death|4|||
131536320|NCT00130533|473585031|FG001|Overall Study|Death|2|||
131536321|NCT00130533|473585030|FG000|Overall Study|Protocol Violation|5|||
131536322|NCT00130533|473585031|FG001|Overall Study|Protocol Violation|1|||
131536323|NCT00130533|473585030|FG000|Overall Study|Lost to Follow-up|1|||
131536324|NCT00130533|473585031|FG001|Overall Study|Lost to Follow-up|1|||
131536325|NCT00130533|473585030|FG000|Overall Study|Sponsor´s decision|2|||
131536326|NCT00130533|473585031|FG001|Overall Study|Sponsor´s decision|0|||
131536327|NCT00130533|473585030|FG000|Overall Study|Second Primary Malignancy|0|||
131536328|NCT00130533|473585031|FG001|Overall Study|Second Primary Malignancy|1|||
131536329|NCT00130533|473585030|FG000|Overall Study|Other|12|||
131536330|NCT00130533|473585031|FG001|Overall Study|Other|5|||
131536331|NCT01059565|473585032|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
131536332|NCT01059565|473585033|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
131536333|NCT01059565|473585032|FG000|24-Week Randomized Phase|Adverse Event|5|||
131536334|NCT01059565|473585033|FG001|24-Week Randomized Phase|Adverse Event|0|||
131536335|NCT01059565|473585032|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
131536336|NCT01059565|473585033|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
131536337|NCT01059565|473585032|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
131536338|NCT01059565|473585033|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
131536339|NCT01059565|473585032|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
131536340|NCT01059565|473585033|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
131536341|NCT01059565|473585032|FG000|24-Week Open-Label Phase|Adverse Event|2|||
131536342|NCT01059565|473585033|FG001|24-Week Open-Label Phase|Adverse Event|0|||
131536343|NCT01059565|473585032|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
131536344|NCT01059565|473585033|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
131536345|NCT01059565|473585032|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
131536346|NCT01059565|473585033|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
131536347|NCT01059565|473585032|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
131536348|NCT01059565|473585033|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
131536349|NCT01059565|473585032|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
131536350|NCT01059565|473585033|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
131536351|NCT01059565|473585032|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
131536352|NCT01059565|473585033|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
131536353|NCT03263429|473585038|FG000|Overall Study|Withdrawal by Subject|0|||
131536354|NCT03263429|473585039|FG001|Overall Study|Withdrawal by Subject|1|||
131536355|NCT03263429|473585040|FG002|Overall Study|Withdrawal by Subject|0|||
131536356|NCT03263429|473585038|FG000|Overall Study|Follow-Up Period Completed|0|||
131536357|NCT03263429|473585039|FG001|Overall Study|Follow-Up Period Completed|2|||
131536358|NCT03263429|473585040|FG002|Overall Study|Follow-Up Period Completed|0|||
131536359|NCT03263429|473585038|FG000|Overall Study|Death|3|||
131536360|NCT03263429|473585039|FG001|Overall Study|Death|5|||
131536361|NCT03263429|473585040|FG002|Overall Study|Death|16|||
131536362|NCT03263429|473585038|FG000|Overall Study|Participant unable to return|0|||
131536363|NCT03263429|473585039|FG001|Overall Study|Participant unable to return|0|||
131536364|NCT03263429|473585040|FG002|Overall Study|Participant unable to return|1|||
131536365|NCT03263429|473585038|FG000|Overall Study|Study Closed|0|||
131536366|NCT03263429|473585039|FG001|Overall Study|Study Closed|0|||
131536367|NCT03263429|473585040|FG002|Overall Study|Study Closed|1|||
131536368|NCT01605617|473585041|FG000|First Intervention|Adverse Event|0|||
131536369|NCT01605617|473585042|FG001|First Intervention|Adverse Event|1|||
131536370|NCT01605617|473585041|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
131536371|NCT01605617|473585042|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
131536372|NCT03759873|473585047|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
131536373|NCT03759873|473585048|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
131536374|NCT03759873|473585049|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
131536375|NCT03759873|473585050|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
131536376|NCT03759873|473585047|FG000|Overall Study|Moved outside eligible area|0|||
131536377|NCT03759873|473585048|FG001|Overall Study|Moved outside eligible area|2|||
131536378|NCT03759873|473585049|FG002|Overall Study|Moved outside eligible area|0|||
131536379|NCT03759873|473585050|FG003|Overall Study|Moved outside eligible area|0|||
131536380|NCT03759873|473585047|FG000|Overall Study|Withdrawal by Subject|0|||
131536381|NCT03759873|473585048|FG001|Overall Study|Withdrawal by Subject|0|||
131536382|NCT03759873|473585049|FG002|Overall Study|Withdrawal by Subject|1|||
131536383|NCT03759873|473585050|FG003|Overall Study|Withdrawal by Subject|0|||
131536384|NCT03579563|473585051|FG000|Overall Study|Lost to Follow-up|0|||
131536385|NCT03579563|473585052|FG001|Overall Study|Lost to Follow-up|0|||
131536386|NCT03579563|473585053|FG002|Overall Study|Lost to Follow-up|0|||
131536387|NCT03579563|473585054|FG003|Overall Study|Lost to Follow-up|0|||
131536388|NCT03579563|473585055|FG004|Overall Study|Lost to Follow-up|1|||
131536389|NCT03579563|473585056|FG005|Overall Study|Lost to Follow-up|0|||
131536390|NCT03579563|473585051|FG000|Overall Study|Lack of Efficacy|1|||
131536391|NCT03579563|473585052|FG001|Overall Study|Lack of Efficacy|1|||
131536392|NCT03579563|473585053|FG002|Overall Study|Lack of Efficacy|4|||
131536393|NCT03579563|473585054|FG003|Overall Study|Lack of Efficacy|1|||
131536394|NCT03579563|473585055|FG004|Overall Study|Lack of Efficacy|2|||
131536395|NCT03579563|473585056|FG005|Overall Study|Lack of Efficacy|3|||
131536396|NCT03579563|473585051|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
131536397|NCT03579563|473585052|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
131536398|NCT03579563|473585053|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
131536399|NCT03579563|473585054|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
131536400|NCT03579563|473585055|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
131536401|NCT03579563|473585056|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
131536402|NCT03579563|473585051|FG000|Overall Study|Time/distance concern|0|||
131536403|NCT03579563|473585052|FG001|Overall Study|Time/distance concern|0|||
131536404|NCT03579563|473585053|FG002|Overall Study|Time/distance concern|1|||
131536405|NCT03579563|473585054|FG003|Overall Study|Time/distance concern|0|||
131536406|NCT03579563|473585055|FG004|Overall Study|Time/distance concern|0|||
131536407|NCT03579563|473585056|FG005|Overall Study|Time/distance concern|1|||
131536408|NCT03579563|473585051|FG000|Overall Study|COVID shutdown|2|||
131536409|NCT03579563|473585052|FG001|Overall Study|COVID shutdown|3|||
131536410|NCT03579563|473585053|FG002|Overall Study|COVID shutdown|4|||
131536411|NCT03579563|473585054|FG003|Overall Study|COVID shutdown|3|||
131536412|NCT03579563|473585055|FG004|Overall Study|COVID shutdown|1|||
131536413|NCT03579563|473585056|FG005|Overall Study|COVID shutdown|2|||
131536414|NCT03579563|473585051|FG000|Overall Study|Protocol administration error|1|||
131536415|NCT03579563|473585052|FG001|Overall Study|Protocol administration error|0|||
131536416|NCT03579563|473585053|FG002|Overall Study|Protocol administration error|1|||
131536417|NCT03579563|473585054|FG003|Overall Study|Protocol administration error|0|||
131536418|NCT03579563|473585055|FG004|Overall Study|Protocol administration error|1|||
131536419|NCT03579563|473585056|FG005|Overall Study|Protocol administration error|5|||
131536420|NCT03526250|473585057|FG000|Overall Study|Adverse Event|4|||
131536421|NCT03526250|473585057|FG000|Overall Study|Progressive Disease|16|||
131536422|NCT03526250|473585057|FG000|Overall Study|No Treatment|3|||
131536423|NCT02647359|473585058|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
131536424|NCT02647359|473585059|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
131536425|NCT02647359|473585058|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
131536426|NCT02647359|473585059|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
131536427|NCT02647359|473585058|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
131536428|NCT02647359|473585059|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
131536429|NCT02647359|473585058|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
131536430|NCT02647359|473585059|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
131536431|NCT02647359|473585058|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
131536432|NCT02647359|473585059|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
131536433|NCT02647359|473585058|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
131536434|NCT02647359|473585059|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
131536435|NCT00511004|473585060|FG000|Overall Study|Lost to Follow-up|0|||
131536436|NCT00511004|473585061|FG001|Overall Study|Lost to Follow-up|0|||
131536437|NCT00511004|473585062|FG002|Overall Study|Lost to Follow-up|4|||
131536438|NCT02096900|473585064|FG000|Overall Study|Did not receive medication|3|||
131536439|NCT02096900|473585065|FG001|Overall Study|Did not receive medication|1|||
131536440|NCT02096900|473585064|FG000|Overall Study|Surgery cancelled- medication received|1|||
131536441|NCT02096900|473585065|FG001|Overall Study|Surgery cancelled- medication received|1|||
131536442|NCT03034577|473585066|FG000|Overall Study|Withdrawal by Subject|6|||
131536443|NCT03034577|473585067|FG001|Overall Study|Withdrawal by Subject|9|||
131536444|NCT03034577|473585066|FG000|Overall Study|Lost to Follow-up|25|||
131536445|NCT03034577|473585067|FG001|Overall Study|Lost to Follow-up|26|||
131536446|NCT01128413|473585071|FG000|Overall Study|Withdrawal by Subject|1|||
131536447|NCT01128413|473585072|FG001|Overall Study|Withdrawal by Subject|0|||
131536448|NCT01128413|473585071|FG000|Overall Study|NICOM Monitor Problems|2|||
131536449|NCT01128413|473585072|FG001|Overall Study|NICOM Monitor Problems|1|||
131536450|NCT01128413|473585071|FG000|Overall Study|Pt made DNR|1|||
131536451|NCT01128413|473585072|FG001|Overall Study|Pt made DNR|0|||
131536452|NCT02010060|473585076|FG000|Overall Study|Lost to Follow-up|1|||
131536453|NCT02010060|473585077|FG001|Overall Study|Lost to Follow-up|2|||
131536454|NCT02010060|473585078|FG002|Overall Study|Lost to Follow-up|2|||
131536455|NCT02010060|473585076|FG000|Overall Study|Injury|0|||
131536456|NCT02010060|473585077|FG001|Overall Study|Injury|1|||
131536457|NCT02010060|473585078|FG002|Overall Study|Injury|0|||
131536458|NCT00680407|473585081|FG000|Overall Study|Lost to Follow-up|3|||
131536459|NCT00680407|473585082|FG001|Overall Study|Lost to Follow-up|3|||
131536460|NCT00680407|473585083|FG002|Overall Study|Lost to Follow-up|1|||
131536461|NCT00680407|473585081|FG000|Overall Study|Withdrawal by Subject|5|||
131536462|NCT00680407|473585082|FG001|Overall Study|Withdrawal by Subject|2|||
131536463|NCT00680407|473585083|FG002|Overall Study|Withdrawal by Subject|2|||
131536464|NCT03069482|473586614|FG000|Overall Study|Lost to Follow-up|0|||
131536465|NCT03069482|473586615|FG001|Overall Study|Lost to Follow-up|1|||
131536466|NCT03069482|473586614|FG000|Overall Study|Physician Decision|1|||
131536467|NCT03069482|473586615|FG001|Overall Study|Physician Decision|0|||
131536468|NCT00791765|473586616|FG000|Weeks 1 to 12|Adverse Event|0|||
131536469|NCT00791765|473586617|FG001|Weeks 1 to 12|Adverse Event|1|||
131536470|NCT00791765|473586616|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
131536471|NCT00791765|473586617|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
131536472|NCT00791765|473586616|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
131536473|NCT00791765|473586617|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
131536474|NCT00791765|473586616|FG000|Weeks 1 to 12|Physician Decision|1|||
131536475|NCT00791765|473586617|FG001|Weeks 1 to 12|Physician Decision|0|||
131536476|NCT00791765|473586616|FG000|Weeks 1 to 12|Disease progression|3|||
131536477|NCT00791765|473586617|FG001|Weeks 1 to 12|Disease progression|0|||
131536478|NCT00791765|473586616|FG000|Weeks 1 to 12|Ineligibility determined|0|||
131536479|NCT00791765|473586617|FG001|Weeks 1 to 12|Ineligibility determined|3|||
131536480|NCT00791765|473586616|FG000|Weeks 13 to 24|Protocol deviation|2|||
131536481|NCT00791765|473586617|FG001|Weeks 13 to 24|Protocol deviation|0|||
131536482|NCT00791765|473586616|FG000|Weeks 13 to 24|Adverse Event|0|||
131536483|NCT00791765|473586617|FG001|Weeks 13 to 24|Adverse Event|3|||
131536484|NCT00791765|473586616|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
131536485|NCT00791765|473586617|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
131536486|NCT00791765|473586616|FG000|Weeks 13 to 24|Disease progression|0|||
131536487|NCT00791765|473586617|FG001|Weeks 13 to 24|Disease progression|1|||
131536488|NCT00791765|473586616|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
131536489|NCT00791765|473586617|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
131536490|NCT00791765|473586616|FG000|Weeks 13 to 24|Other|0|||
131536491|NCT00791765|473586617|FG001|Weeks 13 to 24|Other|1|||
131536492|NCT01877408|473586628|FG000|Overall Study|Lost to Follow-up|0|||
131536493|NCT01877408|473586629|FG001|Overall Study|Lost to Follow-up|2|||
131536494|NCT00156065|473586630|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
131536495|NCT00156065|473586631|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
131536496|NCT00156065|473586632|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
131536497|NCT00156065|473586630|FG000|Overall Study|Adverse Event|8|||
131536498|NCT00156065|473586631|FG001|Overall Study|Adverse Event|11|||
131536499|NCT00156065|473586632|FG002|Overall Study|Adverse Event|4|||
131536500|NCT00156065|473586630|FG000|Overall Study|Lack of Efficacy|2|||
131536501|NCT00156065|473586631|FG001|Overall Study|Lack of Efficacy|9|||
131536502|NCT00156065|473586632|FG002|Overall Study|Lack of Efficacy|3|||
131536503|NCT00156065|473586630|FG000|Overall Study|Withdrawal by Subject|13|||
131536504|NCT00156065|473586631|FG001|Overall Study|Withdrawal by Subject|26|||
131536505|NCT00156065|473586632|FG002|Overall Study|Withdrawal by Subject|16|||
131536506|NCT00156065|473586630|FG000|Overall Study|Lost to Follow-up|5|||
131536507|NCT00156065|473586631|FG001|Overall Study|Lost to Follow-up|7|||
131536508|NCT00156065|473586632|FG002|Overall Study|Lost to Follow-up|1|||
131536509|NCT00156065|473586630|FG000|Overall Study|Other|2|||
131536510|NCT00156065|473586631|FG001|Overall Study|Other|9|||
131536511|NCT00156065|473586632|FG002|Overall Study|Other|3|||
131536512|NCT01292603|473586633|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
131536513|NCT01292603|473586634|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
131536514|NCT01292603|473586635|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
131536515|NCT01292603|473586636|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
131536516|NCT01292603|473586637|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
131536517|NCT01292603|473586638|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
131536518|NCT01292603|473586633|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
131536519|NCT01292603|473586634|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
131536520|NCT01292603|473586635|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
131536521|NCT01292603|473586636|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
131536522|NCT01292603|473586637|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
131536523|NCT01292603|473586638|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
131536524|NCT01292603|473586633|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
131536525|NCT01292603|473586634|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
131536526|NCT01292603|473586635|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
131536527|NCT01292603|473586636|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
131536528|NCT01292603|473586637|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
131536529|NCT01292603|473586638|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
131536530|NCT01292603|473586633|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
131536531|NCT01292603|473586634|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
131536532|NCT01292603|473586635|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
131536533|NCT01292603|473586636|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
131536534|NCT01292603|473586637|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
131536535|NCT01292603|473586638|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
131536536|NCT01292603|473586633|FG000|Part 1: Regular Follow-Up Period|Death|3|||
131536537|NCT01292603|473586634|FG001|Part 1: Regular Follow-Up Period|Death|1|||
131536538|NCT01292603|473586635|FG002|Part 1: Regular Follow-Up Period|Death|3|||
131536539|NCT01292603|473586636|FG003|Part 1: Regular Follow-Up Period|Death|1|||
131536540|NCT01292603|473586637|FG004|Part 1: Regular Follow-Up Period|Death|0|||
131536541|NCT01292603|473586638|FG005|Part 1: Regular Follow-Up Period|Death|0|||
131536542|NCT01292603|473586633|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
131536543|NCT01292603|473586634|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
131536544|NCT01292603|473586635|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
131536545|NCT01292603|473586636|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
131536546|NCT01292603|473586637|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
131536547|NCT01292603|473586638|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
131536548|NCT01292603|473586633|FG000|Part 2: Dose Confirmation Period|Death|0|||
131536549|NCT01292603|473586634|FG001|Part 2: Dose Confirmation Period|Death|0|||
131536550|NCT01292603|473586635|FG002|Part 2: Dose Confirmation Period|Death|0|||
131536551|NCT01292603|473586636|FG003|Part 2: Dose Confirmation Period|Death|0|||
131536552|NCT01292603|473586637|FG004|Part 2: Dose Confirmation Period|Death|1|||
131536553|NCT01292603|473586638|FG005|Part 2: Dose Confirmation Period|Death|0|||
131536554|NCT01292603|473586633|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
131536555|NCT01292603|473586634|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
131536556|NCT01292603|473586635|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
131536557|NCT01292603|473586636|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
131536558|NCT01292603|473586637|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
131536559|NCT01292603|473586638|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
131536560|NCT01292603|473586633|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
131536561|NCT01292603|473586634|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
131536562|NCT01292603|473586635|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
131536563|NCT01292603|473586636|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
131536564|NCT01292603|473586637|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
131536565|NCT01292603|473586638|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
131536566|NCT01292603|473586633|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
131536567|NCT01292603|473586634|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
131536568|NCT01292603|473586635|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
131536569|NCT01292603|473586636|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
131536570|NCT01292603|473586637|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
131536571|NCT01292603|473586638|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
131536572|NCT01292603|473586633|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
131536573|NCT01292603|473586634|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
131536574|NCT01292603|473586635|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
131536575|NCT01292603|473586636|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
131536576|NCT01292603|473586637|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
131536577|NCT01292603|473586638|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
131536578|NCT01292603|473586633|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
131536579|NCT01292603|473586634|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
131536580|NCT01292603|473586635|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
131536581|NCT01292603|473586636|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
131536582|NCT01292603|473586637|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
131536583|NCT01292603|473586638|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
131536584|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Death|0|||
131536585|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Death|0|||
131536586|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Death|0|||
131536587|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Death|0|||
131536588|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Death|6|||
131536589|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Death|3|||
131536590|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
131536591|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
131536592|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
131536593|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
131536594|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
131536595|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
131536596|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
131536597|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
131536598|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
131536599|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
131536600|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
131536601|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
131536602|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
131536603|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
131536604|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
131536605|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
131536606|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
131536607|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
131536608|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
131536609|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
131536610|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
131536611|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
131536612|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
131536613|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
131536614|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
131536615|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
131536616|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
131536617|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
131536618|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
131536619|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
131536620|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
131536621|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
131536622|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
131536623|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
131536624|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
131536625|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
131536626|NCT01292603|473586633|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
131536627|NCT01292603|473586634|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
131536628|NCT01292603|473586635|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
131536629|NCT01292603|473586636|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
131536630|NCT01292603|473586637|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
131536631|NCT01292603|473586638|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
131536632|NCT01292603|473586633|FG000|Overall Survival Status|Death|3|||
131536633|NCT01292603|473586634|FG001|Overall Survival Status|Death|1|||
131536634|NCT01292603|473586635|FG002|Overall Survival Status|Death|3|||
131536635|NCT01292603|473586636|FG003|Overall Survival Status|Death|1|||
131536636|NCT01292603|473586637|FG004|Overall Survival Status|Death|16|||
131536637|NCT01292603|473586638|FG005|Overall Survival Status|Death|10|||
131536638|NCT03870763|473586641|FG000|Overall Study|Study terminated by sponsor|0|||
131536639|NCT03870763|473586642|FG001|Overall Study|Study terminated by sponsor|2|||
131536640|NCT03870763|473586643|FG002|Overall Study|Study terminated by sponsor|0|||
131536641|NCT03870763|473586641|FG000|Overall Study|Withdrawal by Subject|0|||
131536642|NCT03870763|473586642|FG001|Overall Study|Withdrawal by Subject|1|||
131536643|NCT03870763|473586643|FG002|Overall Study|Withdrawal by Subject|0|||
131536644|NCT03870763|473586641|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
131536645|NCT03870763|473586642|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
131536646|NCT03870763|473586643|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
131536647|NCT03586648|473586646|FG000|Period 1|Withdrawal by Subject|0|||
131536648|NCT03586648|473586647|FG001|Period 1|Withdrawal by Subject|1|||
131536649|NCT03586648|473586646|FG000|Period 1|Lost to Follow-up|1|||
131536650|NCT03586648|473586647|FG001|Period 1|Lost to Follow-up|1|||
131536651|NCT03586648|473586646|FG000|Period 1|Adverse Event|1|||
131536652|NCT03586648|473586647|FG001|Period 1|Adverse Event|0|||
131536653|NCT03586648|473586646|FG000|Period 1|Study related symptoms or complaints|2|||
131536654|NCT03586648|473586647|FG001|Period 1|Study related symptoms or complaints|1|||
131536655|NCT03586648|473586646|FG000|Period 1|Physician Decision|0|||
131536656|NCT03586648|473586647|FG001|Period 1|Physician Decision|1|||
131536657|NCT03586648|473586646|FG000|Period 2|Adverse Event|1|||
131536658|NCT03586648|473586647|FG001|Period 2|Adverse Event|0|||
131536659|NCT00907153|473586651|FG000|Overall Study|Lost to Follow-up|1|||
131536660|NCT00907153|473586652|FG001|Overall Study|Lost to Follow-up|1|||
131536661|NCT00907153|473586651|FG000|Overall Study|Withdrawal by Subject|1|||
131536662|NCT00907153|473586652|FG001|Overall Study|Withdrawal by Subject|3|||
131536663|NCT03147248|473586653|FG000|Overall Study|Adverse Event|0|||
131536664|NCT03147248|473586654|FG001|Overall Study|Adverse Event|2|||
131536665|NCT03147248|473586655|FG002|Overall Study|Adverse Event|2|||
131536666|NCT03147248|473586656|FG003|Overall Study|Adverse Event|2|||
131536667|NCT03147248|473586657|FG004|Overall Study|Adverse Event|6|||
131536668|NCT03147248|473586658|FG005|Overall Study|Adverse Event|11|||
131536669|NCT03147248|473586653|FG000|Overall Study|Disease progression|1|||
131536670|NCT03147248|473586654|FG001|Overall Study|Disease progression|0|||
131536671|NCT03147248|473586655|FG002|Overall Study|Disease progression|0|||
131536672|NCT03147248|473586656|FG003|Overall Study|Disease progression|0|||
131536673|NCT03147248|473586657|FG004|Overall Study|Disease progression|0|||
131536674|NCT03147248|473586658|FG005|Overall Study|Disease progression|2|||
131536675|NCT03147248|473586653|FG000|Overall Study|Withdrawal by Subject|0|||
131536676|NCT03147248|473586654|FG001|Overall Study|Withdrawal by Subject|0|||
131536677|NCT03147248|473586655|FG002|Overall Study|Withdrawal by Subject|0|||
131536678|NCT03147248|473586656|FG003|Overall Study|Withdrawal by Subject|0|||
131536679|NCT03147248|473586657|FG004|Overall Study|Withdrawal by Subject|12|||
131536680|NCT03147248|473586658|FG005|Overall Study|Withdrawal by Subject|9|||
131536681|NCT03147248|473586653|FG000|Overall Study|Protocol Violation|0|||
131536682|NCT03147248|473586654|FG001|Overall Study|Protocol Violation|0|||
131536683|NCT03147248|473586655|FG002|Overall Study|Protocol Violation|0|||
131536684|NCT03147248|473586656|FG003|Overall Study|Protocol Violation|0|||
131536685|NCT03147248|473586657|FG004|Overall Study|Protocol Violation|2|||
131536686|NCT03147248|473586658|FG005|Overall Study|Protocol Violation|0|||
131536687|NCT03147248|473586653|FG000|Overall Study|Lost to Follow-up|0|||
131536688|NCT03147248|473586654|FG001|Overall Study|Lost to Follow-up|0|||
131536689|NCT03147248|473586655|FG002|Overall Study|Lost to Follow-up|0|||
131536690|NCT03147248|473586656|FG003|Overall Study|Lost to Follow-up|0|||
131536691|NCT03147248|473586657|FG004|Overall Study|Lost to Follow-up|2|||
131536692|NCT03147248|473586658|FG005|Overall Study|Lost to Follow-up|0|||
131536693|NCT03147248|473586653|FG000|Overall Study|Pregnancy|0|||
131536694|NCT03147248|473586654|FG001|Overall Study|Pregnancy|0|||
131536695|NCT03147248|473586655|FG002|Overall Study|Pregnancy|0|||
131536696|NCT03147248|473586656|FG003|Overall Study|Pregnancy|0|||
131536697|NCT03147248|473586657|FG004|Overall Study|Pregnancy|1|||
131536698|NCT03147248|473586658|FG005|Overall Study|Pregnancy|0|||
131536699|NCT03147248|473586653|FG000|Overall Study|Death|0|||
131536700|NCT03147248|473586654|FG001|Overall Study|Death|0|||
131536701|NCT03147248|473586655|FG002|Overall Study|Death|0|||
131536702|NCT03147248|473586656|FG003|Overall Study|Death|0|||
131536703|NCT03147248|473586657|FG004|Overall Study|Death|0|||
131536704|NCT03147248|473586658|FG005|Overall Study|Death|4|||
131536705|NCT03147248|473586653|FG000|Overall Study|Physician Decision|0|||
131536706|NCT03147248|473586654|FG001|Overall Study|Physician Decision|0|||
131536707|NCT03147248|473586655|FG002|Overall Study|Physician Decision|0|||
131536708|NCT03147248|473586656|FG003|Overall Study|Physician Decision|0|||
131536709|NCT03147248|473586657|FG004|Overall Study|Physician Decision|2|||
131536710|NCT03147248|473586658|FG005|Overall Study|Physician Decision|4|||
131536711|NCT03147248|473586653|FG000|Overall Study|Prolonged Dosing Interval|0|||
131536712|NCT03147248|473586654|FG001|Overall Study|Prolonged Dosing Interval|0|||
131536713|NCT03147248|473586655|FG002|Overall Study|Prolonged Dosing Interval|0|||
131536714|NCT03147248|473586656|FG003|Overall Study|Prolonged Dosing Interval|0|||
131536715|NCT03147248|473586657|FG004|Overall Study|Prolonged Dosing Interval|1|||
131536716|NCT03147248|473586658|FG005|Overall Study|Prolonged Dosing Interval|1|||
131536717|NCT02388724|473586662|FG000|Overall Study|Reason not Specified|0|||
131536718|NCT02388724|473586663|FG001|Overall Study|Reason not Specified|1|||
131536719|NCT02388724|473586662|FG000|Overall Study|Major Protocol Deviation|3|||
131536720|NCT02388724|473586663|FG001|Overall Study|Major Protocol Deviation|3|||
131536721|NCT02388724|473586662|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
131536722|NCT02388724|473586663|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
131536723|NCT02388724|473586662|FG000|Overall Study|Voluntary Withdrawal|6|||
131536724|NCT02388724|473586663|FG001|Overall Study|Voluntary Withdrawal|5|||
131536725|NCT02388724|473586662|FG000|Overall Study|Randomized but not Treated|0|||
131536726|NCT02388724|473586663|FG001|Overall Study|Randomized but not Treated|2|||
131536727|NCT02605954|473586664|FG000|Overall Study|Adverse Event|5|||
131536728|NCT02605954|473586665|FG001|Overall Study|Adverse Event|1|||
131536729|NCT02605954|473586664|FG000|Overall Study|Investigator's Discretion|1|||
131536730|NCT02605954|473586665|FG001|Overall Study|Investigator's Discretion|0|||
131536731|NCT02605954|473586664|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131536732|NCT02605954|473586665|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131536733|NCT02605954|473586664|FG000|Overall Study|Withdrew Consent|2|||
131536734|NCT02605954|473586665|FG001|Overall Study|Withdrew Consent|2|||
131536735|NCT02605954|473586664|FG000|Overall Study|Lost to Follow-up|3|||
131536736|NCT02605954|473586665|FG001|Overall Study|Lost to Follow-up|0|||
131536737|NCT02605954|473586664|FG000|Overall Study|Randomized but not treated|0|||
131536738|NCT02605954|473586665|FG001|Overall Study|Randomized but not treated|1|||
131536739|NCT03638141|473586676|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
131536740|NCT02513563|473586677|FG000|Overall Study|Death|4|||
131536741|NCT02513563|473586677|FG000|Overall Study|Withdrawal by Subject|4|||
131536742|NCT02513563|473586677|FG000|Overall Study|Physician Decision|1|||
131536743|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
131536744|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
131536745|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
131536746|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
131536747|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
131536748|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
131536749|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
131536750|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
131536751|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
131536752|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
131536753|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
131536754|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
131536755|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
131536756|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
131536757|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
131536758|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
131536759|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
131536760|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
131536761|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
131536762|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
131536763|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
131536764|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
131536765|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
131536766|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
131536767|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
131536768|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
131536769|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
131536770|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
131536771|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
131536772|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
131536773|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
131536774|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
131536775|NCT04818346|473586682|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
131536776|NCT04818346|473586683|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
131536777|NCT04818346|473586684|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
131536778|NCT04818346|473586685|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
131536779|NCT04818346|473586682|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
131536780|NCT04818346|473586683|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
131536781|NCT04818346|473586684|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
131536782|NCT04818346|473586685|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
131536783|NCT04818346|473586682|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
131536784|NCT04818346|473586683|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
131536785|NCT04818346|473586684|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
131536786|NCT04818346|473586685|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
131536787|NCT04818346|473586682|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
131536788|NCT04818346|473586683|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
131536789|NCT04818346|473586684|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
131536790|NCT04818346|473586685|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
131536791|NCT04818346|473586682|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
131536792|NCT04818346|473586683|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
131536793|NCT04818346|473586684|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
131536794|NCT04818346|473586685|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
131536795|NCT04818346|473586682|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
131536796|NCT04818346|473586683|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
131536797|NCT04818346|473586684|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
131658520|NCT01142232|474035353|FG002|Overall Study|Physician Decision|0|||
131536798|NCT04818346|473586685|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
131536799|NCT04818346|473586682|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
131536800|NCT04818346|473586683|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
131536801|NCT04818346|473586684|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
131536802|NCT04818346|473586685|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
131536803|NCT01672801|473586686|FG000|Overall Study|Screen Failure|0|||
131536804|NCT01672801|473586687|FG001|Overall Study|Screen Failure|1|||
131536805|NCT01362140|473586688|FG000|Overall Study|Noncompliance|1|||
131536806|NCT01362140|473586689|FG001|Overall Study|Noncompliance|0|||
131536807|NCT01362140|473586688|FG000|Overall Study|Adverse Event|2|||
131536808|NCT01362140|473586689|FG001|Overall Study|Adverse Event|2|||
131536809|NCT01362140|473586688|FG000|Overall Study|Withdrawal by Subject|3|||
131536810|NCT01362140|473586689|FG001|Overall Study|Withdrawal by Subject|3|||
131536811|NCT01362140|473586688|FG000|Overall Study|Administrative Decision|0|||
131536812|NCT01362140|473586689|FG001|Overall Study|Administrative Decision|1|||
131536813|NCT01362140|473586688|FG000|Overall Study|Death|2|||
131536814|NCT01362140|473586689|FG001|Overall Study|Death|1|||
131536815|NCT01362140|473586688|FG000|Overall Study|Other|1|||
131536816|NCT01362140|473586689|FG001|Overall Study|Other|1|||
131536817|NCT01362140|473586688|FG000|Overall Study|Protocol-specified Criteria|1|||
131536818|NCT01362140|473586689|FG001|Overall Study|Protocol-specified Criteria|2|||
131536819|NCT01362140|473586688|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
131536820|NCT01362140|473586689|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
131536821|NCT00492284|473586691|FG000|Overall Study|Adverse Event|0|||
131536822|NCT00492284|473586692|FG001|Overall Study|Adverse Event|1|||
131536823|NCT00492284|473586693|FG002|Overall Study|Adverse Event|1|||
131536824|NCT00492284|473586694|FG003|Overall Study|Adverse Event|2|||
131536825|NCT00492284|473586691|FG000|Overall Study|Lost to Follow-up|0|||
131536826|NCT00492284|473586692|FG001|Overall Study|Lost to Follow-up|0|||
131536827|NCT00492284|473586693|FG002|Overall Study|Lost to Follow-up|3|||
131536828|NCT00492284|473586694|FG003|Overall Study|Lost to Follow-up|1|||
131536829|NCT00492284|473586691|FG000|Overall Study|Death|0|||
131536830|NCT00492284|473586692|FG001|Overall Study|Death|3|||
131536831|NCT00492284|473586693|FG002|Overall Study|Death|2|||
131536832|NCT00492284|473586694|FG003|Overall Study|Death|5|||
131536833|NCT00492284|473586691|FG000|Overall Study|Withdrawal by Subject|1|||
131536834|NCT00492284|473586692|FG001|Overall Study|Withdrawal by Subject|0|||
131536835|NCT00492284|473586693|FG002|Overall Study|Withdrawal by Subject|0|||
131536836|NCT00492284|473586694|FG003|Overall Study|Withdrawal by Subject|2|||
131536837|NCT06476366|473586695|FG000|Overall Study|Lost to Follow-up|1|||
131536838|NCT06476366|473586696|FG001|Overall Study|Lost to Follow-up|3|||
131536839|NCT06476366|473586695|FG000|Overall Study|Adverse Event|1|||
131536840|NCT06476366|473586696|FG001|Overall Study|Adverse Event|0|||
131536841|NCT02384954|473586700|FG000|Phase 1|Progressive Disease|2|||
131536842|NCT02384954|473586701|FG001|Phase 1|Progressive Disease|0|||
131536843|NCT02384954|473586702|FG002|Phase 1|Progressive Disease|1|||
131536844|NCT02384954|473586703|FG003|Phase 1|Progressive Disease|1|||
131536845|NCT02384954|473586704|FG004|Phase 1|Progressive Disease|0|||
131536846|NCT02384954|473586705|FG005|Phase 1|Progressive Disease|0|||
131536847|NCT02384954|473586706|FG006|Phase 1|Progressive Disease|0|||
131536848|NCT02384954|473586707|FG007|Phase 1|Progressive Disease|0|||
131536849|NCT02384954|473586708|FG008|Phase 1|Progressive Disease|0|||
131536850|NCT02384954|473586700|FG000|Phase 1|Adverse Event|0|||
131536851|NCT02384954|473586701|FG001|Phase 1|Adverse Event|0|||
131536852|NCT02384954|473586702|FG002|Phase 1|Adverse Event|1|||
131536853|NCT02384954|473586703|FG003|Phase 1|Adverse Event|0|||
131536854|NCT02384954|473586704|FG004|Phase 1|Adverse Event|0|||
131536855|NCT02384954|473586705|FG005|Phase 1|Adverse Event|0|||
131536856|NCT02384954|473586706|FG006|Phase 1|Adverse Event|0|||
131536857|NCT02384954|473586707|FG007|Phase 1|Adverse Event|0|||
131536858|NCT02384954|473586708|FG008|Phase 1|Adverse Event|0|||
131536859|NCT02384954|473586700|FG000|Phase 2|Progressive Disease|0|||
131536860|NCT02384954|473586701|FG001|Phase 2|Progressive Disease|0|||
131536861|NCT02384954|473586702|FG002|Phase 2|Progressive Disease|0|||
131536862|NCT02384954|473586703|FG003|Phase 2|Progressive Disease|0|||
131536863|NCT02384954|473586704|FG004|Phase 2|Progressive Disease|0|||
131536864|NCT02384954|473586705|FG005|Phase 2|Progressive Disease|0|||
131536865|NCT02384954|473586706|FG006|Phase 2|Progressive Disease|0|||
131536866|NCT02384954|473586707|FG007|Phase 2|Progressive Disease|1|||
131536867|NCT02384954|473586708|FG008|Phase 2|Progressive Disease|2|||
131536868|NCT02384954|473586700|FG000|Phase 2|Adverse Event|0|||
131536869|NCT02384954|473586701|FG001|Phase 2|Adverse Event|0|||
131536870|NCT02384954|473586702|FG002|Phase 2|Adverse Event|0|||
131536871|NCT02384954|473586703|FG003|Phase 2|Adverse Event|0|||
131536872|NCT02384954|473586704|FG004|Phase 2|Adverse Event|0|||
131536873|NCT02384954|473586705|FG005|Phase 2|Adverse Event|0|||
131536874|NCT02384954|473586706|FG006|Phase 2|Adverse Event|0|||
131536875|NCT02384954|473586707|FG007|Phase 2|Adverse Event|1|||
131536876|NCT02384954|473586708|FG008|Phase 2|Adverse Event|1|||
131536877|NCT02384954|473586700|FG000|Phase 2|Failure to meet continuation criteria|0|||
131536878|NCT02384954|473586701|FG001|Phase 2|Failure to meet continuation criteria|0|||
131536879|NCT02384954|473586702|FG002|Phase 2|Failure to meet continuation criteria|0|||
131536880|NCT02384954|473586703|FG003|Phase 2|Failure to meet continuation criteria|0|||
131536881|NCT02384954|473586704|FG004|Phase 2|Failure to meet continuation criteria|0|||
131536882|NCT02384954|473586705|FG005|Phase 2|Failure to meet continuation criteria|0|||
131536883|NCT02384954|473586706|FG006|Phase 2|Failure to meet continuation criteria|0|||
131536884|NCT02384954|473586707|FG007|Phase 2|Failure to meet continuation criteria|1|||
131536885|NCT02384954|473586708|FG008|Phase 2|Failure to meet continuation criteria|0|||
131536886|NCT01910129|473586716|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
131536887|NCT01910129|473586717|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
131536888|NCT01910129|473586718|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
131536889|NCT01910129|473586716|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
131536890|NCT01910129|473586717|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
131536891|NCT01910129|473586718|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
131536892|NCT03150056|473586719|FG000|Overall Study|Withdrawal by Subject|0|||
131536893|NCT03150056|473586720|FG001|Overall Study|Withdrawal by Subject|0|||
131536894|NCT03150056|473586721|FG002|Overall Study|Withdrawal by Subject|0|||
131536895|NCT03150056|473586722|FG003|Overall Study|Withdrawal by Subject|0|||
131536896|NCT03150056|473586723|FG004|Overall Study|Withdrawal by Subject|0|||
131536897|NCT03150056|473586724|FG005|Overall Study|Withdrawal by Subject|2|||
131536898|NCT03150056|473586719|FG000|Overall Study|Study terminated by Sponsor|1|||
131536899|NCT03150056|473586720|FG001|Overall Study|Study terminated by Sponsor|3|||
131536900|NCT03150056|473586721|FG002|Overall Study|Study terminated by Sponsor|1|||
131536901|NCT03150056|473586722|FG003|Overall Study|Study terminated by Sponsor|1|||
131536902|NCT03150056|473586723|FG004|Overall Study|Study terminated by Sponsor|5|||
131536903|NCT03150056|473586724|FG005|Overall Study|Study terminated by Sponsor|6|||
131536904|NCT03150056|473586719|FG000|Overall Study|Death|9|||
131536905|NCT03150056|473586720|FG001|Overall Study|Death|2|||
131536906|NCT03150056|473586721|FG002|Overall Study|Death|2|||
131536907|NCT03150056|473586722|FG003|Overall Study|Death|7|||
131536908|NCT03150056|473586723|FG004|Overall Study|Death|8|||
131536909|NCT03150056|473586724|FG005|Overall Study|Death|10|||
131536910|NCT03595904|473586725|FG000|Overall Study|Protocol Violation|3|||
131536911|NCT03595904|473586726|FG001|Overall Study|Protocol Violation|1|||
131536912|NCT03595904|473586725|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
131536913|NCT03595904|473586726|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
131536914|NCT03595904|473586725|FG000|Overall Study|Insurance complications|1|||
131536915|NCT03595904|473586726|FG001|Overall Study|Insurance complications|0|||
131536916|NCT03595904|473586725|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
131536917|NCT03595904|473586726|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
131536918|NCT01581281|473586727|FG000|Overall Study|Early Study Closure|15|||
131536919|NCT01581281|473586728|FG001|Overall Study|Early Study Closure|6|||
131536920|NCT01581281|473586729|FG002|Overall Study|Early Study Closure|12|||
131536921|NCT02187991|473586730|FG000|Overall Study|Adverse Event|13|||
131536922|NCT02187991|473586731|FG001|Overall Study|Adverse Event|14|||
131536923|NCT02187991|473586732|FG002|Overall Study|Adverse Event|3|||
131536924|NCT02187991|473586733|FG003|Overall Study|Adverse Event|2|||
131536925|NCT02187991|473586730|FG000|Overall Study|Withdrawal by Subject|9|||
131536926|NCT02187991|473586731|FG001|Overall Study|Withdrawal by Subject|6|||
131536927|NCT02187991|473586732|FG002|Overall Study|Withdrawal by Subject|3|||
131536928|NCT02187991|473586733|FG003|Overall Study|Withdrawal by Subject|2|||
131536929|NCT02187991|473586730|FG000|Overall Study|Physician Decision|4|||
131536930|NCT02187991|473586731|FG001|Overall Study|Physician Decision|4|||
131536931|NCT02187991|473586732|FG002|Overall Study|Physician Decision|0|||
131536932|NCT02187991|473586733|FG003|Overall Study|Physician Decision|2|||
131536933|NCT02187991|473586730|FG000|Overall Study|Other, unrelated complication|7|||
131536934|NCT02187991|473586731|FG001|Overall Study|Other, unrelated complication|1|||
131536935|NCT02187991|473586732|FG002|Overall Study|Other, unrelated complication|1|||
131536936|NCT02187991|473586733|FG003|Overall Study|Other, unrelated complication|2|||
131536937|NCT02187991|473586730|FG000|Overall Study|Death|1|||
131536938|NCT02187991|473586731|FG001|Overall Study|Death|3|||
131536939|NCT02187991|473586732|FG002|Overall Study|Death|0|||
131536940|NCT02187991|473586733|FG003|Overall Study|Death|0|||
131536941|NCT01392560|473586734|FG000|Overall Study|Adverse Event|2|||
131536942|NCT01392560|473586734|FG000|Overall Study|not entered|8|||
131536943|NCT01392560|473586734|FG000|Overall Study|discontinued during placebo run-in|2|||
131536944|NCT00700401|473586743|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
131536945|NCT00700401|473586743|FG000|Overall Study|Adverse Event|5|||
131536946|NCT00700401|473586743|FG000|Overall Study|Refused Treatment|2|||
131536947|NCT00700401|473586743|FG000|Overall Study|Lost to Follow-up|1|||
131536948|NCT00700401|473586743|FG000|Overall Study|Treatment never started|1|||
131536949|NCT00700401|473586743|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
131536950|NCT00700401|473586743|FG000|Overall Study|Withdrawal by Subject|2|||
131536951|NCT03273946|473586744|FG000|Overall Study|Withdrawal by Subject|5|||
131536952|NCT03273946|473586744|FG000|Overall Study|Unwillingness of the guardian|1|||
131536953|NCT03273946|473586744|FG000|Overall Study|Participant refused to use the drug|2|||
131536954|NCT03273946|473586744|FG000|Overall Study|Participant relative refused to use drug|1|||
131536955|NCT00295750|473586747|FG000|Overall Study|Adverse Event|19|||
131536956|NCT00295750|473586748|FG001|Overall Study|Adverse Event|15|||
131536957|NCT00295750|473586749|FG002|Overall Study|Adverse Event|12|||
131536958|NCT00295750|473586747|FG000|Overall Study|Lack of Efficacy|1|||
131536959|NCT00295750|473586748|FG001|Overall Study|Lack of Efficacy|1|||
131536960|NCT00295750|473586749|FG002|Overall Study|Lack of Efficacy|0|||
131536961|NCT00295750|473586747|FG000|Overall Study|Lost to Follow-up|1|||
131536962|NCT00295750|473586748|FG001|Overall Study|Lost to Follow-up|4|||
131536963|NCT00295750|473586749|FG002|Overall Study|Lost to Follow-up|1|||
131536964|NCT00295750|473586747|FG000|Overall Study|Taking prohibited therapy|2|||
131536965|NCT00295750|473586748|FG001|Overall Study|Taking prohibited therapy|3|||
131536966|NCT00295750|473586749|FG002|Overall Study|Taking prohibited therapy|2|||
131536967|NCT00295750|473586747|FG000|Overall Study|Administrative errors|2|||
131536968|NCT00295750|473586748|FG001|Overall Study|Administrative errors|4|||
131536969|NCT00295750|473586749|FG002|Overall Study|Administrative errors|5|||
131536970|NCT00295750|473586747|FG000|Overall Study|Trial drug errors|1|||
131536971|NCT00295750|473586748|FG001|Overall Study|Trial drug errors|1|||
131536972|NCT00295750|473586749|FG002|Overall Study|Trial drug errors|0|||
131536973|NCT00295750|473586747|FG000|Overall Study|Disease progression|2|||
131536974|NCT00295750|473586748|FG001|Overall Study|Disease progression|1|||
131536975|NCT00295750|473586749|FG002|Overall Study|Disease progression|0|||
131536976|NCT00295750|473586747|FG000|Overall Study|Personal reasons|0|||
131536977|NCT00295750|473586748|FG001|Overall Study|Personal reasons|1|||
131536978|NCT00295750|473586749|FG002|Overall Study|Personal reasons|0|||
131536979|NCT00295750|473586747|FG000|Overall Study|Randomized but never received trial drug|4|||
131536980|NCT00295750|473586748|FG001|Overall Study|Randomized but never received trial drug|3|||
131536981|NCT00295750|473586749|FG002|Overall Study|Randomized but never received trial drug|3|||
131536982|NCT00295750|473586747|FG000|Overall Study|Withdrawal by Subject|9|||
131536983|NCT00295750|473586748|FG001|Overall Study|Withdrawal by Subject|4|||
131536984|NCT00295750|473586749|FG002|Overall Study|Withdrawal by Subject|7|||
131536985|NCT00295750|473586747|FG000|Overall Study|Protocol Violation|2|||
131536986|NCT00295750|473586748|FG001|Overall Study|Protocol Violation|4|||
131536987|NCT00295750|473586749|FG002|Overall Study|Protocol Violation|2|||
131536988|NCT02199028|473586755|FG000|Week 1|Adverse Event|1|||
131536989|NCT02199028|473586756|FG001|Week 1|Adverse Event|0|||
131536990|NCT02199028|473586755|FG000|Week 3|Adverse Event|1|||
131536991|NCT02199028|473586756|FG001|Week 3|Adverse Event|0|||
131536992|NCT00355082|473586757|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
131536993|NCT00355082|473586758|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
131536994|NCT00355082|473586759|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
131536995|NCT00355082|473586757|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
131536996|NCT00355082|473586758|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
131536997|NCT00355082|473586759|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
131536998|NCT00355082|473586757|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
131536999|NCT00355082|473586758|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
131537000|NCT00355082|473586759|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
131537001|NCT00355082|473586757|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
131537002|NCT00355082|473586758|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
131537003|NCT00355082|473586759|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
131537004|NCT00355082|473586757|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
131537005|NCT00355082|473586758|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
131537006|NCT00355082|473586759|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
131537007|NCT00355082|473586757|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
131537008|NCT00355082|473586758|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
131537009|NCT00355082|473586759|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
131537010|NCT00355082|473586757|FG000|Continuation Phase|Adverse Event|2|||
131537011|NCT00355082|473586758|FG001|Continuation Phase|Adverse Event|0|||
131537012|NCT00355082|473586759|FG002|Continuation Phase|Adverse Event|1|||
131537013|NCT00355082|473586757|FG000|Continuation Phase|Lost to Follow-up|2|||
131537014|NCT00355082|473586758|FG001|Continuation Phase|Lost to Follow-up|0|||
131537015|NCT00355082|473586759|FG002|Continuation Phase|Lost to Follow-up|1|||
131537016|NCT00355082|473586757|FG000|Continuation Phase|Protocol Violation|1|||
131537017|NCT00355082|473586758|FG001|Continuation Phase|Protocol Violation|0|||
131537018|NCT00355082|473586759|FG002|Continuation Phase|Protocol Violation|1|||
131537019|NCT00355082|473586757|FG000|Continuation Phase|Withdrawal by Subject|4|||
131537020|NCT00355082|473586758|FG001|Continuation Phase|Withdrawal by Subject|0|||
131537021|NCT00355082|473586759|FG002|Continuation Phase|Withdrawal by Subject|0|||
131537022|NCT00355082|473586757|FG000|Continuation Phase|Lack of Efficacy|5|||
131537023|NCT00355082|473586758|FG001|Continuation Phase|Lack of Efficacy|0|||
131537024|NCT00355082|473586759|FG002|Continuation Phase|Lack of Efficacy|0|||
131537025|NCT00355082|473586757|FG000|Continuation Phase|Site Closed by Sponsor|8|||
131537026|NCT00355082|473586758|FG001|Continuation Phase|Site Closed by Sponsor|0|||
131537027|NCT00355082|473586759|FG002|Continuation Phase|Site Closed by Sponsor|0|||
131537028|NCT00355082|473586757|FG000|Continuation Phase|Scheduling Error|1|||
131537029|NCT00355082|473586758|FG001|Continuation Phase|Scheduling Error|0|||
131537030|NCT00355082|473586759|FG002|Continuation Phase|Scheduling Error|0|||
131537031|NCT00355082|473586757|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
131537032|NCT00355082|473586758|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
131537033|NCT00355082|473586759|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
131537034|NCT04598152|473586763|FG000|Overall Study|Lost to Follow-up|0|||
131537035|NCT04598152|473586764|FG001|Overall Study|Lost to Follow-up|1|||
131537036|NCT03346759|473586765|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
131537037|NCT03346759|473586766|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
131537038|NCT03346759|473586765|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
131537039|NCT03346759|473586766|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
131537040|NCT03346759|473586765|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
131537041|NCT03346759|473586766|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
131537042|NCT03230916|473586767|FG000|Overall Study|Withdrawal by Subject|0|||
131537043|NCT03230916|473586768|FG001|Overall Study|Withdrawal by Subject|0|||
131537044|NCT03230916|473586769|FG002|Overall Study|Withdrawal by Subject|0|||
131537045|NCT03230916|473586770|FG003|Overall Study|Withdrawal by Subject|0|||
131537046|NCT03230916|473586771|FG004|Overall Study|Withdrawal by Subject|0|||
131537047|NCT03230916|473586772|FG005|Overall Study|Withdrawal by Subject|1|||
131537048|NCT03230916|473586773|FG006|Overall Study|Withdrawal by Subject|0|||
131537049|NCT03230916|473586774|FG007|Overall Study|Withdrawal by Subject|0|||
131537050|NCT03230916|473586775|FG008|Overall Study|Withdrawal by Subject|0|||
131537051|NCT03230916|473586776|FG009|Overall Study|Withdrawal by Subject|0|||
131537052|NCT03230916|473586777|FG010|Overall Study|Withdrawal by Subject|0|||
131537053|NCT04370054|473586778|FG000|Treatment Phase|Lost to Follow-up|1|||
131537054|NCT04370054|473586778|FG000|Treatment Phase|Withdrawal by Subject|1|||
131537055|NCT04370054|473586778|FG000|Follow-Up Phase|Ongoing|75|||
131537056|NCT00722761|473586779|FG000|Overall Study|Lost to Follow-up|1|||
131537057|NCT00722761|473586780|FG001|Overall Study|Lost to Follow-up|4|||
131537058|NCT00722761|473586779|FG000|Overall Study|Withdrawal by Subject|5|||
131537059|NCT00722761|473586780|FG001|Overall Study|Withdrawal by Subject|2|||
131537060|NCT05819749|473586782|FG000|Overall Study|Lost to Follow-up|1|||
131537061|NCT03214367|473588911|FG000|Lead-in Period|Withdrawal by Subject|50|||
131537062|NCT03214367|473588912|FG001|Lead-in Period|Withdrawal by Subject|0|||
131537063|NCT03214367|473588913|FG002|Lead-in Period|Withdrawal by Subject|0|||
131537064|NCT03214367|473588914|FG003|Lead-in Period|Withdrawal by Subject|0|||
131537065|NCT03214367|473588915|FG004|Lead-in Period|Withdrawal by Subject|2|||
131537066|NCT03214367|473588916|FG005|Lead-in Period|Withdrawal by Subject|0|||
131537067|NCT03214367|473588917|FG006|Lead-in Period|Withdrawal by Subject|0|||
131537068|NCT03214367|473588918|FG007|Lead-in Period|Withdrawal by Subject|0|||
131537069|NCT03214367|473588911|FG000|Lead-in Period|Adverse Event|3|||
131537070|NCT03214367|473588912|FG001|Lead-in Period|Adverse Event|0|||
131537071|NCT03214367|473588913|FG002|Lead-in Period|Adverse Event|0|||
131537072|NCT03214367|473588914|FG003|Lead-in Period|Adverse Event|0|||
131537073|NCT03214367|473588915|FG004|Lead-in Period|Adverse Event|0|||
131537074|NCT03214367|473588916|FG005|Lead-in Period|Adverse Event|0|||
131537075|NCT03214367|473588917|FG006|Lead-in Period|Adverse Event|0|||
131537076|NCT03214367|473588918|FG007|Lead-in Period|Adverse Event|0|||
131537077|NCT03214367|473588911|FG000|Lead-in Period|Lost to Follow-up|12|||
131537078|NCT03214367|473588912|FG001|Lead-in Period|Lost to Follow-up|0|||
131537079|NCT03214367|473588913|FG002|Lead-in Period|Lost to Follow-up|0|||
131537080|NCT03214367|473588914|FG003|Lead-in Period|Lost to Follow-up|0|||
131537081|NCT03214367|473588915|FG004|Lead-in Period|Lost to Follow-up|0|||
131537082|NCT03214367|473588916|FG005|Lead-in Period|Lost to Follow-up|0|||
131537083|NCT03214367|473588917|FG006|Lead-in Period|Lost to Follow-up|0|||
131537084|NCT03214367|473588918|FG007|Lead-in Period|Lost to Follow-up|0|||
131537085|NCT03214367|473588911|FG000|Lead-in Period|Sponsor Decision|11|||
131537086|NCT03214367|473588912|FG001|Lead-in Period|Sponsor Decision|0|||
131537087|NCT03214367|473588913|FG002|Lead-in Period|Sponsor Decision|0|||
131537088|NCT03214367|473588914|FG003|Lead-in Period|Sponsor Decision|0|||
131537089|NCT03214367|473588915|FG004|Lead-in Period|Sponsor Decision|0|||
131537090|NCT03214367|473588916|FG005|Lead-in Period|Sponsor Decision|0|||
131537091|NCT03214367|473588917|FG006|Lead-in Period|Sponsor Decision|0|||
131537092|NCT03214367|473588918|FG007|Lead-in Period|Sponsor Decision|0|||
131537093|NCT03214367|473588911|FG000|Lead-in Period|Physician Decision|12|||
131537094|NCT03214367|473588912|FG001|Lead-in Period|Physician Decision|0|||
131537095|NCT03214367|473588913|FG002|Lead-in Period|Physician Decision|0|||
131537096|NCT03214367|473588914|FG003|Lead-in Period|Physician Decision|0|||
131537097|NCT03214367|473588915|FG004|Lead-in Period|Physician Decision|0|||
131537098|NCT03214367|473588916|FG005|Lead-in Period|Physician Decision|0|||
131537099|NCT03214367|473588917|FG006|Lead-in Period|Physician Decision|0|||
131537100|NCT03214367|473588918|FG007|Lead-in Period|Physician Decision|0|||
131537101|NCT03214367|473588911|FG000|Lead-in Period|Protocol Violation|5|||
131537102|NCT03214367|473588912|FG001|Lead-in Period|Protocol Violation|0|||
131537103|NCT03214367|473588913|FG002|Lead-in Period|Protocol Violation|0|||
131537104|NCT03214367|473588914|FG003|Lead-in Period|Protocol Violation|0|||
131537105|NCT03214367|473588915|FG004|Lead-in Period|Protocol Violation|0|||
131537106|NCT03214367|473588916|FG005|Lead-in Period|Protocol Violation|0|||
131537107|NCT03214367|473588917|FG006|Lead-in Period|Protocol Violation|0|||
131537108|NCT03214367|473588918|FG007|Lead-in Period|Protocol Violation|0|||
131537109|NCT03214367|473588911|FG000|Lead-in Period|Treatment Interruption|1|||
131537110|NCT03214367|473588912|FG001|Lead-in Period|Treatment Interruption|0|||
131537111|NCT03214367|473588913|FG002|Lead-in Period|Treatment Interruption|0|||
131537112|NCT03214367|473588914|FG003|Lead-in Period|Treatment Interruption|0|||
131537113|NCT03214367|473588915|FG004|Lead-in Period|Treatment Interruption|0|||
131537114|NCT03214367|473588916|FG005|Lead-in Period|Treatment Interruption|0|||
131537115|NCT03214367|473588917|FG006|Lead-in Period|Treatment Interruption|0|||
131537116|NCT03214367|473588918|FG007|Lead-in Period|Treatment Interruption|0|||
131537117|NCT03214367|473588911|FG000|Treatment Period|Adverse Event|0|||
131537118|NCT03214367|473588912|FG001|Treatment Period|Adverse Event|1|||
131537119|NCT03214367|473588913|FG002|Treatment Period|Adverse Event|4|||
131537120|NCT03214367|473588914|FG003|Treatment Period|Adverse Event|2|||
131537121|NCT03214367|473588915|FG004|Treatment Period|Adverse Event|0|||
131537122|NCT03214367|473588916|FG005|Treatment Period|Adverse Event|0|||
131537123|NCT03214367|473588917|FG006|Treatment Period|Adverse Event|0|||
131537124|NCT03214367|473588918|FG007|Treatment Period|Adverse Event|0|||
131537125|NCT03214367|473588911|FG000|Treatment Period|Death|0|||
131537126|NCT03214367|473588912|FG001|Treatment Period|Death|1|||
131537127|NCT03214367|473588913|FG002|Treatment Period|Death|1|||
131537128|NCT03214367|473588914|FG003|Treatment Period|Death|1|||
131537129|NCT03214367|473588915|FG004|Treatment Period|Death|0|||
131537130|NCT03214367|473588916|FG005|Treatment Period|Death|0|||
131537131|NCT03214367|473588917|FG006|Treatment Period|Death|0|||
131537132|NCT03214367|473588918|FG007|Treatment Period|Death|0|||
131537133|NCT03214367|473588911|FG000|Treatment Period|Lost to Follow-up|0|||
131537134|NCT03214367|473588912|FG001|Treatment Period|Lost to Follow-up|5|||
131537135|NCT03214367|473588913|FG002|Treatment Period|Lost to Follow-up|3|||
131537136|NCT03214367|473588914|FG003|Treatment Period|Lost to Follow-up|2|||
131537137|NCT03214367|473588915|FG004|Treatment Period|Lost to Follow-up|0|||
131537138|NCT03214367|473588916|FG005|Treatment Period|Lost to Follow-up|2|||
131537139|NCT03214367|473588917|FG006|Treatment Period|Lost to Follow-up|1|||
131537140|NCT03214367|473588918|FG007|Treatment Period|Lost to Follow-up|0|||
131537141|NCT03214367|473588911|FG000|Treatment Period|Sponsor Decision|0|||
131537142|NCT03214367|473588912|FG001|Treatment Period|Sponsor Decision|3|||
131537143|NCT03214367|473588913|FG002|Treatment Period|Sponsor Decision|0|||
131537144|NCT03214367|473588914|FG003|Treatment Period|Sponsor Decision|0|||
131537145|NCT03214367|473588915|FG004|Treatment Period|Sponsor Decision|0|||
131537146|NCT03214367|473588916|FG005|Treatment Period|Sponsor Decision|0|||
131537147|NCT03214367|473588917|FG006|Treatment Period|Sponsor Decision|0|||
131537148|NCT03214367|473588918|FG007|Treatment Period|Sponsor Decision|0|||
131537149|NCT03214367|473588911|FG000|Treatment Period|Physician Decision|0|||
131537150|NCT03214367|473588912|FG001|Treatment Period|Physician Decision|1|||
131537151|NCT03214367|473588913|FG002|Treatment Period|Physician Decision|2|||
131537152|NCT03214367|473588914|FG003|Treatment Period|Physician Decision|0|||
131537153|NCT03214367|473588915|FG004|Treatment Period|Physician Decision|0|||
131537154|NCT03214367|473588916|FG005|Treatment Period|Physician Decision|0|||
131537155|NCT03214367|473588917|FG006|Treatment Period|Physician Decision|0|||
131537156|NCT03214367|473588918|FG007|Treatment Period|Physician Decision|0|||
131537157|NCT03214367|473588911|FG000|Treatment Period|Protocol Violation|0|||
131537158|NCT03214367|473588912|FG001|Treatment Period|Protocol Violation|3|||
131537159|NCT03214367|473588913|FG002|Treatment Period|Protocol Violation|0|||
131537160|NCT03214367|473588914|FG003|Treatment Period|Protocol Violation|0|||
131537161|NCT03214367|473588915|FG004|Treatment Period|Protocol Violation|0|||
131537162|NCT03214367|473588916|FG005|Treatment Period|Protocol Violation|0|||
131537163|NCT03214367|473588917|FG006|Treatment Period|Protocol Violation|0|||
131537164|NCT03214367|473588918|FG007|Treatment Period|Protocol Violation|0|||
131537165|NCT03214367|473588911|FG000|Treatment Period|Withdrawal by Subject|0|||
131537166|NCT03214367|473588912|FG001|Treatment Period|Withdrawal by Subject|20|||
131537167|NCT03214367|473588913|FG002|Treatment Period|Withdrawal by Subject|23|||
131537168|NCT03214367|473588914|FG003|Treatment Period|Withdrawal by Subject|14|||
131537169|NCT03214367|473588915|FG004|Treatment Period|Withdrawal by Subject|0|||
131537170|NCT03214367|473588916|FG005|Treatment Period|Withdrawal by Subject|1|||
131537171|NCT03214367|473588917|FG006|Treatment Period|Withdrawal by Subject|1|||
131537172|NCT03214367|473588918|FG007|Treatment Period|Withdrawal by Subject|1|||
131537173|NCT03508843|473588919|FG000|Overall Study|Withdrawal by Subject|1|||
131537174|NCT03508843|473588919|FG000|Overall Study|technical difficulties|2|||
131537175|NCT03555396|473588920|FG000|Overall Study|Death|3|||
131537176|NCT03555396|473588921|FG001|Overall Study|Death|1|||
131537177|NCT03555396|473588920|FG000|Overall Study|Lost to Follow-up|0|||
131537178|NCT03555396|473588921|FG001|Overall Study|Lost to Follow-up|2|||
131537179|NCT01816594|473588929|FG000|Overall Study|Local Progress|0|||
131537180|NCT01816594|473588930|FG001|Overall Study|Local Progress|2|||
131537181|NCT01816594|473588929|FG000|Overall Study|Adverse Event|9|||
131537182|NCT01816594|473588930|FG001|Overall Study|Adverse Event|0|||
131537183|NCT01816594|473588929|FG000|Overall Study|Withdrawal by Subject|1|||
131658521|NCT01142232|474035354|FG003|Overall Study|Physician Decision|2|||
131537184|NCT01816594|473588930|FG001|Overall Study|Withdrawal by Subject|0|||
131537185|NCT01816594|473588929|FG000|Overall Study|Physician Decision|1|||
131537186|NCT01816594|473588930|FG001|Overall Study|Physician Decision|0|||
131537187|NCT03905655|473588931|FG000|Overall Study|Adverse Event|1|||
131537188|NCT03905655|473588932|FG001|Overall Study|Adverse Event|0|||
131537189|NCT03905655|473588933|FG002|Overall Study|Adverse Event|1|||
131537190|NCT03905655|473588934|FG003|Overall Study|Adverse Event|1|||
131537191|NCT02566031|473588935|FG000|Overall Study|Patient/guardian decision|14|||
131537192|NCT02566031|473588936|FG001|Overall Study|Patient/guardian decision|7|||
131537193|NCT02566031|473588935|FG000|Overall Study|Protocol deviation|2|||
131537194|NCT02566031|473588936|FG001|Overall Study|Protocol deviation|3|||
131537195|NCT02566031|473588935|FG000|Overall Study|Adverse Event|3|||
131537196|NCT02566031|473588936|FG001|Overall Study|Adverse Event|1|||
131537197|NCT02566031|473588935|FG000|Overall Study|Lost to Follow-up|1|||
131537198|NCT02566031|473588936|FG001|Overall Study|Lost to Follow-up|1|||
131537199|NCT00121238|473588937|FG000|Overall Study|disease progression before intervention|1|||
131537200|NCT00121238|473588937|FG000|Overall Study|Protocol Violation|2|||
131537201|NCT01026974|473588946|FG000|Overall Study|Withdrawal by Subject|0|||
131537202|NCT01026974|473588947|FG001|Overall Study|Withdrawal by Subject|1|||
131537203|NCT01026974|473588948|FG002|Overall Study|Withdrawal by Subject|7|||
131537204|NCT01026974|473588949|FG003|Overall Study|Withdrawal by Subject|2|||
131537205|NCT01026974|473588946|FG000|Overall Study|Lost to Follow-up|1|||
131537206|NCT01026974|473588947|FG001|Overall Study|Lost to Follow-up|1|||
131537207|NCT01026974|473588948|FG002|Overall Study|Lost to Follow-up|4|||
131537208|NCT01026974|473588949|FG003|Overall Study|Lost to Follow-up|0|||
131537209|NCT01026974|473588946|FG000|Overall Study|Adverse Event|0|||
131537210|NCT01026974|473588947|FG001|Overall Study|Adverse Event|0|||
131537211|NCT01026974|473588948|FG002|Overall Study|Adverse Event|0|||
131537212|NCT01026974|473588949|FG003|Overall Study|Adverse Event|1|||
131537213|NCT01026974|473588946|FG000|Overall Study|Inappropriate enrollment|0|||
131537214|NCT01026974|473588947|FG001|Overall Study|Inappropriate enrollment|0|||
131537215|NCT01026974|473588948|FG002|Overall Study|Inappropriate enrollment|1|||
131537216|NCT01026974|473588949|FG003|Overall Study|Inappropriate enrollment|0|||
131537217|NCT00325468|473588951|FG000|Overall Study|Adverse Event|1|||
131537218|NCT00325468|473588952|FG001|Overall Study|Adverse Event|1|||
131537219|NCT00325468|473588953|FG002|Overall Study|Adverse Event|0|||
131537220|NCT00325468|473588954|FG003|Overall Study|Adverse Event|5|||
131537221|NCT00325468|473588955|FG004|Overall Study|Adverse Event|1|||
131537222|NCT00325468|473588951|FG000|Overall Study|Death|2|||
131537223|NCT00325468|473588952|FG001|Overall Study|Death|0|||
131537224|NCT00325468|473588953|FG002|Overall Study|Death|2|||
131537225|NCT00325468|473588954|FG003|Overall Study|Death|4|||
131537226|NCT00325468|473588955|FG004|Overall Study|Death|0|||
131537227|NCT00325468|473588951|FG000|Overall Study|Lost to Follow-up|0|||
131537228|NCT00325468|473588952|FG001|Overall Study|Lost to Follow-up|0|||
131537229|NCT00325468|473588953|FG002|Overall Study|Lost to Follow-up|1|||
131537230|NCT00325468|473588954|FG003|Overall Study|Lost to Follow-up|2|||
131537231|NCT00325468|473588955|FG004|Overall Study|Lost to Follow-up|2|||
131537232|NCT00325468|473588951|FG000|Overall Study|Physician Decision|1|||
131537233|NCT00325468|473588952|FG001|Overall Study|Physician Decision|1|||
131537234|NCT00325468|473588953|FG002|Overall Study|Physician Decision|0|||
131537235|NCT00325468|473588954|FG003|Overall Study|Physician Decision|1|||
131537236|NCT00325468|473588955|FG004|Overall Study|Physician Decision|0|||
131537237|NCT00325468|473588951|FG000|Overall Study|Withdrawal by Subject|3|||
131537238|NCT00325468|473588952|FG001|Overall Study|Withdrawal by Subject|1|||
131537239|NCT00325468|473588953|FG002|Overall Study|Withdrawal by Subject|0|||
131537240|NCT00325468|473588954|FG003|Overall Study|Withdrawal by Subject|14|||
131537241|NCT00325468|473588955|FG004|Overall Study|Withdrawal by Subject|4|||
131537242|NCT00325468|473588951|FG000|Overall Study|site closure etc|4|||
131537243|NCT00325468|473588952|FG001|Overall Study|site closure etc|2|||
131537244|NCT00325468|473588953|FG002|Overall Study|site closure etc|1|||
131537245|NCT00325468|473588954|FG003|Overall Study|site closure etc|8|||
131537246|NCT00325468|473588955|FG004|Overall Study|site closure etc|1|||
131537247|NCT03280121|473588956|FG000|Overall Study|Physician Decision|1|||
131537248|NCT03280121|473588956|FG000|Overall Study|Lost to Follow-up|1|||
131537249|NCT03280121|473588956|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
131537250|NCT01314118|473588957|FG000|Overall Study|Adverse Event|9|||
131537251|NCT01314118|473588957|FG000|Overall Study|Progressive disease|27|||
131537252|NCT01314118|473588957|FG000|Overall Study|Physician Decision|11|||
131537253|NCT01314118|473588957|FG000|Overall Study|Death|4|||
131537254|NCT01314118|473588957|FG000|Overall Study|Protocol Violation|5|||
131537255|NCT01314118|473588957|FG000|Overall Study|Withdrawal by Subject|11|||
131537256|NCT01314118|473588957|FG000|Overall Study|Other|2|||
131537257|NCT01314118|473588957|FG000|Overall Study|Ongoing|62|||
131537258|NCT05585307|473588958|FG000|Overall Study|Lost to Follow-up|0|||
131537259|NCT05585307|473588959|FG001|Overall Study|Lost to Follow-up|0|||
131537260|NCT05585307|473588960|FG002|Overall Study|Lost to Follow-up|0|||
131537261|NCT05585307|473588961|FG003|Overall Study|Lost to Follow-up|0|||
131537262|NCT05585307|473588962|FG004|Overall Study|Lost to Follow-up|0|||
131537263|NCT05585307|473588963|FG005|Overall Study|Lost to Follow-up|0|||
131537264|NCT05585307|473588964|FG006|Overall Study|Lost to Follow-up|1|||
131537265|NCT05585307|473588965|FG007|Overall Study|Lost to Follow-up|0|||
131537266|NCT04420221|473588969|FG000|Overall Study|Withdrawal by Subject|0|||
131537267|NCT04420221|473588970|FG001|Overall Study|Withdrawal by Subject|0|||
131537268|NCT04420221|473588971|FG002|Overall Study|Withdrawal by Subject|0|||
131537269|NCT04420221|473588972|FG003|Overall Study|Withdrawal by Subject|0|||
131537270|NCT04420221|473588973|FG004|Overall Study|Withdrawal by Subject|0|||
131537271|NCT04420221|473588974|FG005|Overall Study|Withdrawal by Subject|20|||
131537272|NCT04420221|473588975|FG006|Overall Study|Withdrawal by Subject|5|||
131537273|NCT04420221|473588969|FG000|Overall Study|Other|0|||
131537274|NCT04420221|473588970|FG001|Overall Study|Other|0|||
131537275|NCT04420221|473588971|FG002|Overall Study|Other|0|||
131537276|NCT04420221|473588972|FG003|Overall Study|Other|0|||
131537277|NCT04420221|473588973|FG004|Overall Study|Other|0|||
131537278|NCT04420221|473588974|FG005|Overall Study|Other|1|||
131537279|NCT04420221|473588975|FG006|Overall Study|Other|1|||
131537280|NCT04420221|473588969|FG000|Overall Study|Lost to Follow-up|0|||
131537281|NCT04420221|473588970|FG001|Overall Study|Lost to Follow-up|0|||
131537282|NCT04420221|473588971|FG002|Overall Study|Lost to Follow-up|0|||
131537283|NCT04420221|473588972|FG003|Overall Study|Lost to Follow-up|0|||
131537284|NCT04420221|473588973|FG004|Overall Study|Lost to Follow-up|0|||
131537285|NCT04420221|473588974|FG005|Overall Study|Lost to Follow-up|3|||
131537286|NCT04420221|473588975|FG006|Overall Study|Lost to Follow-up|2|||
131537287|NCT04420221|473588969|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
131537288|NCT04420221|473588970|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
131537289|NCT04420221|473588971|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
131537290|NCT04420221|473588972|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
131537291|NCT04420221|473588973|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
131537292|NCT04420221|473588974|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
131537293|NCT04420221|473588975|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
131537294|NCT01556438|473588978|FG000|Overall Study|Adverse Event|4|||
131537295|NCT01556438|473588979|FG001|Overall Study|Adverse Event|2|||
131537296|NCT01556438|473588978|FG000|Overall Study|Sponsor Decision|0|||
131537297|NCT01556438|473588979|FG001|Overall Study|Sponsor Decision|2|||
131537298|NCT01556438|473588978|FG000|Overall Study|Progressive Disease|0|||
131537299|NCT01556438|473588979|FG001|Overall Study|Progressive Disease|6|||
131537300|NCT01556438|473588978|FG000|Overall Study|Death|0|||
131537301|NCT01556438|473588979|FG001|Overall Study|Death|1|||
131537302|NCT03695172|473588980|FG000|Overall Study|Withdrawal by Subject|1|||
131537303|NCT03695172|473588981|FG001|Overall Study|Withdrawal by Subject|1|||
131537304|NCT03695172|473588982|FG002|Overall Study|Withdrawal by Subject|0|||
131537305|NCT02734212|473588986|FG000|Overall Study|Lost to Follow-up|5|||
131537306|NCT02734212|473588987|FG001|Overall Study|Lost to Follow-up|10|||
131537307|NCT00688636|473588990|FG000|Overall Study|Adverse Event|2|||
131537308|NCT00688636|473588991|FG001|Overall Study|Adverse Event|1|||
131537309|NCT04053764|473588992|FG000|Overall Study|Withdrawal by Subject|6|||
131537310|NCT04053764|473588993|FG001|Overall Study|Withdrawal by Subject|2|||
131537311|NCT04053764|473588992|FG000|Overall Study|Physician Decision|2|||
131537312|NCT04053764|473588993|FG001|Overall Study|Physician Decision|1|||
131537313|NCT04053764|473588992|FG000|Overall Study|Adverse Event|1|||
131537314|NCT04053764|473588993|FG001|Overall Study|Adverse Event|0|||
131537315|NCT04053764|473588992|FG000|Overall Study|Pregnancy|1|||
131537316|NCT04053764|473588993|FG001|Overall Study|Pregnancy|0|||
131537317|NCT00965523|473588994|FG000|Study 221|Progressive Disease|4|||
131537318|NCT00965523|473588994|FG000|Study 221|Physician Decision|3|||
131537319|NCT00965523|473588994|FG000|Study 224|Progressive Disease|5|||
131537320|NCT00965523|473588994|FG000|Study 224|Physician Decision|1|||
131537321|NCT01939028|473588996|FG000|Overall Study|Withdrawal by Subject|5|||
131537322|NCT01939028|473588996|FG000|Overall Study|Physician Decision|7|||
131537323|NCT01881126|473589020|FG000|Overall Study|Non-compliance|1|||
131537324|NCT01881126|473589021|FG001|Overall Study|Non-compliance|1|||
131537325|NCT01881126|473589020|FG000|Overall Study|Adverse Event|0|||
131537326|NCT01881126|473589021|FG001|Overall Study|Adverse Event|1|||
131537327|NCT01090453|473589024|FG000|Overall Study|Withdrawal by Subject|1|||
131537328|NCT01090453|473589025|FG001|Overall Study|Withdrawal by Subject|2|||
131537329|NCT01090453|473589024|FG000|Overall Study|Lost to Follow-up|7|||
131537330|NCT01090453|473589025|FG001|Overall Study|Lost to Follow-up|7|||
131537331|NCT01090453|473589024|FG000|Overall Study|Non serious AEs|1|||
131537332|NCT01090453|473589025|FG001|Overall Study|Non serious AEs|0|||
131537333|NCT01090453|473589024|FG000|Overall Study|Protocol Violation|2|||
131537334|NCT01090453|473589025|FG001|Overall Study|Protocol Violation|0|||
131537335|NCT01090453|473589024|FG000|Overall Study|Other|2|||
131537336|NCT01090453|473589025|FG001|Overall Study|Other|4|||
131537337|NCT01090453|473589024|FG000|Overall Study|Eligibility Criteria|0|||
131537338|NCT01090453|473589025|FG001|Overall Study|Eligibility Criteria|1|||
131537339|NCT04072159|473589026|FG000|Overall Study|Lost to Follow-up|6|||
131537340|NCT04072159|473589027|FG001|Overall Study|Lost to Follow-up|6|||
131537341|NCT04072159|473589026|FG000|Overall Study|Withdrawal by Subject|2|||
131537342|NCT04072159|473589027|FG001|Overall Study|Withdrawal by Subject|0|||
131537343|NCT00522275|473589032|FG000|Overall Study|Adverse Event|35|||
131537344|NCT00522275|473589032|FG000|Overall Study|Lack of Efficacy|80|||
131537345|NCT00522275|473589032|FG000|Overall Study|Subject withdrew consent|16|||
131537346|NCT00522275|473589032|FG000|Overall Study|Protocol deviation|1|||
131537347|NCT00522275|473589032|FG000|Overall Study|Unsatisfactory compliance|11|||
131537348|NCT00522275|473589032|FG000|Overall Study|Lost to Follow-up|8|||
131537349|NCT00522275|473589032|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
131537350|NCT00522275|473589032|FG000|Overall Study|Other: Subject is pregnant|2|||
131537351|NCT00522275|473589032|FG000|Overall Study|Other: Subject relocated|2|||
131537352|NCT00522275|473589032|FG000|Overall Study|Other: Subject arrested|1|||
131537353|NCT00522275|473589032|FG000|Overall Study|Other: Site / clinic closed|4|||
131537354|NCT00522275|473589032|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
131537355|NCT00522275|473589032|FG000|Overall Study|Other: Sponsor request|2|||
131537356|NCT00522275|473589032|FG000|Overall Study|Other: Subject ran out of medication|1|||
131537357|NCT00522275|473589032|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
131537358|NCT00695669|473589034|FG000|Overall Study|Adverse Event|0|||
131537359|NCT00695669|473589035|FG001|Overall Study|Adverse Event|0|||
131537360|NCT00695669|473589036|FG002|Overall Study|Adverse Event|2|||
131537361|NCT00695669|473589037|FG003|Overall Study|Adverse Event|0|||
131537362|NCT00695669|473589034|FG000|Overall Study|Lost to Follow-up|4|||
131537363|NCT00695669|473589035|FG001|Overall Study|Lost to Follow-up|4|||
131537364|NCT00695669|473589036|FG002|Overall Study|Lost to Follow-up|1|||
131537365|NCT00695669|473589037|FG003|Overall Study|Lost to Follow-up|4|||
131537366|NCT05045625|473589038|FG000|Overall Study|Lost to Follow-up|3|||
131537367|NCT00092131|473589039|FG000|Treatment Period I|Adverse Event|1|||
131537368|NCT00092131|473589040|FG001|Treatment Period I|Adverse Event|0|||
131537369|NCT00092131|473589039|FG000|Treatment Period II|Adverse Event|0|||
131537370|NCT00092131|473589040|FG001|Treatment Period II|Adverse Event|1|||
131537371|NCT02341417|473589041|FG000|Overall Study|Withdrawal by Subject|0|||
131537372|NCT02341417|473589042|FG001|Overall Study|Withdrawal by Subject|2|||
131537373|NCT02341417|473589043|FG002|Overall Study|Withdrawal by Subject|0|||
131537374|NCT02341417|473589041|FG000|Overall Study|Decision by sponsor|2|||
131537375|NCT02341417|473589042|FG001|Overall Study|Decision by sponsor|0|||
131537376|NCT02341417|473589043|FG002|Overall Study|Decision by sponsor|0|||
131537377|NCT02341417|473589041|FG000|Overall Study|Death|0|||
131537378|NCT02341417|473589042|FG001|Overall Study|Death|0|||
131537379|NCT02341417|473589043|FG002|Overall Study|Death|1|||
131537380|NCT02576067|473589057|FG000|Overall Study|Death|0|||
131537381|NCT02576067|473589058|FG001|Overall Study|Death|1|||
131537382|NCT02576067|473589057|FG000|Overall Study|Lack of Efficacy|1|||
131537383|NCT02576067|473589058|FG001|Overall Study|Lack of Efficacy|0|||
131537384|NCT02576067|473589057|FG000|Overall Study|Lost to Follow-up|11|||
131537385|NCT02576067|473589058|FG001|Overall Study|Lost to Follow-up|0|||
131537386|NCT02576067|473589057|FG000|Overall Study|Withdrawal by Subject|11|||
131537387|NCT02576067|473589058|FG001|Overall Study|Withdrawal by Subject|2|||
131537388|NCT02576067|473589057|FG000|Overall Study|study closure of main CIRT trial)|0|||
131537389|NCT02576067|473589058|FG001|Overall Study|study closure of main CIRT trial)|8|||
131537390|NCT02576067|473589057|FG000|Overall Study|not randomized, failed run-in|7|||
131537391|NCT02576067|473589058|FG001|Overall Study|not randomized, failed run-in|0|||
131537392|NCT02576067|473589057|FG000|Overall Study|screen failure/ re-enrolled|0|||
131537393|NCT02576067|473589058|FG001|Overall Study|screen failure/ re-enrolled|25|||
131537394|NCT02576067|473589057|FG000|Overall Study|Physician Decision|4|||
131537395|NCT02576067|473589058|FG001|Overall Study|Physician Decision|0|||
131537396|NCT04773587|473589061|FG000|Overall Study|Lost to Follow-up|11|||
131537397|NCT04773587|473589062|FG001|Overall Study|Lost to Follow-up|3|||
131537398|NCT04773587|473589061|FG000|Overall Study|Adverse Event|6|||
131537399|NCT04773587|473589062|FG001|Overall Study|Adverse Event|3|||
131537400|NCT04773587|473589061|FG000|Overall Study|Lack of Efficacy|5|||
131537401|NCT04773587|473589062|FG001|Overall Study|Lack of Efficacy|2|||
131537402|NCT04773587|473589061|FG000|Overall Study|Withdrawal by Subject|4|||
131537403|NCT04773587|473589062|FG001|Overall Study|Withdrawal by Subject|5|||
131537404|NCT04773587|473589061|FG000|Overall Study|Noncompliance|1|||
131537405|NCT04773587|473589062|FG001|Overall Study|Noncompliance|0|||
131537406|NCT04773587|473589061|FG000|Overall Study|Protocol Violation|1|||
131537407|NCT04773587|473589062|FG001|Overall Study|Protocol Violation|0|||
131537408|NCT04773587|473589061|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
131537409|NCT04773587|473589062|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
131537410|NCT02372409|473589063|FG000|Overall Study|Lost to Follow-up|1|||
131537411|NCT02372409|473589064|FG001|Overall Study|Lost to Follow-up|0|||
131537412|NCT02372409|473589063|FG000|Overall Study|Disease progression|1|||
131537413|NCT02372409|473589064|FG001|Overall Study|Disease progression|1|||
131537414|NCT01808313|473589065|FG000|Overall Study|Adverse Event|5|||
131537415|NCT01808313|473589065|FG000|Overall Study|Protocol Violation|2|||
131537416|NCT01808313|473589065|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131537417|NCT01808313|473589065|FG000|Overall Study|Lost to Follow-up|1|||
131537418|NCT01808313|473589065|FG000|Overall Study|Physician Decision|1|||
131537419|NCT04656847|473589068|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
131537420|NCT03301051|473589069|FG000|Overall Study|Adverse Event|0|||
131537421|NCT03301051|473589070|FG001|Overall Study|Adverse Event|4|||
131537422|NCT03301051|473589069|FG000|Overall Study|Withdrawal by Subject|59|||
131537423|NCT03301051|473589070|FG001|Overall Study|Withdrawal by Subject|65|||
131537424|NCT03301051|473589069|FG000|Overall Study|Lost to Follow-up|263|||
131537425|NCT03301051|473589070|FG001|Overall Study|Lost to Follow-up|282|||
131537426|NCT03301051|473589069|FG000|Overall Study|Protocol Violation|1|||
131537427|NCT03301051|473589070|FG001|Overall Study|Protocol Violation|3|||
131537428|NCT03301051|473589069|FG000|Overall Study|Physician Decision|1|||
131537429|NCT03301051|473589070|FG001|Overall Study|Physician Decision|3|||
131537430|NCT03301051|473589069|FG000|Overall Study|Death|1|||
131537431|NCT03301051|473589070|FG001|Overall Study|Death|1|||
131537432|NCT03301051|473589069|FG000|Overall Study|Miscellaneous|8|||
131537433|NCT03301051|473589070|FG001|Overall Study|Miscellaneous|4|||
131537434|NCT03301051|473589069|FG000|Overall Study|Randomized, not vaccinated|13|||
131537435|NCT03301051|473589070|FG001|Overall Study|Randomized, not vaccinated|10|||
131537436|NCT00047879|473589071|FG000|Overall Study|Progressive disease|4|||
131537437|NCT00047879|473589072|FG001|Overall Study|Progressive disease|3|||
131537438|NCT00622167|473589073|FG000|Overall Study|Did not meet angiographic criteria|20|||
131537439|NCT01954017|473589076|FG000|Overall Study|Adverse Event|0|||
131537440|NCT01954017|473589077|FG001|Overall Study|Adverse Event|0|||
131537441|NCT01954017|473589078|FG002|Overall Study|Adverse Event|1|||
131537442|NCT01954017|473589076|FG000|Overall Study|Death|2|||
131537443|NCT01954017|473589077|FG001|Overall Study|Death|1|||
131537444|NCT01954017|473589078|FG002|Overall Study|Death|1|||
131537445|NCT01954017|473589076|FG000|Overall Study|Withdrawal by Subject|0|||
131537446|NCT01954017|473589077|FG001|Overall Study|Withdrawal by Subject|1|||
131537447|NCT01954017|473589078|FG002|Overall Study|Withdrawal by Subject|0|||
131537448|NCT01954017|473589076|FG000|Overall Study|Protocol Violation|0|||
131537449|NCT01954017|473589077|FG001|Overall Study|Protocol Violation|3|||
131537450|NCT01954017|473589078|FG002|Overall Study|Protocol Violation|2|||
131537451|NCT01954017|473589076|FG000|Overall Study|Necrotizing enterocolitis|1|||
131537452|NCT01954017|473589077|FG001|Overall Study|Necrotizing enterocolitis|0|||
131537453|NCT01954017|473589078|FG002|Overall Study|Necrotizing enterocolitis|1|||
131537454|NCT01954017|473589076|FG000|Overall Study|Enteral intake stopped >7 days|0|||
131537455|NCT01954017|473589077|FG001|Overall Study|Enteral intake stopped >7 days|1|||
131537456|NCT01954017|473589078|FG002|Overall Study|Enteral intake stopped >7 days|1|||
131537457|NCT01954017|473589076|FG000|Overall Study|All other reasons|2|||
131537458|NCT01954017|473589077|FG001|Overall Study|All other reasons|2|||
131537459|NCT01954017|473589078|FG002|Overall Study|All other reasons|7|||
131537460|NCT00435370|473589083|FG000|Overall Study|Adverse Event|8|||
131537461|NCT00435370|473589084|FG001|Overall Study|Adverse Event|8|||
131537462|NCT00435370|473589083|FG000|Overall Study|Withdrawal by Subject|10|||
131537463|NCT00435370|473589084|FG001|Overall Study|Withdrawal by Subject|10|||
131537464|NCT00435370|473589083|FG000|Overall Study|Antipsychotic medication changed|4|||
131537465|NCT00435370|473589084|FG001|Overall Study|Antipsychotic medication changed|2|||
131537466|NCT03674177|473589088|FG000|Overall Study|Lost to Follow-up|2|||
131537467|NCT03674177|473589089|FG001|Overall Study|Lost to Follow-up|1|||
131537468|NCT03674177|473589090|FG002|Overall Study|Lost to Follow-up|0|||
131537469|NCT03674177|473589091|FG003|Overall Study|Lost to Follow-up|2|||
131537470|NCT00714168|473589092|FG000|Overall Study|Pregnancy|5|||
131537471|NCT00714168|473589093|FG001|Overall Study|Pregnancy|4|||
131537472|NCT00714168|473589092|FG000|Overall Study|Lost to Follow-up|32|||
131537473|NCT00714168|473589093|FG001|Overall Study|Lost to Follow-up|50|||
131537474|NCT00714168|473589092|FG000|Overall Study|Relocation|4|||
131537475|NCT00714168|473589093|FG001|Overall Study|Relocation|3|||
131537476|NCT00714168|473589092|FG000|Overall Study|Non-study medical condition|3|||
131537477|NCT00714168|473589093|FG001|Overall Study|Non-study medical condition|2|||
131537478|NCT02298192|473589100|FG000|Overall Study|Unclassified|3|||
131537479|NCT02298192|473589101|FG001|Overall Study|Unclassified|2|||
131537480|NCT02298192|473589100|FG000|Overall Study|Withdrawal criteria|2|||
131537481|NCT02298192|473589101|FG001|Overall Study|Withdrawal criteria|0|||
131537482|NCT02298192|473589100|FG000|Overall Study|Withdrawal by Subject|6|||
131537483|NCT02298192|473589101|FG001|Overall Study|Withdrawal by Subject|1|||
131537484|NCT02298192|473589100|FG000|Overall Study|Lost to Follow-up|2|||
131537485|NCT02298192|473589101|FG001|Overall Study|Lost to Follow-up|1|||
131537486|NCT02298192|473589100|FG000|Overall Study|Adverse Event|6|||
131537487|NCT02298192|473589101|FG001|Overall Study|Adverse Event|2|||
131537488|NCT04764396|473589102|FG000|Overall Study|Physician Decision|1|||
131537489|NCT04764396|473589103|FG001|Overall Study|Physician Decision|0|||
131537490|NCT02653482|473589105|FG000|Overall Study|Death|1|||
131537491|NCT02653482|473589106|FG001|Overall Study|Death|1|||
131537492|NCT01864564|473589109|FG000|Overall Study|Lost to Follow-up|17|||
131537493|NCT01864564|473589110|FG001|Overall Study|Lost to Follow-up|23|||
131537494|NCT01864564|473589109|FG000|Overall Study|Withdrawal by Subject|20|||
131537495|NCT01864564|473589110|FG001|Overall Study|Withdrawal by Subject|11|||
131537496|NCT01864564|473589109|FG000|Overall Study|Protocol Violation|0|||
131537497|NCT01864564|473589110|FG001|Overall Study|Protocol Violation|27|||
131537498|NCT01864564|473589109|FG000|Overall Study|not reported|0|||
131537499|NCT01864564|473589110|FG001|Overall Study|not reported|34|||
131537500|NCT03077724|473589111|FG000|Overall Study|Lost to Follow-up|5|||
131537501|NCT03077724|473589112|FG001|Overall Study|Lost to Follow-up|1|||
131537502|NCT03077724|473589111|FG000|Overall Study|Withdrawal by Subject|3|||
131537503|NCT03077724|473589112|FG001|Overall Study|Withdrawal by Subject|1|||
131537504|NCT06273774|473589115|FG000|Overall Study|Participant was out of state.|0|||
131537505|NCT06273774|473589116|FG001|Overall Study|Participant was out of state.|0|||
131537506|NCT06273774|473589117|FG002|Overall Study|Participant was out of state.|0|||
131537507|NCT06273774|473589118|FG003|Overall Study|Participant was out of state.|0|||
131537508|NCT06273774|473589119|FG004|Overall Study|Participant was out of state.|0|||
131537509|NCT06273774|473589120|FG005|Overall Study|Participant was out of state.|1|||
131537510|NCT06273774|473589115|FG000|Overall Study|Lost to Follow-up|0|||
131537511|NCT06273774|473589116|FG001|Overall Study|Lost to Follow-up|0|||
131537512|NCT06273774|473589117|FG002|Overall Study|Lost to Follow-up|0|||
131537513|NCT06273774|473589118|FG003|Overall Study|Lost to Follow-up|0|||
131537514|NCT06273774|473589119|FG004|Overall Study|Lost to Follow-up|1|||
131537515|NCT06273774|473589120|FG005|Overall Study|Lost to Follow-up|0|||
131537516|NCT04414696|473589125|FG000|3-month Follow up|Withdrawal by Subject|1|||
131537517|NCT04414696|473589126|FG001|3-month Follow up|Withdrawal by Subject|0|||
131537518|NCT04414696|473589125|FG000|3-month Follow up|Lost to Follow-up|22|||
131537519|NCT04414696|473589126|FG001|3-month Follow up|Lost to Follow-up|23|||
131537520|NCT04414696|473589125|FG000|6-month Follow up|Withdrawal by Subject|1|||
131537521|NCT04414696|473589126|FG001|6-month Follow up|Withdrawal by Subject|2|||
131537522|NCT04414696|473589125|FG000|6-month Follow up|Lost to Follow-up|5|||
131537523|NCT04414696|473589126|FG001|6-month Follow up|Lost to Follow-up|2|||
131537524|NCT00924287|473592037|FG000|Overall Study|Death|1|||
131537525|NCT01625897|473592038|FG000|Overall Study|Adverse Event|27|||
131537526|NCT01625897|473592039|FG001|Overall Study|Adverse Event|10|||
131537527|NCT01625897|473592038|FG000|Overall Study|Physician Decision|0|||
131537528|NCT01625897|473592039|FG001|Overall Study|Physician Decision|1|||
131537529|NCT01625897|473592038|FG000|Overall Study|Withdrawal by Subject|25|||
131537530|NCT01625897|473592039|FG001|Overall Study|Withdrawal by Subject|3|||
131537531|NCT01912612|473592042|FG000|Overall Study|Adverse Event|4|||
131537532|NCT01912612|473592043|FG001|Overall Study|Adverse Event|0|||
131537533|NCT01912612|473592044|FG002|Overall Study|Adverse Event|0|||
131537534|NCT01912612|473592042|FG000|Overall Study|Withdrew consent|1|||
131537535|NCT01912612|473592043|FG001|Overall Study|Withdrew consent|0|||
131537536|NCT01912612|473592044|FG002|Overall Study|Withdrew consent|0|||
131537537|NCT01912612|473592042|FG000|Overall Study|Study design change|0|||
131537538|NCT01912612|473592043|FG001|Overall Study|Study design change|0|||
131537539|NCT01912612|473592044|FG002|Overall Study|Study design change|3|||
131537540|NCT01588184|473592045|FG000|Overall Study|Death|1|||
131537541|NCT01588184|473592046|FG001|Overall Study|Death|0|||
131537542|NCT01588184|473592047|FG002|Overall Study|Death|0|||
131537543|NCT01588184|473592048|FG003|Overall Study|Death|1|||
131537544|NCT01588184|473592049|FG004|Overall Study|Death|1|||
131537545|NCT01588184|473592050|FG005|Overall Study|Death|1|||
131537546|NCT01588184|473592045|FG000|Overall Study|Withdrawal by Subject|2|||
131537547|NCT01588184|473592046|FG001|Overall Study|Withdrawal by Subject|4|||
131537548|NCT01588184|473592047|FG002|Overall Study|Withdrawal by Subject|0|||
131537549|NCT01588184|473592048|FG003|Overall Study|Withdrawal by Subject|1|||
131537550|NCT01588184|473592049|FG004|Overall Study|Withdrawal by Subject|0|||
131537551|NCT01588184|473592050|FG005|Overall Study|Withdrawal by Subject|0|||
131537552|NCT01588184|473592045|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
131537553|NCT01588184|473592046|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
131537554|NCT01588184|473592047|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
131537555|NCT01588184|473592048|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
131537556|NCT01588184|473592049|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
131537557|NCT01588184|473592050|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
131537558|NCT01588184|473592045|FG000|Overall Study|multiple reasons|0|||
131537559|NCT01588184|473592046|FG001|Overall Study|multiple reasons|3|||
131537560|NCT01588184|473592047|FG002|Overall Study|multiple reasons|0|||
131537561|NCT01588184|473592048|FG003|Overall Study|multiple reasons|1|||
131537562|NCT01588184|473592049|FG004|Overall Study|multiple reasons|0|||
131537563|NCT01588184|473592050|FG005|Overall Study|multiple reasons|0|||
131537564|NCT02008890|473592052|FG000|Period 1|Withdrawal by Subject|7|||
131537565|NCT02008890|473592053|FG001|Period 1|Withdrawal by Subject|7|||
131537566|NCT02008890|473592054|FG002|Period 1|Withdrawal by Subject|5|||
131537567|NCT02008890|473592055|FG003|Period 1|Withdrawal by Subject|0|||
131537568|NCT02008890|473592056|FG004|Period 1|Withdrawal by Subject|0|||
131537569|NCT02008890|473592052|FG000|Period 1|Pregnancy|1|||
131537570|NCT02008890|473592053|FG001|Period 1|Pregnancy|0|||
131537571|NCT02008890|473592054|FG002|Period 1|Pregnancy|0|||
131537572|NCT02008890|473592055|FG003|Period 1|Pregnancy|0|||
131537573|NCT02008890|473592056|FG004|Period 1|Pregnancy|0|||
131537574|NCT02008890|473592052|FG000|Period 1|Physician Decision|1|||
131537575|NCT02008890|473592053|FG001|Period 1|Physician Decision|0|||
131537576|NCT02008890|473592054|FG002|Period 1|Physician Decision|1|||
131537577|NCT02008890|473592055|FG003|Period 1|Physician Decision|0|||
131537578|NCT02008890|473592056|FG004|Period 1|Physician Decision|0|||
131537579|NCT02008890|473592052|FG000|Period 1|Adverse Event|6|||
131537580|NCT02008890|473592053|FG001|Period 1|Adverse Event|8|||
131537581|NCT02008890|473592054|FG002|Period 1|Adverse Event|6|||
131537582|NCT02008890|473592055|FG003|Period 1|Adverse Event|0|||
131537583|NCT02008890|473592056|FG004|Period 1|Adverse Event|0|||
131537584|NCT02008890|473592052|FG000|Period 2|Adverse Event|12|||
131537585|NCT02008890|473592053|FG001|Period 2|Adverse Event|7|||
131537586|NCT02008890|473592054|FG002|Period 2|Adverse Event|0|||
131537587|NCT02008890|473592055|FG003|Period 2|Adverse Event|5|||
131537588|NCT02008890|473592056|FG004|Period 2|Adverse Event|5|||
131537589|NCT02008890|473592052|FG000|Period 2|Withdrawal by Subject|11|||
131537590|NCT02008890|473592053|FG001|Period 2|Withdrawal by Subject|8|||
131537591|NCT02008890|473592054|FG002|Period 2|Withdrawal by Subject|0|||
131537592|NCT02008890|473592055|FG003|Period 2|Withdrawal by Subject|7|||
131537593|NCT02008890|473592056|FG004|Period 2|Withdrawal by Subject|2|||
131537594|NCT02008890|473592052|FG000|Period 2|Physician Decision|4|||
131537595|NCT02008890|473592053|FG001|Period 2|Physician Decision|0|||
131537596|NCT02008890|473592054|FG002|Period 2|Physician Decision|0|||
131537597|NCT02008890|473592055|FG003|Period 2|Physician Decision|2|||
131537598|NCT02008890|473592056|FG004|Period 2|Physician Decision|1|||
131537599|NCT02008890|473592052|FG000|Period 2|Lost to Follow-up|0|||
131537600|NCT02008890|473592053|FG001|Period 2|Lost to Follow-up|0|||
131537601|NCT02008890|473592054|FG002|Period 2|Lost to Follow-up|1|||
131537602|NCT02008890|473592055|FG003|Period 2|Lost to Follow-up|0|||
131537603|NCT02008890|473592056|FG004|Period 2|Lost to Follow-up|0|||
131537604|NCT02008890|473592052|FG000|Extension Period|Withdrawal by Subject|3|||
131537605|NCT02008890|473592053|FG001|Extension Period|Withdrawal by Subject|2|||
131537606|NCT02008890|473592054|FG002|Extension Period|Withdrawal by Subject|0|||
131537607|NCT02008890|473592055|FG003|Extension Period|Withdrawal by Subject|4|||
131537608|NCT02008890|473592056|FG004|Extension Period|Withdrawal by Subject|2|||
131537609|NCT02008890|473592052|FG000|Extension Period|Lost to Follow-up|1|||
131537610|NCT02008890|473592053|FG001|Extension Period|Lost to Follow-up|0|||
131537611|NCT02008890|473592054|FG002|Extension Period|Lost to Follow-up|0|||
131537612|NCT02008890|473592055|FG003|Extension Period|Lost to Follow-up|0|||
131537613|NCT02008890|473592056|FG004|Extension Period|Lost to Follow-up|0|||
131537614|NCT02008890|473592052|FG000|Extension Period|Adverse Event|1|||
131537615|NCT02008890|473592053|FG001|Extension Period|Adverse Event|3|||
131537616|NCT02008890|473592054|FG002|Extension Period|Adverse Event|0|||
131537617|NCT02008890|473592055|FG003|Extension Period|Adverse Event|0|||
131537618|NCT02008890|473592056|FG004|Extension Period|Adverse Event|2|||
131537619|NCT02207816|473592057|FG000|Overall Study|Serious Adverse Event|0|||
131537620|NCT02207816|473592058|FG001|Overall Study|Serious Adverse Event|5|||
131537621|NCT02207816|473592059|FG002|Overall Study|Serious Adverse Event|2|||
131537622|NCT02207816|473592057|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
131537623|NCT02207816|473592058|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
131537624|NCT02207816|473592059|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
131537625|NCT02207816|473592057|FG000|Overall Study|Withdrawal by Subject|4|||
131537626|NCT02207816|473592058|FG001|Overall Study|Withdrawal by Subject|9|||
131537627|NCT02207816|473592059|FG002|Overall Study|Withdrawal by Subject|7|||
131537628|NCT02207816|473592057|FG000|Overall Study|Migrated/Moved From Study Area|41|||
131537629|NCT02207816|473592058|FG001|Overall Study|Migrated/Moved From Study Area|60|||
131537630|NCT02207816|473592059|FG002|Overall Study|Migrated/Moved From Study Area|51|||
131537631|NCT02207816|473592057|FG000|Overall Study|Lost to Follow-up|3|||
131537632|NCT02207816|473592058|FG001|Overall Study|Lost to Follow-up|9|||
131537633|NCT02207816|473592059|FG002|Overall Study|Lost to Follow-up|1|||
131537634|NCT02207816|473592057|FG000|Overall Study|Other|1|||
131537635|NCT02207816|473592058|FG001|Overall Study|Other|2|||
131537636|NCT02207816|473592059|FG002|Overall Study|Other|4|||
131537637|NCT05912400|473592060|FG000|Overall Study|Lost to Follow-up|1|||
131537638|NCT05912400|473592061|FG001|Overall Study|Lost to Follow-up|0|||
131537639|NCT05912400|473592060|FG000|Overall Study|Physician Decision|6|||
131537640|NCT05912400|473592061|FG001|Overall Study|Physician Decision|0|||
131537641|NCT05912400|473592060|FG000|Overall Study|Withdrawal by Subject|1|||
131537642|NCT05912400|473592061|FG001|Overall Study|Withdrawal by Subject|0|||
131537643|NCT02522494|473592064|FG000|Overall Study|Lost to Follow-up|6|||
131537644|NCT02522494|473592065|FG001|Overall Study|Lost to Follow-up|2|||
131537645|NCT02522494|473592064|FG000|Overall Study|Withdrawal by Subject|1|||
131537646|NCT02522494|473592065|FG001|Overall Study|Withdrawal by Subject|0|||
131537647|NCT02522494|473592064|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
131537648|NCT02522494|473592065|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
131537649|NCT02522494|473592064|FG000|Overall Study|Participant did not watch the video|1|||
131537650|NCT02522494|473592065|FG001|Overall Study|Participant did not watch the video|0|||
131537651|NCT02522494|473592064|FG000|Overall Study|Death|0|||
131537652|NCT02522494|473592065|FG001|Overall Study|Death|1|||
131537653|NCT02811861|473592066|FG000|Overall Study|Radiological Disease Progression|123|||
131537654|NCT02811861|473592067|FG001|Overall Study|Radiological Disease Progression|97|||
131537655|NCT02811861|473592068|FG002|Overall Study|Radiological Disease Progression|174|||
131537656|NCT02811861|473592066|FG000|Overall Study|Clinical Disease Progression|20|||
131537657|NCT02811861|473592067|FG001|Overall Study|Clinical Disease Progression|19|||
131537658|NCT02811861|473592068|FG002|Overall Study|Clinical Disease Progression|22|||
131537659|NCT02811861|473592066|FG000|Overall Study|Adverse Event|63|||
131537660|NCT02811861|473592067|FG001|Overall Study|Adverse Event|60|||
131537661|NCT02811861|473592068|FG002|Overall Study|Adverse Event|41|||
131537662|NCT02811861|473592066|FG000|Overall Study|Lost to Follow-up|0|||
131537663|NCT02811861|473592067|FG001|Overall Study|Lost to Follow-up|0|||
131537664|NCT02811861|473592068|FG002|Overall Study|Lost to Follow-up|1|||
131537665|NCT02811861|473592066|FG000|Overall Study|Subject Choice|29|||
131537666|NCT02811861|473592067|FG001|Overall Study|Subject Choice|17|||
131537667|NCT02811861|473592068|FG002|Overall Study|Subject Choice|23|||
131537668|NCT02811861|473592066|FG000|Overall Study|Withdrawal by Subject|4|||
131537669|NCT02811861|473592067|FG001|Overall Study|Withdrawal by Subject|4|||
131537670|NCT02811861|473592068|FG002|Overall Study|Withdrawal by Subject|9|||
131537671|NCT02811861|473592066|FG000|Overall Study|Other|4|||
131537672|NCT02811861|473592067|FG001|Overall Study|Other|13|||
131537673|NCT02811861|473592068|FG002|Overall Study|Other|3|||
131537674|NCT02811861|473592066|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
131537675|NCT02811861|473592067|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
131537676|NCT02811861|473592068|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
131537677|NCT02811861|473592066|FG000|Overall Study|Randomized but not treated|2|||
131537678|NCT02811861|473592067|FG001|Overall Study|Randomized but not treated|3|||
131537679|NCT02811861|473592068|FG002|Overall Study|Randomized but not treated|17|||
131537680|NCT00360308|473592069|FG000|Overall Study|Adverse Event|15|||
131537681|NCT00360308|473592070|FG001|Overall Study|Adverse Event|14|||
131537682|NCT00360308|473592071|FG002|Overall Study|Adverse Event|25|||
131537683|NCT00360308|473592069|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
131537684|NCT00360308|473592070|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
131537685|NCT00360308|473592071|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131537686|NCT00360308|473592069|FG000|Overall Study|Protocol Violation|2|||
131537687|NCT00360308|473592070|FG001|Overall Study|Protocol Violation|1|||
131537688|NCT00360308|473592071|FG002|Overall Study|Protocol Violation|2|||
131537689|NCT00360308|473592069|FG000|Overall Study|Withdrawal by Subject|11|||
131537690|NCT00360308|473592070|FG001|Overall Study|Withdrawal by Subject|7|||
131537691|NCT00360308|473592071|FG002|Overall Study|Withdrawal by Subject|14|||
131537692|NCT00360308|473592069|FG000|Overall Study|Lack of Efficacy|3|||
131537693|NCT00360308|473592070|FG001|Overall Study|Lack of Efficacy|0|||
131537694|NCT00360308|473592071|FG002|Overall Study|Lack of Efficacy|2|||
131537695|NCT00360308|473592069|FG000|Overall Study|Other|2|||
131537696|NCT00360308|473592070|FG001|Overall Study|Other|1|||
131537697|NCT00360308|473592071|FG002|Overall Study|Other|1|||
131537698|NCT00360308|473592069|FG000|Overall Study|Study termination by sponsor|43|||
131537699|NCT00360308|473592070|FG001|Overall Study|Study termination by sponsor|55|||
131537700|NCT00360308|473592071|FG002|Overall Study|Study termination by sponsor|44|||
131537701|NCT03461003|473592072|FG000|Overall Study|Lost to Follow-up|2|||
131537702|NCT03461003|473592073|FG001|Overall Study|Lost to Follow-up|2|||
131537703|NCT03461003|473592072|FG000|Overall Study|Withdrawal by Subject|3|||
131537704|NCT03461003|473592073|FG001|Overall Study|Withdrawal by Subject|1|||
131537705|NCT03489304|473592074|FG000|Overall Study|Lost to Follow-up|4|||
131537706|NCT02239679|473592078|FG000|Overall Study|Lost to Follow-up|1|||
131537707|NCT02239679|473592079|FG001|Overall Study|Lost to Follow-up|0|||
131537708|NCT02239679|473592080|FG002|Overall Study|Lost to Follow-up|0|||
131537709|NCT02239679|473592078|FG000|Overall Study|Withdrawal by Subject|2|||
131537710|NCT02239679|473592079|FG001|Overall Study|Withdrawal by Subject|3|||
131537711|NCT02239679|473592080|FG002|Overall Study|Withdrawal by Subject|1|||
131537712|NCT01217073|473592081|FG000|Base Period|Adverse Event|1|||
131537713|NCT01217073|473592082|FG001|Base Period|Adverse Event|0|||
131537714|NCT01217073|473592083|FG002|Base Period|Adverse Event|1|||
131537715|NCT01217073|473592084|FG003|Base Period|Adverse Event|0|||
131537716|NCT01217073|473592085|FG004|Base Period|Adverse Event|4|||
131537717|NCT01217073|473592086|FG005|Base Period|Adverse Event|1|||
131537718|NCT01217073|473592087|FG006|Base Period|Adverse Event|0|||
131537719|NCT01217073|473592088|FG007|Base Period|Adverse Event|0|||
131537720|NCT01217073|473592081|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
131537721|NCT01217073|473592082|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537722|NCT01217073|473592083|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537723|NCT01217073|473592084|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537724|NCT01217073|473592085|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537725|NCT01217073|473592086|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537726|NCT01217073|473592087|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537727|NCT01217073|473592088|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
131537728|NCT01217073|473592081|FG000|Base Period|Excluded medication|0|||
131537729|NCT01217073|473592082|FG001|Base Period|Excluded medication|0|||
131537730|NCT01217073|473592083|FG002|Base Period|Excluded medication|0|||
131537731|NCT01217073|473592084|FG003|Base Period|Excluded medication|0|||
131537732|NCT01217073|473592085|FG004|Base Period|Excluded medication|1|||
131537733|NCT01217073|473592086|FG005|Base Period|Excluded medication|0|||
131537734|NCT01217073|473592087|FG006|Base Period|Excluded medication|0|||
131537735|NCT01217073|473592088|FG007|Base Period|Excluded medication|0|||
131537736|NCT01217073|473592081|FG000|Base Period|Lack of Efficacy|0|||
131537737|NCT01217073|473592082|FG001|Base Period|Lack of Efficacy|0|||
131537738|NCT01217073|473592083|FG002|Base Period|Lack of Efficacy|0|||
131537739|NCT01217073|473592084|FG003|Base Period|Lack of Efficacy|0|||
131537740|NCT01217073|473592085|FG004|Base Period|Lack of Efficacy|0|||
131537741|NCT01217073|473592086|FG005|Base Period|Lack of Efficacy|1|||
131537742|NCT01217073|473592087|FG006|Base Period|Lack of Efficacy|0|||
131537743|NCT01217073|473592088|FG007|Base Period|Lack of Efficacy|0|||
131537744|NCT01217073|473592081|FG000|Base Period|Lost to Follow-up|0|||
131537745|NCT01217073|473592082|FG001|Base Period|Lost to Follow-up|0|||
131537746|NCT01217073|473592083|FG002|Base Period|Lost to Follow-up|1|||
131537747|NCT01217073|473592084|FG003|Base Period|Lost to Follow-up|1|||
131537748|NCT01217073|473592085|FG004|Base Period|Lost to Follow-up|3|||
131537749|NCT01217073|473592086|FG005|Base Period|Lost to Follow-up|0|||
131537750|NCT01217073|473592087|FG006|Base Period|Lost to Follow-up|0|||
131537751|NCT01217073|473592088|FG007|Base Period|Lost to Follow-up|0|||
131537752|NCT01217073|473592081|FG000|Base Period|Physician Decision|0|||
131537753|NCT01217073|473592082|FG001|Base Period|Physician Decision|0|||
131537754|NCT01217073|473592083|FG002|Base Period|Physician Decision|0|||
131537755|NCT01217073|473592084|FG003|Base Period|Physician Decision|0|||
131537756|NCT01217073|473592085|FG004|Base Period|Physician Decision|1|||
131537757|NCT01217073|473592086|FG005|Base Period|Physician Decision|0|||
131537758|NCT01217073|473592087|FG006|Base Period|Physician Decision|0|||
131537759|NCT01217073|473592088|FG007|Base Period|Physician Decision|0|||
131537760|NCT01217073|473592081|FG000|Base Period|Protocol Violation|1|||
131537761|NCT01217073|473592082|FG001|Base Period|Protocol Violation|0|||
131537762|NCT01217073|473592083|FG002|Base Period|Protocol Violation|0|||
131537763|NCT01217073|473592084|FG003|Base Period|Protocol Violation|0|||
131537764|NCT01217073|473592085|FG004|Base Period|Protocol Violation|1|||
131537765|NCT01217073|473592086|FG005|Base Period|Protocol Violation|2|||
131537766|NCT01217073|473592087|FG006|Base Period|Protocol Violation|0|||
131537767|NCT01217073|473592088|FG007|Base Period|Protocol Violation|0|||
131537768|NCT01217073|473592081|FG000|Base Period|Withdrawal by Subject|4|||
131537769|NCT01217073|473592082|FG001|Base Period|Withdrawal by Subject|5|||
131537770|NCT01217073|473592083|FG002|Base Period|Withdrawal by Subject|5|||
131537771|NCT01217073|473592084|FG003|Base Period|Withdrawal by Subject|1|||
131537772|NCT01217073|473592085|FG004|Base Period|Withdrawal by Subject|5|||
131537773|NCT01217073|473592086|FG005|Base Period|Withdrawal by Subject|5|||
131537774|NCT01217073|473592087|FG006|Base Period|Withdrawal by Subject|0|||
131537775|NCT01217073|473592088|FG007|Base Period|Withdrawal by Subject|0|||
131537776|NCT01217073|473592081|FG000|Extension Period|Adverse Event|0|||
131537777|NCT01217073|473592082|FG001|Extension Period|Adverse Event|0|||
131537778|NCT01217073|473592083|FG002|Extension Period|Adverse Event|0|||
131537779|NCT01217073|473592084|FG003|Extension Period|Adverse Event|0|||
131537780|NCT01217073|473592085|FG004|Extension Period|Adverse Event|0|||
131537781|NCT01217073|473592086|FG005|Extension Period|Adverse Event|0|||
131537782|NCT01217073|473592087|FG006|Extension Period|Adverse Event|19|||
131537783|NCT01217073|473592088|FG007|Extension Period|Adverse Event|5|||
131537784|NCT01217073|473592081|FG000|Extension Period|ALT/AST|0|||
131537785|NCT01217073|473592082|FG001|Extension Period|ALT/AST|0|||
131537786|NCT01217073|473592083|FG002|Extension Period|ALT/AST|0|||
131537787|NCT01217073|473592084|FG003|Extension Period|ALT/AST|0|||
131537788|NCT01217073|473592085|FG004|Extension Period|ALT/AST|0|||
131537789|NCT01217073|473592086|FG005|Extension Period|ALT/AST|0|||
131537790|NCT01217073|473592087|FG006|Extension Period|ALT/AST|2|||
131537791|NCT01217073|473592088|FG007|Extension Period|ALT/AST|0|||
131537792|NCT01217073|473592081|FG000|Extension Period|Contraindication to study medication|0|||
131537793|NCT01217073|473592082|FG001|Extension Period|Contraindication to study medication|0|||
131537794|NCT01217073|473592083|FG002|Extension Period|Contraindication to study medication|0|||
131537795|NCT01217073|473592084|FG003|Extension Period|Contraindication to study medication|0|||
131537796|NCT01217073|473592085|FG004|Extension Period|Contraindication to study medication|0|||
131537797|NCT01217073|473592086|FG005|Extension Period|Contraindication to study medication|0|||
131537798|NCT01217073|473592087|FG006|Extension Period|Contraindication to study medication|1|||
131537799|NCT01217073|473592088|FG007|Extension Period|Contraindication to study medication|0|||
131537800|NCT01217073|473592081|FG000|Extension Period|Creatinine/eGFR|0|||
131537801|NCT01217073|473592082|FG001|Extension Period|Creatinine/eGFR|0|||
131537802|NCT01217073|473592083|FG002|Extension Period|Creatinine/eGFR|0|||
131537803|NCT01217073|473592084|FG003|Extension Period|Creatinine/eGFR|0|||
131537804|NCT01217073|473592085|FG004|Extension Period|Creatinine/eGFR|0|||
131537805|NCT01217073|473592086|FG005|Extension Period|Creatinine/eGFR|0|||
131537806|NCT01217073|473592087|FG006|Extension Period|Creatinine/eGFR|11|||
131537807|NCT01217073|473592088|FG007|Extension Period|Creatinine/eGFR|1|||
131537808|NCT01217073|473592081|FG000|Extension Period|Death|0|||
131537809|NCT01217073|473592082|FG001|Extension Period|Death|0|||
131537810|NCT01217073|473592083|FG002|Extension Period|Death|0|||
131537811|NCT01217073|473592084|FG003|Extension Period|Death|0|||
131537812|NCT01217073|473592085|FG004|Extension Period|Death|0|||
131537813|NCT01217073|473592086|FG005|Extension Period|Death|0|||
131537814|NCT01217073|473592087|FG006|Extension Period|Death|1|||
131537815|NCT01217073|473592088|FG007|Extension Period|Death|0|||
131537816|NCT01217073|473592081|FG000|Extension Period|Excluded medication|0|||
131537817|NCT01217073|473592082|FG001|Extension Period|Excluded medication|0|||
131537818|NCT01217073|473592083|FG002|Extension Period|Excluded medication|0|||
131537819|NCT01217073|473592084|FG003|Extension Period|Excluded medication|0|||
131537820|NCT01217073|473592085|FG004|Extension Period|Excluded medication|0|||
131537821|NCT01217073|473592086|FG005|Extension Period|Excluded medication|0|||
131537822|NCT01217073|473592087|FG006|Extension Period|Excluded medication|2|||
131537823|NCT01217073|473592088|FG007|Extension Period|Excluded medication|0|||
131537824|NCT01217073|473592081|FG000|Extension Period|Lack of Efficacy|0|||
131537825|NCT01217073|473592082|FG001|Extension Period|Lack of Efficacy|0|||
131537826|NCT01217073|473592083|FG002|Extension Period|Lack of Efficacy|0|||
131537827|NCT01217073|473592084|FG003|Extension Period|Lack of Efficacy|0|||
131537828|NCT01217073|473592085|FG004|Extension Period|Lack of Efficacy|0|||
131537829|NCT01217073|473592086|FG005|Extension Period|Lack of Efficacy|0|||
131537830|NCT01217073|473592087|FG006|Extension Period|Lack of Efficacy|3|||
131537831|NCT01217073|473592088|FG007|Extension Period|Lack of Efficacy|0|||
131537832|NCT01217073|473592081|FG000|Extension Period|Lost to Follow-up|0|||
131537833|NCT01217073|473592082|FG001|Extension Period|Lost to Follow-up|0|||
131537834|NCT01217073|473592083|FG002|Extension Period|Lost to Follow-up|0|||
131537835|NCT01217073|473592084|FG003|Extension Period|Lost to Follow-up|0|||
131537836|NCT01217073|473592085|FG004|Extension Period|Lost to Follow-up|0|||
131537837|NCT01217073|473592086|FG005|Extension Period|Lost to Follow-up|0|||
131537838|NCT01217073|473592087|FG006|Extension Period|Lost to Follow-up|9|||
131537839|NCT01217073|473592088|FG007|Extension Period|Lost to Follow-up|1|||
131537840|NCT01217073|473592081|FG000|Extension Period|Non-compliance with study drug|0|||
131537841|NCT01217073|473592082|FG001|Extension Period|Non-compliance with study drug|0|||
131537842|NCT01217073|473592083|FG002|Extension Period|Non-compliance with study drug|0|||
131537843|NCT01217073|473592084|FG003|Extension Period|Non-compliance with study drug|0|||
131537844|NCT01217073|473592085|FG004|Extension Period|Non-compliance with study drug|0|||
131537845|NCT01217073|473592086|FG005|Extension Period|Non-compliance with study drug|0|||
131537846|NCT01217073|473592087|FG006|Extension Period|Non-compliance with study drug|0|||
131537847|NCT01217073|473592088|FG007|Extension Period|Non-compliance with study drug|1|||
131537848|NCT01217073|473592081|FG000|Extension Period|Physician Decision|0|||
131537849|NCT01217073|473592082|FG001|Extension Period|Physician Decision|0|||
131537850|NCT01217073|473592083|FG002|Extension Period|Physician Decision|0|||
131537851|NCT01217073|473592084|FG003|Extension Period|Physician Decision|0|||
131537852|NCT01217073|473592085|FG004|Extension Period|Physician Decision|0|||
131537853|NCT01217073|473592086|FG005|Extension Period|Physician Decision|0|||
131537854|NCT01217073|473592087|FG006|Extension Period|Physician Decision|4|||
131537855|NCT01217073|473592088|FG007|Extension Period|Physician Decision|1|||
131537856|NCT01217073|473592081|FG000|Extension Period|Protocol Violation|0|||
131537857|NCT01217073|473592082|FG001|Extension Period|Protocol Violation|0|||
131537858|NCT01217073|473592083|FG002|Extension Period|Protocol Violation|0|||
131537859|NCT01217073|473592084|FG003|Extension Period|Protocol Violation|0|||
131537860|NCT01217073|473592085|FG004|Extension Period|Protocol Violation|0|||
131537861|NCT01217073|473592086|FG005|Extension Period|Protocol Violation|0|||
131537862|NCT01217073|473592087|FG006|Extension Period|Protocol Violation|2|||
131537863|NCT01217073|473592088|FG007|Extension Period|Protocol Violation|1|||
131537864|NCT01217073|473592081|FG000|Extension Period|Site discontinued study participation|0|||
131537865|NCT01217073|473592082|FG001|Extension Period|Site discontinued study participation|0|||
131537866|NCT01217073|473592083|FG002|Extension Period|Site discontinued study participation|0|||
131537867|NCT01217073|473592084|FG003|Extension Period|Site discontinued study participation|0|||
131537868|NCT01217073|473592085|FG004|Extension Period|Site discontinued study participation|0|||
131537869|NCT01217073|473592086|FG005|Extension Period|Site discontinued study participation|0|||
131537870|NCT01217073|473592087|FG006|Extension Period|Site discontinued study participation|7|||
131537871|NCT01217073|473592088|FG007|Extension Period|Site discontinued study participation|2|||
131537872|NCT01217073|473592081|FG000|Extension Period|Withdrawal by Subject|0|||
131537873|NCT01217073|473592082|FG001|Extension Period|Withdrawal by Subject|0|||
131537874|NCT01217073|473592083|FG002|Extension Period|Withdrawal by Subject|0|||
131537875|NCT01217073|473592084|FG003|Extension Period|Withdrawal by Subject|0|||
131537876|NCT01217073|473592085|FG004|Extension Period|Withdrawal by Subject|0|||
131537877|NCT01217073|473592086|FG005|Extension Period|Withdrawal by Subject|0|||
131537878|NCT01217073|473592087|FG006|Extension Period|Withdrawal by Subject|30|||
131537879|NCT01217073|473592088|FG007|Extension Period|Withdrawal by Subject|8|||
131537880|NCT02047045|473592089|FG000|Baseline|Withdrawal by Subject|3|||
131537881|NCT02047045|473592090|FG001|Baseline|Withdrawal by Subject|2|||
131537882|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
131537883|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
131537884|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
131537885|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
131537886|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
131537887|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
131537888|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
131537889|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
131537890|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
131537891|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
131537892|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
131537893|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
131537894|NCT02047045|473592089|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
131537895|NCT02047045|473592090|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
131537896|NCT02047045|473592089|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
131537897|NCT02047045|473592090|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
131537898|NCT00765843|473592091|FG000|Overall Study|Lost to Follow-up|1|||
131537899|NCT00765843|473592092|FG001|Overall Study|Lost to Follow-up|3|||
131537900|NCT00765843|473592093|FG002|Overall Study|Lost to Follow-up|2|||
131537901|NCT00765843|473592091|FG000|Overall Study|did not return to receive intervention|0|||
131537902|NCT00765843|473592092|FG001|Overall Study|did not return to receive intervention|1|||
131537903|NCT00765843|473592093|FG002|Overall Study|did not return to receive intervention|0|||
131537904|NCT00765843|473592091|FG000|Overall Study|Adverse Event|0|||
131537905|NCT00765843|473592092|FG001|Overall Study|Adverse Event|0|||
131537906|NCT00765843|473592093|FG002|Overall Study|Adverse Event|1|||
131537907|NCT04066114|473592094|FG000|Overall Study|Adverse Event|1|||
131537908|NCT04066114|473592095|FG001|Overall Study|Adverse Event|0|||
131537909|NCT04066114|473592096|FG002|Overall Study|Adverse Event|0|||
131537910|NCT04066114|473592094|FG000|Overall Study|Withdrawal by Subject|1|||
131537911|NCT04066114|473592095|FG001|Overall Study|Withdrawal by Subject|0|||
131537912|NCT04066114|473592096|FG002|Overall Study|Withdrawal by Subject|0|||
131537913|NCT04066114|473592094|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
131537914|NCT04066114|473592095|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
131537915|NCT04066114|473592096|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
131537916|NCT02564523|473592099|FG000|Overall Study|Withdrawal by Subject|3|||
131537917|NCT02564523|473592100|FG001|Overall Study|Withdrawal by Subject|0|||
131537918|NCT02564523|473592101|FG002|Overall Study|Withdrawal by Subject|1|||
131537919|NCT02564523|473592102|FG003|Overall Study|Withdrawal by Subject|0|||
131537920|NCT02564523|473592103|FG004|Overall Study|Withdrawal by Subject|1|||
131537921|NCT02564523|473592104|FG005|Overall Study|Withdrawal by Subject|0|||
131537922|NCT02564523|473592105|FG006|Overall Study|Withdrawal by Subject|1|||
131537923|NCT02564523|473592106|FG007|Overall Study|Withdrawal by Subject|0|||
131537924|NCT02564523|473592107|FG008|Overall Study|Withdrawal by Subject|0|||
131537925|NCT02564523|473592108|FG009|Overall Study|Withdrawal by Subject|0|||
131537926|NCT02564523|473592109|FG010|Overall Study|Withdrawal by Subject|1|||
131537927|NCT02564523|473592110|FG011|Overall Study|Withdrawal by Subject|0|||
131537928|NCT02564523|473592111|FG012|Overall Study|Withdrawal by Subject|1|||
131537929|NCT02564523|473592112|FG013|Overall Study|Withdrawal by Subject|0|||
131537930|NCT02564523|473592113|FG014|Overall Study|Withdrawal by Subject|0|||
131537931|NCT02564523|473592114|FG015|Overall Study|Withdrawal by Subject|0|||
131537932|NCT02564523|473592115|FG016|Overall Study|Withdrawal by Subject|0|||
131537933|NCT02564523|473592116|FG017|Overall Study|Withdrawal by Subject|0|||
131537934|NCT02564523|473592099|FG000|Overall Study|Adverse Event|0|||
131537935|NCT02564523|473592100|FG001|Overall Study|Adverse Event|0|||
131537936|NCT02564523|473592101|FG002|Overall Study|Adverse Event|0|||
131537937|NCT02564523|473592102|FG003|Overall Study|Adverse Event|0|||
131537938|NCT02564523|473592103|FG004|Overall Study|Adverse Event|0|||
131537939|NCT02564523|473592104|FG005|Overall Study|Adverse Event|0|||
131537940|NCT02564523|473592105|FG006|Overall Study|Adverse Event|0|||
131537941|NCT02564523|473592106|FG007|Overall Study|Adverse Event|0|||
131537942|NCT02564523|473592107|FG008|Overall Study|Adverse Event|0|||
131537943|NCT02564523|473592108|FG009|Overall Study|Adverse Event|0|||
131537944|NCT02564523|473592109|FG010|Overall Study|Adverse Event|0|||
131537945|NCT02564523|473592110|FG011|Overall Study|Adverse Event|0|||
131537946|NCT02564523|473592111|FG012|Overall Study|Adverse Event|0|||
131537947|NCT02564523|473592112|FG013|Overall Study|Adverse Event|0|||
131537948|NCT02564523|473592113|FG014|Overall Study|Adverse Event|0|||
131537949|NCT02564523|473592114|FG015|Overall Study|Adverse Event|0|||
131537950|NCT02564523|473592115|FG016|Overall Study|Adverse Event|0|||
131537951|NCT02564523|473592116|FG017|Overall Study|Adverse Event|1|||
131537952|NCT02564523|473592099|FG000|Overall Study|Death|0|||
131537953|NCT02564523|473592100|FG001|Overall Study|Death|0|||
131537954|NCT02564523|473592101|FG002|Overall Study|Death|0|||
131537955|NCT02564523|473592102|FG003|Overall Study|Death|0|||
131537956|NCT02564523|473592103|FG004|Overall Study|Death|0|||
131537957|NCT02564523|473592104|FG005|Overall Study|Death|0|||
131537958|NCT02564523|473592105|FG006|Overall Study|Death|1|||
131537959|NCT02564523|473592106|FG007|Overall Study|Death|0|||
131537960|NCT02564523|473592107|FG008|Overall Study|Death|0|||
131537961|NCT02564523|473592108|FG009|Overall Study|Death|0|||
131537962|NCT02564523|473592109|FG010|Overall Study|Death|1|||
131537963|NCT02564523|473592110|FG011|Overall Study|Death|0|||
131537964|NCT02564523|473592111|FG012|Overall Study|Death|0|||
131537965|NCT02564523|473592112|FG013|Overall Study|Death|0|||
131537966|NCT02564523|473592113|FG014|Overall Study|Death|0|||
131537967|NCT02564523|473592114|FG015|Overall Study|Death|0|||
131537968|NCT02564523|473592115|FG016|Overall Study|Death|0|||
131537969|NCT02564523|473592116|FG017|Overall Study|Death|0|||
131537970|NCT02564523|473592099|FG000|Overall Study|Lost to Follow-up|2|||
131537971|NCT02564523|473592100|FG001|Overall Study|Lost to Follow-up|1|||
131537972|NCT02564523|473592101|FG002|Overall Study|Lost to Follow-up|4|||
131537973|NCT02564523|473592102|FG003|Overall Study|Lost to Follow-up|0|||
131537974|NCT02564523|473592103|FG004|Overall Study|Lost to Follow-up|1|||
131537975|NCT02564523|473592104|FG005|Overall Study|Lost to Follow-up|0|||
131537976|NCT02564523|473592105|FG006|Overall Study|Lost to Follow-up|1|||
131537977|NCT02564523|473592106|FG007|Overall Study|Lost to Follow-up|0|||
131537978|NCT02564523|473592107|FG008|Overall Study|Lost to Follow-up|0|||
131537979|NCT02564523|473592108|FG009|Overall Study|Lost to Follow-up|0|||
131537980|NCT02564523|473592109|FG010|Overall Study|Lost to Follow-up|0|||
131537981|NCT02564523|473592110|FG011|Overall Study|Lost to Follow-up|1|||
131537982|NCT02564523|473592111|FG012|Overall Study|Lost to Follow-up|1|||
131537983|NCT02564523|473592112|FG013|Overall Study|Lost to Follow-up|0|||
131537984|NCT02564523|473592113|FG014|Overall Study|Lost to Follow-up|0|||
131537985|NCT02564523|473592114|FG015|Overall Study|Lost to Follow-up|0|||
131537986|NCT02564523|473592115|FG016|Overall Study|Lost to Follow-up|0|||
131537987|NCT02564523|473592116|FG017|Overall Study|Lost to Follow-up|0|||
131537988|NCT02564523|473592099|FG000|Overall Study|Physician Decision|0|||
131537989|NCT02564523|473592100|FG001|Overall Study|Physician Decision|0|||
131537990|NCT02564523|473592101|FG002|Overall Study|Physician Decision|0|||
131537991|NCT02564523|473592102|FG003|Overall Study|Physician Decision|0|||
131537992|NCT02564523|473592103|FG004|Overall Study|Physician Decision|1|||
131537993|NCT02564523|473592104|FG005|Overall Study|Physician Decision|0|||
131537994|NCT02564523|473592105|FG006|Overall Study|Physician Decision|0|||
131537995|NCT02564523|473592106|FG007|Overall Study|Physician Decision|0|||
131537996|NCT02564523|473592107|FG008|Overall Study|Physician Decision|0|||
131537997|NCT02564523|473592108|FG009|Overall Study|Physician Decision|0|||
131537998|NCT02564523|473592109|FG010|Overall Study|Physician Decision|1|||
131537999|NCT02564523|473592110|FG011|Overall Study|Physician Decision|0|||
131538000|NCT02564523|473592111|FG012|Overall Study|Physician Decision|0|||
131538001|NCT02564523|473592112|FG013|Overall Study|Physician Decision|0|||
131538002|NCT02564523|473592113|FG014|Overall Study|Physician Decision|0|||
131538003|NCT02564523|473592114|FG015|Overall Study|Physician Decision|0|||
131538004|NCT02564523|473592115|FG016|Overall Study|Physician Decision|0|||
131538005|NCT02564523|473592116|FG017|Overall Study|Physician Decision|0|||
131538006|NCT02564523|473592099|FG000|Overall Study|Protocol Violation|2|||
131538007|NCT02564523|473592100|FG001|Overall Study|Protocol Violation|2|||
131538008|NCT02564523|473592101|FG002|Overall Study|Protocol Violation|5|||
131538009|NCT02564523|473592102|FG003|Overall Study|Protocol Violation|0|||
131538010|NCT02564523|473592103|FG004|Overall Study|Protocol Violation|1|||
131538011|NCT02564523|473592104|FG005|Overall Study|Protocol Violation|0|||
131538012|NCT02564523|473592105|FG006|Overall Study|Protocol Violation|0|||
131538013|NCT02564523|473592106|FG007|Overall Study|Protocol Violation|0|||
131538014|NCT02564523|473592107|FG008|Overall Study|Protocol Violation|0|||
131538015|NCT02564523|473592108|FG009|Overall Study|Protocol Violation|0|||
131538016|NCT02564523|473592109|FG010|Overall Study|Protocol Violation|0|||
131538017|NCT02564523|473592110|FG011|Overall Study|Protocol Violation|0|||
131538018|NCT02564523|473592111|FG012|Overall Study|Protocol Violation|0|||
131538019|NCT02564523|473592112|FG013|Overall Study|Protocol Violation|0|||
131538020|NCT02564523|473592113|FG014|Overall Study|Protocol Violation|0|||
131538021|NCT02564523|473592114|FG015|Overall Study|Protocol Violation|0|||
131538022|NCT02564523|473592115|FG016|Overall Study|Protocol Violation|0|||
131538023|NCT02564523|473592116|FG017|Overall Study|Protocol Violation|0|||
131538024|NCT02564523|473592099|FG000|Overall Study|Other|3|||
131538025|NCT02564523|473592100|FG001|Overall Study|Other|0|||
131538026|NCT02564523|473592101|FG002|Overall Study|Other|0|||
131538027|NCT02564523|473592102|FG003|Overall Study|Other|1|||
131538028|NCT02564523|473592103|FG004|Overall Study|Other|0|||
131538029|NCT02564523|473592104|FG005|Overall Study|Other|0|||
131538030|NCT02564523|473592105|FG006|Overall Study|Other|0|||
131538031|NCT02564523|473592106|FG007|Overall Study|Other|0|||
131538032|NCT02564523|473592107|FG008|Overall Study|Other|0|||
131538033|NCT02564523|473592108|FG009|Overall Study|Other|0|||
131538034|NCT02564523|473592109|FG010|Overall Study|Other|0|||
131538035|NCT02564523|473592110|FG011|Overall Study|Other|0|||
131538036|NCT02564523|473592111|FG012|Overall Study|Other|0|||
131538037|NCT02564523|473592112|FG013|Overall Study|Other|0|||
131538038|NCT02564523|473592113|FG014|Overall Study|Other|0|||
131538039|NCT02564523|473592114|FG015|Overall Study|Other|0|||
131538040|NCT02564523|473592115|FG016|Overall Study|Other|0|||
131538041|NCT02564523|473592116|FG017|Overall Study|Other|0|||
131538042|NCT04862143|473592131|FG000|Overall Study|Adverse Event|1|||
131538043|NCT04862143|473592131|FG000|Overall Study|Study terminated by sponsor|1|||
131538044|NCT02277106|473592132|FG000|Stage 2|Adverse Event|0|||
131538045|NCT02277106|473592133|FG001|Stage 2|Adverse Event|0|||
131538046|NCT02277106|473592134|FG002|Stage 2|Adverse Event|1|||
131538047|NCT01064739|473592135|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
131538048|NCT03031938|473592136|FG000|Overall Study|Death|1|||
131538049|NCT03031938|473592137|FG001|Overall Study|Death|0|||
131538050|NCT02479412|473592142|FG000|Overall Study|Adverse Event|0|||
131538051|NCT02479412|473592143|FG001|Overall Study|Adverse Event|0|||
131538052|NCT02479412|473592144|FG002|Overall Study|Adverse Event|1|||
131538053|NCT02479412|473592145|FG003|Overall Study|Adverse Event|0|||
131538054|NCT02479412|473592146|FG004|Overall Study|Adverse Event|0|||
131538055|NCT02479412|473592147|FG005|Overall Study|Adverse Event|0|||
131538056|NCT02479412|473592148|FG006|Overall Study|Adverse Event|0|||
131538057|NCT02479412|473592149|FG007|Overall Study|Adverse Event|0|||
131538058|NCT02479412|473592150|FG008|Overall Study|Adverse Event|0|||
131538059|NCT02479412|473592142|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131538060|NCT02479412|473592143|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131538061|NCT02479412|473592144|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131538062|NCT02479412|473592145|FG003|Overall Study|Study-specific withdrawal criteria|1|||
131538063|NCT02479412|473592146|FG004|Overall Study|Study-specific withdrawal criteria|0|||
131538064|NCT02479412|473592147|FG005|Overall Study|Study-specific withdrawal criteria|0|||
131538065|NCT02479412|473592148|FG006|Overall Study|Study-specific withdrawal criteria|0|||
131538066|NCT02479412|473592149|FG007|Overall Study|Study-specific withdrawal criteria|1|||
131538067|NCT02479412|473592150|FG008|Overall Study|Study-specific withdrawal criteria|1|||
131538068|NCT02479412|473592142|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
131538069|NCT02479412|473592143|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
131538070|NCT02479412|473592144|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
131538071|NCT02479412|473592145|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
131538072|NCT02479412|473592146|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
131538073|NCT02479412|473592147|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
131538074|NCT02479412|473592148|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
131538075|NCT02479412|473592149|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
131538076|NCT02479412|473592150|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
131538077|NCT00454051|473592151|FG000|Overall Study|Adverse Event|1|||
131538078|NCT00454051|473592152|FG001|Overall Study|Adverse Event|2|||
131538079|NCT00454051|473592151|FG000|Overall Study|Withdrawal by Subject|1|||
131538080|NCT00454051|473592152|FG001|Overall Study|Withdrawal by Subject|0|||
131538081|NCT00454051|473592151|FG000|Overall Study|Protocol Violation|1|||
131538082|NCT00454051|473592152|FG001|Overall Study|Protocol Violation|1|||
131538083|NCT01571362|473592153|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
131538084|NCT01571362|473592154|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
131538085|NCT01571362|473592155|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
131538086|NCT01571362|473592153|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
131538087|NCT01571362|473592154|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
131538088|NCT01571362|473592155|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
131538089|NCT01571362|473592153|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
131538090|NCT01571362|473592154|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
131538091|NCT01571362|473592155|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
131538092|NCT01571362|473592153|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
131538093|NCT01571362|473592154|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
131538094|NCT01571362|473592155|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
131538095|NCT01571362|473592153|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
131538096|NCT01571362|473592154|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
131538097|NCT01571362|473592155|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
131538098|NCT01571362|473592153|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
131538099|NCT01571362|473592154|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
131538100|NCT01571362|473592155|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
131538101|NCT01571362|473592153|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131538102|NCT01571362|473592154|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
131538103|NCT01571362|473592155|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
131538104|NCT01571362|473592153|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131538105|NCT01571362|473592154|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
131538106|NCT01571362|473592155|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
131538107|NCT01571362|473592153|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131538108|NCT01571362|473592154|FG001|Double-Blind Treatment Period|Adverse Event|9|||
131538109|NCT01571362|473592155|FG002|Double-Blind Treatment Period|Adverse Event|14|||
131538110|NCT01571362|473592153|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131538111|NCT01571362|473592154|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
131538112|NCT01571362|473592155|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
131538113|NCT01571362|473592153|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
131538114|NCT01571362|473592154|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
131538115|NCT01571362|473592155|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
131538116|NCT01571362|473592153|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
131538117|NCT01571362|473592154|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
131538118|NCT01571362|473592155|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
131538119|NCT03117738|473592156|FG000|Overall Study|Withdrawal by Subject|3|||
131538120|NCT03117738|473592157|FG001|Overall Study|Withdrawal by Subject|1|||
131538121|NCT03117738|473592156|FG000|Overall Study|Lost to Follow-up|1|||
131538122|NCT03117738|473592157|FG001|Overall Study|Lost to Follow-up|4|||
131538123|NCT01669629|473592159|FG000|Period 1|protocol deviation|1|||
131538124|NCT01669629|473592160|FG001|Period 1|protocol deviation|2|||
131538125|NCT01221597|473592161|FG000|Overall Study|Adverse Event|4|||
131538126|NCT01221597|473592162|FG001|Overall Study|Adverse Event|1|||
131538127|NCT01221597|473592161|FG000|Overall Study|Withdrawal by Subject|20|||
131538128|NCT01221597|473592162|FG001|Overall Study|Withdrawal by Subject|6|||
131538129|NCT01221597|473592161|FG000|Overall Study|Lost to Follow-up|6|||
131538130|NCT01221597|473592162|FG001|Overall Study|Lost to Follow-up|5|||
131538131|NCT01221597|473592161|FG000|Overall Study|Protocol Violation|1|||
131538132|NCT01221597|473592162|FG001|Overall Study|Protocol Violation|0|||
131538133|NCT01221597|473592161|FG000|Overall Study|Other|3|||
131538134|NCT01221597|473592162|FG001|Overall Study|Other|4|||
131538135|NCT01221597|473592161|FG000|Overall Study|Death|2|||
131538136|NCT01221597|473592162|FG001|Overall Study|Death|0|||
131538137|NCT03667053|473592164|FG000|Overall Study|Withdrawal by Subject|1|||
131538138|NCT03667053|473592165|FG001|Overall Study|Withdrawal by Subject|0|||
131538139|NCT03667053|473592166|FG002|Overall Study|Withdrawal by Subject|0|||
131538140|NCT03927950|473592167|FG000|Overall Study|Adverse Event|9|||
131538141|NCT04642638|473592170|FG000|Overall Study|Withdrawal by Subject|23|||
131538142|NCT04642638|473592171|FG001|Overall Study|Withdrawal by Subject|29|||
131538143|NCT04642638|473592172|FG002|Overall Study|Withdrawal by Subject|9|||
131538144|NCT04642638|473592173|FG003|Overall Study|Withdrawal by Subject|7|||
131538145|NCT04642638|473592174|FG004|Overall Study|Withdrawal by Subject|61|||
131538146|NCT04642638|473592175|FG005|Overall Study|Withdrawal by Subject|27|||
131538147|NCT04642638|473592170|FG000|Overall Study|Lost to Follow-up|17|||
131538148|NCT04642638|473592171|FG001|Overall Study|Lost to Follow-up|18|||
131538149|NCT04642638|473592172|FG002|Overall Study|Lost to Follow-up|5|||
131538150|NCT04642638|473592173|FG003|Overall Study|Lost to Follow-up|5|||
131538151|NCT04642638|473592174|FG004|Overall Study|Lost to Follow-up|6|||
131538152|NCT04642638|473592175|FG005|Overall Study|Lost to Follow-up|3|||
131538153|NCT04642638|473592170|FG000|Overall Study|Adverse Event|0|||
131538154|NCT04642638|473592171|FG001|Overall Study|Adverse Event|0|||
131538155|NCT04642638|473592172|FG002|Overall Study|Adverse Event|1|||
131538156|NCT04642638|473592173|FG003|Overall Study|Adverse Event|0|||
131538157|NCT04642638|473592174|FG004|Overall Study|Adverse Event|10|||
131538158|NCT04642638|473592175|FG005|Overall Study|Adverse Event|3|||
131538159|NCT04642638|473592170|FG000|Overall Study|Reason Not Specified|1|||
131538160|NCT04642638|473592171|FG001|Overall Study|Reason Not Specified|4|||
131538161|NCT04642638|473592172|FG002|Overall Study|Reason Not Specified|0|||
131538162|NCT04642638|473592173|FG003|Overall Study|Reason Not Specified|0|||
131538163|NCT04642638|473592174|FG004|Overall Study|Reason Not Specified|38|||
131538164|NCT04642638|473592175|FG005|Overall Study|Reason Not Specified|16|||
131538165|NCT04642638|473592170|FG000|Overall Study|Physician Decision|0|||
131538166|NCT04642638|473592171|FG001|Overall Study|Physician Decision|0|||
131538167|NCT04642638|473592172|FG002|Overall Study|Physician Decision|0|||
131538168|NCT04642638|473592173|FG003|Overall Study|Physician Decision|0|||
131538169|NCT04642638|473592174|FG004|Overall Study|Physician Decision|2|||
131538170|NCT04642638|473592175|FG005|Overall Study|Physician Decision|1|||
131538171|NCT04642638|473592170|FG000|Overall Study|Protocol Deviation|0|||
131538172|NCT04642638|473592171|FG001|Overall Study|Protocol Deviation|0|||
131538173|NCT04642638|473592172|FG002|Overall Study|Protocol Deviation|0|||
131538174|NCT04642638|473592173|FG003|Overall Study|Protocol Deviation|0|||
131538175|NCT04642638|473592174|FG004|Overall Study|Protocol Deviation|1|||
131538176|NCT04642638|473592175|FG005|Overall Study|Protocol Deviation|3|||
131538177|NCT04642638|473592170|FG000|Overall Study|Study Terminated|0|||
131538178|NCT04642638|473592171|FG001|Overall Study|Study Terminated|0|||
131538179|NCT04642638|473592172|FG002|Overall Study|Study Terminated|0|||
131538180|NCT04642638|473592173|FG003|Overall Study|Study Terminated|0|||
131538181|NCT04642638|473592174|FG004|Overall Study|Study Terminated|484|||
131538182|NCT04642638|473592175|FG005|Overall Study|Study Terminated|250|||
131538183|NCT04642638|473592170|FG000|Overall Study|Pregnancy|0|||
131538184|NCT04642638|473592171|FG001|Overall Study|Pregnancy|0|||
131538185|NCT04642638|473592172|FG002|Overall Study|Pregnancy|0|||
131538186|NCT04642638|473592173|FG003|Overall Study|Pregnancy|0|||
131538187|NCT04642638|473592174|FG004|Overall Study|Pregnancy|1|||
131538188|NCT04642638|473592175|FG005|Overall Study|Pregnancy|0|||
131538189|NCT00990652|473592176|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
131538190|NCT00990652|473592176|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
131538191|NCT02085408|473592178|FG000|Step 1: Induction|Disease Progression|19|||
131538192|NCT02085408|473592179|FG001|Step 1: Induction|Disease Progression|19|||
131538193|NCT02085408|473592178|FG000|Step 1: Induction|Adverse Event|18|||
131538194|NCT02085408|473592179|FG001|Step 1: Induction|Adverse Event|17|||
131538195|NCT02085408|473592178|FG000|Step 1: Induction|Death|33|||
131538196|NCT02085408|473592179|FG001|Step 1: Induction|Death|30|||
131538197|NCT02085408|473592178|FG000|Step 1: Induction|Withdrawal by Subject|16|||
131538198|NCT02085408|473592179|FG001|Step 1: Induction|Withdrawal by Subject|8|||
131538199|NCT02085408|473592178|FG000|Step 1: Induction|Alternative Therapy|15|||
131538200|NCT02085408|473592179|FG001|Step 1: Induction|Alternative Therapy|19|||
131538201|NCT02085408|473592178|FG000|Step 1: Induction|Complicating Disease|2|||
131538202|NCT02085408|473592179|FG001|Step 1: Induction|Complicating Disease|3|||
131538203|NCT02085408|473592178|FG000|Step 1: Induction|Other|27|||
131538204|NCT02085408|473592179|FG001|Step 1: Induction|Other|39|||
131538205|NCT02085408|473592178|FG000|Step 1: Induction|Never started treatment|6|||
131538206|NCT02085408|473592179|FG001|Step 1: Induction|Never started treatment|4|||
131538207|NCT02085408|473592178|FG000|Step 2: Consolidation|Disease Progression|5|||
131538208|NCT02085408|473592179|FG001|Step 2: Consolidation|Disease Progression|20|||
131538209|NCT02085408|473592178|FG000|Step 2: Consolidation|Adverse Event|9|||
131538210|NCT02085408|473592179|FG001|Step 2: Consolidation|Adverse Event|8|||
131538211|NCT02085408|473592178|FG000|Step 2: Consolidation|Death|4|||
131538212|NCT02085408|473592179|FG001|Step 2: Consolidation|Death|3|||
131538213|NCT02085408|473592178|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
131538214|NCT02085408|473592179|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
131538215|NCT02085408|473592178|FG000|Step 2: Consolidation|Alternative Therapy|9|||
131538216|NCT02085408|473592179|FG001|Step 2: Consolidation|Alternative Therapy|3|||
131538217|NCT02085408|473592178|FG000|Step 2: Consolidation|Complicating Disease|0|||
131538218|NCT02085408|473592179|FG001|Step 2: Consolidation|Complicating Disease|2|||
131538219|NCT02085408|473592178|FG000|Step 2: Consolidation|Other|6|||
131538220|NCT02085408|473592179|FG001|Step 2: Consolidation|Other|6|||
131538221|NCT02085408|473592178|FG000|Step 2: Consolidation|Never started treatment|4|||
131538222|NCT02085408|473592179|FG001|Step 2: Consolidation|Never started treatment|3|||
131538223|NCT02085408|473592178|FG000|Step 3: Maintenance|Disease Progression|13|||
131538224|NCT02085408|473592179|FG001|Step 3: Maintenance|Disease Progression|11|||
131538225|NCT02085408|473592178|FG000|Step 3: Maintenance|Adverse Event|2|||
131538226|NCT02085408|473592179|FG001|Step 3: Maintenance|Adverse Event|4|||
131538227|NCT02085408|473592178|FG000|Step 3: Maintenance|Death|1|||
131538228|NCT02085408|473592179|FG001|Step 3: Maintenance|Death|2|||
131538229|NCT02085408|473592178|FG000|Step 3: Maintenance|Alternative Therapy|1|||
131538230|NCT02085408|473592179|FG001|Step 3: Maintenance|Alternative Therapy|1|||
131538231|NCT02085408|473592178|FG000|Step 3: Maintenance|Complicating Disease|0|||
131538232|NCT02085408|473592179|FG001|Step 3: Maintenance|Complicating Disease|1|||
131538233|NCT02085408|473592178|FG000|Step 3: Maintenance|Other|3|||
131538234|NCT02085408|473592179|FG001|Step 3: Maintenance|Other|2|||
131538235|NCT02085408|473592178|FG000|Step 3: Maintenance|Never started treatment|5|||
131538236|NCT02085408|473592179|FG001|Step 3: Maintenance|Never started treatment|1|||
131538237|NCT01572727|473592182|FG000|Overall Study|Adverse Event|43|||
131538238|NCT01572727|473592183|FG001|Overall Study|Adverse Event|15|||
131538239|NCT01572727|473592182|FG000|Overall Study|Lost to Follow-up|1|||
131538240|NCT01572727|473592183|FG001|Overall Study|Lost to Follow-up|1|||
131538241|NCT01572727|473592182|FG000|Overall Study|Physician Decision|23|||
131538242|NCT01572727|473592183|FG001|Overall Study|Physician Decision|9|||
131538243|NCT01572727|473592182|FG000|Overall Study|Progressive disease|59|||
131538244|NCT01572727|473592183|FG001|Overall Study|Progressive disease|82|||
131538245|NCT01572727|473592182|FG000|Overall Study|Protocol Violation|0|||
131538246|NCT01572727|473592183|FG001|Overall Study|Protocol Violation|1|||
131538247|NCT01572727|473592182|FG000|Overall Study|Study terminated by sponsor|61|||
131538248|NCT01572727|473592183|FG001|Overall Study|Study terminated by sponsor|83|||
131538249|NCT01572727|473592182|FG000|Overall Study|Parent/guardian decision|14|||
131538250|NCT01572727|473592183|FG001|Overall Study|Parent/guardian decision|9|||
131538251|NCT01572727|473592182|FG000|Overall Study|Death|2|||
131538252|NCT01572727|473592183|FG001|Overall Study|Death|2|||
131538253|NCT01572727|473592182|FG000|Overall Study|Untreated|4|||
131538254|NCT01572727|473592183|FG001|Overall Study|Untreated|7|||
131538255|NCT04732286|473592184|FG000|Overall Study|Progressive Disease|2|||
131538256|NCT04732286|473592184|FG000|Overall Study|Physician Decision|1|||
131538257|NCT04732286|473592184|FG000|Overall Study|Study Terminated by Sponsor|31|||
131538258|NCT04732286|473592184|FG000|Overall Study|Withdrawal by Subject|10|||
131538259|NCT04732286|473592184|FG000|Overall Study|Non-compliance With Study Drug|1|||
131538260|NCT04732286|473592184|FG000|Overall Study|Lost to Follow-up|4|||
131538261|NCT04732286|473592184|FG000|Overall Study|Death|51|||
131538262|NCT00319098|473592185|FG000|Overall Study|Serious adverse event|3|||
131538263|NCT00319098|473592186|FG001|Overall Study|Serious adverse event|0|||
131538264|NCT00319098|473592185|FG000|Overall Study|Adverse Event|20|||
131538265|NCT00319098|473592186|FG001|Overall Study|Adverse Event|1|||
131538266|NCT00319098|473592185|FG000|Overall Study|Withdrawal by Subject|37|||
131538267|NCT00319098|473592186|FG001|Overall Study|Withdrawal by Subject|8|||
131538268|NCT00319098|473592185|FG000|Overall Study|Migrated/moved from study area|2|||
131538269|NCT00319098|473592186|FG001|Overall Study|Migrated/moved from study area|1|||
131538270|NCT00319098|473592185|FG000|Overall Study|Lost to Follow-up|37|||
131538271|NCT00319098|473592186|FG001|Overall Study|Lost to Follow-up|13|||
131538272|NCT00319098|473592185|FG000|Overall Study|Others|33|||
131538273|NCT00319098|473592186|FG001|Overall Study|Others|8|||
131538274|NCT00319098|473592185|FG000|Overall Study|Protocol Violation|3|||
131538275|NCT00319098|473592186|FG001|Overall Study|Protocol Violation|1|||
131538276|NCT03449030|473592187|FG000|Overall Study|Withdrawal by Subject|0|||
131538277|NCT03449030|473592188|FG001|Overall Study|Withdrawal by Subject|0|||
131538278|NCT03449030|473592189|FG002|Overall Study|Withdrawal by Subject|0|||
131538279|NCT03449030|473592190|FG003|Overall Study|Withdrawal by Subject|1|||
131538280|NCT03449030|473592191|FG004|Overall Study|Withdrawal by Subject|1|||
131538281|NCT03449030|473592192|FG005|Overall Study|Withdrawal by Subject|1|||
131538282|NCT03449030|473592193|FG006|Overall Study|Withdrawal by Subject|1|||
131538283|NCT03449030|473592194|FG007|Overall Study|Withdrawal by Subject|2|||
131538284|NCT03449030|473592195|FG008|Overall Study|Withdrawal by Subject|0|||
131538285|NCT03449030|473592196|FG009|Overall Study|Withdrawal by Subject|0|||
131538286|NCT03449030|473592187|FG000|Overall Study|Symptomatic Deterioration|0|||
131538287|NCT03449030|473592188|FG001|Overall Study|Symptomatic Deterioration|1|||
131538288|NCT03449030|473592189|FG002|Overall Study|Symptomatic Deterioration|0|||
131538289|NCT03449030|473592190|FG003|Overall Study|Symptomatic Deterioration|0|||
131538290|NCT03449030|473592191|FG004|Overall Study|Symptomatic Deterioration|0|||
131538291|NCT03449030|473592192|FG005|Overall Study|Symptomatic Deterioration|1|||
131538292|NCT03449030|473592193|FG006|Overall Study|Symptomatic Deterioration|1|||
131538293|NCT03449030|473592194|FG007|Overall Study|Symptomatic Deterioration|0|||
131538294|NCT03449030|473592195|FG008|Overall Study|Symptomatic Deterioration|2|||
131538295|NCT03449030|473592196|FG009|Overall Study|Symptomatic Deterioration|0|||
131538296|NCT03449030|473592187|FG000|Overall Study|Progressive Disease|1|||
131538297|NCT03449030|473592188|FG001|Overall Study|Progressive Disease|0|||
131538298|NCT03449030|473592189|FG002|Overall Study|Progressive Disease|1|||
131538299|NCT03449030|473592190|FG003|Overall Study|Progressive Disease|4|||
131538300|NCT03449030|473592191|FG004|Overall Study|Progressive Disease|5|||
131538301|NCT03449030|473592192|FG005|Overall Study|Progressive Disease|3|||
131538302|NCT03449030|473592193|FG006|Overall Study|Progressive Disease|0|||
131538303|NCT03449030|473592194|FG007|Overall Study|Progressive Disease|1|||
131538304|NCT03449030|473592195|FG008|Overall Study|Progressive Disease|1|||
131538305|NCT03449030|473592196|FG009|Overall Study|Progressive Disease|1|||
131538306|NCT03449030|473592187|FG000|Overall Study|Adverse Event|0|||
131538307|NCT03449030|473592188|FG001|Overall Study|Adverse Event|0|||
131538308|NCT03449030|473592189|FG002|Overall Study|Adverse Event|0|||
131538309|NCT03449030|473592190|FG003|Overall Study|Adverse Event|0|||
131538310|NCT03449030|473592191|FG004|Overall Study|Adverse Event|0|||
131538311|NCT03449030|473592192|FG005|Overall Study|Adverse Event|2|||
131538312|NCT03449030|473592193|FG006|Overall Study|Adverse Event|0|||
131538313|NCT03449030|473592194|FG007|Overall Study|Adverse Event|0|||
131538314|NCT03449030|473592195|FG008|Overall Study|Adverse Event|0|||
131538315|NCT03449030|473592196|FG009|Overall Study|Adverse Event|0|||
131538316|NCT03449030|473592187|FG000|Overall Study|Death|0|||
131538317|NCT03449030|473592188|FG001|Overall Study|Death|0|||
131538318|NCT03449030|473592189|FG002|Overall Study|Death|0|||
131538319|NCT03449030|473592190|FG003|Overall Study|Death|0|||
131538320|NCT03449030|473592191|FG004|Overall Study|Death|1|||
131538321|NCT03449030|473592192|FG005|Overall Study|Death|0|||
131538322|NCT03449030|473592193|FG006|Overall Study|Death|0|||
131538323|NCT03449030|473592194|FG007|Overall Study|Death|0|||
131538324|NCT03449030|473592195|FG008|Overall Study|Death|0|||
131538325|NCT03449030|473592196|FG009|Overall Study|Death|0|||
131538326|NCT01857531|473592197|FG000|Overall Study|Withdrawal by Subject|4|||
131538327|NCT03943095|473592198|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
131538328|NCT03943095|473592199|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
131538329|NCT03943095|473592198|FG000|Overall Study|Withdrawal by Subject|1|||
131538330|NCT03943095|473592199|FG001|Overall Study|Withdrawal by Subject|0|||
131538331|NCT00679939|473592201|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
131538332|NCT00679939|473592202|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
131538333|NCT00679939|473592201|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
131538334|NCT00679939|473592202|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
131538335|NCT00679939|473592201|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
131538336|NCT00679939|473592202|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
131538337|NCT00679939|473592201|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
131538338|NCT00679939|473592202|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
131538339|NCT00679939|473592201|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
131538340|NCT00679939|473592202|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
131538341|NCT00679939|473592201|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
131538342|NCT00679939|473592202|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
131538343|NCT00679939|473592201|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
131538344|NCT00679939|473592202|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
131538345|NCT00679939|473592201|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
131538346|NCT00679939|473592202|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
131538347|NCT00679939|473592201|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
131538348|NCT00679939|473592202|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
131538349|NCT00679939|473592201|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
131538350|NCT00679939|473592202|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
131538351|NCT02269670|473592207|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
131538352|NCT04657211|473592210|FG000|Overall Study|Withdrawal by Subject|21|||
131538353|NCT04657211|473592210|FG000|Overall Study|Lost to Follow-up|113|||
131538354|NCT04657211|473592210|FG000|Overall Study|Death|47|||
131538355|NCT04657211|473592210|FG000|Overall Study|Transfer to another institution|21|||
131538356|NCT04657211|473592210|FG000|Overall Study|Other|29|||
131538357|NCT02693665|473592211|FG000|Overall Study|Death|3|||
131538358|NCT02693665|473592212|FG001|Overall Study|Death|2|||
131538359|NCT02693665|473592211|FG000|Overall Study|Lost to Follow-up|7|||
131538360|NCT02693665|473592212|FG001|Overall Study|Lost to Follow-up|3|||
131538361|NCT02693665|473592211|FG000|Overall Study|Protocol Violation|1|||
131538362|NCT02693665|473592212|FG001|Overall Study|Protocol Violation|0|||
131538363|NCT02693665|473592211|FG000|Overall Study|Withdrawal by Subject|2|||
131538364|NCT02693665|473592212|FG001|Overall Study|Withdrawal by Subject|0|||
131538365|NCT02693665|473592211|FG000|Overall Study|patient wanted to leave it behind|1|||
131538366|NCT02693665|473592212|FG001|Overall Study|patient wanted to leave it behind|0|||
131538367|NCT02693665|473592211|FG000|Overall Study|anxiety|1|||
131538368|NCT02693665|473592212|FG001|Overall Study|anxiety|0|||
131538369|NCT02693665|473592211|FG000|Overall Study|family issues|1|||
131538370|NCT02693665|473592212|FG001|Overall Study|family issues|0|||
131538371|NCT02693665|473592211|FG000|Overall Study|no reason given|1|||
131538372|NCT02693665|473592212|FG001|Overall Study|no reason given|0|||
131538373|NCT00710424|473592215|FG000|Overall Study|Adverse Event|30|||
131538374|NCT00710424|473592216|FG001|Overall Study|Adverse Event|12|||
131538375|NCT00710424|473592215|FG000|Overall Study|Lack of Efficacy|4|||
131538376|NCT00710424|473592216|FG001|Overall Study|Lack of Efficacy|5|||
131538377|NCT00710424|473592215|FG000|Overall Study|Withdrawal by Subject|5|||
131538378|NCT00710424|473592216|FG001|Overall Study|Withdrawal by Subject|3|||
131538379|NCT00710424|473592215|FG000|Overall Study|Lost to Follow-up|0|||
131538380|NCT00710424|473592216|FG001|Overall Study|Lost to Follow-up|1|||
131538381|NCT00710424|473592215|FG000|Overall Study|Refused medication, no side effects|1|||
131538382|NCT00710424|473592216|FG001|Overall Study|Refused medication, no side effects|0|||
131538383|NCT00710424|473592215|FG000|Overall Study|Non-compliance with stable analgesia|1|||
131538384|NCT00710424|473592216|FG001|Overall Study|Non-compliance with stable analgesia|0|||
131538385|NCT00710424|473592215|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
131538386|NCT00710424|473592216|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
131538387|NCT00710424|473592215|FG000|Overall Study|Subject thought medication changed|1|||
131538388|NCT00710424|473592216|FG001|Overall Study|Subject thought medication changed|0|||
131538389|NCT00710424|473592215|FG000|Overall Study|Ceased treatment due to travel|1|||
131538390|NCT00710424|473592216|FG001|Overall Study|Ceased treatment due to travel|0|||
131538391|NCT00710424|473592215|FG000|Overall Study|Subject preferred paracetamol|0|||
131538392|NCT00710424|473592216|FG001|Overall Study|Subject preferred paracetamol|1|||
131538393|NCT00710424|473592215|FG000|Overall Study|Felt good so stopped treatment|0|||
131538394|NCT00710424|473592216|FG001|Overall Study|Felt good so stopped treatment|1|||
131538395|NCT01962493|473592217|FG000|Overall Study|Adverse Event|1|||
131538396|NCT01962493|473592218|FG001|Overall Study|Adverse Event|2|||
131538397|NCT01962493|473592217|FG000|Overall Study|Protocol Violation|0|||
131538398|NCT01962493|473592218|FG001|Overall Study|Protocol Violation|1|||
131538399|NCT01962493|473592217|FG000|Overall Study|Withdrawal by Subject|4|||
131538400|NCT01962493|473592218|FG001|Overall Study|Withdrawal by Subject|2|||
131538401|NCT03776136|473592219|FG000|Overall Study|Death|85|||
131538402|NCT03776136|473592219|FG000|Overall Study|Withdrawal by Subject|3|||
131538403|NCT03776136|473592219|FG000|Overall Study|Sponsor Decision|15|||
131538404|NCT02621931|473594057|FG000|Overall Study|Death|0|||
131538405|NCT02621931|473594058|FG001|Overall Study|Death|1|||
131538406|NCT02621931|473594059|FG002|Overall Study|Death|0|||
131538407|NCT02621931|473594057|FG000|Overall Study|Adverse Event|8|||
131538408|NCT02621931|473594058|FG001|Overall Study|Adverse Event|5|||
131538409|NCT02621931|473594059|FG002|Overall Study|Adverse Event|7|||
131538410|NCT02621931|473594057|FG000|Overall Study|Withdrawal by Subject|12|||
131538411|NCT02621931|473594058|FG001|Overall Study|Withdrawal by Subject|10|||
131538412|NCT02621931|473594059|FG002|Overall Study|Withdrawal by Subject|11|||
131538413|NCT02621931|473594057|FG000|Overall Study|Protocol Violation|2|||
131538414|NCT02621931|473594058|FG001|Overall Study|Protocol Violation|2|||
131538415|NCT02621931|473594059|FG002|Overall Study|Protocol Violation|2|||
131538416|NCT02621931|473594057|FG000|Overall Study|Pregnancy|2|||
131538417|NCT02621931|473594058|FG001|Overall Study|Pregnancy|0|||
131538418|NCT02621931|473594059|FG002|Overall Study|Pregnancy|0|||
131538419|NCT02621931|473594057|FG000|Overall Study|Noncompliance to study procedures|0|||
131538420|NCT02621931|473594058|FG001|Overall Study|Noncompliance to study procedures|1|||
131538421|NCT02621931|473594059|FG002|Overall Study|Noncompliance to study procedures|2|||
131538422|NCT02621931|473594057|FG000|Overall Study|Lost to Follow-up|8|||
131538423|NCT02621931|473594058|FG001|Overall Study|Lost to Follow-up|7|||
131538424|NCT02621931|473594059|FG002|Overall Study|Lost to Follow-up|10|||
131538425|NCT02621931|473594057|FG000|Overall Study|Lack of Efficacy|0|||
131538426|NCT02621931|473594058|FG001|Overall Study|Lack of Efficacy|0|||
131538427|NCT02621931|473594059|FG002|Overall Study|Lack of Efficacy|1|||
131538428|NCT02621931|473594057|FG000|Overall Study|Other|1|||
131538429|NCT02621931|473594058|FG001|Overall Study|Other|1|||
131538430|NCT02621931|473594059|FG002|Overall Study|Other|3|||
131538431|NCT02925455|473594060|FG000|Overall Study|Withdrawal by Subject|2|||
131538432|NCT02925455|473594061|FG001|Overall Study|Withdrawal by Subject|0|||
131538433|NCT04004611|473594064|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538434|NCT04004611|473594065|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538435|NCT04004611|473594066|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538436|NCT04004611|473594067|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538437|NCT04004611|473594068|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538438|NCT04004611|473594069|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538439|NCT04004611|473594070|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538440|NCT04004611|473594071|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
131538441|NCT04004611|473594072|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
131538442|NCT04004611|473594064|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
131538443|NCT04004611|473594065|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
131538444|NCT04004611|473594066|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
131538445|NCT04004611|473594067|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
131538446|NCT04004611|473594068|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
131538447|NCT04004611|473594069|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
131538448|NCT04004611|473594070|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
131538449|NCT04004611|473594071|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
131538450|NCT04004611|473594072|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
131538451|NCT04004611|473594064|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538452|NCT04004611|473594065|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538453|NCT04004611|473594066|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538454|NCT04004611|473594067|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538455|NCT04004611|473594068|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
131538456|NCT04004611|473594069|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538457|NCT04004611|473594070|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538458|NCT04004611|473594071|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538459|NCT04004611|473594072|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131538460|NCT04004611|473594064|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
131538461|NCT04004611|473594065|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
131538462|NCT04004611|473594066|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
131538463|NCT04004611|473594067|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
131538464|NCT04004611|473594068|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
131538465|NCT04004611|473594069|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
131538466|NCT04004611|473594070|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
131538467|NCT04004611|473594071|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
131538468|NCT04004611|473594072|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
131538469|NCT04004611|473594064|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
131538470|NCT04004611|473594065|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538471|NCT04004611|473594066|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
131538472|NCT04004611|473594067|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538473|NCT04004611|473594068|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538474|NCT04004611|473594069|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538475|NCT04004611|473594070|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538476|NCT04004611|473594071|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538477|NCT04004611|473594072|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
131538478|NCT04004611|473594064|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538479|NCT04004611|473594065|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
131538480|NCT04004611|473594066|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538481|NCT04004611|473594067|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538482|NCT04004611|473594068|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538483|NCT04004611|473594069|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538484|NCT04004611|473594070|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538485|NCT04004611|473594071|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538486|NCT04004611|473594072|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
131538487|NCT04420689|473594073|FG000|Overall Study|COVID-19 related hospitalization|0|||
131538488|NCT04420689|473594074|FG001|Overall Study|COVID-19 related hospitalization|0|||
131538489|NCT04420689|473594075|FG002|Overall Study|COVID-19 related hospitalization|0|||
131538490|NCT04420689|473594076|FG003|Overall Study|COVID-19 related hospitalization|0|||
131538491|NCT04420689|473594077|FG004|Overall Study|COVID-19 related hospitalization|1|||
131538492|NCT04420689|473594078|FG005|Overall Study|COVID-19 related hospitalization|0|||
131538493|NCT04420689|473594079|FG006|Overall Study|COVID-19 related hospitalization|0|||
131538494|NCT04420689|473594073|FG000|Overall Study|Physician Decision|0|||
131538495|NCT04420689|473594074|FG001|Overall Study|Physician Decision|0|||
131538496|NCT04420689|473594075|FG002|Overall Study|Physician Decision|0|||
131538497|NCT04420689|473594076|FG003|Overall Study|Physician Decision|0|||
131538498|NCT04420689|473594077|FG004|Overall Study|Physician Decision|0|||
131538499|NCT04420689|473594078|FG005|Overall Study|Physician Decision|1|||
131538500|NCT04420689|473594079|FG006|Overall Study|Physician Decision|0|||
131538501|NCT00487162|473594085|FG000|Overall Study|Adverse Event|0|||
131538502|NCT00487162|473594086|FG001|Overall Study|Adverse Event|1|||
131538503|NCT00487162|473594085|FG000|Overall Study|Physician Decision|0|||
131538504|NCT00487162|473594086|FG001|Overall Study|Physician Decision|1|||
131538505|NCT00487162|473594085|FG000|Overall Study|Withdrawal by Subject|2|||
131538506|NCT00487162|473594086|FG001|Overall Study|Withdrawal by Subject|3|||
131538507|NCT00515502|473594088|FG000|Treatment Period 1|Adverse Event|0|||
131538508|NCT00515502|473594089|FG001|Treatment Period 1|Adverse Event|0|||
131538509|NCT00515502|473594090|FG002|Treatment Period 1|Adverse Event|0|||
131538510|NCT00515502|473594091|FG003|Treatment Period 1|Adverse Event|0|||
131538511|NCT00515502|473594092|FG004|Treatment Period 1|Adverse Event|0|||
131538512|NCT00515502|473594093|FG005|Treatment Period 1|Adverse Event|0|||
131538513|NCT00515502|473594094|FG006|Treatment Period 1|Adverse Event|1|||
131538514|NCT00515502|473594095|FG007|Treatment Period 1|Adverse Event|0|||
131538515|NCT00515502|473594096|FG008|Treatment Period 1|Adverse Event|1|||
131538516|NCT00515502|473594097|FG009|Treatment Period 1|Adverse Event|0|||
131538517|NCT00515502|473594098|FG010|Treatment Period 1|Adverse Event|0|||
131538518|NCT00515502|473594099|FG011|Treatment Period 1|Adverse Event|1|||
131538519|NCT00515502|473594088|FG000|Treatment Period 2|Adverse Event|0|||
131538520|NCT00515502|473594089|FG001|Treatment Period 2|Adverse Event|1|||
131538521|NCT00515502|473594090|FG002|Treatment Period 2|Adverse Event|0|||
131538522|NCT00515502|473594091|FG003|Treatment Period 2|Adverse Event|0|||
131538523|NCT00515502|473594092|FG004|Treatment Period 2|Adverse Event|0|||
131538524|NCT00515502|473594093|FG005|Treatment Period 2|Adverse Event|0|||
131538525|NCT00515502|473594094|FG006|Treatment Period 2|Adverse Event|0|||
131538526|NCT00515502|473594095|FG007|Treatment Period 2|Adverse Event|0|||
131538527|NCT00515502|473594096|FG008|Treatment Period 2|Adverse Event|0|||
131538528|NCT00515502|473594097|FG009|Treatment Period 2|Adverse Event|0|||
131538529|NCT00515502|473594098|FG010|Treatment Period 2|Adverse Event|0|||
131538530|NCT00515502|473594099|FG011|Treatment Period 2|Adverse Event|0|||
131538531|NCT02732938|473594103|FG000|Overall Study|Death|0|||
131538532|NCT02732938|473594104|FG001|Overall Study|Death|11|||
131538533|NCT02732938|473594105|FG002|Overall Study|Death|0|||
131538534|NCT02732938|473594103|FG000|Overall Study|Randomized but did not receive treatment|0|||
131538535|NCT02732938|473594104|FG001|Overall Study|Randomized but did not receive treatment|1|||
131538536|NCT02732938|473594105|FG002|Overall Study|Randomized but did not receive treatment|0|||
131538537|NCT02732938|473594103|FG000|Overall Study|Refused further follow-up|1|||
131538538|NCT02732938|473594104|FG001|Overall Study|Refused further follow-up|0|||
131538539|NCT02732938|473594105|FG002|Overall Study|Refused further follow-up|0|||
131538540|NCT02732938|473594103|FG000|Overall Study|Study terminated by sponsor|3|||
131538541|NCT02732938|473594104|FG001|Overall Study|Study terminated by sponsor|6|||
131538542|NCT02732938|473594105|FG002|Overall Study|Study terminated by sponsor|0|||
131538543|NCT03647501|473594106|FG000|Overall Study|Lost to Follow-up|1|||
131538544|NCT03647501|473594107|FG001|Overall Study|Lost to Follow-up|1|||
131538545|NCT03647501|473594106|FG000|Overall Study|Withdrawal by Subject|0|||
131538546|NCT03647501|473594107|FG001|Overall Study|Withdrawal by Subject|1|||
131538547|NCT04530448|473594108|FG000|Overall Study|Physician Decision|3|||
131538548|NCT04530448|473594109|FG001|Overall Study|Physician Decision|0|||
131538549|NCT01491854|473594110|FG000|Overall Study|mainly due to premature termination|93|||
131538550|NCT01491854|473594110|FG000|Overall Study|Death|1|||
131538551|NCT01491854|473594110|FG000|Overall Study|Withdrawal by Subject|3|||
131538552|NCT01491854|473594110|FG000|Overall Study|Lost to Follow-up|33|||
131538553|NCT01433354|473594113|FG000|Overall Study|Adverse Event|6|||
131538554|NCT01433354|473594113|FG000|Overall Study|Lost to Follow-up|1|||
131538555|NCT01433354|473594113|FG000|Overall Study|Administrative problems|90|||
131538556|NCT01433354|473594113|FG000|Overall Study|Protocol Violation|2|||
131538557|NCT01433354|473594113|FG000|Overall Study|Lack of Efficacy|17|||
131538558|NCT01433354|473594113|FG000|Overall Study|Subject Withdrew Consent|3|||
131538559|NCT01540851|473594117|FG000|Overall Study|Lost to Follow-up|14|||
131538560|NCT01540851|473594118|FG001|Overall Study|Lost to Follow-up|15|||
131538561|NCT01540851|473594117|FG000|Overall Study|Withdrawal by Subject|7|||
131538562|NCT01540851|473594118|FG001|Overall Study|Withdrawal by Subject|3|||
131538563|NCT02013622|473594119|FG000|Overall Study|Lost to Follow-up|10|||
131538564|NCT02013622|473594119|FG000|Overall Study|Adverse Event|3|||
131538565|NCT02013622|473594119|FG000|Overall Study|Met Withdrawal Criteria|3|||
131538566|NCT02013622|473594119|FG000|Overall Study|Withdrawal by Subject|6|||
131538567|NCT02013622|473594119|FG000|Overall Study|Protocol Deviation|1|||
131538568|NCT02013622|473594119|FG000|Overall Study|Lack of Efficacy|1|||
131538569|NCT04307004|473594132|FG000|Randomization 1|Withdrawal by Subject|25|||
131538570|NCT04307004|473594133|FG001|Randomization 1|Withdrawal by Subject|26|||
131538571|NCT04307004|473594134|FG002|Randomization 1|Withdrawal by Subject|0|||
131538572|NCT04307004|473594135|FG003|Randomization 1|Withdrawal by Subject|0|||
131538573|NCT04307004|473594132|FG000|Randomization 2|Withdrawal by Subject|0|||
131538574|NCT04307004|473594133|FG001|Randomization 2|Withdrawal by Subject|0|||
131538575|NCT04307004|473594134|FG002|Randomization 2|Withdrawal by Subject|28|||
131538576|NCT04307004|473594135|FG003|Randomization 2|Withdrawal by Subject|23|||
131538577|NCT05545072|473594136|FG000|Overall Study|Lost to Follow-up|1|||
131538578|NCT05545072|473594137|FG001|Overall Study|Lost to Follow-up|0|||
131538579|NCT05545072|473594136|FG000|Overall Study|Study ended prematurely due to funding|2|||
131538580|NCT05545072|473594137|FG001|Overall Study|Study ended prematurely due to funding|2|||
131538581|NCT01324271|473594138|FG000|Overall Study|Lost to Follow-up|3|||
131538582|NCT01324271|473594139|FG001|Overall Study|Lost to Follow-up|0|||
131538583|NCT01324271|473594138|FG000|Overall Study|Physician Decision|1|||
131538584|NCT01324271|473594139|FG001|Overall Study|Physician Decision|0|||
131538585|NCT05130970|473594140|FG000|Overall Study|Adverse Event|1|||
131538586|NCT05130970|473594141|FG001|Overall Study|Adverse Event|1|||
131538587|NCT05130970|473594140|FG000|Overall Study|Death|0|||
131538588|NCT05130970|473594141|FG001|Overall Study|Death|1|||
131538589|NCT05130970|473594140|FG000|Overall Study|Lost to Follow-up|0|||
131538590|NCT05130970|473594141|FG001|Overall Study|Lost to Follow-up|1|||
131538591|NCT05130970|473594140|FG000|Overall Study|Physician Decision|0|||
131538592|NCT05130970|473594141|FG001|Overall Study|Physician Decision|1|||
131538593|NCT05130970|473594140|FG000|Overall Study|Withdrawal by Subject|1|||
131538594|NCT05130970|473594141|FG001|Overall Study|Withdrawal by Subject|1|||
131538595|NCT03996473|473594142|FG000|Treatment Assignment|Withdrawal by Subject|1|||
131538596|NCT03996473|473594142|FG000|Treatment Assignment|Progressive disease|6|||
131538597|NCT03996473|473594142|FG000|Treatment Assignment|Study drug never administered|1|||
131538598|NCT03996473|473594142|FG000|Active Follow-up|Death|1|||
131538599|NCT03996473|473594142|FG000|Long-term Follow-up|Death|5|||
131538600|NCT06116591|473594143|FG000|Overall Study|No longer met eligibility criteria|0|||
131538601|NCT06116591|473594144|FG001|Overall Study|No longer met eligibility criteria|1|||
131538602|NCT06116591|473594143|FG000|Overall Study|Other: Change in life situation|0|||
131538603|NCT06116591|473594144|FG001|Overall Study|Other: Change in life situation|1|||
131538604|NCT01381692|473594147|FG000|Overall Study|Adverse Event|1|||
131538605|NCT01381692|473594148|FG001|Overall Study|Adverse Event|0|||
131538606|NCT01381692|473594149|FG002|Overall Study|Adverse Event|0|||
131538607|NCT01381692|473594150|FG003|Overall Study|Adverse Event|0|||
131538608|NCT01381692|473594151|FG004|Overall Study|Adverse Event|0|||
131538609|NCT01381692|473594152|FG005|Overall Study|Adverse Event|0|||
131538610|NCT01270347|473594153|FG000|Core Phase|Adverse Event|1|||
131538611|NCT01270347|473594154|FG001|Core Phase|Adverse Event|6|||
131538612|NCT01270347|473594153|FG000|Core Phase|Withdrawal by Subject|1|||
131538613|NCT01270347|473594154|FG001|Core Phase|Withdrawal by Subject|2|||
131538614|NCT01270347|473594153|FG000|Core Phase|Lost to Follow-up|0|||
131538615|NCT01270347|473594154|FG001|Core Phase|Lost to Follow-up|1|||
131538616|NCT01270347|473594153|FG000|Core Phase|Miscellaneous|8|||
131538617|NCT01270347|473594154|FG001|Core Phase|Miscellaneous|14|||
131538618|NCT01270347|473594153|FG000|Extension Phase|Adverse Event|1|||
131538619|NCT01270347|473594154|FG001|Extension Phase|Adverse Event|3|||
131538620|NCT01270347|473594153|FG000|Extension Phase|Withdrawal by Subject|3|||
131538621|NCT01270347|473594154|FG001|Extension Phase|Withdrawal by Subject|4|||
131538622|NCT01270347|473594153|FG000|Extension Phase|Miscellaneous|2|||
131538623|NCT01270347|473594154|FG001|Extension Phase|Miscellaneous|2|||
131538624|NCT02189798|473594155|FG000|Extended Use Phase|Withdrawal by Subject|0|||
131538625|NCT02189798|473594156|FG001|Extended Use Phase|Withdrawal by Subject|4|||
131538626|NCT02189798|473594155|FG000|Extended Use Phase|Physician Decision|1|||
131538627|NCT02189798|473594156|FG001|Extended Use Phase|Physician Decision|0|||
131538628|NCT02189798|473594155|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
131538629|NCT02189798|473594156|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
131538630|NCT02189798|473594155|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
131538631|NCT02189798|473594156|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
131538632|NCT02189798|473594155|FG000|Extended Use Phase|Travel Issues|2|||
131538633|NCT02189798|473594156|FG001|Extended Use Phase|Travel Issues|1|||
131538634|NCT02189798|473594155|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
131538635|NCT02189798|473594156|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
131538636|NCT02273141|473594157|FG000|Overall Study|Adverse Event|0|||
131538637|NCT02273141|473594158|FG001|Overall Study|Adverse Event|1|||
131538638|NCT02273141|473594157|FG000|Overall Study|Lost to Follow-up|1|||
131538639|NCT02273141|473594158|FG001|Overall Study|Lost to Follow-up|3|||
131538640|NCT02273141|473594157|FG000|Overall Study|Withdrawal by Subject|10|||
131538641|NCT02273141|473594158|FG001|Overall Study|Withdrawal by Subject|15|||
131538642|NCT02273141|473594157|FG000|Overall Study|Various|6|||
131538643|NCT02273141|473594158|FG001|Overall Study|Various|6|||
131538644|NCT00529399|473594159|FG000|Overall Study|Lost to Follow-up|1|||
131538645|NCT00529399|473594160|FG001|Overall Study|Lost to Follow-up|0|||
131538646|NCT00529399|473594161|FG002|Overall Study|Lost to Follow-up|1|||
131538647|NCT00529399|473594159|FG000|Overall Study|Withdrawal by Subject|1|||
131538648|NCT00529399|473594160|FG001|Overall Study|Withdrawal by Subject|0|||
131538649|NCT00529399|473594161|FG002|Overall Study|Withdrawal by Subject|1|||
131538650|NCT00529399|473594159|FG000|Overall Study|Non-compliant|0|||
131538651|NCT00529399|473594160|FG001|Overall Study|Non-compliant|1|||
131538652|NCT00529399|473594161|FG002|Overall Study|Non-compliant|0|||
131538653|NCT04313881|473594173|FG000|Overall Study|Death|138|||
131538654|NCT04313881|473594174|FG001|Overall Study|Death|126|||
131538655|NCT04313881|473594173|FG000|Overall Study|Study terminated by sponsor|108|||
131538656|NCT04313881|473594174|FG001|Overall Study|Study terminated by sponsor|129|||
131538657|NCT04313881|473594173|FG000|Overall Study|Consent withdrawn|19|||
131538658|NCT04313881|473594174|FG001|Overall Study|Consent withdrawn|15|||
131538659|NCT04313881|473594173|FG000|Overall Study|Reason not Specified|3|||
131538660|NCT04313881|473594174|FG001|Overall Study|Reason not Specified|1|||
131538661|NCT00727272|473594175|FG000|Washout Period A|Adverse Event|0|||
131538662|NCT00727272|473594176|FG001|Washout Period A|Adverse Event|0|||
131538663|NCT00727272|473594177|FG002|Washout Period A|Adverse Event|1|||
131538664|NCT00727272|473594175|FG000|Washout Period B|Withdrawal by Subject|0|||
131538665|NCT00727272|473594176|FG001|Washout Period B|Withdrawal by Subject|0|||
131538666|NCT00727272|473594177|FG002|Washout Period B|Withdrawal by Subject|1|||
131538667|NCT00651664|473594178|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
131538668|NCT00651664|473594179|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
131538669|NCT00651664|473594180|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
131538670|NCT00651664|473594181|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
131538671|NCT00651664|473594182|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
131538672|NCT00651664|473594183|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
131538673|NCT00651664|473594184|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
131538674|NCT00651664|473594185|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
131538675|NCT00651664|473594186|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
131538676|NCT00651664|473594187|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
131538677|NCT00651664|473594178|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
131538678|NCT00651664|473594179|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
131538679|NCT00651664|473594180|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
131538680|NCT00651664|473594181|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
131538681|NCT00651664|473594182|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
131538682|NCT00651664|473594183|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
131538683|NCT00651664|473594184|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
131538684|NCT00651664|473594185|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
131538685|NCT00651664|473594186|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
131538686|NCT00651664|473594187|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
131538687|NCT00651664|473594178|FG000|Overall Study|Progressive Disease|3|||
131538688|NCT00651664|473594179|FG001|Overall Study|Progressive Disease|3|||
131538689|NCT00651664|473594180|FG002|Overall Study|Progressive Disease|3|||
131538690|NCT00651664|473594181|FG003|Overall Study|Progressive Disease|12|||
131538691|NCT00651664|473594182|FG004|Overall Study|Progressive Disease|4|||
131538692|NCT00651664|473594183|FG005|Overall Study|Progressive Disease|1|||
131538693|NCT00651664|473594184|FG006|Overall Study|Progressive Disease|3|||
131538694|NCT00651664|473594185|FG007|Overall Study|Progressive Disease|6|||
131538695|NCT00651664|473594186|FG008|Overall Study|Progressive Disease|5|||
131538696|NCT00651664|473594187|FG009|Overall Study|Progressive Disease|5|||
131538697|NCT00651664|473594178|FG000|Overall Study|Patient Declined Further Treatment|0|||
131538698|NCT00651664|473594179|FG001|Overall Study|Patient Declined Further Treatment|0|||
131538699|NCT00651664|473594180|FG002|Overall Study|Patient Declined Further Treatment|0|||
131538700|NCT00651664|473594181|FG003|Overall Study|Patient Declined Further Treatment|1|||
131538701|NCT00651664|473594182|FG004|Overall Study|Patient Declined Further Treatment|1|||
131538702|NCT00651664|473594183|FG005|Overall Study|Patient Declined Further Treatment|1|||
131538703|NCT00651664|473594184|FG006|Overall Study|Patient Declined Further Treatment|0|||
131538704|NCT00651664|473594185|FG007|Overall Study|Patient Declined Further Treatment|0|||
131538705|NCT00651664|473594186|FG008|Overall Study|Patient Declined Further Treatment|0|||
131538706|NCT00651664|473594187|FG009|Overall Study|Patient Declined Further Treatment|1|||
131538707|NCT00651664|473594178|FG000|Overall Study|Symptomatic Deterioration|0|||
131538708|NCT00651664|473594179|FG001|Overall Study|Symptomatic Deterioration|0|||
131538709|NCT00651664|473594180|FG002|Overall Study|Symptomatic Deterioration|0|||
131538710|NCT00651664|473594181|FG003|Overall Study|Symptomatic Deterioration|1|||
131538711|NCT00651664|473594182|FG004|Overall Study|Symptomatic Deterioration|0|||
131538712|NCT00651664|473594183|FG005|Overall Study|Symptomatic Deterioration|0|||
131538713|NCT00651664|473594184|FG006|Overall Study|Symptomatic Deterioration|1|||
131538714|NCT00651664|473594185|FG007|Overall Study|Symptomatic Deterioration|0|||
131538715|NCT00651664|473594186|FG008|Overall Study|Symptomatic Deterioration|1|||
131538716|NCT00651664|473594187|FG009|Overall Study|Symptomatic Deterioration|0|||
131538717|NCT00651664|473594178|FG000|Overall Study|Reason not Specified|0|||
131538718|NCT00651664|473594179|FG001|Overall Study|Reason not Specified|0|||
131538719|NCT00651664|473594180|FG002|Overall Study|Reason not Specified|0|||
131538720|NCT00651664|473594181|FG003|Overall Study|Reason not Specified|0|||
131538721|NCT00651664|473594182|FG004|Overall Study|Reason not Specified|0|||
131538722|NCT00651664|473594183|FG005|Overall Study|Reason not Specified|0|||
131538723|NCT00651664|473594184|FG006|Overall Study|Reason not Specified|1|||
131538724|NCT00651664|473594185|FG007|Overall Study|Reason not Specified|0|||
131658522|NCT01142232|474035355|FG004|Overall Study|Physician Decision|10|||
131538725|NCT00651664|473594186|FG008|Overall Study|Reason not Specified|0|||
131538726|NCT00651664|473594187|FG009|Overall Study|Reason not Specified|0|||
131538727|NCT01474681|473594188|FG000|Overall Study|Death|0|||
131538728|NCT01474681|473594189|FG001|Overall Study|Death|3|||
131538729|NCT01474681|473594190|FG002|Overall Study|Death|2|||
131538730|NCT01474681|473594191|FG003|Overall Study|Death|6|||
131538731|NCT03998618|473594194|FG000|Overall Study|Death|7|||
131538732|NCT03998618|473594195|FG001|Overall Study|Death|11|||
131538733|NCT03998618|473594194|FG000|Overall Study|hospice enrollment|3|||
131538734|NCT03998618|473594195|FG001|Overall Study|hospice enrollment|3|||
131538735|NCT03998618|473594194|FG000|Overall Study|Not feeling well/health problems|3|||
131538736|NCT03998618|473594195|FG001|Overall Study|Not feeling well/health problems|5|||
131538737|NCT03998618|473594194|FG000|Overall Study|Lost to Follow-up|6|||
131538738|NCT03998618|473594195|FG001|Overall Study|Lost to Follow-up|6|||
131538739|NCT03998618|473594194|FG000|Overall Study|Withdrawal by Subject|0|||
131538740|NCT03998618|473594195|FG001|Overall Study|Withdrawal by Subject|4|||
131538741|NCT02195986|473594196|FG000|Overall Study|Adverse Event|3|||
131538742|NCT02195986|473594197|FG001|Overall Study|Adverse Event|0|||
131538743|NCT02195986|473594198|FG002|Overall Study|Adverse Event|0|||
131538744|NCT02195986|473594196|FG000|Overall Study|Withdrawal by Subject|0|||
131538745|NCT02195986|473594197|FG001|Overall Study|Withdrawal by Subject|3|||
131538746|NCT02195986|473594198|FG002|Overall Study|Withdrawal by Subject|0|||
131538747|NCT02195986|473594196|FG000|Overall Study|Family Emergency|0|||
131538748|NCT02195986|473594197|FG001|Overall Study|Family Emergency|0|||
131538749|NCT02195986|473594198|FG002|Overall Study|Family Emergency|1|||
131538750|NCT02195986|473594196|FG000|Overall Study|Protocol Violation|0|||
131538751|NCT02195986|473594197|FG001|Overall Study|Protocol Violation|1|||
131538752|NCT02195986|473594198|FG002|Overall Study|Protocol Violation|1|||
131538753|NCT02195986|473594196|FG000|Overall Study|Non-compliance|0|||
131538754|NCT02195986|473594197|FG001|Overall Study|Non-compliance|1|||
131538755|NCT02195986|473594198|FG002|Overall Study|Non-compliance|0|||
131538756|NCT02834780|473594201|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
131538757|NCT02834780|473594202|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
131538758|NCT02834780|473594203|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
131538759|NCT02834780|473594204|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
131538760|NCT02834780|473594205|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
131538761|NCT02834780|473594206|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
131538762|NCT02834780|473594207|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
131538763|NCT02834780|473594208|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
131538764|NCT02834780|473594209|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
131538765|NCT02834780|473594210|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
131538766|NCT02834780|473594211|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
131538767|NCT02834780|473594212|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
131538768|NCT02834780|473594213|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
131538769|NCT02834780|473594201|FG000|Overall Study|Withdrawal by Subject|0|||
131538770|NCT02834780|473594202|FG001|Overall Study|Withdrawal by Subject|0|||
131538771|NCT02834780|473594203|FG002|Overall Study|Withdrawal by Subject|1|||
131538772|NCT02834780|473594204|FG003|Overall Study|Withdrawal by Subject|0|||
131538773|NCT02834780|473594205|FG004|Overall Study|Withdrawal by Subject|0|||
131538774|NCT02834780|473594206|FG005|Overall Study|Withdrawal by Subject|0|||
131538775|NCT02834780|473594207|FG006|Overall Study|Withdrawal by Subject|0|||
131538776|NCT02834780|473594208|FG007|Overall Study|Withdrawal by Subject|0|||
131538777|NCT02834780|473594209|FG008|Overall Study|Withdrawal by Subject|0|||
131538778|NCT02834780|473594210|FG009|Overall Study|Withdrawal by Subject|0|||
131538779|NCT02834780|473594211|FG010|Overall Study|Withdrawal by Subject|1|||
131538780|NCT02834780|473594212|FG011|Overall Study|Withdrawal by Subject|0|||
131538781|NCT02834780|473594213|FG012|Overall Study|Withdrawal by Subject|0|||
131538782|NCT02834780|473594201|FG000|Overall Study|Adverse Event|0|||
131538783|NCT02834780|473594202|FG001|Overall Study|Adverse Event|0|||
131538784|NCT02834780|473594203|FG002|Overall Study|Adverse Event|0|||
131538785|NCT02834780|473594204|FG003|Overall Study|Adverse Event|0|||
131538786|NCT02834780|473594205|FG004|Overall Study|Adverse Event|1|||
131538787|NCT02834780|473594206|FG005|Overall Study|Adverse Event|0|||
131538788|NCT02834780|473594207|FG006|Overall Study|Adverse Event|1|||
131538789|NCT02834780|473594208|FG007|Overall Study|Adverse Event|1|||
131538790|NCT02834780|473594209|FG008|Overall Study|Adverse Event|0|||
131538791|NCT02834780|473594210|FG009|Overall Study|Adverse Event|2|||
131538792|NCT02834780|473594211|FG010|Overall Study|Adverse Event|0|||
131538793|NCT02834780|473594212|FG011|Overall Study|Adverse Event|3|||
131538794|NCT02834780|473594213|FG012|Overall Study|Adverse Event|2|||
131538795|NCT02834780|473594201|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
131538796|NCT02834780|473594202|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
131538797|NCT02834780|473594203|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
131538798|NCT02834780|473594204|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
131658523|NCT01142232|474035351|FG000|Overall Study|Alternative Therapy|0|||
131538799|NCT02834780|473594205|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
131538800|NCT02834780|473594206|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
131538801|NCT02834780|473594207|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
131538802|NCT02834780|473594208|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
131538803|NCT02834780|473594209|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
131538804|NCT02834780|473594210|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
131538805|NCT02834780|473594211|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
131538806|NCT02834780|473594212|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
131538807|NCT02834780|473594213|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
131538808|NCT02834780|473594201|FG000|Overall Study|Other|1|||
131538809|NCT02834780|473594202|FG001|Overall Study|Other|0|||
131538810|NCT02834780|473594203|FG002|Overall Study|Other|1|||
131538811|NCT02834780|473594204|FG003|Overall Study|Other|2|||
131538812|NCT02834780|473594205|FG004|Overall Study|Other|0|||
131538813|NCT02834780|473594206|FG005|Overall Study|Other|0|||
131538814|NCT02834780|473594207|FG006|Overall Study|Other|0|||
131538815|NCT02834780|473594208|FG007|Overall Study|Other|0|||
131538816|NCT02834780|473594209|FG008|Overall Study|Other|0|||
131538817|NCT02834780|473594210|FG009|Overall Study|Other|0|||
131538818|NCT02834780|473594211|FG010|Overall Study|Other|0|||
131538819|NCT02834780|473594212|FG011|Overall Study|Other|0|||
131538820|NCT02834780|473594213|FG012|Overall Study|Other|1|||
131538821|NCT02415400|473594214|FG000|Overall Study|Adverse Event|0|||
131538822|NCT02415400|473594215|FG001|Overall Study|Adverse Event|1|||
131538823|NCT02415400|473594216|FG002|Overall Study|Adverse Event|1|||
131538824|NCT02415400|473594217|FG003|Overall Study|Adverse Event|2|||
131538825|NCT02415400|473594214|FG000|Overall Study|Participant request to stop therapy|4|||
131538826|NCT02415400|473594215|FG001|Overall Study|Participant request to stop therapy|3|||
131538827|NCT02415400|473594216|FG002|Overall Study|Participant request to stop therapy|8|||
131538828|NCT02415400|473594217|FG003|Overall Study|Participant request to stop therapy|6|||
131538829|NCT02415400|473594214|FG000|Overall Study|Participant withdrew consent|14|||
131538830|NCT02415400|473594215|FG001|Overall Study|Participant withdrew consent|12|||
131538831|NCT02415400|473594216|FG002|Overall Study|Participant withdrew consent|30|||
131538832|NCT02415400|473594217|FG003|Overall Study|Participant withdrew consent|21|||
131538833|NCT02415400|473594214|FG000|Overall Study|Death|39|||
131538834|NCT02415400|473594215|FG001|Overall Study|Death|41|||
131538835|NCT02415400|473594216|FG002|Overall Study|Death|35|||
131538836|NCT02415400|473594217|FG003|Overall Study|Death|42|||
131538837|NCT02415400|473594214|FG000|Overall Study|Lost to Follow-up|3|||
131538838|NCT02415400|473594215|FG001|Overall Study|Lost to Follow-up|3|||
131538839|NCT02415400|473594216|FG002|Overall Study|Lost to Follow-up|2|||
131538840|NCT02415400|473594217|FG003|Overall Study|Lost to Follow-up|5|||
131538841|NCT02415400|473594214|FG000|Overall Study|Poor/Non-Compliance|0|||
131538842|NCT02415400|473594215|FG001|Overall Study|Poor/Non-Compliance|1|||
131538843|NCT02415400|473594216|FG002|Overall Study|Poor/Non-Compliance|3|||
131538844|NCT02415400|473594217|FG003|Overall Study|Poor/Non-Compliance|4|||
131538845|NCT02415400|473594214|FG000|Overall Study|Participant no longer meets criteria|2|||
131538846|NCT02415400|473594215|FG001|Overall Study|Participant no longer meets criteria|0|||
131538847|NCT02415400|473594216|FG002|Overall Study|Participant no longer meets criteria|0|||
131538848|NCT02415400|473594217|FG003|Overall Study|Participant no longer meets criteria|1|||
131538849|NCT02415400|473594214|FG000|Overall Study|Participant doesn't answer phone|1|||
131538850|NCT02415400|473594215|FG001|Overall Study|Participant doesn't answer phone|0|||
131538851|NCT02415400|473594216|FG002|Overall Study|Participant doesn't answer phone|0|||
131538852|NCT02415400|473594217|FG003|Overall Study|Participant doesn't answer phone|0|||
131538853|NCT02415400|473594214|FG000|Overall Study|Participant wanted home visits|1|||
131538854|NCT02415400|473594215|FG001|Overall Study|Participant wanted home visits|0|||
131538855|NCT02415400|473594216|FG002|Overall Study|Participant wanted home visits|0|||
131538856|NCT02415400|473594217|FG003|Overall Study|Participant wanted home visits|0|||
131538857|NCT02415400|473594214|FG000|Overall Study|Randomized in error|2|||
131538858|NCT02415400|473594215|FG001|Overall Study|Randomized in error|0|||
131538859|NCT02415400|473594216|FG002|Overall Study|Randomized in error|0|||
131538860|NCT02415400|473594217|FG003|Overall Study|Randomized in error|0|||
131538861|NCT02415400|473594214|FG000|Overall Study|No study drug on site|0|||
131538862|NCT02415400|473594215|FG001|Overall Study|No study drug on site|1|||
131538863|NCT02415400|473594216|FG002|Overall Study|No study drug on site|0|||
131538864|NCT02415400|473594217|FG003|Overall Study|No study drug on site|0|||
131538865|NCT02415400|473594214|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
131538866|NCT02415400|473594215|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
131538867|NCT02415400|473594216|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
131538868|NCT02415400|473594217|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
131538869|NCT02415400|473594214|FG000|Overall Study|Coagulation values cannot be set|0|||
131538870|NCT02415400|473594215|FG001|Overall Study|Coagulation values cannot be set|0|||
131538871|NCT02415400|473594216|FG002|Overall Study|Coagulation values cannot be set|1|||
131538872|NCT02415400|473594217|FG003|Overall Study|Coagulation values cannot be set|0|||
131538873|NCT02415400|473594214|FG000|Overall Study|State regulations prevent participation|0|||
131538874|NCT02415400|473594215|FG001|Overall Study|State regulations prevent participation|0|||
131538875|NCT02415400|473594216|FG002|Overall Study|State regulations prevent participation|1|||
131538876|NCT02415400|473594217|FG003|Overall Study|State regulations prevent participation|0|||
131538877|NCT02415400|473594214|FG000|Overall Study|Poor treatment monitoring|0|||
131538878|NCT02415400|473594215|FG001|Overall Study|Poor treatment monitoring|0|||
131538879|NCT02415400|473594216|FG002|Overall Study|Poor treatment monitoring|1|||
131538880|NCT02415400|473594217|FG003|Overall Study|Poor treatment monitoring|0|||
131538881|NCT02415400|473594214|FG000|Overall Study|Participant in jail|0|||
131538882|NCT02415400|473594215|FG001|Overall Study|Participant in jail|0|||
131538883|NCT02415400|473594216|FG002|Overall Study|Participant in jail|1|||
131538884|NCT02415400|473594217|FG003|Overall Study|Participant in jail|0|||
131538885|NCT02415400|473594214|FG000|Overall Study|Investigator decision|0|||
131538886|NCT02415400|473594215|FG001|Overall Study|Investigator decision|0|||
131538887|NCT02415400|473594216|FG002|Overall Study|Investigator decision|1|||
131538888|NCT02415400|473594217|FG003|Overall Study|Investigator decision|1|||
131538889|NCT02415400|473594214|FG000|Overall Study|Site closure; participant won't transfer|0|||
131538890|NCT02415400|473594215|FG001|Overall Study|Site closure; participant won't transfer|0|||
131538891|NCT02415400|473594216|FG002|Overall Study|Site closure; participant won't transfer|0|||
131538892|NCT02415400|473594217|FG003|Overall Study|Site closure; participant won't transfer|1|||
131538893|NCT02270450|473594218|FG000|Overall Study|Refusal unrelated to adverse event|3|||
131538894|NCT02270450|473594219|FG001|Overall Study|Refusal unrelated to adverse event|1|||
131538895|NCT02270450|473594220|FG002|Overall Study|Refusal unrelated to adverse event|5|||
131538896|NCT02270450|473594221|FG003|Overall Study|Refusal unrelated to adverse event|14|||
131538897|NCT02270450|473594218|FG000|Overall Study|Progression/relapse|1|||
131538898|NCT02270450|473594219|FG001|Overall Study|Progression/relapse|2|||
131538899|NCT02270450|473594220|FG002|Overall Study|Progression/relapse|4|||
131538900|NCT02270450|473594221|FG003|Overall Study|Progression/relapse|9|||
131538901|NCT02270450|473594218|FG000|Overall Study|Death|19|||
131538902|NCT02270450|473594219|FG001|Overall Study|Death|19|||
131538903|NCT02270450|473594220|FG002|Overall Study|Death|31|||
131538904|NCT02270450|473594221|FG003|Overall Study|Death|59|||
131538905|NCT02363738|473594223|FG000|Overall Study|Adverse Event|5|||
131538906|NCT02363738|473594224|FG001|Overall Study|Adverse Event|2|||
131538907|NCT02363738|473594223|FG000|Overall Study|Lack of Efficacy|1|||
131538908|NCT02363738|473594224|FG001|Overall Study|Lack of Efficacy|2|||
131538909|NCT02363738|473594223|FG000|Overall Study|Lost to Follow-up|2|||
131538910|NCT02363738|473594224|FG001|Overall Study|Lost to Follow-up|1|||
131538911|NCT02081846|473594229|FG000|Overall Study|Withdrawal by Subject|1|||
131538912|NCT02081846|473594230|FG001|Overall Study|Withdrawal by Subject|0|||
131538913|NCT02081846|473594229|FG000|Overall Study|invalid consent|1|||
131538914|NCT02081846|473594230|FG001|Overall Study|invalid consent|0|||
131538915|NCT03282227|473594231|FG000|Overall Study|Exposure Goals Achieved|60|||
131538916|NCT03282227|473594231|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
131538917|NCT03282227|473594231|FG000|Overall Study|Adverse Event|15|||
131538918|NCT03282227|473594231|FG000|Overall Study|Lost to Follow-up|21|||
131538919|NCT03282227|473594231|FG000|Overall Study|Withdrawal by Subject|20|||
131538920|NCT03282227|473594231|FG000|Overall Study|Lack of Efficacy|12|||
131538921|NCT03282227|473594231|FG000|Overall Study|Sponsor decision|3|||
131538922|NCT03282227|473594231|FG000|Overall Study|Physician Decision|2|||
131538923|NCT03282227|473594231|FG000|Overall Study|Pregnancy|2|||
131538924|NCT03282227|473594231|FG000|Overall Study|Other|1|||
131538925|NCT02576678|473594232|FG000|Overall Study|Adverse Event|0|||
131538926|NCT02576678|473594233|FG001|Overall Study|Adverse Event|0|||
131538927|NCT02576678|473594234|FG002|Overall Study|Adverse Event|2|||
131538928|NCT02576678|473594232|FG000|Overall Study|Withdrawal by Subject|3|||
131538929|NCT02576678|473594233|FG001|Overall Study|Withdrawal by Subject|1|||
131538930|NCT02576678|473594234|FG002|Overall Study|Withdrawal by Subject|2|||
131538931|NCT02576678|473594232|FG000|Overall Study|Lost to Follow-up|0|||
131538932|NCT02576678|473594233|FG001|Overall Study|Lost to Follow-up|0|||
131538933|NCT02576678|473594234|FG002|Overall Study|Lost to Follow-up|1|||
131538934|NCT02576678|473594232|FG000|Overall Study|Miscellaneous|2|||
131538935|NCT02576678|473594233|FG001|Overall Study|Miscellaneous|0|||
131538936|NCT02576678|473594234|FG002|Overall Study|Miscellaneous|0|||
131538937|NCT02491671|473594238|FG000|Overall Study|Adverse Event|6|||
131538938|NCT02491671|473594239|FG001|Overall Study|Adverse Event|8|||
131538939|NCT02491671|473594238|FG000|Overall Study|Death|0|||
131538940|NCT02491671|473594239|FG001|Overall Study|Death|2|||
131538941|NCT02491671|473594238|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
131538942|NCT02491671|473594239|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
131538943|NCT02251990|473594243|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
131538944|NCT02251990|473594244|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
131538945|NCT02251990|473594243|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
131538946|NCT02251990|473594244|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
131538947|NCT02251990|473594243|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
131538948|NCT02251990|473594244|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
131538949|NCT02251990|473594243|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
131538950|NCT02251990|473594244|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
131538951|NCT02251990|473594243|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
131538952|NCT02251990|473594244|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
131538953|NCT02251990|473594243|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
131538954|NCT02251990|473594244|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
131538955|NCT03265600|473594245|FG000|Overall Study|Lost to Follow-up|17|||
131538956|NCT03265600|473594246|FG001|Overall Study|Lost to Follow-up|5|||
131538957|NCT03265600|473594245|FG000|Overall Study|Withdrawal by Subject|4|||
131538958|NCT03265600|473594246|FG001|Overall Study|Withdrawal by Subject|2|||
131538959|NCT03265600|473594245|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
131538960|NCT03265600|473594246|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
131538961|NCT00535730|473594247|FG000|Overall Study|Adverse Event|1|||
131538962|NCT00535730|473594248|FG001|Overall Study|Adverse Event|1|||
131538963|NCT00535730|473594247|FG000|Overall Study|Lost to Follow-up|0|||
131538964|NCT00535730|473594248|FG001|Overall Study|Lost to Follow-up|1|||
131538965|NCT00535730|473594247|FG000|Overall Study|Physician Decision|0|||
131538966|NCT00535730|473594248|FG001|Overall Study|Physician Decision|1|||
131538967|NCT00535730|473594247|FG000|Overall Study|Protocol Violation|1|||
131538968|NCT00535730|473594248|FG001|Overall Study|Protocol Violation|0|||
131538969|NCT00535730|473594247|FG000|Overall Study|Withdrawal by Subject|0|||
131538970|NCT00535730|473594248|FG001|Overall Study|Withdrawal by Subject|4|||
131538971|NCT04330638|473594249|FG000|Overall Study|Adverse Event|9|||
131538972|NCT04330638|473594250|FG001|Overall Study|Adverse Event|10|||
131538973|NCT04330638|473594251|FG002|Overall Study|Adverse Event|15|||
131538974|NCT04330638|473594252|FG003|Overall Study|Adverse Event|6|||
131538975|NCT04330638|473594253|FG004|Overall Study|Adverse Event|10|||
131538976|NCT04330638|473594254|FG005|Overall Study|Adverse Event|5|||
131538977|NCT04330638|473594249|FG000|Overall Study|Other|2|||
131538978|NCT04330638|473594250|FG001|Overall Study|Other|2|||
131538979|NCT04330638|473594251|FG002|Overall Study|Other|5|||
131538980|NCT04330638|473594252|FG003|Overall Study|Other|1|||
131538981|NCT04330638|473594253|FG004|Overall Study|Other|3|||
131538982|NCT04330638|473594254|FG005|Overall Study|Other|2|||
131538983|NCT04330638|473594249|FG000|Overall Study|Withdrawal by Subject|4|||
131538984|NCT04330638|473594250|FG001|Overall Study|Withdrawal by Subject|0|||
131538985|NCT04330638|473594251|FG002|Overall Study|Withdrawal by Subject|0|||
131538986|NCT04330638|473594252|FG003|Overall Study|Withdrawal by Subject|0|||
131538987|NCT04330638|473594253|FG004|Overall Study|Withdrawal by Subject|0|||
131538988|NCT04330638|473594254|FG005|Overall Study|Withdrawal by Subject|0|||
131538989|NCT04330638|473594249|FG000|Overall Study|Lost to Follow-up|3|||
131538990|NCT04330638|473594250|FG001|Overall Study|Lost to Follow-up|2|||
131538991|NCT04330638|473594251|FG002|Overall Study|Lost to Follow-up|3|||
131538992|NCT04330638|473594252|FG003|Overall Study|Lost to Follow-up|2|||
131538993|NCT04330638|473594253|FG004|Overall Study|Lost to Follow-up|3|||
131538994|NCT04330638|473594254|FG005|Overall Study|Lost to Follow-up|0|||
131538995|NCT02293538|473594255|FG000|Overall Study|Adverse Event|0|||
131538996|NCT02293538|473594256|FG001|Overall Study|Adverse Event|1|||
131538997|NCT02293538|473594255|FG000|Overall Study|Lost to Follow-up|1|||
131538998|NCT02293538|473594256|FG001|Overall Study|Lost to Follow-up|0|||
131538999|NCT02293538|473594255|FG000|Overall Study|Withdrawal by Subject|0|||
131539000|NCT02293538|473594256|FG001|Overall Study|Withdrawal by Subject|1|||
131539001|NCT00322348|473594257|FG000|Overall Study|Adverse Event|0|||
131539002|NCT00322348|473594258|FG001|Overall Study|Adverse Event|1|||
131539003|NCT00322348|473594257|FG000|Overall Study|Withdrawal by Subject|1|||
131539004|NCT00322348|473594258|FG001|Overall Study|Withdrawal by Subject|4|||
131539005|NCT00322348|473594257|FG000|Overall Study|Lost to Follow-up|1|||
131539006|NCT00322348|473594258|FG001|Overall Study|Lost to Follow-up|0|||
131539007|NCT00322348|473594257|FG000|Overall Study|Death|0|||
131539008|NCT00322348|473594258|FG001|Overall Study|Death|2|||
131539009|NCT00322348|473594257|FG000|Overall Study|Disease Progression|30|||
131539010|NCT00322348|473594258|FG001|Overall Study|Disease Progression|25|||
131539011|NCT00322348|473594257|FG000|Overall Study|Reasons not specified|5|||
131539012|NCT00322348|473594258|FG001|Overall Study|Reasons not specified|1|||
131539013|NCT00936858|473594259|FG000|Overall Study|Death|3|||
131539014|NCT00936858|473594259|FG000|Overall Study|Progression|29|||
131539015|NCT00936858|473594259|FG000|Overall Study|Withdrawal by Subject|5|||
131539016|NCT00936858|473594259|FG000|Overall Study|Adverse Event|1|||
131539017|NCT00936858|473594259|FG000|Overall Study|Physician Decision|7|||
131539018|NCT00936858|473594259|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
131539019|NCT00936858|473594259|FG000|Overall Study|Lost to Follow-up|1|||
131539020|NCT02985866|473595749|FG000|Overall Study|Poor CGM data|1|||
131539021|NCT02985866|473595750|FG001|Overall Study|Poor CGM data|1|||
131539022|NCT00686166|473595755|FG000|Overall Study|Adverse Event|7|||
131539023|NCT00686166|473595755|FG000|Overall Study|Withdrawal by Subject|1|||
131539024|NCT00686166|473595755|FG000|Overall Study|Progression/Relapse|1|||
131539025|NCT00686166|473595755|FG000|Overall Study|Death|1|||
131539026|NCT00686166|473595755|FG000|Overall Study|Not Protocol Specified|1|||
131539027|NCT00686166|473595755|FG000|Overall Study|Ineligible|5|||
131658524|NCT01142232|474035352|FG001|Overall Study|Alternative Therapy|1|||
131539028|NCT00686166|473595755|FG000|Overall Study|Did not begin protocol therapy|4|||
131539029|NCT01549613|473595758|FG000|Overall Study|Lost to Follow-up|11|||
131539030|NCT01549613|473595759|FG001|Overall Study|Lost to Follow-up|11|||
131539031|NCT02216123|473595760|FG000|Overall Study|Lost to Follow-up|4|||
131539032|NCT02216123|473595761|FG001|Overall Study|Lost to Follow-up|2|||
131539033|NCT02216123|473595760|FG000|Overall Study|Withdrawal by Subject|2|||
131539034|NCT02216123|473595761|FG001|Overall Study|Withdrawal by Subject|0|||
131539035|NCT00464815|473595765|FG000|Overall Study|Withdrawal by Subject|6|||
131539036|NCT00464815|473595766|FG001|Overall Study|Withdrawal by Subject|3|||
131539037|NCT00254982|473595767|FG000|Overall Study|Other|2|||
131539038|NCT00254982|473595768|FG001|Overall Study|Other|1|||
131539039|NCT00254982|473595767|FG000|Overall Study|Lack of Efficacy|5|||
131539040|NCT00254982|473595768|FG001|Overall Study|Lack of Efficacy|3|||
131539041|NCT00254982|473595767|FG000|Overall Study|Lost to Follow-up|5|||
131539042|NCT00254982|473595768|FG001|Overall Study|Lost to Follow-up|3|||
131539043|NCT00254982|473595767|FG000|Overall Study|Adverse Event|18|||
131539044|NCT00254982|473595768|FG001|Overall Study|Adverse Event|16|||
131539045|NCT00254982|473595767|FG000|Overall Study|Withdrawal by Subject|1|||
131539046|NCT00254982|473595768|FG001|Overall Study|Withdrawal by Subject|1|||
131539047|NCT00254982|473595767|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
131539048|NCT00254982|473595768|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
131539049|NCT00254982|473595767|FG000|Overall Study|Protocol deviation|1|||
131539050|NCT00254982|473595768|FG001|Overall Study|Protocol deviation|1|||
131539051|NCT00254982|473595767|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
131539052|NCT00254982|473595768|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
131539053|NCT00254982|473595767|FG000|Overall Study|Malignancy|0|||
131539054|NCT00254982|473595768|FG001|Overall Study|Malignancy|2|||
131539055|NCT00254982|473595767|FG000|Overall Study|Opportunistic infection|1|||
131539056|NCT00254982|473595768|FG001|Overall Study|Opportunistic infection|0|||
131539057|NCT00254982|473595767|FG000|Overall Study|Abnormal liver function tests|2|||
131539058|NCT00254982|473595768|FG001|Overall Study|Abnormal liver function tests|1|||
131539059|NCT01613248|473595771|FG000|Overall Study|Adverse Event|0|||
131539060|NCT01613248|473595772|FG001|Overall Study|Adverse Event|0|||
131539061|NCT01613248|473595773|FG002|Overall Study|Adverse Event|0|||
131539062|NCT01613248|473595774|FG003|Overall Study|Adverse Event|1|||
131539063|NCT01613248|473595775|FG004|Overall Study|Adverse Event|0|||
131539064|NCT01613248|473595776|FG005|Overall Study|Adverse Event|0|||
131539065|NCT01613248|473595771|FG000|Overall Study|Withdrawal by Subject|3|||
131539066|NCT01613248|473595772|FG001|Overall Study|Withdrawal by Subject|2|||
131539067|NCT01613248|473595773|FG002|Overall Study|Withdrawal by Subject|2|||
131539068|NCT01613248|473595774|FG003|Overall Study|Withdrawal by Subject|5|||
131539069|NCT01613248|473595775|FG004|Overall Study|Withdrawal by Subject|0|||
131539070|NCT01613248|473595776|FG005|Overall Study|Withdrawal by Subject|1|||
131539071|NCT01613248|473595771|FG000|Overall Study|Lost to Follow-up|5|||
131539072|NCT01613248|473595772|FG001|Overall Study|Lost to Follow-up|7|||
131539073|NCT01613248|473595773|FG002|Overall Study|Lost to Follow-up|4|||
131539074|NCT01613248|473595774|FG003|Overall Study|Lost to Follow-up|8|||
131539075|NCT01613248|473595775|FG004|Overall Study|Lost to Follow-up|4|||
131539076|NCT01613248|473595776|FG005|Overall Study|Lost to Follow-up|2|||
131539077|NCT01613248|473595771|FG000|Overall Study|Study Terminated by Sponsor|4|||
131539078|NCT01613248|473595772|FG001|Overall Study|Study Terminated by Sponsor|6|||
131539079|NCT01613248|473595773|FG002|Overall Study|Study Terminated by Sponsor|8|||
131539080|NCT01613248|473595774|FG003|Overall Study|Study Terminated by Sponsor|8|||
131539081|NCT01613248|473595775|FG004|Overall Study|Study Terminated by Sponsor|9|||
131539082|NCT01613248|473595776|FG005|Overall Study|Study Terminated by Sponsor|11|||
131539083|NCT01613248|473595771|FG000|Overall Study|Physician Decision|8|||
131539084|NCT01613248|473595772|FG001|Overall Study|Physician Decision|8|||
131539085|NCT01613248|473595773|FG002|Overall Study|Physician Decision|9|||
131539086|NCT01613248|473595774|FG003|Overall Study|Physician Decision|4|||
131539087|NCT01613248|473595775|FG004|Overall Study|Physician Decision|7|||
131539088|NCT01613248|473595776|FG005|Overall Study|Physician Decision|6|||
131539089|NCT01613248|473595771|FG000|Overall Study|Lack of Qualifying Event|9|||
131539090|NCT01613248|473595772|FG001|Overall Study|Lack of Qualifying Event|11|||
131539091|NCT01613248|473595773|FG002|Overall Study|Lack of Qualifying Event|10|||
131539092|NCT01613248|473595774|FG003|Overall Study|Lack of Qualifying Event|11|||
131539093|NCT01613248|473595775|FG004|Overall Study|Lack of Qualifying Event|15|||
131539094|NCT01613248|473595776|FG005|Overall Study|Lack of Qualifying Event|18|||
131539095|NCT01613248|473595771|FG000|Overall Study|Pregnancy|0|||
131539096|NCT01613248|473595772|FG001|Overall Study|Pregnancy|0|||
131539097|NCT01613248|473595773|FG002|Overall Study|Pregnancy|0|||
131539098|NCT01613248|473595774|FG003|Overall Study|Pregnancy|1|||
131539099|NCT01613248|473595775|FG004|Overall Study|Pregnancy|0|||
131539100|NCT01613248|473595776|FG005|Overall Study|Pregnancy|0|||
131539101|NCT02015676|473595781|FG000|Overall Study|Adverse Event|2|||
131539102|NCT02015676|473595782|FG001|Overall Study|Adverse Event|18|||
131539103|NCT02015676|473595783|FG002|Overall Study|Adverse Event|0|||
131539104|NCT02015676|473595781|FG000|Overall Study|Lack of Efficacy|2|||
131539105|NCT02015676|473595782|FG001|Overall Study|Lack of Efficacy|4|||
131539106|NCT02015676|473595783|FG002|Overall Study|Lack of Efficacy|0|||
131539107|NCT02015676|473595781|FG000|Overall Study|Protocol Violation|1|||
131539108|NCT02015676|473595782|FG001|Overall Study|Protocol Violation|0|||
131539109|NCT02015676|473595783|FG002|Overall Study|Protocol Violation|0|||
131539110|NCT02015676|473595781|FG000|Overall Study|Withdrawal by Subject|1|||
131539111|NCT02015676|473595782|FG001|Overall Study|Withdrawal by Subject|7|||
131539112|NCT02015676|473595783|FG002|Overall Study|Withdrawal by Subject|1|||
131539113|NCT02015676|473595781|FG000|Overall Study|Administrative reasons|0|||
131539114|NCT02015676|473595782|FG001|Overall Study|Administrative reasons|3|||
131539115|NCT02015676|473595783|FG002|Overall Study|Administrative reasons|1|||
131539116|NCT02015676|473595781|FG000|Overall Study|Death|0|||
131539117|NCT02015676|473595782|FG001|Overall Study|Death|1|||
131539118|NCT02015676|473595783|FG002|Overall Study|Death|0|||
131539119|NCT02015676|473595781|FG000|Overall Study|Disease progression|3|||
131539120|NCT02015676|473595782|FG001|Overall Study|Disease progression|1|||
131539121|NCT02015676|473595783|FG002|Overall Study|Disease progression|1|||
131539122|NCT00971048|473595788|FG000|Overall Study|Protocol Violation|1|||
131539123|NCT00971048|473595789|FG001|Overall Study|Protocol Violation|2|||
131539124|NCT00971048|473595790|FG002|Overall Study|Protocol Violation|0|||
131539125|NCT00971048|473595791|FG003|Overall Study|Protocol Violation|1|||
131539126|NCT00971048|473595788|FG000|Overall Study|Adverse Event|0|||
131539127|NCT00971048|473595789|FG001|Overall Study|Adverse Event|0|||
131539128|NCT00971048|473595790|FG002|Overall Study|Adverse Event|1|||
131539129|NCT00971048|473595791|FG003|Overall Study|Adverse Event|0|||
131539130|NCT00971048|473595788|FG000|Overall Study|Physician Decision|0|||
131539131|NCT00971048|473595789|FG001|Overall Study|Physician Decision|0|||
131539132|NCT00971048|473595790|FG002|Overall Study|Physician Decision|0|||
131539133|NCT00971048|473595791|FG003|Overall Study|Physician Decision|1|||
131539134|NCT03321396|473595792|FG000|Overall Study|Physician Decision|1|||
131539135|NCT01654549|473595793|FG000|Overall Study|H.pylori eradication not successful|0|||
131539136|NCT01654549|473595794|FG001|Overall Study|H.pylori eradication not successful|1|||
131539137|NCT01869491|473595795|FG000|Overall Study|Adverse Event|3|||
131539138|NCT01869491|473595796|FG001|Overall Study|Adverse Event|5|||
131539139|NCT01869491|473595795|FG000|Overall Study|Lack of Efficacy|0|||
131539140|NCT01869491|473595796|FG001|Overall Study|Lack of Efficacy|3|||
131539141|NCT01869491|473595795|FG000|Overall Study|Withdrawal by Subject|6|||
131539142|NCT01869491|473595796|FG001|Overall Study|Withdrawal by Subject|7|||
131539143|NCT01869491|473595795|FG000|Overall Study|Lost to Follow-up|11|||
131539144|NCT01869491|473595796|FG001|Overall Study|Lost to Follow-up|9|||
131539145|NCT01869491|473595795|FG000|Overall Study|No further need of investigational product|1|||
131539146|NCT01869491|473595796|FG001|Overall Study|No further need of investigational product|0|||
131539147|NCT04009291|473595797|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
131539148|NCT04009291|473595798|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
131539149|NCT04009291|473595799|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
131539150|NCT04009291|473595800|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
131539151|NCT04009291|473595801|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
131539152|NCT04009291|473595797|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
131539153|NCT04009291|473595798|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
131539154|NCT04009291|473595799|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
131539155|NCT04009291|473595800|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
131539156|NCT04009291|473595801|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
131539157|NCT05553808|473595804|FG000|Overall Study|Death|25|||
131539158|NCT05553808|473595805|FG001|Overall Study|Death|62|||
131539159|NCT05553808|473595804|FG000|Overall Study|Site Closed|6|||
131539160|NCT05553808|473595805|FG001|Overall Study|Site Closed|6|||
131539161|NCT05553808|473595804|FG000|Overall Study|Lost to Follow-up|1|||
131539162|NCT05553808|473595805|FG001|Overall Study|Lost to Follow-up|0|||
131539163|NCT05553808|473595804|FG000|Overall Study|Withdrawal by Subject|3|||
131539164|NCT05553808|473595805|FG001|Overall Study|Withdrawal by Subject|2|||
131539165|NCT00989287|473595808|FG000|Overall Study|Adverse Event|1|||
131539166|NCT00989287|473595809|FG001|Overall Study|Adverse Event|0|||
131539167|NCT00989287|473595808|FG000|Overall Study|Lost to Follow-up|0|||
131539168|NCT00989287|473595809|FG001|Overall Study|Lost to Follow-up|1|||
131539169|NCT00729833|473595810|FG000|Overall Study|Death|5|||
131539170|NCT00729833|473595811|FG001|Overall Study|Death|1|||
131539171|NCT00729833|473595812|FG002|Overall Study|Death|3|||
131539172|NCT00729833|473595813|FG003|Overall Study|Death|5|||
131539173|NCT00729833|473595810|FG000|Overall Study|Study Terminated by Sponsor|0|||
131539174|NCT00729833|473595811|FG001|Overall Study|Study Terminated by Sponsor|0|||
131539175|NCT00729833|473595812|FG002|Overall Study|Study Terminated by Sponsor|1|||
131539176|NCT00729833|473595813|FG003|Overall Study|Study Terminated by Sponsor|0|||
131539177|NCT00729833|473595810|FG000|Overall Study|Lost to Follow-up|1|||
131539178|NCT00729833|473595811|FG001|Overall Study|Lost to Follow-up|0|||
131539179|NCT00729833|473595812|FG002|Overall Study|Lost to Follow-up|0|||
131539180|NCT00729833|473595813|FG003|Overall Study|Lost to Follow-up|0|||
131539181|NCT00729833|473595810|FG000|Overall Study|Withdrawal by Subject|3|||
131539182|NCT00729833|473595811|FG001|Overall Study|Withdrawal by Subject|1|||
131539183|NCT00729833|473595812|FG002|Overall Study|Withdrawal by Subject|3|||
131539184|NCT00729833|473595813|FG003|Overall Study|Withdrawal by Subject|0|||
131539185|NCT00729833|473595810|FG000|Overall Study|Unspecified Reasons|11|||
131539186|NCT00729833|473595811|FG001|Overall Study|Unspecified Reasons|5|||
131539187|NCT00729833|473595812|FG002|Overall Study|Unspecified Reasons|5|||
131539188|NCT00729833|473595813|FG003|Overall Study|Unspecified Reasons|1|||
131539189|NCT01041638|473595814|FG000|Overall Study|Adverse Event|4|||
131539190|NCT01041638|473595814|FG000|Overall Study|Death|1|||
131539191|NCT01041638|473595814|FG000|Overall Study|Lack of Efficacy|7|||
131539192|NCT01041638|473595814|FG000|Overall Study|Physician Decision|4|||
131539193|NCT01041638|473595814|FG000|Overall Study|Withdrawal by Subject|11|||
131539194|NCT00417079|473595815|FG000|Overall Study|Disease progression|267|||
131539195|NCT00417079|473595816|FG001|Overall Study|Disease progression|180|||
131539196|NCT00417079|473595815|FG000|Overall Study|Adverse Event|32|||
131539197|NCT00417079|473595816|FG001|Overall Study|Adverse Event|67|||
131539198|NCT00417079|473595815|FG000|Overall Study|Non-compliance to protocol|0|||
131539199|NCT00417079|473595816|FG001|Overall Study|Non-compliance to protocol|1|||
131539200|NCT00417079|473595815|FG000|Overall Study|Lost to Follow-up|2|||
131539201|NCT00417079|473595816|FG001|Overall Study|Lost to Follow-up|0|||
131539202|NCT00417079|473595815|FG000|Overall Study|Withdrawal by Subject|17|||
131539203|NCT00417079|473595816|FG001|Overall Study|Withdrawal by Subject|8|||
131539204|NCT00417079|473595815|FG000|Overall Study|Not treated|6|||
131539205|NCT00417079|473595816|FG001|Overall Study|Not treated|7|||
131539206|NCT00417079|473595815|FG000|Overall Study|Screened failure|2|||
131539207|NCT00417079|473595816|FG001|Overall Study|Screened failure|1|||
131539208|NCT00417079|473595815|FG000|Overall Study|Investigator's decision|1|||
131539209|NCT00417079|473595816|FG001|Overall Study|Investigator's decision|4|||
131539210|NCT00417079|473595815|FG000|Overall Study|Non-confirmed Disease progression|1|||
131539211|NCT00417079|473595816|FG001|Overall Study|Non-confirmed Disease progression|1|||
131539212|NCT00417079|473595815|FG000|Overall Study|Clinical deterioration|1|||
131539213|NCT00417079|473595816|FG001|Overall Study|Clinical deterioration|0|||
131539214|NCT00417079|473595815|FG000|Overall Study|Screening error|2|||
131539215|NCT00417079|473595816|FG001|Overall Study|Screening error|1|||
131539216|NCT00417079|473595815|FG000|Overall Study|Withdrawal by subject's family|0|||
131539217|NCT00417079|473595816|FG001|Overall Study|Withdrawal by subject's family|1|||
131539218|NCT00417079|473595815|FG000|Overall Study|Patient unable to come to the clinic|0|||
131539219|NCT00417079|473595816|FG001|Overall Study|Patient unable to come to the clinic|1|||
131539220|NCT00417079|473595815|FG000|Overall Study|abnormal liver function tests|0|||
131539221|NCT00417079|473595816|FG001|Overall Study|abnormal liver function tests|1|||
131539222|NCT01687257|473595818|FG000|Overall Study|Efficacy Failure|6|||
131539223|NCT01687257|473595819|FG001|Overall Study|Efficacy Failure|0|||
131539224|NCT01687257|473595820|FG002|Overall Study|Efficacy Failure|5|||
131539225|NCT01687257|473595818|FG000|Overall Study|Subject Withdrew Consent|1|||
131539226|NCT01687257|473595819|FG001|Overall Study|Subject Withdrew Consent|1|||
131539227|NCT01687257|473595820|FG002|Overall Study|Subject Withdrew Consent|1|||
131539228|NCT01687257|473595818|FG000|Overall Study|Adverse Event|1|||
131539229|NCT01687257|473595819|FG001|Overall Study|Adverse Event|0|||
131539230|NCT01687257|473595820|FG002|Overall Study|Adverse Event|0|||
131539231|NCT01687257|473595818|FG000|Overall Study|Investigator's Discretion|0|||
131539232|NCT01687257|473595819|FG001|Overall Study|Investigator's Discretion|3|||
131539233|NCT01687257|473595820|FG002|Overall Study|Investigator's Discretion|0|||
131539234|NCT04403698|473595822|FG000|Overall Study|Adverse Event|1|||
131539235|NCT04403698|473595823|FG001|Overall Study|Adverse Event|1|||
131539236|NCT04403698|473595822|FG000|Overall Study|Lost to Follow-up|1|||
131539237|NCT04403698|473595823|FG001|Overall Study|Lost to Follow-up|0|||
131539238|NCT04403698|473595822|FG000|Overall Study|Protocol Violation|0|||
131539239|NCT04403698|473595823|FG001|Overall Study|Protocol Violation|1|||
131539240|NCT03152552|473595824|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
131539241|NCT03152552|473595825|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
131539242|NCT03152552|473595826|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
131539243|NCT03152552|473595827|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
131539244|NCT03152552|473595828|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
131539245|NCT03152552|473595824|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
131539246|NCT03152552|473595825|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
131539247|NCT03152552|473595826|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
131539248|NCT03152552|473595827|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
131539249|NCT03152552|473595828|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
131539250|NCT03152552|473595824|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
131539251|NCT03152552|473595825|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
131539252|NCT03152552|473595826|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
131539253|NCT03152552|473595827|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
131539254|NCT03152552|473595828|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
131539255|NCT03152552|473595824|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131539256|NCT03152552|473595825|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131539257|NCT03152552|473595826|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131539258|NCT03152552|473595827|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131539259|NCT03152552|473595828|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131658525|NCT01142232|474035353|FG002|Overall Study|Alternative Therapy|1|||
131539260|NCT03152552|473595824|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
131539261|NCT03152552|473595825|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
131539262|NCT03152552|473595826|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
131539263|NCT03152552|473595827|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
131539264|NCT03152552|473595828|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
131539265|NCT03152552|473595824|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
131539266|NCT03152552|473595825|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
131539267|NCT03152552|473595826|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
131539268|NCT03152552|473595827|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
131539269|NCT03152552|473595828|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
131539270|NCT03152552|473595824|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
131539271|NCT03152552|473595825|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
131539272|NCT03152552|473595826|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
131539273|NCT03152552|473595827|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
131539274|NCT03152552|473595828|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
131539275|NCT04899349|473595831|FG000|Overall Study|Study terminated by Sponsor|2|||
131539276|NCT04899349|473595832|FG001|Overall Study|Study terminated by Sponsor|0|||
131539277|NCT01022762|473595834|FG000|Overall Study|Adverse Event|3|||
131539278|NCT01022762|473595835|FG001|Overall Study|Adverse Event|1|||
131539279|NCT01022762|473595834|FG000|Overall Study|Lack of Efficacy|0|||
131539280|NCT01022762|473595835|FG001|Overall Study|Lack of Efficacy|1|||
131539281|NCT01022762|473595834|FG000|Overall Study|Protocol Violation|7|||
131539282|NCT01022762|473595835|FG001|Overall Study|Protocol Violation|6|||
131539283|NCT01022762|473595834|FG000|Overall Study|Unclassified|12|||
131539284|NCT01022762|473595835|FG001|Overall Study|Unclassified|20|||
131539285|NCT01302119|473595836|FG000|Overall Study|Withdrawal by Subject|30|||
131539286|NCT01302119|473595837|FG001|Overall Study|Withdrawal by Subject|20|||
131539287|NCT01302119|473595836|FG000|Overall Study|Lost to Follow-up|10|||
131539288|NCT01302119|473595837|FG001|Overall Study|Lost to Follow-up|4|||
131539289|NCT01302119|473595836|FG000|Overall Study|Adverse Event|2|||
131539290|NCT01302119|473595837|FG001|Overall Study|Adverse Event|1|||
131539291|NCT01302119|473595836|FG000|Overall Study|Non-compliance|4|||
131539292|NCT01302119|473595837|FG001|Overall Study|Non-compliance|2|||
131539293|NCT01302119|473595836|FG000|Overall Study|Non-specific|4|||
131539294|NCT01302119|473595837|FG001|Overall Study|Non-specific|1|||
131539295|NCT04084314|473595841|FG000|Overall Study|Subject/guardian decision|91|||
131539296|NCT04084314|473595841|FG000|Overall Study|Adverse Event|24|||
131539297|NCT04084314|473595841|FG000|Overall Study|Lost to Follow-up|19|||
131539298|NCT04084314|473595841|FG000|Overall Study|New therapy for study indication|9|||
131539299|NCT04084314|473595841|FG000|Overall Study|Pregnancy|9|||
131539300|NCT04084314|473595841|FG000|Overall Study|Withdrawal of informed consent|8|||
131539301|NCT04084314|473595841|FG000|Overall Study|Physician Decision|4|||
131539302|NCT04084314|473595841|FG000|Overall Study|Protocol Deviation|3|||
131539303|NCT00802074|473595842|FG000|Overall Study|Adverse Event|1|||
131539304|NCT00802074|473595843|FG001|Overall Study|Adverse Event|1|||
131539305|NCT00802074|473595844|FG002|Overall Study|Adverse Event|1|||
131539306|NCT00802074|473595845|FG003|Overall Study|Adverse Event|0|||
131539307|NCT00802074|473595846|FG004|Overall Study|Adverse Event|0|||
131539308|NCT00802074|473595847|FG005|Overall Study|Adverse Event|0|||
131539309|NCT00802074|473595842|FG000|Overall Study|Withdrawal by Subject|1|||
131539310|NCT00802074|473595843|FG001|Overall Study|Withdrawal by Subject|0|||
131539311|NCT00802074|473595844|FG002|Overall Study|Withdrawal by Subject|0|||
131539312|NCT00802074|473595845|FG003|Overall Study|Withdrawal by Subject|0|||
131539313|NCT00802074|473595846|FG004|Overall Study|Withdrawal by Subject|0|||
131539314|NCT00802074|473595847|FG005|Overall Study|Withdrawal by Subject|0|||
131539315|NCT03336619|473595848|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
131539316|NCT03336619|473595849|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
131539317|NCT03336619|473595848|FG000|Overall Study|Withdrawal by Subject|17|||
131539318|NCT03336619|473595849|FG001|Overall Study|Withdrawal by Subject|16|||
131539319|NCT03336619|473595848|FG000|Overall Study|Adverse Event|2|||
131539320|NCT03336619|473595849|FG001|Overall Study|Adverse Event|5|||
131539321|NCT03336619|473595848|FG000|Overall Study|Physician Decision|3|||
131539322|NCT03336619|473595849|FG001|Overall Study|Physician Decision|0|||
131539323|NCT03743038|473595850|FG000|Overall Study|Physician Decision|1|||
131539324|NCT01300546|473595851|FG000|Overall Study|Withdrawal by Subject|1|||
131539325|NCT01300546|473595852|FG001|Overall Study|Withdrawal by Subject|0|||
131539326|NCT01300546|473595851|FG000|Overall Study|Lost to Follow-up|0|||
131539327|NCT01300546|473595852|FG001|Overall Study|Lost to Follow-up|2|||
131539328|NCT01300546|473595851|FG000|Overall Study|Lack of Efficacy|0|||
131539329|NCT01300546|473595852|FG001|Overall Study|Lack of Efficacy|3|||
131539330|NCT01300546|473595851|FG000|Overall Study|Adverse Event|0|||
131539331|NCT01300546|473595852|FG001|Overall Study|Adverse Event|1|||
131539332|NCT02820623|473595853|FG000|Overall Study|Withdrawal by Subject|1|||
131539333|NCT02820623|473595854|FG001|Overall Study|Withdrawal by Subject|3|||
131539334|NCT02820623|473595855|FG002|Overall Study|Withdrawal by Subject|3|||
131539335|NCT02820623|473595853|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
131539336|NCT02820623|473595854|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
131539337|NCT02820623|473595855|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
131539338|NCT02820623|473595853|FG000|Overall Study|Therapist unable to enroll clients|1|||
131539339|NCT02820623|473595854|FG001|Overall Study|Therapist unable to enroll clients|1|||
131539340|NCT02820623|473595855|FG002|Overall Study|Therapist unable to enroll clients|3|||
131539341|NCT02820623|473595853|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
131539342|NCT02820623|473595854|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
131539343|NCT02820623|473595855|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
131539344|NCT01965834|473595856|FG000|Overall Study|Lack of Efficacy|4|||
131539345|NCT04988308|473595857|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
131539346|NCT04988308|473595858|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
131539347|NCT04988308|473595859|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
131539348|NCT04988308|473595860|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
131539349|NCT04988308|473595861|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
131539350|NCT04988308|473595862|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
131539351|NCT04988308|473595857|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
131539352|NCT04988308|473595858|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
131539353|NCT04988308|473595859|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
131539354|NCT04988308|473595860|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
131539355|NCT04988308|473595861|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
131539356|NCT04988308|473595862|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
131539357|NCT04988308|473595857|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
131539358|NCT04988308|473595858|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
131539359|NCT04988308|473595859|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
131539360|NCT04988308|473595860|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
131539361|NCT04988308|473595861|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
131539362|NCT04988308|473595862|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
131539363|NCT04988308|473595857|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
131539364|NCT04988308|473595858|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
131539365|NCT04988308|473595859|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
131539366|NCT04988308|473595860|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
131539367|NCT04988308|473595861|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
131539368|NCT04988308|473595862|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
131539369|NCT04988308|473595857|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
131539370|NCT04988308|473595858|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
131539371|NCT04988308|473595859|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
131539372|NCT04988308|473595860|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
131539373|NCT04988308|473595861|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
131539374|NCT04988308|473595862|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
131539375|NCT04988308|473595857|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131539376|NCT04988308|473595858|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131539377|NCT04988308|473595859|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131539378|NCT04988308|473595860|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
131539379|NCT04988308|473595861|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
131539380|NCT04988308|473595862|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
131539381|NCT04988308|473595857|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131539382|NCT04988308|473595858|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131539383|NCT04988308|473595859|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131539384|NCT04988308|473595860|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
131539385|NCT04988308|473595861|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
131539386|NCT04988308|473595862|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
131539387|NCT04988308|473595857|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131539388|NCT04988308|473595858|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131539389|NCT04988308|473595859|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
131539390|NCT04988308|473595860|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
131539391|NCT04988308|473595861|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
131539392|NCT04988308|473595862|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
131539393|NCT04988308|473595857|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
131539394|NCT04988308|473595858|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
131539395|NCT04988308|473595859|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
131539396|NCT04988308|473595860|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
131539397|NCT04988308|473595861|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
131539398|NCT04988308|473595862|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
131539399|NCT02625623|473595871|FG000|Overall Study|Participants randomized but not treated|9|||
131539400|NCT02625623|473595872|FG001|Overall Study|Participants randomized but not treated|1|||
131539401|NCT00744653|473595873|FG000|Overall Study|antineoplastic treatment|11|||
131539402|NCT00744653|473595873|FG000|Overall Study|Death|1|||
131539403|NCT00744653|473595873|FG000|Overall Study|Lost to Follow-up|1|||
131539404|NCT00744653|473595873|FG000|Overall Study|Physician Decision|3|||
131539405|NCT03826667|473595876|FG000|Overall Study|Protocol deviation|21|||
131539406|NCT00808808|473595877|FG000|Overall Study|Vaccinated; survey not completed|131|||
131539407|NCT00808808|473595878|FG001|Overall Study|Vaccinated; survey not completed|169|||
131539408|NCT00808808|473595879|FG002|Overall Study|Vaccinated; survey not completed|302|||
131539409|NCT00808808|473595877|FG000|Overall Study|Employee was not vaccinated.|2686|||
131539410|NCT00808808|473595878|FG001|Overall Study|Employee was not vaccinated.|2268|||
131539411|NCT00808808|473595879|FG002|Overall Study|Employee was not vaccinated.|2255|||
131539412|NCT00617344|473595880|FG000|Overall Study|Serious adverse event|1|||
131539413|NCT00617344|473595881|FG001|Overall Study|Serious adverse event|0|||
131539414|NCT00617344|473595882|FG002|Overall Study|Serious adverse event|0|||
131539415|NCT00617344|473595880|FG000|Overall Study|Other Adverse Event|1|||
131539416|NCT00617344|473595881|FG001|Overall Study|Other Adverse Event|1|||
131539417|NCT00617344|473595882|FG002|Overall Study|Other Adverse Event|0|||
131539418|NCT00617344|473595880|FG000|Overall Study|Protocol Violation|10|||
131539419|NCT00617344|473595881|FG001|Overall Study|Protocol Violation|8|||
131539420|NCT00617344|473595882|FG002|Overall Study|Protocol Violation|5|||
131539421|NCT00617344|473595880|FG000|Overall Study|Lost to Follow-up|5|||
131539422|NCT00617344|473595881|FG001|Overall Study|Lost to Follow-up|4|||
131539423|NCT00617344|473595882|FG002|Overall Study|Lost to Follow-up|1|||
131539424|NCT00617344|473595880|FG000|Overall Study|Withdrawal by Subject|8|||
131539425|NCT00617344|473595881|FG001|Overall Study|Withdrawal by Subject|9|||
131539426|NCT00617344|473595882|FG002|Overall Study|Withdrawal by Subject|2|||
131539427|NCT02352948|473595884|FG000|Overall Study|Death|47|||
131539428|NCT02352948|473595885|FG001|Overall Study|Death|48|||
131539429|NCT02352948|473595886|FG002|Overall Study|Death|114|||
131539430|NCT02352948|473595887|FG003|Overall Study|Death|74|||
131539431|NCT02352948|473595888|FG004|Overall Study|Death|77|||
131539432|NCT02352948|473595889|FG005|Overall Study|Death|44|||
131539433|NCT02352948|473595884|FG000|Overall Study|Lost to Follow-up|1|||
131539434|NCT02352948|473595885|FG001|Overall Study|Lost to Follow-up|0|||
131539435|NCT02352948|473595886|FG002|Overall Study|Lost to Follow-up|2|||
131539436|NCT02352948|473595887|FG003|Overall Study|Lost to Follow-up|1|||
131539437|NCT02352948|473595888|FG004|Overall Study|Lost to Follow-up|2|||
131539438|NCT02352948|473595889|FG005|Overall Study|Lost to Follow-up|1|||
131539439|NCT02352948|473595884|FG000|Overall Study|Withdrawal by Subject|1|||
131539440|NCT02352948|473595885|FG001|Overall Study|Withdrawal by Subject|10|||
131539441|NCT02352948|473595886|FG002|Overall Study|Withdrawal by Subject|11|||
131539442|NCT02352948|473595887|FG003|Overall Study|Withdrawal by Subject|23|||
131539443|NCT02352948|473595888|FG004|Overall Study|Withdrawal by Subject|9|||
131539444|NCT02352948|473595889|FG005|Overall Study|Withdrawal by Subject|4|||
131539445|NCT02352948|473595884|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131539446|NCT02352948|473595885|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131539447|NCT02352948|473595886|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
131539448|NCT02352948|473595887|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
131539449|NCT02352948|473595888|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
131539450|NCT02352948|473595889|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
131539451|NCT02352948|473595884|FG000|Overall Study|Other|0|||
131539452|NCT02352948|473595885|FG001|Overall Study|Other|0|||
131539453|NCT02352948|473595886|FG002|Overall Study|Other|2|||
131539454|NCT02352948|473595887|FG003|Overall Study|Other|0|||
131539455|NCT02352948|473595888|FG004|Overall Study|Other|0|||
131539456|NCT02352948|473595889|FG005|Overall Study|Other|0|||
131539457|NCT01453595|473595891|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131539458|NCT01453595|473595892|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131539459|NCT01453595|473595893|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131539460|NCT00941330|473595894|FG000|Overall Study|Other|1|||
131539461|NCT00941330|473595895|FG001|Overall Study|Other|0|||
131539462|NCT00941330|473595894|FG000|Overall Study|Physician Decision|0|||
131539463|NCT00941330|473595895|FG001|Overall Study|Physician Decision|2|||
131539464|NCT00506493|473595898|FG000|Overall Study|Death|6|||
131539465|NCT00506493|473595898|FG000|Overall Study|Withdrawal by Subject|5|||
131539466|NCT02943408|473597661|FG000|Overall Study|Lost to Follow-up|7|||
131539467|NCT02943408|473597662|FG001|Overall Study|Lost to Follow-up|1|||
131539468|NCT02943408|473597661|FG000|Overall Study|Withdrawal by Subject|0|||
131539469|NCT02943408|473597662|FG001|Overall Study|Withdrawal by Subject|1|||
131539470|NCT01621126|473597665|FG000|Overall Study|Physician Decision|6|||
131539471|NCT00886340|473597667|FG000|Overall Study|Withdrawal by Subject|0|||
131539472|NCT00886340|473597668|FG001|Overall Study|Withdrawal by Subject|7|||
131539473|NCT01949311|473597669|FG000|Overall Study|Lost to Follow-up|73|||
131539474|NCT01949311|473597669|FG000|Overall Study|Terminated by Sponsor|708|||
131539475|NCT01949311|473597669|FG000|Overall Study|Withdrawal by Subject|375|||
131539476|NCT01949311|473597669|FG000|Overall Study|Lack of Efficacy|50|||
131539477|NCT01949311|473597669|FG000|Overall Study|Protocol Deviation|34|||
131539478|NCT01949311|473597669|FG000|Overall Study|Pregnancy|20|||
131539479|NCT01949311|473597669|FG000|Overall Study|Physician Decision|9|||
131539480|NCT01949311|473597669|FG000|Overall Study|Other|4|||
131539481|NCT01949311|473597669|FG000|Overall Study|Adverse Event|107|||
131539482|NCT02338154|473597670|FG000|Overall Study|Death|46|||
131539483|NCT02338154|473597670|FG000|Overall Study|Valve Implant Failure|17|||
131539484|NCT02338154|473597670|FG000|Overall Study|Valve Explant|11|||
131539485|NCT02338154|473597670|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
131539486|NCT02338154|473597670|FG000|Overall Study|Lost to Follow-up|8|||
131539487|NCT02338154|473597670|FG000|Overall Study|Other Reason|3|||
131539488|NCT02338154|473597670|FG000|Overall Study|Patients Without Exit Form|47|||
131539489|NCT02338154|473597670|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
131539490|NCT02120027|473597673|FG000|Overall Study|Adverse Event|4|||
131539491|NCT02120027|473597674|FG001|Overall Study|Adverse Event|5|||
131539492|NCT02120027|473597673|FG000|Overall Study|Lack of Efficacy|3|||
131539493|NCT02120027|473597674|FG001|Overall Study|Lack of Efficacy|5|||
131539494|NCT02120027|473597673|FG000|Overall Study|Lost to Follow-up|5|||
131539495|NCT02120027|473597674|FG001|Overall Study|Lost to Follow-up|13|||
131539496|NCT02120027|473597673|FG000|Overall Study|Other|4|||
131539497|NCT02120027|473597674|FG001|Overall Study|Other|0|||
131539498|NCT02120027|473597673|FG000|Overall Study|Physician Decision|4|||
131539499|NCT02120027|473597674|FG001|Overall Study|Physician Decision|3|||
131539500|NCT02120027|473597673|FG000|Overall Study|Protocol Violation|18|||
131539501|NCT02120027|473597674|FG001|Overall Study|Protocol Violation|21|||
131539502|NCT02120027|473597673|FG000|Overall Study|Study terminated by Sponsor|45|||
131539503|NCT02120027|473597674|FG001|Overall Study|Study terminated by Sponsor|47|||
131539504|NCT02120027|473597673|FG000|Overall Study|Withdrawal by Subject|33|||
131539505|NCT02120027|473597674|FG001|Overall Study|Withdrawal by Subject|25|||
131539506|NCT01925950|473597680|FG000|Part 2|Withdrawal by Subject|1|||
131539507|NCT01925950|473597681|FG001|Part 2|Withdrawal by Subject|0|||
131539508|NCT00381940|473597682|FG000|Overall Study|Lack of Efficacy|3|||
131539509|NCT00381940|473597682|FG000|Overall Study|Protocol Violation|1|||
131539510|NCT00381940|473597682|FG000|Overall Study|Ineligible|1|||
131539511|NCT03162224|473597683|FG000|Overall Study|Death|4|||
131539512|NCT03162224|473597684|FG001|Overall Study|Death|5|||
131539513|NCT03162224|473597685|FG002|Overall Study|Death|8|||
131539514|NCT03162224|473597683|FG000|Overall Study|Withdrawal by Subject|1|||
131539515|NCT03162224|473597684|FG001|Overall Study|Withdrawal by Subject|0|||
131539516|NCT03162224|473597685|FG002|Overall Study|Withdrawal by Subject|1|||
131539517|NCT03162224|473597683|FG000|Overall Study|Lost to Follow-up|0|||
131539518|NCT03162224|473597684|FG001|Overall Study|Lost to Follow-up|1|||
131539519|NCT03162224|473597685|FG002|Overall Study|Lost to Follow-up|0|||
131539520|NCT03162224|473597683|FG000|Overall Study|Other|6|||
131539521|NCT03162224|473597684|FG001|Overall Study|Other|2|||
131539522|NCT03162224|473597685|FG002|Overall Study|Other|1|||
131539523|NCT04162769|473597686|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
131539524|NCT04162769|473597687|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
131539525|NCT04162769|473597688|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
131539526|NCT04162769|473597689|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
131539527|NCT04162769|473597686|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
131539528|NCT04162769|473597687|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
131539529|NCT04162769|473597688|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
131539530|NCT04162769|473597689|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
131539531|NCT04162769|473597686|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
131539532|NCT04162769|473597687|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
131539533|NCT04162769|473597688|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
131539534|NCT04162769|473597689|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
131539535|NCT04162769|473597686|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
131539536|NCT04162769|473597687|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
131539537|NCT04162769|473597688|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
131539538|NCT04162769|473597689|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
131539539|NCT04162769|473597686|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
131539540|NCT04162769|473597687|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
131539541|NCT04162769|473597688|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
131539542|NCT04162769|473597689|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
131539543|NCT04162769|473597686|FG000|Double-blind Treatment (12-Week)|Other|0|||
131539544|NCT04162769|473597687|FG001|Double-blind Treatment (12-Week)|Other|1|||
131539545|NCT04162769|473597688|FG002|Double-blind Treatment (12-Week)|Other|1|||
131539546|NCT04162769|473597689|FG003|Double-blind Treatment (12-Week)|Other|0|||
131539547|NCT04162769|473597686|FG000|OLE Period (52-Week)|Adverse Event|0|||
131539548|NCT04162769|473597687|FG001|OLE Period (52-Week)|Adverse Event|0|||
131539549|NCT04162769|473597688|FG002|OLE Period (52-Week)|Adverse Event|0|||
131539550|NCT04162769|473597689|FG003|OLE Period (52-Week)|Adverse Event|5|||
131539551|NCT04162769|473597686|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
131539552|NCT04162769|473597687|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
131539553|NCT04162769|473597688|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
131539554|NCT04162769|473597689|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
131539555|NCT04162769|473597686|FG000|OLE Period (52-Week)|Physician Decision|0|||
131539556|NCT04162769|473597687|FG001|OLE Period (52-Week)|Physician Decision|0|||
131539557|NCT04162769|473597688|FG002|OLE Period (52-Week)|Physician Decision|0|||
131539558|NCT04162769|473597689|FG003|OLE Period (52-Week)|Physician Decision|1|||
131539559|NCT04162769|473597686|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
131539560|NCT04162769|473597687|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
131539561|NCT04162769|473597688|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
131539562|NCT04162769|473597689|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
131539563|NCT04162769|473597686|FG000|OLE Period (52-Week)|Protocol deviation|0|||
131539564|NCT04162769|473597687|FG001|OLE Period (52-Week)|Protocol deviation|0|||
131539565|NCT04162769|473597688|FG002|OLE Period (52-Week)|Protocol deviation|0|||
131539566|NCT04162769|473597689|FG003|OLE Period (52-Week)|Protocol deviation|2|||
131539567|NCT00725452|473597692|FG000|Overall Study|Adverse Event|3|||
131539568|NCT00725452|473597692|FG000|Overall Study|Lack of Efficacy|2|||
131539569|NCT00725452|473597692|FG000|Overall Study|Reason not specified|1|||
131539570|NCT00725452|473597692|FG000|Overall Study|Physician Decision|1|||
131539571|NCT00725452|473597692|FG000|Overall Study|Withdrawal by Subject|3|||
131539572|NCT00725452|473597692|FG000|Overall Study|Lost to Follow-up|1|||
131539573|NCT00620750|473597694|FG000|Overall Study|Lost to Follow-up|25|||
131539574|NCT04477187|473597695|FG000|Overall Study|Lost to Follow-up|2|||
131539575|NCT00746590|473597696|FG000|Overall Study|Death|1|||
131539576|NCT04402866|473597698|FG000|Overall Study|Discontinued Prior to Treatment|0|||
131539577|NCT04402866|473597699|FG001|Overall Study|Discontinued Prior to Treatment|0|||
131539578|NCT04402866|473597700|FG002|Overall Study|Discontinued Prior to Treatment|0|||
131539579|NCT04402866|473597701|FG003|Overall Study|Discontinued Prior to Treatment|0|||
131539580|NCT04402866|473597702|FG004|Overall Study|Discontinued Prior to Treatment|2|||
131539581|NCT04402866|473597703|FG005|Overall Study|Discontinued Prior to Treatment|3|||
131539582|NCT04402866|473597698|FG000|Overall Study|Adverse Event|2|||
131539583|NCT04402866|473597699|FG001|Overall Study|Adverse Event|1|||
131539584|NCT04402866|473597700|FG002|Overall Study|Adverse Event|0|||
131539585|NCT04402866|473597701|FG003|Overall Study|Adverse Event|0|||
131539586|NCT04402866|473597702|FG004|Overall Study|Adverse Event|13|||
131539587|NCT04402866|473597703|FG005|Overall Study|Adverse Event|8|||
131539588|NCT04402866|473597698|FG000|Overall Study|Miscellaneous|0|||
131539589|NCT04402866|473597699|FG001|Overall Study|Miscellaneous|0|||
131539590|NCT04402866|473597700|FG002|Overall Study|Miscellaneous|1|||
131539591|NCT04402866|473597701|FG003|Overall Study|Miscellaneous|0|||
131539592|NCT04402866|473597702|FG004|Overall Study|Miscellaneous|0|||
131539593|NCT04402866|473597703|FG005|Overall Study|Miscellaneous|0|||
131539594|NCT04402866|473597698|FG000|Overall Study|Lost to Follow-up|0|||
131539595|NCT04402866|473597699|FG001|Overall Study|Lost to Follow-up|0|||
131539596|NCT04402866|473597700|FG002|Overall Study|Lost to Follow-up|0|||
131539597|NCT04402866|473597701|FG003|Overall Study|Lost to Follow-up|0|||
131539598|NCT04402866|473597702|FG004|Overall Study|Lost to Follow-up|0|||
131539599|NCT04402866|473597703|FG005|Overall Study|Lost to Follow-up|1|||
131539600|NCT04402866|473597698|FG000|Overall Study|Withdrawal by Subject|0|||
131539601|NCT04402866|473597699|FG001|Overall Study|Withdrawal by Subject|0|||
131539602|NCT04402866|473597700|FG002|Overall Study|Withdrawal by Subject|0|||
131539603|NCT04402866|473597701|FG003|Overall Study|Withdrawal by Subject|0|||
131539604|NCT04402866|473597702|FG004|Overall Study|Withdrawal by Subject|0|||
131539605|NCT04402866|473597703|FG005|Overall Study|Withdrawal by Subject|2|||
131539606|NCT00476476|473597710|FG000|Overall Study|Adverse Event|2|||
131539607|NCT00476476|473597711|FG001|Overall Study|Adverse Event|7|||
131539608|NCT00476476|473597710|FG000|Overall Study|Progressive Disease|0|||
131539609|NCT00476476|473597711|FG001|Overall Study|Progressive Disease|17|||
131539610|NCT02633137|473597719|FG000|Overall Study|Adverse Event|1|||
131539611|NCT02633137|473597719|FG000|Overall Study|Lack of Efficacy|2|||
131539612|NCT02633137|473597719|FG000|Overall Study|Withdrawal by Subject|1|||
131539613|NCT01972841|473597722|FG000|Overall Study|Randomized but Never Received Treatment|2|||
131539614|NCT01972841|473597723|FG001|Overall Study|Randomized but Never Received Treatment|5|||
131539615|NCT01972841|473597724|FG002|Overall Study|Randomized but Never Received Treatment|4|||
131539616|NCT01972841|473597725|FG003|Overall Study|Randomized but Never Received Treatment|2|||
131539617|NCT01972841|473597726|FG004|Overall Study|Randomized but Never Received Treatment|6|||
131539618|NCT01972841|473597727|FG005|Overall Study|Randomized but Never Received Treatment|13|||
131539619|NCT01972841|473597722|FG000|Overall Study|Adverse Event|13|||
131539620|NCT01972841|473597723|FG001|Overall Study|Adverse Event|8|||
131539621|NCT01972841|473597724|FG002|Overall Study|Adverse Event|12|||
131539622|NCT01972841|473597725|FG003|Overall Study|Adverse Event|9|||
131539623|NCT01972841|473597726|FG004|Overall Study|Adverse Event|21|||
131539624|NCT01972841|473597727|FG005|Overall Study|Adverse Event|26|||
131539625|NCT01972841|473597722|FG000|Overall Study|Lack of Efficacy|1|||
131539626|NCT01972841|473597723|FG001|Overall Study|Lack of Efficacy|0|||
131539627|NCT01972841|473597724|FG002|Overall Study|Lack of Efficacy|0|||
131539628|NCT01972841|473597725|FG003|Overall Study|Lack of Efficacy|2|||
131539629|NCT01972841|473597726|FG004|Overall Study|Lack of Efficacy|4|||
131539630|NCT01972841|473597727|FG005|Overall Study|Lack of Efficacy|1|||
131539631|NCT01972841|473597722|FG000|Overall Study|Lost to Follow-up|4|||
131539632|NCT01972841|473597723|FG001|Overall Study|Lost to Follow-up|2|||
131539633|NCT01972841|473597724|FG002|Overall Study|Lost to Follow-up|4|||
131539634|NCT01972841|473597725|FG003|Overall Study|Lost to Follow-up|2|||
131539635|NCT01972841|473597726|FG004|Overall Study|Lost to Follow-up|9|||
131539636|NCT01972841|473597727|FG005|Overall Study|Lost to Follow-up|3|||
131539637|NCT01972841|473597722|FG000|Overall Study|Protocol Violation|2|||
131539638|NCT01972841|473597723|FG001|Overall Study|Protocol Violation|2|||
131539639|NCT01972841|473597724|FG002|Overall Study|Protocol Violation|3|||
131539640|NCT01972841|473597725|FG003|Overall Study|Protocol Violation|5|||
131539641|NCT01972841|473597726|FG004|Overall Study|Protocol Violation|9|||
131539642|NCT01972841|473597727|FG005|Overall Study|Protocol Violation|4|||
131539643|NCT01972841|473597722|FG000|Overall Study|Withdrawal by participants|21|||
131539644|NCT01972841|473597723|FG001|Overall Study|Withdrawal by participants|27|||
131539645|NCT01972841|473597724|FG002|Overall Study|Withdrawal by participants|23|||
131539646|NCT01972841|473597725|FG003|Overall Study|Withdrawal by participants|16|||
131539647|NCT01972841|473597726|FG004|Overall Study|Withdrawal by participants|33|||
131539648|NCT01972841|473597727|FG005|Overall Study|Withdrawal by participants|34|||
131539649|NCT01972841|473597722|FG000|Overall Study|Miscellaneous|0|||
131539650|NCT01972841|473597723|FG001|Overall Study|Miscellaneous|0|||
131539651|NCT01972841|473597724|FG002|Overall Study|Miscellaneous|4|||
131539652|NCT01972841|473597725|FG003|Overall Study|Miscellaneous|1|||
131539653|NCT01972841|473597726|FG004|Overall Study|Miscellaneous|0|||
131539654|NCT01972841|473597727|FG005|Overall Study|Miscellaneous|4|||
131539655|NCT01972841|473597722|FG000|Overall Study|Did not have end of treatment page|0|||
131539656|NCT01972841|473597723|FG001|Overall Study|Did not have end of treatment page|0|||
131539657|NCT01972841|473597724|FG002|Overall Study|Did not have end of treatment page|0|||
131539658|NCT01972841|473597725|FG003|Overall Study|Did not have end of treatment page|0|||
131539659|NCT01972841|473597726|FG004|Overall Study|Did not have end of treatment page|1|||
131539660|NCT01972841|473597727|FG005|Overall Study|Did not have end of treatment page|0|||
131539661|NCT03644186|473597728|FG000|Overall Study|Withdrawal by Subject|1|||
131539662|NCT03644186|473597729|FG001|Overall Study|Withdrawal by Subject|1|||
131539663|NCT04391023|473597733|FG000|Overall Study|Withdrawal by Subject|2|||
131539664|NCT04391023|473597734|FG001|Overall Study|Withdrawal by Subject|2|||
131539665|NCT02308748|473597735|FG000|Period 1|Withdrawal by Subject|0|||
131539666|NCT02308748|473597736|FG001|Period 1|Withdrawal by Subject|0|||
131539667|NCT02308748|473597737|FG002|Period 1|Withdrawal by Subject|1|||
131539668|NCT02308748|473597738|FG003|Period 1|Withdrawal by Subject|0|||
131539669|NCT02308748|473597739|FG004|Period 1|Withdrawal by Subject|0|||
131539670|NCT02308748|473597740|FG005|Period 1|Withdrawal by Subject|0|||
131539671|NCT02308748|473597741|FG006|Period 1|Withdrawal by Subject|0|||
131539672|NCT02308748|473597742|FG007|Period 1|Withdrawal by Subject|0|||
131539673|NCT02308748|473597743|FG008|Period 1|Withdrawal by Subject|0|||
131539674|NCT02308748|473597744|FG009|Period 1|Withdrawal by Subject|0|||
131539675|NCT02308748|473597735|FG000|Period 2|Adverse Event|0|||
131539676|NCT02308748|473597736|FG001|Period 2|Adverse Event|0|||
131539677|NCT02308748|473597737|FG002|Period 2|Adverse Event|0|||
131539678|NCT02308748|473597738|FG003|Period 2|Adverse Event|0|||
131539679|NCT02308748|473597739|FG004|Period 2|Adverse Event|0|||
131539680|NCT02308748|473597740|FG005|Period 2|Adverse Event|0|||
131539681|NCT02308748|473597741|FG006|Period 2|Adverse Event|0|||
131539682|NCT02308748|473597742|FG007|Period 2|Adverse Event|1|||
131539683|NCT02308748|473597743|FG008|Period 2|Adverse Event|0|||
131539684|NCT02308748|473597744|FG009|Period 2|Adverse Event|0|||
131539685|NCT02308748|473597735|FG000|Period 3|Protocol Violation|0|||
131539686|NCT02308748|473597736|FG001|Period 3|Protocol Violation|0|||
131539687|NCT02308748|473597737|FG002|Period 3|Protocol Violation|0|||
131539688|NCT02308748|473597738|FG003|Period 3|Protocol Violation|0|||
131539689|NCT02308748|473597739|FG004|Period 3|Protocol Violation|0|||
131539690|NCT02308748|473597740|FG005|Period 3|Protocol Violation|0|||
131539691|NCT02308748|473597741|FG006|Period 3|Protocol Violation|0|||
131539692|NCT02308748|473597742|FG007|Period 3|Protocol Violation|0|||
131539693|NCT02308748|473597743|FG008|Period 3|Protocol Violation|0|||
131539694|NCT02308748|473597744|FG009|Period 3|Protocol Violation|1|||
131539695|NCT02308748|473597735|FG000|Period 5|Adverse Event|1|||
131539696|NCT02308748|473597736|FG001|Period 5|Adverse Event|0|||
131539697|NCT02308748|473597737|FG002|Period 5|Adverse Event|0|||
131539698|NCT02308748|473597738|FG003|Period 5|Adverse Event|0|||
131539699|NCT02308748|473597739|FG004|Period 5|Adverse Event|0|||
131539700|NCT02308748|473597740|FG005|Period 5|Adverse Event|0|||
131539701|NCT02308748|473597741|FG006|Period 5|Adverse Event|0|||
131539702|NCT02308748|473597742|FG007|Period 5|Adverse Event|0|||
131539703|NCT02308748|473597743|FG008|Period 5|Adverse Event|1|||
131539704|NCT02308748|473597744|FG009|Period 5|Adverse Event|0|||
131539705|NCT03570619|473597750|FG000|Overall Study|Adverse Event|2|||
131539706|NCT03570619|473597751|FG001|Overall Study|Adverse Event|0|||
131539707|NCT03570619|473597752|FG002|Overall Study|Adverse Event|1|||
131539708|NCT03570619|473597750|FG000|Overall Study|new diagnosis of new malignancy|1|||
131539709|NCT03570619|473597751|FG001|Overall Study|new diagnosis of new malignancy|0|||
131539710|NCT03570619|473597752|FG002|Overall Study|new diagnosis of new malignancy|0|||
131539711|NCT03570619|473597750|FG000|Overall Study|Physician Decision|1|||
131539712|NCT03570619|473597751|FG001|Overall Study|Physician Decision|1|||
131539713|NCT03570619|473597752|FG002|Overall Study|Physician Decision|0|||
131539714|NCT03570619|473597750|FG000|Overall Study|Withdrawal by Subject|0|||
131539715|NCT03570619|473597751|FG001|Overall Study|Withdrawal by Subject|2|||
131539716|NCT03570619|473597752|FG002|Overall Study|Withdrawal by Subject|0|||
131539717|NCT01565707|473597755|FG000|Overall Study|Adverse Event|1|||
131539718|NCT01565707|473597756|FG001|Overall Study|Adverse Event|6|||
131539719|NCT01565707|473597757|FG002|Overall Study|Adverse Event|2|||
131539720|NCT01565707|473597758|FG003|Overall Study|Adverse Event|1|||
131539721|NCT01565707|473597755|FG000|Overall Study|Lost to Follow-up|1|||
131539722|NCT01565707|473597756|FG001|Overall Study|Lost to Follow-up|0|||
131539723|NCT01565707|473597757|FG002|Overall Study|Lost to Follow-up|0|||
131539724|NCT01565707|473597758|FG003|Overall Study|Lost to Follow-up|0|||
131539725|NCT01565707|473597755|FG000|Overall Study|Protocol Violation|1|||
131539726|NCT01565707|473597756|FG001|Overall Study|Protocol Violation|0|||
131539727|NCT01565707|473597757|FG002|Overall Study|Protocol Violation|0|||
131539728|NCT01565707|473597758|FG003|Overall Study|Protocol Violation|1|||
131539729|NCT01565707|473597755|FG000|Overall Study|Withdrawal by Subject|3|||
131539730|NCT01565707|473597756|FG001|Overall Study|Withdrawal by Subject|1|||
131539731|NCT01565707|473597757|FG002|Overall Study|Withdrawal by Subject|1|||
131539732|NCT01565707|473597758|FG003|Overall Study|Withdrawal by Subject|1|||
131539733|NCT01565707|473597755|FG000|Overall Study|Randomized but not evaluable|2|||
131539734|NCT01565707|473597756|FG001|Overall Study|Randomized but not evaluable|0|||
131539735|NCT01565707|473597757|FG002|Overall Study|Randomized but not evaluable|0|||
131539736|NCT01565707|473597758|FG003|Overall Study|Randomized but not evaluable|0|||
131539737|NCT01565707|473597755|FG000|Overall Study|Miscellaneous|1|||
131539738|NCT01565707|473597756|FG001|Overall Study|Miscellaneous|1|||
131539739|NCT01565707|473597757|FG002|Overall Study|Miscellaneous|0|||
131539740|NCT01565707|473597758|FG003|Overall Study|Miscellaneous|2|||
131539741|NCT00983073|473597763|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
131539742|NCT00983073|473597763|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
131539743|NCT00983073|473597763|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
131539744|NCT00983073|473597763|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
131539745|NCT00983073|473597763|FG000|Titration and Optimal Dose Period|Other reason|4|||
131539746|NCT00983073|473597763|FG000|Maintenance Period|Adverse Event|5|||
131539747|NCT00983073|473597763|FG000|Maintenance Period|Withdrawal by Subject|2|||
131539748|NCT00983073|473597763|FG000|Maintenance Period|Lack of Efficacy|2|||
131539749|NCT00983073|473597763|FG000|Maintenance Period|Other Reason|7|||
131539750|NCT05374421|473597764|FG000|Overall Study|Withdrawal by Subject|3|||
131539751|NCT05374421|473597765|FG001|Overall Study|Withdrawal by Subject|4|||
131539752|NCT05557942|473597766|FG000|Overall Study|Death|0|||
131539753|NCT05557942|473597767|FG001|Overall Study|Death|0|||
131539754|NCT05557942|473597768|FG002|Overall Study|Death|0|||
131539755|NCT05557942|473597769|FG003|Overall Study|Death|2|||
131539756|NCT05557942|473597770|FG004|Overall Study|Death|1|||
131539757|NCT05557942|473597771|FG005|Overall Study|Death|1|||
131539758|NCT05557942|473597766|FG000|Overall Study|Physician Decision|1|||
131539759|NCT05557942|473597767|FG001|Overall Study|Physician Decision|1|||
131539760|NCT05557942|473597768|FG002|Overall Study|Physician Decision|2|||
131539761|NCT05557942|473597769|FG003|Overall Study|Physician Decision|3|||
131539762|NCT05557942|473597770|FG004|Overall Study|Physician Decision|0|||
131539763|NCT05557942|473597771|FG005|Overall Study|Physician Decision|2|||
131539764|NCT05557942|473597766|FG000|Overall Study|Study terminated by sponsor|17|||
131539765|NCT05557942|473597767|FG001|Overall Study|Study terminated by sponsor|17|||
131539766|NCT05557942|473597768|FG002|Overall Study|Study terminated by sponsor|14|||
131539767|NCT05557942|473597769|FG003|Overall Study|Study terminated by sponsor|40|||
131539768|NCT05557942|473597770|FG004|Overall Study|Study terminated by sponsor|45|||
131539769|NCT05557942|473597771|FG005|Overall Study|Study terminated by sponsor|37|||
131539770|NCT05557942|473597766|FG000|Overall Study|Protocol Violation|0|||
131539771|NCT05557942|473597767|FG001|Overall Study|Protocol Violation|0|||
131539772|NCT05557942|473597768|FG002|Overall Study|Protocol Violation|0|||
131539773|NCT05557942|473597769|FG003|Overall Study|Protocol Violation|0|||
131539774|NCT05557942|473597770|FG004|Overall Study|Protocol Violation|0|||
131539775|NCT05557942|473597771|FG005|Overall Study|Protocol Violation|1|||
131539776|NCT05557942|473597766|FG000|Overall Study|Withdrawal by Subject|0|||
131539777|NCT05557942|473597767|FG001|Overall Study|Withdrawal by Subject|0|||
131539778|NCT05557942|473597768|FG002|Overall Study|Withdrawal by Subject|0|||
131539779|NCT05557942|473597769|FG003|Overall Study|Withdrawal by Subject|0|||
131539780|NCT05557942|473597770|FG004|Overall Study|Withdrawal by Subject|2|||
131539781|NCT05557942|473597771|FG005|Overall Study|Withdrawal by Subject|0|||
131539782|NCT00613951|473597773|FG000|Overall Study|Adverse Event|1|||
131539783|NCT00613951|473597774|FG001|Overall Study|Adverse Event|0|||
131539784|NCT00613951|473597775|FG002|Overall Study|Adverse Event|1|||
131539785|NCT00613951|473597773|FG000|Overall Study|Lack of Efficacy|0|||
131539786|NCT00613951|473597774|FG001|Overall Study|Lack of Efficacy|1|||
131539787|NCT00613951|473597775|FG002|Overall Study|Lack of Efficacy|1|||
131539788|NCT00613951|473597773|FG000|Overall Study|Protocol Violation|1|||
131539789|NCT00613951|473597774|FG001|Overall Study|Protocol Violation|1|||
131539790|NCT00613951|473597775|FG002|Overall Study|Protocol Violation|1|||
131539791|NCT00613951|473597773|FG000|Overall Study|Unclassified|5|||
131539792|NCT00613951|473597774|FG001|Overall Study|Unclassified|3|||
131539793|NCT00613951|473597775|FG002|Overall Study|Unclassified|2|||
131539794|NCT00655980|473597779|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
131539795|NCT00655980|473597780|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
131539796|NCT00655980|473597781|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
131539797|NCT05540522|473597782|FG000|Overall Study|Adverse Event|1|||
131539798|NCT05540522|473597783|FG001|Overall Study|Adverse Event|0|||
131539799|NCT05540522|473597784|FG002|Overall Study|Adverse Event|2|||
131539800|NCT05540522|473597785|FG003|Overall Study|Adverse Event|5|||
131539801|NCT05540522|473597782|FG000|Overall Study|Lost to Follow-up|487|||
131539802|NCT05540522|473597783|FG001|Overall Study|Lost to Follow-up|427|||
131539803|NCT05540522|473597784|FG002|Overall Study|Lost to Follow-up|146|||
131539804|NCT05540522|473597785|FG003|Overall Study|Lost to Follow-up|166|||
131539805|NCT05540522|473597782|FG000|Overall Study|Physician Decision|11|||
131539806|NCT05540522|473597783|FG001|Overall Study|Physician Decision|19|||
131539807|NCT05540522|473597784|FG002|Overall Study|Physician Decision|8|||
131539808|NCT05540522|473597785|FG003|Overall Study|Physician Decision|13|||
131539809|NCT05540522|473597782|FG000|Overall Study|Pregnancy|1|||
131539810|NCT05540522|473597783|FG001|Overall Study|Pregnancy|0|||
131539811|NCT05540522|473597784|FG002|Overall Study|Pregnancy|0|||
131539812|NCT05540522|473597785|FG003|Overall Study|Pregnancy|0|||
131539813|NCT05540522|473597782|FG000|Overall Study|Protocol Violation|3|||
131539814|NCT05540522|473597783|FG001|Overall Study|Protocol Violation|1|||
131539815|NCT05540522|473597784|FG002|Overall Study|Protocol Violation|9|||
131539816|NCT05540522|473597785|FG003|Overall Study|Protocol Violation|7|||
131539817|NCT05540522|473597782|FG000|Overall Study|Withdrawal by Subject|168|||
131539818|NCT05540522|473597783|FG001|Overall Study|Withdrawal by Subject|134|||
131539819|NCT05540522|473597784|FG002|Overall Study|Withdrawal by Subject|331|||
131539820|NCT05540522|473597785|FG003|Overall Study|Withdrawal by Subject|322|||
131539821|NCT05540522|473597782|FG000|Overall Study|Death|7|||
131539822|NCT05540522|473597783|FG001|Overall Study|Death|9|||
131539823|NCT05540522|473597784|FG002|Overall Study|Death|49|||
131539824|NCT05540522|473597785|FG003|Overall Study|Death|46|||
131539825|NCT05540522|473597782|FG000|Overall Study|Not vaccinated|34|||
131539826|NCT05540522|473597783|FG001|Overall Study|Not vaccinated|53|||
131539827|NCT05540522|473597784|FG002|Overall Study|Not vaccinated|57|||
131539828|NCT05540522|473597785|FG003|Overall Study|Not vaccinated|50|||
131539829|NCT05540522|473597782|FG000|Overall Study|No longer meets eligibility criteria|0|||
131539830|NCT05540522|473597783|FG001|Overall Study|No longer meets eligibility criteria|0|||
131539831|NCT05540522|473597784|FG002|Overall Study|No longer meets eligibility criteria|3|||
131539832|NCT05540522|473597785|FG003|Overall Study|No longer meets eligibility criteria|2|||
131539833|NCT05540522|473597782|FG000|Overall Study|Other (Unspecified)|8|||
131539834|NCT05540522|473597783|FG001|Overall Study|Other (Unspecified)|10|||
131539835|NCT05540522|473597784|FG002|Overall Study|Other (Unspecified)|4|||
131539836|NCT05540522|473597785|FG003|Overall Study|Other (Unspecified)|2|||
131539837|NCT03754803|473597786|FG000|Overall Study|Withdrawal by Subject|2|||
131539838|NCT04439110|473597787|FG000|Overall Study|Ineligible|2|||
131539839|NCT04439110|473597787|FG000|Overall Study|Adverse Event|4|||
131539840|NCT04439110|473597787|FG000|Overall Study|Death|2|||
131539841|NCT04439110|473597787|FG000|Overall Study|Disease proression|25|||
131539842|NCT04439110|473597787|FG000|Overall Study|Withdrawal by Subject|1|||
131539843|NCT04439110|473597787|FG000|Overall Study|Alternative therapy|1|||
131539844|NCT04439110|473597787|FG000|Overall Study|Other complicating disease|1|||
131539845|NCT04439110|473597787|FG000|Overall Study|Personal reasons|1|||
131539846|NCT04439110|473597787|FG000|Overall Study|Still on treatment|1|||
131539847|NCT04348604|473597788|FG000|Week 8|Withdrawal by Subject|1|||
131539848|NCT04348604|473597789|FG001|Week 8|Withdrawal by Subject|1|||
131539849|NCT04348604|473597788|FG000|Week 8|Lost to Follow-up|1|||
131539850|NCT04348604|473597789|FG001|Week 8|Lost to Follow-up|2|||
131539851|NCT04348604|473597788|FG000|Week 8|Suspended|0|||
131539852|NCT04348604|473597789|FG001|Week 8|Suspended|1|||
131539853|NCT04348604|473597788|FG000|Week 12|Lost to Follow-up|1|||
131539854|NCT04348604|473597789|FG001|Week 12|Lost to Follow-up|2|||
131539855|NCT04348604|473597788|FG000|Week 12|Withdrawal by Subject|1|||
131539856|NCT04348604|473597789|FG001|Week 12|Withdrawal by Subject|0|||
131539857|NCT04348604|473597788|FG000|Week 24|Lost to Follow-up|2|||
131539858|NCT04348604|473597789|FG001|Week 24|Lost to Follow-up|1|||
131539859|NCT02097108|473597790|FG000|Overall Study|Adverse Event|1|||
131539860|NCT02097108|473597790|FG000|Overall Study|patient was abroad for 6 months|1|||
131539861|NCT00127608|473597791|FG000|Overall Study|VZV DNA negative|1|||
131539862|NCT05245864|473597792|FG000|Overall Study|Withdrawal by Subject|1|||
131539863|NCT05245864|473597793|FG001|Overall Study|Withdrawal by Subject|1|||
131539864|NCT01329029|473597794|FG000|Overall Study|Withdrawal by Subject|117|||
131539865|NCT01329029|473597795|FG001|Overall Study|Withdrawal by Subject|87|||
131539866|NCT01329029|473597794|FG000|Overall Study|Adverse Event|82|||
131539867|NCT01329029|473597795|FG001|Overall Study|Adverse Event|29|||
131539868|NCT01329029|473597794|FG000|Overall Study|Death|16|||
131539869|NCT01329029|473597795|FG001|Overall Study|Death|19|||
131539870|NCT01329029|473597794|FG000|Overall Study|Other|14|||
131539871|NCT01329029|473597795|FG001|Overall Study|Other|20|||
131539872|NCT01329029|473597794|FG000|Overall Study|COPD Exacerbation|11|||
131539873|NCT01329029|473597795|FG001|Overall Study|COPD Exacerbation|18|||
131539874|NCT01329029|473597794|FG000|Overall Study|Physician Decision|16|||
131539875|NCT01329029|473597795|FG001|Overall Study|Physician Decision|13|||
131539876|NCT01329029|473597794|FG000|Overall Study|Lost to Follow-up|8|||
131539877|NCT01329029|473597795|FG001|Overall Study|Lost to Follow-up|5|||
131539878|NCT01329029|473597794|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
131539879|NCT01329029|473597795|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
131539880|NCT01266642|473597801|FG000|Overall Study|Protocol Violation|0|||
131539881|NCT01266642|473597802|FG001|Overall Study|Protocol Violation|1|||
131539882|NCT02119260|473599335|FG000|Overall Study|Adverse Event|1|||
131539883|NCT02119260|473599336|FG001|Overall Study|Adverse Event|0|||
131539884|NCT02119260|473599337|FG002|Overall Study|Adverse Event|0|||
131539885|NCT02119260|473599338|FG003|Overall Study|Adverse Event|0|||
131539886|NCT02119260|473599339|FG004|Overall Study|Adverse Event|0|||
131539887|NCT02119260|473599340|FG005|Overall Study|Adverse Event|0|||
131539888|NCT02119260|473599341|FG006|Overall Study|Adverse Event|0|||
131539889|NCT02119260|473599335|FG000|Overall Study|Withdrew consent|0|||
131539890|NCT02119260|473599336|FG001|Overall Study|Withdrew consent|1|||
131539891|NCT02119260|473599337|FG002|Overall Study|Withdrew consent|1|||
131539892|NCT02119260|473599338|FG003|Overall Study|Withdrew consent|0|||
131539893|NCT02119260|473599339|FG004|Overall Study|Withdrew consent|0|||
131539894|NCT02119260|473599340|FG005|Overall Study|Withdrew consent|0|||
131539895|NCT02119260|473599341|FG006|Overall Study|Withdrew consent|0|||
131539896|NCT01738984|473599342|FG000|Overall Study|Pregnancy|4|||
131539897|NCT01738984|473599343|FG001|Overall Study|Pregnancy|0|||
131539898|NCT01738984|473599342|FG000|Overall Study|Withdrawal by Subject|1|||
131539899|NCT01738984|473599343|FG001|Overall Study|Withdrawal by Subject|0|||
131539900|NCT01738984|473599342|FG000|Overall Study|Lost to Follow-up|59|||
131539901|NCT01738984|473599343|FG001|Overall Study|Lost to Follow-up|39|||
131539902|NCT00857207|473599344|FG000|Overall Study|Withdrawal by Subject|13|||
131539903|NCT00857207|473599345|FG001|Overall Study|Withdrawal by Subject|0|||
131539904|NCT00857207|473599344|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
131539905|NCT00857207|473599345|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
131539906|NCT00857207|473599344|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
131539907|NCT00857207|473599345|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
131539908|NCT00955357|473599347|FG000|Titration Phase|Adverse Event|9|||
131539909|NCT00955357|473599348|FG001|Titration Phase|Adverse Event|46|||
131539910|NCT00955357|473599347|FG000|Titration Phase|Lack of Efficacy|0|||
131539911|NCT00955357|473599348|FG001|Titration Phase|Lack of Efficacy|2|||
131539912|NCT00955357|473599347|FG000|Titration Phase|Protocol Violation|3|||
131539913|NCT00955357|473599348|FG001|Titration Phase|Protocol Violation|7|||
131539914|NCT00955357|473599347|FG000|Titration Phase|Lost to Follow-up|1|||
131539915|NCT00955357|473599348|FG001|Titration Phase|Lost to Follow-up|3|||
131539916|NCT00955357|473599347|FG000|Titration Phase|Withdrawal by Subject|3|||
131539917|NCT00955357|473599348|FG001|Titration Phase|Withdrawal by Subject|5|||
131539918|NCT00955357|473599347|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
131539919|NCT00955357|473599348|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
131539920|NCT00955357|473599347|FG000|Titration Phase|Study medication not tolerated|0|||
131539921|NCT00955357|473599348|FG001|Titration Phase|Study medication not tolerated|1|||
131539922|NCT00955357|473599347|FG000|Titration Phase|Non compliance to study procedures|0|||
131539923|NCT00955357|473599348|FG001|Titration Phase|Non compliance to study procedures|1|||
131539924|NCT00955357|473599347|FG000|Maintenance Phase|Adverse Event|3|||
131539925|NCT00955357|473599348|FG001|Maintenance Phase|Adverse Event|23|||
131539926|NCT00955357|473599347|FG000|Maintenance Phase|Lack of Efficacy|0|||
131539927|NCT00955357|473599348|FG001|Maintenance Phase|Lack of Efficacy|4|||
131539928|NCT00955357|473599347|FG000|Maintenance Phase|Protocol Violation|2|||
131539929|NCT00955357|473599348|FG001|Maintenance Phase|Protocol Violation|6|||
131539930|NCT00955357|473599347|FG000|Maintenance Phase|Lost to Follow-up|2|||
131539931|NCT00955357|473599348|FG001|Maintenance Phase|Lost to Follow-up|7|||
131539932|NCT00955357|473599347|FG000|Maintenance Phase|Withdrawal by Subject|4|||
131539933|NCT00955357|473599348|FG001|Maintenance Phase|Withdrawal by Subject|4|||
131539934|NCT00955357|473599347|FG000|Maintenance Phase|Patient moving out of area|0|||
131539935|NCT00955357|473599348|FG001|Maintenance Phase|Patient moving out of area|1|||
131539936|NCT00955357|473599347|FG000|Maintenance Phase|Non compliance to study procedures|1|||
131539937|NCT00955357|473599348|FG001|Maintenance Phase|Non compliance to study procedures|0|||
131539938|NCT01258608|473599349|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
131539939|NCT01258608|473599350|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
131539940|NCT01258608|473599349|FG000|Overall Study|Clinical progression|1|||
131539941|NCT01258608|473599350|FG001|Overall Study|Clinical progression|0|||
131539942|NCT01258608|473599349|FG000|Overall Study|Sponsor decision|0|||
131539943|NCT01258608|473599350|FG001|Overall Study|Sponsor decision|1|||
131539944|NCT01258608|473599349|FG000|Overall Study|Physician Decision|6|||
131539945|NCT01258608|473599350|FG001|Overall Study|Physician Decision|1|||
131539946|NCT01258608|473599349|FG000|Overall Study|Lost to Follow-up|0|||
131539947|NCT01258608|473599350|FG001|Overall Study|Lost to Follow-up|1|||
131539948|NCT01258608|473599349|FG000|Overall Study|Lack of compliance|1|||
131539949|NCT01258608|473599350|FG001|Overall Study|Lack of compliance|0|||
131539950|NCT01258608|473599349|FG000|Overall Study|Lack of Efficacy|0|||
131539951|NCT01258608|473599350|FG001|Overall Study|Lack of Efficacy|1|||
131539952|NCT01258608|473599349|FG000|Overall Study|Adverse Event|6|||
131539953|NCT01258608|473599350|FG001|Overall Study|Adverse Event|10|||
131539954|NCT01258608|473599349|FG000|Overall Study|Withdrawal by Subject|6|||
131539955|NCT01258608|473599350|FG001|Overall Study|Withdrawal by Subject|5|||
131539956|NCT01471054|473599351|FG000|Overall Study|Study terminated prematurely|4|||
131539957|NCT01471054|473599352|FG001|Overall Study|Study terminated prematurely|0|||
131539958|NCT01843192|473599353|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
131539959|NCT01843192|473599354|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
131539960|NCT01843192|473599355|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
131539961|NCT02181803|473599356|FG000|Overall Study|Withdrawal by Subject|0|||
131539962|NCT02181803|473599357|FG001|Overall Study|Withdrawal by Subject|2|||
131539963|NCT02181803|473599358|FG002|Overall Study|Withdrawal by Subject|0|||
131539964|NCT02181803|473599359|FG003|Overall Study|Withdrawal by Subject|0|||
131539965|NCT02181803|473599360|FG004|Overall Study|Withdrawal by Subject|0|||
131539966|NCT02181803|473599361|FG005|Overall Study|Withdrawal by Subject|0|||
131539967|NCT02181803|473599362|FG006|Overall Study|Withdrawal by Subject|0|||
131539968|NCT02181803|473599363|FG007|Overall Study|Withdrawal by Subject|0|||
131539969|NCT02181803|473599364|FG008|Overall Study|Withdrawal by Subject|0|||
131539970|NCT02181803|473599356|FG000|Overall Study|Physician Decision|0|||
131539971|NCT02181803|473599357|FG001|Overall Study|Physician Decision|0|||
131539972|NCT02181803|473599358|FG002|Overall Study|Physician Decision|0|||
131539973|NCT02181803|473599359|FG003|Overall Study|Physician Decision|1|||
131539974|NCT02181803|473599360|FG004|Overall Study|Physician Decision|0|||
131539975|NCT02181803|473599361|FG005|Overall Study|Physician Decision|0|||
131539976|NCT02181803|473599362|FG006|Overall Study|Physician Decision|0|||
131539977|NCT02181803|473599363|FG007|Overall Study|Physician Decision|1|||
131539978|NCT02181803|473599364|FG008|Overall Study|Physician Decision|0|||
131539979|NCT02181803|473599356|FG000|Overall Study|Adverse Event|0|||
131539980|NCT02181803|473599357|FG001|Overall Study|Adverse Event|2|||
131539981|NCT02181803|473599358|FG002|Overall Study|Adverse Event|0|||
131539982|NCT02181803|473599359|FG003|Overall Study|Adverse Event|1|||
131539983|NCT02181803|473599360|FG004|Overall Study|Adverse Event|0|||
131539984|NCT02181803|473599361|FG005|Overall Study|Adverse Event|0|||
131539985|NCT02181803|473599362|FG006|Overall Study|Adverse Event|1|||
131539986|NCT02181803|473599363|FG007|Overall Study|Adverse Event|0|||
131539987|NCT02181803|473599364|FG008|Overall Study|Adverse Event|0|||
131539988|NCT03912259|473599365|FG000|Overall Study|Adverse Event (AE)|2|||
131539989|NCT03912259|473599366|FG001|Overall Study|Adverse Event (AE)|4|||
131539990|NCT03912259|473599365|FG000|Overall Study|Lack of Efficacy|4|||
131539991|NCT03912259|473599366|FG001|Overall Study|Lack of Efficacy|1|||
131539992|NCT03912259|473599365|FG000|Overall Study|Withdrawal by Subject|11|||
131539993|NCT03912259|473599366|FG001|Overall Study|Withdrawal by Subject|1|||
131539994|NCT02131272|473599367|FG000|Overall Study|Withdrawal by parent|0|||
131539995|NCT02131272|473599368|FG001|Overall Study|Withdrawal by parent|1|||
131539996|NCT02131272|473599367|FG000|Overall Study|Withdrawal by Subject|0|||
131539997|NCT02131272|473599368|FG001|Overall Study|Withdrawal by Subject|1|||
131539998|NCT02131272|473599367|FG000|Overall Study|Withdrawal Criteria|1|||
131539999|NCT02131272|473599368|FG001|Overall Study|Withdrawal Criteria|0|||
131540000|NCT03166618|473599369|FG000|Overall Study|Study was Terminated|0|||
131540001|NCT03166618|473599370|FG001|Overall Study|Study was Terminated|1|||
131540002|NCT03561090|473599371|FG000|Overall Study|Adverse Event|11|||
131540003|NCT03561090|473599372|FG001|Overall Study|Adverse Event|7|||
131540004|NCT03561090|473599371|FG000|Overall Study|Non-Compliance With Study Drug|2|||
131540005|NCT03561090|473599372|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131540006|NCT03561090|473599371|FG000|Overall Study|Protocol Violation|2|||
131540007|NCT03561090|473599372|FG001|Overall Study|Protocol Violation|2|||
131540008|NCT03561090|473599371|FG000|Overall Study|Withdrawal by Subject|7|||
131540009|NCT03561090|473599372|FG001|Overall Study|Withdrawal by Subject|7|||
131540010|NCT03561090|473599371|FG000|Overall Study|Lost to Follow-up|7|||
131540011|NCT03561090|473599372|FG001|Overall Study|Lost to Follow-up|2|||
131540012|NCT03561090|473599371|FG000|Overall Study|Study Terminated by Sponsor|10|||
131540013|NCT03561090|473599372|FG001|Overall Study|Study Terminated by Sponsor|15|||
131540014|NCT03561090|473599371|FG000|Overall Study|Randomized by Mistake|1|||
131540015|NCT03561090|473599372|FG001|Overall Study|Randomized by Mistake|1|||
131540016|NCT03561090|473599371|FG000|Overall Study|Other Not Specified|0|||
131540017|NCT03561090|473599372|FG001|Overall Study|Other Not Specified|2|||
131540018|NCT02163733|473599379|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
131540019|NCT02163733|473599380|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
131540020|NCT02163733|473599381|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
131540021|NCT02163733|473599379|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
131540022|NCT02163733|473599380|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
131540023|NCT02163733|473599381|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
131540024|NCT00713648|473599382|FG000|Overall Study|Adverse Event|1|||
131540025|NCT00713648|473599382|FG000|Overall Study|Unclassified|2|||
131540026|NCT00713648|473599382|FG000|Overall Study|According to Protocol|2|||
131540027|NCT00713648|473599382|FG000|Overall Study|Development of antibodies|3|||
131540028|NCT02633800|473599383|FG000|Overall Study|Death|3|||
131540029|NCT02633800|473599384|FG001|Overall Study|Death|3|||
131540030|NCT02633800|473599383|FG000|Overall Study|Reason not provided|1|||
131540031|NCT02633800|473599384|FG001|Overall Study|Reason not provided|0|||
131540032|NCT02633800|473599383|FG000|Overall Study|Radiologic(al) progression|23|||
131540033|NCT02633800|473599384|FG001|Overall Study|Radiologic(al) progression|23|||
131540034|NCT02633800|473599383|FG000|Overall Study|Clinical progression|3|||
131540035|NCT02633800|473599384|FG001|Overall Study|Clinical progression|6|||
131540036|NCT02633800|473599383|FG000|Overall Study|Study terminated by sponsor|6|||
131540037|NCT02633800|473599384|FG001|Overall Study|Study terminated by sponsor|5|||
131540038|NCT02633800|473599383|FG000|Overall Study|Adverse event, non-fatal|7|||
131540039|NCT02633800|473599384|FG001|Overall Study|Adverse event, non-fatal|2|||
131540040|NCT02633800|473599383|FG000|Overall Study|Withdrawal by Subject|0|||
131540041|NCT02633800|473599384|FG001|Overall Study|Withdrawal by Subject|3|||
131540042|NCT02633800|473599383|FG000|Overall Study|Patient Request|1|||
131540043|NCT02633800|473599384|FG001|Overall Study|Patient Request|1|||
131540044|NCT00082173|473599385|FG000|Overall Study|Withdrawal by Subject|3|||
131540045|NCT00082173|473599386|FG001|Overall Study|Withdrawal by Subject|5|||
131540046|NCT00082173|473599385|FG000|Overall Study|Lost to Follow-up|1|||
131540047|NCT00082173|473599386|FG001|Overall Study|Lost to Follow-up|0|||
131540048|NCT00082173|473599385|FG000|Overall Study|Adverse Event|1|||
131540049|NCT00082173|473599386|FG001|Overall Study|Adverse Event|0|||
131540050|NCT00082173|473599385|FG000|Overall Study|Culture negative or resistant at baselin|5|||
131540051|NCT00082173|473599386|FG001|Overall Study|Culture negative or resistant at baselin|6|||
131540052|NCT01733732|473599387|FG000|Overall Study|Adverse Event|1|||
131540053|NCT01733732|473599388|FG001|Overall Study|Adverse Event|0|||
131540054|NCT01733732|473599387|FG000|Overall Study|Did not attend all study visits|1|||
131540055|NCT01733732|473599388|FG001|Overall Study|Did not attend all study visits|0|||
131540056|NCT01260350|473599400|FG000|Overall Study|Lack of Efficacy|0|||
131540057|NCT01260350|473599401|FG001|Overall Study|Lack of Efficacy|0|||
131540058|NCT01260350|473599402|FG002|Overall Study|Lack of Efficacy|0|||
131540059|NCT01260350|473599403|FG003|Overall Study|Lack of Efficacy|0|||
131540060|NCT01260350|473599404|FG004|Overall Study|Lack of Efficacy|0|||
131540061|NCT01260350|473599405|FG005|Overall Study|Lack of Efficacy|0|||
131540062|NCT01260350|473599406|FG006|Overall Study|Lack of Efficacy|0|||
131540063|NCT01260350|473599407|FG007|Overall Study|Lack of Efficacy|0|||
131540064|NCT01260350|473599408|FG008|Overall Study|Lack of Efficacy|0|||
131540065|NCT01260350|473599409|FG009|Overall Study|Lack of Efficacy|0|||
131540066|NCT01260350|473599410|FG010|Overall Study|Lack of Efficacy|0|||
131540067|NCT01260350|473599411|FG011|Overall Study|Lack of Efficacy|0|||
131540068|NCT01260350|473599412|FG012|Overall Study|Lack of Efficacy|0|||
131540069|NCT01260350|473599413|FG013|Overall Study|Lack of Efficacy|0|||
131540070|NCT01260350|473599414|FG014|Overall Study|Lack of Efficacy|0|||
131540071|NCT01260350|473599415|FG015|Overall Study|Lack of Efficacy|0|||
131540072|NCT01260350|473599416|FG016|Overall Study|Lack of Efficacy|0|||
131540073|NCT01260350|473599417|FG017|Overall Study|Lack of Efficacy|1|||
131540074|NCT01260350|473599418|FG018|Overall Study|Lack of Efficacy|0|||
131540075|NCT01260350|473599419|FG019|Overall Study|Lack of Efficacy|0|||
131540076|NCT01260350|473599420|FG020|Overall Study|Lack of Efficacy|3|||
131540077|NCT01260350|473599421|FG021|Overall Study|Lack of Efficacy|0|||
131540078|NCT01260350|473599400|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540079|NCT01260350|473599401|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540080|NCT01260350|473599402|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540081|NCT01260350|473599403|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540082|NCT01260350|473599404|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540083|NCT01260350|473599405|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540084|NCT01260350|473599406|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540085|NCT01260350|473599407|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540086|NCT01260350|473599408|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
131540087|NCT01260350|473599409|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540088|NCT01260350|473599410|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540089|NCT01260350|473599411|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540090|NCT01260350|473599412|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540091|NCT01260350|473599413|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540092|NCT01260350|473599414|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540093|NCT01260350|473599415|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540094|NCT01260350|473599416|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540095|NCT01260350|473599417|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131658526|NCT01142232|474035354|FG003|Overall Study|Alternative Therapy|0|||
131540096|NCT01260350|473599418|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540097|NCT01260350|473599419|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540098|NCT01260350|473599420|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540099|NCT01260350|473599421|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
131540100|NCT02794285|473599424|FG000|Overall Study|Adverse Event|11|||
131540101|NCT02794285|473599425|FG001|Overall Study|Adverse Event|4|||
131540102|NCT02794285|473599426|FG002|Overall Study|Adverse Event|5|||
131540103|NCT02794285|473599427|FG003|Overall Study|Adverse Event|8|||
131540104|NCT02794285|473599424|FG000|Overall Study|Condition Under Investigation Improved|1|||
131540105|NCT02794285|473599425|FG001|Overall Study|Condition Under Investigation Improved|0|||
131540106|NCT02794285|473599426|FG002|Overall Study|Condition Under Investigation Improved|0|||
131540107|NCT02794285|473599427|FG003|Overall Study|Condition Under Investigation Improved|0|||
131540108|NCT02794285|473599424|FG000|Overall Study|Condition Under Investigation Worsened|0|||
131540109|NCT02794285|473599425|FG001|Overall Study|Condition Under Investigation Worsened|2|||
131540110|NCT02794285|473599426|FG002|Overall Study|Condition Under Investigation Worsened|1|||
131540111|NCT02794285|473599427|FG003|Overall Study|Condition Under Investigation Worsened|0|||
131540112|NCT02794285|473599424|FG000|Overall Study|Death|2|||
131540113|NCT02794285|473599425|FG001|Overall Study|Death|1|||
131540114|NCT02794285|473599426|FG002|Overall Study|Death|2|||
131540115|NCT02794285|473599427|FG003|Overall Study|Death|0|||
131540116|NCT02794285|473599424|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
131540117|NCT02794285|473599425|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
131540118|NCT02794285|473599426|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
131540119|NCT02794285|473599427|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
131540120|NCT02794285|473599424|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
131540121|NCT02794285|473599425|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
131540122|NCT02794285|473599426|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
131540123|NCT02794285|473599427|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
131540124|NCT02794285|473599424|FG000|Overall Study|Lack of Efficacy|10|||
131540125|NCT02794285|473599425|FG001|Overall Study|Lack of Efficacy|6|||
131540126|NCT02794285|473599426|FG002|Overall Study|Lack of Efficacy|3|||
131540127|NCT02794285|473599427|FG003|Overall Study|Lack of Efficacy|3|||
131540128|NCT02794285|473599424|FG000|Overall Study|Lost to Follow-up|5|||
131540129|NCT02794285|473599425|FG001|Overall Study|Lost to Follow-up|6|||
131540130|NCT02794285|473599426|FG002|Overall Study|Lost to Follow-up|3|||
131540131|NCT02794285|473599427|FG003|Overall Study|Lost to Follow-up|1|||
131540132|NCT02794285|473599424|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
131540133|NCT02794285|473599425|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
131540134|NCT02794285|473599426|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
131540135|NCT02794285|473599427|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
131540136|NCT02794285|473599424|FG000|Overall Study|Withdrawal by Subject|38|||
131540137|NCT02794285|473599425|FG001|Overall Study|Withdrawal by Subject|29|||
131540138|NCT02794285|473599426|FG002|Overall Study|Withdrawal by Subject|20|||
131540139|NCT02794285|473599427|FG003|Overall Study|Withdrawal by Subject|12|||
131540140|NCT02794285|473599424|FG000|Overall Study|Missing|1|||
131540141|NCT02794285|473599425|FG001|Overall Study|Missing|0|||
131540142|NCT02794285|473599426|FG002|Overall Study|Missing|0|||
131540143|NCT02794285|473599427|FG003|Overall Study|Missing|0|||
131540144|NCT02794285|473599424|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
131540145|NCT02794285|473599425|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
131540146|NCT02794285|473599426|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
131540147|NCT02794285|473599427|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
131540148|NCT02794285|473599424|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
131540149|NCT02794285|473599425|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
131540150|NCT02794285|473599426|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
131540151|NCT02794285|473599427|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
131540152|NCT00868439|473599428|FG000|Overall Study|Adverse Event|4|||
131540153|NCT00868439|473599429|FG001|Overall Study|Adverse Event|3|||
131540154|NCT00868439|473599428|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
131540155|NCT00868439|473599429|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
131540156|NCT00868439|473599428|FG000|Overall Study|Death|0|||
131540157|NCT00868439|473599429|FG001|Overall Study|Death|1|||
131540158|NCT00868439|473599428|FG000|Overall Study|Protocol Violation|1|||
131540159|NCT00868439|473599429|FG001|Overall Study|Protocol Violation|1|||
131540160|NCT00868439|473599428|FG000|Overall Study|Physician Decision|1|||
131540161|NCT00868439|473599429|FG001|Overall Study|Physician Decision|0|||
131540162|NCT00868439|473599428|FG000|Overall Study|Withdrawal by Subject|0|||
131540163|NCT00868439|473599429|FG001|Overall Study|Withdrawal by Subject|1|||
131540164|NCT00937924|473599440|FG000|Overall Study|Lost to Follow-up|44|||
131540165|NCT00937924|473599441|FG001|Overall Study|Lost to Follow-up|44|||
131540166|NCT00937924|473599442|FG002|Overall Study|Lost to Follow-up|41|||
131540167|NCT00224874|473599443|FG000|Overall Study|Withdrawal by Subject|0|||
131540168|NCT00224874|473599444|FG001|Overall Study|Withdrawal by Subject|0|||
131540169|NCT00224874|473599445|FG002|Overall Study|Withdrawal by Subject|1|||
131540170|NCT00224874|473599446|FG003|Overall Study|Withdrawal by Subject|0|||
131540171|NCT05072080|473599449|FG000|Overall Study|Death|0|||
131540172|NCT05072080|473599450|FG001|Overall Study|Death|0|||
131540173|NCT05072080|473599451|FG002|Overall Study|Death|1|||
131540174|NCT05072080|473599452|FG003|Overall Study|Death|0|||
131540175|NCT05072080|473599449|FG000|Overall Study|Lost to Follow-up|65|||
131540176|NCT05072080|473599450|FG001|Overall Study|Lost to Follow-up|70|||
131540177|NCT05072080|473599451|FG002|Overall Study|Lost to Follow-up|58|||
131540178|NCT05072080|473599452|FG003|Overall Study|Lost to Follow-up|23|||
131540179|NCT05072080|473599449|FG000|Overall Study|Physician Decision|2|||
131540180|NCT05072080|473599450|FG001|Overall Study|Physician Decision|1|||
131540181|NCT05072080|473599451|FG002|Overall Study|Physician Decision|1|||
131540182|NCT05072080|473599452|FG003|Overall Study|Physician Decision|0|||
131540183|NCT05072080|473599449|FG000|Overall Study|Withdrawal by Subject|45|||
131540184|NCT05072080|473599450|FG001|Overall Study|Withdrawal by Subject|30|||
131540185|NCT05072080|473599451|FG002|Overall Study|Withdrawal by Subject|27|||
131540186|NCT05072080|473599452|FG003|Overall Study|Withdrawal by Subject|7|||
131540187|NCT05072080|473599449|FG000|Overall Study|Sponsor Decision|0|||
131540188|NCT05072080|473599450|FG001|Overall Study|Sponsor Decision|1|||
131540189|NCT05072080|473599451|FG002|Overall Study|Sponsor Decision|0|||
131540190|NCT05072080|473599452|FG003|Overall Study|Sponsor Decision|0|||
131540191|NCT05072080|473599449|FG000|Overall Study|Subject moved|1|||
131540192|NCT05072080|473599450|FG001|Overall Study|Subject moved|3|||
131540193|NCT05072080|473599451|FG002|Overall Study|Subject moved|5|||
131540194|NCT05072080|473599452|FG003|Overall Study|Subject moved|2|||
131540195|NCT05072080|473599449|FG000|Overall Study|Withdrawal by parent|0|||
131540196|NCT05072080|473599450|FG001|Overall Study|Withdrawal by parent|0|||
131540197|NCT05072080|473599451|FG002|Overall Study|Withdrawal by parent|1|||
131540198|NCT05072080|473599452|FG003|Overall Study|Withdrawal by parent|0|||
131540199|NCT05072080|473599449|FG000|Overall Study|Subject was deployed|0|||
131540200|NCT05072080|473599450|FG001|Overall Study|Subject was deployed|1|||
131540201|NCT05072080|473599451|FG002|Overall Study|Subject was deployed|0|||
131540202|NCT05072080|473599452|FG003|Overall Study|Subject was deployed|0|||
131540203|NCT05072080|473599449|FG000|Overall Study|Subject left site without receiving dose|0|||
131540204|NCT05072080|473599450|FG001|Overall Study|Subject left site without receiving dose|1|||
131540205|NCT05072080|473599451|FG002|Overall Study|Subject left site without receiving dose|0|||
131540206|NCT05072080|473599452|FG003|Overall Study|Subject left site without receiving dose|0|||
131540207|NCT05072080|473599449|FG000|Overall Study|Subject incarcerated|0|||
131540208|NCT05072080|473599450|FG001|Overall Study|Subject incarcerated|1|||
131540209|NCT05072080|473599451|FG002|Overall Study|Subject incarcerated|0|||
131540210|NCT05072080|473599452|FG003|Overall Study|Subject incarcerated|1|||
131540211|NCT05072080|473599449|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
131540212|NCT05072080|473599450|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
131540213|NCT05072080|473599451|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
131540214|NCT05072080|473599452|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
131540215|NCT05072080|473599449|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
131540216|NCT05072080|473599450|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
131540217|NCT05072080|473599451|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
131540218|NCT05072080|473599452|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
131540219|NCT03152526|473599453|FG000|Overall Study|Withdrawal by Subject|0|||
131540220|NCT03152526|473599454|FG001|Overall Study|Withdrawal by Subject|1|||
131540221|NCT02395042|473599455|FG000|Treatment 1 Period|Adverse Event|1|||
131540222|NCT02395042|473599456|FG001|Treatment 1 Period|Adverse Event|3|||
131540223|NCT02395042|473599457|FG002|Treatment 1 Period|Adverse Event|1|||
131540224|NCT02395042|473599455|FG000|Treatment 1 Period|Lack of Efficacy|1|||
131540225|NCT02395042|473599456|FG001|Treatment 1 Period|Lack of Efficacy|1|||
131540226|NCT02395042|473599457|FG002|Treatment 1 Period|Lack of Efficacy|0|||
131540227|NCT02395042|473599455|FG000|Treatment 1 Period|Lost to Follow-up|1|||
131540228|NCT02395042|473599456|FG001|Treatment 1 Period|Lost to Follow-up|0|||
131540229|NCT02395042|473599457|FG002|Treatment 1 Period|Lost to Follow-up|0|||
131540230|NCT02395042|473599455|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
131540231|NCT02395042|473599456|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
131540232|NCT02395042|473599457|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
131540233|NCT02395042|473599455|FG000|Treatment 2 Period|Lack of Efficacy|1|||
131540234|NCT02395042|473599456|FG001|Treatment 2 Period|Lack of Efficacy|1|||
131540235|NCT02395042|473599457|FG002|Treatment 2 Period|Lack of Efficacy|0|||
131540236|NCT02807558|473599458|FG000|Overall Study|Consent withdrawn by participant|4|||
131540237|NCT02807558|473599459|FG001|Overall Study|Consent withdrawn by participant|0|||
131540238|NCT02807558|473599460|FG002|Overall Study|Consent withdrawn by participant|4|||
131540239|NCT02807558|473599461|FG003|Overall Study|Consent withdrawn by participant|2|||
131540240|NCT02807558|473599462|FG004|Overall Study|Consent withdrawn by participant|1|||
131540241|NCT02807558|473599463|FG005|Overall Study|Consent withdrawn by participant|0|||
131540242|NCT02807558|473599458|FG000|Overall Study|Non-compliance with Study Drug|0|||
131540243|NCT02807558|473599459|FG001|Overall Study|Non-compliance with Study Drug|0|||
131540244|NCT02807558|473599460|FG002|Overall Study|Non-compliance with Study Drug|1|||
131540245|NCT02807558|473599461|FG003|Overall Study|Non-compliance with Study Drug|0|||
131540246|NCT02807558|473599462|FG004|Overall Study|Non-compliance with Study Drug|0|||
131540247|NCT02807558|473599463|FG005|Overall Study|Non-compliance with Study Drug|0|||
131540248|NCT02807558|473599458|FG000|Overall Study|Adverse Event|0|||
131540249|NCT02807558|473599459|FG001|Overall Study|Adverse Event|0|||
131540250|NCT02807558|473599460|FG002|Overall Study|Adverse Event|9|||
131540251|NCT02807558|473599461|FG003|Overall Study|Adverse Event|0|||
131540252|NCT02807558|473599462|FG004|Overall Study|Adverse Event|0|||
131540253|NCT02807558|473599463|FG005|Overall Study|Adverse Event|0|||
131540254|NCT02807558|473599458|FG000|Overall Study|Death|23|||
131540255|NCT02807558|473599459|FG001|Overall Study|Death|2|||
131540256|NCT02807558|473599460|FG002|Overall Study|Death|3|||
131540257|NCT02807558|473599461|FG003|Overall Study|Death|43|||
131540258|NCT02807558|473599462|FG004|Overall Study|Death|24|||
131540259|NCT02807558|473599463|FG005|Overall Study|Death|15|||
131540260|NCT02807558|473599458|FG000|Overall Study|Progressive Disease|0|||
131540261|NCT02807558|473599459|FG001|Overall Study|Progressive Disease|0|||
131540262|NCT02807558|473599460|FG002|Overall Study|Progressive Disease|1|||
131540263|NCT02807558|473599461|FG003|Overall Study|Progressive Disease|0|||
131540264|NCT02807558|473599462|FG004|Overall Study|Progressive Disease|0|||
131540265|NCT02807558|473599463|FG005|Overall Study|Progressive Disease|0|||
131540266|NCT02807558|473599458|FG000|Overall Study|Other than specified|1|||
131540267|NCT02807558|473599459|FG001|Overall Study|Other than specified|0|||
131540268|NCT02807558|473599460|FG002|Overall Study|Other than specified|2|||
131540269|NCT02807558|473599461|FG003|Overall Study|Other than specified|0|||
131540270|NCT02807558|473599462|FG004|Overall Study|Other than specified|1|||
131540271|NCT02807558|473599463|FG005|Overall Study|Other than specified|1|||
131540272|NCT02807558|473599458|FG000|Overall Study|Lack of Efficacy|0|||
131540273|NCT02807558|473599459|FG001|Overall Study|Lack of Efficacy|0|||
131540274|NCT02807558|473599460|FG002|Overall Study|Lack of Efficacy|9|||
131540275|NCT02807558|473599461|FG003|Overall Study|Lack of Efficacy|0|||
131540276|NCT02807558|473599462|FG004|Overall Study|Lack of Efficacy|0|||
131540277|NCT02807558|473599463|FG005|Overall Study|Lack of Efficacy|0|||
131540278|NCT04969198|473599464|FG000|Overall Study|Withdrawal by Subject|20|||
131540279|NCT04969198|473599464|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
131540280|NCT04969198|473599464|FG000|Overall Study|Lost to Follow-up|20|||
131540281|NCT02701985|473599465|FG000|Overall Study|Withdrawal by Subject|1|||
131540282|NCT02701985|473599466|FG001|Overall Study|Withdrawal by Subject|1|||
131540283|NCT02701985|473599465|FG000|Overall Study|Lost to Follow-up|1|||
131540284|NCT02701985|473599466|FG001|Overall Study|Lost to Follow-up|0|||
131540285|NCT02701985|473599465|FG000|Overall Study|Death|1|||
131540286|NCT02701985|473599466|FG001|Overall Study|Death|0|||
131540287|NCT02701985|473599465|FG000|Overall Study|Adverse Event|0|||
131540288|NCT02701985|473599466|FG001|Overall Study|Adverse Event|5|||
131540289|NCT01640808|473599468|FG000|Overall Study|Unable to continue dynamic CT|14|||
131540290|NCT01640808|473599469|FG001|Overall Study|Unable to continue dynamic CT|4|||
131540291|NCT01640808|473599468|FG000|Overall Study|Withdrawal by Subject|12|||
131540292|NCT01640808|473599469|FG001|Overall Study|Withdrawal by Subject|4|||
131540293|NCT01640808|473599468|FG000|Overall Study|Lost to Follow-up|4|||
131540294|NCT01640808|473599469|FG001|Overall Study|Lost to Follow-up|0|||
131540295|NCT01640808|473599468|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
131540296|NCT01640808|473599469|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
131540297|NCT01640808|473599468|FG000|Overall Study|Administration of anticancer drugs|2|||
131540298|NCT01640808|473599469|FG001|Overall Study|Administration of anticancer drugs|1|||
131540299|NCT01640808|473599468|FG000|Overall Study|Physician Decision|19|||
131540300|NCT01640808|473599469|FG001|Overall Study|Physician Decision|5|||
131540301|NCT01640808|473599468|FG000|Overall Study|Randomized but not treated|4|||
131540302|NCT01640808|473599469|FG001|Overall Study|Randomized but not treated|2|||
131540303|NCT05207813|473599475|FG000|Overall Study|Lost to Follow-up|2|||
131540304|NCT01371851|473599476|FG000|Overall Study|Lost to Follow-up|5|||
131540305|NCT01371851|473599477|FG001|Overall Study|Lost to Follow-up|8|||
131540306|NCT01371851|473599476|FG000|Overall Study|was arrested and put in jail|0|||
131540307|NCT01371851|473599477|FG001|Overall Study|was arrested and put in jail|1|||
131540308|NCT01371851|473599476|FG000|Overall Study|non study related adverse event|1|||
131540309|NCT01371851|473599477|FG001|Overall Study|non study related adverse event|0|||
131540310|NCT01371851|473599476|FG000|Overall Study|Blood Pressure outside study parameters|2|||
131540311|NCT01371851|473599477|FG001|Overall Study|Blood Pressure outside study parameters|0|||
131540312|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
131540313|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
131540314|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
131540315|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
131540316|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
131540317|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
131540318|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
131658527|NCT01142232|474035355|FG004|Overall Study|Alternative Therapy|1|||
131540319|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
131540320|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
131540321|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
131540322|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
131540323|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
131540324|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
131540325|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
131540326|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
131540327|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
131540328|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
131540329|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
131540330|NCT00833638|473599478|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
131540331|NCT00833638|473599479|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
131540332|NCT00833638|473599480|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
131540333|NCT00833638|473599478|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
131540334|NCT00833638|473599479|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
131540335|NCT00833638|473599480|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
131540336|NCT00833638|473599478|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
131540337|NCT00833638|473599479|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
131540338|NCT00833638|473599480|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
131540339|NCT00490646|473599481|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
131540340|NCT00490646|473599482|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
131540341|NCT00490646|473599481|FG000|Overall Study|Never Treated (had an adverse event)|1|||
131540342|NCT00490646|473599482|FG001|Overall Study|Never Treated (had an adverse event)|0|||
131540343|NCT00490646|473599481|FG000|Overall Study|Never Treated (withdrew consent)|0|||
131540344|NCT00490646|473599482|FG001|Overall Study|Never Treated (withdrew consent)|1|||
131540345|NCT01178086|473599483|FG000|Overall Study|Participant refusal|7|||
131540346|NCT01178086|473599483|FG000|Overall Study|Physician Decision|44|||
131540347|NCT01178086|473599483|FG000|Overall Study|Switch to other CLL therapy|113|||
131540348|NCT01178086|473599483|FG000|Overall Study|Death|59|||
131540349|NCT01178086|473599483|FG000|Overall Study|Other unspecified|89|||
131540350|NCT01178086|473599483|FG000|Overall Study|Excluded from EAS|20|||
131540351|NCT05608629|473599484|FG000|Overall Study|Lost to Follow-up|2|||
131540352|NCT02962908|473599487|FG000|Overall Study|Lost to Follow-up|0|||
131540353|NCT02962908|473599488|FG001|Overall Study|Lost to Follow-up|3|||
131540354|NCT02962908|473599489|FG002|Overall Study|Lost to Follow-up|0|||
131540355|NCT02962908|473599490|FG003|Overall Study|Lost to Follow-up|1|||
131540356|NCT02962908|473599487|FG000|Overall Study|Withdrawal by Subject|0|||
131540357|NCT02962908|473599488|FG001|Overall Study|Withdrawal by Subject|3|||
131540358|NCT02962908|473599489|FG002|Overall Study|Withdrawal by Subject|0|||
131540359|NCT02962908|473599490|FG003|Overall Study|Withdrawal by Subject|2|||
131540360|NCT02962908|473599487|FG000|Overall Study|Protocol Violation|0|||
131540361|NCT02962908|473599488|FG001|Overall Study|Protocol Violation|1|||
131540362|NCT02962908|473599489|FG002|Overall Study|Protocol Violation|0|||
131540363|NCT02962908|473599490|FG003|Overall Study|Protocol Violation|0|||
131540364|NCT02962908|473599487|FG000|Overall Study|Physician Decision|0|||
131540365|NCT02962908|473599488|FG001|Overall Study|Physician Decision|1|||
131540366|NCT02962908|473599489|FG002|Overall Study|Physician Decision|0|||
131540367|NCT02962908|473599490|FG003|Overall Study|Physician Decision|0|||
131540368|NCT03543254|473599491|FG000|Overall Study|Lost to Follow-up|1|||
131540369|NCT01261338|473599492|FG000|Overall Study|Withdrawal by Subject|3|||
131540370|NCT01261338|473599493|FG001|Overall Study|Withdrawal by Subject|2|||
131540371|NCT00234065|473599494|FG000|Overall Study|Adverse Event|268|||
131540372|NCT00234065|473599495|FG001|Overall Study|Adverse Event|166|||
131540373|NCT00234065|473599494|FG000|Overall Study|Withdrawal by Subject|73|||
131540374|NCT00234065|473599495|FG001|Overall Study|Withdrawal by Subject|56|||
131540375|NCT00234065|473599494|FG000|Overall Study|Physician Decision|23|||
131540376|NCT00234065|473599495|FG001|Overall Study|Physician Decision|22|||
131540377|NCT00234065|473599494|FG000|Overall Study|Not Classified|111|||
131540378|NCT00234065|473599495|FG001|Overall Study|Not Classified|112|||
131540379|NCT00126438|473599496|FG000|Overall Study|Withdrawal due to adverse event|1|||
131540380|NCT00126438|473599497|FG001|Overall Study|Withdrawal due to adverse event|0|||
131540381|NCT00126438|473599496|FG000|Overall Study|Lost to Follow-up|22|||
131540382|NCT00126438|473599497|FG001|Overall Study|Lost to Follow-up|0|||
131540383|NCT00126438|473599496|FG000|Overall Study|Protocol Violation|8|||
131540384|NCT00126438|473599497|FG001|Overall Study|Protocol Violation|8|||
131540385|NCT00126438|473599496|FG000|Overall Study|Withdrawal by Subject|3|||
131540386|NCT00126438|473599497|FG001|Overall Study|Withdrawal by Subject|2|||
131540387|NCT02313428|473599498|FG000|Overall Study|Lost to Follow-up|1|||
131540388|NCT02313428|473599499|FG001|Overall Study|Lost to Follow-up|1|||
131540389|NCT02899728|473599500|FG000|Overall Study|Withdrawal by Subject|1|||
131540390|NCT02899728|473599501|FG001|Overall Study|Withdrawal by Subject|1|||
131540391|NCT00593567|473601376|FG000|Overall Study|Adverse Event|2|||
131540392|NCT00593567|473601377|FG001|Overall Study|Adverse Event|0|||
131540393|NCT00593567|473601376|FG000|Overall Study|Physician Decision|2|||
131540394|NCT00593567|473601377|FG001|Overall Study|Physician Decision|0|||
131540395|NCT00593567|473601376|FG000|Overall Study|Protocol Violation|13|||
131540396|NCT00593567|473601377|FG001|Overall Study|Protocol Violation|7|||
131540397|NCT00593567|473601376|FG000|Overall Study|Lack of Efficacy|2|||
131540398|NCT00593567|473601377|FG001|Overall Study|Lack of Efficacy|1|||
131540399|NCT00593567|473601376|FG000|Overall Study|Withdrawal by Subject|1|||
131540400|NCT00593567|473601377|FG001|Overall Study|Withdrawal by Subject|2|||
131540401|NCT00844857|473601380|FG000|Overall Study|Adverse Event|24|||
131540402|NCT00844857|473601381|FG001|Overall Study|Adverse Event|5|||
131540403|NCT00844857|473601380|FG000|Overall Study|Sponsor Decision|1|||
131540404|NCT00844857|473601381|FG001|Overall Study|Sponsor Decision|1|||
131540405|NCT00844857|473601380|FG000|Overall Study|Physician Decision|2|||
131540406|NCT00844857|473601381|FG001|Overall Study|Physician Decision|0|||
131540407|NCT00844857|473601380|FG000|Overall Study|Parent/Caregiver Decision|6|||
131540408|NCT00844857|473601381|FG001|Overall Study|Parent/Caregiver Decision|2|||
131540409|NCT00844857|473601380|FG000|Overall Study|Withdrawal by Subject|8|||
131540410|NCT00844857|473601381|FG001|Overall Study|Withdrawal by Subject|7|||
131540411|NCT00844857|473601380|FG000|Overall Study|Protocol Violation|6|||
131540412|NCT00844857|473601381|FG001|Overall Study|Protocol Violation|0|||
131540413|NCT00844857|473601380|FG000|Overall Study|Lack of Efficacy|5|||
131540414|NCT00844857|473601381|FG001|Overall Study|Lack of Efficacy|5|||
131540415|NCT00844857|473601380|FG000|Overall Study|Clinical Relapse|0|||
131540416|NCT00844857|473601381|FG001|Overall Study|Clinical Relapse|1|||
131540417|NCT00844857|473601380|FG000|Overall Study|Entry Criteria Not Met|0|||
131540418|NCT00844857|473601381|FG001|Overall Study|Entry Criteria Not Met|1|||
131540419|NCT00844857|473601380|FG000|Overall Study|Lost to Follow-up|2|||
131540420|NCT00844857|473601381|FG001|Overall Study|Lost to Follow-up|3|||
131540421|NCT00844857|473601380|FG000|Overall Study|Did Not Take Study Drug|3|||
131540422|NCT00844857|473601381|FG001|Overall Study|Did Not Take Study Drug|1|||
131540423|NCT00844857|473601380|FG000|Overall Study|Good Clinical Practice Violations|21|||
131540424|NCT00844857|473601381|FG001|Overall Study|Good Clinical Practice Violations|11|||
131540425|NCT02057874|473601382|FG000|Overall Study|participant did not return for scan|1|||
131540426|NCT00447057|473601388|FG000|Overall Study|Adverse Event|4|||
131540427|NCT00447057|473601389|FG001|Overall Study|Adverse Event|10|||
131540428|NCT00447057|473601390|FG002|Overall Study|Adverse Event|0|||
131540429|NCT00447057|473601391|FG003|Overall Study|Adverse Event|3|||
131540430|NCT00447057|473601388|FG000|Overall Study|Death due to study disease|6|||
131540431|NCT00447057|473601389|FG001|Overall Study|Death due to study disease|4|||
131540432|NCT00447057|473601390|FG002|Overall Study|Death due to study disease|1|||
131540433|NCT00447057|473601391|FG003|Overall Study|Death due to study disease|1|||
131540434|NCT00447057|473601388|FG000|Overall Study|Lost to Follow-up|0|||
131540435|NCT00447057|473601389|FG001|Overall Study|Lost to Follow-up|1|||
131540436|NCT00447057|473601390|FG002|Overall Study|Lost to Follow-up|0|||
131540437|NCT00447057|473601391|FG003|Overall Study|Lost to Follow-up|0|||
131540438|NCT00447057|473601388|FG000|Overall Study|Entry criteria not met|1|||
131540439|NCT00447057|473601389|FG001|Overall Study|Entry criteria not met|1|||
131540440|NCT00447057|473601390|FG002|Overall Study|Entry criteria not met|0|||
131540441|NCT00447057|473601391|FG003|Overall Study|Entry criteria not met|0|||
131540442|NCT00447057|473601388|FG000|Overall Study|Protocol Violation|0|||
131540443|NCT00447057|473601389|FG001|Overall Study|Protocol Violation|1|||
131540444|NCT00447057|473601390|FG002|Overall Study|Protocol Violation|0|||
131540445|NCT00447057|473601391|FG003|Overall Study|Protocol Violation|0|||
131540446|NCT00447057|473601388|FG000|Overall Study|Withdrawal by Subject|4|||
131540447|NCT00447057|473601389|FG001|Overall Study|Withdrawal by Subject|5|||
131540448|NCT00447057|473601390|FG002|Overall Study|Withdrawal by Subject|1|||
131540449|NCT00447057|473601391|FG003|Overall Study|Withdrawal by Subject|1|||
131540450|NCT00447057|473601388|FG000|Overall Study|Physician Decision|9|||
131540451|NCT00447057|473601389|FG001|Overall Study|Physician Decision|6|||
131540452|NCT00447057|473601390|FG002|Overall Study|Physician Decision|3|||
131540453|NCT00447057|473601391|FG003|Overall Study|Physician Decision|1|||
131540454|NCT00447057|473601388|FG000|Overall Study|Sponsor decision|1|||
131540455|NCT00447057|473601389|FG001|Overall Study|Sponsor decision|1|||
131540456|NCT00447057|473601390|FG002|Overall Study|Sponsor decision|0|||
131540457|NCT00447057|473601391|FG003|Overall Study|Sponsor decision|0|||
131540458|NCT00447057|473601388|FG000|Overall Study|Progressive disease|58|||
131540459|NCT00447057|473601389|FG001|Overall Study|Progressive disease|43|||
131540460|NCT00447057|473601390|FG002|Overall Study|Progressive disease|13|||
131540461|NCT00447057|473601391|FG003|Overall Study|Progressive disease|18|||
131540462|NCT00447057|473601388|FG000|Overall Study|Death due to adverse event|0|||
131540463|NCT00447057|473601389|FG001|Overall Study|Death due to adverse event|0|||
131540464|NCT00447057|473601390|FG002|Overall Study|Death due to adverse event|1|||
131540465|NCT00447057|473601391|FG003|Overall Study|Death due to adverse event|2|||
131540466|NCT00447057|473601388|FG000|Overall Study|Death, study drug related|0|||
131540467|NCT00447057|473601389|FG001|Overall Study|Death, study drug related|1|||
131540468|NCT00447057|473601390|FG002|Overall Study|Death, study drug related|0|||
131540469|NCT00447057|473601391|FG003|Overall Study|Death, study drug related|0|||
131540470|NCT00440531|473601392|FG000|Overall Study|Adverse Event|1|||
131540471|NCT00440531|473601393|FG001|Overall Study|Adverse Event|0|||
131540472|NCT00440531|473601394|FG002|Overall Study|Adverse Event|2|||
131540473|NCT00440531|473601392|FG000|Overall Study|Withdrawal by Subject|2|||
131540474|NCT00440531|473601393|FG001|Overall Study|Withdrawal by Subject|0|||
131540475|NCT00440531|473601394|FG002|Overall Study|Withdrawal by Subject|0|||
131540476|NCT00440531|473601392|FG000|Overall Study|Protocol Violation|1|||
131540477|NCT00440531|473601393|FG001|Overall Study|Protocol Violation|2|||
131540478|NCT00440531|473601394|FG002|Overall Study|Protocol Violation|0|||
131540479|NCT00440531|473601392|FG000|Overall Study|Lost to Follow-up|4|||
131540480|NCT00440531|473601393|FG001|Overall Study|Lost to Follow-up|3|||
131540481|NCT00440531|473601394|FG002|Overall Study|Lost to Follow-up|5|||
131540482|NCT00440531|473601392|FG000|Overall Study|see pre-assignment details|2|||
131540483|NCT00440531|473601393|FG001|Overall Study|see pre-assignment details|0|||
131540484|NCT00440531|473601394|FG002|Overall Study|see pre-assignment details|0|||
131540485|NCT03393000|473601398|FG000|Overall Study|Death|11|||
131540486|NCT03393000|473601398|FG000|Overall Study|Withdrawal by Subject|2|||
131540487|NCT03393000|473601398|FG000|Overall Study|Physician Decision|1|||
131540488|NCT04493216|473601399|FG000|Overall Study|Study terminated by sponsor|30|||
131540489|NCT04493216|473601400|FG001|Overall Study|Study terminated by sponsor|33|||
131540490|NCT04493216|473601401|FG002|Overall Study|Study terminated by sponsor|28|||
131540491|NCT04493216|473601402|FG003|Overall Study|Study terminated by sponsor|27|||
131540492|NCT04493216|473601399|FG000|Overall Study|Withdrawal by Subject|2|||
131540493|NCT04493216|473601400|FG001|Overall Study|Withdrawal by Subject|1|||
131540494|NCT04493216|473601401|FG002|Overall Study|Withdrawal by Subject|1|||
131540495|NCT04493216|473601402|FG003|Overall Study|Withdrawal by Subject|2|||
131540496|NCT04493216|473601399|FG000|Overall Study|Protocol Violation|1|||
131540497|NCT04493216|473601400|FG001|Overall Study|Protocol Violation|2|||
131540498|NCT04493216|473601401|FG002|Overall Study|Protocol Violation|0|||
131540499|NCT04493216|473601402|FG003|Overall Study|Protocol Violation|2|||
131540500|NCT04493216|473601399|FG000|Overall Study|Physician Decision|0|||
131540501|NCT04493216|473601400|FG001|Overall Study|Physician Decision|0|||
131540502|NCT04493216|473601401|FG002|Overall Study|Physician Decision|1|||
131540503|NCT04493216|473601402|FG003|Overall Study|Physician Decision|0|||
131540504|NCT04493216|473601399|FG000|Overall Study|Lost to Follow-up|2|||
131540505|NCT04493216|473601400|FG001|Overall Study|Lost to Follow-up|1|||
131540506|NCT04493216|473601401|FG002|Overall Study|Lost to Follow-up|0|||
131540507|NCT04493216|473601402|FG003|Overall Study|Lost to Follow-up|1|||
131540508|NCT04493216|473601399|FG000|Overall Study|Adverse Event|1|||
131540509|NCT04493216|473601400|FG001|Overall Study|Adverse Event|4|||
131540510|NCT04493216|473601401|FG002|Overall Study|Adverse Event|5|||
131540511|NCT04493216|473601402|FG003|Overall Study|Adverse Event|2|||
131540512|NCT04493216|473601399|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
131540513|NCT04493216|473601400|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
131540514|NCT04493216|473601401|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
131540515|NCT04493216|473601402|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
131540516|NCT01559844|473601403|FG000|Overall Study|Consent Withdrawn|7|||
131540517|NCT01559844|473601403|FG000|Overall Study|Death|5|||
131540518|NCT01559844|473601403|FG000|Overall Study|Efficacy Failure|10|||
131540519|NCT01559844|473601403|FG000|Overall Study|No Longer A Transplant Candidate|3|||
131540520|NCT00951041|473601406|FG000|Overall Study|Withdrawal by Subject|1|||
131540521|NCT00951041|473601407|FG001|Overall Study|Withdrawal by Subject|1|||
131540522|NCT00951041|473601406|FG000|Overall Study|Lost to Follow-up|1|||
131540523|NCT00951041|473601407|FG001|Overall Study|Lost to Follow-up|0|||
131540524|NCT00951041|473601406|FG000|Overall Study|Other|3|||
131540525|NCT00951041|473601407|FG001|Overall Study|Other|0|||
131540526|NCT01514448|473601408|FG000|Overall Study|Death|7|||
131540527|NCT01514448|473601409|FG001|Overall Study|Death|8|||
131540528|NCT01514448|473601408|FG000|Overall Study|Withdrawal by Subject|2|||
131540529|NCT01514448|473601409|FG001|Overall Study|Withdrawal by Subject|0|||
131540530|NCT01514448|473601408|FG000|Overall Study|Lost to Follow-up|2|||
131540531|NCT01514448|473601409|FG001|Overall Study|Lost to Follow-up|0|||
131540532|NCT01514448|473601408|FG000|Overall Study|New Cancer Therapy|1|||
131540533|NCT01514448|473601409|FG001|Overall Study|New Cancer Therapy|0|||
131540534|NCT02314624|473601410|FG000|Overall Study|No participating patient|16|||
131540535|NCT02314624|473601411|FG001|Overall Study|No participating patient|13|||
131540536|NCT02314624|473601410|FG000|Overall Study|Participant withdrew|7|||
131540537|NCT02314624|473601411|FG001|Overall Study|Participant withdrew|2|||
131540538|NCT02314624|473601410|FG000|Overall Study|Lost to Follow-up|2|||
131540539|NCT02314624|473601411|FG001|Overall Study|Lost to Follow-up|5|||
131540540|NCT02314624|473601410|FG000|Overall Study|Dropped/Excluded by PI|6|||
131540541|NCT02314624|473601411|FG001|Overall Study|Dropped/Excluded by PI|6|||
131540542|NCT03151005|473601412|FG000|Overall Study|Lost to Follow-up|5|||
131540543|NCT03151005|473601413|FG001|Overall Study|Lost to Follow-up|5|||
131540544|NCT04786444|473601416|FG000|Overall Study|Withdrawal by Subject|4|||
131540545|NCT04786444|473601417|FG001|Overall Study|Withdrawal by Subject|7|||
131540546|NCT04786444|473601418|FG002|Overall Study|Withdrawal by Subject|2|||
131540547|NCT04786444|473601416|FG000|Overall Study|Lost to Follow-up|11|||
131540548|NCT04786444|473601417|FG001|Overall Study|Lost to Follow-up|9|||
131540549|NCT04786444|473601418|FG002|Overall Study|Lost to Follow-up|10|||
131540550|NCT04786444|473601416|FG000|Overall Study|Subject would like to become pregnant|0|||
131540551|NCT04786444|473601417|FG001|Overall Study|Subject would like to become pregnant|1|||
131540552|NCT04786444|473601418|FG002|Overall Study|Subject would like to become pregnant|0|||
131540553|NCT02462876|473601419|FG000|Overall Study|Death|3|||
131540554|NCT02462876|473601419|FG000|Overall Study|Lost to Follow-up|7|||
131540555|NCT02462876|473601419|FG000|Overall Study|Surgical Bypass|9|||
131540556|NCT02462876|473601419|FG000|Overall Study|Amputation Above the Metatarsals|1|||
131540557|NCT02462876|473601419|FG000|Overall Study|36 months follow-up visit missed|1|||
131540558|NCT02462876|473601419|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
131540559|NCT02462876|473601419|FG000|Overall Study|Patient did not come back to the vascular department|1|||
131540560|NCT02462876|473601419|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
131540561|NCT02462876|473601419|FG000|Overall Study|Patient refused to come back|1|||
131540562|NCT02462876|473601419|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
131540563|NCT02462876|473601419|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
131540564|NCT01786512|473601424|FG000|Overall Study|Lost to Follow-up|0|||
131540565|NCT01786512|473601425|FG001|Overall Study|Lost to Follow-up|0|||
131540566|NCT01786512|473601426|FG002|Overall Study|Lost to Follow-up|0|||
131540567|NCT01786512|473601427|FG003|Overall Study|Lost to Follow-up|0|||
131540568|NCT01786512|473601428|FG004|Overall Study|Lost to Follow-up|0|||
131540569|NCT01786512|473601429|FG005|Overall Study|Lost to Follow-up|0|||
131540570|NCT01786512|473601430|FG006|Overall Study|Lost to Follow-up|0|||
131540571|NCT01786512|473601431|FG007|Overall Study|Lost to Follow-up|0|||
131540572|NCT01786512|473601432|FG008|Overall Study|Lost to Follow-up|0|||
131540573|NCT01786512|473601433|FG009|Overall Study|Lost to Follow-up|1|||
131540574|NCT01786512|473601434|FG010|Overall Study|Lost to Follow-up|0|||
131540575|NCT01786512|473601424|FG000|Overall Study|Decision by sponsor|0|||
131540576|NCT01786512|473601425|FG001|Overall Study|Decision by sponsor|0|||
131540577|NCT01786512|473601426|FG002|Overall Study|Decision by sponsor|0|||
131540578|NCT01786512|473601427|FG003|Overall Study|Decision by sponsor|0|||
131540579|NCT01786512|473601428|FG004|Overall Study|Decision by sponsor|0|||
131540580|NCT01786512|473601429|FG005|Overall Study|Decision by sponsor|0|||
131540581|NCT01786512|473601430|FG006|Overall Study|Decision by sponsor|0|||
131540582|NCT01786512|473601431|FG007|Overall Study|Decision by sponsor|0|||
131540583|NCT01786512|473601432|FG008|Overall Study|Decision by sponsor|0|||
131540584|NCT01786512|473601433|FG009|Overall Study|Decision by sponsor|0|||
131540585|NCT01786512|473601434|FG010|Overall Study|Decision by sponsor|2|||
131540586|NCT01786512|473601424|FG000|Overall Study|Withdrawal by Subject|0|||
131540587|NCT01786512|473601425|FG001|Overall Study|Withdrawal by Subject|1|||
131540588|NCT01786512|473601426|FG002|Overall Study|Withdrawal by Subject|0|||
131540589|NCT01786512|473601427|FG003|Overall Study|Withdrawal by Subject|0|||
131540590|NCT01786512|473601428|FG004|Overall Study|Withdrawal by Subject|0|||
131540591|NCT01786512|473601429|FG005|Overall Study|Withdrawal by Subject|0|||
131540592|NCT01786512|473601430|FG006|Overall Study|Withdrawal by Subject|1|||
131540593|NCT01786512|473601431|FG007|Overall Study|Withdrawal by Subject|0|||
131540594|NCT01786512|473601432|FG008|Overall Study|Withdrawal by Subject|0|||
131540595|NCT01786512|473601433|FG009|Overall Study|Withdrawal by Subject|3|||
131540596|NCT01786512|473601434|FG010|Overall Study|Withdrawal by Subject|7|||
131540597|NCT01786512|473601424|FG000|Overall Study|Death|0|||
131540598|NCT01786512|473601425|FG001|Overall Study|Death|0|||
131540599|NCT01786512|473601426|FG002|Overall Study|Death|0|||
131540600|NCT01786512|473601427|FG003|Overall Study|Death|0|||
131540601|NCT01786512|473601428|FG004|Overall Study|Death|0|||
131540602|NCT01786512|473601429|FG005|Overall Study|Death|0|||
131540603|NCT01786512|473601430|FG006|Overall Study|Death|0|||
131540604|NCT01786512|473601431|FG007|Overall Study|Death|0|||
131540605|NCT01786512|473601432|FG008|Overall Study|Death|4|||
131540606|NCT01786512|473601433|FG009|Overall Study|Death|1|||
131540607|NCT01786512|473601434|FG010|Overall Study|Death|3|||
131540608|NCT00605293|473601435|FG000|Overall Study|Death|2|||
131540609|NCT00605293|473601436|FG001|Overall Study|Death|1|||
131540610|NCT00605293|473601435|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131540611|NCT00605293|473601436|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131540612|NCT00605293|473601435|FG000|Overall Study|Adverse Event|1|||
131540613|NCT00605293|473601436|FG001|Overall Study|Adverse Event|0|||
131540614|NCT00605293|473601435|FG000|Overall Study|Holidays Dialysis Out|1|||
131540615|NCT00605293|473601436|FG001|Overall Study|Holidays Dialysis Out|0|||
131540616|NCT00605293|473601435|FG000|Overall Study|Blood Transfusion|7|||
131540617|NCT00605293|473601436|FG001|Overall Study|Blood Transfusion|1|||
131540618|NCT00605293|473601435|FG000|Overall Study|Renal Transplantation|3|||
131540619|NCT00605293|473601436|FG001|Overall Study|Renal Transplantation|1|||
131540620|NCT00605293|473601435|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
131540621|NCT00605293|473601436|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
131540622|NCT00605293|473601435|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
131540623|NCT00605293|473601436|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
131540624|NCT00605293|473601435|FG000|Overall Study|Principal Investigator Decision|0|||
131540625|NCT00605293|473601436|FG001|Overall Study|Principal Investigator Decision|1|||
131540626|NCT03137303|473601438|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
131540627|NCT03137303|473601439|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
131540628|NCT03137303|473601438|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
131540629|NCT03137303|473601439|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
131540630|NCT03137303|473601438|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
131540631|NCT03137303|473601439|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
131540632|NCT03137303|473601438|FG000|T3: 9-month Follow-up|Death|1|||
131540633|NCT03137303|473601439|FG001|T3: 9-month Follow-up|Death|0|||
131540634|NCT03137303|473601438|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
131540635|NCT03137303|473601439|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
131540636|NCT03137303|473601438|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
131540637|NCT03137303|473601439|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
131540638|NCT03137303|473601438|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
131540639|NCT03137303|473601439|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
131540640|NCT02723864|473601442|FG000|Overall Study|Refused further treatment|1|||
131540641|NCT02723864|473601443|FG001|Overall Study|Refused further treatment|0|||
131540642|NCT02723864|473601444|FG002|Overall Study|Refused further treatment|0|||
131540643|NCT02723864|473601445|FG003|Overall Study|Refused further treatment|0|||
131540644|NCT02723864|473601446|FG004|Overall Study|Refused further treatment|1|||
131540645|NCT02723864|473601447|FG005|Overall Study|Refused further treatment|2|||
131540646|NCT02723864|473601448|FG006|Overall Study|Refused further treatment|0|||
131540647|NCT02723864|473601442|FG000|Overall Study|Exceed treatment hold time|0|||
131540648|NCT02723864|473601443|FG001|Overall Study|Exceed treatment hold time|1|||
131540649|NCT02723864|473601444|FG002|Overall Study|Exceed treatment hold time|0|||
131540650|NCT02723864|473601445|FG003|Overall Study|Exceed treatment hold time|0|||
131540651|NCT02723864|473601446|FG004|Overall Study|Exceed treatment hold time|0|||
131540652|NCT02723864|473601447|FG005|Overall Study|Exceed treatment hold time|0|||
131540653|NCT02723864|473601448|FG006|Overall Study|Exceed treatment hold time|0|||
131540654|NCT02723864|473601442|FG000|Overall Study|Clinical progression|0|||
131540655|NCT02723864|473601443|FG001|Overall Study|Clinical progression|0|||
131540656|NCT02723864|473601444|FG002|Overall Study|Clinical progression|1|||
131540657|NCT02723864|473601445|FG003|Overall Study|Clinical progression|0|||
131540658|NCT02723864|473601446|FG004|Overall Study|Clinical progression|0|||
131540659|NCT02723864|473601447|FG005|Overall Study|Clinical progression|3|||
131540660|NCT02723864|473601448|FG006|Overall Study|Clinical progression|1|||
131540661|NCT02723864|473601442|FG000|Overall Study|Physician Decision|0|||
131540662|NCT02723864|473601443|FG001|Overall Study|Physician Decision|0|||
131540663|NCT02723864|473601444|FG002|Overall Study|Physician Decision|0|||
131540664|NCT02723864|473601445|FG003|Overall Study|Physician Decision|0|||
131540665|NCT02723864|473601446|FG004|Overall Study|Physician Decision|0|||
131540666|NCT02723864|473601447|FG005|Overall Study|Physician Decision|0|||
131540667|NCT02723864|473601448|FG006|Overall Study|Physician Decision|1|||
131540668|NCT02723864|473601442|FG000|Overall Study|Changes in patient condition|0|||
131540669|NCT02723864|473601443|FG001|Overall Study|Changes in patient condition|0|||
131540670|NCT02723864|473601444|FG002|Overall Study|Changes in patient condition|0|||
131540671|NCT02723864|473601445|FG003|Overall Study|Changes in patient condition|0|||
131540672|NCT02723864|473601446|FG004|Overall Study|Changes in patient condition|0|||
131540673|NCT02723864|473601447|FG005|Overall Study|Changes in patient condition|1|||
131540674|NCT02723864|473601448|FG006|Overall Study|Changes in patient condition|0|||
131540675|NCT02723864|473601442|FG000|Overall Study|Patient choice|0|||
131540676|NCT02723864|473601443|FG001|Overall Study|Patient choice|0|||
131540677|NCT02723864|473601444|FG002|Overall Study|Patient choice|0|||
131540678|NCT02723864|473601445|FG003|Overall Study|Patient choice|0|||
131540679|NCT02723864|473601446|FG004|Overall Study|Patient choice|0|||
131540680|NCT02723864|473601447|FG005|Overall Study|Patient choice|1|||
131540681|NCT02723864|473601448|FG006|Overall Study|Patient choice|0|||
131540682|NCT02723864|473601442|FG000|Overall Study|Adverse Event|0|||
131540683|NCT02723864|473601443|FG001|Overall Study|Adverse Event|0|||
131540684|NCT02723864|473601444|FG002|Overall Study|Adverse Event|0|||
131540685|NCT02723864|473601445|FG003|Overall Study|Adverse Event|0|||
131540686|NCT02723864|473601446|FG004|Overall Study|Adverse Event|0|||
131540687|NCT02723864|473601447|FG005|Overall Study|Adverse Event|1|||
131540688|NCT02723864|473601448|FG006|Overall Study|Adverse Event|0|||
131540689|NCT02723864|473601442|FG000|Overall Study|Started new treatment|0|||
131540690|NCT02723864|473601443|FG001|Overall Study|Started new treatment|0|||
131540691|NCT02723864|473601444|FG002|Overall Study|Started new treatment|0|||
131540692|NCT02723864|473601445|FG003|Overall Study|Started new treatment|0|||
131540693|NCT02723864|473601446|FG004|Overall Study|Started new treatment|0|||
131540694|NCT02723864|473601447|FG005|Overall Study|Started new treatment|1|||
131540695|NCT02723864|473601448|FG006|Overall Study|Started new treatment|0|||
131540696|NCT02723864|473601442|FG000|Overall Study|Switched to alternative treatment|0|||
131540697|NCT02723864|473601443|FG001|Overall Study|Switched to alternative treatment|0|||
131540698|NCT02723864|473601444|FG002|Overall Study|Switched to alternative treatment|0|||
131540699|NCT02723864|473601445|FG003|Overall Study|Switched to alternative treatment|0|||
131540700|NCT02723864|473601446|FG004|Overall Study|Switched to alternative treatment|0|||
131540701|NCT02723864|473601447|FG005|Overall Study|Switched to alternative treatment|1|||
131540702|NCT02723864|473601448|FG006|Overall Study|Switched to alternative treatment|0|||
131540703|NCT02723864|473601442|FG000|Overall Study|Late determination of ineligibility|0|||
131540704|NCT02723864|473601443|FG001|Overall Study|Late determination of ineligibility|0|||
131540705|NCT02723864|473601444|FG002|Overall Study|Late determination of ineligibility|0|||
131540706|NCT02723864|473601445|FG003|Overall Study|Late determination of ineligibility|0|||
131540707|NCT02723864|473601446|FG004|Overall Study|Late determination of ineligibility|0|||
131540708|NCT02723864|473601447|FG005|Overall Study|Late determination of ineligibility|1|||
131540709|NCT02723864|473601448|FG006|Overall Study|Late determination of ineligibility|0|||
131540710|NCT00815295|473601456|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
131540711|NCT00815295|473601457|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
131540712|NCT00815295|473601458|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
131540713|NCT00530855|473601459|FG000|Overall Study|Lack of Efficacy|20|||
131540714|NCT00530855|473601459|FG000|Overall Study|Withdrawal by Subject|30|||
131540715|NCT00530855|473601459|FG000|Overall Study|Fatal Serious AE|3|||
131540716|NCT00530855|473601459|FG000|Overall Study|Non Fatal Serious AE|7|||
131540717|NCT00530855|473601459|FG000|Overall Study|Non Fatal Non Serious AE|12|||
131540718|NCT00530855|473601459|FG000|Overall Study|Protocol Violation|3|||
131540719|NCT00530855|473601459|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
131540720|NCT00530855|473601459|FG000|Overall Study|Lost to Follow-up|9|||
131540721|NCT00530855|473601459|FG000|Overall Study|Other reason for premature termination|17|||
131540722|NCT01292876|473601460|FG000|Overall Study|Physician Decision|4|||
131540723|NCT01328574|473601476|FG000|Overall Study|Refused further treatment|1|||
131540724|NCT00003298|473601477|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
131540725|NCT00003298|473601477|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
131540726|NCT00003298|473601477|FG000|Surgery|Unresectable at surgery|3|||
131540727|NCT00003298|473601477|FG000|Surgery|Progression before surgery|2|||
131540728|NCT00003298|473601477|FG000|Surgery|Unevaluable and off study|2|||
131540729|NCT00003298|473601477|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
131540730|NCT00003298|473601477|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
131540731|NCT00003298|473601477|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
131540732|NCT00003298|473601477|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
131540733|NCT00003298|473601477|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
131540734|NCT00003298|473601477|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
131540735|NCT00003298|473601477|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
131540736|NCT00003298|473601477|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
131540737|NCT00003298|473601477|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
131540738|NCT00003298|473601477|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
131540739|NCT01994954|473601482|FG000|Overall Study|Death|1|||
131540740|NCT01994954|473601483|FG001|Overall Study|Death|0|||
131540741|NCT01994954|473601482|FG000|Overall Study|Withdrawal by Subject|9|||
131540742|NCT01994954|473601483|FG001|Overall Study|Withdrawal by Subject|14|||
131540743|NCT01994954|473601482|FG000|Overall Study|Physician Decision|2|||
131540744|NCT01994954|473601483|FG001|Overall Study|Physician Decision|2|||
131540745|NCT01994954|473601482|FG000|Overall Study|Lost to Follow-up|8|||
131540746|NCT01994954|473601483|FG001|Overall Study|Lost to Follow-up|10|||
131540747|NCT01994954|473601482|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
131540748|NCT01994954|473601483|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
131540749|NCT01454583|473601488|FG000|1st Year|Lost to Follow-up|1057|||
131540750|NCT01454583|473601489|FG001|1st Year|Lost to Follow-up|318|||
131540751|NCT01454583|473601490|FG002|1st Year|Lost to Follow-up|180|||
131540752|NCT01454583|473601488|FG000|2nd Year|Lost to Follow-up|3965|||
131540753|NCT01454583|473601489|FG001|2nd Year|Lost to Follow-up|1049|||
131540754|NCT01454583|473601490|FG002|2nd Year|Lost to Follow-up|737|||
131540755|NCT01454583|473601488|FG000|3rd Year|Lost to Follow-up|1959|||
131540756|NCT01454583|473601489|FG001|3rd Year|Lost to Follow-up|512|||
131540757|NCT01454583|473601490|FG002|3rd Year|Lost to Follow-up|297|||
131540758|NCT02677116|473601493|FG000|Overall Study|Adverse Event|0|||
131540759|NCT02677116|473601494|FG001|Overall Study|Adverse Event|1|||
131540760|NCT02677116|473601495|FG002|Overall Study|Adverse Event|0|||
131540761|NCT02677116|473601496|FG003|Overall Study|Adverse Event|0|||
131540762|NCT02677116|473601497|FG004|Overall Study|Adverse Event|0|||
131540763|NCT02677116|473601498|FG005|Overall Study|Adverse Event|1|||
131540764|NCT02677116|473601499|FG006|Overall Study|Adverse Event|1|||
131540765|NCT02677116|473601500|FG007|Overall Study|Adverse Event|0|||
131540766|NCT02677116|473601501|FG008|Overall Study|Adverse Event|0|||
131540767|NCT02677116|473601493|FG000|Overall Study|Physician Decision|0|||
131540768|NCT02677116|473601494|FG001|Overall Study|Physician Decision|2|||
131540769|NCT02677116|473601495|FG002|Overall Study|Physician Decision|3|||
131540770|NCT02677116|473601496|FG003|Overall Study|Physician Decision|2|||
131540771|NCT02677116|473601497|FG004|Overall Study|Physician Decision|1|||
131540772|NCT02677116|473601498|FG005|Overall Study|Physician Decision|3|||
131540773|NCT02677116|473601499|FG006|Overall Study|Physician Decision|1|||
131540774|NCT02677116|473601500|FG007|Overall Study|Physician Decision|1|||
131540775|NCT02677116|473601501|FG008|Overall Study|Physician Decision|2|||
131658600|NCT02003222|474035396|FG001|Induction|Adverse Event|0|||
131540776|NCT02677116|473601493|FG000|Overall Study|Withdrawal by parent or guardian|2|||
131540777|NCT02677116|473601494|FG001|Overall Study|Withdrawal by parent or guardian|1|||
131540778|NCT02677116|473601495|FG002|Overall Study|Withdrawal by parent or guardian|0|||
131540779|NCT02677116|473601496|FG003|Overall Study|Withdrawal by parent or guardian|1|||
131540780|NCT02677116|473601497|FG004|Overall Study|Withdrawal by parent or guardian|0|||
131540781|NCT02677116|473601498|FG005|Overall Study|Withdrawal by parent or guardian|0|||
131540782|NCT02677116|473601499|FG006|Overall Study|Withdrawal by parent or guardian|2|||
131540783|NCT02677116|473601500|FG007|Overall Study|Withdrawal by parent or guardian|1|||
131540784|NCT02677116|473601501|FG008|Overall Study|Withdrawal by parent or guardian|0|||
131540785|NCT02677116|473601493|FG000|Overall Study|Withdrawal by Subject|1|||
131540786|NCT02677116|473601494|FG001|Overall Study|Withdrawal by Subject|0|||
131540787|NCT02677116|473601495|FG002|Overall Study|Withdrawal by Subject|0|||
131540788|NCT02677116|473601496|FG003|Overall Study|Withdrawal by Subject|0|||
131540789|NCT02677116|473601497|FG004|Overall Study|Withdrawal by Subject|0|||
131540790|NCT02677116|473601498|FG005|Overall Study|Withdrawal by Subject|0|||
131540791|NCT02677116|473601499|FG006|Overall Study|Withdrawal by Subject|0|||
131540792|NCT02677116|473601500|FG007|Overall Study|Withdrawal by Subject|0|||
131540793|NCT02677116|473601501|FG008|Overall Study|Withdrawal by Subject|0|||
131540794|NCT02363946|473601502|FG000|Overall Study|Lost to Follow-up|0|||
131540795|NCT02363946|473601503|FG001|Overall Study|Lost to Follow-up|0|||
131540796|NCT02363946|473601504|FG002|Overall Study|Lost to Follow-up|0|||
131540797|NCT02363946|473601505|FG003|Overall Study|Lost to Follow-up|0|||
131540798|NCT02363946|473601506|FG004|Overall Study|Lost to Follow-up|0|||
131540799|NCT02363946|473601507|FG005|Overall Study|Lost to Follow-up|0|||
131540800|NCT02363946|473601508|FG006|Overall Study|Lost to Follow-up|0|||
131540801|NCT02363946|473601509|FG007|Overall Study|Lost to Follow-up|1|||
131540802|NCT02363946|473601510|FG008|Overall Study|Lost to Follow-up|0|||
131540803|NCT02363946|473601511|FG009|Overall Study|Lost to Follow-up|0|||
131540804|NCT02363946|473601512|FG010|Overall Study|Lost to Follow-up|0|||
131540805|NCT02363946|473601513|FG011|Overall Study|Lost to Follow-up|0|||
131540806|NCT02363946|473601514|FG012|Overall Study|Lost to Follow-up|0|||
131540807|NCT01967732|473601515|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
131540808|NCT01967732|473601516|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
131540809|NCT01967732|473601517|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
131540810|NCT01967732|473601518|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
131540811|NCT01967732|473601515|FG000|First Intervention (Day 1)|Poor venous access|0|||
131540812|NCT01967732|473601516|FG001|First Intervention (Day 1)|Poor venous access|1|||
131540813|NCT01967732|473601517|FG002|First Intervention (Day 1)|Poor venous access|0|||
131540814|NCT01967732|473601518|FG003|First Intervention (Day 1)|Poor venous access|0|||
131540815|NCT03342638|473601519|FG000|Overall Study|Withdrawal by Subject|1|||
131540816|NCT03342638|473601520|FG001|Overall Study|Withdrawal by Subject|0|||
131540817|NCT03342638|473601519|FG000|Overall Study|Physician Decision|0|||
131540818|NCT03342638|473601520|FG001|Overall Study|Physician Decision|1|||
131540819|NCT01292239|473601536|FG000|Overall Study|Other|1|||
131540820|NCT01292239|473601537|FG001|Overall Study|Other|1|||
131540821|NCT01292239|473601536|FG000|Overall Study|Withdrawal by Subject|3|||
131540822|NCT01292239|473601537|FG001|Overall Study|Withdrawal by Subject|6|||
131540823|NCT00113568|473601538|FG000|Overall Study|Adverse Event|97|||
131540824|NCT00113568|473601538|FG000|Overall Study|Death|1|||
131540825|NCT00113568|473601538|FG000|Overall Study|Lack of Efficacy|30|||
131540826|NCT00113568|473601538|FG000|Overall Study|Lost to Follow-up|156|||
131540827|NCT00113568|473601538|FG000|Overall Study|Protocol Violation|32|||
131540828|NCT00113568|473601538|FG000|Overall Study|Withdrawal by Subject|117|||
131540829|NCT00113568|473601538|FG000|Overall Study|Other|112|||
131540830|NCT00262821|473601539|FG000|Overall Study|Ineligible - wrong stage|0|||
131540831|NCT00262821|473601540|FG001|Overall Study|Ineligible - wrong stage|3|||
131540832|NCT00262821|473601539|FG000|Overall Study|Ineligible - wrong cell type|2|||
131540833|NCT00262821|473601540|FG001|Overall Study|Ineligible - wrong cell type|2|||
131540834|NCT00262821|473601539|FG000|Overall Study|Ineligible - wrong primary|0|||
131540835|NCT00262821|473601540|FG001|Overall Study|Ineligible - wrong primary|1|||
131540836|NCT00262821|473601539|FG000|Overall Study|Ineligible - inadequate pathology|1|||
131540837|NCT00262821|473601540|FG001|Overall Study|Ineligible - inadequate pathology|3|||
131540838|NCT00262821|473601539|FG000|Overall Study|Ineligible - elevated creatinine|0|||
131540839|NCT00262821|473601540|FG001|Overall Study|Ineligible - elevated creatinine|2|||
131540840|NCT00262821|473601539|FG000|Overall Study|Ineligible - required test not done|1|||
131540841|NCT00262821|473601540|FG001|Overall Study|Ineligible - required test not done|4|||
131540842|NCT00262821|473601539|FG000|Overall Study|Inevaluable - inadequate data|0|||
131540843|NCT00262821|473601540|FG001|Overall Study|Inevaluable - inadequate data|4|||
131540844|NCT01988779|473601542|FG000|Overall Study|Withdrawal by Subject|2|||
131540845|NCT01988779|473601543|FG001|Overall Study|Withdrawal by Subject|2|||
131540846|NCT01988779|473601542|FG000|Overall Study|Protocol Violation|1|||
131540847|NCT01988779|473601543|FG001|Overall Study|Protocol Violation|0|||
131540848|NCT00584727|473601544|FG000|First Intervention|Discontinuation|0|||
131540849|NCT00584727|473601545|FG001|First Intervention|Discontinuation|0|||
131540850|NCT00584727|473601546|FG002|First Intervention|Discontinuation|1|||
131540851|NCT00584727|473601547|FG003|First Intervention|Discontinuation|0|||
131540852|NCT00584727|473601548|FG004|First Intervention|Discontinuation|0|||
131540853|NCT00584727|473601549|FG005|First Intervention|Discontinuation|0|||
131540854|NCT00584727|473601544|FG000|Third Intervention|Protocol Violation|0|||
131540855|NCT00584727|473601545|FG001|Third Intervention|Protocol Violation|0|||
131540856|NCT00584727|473601546|FG002|Third Intervention|Protocol Violation|1|||
131540857|NCT00584727|473601547|FG003|Third Intervention|Protocol Violation|0|||
131540858|NCT00584727|473601548|FG004|Third Intervention|Protocol Violation|4|||
131540859|NCT00584727|473601549|FG005|Third Intervention|Protocol Violation|2|||
131540860|NCT00377403|473601551|FG000|Overall Study|Unable to contact for telephone intervie|4|||
131540861|NCT00377403|473601552|FG001|Overall Study|Unable to contact for telephone intervie|7|||
131540862|NCT01922076|473601553|FG000|Overall Study|Adverse Event|0|||
131540863|NCT01922076|473601554|FG001|Overall Study|Adverse Event|0|||
131540864|NCT01922076|473601555|FG002|Overall Study|Adverse Event|0|||
131540865|NCT01922076|473601556|FG003|Overall Study|Adverse Event|0|||
131540866|NCT01922076|473601557|FG004|Overall Study|Adverse Event|1|||
131540867|NCT01922076|473601558|FG005|Overall Study|Adverse Event|0|||
131540868|NCT01922076|473601559|FG006|Overall Study|Adverse Event|0|||
131540869|NCT01922076|473601553|FG000|Overall Study|Physician Decision|0|||
131540870|NCT01922076|473601554|FG001|Overall Study|Physician Decision|0|||
131540871|NCT01922076|473601555|FG002|Overall Study|Physician Decision|1|||
131540872|NCT01922076|473601556|FG003|Overall Study|Physician Decision|0|||
131540873|NCT01922076|473601557|FG004|Overall Study|Physician Decision|0|||
131540874|NCT01922076|473601558|FG005|Overall Study|Physician Decision|0|||
131540875|NCT01922076|473601559|FG006|Overall Study|Physician Decision|0|||
131540876|NCT01922076|473601553|FG000|Overall Study|Withdrawal by Subject|0|||
131540877|NCT01922076|473601554|FG001|Overall Study|Withdrawal by Subject|0|||
131540878|NCT01922076|473601555|FG002|Overall Study|Withdrawal by Subject|0|||
131540879|NCT01922076|473601556|FG003|Overall Study|Withdrawal by Subject|1|||
131540880|NCT01922076|473601557|FG004|Overall Study|Withdrawal by Subject|0|||
131540881|NCT01922076|473601558|FG005|Overall Study|Withdrawal by Subject|1|||
131540882|NCT01922076|473601559|FG006|Overall Study|Withdrawal by Subject|1|||
131540883|NCT01018394|473601560|FG000|Overall Study|Withdrawal by Subject|5|||
131540884|NCT01018394|473601561|FG001|Overall Study|Withdrawal by Subject|5|||
131540885|NCT01018394|473601560|FG000|Overall Study|Lost to Follow-up|4|||
131540886|NCT01018394|473601561|FG001|Overall Study|Lost to Follow-up|3|||
131540887|NCT00683644|473601562|FG000|Overall Study|Withdrawal by Subject|4|||
131540888|NCT00683644|473601563|FG001|Overall Study|Withdrawal by Subject|2|||
131540889|NCT00683644|473601562|FG000|Overall Study|Lost to Follow-up|1|||
131540890|NCT00683644|473601563|FG001|Overall Study|Lost to Follow-up|4|||
131540891|NCT00683644|473601562|FG000|Overall Study|Adverse Event|1|||
131540892|NCT00683644|473601563|FG001|Overall Study|Adverse Event|2|||
131540893|NCT00683644|473601562|FG000|Overall Study|Low copper, other health problems,|7|||
131540894|NCT00683644|473601563|FG001|Overall Study|Low copper, other health problems,|6|||
131540895|NCT01669122|473601564|FG000|Period I|Lost to Follow-up|1|||
131540896|NCT01669122|473601564|FG000|Washout Period II|Protocol Violation|2|||
131540897|NCT03762473|473601565|FG000|Overall Study|Death|1|||
131540898|NCT03762473|473601566|FG001|Overall Study|Death|0|||
131540899|NCT05132699|473601567|FG000|Overall Study|Withdrawal by Subject|3|||
131540900|NCT05132699|473601568|FG001|Overall Study|Withdrawal by Subject|0|||
131540901|NCT02858895|473601571|FG000|Overall Study|Disease progression|31|||
131540902|NCT02858895|473601571|FG000|Overall Study|Death|2|||
131540903|NCT02858895|473601571|FG000|Overall Study|Adverse Event|1|||
131540904|NCT02858895|473601571|FG000|Overall Study|Withdrawal by Subject|3|||
131540905|NCT02858895|473601571|FG000|Overall Study|hospice,|1|||
131540906|NCT02858895|473601571|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
131540907|NCT00785291|473603984|FG000|Overall Study|Never began treatment|8|||
131540908|NCT00785291|473603985|FG001|Overall Study|Never began treatment|4|||
131540909|NCT00785291|473603986|FG002|Overall Study|Never began treatment|4|||
131540910|NCT00785291|473603984|FG000|Overall Study|Adverse Event|39|||
131540911|NCT00785291|473603985|FG001|Overall Study|Adverse Event|70|||
131540912|NCT00785291|473603986|FG002|Overall Study|Adverse Event|56|||
131540913|NCT00785291|473603984|FG000|Overall Study|Death|7|||
131540914|NCT00785291|473603985|FG001|Overall Study|Death|4|||
131540915|NCT00785291|473603986|FG002|Overall Study|Death|3|||
131540916|NCT00785291|473603984|FG000|Overall Study|Withdrawal by Subject|35|||
131540917|NCT00785291|473603985|FG001|Overall Study|Withdrawal by Subject|36|||
131540918|NCT00785291|473603986|FG002|Overall Study|Withdrawal by Subject|17|||
131540919|NCT00785291|473603984|FG000|Overall Study|Alternative Therapy|12|||
131540920|NCT00785291|473603985|FG001|Overall Study|Alternative Therapy|6|||
131540921|NCT00785291|473603986|FG002|Overall Study|Alternative Therapy|7|||
131540922|NCT00785291|473603984|FG000|Overall Study|Complicating illness|6|||
131540923|NCT00785291|473603985|FG001|Overall Study|Complicating illness|4|||
131540924|NCT00785291|473603986|FG002|Overall Study|Complicating illness|4|||
131540925|NCT00785291|473603984|FG000|Overall Study|Other Medical Reasons|29|||
131540926|NCT00785291|473603985|FG001|Overall Study|Other Medical Reasons|25|||
131540927|NCT00785291|473603986|FG002|Overall Study|Other Medical Reasons|15|||
131540928|NCT00570674|473603987|FG000|Overall Study|Withdrawal by Subject|0|||
131540929|NCT00570674|473603988|FG001|Overall Study|Withdrawal by Subject|0|||
131540930|NCT00570674|473603989|FG002|Overall Study|Withdrawal by Subject|1|||
131540931|NCT00570674|473603990|FG003|Overall Study|Withdrawal by Subject|0|||
131540932|NCT00570674|473603991|FG004|Overall Study|Withdrawal by Subject|0|||
131540933|NCT00570674|473603992|FG005|Overall Study|Withdrawal by Subject|0|||
131540934|NCT00570674|473603993|FG006|Overall Study|Withdrawal by Subject|0|||
131540935|NCT02979639|473603994|FG000|Overall Study|Withdrawal based on medical judgement|1|||
131540936|NCT02979639|473603994|FG000|Overall Study|Lost to Follow-up|8|||
131540937|NCT02979639|473603994|FG000|Overall Study|Withdrawal by Subject|3|||
131540938|NCT02979639|473603994|FG000|Overall Study|Adverse Event|2|||
131540939|NCT00160680|473604009|FG000|Overall Study|Adverse Event|0|||
131540940|NCT00160680|473604010|FG001|Overall Study|Adverse Event|1|||
131540941|NCT00160680|473604009|FG000|Overall Study|Lack of Efficacy|2|||
131540942|NCT00160680|473604010|FG001|Overall Study|Lack of Efficacy|1|||
131540943|NCT00160680|473604009|FG000|Overall Study|Lost to Follow-up|3|||
131540944|NCT00160680|473604010|FG001|Overall Study|Lost to Follow-up|2|||
131540945|NCT00160680|473604009|FG000|Overall Study|Withdrawal by Subject|4|||
131540946|NCT00160680|473604010|FG001|Overall Study|Withdrawal by Subject|9|||
131540947|NCT01773070|473604011|FG000|Overall Study|Withdrawal by Subject|24|||
131540948|NCT01773070|473604011|FG000|Overall Study|Lost to Follow-up|39|||
131540949|NCT01773070|473604011|FG000|Overall Study|Other|15|||
131540950|NCT01773070|473604011|FG000|Overall Study|Death (unrelated to study procedures)|3|||
131540951|NCT02450331|473604012|FG000|Overall Study|Death|162|||
131540952|NCT02450331|473604013|FG001|Overall Study|Death|171|||
131540953|NCT02450331|473604012|FG000|Overall Study|Lost to Follow-up|14|||
131540954|NCT02450331|473604013|FG001|Overall Study|Lost to Follow-up|12|||
131540955|NCT02450331|473604012|FG000|Overall Study|Withdrawal by Subject|55|||
131540956|NCT02450331|473604013|FG001|Overall Study|Withdrawal by Subject|44|||
131540957|NCT02450331|473604012|FG000|Overall Study|Non-specified other|1|||
131540958|NCT02450331|473604013|FG001|Overall Study|Non-specified other|1|||
131540959|NCT03232983|473604014|FG000|Period 1|Physician Decision|0|||
131540960|NCT03232983|473604015|FG001|Period 1|Physician Decision|0|||
131540961|NCT03232983|473604016|FG002|Period 1|Physician Decision|1|||
131540962|NCT03232983|473604017|FG003|Period 1|Physician Decision|0|||
131540963|NCT03232983|473604014|FG000|Washout Period 2|Physician Decision|0|||
131540964|NCT03232983|473604015|FG001|Washout Period 2|Physician Decision|0|||
131540965|NCT03232983|473604016|FG002|Washout Period 2|Physician Decision|1|||
131540966|NCT03232983|473604017|FG003|Washout Period 2|Physician Decision|0|||
131540967|NCT03232983|473604014|FG000|Washout Period 2|Withdrawal by Subject|0|||
131540968|NCT03232983|473604015|FG001|Washout Period 2|Withdrawal by Subject|0|||
131540969|NCT03232983|473604016|FG002|Washout Period 2|Withdrawal by Subject|0|||
131540970|NCT03232983|473604017|FG003|Washout Period 2|Withdrawal by Subject|1|||
131540971|NCT03232983|473604014|FG000|Period 4|Withdrawal by Subject|1|||
131540972|NCT03232983|473604015|FG001|Period 4|Withdrawal by Subject|0|||
131540973|NCT03232983|473604016|FG002|Period 4|Withdrawal by Subject|0|||
131540974|NCT03232983|473604017|FG003|Period 4|Withdrawal by Subject|0|||
131540975|NCT03643952|473604018|FG000|Overall Study|Lack of Efficacy|1|||
131540976|NCT01358968|473604019|FG000|Period 2|Adverse Event|0|||
131540977|NCT01358968|473604020|FG001|Period 2|Adverse Event|1|||
131540978|NCT01358968|473604021|FG002|Period 2|Adverse Event|0|||
131540979|NCT01358968|473604022|FG003|Period 2|Adverse Event|0|||
131540980|NCT01358968|473604019|FG000|Continued Access Phase|Progression of Disease|0|||
131540981|NCT01358968|473604020|FG001|Continued Access Phase|Progression of Disease|0|||
131540982|NCT01358968|473604021|FG002|Continued Access Phase|Progression of Disease|8|||
131540983|NCT01358968|473604022|FG003|Continued Access Phase|Progression of Disease|4|||
131540984|NCT01358968|473604019|FG000|Continued Access Phase|Protocol Violation|0|||
131540985|NCT01358968|473604020|FG001|Continued Access Phase|Protocol Violation|0|||
131540986|NCT01358968|473604021|FG002|Continued Access Phase|Protocol Violation|0|||
131540987|NCT01358968|473604022|FG003|Continued Access Phase|Protocol Violation|2|||
131540988|NCT01358968|473604019|FG000|Continued Access Phase|Withdrawal by Subject|0|||
131540989|NCT01358968|473604020|FG001|Continued Access Phase|Withdrawal by Subject|0|||
131540990|NCT01358968|473604021|FG002|Continued Access Phase|Withdrawal by Subject|3|||
131540991|NCT01358968|473604022|FG003|Continued Access Phase|Withdrawal by Subject|0|||
131540992|NCT01358968|473604019|FG000|Continued Access Phase|Death|0|||
131540993|NCT01358968|473604020|FG001|Continued Access Phase|Death|0|||
131540994|NCT01358968|473604021|FG002|Continued Access Phase|Death|1|||
131540995|NCT01358968|473604022|FG003|Continued Access Phase|Death|1|||
131540996|NCT01627327|473604023|FG000|Overall Study|Adverse Event|6|||
131540997|NCT01627327|473604024|FG001|Overall Study|Adverse Event|12|||
131540998|NCT01627327|473604023|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
131540999|NCT01627327|473604024|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
131541000|NCT01627327|473604023|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
131541001|NCT01627327|473604024|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
131541002|NCT01627327|473604023|FG000|Overall Study|Protocol Violation|4|||
131541003|NCT01627327|473604024|FG001|Overall Study|Protocol Violation|10|||
131541004|NCT01627327|473604023|FG000|Overall Study|Lost to Follow-up|1|||
131541005|NCT01627327|473604024|FG001|Overall Study|Lost to Follow-up|3|||
131541006|NCT01627327|473604023|FG000|Overall Study|Physician Decision|1|||
131541007|NCT01627327|473604024|FG001|Overall Study|Physician Decision|0|||
131541008|NCT01627327|473604023|FG000|Overall Study|Withdrawal by Subject|3|||
131541009|NCT01627327|473604024|FG001|Overall Study|Withdrawal by Subject|3|||
131541010|NCT04528069|473604028|FG000|Overall Study|Adverse Event|1|||
131541011|NCT04528069|473604028|FG000|Overall Study|Lost to Follow-up|1|||
131541012|NCT04528069|473604028|FG000|Overall Study|Patient Unable to Come|1|||
131541013|NCT04528069|473604028|FG000|Overall Study|Patient Unable to Attend|1|||
131541014|NCT02525874|473604029|FG000|Overall Study|Other|1|||
131541015|NCT02525874|473604029|FG000|Overall Study|Investigator Decision|1|||
131541016|NCT02525874|473604029|FG000|Overall Study|Consent withdrawn|22|||
131541017|NCT02525874|473604029|FG000|Overall Study|Non-compliance with study drug|3|||
131541018|NCT02525874|473604029|FG000|Overall Study|Adverse Event|17|||
131541019|NCT02525874|473604029|FG000|Overall Study|Lost to Follow-up|7|||
131541020|NCT02525874|473604029|FG000|Overall Study|Disease progression, defined by protocol|2|||
131541021|NCT02525874|473604029|FG000|Overall Study|Disease relapse|4|||
131541022|NCT02525874|473604029|FG000|Overall Study|Alternative Treatment for MS|2|||
131541023|NCT02525874|473604029|FG000|Overall Study|New lesions in Brain|1|||
131541024|NCT01814371|473604030|FG000|Overall Study|Lost to Follow-up|30|||
131541025|NCT01814371|473604031|FG001|Overall Study|Lost to Follow-up|27|||
131541026|NCT01692782|473604032|FG000|Overall Study|Adverse Event|12|||
131541027|NCT01692782|473604033|FG001|Overall Study|Adverse Event|32|||
131541028|NCT01692782|473604034|FG002|Overall Study|Adverse Event|2|||
131541029|NCT01692782|473604032|FG000|Overall Study|Lack of Efficacy|1|||
131541030|NCT01692782|473604033|FG001|Overall Study|Lack of Efficacy|2|||
131541031|NCT01692782|473604034|FG002|Overall Study|Lack of Efficacy|0|||
131541032|NCT01692782|473604032|FG000|Overall Study|Lost to Follow-up|2|||
131541033|NCT01692782|473604033|FG001|Overall Study|Lost to Follow-up|7|||
131541034|NCT01692782|473604034|FG002|Overall Study|Lost to Follow-up|1|||
131541035|NCT01692782|473604032|FG000|Overall Study|Pregnancy|1|||
131541036|NCT01692782|473604033|FG001|Overall Study|Pregnancy|0|||
131541037|NCT01692782|473604034|FG002|Overall Study|Pregnancy|0|||
131541038|NCT01692782|473604032|FG000|Overall Study|Protocol Violation|1|||
131541039|NCT01692782|473604033|FG001|Overall Study|Protocol Violation|0|||
131541040|NCT01692782|473604034|FG002|Overall Study|Protocol Violation|2|||
131541041|NCT01692782|473604032|FG000|Overall Study|Non-complance with study drug|0|||
131541042|NCT01692782|473604033|FG001|Overall Study|Non-complance with study drug|4|||
131541043|NCT01692782|473604034|FG002|Overall Study|Non-complance with study drug|1|||
131541044|NCT01692782|473604032|FG000|Overall Study|Non-compliant with study visits|0|||
131541045|NCT01692782|473604033|FG001|Overall Study|Non-compliant with study visits|0|||
131541046|NCT01692782|473604034|FG002|Overall Study|Non-compliant with study visits|1|||
131541047|NCT01692782|473604032|FG000|Overall Study|SAE not related to study drug|0|||
131541048|NCT01692782|473604033|FG001|Overall Study|SAE not related to study drug|1|||
131541049|NCT01692782|473604034|FG002|Overall Study|SAE not related to study drug|0|||
131541050|NCT01692782|473604032|FG000|Overall Study|Withdrawal by Subject|3|||
131541051|NCT01692782|473604033|FG001|Overall Study|Withdrawal by Subject|10|||
131541052|NCT01692782|473604034|FG002|Overall Study|Withdrawal by Subject|3|||
131541053|NCT03252587|473604035|FG000|Overall Study|Adverse Event|3|||
131541054|NCT03252587|473604036|FG001|Overall Study|Adverse Event|8|||
131541055|NCT03252587|473604037|FG002|Overall Study|Adverse Event|6|||
131541056|NCT03252587|473604038|FG003|Overall Study|Adverse Event|12|||
131541057|NCT03252587|473604035|FG000|Overall Study|Lack of Efficacy|7|||
131541058|NCT03252587|473604036|FG001|Overall Study|Lack of Efficacy|2|||
131541059|NCT03252587|473604037|FG002|Overall Study|Lack of Efficacy|2|||
131541060|NCT03252587|473604038|FG003|Overall Study|Lack of Efficacy|4|||
131541061|NCT03252587|473604035|FG000|Overall Study|Lost to Follow-up|2|||
131541062|NCT03252587|473604036|FG001|Overall Study|Lost to Follow-up|0|||
131541063|NCT03252587|473604037|FG002|Overall Study|Lost to Follow-up|0|||
131541064|NCT03252587|473604038|FG003|Overall Study|Lost to Follow-up|2|||
131541065|NCT03252587|473604035|FG000|Overall Study|Pregnancy|2|||
131541066|NCT03252587|473604036|FG001|Overall Study|Pregnancy|1|||
131541067|NCT03252587|473604037|FG002|Overall Study|Pregnancy|0|||
131541068|NCT03252587|473604038|FG003|Overall Study|Pregnancy|1|||
131541069|NCT03252587|473604035|FG000|Overall Study|Withdrawal by Subject|8|||
131541070|NCT03252587|473604036|FG001|Overall Study|Withdrawal by Subject|4|||
131541071|NCT03252587|473604037|FG002|Overall Study|Withdrawal by Subject|4|||
131541072|NCT03252587|473604038|FG003|Overall Study|Withdrawal by Subject|4|||
131541073|NCT03252587|473604035|FG000|Overall Study|Other Reasons|2|||
131541074|NCT03252587|473604036|FG001|Overall Study|Other Reasons|5|||
131541075|NCT03252587|473604037|FG002|Overall Study|Other Reasons|5|||
131541076|NCT03252587|473604038|FG003|Overall Study|Other Reasons|4|||
131541077|NCT04052204|473604039|FG000|Overall Study|Death|1|||
131541078|NCT04052204|473604040|FG001|Overall Study|Death|0|||
131541079|NCT04052204|473604041|FG002|Overall Study|Death|0|||
131541080|NCT04052204|473604039|FG000|Overall Study|Progressive disease|1|||
131541081|NCT04052204|473604040|FG001|Overall Study|Progressive disease|0|||
131541082|NCT04052204|473604041|FG002|Overall Study|Progressive disease|0|||
131541083|NCT04052204|473604039|FG000|Overall Study|Other|1|||
131541084|NCT04052204|473604040|FG001|Overall Study|Other|0|||
131541085|NCT04052204|473604041|FG002|Overall Study|Other|0|||
131541086|NCT03945188|473604047|FG000|Overall Study|Protocol Violation|1|||
131541087|NCT03945188|473604048|FG001|Overall Study|Protocol Violation|0|||
131541088|NCT03945188|473604047|FG000|Overall Study|Disease worsening|79|||
131541089|NCT03945188|473604048|FG001|Overall Study|Disease worsening|73|||
131541090|NCT03945188|473604047|FG000|Overall Study|Physician Decision|2|||
131541091|NCT03945188|473604048|FG001|Overall Study|Physician Decision|2|||
131541092|NCT03945188|473604047|FG000|Overall Study|Lack of Efficacy|7|||
131541093|NCT03945188|473604048|FG001|Overall Study|Lack of Efficacy|4|||
131541094|NCT03945188|473604047|FG000|Overall Study|Pregnancy|2|||
131541095|NCT03945188|473604048|FG001|Overall Study|Pregnancy|0|||
131541096|NCT03945188|473604047|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
131541097|NCT03945188|473604048|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
131541098|NCT03945188|473604047|FG000|Overall Study|Adverse Event|10|||
131541099|NCT03945188|473604048|FG001|Overall Study|Adverse Event|5|||
131541100|NCT03945188|473604047|FG000|Overall Study|Other|2|||
131541101|NCT03945188|473604048|FG001|Overall Study|Other|2|||
131541102|NCT03945188|473604047|FG000|Overall Study|Lost to Follow-up|1|||
131541103|NCT03945188|473604048|FG001|Overall Study|Lost to Follow-up|2|||
131541104|NCT04794803|473604076|FG000|Overall Study|Death|1|||
131541105|NCT04794803|473604077|FG001|Overall Study|Death|3|||
131541106|NCT04794803|473604076|FG000|Overall Study|Lost to Follow-up|2|||
131541107|NCT04794803|473604077|FG001|Overall Study|Lost to Follow-up|2|||
131541108|NCT04794803|473604076|FG000|Overall Study|Withdrawal by Subject|1|||
131541109|NCT04794803|473604077|FG001|Overall Study|Withdrawal by Subject|0|||
131541110|NCT04794803|473604076|FG000|Overall Study|Physician Decision|1|||
131541111|NCT04794803|473604077|FG001|Overall Study|Physician Decision|1|||
131541112|NCT04794803|473604076|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
131541113|NCT04794803|473604077|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
131541114|NCT04794803|473604076|FG000|Overall Study|Refused to continue the treatment|1|||
131541115|NCT04794803|473604077|FG001|Overall Study|Refused to continue the treatment|0|||
131541116|NCT04794803|473604076|FG000|Overall Study|Patient admitted to ICU|0|||
131541117|NCT04794803|473604077|FG001|Overall Study|Patient admitted to ICU|1|||
131541118|NCT01618162|473604078|FG000|Overall Study|Protocol Violation|13|||
131541119|NCT01618162|473604079|FG001|Overall Study|Protocol Violation|10|||
131541120|NCT01618162|473604078|FG000|Overall Study|Adverse Event|9|||
131541121|NCT01618162|473604079|FG001|Overall Study|Adverse Event|2|||
131541122|NCT01618162|473604078|FG000|Overall Study|Withdrawal Criteria|2|||
131541123|NCT01618162|473604079|FG001|Overall Study|Withdrawal Criteria|10|||
131541124|NCT01618162|473604078|FG000|Overall Study|Unclassified|14|||
131541125|NCT01618162|473604079|FG001|Overall Study|Unclassified|13|||
131541126|NCT04124926|473604080|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
131541127|NCT04124926|473604081|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
131541128|NCT04124926|473604082|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
131541129|NCT04124926|473604083|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
131541130|NCT04124926|473604084|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
131541131|NCT04124926|473604080|FG000|Healing Phase|Protocol Violation|0|||
131541132|NCT04124926|473604081|FG001|Healing Phase|Protocol Violation|1|||
131541133|NCT04124926|473604082|FG002|Healing Phase|Protocol Violation|0|||
131541134|NCT04124926|473604083|FG003|Healing Phase|Protocol Violation|0|||
131541135|NCT04124926|473604084|FG004|Healing Phase|Protocol Violation|0|||
131541136|NCT04124926|473604080|FG000|Healing Phase|Lost to Follow-up|5|||
131541137|NCT04124926|473604081|FG001|Healing Phase|Lost to Follow-up|4|||
131541138|NCT04124926|473604082|FG002|Healing Phase|Lost to Follow-up|0|||
131541139|NCT04124926|473604083|FG003|Healing Phase|Lost to Follow-up|0|||
131541140|NCT04124926|473604084|FG004|Healing Phase|Lost to Follow-up|0|||
131541141|NCT04124926|473604080|FG000|Healing Phase|Voluntary Withdrawal|10|||
131541142|NCT04124926|473604081|FG001|Healing Phase|Voluntary Withdrawal|7|||
131541143|NCT04124926|473604082|FG002|Healing Phase|Voluntary Withdrawal|0|||
131541144|NCT04124926|473604083|FG003|Healing Phase|Voluntary Withdrawal|0|||
131541145|NCT04124926|473604084|FG004|Healing Phase|Voluntary Withdrawal|0|||
131541146|NCT04124926|473604080|FG000|Healing Phase|Withdrawal of Consent|5|||
131541147|NCT04124926|473604081|FG001|Healing Phase|Withdrawal of Consent|3|||
131541148|NCT04124926|473604082|FG002|Healing Phase|Withdrawal of Consent|0|||
131541149|NCT04124926|473604083|FG003|Healing Phase|Withdrawal of Consent|0|||
131541150|NCT04124926|473604084|FG004|Healing Phase|Withdrawal of Consent|0|||
131541151|NCT04124926|473604080|FG000|Healing Phase|Miscellaneous|8|||
131541152|NCT04124926|473604081|FG001|Healing Phase|Miscellaneous|7|||
131541153|NCT04124926|473604082|FG002|Healing Phase|Miscellaneous|0|||
131541154|NCT04124926|473604083|FG003|Healing Phase|Miscellaneous|0|||
131541155|NCT04124926|473604084|FG004|Healing Phase|Miscellaneous|0|||
131541156|NCT04124926|473604080|FG000|Healing Phase|Randomized but not Treated|0|||
131541157|NCT04124926|473604081|FG001|Healing Phase|Randomized but not Treated|3|||
131541158|NCT04124926|473604082|FG002|Healing Phase|Randomized but not Treated|0|||
131541159|NCT04124926|473604083|FG003|Healing Phase|Randomized but not Treated|0|||
131541160|NCT04124926|473604084|FG004|Healing Phase|Randomized but not Treated|0|||
131541161|NCT04124926|473604080|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
131541162|NCT04124926|473604081|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
131541163|NCT04124926|473604082|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
131541164|NCT04124926|473604083|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
131541165|NCT04124926|473604084|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
131541166|NCT04124926|473604080|FG000|Maintenance Phase|Protocol Violation|0|||
131541167|NCT04124926|473604081|FG001|Maintenance Phase|Protocol Violation|0|||
131541168|NCT04124926|473604082|FG002|Maintenance Phase|Protocol Violation|3|||
131541169|NCT04124926|473604083|FG003|Maintenance Phase|Protocol Violation|0|||
131541170|NCT04124926|473604084|FG004|Maintenance Phase|Protocol Violation|0|||
131541171|NCT04124926|473604080|FG000|Maintenance Phase|Lost to Follow-up|0|||
131541172|NCT04124926|473604081|FG001|Maintenance Phase|Lost to Follow-up|0|||
131541173|NCT04124926|473604082|FG002|Maintenance Phase|Lost to Follow-up|7|||
131541174|NCT04124926|473604083|FG003|Maintenance Phase|Lost to Follow-up|8|||
131541175|NCT04124926|473604084|FG004|Maintenance Phase|Lost to Follow-up|9|||
131541176|NCT04124926|473604080|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
131541177|NCT04124926|473604081|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
131541178|NCT04124926|473604082|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
131541179|NCT04124926|473604083|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
131541180|NCT04124926|473604084|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
131541181|NCT04124926|473604080|FG000|Maintenance Phase|Pregnancy|0|||
131541182|NCT04124926|473604081|FG001|Maintenance Phase|Pregnancy|0|||
131541183|NCT04124926|473604082|FG002|Maintenance Phase|Pregnancy|0|||
131541184|NCT04124926|473604083|FG003|Maintenance Phase|Pregnancy|1|||
131541185|NCT04124926|473604084|FG004|Maintenance Phase|Pregnancy|0|||
131541186|NCT04124926|473604080|FG000|Maintenance Phase|Lack of Efficacy|0|||
131541187|NCT04124926|473604081|FG001|Maintenance Phase|Lack of Efficacy|0|||
131541188|NCT04124926|473604082|FG002|Maintenance Phase|Lack of Efficacy|0|||
131541189|NCT04124926|473604083|FG003|Maintenance Phase|Lack of Efficacy|0|||
131541190|NCT04124926|473604084|FG004|Maintenance Phase|Lack of Efficacy|1|||
131541191|NCT04124926|473604080|FG000|Maintenance Phase|Withdrawal of Consent|0|||
131541192|NCT04124926|473604081|FG001|Maintenance Phase|Withdrawal of Consent|0|||
131541193|NCT04124926|473604082|FG002|Maintenance Phase|Withdrawal of Consent|5|||
131541194|NCT04124926|473604083|FG003|Maintenance Phase|Withdrawal of Consent|5|||
131541195|NCT04124926|473604084|FG004|Maintenance Phase|Withdrawal of Consent|5|||
131541196|NCT04124926|473604080|FG000|Maintenance Phase|Miscellaneous|0|||
131541197|NCT04124926|473604081|FG001|Maintenance Phase|Miscellaneous|0|||
131541198|NCT04124926|473604082|FG002|Maintenance Phase|Miscellaneous|1|||
131541199|NCT04124926|473604083|FG003|Maintenance Phase|Miscellaneous|2|||
131541200|NCT04124926|473604084|FG004|Maintenance Phase|Miscellaneous|4|||
131541201|NCT04124926|473604080|FG000|Maintenance Phase|Randomized but not Treated|0|||
131541202|NCT04124926|473604081|FG001|Maintenance Phase|Randomized but not Treated|0|||
131541203|NCT04124926|473604082|FG002|Maintenance Phase|Randomized but not Treated|2|||
131541204|NCT04124926|473604083|FG003|Maintenance Phase|Randomized but not Treated|2|||
131541205|NCT04124926|473604084|FG004|Maintenance Phase|Randomized but not Treated|0|||
131541206|NCT00423176|473604088|FG000|Overall Study|Adverse Event|4|||
131541207|NCT00423176|473604089|FG001|Overall Study|Adverse Event|6|||
131541208|NCT00423176|473604088|FG000|Overall Study|Treatment Failure|1|||
131541209|NCT00423176|473604089|FG001|Overall Study|Treatment Failure|6|||
131541210|NCT00423176|473604088|FG000|Overall Study|Lost to Follow-up|4|||
131541211|NCT00423176|473604089|FG001|Overall Study|Lost to Follow-up|7|||
131541212|NCT00423176|473604088|FG000|Overall Study|Withdrawal by Subject|4|||
131541213|NCT00423176|473604089|FG001|Overall Study|Withdrawal by Subject|3|||
131541214|NCT00423176|473604088|FG000|Overall Study|Protocol Violation|1|||
131541215|NCT00423176|473604089|FG001|Overall Study|Protocol Violation|3|||
131541216|NCT00423176|473604088|FG000|Overall Study|Did not meet protocol eligibility|2|||
131541217|NCT00423176|473604089|FG001|Overall Study|Did not meet protocol eligibility|4|||
131541218|NCT04867369|473604092|FG000|Overall Study|Withdrawal by Subject|1|||
131541219|NCT04867369|473604093|FG001|Overall Study|Withdrawal by Subject|0|||
131541220|NCT05554237|473604094|FG000|Part 2 (7 Days)|Adverse Event|0|||
131541221|NCT05554237|473604095|FG001|Part 2 (7 Days)|Adverse Event|0|||
131541222|NCT05554237|473604096|FG002|Part 2 (7 Days)|Adverse Event|0|||
131541223|NCT05554237|473604097|FG003|Part 2 (7 Days)|Adverse Event|0|||
131541224|NCT05554237|473604098|FG004|Part 2 (7 Days)|Adverse Event|2|||
131541225|NCT05554237|473604099|FG005|Part 2 (7 Days)|Adverse Event|0|||
131541226|NCT05554237|473604100|FG006|Part 2 (7 Days)|Adverse Event|0|||
131541227|NCT05554237|473604101|FG007|Part 2 (7 Days)|Adverse Event|0|||
131541228|NCT05554237|473604102|FG008|Part 2 (7 Days)|Adverse Event|0|||
131541229|NCT05554237|473604103|FG009|Part 2 (7 Days)|Adverse Event|1|||
131541230|NCT05554237|473604104|FG010|Part 2 (7 Days)|Adverse Event|0|||
131541231|NCT05554237|473604105|FG011|Part 2 (7 Days)|Adverse Event|0|||
131541232|NCT05554237|473604106|FG012|Part 2 (7 Days)|Adverse Event|1|||
131541233|NCT05554237|473604107|FG013|Part 2 (7 Days)|Adverse Event|0|||
131541264|NCT02477111|473604111|FG000|Overall Study|Death|28|||
131541265|NCT02477111|473604111|FG000|Overall Study|Withdrawal by Subject|19|||
131541266|NCT02477111|473604111|FG000|Overall Study|Lost to Follow-up|4|||
131541267|NCT02192502|473604112|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
131541268|NCT02192502|473604113|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
131541269|NCT02192502|473604112|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
131541270|NCT02192502|473604113|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
131541271|NCT02192502|473604112|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
131541272|NCT02192502|473604113|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
131541273|NCT03896035|473604117|FG000|Overall Study|Lost to Follow-up|2|||
131541274|NCT03896035|473604118|FG001|Overall Study|Lost to Follow-up|6|||
131541275|NCT03896035|473604117|FG000|Overall Study|Withdrawal by Subject|0|||
131541276|NCT03896035|473604118|FG001|Overall Study|Withdrawal by Subject|1|||
131541277|NCT03896035|473604117|FG000|Overall Study|Health/family health issues during COVID|0|||
131541278|NCT03896035|473604118|FG001|Overall Study|Health/family health issues during COVID|4|||
131541279|NCT03492281|473604119|FG000|Overall Study|Withdrawal by Subject|21|||
131541280|NCT03492281|473604120|FG001|Overall Study|Withdrawal by Subject|14|||
131541281|NCT03492281|473604121|FG002|Overall Study|Withdrawal by Subject|13|||
131541282|NCT03492281|473604119|FG000|Overall Study|Lost to Follow-up|14|||
131541283|NCT03492281|473604120|FG001|Overall Study|Lost to Follow-up|15|||
131541284|NCT03492281|473604121|FG002|Overall Study|Lost to Follow-up|10|||
131541285|NCT03492281|473604119|FG000|Overall Study|Adverse Event|6|||
131541286|NCT03492281|473604120|FG001|Overall Study|Adverse Event|8|||
131541287|NCT03492281|473604121|FG002|Overall Study|Adverse Event|13|||
131541288|NCT03492281|473604119|FG000|Overall Study|Lack of Efficacy|3|||
131541289|NCT03492281|473604120|FG001|Overall Study|Lack of Efficacy|0|||
131541290|NCT03492281|473604121|FG002|Overall Study|Lack of Efficacy|1|||
131541291|NCT03492281|473604119|FG000|Overall Study|Physician Decision|1|||
131541292|NCT03492281|473604120|FG001|Overall Study|Physician Decision|0|||
131541293|NCT03492281|473604121|FG002|Overall Study|Physician Decision|3|||
131541294|NCT03492281|473604119|FG000|Overall Study|Protocol Violation|0|||
131541295|NCT03492281|473604120|FG001|Overall Study|Protocol Violation|2|||
131541296|NCT03492281|473604121|FG002|Overall Study|Protocol Violation|1|||
131541297|NCT03492281|473604119|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
131541298|NCT03492281|473604120|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
131541299|NCT03492281|473604121|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
131541300|NCT03492281|473604119|FG000|Overall Study|Death|0|||
131541301|NCT03492281|473604120|FG001|Overall Study|Death|0|||
131541302|NCT03492281|473604121|FG002|Overall Study|Death|1|||
131541303|NCT03492281|473604119|FG000|Overall Study|Captured as Other in Database|8|||
131541304|NCT03492281|473604120|FG001|Overall Study|Captured as Other in Database|6|||
131541305|NCT03492281|473604121|FG002|Overall Study|Captured as Other in Database|3|||
131541306|NCT01506193|473604122|FG000|Overall Study|Protocol Violation|1|||
131541307|NCT01506193|473604123|FG001|Overall Study|Protocol Violation|0|||
131541308|NCT01506193|473604124|FG002|Overall Study|Protocol Violation|1|||
131541309|NCT01506193|473604122|FG000|Overall Study|Migrated/moved from study area|0|||
131541310|NCT01506193|473604123|FG001|Overall Study|Migrated/moved from study area|0|||
131541311|NCT01506193|473604124|FG002|Overall Study|Migrated/moved from study area|1|||
131541312|NCT01506193|473604122|FG000|Overall Study|Adverse event, non-fatal|0|||
131541313|NCT01506193|473604123|FG001|Overall Study|Adverse event, non-fatal|0|||
131541314|NCT01506193|473604124|FG002|Overall Study|Adverse event, non-fatal|1|||
131541315|NCT01506193|473604122|FG000|Overall Study|Withdrawal by Subject|5|||
131541316|NCT01506193|473604123|FG001|Overall Study|Withdrawal by Subject|1|||
131541317|NCT01506193|473604124|FG002|Overall Study|Withdrawal by Subject|8|||
131541318|NCT01506193|473604122|FG000|Overall Study|Lost to Follow-up|8|||
131541319|NCT01506193|473604123|FG001|Overall Study|Lost to Follow-up|3|||
131541320|NCT01506193|473604124|FG002|Overall Study|Lost to Follow-up|3|||
131541321|NCT04575467|473604127|FG000|Overall Study|Adverse Event|0|||
131541322|NCT04575467|473604128|FG001|Overall Study|Adverse Event|1|||
131541323|NCT04575467|473604129|FG002|Overall Study|Adverse Event|0|||
131541324|NCT04575467|473604130|FG003|Overall Study|Adverse Event|0|||
131541325|NCT00743366|473604131|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
131541326|NCT00743366|473604132|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
131541327|NCT03206203|473604133|FG000|Treatment|Death|38|||
131541328|NCT03206203|473604134|FG001|Treatment|Death|26|||
131541329|NCT03206203|473604135|FG002|Treatment|Death|0|||
131541330|NCT03206203|473604133|FG000|Treatment|Withdrawal by Subject|1|||
131541331|NCT03206203|473604134|FG001|Treatment|Withdrawal by Subject|0|||
131541332|NCT03206203|473604135|FG002|Treatment|Withdrawal by Subject|0|||
131541333|NCT03206203|473604133|FG000|Treatment|Lost to Follow-up|4|||
131541334|NCT03206203|473604134|FG001|Treatment|Lost to Follow-up|0|||
131541335|NCT03206203|473604135|FG002|Treatment|Lost to Follow-up|0|||
131541336|NCT03206203|473604133|FG000|Treatment|N/A in Follow-Up|8|||
131541337|NCT03206203|473604134|FG001|Treatment|N/A in Follow-Up|1|||
131541338|NCT03206203|473604135|FG002|Treatment|N/A in Follow-Up|0|||
131541339|NCT03206203|473604133|FG000|Treatment|Disease progression|0|||
131541340|NCT03206203|473604134|FG001|Treatment|Disease progression|1|||
131541341|NCT03206203|473604135|FG002|Treatment|Disease progression|0|||
131541342|NCT03206203|473604133|FG000|Treatment|Refused follow-up|0|||
131541343|NCT03206203|473604134|FG001|Treatment|Refused follow-up|1|||
131541344|NCT03206203|473604135|FG002|Treatment|Refused follow-up|0|||
131541345|NCT03206203|473604133|FG000|Treatment|Cross over to Arm 1|0|||
131541346|NCT03206203|473604134|FG001|Treatment|Cross over to Arm 1|19|||
131541347|NCT03206203|473604135|FG002|Treatment|Cross over to Arm 1|0|||
131541348|NCT03206203|473604133|FG000|Optional Cross-Over|Death|0|||
131541349|NCT03206203|473604134|FG001|Optional Cross-Over|Death|0|||
131541350|NCT03206203|473604135|FG002|Optional Cross-Over|Death|14|||
131541351|NCT03206203|473604133|FG000|Optional Cross-Over|Refused follow-up|0|||
131541352|NCT03206203|473604134|FG001|Optional Cross-Over|Refused follow-up|0|||
131541353|NCT03206203|473604135|FG002|Optional Cross-Over|Refused follow-up|2|||
131541354|NCT01483924|473604136|FG000|Overall Study|Withdrawal by Subject|2|||
131541355|NCT01483924|473604137|FG001|Overall Study|Withdrawal by Subject|0|||
131541356|NCT01483924|473604138|FG002|Overall Study|Withdrawal by Subject|0|||
131541357|NCT01483924|473604139|FG003|Overall Study|Withdrawal by Subject|1|||
131541358|NCT01483924|473604140|FG004|Overall Study|Withdrawal by Subject|1|||
131541359|NCT01483924|473604136|FG000|Overall Study|Adverse Event|0|||
131541360|NCT01483924|473604137|FG001|Overall Study|Adverse Event|0|||
131541361|NCT01483924|473604138|FG002|Overall Study|Adverse Event|1|||
131541362|NCT01483924|473604139|FG003|Overall Study|Adverse Event|1|||
131541363|NCT01483924|473604140|FG004|Overall Study|Adverse Event|0|||
131541364|NCT01483924|473604136|FG000|Overall Study|Non-compliance|0|||
131541365|NCT01483924|473604137|FG001|Overall Study|Non-compliance|0|||
131541366|NCT01483924|473604138|FG002|Overall Study|Non-compliance|0|||
131541367|NCT01483924|473604139|FG003|Overall Study|Non-compliance|1|||
131541368|NCT01483924|473604140|FG004|Overall Study|Non-compliance|1|||
131541369|NCT01483924|473604136|FG000|Overall Study|Sponsor concern over ECG result|0|||
131541370|NCT01483924|473604137|FG001|Overall Study|Sponsor concern over ECG result|0|||
131541371|NCT01483924|473604138|FG002|Overall Study|Sponsor concern over ECG result|0|||
131541372|NCT01483924|473604139|FG003|Overall Study|Sponsor concern over ECG result|1|||
131541373|NCT01483924|473604140|FG004|Overall Study|Sponsor concern over ECG result|0|||
131541374|NCT03565887|473604146|FG000|Overall Study|Adverse Event|1|||
131541375|NCT03565887|473604147|FG001|Overall Study|Adverse Event|0|||
131541376|NCT03565887|473604146|FG000|Overall Study|Withdrawal by Subject|0|||
131541377|NCT03565887|473604147|FG001|Overall Study|Withdrawal by Subject|2|||
131541378|NCT01152580|473604148|FG000|Overall Study|Withdrawal by Subject|0|||
131541379|NCT01152580|473604149|FG001|Overall Study|Withdrawal by Subject|1|||
131541380|NCT00449176|473604151|FG000|Overall Study|Withdrawal by Subject|39|||
131541381|NCT00449176|473604152|FG001|Overall Study|Withdrawal by Subject|43|||
131541382|NCT00449176|473604153|FG002|Overall Study|Withdrawal by Subject|59|||
131541383|NCT00449176|473604151|FG000|Overall Study|Lost to Follow-up|13|||
131541384|NCT00449176|473604152|FG001|Overall Study|Lost to Follow-up|8|||
131541385|NCT00449176|473604153|FG002|Overall Study|Lost to Follow-up|12|||
131541386|NCT00449176|473604151|FG000|Overall Study|Adverse Event|51|||
131541387|NCT00449176|473604152|FG001|Overall Study|Adverse Event|107|||
131541388|NCT00449176|473604153|FG002|Overall Study|Adverse Event|15|||
131541389|NCT00449176|473604151|FG000|Overall Study|Lack of Efficacy|13|||
131541390|NCT00449176|473604152|FG001|Overall Study|Lack of Efficacy|7|||
131541391|NCT00449176|473604153|FG002|Overall Study|Lack of Efficacy|50|||
131541392|NCT00449176|473604151|FG000|Overall Study|Study drug non-compliant|14|||
131541393|NCT00449176|473604152|FG001|Overall Study|Study drug non-compliant|11|||
131541394|NCT00449176|473604153|FG002|Overall Study|Study drug non-compliant|11|||
131541395|NCT00449176|473604151|FG000|Overall Study|all other|22|||
131541396|NCT00449176|473604152|FG001|Overall Study|all other|19|||
131541397|NCT00449176|473604153|FG002|Overall Study|all other|20|||
131541398|NCT00675766|473604154|FG000|Overall Study|Lost to Follow-up|6|||
131541399|NCT00675766|473604155|FG001|Overall Study|Lost to Follow-up|5|||
131541400|NCT00675766|473604156|FG002|Overall Study|Lost to Follow-up|21|||
131541401|NCT00675766|473604157|FG003|Overall Study|Lost to Follow-up|26|||
131541402|NCT03182868|473604160|FG000|Overall Study|Protocol Violation|3|||
131541403|NCT03182868|473604161|FG001|Overall Study|Protocol Violation|0|||
131541404|NCT03182868|473604162|FG002|Overall Study|Protocol Violation|4|||
131541405|NCT03182868|473604163|FG003|Overall Study|Protocol Violation|1|||
131541406|NCT03182868|473604164|FG004|Overall Study|Protocol Violation|8|||
131541407|NCT03015402|473604167|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131541408|NCT03015402|473604168|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
131541409|NCT03015402|473604167|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
131541410|NCT03015402|473604168|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
131541411|NCT03213158|473604169|FG000|Overall Study|Withdrawal by Subject|1|||
131541412|NCT03213158|473604169|FG000|Overall Study|Physician Decision|2|||
131541413|NCT01995461|473604172|FG000|Overall Study|Death|1|||
131541414|NCT01995461|473604172|FG000|Overall Study|Lost to Follow-up|2|||
131541415|NCT01995461|473604172|FG000|Overall Study|Withdrawal by Subject|2|||
131541416|NCT00736645|473604173|FG000|Overall Study|Adverse Event|0|||
131541417|NCT00736645|473604174|FG001|Overall Study|Adverse Event|2|||
131541418|NCT00736645|473604175|FG002|Overall Study|Adverse Event|0|||
131541419|NCT00736645|473604176|FG003|Overall Study|Adverse Event|0|||
131541420|NCT00295022|473604179|FG000|Overall Study|Adverse Event|1|||
131541421|NCT00295022|473604180|FG001|Overall Study|Adverse Event|1|||
131541422|NCT00295022|473604181|FG002|Overall Study|Adverse Event|2|||
131541423|NCT00295022|473604179|FG000|Overall Study|Lost to Follow-up|0|||
131541424|NCT00295022|473604180|FG001|Overall Study|Lost to Follow-up|0|||
131541425|NCT00295022|473604181|FG002|Overall Study|Lost to Follow-up|1|||
131541426|NCT00295022|473604179|FG000|Overall Study|Withdrawal by Subject|0|||
131541427|NCT00295022|473604180|FG001|Overall Study|Withdrawal by Subject|0|||
131541428|NCT00295022|473604181|FG002|Overall Study|Withdrawal by Subject|2|||
131541429|NCT00734630|473604182|FG000|Overall Study|Lack of Efficacy|4|||
131541430|NCT00734630|473604183|FG001|Overall Study|Lack of Efficacy|4|||
131541431|NCT00734630|473604182|FG000|Overall Study|Withdrawal by Subject|7|||
131541432|NCT00734630|473604183|FG001|Overall Study|Withdrawal by Subject|9|||
131541433|NCT00734630|473604182|FG000|Overall Study|Lost to Follow-up|13|||
131541434|NCT00734630|473604183|FG001|Overall Study|Lost to Follow-up|7|||
131541435|NCT00734630|473604182|FG000|Overall Study|Protocol Violation|0|||
131541436|NCT00734630|473604183|FG001|Overall Study|Protocol Violation|3|||
131541437|NCT00734630|473604182|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
131541438|NCT00734630|473604183|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
131541439|NCT00734630|473604182|FG000|Overall Study|Adverse Event|3|||
131541440|NCT00734630|473604183|FG001|Overall Study|Adverse Event|6|||
131541441|NCT00734630|473604182|FG000|Overall Study|Randomized in Error|0|||
131541442|NCT00734630|473604183|FG001|Overall Study|Randomized in Error|1|||
131541443|NCT00734630|473604182|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
131541444|NCT00734630|473604183|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
131541445|NCT00734630|473604182|FG000|Overall Study|Poor Compliance|1|||
131541446|NCT00734630|473604183|FG001|Overall Study|Poor Compliance|1|||
131541447|NCT03085485|473604193|FG000|Overall Study|Death|1|||
131541448|NCT03085485|473604194|FG001|Overall Study|Death|0|||
131541449|NCT03085485|473604193|FG000|Overall Study|Lost to Follow-up|1|||
131541450|NCT03085485|473604194|FG001|Overall Study|Lost to Follow-up|0|||
131541451|NCT00450411|473604198|FG000|Overall Study|Protocol Violation|6|||
131541452|NCT00450411|473604198|FG000|Overall Study|No protocol treatment|2|||
131541453|NCT02130193|473604202|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
131541454|NCT02130193|473604203|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
131541455|NCT02130193|473604204|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
131541456|NCT02130193|473604202|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
131541457|NCT02130193|473604203|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
131541458|NCT02130193|473604204|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
131541459|NCT02130193|473604202|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
131541460|NCT02130193|473604203|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
131541461|NCT02130193|473604204|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
131541462|NCT02130193|473604202|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
131541463|NCT02130193|473604203|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
131541464|NCT02130193|473604204|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
131541465|NCT02077166|473604205|FG000|Overall Study|Death|6|||
131541466|NCT02077166|473604206|FG001|Overall Study|Death|7|||
131541467|NCT02077166|473604207|FG002|Overall Study|Death|5|||
131541468|NCT02077166|473604208|FG003|Overall Study|Death|6|||
131541469|NCT02077166|473604209|FG004|Overall Study|Death|4|||
131541470|NCT02077166|473604210|FG005|Overall Study|Death|32|||
131541471|NCT02077166|473604211|FG006|Overall Study|Death|22|||
131541472|NCT02077166|473604205|FG000|Overall Study|Study Closure by Sponsor|3|||
131541473|NCT02077166|473604206|FG001|Overall Study|Study Closure by Sponsor|0|||
131541474|NCT02077166|473604207|FG002|Overall Study|Study Closure by Sponsor|2|||
131541475|NCT02077166|473604208|FG003|Overall Study|Study Closure by Sponsor|2|||
131541476|NCT02077166|473604209|FG004|Overall Study|Study Closure by Sponsor|2|||
131541477|NCT02077166|473604210|FG005|Overall Study|Study Closure by Sponsor|12|||
131541478|NCT02077166|473604211|FG006|Overall Study|Study Closure by Sponsor|4|||
131541479|NCT02077166|473604205|FG000|Overall Study|Lost to Follow-up|0|||
131541480|NCT02077166|473604206|FG001|Overall Study|Lost to Follow-up|0|||
131541481|NCT02077166|473604207|FG002|Overall Study|Lost to Follow-up|0|||
131541482|NCT02077166|473604208|FG003|Overall Study|Lost to Follow-up|0|||
131541483|NCT02077166|473604209|FG004|Overall Study|Lost to Follow-up|0|||
131541484|NCT02077166|473604210|FG005|Overall Study|Lost to Follow-up|1|||
131541485|NCT02077166|473604211|FG006|Overall Study|Lost to Follow-up|0|||
131541486|NCT02077166|473604205|FG000|Overall Study|Withdrawal by Subject|3|||
131541487|NCT02077166|473604206|FG001|Overall Study|Withdrawal by Subject|0|||
131541488|NCT02077166|473604207|FG002|Overall Study|Withdrawal by Subject|1|||
131541489|NCT02077166|473604208|FG003|Overall Study|Withdrawal by Subject|1|||
131541490|NCT02077166|473604209|FG004|Overall Study|Withdrawal by Subject|1|||
131541491|NCT02077166|473604210|FG005|Overall Study|Withdrawal by Subject|3|||
131541492|NCT02077166|473604211|FG006|Overall Study|Withdrawal by Subject|0|||
131541493|NCT02077166|473604205|FG000|Overall Study|Other, Not Specified|0|||
131541494|NCT02077166|473604206|FG001|Overall Study|Other, Not Specified|0|||
131541495|NCT02077166|473604207|FG002|Overall Study|Other, Not Specified|1|||
131541496|NCT02077166|473604208|FG003|Overall Study|Other, Not Specified|0|||
131541497|NCT02077166|473604209|FG004|Overall Study|Other, Not Specified|1|||
131541498|NCT02077166|473604210|FG005|Overall Study|Other, Not Specified|7|||
131541499|NCT02077166|473604211|FG006|Overall Study|Other, Not Specified|8|||
131541500|NCT02277444|473604219|FG000|Overall Study|Adverse Event|10|||
131541501|NCT02277444|473604219|FG000|Overall Study|Withdrawal by Subject|3|||
131541502|NCT02277444|473604219|FG000|Overall Study|Other|1|||
131541503|NCT02277444|473604219|FG000|Overall Study|Enrolled and not Treated|3|||
131541504|NCT02277444|473604219|FG000|Overall Study|Ongoing|113|||
131541505|NCT03576768|473606156|FG000|Overall Study|Lost to Follow-up|3|||
131541506|NCT03576768|473606157|FG001|Overall Study|Lost to Follow-up|3|||
131541507|NCT03576768|473606158|FG002|Overall Study|Lost to Follow-up|0|||
131541508|NCT03576768|473606159|FG003|Overall Study|Lost to Follow-up|0|||
131541509|NCT04050865|473606160|FG000|Overall Study|Adverse Event|1|||
131541510|NCT04050865|473606161|FG001|Overall Study|Adverse Event|0|||
131541511|NCT04050865|473606160|FG000|Overall Study|no insert|1|||
131541512|NCT04050865|473606161|FG001|Overall Study|no insert|0|||
131541513|NCT04050865|473606160|FG000|Overall Study|Only 1 insert|2|||
131541514|NCT04050865|473606161|FG001|Overall Study|Only 1 insert|3|||
131541515|NCT04050865|473606160|FG000|Overall Study|Physician Decision|0|||
131541516|NCT04050865|473606161|FG001|Overall Study|Physician Decision|1|||
131541517|NCT04050865|473606160|FG000|Overall Study|Withdrawal by Subject|0|||
131541518|NCT04050865|473606161|FG001|Overall Study|Withdrawal by Subject|1|||
131541519|NCT04205630|473606162|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
131541520|NCT04205630|473606162|FG000|Overall Study|Disease clinical progression|7|||
131541521|NCT04205630|473606162|FG000|Overall Study|Withdrawal by Subject|2|||
131541522|NCT04205630|473606162|FG000|Overall Study|Adverse Event|17|||
131541523|NCT04205630|473606162|FG000|Overall Study|Other|1|||
131541524|NCT04279314|473606167|FG000|Overall Study|Adverse Event|55|||
131541525|NCT04279314|473606167|FG000|Overall Study|Withdrawal by Subject|5|||
131541526|NCT04279314|473606167|FG000|Overall Study|Lack of Efficacy|5|||
131541527|NCT04279314|473606167|FG000|Overall Study|Protocol Violation|3|||
131541528|NCT04279314|473606167|FG000|Overall Study|Other (not COVID-19 related)|2|||
131541529|NCT02481310|473606168|FG000|Follow up|Still in follow up|0|||
131541530|NCT02481310|473606169|FG001|Follow up|Still in follow up|3|||
131541531|NCT02481310|473606170|FG002|Follow up|Still in follow up|0|||
131541532|NCT02583425|473606179|FG000|Screening|Did not meet entry criteria|12|||
131541533|NCT02583425|473606179|FG000|Baseline|Did not meet continued criteria|5|||
131541534|NCT02583425|473606179|FG000|Treatment Period|Adverse Event|1|||
131541535|NCT01597050|473606182|FG000|Overall Study|Withdrawal by Subject|1|||
131541536|NCT01597050|473606183|FG001|Overall Study|Withdrawal by Subject|0|||
131541537|NCT00483184|473606184|FG000|Overall Study|Withdrawal by Subject|2|||
131541538|NCT00483184|473606185|FG001|Overall Study|Withdrawal by Subject|2|||
131541539|NCT00483184|473606186|FG002|Overall Study|Withdrawal by Subject|0|||
131541540|NCT00483184|473606184|FG000|Overall Study|Lost to Follow-up|1|||
131541541|NCT00483184|473606185|FG001|Overall Study|Lost to Follow-up|0|||
131541542|NCT00483184|473606186|FG002|Overall Study|Lost to Follow-up|0|||
131541543|NCT00483184|473606184|FG000|Overall Study|Adverse Event|1|||
131541544|NCT00483184|473606185|FG001|Overall Study|Adverse Event|2|||
131541545|NCT00483184|473606186|FG002|Overall Study|Adverse Event|2|||
131541546|NCT00483184|473606184|FG000|Overall Study|Protocol Violation|1|||
131541547|NCT00483184|473606185|FG001|Overall Study|Protocol Violation|0|||
131541548|NCT00483184|473606186|FG002|Overall Study|Protocol Violation|1|||
131541549|NCT00558428|473606187|FG000|Overall Study|Adverse Event|6|||
131541550|NCT00558428|473606188|FG001|Overall Study|Adverse Event|22|||
131541551|NCT00558428|473606189|FG002|Overall Study|Adverse Event|3|||
131541552|NCT00558428|473606190|FG003|Overall Study|Adverse Event|4|||
131541553|NCT00558428|473606187|FG000|Overall Study|Lost to Follow-up|0|||
131541554|NCT00558428|473606188|FG001|Overall Study|Lost to Follow-up|1|||
131541555|NCT00558428|473606189|FG002|Overall Study|Lost to Follow-up|0|||
131541556|NCT00558428|473606190|FG003|Overall Study|Lost to Follow-up|0|||
131541557|NCT00558428|473606187|FG000|Overall Study|Lack of Efficacy|0|||
131541558|NCT00558428|473606188|FG001|Overall Study|Lack of Efficacy|0|||
131541559|NCT00558428|473606189|FG002|Overall Study|Lack of Efficacy|1|||
131541560|NCT00558428|473606190|FG003|Overall Study|Lack of Efficacy|2|||
131541561|NCT00558428|473606187|FG000|Overall Study|Non compliant with protocol|1|||
131541562|NCT00558428|473606188|FG001|Overall Study|Non compliant with protocol|0|||
131541563|NCT00558428|473606189|FG002|Overall Study|Non compliant with protocol|0|||
131541564|NCT00558428|473606190|FG003|Overall Study|Non compliant with protocol|3|||
131541565|NCT00558428|473606187|FG000|Overall Study|Consent withdrawn|2|||
131541566|NCT00558428|473606188|FG001|Overall Study|Consent withdrawn|1|||
131541567|NCT00558428|473606189|FG002|Overall Study|Consent withdrawn|0|||
131541568|NCT00558428|473606190|FG003|Overall Study|Consent withdrawn|1|||
131541569|NCT00558428|473606187|FG000|Overall Study|Other|3|||
131541570|NCT00558428|473606188|FG001|Overall Study|Other|0|||
131541571|NCT00558428|473606189|FG002|Overall Study|Other|0|||
131541572|NCT00558428|473606190|FG003|Overall Study|Other|1|||
131541573|NCT05224050|473606191|FG000|Overall Study|Withdrawal by Subject|9|||
131541574|NCT05224050|473606191|FG000|Overall Study|Lost to Follow-up|3|||
131541575|NCT01137474|473606192|FG000|Overall Study|Adverse Event|3|||
131541576|NCT01137474|473606193|FG001|Overall Study|Adverse Event|5|||
131541577|NCT01137474|473606194|FG002|Overall Study|Adverse Event|1|||
131541578|NCT01137474|473606195|FG003|Overall Study|Adverse Event|3|||
131541579|NCT01137474|473606192|FG000|Overall Study|Withdrawal by Subject|7|||
131541580|NCT01137474|473606193|FG001|Overall Study|Withdrawal by Subject|2|||
131541581|NCT01137474|473606194|FG002|Overall Study|Withdrawal by Subject|6|||
131541582|NCT01137474|473606195|FG003|Overall Study|Withdrawal by Subject|9|||
131541583|NCT01137474|473606192|FG000|Overall Study|No longer met study criteria|6|||
131541584|NCT01137474|473606193|FG001|Overall Study|No longer met study criteria|1|||
131541585|NCT01137474|473606194|FG002|Overall Study|No longer met study criteria|0|||
131541586|NCT01137474|473606195|FG003|Overall Study|No longer met study criteria|5|||
131541587|NCT01137474|473606192|FG000|Overall Study|Lost to Follow-up|5|||
131541588|NCT01137474|473606193|FG001|Overall Study|Lost to Follow-up|1|||
131541589|NCT01137474|473606194|FG002|Overall Study|Lost to Follow-up|0|||
131541590|NCT01137474|473606195|FG003|Overall Study|Lost to Follow-up|2|||
131541591|NCT01137474|473606192|FG000|Overall Study|Lack of Efficacy|0|||
131541592|NCT01137474|473606193|FG001|Overall Study|Lack of Efficacy|0|||
131541593|NCT01137474|473606194|FG002|Overall Study|Lack of Efficacy|0|||
131541594|NCT01137474|473606195|FG003|Overall Study|Lack of Efficacy|2|||
131541595|NCT01137474|473606192|FG000|Overall Study|Other|3|||
131541596|NCT01137474|473606193|FG001|Overall Study|Other|1|||
131541597|NCT01137474|473606194|FG002|Overall Study|Other|0|||
131541598|NCT01137474|473606195|FG003|Overall Study|Other|0|||
131541599|NCT01137474|473606192|FG000|Overall Study|Pregnancy|0|||
131541600|NCT01137474|473606193|FG001|Overall Study|Pregnancy|1|||
131541601|NCT01137474|473606194|FG002|Overall Study|Pregnancy|0|||
131541602|NCT01137474|473606195|FG003|Overall Study|Pregnancy|0|||
131541603|NCT01137474|473606192|FG000|Overall Study|Administrative reason by sponsor|0|||
131541604|NCT01137474|473606193|FG001|Overall Study|Administrative reason by sponsor|1|||
131541605|NCT01137474|473606194|FG002|Overall Study|Administrative reason by sponsor|0|||
131541606|NCT01137474|473606195|FG003|Overall Study|Administrative reason by sponsor|0|||
131541607|NCT02219048|473606196|FG000|Overall Study|Adverse Event|2|||
131541608|NCT02219048|473606197|FG001|Overall Study|Adverse Event|5|||
131541609|NCT02219048|473606196|FG000|Overall Study|No longer meets eligibility criteria|1|||
131541610|NCT02219048|473606197|FG001|Overall Study|No longer meets eligibility criteria|0|||
131541611|NCT02219048|473606196|FG000|Overall Study|Study terminated by sponsor|16|||
131541612|NCT02219048|473606197|FG001|Overall Study|Study terminated by sponsor|15|||
131541613|NCT02219048|473606196|FG000|Overall Study|Withdrawal by Subject|2|||
131541614|NCT02219048|473606197|FG001|Overall Study|Withdrawal by Subject|0|||
131541615|NCT02219048|473606196|FG000|Overall Study|Other|0|||
131541616|NCT02219048|473606197|FG001|Overall Study|Other|1|||
131541617|NCT00911534|473606198|FG000|Overall Study|Adverse Event|4|||
131541618|NCT00911534|473606199|FG001|Overall Study|Adverse Event|4|||
131541619|NCT00911534|473606198|FG000|Overall Study|Lost to Follow-up|2|||
131541620|NCT00911534|473606199|FG001|Overall Study|Lost to Follow-up|4|||
131541621|NCT00911534|473606198|FG000|Overall Study|Withdrawal by Subject|2|||
131541622|NCT00911534|473606199|FG001|Overall Study|Withdrawal by Subject|1|||
131541623|NCT00911534|473606198|FG000|Overall Study|Lack of Efficacy|4|||
131541624|NCT00911534|473606199|FG001|Overall Study|Lack of Efficacy|1|||
131541625|NCT00911534|473606198|FG000|Overall Study|Withdrawal of consent|1|||
131541626|NCT00911534|473606199|FG001|Overall Study|Withdrawal of consent|4|||
131541627|NCT00911534|473606198|FG000|Overall Study|Other|2|||
131541628|NCT00911534|473606199|FG001|Overall Study|Other|2|||
131541629|NCT01388816|473606200|FG000|Overall Study|Adverse Event|0|||
131541630|NCT01388816|473606201|FG001|Overall Study|Adverse Event|2|||
131541631|NCT01388816|473606202|FG002|Overall Study|Adverse Event|0|||
131541632|NCT01388816|473606203|FG003|Overall Study|Adverse Event|0|||
131541633|NCT01388816|473606200|FG000|Overall Study|Lost to Follow-up|0|||
131541634|NCT01388816|473606201|FG001|Overall Study|Lost to Follow-up|1|||
131541635|NCT01388816|473606202|FG002|Overall Study|Lost to Follow-up|0|||
131541636|NCT01388816|473606203|FG003|Overall Study|Lost to Follow-up|0|||
131541637|NCT01388816|473606200|FG000|Overall Study|Withdrawal by Subject|2|||
131541638|NCT01388816|473606201|FG001|Overall Study|Withdrawal by Subject|1|||
131541639|NCT01388816|473606202|FG002|Overall Study|Withdrawal by Subject|1|||
131541640|NCT01388816|473606203|FG003|Overall Study|Withdrawal by Subject|0|||
131541641|NCT01388816|473606200|FG000|Overall Study|Protocol Violation|0|||
131541642|NCT01388816|473606201|FG001|Overall Study|Protocol Violation|0|||
131541643|NCT01388816|473606202|FG002|Overall Study|Protocol Violation|2|||
131541644|NCT01388816|473606203|FG003|Overall Study|Protocol Violation|0|||
131541645|NCT03792126|473606204|FG000|Overall Study|Adverse Event|1|||
131541646|NCT03792126|473606205|FG001|Overall Study|Adverse Event|2|||
131541647|NCT03792126|473606204|FG000|Overall Study|Death|0|||
131541648|NCT03792126|473606205|FG001|Overall Study|Death|1|||
131541649|NCT03792126|473606204|FG000|Overall Study|Lost to Follow-up|1|||
131541650|NCT03792126|473606205|FG001|Overall Study|Lost to Follow-up|0|||
131541651|NCT03792126|473606204|FG000|Overall Study|Withdrawal by Subject|0|||
131541652|NCT03792126|473606205|FG001|Overall Study|Withdrawal by Subject|1|||
131541653|NCT03792126|473606204|FG000|Overall Study|COVID-19 Restrictions|1|||
131541654|NCT03792126|473606205|FG001|Overall Study|COVID-19 Restrictions|3|||
131541655|NCT03792126|473606204|FG000|Overall Study|Symptoms resolved|0|||
131541656|NCT03792126|473606205|FG001|Overall Study|Symptoms resolved|3|||
131541657|NCT03240692|473606206|FG000|Overall Study|Physician Decision|1|||
131541658|NCT03240692|473606206|FG000|Overall Study|Withdrawal by Subject|1|||
131541659|NCT02300220|473606207|FG000|Overall Study|Lost to Follow-up|1|||
131541660|NCT02300220|473606208|FG001|Overall Study|Lost to Follow-up|2|||
131541661|NCT02300220|473606207|FG000|Overall Study|Death|1|||
131541662|NCT02300220|473606208|FG001|Overall Study|Death|1|||
131541663|NCT02300220|473606207|FG000|Overall Study|Adverse Event|1|||
131541664|NCT02300220|473606208|FG001|Overall Study|Adverse Event|1|||
131541665|NCT02300220|473606207|FG000|Overall Study|Protocol Violation|1|||
131541666|NCT02300220|473606208|FG001|Overall Study|Protocol Violation|0|||
131541667|NCT02300220|473606207|FG000|Overall Study|Withdrawal by Subject|0|||
131541668|NCT02300220|473606208|FG001|Overall Study|Withdrawal by Subject|2|||
131541669|NCT02300220|473606207|FG000|Overall Study|Did not tolerate IMP|0|||
131541670|NCT02300220|473606208|FG001|Overall Study|Did not tolerate IMP|1|||
131541671|NCT04322682|473606209|FG000|Overall Study|Withdrawal by Subject|33|||
131541672|NCT04322682|473606210|FG001|Overall Study|Withdrawal by Subject|47|||
131541673|NCT04322682|473606209|FG000|Overall Study|Death|5|||
131541674|NCT04322682|473606210|FG001|Overall Study|Death|9|||
131541675|NCT04322682|473606209|FG000|Overall Study|Lost to Follow-up|4|||
131541676|NCT04322682|473606210|FG001|Overall Study|Lost to Follow-up|8|||
131541677|NCT04322682|473606209|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
131541678|NCT04322682|473606210|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
131541679|NCT04123067|473606212|FG000|Overall Study|Lost to Follow-up|0|||
131541680|NCT04123067|473606213|FG001|Overall Study|Lost to Follow-up|1|||
131541681|NCT02238379|473606214|FG000|Overall Study|Lost to Follow-up|1|||
131541682|NCT02238379|473606215|FG001|Overall Study|Lost to Follow-up|0|||
131541683|NCT00441090|473606216|FG000|Overall Study|Adverse Event|0|||
131541684|NCT00441090|473606217|FG001|Overall Study|Adverse Event|1|||
131541685|NCT00441090|473606218|FG002|Overall Study|Adverse Event|1|||
131541686|NCT00441090|473606219|FG003|Overall Study|Adverse Event|0|||
131541687|NCT00441090|473606220|FG004|Overall Study|Adverse Event|0|||
131541688|NCT00441090|473606216|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
131541689|NCT00441090|473606217|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
131541690|NCT00441090|473606218|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
131541691|NCT00441090|473606219|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
131541692|NCT00441090|473606220|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
131541693|NCT00441090|473606216|FG000|Overall Study|Withdrawal by Subject|1|||
131541694|NCT00441090|473606217|FG001|Overall Study|Withdrawal by Subject|0|||
131541695|NCT00441090|473606218|FG002|Overall Study|Withdrawal by Subject|1|||
131541696|NCT00441090|473606219|FG003|Overall Study|Withdrawal by Subject|0|||
131541697|NCT00441090|473606220|FG004|Overall Study|Withdrawal by Subject|0|||
131541698|NCT00441090|473606216|FG000|Overall Study|Lack of Efficacy|1|||
131541699|NCT00441090|473606217|FG001|Overall Study|Lack of Efficacy|0|||
131541700|NCT00441090|473606218|FG002|Overall Study|Lack of Efficacy|0|||
131541701|NCT00441090|473606219|FG003|Overall Study|Lack of Efficacy|0|||
131541702|NCT00441090|473606220|FG004|Overall Study|Lack of Efficacy|0|||
131541703|NCT01441102|473606221|FG000|Overall Study|Adverse Event|1|||
131541704|NCT01441102|473606221|FG000|Overall Study|Withdrawal by Subject|2|||
131541705|NCT00605280|473606222|FG000|Year 1|Protocol Violation|0|||
131541706|NCT00605280|473606223|FG001|Year 1|Protocol Violation|0|||
131541707|NCT00605280|473606224|FG002|Year 1|Protocol Violation|0|||
131541708|NCT00605280|473606225|FG003|Year 1|Protocol Violation|1|||
131541709|NCT00605280|473606222|FG000|Year 1|Adverse Event|3|||
131541710|NCT00605280|473606223|FG001|Year 1|Adverse Event|1|||
131541711|NCT00605280|473606224|FG002|Year 1|Adverse Event|1|||
131541712|NCT00605280|473606225|FG003|Year 1|Adverse Event|5|||
131541713|NCT00605280|473606222|FG000|Year 1|Physician Decision|7|||
131541714|NCT00605280|473606223|FG001|Year 1|Physician Decision|4|||
131541715|NCT00605280|473606224|FG002|Year 1|Physician Decision|0|||
131541716|NCT00605280|473606225|FG003|Year 1|Physician Decision|6|||
131541717|NCT00605280|473606222|FG000|Year 1|Withdrawal by Subject|2|||
131541718|NCT00605280|473606223|FG001|Year 1|Withdrawal by Subject|4|||
131541719|NCT00605280|473606224|FG002|Year 1|Withdrawal by Subject|0|||
131541720|NCT00605280|473606225|FG003|Year 1|Withdrawal by Subject|4|||
131541721|NCT00605280|473606222|FG000|Year 1|Other|2|||
131541722|NCT00605280|473606223|FG001|Year 1|Other|1|||
131541723|NCT00605280|473606224|FG002|Year 1|Other|0|||
131541724|NCT00605280|473606225|FG003|Year 1|Other|1|||
131541725|NCT00605280|473606222|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
131541726|NCT00605280|473606223|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
131541727|NCT00605280|473606224|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
131541728|NCT00605280|473606225|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
131541729|NCT00605280|473606222|FG000|Year 2|Adverse Event|4|||
131541730|NCT00605280|473606223|FG001|Year 2|Adverse Event|0|||
131541731|NCT00605280|473606224|FG002|Year 2|Adverse Event|2|||
131541732|NCT00605280|473606225|FG003|Year 2|Adverse Event|4|||
131541733|NCT00605280|473606222|FG000|Year 2|Physician Decision|11|||
131541734|NCT00605280|473606223|FG001|Year 2|Physician Decision|6|||
131541735|NCT00605280|473606224|FG002|Year 2|Physician Decision|4|||
131541736|NCT00605280|473606225|FG003|Year 2|Physician Decision|11|||
131541737|NCT00605280|473606222|FG000|Year 2|Withdrawal by Subject|4|||
131541738|NCT00605280|473606223|FG001|Year 2|Withdrawal by Subject|0|||
131541739|NCT00605280|473606224|FG002|Year 2|Withdrawal by Subject|0|||
131541740|NCT00605280|473606225|FG003|Year 2|Withdrawal by Subject|4|||
131541741|NCT00605280|473606222|FG000|Year 2|Other|1|||
131541742|NCT00605280|473606223|FG001|Year 2|Other|0|||
131541743|NCT00605280|473606224|FG002|Year 2|Other|0|||
131541744|NCT00605280|473606225|FG003|Year 2|Other|1|||
131541745|NCT00605280|473606222|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
131541746|NCT00605280|473606223|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
131541747|NCT00605280|473606224|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
131541748|NCT00605280|473606225|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
131541749|NCT00605280|473606222|FG000|Year 3 Extension|Adverse Event|2|||
131541750|NCT00605280|473606223|FG001|Year 3 Extension|Adverse Event|0|||
131541751|NCT00605280|473606224|FG002|Year 3 Extension|Adverse Event|0|||
131541752|NCT00605280|473606225|FG003|Year 3 Extension|Adverse Event|2|||
131541753|NCT00605280|473606222|FG000|Year 3 Extension|Physician Decision|0|||
131541754|NCT00605280|473606223|FG001|Year 3 Extension|Physician Decision|0|||
131541755|NCT00605280|473606224|FG002|Year 3 Extension|Physician Decision|0|||
131541756|NCT00605280|473606225|FG003|Year 3 Extension|Physician Decision|2|||
131541757|NCT00605280|473606222|FG000|Year 3 Extension|Withdrawal by Subject|2|||
131541758|NCT00605280|473606223|FG001|Year 3 Extension|Withdrawal by Subject|0|||
131541759|NCT00605280|473606224|FG002|Year 3 Extension|Withdrawal by Subject|0|||
131541760|NCT00605280|473606225|FG003|Year 3 Extension|Withdrawal by Subject|5|||
131541761|NCT00605280|473606222|FG000|Year 3 Extension|Other|2|||
131541762|NCT00605280|473606223|FG001|Year 3 Extension|Other|0|||
131541763|NCT00605280|473606224|FG002|Year 3 Extension|Other|0|||
131541764|NCT00605280|473606225|FG003|Year 3 Extension|Other|0|||
131541765|NCT00605280|473606222|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
131541766|NCT00605280|473606223|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
131541767|NCT00605280|473606224|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
131541768|NCT00605280|473606225|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
131541769|NCT01775904|473606229|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
131541770|NCT01775904|473606229|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
131541771|NCT00518115|473606230|FG000|Overall Study|Adverse Event|6|||
131541772|NCT00518115|473606231|FG001|Overall Study|Adverse Event|1|||
131541773|NCT00518115|473606232|FG002|Overall Study|Adverse Event|5|||
131541774|NCT00518115|473606233|FG003|Overall Study|Adverse Event|6|||
131541775|NCT00518115|473606234|FG004|Overall Study|Adverse Event|5|||
131541776|NCT00518115|473606235|FG005|Overall Study|Adverse Event|5|||
131541777|NCT00518115|473606236|FG006|Overall Study|Adverse Event|5|||
131541778|NCT00518115|473606237|FG007|Overall Study|Adverse Event|10|||
131541779|NCT00518115|473606238|FG008|Overall Study|Adverse Event|2|||
131541780|NCT00518115|473606239|FG009|Overall Study|Adverse Event|9|||
131541781|NCT00518115|473606230|FG000|Overall Study|Lost to Follow-up|0|||
131541782|NCT00518115|473606231|FG001|Overall Study|Lost to Follow-up|0|||
131541783|NCT00518115|473606232|FG002|Overall Study|Lost to Follow-up|2|||
131541784|NCT00518115|473606233|FG003|Overall Study|Lost to Follow-up|3|||
131541785|NCT00518115|473606234|FG004|Overall Study|Lost to Follow-up|1|||
131541786|NCT00518115|473606235|FG005|Overall Study|Lost to Follow-up|3|||
131541787|NCT00518115|473606236|FG006|Overall Study|Lost to Follow-up|0|||
131541788|NCT00518115|473606237|FG007|Overall Study|Lost to Follow-up|1|||
131541789|NCT00518115|473606238|FG008|Overall Study|Lost to Follow-up|1|||
131541790|NCT00518115|473606239|FG009|Overall Study|Lost to Follow-up|1|||
131541791|NCT00518115|473606230|FG000|Overall Study|Protocol Violation|1|||
131541792|NCT00518115|473606231|FG001|Overall Study|Protocol Violation|3|||
131541793|NCT00518115|473606232|FG002|Overall Study|Protocol Violation|1|||
131541794|NCT00518115|473606233|FG003|Overall Study|Protocol Violation|0|||
131541795|NCT00518115|473606234|FG004|Overall Study|Protocol Violation|0|||
131541796|NCT00518115|473606235|FG005|Overall Study|Protocol Violation|0|||
131541797|NCT00518115|473606236|FG006|Overall Study|Protocol Violation|0|||
131541798|NCT00518115|473606237|FG007|Overall Study|Protocol Violation|0|||
131541799|NCT00518115|473606238|FG008|Overall Study|Protocol Violation|0|||
131541800|NCT00518115|473606239|FG009|Overall Study|Protocol Violation|0|||
131541801|NCT00518115|473606230|FG000|Overall Study|Withdrawal by Subject|1|||
131541802|NCT00518115|473606231|FG001|Overall Study|Withdrawal by Subject|1|||
131541803|NCT00518115|473606232|FG002|Overall Study|Withdrawal by Subject|5|||
131541804|NCT00518115|473606233|FG003|Overall Study|Withdrawal by Subject|0|||
131541805|NCT00518115|473606234|FG004|Overall Study|Withdrawal by Subject|2|||
131541806|NCT00518115|473606235|FG005|Overall Study|Withdrawal by Subject|1|||
131541807|NCT00518115|473606236|FG006|Overall Study|Withdrawal by Subject|0|||
131541808|NCT00518115|473606237|FG007|Overall Study|Withdrawal by Subject|2|||
131541809|NCT00518115|473606238|FG008|Overall Study|Withdrawal by Subject|1|||
131541810|NCT00518115|473606239|FG009|Overall Study|Withdrawal by Subject|3|||
131541811|NCT00518115|473606230|FG000|Overall Study|Lack of Efficacy|1|||
131541812|NCT00518115|473606231|FG001|Overall Study|Lack of Efficacy|0|||
131541813|NCT00518115|473606232|FG002|Overall Study|Lack of Efficacy|1|||
131541814|NCT00518115|473606233|FG003|Overall Study|Lack of Efficacy|1|||
131541815|NCT00518115|473606234|FG004|Overall Study|Lack of Efficacy|0|||
131541816|NCT00518115|473606235|FG005|Overall Study|Lack of Efficacy|0|||
131541817|NCT00518115|473606236|FG006|Overall Study|Lack of Efficacy|0|||
131541818|NCT00518115|473606237|FG007|Overall Study|Lack of Efficacy|1|||
131541819|NCT00518115|473606238|FG008|Overall Study|Lack of Efficacy|0|||
131541820|NCT00518115|473606239|FG009|Overall Study|Lack of Efficacy|0|||
131541821|NCT00518115|473606230|FG000|Overall Study|Non-Compliance|1|||
131541822|NCT00518115|473606231|FG001|Overall Study|Non-Compliance|0|||
131541823|NCT00518115|473606232|FG002|Overall Study|Non-Compliance|1|||
131541824|NCT00518115|473606233|FG003|Overall Study|Non-Compliance|0|||
131541825|NCT00518115|473606234|FG004|Overall Study|Non-Compliance|1|||
131541826|NCT00518115|473606235|FG005|Overall Study|Non-Compliance|1|||
131541827|NCT00518115|473606236|FG006|Overall Study|Non-Compliance|1|||
131541828|NCT00518115|473606237|FG007|Overall Study|Non-Compliance|1|||
131541829|NCT00518115|473606238|FG008|Overall Study|Non-Compliance|0|||
131541830|NCT00518115|473606239|FG009|Overall Study|Non-Compliance|1|||
131541831|NCT00518115|473606230|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
131541832|NCT00518115|473606231|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
131541833|NCT00518115|473606232|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541834|NCT00518115|473606233|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541835|NCT00518115|473606234|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541836|NCT00518115|473606235|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
131541837|NCT00518115|473606236|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541838|NCT00518115|473606237|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541839|NCT00518115|473606238|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541840|NCT00518115|473606239|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131541841|NCT00518115|473606230|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
131541842|NCT00518115|473606231|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541843|NCT00518115|473606232|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541844|NCT00518115|473606233|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541845|NCT00518115|473606234|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541846|NCT00518115|473606235|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541847|NCT00518115|473606236|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541848|NCT00518115|473606237|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541849|NCT00518115|473606238|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541850|NCT00518115|473606239|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
131541851|NCT00518115|473606230|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541852|NCT00518115|473606231|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541853|NCT00518115|473606232|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
131541854|NCT00518115|473606233|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541855|NCT00518115|473606234|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541856|NCT00518115|473606235|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541857|NCT00518115|473606236|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541858|NCT00518115|473606237|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541859|NCT00518115|473606238|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
131541860|NCT00518115|473606239|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
131541861|NCT00518115|473606230|FG000|Overall Study|Wrong Monotherapy Administered|0|||
131541862|NCT00518115|473606231|FG001|Overall Study|Wrong Monotherapy Administered|0|||
131541863|NCT00518115|473606232|FG002|Overall Study|Wrong Monotherapy Administered|1|||
131541864|NCT00518115|473606233|FG003|Overall Study|Wrong Monotherapy Administered|0|||
131541865|NCT00518115|473606234|FG004|Overall Study|Wrong Monotherapy Administered|0|||
131541866|NCT00518115|473606235|FG005|Overall Study|Wrong Monotherapy Administered|0|||
131541867|NCT00518115|473606236|FG006|Overall Study|Wrong Monotherapy Administered|1|||
131541868|NCT00518115|473606237|FG007|Overall Study|Wrong Monotherapy Administered|0|||
131541869|NCT00518115|473606238|FG008|Overall Study|Wrong Monotherapy Administered|0|||
131541870|NCT00518115|473606239|FG009|Overall Study|Wrong Monotherapy Administered|0|||
131541871|NCT00518115|473606230|FG000|Overall Study|Violation of Exclusion Criteria|0|||
131541872|NCT00518115|473606231|FG001|Overall Study|Violation of Exclusion Criteria|0|||
131541873|NCT00518115|473606232|FG002|Overall Study|Violation of Exclusion Criteria|0|||
131541874|NCT00518115|473606233|FG003|Overall Study|Violation of Exclusion Criteria|1|||
131541875|NCT00518115|473606234|FG004|Overall Study|Violation of Exclusion Criteria|0|||
131541876|NCT00518115|473606235|FG005|Overall Study|Violation of Exclusion Criteria|0|||
131541877|NCT00518115|473606236|FG006|Overall Study|Violation of Exclusion Criteria|1|||
131541878|NCT00518115|473606237|FG007|Overall Study|Violation of Exclusion Criteria|0|||
131541879|NCT00518115|473606238|FG008|Overall Study|Violation of Exclusion Criteria|0|||
131541880|NCT00518115|473606239|FG009|Overall Study|Violation of Exclusion Criteria|0|||
131541881|NCT00518115|473606230|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
131541882|NCT00518115|473606231|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
131541883|NCT00518115|473606232|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
131541884|NCT00518115|473606233|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
131541885|NCT00518115|473606234|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
131541886|NCT00518115|473606235|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
131541887|NCT00518115|473606236|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
131541888|NCT00518115|473606237|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
131541889|NCT00518115|473606238|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
131541890|NCT00518115|473606239|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
131541891|NCT00518115|473606230|FG000|Overall Study|Withdrew Consent|0|||
131541892|NCT00518115|473606231|FG001|Overall Study|Withdrew Consent|0|||
131541893|NCT00518115|473606232|FG002|Overall Study|Withdrew Consent|0|||
131541894|NCT00518115|473606233|FG003|Overall Study|Withdrew Consent|0|||
131541895|NCT00518115|473606234|FG004|Overall Study|Withdrew Consent|0|||
131541896|NCT00518115|473606235|FG005|Overall Study|Withdrew Consent|1|||
131541897|NCT00518115|473606236|FG006|Overall Study|Withdrew Consent|0|||
131541898|NCT00518115|473606237|FG007|Overall Study|Withdrew Consent|0|||
131541899|NCT00518115|473606238|FG008|Overall Study|Withdrew Consent|0|||
131541900|NCT00518115|473606239|FG009|Overall Study|Withdrew Consent|0|||
131541901|NCT00518115|473606230|FG000|Overall Study|Moved Out of State|0|||
131541902|NCT00518115|473606231|FG001|Overall Study|Moved Out of State|0|||
131541903|NCT00518115|473606232|FG002|Overall Study|Moved Out of State|0|||
131541904|NCT00518115|473606233|FG003|Overall Study|Moved Out of State|0|||
131541905|NCT00518115|473606234|FG004|Overall Study|Moved Out of State|0|||
131541906|NCT00518115|473606235|FG005|Overall Study|Moved Out of State|0|||
131541907|NCT00518115|473606236|FG006|Overall Study|Moved Out of State|0|||
131541908|NCT00518115|473606237|FG007|Overall Study|Moved Out of State|0|||
131541909|NCT00518115|473606238|FG008|Overall Study|Moved Out of State|0|||
131541910|NCT00518115|473606239|FG009|Overall Study|Moved Out of State|1|||
131541911|NCT04891419|473606240|FG000|Overall Study|Withdrawal by Subject|4|||
131541912|NCT04891419|473606241|FG001|Overall Study|Withdrawal by Subject|0|||
131541913|NCT04891419|473606240|FG000|Overall Study|Lost to Follow-up|1|||
131541914|NCT04891419|473606241|FG001|Overall Study|Lost to Follow-up|3|||
131541915|NCT00127101|473606242|FG000|Base Protocol|Adverse Event|0|||
131541916|NCT00127101|473606243|FG001|Base Protocol|Adverse Event|2|||
131541917|NCT00127101|473606244|FG002|Base Protocol|Adverse Event|1|||
131541918|NCT00127101|473606245|FG003|Base Protocol|Adverse Event|0|||
131541919|NCT00127101|473606246|FG004|Base Protocol|Adverse Event|0|||
131541920|NCT00127101|473606247|FG005|Base Protocol|Adverse Event|0|||
131541921|NCT00127101|473606242|FG000|Base Protocol|Lack of Efficacy|1|||
131541922|NCT00127101|473606243|FG001|Base Protocol|Lack of Efficacy|0|||
131541923|NCT00127101|473606244|FG002|Base Protocol|Lack of Efficacy|0|||
131541924|NCT00127101|473606245|FG003|Base Protocol|Lack of Efficacy|0|||
131541925|NCT00127101|473606246|FG004|Base Protocol|Lack of Efficacy|2|||
131541926|NCT00127101|473606247|FG005|Base Protocol|Lack of Efficacy|0|||
131541927|NCT00127101|473606242|FG000|Base Protocol|Withdrawal by Subject|1|||
131541928|NCT00127101|473606243|FG001|Base Protocol|Withdrawal by Subject|2|||
131541929|NCT00127101|473606244|FG002|Base Protocol|Withdrawal by Subject|1|||
131541930|NCT00127101|473606245|FG003|Base Protocol|Withdrawal by Subject|0|||
131541931|NCT00127101|473606246|FG004|Base Protocol|Withdrawal by Subject|0|||
131541932|NCT00127101|473606247|FG005|Base Protocol|Withdrawal by Subject|1|||
131541933|NCT00127101|473606242|FG000|Continuation Phase|Adverse Event|0|||
131541934|NCT00127101|473606243|FG001|Continuation Phase|Adverse Event|0|||
131541935|NCT00127101|473606244|FG002|Continuation Phase|Adverse Event|0|||
131541936|NCT00127101|473606245|FG003|Continuation Phase|Adverse Event|0|||
131541937|NCT00127101|473606246|FG004|Continuation Phase|Adverse Event|1|||
131541938|NCT00127101|473606247|FG005|Continuation Phase|Adverse Event|1|||
131541939|NCT00127101|473606242|FG000|Continuation Phase|Lack of Efficacy|0|||
131541940|NCT00127101|473606243|FG001|Continuation Phase|Lack of Efficacy|0|||
131541941|NCT00127101|473606244|FG002|Continuation Phase|Lack of Efficacy|0|||
131541942|NCT00127101|473606245|FG003|Continuation Phase|Lack of Efficacy|0|||
131541943|NCT00127101|473606246|FG004|Continuation Phase|Lack of Efficacy|0|||
131541944|NCT00127101|473606247|FG005|Continuation Phase|Lack of Efficacy|1|||
131541945|NCT00127101|473606242|FG000|Continuation Phase|Withdrawal by Subject|0|||
131541946|NCT00127101|473606243|FG001|Continuation Phase|Withdrawal by Subject|0|||
131541947|NCT00127101|473606244|FG002|Continuation Phase|Withdrawal by Subject|1|||
131541948|NCT00127101|473606245|FG003|Continuation Phase|Withdrawal by Subject|0|||
131541949|NCT00127101|473606246|FG004|Continuation Phase|Withdrawal by Subject|2|||
131541950|NCT00127101|473606247|FG005|Continuation Phase|Withdrawal by Subject|1|||
131541951|NCT02291614|473606250|FG000|Overall Study|Lost to Follow-up|0|||
131541952|NCT02291614|473606251|FG001|Overall Study|Lost to Follow-up|0|||
131541953|NCT02291614|473606252|FG002|Overall Study|Lost to Follow-up|0|||
131541954|NCT02291614|473606253|FG003|Overall Study|Lost to Follow-up|0|||
131541955|NCT02291614|473606254|FG004|Overall Study|Lost to Follow-up|0|||
131541956|NCT02291614|473606255|FG005|Overall Study|Lost to Follow-up|0|||
131541957|NCT02291614|473606256|FG006|Overall Study|Lost to Follow-up|0|||
131541958|NCT02291614|473606257|FG007|Overall Study|Lost to Follow-up|1|||
131541959|NCT02291614|473606258|FG008|Overall Study|Lost to Follow-up|0|||
131541960|NCT02291614|473606259|FG009|Overall Study|Lost to Follow-up|0|||
131541961|NCT02291614|473606260|FG010|Overall Study|Lost to Follow-up|0|||
131541962|NCT02291614|473606250|FG000|Overall Study|Withdrawal by Subject|0|||
131541963|NCT02291614|473606251|FG001|Overall Study|Withdrawal by Subject|1|||
131541964|NCT02291614|473606252|FG002|Overall Study|Withdrawal by Subject|0|||
131541965|NCT02291614|473606253|FG003|Overall Study|Withdrawal by Subject|0|||
131541966|NCT02291614|473606254|FG004|Overall Study|Withdrawal by Subject|0|||
131541967|NCT02291614|473606255|FG005|Overall Study|Withdrawal by Subject|0|||
131541968|NCT02291614|473606256|FG006|Overall Study|Withdrawal by Subject|0|||
131541969|NCT02291614|473606257|FG007|Overall Study|Withdrawal by Subject|0|||
131541970|NCT02291614|473606258|FG008|Overall Study|Withdrawal by Subject|0|||
131541971|NCT02291614|473606259|FG009|Overall Study|Withdrawal by Subject|2|||
131541972|NCT02291614|473606260|FG010|Overall Study|Withdrawal by Subject|2|||
131541973|NCT02291614|473606250|FG000|Overall Study|Decision by sponsor|0|||
131541974|NCT02291614|473606251|FG001|Overall Study|Decision by sponsor|0|||
131541975|NCT02291614|473606252|FG002|Overall Study|Decision by sponsor|0|||
131541976|NCT02291614|473606253|FG003|Overall Study|Decision by sponsor|1|||
131541977|NCT02291614|473606254|FG004|Overall Study|Decision by sponsor|0|||
131541978|NCT02291614|473606255|FG005|Overall Study|Decision by sponsor|0|||
131541979|NCT02291614|473606256|FG006|Overall Study|Decision by sponsor|0|||
131541980|NCT02291614|473606257|FG007|Overall Study|Decision by sponsor|0|||
131541981|NCT02291614|473606258|FG008|Overall Study|Decision by sponsor|0|||
131541982|NCT02291614|473606259|FG009|Overall Study|Decision by sponsor|0|||
131541983|NCT02291614|473606260|FG010|Overall Study|Decision by sponsor|0|||
131541984|NCT02291614|473606250|FG000|Overall Study|Death|0|||
131541985|NCT02291614|473606251|FG001|Overall Study|Death|0|||
131541986|NCT02291614|473606252|FG002|Overall Study|Death|1|||
131541987|NCT02291614|473606253|FG003|Overall Study|Death|0|||
131541988|NCT02291614|473606254|FG004|Overall Study|Death|1|||
131541989|NCT02291614|473606255|FG005|Overall Study|Death|1|||
131541990|NCT02291614|473606256|FG006|Overall Study|Death|1|||
131541991|NCT02291614|473606257|FG007|Overall Study|Death|0|||
131541992|NCT02291614|473606258|FG008|Overall Study|Death|0|||
131541993|NCT02291614|473606259|FG009|Overall Study|Death|0|||
131541994|NCT02291614|473606260|FG010|Overall Study|Death|0|||
131541995|NCT00843167|473606261|FG000|Treatment Period|Adverse Event|1|||
131541996|NCT00843167|473606262|FG001|Treatment Period|Adverse Event|5|||
131541997|NCT00843167|473606261|FG000|Treatment Period|Withdrawal by Subject|2|||
131541998|NCT00843167|473606262|FG001|Treatment Period|Withdrawal by Subject|3|||
131541999|NCT01662310|473606263|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
131542000|NCT01662310|473606264|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
131542001|NCT01662310|473606265|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
131542002|NCT01662310|473606266|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
131542003|NCT01662310|473606267|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
131542004|NCT01662310|473606263|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
131542005|NCT01662310|473606264|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
131542006|NCT01662310|473606265|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
131542007|NCT01662310|473606266|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
131542008|NCT01662310|473606267|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
131542009|NCT01662310|473606263|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
131542010|NCT01662310|473606264|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
131542011|NCT01662310|473606265|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
131542012|NCT01662310|473606266|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
131542013|NCT01662310|473606267|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
131542014|NCT01662310|473606263|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
131542015|NCT01662310|473606264|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
131542016|NCT01662310|473606265|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
131542017|NCT01662310|473606266|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
131542018|NCT01662310|473606267|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
131542019|NCT01662310|473606263|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
131542020|NCT01662310|473606264|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
131542021|NCT01662310|473606265|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
131542022|NCT01662310|473606266|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
131542023|NCT01662310|473606267|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
131542024|NCT01662310|473606263|FG000|Run-In or Stabilization Phase|Other|1|||
131542025|NCT01662310|473606264|FG001|Run-In or Stabilization Phase|Other|0|||
131542026|NCT01662310|473606265|FG002|Run-In or Stabilization Phase|Other|0|||
131542027|NCT01662310|473606266|FG003|Run-In or Stabilization Phase|Other|0|||
131542028|NCT01662310|473606267|FG004|Run-In or Stabilization Phase|Other|0|||
131542029|NCT01662310|473606263|FG000|Double-Blind Phase|Adverse Event|0|||
131542030|NCT01662310|473606264|FG001|Double-Blind Phase|Adverse Event|0|||
131542031|NCT01662310|473606265|FG002|Double-Blind Phase|Adverse Event|1|||
131542032|NCT01662310|473606266|FG003|Double-Blind Phase|Adverse Event|0|||
131542033|NCT01662310|473606267|FG004|Double-Blind Phase|Adverse Event|0|||
131542034|NCT01662310|473606263|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131542035|NCT01662310|473606264|FG001|Double-Blind Phase|Lost to Follow-up|3|||
131542036|NCT01662310|473606265|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131542037|NCT01662310|473606266|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131542038|NCT01662310|473606267|FG004|Double-Blind Phase|Lost to Follow-up|0|||
131542039|NCT01662310|473606263|FG000|Double-Blind Phase|Pregnancy|0|||
131542040|NCT01662310|473606264|FG001|Double-Blind Phase|Pregnancy|2|||
131542041|NCT01662310|473606265|FG002|Double-Blind Phase|Pregnancy|0|||
131542042|NCT01662310|473606266|FG003|Double-Blind Phase|Pregnancy|0|||
131542043|NCT01662310|473606267|FG004|Double-Blind Phase|Pregnancy|0|||
131542044|NCT01662310|473606263|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131542045|NCT01662310|473606264|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
131542046|NCT01662310|473606265|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
131542047|NCT01662310|473606266|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131542048|NCT01662310|473606267|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
131542049|NCT01662310|473606263|FG000|Double-Blind Phase|Other|0|||
131542050|NCT01662310|473606264|FG001|Double-Blind Phase|Other|0|||
131542051|NCT01662310|473606265|FG002|Double-Blind Phase|Other|1|||
131542052|NCT01662310|473606266|FG003|Double-Blind Phase|Other|0|||
131542053|NCT01662310|473606267|FG004|Double-Blind Phase|Other|0|||
131542054|NCT01662310|473606263|FG000|Double-Blind Phase|Randomized but not treated|0|||
131542055|NCT01662310|473606264|FG001|Double-Blind Phase|Randomized but not treated|1|||
131542056|NCT01662310|473606265|FG002|Double-Blind Phase|Randomized but not treated|0|||
131542057|NCT01662310|473606266|FG003|Double-Blind Phase|Randomized but not treated|0|||
131542058|NCT01662310|473606267|FG004|Double-Blind Phase|Randomized but not treated|0|||
131542059|NCT01662310|473606263|FG000|Open-Label Extension Phase|Adverse Event|0|||
131542060|NCT01662310|473606264|FG001|Open-Label Extension Phase|Adverse Event|0|||
131542061|NCT01662310|473606265|FG002|Open-Label Extension Phase|Adverse Event|0|||
131542062|NCT01662310|473606266|FG003|Open-Label Extension Phase|Adverse Event|3|||
131542063|NCT01662310|473606267|FG004|Open-Label Extension Phase|Adverse Event|0|||
131542064|NCT01662310|473606263|FG000|Open-Label Extension Phase|Death|0|||
131542065|NCT01662310|473606264|FG001|Open-Label Extension Phase|Death|0|||
131542066|NCT01662310|473606265|FG002|Open-Label Extension Phase|Death|0|||
131542067|NCT01662310|473606266|FG003|Open-Label Extension Phase|Death|1|||
131542068|NCT01662310|473606267|FG004|Open-Label Extension Phase|Death|0|||
131542069|NCT01662310|473606263|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
131542070|NCT01662310|473606264|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
131542071|NCT01662310|473606265|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
131542072|NCT01662310|473606266|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
131542073|NCT01662310|473606267|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
131542074|NCT01662310|473606263|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
131542075|NCT01662310|473606264|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
131542076|NCT01662310|473606265|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
131542077|NCT01662310|473606266|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
131542078|NCT01662310|473606267|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
131542079|NCT01662310|473606263|FG000|Open-Label Extension Phase|Pregnancy|0|||
131542080|NCT01662310|473606264|FG001|Open-Label Extension Phase|Pregnancy|0|||
131542081|NCT01662310|473606265|FG002|Open-Label Extension Phase|Pregnancy|0|||
131542082|NCT01662310|473606266|FG003|Open-Label Extension Phase|Pregnancy|1|||
131542083|NCT01662310|473606267|FG004|Open-Label Extension Phase|Pregnancy|0|||
131542084|NCT01662310|473606263|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
131542085|NCT01662310|473606264|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
131542086|NCT01662310|473606265|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
131542087|NCT01662310|473606266|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
131542088|NCT01662310|473606267|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
131542089|NCT04302350|473606272|FG000|Overall Study|Physician Decision|1|||
131542090|NCT04302350|473606273|FG001|Overall Study|Physician Decision|1|||
131542091|NCT04302350|473606274|FG002|Overall Study|Physician Decision|2|||
131542092|NCT04302350|473606272|FG000|Overall Study|Lack of Efficacy|1|||
131542093|NCT04302350|473606273|FG001|Overall Study|Lack of Efficacy|1|||
131542094|NCT04302350|473606274|FG002|Overall Study|Lack of Efficacy|4|||
131542095|NCT04302350|473606272|FG000|Overall Study|Adverse Event|0|||
131542096|NCT04302350|473606273|FG001|Overall Study|Adverse Event|1|||
131542097|NCT04302350|473606274|FG002|Overall Study|Adverse Event|2|||
131542098|NCT02012491|473606275|FG000|Overall Study|Lost to Follow-up|1|||
131542099|NCT02012491|473606276|FG001|Overall Study|Lost to Follow-up|0|||
131542100|NCT02012491|473606275|FG000|Overall Study|Protocol Violation|0|||
131542101|NCT02012491|473606276|FG001|Overall Study|Protocol Violation|1|||
131542102|NCT02012491|473606275|FG000|Overall Study|Withdrawal by Subject|1|||
131542103|NCT02012491|473606276|FG001|Overall Study|Withdrawal by Subject|0|||
131542104|NCT02137369|473606287|FG000|Overall Study|Withdrawal by Subject|3|||
131542105|NCT02137369|473606288|FG001|Overall Study|Withdrawal by Subject|2|||
131542106|NCT02137369|473606287|FG000|Overall Study|Adverse Event|2|||
131542107|NCT02137369|473606288|FG001|Overall Study|Adverse Event|0|||
131542108|NCT02137369|473606287|FG000|Overall Study|Lost to Follow-up|1|||
131542109|NCT02137369|473606288|FG001|Overall Study|Lost to Follow-up|0|||
131542110|NCT02137369|473606287|FG000|Overall Study|Moved away|2|||
131542111|NCT02137369|473606288|FG001|Overall Study|Moved away|0|||
131542112|NCT03969719|473606289|FG000|Overall Study|Other reasons not specified|1|||
131542113|NCT03969719|473606290|FG001|Overall Study|Other reasons not specified|1|||
131542114|NCT03969719|473606291|FG002|Overall Study|Other reasons not specified|3|||
131542115|NCT03969719|473606289|FG000|Overall Study|Withdrawal by Subject|2|||
131542116|NCT03969719|473606290|FG001|Overall Study|Withdrawal by Subject|3|||
131542117|NCT03969719|473606291|FG002|Overall Study|Withdrawal by Subject|2|||
131542118|NCT03969719|473606289|FG000|Overall Study|Protocol Violation|1|||
131542119|NCT03969719|473606290|FG001|Overall Study|Protocol Violation|2|||
131542120|NCT03969719|473606291|FG002|Overall Study|Protocol Violation|0|||
131542121|NCT03969719|473606289|FG000|Overall Study|Adverse Event|0|||
131542122|NCT03969719|473606290|FG001|Overall Study|Adverse Event|2|||
131542123|NCT03969719|473606291|FG002|Overall Study|Adverse Event|0|||
131542124|NCT03969719|473606289|FG000|Overall Study|Lost to Follow-up|0|||
131542125|NCT03969719|473606290|FG001|Overall Study|Lost to Follow-up|1|||
131542126|NCT03969719|473606291|FG002|Overall Study|Lost to Follow-up|0|||
131542127|NCT01297959|473606292|FG000|Overall Study|Adverse Event|0|||
131542128|NCT01297959|473606293|FG001|Overall Study|Adverse Event|1|||
131542129|NCT01297959|473606292|FG000|Overall Study|Protocol Violation|2|||
131542130|NCT01297959|473606293|FG001|Overall Study|Protocol Violation|1|||
131542131|NCT01297959|473606292|FG000|Overall Study|Withdrawal by Subject|5|||
131542132|NCT01297959|473606293|FG001|Overall Study|Withdrawal by Subject|4|||
131542133|NCT01297959|473606292|FG000|Overall Study|Physician Decision|0|||
131542134|NCT01297959|473606293|FG001|Overall Study|Physician Decision|1|||
131542135|NCT01297959|473606292|FG000|Overall Study|Unrelated medical illness / complication|0|||
131542136|NCT01297959|473606293|FG001|Overall Study|Unrelated medical illness / complication|2|||
131542137|NCT01297959|473606292|FG000|Overall Study|Other|13|||
131542138|NCT01297959|473606293|FG001|Overall Study|Other|7|||
131542139|NCT01667432|473606294|FG000|Overall Study|Premature Study Termination|26|||
131542140|NCT01667432|473606294|FG000|Overall Study|Failure to Return|10|||
131542141|NCT01667432|473606294|FG000|Overall Study|Moved to Another Center|3|||
131542142|NCT01667432|473606294|FG000|Overall Study|Lost to Follow-up|3|||
131542143|NCT01667432|473606294|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
131542144|NCT01667432|473606294|FG000|Overall Study|Insufficient Therapeutic Response|4|||
131542145|NCT01667432|473606294|FG000|Overall Study|Adverse Event|1|||
131542146|NCT01667432|473606294|FG000|Overall Study|Protocol Deviation|2|||
131542147|NCT01667432|473606294|FG000|Overall Study|Principal Investigator Decision|1|||
131542148|NCT01667432|473606294|FG000|Overall Study|Reason Not Specified|2|||
131542149|NCT01667432|473606294|FG000|Overall Study|Missing Information|4|||
131542150|NCT00829387|473606295|FG000|Overall Study|Withdrawal by Subject|2|||
131542151|NCT00829387|473606296|FG001|Overall Study|Withdrawal by Subject|3|||
131542152|NCT00829387|473606295|FG000|Overall Study|Disqualified by PI|1|||
131542153|NCT00829387|473606296|FG001|Overall Study|Disqualified by PI|0|||
131542154|NCT00707031|473606297|FG000|Overall Study|Adverse Event|45|||
131542155|NCT00707031|473606298|FG001|Overall Study|Adverse Event|45|||
131542156|NCT00707031|473606297|FG000|Overall Study|Lack of Efficacy|19|||
131542157|NCT00707031|473606298|FG001|Overall Study|Lack of Efficacy|6|||
131542158|NCT00707031|473606297|FG000|Overall Study|Lost to Follow-up|2|||
131542159|NCT00707031|473606298|FG001|Overall Study|Lost to Follow-up|1|||
131542160|NCT00707031|473606297|FG000|Overall Study|Protocol Violation|1|||
131542161|NCT00707031|473606298|FG001|Overall Study|Protocol Violation|0|||
131542162|NCT00707031|473606297|FG000|Overall Study|Withdrawal by Subject|7|||
131542163|NCT00707031|473606298|FG001|Overall Study|Withdrawal by Subject|8|||
131542164|NCT00707031|473606297|FG000|Overall Study|Poor Compliance to Protocol|7|||
131542165|NCT00707031|473606298|FG001|Overall Study|Poor Compliance to Protocol|13|||
131542166|NCT00707031|473606297|FG000|Overall Study|Familial or Personal Reasons|12|||
131542167|NCT00707031|473606298|FG001|Overall Study|Familial or Personal Reasons|15|||
131658601|NCT02003222|474035397|FG002|Induction|Adverse Event|0|||
131542168|NCT00707031|473606297|FG000|Overall Study|Serious Noncompliance|2|||
131542169|NCT00707031|473606298|FG001|Overall Study|Serious Noncompliance|3|||
131542170|NCT00707031|473606297|FG000|Overall Study|Sponsor Decision|9|||
131542171|NCT00707031|473606298|FG001|Overall Study|Sponsor Decision|8|||
131542172|NCT03519854|473606299|FG000|Overall Study|Technical Error|0|||
131542173|NCT03519854|473606300|FG001|Overall Study|Technical Error|0|||
131542174|NCT03519854|473606301|FG002|Overall Study|Technical Error|1|||
131542175|NCT03519854|473606302|FG003|Overall Study|Technical Error|0|||
131542176|NCT03519854|473606303|FG004|Overall Study|Technical Error|0|||
131542177|NCT03519854|473606304|FG005|Overall Study|Technical Error|0|||
131542178|NCT03519854|473606305|FG006|Overall Study|Technical Error|0|||
131542179|NCT03519854|473606306|FG007|Overall Study|Technical Error|0|||
131542180|NCT03519854|473606307|FG008|Overall Study|Technical Error|0|||
131542181|NCT03519854|473606308|FG009|Overall Study|Technical Error|0|||
131542182|NCT03519854|473606309|FG010|Overall Study|Technical Error|0|||
131542183|NCT03519854|473606310|FG011|Overall Study|Technical Error|0|||
131542184|NCT03519854|473606311|FG012|Overall Study|Technical Error|0|||
131542185|NCT03519854|473606312|FG013|Overall Study|Technical Error|0|||
131542186|NCT03519854|473606313|FG014|Overall Study|Technical Error|0|||
131542187|NCT03519854|473606314|FG015|Overall Study|Technical Error|0|||
131542188|NCT03519854|473606315|FG016|Overall Study|Technical Error|0|||
131542189|NCT03519854|473606316|FG017|Overall Study|Technical Error|0|||
131542190|NCT02747238|473606317|FG000|Overall Study|Lack of Efficacy|0|||
131542191|NCT02747238|473606318|FG001|Overall Study|Lack of Efficacy|1|||
131542192|NCT02747238|473606317|FG000|Overall Study|Data lost|3|||
131542193|NCT02747238|473606318|FG001|Overall Study|Data lost|5|||
131542194|NCT00951275|473606319|FG000|Overall Study|Administrative Reason|1|||
131542195|NCT00951275|473606319|FG000|Overall Study|Adverse Event|7|||
131542196|NCT00951275|473606319|FG000|Overall Study|Withdrawal by Subject|4|||
131542197|NCT00951275|473606319|FG000|Overall Study|Protocol Violation|1|||
131542198|NCT01389973|473606328|FG000|Overall Study|Lost to Follow-up|1|||
131542199|NCT01389973|473606328|FG000|Overall Study|Trial Stopped by Sponsor|9|||
131542200|NCT01389973|473606328|FG000|Overall Study|Other|10|||
131542201|NCT02626780|473606329|FG000|Overall Study|Withdrawal by Subject|3|||
131542202|NCT04304833|473606330|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
131542203|NCT04304833|473606331|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
131542204|NCT03456700|473606332|FG000|Overall Study|Withdrawal by Subject|1|||
131542205|NCT04154787|473606333|FG000|Overall Study|Adverse Event|0|||
131542206|NCT04154787|473606334|FG001|Overall Study|Adverse Event|1|||
131542207|NCT04154787|473606335|FG002|Overall Study|Adverse Event|0|||
131542208|NCT04154787|473606333|FG000|Overall Study|Patient Requires Other Treatment|0|||
131542209|NCT04154787|473606334|FG001|Overall Study|Patient Requires Other Treatment|1|||
131542210|NCT04154787|473606335|FG002|Overall Study|Patient Requires Other Treatment|0|||
131542211|NCT04154787|473606333|FG000|Overall Study|Study Terminated By Sponsor|0|||
131542212|NCT04154787|473606334|FG001|Overall Study|Study Terminated By Sponsor|6|||
131542213|NCT04154787|473606335|FG002|Overall Study|Study Terminated By Sponsor|1|||
131542214|NCT04154787|473606333|FG000|Overall Study|Subject Decision|0|||
131542215|NCT04154787|473606334|FG001|Overall Study|Subject Decision|1|||
131542216|NCT04154787|473606335|FG002|Overall Study|Subject Decision|0|||
131542217|NCT04154787|473606333|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
131542218|NCT04154787|473606334|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
131542219|NCT04154787|473606335|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
131542220|NCT01951625|473606336|FG000|Treatment Period|Protocol Violation|2|||
131542221|NCT01951625|473606337|FG001|Treatment Period|Protocol Violation|0|||
131542222|NCT01951625|473606338|FG002|Treatment Period|Protocol Violation|1|||
131542223|NCT01951625|473606339|FG003|Treatment Period|Protocol Violation|3|||
131542224|NCT01951625|473606340|FG004|Treatment Period|Protocol Violation|2|||
131542225|NCT01951625|473606336|FG000|Treatment Period|Physician Decision|0|||
131542226|NCT01951625|473606337|FG001|Treatment Period|Physician Decision|0|||
131542227|NCT01951625|473606338|FG002|Treatment Period|Physician Decision|0|||
131542228|NCT01951625|473606339|FG003|Treatment Period|Physician Decision|0|||
131542229|NCT01951625|473606340|FG004|Treatment Period|Physician Decision|1|||
131542230|NCT01951625|473606336|FG000|Treatment Period|Protocol driven decision point|0|||
131542231|NCT01951625|473606337|FG001|Treatment Period|Protocol driven decision point|5|||
131542232|NCT01951625|473606338|FG002|Treatment Period|Protocol driven decision point|0|||
131542233|NCT01951625|473606339|FG003|Treatment Period|Protocol driven decision point|2|||
131542234|NCT01951625|473606340|FG004|Treatment Period|Protocol driven decision point|1|||
131542235|NCT01951625|473606336|FG000|Treatment Period|Non compliance with study drug|1|||
131542236|NCT01951625|473606337|FG001|Treatment Period|Non compliance with study drug|2|||
131542237|NCT01951625|473606338|FG002|Treatment Period|Non compliance with study drug|2|||
131542238|NCT01951625|473606339|FG003|Treatment Period|Non compliance with study drug|0|||
131542239|NCT01951625|473606340|FG004|Treatment Period|Non compliance with study drug|0|||
131542240|NCT01951625|473606336|FG000|Treatment Period|Death|3|||
131542241|NCT01951625|473606337|FG001|Treatment Period|Death|2|||
131542242|NCT01951625|473606338|FG002|Treatment Period|Death|2|||
131542243|NCT01951625|473606339|FG003|Treatment Period|Death|1|||
131542244|NCT01951625|473606340|FG004|Treatment Period|Death|2|||
131542245|NCT01951625|473606336|FG000|Treatment Period|Adverse Event|7|||
131542246|NCT01951625|473606337|FG001|Treatment Period|Adverse Event|10|||
131542247|NCT01951625|473606338|FG002|Treatment Period|Adverse Event|9|||
131542248|NCT01951625|473606339|FG003|Treatment Period|Adverse Event|8|||
131542249|NCT01951625|473606340|FG004|Treatment Period|Adverse Event|8|||
131542250|NCT01951625|473606336|FG000|Treatment Period|Withdrawal by Subject|5|||
131542251|NCT01951625|473606337|FG001|Treatment Period|Withdrawal by Subject|2|||
131542252|NCT01951625|473606338|FG002|Treatment Period|Withdrawal by Subject|1|||
131542253|NCT01951625|473606339|FG003|Treatment Period|Withdrawal by Subject|7|||
131542254|NCT01951625|473606340|FG004|Treatment Period|Withdrawal by Subject|3|||
131542255|NCT01951625|473606336|FG000|Treatment Period|Lost to Follow-up|1|||
131542256|NCT01951625|473606337|FG001|Treatment Period|Lost to Follow-up|0|||
131542257|NCT01951625|473606338|FG002|Treatment Period|Lost to Follow-up|0|||
131542258|NCT01951625|473606339|FG003|Treatment Period|Lost to Follow-up|1|||
131542259|NCT01951625|473606340|FG004|Treatment Period|Lost to Follow-up|0|||
131542260|NCT01951625|473606336|FG000|Follow Up Period|Non-compliance with study drug|1|||
131542261|NCT01951625|473606337|FG001|Follow Up Period|Non-compliance with study drug|0|||
131542262|NCT01951625|473606338|FG002|Follow Up Period|Non-compliance with study drug|0|||
131542263|NCT01951625|473606339|FG003|Follow Up Period|Non-compliance with study drug|0|||
131542264|NCT01951625|473606340|FG004|Follow Up Period|Non-compliance with study drug|0|||
131542265|NCT01951625|473606336|FG000|Follow Up Period|Death|1|||
131542266|NCT01951625|473606337|FG001|Follow Up Period|Death|3|||
131542267|NCT01951625|473606338|FG002|Follow Up Period|Death|2|||
131542268|NCT01951625|473606339|FG003|Follow Up Period|Death|2|||
131542269|NCT01951625|473606340|FG004|Follow Up Period|Death|1|||
131542270|NCT01951625|473606336|FG000|Follow Up Period|Logistical difficulties|1|||
131542271|NCT01951625|473606337|FG001|Follow Up Period|Logistical difficulties|2|||
131542272|NCT01951625|473606338|FG002|Follow Up Period|Logistical difficulties|0|||
131542273|NCT01951625|473606339|FG003|Follow Up Period|Logistical difficulties|0|||
131542274|NCT01951625|473606340|FG004|Follow Up Period|Logistical difficulties|0|||
131542275|NCT01951625|473606336|FG000|Follow Up Period|Adverse Event|0|||
131542276|NCT01951625|473606337|FG001|Follow Up Period|Adverse Event|3|||
131542277|NCT01951625|473606338|FG002|Follow Up Period|Adverse Event|2|||
131542278|NCT01951625|473606339|FG003|Follow Up Period|Adverse Event|3|||
131542279|NCT01951625|473606340|FG004|Follow Up Period|Adverse Event|5|||
131542280|NCT01951625|473606336|FG000|Follow Up Period|Withdrawal by Subject|4|||
131542281|NCT01951625|473606337|FG001|Follow Up Period|Withdrawal by Subject|1|||
131542282|NCT01951625|473606338|FG002|Follow Up Period|Withdrawal by Subject|0|||
131542283|NCT01951625|473606339|FG003|Follow Up Period|Withdrawal by Subject|5|||
131542284|NCT01951625|473606340|FG004|Follow Up Period|Withdrawal by Subject|3|||
131542285|NCT01951625|473606336|FG000|Follow Up Period|Lost to Follow-up|1|||
131542286|NCT01951625|473606337|FG001|Follow Up Period|Lost to Follow-up|0|||
131542287|NCT01951625|473606338|FG002|Follow Up Period|Lost to Follow-up|0|||
131542288|NCT01951625|473606339|FG003|Follow Up Period|Lost to Follow-up|1|||
131542289|NCT01951625|473606340|FG004|Follow Up Period|Lost to Follow-up|1|||
131542290|NCT03053050|473606343|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
131542291|NCT03053050|473606344|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
131542292|NCT03053050|473606345|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
131542293|NCT03053050|473606346|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
131542294|NCT03053050|473606343|FG000|Randomized Phase|Withdrew Consent|16|||
131542295|NCT03053050|473606344|FG001|Randomized Phase|Withdrew Consent|8|||
131542296|NCT03053050|473606345|FG002|Randomized Phase|Withdrew Consent|9|||
131542297|NCT03053050|473606346|FG003|Randomized Phase|Withdrew Consent|0|||
131542298|NCT03053050|473606343|FG000|Randomized Phase|Investigator's Discretion|6|||
131542299|NCT03053050|473606344|FG001|Randomized Phase|Investigator's Discretion|6|||
131542300|NCT03053050|473606345|FG002|Randomized Phase|Investigator's Discretion|3|||
131542301|NCT03053050|473606346|FG003|Randomized Phase|Investigator's Discretion|0|||
131542302|NCT03053050|473606343|FG000|Randomized Phase|Lost to Follow-up|5|||
131542303|NCT03053050|473606344|FG001|Randomized Phase|Lost to Follow-up|1|||
131542304|NCT03053050|473606345|FG002|Randomized Phase|Lost to Follow-up|1|||
131542305|NCT03053050|473606346|FG003|Randomized Phase|Lost to Follow-up|0|||
131542306|NCT03053050|473606343|FG000|Randomized Phase|Adverse Event|0|||
131542307|NCT03053050|473606344|FG001|Randomized Phase|Adverse Event|1|||
131542308|NCT03053050|473606345|FG002|Randomized Phase|Adverse Event|0|||
131542309|NCT03053050|473606346|FG003|Randomized Phase|Adverse Event|0|||
131542310|NCT03053050|473606343|FG000|Randomized Phase|Randomized but Never Treated|2|||
131542311|NCT03053050|473606344|FG001|Randomized Phase|Randomized but Never Treated|2|||
131542312|NCT03053050|473606345|FG002|Randomized Phase|Randomized but Never Treated|2|||
131542313|NCT03053050|473606346|FG003|Randomized Phase|Randomized but Never Treated|0|||
131542314|NCT03053050|473606343|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
131542315|NCT03053050|473606344|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
131542316|NCT03053050|473606345|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
131542317|NCT03053050|473606346|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
131542318|NCT03053050|473606343|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
131542319|NCT03053050|473606344|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
131658602|NCT02003222|474035398|FG003|Induction|Adverse Event|0|||
131542320|NCT03053050|473606345|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
131542321|NCT03053050|473606346|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
131542322|NCT03053050|473606343|FG000|Open-label Phase|Withdrew Consent|0|||
131542323|NCT03053050|473606344|FG001|Open-label Phase|Withdrew Consent|0|||
131542324|NCT03053050|473606345|FG002|Open-label Phase|Withdrew Consent|0|||
131542325|NCT03053050|473606346|FG003|Open-label Phase|Withdrew Consent|6|||
131542326|NCT03053050|473606343|FG000|Open-label Phase|Investigator's Discretion|0|||
131542327|NCT03053050|473606344|FG001|Open-label Phase|Investigator's Discretion|0|||
131542328|NCT03053050|473606345|FG002|Open-label Phase|Investigator's Discretion|0|||
131542329|NCT03053050|473606346|FG003|Open-label Phase|Investigator's Discretion|4|||
131542330|NCT05338333|473606347|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
131542331|NCT05338333|473606348|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
131542332|NCT02459574|473606352|FG000|Overall Study|Withdrawal by Subject|6|||
131542333|NCT02459574|473606353|FG001|Overall Study|Withdrawal by Subject|6|||
131542334|NCT02459574|473606354|FG002|Overall Study|Withdrawal by Subject|2|||
131542335|NCT02459574|473606352|FG000|Overall Study|Lost to Follow-up|1|||
131542336|NCT02459574|473606353|FG001|Overall Study|Lost to Follow-up|1|||
131542337|NCT02459574|473606354|FG002|Overall Study|Lost to Follow-up|0|||
131542338|NCT02459574|473606352|FG000|Overall Study|Death|0|||
131542339|NCT02459574|473606353|FG001|Overall Study|Death|1|||
131542340|NCT02459574|473606354|FG002|Overall Study|Death|0|||
131542341|NCT00251745|473606355|FG000|Overall Study|Adverse Event|7|||
131542342|NCT00251745|473606356|FG001|Overall Study|Adverse Event|9|||
131542343|NCT00251745|473606357|FG002|Overall Study|Adverse Event|11|||
131542344|NCT00251745|473606355|FG000|Overall Study|Lost to Follow-up|4|||
131542345|NCT00251745|473606356|FG001|Overall Study|Lost to Follow-up|2|||
131542346|NCT00251745|473606357|FG002|Overall Study|Lost to Follow-up|5|||
131542347|NCT00251745|473606355|FG000|Overall Study|Withdrawal by Subject|13|||
131542348|NCT00251745|473606356|FG001|Overall Study|Withdrawal by Subject|7|||
131542349|NCT00251745|473606357|FG002|Overall Study|Withdrawal by Subject|3|||
131542350|NCT00251745|473606355|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
131542351|NCT00251745|473606356|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
131542352|NCT00251745|473606357|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
131542353|NCT00251745|473606355|FG000|Overall Study|Lack of Efficacy|3|||
131542354|NCT00251745|473606356|FG001|Overall Study|Lack of Efficacy|0|||
131542355|NCT00251745|473606357|FG002|Overall Study|Lack of Efficacy|0|||
131542356|NCT00251745|473606355|FG000|Overall Study|Noncompliant|0|||
131542357|NCT00251745|473606356|FG001|Overall Study|Noncompliant|2|||
131542358|NCT00251745|473606357|FG002|Overall Study|Noncompliant|2|||
131542359|NCT00251745|473606355|FG000|Overall Study|Pregnancy|0|||
131542360|NCT00251745|473606356|FG001|Overall Study|Pregnancy|1|||
131542361|NCT00251745|473606357|FG002|Overall Study|Pregnancy|0|||
131542362|NCT00251745|473606355|FG000|Overall Study|Per Subject Request|0|||
131542363|NCT00251745|473606356|FG001|Overall Study|Per Subject Request|0|||
131542364|NCT00251745|473606357|FG002|Overall Study|Per Subject Request|1|||
131542365|NCT00251745|473606355|FG000|Overall Study|Per Investigator Request|1|||
131542366|NCT00251745|473606356|FG001|Overall Study|Per Investigator Request|0|||
131542367|NCT00251745|473606357|FG002|Overall Study|Per Investigator Request|0|||
131542368|NCT04866017|473606360|FG000|Overall Study|Study Terminated by Sponsor|13|||
131542369|NCT04866017|473606361|FG001|Overall Study|Study Terminated by Sponsor|14|||
131542370|NCT04866017|473606362|FG002|Overall Study|Study Terminated by Sponsor|13|||
131542371|NCT04866017|473606360|FG000|Overall Study|Death|8|||
131542372|NCT04866017|473606361|FG001|Overall Study|Death|4|||
131542373|NCT04866017|473606362|FG002|Overall Study|Death|8|||
131542374|NCT04866017|473606360|FG000|Overall Study|Withdrawal by Subject|1|||
131542375|NCT04866017|473606361|FG001|Overall Study|Withdrawal by Subject|0|||
131542376|NCT04866017|473606362|FG002|Overall Study|Withdrawal by Subject|1|||
131542377|NCT04866017|473606360|FG000|Overall Study|Physician Decision|0|||
131542378|NCT04866017|473606361|FG001|Overall Study|Physician Decision|1|||
131542379|NCT04866017|473606362|FG002|Overall Study|Physician Decision|0|||
131542380|NCT01475136|473606363|FG000|Overall Study|Sponsor Decision|0|||
131542381|NCT01475136|473606364|FG001|Overall Study|Sponsor Decision|1|||
131542382|NCT01475136|473606365|FG002|Overall Study|Sponsor Decision|0|||
131542383|NCT01475136|473606366|FG003|Overall Study|Sponsor Decision|0|||
131542384|NCT01475136|473606363|FG000|Overall Study|Entry Criteria Not Met|0|||
131542385|NCT01475136|473606364|FG001|Overall Study|Entry Criteria Not Met|2|||
131542386|NCT01475136|473606365|FG002|Overall Study|Entry Criteria Not Met|3|||
131542387|NCT01475136|473606366|FG003|Overall Study|Entry Criteria Not Met|1|||
131542388|NCT01475136|473606363|FG000|Overall Study|Withdrawal by Subject|0|||
131542389|NCT01475136|473606364|FG001|Overall Study|Withdrawal by Subject|0|||
131542390|NCT01475136|473606365|FG002|Overall Study|Withdrawal by Subject|0|||
131542391|NCT01475136|473606366|FG003|Overall Study|Withdrawal by Subject|2|||
131542392|NCT01475136|473606363|FG000|Overall Study|Adverse Event|1|||
131542393|NCT01475136|473606364|FG001|Overall Study|Adverse Event|0|||
131542394|NCT01475136|473606365|FG002|Overall Study|Adverse Event|0|||
131542395|NCT01475136|473606366|FG003|Overall Study|Adverse Event|1|||
131542396|NCT01475136|473606363|FG000|Overall Study|Death|0|||
131542397|NCT01475136|473606364|FG001|Overall Study|Death|0|||
131542398|NCT01475136|473606365|FG002|Overall Study|Death|0|||
131542399|NCT01475136|473606366|FG003|Overall Study|Death|1|||
131542400|NCT00003508|473608543|FG000|Overall Study|Not evaluable|5|||
131542401|NCT01712009|473608544|FG000|Overall Study|Withdrawal by Subject|24|||
131542402|NCT01712009|473608545|FG001|Overall Study|Withdrawal by Subject|15|||
131542403|NCT01712009|473608546|FG002|Overall Study|Withdrawal by Subject|8|||
131542404|NCT01712009|473608544|FG000|Overall Study|Lost to Follow-up|2|||
131542405|NCT01712009|473608545|FG001|Overall Study|Lost to Follow-up|0|||
131542406|NCT01712009|473608546|FG002|Overall Study|Lost to Follow-up|1|||
131542407|NCT01712009|473608544|FG000|Overall Study|Decision by Sponsor|12|||
131542408|NCT01712009|473608545|FG001|Overall Study|Decision by Sponsor|14|||
131542409|NCT01712009|473608546|FG002|Overall Study|Decision by Sponsor|12|||
131542410|NCT02160314|473608547|FG000|Overall Study|Adverse Event|0|||
131542411|NCT02160314|473608548|FG001|Overall Study|Adverse Event|6|||
131542412|NCT02160314|473608547|FG000|Overall Study|Protocol Violation|0|||
131542413|NCT02160314|473608548|FG001|Overall Study|Protocol Violation|4|||
131542414|NCT02160314|473608547|FG000|Overall Study|Withdrawal by Subject|1|||
131542415|NCT02160314|473608548|FG001|Overall Study|Withdrawal by Subject|2|||
131542416|NCT02160314|473608547|FG000|Overall Study|Lost to Follow-up|0|||
131542417|NCT02160314|473608548|FG001|Overall Study|Lost to Follow-up|1|||
131542418|NCT01377480|473608552|FG000|Overall Study|Protocol Violation|0|||
131542419|NCT01377480|473608553|FG001|Overall Study|Protocol Violation|0|||
131542420|NCT01377480|473608554|FG002|Overall Study|Protocol Violation|0|||
131542421|NCT01377480|473608555|FG003|Overall Study|Protocol Violation|4|||
131542422|NCT01377480|473608552|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
131542423|NCT01377480|473608553|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
131542424|NCT01377480|473608554|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
131542425|NCT01377480|473608555|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
131542426|NCT01377480|473608552|FG000|Overall Study|Withdrawal by Subject|0|||
131542427|NCT01377480|473608553|FG001|Overall Study|Withdrawal by Subject|0|||
131542428|NCT01377480|473608554|FG002|Overall Study|Withdrawal by Subject|1|||
131542429|NCT01377480|473608555|FG003|Overall Study|Withdrawal by Subject|0|||
131542430|NCT01377480|473608552|FG000|Overall Study|Serious adverse event|0|||
131542431|NCT01377480|473608553|FG001|Overall Study|Serious adverse event|0|||
131542432|NCT01377480|473608554|FG002|Overall Study|Serious adverse event|1|||
131542433|NCT01377480|473608555|FG003|Overall Study|Serious adverse event|1|||
131542434|NCT01377480|473608552|FG000|Overall Study|Other|0|||
131542435|NCT01377480|473608553|FG001|Overall Study|Other|0|||
131542436|NCT01377480|473608554|FG002|Overall Study|Other|7|||
131542437|NCT01377480|473608555|FG003|Overall Study|Other|6|||
131542438|NCT00590902|473608559|FG000|Overall Study|Death|1|||
131542439|NCT01986881|473608560|FG000|Overall Study|Death|228|||
131542440|NCT01986881|473608561|FG001|Overall Study|Death|233|||
131542441|NCT01986881|473608562|FG002|Overall Study|Death|247|||
131542442|NCT01986881|473608560|FG000|Overall Study|Lost to Follow-up|51|||
131542443|NCT01986881|473608561|FG001|Overall Study|Lost to Follow-up|44|||
131542444|NCT01986881|473608562|FG002|Overall Study|Lost to Follow-up|55|||
131542445|NCT01986881|473608560|FG000|Overall Study|Physician Decision|7|||
131542446|NCT01986881|473608561|FG001|Overall Study|Physician Decision|4|||
131542447|NCT01986881|473608562|FG002|Overall Study|Physician Decision|6|||
131542448|NCT01986881|473608560|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
131542449|NCT01986881|473608561|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
131542450|NCT01986881|473608562|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
131542451|NCT01986881|473608560|FG000|Overall Study|Withdrawal by Subject|41|||
131542452|NCT01986881|473608561|FG001|Overall Study|Withdrawal by Subject|60|||
131542453|NCT01986881|473608562|FG002|Overall Study|Withdrawal by Subject|45|||
131542454|NCT01986881|473608560|FG000|Overall Study|Subject Moved|0|||
131542455|NCT01986881|473608561|FG001|Overall Study|Subject Moved|1|||
131542456|NCT01986881|473608562|FG002|Overall Study|Subject Moved|0|||
131542457|NCT01986881|473608560|FG000|Overall Study|Other|1|||
131542458|NCT01986881|473608561|FG001|Overall Study|Other|2|||
131542459|NCT01986881|473608562|FG002|Overall Study|Other|2|||
131542460|NCT03224182|473608568|FG000|Overall Study|Study Drug Not Instilled|6|||
131542461|NCT03224182|473608569|FG001|Overall Study|Study Drug Not Instilled|1|||
131542462|NCT03224182|473608568|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
131542463|NCT03224182|473608569|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
131542464|NCT03224182|473608568|FG000|Overall Study|Withdrew of Consent|4|||
131542465|NCT03224182|473608569|FG001|Overall Study|Withdrew of Consent|2|||
131542466|NCT03224182|473608568|FG000|Overall Study|Investigator Decision|3|||
131542467|NCT03224182|473608569|FG001|Overall Study|Investigator Decision|1|||
131542468|NCT03224182|473608568|FG000|Overall Study|Sponsor Decision|26|||
131542469|NCT03224182|473608569|FG001|Overall Study|Sponsor Decision|12|||
131542470|NCT03224182|473608568|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
131542471|NCT03224182|473608569|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
131542472|NCT03224182|473608568|FG000|Overall Study|Lost to Follow-up|1|||
131542473|NCT03224182|473608569|FG001|Overall Study|Lost to Follow-up|0|||
131542474|NCT03224182|473608568|FG000|Overall Study|Participant Had Recurrence|11|||
131542475|NCT03224182|473608569|FG001|Overall Study|Participant Had Recurrence|5|||
131542476|NCT03224182|473608568|FG000|Overall Study|Death|0|||
131542477|NCT03224182|473608569|FG001|Overall Study|Death|1|||
131542478|NCT03224182|473608568|FG000|Overall Study|Reason not Specified|3|||
131542479|NCT03224182|473608569|FG001|Overall Study|Reason not Specified|3|||
131542480|NCT03224182|473608568|FG000|Overall Study|Other|1|||
131542481|NCT03224182|473608569|FG001|Overall Study|Other|0|||
131542482|NCT02822222|473608570|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
131542483|NCT02822222|473608571|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
131542484|NCT00643916|473608572|FG000|Overall Study|Protocol Violation|0|||
131542485|NCT00643916|473608573|FG001|Overall Study|Protocol Violation|1|||
131542486|NCT00643916|473608574|FG002|Overall Study|Protocol Violation|1|||
131542487|NCT00643916|473608575|FG003|Overall Study|Protocol Violation|1|||
131542488|NCT00643916|473608576|FG004|Overall Study|Protocol Violation|0|||
131542489|NCT00643916|473608577|FG005|Overall Study|Protocol Violation|0|||
131542490|NCT00643916|473608572|FG000|Overall Study|Lost to Follow-up|0|||
131542491|NCT00643916|473608573|FG001|Overall Study|Lost to Follow-up|1|||
131542492|NCT00643916|473608574|FG002|Overall Study|Lost to Follow-up|0|||
131542493|NCT00643916|473608575|FG003|Overall Study|Lost to Follow-up|0|||
131542494|NCT00643916|473608576|FG004|Overall Study|Lost to Follow-up|0|||
131542495|NCT00643916|473608577|FG005|Overall Study|Lost to Follow-up|0|||
131542496|NCT00643916|473608572|FG000|Overall Study|Withdrawal by Subject|2|||
131542497|NCT00643916|473608573|FG001|Overall Study|Withdrawal by Subject|2|||
131542498|NCT00643916|473608574|FG002|Overall Study|Withdrawal by Subject|2|||
131542499|NCT00643916|473608575|FG003|Overall Study|Withdrawal by Subject|1|||
131542500|NCT00643916|473608576|FG004|Overall Study|Withdrawal by Subject|0|||
131542501|NCT00643916|473608577|FG005|Overall Study|Withdrawal by Subject|1|||
131542502|NCT00643916|473608572|FG000|Overall Study|Not Vaccinated|2|||
131542503|NCT00643916|473608573|FG001|Overall Study|Not Vaccinated|2|||
131542504|NCT00643916|473608574|FG002|Overall Study|Not Vaccinated|3|||
131542505|NCT00643916|473608575|FG003|Overall Study|Not Vaccinated|0|||
131542506|NCT00643916|473608576|FG004|Overall Study|Not Vaccinated|2|||
131542507|NCT00643916|473608577|FG005|Overall Study|Not Vaccinated|0|||
131542508|NCT00499031|473608578|FG000|Overall Study|Improper pre-protocol treatment|1|||
131542509|NCT00499031|473608578|FG000|Overall Study|Required test not done|1|||
131542510|NCT00499031|473608578|FG000|Overall Study|Never treated|1|||
131542511|NCT02606279|473608580|FG000|Overall Study|Lost to Follow-up|0|||
131542512|NCT02606279|473608581|FG001|Overall Study|Lost to Follow-up|1|||
131542513|NCT02184611|473608582|FG000|Overall Study|Lack of Efficacy|11|||
131542514|NCT02184611|473608583|FG001|Overall Study|Lack of Efficacy|15|||
131542515|NCT02184611|473608582|FG000|Overall Study|Withdrawal by Subject|5|||
131542516|NCT02184611|473608583|FG001|Overall Study|Withdrawal by Subject|6|||
131542517|NCT02184611|473608582|FG000|Overall Study|Adverse Event|4|||
131542518|NCT02184611|473608583|FG001|Overall Study|Adverse Event|5|||
131542519|NCT02184611|473608582|FG000|Overall Study|Protocol Violation|1|||
131542520|NCT02184611|473608583|FG001|Overall Study|Protocol Violation|1|||
131542521|NCT02184611|473608582|FG000|Overall Study|Protocol defined stopping criteria|0|||
131542522|NCT02184611|473608583|FG001|Overall Study|Protocol defined stopping criteria|1|||
131542523|NCT00985725|473608589|FG000|Overall Study|Adverse Event|4|||
131542524|NCT00985725|473608590|FG001|Overall Study|Adverse Event|1|||
131542525|NCT00985725|473608589|FG000|Overall Study|Protocol Violation|1|||
131542526|NCT00985725|473608590|FG001|Overall Study|Protocol Violation|3|||
131542527|NCT00985725|473608589|FG000|Overall Study|Withdrawal by Subject|4|||
131542528|NCT00985725|473608590|FG001|Overall Study|Withdrawal by Subject|4|||
131542529|NCT00985725|473608589|FG000|Overall Study|Lost to Follow-up|1|||
131542530|NCT00985725|473608590|FG001|Overall Study|Lost to Follow-up|1|||
131542531|NCT00985725|473608589|FG000|Overall Study|Lack of Efficacy|0|||
131542532|NCT00985725|473608590|FG001|Overall Study|Lack of Efficacy|1|||
131542533|NCT00985725|473608589|FG000|Overall Study|Non-compliance|1|||
131542534|NCT00985725|473608590|FG001|Overall Study|Non-compliance|2|||
131542535|NCT00985725|473608589|FG000|Overall Study|Out-of-window visits|0|||
131542536|NCT00985725|473608590|FG001|Overall Study|Out-of-window visits|1|||
131542537|NCT03563716|473608591|FG000|Overall Study|Death|20|||
131542538|NCT03563716|473608592|FG001|Overall Study|Death|14|||
131542539|NCT03563716|473608591|FG000|Overall Study|Withdrawal by Subject|3|||
131542540|NCT03563716|473608592|FG001|Overall Study|Withdrawal by Subject|3|||
131542541|NCT03563716|473608591|FG000|Overall Study|Still on Study|45|||
131542542|NCT03563716|473608592|FG001|Overall Study|Still on Study|50|||
131542543|NCT02080871|473608595|FG000|Overall Study|Death|1|||
131542544|NCT02080871|473608595|FG000|Overall Study|Lost to Follow-up|1|||
131542545|NCT00234052|473608596|FG000|Treatment|Withdrawal by Subject|3|||
131542546|NCT00234052|473608596|FG000|Treatment|Adverse Event|5|||
131542547|NCT00234052|473608596|FG000|Treatment|Death|2|||
131542548|NCT00234052|473608596|FG000|Treatment|Progressive Disease|11|||
131542549|NCT00234052|473608596|FG000|Follow-up for 5 Years|Death|41|||
131542550|NCT00234052|473608596|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
131542551|NCT00234052|473608596|FG000|Follow-up for 5 Years|Other|7|||
131542552|NCT02428296|473608597|FG000|Overall Study|Adverse Event|7|||
131542553|NCT02428296|473608597|FG000|Overall Study|Withdrawal by Subject|2|||
131542554|NCT01615328|473608598|FG000|Overall Study|Lost to Follow-up|3|||
131542555|NCT01615328|473608599|FG001|Overall Study|Lost to Follow-up|5|||
131542556|NCT02548455|473608602|FG000|Overall Study|Withdrawal by Subject|27|||
131542557|NCT02548455|473608602|FG000|Overall Study|Death|26|||
131542558|NCT02548455|473608602|FG000|Overall Study|Lost to Follow-up|14|||
131542559|NCT02548455|473608602|FG000|Overall Study|Visit not completed|173|||
131542560|NCT02261493|473608606|FG000|Overall Study|Noncompliance|0|||
131542561|NCT02261493|473608607|FG001|Overall Study|Noncompliance|0|||
131542562|NCT02261493|473608608|FG002|Overall Study|Noncompliance|2|||
131542563|NCT02261493|473608606|FG000|Overall Study|Physician Decision|0|||
131542564|NCT02261493|473608607|FG001|Overall Study|Physician Decision|1|||
131542565|NCT02261493|473608608|FG002|Overall Study|Physician Decision|0|||
131542566|NCT02261493|473608606|FG000|Overall Study|Undisclosed alcohol abuse|0|||
131542567|NCT02261493|473608607|FG001|Overall Study|Undisclosed alcohol abuse|1|||
131542568|NCT02261493|473608608|FG002|Overall Study|Undisclosed alcohol abuse|0|||
131542569|NCT02261493|473608606|FG000|Overall Study|Protocol Violation|1|||
131542570|NCT02261493|473608607|FG001|Overall Study|Protocol Violation|0|||
131542571|NCT02261493|473608608|FG002|Overall Study|Protocol Violation|0|||
131542572|NCT02261493|473608606|FG000|Overall Study|Personal Reasons|14|||
131542573|NCT02261493|473608607|FG001|Overall Study|Personal Reasons|14|||
131542574|NCT02261493|473608608|FG002|Overall Study|Personal Reasons|16|||
131542575|NCT02261493|473608606|FG000|Overall Study|Lost to Follow-up|14|||
131542576|NCT02261493|473608607|FG001|Overall Study|Lost to Follow-up|27|||
131542577|NCT02261493|473608608|FG002|Overall Study|Lost to Follow-up|8|||
131542578|NCT02261493|473608606|FG000|Overall Study|Pregnancy|1|||
131542579|NCT02261493|473608607|FG001|Overall Study|Pregnancy|2|||
131542580|NCT02261493|473608608|FG002|Overall Study|Pregnancy|0|||
131542581|NCT02261493|473608606|FG000|Overall Study|Lack of Efficacy|0|||
131542582|NCT02261493|473608607|FG001|Overall Study|Lack of Efficacy|1|||
131542583|NCT02261493|473608608|FG002|Overall Study|Lack of Efficacy|0|||
131542584|NCT02261493|473608606|FG000|Overall Study|Adverse Event|0|||
131542585|NCT02261493|473608607|FG001|Overall Study|Adverse Event|1|||
131542586|NCT02261493|473608608|FG002|Overall Study|Adverse Event|0|||
131542587|NCT02230956|473608609|FG000|Overall Study|Adverse Event|1|||
131542588|NCT02230956|473608610|FG001|Overall Study|Adverse Event|1|||
131542589|NCT02230956|473608611|FG002|Overall Study|Adverse Event|0|||
131542590|NCT02230956|473608609|FG000|Overall Study|Lack of Efficacy|1|||
131542591|NCT02230956|473608610|FG001|Overall Study|Lack of Efficacy|1|||
131542592|NCT02230956|473608611|FG002|Overall Study|Lack of Efficacy|1|||
131542593|NCT02230956|473608609|FG000|Overall Study|Lost to Follow-up|1|||
131542594|NCT02230956|473608610|FG001|Overall Study|Lost to Follow-up|1|||
131542595|NCT02230956|473608611|FG002|Overall Study|Lost to Follow-up|2|||
131542596|NCT02230956|473608609|FG000|Overall Study|Personal Reasons|2|||
131542597|NCT02230956|473608610|FG001|Overall Study|Personal Reasons|1|||
131542598|NCT02230956|473608611|FG002|Overall Study|Personal Reasons|1|||
131542599|NCT02230956|473608609|FG000|Overall Study|Protocol Violation|0|||
131542600|NCT02230956|473608610|FG001|Overall Study|Protocol Violation|1|||
131542601|NCT02230956|473608611|FG002|Overall Study|Protocol Violation|1|||
131542602|NCT02230956|473608609|FG000|Overall Study|Other Miscellaneous Reason|0|||
131542603|NCT02230956|473608610|FG001|Overall Study|Other Miscellaneous Reason|1|||
131542604|NCT02230956|473608611|FG002|Overall Study|Other Miscellaneous Reason|2|||
131542605|NCT00338884|473608612|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
131542606|NCT00338884|473608612|FG000|Overall Study|Adverse Event|14|||
131542607|NCT00338884|473608612|FG000|Overall Study|Death|8|||
131542608|NCT00338884|473608612|FG000|Overall Study|Other|4|||
131542609|NCT00338884|473608612|FG000|Overall Study|Global Deterioration of Health Status|3|||
131542610|NCT00338884|473608612|FG000|Overall Study|Withdrawal by Subject|3|||
131542611|NCT00338884|473608612|FG000|Overall Study|Lost to Follow-up|1|||
131542612|NCT00338884|473608612|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
131542613|NCT01970982|473608614|FG000|Overall Study|Withdrawal by Subject|0|||
131542614|NCT01970982|473608615|FG001|Overall Study|Withdrawal by Subject|0|||
131542615|NCT01970982|473608616|FG002|Overall Study|Withdrawal by Subject|2|||
131542616|NCT01984684|473608621|FG000|Overall Study|Lost to Follow-up|25|||
131542617|NCT01984684|473608622|FG001|Overall Study|Lost to Follow-up|24|||
131542618|NCT01984684|473608621|FG000|Overall Study|Adverse Event|8|||
131542619|NCT01984684|473608622|FG001|Overall Study|Adverse Event|12|||
131542620|NCT01984684|473608621|FG000|Overall Study|Withdrawal by Subject|9|||
131542621|NCT01984684|473608622|FG001|Overall Study|Withdrawal by Subject|9|||
131542622|NCT01984684|473608621|FG000|Overall Study|Lack of Efficacy|3|||
131542623|NCT01984684|473608622|FG001|Overall Study|Lack of Efficacy|6|||
131542624|NCT01984684|473608621|FG000|Overall Study|Physician Decision|4|||
131542625|NCT01984684|473608622|FG001|Overall Study|Physician Decision|2|||
131542626|NCT01984684|473608621|FG000|Overall Study|Protocol Violation|4|||
131542627|NCT01984684|473608622|FG001|Overall Study|Protocol Violation|2|||
131542628|NCT01984684|473608621|FG000|Overall Study|Death|0|||
131542629|NCT01984684|473608622|FG001|Overall Study|Death|1|||
131542630|NCT01984684|473608621|FG000|Overall Study|Noncompliance with study drug|2|||
131542631|NCT01984684|473608622|FG001|Overall Study|Noncompliance with study drug|1|||
131542632|NCT01984684|473608621|FG000|Overall Study|Subject incarcerated|1|||
131542633|NCT01984684|473608622|FG001|Overall Study|Subject incarcerated|0|||
131542634|NCT01984684|473608621|FG000|Overall Study|Study drug not available at site|1|||
131542635|NCT01984684|473608622|FG001|Overall Study|Study drug not available at site|1|||
131542636|NCT01984684|473608621|FG000|Overall Study|Subject had inadequate IV access|0|||
131542637|NCT01984684|473608622|FG001|Overall Study|Subject had inadequate IV access|1|||
131542638|NCT05711641|473608627|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
131542639|NCT05711641|473608628|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
131542640|NCT05711641|473608627|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
131542641|NCT05711641|473608628|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
131542642|NCT04575051|473608629|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
131542643|NCT04575051|473608630|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
131542644|NCT04575051|473608631|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
131542645|NCT04575051|473608632|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
131542646|NCT04575051|473608633|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
131542647|NCT04575051|473608629|FG000|Time Period 1|Missing follow up|1|||
131542648|NCT04575051|473608630|FG001|Time Period 1|Missing follow up|3|||
131542649|NCT04575051|473608631|FG002|Time Period 1|Missing follow up|1|||
131542650|NCT04575051|473608632|FG003|Time Period 1|Missing follow up|3|||
131542651|NCT04575051|473608633|FG004|Time Period 1|Missing follow up|2|||
131542652|NCT04575051|473608629|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
131542653|NCT04575051|473608630|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
131542654|NCT04575051|473608631|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
131542655|NCT04575051|473608632|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
131542656|NCT04575051|473608633|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
131542657|NCT04575051|473608629|FG000|Time Period 2|Missing follow up|1|||
131542658|NCT04575051|473608630|FG001|Time Period 2|Missing follow up|8|||
131542659|NCT04575051|473608631|FG002|Time Period 2|Missing follow up|7|||
131542660|NCT04575051|473608632|FG003|Time Period 2|Missing follow up|0|||
131542661|NCT04575051|473608633|FG004|Time Period 2|Missing follow up|1|||
131542662|NCT04575051|473608629|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
131542663|NCT04575051|473608630|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
131542664|NCT04575051|473608631|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
131542665|NCT04575051|473608632|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
131542666|NCT04575051|473608633|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
131542667|NCT04575051|473608629|FG000|Time Period 3|Missing follow up|8|||
131542668|NCT04575051|473608630|FG001|Time Period 3|Missing follow up|6|||
131542669|NCT04575051|473608631|FG002|Time Period 3|Missing follow up|4|||
131542670|NCT04575051|473608632|FG003|Time Period 3|Missing follow up|3|||
131542671|NCT04575051|473608633|FG004|Time Period 3|Missing follow up|0|||
131542672|NCT04575051|473608629|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
131542673|NCT04575051|473608630|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
131542674|NCT04575051|473608631|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
131542675|NCT04575051|473608632|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
131542676|NCT04575051|473608633|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
131542677|NCT04575051|473608629|FG000|Time Period 4|Missing follow up|17|||
131542678|NCT04575051|473608630|FG001|Time Period 4|Missing follow up|3|||
131542679|NCT04575051|473608631|FG002|Time Period 4|Missing follow up|4|||
131542680|NCT04575051|473608632|FG003|Time Period 4|Missing follow up|2|||
131542681|NCT04575051|473608633|FG004|Time Period 4|Missing follow up|1|||
131542682|NCT04575051|473608629|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
131542683|NCT04575051|473608630|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
131542684|NCT04575051|473608631|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
131542685|NCT04575051|473608632|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
131542686|NCT04575051|473608633|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
131542687|NCT04575051|473608629|FG000|Time Period 5|Missing follow up|11|||
131542688|NCT04575051|473608630|FG001|Time Period 5|Missing follow up|8|||
131542689|NCT04575051|473608631|FG002|Time Period 5|Missing follow up|12|||
131542690|NCT04575051|473608632|FG003|Time Period 5|Missing follow up|3|||
131542691|NCT04575051|473608633|FG004|Time Period 5|Missing follow up|11|||
131542692|NCT03624504|473608634|FG000|Overall Study|Unsuccessful Implant|1|||
131542693|NCT02862457|473608635|FG000|Overall Study|Death|1|||
131542694|NCT02862457|473608636|FG001|Overall Study|Death|3|||
131542695|NCT02862457|473608637|FG002|Overall Study|Death|2|||
131542696|NCT02862457|473608638|FG003|Overall Study|Death|3|||
131542697|NCT02862457|473608639|FG004|Overall Study|Death|0|||
131542698|NCT02862457|473608640|FG005|Overall Study|Death|2|||
131542699|NCT02862457|473608641|FG006|Overall Study|Death|1|||
131542700|NCT02862457|473608635|FG000|Overall Study|Lost to Follow-up|1|||
131542701|NCT02862457|473608636|FG001|Overall Study|Lost to Follow-up|0|||
131542702|NCT02862457|473608637|FG002|Overall Study|Lost to Follow-up|0|||
131542703|NCT02862457|473608638|FG003|Overall Study|Lost to Follow-up|1|||
131542704|NCT02862457|473608639|FG004|Overall Study|Lost to Follow-up|0|||
131542705|NCT02862457|473608640|FG005|Overall Study|Lost to Follow-up|0|||
131542706|NCT02862457|473608641|FG006|Overall Study|Lost to Follow-up|0|||
131542707|NCT02862457|473608635|FG000|Overall Study|Withdrawal by Subject|0|||
131542708|NCT02862457|473608636|FG001|Overall Study|Withdrawal by Subject|0|||
131542709|NCT02862457|473608637|FG002|Overall Study|Withdrawal by Subject|1|||
131542710|NCT02862457|473608638|FG003|Overall Study|Withdrawal by Subject|0|||
131542711|NCT02862457|473608639|FG004|Overall Study|Withdrawal by Subject|0|||
131542712|NCT02862457|473608640|FG005|Overall Study|Withdrawal by Subject|1|||
131542713|NCT02862457|473608641|FG006|Overall Study|Withdrawal by Subject|0|||
131542714|NCT00951483|473608644|FG000|Overall Study|Physician Decision|4|||
131542715|NCT00951483|473608645|FG001|Overall Study|Physician Decision|0|||
131542716|NCT00951483|473608644|FG000|Overall Study|Withdrawal by Subject|15|||
131542717|NCT00951483|473608645|FG001|Overall Study|Withdrawal by Subject|0|||
131542718|NCT00335322|473608646|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
131542719|NCT00335322|473608647|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
131542720|NCT00335322|473608648|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
131542721|NCT03364751|473608651|FG000|Overall Study|Withdrawal by Subject|1|||
131542722|NCT03364751|473608652|FG001|Overall Study|Withdrawal by Subject|0|||
131542723|NCT03364751|473608653|FG002|Overall Study|Withdrawal by Subject|0|||
131542724|NCT03364751|473608654|FG003|Overall Study|Withdrawal by Subject|0|||
131542725|NCT03364751|473608651|FG000|Overall Study|Lost to Follow-up|0|||
131542726|NCT03364751|473608652|FG001|Overall Study|Lost to Follow-up|1|||
131542727|NCT03364751|473608653|FG002|Overall Study|Lost to Follow-up|0|||
131542728|NCT03364751|473608654|FG003|Overall Study|Lost to Follow-up|0|||
131542729|NCT03583554|473608655|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
131542730|NCT03583554|473608656|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
131542731|NCT03583554|473608657|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
131542732|NCT03178266|473608658|FG000|Overall Study|Death|0|||
131542733|NCT03178266|473608659|FG001|Overall Study|Death|1|||
131542734|NCT03178266|473608658|FG000|Overall Study|Disont. Early|0|||
131542735|NCT03178266|473608659|FG001|Overall Study|Disont. Early|1|||
131542736|NCT03178266|473608658|FG000|Overall Study|Withdrawal by Subject|0|||
131542737|NCT03178266|473608659|FG001|Overall Study|Withdrawal by Subject|2|||
131542738|NCT02342886|473608660|FG000|Overall Study|Treatment non-compliance|1|||
131542739|NCT02342886|473608661|FG001|Overall Study|Treatment non-compliance|0|||
131542740|NCT02342886|473608662|FG002|Overall Study|Treatment non-compliance|0|||
131542741|NCT02342886|473608663|FG003|Overall Study|Treatment non-compliance|1|||
131542742|NCT02342886|473608664|FG004|Overall Study|Treatment non-compliance|0|||
131542743|NCT02342886|473608660|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
131542744|NCT02342886|473608661|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
131542745|NCT02342886|473608662|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
131542746|NCT02342886|473608663|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
131542747|NCT02342886|473608664|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
131542748|NCT02342886|473608660|FG000|Overall Study|Adverse event/specific toxicity|4|||
131542749|NCT02342886|473608661|FG001|Overall Study|Adverse event/specific toxicity|3|||
131542750|NCT02342886|473608662|FG002|Overall Study|Adverse event/specific toxicity|11|||
131542751|NCT02342886|473608663|FG003|Overall Study|Adverse event/specific toxicity|2|||
131542752|NCT02342886|473608664|FG004|Overall Study|Adverse event/specific toxicity|1|||
131542753|NCT02342886|473608660|FG000|Overall Study|Lost to Follow-up|1|||
131542754|NCT02342886|473608661|FG001|Overall Study|Lost to Follow-up|0|||
131542755|NCT02342886|473608662|FG002|Overall Study|Lost to Follow-up|0|||
131542756|NCT02342886|473608663|FG003|Overall Study|Lost to Follow-up|0|||
131542757|NCT02342886|473608664|FG004|Overall Study|Lost to Follow-up|0|||
131542758|NCT02342886|473608660|FG000|Overall Study|Death|1|||
131542759|NCT02342886|473608661|FG001|Overall Study|Death|2|||
131542760|NCT02342886|473608662|FG002|Overall Study|Death|1|||
131542761|NCT02342886|473608663|FG003|Overall Study|Death|0|||
131542762|NCT02342886|473608664|FG004|Overall Study|Death|1|||
131542763|NCT02342886|473608660|FG000|Overall Study|Withdrawal by Subject|0|||
131542764|NCT02342886|473608661|FG001|Overall Study|Withdrawal by Subject|1|||
131542765|NCT02342886|473608662|FG002|Overall Study|Withdrawal by Subject|0|||
131542766|NCT02342886|473608663|FG003|Overall Study|Withdrawal by Subject|1|||
131542767|NCT02342886|473608664|FG004|Overall Study|Withdrawal by Subject|0|||
131542768|NCT02342886|473608660|FG000|Overall Study|Investigator/sponsor decision|0|||
131542769|NCT02342886|473608661|FG001|Overall Study|Investigator/sponsor decision|2|||
131542770|NCT02342886|473608662|FG002|Overall Study|Investigator/sponsor decision|0|||
131542771|NCT02342886|473608663|FG003|Overall Study|Investigator/sponsor decision|3|||
131542772|NCT02342886|473608664|FG004|Overall Study|Investigator/sponsor decision|1|||
131542773|NCT02342886|473608660|FG000|Overall Study|Pregnancy|0|||
131542774|NCT02342886|473608661|FG001|Overall Study|Pregnancy|0|||
131542775|NCT02342886|473608662|FG002|Overall Study|Pregnancy|2|||
131542776|NCT02342886|473608663|FG003|Overall Study|Pregnancy|0|||
131542777|NCT02342886|473608664|FG004|Overall Study|Pregnancy|0|||
131542778|NCT02342886|473608660|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
131542779|NCT02342886|473608661|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
131542780|NCT02342886|473608662|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
131542781|NCT02342886|473608663|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
131542782|NCT02342886|473608664|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
131542783|NCT02342886|473608660|FG000|Overall Study|Protocol Violation|0|||
131542784|NCT02342886|473608661|FG001|Overall Study|Protocol Violation|0|||
131542785|NCT02342886|473608662|FG002|Overall Study|Protocol Violation|0|||
131542786|NCT02342886|473608663|FG003|Overall Study|Protocol Violation|2|||
131542787|NCT02342886|473608664|FG004|Overall Study|Protocol Violation|0|||
131542788|NCT02275065|473608665|FG000|Overall Study|Randomized but not treated|1|||
131542789|NCT02275065|473608666|FG001|Overall Study|Randomized but not treated|0|||
131542790|NCT02275065|473608667|FG002|Overall Study|Randomized but not treated|1|||
131542791|NCT02275065|473608668|FG003|Overall Study|Randomized but not treated|1|||
131542792|NCT02275065|473608669|FG004|Overall Study|Randomized but not treated|0|||
131542793|NCT01328080|473608670|FG000|Overall Study|Lost to Follow-up|5|||
131542794|NCT00862134|473608671|FG000|Overall Study|Death|1|||
131542795|NCT00862134|473608672|FG001|Overall Study|Death|0|||
131542796|NCT00862134|473608671|FG000|Overall Study|Physician Decision|0|||
131542797|NCT00862134|473608672|FG001|Overall Study|Physician Decision|1|||
131542798|NCT00862134|473608671|FG000|Overall Study|Withdrawal by Subject|1|||
131542799|NCT00862134|473608672|FG001|Overall Study|Withdrawal by Subject|2|||
131542800|NCT00862134|473608671|FG000|Overall Study|Sponsor terminated study|5|||
131542801|NCT00862134|473608672|FG001|Overall Study|Sponsor terminated study|7|||
131542802|NCT00862134|473608671|FG000|Overall Study|Adverse Event|2|||
131542803|NCT00862134|473608672|FG001|Overall Study|Adverse Event|2|||
131542804|NCT00862134|473608671|FG000|Overall Study|Withdrew prior to dosing|2|||
131542805|NCT00862134|473608672|FG001|Overall Study|Withdrew prior to dosing|0|||
131542806|NCT02191267|473608673|FG000|Overall Study|Withdrawal by Subject|1|||
131542807|NCT02191267|473608674|FG001|Overall Study|Withdrawal by Subject|0|||
131542808|NCT02191267|473608675|FG002|Overall Study|Withdrawal by Subject|0|||
131542809|NCT00765674|473608676|FG000|Overall Study|Adverse Event|7|||
131542810|NCT00765674|473608677|FG001|Overall Study|Adverse Event|2|||
131542811|NCT00765674|473608678|FG002|Overall Study|Adverse Event|8|||
131542812|NCT00765674|473608679|FG003|Overall Study|Adverse Event|11|||
131542813|NCT00765674|473608676|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
131542814|NCT00765674|473608677|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
131542815|NCT00765674|473608678|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
131542816|NCT00765674|473608679|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
131542817|NCT00765674|473608676|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
131542818|NCT00765674|473608677|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
131542819|NCT00765674|473608678|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
131542820|NCT00765674|473608679|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
131542821|NCT00765674|473608676|FG000|Overall Study|Lack of Efficacy|2|||
131542822|NCT00765674|473608677|FG001|Overall Study|Lack of Efficacy|3|||
131542823|NCT00765674|473608678|FG002|Overall Study|Lack of Efficacy|1|||
131542824|NCT00765674|473608679|FG003|Overall Study|Lack of Efficacy|2|||
131542825|NCT00765674|473608676|FG000|Overall Study|Protocol Violation|2|||
131542826|NCT00765674|473608677|FG001|Overall Study|Protocol Violation|0|||
131542827|NCT00765674|473608678|FG002|Overall Study|Protocol Violation|1|||
131542828|NCT00765674|473608679|FG003|Overall Study|Protocol Violation|0|||
131542829|NCT00765674|473608676|FG000|Overall Study|Withdrawal by Subject|5|||
131542830|NCT00765674|473608677|FG001|Overall Study|Withdrawal by Subject|7|||
131542831|NCT00765674|473608678|FG002|Overall Study|Withdrawal by Subject|3|||
131542832|NCT00765674|473608679|FG003|Overall Study|Withdrawal by Subject|8|||
131542833|NCT00765674|473608676|FG000|Overall Study|Lost to Follow-up|4|||
131542834|NCT00765674|473608677|FG001|Overall Study|Lost to Follow-up|6|||
131542835|NCT00765674|473608678|FG002|Overall Study|Lost to Follow-up|2|||
131542836|NCT00765674|473608679|FG003|Overall Study|Lost to Follow-up|1|||
131542837|NCT00765674|473608676|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
131542838|NCT00765674|473608677|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
131542839|NCT00765674|473608678|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
131542840|NCT00765674|473608679|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
131542841|NCT01813474|473608680|FG000|Overall Study|Withdrawal by Subject|0|||
131542842|NCT01813474|473608681|FG001|Overall Study|Withdrawal by Subject|0|||
131542843|NCT01813474|473608682|FG002|Overall Study|Withdrawal by Subject|1|||
131542844|NCT01813474|473608680|FG000|Overall Study|Adverse Event|1|||
131542845|NCT01813474|473608681|FG001|Overall Study|Adverse Event|1|||
131542846|NCT01813474|473608682|FG002|Overall Study|Adverse Event|0|||
131542847|NCT01813474|473608680|FG000|Overall Study|Lack of Efficacy|2|||
131542848|NCT01813474|473608681|FG001|Overall Study|Lack of Efficacy|6|||
131542849|NCT01813474|473608682|FG002|Overall Study|Lack of Efficacy|9|||
131542850|NCT01813474|473608680|FG000|Overall Study|Death|0|||
131542851|NCT01813474|473608681|FG001|Overall Study|Death|0|||
131542852|NCT01813474|473608682|FG002|Overall Study|Death|1|||
131542853|NCT00316082|473608683|FG000|Overall Study|Lack of Efficacy|2|||
131542854|NCT00316082|473608684|FG001|Overall Study|Lack of Efficacy|3|||
131542855|NCT00316082|473608685|FG002|Overall Study|Lack of Efficacy|3|||
131542856|NCT00316082|473608686|FG003|Overall Study|Lack of Efficacy|4|||
131542857|NCT00316082|473608687|FG004|Overall Study|Lack of Efficacy|6|||
131658603|NCT02003222|474035399|FG004|Induction|Adverse Event|13|||
131542858|NCT00316082|473608683|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
131542859|NCT00316082|473608684|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
131542860|NCT00316082|473608685|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
131542861|NCT00316082|473608686|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
131542862|NCT00316082|473608687|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
131542863|NCT00316082|473608683|FG000|Overall Study|Lost to Follow-up|7|||
131542864|NCT00316082|473608684|FG001|Overall Study|Lost to Follow-up|6|||
131542865|NCT00316082|473608685|FG002|Overall Study|Lost to Follow-up|7|||
131542866|NCT00316082|473608686|FG003|Overall Study|Lost to Follow-up|8|||
131542867|NCT00316082|473608687|FG004|Overall Study|Lost to Follow-up|6|||
131542868|NCT00316082|473608683|FG000|Overall Study|Poor/noncompliance|6|||
131542869|NCT00316082|473608684|FG001|Overall Study|Poor/noncompliance|1|||
131542870|NCT00316082|473608685|FG002|Overall Study|Poor/noncompliance|4|||
131542871|NCT00316082|473608686|FG003|Overall Study|Poor/noncompliance|1|||
131542872|NCT00316082|473608687|FG004|Overall Study|Poor/noncompliance|4|||
131542873|NCT00316082|473608683|FG000|Overall Study|Adverse Event|4|||
131542874|NCT00316082|473608684|FG001|Overall Study|Adverse Event|2|||
131542875|NCT00316082|473608685|FG002|Overall Study|Adverse Event|5|||
131542876|NCT00316082|473608686|FG003|Overall Study|Adverse Event|1|||
131542877|NCT00316082|473608687|FG004|Overall Study|Adverse Event|3|||
131542878|NCT00316082|473608683|FG000|Overall Study|Subject no longer meets study criteria|3|||
131542879|NCT00316082|473608684|FG001|Overall Study|Subject no longer meets study criteria|1|||
131542880|NCT00316082|473608685|FG002|Overall Study|Subject no longer meets study criteria|2|||
131542881|NCT00316082|473608686|FG003|Overall Study|Subject no longer meets study criteria|2|||
131542882|NCT00316082|473608687|FG004|Overall Study|Subject no longer meets study criteria|1|||
131542883|NCT00316082|473608683|FG000|Overall Study|Physician Decision|1|||
131542884|NCT00316082|473608684|FG001|Overall Study|Physician Decision|1|||
131542885|NCT00316082|473608685|FG002|Overall Study|Physician Decision|2|||
131542886|NCT00316082|473608686|FG003|Overall Study|Physician Decision|1|||
131542887|NCT00316082|473608687|FG004|Overall Study|Physician Decision|1|||
131542888|NCT00316082|473608683|FG000|Overall Study|Death|0|||
131542889|NCT00316082|473608684|FG001|Overall Study|Death|0|||
131542890|NCT00316082|473608685|FG002|Overall Study|Death|1|||
131542891|NCT00316082|473608686|FG003|Overall Study|Death|0|||
131542892|NCT00316082|473608687|FG004|Overall Study|Death|0|||
131542893|NCT00316082|473608683|FG000|Overall Study|Administrative reason by sponsor|0|||
131542894|NCT00316082|473608684|FG001|Overall Study|Administrative reason by sponsor|0|||
131542895|NCT00316082|473608685|FG002|Overall Study|Administrative reason by sponsor|1|||
131542896|NCT00316082|473608686|FG003|Overall Study|Administrative reason by sponsor|0|||
131542897|NCT00316082|473608687|FG004|Overall Study|Administrative reason by sponsor|0|||
131542898|NCT00528775|473608690|FG000|Overall Study|Other not specified|1|||
131542899|NCT01569438|473608697|FG000|Overall Study|Lack of Efficacy|1|||
131542900|NCT01569438|473608698|FG001|Overall Study|Lack of Efficacy|2|||
131542901|NCT01569438|473608697|FG000|Overall Study|Withdrawal by Subject|0|||
131542902|NCT01569438|473608698|FG001|Overall Study|Withdrawal by Subject|3|||
131542903|NCT01569438|473608697|FG000|Overall Study|Adverse Event|2|||
131542904|NCT01569438|473608698|FG001|Overall Study|Adverse Event|15|||
131542905|NCT01569438|473608697|FG000|Overall Study|Protocol Violation|2|||
131542906|NCT01569438|473608698|FG001|Overall Study|Protocol Violation|0|||
131542907|NCT01569438|473608697|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
131542908|NCT01569438|473608698|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
131542909|NCT01569438|473608697|FG000|Overall Study|Sponsor/Physician decision|1|||
131542910|NCT01569438|473608698|FG001|Overall Study|Sponsor/Physician decision|1|||
131542911|NCT01569438|473608697|FG000|Overall Study|Unable to adhere to study schedule|0|||
131542912|NCT01569438|473608698|FG001|Overall Study|Unable to adhere to study schedule|1|||
131542913|NCT00827918|473608702|FG000|Overall Study|Adverse Event|4|||
131542914|NCT00827918|473608703|FG001|Overall Study|Adverse Event|0|||
131542915|NCT00827918|473608704|FG002|Overall Study|Adverse Event|0|||
131542916|NCT00827918|473608702|FG000|Overall Study|Lack of Efficacy|16|||
131542917|NCT00827918|473608703|FG001|Overall Study|Lack of Efficacy|4|||
131542918|NCT00827918|473608704|FG002|Overall Study|Lack of Efficacy|15|||
131542919|NCT00827918|473608702|FG000|Overall Study|Physician Decision|1|||
131542920|NCT00827918|473608703|FG001|Overall Study|Physician Decision|0|||
131542921|NCT00827918|473608704|FG002|Overall Study|Physician Decision|0|||
131542922|NCT00827918|473608702|FG000|Overall Study|Pregnancy|0|||
131542923|NCT00827918|473608703|FG001|Overall Study|Pregnancy|1|||
131542924|NCT00827918|473608704|FG002|Overall Study|Pregnancy|0|||
131542925|NCT00827918|473608702|FG000|Overall Study|Progressive Disease|1|||
131542926|NCT00827918|473608703|FG001|Overall Study|Progressive Disease|1|||
131542927|NCT00827918|473608704|FG002|Overall Study|Progressive Disease|0|||
131542928|NCT00827918|473608702|FG000|Overall Study|Protocol Violation|0|||
131542929|NCT00827918|473608703|FG001|Overall Study|Protocol Violation|1|||
131542930|NCT00827918|473608704|FG002|Overall Study|Protocol Violation|0|||
131542931|NCT00827918|473608702|FG000|Overall Study|Withdrawal by Subject|6|||
131542932|NCT00827918|473608703|FG001|Overall Study|Withdrawal by Subject|2|||
131542933|NCT00827918|473608704|FG002|Overall Study|Withdrawal by Subject|6|||
131542934|NCT02432105|473608706|FG000|Overall Study|Lost to Follow-up|1|||
131542935|NCT02432105|473608707|FG001|Overall Study|Lost to Follow-up|1|||
131542936|NCT02432105|473608708|FG002|Overall Study|Lost to Follow-up|0|||
131542937|NCT02432105|473608706|FG000|Overall Study|Withdrawal by Subject|1|||
131542938|NCT02432105|473608707|FG001|Overall Study|Withdrawal by Subject|0|||
131542939|NCT02432105|473608708|FG002|Overall Study|Withdrawal by Subject|1|||
131542940|NCT02432105|473608706|FG000|Overall Study|Culture positive for yeast|0|||
131542941|NCT02432105|473608707|FG001|Overall Study|Culture positive for yeast|1|||
131542942|NCT02432105|473608708|FG002|Overall Study|Culture positive for yeast|0|||
131542943|NCT02432105|473608706|FG000|Overall Study|Randomized in error|0|||
131542944|NCT02432105|473608707|FG001|Overall Study|Randomized in error|0|||
131542945|NCT02432105|473608708|FG002|Overall Study|Randomized in error|2|||
131542946|NCT01302847|473608709|FG000|Overall Study|Death|0|||
131542947|NCT01302847|473608710|FG001|Overall Study|Death|1|||
131542948|NCT01302847|473608711|FG002|Overall Study|Death|0|||
131542949|NCT01302847|473608712|FG003|Overall Study|Death|0|||
131542950|NCT01302847|473608713|FG004|Overall Study|Death|0|||
131542951|NCT01302847|473608714|FG005|Overall Study|Death|1|||
131542952|NCT01302847|473608715|FG006|Overall Study|Death|1|||
131542953|NCT01302847|473608716|FG007|Overall Study|Death|0|||
131542954|NCT01302847|473608709|FG000|Overall Study|Pregnancy|2|||
131542955|NCT01302847|473608710|FG001|Overall Study|Pregnancy|0|||
131542956|NCT01302847|473608711|FG002|Overall Study|Pregnancy|0|||
131542957|NCT01302847|473608712|FG003|Overall Study|Pregnancy|0|||
131542958|NCT01302847|473608713|FG004|Overall Study|Pregnancy|0|||
131542959|NCT01302847|473608714|FG005|Overall Study|Pregnancy|0|||
131542960|NCT01302847|473608715|FG006|Overall Study|Pregnancy|0|||
131542961|NCT01302847|473608716|FG007|Overall Study|Pregnancy|0|||
131542962|NCT01302847|473608709|FG000|Overall Study|Virologic failure|0|||
131542963|NCT01302847|473608710|FG001|Overall Study|Virologic failure|2|||
131542964|NCT01302847|473608711|FG002|Overall Study|Virologic failure|0|||
131542965|NCT01302847|473608712|FG003|Overall Study|Virologic failure|2|||
131542966|NCT01302847|473608713|FG004|Overall Study|Virologic failure|1|||
131542967|NCT01302847|473608714|FG005|Overall Study|Virologic failure|3|||
131542968|NCT01302847|473608715|FG006|Overall Study|Virologic failure|1|||
131542969|NCT01302847|473608716|FG007|Overall Study|Virologic failure|2|||
131542970|NCT01302847|473608709|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131542971|NCT01302847|473608710|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131542972|NCT01302847|473608711|FG002|Overall Study|Severe debilitation, unable to continue|0|||
131542973|NCT01302847|473608712|FG003|Overall Study|Severe debilitation, unable to continue|0|||
131542974|NCT01302847|473608713|FG004|Overall Study|Severe debilitation, unable to continue|0|||
131542975|NCT01302847|473608714|FG005|Overall Study|Severe debilitation, unable to continue|1|||
131542976|NCT01302847|473608715|FG006|Overall Study|Severe debilitation, unable to continue|1|||
131542977|NCT01302847|473608716|FG007|Overall Study|Severe debilitation, unable to continue|0|||
131542978|NCT01302847|473608709|FG000|Overall Study|Not able to get to clinic|1|||
131542979|NCT01302847|473608710|FG001|Overall Study|Not able to get to clinic|1|||
131542980|NCT01302847|473608711|FG002|Overall Study|Not able to get to clinic|0|||
131542981|NCT01302847|473608712|FG003|Overall Study|Not able to get to clinic|0|||
131542982|NCT01302847|473608713|FG004|Overall Study|Not able to get to clinic|0|||
131542983|NCT01302847|473608714|FG005|Overall Study|Not able to get to clinic|0|||
131542984|NCT01302847|473608715|FG006|Overall Study|Not able to get to clinic|0|||
131542985|NCT01302847|473608716|FG007|Overall Study|Not able to get to clinic|0|||
131542986|NCT01302847|473608709|FG000|Overall Study|Site closing|2|||
131542987|NCT01302847|473608710|FG001|Overall Study|Site closing|2|||
131542988|NCT01302847|473608711|FG002|Overall Study|Site closing|0|||
131542989|NCT01302847|473608712|FG003|Overall Study|Site closing|0|||
131542990|NCT01302847|473608713|FG004|Overall Study|Site closing|0|||
131542991|NCT01302847|473608714|FG005|Overall Study|Site closing|0|||
131542992|NCT01302847|473608715|FG006|Overall Study|Site closing|0|||
131542993|NCT01302847|473608716|FG007|Overall Study|Site closing|0|||
131542994|NCT01302847|473608709|FG000|Overall Study|Withdrawal by Subject|1|||
131542995|NCT01302847|473608710|FG001|Overall Study|Withdrawal by Subject|0|||
131542996|NCT01302847|473608711|FG002|Overall Study|Withdrawal by Subject|0|||
131542997|NCT01302847|473608712|FG003|Overall Study|Withdrawal by Subject|0|||
131542998|NCT01302847|473608713|FG004|Overall Study|Withdrawal by Subject|1|||
131542999|NCT01302847|473608714|FG005|Overall Study|Withdrawal by Subject|0|||
131543000|NCT01302847|473608715|FG006|Overall Study|Withdrawal by Subject|0|||
131543001|NCT01302847|473608716|FG007|Overall Study|Withdrawal by Subject|1|||
131543002|NCT01302847|473608709|FG000|Overall Study|Not willing to adhere to requirements|5|||
131543003|NCT01302847|473608710|FG001|Overall Study|Not willing to adhere to requirements|0|||
131543004|NCT01302847|473608711|FG002|Overall Study|Not willing to adhere to requirements|1|||
131543005|NCT01302847|473608712|FG003|Overall Study|Not willing to adhere to requirements|0|||
131543006|NCT01302847|473608713|FG004|Overall Study|Not willing to adhere to requirements|0|||
131543007|NCT01302847|473608714|FG005|Overall Study|Not willing to adhere to requirements|0|||
131543008|NCT01302847|473608715|FG006|Overall Study|Not willing to adhere to requirements|0|||
131543009|NCT01302847|473608716|FG007|Overall Study|Not willing to adhere to requirements|2|||
131543010|NCT01302847|473608709|FG000|Overall Study|Site unable to contact participant|2|||
131543011|NCT01302847|473608710|FG001|Overall Study|Site unable to contact participant|1|||
131658604|NCT02003222|474035395|FG000|Induction|Alternative therapy|0|||
131543012|NCT01302847|473608711|FG002|Overall Study|Site unable to contact participant|0|||
131543013|NCT01302847|473608712|FG003|Overall Study|Site unable to contact participant|0|||
131543014|NCT01302847|473608713|FG004|Overall Study|Site unable to contact participant|0|||
131543015|NCT01302847|473608714|FG005|Overall Study|Site unable to contact participant|0|||
131543016|NCT01302847|473608715|FG006|Overall Study|Site unable to contact participant|2|||
131543017|NCT01302847|473608716|FG007|Overall Study|Site unable to contact participant|0|||
131543018|NCT00374322|473608717|FG000|Overall Study|Lost to Follow-up|92|||
131543019|NCT00374322|473608718|FG001|Overall Study|Lost to Follow-up|90|||
131543020|NCT00374322|473608717|FG000|Overall Study|Protocol Violation|8|||
131543021|NCT00374322|473608718|FG001|Overall Study|Protocol Violation|3|||
131543022|NCT00374322|473608717|FG000|Overall Study|Withdrawal by Subject|235|||
131543023|NCT00374322|473608718|FG001|Overall Study|Withdrawal by Subject|167|||
131543024|NCT00374322|473608717|FG000|Overall Study|Sponsor Terminated Study|866|||
131543025|NCT00374322|473608718|FG001|Overall Study|Sponsor Terminated Study|990|||
131543026|NCT00374322|473608717|FG000|Overall Study|Physician Decision|36|||
131543027|NCT00374322|473608718|FG001|Overall Study|Physician Decision|32|||
131543028|NCT00374322|473608717|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
131543029|NCT00374322|473608718|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
131543030|NCT00374322|473608717|FG000|Overall Study|Sponsor Decision|2|||
131543031|NCT00374322|473608718|FG001|Overall Study|Sponsor Decision|3|||
131543032|NCT00374322|473608717|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
131543033|NCT00374322|473608718|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
131543034|NCT00374322|473608717|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
131543035|NCT00374322|473608718|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
131543036|NCT00374322|473608717|FG000|Overall Study|Severe Toxicity|1|||
131543037|NCT00374322|473608718|FG001|Overall Study|Severe Toxicity|0|||
131543038|NCT00374322|473608717|FG000|Overall Study|Site Closed|2|||
131543039|NCT00374322|473608718|FG001|Overall Study|Site Closed|2|||
131543040|NCT00374322|473608717|FG000|Overall Study|Participant Changed Physician|1|||
131543041|NCT00374322|473608718|FG001|Overall Study|Participant Changed Physician|0|||
131543042|NCT00374322|473608717|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
131543043|NCT00374322|473608718|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
131543044|NCT00374322|473608717|FG000|Overall Study|Noncompliance with Study Requirements|0|||
131543045|NCT00374322|473608718|FG001|Overall Study|Noncompliance with Study Requirements|1|||
131543046|NCT00374322|473608717|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
131543047|NCT00374322|473608718|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
131543048|NCT00374322|473608717|FG000|Overall Study|Did Not Receive Study Medication|8|||
131543049|NCT00374322|473608718|FG001|Overall Study|Did Not Receive Study Medication|6|||
131543050|NCT01112579|473608723|FG000|Overall Study|Missed Visit|1|||
131543051|NCT01112579|473608724|FG001|Overall Study|Missed Visit|1|||
131543052|NCT01112579|473608723|FG000|Overall Study|Death|0|||
131543053|NCT01112579|473608724|FG001|Overall Study|Death|2|||
131543054|NCT00818753|473608725|FG000|Overall Study|Protocol Violation|1|||
131543055|NCT00818753|473608726|FG001|Overall Study|Protocol Violation|0|||
131543056|NCT00818753|473608727|FG002|Overall Study|Protocol Violation|0|||
131543057|NCT00818753|473608725|FG000|Overall Study|Other reason (not specified)|0|||
131543058|NCT00818753|473608726|FG001|Overall Study|Other reason (not specified)|0|||
131543059|NCT00818753|473608727|FG002|Overall Study|Other reason (not specified)|1|||
131543060|NCT00818753|473608725|FG000|Overall Study|Randomised and not treated|2|||
131543061|NCT00818753|473608726|FG001|Overall Study|Randomised and not treated|0|||
131543062|NCT00818753|473608727|FG002|Overall Study|Randomised and not treated|0|||
131543063|NCT03703466|473608728|FG000|Overall Study|Death|2|||
131543064|NCT03703466|473608729|FG001|Overall Study|Death|1|||
131543065|NCT03703466|473608730|FG002|Overall Study|Death|0|||
131543066|NCT03703466|473608728|FG000|Overall Study|Withdrawal by Subject|0|||
131543067|NCT03703466|473608729|FG001|Overall Study|Withdrawal by Subject|3|||
131543068|NCT03703466|473608730|FG002|Overall Study|Withdrawal by Subject|0|||
131543069|NCT03703466|473608728|FG000|Overall Study|Completed < 3 Cycles|2|||
131543070|NCT03703466|473608729|FG001|Overall Study|Completed < 3 Cycles|2|||
131543071|NCT03703466|473608730|FG002|Overall Study|Completed < 3 Cycles|2|||
131543072|NCT04508699|473608732|FG000|Overall Study|Lack of Efficacy|2|||
131543073|NCT04508699|473608733|FG001|Overall Study|Lack of Efficacy|15|||
131543074|NCT04508699|473608732|FG000|Overall Study|Withdrawal by Subject|0|||
131543075|NCT04508699|473608733|FG001|Overall Study|Withdrawal by Subject|2|||
131543076|NCT03355326|473608734|FG000|Overall Study|Protocol Violation|3|||
131543077|NCT03355326|473608735|FG001|Overall Study|Protocol Violation|3|||
131543078|NCT04918784|473610532|FG000|Overall Study|Amputation - no longer eligible|1|||
131543079|NCT04918784|473610533|FG001|Overall Study|Amputation - no longer eligible|2|||
131543080|NCT04918784|473610532|FG000|Overall Study|Death|1|||
131543081|NCT04918784|473610533|FG001|Overall Study|Death|0|||
131543082|NCT04918784|473610532|FG000|Overall Study|patient non-compliance|3|||
131543083|NCT04918784|473610533|FG001|Overall Study|patient non-compliance|1|||
131543084|NCT04918784|473610532|FG000|Overall Study|Adverse Event|1|||
131543085|NCT04918784|473610533|FG001|Overall Study|Adverse Event|0|||
131543086|NCT04179175|473610537|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
131543087|NCT04179175|473610538|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
131543088|NCT04179175|473610539|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
131543089|NCT04179175|473610540|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
131543090|NCT04179175|473610541|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
131543091|NCT04179175|473610542|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
131543092|NCT04179175|473610537|FG000|Overall Study|Adverse Event|5|||
131543093|NCT04179175|473610538|FG001|Overall Study|Adverse Event|3|||
131543094|NCT04179175|473610539|FG002|Overall Study|Adverse Event|3|||
131543095|NCT04179175|473610540|FG003|Overall Study|Adverse Event|4|||
131543096|NCT04179175|473610541|FG004|Overall Study|Adverse Event|6|||
131543097|NCT04179175|473610542|FG005|Overall Study|Adverse Event|6|||
131543098|NCT04179175|473610537|FG000|Overall Study|Lack of Efficacy|5|||
131543099|NCT04179175|473610538|FG001|Overall Study|Lack of Efficacy|1|||
131543100|NCT04179175|473610539|FG002|Overall Study|Lack of Efficacy|3|||
131543101|NCT04179175|473610540|FG003|Overall Study|Lack of Efficacy|2|||
131543102|NCT04179175|473610541|FG004|Overall Study|Lack of Efficacy|18|||
131543103|NCT04179175|473610542|FG005|Overall Study|Lack of Efficacy|7|||
131543104|NCT04179175|473610537|FG000|Overall Study|Lost to Follow-up|5|||
131543105|NCT04179175|473610538|FG001|Overall Study|Lost to Follow-up|3|||
131543106|NCT04179175|473610539|FG002|Overall Study|Lost to Follow-up|2|||
131543107|NCT04179175|473610540|FG003|Overall Study|Lost to Follow-up|2|||
131543108|NCT04179175|473610541|FG004|Overall Study|Lost to Follow-up|4|||
131543109|NCT04179175|473610542|FG005|Overall Study|Lost to Follow-up|5|||
131543110|NCT04179175|473610537|FG000|Overall Study|Physician Decision|2|||
131543111|NCT04179175|473610538|FG001|Overall Study|Physician Decision|0|||
131543112|NCT04179175|473610539|FG002|Overall Study|Physician Decision|2|||
131543113|NCT04179175|473610540|FG003|Overall Study|Physician Decision|3|||
131543114|NCT04179175|473610541|FG004|Overall Study|Physician Decision|1|||
131543115|NCT04179175|473610542|FG005|Overall Study|Physician Decision|1|||
131543116|NCT04179175|473610537|FG000|Overall Study|Pregnancy|3|||
131543117|NCT04179175|473610538|FG001|Overall Study|Pregnancy|0|||
131543118|NCT04179175|473610539|FG002|Overall Study|Pregnancy|3|||
131543119|NCT04179175|473610540|FG003|Overall Study|Pregnancy|0|||
131543120|NCT04179175|473610541|FG004|Overall Study|Pregnancy|1|||
131543121|NCT04179175|473610542|FG005|Overall Study|Pregnancy|2|||
131543122|NCT04179175|473610537|FG000|Overall Study|Withdrawal by Subject|22|||
131543123|NCT04179175|473610538|FG001|Overall Study|Withdrawal by Subject|10|||
131543124|NCT04179175|473610539|FG002|Overall Study|Withdrawal by Subject|12|||
131543125|NCT04179175|473610540|FG003|Overall Study|Withdrawal by Subject|8|||
131543126|NCT04179175|473610541|FG004|Overall Study|Withdrawal by Subject|23|||
131543127|NCT04179175|473610542|FG005|Overall Study|Withdrawal by Subject|31|||
131543128|NCT04179175|473610537|FG000|Overall Study|Technical problems|0|||
131543129|NCT04179175|473610538|FG001|Overall Study|Technical problems|0|||
131543130|NCT04179175|473610539|FG002|Overall Study|Technical problems|1|||
131543131|NCT04179175|473610540|FG003|Overall Study|Technical problems|1|||
131543132|NCT04179175|473610541|FG004|Overall Study|Technical problems|0|||
131543133|NCT04179175|473610542|FG005|Overall Study|Technical problems|0|||
131543134|NCT02586025|473610552|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
131543135|NCT02586025|473610553|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
131543136|NCT02586025|473610552|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
131543137|NCT02586025|473610553|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
131543138|NCT02586025|473610552|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
131543139|NCT02586025|473610553|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
131543140|NCT02586025|473610552|FG000|Neoadjuvant Treatment|Death|1|||
131543141|NCT02586025|473610553|FG001|Neoadjuvant Treatment|Death|0|||
131543142|NCT02586025|473610552|FG000|Neoadjuvant Treatment|Adverse Event|1|||
131543143|NCT02586025|473610553|FG001|Neoadjuvant Treatment|Adverse Event|0|||
131543144|NCT02586025|473610552|FG000|Neoadjuvant Treatment|Physician Decision|2|||
131543145|NCT02586025|473610553|FG001|Neoadjuvant Treatment|Physician Decision|1|||
131543146|NCT02586025|473610552|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
131543147|NCT02586025|473610553|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
131543148|NCT02586025|473610552|FG000|Adjuvant Treatment|Recurrent Disease|4|||
131543149|NCT02586025|473610553|FG001|Adjuvant Treatment|Recurrent Disease|5|||
131543150|NCT02586025|473610552|FG000|Adjuvant Treatment|Physician Decision|0|||
131543151|NCT02586025|473610553|FG001|Adjuvant Treatment|Physician Decision|1|||
131543152|NCT02586025|473610552|FG000|Adjuvant Treatment|Pregnancy|1|||
131543153|NCT02586025|473610553|FG001|Adjuvant Treatment|Pregnancy|0|||
131543154|NCT02586025|473610552|FG000|Treatment-Free Follow-Up|Death|11|||
131543155|NCT02586025|473610553|FG001|Treatment-Free Follow-Up|Death|11|||
131543156|NCT02586025|473610552|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
131543157|NCT02586025|473610553|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
131543158|NCT02586025|473610552|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
131543159|NCT02586025|473610553|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
131543160|NCT02586025|473610552|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
131543161|NCT02586025|473610553|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
131543162|NCT02586025|473610552|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
131543163|NCT02586025|473610553|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
131543164|NCT00175825|473610554|FG000|Overall Study|Adverse Event|3|||
131543165|NCT00175825|473610555|FG001|Overall Study|Adverse Event|2|||
131543166|NCT00175825|473610556|FG002|Overall Study|Adverse Event|1|||
131543167|NCT00175825|473610557|FG003|Overall Study|Adverse Event|1|||
131543168|NCT00175825|473610554|FG000|Overall Study|Lost to Follow-up|1|||
131543169|NCT00175825|473610555|FG001|Overall Study|Lost to Follow-up|2|||
131543170|NCT00175825|473610556|FG002|Overall Study|Lost to Follow-up|0|||
131543171|NCT00175825|473610557|FG003|Overall Study|Lost to Follow-up|0|||
131543172|NCT00175825|473610554|FG000|Overall Study|Withdrawal by Subject|1|||
131543173|NCT00175825|473610555|FG001|Overall Study|Withdrawal by Subject|0|||
131543174|NCT00175825|473610556|FG002|Overall Study|Withdrawal by Subject|0|||
131543175|NCT00175825|473610557|FG003|Overall Study|Withdrawal by Subject|0|||
131543176|NCT02030015|473610558|FG000|Overall Study|Withdrawal by Subject|3|||
131543177|NCT02030015|473610558|FG000|Overall Study|Death|13|||
131543178|NCT03014674|473610560|FG000|Overall Study|Withdrawal by Subject|1|||
131543179|NCT03014674|473610561|FG001|Overall Study|Withdrawal by Subject|0|||
131543180|NCT03014674|473610562|FG002|Overall Study|Withdrawal by Subject|0|||
131543181|NCT00833560|473610563|FG000|Overall Study|Toxicity|13|||
131543182|NCT00833560|473610563|FG000|Overall Study|Adverse Event|11|||
131543183|NCT00833560|473610563|FG000|Overall Study|Protocol Violation|6|||
131543184|NCT00833560|473610563|FG000|Overall Study|Lack of Efficacy|4|||
131543185|NCT00833560|473610563|FG000|Overall Study|Death|2|||
131543186|NCT00833560|473610563|FG000|Overall Study|Pregression of other disease|1|||
131543187|NCT00833560|473610563|FG000|Overall Study|Other|5|||
131543188|NCT04605978|473610572|FG000|Overall Study|Adverse Event|2|||
131543189|NCT04605978|473610573|FG001|Overall Study|Adverse Event|1|||
131543190|NCT04605978|473610572|FG000|Overall Study|Withdrawal nonmedical reason|1|||
131543191|NCT04605978|473610573|FG001|Overall Study|Withdrawal nonmedical reason|1|||
131543192|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
131543193|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
131543194|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
131543195|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
131543196|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
131543197|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
131543198|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
131543199|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
131543200|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
131543201|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
131543202|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
131543203|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
131543204|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Death|6|||
131543205|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Death|3|||
131543206|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Death|0|||
131543207|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Death|1|||
131543208|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Death|1|||
131543209|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Death|0|||
131543210|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
131543211|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
131543212|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
131543213|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
131543214|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
131543215|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
131543216|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
131543217|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
131543218|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
131543219|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
131543220|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
131543221|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
131543222|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
131543223|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
131543224|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
131543225|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
131543226|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
131543227|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
131543228|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
131543229|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
131543230|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
131543231|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
131543232|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
131543233|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
131543234|NCT03104699|473610574|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
131543235|NCT03104699|473610575|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
131543236|NCT03104699|473610576|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
131543237|NCT03104699|473610577|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
131543238|NCT03104699|473610578|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
131543239|NCT03104699|473610579|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
131543240|NCT03104699|473610574|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131543241|NCT03104699|473610575|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131543242|NCT03104699|473610576|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131543243|NCT03104699|473610577|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131543244|NCT03104699|473610578|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
131543245|NCT03104699|473610579|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
131543246|NCT03104699|473610574|FG000|Phase 2: Dose Expansion|Death|0|||
131543247|NCT03104699|473610575|FG001|Phase 2: Dose Expansion|Death|0|||
131543248|NCT03104699|473610576|FG002|Phase 2: Dose Expansion|Death|0|||
131543249|NCT03104699|473610577|FG003|Phase 2: Dose Expansion|Death|0|||
131543250|NCT03104699|473610578|FG004|Phase 2: Dose Expansion|Death|0|||
131543251|NCT03104699|473610579|FG005|Phase 2: Dose Expansion|Death|107|||
131543252|NCT03104699|473610574|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
131543253|NCT03104699|473610575|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
131543254|NCT03104699|473610576|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
131543255|NCT03104699|473610577|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
131543256|NCT03104699|473610578|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
131543257|NCT03104699|473610579|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
131543258|NCT03104699|473610574|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
131543259|NCT03104699|473610575|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
131543260|NCT03104699|473610576|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
131543261|NCT03104699|473610577|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
131543262|NCT03104699|473610578|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
131543263|NCT03104699|473610579|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
131543264|NCT03104699|473610574|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131543265|NCT03104699|473610575|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131543266|NCT03104699|473610576|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131543267|NCT03104699|473610577|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131543268|NCT03104699|473610578|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131543269|NCT03104699|473610579|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
131543270|NCT03104699|473610574|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
131543271|NCT03104699|473610575|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
131543272|NCT03104699|473610576|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
131543273|NCT03104699|473610577|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
131543274|NCT03104699|473610578|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
131543275|NCT03104699|473610579|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
131543276|NCT01690130|473610580|FG000|Overall Study|Subject have cancelled visit.|1|||
131543277|NCT01690130|473610581|FG001|Overall Study|Subject have cancelled visit.|0|||
131543278|NCT01644734|473610582|FG000|Overall Study|Adverse Event|4|||
131543279|NCT01644734|473610582|FG000|Overall Study|Lost to Follow-up|17|||
131543280|NCT01644734|473610582|FG000|Overall Study|Reasons other than stated above|7|||
131543281|NCT01644734|473610582|FG000|Overall Study|Missing documentation|238|||
131543282|NCT05159622|473610583|FG000|Overall Study|Lost to Follow-up|4|||
131543283|NCT05159622|473610584|FG001|Overall Study|Lost to Follow-up|5|||
131543284|NCT03318523|473610585|FG000|PC Period: Up to Year 1|Adverse Event|1|||
131543285|NCT03318523|473610586|FG001|PC Period: Up to Year 1|Adverse Event|0|||
131543286|NCT03318523|473610587|FG002|PC Period: Up to Year 1|Adverse Event|2|||
131543287|NCT03318523|473610588|FG003|PC Period: Up to Year 1|Adverse Event|0|||
131543288|NCT03318523|473610589|FG004|PC Period: Up to Year 1|Adverse Event|0|||
131543289|NCT03318523|473610590|FG005|PC Period: Up to Year 1|Adverse Event|0|||
131543290|NCT03318523|473610591|FG006|PC Period: Up to Year 1|Adverse Event|0|||
131543291|NCT03318523|473610592|FG007|PC Period: Up to Year 1|Adverse Event|0|||
131543292|NCT03318523|473610593|FG008|PC Period: Up to Year 1|Adverse Event|0|||
131543293|NCT03318523|473610594|FG009|PC Period: Up to Year 1|Adverse Event|0|||
131543294|NCT03318523|473610585|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
131543295|NCT03318523|473610586|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
131543296|NCT03318523|473610587|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543297|NCT03318523|473610588|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
131543298|NCT03318523|473610589|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543299|NCT03318523|473610590|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543300|NCT03318523|473610591|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543301|NCT03318523|473610592|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543302|NCT03318523|473610593|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543303|NCT03318523|473610594|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
131543304|NCT03318523|473610585|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543305|NCT03318523|473610586|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543306|NCT03318523|473610587|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543307|NCT03318523|473610588|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543308|NCT03318523|473610589|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
131543309|NCT03318523|473610590|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543310|NCT03318523|473610591|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543311|NCT03318523|473610592|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
131543312|NCT03318523|473610593|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
131543313|NCT03318523|473610594|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
131543314|NCT03318523|473610585|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
131543315|NCT03318523|473610586|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
131543316|NCT03318523|473610587|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
131543317|NCT03318523|473610588|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
131543318|NCT03318523|473610589|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
131543319|NCT03318523|473610590|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
131543320|NCT03318523|473610591|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
131543321|NCT03318523|473610592|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
131543322|NCT03318523|473610593|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
131543323|NCT03318523|473610594|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
131543324|NCT03318523|473610585|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543325|NCT03318523|473610586|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543326|NCT03318523|473610587|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543327|NCT03318523|473610588|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543328|NCT03318523|473610589|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543329|NCT03318523|473610590|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
131543330|NCT03318523|473610591|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543331|NCT03318523|473610592|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543332|NCT03318523|473610593|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543333|NCT03318523|473610594|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
131543334|NCT03318523|473610585|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543335|NCT03318523|473610586|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543336|NCT03318523|473610587|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543337|NCT03318523|473610588|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543338|NCT03318523|473610589|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543339|NCT03318523|473610590|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543340|NCT03318523|473610591|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543341|NCT03318523|473610592|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543342|NCT03318523|473610593|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
131543343|NCT03318523|473610594|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
131543344|NCT03318523|473610585|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
131543345|NCT03318523|473610586|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
131543346|NCT03318523|473610587|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
131543347|NCT03318523|473610588|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
131543348|NCT03318523|473610589|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
131543349|NCT03318523|473610590|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
131543350|NCT03318523|473610591|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
131543351|NCT03318523|473610592|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
131543352|NCT03318523|473610593|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
131543353|NCT03318523|473610594|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
131543354|NCT03318523|473610585|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543355|NCT03318523|473610586|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543356|NCT03318523|473610587|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543357|NCT03318523|473610588|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543358|NCT03318523|473610589|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
131543359|NCT03318523|473610590|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543360|NCT03318523|473610591|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543361|NCT03318523|473610592|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
131543362|NCT03318523|473610593|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
131543363|NCT03318523|473610594|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131543364|NCT03581981|473610598|FG000|Overall Study|Withdrawal by Subject|12|||
131543365|NCT03581981|473610599|FG001|Overall Study|Withdrawal by Subject|13|||
131543366|NCT03581981|473610598|FG000|Overall Study|Physician Decision|1|||
131543367|NCT03581981|473610599|FG001|Overall Study|Physician Decision|2|||
131543368|NCT03581981|473610598|FG000|Overall Study|Lost to Follow-up|0|||
131543369|NCT03581981|473610599|FG001|Overall Study|Lost to Follow-up|4|||
131543370|NCT01410474|473610600|FG000|Overall Study|Withdrawal by Subject|0|||
131543371|NCT01410474|473610601|FG001|Overall Study|Withdrawal by Subject|1|||
131543372|NCT00828984|473610603|FG000|Overall Study|Adverse Event|2|||
131543373|NCT00828984|473610604|FG001|Overall Study|Adverse Event|3|||
131543374|NCT00828984|473610605|FG002|Overall Study|Adverse Event|0|||
131543375|NCT00828984|473610603|FG000|Overall Study|Lost to Follow-up|5|||
131543376|NCT00828984|473610604|FG001|Overall Study|Lost to Follow-up|3|||
131543377|NCT00828984|473610605|FG002|Overall Study|Lost to Follow-up|1|||
131543378|NCT00828984|473610603|FG000|Overall Study|Withdrawal by Subject|4|||
131543379|NCT00828984|473610604|FG001|Overall Study|Withdrawal by Subject|4|||
131543380|NCT00828984|473610605|FG002|Overall Study|Withdrawal by Subject|4|||
131543381|NCT00828984|473610603|FG000|Overall Study|Ineligable|1|||
131543382|NCT00828984|473610604|FG001|Overall Study|Ineligable|2|||
131543383|NCT00828984|473610605|FG002|Overall Study|Ineligable|0|||
131543384|NCT00828984|473610603|FG000|Overall Study|Medical Contraindication|0|||
131543385|NCT00828984|473610604|FG001|Overall Study|Medical Contraindication|1|||
131543386|NCT00828984|473610605|FG002|Overall Study|Medical Contraindication|0|||
131543387|NCT00828984|473610603|FG000|Overall Study|Noncompliant|1|||
131543388|NCT00828984|473610604|FG001|Overall Study|Noncompliant|2|||
131543389|NCT00828984|473610605|FG002|Overall Study|Noncompliant|3|||
131543390|NCT00828984|473610603|FG000|Overall Study|ConMed|1|||
131543391|NCT00828984|473610604|FG001|Overall Study|ConMed|1|||
131543392|NCT00828984|473610605|FG002|Overall Study|ConMed|1|||
131543393|NCT00863655|473610609|FG000|Overall Study|Protocol Violation|4|||
131543394|NCT00863655|473610610|FG001|Overall Study|Protocol Violation|0|||
131543395|NCT00863655|473610609|FG000|Overall Study|Adverse Event|52|||
131543396|NCT00863655|473610610|FG001|Overall Study|Adverse Event|8|||
131543397|NCT00863655|473610609|FG000|Overall Study|Withdrawal by Subject|47|||
131543398|NCT00863655|473610610|FG001|Overall Study|Withdrawal by Subject|7|||
131543399|NCT00863655|473610609|FG000|Overall Study|Administrative problems|1|||
131543400|NCT00863655|473610610|FG001|Overall Study|Administrative problems|0|||
131543401|NCT00863655|473610609|FG000|Overall Study|Death|7|||
131543402|NCT00863655|473610610|FG001|Overall Study|Death|1|||
131543403|NCT00863655|473610609|FG000|Overall Study|New cancer therapy|5|||
131543404|NCT00863655|473610610|FG001|Overall Study|New cancer therapy|1|||
131543405|NCT00863655|473610609|FG000|Overall Study|Disease progression|364|||
131543406|NCT00863655|473610610|FG001|Overall Study|Disease progression|221|||
131543407|NCT00863655|473610609|FG000|Overall Study|Treatment completed as per protocol|5|||
131543408|NCT00863655|473610610|FG001|Overall Study|Treatment completed as per protocol|1|||
131543409|NCT02157779|473610613|FG000|Overall Study|Logistical|9|||
131543410|NCT02157779|473610614|FG001|Overall Study|Logistical|3|||
131543411|NCT02157779|473610613|FG000|Overall Study|Stopped attending, reason unknown|11|||
131543412|NCT02157779|473610614|FG001|Overall Study|Stopped attending, reason unknown|7|||
131543413|NCT02157779|473610613|FG000|Overall Study|No response to outreach after Baseline|1|||
131543414|NCT02157779|473610614|FG001|Overall Study|No response to outreach after Baseline|1|||
131543415|NCT02157779|473610613|FG000|Overall Study|Moved|1|||
131543416|NCT02157779|473610614|FG001|Overall Study|Moved|0|||
131543417|NCT02157779|473610613|FG000|Overall Study|Medical|1|||
131543418|NCT02157779|473610614|FG001|Overall Study|Medical|0|||
131543419|NCT02157779|473610613|FG000|Overall Study|Legal issue|1|||
131543420|NCT02157779|473610614|FG001|Overall Study|Legal issue|0|||
131543421|NCT00002558|473610618|FG000|Overall Study|Withdrawal by Subject|0|||
131543422|NCT00002558|473610619|FG001|Overall Study|Withdrawal by Subject|1|||
131543423|NCT02065336|473610620|FG000|Extension Phase|Study Terminated by Sponsor|0|||
131543424|NCT02065336|473610621|FG001|Extension Phase|Study Terminated by Sponsor|0|||
131543425|NCT02065336|473610622|FG002|Extension Phase|Study Terminated by Sponsor|0|||
131543426|NCT02065336|473610623|FG003|Extension Phase|Study Terminated by Sponsor|0|||
131543427|NCT02065336|473610624|FG004|Extension Phase|Study Terminated by Sponsor|0|||
131543428|NCT02065336|473610625|FG005|Extension Phase|Study Terminated by Sponsor|0|||
131543429|NCT02065336|473610626|FG006|Extension Phase|Study Terminated by Sponsor|0|||
131543430|NCT02065336|473610627|FG007|Extension Phase|Study Terminated by Sponsor|0|||
131543431|NCT02065336|473610628|FG008|Extension Phase|Study Terminated by Sponsor|2|||
131543432|NCT02065336|473610629|FG009|Extension Phase|Study Terminated by Sponsor|8|||
131543433|NCT00626028|473610630|FG000|Overall Study|Adverse Event|1|||
131543434|NCT00626028|473610631|FG001|Overall Study|Adverse Event|1|||
131543435|NCT00626028|473610630|FG000|Overall Study|Device Failure|0|||
131543436|NCT00626028|473610631|FG001|Overall Study|Device Failure|1|||
131543437|NCT00626028|473610630|FG000|Overall Study|Physician Decision|2|||
131543438|NCT00626028|473610631|FG001|Overall Study|Physician Decision|1|||
131543439|NCT00626028|473610630|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
131543440|NCT00626028|473610631|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
131543441|NCT00831779|473610633|FG000|Overall Study|Lost to Follow-up|1|||
131543442|NCT00831779|473610634|FG001|Overall Study|Lost to Follow-up|0|||
131543443|NCT00831779|473610633|FG000|Overall Study|No longer met criteria|0|||
131543444|NCT00831779|473610634|FG001|Overall Study|No longer met criteria|1|||
131543445|NCT02436330|473610635|FG000|Cohort 1|Lost to Follow-up|5|||
131543446|NCT02436330|473610636|FG001|Cohort 1|Lost to Follow-up|2|||
131543447|NCT02436330|473610635|FG000|Cohort 1|Withdrawal by Subject|0|||
131543448|NCT02436330|473610636|FG001|Cohort 1|Withdrawal by Subject|1|||
131543449|NCT02436330|473610635|FG000|Cohort 2|Lost to Follow-up|2|||
131543450|NCT02436330|473610636|FG001|Cohort 2|Lost to Follow-up|0|||
131543451|NCT02436330|473610635|FG000|Cohort 2|Withdrawal by Subject|2|||
131543452|NCT02436330|473610636|FG001|Cohort 2|Withdrawal by Subject|3|||
131543453|NCT02436330|473610635|FG000|Cohort 3|Lost to Follow-up|1|||
131543454|NCT02436330|473610636|FG001|Cohort 3|Lost to Follow-up|0|||
131543455|NCT02436330|473610635|FG000|Cohort 3|Withdrawal by Subject|4|||
131543456|NCT02436330|473610636|FG001|Cohort 3|Withdrawal by Subject|0|||
131543457|NCT02436330|473610635|FG000|Cohort 4|Lost to Follow-up|1|||
131543458|NCT02436330|473610636|FG001|Cohort 4|Lost to Follow-up|0|||
131543459|NCT02436330|473610635|FG000|Cohort 4|Withdrawal by Subject|1|||
131543460|NCT02436330|473610636|FG001|Cohort 4|Withdrawal by Subject|0|||
131543461|NCT02436330|473610635|FG000|Cohort 5|Lost to Follow-up|3|||
131543462|NCT02436330|473610636|FG001|Cohort 5|Lost to Follow-up|2|||
131543463|NCT02436330|473610635|FG000|Cohort 5|Withdrawal by Subject|3|||
131543464|NCT02436330|473610636|FG001|Cohort 5|Withdrawal by Subject|2|||
131543465|NCT02436330|473610635|FG000|Cohort 6|Lost to Follow-up|2|||
131543466|NCT02436330|473610636|FG001|Cohort 6|Lost to Follow-up|0|||
131543467|NCT02436330|473610635|FG000|Cohort 6|Withdrawal by Subject|1|||
131543468|NCT02436330|473610636|FG001|Cohort 6|Withdrawal by Subject|1|||
131543469|NCT01375114|473610638|FG000|Overall Study|Lost to Follow-up|1|||
131543470|NCT01375114|473610639|FG001|Overall Study|Lost to Follow-up|0|||
131543471|NCT01375114|473610640|FG002|Overall Study|Lost to Follow-up|1|||
131543472|NCT01375114|473610638|FG000|Overall Study|Disease Progression|3|||
131543473|NCT01375114|473610639|FG001|Overall Study|Disease Progression|2|||
131543474|NCT01375114|473610640|FG002|Overall Study|Disease Progression|2|||
131543475|NCT01375114|473610638|FG000|Overall Study|Patient Changed Mind|0|||
131543476|NCT01375114|473610639|FG001|Overall Study|Patient Changed Mind|0|||
131543477|NCT01375114|473610640|FG002|Overall Study|Patient Changed Mind|2|||
131543478|NCT01375114|473610638|FG000|Overall Study|Pruritus|0|||
131543479|NCT01375114|473610639|FG001|Overall Study|Pruritus|0|||
131543480|NCT01375114|473610640|FG002|Overall Study|Pruritus|1|||
131543481|NCT01375114|473610638|FG000|Overall Study|Restlessness|0|||
131543482|NCT01375114|473610639|FG001|Overall Study|Restlessness|0|||
131543483|NCT01375114|473610640|FG002|Overall Study|Restlessness|1|||
131543484|NCT01375114|473610638|FG000|Overall Study|Diarrhea|0|||
131543485|NCT01375114|473610639|FG001|Overall Study|Diarrhea|0|||
131543486|NCT01375114|473610640|FG002|Overall Study|Diarrhea|1|||
131543487|NCT01375114|473610638|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
131543488|NCT01375114|473610639|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
131543489|NCT01375114|473610640|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
131543490|NCT01375114|473610638|FG000|Overall Study|Nausea|0|||
131543491|NCT01375114|473610639|FG001|Overall Study|Nausea|1|||
131543492|NCT01375114|473610640|FG002|Overall Study|Nausea|0|||
131543493|NCT01375114|473610638|FG000|Overall Study|Increased AST/ALT|0|||
131543494|NCT01375114|473610639|FG001|Overall Study|Increased AST/ALT|1|||
131543495|NCT01375114|473610640|FG002|Overall Study|Increased AST/ALT|0|||
131543496|NCT01375114|473610638|FG000|Overall Study|Vaginal Hemorrhage|0|||
131543497|NCT01375114|473610639|FG001|Overall Study|Vaginal Hemorrhage|1|||
131543498|NCT01375114|473610640|FG002|Overall Study|Vaginal Hemorrhage|0|||
131543499|NCT01375114|473610638|FG000|Overall Study|Family problem|0|||
131543500|NCT01375114|473610639|FG001|Overall Study|Family problem|1|||
131543501|NCT01375114|473610640|FG002|Overall Study|Family problem|0|||
131543502|NCT01375114|473610638|FG000|Overall Study|Protocol Violation|2|||
131543503|NCT01375114|473610639|FG001|Overall Study|Protocol Violation|0|||
131543504|NCT01375114|473610640|FG002|Overall Study|Protocol Violation|0|||
131543505|NCT03575325|473610641|FG000|Overall Study|Death|1|||
131543506|NCT00162370|473610642|FG000|Efficacy Population|Lost to Follow-up|51|||
131543507|NCT04040751|473610643|FG000|Overall Study|Withdrawal by Subject|2|||
131543508|NCT04040751|473610644|FG001|Overall Study|Withdrawal by Subject|0|||
131543509|NCT04040751|473610645|FG002|Overall Study|Withdrawal by Subject|2|||
131543510|NCT04040751|473610646|FG003|Overall Study|Withdrawal by Subject|0|||
131543511|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
131543512|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
131543513|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|disease progression|58|||
131543514|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|disease progression|47|||
131543515|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|Death|3|||
131543516|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|Death|6|||
131543517|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
131543518|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
131543519|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
131543520|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
131543521|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
131543522|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
131543523|NCT02472964|473610647|FG000|Part 1 (up to Week 24)|Other|2|||
131543524|NCT02472964|473610648|FG001|Part 1 (up to Week 24)|Other|1|||
131543525|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
131543526|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
131543527|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
131543528|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
131543529|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Death|0|||
131543530|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Death|1|||
131543531|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
131543532|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
131543533|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
131543534|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
131543535|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
131543536|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
131543537|NCT02472964|473610647|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
131543538|NCT02472964|473610648|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
131543539|NCT01749982|473610649|FG000|Overall Study|Physician Decision|0|||
131543540|NCT01749982|473610650|FG001|Overall Study|Physician Decision|0|||
131543541|NCT01749982|473610651|FG002|Overall Study|Physician Decision|0|||
131543542|NCT01749982|473610652|FG003|Overall Study|Physician Decision|1|||
131543543|NCT01749982|473610649|FG000|Overall Study|Lost to Follow-up|0|||
131543544|NCT01749982|473610650|FG001|Overall Study|Lost to Follow-up|0|||
131543545|NCT01749982|473610651|FG002|Overall Study|Lost to Follow-up|0|||
131543546|NCT01749982|473610652|FG003|Overall Study|Lost to Follow-up|1|||
131543547|NCT01749982|473610649|FG000|Overall Study|Withdrawal by Subject|0|||
131543548|NCT01749982|473610650|FG001|Overall Study|Withdrawal by Subject|0|||
131543549|NCT01749982|473610651|FG002|Overall Study|Withdrawal by Subject|0|||
131543550|NCT01749982|473610652|FG003|Overall Study|Withdrawal by Subject|1|||
131543551|NCT01596582|473610653|FG000|Overall Study|Deemed ineligible after study visit|3|||
131543552|NCT01596582|473610654|FG001|Overall Study|Deemed ineligible after study visit|6|||
131543553|NCT01596582|473610653|FG000|Overall Study|Missing all outcome data|1|||
131543554|NCT01596582|473610654|FG001|Overall Study|Missing all outcome data|1|||
131543555|NCT03923933|473610659|FG000|Overall Study|Lost to Follow-up|1|||
131543556|NCT03923933|473610660|FG001|Overall Study|Lost to Follow-up|0|||
131543557|NCT03923933|473610659|FG000|Overall Study|Withdrawal by Subject|0|||
131543558|NCT03923933|473610660|FG001|Overall Study|Withdrawal by Subject|1|||
131543559|NCT00419263|473610661|FG000|Overall Study|Lost to Follow-up|2|||
131543560|NCT00419263|473610662|FG001|Overall Study|Lost to Follow-up|1|||
131543561|NCT00419263|473610663|FG002|Overall Study|Lost to Follow-up|1|||
131543562|NCT00419263|473610661|FG000|Overall Study|Randomized in Error, Not Treated|1|||
131543563|NCT00419263|473610662|FG001|Overall Study|Randomized in Error, Not Treated|1|||
131543564|NCT00419263|473610663|FG002|Overall Study|Randomized in Error, Not Treated|0|||
131543565|NCT00419263|473610661|FG000|Overall Study|Adverse Event|0|||
131543566|NCT00419263|473610662|FG001|Overall Study|Adverse Event|0|||
131543567|NCT00419263|473610663|FG002|Overall Study|Adverse Event|1|||
131543568|NCT00419263|473610661|FG000|Overall Study|Withdrawal by Subject|0|||
131543569|NCT00419263|473610662|FG001|Overall Study|Withdrawal by Subject|0|||
131543570|NCT00419263|473610663|FG002|Overall Study|Withdrawal by Subject|1|||
131543571|NCT00587964|473610664|FG000|Overall Study|Withdrawal by Subject|1|||
131543572|NCT00587964|473610664|FG000|Overall Study|Lost to Follow-up|1|||
131543573|NCT00587964|473610664|FG000|Overall Study|Patient found to be ineligible|1|||
131543574|NCT00587964|473610664|FG000|Overall Study|Patient did not receive intervention|5|||
131543575|NCT00587964|473610664|FG000|Overall Study|Progression of Disease|4|||
131543576|NCT00540124|473610665|FG000|Overall Study|Adverse Event|0|||
131543577|NCT00540124|473610666|FG001|Overall Study|Adverse Event|2|||
131543578|NCT00540124|473610667|FG002|Overall Study|Adverse Event|1|||
131543579|NCT00540124|473610665|FG000|Overall Study|Entry Criteria Not Met|2|||
131543580|NCT00540124|473610666|FG001|Overall Study|Entry Criteria Not Met|0|||
131543581|NCT00540124|473610667|FG002|Overall Study|Entry Criteria Not Met|0|||
131543582|NCT00540124|473610665|FG000|Overall Study|Lack of Efficacy|1|||
131543583|NCT00540124|473610666|FG001|Overall Study|Lack of Efficacy|0|||
131543584|NCT00540124|473610667|FG002|Overall Study|Lack of Efficacy|0|||
131543585|NCT00540124|473610665|FG000|Overall Study|Withdrawal by Subject|1|||
131543586|NCT00540124|473610666|FG001|Overall Study|Withdrawal by Subject|1|||
131543587|NCT00540124|473610667|FG002|Overall Study|Withdrawal by Subject|0|||
131543588|NCT01207102|473610674|FG000|Overall Study|Withdrawal by Subject|5|||
131543589|NCT01207102|473610674|FG000|Overall Study|Adverse Event|2|||
131543590|NCT01207102|473610674|FG000|Overall Study|progression|2|||
131543591|NCT01207102|473610674|FG000|Overall Study|Withdrawal by Treating Physician|1|||
131543592|NCT01777854|473610677|FG000|Overall Study|Physician Decision|3|||
131543593|NCT01777854|473610678|FG001|Overall Study|Physician Decision|3|||
131543594|NCT03649230|473610679|FG000|Overall Study|Adverse Event|12|||
131543595|NCT03649230|473610679|FG000|Overall Study|Death|8|||
131543596|NCT03649230|473610679|FG000|Overall Study|Withdrawal by Subject|6|||
131543597|NCT03649230|473610679|FG000|Overall Study|Physician Decision|5|||
131543598|NCT03649230|473610679|FG000|Overall Study|Disease progression|5|||
131543599|NCT03649230|473610679|FG000|Overall Study|Switched to non-HEC|5|||
131543600|NCT03649230|473610679|FG000|Overall Study|Chemotherapy discontinued|4|||
131543601|NCT03649230|473610679|FG000|Overall Study|Received only 3 HEC cycles|4|||
131543602|NCT03649230|473610679|FG000|Overall Study|Screen Failure|3|||
131543603|NCT03649230|473610679|FG000|Overall Study|Patient stopped treatment|2|||
131543604|NCT03649230|473610679|FG000|Overall Study|Protocol Violation|1|||
131543605|NCT03649230|473610679|FG000|Overall Study|Non-compliance|1|||
131543606|NCT03649230|473610679|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
131543607|NCT01693068|473610681|FG000|Randomization Period|On-study|2|||
131543608|NCT01693068|473610682|FG001|Randomization Period|On-study|5|||
131543609|NCT01693068|473610683|FG002|Randomization Period|On-study|0|||
131543610|NCT01693068|473610681|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
131543611|NCT01693068|473610682|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
131543612|NCT01693068|473610683|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
131543613|NCT03311373|473610690|FG000|Overall Study|Adverse Event|1|||
131543614|NCT03311373|473610690|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
131543615|NCT03311373|473610690|FG000|Overall Study|Lost to Follow-up|1|||
131543616|NCT03311373|473610690|FG000|Overall Study|Physician Decision|1|||
131543617|NCT03311373|473610690|FG000|Overall Study|Withdrawal by Subject|3|||
131543618|NCT01400503|473610694|FG000|Overall Study|Withdrawal by Subject|1|||
131543619|NCT01400503|473610694|FG000|Overall Study|Study Terminated by Sponsor|58|||
131543620|NCT01400503|473610694|FG000|Overall Study|Other|1|||
131543621|NCT00058123|473610695|FG000|Overall Study|Wrong histology|9|||
131543622|NCT00058123|473610695|FG000|Overall Study|Received >3 prior treatments|1|||
131543623|NCT01212770|473610696|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
131543624|NCT01212770|473610697|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
131543625|NCT01212770|473610698|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
131543626|NCT01212770|473610699|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131543627|NCT01212770|473610700|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131543628|NCT01212770|473610701|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131543629|NCT01212770|473610702|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131543630|NCT01212770|473610703|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131543631|NCT01212770|473610704|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131543632|NCT01212770|473610696|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
131543633|NCT01212770|473610697|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
131543634|NCT01212770|473610698|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
131543635|NCT01212770|473610699|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131543636|NCT01212770|473610700|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131543637|NCT01212770|473610701|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131543638|NCT01212770|473610702|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131543639|NCT01212770|473610703|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131543640|NCT01212770|473610704|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131543641|NCT01212770|473610696|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
131543642|NCT01212770|473610697|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
131543643|NCT01212770|473610698|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
131543644|NCT01212770|473610699|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131543645|NCT01212770|473610700|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131543646|NCT01212770|473610701|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131543647|NCT01212770|473610702|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131543648|NCT01212770|473610703|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131543649|NCT01212770|473610704|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131543650|NCT01212770|473610696|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131543651|NCT01212770|473610697|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543652|NCT01212770|473610698|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
131543653|NCT01212770|473610699|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543654|NCT01212770|473610700|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543655|NCT01212770|473610701|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543656|NCT01212770|473610702|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543657|NCT01212770|473610703|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543658|NCT01212770|473610704|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131543659|NCT01212770|473610696|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543660|NCT01212770|473610697|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543661|NCT01212770|473610698|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131543662|NCT01212770|473610699|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543663|NCT01212770|473610700|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543664|NCT01212770|473610701|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543665|NCT01212770|473610702|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543666|NCT01212770|473610703|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543667|NCT01212770|473610704|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131543668|NCT01212770|473610696|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
131543669|NCT01212770|473610697|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
131543670|NCT01212770|473610698|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
131543671|NCT01212770|473610699|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
131543672|NCT01212770|473610700|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
131543673|NCT01212770|473610701|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
131543674|NCT01212770|473610702|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
131543675|NCT01212770|473610703|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
131543676|NCT01212770|473610704|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
131543677|NCT01212770|473610696|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
131543678|NCT01212770|473610697|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
131543679|NCT01212770|473610698|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
131543680|NCT01212770|473610699|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
131543681|NCT01212770|473610700|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
131543682|NCT01212770|473610701|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
131543683|NCT01212770|473610702|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
131543684|NCT01212770|473610703|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
131543685|NCT01212770|473610704|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
131543686|NCT01212770|473610696|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
131543687|NCT01212770|473610697|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
131543688|NCT01212770|473610698|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
131543689|NCT01212770|473610699|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
131543690|NCT01212770|473610700|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
131543691|NCT01212770|473610701|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
131543692|NCT01212770|473610702|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
131543693|NCT01212770|473610703|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
131543694|NCT01212770|473610704|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
131543695|NCT01212770|473610696|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
131543696|NCT01212770|473610697|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
131543697|NCT01212770|473610698|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
131543698|NCT01212770|473610699|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
131543699|NCT01212770|473610700|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
131543700|NCT01212770|473610701|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
131543701|NCT01212770|473610702|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
131543702|NCT01212770|473610703|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
131543703|NCT01212770|473610704|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
131543704|NCT01212770|473610696|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543705|NCT01212770|473610697|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543706|NCT01212770|473610698|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
131543707|NCT01212770|473610699|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543708|NCT01212770|473610700|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543709|NCT01212770|473610701|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543710|NCT01212770|473610702|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543711|NCT01212770|473610703|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543712|NCT01212770|473610704|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
131543713|NCT01212770|473610696|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543714|NCT01212770|473610697|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543715|NCT01212770|473610698|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543716|NCT01212770|473610699|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
131543717|NCT01212770|473610700|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543718|NCT01212770|473610701|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543719|NCT01212770|473610702|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543720|NCT01212770|473610703|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543721|NCT01212770|473610704|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131543722|NCT01212770|473610696|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543723|NCT01212770|473610697|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543724|NCT01212770|473610698|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
131543725|NCT01212770|473610699|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
131543726|NCT01212770|473610700|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543727|NCT01212770|473610701|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543728|NCT01212770|473610702|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543729|NCT01212770|473610703|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543730|NCT01212770|473610704|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
131543731|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131543732|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
131543733|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
131543734|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131543735|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131543736|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131543737|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131543738|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131543739|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
131543740|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131543741|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
131543742|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
131543743|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131543744|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131543745|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131543746|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131543747|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
131543748|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
131543749|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543750|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
131543751|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543752|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543753|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543754|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543755|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543756|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543757|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
131543758|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131543759|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
131543760|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
131543761|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131543762|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131543763|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131543764|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131543765|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
131543766|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
131543767|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
131543768|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
131543769|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
131543770|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
131543771|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
131543772|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
131543773|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
131543774|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
131543775|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
131543776|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131543777|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
131543778|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131543779|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131543780|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131543781|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131543782|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131543783|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131543784|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131543785|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131543786|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
131543787|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
131543788|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131543789|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131543790|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131543791|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131543792|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
131543793|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
131543794|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131543795|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
131543796|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
131543797|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131543798|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131543799|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131543800|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131543801|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
131543802|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
131543803|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131543804|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
131543805|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
131543806|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131543807|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131543808|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131543809|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131543810|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131543811|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131543812|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543813|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
131543814|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543815|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543816|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543817|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543818|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543819|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543820|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131543821|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543822|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543823|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543824|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543825|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543826|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543827|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543828|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
131543829|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
131543830|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131543831|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
131543832|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131543833|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131543834|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131543835|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131543836|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131543837|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131543838|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131543839|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131543840|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
131543841|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
131543842|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131543843|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131543844|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131543845|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131543846|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131543847|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
131543848|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131543849|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
131543850|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
131543851|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131543852|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131543853|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131543854|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131543855|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
131543856|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131543857|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
131543858|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
131543859|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
131543860|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
131543861|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
131543862|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
131543863|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
131543864|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
131543865|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
131543866|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543867|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
131543868|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
131543869|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543870|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543871|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543872|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543873|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543874|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131543875|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543876|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543877|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
131543878|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543879|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543880|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543881|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543882|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543883|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131543884|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543885|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
131543886|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543887|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543888|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543889|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543890|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543891|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131543892|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
131543893|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
131543894|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
131543895|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
131543896|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
131543897|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
131543898|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
131543899|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
131543900|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
131543901|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
131543902|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543903|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543904|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
131543905|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543906|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543907|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543908|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543909|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543910|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131543911|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543912|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543913|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
131543914|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543915|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543916|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543917|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543918|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131543919|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131543920|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543921|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543922|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
131543923|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543924|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543925|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543926|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543927|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543928|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131543929|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131543930|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
131543931|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131543932|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131543933|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131543934|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131543935|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131543936|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131543937|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131543938|NCT01212770|473610696|FG000|Long-term Safety Phase (Year 5)|Death|0|||
131543939|NCT01212770|473610697|FG001|Long-term Safety Phase (Year 5)|Death|0|||
131543940|NCT01212770|473610698|FG002|Long-term Safety Phase (Year 5)|Death|0|||
131543941|NCT01212770|473610699|FG003|Long-term Safety Phase (Year 5)|Death|0|||
131543942|NCT01212770|473610700|FG004|Long-term Safety Phase (Year 5)|Death|0|||
131543943|NCT01212770|473610701|FG005|Long-term Safety Phase (Year 5)|Death|0|||
131543944|NCT01212770|473610702|FG006|Long-term Safety Phase (Year 5)|Death|0|||
131543945|NCT01212770|473610703|FG007|Long-term Safety Phase (Year 5)|Death|1|||
131543946|NCT01212770|473610704|FG008|Long-term Safety Phase (Year 5)|Death|0|||
131543947|NCT00289887|473611991|FG000|Overall Study|Adverse Event|3|||
131543948|NCT00289887|473611992|FG001|Overall Study|Adverse Event|3|||
131543949|NCT00289887|473611991|FG000|Overall Study|Lack of Efficacy|3|||
131543950|NCT00289887|473611992|FG001|Overall Study|Lack of Efficacy|11|||
131543951|NCT00289887|473611991|FG000|Overall Study|Lost to Follow-up|3|||
131543952|NCT00289887|473611992|FG001|Overall Study|Lost to Follow-up|3|||
131543953|NCT00289887|473611991|FG000|Overall Study|Protocol Violation|3|||
131543954|NCT00289887|473611992|FG001|Overall Study|Protocol Violation|1|||
131543955|NCT00289887|473611991|FG000|Overall Study|Withdrawal by Subject|3|||
131543956|NCT00289887|473611992|FG001|Overall Study|Withdrawal by Subject|8|||
131543957|NCT00289887|473611991|FG000|Overall Study|Other|7|||
131543958|NCT00289887|473611992|FG001|Overall Study|Other|3|||
131543959|NCT00428090|473612001|FG000|Overall Study|Adverse Event|10|||
131543960|NCT00428090|473612002|FG001|Overall Study|Adverse Event|8|||
131543961|NCT00428090|473612003|FG002|Overall Study|Adverse Event|10|||
131543962|NCT00428090|473612004|FG003|Overall Study|Adverse Event|11|||
131543963|NCT00428090|473612001|FG000|Overall Study|Lost to Follow-up|3|||
131543964|NCT00428090|473612002|FG001|Overall Study|Lost to Follow-up|6|||
131543965|NCT00428090|473612003|FG002|Overall Study|Lost to Follow-up|1|||
131543966|NCT00428090|473612004|FG003|Overall Study|Lost to Follow-up|4|||
131543967|NCT00428090|473612001|FG000|Overall Study|Protocol Violation|3|||
131543968|NCT00428090|473612002|FG001|Overall Study|Protocol Violation|1|||
131543969|NCT00428090|473612003|FG002|Overall Study|Protocol Violation|3|||
131543970|NCT00428090|473612004|FG003|Overall Study|Protocol Violation|3|||
131543971|NCT00428090|473612001|FG000|Overall Study|Withdrawal by Subject|10|||
131543972|NCT00428090|473612002|FG001|Overall Study|Withdrawal by Subject|12|||
131543973|NCT00428090|473612003|FG002|Overall Study|Withdrawal by Subject|15|||
131543974|NCT00428090|473612004|FG003|Overall Study|Withdrawal by Subject|5|||
131543975|NCT00428090|473612001|FG000|Overall Study|Sponsor terminated study|0|||
131543976|NCT00428090|473612002|FG001|Overall Study|Sponsor terminated study|1|||
131543977|NCT00428090|473612003|FG002|Overall Study|Sponsor terminated study|0|||
131543978|NCT00428090|473612004|FG003|Overall Study|Sponsor terminated study|0|||
131543979|NCT00428090|473612001|FG000|Overall Study|Non-compliance|4|||
131543980|NCT00428090|473612002|FG001|Overall Study|Non-compliance|0|||
131543981|NCT00428090|473612003|FG002|Overall Study|Non-compliance|1|||
131543982|NCT00428090|473612004|FG003|Overall Study|Non-compliance|3|||
131543983|NCT00428090|473612001|FG000|Overall Study|Par. did not returned to visit|1|||
131543984|NCT00428090|473612002|FG001|Overall Study|Par. did not returned to visit|0|||
131543985|NCT00428090|473612003|FG002|Overall Study|Par. did not returned to visit|0|||
131543986|NCT00428090|473612004|FG003|Overall Study|Par. did not returned to visit|1|||
131543987|NCT00428090|473612001|FG000|Overall Study|Follow-Up visit not possible|1|||
131543988|NCT00428090|473612002|FG001|Overall Study|Follow-Up visit not possible|0|||
131543989|NCT00428090|473612003|FG002|Overall Study|Follow-Up visit not possible|0|||
131543990|NCT00428090|473612004|FG003|Overall Study|Follow-Up visit not possible|0|||
131543991|NCT00428090|473612001|FG000|Overall Study|Prohibited medication used for SAE|1|||
131543992|NCT00428090|473612002|FG001|Overall Study|Prohibited medication used for SAE|0|||
131543993|NCT00428090|473612003|FG002|Overall Study|Prohibited medication used for SAE|0|||
131543994|NCT00428090|473612004|FG003|Overall Study|Prohibited medication used for SAE|0|||
131543995|NCT00428090|473612001|FG000|Overall Study|Death of par.|1|||
131543996|NCT00428090|473612002|FG001|Overall Study|Death of par.|0|||
131543997|NCT00428090|473612003|FG002|Overall Study|Death of par.|1|||
131543998|NCT00428090|473612004|FG003|Overall Study|Death of par.|0|||
131543999|NCT00428090|473612001|FG000|Overall Study|Visit 7 exceed the visit window|0|||
131544000|NCT00428090|473612002|FG001|Overall Study|Visit 7 exceed the visit window|1|||
131544001|NCT00428090|473612003|FG002|Overall Study|Visit 7 exceed the visit window|0|||
131544002|NCT00428090|473612004|FG003|Overall Study|Visit 7 exceed the visit window|0|||
131544003|NCT00428090|473612001|FG000|Overall Study|Medical monitor terminated par.|0|||
131544004|NCT00428090|473612002|FG001|Overall Study|Medical monitor terminated par.|1|||
131544005|NCT00428090|473612003|FG002|Overall Study|Medical monitor terminated par.|0|||
131544006|NCT00428090|473612004|FG003|Overall Study|Medical monitor terminated par.|0|||
131544007|NCT00428090|473612001|FG000|Overall Study|Mental status of par. was|0|||
131544008|NCT00428090|473612002|FG001|Overall Study|Mental status of par. was|1|||
131544009|NCT00428090|473612003|FG002|Overall Study|Mental status of par. was|0|||
131544010|NCT00428090|473612004|FG003|Overall Study|Mental status of par. was|0|||
131544011|NCT00428090|473612001|FG000|Overall Study|Worsening of AD|0|||
131544012|NCT00428090|473612002|FG001|Overall Study|Worsening of AD|0|||
131544013|NCT00428090|473612003|FG002|Overall Study|Worsening of AD|1|||
131544014|NCT00428090|473612004|FG003|Overall Study|Worsening of AD|0|||
131544015|NCT00428090|473612001|FG000|Overall Study|Excluded for concerning QTc value|0|||
131544016|NCT00428090|473612002|FG001|Overall Study|Excluded for concerning QTc value|0|||
131544017|NCT00428090|473612003|FG002|Overall Study|Excluded for concerning QTc value|1|||
131544018|NCT00428090|473612004|FG003|Overall Study|Excluded for concerning QTc value|0|||
131544019|NCT00428090|473612001|FG000|Overall Study|Insufficient AD documentation|0|||
131544020|NCT00428090|473612002|FG001|Overall Study|Insufficient AD documentation|0|||
131544021|NCT00428090|473612003|FG002|Overall Study|Insufficient AD documentation|1|||
131544022|NCT00428090|473612004|FG003|Overall Study|Insufficient AD documentation|0|||
131544023|NCT00428090|473612001|FG000|Overall Study|High MMSE scores|0|||
131544024|NCT00428090|473612002|FG001|Overall Study|High MMSE scores|0|||
131544025|NCT00428090|473612003|FG002|Overall Study|High MMSE scores|1|||
131544026|NCT00428090|473612004|FG003|Overall Study|High MMSE scores|0|||
131544027|NCT00428090|473612001|FG000|Overall Study|Deterioration of cognitive status|0|||
131544028|NCT00428090|473612002|FG001|Overall Study|Deterioration of cognitive status|0|||
131544029|NCT00428090|473612003|FG002|Overall Study|Deterioration of cognitive status|1|||
131544030|NCT00428090|473612004|FG003|Overall Study|Deterioration of cognitive status|0|||
131544031|NCT00428090|473612001|FG000|Overall Study|Serious adverse event|0|||
131544032|NCT00428090|473612002|FG001|Overall Study|Serious adverse event|0|||
131544033|NCT00428090|473612003|FG002|Overall Study|Serious adverse event|1|||
131544034|NCT00428090|473612004|FG003|Overall Study|Serious adverse event|0|||
131544035|NCT00428090|473612001|FG000|Overall Study|Excluded for heart insufficiency|0|||
131544036|NCT00428090|473612002|FG001|Overall Study|Excluded for heart insufficiency|0|||
131544037|NCT00428090|473612003|FG002|Overall Study|Excluded for heart insufficiency|1|||
131544038|NCT00428090|473612004|FG003|Overall Study|Excluded for heart insufficiency|0|||
131544039|NCT00428090|473612001|FG000|Overall Study|Raised Creatinine Value|0|||
131544040|NCT00428090|473612002|FG001|Overall Study|Raised Creatinine Value|0|||
131544041|NCT00428090|473612003|FG002|Overall Study|Raised Creatinine Value|0|||
131544042|NCT00428090|473612004|FG003|Overall Study|Raised Creatinine Value|1|||
131544043|NCT03409666|473612005|FG000|Overall Study|Physician Decision|0|||
131544044|NCT03409666|473612006|FG001|Overall Study|Physician Decision|1|||
131544045|NCT03409666|473612005|FG000|Overall Study|Protocol Violation|0|||
131544046|NCT03409666|473612006|FG001|Overall Study|Protocol Violation|3|||
131544047|NCT00512148|473612010|FG000|Primay Study Period|Withdrawal by Subject|1|||
131544048|NCT00677833|473612011|FG000|Overall Study|Withdrawal by Subject|4|||
131544049|NCT00677833|473612012|FG001|Overall Study|Withdrawal by Subject|0|||
131544050|NCT00677833|473612013|FG002|Overall Study|Withdrawal by Subject|1|||
131544051|NCT00677833|473612014|FG003|Overall Study|Withdrawal by Subject|3|||
131544052|NCT00677833|473612011|FG000|Overall Study|Lost to Follow-up|0|||
131544053|NCT00677833|473612012|FG001|Overall Study|Lost to Follow-up|0|||
131544054|NCT00677833|473612013|FG002|Overall Study|Lost to Follow-up|1|||
131544055|NCT00677833|473612014|FG003|Overall Study|Lost to Follow-up|0|||
131544056|NCT02690974|473612017|FG000|Overall Study|Adverse Event|16|||
131544057|NCT02690974|473612017|FG000|Overall Study|Death|9|||
131544058|NCT02690974|473612017|FG000|Overall Study|Subject/guardian decision|4|||
131544059|NCT02690974|473612017|FG000|Overall Study|Lost to Follow-up|3|||
131544060|NCT02690974|473612017|FG000|Overall Study|Withdrawal of Informed Consent|3|||
131544061|NCT02690974|473612017|FG000|Overall Study|Physician Decision|2|||
131544062|NCT02690974|473612017|FG000|Overall Study|Non-compliance with study treatment|1|||
131544063|NCT02690974|473612017|FG000|Overall Study|Protocol-defined stopping criteria|1|||
131544064|NCT02690974|473612017|FG000|Overall Study|Protocol Deviation|1|||
131544065|NCT01666951|473612022|FG000|Overall Study|Not dosed|1|||
131544066|NCT01666951|473612023|FG001|Overall Study|Not dosed|1|||
131544067|NCT00522301|473612024|FG000|Overall Study|Withdrawal by Subject|1|||
131544068|NCT00522301|473612024|FG000|Overall Study|Adverse Event|5|||
131544069|NCT00337272|473612025|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
131544070|NCT00337272|473612026|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
131544071|NCT00337272|473612025|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
131544072|NCT00337272|473612026|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
131544073|NCT00337272|473612025|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
131544074|NCT00337272|473612026|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
131544075|NCT00337272|473612025|FG000|Treatment Period|Non-compliance|1|||
131544076|NCT00337272|473612026|FG001|Treatment Period|Non-compliance|1|||
131544077|NCT00337272|473612025|FG000|Treatment Period|Withdrawal by Subject|0|||
131544078|NCT00337272|473612026|FG001|Treatment Period|Withdrawal by Subject|1|||
131544079|NCT00337272|473612025|FG000|Withdrawal Period|Non-compliance|0|||
131544080|NCT00337272|473612026|FG001|Withdrawal Period|Non-compliance|1|||
131544081|NCT02366910|473612030|FG000|Overall Study|Withdrawal by Subject|2|||
131544082|NCT02366910|473612030|FG000|Overall Study|Screen Failure|3|||
131544083|NCT02623322|473612034|FG000|Overall Study|Lost to Follow-up|2|||
131544084|NCT02623322|473612035|FG001|Overall Study|Lost to Follow-up|1|||
131544085|NCT02623322|473612036|FG002|Overall Study|Lost to Follow-up|0|||
131544086|NCT03284788|473612037|FG000|Overall Study|Withdrawal by Subject|2|||
131544087|NCT03813238|473612044|FG000|Overall Study|Adverse Event|0|||
131544088|NCT03813238|473612045|FG001|Overall Study|Adverse Event|6|||
131544089|NCT03813238|473612044|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131544090|NCT03813238|473612045|FG001|Overall Study|Withdrawal by parent/guardian|2|||
131544091|NCT03813238|473612044|FG000|Overall Study|Lost to Follow-up|0|||
131544092|NCT03813238|473612045|FG001|Overall Study|Lost to Follow-up|1|||
131544093|NCT03813238|473612044|FG000|Overall Study|Other than specified|1|||
131544094|NCT03813238|473612045|FG001|Overall Study|Other than specified|2|||
131544095|NCT03338894|473612046|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
131544096|NCT04465357|473612047|FG000|Overall Study|Adverse Event|2|||
131544097|NCT04465357|473612047|FG000|Overall Study|Lack of Efficacy|1|||
131544098|NCT04465357|473612047|FG000|Overall Study|Lost to Follow-up|2|||
131544099|NCT04465357|473612047|FG000|Overall Study|Withdrawal by Subject|6|||
131544100|NCT04465357|473612047|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
131544101|NCT00420199|473612048|FG000|Overall Study|Participant no longer met study criteria|1|||
131544102|NCT00420199|473612049|FG001|Overall Study|Participant no longer met study criteria|0|||
131544103|NCT01239030|473612056|FG000|Double Blind|Adverse Event|0|||
131544104|NCT01239030|473612057|FG001|Double Blind|Adverse Event|1|||
131544105|NCT01239030|473612058|FG002|Double Blind|Adverse Event|0|||
131544106|NCT01239030|473612059|FG003|Double Blind|Adverse Event|2|||
131544107|NCT01239030|473612060|FG004|Double Blind|Adverse Event|0|||
131544108|NCT01239030|473612056|FG000|Double Blind|Withdrawal by Subject|0|||
131544109|NCT01239030|473612057|FG001|Double Blind|Withdrawal by Subject|1|||
131544110|NCT01239030|473612058|FG002|Double Blind|Withdrawal by Subject|1|||
131544111|NCT01239030|473612059|FG003|Double Blind|Withdrawal by Subject|0|||
131544112|NCT01239030|473612060|FG004|Double Blind|Withdrawal by Subject|1|||
131544113|NCT01239030|473612056|FG000|Double Blind|Lost to Follow-up|1|||
131544114|NCT01239030|473612057|FG001|Double Blind|Lost to Follow-up|1|||
131544115|NCT01239030|473612058|FG002|Double Blind|Lost to Follow-up|0|||
131544116|NCT01239030|473612059|FG003|Double Blind|Lost to Follow-up|0|||
131544117|NCT01239030|473612060|FG004|Double Blind|Lost to Follow-up|0|||
131544118|NCT01239030|473612056|FG000|Double Blind|Physician Decision|0|||
131544119|NCT01239030|473612057|FG001|Double Blind|Physician Decision|1|||
131544120|NCT01239030|473612058|FG002|Double Blind|Physician Decision|0|||
131544121|NCT01239030|473612059|FG003|Double Blind|Physician Decision|0|||
131544122|NCT01239030|473612060|FG004|Double Blind|Physician Decision|0|||
131544123|NCT01239030|473612056|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
131544124|NCT01239030|473612057|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
131544125|NCT01239030|473612058|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
131544126|NCT01239030|473612059|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
131544127|NCT01239030|473612060|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
131544128|NCT01239030|473612056|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
131544129|NCT01239030|473612057|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
131544130|NCT01239030|473612058|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
131544131|NCT01239030|473612059|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
131544132|NCT01239030|473612060|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
131544133|NCT01239030|473612056|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
131544134|NCT01239030|473612057|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
131544135|NCT01239030|473612058|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
131544136|NCT01239030|473612059|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
131544137|NCT01239030|473612060|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
131544138|NCT01239030|473612056|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
131544139|NCT01239030|473612057|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
131544140|NCT01239030|473612058|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
131544141|NCT01239030|473612059|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
131544142|NCT01239030|473612060|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
131544143|NCT00977665|473612061|FG000|Overall Study|Withdrawal by Subject|1|||
131544144|NCT00977665|473612062|FG001|Overall Study|Withdrawal by Subject|3|||
131544145|NCT00977665|473612061|FG000|Overall Study|Physician Decision|2|||
131544146|NCT00977665|473612062|FG001|Overall Study|Physician Decision|1|||
131544147|NCT00977665|473612061|FG000|Overall Study|Sponsor requested withdrawal|0|||
131544148|NCT00977665|473612062|FG001|Overall Study|Sponsor requested withdrawal|1|||
131544149|NCT00977665|473612061|FG000|Overall Study|Lost to Follow-up|1|||
131544150|NCT00977665|473612062|FG001|Overall Study|Lost to Follow-up|0|||
131544151|NCT00977665|473612061|FG000|Overall Study|Death|3|||
131544152|NCT00977665|473612062|FG001|Overall Study|Death|2|||
131544153|NCT00977665|473612061|FG000|Overall Study|Adverse Event|14|||
131544154|NCT00977665|473612062|FG001|Overall Study|Adverse Event|7|||
131544155|NCT00977665|473612061|FG000|Overall Study|Treatment failure|0|||
131544156|NCT00977665|473612062|FG001|Overall Study|Treatment failure|1|||
131544157|NCT02085252|473612081|FG000|Overall Study|Withdrawal of Consent|1|||
131544158|NCT02085252|473612082|FG001|Overall Study|Withdrawal of Consent|0|||
131544159|NCT02085252|473612081|FG000|Overall Study|Adverse Event|0|||
131544160|NCT02085252|473612082|FG001|Overall Study|Adverse Event|1|||
131544161|NCT02085252|473612081|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
131544162|NCT02085252|473612082|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
131544163|NCT02085252|473612081|FG000|Overall Study|Reason Not Specified|0|||
131544164|NCT02085252|473612082|FG001|Overall Study|Reason Not Specified|1|||
131544165|NCT02085252|473612081|FG000|Overall Study|Reason Unknown|0|||
131544166|NCT02085252|473612082|FG001|Overall Study|Reason Unknown|1|||
131544167|NCT02925676|473612084|FG000|Overall Study|Withdrawal by Subject|1|||
131544168|NCT03260868|473612088|FG000|Overall Study|Poor Compliance to Protocol|0|||
131544169|NCT03260868|473612089|FG001|Overall Study|Poor Compliance to Protocol|2|||
131544170|NCT03260868|473612088|FG000|Overall Study|Study Terminated By Sponsor|2|||
131544171|NCT03260868|473612089|FG001|Overall Study|Study Terminated By Sponsor|1|||
131544172|NCT03260868|473612088|FG000|Overall Study|Other than specified above|1|||
131544173|NCT03260868|473612089|FG001|Overall Study|Other than specified above|0|||
131544174|NCT01298999|473612090|FG000|Overall Study|Physician Decision|0|||
131544175|NCT01298999|473612091|FG001|Overall Study|Physician Decision|1|||
131544176|NCT01298999|473612090|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
131544177|NCT01298999|473612091|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
131544178|NCT00541450|473612092|FG000|Phase A|Adverse Event|3|||
131544179|NCT00541450|473612093|FG001|Phase A|Adverse Event|0|||
131544180|NCT00541450|473612092|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
131544181|NCT00541450|473612093|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
131544182|NCT00541450|473612092|FG000|Phase A|Hyperglycemia|0|||
131544183|NCT00541450|473612093|FG001|Phase A|Hyperglycemia|1|||
131544184|NCT00541450|473612092|FG000|Phase A|Lost to Follow-up|6|||
131544185|NCT00541450|473612093|FG001|Phase A|Lost to Follow-up|4|||
131544186|NCT00541450|473612092|FG000|Phase A|Physician Decision|2|||
131544187|NCT00541450|473612093|FG001|Phase A|Physician Decision|0|||
131544188|NCT00541450|473612092|FG000|Phase A|Protocol Violation|2|||
131544189|NCT00541450|473612093|FG001|Phase A|Protocol Violation|3|||
131544190|NCT00541450|473612092|FG000|Phase A|Withdrawal by Subject|7|||
131544191|NCT00541450|473612093|FG001|Phase A|Withdrawal by Subject|7|||
131544192|NCT00541450|473612092|FG000|Phase B|Adverse Event|6|||
131544193|NCT00541450|473612093|FG001|Phase B|Adverse Event|6|||
131544194|NCT00541450|473612092|FG000|Phase B|Hyperglycemia|10|||
131544195|NCT00541450|473612093|FG001|Phase B|Hyperglycemia|9|||
131544196|NCT00541450|473612092|FG000|Phase B|Lost to Follow-up|6|||
131544197|NCT00541450|473612093|FG001|Phase B|Lost to Follow-up|4|||
131544198|NCT00541450|473612092|FG000|Phase B|Physician Decision|4|||
131544199|NCT00541450|473612093|FG001|Phase B|Physician Decision|2|||
131544200|NCT00541450|473612092|FG000|Phase B|Pregnancy|0|||
131544201|NCT00541450|473612093|FG001|Phase B|Pregnancy|1|||
131544202|NCT00541450|473612092|FG000|Phase B|Protocol Violation|3|||
131544203|NCT00541450|473612093|FG001|Phase B|Protocol Violation|3|||
131544204|NCT00541450|473612092|FG000|Phase B|Withdrawal by Subject|8|||
131544205|NCT00541450|473612093|FG001|Phase B|Withdrawal by Subject|6|||
131544206|NCT02151266|473612094|FG000|Overall Study|Lost to Follow-up|1|||
131544207|NCT02151266|473612095|FG001|Overall Study|Lost to Follow-up|4|||
131544208|NCT02151266|473612096|FG002|Overall Study|Lost to Follow-up|1|||
131544209|NCT02151266|473612094|FG000|Overall Study|Did NOT receive intervention|3|||
131544210|NCT02151266|473612095|FG001|Overall Study|Did NOT receive intervention|6|||
131544211|NCT02151266|473612096|FG002|Overall Study|Did NOT receive intervention|2|||
131544212|NCT02151266|473612094|FG000|Overall Study|Not able to exercise|4|||
131544213|NCT02151266|473612095|FG001|Overall Study|Not able to exercise|5|||
131544214|NCT02151266|473612096|FG002|Overall Study|Not able to exercise|4|||
131544215|NCT00803452|473612097|FG000|Overall Study|Adverse Event|0|||
131544216|NCT00803452|473612098|FG001|Overall Study|Adverse Event|2|||
131544217|NCT00803452|473612097|FG000|Overall Study|Lost to Follow-up|0|||
131544218|NCT00803452|473612098|FG001|Overall Study|Lost to Follow-up|3|||
131544219|NCT02816138|473612102|FG000|Overall Study|Adverse Event|1|||
131544220|NCT02291679|473612103|FG000|Overall Study|Adverse Event|2|||
131544221|NCT02291679|473612104|FG001|Overall Study|Adverse Event|12|||
131544222|NCT02291679|473612105|FG002|Overall Study|Adverse Event|19|||
131544223|NCT02291679|473612103|FG000|Overall Study|Protocol Violation|5|||
131544224|NCT02291679|473612104|FG001|Overall Study|Protocol Violation|1|||
131544225|NCT02291679|473612105|FG002|Overall Study|Protocol Violation|7|||
131544226|NCT02291679|473612103|FG000|Overall Study|Withdrew Consent|18|||
131544227|NCT02291679|473612104|FG001|Overall Study|Withdrew Consent|10|||
131544228|NCT02291679|473612105|FG002|Overall Study|Withdrew Consent|15|||
131544229|NCT02291679|473612103|FG000|Overall Study|Lost to Follow-up|12|||
131544230|NCT02291679|473612104|FG001|Overall Study|Lost to Follow-up|10|||
131544231|NCT02291679|473612105|FG002|Overall Study|Lost to Follow-up|9|||
131544232|NCT02291679|473612103|FG000|Overall Study|Insufficient Therapeutic Response|5|||
131544233|NCT02291679|473612104|FG001|Overall Study|Insufficient Therapeutic Response|5|||
131544234|NCT02291679|473612105|FG002|Overall Study|Insufficient Therapeutic Response|7|||
131544235|NCT02291679|473612103|FG000|Overall Study|Other|2|||
131544236|NCT02291679|473612104|FG001|Overall Study|Other|4|||
131544237|NCT02291679|473612105|FG002|Overall Study|Other|2|||
131544238|NCT00981084|473612106|FG000|Post Intervention (Data Analysis)|poor effort|1|||
131544239|NCT00981084|473612107|FG001|Post Intervention (Data Analysis)|poor effort|1|||
131544240|NCT00981084|473612106|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
131544241|NCT00981084|473612107|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
131544242|NCT00725296|473612108|FG000|Overall Study|Adverse Event|11|||
131544243|NCT00725296|473612108|FG000|Overall Study|Lack of Efficacy|7|||
131544244|NCT00725296|473612108|FG000|Overall Study|Withdrawal by Subject|3|||
131544245|NCT00725296|473612108|FG000|Overall Study|Non-Compliance|2|||
131544246|NCT00725296|473612108|FG000|Overall Study|Lost to Follow-up|1|||
131544247|NCT00725296|473612108|FG000|Overall Study|Other|38|||
131544248|NCT03360942|473612109|FG000|Overall Study|Device explanted|2|||
131544249|NCT03360942|473612109|FG000|Overall Study|Study closure|1|||
131544250|NCT03360942|473612109|FG000|Overall Study|Withdrawal by Subject|2|||
131544251|NCT05073133|473612110|FG000|Overall Study|Death|2|||
131544252|NCT00608582|473612114|FG000|Overall Study|Lost to Follow-up|2|||
131544253|NCT00608582|473612115|FG001|Overall Study|Lost to Follow-up|0|||
131544254|NCT00608582|473612114|FG000|Overall Study|No Best Response in Phase 1 located|1|||
131544255|NCT00608582|473612115|FG001|Overall Study|No Best Response in Phase 1 located|1|||
131544256|NCT00608582|473612114|FG000|Overall Study|Illicit Drug Use|1|||
131544257|NCT00608582|473612115|FG001|Overall Study|Illicit Drug Use|0|||
131544258|NCT00608582|473612114|FG000|Overall Study|Early stage Design Change|0|||
131544259|NCT00608582|473612115|FG001|Overall Study|Early stage Design Change|3|||
131544260|NCT01266850|473613580|FG000|Overall Study|Lost to Follow-up|19|||
131544261|NCT01266850|473613581|FG001|Overall Study|Lost to Follow-up|19|||
131544262|NCT01266850|473613582|FG002|Overall Study|Lost to Follow-up|13|||
131544263|NCT01266850|473613583|FG003|Overall Study|Lost to Follow-up|13|||
131544264|NCT01266850|473613584|FG004|Overall Study|Lost to Follow-up|12|||
131544265|NCT01266850|473613580|FG000|Overall Study|Withdrawal by Subject|8|||
131544266|NCT01266850|473613581|FG001|Overall Study|Withdrawal by Subject|9|||
131544267|NCT01266850|473613582|FG002|Overall Study|Withdrawal by Subject|6|||
131544268|NCT01266850|473613583|FG003|Overall Study|Withdrawal by Subject|9|||
131544269|NCT01266850|473613584|FG004|Overall Study|Withdrawal by Subject|12|||
131544270|NCT01266850|473613580|FG000|Overall Study|Physician Decision|3|||
131544271|NCT01266850|473613581|FG001|Overall Study|Physician Decision|6|||
131544272|NCT01266850|473613582|FG002|Overall Study|Physician Decision|4|||
131544273|NCT01266850|473613583|FG003|Overall Study|Physician Decision|4|||
131544274|NCT01266850|473613584|FG004|Overall Study|Physician Decision|3|||
131544275|NCT01266850|473613580|FG000|Overall Study|Protocol Violation|0|||
131544276|NCT01266850|473613581|FG001|Overall Study|Protocol Violation|1|||
131544277|NCT01266850|473613582|FG002|Overall Study|Protocol Violation|0|||
131544278|NCT01266850|473613583|FG003|Overall Study|Protocol Violation|1|||
131544279|NCT01266850|473613584|FG004|Overall Study|Protocol Violation|2|||
131544280|NCT01266850|473613580|FG000|Overall Study|Adverse Event|0|||
131544281|NCT01266850|473613581|FG001|Overall Study|Adverse Event|0|||
131544282|NCT01266850|473613582|FG002|Overall Study|Adverse Event|0|||
131544283|NCT01266850|473613583|FG003|Overall Study|Adverse Event|0|||
131544284|NCT01266850|473613584|FG004|Overall Study|Adverse Event|1|||
131544285|NCT01266850|473613580|FG000|Overall Study|Site Closure|0|||
131544286|NCT01266850|473613581|FG001|Overall Study|Site Closure|1|||
131544287|NCT01266850|473613582|FG002|Overall Study|Site Closure|1|||
131544288|NCT01266850|473613583|FG003|Overall Study|Site Closure|1|||
131544289|NCT01266850|473613584|FG004|Overall Study|Site Closure|0|||
131544290|NCT00437645|473613585|FG000|Overall Study|Adverse Event|15|||
131544291|NCT00437645|473613586|FG001|Overall Study|Adverse Event|84|||
131544292|NCT00437645|473613585|FG000|Overall Study|Withdrawal by Subject|10|||
131544293|NCT00437645|473613586|FG001|Overall Study|Withdrawal by Subject|22|||
131544294|NCT00437645|473613585|FG000|Overall Study|Protocol Violation|3|||
131544295|NCT00437645|473613586|FG001|Overall Study|Protocol Violation|3|||
131544296|NCT00437645|473613585|FG000|Overall Study|Lost to Follow-up|2|||
131544297|NCT00437645|473613586|FG001|Overall Study|Lost to Follow-up|3|||
131544298|NCT00437645|473613585|FG000|Overall Study|Administrative problems|2|||
131544299|NCT00437645|473613586|FG001|Overall Study|Administrative problems|1|||
131544300|NCT00437645|473613585|FG000|Overall Study|Lack of Efficacy|2|||
131544301|NCT00437645|473613586|FG001|Overall Study|Lack of Efficacy|1|||
131544302|NCT00437645|473613585|FG000|Overall Study|Condition no longer requires study drug|1|||
131544303|NCT00437645|473613586|FG001|Overall Study|Condition no longer requires study drug|1|||
131544304|NCT03751631|473613590|FG000|Overall Study|Withdrawal by Subject|0|||
131544305|NCT03751631|473613591|FG001|Overall Study|Withdrawal by Subject|0|||
131544306|NCT03751631|473613592|FG002|Overall Study|Withdrawal by Subject|1|||
131544307|NCT03751631|473613593|FG003|Overall Study|Withdrawal by Subject|1|||
131544308|NCT03751631|473613594|FG004|Overall Study|Withdrawal by Subject|0|||
131544309|NCT03751631|473613595|FG005|Overall Study|Withdrawal by Subject|0|||
131544310|NCT03382782|473613597|FG000|Cohort 1|Withdrawal by Subject|11|||
131544311|NCT03382782|473613598|FG001|Cohort 1|Withdrawal by Subject|5|||
131544312|NCT03382782|473613599|FG002|Cohort 1|Withdrawal by Subject|0|||
131544313|NCT03382782|473613597|FG000|Cohort 2|Withdrawal by Subject|1|||
131544314|NCT03382782|473613598|FG001|Cohort 2|Withdrawal by Subject|1|||
131544315|NCT03382782|473613599|FG002|Cohort 2|Withdrawal by Subject|0|||
131544316|NCT03382782|473613597|FG000|Cohort 3|Withdrawal by Subject|1|||
131544317|NCT03382782|473613598|FG001|Cohort 3|Withdrawal by Subject|2|||
131544318|NCT03382782|473613599|FG002|Cohort 3|Withdrawal by Subject|0|||
131544319|NCT01791725|473613600|FG000|Overall Study|Withdrawal by Subject|0|||
131544320|NCT01791725|473613601|FG001|Overall Study|Withdrawal by Subject|1|||
131544321|NCT01791725|473613602|FG002|Overall Study|Withdrawal by Subject|0|||
131544322|NCT03255824|473613603|FG000|Overall Study|Under-sedation|2|||
131544323|NCT03255824|473613604|FG001|Overall Study|Under-sedation|1|||
131544324|NCT02001194|473613606|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
131544325|NCT02001194|473613607|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
131544326|NCT02001194|473613608|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
131544327|NCT02001194|473613609|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
131544328|NCT02001194|473613606|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
131544329|NCT02001194|473613607|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
131658605|NCT02003222|474035396|FG001|Induction|Alternative therapy|0|||
131544330|NCT02001194|473613608|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
131544331|NCT02001194|473613609|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
131544332|NCT03320018|473613613|FG000|Treatment Period|Withdrawal by Subject|1|||
131544333|NCT03320018|473613614|FG001|Treatment Period|Withdrawal by Subject|0|||
131544334|NCT03320018|473613613|FG000|Day 90 Follow up|Death|0|||
131544335|NCT03320018|473613614|FG001|Day 90 Follow up|Death|1|||
131544336|NCT03205371|473613622|FG000|Overall Study|Withdrawal by Subject|4|||
131544337|NCT03205371|473613623|FG001|Overall Study|Withdrawal by Subject|1|||
131544338|NCT03205371|473613624|FG002|Overall Study|Withdrawal by Subject|0|||
131544339|NCT03205371|473613625|FG003|Overall Study|Withdrawal by Subject|0|||
131544340|NCT03205371|473613626|FG004|Overall Study|Withdrawal by Subject|0|||
131544341|NCT03205371|473613627|FG005|Overall Study|Withdrawal by Subject|0|||
131544342|NCT03205371|473613628|FG006|Overall Study|Withdrawal by Subject|4|||
131544343|NCT03205371|473613629|FG007|Overall Study|Withdrawal by Subject|0|||
131544344|NCT03205371|473613630|FG008|Overall Study|Withdrawal by Subject|2|||
131544345|NCT03205371|473613631|FG009|Overall Study|Withdrawal by Subject|0|||
131544346|NCT03205371|473613632|FG010|Overall Study|Withdrawal by Subject|0|||
131544347|NCT03205371|473613633|FG011|Overall Study|Withdrawal by Subject|1|||
131544348|NCT03205371|473613622|FG000|Overall Study|Lost to Follow-up|0|||
131544349|NCT03205371|473613623|FG001|Overall Study|Lost to Follow-up|0|||
131544350|NCT03205371|473613624|FG002|Overall Study|Lost to Follow-up|0|||
131544351|NCT03205371|473613625|FG003|Overall Study|Lost to Follow-up|0|||
131544352|NCT03205371|473613626|FG004|Overall Study|Lost to Follow-up|0|||
131544353|NCT03205371|473613627|FG005|Overall Study|Lost to Follow-up|0|||
131544354|NCT03205371|473613628|FG006|Overall Study|Lost to Follow-up|5|||
131544355|NCT03205371|473613629|FG007|Overall Study|Lost to Follow-up|2|||
131544356|NCT03205371|473613630|FG008|Overall Study|Lost to Follow-up|3|||
131544357|NCT03205371|473613631|FG009|Overall Study|Lost to Follow-up|0|||
131544358|NCT03205371|473613632|FG010|Overall Study|Lost to Follow-up|0|||
131544359|NCT03205371|473613633|FG011|Overall Study|Lost to Follow-up|0|||
131544360|NCT03205371|473613622|FG000|Overall Study|Protocol Violation|0|||
131544361|NCT03205371|473613623|FG001|Overall Study|Protocol Violation|0|||
131544362|NCT03205371|473613624|FG002|Overall Study|Protocol Violation|0|||
131544363|NCT03205371|473613625|FG003|Overall Study|Protocol Violation|0|||
131544364|NCT03205371|473613626|FG004|Overall Study|Protocol Violation|0|||
131544365|NCT03205371|473613627|FG005|Overall Study|Protocol Violation|0|||
131544366|NCT03205371|473613628|FG006|Overall Study|Protocol Violation|1|||
131544367|NCT03205371|473613629|FG007|Overall Study|Protocol Violation|0|||
131544368|NCT03205371|473613630|FG008|Overall Study|Protocol Violation|0|||
131544369|NCT03205371|473613631|FG009|Overall Study|Protocol Violation|0|||
131544370|NCT03205371|473613632|FG010|Overall Study|Protocol Violation|0|||
131544371|NCT03205371|473613633|FG011|Overall Study|Protocol Violation|0|||
131544372|NCT03205371|473613622|FG000|Overall Study|Adverse Event|0|||
131544373|NCT03205371|473613623|FG001|Overall Study|Adverse Event|0|||
131544374|NCT03205371|473613624|FG002|Overall Study|Adverse Event|0|||
131544375|NCT03205371|473613625|FG003|Overall Study|Adverse Event|0|||
131544376|NCT03205371|473613626|FG004|Overall Study|Adverse Event|0|||
131544377|NCT03205371|473613627|FG005|Overall Study|Adverse Event|0|||
131544378|NCT03205371|473613628|FG006|Overall Study|Adverse Event|0|||
131544379|NCT03205371|473613629|FG007|Overall Study|Adverse Event|1|||
131544380|NCT03205371|473613630|FG008|Overall Study|Adverse Event|0|||
131544381|NCT03205371|473613631|FG009|Overall Study|Adverse Event|0|||
131544382|NCT03205371|473613632|FG010|Overall Study|Adverse Event|0|||
131544383|NCT03205371|473613633|FG011|Overall Study|Adverse Event|0|||
131544384|NCT02618967|473613635|FG000|Overall Study|Lost to Follow-up|0|||
131544385|NCT02618967|473613636|FG001|Overall Study|Lost to Follow-up|0|||
131544386|NCT02618967|473613637|FG002|Overall Study|Lost to Follow-up|1|||
131544387|NCT02618967|473613638|FG003|Overall Study|Lost to Follow-up|0|||
131544388|NCT02618967|473613639|FG004|Overall Study|Lost to Follow-up|2|||
131544389|NCT02618967|473613640|FG005|Overall Study|Lost to Follow-up|0|||
131544390|NCT02618967|473613641|FG006|Overall Study|Lost to Follow-up|0|||
131544391|NCT02618967|473613642|FG007|Overall Study|Lost to Follow-up|0|||
131544392|NCT02618967|473613635|FG000|Overall Study|Withdrawal by Subject|1|||
131544393|NCT02618967|473613636|FG001|Overall Study|Withdrawal by Subject|0|||
131544394|NCT02618967|473613637|FG002|Overall Study|Withdrawal by Subject|0|||
131544395|NCT02618967|473613638|FG003|Overall Study|Withdrawal by Subject|0|||
131544396|NCT02618967|473613639|FG004|Overall Study|Withdrawal by Subject|0|||
131544397|NCT02618967|473613640|FG005|Overall Study|Withdrawal by Subject|0|||
131544398|NCT02618967|473613641|FG006|Overall Study|Withdrawal by Subject|0|||
131544399|NCT02618967|473613642|FG007|Overall Study|Withdrawal by Subject|0|||
131544400|NCT02612311|473613643|FG000|Overall Study|Adverse Event|16|||
131544401|NCT02612311|473613644|FG001|Overall Study|Adverse Event|12|||
131544402|NCT02612311|473613645|FG002|Overall Study|Adverse Event|7|||
131544403|NCT02612311|473613646|FG003|Overall Study|Adverse Event|13|||
131544404|NCT02612311|473613643|FG000|Overall Study|Death|29|||
131544405|NCT02612311|473613644|FG001|Overall Study|Death|10|||
131544406|NCT02612311|473613645|FG002|Overall Study|Death|11|||
131544407|NCT02612311|473613646|FG003|Overall Study|Death|11|||
131544408|NCT02612311|473613643|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
131544409|NCT02612311|473613644|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
131544410|NCT02612311|473613645|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
131544411|NCT02612311|473613646|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
131544412|NCT02612311|473613643|FG000|Overall Study|Investigator's Decision|11|||
131544413|NCT02612311|473613644|FG001|Overall Study|Investigator's Decision|15|||
131544414|NCT02612311|473613645|FG002|Overall Study|Investigator's Decision|6|||
131544415|NCT02612311|473613646|FG003|Overall Study|Investigator's Decision|6|||
131544416|NCT02612311|473613643|FG000|Overall Study|Lack of Efficacy|0|||
131544417|NCT02612311|473613644|FG001|Overall Study|Lack of Efficacy|0|||
131544418|NCT02612311|473613645|FG002|Overall Study|Lack of Efficacy|1|||
131544419|NCT02612311|473613646|FG003|Overall Study|Lack of Efficacy|1|||
131544420|NCT02612311|473613643|FG000|Overall Study|Lost to Follow-up|2|||
131544421|NCT02612311|473613644|FG001|Overall Study|Lost to Follow-up|2|||
131544422|NCT02612311|473613645|FG002|Overall Study|Lost to Follow-up|1|||
131544423|NCT02612311|473613646|FG003|Overall Study|Lost to Follow-up|2|||
131544424|NCT02612311|473613643|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
131544425|NCT02612311|473613644|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
131544426|NCT02612311|473613645|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
131544427|NCT02612311|473613646|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
131544428|NCT02612311|473613643|FG000|Overall Study|Site Terminated by Sponsor|29|||
131544429|NCT02612311|473613644|FG001|Overall Study|Site Terminated by Sponsor|12|||
131544430|NCT02612311|473613645|FG002|Overall Study|Site Terminated by Sponsor|13|||
131544431|NCT02612311|473613646|FG003|Overall Study|Site Terminated by Sponsor|5|||
131544432|NCT02612311|473613643|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
131544433|NCT02612311|473613644|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
131544434|NCT02612311|473613645|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
131544435|NCT02612311|473613646|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
131544436|NCT02612311|473613643|FG000|Overall Study|Reason Not Specified|3|||
131544437|NCT02612311|473613644|FG001|Overall Study|Reason Not Specified|7|||
131544438|NCT02612311|473613645|FG002|Overall Study|Reason Not Specified|4|||
131544439|NCT02612311|473613646|FG003|Overall Study|Reason Not Specified|5|||
131544440|NCT02612311|473613643|FG000|Overall Study|Unknown/Missing|10|||
131544441|NCT02612311|473613644|FG001|Overall Study|Unknown/Missing|13|||
131544442|NCT02612311|473613645|FG002|Overall Study|Unknown/Missing|4|||
131544443|NCT02612311|473613646|FG003|Overall Study|Unknown/Missing|0|||
131544444|NCT02612311|473613643|FG000|Overall Study|Non-Compliance with Study|1|||
131544445|NCT02612311|473613644|FG001|Overall Study|Non-Compliance with Study|0|||
131544446|NCT02612311|473613645|FG002|Overall Study|Non-Compliance with Study|0|||
131544447|NCT02612311|473613646|FG003|Overall Study|Non-Compliance with Study|0|||
131544448|NCT04393441|473613647|FG000|Overall Study|Adverse Event|0|||
131544449|NCT04393441|473613648|FG001|Overall Study|Adverse Event|3|||
131544450|NCT04393441|473613647|FG000|Overall Study|Withdrawal by Subject|5|||
131544451|NCT04393441|473613648|FG001|Overall Study|Withdrawal by Subject|7|||
131544452|NCT04393441|473613647|FG000|Overall Study|Lost to Follow-up|0|||
131544453|NCT04393441|473613648|FG001|Overall Study|Lost to Follow-up|2|||
131544454|NCT04393441|473613647|FG000|Overall Study|Protocol Deviation|2|||
131544455|NCT04393441|473613648|FG001|Overall Study|Protocol Deviation|1|||
131544456|NCT04393441|473613647|FG000|Overall Study|Reason not Specified|1|||
131544457|NCT04393441|473613648|FG001|Overall Study|Reason not Specified|1|||
131544458|NCT04542018|473613652|FG000|Overall Study|Withdrawal by Subject|0|||
131544459|NCT04542018|473613653|FG001|Overall Study|Withdrawal by Subject|0|||
131544460|NCT04542018|473613654|FG002|Overall Study|Withdrawal by Subject|4|||
131544461|NCT04542018|473613652|FG000|Overall Study|Protocol Violation|0|||
131544462|NCT04542018|473613653|FG001|Overall Study|Protocol Violation|0|||
131544463|NCT04542018|473613654|FG002|Overall Study|Protocol Violation|2|||
131544464|NCT00689221|473613655|FG000|Overall Study|Ongoing at cut-off date|39|||
131544465|NCT00689221|473613656|FG001|Overall Study|Ongoing at cut-off date|36|||
131544466|NCT01812655|473613657|FG000|Overall Study|Protocol Violation|1|||
131544467|NCT01812655|473613658|FG001|Overall Study|Protocol Violation|1|||
131544468|NCT01812655|473613659|FG002|Overall Study|Protocol Violation|0|||
131544469|NCT04672941|473613661|FG000|Overall Study|Investigator decision|1|||
131544470|NCT04672941|473613661|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
131544471|NCT04672941|473613661|FG000|Overall Study|COVID-19 related but no adverse event|1|||
131544472|NCT04672941|473613661|FG000|Overall Study|Adverse Event|2|||
131544473|NCT04672941|473613661|FG000|Overall Study|Lost to Follow-up|2|||
131544474|NCT04435665|473613662|FG000|Overall Study|Lost to Follow-up|0|||
131544475|NCT04435665|473613663|FG001|Overall Study|Lost to Follow-up|0|||
131544476|NCT04435665|473613664|FG002|Overall Study|Lost to Follow-up|0|||
131544477|NCT04435665|473613665|FG003|Overall Study|Lost to Follow-up|1|||
131544478|NCT00765388|473613666|FG000|Period 1|Lack of Efficacy|1|||
131544479|NCT00765388|473613667|FG001|Period 1|Lack of Efficacy|2|||
131544480|NCT00765388|473613666|FG000|Period 1|Lost to Follow-up|0|||
131544481|NCT00765388|473613667|FG001|Period 1|Lost to Follow-up|1|||
131544482|NCT00765388|473613666|FG000|Period 1|Herpes Zoster|0|||
131544483|NCT00765388|473613667|FG001|Period 1|Herpes Zoster|1|||
131544484|NCT00765388|473613666|FG000|Period 1|Hip operation|0|||
131544485|NCT00765388|473613667|FG001|Period 1|Hip operation|1|||
131544486|NCT01563536|473613676|FG000|Overall Study|Withdrawal by Subject|0|||
131544487|NCT01563536|473613677|FG001|Overall Study|Withdrawal by Subject|2|||
131544488|NCT01563536|473613676|FG000|Overall Study|Lost to Follow-up|1|||
131544489|NCT01563536|473613677|FG001|Overall Study|Lost to Follow-up|0|||
131544490|NCT00538590|473613680|FG000|Overall Study|Death|1|||
131544491|NCT00538590|473613681|FG001|Overall Study|Death|0|||
131544492|NCT01256567|473613682|FG000|Overall Study|Withdrawal by Subject|1|||
131544493|NCT00344461|473613697|FG000|Overall Study|Adverse Event|6|||
131544494|NCT00344461|473613697|FG000|Overall Study|Death|1|||
131544495|NCT00344461|473613697|FG000|Overall Study|Lack of Efficacy|2|||
131544496|NCT00344461|473613697|FG000|Overall Study|Lost to Follow-up|2|||
131544497|NCT00344461|473613697|FG000|Overall Study|Physician Decision|2|||
131544498|NCT00344461|473613697|FG000|Overall Study|Protocol Violation|6|||
131544499|NCT00344461|473613697|FG000|Overall Study|Withdrawal by Subject|2|||
131544500|NCT00636610|473613698|FG000|Overall Study|Adverse Event|4|||
131544501|NCT00636610|473613699|FG001|Overall Study|Adverse Event|4|||
131544502|NCT00636610|473613698|FG000|Overall Study|Death|6|||
131544503|NCT00636610|473613699|FG001|Overall Study|Death|3|||
131544504|NCT00636610|473613698|FG000|Overall Study|Physician decision to withdraw patient|15|||
131544505|NCT00636610|473613699|FG001|Overall Study|Physician decision to withdraw patient|9|||
131544506|NCT00636610|473613698|FG000|Overall Study|Subject decision to withdraw|15|||
131544507|NCT00636610|473613699|FG001|Overall Study|Subject decision to withdraw|11|||
131544508|NCT00636610|473613698|FG000|Overall Study|Disease progression - radiographic|41|||
131544509|NCT00636610|473613699|FG001|Overall Study|Disease progression - radiographic|51|||
131544510|NCT00636610|473613698|FG000|Overall Study|Disease progression - clinical|8|||
131544511|NCT00636610|473613699|FG001|Overall Study|Disease progression - clinical|3|||
131544512|NCT00636610|473613698|FG000|Overall Study|Reason for discontinuation not available|3|||
131544513|NCT00636610|473613699|FG001|Overall Study|Reason for discontinuation not available|2|||
131544514|NCT00671931|473613700|FG000|Overall Study|Physician Decision|1|||
131544515|NCT00671931|473613701|FG001|Overall Study|Physician Decision|0|||
131544516|NCT00671931|473613702|FG002|Overall Study|Physician Decision|0|||
131544517|NCT00671931|473613703|FG003|Overall Study|Physician Decision|2|||
131544518|NCT00671931|473613704|FG004|Overall Study|Physician Decision|1|||
131544519|NCT01169675|473613707|FG000|Overall Study|Progressive disease|13|||
131544520|NCT01169675|473613708|FG001|Overall Study|Progressive disease|2|||
131544521|NCT01169675|473613709|FG002|Overall Study|Progressive disease|5|||
131544522|NCT01169675|473613710|FG003|Overall Study|Progressive disease|15|||
131544523|NCT01169675|473613711|FG004|Overall Study|Progressive disease|1|||
131544524|NCT01169675|473613707|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131544525|NCT01169675|473613708|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131544526|NCT01169675|473613709|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131544527|NCT01169675|473613710|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131544528|NCT01169675|473613711|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131544529|NCT01169675|473613707|FG000|Overall Study|Adverse Event|5|||
131544530|NCT01169675|473613708|FG001|Overall Study|Adverse Event|1|||
131544531|NCT01169675|473613709|FG002|Overall Study|Adverse Event|2|||
131544532|NCT01169675|473613710|FG003|Overall Study|Adverse Event|0|||
131544533|NCT01169675|473613711|FG004|Overall Study|Adverse Event|0|||
131544534|NCT01169675|473613707|FG000|Overall Study|Withdrawal by Subject|1|||
131544535|NCT01169675|473613708|FG001|Overall Study|Withdrawal by Subject|0|||
131544536|NCT01169675|473613709|FG002|Overall Study|Withdrawal by Subject|0|||
131544537|NCT01169675|473613710|FG003|Overall Study|Withdrawal by Subject|1|||
131544538|NCT01169675|473613711|FG004|Overall Study|Withdrawal by Subject|2|||
131544539|NCT01169675|473613707|FG000|Overall Study|Other Reason Not Defined Above|0|||
131544540|NCT01169675|473613708|FG001|Overall Study|Other Reason Not Defined Above|0|||
131544541|NCT01169675|473613709|FG002|Overall Study|Other Reason Not Defined Above|0|||
131544542|NCT01169675|473613710|FG003|Overall Study|Other Reason Not Defined Above|1|||
131544543|NCT01169675|473613711|FG004|Overall Study|Other Reason Not Defined Above|1|||
131544544|NCT01971723|473613712|FG000|Overall Study|Withdrawal by Subject|1|||
131544545|NCT01971723|473613713|FG001|Overall Study|Withdrawal by Subject|1|||
131544546|NCT01971723|473613712|FG000|Overall Study|Protocol Violation|1|||
131544547|NCT01971723|473613713|FG001|Overall Study|Protocol Violation|2|||
131544548|NCT01648270|473613714|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
131544549|NCT04969263|473613715|FG000|Overall Study|Death|1|||
131544550|NCT04969263|473613715|FG000|Overall Study|Lost to Follow-up|2|||
131544551|NCT04969263|473613715|FG000|Overall Study|Withdrawal by Subject|5|||
131544552|NCT04969263|473613715|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
131544553|NCT02693743|473613717|FG000|Overall Study|Physician Decision|1|||
131544554|NCT02693743|473613718|FG001|Overall Study|Physician Decision|0|||
131544555|NCT01024608|473613720|FG000|Overall Study|Adverse Event|1|||
131544556|NCT01024608|473613721|FG001|Overall Study|Adverse Event|0|||
131544557|NCT01024608|473613720|FG000|Overall Study|Withdrawal by Subject|1|||
131544558|NCT01024608|473613721|FG001|Overall Study|Withdrawal by Subject|0|||
131544559|NCT01024608|473613720|FG000|Overall Study|Lost to Follow-up|0|||
131544560|NCT01024608|473613721|FG001|Overall Study|Lost to Follow-up|1|||
131544561|NCT01024608|473613720|FG000|Overall Study|Protocol Violation|0|||
131544562|NCT01024608|473613721|FG001|Overall Study|Protocol Violation|3|||
131544563|NCT01024608|473613720|FG000|Overall Study|Never received study treatment|2|||
131544564|NCT01024608|473613721|FG001|Overall Study|Never received study treatment|0|||
131544565|NCT02412137|473613739|FG000|Overall Study|Withdrawal by Subject|2|||
131544566|NCT02412137|473613740|FG001|Overall Study|Withdrawal by Subject|0|||
131544567|NCT02412137|473613739|FG000|Overall Study|Lost to Follow-up|21|||
131544568|NCT02412137|473613740|FG001|Overall Study|Lost to Follow-up|14|||
131544569|NCT02412137|473613739|FG000|Overall Study|Physician Decision|28|||
131544570|NCT02412137|473613740|FG001|Overall Study|Physician Decision|9|||
131544571|NCT01323530|473615836|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
131544572|NCT01323530|473615837|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131544573|NCT01323530|473615838|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131544574|NCT01323530|473615839|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131544575|NCT01323530|473615840|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131544576|NCT01323530|473615841|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
131544577|NCT01323530|473615842|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
131544578|NCT01323530|473615836|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
131544579|NCT01323530|473615837|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
131544580|NCT01323530|473615838|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
131544581|NCT01323530|473615839|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131544582|NCT01323530|473615840|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
131544583|NCT01323530|473615841|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131544584|NCT01323530|473615842|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131544585|NCT01323530|473615836|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
131544586|NCT01323530|473615837|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
131544587|NCT01323530|473615838|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
131544588|NCT01323530|473615839|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
131544589|NCT01323530|473615840|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
131544590|NCT01323530|473615841|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
131544591|NCT01323530|473615842|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
131544592|NCT01323530|473615836|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
131544593|NCT01323530|473615837|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
131544594|NCT01323530|473615838|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
131544595|NCT01323530|473615839|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
131544596|NCT01323530|473615840|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
131544597|NCT01323530|473615841|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
131544598|NCT01323530|473615842|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
131544599|NCT01323530|473615836|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
131544600|NCT01323530|473615837|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
131544601|NCT01323530|473615838|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
131544602|NCT01323530|473615839|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
131544603|NCT01323530|473615840|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
131544604|NCT01323530|473615841|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
131544605|NCT01323530|473615842|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
131544606|NCT01323530|473615836|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
131544607|NCT01323530|473615837|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
131544608|NCT01323530|473615838|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
131544609|NCT01323530|473615839|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
131544610|NCT01323530|473615840|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
131544611|NCT01323530|473615841|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
131544612|NCT01323530|473615842|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
131544613|NCT01323530|473615836|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
131544614|NCT01323530|473615837|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
131544615|NCT01323530|473615838|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
131544616|NCT01323530|473615839|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
131544617|NCT01323530|473615840|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
131544618|NCT01323530|473615841|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
131544619|NCT01323530|473615842|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
131544620|NCT01323530|473615836|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131544621|NCT01323530|473615837|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131544622|NCT01323530|473615838|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131544623|NCT01323530|473615839|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131544624|NCT01323530|473615840|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131544625|NCT01323530|473615841|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131544626|NCT01323530|473615842|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
131544627|NCT02532179|473615843|FG000|Overall Study|Lost to Follow-up|1|||
131544628|NCT02532179|473615843|FG000|Overall Study|Pregnancy|1|||
131544629|NCT02532179|473615843|FG000|Overall Study|Subject received depot steroid injection|1|||
131544630|NCT01735201|473615848|FG000|Overall Study|Adverse Event|1|||
131544631|NCT01735201|473615849|FG001|Overall Study|Adverse Event|1|||
131544632|NCT01735201|473615850|FG002|Overall Study|Adverse Event|0|||
131544633|NCT01735201|473615851|FG003|Overall Study|Adverse Event|1|||
131544634|NCT01735201|473615852|FG004|Overall Study|Adverse Event|1|||
131544635|NCT01735201|473615853|FG005|Overall Study|Adverse Event|3|||
131544636|NCT01735201|473615854|FG006|Overall Study|Adverse Event|2|||
131544637|NCT01735201|473615855|FG007|Overall Study|Adverse Event|1|||
131544638|NCT01735201|473615848|FG000|Overall Study|Personal Reasons|1|||
131544639|NCT01735201|473615849|FG001|Overall Study|Personal Reasons|0|||
131544640|NCT01735201|473615850|FG002|Overall Study|Personal Reasons|0|||
131544641|NCT01735201|473615851|FG003|Overall Study|Personal Reasons|0|||
131544642|NCT01735201|473615852|FG004|Overall Study|Personal Reasons|0|||
131544643|NCT01735201|473615853|FG005|Overall Study|Personal Reasons|0|||
131544644|NCT01735201|473615854|FG006|Overall Study|Personal Reasons|0|||
131544645|NCT01735201|473615855|FG007|Overall Study|Personal Reasons|0|||
131544646|NCT01735201|473615848|FG000|Overall Study|Protocol Violation|1|||
131544647|NCT01735201|473615849|FG001|Overall Study|Protocol Violation|0|||
131544648|NCT01735201|473615850|FG002|Overall Study|Protocol Violation|0|||
131544649|NCT01735201|473615851|FG003|Overall Study|Protocol Violation|0|||
131544650|NCT01735201|473615852|FG004|Overall Study|Protocol Violation|0|||
131544651|NCT01735201|473615853|FG005|Overall Study|Protocol Violation|0|||
131544652|NCT01735201|473615854|FG006|Overall Study|Protocol Violation|0|||
131544653|NCT01735201|473615855|FG007|Overall Study|Protocol Violation|0|||
131544654|NCT01735201|473615848|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131544655|NCT01735201|473615849|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131544656|NCT01735201|473615850|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131544657|NCT01735201|473615851|FG003|Overall Study|Other Miscellaneous Reasons|1|||
131544658|NCT01735201|473615852|FG004|Overall Study|Other Miscellaneous Reasons|0|||
131544659|NCT01735201|473615853|FG005|Overall Study|Other Miscellaneous Reasons|2|||
131544660|NCT01735201|473615854|FG006|Overall Study|Other Miscellaneous Reasons|1|||
131544661|NCT01735201|473615855|FG007|Overall Study|Other Miscellaneous Reasons|1|||
131544662|NCT01553318|473615856|FG000|Overall Study|Protocol Violation|3|||
131544663|NCT01553318|473615857|FG001|Overall Study|Protocol Violation|2|||
131544664|NCT04128293|473615860|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
131544665|NCT04128293|473615861|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
131544666|NCT04128293|473615862|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
131544667|NCT04128293|473615863|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
131544668|NCT02127372|473615864|FG000|Overall Study|Withdrawal by Subject|1|||
131544669|NCT02127372|473615865|FG001|Overall Study|Withdrawal by Subject|0|||
131544670|NCT03432364|473615867|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
131544671|NCT04493931|473615869|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
131544672|NCT04493931|473615870|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
131544673|NCT04493931|473615871|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
131544674|NCT04493931|473615872|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
131544675|NCT04493931|473615873|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
131544676|NCT04493931|473615874|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
131544677|NCT04493931|473615875|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
131544678|NCT04493931|473615869|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131544679|NCT04493931|473615870|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
131544680|NCT04493931|473615871|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131544681|NCT04493931|473615872|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131544682|NCT04493931|473615873|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131544683|NCT04493931|473615874|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131544684|NCT04493931|473615875|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131544685|NCT04493931|473615869|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
131544686|NCT04493931|473615870|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
131544687|NCT04493931|473615871|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
131544688|NCT04493931|473615872|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
131544689|NCT04493931|473615873|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
131544690|NCT04493931|473615874|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
131544691|NCT04493931|473615875|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
131544692|NCT04493931|473615869|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
131544693|NCT04493931|473615870|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
131544694|NCT04493931|473615871|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
131544695|NCT04493931|473615872|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
131544696|NCT04493931|473615873|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
131544697|NCT04493931|473615874|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
131544698|NCT04493931|473615875|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
131544699|NCT00430248|473615877|FG000|Overall Study|Adverse Event|49|||
131544700|NCT00430248|473615878|FG001|Overall Study|Adverse Event|61|||
131544701|NCT00430248|473615879|FG002|Overall Study|Adverse Event|64|||
131544702|NCT00430248|473615877|FG000|Overall Study|Protocol Violation|10|||
131544703|NCT00430248|473615878|FG001|Overall Study|Protocol Violation|2|||
131544704|NCT00430248|473615879|FG002|Overall Study|Protocol Violation|4|||
131544705|NCT00430248|473615877|FG000|Overall Study|Personal Reasons|12|||
131544706|NCT00430248|473615878|FG001|Overall Study|Personal Reasons|24|||
131544707|NCT00430248|473615879|FG002|Overall Study|Personal Reasons|9|||
131544708|NCT00430248|473615877|FG000|Overall Study|Lost to Follow-up|28|||
131544709|NCT00430248|473615878|FG001|Overall Study|Lost to Follow-up|33|||
131544710|NCT00430248|473615879|FG002|Overall Study|Lost to Follow-up|28|||
131544711|NCT00430248|473615877|FG000|Overall Study|Therapeutic Failure|1|||
131544712|NCT00430248|473615878|FG001|Overall Study|Therapeutic Failure|1|||
131544713|NCT00430248|473615879|FG002|Overall Study|Therapeutic Failure|1|||
131544714|NCT00430248|473615877|FG000|Overall Study|Withdrawal by Subject|14|||
131544715|NCT00430248|473615878|FG001|Overall Study|Withdrawal by Subject|20|||
131544716|NCT00430248|473615879|FG002|Overall Study|Withdrawal by Subject|16|||
131544717|NCT00430248|473615877|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131544718|NCT00430248|473615878|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
131544719|NCT00430248|473615879|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131544720|NCT00430248|473615877|FG000|Overall Study|Gout Flare|3|||
131544721|NCT00430248|473615878|FG001|Overall Study|Gout Flare|7|||
131544722|NCT00430248|473615879|FG002|Overall Study|Gout Flare|2|||
131544723|NCT00430248|473615877|FG000|Overall Study|Reason Not Specified|8|||
131544724|NCT00430248|473615878|FG001|Overall Study|Reason Not Specified|8|||
131544725|NCT00430248|473615879|FG002|Overall Study|Reason Not Specified|11|||
131544726|NCT01754467|473615883|FG000|Overall Study|Lost to Follow-up|1|||
131544727|NCT01970462|473615884|FG000|Overall Study|Lost to Follow-up|0|||
131544728|NCT01970462|473615885|FG001|Overall Study|Lost to Follow-up|2|||
131544729|NCT00754338|473615886|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
131544730|NCT00754338|473615887|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
131544731|NCT00754338|473615888|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
131544732|NCT00754338|473615889|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
131544733|NCT00754338|473615886|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
131544734|NCT00754338|473615887|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
131544735|NCT00754338|473615888|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
131544736|NCT00754338|473615889|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
131544737|NCT04020341|473615892|FG000|Overall Study|Adverse Event|8|||
131544738|NCT04020341|473615893|FG001|Overall Study|Adverse Event|6|||
131544739|NCT04020341|473615892|FG000|Overall Study|Lost to Follow-up|8|||
131544740|NCT04020341|473615893|FG001|Overall Study|Lost to Follow-up|2|||
131544741|NCT04020341|473615892|FG000|Overall Study|Withdrawal by Subject|16|||
131544742|NCT04020341|473615893|FG001|Overall Study|Withdrawal by Subject|16|||
131544743|NCT04020341|473615892|FG000|Overall Study|Participant not able to swallow the tablet|1|||
131544744|NCT04020341|473615893|FG001|Overall Study|Participant not able to swallow the tablet|0|||
131544745|NCT04020341|473615892|FG000|Overall Study|Physician Decision|0|||
131544746|NCT04020341|473615893|FG001|Overall Study|Physician Decision|2|||
131544747|NCT04020341|473615892|FG000|Overall Study|Protocol Deviation|0|||
131544748|NCT04020341|473615893|FG001|Overall Study|Protocol Deviation|2|||
131544749|NCT05763628|473615894|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
131544750|NCT05763628|473615895|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
131544751|NCT05763628|473615894|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
131544752|NCT05763628|473615895|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
131544753|NCT05763628|473615894|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
131544754|NCT05763628|473615895|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
131544755|NCT04683926|473615896|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
131544756|NCT04683926|473615897|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
131544757|NCT04683926|473615898|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
131544758|NCT04683926|473615899|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
131544759|NCT04385368|473615900|FG000|Overall Study|Death|5|||
131544760|NCT04385368|473615901|FG001|Overall Study|Death|5|||
131544761|NCT04385368|473615900|FG000|Overall Study|Physician Decision|3|||
131544762|NCT04385368|473615901|FG001|Overall Study|Physician Decision|0|||
131544763|NCT04385368|473615900|FG000|Overall Study|Withdrawal by Subject|4|||
131544764|NCT04385368|473615901|FG001|Overall Study|Withdrawal by Subject|3|||
131544765|NCT02123108|473615904|FG000|Overall Study|Death|2|||
131544766|NCT02123108|473615905|FG001|Overall Study|Death|3|||
131544767|NCT00716092|473615906|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
131544768|NCT00716092|473615907|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
131544769|NCT00716092|473615908|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
131544770|NCT02054806|473615909|FG000|Overall Study|Sponsor Decision|31|||
131544771|NCT02054806|473615909|FG000|Overall Study|Withdrawal by Subject|43|||
131544772|NCT02054806|473615909|FG000|Overall Study|Protocol Violation|2|||
131544773|NCT02054806|473615909|FG000|Overall Study|Lost to Follow-up|10|||
131544774|NCT02054806|473615909|FG000|Overall Study|Death|391|||
131544775|NCT04721925|473615910|FG000|2-Month Assessment|Lost to Follow-up|5|||
131544776|NCT04721925|473615911|FG001|2-Month Assessment|Lost to Follow-up|3|||
131544777|NCT04721925|473615910|FG000|4-Month Assessment|Lost to Follow-up|3|||
131544778|NCT04721925|473615911|FG001|4-Month Assessment|Lost to Follow-up|6|||
131544779|NCT01132326|473615912|FG000|Overall Study|Lack of Efficacy|25|||
131544780|NCT01132326|473615912|FG000|Overall Study|Adverse Event|37|||
131544781|NCT01132326|473615912|FG000|Overall Study|Protocol Violation|1|||
131544782|NCT01132326|473615912|FG000|Overall Study|Lost to Follow-up|16|||
131544783|NCT01132326|473615912|FG000|Overall Study|Withdrawal by Subject|40|||
131544784|NCT01132326|473615912|FG000|Overall Study|Physician Decision|10|||
131544785|NCT01132326|473615912|FG000|Overall Study|Study Termination|80|||
131544786|NCT01132326|473615912|FG000|Overall Study|Declining Health|1|||
131544787|NCT01132326|473615912|FG000|Overall Study|Pregnancy|1|||
131544788|NCT01132326|473615912|FG000|Overall Study|Caregiver Withdrew Consent|1|||
131544789|NCT01132326|473615912|FG000|Overall Study|Death|5|||
131544790|NCT01132326|473615912|FG000|Overall Study|Subject Unable to Come To Visits|1|||
131544791|NCT00677235|473615913|FG000|Overall Study|Withdrawal by Subject|1|||
131544792|NCT00677235|473615914|FG001|Overall Study|Withdrawal by Subject|1|||
131544793|NCT00677235|473615913|FG000|Overall Study|Lost to Follow-up|2|||
131544794|NCT00677235|473615914|FG001|Overall Study|Lost to Follow-up|1|||
131544795|NCT00677235|473615913|FG000|Overall Study|Death|37|||
131544796|NCT00677235|473615914|FG001|Overall Study|Death|36|||
131544797|NCT00677235|473615913|FG000|Overall Study|Adverse Experience|1|||
131544798|NCT00677235|473615914|FG001|Overall Study|Adverse Experience|0|||
131544799|NCT00952367|473615915|FG000|Overall Study|Withdrawal by Subject|2|||
131544800|NCT00952367|473615915|FG000|Overall Study|Noncoordination|1|||
131544801|NCT00952367|473615915|FG000|Overall Study|Protocol Violation|3|||
131544802|NCT01040260|473615916|FG000|Overall Study|Withdrawal by Subject|12|||
131544803|NCT01040260|473615917|FG001|Overall Study|Withdrawal by Subject|6|||
131544804|NCT01040260|473615916|FG000|Overall Study|Lost to Follow-up|3|||
131544805|NCT01040260|473615917|FG001|Overall Study|Lost to Follow-up|5|||
131544806|NCT01113502|473615922|FG000|Overall Study|Withdrawal by Subject|1|||
131544807|NCT01113502|473615923|FG001|Overall Study|Withdrawal by Subject|0|||
131544808|NCT01113502|473615924|FG002|Overall Study|Withdrawal by Subject|1|||
131544809|NCT01113502|473615925|FG003|Overall Study|Withdrawal by Subject|1|||
131544810|NCT01113502|473615926|FG004|Overall Study|Withdrawal by Subject|0|||
131544811|NCT01113502|473615922|FG000|Overall Study|Adverse Event|0|||
131544812|NCT01113502|473615923|FG001|Overall Study|Adverse Event|0|||
131544813|NCT01113502|473615924|FG002|Overall Study|Adverse Event|3|||
131544814|NCT01113502|473615925|FG003|Overall Study|Adverse Event|2|||
131544815|NCT01113502|473615926|FG004|Overall Study|Adverse Event|0|||
131544816|NCT04570436|473615929|FG000|Overall Study|Adverse Event|0|||
131544817|NCT04570436|473615930|FG001|Overall Study|Adverse Event|0|||
131544818|NCT04570436|473615931|FG002|Overall Study|Adverse Event|1|||
131544819|NCT04570436|473615932|FG003|Overall Study|Adverse Event|0|||
131544820|NCT04570436|473615933|FG004|Overall Study|Adverse Event|0|||
131544821|NCT04570436|473615934|FG005|Overall Study|Adverse Event|0|||
131544822|NCT04570436|473615935|FG006|Overall Study|Adverse Event|0|||
131544823|NCT04570436|473615936|FG007|Overall Study|Adverse Event|0|||
131544824|NCT04570436|473615937|FG008|Overall Study|Adverse Event|0|||
131544825|NCT04570436|473615938|FG009|Overall Study|Adverse Event|0|||
131544826|NCT04570436|473615929|FG000|Overall Study|Physician Decision|1|||
131544827|NCT04570436|473615930|FG001|Overall Study|Physician Decision|0|||
131544828|NCT04570436|473615931|FG002|Overall Study|Physician Decision|0|||
131544829|NCT04570436|473615932|FG003|Overall Study|Physician Decision|0|||
131544830|NCT04570436|473615933|FG004|Overall Study|Physician Decision|0|||
131544831|NCT04570436|473615934|FG005|Overall Study|Physician Decision|0|||
131544832|NCT04570436|473615935|FG006|Overall Study|Physician Decision|0|||
131544833|NCT04570436|473615936|FG007|Overall Study|Physician Decision|0|||
131544834|NCT04570436|473615937|FG008|Overall Study|Physician Decision|0|||
131544835|NCT04570436|473615938|FG009|Overall Study|Physician Decision|0|||
131544836|NCT00781391|473615939|FG000|Overall Study|never received study drug|24|||
131544837|NCT00781391|473615940|FG001|Overall Study|never received study drug|23|||
131544838|NCT00781391|473615941|FG002|Overall Study|never received study drug|32|||
131544839|NCT00781391|473615939|FG000|Overall Study|Protocol Violation|19|||
131544840|NCT00781391|473615940|FG001|Overall Study|Protocol Violation|17|||
131544841|NCT00781391|473615941|FG002|Overall Study|Protocol Violation|20|||
131544842|NCT00781391|473615939|FG000|Overall Study|Death|789|||
131544843|NCT00781391|473615940|FG001|Overall Study|Death|730|||
131544844|NCT00781391|473615941|FG002|Overall Study|Death|706|||
131544845|NCT00781391|473615939|FG000|Overall Study|Withdrawal by Subject|47|||
131544846|NCT00781391|473615940|FG001|Overall Study|Withdrawal by Subject|37|||
131544847|NCT00781391|473615941|FG002|Overall Study|Withdrawal by Subject|25|||
131544848|NCT00781391|473615939|FG000|Overall Study|Lost to Follow-up|0|||
131544849|NCT00781391|473615940|FG001|Overall Study|Lost to Follow-up|0|||
131544850|NCT00781391|473615941|FG002|Overall Study|Lost to Follow-up|1|||
131544851|NCT00929162|473615942|FG000|Overall Study|Adverse Event|8|||
131544852|NCT00929162|473615943|FG001|Overall Study|Adverse Event|5|||
131544853|NCT00929162|473615942|FG000|Overall Study|Withdrawal by Subject|3|||
131544854|NCT00929162|473615943|FG001|Overall Study|Withdrawal by Subject|1|||
131544855|NCT00929162|473615942|FG000|Overall Study|Protocol Violation|32|||
131544856|NCT00929162|473615943|FG001|Overall Study|Protocol Violation|30|||
131544857|NCT00929162|473615942|FG000|Overall Study|Other termination reason|5|||
131544858|NCT00929162|473615943|FG001|Overall Study|Other termination reason|6|||
131544859|NCT02355002|473615944|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
131544860|NCT02355002|473615945|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
131544861|NCT02355002|473615944|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
131544862|NCT02355002|473615945|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
131544863|NCT02355002|473615944|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
131544864|NCT02355002|473615945|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
131544865|NCT02355002|473615944|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
131544866|NCT02355002|473615945|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
131544867|NCT02355002|473615944|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
131544868|NCT02355002|473615945|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
131544869|NCT02355002|473615944|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
131544870|NCT02355002|473615945|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
131544871|NCT02355002|473615944|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
131544872|NCT02355002|473615945|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
131544873|NCT00708916|473615946|FG000|Overall Study|Subject Noncompliance|2|||
131544874|NCT00708916|473615946|FG000|Overall Study|Adverse Event|2|||
131544875|NCT02835339|473615952|FG000|Overall Study|Did not receive allocated intervention|13|||
131544876|NCT02835339|473615953|FG001|Overall Study|Did not receive allocated intervention|16|||
131544877|NCT01077544|473615954|FG000|Overall Study|New Cancer Therapy|3|||
131544878|NCT01077544|473615955|FG001|Overall Study|New Cancer Therapy|3|||
131544879|NCT01077544|473615954|FG000|Overall Study|Adverse Event|0|||
131544880|NCT01077544|473615955|FG001|Overall Study|Adverse Event|1|||
131544881|NCT01077544|473615954|FG000|Overall Study|Disease Progression|0|||
131544882|NCT01077544|473615955|FG001|Overall Study|Disease Progression|1|||
131544883|NCT04918147|473615956|FG000|Overall Study|Disease flare as defined in protocol|0|||
131544884|NCT04918147|473615957|FG001|Overall Study|Disease flare as defined in protocol|2|||
131544885|NCT03804710|473615959|FG000|Overall Study|Adverse Event|0|||
131544886|NCT03804710|473615960|FG001|Overall Study|Adverse Event|3|||
131544887|NCT03804710|473615959|FG000|Overall Study|Withdrawal by Subject|2|||
131544888|NCT03804710|473615960|FG001|Overall Study|Withdrawal by Subject|1|||
131544889|NCT03804710|473615959|FG000|Overall Study|Other|0|||
131544890|NCT03804710|473615960|FG001|Overall Study|Other|1|||
131544891|NCT04198805|473615961|FG000|Overall Study|Death|0|||
131544892|NCT04198805|473615962|FG001|Overall Study|Death|0|||
131544893|NCT04198805|473615963|FG002|Overall Study|Death|0|||
131544894|NCT04198805|473615964|FG003|Overall Study|Death|1|||
131544895|NCT04198805|473615961|FG000|Overall Study|Early Termination|8|||
131544896|NCT04198805|473615962|FG001|Overall Study|Early Termination|4|||
131544897|NCT04198805|473615963|FG002|Overall Study|Early Termination|6|||
131544898|NCT04198805|473615964|FG003|Overall Study|Early Termination|9|||
131544899|NCT01330433|473615965|FG000|Overall Study|Death|1|||
131544900|NCT01330433|473615966|FG001|Overall Study|Death|3|||
131544901|NCT01330433|473615965|FG000|Overall Study|Lost to Follow-up|1|||
131544902|NCT01330433|473615966|FG001|Overall Study|Lost to Follow-up|0|||
131544903|NCT03599349|473615967|FG000|Overall Study|Lost to Follow-up|1|||
131544904|NCT01830127|473615968|FG000|Overall Study|Adverse Event|1|||
131544905|NCT01830127|473615969|FG001|Overall Study|Adverse Event|6|||
131544906|NCT01830127|473615968|FG000|Overall Study|Lack of Efficacy|3|||
131544907|NCT01830127|473615969|FG001|Overall Study|Lack of Efficacy|0|||
131544908|NCT01830127|473615968|FG000|Overall Study|Withdrawal by Subject|1|||
131544909|NCT01830127|473615969|FG001|Overall Study|Withdrawal by Subject|1|||
131544910|NCT01830127|473615968|FG000|Overall Study|Other reason not defined above|0|||
131544911|NCT01830127|473615969|FG001|Overall Study|Other reason not defined above|2|||
131544912|NCT00567190|473615975|FG000|Overall Study|Death|235|||
131544913|NCT00567190|473615976|FG001|Overall Study|Death|280|||
131544914|NCT00567190|473615975|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
131544915|NCT00567190|473615976|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
131544916|NCT00553696|473615980|FG000|Overall Study|Adverse Event|2|||
131544917|NCT00553696|473615981|FG001|Overall Study|Adverse Event|4|||
131544918|NCT00553696|473615982|FG002|Overall Study|Adverse Event|0|||
131544919|NCT00553696|473615983|FG003|Overall Study|Adverse Event|1|||
131544920|NCT00553696|473615980|FG000|Overall Study|Global deterioration of health status|0|||
131544921|NCT00553696|473615981|FG001|Overall Study|Global deterioration of health status|2|||
131544922|NCT00553696|473615982|FG002|Overall Study|Global deterioration of health status|0|||
131544923|NCT00553696|473615983|FG003|Overall Study|Global deterioration of health status|0|||
131544924|NCT00553696|473615980|FG000|Overall Study|Objective progression or relapse|2|||
131544925|NCT00553696|473615981|FG001|Overall Study|Objective progression or relapse|9|||
131544926|NCT00553696|473615982|FG002|Overall Study|Objective progression or relapse|6|||
131544927|NCT00553696|473615983|FG003|Overall Study|Objective progression or relapse|0|||
131544928|NCT00553696|473615980|FG000|Overall Study|Withdrawal by Subject|0|||
131544929|NCT00553696|473615981|FG001|Overall Study|Withdrawal by Subject|1|||
131544930|NCT00553696|473615982|FG002|Overall Study|Withdrawal by Subject|0|||
131544931|NCT00553696|473615983|FG003|Overall Study|Withdrawal by Subject|0|||
131544932|NCT04839965|473615984|FG000|Overall Study|Death|6|||
131544933|NCT04839965|473615985|FG001|Overall Study|Death|6|||
131544934|NCT04839965|473615984|FG000|Overall Study|Lost to Follow-up|1|||
131544935|NCT04839965|473615985|FG001|Overall Study|Lost to Follow-up|0|||
131544936|NCT02365519|473615986|FG000|Randomized and Treated|Adverse Event|0|||
131544937|NCT02365519|473615987|FG001|Randomized and Treated|Adverse Event|1|||
131544938|NCT02365519|473615988|FG002|Randomized and Treated|Adverse Event|0|||
131544939|NCT02365519|473615986|FG000|Randomized and Treated|Withdrawal by Subject|0|||
131544940|NCT02365519|473615987|FG001|Randomized and Treated|Withdrawal by Subject|1|||
131544941|NCT02365519|473615988|FG002|Randomized and Treated|Withdrawal by Subject|1|||
131544942|NCT02048072|473615989|FG000|Overall Study|Adverse Event|3|||
131544943|NCT02048072|473615989|FG000|Overall Study|Lost to Follow-up|1|||
131544944|NCT02355028|473615990|FG000|Overall Study|Adverse Event|2|||
131544945|NCT02355028|473615991|FG001|Overall Study|Adverse Event|0|||
131544946|NCT02355028|473615990|FG000|Overall Study|Withdrawal by Subject|1|||
131544947|NCT02355028|473615991|FG001|Overall Study|Withdrawal by Subject|1|||
131544948|NCT02355028|473615990|FG000|Overall Study|Deemed ineligible after randomization|8|||
131544949|NCT02355028|473615991|FG001|Overall Study|Deemed ineligible after randomization|4|||
131544950|NCT02276222|473615992|FG000|Overall Study|Adverse Event|62|||
131544951|NCT02276222|473615993|FG001|Overall Study|Adverse Event|11|||
131544952|NCT02276222|473615992|FG000|Overall Study|Death|3|||
131544953|NCT02276222|473615993|FG001|Overall Study|Death|4|||
131544954|NCT02276222|473615992|FG000|Overall Study|Lack of Efficacy|13|||
131544955|NCT02276222|473615993|FG001|Overall Study|Lack of Efficacy|3|||
131544956|NCT02276222|473615992|FG000|Overall Study|Protocol Violation|3|||
131544957|NCT02276222|473615993|FG001|Overall Study|Protocol Violation|2|||
131544958|NCT02276222|473615992|FG000|Overall Study|Withdrawal by Subject|79|||
131544959|NCT02276222|473615993|FG001|Overall Study|Withdrawal by Subject|33|||
131544960|NCT02276222|473615992|FG000|Overall Study|non compliance with study medication|6|||
131544961|NCT02276222|473615993|FG001|Overall Study|non compliance with study medication|2|||
131544962|NCT02276222|473615992|FG000|Overall Study|sponsor decision|0|||
131544963|NCT02276222|473615993|FG001|Overall Study|sponsor decision|3|||
131544964|NCT02276222|473615992|FG000|Overall Study|Lost to Follow-up|15|||
131544965|NCT02276222|473615993|FG001|Overall Study|Lost to Follow-up|5|||
131544966|NCT02276222|473615992|FG000|Overall Study|Physician Decision|2|||
131544967|NCT02276222|473615993|FG001|Overall Study|Physician Decision|1|||
131544968|NCT02276222|473615992|FG000|Overall Study|sheduling conflict|1|||
131544969|NCT02276222|473615993|FG001|Overall Study|sheduling conflict|0|||
131544970|NCT02276222|473615992|FG000|Overall Study|subject withdrew after randomization|1|||
131544971|NCT02276222|473615993|FG001|Overall Study|subject withdrew after randomization|0|||
131544972|NCT03645759|473615994|FG000|Overall Study|Lost to Follow-up|3|||
131544973|NCT03645759|473615995|FG001|Overall Study|Lost to Follow-up|2|||
131544974|NCT00902694|473615996|FG000|Overall Study|Death|1|||
131544975|NCT00902694|473615997|FG001|Overall Study|Death|3|||
131544976|NCT00902694|473615996|FG000|Overall Study|Lost to Follow-up|1|||
131544977|NCT00902694|473615997|FG001|Overall Study|Lost to Follow-up|0|||
131544978|NCT00902694|473615996|FG000|Overall Study|Censored per protocol|3|||
131544979|NCT00902694|473615997|FG001|Overall Study|Censored per protocol|1|||
131544980|NCT00902694|473615996|FG000|Overall Study|Pregnancy|1|||
131544981|NCT00902694|473615997|FG001|Overall Study|Pregnancy|1|||
131544982|NCT00902694|473615996|FG000|Overall Study|Incarceration|1|||
131544983|NCT00902694|473615997|FG001|Overall Study|Incarceration|0|||
131545040|NCT04922554|473616007|FG000|Overall Study|Adverse Event|4|||
131545041|NCT04922554|473616008|FG001|Overall Study|Adverse Event|0|||
131545042|NCT04922554|473616007|FG000|Overall Study|Withdrawal by Subject|1|||
131545043|NCT04922554|473616008|FG001|Overall Study|Withdrawal by Subject|0|||
131545044|NCT01111123|473617807|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
131545045|NCT01111123|473617808|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
131545046|NCT01111123|473617807|FG000|Maintenance Phase|Lost to Follow-up|0|||
131545047|NCT01111123|473617808|FG001|Maintenance Phase|Lost to Follow-up|2|||
131545048|NCT00119405|473617809|FG000|Overall Study|Withdrawal by Subject|1|||
131545049|NCT03597568|473617829|FG000|Overall Study|Withdrawal by Subject|1|||
131545050|NCT03597568|473617830|FG001|Overall Study|Withdrawal by Subject|1|||
131545051|NCT03597568|473617829|FG000|Overall Study|Unable to analyze vascular data|1|||
131545052|NCT03597568|473617830|FG001|Overall Study|Unable to analyze vascular data|1|||
131545053|NCT01357616|473617831|FG000|Overall Study|Adverse Event|1|||
131545054|NCT01357616|473617832|FG001|Overall Study|Adverse Event|1|||
131545055|NCT01357616|473617831|FG000|Overall Study|Lost to Follow-up|4|||
131545056|NCT01357616|473617832|FG001|Overall Study|Lost to Follow-up|3|||
131545057|NCT01357616|473617831|FG000|Overall Study|Protocol Violation|0|||
131545058|NCT01357616|473617832|FG001|Overall Study|Protocol Violation|2|||
131545059|NCT01357616|473617831|FG000|Overall Study|Inadequate Control of IOP|1|||
131545060|NCT01357616|473617832|FG001|Overall Study|Inadequate Control of IOP|2|||
131545061|NCT01357616|473617831|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
131545062|NCT01357616|473617832|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
131545063|NCT01357616|473617831|FG000|Overall Study|Withdrawal by Subject|1|||
131545064|NCT01357616|473617832|FG001|Overall Study|Withdrawal by Subject|0|||
131545065|NCT01699022|473617837|FG000|Overall Study|Early discontinuation from the study|3|||
131545066|NCT02052310|473617838|FG000|Overall Study|Death|64|||
131545067|NCT02052310|473617839|FG001|Overall Study|Death|54|||
131545068|NCT02052310|473617838|FG000|Overall Study|Withdrawal by Subject|37|||
131545069|NCT02052310|473617839|FG001|Overall Study|Withdrawal by Subject|49|||
131545070|NCT02052310|473617838|FG000|Overall Study|Other than specified|32|||
131545071|NCT02052310|473617839|FG001|Overall Study|Other than specified|29|||
131545072|NCT02052310|473617838|FG000|Overall Study|Adverse Event|29|||
131545073|NCT02052310|473617839|FG001|Overall Study|Adverse Event|22|||
131545074|NCT02052310|473617838|FG000|Overall Study|Kidney Transplant|23|||
131545075|NCT02052310|473617839|FG001|Overall Study|Kidney Transplant|29|||
131545076|NCT02052310|473617838|FG000|Overall Study|Physician Decision|14|||
131545077|NCT02052310|473617839|FG001|Overall Study|Physician Decision|7|||
131545078|NCT02052310|473617838|FG000|Overall Study|Lack of Efficacy|6|||
131545079|NCT02052310|473617839|FG001|Overall Study|Lack of Efficacy|1|||
131545080|NCT02052310|473617838|FG000|Overall Study|Site Terminated by Sponsor|5|||
131545081|NCT02052310|473617839|FG001|Overall Study|Site Terminated by Sponsor|13|||
131545082|NCT02052310|473617838|FG000|Overall Study|Lost to Follow-up|4|||
131545083|NCT02052310|473617839|FG001|Overall Study|Lost to Follow-up|2|||
131545084|NCT02052310|473617838|FG000|Overall Study|Protocol Violation|1|||
131545085|NCT02052310|473617839|FG001|Overall Study|Protocol Violation|6|||
131545086|NCT02066402|473617844|FG000|Overall Study|Adverse Event|1|||
131545087|NCT02066402|473617845|FG001|Overall Study|Adverse Event|2|||
131545088|NCT02066402|473617844|FG000|Overall Study|Lost to Follow-up|11|||
131545089|NCT02066402|473617845|FG001|Overall Study|Lost to Follow-up|8|||
131545090|NCT02066402|473617844|FG000|Overall Study|Withdrawal by Subject|14|||
131545091|NCT02066402|473617845|FG001|Overall Study|Withdrawal by Subject|11|||
131545092|NCT02066402|473617844|FG000|Overall Study|Progressive disease-clinical progression|0|||
131545093|NCT02066402|473617845|FG001|Overall Study|Progressive disease-clinical progression|1|||
131545094|NCT02066402|473617844|FG000|Overall Study|Protocol driven decision point|0|||
131545095|NCT02066402|473617845|FG001|Overall Study|Protocol driven decision point|1|||
131545096|NCT00152464|473617846|FG000|Overall Study|Adverse Event|3|||
131545097|NCT00152464|473617847|FG001|Overall Study|Adverse Event|6|||
131545098|NCT00152464|473617846|FG000|Overall Study|Lost to Follow-up|8|||
131545099|NCT00152464|473617847|FG001|Overall Study|Lost to Follow-up|4|||
131545100|NCT00152464|473617846|FG000|Overall Study|Protocol Violation|3|||
131545101|NCT00152464|473617847|FG001|Overall Study|Protocol Violation|1|||
131545102|NCT00152464|473617846|FG000|Overall Study|Withdrawal by Subject|21|||
131545103|NCT00152464|473617847|FG001|Overall Study|Withdrawal by Subject|22|||
131545104|NCT00152464|473617846|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
131545105|NCT00152464|473617847|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
131545106|NCT00152464|473617846|FG000|Overall Study|Eczema deterioration|0|||
131545107|NCT00152464|473617847|FG001|Overall Study|Eczema deterioration|1|||
131545108|NCT00152464|473617846|FG000|Overall Study|Parent decision|1|||
131545109|NCT00152464|473617847|FG001|Overall Study|Parent decision|1|||
131545110|NCT00152464|473617846|FG000|Overall Study|Investigator decision|1|||
131545111|NCT00152464|473617847|FG001|Overall Study|Investigator decision|0|||
131545112|NCT00152464|473617846|FG000|Overall Study|Lack of Efficacy|1|||
131545113|NCT00152464|473617847|FG001|Overall Study|Lack of Efficacy|0|||
131545114|NCT00152464|473617846|FG000|Overall Study|Eczema poorly controlled|1|||
131545115|NCT00152464|473617847|FG001|Overall Study|Eczema poorly controlled|0|||
131545116|NCT00152464|473617846|FG000|Overall Study|Patient relocated|1|||
131545117|NCT00152464|473617847|FG001|Overall Study|Patient relocated|0|||
131545118|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
131545119|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
131545120|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
131545121|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
131545122|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
131545123|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
131545124|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
131545125|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
131545126|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Other|18|||
131545127|NCT02565914|473617848|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
131545128|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
131545129|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Other|1|||
131545130|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
131545131|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
131545132|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
131545133|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
131545134|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
131545135|NCT02565914|473617848|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
131545136|NCT02565914|473617848|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
131545137|NCT02565914|473617848|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
131545138|NCT02565914|473617848|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
131545139|NCT02565914|473617848|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
131545140|NCT02565914|473617848|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
131545141|NCT02565914|473617848|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
131545142|NCT01505387|473617849|FG000|Overall Study|Protocol Violation|1|||
131545143|NCT01505387|473617850|FG001|Overall Study|Protocol Violation|0|||
131545144|NCT01505387|473617849|FG000|Overall Study|Withdrawal by Subject|1|||
131545145|NCT01505387|473617850|FG001|Overall Study|Withdrawal by Subject|1|||
131545146|NCT01197508|473617857|FG000|Overall Study|Withdrawal by Subject|8|||
131545147|NCT01197508|473617858|FG001|Overall Study|Withdrawal by Subject|7|||
131545148|NCT01197508|473617859|FG002|Overall Study|Withdrawal by Subject|15|||
131545149|NCT01197508|473617860|FG003|Overall Study|Withdrawal by Subject|4|||
131545150|NCT01197508|473617857|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
131545151|NCT01197508|473617858|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
131658606|NCT02003222|474035397|FG002|Induction|Alternative therapy|0|||
131545152|NCT01197508|473617859|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
131545153|NCT01197508|473617860|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
131545154|NCT01197508|473617857|FG000|Overall Study|Adverse Event|10|||
131545155|NCT01197508|473617858|FG001|Overall Study|Adverse Event|13|||
131545156|NCT01197508|473617859|FG002|Overall Study|Adverse Event|23|||
131545157|NCT01197508|473617860|FG003|Overall Study|Adverse Event|3|||
131545158|NCT01197508|473617857|FG000|Overall Study|Severe non-compliance to protocol|0|||
131545159|NCT01197508|473617858|FG001|Overall Study|Severe non-compliance to protocol|3|||
131545160|NCT01197508|473617859|FG002|Overall Study|Severe non-compliance to protocol|1|||
131545161|NCT01197508|473617860|FG003|Overall Study|Severe non-compliance to protocol|3|||
131545162|NCT01197508|473617857|FG000|Overall Study|Condition under investigation worsened|1|||
131545163|NCT01197508|473617858|FG001|Overall Study|Condition under investigation worsened|1|||
131545164|NCT01197508|473617859|FG002|Overall Study|Condition under investigation worsened|1|||
131545165|NCT01197508|473617860|FG003|Overall Study|Condition under investigation worsened|1|||
131545166|NCT01197508|473617857|FG000|Overall Study|Lack of Efficacy|1|||
131545167|NCT01197508|473617858|FG001|Overall Study|Lack of Efficacy|2|||
131545168|NCT01197508|473617859|FG002|Overall Study|Lack of Efficacy|2|||
131545169|NCT01197508|473617860|FG003|Overall Study|Lack of Efficacy|1|||
131545170|NCT01197508|473617857|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131545171|NCT01197508|473617858|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131545172|NCT01197508|473617859|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131545173|NCT01197508|473617860|FG003|Overall Study|Study-specific withdrawal criteria|2|||
131545174|NCT01197508|473617857|FG000|Overall Study|Lost to Follow-up|1|||
131545175|NCT01197508|473617858|FG001|Overall Study|Lost to Follow-up|1|||
131545176|NCT01197508|473617859|FG002|Overall Study|Lost to Follow-up|2|||
131545177|NCT01197508|473617860|FG003|Overall Study|Lost to Follow-up|0|||
131545178|NCT01197508|473617857|FG000|Overall Study|Other|2|||
131545179|NCT01197508|473617858|FG001|Overall Study|Other|3|||
131545180|NCT01197508|473617859|FG002|Overall Study|Other|2|||
131545181|NCT01197508|473617860|FG003|Overall Study|Other|2|||
131545182|NCT00266825|473617861|FG000|Completed Follow-Up|Lost to Follow-up|14|||
131545183|NCT00266825|473617862|FG001|Completed Follow-Up|Lost to Follow-up|19|||
131545184|NCT00266825|473617861|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
131545185|NCT00266825|473617862|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
131545186|NCT01301391|473617865|FG000|Overall Study|Death|13|||
131545187|NCT01301391|473617865|FG000|Overall Study|Lost to Follow-up|3|||
131545188|NCT01301391|473617865|FG000|Overall Study|Physician Decision|2|||
131545189|NCT01301391|473617865|FG000|Overall Study|Sponsor's decision|8|||
131545190|NCT02799784|473617869|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
131545191|NCT02799784|473617870|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
131545192|NCT02799784|473617869|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
131545193|NCT02799784|473617870|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
131545194|NCT02799784|473617869|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
131545195|NCT02799784|473617870|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
131545196|NCT02799784|473617869|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
131545197|NCT02799784|473617870|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
131545198|NCT02799784|473617869|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
131545199|NCT02799784|473617870|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
131545200|NCT02799784|473617869|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
131545201|NCT02799784|473617870|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
131545202|NCT02570126|473617877|FG000|Overall Study|Lost to Follow-up|2|||
131545203|NCT02570126|473617878|FG001|Overall Study|Lost to Follow-up|0|||
131545204|NCT02570126|473617877|FG000|Overall Study|Unable To Arrange Visit 3|1|||
131545205|NCT02570126|473617878|FG001|Overall Study|Unable To Arrange Visit 3|0|||
131545206|NCT02570126|473617877|FG000|Overall Study|Violation Of Procedures GSK|0|||
131545207|NCT02570126|473617878|FG001|Overall Study|Violation Of Procedures GSK|1|||
131545208|NCT02570126|473617877|FG000|Overall Study|Protocol Violation|0|||
131545209|NCT02570126|473617878|FG001|Overall Study|Protocol Violation|1|||
131545210|NCT02570126|473617877|FG000|Overall Study|Withdrawal by Subject|3|||
131545211|NCT02570126|473617878|FG001|Overall Study|Withdrawal by Subject|7|||
131545212|NCT00917579|473617879|FG000|Washout >= 2 Weeks|Adverse Event|1|||
131545213|NCT00917579|473617880|FG001|Washout >= 2 Weeks|Adverse Event|0|||
131545214|NCT00917579|473617879|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
131545215|NCT00917579|473617880|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
131545216|NCT01235546|473617889|FG000|Overall Study|Staff error, medication not administered|1|||
131545217|NCT01235546|473617890|FG001|Overall Study|Staff error, medication not administered|0|||
131545218|NCT01235546|473617889|FG000|Overall Study|Protocol Violation|1|||
131545219|NCT01235546|473617890|FG001|Overall Study|Protocol Violation|1|||
131545220|NCT02740049|473617892|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
131545221|NCT01256411|473617893|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
131545222|NCT01256411|473617894|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
131545223|NCT01256411|473617895|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
131545224|NCT01256411|473617896|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
131658607|NCT02003222|474035398|FG003|Induction|Alternative therapy|0|||
131545225|NCT01256411|473617897|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
131545226|NCT01256411|473617898|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
131545227|NCT01256411|473617893|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
131545228|NCT01256411|473617894|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
131545229|NCT01256411|473617895|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
131545230|NCT01256411|473617896|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
131545231|NCT01256411|473617897|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
131545232|NCT01256411|473617898|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
131545233|NCT01256411|473617893|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
131545234|NCT01256411|473617894|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
131545235|NCT01256411|473617895|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
131545236|NCT01256411|473617896|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
131545237|NCT01256411|473617897|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
131545238|NCT01256411|473617898|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
131545239|NCT01256411|473617893|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
131545240|NCT01256411|473617894|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
131545241|NCT01256411|473617895|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
131545242|NCT01256411|473617896|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
131545243|NCT01256411|473617897|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
131545244|NCT01256411|473617898|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
131545245|NCT01256411|473617893|FG000|Extension by Maximum Treatment|Adverse Event|4|||
131545246|NCT01256411|473617894|FG001|Extension by Maximum Treatment|Adverse Event|2|||
131545247|NCT01256411|473617895|FG002|Extension by Maximum Treatment|Adverse Event|1|||
131545248|NCT01256411|473617896|FG003|Extension by Maximum Treatment|Adverse Event|0|||
131545249|NCT01256411|473617897|FG004|Extension by Maximum Treatment|Adverse Event|0|||
131545250|NCT01256411|473617898|FG005|Extension by Maximum Treatment|Adverse Event|0|||
131545251|NCT01256411|473617893|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
131545252|NCT01256411|473617894|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
131545253|NCT01256411|473617895|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
131545254|NCT01256411|473617896|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
131545255|NCT01256411|473617897|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
131545256|NCT01256411|473617898|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
131545257|NCT01256411|473617893|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
131545258|NCT01256411|473617894|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
131545259|NCT01256411|473617895|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
131545260|NCT01256411|473617896|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
131545261|NCT01256411|473617897|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
131545262|NCT01256411|473617898|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
131545263|NCT01256411|473617893|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
131545264|NCT01256411|473617894|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
131545265|NCT01256411|473617895|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
131545266|NCT01256411|473617896|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
131545267|NCT01256411|473617897|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
131545268|NCT01256411|473617898|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
131545269|NCT01256411|473617893|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
131545270|NCT01256411|473617894|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
131545271|NCT01256411|473617895|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
131545272|NCT01256411|473617896|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
131545273|NCT01256411|473617897|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
131545274|NCT01256411|473617898|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
131545275|NCT01256411|473617893|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
131545276|NCT01256411|473617894|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
131545277|NCT01256411|473617895|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
131545278|NCT01256411|473617896|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
131545279|NCT01256411|473617897|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
131545280|NCT01256411|473617898|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
131545281|NCT02316769|473617899|FG000|Overall Study|Physician Decision|1|||
131545282|NCT02316769|473617900|FG001|Overall Study|Physician Decision|0|||
131545283|NCT02316769|473617899|FG000|Overall Study|Withdrawal by Subject|1|||
131545284|NCT02316769|473617900|FG001|Overall Study|Withdrawal by Subject|0|||
131545285|NCT04535947|473617903|FG000|Overall Study|Adverse Event|1|||
131545286|NCT04535947|473617904|FG001|Overall Study|Adverse Event|4|||
131545287|NCT04535947|473617903|FG000|Overall Study|Other reasons not specified|2|||
131545288|NCT04535947|473617904|FG001|Overall Study|Other reasons not specified|0|||
131545289|NCT04535947|473617903|FG000|Overall Study|Withdrawal by Subject|1|||
131545290|NCT04535947|473617904|FG001|Overall Study|Withdrawal by Subject|1|||
131545291|NCT03002610|473617913|FG000|Overall Study|Withdrawal by Subject|6|||
131545292|NCT03002610|473617914|FG001|Overall Study|Withdrawal by Subject|25|||
131545293|NCT03002610|473617915|FG002|Overall Study|Withdrawal by Subject|13|||
131545294|NCT03802123|473617916|FG000|Overall Study|Withdrawal by Subject|3|||
131545295|NCT03802123|473617916|FG000|Overall Study|Physician Decision|1|||
131545296|NCT03802123|473617916|FG000|Overall Study|Subject moved to hospice care|1|||
131545297|NCT03802123|473617916|FG000|Overall Study|technician error|1|||
131545298|NCT03802123|473617916|FG000|Overall Study|Death|3|||
131545299|NCT01822587|473617917|FG000|Overall Study|Lost to Follow-up|7|||
131545300|NCT01822587|473617918|FG001|Overall Study|Lost to Follow-up|9|||
131545301|NCT01822587|473617919|FG002|Overall Study|Lost to Follow-up|12|||
131545302|NCT01822587|473617917|FG000|Overall Study|Physician Decision|9|||
131545303|NCT01822587|473617918|FG001|Overall Study|Physician Decision|6|||
131545304|NCT01822587|473617919|FG002|Overall Study|Physician Decision|6|||
131545305|NCT01274182|473617920|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
131545306|NCT01274182|473617921|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131545307|NCT01274182|473617922|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
131545308|NCT01274182|473617920|FG000|Overall Study|Adverse Event|4|||
131545309|NCT01274182|473617921|FG001|Overall Study|Adverse Event|5|||
131545310|NCT01274182|473617922|FG002|Overall Study|Adverse Event|3|||
131545311|NCT01274182|473617920|FG000|Overall Study|Withdrawal by Subject|5|||
131545312|NCT01274182|473617921|FG001|Overall Study|Withdrawal by Subject|5|||
131545313|NCT01274182|473617922|FG002|Overall Study|Withdrawal by Subject|3|||
131545314|NCT01274182|473617920|FG000|Overall Study|Lost to Follow-up|2|||
131545315|NCT01274182|473617921|FG001|Overall Study|Lost to Follow-up|3|||
131545316|NCT01274182|473617922|FG002|Overall Study|Lost to Follow-up|1|||
131545317|NCT01274182|473617920|FG000|Overall Study|Protocol Violation|3|||
131545318|NCT01274182|473617921|FG001|Overall Study|Protocol Violation|2|||
131545319|NCT01274182|473617922|FG002|Overall Study|Protocol Violation|0|||
131545320|NCT01274182|473617920|FG000|Overall Study|Death|1|||
131545321|NCT01274182|473617921|FG001|Overall Study|Death|0|||
131545322|NCT01274182|473617922|FG002|Overall Study|Death|1|||
131545323|NCT01362439|473617926|FG000|Overall Study|Adverse Event|1|||
131545324|NCT01362439|473617926|FG000|Overall Study|Lack of Efficacy|3|||
131545325|NCT01362439|473617926|FG000|Overall Study|Lost to Follow-up|2|||
131545326|NCT01362439|473617926|FG000|Overall Study|Study medication non-compliant|1|||
131545327|NCT01362439|473617926|FG000|Overall Study|Participant who withdrew consent|8|||
131545328|NCT00658567|473617927|FG000|Overall Study|Adverse Event|5|||
131545329|NCT00658567|473617928|FG001|Overall Study|Adverse Event|2|||
131545330|NCT00658567|473617929|FG002|Overall Study|Adverse Event|3|||
131545331|NCT00658567|473617927|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
131545332|NCT00658567|473617928|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
131545333|NCT00658567|473617929|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
131545334|NCT00658567|473617927|FG000|Overall Study|Physician Decision|0|||
131545335|NCT00658567|473617928|FG001|Overall Study|Physician Decision|1|||
131545336|NCT00658567|473617929|FG002|Overall Study|Physician Decision|0|||
131545337|NCT00658567|473617927|FG000|Overall Study|At Discretion of Sponsor|1|||
131545338|NCT00658567|473617928|FG001|Overall Study|At Discretion of Sponsor|1|||
131545339|NCT00658567|473617929|FG002|Overall Study|At Discretion of Sponsor|1|||
131545340|NCT01281644|473617930|FG000|Overall Study|Lost to Follow-up|3|||
131545341|NCT01281644|473617930|FG000|Overall Study|Withdrawal by Subject|2|||
131545342|NCT01755702|473617931|FG000|Wash Out Period I|Other Reason|3|||
131545343|NCT01755702|473617931|FG000|Washout Period II|Other Reason|5|||
131545344|NCT03172702|473617934|FG000|Overall Study|Adverse Event|9|||
131545345|NCT03172702|473617934|FG000|Overall Study|Death|2|||
131545346|NCT03172702|473617934|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
131545347|NCT03172702|473617934|FG000|Overall Study|Withdrawal by Subject|5|||
131545348|NCT03172702|473617934|FG000|Overall Study|Other|2|||
131545349|NCT03923959|473617935|FG000|Overall Study|Death|16|||
131545350|NCT03923959|473617936|FG001|Overall Study|Death|12|||
131545351|NCT03923959|473617935|FG000|Overall Study|Lost to Follow-up|56|||
131545352|NCT03923959|473617936|FG001|Overall Study|Lost to Follow-up|56|||
131545353|NCT03923959|473617935|FG000|Overall Study|Withdrawal by Subject|1|||
131545354|NCT03923959|473617936|FG001|Overall Study|Withdrawal by Subject|1|||
131545355|NCT03923959|473617935|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
131545356|NCT03923959|473617936|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
131545357|NCT02954354|473617937|FG000|Overall Study|Adverse Event|2|||
131545358|NCT02954354|473617938|FG001|Overall Study|Adverse Event|2|||
131545359|NCT02954354|473617939|FG002|Overall Study|Adverse Event|4|||
131545360|NCT02954354|473617937|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
131545361|NCT02954354|473617938|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
131545362|NCT02954354|473617939|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
131545363|NCT02954354|473617937|FG000|Overall Study|Lack of Efficacy|0|||
131545364|NCT02954354|473617938|FG001|Overall Study|Lack of Efficacy|2|||
131545365|NCT02954354|473617939|FG002|Overall Study|Lack of Efficacy|0|||
131545366|NCT02954354|473617937|FG000|Overall Study|Withdrawal by Subject|17|||
131545367|NCT02954354|473617938|FG001|Overall Study|Withdrawal by Subject|9|||
131545368|NCT02954354|473617939|FG002|Overall Study|Withdrawal by Subject|11|||
131545369|NCT02954354|473617937|FG000|Overall Study|Lost to Follow-up|12|||
131545370|NCT02954354|473617938|FG001|Overall Study|Lost to Follow-up|5|||
131545371|NCT02954354|473617939|FG002|Overall Study|Lost to Follow-up|0|||
131545372|NCT02954354|473617937|FG000|Overall Study|Miscellaneous|2|||
131545373|NCT02954354|473617938|FG001|Overall Study|Miscellaneous|2|||
131545374|NCT02954354|473617939|FG002|Overall Study|Miscellaneous|1|||
131545375|NCT04495179|473617940|FG000|Overall Study|Lost to Follow-up|0|||
131545376|NCT04495179|473617941|FG001|Overall Study|Lost to Follow-up|1|||
131545377|NCT04495179|473617940|FG000|Overall Study|Withdrawal by Subject|2|||
131545378|NCT04495179|473617941|FG001|Overall Study|Withdrawal by Subject|4|||
131545379|NCT04495179|473617940|FG000|Overall Study|Study terminated by sponsor|0|||
131545380|NCT04495179|473617941|FG001|Overall Study|Study terminated by sponsor|18|||
131545381|NCT04495179|473617940|FG000|Overall Study|Death|0|||
131545382|NCT04495179|473617941|FG001|Overall Study|Death|4|||
131545383|NCT04495179|473617940|FG000|Overall Study|Adverse Event|0|||
131545384|NCT04495179|473617941|FG001|Overall Study|Adverse Event|1|||
131545385|NCT04212091|473617942|FG000|Overall Study|Lost to Follow-up|0|||
131545386|NCT04212091|473617943|FG001|Overall Study|Lost to Follow-up|0|||
131545387|NCT04212091|473617944|FG002|Overall Study|Lost to Follow-up|0|||
131545388|NCT04212091|473617945|FG003|Overall Study|Lost to Follow-up|0|||
131545389|NCT04212091|473617946|FG004|Overall Study|Lost to Follow-up|1|||
131545390|NCT04212091|473617947|FG005|Overall Study|Lost to Follow-up|1|||
131545391|NCT04212091|473617942|FG000|Overall Study|Participant unable to adhere to visit|0|||
131545392|NCT04212091|473617943|FG001|Overall Study|Participant unable to adhere to visit|0|||
131545393|NCT04212091|473617944|FG002|Overall Study|Participant unable to adhere to visit|0|||
131545394|NCT04212091|473617945|FG003|Overall Study|Participant unable to adhere to visit|0|||
131545395|NCT04212091|473617946|FG004|Overall Study|Participant unable to adhere to visit|1|||
131545396|NCT04212091|473617947|FG005|Overall Study|Participant unable to adhere to visit|0|||
131545397|NCT01428076|473617956|FG000|Overall Study|Adverse Event|0|||
131545398|NCT01428076|473617957|FG001|Overall Study|Adverse Event|1|||
131545399|NCT02454101|473617958|FG000|Overall Study|Adverse Event|2|||
131545400|NCT02454101|473617959|FG001|Overall Study|Adverse Event|3|||
131545401|NCT02454101|473617958|FG000|Overall Study|Lost to Follow-up|3|||
131545402|NCT02454101|473617959|FG001|Overall Study|Lost to Follow-up|4|||
131545403|NCT02216773|473617960|FG000|Overall Study|Disease progression|4|||
131545404|NCT02216773|473617961|FG001|Overall Study|Disease progression|2|||
131545405|NCT02216773|473617960|FG000|Overall Study|Insufficient FLRV|4|||
131545406|NCT02216773|473617961|FG001|Overall Study|Insufficient FLRV|0|||
131545407|NCT02216773|473617960|FG000|Overall Study|Abandoned|4|||
131545408|NCT02216773|473617961|FG001|Overall Study|Abandoned|3|||
131545409|NCT04274894|473617962|FG000|Overall Study|Adverse Event|7|||
131545410|NCT04274894|473617962|FG000|Overall Study|Withdrew consent|5|||
131545411|NCT04274894|473617962|FG000|Overall Study|Lost to Follow-up|9|||
131545412|NCT04274894|473617962|FG000|Overall Study|COVID-19 infection|1|||
131545413|NCT04274894|473617962|FG000|Overall Study|Other, not specified|20|||
131545414|NCT04510675|473617963|FG000|Overall Study|Withdrawal by Subject|5|||
131545415|NCT01494584|473617964|FG000|Overall Study|Study Closed/Terminated|1|||
131545416|NCT01666808|473617965|FG000|Overall Study|Lost to Follow-up|9|||
131545417|NCT01666808|473617966|FG001|Overall Study|Lost to Follow-up|15|||
131545418|NCT01666808|473617965|FG000|Overall Study|Withdrawal by Subject|3|||
131545419|NCT01666808|473617966|FG001|Overall Study|Withdrawal by Subject|1|||
131545420|NCT01666808|473617965|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
131545421|NCT01666808|473617966|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
131545422|NCT01499082|473617967|FG000|Overall Study|Randomized but not Treated|0|||
131545423|NCT01499082|473617968|FG001|Overall Study|Randomized but not Treated|1|||
131545424|NCT01499082|473617967|FG000|Overall Study|Adverse Event|12|||
131545425|NCT01499082|473617968|FG001|Overall Study|Adverse Event|16|||
131545426|NCT01499082|473617967|FG000|Overall Study|Lack of Efficacy|1|||
131545427|NCT01499082|473617968|FG001|Overall Study|Lack of Efficacy|1|||
131545428|NCT01499082|473617967|FG000|Overall Study|Protocol Violation|6|||
131545429|NCT01499082|473617968|FG001|Overall Study|Protocol Violation|8|||
131545430|NCT01499082|473617967|FG000|Overall Study|Diverse Reasons|18|||
131545431|NCT01499082|473617968|FG001|Overall Study|Diverse Reasons|14|||
131545432|NCT01499082|473617967|FG000|Overall Study|Site Closure for Noncompliance|5|||
131545433|NCT01499082|473617968|FG001|Overall Study|Site Closure for Noncompliance|2|||
131545434|NCT01499082|473617967|FG000|Overall Study|Hypoglycemia|2|||
131545435|NCT01499082|473617968|FG001|Overall Study|Hypoglycemia|3|||
131545436|NCT01499082|473617967|FG000|Overall Study|Lost to Follow-up|1|||
131545437|NCT01499082|473617968|FG001|Overall Study|Lost to Follow-up|3|||
131545438|NCT00686881|473617974|FG000|Overall Study|Withdrawal by Subject|11|||
131545439|NCT00686881|473617975|FG001|Overall Study|Withdrawal by Subject|18|||
131545440|NCT00686881|473617974|FG000|Overall Study|Lost to Follow-up|0|||
131545441|NCT00686881|473617975|FG001|Overall Study|Lost to Follow-up|1|||
131545442|NCT00686881|473617974|FG000|Overall Study|Treatment-related adverse event|10|||
131545443|NCT00686881|473617975|FG001|Overall Study|Treatment-related adverse event|9|||
131545444|NCT00686881|473617974|FG000|Overall Study|Met discontinuation criteria|5|||
131545445|NCT00686881|473617975|FG001|Overall Study|Met discontinuation criteria|0|||
131545446|NCT00686881|473617974|FG000|Overall Study|Onset of malignant tumor|11|||
131545447|NCT00686881|473617975|FG001|Overall Study|Onset of malignant tumor|11|||
131545448|NCT00686881|473617974|FG000|Overall Study|Lack of Efficacy|4|||
131545449|NCT00686881|473617975|FG001|Overall Study|Lack of Efficacy|3|||
131545450|NCT00686881|473617974|FG000|Overall Study|Physician Decision|1|||
131545451|NCT00686881|473617975|FG001|Overall Study|Physician Decision|0|||
131545452|NCT00686881|473617974|FG000|Overall Study|Circumstances of site|1|||
131545453|NCT00686881|473617975|FG001|Overall Study|Circumstances of site|1|||
131545454|NCT00686881|473617974|FG000|Overall Study|Did not meet protocol eligibility|1|||
131545455|NCT00686881|473617975|FG001|Overall Study|Did not meet protocol eligibility|0|||
131545456|NCT00686881|473617974|FG000|Overall Study|Irregular visits|1|||
131545457|NCT00686881|473617975|FG001|Overall Study|Irregular visits|0|||
131545458|NCT00686881|473617974|FG000|Overall Study|Study discontinuation|35|||
131545459|NCT00686881|473617975|FG001|Overall Study|Study discontinuation|32|||
131545460|NCT00686881|473617974|FG000|Overall Study|Never received study drug|2|||
131545461|NCT00686881|473617975|FG001|Overall Study|Never received study drug|6|||
131545462|NCT05899686|473617976|FG000|Overall Study|Protocol Violation|1|||
131545463|NCT02170025|473617977|FG000|Overall Study|Adverse Event|2|||
131545464|NCT02170025|473617978|FG001|Overall Study|Adverse Event|0|||
131545465|NCT00572195|473617979|FG000|Overall Study|Withdrawal by Subject|50|||
131545466|NCT00572195|473617979|FG000|Overall Study|Death|9|||
131545467|NCT00572195|473617979|FG000|Overall Study|Adverse Event|4|||
131545468|NCT00572195|473617979|FG000|Overall Study|Lost to Follow-up|5|||
131545469|NCT01525602|473617980|FG000|Overall Study|Adverse Event|1|||
131545470|NCT01525602|473617981|FG001|Overall Study|Adverse Event|0|||
131545471|NCT01525602|473617982|FG002|Overall Study|Adverse Event|1|||
131545472|NCT01525602|473617983|FG003|Overall Study|Adverse Event|1|||
131545473|NCT01525602|473617984|FG004|Overall Study|Adverse Event|3|||
131545474|NCT01525602|473617985|FG005|Overall Study|Adverse Event|3|||
131545475|NCT01525602|473617986|FG006|Overall Study|Adverse Event|0|||
131545476|NCT01525602|473617987|FG007|Overall Study|Adverse Event|1|||
131545477|NCT01525602|473617980|FG000|Overall Study|Disease progression|6|||
131545478|NCT01525602|473617981|FG001|Overall Study|Disease progression|3|||
131545479|NCT01525602|473617982|FG002|Overall Study|Disease progression|2|||
131545480|NCT01525602|473617983|FG003|Overall Study|Disease progression|5|||
131545481|NCT01525602|473617984|FG004|Overall Study|Disease progression|22|||
131545482|NCT01525602|473617985|FG005|Overall Study|Disease progression|2|||
131545483|NCT01525602|473617986|FG006|Overall Study|Disease progression|3|||
131545484|NCT01525602|473617987|FG007|Overall Study|Disease progression|3|||
131545485|NCT01525602|473617980|FG000|Overall Study|Clinical progression|2|||
131545486|NCT01525602|473617981|FG001|Overall Study|Clinical progression|0|||
131545487|NCT01525602|473617982|FG002|Overall Study|Clinical progression|0|||
131545488|NCT01525602|473617983|FG003|Overall Study|Clinical progression|0|||
131545489|NCT01525602|473617984|FG004|Overall Study|Clinical progression|0|||
131545490|NCT01525602|473617985|FG005|Overall Study|Clinical progression|0|||
131545491|NCT01525602|473617986|FG006|Overall Study|Clinical progression|1|||
131545492|NCT01525602|473617987|FG007|Overall Study|Clinical progression|1|||
131545493|NCT01525602|473617980|FG000|Overall Study|Non-compliance|0|||
131545494|NCT01525602|473617981|FG001|Overall Study|Non-compliance|0|||
131545495|NCT01525602|473617982|FG002|Overall Study|Non-compliance|0|||
131545496|NCT01525602|473617983|FG003|Overall Study|Non-compliance|0|||
131545497|NCT01525602|473617984|FG004|Overall Study|Non-compliance|1|||
131545498|NCT01525602|473617985|FG005|Overall Study|Non-compliance|0|||
131545499|NCT01525602|473617986|FG006|Overall Study|Non-compliance|0|||
131545500|NCT01525602|473617987|FG007|Overall Study|Non-compliance|0|||
131545501|NCT01525602|473617980|FG000|Overall Study|Withdrawal by Subject|0|||
131545502|NCT01525602|473617981|FG001|Overall Study|Withdrawal by Subject|0|||
131545503|NCT01525602|473617982|FG002|Overall Study|Withdrawal by Subject|0|||
131545504|NCT01525602|473617983|FG003|Overall Study|Withdrawal by Subject|0|||
131545505|NCT01525602|473617984|FG004|Overall Study|Withdrawal by Subject|3|||
131545506|NCT01525602|473617985|FG005|Overall Study|Withdrawal by Subject|1|||
131545507|NCT01525602|473617986|FG006|Overall Study|Withdrawal by Subject|0|||
131545508|NCT01525602|473617987|FG007|Overall Study|Withdrawal by Subject|1|||
131545509|NCT01525602|473617980|FG000|Overall Study|Physician Decision|0|||
131545510|NCT01525602|473617981|FG001|Overall Study|Physician Decision|0|||
131545511|NCT01525602|473617982|FG002|Overall Study|Physician Decision|0|||
131545512|NCT01525602|473617983|FG003|Overall Study|Physician Decision|0|||
131545513|NCT01525602|473617984|FG004|Overall Study|Physician Decision|3|||
131545514|NCT01525602|473617985|FG005|Overall Study|Physician Decision|0|||
131545515|NCT01525602|473617986|FG006|Overall Study|Physician Decision|1|||
131545516|NCT01525602|473617987|FG007|Overall Study|Physician Decision|0|||
131545517|NCT01525602|473617980|FG000|Overall Study|Death|0|||
131545518|NCT01525602|473617981|FG001|Overall Study|Death|0|||
131545519|NCT01525602|473617982|FG002|Overall Study|Death|0|||
131545520|NCT01525602|473617983|FG003|Overall Study|Death|0|||
131545521|NCT01525602|473617984|FG004|Overall Study|Death|1|||
131545522|NCT01525602|473617985|FG005|Overall Study|Death|1|||
131545523|NCT01525602|473617986|FG006|Overall Study|Death|0|||
131545524|NCT01525602|473617987|FG007|Overall Study|Death|0|||
131658608|NCT02003222|474035399|FG004|Induction|Alternative therapy|12|||
131545525|NCT01525602|473617980|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
131545526|NCT01525602|473617981|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
131545527|NCT01525602|473617982|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
131545528|NCT01525602|473617983|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
131545529|NCT01525602|473617984|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
131545530|NCT01525602|473617985|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
131545531|NCT01525602|473617986|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
131545532|NCT01525602|473617987|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
131545533|NCT03657277|473617988|FG000|Overall Study|Physician Decision|2|||
131545534|NCT03657277|473617988|FG000|Overall Study|Lost to Follow-up|1|||
131545535|NCT03657277|473617988|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
131545536|NCT04349280|473617989|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
131545537|NCT04349280|473617990|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
131545538|NCT04349280|473617989|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
131545539|NCT04349280|473617990|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
131545540|NCT04349280|473617989|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
131545541|NCT04349280|473617990|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
131545542|NCT00657618|473617991|FG000|Overall Study|Adverse Event|32|||
131545543|NCT00657618|473617991|FG000|Overall Study|Withdrawal by Subject|8|||
131545544|NCT00657618|473617991|FG000|Overall Study|negative for leishmaniasis|2|||
131545545|NCT00657618|473617991|FG000|Overall Study|didn't start due to schedule conflicts|1|||
131545546|NCT04981678|473617992|FG000|Overall Study|Lost to Follow-up|0|||
131545547|NCT04981678|473617993|FG001|Overall Study|Lost to Follow-up|1|||
131545548|NCT01194570|473619881|FG000|Overall Study|Adverse Event|22|||
131545549|NCT01194570|473619882|FG001|Overall Study|Adverse Event|40|||
131545550|NCT01194570|473619881|FG000|Overall Study|Death|6|||
131545551|NCT01194570|473619882|FG001|Overall Study|Death|20|||
131545552|NCT01194570|473619881|FG000|Overall Study|Lack of Efficacy|32|||
131545553|NCT01194570|473619882|FG001|Overall Study|Lack of Efficacy|33|||
131545554|NCT01194570|473619881|FG000|Overall Study|Lost to Follow-up|4|||
131545555|NCT01194570|473619882|FG001|Overall Study|Lost to Follow-up|15|||
131545556|NCT01194570|473619881|FG000|Overall Study|Non-Compliance|2|||
131545557|NCT01194570|473619882|FG001|Overall Study|Non-Compliance|2|||
131545558|NCT01194570|473619881|FG000|Overall Study|Non-Compliance With Study Drug|2|||
131545559|NCT01194570|473619882|FG001|Overall Study|Non-Compliance With Study Drug|2|||
131545560|NCT01194570|473619881|FG000|Overall Study|Other|18|||
131545561|NCT01194570|473619882|FG001|Overall Study|Other|47|||
131545562|NCT01194570|473619881|FG000|Overall Study|Physician Decision|10|||
131545563|NCT01194570|473619882|FG001|Overall Study|Physician Decision|25|||
131545564|NCT01194570|473619881|FG000|Overall Study|Protocol Violation|1|||
131545565|NCT01194570|473619882|FG001|Overall Study|Protocol Violation|2|||
131545566|NCT01194570|473619881|FG000|Overall Study|Study Terminated By Sponsor|0|||
131545567|NCT01194570|473619882|FG001|Overall Study|Study Terminated By Sponsor|1|||
131545568|NCT01194570|473619881|FG000|Overall Study|Withdrawal by Subject|57|||
131545569|NCT01194570|473619882|FG001|Overall Study|Withdrawal by Subject|82|||
131545570|NCT01194570|473619881|FG000|Overall Study|Pregnancy|1|||
131545571|NCT01194570|473619882|FG001|Overall Study|Pregnancy|1|||
131545572|NCT03076970|473619886|FG000|Washout Period 2|Adverse Event|0|||
131545573|NCT03076970|473619887|FG001|Washout Period 2|Adverse Event|0|||
131545574|NCT03076970|473619888|FG002|Washout Period 2|Adverse Event|0|||
131545575|NCT03076970|473619889|FG003|Washout Period 2|Adverse Event|0|||
131545576|NCT03076970|473619890|FG004|Washout Period 2|Adverse Event|1|||
131545577|NCT03076970|473619891|FG005|Washout Period 2|Adverse Event|0|||
131545578|NCT03076970|473619886|FG000|Period 3|Withdrawal by Subject|0|||
131545579|NCT03076970|473619887|FG001|Period 3|Withdrawal by Subject|0|||
131545580|NCT03076970|473619888|FG002|Period 3|Withdrawal by Subject|0|||
131545581|NCT03076970|473619889|FG003|Period 3|Withdrawal by Subject|0|||
131545582|NCT03076970|473619890|FG004|Period 3|Withdrawal by Subject|0|||
131545583|NCT03076970|473619891|FG005|Period 3|Withdrawal by Subject|1|||
131653851|NCT03307785|474018494|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
131653852|NCT03307785|474018495|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
131653853|NCT03307785|474018485|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
131653854|NCT03307785|474018486|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
131653855|NCT03307785|474018487|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653856|NCT03307785|474018488|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653857|NCT03307785|474018489|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653858|NCT03307785|474018490|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653859|NCT03307785|474018491|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653860|NCT03307785|474018492|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653861|NCT03307785|474018493|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653862|NCT03307785|474018494|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653863|NCT03307785|474018495|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131653864|NCT03307785|474018485|FG000|Part A: Up to 28.5 Months|Death|4|||
131653865|NCT03307785|474018486|FG001|Part A: Up to 28.5 Months|Death|4|||
131653866|NCT03307785|474018487|FG002|Part A: Up to 28.5 Months|Death|0|||
131653867|NCT03307785|474018488|FG003|Part A: Up to 28.5 Months|Death|0|||
131653868|NCT03307785|474018489|FG004|Part A: Up to 28.5 Months|Death|0|||
131653869|NCT03307785|474018490|FG005|Part A: Up to 28.5 Months|Death|0|||
131653870|NCT03307785|474018491|FG006|Part A: Up to 28.5 Months|Death|0|||
131653871|NCT03307785|474018492|FG007|Part A: Up to 28.5 Months|Death|0|||
131653872|NCT03307785|474018493|FG008|Part A: Up to 28.5 Months|Death|0|||
131653873|NCT03307785|474018494|FG009|Part A: Up to 28.5 Months|Death|0|||
131653874|NCT03307785|474018495|FG010|Part A: Up to 28.5 Months|Death|0|||
131653875|NCT03307785|474018485|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
131653876|NCT03307785|474018486|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
131653877|NCT03307785|474018487|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
131653878|NCT03307785|474018488|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
131653879|NCT03307785|474018489|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
131653880|NCT03307785|474018490|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
131653881|NCT03307785|474018491|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
131653882|NCT03307785|474018492|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
131653883|NCT03307785|474018493|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
131653884|NCT03307785|474018494|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
131653885|NCT03307785|474018495|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
131653886|NCT03307785|474018485|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653887|NCT03307785|474018486|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653888|NCT03307785|474018487|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
131653889|NCT03307785|474018488|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653890|NCT03307785|474018489|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653891|NCT03307785|474018490|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653892|NCT03307785|474018491|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653893|NCT03307785|474018492|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653894|NCT03307785|474018493|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653895|NCT03307785|474018494|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653896|NCT03307785|474018495|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
131653897|NCT03307785|474018485|FG000|Part B: Up to Approx. 66 Months|Death|0|||
131653898|NCT03307785|474018486|FG001|Part B: Up to Approx. 66 Months|Death|0|||
131653899|NCT03307785|474018487|FG002|Part B: Up to Approx. 66 Months|Death|7|||
131653900|NCT03307785|474018488|FG003|Part B: Up to Approx. 66 Months|Death|0|||
131653901|NCT03307785|474018489|FG004|Part B: Up to Approx. 66 Months|Death|0|||
131653902|NCT03307785|474018490|FG005|Part B: Up to Approx. 66 Months|Death|0|||
131653903|NCT03307785|474018491|FG006|Part B: Up to Approx. 66 Months|Death|0|||
131653904|NCT03307785|474018492|FG007|Part B: Up to Approx. 66 Months|Death|0|||
131653905|NCT03307785|474018493|FG008|Part B: Up to Approx. 66 Months|Death|0|||
131653906|NCT03307785|474018494|FG009|Part B: Up to Approx. 66 Months|Death|0|||
131653907|NCT03307785|474018495|FG010|Part B: Up to Approx. 66 Months|Death|0|||
131653908|NCT03307785|474018485|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653909|NCT03307785|474018486|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653910|NCT03307785|474018487|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
131653911|NCT03307785|474018488|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653912|NCT03307785|474018489|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653913|NCT03307785|474018490|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653914|NCT03307785|474018491|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653915|NCT03307785|474018492|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653916|NCT03307785|474018493|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653917|NCT03307785|474018494|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653918|NCT03307785|474018495|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131653919|NCT03307785|474018485|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653920|NCT03307785|474018486|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653921|NCT03307785|474018487|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
131653922|NCT03307785|474018488|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653923|NCT03307785|474018489|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653924|NCT03307785|474018490|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653925|NCT03307785|474018491|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653926|NCT03307785|474018492|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653927|NCT03307785|474018493|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653928|NCT03307785|474018494|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653929|NCT03307785|474018495|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131653930|NCT03307785|474018485|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653931|NCT03307785|474018486|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653932|NCT03307785|474018487|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
131653933|NCT03307785|474018488|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653934|NCT03307785|474018489|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653935|NCT03307785|474018490|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653936|NCT03307785|474018491|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653937|NCT03307785|474018492|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653938|NCT03307785|474018493|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653939|NCT03307785|474018494|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653940|NCT03307785|474018495|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131653941|NCT03307785|474018485|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653942|NCT03307785|474018486|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653943|NCT03307785|474018487|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653944|NCT03307785|474018488|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
131653945|NCT03307785|474018489|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
131653946|NCT03307785|474018490|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653947|NCT03307785|474018491|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653948|NCT03307785|474018492|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653949|NCT03307785|474018493|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653950|NCT03307785|474018494|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653951|NCT03307785|474018495|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131653952|NCT03307785|474018485|FG000|Part C: Up to Approx. 60 Months|Death|0|||
131653953|NCT03307785|474018486|FG001|Part C: Up to Approx. 60 Months|Death|0|||
131653954|NCT03307785|474018487|FG002|Part C: Up to Approx. 60 Months|Death|0|||
131653955|NCT03307785|474018488|FG003|Part C: Up to Approx. 60 Months|Death|2|||
131653956|NCT03307785|474018489|FG004|Part C: Up to Approx. 60 Months|Death|5|||
131653957|NCT03307785|474018490|FG005|Part C: Up to Approx. 60 Months|Death|0|||
131653958|NCT03307785|474018491|FG006|Part C: Up to Approx. 60 Months|Death|0|||
131653959|NCT03307785|474018492|FG007|Part C: Up to Approx. 60 Months|Death|0|||
131653960|NCT03307785|474018493|FG008|Part C: Up to Approx. 60 Months|Death|0|||
131653961|NCT03307785|474018494|FG009|Part C: Up to Approx. 60 Months|Death|0|||
131653962|NCT03307785|474018495|FG010|Part C: Up to Approx. 60 Months|Death|0|||
131653963|NCT03307785|474018485|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131545584|NCT03076970|473619886|FG000|Period 3|Failure to meet I/E criteria|0|||
131545585|NCT03076970|473619887|FG001|Period 3|Failure to meet I/E criteria|0|||
131545586|NCT03076970|473619888|FG002|Period 3|Failure to meet I/E criteria|0|||
131545587|NCT03076970|473619889|FG003|Period 3|Failure to meet I/E criteria|0|||
131545588|NCT03076970|473619890|FG004|Period 3|Failure to meet I/E criteria|1|||
131545589|NCT03076970|473619891|FG005|Period 3|Failure to meet I/E criteria|0|||
131545590|NCT02543658|473619892|FG000|Overall Study|Lack of Efficacy|0|||
131545591|NCT02543658|473619893|FG001|Overall Study|Lack of Efficacy|4|||
131545592|NCT00789815|473619894|FG000|Overall Study|Protocol Violation|6|||
131545593|NCT00789815|473619895|FG001|Overall Study|Protocol Violation|1|||
131545594|NCT00789815|473619894|FG000|Overall Study|Intubation due to massive bleeding|1|||
131545595|NCT00789815|473619895|FG001|Overall Study|Intubation due to massive bleeding|0|||
131545596|NCT02035332|473619896|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
131545597|NCT00662857|473619897|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
131545598|NCT00662857|473619898|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
131545599|NCT00662857|473619897|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
131545600|NCT00662857|473619898|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
131545601|NCT00662857|473619897|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
131545602|NCT00662857|473619898|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
131545603|NCT03966053|473619899|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
131545604|NCT01332227|473619901|FG000|Overall Study|Adverse Event|4|||
131545605|NCT01332227|473619902|FG001|Overall Study|Adverse Event|1|||
131545606|NCT01332227|473619901|FG000|Overall Study|Withdrawal by Subject|5|||
131545607|NCT01332227|473619902|FG001|Overall Study|Withdrawal by Subject|1|||
131545608|NCT01332227|473619901|FG000|Overall Study|Lost to Follow-up|2|||
131545609|NCT01332227|473619902|FG001|Overall Study|Lost to Follow-up|0|||
131545610|NCT01332227|473619901|FG000|Overall Study|Lack of Efficacy|3|||
131545611|NCT01332227|473619902|FG001|Overall Study|Lack of Efficacy|1|||
131545612|NCT01332227|473619901|FG000|Overall Study|Poor compliance/noncompliance|1|||
131545613|NCT01332227|473619902|FG001|Overall Study|Poor compliance/noncompliance|1|||
131545614|NCT01332227|473619901|FG000|Overall Study|Patient moved from area|1|||
131545615|NCT01332227|473619902|FG001|Overall Study|Patient moved from area|0|||
131545616|NCT01332227|473619901|FG000|Overall Study|Patient began prohibited medication|0|||
131545617|NCT01332227|473619902|FG001|Overall Study|Patient began prohibited medication|1|||
131545618|NCT00514943|473619903|FG000|Stage 1|Progressive disease|4|||
131545619|NCT00514943|473619904|FG001|Stage 1|Progressive disease|8|||
131653964|NCT03307785|474018486|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653965|NCT03307785|474018487|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653966|NCT03307785|474018488|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
131653967|NCT03307785|474018489|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653968|NCT03307785|474018490|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653969|NCT03307785|474018491|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653970|NCT03307785|474018492|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653971|NCT03307785|474018493|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653972|NCT03307785|474018494|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653973|NCT03307785|474018495|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131653974|NCT03307785|474018485|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653975|NCT03307785|474018486|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653976|NCT03307785|474018487|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653977|NCT03307785|474018488|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653978|NCT03307785|474018489|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
131545620|NCT00514943|473619903|FG000|Stage 1|Other Adverse Event|16|||
131545621|NCT00514943|473619904|FG001|Stage 1|Other Adverse Event|6|||
131545622|NCT00514943|473619903|FG000|Stage 1|Not treated|1|||
131545623|NCT00514943|473619904|FG001|Stage 1|Not treated|2|||
131545624|NCT00514943|473619903|FG000|Stage 1|Patient refused to continue study meds|8|||
131545625|NCT00514943|473619904|FG001|Stage 1|Patient refused to continue study meds|3|||
131545626|NCT00514943|473619903|FG000|Stage 1|Other than stated above|1|||
131545627|NCT00514943|473619904|FG001|Stage 1|Other than stated above|7|||
131545628|NCT00514943|473619903|FG000|Stage 2|Progressive disease|27|||
131545629|NCT00514943|473619904|FG001|Stage 2|Progressive disease|24|||
131545630|NCT00514943|473619903|FG000|Stage 2|Other Adverse Event|3|||
131545631|NCT00514943|473619904|FG001|Stage 2|Other Adverse Event|10|||
131545632|NCT00514943|473619903|FG000|Stage 2|Patient refused to continue study meds|2|||
131545633|NCT00514943|473619904|FG001|Stage 2|Patient refused to continue study meds|0|||
131545634|NCT00514943|473619903|FG000|Stage 2|Other than stated above|0|||
131653979|NCT03307785|474018490|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653980|NCT03307785|474018491|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653981|NCT03307785|474018492|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653982|NCT03307785|474018493|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653983|NCT03307785|474018494|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653984|NCT03307785|474018495|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131653985|NCT03307785|474018485|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653986|NCT03307785|474018486|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653987|NCT03307785|474018487|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653988|NCT03307785|474018488|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653989|NCT03307785|474018489|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653990|NCT03307785|474018490|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
131653991|NCT03307785|474018491|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653992|NCT03307785|474018492|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653993|NCT03307785|474018493|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653994|NCT03307785|474018494|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653995|NCT03307785|474018495|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131653996|NCT03307785|474018485|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
131545635|NCT00514943|473619904|FG001|Stage 2|Other than stated above|2|||
131545636|NCT01783418|473619909|FG000|Overall Study|Withdrawal by Subject|1|||
131545637|NCT01783418|473619910|FG001|Overall Study|Withdrawal by Subject|0|||
131545638|NCT03548207|473619911|FG000|Overall Study|Death|10|||
131545639|NCT03548207|473619912|FG001|Overall Study|Death|23|||
131545640|NCT03548207|473619913|FG002|Overall Study|Death|3|||
131545641|NCT03548207|473619911|FG000|Overall Study|Lost to Follow-up|0|||
131545642|NCT03548207|473619912|FG001|Overall Study|Lost to Follow-up|2|||
131545643|NCT03548207|473619913|FG002|Overall Study|Lost to Follow-up|0|||
131545644|NCT03548207|473619911|FG000|Overall Study|Withdrawal by Subject|0|||
131545645|NCT03548207|473619912|FG001|Overall Study|Withdrawal by Subject|3|||
131545646|NCT03548207|473619913|FG002|Overall Study|Withdrawal by Subject|0|||
131545647|NCT03548207|473619911|FG000|Overall Study|Sponsor decision|19|||
131545648|NCT03548207|473619912|FG001|Overall Study|Sponsor decision|40|||
131545649|NCT03548207|473619913|FG002|Overall Study|Sponsor decision|6|||
131545650|NCT03548207|473619911|FG000|Overall Study|Randomized but not treated|6|||
131545651|NCT03548207|473619912|FG001|Overall Study|Randomized but not treated|10|||
131545652|NCT03548207|473619913|FG002|Overall Study|Randomized but not treated|4|||
131545653|NCT00999466|473619914|FG000|Main Part|Withdrawal by Subject|0|||
131545654|NCT00999466|473619915|FG001|Main Part|Withdrawal by Subject|0|||
131545655|NCT00999466|473619916|FG002|Main Part|Withdrawal by Subject|2|||
131545656|NCT00999466|473619914|FG000|Main Part|Adverse Event|0|||
131545657|NCT00999466|473619915|FG001|Main Part|Adverse Event|4|||
131545658|NCT00999466|473619916|FG002|Main Part|Adverse Event|2|||
131545659|NCT03040713|473619917|FG000|Overall Study|Positive amyloid scan|3|||
131545660|NCT02563002|473619918|FG000|Overall Study|Death|72|||
131545661|NCT02563002|473619919|FG001|Overall Study|Death|87|||
131545662|NCT02563002|473619918|FG000|Overall Study|Lost to Follow-up|5|||
131545663|NCT02563002|473619919|FG001|Overall Study|Lost to Follow-up|0|||
131545664|NCT02563002|473619918|FG000|Overall Study|Physician Decision|0|||
131545665|NCT02563002|473619919|FG001|Overall Study|Physician Decision|2|||
131545666|NCT02563002|473619918|FG000|Overall Study|Withdrawal by Subject|2|||
131545667|NCT02563002|473619919|FG001|Overall Study|Withdrawal by Subject|10|||
131545668|NCT02563002|473619918|FG000|Overall Study|Sponsor decision|74|||
131545669|NCT02563002|473619919|FG001|Overall Study|Sponsor decision|55|||
131545670|NCT03466086|473619920|FG000|Period 1|Sponsor decision due to study timeline|1|||
131545671|NCT03466086|473619921|FG001|Period 1|Sponsor decision due to study timeline|0|||
131545672|NCT03466086|473619920|FG000|Period 1|Withdrawal by Subject|1|||
131545673|NCT03466086|473619921|FG001|Period 1|Withdrawal by Subject|0|||
131545674|NCT00595504|473619922|FG000|Overall Study|Withdrawal by Subject|1|||
131545675|NCT00595504|473619923|FG001|Overall Study|Withdrawal by Subject|3|||
131545676|NCT00595504|473619922|FG000|Overall Study|Physician Decision|1|||
131545677|NCT00595504|473619923|FG001|Overall Study|Physician Decision|0|||
131545678|NCT01949870|473619924|FG000|Overall Study|Lack of Efficacy|2|||
131545679|NCT01949870|473619924|FG000|Overall Study|Adverse Event|1|||
131545680|NCT01949870|473619924|FG000|Overall Study|Study termination|1|||
131545681|NCT01949870|473619924|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
131545682|NCT00677352|473619925|FG000|Treatment Phase|Adverse Event|14|||
131545683|NCT00677352|473619926|FG001|Treatment Phase|Adverse Event|22|||
131545684|NCT00677352|473619925|FG000|Treatment Phase|Lack of Efficacy|2|||
131545685|NCT00677352|473619926|FG001|Treatment Phase|Lack of Efficacy|3|||
131545686|NCT00677352|473619925|FG000|Treatment Phase|Lost to Follow-up|0|||
131653997|NCT03307785|474018486|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
131653998|NCT03307785|474018487|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
131653999|NCT03307785|474018488|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
131654000|NCT03307785|474018489|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
131654001|NCT03307785|474018490|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
131654002|NCT03307785|474018491|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
131654003|NCT03307785|474018492|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
131654004|NCT03307785|474018493|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
131654005|NCT03307785|474018494|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
131654006|NCT03307785|474018495|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
131654007|NCT03307785|474018485|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654008|NCT03307785|474018486|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654009|NCT03307785|474018487|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654010|NCT03307785|474018488|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654011|NCT03307785|474018489|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654012|NCT03307785|474018490|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
131654013|NCT03307785|474018491|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654014|NCT03307785|474018492|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131545687|NCT00677352|473619926|FG001|Treatment Phase|Lost to Follow-up|1|||
131545688|NCT00677352|473619925|FG000|Treatment Phase|Withdrawal by Subject|7|||
131545689|NCT00677352|473619926|FG001|Treatment Phase|Withdrawal by Subject|7|||
131545690|NCT00677352|473619925|FG000|Treatment Phase|Physician Decision|1|||
131545691|NCT00677352|473619926|FG001|Treatment Phase|Physician Decision|0|||
131545692|NCT00677352|473619925|FG000|Treatment Phase|Pregnancy|0|||
131545693|NCT00677352|473619926|FG001|Treatment Phase|Pregnancy|1|||
131545694|NCT00677352|473619925|FG000|Treatment Phase|Protocol Violation|1|||
131545695|NCT00677352|473619926|FG001|Treatment Phase|Protocol Violation|1|||
131545696|NCT00677352|473619925|FG000|Treatment Phase|Transference or work related matter|0|||
131545697|NCT00677352|473619926|FG001|Treatment Phase|Transference or work related matter|5|||
131545698|NCT00677352|473619925|FG000|Treatment Phase|Not treated|0|||
131545699|NCT00677352|473619926|FG001|Treatment Phase|Not treated|2|||
131545700|NCT00677352|473619925|FG000|Tapering Phase|Adverse Event|1|||
131545701|NCT00677352|473619926|FG001|Tapering Phase|Adverse Event|5|||
131545702|NCT00677352|473619925|FG000|Tapering Phase|Withdrawal by Subject|5|||
131545703|NCT00677352|473619926|FG001|Tapering Phase|Withdrawal by Subject|3|||
131545704|NCT00677352|473619925|FG000|Tapering Phase|Pregnancy|0|||
131545705|NCT00677352|473619926|FG001|Tapering Phase|Pregnancy|1|||
131545706|NCT00677352|473619925|FG000|Tapering Phase|Job transfer|0|||
131654015|NCT03307785|474018493|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131545707|NCT00677352|473619926|FG001|Tapering Phase|Job transfer|1|||
131545708|NCT02182973|473619927|FG000|Overall Study|Withdrawal by Subject|3|||
131545709|NCT02182973|473619928|FG001|Overall Study|Withdrawal by Subject|0|||
131545710|NCT01123382|473619929|FG000|Overall Study|Withdrawal by Subject|1|||
131545711|NCT01123382|473619930|FG001|Overall Study|Withdrawal by Subject|4|||
131545712|NCT01123382|473619929|FG000|Overall Study|Lost to Follow-up|1|||
131545713|NCT01123382|473619930|FG001|Overall Study|Lost to Follow-up|2|||
131545714|NCT00594854|473619931|FG000|Overall Study|Study terminated|7|||
131545715|NCT00594854|473619932|FG001|Overall Study|Study terminated|10|||
131545716|NCT06134180|473619943|FG000|Overall Study|Lost to Follow-up|4|||
131545717|NCT03338829|473619944|FG000|Overall Study|Lost to Follow-up|4|||
131545718|NCT03338829|473619945|FG001|Overall Study|Lost to Follow-up|2|||
131545719|NCT03338829|473619946|FG002|Overall Study|Lost to Follow-up|4|||
131545720|NCT03338829|473619944|FG000|Overall Study|Pregnancy loss|1|||
131545721|NCT03338829|473619945|FG001|Overall Study|Pregnancy loss|1|||
131545722|NCT03338829|473619946|FG002|Overall Study|Pregnancy loss|0|||
131545723|NCT03338829|473619944|FG000|Overall Study|Protocol Violation|0|||
131545724|NCT03338829|473619945|FG001|Overall Study|Protocol Violation|1|||
131545725|NCT03338829|473619946|FG002|Overall Study|Protocol Violation|0|||
131545726|NCT02684006|473619947|FG000|Overall Study|Other|18|||
131545727|NCT02684006|473619948|FG001|Overall Study|Other|6|||
131545728|NCT02684006|473619947|FG000|Overall Study|Protocol Violation|2|||
131545729|NCT02684006|473619948|FG001|Overall Study|Protocol Violation|1|||
131545730|NCT02684006|473619947|FG000|Overall Study|Non-compliance with study drug|1|||
131545731|NCT02684006|473619948|FG001|Overall Study|Non-compliance with study drug|1|||
131545732|NCT02684006|473619947|FG000|Overall Study|No longer met eligibility criteria|6|||
131545733|NCT02684006|473619948|FG001|Overall Study|No longer met eligibility criteria|2|||
131545734|NCT02684006|473619947|FG000|Overall Study|Lost to Follow-up|0|||
131545735|NCT02684006|473619948|FG001|Overall Study|Lost to Follow-up|1|||
131545736|NCT02684006|473619947|FG000|Overall Study|Death|25|||
131545737|NCT02684006|473619948|FG001|Overall Study|Death|22|||
131545738|NCT02684006|473619947|FG000|Overall Study|Global deterioration of health status|18|||
131545739|NCT02684006|473619948|FG001|Overall Study|Global deterioration of health status|20|||
131545740|NCT02684006|473619947|FG000|Overall Study|Physician Decision|15|||
131545741|NCT02684006|473619948|FG001|Overall Study|Physician Decision|8|||
131545742|NCT02684006|473619947|FG000|Overall Study|Adverse Event|86|||
131654016|NCT03307785|474018494|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654017|NCT03307785|474018495|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131654018|NCT03307785|474018485|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654019|NCT03307785|474018486|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654020|NCT03307785|474018487|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654021|NCT03307785|474018488|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654022|NCT03307785|474018489|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654023|NCT03307785|474018490|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
131654024|NCT03307785|474018491|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654025|NCT03307785|474018492|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654026|NCT03307785|474018493|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654027|NCT03307785|474018494|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654028|NCT03307785|474018495|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131654029|NCT03307785|474018485|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654030|NCT03307785|474018486|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654031|NCT03307785|474018487|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654032|NCT03307785|474018488|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654033|NCT03307785|474018489|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654034|NCT03307785|474018490|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
131654035|NCT03307785|474018491|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654036|NCT03307785|474018492|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654037|NCT03307785|474018493|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654038|NCT03307785|474018494|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131654039|NCT03307785|474018495|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131545743|NCT02684006|473619948|FG001|Overall Study|Adverse Event|65|||
131545744|NCT02684006|473619947|FG000|Overall Study|Withdrawal by Subject|29|||
131545745|NCT02684006|473619948|FG001|Overall Study|Withdrawal by Subject|43|||
131654040|NCT03307785|474018485|FG000|Part E: Up to 4.4 Months|Death|0|||
131654041|NCT03307785|474018486|FG001|Part E: Up to 4.4 Months|Death|0|||
131654042|NCT03307785|474018487|FG002|Part E: Up to 4.4 Months|Death|0|||
131654043|NCT03307785|474018488|FG003|Part E: Up to 4.4 Months|Death|0|||
131654044|NCT03307785|474018489|FG004|Part E: Up to 4.4 Months|Death|0|||
131654045|NCT03307785|474018490|FG005|Part E: Up to 4.4 Months|Death|0|||
131654046|NCT03307785|474018491|FG006|Part E: Up to 4.4 Months|Death|1|||
131654047|NCT03307785|474018492|FG007|Part E: Up to 4.4 Months|Death|0|||
131654048|NCT03307785|474018493|FG008|Part E: Up to 4.4 Months|Death|0|||
131654049|NCT03307785|474018494|FG009|Part E: Up to 4.4 Months|Death|0|||
131654050|NCT03307785|474018495|FG010|Part E: Up to 4.4 Months|Death|0|||
131654051|NCT03307785|474018485|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
131654052|NCT03307785|474018486|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
131654053|NCT03307785|474018487|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
131654054|NCT03307785|474018488|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
131654055|NCT03307785|474018489|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
131654056|NCT03307785|474018490|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
131654057|NCT03307785|474018491|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
131654058|NCT03307785|474018492|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
131654059|NCT03307785|474018493|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
131654060|NCT03307785|474018494|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
131545746|NCT02684006|473619947|FG000|Overall Study|Progressive disease|236|||
131654061|NCT03307785|474018495|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
131654062|NCT03307785|474018485|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
131654063|NCT03307785|474018486|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
131654064|NCT03307785|474018487|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
131654065|NCT03307785|474018488|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
131654066|NCT03307785|474018489|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
131654067|NCT03307785|474018490|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
131654068|NCT03307785|474018491|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
131654069|NCT03307785|474018492|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
131654070|NCT03307785|474018493|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
131654071|NCT03307785|474018494|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
131654072|NCT03307785|474018495|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
131654073|NCT03217747|474018496|FG000|Overall Study|Adverse Event|0|||
131654074|NCT03217747|474018497|FG001|Overall Study|Adverse Event|1|||
131654075|NCT03217747|474018498|FG002|Overall Study|Adverse Event|0|||
131654076|NCT03217747|474018499|FG003|Overall Study|Adverse Event|0|||
131654077|NCT03217747|474018500|FG004|Overall Study|Adverse Event|0|||
131654078|NCT03217747|474018501|FG005|Overall Study|Adverse Event|0|||
131654079|NCT03217747|474018502|FG006|Overall Study|Adverse Event|0|||
131654080|NCT03217747|474018503|FG007|Overall Study|Adverse Event|0|||
131654081|NCT03217747|474018504|FG008|Overall Study|Adverse Event|0|||
131654082|NCT03217747|474018505|FG009|Overall Study|Adverse Event|0|||
131545747|NCT02684006|473619948|FG001|Overall Study|Progressive disease|266|||
131545748|NCT02684006|473619947|FG000|Overall Study|Participation terminated by sponsor|6|||
131545749|NCT02684006|473619948|FG001|Overall Study|Participation terminated by sponsor|9|||
131545750|NCT01368965|473619952|FG000|Overall Study|Lost to Follow-up|12|||
131545751|NCT00569582|473619963|FG000|Overall Study|Withdrawal by Subject|5|||
131545752|NCT00569582|473619963|FG000|Overall Study|Death|2|||
131545753|NCT00569582|473619963|FG000|Overall Study|Adverse Event|7|||
131545754|NCT00569582|473619963|FG000|Overall Study|Subject was too ill to travel.|1|||
131545755|NCT00569582|473619963|FG000|Overall Study|Subject was non-compliant.|1|||
131545756|NCT02355743|473619967|FG000|Overall Study|Withdrawal by Subject|1|||
131545757|NCT02355743|473619967|FG000|Overall Study|Lost to Follow-up|1|||
131545758|NCT00715429|473619973|FG000|Overall Study|Did not complete the study diary|0|||
131545759|NCT00715429|473619974|FG001|Overall Study|Did not complete the study diary|1|||
131545760|NCT04085328|473619975|FG000|Overall Study|Witihdrew Consent|16|||
131545761|NCT04085328|473619976|FG001|Overall Study|Witihdrew Consent|16|||
131545762|NCT04085328|473619975|FG000|Overall Study|Adverse Event|8|||
131545763|NCT04085328|473619976|FG001|Overall Study|Adverse Event|7|||
131545764|NCT04085328|473619975|FG000|Overall Study|Lost to Follow-up|7|||
131545765|NCT04085328|473619976|FG001|Overall Study|Lost to Follow-up|2|||
131545766|NCT04085328|473619975|FG000|Overall Study|Physician Decision|0|||
131545767|NCT04085328|473619976|FG001|Overall Study|Physician Decision|1|||
131545768|NCT04085328|473619975|FG000|Overall Study|Pregnancy|0|||
131545769|NCT04085328|473619976|FG001|Overall Study|Pregnancy|1|||
131545770|NCT04085328|473619975|FG000|Overall Study|Reasons Related to COVID-19|5|||
131545771|NCT04085328|473619976|FG001|Overall Study|Reasons Related to COVID-19|8|||
131545772|NCT04085328|473619975|FG000|Overall Study|Did not meet inclusion criteria|1|||
131545773|NCT04085328|473619976|FG001|Overall Study|Did not meet inclusion criteria|1|||
131545774|NCT04085328|473619975|FG000|Overall Study|Early termination|1|||
131545775|NCT04085328|473619976|FG001|Overall Study|Early termination|0|||
131545776|NCT00514735|473619977|FG000|Overall Study|Withdrawal by Subject|13|||
131545777|NCT00514735|473619978|FG001|Overall Study|Withdrawal by Subject|5|||
131545778|NCT00514735|473619977|FG000|Overall Study|Death|1|||
131545779|NCT00514735|473619978|FG001|Overall Study|Death|0|||
131545780|NCT00514735|473619977|FG000|Overall Study|Lost to Follow-up|0|||
131545781|NCT00514735|473619978|FG001|Overall Study|Lost to Follow-up|1|||
131545782|NCT02782169|473619979|FG000|Overall Study|Lost to Follow-up|1|||
131545783|NCT02782169|473619980|FG001|Overall Study|Lost to Follow-up|2|||
131545784|NCT02975973|473619981|FG000|Overall Study|Adverse Event|1|||
131545785|NCT02975973|473619982|FG001|Overall Study|Adverse Event|1|||
131545786|NCT02975973|473619983|FG002|Overall Study|Adverse Event|1|||
131545787|NCT02975973|473619984|FG003|Overall Study|Adverse Event|0|||
131545788|NCT00771810|473619985|FG000|Overall Study|Adverse Event|3|||
131545789|NCT00771810|473619986|FG001|Overall Study|Adverse Event|0|||
131545790|NCT00771810|473619987|FG002|Overall Study|Adverse Event|2|||
131545791|NCT00771810|473619985|FG000|Overall Study|Lost to Follow-up|0|||
131545792|NCT00771810|473619986|FG001|Overall Study|Lost to Follow-up|0|||
131545793|NCT00771810|473619987|FG002|Overall Study|Lost to Follow-up|1|||
131545794|NCT00771810|473619985|FG000|Overall Study|Physician Decision|1|||
131545795|NCT00771810|473619986|FG001|Overall Study|Physician Decision|2|||
131545796|NCT00771810|473619987|FG002|Overall Study|Physician Decision|2|||
131545797|NCT00771810|473619985|FG000|Overall Study|Protocol Violation|0|||
131545798|NCT00771810|473619986|FG001|Overall Study|Protocol Violation|1|||
131545799|NCT00771810|473619987|FG002|Overall Study|Protocol Violation|1|||
131545800|NCT00771810|473619985|FG000|Overall Study|Withdrawal by Subject|1|||
131545801|NCT00771810|473619986|FG001|Overall Study|Withdrawal by Subject|2|||
131545802|NCT00771810|473619987|FG002|Overall Study|Withdrawal by Subject|0|||
131545803|NCT00771810|473619985|FG000|Overall Study|Other|0|||
131545804|NCT00771810|473619986|FG001|Overall Study|Other|0|||
131545805|NCT00771810|473619987|FG002|Overall Study|Other|1|||
131545806|NCT00045305|473619993|FG000|Overall Study|Lack of Efficacy|6|||
131545807|NCT00045305|473619993|FG000|Overall Study|Adverse Event|3|||
131545808|NCT00045305|473619993|FG000|Overall Study|Death|3|||
131545809|NCT00045305|473619993|FG000|Overall Study|site error|2|||
131545810|NCT01936857|473619999|FG000|Overall Study|Sent to prison or 06 center|11|||
131545811|NCT01936857|473620000|FG001|Overall Study|Sent to prison or 06 center|12|||
131545812|NCT01936857|473619999|FG000|Overall Study|Lost to Follow-up|10|||
131545813|NCT01936857|473620000|FG001|Overall Study|Lost to Follow-up|7|||
131545814|NCT01936857|473619999|FG000|Overall Study|Death|7|||
131545815|NCT01936857|473620000|FG001|Overall Study|Death|3|||
131545816|NCT01936857|473619999|FG000|Overall Study|Moved|2|||
131545817|NCT01936857|473620000|FG001|Overall Study|Moved|1|||
131545818|NCT01936857|473619999|FG000|Overall Study|Withdrawal by Subject|1|||
131654083|NCT03217747|474018506|FG010|Overall Study|Adverse Event|0|||
131654084|NCT03217747|474018507|FG011|Overall Study|Adverse Event|0|||
131654085|NCT03217747|474018508|FG012|Overall Study|Adverse Event|1|||
131654086|NCT03217747|474018509|FG013|Overall Study|Adverse Event|1|||
131654087|NCT03217747|474018496|FG000|Overall Study|Death|0|||
131654088|NCT03217747|474018497|FG001|Overall Study|Death|0|||
131654089|NCT03217747|474018498|FG002|Overall Study|Death|0|||
131654090|NCT03217747|474018499|FG003|Overall Study|Death|0|||
131654091|NCT03217747|474018500|FG004|Overall Study|Death|0|||
131654092|NCT03217747|474018501|FG005|Overall Study|Death|0|||
131654093|NCT03217747|474018502|FG006|Overall Study|Death|0|||
131654094|NCT03217747|474018503|FG007|Overall Study|Death|0|||
131654095|NCT03217747|474018504|FG008|Overall Study|Death|1|||
131654096|NCT03217747|474018505|FG009|Overall Study|Death|0|||
131654097|NCT03217747|474018506|FG010|Overall Study|Death|0|||
131654098|NCT03217747|474018507|FG011|Overall Study|Death|0|||
131654099|NCT03217747|474018508|FG012|Overall Study|Death|0|||
131654100|NCT03217747|474018509|FG013|Overall Study|Death|0|||
131654101|NCT03217747|474018496|FG000|Overall Study|Lack of Efficacy|12|||
131654102|NCT03217747|474018497|FG001|Overall Study|Lack of Efficacy|6|||
131654103|NCT03217747|474018498|FG002|Overall Study|Lack of Efficacy|15|||
131654104|NCT03217747|474018499|FG003|Overall Study|Lack of Efficacy|11|||
131654105|NCT03217747|474018500|FG004|Overall Study|Lack of Efficacy|3|||
131654106|NCT03217747|474018501|FG005|Overall Study|Lack of Efficacy|14|||
131654107|NCT03217747|474018502|FG006|Overall Study|Lack of Efficacy|10|||
131654108|NCT03217747|474018503|FG007|Overall Study|Lack of Efficacy|4|||
131654109|NCT03217747|474018504|FG008|Overall Study|Lack of Efficacy|2|||
131654110|NCT03217747|474018505|FG009|Overall Study|Lack of Efficacy|7|||
131654111|NCT03217747|474018506|FG010|Overall Study|Lack of Efficacy|3|||
131654112|NCT03217747|474018507|FG011|Overall Study|Lack of Efficacy|1|||
131654113|NCT03217747|474018508|FG012|Overall Study|Lack of Efficacy|3|||
131654114|NCT03217747|474018509|FG013|Overall Study|Lack of Efficacy|1|||
131654115|NCT03217747|474018496|FG000|Overall Study|Withdrawal by Subject|2|||
131654116|NCT03217747|474018497|FG001|Overall Study|Withdrawal by Subject|1|||
131654117|NCT03217747|474018498|FG002|Overall Study|Withdrawal by Subject|1|||
131654118|NCT03217747|474018499|FG003|Overall Study|Withdrawal by Subject|1|||
131654119|NCT03217747|474018500|FG004|Overall Study|Withdrawal by Subject|1|||
131654120|NCT03217747|474018501|FG005|Overall Study|Withdrawal by Subject|2|||
131654121|NCT03217747|474018502|FG006|Overall Study|Withdrawal by Subject|1|||
131654122|NCT03217747|474018503|FG007|Overall Study|Withdrawal by Subject|0|||
131654123|NCT03217747|474018504|FG008|Overall Study|Withdrawal by Subject|0|||
131654124|NCT03217747|474018505|FG009|Overall Study|Withdrawal by Subject|0|||
131654125|NCT03217747|474018506|FG010|Overall Study|Withdrawal by Subject|0|||
131654126|NCT03217747|474018507|FG011|Overall Study|Withdrawal by Subject|1|||
131654127|NCT03217747|474018508|FG012|Overall Study|Withdrawal by Subject|0|||
131654128|NCT03217747|474018509|FG013|Overall Study|Withdrawal by Subject|1|||
131654129|NCT03217747|474018496|FG000|Overall Study|Toxicity and progression|1|||
131654130|NCT03217747|474018497|FG001|Overall Study|Toxicity and progression|0|||
131654131|NCT03217747|474018498|FG002|Overall Study|Toxicity and progression|0|||
131654132|NCT03217747|474018499|FG003|Overall Study|Toxicity and progression|0|||
131654133|NCT03217747|474018500|FG004|Overall Study|Toxicity and progression|0|||
131654134|NCT03217747|474018501|FG005|Overall Study|Toxicity and progression|0|||
131654135|NCT03217747|474018502|FG006|Overall Study|Toxicity and progression|0|||
131654136|NCT03217747|474018503|FG007|Overall Study|Toxicity and progression|0|||
131654137|NCT03217747|474018504|FG008|Overall Study|Toxicity and progression|0|||
131654138|NCT03217747|474018505|FG009|Overall Study|Toxicity and progression|0|||
131654139|NCT03217747|474018506|FG010|Overall Study|Toxicity and progression|0|||
131654140|NCT03217747|474018507|FG011|Overall Study|Toxicity and progression|0|||
131654141|NCT03217747|474018508|FG012|Overall Study|Toxicity and progression|0|||
131654142|NCT03217747|474018509|FG013|Overall Study|Toxicity and progression|0|||
131545819|NCT01936857|473620000|FG001|Overall Study|Withdrawal by Subject|0|||
131545820|NCT01936857|473619999|FG000|Overall Study|Side effect of medication|1|||
131654143|NCT03217747|474018496|FG000|Overall Study|Removal of sole target lesion|1|||
131654144|NCT03217747|474018497|FG001|Overall Study|Removal of sole target lesion|0|||
131654145|NCT03217747|474018498|FG002|Overall Study|Removal of sole target lesion|0|||
131654146|NCT03217747|474018499|FG003|Overall Study|Removal of sole target lesion|0|||
131654147|NCT03217747|474018500|FG004|Overall Study|Removal of sole target lesion|0|||
131654148|NCT03217747|474018501|FG005|Overall Study|Removal of sole target lesion|0|||
131654149|NCT03217747|474018502|FG006|Overall Study|Removal of sole target lesion|0|||
131654150|NCT03217747|474018503|FG007|Overall Study|Removal of sole target lesion|0|||
131654151|NCT03217747|474018504|FG008|Overall Study|Removal of sole target lesion|0|||
131654152|NCT03217747|474018505|FG009|Overall Study|Removal of sole target lesion|0|||
131654153|NCT03217747|474018506|FG010|Overall Study|Removal of sole target lesion|0|||
131654154|NCT03217747|474018507|FG011|Overall Study|Removal of sole target lesion|0|||
131654155|NCT03217747|474018508|FG012|Overall Study|Removal of sole target lesion|0|||
131654156|NCT03217747|474018509|FG013|Overall Study|Removal of sole target lesion|0|||
131654157|NCT03217747|474018496|FG000|Overall Study|Stroke|0|||
131654158|NCT03217747|474018497|FG001|Overall Study|Stroke|0|||
131654159|NCT03217747|474018498|FG002|Overall Study|Stroke|0|||
131654160|NCT03217747|474018499|FG003|Overall Study|Stroke|0|||
131654161|NCT03217747|474018500|FG004|Overall Study|Stroke|0|||
131654162|NCT03217747|474018501|FG005|Overall Study|Stroke|1|||
131654163|NCT03217747|474018502|FG006|Overall Study|Stroke|0|||
131654164|NCT03217747|474018503|FG007|Overall Study|Stroke|0|||
131654165|NCT03217747|474018504|FG008|Overall Study|Stroke|0|||
131654166|NCT03217747|474018505|FG009|Overall Study|Stroke|0|||
131654167|NCT03217747|474018506|FG010|Overall Study|Stroke|0|||
131654168|NCT03217747|474018507|FG011|Overall Study|Stroke|1|||
131654169|NCT03217747|474018508|FG012|Overall Study|Stroke|0|||
131654170|NCT03217747|474018509|FG013|Overall Study|Stroke|0|||
131654171|NCT04103892|474018510|FG000|Overall Study|Adverse Event|0|||
131654172|NCT04103892|474018511|FG001|Overall Study|Adverse Event|0|||
131654173|NCT04103892|474018512|FG002|Overall Study|Adverse Event|0|||
131654174|NCT04103892|474018513|FG003|Overall Study|Adverse Event|3|||
131654175|NCT04103892|474018510|FG000|Overall Study|Lost to Follow-up|0|||
131654176|NCT04103892|474018511|FG001|Overall Study|Lost to Follow-up|0|||
131654177|NCT04103892|474018512|FG002|Overall Study|Lost to Follow-up|2|||
131654178|NCT04103892|474018513|FG003|Overall Study|Lost to Follow-up|0|||
131654179|NCT04103892|474018510|FG000|Overall Study|Protocol Violation|0|||
131654180|NCT04103892|474018511|FG001|Overall Study|Protocol Violation|0|||
131654181|NCT04103892|474018512|FG002|Overall Study|Protocol Violation|1|||
131654182|NCT04103892|474018513|FG003|Overall Study|Protocol Violation|1|||
131654183|NCT04103892|474018510|FG000|Overall Study|Withdrawal by Subject|1|||
131654184|NCT04103892|474018511|FG001|Overall Study|Withdrawal by Subject|0|||
131654185|NCT04103892|474018512|FG002|Overall Study|Withdrawal by Subject|2|||
131654186|NCT04103892|474018513|FG003|Overall Study|Withdrawal by Subject|5|||
131654187|NCT04103892|474018510|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
131654188|NCT04103892|474018511|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
131654189|NCT04103892|474018512|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
131654190|NCT04103892|474018513|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
131654191|NCT05217641|474018514|FG000|Overall Study|Lost to Follow-up|1|||
131654192|NCT05217641|474018515|FG001|Overall Study|Lost to Follow-up|1|||
131654193|NCT05217641|474018516|FG002|Overall Study|Lost to Follow-up|0|||
131654194|NCT05217641|474018517|FG003|Overall Study|Lost to Follow-up|1|||
131654195|NCT05217641|474018518|FG004|Overall Study|Lost to Follow-up|1|||
131654196|NCT05217641|474018519|FG005|Overall Study|Lost to Follow-up|0|||
131654197|NCT05217641|474018514|FG000|Overall Study|Withdrawal by Subject|0|||
131654198|NCT05217641|474018515|FG001|Overall Study|Withdrawal by Subject|0|||
131654199|NCT05217641|474018516|FG002|Overall Study|Withdrawal by Subject|0|||
131654200|NCT05217641|474018517|FG003|Overall Study|Withdrawal by Subject|3|||
131654201|NCT05217641|474018518|FG004|Overall Study|Withdrawal by Subject|1|||
131654202|NCT05217641|474018519|FG005|Overall Study|Withdrawal by Subject|0|||
131654203|NCT05217641|474018514|FG000|Overall Study|Other: participant did not specify reason|0|||
131654204|NCT05217641|474018515|FG001|Overall Study|Other: participant did not specify reason|0|||
131654205|NCT05217641|474018516|FG002|Overall Study|Other: participant did not specify reason|0|||
131654206|NCT05217641|474018517|FG003|Overall Study|Other: participant did not specify reason|0|||
131654207|NCT05217641|474018518|FG004|Overall Study|Other: participant did not specify reason|1|||
131654208|NCT05217641|474018519|FG005|Overall Study|Other: participant did not specify reason|0|||
131654209|NCT05217641|474018514|FG000|Overall Study|Extended Follow up|1|||
131654210|NCT05217641|474018515|FG001|Overall Study|Extended Follow up|1|||
131654211|NCT05217641|474018516|FG002|Overall Study|Extended Follow up|0|||
131654212|NCT05217641|474018517|FG003|Overall Study|Extended Follow up|0|||
131654213|NCT05217641|474018518|FG004|Overall Study|Extended Follow up|1|||
131654214|NCT05217641|474018519|FG005|Overall Study|Extended Follow up|0|||
131654215|NCT03939689|474019277|FG000|Overall Study|Radiographic progression|14|||
131654216|NCT03939689|474019278|FG001|Overall Study|Radiographic progression|17|||
131654217|NCT03939689|474019277|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
131654218|NCT03939689|474019278|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
131654219|NCT03939689|474019277|FG000|Overall Study|Adverse Event|1|||
131654220|NCT03939689|474019278|FG001|Overall Study|Adverse Event|8|||
131654221|NCT03939689|474019277|FG000|Overall Study|Unequivocal clinical progression|2|||
131654222|NCT03939689|474019278|FG001|Overall Study|Unequivocal clinical progression|5|||
131654223|NCT03939689|474019277|FG000|Overall Study|Other|1|||
131654224|NCT03939689|474019278|FG001|Overall Study|Other|4|||
131654225|NCT03939689|474019277|FG000|Overall Study|Death|0|||
131654226|NCT03939689|474019278|FG001|Overall Study|Death|3|||
131654227|NCT03939689|474019277|FG000|Overall Study|Participant decision|0|||
131654228|NCT03939689|474019278|FG001|Overall Study|Participant decision|3|||
131654229|NCT03939689|474019277|FG000|Overall Study|Withdrawal of consent|2|||
131654230|NCT03939689|474019278|FG001|Overall Study|Withdrawal of consent|1|||
131654231|NCT03939689|474019277|FG000|Overall Study|Investigator decision|1|||
131654232|NCT03939689|474019278|FG001|Overall Study|Investigator decision|0|||
131654233|NCT02964013|474019279|FG000|Overall Study|Death|58|||
131654234|NCT02964013|474019280|FG001|Overall Study|Death|239|||
131654235|NCT02964013|474019281|FG002|Overall Study|Death|38|||
131654236|NCT02964013|474019282|FG003|Overall Study|Death|10|||
131654237|NCT02964013|474019283|FG004|Overall Study|Death|33|||
131654238|NCT02964013|474019279|FG000|Overall Study|Lost to Follow-up|1|||
131654239|NCT02964013|474019280|FG001|Overall Study|Lost to Follow-up|4|||
131654240|NCT02964013|474019281|FG002|Overall Study|Lost to Follow-up|2|||
131654241|NCT02964013|474019282|FG003|Overall Study|Lost to Follow-up|0|||
131654242|NCT02964013|474019283|FG004|Overall Study|Lost to Follow-up|0|||
131654243|NCT02964013|474019279|FG000|Overall Study|Physician Decision|0|||
131654244|NCT02964013|474019280|FG001|Overall Study|Physician Decision|1|||
131654245|NCT02964013|474019281|FG002|Overall Study|Physician Decision|0|||
131654246|NCT02964013|474019282|FG003|Overall Study|Physician Decision|0|||
131654247|NCT02964013|474019283|FG004|Overall Study|Physician Decision|0|||
131654248|NCT02964013|474019279|FG000|Overall Study|Sponsor Decision|3|||
131654249|NCT02964013|474019280|FG001|Overall Study|Sponsor Decision|22|||
131654250|NCT02964013|474019281|FG002|Overall Study|Sponsor Decision|11|||
131654251|NCT02964013|474019282|FG003|Overall Study|Sponsor Decision|0|||
131654252|NCT02964013|474019283|FG004|Overall Study|Sponsor Decision|7|||
131654253|NCT02964013|474019279|FG000|Overall Study|Withdrawal by Subject|6|||
131654254|NCT02964013|474019280|FG001|Overall Study|Withdrawal by Subject|27|||
131654255|NCT02964013|474019281|FG002|Overall Study|Withdrawal by Subject|9|||
131654256|NCT02964013|474019282|FG003|Overall Study|Withdrawal by Subject|0|||
131654257|NCT02964013|474019283|FG004|Overall Study|Withdrawal by Subject|0|||
131654258|NCT02964013|474019279|FG000|Overall Study|Not Treated|0|||
131654259|NCT02964013|474019280|FG001|Overall Study|Not Treated|2|||
131654260|NCT02964013|474019281|FG002|Overall Study|Not Treated|0|||
131654261|NCT02964013|474019282|FG003|Overall Study|Not Treated|1|||
131654262|NCT02964013|474019283|FG004|Overall Study|Not Treated|0|||
131654263|NCT05332912|474019289|FG000|Overall Study|Withdrawal by Subject|0|||
131654264|NCT05332912|474019290|FG001|Overall Study|Withdrawal by Subject|1|||
131654265|NCT05332912|474019291|FG002|Overall Study|Withdrawal by Subject|2|||
131654266|NCT05332912|474019292|FG003|Overall Study|Withdrawal by Subject|0|||
131654267|NCT05332912|474019289|FG000|Overall Study|Lost to Follow-up|0|||
131654268|NCT05332912|474019290|FG001|Overall Study|Lost to Follow-up|0|||
131654269|NCT05332912|474019291|FG002|Overall Study|Lost to Follow-up|1|||
131654270|NCT05332912|474019292|FG003|Overall Study|Lost to Follow-up|0|||
131654271|NCT04868539|474019295|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
131654272|NCT04868539|474019296|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
131654273|NCT05479734|474019299|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
131654274|NCT05479734|474019300|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
131654275|NCT05479734|474019299|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
131654276|NCT05479734|474019300|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
131654277|NCT05479734|474019299|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
131654278|NCT05479734|474019300|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
131654279|NCT05479734|474019299|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
131654280|NCT05479734|474019300|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
131654281|NCT06285240|474019301|FG000|Overall Study|Withdrawal by Subject|2|||
131654282|NCT06285240|474019302|FG001|Overall Study|Withdrawal by Subject|0|||
131654283|NCT06285240|474019303|FG002|Overall Study|Withdrawal by Subject|0|||
131654284|NCT06285240|474019304|FG003|Overall Study|Withdrawal by Subject|0|||
131654285|NCT06285240|474019301|FG000|Overall Study|Serious Adverse Event|0|||
131654286|NCT06285240|474019302|FG001|Overall Study|Serious Adverse Event|0|||
131654287|NCT06285240|474019303|FG002|Overall Study|Serious Adverse Event|1|||
131654288|NCT06285240|474019304|FG003|Overall Study|Serious Adverse Event|0|||
131654289|NCT04428151|474019305|FG000|Overall Study|Death|100|||
131654290|NCT04428151|474019306|FG001|Overall Study|Death|86|||
131654291|NCT04428151|474019307|FG002|Overall Study|Death|57|||
131654292|NCT04428151|474019305|FG000|Overall Study|Lost to Follow-up|1|||
131654293|NCT04428151|474019306|FG001|Overall Study|Lost to Follow-up|1|||
131654294|NCT04428151|474019307|FG002|Overall Study|Lost to Follow-up|0|||
131654295|NCT04428151|474019305|FG000|Overall Study|Withdrawal by Subject|2|||
131654296|NCT04428151|474019306|FG001|Overall Study|Withdrawal by Subject|2|||
131654297|NCT04428151|474019307|FG002|Overall Study|Withdrawal by Subject|3|||
131654298|NCT04428151|474019305|FG000|Overall Study|Participant Ongoing in Study|41|||
131654299|NCT04428151|474019306|FG001|Overall Study|Participant Ongoing in Study|53|||
131654300|NCT04428151|474019307|FG002|Overall Study|Participant Ongoing in Study|28|||
131654301|NCT06152224|474019308|FG000|Overall Study|Withdrawal by Subject|1|||
131654302|NCT06152224|474019309|FG001|Overall Study|Withdrawal by Subject|0|||
131654303|NCT06152224|474019308|FG000|Overall Study|Lost to Follow-up|0|||
131654304|NCT06152224|474019309|FG001|Overall Study|Lost to Follow-up|1|||
131654305|NCT06152224|474019308|FG000|Overall Study|On Follow Up|18|||
131654306|NCT06152224|474019309|FG001|Overall Study|On Follow Up|18|||
131654307|NCT02367040|474019313|FG000|Overall Study|Lost to Follow-up|1|||
131654308|NCT02367040|474019314|FG001|Overall Study|Lost to Follow-up|1|||
131654309|NCT02367040|474019313|FG000|Overall Study|Lack of Efficacy|1|||
131654310|NCT02367040|474019314|FG001|Overall Study|Lack of Efficacy|0|||
131654311|NCT02367040|474019313|FG000|Overall Study|Additional primary malignancy|1|||
131654312|NCT02367040|474019314|FG001|Overall Study|Additional primary malignancy|1|||
131654313|NCT02367040|474019313|FG000|Overall Study|AE not associated with clinical disease progression|117|||
131654314|NCT02367040|474019314|FG001|Overall Study|AE not associated with clinical disease progression|12|||
131654315|NCT02367040|474019313|FG000|Overall Study|AE associated with clinical disease progression|1|||
131654316|NCT02367040|474019314|FG001|Overall Study|AE associated with clinical disease progression|4|||
131654317|NCT02367040|474019313|FG000|Overall Study|Physician Decision|2|||
131654318|NCT02367040|474019314|FG001|Overall Study|Physician Decision|8|||
131654319|NCT02367040|474019313|FG000|Overall Study|Non-compliance to study drug|1|||
131654320|NCT02367040|474019314|FG001|Overall Study|Non-compliance to study drug|0|||
131654321|NCT02367040|474019313|FG000|Overall Study|Failure to meet continuation criteria|1|||
131654322|NCT02367040|474019314|FG001|Overall Study|Failure to meet continuation criteria|0|||
131654323|NCT02367040|474019313|FG000|Overall Study|Switching to other therapy|2|||
131654324|NCT02367040|474019314|FG001|Overall Study|Switching to other therapy|0|||
131654325|NCT02367040|474019313|FG000|Overall Study|Withdrawal by Subject|51|||
131654326|NCT02367040|474019314|FG001|Overall Study|Withdrawal by Subject|16|||
131654327|NCT02367040|474019313|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
131654328|NCT02367040|474019314|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131654329|NCT02367040|474019313|FG000|Overall Study|Patient decision|40|||
131654330|NCT02367040|474019314|FG001|Overall Study|Patient decision|14|||
131654331|NCT02367040|474019313|FG000|Overall Study|Required procedure failed|1|||
131654332|NCT02367040|474019314|FG001|Overall Study|Required procedure failed|0|||
131654333|NCT02367040|474019313|FG000|Overall Study|Randomized by mistake with study treatment|1|||
131654334|NCT02367040|474019314|FG001|Overall Study|Randomized by mistake with study treatment|0|||
131654335|NCT02367040|474019313|FG000|Overall Study|Protocol Violation|1|||
131654336|NCT02367040|474019314|FG001|Overall Study|Protocol Violation|0|||
131654337|NCT02367040|474019313|FG000|Overall Study|Progressive disease - radiological progression|54|||
131654338|NCT02367040|474019314|FG001|Overall Study|Progressive disease - radiological progression|80|||
131654339|NCT02367040|474019313|FG000|Overall Study|Progressive disease - clinical progression|6|||
131654340|NCT02367040|474019314|FG001|Overall Study|Progressive disease - clinical progression|6|||
131654341|NCT02367040|474019313|FG000|Overall Study|Drug not administered|3|||
131654342|NCT02367040|474019314|FG001|Overall Study|Drug not administered|2|||
131654343|NCT02367040|474019313|FG000|Overall Study|Progressive disease|0|||
131654344|NCT02367040|474019314|FG001|Overall Study|Progressive disease|1|||
131654345|NCT02367040|474019313|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
131654346|NCT02367040|474019314|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
131654347|NCT02367040|474019313|FG000|Overall Study|Death|2|||
131654348|NCT02367040|474019314|FG001|Overall Study|Death|0|||
131654349|NCT02367040|474019313|FG000|Overall Study|Study terminated by sponsor|19|||
131654350|NCT02367040|474019314|FG001|Overall Study|Study terminated by sponsor|2|||
131654351|NCT02477618|474019315|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
131654352|NCT02477618|474019316|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
131654353|NCT02477618|474019315|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
131654354|NCT02477618|474019316|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
131654355|NCT02477618|474019315|FG000|Overall Study|Adverse Event|1|||
131654356|NCT02477618|474019316|FG001|Overall Study|Adverse Event|1|||
131654357|NCT02477618|474019315|FG000|Overall Study|Transferred Away from Study Site|1|||
131654358|NCT02477618|474019316|FG001|Overall Study|Transferred Away from Study Site|0|||
131654359|NCT02477618|474019315|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
131654360|NCT02477618|474019316|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
131654361|NCT01892722|474019317|FG000|Overall Study|Protocol deviation|0|||
131654362|NCT01892722|474019318|FG001|Overall Study|Protocol deviation|1|||
131654363|NCT01892722|474019317|FG000|Overall Study|Administrative problems|0|||
131654364|NCT01892722|474019318|FG001|Overall Study|Administrative problems|1|||
131654365|NCT01892722|474019317|FG000|Overall Study|Patient/guardian decision|0|||
131654366|NCT01892722|474019318|FG001|Overall Study|Patient/guardian decision|2|||
131654367|NCT01892722|474019317|FG000|Overall Study|Physician Decision|1|||
131654368|NCT01892722|474019318|FG001|Overall Study|Physician Decision|2|||
131654369|NCT01892722|474019317|FG000|Overall Study|Adverse Event|3|||
131654370|NCT01892722|474019318|FG001|Overall Study|Adverse Event|2|||
131654371|NCT01892722|474019317|FG000|Overall Study|Lack of Efficacy|0|||
131654372|NCT01892722|474019318|FG001|Overall Study|Lack of Efficacy|7|||
131654373|NCT01892722|474019317|FG000|Overall Study|Withdrawal by Subject|3|||
131654374|NCT01892722|474019318|FG001|Overall Study|Withdrawal by Subject|5|||
131654375|NCT03007420|474019319|FG000|Overall Study|Withdrawal by Subject|0|||
131654376|NCT03007420|474019320|FG001|Overall Study|Withdrawal by Subject|2|||
131654377|NCT03007420|474019319|FG000|Overall Study|Physician Decision|0|||
131654378|NCT03007420|474019320|FG001|Overall Study|Physician Decision|1|||
131654379|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
131654380|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
131654381|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
131654382|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
131654383|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
131654384|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
131654385|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
131654386|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
131654387|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
131654388|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
131654389|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
131654390|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
131654391|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131654392|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
131654393|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131654394|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131654395|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131654396|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131654397|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131654398|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
131654399|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131654400|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131654401|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131654402|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131654403|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131654404|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131654405|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
131654406|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131654407|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131654408|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131654409|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131654410|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
131654411|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
131654412|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131654413|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131654414|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131654415|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
131654416|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
131654417|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
131654418|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
131654419|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
131654420|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
131654421|NCT03524092|474019327|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
131654422|NCT03524092|474019328|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
131654423|NCT03524092|474019329|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
131654424|NCT03524092|474019330|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
131654425|NCT03524092|474019331|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
131654426|NCT03524092|474019332|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
131654427|NCT03524092|474019327|FG000|Loss of Response Rescue Period|Adverse Event|0|||
131654428|NCT03524092|474019328|FG001|Loss of Response Rescue Period|Adverse Event|0|||
131654429|NCT03524092|474019329|FG002|Loss of Response Rescue Period|Adverse Event|0|||
131654430|NCT03524092|474019330|FG003|Loss of Response Rescue Period|Adverse Event|2|||
131654431|NCT03524092|474019331|FG004|Loss of Response Rescue Period|Adverse Event|0|||
131654432|NCT03524092|474019332|FG005|Loss of Response Rescue Period|Adverse Event|0|||
131654433|NCT03524092|474019327|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
131654434|NCT03524092|474019328|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
131654435|NCT03524092|474019329|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
131654436|NCT03524092|474019330|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
131654437|NCT03524092|474019331|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
131654438|NCT03524092|474019332|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
131654439|NCT03524092|474019327|FG000|Loss of Response Rescue Period|Pregnancy|0|||
131654440|NCT03524092|474019328|FG001|Loss of Response Rescue Period|Pregnancy|0|||
131654441|NCT03524092|474019329|FG002|Loss of Response Rescue Period|Pregnancy|0|||
131654442|NCT03524092|474019330|FG003|Loss of Response Rescue Period|Pregnancy|1|||
131654443|NCT03524092|474019331|FG004|Loss of Response Rescue Period|Pregnancy|0|||
131654444|NCT03524092|474019332|FG005|Loss of Response Rescue Period|Pregnancy|0|||
131654445|NCT03524092|474019327|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131654446|NCT03524092|474019328|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131654447|NCT03524092|474019329|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131654448|NCT03524092|474019330|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
131654449|NCT03524092|474019331|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131654450|NCT03524092|474019332|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131654451|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131654452|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131654453|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131654454|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131654455|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
131654456|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131654457|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131654458|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131654459|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131654460|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131654461|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
131654462|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131654463|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131654464|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131654465|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131654466|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131654467|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
131654468|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131654469|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131654470|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131654471|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131654472|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131654473|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
131654474|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131654475|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131654476|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131654477|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131654478|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131654479|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
131654480|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131654481|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131654482|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131654483|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131654484|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131654485|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
131654486|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131654487|NCT03524092|474019327|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131654488|NCT03524092|474019328|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131654489|NCT03524092|474019329|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131654490|NCT03524092|474019330|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131654491|NCT03524092|474019331|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
131654492|NCT03524092|474019332|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131654493|NCT03524092|474019327|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131654494|NCT03524092|474019328|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131654495|NCT03524092|474019329|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131654496|NCT03524092|474019330|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131654497|NCT03524092|474019331|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131654498|NCT03524092|474019332|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
131654499|NCT03524092|474019327|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131654500|NCT03524092|474019328|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131654501|NCT03524092|474019329|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131654502|NCT03524092|474019330|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131654503|NCT03524092|474019331|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131654504|NCT03524092|474019332|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
131654505|NCT03524092|474019327|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131654506|NCT03524092|474019328|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131654507|NCT03524092|474019329|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131654508|NCT03524092|474019330|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131654509|NCT03524092|474019331|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131654510|NCT03524092|474019332|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
131654511|NCT03524092|474019327|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131654512|NCT03524092|474019328|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131654513|NCT03524092|474019329|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131654514|NCT03524092|474019330|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131654515|NCT03524092|474019331|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131654516|NCT03524092|474019332|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
131654517|NCT04303780|474019333|FG000|Overall Study|Death|104|||
131654518|NCT04303780|474019334|FG001|Overall Study|Death|85|||
131654519|NCT04303780|474019333|FG000|Overall Study|Lost to Follow-up|5|||
131654520|NCT04303780|474019334|FG001|Overall Study|Lost to Follow-up|2|||
131654521|NCT04303780|474019333|FG000|Overall Study|Withdrawal by Subject|12|||
131654522|NCT04303780|474019334|FG001|Overall Study|Withdrawal by Subject|39|||
131654523|NCT04303780|474019333|FG000|Overall Study|Ongoing in study|50|||
131654524|NCT04303780|474019334|FG001|Overall Study|Ongoing in study|45|||
131654525|NCT07149155|474019335|FG000|Overall Study|Lost to Follow-up|10|||
131654526|NCT03345576|474019336|FG000|Overall Study|Withdrawal by Subject|2|||
131654527|NCT03345576|474019337|FG001|Overall Study|Withdrawal by Subject|2|||
131654528|NCT03345576|474019336|FG000|Overall Study|Adverse Event|1|||
131654529|NCT03345576|474019337|FG001|Overall Study|Adverse Event|0|||
131654530|NCT02304705|474021038|FG000|Overall Study|Withdrawal by Subject|2|||
131654531|NCT02304705|474021039|FG001|Overall Study|Withdrawal by Subject|0|||
131654532|NCT02304705|474021038|FG000|Overall Study|Physician Decision|2|||
131654533|NCT02304705|474021039|FG001|Overall Study|Physician Decision|4|||
131654534|NCT02304705|474021038|FG000|Overall Study|Death|0|||
131654535|NCT02304705|474021039|FG001|Overall Study|Death|1|||
131654536|NCT02304705|474021038|FG000|Overall Study|Lost to Follow-up|0|||
131654537|NCT02304705|474021039|FG001|Overall Study|Lost to Follow-up|2|||
131654538|NCT01195948|474021040|FG000|Overall Study|Lost to Follow-up|0|||
131654539|NCT01195948|474021041|FG001|Overall Study|Lost to Follow-up|1|||
131654540|NCT01195948|474021042|FG002|Overall Study|Lost to Follow-up|2|||
131654541|NCT00770029|474021043|FG000|Overall Study|Lost to Follow-up|2|||
131654542|NCT00770029|474021044|FG001|Overall Study|Lost to Follow-up|0|||
131654543|NCT00770029|474021043|FG000|Overall Study|Withdrawal by Subject|3|||
131654544|NCT00770029|474021044|FG001|Overall Study|Withdrawal by Subject|3|||
131654545|NCT00770029|474021043|FG000|Overall Study|Adverse Event|1|||
131654546|NCT00770029|474021044|FG001|Overall Study|Adverse Event|0|||
131654547|NCT02124811|474021045|FG000|Overall Study|Early termination|2|||
131654548|NCT02124811|474021046|FG001|Overall Study|Early termination|2|||
131654549|NCT02124811|474021045|FG000|Overall Study|Withdrawal by Subject|1|||
131654550|NCT02124811|474021046|FG001|Overall Study|Withdrawal by Subject|0|||
131654551|NCT01757197|474021049|FG000|Overall Study|Death|2|||
131654552|NCT01174446|474021052|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
131654553|NCT01174446|474021053|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
131654554|NCT01174446|474021054|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
131654555|NCT01174446|474021055|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
131654556|NCT01174446|474021052|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
131654557|NCT01174446|474021053|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
131654558|NCT01174446|474021054|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
131654559|NCT01174446|474021055|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
131654560|NCT01174446|474021052|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
131654561|NCT01174446|474021053|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
131654562|NCT01174446|474021054|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
131654563|NCT01174446|474021055|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
131654564|NCT01174446|474021052|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
131654565|NCT01174446|474021053|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
131654566|NCT01174446|474021054|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
131654567|NCT01174446|474021055|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
131654568|NCT03057847|474021056|FG000|Overall Study|Lost to Follow-up|16|||
131654569|NCT01706705|474021058|FG000|Overall Study|Death|1|||
131654570|NCT01706705|474021058|FG000|Overall Study|Lack of Efficacy|13|||
131654571|NCT01706705|474021058|FG000|Overall Study|Non-clinical|6|||
131654572|NCT05627258|474021059|FG000|Overall Study|Lost to Follow-up|1|||
131654573|NCT05627258|474021060|FG001|Overall Study|Lost to Follow-up|0|||
131654574|NCT05627258|474021061|FG002|Overall Study|Lost to Follow-up|0|||
131654575|NCT05627258|474021062|FG003|Overall Study|Lost to Follow-up|0|||
131654576|NCT05627258|474021063|FG004|Overall Study|Lost to Follow-up|0|||
131654577|NCT05627258|474021064|FG005|Overall Study|Lost to Follow-up|0|||
131654578|NCT05627258|474021059|FG000|Overall Study|Withdrawal by Subject|0|||
131654579|NCT05627258|474021060|FG001|Overall Study|Withdrawal by Subject|0|||
131654580|NCT05627258|474021061|FG002|Overall Study|Withdrawal by Subject|0|||
131654581|NCT05627258|474021062|FG003|Overall Study|Withdrawal by Subject|0|||
131654582|NCT05627258|474021063|FG004|Overall Study|Withdrawal by Subject|2|||
131654583|NCT05627258|474021064|FG005|Overall Study|Withdrawal by Subject|0|||
131654584|NCT05627258|474021059|FG000|Overall Study|Enrolled, but product not administered|1|||
131654585|NCT05627258|474021060|FG001|Overall Study|Enrolled, but product not administered|0|||
131654586|NCT05627258|474021061|FG002|Overall Study|Enrolled, but product not administered|0|||
131654587|NCT05627258|474021062|FG003|Overall Study|Enrolled, but product not administered|0|||
131654588|NCT05627258|474021063|FG004|Overall Study|Enrolled, but product not administered|0|||
131654589|NCT05627258|474021064|FG005|Overall Study|Enrolled, but product not administered|0|||
131654590|NCT05627258|474021059|FG000|Overall Study|Other subject illness/injury|1|||
131654591|NCT05627258|474021060|FG001|Overall Study|Other subject illness/injury|0|||
131654592|NCT05627258|474021061|FG002|Overall Study|Other subject illness/injury|0|||
131654593|NCT05627258|474021062|FG003|Overall Study|Other subject illness/injury|0|||
131654594|NCT05627258|474021063|FG004|Overall Study|Other subject illness/injury|0|||
131654595|NCT05627258|474021064|FG005|Overall Study|Other subject illness/injury|0|||
131654596|NCT05627258|474021059|FG000|Overall Study|Subject moved from area|0|||
131654597|NCT05627258|474021060|FG001|Overall Study|Subject moved from area|0|||
131654598|NCT05627258|474021061|FG002|Overall Study|Subject moved from area|1|||
131654599|NCT05627258|474021062|FG003|Overall Study|Subject moved from area|0|||
131654600|NCT05627258|474021063|FG004|Overall Study|Subject moved from area|0|||
131654601|NCT05627258|474021064|FG005|Overall Study|Subject moved from area|0|||
131654602|NCT02138786|474021065|FG000|Overall Study|Adverse Event|0|||
131654603|NCT02138786|474021066|FG001|Overall Study|Adverse Event|2|||
131654604|NCT02138786|474021067|FG002|Overall Study|Adverse Event|1|||
131654605|NCT02138786|474021065|FG000|Overall Study|Death|1|||
131654606|NCT02138786|474021066|FG001|Overall Study|Death|7|||
131654607|NCT02138786|474021067|FG002|Overall Study|Death|2|||
131654608|NCT02138786|474021065|FG000|Overall Study|Disease Progression|1|||
131654609|NCT02138786|474021066|FG001|Overall Study|Disease Progression|1|||
131654610|NCT02138786|474021067|FG002|Overall Study|Disease Progression|3|||
131654611|NCT02138786|474021065|FG000|Overall Study|Withdrawal by Subject|1|||
131654612|NCT02138786|474021066|FG001|Overall Study|Withdrawal by Subject|2|||
131654613|NCT02138786|474021067|FG002|Overall Study|Withdrawal by Subject|0|||
131654614|NCT02138786|474021065|FG000|Overall Study|Patient's Wish|0|||
131654615|NCT02138786|474021066|FG001|Overall Study|Patient's Wish|2|||
131654616|NCT02138786|474021067|FG002|Overall Study|Patient's Wish|0|||
131654617|NCT02138786|474021065|FG000|Overall Study|Sponsor Terminated Study|0|||
131654618|NCT02138786|474021066|FG001|Overall Study|Sponsor Terminated Study|1|||
131654619|NCT02138786|474021067|FG002|Overall Study|Sponsor Terminated Study|1|||
131654620|NCT02138786|474021065|FG000|Overall Study|Non-Compliance|0|||
131654621|NCT02138786|474021066|FG001|Overall Study|Non-Compliance|0|||
131654622|NCT02138786|474021067|FG002|Overall Study|Non-Compliance|1|||
131654623|NCT02088957|474021068|FG000|Overall Study|Lack of Efficacy|1|||
131654624|NCT02088957|474021069|FG001|Overall Study|Lack of Efficacy|0|||
131654625|NCT01199068|474021070|FG000|Overall Study|Unacceptable toxicity|0|||
131654626|NCT01199068|474021071|FG001|Overall Study|Unacceptable toxicity|0|||
131654627|NCT01199068|474021072|FG002|Overall Study|Unacceptable toxicity|2|||
131654628|NCT01199068|474021070|FG000|Overall Study|Progressive disease|3|||
131654629|NCT01199068|474021071|FG001|Overall Study|Progressive disease|3|||
131654630|NCT01199068|474021072|FG002|Overall Study|Progressive disease|6|||
131654631|NCT01199068|474021070|FG000|Overall Study|Withdrawal by Subject|0|||
131654632|NCT01199068|474021071|FG001|Overall Study|Withdrawal by Subject|0|||
131654633|NCT01199068|474021072|FG002|Overall Study|Withdrawal by Subject|1|||
131654634|NCT03338296|474021073|FG000|Overall Study|Adverse Event|0|||
131654635|NCT03338296|474021074|FG001|Overall Study|Adverse Event|1|||
131654636|NCT03338296|474021073|FG000|Overall Study|Withdrawal by Subject|14|||
131654637|NCT03338296|474021074|FG001|Overall Study|Withdrawal by Subject|13|||
131654638|NCT03338296|474021073|FG000|Overall Study|Lost to Follow-up|10|||
131654639|NCT03338296|474021074|FG001|Overall Study|Lost to Follow-up|10|||
131654640|NCT03338296|474021073|FG000|Overall Study|Study Terminated by Sponsor|77|||
131654641|NCT03338296|474021074|FG001|Overall Study|Study Terminated by Sponsor|76|||
131654642|NCT03338296|474021073|FG000|Overall Study|Other|2|||
131654643|NCT03338296|474021074|FG001|Overall Study|Other|7|||
131654644|NCT03338296|474021073|FG000|Overall Study|Missing|0|||
131654645|NCT03338296|474021074|FG001|Overall Study|Missing|1|||
131654646|NCT02687035|474021079|FG000|Overall Study|Withdrawal by Subject|1|||
131654647|NCT02687035|474021079|FG000|Overall Study|Death|87|||
131654648|NCT02687035|474021079|FG000|Overall Study|Lost to Follow-up|1|||
131654649|NCT02687035|474021079|FG000|Overall Study|Missed Visit|87|||
131654650|NCT02687035|474021079|FG000|Overall Study|Did not receive Study Device|8|||
131654651|NCT00667394|474021080|FG000|Overall Study|Adverse Event|3|||
131654652|NCT00667394|474021081|FG001|Overall Study|Adverse Event|0|||
131654653|NCT00667394|474021080|FG000|Overall Study|Progressive disease|1|||
131654654|NCT00667394|474021081|FG001|Overall Study|Progressive disease|0|||
131654655|NCT04076943|474021083|FG000|Overall Study|Withdrawal by Subject|12|||
131654656|NCT04076943|474021083|FG000|Overall Study|Adverse Event|1|||
131654657|NCT04076943|474021083|FG000|Overall Study|Progressive Disease|2|||
131654658|NCT04076943|474021083|FG000|Overall Study|Death|13|||
131654659|NCT04076943|474021083|FG000|Overall Study|Other than specified|6|||
131654660|NCT02224703|474021089|FG000|Overall Study|Adverse Event|0|||
131654661|NCT02224703|474021090|FG001|Overall Study|Adverse Event|5|||
131654662|NCT02224703|474021091|FG002|Overall Study|Adverse Event|0|||
131654663|NCT02224703|474021089|FG000|Overall Study|Withdrawn by investigator|1|||
131654664|NCT02224703|474021090|FG001|Overall Study|Withdrawn by investigator|0|||
131654665|NCT02224703|474021091|FG002|Overall Study|Withdrawn by investigator|0|||
131654666|NCT02224703|474021089|FG000|Overall Study|Advised by medical monitor|1|||
131654667|NCT02224703|474021090|FG001|Overall Study|Advised by medical monitor|0|||
131654668|NCT02224703|474021091|FG002|Overall Study|Advised by medical monitor|0|||
131654669|NCT02224703|474021089|FG000|Overall Study|Withdrawn by parent/guardian|0|||
131654670|NCT02224703|474021090|FG001|Overall Study|Withdrawn by parent/guardian|1|||
131654671|NCT02224703|474021091|FG002|Overall Study|Withdrawn by parent/guardian|0|||
131654672|NCT02224703|474021089|FG000|Overall Study|Lack of Efficacy|1|||
131654673|NCT02224703|474021090|FG001|Overall Study|Lack of Efficacy|0|||
131654674|NCT02224703|474021091|FG002|Overall Study|Lack of Efficacy|0|||
131654675|NCT02922023|474021092|FG000|Overall Study|Lost to Follow-up|2|||
131654676|NCT02922023|474021093|FG001|Overall Study|Lost to Follow-up|0|||
131654677|NCT02593123|474021094|FG000|Overall Study|Physician Decision|2|||
131654678|NCT02593123|474021095|FG001|Overall Study|Physician Decision|1|||
131654679|NCT02593123|474021094|FG000|Overall Study|Relapse|1|||
131654680|NCT02593123|474021095|FG001|Overall Study|Relapse|1|||
131654681|NCT00504777|474021096|FG000|Overall Study|Adverse Event|1|||
131654682|NCT01465763|474021097|FG000|Overall Study|Withdrawal by Subject|4|||
131654683|NCT01465763|474021098|FG001|Overall Study|Withdrawal by Subject|0|||
131654684|NCT01465763|474021099|FG002|Overall Study|Withdrawal by Subject|1|||
131654685|NCT01465763|474021097|FG000|Overall Study|Insufficient Clinical Response|11|||
131654686|NCT01465763|474021098|FG001|Overall Study|Insufficient Clinical Response|0|||
131654687|NCT01465763|474021099|FG002|Overall Study|Insufficient Clinical Response|1|||
131654688|NCT01465763|474021097|FG000|Overall Study|Adverse Event|9|||
131654689|NCT01465763|474021098|FG001|Overall Study|Adverse Event|0|||
131654690|NCT01465763|474021099|FG002|Overall Study|Adverse Event|1|||
131654691|NCT01465763|474021097|FG000|Overall Study|Other|2|||
131654692|NCT01465763|474021098|FG001|Overall Study|Other|0|||
131654693|NCT01465763|474021099|FG002|Overall Study|Other|0|||
131654694|NCT01465763|474021097|FG000|Overall Study|Protocol Violation|4|||
131654695|NCT01465763|474021098|FG001|Overall Study|Protocol Violation|1|||
131654696|NCT01465763|474021099|FG002|Overall Study|Protocol Violation|1|||
131654697|NCT01465763|474021097|FG000|Overall Study|Death|1|||
131654698|NCT01465763|474021098|FG001|Overall Study|Death|0|||
131654699|NCT01465763|474021099|FG002|Overall Study|Death|0|||
131654700|NCT03538938|474021100|FG000|Overall Study|Death|0|||
131654701|NCT03538938|474021101|FG001|Overall Study|Death|0|||
131654702|NCT03538938|474021102|FG002|Overall Study|Death|2|||
131654703|NCT03538938|474021103|FG003|Overall Study|Death|0|||
131654704|NCT03538938|474021104|FG004|Overall Study|Death|0|||
131654705|NCT03538938|474021105|FG005|Overall Study|Death|1|||
131654706|NCT03538938|474021106|FG006|Overall Study|Death|0|||
131654707|NCT03538938|474021107|FG007|Overall Study|Death|1|||
131654708|NCT03538938|474021108|FG008|Overall Study|Death|1|||
131654709|NCT03538938|474021109|FG009|Overall Study|Death|1|||
131654710|NCT03538938|474021110|FG010|Overall Study|Death|0|||
131654711|NCT03538938|474021111|FG011|Overall Study|Death|0|||
131654712|NCT03538938|474021112|FG012|Overall Study|Death|1|||
131654713|NCT03538938|474021113|FG013|Overall Study|Death|1|||
131654714|NCT03538938|474021114|FG014|Overall Study|Death|0|||
131654715|NCT03538938|474021115|FG015|Overall Study|Death|1|||
131654716|NCT03538938|474021100|FG000|Overall Study|Withdrawal by Subject|4|||
131654717|NCT03538938|474021101|FG001|Overall Study|Withdrawal by Subject|6|||
131654718|NCT03538938|474021102|FG002|Overall Study|Withdrawal by Subject|5|||
131654719|NCT03538938|474021103|FG003|Overall Study|Withdrawal by Subject|3|||
131654720|NCT03538938|474021104|FG004|Overall Study|Withdrawal by Subject|0|||
131654721|NCT03538938|474021105|FG005|Overall Study|Withdrawal by Subject|0|||
131654722|NCT03538938|474021106|FG006|Overall Study|Withdrawal by Subject|3|||
131654723|NCT03538938|474021107|FG007|Overall Study|Withdrawal by Subject|1|||
131654724|NCT03538938|474021108|FG008|Overall Study|Withdrawal by Subject|5|||
131654725|NCT03538938|474021109|FG009|Overall Study|Withdrawal by Subject|1|||
131654726|NCT03538938|474021110|FG010|Overall Study|Withdrawal by Subject|2|||
131654727|NCT03538938|474021111|FG011|Overall Study|Withdrawal by Subject|1|||
131654728|NCT03538938|474021112|FG012|Overall Study|Withdrawal by Subject|3|||
131654729|NCT03538938|474021113|FG013|Overall Study|Withdrawal by Subject|0|||
131654730|NCT03538938|474021114|FG014|Overall Study|Withdrawal by Subject|2|||
131654731|NCT03538938|474021115|FG015|Overall Study|Withdrawal by Subject|4|||
131654732|NCT03538938|474021100|FG000|Overall Study|Incarcerated|0|||
131654733|NCT03538938|474021101|FG001|Overall Study|Incarcerated|0|||
131654734|NCT03538938|474021102|FG002|Overall Study|Incarcerated|0|||
131654735|NCT03538938|474021103|FG003|Overall Study|Incarcerated|0|||
131654736|NCT03538938|474021104|FG004|Overall Study|Incarcerated|0|||
131654737|NCT03538938|474021105|FG005|Overall Study|Incarcerated|0|||
131654738|NCT03538938|474021106|FG006|Overall Study|Incarcerated|0|||
131654739|NCT03538938|474021107|FG007|Overall Study|Incarcerated|0|||
131654740|NCT03538938|474021108|FG008|Overall Study|Incarcerated|0|||
131654741|NCT03538938|474021109|FG009|Overall Study|Incarcerated|0|||
131654742|NCT03538938|474021110|FG010|Overall Study|Incarcerated|0|||
131654743|NCT03538938|474021111|FG011|Overall Study|Incarcerated|1|||
131654744|NCT03538938|474021112|FG012|Overall Study|Incarcerated|0|||
131654745|NCT03538938|474021113|FG013|Overall Study|Incarcerated|0|||
131654746|NCT03538938|474021114|FG014|Overall Study|Incarcerated|0|||
131654747|NCT03538938|474021115|FG015|Overall Study|Incarcerated|0|||
131654748|NCT03995316|474021116|FG000|Overall Study|Lost to Follow-up|10|||
131654749|NCT03995316|474021117|FG001|Overall Study|Lost to Follow-up|3|||
131654750|NCT01361594|474021118|FG000|Overall Study|Withdrawal by Subject|1|||
131654751|NCT01361594|474021119|FG001|Overall Study|Withdrawal by Subject|2|||
131654752|NCT00203268|474021127|FG000|Early Treatment|only treated one headache|2|||
131654753|NCT00203268|474021127|FG000|Early Treatment|Lost to Follow-up|1|||
131654754|NCT00203268|474021127|FG000|Early Treatment|Withdrawal by Subject|1|||
131654755|NCT00839956|474021129|FG000|Overall Study|Adverse Event|2|||
131654756|NCT00839956|474021129|FG000|Overall Study|Lack of Efficacy|6|||
131654757|NCT00839956|474021129|FG000|Overall Study|Physician Decision|1|||
131654758|NCT00839956|474021129|FG000|Overall Study|Withdrawal by Subject|3|||
131654759|NCT02807883|474021130|FG000|Overall Study|Withdrawal by Subject|2|||
131654760|NCT01399918|474021134|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
131654761|NCT03197766|474021135|FG000|Overall Study|Withdrawal by Subject|2|||
131654762|NCT03197766|474021136|FG001|Overall Study|Withdrawal by Subject|0|||
131654763|NCT00972322|474021138|FG000|Overall Study|Adverse Event|2|||
131654764|NCT00972322|474021139|FG001|Overall Study|Adverse Event|1|||
131654765|NCT00972322|474021138|FG000|Overall Study|Positive drug screen|0|||
131654766|NCT00972322|474021139|FG001|Overall Study|Positive drug screen|1|||
131654767|NCT00972322|474021138|FG000|Overall Study|Lost to Follow-up|0|||
131654768|NCT00972322|474021139|FG001|Overall Study|Lost to Follow-up|1|||
131654769|NCT00972322|474021138|FG000|Overall Study|Consistently high glucose values|1|||
131654770|NCT00972322|474021139|FG001|Overall Study|Consistently high glucose values|0|||
131654771|NCT00277095|474021142|FG000|Overall Study|Death|2|||
131654772|NCT00277095|474021142|FG000|Overall Study|Explanted|7|||
131654773|NCT00277095|474021142|FG000|Overall Study|Lost to Follow-up|2|||
131654774|NCT00277095|474021142|FG000|Overall Study|Missed Follow-up|9|||
131654775|NCT00277095|474021142|FG000|Overall Study|Physician Decision|1|||
131654776|NCT05140915|474021144|FG000|Overall Study|Lost to Follow-up|2|||
131654777|NCT05140915|474021145|FG001|Overall Study|Lost to Follow-up|1|||
131654778|NCT04520659|474021146|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
131654779|NCT04520659|474021147|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
131654780|NCT04520659|474021148|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
131654781|NCT04520659|474021149|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
131654782|NCT04879849|474021154|FG000|Overall Study|Lost to Follow-up|0|||
131654783|NCT04879849|474021155|FG001|Overall Study|Lost to Follow-up|0|||
131654784|NCT04879849|474021156|FG002|Overall Study|Lost to Follow-up|0|||
131654785|NCT04879849|474021157|FG003|Overall Study|Lost to Follow-up|1|||
131654786|NCT04879849|474021158|FG004|Overall Study|Lost to Follow-up|0|||
131654787|NCT04879849|474021159|FG005|Overall Study|Lost to Follow-up|0|||
131654788|NCT04879849|474021160|FG006|Overall Study|Lost to Follow-up|0|||
131654789|NCT04879849|474021161|FG007|Overall Study|Lost to Follow-up|0|||
131654790|NCT04879849|474021154|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
131654791|NCT04879849|474021155|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
131654792|NCT04879849|474021156|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
131654793|NCT04879849|474021157|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
131654794|NCT04879849|474021158|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
131654795|NCT04879849|474021159|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
131654796|NCT04879849|474021160|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
131654797|NCT04879849|474021161|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
131654798|NCT04879849|474021154|FG000|Overall Study|Withdrawal by Subject|0|||
131654799|NCT04879849|474021155|FG001|Overall Study|Withdrawal by Subject|0|||
131654800|NCT04879849|474021156|FG002|Overall Study|Withdrawal by Subject|0|||
131654801|NCT04879849|474021157|FG003|Overall Study|Withdrawal by Subject|0|||
131654802|NCT04879849|474021158|FG004|Overall Study|Withdrawal by Subject|2|||
131654803|NCT04879849|474021159|FG005|Overall Study|Withdrawal by Subject|0|||
131654804|NCT04879849|474021160|FG006|Overall Study|Withdrawal by Subject|1|||
131654805|NCT04879849|474021161|FG007|Overall Study|Withdrawal by Subject|0|||
131654806|NCT04879849|474021154|FG000|Overall Study|Progressive Disease|0|||
131654807|NCT04879849|474021155|FG001|Overall Study|Progressive Disease|0|||
131654808|NCT04879849|474021156|FG002|Overall Study|Progressive Disease|1|||
131654809|NCT04879849|474021157|FG003|Overall Study|Progressive Disease|0|||
131654810|NCT04879849|474021158|FG004|Overall Study|Progressive Disease|0|||
131654811|NCT04879849|474021159|FG005|Overall Study|Progressive Disease|0|||
131654812|NCT04879849|474021160|FG006|Overall Study|Progressive Disease|0|||
131654813|NCT04879849|474021161|FG007|Overall Study|Progressive Disease|0|||
131654814|NCT04879849|474021154|FG000|Overall Study|Death|0|||
131654815|NCT04879849|474021155|FG001|Overall Study|Death|0|||
131654816|NCT04879849|474021156|FG002|Overall Study|Death|1|||
131654817|NCT04879849|474021157|FG003|Overall Study|Death|1|||
131654818|NCT04879849|474021158|FG004|Overall Study|Death|1|||
131654819|NCT04879849|474021159|FG005|Overall Study|Death|2|||
131654820|NCT04879849|474021160|FG006|Overall Study|Death|1|||
131654821|NCT04879849|474021161|FG007|Overall Study|Death|2|||
131654822|NCT04879849|474021154|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
131654823|NCT04879849|474021155|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
131654824|NCT04879849|474021156|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
131654825|NCT04879849|474021157|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
131654826|NCT04879849|474021158|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
131654827|NCT04879849|474021159|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
131654828|NCT04879849|474021160|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
131654829|NCT04879849|474021161|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
131654830|NCT04879849|474021154|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654831|NCT04879849|474021155|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654832|NCT04879849|474021156|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654833|NCT04879849|474021157|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654834|NCT04879849|474021158|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654835|NCT04879849|474021159|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654836|NCT04879849|474021160|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
131654837|NCT04879849|474021161|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131654838|NCT04879849|474021154|FG000|Overall Study|Reason Not Specified|1|||
131654839|NCT04879849|474021155|FG001|Overall Study|Reason Not Specified|0|||
131654840|NCT04879849|474021156|FG002|Overall Study|Reason Not Specified|0|||
131654841|NCT04879849|474021157|FG003|Overall Study|Reason Not Specified|0|||
131654842|NCT04879849|474021158|FG004|Overall Study|Reason Not Specified|0|||
131654843|NCT04879849|474021159|FG005|Overall Study|Reason Not Specified|0|||
131654844|NCT04879849|474021160|FG006|Overall Study|Reason Not Specified|0|||
131654845|NCT04879849|474021161|FG007|Overall Study|Reason Not Specified|0|||
131654846|NCT03361865|474021162|FG000|Overall Study|Death|17|||
131654847|NCT03361865|474021163|FG001|Overall Study|Death|18|||
131654848|NCT03361865|474021162|FG000|Overall Study|Physician Decision|1|||
131654849|NCT03361865|474021163|FG001|Overall Study|Physician Decision|9|||
131654850|NCT03361865|474021162|FG000|Overall Study|Withdrawal by Subject|1|||
131654851|NCT03361865|474021163|FG001|Overall Study|Withdrawal by Subject|0|||
131654852|NCT03852719|474021164|FG000|Overall Study|Withdrawal of consent|8|||
131654853|NCT03852719|474021165|FG001|Overall Study|Withdrawal of consent|8|||
131654854|NCT03852719|474021166|FG002|Overall Study|Withdrawal of consent|9|||
131654855|NCT03852719|474021164|FG000|Overall Study|Physician Decision|5|||
131654856|NCT03852719|474021165|FG001|Overall Study|Physician Decision|4|||
131654857|NCT03852719|474021166|FG002|Overall Study|Physician Decision|1|||
131654858|NCT03852719|474021164|FG000|Overall Study|Pregnancy|2|||
131654859|NCT03852719|474021165|FG001|Overall Study|Pregnancy|1|||
131654860|NCT03852719|474021166|FG002|Overall Study|Pregnancy|0|||
131654861|NCT03852719|474021164|FG000|Overall Study|Death|1|||
131654862|NCT03852719|474021165|FG001|Overall Study|Death|0|||
131654863|NCT03852719|474021166|FG002|Overall Study|Death|0|||
131654864|NCT03852719|474021164|FG000|Overall Study|Reason not Specified|3|||
131654865|NCT03852719|474021165|FG001|Overall Study|Reason not Specified|3|||
131654866|NCT03852719|474021166|FG002|Overall Study|Reason not Specified|5|||
131654867|NCT03852719|474021164|FG000|Overall Study|Adverse Event|2|||
131654868|NCT03852719|474021165|FG001|Overall Study|Adverse Event|1|||
131654869|NCT03852719|474021166|FG002|Overall Study|Adverse Event|4|||
131654870|NCT03852719|474021164|FG000|Overall Study|Progressive disease|1|||
131654871|NCT03852719|474021165|FG001|Overall Study|Progressive disease|4|||
131654872|NCT03852719|474021166|FG002|Overall Study|Progressive disease|1|||
131654873|NCT03852719|474021164|FG000|Overall Study|Lost to Follow-up|1|||
131654874|NCT03852719|474021165|FG001|Overall Study|Lost to Follow-up|0|||
131654875|NCT03852719|474021166|FG002|Overall Study|Lost to Follow-up|0|||
131654876|NCT05543187|474021169|FG000|Overall Study|Ongoing|3|||
131654877|NCT05543187|474021170|FG001|Overall Study|Ongoing|2|||
131654878|NCT03810235|474021171|FG000|Overall Study|Withdrawal by Subject|2|||
131654879|NCT03810235|474021172|FG001|Overall Study|Withdrawal by Subject|0|||
131654880|NCT04777864|474021173|FG000|Overall Study|Lost to Follow-up|8|||
131654881|NCT04777864|474021174|FG001|Overall Study|Lost to Follow-up|19|||
131654882|NCT01647542|474021176|FG000|Overall Study|Major Protocol Deviation|1|||
131654883|NCT01647542|474021177|FG001|Overall Study|Major Protocol Deviation|0|||
131654884|NCT01647542|474021178|FG002|Overall Study|Major Protocol Deviation|0|||
131654885|NCT01647542|474021176|FG000|Overall Study|Adverse Event|4|||
131654886|NCT01647542|474021177|FG001|Overall Study|Adverse Event|5|||
131654887|NCT01647542|474021178|FG002|Overall Study|Adverse Event|4|||
131654888|NCT01647542|474021176|FG000|Overall Study|Lost to Follow-up|0|||
131654889|NCT01647542|474021177|FG001|Overall Study|Lost to Follow-up|2|||
131654890|NCT01647542|474021178|FG002|Overall Study|Lost to Follow-up|2|||
131654891|NCT01647542|474021176|FG000|Overall Study|Withdrawal by Subject|6|||
131654892|NCT01647542|474021177|FG001|Overall Study|Withdrawal by Subject|4|||
131654893|NCT01647542|474021178|FG002|Overall Study|Withdrawal by Subject|0|||
131654894|NCT01647542|474021176|FG000|Overall Study|Study Termination|64|||
131654895|NCT01647542|474021177|FG001|Overall Study|Study Termination|61|||
131654896|NCT01647542|474021178|FG002|Overall Study|Study Termination|65|||
131654897|NCT01647542|474021176|FG000|Overall Study|Lack of Efficacy|1|||
131654898|NCT01647542|474021177|FG001|Overall Study|Lack of Efficacy|1|||
131654899|NCT01647542|474021178|FG002|Overall Study|Lack of Efficacy|0|||
131654900|NCT01647542|474021176|FG000|Overall Study|Death|0|||
131654901|NCT01647542|474021177|FG001|Overall Study|Death|0|||
131654902|NCT01647542|474021178|FG002|Overall Study|Death|1|||
131654903|NCT03086655|474021179|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
131654904|NCT03086655|474021180|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
131654905|NCT03086655|474021179|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
131654906|NCT03086655|474021180|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
131654907|NCT03086655|474021179|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
131654908|NCT03086655|474021180|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
131654909|NCT03086655|474021179|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
131654910|NCT03086655|474021180|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
131654911|NCT03086655|474021179|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
131654912|NCT03086655|474021180|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
131654913|NCT03086655|474021179|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
131654914|NCT03086655|474021180|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
131654915|NCT03086655|474021179|FG000|12 Month Follow-up = Final Assessment|Death|0|||
131654916|NCT03086655|474021180|FG001|12 Month Follow-up = Final Assessment|Death|1|||
131654917|NCT05576662|474021181|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
131654918|NCT05576662|474021182|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
131654919|NCT05576662|474021181|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
131654920|NCT05576662|474021182|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
131654921|NCT05576662|474021181|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
131654922|NCT05576662|474021182|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
131654923|NCT05576662|474021181|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
131654924|NCT05576662|474021182|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
131654925|NCT03008005|474021183|FG000|Overall Study|Physician Decision|1|||
131654926|NCT03008005|474021184|FG001|Overall Study|Physician Decision|0|||
131654927|NCT03008005|474021185|FG002|Overall Study|Physician Decision|0|||
131654928|NCT03008005|474021183|FG000|Overall Study|Withdrawal by Subject|1|||
131654929|NCT03008005|474021184|FG001|Overall Study|Withdrawal by Subject|0|||
131654930|NCT03008005|474021185|FG002|Overall Study|Withdrawal by Subject|0|||
131654931|NCT03008005|474021183|FG000|Overall Study|Ineligible|0|||
131654932|NCT03008005|474021184|FG001|Overall Study|Ineligible|1|||
131654933|NCT03008005|474021185|FG002|Overall Study|Ineligible|0|||
131654934|NCT01040169|474021198|FG000|Overall Study|Lost to Follow-up|3|||
131654935|NCT01040169|474021199|FG001|Overall Study|Lost to Follow-up|8|||
131654936|NCT00350727|474021200|FG000|Phase I: Dose Escalation|Adverse Event|4|||
131654937|NCT00350727|474021201|FG001|Phase I: Dose Escalation|Adverse Event|0|||
131654938|NCT00350727|474021202|FG002|Phase I: Dose Escalation|Adverse Event|0|||
131654939|NCT00350727|474021200|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
131654940|NCT00350727|474021201|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
131654941|NCT00350727|474021202|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
131654942|NCT00350727|474021200|FG000|Phase I: Dose Escalation|Death|1|||
131654943|NCT00350727|474021201|FG001|Phase I: Dose Escalation|Death|0|||
131654944|NCT00350727|474021202|FG002|Phase I: Dose Escalation|Death|0|||
131654945|NCT00350727|474021200|FG000|Phase I: Dose Escalation|Physician Decision|1|||
131654946|NCT00350727|474021201|FG001|Phase I: Dose Escalation|Physician Decision|0|||
131654947|NCT00350727|474021202|FG002|Phase I: Dose Escalation|Physician Decision|0|||
131654948|NCT00350727|474021200|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
131654949|NCT00350727|474021201|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
131654950|NCT00350727|474021202|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
131654951|NCT00350727|474021200|FG000|Phase II|Disease Progression|0|||
131654952|NCT00350727|474021201|FG001|Phase II|Disease Progression|15|||
131654953|NCT00350727|474021202|FG002|Phase II|Disease Progression|16|||
131654954|NCT00350727|474021200|FG000|Phase II|Clinical Deterioration|0|||
131654955|NCT00350727|474021201|FG001|Phase II|Clinical Deterioration|1|||
131654956|NCT00350727|474021202|FG002|Phase II|Clinical Deterioration|0|||
131654957|NCT00350727|474021200|FG000|Phase II|Withdrawal by Subject|0|||
131654958|NCT00350727|474021201|FG001|Phase II|Withdrawal by Subject|2|||
131654959|NCT00350727|474021202|FG002|Phase II|Withdrawal by Subject|1|||
131654960|NCT00350727|474021200|FG000|Phase II|Adverse Event|0|||
131654961|NCT00350727|474021201|FG001|Phase II|Adverse Event|1|||
131654962|NCT00350727|474021202|FG002|Phase II|Adverse Event|1|||
131654963|NCT00350727|474021200|FG000|Phase II|Death|0|||
131654964|NCT00350727|474021201|FG001|Phase II|Death|0|||
131654965|NCT00350727|474021202|FG002|Phase II|Death|2|||
131654966|NCT00350727|474021200|FG000|Phase II|Sponsor Terminated Study|0|||
131654967|NCT00350727|474021201|FG001|Phase II|Sponsor Terminated Study|0|||
131654968|NCT00350727|474021202|FG002|Phase II|Sponsor Terminated Study|1|||
131654969|NCT00350727|474021200|FG000|Phase II|Enrolled in Rollover Study|0|||
131654970|NCT00350727|474021201|FG001|Phase II|Enrolled in Rollover Study|0|||
131654971|NCT00350727|474021202|FG002|Phase II|Enrolled in Rollover Study|1|||
131654972|NCT03633799|474021210|FG000|Overall Study|Adverse Event|349|||
131654973|NCT03633799|474021210|FG000|Overall Study|Withdrawal by Subject|288|||
131654974|NCT03633799|474021210|FG000|Overall Study|Lost to Follow-up|97|||
131654975|NCT03633799|474021210|FG000|Overall Study|Physician Decision|9|||
131654976|NCT03633799|474021210|FG000|Overall Study|Protocol Violation|4|||
131654977|NCT03633799|474021210|FG000|Overall Study|Pregnancy|20|||
131654978|NCT03633799|474021210|FG000|Overall Study|other|39|||
131654979|NCT03633799|474021210|FG000|Overall Study|ongoing within third year of study|106|||
131654980|NCT03633799|474021210|FG000|Overall Study|unsuccessful study drug placement|19|||
131654981|NCT03551691|474021211|FG000|Overall Study|Withdrawal by Subject|3|||
131658609|NCT02003222|474035395|FG000|Induction|Disease progression|0|||
131654982|NCT03551691|474021212|FG001|Overall Study|Withdrawal by Subject|3|||
131654983|NCT03520712|474021213|FG000|Overall Study|Early termination of the study by Sponsor|2|||
131654984|NCT05855967|474021214|FG000|Overall Study|Withdrawal by Subject|7|||
131654985|NCT05855967|474021215|FG001|Overall Study|Withdrawal by Subject|5|||
131654986|NCT05855967|474021214|FG000|Overall Study|Lost to Follow-up|2|||
131654987|NCT05855967|474021215|FG001|Overall Study|Lost to Follow-up|1|||
131654988|NCT02446821|474021216|FG000|Overall Study|Adverse Event|28|||
131654989|NCT02446821|474021216|FG000|Overall Study|Withdrawal by Subject|6|||
131654990|NCT02446821|474021216|FG000|Overall Study|Lost to Follow-up|22|||
131654991|NCT02446821|474021216|FG000|Overall Study|other|9|||
131654992|NCT02446821|474021216|FG000|Overall Study|insertion failure|3|||
131654993|NCT02994069|474021218|FG000|Overall Study|Death|7|||
131654994|NCT02994069|474021219|FG001|Overall Study|Death|13|||
131654995|NCT02994069|474021218|FG000|Overall Study|Adverse Event|1|||
131654996|NCT02994069|474021219|FG001|Overall Study|Adverse Event|0|||
131654997|NCT02994069|474021218|FG000|Overall Study|Other|2|||
131654998|NCT02994069|474021219|FG001|Overall Study|Other|0|||
131654999|NCT02994069|474021218|FG000|Overall Study|still on follow up/treatment|5|||
131655000|NCT02994069|474021219|FG001|Overall Study|still on follow up/treatment|6|||
131655001|NCT05212168|474021220|FG000|Overall Study|Lost to Follow-up|0|||
131655002|NCT05212168|474021221|FG001|Overall Study|Lost to Follow-up|3|||
131655003|NCT05212168|474021220|FG000|Overall Study|Study terminated by sponsor|30|||
131655004|NCT05212168|474021221|FG001|Overall Study|Study terminated by sponsor|27|||
131655005|NCT05212168|474021220|FG000|Overall Study|Other|4|||
131655006|NCT05212168|474021221|FG001|Overall Study|Other|7|||
131655007|NCT04427280|474023281|FG000|Overall Study|Withdrawal by Subject|0|||
131655008|NCT04427280|474023282|FG001|Overall Study|Withdrawal by Subject|2|||
131655009|NCT04942366|474023290|FG000|Overall Study|Withdrawal by Subject|5|||
131655010|NCT04942366|474023291|FG001|Overall Study|Withdrawal by Subject|5|||
131655011|NCT04996004|474023292|FG000|Phase I|Death|1|||
131655012|NCT04996004|474023293|FG001|Phase I|Death|2|||
131655013|NCT04996004|474023294|FG002|Phase I|Death|1|||
131655014|NCT04996004|474023295|FG003|Phase I|Death|0|||
131655015|NCT04996004|474023296|FG004|Phase I|Death|0|||
131655016|NCT04996004|474023297|FG005|Phase I|Death|0|||
131655017|NCT04996004|474023292|FG000|Phase I|Study terminated by sponsor|2|||
131655018|NCT04996004|474023293|FG001|Phase I|Study terminated by sponsor|1|||
131655019|NCT04996004|474023294|FG002|Phase I|Study terminated by sponsor|2|||
131655020|NCT04996004|474023295|FG003|Phase I|Study terminated by sponsor|0|||
131655021|NCT04996004|474023296|FG004|Phase I|Study terminated by sponsor|0|||
131655022|NCT04996004|474023297|FG005|Phase I|Study terminated by sponsor|0|||
131655023|NCT04996004|474023292|FG000|Phase II|Study terminated by sponsor|0|||
131655024|NCT04996004|474023293|FG001|Phase II|Study terminated by sponsor|0|||
131655025|NCT04996004|474023294|FG002|Phase II|Study terminated by sponsor|0|||
131655026|NCT04996004|474023295|FG003|Phase II|Study terminated by sponsor|20|||
131655027|NCT04996004|474023296|FG004|Phase II|Study terminated by sponsor|10|||
131655028|NCT04996004|474023297|FG005|Phase II|Study terminated by sponsor|10|||
131655029|NCT04996004|474023292|FG000|Phase II|Withdrawal by Subject|0|||
131655030|NCT04996004|474023293|FG001|Phase II|Withdrawal by Subject|0|||
131655031|NCT04996004|474023294|FG002|Phase II|Withdrawal by Subject|0|||
131655032|NCT04996004|474023295|FG003|Phase II|Withdrawal by Subject|0|||
131655033|NCT04996004|474023296|FG004|Phase II|Withdrawal by Subject|1|||
131655034|NCT04996004|474023297|FG005|Phase II|Withdrawal by Subject|2|||
131655035|NCT04996004|474023292|FG000|Phase II|Death|0|||
131655036|NCT04996004|474023293|FG001|Phase II|Death|0|||
131655037|NCT04996004|474023294|FG002|Phase II|Death|0|||
131655038|NCT04996004|474023295|FG003|Phase II|Death|12|||
131655039|NCT04996004|474023296|FG004|Phase II|Death|2|||
131655040|NCT04996004|474023297|FG005|Phase II|Death|9|||
131655041|NCT04996004|474023292|FG000|Phase II|Other|0|||
131655042|NCT04996004|474023293|FG001|Phase II|Other|0|||
131655043|NCT04996004|474023294|FG002|Phase II|Other|0|||
131655044|NCT04996004|474023295|FG003|Phase II|Other|0|||
131655045|NCT04996004|474023296|FG004|Phase II|Other|0|||
131655046|NCT04996004|474023297|FG005|Phase II|Other|1|||
131655047|NCT02942277|474023298|FG000|Year 1|Withdrawal by Subject|0|||
131655048|NCT02942277|474023299|FG001|Year 1|Withdrawal by Subject|0|||
131655049|NCT02942277|474023300|FG002|Year 1|Withdrawal by Subject|0|||
131655050|NCT02942277|474023301|FG003|Year 1|Withdrawal by Subject|0|||
131655051|NCT02942277|474023302|FG004|Year 1|Withdrawal by Subject|1|||
131655052|NCT02942277|474023303|FG005|Year 1|Withdrawal by Subject|3|||
131655053|NCT02942277|474023304|FG006|Year 1|Withdrawal by Subject|0|||
131655054|NCT02942277|474023305|FG007|Year 1|Withdrawal by Subject|1|||
131655055|NCT02942277|474023306|FG008|Year 1|Withdrawal by Subject|0|||
131655056|NCT02942277|474023307|FG009|Year 1|Withdrawal by Subject|0|||
131655057|NCT02942277|474023308|FG010|Year 1|Withdrawal by Subject|3|||
131655058|NCT02942277|474023298|FG000|Year 1|Travel|0|||
131655059|NCT02942277|474023299|FG001|Year 1|Travel|1|||
131655060|NCT02942277|474023300|FG002|Year 1|Travel|0|||
131655061|NCT02942277|474023301|FG003|Year 1|Travel|0|||
131655062|NCT02942277|474023302|FG004|Year 1|Travel|4|||
131655063|NCT02942277|474023303|FG005|Year 1|Travel|5|||
131655064|NCT02942277|474023304|FG006|Year 1|Travel|0|||
131655065|NCT02942277|474023305|FG007|Year 1|Travel|0|||
131655066|NCT02942277|474023306|FG008|Year 1|Travel|0|||
131655067|NCT02942277|474023307|FG009|Year 1|Travel|0|||
131655068|NCT02942277|474023308|FG010|Year 1|Travel|8|||
131655069|NCT02942277|474023298|FG000|Year 1|Joined Army|0|||
131655070|NCT02942277|474023299|FG001|Year 1|Joined Army|1|||
131655071|NCT02942277|474023300|FG002|Year 1|Joined Army|0|||
131655072|NCT02942277|474023301|FG003|Year 1|Joined Army|0|||
131655073|NCT02942277|474023302|FG004|Year 1|Joined Army|0|||
131655074|NCT02942277|474023303|FG005|Year 1|Joined Army|0|||
131655075|NCT02942277|474023304|FG006|Year 1|Joined Army|0|||
131655076|NCT02942277|474023305|FG007|Year 1|Joined Army|0|||
131655077|NCT02942277|474023306|FG008|Year 1|Joined Army|0|||
131655078|NCT02942277|474023307|FG009|Year 1|Joined Army|0|||
131655079|NCT02942277|474023308|FG010|Year 1|Joined Army|0|||
131655080|NCT02942277|474023298|FG000|Year 1|Subject met withdrawal criteria|0|||
131655081|NCT02942277|474023299|FG001|Year 1|Subject met withdrawal criteria|0|||
131655082|NCT02942277|474023300|FG002|Year 1|Subject met withdrawal criteria|0|||
131655083|NCT02942277|474023301|FG003|Year 1|Subject met withdrawal criteria|1|||
131655084|NCT02942277|474023302|FG004|Year 1|Subject met withdrawal criteria|0|||
131655085|NCT02942277|474023303|FG005|Year 1|Subject met withdrawal criteria|0|||
131655086|NCT02942277|474023304|FG006|Year 1|Subject met withdrawal criteria|0|||
131655087|NCT02942277|474023305|FG007|Year 1|Subject met withdrawal criteria|0|||
131655088|NCT02942277|474023306|FG008|Year 1|Subject met withdrawal criteria|0|||
131655089|NCT02942277|474023307|FG009|Year 1|Subject met withdrawal criteria|0|||
131655090|NCT02942277|474023308|FG010|Year 1|Subject met withdrawal criteria|0|||
131655091|NCT02942277|474023298|FG000|Year 1|Lost to Follow-up|0|||
131655092|NCT02942277|474023299|FG001|Year 1|Lost to Follow-up|0|||
131655093|NCT02942277|474023300|FG002|Year 1|Lost to Follow-up|0|||
131655094|NCT02942277|474023301|FG003|Year 1|Lost to Follow-up|0|||
131655095|NCT02942277|474023302|FG004|Year 1|Lost to Follow-up|1|||
131655096|NCT02942277|474023303|FG005|Year 1|Lost to Follow-up|0|||
131655097|NCT02942277|474023304|FG006|Year 1|Lost to Follow-up|0|||
131655098|NCT02942277|474023305|FG007|Year 1|Lost to Follow-up|0|||
131655099|NCT02942277|474023306|FG008|Year 1|Lost to Follow-up|0|||
131655100|NCT02942277|474023307|FG009|Year 1|Lost to Follow-up|0|||
131655101|NCT02942277|474023308|FG010|Year 1|Lost to Follow-up|2|||
131655102|NCT02942277|474023298|FG000|Year 1|Protocol Violation|0|||
131655103|NCT02942277|474023299|FG001|Year 1|Protocol Violation|0|||
131655104|NCT02942277|474023300|FG002|Year 1|Protocol Violation|0|||
131655105|NCT02942277|474023301|FG003|Year 1|Protocol Violation|0|||
131655106|NCT02942277|474023302|FG004|Year 1|Protocol Violation|1|||
131655107|NCT02942277|474023303|FG005|Year 1|Protocol Violation|1|||
131655108|NCT02942277|474023304|FG006|Year 1|Protocol Violation|0|||
131655109|NCT02942277|474023305|FG007|Year 1|Protocol Violation|0|||
131655110|NCT02942277|474023306|FG008|Year 1|Protocol Violation|0|||
131655111|NCT02942277|474023307|FG009|Year 1|Protocol Violation|0|||
131655112|NCT02942277|474023308|FG010|Year 1|Protocol Violation|2|||
131655113|NCT02942277|474023298|FG000|Year 1|Pregnancy|0|||
131655114|NCT02942277|474023299|FG001|Year 1|Pregnancy|0|||
131655115|NCT02942277|474023300|FG002|Year 1|Pregnancy|0|||
131655116|NCT02942277|474023301|FG003|Year 1|Pregnancy|0|||
131655117|NCT02942277|474023302|FG004|Year 1|Pregnancy|0|||
131655118|NCT02942277|474023303|FG005|Year 1|Pregnancy|1|||
131655119|NCT02942277|474023304|FG006|Year 1|Pregnancy|0|||
131655120|NCT02942277|474023305|FG007|Year 1|Pregnancy|0|||
131655121|NCT02942277|474023306|FG008|Year 1|Pregnancy|0|||
131655122|NCT02942277|474023307|FG009|Year 1|Pregnancy|0|||
131655123|NCT02942277|474023308|FG010|Year 1|Pregnancy|0|||
131655124|NCT02942277|474023298|FG000|Year 2|Lost to Follow-up|0|||
131655125|NCT02942277|474023299|FG001|Year 2|Lost to Follow-up|0|||
131655126|NCT02942277|474023300|FG002|Year 2|Lost to Follow-up|0|||
131655127|NCT02942277|474023301|FG003|Year 2|Lost to Follow-up|0|||
131655128|NCT02942277|474023302|FG004|Year 2|Lost to Follow-up|2|||
131655129|NCT02942277|474023303|FG005|Year 2|Lost to Follow-up|1|||
131655130|NCT02942277|474023304|FG006|Year 2|Lost to Follow-up|0|||
131655131|NCT02942277|474023305|FG007|Year 2|Lost to Follow-up|0|||
131655132|NCT02942277|474023306|FG008|Year 2|Lost to Follow-up|0|||
131655133|NCT02942277|474023307|FG009|Year 2|Lost to Follow-up|0|||
131655134|NCT02942277|474023308|FG010|Year 2|Lost to Follow-up|0|||
131655135|NCT02942277|474023298|FG000|Year 2|Did not rescreen|0|||
131655136|NCT02942277|474023299|FG001|Year 2|Did not rescreen|0|||
131655137|NCT02942277|474023300|FG002|Year 2|Did not rescreen|1|||
131655138|NCT02942277|474023301|FG003|Year 2|Did not rescreen|1|||
131655139|NCT02942277|474023302|FG004|Year 2|Did not rescreen|9|||
131655140|NCT02942277|474023303|FG005|Year 2|Did not rescreen|6|||
131655141|NCT02942277|474023304|FG006|Year 2|Did not rescreen|0|||
131655142|NCT02942277|474023305|FG007|Year 2|Did not rescreen|1|||
131655143|NCT02942277|474023306|FG008|Year 2|Did not rescreen|0|||
131655144|NCT02942277|474023307|FG009|Year 2|Did not rescreen|0|||
131655145|NCT02942277|474023308|FG010|Year 2|Did not rescreen|21|||
131655146|NCT02942277|474023298|FG000|Year 2|Met withdrawal criteria|0|||
131655147|NCT02942277|474023299|FG001|Year 2|Met withdrawal criteria|0|||
131655148|NCT02942277|474023300|FG002|Year 2|Met withdrawal criteria|0|||
131655149|NCT02942277|474023301|FG003|Year 2|Met withdrawal criteria|0|||
131655150|NCT02942277|474023302|FG004|Year 2|Met withdrawal criteria|1|||
131655151|NCT02942277|474023303|FG005|Year 2|Met withdrawal criteria|2|||
131655152|NCT02942277|474023304|FG006|Year 2|Met withdrawal criteria|0|||
131655153|NCT02942277|474023305|FG007|Year 2|Met withdrawal criteria|0|||
131655154|NCT02942277|474023306|FG008|Year 2|Met withdrawal criteria|0|||
131655155|NCT02942277|474023307|FG009|Year 2|Met withdrawal criteria|0|||
131655156|NCT02942277|474023308|FG010|Year 2|Met withdrawal criteria|1|||
131655157|NCT02942277|474023298|FG000|Year 2|Travel|0|||
131655158|NCT02942277|474023299|FG001|Year 2|Travel|1|||
131655159|NCT02942277|474023300|FG002|Year 2|Travel|0|||
131655160|NCT02942277|474023301|FG003|Year 2|Travel|0|||
131655161|NCT02942277|474023302|FG004|Year 2|Travel|0|||
131655162|NCT02942277|474023303|FG005|Year 2|Travel|1|||
131655163|NCT02942277|474023304|FG006|Year 2|Travel|0|||
131655164|NCT02942277|474023305|FG007|Year 2|Travel|0|||
131655165|NCT02942277|474023306|FG008|Year 2|Travel|0|||
131655166|NCT02942277|474023307|FG009|Year 2|Travel|1|||
131655167|NCT02942277|474023308|FG010|Year 2|Travel|3|||
131655168|NCT02942277|474023298|FG000|Year 2|Non-compliant|0|||
131655169|NCT02942277|474023299|FG001|Year 2|Non-compliant|0|||
131655170|NCT02942277|474023300|FG002|Year 2|Non-compliant|0|||
131655171|NCT02942277|474023301|FG003|Year 2|Non-compliant|0|||
131655172|NCT02942277|474023302|FG004|Year 2|Non-compliant|1|||
131655173|NCT02942277|474023303|FG005|Year 2|Non-compliant|1|||
131655174|NCT02942277|474023304|FG006|Year 2|Non-compliant|0|||
131655175|NCT02942277|474023305|FG007|Year 2|Non-compliant|0|||
131655176|NCT02942277|474023306|FG008|Year 2|Non-compliant|0|||
131655177|NCT02942277|474023307|FG009|Year 2|Non-compliant|0|||
131655178|NCT02942277|474023308|FG010|Year 2|Non-compliant|0|||
131655179|NCT02942277|474023298|FG000|Year 2|Withdrawal by Subject|0|||
131655180|NCT02942277|474023299|FG001|Year 2|Withdrawal by Subject|0|||
131655181|NCT02942277|474023300|FG002|Year 2|Withdrawal by Subject|0|||
131655182|NCT02942277|474023301|FG003|Year 2|Withdrawal by Subject|0|||
131655183|NCT02942277|474023302|FG004|Year 2|Withdrawal by Subject|0|||
131655184|NCT02942277|474023303|FG005|Year 2|Withdrawal by Subject|0|||
131655185|NCT02942277|474023304|FG006|Year 2|Withdrawal by Subject|1|||
131655186|NCT02942277|474023305|FG007|Year 2|Withdrawal by Subject|0|||
131655187|NCT02942277|474023306|FG008|Year 2|Withdrawal by Subject|0|||
131655188|NCT02942277|474023307|FG009|Year 2|Withdrawal by Subject|0|||
131655189|NCT02942277|474023308|FG010|Year 2|Withdrawal by Subject|0|||
131655190|NCT05577715|474023309|FG000|Overall Study|Withdrawal by Subject|1|||
131655191|NCT05577715|474023309|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
131655192|NCT05577715|474023309|FG000|Overall Study|Lost to Follow-up|1|||
131655193|NCT05577715|474023309|FG000|Overall Study|Death|6|||
131655194|NCT01736189|474023312|FG000|Overall Study|Violation of registration criteria|41|||
131655195|NCT01736189|474023312|FG000|Overall Study|Protocol Violation|4|||
131655196|NCT01736189|474023312|FG000|Overall Study|Criteria and protocol violations|1|||
131655197|NCT01077128|474023314|FG000|Overall Study|Adverse Event|8|||
131655198|NCT01077128|474023314|FG000|Overall Study|Lack of Efficacy|1|||
131655199|NCT01077128|474023314|FG000|Overall Study|Disease exacerbation|1|||
131655200|NCT01077128|474023314|FG000|Overall Study|Adverse event and consent withdrawal|1|||
131655201|NCT01077128|474023314|FG000|Overall Study|Adverse event and disease exacerbation|1|||
131655202|NCT01077128|474023314|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
131655203|NCT01077128|474023314|FG000|Overall Study|Other|54|||
131655204|NCT00847626|474023317|FG000|Overall Study|Adverse Event|10|||
131655205|NCT00847626|474023318|FG001|Overall Study|Adverse Event|10|||
131655206|NCT00847626|474023319|FG002|Overall Study|Adverse Event|6|||
131655207|NCT00847626|474023320|FG003|Overall Study|Adverse Event|19|||
131655208|NCT00847626|474023321|FG004|Overall Study|Adverse Event|11|||
131655209|NCT00847626|474023322|FG005|Overall Study|Adverse Event|22|||
131655210|NCT00847626|474023323|FG006|Overall Study|Adverse Event|4|||
131655211|NCT00847626|474023324|FG007|Overall Study|Adverse Event|6|||
131655212|NCT00847626|474023325|FG008|Overall Study|Adverse Event|3|||
131655213|NCT00847626|474023326|FG009|Overall Study|Adverse Event|6|||
131655214|NCT00847626|474023327|FG010|Overall Study|Adverse Event|6|||
131655215|NCT00847626|474023317|FG000|Overall Study|Protocol Violation|2|||
131655216|NCT00847626|474023318|FG001|Overall Study|Protocol Violation|1|||
131655217|NCT00847626|474023319|FG002|Overall Study|Protocol Violation|2|||
131655218|NCT00847626|474023320|FG003|Overall Study|Protocol Violation|1|||
131655219|NCT00847626|474023321|FG004|Overall Study|Protocol Violation|1|||
131655220|NCT00847626|474023322|FG005|Overall Study|Protocol Violation|1|||
131655221|NCT00847626|474023323|FG006|Overall Study|Protocol Violation|1|||
131655222|NCT00847626|474023324|FG007|Overall Study|Protocol Violation|1|||
131655223|NCT00847626|474023325|FG008|Overall Study|Protocol Violation|0|||
131655224|NCT00847626|474023326|FG009|Overall Study|Protocol Violation|1|||
131655225|NCT00847626|474023327|FG010|Overall Study|Protocol Violation|1|||
131655226|NCT00847626|474023317|FG000|Overall Study|Lost to Follow-up|0|||
131655227|NCT00847626|474023318|FG001|Overall Study|Lost to Follow-up|1|||
131655228|NCT00847626|474023319|FG002|Overall Study|Lost to Follow-up|1|||
131655229|NCT00847626|474023320|FG003|Overall Study|Lost to Follow-up|1|||
131655230|NCT00847626|474023321|FG004|Overall Study|Lost to Follow-up|0|||
131655231|NCT00847626|474023322|FG005|Overall Study|Lost to Follow-up|3|||
131655232|NCT00847626|474023323|FG006|Overall Study|Lost to Follow-up|1|||
131655233|NCT00847626|474023324|FG007|Overall Study|Lost to Follow-up|3|||
131655234|NCT00847626|474023325|FG008|Overall Study|Lost to Follow-up|1|||
131655235|NCT00847626|474023326|FG009|Overall Study|Lost to Follow-up|0|||
131655236|NCT00847626|474023327|FG010|Overall Study|Lost to Follow-up|1|||
131655237|NCT00847626|474023317|FG000|Overall Study|Withdrawal by Subject|5|||
131655238|NCT00847626|474023318|FG001|Overall Study|Withdrawal by Subject|5|||
131655239|NCT00847626|474023319|FG002|Overall Study|Withdrawal by Subject|3|||
131655240|NCT00847626|474023320|FG003|Overall Study|Withdrawal by Subject|8|||
131655241|NCT00847626|474023321|FG004|Overall Study|Withdrawal by Subject|12|||
131655242|NCT00847626|474023322|FG005|Overall Study|Withdrawal by Subject|9|||
131655243|NCT00847626|474023323|FG006|Overall Study|Withdrawal by Subject|8|||
131655244|NCT00847626|474023324|FG007|Overall Study|Withdrawal by Subject|4|||
131655245|NCT00847626|474023325|FG008|Overall Study|Withdrawal by Subject|4|||
131655246|NCT00847626|474023326|FG009|Overall Study|Withdrawal by Subject|5|||
131655247|NCT00847626|474023327|FG010|Overall Study|Withdrawal by Subject|2|||
131655248|NCT00847626|474023317|FG000|Overall Study|Lack of Efficacy|3|||
131655249|NCT00847626|474023318|FG001|Overall Study|Lack of Efficacy|1|||
131655250|NCT00847626|474023319|FG002|Overall Study|Lack of Efficacy|0|||
131655251|NCT00847626|474023320|FG003|Overall Study|Lack of Efficacy|1|||
131655252|NCT00847626|474023321|FG004|Overall Study|Lack of Efficacy|2|||
131655253|NCT00847626|474023322|FG005|Overall Study|Lack of Efficacy|0|||
131655254|NCT00847626|474023323|FG006|Overall Study|Lack of Efficacy|6|||
131655255|NCT00847626|474023324|FG007|Overall Study|Lack of Efficacy|2|||
131655256|NCT00847626|474023325|FG008|Overall Study|Lack of Efficacy|5|||
131655257|NCT00847626|474023326|FG009|Overall Study|Lack of Efficacy|1|||
131655258|NCT00847626|474023327|FG010|Overall Study|Lack of Efficacy|7|||
131655259|NCT00847626|474023317|FG000|Overall Study|Other|1|||
131655260|NCT00847626|474023318|FG001|Overall Study|Other|5|||
131655261|NCT00847626|474023319|FG002|Overall Study|Other|4|||
131655262|NCT00847626|474023320|FG003|Overall Study|Other|1|||
131655263|NCT00847626|474023321|FG004|Overall Study|Other|2|||
131655264|NCT00847626|474023322|FG005|Overall Study|Other|2|||
131655265|NCT00847626|474023323|FG006|Overall Study|Other|2|||
131655266|NCT00847626|474023324|FG007|Overall Study|Other|3|||
131655267|NCT00847626|474023325|FG008|Overall Study|Other|1|||
131655268|NCT00847626|474023326|FG009|Overall Study|Other|1|||
131655269|NCT00847626|474023327|FG010|Overall Study|Other|3|||
131655270|NCT03809039|474023328|FG000|Part 1|Withdrawal by Subject|1|||
131655271|NCT03809039|474023329|FG001|Part 1|Withdrawal by Subject|0|||
131655272|NCT03809039|474023330|FG002|Part 1|Withdrawal by Subject|0|||
131655273|NCT03809039|474023331|FG003|Part 1|Withdrawal by Subject|1|||
131655274|NCT03809039|474023332|FG004|Part 1|Withdrawal by Subject|0|||
131655275|NCT03809039|474023333|FG005|Part 1|Withdrawal by Subject|0|||
131655276|NCT03809039|474023334|FG006|Part 1|Withdrawal by Subject|0|||
131655277|NCT03809039|474023335|FG007|Part 1|Withdrawal by Subject|0|||
131655278|NCT03809039|474023336|FG008|Part 1|Withdrawal by Subject|0|||
131655279|NCT03809039|474023328|FG000|Part 3|Withdrawn by study termination|0|||
131655280|NCT03809039|474023329|FG001|Part 3|Withdrawn by study termination|0|||
131655281|NCT03809039|474023330|FG002|Part 3|Withdrawn by study termination|0|||
131655282|NCT03809039|474023331|FG003|Part 3|Withdrawn by study termination|0|||
131655283|NCT03809039|474023332|FG004|Part 3|Withdrawn by study termination|0|||
131655284|NCT03809039|474023333|FG005|Part 3|Withdrawn by study termination|0|||
131655285|NCT03809039|474023334|FG006|Part 3|Withdrawn by study termination|0|||
131655286|NCT03809039|474023335|FG007|Part 3|Withdrawn by study termination|2|||
131655287|NCT03809039|474023336|FG008|Part 3|Withdrawn by study termination|6|||
131655288|NCT01250925|474023339|FG000|Overall Study|Lost to Follow-up|1|||
131655289|NCT01250925|474023340|FG001|Overall Study|Lost to Follow-up|1|||
131655290|NCT01250925|474023341|FG002|Overall Study|Lost to Follow-up|0|||
131655291|NCT01250925|474023339|FG000|Overall Study|Withdrawal by Subject|2|||
131655292|NCT01250925|474023340|FG001|Overall Study|Withdrawal by Subject|0|||
131655293|NCT01250925|474023341|FG002|Overall Study|Withdrawal by Subject|0|||
131655294|NCT01250925|474023339|FG000|Overall Study|Protocol Violation|2|||
131655295|NCT01250925|474023340|FG001|Overall Study|Protocol Violation|0|||
131655296|NCT01250925|474023341|FG002|Overall Study|Protocol Violation|0|||
131655297|NCT01250925|474023339|FG000|Overall Study|Physician Decision|0|||
131655298|NCT01250925|474023340|FG001|Overall Study|Physician Decision|2|||
131655299|NCT01250925|474023341|FG002|Overall Study|Physician Decision|1|||
131655300|NCT01250925|474023339|FG000|Overall Study|Adverse Event|0|||
131655301|NCT01250925|474023340|FG001|Overall Study|Adverse Event|0|||
131655302|NCT01250925|474023341|FG002|Overall Study|Adverse Event|1|||
131655303|NCT04421950|474023342|FG000|Overall Study|Dropped or lost to follow up|4|||
131655304|NCT04421950|474023343|FG001|Overall Study|Dropped or lost to follow up|2|||
131655305|NCT01252355|474023344|FG000|Overall Study|Adverse Event|9|||
131655306|NCT01252355|474023345|FG001|Overall Study|Adverse Event|17|||
131655307|NCT01252355|474023346|FG002|Overall Study|Adverse Event|22|||
131655308|NCT01252355|474023344|FG000|Overall Study|Lack of Efficacy|6|||
131655309|NCT01252355|474023345|FG001|Overall Study|Lack of Efficacy|4|||
131655310|NCT01252355|474023346|FG002|Overall Study|Lack of Efficacy|2|||
131655311|NCT01252355|474023344|FG000|Overall Study|Lost to Follow-up|0|||
131655312|NCT01252355|474023345|FG001|Overall Study|Lost to Follow-up|0|||
131655313|NCT01252355|474023346|FG002|Overall Study|Lost to Follow-up|1|||
131655314|NCT01252355|474023344|FG000|Overall Study|Poor Compliance to Protocol|1|||
131655315|NCT01252355|474023345|FG001|Overall Study|Poor Compliance to Protocol|1|||
131655316|NCT01252355|474023346|FG002|Overall Study|Poor Compliance to Protocol|1|||
131655317|NCT01252355|474023344|FG000|Overall Study|Progressive Disease|2|||
131655318|NCT01252355|474023345|FG001|Overall Study|Progressive Disease|0|||
131655319|NCT01252355|474023346|FG002|Overall Study|Progressive Disease|0|||
131655320|NCT01252355|474023344|FG000|Overall Study|Sponsor Early Termination of Study|149|||
131655321|NCT01252355|474023345|FG001|Overall Study|Sponsor Early Termination of Study|149|||
131655322|NCT01252355|474023346|FG002|Overall Study|Sponsor Early Termination of Study|146|||
131655323|NCT01252355|474023344|FG000|Overall Study|Randomized but not Treated|2|||
131655324|NCT01252355|474023345|FG001|Overall Study|Randomized but not Treated|0|||
131655325|NCT01252355|474023346|FG002|Overall Study|Randomized but not Treated|0|||
131655326|NCT01252355|474023344|FG000|Overall Study|Other Than Above|8|||
131655327|NCT01252355|474023345|FG001|Overall Study|Other Than Above|7|||
131655328|NCT01252355|474023346|FG002|Overall Study|Other Than Above|7|||
131655329|NCT00335140|474023347|FG000|Overall Study|Ineligible|1|||
131655330|NCT04546425|474023348|FG000|Overall Study|Protocol Violation|1|||
131655331|NCT04546425|474023349|FG001|Overall Study|Protocol Violation|1|||
131655332|NCT04546425|474023350|FG002|Overall Study|Protocol Violation|0|||
131655333|NCT04546425|474023351|FG003|Overall Study|Protocol Violation|0|||
131655334|NCT04546425|474023348|FG000|Overall Study|Adverse Event|3|||
131655335|NCT04546425|474023349|FG001|Overall Study|Adverse Event|0|||
131655336|NCT04546425|474023350|FG002|Overall Study|Adverse Event|0|||
131655337|NCT04546425|474023351|FG003|Overall Study|Adverse Event|0|||
131655338|NCT04546425|474023348|FG000|Overall Study|Lost to Follow-up|5|||
131655339|NCT04546425|474023349|FG001|Overall Study|Lost to Follow-up|4|||
131655340|NCT04546425|474023350|FG002|Overall Study|Lost to Follow-up|0|||
131655341|NCT04546425|474023351|FG003|Overall Study|Lost to Follow-up|0|||
131655342|NCT04546425|474023348|FG000|Overall Study|No Longer met eligibility criteria|3|||
131655343|NCT04546425|474023349|FG001|Overall Study|No Longer met eligibility criteria|3|||
131655344|NCT04546425|474023350|FG002|Overall Study|No Longer met eligibility criteria|1|||
131655345|NCT04546425|474023351|FG003|Overall Study|No Longer met eligibility criteria|1|||
131655346|NCT04546425|474023348|FG000|Overall Study|Withdrawal by parent/guardian|6|||
131655347|NCT04546425|474023349|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131655348|NCT04546425|474023350|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131655349|NCT04546425|474023351|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131655350|NCT01725126|474023352|FG000|Overall Study|Protocol Violation|0|||
131655351|NCT01725126|474023353|FG001|Overall Study|Protocol Violation|1|||
131655352|NCT01725126|474023354|FG002|Overall Study|Protocol Violation|0|||
131655353|NCT01725126|474023355|FG003|Overall Study|Protocol Violation|0|||
131655354|NCT01725126|474023356|FG004|Overall Study|Protocol Violation|0|||
131655355|NCT01725126|474023357|FG005|Overall Study|Protocol Violation|0|||
131655356|NCT01725126|474023352|FG000|Overall Study|Withdrawal by Subject|0|||
131655357|NCT01725126|474023353|FG001|Overall Study|Withdrawal by Subject|0|||
131655358|NCT01725126|474023354|FG002|Overall Study|Withdrawal by Subject|0|||
131655359|NCT01725126|474023355|FG003|Overall Study|Withdrawal by Subject|1|||
131655360|NCT01725126|474023356|FG004|Overall Study|Withdrawal by Subject|0|||
131655361|NCT01725126|474023357|FG005|Overall Study|Withdrawal by Subject|0|||
131655362|NCT00677534|474023358|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
131655363|NCT00677534|474023358|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
131655364|NCT00677534|474023358|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
131655365|NCT00863681|474023365|FG000|Overall Study|Other|2|||
131655366|NCT00863681|474023366|FG001|Overall Study|Other|0|||
131655367|NCT00863681|474023367|FG002|Overall Study|Other|0|||
131655368|NCT00863681|474023365|FG000|Overall Study|Missing|1|||
131655369|NCT00863681|474023366|FG001|Overall Study|Missing|0|||
131655370|NCT00863681|474023367|FG002|Overall Study|Missing|0|||
131655371|NCT00863681|474023365|FG000|Overall Study|Death|40|||
131655372|NCT00863681|474023366|FG001|Overall Study|Death|23|||
131655373|NCT00863681|474023367|FG002|Overall Study|Death|6|||
131655374|NCT00863681|474023365|FG000|Overall Study|Withdrawal by Subject|12|||
131655375|NCT00863681|474023366|FG001|Overall Study|Withdrawal by Subject|5|||
131655376|NCT00863681|474023367|FG002|Overall Study|Withdrawal by Subject|2|||
131655377|NCT00863681|474023365|FG000|Overall Study|Protocol Violation|2|||
131655378|NCT00863681|474023366|FG001|Overall Study|Protocol Violation|0|||
131655379|NCT00863681|474023367|FG002|Overall Study|Protocol Violation|0|||
131655380|NCT00863681|474023365|FG000|Overall Study|Lost to Follow-up|3|||
131655381|NCT00863681|474023366|FG001|Overall Study|Lost to Follow-up|0|||
131655382|NCT00863681|474023367|FG002|Overall Study|Lost to Follow-up|3|||
131655383|NCT00863681|474023365|FG000|Overall Study|Adverse Event|28|||
131655384|NCT00863681|474023366|FG001|Overall Study|Adverse Event|10|||
131655385|NCT00863681|474023367|FG002|Overall Study|Adverse Event|6|||
131655386|NCT00863681|474023365|FG000|Overall Study|Lack of Efficacy|2|||
131655387|NCT00863681|474023366|FG001|Overall Study|Lack of Efficacy|2|||
131655388|NCT00863681|474023367|FG002|Overall Study|Lack of Efficacy|1|||
131655389|NCT00863681|474023365|FG000|Overall Study|Non-compliance with study drug|1|||
131655390|NCT00863681|474023366|FG001|Overall Study|Non-compliance with study drug|3|||
131655391|NCT00863681|474023367|FG002|Overall Study|Non-compliance with study drug|0|||
131655392|NCT03031496|474023368|FG000|Period 1|Adverse Event|2|||
131655393|NCT03031496|474023369|FG001|Period 1|Adverse Event|0|||
131655394|NCT03031496|474023368|FG000|Period 1|Withdrawal by Subject|0|||
131655395|NCT03031496|474023369|FG001|Period 1|Withdrawal by Subject|2|||
131655396|NCT02979249|474023371|FG000|Overall Study|Lost to Follow-up|2|||
131655397|NCT02979249|474023371|FG000|Overall Study|Withdrawal by Subject|4|||
131655398|NCT01125046|474023372|FG000|First 6 Months of Treatment|Death|1|||
131655399|NCT01125046|474023372|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
131655400|NCT01125046|474023372|FG000|First 6 Months of Treatment|Non-compliance|1|||
131655401|NCT01125046|474023372|FG000|First 6 Months of Treatment|Surgery|1|||
131655402|NCT01125046|474023372|FG000|First 6 Months of Treatment|Progressive Disease|7|||
131655403|NCT01125046|474023372|FG000|First 6 Months of Treatment|Adverse Event|2|||
131655404|NCT01125046|474023372|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
131655405|NCT01125046|474023372|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
131655406|NCT01125046|474023372|FG000|Follow-up/Data Cut Off Point|Death|29|||
131655407|NCT01125046|474023372|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
131655408|NCT01685229|474023374|FG000|Overall Study|Subjects missing Study Exit form|3|||
131655409|NCT01685229|474023375|FG001|Overall Study|Subjects missing Study Exit form|1|||
131655410|NCT01685229|474023374|FG000|Overall Study|Lost to Follow-up|16|||
131655411|NCT01685229|474023375|FG001|Overall Study|Lost to Follow-up|10|||
131655412|NCT01685229|474023374|FG000|Overall Study|Withdrawal by Subject|6|||
131655413|NCT01685229|474023375|FG001|Overall Study|Withdrawal by Subject|5|||
131655414|NCT01685229|474023374|FG000|Overall Study|Death|1|||
131655415|NCT01685229|474023375|FG001|Overall Study|Death|0|||
131655416|NCT00895895|474023376|FG000|Period 1|Adverse Event|7|||
131655417|NCT00895895|474023377|FG001|Period 1|Adverse Event|6|||
131655418|NCT00895895|474023378|FG002|Period 1|Adverse Event|4|||
131655419|NCT00895895|474023379|FG003|Period 1|Adverse Event|6|||
131655420|NCT00895895|474023380|FG004|Period 1|Adverse Event|7|||
131655421|NCT00895895|474023376|FG000|Period 1|Death|0|||
131655422|NCT00895895|474023377|FG001|Period 1|Death|0|||
131655423|NCT00895895|474023378|FG002|Period 1|Death|0|||
131655424|NCT00895895|474023379|FG003|Period 1|Death|0|||
131655425|NCT00895895|474023380|FG004|Period 1|Death|1|||
131655426|NCT00895895|474023376|FG000|Period 1|discontinued by sponsor|2|||
131655427|NCT00895895|474023377|FG001|Period 1|discontinued by sponsor|1|||
131655428|NCT00895895|474023378|FG002|Period 1|discontinued by sponsor|2|||
131655429|NCT00895895|474023379|FG003|Period 1|discontinued by sponsor|1|||
131655430|NCT00895895|474023380|FG004|Period 1|discontinued by sponsor|1|||
131655431|NCT00895895|474023376|FG000|Period 1|failed to return|0|||
131655432|NCT00895895|474023377|FG001|Period 1|failed to return|0|||
131655433|NCT00895895|474023378|FG002|Period 1|failed to return|1|||
131655434|NCT00895895|474023379|FG003|Period 1|failed to return|0|||
131655435|NCT00895895|474023380|FG004|Period 1|failed to return|1|||
131655436|NCT00895895|474023376|FG000|Period 1|investigator request|0|||
131655437|NCT00895895|474023377|FG001|Period 1|investigator request|1|||
131655438|NCT00895895|474023378|FG002|Period 1|investigator request|0|||
131655439|NCT00895895|474023379|FG003|Period 1|investigator request|0|||
131655440|NCT00895895|474023380|FG004|Period 1|investigator request|0|||
131655441|NCT00895895|474023376|FG000|Period 1|Lost to Follow-up|2|||
131655442|NCT00895895|474023377|FG001|Period 1|Lost to Follow-up|1|||
131655443|NCT00895895|474023378|FG002|Period 1|Lost to Follow-up|3|||
131655444|NCT00895895|474023379|FG003|Period 1|Lost to Follow-up|2|||
131655445|NCT00895895|474023380|FG004|Period 1|Lost to Follow-up|3|||
131655446|NCT00895895|474023376|FG000|Period 1|Other|1|||
131655447|NCT00895895|474023377|FG001|Period 1|Other|2|||
131655448|NCT00895895|474023378|FG002|Period 1|Other|1|||
131655449|NCT00895895|474023379|FG003|Period 1|Other|1|||
131655450|NCT00895895|474023380|FG004|Period 1|Other|1|||
131655451|NCT00895895|474023376|FG000|Period 1|Protocol Violation|0|||
131655452|NCT00895895|474023377|FG001|Period 1|Protocol Violation|1|||
131655453|NCT00895895|474023378|FG002|Period 1|Protocol Violation|0|||
131655454|NCT00895895|474023379|FG003|Period 1|Protocol Violation|0|||
131655455|NCT00895895|474023380|FG004|Period 1|Protocol Violation|0|||
131655456|NCT00895895|474023376|FG000|Period 1|Withdrawal by Subject|6|||
131655457|NCT00895895|474023377|FG001|Period 1|Withdrawal by Subject|6|||
131655458|NCT00895895|474023378|FG002|Period 1|Withdrawal by Subject|8|||
131655459|NCT00895895|474023379|FG003|Period 1|Withdrawal by Subject|2|||
131655460|NCT00895895|474023380|FG004|Period 1|Withdrawal by Subject|4|||
131655461|NCT00895895|474023376|FG000|Period 1|unsatisfactory response-efficacy|2|||
131655462|NCT00895895|474023377|FG001|Period 1|unsatisfactory response-efficacy|0|||
131655463|NCT00895895|474023378|FG002|Period 1|unsatisfactory response-efficacy|0|||
131655464|NCT00895895|474023379|FG003|Period 1|unsatisfactory response-efficacy|0|||
131655465|NCT00895895|474023380|FG004|Period 1|unsatisfactory response-efficacy|0|||
131655466|NCT00895895|474023376|FG000|Period 1|randomized and not treated|1|||
131655467|NCT00895895|474023377|FG001|Period 1|randomized and not treated|3|||
131655468|NCT00895895|474023378|FG002|Period 1|randomized and not treated|1|||
131655469|NCT00895895|474023379|FG003|Period 1|randomized and not treated|1|||
131655470|NCT00895895|474023380|FG004|Period 1|randomized and not treated|2|||
131655471|NCT00895895|474023376|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
131655472|NCT00895895|474023377|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
131655473|NCT00895895|474023378|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
131655474|NCT00895895|474023379|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
131655475|NCT00895895|474023380|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
131655476|NCT00895895|474023376|FG000|After Period 1, Prior to Period 2|Other|0|||
131655477|NCT00895895|474023377|FG001|After Period 1, Prior to Period 2|Other|0|||
131655478|NCT00895895|474023378|FG002|After Period 1, Prior to Period 2|Other|1|||
131655479|NCT00895895|474023379|FG003|After Period 1, Prior to Period 2|Other|0|||
131655480|NCT00895895|474023380|FG004|After Period 1, Prior to Period 2|Other|0|||
131655481|NCT00895895|474023376|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
131655482|NCT00895895|474023377|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
131655483|NCT00895895|474023378|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
131655484|NCT00895895|474023379|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
131655485|NCT00895895|474023380|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
131655486|NCT00895895|474023376|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131655487|NCT00895895|474023377|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131655488|NCT00895895|474023378|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131655489|NCT00895895|474023379|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131655490|NCT00895895|474023380|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
131655491|NCT00895895|474023376|FG000|Period 2|Adverse Event|3|||
131655492|NCT00895895|474023377|FG001|Period 2|Adverse Event|3|||
131655493|NCT00895895|474023378|FG002|Period 2|Adverse Event|5|||
131655494|NCT00895895|474023379|FG003|Period 2|Adverse Event|2|||
131655495|NCT00895895|474023380|FG004|Period 2|Adverse Event|5|||
131655496|NCT00895895|474023376|FG000|Period 2|Death|0|||
131655497|NCT00895895|474023377|FG001|Period 2|Death|0|||
131655498|NCT00895895|474023378|FG002|Period 2|Death|1|||
131655499|NCT00895895|474023379|FG003|Period 2|Death|0|||
131655500|NCT00895895|474023380|FG004|Period 2|Death|0|||
131655501|NCT00895895|474023376|FG000|Period 2|discontinued by sponsor|44|||
131655502|NCT00895895|474023377|FG001|Period 2|discontinued by sponsor|44|||
131655503|NCT00895895|474023378|FG002|Period 2|discontinued by sponsor|38|||
131655504|NCT00895895|474023379|FG003|Period 2|discontinued by sponsor|46|||
131655505|NCT00895895|474023380|FG004|Period 2|discontinued by sponsor|37|||
131655506|NCT00895895|474023376|FG000|Period 2|failed to return|2|||
131655507|NCT00895895|474023377|FG001|Period 2|failed to return|0|||
131655508|NCT00895895|474023378|FG002|Period 2|failed to return|0|||
131655509|NCT00895895|474023379|FG003|Period 2|failed to return|0|||
131655510|NCT00895895|474023380|FG004|Period 2|failed to return|0|||
131655511|NCT00895895|474023376|FG000|Period 2|investigator request|2|||
131655512|NCT00895895|474023377|FG001|Period 2|investigator request|0|||
131655513|NCT00895895|474023378|FG002|Period 2|investigator request|0|||
131655514|NCT00895895|474023379|FG003|Period 2|investigator request|0|||
131655515|NCT00895895|474023380|FG004|Period 2|investigator request|0|||
131655516|NCT00895895|474023376|FG000|Period 2|Lost to Follow-up|1|||
131655517|NCT00895895|474023377|FG001|Period 2|Lost to Follow-up|2|||
131655518|NCT00895895|474023378|FG002|Period 2|Lost to Follow-up|1|||
131655519|NCT00895895|474023379|FG003|Period 2|Lost to Follow-up|1|||
131655520|NCT00895895|474023380|FG004|Period 2|Lost to Follow-up|0|||
131655521|NCT00895895|474023376|FG000|Period 2|Other|1|||
131655522|NCT00895895|474023377|FG001|Period 2|Other|1|||
131655523|NCT00895895|474023378|FG002|Period 2|Other|3|||
131655524|NCT00895895|474023379|FG003|Period 2|Other|1|||
131655525|NCT00895895|474023380|FG004|Period 2|Other|1|||
131655526|NCT00895895|474023376|FG000|Period 2|Protocol Violation|1|||
131655527|NCT00895895|474023377|FG001|Period 2|Protocol Violation|0|||
131655528|NCT00895895|474023378|FG002|Period 2|Protocol Violation|1|||
131655529|NCT00895895|474023379|FG003|Period 2|Protocol Violation|1|||
131655530|NCT00895895|474023380|FG004|Period 2|Protocol Violation|1|||
131655531|NCT00895895|474023376|FG000|Period 2|Withdrawal by Subject|0|||
131655532|NCT00895895|474023377|FG001|Period 2|Withdrawal by Subject|2|||
131655533|NCT00895895|474023378|FG002|Period 2|Withdrawal by Subject|0|||
131655534|NCT00895895|474023379|FG003|Period 2|Withdrawal by Subject|3|||
131655535|NCT00895895|474023380|FG004|Period 2|Withdrawal by Subject|5|||
131655536|NCT00895895|474023376|FG000|Period 2|unsatisfactory response-efficacy|2|||
131655537|NCT00895895|474023377|FG001|Period 2|unsatisfactory response-efficacy|1|||
131655538|NCT00895895|474023378|FG002|Period 2|unsatisfactory response-efficacy|0|||
131655539|NCT00895895|474023379|FG003|Period 2|unsatisfactory response-efficacy|0|||
131655540|NCT00895895|474023380|FG004|Period 2|unsatisfactory response-efficacy|0|||
131655541|NCT00820170|474023383|FG000|Overall Study|Adverse Event|0|||
131655542|NCT00820170|474023384|FG001|Overall Study|Adverse Event|0|||
131655543|NCT00820170|474023385|FG002|Overall Study|Adverse Event|0|||
131655544|NCT00820170|474023386|FG003|Overall Study|Adverse Event|0|||
131655545|NCT00820170|474023387|FG004|Overall Study|Adverse Event|2|||
131655546|NCT00820170|474023383|FG000|Overall Study|Progressive Disease|0|||
131655547|NCT00820170|474023384|FG001|Overall Study|Progressive Disease|0|||
131655548|NCT00820170|474023385|FG002|Overall Study|Progressive Disease|0|||
131655549|NCT00820170|474023386|FG003|Overall Study|Progressive Disease|0|||
131655550|NCT00820170|474023387|FG004|Overall Study|Progressive Disease|2|||
131655551|NCT03682185|474023393|FG000|Overall Study|Lost to Follow-up|4|||
131655552|NCT03682185|474023394|FG001|Overall Study|Lost to Follow-up|7|||
131655553|NCT03682185|474023395|FG002|Overall Study|Lost to Follow-up|4|||
131655554|NCT03682185|474023396|FG003|Overall Study|Lost to Follow-up|7|||
131655555|NCT03682185|474023397|FG004|Overall Study|Lost to Follow-up|1|||
131655556|NCT03682185|474023393|FG000|Overall Study|Withdrawal by Subject|7|||
131655557|NCT03682185|474023394|FG001|Overall Study|Withdrawal by Subject|3|||
131655558|NCT03682185|474023395|FG002|Overall Study|Withdrawal by Subject|7|||
131655559|NCT03682185|474023396|FG003|Overall Study|Withdrawal by Subject|3|||
131655560|NCT03682185|474023397|FG004|Overall Study|Withdrawal by Subject|0|||
131655561|NCT04908631|474023398|FG000|Overall Study|Lost to Follow-up|1|||
131655562|NCT04908631|474023398|FG000|Overall Study|Physician Decision|1|||
131655563|NCT04908631|474023398|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
131655564|NCT02284009|474023399|FG000|Overall Study|Adverse Event|3|||
131655565|NCT02284009|474023400|FG001|Overall Study|Adverse Event|0|||
131655566|NCT02284009|474023399|FG000|Overall Study|Lost to Follow-up|1|||
131655567|NCT02284009|474023400|FG001|Overall Study|Lost to Follow-up|3|||
131655568|NCT02284009|474023399|FG000|Overall Study|Physician Decision|0|||
131655569|NCT02284009|474023400|FG001|Overall Study|Physician Decision|2|||
131655570|NCT02284009|474023399|FG000|Overall Study|Withdrawal by Subject|2|||
131655571|NCT02284009|474023400|FG001|Overall Study|Withdrawal by Subject|5|||
131655572|NCT04047862|474023413|FG000|Overall Study|Death|0|||
131655573|NCT04047862|474023414|FG001|Overall Study|Death|0|||
131655574|NCT04047862|474023415|FG002|Overall Study|Death|4|||
131655575|NCT04047862|474023416|FG003|Overall Study|Death|7|||
131655576|NCT04047862|474023417|FG004|Overall Study|Death|2|||
131655577|NCT04047862|474023418|FG005|Overall Study|Death|4|||
131655578|NCT04047862|474023419|FG006|Overall Study|Death|3|||
131655579|NCT04047862|474023420|FG007|Overall Study|Death|24|||
131655580|NCT04047862|474023421|FG008|Overall Study|Death|24|||
131655581|NCT04047862|474023422|FG009|Overall Study|Death|22|||
131655582|NCT04047862|474023423|FG010|Overall Study|Death|35|||
131655583|NCT04047862|474023424|FG011|Overall Study|Death|18|||
131655584|NCT04047862|474023425|FG012|Overall Study|Death|14|||
131655585|NCT04047862|474023426|FG013|Overall Study|Death|6|||
131655586|NCT04047862|474023427|FG014|Overall Study|Death|19|||
131655587|NCT04047862|474023428|FG015|Overall Study|Death|42|||
131655588|NCT04047862|474023429|FG016|Overall Study|Death|9|||
131655589|NCT04047862|474023430|FG017|Overall Study|Death|8|||
131655590|NCT04047862|474023431|FG018|Overall Study|Death|10|||
131655591|NCT04047862|474023413|FG000|Overall Study|Withdrawal by Subject|0|||
131655592|NCT04047862|474023414|FG001|Overall Study|Withdrawal by Subject|0|||
131655593|NCT04047862|474023415|FG002|Overall Study|Withdrawal by Subject|0|||
131655594|NCT04047862|474023416|FG003|Overall Study|Withdrawal by Subject|5|||
131655595|NCT04047862|474023417|FG004|Overall Study|Withdrawal by Subject|2|||
131655596|NCT04047862|474023418|FG005|Overall Study|Withdrawal by Subject|0|||
131655597|NCT04047862|474023419|FG006|Overall Study|Withdrawal by Subject|1|||
131655598|NCT04047862|474023420|FG007|Overall Study|Withdrawal by Subject|0|||
131655599|NCT04047862|474023421|FG008|Overall Study|Withdrawal by Subject|4|||
131655600|NCT04047862|474023422|FG009|Overall Study|Withdrawal by Subject|4|||
131655601|NCT04047862|474023423|FG010|Overall Study|Withdrawal by Subject|4|||
131655602|NCT04047862|474023424|FG011|Overall Study|Withdrawal by Subject|2|||
131655603|NCT04047862|474023425|FG012|Overall Study|Withdrawal by Subject|3|||
131655604|NCT04047862|474023426|FG013|Overall Study|Withdrawal by Subject|0|||
131655605|NCT04047862|474023427|FG014|Overall Study|Withdrawal by Subject|9|||
131655606|NCT04047862|474023428|FG015|Overall Study|Withdrawal by Subject|5|||
131655607|NCT04047862|474023429|FG016|Overall Study|Withdrawal by Subject|1|||
131655608|NCT04047862|474023430|FG017|Overall Study|Withdrawal by Subject|3|||
131655609|NCT04047862|474023431|FG018|Overall Study|Withdrawal by Subject|1|||
131655610|NCT04047862|474023413|FG000|Overall Study|Lost to Follow-up|0|||
131655611|NCT04047862|474023414|FG001|Overall Study|Lost to Follow-up|0|||
131655612|NCT04047862|474023415|FG002|Overall Study|Lost to Follow-up|1|||
131655613|NCT04047862|474023416|FG003|Overall Study|Lost to Follow-up|0|||
131655614|NCT04047862|474023417|FG004|Overall Study|Lost to Follow-up|0|||
131655615|NCT04047862|474023418|FG005|Overall Study|Lost to Follow-up|0|||
131655616|NCT04047862|474023419|FG006|Overall Study|Lost to Follow-up|0|||
131655617|NCT04047862|474023420|FG007|Overall Study|Lost to Follow-up|1|||
131655618|NCT04047862|474023421|FG008|Overall Study|Lost to Follow-up|0|||
131655619|NCT04047862|474023422|FG009|Overall Study|Lost to Follow-up|1|||
131655620|NCT04047862|474023423|FG010|Overall Study|Lost to Follow-up|0|||
131655621|NCT04047862|474023424|FG011|Overall Study|Lost to Follow-up|3|||
131655622|NCT04047862|474023425|FG012|Overall Study|Lost to Follow-up|0|||
131655623|NCT04047862|474023426|FG013|Overall Study|Lost to Follow-up|0|||
131655624|NCT04047862|474023427|FG014|Overall Study|Lost to Follow-up|2|||
131655625|NCT04047862|474023428|FG015|Overall Study|Lost to Follow-up|2|||
131655626|NCT04047862|474023429|FG016|Overall Study|Lost to Follow-up|1|||
131655627|NCT04047862|474023430|FG017|Overall Study|Lost to Follow-up|0|||
131655628|NCT04047862|474023431|FG018|Overall Study|Lost to Follow-up|0|||
131655629|NCT04047862|474023413|FG000|Overall Study|Physician Decision|0|||
131655630|NCT04047862|474023414|FG001|Overall Study|Physician Decision|0|||
131655631|NCT04047862|474023415|FG002|Overall Study|Physician Decision|0|||
131655632|NCT04047862|474023416|FG003|Overall Study|Physician Decision|1|||
131655633|NCT04047862|474023417|FG004|Overall Study|Physician Decision|0|||
131655634|NCT04047862|474023418|FG005|Overall Study|Physician Decision|0|||
131655635|NCT04047862|474023419|FG006|Overall Study|Physician Decision|0|||
131655636|NCT04047862|474023420|FG007|Overall Study|Physician Decision|0|||
131655637|NCT04047862|474023421|FG008|Overall Study|Physician Decision|0|||
131655638|NCT04047862|474023422|FG009|Overall Study|Physician Decision|0|||
131655639|NCT04047862|474023423|FG010|Overall Study|Physician Decision|0|||
131655640|NCT04047862|474023424|FG011|Overall Study|Physician Decision|0|||
131655641|NCT04047862|474023425|FG012|Overall Study|Physician Decision|0|||
131655642|NCT04047862|474023426|FG013|Overall Study|Physician Decision|0|||
131655643|NCT04047862|474023427|FG014|Overall Study|Physician Decision|1|||
131655644|NCT04047862|474023428|FG015|Overall Study|Physician Decision|0|||
131655645|NCT04047862|474023429|FG016|Overall Study|Physician Decision|1|||
131655646|NCT04047862|474023430|FG017|Overall Study|Physician Decision|0|||
131655647|NCT04047862|474023431|FG018|Overall Study|Physician Decision|0|||
131655648|NCT04047862|474023413|FG000|Overall Study|Completed all Assessments|1|||
131655649|NCT04047862|474023414|FG001|Overall Study|Completed all Assessments|3|||
131655650|NCT04047862|474023415|FG002|Overall Study|Completed all Assessments|1|||
131655651|NCT04047862|474023416|FG003|Overall Study|Completed all Assessments|3|||
131655652|NCT04047862|474023417|FG004|Overall Study|Completed all Assessments|2|||
131655653|NCT04047862|474023418|FG005|Overall Study|Completed all Assessments|5|||
131655654|NCT04047862|474023419|FG006|Overall Study|Completed all Assessments|7|||
131655655|NCT04047862|474023420|FG007|Overall Study|Completed all Assessments|0|||
131655656|NCT04047862|474023421|FG008|Overall Study|Completed all Assessments|0|||
131655657|NCT04047862|474023422|FG009|Overall Study|Completed all Assessments|0|||
131655658|NCT04047862|474023423|FG010|Overall Study|Completed all Assessments|0|||
131655659|NCT04047862|474023424|FG011|Overall Study|Completed all Assessments|0|||
131655660|NCT04047862|474023425|FG012|Overall Study|Completed all Assessments|0|||
131655661|NCT04047862|474023426|FG013|Overall Study|Completed all Assessments|0|||
131655662|NCT04047862|474023427|FG014|Overall Study|Completed all Assessments|0|||
131655663|NCT04047862|474023428|FG015|Overall Study|Completed all Assessments|0|||
131655664|NCT04047862|474023429|FG016|Overall Study|Completed all Assessments|0|||
131655665|NCT04047862|474023430|FG017|Overall Study|Completed all Assessments|0|||
131655666|NCT04047862|474023431|FG018|Overall Study|Completed all Assessments|0|||
131655667|NCT04047862|474023413|FG000|Overall Study|Sponsor Decision|0|||
131655668|NCT04047862|474023414|FG001|Overall Study|Sponsor Decision|0|||
131655669|NCT04047862|474023415|FG002|Overall Study|Sponsor Decision|0|||
131655670|NCT04047862|474023416|FG003|Overall Study|Sponsor Decision|0|||
131655671|NCT04047862|474023417|FG004|Overall Study|Sponsor Decision|0|||
131655672|NCT04047862|474023418|FG005|Overall Study|Sponsor Decision|0|||
131655673|NCT04047862|474023419|FG006|Overall Study|Sponsor Decision|0|||
131655674|NCT04047862|474023420|FG007|Overall Study|Sponsor Decision|13|||
131655675|NCT04047862|474023421|FG008|Overall Study|Sponsor Decision|10|||
131655676|NCT04047862|474023422|FG009|Overall Study|Sponsor Decision|18|||
131655677|NCT04047862|474023423|FG010|Overall Study|Sponsor Decision|3|||
131655678|NCT04047862|474023424|FG011|Overall Study|Sponsor Decision|3|||
131655679|NCT04047862|474023425|FG012|Overall Study|Sponsor Decision|4|||
131655680|NCT04047862|474023426|FG013|Overall Study|Sponsor Decision|0|||
131655681|NCT04047862|474023427|FG014|Overall Study|Sponsor Decision|7|||
131655682|NCT04047862|474023428|FG015|Overall Study|Sponsor Decision|8|||
131655683|NCT04047862|474023429|FG016|Overall Study|Sponsor Decision|9|||
131655684|NCT04047862|474023430|FG017|Overall Study|Sponsor Decision|7|||
131655685|NCT04047862|474023431|FG018|Overall Study|Sponsor Decision|8|||
131655686|NCT04047862|474023413|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655687|NCT04047862|474023414|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655688|NCT04047862|474023415|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655689|NCT04047862|474023416|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655690|NCT04047862|474023417|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655691|NCT04047862|474023418|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655692|NCT04047862|474023419|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655693|NCT04047862|474023420|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
131655694|NCT04047862|474023421|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
131655695|NCT04047862|474023422|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655696|NCT04047862|474023423|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
131655697|NCT04047862|474023424|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655698|NCT04047862|474023425|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655699|NCT04047862|474023426|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131655700|NCT04047862|474023427|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
131655701|NCT04047862|474023428|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
131655702|NCT04047862|474023429|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
131655703|NCT04047862|474023430|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
131655704|NCT04047862|474023431|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
131655705|NCT04047862|474023413|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655706|NCT04047862|474023414|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655707|NCT04047862|474023415|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655708|NCT04047862|474023416|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655709|NCT04047862|474023417|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655710|NCT04047862|474023418|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655711|NCT04047862|474023419|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655712|NCT04047862|474023420|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655713|NCT04047862|474023421|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655714|NCT04047862|474023422|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655715|NCT04047862|474023423|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655716|NCT04047862|474023424|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655717|NCT04047862|474023425|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655718|NCT04047862|474023426|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655719|NCT04047862|474023427|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655720|NCT04047862|474023428|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
131655721|NCT04047862|474023429|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655722|NCT04047862|474023430|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131655723|NCT04047862|474023431|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
131655724|NCT04047862|474023413|FG000|Overall Study|Other|0|||
131655725|NCT04047862|474023414|FG001|Overall Study|Other|0|||
131655726|NCT04047862|474023415|FG002|Overall Study|Other|0|||
131655727|NCT04047862|474023416|FG003|Overall Study|Other|0|||
131655728|NCT04047862|474023417|FG004|Overall Study|Other|0|||
131655729|NCT04047862|474023418|FG005|Overall Study|Other|0|||
131655730|NCT04047862|474023419|FG006|Overall Study|Other|0|||
131655731|NCT04047862|474023420|FG007|Overall Study|Other|0|||
131655732|NCT04047862|474023421|FG008|Overall Study|Other|0|||
131655733|NCT04047862|474023422|FG009|Overall Study|Other|0|||
131655734|NCT04047862|474023423|FG010|Overall Study|Other|0|||
131655735|NCT04047862|474023424|FG011|Overall Study|Other|0|||
131655736|NCT04047862|474023425|FG012|Overall Study|Other|0|||
131655737|NCT04047862|474023426|FG013|Overall Study|Other|0|||
131655738|NCT04047862|474023427|FG014|Overall Study|Other|2|||
131655739|NCT04047862|474023428|FG015|Overall Study|Other|1|||
131655740|NCT04047862|474023429|FG016|Overall Study|Other|1|||
131655741|NCT04047862|474023430|FG017|Overall Study|Other|1|||
131655742|NCT04047862|474023431|FG018|Overall Study|Other|0|||
131655743|NCT01876082|474024970|FG000|Overall Study|Withdrawal by Subject|0|||
131655744|NCT01876082|474024971|FG001|Overall Study|Withdrawal by Subject|2|||
131655745|NCT01876082|474024970|FG000|Overall Study|Protocol Violation|1|||
131655746|NCT01876082|474024971|FG001|Overall Study|Protocol Violation|0|||
131655747|NCT01876082|474024970|FG000|Overall Study|Adverse Event|1|||
131655748|NCT01876082|474024971|FG001|Overall Study|Adverse Event|1|||
131655749|NCT01876082|474024970|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
131655750|NCT01876082|474024971|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
131655751|NCT00626197|474024978|FG000|Overall Study|Did not cooperate|2|||
131655752|NCT00626197|474024979|FG001|Overall Study|Did not cooperate|6|||
131655753|NCT00626197|474024980|FG002|Overall Study|Did not cooperate|1|||
131655754|NCT00626197|474024978|FG000|Overall Study|Failure to return|6|||
131655755|NCT00626197|474024979|FG001|Overall Study|Failure to return|5|||
131655756|NCT00626197|474024980|FG002|Overall Study|Failure to return|6|||
131655757|NCT00626197|474024978|FG000|Overall Study|Adverse event, serious fatal|3|||
131655758|NCT00626197|474024979|FG001|Overall Study|Adverse event, serious fatal|6|||
131655759|NCT00626197|474024980|FG002|Overall Study|Adverse event, serious fatal|6|||
131655760|NCT00626197|474024978|FG000|Overall Study|Adverse Event|1|||
131655761|NCT00626197|474024979|FG001|Overall Study|Adverse Event|1|||
131655762|NCT00626197|474024980|FG002|Overall Study|Adverse Event|2|||
131655763|NCT00626197|474024978|FG000|Overall Study|Withdrawal by Subject|17|||
131655764|NCT00626197|474024979|FG001|Overall Study|Withdrawal by Subject|17|||
131655765|NCT00626197|474024980|FG002|Overall Study|Withdrawal by Subject|7|||
131655766|NCT00626197|474024978|FG000|Overall Study|Administrative reasons|15|||
131655767|NCT00626197|474024979|FG001|Overall Study|Administrative reasons|19|||
131655768|NCT00626197|474024980|FG002|Overall Study|Administrative reasons|55|||
131655769|NCT04833127|474024981|FG000|Overall Study|Lost to Follow-up|1|||
131655770|NCT04833127|474024982|FG001|Overall Study|Lost to Follow-up|1|||
131655771|NCT05282121|474024985|FG000|Overall Study|Adverse Event|1|||
131655772|NCT05282121|474024986|FG001|Overall Study|Adverse Event|1|||
131655773|NCT05282121|474024987|FG002|Overall Study|Adverse Event|4|||
131655774|NCT05282121|474024988|FG003|Overall Study|Adverse Event|1|||
131655775|NCT05282121|474024985|FG000|Overall Study|Study Terminated by Sponsor|1|||
131655776|NCT05282121|474024986|FG001|Overall Study|Study Terminated by Sponsor|2|||
131655777|NCT05282121|474024987|FG002|Overall Study|Study Terminated by Sponsor|2|||
131655778|NCT05282121|474024988|FG003|Overall Study|Study Terminated by Sponsor|2|||
131655779|NCT05282121|474024985|FG000|Overall Study|Other than listed|0|||
131655780|NCT05282121|474024986|FG001|Overall Study|Other than listed|0|||
131655781|NCT05282121|474024987|FG002|Overall Study|Other than listed|1|||
131655782|NCT05282121|474024988|FG003|Overall Study|Other than listed|0|||
131655783|NCT05282121|474024985|FG000|Overall Study|No reason available|0|||
131655784|NCT05282121|474024986|FG001|Overall Study|No reason available|0|||
131655785|NCT05282121|474024987|FG002|Overall Study|No reason available|1|||
131655786|NCT05282121|474024988|FG003|Overall Study|No reason available|0|||
131655787|NCT00461981|474024992|FG000|Overall Study|Lost to Follow-up|9|||
131655788|NCT00461981|474024993|FG001|Overall Study|Lost to Follow-up|6|||
131655789|NCT00461981|474024992|FG000|Overall Study|Withdrawal by Subject|2|||
131655790|NCT00461981|474024993|FG001|Overall Study|Withdrawal by Subject|3|||
131655791|NCT03301155|474024997|FG000|Overall Study|Сompliance with exclusion criteria|8|||
131655792|NCT03301155|474024998|FG001|Overall Study|Сompliance with exclusion criteria|7|||
131655793|NCT00731133|474025001|FG000|Overall Study|Withdrawal by Subject|10|||
131655794|NCT03510455|474025002|FG000|Overall Study|Physician Decision|1|||
131655795|NCT00384189|474025003|FG000|Overall Study|Reason Not Specified|50|||
131655796|NCT00384189|474025004|FG001|Overall Study|Reason Not Specified|57|||
131655797|NCT00384189|474025005|FG002|Overall Study|Reason Not Specified|58|||
131655798|NCT00384189|474025006|FG003|Overall Study|Reason Not Specified|40|||
131655799|NCT04958642|474025007|FG000|Overall Study|Transferred to OLEX program|3|||
131655800|NCT04958642|474025008|FG001|Overall Study|Transferred to OLEX program|0|||
131655801|NCT04958642|474025009|FG002|Overall Study|Transferred to OLEX program|5|||
131655802|NCT04958642|474025007|FG000|Overall Study|Death|0|||
131655803|NCT04958642|474025008|FG001|Overall Study|Death|0|||
131655804|NCT04958642|474025009|FG002|Overall Study|Death|1|||
131655805|NCT04958642|474025007|FG000|Overall Study|Withdrawal by Subject|4|||
131655806|NCT04958642|474025008|FG001|Overall Study|Withdrawal by Subject|9|||
131655807|NCT04958642|474025009|FG002|Overall Study|Withdrawal by Subject|13|||
131655808|NCT04958642|474025007|FG000|Overall Study|Investigator's Decision|0|||
131655809|NCT04958642|474025008|FG001|Overall Study|Investigator's Decision|0|||
131655810|NCT04958642|474025009|FG002|Overall Study|Investigator's Decision|1|||
131655811|NCT04958642|474025007|FG000|Overall Study|Adverse Event|1|||
131655812|NCT04958642|474025008|FG001|Overall Study|Adverse Event|0|||
131655813|NCT04958642|474025009|FG002|Overall Study|Adverse Event|1|||
131655814|NCT04958642|474025007|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
131655815|NCT04958642|474025008|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
131655816|NCT04958642|474025009|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
131655817|NCT04958642|474025007|FG000|Overall Study|Lost to Follow-up|1|||
131655818|NCT04958642|474025008|FG001|Overall Study|Lost to Follow-up|0|||
131655819|NCT04958642|474025009|FG002|Overall Study|Lost to Follow-up|0|||
131655820|NCT04958642|474025007|FG000|Overall Study|Transferred to EAP following study termination|0|||
131655821|NCT04958642|474025008|FG001|Overall Study|Transferred to EAP following study termination|0|||
131655822|NCT04958642|474025009|FG002|Overall Study|Transferred to EAP following study termination|1|||
131655823|NCT04958642|474025007|FG000|Overall Study|Transferred to Expanded Access Program|1|||
131655824|NCT04958642|474025008|FG001|Overall Study|Transferred to Expanded Access Program|0|||
131655825|NCT04958642|474025009|FG002|Overall Study|Transferred to Expanded Access Program|0|||
131655826|NCT00608868|474025010|FG000|Overall Study|Withdrawal by Subject|7|||
131655827|NCT00608868|474025010|FG000|Overall Study|Protocol Violation|3|||
131655828|NCT00608868|474025010|FG000|Overall Study|Lost to Follow-up|2|||
131655829|NCT00608868|474025010|FG000|Overall Study|Adverse Event|1|||
131655830|NCT00608868|474025010|FG000|Overall Study|Physician Decision|2|||
131655831|NCT02476175|474025014|FG000|Overall Study|Adverse Event|2|||
131655832|NCT03868787|474025024|FG000|Overall Study|Withdrawal by Subject|2|||
131655833|NCT03868787|474025025|FG001|Overall Study|Withdrawal by Subject|1|||
131655834|NCT01399697|474025036|FG000|Overall Study|Adverse Event|13|||
131655835|NCT01399697|474025037|FG001|Overall Study|Adverse Event|3|||
131655836|NCT01399697|474025038|FG002|Overall Study|Adverse Event|1|||
131655837|NCT01399697|474025036|FG000|Overall Study|Lost to Follow-up|2|||
131655838|NCT01399697|474025037|FG001|Overall Study|Lost to Follow-up|0|||
131655839|NCT01399697|474025038|FG002|Overall Study|Lost to Follow-up|0|||
131655840|NCT01399697|474025036|FG000|Overall Study|Withdrawal by Subject|8|||
131655841|NCT01399697|474025037|FG001|Overall Study|Withdrawal by Subject|0|||
131655842|NCT01399697|474025038|FG002|Overall Study|Withdrawal by Subject|0|||
131655843|NCT01399697|474025036|FG000|Overall Study|Investigator Decisión|1|||
131655844|NCT01399697|474025037|FG001|Overall Study|Investigator Decisión|0|||
131655845|NCT01399697|474025038|FG002|Overall Study|Investigator Decisión|2|||
131655846|NCT01399697|474025036|FG000|Overall Study|Lack of Efficacy|9|||
131655847|NCT01399697|474025037|FG001|Overall Study|Lack of Efficacy|0|||
131655848|NCT01399697|474025038|FG002|Overall Study|Lack of Efficacy|1|||
131655849|NCT01399697|474025036|FG000|Overall Study|Protocol Violation|2|||
131655850|NCT01399697|474025037|FG001|Overall Study|Protocol Violation|0|||
131655851|NCT01399697|474025038|FG002|Overall Study|Protocol Violation|0|||
131655852|NCT01399697|474025036|FG000|Overall Study|Non-Compliant|1|||
131655853|NCT01399697|474025037|FG001|Overall Study|Non-Compliant|0|||
131655854|NCT01399697|474025038|FG002|Overall Study|Non-Compliant|0|||
131655855|NCT01399697|474025036|FG000|Overall Study|Inclusion Error|2|||
131655856|NCT01399697|474025037|FG001|Overall Study|Inclusion Error|0|||
131655857|NCT01399697|474025038|FG002|Overall Study|Inclusion Error|0|||
131655858|NCT01399697|474025036|FG000|Overall Study|Positive result for hepatitis B|1|||
131655859|NCT01399697|474025037|FG001|Overall Study|Positive result for hepatitis B|0|||
131655860|NCT01399697|474025038|FG002|Overall Study|Positive result for hepatitis B|0|||
131655861|NCT01399697|474025036|FG000|Overall Study|Clinical RA remission|1|||
131655862|NCT01399697|474025037|FG001|Overall Study|Clinical RA remission|0|||
131655863|NCT01399697|474025038|FG002|Overall Study|Clinical RA remission|0|||
131655864|NCT01399697|474025036|FG000|Overall Study|Sponsor Decision|1|||
131655865|NCT01399697|474025037|FG001|Overall Study|Sponsor Decision|0|||
131655866|NCT01399697|474025038|FG002|Overall Study|Sponsor Decision|0|||
131655867|NCT02766777|474025043|FG000|Overall Study|Adverse Event|12|||
131655868|NCT02766777|474025043|FG000|Overall Study|Lost to Follow-up|16|||
131655869|NCT02766777|474025043|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131655870|NCT02766777|474025043|FG000|Overall Study|Protocol Violation|1|||
131655871|NCT02766777|474025043|FG000|Overall Study|Withdrawal by Subject|4|||
131655872|NCT02964325|474025044|FG000|Overall Study|Lost to Follow-up|3|||
131655873|NCT02964325|474025045|FG001|Overall Study|Lost to Follow-up|3|||
131655874|NCT02964325|474025044|FG000|Overall Study|Physician Decision|5|||
131655875|NCT02964325|474025045|FG001|Overall Study|Physician Decision|4|||
131655876|NCT02964325|474025044|FG000|Overall Study|Death|1|||
131655877|NCT02964325|474025045|FG001|Overall Study|Death|3|||
131655878|NCT02964325|474025044|FG000|Overall Study|Withdrawal by Subject|2|||
131655879|NCT02964325|474025045|FG001|Overall Study|Withdrawal by Subject|1|||
131655880|NCT02964325|474025044|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
131655881|NCT02964325|474025045|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
131655882|NCT02510040|474025046|FG000|Overall Study|Deemed no longer eligible|18|||
131655883|NCT02510040|474025047|FG001|Overall Study|Deemed no longer eligible|3|||
131655884|NCT02510040|474025048|FG002|Overall Study|Deemed no longer eligible|1|||
131655885|NCT00967005|474025056|FG000|Overall Study|Lost to Follow-up|7|||
131655886|NCT00967005|474025057|FG001|Overall Study|Lost to Follow-up|10|||
131655887|NCT01371825|474025060|FG000|Overall Study|Death|4|||
131655888|NCT03019640|474025061|FG000|Overall Study|Screen Failures|4|||
131655889|NCT03019640|474025061|FG000|Overall Study|Adverse Event|3|||
131655890|NCT03019640|474025061|FG000|Overall Study|Participant Relapsed|1|||
131655891|NCT00534495|474025067|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
131655892|NCT00534495|474025068|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
131655893|NCT00534495|474025069|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
131655894|NCT00534495|474025067|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
131655895|NCT00534495|474025068|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
131655896|NCT00534495|474025069|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
131655897|NCT00534495|474025067|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
131655898|NCT00534495|474025068|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
131655899|NCT00534495|474025069|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
131655900|NCT00534495|474025067|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
131655901|NCT00534495|474025068|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
131655902|NCT00534495|474025069|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
131655903|NCT00534495|474025067|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
131655904|NCT00534495|474025068|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
131655905|NCT00534495|474025069|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
131655906|NCT00534495|474025067|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
131655907|NCT00534495|474025068|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
131655908|NCT00534495|474025069|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
131655909|NCT00534495|474025067|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
131655910|NCT00534495|474025068|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
131655911|NCT00534495|474025069|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
131655912|NCT00534495|474025067|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
131655913|NCT00534495|474025068|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
131655914|NCT00534495|474025069|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
131655915|NCT00534495|474025067|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
131655916|NCT00534495|474025068|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
131655917|NCT00534495|474025069|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
131655918|NCT00588692|474025070|FG000|Overall Study|Withdrawal by Subject|4|||
131655919|NCT00588692|474025071|FG001|Overall Study|Withdrawal by Subject|2|||
131655920|NCT00588692|474025070|FG000|Overall Study|Hip Surgery|0|||
131655921|NCT00588692|474025071|FG001|Overall Study|Hip Surgery|1|||
131655922|NCT00588692|474025070|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
131655923|NCT00588692|474025071|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
131655924|NCT00588692|474025070|FG000|Overall Study|Cancer|1|||
131655925|NCT00588692|474025071|FG001|Overall Study|Cancer|0|||
131655926|NCT00588692|474025070|FG000|Overall Study|Death|1|||
131655927|NCT00588692|474025071|FG001|Overall Study|Death|0|||
131655928|NCT03552523|474025072|FG000|Overall Study|Withdrawal by Subject|1|||
131655929|NCT03552523|474025073|FG001|Overall Study|Withdrawal by Subject|1|||
131655930|NCT00780559|474025074|FG000|Overall Study|Lost to Follow-up|2|||
131655931|NCT00780559|474025075|FG001|Overall Study|Lost to Follow-up|7|||
131655932|NCT00780559|474025074|FG000|Overall Study|Death|1|||
131655933|NCT00780559|474025075|FG001|Overall Study|Death|0|||
131655934|NCT04462289|474025076|FG000|Overall Study|Lost to Follow-up|4|||
131655935|NCT04462289|474025077|FG001|Overall Study|Lost to Follow-up|5|||
131655936|NCT04462289|474025076|FG000|Overall Study|Death|0|||
131655937|NCT04462289|474025077|FG001|Overall Study|Death|3|||
131655938|NCT04462289|474025076|FG000|Overall Study|Withdrawal by Subject|1|||
131655939|NCT04462289|474025077|FG001|Overall Study|Withdrawal by Subject|3|||
131655940|NCT03686423|474025078|FG000|Overall Study|Withdrawal by Subject|9|||
131655941|NCT03686423|474025078|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
131655942|NCT01077518|474025079|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
131655943|NCT01077518|474025080|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
131655944|NCT01077518|474025081|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
131655945|NCT01077518|474025079|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
131655946|NCT01077518|474025080|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
131655947|NCT01077518|474025081|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
131655948|NCT01077518|474025079|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
131655949|NCT01077518|474025080|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
131655950|NCT01077518|474025081|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
131655951|NCT01077518|474025079|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
131655952|NCT01077518|474025080|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
131655953|NCT01077518|474025081|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
131655954|NCT01077518|474025079|FG000|Optional Ofa Phase|Physician Decision|0|||
131655955|NCT01077518|474025080|FG001|Optional Ofa Phase|Physician Decision|0|||
131655956|NCT01077518|474025081|FG002|Optional Ofa Phase|Physician Decision|1|||
131655957|NCT01077518|474025079|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
131655958|NCT01077518|474025080|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
131655959|NCT01077518|474025081|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
131655960|NCT01077518|474025079|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
131655961|NCT01077518|474025080|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
131655962|NCT01077518|474025081|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
131655963|NCT02387970|474025082|FG000|Overall Study|Did not complete 1-year follow up|1|||
131655964|NCT02387970|474025083|FG001|Overall Study|Did not complete 1-year follow up|2|||
131655965|NCT01436253|474025088|FG000|Overall Study|Lost to Follow-up|182|||
131655966|NCT01436253|474025088|FG000|Overall Study|Not meeting all eligibility criteria|117|||
131655967|NCT01495598|474025090|FG000|Overall Study|Death during follow up period|2|||
131655968|NCT01495598|474025090|FG000|Overall Study|Death on study|1|||
131655969|NCT01495598|474025090|FG000|Overall Study|Lost to Follow-up|3|||
131655970|NCT01495598|474025090|FG000|Overall Study|Physician Decision|8|||
131655971|NCT02671500|474025093|FG000|Overall Study|Lack of Efficacy|12|||
131655972|NCT02671500|474025093|FG000|Overall Study|Lost to Follow-up|2|||
131655973|NCT05511038|474025095|FG000|Overall|Withdrawal by Subject|5|||
131655974|NCT05511038|474025096|FG001|Overall|Withdrawal by Subject|3|||
131655975|NCT05511038|474025095|FG000|Overall|Screen Failure|20|||
131655976|NCT05511038|474025096|FG001|Overall|Screen Failure|1|||
131655977|NCT05511038|474025095|FG000|Overall|Physician Decision|3|||
131655978|NCT05511038|474025096|FG001|Overall|Physician Decision|0|||
131655979|NCT05511038|474025095|FG000|Overall|Lost to Follow-up|3|||
131655980|NCT05511038|474025096|FG001|Overall|Lost to Follow-up|0|||
131655981|NCT05511038|474025095|FG000|Overall|Death|1|||
131655982|NCT05511038|474025096|FG001|Overall|Death|0|||
131655983|NCT05511038|474025095|FG000|Screening|Withdrawal by Subject|1|||
131655984|NCT05511038|474025096|FG001|Screening|Withdrawal by Subject|0|||
131655985|NCT05511038|474025095|FG000|Screening|Lost to Follow Up (1 participant)|1|||
131655986|NCT05511038|474025096|FG001|Screening|Lost to Follow Up (1 participant)|0|||
131655987|NCT05511038|474025095|FG000|Screening|Screen Failure|3|||
131655988|NCT05511038|474025096|FG001|Screening|Screen Failure|0|||
131655989|NCT05511038|474025095|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
131655990|NCT05511038|474025096|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
131655991|NCT05511038|474025095|FG000|Treatment|Withdrawal by Subject|5|||
131655992|NCT05511038|474025096|FG001|Treatment|Withdrawal by Subject|3|||
131655993|NCT05511038|474025095|FG000|Treatment|Physician Decision|4|||
131655994|NCT05511038|474025096|FG001|Treatment|Physician Decision|0|||
131655995|NCT05511038|474025095|FG000|Treatment|Lost to Follow-up|2|||
131655996|NCT05511038|474025096|FG001|Treatment|Lost to Follow-up|0|||
131655997|NCT05511038|474025095|FG000|Treatment|Death|1|||
131655998|NCT05511038|474025096|FG001|Treatment|Death|0|||
131655999|NCT05511038|474025095|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
131656000|NCT05511038|474025096|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
131656001|NCT05511038|474025095|FG000|Treatment|Refuse by subject|1|||
131656002|NCT05511038|474025096|FG001|Treatment|Refuse by subject|0|||
131656003|NCT05511038|474025095|FG000|Treatment|Subject did not go to the site for visit|1|||
131656004|NCT05511038|474025096|FG001|Treatment|Subject did not go to the site for visit|0|||
131656005|NCT04485611|474025097|FG000|Prehabilitation|Physician Decision|1|||
131656006|NCT05292586|474025100|FG000|Overall Study|Withdrawal by Subject|3|||
131656007|NCT05292586|474025101|FG001|Overall Study|Withdrawal by Subject|10|||
131656008|NCT05292586|474025100|FG000|Overall Study|Randomization error|3|||
131656009|NCT05292586|474025101|FG001|Overall Study|Randomization error|7|||
131656010|NCT05292586|474025100|FG000|Overall Study|Adverse Event|3|||
131656011|NCT05292586|474025101|FG001|Overall Study|Adverse Event|0|||
131656012|NCT05292586|474025100|FG000|Overall Study|Lost to Follow-up|0|||
131656013|NCT05292586|474025101|FG001|Overall Study|Lost to Follow-up|1|||
131656014|NCT05292586|474025100|FG000|Overall Study|Patient refused treatment|1|||
131656015|NCT05292586|474025101|FG001|Overall Study|Patient refused treatment|0|||
131656016|NCT05292586|474025100|FG000|Overall Study|Patient could not travel to the study site|1|||
131656017|NCT05292586|474025101|FG001|Overall Study|Patient could not travel to the study site|0|||
131656018|NCT05292586|474025100|FG000|Overall Study|Technical issues with the masterscope|0|||
131656019|NCT05292586|474025101|FG001|Overall Study|Technical issues with the masterscope|3|||
131656020|NCT05292586|474025100|FG000|Overall Study|Patient moved to a different state|0|||
131656021|NCT05292586|474025101|FG001|Overall Study|Patient moved to a different state|1|||
131656022|NCT04531982|474025102|FG000|Overall Study|Withdrawal by Subject|10|||
131656023|NCT04531982|474025103|FG001|Overall Study|Withdrawal by Subject|11|||
131656024|NCT04531982|474025102|FG000|Overall Study|Adverse Event|6|||
131656025|NCT04531982|474025103|FG001|Overall Study|Adverse Event|14|||
131656026|NCT04531982|474025102|FG000|Overall Study|Protocol Violation|6|||
131656027|NCT04531982|474025103|FG001|Overall Study|Protocol Violation|9|||
131656028|NCT04531982|474025102|FG000|Overall Study|Non-compliance with study drug|3|||
131656029|NCT04531982|474025103|FG001|Overall Study|Non-compliance with study drug|2|||
131656030|NCT04531982|474025102|FG000|Overall Study|Use of prohibited medication|2|||
131656031|NCT04531982|474025103|FG001|Overall Study|Use of prohibited medication|0|||
131656032|NCT04531982|474025102|FG000|Overall Study|Lost to Follow-up|0|||
131656033|NCT04531982|474025103|FG001|Overall Study|Lost to Follow-up|1|||
131656034|NCT04531982|474025102|FG000|Overall Study|Geopolitical conflict|2|||
131656035|NCT04531982|474025103|FG001|Overall Study|Geopolitical conflict|0|||
131656036|NCT04531982|474025102|FG000|Overall Study|Lack of Efficacy|3|||
131656037|NCT04531982|474025103|FG001|Overall Study|Lack of Efficacy|1|||
131656038|NCT03841526|474025104|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
131656039|NCT03841526|474025105|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131656040|NCT03841526|474025106|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131656041|NCT03841526|474025107|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
131656042|NCT03841526|474025108|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131656043|NCT03841526|474025109|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131656044|NCT03841526|474025104|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
131656045|NCT03841526|474025105|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
131656046|NCT03841526|474025106|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
131656047|NCT03841526|474025107|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
131656048|NCT03841526|474025108|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
131656049|NCT03841526|474025109|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
131656050|NCT03841526|474025104|FG000|Outpatient Phase Treatment|Physician Decision|0|||
131656051|NCT03841526|474025105|FG001|Outpatient Phase Treatment|Physician Decision|1|||
131656052|NCT03841526|474025106|FG002|Outpatient Phase Treatment|Physician Decision|0|||
131656053|NCT03841526|474025107|FG003|Outpatient Phase Treatment|Physician Decision|0|||
131656054|NCT03841526|474025108|FG004|Outpatient Phase Treatment|Physician Decision|0|||
131656055|NCT03841526|474025109|FG005|Outpatient Phase Treatment|Physician Decision|0|||
131656056|NCT03841526|474025104|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131656057|NCT03841526|474025105|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131656058|NCT03841526|474025106|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
131656059|NCT03841526|474025107|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131656060|NCT03841526|474025108|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131656061|NCT03841526|474025109|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
131656062|NCT03829501|474026535|FG000|Overall Study|Withdrawal of Consent|2|||
131656063|NCT03829501|474026536|FG001|Overall Study|Withdrawal of Consent|0|||
131656064|NCT03829501|474026537|FG002|Overall Study|Withdrawal of Consent|3|||
131656065|NCT03829501|474026538|FG003|Overall Study|Withdrawal of Consent|0|||
131656066|NCT03829501|474026539|FG004|Overall Study|Withdrawal of Consent|1|||
131656067|NCT03829501|474026540|FG005|Overall Study|Withdrawal of Consent|1|||
131656068|NCT03829501|474026541|FG006|Overall Study|Withdrawal of Consent|0|||
131656069|NCT03829501|474026542|FG007|Overall Study|Withdrawal of Consent|10|||
131656070|NCT03829501|474026543|FG008|Overall Study|Withdrawal of Consent|10|||
131656071|NCT03829501|474026544|FG009|Overall Study|Withdrawal of Consent|3|||
131656072|NCT03829501|474026545|FG010|Overall Study|Withdrawal of Consent|4|||
131656073|NCT03829501|474026546|FG011|Overall Study|Withdrawal of Consent|4|||
131656074|NCT03829501|474026547|FG012|Overall Study|Withdrawal of Consent|4|||
131656075|NCT03829501|474026548|FG013|Overall Study|Withdrawal of Consent|0|||
131656076|NCT03829501|474026549|FG014|Overall Study|Withdrawal of Consent|3|||
131656077|NCT03829501|474026550|FG015|Overall Study|Withdrawal of Consent|0|||
131656078|NCT03829501|474026551|FG016|Overall Study|Withdrawal of Consent|1|||
131656079|NCT03829501|474026552|FG017|Overall Study|Withdrawal of Consent|1|||
131656080|NCT03829501|474026553|FG018|Overall Study|Withdrawal of Consent|0|||
131656081|NCT03829501|474026554|FG019|Overall Study|Withdrawal of Consent|0|||
131656082|NCT03829501|474026555|FG020|Overall Study|Withdrawal of Consent|3|||
131656083|NCT03829501|474026556|FG021|Overall Study|Withdrawal of Consent|0|||
131656084|NCT03829501|474026557|FG022|Overall Study|Withdrawal of Consent|1|||
131656085|NCT03829501|474026535|FG000|Overall Study|PD|0|||
131656086|NCT03829501|474026536|FG001|Overall Study|PD|0|||
131656087|NCT03829501|474026537|FG002|Overall Study|PD|0|||
131656088|NCT03829501|474026538|FG003|Overall Study|PD|2|||
131656089|NCT03829501|474026539|FG004|Overall Study|PD|0|||
131656090|NCT03829501|474026540|FG005|Overall Study|PD|0|||
131656091|NCT03829501|474026541|FG006|Overall Study|PD|0|||
131656092|NCT03829501|474026542|FG007|Overall Study|PD|0|||
131656093|NCT03829501|474026543|FG008|Overall Study|PD|0|||
131656094|NCT03829501|474026544|FG009|Overall Study|PD|0|||
131656095|NCT03829501|474026545|FG010|Overall Study|PD|0|||
131656096|NCT03829501|474026546|FG011|Overall Study|PD|0|||
131656097|NCT03829501|474026547|FG012|Overall Study|PD|0|||
131656098|NCT03829501|474026548|FG013|Overall Study|PD|0|||
131656099|NCT03829501|474026549|FG014|Overall Study|PD|0|||
131656100|NCT03829501|474026550|FG015|Overall Study|PD|1|||
131656101|NCT03829501|474026551|FG016|Overall Study|PD|0|||
131656102|NCT03829501|474026552|FG017|Overall Study|PD|0|||
131656103|NCT03829501|474026553|FG018|Overall Study|PD|0|||
131656104|NCT03829501|474026554|FG019|Overall Study|PD|0|||
131656105|NCT03829501|474026555|FG020|Overall Study|PD|1|||
131656106|NCT03829501|474026556|FG021|Overall Study|PD|0|||
131656107|NCT03829501|474026557|FG022|Overall Study|PD|0|||
131656108|NCT03829501|474026535|FG000|Overall Study|Study Terminated by Sponsor|0|||
131656109|NCT03829501|474026536|FG001|Overall Study|Study Terminated by Sponsor|0|||
131656110|NCT03829501|474026537|FG002|Overall Study|Study Terminated by Sponsor|0|||
131656111|NCT03829501|474026538|FG003|Overall Study|Study Terminated by Sponsor|0|||
131656112|NCT03829501|474026539|FG004|Overall Study|Study Terminated by Sponsor|0|||
131656113|NCT03829501|474026540|FG005|Overall Study|Study Terminated by Sponsor|0|||
131656114|NCT03829501|474026541|FG006|Overall Study|Study Terminated by Sponsor|0|||
131656115|NCT03829501|474026542|FG007|Overall Study|Study Terminated by Sponsor|3|||
131656116|NCT03829501|474026543|FG008|Overall Study|Study Terminated by Sponsor|1|||
131656117|NCT03829501|474026544|FG009|Overall Study|Study Terminated by Sponsor|0|||
131656118|NCT03829501|474026545|FG010|Overall Study|Study Terminated by Sponsor|0|||
131656119|NCT03829501|474026546|FG011|Overall Study|Study Terminated by Sponsor|0|||
131656120|NCT03829501|474026547|FG012|Overall Study|Study Terminated by Sponsor|0|||
131656121|NCT03829501|474026548|FG013|Overall Study|Study Terminated by Sponsor|0|||
131656122|NCT03829501|474026549|FG014|Overall Study|Study Terminated by Sponsor|3|||
131656123|NCT03829501|474026550|FG015|Overall Study|Study Terminated by Sponsor|2|||
131656124|NCT03829501|474026551|FG016|Overall Study|Study Terminated by Sponsor|2|||
131656125|NCT03829501|474026552|FG017|Overall Study|Study Terminated by Sponsor|0|||
131656126|NCT03829501|474026553|FG018|Overall Study|Study Terminated by Sponsor|0|||
131656127|NCT03829501|474026554|FG019|Overall Study|Study Terminated by Sponsor|0|||
131656128|NCT03829501|474026555|FG020|Overall Study|Study Terminated by Sponsor|1|||
131656129|NCT03829501|474026556|FG021|Overall Study|Study Terminated by Sponsor|0|||
131656130|NCT03829501|474026557|FG022|Overall Study|Study Terminated by Sponsor|3|||
131656131|NCT03829501|474026535|FG000|Overall Study|Lost to Follow Up|0|||
131656132|NCT03829501|474026536|FG001|Overall Study|Lost to Follow Up|0|||
131656133|NCT03829501|474026537|FG002|Overall Study|Lost to Follow Up|0|||
131656134|NCT03829501|474026538|FG003|Overall Study|Lost to Follow Up|0|||
131656135|NCT03829501|474026539|FG004|Overall Study|Lost to Follow Up|1|||
131656136|NCT03829501|474026540|FG005|Overall Study|Lost to Follow Up|0|||
131656137|NCT03829501|474026541|FG006|Overall Study|Lost to Follow Up|0|||
131656138|NCT03829501|474026542|FG007|Overall Study|Lost to Follow Up|2|||
131656139|NCT03829501|474026543|FG008|Overall Study|Lost to Follow Up|2|||
131656140|NCT03829501|474026544|FG009|Overall Study|Lost to Follow Up|0|||
131656141|NCT03829501|474026545|FG010|Overall Study|Lost to Follow Up|2|||
131656142|NCT03829501|474026546|FG011|Overall Study|Lost to Follow Up|1|||
131656143|NCT03829501|474026547|FG012|Overall Study|Lost to Follow Up|0|||
131656144|NCT03829501|474026548|FG013|Overall Study|Lost to Follow Up|1|||
131656145|NCT03829501|474026549|FG014|Overall Study|Lost to Follow Up|1|||
131656146|NCT03829501|474026550|FG015|Overall Study|Lost to Follow Up|0|||
131656147|NCT03829501|474026551|FG016|Overall Study|Lost to Follow Up|0|||
131656148|NCT03829501|474026552|FG017|Overall Study|Lost to Follow Up|0|||
131656149|NCT03829501|474026553|FG018|Overall Study|Lost to Follow Up|0|||
131656150|NCT03829501|474026554|FG019|Overall Study|Lost to Follow Up|0|||
131656151|NCT03829501|474026555|FG020|Overall Study|Lost to Follow Up|0|||
131656152|NCT03829501|474026556|FG021|Overall Study|Lost to Follow Up|0|||
131656153|NCT03829501|474026557|FG022|Overall Study|Lost to Follow Up|1|||
131656154|NCT03829501|474026535|FG000|Overall Study|Death|2|||
131656155|NCT03829501|474026536|FG001|Overall Study|Death|4|||
131656156|NCT03829501|474026537|FG002|Overall Study|Death|5|||
131656157|NCT03829501|474026538|FG003|Overall Study|Death|6|||
131656158|NCT03829501|474026539|FG004|Overall Study|Death|5|||
131656159|NCT03829501|474026540|FG005|Overall Study|Death|4|||
131656160|NCT03829501|474026541|FG006|Overall Study|Death|5|||
131656161|NCT03829501|474026542|FG007|Overall Study|Death|24|||
131656162|NCT03829501|474026543|FG008|Overall Study|Death|22|||
131656163|NCT03829501|474026544|FG009|Overall Study|Death|6|||
131656164|NCT03829501|474026545|FG010|Overall Study|Death|3|||
131656165|NCT03829501|474026546|FG011|Overall Study|Death|10|||
131656166|NCT03829501|474026547|FG012|Overall Study|Death|10|||
131656167|NCT03829501|474026548|FG013|Overall Study|Death|5|||
131656168|NCT03829501|474026549|FG014|Overall Study|Death|7|||
131656169|NCT03829501|474026550|FG015|Overall Study|Death|2|||
131656170|NCT03829501|474026551|FG016|Overall Study|Death|2|||
131656171|NCT03829501|474026552|FG017|Overall Study|Death|1|||
131656172|NCT03829501|474026553|FG018|Overall Study|Death|1|||
131656173|NCT03829501|474026554|FG019|Overall Study|Death|1|||
131656174|NCT03829501|474026555|FG020|Overall Study|Death|1|||
131656175|NCT03829501|474026556|FG021|Overall Study|Death|2|||
131656176|NCT03829501|474026557|FG022|Overall Study|Death|3|||
131656177|NCT03829501|474026535|FG000|Overall Study|Miscellaneous|0|||
131656178|NCT03829501|474026536|FG001|Overall Study|Miscellaneous|0|||
131656179|NCT03829501|474026537|FG002|Overall Study|Miscellaneous|1|||
131656180|NCT03829501|474026538|FG003|Overall Study|Miscellaneous|0|||
131656181|NCT03829501|474026539|FG004|Overall Study|Miscellaneous|0|||
131656182|NCT03829501|474026540|FG005|Overall Study|Miscellaneous|0|||
131656183|NCT03829501|474026541|FG006|Overall Study|Miscellaneous|0|||
131656184|NCT03829501|474026542|FG007|Overall Study|Miscellaneous|1|||
131656185|NCT03829501|474026543|FG008|Overall Study|Miscellaneous|0|||
131656186|NCT03829501|474026544|FG009|Overall Study|Miscellaneous|0|||
131656187|NCT03829501|474026545|FG010|Overall Study|Miscellaneous|0|||
131656188|NCT03829501|474026546|FG011|Overall Study|Miscellaneous|0|||
131656189|NCT03829501|474026547|FG012|Overall Study|Miscellaneous|0|||
131656190|NCT03829501|474026548|FG013|Overall Study|Miscellaneous|0|||
131656191|NCT03829501|474026549|FG014|Overall Study|Miscellaneous|0|||
131656192|NCT03829501|474026550|FG015|Overall Study|Miscellaneous|0|||
131656193|NCT03829501|474026551|FG016|Overall Study|Miscellaneous|0|||
131656194|NCT03829501|474026552|FG017|Overall Study|Miscellaneous|0|||
131656195|NCT03829501|474026553|FG018|Overall Study|Miscellaneous|0|||
131656196|NCT03829501|474026554|FG019|Overall Study|Miscellaneous|0|||
131656197|NCT03829501|474026555|FG020|Overall Study|Miscellaneous|0|||
131656198|NCT03829501|474026556|FG021|Overall Study|Miscellaneous|0|||
131656199|NCT03829501|474026557|FG022|Overall Study|Miscellaneous|1|||
131656200|NCT04165031|474026558|FG000|Overall Study|Adverse Event|1|||
131656201|NCT04165031|474026559|FG001|Overall Study|Adverse Event|1|||
131656202|NCT04165031|474026560|FG002|Overall Study|Adverse Event|0|||
131656203|NCT04165031|474026561|FG003|Overall Study|Adverse Event|0|||
131656204|NCT04165031|474026562|FG004|Overall Study|Adverse Event|0|||
131656205|NCT04165031|474026563|FG005|Overall Study|Adverse Event|0|||
131656206|NCT04165031|474026558|FG000|Overall Study|Withdrawal by Subject|0|||
131656207|NCT04165031|474026559|FG001|Overall Study|Withdrawal by Subject|0|||
131656208|NCT04165031|474026560|FG002|Overall Study|Withdrawal by Subject|1|||
131656209|NCT04165031|474026561|FG003|Overall Study|Withdrawal by Subject|0|||
131656210|NCT04165031|474026562|FG004|Overall Study|Withdrawal by Subject|0|||
131656211|NCT04165031|474026563|FG005|Overall Study|Withdrawal by Subject|0|||
131656212|NCT01332630|474026564|FG000|Overall Study|Withdrawal by Subject|3|||
131656213|NCT03140280|474026565|FG000|Overall Study|Physician Decision|5|||
131656214|NCT00663702|474026574|FG000|Overall Study|Adverse Event|8|||
131656215|NCT00663702|474026575|FG001|Overall Study|Adverse Event|4|||
131656216|NCT00663702|474026574|FG000|Overall Study|Withdrawal by Subject|3|||
131656217|NCT00663702|474026575|FG001|Overall Study|Withdrawal by Subject|1|||
131656218|NCT00663702|474026574|FG000|Overall Study|Pregnancy|0|||
131656219|NCT00663702|474026575|FG001|Overall Study|Pregnancy|1|||
131656220|NCT00663702|474026574|FG000|Overall Study|Lost to Follow-up|3|||
131656221|NCT00663702|474026575|FG001|Overall Study|Lost to Follow-up|0|||
131656222|NCT00663702|474026574|FG000|Overall Study|Death|1|||
131656223|NCT00663702|474026575|FG001|Overall Study|Death|1|||
131656224|NCT00663702|474026574|FG000|Overall Study|Lack of Efficacy|3|||
131656225|NCT00663702|474026575|FG001|Overall Study|Lack of Efficacy|3|||
131656226|NCT01498887|474026576|FG000|Overall Study|Administrative problems|1|||
131656227|NCT01498887|474026577|FG001|Overall Study|Administrative problems|0|||
131656228|NCT01498887|474026576|FG000|Overall Study|Lost to Follow-up|1|||
131656229|NCT01498887|474026577|FG001|Overall Study|Lost to Follow-up|1|||
131656230|NCT01498887|474026576|FG000|Overall Study|Withdrawal by Subject|1|||
131656231|NCT01498887|474026577|FG001|Overall Study|Withdrawal by Subject|0|||
131656232|NCT01498887|474026576|FG000|Overall Study|Protocol Violation|1|||
131656233|NCT01498887|474026577|FG001|Overall Study|Protocol Violation|3|||
131656234|NCT01498887|474026576|FG000|Overall Study|Lack of Efficacy|5|||
131656235|NCT01498887|474026577|FG001|Overall Study|Lack of Efficacy|3|||
131656236|NCT01498887|474026576|FG000|Overall Study|Abnormal result from test procedure|1|||
131656237|NCT01498887|474026577|FG001|Overall Study|Abnormal result from test procedure|1|||
131656238|NCT01498887|474026576|FG000|Overall Study|Abnormal laboratory value|2|||
131656239|NCT01498887|474026577|FG001|Overall Study|Abnormal laboratory value|2|||
131656240|NCT01498887|474026576|FG000|Overall Study|Adverse Event|4|||
131656241|NCT01498887|474026577|FG001|Overall Study|Adverse Event|1|||
131656242|NCT00667225|474026580|FG000|Overall Study|Subject had no more lesions to treat.|1|||
131656243|NCT00667225|474026581|FG001|Overall Study|Subject had no more lesions to treat.|0|||
131656244|NCT00667225|474026580|FG000|Overall Study|Lost to Follow-up|0|||
131656245|NCT00667225|474026581|FG001|Overall Study|Lost to Follow-up|1|||
131656246|NCT04313608|474026584|FG000|Overall Study|Death|12|||
131656247|NCT04313608|474026585|FG001|Overall Study|Death|3|||
131656248|NCT02440425|474026586|FG000|Overall Study|Death likely due to disease progression|1|||
131656249|NCT02440425|474026586|FG000|Overall Study|Withdrawal by Subject|2|||
131656250|NCT02440425|474026586|FG000|Overall Study|Adverse Event|1|||
131656251|NCT02440425|474026586|FG000|Overall Study|Adverse Event/Ineligible|1|||
131656252|NCT00214019|474026587|FG000|Overall Study|Lost to Follow-up|11|||
131656253|NCT00214019|474026587|FG000|Overall Study|Withdrawal by Subject|2|||
131656254|NCT00214019|474026587|FG000|Overall Study|Screen Failed prior to randomization|17|||
131656255|NCT03635099|474026590|FG000|Period 1|Adverse Event|1|||
131656256|NCT03635099|474026591|FG001|Period 1|Adverse Event|0|||
131656257|NCT03635099|474026592|FG002|Period 1|Adverse Event|0|||
131656258|NCT03635099|474026593|FG003|Period 1|Adverse Event|1|||
131656259|NCT03635099|474026594|FG004|Period 1|Adverse Event|0|||
131656260|NCT03635099|474026595|FG005|Period 1|Adverse Event|0|||
131656261|NCT03635099|474026596|FG006|Period 1|Adverse Event|0|||
131656262|NCT03635099|474026597|FG007|Period 1|Adverse Event|0|||
131656263|NCT03635099|474026590|FG000|Period 1|Protocol Violation|0|||
131656264|NCT03635099|474026591|FG001|Period 1|Protocol Violation|0|||
131656265|NCT03635099|474026592|FG002|Period 1|Protocol Violation|1|||
131656266|NCT03635099|474026593|FG003|Period 1|Protocol Violation|0|||
131656267|NCT03635099|474026594|FG004|Period 1|Protocol Violation|0|||
131656268|NCT03635099|474026595|FG005|Period 1|Protocol Violation|0|||
131656269|NCT03635099|474026596|FG006|Period 1|Protocol Violation|0|||
131656270|NCT03635099|474026597|FG007|Period 1|Protocol Violation|0|||
131656271|NCT03635099|474026590|FG000|Period 1|Lost to Follow-up|0|||
131656272|NCT03635099|474026591|FG001|Period 1|Lost to Follow-up|0|||
131656273|NCT03635099|474026592|FG002|Period 1|Lost to Follow-up|1|||
131656274|NCT03635099|474026593|FG003|Period 1|Lost to Follow-up|2|||
131656275|NCT03635099|474026594|FG004|Period 1|Lost to Follow-up|1|||
131656276|NCT03635099|474026595|FG005|Period 1|Lost to Follow-up|0|||
131656277|NCT03635099|474026596|FG006|Period 1|Lost to Follow-up|1|||
131656278|NCT03635099|474026597|FG007|Period 1|Lost to Follow-up|2|||
131656279|NCT03635099|474026590|FG000|Period 1|Withdrawal by Subject|3|||
131656280|NCT03635099|474026591|FG001|Period 1|Withdrawal by Subject|3|||
131656281|NCT03635099|474026592|FG002|Period 1|Withdrawal by Subject|5|||
131656282|NCT03635099|474026593|FG003|Period 1|Withdrawal by Subject|2|||
131656283|NCT03635099|474026594|FG004|Period 1|Withdrawal by Subject|2|||
131656284|NCT03635099|474026595|FG005|Period 1|Withdrawal by Subject|0|||
131656285|NCT03635099|474026596|FG006|Period 1|Withdrawal by Subject|3|||
131656286|NCT03635099|474026597|FG007|Period 1|Withdrawal by Subject|0|||
131656287|NCT03635099|474026590|FG000|Period 1|History of suicidal ideation|0|||
131656288|NCT03635099|474026591|FG001|Period 1|History of suicidal ideation|0|||
131656289|NCT03635099|474026592|FG002|Period 1|History of suicidal ideation|1|||
131656290|NCT03635099|474026593|FG003|Period 1|History of suicidal ideation|0|||
131656291|NCT03635099|474026594|FG004|Period 1|History of suicidal ideation|0|||
131656292|NCT03635099|474026595|FG005|Period 1|History of suicidal ideation|0|||
131656293|NCT03635099|474026596|FG006|Period 1|History of suicidal ideation|0|||
131656294|NCT03635099|474026597|FG007|Period 1|History of suicidal ideation|0|||
131656295|NCT03635099|474026590|FG000|Period 1|pursue other treatment options|0|||
131656296|NCT03635099|474026591|FG001|Period 1|pursue other treatment options|0|||
131656297|NCT03635099|474026592|FG002|Period 1|pursue other treatment options|0|||
131656298|NCT03635099|474026593|FG003|Period 1|pursue other treatment options|0|||
131656299|NCT03635099|474026594|FG004|Period 1|pursue other treatment options|0|||
131656300|NCT03635099|474026595|FG005|Period 1|pursue other treatment options|1|||
131656301|NCT03635099|474026596|FG006|Period 1|pursue other treatment options|0|||
131656302|NCT03635099|474026597|FG007|Period 1|pursue other treatment options|0|||
131656303|NCT03635099|474026590|FG000|Not Eligible for Period 2|Pregnancy|0|||
131656304|NCT03635099|474026591|FG001|Not Eligible for Period 2|Pregnancy|0|||
131656305|NCT03635099|474026592|FG002|Not Eligible for Period 2|Pregnancy|0|||
131656306|NCT03635099|474026593|FG003|Not Eligible for Period 2|Pregnancy|1|||
131656307|NCT03635099|474026594|FG004|Not Eligible for Period 2|Pregnancy|0|||
131656308|NCT03635099|474026595|FG005|Not Eligible for Period 2|Pregnancy|0|||
131656309|NCT03635099|474026596|FG006|Not Eligible for Period 2|Pregnancy|0|||
131656310|NCT03635099|474026597|FG007|Not Eligible for Period 2|Pregnancy|0|||
131656311|NCT03635099|474026590|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
131656312|NCT03635099|474026591|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656313|NCT03635099|474026592|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656314|NCT03635099|474026593|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656315|NCT03635099|474026594|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656316|NCT03635099|474026595|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656317|NCT03635099|474026596|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656318|NCT03635099|474026597|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
131656319|NCT03635099|474026590|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131656320|NCT03635099|474026591|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131656321|NCT03635099|474026592|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131656322|NCT03635099|474026593|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131656323|NCT03635099|474026594|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131656324|NCT03635099|474026595|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
131656325|NCT03635099|474026596|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
131656326|NCT03635099|474026597|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
131656327|NCT03635099|474026590|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
131656328|NCT03635099|474026591|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
131656329|NCT03635099|474026592|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
131656330|NCT03635099|474026593|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
131656331|NCT03635099|474026594|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131656332|NCT03635099|474026595|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131656333|NCT03635099|474026596|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131656334|NCT03635099|474026597|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131656335|NCT03635099|474026590|FG000|Period 2|Adverse Event|0|||
131656336|NCT03635099|474026591|FG001|Period 2|Adverse Event|0|||
131656337|NCT03635099|474026592|FG002|Period 2|Adverse Event|1|||
131656338|NCT03635099|474026593|FG003|Period 2|Adverse Event|0|||
131656339|NCT03635099|474026594|FG004|Period 2|Adverse Event|1|||
131656340|NCT03635099|474026595|FG005|Period 2|Adverse Event|0|||
131656341|NCT03635099|474026596|FG006|Period 2|Adverse Event|0|||
131656342|NCT03635099|474026597|FG007|Period 2|Adverse Event|0|||
131656343|NCT03635099|474026590|FG000|Period 2|Lost to Follow-up|0|||
131656344|NCT03635099|474026591|FG001|Period 2|Lost to Follow-up|0|||
131656345|NCT03635099|474026592|FG002|Period 2|Lost to Follow-up|1|||
131656346|NCT03635099|474026593|FG003|Period 2|Lost to Follow-up|0|||
131656347|NCT03635099|474026594|FG004|Period 2|Lost to Follow-up|4|||
131656348|NCT03635099|474026595|FG005|Period 2|Lost to Follow-up|0|||
131656349|NCT03635099|474026596|FG006|Period 2|Lost to Follow-up|0|||
131656350|NCT03635099|474026597|FG007|Period 2|Lost to Follow-up|0|||
131656351|NCT03635099|474026590|FG000|Period 2|Withdrawal by Subject|0|||
131656352|NCT03635099|474026591|FG001|Period 2|Withdrawal by Subject|0|||
131656353|NCT03635099|474026592|FG002|Period 2|Withdrawal by Subject|7|||
131656354|NCT03635099|474026593|FG003|Period 2|Withdrawal by Subject|4|||
131656355|NCT03635099|474026594|FG004|Period 2|Withdrawal by Subject|7|||
131656356|NCT03635099|474026595|FG005|Period 2|Withdrawal by Subject|0|||
131656357|NCT03635099|474026596|FG006|Period 2|Withdrawal by Subject|0|||
131656358|NCT03635099|474026597|FG007|Period 2|Withdrawal by Subject|0|||
131656359|NCT01068665|474026598|FG000|Overall Study|Adverse Event|5|||
131656360|NCT01068665|474026599|FG001|Overall Study|Adverse Event|4|||
131656361|NCT01068665|474026598|FG000|Overall Study|Lack of Efficacy|0|||
131656362|NCT01068665|474026599|FG001|Overall Study|Lack of Efficacy|2|||
131656363|NCT01068665|474026598|FG000|Overall Study|Protocol Violation|5|||
131656364|NCT01068665|474026599|FG001|Overall Study|Protocol Violation|2|||
131656365|NCT01068665|474026598|FG000|Overall Study|Withdrawal Criteria|3|||
131656366|NCT01068665|474026599|FG001|Overall Study|Withdrawal Criteria|9|||
131656367|NCT01068665|474026598|FG000|Overall Study|Other|17|||
131656368|NCT01068665|474026599|FG001|Overall Study|Other|12|||
131656369|NCT02807272|474026601|FG000|Overall Study|Death|9|||
131656370|NCT02807272|474026602|FG001|Overall Study|Death|5|||
131656371|NCT02807272|474026603|FG002|Overall Study|Death|2|||
131656372|NCT02807272|474026604|FG003|Overall Study|Death|0|||
131656373|NCT02807272|474026605|FG004|Overall Study|Death|1|||
131656374|NCT02807272|474026601|FG000|Overall Study|Lost to Follow-up|1|||
131656375|NCT02807272|474026602|FG001|Overall Study|Lost to Follow-up|0|||
131656376|NCT02807272|474026603|FG002|Overall Study|Lost to Follow-up|0|||
131656377|NCT02807272|474026604|FG003|Overall Study|Lost to Follow-up|0|||
131656378|NCT02807272|474026605|FG004|Overall Study|Lost to Follow-up|0|||
131656379|NCT02807272|474026601|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
131656380|NCT02807272|474026602|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
131656381|NCT02807272|474026603|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
131656382|NCT02807272|474026604|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
131656383|NCT02807272|474026605|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
131656384|NCT02807272|474026601|FG000|Overall Study|Protocol-defined Disease Progression|0|||
131656385|NCT02807272|474026602|FG001|Overall Study|Protocol-defined Disease Progression|1|||
131656386|NCT02807272|474026603|FG002|Overall Study|Protocol-defined Disease Progression|0|||
131656387|NCT02807272|474026604|FG003|Overall Study|Protocol-defined Disease Progression|0|||
131656388|NCT02807272|474026605|FG004|Overall Study|Protocol-defined Disease Progression|1|||
131656389|NCT02807272|474026601|FG000|Overall Study|Study Terminated by Sponsor|1|||
131656390|NCT02807272|474026602|FG001|Overall Study|Study Terminated by Sponsor|0|||
131656391|NCT02807272|474026603|FG002|Overall Study|Study Terminated by Sponsor|0|||
131656392|NCT02807272|474026604|FG003|Overall Study|Study Terminated by Sponsor|1|||
131656393|NCT02807272|474026605|FG004|Overall Study|Study Terminated by Sponsor|0|||
131656394|NCT02807272|474026601|FG000|Overall Study|Other|1|||
131656395|NCT02807272|474026602|FG001|Overall Study|Other|0|||
131656396|NCT02807272|474026603|FG002|Overall Study|Other|0|||
131656397|NCT02807272|474026604|FG003|Overall Study|Other|0|||
131656398|NCT02807272|474026605|FG004|Overall Study|Other|1|||
131656399|NCT01038427|474026607|FG000|Overall Study|Lost to follow up|1|||
131656400|NCT01038427|474026608|FG001|Overall Study|Lost to follow up|1|||
131656401|NCT01038427|474026609|FG002|Overall Study|Lost to follow up|0|||
131656402|NCT01038427|474026607|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131656403|NCT01038427|474026608|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131656404|NCT01038427|474026609|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
131656405|NCT01038427|474026607|FG000|Overall Study|Withdrew consent|0|||
131656406|NCT01038427|474026608|FG001|Overall Study|Withdrew consent|0|||
131656407|NCT01038427|474026609|FG002|Overall Study|Withdrew consent|1|||
131656408|NCT01038427|474026607|FG000|Overall Study|Adverse Event|2|||
131656409|NCT01038427|474026608|FG001|Overall Study|Adverse Event|2|||
131656410|NCT01038427|474026609|FG002|Overall Study|Adverse Event|1|||
131656411|NCT01038427|474026607|FG000|Overall Study|Enrolled in error|0|||
131656412|NCT01038427|474026608|FG001|Overall Study|Enrolled in error|1|||
131656413|NCT01038427|474026609|FG002|Overall Study|Enrolled in error|1|||
131656414|NCT01038427|474026607|FG000|Overall Study|Other|0|||
131656415|NCT01038427|474026608|FG001|Overall Study|Other|2|||
131656416|NCT01038427|474026609|FG002|Overall Study|Other|0|||
131656417|NCT04191616|474026610|FG000|Pre-assignment Period|Did not receive study treatment|2|||
131656418|NCT04191616|474026610|FG000|Treatment Period|Death|37|||
131656419|NCT04191616|474026610|FG000|Treatment Period|Sponsor decision|11|||
131656420|NCT04191616|474026610|FG000|Treatment Period|Withdrawal by Subject|4|||
131656421|NCT01162863|474026611|FG000|Overall Study|Lack of Efficacy|1|||
131656422|NCT01162863|474026612|FG001|Overall Study|Lack of Efficacy|0|||
131656423|NCT01162863|474026613|FG002|Overall Study|Lack of Efficacy|0|||
131656424|NCT01162863|474026611|FG000|Overall Study|Adverse Event|0|||
131656425|NCT01162863|474026612|FG001|Overall Study|Adverse Event|1|||
131656426|NCT01162863|474026613|FG002|Overall Study|Adverse Event|0|||
131656427|NCT04230122|474026614|FG000|Overall Study|Lost to Follow-up|1|||
131656428|NCT04230122|474026615|FG001|Overall Study|Lost to Follow-up|0|||
131656429|NCT00604708|474026616|FG000|Overall Study|Withdrawal by Subject|9|||
131656430|NCT00604708|474026617|FG001|Overall Study|Withdrawal by Subject|10|||
131656431|NCT00604708|474026616|FG000|Overall Study|Protocol Violation|2|||
131656432|NCT00604708|474026617|FG001|Overall Study|Protocol Violation|8|||
131656433|NCT00604708|474026616|FG000|Overall Study|Lost to Follow-up|5|||
131656434|NCT00604708|474026617|FG001|Overall Study|Lost to Follow-up|5|||
131656435|NCT00604708|474026616|FG000|Overall Study|administrative reasons|9|||
131656436|NCT00604708|474026617|FG001|Overall Study|administrative reasons|11|||
131656437|NCT00604708|474026616|FG000|Overall Study|Adverse Event|6|||
131656438|NCT00604708|474026617|FG001|Overall Study|Adverse Event|6|||
131656439|NCT02202785|474026618|FG000|Overall Study|Study Terminated by Sponsor|1|||
131656440|NCT02202785|474026619|FG001|Overall Study|Study Terminated by Sponsor|6|||
131656441|NCT02202785|474026620|FG002|Overall Study|Study Terminated by Sponsor|4|||
131656442|NCT02202785|474026618|FG000|Overall Study|Withdrawal by Subject|0|||
131656443|NCT02202785|474026619|FG001|Overall Study|Withdrawal by Subject|1|||
131656444|NCT02202785|474026620|FG002|Overall Study|Withdrawal by Subject|0|||
131656445|NCT02202785|474026618|FG000|Overall Study|Lost to Follow-up|0|||
131656446|NCT02202785|474026619|FG001|Overall Study|Lost to Follow-up|1|||
131656447|NCT02202785|474026620|FG002|Overall Study|Lost to Follow-up|0|||
131656448|NCT02202785|474026618|FG000|Overall Study|Reason not Specified|10|||
131656449|NCT02202785|474026619|FG001|Overall Study|Reason not Specified|7|||
131656450|NCT02202785|474026620|FG002|Overall Study|Reason not Specified|13|||
131656451|NCT02180243|474026621|FG000|Overall Study|Withdrawal by Subject|12|||
131656452|NCT02180243|474026622|FG001|Overall Study|Withdrawal by Subject|12|||
131656453|NCT02180243|474026621|FG000|Overall Study|Lost to Follow-up|12|||
131656454|NCT02180243|474026622|FG001|Overall Study|Lost to Follow-up|2|||
131656455|NCT01137578|474026623|FG000|Overall Study|Participant requested to Discontinue|3|||
131656456|NCT01137578|474026624|FG001|Overall Study|Participant requested to Discontinue|0|||
131656457|NCT01137578|474026625|FG002|Overall Study|Participant requested to Discontinue|0|||
131656458|NCT01137578|474026623|FG000|Overall Study|Withdrawal by Subject|1|||
131656459|NCT01137578|474026624|FG001|Overall Study|Withdrawal by Subject|0|||
131656460|NCT01137578|474026625|FG002|Overall Study|Withdrawal by Subject|0|||
131656461|NCT01137578|474026623|FG000|Overall Study|Other|12|||
131656462|NCT01137578|474026624|FG001|Overall Study|Other|2|||
131656463|NCT01137578|474026625|FG002|Overall Study|Other|6|||
131656464|NCT04145700|474026626|FG000|Overall Study|Withdrawal by Subject|8|||
131656465|NCT04145700|474026627|FG001|Overall Study|Withdrawal by Subject|3|||
131656466|NCT00818779|474026630|FG000|Overall Study|Protocol Violation|1|||
131656467|NCT00818779|474026631|FG001|Overall Study|Protocol Violation|0|||
131656468|NCT00818779|474026630|FG000|Overall Study|Lost to Follow-up|1|||
131656469|NCT00818779|474026631|FG001|Overall Study|Lost to Follow-up|0|||
131656470|NCT00818779|474026630|FG000|Overall Study|Adverse Event|4|||
131656471|NCT00818779|474026631|FG001|Overall Study|Adverse Event|1|||
131656472|NCT04978493|474026632|FG000|Overall Study|No reason available|0|||
131656473|NCT04978493|474026633|FG001|Overall Study|No reason available|1|||
131656474|NCT04978493|474026632|FG000|Overall Study|Adverse Event|1|||
131656475|NCT04978493|474026633|FG001|Overall Study|Adverse Event|0|||
131656476|NCT01327846|474026636|FG000|Core Phase|Subject decision (vital status: missing)|1|||
131656477|NCT01327846|474026637|FG001|Core Phase|Subject decision (vital status: missing)|2|||
131656478|NCT01327846|474026638|FG002|Core Phase|Subject decision (vital status: missing)|2|||
131656479|NCT01327846|474026639|FG003|Core Phase|Subject decision (vital status: missing)|1|||
131656480|NCT01327846|474026636|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
131656481|NCT01327846|474026637|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
131656482|NCT01327846|474026638|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
131656483|NCT01327846|474026639|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
131656484|NCT01327846|474026636|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
131656485|NCT01327846|474026637|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
131656486|NCT01327846|474026638|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
131656487|NCT01327846|474026639|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
131656488|NCT01327846|474026636|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
131656489|NCT01327846|474026637|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
131656490|NCT01327846|474026638|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
131656491|NCT01327846|474026639|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
131656492|NCT01327846|474026636|FG000|Core Phase|Lost to Follow-up|3|||
131656493|NCT01327846|474026637|FG001|Core Phase|Lost to Follow-up|3|||
131656494|NCT01327846|474026638|FG002|Core Phase|Lost to Follow-up|4|||
131656495|NCT01327846|474026639|FG003|Core Phase|Lost to Follow-up|5|||
131656496|NCT01327846|474026636|FG000|Extension Phase|Study terminated by sponsor|1073|||
131656497|NCT01327846|474026637|FG001|Extension Phase|Study terminated by sponsor|1124|||
131656498|NCT01327846|474026638|FG002|Extension Phase|Study terminated by sponsor|1067|||
131656499|NCT01327846|474026639|FG003|Extension Phase|Study terminated by sponsor|1660|||
131656500|NCT01327846|474026636|FG000|Extension Phase|Withdrawal by Subject|20|||
131656501|NCT01327846|474026637|FG001|Extension Phase|Withdrawal by Subject|13|||
131656502|NCT01327846|474026638|FG002|Extension Phase|Withdrawal by Subject|19|||
131656503|NCT01327846|474026639|FG003|Extension Phase|Withdrawal by Subject|37|||
131656504|NCT01327846|474026636|FG000|Extension Phase|Lost to Follow-up|4|||
131656505|NCT01327846|474026637|FG001|Extension Phase|Lost to Follow-up|3|||
131656506|NCT01327846|474026638|FG002|Extension Phase|Lost to Follow-up|4|||
131656507|NCT01327846|474026639|FG003|Extension Phase|Lost to Follow-up|7|||
131656508|NCT01327846|474026636|FG000|Extension Phase|Technical Problems|2|||
131656509|NCT01327846|474026637|FG001|Extension Phase|Technical Problems|4|||
131656510|NCT01327846|474026638|FG002|Extension Phase|Technical Problems|2|||
131656511|NCT01327846|474026639|FG003|Extension Phase|Technical Problems|2|||
131656512|NCT01840410|474026640|FG000|Overall Study|Physician Decision|1|||
131656513|NCT01840410|474026641|FG001|Overall Study|Physician Decision|2|||
131656514|NCT01840410|474026640|FG000|Overall Study|Pregnancy|1|||
131656515|NCT01840410|474026641|FG001|Overall Study|Pregnancy|0|||
131656516|NCT01840410|474026640|FG000|Overall Study|Protocol deviation|1|||
131656517|NCT01840410|474026641|FG001|Overall Study|Protocol deviation|0|||
131656518|NCT01840410|474026640|FG000|Overall Study|Lost to Follow-up|1|||
131656519|NCT01840410|474026641|FG001|Overall Study|Lost to Follow-up|0|||
131656520|NCT01840410|474026640|FG000|Overall Study|Withdrawal by Subject|2|||
131656521|NCT01840410|474026641|FG001|Overall Study|Withdrawal by Subject|1|||
131656522|NCT01840410|474026640|FG000|Overall Study|Adverse Event|1|||
131656523|NCT01840410|474026641|FG001|Overall Study|Adverse Event|1|||
131656524|NCT00594880|474026642|FG000|Overall Study|Withdrawal by Subject|1|||
131656525|NCT00594880|474026643|FG001|Overall Study|Withdrawal by Subject|1|||
131656526|NCT00594880|474026642|FG000|Overall Study|Lost to Follow-up|1|||
131656527|NCT00594880|474026643|FG001|Overall Study|Lost to Follow-up|0|||
131656528|NCT00694109|474026644|FG000|Overall Study|Physician Decision|3|||
131656529|NCT00694109|474026644|FG000|Overall Study|Adverse Event|74|||
131656530|NCT00694109|474026644|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
131656531|NCT00694109|474026644|FG000|Overall Study|Lack of Efficacy|2|||
131656532|NCT00694109|474026644|FG000|Overall Study|Withdrawal by Subject|13|||
131656533|NCT00694109|474026644|FG000|Overall Study|Pregnancy|1|||
131656534|NCT00694109|474026644|FG000|Overall Study|Enrolled but not treated|1|||
131656535|NCT00694109|474026644|FG000|Overall Study|Other|2|||
131656536|NCT00694109|474026644|FG000|Overall Study|Consented but no additional treatment|3|||
131656537|NCT01254747|474026645|FG000|Overall Study|Unacceptable subjective vision|0|||
131656538|NCT01254747|474026646|FG001|Overall Study|Unacceptable subjective vision|0|||
131656539|NCT01254747|474026647|FG002|Overall Study|Unacceptable subjective vision|0|||
131656540|NCT01254747|474026648|FG003|Overall Study|Unacceptable subjective vision|2|||
131656541|NCT01254747|474026645|FG000|Overall Study|Difficult removal handling|0|||
131656542|NCT01254747|474026646|FG001|Overall Study|Difficult removal handling|0|||
131656543|NCT01254747|474026647|FG002|Overall Study|Difficult removal handling|1|||
131656544|NCT01254747|474026648|FG003|Overall Study|Difficult removal handling|0|||
131656545|NCT01254747|474026645|FG000|Overall Study|Symptoms and problems|0|||
131656546|NCT01254747|474026646|FG001|Overall Study|Symptoms and problems|2|||
131656547|NCT01254747|474026647|FG002|Overall Study|Symptoms and problems|1|||
131656548|NCT01254747|474026648|FG003|Overall Study|Symptoms and problems|0|||
131656549|NCT01254747|474026645|FG000|Overall Study|Lost to Follow-up|0|||
131656550|NCT01254747|474026646|FG001|Overall Study|Lost to Follow-up|0|||
131656551|NCT01254747|474026647|FG002|Overall Study|Lost to Follow-up|1|||
131656552|NCT01254747|474026648|FG003|Overall Study|Lost to Follow-up|0|||
131656553|NCT01254747|474026645|FG000|Overall Study|Biomicroscopy|0|||
131656554|NCT01254747|474026646|FG001|Overall Study|Biomicroscopy|0|||
131656555|NCT01254747|474026647|FG002|Overall Study|Biomicroscopy|1|||
131656556|NCT01254747|474026648|FG003|Overall Study|Biomicroscopy|0|||
131656557|NCT01254747|474026645|FG000|Overall Study|Discomfort|0|||
131656558|NCT01254747|474026646|FG001|Overall Study|Discomfort|4|||
131656559|NCT01254747|474026647|FG002|Overall Study|Discomfort|0|||
131656560|NCT01254747|474026648|FG003|Overall Study|Discomfort|0|||
131656561|NCT00846807|474026649|FG000|Overall Study|Adverse Event|270|||
131656562|NCT00846807|474026649|FG000|Overall Study|Lost to Follow-up|94|||
131656563|NCT00846807|474026649|FG000|Overall Study|Withdrawal by Subject|56|||
131656564|NCT00846807|474026649|FG000|Overall Study|Non compliant with European label|7|||
131656565|NCT00846807|474026649|FG000|Overall Study|Switch to other anticoagulants|89|||
131656566|NCT00846807|474026649|FG000|Overall Study|No prescription after hospital discharge|56|||
131656567|NCT00846807|474026649|FG000|Overall Study|Other|60|||
131656568|NCT00245960|474026650|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
131656569|NCT00245960|474026651|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
131656570|NCT00245960|474026650|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
131656571|NCT00245960|474026651|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
131656572|NCT00245960|474026650|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
131656573|NCT00245960|474026651|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
131656574|NCT00245960|474026650|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
131656575|NCT00245960|474026651|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
131656576|NCT00245960|474026650|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
131656577|NCT00245960|474026651|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
131656578|NCT00245960|474026650|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
131656579|NCT00245960|474026651|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
131656580|NCT00245960|474026650|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
131656581|NCT00245960|474026651|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
131656582|NCT00245960|474026650|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
131656583|NCT00245960|474026651|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
131656584|NCT00245960|474026650|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
131656585|NCT00245960|474026651|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
131656586|NCT00245960|474026650|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
131656587|NCT00245960|474026651|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
131656588|NCT00245960|474026650|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
131656589|NCT00245960|474026651|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
131656590|NCT00245960|474026650|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
131656591|NCT00245960|474026651|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
131656592|NCT00737698|474026652|FG000|Overall Study|Withdrawal by Subject|6|||
131656593|NCT00737698|474026653|FG001|Overall Study|Withdrawal by Subject|5|||
131656594|NCT00737698|474026654|FG002|Overall Study|Withdrawal by Subject|3|||
131656595|NCT00737698|474026652|FG000|Overall Study|Death|0|||
131656596|NCT00737698|474026653|FG001|Overall Study|Death|0|||
131656597|NCT00737698|474026654|FG002|Overall Study|Death|1|||
131656598|NCT01067846|474026655|FG000|Overall Study|Lost to Follow-up|17|||
131656599|NCT01067846|474026656|FG001|Overall Study|Lost to Follow-up|19|||
131656600|NCT01067846|474026655|FG000|Overall Study|Withdrawal by Subject|1|||
131656601|NCT01067846|474026656|FG001|Overall Study|Withdrawal by Subject|0|||
131656602|NCT01067846|474026655|FG000|Overall Study|participation in other tx study|1|||
131656603|NCT01067846|474026656|FG001|Overall Study|participation in other tx study|0|||
131656604|NCT02817906|474026657|FG000|Overall Study|Adverse Event|3|||
131656605|NCT02817906|474026658|FG001|Overall Study|Adverse Event|0|||
131656606|NCT02817906|474026657|FG000|Overall Study|Lack of Efficacy|1|||
131656607|NCT02817906|474026658|FG001|Overall Study|Lack of Efficacy|0|||
131656608|NCT02817906|474026657|FG000|Overall Study|Protocol Violation|1|||
131656609|NCT02817906|474026658|FG001|Overall Study|Protocol Violation|1|||
131656610|NCT02817906|474026657|FG000|Overall Study|Study Terminated by Sponsor|2|||
131656611|NCT02817906|474026658|FG001|Overall Study|Study Terminated by Sponsor|2|||
131656612|NCT02817906|474026657|FG000|Overall Study|Withdrawal by Subject|7|||
131656613|NCT02817906|474026658|FG001|Overall Study|Withdrawal by Subject|0|||
131656614|NCT02817906|474026657|FG000|Overall Study|Other|2|||
131656615|NCT02817906|474026658|FG001|Overall Study|Other|2|||
131656616|NCT04608773|474026659|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
131656617|NCT04608773|474026660|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
131656618|NCT04608773|474026659|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
131656619|NCT04608773|474026660|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
131656620|NCT04608773|474026659|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
131656621|NCT04608773|474026660|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
131656622|NCT04608773|474026659|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
131656623|NCT04608773|474026660|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
131656624|NCT04608773|474026659|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
131656625|NCT04608773|474026660|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
131656626|NCT02833077|474026661|FG000|Overall Study|Adverse Event|1|||
131656627|NCT02833077|474026662|FG001|Overall Study|Adverse Event|2|||
131656628|NCT02833077|474026661|FG000|Overall Study|Lost to Follow-up|10|||
131656629|NCT02833077|474026662|FG001|Overall Study|Lost to Follow-up|1|||
131656630|NCT02833077|474026661|FG000|Overall Study|Personal Reasons|6|||
131656631|NCT02833077|474026662|FG001|Overall Study|Personal Reasons|4|||
131656632|NCT02833077|474026661|FG000|Overall Study|Protocol Deviation|0|||
131656633|NCT02833077|474026662|FG001|Overall Study|Protocol Deviation|1|||
131656634|NCT00316017|474026663|FG000|Overall Study|Protocol Violation|11|||
131656635|NCT00316017|474026664|FG001|Overall Study|Protocol Violation|13|||
131656636|NCT00316017|474026665|FG002|Overall Study|Protocol Violation|19|||
131656637|NCT01217437|474026666|FG000|Overall Study|Adverse Event|0|||
131656638|NCT01217437|474026667|FG001|Overall Study|Adverse Event|8|||
131656639|NCT01217437|474026666|FG000|Overall Study|Death|5|||
131656640|NCT01217437|474026667|FG001|Overall Study|Death|0|||
131656641|NCT01217437|474026666|FG000|Overall Study|Lack of Efficacy|29|||
131656642|NCT01217437|474026667|FG001|Overall Study|Lack of Efficacy|25|||
131656643|NCT01217437|474026666|FG000|Overall Study|Physician Decision|8|||
131656644|NCT01217437|474026667|FG001|Overall Study|Physician Decision|5|||
131656645|NCT01217437|474026666|FG000|Overall Study|Withdrawal by Subject|0|||
131656646|NCT01217437|474026667|FG001|Overall Study|Withdrawal by Subject|2|||
131656647|NCT01217437|474026666|FG000|Overall Study|Ineligible|1|||
131656648|NCT01217437|474026667|FG001|Overall Study|Ineligible|1|||
131656649|NCT06748729|474026670|FG000|Overall Study|Withdrawal by Subject|1|||
131656650|NCT01123070|474027626|FG000|Part B Double Blind Period|Protocol Violation|0|||
131656651|NCT01123070|474027627|FG001|Part B Double Blind Period|Protocol Violation|0|||
131656652|NCT01123070|474027628|FG002|Part B Double Blind Period|Protocol Violation|0|||
131656653|NCT01123070|474027629|FG003|Part B Double Blind Period|Protocol Violation|1|||
131656654|NCT01123070|474027626|FG000|Part B Double Blind Period|Adverse Event|0|||
131656655|NCT01123070|474027627|FG001|Part B Double Blind Period|Adverse Event|0|||
131656656|NCT01123070|474027628|FG002|Part B Double Blind Period|Adverse Event|2|||
131656657|NCT01123070|474027629|FG003|Part B Double Blind Period|Adverse Event|0|||
131656658|NCT01123070|474027626|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
131656659|NCT01123070|474027627|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
131656660|NCT01123070|474027628|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
131656661|NCT01123070|474027629|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
131656662|NCT03284229|474027630|FG000|Overall Study|Lost to Follow-up|3|||
131656663|NCT01977677|474027637|FG000|Overall Study|Unrelated Adverse Event|0|||
131656664|NCT01977677|474027638|FG001|Overall Study|Unrelated Adverse Event|0|||
131656665|NCT01977677|474027639|FG002|Overall Study|Unrelated Adverse Event|1|||
131656666|NCT02993406|474027640|FG000|Overall Study|Withdrawal by Subject|170|||
131656667|NCT02993406|474027641|FG001|Overall Study|Withdrawal by Subject|196|||
131656668|NCT02993406|474027640|FG000|Overall Study|Physician Decision|3|||
131656669|NCT02993406|474027641|FG001|Overall Study|Physician Decision|5|||
131656670|NCT02993406|474027640|FG000|Overall Study|Lost to Follow-up|12|||
131656671|NCT02993406|474027641|FG001|Overall Study|Lost to Follow-up|13|||
131656672|NCT02993406|474027640|FG000|Overall Study|Unclassifiable Response|105|||
131656673|NCT02993406|474027641|FG001|Overall Study|Unclassifiable Response|139|||
131656674|NCT02993406|474027640|FG000|Overall Study|Administrative decision|1|||
131656675|NCT02993406|474027641|FG001|Overall Study|Administrative decision|0|||
131656676|NCT02993406|474027640|FG000|Overall Study|Sponsor decision|4|||
131656677|NCT02993406|474027641|FG001|Overall Study|Sponsor decision|5|||
131656678|NCT02248818|474027642|FG000|Screening|Protocol Violation|0|||
131656679|NCT02248818|474027643|FG001|Screening|Protocol Violation|0|||
131656680|NCT02248818|474027644|FG002|Screening|Protocol Violation|0|||
131656681|NCT02248818|474027645|FG003|Screening|Protocol Violation|0|||
131656682|NCT02248818|474027646|FG004|Screening|Protocol Violation|0|||
131656683|NCT02248818|474027647|FG005|Screening|Protocol Violation|0|||
131656684|NCT02248818|474027648|FG006|Screening|Protocol Violation|0|||
131656685|NCT02248818|474027649|FG007|Screening|Protocol Violation|0|||
131656686|NCT02248818|474027650|FG008|Screening|Protocol Violation|7|||
131656687|NCT02248818|474027642|FG000|Screening|Study fully enrolled|0|||
131656688|NCT02248818|474027643|FG001|Screening|Study fully enrolled|0|||
131656689|NCT02248818|474027644|FG002|Screening|Study fully enrolled|0|||
131656690|NCT02248818|474027645|FG003|Screening|Study fully enrolled|0|||
131656691|NCT02248818|474027646|FG004|Screening|Study fully enrolled|0|||
131656692|NCT02248818|474027647|FG005|Screening|Study fully enrolled|0|||
131656693|NCT02248818|474027648|FG006|Screening|Study fully enrolled|0|||
131656694|NCT02248818|474027649|FG007|Screening|Study fully enrolled|0|||
131656695|NCT02248818|474027650|FG008|Screening|Study fully enrolled|14|||
131656696|NCT02248818|474027642|FG000|Screening|Physician Decision|0|||
131656697|NCT02248818|474027643|FG001|Screening|Physician Decision|0|||
131656698|NCT02248818|474027644|FG002|Screening|Physician Decision|0|||
131656699|NCT02248818|474027645|FG003|Screening|Physician Decision|0|||
131656700|NCT02248818|474027646|FG004|Screening|Physician Decision|0|||
131656701|NCT02248818|474027647|FG005|Screening|Physician Decision|0|||
131656702|NCT02248818|474027648|FG006|Screening|Physician Decision|0|||
131656703|NCT02248818|474027649|FG007|Screening|Physician Decision|0|||
131656704|NCT02248818|474027650|FG008|Screening|Physician Decision|73|||
131656705|NCT02248818|474027642|FG000|Screening|Withdrawal by Subject|0|||
131656706|NCT02248818|474027643|FG001|Screening|Withdrawal by Subject|0|||
131656707|NCT02248818|474027644|FG002|Screening|Withdrawal by Subject|0|||
131656708|NCT02248818|474027645|FG003|Screening|Withdrawal by Subject|0|||
131656709|NCT02248818|474027646|FG004|Screening|Withdrawal by Subject|0|||
131656710|NCT02248818|474027647|FG005|Screening|Withdrawal by Subject|0|||
131656711|NCT02248818|474027648|FG006|Screening|Withdrawal by Subject|0|||
131656712|NCT02248818|474027649|FG007|Screening|Withdrawal by Subject|0|||
131656713|NCT02248818|474027650|FG008|Screening|Withdrawal by Subject|6|||
131656714|NCT02248818|474027642|FG000|Screening|Lost to Follow-up|0|||
131656715|NCT02248818|474027643|FG001|Screening|Lost to Follow-up|0|||
131656716|NCT02248818|474027644|FG002|Screening|Lost to Follow-up|0|||
131656717|NCT02248818|474027645|FG003|Screening|Lost to Follow-up|0|||
131656718|NCT02248818|474027646|FG004|Screening|Lost to Follow-up|0|||
131656719|NCT02248818|474027647|FG005|Screening|Lost to Follow-up|0|||
131656720|NCT02248818|474027648|FG006|Screening|Lost to Follow-up|0|||
131656721|NCT02248818|474027649|FG007|Screening|Lost to Follow-up|0|||
131656722|NCT02248818|474027650|FG008|Screening|Lost to Follow-up|7|||
131656723|NCT02248818|474027642|FG000|Randomised Study|Administrative - randomization error|0|||
131656724|NCT02248818|474027643|FG001|Randomised Study|Administrative - randomization error|0|||
131656725|NCT02248818|474027644|FG002|Randomised Study|Administrative - randomization error|0|||
131656726|NCT02248818|474027645|FG003|Randomised Study|Administrative - randomization error|0|||
131656727|NCT02248818|474027646|FG004|Randomised Study|Administrative - randomization error|0|||
131656728|NCT02248818|474027647|FG005|Randomised Study|Administrative - randomization error|8|||
131656729|NCT02248818|474027648|FG006|Randomised Study|Administrative - randomization error|0|||
131656730|NCT02248818|474027649|FG007|Randomised Study|Administrative - randomization error|0|||
131656731|NCT02248818|474027650|FG008|Randomised Study|Administrative - randomization error|0|||
131656732|NCT05262517|474027651|FG000|Overall Study|Randomized but not treated|5|||
131656733|NCT05262517|474027652|FG001|Overall Study|Randomized but not treated|11|||
131656734|NCT04325282|474027653|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
131656735|NCT04325282|474027654|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
131656736|NCT04325282|474027653|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
131656737|NCT04325282|474027654|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
131656738|NCT01283152|474027658|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
131656739|NCT01283152|474027659|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
131656740|NCT01283152|474027658|FG000|Overall Study|Refused HESA|1|||
131656741|NCT01283152|474027659|FG001|Overall Study|Refused HESA|0|||
131656742|NCT02643303|474027662|FG000|Overall Study|Progressive Disease|4|||
131656743|NCT02643303|474027663|FG001|Overall Study|Progressive Disease|4|||
131656744|NCT02643303|474027664|FG002|Overall Study|Progressive Disease|1|||
131656745|NCT02643303|474027665|FG003|Overall Study|Progressive Disease|12|||
131656746|NCT02643303|474027666|FG004|Overall Study|Progressive Disease|6|||
131656747|NCT02643303|474027667|FG005|Overall Study|Progressive Disease|4|||
131656748|NCT02643303|474027668|FG006|Overall Study|Progressive Disease|8|||
131656749|NCT02643303|474027669|FG007|Overall Study|Progressive Disease|2|||
131656750|NCT02643303|474027670|FG008|Overall Study|Progressive Disease|6|||
131656751|NCT02643303|474027662|FG000|Overall Study|Adverse Event|0|||
131656752|NCT02643303|474027663|FG001|Overall Study|Adverse Event|1|||
131656753|NCT02643303|474027664|FG002|Overall Study|Adverse Event|0|||
131656754|NCT02643303|474027665|FG003|Overall Study|Adverse Event|0|||
131656755|NCT02643303|474027666|FG004|Overall Study|Adverse Event|1|||
131656756|NCT02643303|474027667|FG005|Overall Study|Adverse Event|0|||
131656757|NCT02643303|474027668|FG006|Overall Study|Adverse Event|0|||
131656758|NCT02643303|474027669|FG007|Overall Study|Adverse Event|0|||
131656759|NCT02643303|474027670|FG008|Overall Study|Adverse Event|0|||
131656760|NCT02643303|474027662|FG000|Overall Study|Withdrawal by Subject|0|||
131656761|NCT02643303|474027663|FG001|Overall Study|Withdrawal by Subject|0|||
131656762|NCT02643303|474027664|FG002|Overall Study|Withdrawal by Subject|0|||
131656763|NCT02643303|474027665|FG003|Overall Study|Withdrawal by Subject|1|||
131656764|NCT02643303|474027666|FG004|Overall Study|Withdrawal by Subject|0|||
131656765|NCT02643303|474027667|FG005|Overall Study|Withdrawal by Subject|0|||
131656766|NCT02643303|474027668|FG006|Overall Study|Withdrawal by Subject|1|||
131656767|NCT02643303|474027669|FG007|Overall Study|Withdrawal by Subject|1|||
131656768|NCT02643303|474027670|FG008|Overall Study|Withdrawal by Subject|1|||
131656769|NCT04552899|474027677|FG000|Overall Study|Adverse Event|4|||
131656770|NCT04552899|474027678|FG001|Overall Study|Adverse Event|3|||
131656771|NCT04552899|474027677|FG000|Overall Study|Death|4|||
131656772|NCT04552899|474027678|FG001|Overall Study|Death|4|||
131656773|NCT04552899|474027677|FG000|Overall Study|Lost to Follow-up|8|||
131656774|NCT04552899|474027678|FG001|Overall Study|Lost to Follow-up|13|||
131656775|NCT04552899|474027677|FG000|Overall Study|Lung Transplant|4|||
131656776|NCT04552899|474027678|FG001|Overall Study|Lung Transplant|3|||
131656777|NCT04552899|474027677|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
131656778|NCT04552899|474027678|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
131656779|NCT04552899|474027677|FG000|Overall Study|Physician Decision|3|||
131656780|NCT04552899|474027678|FG001|Overall Study|Physician Decision|4|||
131656781|NCT04552899|474027677|FG000|Overall Study|Study Terminated By Sponsor|237|||
131656782|NCT04552899|474027678|FG001|Overall Study|Study Terminated By Sponsor|239|||
131656783|NCT04552899|474027677|FG000|Overall Study|Withdrawal by Subject|15|||
131656784|NCT04552899|474027678|FG001|Overall Study|Withdrawal by Subject|17|||
131656785|NCT01499303|474027679|FG000|Overall Study|Ongoing|2|||
131656786|NCT01499303|474027680|FG001|Overall Study|Ongoing|1|||
131656787|NCT01499303|474027679|FG000|Overall Study|Withdrawal by Subject|0|||
131656788|NCT01499303|474027680|FG001|Overall Study|Withdrawal by Subject|1|||
131656789|NCT01499303|474027679|FG000|Overall Study|Adverse Event|1|||
131656790|NCT01499303|474027680|FG001|Overall Study|Adverse Event|4|||
131656791|NCT01499303|474027679|FG000|Overall Study|Other|0|||
131656792|NCT01499303|474027680|FG001|Overall Study|Other|1|||
131656793|NCT02383940|474027689|FG000|Overall Study|Adverse Event|1|||
131656794|NCT02383940|474027690|FG001|Overall Study|Adverse Event|0|||
131656795|NCT02383940|474027689|FG000|Overall Study|Lost to Follow-up|2|||
131656796|NCT02383940|474027690|FG001|Overall Study|Lost to Follow-up|2|||
131656797|NCT02383940|474027689|FG000|Overall Study|Physician Decision|2|||
131656798|NCT02383940|474027690|FG001|Overall Study|Physician Decision|0|||
131656799|NCT02383940|474027689|FG000|Overall Study|Withdrawal by Subject|1|||
131656800|NCT02383940|474027690|FG001|Overall Study|Withdrawal by Subject|1|||
131656801|NCT02383940|474027689|FG000|Overall Study|Randomized but not treated|2|||
131656802|NCT02383940|474027690|FG001|Overall Study|Randomized but not treated|0|||
131656803|NCT02383940|474027689|FG000|Overall Study|Other than specified above|1|||
131656804|NCT02383940|474027690|FG001|Overall Study|Other than specified above|0|||
131656805|NCT04308590|474027691|FG000|Overall Study|Adverse Event|12|||
131656806|NCT04308590|474027692|FG001|Overall Study|Adverse Event|2|||
131656807|NCT04308590|474027691|FG000|Overall Study|Withdrawal by Subject|10|||
131656808|NCT04308590|474027692|FG001|Overall Study|Withdrawal by Subject|4|||
131656809|NCT04308590|474027691|FG000|Overall Study|Death|1|||
131656810|NCT04308590|474027692|FG001|Overall Study|Death|0|||
131656811|NCT04308590|474027691|FG000|Overall Study|Lost to Follow-up|1|||
131656812|NCT04308590|474027692|FG001|Overall Study|Lost to Follow-up|1|||
131656813|NCT04308590|474027691|FG000|Overall Study|Physician Decision|1|||
131656814|NCT04308590|474027692|FG001|Overall Study|Physician Decision|0|||
131656815|NCT04308590|474027691|FG000|Overall Study|Subject does not want to continue with Pi|0|||
131656816|NCT04308590|474027692|FG001|Overall Study|Subject does not want to continue with Pi|1|||
131656817|NCT01401153|474027693|FG000|First Test Day|Learning disabilities; illness|1|||
131656818|NCT01401153|474027694|FG001|First Test Day|Learning disabilities; illness|10|||
131656819|NCT01401153|474027693|FG000|Second Test Day|illness|0|||
131656820|NCT01401153|474027694|FG001|Second Test Day|illness|5|||
131656821|NCT04343976|474027695|FG000|Overall Study|Withdrawal by Subject|0|||
131656822|NCT04343976|474027696|FG001|Overall Study|Withdrawal by Subject|1|||
131656823|NCT04187326|474027697|FG000|Overall Study|Lost to Follow-up|2|||
131656824|NCT04187326|474027698|FG001|Overall Study|Lost to Follow-up|1|||
131656825|NCT04187326|474027697|FG000|Overall Study|Computer error- task was only partially completed.|0|||
131656826|NCT04187326|474027698|FG001|Overall Study|Computer error- task was only partially completed.|1|||
131656827|NCT05235269|474027702|FG000|Overall Study|Adverse Event|1|||
131656828|NCT05235269|474027702|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
131656829|NCT05235269|474027702|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
131656830|NCT00798434|474027703|FG000|Double-Blind|Adverse Event|22|||
131656831|NCT00798434|474027704|FG001|Double-Blind|Adverse Event|46|||
131656832|NCT00798434|474027703|FG000|Double-Blind|Death|0|||
131656833|NCT00798434|474027704|FG001|Double-Blind|Death|1|||
131656834|NCT00798434|474027703|FG000|Double-Blind|Lost to Follow-up|1|||
131656835|NCT00798434|474027704|FG001|Double-Blind|Lost to Follow-up|0|||
131656836|NCT00798434|474027703|FG000|Double-Blind|Lack of Efficacy|8|||
131656837|NCT00798434|474027704|FG001|Double-Blind|Lack of Efficacy|12|||
131656838|NCT00798434|474027703|FG000|Double-Blind|Withdrawal by Subject|17|||
131656839|NCT00798434|474027704|FG001|Double-Blind|Withdrawal by Subject|14|||
131656840|NCT00798434|474027703|FG000|Double-Blind|Protocol Violation|1|||
131656841|NCT00798434|474027704|FG001|Double-Blind|Protocol Violation|4|||
131656842|NCT00798434|474027703|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
131656843|NCT00798434|474027704|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
131656844|NCT00798434|474027703|FG000|Double-Blind|Other|1|||
131656845|NCT00798434|474027704|FG001|Double-Blind|Other|0|||
131656846|NCT00798434|474027703|FG000|Double-Blind|Not Treated|3|||
131656847|NCT00798434|474027704|FG001|Double-Blind|Not Treated|6|||
131656848|NCT00798434|474027703|FG000|Open-Label|Adverse Event|33|||
131656849|NCT00798434|474027704|FG001|Open-Label|Adverse Event|11|||
131656850|NCT00798434|474027703|FG000|Open-Label|Lack of Efficacy|5|||
131656851|NCT00798434|474027704|FG001|Open-Label|Lack of Efficacy|11|||
131656852|NCT00798434|474027703|FG000|Open-Label|Withdrawal by Subject|2|||
131656853|NCT00798434|474027704|FG001|Open-Label|Withdrawal by Subject|7|||
131656854|NCT00798434|474027703|FG000|Open-Label|Protocol Violation|1|||
131656855|NCT00798434|474027704|FG001|Open-Label|Protocol Violation|0|||
131656856|NCT00798434|474027703|FG000|Open-Label|Other|1|||
131656857|NCT00798434|474027704|FG001|Open-Label|Other|2|||
131656858|NCT00798434|474027703|FG000|Open-Label|Not Treated|0|||
131656859|NCT00798434|474027704|FG001|Open-Label|Not Treated|1|||
131656860|NCT03898167|474027705|FG000|Overall Study|Terminated phone call early|7|||
131656861|NCT03898167|474027706|FG001|Overall Study|Terminated phone call early|0|||
131656862|NCT03898167|474027707|FG002|Overall Study|Terminated phone call early|0|||
131656863|NCT03898167|474027705|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
131656864|NCT03898167|474027706|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
131656865|NCT03898167|474027707|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
131656866|NCT05177354|474027708|FG000|Implant to 30-day Visit|Physician Decision|1|||
131656867|NCT05177354|474027708|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
131656868|NCT05177354|474027708|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
131656869|NCT05177354|474027708|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
131656870|NCT03548220|474027710|FG000|Overall Study|Lost to Follow-up|1|||
131656871|NCT03548220|474027711|FG001|Overall Study|Lost to Follow-up|0|||
131656872|NCT03548220|474027712|FG002|Overall Study|Lost to Follow-up|0|||
131656873|NCT03548220|474027713|FG003|Overall Study|Lost to Follow-up|0|||
131656874|NCT02906007|474027714|FG000|Overall Study|Physician Decision|0|||
131656875|NCT02906007|474027715|FG001|Overall Study|Physician Decision|0|||
131656876|NCT02906007|474027716|FG002|Overall Study|Physician Decision|1|||
131656877|NCT02906007|474027714|FG000|Overall Study|Died|1|||
131656878|NCT02906007|474027715|FG001|Overall Study|Died|0|||
131656879|NCT02906007|474027716|FG002|Overall Study|Died|0|||
131656880|NCT01901432|474028990|FG000|Overall Study|Adverse Event|0|||
131656881|NCT01901432|474028991|FG001|Overall Study|Adverse Event|1|||
131656882|NCT01901432|474028992|FG002|Overall Study|Adverse Event|1|||
131656883|NCT01901432|474028993|FG003|Overall Study|Adverse Event|0|||
131656884|NCT01901432|474028994|FG004|Overall Study|Adverse Event|1|||
131656885|NCT01901432|474028990|FG000|Overall Study|Withdrawal by Subject|0|||
131656886|NCT01901432|474028991|FG001|Overall Study|Withdrawal by Subject|0|||
131656887|NCT01901432|474028992|FG002|Overall Study|Withdrawal by Subject|1|||
131656888|NCT01901432|474028993|FG003|Overall Study|Withdrawal by Subject|0|||
131656889|NCT01901432|474028994|FG004|Overall Study|Withdrawal by Subject|5|||
131656890|NCT01901432|474028990|FG000|Overall Study|Physician Decision|0|||
131656891|NCT01901432|474028991|FG001|Overall Study|Physician Decision|0|||
131656892|NCT01901432|474028992|FG002|Overall Study|Physician Decision|0|||
131656893|NCT01901432|474028993|FG003|Overall Study|Physician Decision|0|||
131656894|NCT01901432|474028994|FG004|Overall Study|Physician Decision|2|||
131656895|NCT01901432|474028990|FG000|Overall Study|Patient decision to stop study drug|0|||
131656896|NCT01901432|474028991|FG001|Overall Study|Patient decision to stop study drug|0|||
131656897|NCT01901432|474028992|FG002|Overall Study|Patient decision to stop study drug|0|||
131656898|NCT01901432|474028993|FG003|Overall Study|Patient decision to stop study drug|0|||
131656899|NCT01901432|474028994|FG004|Overall Study|Patient decision to stop study drug|1|||
131656900|NCT00379288|474028995|FG000|Overall Study|Adverse Event|5|||
131656901|NCT00379288|474028996|FG001|Overall Study|Adverse Event|6|||
131656902|NCT00379288|474028997|FG002|Overall Study|Adverse Event|2|||
131656903|NCT00379288|474028998|FG003|Overall Study|Adverse Event|0|||
131656904|NCT00379288|474028995|FG000|Overall Study|Treatment Failure|0|||
131656905|NCT00379288|474028996|FG001|Overall Study|Treatment Failure|1|||
131656906|NCT00379288|474028997|FG002|Overall Study|Treatment Failure|0|||
131656907|NCT00379288|474028998|FG003|Overall Study|Treatment Failure|1|||
131656908|NCT00379288|474028995|FG000|Overall Study|Lost to Follow-up|3|||
131656909|NCT00379288|474028996|FG001|Overall Study|Lost to Follow-up|3|||
131656910|NCT00379288|474028997|FG002|Overall Study|Lost to Follow-up|2|||
131656911|NCT00379288|474028998|FG003|Overall Study|Lost to Follow-up|0|||
131656912|NCT00379288|474028995|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
131658610|NCT02003222|474035396|FG001|Induction|Disease progression|0|||
131656913|NCT00379288|474028996|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
131656914|NCT00379288|474028997|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
131656915|NCT00379288|474028998|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
131656916|NCT00379288|474028995|FG000|Overall Study|Subject withdrew-related to study drug|1|||
131656917|NCT00379288|474028996|FG001|Overall Study|Subject withdrew-related to study drug|0|||
131656918|NCT00379288|474028997|FG002|Overall Study|Subject withdrew-related to study drug|0|||
131656919|NCT00379288|474028998|FG003|Overall Study|Subject withdrew-related to study drug|1|||
131656920|NCT00379288|474028995|FG000|Overall Study|Noncompliance with protocol|8|||
131656921|NCT00379288|474028996|FG001|Overall Study|Noncompliance with protocol|6|||
131656922|NCT00379288|474028997|FG002|Overall Study|Noncompliance with protocol|2|||
131656923|NCT00379288|474028998|FG003|Overall Study|Noncompliance with protocol|1|||
131656924|NCT00379288|474028995|FG000|Overall Study|Did not meet protocol eligibility|0|||
131656925|NCT00379288|474028996|FG001|Overall Study|Did not meet protocol eligibility|1|||
131656926|NCT00379288|474028997|FG002|Overall Study|Did not meet protocol eligibility|0|||
131656927|NCT00379288|474028998|FG003|Overall Study|Did not meet protocol eligibility|2|||
131656928|NCT00379288|474028995|FG000|Overall Study|Administrative|2|||
131656929|NCT00379288|474028996|FG001|Overall Study|Administrative|2|||
131656930|NCT00379288|474028997|FG002|Overall Study|Administrative|0|||
131656931|NCT00379288|474028998|FG003|Overall Study|Administrative|1|||
131656932|NCT00515671|474029009|FG000|Overall Study|Lost to Follow-up|13|||
131656933|NCT00515671|474029010|FG001|Overall Study|Lost to Follow-up|10|||
131656934|NCT00515671|474029009|FG000|Overall Study|Withdrawal by Subject|3|||
131656935|NCT00515671|474029010|FG001|Overall Study|Withdrawal by Subject|5|||
131656936|NCT00515671|474029009|FG000|Overall Study|incarcerated|1|||
131656937|NCT00515671|474029010|FG001|Overall Study|incarcerated|2|||
131656938|NCT00288639|474029013|FG000|Overall Study|Adverse Event|5|||
131656939|NCT00288639|474029013|FG000|Overall Study|Lack of Efficacy|4|||
131656940|NCT00288639|474029013|FG000|Overall Study|Withdrawal by Subject|2|||
131656941|NCT00288639|474029013|FG000|Overall Study|Other|1|||
131656942|NCT01014208|474029022|FG000|Overall Study|Lost to Follow-up|2|||
131656943|NCT01014208|474029023|FG001|Overall Study|Lost to Follow-up|5|||
131656944|NCT01014208|474029022|FG000|Overall Study|Participant Withdrew Consent|12|||
131656945|NCT01014208|474029023|FG001|Overall Study|Participant Withdrew Consent|12|||
131656946|NCT01014208|474029022|FG000|Overall Study|Did Not Receive Study Drug|2|||
131656947|NCT01014208|474029023|FG001|Overall Study|Did Not Receive Study Drug|0|||
131656948|NCT01014208|474029022|FG000|Overall Study|Study Closed/terminated|78|||
131656949|NCT01014208|474029023|FG001|Overall Study|Study Closed/terminated|83|||
131656950|NCT00527787|474029031|FG000|Overall Study|Adverse Event|14|||
131656951|NCT00527787|474029032|FG001|Overall Study|Adverse Event|24|||
131656952|NCT00527787|474029031|FG000|Overall Study|Withdrawal by Subject|13|||
131656953|NCT00527787|474029032|FG001|Overall Study|Withdrawal by Subject|25|||
131656954|NCT00527787|474029031|FG000|Overall Study|Lost to Follow-up|5|||
131656955|NCT00527787|474029032|FG001|Overall Study|Lost to Follow-up|2|||
131656956|NCT00527787|474029031|FG000|Overall Study|Duodenal Ulcer|1|||
131656957|NCT00527787|474029032|FG001|Overall Study|Duodenal Ulcer|10|||
131656958|NCT00527787|474029031|FG000|Overall Study|misc|5|||
131656959|NCT00527787|474029032|FG001|Overall Study|misc|2|||
131656960|NCT04939701|474029033|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
131656961|NCT04939701|474029034|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
131656962|NCT04939701|474029035|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
131656963|NCT04939701|474029033|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
131656964|NCT04939701|474029034|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
131656965|NCT04939701|474029035|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
131656966|NCT04939701|474029033|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
131656967|NCT04939701|474029034|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
131656968|NCT04939701|474029035|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
131656969|NCT04939701|474029033|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
131656970|NCT04939701|474029034|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
131656971|NCT04939701|474029035|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
131656972|NCT04939701|474029033|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
131656973|NCT04939701|474029034|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
131656974|NCT04939701|474029035|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
131656975|NCT04939701|474029033|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
131656976|NCT04939701|474029034|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
131656977|NCT04939701|474029035|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
131656978|NCT04939701|474029033|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
131656979|NCT04939701|474029034|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
131656980|NCT04939701|474029035|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
131656981|NCT02672852|474029037|FG000|Part A1|Disease Worsening|1|||
131656982|NCT02672852|474029038|FG001|Part A1|Disease Worsening|0|||
131656983|NCT02672852|474029039|FG002|Part A1|Disease Worsening|0|||
131656984|NCT02672852|474029040|FG003|Part A1|Disease Worsening|0|||
131656985|NCT02672852|474029041|FG004|Part A1|Disease Worsening|0|||
131656986|NCT02672852|474029042|FG005|Part A1|Disease Worsening|0|||
131656987|NCT02672852|474029043|FG006|Part A1|Disease Worsening|0|||
131656988|NCT02672852|474029037|FG000|Part A1|Adverse Event|0|||
131656989|NCT02672852|474029038|FG001|Part A1|Adverse Event|1|||
131656990|NCT02672852|474029039|FG002|Part A1|Adverse Event|0|||
131656991|NCT02672852|474029040|FG003|Part A1|Adverse Event|0|||
131656992|NCT02672852|474029041|FG004|Part A1|Adverse Event|0|||
131656993|NCT02672852|474029042|FG005|Part A1|Adverse Event|0|||
131656994|NCT02672852|474029043|FG006|Part A1|Adverse Event|0|||
131656995|NCT02672852|474029037|FG000|Part A1|Lost to Follow-up|1|||
131656996|NCT02672852|474029038|FG001|Part A1|Lost to Follow-up|2|||
131656997|NCT02672852|474029039|FG002|Part A1|Lost to Follow-up|0|||
131656998|NCT02672852|474029040|FG003|Part A1|Lost to Follow-up|0|||
131656999|NCT02672852|474029041|FG004|Part A1|Lost to Follow-up|0|||
131657000|NCT02672852|474029042|FG005|Part A1|Lost to Follow-up|0|||
131657001|NCT02672852|474029043|FG006|Part A1|Lost to Follow-up|0|||
131657002|NCT02672852|474029037|FG000|Part A1|Withdrawal by Subject|1|||
131657003|NCT02672852|474029038|FG001|Part A1|Withdrawal by Subject|1|||
131657004|NCT02672852|474029039|FG002|Part A1|Withdrawal by Subject|0|||
131657005|NCT02672852|474029040|FG003|Part A1|Withdrawal by Subject|0|||
131657006|NCT02672852|474029041|FG004|Part A1|Withdrawal by Subject|0|||
131657007|NCT02672852|474029042|FG005|Part A1|Withdrawal by Subject|0|||
131657008|NCT02672852|474029043|FG006|Part A1|Withdrawal by Subject|0|||
131657009|NCT02672852|474029037|FG000|Part A2|Disease worsening|0|||
131657010|NCT02672852|474029038|FG001|Part A2|Disease worsening|0|||
131657011|NCT02672852|474029039|FG002|Part A2|Disease worsening|1|||
131657012|NCT02672852|474029040|FG003|Part A2|Disease worsening|0|||
131657013|NCT02672852|474029041|FG004|Part A2|Disease worsening|0|||
131657014|NCT02672852|474029042|FG005|Part A2|Disease worsening|0|||
131657015|NCT02672852|474029043|FG006|Part A2|Disease worsening|0|||
131657016|NCT02672852|474029037|FG000|Part A2|Adverse Event|0|||
131657017|NCT02672852|474029038|FG001|Part A2|Adverse Event|0|||
131657018|NCT02672852|474029039|FG002|Part A2|Adverse Event|3|||
131657019|NCT02672852|474029040|FG003|Part A2|Adverse Event|0|||
131657020|NCT02672852|474029041|FG004|Part A2|Adverse Event|0|||
131657021|NCT02672852|474029042|FG005|Part A2|Adverse Event|0|||
131657022|NCT02672852|474029043|FG006|Part A2|Adverse Event|0|||
131657023|NCT02672852|474029037|FG000|Part A2|Lost to Follow-up|0|||
131657024|NCT02672852|474029038|FG001|Part A2|Lost to Follow-up|0|||
131657025|NCT02672852|474029039|FG002|Part A2|Lost to Follow-up|2|||
131657026|NCT02672852|474029040|FG003|Part A2|Lost to Follow-up|0|||
131657027|NCT02672852|474029041|FG004|Part A2|Lost to Follow-up|0|||
131657028|NCT02672852|474029042|FG005|Part A2|Lost to Follow-up|0|||
131657029|NCT02672852|474029043|FG006|Part A2|Lost to Follow-up|0|||
131657030|NCT02672852|474029037|FG000|Part A2|Withdrawal by Subject|0|||
131657031|NCT02672852|474029038|FG001|Part A2|Withdrawal by Subject|0|||
131657032|NCT02672852|474029039|FG002|Part A2|Withdrawal by Subject|1|||
131657033|NCT02672852|474029040|FG003|Part A2|Withdrawal by Subject|0|||
131657034|NCT02672852|474029041|FG004|Part A2|Withdrawal by Subject|0|||
131657035|NCT02672852|474029042|FG005|Part A2|Withdrawal by Subject|0|||
131657036|NCT02672852|474029043|FG006|Part A2|Withdrawal by Subject|0|||
131657037|NCT02672852|474029037|FG000|Part A2|Other|0|||
131657038|NCT02672852|474029038|FG001|Part A2|Other|0|||
131657039|NCT02672852|474029039|FG002|Part A2|Other|3|||
131657040|NCT02672852|474029040|FG003|Part A2|Other|0|||
131657041|NCT02672852|474029041|FG004|Part A2|Other|0|||
131657042|NCT02672852|474029042|FG005|Part A2|Other|0|||
131657043|NCT02672852|474029043|FG006|Part A2|Other|0|||
131657044|NCT02672852|474029037|FG000|Part A2|Not entered in Part B|0|||
131657045|NCT02672852|474029038|FG001|Part A2|Not entered in Part B|0|||
131657046|NCT02672852|474029039|FG002|Part A2|Not entered in Part B|0|||
131657047|NCT02672852|474029040|FG003|Part A2|Not entered in Part B|4|||
131657048|NCT02672852|474029041|FG004|Part A2|Not entered in Part B|0|||
131657049|NCT02672852|474029042|FG005|Part A2|Not entered in Part B|0|||
131657050|NCT02672852|474029043|FG006|Part A2|Not entered in Part B|0|||
131657051|NCT02672852|474029037|FG000|Part B|Disease worsening|0|||
131657052|NCT02672852|474029038|FG001|Part B|Disease worsening|0|||
131657053|NCT02672852|474029039|FG002|Part B|Disease worsening|0|||
131657054|NCT02672852|474029040|FG003|Part B|Disease worsening|0|||
131657055|NCT02672852|474029041|FG004|Part B|Disease worsening|1|||
131657056|NCT02672852|474029042|FG005|Part B|Disease worsening|0|||
131657057|NCT02672852|474029043|FG006|Part B|Disease worsening|1|||
131657058|NCT02672852|474029037|FG000|Part B|Worsening pre-existing condition|0|||
131657059|NCT02672852|474029038|FG001|Part B|Worsening pre-existing condition|0|||
131657060|NCT02672852|474029039|FG002|Part B|Worsening pre-existing condition|0|||
131657061|NCT02672852|474029040|FG003|Part B|Worsening pre-existing condition|0|||
131657062|NCT02672852|474029041|FG004|Part B|Worsening pre-existing condition|0|||
131657063|NCT02672852|474029042|FG005|Part B|Worsening pre-existing condition|1|||
131657064|NCT02672852|474029043|FG006|Part B|Worsening pre-existing condition|0|||
131657065|NCT02672852|474029037|FG000|Part B|Other adverse event|0|||
131657066|NCT02672852|474029038|FG001|Part B|Other adverse event|0|||
131657067|NCT02672852|474029039|FG002|Part B|Other adverse event|0|||
131657068|NCT02672852|474029040|FG003|Part B|Other adverse event|0|||
131657069|NCT02672852|474029041|FG004|Part B|Other adverse event|3|||
131657070|NCT02672852|474029042|FG005|Part B|Other adverse event|5|||
131657071|NCT02672852|474029043|FG006|Part B|Other adverse event|1|||
131657072|NCT02672852|474029037|FG000|Part B|Lost to Follow-up|0|||
131657073|NCT02672852|474029038|FG001|Part B|Lost to Follow-up|0|||
131657074|NCT02672852|474029039|FG002|Part B|Lost to Follow-up|0|||
131657075|NCT02672852|474029040|FG003|Part B|Lost to Follow-up|0|||
131657076|NCT02672852|474029041|FG004|Part B|Lost to Follow-up|3|||
131657077|NCT02672852|474029042|FG005|Part B|Lost to Follow-up|4|||
131657078|NCT02672852|474029043|FG006|Part B|Lost to Follow-up|1|||
131657079|NCT02672852|474029037|FG000|Part B|Withdrawal by Subject|0|||
131657080|NCT02672852|474029038|FG001|Part B|Withdrawal by Subject|0|||
131657081|NCT02672852|474029039|FG002|Part B|Withdrawal by Subject|0|||
131657082|NCT02672852|474029040|FG003|Part B|Withdrawal by Subject|0|||
131657083|NCT02672852|474029041|FG004|Part B|Withdrawal by Subject|5|||
131657084|NCT02672852|474029042|FG005|Part B|Withdrawal by Subject|0|||
131657085|NCT02672852|474029043|FG006|Part B|Withdrawal by Subject|7|||
131657086|NCT02672852|474029037|FG000|Part B|Other|0|||
131657087|NCT02672852|474029038|FG001|Part B|Other|0|||
131657088|NCT02672852|474029039|FG002|Part B|Other|0|||
131657089|NCT02672852|474029040|FG003|Part B|Other|0|||
131657090|NCT02672852|474029041|FG004|Part B|Other|4|||
131657091|NCT02672852|474029042|FG005|Part B|Other|1|||
131657092|NCT02672852|474029043|FG006|Part B|Other|2|||
131657093|NCT03853551|474029044|FG000|Overall Study|Death|2|||
131657094|NCT03853551|474029044|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
131657095|NCT00702962|474029045|FG000|Overall Study|Progressive disease|0|||
131657096|NCT00702962|474029046|FG001|Overall Study|Progressive disease|1|||
131657097|NCT00702962|474029045|FG000|Overall Study|Hospitalized for other health disorder|1|||
131657098|NCT00702962|474029046|FG001|Overall Study|Hospitalized for other health disorder|0|||
131657099|NCT02175641|474029047|FG000|Overall Study|Death|3|||
131657100|NCT02175641|474029048|FG001|Overall Study|Death|4|||
131657101|NCT02175641|474029047|FG000|Overall Study|Lost to Follow-up|4|||
131657102|NCT02175641|474029048|FG001|Overall Study|Lost to Follow-up|4|||
131657103|NCT02175641|474029047|FG000|Overall Study|Withdrawal by Subject|7|||
131657104|NCT02175641|474029048|FG001|Overall Study|Withdrawal by Subject|4|||
131657105|NCT02175641|474029047|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
131657106|NCT02175641|474029048|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
131657107|NCT02175641|474029047|FG000|Overall Study|Developed Contraindicated Condition|8|||
131657108|NCT02175641|474029048|FG001|Overall Study|Developed Contraindicated Condition|0|||
131657109|NCT01923467|474029050|FG000|Overall Study|Lost to Follow-up|62|||
131657110|NCT01923467|474029050|FG000|Overall Study|Subject non-interest|479|||
131657111|NCT01876901|474029051|FG000|Overall Study|Protocol Violation|10|||
131657112|NCT01876901|474029052|FG001|Overall Study|Protocol Violation|2|||
131657113|NCT01876901|474029051|FG000|Overall Study|No or other surgical intervention|7|||
131657114|NCT01876901|474029052|FG001|Overall Study|No or other surgical intervention|5|||
131657115|NCT02242097|474029053|FG000|Ibrutinib Treatment|Adverse Event|16|||
131657116|NCT02242097|474029053|FG000|Ibrutinib Treatment|Physician Decision|1|||
131657117|NCT02242097|474029053|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
131657118|NCT02242097|474029053|FG000|Ibrutinib Treatment|Death|1|||
131657119|NCT02242097|474029053|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
131657120|NCT02242097|474029053|FG000|Post Therapy Follow Up|Death|3|||
131657121|NCT02242097|474029053|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
131657122|NCT01598662|474029055|FG000|Overall Study|Lost to Follow-up|10|||
131657123|NCT01598662|474029056|FG001|Overall Study|Lost to Follow-up|17|||
131657124|NCT01598662|474029055|FG000|Overall Study|Physician Decision|1|||
131657125|NCT01598662|474029056|FG001|Overall Study|Physician Decision|2|||
131657126|NCT01598662|474029055|FG000|Overall Study|IUD expelled before month 6|0|||
131657127|NCT01598662|474029056|FG001|Overall Study|IUD expelled before month 6|2|||
131657128|NCT02574845|474029057|FG000|Overall Study|Consent withdrawn further participation|0|||
131657129|NCT02574845|474029058|FG001|Overall Study|Consent withdrawn further participation|0|||
131657130|NCT02574845|474029059|FG002|Overall Study|Consent withdrawn further participation|0|||
131657131|NCT02574845|474029060|FG003|Overall Study|Consent withdrawn further participation|0|||
131657132|NCT02574845|474029061|FG004|Overall Study|Consent withdrawn further participation|1|||
131657133|NCT02574845|474029062|FG005|Overall Study|Consent withdrawn further participation|0|||
131657134|NCT02574845|474029057|FG000|Overall Study|Adverse Event|0|||
131657135|NCT02574845|474029058|FG001|Overall Study|Adverse Event|1|||
131657136|NCT02574845|474029059|FG002|Overall Study|Adverse Event|0|||
131657137|NCT02574845|474029060|FG003|Overall Study|Adverse Event|0|||
131657138|NCT02574845|474029061|FG004|Overall Study|Adverse Event|0|||
131657139|NCT02574845|474029062|FG005|Overall Study|Adverse Event|1|||
131657140|NCT03435692|474029064|FG000|Overall Study|Lack of Efficacy|2|||
131657141|NCT03435692|474029065|FG001|Overall Study|Lack of Efficacy|2|||
131657142|NCT03435692|474029066|FG002|Overall Study|Lack of Efficacy|0|||
131657143|NCT02781090|474029067|FG000|3-Month Follow-Up|Missed Visit|20|||
131657144|NCT02781090|474029068|FG001|3-Month Follow-Up|Missed Visit|20|||
131657145|NCT02781090|474029067|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
131657146|NCT02781090|474029068|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
131657147|NCT02781090|474029067|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
131657148|NCT02781090|474029068|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
131657149|NCT02781090|474029067|FG000|3-Month Follow-Up|Death|1|||
131657150|NCT02781090|474029068|FG001|3-Month Follow-Up|Death|0|||
131657151|NCT02781090|474029067|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
131657152|NCT02781090|474029068|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
131657153|NCT02781090|474029067|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
131657154|NCT02781090|474029068|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
131657155|NCT02781090|474029067|FG000|6-Month Follow-Up|Death|0|||
131657156|NCT02781090|474029068|FG001|6-Month Follow-Up|Death|1|||
131657157|NCT01145898|474029069|FG000|3-year Treatment|medication change by treating physician|3|||
131657158|NCT01145898|474029070|FG001|3-year Treatment|medication change by treating physician|16|||
131657159|NCT01712061|474029071|FG000|Overall Study|Adverse Event|4|||
131657160|NCT01712061|474029072|FG001|Overall Study|Adverse Event|9|||
131657161|NCT01712061|474029073|FG002|Overall Study|Adverse Event|5|||
131657162|NCT01712061|474029071|FG000|Overall Study|Death|0|||
131657163|NCT01712061|474029072|FG001|Overall Study|Death|0|||
131657164|NCT01712061|474029073|FG002|Overall Study|Death|1|||
131657165|NCT01712061|474029071|FG000|Overall Study|Lost to Follow-up|1|||
131657166|NCT01712061|474029072|FG001|Overall Study|Lost to Follow-up|0|||
131657167|NCT01712061|474029073|FG002|Overall Study|Lost to Follow-up|1|||
131657168|NCT01712061|474029071|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
131657169|NCT01712061|474029072|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
131657170|NCT01712061|474029073|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
131657171|NCT01712061|474029071|FG000|Overall Study|Medication Error Without Associated AE|0|||
131657172|NCT01712061|474029072|FG001|Overall Study|Medication Error Without Associated AE|1|||
131657173|NCT01712061|474029073|FG002|Overall Study|Medication Error Without Associated AE|0|||
131657174|NCT01712061|474029071|FG000|Overall Study|Withdrawal by Subject|1|||
131657175|NCT01712061|474029072|FG001|Overall Study|Withdrawal by Subject|7|||
131657176|NCT01712061|474029073|FG002|Overall Study|Withdrawal by Subject|1|||
131657177|NCT01712061|474029071|FG000|Overall Study|Other|0|||
131657178|NCT01712061|474029072|FG001|Overall Study|Other|3|||
131657179|NCT01712061|474029073|FG002|Overall Study|Other|0|||
131657180|NCT00879775|474029074|FG000|Overall Study|Lost to Follow-up|2|||
131657181|NCT00879775|474029075|FG001|Overall Study|Lost to Follow-up|1|||
131657182|NCT02683785|474029078|FG000|Overall Study|Withdrawal by Subject|1|||
131657183|NCT02683785|474029079|FG001|Overall Study|Withdrawal by Subject|1|||
131657184|NCT02683785|474029078|FG000|Overall Study|Lost to Follow-up|0|||
131657185|NCT02683785|474029079|FG001|Overall Study|Lost to Follow-up|1|||
131657186|NCT02683785|474029078|FG000|Overall Study|Adverse Event|0|||
131657187|NCT02683785|474029079|FG001|Overall Study|Adverse Event|2|||
131657188|NCT01195623|474029080|FG000|Overall Study|Lost to Follow-up|35|||
131657189|NCT01195623|474029081|FG001|Overall Study|Lost to Follow-up|37|||
131657190|NCT01677767|474029087|FG000|Overall Study|Adverse Event|1|||
131657191|NCT01677767|474029087|FG000|Overall Study|Death|4|||
131657192|NCT01677767|474029087|FG000|Overall Study|Protocol Violation|4|||
131657193|NCT01677767|474029087|FG000|Overall Study|Withdrawal by Subject|10|||
131657194|NCT01677767|474029087|FG000|Overall Study|Non-compliance by the participants|3|||
131657195|NCT00842244|474029088|FG000|Overall Study|Death|3|||
131657196|NCT00842244|474029088|FG000|Overall Study|Withdrawal by Subject|1|||
131657197|NCT00842244|474029088|FG000|Overall Study|Other|17|||
131657198|NCT02233803|474029093|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
131657199|NCT02233803|474029094|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
131657200|NCT02233803|474029093|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
131657201|NCT02233803|474029094|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
131657202|NCT02233803|474029093|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
131657203|NCT02233803|474029094|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
131657204|NCT02233803|474029093|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
131657205|NCT02233803|474029094|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
131657206|NCT02233803|474029093|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
131657207|NCT02233803|474029094|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
131657208|NCT02233803|474029093|FG000|Washout Period (4-Wks)|Physician Decision|1|||
131657209|NCT02233803|474029094|FG001|Washout Period (4-Wks)|Physician Decision|0|||
131657210|NCT02233803|474029093|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
131657211|NCT02233803|474029094|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
131657212|NCT02233803|474029093|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
131657213|NCT02233803|474029094|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
131657214|NCT02233803|474029093|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
131657215|NCT02233803|474029094|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
131657216|NCT00757627|474029095|FG000|Overall Study|Adverse Event|15|||
131657217|NCT00757627|474029095|FG000|Overall Study|Lack of Efficacy|10|||
131657218|NCT00757627|474029095|FG000|Overall Study|Lost to Follow-up|28|||
131657219|NCT00757627|474029095|FG000|Overall Study|Withdrawal by Subject|27|||
131657220|NCT00757627|474029095|FG000|Overall Study|Other|1|||
131657221|NCT03846453|474029096|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
131657222|NCT03846453|474029097|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
131657223|NCT03846453|474029098|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
131657224|NCT03846453|474029096|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
131657225|NCT03846453|474029097|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
131657226|NCT03846453|474029098|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
131657227|NCT03846453|474029096|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
131657228|NCT03846453|474029097|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
131657229|NCT03846453|474029098|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
131657230|NCT03846453|474029096|FG000|Placebo Run-in (14 Days)|Other|2|||
131657231|NCT03846453|474029097|FG001|Placebo Run-in (14 Days)|Other|0|||
131657232|NCT03846453|474029098|FG002|Placebo Run-in (14 Days)|Other|0|||
131657233|NCT03846453|474029096|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
131657234|NCT03846453|474029097|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
131657235|NCT03846453|474029098|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
131657236|NCT03846453|474029096|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
131657237|NCT03846453|474029097|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
131657238|NCT03846453|474029098|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
131657239|NCT03846453|474029096|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
131657240|NCT03846453|474029097|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
131657241|NCT03846453|474029098|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
131657242|NCT03846453|474029096|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
131657243|NCT03846453|474029097|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
131657244|NCT03846453|474029098|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
131657245|NCT03846453|474029096|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
131657246|NCT03846453|474029097|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
131657247|NCT03846453|474029098|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
131657248|NCT00635661|474029099|FG000|Overall Study|Withdrawal by Subject|4|||
131657249|NCT00468143|474029102|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
131657250|NCT00468143|474029103|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
131657251|NCT00468143|474029102|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
131657252|NCT00468143|474029103|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
131657253|NCT01606670|474029104|FG000|Overall Study|Adverse Event|6|||
131657254|NCT01606670|474029104|FG000|Overall Study|Lack of Efficacy|2|||
131657255|NCT01606670|474029104|FG000|Overall Study|Lost to Follow-up|3|||
131657256|NCT01606670|474029104|FG000|Overall Study|Withdrawal by Subject|3|||
131657257|NCT01606670|474029104|FG000|Overall Study|Other Reason|2|||
131657258|NCT01559129|474029108|FG000|Treatment Phase|Adverse Event|0|||
131657259|NCT01559129|474029109|FG001|Treatment Phase|Adverse Event|2|||
131657260|NCT01559129|474029108|FG000|Treatment Phase|Progressive Disease|1|||
131657261|NCT01559129|474029109|FG001|Treatment Phase|Progressive Disease|1|||
131657262|NCT01559129|474029108|FG000|Treatment Phase|Lack of Efficacy|0|||
131657263|NCT01559129|474029109|FG001|Treatment Phase|Lack of Efficacy|1|||
131657264|NCT01559129|474029108|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
131657265|NCT01559129|474029109|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
131657266|NCT01559129|474029108|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
131657267|NCT01559129|474029109|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
131657268|NCT01559129|474029108|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
131657269|NCT01559129|474029109|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
131657270|NCT01559129|474029108|FG000|Open-label Extension Period|Adverse Event|1|||
131657271|NCT01559129|474029109|FG001|Open-label Extension Period|Adverse Event|0|||
131657272|NCT01559129|474029108|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
131657273|NCT01559129|474029109|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
131657274|NCT00368927|474029110|FG000|Overall Study|Lost to Follow-up|2|||
131657275|NCT00368927|474029111|FG001|Overall Study|Lost to Follow-up|0|||
131657276|NCT00368927|474029110|FG000|Overall Study|Adverse Event|1|||
131657277|NCT00368927|474029111|FG001|Overall Study|Adverse Event|1|||
131657278|NCT00368927|474029110|FG000|Overall Study|Withdrawal by Subject|1|||
131657279|NCT00368927|474029111|FG001|Overall Study|Withdrawal by Subject|2|||
131657280|NCT00368927|474029110|FG000|Overall Study|Physician Decision|1|||
131657281|NCT00368927|474029111|FG001|Overall Study|Physician Decision|0|||
131657282|NCT03525392|474029112|FG000|Overall Study|Adverse Event|1|||
131657283|NCT03525392|474029113|FG001|Overall Study|Adverse Event|0|||
131657284|NCT03525392|474029114|FG002|Overall Study|Adverse Event|2|||
131657285|NCT03525392|474029115|FG003|Overall Study|Adverse Event|0|||
131657286|NCT03525392|474029116|FG004|Overall Study|Adverse Event|0|||
131657287|NCT03525392|474029112|FG000|Overall Study|Progressive disease|0|||
131657288|NCT03525392|474029113|FG001|Overall Study|Progressive disease|1|||
131657289|NCT03525392|474029114|FG002|Overall Study|Progressive disease|1|||
131657290|NCT03525392|474029115|FG003|Overall Study|Progressive disease|3|||
131657291|NCT03525392|474029116|FG004|Overall Study|Progressive disease|1|||
131657292|NCT01946529|474029123|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
131657293|NCT01946529|474029124|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
131657294|NCT01946529|474029125|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
131657295|NCT01946529|474029123|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
131657296|NCT01946529|474029124|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
131657297|NCT01946529|474029125|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
131657298|NCT06655558|474029126|FG000|Overall Study|Protocol Violation|1|||
131657299|NCT03578887|474029127|FG000|Overall Study|Withdrawal by Subject|7|||
131657300|NCT03578887|474029128|FG001|Overall Study|Withdrawal by Subject|2|||
131657301|NCT03578887|474029129|FG002|Overall Study|Withdrawal by Subject|1|||
131657302|NCT03578887|474029127|FG000|Overall Study|Lost to Follow-up|13|||
131657303|NCT03578887|474029128|FG001|Overall Study|Lost to Follow-up|1|||
131657304|NCT03578887|474029129|FG002|Overall Study|Lost to Follow-up|4|||
131657305|NCT03578887|474029127|FG000|Overall Study|Physician Decision|0|||
131657306|NCT03578887|474029128|FG001|Overall Study|Physician Decision|1|||
131657307|NCT03578887|474029129|FG002|Overall Study|Physician Decision|1|||
131657308|NCT00387426|474030683|FG000|Overall Study|Lack of Response|7|||
131657309|NCT00387426|474030683|FG000|Overall Study|Toxicities|4|||
131657310|NCT00387426|474030683|FG000|Overall Study|Disease Progression|3|||
131657311|NCT00747227|474030690|FG000|Overall Study|Death|3|||
131657312|NCT00747227|474030691|FG001|Overall Study|Death|1|||
131657313|NCT00747227|474030690|FG000|Overall Study|Withdrawal by Subject|1|||
131657314|NCT00747227|474030691|FG001|Overall Study|Withdrawal by Subject|0|||
131657315|NCT00747227|474030690|FG000|Overall Study|Lost to Follow-up|1|||
131657316|NCT00747227|474030691|FG001|Overall Study|Lost to Follow-up|2|||
131657317|NCT00747227|474030690|FG000|Overall Study|Illness|1|||
131657318|NCT00747227|474030691|FG001|Overall Study|Illness|1|||
131657319|NCT03554629|474030692|FG000|Overall Study|Inadequate data|6|||
131657320|NCT00918879|474030693|FG000|Overall Study|Withdrawal by Subject|4|||
131657321|NCT00918879|474030694|FG001|Overall Study|Withdrawal by Subject|4|||
131657322|NCT00918879|474030693|FG000|Overall Study|Lost to Follow-up|1|||
131657323|NCT00918879|474030694|FG001|Overall Study|Lost to Follow-up|1|||
131657324|NCT00918879|474030693|FG000|Overall Study|Severe non-compliance to protocol|1|||
131657325|NCT00918879|474030694|FG001|Overall Study|Severe non-compliance to protocol|1|||
131657326|NCT00357110|474030695|FG000|Overall Study|Early study termination|5|||
131657327|NCT00357110|474030696|FG001|Overall Study|Early study termination|5|||
131657328|NCT01008553|474030697|FG000|Period 1 (Titration Period)|Physician Decision|2|||
131657329|NCT01008553|474030698|FG001|Period 1 (Titration Period)|Physician Decision|0|||
131657330|NCT01008553|474030699|FG002|Period 1 (Titration Period)|Physician Decision|0|||
131657331|NCT01008553|474030697|FG000|Period 1 (Titration Period)|Adverse Event|33|||
131657332|NCT01008553|474030698|FG001|Period 1 (Titration Period)|Adverse Event|0|||
131657333|NCT01008553|474030699|FG002|Period 1 (Titration Period)|Adverse Event|0|||
131657334|NCT01008553|474030697|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
131657335|NCT01008553|474030698|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
131657336|NCT01008553|474030699|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
131657337|NCT01008553|474030697|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
131657338|NCT01008553|474030698|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
131657339|NCT01008553|474030699|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
131657340|NCT01008553|474030697|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
131657341|NCT01008553|474030698|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
131657342|NCT01008553|474030699|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
131657343|NCT01008553|474030697|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
131657344|NCT01008553|474030698|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
131657345|NCT01008553|474030699|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
131657346|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
131657347|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
131657348|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
131657349|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
131657350|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
131657351|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
131657352|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
131657353|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
131657354|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
131657355|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
131657356|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
131657357|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
131657358|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
131657359|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
131657360|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
131657361|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
131657362|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
131657363|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
131657364|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
131657365|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
131657366|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
131657367|NCT01008553|474030697|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
131657368|NCT01008553|474030698|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
131657369|NCT01008553|474030699|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
131657370|NCT01008410|474030701|FG000|Overall Study|Adverse Event|13|||
131657371|NCT01008410|474030702|FG001|Overall Study|Adverse Event|7|||
131657372|NCT01008410|474030701|FG000|Overall Study|Withdrawal by Subject|6|||
131657373|NCT01008410|474030702|FG001|Overall Study|Withdrawal by Subject|2|||
131657374|NCT01008410|474030701|FG000|Overall Study|Lost to Follow-up|1|||
131657375|NCT01008410|474030702|FG001|Overall Study|Lost to Follow-up|0|||
131657376|NCT01008410|474030701|FG000|Overall Study|Noncompliance|1|||
131657377|NCT01008410|474030702|FG001|Overall Study|Noncompliance|0|||
131657378|NCT01008410|474030701|FG000|Overall Study|Low Cortisol|2|||
131657379|NCT01008410|474030702|FG001|Overall Study|Low Cortisol|0|||
131657380|NCT01008410|474030701|FG000|Overall Study|Lack of Efficacy|2|||
131657381|NCT01008410|474030702|FG001|Overall Study|Lack of Efficacy|6|||
131657382|NCT01008410|474030701|FG000|Overall Study|Met Exclusion Criterion|0|||
131657383|NCT01008410|474030702|FG001|Overall Study|Met Exclusion Criterion|1|||
131657384|NCT03056300|474030705|FG000|Overall Study|Surgical reason per study protocol|3|||
131657385|NCT03563157|474030706|FG000|Overall Study|Progressive Disease|2|||
131657386|NCT05602727|474030709|FG000|Overall Study|Physician Decision|0|||
131657387|NCT05602727|474030710|FG001|Overall Study|Physician Decision|1|||
131657388|NCT05602727|474030711|FG002|Overall Study|Physician Decision|0|||
131657389|NCT05602727|474030709|FG000|Overall Study|Randomized by mistake without study medication|1|||
131657390|NCT05602727|474030710|FG001|Overall Study|Randomized by mistake without study medication|0|||
131657391|NCT05602727|474030711|FG002|Overall Study|Randomized by mistake without study medication|0|||
131657392|NCT05602727|474030709|FG000|Overall Study|Study termination by Sponsor|18|||
131657393|NCT05602727|474030710|FG001|Overall Study|Study termination by Sponsor|15|||
131657394|NCT05602727|474030711|FG002|Overall Study|Study termination by Sponsor|19|||
131657395|NCT05602727|474030709|FG000|Overall Study|Withdrawal by Subject|2|||
131657396|NCT05602727|474030710|FG001|Overall Study|Withdrawal by Subject|1|||
131657397|NCT05602727|474030711|FG002|Overall Study|Withdrawal by Subject|1|||
131657398|NCT05602727|474030709|FG000|Overall Study|Various reasons|1|||
131657399|NCT05602727|474030710|FG001|Overall Study|Various reasons|6|||
131657400|NCT05602727|474030711|FG002|Overall Study|Various reasons|1|||
131657401|NCT02187159|474030712|FG000|Overall Study|Protocol Violation|4|||
131657402|NCT02187159|474030713|FG001|Overall Study|Protocol Violation|6|||
131657403|NCT02187159|474030714|FG002|Overall Study|Protocol Violation|3|||
131657404|NCT02187159|474030715|FG003|Overall Study|Protocol Violation|4|||
131657405|NCT02187159|474030712|FG000|Overall Study|Lack of Efficacy|10|||
131657406|NCT02187159|474030713|FG001|Overall Study|Lack of Efficacy|5|||
131657407|NCT02187159|474030714|FG002|Overall Study|Lack of Efficacy|4|||
131657408|NCT02187159|474030715|FG003|Overall Study|Lack of Efficacy|7|||
131657409|NCT02187159|474030712|FG000|Overall Study|Adverse Event|28|||
131657410|NCT02187159|474030713|FG001|Overall Study|Adverse Event|33|||
131657411|NCT02187159|474030714|FG002|Overall Study|Adverse Event|42|||
131657412|NCT02187159|474030715|FG003|Overall Study|Adverse Event|50|||
131657413|NCT02187159|474030712|FG000|Overall Study|Withdrawal by Subject|24|||
131657414|NCT02187159|474030713|FG001|Overall Study|Withdrawal by Subject|28|||
131657415|NCT02187159|474030714|FG002|Overall Study|Withdrawal by Subject|25|||
131657416|NCT02187159|474030715|FG003|Overall Study|Withdrawal by Subject|26|||
131657417|NCT02187159|474030712|FG000|Overall Study|Other|3|||
131657418|NCT02187159|474030713|FG001|Overall Study|Other|7|||
131657419|NCT02187159|474030714|FG002|Overall Study|Other|3|||
131657420|NCT02187159|474030715|FG003|Overall Study|Other|9|||
131657421|NCT04020185|474030716|FG000|Overall Study|Death|0|||
131657422|NCT04020185|474030717|FG001|Overall Study|Death|0|||
131657423|NCT04020185|474030718|FG002|Overall Study|Death|1|||
131657424|NCT04020185|474030719|FG003|Overall Study|Death|2|||
131657425|NCT04020185|474030720|FG004|Overall Study|Death|1|||
131657426|NCT04020185|474030721|FG005|Overall Study|Death|0|||
131657427|NCT04020185|474030722|FG006|Overall Study|Death|1|||
131657428|NCT04020185|474030723|FG007|Overall Study|Death|0|||
131657429|NCT04020185|474030716|FG000|Overall Study|Consent withdrawn|1|||
131657430|NCT04020185|474030717|FG001|Overall Study|Consent withdrawn|0|||
131657431|NCT04020185|474030718|FG002|Overall Study|Consent withdrawn|0|||
131657432|NCT04020185|474030719|FG003|Overall Study|Consent withdrawn|0|||
131657433|NCT04020185|474030720|FG004|Overall Study|Consent withdrawn|2|||
131657434|NCT04020185|474030721|FG005|Overall Study|Consent withdrawn|0|||
131657435|NCT04020185|474030722|FG006|Overall Study|Consent withdrawn|1|||
131657436|NCT04020185|474030723|FG007|Overall Study|Consent withdrawn|1|||
131657437|NCT04020185|474030716|FG000|Overall Study|Patient in hospice|0|||
131657438|NCT04020185|474030717|FG001|Overall Study|Patient in hospice|1|||
131657439|NCT04020185|474030718|FG002|Overall Study|Patient in hospice|0|||
131657440|NCT04020185|474030719|FG003|Overall Study|Patient in hospice|0|||
131657441|NCT04020185|474030720|FG004|Overall Study|Patient in hospice|0|||
131657442|NCT04020185|474030721|FG005|Overall Study|Patient in hospice|0|||
131657443|NCT04020185|474030722|FG006|Overall Study|Patient in hospice|0|||
131657444|NCT04020185|474030723|FG007|Overall Study|Patient in hospice|0|||
131657445|NCT04020185|474030716|FG000|Overall Study|Continuing on expanded access|0|||
131657446|NCT04020185|474030717|FG001|Overall Study|Continuing on expanded access|0|||
131657447|NCT04020185|474030718|FG002|Overall Study|Continuing on expanded access|0|||
131657448|NCT04020185|474030719|FG003|Overall Study|Continuing on expanded access|0|||
131657449|NCT04020185|474030720|FG004|Overall Study|Continuing on expanded access|0|||
131657450|NCT04020185|474030721|FG005|Overall Study|Continuing on expanded access|0|||
131657451|NCT04020185|474030722|FG006|Overall Study|Continuing on expanded access|1|||
131657452|NCT04020185|474030723|FG007|Overall Study|Continuing on expanded access|1|||
131657453|NCT00567567|474030724|FG000|Overall Study|Adverse Event|0|||
131657454|NCT00567567|474030725|FG001|Overall Study|Adverse Event|2|||
131657455|NCT00567567|474030726|FG002|Overall Study|Adverse Event|5|||
131657456|NCT00567567|474030724|FG000|Overall Study|Death|8|||
131657457|NCT00567567|474030725|FG001|Overall Study|Death|1|||
131657458|NCT00567567|474030726|FG002|Overall Study|Death|5|||
131657459|NCT00567567|474030724|FG000|Overall Study|Lack of Efficacy|16|||
131657460|NCT00567567|474030725|FG001|Overall Study|Lack of Efficacy|17|||
131657461|NCT00567567|474030726|FG002|Overall Study|Lack of Efficacy|48|||
131657462|NCT00567567|474030724|FG000|Overall Study|Lost to Follow-up|0|||
131657463|NCT00567567|474030725|FG001|Overall Study|Lost to Follow-up|0|||
131657464|NCT00567567|474030726|FG002|Overall Study|Lost to Follow-up|1|||
131657465|NCT00567567|474030724|FG000|Overall Study|Physician Decision|16|||
131657466|NCT00567567|474030725|FG001|Overall Study|Physician Decision|18|||
131657467|NCT00567567|474030726|FG002|Overall Study|Physician Decision|84|||
131657468|NCT00567567|474030724|FG000|Overall Study|Withdrawal by Subject|0|||
131657469|NCT00567567|474030725|FG001|Overall Study|Withdrawal by Subject|0|||
131657470|NCT00567567|474030726|FG002|Overall Study|Withdrawal by Subject|2|||
131657471|NCT00567567|474030724|FG000|Overall Study|Ineligible|4|||
131657472|NCT00567567|474030725|FG001|Overall Study|Ineligible|0|||
131657473|NCT00567567|474030726|FG002|Overall Study|Ineligible|9|||
131657474|NCT00567567|474030724|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
131657475|NCT00567567|474030725|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
131657476|NCT00567567|474030726|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
131657477|NCT00567567|474030724|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
131657478|NCT00567567|474030725|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
131657479|NCT00567567|474030726|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
131657480|NCT00567567|474030724|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
131657481|NCT00567567|474030725|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
131657482|NCT00567567|474030726|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
131657483|NCT03433677|474030727|FG000|Period 1|Protocol Violation|1|||
131657484|NCT03433677|474030728|FG001|Period 1|Protocol Violation|0|||
131657485|NCT03433677|474030727|FG000|Period 2|Withdrawal by Subject|1|||
131657486|NCT03433677|474030728|FG001|Period 2|Withdrawal by Subject|1|||
131657487|NCT03330405|474030729|FG000|Overall Study|Other|1|||
131657488|NCT03330405|474030730|FG001|Overall Study|Other|3|||
131657489|NCT03330405|474030731|FG002|Overall Study|Other|1|||
131657490|NCT03330405|474030732|FG003|Overall Study|Other|0|||
131657491|NCT03330405|474030733|FG004|Overall Study|Other|2|||
131657492|NCT03330405|474030734|FG005|Overall Study|Other|0|||
131657493|NCT03330405|474030735|FG006|Overall Study|Other|1|||
131657494|NCT03330405|474030736|FG007|Overall Study|Other|0|||
131657495|NCT03330405|474030737|FG008|Overall Study|Other|0|||
131657496|NCT03330405|474030738|FG009|Overall Study|Other|0|||
131657497|NCT03330405|474030739|FG010|Overall Study|Other|0|||
131657498|NCT03330405|474030729|FG000|Overall Study|Progressive disease|8|||
131657499|NCT03330405|474030730|FG001|Overall Study|Progressive disease|27|||
131657500|NCT03330405|474030731|FG002|Overall Study|Progressive disease|4|||
131657501|NCT03330405|474030732|FG003|Overall Study|Progressive disease|18|||
131657502|NCT03330405|474030733|FG004|Overall Study|Progressive disease|16|||
131657503|NCT03330405|474030734|FG005|Overall Study|Progressive disease|14|||
131657504|NCT03330405|474030735|FG006|Overall Study|Progressive disease|7|||
131657505|NCT03330405|474030736|FG007|Overall Study|Progressive disease|29|||
131657506|NCT03330405|474030737|FG008|Overall Study|Progressive disease|9|||
131657507|NCT03330405|474030738|FG009|Overall Study|Progressive disease|11|||
131657508|NCT03330405|474030739|FG010|Overall Study|Progressive disease|5|||
131657509|NCT03330405|474030729|FG000|Overall Study|Withdrawal by Subject|1|||
131657510|NCT03330405|474030730|FG001|Overall Study|Withdrawal by Subject|4|||
131657511|NCT03330405|474030731|FG002|Overall Study|Withdrawal by Subject|0|||
131657512|NCT03330405|474030732|FG003|Overall Study|Withdrawal by Subject|1|||
131657513|NCT03330405|474030733|FG004|Overall Study|Withdrawal by Subject|1|||
131657514|NCT03330405|474030734|FG005|Overall Study|Withdrawal by Subject|1|||
131657515|NCT03330405|474030735|FG006|Overall Study|Withdrawal by Subject|0|||
131657516|NCT03330405|474030736|FG007|Overall Study|Withdrawal by Subject|2|||
131657517|NCT03330405|474030737|FG008|Overall Study|Withdrawal by Subject|2|||
131657518|NCT03330405|474030738|FG009|Overall Study|Withdrawal by Subject|1|||
131657519|NCT03330405|474030739|FG010|Overall Study|Withdrawal by Subject|1|||
131657520|NCT03330405|474030729|FG000|Overall Study|Global deterioration of health status|2|||
131657521|NCT03330405|474030730|FG001|Overall Study|Global deterioration of health status|3|||
131657522|NCT03330405|474030731|FG002|Overall Study|Global deterioration of health status|0|||
131657523|NCT03330405|474030732|FG003|Overall Study|Global deterioration of health status|2|||
131658611|NCT02003222|474035397|FG002|Induction|Disease progression|0|||
131657524|NCT03330405|474030733|FG004|Overall Study|Global deterioration of health status|3|||
131657525|NCT03330405|474030734|FG005|Overall Study|Global deterioration of health status|3|||
131657526|NCT03330405|474030735|FG006|Overall Study|Global deterioration of health status|0|||
131657527|NCT03330405|474030736|FG007|Overall Study|Global deterioration of health status|2|||
131657528|NCT03330405|474030737|FG008|Overall Study|Global deterioration of health status|8|||
131657529|NCT03330405|474030738|FG009|Overall Study|Global deterioration of health status|4|||
131657530|NCT03330405|474030739|FG010|Overall Study|Global deterioration of health status|1|||
131657531|NCT03330405|474030729|FG000|Overall Study|Adverse Event|0|||
131657532|NCT03330405|474030730|FG001|Overall Study|Adverse Event|1|||
131657533|NCT03330405|474030731|FG002|Overall Study|Adverse Event|0|||
131657534|NCT03330405|474030732|FG003|Overall Study|Adverse Event|1|||
131657535|NCT03330405|474030733|FG004|Overall Study|Adverse Event|1|||
131657536|NCT03330405|474030734|FG005|Overall Study|Adverse Event|1|||
131657537|NCT03330405|474030735|FG006|Overall Study|Adverse Event|3|||
131657538|NCT03330405|474030736|FG007|Overall Study|Adverse Event|4|||
131657539|NCT03330405|474030737|FG008|Overall Study|Adverse Event|2|||
131657540|NCT03330405|474030738|FG009|Overall Study|Adverse Event|2|||
131657541|NCT03330405|474030739|FG010|Overall Study|Adverse Event|2|||
131657542|NCT03330405|474030729|FG000|Overall Study|Death|0|||
131657543|NCT03330405|474030730|FG001|Overall Study|Death|4|||
131657544|NCT03330405|474030731|FG002|Overall Study|Death|0|||
131657545|NCT03330405|474030732|FG003|Overall Study|Death|0|||
131657546|NCT03330405|474030733|FG004|Overall Study|Death|0|||
131657547|NCT03330405|474030734|FG005|Overall Study|Death|1|||
131657548|NCT03330405|474030735|FG006|Overall Study|Death|0|||
131657549|NCT03330405|474030736|FG007|Overall Study|Death|2|||
131657550|NCT03330405|474030737|FG008|Overall Study|Death|0|||
131657551|NCT03330405|474030738|FG009|Overall Study|Death|0|||
131657552|NCT03330405|474030739|FG010|Overall Study|Death|0|||
131657553|NCT03330405|474030729|FG000|Overall Study|Physician Decision|0|||
131657554|NCT03330405|474030730|FG001|Overall Study|Physician Decision|0|||
131657555|NCT03330405|474030731|FG002|Overall Study|Physician Decision|0|||
131657556|NCT03330405|474030732|FG003|Overall Study|Physician Decision|0|||
131657557|NCT03330405|474030733|FG004|Overall Study|Physician Decision|0|||
131657558|NCT03330405|474030734|FG005|Overall Study|Physician Decision|0|||
131657559|NCT03330405|474030735|FG006|Overall Study|Physician Decision|0|||
131657560|NCT03330405|474030736|FG007|Overall Study|Physician Decision|1|||
131657561|NCT03330405|474030737|FG008|Overall Study|Physician Decision|0|||
131657562|NCT03330405|474030738|FG009|Overall Study|Physician Decision|0|||
131657563|NCT03330405|474030739|FG010|Overall Study|Physician Decision|0|||
131657564|NCT03889704|474030740|FG000|Overall Study|Study terminated due to pandemic|1|||
131657565|NCT03482466|474030741|FG000|Overall Study|Protocol Violation|2|||
131657566|NCT04335591|474030742|FG000|Overall Study|Adverse Event|5|||
131657567|NCT04335591|474030743|FG001|Overall Study|Adverse Event|2|||
131657568|NCT04335591|474030744|FG002|Overall Study|Adverse Event|3|||
131657569|NCT04335591|474030745|FG003|Overall Study|Adverse Event|2|||
131657570|NCT04335591|474030742|FG000|Overall Study|Protocol Violation|1|||
131657571|NCT04335591|474030743|FG001|Overall Study|Protocol Violation|0|||
131657572|NCT04335591|474030744|FG002|Overall Study|Protocol Violation|0|||
131657573|NCT04335591|474030745|FG003|Overall Study|Protocol Violation|0|||
131657574|NCT04335591|474030742|FG000|Overall Study|Withdrawal by Subject|8|||
131657575|NCT04335591|474030743|FG001|Overall Study|Withdrawal by Subject|4|||
131657576|NCT04335591|474030744|FG002|Overall Study|Withdrawal by Subject|4|||
131657577|NCT04335591|474030745|FG003|Overall Study|Withdrawal by Subject|5|||
131657578|NCT04335591|474030742|FG000|Overall Study|Subject planning pregnancy|0|||
131657579|NCT04335591|474030743|FG001|Overall Study|Subject planning pregnancy|1|||
131657580|NCT04335591|474030744|FG002|Overall Study|Subject planning pregnancy|0|||
131657581|NCT04335591|474030745|FG003|Overall Study|Subject planning pregnancy|0|||
131657582|NCT04335591|474030742|FG000|Overall Study|Ukrainian Russian war conflict|4|||
131657583|NCT04335591|474030743|FG001|Overall Study|Ukrainian Russian war conflict|5|||
131657584|NCT04335591|474030744|FG002|Overall Study|Ukrainian Russian war conflict|2|||
131657585|NCT04335591|474030745|FG003|Overall Study|Ukrainian Russian war conflict|0|||
131657586|NCT03268603|474030746|FG000|Overall Study|Withdrawal by Subject|6|||
131657587|NCT03268603|474030746|FG000|Overall Study|Physician Decision|1|||
131657588|NCT03268603|474030746|FG000|Overall Study|Withdrawn due to disease progression|2|||
131657589|NCT02060370|474030747|FG000|Overall Study|Physician Decision|1|||
131657590|NCT00356408|474030748|FG000|Overall Study|Adverse Event|9|||
131657591|NCT00356408|474030748|FG000|Overall Study|Lack of Efficacy|36|||
131657592|NCT00356408|474030748|FG000|Overall Study|Lost to Follow-up|2|||
131657593|NCT00356408|474030748|FG000|Overall Study|Withdrawal by Subject|6|||
131657594|NCT00356408|474030748|FG000|Overall Study|Other: Principal investigator discretion|3|||
131657595|NCT00356408|474030748|FG000|Overall Study|Other: Sponsor request|1|||
131657596|NCT00356408|474030748|FG000|Overall Study|Other: Azathioprine stopped|1|||
131657597|NCT00356408|474030748|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
131657598|NCT00356408|474030748|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
131657599|NCT05487586|474030750|FG000|Overall Study|Death|22|||
131657600|NCT05487586|474030750|FG000|Overall Study|Physician Decision|1|||
131657601|NCT05487586|474030750|FG000|Overall Study|Transfer to another hospital|4|||
131657602|NCT05487586|474030750|FG000|Overall Study|Other|1|||
131657603|NCT01493427|474030751|FG000|Overall Study|Adverse Event|10|||
131657604|NCT01493427|474030751|FG000|Overall Study|Personal Reasons|4|||
131657605|NCT01493427|474030751|FG000|Overall Study|Lost to Follow-up|2|||
131657606|NCT01493427|474030751|FG000|Overall Study|Inability to Follow Instructions|2|||
131657607|NCT01493427|474030751|FG000|Overall Study|Other|2|||
131657608|NCT00565773|474030752|FG000|Overall Study|Withdrawal by Subject|1|||
131657609|NCT00565773|474030752|FG000|Overall Study|Physician Decision|1|||
131657610|NCT04798781|474030753|FG000|Overall Study|Withdrawal by Subject|1|||
131657611|NCT05775991|474030754|FG000|Overall Study|Withdrawal by Subject|0|||
131657612|NCT05775991|474030755|FG001|Overall Study|Withdrawal by Subject|0|||
131657613|NCT05775991|474030756|FG002|Overall Study|Withdrawal by Subject|2|||
131657614|NCT03921723|474030759|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
131657615|NCT03921723|474030759|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
131657616|NCT01461811|474030760|FG000|Overall Study|Adverse Event|2|||
131657617|NCT01461811|474030761|FG001|Overall Study|Adverse Event|1|||
131657618|NCT01461811|474030760|FG000|Overall Study|Subject decision unrelated to an AE|1|||
131657619|NCT01461811|474030761|FG001|Overall Study|Subject decision unrelated to an AE|1|||
131657620|NCT01461811|474030760|FG000|Overall Study|Noncompliance|1|||
131657621|NCT01461811|474030761|FG001|Overall Study|Noncompliance|1|||
131657622|NCT03015129|474030762|FG000|Overall Study|Death|2|||
131657623|NCT03015129|474030763|FG001|Overall Study|Death|2|||
131657624|NCT03015129|474030762|FG000|Overall Study|Lost to Follow-up|0|||
131657625|NCT03015129|474030763|FG001|Overall Study|Lost to Follow-up|1|||
131657626|NCT03015129|474030762|FG000|Overall Study|Progression of disease|38|||
131657627|NCT03015129|474030763|FG001|Overall Study|Progression of disease|33|||
131657628|NCT03015129|474030762|FG000|Overall Study|Adverse Event|0|||
131657629|NCT03015129|474030763|FG001|Overall Study|Adverse Event|4|||
131657630|NCT00406692|474030769|FG000|Overall Study|Withdrawal by Subject|4|||
131657631|NCT00406692|474030769|FG000|Overall Study|Physician Decision|1|||
131657632|NCT00406692|474030769|FG000|Overall Study|Adverse Event|1|||
131657633|NCT00406692|474030769|FG000|Overall Study|Lack of Efficacy|1|||
131657634|NCT00821587|474030770|FG000|Overall Study|Physician Decision|0|||
131657635|NCT00821587|474030771|FG001|Overall Study|Physician Decision|1|||
131657636|NCT00643617|474030774|FG000|Overall Study|Death|6|||
131657637|NCT00643617|474030775|FG001|Overall Study|Death|9|||
131657638|NCT00643617|474030774|FG000|Overall Study|Lost to Follow-up|42|||
131657639|NCT00643617|474030775|FG001|Overall Study|Lost to Follow-up|51|||
131657640|NCT04958200|474030782|FG000|Overall Study|Withdrawal by Subject|0|||
131657641|NCT04958200|474030783|FG001|Overall Study|Withdrawal by Subject|2|||
131657642|NCT04958200|474030782|FG000|Overall Study|Lost to Follow-up|3|||
131657643|NCT04958200|474030783|FG001|Overall Study|Lost to Follow-up|2|||
131657644|NCT04531098|474030784|FG000|Stage I|Adverse Event|0|||
131657645|NCT04531098|474030785|FG001|Stage I|Adverse Event|0|||
131657646|NCT04531098|474030786|FG002|Stage I|Adverse Event|3|||
131657647|NCT04531098|474030784|FG000|Stage I|Protocol Violation|0|||
131657648|NCT04531098|474030785|FG001|Stage I|Protocol Violation|0|||
131657649|NCT04531098|474030786|FG002|Stage I|Protocol Violation|5|||
131657650|NCT04531098|474030784|FG000|Stage I|Withdrawal by Subject|0|||
131657651|NCT04531098|474030785|FG001|Stage I|Withdrawal by Subject|5|||
131657652|NCT04531098|474030786|FG002|Stage I|Withdrawal by Subject|10|||
131657653|NCT04531098|474030784|FG000|Stage II|Adverse Event|1|||
131657654|NCT04531098|474030785|FG001|Stage II|Adverse Event|2|||
131657655|NCT04531098|474030786|FG002|Stage II|Adverse Event|0|||
131657656|NCT04531098|474030784|FG000|Stage II|Protocol Violation|1|||
131657657|NCT04531098|474030785|FG001|Stage II|Protocol Violation|2|||
131657658|NCT04531098|474030786|FG002|Stage II|Protocol Violation|0|||
131657659|NCT04531098|474030784|FG000|Stage II|Withdrawal by Subject|3|||
131657660|NCT04531098|474030785|FG001|Stage II|Withdrawal by Subject|1|||
131657661|NCT04531098|474030786|FG002|Stage II|Withdrawal by Subject|0|||
131657662|NCT04531098|474030784|FG000|Stage II|Moved from study area|8|||
131657663|NCT04531098|474030785|FG001|Stage II|Moved from study area|5|||
131657664|NCT04531098|474030786|FG002|Stage II|Moved from study area|0|||
131657665|NCT02628028|474030787|FG000|Dosing Period|Withdrawal by Subject|0|||
131657666|NCT02628028|474030788|FG001|Dosing Period|Withdrawal by Subject|0|||
131657667|NCT02628028|474030789|FG002|Dosing Period|Withdrawal by Subject|1|||
131657668|NCT02628028|474030790|FG003|Dosing Period|Withdrawal by Subject|0|||
131657669|NCT02628028|474030791|FG004|Dosing Period|Withdrawal by Subject|2|||
131657670|NCT02628028|474030792|FG005|Dosing Period|Withdrawal by Subject|4|||
131657671|NCT02628028|474030793|FG006|Dosing Period|Withdrawal by Subject|1|||
131657672|NCT02628028|474030794|FG007|Dosing Period|Withdrawal by Subject|1|||
131657673|NCT02628028|474030787|FG000|Dosing Period|Adverse Event|0|||
131657674|NCT02628028|474030788|FG001|Dosing Period|Adverse Event|0|||
131657675|NCT02628028|474030789|FG002|Dosing Period|Adverse Event|0|||
131657676|NCT02628028|474030790|FG003|Dosing Period|Adverse Event|0|||
131657677|NCT02628028|474030791|FG004|Dosing Period|Adverse Event|2|||
131657678|NCT02628028|474030792|FG005|Dosing Period|Adverse Event|1|||
131657679|NCT02628028|474030793|FG006|Dosing Period|Adverse Event|3|||
131657680|NCT02628028|474030794|FG007|Dosing Period|Adverse Event|2|||
131657681|NCT02628028|474030787|FG000|Dosing Period|Death|0|||
131657682|NCT02628028|474030788|FG001|Dosing Period|Death|0|||
131657683|NCT02628028|474030789|FG002|Dosing Period|Death|0|||
131657684|NCT02628028|474030790|FG003|Dosing Period|Death|0|||
131657685|NCT02628028|474030791|FG004|Dosing Period|Death|0|||
131657686|NCT02628028|474030792|FG005|Dosing Period|Death|0|||
131657687|NCT02628028|474030793|FG006|Dosing Period|Death|0|||
131657688|NCT02628028|474030794|FG007|Dosing Period|Death|1|||
131657689|NCT02628028|474030787|FG000|Dosing Period|Lack of Efficacy|0|||
131657690|NCT02628028|474030788|FG001|Dosing Period|Lack of Efficacy|0|||
131657691|NCT02628028|474030789|FG002|Dosing Period|Lack of Efficacy|0|||
131657692|NCT02628028|474030790|FG003|Dosing Period|Lack of Efficacy|0|||
131657693|NCT02628028|474030791|FG004|Dosing Period|Lack of Efficacy|3|||
131657694|NCT02628028|474030792|FG005|Dosing Period|Lack of Efficacy|0|||
131657695|NCT02628028|474030793|FG006|Dosing Period|Lack of Efficacy|1|||
131657696|NCT02628028|474030794|FG007|Dosing Period|Lack of Efficacy|0|||
131657697|NCT02628028|474030787|FG000|Dosing Period|Study Terminated by Sponsor|0|||
131657698|NCT02628028|474030788|FG001|Dosing Period|Study Terminated by Sponsor|0|||
131657699|NCT02628028|474030789|FG002|Dosing Period|Study Terminated by Sponsor|0|||
131657700|NCT02628028|474030790|FG003|Dosing Period|Study Terminated by Sponsor|0|||
131657701|NCT02628028|474030791|FG004|Dosing Period|Study Terminated by Sponsor|7|||
131657702|NCT02628028|474030792|FG005|Dosing Period|Study Terminated by Sponsor|6|||
131657703|NCT02628028|474030793|FG006|Dosing Period|Study Terminated by Sponsor|7|||
131657704|NCT02628028|474030794|FG007|Dosing Period|Study Terminated by Sponsor|7|||
131657705|NCT02628028|474030787|FG000|Dosing Period|Physician Decision|0|||
131657706|NCT02628028|474030788|FG001|Dosing Period|Physician Decision|0|||
131657707|NCT02628028|474030789|FG002|Dosing Period|Physician Decision|0|||
131657708|NCT02628028|474030790|FG003|Dosing Period|Physician Decision|0|||
131657709|NCT02628028|474030791|FG004|Dosing Period|Physician Decision|0|||
131657710|NCT02628028|474030792|FG005|Dosing Period|Physician Decision|1|||
131657711|NCT02628028|474030793|FG006|Dosing Period|Physician Decision|0|||
131657712|NCT02628028|474030794|FG007|Dosing Period|Physician Decision|0|||
131657713|NCT02628028|474030787|FG000|Dosing Period|Site Terminated by Sponsor|0|||
131657714|NCT02628028|474030788|FG001|Dosing Period|Site Terminated by Sponsor|0|||
131657715|NCT02628028|474030789|FG002|Dosing Period|Site Terminated by Sponsor|0|||
131657716|NCT02628028|474030790|FG003|Dosing Period|Site Terminated by Sponsor|0|||
131657717|NCT02628028|474030791|FG004|Dosing Period|Site Terminated by Sponsor|0|||
131657718|NCT02628028|474030792|FG005|Dosing Period|Site Terminated by Sponsor|1|||
131657719|NCT02628028|474030793|FG006|Dosing Period|Site Terminated by Sponsor|1|||
131657720|NCT02628028|474030794|FG007|Dosing Period|Site Terminated by Sponsor|0|||
131657721|NCT02628028|474030787|FG000|Dosing Period|Lost to Follow-up|0|||
131657722|NCT02628028|474030788|FG001|Dosing Period|Lost to Follow-up|0|||
131657723|NCT02628028|474030789|FG002|Dosing Period|Lost to Follow-up|0|||
131657724|NCT02628028|474030790|FG003|Dosing Period|Lost to Follow-up|0|||
131657725|NCT02628028|474030791|FG004|Dosing Period|Lost to Follow-up|0|||
131657726|NCT02628028|474030792|FG005|Dosing Period|Lost to Follow-up|0|||
131657727|NCT02628028|474030793|FG006|Dosing Period|Lost to Follow-up|1|||
131657728|NCT02628028|474030794|FG007|Dosing Period|Lost to Follow-up|0|||
131657729|NCT02628028|474030787|FG000|Dosing Period|Other|0|||
131657730|NCT02628028|474030788|FG001|Dosing Period|Other|0|||
131657731|NCT02628028|474030789|FG002|Dosing Period|Other|0|||
131657732|NCT02628028|474030790|FG003|Dosing Period|Other|0|||
131657733|NCT02628028|474030791|FG004|Dosing Period|Other|2|||
131657734|NCT02628028|474030792|FG005|Dosing Period|Other|1|||
131657735|NCT02628028|474030793|FG006|Dosing Period|Other|2|||
131657736|NCT02628028|474030794|FG007|Dosing Period|Other|4|||
131657737|NCT02628028|474030787|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
131657738|NCT02628028|474030788|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
131657739|NCT02628028|474030789|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
131657740|NCT02628028|474030790|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
131657741|NCT02628028|474030791|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
131657742|NCT02628028|474030792|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
131657743|NCT02628028|474030793|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
131657744|NCT02628028|474030794|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
131657745|NCT02628028|474030787|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131657746|NCT02628028|474030788|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131657747|NCT02628028|474030789|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131657748|NCT02628028|474030790|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131657749|NCT02628028|474030791|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131657750|NCT02628028|474030792|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
131657751|NCT02628028|474030793|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131657752|NCT02628028|474030794|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
131657753|NCT02628028|474030787|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131657754|NCT02628028|474030788|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131657755|NCT02628028|474030789|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131657756|NCT02628028|474030790|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131657757|NCT02628028|474030791|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131657758|NCT02628028|474030792|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
131657759|NCT02628028|474030793|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
131657760|NCT02628028|474030794|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
131657761|NCT02628028|474030787|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131657762|NCT02628028|474030788|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131657763|NCT02628028|474030789|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131657764|NCT02628028|474030790|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131657765|NCT02628028|474030791|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131657766|NCT02628028|474030792|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
131657767|NCT02628028|474030793|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
131657768|NCT02628028|474030794|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
131657769|NCT02628028|474030787|FG000|Long-term Extension (LTE) Period|Other|0|||
131657770|NCT02628028|474030788|FG001|Long-term Extension (LTE) Period|Other|0|||
131657771|NCT02628028|474030789|FG002|Long-term Extension (LTE) Period|Other|0|||
131657772|NCT02628028|474030790|FG003|Long-term Extension (LTE) Period|Other|0|||
131657773|NCT02628028|474030791|FG004|Long-term Extension (LTE) Period|Other|0|||
131657774|NCT02628028|474030792|FG005|Long-term Extension (LTE) Period|Other|3|||
131657775|NCT02628028|474030793|FG006|Long-term Extension (LTE) Period|Other|4|||
131657776|NCT02628028|474030794|FG007|Long-term Extension (LTE) Period|Other|3|||
131657777|NCT02145468|474030795|FG000|Overall Study|Withdrawal by Subject|5|||
131657778|NCT02145468|474030796|FG001|Overall Study|Withdrawal by Subject|8|||
131657779|NCT00623805|474030798|FG000|Overall Study|Adverse Event|9|||
131657780|NCT00623805|474030799|FG001|Overall Study|Adverse Event|6|||
131657781|NCT00623805|474030798|FG000|Overall Study|Death|2|||
131657782|NCT00623805|474030799|FG001|Overall Study|Death|0|||
131657783|NCT00623805|474030798|FG000|Overall Study|Lack of Efficacy|3|||
131657784|NCT00623805|474030799|FG001|Overall Study|Lack of Efficacy|7|||
131657785|NCT00623805|474030798|FG000|Overall Study|Lost to Follow-up|2|||
131657786|NCT00623805|474030799|FG001|Overall Study|Lost to Follow-up|2|||
131657787|NCT00623805|474030798|FG000|Overall Study|Protocol Violation|1|||
131657788|NCT00623805|474030799|FG001|Overall Study|Protocol Violation|1|||
131657789|NCT00623805|474030798|FG000|Overall Study|Reason not Specified|3|||
131657790|NCT00623805|474030799|FG001|Overall Study|Reason not Specified|6|||
131657791|NCT02336451|474030818|FG000|Overall Study|Adverse Event|1|||
131657792|NCT02336451|474030819|FG001|Overall Study|Adverse Event|2|||
131657793|NCT02336451|474030820|FG002|Overall Study|Adverse Event|0|||
131657794|NCT02336451|474030821|FG003|Overall Study|Adverse Event|6|||
131657795|NCT02336451|474030822|FG004|Overall Study|Adverse Event|4|||
131657796|NCT02336451|474030818|FG000|Overall Study|Death|6|||
131657797|NCT02336451|474030819|FG001|Overall Study|Death|2|||
131657798|NCT02336451|474030820|FG002|Overall Study|Death|3|||
131657799|NCT02336451|474030821|FG003|Overall Study|Death|6|||
131657800|NCT02336451|474030822|FG004|Overall Study|Death|6|||
131657801|NCT02336451|474030818|FG000|Overall Study|Physician Decision|9|||
131657802|NCT02336451|474030819|FG001|Overall Study|Physician Decision|6|||
131657803|NCT02336451|474030820|FG002|Overall Study|Physician Decision|7|||
131657804|NCT02336451|474030821|FG003|Overall Study|Physician Decision|16|||
131657805|NCT02336451|474030822|FG004|Overall Study|Physician Decision|3|||
131657806|NCT02336451|474030818|FG000|Overall Study|Progressive disease|23|||
131657807|NCT02336451|474030819|FG001|Overall Study|Progressive disease|26|||
131657808|NCT02336451|474030820|FG002|Overall Study|Progressive disease|2|||
131657809|NCT02336451|474030821|FG003|Overall Study|Progressive disease|14|||
131657810|NCT02336451|474030822|FG004|Overall Study|Progressive disease|4|||
131657811|NCT02336451|474030818|FG000|Overall Study|Protocol Violation|1|||
131657812|NCT02336451|474030819|FG001|Overall Study|Protocol Violation|0|||
131657813|NCT02336451|474030820|FG002|Overall Study|Protocol Violation|0|||
131657814|NCT02336451|474030821|FG003|Overall Study|Protocol Violation|0|||
131657815|NCT02336451|474030822|FG004|Overall Study|Protocol Violation|0|||
131657816|NCT02336451|474030818|FG000|Overall Study|Patient/guardian decision|2|||
131657817|NCT02336451|474030819|FG001|Overall Study|Patient/guardian decision|4|||
131657818|NCT02336451|474030820|FG002|Overall Study|Patient/guardian decision|0|||
131657819|NCT02336451|474030821|FG003|Overall Study|Patient/guardian decision|2|||
131657820|NCT02336451|474030822|FG004|Overall Study|Patient/guardian decision|1|||
131657821|NCT04998812|474030829|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
131657822|NCT04998812|474030830|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
131545821|NCT01936857|473620000|FG001|Overall Study|Side effect of medication|0|||
131545822|NCT01936857|473619999|FG000|Overall Study|Other|2|||
131545823|NCT01936857|473620000|FG001|Overall Study|Other|2|||
131545824|NCT02279043|473620001|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
131545825|NCT02279043|473620002|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
131545826|NCT02279043|473620003|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
131545827|NCT02279043|473620001|FG000|Overall Study|Lost to Follow-up|46|||
131545828|NCT02279043|473620002|FG001|Overall Study|Lost to Follow-up|88|||
131545829|NCT02279043|473620003|FG002|Overall Study|Lost to Follow-up|0|||
131545830|NCT03848403|473620004|FG000|Period 2 (Day 8)|Adverse Event|1|||
131545831|NCT03848403|473620005|FG001|Period 2 (Day 8)|Adverse Event|2|||
131545832|NCT03848403|473620006|FG002|Period 2 (Day 8)|Adverse Event|2|||
131545833|NCT03848403|473620004|FG000|Period 2 (Day 8)|Physician Decision|0|||
131545834|NCT03848403|473620005|FG001|Period 2 (Day 8)|Physician Decision|1|||
131658612|NCT02003222|474035398|FG003|Induction|Disease progression|0|||
131545850|NCT01939548|473620009|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
131545851|NCT01939548|473620007|FG000|Overall Study|Withdrawal by Subject|4|||
131545852|NCT01939548|473620008|FG001|Overall Study|Withdrawal by Subject|4|||
131545853|NCT01939548|473620009|FG002|Overall Study|Withdrawal by Subject|1|||
131545854|NCT01939548|473620007|FG000|Overall Study|Protocol Violation|7|||
131545855|NCT01939548|473620008|FG001|Overall Study|Protocol Violation|6|||
131545856|NCT01939548|473620009|FG002|Overall Study|Protocol Violation|5|||
131545857|NCT01939548|473620007|FG000|Overall Study|Lost to Follow-up|5|||
131545858|NCT01939548|473620008|FG001|Overall Study|Lost to Follow-up|5|||
131545859|NCT01939548|473620009|FG002|Overall Study|Lost to Follow-up|3|||
131545860|NCT01939548|473620007|FG000|Overall Study|Adverse Event|2|||
131545861|NCT01939548|473620008|FG001|Overall Study|Adverse Event|9|||
131545862|NCT01939548|473620009|FG002|Overall Study|Adverse Event|7|||
131545863|NCT01939548|473620007|FG000|Overall Study|Death|0|||
131545864|NCT01939548|473620008|FG001|Overall Study|Death|0|||
131545865|NCT01939548|473620009|FG002|Overall Study|Death|1|||
131545866|NCT01939548|473620007|FG000|Overall Study|Participant dropped|0|||
131545867|NCT01939548|473620008|FG001|Overall Study|Participant dropped|0|||
131545868|NCT01939548|473620009|FG002|Overall Study|Participant dropped|1|||
131545869|NCT01939548|473620007|FG000|Overall Study|Participant unwilling to continue|0|||
131545870|NCT01939548|473620008|FG001|Overall Study|Participant unwilling to continue|1|||
131545871|NCT01939548|473620009|FG002|Overall Study|Participant unwilling to continue|0|||
131545872|NCT01939548|473620007|FG000|Overall Study|Participant withdrew consent|0|||
131545873|NCT01939548|473620008|FG001|Overall Study|Participant withdrew consent|2|||
131545874|NCT01939548|473620009|FG002|Overall Study|Participant withdrew consent|0|||
131545875|NCT01939548|473620007|FG000|Overall Study|Did not complete follow-up|0|||
131545876|NCT01939548|473620008|FG001|Overall Study|Did not complete follow-up|1|||
131545877|NCT01939548|473620009|FG002|Overall Study|Did not complete follow-up|0|||
131545878|NCT02124265|473620010|FG000|Overall Study|Adverse Event|1|||
131545879|NCT00490282|473620011|FG000|Overall Study|Withdrawal by Subject|3|||
131545880|NCT02114151|473620019|FG000|Overall Study|Death|1|||
131545881|NCT02114151|473620019|FG000|Overall Study|Lost to Follow-up|1|||
131545882|NCT02114151|473620019|FG000|Overall Study|Withdrawal by Subject|5|||
131545883|NCT01337674|473621397|FG000|Treatment Period 1|Adverse Event|0|||
131545884|NCT01337674|473621398|FG001|Treatment Period 1|Adverse Event|1|||
131545885|NCT01337674|473621399|FG002|Treatment Period 1|Adverse Event|0|||
131545886|NCT01337674|473621400|FG003|Treatment Period 1|Adverse Event|0|||
131545887|NCT01337674|473621397|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
131545888|NCT01337674|473621398|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
131545889|NCT01337674|473621399|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
131545890|NCT01337674|473621400|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
131545891|NCT01337674|473621397|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131545892|NCT01337674|473621398|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131545893|NCT01337674|473621399|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131545894|NCT01337674|473621400|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131545895|NCT01203930|473621401|FG000|Overall Study|Disease Progression|0|||
131545896|NCT01203930|473621402|FG001|Overall Study|Disease Progression|4|||
131545897|NCT01203930|473621401|FG000|Overall Study|Death|3|||
131545898|NCT01203930|473621402|FG001|Overall Study|Death|1|||
131545899|NCT01203930|473621401|FG000|Overall Study|Withdrew Consent|1|||
131545900|NCT01203930|473621402|FG001|Overall Study|Withdrew Consent|10|||
131545901|NCT01203930|473621401|FG000|Overall Study|Investigator Request|0|||
131545902|NCT01203930|473621402|FG001|Overall Study|Investigator Request|8|||
131545903|NCT01203930|473621401|FG000|Overall Study|Study Terminated by Sponsor|0|||
131545904|NCT01203930|473621402|FG001|Overall Study|Study Terminated by Sponsor|12|||
131545905|NCT01203930|473621401|FG000|Overall Study|Poor tolerance of study drug|0|||
131545906|NCT01203930|473621402|FG001|Overall Study|Poor tolerance of study drug|1|||
131545907|NCT01203930|473621401|FG000|Overall Study|Adverse Event|17|||
131545908|NCT01203930|473621402|FG001|Overall Study|Adverse Event|5|||
131545909|NCT02178059|473621403|FG000|Washout|Physician Decision|1|||
131545910|NCT02178059|473621404|FG001|Washout|Physician Decision|0|||
131545911|NCT05178121|473621405|FG000|Overall Study|Other|4|||
131545912|NCT05178121|473621405|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
131545913|NCT00838682|473621409|FG000|Overall Study|Lost to Follow-up|21|||
131545914|NCT00838682|473621410|FG001|Overall Study|Lost to Follow-up|14|||
131545915|NCT00838682|473621409|FG000|Overall Study|detection of exclusion criteria|4|||
131545916|NCT00838682|473621410|FG001|Overall Study|detection of exclusion criteria|3|||
131545917|NCT00838682|473621409|FG000|Overall Study|Protocol Violation|0|||
131545918|NCT00838682|473621410|FG001|Overall Study|Protocol Violation|1|||
131545919|NCT00838682|473621409|FG000|Overall Study|Withdrawal by Subject|0|||
131545920|NCT00838682|473621410|FG001|Overall Study|Withdrawal by Subject|1|||
131545921|NCT00989092|473621413|FG000|Overall Study|Physician Decision|9|||
131545922|NCT00989092|473621414|FG001|Overall Study|Physician Decision|6|||
131545923|NCT00989092|473621413|FG000|Overall Study|Adverse Event|20|||
131545924|NCT00989092|473621414|FG001|Overall Study|Adverse Event|1|||
131545925|NCT00989092|473621413|FG000|Overall Study|Chemotherapy initiated|12|||
131545926|NCT00989092|473621414|FG001|Overall Study|Chemotherapy initiated|4|||
131545927|NCT00989092|473621413|FG000|Overall Study|Withdrawal by Subject|17|||
131545928|NCT00989092|473621414|FG001|Overall Study|Withdrawal by Subject|9|||
131545929|NCT00989092|473621413|FG000|Overall Study|Death|14|||
131545930|NCT00989092|473621414|FG001|Overall Study|Death|2|||
131545931|NCT00989092|473621413|FG000|Overall Study|Ineligibility determined|3|||
131545932|NCT00989092|473621414|FG001|Overall Study|Ineligibility determined|3|||
131545933|NCT00989092|473621413|FG000|Overall Study|Lost to Follow-up|6|||
131545934|NCT00989092|473621414|FG001|Overall Study|Lost to Follow-up|2|||
131545935|NCT00989092|473621413|FG000|Overall Study|Other|3|||
131545936|NCT00989092|473621414|FG001|Overall Study|Other|1|||
131545937|NCT00989092|473621413|FG000|Overall Study|Protocol deviation|2|||
131545938|NCT00989092|473621414|FG001|Overall Study|Protocol deviation|0|||
131545939|NCT00989092|473621413|FG000|Overall Study|Erythropoietin therapy initiated|2|||
131545940|NCT00989092|473621414|FG001|Overall Study|Erythropoietin therapy initiated|0|||
131545941|NCT00989092|473621413|FG000|Overall Study|Did not receive study drug|2|||
131545942|NCT00989092|473621414|FG001|Overall Study|Did not receive study drug|0|||
131545943|NCT04098406|473621417|FG000|Overall Study|Adverse Event|2|||
131545944|NCT04098406|473621418|FG001|Overall Study|Adverse Event|1|||
131545945|NCT04098406|473621417|FG000|Overall Study|Withdrawal by Subject|1|||
131545946|NCT04098406|473621418|FG001|Overall Study|Withdrawal by Subject|0|||
131545947|NCT02173548|473621419|FG000|Overall Study|Lost to Follow-up|0|||
131545948|NCT02173548|473621420|FG001|Overall Study|Lost to Follow-up|2|||
131545949|NCT02173548|473621419|FG000|Overall Study|Withdrawal by Subject|1|||
131545950|NCT02173548|473621420|FG001|Overall Study|Withdrawal by Subject|0|||
131545951|NCT00415610|473621424|FG000|Overall Study|Death|3|||
131545952|NCT00415610|473621425|FG001|Overall Study|Death|2|||
131545953|NCT00415610|473621426|FG002|Overall Study|Death|5|||
131545954|NCT04539821|473621429|FG000|Overall Study|Withdrawal by Subject|2|||
131545955|NCT04539821|473621429|FG000|Overall Study|continued care with their physician|20|||
131545956|NCT04539821|473621429|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
131545957|NCT02691182|473621430|FG000|Overall Study|Withdrawal by Subject|4|||
131545958|NCT02691182|473621431|FG001|Overall Study|Withdrawal by Subject|7|||
131545959|NCT02691182|473621432|FG002|Overall Study|Withdrawal by Subject|6|||
131545960|NCT02691182|473621433|FG003|Overall Study|Withdrawal by Subject|8|||
131545961|NCT02691182|473621430|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
131545962|NCT02691182|473621431|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
131545963|NCT02691182|473621432|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
131545964|NCT02691182|473621433|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
131545965|NCT02691182|473621430|FG000|Overall Study|Lost to Follow-up|8|||
131545966|NCT02691182|473621431|FG001|Overall Study|Lost to Follow-up|33|||
131545967|NCT02691182|473621432|FG002|Overall Study|Lost to Follow-up|19|||
131545968|NCT02691182|473621433|FG003|Overall Study|Lost to Follow-up|22|||
131545969|NCT02691182|473621430|FG000|Overall Study|Adverse Event|3|||
131545970|NCT02691182|473621431|FG001|Overall Study|Adverse Event|10|||
131545971|NCT02691182|473621432|FG002|Overall Study|Adverse Event|10|||
131545972|NCT02691182|473621433|FG003|Overall Study|Adverse Event|11|||
131545973|NCT02691182|473621430|FG000|Overall Study|Physician Decision|3|||
131545974|NCT02691182|473621431|FG001|Overall Study|Physician Decision|7|||
131545975|NCT02691182|473621432|FG002|Overall Study|Physician Decision|14|||
131545976|NCT02691182|473621433|FG003|Overall Study|Physician Decision|8|||
131545977|NCT02691182|473621430|FG000|Overall Study|Lack of Efficacy|0|||
131545978|NCT02691182|473621431|FG001|Overall Study|Lack of Efficacy|0|||
131545979|NCT02691182|473621432|FG002|Overall Study|Lack of Efficacy|0|||
131545980|NCT02691182|473621433|FG003|Overall Study|Lack of Efficacy|4|||
131545981|NCT02691182|473621430|FG000|Overall Study|Protocol Violation|2|||
131545982|NCT02691182|473621431|FG001|Overall Study|Protocol Violation|6|||
131545983|NCT02691182|473621432|FG002|Overall Study|Protocol Violation|6|||
131545984|NCT02691182|473621433|FG003|Overall Study|Protocol Violation|8|||
131545985|NCT02691182|473621430|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
131545986|NCT02691182|473621431|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
131545987|NCT02691182|473621432|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
131545988|NCT02691182|473621433|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
131545989|NCT02691182|473621430|FG000|Overall Study|Missing|0|||
131545990|NCT02691182|473621431|FG001|Overall Study|Missing|5|||
131545991|NCT02691182|473621432|FG002|Overall Study|Missing|1|||
131545992|NCT02691182|473621433|FG003|Overall Study|Missing|5|||
131545993|NCT00645164|473621434|FG000|Overall Study|Lost to Follow-up|2|||
131545994|NCT00645164|473621434|FG000|Overall Study|Withdrawal by Subject|4|||
131545995|NCT00645164|473621434|FG000|Overall Study|Protocol Violation|1|||
131545996|NCT00117676|473621435|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
131545997|NCT00117676|473621436|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
131545998|NCT00117676|473621435|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
131545999|NCT00117676|473621436|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
131546000|NCT00117676|473621435|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
131546001|NCT00117676|473621436|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
131546002|NCT00117676|473621435|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
131546003|NCT00117676|473621436|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
131546004|NCT00117676|473621435|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
131546005|NCT00117676|473621436|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
131546006|NCT00117676|473621435|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
131546007|NCT00117676|473621436|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
131546008|NCT00117676|473621435|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
131546009|NCT00117676|473621436|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
131546010|NCT00117676|473621435|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
131546011|NCT00117676|473621436|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
131546012|NCT00117676|473621435|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
131546013|NCT00117676|473621436|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
131546014|NCT00117676|473621435|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
131546015|NCT00117676|473621436|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
131546016|NCT00117676|473621435|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
131546017|NCT00117676|473621436|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
131546018|NCT00117676|473621435|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
131546019|NCT00117676|473621436|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
131546020|NCT00117676|473621435|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
131546021|NCT00117676|473621436|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
131546022|NCT00117676|473621435|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
131546023|NCT00117676|473621436|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
131546024|NCT00117676|473621435|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
131546025|NCT00117676|473621436|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
131546026|NCT00117676|473621435|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
131546027|NCT00117676|473621436|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
131546028|NCT00117676|473621435|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
131546029|NCT00117676|473621436|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
131546030|NCT00117676|473621435|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
131546031|NCT00117676|473621436|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
131546032|NCT00117676|473621435|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
131546033|NCT00117676|473621436|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
131546034|NCT00117676|473621435|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
131546035|NCT00117676|473621436|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
131546036|NCT00117676|473621435|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
131546037|NCT00117676|473621436|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
131546038|NCT00117676|473621435|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
131546039|NCT00117676|473621436|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
131546040|NCT00117676|473621435|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
131546041|NCT00117676|473621436|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
131546042|NCT00117676|473621435|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
131546043|NCT00117676|473621436|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
131546044|NCT00117676|473621435|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
131546045|NCT00117676|473621436|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
131546046|NCT00117676|473621435|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
131546047|NCT00117676|473621436|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
131546048|NCT00117676|473621435|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
131546049|NCT00117676|473621436|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
131546050|NCT00117676|473621435|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
131546051|NCT00117676|473621436|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
131546052|NCT00117676|473621435|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
131546053|NCT00117676|473621436|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
131546054|NCT00117676|473621435|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
131546055|NCT00117676|473621436|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
131546056|NCT00117676|473621435|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
131546057|NCT00117676|473621436|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
131546058|NCT00117676|473621435|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
131546059|NCT00117676|473621436|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
131546060|NCT00117676|473621435|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
131546061|NCT00117676|473621436|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
131546062|NCT00117676|473621435|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
131546063|NCT00117676|473621436|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
131546064|NCT00117676|473621435|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
131546065|NCT00117676|473621436|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
131546066|NCT00952822|473621437|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
131546067|NCT00952822|473621438|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
131546068|NCT00952822|473621439|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
131546069|NCT00952822|473621440|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
131546070|NCT00952822|473621437|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
131546071|NCT00952822|473621438|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
131546072|NCT00952822|473621439|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
131546073|NCT00952822|473621440|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
131546074|NCT00691938|473621444|FG000|Overall Study|QTc prolongation|1|||
131546075|NCT00691938|473621445|FG001|Overall Study|QTc prolongation|0|||
131546076|NCT00691938|473621446|FG002|Overall Study|QTc prolongation|0|||
131546077|NCT00691938|473621447|FG003|Overall Study|QTc prolongation|0|||
131546078|NCT00691938|473621448|FG004|Overall Study|QTc prolongation|0|||
131546079|NCT00691938|473621449|FG005|Overall Study|QTc prolongation|0|||
131546080|NCT00691938|473621450|FG006|Overall Study|QTc prolongation|0|||
131546081|NCT04860518|473621453|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
131546082|NCT04860518|473621454|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
131546083|NCT04555096|473621459|FG000|Overall Study|Death|4|||
131546084|NCT04555096|473621460|FG001|Overall Study|Death|4|||
131546085|NCT04555096|473621459|FG000|Overall Study|Withdrawal by Subject|1|||
131546086|NCT04555096|473621460|FG001|Overall Study|Withdrawal by Subject|0|||
131546087|NCT04555096|473621459|FG000|Overall Study|Other|0|||
131546088|NCT04555096|473621460|FG001|Overall Study|Other|1|||
131546089|NCT04642898|473621463|FG000|Overall Study|Withdrawal by Subject|2|||
131546090|NCT04642898|473621464|FG001|Overall Study|Withdrawal by Subject|4|||
131546091|NCT04642898|473621465|FG002|Overall Study|Withdrawal by Subject|4|||
131546092|NCT04642898|473621466|FG003|Overall Study|Withdrawal by Subject|6|||
131546093|NCT04642898|473621467|FG004|Overall Study|Withdrawal by Subject|2|||
131546094|NCT04642898|473621468|FG005|Overall Study|Withdrawal by Subject|6|||
131546095|NCT04642898|473621463|FG000|Overall Study|Lost to Follow-up|0|||
131546096|NCT04642898|473621464|FG001|Overall Study|Lost to Follow-up|0|||
131546097|NCT04642898|473621465|FG002|Overall Study|Lost to Follow-up|0|||
131546098|NCT04642898|473621466|FG003|Overall Study|Lost to Follow-up|2|||
131546099|NCT04642898|473621467|FG004|Overall Study|Lost to Follow-up|0|||
131546100|NCT04642898|473621468|FG005|Overall Study|Lost to Follow-up|1|||
131546101|NCT04642898|473621463|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
131546102|NCT04642898|473621464|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
131546103|NCT04642898|473621465|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
131546104|NCT04642898|473621466|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
131546105|NCT04642898|473621467|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
131546106|NCT04642898|473621468|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
131546107|NCT04642898|473621463|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
131546108|NCT04642898|473621464|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
131546109|NCT04642898|473621465|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
131546110|NCT04642898|473621466|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
131546111|NCT04642898|473621467|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
131546112|NCT04642898|473621468|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
131546113|NCT03574597|473621469|FG000|Overall Study|Withdrawal by Subject|67|||
131546114|NCT03574597|473621470|FG001|Overall Study|Withdrawal by Subject|96|||
131546115|NCT03574597|473621469|FG000|Overall Study|Lost to Follow-up|192|||
131546116|NCT03574597|473621470|FG001|Overall Study|Lost to Follow-up|188|||
131546117|NCT03434678|473621471|FG000|Overall Study|Withdrawal by Subject|13|||
131546118|NCT03434678|473621472|FG001|Overall Study|Withdrawal by Subject|13|||
131546119|NCT03434678|473621471|FG000|Overall Study|Found to be ineligible post randomization|2|||
131546120|NCT03434678|473621472|FG001|Overall Study|Found to be ineligible post randomization|1|||
131546121|NCT06060457|473621475|FG000|Overall Study|Adverse Event|1|||
131546122|NCT06060457|473621476|FG001|Overall Study|Adverse Event|1|||
131546123|NCT06060457|473621475|FG000|Overall Study|Death|2|||
131546124|NCT06060457|473621476|FG001|Overall Study|Death|2|||
131546125|NCT06060457|473621475|FG000|Overall Study|Lost to Follow-up|17|||
131546126|NCT06060457|473621476|FG001|Overall Study|Lost to Follow-up|19|||
131546127|NCT06060457|473621475|FG000|Overall Study|Physician Decision|0|||
131546128|NCT06060457|473621476|FG001|Overall Study|Physician Decision|1|||
131546129|NCT06060457|473621475|FG000|Overall Study|Protocol Violation|1|||
131546130|NCT06060457|473621476|FG001|Overall Study|Protocol Violation|1|||
131546131|NCT06060457|473621475|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
131546132|NCT06060457|473621476|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
131546133|NCT06060457|473621475|FG000|Overall Study|Withdrawal by Subject|12|||
131546134|NCT06060457|473621476|FG001|Overall Study|Withdrawal by Subject|15|||
131546135|NCT06060457|473621475|FG000|Overall Study|Other Than Specified|2|||
131546136|NCT06060457|473621476|FG001|Overall Study|Other Than Specified|1|||
131546137|NCT02061202|473621477|FG000|Overall Study|Lost to Follow-up|1|||
131546138|NCT02061202|473621478|FG001|Overall Study|Lost to Follow-up|1|||
131546139|NCT01533493|473621479|FG000|Overall Study|Adverse Event|2|||
131546140|NCT01533493|473621480|FG001|Overall Study|Adverse Event|1|||
131546141|NCT01533493|473621479|FG000|Overall Study|Withdrawal by Subject|1|||
131546142|NCT01533493|473621480|FG001|Overall Study|Withdrawal by Subject|2|||
131546143|NCT01533493|473621479|FG000|Overall Study|Lost to Follow-up|2|||
131546144|NCT01533493|473621480|FG001|Overall Study|Lost to Follow-up|0|||
131546145|NCT05163522|473621481|FG000|Overall Study|Withdrawal by Subject|0|||
131546146|NCT05163522|473621482|FG001|Overall Study|Withdrawal by Subject|0|||
131546147|NCT05163522|473621483|FG002|Overall Study|Withdrawal by Subject|1|||
131546148|NCT05163522|473621484|FG003|Overall Study|Withdrawal by Subject|0|||
131546149|NCT05163522|473621485|FG004|Overall Study|Withdrawal by Subject|0|||
131546150|NCT05163522|473621486|FG005|Overall Study|Withdrawal by Subject|0|||
131546151|NCT05163522|473621487|FG006|Overall Study|Withdrawal by Subject|0|||
131546152|NCT05163522|473621488|FG007|Overall Study|Withdrawal by Subject|0|||
131546153|NCT05163522|473621489|FG008|Overall Study|Withdrawal by Subject|0|||
131546154|NCT05163522|473621490|FG009|Overall Study|Withdrawal by Subject|0|||
131546155|NCT05163522|473621491|FG010|Overall Study|Withdrawal by Subject|0|||
131546156|NCT02660827|473621494|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
131546157|NCT02660827|473621494|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
131546158|NCT02660827|473621494|FG000|From Study to End of Continued Access|Adverse Event|3|||
131546159|NCT02660827|473621494|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
131546160|NCT02660827|473621494|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
131546161|NCT02660827|473621494|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
131546162|NCT02660827|473621494|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
131546163|NCT02660827|473621494|FG000|Period 2: Continued Access Period|Adverse Event|3|||
131546164|NCT02638948|473621500|FG000|Overall Study|Withdrawal by Subject|4|||
131546165|NCT02638948|473621501|FG001|Overall Study|Withdrawal by Subject|5|||
131546166|NCT02638948|473621502|FG002|Overall Study|Withdrawal by Subject|3|||
131546167|NCT02638948|473621503|FG003|Overall Study|Withdrawal by Subject|1|||
131546168|NCT02638948|473621500|FG000|Overall Study|Administrative Reason by Sponsor|0|||
131546169|NCT02638948|473621501|FG001|Overall Study|Administrative Reason by Sponsor|1|||
131546170|NCT02638948|473621502|FG002|Overall Study|Administrative Reason by Sponsor|0|||
131546171|NCT02638948|473621503|FG003|Overall Study|Administrative Reason by Sponsor|4|||
131546172|NCT02638948|473621500|FG000|Overall Study|Adverse Event|0|||
131546173|NCT02638948|473621501|FG001|Overall Study|Adverse Event|0|||
131546174|NCT02638948|473621502|FG002|Overall Study|Adverse Event|1|||
131546175|NCT02638948|473621503|FG003|Overall Study|Adverse Event|1|||
131546176|NCT02638948|473621500|FG000|Overall Study|Lack of Efficacy|1|||
131546177|NCT02638948|473621501|FG001|Overall Study|Lack of Efficacy|1|||
131546178|NCT02638948|473621502|FG002|Overall Study|Lack of Efficacy|0|||
131546179|NCT02638948|473621503|FG003|Overall Study|Lack of Efficacy|0|||
131546180|NCT02638948|473621500|FG000|Overall Study|Lost to Follow-up|0|||
131546181|NCT02638948|473621501|FG001|Overall Study|Lost to Follow-up|0|||
131546182|NCT02638948|473621502|FG002|Overall Study|Lost to Follow-up|1|||
131546183|NCT02638948|473621503|FG003|Overall Study|Lost to Follow-up|1|||
131546184|NCT02638948|473621500|FG000|Overall Study|Poor/Non-Compliance|0|||
131546185|NCT02638948|473621501|FG001|Overall Study|Poor/Non-Compliance|2|||
131546186|NCT02638948|473621502|FG002|Overall Study|Poor/Non-Compliance|1|||
131546187|NCT02638948|473621503|FG003|Overall Study|Poor/Non-Compliance|0|||
131546188|NCT02638948|473621500|FG000|Overall Study|Participant no longer met study criteria|0|||
131546189|NCT02638948|473621501|FG001|Overall Study|Participant no longer met study criteria|1|||
131546190|NCT02638948|473621502|FG002|Overall Study|Participant no longer met study criteria|0|||
131546191|NCT02638948|473621503|FG003|Overall Study|Participant no longer met study criteria|0|||
131546192|NCT02638948|473621500|FG000|Overall Study|Other than specified above|4|||
131546193|NCT02638948|473621501|FG001|Overall Study|Other than specified above|1|||
131546194|NCT02638948|473621502|FG002|Overall Study|Other than specified above|1|||
131546195|NCT02638948|473621503|FG003|Overall Study|Other than specified above|1|||
131546196|NCT00810264|473621507|FG000|Overall Study|Lost to Follow-up|191|||
131546197|NCT00810264|473621507|FG000|Overall Study|Withdrawal by subject or physician|721|||
131546198|NCT00810264|473621507|FG000|Overall Study|Death|641|||
131546199|NCT06213701|473621508|FG000|Overall Study|Withdrawal by Subject|2|||
131546200|NCT06213701|473621509|FG001|Overall Study|Withdrawal by Subject|1|||
131546201|NCT06213701|473621510|FG002|Overall Study|Withdrawal by Subject|0|||
131546202|NCT02495025|473621517|FG000|Overall Study|Lost to Follow-up|21|||
131546203|NCT02495025|473621518|FG001|Overall Study|Lost to Follow-up|14|||
131546204|NCT02495025|473621517|FG000|Overall Study|Withdrawal by Subject|5|||
131546205|NCT02495025|473621518|FG001|Overall Study|Withdrawal by Subject|0|||
131546206|NCT00313820|473621520|FG000|Assigned to Treatment|Other|1|||
131546207|NCT00313820|473621521|FG001|Assigned to Treatment|Other|0|||
131546208|NCT00313820|473621520|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
131546209|NCT00313820|473621521|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
131658613|NCT02003222|474035399|FG004|Induction|Disease progression|22|||
131546210|NCT00313820|473621520|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
131546211|NCT00313820|473621521|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
131546212|NCT00313820|473621520|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
131546213|NCT00313820|473621521|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
131546214|NCT00313820|473621520|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
131546215|NCT00313820|473621521|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
131546216|NCT00313820|473621520|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
131546217|NCT00313820|473621521|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
131546218|NCT00265889|473621524|FG000|Overall Study|Physician Decision|1|||
131546219|NCT00265889|473621524|FG000|Overall Study|Protocol Violation|1|||
131546220|NCT00265889|473621524|FG000|Overall Study|Insurance denied the request|3|||
131546221|NCT02134587|473621525|FG000|Overall Study|Did not completed all meetings|30|||
131546222|NCT01515748|473621529|FG000|Overall Study|Withdrawal by Subject|32|||
131546223|NCT01515748|473621530|FG001|Overall Study|Withdrawal by Subject|41|||
131546224|NCT01515748|473621529|FG000|Overall Study|Lost to Follow-up|2|||
131546225|NCT01515748|473621530|FG001|Overall Study|Lost to Follow-up|4|||
131546226|NCT01515748|473621529|FG000|Overall Study|Other than specified above|5|||
131546227|NCT01515748|473621530|FG001|Overall Study|Other than specified above|10|||
131546228|NCT03221387|473621533|FG000|Overall Study|Lost to Follow-up|1|||
131546229|NCT03221387|473621533|FG000|Overall Study|Lung transplant|1|||
131546230|NCT00522626|473621534|FG000|Overall Study|Lost to Follow-up|7|||
131546231|NCT04102579|473621540|FG000|Overall Study|Withdrawal by Subject|3|||
131546232|NCT04102579|473621541|FG001|Overall Study|Withdrawal by Subject|4|||
131546233|NCT04102579|473621540|FG000|Overall Study|Lost to Follow-up|0|||
131546234|NCT04102579|473621541|FG001|Overall Study|Lost to Follow-up|1|||
131546235|NCT04102579|473621540|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
131546236|NCT04102579|473621541|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
131546237|NCT04102579|473621540|FG000|Overall Study|Other than Specified|1|||
131546238|NCT04102579|473621541|FG001|Overall Study|Other than Specified|0|||
131546239|NCT04102579|473621540|FG000|Overall Study|Not Dosed with Study Drug|0|||
131546240|NCT04102579|473621541|FG001|Overall Study|Not Dosed with Study Drug|1|||
131546241|NCT03419364|473621542|FG000|Overall Study|Delivery due to maternal condition|2|||
131546242|NCT03419364|473621543|FG001|Overall Study|Delivery due to maternal condition|0|||
131546243|NCT03419364|473621544|FG002|Overall Study|Delivery due to maternal condition|0|||
131657823|NCT04998812|474030829|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
131657824|NCT04998812|474030830|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
131657825|NCT04998812|474030829|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
131657826|NCT04998812|474030830|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
131657827|NCT04998812|474030829|FG000|Vaccination Period|Ongoing in study|23|||
131657828|NCT04998812|474030830|FG001|Vaccination Period|Ongoing in study|23|||
131657829|NCT04893460|474030839|FG000|Overall Study|Lost to Follow-up|18|||
131657830|NCT05718466|474032896|FG000|Overall Study|Withdrawal by Subject|1|||
131657831|NCT05718466|474032897|FG001|Overall Study|Withdrawal by Subject|2|||
131657832|NCT05718466|474032896|FG000|Overall Study|Death|0|||
131657833|NCT05718466|474032897|FG001|Overall Study|Death|1|||
131657834|NCT01099215|474032898|FG000|Overall Study|Withdrawal by Subject|1|||
131657835|NCT01099215|474032899|FG001|Overall Study|Withdrawal by Subject|0|||
131657836|NCT01099215|474032898|FG000|Overall Study|Adverse Event|0|||
131657837|NCT01099215|474032899|FG001|Overall Study|Adverse Event|1|||
131657838|NCT01253135|474032901|FG000|Original Protocol|Protocol Amendment|15|||
131657839|NCT01253135|474032901|FG000|Amended Protocol|Non-compliance|1|||
131657840|NCT00833261|474032908|FG000|Overall Study|Withdrawal by Subject|4|||
131657841|NCT03248882|474032911|FG000|Overall Study|Adverse Event|3|||
131657842|NCT03248882|474032912|FG001|Overall Study|Adverse Event|3|||
131657843|NCT03248882|474032913|FG002|Overall Study|Adverse Event|2|||
131657844|NCT03248882|474032914|FG003|Overall Study|Adverse Event|6|||
131657845|NCT03248882|474032915|FG004|Overall Study|Adverse Event|9|||
131657846|NCT03248882|474032911|FG000|Overall Study|Lost to Follow-up|0|||
131657847|NCT03248882|474032912|FG001|Overall Study|Lost to Follow-up|0|||
131657848|NCT03248882|474032913|FG002|Overall Study|Lost to Follow-up|0|||
131657849|NCT03248882|474032914|FG003|Overall Study|Lost to Follow-up|0|||
131657850|NCT03248882|474032915|FG004|Overall Study|Lost to Follow-up|1|||
131657851|NCT03248882|474032911|FG000|Overall Study|Protocol Violation|2|||
131657852|NCT03248882|474032912|FG001|Overall Study|Protocol Violation|0|||
131657853|NCT03248882|474032913|FG002|Overall Study|Protocol Violation|2|||
131657854|NCT03248882|474032914|FG003|Overall Study|Protocol Violation|0|||
131657855|NCT03248882|474032915|FG004|Overall Study|Protocol Violation|1|||
131657856|NCT03248882|474032911|FG000|Overall Study|Withdrawal by Subject|2|||
131657857|NCT03248882|474032912|FG001|Overall Study|Withdrawal by Subject|2|||
131657858|NCT03248882|474032913|FG002|Overall Study|Withdrawal by Subject|3|||
131657859|NCT03248882|474032914|FG003|Overall Study|Withdrawal by Subject|4|||
131657860|NCT03248882|474032915|FG004|Overall Study|Withdrawal by Subject|2|||
131657861|NCT01156376|474032918|FG000|Overall Study|Adverse Event|1|||
131657862|NCT01156376|474032919|FG001|Overall Study|Adverse Event|0|||
131657863|NCT01156376|474032920|FG002|Overall Study|Adverse Event|1|||
131657865|NCT01156376|474032919|FG001|Overall Study|Withdrawal by Subject|0|||
131657866|NCT01156376|474032920|FG002|Overall Study|Withdrawal by Subject|3|||
131657867|NCT01075958|474032921|FG000|Overall Study|Blood sample could not be obtained|44|||
131657868|NCT03733314|474032922|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
131657869|NCT03733314|474032923|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
131657870|NCT03733314|474032922|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
131657871|NCT03733314|474032923|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
131657872|NCT03733314|474032922|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
131657873|NCT03733314|474032923|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
131657874|NCT03733314|474032922|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
131657875|NCT03733314|474032923|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
131657876|NCT03733314|474032922|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
131657877|NCT03733314|474032923|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
131657878|NCT03733314|474032922|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
131657879|NCT03733314|474032923|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
131657880|NCT01240915|474032924|FG000|Overall Study|Adverse Event|0|||
131657881|NCT01240915|474032925|FG001|Overall Study|Adverse Event|0|||
131657882|NCT01240915|474032926|FG002|Overall Study|Adverse Event|0|||
131657883|NCT01240915|474032927|FG003|Overall Study|Adverse Event|1|||
131657884|NCT01240915|474032928|FG004|Overall Study|Adverse Event|0|||
131657885|NCT01240915|474032929|FG005|Overall Study|Adverse Event|2|||
131657886|NCT01240915|474032930|FG006|Overall Study|Adverse Event|0|||
131657887|NCT01240915|474032931|FG007|Overall Study|Adverse Event|0|||
131657888|NCT01240915|474032932|FG008|Overall Study|Adverse Event|1|||
131657889|NCT01240915|474032924|FG000|Overall Study|Lost to Follow-up|0|||
131657890|NCT01240915|474032925|FG001|Overall Study|Lost to Follow-up|0|||
131657891|NCT01240915|474032926|FG002|Overall Study|Lost to Follow-up|0|||
131657892|NCT01240915|474032927|FG003|Overall Study|Lost to Follow-up|0|||
131657893|NCT01240915|474032928|FG004|Overall Study|Lost to Follow-up|1|||
131657894|NCT01240915|474032929|FG005|Overall Study|Lost to Follow-up|1|||
131657895|NCT01240915|474032930|FG006|Overall Study|Lost to Follow-up|0|||
131657896|NCT01240915|474032931|FG007|Overall Study|Lost to Follow-up|1|||
131657897|NCT01240915|474032932|FG008|Overall Study|Lost to Follow-up|1|||
131657898|NCT01240915|474032924|FG000|Overall Study|Withdrawal by Subject|2|||
131657899|NCT01240915|474032925|FG001|Overall Study|Withdrawal by Subject|1|||
131657900|NCT01240915|474032926|FG002|Overall Study|Withdrawal by Subject|0|||
131657901|NCT01240915|474032927|FG003|Overall Study|Withdrawal by Subject|2|||
131657902|NCT01240915|474032928|FG004|Overall Study|Withdrawal by Subject|0|||
131657903|NCT01240915|474032929|FG005|Overall Study|Withdrawal by Subject|4|||
131657904|NCT01240915|474032930|FG006|Overall Study|Withdrawal by Subject|2|||
131657905|NCT01240915|474032931|FG007|Overall Study|Withdrawal by Subject|3|||
131657906|NCT01240915|474032932|FG008|Overall Study|Withdrawal by Subject|3|||
131657907|NCT01240915|474032924|FG000|Overall Study|Other|0|||
131657908|NCT01240915|474032925|FG001|Overall Study|Other|0|||
131657909|NCT01240915|474032926|FG002|Overall Study|Other|0|||
131657910|NCT01240915|474032927|FG003|Overall Study|Other|0|||
131657911|NCT01240915|474032928|FG004|Overall Study|Other|2|||
131657912|NCT01240915|474032929|FG005|Overall Study|Other|0|||
131657913|NCT01240915|474032930|FG006|Overall Study|Other|0|||
131657914|NCT01240915|474032931|FG007|Overall Study|Other|0|||
131657915|NCT01240915|474032932|FG008|Overall Study|Other|0|||
131657916|NCT01240915|474032924|FG000|Overall Study|Insufficient Clinical Response|0|||
131657917|NCT01240915|474032925|FG001|Overall Study|Insufficient Clinical Response|0|||
131657918|NCT01240915|474032926|FG002|Overall Study|Insufficient Clinical Response|0|||
131657919|NCT01240915|474032927|FG003|Overall Study|Insufficient Clinical Response|0|||
131657920|NCT01240915|474032928|FG004|Overall Study|Insufficient Clinical Response|1|||
131657921|NCT01240915|474032929|FG005|Overall Study|Insufficient Clinical Response|3|||
131657922|NCT01240915|474032930|FG006|Overall Study|Insufficient Clinical Response|6|||
131657923|NCT01240915|474032931|FG007|Overall Study|Insufficient Clinical Response|0|||
131657924|NCT01240915|474032932|FG008|Overall Study|Insufficient Clinical Response|3|||
131657925|NCT04514510|474032933|FG000|Overall Study|Lost to Follow-up|0|||
131657926|NCT04514510|474032934|FG001|Overall Study|Lost to Follow-up|1|||
131657927|NCT04514510|474032933|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
131657928|NCT04514510|474032934|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
131657929|NCT04488770|474032935|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657930|NCT04488770|474032936|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657931|NCT04488770|474032937|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657932|NCT04488770|474032938|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
131657933|NCT04488770|474032939|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657934|NCT04488770|474032940|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657935|NCT04488770|474032941|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657936|NCT04488770|474032942|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657937|NCT04488770|474032943|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657938|NCT04488770|474032944|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657939|NCT04488770|474032945|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657940|NCT04488770|474032946|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657941|NCT04488770|474032947|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131657942|NCT04488770|474032935|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
131657943|NCT04488770|474032936|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657944|NCT04488770|474032937|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657945|NCT04488770|474032938|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657946|NCT04488770|474032939|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657947|NCT04488770|474032940|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657948|NCT04488770|474032941|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657949|NCT04488770|474032942|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657950|NCT04488770|474032943|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657951|NCT04488770|474032944|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657952|NCT04488770|474032945|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657953|NCT04488770|474032946|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657954|NCT04488770|474032947|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131657955|NCT04488770|474032935|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657956|NCT04488770|474032936|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657957|NCT04488770|474032937|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657958|NCT04488770|474032938|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657959|NCT04488770|474032939|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657960|NCT04488770|474032940|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
131657961|NCT04488770|474032941|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
131657962|NCT04488770|474032942|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657963|NCT04488770|474032943|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657964|NCT04488770|474032944|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657965|NCT04488770|474032945|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657966|NCT04488770|474032946|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657967|NCT04488770|474032947|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131657968|NCT04488770|474032935|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657969|NCT04488770|474032936|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657970|NCT04488770|474032937|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657971|NCT04488770|474032938|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657972|NCT04488770|474032939|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
131657973|NCT04488770|474032940|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657974|NCT04488770|474032941|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657975|NCT04488770|474032942|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657976|NCT04488770|474032943|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657977|NCT04488770|474032944|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657978|NCT04488770|474032945|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657979|NCT04488770|474032946|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657980|NCT04488770|474032947|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131657981|NCT01867333|474032948|FG000|Overall Study|Withdrawal by Subject|1|||
131657982|NCT01867333|474032949|FG001|Overall Study|Withdrawal by Subject|0|||
131657983|NCT01867333|474032948|FG000|Overall Study|Adverse Event|1|||
131657984|NCT01867333|474032949|FG001|Overall Study|Adverse Event|0|||
131657985|NCT01867333|474032948|FG000|Overall Study|Participant choice|1|||
131657986|NCT01867333|474032949|FG001|Overall Study|Participant choice|2|||
131657987|NCT01867333|474032948|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
131657988|NCT01867333|474032949|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
131657989|NCT01867333|474032948|FG000|Overall Study|Death|0|||
131657990|NCT01867333|474032949|FG001|Overall Study|Death|1|||
131657991|NCT01867333|474032948|FG000|Overall Study|Physician Decision|3|||
131657992|NCT01867333|474032949|FG001|Overall Study|Physician Decision|2|||
131657993|NCT01867333|474032948|FG000|Overall Study|Switched to alternative treatment|1|||
131657994|NCT01867333|474032949|FG001|Overall Study|Switched to alternative treatment|0|||
131657995|NCT02636725|474032952|FG000|Overall Study|Adverse Event|1|||
131657996|NCT05330676|474032955|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
131657997|NCT05330676|474032956|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
131657998|NCT03653208|474032957|FG000|Overall Study|Withdrawal by Subject|0|||
131657999|NCT03653208|474032958|FG001|Overall Study|Withdrawal by Subject|0|||
131658000|NCT03653208|474032959|FG002|Overall Study|Withdrawal by Subject|0|||
131658001|NCT03653208|474032960|FG003|Overall Study|Withdrawal by Subject|0|||
131658002|NCT03653208|474032961|FG004|Overall Study|Withdrawal by Subject|1|||
131658003|NCT03653208|474032962|FG005|Overall Study|Withdrawal by Subject|0|||
131658004|NCT03653208|474032963|FG006|Overall Study|Withdrawal by Subject|0|||
131658005|NCT03653208|474032964|FG007|Overall Study|Withdrawal by Subject|1|||
131658006|NCT03653208|474032965|FG008|Overall Study|Withdrawal by Subject|1|||
131658007|NCT01696045|474032968|FG000|Overall Study|Study drug toxicity|1|||
131658008|NCT01696045|474032969|FG001|Overall Study|Study drug toxicity|5|||
131658009|NCT01696045|474032968|FG000|Overall Study|Disease progression|2|||
131658010|NCT01696045|474032969|FG001|Overall Study|Disease progression|2|||
131658011|NCT00573859|474032970|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
131658012|NCT00573859|474032970|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
131658013|NCT00864253|474032979|FG000|Overall Study|Adverse Event|56|||
131658014|NCT00864253|474032980|FG001|Overall Study|Adverse Event|11|||
131658015|NCT00864253|474032979|FG000|Overall Study|Unrelated Adverse Event|3|||
131658016|NCT00864253|474032980|FG001|Overall Study|Unrelated Adverse Event|1|||
131658017|NCT00864253|474032979|FG000|Overall Study|Physician Decision|11|||
131658018|NCT00864253|474032980|FG001|Overall Study|Physician Decision|15|||
131658019|NCT00864253|474032979|FG000|Overall Study|Protocol Violation|0|||
131658020|NCT00864253|474032980|FG001|Overall Study|Protocol Violation|2|||
131658021|NCT00864253|474032979|FG000|Overall Study|Lost to Follow-up|1|||
131658022|NCT00864253|474032980|FG001|Overall Study|Lost to Follow-up|1|||
131658023|NCT00864253|474032979|FG000|Overall Study|Withdrawal by Subject|18|||
131658024|NCT00864253|474032980|FG001|Overall Study|Withdrawal by Subject|18|||
131658025|NCT00864253|474032979|FG000|Overall Study|Death|1|||
131658026|NCT00864253|474032980|FG001|Overall Study|Death|0|||
131658027|NCT00864253|474032979|FG000|Overall Study|Ongoing|2|||
131658028|NCT00864253|474032980|FG001|Overall Study|Ongoing|3|||
131658029|NCT00864253|474032979|FG000|Overall Study|Untreated|7|||
131658030|NCT00864253|474032980|FG001|Overall Study|Untreated|7|||
131658031|NCT01896726|474032981|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
131658032|NCT01896726|474032981|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
131658033|NCT01128114|474032982|FG000|Overall Study|Treatment Withdrawn|6|||
131658034|NCT01128114|474032982|FG000|Overall Study|Screening Failed|2|||
131658035|NCT01111240|474032983|FG000|Overall Study|Adverse Event|190|||
131658036|NCT01111240|474032983|FG000|Overall Study|Lack of Efficacy|545|||
131658037|NCT01111240|474032983|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
131658038|NCT01111240|474032983|FG000|Overall Study|Other|312|||
131658039|NCT00208325|474032984|FG000|Overall Study|Death|18|||
131658040|NCT00208325|474032985|FG001|Overall Study|Death|19|||
131658041|NCT00208325|474032986|FG002|Overall Study|Death|7|||
131658042|NCT00208325|474032987|FG003|Overall Study|Death|5|||
131658043|NCT00208325|474032984|FG000|Overall Study|Withdrawal by Subject|0|||
131658044|NCT00208325|474032985|FG001|Overall Study|Withdrawal by Subject|1|||
131658045|NCT00208325|474032986|FG002|Overall Study|Withdrawal by Subject|0|||
131658046|NCT00208325|474032987|FG003|Overall Study|Withdrawal by Subject|0|||
131658047|NCT00208325|474032984|FG000|Overall Study|Revision|4|||
131658048|NCT00208325|474032985|FG001|Overall Study|Revision|1|||
131658049|NCT00208325|474032986|FG002|Overall Study|Revision|0|||
131658050|NCT00208325|474032987|FG003|Overall Study|Revision|4|||
131658051|NCT00208325|474032984|FG000|Overall Study|Lost to Follow-up|1|||
131658052|NCT00208325|474032985|FG001|Overall Study|Lost to Follow-up|0|||
131658053|NCT00208325|474032986|FG002|Overall Study|Lost to Follow-up|2|||
131658054|NCT00208325|474032987|FG003|Overall Study|Lost to Follow-up|0|||
131658055|NCT00208325|474032984|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
131658056|NCT00208325|474032985|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
131658057|NCT00208325|474032986|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
131658058|NCT00208325|474032987|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
131658059|NCT00208325|474032984|FG000|Overall Study|Does not wish to Continue in Study|5|||
131658060|NCT00208325|474032985|FG001|Overall Study|Does not wish to Continue in Study|8|||
131658061|NCT00208325|474032986|FG002|Overall Study|Does not wish to Continue in Study|3|||
131658062|NCT00208325|474032987|FG003|Overall Study|Does not wish to Continue in Study|2|||
131658063|NCT00208325|474032984|FG000|Overall Study|Other|2|||
131658064|NCT00208325|474032985|FG001|Overall Study|Other|1|||
131658065|NCT00208325|474032986|FG002|Overall Study|Other|1|||
131658066|NCT00208325|474032987|FG003|Overall Study|Other|0|||
131658067|NCT00208325|474032984|FG000|Overall Study|Mis-Randomized|17|||
131658068|NCT00208325|474032985|FG001|Overall Study|Mis-Randomized|20|||
131658069|NCT00208325|474032986|FG002|Overall Study|Mis-Randomized|0|||
131658070|NCT00208325|474032987|FG003|Overall Study|Mis-Randomized|0|||
131658071|NCT02206061|474032988|FG000|Overall Study|Withdrawal by Subject|4|||
131658072|NCT02206061|474032989|FG001|Overall Study|Withdrawal by Subject|7|||
131658073|NCT02206061|474032990|FG002|Overall Study|Withdrawal by Subject|1|||
131658074|NCT02206061|474032988|FG000|Overall Study|Lost to Follow-up|14|||
131658075|NCT02206061|474032989|FG001|Overall Study|Lost to Follow-up|7|||
131658076|NCT02206061|474032990|FG002|Overall Study|Lost to Follow-up|20|||
131658077|NCT01607476|474032991|FG000|Overall Study|Withdrawal by Subject|1|||
131658078|NCT01607476|474032992|FG001|Overall Study|Withdrawal by Subject|0|||
131658079|NCT01607476|474032993|FG002|Overall Study|Withdrawal by Subject|1|||
131658080|NCT01607476|474032991|FG000|Overall Study|Lost to Follow-up|0|||
131658081|NCT01607476|474032992|FG001|Overall Study|Lost to Follow-up|0|||
131658082|NCT01607476|474032993|FG002|Overall Study|Lost to Follow-up|2|||
131658083|NCT04445987|474032994|FG000|Overall Study|Adverse Event|0|||
131658084|NCT04445987|474032995|FG001|Overall Study|Adverse Event|0|||
131658107|NCT04445987|474032994|FG000|Overall Study|Withdrawal by Subject|4|||
131658108|NCT04445987|474032995|FG001|Overall Study|Withdrawal by Subject|0|||
131658109|NCT04445987|474032996|FG002|Overall Study|Withdrawal by Subject|1|||
131658110|NCT04445987|474032997|FG003|Overall Study|Withdrawal by Subject|0|||
131658111|NCT04445987|474032998|FG004|Overall Study|Withdrawal by Subject|18|||
131658112|NCT04445987|474032999|FG005|Overall Study|Withdrawal by Subject|1|||
131658113|NCT04445987|474032994|FG000|Overall Study|Other reason|0|||
131658114|NCT04445987|474032995|FG001|Overall Study|Other reason|0|||
131658115|NCT04445987|474032996|FG002|Overall Study|Other reason|1|||
131658116|NCT04445987|474032997|FG003|Overall Study|Other reason|0|||
131658117|NCT04445987|474032998|FG004|Overall Study|Other reason|2|||
131658118|NCT04445987|474032999|FG005|Overall Study|Other reason|0|||
131658119|NCT01114880|474033000|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
131658120|NCT01114880|474033001|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
131658121|NCT01114880|474033000|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
131658122|NCT01114880|474033001|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
131658123|NCT01114880|474033000|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
131658124|NCT01114880|474033001|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
131658125|NCT01114880|474033000|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
131658126|NCT01114880|474033001|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
131658127|NCT01114880|474033000|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
131658128|NCT01114880|474033001|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
131658129|NCT01114880|474033000|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
131658130|NCT01114880|474033001|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
131658131|NCT04157400|474033007|FG000|Overall Study|Withdrawal by Subject|1|||
131658132|NCT04157400|474033007|FG000|Overall Study|Lost to Follow-up|3|||
131658133|NCT04655027|474033008|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
131658134|NCT04655027|474033009|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
131658135|NCT03519997|474033012|FG000|Overall Study|Adverse Event|4|||
131658136|NCT03519997|474033012|FG000|Overall Study|Withdrawal by Subject|2|||
131658137|NCT03519997|474033012|FG000|Overall Study|Protocol Violation|1|||
131658138|NCT05543707|474033013|FG000|Overall Study|Study drug non-compliance/|5|||
131658139|NCT05543707|474033014|FG001|Overall Study|Study drug non-compliance/|0|||
131658140|NCT05543707|474033013|FG000|Overall Study|Withdrawal by Subject|1|||
131658141|NCT05543707|474033014|FG001|Overall Study|Withdrawal by Subject|1|||
131658142|NCT05543707|474033013|FG000|Overall Study|Adverse Event|1|||
131658143|NCT05543707|474033014|FG001|Overall Study|Adverse Event|0|||
131658144|NCT05543707|474033013|FG000|Overall Study|concurrent illness|0|||
131658145|NCT05543707|474033014|FG001|Overall Study|concurrent illness|1|||
131658146|NCT05543707|474033013|FG000|Overall Study|Pregnancy|1|||
131658147|NCT05543707|474033014|FG001|Overall Study|Pregnancy|1|||
131658148|NCT00186888|474033015|FG000|Overall Study|Toxicity|0|||
131658149|NCT00186888|474033016|FG001|Overall Study|Toxicity|1|||
131658150|NCT00186888|474033017|FG002|Overall Study|Toxicity|0|||
131658151|NCT00186888|474033015|FG000|Overall Study|Relapse or progression of disease|4|||
131658152|NCT00186888|474033016|FG001|Overall Study|Relapse or progression of disease|2|||
131658153|NCT00186888|474033017|FG002|Overall Study|Relapse or progression of disease|0|||
131658154|NCT03006848|474033018|FG000|Overall Study|Adverse Event|1|||
131658155|NCT03006848|474033018|FG000|Overall Study|Physician Decision|1|||
131658156|NCT03006848|474033018|FG000|Overall Study|Lack of Efficacy|16|||
131658157|NCT04372121|474033022|FG000|Overall Study|Lost to Follow-up|0|||
131658158|NCT04372121|474033023|FG001|Overall Study|Lost to Follow-up|0|||
131658159|NCT04372121|474033024|FG002|Overall Study|Lost to Follow-up|0|||
131658160|NCT04372121|474033025|FG003|Overall Study|Lost to Follow-up|1|||
131658161|NCT04372121|474033022|FG000|Overall Study|Protocol Violation|0|||
131658162|NCT04372121|474033023|FG001|Overall Study|Protocol Violation|0|||
131658163|NCT04372121|474033024|FG002|Overall Study|Protocol Violation|1|||
131658164|NCT04372121|474033025|FG003|Overall Study|Protocol Violation|0|||
131658165|NCT04372121|474033022|FG000|Overall Study|Withdrawal by Subject|3|||
131658166|NCT04372121|474033023|FG001|Overall Study|Withdrawal by Subject|1|||
131658167|NCT04372121|474033024|FG002|Overall Study|Withdrawal by Subject|0|||
131658168|NCT04372121|474033025|FG003|Overall Study|Withdrawal by Subject|0|||
131658169|NCT04372121|474033022|FG000|Overall Study|Study termination|6|||
131658170|NCT04372121|474033023|FG001|Overall Study|Study termination|5|||
131658171|NCT04372121|474033024|FG002|Overall Study|Study termination|1|||
131658172|NCT04372121|474033025|FG003|Overall Study|Study termination|1|||
131658173|NCT04372121|474033022|FG000|Overall Study|Hysterectomy planned|1|||
131658174|NCT04372121|474033023|FG001|Overall Study|Hysterectomy planned|0|||
131658175|NCT04372121|474033024|FG002|Overall Study|Hysterectomy planned|0|||
131658176|NCT04372121|474033025|FG003|Overall Study|Hysterectomy planned|0|||
131658177|NCT02344290|474033026|FG000|Overall Study|Withdrawal by Subject|315|||
131658178|NCT02344290|474033027|FG001|Overall Study|Withdrawal by Subject|324|||
131658179|NCT02344290|474033026|FG000|Overall Study|Lost to Follow-up|258|||
131658180|NCT02344290|474033027|FG001|Overall Study|Lost to Follow-up|249|||
131658181|NCT02344290|474033026|FG000|Overall Study|Unable to get to clinic|69|||
131658182|NCT02344290|474033027|FG001|Overall Study|Unable to get to clinic|60|||
131658189|NCT03826030|474033028|FG000|Overall Study|Withdrawal by Subject|2|||
131658190|NCT03826030|474033029|FG001|Overall Study|Withdrawal by Subject|0|||
131658191|NCT03826030|474033030|FG002|Overall Study|Withdrawal by Subject|1|||
131658192|NCT03826030|474033028|FG000|Overall Study|Lost to Follow-up|1|||
131658193|NCT03826030|474033029|FG001|Overall Study|Lost to Follow-up|1|||
131658194|NCT03826030|474033030|FG002|Overall Study|Lost to Follow-up|1|||
131658195|NCT03826030|474033028|FG000|Overall Study|Too busy to return for visits|1|||
131658196|NCT03826030|474033029|FG001|Overall Study|Too busy to return for visits|0|||
131658197|NCT03826030|474033030|FG002|Overall Study|Too busy to return for visits|0|||
131658198|NCT03820947|474033035|FG000|Overall Study|Physician Decision|0|||
131658199|NCT03820947|474033036|FG001|Overall Study|Physician Decision|1|||
131658200|NCT03820947|474033037|FG002|Overall Study|Physician Decision|1|||
131658201|NCT03820947|474033038|FG003|Overall Study|Physician Decision|0|||
131658202|NCT03820947|474033039|FG004|Overall Study|Physician Decision|3|||
131658203|NCT03820947|474033035|FG000|Overall Study|Withdrawal by Subject|6|||
131658204|NCT03820947|474033036|FG001|Overall Study|Withdrawal by Subject|10|||
131658205|NCT03820947|474033037|FG002|Overall Study|Withdrawal by Subject|3|||
131658206|NCT03820947|474033038|FG003|Overall Study|Withdrawal by Subject|8|||
131658207|NCT03820947|474033039|FG004|Overall Study|Withdrawal by Subject|5|||
131658208|NCT03820947|474033035|FG000|Overall Study|Procedure Not Attempted|0|||
131658209|NCT03820947|474033036|FG001|Overall Study|Procedure Not Attempted|2|||
131658210|NCT03820947|474033037|FG002|Overall Study|Procedure Not Attempted|1|||
131658211|NCT03820947|474033038|FG003|Overall Study|Procedure Not Attempted|0|||
131658212|NCT03820947|474033039|FG004|Overall Study|Procedure Not Attempted|0|||
131658213|NCT03820947|474033035|FG000|Overall Study|Other Exit|1|||
131658214|NCT03820947|474033036|FG001|Overall Study|Other Exit|3|||
131658215|NCT03820947|474033037|FG002|Overall Study|Other Exit|3|||
131658216|NCT03820947|474033038|FG003|Overall Study|Other Exit|3|||
131658217|NCT03820947|474033039|FG004|Overall Study|Other Exit|0|||
131658218|NCT03820947|474033035|FG000|Overall Study|Follow-up Not Done|10|||
131658219|NCT03820947|474033036|FG001|Overall Study|Follow-up Not Done|13|||
131658220|NCT03820947|474033037|FG002|Overall Study|Follow-up Not Done|2|||
131658221|NCT03820947|474033038|FG003|Overall Study|Follow-up Not Done|3|||
131658222|NCT03820947|474033039|FG004|Overall Study|Follow-up Not Done|12|||
131658223|NCT03820947|474033035|FG000|Overall Study|Death|0|||
131658224|NCT03820947|474033036|FG001|Overall Study|Death|0|||
131658225|NCT03820947|474033037|FG002|Overall Study|Death|0|||
131658226|NCT03820947|474033038|FG003|Overall Study|Death|0|||
131658227|NCT03820947|474033039|FG004|Overall Study|Death|9|||
131658228|NCT03820947|474033035|FG000|Overall Study|Lost to Follow-up|4|||
131658229|NCT03820947|474033036|FG001|Overall Study|Lost to Follow-up|6|||
131658230|NCT03820947|474033037|FG002|Overall Study|Lost to Follow-up|0|||
131658231|NCT03820947|474033038|FG003|Overall Study|Lost to Follow-up|0|||
131658232|NCT03820947|474033039|FG004|Overall Study|Lost to Follow-up|9|||
131658233|NCT04500769|474035270|FG000|Overall Study|Withdrawal by Subject|5|||
131658234|NCT01967147|474035271|FG000|Overall Study|Adverse Event|5|||
131658235|NCT01967147|474035272|FG001|Overall Study|Adverse Event|2|||
131658236|NCT01967147|474035271|FG000|Overall Study|Lack of Efficacy|1|||
131658237|NCT01967147|474035272|FG001|Overall Study|Lack of Efficacy|4|||
131658238|NCT01967147|474035271|FG000|Overall Study|Lost to Follow-up|1|||
131658239|NCT01967147|474035272|FG001|Overall Study|Lost to Follow-up|2|||
131658240|NCT01967147|474035271|FG000|Overall Study|Withdrawal by Subject|2|||
131658241|NCT01967147|474035272|FG001|Overall Study|Withdrawal by Subject|4|||
131658242|NCT01967147|474035271|FG000|Overall Study|Non-compliance with Study Drug|0|||
131658243|NCT01967147|474035272|FG001|Overall Study|Non-compliance with Study Drug|3|||
131658244|NCT01967147|474035271|FG000|Overall Study|Other|4|||
131658245|NCT01967147|474035272|FG001|Overall Study|Other|5|||
131658246|NCT02218606|474035273|FG000|Overall Study|Adverse Event|1|||
131658247|NCT02218606|474035274|FG001|Overall Study|Adverse Event|1|||
131658248|NCT02218606|474035273|FG000|Overall Study|Death|15|||
131658249|NCT02218606|474035274|FG001|Overall Study|Death|28|||
131658250|NCT02218606|474035273|FG000|Overall Study|Physician Decision|0|||
131658251|NCT02218606|474035274|FG001|Overall Study|Physician Decision|1|||
131658252|NCT02218606|474035273|FG000|Overall Study|Withdrawal by Subject|4|||
131658253|NCT02218606|474035274|FG001|Overall Study|Withdrawal by Subject|0|||
131658254|NCT02218606|474035273|FG000|Overall Study|Noncompliance|1|||
131658255|NCT02218606|474035274|FG001|Overall Study|Noncompliance|0|||
131658256|NCT02218606|474035273|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
131658257|NCT02218606|474035274|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
131658258|NCT02218606|474035273|FG000|Overall Study|Other|2|||
131658259|NCT02218606|474035274|FG001|Overall Study|Other|1|||
131658260|NCT02218606|474035273|FG000|Overall Study|Never started treatment|0|||
131658261|NCT02218606|474035274|FG001|Overall Study|Never started treatment|1|||
131658262|NCT03203473|474035275|FG000|Induction Phase|Never started primary treatment|2|||
131658263|NCT03203473|474035276|FG001|Induction Phase|Never started primary treatment|0|||
131658264|NCT03203473|474035277|FG002|Induction Phase|Never started primary treatment|0|||
131658265|NCT03203473|474035275|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
131658266|NCT03203473|474035276|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
131658267|NCT03203473|474035277|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
131658268|NCT03203473|474035275|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
131658269|NCT03203473|474035276|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
131658270|NCT03203473|474035277|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
131658271|NCT03203473|474035275|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
131658272|NCT03203473|474035276|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
131658273|NCT03203473|474035277|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
131658274|NCT03203473|474035275|FG000|Arm Allocation Phase|started salvage therapy|0|||
131658275|NCT03203473|474035276|FG001|Arm Allocation Phase|started salvage therapy|5|||
131658276|NCT03203473|474035277|FG002|Arm Allocation Phase|started salvage therapy|0|||
131658277|NCT03203473|474035275|FG000|Arm Allocation Phase|Disease progression|0|||
131658278|NCT03203473|474035276|FG001|Arm Allocation Phase|Disease progression|0|||
131658279|NCT03203473|474035277|FG002|Arm Allocation Phase|Disease progression|37|||
131658280|NCT03203473|474035275|FG000|Arm Allocation Phase|Adverse Event|0|||
131658281|NCT03203473|474035276|FG001|Arm Allocation Phase|Adverse Event|0|||
131658282|NCT03203473|474035277|FG002|Arm Allocation Phase|Adverse Event|11|||
131658283|NCT03203473|474035275|FG000|Arm Allocation Phase|Physician Decision|0|||
131658284|NCT03203473|474035276|FG001|Arm Allocation Phase|Physician Decision|0|||
131658285|NCT03203473|474035277|FG002|Arm Allocation Phase|Physician Decision|3|||
131658286|NCT03203473|474035275|FG000|Arm Allocation Phase|Death|0|||
131658287|NCT03203473|474035276|FG001|Arm Allocation Phase|Death|0|||
131658288|NCT03203473|474035277|FG002|Arm Allocation Phase|Death|1|||
131658289|NCT03203473|474035275|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
131658290|NCT03203473|474035276|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
131658291|NCT03203473|474035277|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
131658292|NCT03203473|474035275|FG000|Arm Allocation Phase|Intercurrent illness|0|||
131658293|NCT03203473|474035276|FG001|Arm Allocation Phase|Intercurrent illness|0|||
131658294|NCT03203473|474035277|FG002|Arm Allocation Phase|Intercurrent illness|1|||
131658295|NCT03203473|474035275|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
131658296|NCT03203473|474035276|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
131658297|NCT03203473|474035277|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
131658298|NCT00890695|474035278|FG000|Overall Study|Protocol Violation|1|||
131658299|NCT00890695|474035279|FG001|Overall Study|Protocol Violation|0|||
131658300|NCT01255631|474035284|FG000|Overall Study|poor enrollment, no data analyzed|9|||
131658301|NCT01255631|474035285|FG001|Overall Study|poor enrollment, no data analyzed|6|||
131658302|NCT00568178|474035293|FG000|Double Blind Base Study|Adverse Event|0|||
131658303|NCT00568178|474035294|FG001|Double Blind Base Study|Adverse Event|2|||
131658304|NCT00568178|474035295|FG002|Double Blind Base Study|Adverse Event|1|||
131658305|NCT00568178|474035296|FG003|Double Blind Base Study|Adverse Event|2|||
131658306|NCT00568178|474035297|FG004|Double Blind Base Study|Adverse Event|0|||
131658307|NCT00568178|474035298|FG005|Double Blind Base Study|Adverse Event|0|||
131658308|NCT00568178|474035293|FG000|Double Blind Base Study|Lost to Follow-up|1|||
131658309|NCT00568178|474035294|FG001|Double Blind Base Study|Lost to Follow-up|0|||
131658310|NCT00568178|474035295|FG002|Double Blind Base Study|Lost to Follow-up|0|||
131658311|NCT00568178|474035296|FG003|Double Blind Base Study|Lost to Follow-up|1|||
131658312|NCT00568178|474035297|FG004|Double Blind Base Study|Lost to Follow-up|0|||
131658313|NCT00568178|474035298|FG005|Double Blind Base Study|Lost to Follow-up|0|||
131658314|NCT00568178|474035293|FG000|Double Blind Base Study|Physician Decision|1|||
131658315|NCT00568178|474035294|FG001|Double Blind Base Study|Physician Decision|1|||
131658316|NCT00568178|474035295|FG002|Double Blind Base Study|Physician Decision|0|||
131658317|NCT00568178|474035296|FG003|Double Blind Base Study|Physician Decision|1|||
131658318|NCT00568178|474035297|FG004|Double Blind Base Study|Physician Decision|0|||
131658319|NCT00568178|474035298|FG005|Double Blind Base Study|Physician Decision|0|||
131658320|NCT00568178|474035293|FG000|Double Blind Base Study|Protocol Violation|3|||
131658321|NCT00568178|474035294|FG001|Double Blind Base Study|Protocol Violation|2|||
131658322|NCT00568178|474035295|FG002|Double Blind Base Study|Protocol Violation|0|||
131658323|NCT00568178|474035296|FG003|Double Blind Base Study|Protocol Violation|0|||
131658324|NCT00568178|474035297|FG004|Double Blind Base Study|Protocol Violation|0|||
131658325|NCT00568178|474035298|FG005|Double Blind Base Study|Protocol Violation|0|||
131658326|NCT00568178|474035293|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
131658327|NCT00568178|474035294|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
131658328|NCT00568178|474035295|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
131658329|NCT00568178|474035296|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
131658330|NCT00568178|474035297|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
131658331|NCT00568178|474035298|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
131658332|NCT00568178|474035293|FG000|Double Blind Base Study|Progressive Disease|0|||
131658333|NCT00568178|474035294|FG001|Double Blind Base Study|Progressive Disease|0|||
131658334|NCT00568178|474035295|FG002|Double Blind Base Study|Progressive Disease|0|||
131658335|NCT00568178|474035296|FG003|Double Blind Base Study|Progressive Disease|1|||
131658336|NCT00568178|474035297|FG004|Double Blind Base Study|Progressive Disease|0|||
131658337|NCT00568178|474035298|FG005|Double Blind Base Study|Progressive Disease|0|||
131658338|NCT00568178|474035293|FG000|Open Label Extension|Adverse Event|0|||
131658339|NCT00568178|474035294|FG001|Open Label Extension|Adverse Event|0|||
131658340|NCT00568178|474035295|FG002|Open Label Extension|Adverse Event|0|||
131658341|NCT00568178|474035296|FG003|Open Label Extension|Adverse Event|0|||
131658342|NCT00568178|474035297|FG004|Open Label Extension|Adverse Event|11|||
131658343|NCT00568178|474035298|FG005|Open Label Extension|Adverse Event|8|||
131658344|NCT00568178|474035293|FG000|Open Label Extension|Protocol Violation|0|||
131658345|NCT00568178|474035294|FG001|Open Label Extension|Protocol Violation|0|||
131658346|NCT00568178|474035295|FG002|Open Label Extension|Protocol Violation|0|||
131658347|NCT00568178|474035296|FG003|Open Label Extension|Protocol Violation|0|||
131658348|NCT00568178|474035297|FG004|Open Label Extension|Protocol Violation|1|||
131658349|NCT00568178|474035298|FG005|Open Label Extension|Protocol Violation|0|||
131658350|NCT00568178|474035293|FG000|Open Label Extension|Lost to Follow-up|0|||
131658351|NCT00568178|474035294|FG001|Open Label Extension|Lost to Follow-up|0|||
131658352|NCT00568178|474035295|FG002|Open Label Extension|Lost to Follow-up|0|||
131658353|NCT00568178|474035296|FG003|Open Label Extension|Lost to Follow-up|0|||
131658354|NCT00568178|474035297|FG004|Open Label Extension|Lost to Follow-up|6|||
131658355|NCT00568178|474035298|FG005|Open Label Extension|Lost to Follow-up|11|||
131658356|NCT00568178|474035293|FG000|Open Label Extension|Physician Decision|0|||
131658357|NCT00568178|474035294|FG001|Open Label Extension|Physician Decision|0|||
131658358|NCT00568178|474035295|FG002|Open Label Extension|Physician Decision|0|||
131658359|NCT00568178|474035296|FG003|Open Label Extension|Physician Decision|0|||
131658360|NCT00568178|474035297|FG004|Open Label Extension|Physician Decision|9|||
131658361|NCT00568178|474035298|FG005|Open Label Extension|Physician Decision|8|||
131658362|NCT00568178|474035293|FG000|Open Label Extension|Pregnancy|0|||
131658363|NCT00568178|474035294|FG001|Open Label Extension|Pregnancy|0|||
131658364|NCT00568178|474035295|FG002|Open Label Extension|Pregnancy|0|||
131658365|NCT00568178|474035296|FG003|Open Label Extension|Pregnancy|0|||
131658366|NCT00568178|474035297|FG004|Open Label Extension|Pregnancy|0|||
131658367|NCT00568178|474035298|FG005|Open Label Extension|Pregnancy|1|||
131658368|NCT00568178|474035293|FG000|Open Label Extension|Progressive Disease|0|||
131658369|NCT00568178|474035294|FG001|Open Label Extension|Progressive Disease|0|||
131658370|NCT00568178|474035295|FG002|Open Label Extension|Progressive Disease|0|||
131658371|NCT00568178|474035296|FG003|Open Label Extension|Progressive Disease|0|||
131658372|NCT00568178|474035297|FG004|Open Label Extension|Progressive Disease|3|||
131658373|NCT00568178|474035298|FG005|Open Label Extension|Progressive Disease|1|||
131658374|NCT00568178|474035293|FG000|Open Label Extension|Termination of Trial|0|||
131658375|NCT00568178|474035294|FG001|Open Label Extension|Termination of Trial|0|||
131658376|NCT00568178|474035295|FG002|Open Label Extension|Termination of Trial|0|||
131658377|NCT00568178|474035296|FG003|Open Label Extension|Termination of Trial|0|||
131658378|NCT00568178|474035297|FG004|Open Label Extension|Termination of Trial|45|||
131658379|NCT00568178|474035298|FG005|Open Label Extension|Termination of Trial|47|||
131658380|NCT00568178|474035293|FG000|Open Label Extension|Withdrawal by Subject|0|||
131658381|NCT00568178|474035294|FG001|Open Label Extension|Withdrawal by Subject|0|||
131658382|NCT00568178|474035295|FG002|Open Label Extension|Withdrawal by Subject|0|||
131658383|NCT00568178|474035296|FG003|Open Label Extension|Withdrawal by Subject|0|||
131658384|NCT00568178|474035297|FG004|Open Label Extension|Withdrawal by Subject|4|||
131658385|NCT00568178|474035298|FG005|Open Label Extension|Withdrawal by Subject|4|||
131658386|NCT01531673|474035299|FG000|Overall Study|Non-Compliance|0|||
131658387|NCT01531673|474035300|FG001|Overall Study|Non-Compliance|0|||
131658388|NCT01531673|474035301|FG002|Overall Study|Non-Compliance|0|||
131658389|NCT01531673|474035302|FG003|Overall Study|Non-Compliance|0|||
131658390|NCT01531673|474035303|FG004|Overall Study|Non-Compliance|0|||
131658391|NCT01531673|474035304|FG005|Overall Study|Non-Compliance|1|||
131658392|NCT01531673|474035305|FG006|Overall Study|Non-Compliance|0|||
131658393|NCT01531673|474035306|FG007|Overall Study|Non-Compliance|0|||
131658394|NCT01531673|474035307|FG008|Overall Study|Non-Compliance|0|||
131658395|NCT01531673|474035308|FG009|Overall Study|Non-Compliance|0|||
131658396|NCT01531673|474035309|FG010|Overall Study|Non-Compliance|0|||
131658397|NCT01531673|474035310|FG011|Overall Study|Non-Compliance|0|||
131658398|NCT01531673|474035311|FG012|Overall Study|Non-Compliance|0|||
131658399|NCT01531673|474035299|FG000|Overall Study|Adverse Event|0|||
131658400|NCT01531673|474035300|FG001|Overall Study|Adverse Event|1|||
131658401|NCT01531673|474035301|FG002|Overall Study|Adverse Event|0|||
131658402|NCT01531673|474035302|FG003|Overall Study|Adverse Event|0|||
131658403|NCT01531673|474035303|FG004|Overall Study|Adverse Event|0|||
131658404|NCT01531673|474035304|FG005|Overall Study|Adverse Event|0|||
131658405|NCT01531673|474035305|FG006|Overall Study|Adverse Event|0|||
131658406|NCT01531673|474035306|FG007|Overall Study|Adverse Event|0|||
131658407|NCT01531673|474035307|FG008|Overall Study|Adverse Event|0|||
131658408|NCT01531673|474035308|FG009|Overall Study|Adverse Event|0|||
131658409|NCT01531673|474035309|FG010|Overall Study|Adverse Event|0|||
131658410|NCT01531673|474035310|FG011|Overall Study|Adverse Event|0|||
131658411|NCT01531673|474035311|FG012|Overall Study|Adverse Event|0|||
131658412|NCT01531673|474035299|FG000|Overall Study|Lost to Follow-up|0|||
131658413|NCT01531673|474035300|FG001|Overall Study|Lost to Follow-up|0|||
131658414|NCT01531673|474035301|FG002|Overall Study|Lost to Follow-up|0|||
131658415|NCT01531673|474035302|FG003|Overall Study|Lost to Follow-up|0|||
131658444|NCT00264303|474035312|FG000|Overall Study|Withdrawal by Subject|2|||
131658445|NCT00264303|474035313|FG001|Overall Study|Withdrawal by Subject|3|||
131658446|NCT00264303|474035312|FG000|Overall Study|Various reasons listed in study report|6|||
131658447|NCT00264303|474035313|FG001|Overall Study|Various reasons listed in study report|7|||
131658448|NCT02815579|474035314|FG000|Overall Study|Non-payment of loan down-payment|16|||
131658449|NCT02815579|474035315|FG001|Overall Study|Non-payment of loan down-payment|0|||
131658450|NCT02815579|474035314|FG000|Overall Study|Withdrawal by Subject|7|||
131658451|NCT02815579|474035315|FG001|Overall Study|Withdrawal by Subject|1|||
131658452|NCT02815579|474035314|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
131658453|NCT02815579|474035315|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
131658454|NCT02815579|474035314|FG000|Overall Study|Lost to Follow-up|7|||
131658455|NCT02815579|474035315|FG001|Overall Study|Lost to Follow-up|4|||
131658456|NCT02815579|474035314|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
131658457|NCT02815579|474035315|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
131658458|NCT02815579|474035314|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
131658459|NCT02815579|474035315|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
131658460|NCT02815579|474035314|FG000|Overall Study|Death|5|||
131658461|NCT02815579|474035315|FG001|Overall Study|Death|4|||
131658462|NCT02815579|474035314|FG000|Overall Study|Imprisoned|0|||
131658463|NCT02815579|474035315|FG001|Overall Study|Imprisoned|2|||
131658464|NCT02815579|474035314|FG000|Overall Study|Did not meet enrollment criteria|0|||
131658465|NCT02815579|474035315|FG001|Overall Study|Did not meet enrollment criteria|1|||
131658466|NCT02389452|474035316|FG000|Overall Study|Lost to Follow-up|13|||
131658467|NCT02389452|474035316|FG000|Overall Study|Adverse Event|1|||
131658468|NCT02389452|474035316|FG000|Overall Study|Withdrawal by Subject|5|||
131658469|NCT02389452|474035316|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
131658470|NCT02311673|474035317|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
131658471|NCT02311673|474035318|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
131658472|NCT02311673|474035319|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
131658473|NCT02311673|474035320|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
131658474|NCT00414908|474035331|FG000|Overall Study|Protocol Violation|1|||
131658475|NCT00414908|474035332|FG001|Overall Study|Protocol Violation|1|||
131658476|NCT01076153|474035333|FG000|Overall Study|Symptoms improved/resolved|10|||
131658477|NCT01076153|474035333|FG000|Overall Study|Adverse Event|1|||
131658478|NCT00818168|474035334|FG000|Overall Study|Lack of Efficacy|18|||
131658479|NCT00818168|474035334|FG000|Overall Study|Pregnancy|2|||
131658480|NCT00818168|474035334|FG000|Overall Study|Withdrawal by Subject|16|||
131658481|NCT00818168|474035334|FG000|Overall Study|Lost to Follow-up|7|||
131658482|NCT00818168|474035334|FG000|Overall Study|Adverse Event|19|||
131658483|NCT00818168|474035334|FG000|Overall Study|Reason for Non-completion Not reported|6|||
131658484|NCT00818168|474035334|FG000|Overall Study|Participant Moved|2|||
131658485|NCT02040259|474035337|FG000|Overall Study|Death|280|||
131658486|NCT02040259|474035337|FG000|Overall Study|Lost to Follow-up|76|||
131658487|NCT02040259|474035337|FG000|Overall Study|Assessment not completed|3|||
131658488|NCT02040259|474035337|FG000|Overall Study|Withdrawal by Subject|4|||
131658489|NCT04476251|474035338|FG000|Overall Study|Not treated|1|||
131658490|NCT00316602|474035349|FG000|Overall Study|Withdrawal by Subject|3|||
131658491|NCT00316602|474035350|FG001|Overall Study|Withdrawal by Subject|2|||
131658492|NCT00316602|474035349|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
131658493|NCT00316602|474035350|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
131658494|NCT00316602|474035349|FG000|Overall Study|Adverse Event|1|||
131658495|NCT00316602|474035350|FG001|Overall Study|Adverse Event|0|||
131658496|NCT00316602|474035349|FG000|Overall Study|Other|3|||
131658497|NCT00316602|474035350|FG001|Overall Study|Other|6|||
131658498|NCT01142232|474035351|FG000|Overall Study|Adverse Event|1|||
131658499|NCT01142232|474035352|FG001|Overall Study|Adverse Event|2|||
131658500|NCT01142232|474035353|FG002|Overall Study|Adverse Event|1|||
131658501|NCT01142232|474035354|FG003|Overall Study|Adverse Event|0|||
131658502|NCT01142232|474035355|FG004|Overall Study|Adverse Event|4|||
131658503|NCT01142232|474035351|FG000|Overall Study|Death|0|||
131658504|NCT01142232|474035352|FG001|Overall Study|Death|0|||
131658505|NCT01142232|474035353|FG002|Overall Study|Death|0|||
131658506|NCT01142232|474035354|FG003|Overall Study|Death|0|||
131658507|NCT01142232|474035355|FG004|Overall Study|Death|1|||
131658508|NCT01142232|474035351|FG000|Overall Study|Disease Progression|2|||
131658509|NCT01142232|474035352|FG001|Overall Study|Disease Progression|0|||
131658510|NCT01142232|474035353|FG002|Overall Study|Disease Progression|1|||
131658511|NCT01142232|474035354|FG003|Overall Study|Disease Progression|2|||
131658512|NCT01142232|474035355|FG004|Overall Study|Disease Progression|12|||
131658513|NCT01142232|474035351|FG000|Overall Study|Withdrawal by Subject|0|||
131658514|NCT01142232|474035352|FG001|Overall Study|Withdrawal by Subject|0|||
131658515|NCT01142232|474035353|FG002|Overall Study|Withdrawal by Subject|0|||
131658516|NCT01142232|474035354|FG003|Overall Study|Withdrawal by Subject|1|||
131658517|NCT01142232|474035355|FG004|Overall Study|Withdrawal by Subject|3|||
131658528|NCT01142232|474035351|FG000|Overall Study|Off Trt for other complicating disease|0|||
131658529|NCT01142232|474035352|FG001|Overall Study|Off Trt for other complicating disease|0|||
131658530|NCT01142232|474035353|FG002|Overall Study|Off Trt for other complicating disease|0|||
131658531|NCT01142232|474035354|FG003|Overall Study|Off Trt for other complicating disease|0|||
131658532|NCT01142232|474035355|FG004|Overall Study|Off Trt for other complicating disease|1|||
131658533|NCT01142232|474035351|FG000|Overall Study|Noncompliance|0|||
131658534|NCT01142232|474035352|FG001|Overall Study|Noncompliance|0|||
131658535|NCT01142232|474035353|FG002|Overall Study|Noncompliance|0|||
131658536|NCT01142232|474035354|FG003|Overall Study|Noncompliance|0|||
131658537|NCT01142232|474035355|FG004|Overall Study|Noncompliance|2|||
131658538|NCT00626990|474035358|FG000|Overall Study|Lack of Efficacy|6|||
131658539|NCT00626990|474035359|FG001|Overall Study|Lack of Efficacy|7|||
131658540|NCT00626990|474035360|FG002|Overall Study|Lack of Efficacy|49|||
131658541|NCT00626990|474035361|FG003|Overall Study|Lack of Efficacy|40|||
131658542|NCT00626990|474035358|FG000|Overall Study|Adverse Event|1|||
131658543|NCT00626990|474035359|FG001|Overall Study|Adverse Event|7|||
131658544|NCT00626990|474035360|FG002|Overall Study|Adverse Event|14|||
131658545|NCT00626990|474035361|FG003|Overall Study|Adverse Event|28|||
131658546|NCT00626990|474035358|FG000|Overall Study|Death|0|||
131658547|NCT00626990|474035359|FG001|Overall Study|Death|1|||
131658548|NCT00626990|474035360|FG002|Overall Study|Death|0|||
131658549|NCT00626990|474035361|FG003|Overall Study|Death|0|||
131658550|NCT00626990|474035358|FG000|Overall Study|Withdrawal by Subject|3|||
131658551|NCT00626990|474035359|FG001|Overall Study|Withdrawal by Subject|1|||
131658552|NCT00626990|474035360|FG002|Overall Study|Withdrawal by Subject|5|||
131658553|NCT00626990|474035361|FG003|Overall Study|Withdrawal by Subject|11|||
131658554|NCT00626990|474035358|FG000|Overall Study|Protocol Violation|0|||
131658555|NCT00626990|474035359|FG001|Overall Study|Protocol Violation|1|||
131658556|NCT00626990|474035360|FG002|Overall Study|Protocol Violation|1|||
131658557|NCT00626990|474035361|FG003|Overall Study|Protocol Violation|0|||
131658558|NCT00626990|474035358|FG000|Overall Study|Various different reasons/missing|4|||
131658559|NCT00626990|474035359|FG001|Overall Study|Various different reasons/missing|8|||
131658560|NCT00626990|474035360|FG002|Overall Study|Various different reasons/missing|8|||
131658561|NCT00626990|474035361|FG003|Overall Study|Various different reasons/missing|16|||
131658562|NCT04138576|474035366|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
131658563|NCT00297427|474035367|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
131658564|NCT00297427|474035368|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
131658565|NCT00297427|474035367|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
131658566|NCT00297427|474035368|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
131658567|NCT00297427|474035367|FG000|Phase 1: Initial Intervention|Death|0|||
131658568|NCT00297427|474035368|FG001|Phase 1: Initial Intervention|Death|1|||
131658569|NCT00297427|474035367|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
131658570|NCT00297427|474035368|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
131658571|NCT00297427|474035367|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
131658572|NCT00297427|474035368|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
131658573|NCT00297427|474035367|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
131658574|NCT00297427|474035368|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
131658575|NCT00297427|474035367|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
131658576|NCT00297427|474035368|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
131658577|NCT00297427|474035367|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
131658578|NCT00297427|474035368|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
131658579|NCT02787044|474035371|FG000|Overall Study|Lost to Follow-up|15|||
131658580|NCT02787044|474035372|FG001|Overall Study|Lost to Follow-up|19|||
131658581|NCT02591953|474035374|FG000|Overall Study|Lost to Follow-up|6|||
131658582|NCT02591953|474035375|FG001|Overall Study|Lost to Follow-up|6|||
131658583|NCT01517295|474035378|FG000|Overall Study|Physician Decision|1|||
131658584|NCT01517295|474035379|FG001|Overall Study|Physician Decision|0|||
131658585|NCT02182947|474035380|FG000|Overall Study|Withdrawal by Subject|7|||
131658586|NCT02182947|474035380|FG000|Overall Study|Lost to Follow-up|3|||
131658587|NCT02182947|474035380|FG000|Overall Study|Failed screening activities|8|||
131658588|NCT01656200|474035381|FG000|Overall Study|Withdrawal by Subject|1|||
131658589|NCT02003222|474035395|FG000|Induction|Never started treatment|0|||
131658590|NCT02003222|474035396|FG001|Induction|Never started treatment|0|||
131658591|NCT02003222|474035397|FG002|Induction|Never started treatment|0|||
131658592|NCT02003222|474035398|FG003|Induction|Never started treatment|0|||
131658593|NCT02003222|474035399|FG004|Induction|Never started treatment|8|||
131658594|NCT02003222|474035395|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
131658595|NCT02003222|474035396|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
131658596|NCT02003222|474035397|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
131658597|NCT02003222|474035398|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
131658598|NCT02003222|474035399|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
131658599|NCT02003222|474035395|FG000|Induction|Adverse Event|0|||
131658639|NCT02003222|474035395|FG000|Intensification|Alternative therapy|0|||
131658640|NCT02003222|474035396|FG001|Intensification|Alternative therapy|0|||
131658641|NCT02003222|474035397|FG002|Intensification|Alternative therapy|0|||
131658642|NCT02003222|474035398|FG003|Intensification|Alternative therapy|0|||
131658643|NCT02003222|474035399|FG004|Intensification|Alternative therapy|8|||
131658644|NCT02003222|474035395|FG000|Intensification|Disease progression|0|||
131658645|NCT02003222|474035396|FG001|Intensification|Disease progression|0|||
131658646|NCT02003222|474035397|FG002|Intensification|Disease progression|0|||
131658647|NCT02003222|474035398|FG003|Intensification|Disease progression|0|||
131658648|NCT02003222|474035399|FG004|Intensification|Disease progression|18|||
131658649|NCT02003222|474035395|FG000|Intensification|Withdrawal by Subject|0|||
131658650|NCT02003222|474035396|FG001|Intensification|Withdrawal by Subject|0|||
131658651|NCT02003222|474035397|FG002|Intensification|Withdrawal by Subject|0|||
131658652|NCT02003222|474035398|FG003|Intensification|Withdrawal by Subject|0|||
131658653|NCT02003222|474035399|FG004|Intensification|Withdrawal by Subject|5|||
131658654|NCT02003222|474035395|FG000|Intensification|Other reasons|0|||
131658655|NCT02003222|474035396|FG001|Intensification|Other reasons|0|||
131658656|NCT02003222|474035397|FG002|Intensification|Other reasons|0|||
131658657|NCT02003222|474035398|FG003|Intensification|Other reasons|0|||
131658658|NCT02003222|474035399|FG004|Intensification|Other reasons|8|||
131658659|NCT01365481|474035400|FG000|Overall Study|Adverse Event|6|||
131658660|NCT01365481|474035401|FG001|Overall Study|Adverse Event|9|||
131658661|NCT01365481|474035402|FG002|Overall Study|Adverse Event|0|||
131658662|NCT01365481|474035403|FG003|Overall Study|Adverse Event|2|||
131658663|NCT01365481|474035400|FG000|Overall Study|Withdrawal by Subject|0|||
131658664|NCT01365481|474035401|FG001|Overall Study|Withdrawal by Subject|2|||
131658665|NCT01365481|474035402|FG002|Overall Study|Withdrawal by Subject|1|||
131658666|NCT01365481|474035403|FG003|Overall Study|Withdrawal by Subject|1|||
131658667|NCT01365481|474035400|FG000|Overall Study|Lost to Follow-up|1|||
131658668|NCT01365481|474035401|FG001|Overall Study|Lost to Follow-up|1|||
131658669|NCT01365481|474035402|FG002|Overall Study|Lost to Follow-up|2|||
131658670|NCT01365481|474035403|FG003|Overall Study|Lost to Follow-up|3|||
131658671|NCT01365481|474035400|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131658672|NCT01365481|474035401|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131658673|NCT01365481|474035402|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131658674|NCT01365481|474035403|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131658675|NCT01365481|474035400|FG000|Overall Study|Administrative problems|0|||
131658676|NCT01365481|474035401|FG001|Overall Study|Administrative problems|1|||
131658677|NCT01365481|474035402|FG002|Overall Study|Administrative problems|0|||
131658678|NCT01365481|474035403|FG003|Overall Study|Administrative problems|0|||
131658679|NCT01365481|474035400|FG000|Overall Study|Protocol deviation|0|||
131658680|NCT01365481|474035401|FG001|Overall Study|Protocol deviation|1|||
131658681|NCT01365481|474035402|FG002|Overall Study|Protocol deviation|0|||
131658682|NCT01365481|474035403|FG003|Overall Study|Protocol deviation|1|||
131658683|NCT01365481|474035400|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131658684|NCT01365481|474035401|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131658685|NCT01365481|474035402|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131658686|NCT01365481|474035403|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131658687|NCT01696955|474035406|FG000|Main Study|Protocol Violation|1|||
131658688|NCT01696955|474035407|FG001|Main Study|Protocol Violation|0|||
131658689|NCT01696955|474035406|FG000|Main Study|Withdrawal by Subject|1|||
131658690|NCT01696955|474035407|FG001|Main Study|Withdrawal by Subject|1|||
131658691|NCT03192475|474035408|FG000|Overall Study|Death|0|||
131658692|NCT03192475|474035409|FG001|Overall Study|Death|1|||
131658693|NCT03192475|474035408|FG000|Overall Study|Lost to Follow-up|13|||
131658694|NCT03192475|474035409|FG001|Overall Study|Lost to Follow-up|8|||
131658695|NCT01641159|474035410|FG000|Overall Study|Lost to Follow-up|2|||
131658696|NCT01641159|474035411|FG001|Overall Study|Lost to Follow-up|1|||
131658697|NCT01641159|474035410|FG000|Overall Study|Withdrawal by Subject|0|||
131658698|NCT01641159|474035411|FG001|Overall Study|Withdrawal by Subject|1|||
131658699|NCT00436605|474035412|FG000|Overall Study|Protocol Violation|3|||
131658700|NCT02229851|474035419|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
131658701|NCT02229851|474035420|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
131658702|NCT02229851|474035421|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
131658703|NCT02229851|474035422|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
131658704|NCT02229851|474035423|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
131658705|NCT02229851|474035424|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
131658706|NCT02229851|474035425|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
131658707|NCT02229851|474035419|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131658708|NCT02229851|474035420|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
131658709|NCT02229851|474035421|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131658710|NCT02229851|474035422|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131658711|NCT02229851|474035423|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131658712|NCT02229851|474035424|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131658713|NCT02229851|474035425|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131658714|NCT02229851|474035419|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
131658715|NCT02229851|474035420|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
131658716|NCT02229851|474035421|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
131658717|NCT02229851|474035422|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131658718|NCT02229851|474035423|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131658719|NCT02229851|474035424|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131658720|NCT02229851|474035425|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131658721|NCT02229851|474035419|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131658722|NCT02229851|474035420|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131658723|NCT02229851|474035421|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
131658724|NCT02229851|474035422|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131658725|NCT02229851|474035423|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131658726|NCT02229851|474035424|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131658727|NCT02229851|474035425|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131658728|NCT02229851|474035419|FG000|Main Phase (Double-blind Phase)|Death|1|||
131658729|NCT02229851|474035420|FG001|Main Phase (Double-blind Phase)|Death|1|||
131658730|NCT02229851|474035421|FG002|Main Phase (Double-blind Phase)|Death|0|||
131658731|NCT02229851|474035422|FG003|Main Phase (Double-blind Phase)|Death|0|||
131658732|NCT02229851|474035423|FG004|Main Phase (Double-blind Phase)|Death|0|||
131658733|NCT02229851|474035424|FG005|Main Phase (Double-blind Phase)|Death|0|||
131658734|NCT02229851|474035425|FG006|Main Phase (Double-blind Phase)|Death|0|||
131658735|NCT02229851|474035419|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131658736|NCT02229851|474035420|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131658737|NCT02229851|474035421|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131658738|NCT02229851|474035422|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131658739|NCT02229851|474035423|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
131658740|NCT02229851|474035424|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
131658741|NCT02229851|474035425|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
131658742|NCT02229851|474035419|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
131658743|NCT02229851|474035420|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
131658744|NCT02229851|474035421|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
131658745|NCT02229851|474035422|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
131658746|NCT02229851|474035423|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
131658747|NCT02229851|474035424|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
131658748|NCT02229851|474035425|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
131658749|NCT02229851|474035419|FG000|Extension Phase (Open-label Phase)|Death|0|||
131658750|NCT02229851|474035420|FG001|Extension Phase (Open-label Phase)|Death|0|||
131658751|NCT02229851|474035421|FG002|Extension Phase (Open-label Phase)|Death|0|||
131658752|NCT02229851|474035422|FG003|Extension Phase (Open-label Phase)|Death|1|||
131658753|NCT02229851|474035423|FG004|Extension Phase (Open-label Phase)|Death|0|||
131658754|NCT02229851|474035424|FG005|Extension Phase (Open-label Phase)|Death|1|||
131658755|NCT02229851|474035425|FG006|Extension Phase (Open-label Phase)|Death|1|||
131658756|NCT03284203|474035426|FG000|Overall Study|Lost to Follow-up|3|||
131658757|NCT03541200|474035427|FG000|Overall Study|Adverse Event|19|||
131658758|NCT03541200|474035427|FG000|Overall Study|Death|1|||
131658759|NCT03541200|474035427|FG000|Overall Study|Lost to Follow-up|10|||
131658760|NCT03541200|474035427|FG000|Overall Study|Physician Decision|1|||
131658761|NCT03541200|474035427|FG000|Overall Study|Protocol Violation|51|||
131658762|NCT03541200|474035427|FG000|Overall Study|Withdrawal by Subject|23|||
131658763|NCT03541200|474035427|FG000|Overall Study|other|8|||
131658764|NCT00831129|474035428|FG000|Overall Study|Adverse Event|0|||
131658765|NCT00831129|474035429|FG001|Overall Study|Adverse Event|1|||
131658766|NCT00831129|474035428|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
131658767|NCT00831129|474035429|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
131658768|NCT01283516|474035431|FG000|Overall Study|Adverse Event|0|||
131658769|NCT01283516|474035432|FG001|Overall Study|Adverse Event|0|||
131658770|NCT01283516|474035433|FG002|Overall Study|Adverse Event|0|||
131658771|NCT01283516|474035434|FG003|Overall Study|Adverse Event|0|||
131658772|NCT01283516|474035435|FG004|Overall Study|Adverse Event|0|||
131658773|NCT01283516|474035436|FG005|Overall Study|Adverse Event|0|||
131658774|NCT01283516|474035437|FG006|Overall Study|Adverse Event|2|||
131658775|NCT01283516|474035438|FG007|Overall Study|Adverse Event|0|||
131658776|NCT01283516|474035439|FG008|Overall Study|Adverse Event|28|||
131658777|NCT01283516|474035431|FG000|Overall Study|Death|0|||
131658778|NCT01283516|474035432|FG001|Overall Study|Death|0|||
131658779|NCT01283516|474035433|FG002|Overall Study|Death|0|||
131658780|NCT01283516|474035434|FG003|Overall Study|Death|0|||
131658781|NCT01283516|474035435|FG004|Overall Study|Death|0|||
131658782|NCT01283516|474035436|FG005|Overall Study|Death|1|||
131658783|NCT01283516|474035437|FG006|Overall Study|Death|0|||
131658784|NCT01283516|474035438|FG007|Overall Study|Death|1|||
131658785|NCT01283516|474035439|FG008|Overall Study|Death|12|||
131658786|NCT01283516|474035431|FG000|Overall Study|Disease Progression|2|||
131658787|NCT01283516|474035432|FG001|Overall Study|Disease Progression|2|||
131658788|NCT01283516|474035433|FG002|Overall Study|Disease Progression|3|||
131658805|NCT01283516|474035432|FG001|Overall Study|Administrative problems|0|||
131658806|NCT01283516|474035433|FG002|Overall Study|Administrative problems|0|||
131658807|NCT01283516|474035434|FG003|Overall Study|Administrative problems|0|||
131658808|NCT01283516|474035435|FG004|Overall Study|Administrative problems|0|||
131658809|NCT01283516|474035436|FG005|Overall Study|Administrative problems|1|||
131658810|NCT01283516|474035437|FG006|Overall Study|Administrative problems|1|||
131658811|NCT01283516|474035438|FG007|Overall Study|Administrative problems|1|||
131658812|NCT01283516|474035439|FG008|Overall Study|Administrative problems|39|||
131658813|NCT01283516|474035431|FG000|Overall Study|Lost to Follow-up|0|||
131658814|NCT01283516|474035432|FG001|Overall Study|Lost to Follow-up|0|||
131658815|NCT01283516|474035433|FG002|Overall Study|Lost to Follow-up|0|||
131658816|NCT01283516|474035434|FG003|Overall Study|Lost to Follow-up|0|||
131658817|NCT01283516|474035435|FG004|Overall Study|Lost to Follow-up|0|||
131658818|NCT01283516|474035436|FG005|Overall Study|Lost to Follow-up|0|||
131658819|NCT01283516|474035437|FG006|Overall Study|Lost to Follow-up|0|||
131658820|NCT01283516|474035438|FG007|Overall Study|Lost to Follow-up|0|||
131658821|NCT01283516|474035439|FG008|Overall Study|Lost to Follow-up|1|||
131658822|NCT01276379|474035440|FG000|Overall Study|Screening failure|40|||
131658823|NCT02001064|474035443|FG000|Overall Study|Withdrawal by Subject|2|||
131658824|NCT02001064|474035444|FG001|Overall Study|Withdrawal by Subject|1|||
131658825|NCT02108964|474035447|FG000|Overall Study|Progressive disease|15|||
131658826|NCT02108964|474035448|FG001|Overall Study|Progressive disease|31|||
131658827|NCT02108964|474035449|FG002|Overall Study|Progressive disease|54|||
131658828|NCT02108964|474035450|FG003|Overall Study|Progressive disease|7|||
131658829|NCT02108964|474035451|FG004|Overall Study|Progressive disease|20|||
131658830|NCT02108964|474035452|FG005|Overall Study|Progressive disease|4|||
131658831|NCT02108964|474035453|FG006|Overall Study|Progressive disease|6|||
131658832|NCT02108964|474035454|FG007|Overall Study|Progressive disease|33|||
131658833|NCT02108964|474035447|FG000|Overall Study|Physician Decision|1|||
131658834|NCT02108964|474035448|FG001|Overall Study|Physician Decision|5|||
131658835|NCT02108964|474035449|FG002|Overall Study|Physician Decision|7|||
131658836|NCT02108964|474035450|FG003|Overall Study|Physician Decision|1|||
131658837|NCT02108964|474035451|FG004|Overall Study|Physician Decision|2|||
131658838|NCT02108964|474035452|FG005|Overall Study|Physician Decision|1|||
131658839|NCT02108964|474035453|FG006|Overall Study|Physician Decision|1|||
131658840|NCT02108964|474035454|FG007|Overall Study|Physician Decision|3|||
131658841|NCT02108964|474035447|FG000|Overall Study|Adverse Event|0|||
131658842|NCT02108964|474035448|FG001|Overall Study|Adverse Event|0|||
131658843|NCT02108964|474035449|FG002|Overall Study|Adverse Event|4|||
131658844|NCT02108964|474035450|FG003|Overall Study|Adverse Event|0|||
131658845|NCT02108964|474035451|FG004|Overall Study|Adverse Event|1|||
131658846|NCT02108964|474035452|FG005|Overall Study|Adverse Event|0|||
131658847|NCT02108964|474035453|FG006|Overall Study|Adverse Event|3|||
131658848|NCT02108964|474035454|FG007|Overall Study|Adverse Event|2|||
131658849|NCT02108964|474035447|FG000|Overall Study|Death|1|||
131658850|NCT02108964|474035448|FG001|Overall Study|Death|1|||
131658851|NCT02108964|474035449|FG002|Overall Study|Death|4|||
131658852|NCT02108964|474035450|FG003|Overall Study|Death|0|||
131658853|NCT02108964|474035451|FG004|Overall Study|Death|3|||
131658854|NCT02108964|474035452|FG005|Overall Study|Death|0|||
131658855|NCT02108964|474035453|FG006|Overall Study|Death|0|||
131658856|NCT02108964|474035454|FG007|Overall Study|Death|2|||
131658857|NCT02108964|474035447|FG000|Overall Study|Subject/Guardian decision|0|||
131658858|NCT02108964|474035448|FG001|Overall Study|Subject/Guardian decision|1|||
131658859|NCT02108964|474035449|FG002|Overall Study|Subject/Guardian decision|4|||
131658860|NCT02108964|474035450|FG003|Overall Study|Subject/Guardian decision|0|||
131658861|NCT02108964|474035451|FG004|Overall Study|Subject/Guardian decision|2|||
131658862|NCT02108964|474035452|FG005|Overall Study|Subject/Guardian decision|0|||
131658863|NCT02108964|474035453|FG006|Overall Study|Subject/Guardian decision|1|||
131658864|NCT02108964|474035454|FG007|Overall Study|Subject/Guardian decision|2|||
131658865|NCT02108964|474035447|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658866|NCT02108964|474035448|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658867|NCT02108964|474035449|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658868|NCT02108964|474035450|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658869|NCT02108964|474035451|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658870|NCT02108964|474035452|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658871|NCT02108964|474035453|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131658872|NCT02108964|474035454|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
131658873|NCT00384397|474035455|FG000|Overall Study|Adverse Event|0|||
131658874|NCT00384397|474035456|FG001|Overall Study|Adverse Event|1|||
131658875|NCT00384397|474035457|FG002|Overall Study|Adverse Event|2|||
131658876|NCT00384397|474035455|FG000|Overall Study|Protocol Violation|7|||
131658877|NCT00384397|474035456|FG001|Overall Study|Protocol Violation|15|||
131658878|NCT00384397|474035457|FG002|Overall Study|Protocol Violation|13|||
131658924|NCT01214642|474035461|FG003|Overall Study|Withdrawal by Subject|0|||
131658925|NCT01214642|474035462|FG004|Overall Study|Withdrawal by Subject|0|||
131658926|NCT01214642|474035463|FG005|Overall Study|Withdrawal by Subject|0|||
131658927|NCT01214642|474035464|FG006|Overall Study|Withdrawal by Subject|0|||
131658928|NCT01214642|474035465|FG007|Overall Study|Withdrawal by Subject|0|||
131658929|NCT01214642|474035466|FG008|Overall Study|Withdrawal by Subject|3|||
131658930|NCT01214642|474035467|FG009|Overall Study|Withdrawal by Subject|1|||
131658931|NCT01214642|474035468|FG010|Overall Study|Withdrawal by Subject|1|||
131658932|NCT01214642|474035469|FG011|Overall Study|Withdrawal by Subject|0|||
131658933|NCT01214642|474035458|FG000|Overall Study|Physician Decision|0|||
131658934|NCT01214642|474035459|FG001|Overall Study|Physician Decision|0|||
131658935|NCT01214642|474035460|FG002|Overall Study|Physician Decision|1|||
131658936|NCT01214642|474035461|FG003|Overall Study|Physician Decision|1|||
131658937|NCT01214642|474035462|FG004|Overall Study|Physician Decision|1|||
131658938|NCT01214642|474035463|FG005|Overall Study|Physician Decision|0|||
131658939|NCT01214642|474035464|FG006|Overall Study|Physician Decision|0|||
131658940|NCT01214642|474035465|FG007|Overall Study|Physician Decision|0|||
131658941|NCT01214642|474035466|FG008|Overall Study|Physician Decision|0|||
131658942|NCT01214642|474035467|FG009|Overall Study|Physician Decision|0|||
131658943|NCT01214642|474035468|FG010|Overall Study|Physician Decision|0|||
131658944|NCT01214642|474035469|FG011|Overall Study|Physician Decision|2|||
